<SEC-DOCUMENT>0001840706-26-000006.txt : 20260303
<SEC-HEADER>0001840706-26-000006.hdr.sgml : 20260303
<ACCEPTANCE-DATETIME>20260303064719
ACCESSION NUMBER:		0001840706-26-000006
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		178
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260303
DATE AS OF CHANGE:		20260303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SOPHiA GENETICS SA
		CENTRAL INDEX KEY:			0001840706
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
		ORGANIZATION NAME:           	06 Technology
		EIN:				000000000
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40627
		FILM NUMBER:		26710978

	BUSINESS ADDRESS:	
		STREET 1:		LA PIECE, CH-1180
		CITY:			ROLLE
		STATE:			V8
		ZIP:			00000
		BUSINESS PHONE:		41 21 694 10 60

	MAIL ADDRESS:	
		STREET 1:		LA PIECE, CH-1180
		CITY:			ROLLE
		STATE:			V8
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>soph-20251231.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c4318-4e70-7eba-b516-6c06258ef00a,g:b3ab9529-65b6-4117-b100-6d41f692b5c5,d:949f8e5b3f184d2fadfac47a64e0acc8-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full" xmlns:srt="http://fasb.org/srt/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:soph="http://www.sophiagenetics.com/20251231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>soph-20251231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-39">0001840706</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-40">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-41">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-42">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-171" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" id="f-909">P3Y</ix:nonNumeric><ix:nonFraction unitRef="unit" contextRef="c-1" decimals="INF" name="soph:NumberOfCashGeneratingUnit" scale="0" id="f-1115">1</ix:nonFraction><ix:nonNumeric contextRef="c-287" name="soph:LeaseTerm" id="f-1144">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="c-480" name="soph:BorrowingMaturityTerm" id="f-1877">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="c-480" name="soph:RedemptionPeriodOfWarrantRights" id="f-1878">P10Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="soph-20251231.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="chf"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:unit id="chfPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="unit"><xbrli:measure>soph:unit</xbrli:measure></xbrli:unit><xbrli:unit id="lease"><xbrli:measure>soph:lease</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="member"><xbrli:measure>soph:member</xbrli:measure></xbrli:unit><xbrli:unit id="plan"><xbrli:measure>soph:plan</xbrli:measure></xbrli:unit><xbrli:unit id="year"><xbrli:measure>soph:year</xbrli:measure></xbrli:unit><xbrli:unit id="instrument"><xbrli:measure>soph:instrument</xbrli:measure></xbrli:unit><xbrli:unit id="personnel"><xbrli:measure>soph:personnel</xbrli:measure></xbrli:unit><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerCHF"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="usdPerEUR"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="usdPerGBP"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:GBP</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="usdPerBRL"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>iso4217:BRL</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsSASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsIntermediacaoDeNegociosLTDAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsPtyLtdMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsSRLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SOPHiAGENETICSGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-08-01</xbrli:startDate><xbrli:endDate>2025-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:ES</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:ES</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:ES</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInEuropeMiddleEastAndAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInEuropeMiddleEastAndAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInEuropeMiddleEastAndAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:EuropeTheMiddleEastAndAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:EuropeTheMiddleEastAndAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:EuropeTheMiddleEastAndAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInNorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInNorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInNorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:SOPHiADDMPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:SOPHiADDMPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:SOPHiADDMPlatformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:WorkflowEquipmentAndServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:WorkflowEquipmentAndServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:WorkflowEquipmentAndServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">soph:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">soph:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:SellingAndMarketingExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:SellingAndMarketingExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:SellingAndMarketingExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:CostOfRevenue1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:CostOfRevenue1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:CostOfRevenue1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:DepreciationAndAmortizationRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:AccruedPensionRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:RightOfUseAssetsRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:LeaseLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:DepreciationAndAmortizationRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:AccruedPensionRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:RightOfUseAssetsRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:LeaseLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:DepreciationAndAmortizationRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:AccruedPensionRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:RightOfUseAssetsRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:LeaseLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:DepreciationAndAmortizationRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:AccruedPensionRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:RightOfUseAssetsRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:LeaseLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:DepreciationAndAmortizationRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:AccruedPensionRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:RightOfUseAssetsRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:LeaseLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:TemporaryDifferenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:TemporaryDifferenceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsSASMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:ContractAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:ContractAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-03</xbrli:startDate><xbrli:endDate>2021-03-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-25</xbrli:startDate><xbrli:endDate>2022-01-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BostonMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-27</xbrli:startDate><xbrli:endDate>2024-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BostonMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BostonMassachusettsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-09-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BidartFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BidartFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BidartFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BidartFranceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:ConsumerPriceIndicesInSwitzerlandAndFranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:ConsumerPriceIndicesInSwitzerlandAndFranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPensionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">soph:ActuarialAssumptionOfExpectedInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">soph:ActuarialAssumptionOfExpectedInterestRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-22</xbrli:startDate><xbrli:endDate>2021-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2022-01-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:SalesAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:SalesAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:SalesAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:BorrowingTermsAxis">soph:TermSecuredOvernightFinancingRateSOFRFloorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:BorrowingTermsAxis">soph:TermSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:BorrowingTermsAxis">soph:TermSecuredOvernightFinancingRateSOFRUponDefaultMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-25</xbrli:startDate><xbrli:endDate>2025-06-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-23</xbrli:startDate><xbrli:endDate>2026-01-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:BorrowingTermsAxis">soph:TermSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:BorrowingTermsAxis">soph:TermSecuredOvernightFinancingRateSOFRFloorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-23</xbrli:startDate><xbrli:endDate>2026-01-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-01-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-02</xbrli:startDate><xbrli:endDate>2024-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExercisePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExercisePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedVolatilityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedVolatilityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedTermMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedTermMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:DividendYieldMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:DividendYieldMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:BlackScholesPricingModelValueMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:BlackScholesPricingModelValueMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExercisePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExercisePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedVolatilityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedVolatilityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedTermMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedTermMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:DividendYieldMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:DividendYieldMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:BlackScholesPricingModelValueMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:BlackScholesPricingModelValueMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExercisePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:SharePriceMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedVolatilityMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedTermMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:DividendYieldMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:BlackScholesPricingModelValueMeasurementInputMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:CreditSuisseSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementExistingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-23</xbrli:startDate><xbrli:endDate>2024-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:CreditSuisseSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementNewMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-04-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:CreditSuisseSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementNewMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-11-27</xbrli:startDate><xbrli:endDate>2025-11-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:UBSSwitzerlandAGMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementNewMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2026-02-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:CreditSuisseSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementNewMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:CreditSuisseSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementNewMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-02</xbrli:startDate><xbrli:endDate>2024-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:CommencementOfMajorLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">soph:GuardantHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-484"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:CashAndCashEquivalentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-486"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-487"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:OtherFinancialNonCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-488"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:OtherFinancialNonCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-489"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-490"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-491"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-492"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-493"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:AccountsPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-494"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:AccountsPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-495"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-496"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-497"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-498"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-499"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-500"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-501"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:WarrantObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:WarrantObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">soph:GenesisHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-506"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">soph:GenesisHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-507"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">soph:GenesisHealthcareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-10-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-508"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-509"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-510"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-511"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-513"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-516"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-517"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-518"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-519"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-521"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-522"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-523"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-524"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-528"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-529"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:CashAndCashEquivalentsAndTermDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:CashAndCashEquivalentsAndTermDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2026-01-01</xbrli:startDate><xbrli:endDate>2026-03-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-532"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-533"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-534"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-535"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-537"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-538"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-539"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-541"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-542"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-543"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-544"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-545"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-546"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-547"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-548"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-549"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-550"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-551"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-553"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-554"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-556"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-558"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-559"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-560"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-561"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-562"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndEURMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-563"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndEURMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-564"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndEURMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-565"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndEURMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-566"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndGBPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-567"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndGBPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-568"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndGBPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-569"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndGBPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-570"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-571"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840706</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-296 f-297 f-299 f-300 f-302 f-303 f-305 f-306 f-308 f-309 f-311 f-312 f-314 f-315 f-317 f-318 f-320 f-321 f-323 f-324 f-326 f-327 f-329 f-330 f-332 f-333 f-335 f-336 f-338 f-339 f-341 f-342 f-344 f-345 f-347 f-348 f-350 f-351 f-353 f-354 f-356 f-357 f-359 f-360 f-362 f-363 f-365 f-366 f-368 f-369 f-371 f-372 f-374 f-375 f-377 f-378 f-380 f-381 f-383 f-384 f-386 f-387 f-389 f-390 f-392 f-393 f-395 f-396 f-398 f-399" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"/></ix:resources></ix:header></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">20-F</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.628%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentRegistrationStatement" format="ixt:fixed-false" id="f-2">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.628%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-3">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(For the fiscal year ended&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-4"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-5">December 31</ix:nonNumeric>, 2025</ix:nonNumeric>)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.628%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-6">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.072%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.628%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentShellCompanyReport" format="ixt:fixed-false" id="f-7">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Commission file number:&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-8">001-40627</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-9">SOPHiA GENETICS SA</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-10">Switzerland</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">(Jurisdiction of incorporation or organization)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-11">La Pi&#232;ce 12</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">CH-1180</ix:nonNumeric>&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-13">Rolle</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" format="ixt-sec:countrynameen" id="f-14">Switzerland</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">+41 21 694 10 60</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:ContactPersonnelName" id="f-15">George Cardoza</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">SOPHiA GENETICS, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine1" id="f-16">401 Park Drive</ix:nonNumeric> <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine2" id="f-17">Suite 505</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCityOrTown" id="f-18">Boston</ix:nonNumeric>,&#160;<ix:nonNumeric contextRef="c-2" name="dei:EntityAddressStateOrProvince" id="f-19">MA</ix:nonNumeric> <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressPostalZipCode" id="f-20">02215</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-2" name="dei:CityAreaCode" id="f-21">617</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-2" name="dei:LocalPhoneNumber" id="f-22">982-1210</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%">(Name, telephone, e-mail and/or facsimile number and address of company contact person)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Securities registered or to be registered, pursuant to Section&#160;12(b) of the Act.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Title of each class&#160;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Trading symbol(s)&#160;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%">Name of each exchange on which registered&#160;</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-23">Ordinary shares, par value CHF 0.05 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-24">SOPH</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">The&#160;<ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-25">Nasdaq</ix:nonNumeric>&#160;Stock Market LLC</span></div></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:2pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Securities registered or to be registered pursuant to Section&#160;12(g) of the Act: None</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Securities for which there is a reporting obligation pursuant to Section&#160;15(d) of the Act: None</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital stock or common stock as of the close of business covered by the annual report. Ordinary shares, nominal value CHF 0.05 per share: <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-26">68,486,338</ix:nonFraction></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Yes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-27">No</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Yes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-28">No</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-29">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;No</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-30">Yes</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;No</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Large accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-31">Accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%">x</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Emerging&#160;growth&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-32">x</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-33">o</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8224; The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April&#160;5, 2012.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section&#160;404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="f-34">o</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-true" id="f-35">x</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtRestatementRecoveryAnalysisFlag" format="ixt:fixed-false" id="f-36">o</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">U.S. GAAP&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAccountingStandard" id="f-37">International Financial Reporting Standards</ix:nonNumeric> &#160;as issued by the International Accounting Standards Board&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:100%">o</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:2pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If &#8220;Other&#8221; has been checked in response to the previous question indicate by check mark which financial statement item the registrant has elected to follow. Item 17&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Item 18&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">o</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;Yes&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-38">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#160;No</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.960%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.022%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_10">About This Annual Report</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_10">1</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_13">Cautionary Statement Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_13">2</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_16">Part I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_16">4</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_19">Item 3. Key Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_22">D. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_22">4</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_25">Item 4. Information on the Company</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_25">53</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_28">A. History and Development of the Company</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_28">53</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_31">B. Business Overview</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_31">53</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_34">C. Organizational Structure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_34">95</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_37">D. Property, Plants and Equipment</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_37">96</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_40">Item 4A. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_40">96</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_43">Item 5. Operating and Financial Review and Prospects</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_43">96</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_46">A. Operating Results</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_46">96</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_49">B. Liquidity and Capital Resources</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_49">111</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_52">C. Research and Development, Patents and Licenses</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_52">117</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_55">D. Trend Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_55">117</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_58">E. Critical Accounting Estimates</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_58">117</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_61">Item 6. Directors, Senior Management, and Employees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_61">120</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_64">A. Directors and Senior Management</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_64">120</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_67">B. Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_67">122</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_70">C. Board Practices</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_70">124</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_73">D. Employees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_73">128</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_76">E. Share Ownership</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_76">129</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_79">F. Disclosure of a Registrant's Actions to Recover Erroneously Awarded Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_76">129</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_82">Item 7. Major Shareholders and Related Party Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_82">129</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_85">A. Major Shareholders</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_85">129</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_88">B. Related Party Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_88">131</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_91">Item 8. Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_91">131</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_94">A. Consolidated Statements and Other Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_94">131</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_97">B. Significant Changes</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_97">132</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_100">Item 9. The Offer and Listing</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_100">132</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_103">A. Offer and Listing Details</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_103">132</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_106">C. Markets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_106">132</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_109">Item 10. Additional Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_109">132</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_112">B. Memorandum and Articles of Association</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_112">132</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_115">C. Material Contracts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_115">132</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_118">D. Exchange Controls</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_118">136</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_121">E. Taxation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_121">136</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_124">H. Documents on Display</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_124">144</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_127">J. Annual Report to Security Holders</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_127">144</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_130">Item 11. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_130">144</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_136">Part II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_136">147</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_139">Item 13. Defaults, Dividend Arrearages and Delinquencies.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_139">147</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_142">Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_142">147</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_145">Item 15. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_145">147</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_148">A. Disclosure Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_148">147</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_151">B. Management&#8217;s Annual Report on Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_151">147</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_154">C. Attestation Report of the Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_154">148</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_157">D. Changes in Internal Control Over Financial Reporting</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_157">148</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_160">Item 16A. Audit Committee Financial Expert</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_160">148</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_163">Item 16B. Code of Ethics</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_163">148</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_166">Item 16C. Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_166">148</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_169">Item 16D. Exemptions from the Listing Standards for Audit Committees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_169">149</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_172">Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_172">149</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_175">Item 16F. Change in Registrant&#8217;s Certifying Accountant</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_175">149</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_178">Item 16G. Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_178">150</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_181">Item 16H. Mine Safety Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_181">150</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_184">Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_184">150</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_187">Item 16J. Insider Trader Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_187">150</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_190">Item 16K. Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_190">150</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_193">Part III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_193">153</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_196">Item 17. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_196">153</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_199">Item 18. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_199">153</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_202">Item 19. Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_202">153</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_208">Index to Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_208">1</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ABOUT THIS ANNUAL REPORT</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated or the context otherwise requires, all references in this Annual Report to &#8220;SOPHiA GENETICS,&#8221; &#8220;SOPH,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221; &#8220;us&#8221; or similar terms refer to SOPHiA GENETICS SA and its consolidated subsidiaries.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademarks</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own various trademark registrations and applications, and unregistered trademarks, including for &#8220;SOPHiA GENETICS,&#8221; &#8220;SOPHiA DDM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; &#8220;Alamut,&#8221; &#8220;SOPHiA Trial Match,&#8221; &#8220;SOPHiA Insights,&#8221; &#8220;SOPHiA CDx,&#8221; &#8220;SOPHiA Awareness&#8221; and our corporate logo. All other trade names, trademarks and service marks of other companies appearing in this Annual Report are the property of their respective owners. Solely for convenience, the trademarks and trade names in this Annual Report may be referred to without the&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;and&#160;&#8482;&#160;symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend to use or display other companies&#8217; trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of Financial Information</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with IFRS Accounting Standards as issued by the International Accounting Standards Board (&#8220;IASB&#8221;). None of the consolidated financial statements were prepared in accordance with generally accepted accounting principles in the United States (&#8220;U.S. GAAP&#8221;). The terms &#8220;dollar,&#8221; &#8220;USD&#8221; and &#8220;$&#8221; refer to U.S. dollars and the terms &#8220;Swiss franc&#8221; and &#8220;CHF&#8221; refer to the legal currency of Switzerland, unless otherwise indicated. We have made rounding adjustments to some of the figures included in this Annual Report. Accordingly, any numerical discrepancies in any table between totals and sums of the amounts listed are due to rounding.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on December 31. References in this Annual Report to a fiscal year relate to our fiscal year ended on December 31 of that calendar year.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market and Industry Data</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report contains industry, market and competitive position data that are based on general and industry publications, surveys and studies conducted by third parties, some of which may not be publicly available, and our own internal estimates and research. Third-party publications, surveys and studies generally state that they have obtained information from sources believed to be reliable, but do not guarantee the accuracy and completeness of such information. While we are not aware of any misstatements regarding the industry, market and competitive position data presented herein, these data involve a number of assumptions and limitations and contain projections and estimates of the future performance of the industries in which we operate that are subject to a high degree of uncertainty.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this Annual Report, including statements regarding our future results of operations and financial position, market opportunity, business strategy, technology, collaborations and partnerships, as well as plans and objectives of management for future operations are forward-looking statements. Many of the forward-looking statements contained in this Annual Report can be identified by the use of forward-looking words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;should,&#8221; &#8220;plan,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;will&#8221; and &#8220;potential,&#8221; among others.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements appear in a number of places in this Annual Report and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward-looking statements are based on our management&#8217;s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to, those identified in the section titled &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8221; in this Annual Report. These forward-looking statements include, among others:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our expectations regarding our revenue, gross margin, expenses, other operating results, and cash usage;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our plans regarding further development of our SOPHiA DDM Platform and its expansion into additional features, applications and data modalities;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">future investments in our business, our anticipated capital expenditures and our estimates regarding our capital requirements, future revenues, expenses, reimbursement rates and needs for additional financing;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our expectations regarding the market size for our platform, applications, products, and services and the market acceptance they will be able to achieve;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our expectations regarding changes in the healthcare systems in different jurisdictions, in particular with respect to the manner in which electronic health records are collected, distributed and accessed by various stakeholders;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the timing or outcome of any domestic and international regulatory submissions;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">impact from future regulatory, judicial, and legislative changes or developments in the United States and foreign countries;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to acquire new customers and successfully engage and retain customers;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the costs and success of our marketing efforts, and our ability to promote our brand;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to increase demand for our applications, products, and services, obtain favorable coverage and reimbursement determinations from third-party payors and expand geographically;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our expectations of the reliability, accuracy and performance of our applications, products, and services, as well as expectations of the benefits to patients, medical personnel and providers of our applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our expectations regarding our ability, and that of our manufacturers, to manufacture our products;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our efforts to successfully develop and commercialize our applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our competitive position and the development of and projections relating to our competitors or our industry;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to identify and successfully enter into strategic collaborations in the future, and our assumptions regarding any potential revenue that we may generate thereunder;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to obtain, maintain, protect and enforce intellectual property protection for our technology, applications, products, and services, and the scope of such protection;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to operate our business without infringing, misappropriating or otherwise violating the intellectual property or proprietary rights of third parties;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to attract and retain qualified key management and technical personnel; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our expectations regarding the time during which we will be a foreign private issuer.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements speak only as of the date of this Annual Report and are subject to a number of risks, uncertainties and assumptions described in the sections in this Annual Report titled &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8221; and &#8220;Item 5. Operating and Financial Review and Prospects&#8221; and elsewhere in this Annual Report. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Annual Report, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_19"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Key Information</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_22"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D. Risk Factors</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business faces significant risks and uncertainties. You should carefully consider all of the information set forth in this Annual Report and in other documents we file with or furnish to the SEC, including the following risk factors, before deciding to invest in or to maintain an investment in our securities. If any of the events or developments described below were to occur, our business, results of operations, financial condition and prospects could suffer materially and the trading price of our ordinary shares could decline. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">We may not be successful in expanding features, applications and data modalities of our SOPHiA DDM Platform and related solutions, applications, products, and services.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">We may experience challenges with the acquisition, development, enhancement and deployment of technology necessary for our data analytics platform technologies.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">If we are unable to expand our sales and marketing capabilities, including through additional strategic relationships, in a cost-effective manner, we may not be able to grow our revenue.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The coverage and reimbursement status of newly developed applications and products, such as data analytics platforms and related solutions, applications, products, and services, particularly in a new category of diagnostics and therapeutics, is uncertain. An inability to obtain or maintain adequate coverage and reimbursement could limit the commercial potential of our SOPHiA DDM Platform and related solutions, applications, products, and services.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">If we cannot maintain our current relationships and enter into new relationships with hospitals, reference and specialty laboratories and biopharmaceutical companies, our revenue prospects could be reduced.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">We are highly dependent on our senior management team and other qualified personnel, and our business could be harmed if we are unable to retain and attract such personnel.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Our industry is subject to rapid change, which could make our SOPHiA DDM Platform and related solutions, applications, products, and services obsolete. If we are unable to continue to innovate and improve our SOPHiA DDM Platform and related solutions, applications, products, and services, we could fail to attract new customers and expand our market share and we could lose existing customers and market share.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">We face competition from many sources, some of whom have much greater financial resources, and we may be unable to compete successfully.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Cybersecurity or data privacy breaches, other unauthorized or improper access, or (distributed) denial service lack of access (e.g., ransomware, persistent DoS/DDoS) could result in additional costs, loss of revenue, significant liabilities, harm to our brand and decreased use of our SOPHiA DDM Platform and related solutions, applications, products, or services.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">If we are not able to obtain, maintain, defend and enforce patent and other intellectual property protection or if the scope of such patent and other intellectual property protection is not sufficiently broad, our competitors could develop and commercialize applications, products, services and technology similar or identical to ours.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">We license patent rights from third-party owners. If such owners do not properly or successfully obtain, maintain, defend and enforce the patents underlying such licenses, or if they retain or license to others any competing rights, our competitive position and business prospects may be adversely affected. If we fail to comply with our obligations in the agreements under which we license intellectual property rights from third parties or otherwise experience disruptions to our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">relationships with any of our licensors, we could lose license rights that are important to our business. </span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">We are, and we may in the future be, subject to claims against us alleging that we are infringing, misappropriating or otherwise violating the intellectual property rights of third parties, the outcome of which would be uncertain and could have a material adverse effect on our business, and which could result in substantial defense costs, settlement payment, and diversion of management attention, even if claims lack merit.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">We have incurred net losses since our inception and expect to continue to incur losses for the foreseeable future. We may never achieve or sustain profitability.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Development of Our SOPHiA DDM Platform and Related Solutions, Applications, Products, and Services</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in expanding features, applications and data modalities of our SOPHiA DDM Platform and related solutions, applications, products, and services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SOPHiA DDM Platform offers a broad range of genomics applications across oncology, rare diseases, infectious diseases, cardiology, neurology, metabolism and other disease areas. A major part of our long-term strategy is bringing new high-impact content to our customers through updates to our platform, which may include expanding our platform with additional features, applications and data modalities and related solutions, applications, products, and services. However, enhancing our platform and developing new related solutions, applications, products, and services poses various risks and challenges, including the inability to develop features, applications, data modalities and services that achieve the desired results, analytical accuracy and utility; the need to alter our platform, solutions, applications, products, or services; the time and resources required for platform, solution, application, service, and product development; uncertainty regarding and potential limitation in the scope of new features, solutions, applications, data modalities, products, or services; and the potential need to obtain U.S. Food and Drug Administration (the &#8220;FDA&#8221;), European Medicines Agency (the &#8220;EMA&#8221;), United Kingdom (the &#8220;U.K.&#8221;) Medicines and Healthcare products Regulatory Agency (the &#8220;MHRA&#8221;) and other regulatory clearances, authorizations or approvals. Even if we successfully develop a feature, application, data modality, solution, service or product and receive any necessary regulatory clearance, authorization or approval, such feature, application, data modality, solution, service or product may never achieve significant market acceptance among various stakeholders and be commercially successful. The expenses or losses associated with unsuccessful platform innovation or expansion could adversely affect our business revenue growth and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This risk may be heightened as we generally sell our platform, solutions, applications, products, and services in industries that are characterized by rapid technological changes, frequent new application and product introductions and changing industry standards. Operating in and servicing such industries require us to develop platform enhancements based on technological innovation on a timely basis. In addition, whereas we purposefully built our SOPHiA DDM Platform in a decentralized manner and strategically positioned it as a &#8220;universal operating-system&#8221; for multimodal data analytics in order to provide for a broad range of application, product, and service expansion opportunities, European initiatives such as the European Health Data Space (&#8220;EHDS&#8221;) may introduce more centralized or coordinated services architectures for electronic health records (&#8220;EHRs&#8221;), including standardized access layers, national contact points or government-designated data access services, rather than allowing data to be shared directly between healthcare providers. The widespread implementation of these and any other centralized systems may limit the adoption and development of our platform. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strong platform, application, product, and service performance, security and reliability are necessary to maintain and grow our business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We need to maintain and continuously improve the performance, security and reliability of our SOPHiA DDM Platform and related solutions, applications, products, and services. Our platform, solutions, applications, and other products may contain errors or defects, and while we have made efforts to test them and are not aware of any widespread material errors, defects or other performance-related issues, there can be no assurance that our platform, solutions, applications, products, and services do not or will not have performance problems. As we continue to launch more platform features, applications, data modalities, solutions, products, and services, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">these risks may increase. Poor performance, security and reliability could adversely impact our customers and lead to customer dissatisfaction, adversely affect our reputation and revenues and increase our application, service, and product care, and distribution costs and working capital requirements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience challenges with the acquisition, development, enhancement and deployment of technology necessary for our data analytics platform technologies.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business requires sophisticated computer systems and software in order to accurately and efficiently capture, service and process increasing volumes of health data, in particular a growing number of genomic profiles generated by our customers through various NGS test kits, sequencers and sample materials from different manufacturers. Some of the technologies are changing rapidly and we must continue to adapt to these changes in a timely and effective manner at an acceptable cost. There can be no assurance that we will be able to develop, acquire, enhance, deploy or integrate new technologies, including technologies needed to integrate new genomics test kits into our data analytics platform, that these new technologies will be effective and efficient, will meet our needs or achieve our expected goals or that we will be able to do so as quickly or cost-effectively as our competitors. Significant technological change could render our data analytics platform and technologies obsolete and incompatible with new or improved genomics test kits. In addition, we may face challenges in expanding into markets without suitable cloud infrastructure compatible with our SOPHiA DDM Platform. Our continued success will depend on our ability to adapt to changing technologies, manage and process ever-increasing amounts of data and information and improve the performance features of our data analytics platform technologies in response to an ever-changing patient population. We may experience difficulties that could delay or prevent the successful design, development, testing and introduction of new versions of our data analytics platform technologies, limiting our ability to identify new solutions, applications, products, and services. Any of these challenges could have a material adverse effect on our operating results and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any failure to offer high-quality support for our applications, products, and services may adversely affect our relationships with customers and collaborators and negatively impact our reputation and our business, financial condition and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In implementing and using our SOPHiA DDM Platform and related solutions, applications, products, and services, our customers and collaborators depend on our support to resolve issues in a timely manner. We may be unable to respond quickly enough to accommodate short-term increases in demand for customer support. Increased customer demand for support could increase costs and adversely affect our financial condition and results of operations. In addition, we need highly trained technical support personnel. Hiring technical support personnel is very competitive in our industry due to the limited number of people available with the necessary scientific and technical backgrounds and ability to understand our technology at a technical level. Our sales are highly dependent on our reputation and on positive recommendations from our customers, users, care collaborators, providers, laboratories, hospitals and clinics. If we do not maintain high-quality customer support, or if the market perceives that we do not maintain high-quality customer support, our reputation and our business, financial condition and results of operations could be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delays in the commencement and successful completion of multimodal clinical studies, and negative or ambiguous data generated from such studies, could increase costs and delay or prevent regulatory approval of our SOPHiA DDM Platform and related solutions, applications, and products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To further improve our SOPHiA DDM Platform and its capabilities, for example by developing new predictive algorithmic models that we can deploy on our platform, we are sponsoring and intend to continue to sponsor observational multimodal clinical studies in various disease areas. These clinical studies are subject to numerous risks. Events that may prevent successful or timely commencement and completion of multimodal clinical studies include:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">delays in receiving the required regulatory clearance from the appropriate regulatory authorities to commence the studies, delays in reaching an agreement on acceptable terms with prospective contract research organizations (&#8220;CROs&#8221;) and participating sites and difficulties in obtaining required Institutional Review Board (&#8220;IRB&#8221;) or ethics committee approval at each participating site;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">challenges in recruiting and enrolling suitable patients that meet the study criteria to participate in the studies, which challenges may be heightened for any clinical study that seeks to enroll patients with characteristics that are found in a small population;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our CROs or participating sites failing to comply with regulatory requirements or meet their contractual obligations to us, which risk may be heightened by our reliance on third parties; </span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">lower than anticipated patient retention rates and difficulties in maintaining contact with patients, resulting in incomplete data;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">changes in regulatory requirements and guidance;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">lack of adequate funding to continue the study; or</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">delays and disruptions as a result of unforeseen external events.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, there can be no assurance that any multimodal clinical study will produce the data necessary to support further development of our platform in a particular disease area or to support any potential regulatory submission. Even if a study is completed, the data generated may be negative, ambiguous or otherwise insufficient. To obtain sufficient data, we may be required to conduct additional studies beyond those that we currently plan for, which would increase our costs and delay potential regulatory submissions and commercialization activities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not have the support of key opinion leaders or clinical data using our applications and products is not published in peer-reviewed journals, it may be difficult to drive adoption of our applications and products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established relationships with leading thought leaders. If these key opinion leaders determine that our SOPHiA DDM Platform and related solutions, applications, products, and services are not accurate or that alternative technologies, applications, products, and services are more accurate or more cost-effective, or if we fail to establish new relationships with key opinion leaders in different markets, geographies and among various stakeholders, we may see lower demand for our SOPHiA DDM Platform and related solutions, applications, products, and services, which would limit our revenue growth and our ability to achieve profitability.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The publication of clinical data using our applications and products in peer-reviewed journals is also crucial to our success. We are unable to control when, if ever, results of current or future trials and projects are published, which may delay or limit adoption of our SOPHiA DDM Platform and related solutions, applications, products, and services. Such peer-reviewed publications may be limited by many factors, including delays in the completion of, poor design of, or lack of compelling data from, clinical studies, as well as delays in the review, acceptance and publication process. If our SOPHiA DDM Platform and related solutions, applications, products, and services do not receive sufficient favorable exposure in peer-reviewed publications, the rate of adoption of our SOPHiA DDM Platform and related solutions, applications, products, and services among medical personnel and positive reimbursement coverage determinations for them could be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Commercialization</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to expand our sales and marketing capabilities, including through additional strategic relationships, in a cost-effective manner, we may not be able to grow our revenue.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future sales will depend in large part on our ability to develop, train and retain our sales force, to increase the scope of our marketing efforts, including into markets and geographies where our presence is currently limited, and to maintain our current strategic relationships and enter into new strategic relationships. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuously expanding our sales and marketing infrastructure. Retaining and training qualified sales and marketing personnel requires significant time, expense and attention. Competition for such personnel is intense. It often takes several months or more before a sales representative is fully trained and productive, depending on the target market or geography. Our sales force may subject us to higher fixed costs than those incurred by our competitors that utilize independent third parties, which could place us at a competitive disadvantage. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we currently have multiple strategic relationships with third-party providers of solutions, applications, products, and services that can be bundled with our SOPHiA DDM Platform and offer our SOPHiA DDM Platform and related solutions, applications, products, and services through various global and local distributors. There is no guarantee that we will be successful in maintaining our existing arrangements or entering into new arrangements on favorable terms. Most of our distribution relationships are non-exclusive and permit such distributors to distribute competing applications and products. As such, our distributors may not commit the necessary resources to market our applications and products to the level of our expectations or may choose to favor marketing the applications and products of our competitors. If current or future distributors do not perform adequately or we are unable to enter into effective arrangements with distributors in particular geographies, we may not achieve revenue growth and realize our expansion strategy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing activities in the healthcare space are subject to various rules and regulations. In addition, our marketing messaging can be complex and nuanced, and there may be errors or misunderstandings in our sales force&#8217;s communication of such messaging. As we continue to grow our sales and marketing efforts, we face an increased need to continuously monitor and improve our policies, processes and procedures to maintain compliance with a growing number and variety of laws and regulations. To the extent that there is any violation, whether actual, perceived or alleged, of our policies or applicable laws and regulations, we could incur additional training and compliance costs, receive inquiries from third parties or be held liable or otherwise responsible for such acts of noncompliance. Any of the foregoing could adversely affect our business, reputation and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The commercial success of our SOPHiA DDM Platform and current and future applications, products, and services depend on attaining significant market acceptance.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends, in part, on market acceptance of our SOPHiA DDM Platform and our applications, products, and services. We cannot predict how quickly, if at all, our SOPHiA DDM Platform and related solutions, applications, products, and services will attain significant market acceptance or, if accepted, how frequently they will be used. These constituents must believe that our SOPHiA DDM Platform and related solutions, applications, products, and services offer benefits over other available alternatives. The degree of market acceptance of our SOPHiA DDM Platform and related solutions, applications, products, and services depends on a number of factors, including:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">whether there is adequate utilization of our SOPHiA DDM Platform and related solutions, applications, products, and services based on their potential and perceived advantages over those of our competitors;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the safety, accuracy and ease of use of our SOPHiA DDM Platform and related solutions, applications, products, and services relative to those currently on the market;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to develop, commercialize and obtain regulatory clearance or approval for </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic (&#8220;IVD&#8221;) applications and products for diagnostic use and our compliance with the FDA&#8217;s &#8220;Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only&#8221; (the &#8220;RUO Guidance&#8221;) and other laws and regulations governing Research Use Only (&#8220;RUO&#8221;) and IVD applications and products in the United States (&#8220;U.S.&#8221;), and other geographies;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to be compliant with the phased introduction of the European Union (EU) IVD Regulation 2017/746 including new product submissions;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the clinical flexibility, operational versatility and technology agnostic nature of our SOPHiA DDM Platform and related solutions, applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the prices at which we and our distributors offer our SOPHiA DDM Platform and related solutions, applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the effectiveness of our sales and marketing efforts;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to provide incremental data that show the clinical benefits and cost-effectiveness, and operational benefits, of our SOPHiA DDM Platform and related solutions, applications, products, and services;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to build and maintain robust data sets with respect to patient populations, both in geographic regions that we have historically served and in geographic regions that we may seek to enter or further penetrate in the future;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the coverage and reimbursement acceptance of our applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">pricing pressure, including from group purchasing organizations (&#8220;GPOs&#8221;), seeking to obtain discounts on our SOPHiA DDM Platform and related solutions, applications, products, and services based on the collective bargaining power of the GPO members;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">negative publicity regarding our or our competitors&#8217; platforms, applications, products, and services; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the accuracy of our SOPHiA DDM Platform and related solutions, applications, products, and services relative to those of our competitors.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, even if our SOPHiA DDM Platform and related solutions, applications, products, and services achieve widespread market acceptance, they may not maintain that market acceptance over time if more cost-effective or more favorably received platforms, applications, products, services or technologies are introduced. Failure to achieve or maintain market acceptance and/or market share would limit our ability to generate revenue.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that we will be able to further penetrate our existing markets, that our existing markets will be able to sustain our current and future solutions, applications, products, and services offerings and that we will be able to expand into new markets. Any failure to increase penetration in our existing markets or expand into new ones would adversely affect our revenues and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market opportunities for our SOPHiA DDM Platform and related solutions, applications, products, and services may be smaller than we estimate.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates of the addressable market for our SOPHiA DDM Platform and related solutions, applications, products, and services are derived from a variety of sources, including scientific literature, surveys of clinicians, medical personnel and healthcare professionals and other forms of market research. These estimates may be inaccurate or based on imprecise data. Further, these estimates are based on various assumptions, including the outcomes of clinical studies, and whether the clinical studies will achieve objectives needed to meet clinical and payor expectations, the number of people who have a particular disease or condition, our expansion into other features, applications and data modality opportunities and disease areas, maintenance and expansion of our clinical and multimodal data sets for patient populations in specific geographic regions, the prices at which we and our distributors provide or sell our SOPHiA DDM Platform and related solutions, applications, products, and services in the market, the regulatory framework governing the development, sale and use of our SOPHiA DDM Platform and related solutions, applications, products, and services, including the laws and regulations governing RUO and IVD applications and products, the degree of coverage and reimbursement, the cost-containment efforts by payors, customers and collaborators as well as obtaining necessary clearance or regulatory approvals. While we believe our assumptions and estimates are reasonable, these assumptions and estimates may prove to be incorrect and the conditions supporting our assumptions or estimates may change at any time. If the addressable market for our SOPHiA DDM Platform and related solutions, applications, products, and services is smaller than our estimates, or if the prices at which we can sell our SOPHiA DDM Platform and related solutions, applications, products, and services are lower than our estimates, our business, financial condition, and results of operations could be negatively impacted.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The coverage and reimbursement status of newly developed applications and products, such as data analytics platforms and related solutions, applications, products, and services, particularly in a new category of diagnostics and therapeutics, is uncertain. An inability to obtain or maintain adequate coverage and reimbursement could limit the commercial potential of our SOPHiA DDM Platform and related solutions, applications, products, and services.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability and extent of reimbursement by governmental and private payors is essential for most patients to be able to afford our current and future platforms, solutions, applications, products, and services, if approved for IVD use. In addition, because our SOPHiA DDM Platform and related solutions, applications, products, and services represent new approaches to the research, diagnosis, detection and treatment of diseases, we cannot </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accurately estimate how they would be priced, whether reimbursement could be obtained or any potential revenue generated. Sales of our SOPHiA DDM Platform and related solutions, applications, products, and services, if approved for IVD use, may depend substantially on the extent to which they are covered by health maintenance, managed care and similar healthcare management organizations, or reimbursed by government health administration authorities, private health coverage insurers and other third-party payors. If reimbursement is not available, or is available only to limited levels, we may not be able to successfully commercialize our SOPHiA DDM Platform and related solutions, applications, products, and services. Even if coverage is provided, the available reimbursement amount may not be high enough to allow us to establish or maintain pricing sufficient to realize an adequate return on our research and development and sales and marketing costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Coverage and reimbursement are ever changing, and we are not in control of how our competitors&#8217; coverage and pricing strategies are established. Some of our competitors have widespread brand recognition and substantially greater financial and technical resources and development, production and marketing capabilities than we do. Others may develop lower-priced, less complex tests that payors and healthcare professionals could view as functionally equivalent to our applications and products, which could force us to lower the list price of our tests and impact our operating margins and our ability to achieve and maintain profitability. Payors may compare our applications and products to our competitors and utilize them as precedents, which may impact our coverage and reimbursement. In addition, technological innovations that result in the creation of enhanced diagnostic tools that are more effective than ours may enable other clinical laboratories, hospitals, medical personnel or medical providers to provide specialized diagnostic tests similar to ours in a more patient-friendly, efficient or cost-effective manner than is currently possible.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost-containment efforts of our customers and third-party payors could have a material adverse effect on our sales and profitability.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increasing efforts by governmental and third-party payors to cap or reduce healthcare costs may cause such organizations to limit both coverage and level of reimbursement for newly cleared, authorized or approved devices and medicines and, as a result, they may not cover or provide adequate payment for our platform and related solutions, applications, products, and services. Such efforts include legislation and regulations designed to control pharmaceutical and biological pricing and hospitals&#8217; participation in group purchasing organizations (&#8220;GPOs&#8221;) and Integrated Delivery Networks (the &#8220;IDNs&#8221;) that negotiate pricing arrangements with medical device companies and distributors. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that a significant portion of our revenue will be derived from sales to customers for research and development applications. The demand for our SOPHiA DDM Platform and related solutions, applications, products, and services will depend in part upon the research and development budgets of these customers, which are impacted by factors beyond our control. In addition, academic, governmental and other research institutions that fund research and development activities may be subject to stringent budgetary constraints that could results in spending reductions, reduced allocations or budget cutbacks, which could jeopardize the ability of these customers to purchase our applications and products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business Strategy</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our results of operations will be materially harmed if we are unable to accurately forecast customer demand for, and utilization of, our SOPHiA DDM Platform and related solutions, applications, products, and services and manage our inventory.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To ensure adequate inventory supply, we must forecast inventory needs and assemble products related to our SOPHiA DDM Platform and services based on our estimates of future demand. Our ability to accurately forecast demand could be negatively affected by various factors, including our failure to accurately manage our expansion strategy, application and product introductions by competitors, change in customer demand, changes in customer acceptance, changes in general market conditions or regulatory matters and weakening of economic conditions or consumer confidence in future economic conditions. Inventory levels in excess of customer demand may result in inventory write-downs or write-offs, which would adversely affect our gross margin and impair the strength of our brand. Conversely, if we underestimate customer demand for our SOPHiA DDM Platform and related solutions, applications, products, and services, our supply chain, manufacturing collaborators and/or internal manufacturing team may not be able to deliver components to meet our requirements, which could damage our reputation, sales growth, and customer relationships. In addition, if we experience a significant increase in demand, additional supplies of raw materials or additional manufacturing </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">capacity may not be available when required on terms that are acceptable to us, if at all, or suppliers may not be able to allocate sufficient capacity in order to meet our increased requirements, which could adversely affect our business, reputation, and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have in the past and may in the future acquire other businesses, which could require significant management attention, disrupt our business, dilute shareholder value and adversely affect our results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our business strategy, we have in the past and may in the future acquire complementary companies, platforms, applications, products, or technologies that we believe fit within our business model and can address the needs of our current and potential customers. There can be no assurance that we can acquire or successfully integrate such companies, platforms, applications, products, or technologies into our business, in particular that we can successfully integrate any acquired technology into our SOPHiA DDM Platform. We may not be able to find suitable acquisition candidates, and we may not be able to complete such acquisitions on acceptable terms, if at all. In addition, the pursuit of potential acquisitions may divert the attention of management and cause us to incur additional expenses in identifying, investigating and pursuing suitable acquisitions, whether or not they are consummated. If we do complete acquisitions, we may not ultimately strengthen our competitive position or achieve our strategic goals and any acquisitions we complete could be viewed negatively by our customers, investors and industry analysts. We may not be aware of all of the risks associated with the acquired business. In addition, an acquisition may result in unforeseen operating difficulties and expenditures, such as:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">difficulties integrating businesses, services, personnel, operations and financial and other controls and systems and retaining key employees;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">assumption of unknown liabilities, known contingent liabilities, that become realized or known liabilities that prove greater than anticipated;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">difficulties retaining the customers or employees of any acquired business;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">incurrences of debt, contingent liabilities or future write-offs of intangible assets or goodwill;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">entry into a new market or business line in which we have no prior experience and in which we may not successfully compete;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">integration of an acquired company, which may disrupt ongoing operations and require management resources that would otherwise be used in developing our existing business; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">divergent interests from those of our collaborators.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquisitions involve unique risks in addition to those mentioned above, including those related to integration of operations across different cultures and languages, currency risks, and the particular economic, political and regulatory risks associated with specific countries.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any such acquisitions may reduce cash available for operations and other uses and could result in amortization expense related to identifiable assets acquired. We may have to pay cash, incur debt or issue equity securities to pay for any such acquisition, each of which could adversely affect our financial condition and the value of our ordinary shares. The sale or issuance of equity securities to finance any such acquisitions would result in dilution to our current shareholders. The incurrence of indebtedness to finance any such acquisition would result in fixed obligations and could also include restrictive covenants that impede our ability to manage our operations. In addition, our results of operations may be adversely affected by the dilutive effect of an acquisition, performance earn-outs or contingent bonuses, and restructuring costs associated with an acquisition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Relationships with Third Parties</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we cannot maintain our current relationships and enter into new relationships with hospitals, reference and specialty laboratories and biopharmaceutical companies, our revenue prospects could be reduced.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collaborate with various constituents in the healthcare ecosystem, such as hospitals, reference and specialty laboratories, and biopharmaceutical companies to analyze patient samples for multiple applications; strategic partners with whom we combine our SOPHiA DDM Platform with their offerings and with whom we jointly develop application, product, and service offerings; and manufacturers, suppliers and distributors of our products and offerings. See &#8220;Item 10. Additional Information&#8212;Material Contracts.&#8221; There can be no assurance that these collaborations will be successful or provide benefits to us as we expect. The revenue attributable to such relationships may fluctuate from period to period, which could adversely affect our financial condition and results of operations. In addition, the termination of these relationships could result in a temporary or permanent loss of revenue and could negatively impact our reputation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends in part on our ability to maintain these relationships and to establish new relationships, including with additional partners and collaborators and with governmental and third-party payors and patients. Many factors have the potential to impact such relationships, including our customers&#8217; and collaborators&#8217; satisfaction with our SOPHiA DDM Platform and related solutions, applications, products, and services, their perceptions of our SOPHiA DDM Platform, which may be impacted by decisions of our other collaborators, and our ability to respond to the evolving needs of our customers. Furthermore, our customers may decide to decrease or discontinue their use of our SOPHiA DDM Platform and related solutions, applications, products, and services due to changes in clinical routine, research and development plans, financial constraints or utilization of internal testing resources or tests. In addition, our collaborators may decide to discontinue providing services or manufacturing products, for instance testing kits, complementary to or compatible with our SOPHiA DDM Platform and related solutions, applications, products, and services, in particular, applications and products offered as part of &#8220;bundle&#8221; solutions together with our SOPHiA DDM Platform. Furthermore, our collaborators with whom we entered into both manufacturing and distribution agreements may be dis-incentivized from adequately performing their obligations under the applicable distribution agreement if we substantially decrease the quantities of products purchased from them under the manufacturing agreement or terminate the manufacturing agreement. In addition to reducing our revenue, the loss of one or more of these relationships may reduce our exposure to clinical routine and research that facilitate the collection and incorporation of new data, including new genomic profiles, into our SOPHiA DDM Platform.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We engage in conversations with potential collaborators regarding commercial opportunities on an ongoing basis. There can be no assurance that any of these conversations will result in a commercial agreement, or if an agreement is reached, that the resulting relationship will be successful or that clinical or research studies conducted as part of the engagement will produce successful outcomes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results depend on the performance of third-party distributors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A portion of our sales is made through independent global and regional distributors that are not fully under our control. We rely on distributors to grow and develop our customer base and anticipate customer needs, and any lack of such actions by our distributors may adversely affect our results of operations. If the business relationship with such distributor is terminated, whether through industry consolidation or otherwise, and we are unable to find a suitable replacement, our operations and operating results could be materially adversely affected. While in such instances we would revert to using internal resources to service the market in the impacted geography, the hiring process and building a support infrastructure for a given market, can be time consuming and there could be customer attrition in the interim period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These independent distributors also generally represent applications and products offered by several companies and are not subject to any minimum sales requirements or obligation to market our applications and products to their customers. In turn, distributors could reduce their sales efforts for our applications and products or choose to terminate their representation of us. They may also fail to perform their obligations under the agreements with us, including, but not limited to, their obligations to ensure that end users of our SOPHiA DDM Platform are aware that informed consent is required from patients prior to obtaining access to our SOPHiA DDM Platform.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third-party service providers to host and deliver our SOPHiA DDM Platform and related services, and any interruptions or delays in these services could harm our business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently serve our customers from third-party data center hosting facilities located in the United States, Canada, Brazil, Switzerland, France, Netherlands, United Arab Emirates and Australia. Our operations depend, in part, on our third-party facility providers&#8217; ability to protect these facilities against damage or interruption from natural disasters, power or telecommunications failures, criminal acts, and similar events. In the event that our data center arrangements are terminated, or if there are any lapses of service or damage to a center, we could experience lengthy interruptions in providing our SOPHiA DDM Platform and related solutions, applications, products, and services as well as delays and additional expenses in making new arrangements.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we currently use Microsoft Corporation (&#8220;Microsoft&#8221;) and Microsoft Azure Services for a substantial portion of our computing, storage, data processing, networking and other services. Our platform can also be deployed onto other platforms, including Amazon Web Services (&#8220;AWS&#8221;) or Google Cloud Platform (&#8220;Google Cloud&#8221;). Any significant disruption of, or interference with, our use of Microsoft Azure Services, AWS, Google Cloud or other similar cloud platforms, could affect the use of, and our customers&#8217; satisfaction with, our applications, products, and services and could harm our business, results of operations and reputation. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cloud providers have broad discretion to change and interpret the terms of service and other policies with respect to us, and those actions may be unfavorable to our business operations. Cloud providers may also take actions beyond our control that could seriously harm our business, including discontinuing or limiting our access to one or more services, increasing pricing terms, terminating or seeking to terminate our contractual relationship altogether or altering how we are able to process data in a way that is unfavorable or costly to us. If our arrangements with cloud providers were terminated, we could experience interruptions on our platform and in our ability to make our content available to users, as well as delays and additional expenses in arranging for alternative cloud infrastructure services. Any transition to new cloud providers would be difficult to implement and would cause us to incur significant delays and expense.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third-party manufacturers for the supply, manufacture and production of our products. Our reliance on these third parties may impair the advancement and commercialization of our products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely, and expect that we will continue to rely, on third parties for the manufacturing and supply of our products offered with our SOPHiA DDM Platform, and such reliance on third-party manufacturers may expose us to different risks than if we were to manufacture products ourselves. If our agreements with these third parties expire or are terminated, there can be no assurance that we would be able to negotiate new agreements with them or other third parties on equally favorable terms as the current agreements, or at all.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reliance on third-party providers exposes us to different risks than if we were to manufacture and supply products ourselves. For example, third-party manufacturers may fail to deliver the required commercial quantities of materials on a timely basis and at commercially reasonable prices, and we may be unable to find one or more replacement manufacturers capable of production at a substantially equivalent cost in substantially equivalent volumes and quality on a timely basis. Further, as we do not have control over a manufacturer&#8217;s compliance with applicable manufacturing standards and other laws and regulations, we may receive required materials for, or components of, our products that are defective, contaminated or otherwise not conforming to applicable quality control specifications, warranties and statutory and regulatory requirements. Any failure to achieve and maintain compliance with laws, regulations and standards could lead to suspension of the manufacturing and sales of our products, revocation of obtained regulatory clearance, product recalls, marketing or promotional restrictions, litigation, customer loss and reputational harm. Further, our manufacturing collaborators may be unable to successfully increase the manufacturing capacity for our products in a timely or cost-effective manner, or at all, as needed for our development efforts or, if our additional products are developed and approved, our commercialization efforts.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Establishing additional or replacement manufacturers could take a substantial amount of time and be expensive, which may result in interruptions in our operations and product delivery, negatively affect the quality and performance of our products or require that modifications be made to our products&#8217; designs. Even if we are able to find replacement manufacturers, we will be required to verify that the new manufacturer maintains facilities, procedures and operations that comply with our quality expectations and applicable regulatory requirements. If we are unable to find an adequate replacement or another acceptable solution in time, our research and development and commercial activities could be harmed.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties to conduct multimodal clinical studies. If they do not properly and successfully perform their obligations to us, we may not be able to gather data necessary to support further development of our SOPHiA DDM Platform in a particular disease area or to support potential regulatory submissions and commercial activities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely, and we expect that we will continue to rely, on third parties to assist in managing, monitoring and otherwise carrying out multimodal clinical studies of the performance of our SOPHiA DDM Platform and related solutions, applications, and products. As a result of our reliance on these third parties, we have less direct control over the conduct, timing and completion of these studies than we would otherwise have if we relied entirely upon our own staff. If these third parties do not successfully carry out their duties under their agreements, or if the quality or accuracy of the data they obtain is compromised, or if they fail to comply with study protocols or meet expected deadlines, the multimodal clinical studies of our SOPHiA DDM Platform and related solutions, applications, and products, may fail to generate data necessary to support further development of our platform in a particular disease area or to support potential regulatory submissions and commercial activities and could subject us to liability claims. If third parties fail to comply with applicable regulatory requirements, the data generated in the multimodal clinical studies may be unreliable and these studies may be extended, delayed, suspended or terminated and we could be subject to liability claims.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with many other companies for the resources of these third parties. These third parties may have contractual relationships with other entities, some of which may be our competitors, which may draw time and resources away from our studies. If any of our relationships with these third parties terminate, we may not be able to enter into alternative arrangements or to do so on commercially reasonable terms. As a result, delays may occur in our studies, which can materially impact our ability to meet our desired development, regulatory and commercialization timelines. There can be no assurance that we will not encounter challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, results of operations, financial condition and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance issues, service interruptions or price increases by our shipping carriers and warehousing providers could adversely affect our business, reputation and ability to provide our products on a timely basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Expedited, reliable shipping and delivery services and secure warehousing are essential to our operations. We rely on providers of transport services for reliable and secure point-to-point transport of our research and diagnostic products and for tracking of these shipments, and from time to time require warehousing for our products. Should a carrier encounter delivery performance issues such as loss, damage or destruction of any systems, it would be costly to replace such systems in a timely manner and such occurrences may damage our reputation, reduce demand for our SOPHiA DDM Platform and related solutions, applications, products, and services and increase costs and expenses to our business. In addition, any significant increase in shipping or warehousing rates could adversely affect our operating margins and results of operations. Similarly, strikes, severe weather, natural disasters, civil unrest and disturbances or other service interruptions affecting delivery or warehousing services we use would adversely affect our ability to process orders for our products on a timely basis and adversely affect specimen integrity and our ability to process samples in a timely manner. We carry marine cargo insurance, covering certain potential losses related to the shipment of our products, in an amount that we believe is reasonable for our business, but there can be no assurance that such potential losses will be covered or will not exceed our policy limits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Industry</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are highly dependent on our senior management team and other qualified personnel, and our business could be harmed if we are unable to retain and attract such personnel.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are highly dependent on our senior management, including our Chief Executive Officer and co-founder Dr. Jurgi Camblong. Our success will depend on our ability to retain senior management and to attract and retain qualified personnel in the future, including sales and marketing professionals, scientists, clinical specialists and other highly skilled personnel. The inability to attract and retain members of our senior management, sales and marketing professionals, scientists, IT and data experts or clinical and regulatory specialists could result in delays in application and product development and commercialization and harm our business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To induce valuable employees to remain at our company, in addition to salary and cash incentives, we have granted and intend to continue to grant share-based compensation awards that vest over time. The value to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employees of such awards is significantly affected by movements in our share price due to market volatility, and such awards may be insufficient to retain key employees and senior management, as well as to counteract more lucrative offers from other companies. Despite our efforts to retain valuable employees, members of our management, scientific and development teams may terminate their employment with us on short notice. We do not maintain &#8220;key person&#8221; insurance policies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our industry is subject to rapid change, which could make our SOPHiA DDM Platform and related solutions, applications, products, and services obsolete. If we are unable to continue to innovate and improve our SOPHiA DDM Platform and related solutions, applications, products, and services, we could fail to attract new customers and expand our market share and we could lose existing customers and market share.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our industry is characterized by rapid changes, including technological and scientific breakthroughs, frequent new application, product, or service introductions and enhancements and evolving industry standards, all of which could make our SOPHiA DDM Platform and related solutions, applications, products, and services and others we are developing obsolete. Our future success will depend on our ability to keep pace with the evolving needs of our customers on a timely and cost-effective basis and to pursue new market opportunities that develop as a result of scientific and technological advances.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, there have been numerous advancements in genomics and our understanding of cancer, rare diseases, cardiology, neurology, metabolism and infectious diseases. There have also been advancements in methods used to analyze very large amounts of molecular information. New technologies, including new artificial intelligence/machine learning-powered technologies, and evolving business models in the field of precision medicine continue to develop rapidly.&#160;We must continuously enhance our offerings and develop new and improved features, applications and data modalities of our SOPHiA DDM Platform and related solutions, applications, products, and services to keep pace with scientific and industry developments. If we do not leverage or scale our database of genomic profiles or update our data analytics platform and improve our services and research and diagnostic applications and products to reflect new scientific knowledge, including in the fields of oncology and hereditary disorders, our SOPHiA DDM Platform and related solutions, applications, products, and services could become obsolete and sales of our SOPHiA DDM Platform and related solutions, applications, products, and services could decline or fail to grow as expected. A failure to make continuous improvements to our SOPHiA DDM Platform and related solutions, applications, products, and services to keep ahead of those of our competitors could result in the loss of customers or market share.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face competition from many sources and we may be unable to compete successfully.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of healthcare technology companies providing bioinformatics analysis solutions, applications, services, and products in North and South America, Europe and Asia. See &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Competition.&#8221; These competitors provide AI-driven precision medicine platforms, applications, services, and research and diagnostic products to hospitals, researchers, medical personnel, laboratories and other medical facilities. Many of these organizations, particularly in the United States, are more established, possess regulatory clearances and approval, have broader or deeper relations with healthcare professionals, customers and third-party payors, have greater ability to price their platforms, solutions, applications, products, and services competitively and have significantly greater financial and personnel resources and market share than we do. As a consequence, they may be able to spend more on application and product development, marketing, sales and other application and product initiatives than we can. Our continued success depends on our ability to:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">further penetrate the disease diagnostic solutions market and increase utilization of our SOPHiA DDM Platform and related solutions, applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">maintain and widen our technology lead over competitors by continuing to innovate and deliver new application and product enhancements on a continuous basis;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">cost-effectively develop and improve our SOPHiA DDM Platform and related solutions, applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">add new clinically relevant features, applications and data modalities to our SOPHiA DDM Platform and related solutions, applications, products, and services, such as anatomical </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pathology and proteomics, and generate suitable evidence supporting the research and clinical utility of our multimodal analytical approach ahead of our competitors; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">maintain existing and establish additional research and development, manufacturing, distribution and commercialization collaborations and partnerships.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors also compete with us in recruiting and retaining qualified scientific, management and commercial personnel, as well as in acquiring technologies complementary to, or necessary for, development of our SOPHiA DDM Platform and related solutions, applications, products, and services. Because of the complex and technical nature of data-driven healthcare analysis and the dynamic market in which we compete, any failure to attract and retain a sufficient number of qualified employees could materially harm our ability to develop and commercialize our SOPHiA DDM Platform and related solutions, applications, products, and services, which would have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we attain greater commercial success, our competitors are likely to develop technology, platforms, applications, products, and services that offer features and functionality similar to ours. Improvements in existing competitive technology, platforms, applications, products, and services or the introduction of new competitive technology, platforms, applications, products, and services may make it more difficult for us to compete for sales, particularly if competitors demonstrate better accuracy, reliability, convenience or effectiveness or price their platforms, applications, products, and services less expensively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors may develop data analytics platforms, applications, and products or adopt and implement standards or technologies not compatible with our SOPHiA DDM Platform and our other applications, services, and products. This may inhibit our efforts to develop our platform, applications, services, and products in a technology-agnostic manner, which could narrow the addressable market for our SOPHiA DDM Platform and our other applications, services, and products, adversely impact their sales and market acceptance, and limit our revenue growth and potential profitability.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we operate in an ecosystem where we and our customers have multiple offerings and our own customers may become our competitors or may view us as potential competitors. This could dis-incentivize our customers or potential customers from adopting our offerings and sharing data with us, which would adversely impact sales and market acceptance and limit our revenue growth and potential profitability.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity or data privacy breaches, other unauthorized or improper access, or (distributed) denial service lack of access (e.g., ransomware, persistent DoS/DDoS) could result in additional costs, service outages, loss of revenue, significant liabilities, harm to our brand and decreased/denied use of our SOPHiA DDM Platform and related solutions, applications, products, or services.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure to prevent or mitigate cybersecurity incidents or improper access to, use, disclosure or other misappropriation of our data or customers&#8217; personal data or the inability to rightfully access/control any such data (e.g., ransomware, persistent DoS/DDoS, system compromise, IP leak</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> could result in significant liability under state (e.g., state breach notification and privacy laws such as the California Consumer Privacy Act (&#8220;CCPA&#8221;)), federal (e.g., the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act (&#8220;HITECH&#8221;), collectively &#8220;HIPAA&#8221;) and international laws (e.g., the General Data Protection Regulation (&#8220;GDPR&#8221;) and the U.K. General Data Protection Regulation (&#8220;UK GDPR&#8221;)). Such an incident may also cause a material loss of revenue from the potential adverse impact to our reputation and brand, affect our ability to retain or attract new users and customers of our applications, products, and services and potentially disrupt our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we become more dependent on information technologies, to conduct our operations, cybersecurity incidents, including deliberate cybersecurity attacks and attempts to gain unauthorized access to computer systems and cloud/hybrid networks, may increase in frequency and sophistication. Next generation sequencing (NGS) is becoming a new standard in public health sector. Its growing visibility inevitably attracts malicious activity threats, as it combines mission-critical infrastructure and high-value data. In addition to the nature of the data we hold and process, geopolitical factors could make cybersecurity attacks more common and targeted.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These cybersecurity threats pose a risk to the security of our systems and networks, the confidentiality and the availability and integrity of our data, and these risks apply both to us (including via our corporate systems and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">any employees that may be working remotely) and to third parties on whose systems we rely for the conduct of our business. The techniques used to obtain unauthorized access, disable or degrade service or sabotage systems develop and change frequently and often are not recognized until launched against a target. Increasingly, attackers leverage AI-powered cyberattacks to automate and enhance the sophistication of such techniques, making detection and mitigation more challenging. As a result, we and our collaborators may be unable to anticipate these techniques or to implement adequate preventative measures. We may in the future experience security incidents. In particular, we may be subject to cybersecurity incidents as we continue to adapt and upgrade our platform architecture. If we do not allocate and effectively manage the resources necessary to build and sustain the proper technology and cybersecurity infrastructure, we could suffer significant business disruption, data loss or damage to intellectual property or other proprietary information. While no security incidents in the past have had a material adverse effect on our business, financial condition and results of operations,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">we cannot predict the impact of any such future events. Further, although we are obligated under certain laws and regulations to ensure that our platform, systems and servers and those of our service providers remain compliant with the relevant legal requirements with respect to data privacy and cybersecurity, we do not have any control over the operations of the facilities or technology of such providers, including any third-party vendors that collect, process and store personal data on our behalf. Our platform, systems and servers and those of our service providers may be vulnerable to malware or physical or electronic break-ins that our or their security measures may not detect, including via supply chain attacks. Individuals able to circumvent such security measures may misappropriate our confidential or proprietary information, disrupt our operations, damage our computers or otherwise impair our reputation and business. We may need to expend significant resources and make significant capital investments to protect against cybersecurity breaches or to mitigate (compensating controls) the impact of any such breaches. In addition, to the extent that our platform, systems and servers and those of our service providers experience security breaches that result in the unauthorized or improper use of confidential data, employee data or personal data, we may not be indemnified for any losses resulting from such breaches. Currently, we carry cybersecurity insurance in amounts that we believe is reasonable for our business, but there can be no assurance that such potential losses will be covered or will not exceed our policy limits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that we or our third-party providers will be successful in preventing cyberattacks or successfully mitigating their effects. If we are unable to prevent or mitigate the impact of such security breaches, our ability to attract and retain new customers, patients and other collaborators could be harmed as they may be reluctant to entrust their data to us, and we could be exposed to litigation and governmental investigations, proceedings and regulatory actions by federal, state and local regulatory entities in the United States and by other national regulatory entities, and we could breach our contractual obligations, all of which could result in significant legal and financial exposure and reputational damages and lead to a potential disruption to our business or other adverse consequences.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience significant disruptions in our information technology systems, our business may be adversely affected.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We depend on our information technology systems for the efficient functioning of our business, including the performance, distribution and maintenance of our SOPHiA DDM Platform and related solutions, applications, products, and services, as well as for accounting, data storage, compliance, purchasing and inventory management, and our continued growth is dependent on our ability to adapt and upgrade our platform architecture without suffering significant business disruption, data loss or the loss of or damage to intellectual property or other proprietary information. Our information technology systems may fail and are vulnerable to breakdown, cybersecurity breach, interruption or damage from computer viruses, ransomware, DoS/DDoS attacks or other malware, attacks by computer hackers, including sophisticated nation-state and nation-state-supported actors, employee error or malfeasance, theft or misuse, failures during the process of upgrading or replacing software, databases or components thereof, power outages, damage or interruption from fires or other natural disasters, hardware failures, telecommunication failures and user errors, among other malfunctions. We could be subject to an unintentional event that involves a third party gaining unauthorized access to our systems, which could disrupt our operations, corrupt our data or result in release of our confidential information. Technological interruptions would disrupt our operations, including our ability to timely ship and track diagnostic test orders and results, project inventory requirements, manage our supply chain and otherwise adequately service our customers or disrupt our customers&#8217; ability to use our applications, products, and services. In the event we experience significant disruptions, we may be unable to repair our systems in an efficient and timely manner. Accordingly, such events may disrupt or reduce the efficiency of our entire operation and have a material adverse effect on our business, financial condition and results of operations. Due to the confidential nature of the information that we deal in, any loss in customer trust could have a significant adverse impact on our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Currently, we carry business interruption insurance in amounts that we believe is reasonable for our business, but there can be no assurance that such potential losses will be covered or will not exceed our policy limits. We are increasingly dependent on complex information technology to manage our infrastructure. Our information systems require an ongoing commitment of significant resources to maintain, protect and enhance our existing systems. Failure to maintain or protect our information systems and data integrity effectively could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be adversely affected by health epidemics, pandemics and unplanned events.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business could be adversely affected by health epidemics, pandemics and natural disasters. To the extent any pandemic, epidemic or outbreak of an infectious disease adversely affects our business and financial results, it may also have the effect of heightening many of the other risks described in this &#8220;Risk Factors&#8221; section. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any unplanned event, such as a flood, fire, explosion, earthquake, extreme weather condition, power shortage, telecommunication failure or other natural or man-made accidents or incidents that result in us being unable to fully use our facilities, which may render it difficult or impossible for us to operate our platform for some period of time or result in damages to our inventory that require sensitive storage conditions. Certain of these natural events and disasters may become more frequent and severe as a result of the effects of climate change. We do not presently have an emergency back-up generator in place at our Rolle, Switzerland laboratory facility which would otherwise mitigate, to some extent, the effects of a prolonged power outage. Furthermore, our facility and the equipment we use to perform our research and development work could be unavailable or costly and time-consuming to repair or replace, which may increase backlog. It would be difficult, time-consuming and expensive to rebuild our facility, to locate new facilities or license or transfer our proprietary technologies to a third party.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Currently, we carry business continuity insurance in amounts that we believe is reasonable for our business, but there can be no assurance that such potential losses will be covered or will not exceed our policy limits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If product liability lawsuits are brought against us, we may incur substantial liabilities and may be required to limit or halt the marketing and sale of our SOPHiA DDM Platform and related solutions, applications, products, and services.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face an inherent risk of product liability as a result of the marketing and sale of our SOPHiA DDM Platform and related solutions, applications, products, and services and the testing of our SOPHiA DDM Platform in clinical studies. Such claims may be made against us even if the apparent injury is due to the actions of others or the preexisting health of the patient. This risk may be heightened by our reliance on third parties for the manufacturing, marketing and research and development of our SOPHiA DDM Platform and related solutions, applications, products, and services. If we cannot successfully defend ourselves against product liability claims, we may incur substantial liabilities or be required to limit or halt the marketing and sale of our products. Even successful defense would require significant financial and management resources, harm our reputation in our industry and reduce sales.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we have adequate product liability insurance, but it may not prove to be adequate to cover all liabilities that we may incur. Insurance coverage is increasingly expensive. We may not be able to maintain or obtain insurance at a reasonable cost or in an amount adequate to satisfy any liability that may arise. Our insurance policy contains various exclusions, and we may be subject to a product liability claim for which we have no coverage. The potential inability to obtain sufficient product liability insurance at an acceptable cost to protect against product liability claims could prevent or inhibit the marketing and sale of our applications, products, and services. In addition, any product liability claims brought against us, with or without merit, could increase our product liability insurance rates or prevent us from securing continuing coverage.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain an effective system of internal controls over financial reporting, we may not be able to accurately report our financial condition and results of operations in a timely manner or prevent fraud.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent and/or detect errors and/or fraud in a timely manner&#160;&#160;&#160;&#160;. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. As required by Section 404 of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Sarbanes-Oxley Act, our management has conducted an assessment on the effectiveness of our internal controls over financial reporting. However, as an emerging growth company, our independent registered public accounting firm has not provided an attestation report on our internal controls over financial reporting. There can be no assurance that any future testing conducted by us or, if required, by our independent registered public accounting firm will not reveal deficiencies in our internal controls over financial reporting. If we do not maintain an effective system of internal controls over financial reporting, we may be unable to accurately report our financial condition and results of operations in a timely manner, may incur additional financial and management resources to remediate any deficiencies, or may be unable to detect and prevent fraud, all of which would adversely affect our business and investor confidence.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and other legal proceedings may adversely affect our business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in legal proceedings relating to patent and other intellectual property matters, product liability claims, employee claims, tort or contract claims, claims related to our public commitments, regulatory investigations, securities class action and other legal proceedings or investigations, which could have an adverse impact on our reputation, business and financial condition and divert the attention of our management from the operation of our business. Litigation is inherently unpredictable and can result in excessive or unanticipated judgments and/or injunctive relief that affect how we operate our business. We could incur judgments or enter into settlements of claims for monetary damages or for agreements to change the way we operate our business, or both. There may be an increase in the scope of these matters or there may be additional lawsuits, claims, proceedings or investigations in the future, which could have a material adverse effect on our business, financial condition and results of operations. Adverse publicity about regulatory or legal action against us could damage our reputation and brand image, undermine our customers&#8217; confidence and reduce long-term demand for our solutions, applications, products, and services, even if the regulatory or legal action is unfounded or not material to our operations. In this regard, we are currently defending against patent infringement claims brought by Guardant Health in multiple jurisdictions, as described below in section &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property&#8221;.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is subject to economic, political, regulatory and other risks associated with international operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results could be adversely affected by a variety of risks associated with our international operations, including economic weakness, such as inflation and rising interest rates, or political instability in economies and markets; global trends towards pharmaceutical pricing; differing regulatory requirements for bioinformatics analysis services and research and diagnostic products approvals; differing reimbursement, pricing and insurance regimes; potentially reduced protection for, and complexities and difficulties in obtaining, maintaining, protecting and enforcing, intellectual property rights; difficulties in compliance with U.S. and non-U.S. laws and regulations, including data security and data protection laws, which may result in increased compliance costs to us, and anti-corruption and anti-bribery laws; changes in regulations and customs, tariffs and trade barriers; changes in currency exchange rates and currency controls; changes in a specific country&#8217;s or region&#8217;s political or economic environment; trade protection measures, economic sanctions and embargoes on certain countries and persons, import or export licensing requirements or other restrictive actions by governments, including with respect to our applications, products, and services, in particular IT solutions, services and technologies on which our operations rely; changes in tax laws; compliance with tax, employment, immigration and labor laws for employees living or traveling abroad; workforce uncertainty in countries where labor unrest is more common than in Switzerland and the United States; difficulties associated with staffing and managing international operations, including differing labor relations; production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; business interruptions resulting from geopolitical actions, including war and terrorism (including the ongoing conflict between Russia and Ukraine and in the Middle East), or natural disasters including earthquakes, typhoons, floods and fires; and the impact of public health epidemics on employees and the global economy. As a result, we may experience supply chain disruptions and interruptions in our operations. Any of these factors could require us to modify our business plans and strategy and significantly harm our future international expansion and operations and, consequently, our revenue and results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Governmental Regulation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently our applications and products in the United States are labeled as RUO. We intend to seek regulatory clearance or approval to offer our applications and products as IVD applications and products for diagnostic use. We cannot guarantee when, if at all, we will apply for regulatory clearance or approval or that we will be successful in obtaining such clearances or approvals.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have several CE-IVD marked applications and products in the European Union (&#8220;EU&#8221;), our currently available applications and products in the United States are labeled as RUO applications and products and are not intended for diagnostic use. Although we have focused initially on the RUO applications and products only, our strategy is to expand our application and product line to encompass applications and products that are intended to be used as IVDs. Such IVD products will be subject to regulation by the FDA as medical devices, including requirements for regulatory clearance or approval of such applications and products before they can be marketed. Accordingly, we will be required to obtain FDA 510(k) clearance or premarket approval (&#8220;PMA&#8221;) in order to sell our applications and products in a manner consistent with FDA current laws and regulations. Such regulatory approval processes or clearances are expensive, time-consuming and uncertain; our efforts may never result in any premarket approval or 510(k) clearance for our applications and products; and failure by us to obtain or comply with such approvals and clearances could have an adverse effect on our business, financial condition or operating results.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory authorities have substantial discretion in the clearance and approval process. They may refuse to accept any application or may decide that our data are insufficient for clearance or approval and require additional studies. Therefore, even if we believe the data collected from studies of our platform are promising, such data may not be sufficient to support clearance or approval by any regulatory authority. If we are required to conduct additional studies or other testing of any of our platform beyond those we contemplate, we may incur significant additional costs and regulatory approval may be delayed or prevented. Furthermore, approval by one regulatory authority does not ensure approval by regulatory authorities in other jurisdictions, and we may be required to undertake additional studies to access particular markets.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If we successfully obtain such clearances or approvals, we will be subject to a substantial number of additional requirements for medical devices, including, but not limited to, establishment registration, device listing, and compliance with the Quality Management System Regulation (&#8220;QMSR&#8221;), which covers the design, testing, production, control, quality assurance, labeling, packaging, servicing, sterilization (if required), and storage and shipping of medical devices (among other activities), advertising, record keeping, post-market surveillance, post-approval studies, adverse event reporting, and correction and removal (recall) regulations. We may be required to expend significant resources to ensure ongoing compliance with the FDA regulations and/or take satisfactory corrective action in response to enforcement action, which may have a material adverse effect on the ability to design, develop and commercialize applications and products using our technology as planned. Failure to comply with these requirements may subject us to a range of enforcement actions, such as warning letters, injunctions, civil monetary penalties, criminal prosecution, recall and/or seizure of products, and revocation of marketing authorization, as well as significant adverse publicity. If we fail to obtain, or experience significant delays in obtaining, regulatory approvals for IVD or other applications and products, such applications and products may not be able to be launched or successfully commercialized in a timely manner, or at all.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory developed tests (&#8220;LDTs&#8221;) are a subset of IVD tests that are designed, manufactured and used within a single laboratory. The FDA maintains that LDTs are medical devices and has historically exercised enforcement discretion for most LDTs. Regulation of LDTs, however, falls under the purview of the Clinical Laboratory Improvement Amendment (&#8220;CLIA&#8221;) with oversight between the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;), Centers for Disease Control and Prevention (&#8220;CDC&#8221;), and the FDA. On May 6, 2024, the FDA proposed a final rule that would bring LDTs under the current definition of an IVD. The rule was challenged and has since been vacated, resulting in the existing LDT regulatory framework remaining unchanged. While we do not anticipate any changes to the FDA&#8217;s enforcement discretion practices as applicable to any LDTs that our customers develop using our RUO applications and products, there is potential for increased regulator scrutiny following the vacating of the FDA&#8217;s rule.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We develop applications and products for clinical laboratories, which may be qualified as LDTs, as well as market RUO applications and products. Our customers may decide to validate our applications and products to use as an LDT.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and regulations governing the marketing of diagnostic applications and products are evolving, extremely complex and in many instances, there are no significant regulatory or judicial interpretations of these laws and regulations. Pursuant to its authority under the Federal Food, Drug, and Cosmetic Act (the &#8220;FDCA&#8221;), the FDA has jurisdiction over medical devices, including&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;diagnostics and, therefore, potentially our applications and products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the FDCA and its implementing regulations, the FDA regulates the research, testing, manufacturing, safety, labeling, storage, record keeping, premarket clearance or approval, marketing and promotion, and sales and distribution of medical devices in the United States to ensure that medical products distributed domestically are safe and effective for their intended uses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently do not offer any diagnostic applications and products in the United States. We believe that our research applications and products, as utilized in clinical laboratories by our customers, are and would be considered LDTs and that as a result, the FDA does not require that they obtain regulatory clearances or approvals for the LDTs or their components pursuant to the FDA&#8217;s current policies and guidance. Although we believe that our products and test components delivered to our customers, when validated by customers as LDTs, are either exempt from FDA medical device regulations or are subject to an enforcement discretion policy, it is possible that the FDA would not agree with these determinations or that the FDA will change its regulations and policies such that our applications and products become regulated as medical devices.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, changes in the current regulatory framework for diagnostic applications, products, and services can impose additional regulatory burdens on us. For example, the FDA&#8217;s Center for Devices and Radiological Health is currently considering a total product lifecycle-based regulatory framework for artificial intelligence/machine learning (&#8220;AI/ML&#8221;) technologies. On January&#160;12, 2021, the FDA released its Artificial Intelligence/Machine Learning-Based Software as a Medical Device Action Plan. As the regulatory framework evolves, we may incur substantial costs to ensure compliance with new or amended laws and regulations. Failure to comply with any of these laws and regulations could result in enforcement actions against us, damage to our reputation and loss of goodwill, any of which could have a material adverse effect on our business. In addition, legislation could require us to seek FDA-premarket review of other applications, products, and services, including reports that we do not currently believe require premarket authorization but could be subject to additional regulation including premarket review. For any such review, we may be required to conduct extensive analytical validation and user comprehension studies to demonstrate the accuracy of our test results and that they are appropriate for sale directly to consumers. This process will likely be costly, time-consuming and uncertain.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, on January 29, 2026, FDA issued an update to their existing guidance on Clinical Decision Support software. The updated guidance provides additional clarity on the criteria the Agency uses to determine whether a Clinical Decision Support software is non-device, a low-risk device falling under enforcement discretion, or a device requiring regulatory review (FD&amp;C Act 520(o)(1)(E)). This guidance only provides the Agency&#8217;s current thinking on the topic and is subject to future revision. As the specific uses of the SOPHiA DDM Platform would need to be evaluated against the Agency&#8217;s criteria to determine the appropriate regulatory strategy on an individual basis, the regulatory burden may change in scope. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations, therefore, are or may become subject to extensive regulation by the FDA in the United States, the IVDR in the EU, the MHRA in the U.K., and various health authorities, in particular SwissMedic in Switzerland, and the ANSM in France, and in other jurisdictions in which we conduct business. Government regulations specific to medical devices are wide-ranging and govern, among other things:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">test design, development, manufacture, and release;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">laboratory and clinical testing, labeling, packaging, storage and distribution;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">product safety and efficacy;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">pre-marketing clearance, approval or certification;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">service operations;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">record keeping;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">application and product marketing, promotion and advertising, sales and distribution;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">post-marketing surveillance, including reporting of deaths or serious injuries, recalls, correction and removals;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">post-market approval studies; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">product import and export.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, although we believe that our current line of products and their components, as validated and utilized in clinical laboratories by our customers, would be considered LDTs, subject to state licensing requirements and federal regulation by CMS under CLIA, it is possible that the FDA or comparable regulatory authorities would not agree with our determinations. If our products become subject to 510(k) or other similar FDA regulations, we would need to comply with the applicable regulations or face significant civil and criminal penalties. Exposure to these additional regulatory requirements would also affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">We have limited ability to monitor or control how customers use our platform, and customer use of our solutions for off-label purposes, in clinical contexts beyond our intended use statements or regulatory authorizations, or in reliance on outputs in ways we did not design or validate for, could result in patient harm, regulatory enforcement actions, product liability claims, additional regulatory burdens and reputational damage, and could expose us to securities litigation if such risks are alleged to have been inadequately disclosed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our platform and solutions are developed, validated, labeled and marketed for specific intended uses, which may include use solely for research purposes without claims of clinical or diagnostic utility, use in specific disease areas, use with specific specimen types, analysis of data generated on specified sequencing platforms or using defined library preparation and sequencing protocols, or use as clinical decision support to be interpreted in conjunction with other diagnostic information and clinical judgment rather than as a primary or standalone diagnostic test. Where we have obtained regulatory clearances, approvals or CE marks, those authorizations specify particular indications that define the authorized scope of marketing and use. Similarly, products labeled for research use only (&#8220;RUO&#8221;) are not intended or authorized for use in clinical diagnostic procedures. However, once our platform is implemented at customer sites or made available via cloud-based access, we have limited practical ability to monitor, supervise, restrict or control the specific ways in which healthcare providers, laboratory personnel, researchers, bioinformaticians or other end users choose to use the platform, what types of patient samples or cases they analyze, what clinical questions or decisions they seek to inform, how they interpret and communicate results generated by the platform, whether they use our solutions in strict compliance with our intended use labeling and user documentation, or whether they use research-labeled features to inform clinical care decisions contrary to labeling restrictions.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Despite our labeling, training, contractual restrictions and communications, customers may deploy our solutions beyond the validated and authorized scope of use. Such off-label, unanticipated or unauthorized uses, even if we did not explicitly promote or encourage them and took reasonable steps to prevent them, could result in patient harm if our platform has not been adequately validated for the specific use case and if reliance on platform outputs contributes to misdiagnosis, delayed diagnosis, missed actionable findings, selection of ineffective or harmful therapies, inappropriate clinical trial enrollment or other adverse patient outcomes. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Such off-label uses could also subject us to product liability claims, professional malpractice litigation, regulatory complaints or regulatory enforcement actions if authorities determine that we promoted off-label use, failed to include adequate warnings or labeling, failed to implement technical safeguards to prevent clinical use of RUO features, failed to conduct adequate post-market surveillance to detect and respond to off-label use patterns, or otherwise did not take sufficient steps to ensure that our platform is used only for its cleared, approved or intended purposes. This could result in requirements to conduct additional validation studies, seek expanded regulatory authorizations, implement use restrictions or technical controls (such as disabling certain features for certain customer types or requiring additional user attestations), modify labeling or instructions for use, issue field safety notices or customer communications, or undertake other costly corrective and preventive actions. If our products are misused or used for off-label purposes, we could also face adverse publicity, publications in medical or scientific literature describing cases of inappropriate use or adverse outcomes associated with our platform, and reputational harm that could undermine trust among healthcare providers, patients, payers, partners and investors which could lead to loss of customers, difficulty securing new customer contracts, and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">challenges obtaining reimbursement or coverage if payers perceive that our platform is being used beyond validated and evidence-supported applications. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Finally, we could face securities class action litigation or SEC enforcement if investors or regulators allege that we failed to adequately disclose the risks and potential liabilities associated with off-label use, that our disclosures regarding intended use or regulatory status were misleading, or that we did not appropriately recognize or reserve for liabilities related to such use. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Even in circumstances where we believe we have taken all reasonable and legally required steps to communicate intended use, limit off-label use and comply with regulatory requirements, the occurrence of patient harm, regulatory action or significant off-label use could materially harm our business, financial condition, reputation and prospects, could result in significant legal defense costs, settlement payments, judgments, regulatory fines or mandated corrective actions, and could expose us to substantial securities litigation risk if our stock price declines or if our prior disclosures are alleged to have been inadequate.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may fail to obtain required clearances or approvals in additional jurisdictions for any of our applications, products, or services and, even if we do, we may never be able to commercialize them in additional jurisdictions, which would limit our ability to realize their full market potential.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to eventually market any of our current or future applications, products, and services in any particular jurisdiction, we must establish and comply with numerous and varying regulatory requirements on a jurisdiction-by-jurisdiction basis regarding quality, safety, performance and efficacy. In addition, regulatory clearance, authorization or approval in one country does not guarantee regulatory clearance, authorization or approval in any other country. For example, the performance characteristics of our applications, products, and services may need to be validated separately in specific ethnic and genetic populations. Approval processes vary among countries and can involve additional product testing and validation and additional administrative review periods.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seeking regulatory clearance, authorization or approval could result in difficulties and costs. Regulatory requirements and ethical approval obligations can vary widely from country to country and could delay or prevent the introduction of our applications, products, and services in those countries. We have no experience in obtaining regulatory clearance, authorization or approval in international markets. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required regulatory clearances, authorizations or approvals in international markets, or if those approvals are delayed, our target market will be reduced and our ability to realize the full market potential of our applications, products, and services will be unrealized.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products or services may be subject to product or service recalls in the future. A recall of products or services, either voluntarily or at the direction of a regulatory authority, or the discovery of serious safety issues with our products or services, could have a significant adverse impact on us.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory authorities can require the recall of commercialized products or services that are subject to its regulation. Manufacturers may, under their own initiative, recall a product or service if any deficiency is found. A government-mandated or voluntary recall by us or one of our distributors could occur as a result of an unacceptable health risk, component failures, failures in laboratory processes, malfunctions, manufacturing errors, design or labeling defects, or other deficiencies and issues. Recalls of any of our commercialized products or services would divert managerial and financial resources, subject us to liability claims and require us to bear other costs and adversely affect our business, results of operations, financial condition and reputation. If we initiate a recall, including a correction or removal, for one of our commercialized products or services, issue a safety alert, or undertake a field action or recall to reduce a health risk, this could lead to increased scrutiny by the FDA, other governmental and regulatory enforcement bodies, and our customers regarding the quality and safety of our products and services, and to negative publicity, including FDA alerts, press releases, or administrative or judicial actions. Furthermore, the submission of these reports could be used against us by competitors and cause customers to delay purchase decisions or cancel orders, which would harm our reputation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to stringent privacy and, information security laws and regulations and changes in such laws and regulations could adversely affect our business and increase our costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are subject to numerous state, federal and foreign laws and regulations that govern the collection, transmission, storage, dissemination, use, privacy, confidentiality, security, availability, integrity and processing </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of individually identifiable information.  For additional details, please see &#8220;Item 4. Information on the Company&#8212;B. Business Overview&#8212;Government Regulation&#8212;Data Privacy and Security.&#8221; These laws and regulations are complex and change frequently, at times due to changes in political climate, and existing laws and regulations are subject to different and conflicting interpretations, which adds to the complexity of processing personal data from these jurisdictions. Failure to comply with any of these laws and regulations could result in enforcement actions against us, including fines, imprisonment of company officials, public censure, claims for damages by affected individuals, damage to our reputation and loss of goodwill, any of which could have a material adverse effect on our business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This risk is heightened as there is uncertainty regarding the applicability of data privacy regulations to certain types of data that we process, such as health-related and genetic data. While we deploy specific measures and processes designed to de-identify data, we may fail in the comprehensive application of the process resulting in a breach of requirements and our contractual obligation. Some of our product and services rely on anonymized data and while the legal definition is clear, the effective application of the anonymization techniques are subject to multiple interpretation and can prove to be highly difficult and costly.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer of data has been subject to increasing scrutiny. Although there are legal mechanisms to allow for the transfer of personal data from the European Economic Area (the &#8220;EEA&#8221;), Switzerland and the U.K. to the United States, uncertainty remains about such mechanisms. There have been and there may in the future be legal challenges surrounding the mechanisms that allow companies to transfer personal data from the EU and EEA to the United States, which could limit our ability to transfer personal data across borders, particularly if governments are unable or unwilling to reach new or maintain existing agreements that support cross-border data transfers. Inability to transfer personal data from the EU, EEA, Switzerland or the U.K. to the United States may restrict our research and development activities in these territories and limit our ability to offer applications, products, and services we may develop.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because the interpretation and application of health-related and data protection laws, regulations, standards and other obligations are uncertain, and often contradictory and in flux, it is possible that the scope and requirements of these laws may be interpreted and applied in a manner that is inconsistent with our practices and our efforts to comply with the evolving data protection rules may be unsuccessful. If so, this could result in government-imposed fines or orders requiring that we change our practices, which could adversely affect our business. In addition, these privacy regulations may differ from country to country, and may vary based on whether testing is performed in the United States or in the local country, and our operations or business practices may not comply with these regulations in each country.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the possibility of fines, sanctions, lawsuits, regulatory investigations, public censure, other claims and penalties, and significant costs for remediation and damage to our reputation, we could be materially and adversely affected if legislation or regulations are expanded to require changes in our data processing practices and policies or if governing jurisdictions interpret or implement their legislation or regulations in ways that negatively impact our business. Complying with these various laws could cause us to incur substantial costs or require us to change our business practices and compliance procedures in a manner adverse to our business. Any inability to adequately address data privacy or security-related concerns, even if unfounded, or to comply with applicable laws, regulations, standards and other obligations relating to data privacy and security, could result in additional cost and liability to us, harm our reputation and brand, damage our relationships with customers and have a material and adverse impact on our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any failure to comply with our privacy policies or contractual or statutory notification obligations could result in significant liability or reputational harm.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make public statements about our use and disclosure of personal information through our privacy policy, information provided on our internet platform and press statements. Although we endeavor to comply with our public statements and documentation, we may be alleged to have failed to do so. The publication of our privacy policy and other statements that provide promises and assurances about data privacy and security can subject us to potential government or legal action if they are found to be deceptive, unlawful, unfair or misrepresentative of our actual practices. Any failure, real or perceived, by us to comply with our posted privacy policies or with any legal or regulatory requirements, standards, certifications or orders or other privacy or consumer protection-related laws and regulations applicable to us could cause our customers to reduce their use of our applications, products, and services and could materially and adversely affect our business, financial condition and results of operations. In many jurisdictions, enforcement actions and consequences for noncompliance can be significant and are rising. In addition, from time to time, concerns may be expressed about whether our applications, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products, services, or processes compromise the privacy of customers and others. Concerns about our practices with regard to the collection, use and reuse, retention, security, disclosure, transfer and other processing of personal information or other privacy-related or security-related matters, even if unfounded, could damage our reputation and materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Many statutory requirements, both in the United States and abroad, include obligations for companies to notify individuals of security breaches involving certain personal information, which could result from breaches experienced by us or our third-party service providers. For example, the GDPR requires from companies experiencing a personal data breach to report the breach within 72 hours to the supervisory authority and where necessary to the individuals affected by the breach. Also, laws in all 50 U.S. states and the District of Columbia require businesses to provide notice to consumers whose personal information has been disclosed as a result of a data breach. These laws are not consistent, and compliance in the event of a widespread data breach is difficult and may be costly. Moreover, jurisdictions have been frequently amending existing laws, requiring attention to changing regulatory requirements. We also may be contractually required to notify customers or other counterparties of a security breach. Although we may have contractual protections with our third-party service providers, contractors and consultants, any actual or perceived security breach could harm our reputation and brand, expose us to potential liability or require us to expend significant resources on data security and in responding to any such actual or perceived breach. Any contractual protections we may have from our third-party service providers, contractors or consultants may not be sufficient to adequately protect us from any such liabilities and losses, and we may be unable to enforce any such contractual protections.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operations may subject us to various healthcare laws and regulations and could face substantial penalties if we are unable to fully comply with such laws.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations may subject us to healthcare regulation and enforcement by both U.S. (federal government and state governments) and foreign jurisdictions in which we conduct our business, which influence, among other things, how we structure our sales offerings, including discount practices, customer support, education and training programs, and physician consulting and other service arrangements. Applicable U.S. federal and state healthcare laws and regulations include the following:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the federal Anti-Kickback Statute (the &#8220;AKS&#8221;), which prohibits, among other things, persons or entities from soliciting, receiving, offering or providing remuneration, directly or indirectly, overtly or covertly, in cash or in kind, in return for, or to induce, either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or services for which payment may be made under a federal healthcare program such as the Medicare and Medicaid programs;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the federal physician self-referral prohibition, commonly known as the Stark Law, which prohibits physicians from referring Medicare or Medicaid patients to providers of &#8220;designated health services&#8221; with whom the physician or a member of the physician&#8217;s immediate family has an ownership interest or compensation arrangements, unless a statutory or regulatory exception applies;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the federal Eliminating Kickbacks in Recovery Act of 2018 (the &#8220;EKRA&#8221;) prohibits payments for referrals to recovery homes, clinical treatment facilities, and laboratories. EKRA&#8217;s reach extends beyond federal health care programs to include private insurance (i.e., it is an &#8220;all payor&#8221; statute);</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">HIPAA, which established additional federal civil and criminal liability for, among other things, knowingly and willfully executing a scheme to defraud any healthcare benefit program or making false statements in connection with the delivery of or payment for healthcare benefits, items or services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">HIPAA, as amended by HITECH and its implementing regulations, which imposes certain requirements relating to the privacy, security and transmission of individually identifiable health information;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">federal false claims and civil monetary penalties laws, which prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, false or fraudulent claims for payment to the federal government;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the federal Physician Payments Sunshine Act requirements, which require certain manufacturers of drugs, devices, biologics and medical supplies to report to CMS information related to payments and other transfers of value made to or at the request of physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, and certain ownership and investment interests held by physicians and their immediate family members; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws, which may apply to items or services reimbursed by any third-party payor, including commercial insurers.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ensuring that our business and operations comply with applicable healthcare laws and regulations is costly. Any action brought against us for violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. If our operations are found to be in violation of any of these laws and regulations, we may be subject to any applicable penalty associated with the violation, including, among others, significant administrative, civil and criminal penalties, damages, fines, disgorgement, imprisonment, integrity oversight and reporting obligations, and exclusion from participation in government-funded healthcare programs such as Medicare and Medicaid. Additionally, we could be required to refund payments received by us, and we could be required to curtail or cease our operations. Any of the foregoing consequences could seriously harm our business, financial condition and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employees, collaborators, distributors, agents, contractors and collaborators may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot ensure that our compliance controls, policies and procedures will in every instance protect us from acts committed by our employees, collaborators, distributors, agents, contractors or collaborators that would violate the laws or regulations of the jurisdictions in which we operate, including, without limitation, healthcare, employment, anti-corruption, environmental, competition, and patient privacy and other privacy laws and regulations. Misconduct by these parties could include intentional failures to comply with FDA, EMA, MHRA or other applicable regulations, including, without limitation, regulations governing the marketing, sale, labeling and use of RUO and IVD applications and products, provide accurate information to the FDA, the EMA, the MHRA and comparable regulatory authorities, comply with healthcare fraud and abuse laws and regulations in the United States and abroad, report financial information or data accurately or disclose unauthorized activities to us. In addition, because business is heavily regulated and therefore involves significant interaction with public officials, including officials of non-U.S. governments, government purchasers and healthcare providers who are employed by governments, we face heightened risk with respect to compliance with the Foreign Corrupt Practices Act (the &#8220;FCPA&#8221;) and similar anti-bribery or anti-corruption laws, regulations or rules of other countries in which we operate, including the U.K. Bribery Act 2010 and the French Law n&#176; 2016-1691 (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sapin II</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). These laws prohibit offering, promising, giving, or authorizing others to give anything of value, either directly or indirectly, to a government official in order to influence official action, or otherwise obtain or retain business. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is no certainty that all of our employees, collaborators, distributors, agents, contractors and collaborators, or those of our affiliates, will comply with all applicable laws and regulations, particularly given the high level of complexity of these laws. We have provisions in our Code of Business Conduct and Ethics (the &#8220;Code of Ethics&#8221;), an anti-corruption policy, certain provisions in some of our agreements with third parties, including our collaborators and distributors, and certain controls and procedures in place that are designed to mitigate the risk of noncompliance with anti-corruption and anti-bribery laws. However, it is not always possible to identify and deter misconduct by employees and agents, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from government investigations or other actions stemming from a failure to comply with these laws or regulations. Violations of these laws and regulations could result in, among other things, significant administrative, civil and criminal fines and sanctions against us, our officers, or our employees, the closing down of our facilities, exclusion from participation in federal healthcare programs, implementation of compliance programs, integrity oversight and reporting obligations and prohibitions on the conduct of our business. Any such violations could include prohibitions on our ability to offer our SOPHiA DDM Platform and related solutions, applications, products, and services in one or more countries and could materially damage our reputation, our brand, our international </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expansion efforts, our ability to attract and retain employees, and our business, prospects, operating results and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face risks related to handling of hazardous materials and other regulations governing environmental safety.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our activities currently require and may in the future continue to require the use of hazardous chemicals and biohazardous waste, including chemical, biological agents and compounds, blood and bone marrow samples, and other human tissue. We cannot eliminate the risk of accidental contamination or injury to employees or third parties from the use, storage, handling or disposal of these materials. In the event of contamination or injury, we could be held liable for any resulting damages, and any liability could exceed our resources or any applicable insurance coverage we may have. Additionally, we are subject on an ongoing basis to laws and regulations governing the use, storage, handling and disposal of these materials and specified waste services that both public officials and private individuals may seek to enforce. We could discover that we, an acquired business or our suppliers are not in material compliance with these regulations. The cost of compliance with these laws and regulations may become significant and could negatively affect our business, financial condition and results of operations. We do not carry specific biological waste or hazardous waste insurance coverage, workers&#8217; compensation or property and casualty and general liability insurance policies that include coverage for damages and fines arising from biological or hazardous waste exposure or contamination.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If a clinical trial subject&#8217;s or a clinical research study participant&#8217;s informed consent is challenged or proven invalid, unlawful, or otherwise inadequate for our purposes, our application and product development efforts may be hindered and we could become involved in legal challenges.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to ensure that all data and biological samples that we receive from our collaborators and customers have been collected from subjects or participants who have provided appropriate informed consent for purposes that extend to our development activities. We also strive to make sure such data and samples are provided to us in a subject de-identified manner. Our collaborators currently conduct clinical trials and clinical research studies in a number of different countries. The collection of data and samples in many different countries results in complex legal questions regarding the adequacy of informed consent and the status of genomic material under a large number of different legal systems. Therefore, we rely on our collaborators and customers to comply with the informed consent requirements and with applicable local law and international regulation. The subject&#8217;s or participant&#8217;s informed consent obtained in any particular country could be challenged in the future, and those could prove invalid, unlawful or otherwise inadequate for our purposes. Any findings against us, or our collaborators and customers, could deny us access to or force us to stop using some of our data and clinical samples, which would hinder our application and product development efforts, potentially involve us in costly and prolonged litigation, result in reputational harm and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our suppliers fail to comply with ongoing FDA or comparable regulatory authority requirements, or if we experience unanticipated problems with our research and diagnostic, they could be subject to restrictions or withdrawal from the market.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any medical device that we manufacture, including those for which we obtain regulatory clearance, approval, or certification and the manufacturing processes, reporting requirements, post-approval clinical data and promotional activities for such diagnostic test, will be subject to continued regulatory review, oversight and periodic inspections by the FDA and comparable regulatory authorities. In particular, we and our suppliers may be required to comply with the FDA&#8217;s QMSR for medical devices, the International Standards Organization (&#8220;ISO&#8221;) 13485 standards for the manufacture of our diagnostic products and other regulations that cover the methods and documentation of the design, testing, production, control, quality assurance, labeling, packaging, storage and shipping of any diagnostic test for which we obtain clearance or approval. Regulatory authorities such as the FDA enforce the QMSR and other regulations through periodic inspections. The failure by us or one of our suppliers to comply with applicable statutes and regulations administered by the FDA and comparable regulatory authorities, or the failure to timely and adequately respond to any adverse inspection observations or product safety issues, could result in, among other things, one or more of the following enforcement actions:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">unanticipated expenditures to address or defend such actions;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">customer notifications for repair, replacement or refunds;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">recall, detention or seizure of our diagnostics products;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">operating restrictions or partial suspension or total shutdown of production;</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:32.5pt">refusing or delaying our requests for 510(k) clearance or PMA of new diagnostics products or modified versions of such products currently manufactured, as well as CE marking certification (in the EU);</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">operating restrictions;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">withdrawing 510(k) clearances on PMA approvals that have already been granted; </span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">suspending or withdrawing our CE mark certifications; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">criminal prosecution.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are required to conduct surveillance to monitor the safety or effectiveness of our research and diagnostic products, and we must comply with medical device reporting requirements, including the reporting of adverse events and malfunctions related to our research and diagnostic products. Later discovery of previously unknown problems with our diagnostic products, including unanticipated adverse events or adverse events of unanticipated severity or frequency, manufacturing problems, or failure to comply with regulatory requirements such as QMSR, may result in changes to labeling restrictions on such products or manufacturing processes, withdrawal of the research and diagnostic products from the market, voluntary or mandatory recalls, a requirement to repair, replace or refund the cost of any medical device we manufacture or distribute, fines, suspension of regulatory approvals, product seizures, injunctions or the imposition of civil or criminal penalties, which would adversely affect our business, operating results and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tariffs could increase our cost of revenue and our operating expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2025, the United States government announced significant changes to its trade policy, including the imposition of tariffs. The new tariff system consists of two tiers: a 10% baseline tariff on all imports to the United States and higher reciprocal tariffs on imported goods from approximately 60 countries. An initial 31% tariff was announced on goods imported into the U.S. from Switzerland, where our headquarters are located, which was subsequently increased to 39% by Executive Order on July 31, 2025. On December 10, 2025 Switzerland announced an agreement with the U.S. to reduce the tariffs to 15% retroactive to November 14, 2025. The tariffs are to be reduced if the products imported into the U.S. have U.S. content in them.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate internationally, with the majority of our bundles assembled at and shipped from our headquarters in Rolle, Switzerland. While the majority of our revenues are generated from the EMEA region and are not directly impacted by these tariffs, our sale of bundles to the United States are currently subject to additional costs due to the tariffs, leading to increases in our cost of revenue and decreases in our gross margin if we are unable to fully offset such costs by increasing our prices. In addition, the tariffs if they remain in effect, will lead to higher operating expenses. These effects could adversely affect our financial condition and results of operations. Furthermore, the imposition of tariffs by the United States may prompt other countries, including Switzerland, to impose reciprocal tariffs, which could impact the cost of our raw materials purchased from the United States.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to obtain, maintain, defend and enforce patent and other intellectual property protection or if the scope of such patent and other intellectual property protection is not sufficiently broad, our competitors could develop and commercialize applications, products, services, and technology similar or identical to ours.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in part on our ability to obtain, maintain, defend, and enforce patents and other forms of intellectual property rights, including in-licenses of intellectual property rights of others, as well as our ability to preserve our trade secrets and to prevent third parties from infringing, misappropriating or otherwise violating our intellectual property and proprietary rights. Our ability to protect our applications, products, or services from unauthorized use by third parties depends on the extent to which valid and enforceable patents cover them or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">they are effectively protected as trade secrets. Although we have filed a number of patents, our patent portfolio is in an earlier stage of prosecution, and we own a limited number of issued patents related to our applications, products, and technology. For information regarding our patent portfolio, see &#8220;Item 4. Information on the Company&#8212;B. Business Overview&#8212;Intellectual Property.&#8221;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent position of biotechnology and information technology companies generally is highly uncertain, involves complex legal and factual questions, and has been the subject of much litigation in recent years. As a result, the issuance, scope, validity, enforceability, and commercial value of our patent rights are highly uncertain. There can be no assurance that our patent rights will not be invalidated or held to be unenforceable, will adequately protect our technology, applications, products, or services or provide any competitive advantage, or that any of our pending or future patent applications will issue as valid and enforceable patents. Our ability to obtain and maintain patent protection for our methods and related solutions, applications, products, or services is uncertain due to a number of factors, including that:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">we or our licensors may not have been the first to invent the technology covered by our pending patent applications or issued patents;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">we or our licensors may not be the first to file all patent applications, as patent applications in the United States and most other countries are confidential for a period of time after filing;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our methods and related solutions, applications, and products may not be patentable;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our disclosures in patent applications may not be sufficient to meet the statutory requirements for patentability;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">any or all of our pending patent applications may not result in issued patents;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">others may independently develop identical, similar or alternative technologies;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">others may design around our patent claims to produce competitive technologies, methods, applications, or products that fall outside of the scope of our patents;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">we may fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">we may not seek or obtain patent protection in countries that may eventually provide us a significant business opportunity;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">any patents issued to us may not provide a basis for commercially viable methods, applications, or products, may not provide any competitive advantages or may be successfully challenged by third parties;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a third party may challenge our patents in court and, upon such a challenge, a court may not hold that our patents are valid, enforceable and non-infringing;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">a third party may challenge our patents in various patent offices and, if challenged, we may be compelled to limit the scope of our pending, allowed or granted claims or lose some or all of the pending, allowed or granted claims altogether;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the patents of others could harm our business; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our competitors could conduct research and development activities in countries where we will not have enforceable patent rights and then use the information learned from such activities to develop competitive methods, applications, or products for sale in our major commercial markets.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we will endeavor to protect our technology with intellectual property rights such as patents, as appropriate, the process of obtaining patents is time-consuming, expensive and sometimes unpredictable, and we may not be able to file, prosecute, maintain, enforce, or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. Although we enter into non-disclosure and confidentiality agreements with parties who have access to confidential or patentable aspects of our research </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and development output, such as our employees, corporate collaborators, outside scientific collaborators, contract research organizations (&#8220;CROs&#8221;) or manufacturers, consultants, advisors and other third parties, any of these parties may breach the agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection. Furthermore, we cannot guarantee that any patents will be issued from any of our pending or future patent applications. The standards applied by the U.S. Patent and Trademark Office (&#8220;the USPTO&#8221;) and foreign patent offices in granting patents are not always applied uniformly or predictably. For example, there is no uniform worldwide policy regarding patentable subject matter or the scope of claims allowable in biotechnology or information technology patents. Moreover, the coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted after issuance. As such, we do not know the degree of future protection that we will have on our proprietary applications, products, services, and technology. Thus, even if our patent applications issue as patents, they may not issue in a form that will provide us with meaningful protection, prevent competitors from competing with us or otherwise provide us with any competitive advantage.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we have or obtain patents, we may still be barred from making, using, and selling such methods, applications, products, or services because of the patent rights of others. Others may have filed, and in the future may file, patent applications covering compositions, software applications, products, or methods that are similar or identical to ours, which could materially affect our ability to successfully develop our technology or to successfully commercialize any approved assays alone or with collaborators. Patent applications in the United States and elsewhere are generally published approximately 18 months after the earliest filing for which priority is claimed, with such earliest filing date being commonly referred to as the priority date. Therefore, patent applications could have been filed by others without our knowledge. Additionally, pending claims in patent applications which have been published can, subject to certain limitations, be later amended in a manner that could cover our platform technologies or related solutions, applications, products, and services. These patent applications may have priority over patent applications filed by us.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, and our owned and licensed patents may be challenged in the courts or patent offices in the United States and abroad. We may be subject to third party pre-issuance submissions of prior art to the USPTO, or become involved in opposition, derivation, revocation, reexamination, post-grant and&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;review, or interference proceedings challenging our patent rights. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our applications, products, services and technology and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize applications, products, or provide services without infringing third-party patent rights. Moreover, we, or our licensors, may have to participate in interference proceedings declared by the USPTO to determine priority of invention or in post-grant challenge proceedings, such as oppositions in a foreign patent office, that challenge priority of invention or other features of patentability. Such challenges may result in loss of patent rights, loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or identical applications, products, services, and technology, or limit the duration of the patent protection of our applications, products, services, and technology. Such proceedings also may result in substantial cost and require significant time from our employees and management, even if the eventual outcome is favorable to us. In addition, if the breadth or strength of protection provided by the patents and patent applications we own or in-license is threatened, it could dissuade companies from collaborating with us to license, develop or commercialize current or future technology.&#160;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, third parties may be able to develop technology that is similar to, or better than, ours in a way that is not covered by the claims of our patents or may have blocking patents that could prevent us from marketing our applications and products or practicing our own patented technology. Moreover, patents have a limited lifespan. In the United States, the natural expiration of a patent is generally 20 years after it is filed and the life of a patent, and the protection it affords, is limited. Without patent protection for current or future methods and related solutions, applications, products, and services, we may face competing technology. Given the amount of time required for the development and testing, and regulatory review where necessary, patents protecting such technology might expire before or shortly after such technology is commercialized. At the same time, given the rapid pace of technological advancement and innovation in the information technology field, the time needed to obtain patents for novel information technology solutions often renders the protection, once obtained, ineffective if the protected solution has become obsolete or widely-adopted while the patent protection was pending. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing technology similar or identical to that we or our collaborators may develop.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, certain of our patents and patent applications may in the future be, co-owned with third parties. If we are unable to obtain an exclusive license to any such third party co-owners&#8217; interest in such patents or patent applications, such co-owners may be able to use or license their rights to other third parties, including our competitors, and our competitors could market competing applications, products, and technology. In addition, we may need the cooperation of any such co-owners of our patents in order to enforce such patents against third parties, and such cooperation may not be provided to us. Any of the foregoing could have a material adverse effect on our business, financial conditions, results of operations, and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may in the future be involved in lawsuits to defend or enforce our patents and proprietary rights. Such disputes could result in substantial costs or loss of productivity, delay or prevent the development and commercialization of our technology, applications, products, and services, prohibit our use of proprietary technology or put our patents and other proprietary rights at risk.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors and other third parties may infringe, misappropriate or otherwise violate our patents and intellectual property rights or the patents and intellectual property rights of our licensors. The enforcement of such claims can be expensive and time-consuming. In an infringement proceeding, a court may decide that a patent owned or in-licensed by us is invalid or unenforceable or may refuse to stop the other party from using the technology at issue on the grounds that our owned and in-licensed patents do not cover the technology in question. An adverse result in any litigation proceeding could put one or more of our owned or in-licensed patents at risk of being invalidated or interpreted narrowly. In addition, our ability to enforce our patents or other intellectual property rights depends on our ability to detect infringement. It may be difficult to detect those who infringe on our intellectual property rights who do not advertise the components or methods that are used in connection with their applications, products, and services. Moreover, it may be difficult or impossible to obtain evidence of infringement in a competitor&#8217;s or potential competitor&#8217;s application, product, or service.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we were to initiate legal proceedings against any other third party to enforce a patent covering our technology, the defendant could assert that our patent is invalid or unenforceable. In patent litigation in the United States and Europe, defendants alleging invalidity or unenforceability are common responses to a claim of infringement. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, for example, lack of novelty, obviousness, overbreadth or lack of utility. Third parties might allege unenforceability of our patents because during prosecution of the patent, an individual connected with such prosecution withheld relevant information or made a misleading statement. Third parties may also raise challenges to the validity of our patent claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include re-examination, post-grant review,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;review, interference proceedings, derivation proceedings, and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings). Such proceedings could result in the revocation of, cancellation of, or amendment to, our patents in such a way that they no longer cover our technology, applications, or products. The outcome of proceedings involving assertions of invalidity and unenforceability, including during patent litigation, is unpredictable. With respect to the validity of patents, for example, we cannot be certain that there is no invalidating prior art of which we and the patent examiner were unaware during prosecution, but that an adverse third party may identify and submit in support of such assertions of invalidity. If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on our technology. Such a loss of patent protection could have a material adverse effect on our business. Our patents and other intellectual property rights also will not protect our technology if competitors design around our protected technology without infringing our patents or other intellectual property rights.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our personnel from their normal responsibilities. There can be no assurance that we will have sufficient financial or other resources to file and pursue infringement claims, which typically last for years before they are concluded. We may or may not choose to pursue litigation or other actions against those who have infringed on our patents, or have used them without authorization, due to the associated expense and time commitment of monitoring these activities. In addition, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our ordinary shares. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or commercialization activities. We may not have sufficient financial or other resources to conduct such litigation or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proceedings adequately. Uncertainties resulting from patent and other intellectual property litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace, our ability to raise additional funds, and could otherwise have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are, and we may in the future be, subject to claims against us alleging that we are infringing, misappropriating or otherwise violating the intellectual property rights of third parties, the outcome of which would be uncertain and could have a material adverse effect on our business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends in part upon our ability to develop, manufacture, market, and sell our applications, products, and services and use our proprietary technology without infringing, misappropriating or otherwise violating the patents or other intellectual property or proprietary rights of third parties. Litigation relating to infringement, misappropriation or other violations of patents and other intellectual property rights in the biotechnology industry is common, including patent infringement lawsuits, trade secret lawsuits, interferences, oppositions, and&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;review, post-grant review and re-examination proceedings before the USPTO, and corresponding international patent offices.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this regard, we are currently defending against patent infringement claims brought by Guardant Health ("Guardant") in multiple jurisdictions. Guardant filed suit against us in the U.K. in July 2025, and in the EU at the Unified Patent Court (the &#8220;UPC&#8221;) in Paris in August 2025, alleging that our MSK-Access liquid biopsy test infringes certain of their patents and seeking remedies, including unspecified monetary damages and injunctive relief. In the U.K. action, Guardant claims relief in respect of activities in the U.K. said to infringe four patents: EP 3470533 (titled "Systems and Methods to Detect Copy Number Variation"), GB 2510725 (titled "Systems and Methods to Detect Rare Mutations and Copy Number Variation"), EP 3766986 (titled "Detection and Treatment of Disease Exhibiting Disease Cell Heterogeneity and Systems and Methods for Communicating Test Results"), and EP 3443066 (titled "Methods for Early Detection of Cancer"). In the UPC proceedings, Guardant named Sophia Genetics SA, Sophia Genetics SAS, Sophia Genetics SRL, and Sophia Genetics GmbH as defendants and alleged infringement in Belgium, Germany, France, Italy, the Netherlands, Sweden, Switzerland, and Spain, asserting EP 3470533, EP 3591073 (titled "Methods to Detect Rare Mutations and Copy Number Variation"), EP 3766986, and EP 3443066.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 23, 2026, the UPC Paris Local Division issued a final order rejecting Guardant's application for provisional measures and ordered Guardant to pay an interim award of costs of &#8364;400,000. The UPC rejected Guardant's application under three asserted patents (EP 3591073, EP 3443066, and EP 3766986), and Guardant withdrew its request regarding a fourth patent (EP 3470533). On February 9, 2026, Guardant filed an appeal challenging the UPC's finding that EP 3443066 was more likely than not invalid. On February 17, 2026, the UPC Paris Local Division set a payment deadline of March 10, 2026, for this interim costs award. On February 18, 2026, the Court of Appeal rejected Guardant's application for suspensive effect of the interim costs award. We expect to receive payment of the EUR 400,000 interim costs award by March 10, 2026, and are separately pursuing reimbursement of additional legal costs. For further details regarding the Guardant Health litigation, see "Recent Developments&#8212;Guardant Health Litigation." Patent litigation is inherently uncertain, and even favorable preliminary rulings do not guarantee ultimate success. An adverse outcome in any of these or other patent infringement claims could require us to cease selling certain products in major markets, pay significant damages, or obtain licenses on unfavorable terms, any of which could materially harm our business, financial condition, and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These pending litigation cases resulted in higher legal expenses in the second half of 2025 of approximately $2.4 million, and we could incur further costs and divert the attention of our management and technical personnel in defending ourselves against these claims. Furthermore, Guardant may in the future be able to obtain injunctive or other relief, which effectively could block our ability to further develop, commercialize, market or sell products or services in certain jurisdictions, such as the United Kingdom and European Union. Any adverse ruling or perception of an adverse ruling in defending ourselves against these claims could have an adverse impact on our business, financial condition or results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the litigation brought by Guardant alleging patent infringement as set out above, we may in the future be, subject to other third-party claims and similar adversarial proceedings or litigation regarding our infringement, misappropriation, or any other violation of a third party&#8217;s patent or other intellectual property rights. Any such claim or proceeding against us, our collaborators or our third-party service providers could adversely </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">affect our development, manufacturing, marketing, sales, and other commercialization activities. Even if we believe third-party intellectual property claims are without merit, there is no assurance that a court would find in our favor on questions of infringement, validity, enforceability or priority. A court of competent jurisdiction could hold that third-party patents asserted against us are valid, enforceable, and infringed, which could materially and adversely affect our ability to develop, manufacture, market, sell and commercialize any of our applications, products, or services. In order to successfully challenge the validity of any such U.S. patent in federal court, we would need to overcome a presumption of validity. As this burden is a high one requiring us to present clear and convincing evidence as to the invalidity of any such U.S. patent claim, there is no assurance that a court of competent jurisdiction would invalidate the claims of any such U.S. patent. If we are found to infringe any third party&#8217;s patents or other intellectual property rights, and we are unsuccessful in demonstrating that such patents or other intellectual property are invalid or unenforceable, we could be required to obtain a license from such third party to continue developing, manufacturing, marketing, selling, and commercializing our applications, products, and services. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, which would give our competitors and other third parties access to the same technologies licensed to us, and it could require us to make substantial licensing, royalty, and other payments. We also could be forced, including by court order, to cease developing, manufacturing, marketing, selling, and commercializing the infringing application, product, or technology. In addition, we could be found liable for significant monetary damages, including treble damages and attorneys&#8217; fees, if we are found to have willfully infringed a patent or other intellectual property right. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The various markets in which we plan to operate are subject to frequent and extensive litigation regarding patents and other intellectual property rights. It is possible that one or more organizations will hold patent rights to which we will need a license. If those organizations refuse to grant us a license to such patent rights on reasonable terms, we may be unable to develop, manufacture, market, sell, and commercialize applications, products, or services or perform research and development or other activities covered by these patents. Some claimants may have substantially greater resources than we do and may be able to sustain the costs of complex intellectual property litigation to a greater degree and for longer periods of time than we could. In addition, many companies in intellectual property-dependent industries, including the biotechnology industry, have employed intellectual property litigation as a means to gain an advantage over their competitors. Furthermore, patent holding companies that focus solely on extracting royalties and settlements by enforcing patent rights may target us. As the biotechnology industry expands and more patents are issued, and as we gain greater visibility and market exposure as a public company, the risk increases that our applications, products, services, and technology may be subject to intellectual property-related claims by third parties.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our personnel from their normal responsibilities. In addition, intellectual property litigation, regardless of its outcome, may cause negative publicity, adversely impact prospective customers, cause product shipment delays or prohibit us from manufacturing, marketing, selling or otherwise commercializing our applications, products, services, and technology. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our ordinary shares. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or commercialization activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Uncertainties resulting from patent and other intellectual property litigation or other proceedings could have a material adverse effect on our ability to compete in the marketplace, our ability to raise additional funds, and could otherwise have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We license patent rights from third-party owners. If such owners do not properly or successfully obtain, maintain, defend and enforce the patents underlying such licenses, or if they retain or license to others any competing rights, our competitive position and business prospects may be adversely affected. If we fail to comply with our obligations in the agreements under which we license intellectual property rights </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">from third parties or otherwise experience disruptions to our relationships with any of our licensors, we could lose license rights that are important to our business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even though we actively file patent applications, we also rely on intellectual property rights licensed from third parties to protect our technology, including licenses that give us rights to third-party intellectual property that is necessary or useful for our business. For example, we are dependent on licenses from Normandie Valorisation for certain products we commercialize. If one or both of our license agreements with Normandie Valorisation were to terminate for any reason, we may be required to cease the manufacturing, marketing, selling, and commercialization of certain products. For more information regarding these license agreements, please see &#8220;Item 10. Additional Information&#8212;C. Material Contracts.&#8221;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also may license additional third-party intellectual property in the future. Our success will depend in part on the ability of our licensors to obtain, maintain, protect, and enforce patent protection for our licensed intellectual property, in particular, those patents to which we have secured exclusive rights. These licenses, and other licenses we may enter into in the future, may not provide adequate rights to use such intellectual property and proprietary technologies in all relevant fields of use or in all territories in which we may wish to develop or commercialize technology, applications, products, and services in the future. In some cases, patent prosecution of our licensed technology is controlled by the licensor. Therefore, we cannot be certain that these patents and patent applications will be prepared, filed, prosecuted, and maintained in a manner consistent with the best interests of our business. For example, under our license agreements with Normandie Valorisation, Normandie Valorisation controls the prosecution, maintenance and defense of the patents licensed to us pursuant to the agreements. Our licensors may not successfully prosecute the patent applications licensed to us, by failing to draft or prosecute the patents and patent applications licensed to us in compliance with applicable laws and regulations, which may affect the validity and enforceability of such patents or any patents that may issue from such applications. Even if patents issue or are granted, our licensors may fail to maintain these patents, may determine not to pursue litigation against other companies that are infringing these patents, or may pursue litigation less aggressively than we would. Further, we may not obtain exclusive rights, which would allow for third parties to develop competing applications and products. In addition, our licensors may have relied on third-party consultants or collaborators or on funds from third parties such that our licensors are not the sole and exclusive owners of the patents we in-licensed. If our licensors fail to obtain and maintain a patent or other protection for the proprietary intellectual property we license from such licensor, we could lose our rights to such intellectual property or the exclusivity of such rights, and our competitors could market competing technology using such intellectual property. In that event, we may be required to expend significant time and resources to develop or license replacement technology. If we are unable to do so, we or our collaborators may be unable to develop or commercialize the affected technology, which could adversely affect our competitive business position and harm our business prospects.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our existing license agreements impose, and we expect that future license agreements will impose, various development, commercialization, royalty, diligence, patent prosecution and enforcement, and other obligations on us. If we breach any of these obligations, we may be required to pay damages and the licensor may have the right to terminate the license, which could result in our being unable to commercialize related solutions, applications, products, or services that are covered by these agreements, which could materially adversely affect the value of any such technology and our business. In spite of our efforts, our licensors might conclude that we have breached our obligations under such license agreements, and might therefore terminate the license agreements. Termination of these agreements or reduction or elimination of our rights under these agreements may result in our having to negotiate new or reinstated agreements with less favorable terms, or cause us to lose our rights under these agreements, including our rights to important intellectual property or technology. In addition, while we cannot currently determine the amount of the royalty obligations we would be required to pay on sales of future applications and products, if any, the amounts may be significant. The amount of our future royalty obligations will depend on the technology and intellectual property we use in the applications, products, and services that we successfully develop and commercialize, if any. Therefore, even if we successfully develop and commercialize applications, products, and services, we may be unable to achieve or maintain profitability.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, disputes may arise under our license agreements, including regarding the payment of the royalties or other payments due to licensors in connection with our exploitation of the rights we license from them. For example, licensors may contest the basis of royalties we retained and claim that we are obligated to make payments under a broader basis. In addition to the costs of any litigation we may face as a result, any legal </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action against us could increase our payment obligations under the respective agreement and require us to pay interest and potentially damages to such licensors.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disputes may arise regarding intellectual property subject to a license agreement, including those relating to:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the scope of rights, if any, granted under the license agreement and other interpretation-related issues;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the amounts of royalties due under the license agreement;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">whether, and the extent to which, our technology and processes infringe, misappropriate or otherwise violate intellectual property of the licensor that is not subject to the license agreement;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our diligence obligations under the license agreement and what activities satisfy those diligence obligations;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the sublicensing of patent and other rights under the license agreements;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the inventorship and ownership of inventions and know-how resulting from the creation or use of intellectual property by our licensors and by us and our collaborators; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the priority of invention of patented technology.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements under which we currently license intellectual property or technology from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology or increase what we believe to be our financial or other obligations under the relevant agreement. Such disputes may be costly to resolve and may divert management&#8217;s attention away from day-to-day activities. If disputes over intellectual property that we have licensed from third parties prevent or impair our ability to maintain our licensing arrangements on acceptable terms, we or our collaborators may be unable to successfully develop and commercialize the affected technology, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be successful in obtaining necessary rights to any applications, products, or services we may develop through acquisitions and in-licenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have rights to intellectual property, through licenses from third parties, to identify and develop certain applications, products, services and technology. Many pharmaceutical companies, biotechnology companies and academic institutions are competing with us and filing patent applications potentially relevant to our business. In order to avoid infringing these third-party patents, we may find it necessary or prudent to obtain licenses from such third-party intellectual property holders.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, we may be unable to secure such licenses or otherwise acquire or in-license any compositions, methods of use, processes or other intellectual property rights from third parties that we identify as necessary for our business. The licensing or acquisition of third-party intellectual property rights is a competitive area, and several more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources, and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. If we are unable to successfully obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, it could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will not seek to protect our intellectual property rights in all jurisdictions throughout the world, and we may not be able to adequately enforce our intellectual property rights even in the jurisdictions where we seek protection.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filing, prosecuting, and defending patents in all countries and jurisdictions throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States could be less extensive than those in the United States, assuming that rights are obtained in the United States. In-licensing patents covering our technology in all countries throughout the world may similarly be prohibitively expensive, if such opportunities are available at all. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States, even in jurisdictions where we do pursue patent protection. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, even in jurisdictions where we do pursue patent protection, or from selling or importing our technology in and into the United States or other jurisdictions.&#160;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally apply for patents in those countries where we intend to make, have made, use or offer for sale our applications, products, or services, and where we assess the risk of infringement to justify the cost of seeking patent protection. However, we may not seek protection in all countries where we will commercialize our applications, products, and services and we may not accurately predict all the countries where patent protection would ultimately be desirable. If we fail to timely file a patent application in any such country or major market, we may be precluded from doing so at a later date. Competitors may use our technology in jurisdictions where we do not pursue and obtain patent protection to develop their own assays and products and may export otherwise infringing assays and products to territories where we have patent protection, but where our ability to enforce our patent rights is not as strong as in the United States. These applications, products, and services may compete with technologies that we or our collaborators may develop, and our patents or other intellectual property rights may not be effective or sufficient to prevent such competition.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of some other countries do not protect intellectual property rights to the same extent as the laws of the United States. Patent protection must ultimately be sought on a country-by-country basis, which is an expensive and time-consuming process with uncertain outcomes. Accordingly, we may choose not to seek patent protection in certain countries, and we will not have the benefit of patent protection in such countries. In addition, the legal systems of some countries, particularly developing countries, do not favor the enforcement of patents and other intellectual property protection, particularly those relating to biopharmaceuticals or biotechnologies. As a result, many companies have encountered significant difficulties in protecting and defending intellectual property rights in certain jurisdictions outside the United States. Such issues may make it difficult for us to stop the infringement of our patents, if obtained, or the misappropriation or other violation of our other intellectual property rights. For example, many other countries, including countries in the EU, have compulsory licensing laws under which a patent owner must grant licenses to third parties. In addition, many countries limit the enforceability of patents against third parties, including government agencies or government contractors. In these countries, patents may provide limited or no benefit. In those countries, we and our licensors may have limited remedies if patents are infringed or if we or our licensors are compelled to grant a license to a third party, which could materially diminish the value of those patents and could limit our potential revenue opportunities. Accordingly, our and our licensors&#8217; efforts to enforce intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we own or license.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, subject our patents to the risk of being invalidated or interpreted narrowly, subject our patent applications to the risk of not issuing or provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded to us, if any, may not be commercially meaningful, while the damages and other remedies we may be ordered to pay such third parties may be significant.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to execute invention assignment agreements with our employees and consultants or protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to seeking patent protection for certain aspects of our technology, we also consider trade secrets, including confidential and unpatented know-how, important to the maintenance of our competitive position. We protect trade secrets and confidential and unpatented know-how, in part, by entering into non-disclosure and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">confidentiality agreements with parties who have access to such knowledge, such as our employees, corporate collaborators, outside scientific collaborators, CROs, or manufacturers, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants that obligate them to maintain confidentiality and assign their inventions to us.&#160;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary technology and processes or that the assignment agreements that have been entered into are self-executing. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, or claim ownership in intellectual property that we believe is owned by us. Monitoring unauthorized uses and disclosures of our intellectual property is difficult, and we do not know whether the steps we have taken to protect our intellectual property will be effective. In addition, we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts in the United States and certain foreign jurisdictions are less willing or unwilling to protect trade secrets.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, our competitors or other third parties may independently develop knowledge, methods and know-how equivalent to our trade secrets or seek to reverse-engineer our technology for which we do not have patent protection. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third parties, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be harmed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject both in the United States and outside the United States to various regulatory schemes regarding requests for the information we provide to regulatory authorities, which may include, in whole or in part, trade secrets or confidential commercial information. While we are likely to be notified in advance of any disclosure of such information and would likely object to such disclosure, there can be no assurance that our challenge to the request would be successful. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have in the past and may in the future be subject to claims that our employees, consultants or advisors have wrongfully used or disclosed trade secrets or other confidential information of their current or former employers or claims asserting ownership of what we regard as our own intellectual property.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our employees, consultants and advisors are currently or were previously employed at universities, research institutes or other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants and advisors do not use the proprietary information or know-how of others in their work for us, we have in the past and may in the future be subject to claims that we or these individuals have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#8217;s current or former employer. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, while it is our policy to require our employees and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached or invalid, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Such claims could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our registered or unregistered trademarks or trade names may be challenged, infringed, circumvented, declared generic, cancelled or determined to be infringing on other marks. As a means to enforce our trademark </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rights and prevent infringement, we may be required to file trademark claims against third parties or initiate trademark opposition proceedings. This can be expensive, particularly for a company of our size, and time-consuming. In addition, in an infringement proceeding, a court may decide that a trademark of ours is not valid or is unenforceable, or may refuse to stop the other party from using the trademark at issue. We may not be able to protect our rights to these and other trademarks and trade names or may be forced to stop using these names, which we may need to build name recognition with potential collaborators or customers in our markets of interest.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have certain trademark applications pending in the United States and abroad, but there can be no assurance that these applications will be allowed and not opposed. Any denial of our trademark applications or adverse ruling in any opposition proceedings could prevent us from differentiating our applications, products and/or services and maintaining consistency across our brand. Even if these applications proceed to registration, third parties may challenge our use or registration of these trademarks in the future. In the event that our trademarks are successfully challenged, we could be forced to rebrand our applications and products, which could result in loss of brand recognition and could require us to devote resources to advertising and marketing new brands. Other biotechnology companies may be using trademarks that are similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, they may infringe our trademarks and we may not have adequate resources to enforce our trademarks. If we attempt to enforce our trademarks and assert trademark infringement claims, a court may determine that the party against whom we have asserted trademark infringement has superior rights to the marks in question. In this case, we could ultimately be forced to cease use of such trademarks. Furthermore, there could be potential trade name or trademark infringement claims brought by owners of other trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Failure to maintain our trademark registrations, or to obtain new trademark registrations in the future, could limit our ability to protect our trademarks and impede our marketing efforts in the countries in which we operate. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We utilize artificial intelligence, including in our SOPHiA DDM Platform and related solutions, applications, products and services, which could expose us to liability or adversely affect our business</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use artificial intelligence, generative artificial intelligence, machine learning and similar tools and technologies (collectively, &#8220;AI&#8221;) in connection with our business, including in our SOPHiA DDM Platform and related solutions, applications, products and services, and may in the future expand our use of AI. The use of AI poses risks such as incomplete or inaccurate data, human error, or lack of appropriate controls and processes, and the use of generative artificial intelligence, a relatively new and emerging technology in the early stages of commercial use, exposes us to additional risks, each including damage to our reputation, competitive position, and business, legal and regulatory risks and additional costs. For example, generative artificial intelligence has been known to produce false or &#8220;hallucinatory&#8221; inferences or output, and certain generative artificial intelligence uses machine learning and predictive analytics, which can create inaccurate, incomplete, or misleading content, unintended biases and other discriminatory or unexpected results, errors or inadequacies, any of which may not be easily detectable by us or any of our related service providers. Accordingly, while AI systems may help provide more tailored or personalized user experiences, if the content, analyses, or recommendations that AI systems assist in producing in our products and solutions are, or are perceived to be, deficient, inaccurate, biased, unethical or otherwise flawed, our reputation, competitive position and business may be materially and adversely affected. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if any of our employees, contractors, consultants, vendors or service providers use any third-party AI-powered software in connection with our business or the services they provide to us, it may lead to the inadvertent disclosure or incorporation of our confidential information into publicly available training sets, which may impact our ability to realize the benefit of, or adequately maintain, protect and enforce our intellectual property or confidential information, harming our competitive position and business. Any output created by us using AI tools may not be subject to copyright protection, which may adversely affect our intellectual property rights in, or ability to commercialize or use, any such content. In the United States, a number of civil lawsuits have been initiated related to the foregoing and other concerns, any one of which may, among other things, require us to limit the ways in which our AI systems are trained and may affect our ability to develop our AI-powered products and solutions. To the extent that we do not have sufficient rights to use the data or other material or content used in or produced by the AI tools used in our business, or if we experience cybersecurity </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incidents in connection with our use of AI, it could adversely affect our reputation and expose us to legal liability or regulatory risk, including with respect to third-party intellectual property, privacy, data protection and cybersecurity, publicity, contractual or other rights. Further, our competitors or other third parties may incorporate AI into their products more quickly or more successfully than us, which could impair our ability to compete effectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the regulatory framework for AI and similar technologies, and automated decision making, is changing rapidly. It is possible that new laws and regulations will be adopted in the United States and in non-U.S. jurisdictions, or that existing laws and regulations may be interpreted, in ways that would affect the operation of our products and solutions and the way in which we use AI and similar technologies. For example, in Europe, on August 1, 2024, the European Union's Artificial Intelligence Act (the &#8220;AI Act&#8221;) was entered into force. The AI Act establishes, among other things, a risk-based governance framework for regulating AI systems operating in the European Union. This framework would categorize AI systems, based on the risks associated with such AI systems' intended purposes, as creating unacceptable or high risks, with all other AI systems being considered low risk. We may not be able to adequately anticipate or respond to these evolving laws and regulations, and we may need to expend additional resources to adjust our offerings in certain jurisdictions if applicable legal frameworks are inconsistent across jurisdictions. Moreover, because these technologies are themselves highly complex and rapidly developing, it is not possible to predict all of the legal or regulatory risks that may arise relating to our use of such technologies. Further, the cost to comply with such laws or regulations could be significant and would increase our operating expenses, which could adversely affect our business, financial condition and results of operations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the utilization of AI becomes more prevalent, we anticipate that it will continue to present new or unanticipated ethical, reputational, technical, operational, legal, competitive and regulatory issues, among others. We expect that our incorporation of AI in our business will require additional resources, including the incurrence of additional costs, to develop and maintain our products and solutions and features to minimize potentially harmful or unintended consequences, to comply with applicable and emerging laws and regulations, to maintain or extend our competitive position, and to address any ethical, reputational, technical, operational, legal, competitive or regulatory issues which may arise as a result of any of the foregoing. As a result, the challenges presented with our use of AI could adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our AI and machine learning algorithms may experience performance degradation over time due to data drift, evolving genomic knowledge or changes in clinical practice, requiring costly retraining, revalidation or regulatory resubmission and potentially causing temporary performance gaps that could harm our reputation, customer relationships and financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AI and machine learning models that form core components of our SOPHIA DDM platform are trained and validated on genomic, clinical and other data that reflect the state of sequencing technologies, sample preparation methods, disease biology, patient populations, variant classification standards and clinical knowledge at a point in time. The performance of these models may degrade over time due to a variety of factors, including data drift (changes in the statistical distribution of input data caused by adoption of new sequencing instruments, changes in library preparation kits or reagents, shifts in the demographic or clinical characteristics of tested patient populations, changes in disease prevalence or stage at diagnosis, or differences in sample quality or specimen types), concept drift (evolution of the underlying scientific or clinical knowledge such as reclassification of variants in public databases like ClinVar, updates to gene-disease associations, changes in treatment paradigms that alter the clinical significance of biomarkers, or refinement of pathogenicity prediction criteria), adversarial evolution (emergence of novel genomic alterations, fusion transcripts, resistance mutations or tumor escape mechanisms that were not represented in training datasets), infrastructure changes (updates to cloud computing environments, software dependencies, third-party bioinformatics tools or reference databases that subtly alter computational outputs or introduce version incompatibilities), and other factors. When we detect performance degradation, or when customers, regulators or other stakeholders raise concerns about analytical accuracy or clinical utility, we may need to suspend or limit the use of affected algorithms or features while we investigate the root cause, retrain models on updated and more representative datasets (which may be costly, time-consuming and require access to additional data that may be difficult to obtain), revalidate analytical and clinical performance through internal testing or external studies, update our labeling, instructions for use or marketing materials, communicate changes to customers and manage their expectations regarding temporarily reduced functionality or performance, and potentially seek </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">new or modified regulatory clearances, submit notifications to regulatory authorities regarding significant algorithm modifications, or conduct post-market surveillance studies. During investigation, retraining and revalidation periods, we may experience gaps in platform functionality, customer dissatisfaction, loss of competitive advantage if competitors offer superior or more current solutions, heightened regulatory scrutiny, adverse publicity, difficulty acquiring new customers or retaining existing customers, reduction in usage volumes or subscription renewals, or product liability exposure if performance degradation contributed to suboptimal clinical decisions. Additionally, if we fail to detect performance degradation in a timely manner, or if our monitoring and quality control systems do not identify emerging issues before they affect customer results, we may unknowingly deliver outputs of diminished accuracy or clinical utility, exposing us to professional liability claims, regulatory warning letters or enforcement actions, customer contract breaches, reputational harm, and loss of trust in our platform. Any material performance degradation of our AI algorithms, or any failure to promptly detect and remediate such degradation, could materially harm our business, results of operations, financial condition and prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our use of &#8220;open-source&#8221; software could subject our proprietary software to general release, adversely affect our ability to sell our applications and products or provide our services, and subject us to possible litigation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the applications, products, or technologies licensed, developed or distributed by us incorporate so-called &#8220;open-source&#8221; software, and we may incorporate open-source software into other applications, products, or technologies in the future. Such open-source software is generally licensed by its authors or other third parties under open-source licenses. Some open-source licenses may contain requirements that we disclose source code for modifications we make to the open-source software and that we license such modifications to third parties at no cost. In some circumstances, distribution of our software in connection with open-source software could require that we disclose and license some or all of our proprietary code in that software as well as distribute our applications and products that use particular open-source software at no cost to the user.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor our use of open-source software in an effort to avoid uses in a manner that would require us to disclose or grant licenses under our proprietary source code; however, there can be no assurance that such efforts will be successful. Open-source license terms are often ambiguous and such use could inadvertently occur. There is little legal precedent governing the interpretation of many of the terms of certain of these licenses, and the potential impact of these terms on our business may result in unanticipated obligations regarding our applications, products, and technologies.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies that incorporate open-source software into their applications and products have, in the past, faced claims seeking enforcement of open-source license provisions and claims asserting ownership of open-source software incorporated into their applications and products. If an author or other third party that distributes such open-source software were to allege that we had not complied with the conditions of an open-source license, we could incur significant legal costs from defending ourselves against such allegations. In the event such claims were successful, we could be subject to significant damages or be enjoined from the distribution of our applications and products. In addition, if we combine our proprietary software with open-source software in certain ways, under some open-source licenses we could be required to release the source code of our proprietary software, which could substantially help our competitors develop applications, products, and services that are similar to or better than ours and otherwise have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our applications and products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in either the patent laws or interpretation of the patent laws in the United States could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. Changes in either the patent laws or the interpretation of the patent laws in the United States or other jurisdictions could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. Depending on future actions by the U.S. Congress, the U.S. courts, the USPTO and the relevant law-making bodies in other countries, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our existing patent portfolio and our ability to protect and enforce our intellectual property in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Financial Position and Capital Requirements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred net losses since our inception and expect to continue to incur losses for the foreseeable future. We may never achieve or sustain profitability.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred losses since our inception and expect to continue to incur losses for the foreseeable future. For the years ended December 31, 2025 and 2024, we reported net losses of $79.0 million and $62.5 million, respectively. As of December 31, 2025, we had an accumulated deficit of $519.3 million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to incur net losses for the foreseeable future as we continue to devote substantial resources to (i)&#160;research and development, in particular to further expand and enhance the features, applications and data modalities of our SOPHiA DDM Platform in order to accommodate multimodal data analytics capabilities across a wide range of disease areas; (ii)&#160;expanding selling and marketing efforts for our SOPHiA DDM Platform, in particular to drive new customer adoption with clinical customers and biopharmaceutical companies; (iii)&#160;establishing and maintaining relationships with our collaborators and customers across the healthcare system; and (iv)&#160;obtaining regulatory clearance or approval to offer our applications and products as IVD applications and products for diagnostic use. We may encounter unforeseen expenses, difficulties, complications, delays and unknown factors that may adversely affect our business. The size of our future net losses will depend, in part, on the rate of growth of our expenses and of our revenue. In addition, we have incurred and expect to continue to incur increased general and administrative expenses associated with operating as a public company. Our net losses may fluctuate significantly from quarter to quarter and from year to year.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the numerous risks and uncertainties associated with our research and development and commercialization efforts, although we have stated our desire to become cash flow positive in the next few years, we may not be able to achieve this goal. We may never become profitable or cash flow positive. Even if we achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to achieve or sustain profitability could depress our market value and could impair our ability to raise capital, and execute our business plan, develop additional applications, products, and services and continue our operations. A decline in the value of our company could cause our shareholders to lose all or part of their investment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may need to raise additional capital to fund our existing operations; further develop our SOPHiA DDM Platform, applications, and products; commercialize our applications, products, and services; and expand our operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have used substantial amounts of cash. The research and development process as well as selling and marketing efforts are capital intensive and we expect that we will continue to expend substantial resources for the foreseeable future to develop, commercialize and market additional features, applications and data modalities of our SOPHiA DDM Platform and related solutions, applications, products, and services. In addition, we may also raise capital to expand our business and pursue strategic investments, to take advantage of financing opportunities or for other reasons. Additional funds may not be available when we need them or on terms that are acceptable to us. Our ability to raise additional funds will depend on financial, economic and market conditions and other factors, over which we may have no or limited control. Further, as a Swiss company, we have less flexibility to raise capital, particularly in a quick and efficient manner, as compared to U.S. companies. See &#8220;&#8212;Risks Related to Our Securities&#8212;Our shareholders enjoy certain rights that may limit our flexibility to raise capital, issue dividends and otherwise manage ongoing capital needs.&#8221; The restrictions contained in our contractual agreements may also limit our ability to raise capital. For example, subject to certain exceptions, the Perceptive Credit Agreement restricts our ability to incur additional indebtedness. If adequate funds are not available to us on a timely basis or on terms acceptable to us, we may be required to delay, limit, reduce or terminate our research and development, commercialization and growth efforts.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek additional capital through a variety of means, including through public and private equity offerings and debt financings, credit and loan facilities and collaborations. If we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of such equity or convertible debt securities may include liquidation or other preferences that are senior to or otherwise adversely affect your rights as a shareholder. If we raise additional capital through the sale of debt securities or through entering into credit or loan facilities, we may be restricted in our ability to take certain actions, such as incurring additional debt, making capital expenditures, acquiring or licensing intellectual property rights, declaring </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dividends or encumbering our assets to secure future indebtedness. Such restrictions could adversely impact our ability to conduct our operations and execute our business plan. If we raise additional capital through collaborations with third parties, we may be required to relinquish valuable rights to our intellectual property, technology, applications, and products or we may be required to grant licenses for our intellectual property, technology, applications, and products on unfavorable terms.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our indebtedness under the Perceptive Credit Agreement and the associated restrictive covenants thereunder could adversely affect our financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indebtedness under the Perceptive Credit Agreement requires us to dedicate a substantial portion of our cash and cash equivalents to the payment of interest on, and principal of, the indebtedness, thereby reducing the amounts available to fund working capital, capital expenditures, research and development efforts, commercialization efforts and other general corporate purposes. Indebtedness under the Perceptive Credit Agreement bears variable rates of interest based on the prevailing SOFR, thereby making us more vulnerable to rising interest rates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Perceptive Credit Agreement contains certain restrictions on our activities and customary covenants, including an affirmative covenant to maintain qualified cash of at least $3.0 million and an affirmative last twelve months revenue covenant of $67.4 million as of December 31, 2025, and negative covenants including limitations on indebtedness, liens, fundamental changes, asset sales, investments, dividends and other restricted payments and other matters customarily restricted in such agreements. The obligations under the Perceptive Credit Agreement are secured by substantially all of our and certain of our subsidiaries&#8217; assets. Such covenants could limit our flexibility in planning for, or reacting to, changes in our business and our industry; place us at a competitive disadvantage compared to our competitors who have less debt or competitors with comparable debt on more favorable terms; and limit our ability to borrow additional amounts.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to maintain compliance with the covenants imposed by our indebtedness and to repay the principal of, pay interest on and refinance our indebtedness depends on our future performance, which is subject to economic, financial, competitive and other factors, many of which are beyond our control. If we are unable to comply with the covenants imposed by our indebtedness or to generate sufficient cash flow to service or repay our indebtedness, we may be in default of the Perceptive Credit Agreement and be required to adopt one or more alternatives, such as restructuring debt or obtaining additional financing on terms that may be unfavorable to us or highly dilutive.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may fluctuate significantly or may fall below the expectations of investors or securities analysts, each of which may cause the price of our ordinary shares to fluctuate or decline.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly and annual operating results may fluctuate significantly. This fluctuation may be as a result of a variety of factors, many of which are outside our control and, as a result, may not fully reflect the underlying performance of our business. The cumulative effects of these factors could result in large fluctuations and unpredictability in our quarterly and annual financial results. Because a substantial portion of our expenses are relatively fixed in the short-term and require time to adjust, our results of operations and liquidity would suffer if revenue falls below our expectations in a particular period. If our operating results fall below the expectations of investors or securities analysts, the price of our ordinary shares could decline substantially. Furthermore, any fluctuations in our operating results may, in turn, cause the price of our ordinary shares to fluctuate substantially. We believe that quarterly comparisons of our financial results are not necessarily meaningful and should not be relied upon as an indication of our future performance.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to sufficiently reduce our costs to achieve sustainable gross margins.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating our business is costly, and we expect our expenses to continue to increase in the future as we broaden our customer base and expand our platform, applications, services, and product offerings. In particular, a significant portion of our business, including our SOPHiA DDM Platform, is provided through a cloud-native software platform and computational and storage-related costs and fees constitute a significant portion of our cost of revenue. While we seek to negotiate favorable economic arrangements with respect to computational and storage-related costs and fees, in the near term, we expect that our gross profit margin will be adversely impacted by such fees and costs as we have purchased, and may be required to continue to purchase, increased capacity at less favorable rates in order to address increased demand for our SOPHiA DDM Platform and related solutions, applications, products, and services. In addition, we collaborate with manufacturers in the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">assembly and development of our research and diagnostic products, in particular DNA enrichment kits. While we are undertaking a number of initiatives designed to reduce our costs, including provisions in our manufacturing and supply agreements that limit our counterparty&#8217;s ability to increase prices for the manufactured products if certain conditions are met by us, and expect that our gross margin will increase as we broaden our customer base and increase customer engagement, there can be no assurance that we will be able to achieve planned cost reductions. There may also be unforeseen occurrences that increase our costs, such as increased prices of the components of our products, increased costs of hosting and consumer support services, changes to labor costs or less favorable terms with third-party suppliers, service providers or manufacturing collaborators. In addition, if our platform, applications, services and product mix becomes more customer-specific and diversified, our costs may increase. If we are unable to reduce our costs, or if cost reductions are less significant or less timely than those we project, we will not be able to achieve sustainable gross margins, which would adversely affect our ability to invest in and grow our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We customize a substantial portion of our research and diagnostic products to address the needs of individual customers and collaborators. If we cannot sell our&#160;customized&#160;products in the event an order is cancelled, we may be unable to cover our costs and may be left with substantial unsaleable inventory, which could have a material adverse effect on our financial condition and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assemble a substantial portion of our products to address the needs of individual customers. Some of the agreements with our customers require us to cover the initial manufacturing and assembly costs of such products. We will be paid only upon delivery of such products to our customers once the products have been ordered. If our customers fail to purchase these customized products from us in sufficient quantities, do not purchase such products from us at all or otherwise fail to perform their obligations under the agreements with us, we may bear the full cost of manufacturing and assembling of such products, fail to cover our costs and have substantial unsaleable inventory, each of which could have a material adverse effect on our financial condition and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use tax loss carryforwards in Switzerland, the United States and other jurisdictions may be limited.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are entitled to carry forward losses incurred in Switzerland, the United States and other jurisdictions in which we conduct business, which could be used to offset future taxable income. Due to our limited income and ongoing losses, there is a significant risk that our tax loss carryforwards will expire in part or in their entirety and cannot be used to offset future taxable income for corporate income tax purposes. Furthermore, any tax loss carryforwards that we report on our tax returns are subject to review and confirmation by the competent tax authorities in their tax assessment of the tax year for which the tax loss carryforwards are used to offset taxable income. Consequently, we are exposed to the risk that the competent tax authorities may not accept the reported tax loss carryforwards in part or in their entirety.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks related to taxation in multiple jurisdictions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in Switzerland and foreign jurisdictions. Significant judgments based on interpretations of existing tax laws or regulations may be required in determining our provision for income taxes. Our effective income tax rate could be adversely affected by various factors, including, but not limited to, changes in the combination of earnings in tax jurisdictions with different statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in existing tax policies, laws, regulations or rates, changes in the level of non-deductible expenses (including share-based compensation), changes in the location of our operations, changes in our future levels of research and development spending, mergers and acquisitions or the result of examinations by various tax authorities. Although we believe our tax estimates are reasonable, if taxing authorities disagree with the positions taken on our tax returns, we could have additional tax liability, including interest and penalties.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange rate fluctuations have in the past materially affected and may in the future materially affect our results of operations and financial condition.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate internationally and a meaningful portion of our revenue, expenses, assets and liabilities are denominated in currencies other than the U.S. dollar, our presentation currency, and the Swiss franc, SOPHiA GENETICS SA&#8217;s functional currency. In preparing our consolidated financial statements, those revenues, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expenses, assets and liabilities are translated into U.S. dollars at applicable exchange rates. Increases or decreases in exchange rates between the U.S. dollar and other currencies affect the U.S. dollar value of those items, as reflected in the consolidated financial statements. We expect that a significant part of our revenues and expenses will continue to be denominated in currencies other than the U.S. dollar, including the euro and Swiss franc, and to a lesser extent, British pound, Australian dollar, Brazilian real, Turkish lira and Canadian dollar. Therefore, unfavorable developments in the value of the U.S. dollar relative to other relevant currencies could adversely affect our results of operations, financial condition and liquidity. For example, fluctuations in the exchange rate between the U.S. dollar and the Swiss franc has impacted our revenues and results of operations for the year ended December 31, 2025 and 2024.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exchange rates of the U.S. dollar and other currencies are affected by many factors, including forces of supply and demand in the foreign exchange markets and global economic events. These rates are also affected by the international balance of payments and other economic and financial conditions, government intervention, speculation and other factors. We currently do not engage in hedging transactions to protect against uncertainty in future exchange rates between particular foreign currencies and the U.S. dollar and even if we engage in hedging operations in the future, there can be no assurance as to the success of any hedging operations that we may implement. Foreign currency fluctuations may adversely affect our results of operations, financial condition and liquidity.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks related to the accounting treatment of our pension and other post-employment benefit plans.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide retirement benefits to our employees as required by Swiss law by means of a pension fund that is maintained by a life insurance company. The life insurance company operates a pension plan for all of our employees as a defined benefit plan under International Accounting Standards (&#8220;IAS&#8221;) 19,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefits</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;IAS 19&#8221;). As of December 31, 2025, we reported an employee benefit obligation related to our Swiss plan, before deduction of plan assets, of $28.3&#160;million in accordance with IAS 19. The obligation represents our projected obligations towards current and future pensioners discounted at an annual rate of 1.10%. Under Swiss statutory rules and pursuant to our contract with the group life assurance provider, all risks including investment risk are fully covered. That said, no underfunding exists under Swiss law. The variance between Swiss statutory rules and IFRS Accounting Standards is apparent in many Swiss companies, and the IFRS Accounting Standards obligation of our pension plan does not necessarily reflect a true payment obligation under Swiss law because Swiss law allows us to maintain flexibility to adjust benefit levels under the plans and we could use this flexibility to mitigate any liability. For more information, see Note 21&#8212;&#8220;Post-employment benefits&#8221; to the audited consolidated financial statements included elsewhere in this Annual Report. However, should the Swiss statutory rules at any time require a determination that our pension plan is significantly underfunded, we could be obliged to make additional contributions to the pension plan in addition to our obligation to make regular contributions as defined in the pension plan regulation. If such risk materializes, this could have a material adverse effect on our financial position or results of operations.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Securities</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market price of our ordinary shares has historically been, and in the future may continue to be, volatile and may fluctuate due to factors beyond our control.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, we have experienced significant fluctuations in the price of our ordinary shares. The market price of our ordinary shares could be subject to wide fluctuations in response to many risk factors listed in this &#8220;Risk Factors&#8221; section, some of which are beyond our control, including:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">actual or anticipated fluctuations in our financial condition and operating results;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">effectiveness, accuracy and efficiency of our SOPHiA DDM Platform and related solutions, applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">public concern relating to the commercial value or safety of any of our SOPHiA DDM Platform and related solutions, applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the timing and results of multimodal clinical studies of our SOPHiA DDM Platform;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our inability to adequately protect our proprietary and intellectual property rights, including patents, trademarks and trade secrets;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our inability to raise additional capital and the terms on which we raise it;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to enter into strategic collaboration or licensing agreements and the commencement, termination and terms of such agreements;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">regulatory developments, including actions with respect to our and our competitors&#8217; platforms, applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">publication of research reports by securities analysts about us or our competitors or our industry;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our failure or the failure of our competitors to meet analysts&#8217; projections or guidance that we or our competitors may give to the market;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">additions and departures of key personnel;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the passage of legislation or other regulatory developments affecting us or our industry;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">fluctuations in the valuation of companies perceived by investors to be comparable to us;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">sales of our ordinary shares or securities convertible into or exercisable for our ordinary shares by us, our insiders or our other shareholders;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">changes in market conditions for our industry, including changes in the structure of healthcare payment systems; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">changes in general market and economic conditions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the stock market has historically experienced significant volatility, particularly with respect to healthcare technology company stocks. As we operate in a single industry, we are particularly vulnerable to these factors to the extent that they affect our industry. In the past, securities class action litigation has often been initiated against companies following periods of volatility in their stock price. This risk is particularly relevant for healthcare technology companies, which have experienced significant stock price volatility in recent years. Securities litigation could result in substantial costs and divert our management&#8217;s attention and resources and could also require us to make substantial payments to satisfy judgments or to settle litigation.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales, or the possibility of future sales, of a substantial number of our ordinary shares could adversely affect the price of our ordinary shares.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future sales of a substantial number of our ordinary shares, or the perception that such sales will occur, could cause a decline in the market price of our ordinary shares. Ordinary shares that were issued prior to our initial public offering can be sold pursuant to Rule 144 under the Securities Act, subject to current public information and volume and manner of sale limitations applicable to affiliates. In addition, we have registered under the Securities Act all ordinary shares that we may issue under our share-based compensation plans, such that they can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates. We have adopted a sell-to-cover approach for withholding and other taxes upon restricted stock units (&#8220;RSU&#8221;) settlement for executive officers and certain directors, which may result in substantial sales of ordinary shares into the market in relatively short periods of time, particularly around the date of our annual general meeting. If our shareholders sell substantial numbers of ordinary shares in the public market or if the market perceives that such sales may occur, the market price of our ordinary shares and our ability to raise capital through the issuance and sale of equity or equity-linked securities in the future could be adversely affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, shareholders benefit from pre-emptive rights to subscribe on a pro rata basis for issuances of equity or other securities that are convertible into equity, unless such pre-emptive rights are excluded in accordance with Swiss law and our articles of association. However, due to the laws and regulations in certain jurisdictions, shareholders in certain jurisdictions may not be able to exercise such rights, unless we register or otherwise qualify the rights offering, including by complying with Annual Report requirements under the laws of that jurisdiction. There can be no assurance that we will take any action to register or otherwise qualify an </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offering of subscription rights or shares under the laws of any jurisdiction where the offering of such rights is restricted, other than the United States. If shareholders in such jurisdictions are unable to exercise their subscription rights, their ownership interest will be diluted.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have never paid dividends and do not expect to pay any dividends in the foreseeable future.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have not paid any dividends. Even if future operations lead to significant levels of distributable profits, we currently intend to reinvest any earnings in our business and do not anticipate declaring or paying any dividends until we have an established revenue stream to support dividend payments. In addition, any proposal for the payment of future dividends will be at the discretion of our board of directors after taking into account various factors including our business prospects, liquidity requirements, financial performance and new application and product development. Furthermore, payment of future dividends is subject to certain limitations pursuant to our current and future debt instruments, Swiss law and our articles of association. See &#8220;Item 10. Additional Information&#8212;Memorandum and Articles of Association.&#8221; The Perceptive Credit Agreement also limits our ability to pay dividends. Accordingly, investors cannot rely on dividend income from our ordinary shares, and any returns on an investment in our ordinary shares will likely depend entirely upon any future appreciation in the price of our ordinary shares.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts publish inaccurate or unfavorable research about our business or case to publish research about our business, the price of our ordinary shares and our trading volume could decline.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our ordinary shares depends, in part, on the research and reports that securities or industry analysts publish about us or our business. If one or more of the analysts who cover us downgrade our ordinary shares or publish inaccurate or unfavorable research about us or our business, the price of our ordinary shares will likely decline. In addition, if our operating results fail to meet the forecast of analysts, the price of our ordinary shares will likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our ordinary shares could decrease, which might cause the price of our ordinary shares and trading volume to decline.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The rights of our shareholders may be different from the rights of shareholders in companies governed by the laws of U.S. jurisdictions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a Swiss corporation. Our corporate affairs are governed by our articles of association and by the laws governing companies, including listed companies, incorporated in Switzerland. The rights of our shareholders and the responsibilities of members of our board of directors may be different from the rights and obligations of shareholders and directors of companies governed by the laws of U.S. jurisdictions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the performance of its duties, our board of directors is required by Swiss law to consider the interests of our company, our shareholders, our employees and other stakeholders, in all cases with due observation of the principles of reasonableness and fairness. It is possible that some of these parties will have interests that are different from, or in addition to, shareholders&#8217; interests. Swiss law limits the ability of our shareholders to challenge resolutions made or other actions taken by our board of directors in court. Our shareholders generally are not permitted to file a suit to reverse a decision or an action taken by our board of directors, but are instead only permitted to seek damages for breaches of fiduciary duty. As a matter of Swiss law, shareholder claims against a member of our board of directors for breach of fiduciary duty would have to be brought to the competent courts in Switzerland, or where the relevant member of our board of directors is domiciled. In addition, under Swiss law, any claims by our shareholders against us must be brought exclusively to the competent courts in Switzerland. For a further summary of applicable Swiss company law contained in this Annual Report, see &#8220;Item 10. Additional Information&#8212;Memorandum and Articles of Association.&#8221; However, there can be no assurance that Swiss law will not change in the future, which could adversely affect the rights of our shareholders, or that Swiss law will protect our shareholders in a similar fashion as under U.S. corporate law principles.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our shareholders enjoy certain rights that may limit our flexibility to raise capital, issue dividends and otherwise manage ongoing capital needs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Swiss law reserves for approval by shareholders certain corporate actions over which a board of directors would have authority in some other jurisdictions. For example, the payment of dividends and cancellation of treasury </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares must be approved by shareholders. Swiss law also requires that our shareholders themselves resolve to, or authorize our board of directors to, increase our share capital. While our shareholders may authorize share capital that can be issued by our board of directors without additional shareholder approval, Swiss law limits this authorization to 50% of the issued share capital at the time of the authorization. The authorization, furthermore, has a limited duration of up to five years and must be renewed by the shareholders from time to time thereafter in order to be available for raising capital. Additionally, subject to specified exceptions, including exceptions explicitly described in our articles of association, Swiss law grants pre-emptive subscription rights to existing shareholders to subscribe for new issuances of shares. Swiss law also does not provide as much flexibility in the various rights and regulations that can attach to different categories of shares as do the laws of some other jurisdictions. These Swiss law requirements relating to our capital management may limit our flexibility, and situations may arise where greater flexibility would have provided benefits to our shareholders. See &#8220;Item 10. Additional Information&#8212;Memorandum and Articles of Association.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ordinary shares are not listed in Switzerland, our home jurisdiction. As a result, our shareholders will not benefit from certain provisions of Swiss law that are designed to protect shareholders in a public takeover offer or a change-of-control transaction.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our ordinary shares will be listed exclusively on Nasdaq and not in Switzerland, our shareholders will not benefit from the protection afforded by certain provisions of Swiss law that are designed to protect shareholders in the event of a public takeover offer or a change-of-control transaction. For example, Article 120 of the Swiss Financial Market Infrastructure Act and its implementing provisions require investors to disclose their interest in our company if they reach, exceed or fall below certain ownership thresholds. Similarly, the Swiss takeover regime imposes a duty on any person or group of persons who acquires more than one-third of a company&#8217;s voting rights to make a mandatory offer for all of the company&#8217;s outstanding listed equity securities. In addition, the Swiss takeover regime imposes certain restrictions and obligations on bidders in a voluntary public takeover offer that are designed to protect shareholders. However, these protections are applicable only to issuers that list their equity securities in Switzerland, and because our ordinary shares will be listed exclusively on Nasdaq, they will not be applicable to us. Furthermore, since Swiss law restricts our ability to implement rights plans or U.S.-style &#8220;poison pills,&#8221; our ability to resist an unsolicited takeover attempt or to protect minority shareholders in the event of a change-of-control transaction may be limited. Therefore, our shareholders may not be protected in the same degree in a public takeover offer or a change-of-control transaction as are shareholders in a Swiss company listed in Switzerland.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. shareholders may not be able to obtain judgments or enforce civil liabilities against us or our executive officers or members of our board of directors.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are organized under the laws of Switzerland and our registered office and domicile is located in Rolle, Canton of Vaud, Switzerland. Moreover, a number of our directors and executive officers are not residents of the United States, and all or a substantial portion of the assets of such persons are located outside the United States. As a result, it may not be possible for investors to effect service of process within the United States upon us or upon such persons or to enforce against them judgments obtained in U.S. courts, including judgments in actions predicated upon the civil liability provisions of the federal securities laws of the United States. We have been advised by our Swiss counsel that there is doubt as to the enforceability in Switzerland of original actions, or in actions for enforcement of judgments of U.S. courts, of civil liabilities to the extent solely predicated upon the U.S. federal and state securities laws. Original actions against persons in Switzerland based solely upon the federal or state securities laws are governed, among other things, by the principles set forth in the Swiss Federal Act on Private International Law (the &#8220;PILA&#8221;). This statute provides that the application of provisions of non-Swiss law by the courts in Switzerland shall be precluded if the result is incompatible with Swiss public policy (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ordre public</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Also, certain mandatory provisions of Swiss law may be applicable regardless of any other law that would otherwise apply.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Switzerland and the United States do not have a treaty providing for reciprocal recognition and enforcement of judgments in civil and commercial matters. The recognition and enforcement of a judgment of the courts of the United States in Switzerland is governed by the principles set forth in the PILA. This statute provides in principle that a judgment rendered by a non-Swiss court may be enforced in Switzerland only if:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the non-Swiss court had jurisdiction pursuant to the PILA;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the judgment of such non-Swiss court has become final and non-appealable;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the judgment does not contravene Swiss public policy;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the court procedures and the service of documents leading to the judgment were in accordance with the due process of law; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">no proceeding involving the same parties and the same subject matter was first brought in Switzerland, or adjudicated in Switzerland, or was earlier adjudicated in a third state, and this decision is recognizable in Switzerland.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions in our articles of association could make an acquisition of us, which may be beneficial to our shareholders, more difficult.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our articles of association contain provisions that may have the effect of discouraging, delaying or preventing a change in control of us that shareholders may consider favorable, including transactions in which our shareholders may receive a premium for their shares. Our articles of association include provisions that:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">in certain cases, allow our board of directors to place up to 33,199,082 ordinary shares and rights to acquire an additional 33,199,082 ordinary shares with affiliates or third parties, without existing shareholders having statutory pre-emptive rights in relation to this share placement;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">allow our board of directors not to record any acquirer of ordinary shares, or several acquirers acting in concert, in our share register as a shareholder with voting rights with respect to more than 15% of our share capital as set forth in the commercial register;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">limit the exercise of voting rights by shareholders, acting alone or in concert with others, to a maximum of 15% of the share capital recorded in the commercial register;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">limit the size of our board of directors to eight members; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">require two-thirds of the votes represented at a general meeting of the shareholders for amending or repealing most of the above-mentioned authorizations to place shares as well as the above-mentioned voting and recording restrictions, for amending the provision setting a maximum board size or providing for indemnification of our directors and members of our executive committee and for removing the chairman or any member of the board of directors before the end of his or her term of office.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These and other provisions, alone or together, could delay or prevent takeovers and changes in control. See &#8220;Item 10. Additional Information&#8212;Memorandum and Articles of Association.&#8221; These provisions could also limit the price that investors might be willing to pay in the future for our ordinary shares, thereby depressing the market price of our ordinary shares.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There can be no assurance that we were not a passive foreign investment company for any taxable year, which could subject U.S investors in our ordinary shares to significant adverse U.S. federal income tax consequences.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), we will be a passive foreign investment company (&#8220;PFIC&#8221;), for any taxable year in which, after the application of certain look-through rules with respect to subsidiaries, either (i) 75% or more of our gross income consists of &#8220;passive income&#8221; or (ii) 50% or more of the average quarterly value of our assets consists of assets that produce, or are held for the production of, &#8220;passive income&#8221; (including cash). Passive income generally includes dividends, interest, certain non-active rents and royalties, and capital gains.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash is generally characterized as a passive asset for these purposes. Goodwill is generally characterized as a non-passive or passive asset based on the nature of the income produced in the activity to which the goodwill is attributable. The extent to which our goodwill should be characterized as a non-passive asset is not entirely clear. We hold a substantial amount of cash, and while this continues to be the case our PFIC status for any taxable year will depend largely on the value of our goodwill and the characterization of our goodwill as passive or non-passive. The value of our goodwill for any taxable year may be determined in large part by reference to the average of our market capitalization for that year. Although we believe that we were a PFIC for our 2022 taxable year, based on the nature of our operations and assets, as well as certain estimates as to our income </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the relative values of our assets during our 2023, 2024 and 2025 taxable years, we believe that we were not a PFIC for our 2023, 2024 and 2025 taxable years (subject to the discussion in the next paragraph with respect to U.S. Holders who held our ordinary shares during our 2022 taxable year). There can be no assurance that the IRS will agree with our conclusion, however.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are a PFIC for any taxable year during which a U.S. investor holds ordinary shares, we generally will continue to be treated as a PFIC with respect to that U.S. investor for all succeeding years during which the U.S. investor holds ordinary shares, even if we cease to meet the threshold requirements for PFIC status.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, since we believe that we were a PFIC for our 2022 taxable year, we believe that we will remain a PFIC with respect to a U.S. Holder that held our ordinary shares during our 2022 taxable year unless certain mitigating steps were taken. For further discussion, see &#8220;Item 10. Additional Information&#8212;. Taxation&#8212;Material U.S. Federal Income Tax Consequences for U.S. Holders.&#8221;</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are deemed to be a PFIC with respect to a particular U.S. investor, such U.S. investor may be subject to adverse U.S. federal income tax consequences, including (i) the treatment of all or a portion of any gain on disposition as ordinary income; (ii) the application of a deferred interest charge on such gain and the receipt of certain dividends; and (iii) compliance with certain reporting requirements. A &#8220;mark-to-market&#8221; or &#8220;qualified electing fund&#8221; (&#8220;QEF&#8221;) election may be available that will alter the consequences of PFIC status if our ordinary shares are regularly traded on a qualified exchange. For further discussion, see &#8220;Item 10. Additional Information&#8212;E. Taxation&#8212;Material U.S. Federal Income Tax Consequences for U.S. Holders.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Status Under U.S. Securities Laws</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a foreign private issuer, and, as a result, we are not subject to certain rules and obligations that are applicable to a U.S. domestic public company and are not subject to certain Nasdaq corporate governance listing standards that are applicable to a Nasdaq-listed U.S. domestic public company.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report under the Exchange Act as a non-U.S. company with foreign private issuer status. Because we qualify as a foreign private issuer under the Exchange Act and although we intend to furnish quarterly financial information to the SEC, we are exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including (i)&#160;the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act; (ii)&#160;the sections of the Exchange Act imposing liability for insiders who profit from trades made in a short period of time; and (iii)&#160;the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information, or current reports on Form 8-K upon the occurrence of specified significant events. In addition, foreign private issuers are not required to file their annual report on Form 20-F until four months after the end of each financial year, while U.S. domestic issuers are required to file their annual report on Form 10-K in less time. Foreign private issuers are also exempt from the Regulation Fair Disclosure, aimed at preventing issuers from making selective disclosures of material information.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, because we are a foreign private issuer, we comply with our home country governance requirements and certain exemptions thereunder, rather than complying with certain of the Nasdaq corporate governance listing standards that are applicable to U.S. companies listed on Nasdaq. For example, we are exempt from Nasdaq listing standards that require a listed U.S. company to have (i)&#160;a majority of the board of directors consist of independent directors, (ii)&#160;regularly scheduled executive sessions with only independent directors and (iii)&#160;a compensation committee and a nomination and corporate governance committee consisting entirely of independent directors. Furthermore, Nasdaq listing standards generally require Nasdaq-listed U.S. companies to, among other things, seek shareholder approval for the implementation of certain equity compensation plans and issuances of securities, which we are not required to follow as a foreign private issuer. Accordingly, our shareholders may not have the same protections afforded to shareholders of companies that are not foreign private issuers. For an overview of the material differences between our governance principles and Nasdaq corporate governance listing standards, see &#8220;Item 16G&#8212;Corporate Governance.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may lose our foreign private issuer status, which would then require us to comply with the&#160;Exchange Act&#8217;s domestic reporting regime and cause us to incur significant legal, accounting and other expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We qualify as a foreign private issuer, and therefore we are not required to comply with all of the periodic disclosure and current reporting requirements of the&#160;Exchange Act&#160;applicable to U.S. domestic issuers. We may </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no longer be a foreign private issuer as of June&#160;30, 2026, which would require us to comply with all of the periodic disclosure and current reporting requirements of the&#160;Exchange Act&#160;applicable to U.S. domestic issuers, as of January&#160;1, 2027. In that case, we would be required to comply with the&#160;Exchange Act&#160;reporting and other requirements applicable to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We would also be required to make changes in our corporate governance practices in accordance with various SEC and stock exchange rules. The regulatory and compliance costs to us under U.S. securities laws, if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer, may be significantly higher than the cost we would incur as a foreign private issuer. As a result, we expect that a loss of foreign private issuer status would increase our legal and financial compliance costs and would make some activities highly time-consuming and costly. We also expect that if we were required to comply with the rules and regulations applicable to U.S. domestic issuers, it would be more difficult and expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These rules and regulations could also make it more difficult for us to retain and attract qualified members of our board of directors.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are an emerging growth company and will lose this status by the end of 2026. The additional obligations we will face upon losing emerging growth company status could materially increase our costs and compliance burden.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently an "emerging growth company," as defined in the Jumpstart Our Business Startups Act of 2012 (the JOBS Act). We cannot predict if investors will find our ordinary shares less attractive because we are an emerging growth company and rely on exemptions available to emerging growth companies. If some investors find our ordinary shares less attractive as a result, there may be a less active trading market for our ordinary shares and the price of our ordinary shares may be more volatile.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to lose our emerging growth company status by December 31, 2026. When we lose emerging growth company status, we will be required to comply with Section 404(b) of the Sarbanes-Oxley Act, which will require our independent registered public accounting firm to attest to and report on the effectiveness of our internal control over financial reporting. This auditor attestation requirement will significantly increase our annual audit costs, and will require us to dedicate substantial additional internal resources, including finance, accounting, IT and internal audit personnel, to support the auditor's work, document our controls more extensively and implement any enhancements to our control environment that may be necessary to support a favorable attestation opinion. An adverse opinion on the effectiveness of our internal control over financial reporting could result in loss of investor confidence, stock price declines, increased scrutiny from regulators, heightened risk of securities litigation alleging inadequate financial controls or unreliable financial reporting, and difficulty accessing capital markets on favorable terms. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even after we lose emerging growth company status, if we no longer qualify as a foreign private issuer, we may still qualify as a "smaller reporting company," which, under certain circumstances, would allow us to take advantage of some of the same exemptions from disclosure requirements, including not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act (if we have less than $100.0 million in annual revenues and a public float of less than $700.0 million) and reduced disclosure obligations in our periodic reports and proxy statements. However, we cannot predict whether we would qualify as a smaller reporting company if we lost our foreign private issuer status.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to ESG and Sustainability</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our public commitments, targets, and statements relating to environmental, social, and governance ("ESG") matters may expose us to reputational, regulatory, legal, and financial risks.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made, and expect to continue to make, public statements, disclosures, and commitments relating to environmental, social, and governance ("ESG") matters, including statements regarding our greenhouse gas ("GHG") emissions profile, climate-related targets, sustainability strategy, workforce practices, and corporate governance. These disclosures may appear in a variety of contexts, including in our annual report, in standalone sustainability-related publications, in regulatory filings, and in communications with customers, investors, employees, and other stakeholders. The following risks relate to such disclosures and commitments:</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk of Non-Achievement of Environmental Targets.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have established near-term GHG emissions reduction targets, including both absolute Scope 2 and emissions-intensity-based Scope 3 targets, validated by an independent third-party standard-setting body. There is no guarantee that we will achieve these targets within the stated timeframes or at all. Achievement depends on a number of factors outside our control or that may change materially over time, including:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability, cost, and quality of renewable energy sources in the markets in which we operate, including the availability of market-based instruments (such as renewable energy certificates and power purchase agreements) sufficient to support our Scope 2 reduction commitments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the extent to which our operational footprint, facility portfolio, cloud infrastructure usage, and business travel patterns evolve in ways that differ from current assumptions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the accuracy, completeness, and evolving methodology of our Scope 3 emissions data, a significant portion of which is derived from third-party suppliers and other value-chain participants over whom we have limited or no direct control and who may not themselves achieve emissions reductions commensurate with our targets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the fact that our Scope 3 target is expressed as an emissions-intensity metric (per unit of economic value added) rather than an absolute reduction target, meaning that our total absolute Scope 3 emissions may increase even if we achieve our intensity target, particularly if our business grows; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">changes to the criteria, methodologies, or recommendations of any third-party standard-setting body whose framework we have adopted, which may require us to revise, resubmit, or reassess our targets or to adopt more stringent or differently structured objectives.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk of Evolving ESG Standards and Regulatory Requirements. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory and standards landscape governing ESG-related disclosures, GHG emissions reporting, and sustainability practices is evolving, and, in some contexts, diverging, rapidly across multiple jurisdictions, including the United States, the European Union, and Switzerland. Changes in applicable laws, regulations, disclosure standards, or the criteria of voluntary standard-setting bodies may affect the scope, methodology, or comparability of our ESG disclosures and the adequacy of our stated commitments relative to then-current expectations. These may include developments relating to the U.S. Securities and Exchange Commission's climate disclosure framework, the European Union's Corporate Sustainability Reporting Directive and European Sustainability Reporting Standards, the Swiss Code of Obligations non-financial reporting requirements, and other applicable national or international frameworks. Compliance with any new or expanded ESG disclosure or compliance requirements could result in significant additional costs and management burden.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk of Inconsistency Between Public Statements and Actual Performance.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our ESG-related disclosures, including those regarding our environmental commitments, workforce practices, and sustainability initiatives, may be scrutinized for consistency with our actual operational and financial performance. If our public ESG statements are found to be inaccurate, incomplete, overstated, or inconsistent with our actual performance, disclosures in other documents, or information available from third parties, we may be subject to reputational harm, loss of customer or investor confidence, private litigation under applicable securities laws, or regulatory investigation or enforcement action by the SEC or other authorities. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk of Changing Investor, Customer, and Regulatory Expectations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Investor, customer, employee, and regulatory expectations regarding corporate ESG performance and disclosure continue to evolve and, in some contexts, diverge across jurisdictions. We may face pressure from customers, investors, proxy advisory firms, or other stakeholders to adopt more ambitious, differently structured, or more rapidly achievable ESG commitments than those we have established. Conversely, in certain jurisdictions and regulatory environments, ESG-focused disclosures and commitments have attracted increased legal and political scrutiny, including challenges to the use of environmental criteria in corporate strategy and to the accuracy or materiality of ESG-related claims. Our ESG strategy may not satisfy all constituencies, and we may face reputational or business consequences regardless of our actual ESG performance.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk to Reputation and Business from Non-Achievement or Perceived Non-Achievement. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reputation among current and prospective customers, investors, business partners, employees, healthcare system partners, and other stakeholders is an important asset to our business. If we fail to meet, are perceived to have </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">failed to meet, or are required to revise or withdraw our stated ESG commitments, whether due to operational challenges, changes in business scale or strategy, data limitations, changes in applicable methodologies, or other factors, our reputation and brand may be adversely affected, which could result in loss of revenue, increased cost of capital, difficulty attracting and retaining qualified personnel, and other material adverse consequences for our business and financial condition.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk of ESG-Related Contractual Obligations and Commercial Consequences.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Certain of our existing and prospective business partners, customers, and counterparties, including but not limited to hospital systems, healthcare networks, pharmaceutical companies, and other institutional customers, incorporate ESG-related requirements into their commercial agreements and procurement processes, or evaluate potential partners against ESG criteria as part of their own supply chain due diligence and sustainability reporting obligations. Such requirements may include public disclosure of GHG emission reduction targets, representations or warranties regarding our GHG emissions profile, progress toward stated emissions reduction targets, adherence to recognized sustainability frameworks, or compliance with applicable environmental, labor, or governance standards. Where our commercial agreements contain ESG-related representations, covenants, or performance obligations, our failure to meet those obligations, or changes in our ESG commitments, performance, or public disclosures that give rise to a claim of breach, could result in contractual liability, termination rights, financial penalties, loss of preferred vendor status, or exclusion from future procurement processes. Even in the absence of express ESG contractual provisions, customers and partners may decline to renew or expand their relationships with us, or may seek to renegotiate commercial terms, if our ESG performance or disclosures do not meet their expectations or the expectations of their own stakeholders and regulators. As ESG-related contractual requirements become more prevalent, including as a result of supply chain transparency legislation and the proliferation of corporate sustainability commitments among our customer base, the scope and enforceability of ESG-related commercial obligations to which we are or may become subject may increase. There can be no assurance that we will be able to satisfy all such requirements or that our failure to do so will not have an adverse effect on our revenue, customer relationships, and business prospects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk of Increased Costs and Capital Requirements.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Achieving our stated ESG targets and implementing the operational, supply chain, and governance initiatives underlying our sustainability strategy may require, and may over time require at increasing scale, significant investment, including in renewable energy procurement, supplier engagement programs, emissions measurement infrastructure, and enhanced ESG reporting systems and controls. These costs may be material, may not result in commensurate benefits to our business, and may divert resources from other strategic priorities.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Information on the Company</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_28"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. History and Development of the Company</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOPHiA GENETICS SA was incorporated as a Swiss stock corporation (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">soci&#233;t&#233; anonyme</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) under the laws of Switzerland on March 18, 2011. Our principal executive office is located at La Pi&#232;ce 12, CH-1180 Rolle, Switzerland and our telephone number is +41 21 694 10 60. Our agent for service of process in the United States is SOPHiA GENETICS, Inc., 401 Park Drive, Suite 505, Boston, MA 02215, and its telephone number is (617) 982-1210.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our website is www.sophiagenetics.com. The reference to our website is an inactive textual reference only and information contained therein or connected thereto are not incorporated into this Annual Report. We file reports and other information with the SEC, including annual reports on Form 20-F and reports on Form 6-K. The SEC maintains an internet site at www.sec.gov that contains reports, proxy and information statements and other information we have filed electronically with the SEC.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we completed our initial public offering on the Nasdaq Global Select Market (&#8220;Nasdaq&#8221;) and our ordinary shares are listed under the ticker symbol &#8220;SOPH&#8221;.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_31"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Business Overview</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Mission</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOPHiA GENETICS was founded to generate clinically actionable insights from data to improve patient outcomes. Our mission is to provide equal access to knowledge and capabilities by democratizing data-driven medicine.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We observed that across the healthcare ecosystem, a vast amount of digital healthcare data was being generated, fueled by technologies such as NGS, and which held promise to accelerate the understanding of biology and disease. However, this data has been generated primarily using non-standardized methods and by clinicians and researchers across many healthcare institutions. As a result, the data remained siloed and complex and was not fully leveraged for the benefit of patients.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We founded SOPHiA GENETICS to address this issue. We are unlocking data silos, leveraging AI to generate actionable insights from data and helping healthcare professionals work together as a community and deploy their collective expertise for the benefit of patients around the world.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We refer to data-driven medicine as the practice of drawing insights from complex data sets to improve diagnosis, treatment and drug development. Using data-driven medicine, healthcare professionals supplement their own experience and intuition with data insights and shared knowledge from their peers to inform the best course of action for their patients or research. Our goal is to empower clinicians and researchers around the world to practice data-driven medicine and improve clinical and scientific outcomes.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:10pt"><span id="ib32ef6304de64fb88000c99c5a94b529_171765"></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a cloud-native software technology company in the healthcare space dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. We purposefully built a cloud-native software platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. Our platform, SOPHiA DDM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, standardizes, computes and analyzes digital health data and is used across decentralized locations to break down data silos. This enables healthcare institutions to share knowledge and experiences and to build a collective intelligence. We envision a future in which all clinical diagnostic test data is channeled through a decentralized analytics platform that will provide insights powered by large real-world data sets and AI. We believe that a decentralized platform is the most powerful and effective solution to create the largest network, leverage data and bring the benefits of data-driven medicine to customers and patients globally. In doing so, we can both support and benefit from growth across the healthcare ecosystem.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, we launched the first application of our platform to analyze NGS data for cancer diagnosis. We offer a broad range of applications used by healthcare providers, clinical and life sciences research laboratories and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">biopharmaceutical companies for precision medicine across oncology, rare diseases, infectious diseases, cardiology, neurology, metabolism and other disease areas. In 2019, we launched our solution for radiomics data that enables longitudinal monitoring of cancer patients and tumor progression throughout their disease journey. In 2022, we unveiled SOPHiA CarePath, a multimodal module on SOPHiA DDM powered by proprietary artificial intelligence and machine learning algorithms, which also incorporates our original radiomics offering. The module allows healthcare practitioners to visualize data across multiple modalities (including genomic, radiomic, clinical, and biological) for individual patients in a longitudinal manner and derive additional insights through cohort design and comparison. SOPHiA CarePath has already been deployed as part of our Digital Twins tool, a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment decisions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Today, we believe that our SOPHiA DDM Platform, commercialized under the name &#8220;SOPHiA DDM&#8221;, is one of the most widely used decentralized analytics platforms globally for clinical genomics. As of December 31, 2025, we served more than 993 hospital, laboratory and biopharma customers globally through our SOPHiA DDM Platform and related solutions, applications, products, and services, and our SOPHiA DDM Platform has supported the analysis of approximately 2,300,000 genomic profiles and has been utilized in clinical trials and research projects discussed in more than 2,712 peer-reviewed publications. As of December 31, 2025, we had approximately 528 core genomics SOPHiA DDM Platform customers (defined as the number of customers who generated revenue through usage of our bundle access, dry lab, and integrated access models during the specified time period, which, in this case, is the twelve months ended December 31, 2025). In addition to our core genomics customers we have many customers utilizing the Alamut product on a stand alone basis. We commercialize our SOPHiA DDM Platform and related solutions, applications, products, and services as RUO and CE-IVD products. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, our products are labeled and sold for research use only. Because such applications and products are not intended for use in clinical practice and diagnostics and cannot make clinical or diagnostic claims, the FDA regulations require that RUO applications and products be labeled &#8220;For Research Use Only. Not for use in diagnostic procedures.&#8221; In the EU, we have self-certified our applications and products without the intervention of a notified body in order to affix the CE marking.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Data-driven medicine has become possible through technological breakthroughs, like NGS, that have driven creation of digital healthcare data and an accelerated understanding of biology and disease. While genomics has played a large role in these advances, emerging technologies such as radiomics, digital pathology and proteomics are creating new data sets that add phenotypic context to genomic information. Additionally, the adoption of EHRs has enabled the matching of clinical outcome data to these data sets. The digital format of these data sets makes them ideal candidates for data exploration, analysis and interpretation by advanced algorithmic computing solutions. We believe that analytics approaches have traditionally primarily focused on analyzing data from a single modality and not on combining structured data from multiple modalities. Although some institutions and laboratories have created service-based business models designed to capture multimodal data, these approaches are typically centralized at a single institution, which we believe limits their ability to scale globally.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With our SOPHiA DDM Platform, we have the potential to serve and collaborate with all types of institutions in the global life sciences ecosystem, including healthcare providers, clinical and life sciences research laboratories and biopharmaceutical companies. Our platform is built on a decentralized model in which we push data analytics solutions to our customers&#8217; sites, rather than a centralized model that requires samples to be sent to a central location. Our customers therefore generally perform testing on their own samples, retain custody of both their sample and data, and use our SOPHiA DDM Platform to analyze the pseudonymized and de-identified data and share insights with other sites in our network. Through this process, we create and grow a global collective intelligence. Our platform is designed to improve as we analyze more data over time, leveraging AI and then sharing the benefits of this growing collective intelligence with our customers.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our global platform empowers better patient care through data-driven medicine by offering the following benefits for customers:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">high accuracy genomic analysis to support clinical diagnosis and life sciences research;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">rapid turnaround time for data analysis and insights;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">ability to lower cost of data analysis through higher efficiency;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">capacity to develop their own in-house precision medicine expertise and operations, retain custody of their samples and data and use their preferred instrument setup; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">option to rapidly launch new precision medicine applications on our SOPHiA DDM Platform.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our strategic positioning as a universal healthcare analytics platform for multimodal data analytics offers us a broad range of application, product, and service expansion opportunities and significant long-term growth in our total addressable market opportunity. We estimate the total addressable global market opportunities in 2025 for our current commercial clinical applications and for our current biopharma applications were approximately $25&#160;billion and $15&#160;billion, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a range of platform access models to meet our customers&#8217; needs. Our primary pricing strategy for our clinical customers is a pay-per-use model, in which customers can access our platform free of charge but pay for each analysis performed using our platform. To commercialize our applications and products, we employ our direct sales force, use local distributors and form collaborations with other global product and service providers in the healthcare ecosystem to assemble solutions to address customer needs. For example, we combine our solutions and applications with other products used in the genomic testing process to provide customers integrated products in the testing workflow. We offer our SOPHiA DDM Platform and related solutions, applications, products, and services across 75 countries through our direct sales force and our distributor partners. As of December 31, 2025, our direct sales team consisted of more than 105 field-based commercial representatives with a direct presence in 60 countries. To supplement our direct sales force, we also offer our SOPHiA DDM Platform and related solutions, applications, products, and services in 50 countries through our distributor partners.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Importance of Data-Driven Medicine</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the last decade, there has been an explosion in the amount of healthcare data. This growth has been fueled by technologies that enable high throughput analysis and data generation at large scale, as well as the collection and digitization of real-world health data in EHRs. The ability to draw insights from this data has led to an acceleration in the understanding of biology and disease and paved the way for data-driven medicine.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Data-driven medicine aims to produce better clinical and scientific outcomes by drawing insights from complex data sets to improve diagnosis, treatment and drug development. Using data-driven medicine, healthcare professionals are able to supplement their own experience and intuition with shared knowledge and data insights from their peers and have the potential to select the best course of action for their patients or research.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Genomics is propelling data-driven medicine.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;The development of large-scale genomics data is advancing data-driven medicine. With broad access to NGS technologies, the life sciences field is beginning to successfully document the relationship between the genome and various diseases and is deploying this information to improve clinical and scientific outcomes. This has given rise to the field of precision medicine, which is having an increasing impact on a range of life sciences areas. In oncology, for example, advancements in genomics and the understanding of cancer have fueled the growth of a large precision oncology ecosystem, in which genomic information is critical to informing diagnostic, treatment and drug development decisions. In other areas such as rare diseases, cardiology, neurology, metabolism and infectious diseases, the adoption of data-driven medicine is just beginning and represents a significant opportunity for growth. For instance, in cardiology, clinical genomics is becoming more common for screening, diagnostic and therapy selection for certain inherited conditions, while in neurology, clinical genomics is helping direct treatment decisions for therapeutic intervention.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Multimodal data provides novel and deep insights to assess health and disease states.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;While the growing understanding of genomics has dramatically advanced the life sciences field and data-driven medicine, it is only one piece of the biological equation. Phenotypic information is also needed to put genomic information into context and provide a more complete picture of biology and disease. Driven by this need, innovation is accelerating across new health technologies, such as radiomics, digital pathology and proteomics, providing this phenotypic context. We believe that combining data from different instrument modalities, or a multimodal approach, will transform clinical and scientific outcomes by generating clinically actionable insights from combined relevant healthcare data sets. If leveraged properly, these data sets have the potential to provide a stronger &#8220;signal,&#8221; or window into biology and disease, than any single modality alone. In oncology, for example, oncologists can characterize the genetic determinants of a tumor at the time of diagnosis and complement this </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with phenotypic information through radiomics analysis of CT, MRI, SPECT and PET imaging, digital pathology analysis of histology slides and proteomics analysis of the tumor stroma and blood samples. Then, throughout a patient&#8217;s disease journey, the oncologist can collect longitudinal insights through imaging, liquid biopsies and proteomics assessment of repeat blood sampling. This information can be aggregated and linked to clinical outcome data to find associations between disease evolution and response to therapy. In addition, deep-learning algorithms applied to multimodal data sets now make it possible to predict the evolution of a disease or the response to a specific treatment with high accuracy, in order to inform the best treatment decisions for the patient. These unique insights are driving the opportunity and demand for analytics platforms that can draw clinically actionable insights from this information.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AI/ML produce novel insights from large and complex data sets. The output of these new health technologies is generated in a digital format, making data highly amenable to advanced algorithmic computing solutions for exploration, analysis and interpretation. AI approaches have enabled the ability to standardize, classify, analyze and interpret massive volumes of data, and separate the signal from the noise. Large volumes of digital information across modalities can then be mined using AI approaches to generate novel insights, enabling truly data-driven medicine.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Challenges to the Adoption of Data-Driven Medicine Today</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe that data-driven medicine has the potential to transform healthcare, currently, there are significant challenges that limit its democratization and adoption at scale. These challenges include:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Lack of data harmonization and standardization across the healthcare ecosystem.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Data is often produced with different approaches and methodologies, which can result in dramatic variability in data quality. In the clinical genomics field, for example, every experimental step, from using different technologies for nucleic acid extraction and DNA or RNA amplification to using different models of NGS instruments, could lead to inconsistent data across sites and experiments, or &#8220;noise&#8221; in the data. As a result, obtaining a comparable set of clinical genomics data can be challenging, particularly in decentralized settings in which inter-laboratory variability can be considerable.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Data silos and lack of knowledge sharing.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Most healthcare data is produced by different healthcare institutions and by centralized laboratories that use different instrument modalities. As a result, data is created and remains in silos. In hospitals, for example, clinicians may struggle to collect and piece together data sets from clinical genomics to pathology to medical imaging for patients that have been produced in different, non-standardized ways. Pharmaceutical companies face similar challenges when reconciling their clinical trial data with disparate real-world data sources, resulting in highly variable quality of insights.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Barriers to collaboration.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Healthcare professionals and researchers may be limited in their ability to share their patients&#8217; healthcare data for various reasons, such as privacy or concerns over losing control of their data. In addition, they have difficulties collaborating with peers from different sites or different fields. As a result, collaborations among healthcare professionals and researchers across different sites and fields is suboptimal.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Healthcare infrastructure is designed to facilitate healthcare delivery at a local or regional level, rather than on a global scale.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Healthcare infrastructure is generally designed around centralized institutions, such as hospitals and laboratories, that generate data within their own facilities. This centralized design is not built to scale or to provide equal access to data-driven medicine globally.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Existing software analytics approaches are limited in their ability to generate insights from multimodal data.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Traditional approaches to software analytics solutions have primarily focused on analyzing data from a single modality and not on combining structured data from multiple modalities. Existing analytical software solutions thus have limited utility to generate insights from multimodal information.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our SOPHiA DDM Platform</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that a decentralized platform is necessary to create the largest network that will bring the benefits of big data to customers and to both support, and benefit from, growth across the healthcare ecosystem. We purposefully built a cloud-native software platform capable of being used in decentralized locations and of analyzing data from multiple modalities and that can be scaled globally. With our SOPHiA DDM Platform, we have the potential to serve and collaborate with a variety of types of institutions in the healthcare ecosystem, including healthcare providers, centralized laboratories and biopharmaceutical companies.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SOPHiA DDM Platform is a global, cloud-native software platform that we began building in 2011. It is powered by our SOPHiA AI that standardizes, computes and analyzes digital health data, generating insights from complex multimodal data sets that have the potential to improve diagnosis, therapy selection and drug development. Our customers generally perform testing on their own samples, retain custody of both their sample and data, and use our SOPHiA DDM Platform to analyze the pseudonymized and de-identified data and share insights with each other. Through this process, we create and grow a collective intelligence. We offer multiple platform access models that enable customers to choose how they want to use our platform and customer network. These range from models in which customers produce their own data independently through their own testing operations to those in which customers produce the data through testing operations provided by our network of customer institutions. In all cases, customers access their data and our analytics through our SOPHiA DDM Platform. Our platform is designed to continually improve as we analyze more data over time, leveraging AI and then sharing the benefits of this growing collective intelligence with our customers.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our SOPHiA DDM Platform addresses key challenges to the adoption and democratization of data-driven medicine by:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Enabling data harmonization and standardization across the healthcare ecosystem.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The accuracy of our pattern-recognition AI/ML-based algorithms enables our platform to separate the signal from the noise and standardize data at high-quality levels.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Breaking down data silos.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We empower our customers to practice data-driven medicine through a decentralized model and support clinicians, laboratories and researchers across the healthcare ecosystem to improve clinical and scientific outcomes.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Empowering clinicians and researchers to collaborate with peers from different sites or different fields.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our customers use our platform to share insights with each other across sites in our network. Our platform is designed to improve as we analyze more data over time, leveraging AI and then sharing the benefits of this growing collective intelligence with our customers.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Offering a highly scalable platform.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We designed our cloud-native software platform to be capable of scaling globally and to use AI to leverage the data that this scale provides.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Generating insights from complex multimodal data sets.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe our platform is uniquely positioned to combine high-quality data at the patient level to generate multimodal insights, leveraging the power of advanced AI/ML models.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following figure shows how our SOPHiA DDM Platform functions within the healthcare ecosystem.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our SOPHiA DDM Platform within the Healthcare Ecosystem</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="soph-20251231_g1.jpg" alt="SGHeathCareEcoSystem.jpg" style="height:306px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-1"/></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We launched the first commercial application of our platform in 2014 to analyze NGS data for cancer diagnosis. We now offer a broad range of applications focused on precision medicine across oncology, rare diseases, infectious diseases, cardiology, neurology, metabolism and other disease areas. In 2019, we launched our solution for radiomics data that enables longitudinal monitoring of cancer patients and tumor progression throughout their disease journey. In 2022, we unveiled SOPHiA CarePath, a new module that will further enhance our solution for longitudinal monitoring of cancer patients and tumor progression by integrating data across multiple modalities including genomic, radiomic, clinical, and biological). CarePath serves as the successor to our radiomic solution, which we plan to integrate into the module. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Network and Data</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Today, we believe that our SOPHiA DDM Platform, commercialized under the name &#8220;SOPHiA DDM,&#8221; is one of the most widely used decentralized analytics platforms globally for clinical genomics. As of December 31, 2025, we served more than 993 hospitals and laboratory customers globally through our SOPHiA DDM Platform who are part of our clinical genomics network. The establishment and creation of this network of customers has enabled us to capture and compute approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> raw clinical genomics profiles in oncology and other genetic-related disorders as of December 31, 2025, which is now growing by approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33,000</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> new profiles on a monthly basis.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our SOPHiA DDM Platform Architecture</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our platform architecture allows our platform to be highly flexible and scalable in terms of analyzing larger volumes of data, supporting additional data modalities, expanding to new geographies and deploying new applications and functionalities. This flexibility and scalability comes from our platform&#8217;s underlying architecture that is developed based on a deep understanding of our users&#8217; needs and a thorough domain model, allowing us to build re-useable User Interface (&#8220;UI&#8221;) components and services to interact with the data. Our SOPHiA DDM Platform includes multiple tailored analytics engines, each tuned to specific domains and use cases. Each domain is responsible for its own data with a common shared data model that allows powerful Extract-Transform-Load (&#8220;ETL&#8221;) pipelines to process specific data sets, integrating data into a series of regional data warehouses that enable comprehensive and performant multimodal queries to be run across the entire global data set. We have nine regional data centers in Switzerland, France, the Netherlands, the United States, Canada, Brazil, Australia, and the UAE.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, this platform architecture was deployed in 75 countries through our cloud-based solution. We have developed significant operational experience by running such a large-scale cloud-based platform, which we believe enables us to deploy rapidly in new geographies. We have demonstrated that we can deploy in a new geography in approximately one to four weeks if appropriate cloud infrastructure exists in Microsoft Azure, twelve weeks if such cloud infrastructure does not exist.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly release platform updates. Through these updates, we offer our customers either new content, in the form of new applications, or improvements to existing applications, such as new functionalities. We believe the frequency of our updates is a competitive advantage in a rapidly evolving precision medicine ecosystem and allows our customers to benefit from new biological discoveries, such as genomic associations, that are reflected on the platform.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our business, we collect, transmit, receive, process, use and store pseudonymized and de-identified data provided by our customers. Our customers are required to obtain their patients&#8217; consent to our use of the data. We use security techniques designed to safeguard data received from our customers using a combination of data architecture, pseudonymization, anonymization, minimization and segregation, and process and store this data only in accordance with our agreements with customers and applicable data protection laws and regulations. This data is aggregated and analyzed by our proprietary algorithms and models in our SOPHiA DDM Platform to generate insights. These insights, which show aggregated and general trends without identifying specific patients and without providing personally identifiable information, form the growing collective intelligence that we provide to our customers.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cybersecurity and data protection are core tenets of our company. We have processed over 2.3 million genomic profiles and continue to process more than 70 terabytes of data each month for our customers around the world, subject to applicable data protection laws and regulations, including HIPAA and the GDPR. We accomplish this through our global compliance framework that integrates specialized and dedicated personnel, procedures and controls and ISO/IEC 27001:2022, ISO/IEC 27017:2015 and ISO/IEC 27018:2019 security infrastructure and cloud service processing, to protect data against damage, loss and unauthorized access, use, modification, disclosure or other misuse.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Applications of Our Platform</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have commercial applications targeting both clinical and biopharma markets. We serve our clinical market customers through two offerings of our SOPHiA DDM Platform. Our first offering is our SOPHiA DDM Platform for clinical genomics, spanning a broad range of applications that we market for analyzing genomic data across oncology, rare diseases, infectious diseases, cardiology, neurology, metabolism and other disease areas. Our SOPHiA DDM Platform empowers customers to build their own precision medicine operations, including testing, and then use our platform to generate insights from their data. Our second offering is our Alamut suite of genomics mutation interpretation software, which is connected to our SOPHiA DDM Platform and gives our customers advanced analytics capabilities for a deeper and more informed genomic data interpretation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For revenues generated from applications for which the disease end market is known, approximately 73% of our revenue from clinical customers in the year ended December 31, 2025 was attributable to oncology applications, including hereditary cancer, while approximately 27% was attributable to other disease areas such as rare diseases, cardiology, neurology and metabolism, with applications ranging from targeted gene panels to whole-exome solutions. In the future, we intend to pursue additional IVD status and FDA approval for specific solutions. We also intend to support external collaborators in deploying their own IVD or FDA-approved solutions on our SOPHiA DDM Platform.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We serve our biopharma customers by leveraging the capabilities and Data of our SOPHiA DDM Platform to help customers solve bottlenecks across the biopharma value chain, including throughout the Discovery, Development and Deployment stages. We currently have four branded applications for biopharma customers: SOPHiA Insights for generating insights pre- and post-approval of a drug based on our own proprietary SOPHiA DDM Platform data sets or on the biopharma customers&#8217; own data sets; SOPHiA Trial Match for clinical trial </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recruitment of biomarker-defined patient populations; SOPHiA CDx for companion diagnostics development and deployment in our decentralized network of customer institutions; and SOPHiA Awareness for providing real-world insights into NGS testing to inform market-shaping and commercialization strategies. We launched our initial applications for the biopharma market in 2019.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following figure shows our applications that we currently commercialize across both clinical and biopharma markets.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our SOPHiA DDM Platform&#8217;s Applications Currently in Market</span></div><div style="margin-top:10pt;text-align:center"><img src="soph-20251231_g2.jpg" alt="DDMAppinMKT.jpg" style="height:307px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-2"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Applications</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the clinical market, we currently serve three main customer segments: academic and non-academic hospitals (including comprehensive cancer centers and children&#8217;s hospitals), reference laboratories and specialty laboratories. We currently serve our clinical market customers through two offerings of our SOPHiA DDM Platform: our SOPHiA DDM Platform for clinical genomics and our Alamut suite of genomics mutation interpretation software. We have also unveiled SOPHiA CarePath, a multimodal module on our SOPHiA DDM Platform, encompassing the capabilities of our radiomic solution, which we plan to commercialize across our clinical customer base in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oncology Applications</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our oncology applications support both germline and somatic oncology testing across both solid and liquid tumors. Our commercial oncology applications support diagnosis, therapy selection and disease monitoring. Our SOPHiA DDM Platform also supports the deployment of novel oncology testing applications. In genomics, this includes liquid biopsy-based early cancer screening as well as treatment response monitoring and minimal residual disease monitoring. In multimodal, we are able to complement and enhance our genomics capabilities with other data modalities, such as radiomic and clinical data, to include diagnosis, prediction of disease evolution and response to specific therapies, as well as longitudinal follow-up of the tumor for treatment response monitoring. The following figure shows our current applications in oncology.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SOPHiA DDM Platforms&#8217; Oncology Applications</span></div><div style="margin-top:10pt;text-align:center"><img src="soph-20251231_g3.jpg" alt="DDMOncoApp.jpg" style="height:253px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-3"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Oncology Applications</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-oncology applications currently focus on disease areas such as rare diseases, cardiology, neurology and metabolism, with applications ranging from targeted gene panels to whole-exome solutions. While clinical genomics applications are still emerging in these disease areas, we expect significant opportunity as the life sciences field continues to establish the genetic determinants of high-profile diseases such as hereditary cardiovascular conditions, multiple sclerosis, Alzheimer&#8217;s disease, autism and metabolic syndrome. We also see significant promise of multimodality in these other disease areas, for example, in cardiology by generating novel multimodal insights stemming from the joint analysis of genomics data, radiomic analysis of ultrasound images and analysis of electrocardiograms.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our SOPHiA DDM Platform in Genomics</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our technical capabilities are cutting-edge in the genomics space. Our platform can process data from any type of biological sample, including fresh frozen tissue, formalin-fixed paraffin-embedded samples as well as liquid circulating tumor DNA samples. It can also process data from any nucleic acid source across DNA and RNA. We can identify with confidence any type of genomic alteration, including single nucleotide variants (&#8220;SNVs&#8221;), insertions-deletions (&#8220;indels&#8221;), copy-number variations (&#8220;CNVs&#8221;) and gene fusions, as well as more complex mutational signatures such as microsatellite instability (&#8220;MSI&#8221;), tumor mutational burden (&#8220;TMB&#8221;), homologous recombination deficiency or minimal residual disease. Our smart algorithms allow us to reach high accuracy on the detection and identification of challenging genomic alterations, such as mutations in CEBPA or FLT3-ITD, MET exon14 skipping mutations, or rare gene fusions. The following figure shows our SOPHiA DDM Platform&#8217;s capabilities in genomics.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our SOPHiA DDM Platform&#8217;s Capabilities in Genomics</span></div><div style="margin-top:10pt;text-align:center"><img src="soph-20251231_g4.jpg" alt="GenoCapabilities.jpg" style="height:321px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-4"/></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SOPHiA DDM Platform clinical genomics workflow involves CLIA-CAP and equivalent laboratories in academic hospitals, comprehensive cancer centers, children&#8217;s hospitals and reference and specialty laboratories collecting patient samples and conducting the genetic sequencing on their premises. In doing so, they can use different NGS solutions on different NGS sequencing instruments.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For somatic oncology applications, for example, the laboratory technician logs into our SOPHiA DDM Platform and loads the raw, pseudonymized, NGS data of multiple patients from the sequencing run, indicating the oncology indication to be investigated. The genomics data is securely transferred to our platform that operates globally in eight different regional data centers, keeping the data closest to the customer and complying with all local data handling requirements. The data is automatically recognized by our AI-based smart algorithms that check data quality. All types of genomic variants and signatures are then detected and identified with high accuracy, including SNVs, indels, CNVs, fusions, MSI and TMB. This molecular information is then annotated and pre-classified using AI/ML techniques.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal investigator, usually a pathologist or geneticist (for germline applications), accesses the results and completes the interpretation. The principal investigator may flag or store the genomic variants that he or she has recognized as being associated with a certain disease on our platform. Because of the decentralized nature of our network, other users in different sites can see the aggregated flagging of a specific variant from the community to further assist their own interpretation. The more interpretations being conducted in our platform, the more novel knowledge is generated and made available to our community. Our platform is particularly easy to use as it does not require an additional technician and provides a user-friendly interface to upload data and navigate data analytics. We believe that this ease-of-use, coupled with the scale of our decentralized platform, will empower our users to continue to rapidly uncover new variants.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This workflow is technology-agnostic in terms of sequencer type and sample preparation technology and supports a broad range of different commercial NGS solutions. The following figure shows our SOPHiA DDM Platform&#8217;s genomics workflow.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our SOPHiA DDM Platform&#8217;s End-to-End Genomics Workflow</span></div><div style="margin-top:10pt;text-align:center"><img src="soph-20251231_g5.jpg" alt="DDMEtoEWrkFlw.jpg" style="height:347px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-5"/></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our SOPHiA DDM Platform in Multimodal Data Analytics</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our SOPHiA CarePath module on our SOPHiA DDM Platform, we can support the multimodal analysis of any source of digital health data, developing machine learning predictive models of aggregated multimodal data stacks for the same patient. We can support the analysis of clinical, biological, genomics, radiomics data today and intend to support additional data modalities such as digital pathology, proteomics, spatial genomics and metabolomics in the future.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a range of predictive modeling applications ranging from disease screening, disease early detection, disease diagnosis and subtype discrimination, prediction of disease evolution, prediction of response to therapy, therapy selection and monitoring. We develop these multimodal predictive models in close collaboration with leading academic institutions together with cross-functional teams consisting of treating physicians (such as oncologists), radiologists and pathologists. Illustrative examples of advanced clinical research projects in which we have proof-of-concept data include prediction of response to anti-PD-1 immunotherapy for patients with metastatic non-small cell lung cancer, and prediction of pathological complete response after neoadjuvant therapy for patients with triple-negative breast cancer. For example, we sponsored a retrospective 57-patient analysis of the use of nivolumab for the treatment of relapsed or refractory non-small cell lung cancer to identify predictive markers of immune-oncology response based on multiple sources of data through machine learning analysis. We found that machine learning could help predict a patient&#8217;s response using baseline data and can help identify markers that are predictive of the patient&#8217;s response. We are sponsoring multimodal clinical studies to refine and assess the clinical significance of some of these multimodal signatures, which we believe will enable us to further improve our SOPHiA DDM Platform and develop new predictive algorithmic models that we can then deploy on our platform to serve a wide range of stakeholders, including oncologists and other treating physicians. The following figure shows our SOPHiA DDM Platform&#8217;s capabilities in multimodal data analytics.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our SOPHiA DDM Platform&#8217;s Capabilities in Multimodal Data Analytics</span></div><div style="margin-top:10pt;text-align:center"><img src="soph-20251231_g6.jpg" alt="MultimodalDataAnalytics.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-6"/></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among our multimodal capabilities, besides our initial core competency in genomics, we have built out technical capabilities that we believe are cutting-edge in the radiomics space. These capabilities are integrated into and offered through our SOPHiA CarePath module. We can process and analyze data from any type of three-dimensional medical imaging technology, including CT, PET, MRI and SPECT scanners. We have developed AI/ML-powered segmentation algorithms that detect tumors in the scans and that segment and reconstruct tumors in three dimensions on our SOPHiA DDM Platform. Our current segmentation applications cover a wide range of major tumor types, including lung, breast, liver, kidney and brain cancer, supporting the analysis of primary and secondary (i.e., metastatic disease of another organ origin) tumors. In addition, we are developing new applications in areas such as colorectal, prostate, ovarian or neuroendocrine cancers. Radiomics features extraction is conducted on segmented tumors, generating hundreds of data points across volumetric, morphological, first order (i.e., heterogeneity), second order (i.e., texture), and deep-learning generated features. Our features extraction process is compliant with the Image Biomarker Standardization Initiative (&#8220;IBSI&#8221;) recommendations, such that results from our radiomics analyses are standardized and can be readily compared with similar analyses globally. Through our segmentation and radiomics features extraction steps, we turn existing medical images into hundreds of novel data points. We offer radiomics applications ranging from disease detection, discrimination of disease histological subtypes, prediction of tumor evolution and prediction of disease progression. In the future, we intend to develop additional radiomics applications for existing and new tumor types, as well as for disease areas outside of oncology, such as cardiology, neurology and metabolism.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we may expand applications to other imaging modalities such as two-dimensional modalities (e.g., ultrasound, traditional x-rays) as well as testing modalities that can be processed through imaging-based approaches (e.g., electrocardiograms). The following figure shows our SOPHiA DDM Platform&#8217;s capabilities in radiomics.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our SOPHiA DDM Platform&#8217;s Capabilities in Radiomics</span></div><div style="margin-top:10pt;text-align:center"><img src="soph-20251231_g7.jpg" alt="RadiomicsCapabilities.jpg" style="height:330px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-7"/></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the data modality is different for radiomics compared to genomics, the same overall workflow and principles apply. The user, typically a radiologist, identifies the relevant medical images for a specific patient in the local picture archiving and communication system. The user then uploads the images into our SOPHiA DDM Platform. For a metastatic lung cancer case, for example, deep learning and other machine learning proprietary algorithms automatically detect the imaging modality, recognize the organ, segment the tumor and extract more than 200 radiomics features from the tumor image. These radiomics features can then be aggregated with genomics, clinical and biological data from the same patient. The following figure shows our SOPHiA DDM Platform workflow for radiomics.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our SOPHiA DDM Platform&#8217;s End-to-End Radiomics Workflow</span></div><div style="margin-top:10pt;text-align:center"><img src="soph-20251231_g8.jpg" alt="RadioWrkFlw.jpg" style="height:98px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-8"/></div><div><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biopharma Applications</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the biopharma market, we currently serve three types of customers: pharmaceutical companies, biotechnology companies, and CROs. Leveraging both our SOPHiA DDM Platform genomic applications and our customers&#8217; own proprietary data through our AI/ML-powered multimodal analytics capabilities, we help customers solve development complexities and bottlenecks across the biopharma value chain. We categorize our applications based on a framework to address specific needs across the Discovery, Development, and Deployment stages of the drug and therapeutic life cycle both pre- and post-commercialization supported by the underlying data generated on our Platform. Across our application portfolio, we offer four branded applications: SOPHiA Insights, SOPHiA Trial Match, SOPHiA Awareness and SOPHiA CDx, to address the needs of our biopharmaceutical and biotechnology customers, including diagnostic assay development, clinical trial matching and application, drug and therapeutic design optimization, and diagnostic assay deployment. The following figure shows our capabilities across the biopharma value chain.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SOPHiA GENETICS&#8217; Offerings across Biopharma Value Chain</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="soph-20251231_g9.jpg" alt="image.jpg" style="height:222px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-9"/></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We began commercializing biopharma applications in 2019. Our biopharma applications are competitively positioned as insights programs, which utilize data already uploaded to the SOPHiA DDM Platform or proprietary data provided directly by a biopharma customer. We believe that our customers value our biopharma applications for their ability to identify unique patient populations in clinical research and asset commercialization efforts. We signed our first biopharma customer in 2019. We served four biopharma customers accross multiple programs during the fiscal year ended December 31, 2025.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Discovery Applications.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While Moore&#8217;s law has generally played out accordingly in the computation and software space with significantly greater efficiency for lower cost being achieved over time, Eroom&#8217;s law has been used to explain an observed trend in the drug discovery space as the inflation-adjusted costs to bring a drug to market continue to rise over time. Despite the improvements in technology over time, drug discovery has remained very complex with many critical decisions that need to be made along the way at which point could ultimately lead to an unviable path forward.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To address the growing costs of drug discovery, biopharma and biotechnology companies are increasingly turning to technology solutions, particularly artificial intelligence and machine learning, to apply the benefits of Moore&#8217;s law to reverse the observed costs according to Eroom&#8217;s law. With our SOPHiA DDM Platform, we can help our biopharma and biotechnology customers make more informed decisions in the drug discovery process by leveraging the data we generate on our SOPHiA DDM Platform across our global network and applying our proprietary artificial intelligence and machine learning algorithms to the data across our network and the proprietary data of our customers. Within the Discovery segment, our current primary focus is on the later sub-stages post target identification and prior to Development, such as assay development and lead optimization. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Development Applications</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The drug and therapeutic development process can be very long and capital intensive. There are both significant financial and opportunity costs that are incurred but never recouped should a drug or therapeutic fail in development stage. To increase the likelihood of success, biopharmaceutical and biotechnology companies are increasingly turning to algorithm based approaches powered by machine learning and artificial intelligence to better predict drug properties and aid in drug and therapeutic design and clinical trial testing and applications. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are supporting our biopharma and biotechnology customers in the drug and therapeutic development process through our decentralized, technology agnostic SOPHiA DDM Platform powered by our machine learning and artificial intelligence algorithms. Our SOPHiA DDM Platform&#8217;s unique ability to harmonize data derived from diverse genomic instruments and deploy as a robust, standardized solution enables a new model for clinical trial testing through a decentralized approach, allowing our biopharma and biotechnology customers to optimize patient selection and clinical trial design. Leveraging our SOPHiA DDM&#8217;s capabilities and multimodal data, we can also support our customers in developing companion diagnostics (&#8220;CDx&#8221;) to improve testing across the target patient populations and help them in optimizing their drug and therapeutic designs. Through </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our SOPHiA CarePath module, we will also enable our customers to track patients longitudinally across multiple data modalities to support their clinical trials.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Deployment Applications</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As biopharmaceutical companies begin deploying their drugs and therapies, they can face challenges associated with the identification and enrollment of eligible patients. To increase adoption, biopharma companies have partnered with clinical institutions to expand access to diagnostic testing that could help identify new patients eligible for and who can benefit from the new drugs and therapies. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We can help our biopharma customers with their deployment-related challenges in multiple ways. In the absence of an applicable diagnostic assay, the versatility of our SOPHiA DDM Platform allows us to support our customers by helping them develop new targeted assays, including companion diagnostics, to diagnose and identify eligible patients. We can then help our customers expand access to diagnostic testing by deploying a SOPHiA GENETICS developed diagnostic assay or a third-party developed diagnostic assay across our broad global network of hospital and laboratory customers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SOPHiA Insights</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Faced with a complex and fragmented precision medicine environment, we believe biopharmaceutical companies need access to high quality real-world data sets and advanced data analytics capabilities to generate insights from these data sets to inform their decision-making. However, currently, these data sets are often fragmented, siloed and of variable quality, while data analytics capabilities are typically more focused on single-modality applications.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer solutions to support biopharma customers by generating insights pre- and post-approval of a drug throughout the entire pharma value chain, including the research, development and commercialization stages. We can generate these insights both based on our SOPHiA DDM Platform real-world data sets and by leveraging our AI/ML-powered multimodal analytics capabilities on the biopharma customer&#8217;s own data sets, including data from their clinical trials. For example, a biopharmaceutical company may ask us to generate insights from our platform regarding the real-life molecular epidemiology of rare genomic variants in a specific cancer type, including NGS sequencing install base and testing practices across geographies. A biopharmaceutical company may also ask us to support it in the AI/ML-powered multimodal analysis of its own data sets, which could include genomics, clinical, biological and medical imaging data from its clinical trials, for example to identify new biomarkers associated with patient subgroups that may have a higher likelihood of response to an investigational therapy. As we generate increasingly more multimodal patient-level data stacks in our SOPHiA DDM Platform, in the future, we may support biopharmaceutical companies on novel use cases, including real-world virtual control arms for clinical trials.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SOPHiA Trial Match</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Challenges of clinical trial patient enrollment is a major bottleneck for clinical trial sponsors, which leads to delays, increased costs and clinical trial failures. This challenge is magnified in the case of biomarker-targeted investigational therapies associated with rare genomic variants due to the difficulty of finding and recruiting patients with the desired genomic traits.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With SOPHiA Trial Match, sponsors can place &#8220;molecular alerts&#8221; in our SOPHiA DDM Platform for specific genomic variants or signature that may indicate eligibility for a clinical trial. When a genomic profile matching the recruitment criteria is detected in our platform, the participating local healthcare Institutions or research centers are notified in real-time and given the opportunity to connect with the clinical trial sponsor. We provide the real-time trial matching services for our participating customers.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SOPHiA CDx</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are witnessing a steady growth in the number of regulatory approvals for therapies linked to companion diagnostic assays in oncology and other disease areas. Today, these CDx assays are typically used in a centralized model in which healthcare institutions lose access to their samples and data and which can suffer from poor turnaround times due to logistical issues. We believe that in the future CDx assays will become increasingly decentralized which will drive further testing uptake at scale and enable faster turnaround times.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer strategic and operational support for biopharma CDx programs. Biopharma customers can leverage our capabilities to develop genomic variant detection and identification solutions with high accuracy and precision, as well as our ability to decentralize such CDx solutions at scale through our global footprint. We believe that, in the future, CDx programs may become multimodal in nature, which we would be in a position to support through our multimodal analytics capabilities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SOPHiA Awareness</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As biopharmaceutical companies commercially launch new biomarker-targeted therapies (e.g., linked to a specific companion diagnostic assay), they face significant challenges in driving broad adoption and testing rates of specific biomarkers of interest. For example, the genomics testing landscape is currently fragmented with important regional and local variations. In that context, we believe it is imperative for biopharmaceutical companies to adequately manage parallel and interdependent adoption curves across the biomarker testing and therapy prescription dimensions. While biopharmaceutical companies tend to have insights into prescription patterns by health practitioners, they typically lack insights into real-life genomics testing practices across geographies.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We support biopharma customers with real-world insights on NGS testing trends to support their market-shaping and commercial strategies. For example, when novel therapies enter the market, a biopharmaceutical company may ask us to provide regular aggregated statistical reports on NGS testing results in specific geographies to optimize resource allocation for its go-to-market strategy. A biopharmaceutical company may also collaborate with us to increase the NGS testing rate of specific biomarkers in our network, thus supporting the identification of relevant genomic variants for targeted therapies, for example by sponsoring increased testing volumes and NGS panel upgrades. As more data modalities are computed in our SOPHiA DDM Platform, we envision additional market opportunities for SOPHiA Awareness.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Alamut Suite of Genomics Analysis Software</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our offering in the clinical genomics space also includes the Alamut suite of genomics mutations interpretation software. This add-on software is connected to our SOPHiA DDM Platform through an API and provides our customers with advanced analytics capabilities for a deeper and more informed genomic data interpretation. It simplifies and accelerates variant interpretation workflows by providing an exploration and visualization application powered by an extensive collection of top-ranked external databases and proprietary prediction tools, which has the potential to be particularly impactful in deepening genomic investigations in rare diseases.&#160;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we plan to offer other add-on software solutions that are integrated with our SOPHiA DDM Platform, including software solutions from external collaborators, and that provide additional analytics capabilities. Such offerings have the potential to further increase the value of our SOPHiA DDM Platform through indirect network effects, attracting new types of customers and solutions to our network.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Publications</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology and its broad applications have been utilized in clinical trials and research projects discussed in more than 2,712 peer-reviewed publications as of December 31, 2025. These publications support scientists in new discoveries and applications across oncology, immunology, cardiology, neurology, rare diseases and other disease categories.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Access Models</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently have three models through which customers access our SOPHiA DDM Platform. In the dry lab access model and the bundle access model, we empower customers to produce their own data. In the integrated access model, we help customers produce data through our existing network of institutions. In all cases, clinical customers access their data through our SOPHiA DDM Platform. Our biopharma customers can access our SOPHiA DDM Platform through the same three models, but they may also have access to data generated through our SOPHiA DDM Platform in the form of custom reports and analytics. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dry lab access model involves customers using the testing instruments and consumables of their choice and our SOPHiA DDM Platform and algorithms for variant detection and identification. In this model, we provide clinical genomics analytics capabilities without influencing the tools that customers use to generate the data. For </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">example, in genomics, a laboratory might order an NGS kit directly from the manufacturer, conduct the sequencing using its installed sequencer and then use our smart algorithms in our SOPHiA DDM Platform for data analytics.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The bundle access model enables us to support our customers end-to-end across the data generation, analytics and reporting steps. In this model, we bundle third-party instruments and consumable products with our analytics solution to provide customers the ability to perform end-to-end workflows. By bundling our algorithmic capabilities with specific high-performance instruments and consumables from third parties, we can further increase the accuracy of our genomics solutions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The integrated access model provides customers with the ability to access high-quality data on our platform even when they cannot generate data themselves. Customers that are not able or do not wish to locally conduct the sequencing steps, for example, due to a lack of appropriate resources, can have their samples processed and sequenced within our SOPHiA clinical network. We route their samples to selected SOPHiA DDM Platform collaborators who conduct the sequencing process for the customer and upload the resulting data into our SOPHiA DDM Platform. The customer is then able to access the data through our SOPHiA DDM Platform. Through this model, the selected SOPHiA DDM Platform collaborators can increase their sequencing volumes, while our SOPHiA DDM Platform is further enriched by the data produced.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The same conceptual access models apply to our multimodal solution SOPHiA CarePath. For multimodal, including our integrated radiomics solution, we are currently offering a dry lab access model, in which we provide the algorithmic analytics solutions while leaving the data generation at the discretion of our customers. We have developed, and intend to continue to develop, smart algorithms for specific radiomics applications, such as deep learning-enabled algorithms that can automatically recognize a lung CT scan image, detect an advanced lung cancer tumor, segment the tumor and extract radiomics features for further analysis. In the future, we may also offer a bundle access model, in which we offer solutions linked to specific imaging contrasting agents or imaging procedure modalities to optimize the performance of the final signal analysis.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to apply the same conceptual access models to additional data modalities that we may support in our SOPHiA DDM Platform in the future, such as digital pathology, proteomics, spatial genomics and metabolomics.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Benefits to Customers</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform has the potential to offer the following benefits for customers, empowering them to adopt data-driven medicine to improve clinical and scientific outcomes:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Accuracy.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our platform design and data analytics capabilities provide high accuracy analytics for our customers, who have access to high quality, standardized data through our SOPHiA DDM Platform.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Turnaround time.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We empower our customers to generate data themselves locally, which avoids delays associated with shipment, logistics and processing of samples through an external collaborator. We therefore significantly reduce the turnaround time, which is a critical factor in driving toward timely diagnosis and treatment of disease.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Cost-control through increased efficiency.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Customers can compute, detect and annotate any type of genomic alterations through our SOPHiA DDM Platform without the need for specific orthogonal assays, thus reducing additional testing costs.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Maintenance and development of in-house expertise.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> By empowering our customers to retain ownership and access to their biological samples and data, we enable them to build in-house expertise while benefiting from world-class analytics accuracy through our SOPHiA DDM Platform&#8217;s network effects.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Accelerated launch of new precision medicine applications.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The universal nature of our SOPHiA DDM Platform facilitates adding new applications to the same workflow once an institution adopts our platform. Our customers can avoid having to set up parallel and sometimes redundant workflows for different assays and technologies.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Markets</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate that our clinical and biopharma applications targeted a $40&#160;billion global total addressable market opportunity in 2025, approximately $9&#160;billion of which was in the United States based on our addressable clinical market. These estimates are primarily based on epidemiological data, including incidence and prevalence estimates of addressable populations for each application, as well as a range of price assumptions for our applications and products taking into account differences in panel sizes. Further, these estimates do not depend on obtaining regulatory clearances or approvals to market our applications and products as in vitro diagnostics (&#8220;IVD&#8221;) and / or software as a medical device (&#8220;SaMD&#8221;) in the United States. Over time, we believe that our platform and insights enable market opportunity expansion through new application and product development. The following figure shows our estimated total addressable market in 2025.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Total Addressable Market</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="soph-20251231_g10.jpg" alt="image (4).jpg" style="height:289px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-10"/></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Clinical Market Opportunity</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate our total addressable global clinical market opportunity for our current offerings was $25&#160;billion in 2025, with the largest market opportunity being in oncology.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oncology.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;While the majority of commercial business today in the clinical market comprises diagnosis and advanced therapy selection, our capabilities enable us to serve the oncology testing market across the full patient journey. We can also support healthcare practitioners across tumor and sample types at any stage of the patient journey as long as genomic information or 3D medical imaging is applicable. Our clinical oncology market opportunity consists of five market segments: screening, early detection, diagnosis, therapy selection and monitoring.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rare diseases.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;In rare diseases, we believe the adoption of data-driven medicine is just beginning and represents a significant opportunity for growth. In the rare disease market, there has been growing preference among clinical institutions for larger genetic testing panels, including whole-exome and whole genome panels, to test for a more comprehensive array of rare diseases in contrast to the smaller, more targeted panels that are common in the market today. We believe we are well adapted to address this market opportunity with the exome solutions offered through our SOPHiA DDM Platform. In addition to our SOPHiA DDM Platform, our Alamut suite of genomics mutation interpretation software could be particularly impactful in deepening genomic investigations in rare diseases.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other disease areas and conditions.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We believe that the aggregate market opportunity linked to other disease areas beyond oncology and rare diseases could ultimately be larger than our current opportunity in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oncology and rare diseases given their higher prevalence compared to cancer. Our SOPHiA DDM Platform has applications in areas such as cardiology, neurology and metabolism, through applications ranging from targeted gene panels to whole-exome solutions. While genomics applications are still emerging in these disease areas, we expect significant opportunity in the coming years as novel findings establish the genetic determinants of high-profile diseases such as inherited cardiovascular conditions, multiple sclerosis, Alzheimer&#8217;s disease, autism and metabolic syndrome. We provide applications in each of these disease areas today, and plan to further penetrate the testing landscape in these disease areas through genomics and other data modalities in the future.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other data modalities beyond genomics.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We designed our platform architecture to be able to scale with new digital healthcare data modalities beyond genomics. We have already taken the next step in that direction by developing and deploying our proprietary radiomics analytics capabilities onto our SOPHiA DDM Platform. In radiomics, we offer analytics solutions for three-dimensional medical imaging technologies, including CT, MRI, SPECT and PET scanners, regardless of manufacturers. Additionally, we may expand applications to other imaging modalities such as two-dimensional modalities (e.g., ultrasound, traditional x-rays) as well as testing modalities that can be processed through imaging-based approaches (e.g., electrocardiograms). Beyond radiomics, we intend to support additional data modalities in the future, for example digital pathology, proteomics, spatial genomics and metabolomics. We believe that supporting additional data modalities in our SOPHiA DDM Platform, both as stand-alone modalities and in a multimodal approach, has the potential to open significant new market opportunities and increase our total addressable market in the future.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biopharma Opportunity</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Oncology and rare diseases. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate our total addressable biopharma opportunity for our current offerings was $15&#160;billion in 2025 based on three market segments: Discovery, Development, and Deployment. We believe also that our strategic positioning as a healthcare data analytics platform will enable other business opportunities to become available in the future, in, for example, global public health solutions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Market Opportunities Accessible with our Business Model</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our strategic positioning as a healthcare data analytics platform has the potential to enable other business opportunities to become available in the future.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Universal analytics platform for digital health data.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Leveraging our global network and customer base, we may enter into collaboration agreements with third-party providers of solutions and services that can be deployed through our SOPHiA DDM Platform and to our customer network, thereby generating new indirect network effects. We believe that we could provide a single, unified analytical workflow through our SOPHiA DDM Platform for instruments generating many kinds of digital health data, such as digital pathology, proteomics, single-cell sequencing and other similar applications.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global public health solutions.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Our SOPHiA DDM Platform could provide a fast and reliable ecosystem to gather data on a global scale and inform public health agencies on significant health-related events, such as pandemics. The COVID-19 pandemic has demonstrated the need for solutions able to harmonize and analyze vast data sets on a global scale, for example, to track the evolution of new variants of the SARS-CoV-2 virus over time and across geographies. This may apply to other infectious diseases, and to human host factors such as detecting specific susceptibility characteristics through genomics and other phenotypic information across populations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value-based medicine.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As data-driven medicine and multimodality diagnostic approaches are further adopted in the future, we may collaborate with healthcare stakeholders such as payors, providers and integrated healthcare systems to increase the overall affordability of healthcare. We may develop outcomes-based business models in which we enter into risk-sharing agreements with these stakeholders to support the optimal care management of specific patient populations with the goal of achieving better health and economic outcomes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Platform&#8217;s Advantages</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our SOPHiA DDM Platform has several advantages over alternative genomics analytics platforms as well as other business models aimed at providing data-driven medicine.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unique Value Proposition as a Genomics Analytics Platform</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our SOPHiA DDM Platform enables highly sensitive and specific testing and rapid turnaround time, enabling customers to compute, detect and annotate genomic alterations with high confidence. Our platform and its many applications also allow customers to rapidly build and scale precision medicine operations with different applications. We believe that a crucial characteristic for customers and a key differentiator of our platform is accuracy, leading to quality of insight. The accuracy of our pattern-recognition, AI/ML-based algorithms enable our platform to separate the signal from the noise and standardize data at high-quality levels. Our smart algorithms have high accuracy across applications, from oncology to rare diseases and cardiology, and reduce testing costs by obviating the need for orthogonal assays. The accuracy of our algorithms is a result of the scale and diversity of data within our database.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows how our SOPHiA DDM Platform performs on genomic variant detection from NGS data across a range of selected genomics applications versus the analytical performance of widely used orthogonal assays such as Sanger Sequencing, MLPA, array CGH and digital PCR.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our SOPHiA DDM Platform&#8217;s Analytical Performance in Selected Current Genomics Applications</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="soph-20251231_g11.jpg" alt="DDM Analytical Performance.jpg" style="height:245px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-11"/></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:29.34pt">Results of the CE-IVD study based on our Solid Tumor Solution (STS) that included data from 6 different sequencing centers and a total of 155 clinical and commercial FFPE samples in which 192 confirmed variants were used as the standard.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:29.34pt">Results of the CE-IVD study based on our Hereditary Cancer Solution (HCS) that included data from 7 different sequencing centers and a total of 159 clinical and commercial samples in which 1,252 confirmed variants were used as the standard.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:29.34pt">Results based on the clinical exome analysis of the Ashkenazim trio (mother, father and son&#8217;s DNA) from the Genome In a Bottle consortium that included data from 2 different sequencing centers and a total of 9 samples (including replicates) in which an average of 6,241.2 confirmed variants per sample were used as the standard.</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:29.34pt">Results based on two similar studies that included data from 2 different sequencing centers and a total of 113 clinical and commercial samples in which 833 confirmed variants were used as the standard.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sensitivity measures how often a test correctly generates a positive result for samples in which a certain genomic variant is present (&#8220;true positive&#8221; rate). Specificity measures how often a test correctly generates a negative result for samples in which a certain genomic variant is not present (&#8220;true negative&#8221; rate). Accuracy measures the proportion of tested samples that are correctly classified (&#8220;true positives&#8221; plus &#8220;true negatives&#8221;). Precision measures the ability for repeated analyses on the same samples to give similar results.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Broad and Growing Multimodal Application Offering</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The breadth of our applications and multimodal capabilities enables our customers to deploy and scale their data-driven medicine operations rapidly and to incorporate additional clinically relevant data sets over time. We believe our platform is uniquely positioned to combine high-quality data at the patient level to generate multimodal insights, leveraging the power of advanced AI/ML models. We have developed proprietary capabilities in AI/ML-enabled exploration of multimodal signatures. Through these, we can unlock the synergistic power of next-generation healthcare data to advance predictive capabilities. We believe that over time, multimodal data will provide a superior means to diagnose and treat disease relative to the current approach focusing on just a single modality.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Software-based Platform Facilitates Rapid Global Scaling and Data Collection</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We designed our cloud-native software platform to be capable of scaling globally and to use AI to leverage the data that this scale provides. As of December 31, 2025, we served more than 993 hospital, laboratory and biopharma customers globally through our SOPHiA DDM Platform and related solutions, applications, products, and services. We believe that this global footprint is unique and enables us to capture a wide variety of real-world clinical data around the world. The following figure shows our customer base by region as of December 31, 2025.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Customer Base by Region</span></div><div style="margin-top:10pt;text-align:center"><img src="soph-20251231_g12.jpg" alt="country chart 2025.jpg" style="height:350px;margin-bottom:5pt;vertical-align:text-bottom;width:660px" id="i-12"/></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been expanding our customer base as well as the volume of data that we analyze. From December 31, 2016 to December 31, 2025, our number of active customers grew from 182 to more than 993. During the same period, the aggregate number of genomic profiles analyzed using our SOPHiA DDM Platform grew from approximately 80,000 profiles to approximately 2,300,000 profiles, recently growing by approximately 33,000 new profiles on a monthly basis.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly release platform updates, currently at a pace of once every three weeks. Through these updates, we offer our customers either new content, in the form of new applications or improvements to existing applications, such as new functionalities. We believe this update frequency is a competitive advantage in a rapidly evolving precision medicine ecosystem and allows our customers to benefit from new biological discoveries, such as genomic associations, that are reflected on the platform.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ability to Work with All Stakeholders in the Healthcare Ecosystem</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are empowering our customers through a decentralized model and are able to support clinicians, laboratories and researchers across the healthcare ecosystem. This enables us to benefit from growth across the industry and provide the benefits of our network to different stakeholders. We are also able to collaborate with other product providers in the ecosystem to bundle our solutions to provide differentiated end-to-end solutions. For example, we collaborate with testing kit companies, testing hardware providers, software analytics companies, and diagnostic companies operating with a centralized model. We collaborate with companies including Twist, IDT and Agilent to create an integrated solution using our analytics platform and their library preparation products, including DNA enrichment kits, and with hardware and lab automation providers such as Hamilton and PerkinElmer. We believe that we can support and collaborate with any industry </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">player for their data analytics needs and are therefore not dependent on any specific business model or industry segment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that this unique ecosystem positioning strategy, coupled with our industry-leading analytics capabilities and our global footprint, position us as a global leading healthcare data analytics company. The following figure shows our unique position in the healthcare ecosystem.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SOPHiA GENETICS&#8217; Unique Position as an &#8220;Operating System&#8221;</span></div><div style="margin-top:10pt;text-align:center"><img src="soph-20251231_g13.jpg" alt="DDMOpSys.jpg" style="height:133px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-13"/></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Real-time Visibility into the Healthcare Ecosystem Provides Product and Application Expansion Opportunities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strategic positioning as a universal healthcare data analytics platform gives us real-time visibility into data and events in the healthcare ecosystem, including diagnosis, clinical data, customer behavior, performance of third-party technology solutions and other data important to stakeholders. We believe that we are well positioned to provide value to stakeholders across the healthcare ecosystem and to benefit from product and application expansion opportunities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">High Visibility and Predictability into Our Business</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once onboarded onto our SOPHiA DDM Platform, our customers tend to steadily increase their use of our SOPHiA DDM Platform, which offers a level of predictability that helps us project and manage our growth. In addition, customers rarely leave our SOPHiA DDM Platform given that we are generally integrated into their processes. These observed trends hold particularly well for our dry lab and bundle access model customers. We have a revenue churn rate, which we define as the annualized revenues we estimate to have lost from customers who access our platform through our dry lab access and bundle access models and have not generated revenue over the past 12 months in that period based on their average quarterly revenue contributions from point of onboarding as a percentage of total recurring platform revenue, of 0.1% across our customer base over the year ending December 31, 2025. Furthermore, our customers generally increase their use and adopt new applications of our SOPHiA DDM Platform as our relationship with them grows.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Growth Strategy</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mission is to empower clinicians and researchers around the world to practice data-driven medicine and improve clinical and scientific outcomes. Our growth strategy is to:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Drive innovation and advancement of our SOPHiA DDM Platform to increase its capabilities and broaden its applications.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We plan to continue to invest in scientific innovation to bring new, high-impact content to our customers through regular updates to our platform. This may include new features, new applications, new data modalities and new services. Furthermore, we intend to augment our offering across a multimodality framework, generating novel insights enabled by our expanding data assets, including genomics data, radiomics analysis of medical imaging, clinical data and future additional data modalities such as digital pathology, proteomics, spatial genomics and metabolomics.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Drive new customer adoption with clinical customers worldwide.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We intend to continue to raise awareness of the benefits of data-driven medicine and drive adoption of our platform around the world through our direct sales force, our distributors and our collaborator network. We plan to further penetrate the U.S. market, which we see as our largest opportunity, by significantly investing in our direct sales force to further scale the size of our network, both in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">terms of the number and types of customers. In addition, we also plan to focus on commercializing our solutions by forming additional collaborations with reference and specialty laboratories. Outside the United States, we believe there is significant growth opportunity across EMEA and Latin America markets, as well as untapped potential in APAC, including in China, India, Korea and Japan. In selected geographies outside the United States, we intend to utilize a hybrid commercial model including direct sales force or direct collaborations and distributors.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Increase utilization within our clinical customer base.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We employ a &#8220;land and expand&#8221; commercial model that is focused on winning new customers and then driving utilization of our solution by those customers. Once we secure a customer, we use our direct sales force to build further engagement and help that customer profitably increase its testing operations. For example, we may initially support a customer in setting up its NGS testing operations for hereditary cancer screening, including operational support through our set-up programs. Once the customer is fully onboarded onto our SOPHiA DDM Platform, it is then comparatively easier to deploy additional germline testing solutions as well as somatic oncology testing solutions, creating synergies across the offerings and a unified workflow. We also target incremental users within each institution, for example, additional clinicians within a provider across expanded departments such as radiology or pathology.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Leverage our platform and database to drive adoption by biopharmaceutical companies.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have a distinct sales force focused on biopharma opportunities across the discovery, clinical development and commercialization value chain. We continue to promote our current applications, products, and services, which we believe will strengthen existing collaborations with biopharmaceutical companies as well as lead to new relationships. For example, we may collaborate with a biopharmaceutical company to generate insights on the real-world molecular epidemiology of specific genomic variants relevant for an investigational targeted therapy, including insights on testing trends across our network of customers. This may lead to additional collaborations on a multimodal program to investigate new biomarkers of response to the investigational therapy, a tailored companion diagnostic program, clinical trial recruitment efforts, and market-shaping activities on biomarker testing to support the asset go-to-market strategy. Additionally, we plan to develop new offerings for biopharma as we expand the number and type of new applications and data modalities on our platform. Our biopharma strategy is also highly synergistic to our virtuous cycle.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:32.5pt">Establish and grow industry collaborations across the healthcare ecosystem.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We intend to establish new industry collaborations with other companies providing applications, products, and services to our customers. We intend to collaborate with a diverse array of industry participants, including instruments, reagent and software companies in genomics and in other fields such as digital pathology and proteomics. We intend to collaborate with service providers such as centralized laboratory players and interpretation services providers to expand the breadth of our capabilities. We believe that each new collaboration we develop helps facilitate further adoption of our platform, the evolution of the solution we provide to customers and the growth of our network and application and product capabilities. A larger network enables us to continue to collaborate with customers to develop new solutions and to commercialize these solutions, benefiting all users across the healthcare ecosystem.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commercial</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our SOPHiA DDM Platform and related solutions, applications, products, and services to healthcare providers, centralized laboratories and biopharmaceutical companies through our own sales force as well as through distributors and industry collaborators. As of December 31, 2025, our direct sales team consisted of approximately 105 field-based commercial representatives, including sales and business development managers, key account managers and biopharma alliance managers who are engaged in sales efforts and promotional activities towards our customers. We also employ subject matter experts, clinical genomic experts and biopharma operations specialists who provide customer-facing technical and scientific support. As of December 31, 2025, we had a sales presence in 75 countries, including a direct sales presence in 60 countries and 50 countries in which we offer our SOPHiA DDM Platform and related solutions, applications, products, and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services through distributors. The following figure shows our global commercial footprint as of December 31, 2025.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SOPHiA GENETICS&#8217; Global Footprint &#8211; Countries and Sales Force</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="soph-20251231_g14.jpg" alt="Customer Countries FY24 Pt 1.jpg" style="height:292px;margin-bottom:5pt;vertical-align:text-bottom;width:550px" id="i-14"/></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our initial focus has been on winning clinical customers in order to drive data capture and building our reputation for accuracy and quality in the clinical community. We estimate that there are more than 10,000 laboratories globally that are using NGS instrumentation. We believe that there is significant opportunity to expand our customer base as well as grow utilization of our SOPHiA DDM Platform by our existing customers. Our sales strategy is focused on both attracting new customers to our platform and driving their utilization and adoption of our applications. Once we win a new customer, our direct sales team provides set-up programs to accelerate the adoption of our SOPHiA DDM Platform and facilitates our customers to adopt our platform into their routines. [In 2024, we refocused resources from our more established and penetrated markets in EMEA to higher-growth and under-penetrated regions in NORAM and APAC, as well as specific markets in EMEA, such as the U.K., Germany, and the Middle East, and implemented a more strategic approach towards winning and managing key, high-volume accounts in the clinical market.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We started commercializing our biopharma services in 2019. [In 2024, we refocused our sales efforts to target smaller, more repeatable business that we can execute in high volume to expedite our sales cycle.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Suppliers and Manufacturers</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform is a cloud-native software platform. To deploy our platform, we rely on cloud-based service providers. We also collaborate with consumables and hardware suppliers for the bundle access model and with platform customers for the integrated access model.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Platform Suppliers.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Our platform production environment currently runs on Microsoft Azure. As our platform architecture is vendor-agnostic, we could readily deploy our solutions onto any cloud infrastructure, as well as on-premise if necessary. We have ongoing research and development projects on all major cloud solution providers, including Microsoft Azure, Amazon Web Services and Google Cloud Platform. This allows us a strong degree of flexibility and helps manage vendor risks.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumables and Hardware Suppliers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the bundle access model, we work with Integrated DNA Technologies (&#8220;IDT&#8221;), Qiagen, New England Biolabs (&#8220;NEB&#8221;), Watchmaker Genomics, Inc. and others for consumables and hardware equipment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Platform Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the integrated access model, we route a customer&#8217;s samples to selected SOPHiA DDM Platform collaborators who conduct the sequencing process for the customer and upload the resulting </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">data into our SOPHiA DDM Platform. As of December 31, 2025, we collaborated with seven laboratories across seven countries to provide this service.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continually assess our dependence on our suppliers and manufacturers and evaluate alternative solutions. We have built our business such that we do not rely on any single supplier or manufacturer, such that we are able to switch suppliers and manufacturers as necessary. We believe that this mitigates risks to our business and provides us the opportunity to drive down costs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a market characterized by rapidly advancing technologies and a strong emphasis on intellectual property. Our main competitors are institutions that collect multimodal data that have developed in-house analytics solutions, such as Tempus Labs, F. Hoffmann-La Roche and Caris Life Sciences, but we believe these competitors also represent our potential customers. In addition, other companies such as Siemens, Koninklijke Philips and Konika Minolta are also positioning themselves in the market with data analytics platform capabilities to build a multimodal world. We also face competition from companies that have developed software analytics platforms for genomics data, such as Agilent, Fabric Genomics, Illumina, Qiagen Digital Insights, Velsera Inc., Congenica Ltd and Thermo Fisher. We believe that our proprietary technology and the agility and the scalability of our platform distinguishes us from other players. We believe that our position as a &#8220;universal operating system&#8221; enables us to empower and sell to many different players in the ecosystem, including competitors. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Related to Our Business and Industry&#8212;We face competition from many sources and we may be unable to compete successfully.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property is of vital importance in the biotechnology field. Our success depends in part on our ability to obtain and maintain intellectual property and proprietary protection for our technology, defend and enforce our intellectual property rights, preserve the confidentiality of our trade secrets, and operate without infringing, misappropriating or otherwise violating valid and enforceable intellectual property and proprietary rights of others.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are actively involved in research and development and therefore seek to protect the investments made into the development of our technology by relying on a combination of patents, trademarks, copyrights, trade secrets, including know-how, and license agreements. We also seek to protect our proprietary technology, in part, by requiring our employees, consultants, contractors and other third parties to execute confidentiality agreements and invention assignment agreements and by implementing technological measures and other methods.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to stop third parties from making, using, selling, offering to sell or importing our platform, applications, services, and products depends on the extent to which we have rights under valid and enforceable patents, trade secrets or other intellectual property and proprietary rights that cover these activities. We pursue intellectual property protection to the extent we believe it would advance our business objectives. Notwithstanding these efforts, there can be no assurance that we will adequately protect our intellectual property or provide any competitive advantage. For more information regarding risks relating to intellectual property, see &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Related to Intellectual Property.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patents</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our intellectual property strategy is focused on protecting our ongoing research and development through patents and other intellectual property rights.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, we solely owned 10 issued U.S. patents, 21 pending U.S. patent applications, 67 issued patents in foreign jurisdictions and approximately 42 pending patent applications in foreign jurisdictions, including Europe, Canada, Australia, Brazil, China, and India, wherein 4 are pending Patent Cooperation Treaty applications relating to laboratory methods and/or software to provide molecular diagnosis in germline diseases. These include filings for 29 families of utility patents and 22 families of design patents relating to graphical user interfaces. Such issued utility patents and any patents derived from such applications or applications that claim priority from such applications, if granted, would be expected to expire between (2036 and 2045), excluding any additional term for patent term adjustments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2025, our most material patents and patent applications consisted of (i) one issued patent in Israel, one issued patent in Australia, one issued patent in Brazil, one issued patent in Europe, one issued patent in India, three pending U.S. patent applications and two pending foreign patent applications in Canada and China relating to our algorithm for next generation sequencing data which is used in our SOPHiA DDM Platform, (ii) one issued European Patent, one issued U.S. patent, and one pending U.S. patent application relating to a method for processing certain genomic data which is used in our SOPHiA DDM Platform, (iii) one issued European Patent, one issued U.S. patent, and one pending U.S. patent application for a method to improve the accuracy of the estimated length of homopolymer and heteropolymer regions, which is used in our SOPHiA DDM Platform, (iv) three pending U.S. patent applications, one issued European patent, and five pending foreign patent applications in Australia, Brazil, Canada, Japan, and South Korea relating to a unique molecular identifier and related analytics workflow which is incorporated in our software applications and products and into our SOPHiA DDM Platform, (v) one issued European patent, one issued U.S. patent, and one U.S. pending patent application for a method to detect microsatellite instability that is used in our SOPHiA DDM Platform, (vi) two pending European patent applications, three U.S. pending patent application, and seven pending foreign patent applications in Hong Kong, Australia, Brazil, Canada, China, Japan, and South Korea relating to a method to detect homologous recombination deficiency (&#8220;HRD&#8221;), which is used in our SOPHiA DDM Platform and SOPHiA DDM HRD solution, (vii) one pending European patent application and one pending U.S. patent application relating to a Limit of Detection aware variant calling method which is not currently used in our software applications and products, (viii) one issued European patent, one issued U.S. patent, one pending European patent application and one pending U.S. patent application and five pending foreign patent applications in Australia, Brazil, Canada, Japan, and South Korea relating to a unique molecular identifier and related analytics workflow which is incorporated in our probes for detecting gene fusion events in our SOPHiA DDM Platform RNAtarget Technology. Any patents derived from such applications or applications that claim priority from such applications, if granted, would be expected to expire between 2036 and 2045, excluding any additional term for patent term adjustments.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained. In most countries in which we file or intend to file, including the United States, the patent term is 20 years from the earliest date of filing a&#160;non-provisional&#160;patent application. In the United States, a patent&#8217;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the USPTO in examining and granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier filed patent. We cannot be sure that patents will be granted with respect to any current pending patent application or with respect to any patent applications filed by us in the future, and we cannot be sure that any current or future patents will be commercially useful in protecting our platform, applications, products, services, technologies and processes. In addition, any patents that we may hold, whether owned or licensed, may be challenged, circumvented or invalidated by third parties.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trademarks</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our business strategy depends on our continued ability to use our existing intellectual property in order to increase brand awareness and develop our branded services.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, we owned 13 registered U.S. trademarks, 1 pending U.S. trademarks, approximately 138 registered foreign trademarks and 3 pending foreign trademark applications. Our trademark portfolio is designed to protect the brands of our current and future applications and products and includes U.S. trademark registrations for our company name, &#8220;SOPHIA GENETICS&#8221;, and application and product names, such as &#8220;SOPHIA DDM&#8221; and &#8220;ALAMUT&#8221;. We have granted licenses to certain of our trademarks to our domestic and international collaborators.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trade Secrets</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on trade secrets, including know-how, unpatented technology and other proprietary information, to strengthen our competitive position. We have determined that certain technologies that are not amenable to, or that we do not presently consider appropriate for, patent protection, such as our analysis techniques and analysis generated using our proprietary algorithms in the context of our SOPHiA DDM Platform, are better kept as trade secrets in order to protect and maintain our competitive position and aspects of our business and prevent competitors from reverse-engineering or copying our technologies.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to protect trade secrets and confidential and unpatented know-how, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to such knowledge, such as our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employees, corporate collaborators, outside scientific collaborators, CROs, or manufacturers, consultants, advisors and other third parties. We also seek to enter into confidentiality and invention or patent assignment agreements with our employees and consultants that obligate them to maintain confidentiality and assign their inventions to us. We cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary technology and processes or that the assignment agreements that have been entered into are self-executing. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, or claim ownership in intellectual property that we believe is owned by us. In addition, we take other appropriate precautions, such as physical and technological security measures, to guard against misappropriation of our proprietary information by third parties.</span></div><div><span><br/></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laboratory Developed Tests</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CLIA and State Laboratory Licensing</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CLIA is a U.S. federal law that regulates clinical laboratories that perform testing on specimens derived from humans for the purpose of providing information for the diagnosis, prevention, or treatment of disease, or impairment of, or the assessment of the health of, human beings. CLIA regulations require, among other things, clinical laboratories to obtain a certificate and mandate specific standards in the areas of personnel qualifications, administration, participation in proficiency testing, test management, and quality assurance. CLIA certification is also required for us to be eligible to bill state and federal healthcare programs, if such reimbursement is otherwise available, as well as many private third-party payors, for our applications and products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to federal certification requirements of laboratories under CLIA, CLIA provides that states may adopt laboratory regulations and licensure requirements that are more stringent than those under federal law. A number of states have implemented their own more stringent laboratory regulatory requirements. Such laws, among other things, establish standards for the day-to-day operation of a clinical laboratory, including the training and skills required of personnel and quality control. For example, New York state laws and regulations establish standards for day-to-day operation of a clinical laboratory, including training and skill levels.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently operate a CLIA-certified laboratory. Our customers are responsible for obtaining and maintaining their own CLIA certification.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Oversight of Laboratory Developed Tests</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and regulations governing the marketing of clinical laboratory testing and diagnostic products are evolving and extremely complex and, in many instances, there are no significant regulatory or judicial interpretations of these laws and regulations. Clinical laboratory tests are regulated under CLIA, as administered by CMS, as well as by applicable state laws. In addition, the FDCA defines a medical device to include any instrument, apparatus, implement, machine, contrivance, implant, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reagent, or other similar or related article, including a component part, or accessory, intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals. Among other things, pursuant to the FDCA and its implementing regulations, the FDA regulates the research, testing, manufacturing, safety, labeling, storage, recordkeeping, pre-market clearance or approval, marketing and promotion, and sales and distribution of medical devices in the United States to ensure that medical products distributed domestically are safe and effective for their intended uses. In addition, the FDA regulates the export of medical devices manufactured in the United States to international markets.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the FDA has statutory authority to assure that medical devices are safe and effective for their intended uses, the FDA has generally exercised enforcement discretion and not enforced applicable regulations with respect to in vitro diagnostics that are designed, manufactured and used within a single laboratory for use only in that laboratory. These tests are referred to as LDTs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AI/ML-Based Medical Software</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA recognizes that the traditional paradigm of medical device regulation was not designed for adaptive AI/ML technologies. The FDA has cleared or approved several AI/ML-based software as medical devices (&#8220;SaMD&#8221;). Typically, these have only included algorithms that are &#8220;locked&#8221; prior to marketing, where algorithm changes likely require FDA premarket review for changes beyond the original market authorization. However, not all AI/ML-based SaMD are locked; some algorithms can adapt over time. Following distribution, these types of continuously learning and adaptive AI/ML algorithms may provide a different output in comparison to the output initially cleared for a given set of inputs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA&#8217;s Center for Devices and Radiological Health is building a total product lifecycle-based regulatory framework for AI/ML technologies. On January&#160;12, 2021, the FDA released its Artificial Intelligence/Machine Learning-Based Software as a Medical Device Action Plan, which outlines five actions that the FDA intends to take, including:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">further developing the proposed regulatory framework, including through issuance of draft guidance on a predetermined change control plan (for software&#8217;s learning over time);</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">supporting the development of good machine learning practices to evaluate and improve machine learning algorithms;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">fostering a patient-centered approach, including device transparency to users;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">developing methods to evaluate and improve machine learning algorithms; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">advancing real-world performance monitoring pilots.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2023, the FDA further advanced its regulatory efforts by publishing detailed recommendations for Marketing Submissions that incorporate Predetermined Change Control Plans (&#8220;PCCPs&#8221;), emphasizing a structured approach to managing post-market modifications for AI/ML-based medical devices. It requires manufacturers to outline anticipated AI/ML modifications in their initial marketing submission, detailing a structured approach for implementing and validating these updates. The impact of the modifications should be assessed in advance to ensure they maintain safety and performance. It also highlights the need for transparency and traceability, requiring clear documentation of AI/ML updates. Risk mitigation strategies must be in place to address potential issues like model drift or performance degradation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The recommendations have been drafted to ensure continuous compliance of AI-driven medical devices.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Medical Device Regulatory Framework</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to its authority under the FDCA, the FDA has jurisdiction over medical devices, which are defined to include, among other things, IVDs and SaMD. The FDA regulates the research, design, development, preclinical and clinical testing, manufacturing, safety, effectiveness, packaging, labeling, storage, recordkeeping, pre-market clearance or approval, adverse event reporting, marketing, promotion, sales, distribution and import and export of medical devices.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Device Classification</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the FDCA, medical devices are classified into one of three classes (Class I, Class&#160;II, or Class&#160;III) depending on the degree of risk associated with each medical device and the extent of control needed to provide reasonable assurances with respect to safety and effectiveness.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class&#160;I includes devices with the lowest risk to the patient and are those for which safety and effectiveness can be reasonably assured by adherence to General Controls for Medical Devices, which require compliance with the applicable portions of the FDA&#8217;s Quality Management System Regulation, facility registration and product listing, reporting of adverse events and malfunctions, and appropriate, truthful and non-misleading labeling and promotional materials. While some Class&#160;I devices also require premarket clearance by the FDA through the 510(k) premarket notification process described below, most Class&#160;I products are exempt from the premarket notification requirements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class&#160;II devices are those that are subject to the General Controls, as well as Special Controls as deemed necessary by the FDA to ensure the safety and effectiveness of the device. These Special Controls can include performance standards, patient registries, FDA guidance documents and post-market surveillance. Most Class&#160;II devices are subject to premarket review and clearance by the FDA. Premarket review and clearance by the FDA for Class&#160;II devices is accomplished through the 510(k) premarket notification process.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class&#160;III devices include devices deemed by the FDA to pose the greatest risk, such as life-supporting, life-sustaining devices or implantable devices, in addition to those deemed novel and not substantially equivalent following the 510(k) process. The safety and effectiveness of Class&#160;III devices cannot be reasonably assured solely by the General Controls and Special Controls described above. Therefore, these devices are subject to the PMA process, which is generally more costly and time-consuming than the 510(k) process. Through the PMA process, the applicant must submit data and information demonstrating reasonable assurance of the safety and effectiveness of the device for its intended use to the FDA&#8217;s satisfaction. Accordingly, a PMA typically includes, but is not limited to, extensive technical information regarding device design and development, preclinical and clinical trial data, manufacturing information and labeling and financial disclosure information for the clinical investigators in device studies. The PMA application must provide valid scientific evidence that demonstrates to the FDA&#8217;s satisfaction a reasonable assurance of the safety and effectiveness of the device for its intended use.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The 510(k) Clearance Process</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 510(k) clearance process, the manufacturer must submit to the FDA a premarket notification, demonstrating that the device is &#8220;substantially equivalent&#8221; to a legally marketed predicate device. A predicate device is a legally marketed device that is not subject to a PMA, i.e., a device that was legally marketed prior to May&#160;28, 1976 (pre-amendments device) and for which a PMA is not required, a device that has been reclassified from Class&#160;III to Class&#160;II or I, or a device that was previously found substantially equivalent through the 510(k) process. To be &#8220;substantially equivalent,&#8221; the proposed device must have the same intended use as the predicate device, and either have the same technological characteristics as the predicate device or have different technological characteristics and not raise different questions of safety or effectiveness than the predicate device. Clinical data is sometimes required to support substantial equivalence.&#160;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a 510(k) premarket notification is submitted, the FDA determines whether to accept it for substantive review. If it lacks necessary information for substantive review, the FDA will refuse to accept the 510(k) premarket notification. If it is accepted for filing, the FDA begins a substantive review. By statute, the FDA is required to complete its review of a 510(k) notification within 90 days of receiving the 510(k) notification. As a practical matter, clearance often takes longer, and clearance is never assured. Although many 510(k) premarket notifications are cleared without clinical data, the FDA may require further information, including data from samples collected in a clinical setting, to make a determination regarding substantial equivalence which may significantly prolong the review process. If the FDA agrees that the device is substantially equivalent, it will grant clearance to commercially market the device.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA determines that the device is not &#8220;substantially equivalent&#8221; to a predicate device, or if the device is automatically classified into Class&#160;III, the device sponsor must then fulfill the much more rigorous premarketing requirements of the PMA approval process or seek reclassification of the device through the De Novo classification process.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device receives 510(k) clearance, any modification that could significantly affect its safety or effectiveness, or that would constitute a new or major change in its intended use, under current regulations, will require a new 510(k) clearance or, depending on the modification, could require a PMA application. The FDA requires each manufacturer to determine whether the proposed change requires a new submission in the first instance, but the FDA can review any such decision and disagree with a manufacturer&#8217;s determination. Many minor modifications are accomplished by an internal letter-to-file in which the manufacture documents its reasoning for why a change does not require premarket submission to the FDA. The letter-to-file is in lieu of submitting a new 510(k) to obtain clearance for such change. The FDA can always review these letters-to-file in an inspection. If the FDA disagrees with a manufacturer&#8217;s determination regarding whether a new premarket submission is required for the modification of an existing 510(k)-cleared device, the FDA can require the manufacturer to cease marketing and/or recall the modified device until 510(k) clearance or approval of a PMA application is obtained. In addition, in these circumstances, the FDA can impose significant regulatory fines or penalties for failure to submit the requisite application(s).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The De Novo Process</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The De Novo classification process is an alternate pathway to classify medical devices that are automatically classified into Class&#160;II where no predicate currently exists. While rare, Class I devices can also fall under the De Novo classification process when an existing classification does not exist. A manufacturer can submit a petition for direct De Novo review if the manufacturer is unable to identify an appropriate predicate device and the new device or new use of the device presents a moderate or low risk. De Novo classification may also be available after receipt of a &#8220;not substantially equivalent&#8221; letter following submission of a 510(k) to the FDA.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The PMA Approval</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Process</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following receipt of a PMA application, the FDA conducts an administrative review to determine whether the application is sufficiently complete to permit a substantive review. If it is not, the agency will refuse to file the PMA. If it is, the FDA will accept the application for filing and begin the review. The FDA has 180 days to review a filed PMA application, although the review of an application more often occurs over a significantly longer period of time. During this review period, the FDA may request additional information or clarification of information already provided, and the FDA may issue a major deficiency letter to the applicant, requesting the applicant&#8217;s response to deficiencies communicated by the FDA.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before approving or denying a PMA, an FDA advisory committee may review the PMA at a public meeting and provide the FDA with the committee&#8217;s recommendation on whether the FDA should approve the submission, approve it with specific conditions, or not approve it. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to approval of a PMA, the FDA may conduct inspections of the clinical trial data and clinical trial sites, as well as inspections of the manufacturing facility and processes. Overall, the FDA review of a PMA application generally takes between one and three years, but may take significantly longer. The FDA can delay, limit or deny approval of a PMA application for many reasons, including:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The device may not be shown safe or effective to the FDA&#8217;s satisfaction;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The data from pre-clinical studies and/or clinical trials may be found unreliable or insufficient to support approval;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">The manufacturing process or facilities may not meet applicable requirements; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Changes in FDA clearance or approval policies or adoption of new regulations may require additional data.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA evaluation of a PMA is favorable, the FDA will issue either an approval letter or an approvable letter, the latter of which usually contains a number of conditions that must be met in order to secure final approval of the PMA. When and if those conditions have been fulfilled to the satisfaction of the FDA, the agency will issue a PMA approval letter authorizing commercial marketing of the device, subject to the conditions of approval and the limitations established in the approval letter. If the FDA&#8217;s evaluation of a PMA application or manufacturing facilities is not favorable, the FDA will deny approval of the PMA or issue a not-approvable letter. The FDA also may determine that additional tests or clinical trials are necessary, in which case the PMA approval may be delayed for several months or years while the trials are conducted and data is submitted in an amendment to the PMA, or the PMA is withdrawn and resubmitted when the data are available. The PMA process can be expensive, uncertain and lengthy, and a number of devices for which FDA approval has been sought by other companies have never been approved by the FDA for marketing.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New PMA applications or PMA supplements are required for modification to the manufacturing process, equipment or facility, quality control procedures, sterilization, packaging, expiration date, labeling, device specifications, ingredients, materials or design of a device that has been approved through the PMA process. PMA supplements often require submission of the same type of information as an initial PMA application, except that the supplement is limited to information needed to support any changes from the device covered by the approved PMA application and may or may not require as extensive technical or clinical data or the convening of an advisory panel, depending on the nature of the proposed change.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In approving a PMA application, as a condition of approval, the FDA may also require some form of post-approval study or post-market surveillance, whereby the applicant conducts a follow-up study or follows certain patient groups for a number of years and makes periodic reports to the FDA on the clinical status of those patients when necessary to protect the public health or to provide additional or longer-term safety and effectiveness data for the device. The FDA may also approve a PMA application with other post-approval conditions intended to ensure the safety and effectiveness of the device, such as, among other things, restrictions on labeling, promotion, sale, distribution and use. New PMA applications or PMA supplements may also be required for modifications to any approved diagnostic tests, including modifications to manufacturing processes, device labeling and device design, based on the findings of post-approval studies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Clinical Trials </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, absent certain limited exceptions, human clinical trials intended to support medical device clearance or approval require an investigational device exemption (&#8220;IDE&#8221;) application. Some types of studies deemed to present &#8220;non-significant risk&#8221; are deemed to have an approved IDE&#8211;without affirmative submission of an IDE application to the FDA&#8211;once certain requirements are addressed and IRB approval is obtained. If the device presents a &#8220;significant risk&#8221; to human health, as defined by the FDA, the sponsor must submit an IDE application to the FDA and obtain IDE approval prior to commencing the human clinical trials. The IDE application must be supported by appropriate data, such as animal and laboratory testing results, showing that it is safe to test the device in humans and that the testing protocol is scientifically sound. Generally, clinical trials for a significant risk device may begin once the IDE application is approved by the FDA and the study protocol and informed consent are approved by appropriate IRBs at the clinical trial sites. Submission of an IDE will not necessarily result in the ability to commence clinical trials, and although the FDA&#8217;s approval of an IDE allows clinical testing to go forward for a specified number of subjects, it does not bind the FDA to accept the results of the trial as sufficient to prove the product&#8217;s safety and efficacy, even if the trial meets its intended success criteria.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such clinical trials must be conducted in accordance with the FDA&#8217;s IDE regulations that govern investigational device labeling, prohibit promotion and specify an array of recordkeeping, reporting and monitoring responsibilities of study sponsors and study investigators. Clinical trials must further comply with good clinical practice regulations for IRB approval and for informed consent and other human subject protections. Required records and reports are subject to inspection by the FDA for any clinical trials subject to FDA oversight. The results of clinical testing may be unfavorable, or, even if the intended safety and efficacy success criteria are achieved, may not be considered sufficient for the FDA to grant marketing approval or clearance of a product. The commencement or completion of any clinical trial may be delayed or halted, or be inadequate to support approval of a PMA application or clearance of a 510(k) premarket notification, for numerous reasons.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Breakthrough Devices Program is a voluntary program intended to expedite the development, assessment and review of certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating human diseases or conditions for which no approved or cleared treatment exists or that offer significant advantages over existing approved or cleared alternatives. All submissions for devices designated as Breakthrough Devices will receive priority review, meaning that the review of the submission is placed at the top of the appropriate review queue and receives additional review resources, as needed. Although Breakthrough Device designation or access to any other expedited program may expedite the development or approval process, it does not change the standards for approval. Access to an expedited program may also be withdrawn by the FDA if it believes that the designation is no longer supported by data from our clinical development program. Additionally, qualification for any expedited review procedure does not ensure that we will ultimately obtain regulatory clearance or approval for such product.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research Use Only</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, SOPHiA applications and products labeled and sold for research use only, and not for the diagnosis or treatment of disease, are sold to a variety of parties, including biopharmaceutical companies, academic institutions and molecular laboratories. Because such applications and products are not intended for use in clinical practice in diagnostics, and the applications and products cannot include clinical or diagnostic claims, they are exempt from many regulatory requirements otherwise applicable to medical devices. In particular, while the FDA regulations require that RUO applications and products be labeled &#8220;For Research Use Only. Not for use in diagnostic procedures,&#8221; the regulations do not otherwise subject such applications and products to the FDA&#8217;s pre- and post-market controls for medical devices.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant change in the laws governing RUO products or how they are enforced may require a change to our business model in order to maintain compliance. For instance, in November 2013 the FDA issued the RUO Guidance, which highlights the FDA&#8217;s interpretation that distribution of RUO products with any labeling, advertising or promotion that suggests that clinical laboratories can validate the test through their own procedures and subsequently offer it for clinical diagnostic use as a laboratory, developed test is in conflict with RUO status. The RUO Guidance further articulates the FDA&#8217;s position that any assistance offered in performing clinical validation or verification, or similar specialized technical support, to clinical laboratories conflicts with RUO status. If we engage in any activities that the FDA deems to be in conflict with the RUO status held by the applications and products that we sell, we may be subject to immediate, severe and broad FDA enforcement action that would adversely affect our ability to continue operations. Accordingly, if the FDA finds that we are distributing our RUO applications and products in a manner that is inconsistent with its regulations or guidance, we may be forced to stop distribution of our RUO tests until we are in compliance, which would reduce our revenues, increase our costs and adversely affect our business, prospects, results of operations and financial condition. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA requires marketing authorization of our RUO applications and products in the future, there can be no assurance that the FDA will ultimately grant any clearance or approval requested by us in a timely manner, or at all.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Post-Market Regulation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device is cleared or approved for marketing, numerous and pervasive regulatory requirements continue to apply. These include:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">establishment registration and device listing with the FDA;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">QSR requirements, which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control, documentation and other quality assurance procedures during all aspects of the design and manufacturing process;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">labeling regulations and FDA prohibitions against the promotion of investigational products or the promotion of &#8220;off-label&#8221; uses of cleared or approved products;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">requirements related to promotional activities;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">clearance or approval of product modifications to 510(k)-cleared devices that could significantly affect safety or effectiveness or that would constitute a major change in intended use of one of our cleared devices, or approval of certain modifications to PMA-approved devices;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">medical device reporting regulations, which require that a manufacturer report to the FDA if a device it markets may have caused or contributed to a death or serious injury, or has malfunctioned and the device or a similar device that it markets would be likely to cause or contribute to a death or serious injury if the malfunction were to recur;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">correction, removal and recall reporting regulations, which require that manufacturers report to the FDA field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the FDA&#8217;s recall authority, whereby the agency can order device manufacturers to recall from the market a product that is in violation of governing laws and regulations; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">post-market surveillance activities and regulations, which apply when deemed by the FDA to be necessary to protect the public health or to provide additional safety and effectiveness data for the device.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Device manufacturing processes are required to comply with the applicable portions of the QSR, which cover the methods and the facilities and controls for the design, manufacture, testing, production, processes, controls, quality assurance, labeling, packaging, distribution, installation and servicing of finished devices intended for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">human use. The QSR also requires, among other things, maintenance of a device master file, device history file and complaint files. In January 2024, the FDA published a final rule to amend the QSR to align the regulations more closely with the international consensus standard for devices by converging with the quality management system (QMS) requirements used by other regulatory authorities from other countries. Manufacturers had until February 2, 2026, to modify their quality systems to meet QMS Regulations (QMSR). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturers are subject to periodic scheduled or unscheduled inspections by the FDA. A failure to maintain compliance with the regulatory requirements could result in the shut-down of, or restrictions on, manufacturing operations and the recall or seizure of products. The discovery of previously unknown problems with products, including unanticipated adverse events or adverse events of increasing severity or frequency, whether resulting from the use of the device within the scope of its clearance or off-label by a physician in the practice of medicine, could result in restrictions on the device, including the removal of the product from the market or voluntary or mandatory device recalls.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has broad regulatory compliance and enforcement powers. If the FDA determines that a manufacturer has failed to comply with applicable regulatory requirements, it can take a variety of compliance or enforcement actions, including the following:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">issuance of warning letters, untitled letters, fines, injunctions, consent decrees and civil penalties;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">requesting or requiring recalls, withdrawals or administrative detention, or seizure of our products;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">imposing operating restrictions or partial suspension or total shutdown of production;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">refusing or delaying requests for 510(k) marketing clearance or PMA approvals of new products or modified products;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">withdrawing 510(k) clearances or PMA approvals that have already been granted;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">refusal to grant export approvals for our products; or</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">criminal prosecution.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Authorization to Market In Vitro Medical Devices in the European Economic Area</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EEA, in vitro medical devices that are in transition to the new regulations are required to conform with the essential requirements of the EU In Vitro Diagnostic Directive (IVDD Directive No 98/79/EC, as amended, the &#8220;IVDD&#8221;). The scope of 98/79/EC applies to IVD medical devices and accessories, which can include not just reagents and kits but also instruments and software. To demonstrate compliance, ISO 13485 is recognized as the harmonized standard for regulatory quality system compliance. Companies are required to meet the essential requirements of the IVDD.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EU IVD Regulatory Classification</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the IVDD, the risk presented by a device determines the classification and therefore the level of control and regulatory review required. Annex II of the IVDD identifies specific device types that are categorized as either high risk (List A) or moderate risk (List B). General IVDs may self-certify without the intervention of a Notified Body in order to affix the CE Marking. Self-test IVDs, because of the greater risk associated with being used by untrained lay users, have special requirements, while all other devices not classified as either List A, List B or self-test are regarded as general IVDs. SOPHiA currently has self-certified applications and products in the EU market through SwissMedic.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;5, 2017, the EU adopted the new In Vitro Device Regulation (EU) 2017/746 (the &#8220;IVDR&#8221;), which repeals and replaces Directive No 98/79/EC effective May 2022. Unlike directives, which must be implemented into the national laws of the EU member states, a regulation is directly applicable, i.e., without the need for adoption of EU member state laws implementing them, in all EEA member states. The IVDR, among other things, is intended to establish a uniform, transparent, predictable and sustainable regulatory framework across the EU for in vitro diagnostic medical devices and ensure a high level of safety and health while supporting innovation. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IVDR will not become fully applicable until five years following its entry into force. Once applicable, the IVDR will, among other things:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">strengthen the rules on placing devices on the market and reinforce surveillance once they are available;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">establish explicit provisions on manufacturers&#8217; responsibilities for the follow-up of the quality, performance and safety of devices placed on the market;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">improve the traceability of medical devices throughout the supply chain to the end-user or patient through a unique identification number; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">set up a central database to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 9, 2024, the Regulation (EU) 2024/1860 was published in the Official Journal of the European Union, which includes new transitional periods for IVDs. When following certain conditions i.e. QMS requirements and Notified Body agreements the transition deadlines are extended as follows; December 2027 for class D devices that are transitioning from IVDD self declared, December 2028 for class C devices that are transitioning from IVDD self declared, and December 2029 for class B that are transitioning from IVDD self declared and A sterile devices. Moreover, the application of certain requirements of Article 5(5) of the IVDR for devices manufactured and used in the same health institution (so-called &#8216;in-house devices') came into force in May 2024 with full compliance to Article 5(5) required in May 2030. Any products currently on the market with a CE-IVD label before May 2022 may remain on the market until the new deadline or until the product undergoes a significant change, at which point, it must comply with all the requirements of the IVDR.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Brexit and the Regulatory Framework in the U.K.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;23, 2016, the electorate in the U.K. voted in favor of leaving the EU, commonly referred to as Brexit. On December&#160;24, 2020, the U.K. and the EU entered into a Trade and Cooperation Agreement. The agreement sets out certain procedures for approval and recognition of medical products in each jurisdiction. Since the regulatory framework for medical products in the U.K. covering quality, safety and efficacy of medical products, clinical trials, marketing authorization, commercial sales and distribution of pharmaceutical medical is derived from EU directives and regulations, Brexit could materially impact the future regulatory regime which applies to medical products in the U.K., as the U.K. legislation now has the potential to diverge from EU legislation. It remains to be seen how Brexit will impact regulatory requirements for medical products in the U.K. in the long-term. The Medicines and Healthcare products Regulatory Agency published detailed guidance for industry and organizations to follow from January&#160;1, 2021, which will be updated as the U.K.&#8217;s regulatory position on medicinal products evolves over time.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A new UKCA mark will replace the CE mark in Great Britain (CE marks or UKNI marks will be required in Northern Ireland). However, all medical devices and IVD's must be registered with the Medicine and Healthcare products Regulatory Agency to be placed on the Great Britain market, CE marked devices can be placed on the Great Britain market until, at least, 30 June 2030, depending on the device type and classification.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">EU-Swiss Institutional Framework Agreement</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, Switzerland adopted the new Ordinance on In vitro Diagnostic Medical Devices (&#8220;IvDO&#8221;), which replaced the former agreement. Under the new regulation, in order to market products in Switzerland, companies that manufacture diagnostic and medical devices are required to register the products with the Swiss Agency for Therapeutic Products (&#8220;Swissmedic&#8221;) and label the products accordingly. Additionally, products manufactured in the Swiss facilities of companies are subject to additional registration and representation requirements in order to be marketed within the European Economic Area (&#8220;EEA&#8221;), including but not limited to the appointment of an Authorized Representative.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Jurisdictions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the United States, the EU, the U.K. and Switzerland, regulatory pathways for the marketing of medical devices vary greatly from country to country. In many countries, local regulatory agencies conduct an </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent review of medical devices prior to granting marketing approval and may require specific disclosure or localization to access the local market.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, in Brazil all medical devices imported into or distributed within Brazil must first be registered with the Ag&#234;ncia Nacional de Vigil&#226;ncia Sanit&#225;ria (&#8220;ANVISA&#8221;) or the National Health Surveillance Agency. ANVISA is an autonomous regulatory agency responsible for the regulation and oversight of medical devices and other medical products in Brazil, including the registration of medical devices and the maintenance of a registered products database. The medical device company must be located in Brazil or arrange for a licensed third-party company to be the Brazilian registration certificate title holder. Resolution RDC 36/2015 is the central regulation applicable to registration of in vitro diagnostic devices and Resolution RDC 751/2022, which became effective on March 1, 2023, covers software as medical devices in Brazil, describing the protocol and documents required, including localization into Brazilian Portuguese. Chapter II set forth of RDC 36/2015 the classification scheme, assigning devices to one of four risk classes, based upon various rules enumerated therein. This classification structure is aligned with the EU&#8217;s one. If a device fits into more than one risk classification, its final risk class is the one associated with the highest risk level. Class I and Class II registrations do not expire. Class III and IV registrations are valid for ten years. Registration renewals must be initiated no earlier than one year and no later than six months prior to expiration. Manufacturers are also subject to audits to ensure compliance with the Brazilian Good Manufacturing Practices (&#8220;BGMP&#8221;) prior to receiving authorization to sell from ANVISA. BGMP audits may be fulfilled through other audits by recognized entities through the Medical Device Single Audit Program. RUO products are labeled accordingly and are not subject to these registration requirements. While we are currently able to market our SOPHiA DDM Platform and related solutions, products and services in Brazil, including through our Brazilian subsidiary, any changes to the regulatory framework for RUO products could result in additional costs to us, including expenses related to additional audits, translations and registration fees, or delays in accessing the Brazilian market, including due to the time required to obtain necessary ANVISA approvals.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Turkey, medical devices are regulated by the Medicines and Medical Devices Agency within Ministry of Health and pursuant to the Medical Device Regulation, the Regulation on Active Implantable Medical Devices and the Regulation on In Vitro Diagnostic Medical Devices. These regulations generally resemble analogous EU directives and regulations. To be sold in Turkey, medical devices must bear a CE mark and must subsequently be registered in the Turkish Ministry&#8217;s online database (Turkish Drug and Medical Device National Databank, or TITUBB) in order to be marketed in Turkey. Manufacturers without local presence in Turkey must appoint a Local Authorized Representative. A product will generally be considered a medical device if it is marketed as a medical device in the EU. In recent years, software and mobile application medical devices have been increasing and the Medicines and Medical Devices Agency has considered certain software and mobile applications as medical devices, taking into consideration their intended use. In March 2021, the Product Safety and Technical Regulations Law No. 7223 (the &#8220;Product Safety Law&#8221;) became effective. The Product Safety Law reconciled some outstanding differences between Turkish and EU product safety standards, providing in part for manufacturer and importer liability in the event that a noncompliant or unsafe product causes harm or damage and mandating recall of such products. Because the current regulatory framework in Turkey closely parallels the EU&#8217;s framework, we do not currently experience material difficulties in marketing our SOPHiA DDM Platform and related solutions, applications, products, and services in Turkey that are unique to that jurisdiction.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Japan the Ministry of Health, Labour and Welfare (&#8220;MHLW&#8221;) uses a classification system based on risk for IVDs, there are three types of registration procedures; Pre-market notification for Class I (lowest) risk devices, Pre-market certification (&#8220;PMC&#8221;) for Class II devices, and Pre-Market Approval (&#8220;PMA&#8221;) for Class III (highest) risk devices. Companies must comply with the Pharmaceuticals Medical Device Act (&#8220;PMDA&#8221;), manufacturers must also comply with MHLW Ordinance No. 169 relating to quality management systems in addition to appointing an in country representative and registration of design and manufacturing facilities. The Japanese regulatory space requires interactions with authorities in Japanese and therefore partnership or local expertise is required for engagement in the country.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Therapeutic Goods Administration (&#8220;TGA&#8221;) regulates IVDs in Australia which classifies IVDs into four categories based on risk; Class 1 No public health risk or low personal risk, Class II Low public health risk or moderate personal risk, Class III Moderate public health risk or high personal risk, Class 4 High public health risk. Similar to the EU, the TGA allows In-House manufacture of IVDs, this includes assembly of commercially available components which may not be regarded as IVDs because they are marked for RUO. The TGA separates IVDs into two categories the first being in house IVDs in Classes 1-3, the second being in house IVDs </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Class 4. Both categories require the involvement of Australia&#8217;s National Association of Testing Authorities in conjunction with the Royal College of Pathologists in that in house manufacturers must be accredited to ISO 15189 for medical testing labs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal and State Health Care Laws in the United States</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Physician Self-Referral Prohibition</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, we are subject to the federal physician self-referral prohibition, commonly known as the Stark Law. Under this law, physicians who have an ownership interest or a compensation relationship with a clinical laboratory may not, unless an exception applies, refer Medicare or Medicaid patients for testing to the laboratory, regardless of the intent of the parties. Similarly, laboratories may not bill Medicare or Medicaid for services furnished pursuant to a prohibited self-referral. Several Stark Law exceptions are relevant to many common financial relationships involving clinical laboratories and referring physicians, including: (1) fair market value compensation for the provision of items or services; (2) payments by physicians to a laboratory for clinical laboratory services; (3) space and equipment rental arrangements that satisfy certain requirements and (4) personal services arrangements that satisfy certain requirements. Penalties for violating the Stark Law include significant denial of payment, the return of funds received for all prohibited referrals, fines, civil monetary penalties, and exclusion from the federal health care programs. In addition, knowing violations of the Stark Law may also serve as the basis for liability under the federal False Claims Act (the &#8220;FCA&#8221;), which can result in additional civil and criminal penalties. Many states have their own self-referral laws as well, which in some cases apply to all patient referrals, not just government reimbursement programs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Anti-Kickback Law</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Anti-Kickback Statute (AKS) prohibits, among other things, knowingly and willfully offering, paying, soliciting or receiving any remuneration (i.e., anything of value), directly or indirectly, overtly or covertly, in cash or in kind, in order to induce or in return either for the referral of an individual, or for purchasing, leasing, ordering, or arranging for the purchase, lease, or order of any healthcare item or service that is reimbursable under any federal health care program, including Medicare or Medicaid. Liability under the AKS may be established without proving actual knowledge of the statute or specific intent to violate it. Federal and state law enforcement authorities scrutinize arrangements between health care providers and potential referral sources to ensure that the arrangements are not designed as a mechanism to induce patient care referrals or induce the purchase or prescribing of particular applications, products, or services. Generally, courts have taken a broad interpretation of the scope of the AKS, holding that the statute may be violated if merely one purpose of a payment arrangement is to induce referrals or purchases. Although there is  a number of statutory exceptions and regulatory safe harbors protecting certain common business arrangements and activities from prosecution or regulatory sanctions, the exceptions and safe harbors are drawn narrowly and practices that involve remuneration intended to induce prescribing, purchasing or recommending may be subject to scrutiny if they do not fit squarely within an exception or safe harbor. In addition, the government may assert that a claim that includes items or services resulting from a violation of the AKS constitutes a false or fraudulent claim under the federal civil False Claims Act (FCA), which is discussed in greater detail below. Although the AKS applies only to items and services reimbursable under any federal health care program, a number of states have passed statutes substantially similar to the AKS that apply to all payors. Violations of the AKS are punishable by imprisonment, criminal fines, damages, civil monetary penalties, and exclusion from participation in federal healthcare programs.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">False Claims Act </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FCA prohibits, among other things, a person from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment or approval and from making, using, or causing to be made or used, a false record or statement material to a false or fraudulent claim in order to secure payment or retain an overpayment by the federal government. In addition to actions initiated by the government itself, the statute authorizes actions to be brought on behalf of the federal government by a private party having knowledge of the alleged fraud. Because the complaint is initially filed under seal, the action may be pending for some time before the defendant is even aware of the action. If the government intervenes and is ultimately successful in obtaining redress in the matter or if the plaintiff succeeds in obtaining redress without the government&#8217;s involvement, then the plaintiff will receive a percentage of the recovery. Finally, the Social Security Act includes its own provisions </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that prohibit the filing of false claims or submitting false statements in order to obtain payment. Several states have enacted comparable false claims laws which may be broader in scope and apply regardless of payor.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Health Care Laws </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the requirements discussed above, several other health care fraud and abuse laws could have an effect on our business. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Social Security Act includes civil monetary penalty provisions that impose penalties against any person or entity that, among other things, is determined to have presented or caused to be presented a claim to a federal health program that the person knows or should know is for an item or service that was not provided as claimed or is false or fraudulent. In addition, a person who offers or provides to a Medicare or Medicaid beneficiary any remuneration, including waivers of copayments and deductible amounts (or any part thereof), that the person knows or should know is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner or supplier of Medicare or Medicaid payable items or services may be liable under the civil monetary penalties statute. Moreover, in certain cases, providers who routinely waive copayments and deductibles for Medicare and Medicaid beneficiaries, for example, in connection with patient assistance programs, can also be held liable under the AKS and FCA. One of the statutory exceptions to the prohibition is non-routine, unadvertised waivers of copayments or deductible amounts based on individualized determinations of financial need or exhaustion of reasonable collection efforts. The Office of Inspector General of the U.S. Department of Health and Human Services (HHS) emphasizes, however, that this exception should only be used occasionally to address special financial needs of a particular patient.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Health Insurance Portability and Accountability Act of 1996 and its implementing regulations (collectively, &#8220;HIPAA&#8221;) imposes criminal and civil liability for, among other actions, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors, and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement or representation in connection with the delivery of or payment for healthcare benefits, items or services. Like the AKS, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.<br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Eliminating Kickbacks in Recovery Act (EKRA) is an all-payor anti-kickback law that makes it a criminal offense to pay any remuneration to induce referrals to, or in exchange for, patients using the services of recovery homes, substance use clinical treatment facilities, or laboratories. Although the enactment of EKRA focused on patient brokering and similar arrangements to induce the patronage of substance use recovery and treatment, EKRA&#8217;s statutory prohibition is broadly written. The full scope and application of EKRA is uncertain.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Physician Payments Sunshine Act, enacted as part of the Affordable Care Act (ACA), also imposed annual requirements on manufacturers of certain devices, drugs, and biologics to report annually to CMS information related to payments and other transfers of value made to physicians, other health care professionals, and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, many states have laws similar to those listed above that may be broader in scope and may apply regardless of payor.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our operations are found to be in violation of any of the fraud and abuse laws described above or any other laws that apply to us, we may be subject to penalties, including potentially significant criminal, civil and administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government healthcare programs, contractual damages, reputational harm, integrity oversight and reporting obligations, limitations to the sale of certain applications, products, or services, diminished profits and future earnings, and the curtailment or restructuring of our operations. Efforts to ensure that our internal operations and business arrangements with third parties comply with applicable laws and regulations involve substantial costs. Any action brought against us for violation of these or other laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Coverage and Reimbursement</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of our SOPHiA DDM Platform and related solutions, applications, products, and services, if approved for IVD use in the United States, may depend substantially on the extent to which health maintenance organizations, managed care organizations, pharmacy benefit managers, federal and state government health administration authorities, private health coverage insurers and other third-party payors provide coverage for and establish adequate reimbursement levels for such solutions, applications, products, and services.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, many significant decisions about coverage and reimbursement for new diagnostics and medicines are made by CMS, which decides whether and to what extent a new diagnostic or medicine will be covered and reimbursed under Medicare, although it frequently delegates this authority to local Medicare Administrative Contractors (MACs), and by states under their Medicaid programs. Medicare is a federally funded program managed by CMS through MACs and carriers that administer coverage and reimbursement for certain healthcare items and services furnished to the elderly, disabled individuals, and individuals with certain medical conditions. Medicaid is an insurance program for certain categories of patients, including pregnant women, whose income and assets fall below state defined levels, that is both federally and state funded and managed by each state. In the United States, private health insurers and other third-party payors often provide reimbursement for products and services based on the level at which the government provides reimbursement through the Medicare or Medicaid programs for such products and services. It is difficult to predict what CMS, state Medicaid programs, and other third-party payors will decide with respect to coverage and reimbursement for novel platforms, applications, products, and services such as ours. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the United States, the reimbursement process and timelines vary significantly. Certain countries, including a number of member states of the EU, set prices and make reimbursement decisions for diagnostics and pharmaceutical products, or medicinal products, as they are commonly referred to in the EU, with limited participation from the marketing authorization holders or medical device manufacturers, or may take decisions that are unfavorable to the marketing authorization holders or medical device manufacturers where they have participated in the process.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Reform</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and many foreign jurisdictions, there has been significant interest in implementing cost-containment programs to limit the growth of government-paid healthcare costs, including price controls and restrictions on reimbursement. Because private payers often follow Medicare and Medicaid coverage policy and payment limitations in setting their own reimbursement rates, any reduction in reimbursement that results from federal legislation or regulation may result in a similar reduction in payments from private payers. We expect to experience pricing pressures in connection with the sale of any products that we develop due to the trend toward managed healthcare, the increasing influence of health maintenance organizations, and additional legislative and regulatory measures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Such legislative changes in the United States include the ACA, which intended to broaden access to health insurance, reduced or constrained the growth of healthcare spending, enhanced remedies against healthcare fraud and abuse, added new transparency requirements for healthcare and health insurance industries, and imposed additional health policy reforms. We expect that additional federal, state, and foreign healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal, state, and foreign governments will pay for healthcare products and services, which could result in limited coverage and reimbursement and reduced demand for our products, once approved, or additional pricing pressures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data Privacy and Security</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurance Portability And Accountability Act and Other U.S. Laws and Regulations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under HIPAA, as amended by HITECH, HHS has issued security, privacy, and breach notification regulations pertaining to protected health information (PHI) used or disclosed by certain entities, including certain health care providers such as us.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three standards have been promulgated under HIPAA&#8217;s and HITECH&#8217;s regulations: the Standards for Privacy of Individually Identifiable Health Information, which restrict the use and disclosure of certain individually identifiable health information, the Standards for Electronic Transactions, which establish standards for common healthcare transactions, such as claims information, plan eligibility, payment information and the use of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic signatures, and the Security Standards for the Protection of Electronic Protected Health Information, which require covered entities and business associates to implement and maintain certain security measures to safeguard certain electronic health information, including the adoption of administrative, physical and technical safeguards to protect such information.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HIPAA privacy regulations cover the use and disclosure of PHI by covered entities as well as business associates, which are defined to include subcontractors that create, receive, maintain, or transmit PHI on behalf of a covered entity or business associate, as well as their covered subcontractors. They also set forth certain rights that an individual has with respect to his or her PHI maintained by a covered entity, including the right to access or amend certain records containing PHI, or to request restrictions on the use or disclosure of PHI. The HIPAA security regulations establish requirements for safeguarding the confidentiality, integrity and availability of PHI that is electronically transmitted or electronically stored. HITECH, among other things, established certain health information security breach notification requirements. A covered entity must notify any individual whose PHI is breached according to the specifications set forth in the breach notification rule. The HIPAA privacy and security regulations establish a uniform federal &#8220;floor&#8221; for PHI and do not preempt state laws that are more stringent or provide individuals with greater rights with respect to the privacy or security of, and access to, their records containing PHI or insofar as such state laws apply to personal information that is broader in scope than PHI. In addition, individuals (or their personal representatives, as applicable) generally have the right to access test reports directly from laboratories and to direct that copies of those reports be transmitted to persons or entities designated by the individual.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA authorizes U.S. state attorneys general to file suit on behalf of their residents for violations. Courts are able to award damages, costs and attorneys&#8217; fees related to violations of HIPAA in such cases. While HIPAA does not create a private right of action allowing individuals to file suit against us in civil court for violations of HIPAA, its standards have been used as the basis for duty-of-care cases in state civil suits such as those for negligence or recklessness in the misuse or breach of PHI. In addition, violations of HIPAA could result in significant penalties imposed by the HHS&#8217;s Office for Civil Rights. HIPAA also mandates that the Secretary of HHS conduct periodic compliance audits of HIPAA-covered entities, such as us, and their business associates for compliance with the HIPAA privacy and security standards. It also tasks HHS with establishing a methodology whereby harmed individuals who were the victims of breaches of unsecured PHI may receive a percentage of the civil monetary penalty paid by the violator. Our company may receive, as part of the normal course of its business, PHI that is covered by HIPAA. Considering this, we have certain obligations under HIPAA regarding the use and disclosure of any PHI that may be provided to us. Therefore, noncompliance with privacy and security requirements imposed by HIPAA and HITECH could subject us to significant administrative, civil, and criminal penalties.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many states in which we operate have laws that protect the privacy and security of sensitive and personal information. Certain state laws, such as those of California and other states that have adopted versions of the Consumer Data Privacy Act, are more stringent or broader in scope, or offer greater rights to individuals, with respect to sensitive and personal information than federal, international or other state laws, and such laws may differ from each other, which may complicate compliance efforts. In addition, new legislation or constitutional amendments proposed or enacted in various states impose, or have the potential to impose, additional obligations on companies that collect, store, use, retain, disclose, transfer, and otherwise process confidential, sensitive, and personal information, and will continue to shape the data privacy environment nationally. State laws are changing rapidly and there is discussion in the U.S. Congress of a new federal data protection and privacy law to which we would become subject if it is enacted. All of these evolving compliance and operational requirements impose significant costs that are likely to increase over time, and may require us to modify our data processing practices and policies, divert resources from other initiatives and projects, and could restrict the way applications, products, and services involving data are offered, all of which may have a material and adverse impact on our business, financial condition and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous other federal and state laws, including consumer protection laws and regulations, govern the collection, dissemination, use, access to, confidentiality and security of patient health information. We intend to continue to comprehensively protect all personal information and to comply with all applicable laws regarding the protection of such information through our policies and procedures as well as through administrative, physical and technical safeguards.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General Data Protection Regulation and Other Foreign Laws and Regulations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we are operating worldwide, including in the EU and the EEA member states, the U.K., and Switzerland, we have to ensure the compliance of our processing activities with different data protection laws and regulations. Non-compliance with these data protection laws and regulations may not only result in high penalties, it can also cause a loss of reputation and trust.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU and the EEA, processing operations of personal data, including health and genetic personal data, are governed by the GDPR. The GDPR strengthens the powers of the relevant authorities and adds a broad array of requirements for handling personal data, including, for example, requirements to establish a legal basis for processing, higher standards for obtaining consent from individuals to process their personal data, more robust disclosures to individuals and a strengthened individual data rights regime, requirements to implement safeguards to protect the security and confidentiality of personal data that requires the adoption of administrative, physical and technical safeguards, shortened timelines for data breach notifications to appropriate data protection authorities or data subjects, limitations on retention and secondary use of information, increased requirements pertaining to health data and additional obligations when we contract third-party processors in connection with the processing of the personal data. EU and EEA member states are tasked under the GDPR to enact, and have enacted, certain implementing legislation that adds to and/or further interprets the GDPR requirements and potentially extends our obligations and potential liability for failing to meet such obligations. The GDPR, together with national legislation, regulations and guidelines of the EU and the EEA member states governing the processing of personal data, impose strict obligations and restrictions on the ability to collect, use, retain, protect, disclose, transfer, and otherwise process personal data. In particular, the GDPR includes obligations and restrictions concerning the consent and rights of individuals to whom the personal data relates, the transfer of personal data out of the EEA, security breach notifications and the security and confidentiality of personal data, including the following:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Lawfulness, fairness and transparency: Personal data must be processed lawfully, fairly, and in a transparent manner.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Purpose limitation: Personal data must be obtained for specified, explicit and legitimate purposes and not further processed in a manner that is incompatible with those purposes.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Data minimization: Personal data processed must be adequate, relevant, and limited to what is necessary.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Accuracy: Personal data must be accurate and, where necessary, kept up to date.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Storage limitation: Personal data must not be kept longer than is necessary.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Integrity and confidentiality: Appropriate technical and organizational measures must be put in place to guard against unauthorized or unlawful processing, loss, damage, or destruction.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The GDPR authorizes fines for certain violations of up to 4% of global annual revenue or &#8364;20&#160;million, whichever is greater, and other administrative penalties. The U.K. has transposed the GDPR into domestic law, with its version of the GDPR that took effect on January&#160;1, 2021, exposing us to two parallel regimes, each of which authorizes similar fines for certain violations. While the GDPR and the U.K. GDPR remain substantially similar for the time being, the government of the U.K. has adopted reforms to its data privacy and cybersecurity legal framework in its Data Use and Access Act 2025, which became law on June 19, 2025 (phasing in between June 2025 and June 2026) and will introduce significant changes from the GDPR. This may lead to additional compliance costs and could increase overall risk exposure as businesses may no longer be able to take a unified approach across the EEA and the U.K., and such businesses may need to amend their processes and procedures to align with the new framework. Implementing mechanisms to endeavor to ensure compliance with the GDPR and the U.K. GDPR may be onerous and expose businesses to divergent parallel regimes that may be subject to potentially different interpretations and enforcement actions for certain violations and related uncertainty.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, processing of personal data may be governed by the Federal Act on Data Protection (FADP). The FADP entered into force in September 2023 and provides for data protection principles that are substantially similar to those applied under the GDPR. The purpose of the FADP is to protect the personality rights, including privacy rights, and the fundamental rights of data subjects. The FADP is broad in its material scope and applies </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to personal data processing activities carried out by federal authorities, private organizations and individual private persons (excluding processing activities for exclusively personal use). The territorial scope of the FADP goes beyond those processing operations carried out in Switzerland, also covering operations that have an effect in Switzerland, even if they originate in another country. Sensitive personal data, including health data, genetic data and biometric data, which unequivocally identify a natural person, are subject to stricter protective measures in various respects. For example: (i)&#160;if consent is required, it must be given expressly in the case of processing of sensitive personal data; (ii)&#160;controllers must keep record of their data processing activities; (iii)&#160;sensitive data must not be disclosed to third parties without justification; (iv)&#160;the controller of a data file is obliged to inform the data subject of the collection personal data; and (v)&#160;disclosing personal data in breach of a confidentiality obligation may be criminally prosecuted. Processing activities by companies must not harm the privacy or personality of the data subject. If the FADP is violated, the Federal Data Protection and Information Commissioner may request that the processing is fully or partially adjusted, suspended, or terminated. Additionally, the new FADP authorize criminal fines for certain violations of up to CHF 250,000. Such fines are mainly imposed upon the individual responsible for the violation and most likely levied against C-level executives and those responsible for the organization&#8217;s data protection program. The FADP also authorizes fines of up to CHF 50,000 on the responsible data controller or processor. Fines under the FADP may be imposed in addition to fines under other data protection regimes. As part of our processing activities, we implemented a global compliance plan with applicable laws and regulations, which includes in particular:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the appointment of a Data Protection Officer;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the creation of the Information Security and Privacy Committee, of which the Information Security Governance Director and Data Protection Officer is the manager;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the implementation of contractual documentation with our collaborators, aligned with the GDPR requirements;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the preparation of procedures and guidelines, such as a global data protection policy, a data breach responses plan and standard operating procedures for data subject requests; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the realization of global data mapping and record by the Data Protection Officer.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, the purpose of the Information Security and Privacy Committee is to ensure the data and information we process are protected against data protection risks (in compliance with various data privacy regulations and principles of good governance) as well as to assess the effectiveness of our systems, controls and procedures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Data Protection Officer is in charge, in particular, of establishing and maintaining processes for receiving, documenting, tracking, investigating, and taking actions on all complaints concerning data protection and considering the risks associated with processing operations, taking into account the nature, scope, context, and purposes of processing.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information regarding risks relating to data privacy and security laws and regulations, see &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Related to Governmental Regulation&#8212;We are subject to stringent privacy and, information security laws and regulations and changes in such laws and regulations could adversely affect our business and increase our costs.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Information Security</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented protections consistent with the ISO/IEC 27001:2022, ISO/IEC 27017:2015, ISO/IEC 27018:2017 standards with respect to technical and physical security in an effort to ensure a level of security appropriate to the risk of our processing activities, in particular with respect to protecting the personal data and customer data we process in the cloud against damage, loss and unauthorized access, use, modification, disclosure, destruction, or other misuse. For this purpose, we have what we believe are adequate data breach response plans, disaster recovery plans, and security arrangements in place. However, there can be no assurance that our efforts will be successful in protecting against adverse events or successfully mitigating their effects. For more information regarding risks relating to information security, see &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Related to Our Business and Industry&#8212;Cybersecurity or data privacy breaches, other unauthorized or improper access, or (distributed) denial service lack of access (e.g., ransomware, persistent DoS/DDoS) could result in additional costs, service outages, loss of revenue, significant liabilities, harm to our </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand and decreased/denied use of our SOPHiA DDM Platform and related solutions, applications, products, or services.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Data Use Rights</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our activities, we process thousands of genetic profiles for our customers around the world. As a result, and in accordance with applicable data protection laws and regulations, we may produce aggregate anonymized statistical data from the results of all analyses performed using our proprietary algorithms (&#8220;Insights&#8221;), which are our sole and exclusive property.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hence, a distinction is made between customer data (i.e., the data uploaded by our customers on our SOPHiA DDM Platform) on the one hand and other data generated and developed by us (i.e., the results of the performance of our proprietary algorithms, such as Insights) on the other hand. In this respect, Insights are generated using our proprietary algorithms in the context of our SOPHiA DDM Platform and constitute our know-how and trade secrets.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the performance of our services related to our commercial and research and development activities and in accordance with our contractual documentations accepted by our customers and collaborators, we may use our customers&#8217; and collaborators&#8217; data in particular: (i)&#160;for providing services; (ii)&#160;for maintaining, developing, improving, and demonstrating the SOPHiA DDM Platform, products, and services; and (iii)&#160;as permitted by applicable laws and regulations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in accordance with the FADP and the GDPR, we can reuse customer data (including personal data) for further processing activities for statistical purposes. European data protection authorities have previously noted that processing for statistical purposes and for research purposes (including marketing research) are contexts where legitimate purpose can arise. In addition, the processing of personal data for purposes other than those for which the personal data was initially collected should be allowed where the processing is compatible with the purposes for which the personal data was initially collected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specific derogations apply for processing operations for statistical purposes, in accordance with the GDPR, as follows:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">personal data can be stored for longer periods insofar as the personal data will be processed solely for statistical purposes subject to implementation of the appropriate technical and organizational measures; information obligations in processing for statistical purposes do not apply if they would involve a disproportionate effort; consideration of this takes into account the number of data subjects and the age of the data, and appropriate safeguards must be adopted; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">restrictions of the right of a data subject to exercise its &#8220;right to erasure&#8221; apply if it is likely to significantly impair processing for statistical purposes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Meanwhile, processing for statistical purposes is subject to certain requirements to:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">set up appropriate safeguards to protect the rights and freedoms of the data subject; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">implement adequate technical and security measures entrenching the principle of data minimization and using pseudonymized data as the default.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insights consist of aggregated data providing general trends without identifying individual data subjects and do not contain personally identifiable information. The GDPR does not apply to data that does not relate to or identify an individual, such as aggregated data sets. Consequently, such data sets do not constitute personal data or identifiable information under the GDPR. We believe we have taken reasonable measures to ensure appropriate safeguards and adequate technical and security measures for the processing activities required to generate Insights.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental, Health, and Safety Regulations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various federal, state, local, and foreign environmental, health, and safety laws and regulations and permitting and licensing requirements. Such laws include those governing laboratory practices, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the generation, storage, use, manufacture, handling, transportation, treatment, remediation, release and disposal of, and exposure to, hazardous materials and wastes, and worker health and safety. Our operations involve the generation, use, storage and disposal of hazardous materials, and the risk of injury, contamination or non-compliance with environmental, health, and safety laws and regulations or permitting or licensing requirements cannot be eliminated. Compliance with environmental laws and regulations has not had a material effect on our capital expenditures, financial position, or competitive position.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Regulations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many countries in which we may offer any of our diagnostic tests in the future have anti-kickback regulations prohibiting providers from offering, paying, soliciting, or receiving remuneration, directly or indirectly, in order to induce business that is reimbursable under any national health care program. In situations involving physicians employed by state-funded institutions or national health care agencies, violation of the local anti-kickback law may also constitute a violation of the FCPA.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FCPA prohibits individuals and companies, and their employees, agents, and intermediaries from offering, providing, giving, or authorizing the provision of, directly or indirectly through a third party, including any potential distributors we may rely on in certain markets, anything of value to a foreign government official with corrupt intent to influence an award or continuation of business or to gain an unfair advantage, whether or not such conduct violates local laws. We can also be held liable for the corrupt or illegal activities of our agents and intermediaries, even if we do not explicitly authorize or have actual knowledge of such activities. In addition, the FCPA requires public companies to maintain accurate books or records and to maintain a system of internal accounting controls.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the FCPA&#8217;s anti-bribery provisions for corporations and other business entities are subject to a fine of up to $2&#160;million, and officers, directors, stockholders, employees, and agents are subject to a fine of up to $100,000 and imprisonment for up to five years. Other countries, including the U.K. and other member states of the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, have similar anti-corruption regulations, such as the United Kingdom Bribery Act 2010.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When marketing our diagnostic tests outside of the United States, we may be subject to foreign regulatory requirements governing human clinical testing, prohibitions on the import of tissue necessary for us to perform our diagnostic tests or restrictions on the export of tissue imposed by countries outside of the United States or the import of tissue into the United States, and marketing approval. These requirements vary by jurisdiction, differ from those in the United States and may in some cases require us to perform additional pre-clinical or clinical testing. In many countries outside of the United States, coverage, pricing and reimbursement approvals are also required.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C. Organizational Structure</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the following wholly owned subsidiaries:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Incorporation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS S.A.S.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS LTD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware, U.S.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS Intermedia&#231;&#227;o de Neg&#243;cios LTDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS PTY LTD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS S.R.L.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS GmbH</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D. Property, Plants and Equipment</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not own any real property. We believe that our facilities meet our present needs and we are continuously reviewing our space requirements. The table below sets forth the sizes and uses of our facilities as of December 31, 2025:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Primary Function</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Size</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A-ONE Park Building B2 Z.A La Pi&#232;ce 12, 1180 Rolle Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office, Laboratory &amp; Warehouse</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;65,860 sq ft</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technopole Izarbel 158 Alle&#769;e Fauste d'Elhuyar 64210 Bidart France</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,509 sq ft</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401 Park Drive Suite 505 Boston, Massachusetts 02215 USA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,807 sq ft</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B&#226;timent GIENAH 11 avenue de Canteranne 33600 Pessac France</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,450 sq ft</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continuously review our anticipated requirements for facilities and, on the basis of that review, may from time to time acquire or lease additional facilities and/or dispose of existing facilities. We are not aware of any environmental issues or other constraints that would materially impact the intended use of our facilities.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_40"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4A. Unresolved Staff Comments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Operating and Financial Review and Prospects</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_46"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. Operating Results</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a comparison of our results of operations and KPIs for the years ended December 31, 2024 and 2023, see &#8220;Item 5. Operating and Financial Review and Prospects&#8212;A. Operating Results&#8212;Results of Operations&#8221; in our Annual Report on Form 20-F filed with the SEC on March 5, 2025.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a cloud-native software technology company in the healthcare space dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. We purposefully built a cloud-native software platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. Our platform standardizes, computes and analyzes digital health data and is used across decentralized locations to break down data silos. This enables healthcare institutions to share knowledge and experiences and to build a collective intelligence. We envision a future in which all clinical diagnostic test data is channeled through a decentralized analytics platform that will provide insights powered by large real-world data sets and AI. We believe that a decentralized platform is the most powerful and effective solution to create the largest network, leverage data, and bring the benefits of data-driven medicine to customers and patients globally. In doing so, we can both support and benefit from growth across the healthcare ecosystem.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, we launched the first application of our platform to analyze NGS data for cancer diagnosis. We offer a broad range of applications used by healthcare providers, clinical and life sciences research laboratories, and biopharmaceutical companies for precision medicine across oncology, rare diseases, infectious diseases, cardiology, neurology, metabolism, and other disease areas. In 2019, we launched our solution for radiomics data that enables longitudinal monitoring of cancer patients and tumor progression throughout their disease journey. In 2022, we unveiled SOPHiA CarePath, our multimodal solution that integrates the capabilities of our genomics and radiomics solutions with additional modalities to further enable clinical decision-making. Today, we believe that our SOPHiA DDM Platform, commercialized under the name &#8220;SOPHiA DDM,&#8221; is one of the most widely used decentralized analytics platforms globally for clinical genomics. As of December 31, 2025, we served more than 993 hospital, laboratory, and biopharma customers globally through our SOPHiA DDM Platform and related solutions, applications, products, and services, and our SOPHiA DDM Platform has supported the analysis of approximately 2.3 million genomic profiles and has been utilized in clinical trials and research projects discussed in more than 2,712 peer-reviewed publications. As of December 31, 2025, we had 528 core genomics SOPHiA DDM Platform customers (defined as the number of customers who generated </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue through usage of our bundle access, dry lab, and integrated access models during the specified time period, which, in this case, is the twelve months ended December 31, 2025). We commercialize our SOPHiA DDM Platform and related solutions, applications, products, and services as RUO and CE-IVD applications and products. In the United States, our applications and products are labeled and sold for research use only. Because such products are not intended for use in clinical practice in diagnostics and the applications and products cannot include clinical or diagnostic claims, the FDA regulations require that RUO applications and products be labeled &#8220;For Research Use Only. Not for use in diagnostic procedures.&#8221; In the EU, we have self-certified our applications and products without the intervention of a notified body in order to affix the CE marking.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our clinical customers primarily include academic and non-academic hospitals and reference and specialty laboratories. Our biopharma customers primarily include pharmaceutical companies, biotechnology companies, and CROs. Our customers are able to access our SOPHiA DDM Platforms through three primary access models: dry lab access, bundle access, and integrated access. As of December 31, 2025, we operated a global direct sales team of more than 105 field-based commercial representatives across 60 countries in all four of our major regions of operations (Europe, the Middle East, and Africa (&#8220;EMEA&#8221;); North America (&#8220;NORAM&#8221;); Latin America (&#8220;LATAM&#8221;); and Asia-Pacific (&#8220;APAC&#8221;)) and further supplemented our direct sales team with distributors in 50 countries. For the years ended December 31, 2025 and 2024, we generated $77.3&#160;million and $65.2&#160;million in revenue, respectively, representing 19% year-over-year growth.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have funded our operations primarily through equity financings that have generated $499.4 million in gross proceeds as of December 31, 2025, through revenue generated from the sale of access to our SOPHiA DDM Platform and related licenses, solutions, applications, products, and services, and through debt financings. As of December 31, 2025, we had cash and cash equivalents of $70.3&#160;million. Since our inception, we have incurred net losses, which have been significant in recent periods. For the years ended December 31, 2025 and 2024, our net losses were $79.0&#160;million and $62.5&#160;million, respectively. As of December 31, 2025, we had an accumulated deficit of $519.3&#160;million. We expect to continue to incur net losses for the foreseeable future as we continue to devote substantial resources to (i)&#160;research and development, in particular to further expand the features, applications and data modalities of our SOPHiA DDM Platform in order to accommodate multimodal data analytics capabilities across a wide range of disease areas, (ii)&#160;expanding our selling and marketing efforts for our SOPHiA DDM Platform and related solutions, applications, products, and services, in particular to drive new customer adoption with clinical customers and biopharmaceutical companies, (iii)&#160;establishing and maintaining relationships with our collaborators and customers across the healthcare system, and (iv)&#160;obtaining regulatory clearance or approval to offer our applications and products as IVD applications and products for diagnostic use. Our ability to achieve profitability depends on the successful commercialization and further development of our SOPHiA DDM Platform and related solutions, applications, products, and services.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FDA LDT Final Rule</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2025, the U.S. District Court for the Eastern District of Texas, Association for Molecular Pathology, et al. v. U.S. Food and Drug Administration, et al., vacated the FDA&#8217;s Laboratory Developed Tests (&#8220;LDT&#8221;) Final Rule, which was scheduled to be phased in over four years and would have redefined LDTs as in vitro diagnostics, thereby requiring FDA clearance for such tests. Under the LDT Final Rule, the FDA would have mandated premarket review for LDTs and required compliance with other FDA regulations in line with the established medical device guidelines. These requirements would have increased both the cost and time required to commercialize an LDT, reducing the financial incentives for laboratories to develop such tests. This, in turn, could have led to decreased demand for our RUO applications and products, until such time as our tests obtained FDA approval. The FDA had a window to appeal the decision and declined to do so in June 2025, making the court&#8217;s decision final. In September 2025, the FDA formally vacated the LDT Final Rule, reinstating the prior regulatory text. As a result, oversight of LDTs will remain under the Clinical Laboratory Improvement Amendments (CLIA) program rather than under the FDA medical device regulations. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guardant Health Litigation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Guardant filed suit against us in the U.K. in July 2025, and in the EU at the Unified Patent Court in Paris in August 2025, alleging that our MSK-Access liquid biopsy test infringes certain of their patents and seeking remedies, including unspecified monetary damages and injunctive relief. On January 23, 2026, the UPC Paris </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Local Division issued a final order rejecting Guardant's application for provisional measures and ordered Guardant to pay an interim award of costs of EUR 400,000. The UPC rejected Guardant's application under three asserted patents (EP 3591073, EP 3443066, and EP 3766986), and Guardant withdrew its request regarding a fourth patent (EP 3470533).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 9, 2026, Guardant filed an appeal challenging the UPC's finding that EP 3443066 was more likely than not invalid. On February 17, 2026, the UPC Paris Local Division issued a procedural order setting a payment deadline of March 10, 2026, for Guardant to pay the EUR 400,000 interim costs award. On February 18, 2026, the Court of Appeal rejected Guardant's application for suspensive effect of the interim costs award and refused to reduce the EUR 400,000 amount. The Paris Local Division's payment deadline of March 10, 2026, and the original interim award amount of EUR 400,000 therefore stand. Based on the Court of Appeal's rejection of suspensive effect and the Paris Local Division's payment deadline, we expect to receive payment of the EUR 400,000 interim costs award by March 10, 2026.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, on February 12, 2026, we filed an Application for a cost decision under Rules 150 and 151 of the Rules of Procedure at the Court of First Instance, seeking costs exceeding EUR 600,000 incurred during the first instance proceedings. The UPC Paris Local Division has set a deadline of March 2, 2026, for Guardant to respond to our application for full costs, which includes the remaining EUR 200,000 in additional legal fees and approximately EUR 7,000 in travel costs. These additional costs may be decided as part of the appeal proceedings or in separate cost proceedings, but we will continue to pursue reimbursement of our full legal costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.K. proceedings remain pending. We intend to vigorously defend ourselves against these claims. These pending cases resulted in higher legal expenses in the second half of 2025 of $2.4 million, and we could incur further costs and divert the attention of our management and technical personnel in defending ourselves against these claims. Furthermore, Guardant may in the future be able to obtain injunctive or other relief, which effectively could block our ability to further develop, commercialize, market or sell products or services in certain jurisdictions, such as the U.K. and EU. Any adverse ruling or perception of an adverse ruling in defending ourselves against these claims could have an adverse impact on our business, financial condition or results of operations. See &#8220;Risk Factors&#8212;Risks Related to Our Intellectual Property&#8212;We are, and we may in the future be, subject to claims against us alleging that we are infringing, misappropriating or otherwise violating the intellectual property rights of third parties, the outcome of which would be uncertain and could have a material adverse effect on our business.&#8221;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SEC Definition of FPI</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2025, the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) issued a request for public comment on whether the definition of a Foreign Private Issuer (&#8220;FPI&#8221;) should be amended. The comment period was open for 90 days and closed in early September 2025. The SEC is now reviewing public comments in order to decide on any potential rule changes.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC&#8217;s request for comment outlines several potential changes to the FPI definition. These include, among other things, a possible requirement that FPIs be listed on a securities exchange in their home jurisdiction. While SOPHiA GENETICS is headquartered in Rolle, Switzerland, we are not currently listed on a Swiss or European exchange. The SEC has also raised the possibility of implementing a foreign trading volume requirement, which may not be within our control.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the SEC discussed the potential for a mutual recognition framework based on international cooperation agreements. However, there is no assurance that such an approach will be adopted or that Switzerland would qualify under any mutual recognition criteria.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At this time, the outcome of the SEC&#8217;s review is uncertain. Any changes to the FPI definition could impact our status and result in additional compliance obligations or costs, including the potential need to seek listings on additional exchanges. We are actively monitoring developments in this area and will assess and respond to any changes that may affect our FPI status.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Factors Affecting Our Performance</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our financial performance has primarily been driven by, and in the foreseeable future will continue to be primarily driven by, the factors discussed below. While these factors present significant opportunities for our business, they also pose challenges that we must successfully address in order to sustain our growth and improve the results of our operations. Our ability to successfully address these challenges is subject to various risks and uncertainties described elsewhere in this prospectus, particularly in the section titled &#8220;Item 3. Key Information&#8212;D. Risk Factors.&#8221;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Customer Acquisition and Analysis Volume</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We principally derive revenue from the use of our SOPHiA DDM Platform by our customers as well as the sales of related licenses, solutions, applications, products, and services. Our analysis volume is dependent on both the acquisition of new customers as well as usage volume from our existing customers. We employ a &#8220;land and expand&#8221; commercial model focused on winning new customers and then driving subsequent recurring utilization of our solutions by those acquired customers. Once we secure a customer, we use our direct sales force to build further engagement and help that customer increase its testing operations. For example, we may initially support a customer in setting up its NGS testing operations for hereditary cancer screening, including operational support through our set-up programs, also referred to as MaxCare. Once the customer is fully onboarded on our SOPHiA DDM Platform, it is then comparatively easier to deploy additional germline testing solutions as well as somatic oncology testing solutions, creating synergies across the offerings and a unified workflow. We also target incremental users within each customer, for example, additional clinicians within a provider across expanded departments such as radiology or pathology.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our analysis volume to increase and new customer acquisitions to accelerate as we further expand the features, applications, and data modalities of our SOPHiA DDM Platform; expand our presence into new geographies; and further penetrate existing geographies, particularly geographies that represent largely under-penetrated opportunities, such as North America and East Asia. We intend to significantly invest in the development of our SOPHiA DDM Platform to accommodate multimodal data analytics capabilities across a wide range of disease areas, including under-penetrated disease areas such as cardiology and neurology, which we believe will allow us to attract new customers and increase usage of our SOPHiA DDM Platform within our existing customer base. While we believe that our existing sales force can support our near-term growth plans, to continue expanding our presence into new geographies and further penetrate existing geographies, we will continue to opportunistically invest in our direct sales force to further scale the size of our network in under-penetrated geographies such as Japan and North America, form additional collaborations with reference and specialty laboratories, and collaborate with collaborators and distributors in selected geographies outside of North America.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Mix</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive revenue from the use of our SOPHiA DDM Platform by our customers as well as the sales of related licenses, solutions, applications, products, and services. Our clinical customers can access our platform using three different models: dry lab access, bundle access, and integrated access. In the dry lab access model, our customers use the testing instruments and consumables of their choice and our SOPHiA DDM Platform and algorithms for variant detection and identification. In the bundle access model, we bundle DNA enrichment kits with our analytics solution to provide customers the ability to perform end-to-end workflows. In the integrated access model, our customers have their samples processed and sequenced through select SOPHiA DDM Platform collaborators within our clinical network and access their data through our SOPHiA DDM Platform. Our biopharma customers can access our SOPHiA DDM Platform through the same three models, but they may also have access to data generated through our SOPHiA DDM Platform in the form of custom reports and analytics. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced fluctuations in how our clinical customers access our SOPHiA DDM Platform across the three access models. Specifically, certain customers may transition from one access model to another over time. For example, we have observed a trend with certain customers being onboarded onto our platform through the dry lab access model, but, over time, as our relationships with them grow, these customers transition to the bundle access model as customers trust us to curate a set of instruments and consumable products to help increase the accuracy of the analysis they generate. This trend is one illustration of our &#8220;land and expand&#8221; commercial model, as bundle access is typically a higher revenue-generating model compared to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dry lab access based on the incremental value from the sale of consumables and instruments as well as higher platform usage on average for bundle access customers. Certain types of customers are also more likely to access our SOPHiA DDM Platform using one access model compared to other customers. For example, customers who are unable or do not wish to conduct sequencing locally are inclined to use the integrated access model. These customers have historically represented a small percentage of our customer base relative to customers that use the bundle access and dry lab access models. We expect that the revenue contribution from each of the three access models will vary depending on our customer base and the rate of new customer acquisition.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also derive revenue from the sale of licenses for our Alamut suite of genomics mutations interpretation software. While we view Alamut as a complementary add-on to our SOPHiA DDM Platform, there are a number of Alamut users who currently are not customers of our SOPHiA DDM Platform. We expect that revenue contribution from Alamut will continue to vary based on the number of stand-alone Alamut users as well as our ability to cross-sell our SOPHiA DDM Platform to Alamut users and vice versa.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically experience lower usage of our SOPHiA DDM Platform in the first and third quarters compared to the second and fourth quarters, which tend to be seasonally stronger. We typically see relatively lower usage in the first quarter as customers across our global network return from their holidays and new customers are still being onboarded onto our platform. Meanwhile, we believe the relatively lower usage in the third quarter is due to the seasonal slowdown at our customers&#8217; European facilities attributable to vacations and European holiday schedules. As we expand in the North American market, we expect that we will be subject to somewhat lower seasonal variations in our usage per customer. We typically experience the highest usage of our SOPHiA DDM Platform in the fourth quarter as we bring new customers and new applications and products with existing customers into routine usage over the course of the year.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biopharma Expansion</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, the majority of our revenue is generated through our clinical customers, including academic and non-academic hospitals, and reference and specialty laboratories. However, we see potential for our biopharma business to comprise a more significant portion of our revenues. We began commercializing our biopharma application, product, and service offerings in 2019. While we have the ability to offer a robust package of pre- and post-market solutions to our biopharma customers across the Discovery, Development, and Deployment stages through a broad set of solutions, including SOPHiA Trial Match, SOPHiA Insights, SOPHiA CDx, and SOPHiA Awareness, our biopharma business is still nascent with the initial focus on establishing pilot programs with large pharmaceutical and biotech companies to build customer trust and raise awareness about our offerings in a manner similar to the &#8220;land and expand&#8221; strategy we employ for our clinical business. We intend to leverage our platform and database to drive adoption by biopharmaceutical companies through our sales force focused on biopharma opportunities across the value chain. In addition, we plan to develop new offerings for biopharma as we expand the number and type of new applications and data modalities on our platform.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SOPHiA CarePath</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2022, we unveiled SOPHiA CarePath, a new multimodal module on our SOPHiA DDM Platform powered by our artificial intelligence and machine learning algorithms. The module will allow healthcare practitioners to visualize data across multiple modalities (including genomic, radiomic, clinical, and biological) for individual patients in a longitudinal manner and derive additional insights through cohort design and comparison. SOPHiA CarePath has already been deployed as part of our Digital Twins tool, a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment decisions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategic Acquisitions and Collaborations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We vigilantly monitor the market for potential investments to expand or add key technologies to our offerings that we believe will improve our platform&#8217;s ability to address our customers&#8217; needs and catalyze the commercialization of new applications, products, and services. Our investment strategy could take the form of a business acquisition, asset acquisition, or strategic licensing of patented technology, all of which may affect our future financial results. For example, our acquisition of Interactive Biosoftware (&#8220;IBS&#8221;) in 2018 expanded the functionality of our SOPHiA DDM Platform. The Alamut suite of genomics mutation interpretation software is connected to our SOPHiA DDM Platform and gives our customers advanced analytics capabilities for a deeper </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and more informed genomic data interpretation. We view Alamut as a complement to our SOPHiA DDM Platform and expect to be able to accelerate our growth by cross-selling our SOPHiA DDM Platform to Alamut users and vice versa.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To complement our investment strategy, we have also collaborated, and intend to form additional collaborations, with other product providers in the ecosystem to bundle our solutions to provide differentiated end-to-end solutions. We currently collaborate with testing kit companies, testing hardware providers, software analytics companies, and diagnostic companies operating with a centralized model. For example, we formed collaborations with companies including Twist, IDT, and Agilent to create an integrated solution using our analytics platform and their library preparation products, including DNA enrichment kits. We continue to regularly evaluate our role in the genomics and radiomics value chain in order to provide both our existing and new customers with a comprehensive product offering, enhance our overall market and competitive position and expand into adjacent untapped markets and new geographies.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025 we announced a partnership with Myriad Genetics to develop a companion diagnostic (&#8220;CDx&#8221;) liquid biopsy assay. The partnership will leverage Myriad&#8217;s laboratory capabilities and SOPHiA&#8217;s global network to provide pharmaceutical firms with an innovative approach to global companion diagnostics. Myriad will lead regulatory submissions in the United States and SOPHiA will pursue regulatory approvals outside of the United States. Both firms will collaborate across development activities to provide a compelling solution to pharmaceutical firms pursuing CDx programs. Myriad has also publically stated that they plan on adopting the SOPHiA DDM platform for use in their clinical lab testing.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant aspect of our business is our continued investment in research and development, including new features, new applications, new data modalities, and new services. We plan to continue investing in scientific innovation to bring innovative, high-impact content to our customers through regular updates of our platform.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange Rates</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate internationally and a majority of our revenues, expenses, assets, liabilities and cash flows are denominated in currencies other than our presentation currency, the U.S. dollar, and the functional currency of SOPHiA GENETICS SA, the Swiss franc. Our revenues are generated primarily in the U.S. dollar, the euro and Swiss franc and, to a lesser extent, British pound, Australian dollar, Brazilian real, Turkish lira, and Canadian dollar depending on our customers&#8217; geographic location. Our expenses are incurred primarily in the U.S. dollar, the euro and Swiss franc and, to a lesser extent, British pound, Australian dollar, and Brazilian real. We expect that a part of our revenues and expenses will continue to be denominated in currencies other than the U.S. dollar. Therefore, part of the fluctuations in our operating results in any period may result from changes in exchange rates. We currently do not use any financial instruments to manage our exchange rate risks, which we have been partially mitigating by matching costs in the same foreign currency.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Operating Performance Indicators</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly monitor a number of key operating performance indicators and metrics to evaluate our business, measure our performance, identify key operating trends, and formulate financial projections and strategic plans. We believe that the following metrics are representative of our current business, but the metrics we use to measure our performance could change as our business continues to evolve. Our key&#160;operating&#160;performance indicators primarily focus on metrics related to our SOPHiA DDM Platform metrics, as platform revenue comprises the majority of our revenues.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this section, the term &#8220;customer&#8221; refers to any customer who accesses our SOPHiA DDM Platform through the dry lab and bundle access models. We exclude from this definition any customers accessing our SOPHiA DDM Platform using the integrated business model because they tend to use our platform in an ad hoc manner compared to our dry lab and bundle access customers who typically do so in a recurring fashion, generate an immaterial portion of our revenue and analysis volume, and constitute a small part of our customer base. We also exclude from this definition customers who only use Alamut through our SOPHiA DDM Platform.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Platform Analysis Volume</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quarterly Platform Analysis Volume from Q1 2018 to Q4 2025*</span></div><div style="margin-top:10pt;text-align:center"><img src="soph-20251231_g15.jpg" alt="quarterly volume.jpg" style="height:354px;margin-bottom:5pt;vertical-align:text-bottom;width:660px" id="i-15"/></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows platform analysis volume for the year ended December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.992%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA DDM Platform analysis volume*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391,698</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352,628</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:32.89pt">The figures in the bar chart and table above have been adjusted to exclude analyses conducted during the period but for which chargebacks were issued or other adjustments were made to customers after the period. We do not believe that such adjustments are material to the periods presented.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Platform analysis volume represents a key business metric that reflects our overall business performance, as we generate revenue on a pay-per-analysis basis. Platform analysis volume measures the number of analyses that generated revenue to us and were conducted by our Core Genomics Customers. Analysis volume is a direct function of the number of active customers and usage rates across our customer base during a specified time period. While our platform analysis volume is a major driver of our revenue growth, other factors, including application and product pricing, access model used, and customer size mix, also affect our revenue. Because of that, our revenue may increase in periods in which our analysis volume decreases and vice versa.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Analysis volume increased to 391,698 in the year ended December 31, 2025 from 352,628 in the year ended December 31, 2024. We observed an increase in chargeable analysis volume of 11% for the year</span><span style="color:#ee2724;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">ended December 31, 2025, as compared to the year ended December 31, 2024. This increase is primarily attributable to increased usage from our existing customers as well as new customers onboarded onto our platform, with outsized growth in our Hematological Oncology (&#8220;HemOnc&#8221;) applications and primarily related to strong volume growth in EMEA and NORAM. The increase in analyses was partially offset by a decline in analyses in LATAM. We increase prices annually or as necessary throughout the year. While platform analysis volume is a primary driver of our overall revenue, there are other important factors that also contribute to our revenue performance, including access model mix, Alamut license sales, biopharma service revenue and workflow equipment and services revenue. These factors also contributed to year-over-year growth in our overall revenue in 2025.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Core Genomics Customers</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the number of Core Genomics Customers as of December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Core Genomics Customers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We track the number of our Core Genomics Customers, defined as the number of customers who performed revenue generating analyses on our SOPHiA DDM Platform during the specified time period, as a key measure of our ability to generate recurring revenue from our install base. We exclude from this number any customers who do not utilize our SOPHiA DDM Platform through either dry lab access or a bundle sale, such as customers who only use integrated access, Alamut and our biopharma customers. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This number also excludes customers without any usage of our SOPHiA DDM Platform over the past twelve months and customers who have executed agreements with us but have not yet completed any revenue generating analyses, including customers that are in the process of being onboarded onto our SOPHiA DDM Platform. During 2025 we refined our definition of Core Genomic Customers to align our treatment of discrete customers within a larger entity with our new customer acquisition strategy. The impact on the 2024 customer count definition change was less than 1%.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Core Genomics Customers increased to 528 as of December 31, 2025 from 472 as of December 31, 2024. The increase is primarily attributable to our continued customer acquisition momentum by our commercial team over the course of the intervening period net of churn.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Dollar Retention (NDR)</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the net dollar retention as of December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net dollar retention (NDR)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We track net dollar retention for our SOPHiA DDM Platform, Alamut and recurring services, including revenue from dry lab, bundle access, and integrated access customers as a measure of our ability to grow the revenue generated through our &#8220;land and expand&#8221; strategy net of revenue churn, which we define as the revenues we have lost from customers who access our platform and have not generated revenue over the past twelve months in that period. To calculate net dollar retention, we first specify a measurement period consisting of the trailing two-year period from our fiscal period end. Next, we define a measurement cohort consisting of customers who have generated recurring revenue during the first 12 months of the measurement period. We then calculate our net dollar retention as the ratio between the U.S. dollar amount of revenue generated from this cohort in the second year of the measurement period and the U.S. dollar amount of revenue generated in the first year. For customers that did not contribute a full year of revenue in the base period, their revenue is annualized to provide a more representative baseline. Any customer in the cohort that did not use our platform in the second year are included in the calculation as having contributed zero revenue in the second year. Integrated accounts are included in NDR because they generate recurring revenue, even if they do not meet the criteria for customer count. During 2025 we refined our net dollar retention by aligning our customer cohorts with the core genomic customer counts, annualizing revenue for customers that did not contribute a full year of revenue in the base period, incorporating revenue generated from Alamut and recurring services and our calculation of revenue churn by utilizing actual revenue for the trailing 12 months rather than annualized revenues. The impact on the 2024 NDR amount as a result of the definition change was less than 2%.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net dollar retention increased to 115% as of December 31, 2025 from 104% as of December 31, 2024. The year-over-year increase in revenue growth momentum is attributable to growth across our existing customer base as well as higher average selling prices of our products. The annualized churn rate was 0.1%, which was lower than 2024 as a result of the relative size of lost customers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue from goods and services rendered to our clinical and biopharma customers. Our clinical customers include academic and non-academic hospitals (including comprehensive cancer centers and children&#8217;s hospitals), and reference and specialty laboratories. Our biopharma customers include companies along the full biopharma value chain. We group our solutions that we offer our customers into two primary revenue streams: our SOPHiA DDM Platform and workflow equipment and services.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOPHiA DDM Platform revenue comprises the bulk of our revenue and includes goods and services related to the use of our SOPHiA DDM Platform, including our clinical genomics solutions, which span across a broad range of unique applications for analyzing genomic data; our Alamut suite of genomics mutation interpretation software, which gives our clinical customers advanced analytics capabilities for a deeper and more informed genomic data interpretation; and biopharma applications designed to help customers solve bottlenecks across the biopharma value chain, including discovery, clinical development and commercialization; and the sale of third-party instruments and consumables to our bundle access customers.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For clinical customers, our primary pricing strategy for our SOPHiA DDM Platform is a pay-per-use model, in which customers access our platform free of charge but pay for each use of our platform. Pricing varies based on our customer mix, as customers require differing levels of customization. For Alamut, our primary pricing strategy is a licensing model, in which customers access our platform for a contracted price. For biopharma customers, we are continuing to refine our pricing strategy since we launched our initial applications for the biopharma market in 2019. We recognize revenue when our customer obtains control of promised goods or services, in an amount that reflects the consideration that we expect to receive in exchange for those goods or services. For revenue generated from our SOPHiA DDM Platform customers, we recognize revenue from analyses as the analyses are conducted and revenue from bundled instruments and consumables at the point of delivery. For revenue generated from Alamut licenses, we recognize revenue over the course of the license period. Payments from our customers are typically </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">between 30 and 60 days with payment terms extended</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> up to 180 days from the invoice date. Although we have a diverse range of customers, for the years ended December 31, 2025 and December 31, 2024, we generated $8.7 million and $8.2 million, respectively, of revenue from one of our largest distributors.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Workflow equipment and services revenue includes all revenue from the sale of materials and services that do not form part of a contract for the provision of platform services rendered primarily to clinical customers. These include the provision of set-up programs and training and the sale of equipment that are not linked to the use of the platform, such as automation equipment. Set-up programs and training are typically combined with a customer&#8217;s first order prior to the customer being onboarded onto our SOPHiA DDM Platform. Revenue from services is generally recognized when the services are performed. Revenue from&#160;materials are&#160;recognized when control of the goods is transferred to the customer, generally at the time of delivery.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have demonstrated continued revenue growth during 2025 and 2024 as a result of the continued development of our platform and technology and further penetration of the market. Revenue performance is reflective of the strong foundation that has been built, focused around clinical and biopharma customers. This category of revenue also includes the revenue from the sale of DNA sequencing automation equipment accounted for under IFRS 16,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;IFRS 16&#8221;), leasing, and the fees charged for the maintenance of this equipment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue comprises costs directly incurred in earning revenue, including computational and storage-related costs and fees paid to hosting providers, manufacturing costs, materials and consumables, the cost of equipment leased out under finance leases, personnel-related expenses, and amortization of capitalized software development costs. Capitalized software development costs are amortized using the straight-line method over an estimated life of five years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we currently expect increased investments to accelerate growth, we also expect to realize increased efficiencies and economies of scale and undertake cost containment measures to reduce the cost of using cloud infrastructure. Over time, we expect our gross profit margin to increase as we broaden our customer base, increase customer engagement, expand our cloud infrastructure, and negotiate additional arrangements </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with service providers, including computational and storage-related costs and fees paid to hosting providers. However, in the near term, we expect that our gross profit margin may be adversely impacted by increased computational and storage-related costs and fees as we have purchased, and may be required to continue to purchase, increased capacity at less favorable rates in order to address increased demand for our SOPHiA DDM Platform and related solutions, applications, products, and services. Our cost of revenue as a percentage of revenue may fluctuate from period to period depending on the interplay of the various components of cost of revenue. Our cost of revenue as a percentage of revenue is impacted by the sale of higher value testing such as MSK-Access that have a higher price point and margin profile, and thus a lower cost-of-revenue. Certain markets such as India, Turkey and LATAM have lower price points and thus a lower margin profile and expansions in those markets may increase our costs as a percentage of revenue.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses consist of research and development, selling and marketing, general and administrative, and other operating income (expense), net.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Costs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs consist of personnel and related expenses for technology, application, and product development, depreciation and amortization, laboratory supplies, consulting services, computational and data storage fees paid to hosting providers related to research and development, and allocated overhead costs. These costs are stated net of government grants for research and development and innovation received as tax credits and net of capitalized software development costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the long term, we expect our research and development costs to increase in absolute dollars, but not necessarily as a percentage of revenue, while we continue to develop, refine, and optimize our platform, technology, applications, products, and services as we seek to expand the features, applications, and data modalities of our SOPHiA DDM Platform, broaden our customer base, and increase customer engagement to drive revenue growth. We expect research and development costs, inclusive of capitalized software development, to continue to comprise one of the largest components of our overall operating expenses. Our research and development costs as a percentage of revenue may fluctuate from period to period due to the timing and extent of such expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and Marketing Costs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and marketing costs consist of personnel and related expenses for the employees of our sales and marketing organization, costs of communications materials that are produced to generate greater awareness and utilization of our platform among our customers, costs of third-party market research, costs related to transportation and distribution of our products and allocated overhead costs, and commissions to sales employees.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the short term, we expect our selling and marketing costs to increase in absolute dollars and as a percentage of revenue as we seek to broaden our customer base and increase customer engagement to drive revenue growth and as we hire additional sales personnel and related account management and sales support personnel to properly service our growing customer base. However, in the long term, we expect our selling and marketing costs to gradually and modestly decrease as a percentage of revenue. Our selling and marketing costs as a percentage of revenue may fluctuate from period to period due to the timing and extent of such expenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Costs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative costs consist of personnel and related expenses for our executive, accounting and finance, legal, quality, support and human resources functions, depreciation and amortization, professional services fees incurred by these functions, general corporate costs and allocated overhead costs, which include occupancy costs and information technology costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the short term, we expect that our general and administrative costs may vary in absolute dollars and as a percentage of revenue in line with our business needs. However, in the long term, we expect our general and administrative costs to gradually and modestly decrease as a percentage of revenue. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Operating Income (Expense), Net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income (expense), net consists of gains and losses related to the disposal of tangible assets, write-offs of intangible assets and other operating income and expenses. We cannot predict the amount of other operating income (expense), net for future periods.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists of interest income earned on cash and cash equivalents, term deposits and short-term investments, and lease receivables.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists of interest expense incurred on lease liabilities and loans, which includes interest on commercial borrowings.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently do not use any financial instruments to manage our interest risk exposure.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Adjustments on Warrant Obligations </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value adjustments on warrant obligations consists of any gains or losses from changes in fair value to our warrant obligations. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Exchange (Losses) Gains, net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange losses (gains), net consists of foreign exchange realized and unrealized gains and losses arising principally from intercompany receivable balances in the parent company denominated in U.S. Dollar, whose functional currency is the Swiss franc.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to corporate taxation in Switzerland and other jurisdictions in which we operate, in particular, the United States, France, the U.K., Italy, Brazil, Germany and Australia, where our wholly owned subsidiaries are incorporated.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to a written agreement with the Swiss government, we were exempted from corporate taxes (including capital tax) in Switzerland until December&#160;31, 2022. Effective as of January 1, 2023, we are subject to ordinary cantonal and Swiss federal corporate taxes, including capital tax.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are entitled under Swiss laws to carryforward any losses incurred for a period of seven years, which could be used to offset future taxable income. As of December 31, 2025, we had total tax loss carryforwards totaling $448.2&#160;million with $444.0&#160;million of which no deferred tax asset has been recorded as they are expected to expire prior to being utilized to offset future incomes. We currently have tax loss carryforwards in Switzerland, the U.S., the U.K., and Brazil. Of our loss carryforwards, $440.3&#160;million are in Switzerland and can be carried forward through future periods that will expire at various dates between January&#160;1, 2026 and December&#160;31, 2032. There is no certainty that we will make sufficient profits to be able to utilize these tax loss carryforwards in full during the allotted time periods.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results&#160;of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the years ended December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,271</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,173</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,098</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,958)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52,077</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43,937</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,140</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,216)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,366)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,749)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,563)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,953)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,610)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (loss) income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(70,906)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(66,568)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,338)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,362&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,490)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,554)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,913)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,641)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments on warrant obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(497)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(867)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains (losses), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,881)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(77,487)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(61,270)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,223)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss for the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(78,999)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(62,493)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16,506)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents revenue by stream for the years ended December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in USD thousands, except %)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA DDM Platform</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,915&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,546&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,369&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workflow equipment and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,271</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,173</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,098</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue was $77.3&#160;million for the year ended December 31, 2025, compared to $65.2&#160;million for the year ended December 31, 2024. This increase was primarily attributable to an increase in SOPHiA DDM Platform revenue as well as $2.0 million in foreign exchange impact over the course of the year related to the appreciation in the exchange rates between key transactional currencies, particularly the euro, and our reporting currency, the U.S. dollar. SOPHiA DDM Platform revenue was $74.9&#160;million for the year ended December 31, 2025 compared to $63.5&#160;million for the year ended December 31, 2024. This increase was primarily attributable to an increase in analysis volume, particularly across our Oncology application portfolio driven by growth in our HemOnc application, partially offset by a slight decrease in biopharma revenue of $0.7 million. The increase in analysis volume was related to strong volume growth in EMEA and NORAM. Workflow equipment and services revenue was $2.4&#160;million for the year ended December 31, 2025, compared to $1.6&#160;million for the year ended December 31, 2024. This increase was primarily attributable to an increase in workflow automation equipment installations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents cost of revenue, gross profit, and gross margin for the years ended December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in USD thousands, except %)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,194)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,236)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,958)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue was $25.2&#160;million for the year ended December 31, 2025, compared to $21.2&#160;million for the year ended December 31, 2024. The increase was primarily driven by a $2.1 million increase in material costs, including automation equipment and related services associated with higher volumes, a $1.7 million increase in amortization of capitalized development costs as software development projects were put into service and a $1.1 million increase in maintenance and customer support costs due to a higher volume of update releases. These increases were mitigated by ongoing efforts to optimize compute costs and partially offset by a $0.8 million decrease in inventory reserve and inventory scrap. The gross margin was 67% for the year ended December 31, 2025, remaining stable as compared to the year ended December 31, 2024.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents research and development costs, selling and marketing costs, general and administrative costs, and other operating income, net for the years ended December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in USD thousands, except %)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,216)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,366)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,369)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,953)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (expenses)/income, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(122,983)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(110,505)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(12,478)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Costs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs were $34.2&#160;million for the year ended December 31, 2025, compared to $34.4&#160;million for the year ended December 31, 2024. The decrease was primarily driven by $1.2 million of resources that were shifted to support implementation and maintenance activities and $0.5 million related to an R&amp;D grant in France we received. These decreases were offset by a $0.3 million increase in employee-related expenses, including share-based compensation, which includes a $1.1 million foreign exchange impact on salary expenses and a $0.5 million increase in social charges on equity-based compensation as a result of appreciation in the price of our stock.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and Marketing Costs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and marketing costs were $36.1&#160;million for the year ended December 31, 2025, compared to $29.4&#160;million for the year ended December 31, 2024.&#160;The increase was primarily attributable to a $5.0 million increase in employee-related expenses, including commissions and share-based compensation, as we expanded our sales force, and includes a $0.4 million foreign exchange impact on salary expense and a $0.2 million increase in social charges on equity-based compensation as a result of appreciation in the price of our ordinary shares. Our commissions expenses have increased as a result of a larger team on commissions-based programs and the improved overall performance of our sales team. Additionally, there was a $0.6 million increase in marketing spend related to targeted campaigns aimed at accelerating penetration in key markets, a $0.4 million increase in travel and expense, and a $1.0 million increase in shipping costs related to the higher sales volumes.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Costs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative costs were $52.6&#160;million for the year ended December 31, 2025, compared to $47.0&#160;million for the year ended December 31, 2024.&#160;This increase was primarily attributable to a $1.2 million increase in employee-related expenses, including share-based compensation, which includes a $0.8 million foreign exchange impact on salary expense and a $0.8 million increase in social charges on equity-based compensation as a result of appreciation in the price of our stock. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional increases related to $2.4 million in legal expenses related to the Guardant Health litigation and $0.9 million in costs related to our shelf registration statements and an at-the-market offering program which allows for sales of our stock. In connection with the Guardant Health litigation, as discussed in "Recent Developments&#8212;Guardant Health Litigation," we expect to receive reimbursement of a &#8364;400,000 interim costs award by March 10, 2026, and are pursuing reimbursement of additional legal costs exceeding EUR 200,000 through separate cost proceedings at the Unified Patent Court.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income, net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating income, net was an expense of $0.1&#160;million for the year ended December 31, 2025, compared to $0.2&#160;million income for the year ended December 31, 2024 mainly attributable to $0.1 million of non-recoverable VAT costs in 2025. In 2024 the income related to a one-time supplier credit note.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Income</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents interest income for the years ended December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in USD thousands, except %)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,362&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,490)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income was $1.9&#160;million for the year ended December 31, 2025, compared to $3.4&#160;million for the year ended December 31, 2024. The decrease was primarily driven by a $1.5 million decrease in the interest earned on cash held in short term deposits and money market funds due to lower cash balances than in the prior year and decreasing market interest rates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents interest expense for the years ended December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in USD thousands, except %)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,554)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,913)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,641)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $4.6 million for the year ended December 31, 2025, compared to $1.9 million for the year ended December 31, 2024. The increase of $2.6 million was primarily driven by the additional borrowings under the Perceptive Loan Agreement in connection with the drawdown of a second tranche of $35.0 million principal amount of term loans in 2025 as well as a full year of interest on the first tranche of $15.0 million. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Adjustments on Warrant Obligations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the fair value adjustments on warrant obligations for the years ended December 31, 2025 and 2024:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in USD thousands, except %)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments on warrant obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(497)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(867)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value adjustments on warrant obligations had a loss of $0.5&#160;million for the year ended December 31, 2025 compared to a gain of $0.4 million for the year ended December 31, 2024. The change is due to the fair value of the warrants increasing as a result of an increase in the price of our underlying shares in 2025 as well as an increase in the number of warrants outstanding.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Exchange Gains (Losses), net</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the foreign exchange gains (losses), net for the years ended December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in USD thousands, except %)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (losses) / gains, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,402)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,881)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(198)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign exchange losses were $3.4&#160;million for the year ended December 31, 2025, compared to foreign exchange gains of $3.5&#160;million for the year ended December 31, 2024. This increase in foreign exchange losses was primarily driven by the revaluation of intercompany foreign currency receivable balances into SOPHiA GENETICS SA&#8217;s functional currency of the Swiss franc, partially offset by $0.4 million in realized net foreign exchange gains. Unrealized gains and losses do not constitute a cash impact until the related transactions are settled. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents income tax expense for the years ended December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.869%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Amounts in USD thousands, except %)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,223)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense was $1.5&#160;million for the year ended December 31, 2025, compared to $1.2&#160;million for the year ended December 31, 2024. This tax expense is primarily attributed to current and deferred tax expenses recorded in France, the U.S., and Italy, and, to a lesser extent, to the provision for uncertain tax positions, the majority of which were non-cash in 2025 and 2024.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements and Commitments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a minimum purchase agreement with Microsoft related to computational and hosting-related costs. As part of the agreement (as amended on October 10, 2025), we have a total minimum commitment of approximately $80.9&#160;million from the period beginning November 1, 2022 through October 31, 2029 and an additional one-year grace period to meet the minimum commitment by October 31, 2030. As of December 31, 2025 and 2024, our remaining commitments are $58.2 million and $56.9 million, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the above agreement with Microsoft, we did not have, during the periods presented, and we do not currently have, any off-balance sheet arrangements or commitments that may have a material current or future effect on financial condition, changes in financial condition, results of operations, liquidity, capital expenditures, capital resources, or significant components of revenues or expenses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Liquidity and Capital Resources</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our liquidity and capital sources and cash flows for the year ended December 31, 2024 and comparison to the year ended December 31, 2023, see &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8221; in our Annual Report on Form 20-F filed with the SEC on March&#160;4, 2025.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sources of Capital Resources</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of liquidity were cash and cash equivalents totaling $70.3 million as of December 31, 2025 which were held for a variety of growth initiatives and investments in our SOPHiA DDM Platform and related solutions, applications, products, and services as well as working capital purposes. Our cash and cash equivalents are comprised of cash on hand, bank deposits, money market funds, and bank and other short-term highly liquid investments with original maturities of three months or less. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2024 (the &#8220;closing date&#8221;), SOPHiA GENETICS SA and our subsidiary SOPHiA GENETICS, Inc. entered into a credit agreement and guaranty (the &#8220;Perceptive Credit Agreement&#8221;) with Perceptive Credit Holdings IV, LP, as lender and administrative agent, pursuant to which we may borrow up to $50.0 million principal amount of term loans, including (i) an initial tranche of $15.0 million principal amount of term loans on the closing date and (ii) a second tranche of $35.0 million principal amount of term loans that was drawn down on June 25, 2025. The term loans are scheduled to mature on the fifth anniversary of the closing date and accrue interest at Term Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;) (floored at 4% per annum) plus 6.25% per annum; provided that upon the occurrence and during the continuation of any event of default, the term loans will accrue interest at Term SOFR plus 9.25% per annum. The Perceptive Credit Agreement also contains certain mandatory prepayment provisions, including prepayments from the proceeds from certain asset sales and casualty events (subject to a right to reinvest such proceeds in assets used in our business within 180 days) and from issuances or incurrences of non-permitted debt, which will also be subject to prepayment premiums. The obligations under the Perceptive Credit Agreement are secured by substantially all of our and certain of our subsidiaries&#8217; assets and are guaranteed initially on the closing date by SOPHiA GENETICS SA and SOPHiA GENETICS, Inc. The Perceptive Credit Agreement contains customary covenants, including an affirmative covenant to maintain qualified cash of at least $3.0 million, an affirmative last twelve months revenue covenant tested on a quarterly basis beginning June 30, 2024, and negative covenants including limitations on indebtedness, liens, fundamental changes, asset sales, investments, dividends and other restricted payments and other matters customarily restricted in such agreements. We remain in full compliance with all covenants contained in the Perceptive Credit Agreement as of December 31, 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on May 2, 2024 we issued to Perceptive Credit Holdings IV, LP a warrant certificate representing the right to purchase up to 400,000 ordinary shares at $4.9992 per share, with the right to purchase 200,000 ordinary shares available immediately and the right to purchase an additional 200,000 ordinary shares that became available upon the drawdown of the second tranche of the term loans on June 25, 2025. The purchase rights represented by the warrant certificate are exercisable, on a cash basis, at the option of the holder at any time prior to 5:00 p.m., Eastern time on the tenth anniversary of the applicable date of availability. The Warrant Certificate contains customary anti-dilution adjustments. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 23, 2026, SOPHiA GENETICS SA and our subsidiary SOPHiA GENETICS, Inc. entered into an amendment (the &#8220;2026 Amendment&#8221;) to the Perceptive Credit Agreement. The 2026 Amendment provides for, among other things, $25.0 million of additional term loan commitments consisting of (i) an additional $12.5 million tranche of term loan commitments, which may be drawn subject to certain customary conditions, and (ii) an additional $12.5 million tranche of term loan commitments, which may be drawn at such time as SOPHiA GENETICS SA&#8217;s revenue for a trailing twelve-month period exceed $85.0 million and otherwise subject to customary conditions. The two additional tranches, if drawn, will have terms and conditions consistent with the existing term loans, will bear interest at rate per annum equal to Term SOFR (floored at 4% per annum) + 6.25% and will mature in 2029. In connection with the 2026 Amendment, the Company amended and restated the warrant certificate in order to issue to Perceptive Credit Holdings IV, LP the right to purchase an additional 75,000 ordinary shares at $5.00 per share, which right is exercisable immediately. The warrant certificate also grants Perceptive Credit Holdings IV, LP the right to purchase an additional (1) 100,000 ordinary shares, which right will become exercisable upon drawdown of the third tranche and (2) another 100,000 ordinary shares, which right will become exercisable upon drawdown of the fourth tranche.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2024 the Company terminated its existing credit agreement with Credit Suisse SA for up to CHF 5.0&#160;million ($5.5&#160;million). Additionally, the Company entered into a new credit agreement with Credit Suisse SA for up to CHF 0.1&#160;million ($0.1&#160;million) to be used for cash credits, contingent liabilities, or as margin for OTC derivative transactions. Borrowings under the new credit agreement will bear interest at a rate to be established between the Company and Credit Suisse SA at the time of each draw down. On November 27, 2025 the Company terminated this CHF 0.1 million facility ($0.1 million). On February 20, 2025 the Company entered into a new credit agreement with UBS Switzerland AG for up to CHF 0.3 million ($0.3 million), intended solely for the issuance of bank guarantees. As of December 31, 2025 and 2024, the Company had no borrowings outstanding under these credit facilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2025, we established a new at-the-market (&#8220;ATM&#8221;) offering program pursuant to which we may sell, from time to time, ordinary shares having an aggregate offering price of $50.0 million. For the year ended December 31, 2025, we sold 228,238 ordinary shares for total net proceeds of $1.1 million under this program. Through February 20, 2026 the Company has sold 2,795,485 additional shares for total net proceeds of $14.1 million under the same program.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have funded our operations primarily through equity financing and through revenue generated from the sale of access to our SOPHiA DDM Platform and related licenses and services. Invoices for our products and services are a substantial source of revenue for our business, which are included on our consolidated balance sheet as trade receivables prior to collection. Accordingly, collections from our customers have a material impact on our cash flows from operating activities. As we expect our revenue to grow, we also expect our accounts receivable and inventory balances to increase, which could result in greater working capital requirements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Uses of Capital Resources</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have incurred net losses, which have been significant in recent periods. For the years ended December 31, 2025 and 2024, our net losses were $79.0&#160;million and $62.5&#160;million, and our cash burn was $46.0 million and $58.0&#160;million, exclusive of the $35.0 million and $15.0 million in borrowings under the Perceptive Credit Agreement, respectively. As of December 31, 2025, we had an accumulated deficit of $519.3&#160;million. Our primary use of capital sources has been to fund our operations and grow our business, which has included developing new solutions, expanding our market opportunities for our SOPHiA DDM Platform. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Capital Requirements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to incur net losses for the foreseeable future as we continue to devote substantial resources to research and development, in particular, to further expand the applications and modalities of our SOPHiA DDM Platform in order to accommodate multimodal data analytics capabilities across a wide range of disease areas; selling and marketing efforts for our SOPHiA DDM Platform to establish and maintain relationships with our collaborators and customers; and obtaining regulatory clearances or approvals for our SOPHiA DDM Platform and our applications, products, and services. We believe that our existing cash and cash equivalents will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. Our future funding requirements will depend on many factors, including:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to achieve revenue growth;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to secure any required regulatory clearance or approval for additional features, applications and data modalities of our SOPHiA DDM Platform and related solutions, applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the ability of our customers and collaborators to secure any required regulatory clearance or approval for their product candidates, other products, and services the development of which they rely on our SOPHiA DDM Platform and related solutions, applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our rate of progress in, and cost of the sales and marketing activities associated with, establishing adoption of our SOPHiA DDM Platform and related solutions, applications, products, and services;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the rate of progress in establishing payor coverage and reimbursement arrangements with domestic and international commercial third-party payors and government payors by us with respect to our application and products, if approved for IVD use, and by our customers and collaborators, with respect to their product candidates, other products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the cost of expanding our research and development; manufacturing and laboratory operations; and applications, products, and services offerings;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the cost of building out our facilities, including our corporate headquarters in Switzerland and our locations around the world;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our ability to maintain and expand our collaborations with biopharmaceutical companies, both advanced and early stage, and reference and specialist laboratories;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">our rate of progress in, and cost of research and development activities associated with, early research and development efforts;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the effect of competing technological and market developments;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">market acceptance of our platform, solutions, applications, products, and services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">costs related to international expansion; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the potential cost of, and delays in, application and product development as a result of regulatory oversight.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless and until we can generate sufficient revenue to finance our cash requirements, which may never happen, we may seek additional capital through a variety of means, including through public and private equity offerings and debt financings, credit and loan facilities and collaborations. Additional funds may not be available when we need them or on terms that are acceptable to us. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Related to Our Financial Position and Capital Requirements.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the years ended December 31, 2025 and 2024:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December&#160;31,&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in USD thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash from (used in):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,515)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,670)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,755)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,857&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14,386)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(39,413)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate differences on cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,449&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,612)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025 operating activities used $35.9&#160;million primarily resulting from our loss before taxes of $77.5 million, excluding $31.1 million in non-cash charges partially offset by $10.7 million provided by changes in our working capital. Net cash provided by changes in our working capital for the year ended December 31, 2025 consisted primarily of increases in trade payables largely due to the timing of vendor payments, accrued compensation driven by the growth of the Company and deferred contract revenue as a result of a strong sales activity at the end of the year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024 operating activities used $44.5&#160;million primarily resulting from our loss before tax of $61.3 million, excluding $19.9 million in non-cash charges and $2.6 million used in changes in our working capital. Net cash used in changes in our working capital for the year ended December 31, 2024 </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consisted primarily of a $7.4 million decrease in accounts payables, accrued expenses, deferred contract revenue, and other liabilities partially offset by a $5.9 million decrease in accounts receivable. The decrease in current liabilities was primarily as a result of decreases in accrued compensation and deferred contract revenue. The decrease in accounts receivable was primarily as a result of the timing of customer invoicing and collections.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, net cash used in investing activities was $8.7&#160;million, primarily as a result of $7.9 million related to capitalized software development costs as we continue to add new products and upgrade or enhance existing products, $1.9 million related to purchases of equity investments, as well as $0.6 million related to purchases of property and equipment which was driven by our lab expansion at our facility in Rolle, Switzerland to handle our growth.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, net cash used in investing activities was $4.8&#160;million, primarily as a result of $7.8 million related to capitalized software development costs as we continue to add new products and upgrade or enhance existing products.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, net cash provided from financing activities was $30.2&#160;million, primarily as a result of $34.6 million in net proceeds from the second tranche of the Perceptive Credit Agreement and $1.1 million in proceeds from the sale of ordinary shares through our ATM facility.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, net cash provided from financing activities was $9.9&#160;million, primarily related to $13.9 million in net proceeds from the Perceptive Credit Agreement, partially offset by $2.8 million of payments of the principal portion of leases.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-IFRS Measures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To supplement our financial statements prepared in accordance with IFRS, we provide investors with certain non-IFRS financial measures, including adjusted EBITDA and constant currency revenue. The presentation of the non-IFRS financial measures have limitations and you should not consider them in isolation or as a substitute for the financial information prepared and presented in accordance with IFRS. We believe that these non-IFRS financial measures provide useful information about our performance, enhance overall understanding of past performance and future prospects and allow for greater transparency with respect to metrics used by our managements in its financial and operational decision-making. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define adjusted EBITDA as loss for the period before depreciation, amortization, interest income, interest expense, fair value adjustments on warrant obligations, foreign exchange (losses) gains, net, income tax (expense) benefit, share-based compensation expense, non-cash pension expense, certain transaction costs and litigation expenses.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a key business metric we use to evaluate our overall financial performance and to facilitate consistent comparisons across reporting periods. Adjusted EBITDA reflects our earnings excluding items that we believe are not related to our core operating performance, or are non-cash income and expense. We believe this metric provides a meaningful representation of our operating profitability as it excludes items that may fluctuate significantly between periods and are not reflective of our ongoing business operations. We believe that this non-IFRS financial measure provides useful information about our performance, enhances overall understanding of past performance and future prospects and allows for greater transparency with respect to metrics used by our management in its financial and operational decision-making. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA has limitations as a financial measure, and you should not consider it in isolation or as a substitute for analysis of our results as reported under IFRS. For example: </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA excludes the impact of depreciation. Although depreciation is a non-cash charge, the assets being depreciated may need to be replaced in the future and this non-IFRS measure does not reflect capital expenditure requirements for such replacements or for new capital expenditures;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA excludes the impact of interest expense. Interest expense will continue to be for the foreseeable future a recurring expense based on the company&#8217;s financial liabilities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA excludes the impact of interest income. Interest income will continue to be for the foreseeable future recurring income based on the company&#8217;s financial assets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA excludes the impact of income taxes. Income taxes will continue to be for the foreseeable future a recurring expense incurred in the various jurisdictions in which the company operates;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA excludes the impact of foreign exchange gains (losses), net. Foreign exchange gains and losses will continue to be for the foreseeable future a recurring benefit or expense incurred as the company participates in transactions outside of the company&#8217;s functional currency;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA excludes the impact of fair value adjustments of warrant obligations. Fair value adjustments on warrant obligations will continue to be for the foreseeable future a recurring expense incurred as the company has outstanding warrant obligations;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA excludes the impact of amortization of capitalized research and development expenses and intangible assets. Amortization of these assets will continue to be for the foreseeable future a recurring expense incurred as the Company continues to invest in developing revenue-generating products through research and development. Although amortization is a non-cash charge, the assets being amortized may need to be replaced in the future and these non-IFRS measures do not reflect capital expenditure requirements for such replacements or for new capital expenditures; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA excludes the impact of share-based compensation expenses. Share-based compensation has been, and will continue to be for the foreseeable future, a recurring expense in the company&#8217;s business and an important part of its compensation strategy; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA excludes the impact of the non-cash portion of pensions paid in excess of actual contributions to match actuarial expenses. Pension expenses have been, and will continue to be for the foreseeable future, a recurring expense in the business;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA excludes the impact of certain capital markets transaction costs. These costs may occur from time to time in the future as needed to complete the transactions;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA excludes the impact of litigation expenses related to the company's defense of lawsuits filed by Guardant Health. These expenses are expected to continue for the duration of the litigation and may increase in future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally other companies, including companies in our industry, may calculate these non-IFRS measures differently, which reduces their usefulness as comparative measures. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles IFRS net loss to adjusted EBITDA for the years ended December 31, 2025 and 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.181%"><tr><td style="width:1.0%"/><td style="width:53.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.688%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:20.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IFRS loss for the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(78,999)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(62,493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exclude the impact of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,362)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments on warrant obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange losses (gains), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,479)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash pension expense</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation expenses</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,430&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41,500)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(40,178)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.07pt">Share-based compensation expense represents the cost of equity awards issued to our directors, officers, and employees. The fair value of awards is computed at the time the award is granted and is recognized over the vesting period of the award by a charge to the income statement and a corresponding increase in other reserves within equity. These expenses do not have a cash impact but remain a recurring expense for our business and represent an important part of our overall compensation strategy. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.07pt">Non-cash pension expense consists of the amount recognized in excess of actual contributions made to our defined pension plans to match actuarial expenses calculated for IFRS purposes. The difference represents a non-cash expense but remains a recurring expense for our business as we continue to make contributions to our plans for the foreseeable future.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.07pt">Share-based compensation expense does not include social charges on equity-based compensation of $0.8 million and $(0.7) million for the years ended December 31, 2025 and 2024, respectively.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.07pt">Transaction costs consists of expenses incurred in connection with the Company&#8217;s shelf registration statement and the ATM program.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.07pt">Litigation expenses consists of expenses related to the company's defense of lawsuits filed by Guardant Health.</span></div><div style="margin-top:12pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Constant Currency Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define constant currency revenue as revenues received in local (non-U.S. dollar) currencies translated into U.S. dollars using the same average foreign currency exchange rates that we used to translate local currency revenues for the comparable reporting period of the prior year. The company then calculates the difference between the IFRS revenue and the constant currency revenue to yield the &#8220;constant currency impact&#8221; for the current period. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Constant currency revenue is a key business metric we use to assess our underlying revenue performance, excluding the impact of foreign currency exchange rate fluctuations. Since we operate in multiple international markets, our reported revenue is affected by changes in foreign currency exchange rates, which can obscure underlying trends in our business performance. We believe this metric provides our management with an additional measure of our revenue and growth by removing the effects of currency movements. We believe this </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allows management and investors to better understand or performance and make more meaningful comparisons across reporting periods.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Constant currency revenue has limitations as a financial measure, and you should not consider it in isolation or as a substitute for analysis of our results as reported under IFRS. For example:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Constant currency revenue excludes the impact of foreign exchange rate fluctuations. While this allows better comparability between periods, this does not reflect actual changes in revenues and should not be considered in isolation. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Constant currency revenue uses a monthly average exchange rate which does not reflect actual economic impact. This application may overstate or understate the true impact of foreign currency on revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally other companies, including companies in our industry, may calculate this non-IFRS measures differently, which reduces its usefulness as a comparative measure. </span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles IFRS revenue to constant currency revenue for the years ended December 31, 2025 and 2024:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:68.181%"><tr><td style="width:1.0%"/><td style="width:53.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.688%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:20.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.688%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IFRS revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,271</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,173</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period constant currency impact</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,983)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Constant currency revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75,288</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,173</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C. Research and Development, Patents and Licenses</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Item 4. Information on the Company&#8212;B. Business Overview&#8221; and &#8220;Item 5. Operating and Financial Review and Prospects&#8212;A. Operating Results&#8212;Results of Operations.&#8221;</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D. Trend Information</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;A. Operating Results.&#8221;</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E. Critical Accounting Estimates and Judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with IFRS Accounting Standards requires management to make judgments, estimates and assumptions that affect the application of our accounting policies and reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. In particular, information about significant areas of estimation uncertainty and critical judgments in applying accounting policies that have the most significant effect on the amount recognized in the financial statements are described below.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales transactions may consist of various performance obligations that are satisfied at different times. It requires judgment to determine when different obligations are satisfied, including whether enforceable commitments for further obligations exist and when they arise. Depending on the determination of the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">performance obligations and the point in time or period over which those obligations are fulfilled, this may result in all revenue being calculated at inception, and either being recognized at once, or on contract completion or spread over the term of a longer performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for contracts that contain promises to deliver more than one good or service, we have to determine how to allocate the total transaction price to the performance obligations of the contract. We allocate the total transaction price of a customer contract to the distinct performance obligations under the contract based on their standalone selling prices (&#8220;SSP&#8221;), the determination of which can require significant judgment from management. The best evidence of this is an observable price from the standalone sales of the good or service to similarly situated customers. However, where standalone selling prices are not observable, it requires judgment to estimate the cost of satisfying a performance obligation and adding an appropriate margin to that good or service. In some cases, SSP is not available and the residual approach is used to determine the stand-alone selling price of certain performance obligations. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capitalized Internal Software Development Costs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize the costs of work attributable to the development of new data analytics solutions and services or to the improvement or enhancement of existing solutions and services. The costs consist of personnel costs, including related benefits, that are incurred once it is evident that the project is technically and financially feasible and that it will bring economic benefits to us.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review capitalization criteria for each project individually, which requires us to exercise judgment as to what costs are capitalizable. Capitalized costs are amortized over the estimated useful life of the software, which is five years, on a straight-line basis, which represents the manner in which the expected benefit will be derived. We determine the useful lives of identifiable project assets after considering the specific facts and circumstances related to each project. The amortization of costs related to the data analytics solutions is included in cost of revenue in the consolidated statement of loss. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant judgments related to the capitalization of internal use software costs include determining whether it is probable that projects will result in new or additional functionality, concluding on when the application development phase starts and ends, and estimating which costs, especially employee compensation costs, should be capitalized.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2025 and 2024, we granted share options under one plan - the SOPHiA GENETICS 2021 Equity Incentive Plan (the &#8220;2021 Equity Incentive Plan&#8221; or the &#8220;2021 EIP&#8221;). Under this plan, our Board of Directors may offer options to directors, employees and advisors. The fair value of the services and consideration received in exchange for the grant of options is recognized as an expense and as a component of equity. The total amount to be expensed over the vesting period is determined by reference to the fair value of the options granted. The fair value of the share options was determined using a Black-Scholes valuation model. No performance conditions were included in the fair value calculations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measuring the Cost of Share Options</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options outstanding under all plans is estimated at each reporting date using the Black-Scholes option pricing model, taking into account the terms and conditions upon which the options were granted.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes model requires the input of highly subjective assumptions, including the expected volatility, the risk-free rate, expected life and the dividend yield. The expected volatility is based on our own historical volatility as well as the historical volatility of several comparable companies in the same industry. The expected life is based on the longer of each tranche&#8217;s respective weighted-average vesting term. The risk-free rate for periods within the contractual life of the options is based on the market yield of U.S. Treasury Bonds in effect at the time of grant. The dividend yield is based on the Company&#8217;s expected dividend policy over the contractual life of the options.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key inputs used in the valuation model for the stock options are outlined below.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EIP 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December&#160;31,&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average strike price (in USD)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.29</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.78</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (in USD)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;$3.04 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.73</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.40</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.96</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of share options (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P5Y6M0D</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">P7Y0M0D</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.60%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.95%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate (%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.03%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.40%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Benefit Pension Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability or asset recognized on the balance sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation at the end of the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by independent actuaries using the projected unit credit method.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms approximating to the terms of the related obligation. In countries where there is no deep market in such bonds, the market rates on government bonds are used.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the statement of loss.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remeasurement gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which they occur, directly in other comprehensive income. They are included in retained earnings in the statement of changes in equity and on the balance sheet.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in income as past service costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For defined contribution plans, we pay contributions to publicly or privately administered pension insurance plans. Employee contributions to these plans is voluntary and these contributions are matched by the employer. We have no further payment obligations once the contributions have been paid. The contributions are recognized as employee benefit expense when they are due. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in the future payments is available. Contributions are charged to the statement of loss as incurred.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Directors, Senior Management, and Employees</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. Directors and Senior Management</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information about our executive officers and directors. Ages are as of February 15, 2026.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.596%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Position(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Officers and Directors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jurgi Camblong</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ross Muken</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">George Cardoza</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daan van Well</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Legal and Compliance Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manuela da Silva Valente</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief People Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zhenyu Xu</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Scientific Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Philippe Menu</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Medical Officer and Chief Product Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Non-Executive Directors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Troy Cox</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tomer Berkovitz</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kathy Hibbs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Didier Hirsch</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vincent Ossipow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Michel Coss&#233;ry</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officers</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jurgi Camblong, Ph.D., M.B.A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, has served as our Chief Executive Officer and a member of our board of directors since March 2011 when he co-founded our company with Dr.&#160;Pierre Hutter and Professor Lars Steinmetz. From 2010 to 2011, Dr.&#160;Camblong served as the Chief Executive Officer of Gene Predictis SA. Prior to that, Dr.&#160;Camblong was a post-doctoral associate researcher at Oxford University and at the University of Geneva. Dr.&#160;Camblong was a member of the Advisory Council on Digital Transformation to the Swiss Government and is a Board member of the Swiss Biotech Association.&#160;Dr.&#160;Camblong holds a Ph.D. in life sciences from the University of Geneva and an Executive M.B.A. in management of technology from EPFL/HEC Lausanne.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ross Muken, B.Sc.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;has served as our President since November 2024 and was previously our Chief Financial Officer from February 2021 to November 2024 and our Chief Operating Officer from March 2023 to November 2024. From 2019 to 2020, Mr.&#160;Muken served as the Chief Financial Officer of Click Therapeutics, Inc. From 2012 to 2019, Mr.&#160;Muken served as the Senior Managing Director and Partner of Equity Research at Evercore/ISI Group. Prior to that, Mr.&#160;Muken served in various roles at Deutsche Bank, including as Managing Director of Equity Research, and at Thomas Weisel Partners. Mr.&#160;Muken holds a B.Sc. in business administration from Boston University.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">George Cardoza, M.B.A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, has served as our Chief Financial Officer since November 2024. From August 2023 to November 2024, he was the Chief Financial Officer and Head of Service Delivery at Biocartis, a molecular diagnostics company. From July 2022 to August 2023, he was the Chief Executive Officer of AccuraGen. Prior to that, he spent over twelve years with NeoGenomics Laboratories in several executive roles (CFO from November 2009 to March 2018, President Pharma Services Division from March 2018 to July 2021), and President and Chief Operating Officer Laboratory Operations from July 2021 to April 2022), and previously spent more than fourteen years with Quest Diagnostics in various roles including Controller of the Central Region. Mr. Cardoza holds a B.S. in Finance and Accounting from Syracuse University and an M.B.A. from Michigan State University.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Daan van Well, LL.M., M.B.A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, has joined as our General Counsel in June 2019. In March 2023 was appointed Chief Legal &amp; Compliance Officer, and since November 2024 he has served as Chief Legal &amp; Regulatory Officer. Mr.&#8239;Van Well has more than 25 years of legal, governance and compliance experience. From 2018 to 2019, Mr.&#8239;Van Well served as the founder and managing partner of consulting firm SpringWorks S&#224;rl. From 2010 to 2017, Mr.&#8239;Van Well served in various legal positions with PwC Switzerland, including as the Head of Legal from 2011 to 2017. Prior to that, Mr.&#8239;Van Well served as corporate secretary and senior legal counsel of Royal Ahold N.V. (currently Koninklijke Ahold Delhaize N.V.) and practiced law at Loyens&#8239;&amp; Loeff N.V. in Rotterdam, The Netherlands. Mr.&#8239;Van Well holds a LL.M. in Dutch civil law from Utrecht University and an Executive M.B.A. in management and corporate finance from HEC Lausanne.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manuela da Silva Valente, B.A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, has served as our Chief People Officer since January 2019. Ms. Da Silva Valente has more than 20 years of human resources experience. From 2011 to 2018, Ms. Da Silva Valente served in various human resources leadership roles at IQVIA (formerly Quintiles and IMS Health Inc.), including as Global Senior Director of Human Resources from 2016 to 2018. Prior to that, Ms. Da Silva Valente held various human resources roles at Outcome Sciences, Inc. prior to its acquisition by IQVIA. Ms. Da Silva Valente holds a B.A. in business administration from the Business Management School of Zurich and a Management &amp; Human Resources Diploma from CEFCO Lausanne.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zhenyu Xu, Ph.D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, has served as our Chief Scientific Officer since January 2021 and was previously our Chief Technology Officer since May 2014. Dr. Xu was the leader of the technology team that developed our SOPHiA DDM Platform. Prior to that, Dr. Xu was a post-doctoral fellow at the European Molecular Biology Laboratory. Dr. Xu holds a Ph.D. in molecular and computational biology from the European Molecular Biology Laboratory.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Philippe Menu, M.D., Ph.D., M.B.A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, has served as our Chief Medical Officer since February 2020 and our Chief Product Officer since March 2023. From 2011 to 2020, Dr. Menu was a management consultant with McKinsey &amp; Company, focusing on the biopharmaceutical sector and in particular innovative therapies and diagnostics in oncology and rare diseases. Prior to that, Dr. Menu was a post-doctoral fellow at the University of Lausanne. Dr. Menu holds an M.D./Ph.D. in life sciences from the University of Lausanne and an M.B.A. from the Open University Business School.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-Executive Directors</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Troy Cox, M.B.A.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, has served as the Director of our board of directors since June 2019 and as Chairman since February 2020. From 2017 to 2019, Mr.&#8239;Cox served as the chief executive officer of Foundation Medicine Inc. From 2010 to 2017, Mr.&#8239;Cox served as the senior vice president of Genentech, Inc. Prior to that, Mr.&#8239;Cox held various executive and senior positions at UCB S.A., Sanofi-Aventis U.S. LLC and Schering-Plough Corporation. In addition to our board of directors, Mr.&#8239;Cox serves on the board of directors of Standard BioTools, TenaRx, and Fuze Health, and previously served on the board of directors of Foundation Medicine Inc., Zymeworks Inc., and LetsGetChecked. Mr.&#8239;Cox holds an M.B.A. from the University of Missouri and a B.B.A from the University of Kentucky.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tomer Berkovitz, Ph.D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, has served as a member of our board of directors since March 2021. Since 2018, Dr.&#160;Berkovitz has served as General Partner of aMoon Fund, where he co-leads its Growth fund. From 2014 to 2018, Dr.&#160;Berkovitz served as the Chief Operating Officer and Chief Financial Officer of Alcobra Ltd. Prior to that, Mr.&#160;Berkovitz served as an Executive Director in J.P. Morgan&#8217;s investment banking division in New York. In addition to our board of directors, Dr.&#160;Berkovitz serves on the board of directors of several other healthcare companies in the aMoon portfolio. Dr.&#160;Berkovitz holds a Ph.D. in finance from Columbia Business School.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Kathy Hibbs, J.D.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, has served as a member of our board of directors since March 2021. She served as Chief Administrative Officer at 23andMe, Inc. from 2022 to May 2024, and prior to that, as Chief Legal and Regulatory Officer from 2014 to 2022. Earlier in her career, Ms.&#8239;Hibbs held key leadership roles in legal, business development and compliance functions at Genomic Health, Inc., Monogram Biosciences Inc. and Varian Medical Systems, Inc. In addition to our board of directors, Ms. Hibbs serves on the board of directors of Standard BioTools. Ms.&#8239;Hibbs holds a J.D. from the University of California, San Francisco.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Didier Hirsch, M.Sc., M.S.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, has served as a member of our board of directors since June 2020. From 2010 to 2018, Mr.&#160;Hirsch served as the senior vice president and chief financial officer of Agilent Technologies, Inc. Prior to that, Mr.&#160;Hirsch held various leadership roles in finance at Agilent Technologies, Inc. and Hewlett-Packard Company. In addition to our board of directors, Mr.&#160;Hirsch serves on the board of directors of Knowles Corporation and previously served on the board of directors of International Rectifier Corporation, Logitech </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International S.A. and Azenta Inc. Mr.&#160;Hirsch holds an M.Sc. in computer science from Toulouse University and an M.S. in industrial administration from Purdue University.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Vincent Ossipow, Ph.D., CFA, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">has served as a member of our board of directors since June 2014. Dr.&#8239;Ossipow has been a partner at Omega Funds. Dr.&#8239;Ossipow has also served as the Chief Scientific Officer of Omega Alpha SPAC. Prior to that, Dr.&#8239;Ossipow held various investment management positions at Sectoral Asset Management and Pictet Bank. In addition to our board of directors, Dr.&#8239;Ossipow serves on the board of directors of Callio Therapeutics, and previously served on the board of directors of BioInvent International AB, FoRx SA, Aerium Inc, Immunic Inc., eTheRNA NV, Andrew Alliance S.A., Lifespan, Inc., Raindance Technologies, CNx SA and Kuros Biosciences AG. Dr.&#8239;Ossipow is a Chartered Financial Analyst (CFA), CFA Institute, holds a Ph.D. in molecular biology from the University of Geneva and a Certificate in International Finance from Georgetown University.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Jean-Michel Coss&#233;ry, Ph.D., Pharm.D., M.B.A.,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> has served as a member of our board of directors since June 2022. From 2012 to 2018, Dr. Coss&#233;ry served in various senior leadership positions at Eli Lilly and Company, including as Vice President, North America Oncology, as well as Vice President and Managing Director of Lilly U.K. and Northern Europe. Prior to that, he served as Vice President and Chief Marketing Officer of GE Healthcare as well as in senior positions at Novartis International AG and Serono (now Merck (Schweiz) AG). Dr. Coss&#233;ry serves on the board of directors of Malin Corporation plc and is the chairman of Scancell Holdings PLC. He previously served on the boards of Exact Therapeutics AS, Diurnal plc, Eracal Therapeutics Ltd., Immunocore Holdings Limited and Kymab Ltd. When based in the UK he served on the board of directors of ABPI (UK) LIMITED and as chairman of the board of directors of the American Pharmaceutical Group in the UK. Dr. Coss&#233;ry holds an M.B.A. from the Rotterdam School of Management, a Ph.D. with honors in nuclear chemistry and neurobiology from Paris Sud University, and a Pharm.D. with honors in pharmacology from Paris Sud University.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Relationships</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships among any of our directors or executive officers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leadership Changes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2026, we announced that Dr. Camblong will become Executive Chairman, subject to election by the 2026 Annual General Meeting, and Mr. Muken will become Chief Executive Officer, effective July 1, 2026. </span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Compensation </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation of Directors and Executive Officers</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025, the aggregate compensation paid or accrued to the members of our board of directors and our executive officers for services in all capacities, including retirement and similar benefits, was $6.1&#160;million, the total fair value of stock options and non-vested share awards granted to the members of our board of directors and our executive officers was $7.7&#160;million, and the amount set aside or accrued by us to provide pension, retirement or similar benefits to our executive officers was $0.3&#160;million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;29, 2021, our shareholders approved the 2021 Equity Incentive Plan that our board of directors had previously adopted. The purpose of the 2021 Equity Incentive Plan is to motivate and reward performance of our employees, directors, consultants and advisors and further the best interests of the Company and our shareholders.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plan Administration</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The 2021 Equity Incentive Plan is administered by the compensation committee of our board of directors, subject to the board of directors&#8217; discretion to administer or appoint another committee to administer it.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Awards.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Equity incentive awards under the 2021 Equity Incentive Plan may be granted in the form of options (including incentive stock options and non-qualified stock options), share appreciation rights, restricted shares, restricted share units, performance awards or other share-based awards. Options and share appreciation rights will have an exercise price determined by the compensation committee and, in the case of options granted to a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">participant subject to U.S. taxation, will not be less than fair market value of the underlying ordinary shares on the date of grant (or, if such options consist of incentive stock options and the participant owns (or is deemed to own) at least 10% of the total combined voting power of all classes of our capital stock (a &#8220;ten percent shareholder&#8221;), an exercise price not less than 110% of the fair market value of the underlying ordinary shares on the date of grant). In addition, under the 2021 Equity Incentive Plan, options and share appreciation rights may not have a term that exceeds ten years (or, in the case of an incentive stock option granted to a ten percent shareholder, a term that exceeds five years).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eligible Participants</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The compensation committee is able to offer equity awards at its discretion under the 2021 Equity Incentive Plan to (1)&#160;any of our employees or any of our subsidiaries, (2)&#160;any non-employee directors serving on our board of directors and (3)&#160;any consultants or other advisors to us or any of our subsidiaries;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;that only employees of our company or certain of our subsidiaries may be granted incentive stock options. To the extent required by applicable law and our articles of association in effect from time to time, all awards and rights, payments and benefits granted or made under the 2021 Equity Incentive Plan to our directors and executive officers are subject to the approval of the relevant total amount of compensation by our shareholders.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Reserve</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The maximum number of ordinary shares initially reserved for issuance pursuant to awards under the 2021 Equity Incentive Plan is 7,800,740 ordinary shares, which will be increased on the first day of each fiscal year of the Company, beginning with the 2022 fiscal year, in an amount equal to the least of (i)&#160;a number of ordinary shares equal to five percent (5%) of the total number of shares of all classes of shares of the Company outstanding on the last day of the immediately preceding fiscal year, (ii)&#160;such number of shares determined by our board of directors, and (iii)&#160;the aggregate number of shares available to our board of directors under our articles of association or otherwise that may be granted as, or be subject to, equity incentive awards on such date. To ensure that our board of directors can reserve a sufficient number of ordinary shares for purposes of the 2021 Equity Incentive Plan, we plan to request shareholders approve annual increases to the Company&#8217;s conditional share capital for employee participation. In addition, ordinary shares reserved for issuance under the 2021 Equity Incentive Plan are subject to adjustment in the event of certain corporate transactions or events if necessary to prevent dilution or enlargement of the benefits made available under the 2021 Equity Incentive Plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vesting</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The vesting conditions for grants under the equity incentive awards under the 2021 Equity Incentive Plan are set forth in the applicable award documentation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Termination of Service and Change in Control</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event of a participant&#8217;s termination of employment or service, the compensation committee may determine in the applicable award agreement the extent to which an equity incentive award may be exercised, settled, vested, paid or forfeited. Unless otherwise provided in the applicable award agreement, in the event of a change in control by way of a merger, a sale of the Company&#8217;s securities, a sale of all or substantially all of the Company&#8217;s assets or similar transaction, each award that is outstanding as of immediately prior to such change in control will, (i)&#160;to the extent not then vested, accelerate and become fully vested (with any performance award assumed to have achieved the applicable performance criteria at the greater of target and maximum level of performance), and (ii)&#160;be cancelled and converted into the right to receive a payment in cash with a value equal to the value of such award based on the per share value of consideration received or to be received by other shareholders of the Company in such change in control, with the value of the any such award that is an option or a share appreciation right reduced by the applicable exercise price. In the event of a change in control, the compensation committee may also, in lieu of the acceleration and cash out of outstanding awards described above, take any one or more of the following actions with respect to outstanding awards that the compensation committee determines to be appropriate: (i)&#160;cancel any such award in exchange for a payment in securities or other property other than cash or any combination thereof with a value equal to the value of such award based on the per share value of consideration received or to be received by other shareholders in the event (or without payment of consideration if the compensation committee determines that no amount would have been realized upon the exercise of the award or other realization of the participant&#8217;s rights); (ii) require the exercise of any outstanding option; (iii)&#160;provide for the assumption, substitution, replacement or continuation of any award by the successor or surviving corporation, along with appropriate adjustments with respect to the number and type of securities (or other consideration) of the successor or surviving corporation, subject to any replacement awards, the terms and conditions of the replacement awards (including performance targets) and the grant, exercise or purchase price per share for the replacement awards; (iv)&#160;make any other adjustments in the number and type of securities (or other consideration) subject to awards that may be granted in the future; (v)&#160;provide that any such award shall be </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accelerated and become exercisable, payable and/or fully vested with respect to all ordinary shares covered thereby or (vi)&#160;provide that any award shall not vest, be exercised or become payable as a result of such event.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Termination and Amendment</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless terminated earlier, the 2021 Equity Incentive Plan will continue for a term of ten years. Our board of directors has the authority to amend or terminate the 2021 Equity Incentive Plan subject to shareholder approval with respect to certain amendments. However, no such action may materially adversely affect the rights of any participant under any outstanding award without the consent of the affected participant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, we have granted to the members of our board of directors and to our executive officers, in the aggregate, the right to acquire 2,524,323 ordinary shares under the 2021 Equity Incentive Plan. Options granted to executive officers during 2025 vest 25% on the first anniversary of the grant date and the remaining&#160;75% vesting ratably on a monthly basis over the remaining three years. The weighted-average exercise price for the options granted during 2025 was $2.17. During the year ended December 31, 2025, we granted to the members of our board of directors and to our executive officers, in the aggregate, 683,965 RSUs under the 2021 Equity Incentive Plan. The RSUs granted to an executive officer are subject to a four-year vesting schedule with 25% vesting on the first anniversary of the grant date and the remaining 75% ratably on a quarterly basis over the remaining three years, subject to the executive officer&#8217;s continued employment with us; any unvested RSUs will be forfeited should the executive officer terminate his or her employment with us. The restricted share units granted to a non-executive member of the board of directors are subject to a vesting period set to be completed upon the Company&#8217;s 2026 Annual General Meeting, subject to continued service on our board of directors.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employment Agreements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into employment agreements with certain of our executive officers. Each of these agreements provides for an initial salary and annual bonus opportunity, as well as participation in certain pension and welfare benefit plans. These agreements may require advance notice of termination and in some cases provide for paid garden leave. Some of our executive officers have agreed to covenants not to compete against us or solicit our employees or customers during employment and for a period of up to one year following termination. We may be required to pay some of our executive officers compensation for their covenant not to compete with us following termination. If we experience a &#8220;change in control&#8221;, then our executive officers&#8217; then-unvested awards will become fully vested at such time.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required under Swiss law to provide additional disclosure regarding the compensation of our executive officers and directors. We incorporate by reference the information contained in Exhibit 99.2 of the Report on Form 6-K filed with the SEC on March&#160;3, 2026 (other than the Report of the Statutory Auditor and Section 4 Equity and Equity-Linked Instruments Held by Members of the Board of Directors and the Executive Committee). </span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C. Board Practices</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Composition and Election of Directors</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors is composed of seven members. Under the laws of Switzerland, each director is elected for a one-year term. The current members of our board of directors will serve until our annual general meeting of shareholders in 2026.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Practices</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a foreign private issuer under the rules of the SEC. As a result, in accordance with Nasdaq listing standards, we rely on home country governance requirements and certain exemptions thereunder rather than on Nasdaq corporate governance requirements. For an overview of our corporate governance principles, see &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles of Association&#8221; and &#8220;Item 16G&#8212;Corporate Governance.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Independence</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has affirmatively determined that each of Troy Cox, Tomer Berkovitz, Kathy Hibbs, Didier Hirsch, Vincent Ossipow, and Jean-Michel Coss&#233;ry is an independent director within the meaning of applicable Nasdaq standards.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Meetings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2025, our board of directors held 9 meetings.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committees of the Board of Directors</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has three committees: an audit committee, a compensation committee, and a nomination and corporate governance committee.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audit committee, which consists of Didier Hirsch (chair), Tomer Berkovitz, and Kathy Hibbs, assists our board of directors in overseeing our accounting and financial reporting processes and the audits of our consolidated financial statements. In addition, the audit committee is directly responsible for the compensation, retention, and oversight of the work of our independent registered public accounting firm that our shareholders elect as our external auditors. The audit committee consists exclusively of members of our board of directors who are financially literate, and each of Didier Hirsch and Tomer Berkovitz are considered an &#8220;audit committee financial expert&#8221; as defined by the SEC. Our audit committee complies with Rule 10A-3(b)(1) of the Exchange Act. Our board of directors has determined that each of Didier Hirsch, Tomer Berkovitz, and Kathy Hibbs satisfy the &#8220;independence&#8221; requirements under Nasdaq listing standards and Rule 10A-3 under the Exchange Act.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audit committee is governed by a charter that complies with the Nasdaq listing standards that apply to us. The audit committee has the responsibility to, among other things:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">select, appoint, compensate, retain, terminate and oversee the work of any accounting firm engaged for the purpose of preparing or issuing an audit report or performing other audit, review or attest services;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">pre-approve the audit services and non-audit services (including the fees and terms thereof) to be provided by the independent auditor pursuant to pre-approval policies and procedures;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review and approve the planned scope and timing of our independent registered public accounting firm&#8217;s annual audit plan(s);</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">discuss significant findings from the audit and any problems or difficulties encountered, including any restrictions on the scope of our independent registered public accounting firm&#8217;s activities or on access to requested information, and any significant disagreements with management;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">evaluate the independent auditor&#8217;s qualifications, performance and independence, and present its conclusions with respect to the independent auditor to the board of directors on at least an annual basis;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">supervise the ethics committee as provided in the Code of Ethics, consider related party transactions and supervise compliance with any other policies over which the audit committee has oversight authority;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review and discuss with management and the independent auditor the annual audited consolidated and stand-alone financial statements and make its recommendation to the board of directors for their presentation to the general meeting of shareholders for approval;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review and discuss with management and the independent auditor the unaudited condensed consolidated quarterly financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review with management and the independent auditor (i) any analyses or other written communications prepared by management and/or the independent auditor setting forth significant financial reporting issues and judgments made in connection with the preparation of the financial statements, (ii) our material accounting policies and practices, (iii) the effect of regulatory and accounting initiatives, as well as off-balance-sheet transactions and structures, on our financial statements and (iv) any major issues regarding accounting principles and financial statement presentations;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">in conjunction with the chief executive officer and chief financial officer, review disclosure controls and procedures and internal control over financial reporting;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review and discuss with the independent auditor any audit problems or difficulties and management&#8217;s response thereto;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">discuss with the chief financial officer and the chief executive officer the results of its review of the management or internal control letter issued by the independent auditor;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">resolve disagreements between management and the auditor regarding our financial reporting;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review our risk assessment and risk management policies and practices;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">establish procedures for the receipt, retention and treatment of complaints received regarding accounting, internal accounting controls or auditing matters, as well as the receipt of summary whistleblower reports and the confidential, anonymous submission by employees of concerns regarding questionable accounting or auditing matters;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review our compliance with laws and regulations; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review any major litigation or investigations against us that may have a material impact on our financial statements.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audit committee meets as often as it determines is appropriate to carry out its responsibilities, but in any event meets at least quarterly.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation committee, which consists of Kathy Hibbs (chair), Jean-Michel Coss&#233;ry, and Vincent Ossipow, supports our board of directors in establishing and reviewing the compensation and benefits strategy and guidelines as well as in preparing the proposals to the annual general meeting of shareholders regarding the compensation of the members of the board of directors and the executive officers. The compensation committee may submit proposals to the board of directors on other compensation-related matters. Swiss law requires that we have a compensation committee, so in accordance with Nasdaq listing standards, we follow home country requirements with respect to the compensation committee. As a result, our practice varies from Nasdaq listing standards, which set forth certain requirements as to the responsibilities, composition and independence of compensation committees for domestic issuers. Swiss law requires that our board of directors submit the aggregate amount of compensation of all members of our board of directors and of all executive officers to a binding shareholder vote every year. The members of the compensation committee will be elected by our annual general meeting of shareholders. The board of directors appoints the chair of the compensation committee and fills any vacancies until the following annual general meeting of shareholders.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation committee has the responsibility to, among other things:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">regularly review and make recommendations to the board of directors regarding our compensation and benefits strategy and guidelines;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review and make recommendations to the board of directors regarding the compensation of the members of the board of directors, of the executive committee and of our extended management team;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">prepare the proposals to the shareholders&#8217; meeting regarding the compensation of the members of the board of directors and of the executive committee;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review and approve the recommendation of our chief executive officer regarding the fixed and variable compensation, including incentive plan participation and benefits, of the members of the management team other than members of the executive committee;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review and make recommendations to the board of directors regarding our compensation and benefits plans (cash and/or equity-based plans) and, where appropriate or required, make recommendations to adopt, amend, and terminate such plans;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">to the extent not delegated by the compensation committee to a different body or a third party, administer our compensation and benefits plans; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review and assess risks arising from our employee compensation policies and practices and whether any such risks are reasonably likely to have a material adverse effect on us.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nomination and Corporate Governance Committee</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nomination and corporate governance committee, which consists of Troy Cox (chair), Kathy Hibbs, and Didier Hirsch, is responsible for director and board committee nominations, succession planning, performance evaluation, and reviewing and amending, if required, our corporate governance framework and guidelines. The members of the nomination and corporate governance committee and its chair are appointed by our board of directors.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nomination and corporate governance committee has the responsibility to, among other things:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">determine selection criteria for the succession of the members of the board of directors and board committees, our chief executive officer and our chief financial officer, and establish such succession planning (including for the event of the incapacitation, retirement or removal of such individuals) by making recommendations to the board of directors;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">oversee searches, identify qualified individuals and recommend individuals for membership on the board of directors and for the position of chief executive officer;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">recommend individuals for appointment to the audit committee annually and as vacancies or newly created positions occur;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">at least annually, prepare the board of directors&#8217; assessment of the performance of the board of directors and board committees and of our chief executive officer;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review the recommendations of the other board committees based on their self-evaluations and discuss its own evaluation with the board of directors;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">monitor and assess developments and trends in corporate governance to the extent that these do not have an impact on the activities and tasks of the audit committee or the compensation committee;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review proposals to be made to the board of directors for the amendment of our articles of association, our organizational regulations, and any other charter, rules or regulations;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">approve in advance any acceptance by a member of our management of a position as member of the board of directors in companies not belonging to our group;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">periodically review and assess the adequacy of the charter of the nomination and corporate governance committee and recommend any proposed changes to the board of directors for approval;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">if it deems necessary, develop and recommend to the board of directors corporate governance guidelines for us;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">periodically review and reassess the adequacy of the Code of Ethics and recommend any proposed changes to the board of directors;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">oversee compliance with the Code of Ethics and report on such compliance to the board of directors;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">supervise the ethics committee as provided in the Code of Ethics; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">review and consider any requests for waivers of the Code of Ethics for members of our board of the directors, our management and other senior financial officers, and make a recommendation to our board of directors with respect to such request for a waiver.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_73"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D. Employees</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ great minds in biotechnology and machine learning who continuously advance our algorithms, applications, products, and services to benefit clinical researchers around the world. Approximately 29% of our employees hold doctoral degrees in diverse fields that range from cell biology to computer science. Our employees bring widely varied expertise and competencies to our company. Our multidisciplinary team includes bioinformaticians, medical and genetic experts, scientists, software engineers, web developers, graphic designers, commercial experts and lab specialists, as well as staff in our administrative and corporate teams.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pride ourselves on the excellence and integrity of our employees. We work towards the best quality and target the highest performance. Our corporate DNA, rooted in quality, precision and robustness, is the key to our success. We strive to foster an entrepreneurial, innovative and unique culture that ignites employees&#8217; passion and inspires them to challenge the status quo. We create work environments that preserve and value individuality and diversity of viewpoints and approaches such that our employees trust each other and collaborate to achieve our collective goals.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following strategies help ensure that we attract and retain high quality employees:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Attracting Talent</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our dedicated and experienced global talent acquisition team identifies and attracts the most qualified candidates. Our locations were strategically selected to attract highly educated talent from renowned universities and engineering schools, and we regularly attend events and use social media to increase awareness of our brand to prospective candidates. As part of our hiring process, we conduct scientific and technical assessments to ensure that candidates have the appropriate skills and expertise.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Retaining and Developing Talent</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As part of our effort to continuously motivate and engage our employees and provide professional development for our employees, we provide corporate talent reviews and follow-up individual development plans for our employees, and have created career ladders with grading systems for all departments with detailed job descriptions on what is required at each level. We also perform employee engagement surveys that inform our dedicated task forces as they continuously strive to increase employee satisfaction and morale.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.5pt">Training</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To help our employees integrate into our company, advance their knowledge and skills and remain at the forefront of innovation, we created Learning@SOPHiA, which consists of (i) an onboarding program with a new hire learning path, a manager&#8217;s guide to onboarding and a buddy system for new hires, (ii) ongoing learning paths with department specific training modules, technical and non-technical training, cross-functional information sessions, mentoring and soft skill training, and (iii) leadership and development programs for managers. In addition, for our salespersons, our sales success department provides commercial training, including consultative sales, negotiations skills and cold call training.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, we had 415 full-time equivalents (&#8220;FTE&#8221;) across 28 countries, of whom 308 were located in EMEA, 80 were located in North America, 14 were located in Latin America and 13 were located in Asia Pacific. Over the course of the year ended December 31, 2025, we employed, on average, 410 FTEs. Approximately 41% of our employees are engaged in research and development.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain countries in which we operate, we are subject to, and comply with, local labor law requirements, which may automatically make our employees subject to industry-wide collective bargaining agreements. As of December 31, 2025, we have bargaining agreements in place for France, Spain, Italy, Belgium, Brazil and Austria, with 106 employees subject to collective bargaining agreements. We believe that our relationship with our employees is good.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E. Share Ownership</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Item 7. Major Shareholders and Related Party Transactions&#8212;A. Major shareholders.&#8221;</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_79"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F. Disclosure of a Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_82"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Major Shareholders and Related Party Transactions</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. Major Shareholders</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information relating to the beneficial ownership of our ordinary shares as of February&#160;15, 2026 by:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">each person, or group of affiliated persons, known by us to own beneficially 5% or more of our outstanding ordinary shares;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">each of our executive officers and directors and persons nominated to serve in such positions; and</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">all executive officers and directors and persons nominated to serve in such positions as a group.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of ordinary shares beneficially owned by each entity, person, executive officer or director is determined in accordance with the rules of the SEC, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any ordinary shares over which the individual has sole or shared voting power or investment power as well as any ordinary shares that the individual has the right to acquire within 60 days from February&#160;15, 2026 through the exercise of any option or other right. Except as otherwise indicated, and subject to applicable community property laws, we believe that the persons named in the table have sole voting and investment power with respect to all ordinary shares held by that person based on information provided to us by such person.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of outstanding ordinary shares beneficially owned is computed on the basis of 71,668,702 ordinary shares outstanding as of February&#160;15, 2026. Ordinary shares that a person has the right to acquire within 60 days are deemed outstanding for purposes of computing the percentage ownership of the person holding such rights, but are not deemed outstanding for purposes of computing the percentage ownership of any other person, except with respect to the percentage ownership of all executive officers and directors as a group. Unless otherwise indicated below, the business address for each beneficial owner is SOPHiA GENETICS SA, La Pi&#232;ce 12, CH-1180 Rolle, Switzerland.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.204%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of Ordinary Shares</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Shareholders</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beneficially Owned</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beneficially Owned</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">5% or Greater Shareholders</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alychlo NV</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,993,800</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.76%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generation IM Sustainable Solutions Fund III, L.P.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,789,560</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.47%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">aMoon</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,510,564</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.69%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Akre Capital Management</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,719,140</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.19%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Executive Officers and Directors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jurgi Camblong</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,684,023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vincent Ossipow</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469,352</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zhenyu Xu</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424,627</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Troy Cox</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,235</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daan van Well</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,945</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Didier Hirsch</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,712</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Michel Coss&#233;ry</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,704</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ross Muken</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,218</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">George Cardoza</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,225</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Philippe Menu</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,127</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manuela da Silva Valente</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,455</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kathy Hibbs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,492</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tomer Berkovitz</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All executive officers and directors as a group (13 persons)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,880,115</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.81%</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:32.89pt">Less than 1% of our total outstanding ordinary shares.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.24pt">This information is based solely on a Schedule 13G filed by Alychlo NV and Marc Coucke with the SEC on February 14, 2022. Marc Coucke is the principal shareholder, chairman and managing director of Alychlo NV. The principal business address of each of the foregoing persons or entities is Lembergsesteenweg 19, 9820 Merelbeke, Belgium.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.24pt">This information is based solely on a Schedule 13G filed by Generation Investment Management LLP, Generation IM Sustainable Solutions GP III Limited, and Generation IM Sustainable Solutions Fund III, L.P. with the SEC on November 13, 2024. The principal business address of each of the foregoing entities is 20 Air Street, 7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> floor, London, United Kingdom W1B 5AN.</span></div><div style="text-indent:-18pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.24pt">Based on information available to us, aMoon Growth Fund Limited Partnership holds voting and dispositive power over 5,138,023 shares and aMoon Edge Limited Partnership holds voting and dispositive power over 192,541 shares. The principal business address of each of the foregoing entities is 34 Yerushalaim Rd, Beit Gamla, 6th Floor Ra&#8217;anana, 4350110, Israel.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.24pt">This information is based solely on a Schedule 13G filed by Akre Capital Management, LLC, Braddock Partners Offshore, LP and Braddock Capital Offshore, LLC with the SEC on June 27, 2025. The principal business address of Akre Capital Management, LLC and Braddock Capital Offshore, LLC is 100 Princess Street, Charlottesville, Virginia 22902. The principal business address of Braddock Partners Offshoe, LP is c/o Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.24pt">891,320 shares owned by Jurgi Camblong and 147,840 shares owned by Zhenyu Xu have been pledged pursuant to lending arrangements.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February&#160;15, 2026, we estimate that approximately 36.95% our outstanding ordinary shares were held by residents of the Unites States. This estimate is based on a review of information provided by our transfer agent, reports obtained from intermediaries, and other information available to us. Because beneficial owners may hold shares through brokers, nominees, or other custodians, the foregoing estimate may not be representative of the actual number of U.S. beneficial owners or shares beneficially owned by U.S. residents.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Related Party Transactions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain related party transactions we have entered into since January 1, 2025 with any of our executive officers and directors or their affiliates and holders of more than 10% of any class of our voting securities in the aggregate, which we refer to as related parties, other than compensation arrangements, which are described under &#8220;Item 6. Directors, Senior Management, and Employees&#8212;B. Compensation.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indemnification Agreements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into indemnification agreements with our executive officers and directors. The indemnification agreements and our articles of association require us to indemnify our executive officers and directors to the fullest extent permitted by law.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Related Person Transaction Policy</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a related person transaction policy. Our related person transaction policy states that any related person transaction must be approved or ratified by our audit committee or board of directors. In determining whether to approve or ratify a transaction with a related person, our audit committee or board of directors will consider all relevant facts and circumstances, including, without limitation, the commercial reasonableness of the terms of the transaction, the benefit and perceived benefit, or lack thereof, to us, the opportunity costs of an alternative transaction, the materiality and character of the related person&#8217;s direct or indirect interest and the actual or apparent conflict of interest of the related person. Our audit committee or board of directors will not approve or ratify a related person transaction unless it has determined that, upon consideration of all relevant information, such transaction is in, or not inconsistent with, our best interests and the best interests of our shareholders.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_91"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. Financial Information</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_94"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. Consolidated Statements and Other Financial Information</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Item 18. Financial Statements,&#8221; which contains our financial statements prepared in accordance with IFRS Accounting Standards.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may be subject to various legal proceedings and claims that arise in the ordinary course of our business activities. The results of litigation and claims cannot be predicted with certainty. As of the date of this Annual Report, we do not believe that we are party to any claim or litigation the outcome of which would, individually or in the aggregate, be reasonably expected to have a material adverse effect on our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends and Dividend Policy</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our share capital. We intend to retain all available funds and any future earnings, if any, to fund the development and expansion of our business, and we do not anticipate paying any cash dividends in the foreseeable future. Any future determination related to dividend policy will be made at the discretion of our board of directors and will depend upon, among other factors, our results of operations, financial condition, capital requirements, contractual restrictions and business prospects and other factors our board of directors may deem relevant.The Perceptive Credit Agreement also limits our ability to pay </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dividends.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Swiss law, any dividend must be approved by our shareholders. In addition, our auditors must confirm that the dividend proposal of our board of directors to the shareholders conforms to Swiss statutory law and our articles of association. A Swiss corporation may pay dividends only if it has sufficient distributable profits from the previous business year (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">b&#233;n&#233;fice de l&#8217;exercice</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or brought forward from previous business years (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">report des b&#233;n&#233;fices</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or if it has distributable reserves (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">r&#233;serves &#224; libre disposition</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">), each as evidenced by its audited stand-alone statutory balance sheet prepared pursuant to Swiss law and after allocations to reserves required </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by Swiss law and its articles of association have been deducted. Distributable reserves are generally booked either as free reserves (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">r&#233;serves libres</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) or as reserves from capital contributions (apports en capital). Distributions out of share capital, which is the aggregate par value of a corporation&#8217;s issued shares, may be made only by way of a share capital reduction. See &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles of Association.&#8221;</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Significant Changes</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in our business since the date of the annual financial statements, other than those described under &#8220;Item 4. Information on the Company&#8212;B. Business Overview.&#8221;</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_100"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. The Offer and Listing</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_103"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. Offer and Listing Details</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ordinary shares are listed on Nasdaq under the symbol &#8220;SOPH.&#8221;&#160;For a description of our ordinary shares, see &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles of Association.&#8221;</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_106"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C. Markets</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;&#8212;A. Offer and Listing Details.&#8221;</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_109"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. Additional Information</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_112"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Memorandum and Articles of Association</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Exhibit 2.1 to this Annual Report for a description of our ordinary shares and Exhibit 1.1 to this Annual Report for a description of our articles of association.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_115"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C. Material Contracts</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following descriptions of our material agreements are not complete and are qualified in their entirety by reference to the full text of such agreements, which are filed as exhibits to this Annual Report and incorporated herein by reference.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">License Agreements</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Normandie Valorisation&#8212;Exclusive License Agreements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March of 2018, we entered into an Exclusive License of Patents and Results (the &#8220;2018 Normandie Agreement&#8221;) with the University of Rouen Normandy, the Henri Becquerel Centre, INSERM Transfert SA (collectively, the &#8220;Co-Owners&#8221;) and Normandy University, acting through Normandie Valorisation, pursuant to which we obtained an exclusive, royalty-bearing, non-sublicensable license under certain patents related to methods for diagnosing hematological malignancies and an associated diagnostic kit to develop, manufacture and sell products for the diagnosis of acute myeloblastic leukemia, acute lymphoblastic leukemia and chronic myeloid leukemia in the countries covered by the licensed patents.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2019, we entered into an additional Exclusive License of Patents and Results (the &#8220;2019 Normandie Agreement&#8221;) with the same parties, pursuant to which we obtained an identical license under the same patents for products for the diagnosis of carcinomas other than acute myeloblastic leukemia, acute lymphoblastic leukemia and chronic myeloid leukemia.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under each agreement, we are obligated to act with a standard of care to develop, manufacture and sell the licensed products. Our failure to meet the standard of care requirement could subject us to a reduction of applicable territory or respective field of use by way of an amendment to the applicable agreement if (i)&#160;we have not marketed nor implemented necessary steps for the marketing of the applicable licensed products within a reasonable time following the end of the agreed-upon development plan for the commercialization of such products or (ii)&#160;our delay in executing the development plan exceeds a certain specified time. Pursuant to both agreements, Normandie Valorisation is responsible for the prosecution, maintenance and defense of the licensed patents.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the 2018 Normandie Agreement, we paid Normandie Valorisation a low five-digit Euro upfront fee and are obligated to pay to Normandie Valorisation a low-tens Euro fee per each analysis utilizing Myeloid Plus Solution (MYS+). Pursuant to the 2019 Normandie Agreement, we paid Normandie Valorisation a low five-digit Euro upfront fee and are obligated to pay Normandie Valorisation a mid-single-digit Euro fee per each analysis utilizing Solid Tumor Plus Solution (STS+).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The term of each agreement continues until the expiration of the last-to-expire licensed patent in September 2033, unless automatically terminated upon our cessation of business, bankruptcy or insolvency or upon the invalidation of the applicable licensed patents in France. In addition, Normandie Valorisation may terminate either agreement if we challenge the validity or enforceability of the licensed patents. Either party may terminate either agreement in the event of non-performance by the other party of one or more of its obligations under such agreement which is not cured within three months of receipt of written notice of such non-performance. Either party may also terminate the 2019 Normandie Agreement at any time, with one year&#8217;s prior written notice.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaboration Agreements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built an agnostic platform that enables others to get the most out of their data. As such, our model is valuable to all types of players within the health care ecosystem. For hardware and consumable players our platform and smart algorithms bring large benefits to their customer base as it allows for a more rapid set-up of their technology, better results in terms of clinical outcomes on the same hardware, bringing value to a larger number of samples and as such higher volumes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collaborate not only to provide valuable technologies to hospitals and laboratories around the world directly or through collaborators, but also to increase our channels and to offer a variety of application and product choices to our large customer base.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IDT&#8212;Manufacturing and Supply Agreement</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2015, we entered into a manufacturing and supply agreement with IDT for the manufacture and supply of various commercial and research products, in particular DNA enrichment kits. The agreement was amended and restated in October 2018 and amended in March 2019.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement, IDT committed to manufacture and supply to us or directly to our customers, as applicable, various products, in particular DNA enrichment kits. IDT shall manufacture the products covered by this agreement in accordance with product specifications provided by us, (such products, &#8220;commercial products&#8221;). IDT is required to certify that the delivered products were manufactured in accordance with said specifications. In addition, we can purchase products already manufactured by IDT pursuant to its own specifications, (such products, &#8220;research products&#8221;) and resell such products to our customers and collaborators.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase prices for both commercial and research products are set upon completion of the corresponding master specification document. We are obligated to provide IDT on a quarterly basis with written good faith non-binding purchasing forecasts of the aggregate quantities of commercial products to be purchased by us in the following twelve months and IDT is obligated to ensure sufficient inventory and manufacturing capacity to deliver the forecasted quantities. We are not required to purchase the commercial products from IDT in the previously forecasted quantities. However, if we fail to purchase a specified percentage of the forecasted quantities of commercial products, IDT will have the right to increase the prices of such products by amounts in excess of the additional manufacturing costs associated with our reduced purchase. At the same time, we have the right to place purchase orders for products beyond the previously forecasted quantities and IDT is obligated to use its commercially reasonable efforts to fill such orders at regular prices. We are not required to provide IDT with forecasts for research products that we intend to purchase in any given period. The purchase prices for such products are not adjustable based on the quantities actually ordered by us.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All inventions made directly as a result of the manufacture of commercial and research products that are improvements to such products will be owned by us. IDT will obtain a fully-paid up, royalty-free, worldwide license under such improvements to make, have made, use and sell the commercial and research products exclusively for and to us.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement had an initial term of five years. It automatically renews for additional one-year periods unless a party notifies the other of its decision not to renew the agreement. We also have the right to terminate the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreement if we do not agree with changes made by IDT in accordance with the provisions of the agreement, including in connection with changes to master specification documents for any research or commercial product. In addition, each party has the right to terminate the agreement effective immediately if the other party fails to meet essential terms of the agreement and such failure is not cured.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Qiagen&#8212;OEM Supply Agreement</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2018, we entered into an OEM supply agreement with Qiagen for the supply of certain amplification technologies required to complement our NGS technologies. The agreement was amended in June 2019.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement, we receive the exclusive right to offer and resell the products manufactured by Qiagen as part of &#8220;bundle&#8221; solutions. We cannot offer such products as stand-alone or single items, unless it is required for product replacement or quality control reasons or in other special circumstances discussed by the parties in good faith. Qiagen is obligated to use its commercially reasonable efforts to manufacture and deliver products in quantities ordered by us. We are required to provide Qiagen in writing with a monthly rolling forecast covering the next six months. In addition, both parties shall meet at least once every quarter to discuss any adjustments to the forecast. Furthermore, we are obligated to purchase minimum quantities of products every year. If we fail to do so in any given calendar year, we will be obligated to make a one-time payment at the end of the year in an amount equal to the difference between the value of the products forecasted to be purchased in that year and the products actually purchased.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement had an initial term of three years. It automatically extended for one two-year period followed by an additional one-year period, thereafter it automatically extends for one-year periods unless a party notifies the other of its decision not to renew the agreement. The parties may terminate the agreement effective immediately for cause or upon notice in certain situations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New England Biolabs (&#8220;NEB&#8221;)&#8212;Supply Agreement</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, we entered into a supply agreement with NEB for the supply of various reagents. These products may only be used in the research field and in compliance with applicable intended use statements, limited use statements or limited label licenses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to provide NEB with twelve-months' rolling written forecasts of our estimated product supply requirements. The forecasts for the certain months of each twelve-month rolling period are binding, and the forecasts for the remaining months are non-binding and serve only as a good faith estimate to facilitate NEB&#8217;s production scheduling.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NEB shall not unreasonably reject any purchase order and shall use commercially reasonable efforts to fill purchase orders for any quantity of product that, alone or cumulatively with other purchase orders submitted to it for product delivery during the relevant calendar quarter, exceeds the amount specified in the binding portion of the then-current rolling forecast.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to each shipment of products, NEB shall perform quality control procedures reasonably necessary to ensure that the products to be shipped conform fully to the specifications as agreed upon by us with NEB from time to time.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement had an initial term of three years. It has been automatically extended for two additional two-year periods and thereafter it will automatically extend for successive two-year periods, unless either party notifies the other party in writing at least six months prior to the expiration of the then-current term that such party does not wish to continue the agreement.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Watchmaker Genomics, Inc. (&#8220;Watchmaker&#8221;) &#8212; OEM Supply Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, we entered into an OEM supply agreement with Watchmaker for the supply of certain components embedded into our library preparation kits. Under the agreement, we receive the non-exclusive right to offer and resell the products manufactured by Watchmaker as part of &#8220;bundle&#8221; solutions worldwide. We cannot offer such products as stand-alone items or as components of products other than our library preparation kits. Watchmaker is obligated to use its commercially reasonable efforts to manufacture and deliver products in quantities ordered by us. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to provide Watchmaker in writing with a rolling four-quarter forecast on a quarterly basis, which serve as a good faith estimate to facilitate Watchmaker&#8217;s production scheduling and solely impact delivery dates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreement has an initial term of five years. It will renew automatically for one-year periods unless a party notifies the other of its decision not to renew. The parties may terminate the agreement for cause on 30-day prior notice. We may terminate the agreement on 60-day prior notice in the event the company might be prevented from manufacturing or selling &#8220;bundle&#8221; solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Microsoft&#8212;Strategic Framework Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a multi-year integrated strategic partnership agreement with Microsoft to improve healthcare workflows globally by enabling multimodal data curation, development, and deployment. Pursuant to the amendments to our original agreement, effective as of November 1, 2022 and October 10, 2025, respectively, we committed to buy products and services from the Microsoft Azure suite of offerings for an aggregate amount of approximately $80.9&#160;million over a seven-year period ending October 31, 2029 (with an additional one year grace period) in exchange for (i) discounted pricing, (ii) a twelve-month Azure credit for a value of approximately $1.8 million and (iii) the provision by Microsoft of additional consulting and product support services at no cost for SOPHiA GENETICS as part of Microsoft&#8217;s &#8220;End-Customer Investment Funding&#8221; program, for a value of approximately $1.3 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Microsoft may terminate the agreement for cause on 30-day prior notice. None of the parties may terminate the agreement for convenience prior to the coverage period.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Perceptive - Credit Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2024 (the &#8220;Closing Date&#8221;), SOPHiA GENETICS SA and our subsidiary SOPHiA GENETICS, Inc. entered into a credit agreement (the &#8220;Perceptive Credit Agreement&#8221;) and related guaranty with Perceptive Credit Holdings IV, LP, as lender and administrative agent, pursuant to which we may borrow up to $50.0 million principal amount of term loans, including (i) an initial tranche of $15.0 million principal amount of term loans on the closing date and (ii) a second tranche of $35.0 million principal amount of term loans that was drawn down on June 25, 2025. The term loans are scheduled to mature on the fifth anniversary of the Closing Date and accrue interest at Term SOFR (Secured Overnight Financing Rate) (floored at 4% per annum) plus 6.25% per annum; provided that upon the occurrence and during the continuation of any event of default, the term loans will accrue interest at Term SOFR plus 9.25% per annum. We have the right to prepay the term loans at any time subject to applicable prepayment premiums. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Perceptive Credit Agreement also contains certain mandatory prepayment provisions, including prepayments from the proceeds from certain asset sales and casualty events (subject to a right to reinvest such proceeds in assets used in our business within 180 days) and from issuances or incurrences of non-permitted debt, which will also be subject to prepayment premiums. The obligations under the Perceptive Credit Agreement are secured by substantially all of SOPHiA GENETICS SA&#8217;s and certain of its subsidiaries&#8217; assets and are guaranteed initially on the closing date by SOPHiA GENETICS SA and SOPHiA GENETICS, Inc. The Perceptive Credit Agreement contains customary covenants, including an affirmative covenant to maintain qualified cash of at least $3.0 million, an affirmative last twelve months revenue covenant tested on a quarterly basis, and negative covenants including limitations on indebtedness, liens, fundamental changes, asset sales, investments, dividends and other restricted payments and other matters customarily restricted in such agreements. The Perceptive Credit Agreement also contains customary events of default, including payment defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults to certain other agreements, judgments against us and our subsidiaries and change in control, the occurrence of which gives the lenders the right to declare the term loans and all obligations under the Perceptive Credit Agreement immediately due and payable.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we issued to Perceptive Credit Holdings IV, LP a warrant certificate (the &#8220;Warrant Certificate&#8221;) representing the right to purchase up to 400,000 ordinary shares at $4.9992 per share, with the right to purchase 200,000 ordinary shares available immediately and the right to purchase an additional 200,000 ordinary shares to be available upon the drawdown of the second tranche of the term loans. The purchase rights represented by the Warrant Certificate are exercisable after becoming available, on a cash basis, at the option of the holder at any time prior to 5:00 p.m., Eastern time on the tenth anniversary of the applicable date of availability. The Warrant Certificate contains customary anti-dilution adjustments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 23, 2026, SOPHiA GENETICS SA and our subsidiary SOPHiA GENETICS, Inc. entered into an amendment (the &#8220;2026 Amendment&#8221;) to the Perceptive Credit Agreement. The 2026 Amendment provides for, among other things, $25.0 million of additional term loan commitments consisting of (i) an additional $12.5 million tranche of term loan commitments, which may be drawn subject to certain customary conditions, and (ii) an additional $12.5 million tranche of term loan commitments, which may be drawn at such time as SOPHiA GENETICS SA&#8217;s revenue for a trailing twelve-month period exceed $85.0 million and otherwise subject to customary conditions. The two additional tranches, if drawn, will have terms and conditions consistent with the existing term loans, will bear interest at rate per annum equal to Term SOFR (floored at 4% per annum) + 6.25% and will mature in 2029. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2026 Amendment, the Company amended and restated the Warrant Certificate in order to issue to Perceptive Credit Holdings IV, LP the right to purchase an additional 75,000 ordinary shares, which right is exercisable immediately. The amended and restated Warrant Certificate also grants Perceptive Credit Holdings IV, LP the right to purchase an additional (1) 100,000 ordinary shares, which right will become exercisable upon drawdown of the third tranche and (2) another 100,000 ordinary shares, which right will become exercisable upon drawdown of the fourth tranche. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Agreements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Swisscanto Anlagestiftung - Lease Agreement</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a lease agreement with Swisscanto Anlagestiftung, Z&#252;rich for our offices in Rolle, effective as of July 1st, 2021, for a ten-year term ending on June 30th, 2031. The lease in total is for approximately 65,860 square feet, and comprises our headquarters of office space and laboratory facilities. We may terminate the lease agreement after eight years, subject to a 12-month prior notice and liquidated damages. Conversely, we have a right to request the extension of the term under similar terms no later than fourteen months prior to the initial term. The base rent amounts to approximately $1.1&#160;million per year from 2024 onward and is indexed on Swiss Consumer Price Index as published by Swiss Federal Statistical Office. Payment obligations under the lease agreement are secured by bank guarantees. We are prohibited from subleasing all or part of the leased surface or to transfer the lease to a third-party without the lessor&#8217;s prior consent. The parties may terminate the agreement for cause on 30-day prior notice. Upon expiry of the lease, we may leave the facilities &#8220;as is&#8221;, except for the laboratory which must be dismantled, unless otherwise agreed with the lessor. </span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_118"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D. Exchange Controls</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no Swiss governmental laws, decrees or regulations that restrict, in a manner material to us, the export or import of capital, including any foreign exchange controls, or that generally affect the remittance of dividends or other payments to non-residents or non-citizens of Switzerland who hold our ordinary shares.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_121"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E. Taxation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion is based on the tax laws, regulations, and regulatory practices of Switzerland and the United States as in effect on the date hereof, which are subject to change (or subject to changes in interpretation), possibly with retroactive effect.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current and prospective shareholders are advised to consult their own tax advisors in light of their particular circumstances as to the Swiss or U.S. tax laws, regulations and regulatory practices that could be relevant for them, the acquiring, owning and selling or otherwise disposing of our ordinary shares and receiving dividends and similar cash or in-kind distributions on our ordinary shares (including dividends on liquidation proceeds and share dividends) or distributions on our ordinary shares based upon a capital reduction or reserves paid out of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">capital contributions and the consequences thereof under the tax laws, regulations, and regulatory practices of Switzerland or the United States.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Swiss Tax Considerations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Swiss Federal Withholding Tax</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends and other cash or in-kind distributions (including scrip or stock dividends), if any, on ordinary shares made or paid by us out of reserves from capital contributions (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">r&#233;serves d&#8217;apports de capital</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and distributions, if any, on ordinary shares made or paid by us based upon a reduction of nominal value of ordinary shares (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">r&#233;duction de la valeur nominale</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and the purchase price for ordinary shares bought back, if any, by us for a capital reduction booked against reserves from capital contributions and nominal value of ordinary shares, are exempt from Swiss federal withholding tax. The proceeds from the offering of the ordinary shares (net of certain deductions) will qualify as reserves from capital contributions and as nominal value of the ordinary shares.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends and other cash or in-kind distributions (including scrip or stock dividends), if any, on ordinary shares made or paid by us out of profit or reserves other than reserves from capital contributions and the purchase price for ordinary shares bought back, if any, by us for a capital reduction booked against reserves other than reserves from capital contributions, are subject to Swiss federal withholding tax at a rate of 35%. Any Swiss federal withholding tax must be withheld by us on the gross amount of the dividend or distribution or purchase price, as applicable, and be remitted to the Swiss Federal Tax Administration.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital gains realized on the sale of ordinary shares in the secondary market are not subject to Swiss federal withholding tax.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Refund of Withholding Tax on Taxable Distributions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Swiss Federal Tax Administration or the relevant cantonal tax authority, as applicable, will refund or credit Swiss federal withholding tax on dividends or other cash or in-kind distributions (including scrip or stock dividends), if any, on ordinary shares made or paid by us, or the purchase price paid by us for ordinary shares bought back, if any, for a capital reduction, out of or against profit or reserves other than tax-exempt reserves from capital contributions in full to holders who are individuals resident in Switzerland and to holders, who hold the ordinary shares on which the dividends or other distributions have been paid, as part of a trade or business in Switzerland, and, who, in each case,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter alia</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, are the beneficial owners of the ordinary shares and duly report the dividend or distributions or the purchase price paid by us for ordinary shares bought back for a capital reduction in the income tax return or the financial statements, respectively, for the relevant tax period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A holder who is a resident of the U.S. for purposes of the double taxation agreement between the U.S. and Switzerland (the &#8220;Treaty&#8221;) without taxable presence in Switzerland to which the ordinary shares are attributable or who is a qualified U.S. pension fund and who, in each case, is the beneficial owner of the ordinary shares and the dividend or distribution and who meets the conditions of the Treaty may apply for a full refund of the Swiss federal withholding tax in the case of qualified U.S. pension funds or in excess of the amount of the 15% treaty rate in all other cases. The claim for refund must be filed on Swiss Tax Form 82 (82C for corporations, 82I for individuals, 82E for other entities and 82R for regulated investment companies), which forms together with an instruction form may be obtained from any Swiss consulate general in the U.S., the Swiss Federal Tax Administration at the address below or be downloaded from the Swiss Federal Tax Administration&#8217;s website. Four copies of the form must be duly completed and signed before a notary public of the U.S., and three of them must be sent to the Swiss Federal Tax Administration (currently at Eigerstrasse 65, CH-3003, Bern, Switzerland). The form must be accompanied by suitable evidence of deduction of the Swiss federal withholding tax, such as certificates of deduction, bank vouchers or credit slips. The form must be filed no later than December&#160;31 of the third year following the calendar year in which the dividend subject to the tax became payable.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any other holder who is not resident in Switzerland and who does not hold the ordinary shares as part of a trade or business in Switzerland, may be entitled to a full or partial refund of the Swiss federal withholding tax deducted if the country in which the recipient resides for tax purposes has entered into a bilateral treaty for the avoidance of double taxation with Switzerland, the recipient is the beneficial owner of the ordinary shares and the dividend or distribution or the purchase price and the other conditions of the treaty are met. Refund forms are available on the Swiss Federal Tax Administration&#8217;s website.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Swiss Federal Issue Stamp Tax</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be liable to Swiss federal issue stamp tax on the issuance (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">droit d&#8217;&#233;mission sur capital propre)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;of the ordinary shares of 1% of the proceeds from the offering, net of certain deductions.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Swiss Federal Securities Turnover Tax</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The delivery of ordinary shares to the initial purchasers of the ordinary shares against payment of the offer price will not be subject to Swiss securities turnover tax (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">droit de n&#233;gociation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any subsequent transactions in ordinary shares in the secondary markets are subject to Swiss federal securities turnover tax at a rate of 0.15% of the purchase price of the ordinary shares if a Swiss or Liechtenstein domestic bank or securities dealer (as defined in the Swiss Federal Stamp Tax Act) is a party or an intermediary to the transaction, and none of the exemptions provided for in the Swiss Federal Stamp Tax Act applies. Generally, half of the tax is charged to the one party to the transaction and the other half to the other party, subject to applicable statutory exemptions in respect of the one or the other party to the transaction and their respective halves of the tax. Secondary market dealings in ordinary shares where no domestic bank or securities dealer is a party or an intermediary to the transaction are not subject to Swiss federal securities turnover tax.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Swiss Federal, Cantonal, and Communal Income Taxes</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ordinary Shares Held By Holders Resident Outside of Switzerland and With No Trade or Business in Switzerland</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of ordinary shares who are not residents of Switzerland for tax purposes, and who during the taxable year have not held ordinary shares through a permanent establishment within Switzerland for tax purposes, are not subject to any Swiss federal, cantonal or communal income tax in respect of the receipt of dividends, or other distributions, if any, on ordinary shares, or gain realized on the sale or other disposition of ordinary shares.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the Swiss federal withholding tax treatment of dividends and distributions or capital gains on ordinary shares, see above &#8220;&#8212;Swiss Federal Withholding Tax.&#8221; For a discussion of the automatic exchange of information in tax matters, see below &#8220;&#8212;International Automatic Exchange of Information in Tax Matters&#8221; and for a discussion of the Swiss facilitation of the implementation of the Foreign Account Tax Compliance Act (FATCA), see below &#8220;&#8212;Swiss Facilitation of the Implementation of FATCA.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ordinary Shares Held By Swiss Resident Individuals as Private Investments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends and other cash or in-kind distributions (including scrip or stock dividends), if any, on ordinary shares, to the extent made or paid by us out of reserves from capital contributions and distributions, if any, to the extent made or paid by us on ordinary shares based upon a capital reduction, and the purchase price of ordinary shares bought back for a capital reduction charged to reserves from capital contributions are exempt from Swiss federal, cantonal, and communal income tax for holders of ordinary shares who are individuals resident in Switzerland for tax purposes and who hold the ordinary shares as private investments.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conversely, any dividends and other cash or in-kind distributions (including scrip or stock dividends), if any, on ordinary shares to the extent made or paid by us out of profit and reserves other than reserves from capital contributions, and the purchase price for ordinary shares bought back, if any, by us for a capital reduction to the extent booked against reserves other than reserves from capital contributions, will be subject to Swiss federal, cantonal, and communal taxable income for such holders.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A capital gain realized by a holder on the sale of ordinary shares (other than a sale to us in a share buy-back for capital reduction) held as private investments classifies as tax-exempt private capital gain and, vice versa, a capital loss as non-tax deductible private capital loss for purposes of Swiss federal, cantonal, and communal income tax.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See below &#8220;&#8212;Ordinary shares held as assets of a Swiss business&#8221; for a summary of the taxation treatment of Swiss resident individuals who, for income tax purposes, are classified as &#8220;professional securities dealers.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ordinary Shares Held as Assets of a Swiss Business</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a corporation or an individual who holds the ordinary shares as part of a trade or business carried on in Switzerland, any dividends and any other distributions, if any, made or paid by us on ordinary shares, and any capital gain or loss realized on the sale of ordinary shares, are includable in, or deductible from, respectively, the taxable income in the relevant taxation period for purposes of Swiss federal, cantonal, and communal individual or corporate income tax. This taxation treatment also applies to Swiss resident private individuals who, for income tax purposes, are classified as &#8220;professional securities dealers.&#8221;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate taxpayers will be eligible for dividend relief (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">r&#233;duction pour participations</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) in respect of dividends and distributions, if any, on ordinary shares if either the market value of the ordinary shares held by them equals or exceeds CHF 1.0&#160;million or the ordinary shares represent 10% or more of our share capital.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Automatic Exchange of Information in Tax Matters</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Switzerland has concluded a multilateral agreement with the EU on the international automatic exchange of information (&#8220;AEOI&#8221;) in tax matters, which applies to all EU member states. In addition, Switzerland signed the multilateral competent authority agreement on the automatic exchange of financial account information (the &#8220;MCAA&#8221;) and a number of bilateral AEOI agreements with other countries, most of them on the basis of the MCAA. Based on these agreements and the implementing laws of Switzerland, Switzerland collects and exchanges data in respect of financial assets held in, and income derived thereon and credited to, accounts or deposits (including ordinary shares held in such accounts or deposits) with a paying agent in Switzerland for the benefit of individuals resident in an EU member state or in another treaty state. An up-to-date list of the AEOI agreements to which Switzerland is a party that are in effect, or signed but not yet in effect, can be found on the website of the State Secretariat for International Financial Matters.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Swiss Facilitation of the Implementation of FATCA</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The United States and Switzerland entered into an intergovernmental agreement (the &#8220;U.S.-Switzerland IGA&#8221;) to facilitate the implementation of FATCA. Under the U.S.-Switzerland IGA, financial institutions acting out of Switzerland generally are directed to become participating foreign financial institutions. The U.S.-Switzerland IGA ensures that accounts held by U.S. persons with Swiss financial institutions (including accounts in which ordinary shares are held) are disclosed to the U.S. tax authorities either with the consent of the account holder or by means of group requests within the scope of administrative assistance, on the basis of the Treaty. The Treaty, as amended in 2019, includes a mechanism for the exchange of information in tax matters upon request between Switzerland and the United States, which is in line with international standards, and allows the United States to make group requests under FATCA concerning non-consenting U.S. accounts and non-participating foreign financial institutions for periods from June&#160;30, 2014. Furthermore, the Swiss Federal Council approved a mandate for negotiations with the United States on October&#160;8, 2014, with regard to a change from the current direct-notification-based regime to a regime where the relevant information is sent to the Swiss Federal Tax Administration, which in turn provides the information to the U.S. tax authorities. On June 27, 2024, Switzerland and the United States negotiated and signed the mandate adopted on October 8, 2014 (Model 1 of the FATCA agreement), which provides for the reciprocal automatic exchange of information between Switzerland and the U.S. The implementation of this new mandate is to be enforced starting January 1, 2027.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material U.S. Federal Income Tax Consequences for U.S. Holders</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the material U.S. federal income tax consequences to U.S. Holders, as defined below, of owning and disposing of our ordinary shares. It does not describe all tax consequences that may be relevant to a particular person&#8217;s decision to acquire ordinary shares.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion applies only to a U.S. Holder that holds ordinary shares as capital assets for U.S. federal income tax purposes within the meaning of Section 1221 of the Code (generally, property held for investment). In addition, it does not describe any tax consequences other than U.S. federal income tax consequences, including state and local tax consequences and estate or gift tax consequences, and does not describe all of the U.S. federal income tax consequences that may be relevant in light of the U.S. Holder&#8217;s particular circumstances, including alternative minimum tax consequences, the special tax accounting rules under Section 451(b) of the Code, the potential application of the Medicare contribution tax on net investment income, and tax consequences applicable to U.S. Holders subject to special rules, such as:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">certain banks, insurance companies, and other financial institutions;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">brokers, dealers, or traders in securities who use a mark-to-market method of tax accounting;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">persons holding ordinary shares as part of a straddle, wash sale, conversion transaction or other integrated transaction, or persons entering into a constructive sale with respect to the ordinary shares;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">persons whose functional currency for U.S. federal income tax purposes is not the U.S. dollar;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">entities or arrangements classified as partnerships or S corporations for U.S. federal income tax purposes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and investors in such entities;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">tax-exempt entities, including an &#8220;individual retirement account&#8221; or &#8220;Roth IRA&#8221; or governmental entities;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">real estate investment trusts or regulated investment companies;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">former U.S. citizens or long-term residents of the United States;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">persons that own or are deemed to own 10% or more of the voting power or value of our shares; or</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">persons holding ordinary shares in connection with a trade or business conducted outside of the United States or in connection with a permanent establishment or other fixed place of business outside of the United States.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity or arrangement that is classified as a partnership for U.S. federal income tax purposes holds ordinary shares, the U.S. federal income tax treatment of a partner will generally depend on the status of the partner and the activities of the partnership. Partnerships holding ordinary shares and partners in such partnerships should consult their tax advisors as to the particular U.S. federal income tax consequences of owning and disposing of the ordinary shares in their particular circumstances.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion is based on the Code, administrative pronouncements, judicial decisions, final, temporary and proposed Treasury regulations, and the Treaty, all as of the date hereof, any of which is subject to change or differing interpretations, possibly with retroactive effect. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A &#8220;U.S. Holder&#8221; is a holder who, for U.S. federal income tax purposes, is a beneficial owner of ordinary shares, who is eligible for the benefits of the Treaty and who is:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">an individual who is a citizen or resident of the United States;</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">a corporation, or other entity taxable as a corporation, created or organized in or under the laws of the United States, any state therein or the District of Columbia; or</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">an estate or trust, the income of which is subject to U.S. federal income taxation regardless of its source.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Holders should consult their tax advisors concerning the U.S. federal, state, local, and non-U.S. tax consequences of owning and disposing of ordinary shares in their particular circumstances.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury regulations that apply to taxable years beginning on or after December 28, 2021 (the &#8220;Foreign Tax Credit Regulations&#8221;), may in some circumstances prohibit a U.S. person from claiming a foreign tax credit with respect to certain non-U.S. taxes that are not creditable under applicable income tax treaties. Accordingly, U.S. investors that are not eligible for Treaty benefits should consult their tax advisors regarding the creditability or deductibility of any Swiss taxes imposed on dividends on, or dispositions of, the ordinary shares. The discussions below regarding the creditability or deductibility of Swiss taxes, if any, do not apply to investors in this special situation. However, the Internal Revenue Service released a notice that provides relief from certain</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the provisions of the Treasury regulations described above for taxable years ending before the date that a</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">notice or other guidance withdrawing or modifying the temporary relief is issued (or any later date specified in</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such notice or other guidance).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Passive Foreign Investment Company Rules</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Code, we will be a PFIC for any taxable year in which, after the application of certain &#8220;look-through&#8221; rules with respect to subsidiaries, either (i) 75% or more of our gross income consists of &#8220;passive income,&#8221; or (ii) 50% or more of the average quarterly value of our assets consists of assets that produce, or are held for the production of, &#8220;passive income.&#8221; For purposes of the above calculations, we will be treated as if we hold our proportionate share of the assets of, and receive directly our proportionate share of the income of, any other corporation in which we directly or indirectly own at least 25%, by value, of the shares of such corporation. Passive income generally includes dividends, interest, rents, certain non-active royalties and capital gains.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash is generally characterized as a passive asset for these purposes. Goodwill, is generally characterized as a non-passive or passive asset based on the nature of the income produced in the activity to which the goodwill is attributable. The extent to which our goodwill should be characterized as a non-passive asset is not entirely clear. We hold a substantial amount of cash, and while this continues to be the case our PFIC status for any taxable year will depend largely on the value of our goodwill and the characterization of our goodwill as passive or non-passive. The value of our goodwill for any taxable year may be determined in large part by reference to the average of our market capitalization for that year. Although we believe that we were a PFIC for our 2022 taxable year, based the nature of our operations and assets, as well as certain as to our income and the relative values of our assets during our 2023, 2024 and 2025 taxable years, we believe that we were not a PFIC for our 2023, 2024 and 2025 taxable years (subject to the discussion in the next paragraph with respect to U.S. Holders who held our ordinary shares during our 2022 taxable year). There can be no assurance that the IRS will agree with our conclusion. In addition, we have not obtained any valuation of our assets (including goodwill). U.S. Holders should consult their tax advisors regarding the value and characterization of our assets for purposes of the PFIC rules, which are subject to some uncertainties. In addition, our PFIC status is a factual annual determination that can be made only after the end of the relevant taxable year and will depend on the composition of our income and assets and the value of our assets from time to time. Accordingly, our PFIC status for 2026 and any future taxable year is uncertain.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are a PFIC for any year during which a U.S. Holder holds ordinary shares, we would generally continue to be treated as a PFIC with respect to such holder for all succeeding years during which such holder holds ordinary shares, even if we ceased to meet the threshold requirements for PFIC status. Accordingly, since we believe that we were a PFIC for our 2022 taxable year, we believe that we will remain a PFIC with respect to a U.S. Holder that held our ordinary shares during our 2022 taxable year. U.S. Holders should consult their tax advisors regarding the advisability of making a &#8220;deemed sale&#8221; election that will allow them to eliminate the continuing PFIC status under certain circumstances, but may require them to recognize gain taxed under the general PFIC rules described in this section. Additionally, in the event that the U.S. Holder made a qualified electing fund (&#8220;QEF&#8221;) or mark to market election (as described below) for the year that we were a PFIC, special rules may apply that mitigate the rules described in this paragraph.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we were a PFIC for any taxable year and any of our subsidiaries or other companies in which we owned or were treated as owning equity interests were also a PFIC (any such entity, a &#8220;Lower-tier PFIC&#8221;), a U.S. Holder would be deemed to own a proportionate amount (by value) of the shares of each Lower-tier PFIC and would be subject to U.S. federal income tax according to the rules described in the subsequent paragraph on (i) certain distributions by a Lower-tier PFIC and (ii) dispositions of shares of Lower-tier PFICs, in each case as if such holder held such shares directly, even though such holder will not have received the proceeds of those distributions or dispositions.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are a PFIC for any taxable year during which a U.S. Holder holds any of our ordinary shares, such holder will generally be subject to adverse tax consequences. Unless a U.S. Holder makes a timely &#8220;mark to market&#8221; election or QEF election, each as discussed below, gain recognized upon a disposition (including, under certain circumstances, a pledge) of ordinary shares will be allocated ratably over a U.S. Holder&#8217;s holding period for the ordinary shares. The amounts allocated to the taxable year of disposition and to years before we became a PFIC will be taxed as ordinary income. The amount allocated to each other taxable year will be subject to tax at the highest rate in effect for that taxable year for individuals or corporations, as appropriate, and an interest charge will be imposed on the tax on such amount. Further, to the extent that any distributions received on a U.S. Holder&#8217;s ordinary shares during a taxable year exceed 125% of the average of the annual distributions on </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">those shares during the preceding three years or such holder&#8217;s holding period, whichever is shorter, those distributions will be subject to taxation in the same manner as gain, described immediately above.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alternatively, if we are a PFIC and if the ordinary shares are &#8220;regularly traded&#8221; on a &#8220;qualified exchange,&#8221; a U.S. Holder will be eligible to make a mark-to-market election that will result in tax treatment different from the general tax treatment for PFICs described above. The ordinary shares will be treated as &#8220;regularly traded&#8221; if more than a de minimis amount of the ordinary shares are traded on a qualified exchange on at least 15 days during each calendar quarter (the &#8220;15-Day Test&#8221;). The Nasdaq, on which the ordinary shares are listed, is a qualified exchange for this purpose. Once made, the election cannot be revoked without the consent of the IRS unless the shares cease to be marketable.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a U.S. Holder makes the mark-to-market election, such holder will generally recognize as ordinary income any excess of the fair market value of such holder&#8217;s ordinary shares at the end of each taxable year over their adjusted tax basis, and will recognize an ordinary loss in respect of any excess of the adjusted tax basis of the ordinary shares over their fair market value at the end of the taxable year (but only to the extent of the net amount of income previously included as a result of the mark-to-market election). If a U.S. Holder makes the election, such holder&#8217;s tax basis in their ordinary shares will be adjusted to reflect these income or loss amounts. Any gain recognized on the sale or other disposition of ordinary shares in a year when we are a PFIC will be treated as ordinary income and any loss will be treated as an ordinary loss (but only to the extent of the net amount of income previously included as a result of the mark-to-market election). This election will not apply to any of our non-U.S. subsidiaries. Accordingly, a U.S. Holder may continue to be subject to tax under the PFIC excess distribution regime with respect to any Lower-tier PFICs notwithstanding a mark-to-market election for the ordinary shares.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we are a PFIC for any taxable year in which we pay a dividend or for the prior taxable year, the preferential dividend rates discussed below with respect to dividends paid to certain non-corporate U.S. Holders will not apply.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a company that is a PFIC provides certain information to U.S. Holders, a U.S. Holder can then avoid certain adverse tax consequences described above by making a QEF election to be taxed currently on its proportionate share of the PFIC&#8217;s ordinary income and net capital gains.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The QEF election is made on a shareholder-by-shareholder basis and, once made, can be revoked only with the consent of the IRS. A U.S. Holder generally makes a QEF election by attaching a completed IRS Form 8621, including the information provided in a PFIC Annual Information Statement, to a timely filed U.S. federal income tax return for the taxable year to which the election relates. U.S. Holders should consult their tax advisors regarding the availability and tax consequences of a retroactive QEF election under their particular circumstances. In order to comply with the requirements of a QEF election, a U.S. Holder must receive a PFIC Annual Information Statement from us. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a U.S. Holder owns ordinary shares during any year in which we are a PFIC, such holder must generally file annual reports containing such information as the U.S. Treasury may require on IRS Form 8621 (or any successor form) with respect to us, generally with such holder&#8217;s federal income tax return for that year.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rules dealing with PFICs and with the mark-to-market and QEF elections are complex and are affected by various factors in addition to those described above. Accordingly, U.S. Holders should consult their tax advisors concerning the application of the PFIC rules to our ordinary share under their particular circumstances. As discussed above, special rules may apply if a U.S. Holder made a QEF election with respect to our 2022 taxable year. U.S. Holders who made a QEF election for our 2022 taxable year should consult their tax advisors.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Information Returns </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a U.S. Holder owns ordinary shares during any year in which we are a PFIC or in which we hold a direct or indirect equity interest in a Lower-tier PFIC, the U.S. Holder generally must file an annual report on IRS Form 8621 with respect to each such PFIC containing such information as the U.S. Treasury may require, generally with the U.S. Holder&#8217;s U.S. federal income tax return for the relevant year. A U.S. Holder&#8217;s failure to file the annual report will cause the statute of limitations for such U.S. Holder&#8217;s U.S. federal income tax return to remain open with respect to the items required to be included in such report until three years after the U.S. Holder files the annual report and, unless such failure is due to reasonable cause and not willful neglect, the statute of limitations for the U.S. Holder&#8217;s entire U.S. federal income tax return will remain open during such period.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROSPECTIVE U.S. HOLDERS SHOULD CONSULT THEIR TAX ADVISORS REGARDING THE CONSEQUENCES OF OUR POTENTIAL PFIC STATUS ON AN INVESTMENT IN ORDINARY SHARES.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxation of Distributions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is subject to the discussion regarding the PFIC rules described above.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above under &#8220;Item 8. Financial Information&#8212; A. Consolidated Statements and Other Financial Information&#8212;Dividends and Dividend Policy,&#8221; we do not currently expect to make distributions on our ordinary shares. In the event that we do make distributions of cash or other property, distributions paid on ordinary shares, other than certain pro rata distributions of ordinary shares, will generally be treated as dividends to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles). Because we do not maintain calculations of our earnings and profits under U.S. federal income tax principles, we expect that distributions generally will be reported to U.S. Holders as dividends. For so long as our ordinary shares are listed on the Nasdaq or we are eligible for benefits under the Treaty, dividends paid to certain non-corporate U.S. Holders will be eligible for taxation as &#8220;qualified dividend income&#8221; and therefore, subject to applicable holding period requirements, will be taxable at rates not in excess of the long-term capital gain rate applicable to such U.S. Holder.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of a dividend will include any amounts withheld by us in respect of Swiss income taxes. The amount of the dividend will be treated as foreign-source dividend income to U.S. Holders and will not be eligible for the dividends-received deduction generally available to U.S. corporations under the Code. Dividends will be included in a U.S. Holder&#8217;s income on the date of the U.S. Holder&#8217;s receipt of the dividend. The amount of any dividend income paid in Swiss francs will be the U.S. dollar amount calculated by reference to the exchange rate in effect on the date of actual or constructive receipt, regardless of whether the payment is in fact converted into U.S. dollars at that time. If the dividend is converted into U.S. dollars on the date of receipt, a U.S. Holder should not be required to recognize foreign currency gain or loss in respect of the dividend income. A U.S. Holder may have foreign currency gain or loss if the dividend is converted into U.S. dollars after the date of receipt.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to applicable limitations, some of which vary depending upon the U.S. Holder&#8217;s particular circumstances, Swiss income taxes withheld from dividends on ordinary shares (at a rate not exceeding the rate provided by the Treaty) may be creditable against the U.S. Holder&#8217;s U.S. federal income tax liability. The rules governing foreign tax credits are complex and U.S. Holders should consult their tax advisors regarding the creditability of foreign taxes in their particular circumstances. In lieu of claiming a foreign tax credit, U.S. Holders may, at their election, deduct foreign taxes, including any Swiss income tax, in computing their taxable income, subject to generally applicable limitations under U.S. law. An election to deduct foreign taxes instead of claiming foreign tax credits applies to all such foreign taxes paid or accrued in the taxable year.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale or Other Disposition of Ordinary Shares</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is subject to the discussion regarding the PFIC rules described above.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain or loss realized by a U.S. Holder on the sale or other disposition of ordinary shares will be capital gain or loss, and will be long-term capital gain or loss if the U.S. Holder&#8217;s holding period for such ordinary shares was more than one year as of the date of the sale or other disposition. The amount of the gain or loss will equal the difference between the U.S. Holder&#8217;s tax basis in the ordinary shares disposed of and the amount realized on the disposition, in each case as determined in U.S. dollars. Long-term capital gain recognized by a non-corporate U.S. Holder is subject to U.S. federal income tax at rates lower than the rates applicable to ordinary income and short-term capital gains, while short-term capital gains are subject to U.S. federal income tax at the rates applicable to ordinary income. This gain or loss will generally be U.S.-source gain or loss for foreign tax credit purposes. The deductibility of capital losses is subject to various limitations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Information Reporting and Backup Withholding</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments of dividends and sales proceeds that are made within the United States or through certain U.S.-related financial intermediaries generally are subject to information reporting, and may be subject to backup withholding, unless (i) the U.S. Holder is a corporation or other exempt recipient or (ii) in the case of backup withholding, the U.S. Holder provides a correct taxpayer identification number and certifies that it is not subject to backup withholding.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of any backup withholding from a payment to a U.S. Holder will be allowed as a credit against the U.S. Holder&#8217;s U.S. federal income tax liability and may entitle it to a refund, provided that the required information is timely furnished to the IRS.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Information with Respect to Foreign Financial Assets</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain U.S. Holders who are individuals (and, under proposed regulations, certain entities) may be required to report information relating to an interest in our ordinary shares, subject to certain exceptions (including an exception for ordinary shares held in accounts maintained by certain U.S. financial institutions). Such U.S. Holders who fail to timely furnish the required information may be subject to a penalty. Additionally, if a U.S. Holder does not file the required information, the statute of limitations with respect to tax returns of the U.S. Holder to which the information relates may not close until three years after such information is filed. U.S. Holders should consult their tax advisors regarding the effect, if any, of this legislation on their ownership and disposition of the ordinary shares.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">H. Documents on Display</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are subject to the informational requirements of the Exchange Act. Accordingly, we file reports and other information with the SEC, including annual reports on Form 20-F and reports on Form 6-K. The SEC maintains an Internet site at&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">www.sec.gov</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;that contains reports, proxy and information statements and other information we have filed electronically with the SEC. As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and our executive officers, directors and principal shareholders are exempt from short-swing profit recovery provisions contained in Section 16 of the Exchange Act. However, absent an exemption from the SEC, and effective March 18, 2026, our officers and directors will be subject to the insider reporting obligations under Section 16(a) of the Exchange Act, including the requirements to file Forms 3, 4 and 5, pursuant to the Holding Foreign Insiders Accountable Act enacted on December 18, 2025. In addition, we are not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, pursuant to Swiss law, any shareholder of record has the right to receive a free copy of this Annual Report and to inspect this Annual Report at any time at our registered office in&#160;Rolle, Canton of Vaud, Switzerland.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also make available on our website, free of charge, our Annual Report and the text of our reports on Form 6-K, including any amendments to these reports, as well as certain other SEC filings, as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Our website address is&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.sophiagenetics.com</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The reference to our website is an inactive textual reference only, and information contained therein or connected thereto is not incorporated into this Annual Report.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_127"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">J. Annual Report to Security Holders</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are required to provide an annual report to security holders in response to the requirements of Form 6-K, we will submit the annual report to security holders in electronic format in accordance with the EDGAR Filer Manual.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_130"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash and cash equivalents totaling $70.3&#160;million and $80.2&#160;million as of December 31, 2025 and 2024, respectively, which are comprised of money market funds and bank and short-term deposits with maturities up to three months. Our cash and cash equivalents are subject to market risk due to changes in interest rates. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed rate securities may have their market value adversely affected due to a rise in interest rates. Due in part to these factors, our future investment income may fall short of expectation due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that decline in market value due to changes in interest rates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, we currently have $50.0 million of debt outstanding under the Perceptive Credit Agreement. Based on the terms of the Perceptive Credit Agreement, the monthly interest expense fluctuates based on the Term SOFR reference rate that is two business days prior to the first day of the preceding calendar month. Given our outstanding debt under this agreement, we are subject to interest rate risk related to debt obligations if the SOFR were to move significantly.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that a hypothetical 100 basis points change in interest rates would have a material effect on our business, financial condition, or results of operations. We do not enter into investments for trading or speculative purposes. We do not use any financial instruments to manage our interest rate risk exposure.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Exchange Risk</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate internationally and a portion of our revenue, expenses, assets, liabilities, and cash flows are denominated in currencies other than our presentation currency. As a result, we are exposed to fluctuations in foreign exchange rates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sensitivity of our income to possible changes in foreign exchange rates is measured at the local entity level as it depends on the functional currency of each entity. For the years ended December 31, 2025 and 2024, we were exposed principally to movements in four cross-currency pairs. The sensitivity of our loss before tax to such changes was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.172%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.238%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/CHF exchange rate by&#160;10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,101)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,034)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in EUR/CHF exchange rate by&#160;10%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,020)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(508)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in GBP/CHF exchange rate by&#160;10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that foreign exchange risk associated with other cross-currency pairs is material to our business, financial condition or results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Risk</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to credit risk from our operating activities, primarily trade receivables. Credit risk is the risk that a counterparty will be unable to meet its obligations under a financial instrument or customer contract. Allowance is made for lifetime expected credit losses as invoices are issued. The amount of allowance initially recognized is based on historical experience, tempered by expected changes in future cash collections, due to, for example, expected improved customer liquidity or more active credit management.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that credit risk had a material effect on our business, financial condition, or results of operations. The largest outstanding balance represented 15% of trade and other receivables in 2025, which is attributable to one of our biopharma customers. This is due to a large invoice related to significant portions of contracts completed as of December 2025.The customer is one of the largest biopharma firms in the world and has a strong payment history and is in good standing with us. Our cash and cash equivalents are deposited with reputable financial institutions. If customers representing a significant percentage of our trade receivables are unable to meet their payment obligations to us, we may suffer harm to our business, financial condition, or results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflation Risk</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our business is able to pass along increases in the costs of providing our applications, products, and services caused by inflation by increasing the prices of our applications, products, and services. For multi-year </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contracts, our general terms and conditions allow us to increase prices, at minimum on an annual basis. However, we do not believe that inflation had a material effect on our business, financial condition, or results of operations. If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so could harm our business, financial condition or results of operations.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_133"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. Description of Securities Other than Equity Securities</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_139"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13. Defaults, Dividend Arrearages and Delinquencies.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_142"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2024, in connection with the Perceptive Credit Agreement and in a private placement exempt&#160;from registration under Section 4(a)(2) of the Securities Act and the rules and regulations promulgated thereunder, we issued and sold to Perceptive Credit Holdings IV, LP a warrant certificate (the &#8220;Warrant Certificate&#8221;) representing the right to purchase up to 400,000 ordinary shares at $4.9992 per share, with the right to purchase 200,000 ordinary shares available immediately and the right to purchase an additional 200,000 ordinary shares to be available upon the drawdown of the second tranche of the term loans. On January 23, 2026, in connection with the 2026 Amendment to the Perceptive Credit Agreement, we amended and restated the Warrant Certificate in order to issue to Perceptive Credit Holdings IV, LP the right to purchase an additional 75,000 ordinary shares at $5.1829 per share, which right is exercisable immediately. The amended and restated Warrant Certificate also grants Perceptive Credit Holdings IV, LP the right to purchase an additional (1) 100,000 ordinary shares, which right will become exercisable upon drawdown of the third tranche and (2) another 100,000 ordinary shares, which right will become exercisable upon drawdown of the fourth tranche. The purchase rights represented by the Warrant Certificate are exercisable after becoming available, on a cash basis, at the option of the holder at any time prior to 5:00 p.m., Eastern time on the tenth anniversary of the applicable date of availability. The Warrant Certificate contains customary anti-dilution adjustments. We did not receive any proceeds from the sale of the Warrant Certificate beyond our entry into and borrowings under the Perceptive Credit Agreement and 2026 Amendment thereto. </span></div><div><span><br/></span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_145"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15. Controls and Procedures</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_148"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. Disclosure Controls and Procedures</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As&#160;required by Rule 13a-15 under the Exchange Act, management, including our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Disclosure controls and procedures refer to controls and other procedures designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is accumulated and communicated to management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding our required disclosures.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management, with the participation of the Company&#8217;s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures as of the end of the period covered by this report. Based on such evaluations, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, our disclosure controls and procedures were effective.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_151"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Management&#8217;s Annual Report on Internal Control Over Financial Reporting</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act. Our internal control over financial reporting is a process designed by or under the supervision of the Chief Executive Officer and Chief Financial Officer, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with the IFRS Accounting Standards as issued by the IASB. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, our management conducted an assessment of the effectiveness of the Company&#8217;s internal control over financial reporting based on the criteria established in the Internal Control &#8211; Integrated </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). Based on this assessment, our management has determined that the Company&#8217;s internal control over financial reporting as of December 31, 2025 is effective.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_154"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C. Attestation Report of the Registered Public Accounting Firm</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report does not include an attestation report of the company&#8217;s independent registered public accounting firm because we are an emerging growth company under the JOBS Act.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_157"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D. Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes to internal control over financial reporting during the year ended December 31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_160"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16A. Audit Committee Financial Expert</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has determined that each of Didier Hirsch and Tomer Berkovitz are considered an &#8220;audit committee financial expert&#8221; as defined by the SEC. Our board of directors has determined that each of Didier Hirsch, Tomer Berkovitz, and Kathy Hibbs satisfy the &#8220;independence&#8221; requirements under Nasdaq listing standards and Rule 10A-3 under the Exchange Act.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_163"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16B. Code of Ethics</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted the Code of Ethics, which is applicable to all of our employees, executive officers and directors. The Code of Ethics is available on our website&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.sophiagenetics.com</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our board of directors is responsible for overseeing the Code of Ethics and will be required to approve any waivers of the Code of Ethics for our executive officers and directors. We expect that any amendments to the Code of Ethics, or any waivers of its requirements, will be disclosed on our website.&#160;For the year ended December 31, 2025, we did not grant any waivers of the Code of Ethics.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_166"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16C. Principal Accountant Fees and Services</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fees</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December&#160;31,&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,656,830&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890,945&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit-related fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,668,090</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">900,073</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2025 and 2024, PricewaterhouseCoopers SA was the Company&#8217;s auditor for the IFRS Accounting Standards and statutory accounts.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit fees include the standard audit work performed each fiscal year necessary to allow the auditor to issue an opinion on our financial statements and to issue an opinion on the local statutory financial statements. Audit fees also include services that can be provided only by the external auditor such as reviews of quarterly financial results and review of our securities offering documents.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit-related fees consist of fees billed for assurance and related services reasonably related to the performance of the audit or review of our financial statements or for services traditionally performed by an external auditor.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax services represent tax compliance, assistance with historical tax matters, and other tax-related services.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other services include services performed for statutory non-financial requirements and other reporting guidance databases.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-Approval Policies and Procedures</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the requirements of the Sarbanes-Oxley Act and rules issued by the SEC, we review and pre-approve of any services performed by PricewaterhouseCoopers SA. The procedures require that all proposed future engagements of PricewaterhouseCoopers SA for audit and permitted non-audit work are submitted to the audit committee of our board of directors for approval prior to the beginning of any such service. In accordance with this policy, all services performed by and fees paid to PricewaterhouseCoopers SA in this Item 16C were approved by the audit committee.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_169"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16D. Exemptions from the Listing Standards for Audit Committees</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_172"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total number of shares purchased</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average price paid per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total number of shares purchased as part of publicly announced plans or programs</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum number (or approximate dollar value) of shares that may yet be purchased under the plans or programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2025 to January 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2025 to February 28, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2025 to March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1, 2025 to April 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1, 2025 to May 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1, 2025 to June 30, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1, 2025 to July 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2025 to August 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1, 2025 to September 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2025 to October 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1, 2025 to November 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1, 2025 to December 31, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div><span><br/></span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_175"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16F. Change in Registrant&#8217;s Certifying Accountant</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_178"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16G. Corporate Governance</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a &#8220;foreign private issuer,&#8221; as defined by the SEC, we are permitted to follow home country corporate governance practices instead of certain corporate governance standards required by Nasdaq for U.S. companies. Accordingly, we follow Swiss corporate governance rules in lieu of certain of Nasdaq&#8217;s corporate governance requirements. The significant differences between our Swiss corporate governance rules and Nasdaq&#8217;s corporate governance requirements are set forth below:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Exemption from the requirement that a majority of the board of directors be comprised of independent directors and that there be regularly scheduled meetings with only the independent directors present. Swiss law does not have such a requirement.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Exemption from the requirements that the compensation committee and the nomination and corporate governance committee be comprised of independent directors. Swiss law does not have such requirements.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Exemption from quorum requirements applicable to meetings of shareholders. Swiss law does not have such quorum requirements.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Exemption from the requirement that independent directors meet at regularly scheduled executive sessions. Swiss law does not have such a requirement.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Exemption from the requirement to disclose within four business days of any determination to grant a waiver of the Code of Ethics to directors and executive officers. Although we will require approval by our board of directors for any such waiver, we may choose not to disclose the waiver in the manner set forth in the Nasdaq listing standards.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Exemption from the requirement to obtain shareholder approval for certain issuances of securities, including shareholder approval of share option plans. Our articles of association provide that our board of directors is authorized, in certain instances, to issue a certain number of ordinary shares without re-approval by our shareholders.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, Nasdaq Rule 5615(a)(3) provides that a foreign private issuer may rely on home country corporate governance practices in lieu of certain of the rules in the Nasdaq Rule 5600 Series and Rule 5250(d), provided that it nevertheless complies with Nasdaq&#8217;s Notification of Noncompliance requirement (Rule 5625) and the Voting Rights requirement (Rule 5640) and that it has an audit committee that satisfies Rule 5605(c)(3), consisting of committee members that meet the independence requirements of Rule 5605(c)(2)(A)(ii). We intend to use these exemptions for as long as we continue to qualify as a foreign private issuer.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_181"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16H. Mine Safety Disclosure</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_184"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_187"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16J. Insider Trading Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have <ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-43">adopted insider trading policies</ix:nonNumeric> and procedures governing the purchase, sale and other dispositions of our securities by our directors, senior management and employees that are reasonably designed to promote compliance with applicable insider trading laws, rules and regulations and applicable listing standards. Our Insider Trading Policy and Rule 10b5-1 Plan Policy are filed as Exhibits 11.1 and 11.2, respectively, of this Annual Report. In addition, it is our policy not to engage in transactions in company securities while aware of material nonpublic information relating to the company or its securities.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_190"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16K. Cybersecurity</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-46" continuedAt="f-46-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-45" continuedAt="f-45-1" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-44">At SOPHiA GENETICS, cybersecurity risk management is an integral part of our enterprise risk management program.</ix:nonNumeric> Our cybersecurity risk management program is derived from the ISO27001 family of standards and </span></div></ix:nonNumeric></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-45-1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-46-1">underpins our Information Security Management System (&#8220;ISMS&#8221;) framework. This determines how we design our polices, guidelines, controls, and best practices to manage the organization&#8217;s information security risks while permitting us to leverage NIST, STRIDE, and SANS frameworks to inform our handling of cybersecurity threats and incidents. Additionally, we are certified in accordance to and maintain our cybersecurity framework consistent with ISO 27001 standards.</ix:continuation> </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The scope of applicability includes our globally accessible cloud-native solution offering along with all physical associated geographical locations: Switzerland, the U.S., and France. This is designed to achieve comprehensive global risk coverage across operations, application development, wet-lab analysis, and R&amp;D. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-47">Many of these capabilities are delivered in-house, however third-party services are engaged in a modest capacity to support specific activities, such as security operations center capabilities and annual penetration testing.</ix:nonNumeric> Where engaged, the organization has vendor management procedures in place that require cross-functional participation from the areas of Quality, Procurement, Regulatory, Legal, and Cybersecurity. These procedures are also interlinked directly with cybersecurity&#8217;s ISMS.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our framework includes tools and processes to identify and assess the severity of cybersecurity threats and incidents including, but not limited to, data loss, theft, and system penetration. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-48">Additionally our framework allows us to identify if the threat or incident is associated with a third-party provider, dynamically implementing cybersecurity countermeasures and mitigation strategies and informing management and our board of directors of material cybersecurity threats and incidents</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The cybersecurity team is further responsible for assessing our cybersecurity risk management program and communicating these risks to senior leadership and the Board. Although the assessment is solely performed within the cybersecurity team, external engagements influence such determination e.g.:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Annual penetration testing and Tabletop exercises </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Quarterly phishing exercises results</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Monthly SOC read-out calls</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">External threat feeds</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Cyber insurance evaluation</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">External Audit activities (ISO 27001, ISO 27017, ISO 27018, ISO 13485)</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Board and Executive team feedback</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The cybersecurity team is also responsible for providing all employee training, awareness, and education. It performs this by carrying out:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Quarterly phishing exercises </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Digital awareness campaigns through intranet posts, email updates, digital presentations </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Reach-out engagements to cross-functional teams aligned to their delivery schedules.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-49" escape="true">Our board of directors has overall oversight responsibility for our risk management and delegates cybersecurity risk management oversight to the <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-50">audit committee of the board of directors</ix:nonNumeric>. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-51" escape="true">The audit committee is responsible for ensuring that management has processes in place designed to identify and evaluate cybersecurity risks to which the company is exposed and implement processes and programs to manage cybersecurity risks and mitigate cybersecurity incidents.</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-52" escape="true">The audit committee also reports material cybersecurity risks to our full board of directors.</ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-54" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-53" escape="true">Management is responsible for identifying, considering and assessing material cybersecurity risks on an ongoing basis, establishing processes to ensure that such potential cybersecurity risk exposures are monitored, putting in place appropriate mitigation measures and maintaining cybersecurity programs. Our cybersecurity programs are executed under the direction of our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-56" continuedAt="f-56-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-55" continuedAt="f-55-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-57">Chief Technology Officer (&#8220;CTO&#8221;)</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric><ix:continuation id="f-55-1"><ix:continuation id="f-56-1">, who has over 20 years of technology leadership</ix:continuation>, receives reports from our cybersecurity team and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents.</ix:continuation> Our dedicated personnel hold a multitude of certifications, including but not limited to Certified information systems security professional (&#8220;CISSP&#8221;), Certified Ethical Hacker, and experienced information systems security professionals and information security managers with many years of experience. Management, including the CTO and our cybersecurity team, update the audit committee on the company&#8217;s cybersecurity programs, material cybersecurity risks and mitigation strategies and provide cybersecurity reports annually that cover, among other topics, such as, key performance metrics, developments in cybersecurity and updates to the company&#8217;s cybersecurity programs and mitigation strategies.</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-58">In 2025, we did not identify any cybersecurity incidents that have materially affected or are reasonably likely to materially affect our business strategy, results of operations, or financial condition.</ix:nonNumeric> However, despite our efforts, we cannot eliminate all risks from cybersecurity threats, or provide assurances that we have not experienced an undetected cybersecurity incident. For more information about these risks, please see &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Risks Related to Our Business and Industry&#8212; Cybersecurity or data privacy breaches, other unauthorized or improper access, or (distributed) denial service lack of access (e.g., ransomware, persistent DoS/DDoS) could result in additional costs, service outages, loss of revenue, significant liabilities, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">151</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">harm to our brand and decreased/denied use of our SOPHiA DDM Platform and related solutions, applications, products, or services.&#8221; in this annual report on Form 20-F.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_193"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_196"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 17. Financial Statements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Item 18&#8212;Financial Statements.&#8221;</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_199"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 18. Financial Statements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements are filed as part of this Annual Report, beginning on page F-1.</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_202"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Item 19. Exhibits</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as part of Annual Report on Form 20-F:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Incorporation by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit No.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Filing Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit11aoasgsanovember20.htm">Articles of Associat</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit11aoasgsanovember20.htm">ion</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit11aoasgsanovember20.htm"> of SOPHiA GENETICS SA</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit21descriptionofsecu.htm">Description of Securities</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001840706/000119312521207629/d101766dex101.htm">Exclusive License Agreement of Patents and Results between SOPHiA GENETICS SA and ComUE Normandy University, INSERM Transfert SA, The Henri Becquerel Centre and The University of Rouen Normandy, dated March 19, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257646</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 2, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001840706/000119312521207629/d101766dex102.htm">Exclusive License Agreement of Patents and Results between SOPHiA GENETICS SA and ComUE Normandy University, INSERM Transfert SA, The Henri Becquerel Centre and The University of Rouen Normandy, dated May 29, 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257646</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 2, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001840706/000119312521207629/d101766dex105.htm">Amended and Restated Manufacturing and Supply Agreement between SOPHiA GENETICS SA and Integrated DNA Technologies, Inc., dated October 9, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257646</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 2, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001840706/000119312521207629/d101766dex106.htm">Amendment No. 1 to Manufacturing and Supply Agreement between SOPHiA GENETICS SA and Integrated DNA Technologies, Inc., dated May 4, 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257646</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 2, 2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001840706/000119312521207629/d101766dex107.htm">OEM Supply Agreement between SOPHiA GENETICS SA and QIAGEN GmbH, dated as of January 19, 2018</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257646</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 2, 2021</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001840706/000119312521207629/d101766dex108.htm">Amendment No. 1 to the SOPHiA GENETICS SA Agreement between SOPHiA GENETICS SA and QIAGEN GmbH, dated June 7, 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257646</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 2, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.7#&#8224;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000156459022010219/soph-ex411_11.htm">Supply Agreement between SOPHiA GENETICS SA and New England Biolabs, Inc., dated January 4, 2019</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20-F</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40627</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.11</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 15, 2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.8#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070625000009/exhibit48watchmakeragreeme.htm">Supply Agreement between SOPHiA GENETICS SA and Watchmaker Genomics, Inc.,dated December 6, 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20-F</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40627</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 4, 2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9#</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070625000009/exhibit49microsoftagreement.htm">Strategic Partnership Agreement between SOPHiA GENETICS SA and Microsoft, dated October 28, 2022</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20-F</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40627</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 4, 2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070624000059/perceptivecreditagreement.htm">Credit agreement between Perceptive Credit Holdings IV, LP and SOPHiA GENETICS SA</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40627 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 7, 2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.11</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070626000003/sophiageneticssaex991secon.htm">Second Amendment to the Credit Agreement dated May 2, 2024 between Perceptive Credit Holdings IV, LP and SOPHiA GENETICS SA</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070626000003/sophiageneticssaex991secon.htm">, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070626000003/sophiageneticssaex991secon.htm"> dated January 23, 2026</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6-K</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40627</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 28, 2026</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.12</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070626000003/sophiageneticssaex992amend.htm">Amended and Restated</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070626000003/sophiageneticssaex992amend.htm"> Warrant Certificate</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40627 </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 28, 2026</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.13</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070625000009/exhibit412swisscantoagreem.htm">Lease Agreement between SOPHiA GENETICS SA and Swisscanto Anlagestiftung, dated March 8, 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20-F</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40627</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 4, 2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">153</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.14&#167;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001840706/000119312521207629/d101766dex1010.htm">Form of Indemnity Agreement with directors and officers</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257646</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 2, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.15&#167;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001840706/000119312521207629/d101766dex1013.htm">SOPHiA GENETICS SA 2021 Equity Incentive Plan</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257646</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 2, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit81listofsubsidiaries.htm">List of subsidiaries</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070625000009/exhibit111insidertradingpo.htm">SOPHiA GENETICS Insider Trading Policy</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20-F</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40627</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 4, 2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070625000009/exhibit11210b5-1planpolicy.htm">SOPHiA GENETICS 10b5-1 Policy</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20-F</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40627</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 4, 2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit121ceo302certificat.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit122cfo302certificat.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit131ceo906certificat.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit132cfo906certificat.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit151pwcconsentfy25.htm">Consent of PricewaterhouseCoopers SA</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1840706/000184070624000012/clawbackpolicy.htm">SOPHiA GENETICS Clawback policy</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20-F</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40627</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 4, 2024</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">#&#160;&#160;&#160;&#160;Portions of this exhibit have been omitted because they are both (i) not material and (ii) customarily and actually treated by the registrant as private or confidential.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Certain schedules to this exhibit have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule will be furnished supplementally to the SEC upon request; provided, however, that the parties may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act for any document so furnished.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#167;&#160;&#160;&#160;&#160;Indicates a management contract or compensatory plan.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_205"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:45.333%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.032%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.335%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS SA</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jurgi Camblong</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jurgi Camblong</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March&#160;3, 2026</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_208"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:90.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contents</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_211">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(PCAOB ID:<ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-59">1358</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_211">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_214">Consolidated Statements of Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_214">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_217">Consolidated Statements of Comprehensive Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_217">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_220">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_220">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_223">Consolidated Statements of Changes in Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_223">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_226">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_226">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_229">Notes to the Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">F-<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i949f8e5b3f184d2fadfac47a64e0acc8_229">8</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_211"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Report of Independent Registered Public Accounting Firm </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Shareholders of SOPHiA GENETICS SA</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have audited the accompanying consolidated balance sheets of SOPHiA GENETICS SA and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2025 and 2024, and the related consolidated statements of loss, comprehensive loss, changes in equity and cash flows for each of the three years in the period ended December 31, 2025, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025 in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Change in Accounting Principle </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Note 2 to the consolidated financial statements, the Company changed the manner in which it classifies interest received and interest paid in the statement of cash flows in 2025.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis for Opinion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">These consolidated financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audits of these consolidated financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;<ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-60">PricewaterhouseCoopers SA</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-61">Lausanne, Switzerland</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 3, 2026</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2020.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_214"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SOPHiA GENETICS SA</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in USD thousands, except per share data)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.718%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-62">77,271</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-63">65,173</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-64">62,371</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="3" id="f-65">25,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="3" id="f-66">21,236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:CostOfSales" format="ixt:num-dot-decimal" scale="3" id="f-67">19,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-68">52,077</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-69">43,937</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-70">42,913</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-71">34,216</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-72">34,366</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-73">36,969</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:SalesAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-74">36,118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:SalesAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-75">29,369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:SalesAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-76">28,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-77">52,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-78">46,953</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-79">53,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating (loss) income, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:OtherOperatingIncomeExpense" scale="3" id="f-80">86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:OtherOperatingIncomeExpense" scale="3" id="f-81">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:OtherOperatingIncomeExpense" scale="3" id="f-82">954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-83">70,906</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-84">66,568</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ProfitLossFromOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-85">74,826</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:num-dot-decimal" scale="3" id="f-86">1,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:num-dot-decimal" scale="3" id="f-87">3,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:num-dot-decimal" scale="3" id="f-88">4,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-89">4,554</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-90">1,913</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:InterestExpense" scale="3" id="f-91">588</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments on warrant obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="soph:AdjustmentsForFairValueOfWarrantLiability" scale="3" id="f-92">497</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:AdjustmentsForFairValueOfWarrantLiability" scale="3" id="f-93">370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="soph:AdjustmentsForFairValueOfWarrantLiability" format="ixt:fixed-zero" scale="3" id="f-94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange (losses) gains, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="soph:ForeignExchangeAndOtherGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-95">3,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:ForeignExchangeAndOtherGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-96">3,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="soph:ForeignExchangeAndOtherGainLoss" format="ixt:num-dot-decimal" scale="3" id="f-97">7,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-98">77,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-99">61,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-100">78,495</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-101">1,512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-102">1,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="f-103">486</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss for the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-104">78,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-105">62,493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-106">78,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Attributable to the owners of the parent</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="3" id="f-107">78,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="3" id="f-108">62,493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="3" id="f-109">78,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic and diluted loss per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-110"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-111">1.17</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-112"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-113">0.95</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-114"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-115">1.22</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The Notes form an integral part of these consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_217"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SOPHiA GENETICS SA</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in USD thousands)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.203%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss for the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-116">78,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-117">62,493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-118">78,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive (loss) income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Items that may be reclassified to statement of loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" format="ixt:num-dot-decimal" scale="3" id="f-119">11,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" format="ixt:num-dot-decimal" scale="3" id="f-120">9,679</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" format="ixt:num-dot-decimal" scale="3" id="f-121">15,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total items that may be reclassified to statement of loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-122">11,292</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-123">9,679</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-124">15,037</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Items that will not be reclassified to statement of loss (net of tax)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of defined benefit plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-125">704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-126">327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-127">212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total items that will not be reclassified to statement of loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="3" id="f-128">704</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="3" id="f-129">327</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" scale="3" id="f-130">212</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive (loss) income for the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-131">11,996</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-132">9,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-133">14,825</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total comprehensive loss for the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-134">67,003</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-135">71,845</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-136">64,156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Attributable to owners of the parent</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="3" id="f-137">67,003</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="3" id="f-138">71,845</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="3" id="f-139">64,156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The Notes form an integral part of these consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_220"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SOPHiA GENETICS SA</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in USD thousands)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.324%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-140">70,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-141">80,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:TradeAndOtherCurrentReceivables" format="ixt:num-dot-decimal" scale="3" id="f-142">15,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:TradeAndOtherCurrentReceivables" format="ixt:num-dot-decimal" scale="3" id="f-143">7,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="3" id="f-144">6,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="3" id="f-145">5,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-146">7,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-147">5,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-148">99,079</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-149">99,405</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-150">5,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-151">5,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-152">35,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:IntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-153">28,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-154">12,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-155">14,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:NetDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-156">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:NetDeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-157">1,767</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-158">8,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-159">5,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-160">63,952</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-161">55,904</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-162">163,031</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:Assets" format="ixt:num-dot-decimal" scale="3" id="f-163">155,309</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="3" id="f-164">8,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="3" id="f-165">5,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:CurrentAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="f-166">20,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:CurrentAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="f-167">13,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-168">16,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-169">5,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-170">2,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-171">2,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CurrentWarrantLiability" format="ixt:num-dot-decimal" scale="3" id="f-172">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentWarrantLiability" scale="3" id="f-173">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-174">50,528</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-175">26,803</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-176">47,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:LongtermBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-177">13,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:NoncurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-178">12,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-179">14,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defined benefit pension liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" format="ixt:num-dot-decimal" scale="3" id="f-180">4,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" format="ixt:num-dot-decimal" scale="3" id="f-181">3,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:OtherNoncurrentLiabilities" scale="3" id="f-182">876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:OtherNoncurrentLiabilities" scale="3" id="f-183">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-184">65,358</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-185">32,016</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-186">115,886</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-187">58,819</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:IssuedCapital" format="ixt:num-dot-decimal" scale="3" id="f-188">4,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:IssuedCapital" format="ixt:num-dot-decimal" scale="3" id="f-189">4,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share premium</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:SharePremium" format="ixt:num-dot-decimal" scale="3" id="f-190">473,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:SharePremium" format="ixt:num-dot-decimal" scale="3" id="f-191">472,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:TreasuryShares" format="ixt:num-dot-decimal" scale="3" id="f-192">1,218</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:TreasuryShares" scale="3" id="f-193">702</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other reserves</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="3" id="f-194">89,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:OtherReserves" format="ixt:num-dot-decimal" scale="3" id="f-195">61,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="ifrs-full:RetainedEarnings" format="ixt:num-dot-decimal" scale="3" id="f-196">519,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="ifrs-full:RetainedEarnings" format="ixt:num-dot-decimal" scale="3" id="f-197">440,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-198">47,145</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-199">96,490</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:EquityAndLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-200">163,031</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:EquityAndLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-201">155,309</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The Notes form an integral part of these consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_223"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SOPHiA GENETICS SA</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Changes in Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in USD thousands, except share data)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.475%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Share<br/>capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Share<br/>capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Share<br/>premium</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other<br/>reserves</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-202">66,398,164</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-203">3,464</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-204">2,166,944</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" sign="-" name="ifrs-full:Equity" scale="3" id="f-205">117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-206">471,623</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-207">23,963</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-208">298,803</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-209">200,130</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Loss for the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-210">78,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-211">78,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-212">14,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-213">14,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-214">14,825</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-215">78,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-216">64,156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-217">15,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-218">15,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Transactions with owners</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share options exercised and vesting of Restricted Stock Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="soph:NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-219">999,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-220">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-221">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-222">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-223">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of shares to be held as treasury shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="INF" name="soph:NumberOfTreasurySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-224">10,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="ifrs-full:SaleOrIssueOfTreasuryShares" scale="3" id="f-225">584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-15" decimals="INF" name="soph:NumberOfTreasurySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-226">10,500,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="ifrs-full:SaleOrIssueOfTreasuryShares" scale="3" id="f-227">584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:SaleOrIssueOfTreasuryShares" format="ixt:fixed-zero" scale="3" id="f-228">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-229">76,898,164</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-230">4,048</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-19" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-231">11,667,605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" sign="-" name="ifrs-full:Equity" scale="3" id="f-232">646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-233">471,846</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-234">53,978</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-235">377,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-236">151,442</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Loss for the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-237">62,493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-238">62,493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-239">9,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-240">9,352</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-241">9,352</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-242">62,493</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-243">71,845</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-244">16,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-245">16,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Transactions with owners</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share options exercised and vesting of Restricted Stock Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="INF" name="soph:NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-246">1,456,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-247">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-248">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-249">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-250">405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of shares to be held as treasury shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="INF" name="soph:NumberOfTreasurySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-251">2,423,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="ifrs-full:SaleOrIssueOfTreasuryShares" scale="3" id="f-252">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-26" decimals="INF" name="soph:NumberOfTreasurySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-253">2,423,056</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" sign="-" name="ifrs-full:SaleOrIssueOfTreasuryShares" scale="3" id="f-254">140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:SaleOrIssueOfTreasuryShares" format="ixt:fixed-zero" scale="3" id="f-255">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-256">79,321,220</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-257">4,188</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-30" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-258">12,634,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" sign="-" name="ifrs-full:Equity" scale="3" id="f-259">702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-260">472,244</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-261">61,037</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-262">440,277</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-263">96,490</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Loss for the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-264">78,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-265">78,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-266">11,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:OtherComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-267">11,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-268">11,996</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-269">78,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ComprehensiveIncome" format="ixt:num-dot-decimal" scale="3" id="f-270">67,003</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-271">16,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-272">16,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Transactions with owners</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share options exercised and vesting of Restricted Stock Units</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="INF" name="soph:NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-273">1,571,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-274">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-275">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-276">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" scale="3" id="f-277">346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of shares to be held as treasury shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-38" decimals="INF" name="soph:NumberOfTreasurySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-278">10,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="ifrs-full:SaleOrIssueOfTreasuryShares" scale="3" id="f-279">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-36" decimals="INF" name="soph:NumberOfTreasurySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-280">10,000,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" sign="-" name="ifrs-full:SaleOrIssueOfTreasuryShares" scale="3" id="f-281">626</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:SaleOrIssueOfTreasuryShares" format="ixt:fixed-zero" scale="3" id="f-282">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from ATM offering, net of transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="INF" name="soph:NumberOfEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-283">228,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="ifrs-full:IssueOfEquity" scale="3" id="f-284">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="ifrs-full:IssueOfEquity" format="ixt:num-dot-decimal" scale="3" id="f-285">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:IssueOfEquity" format="ixt:num-dot-decimal" scale="3" id="f-286">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-287">89,321,220</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-288">4,814</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-40" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-289">20,834,882</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-290">1,218</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-291">473,675</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-292">89,150</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" sign="-" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-293">519,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:Equity" format="ixt:num-dot-decimal" scale="3" id="f-294">47,145</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">The Notes form an integral part of these consolidated financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_226"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SOPHiA GENETICS SA</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amounts in USD thousands)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.718%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.569%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(As Recast)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(As Recast)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-295">77,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-296">61,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ProfitLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="f-297">78,495</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Adjustments for non-monetary items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,17</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForDepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-298">3,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:AdjustmentsForDepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-299">4,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:AdjustmentsForDepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-300">5,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:num-dot-decimal" scale="3" id="f-301">5,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:num-dot-decimal" scale="3" id="f-302">4,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:num-dot-decimal" scale="3" id="f-303">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance expense (income), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:AdjustmentsForFinanceExpenseIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-304">5,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="soph:AdjustmentsForFinanceExpenseIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-305">5,210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="soph:AdjustmentsForFinanceExpenseIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-306">2,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments on warrant obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="soph:AdjustmentsForFairValueOfWarrantLiability" scale="3" id="f-307">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:AdjustmentsForFairValueOfWarrantLiability" scale="3" id="f-308">370</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="soph:AdjustmentsForFairValueOfWarrantLiability" format="ixt:fixed-zero" scale="3" id="f-309">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected credit loss allowance increase (reversal)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:AdjustmentsForCreditLossAllowance" scale="3" id="f-310">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="soph:AdjustmentsForCreditLossAllowance" scale="3" id="f-311">523</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="soph:AdjustmentsForCreditLossAllowance" scale="3" id="f-312">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForSharebasedPayments" format="ixt:num-dot-decimal" scale="3" id="f-313">16,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:AdjustmentsForSharebasedPayments" format="ixt:num-dot-decimal" scale="3" id="f-314">16,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:AdjustmentsForSharebasedPayments" format="ixt:num-dot-decimal" scale="3" id="f-315">15,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movements in provisions and pensions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,21</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="3" id="f-316">649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-317">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" scale="3" id="f-318">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research tax credit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:AdjustmentsForResearchTaxCredit" scale="3" id="f-319">977</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:AdjustmentsForResearchTaxCredit" scale="3" id="f-320">726</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="soph:AdjustmentsForResearchTaxCredit" format="ixt:num-dot-decimal" scale="3" id="f-321">1,129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on disposal of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-322">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" scale="3" id="f-324">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of lease liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:GainLossOnDisposalOfLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-325">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:GainLossOnDisposalOfLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-326">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="soph:GainLossOnDisposalOfLeaseLiability" scale="3" id="f-327">733</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Working capital changes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Increase) decrease in accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" format="ixt:num-dot-decimal" scale="3" id="f-328">6,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" format="ixt:num-dot-decimal" scale="3" id="f-329">5,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" format="ixt:num-dot-decimal" scale="3" id="f-330">6,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease (increase) in prepaids and other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" scale="3" id="f-331">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-332">1,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-333">1,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease (increase) in inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="3" id="f-334">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="3" id="f-335">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" scale="3" id="f-336">874</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in accounts payables, accrued expenses, deferred contract revenue, and other liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" format="ixt:num-dot-decimal" scale="3" id="f-337">16,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" format="ixt:num-dot-decimal" scale="3" id="f-338">7,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" format="ixt:num-dot-decimal" scale="3" id="f-339">6,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cash used in operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperations" format="ixt:num-dot-decimal" scale="3" id="f-340">35,693</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperations" format="ixt:num-dot-decimal" scale="3" id="f-341">43,979</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperations" format="ixt:num-dot-decimal" scale="3" id="f-342">52,423</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" scale="3" id="f-343">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" scale="3" id="f-344">536</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" scale="3" id="f-345">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Net cash flows used in operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-346">35,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-347">44,515</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-348">53,224</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="f-349">574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" scale="3" id="f-350">244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-351">1,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="f-352">108</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="f-353">195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" scale="3" id="f-354">263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:CapitalizedSoftwareDevelopmentCosts" format="ixt:num-dot-decimal" scale="3" id="f-355">7,938</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:CapitalizedSoftwareDevelopmentCosts" format="ixt:num-dot-decimal" scale="3" id="f-356">7,737</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="soph:CapitalizedSoftwareDevelopmentCosts" format="ixt:num-dot-decimal" scale="3" id="f-357">7,469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of equity investments held at fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="3" id="f-358">1,885</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="3" id="f-359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="3" id="f-360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds upon maturity of term deposits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" format="ixt:fixed-zero" scale="3" id="f-361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" format="ixt:fixed-zero" scale="3" id="f-362">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" format="ixt:num-dot-decimal" scale="3" id="f-363">17,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest received</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-364">1,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-365">3,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:InterestReceivedClassifiedAsInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-366">4,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Net cash flow (used in) provided from investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-367">8,670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-368">4,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-369">12,975</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of share options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" id="f-370">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" id="f-371">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:ProceedsFromExerciseOfOptions" scale="3" id="f-372">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-373">3,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-374">1,728</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:InterestPaidClassifiedAsFinancingActivities" scale="3" id="f-375">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from borrowings, net of transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-376">34,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-377">13,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of common stock in at-the-market offering</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:num-dot-decimal" scale="3" id="f-379">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:fixed-zero" scale="3" id="f-380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:ProceedsFromIssuingShares" format="ixt:fixed-zero" scale="3" id="f-381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of principal portion of lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">17</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-382">1,872</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-383">2,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-384">3,043</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Net cash flow provided from (used in) financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-385">30,177</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-386">9,857</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-387">2,823</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Decrease in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" format="ixt:num-dot-decimal" scale="3" id="f-388">14,386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" format="ixt:num-dot-decimal" scale="3" id="f-389">39,413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" format="ixt:num-dot-decimal" scale="3" id="f-390">43,072</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange differences on cash balances</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-391">4,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-392">3,612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-393">5,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of the year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-394">80,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-395">123,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-396">161,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of the year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-397">70,289</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-398">80,226</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-399">123,251</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-style:italic;font-weight:400;line-height:120%">The notes form an integral part of these consolidated financial statements.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%"> <ix:footnote id="fn-1" footnoteRole="http://www.xbrl.org/2003/role/footnote">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy. </ix:footnote></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_229"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SOPHiA GENETICS SA</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_232"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfCompanyInformationAndOperationsTextBlock" id="f-400" continuedAt="f-400-1" escape="true">Company information and operations</ix:nonNumeric></span></div><ix:continuation id="f-400-1" continuedAt="f-400-2"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General information</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOPHiA GENETICS SA and its consolidated subsidiaries (NASDAQ: SOPH) (&#8220;the Company&#8221;) is a cloud-native software technology company in the healthcare space, incorporated on&#160;March 18, 2011, and headquartered in Rolle, Switzerland. The Company is dedicated to establishing the practice of data-driven medicine as the standard of care in healthcare and for life sciences research. The Company has built a cloud-native software platform capable of analyzing data and generating insights from complex multimodal datasets and different diagnostic modalities. This platform, commercialized as &#8220;SOPHiA DDM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; standardizes, computes, and analyzes digital health data and is used in decentralized locations to break down data silos. The Company collectively refers to SOPHiA DDM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Platform and related products and solutions as &#8220;SOPHiA DDM Platform.&#8221;</span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutSubsidiariesTextBlock" id="f-401" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, the Company had the following wholly-owned subsidiaries:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Country of domicile</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-44" name="ifrs-full:NameOfSubsidiary" id="f-402">SOPHiA GENETICS S.A.S.</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-44" name="ifrs-full:DomicileOfEntity" id="f-403">France</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-45" name="ifrs-full:NameOfSubsidiary" id="f-404">SOPHiA GENETICS LTD</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-45" name="ifrs-full:DomicileOfEntity" id="f-405">U.K.</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-46" name="ifrs-full:NameOfSubsidiary" id="f-406">SOPHiA GENETICS, Inc.</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-46" name="ifrs-full:DomicileOfEntity" id="f-407">U.S.</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-47" name="ifrs-full:NameOfSubsidiary" id="f-408">SOPHiA GENETICS Intermedia&#231;&#227;o de Neg&#243;cios LTDA</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-47" name="ifrs-full:DomicileOfEntity" id="f-409">Brazil</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-48" name="ifrs-full:NameOfSubsidiary" id="f-410">SOPHiA GENETICS PTY LTD</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-48" name="ifrs-full:DomicileOfEntity" id="f-411">Australia</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-49" name="ifrs-full:NameOfSubsidiary" id="f-412">SOPHiA GENETICS S.R.L.</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-49" name="ifrs-full:DomicileOfEntity" id="f-413">Italy</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-50" name="ifrs-full:NameOfSubsidiary" id="f-414">SOPHiA GENETICS GmbH</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-50" name="ifrs-full:DomicileOfEntity" id="f-415">Germany</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board of Directors approved the issue of the consolidated financial statements on&#160;March&#160;3, 2026.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issued share capital</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, the Company had issued <ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-416">89,321,220</ix:nonFraction> shares of which <ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="ifrs-full:NumberOfSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-417">68,486,338</ix:nonFraction> are outstanding and <ix:nonFraction unitRef="shares" contextRef="c-40" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-418">20,834,882</ix:nonFraction> are held by the Company as treasury shares. As of December 31, 2024, the Company had issued <ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-419">79,321,220</ix:nonFraction> shares of which <ix:nonFraction unitRef="shares" contextRef="c-29" decimals="INF" name="ifrs-full:NumberOfSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-420">66,687,085</ix:nonFraction> are outstanding and <ix:nonFraction unitRef="shares" contextRef="c-30" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-421">12,634,135</ix:nonFraction> are held by the Company as treasury shares. All shares were considered paid as of December 31, 2025.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Range</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the Company&#8217;s articles of association, the board of directors is authorized, at any time and including for anti&#8209;takeover and change&#8209;of&#8209;control purposes, to increase the Company&#8217;s nominal share capital until June 18, 2030, within a capital range extending from CHF <ix:nonFraction unitRef="chf" contextRef="c-51" decimals="2" name="soph:IncreaseDecreaseInAuthorisedCapital" format="ixt:num-dot-decimal" scale="0" id="f-422">3,319,908.20</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="2" name="soph:IncreaseDecreaseInAuthorisedCapital" format="ixt:num-dot-decimal" scale="0" id="f-423">4,192,193.63</ix:nonFraction>) (lower limit) to CHF <ix:nonFraction unitRef="chf" contextRef="c-52" decimals="2" name="soph:IncreaseDecreaseInAuthorisedCapital" format="ixt:num-dot-decimal" scale="0" id="f-424">4,979,862.30</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="2" name="soph:IncreaseDecreaseInAuthorisedCapital" format="ixt:num-dot-decimal" scale="0" id="f-425">6,288,042.55</ix:nonFraction>) (upper limit). Within this capital range, the board is authorized to increase the Company&#8217;s nominal share capital by up to CHF <ix:nonFraction unitRef="chf" contextRef="c-52" decimals="2" name="soph:IncreaseDecreaseInAuthorisedCapital" format="ixt:num-dot-decimal" scale="0" id="f-426">4,979,862.30</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="2" name="soph:IncreaseDecreaseInAuthorisedCapital" format="ixt:num-dot-decimal" scale="0" id="f-427">6,288,042.55</ix:nonFraction>) through the issuance of up to <ix:nonFraction unitRef="shares" contextRef="c-53" decimals="INF" name="soph:IncreaseDecreaseInNumberOfSharesAuthorised" format="ixt:num-dot-decimal" scale="0" id="f-428">33,199,082</ix:nonFraction> fully paid&#8209;in ordinary shares, each with a par value of CHF <ix:nonFraction unitRef="chfPerShare" contextRef="c-54" decimals="INF" name="ifrs-full:ParValuePerShare" scale="0" id="f-429">0.05</ix:nonFraction> ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-54" decimals="INF" name="ifrs-full:ParValuePerShare" scale="0" id="f-430">0.06</ix:nonFraction>). In addition to the increase of share capital, our board of directors has the right to reduce the share capital to the minimum amount of CHF<ix:nonFraction unitRef="chf" contextRef="c-51" decimals="2" name="soph:IncreaseDecreaseInAuthorisedCapital" format="ixt:num-dot-decimal" scale="0" id="f-431">3,319,908.20</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="2" name="soph:IncreaseDecreaseInAuthorisedCapital" format="ixt:num-dot-decimal" scale="0" id="f-432">4,192,193.63</ix:nonFraction>). According to the articles of association, our board of directors is entitled to determine the use of the reduction amount, to the extent necessary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Treasury shares</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2023, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-55" decimals="INF" name="soph:NumberOfTreasurySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-433">10,500,000</ix:nonFraction> registered shares to SOPHiA GENETICS LTD pursuant to a share delivery and repurchase agreement, which were immediately exercised, and repurchased the shares to hold as treasury shares. During the third quarter of 2024, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-56" decimals="INF" name="soph:NumberOfTreasurySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-434">2,423,056</ix:nonFraction> registered shares to SOPHiA GENETICS LTD pursuant to a share delivery and repurchase agreement, which were immediately exercised, and repurchased the shares to hold as treasury shares for the purposes of administering the Company's equity incentive programs. During the fourth quarter of 2025, the </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-400-2"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company issued <ix:nonFraction unitRef="shares" contextRef="c-57" decimals="INF" name="soph:NumberOfTreasurySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-435">10,000,000</ix:nonFraction> registered shares to SOPHiA GENETICS LTD pursuant to a share delivery and repurchase agreement, which were immediately exercised, and repurchased the shares to hold as treasury shares. The Company held <ix:nonFraction unitRef="shares" contextRef="c-40" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-436">20,834,882</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-30" decimals="INF" name="ifrs-full:NumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-437">12,634,135</ix:nonFraction> treasury shares as of December 31, 2025 and 2024, respectively. The issuance of the <ix:nonFraction unitRef="shares" contextRef="c-57" decimals="INF" name="soph:NumberOfTreasurySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-438">10,000,000</ix:nonFraction> shares in 2025 was made out of the Company&#8217;s capital range in accordance with the board of directors&#8217; authorization under the Company&#8217;s articles of association.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury shares are recognized at acquisition cost and recorded as treasury shares at the time of the transaction. Upon exercise of share options or vesting of restricted stock units, the treasury shares are subsequently transferred. Any consideration received is included in shareholders&#8217; equity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conditional share capital</span></div><div><span><br/></span></div><div style="margin-top:0.05pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Conditional Share Capital for Financing, Acquisitions and Other Purposes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may increase its share capital for anti&#8209;takeover and change&#8209;of&#8209;control purposes through the exercise or mandatory exercise of conversion, exchange, option, warrant or similar rights granted to shareholders or third parties, whether issued on a standalone basis or in connection with other securities or contractual obligations of the Company or its subsidiaries. As of December 31, 2025, the conditional share capital available for financing, acquisitions and other strategic purposes consisted of <ix:nonFraction unitRef="shares" contextRef="c-58" decimals="INF" name="soph:NumberOfConditionalSharesAuthorised" format="ixt:num-dot-decimal" scale="0" id="f-439">18,277,363</ix:nonFraction> ordinary shares with a par value of CHF <ix:nonFraction unitRef="chfPerShare" contextRef="c-58" decimals="INF" name="ifrs-full:ParValuePerShare" scale="0" id="f-440">0.05</ix:nonFraction> ($ <ix:nonFraction unitRef="usdPerShare" contextRef="c-58" decimals="INF" name="ifrs-full:ParValuePerShare" scale="0" id="f-441">0.06</ix:nonFraction>) each, compared to <ix:nonFraction unitRef="shares" contextRef="c-59" decimals="INF" name="soph:NumberOfConditionalSharesAuthorised" format="ixt:num-dot-decimal" scale="0" id="f-442">21,599,082</ix:nonFraction> ordinary shares as of December 31, 2024.</span></div><div style="margin-top:9.55pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Conditional Share Capital for Employee Participation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may issue registered shares to employees, agents and members of the Board of Directors under its stock option and other equity&#8209;based incentive plans. As of December 31, 2025, the conditional share capital available for employee participation consisted of <ix:nonFraction unitRef="shares" contextRef="c-58" decimals="INF" name="soph:NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-443">21,383,247</ix:nonFraction> ordinary shares with a par value of CHF <ix:nonFraction unitRef="chfPerShare" contextRef="c-58" decimals="INF" name="ifrs-full:ParValuePerShare" scale="0" id="f-444">0.05</ix:nonFraction> ($ <ix:nonFraction unitRef="usdPerShare" contextRef="c-58" decimals="INF" name="ifrs-full:ParValuePerShare" scale="0" id="f-445">0.06</ix:nonFraction>) each, compared to <ix:nonFraction unitRef="shares" contextRef="c-59" decimals="INF" name="soph:NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-446">18,061,528</ix:nonFraction> ordinary shares as of December 31, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ATM Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2025, the Company established a new at-the-market (&#8220;ATM&#8221;) offering program pursuant to which  from time to time the Company may sell ordinary shares having an aggregate offering price of $<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-5" name="ifrs-full:IssueOfEquity" scale="6" id="f-447">50.0</ix:nonFraction>&#160;million. For the year ended December 31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="soph:NumberOfEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-448">228,238</ix:nonFraction> ordinary shares were sold for total gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ifrs-full:ProceedsFromIssuingShares" scale="6" id="f-449">1.1</ix:nonFraction>&#160;million under this program.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_238"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory" id="f-450" continuedAt="f-450-1" escape="true">Material accounting policies</ix:nonNumeric></span></div><ix:continuation id="f-450-1" continuedAt="f-450-2"><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock" id="f-451" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of preparation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with International Financial Reporting Standards</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of the Company have been prepared in accordance with IFRS Accounting Standards and interpretations issued by the IFRS Interpretations Committee (&#8220;IFRS IC&#8221;) applicable to companies reporting under IFRS Accounting Standards. The consolidated financial statements comply with IFRS Accounting Standards as issued by the International Accounting Standards Board (&#8220;IASB&#8221;).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock" id="f-452" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary is an entity over which the Company has control. The Company controls an entity when it has the power to direct its activities and has rights to its variable returns. Subsidiaries are fully consolidated from the date on which control is transferred to the Company and deconsolidated from the date that control ceases.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the consolidation process intercompany transactions, balances, and unrealized gains on transactions between companies are eliminated. Unrealized losses are also eliminated unless there is evidence of an impairment of the transferred asset. In order to ensure consistency with the accounting policies of the Company, the accounting policies of subsidiaries have been changed where necessary.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-450-2" continuedAt="f-450-3"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" id="f-453" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign currency translation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Items included in the consolidated financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic environment in which the entity operates (&#8220;functional currency&#8221;). In individual entities, transactions in foreign currencies are translated as of transaction date. Monetary assets and liabilities in foreign currencies are translated at month end rates. The Company&#8217;s reporting currency of the Company&#8217;s consolidated financial statements is the U.S. dollar (&#8220;USD&#8221;). Assets and liabilities denominated in foreign currencies are translated at the month-end spot exchange rates, income statement accounts are translated at average rates of exchange for the period presented, and equity is translated at historical exchange rates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On consolidation, assets and liabilities of foreign operations reported in their local functional currencies are translated into USD. Differences arising from the retranslation of opening net assets of foreign operations, together with differences arising from the translation of the net results for the year of foreign operations, are recognized in other comprehensive income under currency translation adjustments. Gains or losses resulting from foreign currency transactions are included in net income.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company selected the U.S. dollar as its presentation currency for purposes of its consolidated financial statements instead of the Company&#8217;s functional currency, the Swiss franc, because of the global nature of its business, its expectation that an increasing portion of revenues and expenses will be denominated in USD, and its plans to continue to access U.S. capital markets.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock" id="f-454" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with IFRS Accounting Standards requires the use of accounting estimates. It also requires management to exercise judgment in applying the Company&#8217;s accounting policies. The Company&#8217;s significant estimates and judgments included in the preparation of the consolidated financial statements are related to revenue recognition, capitalized internal software development costs, defined benefit liability and share-based compensation.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosed in the corresponding sections within the footnotes are the areas which require a high degree of judgment, significant assumptions, and/or estimates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock" id="f-455" continuedAt="f-455-1" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going concern basis</span></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-455-1">The consolidated financial statements have been prepared on a going concern basis</ix:continuation> (See Note 27 &#8211; &#8220;Capital management&#8221;).</span></div><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock" id="f-456" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Historical cost convention</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared on a historical cost basis except for certain assets and liabilities, which are carried at fair value.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock" id="f-457" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material accounting policies adopted in the preparation of the consolidated financial statements have been consistently applied, unless otherwise stated.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock" id="f-458" continuedAt="f-458-1" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions and contingencies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions comprise liabilities of uncertain timing or amount. The provisions and liabilities are recognized when the Company has a present legal or constructive obligation as a result of past events, it is probable that an outflow of resources will be required to settle the obligation, and the amount can </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be reliably estim</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ated. Provisions are not recognized for future operating losses. Provisions are measured at the present value of management&#8217;s best estimate of the expenditure required to settle the present obligation at the end of the reporting period, unless the impact of discounting is immaterial. The discount rate used to determine the present value is a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. The increase in the provision due to the passage of time is recognized as interest expense.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-450-3" continuedAt="f-450-4"><ix:continuation id="f-458-1"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent liabilities are possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not fully within the control of the Company.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The likelihood of occurrence of provisions and contingent liabilities requires use of judgment. Judgment is also required to determine if an outflow of economic resources is probable, or possible but not probable. Where it is probable, a liability is recognized, and further judgment is used to determine the level of the provision. Where it is possible but not probable, further judgment is used to determine if the likelihood is remote, in which case no disclosures are provided; if the likelihood is not remote then judgment is used to determine the contingent liability disclosed.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" id="f-459" continuedAt="f-459-1" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial assets classification</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon recognition, financial assets are classified on the basis of how the financial assets are measured: at amortized cost or fair value through income.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification of financial assets at initial recognition depends on the financial asset&#8217;s contractual cash flow characteristics and the Company&#8217;s business model for managing them. Except for accounts receivable that do not contain a significant financing component, the Company initially measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through income, transaction costs. Accounts receivable that do not contain a significant financing component are measured at the transaction price.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business model for managing financial assets is defined by whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets held in order to collect contractual cash flows are measured at amortized cost. Financial assets held both to collect contractual cash flows and for sale are measured at fair value through other comprehensive income/loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases or sales of financial assets that require delivery of assets within a time frame established by regulation or convention in the marketplace (regular way trades) are recognized on the trade date, i.e., the date that the Company commits to purchase or sell the asset.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial assets measured at amortized cost</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets initially measured at amortized cost are subsequently measured using the effective interest rate (&#8220;EIR&#8221;) method and are subject to impairment. Gains and losses are recognized in income when the asset is derecognized, modified, or impaired. The Company&#8217;s financial assets at amortized cost include cash and accounts receivable.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial assets&#8212;derecognition</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Company&#8217;s consolidated balance sheet) when:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the rights to receive cash flows from the asset have expired or;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material delay to a third party under a &#8216;pass-through&#8217; arrangement; and either;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Company has transferred substantially all the risks and rewards of the asset, or;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Company has neither transferred nor retained substantially all the risks and rewards of the asset but has transferred control of the asset.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risks and rewards of ownership.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control of the asset, the Company continues to recognize the transferred asset to the extent of its continuing involvement. In that case, the Company also recognizes an associated liability. The transferred </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-450-4" continuedAt="f-450-5"><ix:continuation id="f-459-1"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">asset and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continuing involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that the Company could be required to repay.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial assets&#8212;impairment</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For cash and cash equivalents, the Company invests in short-term highly liquid assets where it has never incurred and does not expect to incur credit losses.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounts receivable the Company recognizes a loss allowance based on lifetime estimated credit losses (&#8220;ECL&#8221;) at each reporting date. When estimating the ECL the Company takes into consideration: readily available relevant and supportable information (this includes quantitative and qualitative data), the Company&#8217;s historical experience and forward-looking information specific to the receivables and the economic environment.</span></div></ix:continuation><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 &#8211; &#8220;Accounts receivable&#8221; for further information about the Company&#8217;s accounting for trade receivables.</span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" id="f-460" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial liabilities classification</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial liabilities are classified upon initial recognition as financial liabilities measured at fair value through income or at amortized cost. The Company&#8217;s financial liabilities include accounts payable and debt (including borrowings and lease liabilities), which are measured at amortized cost, and derivatives, which are measured at fair value through income.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest-bearing borrowings are initially recognized at fair value less directly attributable costs and subsequently measured at amortized cost using the EIR method. Gains and losses are recognized in income when the liabilities are derecognized as well as through the EIR amortization process.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortized cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included as interest expense in the statement of loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial liabilities&#8212;derecognition</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A financial liability is derecognized when the obligation under the liability is discharged or canceled or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized in the statements of loss.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock" id="f-461" continuedAt="f-461-1" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in accounting policies </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Statement of Cash Flows - Interest Classification</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2025, the Company revised its accounting policy regarding the classification of interest paid and interest received in the Statement of Cash Flows. Interest paid was reclassified from Net cash flows used in operating activities to Net cash flows used in financing activities, and interest received was reclassified from Net cash flows used in operating activities to Net cash flows used in investing activities. The Company assessed the change in accounting policy under IAS 8, in accordance with the guidance regarding a voluntary change in accounting policy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification of interest paid was elected to provide a more cohesive presentation of payments related to the Company&#8217;s borrowings and lease liabilities. Prior to the change in accounting policy, interest paid on borrowings and lease liabilities were classified as operating cash flows, while proceeds from borrowings, net of transaction costs and payments of principal portion of lease liabilities are classified as financing cash flows. The change aligns interest payments with their associated transactions. </span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-450-5"><ix:continuation id="f-461-1" continuedAt="f-461-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company reclassified interest received to investing activities, as the majority of interest received relates to interest earned on cash and cash equivalents and short-term investments. The Company believes this updated classification better reflects the nature and source of these cash inflows and provides more relevant and reliable information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the voluntary change in accounting policy did not have an impact on basic and diluted earnings per share under </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IAS 33 - Earnings per Share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applied the change in accounting policy retrospectively and has recast prior period comparative information within the Statement of Cash Flows to ensure consistency and comparability with the current period presentation. As part of the retrospective application, cash flows changed as follows for the year ended December&#160;31,&#160;2024: Net cash used in operating activities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="6" id="f-462">1.7</ix:nonFraction>&#160;million, Net cash flow used in investing activities decreased by $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" sign="-" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="6" id="f-463">3.4</ix:nonFraction>&#160;million, and Net cash flow provided by financing activities decreased by $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-5" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="6" id="f-464">1.7</ix:nonFraction>&#160;million. Cash flows changed as follows for the year ended December 31, 2023: Net cash used in operating activities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="ifrs-full:CashFlowsFromUsedInOperatingActivities" scale="6" id="f-465">4.6</ix:nonFraction>&#160;million, Net cash flow provided by investing activities increased by $<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" name="ifrs-full:CashFlowsFromUsedInInvestingActivities" scale="6" id="f-466">4.7</ix:nonFraction>&#160;million, and Net cash flow used in financing activities decreased by less than $<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-5" sign="-" name="ifrs-full:CashFlowsFromUsedInFinancingActivities" scale="6" id="f-467">0.1</ix:nonFraction>&#160;million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New standards, amendments to standards and interpretations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">New standards, amendments to standards, and interpretations issued not yet effective</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2024, IFRS 18, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Presentation and Disclosure in Financial Statements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued to achieve comparability of the financial performance of similar entities. The standard, which will replace IAS 1 impacts the presentation of primary financial statements and notes, including the statement of profit and loss where companies will be required to present separate categories of income and expense for operating, investing, and financing activities with prescribed subtotals for each new category. The standard will also require management-defined performance measures to be explained and included in a separate note within the consolidated financial statements. The standard is effective for annual reporting periods beginning on or after January 1, 2027, and requires retrospective application. While IFRS 18 will not change recognition criteria or measurement bases, it might have a significant impact on presenting information in the financial statements, in particular the income statement. The Company is currently assessing impacts and data readiness.</span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-461-2">There are no other IFRS Accounting Standards or IFRS IC interpretations that are not yet effective and that could have a material impact to the consolidated financial statements</ix:continuation>.</span></div></ix:continuation><div><span><br/></span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_241"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOperatingSegmentsExplanatory" id="f-468" continuedAt="f-468-1" escape="true">Segment reporting</ix:nonNumeric></span></div><ix:continuation id="f-468-1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment. The Company&#8217;s financial information is reviewed, and its performance assessed as a single segment by the senior management team led by the Chief Executive Officer (&#8220;CEO&#8221;), the Company&#8217;s Chief Operating Decision Maker (&#8220;CODM&#8221;). As announced in January 2026, the Company&#8217;s President will be promoted to CEO in 2026 and become the CODM.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2025 and 2024, respectively, the Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.&#160;<ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfGeographicalAreasExplanatory" id="f-469" continuedAt="f-469-1" escape="true">An analysis of the location of non-current assets other than financial instruments and deferred tax assets by country is as follows (in USD thousands):</ix:nonNumeric></span></div><ix:continuation id="f-469-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="3" id="f-470">49,777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="3" id="f-471">44,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="3" id="f-472">2,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="3" id="f-473">2,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="3" id="f-474">1,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="3" id="f-475">1,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" scale="3" id="f-476">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" scale="3" id="f-477">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total non-current assets other than financial instruments <br/>and deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="3" id="f-478">53,938</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" format="ixt:num-dot-decimal" scale="3" id="f-479">48,375</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_244"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory" id="f-480" continuedAt="f-480-1" escape="true">Revenue</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue" id="f-481" continuedAt="f-481-1" escape="true"><ix:continuation id="f-480-1" continuedAt="f-480-2"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting estimates and judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sales transactions may consist of various performance obligations that are satisfied at different times. It requires judgment to determine when different obligations are satisfied, including whether enforceable commitments for further obligations exist and when they arise. Depending on the determination of the performance obligations and the point in time or period over which those obligations are fulfilled, this may result in all revenue being calculated at inception, and either being recognized at once, or on contract completion or spread over the term of a longer performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for contracts that contain promises to deliver more than one good or service, management has to determine how to allocate the total transaction price to the performance obligations of the contract. The total transaction price of a customer contract is allocated to the distinct performance obligations under the contract based on their standalone selling prices (&#8220;SSP&#8221;), the determination of which can require significant judgment from management. The best evidence of this is an observable price from the standalone sales of the good or service to similarly situated customers. However, where standalone selling prices are not observable, it requires judgment to estimate the cost of satisfying a performance obligation and adding an appropriate margin to that good or service. In some cases, SSP is not available and the residual approach is used to determine the stand-alone selling price of certain performance obligations. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue represents amounts received and receivable from third parties for goods supplied and services rendered to customers. Revenues are reported net of rebates and discounts and net of sales and value added taxes in an amount that reflects the consideration that is expected to be received for goods or services. The majority of the sales revenue is recognized: (i)&#160;when customers generate analyses on their patient data through the SOPHiA DDM Platform, (ii)&#160;when consumables, namely DNA enrichment kits, are delivered to customers at which point control transfers, (iii)&#160;when services, namely&#160;set-up&#160;programs, are performed and (iv)&#160;over the duration of the software licensing arrangements for the Alamut software offerings.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products and services are sold both directly to customers and through distributors, generally under agreements with payment terms typically o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f <ix:nonNumeric contextRef="c-51" name="soph:RevenueFromContractsWithCustomersPaymentTerm" format="ixt-sec:durday" id="f-482">30</ix:nonNumeric> to <ix:nonNumeric contextRef="c-52" name="soph:RevenueFromContractsWithCustomersPaymentTerm" format="ixt-sec:durday" id="f-483">60</ix:nonNumeric> days and in rare cases with payment terms extended up to&#160;<ix:nonNumeric contextRef="c-1" name="soph:RevenueFromContractsWithCustomersExtendedPaymentTerm" format="ixt-sec:durday" id="f-484">180</ix:nonNumeric> days.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Therefore, contracts do not contain a significant financing component.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all contracts with customers the following steps are performed to determine the amount of revenue to be recognized and when it should be recognized: (1)&#160;identify the contract or contracts; (2)&#160;determine whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (3)&#160;measure the transaction price, including the constraint on variable consideration; (4)&#160;allocate the transaction price to the performance obligations based on estimated selling prices; and (5)&#160;recognize revenue when (or as) each performance obligation is satisfied.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SOPHiA DDM Platform</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the SOPHiA DDM Platform revenue is derived from each use of the SOPHiA DDM Platform by customers to generat</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e analyses on </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their patient data. Analysis revenue is recognized as analysis results are made available to the customer on the SOPHiA DDM Platform. The Company recognizes accrued contract revenue in accounts receivable for any analyses performed by customers that have not been invoiced at the reporting date and where the right to consideration is unconditional. Any payments received in advance of customers generating analyses are recorded as deferred contract revenue until the analyses are performed.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers use the SOPHiA DDM Platform to perform analyses under three different models: dry lab access; bundle access; and integrated solutions.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For dry lab contracts, customers use the testing instruments and consumables of their choice and the SOPHiA DDM Platform and algorithms for variant detection and identification. In these arrangements, the Company has identified one performance obligation, which is the delivery of the analysis result to the customer.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For bundle arrangements, customers purchase a DNA enrichment kit along with each analysis. Customers use the DNA enrichment kit in the process of performing their own sequencing of each sample. Customers then </span></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-481-1" continuedAt="f-481-2"><ix:continuation id="f-480-2" continuedAt="f-480-3"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">upload their patient data to the SOPHiA DDM Platform for analysis. In these arrangements, the Company has identified two performance obligations: the delivery of the DNA enrichment kits and the performance of the analyses. Revenue is recognized for the DNA enrichment kits when control of products has transferred to the customer, which is generally at the time of delivery, as this is when title and risk of loss have been transferred. Revenue for the performance of the analyses is recognized on delivery of the analysis results to the customer. Refer to&#160;"&#8212;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with multiple performance obligations&#8221;&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for how revenue is allocated between the performance obligations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract revenue balances relating to analyses not performed</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within 12 months from the date of the delivery date are recognized as revenue. This policy is not based on contractual conditions but on the Company&#8217;s experience of customer behavior and expiration dates of the kits associated with the analyses.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For integrated arrangements, customers have their samples processed and sequenced through selected SOPHiA DDM Platform partners within the clinical network and access their data through the SOPHiA DDM Platform. The Company has identified one performance obligation, which is delivery of the analysis results to the customer through the SOPHiA DDM Platform.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sells access to its Alamut software application (&#8220;Alamut&#8221;) through the SOPHiA DDM Platform. Some arrangements with customers allow customers to use Alamut as a hosted software service over the contract period without the customer taking possession of the software. Other customers take possession of the software, but the utility of that software is limited by access to the Company&#8217;s proprietary SOPHiA database, which is provided to the customer on a fixed term basis. Under both models, revenue is recognized on a straight-line basis over the duration of the agreement.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also derives revenue from the SOPHiA DDM Platform by providing services to biopharma customers who engage the Company to (i)&#160;develop and perform customized genomic analyses and/or (ii)&#160;access the database for use in clinical trials and other research projects.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does enter into biopharma contracts that contain multiple products or services or&#160;non-standard&#160;terms and conditions. The biopharma contracts are generally unique in nature and each contract is assessed upon execution. Contracts may contain multiple performance obligations or performance obligations that are recognized overtime, at a point-in-time, or a combination depending on the Company&#8217;s ability to satisfy the requirements to recognize revenue over time and reasonably estimate the amount of revenue to recognize. See "&#8212;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with multiple performance obligation</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s&#8221; below for further discussion on treatment of biopharma contracts.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the primary performance obligation in these arrangements is the delivery of analysis results in the form of a final report, resulting in revenue being recognized, in most cases, upon the issuance of the final report or successful recruitment of clinical trial participants.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Workflow materials and services</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from workflow materials and services includes all revenue from the sale of materials and services that do not form part of a contract for the provision of platform services. These include the provision of&#160;set-up&#160;programs and training and the sale of kits and tests that are not linked to use of the platform.&#160;Set-up&#160;programs and training are typically combined with a customer&#8217;s first order prior to the customer beginning to use the SOPHiA DDM Platform.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from services is generally recognized when the services are performed. Revenue from materials is recognized when control of the goods is transferred to the customer, generally at the time of delivery. This category of re</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venue also includes the revenue from the sale of DNA sequencing automation equipment accounted for under IFRS 16,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;IFRS 16&#8221;), leasing </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the fees charged for the maintenance of this equipment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Arrangements with multiple performance obligations</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells different combinations of analyses, consumables, and services to its customers under its various SOPHiA DDM Platform models.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-481-2" continuedAt="f-481-3"><ix:continuation id="f-480-3" continuedAt="f-480-4"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the stand-alone selling prices for services and DNA enrichment kits are directly observable. For&#160;set-up&#160;programs and training sold along with dry lab arrangements or bundle arrangements, the stand-alone selling price of these services is determined on a time and materials basis. For DNA enrichment kits sold as part of a bundle, the SSP is based on an expected cost-plus-margin approach of the kit portion of the bundle.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the SSP for the analyses, in both a dry lab arrangement and bundle arrangeme</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nt, is highly variable and therefore a representative SSP is not discernible from past transactions. As a result, the residual approach is used to determine the stand-alone selling price of the analyses in dry lab arrangements that include services and in bundle arrangements that include DNA enrichment kits and, in some cases, services.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For bundle contracts with a fixed term that also include providing the customer with DNA sequencing automation equipment, the Company determines if there is an IFRS 16 leasing component. In these arrangements the Company provides DNA sequencing automation equipment to the customer over the fixed term and at completion of the contract term the customer takes possession of the equipment. If the Company has determined that it is a dealer lessor, provision of this equipment to the customer is classified as a finance lease. Over the term of the agreement, the minimum lease payment is deducted from the proceeds of the bundle sales in order to reduce the net investment in the corresponding lease receivable over the contract term and interest income is recognized as the discount on the lease receivable unwinds. The remaining proceeds from the contract are accounted for under IFRS 15,&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;IFRS 15&#8221;), using the policies described above.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses biopharma contrac</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ts upon execution of each contract given their unique nature. The Company establishes each performance obligation within the contract and determines the appropriate value to be ascribed to each performance obligation. When relevant the Company utilizes previous established SSPs of its dry lab and bundle solutions or other service. When the performance obligation is specific to only the contract the Company utilizes all available information to reasonably estimate the correct value allocated to the performance obligation. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract balances</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Deferred contract costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract costs comprise deferred fulfillment costs related to biopharma, prepayments on contracts, and prepaid maintenance costs relating to DNA sequencing automation equipment.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs are incurred to fulfill obligations under certain contracts once obtained, but before transferring goods or services to the customer. Fulfillment costs are recognized as an asset, provided these costs are not addressed by other accounting standards, if the following criteria are met: (i)&#160;the costs relate directly to a contract or an anticipated contract that the Company can specifically identify, (ii)&#160;the costs generate or enhance resources of the Company that will be used in satisfying (or continuing to satisfy) performance obligations in the future and (iii)&#160;the costs are expected to be recovered.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The asset recognized from deferring the costs to fulfill a contract is recorded in the consolidated balance sheet as deferred contract costs within other current assets and amortized on a systematic basis consistent with the&#160;pattern of the transfer of the goods or services to which the asset relates, which depends on the nature of the performance obligation(s) in the contract. The amortization of these assets is recorded in cost of revenue.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition and billings can result in accrued contract revenue, which is presented within accounts receivable in the consolidated balance sheet and deferred contract revenue which is presented on the face of the consolidated balance sheet.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accrued contract revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued contract revenue relates to revenue recognized from satisfied performance obligations prior to invoicing and is primarily related to Dry Lab to be invoiced for the most recently completed month and some portions of biopharma contracts. </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-480-4" continuedAt="f-480-5"><ix:continuation id="f-481-3"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Deferred contract revenue</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract revenue relates to prepayments received from customers before revenue is recognized and is primarily related to SOPHiA DDM Platform analyses invoiced in advance of the customers performing the analyses, deferred Alamut software revenue, and progress payments received as part of biopharma contracts.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract revenue brought forward as of January&#160;1, 2025 and 2024 amounts to $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="soph:DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" scale="6" id="f-485">5.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="soph:DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" scale="6" id="f-486">9.5</ix:nonFraction> million, respectively. During the twelve months ended December 31, 2025 and 2024, the Company satisfied the performance obligations associated with that deferred contract revenue to the extent that revenue was recognized of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="soph:DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" scale="6" id="f-487">5.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="soph:DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" scale="6" id="f-488">9.5</ix:nonFraction>&#160;million, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the platform revenue is derived from contracts with</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an original expected length of one year or less. There are also certain biopharma and Alamut contracts in which performance obligations extend over multiple years, however, these contracts are immaterial. The Company has elected to apply the practical expedient not to disclose the value of remaining performance obligations associated with these types of contracts.</span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregated revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When disaggregating revenue, the Company considered all of the economic factors that may affect its revenues. The Company assesses its revenues by four geographic regions Europe, the Middle East, and Africa (&#8220;EMEA&#8221;); North America (&#8220;NORAM&#8221;); Latin America (&#8220;LATAM&#8221;); and Asia-Pacific (&#8220;APAC&#8221;). Additionally, the Company assesses revenues generated in its domiciled country and any country with significant revenue. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" id="f-489" continuedAt="f-489-1" escape="true">The following table disaggregates the Company's revenue from contracts with customers by geographic market (in USD thousands):</ix:nonNumeric></span></div><ix:continuation id="f-489-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-490">1,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-491">1,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-492">1,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-493">11,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-494">10,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-495">10,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-496">10,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-497">9,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-498">8,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-499">6,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-500">5,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-501">6,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of EMEA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-502">25,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-503">19,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-504">17,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EMEA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-505">55,576</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-506">46,929</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-507">43,958</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-508">10,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-509">9,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-510">9,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of NORAM</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-511">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-512">1,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-513">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NORAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-514">13,400</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-515">11,300</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-516">10,726</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LATAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-517">3,086</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-518">2,890</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-519">3,990</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-520">5,209</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-521">4,054</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-522">3,697</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-523">77,271</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-524">65,173</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-525">62,371</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue streams</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue from contracts with customers has been allocated to the revenue streams indicated in the table below (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA DDM Platform</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-526">74,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-527">63,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-528">60,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workflow equipment and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-529">2,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-530">1,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-531">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-532">77,271</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-533">65,173</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:RevenueFromContractsWithCustomers" format="ixt:num-dot-decimal" scale="3" id="f-534">62,371</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-480-5"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Workflow equipment and services includes revenues from payments from leased equipment recognized under IFRS 16, Leases. During the years ended December 31, 2025, 2024, and 2023, the Company recognized <ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="ifrs-full:OperatingLeaseIncome" format="ixt:fixed-zero" scale="0" id="f-535">no</ix:nonFraction> revenue, $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="ifrs-full:OperatingLeaseIncome" scale="6" id="f-536">0.1</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="ifrs-full:OperatingLeaseIncome" scale="6" id="f-537">0.1</ix:nonFraction>&#160;million, respectively related to leased equipment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Major Customers</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from one customer, a distributor for the Company, represented approximately $<ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="f-538">8.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="ifrs-full:RevenueFromContractsWithCustomers" scale="6" id="f-539">8.2</ix:nonFraction> million of the Company&#8217;s total revenues for the fiscal years ended December 31, 2025 and 2024, respectively. The Company did not have revenues greater than 10% from a single customer in the fiscal year ended December 31, 2023.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_247"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfCostOfSalesExplanatory" id="f-540" continuedAt="f-540-1" escape="true">Cost of revenue</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForCostOfSalesTextBlock" id="f-541" escape="true"><ix:continuation id="f-540-1"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue comprises costs directly incurred in earning revenue, including computer costs and data storage fees paid to hosting providers, manufacturing costs, materials and consumables, the cost of equipment leased out under finance leases, personnel-related expenses and amortization of capitalized development costs.</span></div></ix:continuation></ix:nonNumeric><div id="i949f8e5b3f184d2fadfac47a64e0acc8_250"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfOperatingExpenseTextBlock" id="f-542" continuedAt="f-542-1" escape="true">Operating expense</ix:nonNumeric></span></div><ix:continuation id="f-542-1" continuedAt="f-542-2"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" id="f-543" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs consist of personnel and related expenses for technology, application, and product development, depreciation and amortization, laboratory supplies, consulting services, computational and data storage fees paid to hosting providers related to research and development, and allocated overhead costs. These costs are stated net of government grants for research and development and innovation received as tax credits and net of capitalized costs.</span></div></ix:nonNumeric><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Government grants for research and development and innovation received as tax credits</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives government grants in France for research and development and innovation by way of tax credits. Total government grants for research and development and innovation recognized in the statement of loss amounts to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="soph:ResearchTaxCredit" scale="6" id="f-544">1.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="soph:ResearchTaxCredit" scale="6" id="f-545">0.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="soph:ResearchTaxCredit" scale="6" id="f-546">1.1</ix:nonFraction> million f</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or the years ended December 31, 2025, 2024, and 2023, respectively. </span></div><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock" id="f-547" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and marketing costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and marketing costs consist of personnel and related expenses for the employees of the sales and marketing organization, costs of communications materials that are produced to generate greater awareness and utilization of the platform among customers, costs of third-party market research, costs related to transportation and distribution of products and allocated overhead costs, and commissions to sales employees. The Company also records increases to, reversals of, and write-offs of the allowance for expected credit losses to selling and marketing costs.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company pays sales commission to its employees for obtaining contracts. These costs are expensed as part of employee compensation in selling and marketing costs. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The portion of commission payments to employees where the amortization period is greater than one year are capitalized and expensed as the associated revenue is recognized, see Note 14 &#8212; &#8220;Prepaids and other current assets&#8221; and Note 18 &#8212; &#8220;Other non-current assets&#8221; for the amounts capitalized.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock" id="f-548" continuedAt="f-548-1" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and administrative costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative costs consist of personnel and related expenses for executive, accounting and finance, legal, quality, support and human resources functions, depreciation and amortization, professional </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-542-2"><ix:continuation id="f-548-1"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services fees incurred by these functions, general corporate costs and allocated overhead costs, which include occupancy costs and information technology costs.</span></div></ix:continuation><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expense</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock" id="f-549" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization have been charged in the following expense categories (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.778%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.784%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:fixed-zero" scale="3" id="f-550">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:num-dot-decimal" scale="3" id="f-551">5,266</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:fixed-zero" scale="3" id="f-552">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:num-dot-decimal" scale="3" id="f-553">3,524</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:fixed-zero" scale="3" id="f-554">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:num-dot-decimal" scale="3" id="f-555">2,099</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-556">1,649</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:fixed-zero" scale="3" id="f-557">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-558">1,961</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:fixed-zero" scale="3" id="f-559">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-560">2,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:fixed-zero" scale="3" id="f-561">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Selling and marketing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-562">1,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:fixed-zero" scale="3" id="f-563">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-564">1,349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:fixed-zero" scale="3" id="f-565">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-566">1,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:fixed-zero" scale="3" id="f-567">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">General and administrative costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-568">1,101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="ifrs-full:AmortisationExpense" scale="3" id="f-569">287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-570">1,265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="ifrs-full:AmortisationExpense" scale="3" id="f-571">497</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-572">1,546</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="ifrs-full:AmortisationExpense" scale="3" id="f-573">729</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-574">3,976</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:num-dot-decimal" scale="3" id="f-575">5,553</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-576">4,575</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:num-dot-decimal" scale="3" id="f-577">4,021</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:DepreciationExpense" format="ixt:num-dot-decimal" scale="3" id="f-578">5,508</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:AmortisationExpense" format="ixt:num-dot-decimal" scale="3" id="f-579">2,828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock" id="f-580" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table presents employee costs by function,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which consists of &#8220;Employee benefit expenses&#8221;, &#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Social charges&#8221; and &#8220;Share-based compensation&#8221; (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-581">3,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-582">2,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-583">2,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-584">31,638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-585">31,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-586">31,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-587">25,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-588">20,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-589">20,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-590">33,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-591">32,543</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-592">36,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-593">93,657</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-594">86,149</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" format="ixt:num-dot-decimal" scale="3" id="f-595">90,181</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made adjustments to previously reported employee benefit expenses for the years ended December 31, 2024 and 2023 to include $<ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-596">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" scale="6" id="f-597">2.7</ix:nonFraction> million, respectively, of employee benefit expenses included in cost of revenue to correct for immaterial misstatements.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_253"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory" id="f-598" continuedAt="f-598-1" escape="true">Other operating income, net</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="soph:DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock" id="f-599" escape="true"><ix:continuation id="f-598-1"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records income and expenses that are not regularly occurring or normal business income and expense to other operating income, net. Other operating income, net consists of gains and losses related to the disposal of tangible assets, write-offs of intangible assets and other operating income (expense).</span></div></ix:continuation></ix:nonNumeric><div id="i949f8e5b3f184d2fadfac47a64e0acc8_256"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFinanceCostExplanatory" id="f-600" continuedAt="f-600-1" escape="true">Interest income, Interest expense and Foreign exchange (losses) gains, net</ix:nonNumeric></span></div><ix:continuation id="f-600-1" continuedAt="f-600-2"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory" id="f-601" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists of interest income earned on cash and cash equivalents, short-term investments, and lease receivables. Interest expense consists of interest expense incurred on lease liabilities and loans, which includes interest on commercial borrowings. The foreign exchange gains and losses arise principally on intercompany receivable balances in the parent company, whose functional currency is the Swiss Franc.</span></div></ix:nonNumeric><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest income</span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock" id="f-602" continuedAt="f-602-1" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table presents interest income (in USD thousands):</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-600-2"><ix:continuation id="f-602-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:num-dot-decimal" scale="3" id="f-603">1,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:num-dot-decimal" scale="3" id="f-604">3,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:num-dot-decimal" scale="3" id="f-605">4,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:num-dot-decimal" scale="3" id="f-606">1,872</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:num-dot-decimal" scale="3" id="f-607">3,362</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:RevenueFromInterest" format="ixt:num-dot-decimal" scale="3" id="f-608">4,547</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest expense</span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock" id="f-609" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table presents interest expense (in USD thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpenseOnBankLoansAndOverdrafts" format="ixt:num-dot-decimal" scale="3" id="f-610">3,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:InterestExpenseOnBankLoansAndOverdrafts" format="ixt:num-dot-decimal" scale="3" id="f-611">1,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:InterestExpenseOnBankLoansAndOverdrafts" format="ixt:fixed-zero" scale="3" id="f-612">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="f-613">573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="f-614">567</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:InterestExpenseOnLeaseLiabilities" scale="3" id="f-615">545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpenseOnOtherFinancialLiabilities" scale="3" id="f-616">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:InterestExpenseOnOtherFinancialLiabilities" scale="3" id="f-617">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:InterestExpenseOnOtherFinancialLiabilities" scale="3" id="f-618">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-619">4,554</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-620">1,913</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:InterestExpense" scale="3" id="f-621">588</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign exchange gains (losses), net</span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock" id="f-622" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e table presents foreign exchange gains (losses), net (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains (losses), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-623">3,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-624">3,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-625">7,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total foreign exchange gains (losses), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-626">3,402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-627">3,479</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-628">7,628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_259"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfIncomeTaxExplanatory" id="f-629" continuedAt="f-629-1" escape="true">Income tax</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory" id="f-630" continuedAt="f-630-1" escape="true"><ix:continuation id="f-629-1" continuedAt="f-629-2"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to taxes in different countries. Taxes and related fiscal assets and liabilities recognized in the Company&#8217;s consolidated financial statements reflect management&#8217;s best estimate of the outcome based on the facts known at the balance sheet date in each individual country. These facts may include but are not limited to change in tax laws and interpretation thereof in the various jurisdictions where the Company operates. They may have an impact on the income tax as well as the resulting income tax assets and liabilities. Any differences between tax estimates and final tax assessments are charged to the statement of loss in the period in which they are incurred. Taxes include current and deferred taxes on income as well as actual or potential withholding taxes on current and expected transfers of income from subsidiaries and tax adjustments relating to prior years. Income tax is recognized in the statement of loss, except to the extent that it relates to an item directly taken to other comprehensive income/loss or equity, in which case it is recognized against other comprehensive income/loss or equity, respectively.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current income tax liabilities refer to the portion of the tax on the current year taxable profit (as determined according to the rules of the taxation authorities) and includes uncertain tax liabilities. The Company determines the taxable profit (tax loss), tax bases, unused tax losses, unused tax credits and tax rates consistently with the tax treatment used or planned to be used in its income tax filings if the Company concludes it is probable that the taxation authority will accept an uncertain tax treatment.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Otherwise, the Company reflects the effect of uncertainty using either the most likely outcome or the expected value outcome, depending on which method the entity expects to better predict the resolution of the uncertainty.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes are based on the temporary differences that arise when taxation authorities recognize and measure assets and liabilities with rules that differ from the accounting policies of the Company&#8217;s consolidated </span></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-629-2" continuedAt="f-629-3"><ix:continuation id="f-630-1"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements. They also arise on temporary differences stemming from tax losses carried forward. Deferred taxes are measured at the rates of tax expected to prevail when the temporary differences reverse, subject to such rates being substantively enacted at the balance sheet date. Any changes of the tax rates are recognized in the statement of loss unless related to items directly recognized against other comprehensive income. Deferred tax liabilities are recognized on all taxable temporary differences excluding non-deductible goodwill. Deferred tax assets are recognized for unused tax losses, unused tax credits and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If the amount of taxable temporary differences is insufficient to recognize a deferred tax asset in full, then future taxable profits, adjusted for reversals of existing temporary differences, are considered, on the basis of the business plans for individual subsidiaries in the Company. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impact of a transaction or item can be uncertain until a conclusion is reached with the relevant tax authority or through a legal process. The Company uses in-house tax experts when assessing uncertain tax positions and seeks the advice of external professional advisors where appropriate. The assessment of the uncertain tax position is done by first making a determination of whether it is more likely than not that a tax position would be sustained upon an examination, and then by calculating the amount of the benefit, of that tax position that meets the more likely than not threshold, that should be recognized in the financial statements.</span></div></ix:continuation><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, and 2024, the Company recorded a provi</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sion of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="soph:TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties" scale="6" id="f-631">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="soph:TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties" scale="6" id="f-632">0.2</ix:nonFraction> million, respectively,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for unrecognized tax liabilities including interest and penalties. The Company records interest and penalties related to income tax amounts as a component of income tax </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Uncertain tax positions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates and is therefore subject to tax examination by various taxing authorities. In the normal course of business, the Company is subject to examination by local tax authorities in Switzerland, France, Italy, Brazil, Australia, Germany, the U.K. and the U.S. In 2022 a tax assessment examination was rendered by the French tax authority during an audit of the Company&#8217;s 2018 and 2019 tax returns. In 2023, a tax assessment was rendered by the French tax authority during the review of the 2022 tax return with no additional tax liabilities resulting from the review. In 2024, a tax assessment was rendered by the Swiss tax authority regarding the Company&#8217;s 2019 through 2023 tax returns. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is not aware of any additional issues that could result in any other significant payments, accruals or material deviation from its tax positions. There are no tax examinations in progress as of December 31, 2025.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records tax liabilities or benefits for all years subject to examination based upon management&#8217;s evaluation of the facts, circumstances and information available at the reporting date. There is inherent uncertainty in quantifying income tax positions, especially considering the complex tax laws and regulations in each of the jurisdictions in which the Company operates.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-629-3" continuedAt="f-629-4"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of income tax (expense) benefits</span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock" id="f-633" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the current and deferred income tax (expense) benefits (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:56.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.107%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:CurrentTaxExpenseIncome" format="ixt:num-dot-decimal" scale="3" id="f-634">1,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:CurrentTaxExpenseIncome" format="ixt:num-dot-decimal" scale="3" id="f-635">1,115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:CurrentTaxExpenseIncome" scale="3" id="f-636">215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="3" id="f-637">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="3" id="f-638">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="3" id="f-639">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" format="ixt:num-dot-decimal" scale="3" id="f-640">1,542</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" format="ixt:num-dot-decimal" scale="3" id="f-641">1,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" scale="3" id="f-642">255</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred income tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Origination and reversal of temporary differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" scale="3" id="f-643">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" scale="3" id="f-644">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" scale="3" id="f-645">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred income tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:DeferredTaxExpenseIncome" scale="3" id="f-646">30</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:DeferredTaxExpenseIncome" scale="3" id="f-647">47</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:DeferredTaxExpenseIncome" scale="3" id="f-648">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-649">1,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-650">1,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="f-651">486</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock" id="f-652" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reconciliation of the expected tax expense to the tax expense report in the statement of loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:AccountingProfit" format="ixt:num-dot-decimal" scale="3" id="f-653">77,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:AccountingProfit" format="ixt:num-dot-decimal" scale="3" id="f-654">61,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:AccountingProfit" format="ixt:num-dot-decimal" scale="3" id="f-655">78,495</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at Swiss statutory rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-656">10,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-657">8,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-658">10,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of tax rates in foreign jurisdictions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:TaxEffectOfForeignTaxRates" format="ixt:num-dot-decimal" scale="3" id="f-659">1,197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:TaxEffectOfForeignTaxRates" scale="3" id="f-660">893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:TaxEffectOfForeignTaxRates" scale="3" id="f-661">833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tax effect of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Unrecognized deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="soph:TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" format="ixt:num-dot-decimal" scale="3" id="f-662">8,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="soph:TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" format="ixt:num-dot-decimal" scale="3" id="f-663">6,025</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="soph:TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" format="ixt:num-dot-decimal" scale="3" id="f-664">8,879</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Income not subject to tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="soph:TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="3" id="f-665">260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="soph:TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="3" id="f-666">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="soph:TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss" scale="3" id="f-667">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expense not deductible for tax purposes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" format="ixt:num-dot-decimal" scale="3" id="f-668">1,857</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" format="ixt:num-dot-decimal" scale="3" id="f-669">2,263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" format="ixt:num-dot-decimal" scale="3" id="f-670">2,085</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="3" id="f-671">84</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="3" id="f-672">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod" scale="3" id="f-673">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="3" id="f-674">567</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="3" id="f-675">358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" scale="3" id="f-676">595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-677">1,512</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" format="ixt:num-dot-decimal" scale="3" id="f-678">1,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:IncomeTaxExpenseContinuingOperations" scale="3" id="f-679">486</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Movement in the deferred tax balances</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, the Company recognized deferred tax assets for its foreign subsidiaries due to intercompany transfer pricing arrangements that will assure realization of their respective deferred tax assets in each country. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" id="f-680" continuedAt="f-680-1" escape="true">The following table presents the changes in the Company&#8217;s deferred tax assets and deferred tax liabilities (in USD thousands):</ix:nonNumeric></span></div><ix:continuation id="f-680-1" continuedAt="f-680-2"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.996%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Depreciation &amp;<br/>amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU asset</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net operating loss<br/>carryforward</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-681">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-682">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-683">897</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-684">1,047</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-685">603</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-686">1,150</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-687">1,767</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in profit or loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-688">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" format="ixt:fixed-zero" scale="3" id="f-689">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-690">531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-691">523</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-692">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-693">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-694">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" format="ixt:fixed-zero" scale="3" id="f-695">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" sign="-" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" scale="3" id="f-696">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" format="ixt:fixed-zero" scale="3" id="f-697">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" format="ixt:fixed-zero" scale="3" id="f-698">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" format="ixt:fixed-zero" scale="3" id="f-699">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" format="ixt:fixed-zero" scale="3" id="f-700">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" scale="3" id="f-701">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="3" id="f-702">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-703">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="3" id="f-704">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="3" id="f-705">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="3" id="f-706">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="3" id="f-707">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="3" id="f-708">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-709">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-710">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-711">402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-712">570</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-713">517</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-714">1,143</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-715">1,831</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:fixed-zero" scale="3" id="f-716">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-717">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:fixed-zero" scale="3" id="f-718">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-719">570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-720">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-721">1,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-722">2,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="3" id="f-723">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="3" id="f-724">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-725">402</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="3" id="f-726">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-727">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="3" id="f-728">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-729">424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-629-4" continuedAt="f-629-5"><ix:continuation id="f-680-2" continuedAt="f-680-3"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.445%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.996%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Depreciation &amp;<br/>amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU asset</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net operating loss<br/>carryforward</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-730">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-731">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-732">761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-733">794</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-734">696</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-735">1,010</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-736">1,720</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Recognized in profit or loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-737">123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" format="ixt:fixed-zero" scale="3" id="f-738">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-739">166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-740">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-741">91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-742">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" scale="3" id="f-743">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Currency translation differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="3" id="f-744">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-745">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="3" id="f-746">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="3" id="f-747">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" scale="3" id="f-748">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-749">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-751">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-752">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-753">897</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-754">1,047</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" scale="3" id="f-755">603</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-756">1,150</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="ifrs-full:DeferredTaxLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-757">1,767</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:fixed-zero" scale="3" id="f-758">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:fixed-zero" scale="3" id="f-759">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:fixed-zero" scale="3" id="f-760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-761">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="ifrs-full:DeferredTaxAssets" scale="3" id="f-762">670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-763">1,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:DeferredTaxAssets" format="ixt:num-dot-decimal" scale="3" id="f-764">2,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-765">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="3" id="f-766">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-767">897</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="3" id="f-768">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" scale="3" id="f-769">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:fixed-zero" scale="3" id="f-770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-771">1,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized deferred tax assets</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company recognized deferred tax assets to the extent that it was probable that they would be realized.&#160;<ix:continuation id="f-680-3" continuedAt="f-680-4">The following table consists of the gross tax loss carryforwards and the deferred tax assets that have not been recognized because it is not probable that there will be future taxable profits to use these benefits (in USD thousands):</ix:continuation></span></div><ix:continuation id="f-680-4"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:43.664%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.109%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax effect</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax effect</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductible temporary differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="soph:UnrecognizedDeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-772">7,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="ifrs-full:TaxEffectOfTaxLosses" format="ixt:num-dot-decimal" scale="3" id="f-773">1,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="soph:UnrecognizedDeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-774">4,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="ifrs-full:TaxEffectOfTaxLosses" scale="3" id="f-775">661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="soph:UnrecognizedDeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-776">443,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="ifrs-full:TaxEffectOfTaxLosses" format="ixt:num-dot-decimal" scale="3" id="f-777">59,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="soph:UnrecognizedDeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-778">347,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="ifrs-full:TaxEffectOfTaxLosses" format="ixt:num-dot-decimal" scale="3" id="f-779">46,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:UnrecognizedDeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-780">451,324</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:TaxEffectOfTaxLosses" format="ixt:num-dot-decimal" scale="3" id="f-781">60,885</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:UnrecognizedDeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-782">352,156</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:TaxEffectOfTaxLosses" format="ixt:num-dot-decimal" scale="3" id="f-783">47,205</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net operating loss carryforwards</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company had various net operating loss (&#8220;NOL&#8221;) carryforwards in Switzerland, the U.K., the U.S., and Brazil that are available to reduce future taxable income and income taxes, the majority of which will expire at various dates through</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2032.&#160;</span><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock" id="f-784" continuedAt="f-784-1" escape="true"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company had the following expiring amounts of unrecognized NOL carryforwards (in USD thousands):</span></ix:nonNumeric></div><ix:continuation id="f-784-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:NetOperatingLossCarryforwardsYearOne" format="ixt:num-dot-decimal" scale="3" id="f-785">27,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:NetOperatingLossCarryforwardsYearOne" format="ixt:num-dot-decimal" scale="3" id="f-786">15,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Two years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:NetOperatingLossCarryforwardsYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-787">56,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:NetOperatingLossCarryforwardsYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-788">23,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:NetOperatingLossCarryforwardsYearThree" format="ixt:num-dot-decimal" scale="3" id="f-789">78,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:NetOperatingLossCarryforwardsYearThree" format="ixt:num-dot-decimal" scale="3" id="f-790">49,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Four years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:NetOperatingLossCarryforwardsYearFour" format="ixt:num-dot-decimal" scale="3" id="f-791">89,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:NetOperatingLossCarryforwardsYearFour" format="ixt:num-dot-decimal" scale="3" id="f-792">68,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter and unlimited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:NetOperatingLossCarryforwardsThereafter" format="ixt:num-dot-decimal" scale="3" id="f-793">190,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:NetOperatingLossCarryforwardsThereafter" format="ixt:num-dot-decimal" scale="3" id="f-794">189,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:NetOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-795">443,992</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:NetOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-796">347,533</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future realization of the tax benefits of existing temporary differences and NOL carryforwards ultimately depends on the existence of sufficient taxable income within the carryforward period. As of December 31, 2025, the Company performed an evaluation to determine the likelihood of realization of these tax benefits. In assessing the realization of the deferred tax assets, the Company considered whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company considered all available evidence, both positive and negative, which included the results of operations for the current and preceding years. The Company determined that it was not possible to reasonably quantify future taxable income and determined that it is not probable that all of the deferred tax assets will be realized in Switzerland and Brazil but has recognized deferred tax assets in France, Italy, the U.K. and the U.S.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-629-5"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized deferred tax liability on retained earnings of subsidiaries</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its plan to indefinitely reinvest on a periodic basis for each one of its foreign subsidiaries. In making its decision to indefinitely reinvest, the Company evaluates its plans of reinvestment, its ability to control repatriation and to mobilize funds without triggering basis differences, and the profitability of its Swiss operations and associated cash requirements and the need, if any, to repatriate funds. If the assessment of the Company with respect to any earnings of its foreign subsidiaries&#8217; changes, deferred Swiss income taxes, foreign income taxes, and foreign withholding taxes may have to be accrued.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not provide for foreign income and withholding taxes, Swiss income taxes or</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tax benefits on the excess of the financial reporting basis over the tax basis of its investments in foreign subsidiaries to the&#160;extent that such amounts are indefinitely reinvested to support operations and continued growth plans outside of Switzerland, or if the Company has determined that no tax liability would arise in case of distribution. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, the Company plans to indefinitely reinvest any undistributed foreign </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings for all its foreign subsidiaries except France. During the year 2025, the Company received a dividend payment from its French subsidiary in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" name="ifrs-full:DividendsReceived" scale="6" id="f-797">3.5</ix:nonFraction> million, paid on August&#160;28, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the year 2024, the Company received a dividend payment from its French subsidiary in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="ifrs-full:DividendsReceived" scale="6" id="f-798">3.3</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">repatriation of foreign earnings from France does not trigger a tax liability, based on the application of Swiss Participation Exemption rules and exemptions provided by the Double Tax Treaty signed between France and Switzerland, based on which </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dividends are exempt from withholding tax. The total amount of temporary differences associated with the other investments in subsidiaries is not material.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_262"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory" id="f-799" continuedAt="f-799-1" escape="true">Loss per share</ix:nonNumeric></span><ix:continuation id="f-799-1" continuedAt="f-799-2"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:continuation></div><ix:continuation id="f-799-2"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s shares comprised of ordinary shares. Each share has a nominal value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-58" decimals="INF" name="ifrs-full:ParValuePerShare" scale="0" id="f-800">0.06</ix:nonFraction>&#160;(CHF&#160;<ix:nonFraction unitRef="chfPerShare" contextRef="c-58" decimals="INF" name="ifrs-full:ParValuePerShare" scale="0" id="f-801">0.05</ix:nonFraction>). The basic loss per share is calculated by dividing the net loss attributable to shareholders by the weighted average number of shares in issue during the period excluding treasury shares, which are owned by the Company.&#160;<ix:nonNumeric contextRef="c-1" name="ifrs-full:EarningsPerShareExplanatory" id="f-802" continuedAt="f-802-1" escape="true">The table presents the loss for the year ended December 31, 2025, 2024, and 2023, respectively (in USD thousands, except shares and loss per share):</ix:nonNumeric></span></div><ix:continuation id="f-802-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributed to shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="3" id="f-803">78,999</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="3" id="f-804">62,493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ProfitLossAttributableToOwnersOfParent" format="ixt:num-dot-decimal" scale="3" id="f-805">78,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of shares in issue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-806"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-807">67,539,835</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-808"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-809">66,062,205</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="ifrs-full:AdjustedWeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-810"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="ifrs-full:WeightedAverageShares" format="ixt:num-dot-decimal" scale="0" id="f-811">64,750,886</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic and diluted loss per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-812"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-813">1.17</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-814"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-815">0.95</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="ifrs-full:BasicEarningsLossPerShare" scale="0" id="f-816"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="ifrs-full:DilutedEarningsLossPerShare" scale="0" id="f-817">1.22</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2025, 2024 and 2023, the potential impact, on the calculation of loss per share, of the existing potential ordinary shares related to the share option plans and warrants are not presented, as the impact would be to dilute a loss, which causes them to be deemed &#8220;non-dilutive&#8221; for the purposes of the required disclosure, for additional details refer to Note 22 &#8212; &#8220;Share-Based Compensation&#8221; and Note 23 &#8212; &#8220;Borrowings&#8221;.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_265"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory" id="f-818" continuedAt="f-818-1" escape="true">Cash and cash equivalents</ix:nonNumeric></span></div><ix:continuation id="f-818-1" continuedAt="f-818-2"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" id="f-819" continuedAt="f-819-1" escape="true"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-819-1">Cash and cash equivalents include cash on hand, deposits held at call with external financial institutions, money market funds, and short-term deposits and other short-term highly liquid investments with original maturities of three months or less. They are both readily convertible to known amounts of cash and so near to their maturity that they present insignificant risk of changes in value because of changes in interest rates. Amounts held in money market funds are classified as cash equivalents and are measured as level 1 fair value financial instruments.</ix:continuation> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock" id="f-820" escape="true"><ix:continuation id="f-818-2"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the allocation between the Company&#8217;s cash and cash equivalents (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash on hand</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:BalancesWithBanks" format="ixt:num-dot-decimal" scale="3" id="f-821">37,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:BalancesWithBanks" format="ixt:num-dot-decimal" scale="3" id="f-822">13,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:Cash" format="ixt:num-dot-decimal" scale="3" id="f-823">37,459</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:Cash" format="ixt:num-dot-decimal" scale="3" id="f-824">13,783</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-825">27,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-826">39,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term deposits less than 3 months</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-827">5,302</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-828">26,857</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-829">32,830</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-830">66,443</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-831">70,289</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-832">80,226</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-top:10pt"><span><br/></span></div><div><span><br/></span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_268"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory" id="f-833" continuedAt="f-833-1" escape="true">Accounts receivable</ix:nonNumeric></span></div><ix:continuation id="f-833-1" continuedAt="f-833-2"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" id="f-834" escape="true"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable-trade balances are&#160;non-interest&#160;bearing and payment terms are generally under agreements with payment terms typically between <ix:nonNumeric contextRef="c-51" name="soph:AccountsReceivableNonInterestBearingPaymentTerms" format="ixt-sec:durday" id="f-835">30</ix:nonNumeric> and <ix:nonNumeric contextRef="c-52" name="soph:AccountsReceivableNonInterestBearingPaymentTerms" format="ixt-sec:durday" id="f-836">60</ix:nonNumeric> days with payment terms extended up to&#160;<ix:nonNumeric contextRef="c-1" name="soph:AccountsReceivableNonInterestBearingExtendedPaymentTerm" format="ixt-sec:durday" id="f-837">180</ix:nonNumeric> days. The Company&#8217;s customers primarily consist of government-owned or government-funded hospitals, laboratories with low credit risk, and biopharmaceutical companies. The Company has had minimal instances of actual credit losses and believes that this will continue to be the case.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted the simplified method indicated in IFRS 9,&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;IFRS 9&#8221;), to build its allowance for expected credit losses (&#8220;ECL&#8221;). The Company uses a matrix based on a calculation of collectability rates according to historical accounts receivable. Allowance is made for lifetime expected credit losses as invoices are issued or when accrued revenue is recognized. The amount of allowance initially recognized is based on historical experience, tempered by expected changes in future cash collections, due to, for example, expected improved customer liquidity or more active credit management.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock" id="f-838" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the trade receivable</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, accrued contract revenue,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and lease receivable less the expected credit loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-839">14,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-840">7,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="ifrs-full:FinancialAssets" scale="3" id="f-841">963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="ifrs-full:FinancialAssets" scale="3" id="f-842">742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for expected credit losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="ifrs-full:FinancialAssets" scale="3" id="f-843">366</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" sign="-" name="ifrs-full:FinancialAssets" scale="3" id="f-844">394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-845">15,001</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-846">7,436</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span><br/></span></div><div><span><br/></span></div><ix:continuation id="f-833-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records increases to, reversals of, and write-offs of the allowance for expected credit losses as &#8220;Selling and Marketing&#8221; expenses within its consolidated statements of loss. <ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock" id="f-847" continuedAt="f-847-1" escape="true">The following table provides a rollforward of the allowance for expected credit losses for the year ended December 31, 2025 and 2024, that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected (in USD thousands):</ix:nonNumeric></span></div><ix:continuation id="f-847-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" sign="-" name="ifrs-full:FinancialAssets" scale="3" id="f-848">394</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" sign="-" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-849">1,181</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="3" id="f-850">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLoss" scale="3" id="f-851">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="3" id="f-852">463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss" scale="3" id="f-853">637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-off</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" sign="-" name="ifrs-full:DecreaseThroughWriteoffFinancialAssets" scale="3" id="f-854">155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" sign="-" name="ifrs-full:DecreaseThroughWriteoffFinancialAssets" scale="3" id="f-855">213</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" scale="3" id="f-856">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets" scale="3" id="f-857">51</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" sign="-" name="ifrs-full:FinancialAssets" scale="3" id="f-858">366</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" sign="-" name="ifrs-full:FinancialAssets" scale="3" id="f-859">394</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company&#8217;s largest customer balance represented&#160;<ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="soph:PercentageOfCustomerBalanceAccountReceivable" scale="-2" id="f-860">15</ix:nonFraction>% and&#160;<ix:nonFraction unitRef="number" contextRef="c-4" decimals="2" name="soph:PercentageOfCustomerBalanceAccountReceivable" scale="-2" id="f-861">18</ix:nonFraction>% of accounts receivable, respectively. All customer balances that individually exceeded&#160;1% of accounts receivable in aggregate amounted to $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="soph:AccountsReceivableInAggregateAmount" scale="6" id="f-862">8.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="soph:AccountsReceivableInAggregateAmount" scale="6" id="f-863">5.0</ix:nonFraction> million as of December 31, 2025 and 2024, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded <ix:nonFraction unitRef="usd" contextRef="c-3" decimals="INF" name="soph:LongTermLeaseReceivables" format="ixt:fixed-zero" scale="0" id="f-864"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="INF" name="soph:LongTermLeaseReceivables" format="ixt:fixed-zero" scale="0" id="f-865">no</ix:nonFraction></ix:nonFraction> long-term lease receivables as of December 31, 2025 and 2024, respectively. As of December 31, 2025 and 2024, the Company recorded <ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="soph:NetLeaseReceivables" format="ixt:fixed-zero" scale="0" id="f-866"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="soph:NetLeaseReceivables" format="ixt:fixed-zero" scale="0" id="f-867">no</ix:nonFraction></ix:nonFraction> net lease receivables, respectively.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_271"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfInventoriesExplanatory" id="f-868" continuedAt="f-868-1" escape="true">Inventory</ix:nonNumeric></span></div><ix:continuation id="f-868-1"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories" id="f-869" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials and finished goods are stated at the lower of cost calculated using the first-in, first-out (&#8220;FIFO&#8221;) method and net realizable value. Work in progress is stated at the lower of its weighted average cost and net realizable value. Cost comprises direct materials, direct labor, and an appropriate proportion of variable and fixed overhead expenditure, the latter being allocated on the basis of normal operating capacity.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" id="f-870" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:RawMaterials" format="ixt:num-dot-decimal" scale="3" id="f-871">5,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:RawMaterials" format="ixt:num-dot-decimal" scale="3" id="f-872">5,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:WorkInProgress" format="ixt:num-dot-decimal" scale="3" id="f-873">2,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:WorkInProgress" format="ixt:num-dot-decimal" scale="3" id="f-874">1,321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:FinishedGoods" scale="3" id="f-875">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:FinishedGoods" scale="3" id="f-876">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:ProvisionOfInventory" format="ixt:num-dot-decimal" scale="3" id="f-877">1,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:ProvisionOfInventory" format="ixt:num-dot-decimal" scale="3" id="f-878">1,084</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="3" id="f-879">6,351</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:Inventories" format="ixt:num-dot-decimal" scale="3" id="f-880">5,868</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock" id="f-881" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory provision movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:ProvisionOfInventory" format="ixt:num-dot-decimal" scale="3" id="f-882">1,084</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="soph:ProvisionOfInventory" format="ixt:num-dot-decimal" scale="3" id="f-883">2,134</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:InventoryIncreaseInProvision" scale="3" id="f-884">554</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:InventoryIncreaseInProvision" scale="3" id="f-885">284</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-off</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:InventoryWritedown2011" scale="3" id="f-886">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:InventoryWritedown2011" format="ixt:num-dot-decimal" scale="3" id="f-887">1,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:InventoryCurrencyTranslationAdjustment" scale="3" id="f-888">159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="soph:InventoryCurrencyTranslationAdjustment" scale="3" id="f-889">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:ProvisionOfInventory" format="ixt:num-dot-decimal" scale="3" id="f-890">1,443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:ProvisionOfInventory" format="ixt:num-dot-decimal" scale="3" id="f-891">1,084</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_274"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory" id="f-892" continuedAt="f-892-1" escape="true">Prepaids and other current assets</ix:nonNumeric></span></div><ix:continuation id="f-892-1"><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" id="f-893" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents prepaids and other current assets (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CurrentPrepayments" format="ixt:num-dot-decimal" scale="3" id="f-894">3,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentPrepayments" format="ixt:num-dot-decimal" scale="3" id="f-895">3,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CurrentValueAddedTaxReceivables" format="ixt:num-dot-decimal" scale="3" id="f-896">1,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentValueAddedTaxReceivables" format="ixt:num-dot-decimal" scale="3" id="f-897">1,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grants receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:CurrentGovernmentGrantsReceivable" scale="3" id="f-898">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:CurrentGovernmentGrantsReceivable" format="ixt:fixed-zero" scale="3" id="f-899">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current contract acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:CurrentContractAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-900">2,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:CurrentContractAcquisitionCosts" format="ixt:fixed-zero" scale="3" id="f-901">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:CurrentOtherAssetsMiscellaneous" scale="3" id="f-902">758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:CurrentOtherAssetsMiscellaneous" scale="3" id="f-903">835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-904">7,438</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-905">5,875</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="soph:AmortisationCurrentContractAcquisitionCosts" scale="6" id="f-906">0.2</ix:nonFraction> million of current contract acquisition costs were amortized through Selling and marketing costs.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_277"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory" id="f-907" continuedAt="f-907-1" escape="true">Property and equipment</ix:nonNumeric></span></div><ix:continuation id="f-907-1" continuedAt="f-907-2"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" id="f-908" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment include leasehold improvements, computer hardware, machinery, and furniture and fixtures.</span></div></ix:nonNumeric><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are shown on the balance sheet at their historical cost. The cost of an asset, less any residual value, is depreciated using the straight-line method over the useful life of the asset. For this purpose, assets with similar useful lives have been grouped as follows:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Leasehold improvements&#8212;Shorter of the useful life of the asset or the remaining term of the lease</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Computer hardware&#8212;<span style="-sec-ix-hidden:f-909">Three</span> to <ix:nonNumeric contextRef="c-172" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:durwordsen" id="f-910">five years</ix:nonNumeric></span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Machinery and equipment&#8212;<ix:nonNumeric contextRef="c-173" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:durwordsen" id="f-911">Five years</ix:nonNumeric></span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Furniture and fixtures&#8212;<ix:nonNumeric contextRef="c-174" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" format="ixt-sec:durwordsen" id="f-912">Five years</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Useful lives, components, and residual amounts are reviewed annually. Such a review takes into consideration the nature of the assets, their intended use, including but not limited to the closure of facilities, and the evolution of the technology and competitive pressures that may lead to technical obsolescence. Depreciation of property and equipment is allocated to the appropriate headings of expenses by function in the statement of loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reviews of the carrying amount of the Company&#8217;s property and equipment are performed when there is an indication of impairment. If any such indication exists, then the asset&#8217;s recoverable amount is estimated. The recoverable amount of an asset is the greater of its value in use and its fair value less costs of disposal. In assessing the value in use, the estimated future cash flows are discounted to their present value, based on the time value of money and the risks specific to the country where the assets are located.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company rec</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ords property and equipment under</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> accrued expense for amounts to be paid within the next 12 months. F</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or the year ended December 31, 2025, $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="soph:CurrentAccruedExpensesOnPropertyPlantAndEquipment" scale="6" id="f-913">1.0</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was recorded in accrued expense for property and equipment, an</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d for the year ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2024, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="INF" name="soph:CurrentAccruedExpensesOnPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="0" id="f-914">no</ix:nonFraction> amounts were recorded.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-907-2"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" id="f-915" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Computer hardware</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-916">6,456</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-917">1,861</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-918">1,361</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-919">1,244</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-920">10,922</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-921">1,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-922">403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-923">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-924">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-925">1,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-926">252</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-927">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-928">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-929">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-930">488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-931">971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-932">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-933">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-934">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-935">1,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-936">8,285</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-937">2,557</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-938">1,466</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-939">1,216</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-940">13,524</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-941">2,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-942">1,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-943">973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-944">955</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-945">5,713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" sign="-" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-946">1,181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" sign="-" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-947">303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" sign="-" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-948">180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" sign="-" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-949">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" sign="-" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-950">1,810</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-951">252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-952">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-953">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-954">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-955">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-956">399</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-957">185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-958">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-959">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-960">824</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-961">3,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-962">1,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-963">1,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-964">1,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-965">7,859</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-966">4,342</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-967">899</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-968">248</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-969">176</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-970">5,665</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Computer hardware</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-971">6,855</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-972">1,975</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-973">1,460</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-974">1,310</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-975">11,600</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-976">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-977">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-978">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-979">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-980">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-981">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-982">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-983">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-984">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-985">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-986">485</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-987">163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-988">86</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-989">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-990">815</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-991">6,456</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-992">1,861</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-993">1,361</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-994">1,244</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-995">10,922</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-996">1,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-997">993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-998">831</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-999">731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1000">4,131</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" sign="-" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1001">1,182</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" sign="-" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-1002">269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" sign="-" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-1003">208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" sign="-" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" scale="3" id="f-1004">276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" sign="-" name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1005">1,935</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-1006">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-1007">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-1008">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="ifrs-full:DisposalsPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-1009">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" sign="-" name="ifrs-full:DisposalsPropertyPlantAndEquipment" scale="3" id="f-1010">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-1011">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-1012">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-1013">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-1014">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" scale="3" id="f-1015">339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1016">2,615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1017">1,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-1018">973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-1019">955</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" sign="-" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1020">5,713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1021">3,841</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-1022">691</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-1023">388</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" scale="3" id="f-1024">289</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:PropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1025">5,209</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in leasehold improvements and machinery and equipment are </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-5" name="ifrs-full:ConstructionInProgress" scale="6" id="f-1026">1.1</ix:nonFraction> million and</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" name="ifrs-full:ConstructionInProgress" scale="6" id="f-1027">0.3</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, related to assets under construction that have not yet been placed into service and begun depreciating as of December 31, 2025. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are primarily related to a lab expansion that was completed in early 2026.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_280"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory" id="f-1028" continuedAt="f-1028-1" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" id="f-1029" continuedAt="f-1029-1" escape="true"><ix:continuation id="f-1028-1" continuedAt="f-1028-2"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill impairment testing</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as&#160;a single cash-generating unit (&#8220;CGU&#8221;). As a single CGU, goodwill is tested by considering its recoverability in terms of the entire business. Management assesses the recoverable value of </span></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1029-1" continuedAt="f-1029-2"><ix:continuation id="f-1028-2" continuedAt="f-1028-3"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">goodwill by comparing the Company&#8217;s equity value, either from observable market prices or based on discounted cash flow </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forecasts, to the net assets as reported in the Company&#8217;s consolidated financial statements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment testing is performed on an annual basis as of October 1. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized internally developed software costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized costs are based on the employment costs of individuals working on software development and based on timesheets. Special attention is paid to distinguishing between costs incurred on developing new software or software upgrades, which typically are eligible for capitalization, and costs incurred in maintenance and in the correction of problems, which are not eligible.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgment is required in identifying whether individual projects meet all of the criteria required to permit capitalization, in particular, whether the software will generate probable future economic benefits.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is initially measured as the difference between the aggregate of the value of the consideration transferred and the fair value of net assets acquired. Goodwill is not amortized but it is tested for impairment annually, or more frequently if events or changes in circumstances indicate that it might be impaired and is carried at cost less accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment testing</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are allocated to CGUs for the purpose of impairment testing. The allocation is made to those CGUs or groups of CGUs that are expected to benefit from the business combination in which the goodwill arose. The CGUs or groups of CGUs are identified at the lowest level at which goodwill is monitored for internal management purposes, being the operating segments. As the Company operates as a single CGU, the Company has only a single cash generating unit for impairment testing.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assesses the recoverable value of goodwill by comparing the Company&#8217;s equity value, either inferred from the public prices of share issues based on the fair value less cost of disposal (&#8220;FVLCOD&#8221;) method or based on discounted cash flow forecasts, with the net assets as reported in its consolidated financial statements based on the value in use (&#8220;ViU&#8221;) method. The discounted cash flow approach involves key assumptions that leave considerable scope for judgment. The Company typically compares the two methods and utilizes the greater recoverable amount for the purposes of its impairment testing. Impairment testing is performed on an annual basis as of October 1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchased software</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs of accessing software services are not capitalized if the Company does not have any contractual right to take possession of the software at any time during the term of the agreement and it is not feasible for the Company either to run the software on its own hardware or to contract with a third party unrelated to the vendor. Such costs represent software as a service costs and are expensed as incurred.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does capitalize software implementation costs, such as fees paid to outside consultants to set up a software arrangement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For cloud computing costs, the Company capitalized costs for certain configuration and customization costs paid by a customer in a cloud computing or hosting arrangement. IAS 38 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible assets (&#8220;IAS 38&#8221;)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aligns the accounting treatment of these costs incurred in a hosting arrangement treat</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ed as a service contract with the requirements for capitalization and amortization costs to develop or obtain an intangible asset.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased software and associated capitalized costs are amortized using the&#160;straight-line method&#160;over an estimated life of <ix:nonNumeric contextRef="c-233" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:durwordsen" id="f-1030">five years</ix:nonNumeric>.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1028-3" continuedAt="f-1028-4"><ix:continuation id="f-1029-2"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized internally developed software costs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in the internal development of software are capitalized as intangible assets when they satisfy the criteria required by IAS 38 as set out below.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software development costs consist entirely of capitalized internally generated costs that are directly attributable to the design, testing, and enhancement of identifiable and unique software applications and products controlled by the Company and incorporated principally within the Company&#8217;s SOPHiA DDM Platform. They are recognized as intangible assets where the following criteria are met:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">it is technically feasible to complete the software so that it will be available for use;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">management intends to complete the software and use or sell it;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">there is an ability to use or sell the software;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">it can be demonstrated how the software will generate probable future economic benefits;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">adequate technical, financial, and other resources to complete the development and to use or sell the software are available, and;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the expenditure attributable to the software during its development can be reliably measured.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directly attributable costs that are capitalized as part of the software comprise principally employee costs. Capitalized development costs are recorded as intangible assets and amortized from the point at which the asset is ready for use on a straight-line basis over its expected useful life. Capitalized software development costs are amortized using the&#160;straight-line method&#160;over an estimated life of&#160;<ix:nonNumeric contextRef="c-234" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" format="ixt-sec:durwordsen" id="f-1031">five years</ix:nonNumeric>.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" id="f-1032" continuedAt="f-1032-1" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased software</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capitalized internally developed software costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total intangible assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1033">8,342</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1034">4,046</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1035">27,321</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1036">39,709</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-1037">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" scale="3" id="f-1038">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1039">8,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1040">8,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1041">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" scale="3" id="f-1042">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1043">4,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1044">6,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1045">9,556</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1046">4,748</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1047">39,616</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1048">53,920</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-1049">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1050">3,245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1051">7,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1052">10,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-1053">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" sign="-" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" scale="3" id="f-1054">290</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" sign="-" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1055">5,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" sign="-" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1056">5,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-1057">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" scale="3" id="f-1058">494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1059">1,261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1060">1,755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-1061">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1062">4,029</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1063">14,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1064">18,029</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1065">9,556</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" scale="3" id="f-1066">719</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1067">25,616</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1068">35,891</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1028-4"><ix:continuation id="f-1032-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased software</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capitalized internally developed software costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total intangible assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1069">8,999</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1070">4,162</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1071">21,367</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1072">34,528</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-1073">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" scale="3" id="f-1074">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1075">7,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1076">7,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" scale="3" id="f-1077">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" scale="3" id="f-1078">311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1079">1,783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1080">2,751</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1081">8,342</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1082">4,046</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1083">27,321</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1084">39,709</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-1085">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1086">3,001</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1087">4,342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1088">7,343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-1089">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" sign="-" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" scale="3" id="f-1090">484</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" sign="-" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1091">3,537</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" sign="-" name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1092">4,021</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-1093">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" scale="3" id="f-1094">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" scale="3" id="f-1095">413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" scale="3" id="f-1096">653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:fixed-zero" scale="3" id="f-1097">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1098">3,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1099">7,466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" sign="-" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1100">10,711</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1101">8,342</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" scale="3" id="f-1102">801</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1103">19,855</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:IntangibleAssetsAndGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1104">28,998</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill arose from the Company&#8217;s acquisition of Interactive Biosoftware (&#8220;IBS&#8221;) in June 2018. Through this acquisition the Company added Alamut (a genomic mutation interpretation software) to its existing SOPHiA DDM Platform.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment on an annual basis as of October 1 and at the occurrence of a potential indication of impairment. A triggering assessment is performed each quarter to ensure no occurrence of impairment triggering events. As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively,&#160;<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill" format="ixt:fixed-zero" scale="0" id="f-1105"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill" format="ixt:fixed-zero" scale="0" id="f-1106">no</ix:nonFraction></ix:nonFraction>&#160;impairment charges were recorded related to the Company&#8217;s goodwill.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 1, 2025 and 2024, respectively, the Company utilized the equity method (&#8220;FVLCOD&#8221;) to perform its annual assessment. The estimated equity value of the Company as of October 1, 2025 was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets" scale="6" id="f-1107">301.9</ix:nonFraction>&#160;million, which exceeds the reported net assets of the Company of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ifrs-full:IntangibleAssetsOtherThanGoodwillRevaluationSurplus" scale="6" id="f-1108">60.7</ix:nonFraction>&#160;million at that date by $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets" scale="6" id="f-1109">241.2</ix:nonFraction>&#160;million. The estimated equity value of the Company as of October 1, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets" scale="6" id="f-1110">242.5</ix:nonFraction> million, which exceeds the reported net assets of the Company of $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="ifrs-full:IntangibleAssetsOtherThanGoodwillRevaluationSurplus" scale="6" id="f-1111">113.5</ix:nonFraction> at that date by $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets" scale="6" id="f-1112">129.0</ix:nonFraction>&#160;million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the basis of the analyses performed, the Company concludes that the recoverable amount exceeds the carrying amount of the goodwill and&#160;<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill" format="ixt:fixed-zero" scale="0" id="f-1113"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="INF" name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill" format="ixt:fixed-zero" scale="0" id="f-1114">no</ix:nonFraction></ix:nonFraction>&#160;impairment is needed as of December 31, 2025 and 2024.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_283"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfLeasesExplanatory" id="f-1116" continuedAt="f-1116-1" escape="true">Leases</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory" id="f-1117" continuedAt="f-1117-1" escape="true"><ix:continuation id="f-1116-1" continuedAt="f-1116-2"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses at inception of the contract whether a contract is or contains a lease. This assessment involves determining whether the Company obtains substantially all the economic benefits from the use of that asset, and whether the Company has the right to direct the use of the asset. When these conditions are met, the Company recognizes a&#160;right-of-use&#160;(&#8220;ROU&#8221;) asset and a lease liability at the lease commencement date, except for short-term leases of 12 months or less, which are expensed in the statements of loss on a straight-line basis over the lease term.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, the ROU asset comprises the initial lease liability, initial direct costs, and any obligations to refurbish the asset, less any incentives granted by the lessors.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ROU asset is depreciated over the shorter of the duration of the lease contract (including contractually agreed optional extension periods whose exercise is deemed to be reasonably certain) and the useful life of the underlying asset.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ROU asset is subject to testing for impairment if there is an indicator for impairment, as for owned assets.</span></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1116-2" continuedAt="f-1116-3"><ix:continuation id="f-1117-1" continuedAt="f-1117-2"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that is not readily determinable, the incremental borrowing rate (&#8220;IBR&#8221;) at the lease commencement date. The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. Lease payments can include fixed payments; variable payments that depend on an index or rate known at the commencement date; and extension option payments or purchase options that the Company is reasonably certain to exercise.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease liability is subsequently measured at amortized cost using the effective interest rate method and remeasured (with a corresponding adjustment to the related ROU asset) when there is a change in future lease payments due to renegotiation, changes in an index or rate, or a reassessment of options.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s leases include options to extend the lease, and these options are included in the lease term to the extent they are reasonably certain to be exercised.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases out laboratory equipment to certain customers. These leases are classified as finance leases as the Company transfers substantially all the risks and rewards incidental to ownership of the asset to the customer. Refer to Note 4 &#8212; &#8220;Revenue&#8221; fo</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r disclosure of revenue recognized from leased laboratory equipment.</span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1117-2">At the commencement of the lease term, the Company records revenue and the associated costs of sales, being the sale proceeds at fair value of the asset (computed at cost plus a margin) and the cost of the asset, derecognizes the leased asset from inventory, and recognizes a finance lease receivable on the balance sheet equal to the net investment in the lease. The Company notes these lease agreements ended during 2023, and as of December 31, 2025 and 2024, the Company did not have any leases of laboratory equipment.</ix:continuation> </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company leases</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, the Company entered into&#160;<ix:nonFraction unitRef="lease" contextRef="c-271" decimals="INF" name="soph:NumberOfLeases" format="ixt-sec:numwordsen" scale="0" id="f-1118">one</ix:nonFraction>&#160;office lease as described below.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rolle office</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2021, the Company entered into a&#160;<ix:nonNumeric contextRef="c-272" name="soph:LeaseTerm" format="ixt-sec:durwordsen" id="f-1119">120-month</ix:nonNumeric> lease for office space in Rolle, Switzerland primarily to support the expansion of the research and development department. The lease in total is for approximately&#160;<ix:nonFraction unitRef="sqft" contextRef="c-272" decimals="INF" name="soph:AreaOfOfficeSpaceLeased" format="ixt:num-dot-decimal" scale="0" id="f-1120">65,860</ix:nonFraction>&#160;square feet, including an additional <ix:nonFraction unitRef="sqft" contextRef="c-273" decimals="INF" name="soph:AreaOfOfficeSpaceGainedAccessUnderLease" format="ixt:num-dot-decimal" scale="0" id="f-1121"><ix:nonFraction unitRef="sqft" contextRef="c-273" decimals="INF" name="soph:AreaOfOfficeSpaceGainedAccessUnderLease" format="ixt:num-dot-decimal" scale="0" id="f-1122">21,258</ix:nonFraction></ix:nonFraction> square feet based on a lease amendment as described below, with the Company gaining access to areas on prescribed dates. The Company gained access to&#160;<ix:nonFraction unitRef="sqft" contextRef="c-274" decimals="INF" name="soph:AreaOfOfficeSpaceGainedAccessUnderLease" format="ixt:num-dot-decimal" scale="0" id="f-1123">38,761</ix:nonFraction>&#160;square feet on July 1, 2021,&#160;<ix:nonFraction unitRef="sqft" contextRef="c-275" decimals="INF" name="soph:AreaOfOfficeSpaceGainedAccessUnderLease" format="ixt:num-dot-decimal" scale="0" id="f-1124">5,840</ix:nonFraction>&#160;square feet on January 1, 2022, and the remaining&#160;<ix:nonFraction unitRef="sqft" contextRef="c-276" decimals="INF" name="soph:AreaOfOfficeSpaceGainedAccessUnderLease" format="ixt:num-dot-decimal" scale="0" id="f-1125">21,258</ix:nonFraction>&#160;square feet on February 1, 2023. The&#160;expected lease commitments&#160;are linked to changes in the Swiss Consumer Price Index as published by Swiss Federal Statistical Office.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2022, the Company entered into an amendment to the lease for office space in Rolle, Switzerland. The amendment provides the Company with an additional floor of approximately <ix:nonFraction unitRef="sqft" contextRef="c-273" decimals="INF" name="soph:AreaOfOfficeSpaceGainedAccessUnderLease" format="ixt:num-dot-decimal" scale="0" id="f-1126"><ix:nonFraction unitRef="sqft" contextRef="c-273" decimals="INF" name="soph:AreaOfOfficeSpaceGainedAccessUnderLease" format="ixt:num-dot-decimal" scale="0" id="f-1127">21,258</ix:nonFraction></ix:nonFraction> square feet with lease commencement initiating on April 1, 2022. Upon commencement of the lease, the Company recorded a right-of-use asset of $<ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-5" name="ifrs-full:RightofuseAssets" scale="6" id="f-1128">4.5</ix:nonFraction>&#160;million and a lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-5" name="ifrs-full:LeaseLiabilities" scale="6" id="f-1129">4.5</ix:nonFraction>&#160;million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes fixed payments and additional variable payments depending on the usage of the asset during the contract period. Upon commencement of the lease, the Company recorded a ROU asset of $<ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-5" name="ifrs-full:RightofuseAssets" scale="6" id="f-1130">7.7</ix:nonFraction>&#160;million and a lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-5" name="ifrs-full:LeaseLiabilities" scale="6" id="f-1131">8.5</ix:nonFraction>&#160;million. The difference between the ROU and lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-5" name="soph:LeaseIncentivesAndExpectedRestorationCosts" scale="6" id="f-1132">0.8</ix:nonFraction>&#160;million is driven by lease incentives and expected restoration costs.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1116-3" continuedAt="f-1116-4"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Boston office</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2024, the Company entered into a <ix:nonNumeric contextRef="c-280" name="soph:LeaseTerm" format="ixt-sec:durwordsen" id="f-1133">73-month</ix:nonNumeric> lease for office space in Boston, Massachusetts primarily to support the expansion of the Company&#8217;s growth in the United States. The lease in total is for approximately <ix:nonFraction unitRef="sqft" contextRef="c-280" decimals="INF" name="soph:AreaOfOfficeSpaceLeased" format="ixt:num-dot-decimal" scale="0" id="f-1134">12,807</ix:nonFraction> square feet. The Company makes fixed payments and additional variable payments depending on the usage of the asset during the contract period. Upon gaining access to the space in September 2024, the Company recorded a right-of-use asset of $<ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-5" name="ifrs-full:RightofuseAssets" scale="6" id="f-1135">2.0</ix:nonFraction>&#160;million and a lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-5" name="ifrs-full:LeaseLiabilities" scale="6" id="f-1136">1.9</ix:nonFraction>&#160;million. The difference between the ROU and lease liability of less than $<ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-5" name="soph:LeaseDirectCosts" scale="6" id="f-1137">0.1</ix:nonFraction>&#160;million is driven by initial direct costs to obtain the lease. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bidart office</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2023, the Company entered into a <ix:nonNumeric contextRef="c-283" name="soph:LeaseTerm" format="ixt-sec:durwordsen" id="f-1138">108-month</ix:nonNumeric> lease for office space in Bidart, France primarily to support the expansion of the research and development department and the Company&#8217;s administrative functions. The lease in total is for approximately <ix:nonFraction unitRef="sqft" contextRef="c-283" decimals="INF" name="soph:AreaOfOfficeSpaceLeased" format="ixt:num-dot-decimal" scale="0" id="f-1139">13,509</ix:nonFraction> square feet. Upon commencement of the lease, the Company recorded a right-of-use asset of $<ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-5" name="ifrs-full:RightofuseAssets" scale="6" id="f-1140">2.3</ix:nonFraction>&#160;million and a lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-5" name="ifrs-full:LeaseLiabilities" scale="6" id="f-1141">2.3</ix:nonFraction>&#160;million. The expected lease commitments resulting from this contract are $<ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-5" name="soph:ExpectedLeaseCommitments" scale="6" id="f-1142">0.1</ix:nonFraction>&#160;million in 2023 and $<ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-5" name="soph:ExpectedLeaseCommitments" scale="6" id="f-1143">0.3</ix:nonFraction>&#160;million per year from 2024 onward.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, lease terms for office buildings are between <span style="-sec-ix-hidden:f-1144">one</span> and&#160;<ix:nonNumeric contextRef="c-288" name="soph:LeaseTerm" format="ixt-sec:durwordsen" id="f-1145">ten years</ix:nonNumeric>. Any leases with terms less than 12 months and/or with low value are expensed in accordance with the IFRS 16 practical expedients for short-term leases and&#160;low-value&#160;leases. These expenses amounted to $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="soph:LeaseExpenses" scale="6" id="f-1146">0.1</ix:nonFraction>&#160;million,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> less than $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="soph:LeaseExpenses" scale="6" id="f-1147">0.1</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="soph:LeaseExpenses" scale="6" id="f-1148">0.1</ix:nonFraction>&#160;million for the years ended December 31, 2025, 2024, and 2023, respectively. The Company had cash outflows related to leases less than 12 months and/or with low value of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ifrs-full:CashOutflowForLeases" scale="6" id="f-1149">0.1</ix:nonFraction>&#160;million, less than $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ifrs-full:CashOutflowForLeases" scale="6" id="f-1150">0.1</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="ifrs-full:CashOutflowForLeases" scale="6" id="f-1151">0.1</ix:nonFraction>&#160;million for the years ended December 31, 2025, 2024, and 2023, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has lease liabilities amounting to $<ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-5" name="ifrs-full:LeaseLiabilities" scale="6" id="f-1152">12.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-5" name="ifrs-full:LeaseLiabilities" scale="6" id="f-1153">12.1</ix:nonFraction>&#160;million for the years ended December 31, 2025 and 2024, respectively, that are linked to consumer price indices in Switzerland, France, and the United States.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future cash flow in relation to short-term leases and leases of low value assets is disclosed in Note 25 &#8212; &#8220;Commitments and contingencies.&#8221;</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future cash flow in relation to leases accounted for under IFRS 16 is disclosed in Note 26 &#8212; &#8220;Financial instruments and risks.&#8221;</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has several leases with extension and termination options. Management determines, on the basis of the business needs, whether they expect to exercise these options.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that is not readily determinable, the IBR at the lease commencement date. The IBR is the rate of interest that the Company would have had to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. On the basis of this policy, the IBRs used by the Company to discount lease payments outstanding at December 31, 2025 and 2024, respectively, in the countries in which it has recognized&#160;right-of-use&#160;assets and lease liabilities have been in the range of&#160;to&#160;<ix:nonFraction unitRef="number" contextRef="c-3" decimals="4" name="soph:RightOfUseAssetsDiscountedPaymentsRate" scale="-2" id="f-1154">2.76</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-3" decimals="4" name="soph:LeaseLiabilitiesDiscountedPaymentsRate" scale="-2" id="f-1155">11.42</ix:nonFraction>% and&#160;<ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="soph:RightOfUseAssetsDiscountedPaymentsRate" scale="-2" id="f-1156">2.76</ix:nonFraction>% to&#160;<ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="soph:LeaseLiabilitiesDiscountedPaymentsRate" scale="-2" id="f-1157">11.42</ix:nonFraction>%, respectively. The Company notes the variation in IBRs used is due to the timing of lease commencement as well as geographical differences based on the physical location of the lease.</span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" id="f-1158" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presen</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ts the ROU assets (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Office space leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-3" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1159">12,382</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-3" name="ifrs-full:RightofuseAssets" format="ixt:num-dot-decimal" scale="3" id="f-1160">14,168</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1116-4"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2025 and 2024, the Company had additions to ROUs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:AdditionsToRightofuseAssets" scale="6" id="f-1161">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:AdditionsToRightofuseAssets" scale="6" id="f-1162">2.2</ix:nonFraction> million, respectively and depreciation charges of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1163">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:DepreciationRightofuseAssets" scale="6" id="f-1164">2.6</ix:nonFraction> million, respectively.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock" id="f-1165" escape="true"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the lease liabilities (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.909%"><tr><td style="width:1.0%"/><td style="width:51.083%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.888%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.719%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.891%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1166">2,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1167">2,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:NoncurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1168">12,587</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1169">14,603</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1170">15,287</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:LeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1171">16,793</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2025 and 2024, the Company made payments of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:PrincipalPaidOnLeaseLiabilities" scale="6" id="f-1172">2.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:PrincipalPaidOnLeaseLiabilities" scale="6" id="f-1173">3.3</ix:nonFraction> million, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:InterestPaidOnLeaseLiabilities" scale="6" id="f-1174">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:InterestPaidOnLeaseLiabilities" scale="6" id="f-1175">0.6</ix:nonFraction> million was interest, respectively.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_286"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory" id="f-1176" continuedAt="f-1176-1" escape="true">Other non-current assets</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock" id="f-1177" escape="true"><ix:continuation id="f-1176-1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets consist of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:NoncurrentValueAddedTaxReceivables" format="ixt:num-dot-decimal" scale="3" id="f-1178">4,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:NoncurrentValueAddedTaxReceivables" format="ixt:num-dot-decimal" scale="3" id="f-1179">4,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantee deposits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:NonCurrentDepositsGuarantyAssets" format="ixt:num-dot-decimal" scale="3" id="f-1180">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:NonCurrentDepositsGuarantyAssets" format="ixt:num-dot-decimal" scale="3" id="f-1181">1,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:InvestmentAccountedForUsingEquityMethod" format="ixt:num-dot-decimal" scale="3" id="f-1182">1,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:InvestmentAccountedForUsingEquityMethod" format="ixt:fixed-zero" scale="3" id="f-1183">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non&#8209;current contract acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:NonCurrentContractAcquisitionCosts" scale="3" id="f-1184">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:NonCurrentContractAcquisitionCosts" format="ixt:fixed-zero" scale="3" id="f-1185">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1186">8,183</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:OtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-1187">5,762</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i949f8e5b3f184d2fadfac47a64e0acc8_289"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory" id="f-1188" continuedAt="f-1188-1" escape="true">Accounts payable</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock" id="f-1189" escape="true"><ix:continuation id="f-1188-1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable consist of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade payables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="3" id="f-1190">5,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="3" id="f-1191">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related payables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:EmployeeRelatedPayables" format="ixt:num-dot-decimal" scale="3" id="f-1192">2,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:EmployeeRelatedPayables" format="ixt:num-dot-decimal" scale="3" id="f-1193">2,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT, sales, and other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:ValueAddedTaxesSalesTaxesAndOtherTaxesPayables" scale="3" id="f-1194">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:ValueAddedTaxesSalesTaxesAndOtherTaxesPayables" scale="3" id="f-1195">658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="3" id="f-1196">8,960</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" format="ixt:num-dot-decimal" scale="3" id="f-1197">5,220</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i949f8e5b3f184d2fadfac47a64e0acc8_292"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">20. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory" id="f-1198" continuedAt="f-1198-1" escape="true">Accrued expenses</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock" id="f-1199" escape="true"><ix:continuation id="f-1198-1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:AccruedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1200">15,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:AccruedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1201">10,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:AccruedProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-1202">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:AccruedProfessionalFees" format="ixt:num-dot-decimal" scale="3" id="f-1203">1,422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:AccruedInventoryPurchases" scale="3" id="f-1204">420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:AccruedInventoryPurchases" scale="3" id="f-1205">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued IT support</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:AccruedITSupport" scale="3" id="f-1206">701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:AccruedITSupport" scale="3" id="f-1207">570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued legal fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:AccruedLegalFees" scale="3" id="f-1208">824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:AccruedLegalFees" format="ixt:fixed-zero" scale="3" id="f-1209">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:AccruedOther" format="ixt:num-dot-decimal" scale="3" id="f-1210">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:AccruedOther" scale="3" id="f-1211">323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:CurrentAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1212">20,736</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:CurrentAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1213">13,217</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_295"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">21. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfEmployeeBenefitsExplanatory" id="f-1214" continuedAt="f-1214-1" escape="true">Post-employment benefits</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" id="f-1215" continuedAt="f-1215-1" escape="true"><ix:continuation id="f-1214-1" continuedAt="f-1214-2"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting estimates and judgments</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability or asset recognize</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d on the balance</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation at the end of the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by independent actuaries using the projected unit credit method.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms approximating to the terms of the related obligation. In countries where there is no deep market in such bonds, the market rates on government bonds are used.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the statement of loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remeasurement gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which they occur, directly in other comprehens</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ive income. The remeasurement gains and losses are included in retained earnings in the statement of changes in equity and on the balance sheet.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in income as past service costs.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For defined contribution plans, the Company pays contributions to publicly or privately administered pension insurance plans. Employee contributions to these plans is voluntary and these contributions are matched by the employer. The Company has no further payment obligations once the contributions have been paid. The contributions are recognized as employee benefit expense when they are due. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in the future payments is available. Contributions are charged to the statement of loss as incurred.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates defined benefit and defined contribution pension plans. Funded schemes are generally funded through payments to insurance companies or trustee-administered funds, determined by periodic actuarial calculations. A defined </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity (a fund) and has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods. A defined benefit plan is a pension plan that is not a defined contribution plan. Typically, defined benefit plans define an amount of pension benefit that an employee will receive on retirement, usually dependent on one or more factors such as age, years of service and compensation.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual return on plan assets, excluding interest income measured at the discount rate, is recognized in other comprehensive income/loss within defined benefit plan remeasurements.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a funded defined benefit plan in Switzerland, an unfunded defined benefit plan in France, and a defined</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contribution plan in the U.S. The Company has no occupational pension plans in the U.K. and Brazil.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Swiss pension plan</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracted with the Swiss Life Collective BVG Foundation based in Zurich for the provision of occupational benefits. All benefits in accordance with the regulations are reinsured in their entirety with Swiss Life SA within the framework of the corresponding contract. This pension solution fully reinsures the risks of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disability, death and longevity with Swiss Life. Swiss Life invests the vested pension capital and provides a&#160;100% capital and interest guarantee. The pension plan is entitled to an annual bonus from Swiss Life comprising the effective savings, risk and cost results. As of January 1, 2025, the Company switched from Swiss Life Collective BVG Foundation to Profond for the provision of occupational benefits. </span></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1214-2" continuedAt="f-1214-3"><ix:continuation id="f-1215-1"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the amount of ultimate pension benefit is not defined, certain legal obligations of the plan create constructive obligations on the employer to pay further contributions to fund an eventual deficit; this results in the plan nevertheless being accounted for as a defined benefit plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">French pension plan</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In France, the bulk of pensions are paid by national pension schemes, which are unfunded. In addition, French employers are obliged by law to pay a retirement indemnity. Its amount depends on the last salary of the employee and on the period of activity with its employer. Rights to this benefit are acquired during the service life with the same employer on the condition that the employee will be with its employer at retirement date; it means that the rights are only vested on retirement date. This indemnit</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y is in substance a defined benefit plan.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory" id="f-1216" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional details on the defined benefit plans&#8217; funded status (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of defined benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="3" id="f-1217">28,429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="3" id="f-1218">23,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1219">24,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1220">19,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net pension liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="ifrs-full:SurplusDeficitInPlan" format="ixt:num-dot-decimal" scale="3" id="f-1221">4,162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="ifrs-full:SurplusDeficitInPlan" format="ixt:num-dot-decimal" scale="3" id="f-1222">3,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock" id="f-1223" continuedAt="f-1223-1" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the movement in the defined benefit obligation (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.996%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.952%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="3" id="f-1224">23,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="f-1225">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="3" id="f-1226">23,199</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="3" id="f-1227">22,972</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="f-1228">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="3" id="f-1229">23,013</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1230">1,827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" scale="3" id="f-1231">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1232">1,841</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1233">2,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" scale="3" id="f-1234">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1235">2,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">of which current service cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="ifrs-full:CurrentServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1236">1,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="ifrs-full:CurrentServiceCostDefinedBenefitPlans" scale="3" id="f-1237">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:CurrentServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1238">1,841</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="ifrs-full:CurrentServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1239">1,683</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="ifrs-full:CurrentServiceCostDefinedBenefitPlans" scale="3" id="f-1240">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:CurrentServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1241">1,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">of which past service cost including effects from curtailment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1242">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1244">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" sign="-" name="ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" scale="3" id="f-1245">942</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1246">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" scale="3" id="f-1247">942</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="f-1248">227</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="f-1249">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="f-1250">229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="f-1251">293</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="f-1252">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:InterestExpenseDefinedBenefitPlans" scale="3" id="f-1253">294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" scale="3" id="f-1254">185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" sign="-" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" scale="3" id="f-1255">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" scale="3" id="f-1256">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" sign="-" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1257">1,342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1258">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1259">1,342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual plan participants&#8217; contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1260">1,461</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-1261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1262">1,461</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1263">1,295</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-1264">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1265">1,295</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers (in) out due to (joiners) leavers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1266">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1267">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1268">1,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1269">3,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1270">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1271">3,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" sign="-" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1272">3,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" sign="-" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" scale="3" id="f-1273">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1274">3,466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1275">1,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" scale="3" id="f-1276">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1277">1,738</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="3" id="f-1278">28,345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="f-1279">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="3" id="f-1280">28,429</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="3" id="f-1281">23,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" scale="3" id="f-1282">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:DefinedBenefitObligationAtPresentValue" format="ixt:num-dot-decimal" scale="3" id="f-1283">23,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost and interest expense are charged to the statement of loss as research and development, general and administrative costs, selling and marketing, and interest income, net, respectively. Actuarial gains (losses) are credited or charged to other comprehensive income (loss) as defined benefit plan remeasurements.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s of December 31, 2025, the Swiss and French plans had&#160;<ix:nonFraction unitRef="member" contextRef="c-303" decimals="INF" name="soph:NumberOfActiveMembers" scale="0" id="f-1284">210</ix:nonFraction>&#160;and <ix:nonFraction unitRef="member" contextRef="c-304" decimals="INF" name="soph:NumberOfActiveMembers" scale="0" id="f-1285">89</ix:nonFraction>&#160;active members, respectively. As of December 31, 2024, the Swiss and French plans had&#160;<ix:nonFraction unitRef="member" contextRef="c-305" decimals="INF" name="soph:NumberOfActiveMembers" scale="0" id="f-1286">209</ix:nonFraction>&#160;and&#160;<ix:nonFraction unitRef="member" contextRef="c-306" decimals="INF" name="soph:NumberOfActiveMembers" scale="0" id="f-1287">84</ix:nonFraction>&#160;active members, respectively.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the reduction in conversion factors, the Company incurred a past service cost</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gain including curtailment of $<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-5" sign="-" name="ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" scale="6" id="f-1288">0.9</ix:nonFraction>&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the year ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1214-3" continuedAt="f-1214-4"><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock" id="f-1289" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the movement in the defined benefit plans&#8217; assets (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1290">19,360</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1291">19,927</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="3" id="f-1292">203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" scale="3" id="f-1293">270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on plan assets, excl. interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="3" id="f-1294">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1295">1,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:AdministrativeExpensesNetDefinedBenefitLiabilityAsset" scale="3" id="f-1296">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:AdministrativeExpensesNetDefinedBenefitLiabilityAsset" scale="3" id="f-1297">61</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1298">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1299">1,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1300">1,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1301">1,295</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers in (out) due to joiners (leavers)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1302">1,587</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1303">3,644</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1304">2,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1305">1,485</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1306">24,267</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1307">19,360</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory" id="f-1308" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the defined benefit plan assets, which include the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" format="ixt:fixed-zero" scale="0" id="f-1309">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" scale="3" id="f-1310">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1311">24,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="3" id="f-1312">18,895</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1313">24,267</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1314">19,360</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">French plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-3" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1315">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-3" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1316">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swiss plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-3" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1317">24,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-3" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1318">19,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1319">24,267</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:PlanAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1320">19,360</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Profond, and previously the Swiss Life Collective BVG Foundation, to which the Swiss pension plan is affiliated, manages its funds in the interests of all members, with due attention to the priorities of liquidity, security, and return. The Company&#8217;s pension plan benefits from the economies of scale and diversification of risk available through this affiliation. The Company has no influence over the investment policy.</span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock" id="f-1321" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the pension costs recognized in sta</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tement of loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.935%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1322">1,827</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" scale="3" id="f-1323">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1324">1,841</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1325">2,625</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" scale="3" id="f-1326">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1327">2,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1328">1,311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" scale="3" id="f-1329">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="soph:ServiceCostDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1330">1,321</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="ifrs-full:InterestExpenseIncomeDefinedBenefitPlans" scale="3" id="f-1331">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="ifrs-full:InterestExpenseIncomeDefinedBenefitPlans" scale="3" id="f-1332">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:InterestExpenseIncomeDefinedBenefitPlans" scale="3" id="f-1333">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="ifrs-full:InterestExpenseIncomeDefinedBenefitPlans" scale="3" id="f-1334">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="ifrs-full:InterestExpenseIncomeDefinedBenefitPlans" scale="3" id="f-1335">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:InterestExpenseIncomeDefinedBenefitPlans" scale="3" id="f-1336">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="ifrs-full:InterestExpenseIncomeDefinedBenefitPlans" scale="3" id="f-1337">413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="ifrs-full:InterestExpenseIncomeDefinedBenefitPlans" scale="3" id="f-1338">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:InterestExpenseIncomeDefinedBenefitPlans" scale="3" id="f-1339">414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1340">1,851</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="3" id="f-1341">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1342">1,867</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1343">2,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="3" id="f-1344">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1345">2,661</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1346">1,724</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" scale="3" id="f-1347">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1348">1,735</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1214-4" continuedAt="f-1214-5"><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock" id="f-1349" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the pension remeasurement recognized in statement of other comprehensive loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.384%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.328%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in demographic assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1352">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1356">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1357">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1358">700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in financial assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1359">439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1360">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1361">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1362">1,908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1363">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1364">1,908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1365">901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1366">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1367">903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1368">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1370">254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1371">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1373">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1374">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1375">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" scale="3" id="f-1376">606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" scale="3" id="f-1377">185</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" sign="-" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" scale="3" id="f-1378">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" scale="3" id="f-1379">180</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" sign="-" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1380">1,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1381">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" format="ixt:num-dot-decimal" scale="3" id="f-1382">1,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" scale="3" id="f-1383">401</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" scale="3" id="f-1384">2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="soph:ActuarialGainsLossesNetDefinedBenefitPlans" scale="3" id="f-1385">403</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="3" id="f-1386">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-1387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="3" id="f-1388">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1389">1,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-1390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" format="ixt:num-dot-decimal" scale="3" id="f-1391">1,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="3" id="f-1392">654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" format="ixt:fixed-zero" scale="3" id="f-1393">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" scale="3" id="f-1394">654</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1395">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1396">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1397">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" format="ixt:fixed-zero" scale="3" id="f-1398">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" sign="-" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" scale="3" id="f-1399">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" scale="3" id="f-1400">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" sign="-" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" scale="3" id="f-1401">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" sign="-" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" scale="3" id="f-1402">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" scale="3" id="f-1403">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-1404">709</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-1405">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-1406">704</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-1407">326</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-1408">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-1409">327</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-1410">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-1411">4</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" scale="3" id="f-1412">212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demographic assumptions had no impact for 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as these assumptions had no significant changes from 2024. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The positive impact of changes in demographic assumptions in 2023 was due principally to an increase in the weighted turnover f</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rom&#160;<ix:nonFraction unitRef="number" contextRef="c-12" decimals="4" name="soph:DemographicAssumptionOfWeightedTurnoverRates" scale="-2" id="f-1413">15.80</ix:nonFraction>% to&#160;<ix:nonFraction unitRef="number" contextRef="c-23" decimals="4" name="soph:DemographicAssumptionOfWeightedTurnoverRates" scale="-2" id="f-1414">19.50</ix:nonFraction>%. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The positive impact of changes in financial assumptions for the funded plan in 2025 was due to an increase in the discount rate from <ix:nonFraction unitRef="number" contextRef="c-293" decimals="4" name="soph:FinancialAssumptionOfDiscountRates" scale="-2" id="f-1415">0.95</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-301" decimals="4" name="soph:FinancialAssumptionOfDiscountRates" scale="-2" id="f-1416">1.10</ix:nonFraction>%.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The negative impact of chan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ges in financial assumptions in 2024 was due to a decrease in the discount rate from <ix:nonFraction unitRef="number" contextRef="c-23" decimals="4" name="soph:FinancialAssumptionOfDiscountRates" scale="-2" id="f-1417">1.50</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="soph:FinancialAssumptionOfDiscountRates" scale="-2" id="f-1418">0.95</ix:nonFraction>%.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The negative experience adjustments for the funded plan in 2025 was primarily due to actual effective salary increases exceeding the assumed rate as well as by departure-related payments that were lower than expected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The positive experience adjustments in 2024 was due largely to the surplus between the additional defined benefit obligation attributable to new joiners and the assets that they transferred into the plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key actuarial assumptions by plan</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Discount rate</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In estimating the defined benefit obligation, the discount rates used were, for the Swiss plan, <ix:nonFraction unitRef="number" contextRef="c-303" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-1419">1.10</ix:nonFraction>% and&#160;<ix:nonFraction unitRef="number" contextRef="c-305" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-1420">0.95</ix:nonFraction>% and, for the French plan,&#160;<ix:nonFraction unitRef="number" contextRef="c-304" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-1421">4.05</ix:nonFraction>% and&#160;<ix:nonFraction unitRef="number" contextRef="c-306" decimals="4" name="ifrs-full:ActuarialAssumptionOfDiscountRates" scale="-2" id="f-1422">3.55</ix:nonFraction>% for the years ended December 31, 2025 and 2024, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Expected rate of salary increase</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">T</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he expected rate of annual salary increase was assumed to be, for the Swiss plan,&#160;<ix:nonFraction unitRef="number" contextRef="c-303" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-1423">2.50</ix:nonFraction>% and&#160;<ix:nonFraction unitRef="number" contextRef="c-305" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-1424">2.50</ix:nonFraction>% and, for the French plan,&#160;<ix:nonFraction unitRef="number" contextRef="c-304" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-1425">3.00</ix:nonFraction>% and&#160;<ix:nonFraction unitRef="number" contextRef="c-306" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" scale="-2" id="f-1426">3.00</ix:nonFraction>% for the years ended December 31, 2025 and 2024, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pension plan modified duration</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average modified duration of the Swi</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ss plan is <ix:nonNumeric contextRef="c-313" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="f-1427">13.7</ix:nonNumeric> and&#160;<ix:nonNumeric contextRef="c-314" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="f-1428">13.6</ix:nonNumeric> years and of the French plan <ix:nonNumeric contextRef="c-315" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="f-1429">15.1</ix:nonNumeric> and&#160;<ix:nonNumeric contextRef="c-316" name="ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019" format="ixt-sec:duryear" id="f-1430">15.3</ix:nonNumeric> years for the years ended December 31, 2025 and 2024, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1214-5" continuedAt="f-1214-6"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Interest rates</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Swiss plan, the interest on old age accounts is <ix:nonFraction unitRef="number" contextRef="c-313" decimals="4" name="soph:LPPInterestRate" scale="-2" id="f-1431">2.30</ix:nonFraction>% for the year ended December 31, 2025. For the year ended December 31, 2024 the interest on old age accounts is based, for the LPP account, on the LPP interest rate, which was&#160;<ix:nonFraction unitRef="number" contextRef="c-314" decimals="4" name="soph:LPPInterestRate" scale="-2" id="f-1432">2.30</ix:nonFraction>% and, for the extra mandatory part, is equivalent to the discount rate, which was&#160;<ix:nonFraction unitRef="number" contextRef="c-314" decimals="4" name="soph:ExtraMandatoryPartEquivalentToDiscountRate" scale="-2" id="f-1433">2.30</ix:nonFraction>%.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Inflation</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected annual rate of inflation was assumed to be, for the Swiss plan, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-303" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-1434">0.75</ix:nonFraction>% </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-305" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-1435">1.00</ix:nonFraction>%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the French plan </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-304" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-1436">2.00</ix:nonFraction>% </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-306" decimals="4" name="ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation" scale="-2" id="f-1437">2.00</ix:nonFraction>%</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the years ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exp</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ected annual rate of inflation for the Swiss plan is based on the inflation forecast of the Swiss National Bank. and for the French plan is based on the inflation forecast of the European Central Bank.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Mortality tables</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions regarding future mortality experience are set based on actuarial advice provided in accordance with published statistics and experience and are based on the mortality generational tables BGV 2020 (Swiss) and TH/TF&#160;00-02&#160;(French). For the Swiss plan, the average life expectancy in years after retirement of a pensioner retiring at age 65 (male) and 65 (female) on the balance sheet date is, respe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ctively, <ix:nonNumeric contextRef="c-1" name="soph:AverageLifeExpectancyInYearsAfterRetirementForMale" format="ixt-sec:duryear" id="f-1438">23.07</ix:nonNumeric> and <ix:nonNumeric contextRef="c-1" name="soph:AverageLifeExpectancyInYearsAfterRetirementForFemale" format="ixt-sec:duryear" id="f-1439">24.81</ix:nonNumeric> and <ix:nonNumeric contextRef="c-4" name="soph:AverageLifeExpectancyInYearsAfterRetirementForMale" format="ixt-sec:duryear" id="f-1440">22.82</ix:nonNumeric> and <ix:nonNumeric contextRef="c-4" name="soph:AverageLifeExpectancyInYearsAfterRetirementForFemale" format="ixt-sec:duryear" id="f-1441">24.59</ix:nonNumeric>, for the years ended December 31, 2025 and 2024, respectively.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sensitivity analysis</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables demonstrate the sensitivity of the defined benefit obligations to changes in the discount rate, expected rates of salary increase, interest credited on savings accounts (interest rate), inflation, and life expectancy at retirement age.</span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" id="f-1442" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the sensitivity analysis for the funded plans (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of <ix:nonFraction unitRef="number" contextRef="c-317" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-4" id="f-1443">25</ix:nonFraction> basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1444">763</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1445">682</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of <ix:nonFraction unitRef="number" contextRef="c-317" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-4" id="f-1446">25</ix:nonFraction> basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1447">826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1448">738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected rates of salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of <ix:nonFraction unitRef="number" contextRef="c-319" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-4" id="f-1449">25</ix:nonFraction> basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1450">262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1451">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of <ix:nonFraction unitRef="number" contextRef="c-319" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-4" id="f-1452">25</ix:nonFraction> basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1453">261</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1454">137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of <ix:nonFraction unitRef="number" contextRef="c-321" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-4" id="f-1455">25</ix:nonFraction> basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1456">265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1457">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of <ix:nonFraction unitRef="number" contextRef="c-321" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-4" id="f-1458">25</ix:nonFraction> basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1459">258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1460">226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inflation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of <ix:nonFraction unitRef="number" contextRef="c-323" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-4" id="f-1461">25</ix:nonFraction> basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1462">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1463">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of <ix:nonFraction unitRef="number" contextRef="c-323" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-4" id="f-1464">25</ix:nonFraction> basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1465">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1466">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Life expectancy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of <ix:nonNumeric contextRef="c-325" name="soph:PeriodOfReasonablyPossibleIncreaseInActuarialAssumption" format="ixt-sec:duryear" id="f-1467">1</ix:nonNumeric> year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1468">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1469">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of <ix:nonNumeric contextRef="c-325" name="soph:PeriodOfReasonablyPossibleDecreaseInActuarialAssumption" format="ixt-sec:duryear" id="f-1470">1</ix:nonNumeric> year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1471">182</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1472">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1214-6"><ix:continuation id="f-1223-1"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the sensitivity analysis for the unfunded plans (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of&#160;<ix:nonFraction unitRef="number" contextRef="c-327" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-4" id="f-1473">50</ix:nonFraction>&#160;basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1474">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1475">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of <ix:nonFraction unitRef="number" contextRef="c-327" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-4" id="f-1476">50</ix:nonFraction> basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1477">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1478">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected rates of salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of&#160;<ix:nonFraction unitRef="number" contextRef="c-329" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" scale="-4" id="f-1479">50</ix:nonFraction>&#160;basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1480">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-3" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" scale="3" id="f-1481">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of <ix:nonFraction unitRef="number" contextRef="c-329" decimals="4" name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" scale="-4" id="f-1482">50</ix:nonFraction> basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1483">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-3" sign="-" name="ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" scale="3" id="f-1484">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above sensitivity analyses are based on a change in an assumption while holding all other assumptions constant. In practice, this is unlikely to occur, and changes in some of the assumptions may be correlated. When calculating the sensitivity of the defined benefit obligation to significant actuarial assumptions the same method (present value of the defined benefit obligation calculated with the projected unit credit method at the end of the reporting period) has been applied as when calculating the pension liability recognized on the balance sheet.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The methods and types of assumptions used in preparing the sensitivity analysis did not change compared to the prior period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future employer contributions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected employer contributions to the Swiss defined benefit pension plan for the year ending December 31, 2026 amount to $<ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-5" name="ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan" scale="6" id="f-1485">1.3</ix:nonFraction>&#160;million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined contribution plans</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. pension plan</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a multiple employer 401(k) defined contribution plan in the U.S. The expense recognized in respect of the defined contribution plan in the U.S. was $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="6" id="f-1486"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-5" name="ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans" scale="6" id="f-1487">0.3</ix:nonFraction></ix:nonFraction>&#160;million for the years ended December 31, 2025 and 2024, respectively.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_298"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">22. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory" id="f-1488" continuedAt="f-1488-1" escape="true">Share-based compensation</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" id="f-1489" continuedAt="f-1489-1" escape="true"><ix:continuation id="f-1488-1" continuedAt="f-1488-2"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting estimates and judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-based Compensation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2025, 2024, and 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company granted share options under one plan - the SOPHiA GENETICS 2021 Equity Incentive Plan (the &#8220;2021 Equity Incentive Plan&#8221; or the &#8220;2021 EIP&#8221;). Under this plan, directors may offer options to directors, employees, and advisors. The exercise price of the share options is set at the time they are granted. Options, once vested, can be exchanged for an equal number of ordinary shares.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measuring the cost of share options</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options under all plans are measured at each grant date using the Black-Scholes option pricing model, taking into account the terms and conditions upon which the options were granted.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For options up to September 2020, the fair value at grant date is independently determined using an adjusted form of the Black-Scholes option pricing model that takes into account the strike price, the fair value of the share at grant date, the expected life of the award, the expected price volatility of the underlying share, the risk-free interest rate for the term of the award, and the expected dividend yield.&#160;For options granted on and subsequent to September&#160;2020 until July 22, 2021, the fair value at grant date is based </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on a probability-weighted expected returns method that takes account of both the value derived by using an adjusted form of the Black-Scholes </span></div></ix:continuation></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1489-1" continuedAt="f-1489-2"><ix:continuation id="f-1488-2" continuedAt="f-1488-3"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">option pricing model, as described above, and a discounted estimate of the price that might be achieved in a future transaction.&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For options granted on and subsequent to July 22, 2021, the fair value at grant date is determined by using the Black-Scholes option pricing model.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has used an independent valuation firm to assist in calculating the fair value of the award grants per participant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key inputs used in the valuation model, for the stock options granted in the years ended December 31, 2025, 2024, and 2023, respectively, are outlined below. Stock options were only granted under the 2021 Equity Incentive Plan (&#8220;2021 EIP&#8221;).&#160;<ix:nonFraction unitRef="shares" contextRef="c-331" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1490"><ix:nonFraction unitRef="shares" contextRef="c-332" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1491">No</ix:nonFraction></ix:nonFraction>&#160;grants have been made under the 2019 Incentive Share Option Plan (&#8220;2019 ISOP&#8221;) since 2021 and the SOPHiA GENETICS Incentive Share Option Plan (&#8220;2013 ISOP&#8221;) since 2019.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Company&#8217;s IPO, the price of the ordinary shares at grant date, which represents a critical input into this model, has been determined on one of the following two bases:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">B</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y reference to a contemporaneous transaction involving another class of share, using an adjusted form of the Black-Scholes option pricing model as described above, and considering the timing, amount, liquidation preferences, and dividend rights of issues of other classes of shares.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">On the basis of discounted cash flow forecasts, where there was no contemporaneous or closely contemporaneous transaction in another class of share and the time interval was too large to permit an assumption that there had been no significant change in the Company&#8217;s equity value.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the IPO, the price of the ordinary shares at grant date, which represents a critical input into this model, has been determined on the most recent close price of the Company&#8217;s stock price on the date of grant.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has&#160;<ix:nonFraction unitRef="plan" contextRef="c-1" decimals="INF" name="soph:NumberOfShareOptionPlans" format="ixt-sec:numwordsen" scale="0" id="f-1492">three</ix:nonFraction>&#160;share option plans for directors, employees, and advisors which are accounted for as equity-settled share-based compensation plans.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options granted under these plans is recognized as an employee benefits expense, with a corresponding increase in equity. The total amount to be expensed is determined by reference to the fair value of the options granted:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">including any market performance conditions (e.g., the entity&#8217;s share price);</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">excluding the impact of any service and non-market performance vesting conditions (e.g., profitability, sales growth; targets and remaining an employee of the entity over a specified time period), and;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">including the impact of any non-vesting conditions (e.g., the requirement for employees to save or hold shares for a specific period of time).</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total expense is recognized over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied. At the end of each period, the entity revises its estimates of the number of options that are expected to vest based on the non-market vesting and service conditions. It recognizes the impact of the revision to original estimates, if any, in income, with a corresponding adjustment to equity.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating fair value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including the share price, or the fair value of a share, the expected life of the share option, the volatility of the share price, the risk-free interest rate, the dividend yield, and making certain assumptions about the inputs. The assumptions used for estimating fair value for share-based payment transactions are disclosed below.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The volatility used in the estimation of fair value is calculated utilizing a mix of the Company&#8217;s own share price volatility and the volatility of the share prices of a set list of publicly traded peer companies based on a defined proportion. Share price volatility is calculated for each tranche of share options on a historical basis over a </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1488-3" continuedAt="f-1488-4"><ix:continuation id="f-1489-2"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period of time equal to the average life of the share options granted in each tranche. In the event that a company used in the volatility calculation has not been publicly traded for the requisite amount of time, the entirety of its trading history was used.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the shares are not listed, estimating their fair value also requires determination of the most appropriate valuation model, such as:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">By reference to a contemporaneous transaction involving another class of share, using an adjusted form of an option pricing model above, and considering the timing, amount, liquidation preferences and dividend rights of issues of other classes of shares;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">On the basis of discounted cash flow forecasts, where there was no contemporaneous or closely contemporaneous transaction in another class of share and the time interval was too large to permit an assumption that there had been no significant change in the Company&#8217;s equity value;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Share based compensation expense is measured at the fair value of the options at the grant date and recognized over the vesting period. Share based compensation expense is presented in the statement of loss and allocated to the various expense categories based on the functions of the employees to whom the options are granted (e.g., research and development, selling and marketing, general &amp; administrative).</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the cost of the Company&#8217;s share option grants and of the fair value of the ordinary shares at the grant date requires the selection of an appropriate valuation model and is based on key assumptions that leave considerable scope for judgment.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recognizing the cost of share options</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each reporting date, the Company recognizes expense for the vested options granted and for partially earned but&#160;non-vested&#160;portions of options granted. This results in a front-loaded expense to the statement of loss. The Company accounts for these plans as equity-settled transactions. The charge to the statements of loss therefore results in a corresponding credit being booked to &#8220;Other reserves&#8221; within equity.</span></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The plans</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has&#160;<ix:nonFraction unitRef="plan" contextRef="c-1" decimals="INF" name="soph:NumberOfShareOptionPlans" format="ixt-sec:numwordsen" scale="0" id="f-1493">three</ix:nonFraction>&#160;share option plans: the 2013 ISOP (launched in&#160;September 2013), the 2019 ISOP (launched&#160;March 2019), and the 2021 EIP (launched&#160;June 2021). Under these plans, directors may offer options to directors, employees, and advisors. The exercise price of the share options is set at the time they are granted. Options, once vested, can be exchanged for an equal number of ordinary shares. Under the 2021 EIP, the Company can grant restricted stock units (&#8220;RSUs&#8221;) which represent the right to receive ordinary shares upon meeting specific vesting requirements. RSUs are able to be granted to directors, executives, and employees.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The options have a life of&#160;<ix:nonFraction unitRef="year" contextRef="c-333" decimals="INF" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" format="ixt-sec:numwordsen" scale="0" id="f-1494">ten</ix:nonFraction> years.&#160;Options under the 2013 ISOP vest&#160;<ix:nonFraction unitRef="number" contextRef="c-334" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" scale="-2" id="f-1495">50</ix:nonFraction>% on the second anniversary of the grant date and a further&#160;<ix:nonFraction unitRef="number" contextRef="c-335" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" scale="-2" id="f-1496">50</ix:nonFraction>% on the third anniversary of the grant date. Options under the 2019 ISOP vest&#160;<ix:nonFraction unitRef="number" contextRef="c-336" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" scale="-2" id="f-1497">25</ix:nonFraction>% on each anniversary of the grant date over <ix:nonNumeric contextRef="c-336" name="soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" format="ixt-sec:durwordsen" id="f-1498">four years</ix:nonNumeric>. The options under the 2021 EIP vest&#160;under one of five methods, i) <ix:nonFraction unitRef="number" contextRef="c-337" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" scale="-2" id="f-1499">25</ix:nonFraction>% on the first anniversary of the grant date and the remaining&#160;<ix:nonFraction unitRef="number" contextRef="c-337" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis" scale="-2" id="f-1500">75</ix:nonFraction>% vesting ratably on a monthly basis over the remaining <ix:nonNumeric contextRef="c-337" name="soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" format="ixt-sec:durwordsen" id="f-1501">three years</ix:nonNumeric>, ii) <ix:nonFraction unitRef="number" contextRef="c-338" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" scale="-2" id="f-1502">25</ix:nonFraction>% on the first anniversary of the grant date and the remaining&#160;<ix:nonFraction unitRef="number" contextRef="c-338" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" scale="-2" id="f-1503">75</ix:nonFraction>% vesting ratably on a quarterly basis over the remaining <ix:nonNumeric contextRef="c-338" name="soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" format="ixt-sec:durwordsen" id="f-1504">three years</ix:nonNumeric>, iii) on the second anniversary of the grant date, iv) annually over <ix:nonNumeric contextRef="c-338" name="soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" format="ixt-sec:durwordsen" id="f-1505">four years</ix:nonNumeric> on each anniversary of the grant date or v) <ix:nonFraction unitRef="number" contextRef="c-339" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" scale="-2" id="f-1506">50</ix:nonFraction>% on the first anniversary of the grant date and the remaining <ix:nonFraction unitRef="number" contextRef="c-339" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis" scale="-2" id="f-1507">50</ix:nonFraction>% vesting ratably on a monthly basis over the remaining year. Refer to&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Restricted Stock Units&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">below for the vesting schedules of the RSUs under the 2021 EIP.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2021, the Board amended the 2019 ISOP to the effect that, in the event of a successful IPO or public listing of the Company&#8217;s shares, only those unvested options that otherwise would vest within <ix:nonNumeric contextRef="c-340" name="soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" format="ixt-sec:durwordsen" id="f-1508">six months</ix:nonNumeric> following the effective date of the IPO or such public listing should become fully vested immediately as of such date (accelerated vesting). The remaining unvested options (i.e., unvested options that would only vest after the <ix:nonNumeric contextRef="c-340" name="soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" format="ixt-sec:durwordsen" id="f-1509">six-month</ix:nonNumeric> period following the effective date of the IPO or public listing) would not be subject to accelerated vesting and, subject to certain conditions, would vest on the basis of the original vesting schedule. Additionally, the Board instituted a black-out period, irrespective of a successful IPO or public listing of the Company, in which <ix:nonFraction unitRef="shares" contextRef="c-341" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1510">no</ix:nonFraction> options could be exercised from May 1, 2021 to January 19, 2022, and to accelerate the vesting of options that would otherwise vest during that period.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1488-4" continuedAt="f-1488-5"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2013 ISOP</span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" id="f-1511" continuedAt="f-1511-1" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2025, under the 2013 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-342" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1512">560,980</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-342" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1513">3.03</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-343" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1514">2.54</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-333" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1515">68,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-333" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="f-1516">1.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-333" decimals="INF" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1517">12,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-333" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="f-1518">3.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-344" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1519">480,980</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-344" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1520">3.18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-333" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1521">1.73</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-344" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1522">480,980</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-344" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="f-1523">3.18</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-333" name="soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions" format="ixt-sec:duryear" id="f-1524">1.73</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2024, under the 2013 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-345" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1525">606,980</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-345" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1526">3.00</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-346" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1527">3.49</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-343" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1528">32,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-343" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="f-1529">3.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-343" decimals="INF" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1530">14,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-343" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="f-1531">1.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-342" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1532">560,980</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-342" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1533">3.03</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-343" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1534">2.54</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-342" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1535">560,980</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-342" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="f-1536">3.03</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-343" name="soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions" format="ixt-sec:duryear" id="f-1537">2.54</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2023, under the 2013 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-347" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1538">657,980</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-347" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1539">2.92</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-348" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1540">4.24</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-346" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1541">39,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-346" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="f-1542">2.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-346" decimals="INF" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1543">12,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-346" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="f-1544">0.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-345" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1545">606,980</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-345" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1546">3.00</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-346" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1547">3.49</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-345" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1548">606,980</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-345" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="f-1549">3.00</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-346" name="soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions" format="ixt-sec:duryear" id="f-1550">3.49</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding as of December 31, 2025, under the 2013 ISOP expire between&#160;2026&#160;and&#160;2029 and have exercise prices between $<ix:nonFraction unitRef="usdPerShare" contextRef="c-349" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1551">2.96</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-350" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1552">3.34</ix:nonFraction>.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average share price at the date of exercise were $<ix:nonFraction unitRef="usdPerShare" contextRef="c-333" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" id="f-1553">3.48</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-343" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" id="f-1554">4.72</ix:nonFraction>, and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-346" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" id="f-1555">4.82</ix:nonFraction> for the years ended December 31, 2025, 2024, and 2023, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1488-5" continuedAt="f-1488-6"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 ISOP</span></div><ix:continuation id="f-1511-1" continuedAt="f-1511-2"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2025, under the 2019 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-351" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1556">2,308,760</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-351" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1557">4.97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-352" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1558">5.40</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-336" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1559">40,373</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-336" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="f-1560">3.49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-336" decimals="INF" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1561">15,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-336" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="f-1562">5.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-353" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1563">2,253,387</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-353" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1564">5.00</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-336" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1565">4.42</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-353" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1566">2,253,367</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-353" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="f-1567">5.00</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-336" name="soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions" format="ixt-sec:duryear" id="f-1568">4.42</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2024, under the 2019 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-354" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1569">2,402,510</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-354" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1570">4.97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-355" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1571">6.30</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-352" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1572">38,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-352" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="f-1573">4.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-352" decimals="INF" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1574">55,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-352" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="f-1575">5.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-351" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1576">2,308,760</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-351" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1577">4.97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-352" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1578">5.40</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-351" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1579">2,033,490</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-351" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="f-1580">4.80</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-352" name="soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions" format="ixt-sec:duryear" id="f-1581">5.31</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2023, under the 2019 ISOP was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-356" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1582">2,629,516</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-356" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1583">4.96</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-357" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1584">7.21</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-355" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1585">32,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-355" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="f-1586">4.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-355" decimals="INF" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1587">195,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-355" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="f-1588">4.94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-354" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1589">2,402,510</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-354" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1590">4.97</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-355" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1591">6.30</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-354" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1592">1,651,493</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-354" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="f-1593">4.64</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-355" name="soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions" format="ixt-sec:duryear" id="f-1594">6.03</ix:nonNumeric></span></td></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding as of December 31, 2025, under the 2019 ISOP expire between&#160;2028&#160;and&#160;2031 and have exercise prices between $<ix:nonFraction unitRef="usdPerShare" contextRef="c-358" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1595">3.16</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-359" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1596">6.31</ix:nonFraction>.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average share price at the date of exercise were $<ix:nonFraction unitRef="usdPerShare" contextRef="c-336" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" id="f-1597">4.61</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-352" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" id="f-1598">4.70</ix:nonFraction>, and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-355" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" id="f-1599">4.65</ix:nonFraction> for the years ended December 31, 2025, 2024, and 2023, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1488-6" continuedAt="f-1488-7"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 EIP</span></div><ix:continuation id="f-1511-2" continuedAt="f-1511-3"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2025, under the 2021 EIP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-360" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1600">9,044,607</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-360" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1601">6.69</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-361" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1602">8.40</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-362" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1603">3,280,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-362" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="f-1604">3.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-362" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1605">29,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-362" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="f-1606">2.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-362" decimals="INF" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1607">909,956</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-362" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="f-1608">6.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-363" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1609">11,385,514</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-363" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1610">5.72</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-362" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1611">7.98</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-363" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1612">4,989,270</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-363" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="f-1613">7.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-362" name="soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions" format="ixt-sec:duryear" id="f-1614">7.11</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2024, under the 2021 EIP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-364" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1615">5,708,059</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-364" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1616">7.84</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-365" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1617">8.74</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-361" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1618">3,840,087</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-361" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="f-1619">4.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-361" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1620">49,119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-361" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" scale="0" id="f-1621">2.87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-361" decimals="INF" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1622">454,420</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-361" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="f-1623">5.37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-360" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1624">9,044,607</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-360" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1625">6.69</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-361" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1626">8.40</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-360" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1627">2,806,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-360" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="f-1628">10.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-361" name="soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions" format="ixt-sec:duryear" id="f-1629">7.37</ix:nonNumeric></span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1488-7" continuedAt="f-1488-8"><ix:continuation id="f-1511-3"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2023, under the 2021 EIP was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-366" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1630">2,624,297</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-366" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1631">12.32</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-367" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1632">8.88</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-365" decimals="INF" name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1633">3,734,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-365" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" scale="0" id="f-1634">4.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-365" decimals="INF" name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1635">645,310</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-365" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" scale="0" id="f-1636">6.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-364" decimals="INF" name="ifrs-full:NumberOfOutstandingShareOptions" format="ixt:num-dot-decimal" scale="0" id="f-1637">5,708,059</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-364" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1638">7.84</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-365" name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" format="ixt-sec:duryear" id="f-1639">8.74</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-364" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1640">1,155,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-364" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" scale="0" id="f-1641">14.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-365" name="soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions" format="ixt-sec:duryear" id="f-1642">7.57</ix:nonNumeric></span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" id="f-1643" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation inputs for the 2021 EIP grants were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.998%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December&#160;31,&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (in USD)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="c-368" decimals="2" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" format="ixt:num-dot-decimal" id="f-1644">3.04</ix:nonFraction> </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-369" decimals="2" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" id="f-1645">4.73</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-370" decimals="2" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" format="ixt:num-dot-decimal" id="f-1646">3.40</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-371" decimals="2" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" id="f-1647">4.96</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-372" decimals="2" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" format="ixt:num-dot-decimal" id="f-1648">2.53</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-373" decimals="2" name="ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019" scale="0" id="f-1649">4.72</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of share options (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="c-368" decimals="2" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="f-1650">5.50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="c-369" decimals="2" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="f-1651">7.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="c-370" decimals="2" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="f-1652">5.50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="c-371" decimals="2" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="f-1653">7.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="c-372" decimals="2" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="f-1654">5.50</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="year" contextRef="c-373" decimals="2" name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" scale="0" id="f-1655">7.00</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-368" decimals="4" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="f-1656">73.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-369" decimals="4" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="f-1657">77.60</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-370" decimals="4" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="f-1658">72.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-371" decimals="4" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="f-1659">74.95</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-372" decimals="4" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="f-1660">69.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-373" decimals="4" name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" scale="-2" id="f-1661">74.96</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-368" decimals="4" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="f-1662">3.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-369" decimals="4" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="f-1663">4.03</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-370" decimals="4" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="f-1664">3.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-371" decimals="4" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="f-1665">4.40</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-372" decimals="4" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="f-1666">3.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-373" decimals="4" name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" scale="-2" id="f-1667">4.67</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield (%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-362" decimals="INF" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" format="ixt:fixed-zero" scale="-2" id="f-1668">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-361" decimals="INF" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" format="ixt:fixed-zero" scale="-2" id="f-1669">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-365" decimals="INF" name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" format="ixt:fixed-zero" scale="-2" id="f-1670">&#8212;</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding as of December 31, 2025, under the 2021 EIP expire between&#160;2026 and 2034 and have exercise prices between $<ix:nonFraction unitRef="usdPerShare" contextRef="c-374" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1671">2.06</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-375" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" scale="0" id="f-1672">18.00</ix:nonFraction>.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average share price at the date of exercise were $<ix:nonFraction unitRef="usdPerShare" contextRef="c-362" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" id="f-1673">4.14</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-361" decimals="2" name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" scale="0" id="f-1674">4.59</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the years ended December 31, 2025 and 2024, respectively; and <ix:nonFraction unitRef="shares" contextRef="c-365" decimals="INF" name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" format="ixt:fixed-zero" scale="0" id="f-1675">no</ix:nonFraction> options were exercised for the year ended December 31, 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share options granted during the year</span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock" id="f-1676" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December 31, 2025, 2024, and 2023, respectively (in USD):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 EIP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-362" decimals="2" name="soph:WeightedAverageFairValueShareOptionsGranted" scale="0" id="f-1677">2.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-361" decimals="2" name="soph:WeightedAverageFairValueShareOptionsGranted" scale="0" id="f-1678">3.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-365" decimals="2" name="soph:WeightedAverageFairValueShareOptionsGranted" scale="0" id="f-1679">2.91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the 2021 EIP, the Company initiated granting of RSUs, which represent the right to receive shares of ordinary shares upon meeting specified vesting requirements. In the year ended December 31, 2025, the Company granted&#160;<ix:nonFraction unitRef="shares" contextRef="c-376" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1680">1,136,975</ix:nonFraction>&#160;RSUs under the 2021 plan. Under the terms of the 2021 plan,&#160;<ix:nonFraction unitRef="shares" contextRef="c-377" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1681">103,374</ix:nonFraction> of the RSUs granted are subject to a <ix:nonNumeric contextRef="c-377" name="soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" format="ixt-sec:durwordsen" id="f-1682">four-year</ix:nonNumeric> vesting schedule with&#160;<ix:nonFraction unitRef="number" contextRef="c-377" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" scale="-2" id="f-1683">25</ix:nonFraction>% vesting on the first anniversary of the grant date and the remaining&#160;<ix:nonFraction unitRef="number" contextRef="c-377" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" scale="-2" id="f-1684">75</ix:nonFraction>% ratably on a quarterly basis over the remaining <ix:nonNumeric contextRef="c-377" name="soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" format="ixt-sec:durwordsen" id="f-1685">three years</ix:nonNumeric>, <ix:nonFraction unitRef="shares" contextRef="c-378" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1686">864,681</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are subject to a <ix:nonNumeric contextRef="c-378" name="soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" format="ixt-sec:durwordsen" id="f-1687">two year</ix:nonNumeric> vesting period on the second anniversary from the date of grant, and the remaining&#160;<ix:nonFraction unitRef="shares" contextRef="c-379" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1688">168,920</ix:nonFraction>&#160;of the RSUs granted to non-executive members of the Company&#8217;s board of directors are subject to a vesting period </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1488-8" continuedAt="f-1488-9"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">set to be completed upon the Company&#8217;s 2026 Annual General Meeting.&#160;<ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" id="f-1689" continuedAt="f-1689-1" escape="true">The activity for the year ended December 31, 2025 was as follows:</ix:nonNumeric></span></div><ix:continuation id="f-1689-1" continuedAt="f-1689-2"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-380" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1690">3,053,076</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-380" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" scale="0" id="f-1691">4.69</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-381" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1692">1,136,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-381" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" scale="0" id="f-1693">3.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-381" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1694">1,434,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-381" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" scale="0" id="f-1695">4.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-381" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1696">171,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-381" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement" scale="0" id="f-1697">4.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-382" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1698">2,584,209</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-382" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" scale="0" id="f-1699">4.04</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the year ended December 31, 2024, the Company granted <ix:nonFraction unitRef="shares" contextRef="c-383" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1700">1,373,816</ix:nonFraction> RSUs under the 2021 plan. Under the terms of the 2021 plan, <ix:nonFraction unitRef="shares" contextRef="c-384" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1701">1,168,896</ix:nonFraction> of the RSUs granted are subject to a <ix:nonNumeric contextRef="c-384" name="soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" format="ixt-sec:durwordsen" id="f-1702">four-year</ix:nonNumeric> vesting schedule with <ix:nonFraction unitRef="number" contextRef="c-384" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" scale="-2" id="f-1703">25</ix:nonFraction>% vesting on the first anniversary of the grant date and the remaining <ix:nonFraction unitRef="number" contextRef="c-384" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" scale="-2" id="f-1704">75</ix:nonFraction>% ratably on a quarterly basis over the remaining <ix:nonNumeric contextRef="c-384" name="soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" format="ixt-sec:durwordsen" id="f-1705">three years</ix:nonNumeric>, and the remaining <ix:nonFraction unitRef="shares" contextRef="c-385" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1706">204,920</ix:nonFraction> of the RSUs granted to non-executive members of the Company&#8217;s board of directors are subject to a vesting period set to be completed upon the Company&#8217;s 2025 Annual General Meeting. <ix:continuation id="f-1689-2" continuedAt="f-1689-3">The activity for the year ended December 31, 2024 was as follows:</ix:continuation></span></div><ix:continuation id="f-1689-3" continuedAt="f-1689-4"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-386" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1707">3,335,268</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-386" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" scale="0" id="f-1708">4.77</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-387" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1709">1,373,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-387" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" scale="0" id="f-1710">4.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-387" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1711">1,331,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-387" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" scale="0" id="f-1712">4.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-387" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1713">324,277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-387" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement" scale="0" id="f-1714">4.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-380" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1715">3,053,076</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-380" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" scale="0" id="f-1716">4.69</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1488-9"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the year ended December 31, 2023, the Company granted <ix:nonFraction unitRef="shares" contextRef="c-388" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1717">2,658,150</ix:nonFraction> RSUs under the 2021 plan. Under the terms of the 2021 plan, <ix:nonFraction unitRef="shares" contextRef="c-389" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1718">2,260,649</ix:nonFraction> of the RSUs granted are subject to a <ix:nonNumeric contextRef="c-389" name="soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" format="ixt-sec:durwordsen" id="f-1719">four-year</ix:nonNumeric> vesting schedule with <ix:nonFraction unitRef="number" contextRef="c-389" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" scale="-2" id="f-1720">25</ix:nonFraction>% vesting on the first anniversary of the grant date and the remaining <ix:nonFraction unitRef="number" contextRef="c-389" decimals="2" name="soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" scale="-2" id="f-1721">75</ix:nonFraction>% ratably on a monthly basis over the remaining <ix:nonNumeric contextRef="c-389" name="soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" format="ixt-sec:durwordsen" id="f-1722">three years</ix:nonNumeric>, <ix:nonFraction unitRef="shares" contextRef="c-390" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1723">107,647</ix:nonFraction> are subject to a <ix:nonNumeric contextRef="c-389" name="soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" format="ixt-sec:durwordsen" id="f-1724">two year</ix:nonNumeric> vesting period on the second anniversary from the date of grant, and the remaining <ix:nonFraction unitRef="shares" contextRef="c-391" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1725">289,854</ix:nonFraction> of the RSUs granted to non-executive members of the Company&#8217;s board of directors are subject to a vesting period set to be completed upon the Company&#8217;s 2024 Annual General Meeting. <ix:continuation id="f-1689-4" continuedAt="f-1689-5">The activity for the year ended December 31, 2023 was as follows:</ix:continuation></span></div><ix:continuation id="f-1689-5"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-392" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1726">1,865,433</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-392" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" scale="0" id="f-1727">5.20</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-393" decimals="INF" name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-1728">2,658,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-393" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" scale="0" id="f-1729">4.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-393" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1730">927,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-393" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" scale="0" id="f-1731">4.65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-393" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1732">261,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-393" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement" scale="0" id="f-1733">4.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-386" decimals="INF" name="ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" format="ixt:num-dot-decimal" scale="0" id="f-1734">3,335,268</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-386" decimals="2" name="soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" scale="0" id="f-1735">4.77</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-based compensation expense</span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions" id="f-1736" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Movements in the share-based compensation reserve were as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ifrs-full:ReserveOfSharebasedPayments" format="ixt:num-dot-decimal" scale="3" id="f-1737">25,075</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-1738">15,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="ifrs-full:ReserveOfSharebasedPayments" format="ixt:num-dot-decimal" scale="3" id="f-1739">40,317</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-1740">16,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:ReserveOfSharebasedPayments" format="ixt:num-dot-decimal" scale="3" id="f-1741">56,805</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" format="ixt:num-dot-decimal" scale="3" id="f-1742">16,205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:ReserveOfSharebasedPayments" format="ixt:num-dot-decimal" scale="3" id="f-1743">73,010</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by financial statement caption for all stock awards consists of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1744">4,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1745">4,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1746">3,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1747">1,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-398" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1748">1,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-399" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1749">1,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-400" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1750">10,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-401" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1751">10,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-402" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1752">10,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1753">16,205</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1754">16,488</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" format="ixt:num-dot-decimal" scale="3" id="f-1755">15,242</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:10pt"><span><br/></span></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_301"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">23. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfBorrowingsExplanatory" id="f-1756" continuedAt="f-1756-1" escape="true">Borrowings</ix:nonNumeric></span></div><ix:continuation id="f-1756-1" continuedAt="f-1756-2"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perceptive Credit Agreement</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2024 (the &#8220;closing date&#8221;), the Company and its subsidiary SOPHiA GENETICS, Inc. entered into a credit agreement and guaranty (the &#8220;Perceptive Credit Agreement&#8221;) with Perceptive Credit Holdings IV, LP, as lender and administrative agent, pursuant to which the Company may borrow up to $<ix:nonFraction unitRef="usd" contextRef="c-403" decimals="INF" name="soph:BorrowingFacilitiesMaximumBorrowingCapacity" scale="6" id="f-1757">50.0</ix:nonFraction>&#160;million principal amount of term loans, including (i) an initial tranche of $<ix:nonFraction unitRef="usd" contextRef="c-404" decimals="INF" name="soph:BorrowingFacilitiesMaximumBorrowingCapacity" scale="6" id="f-1758">15.0</ix:nonFraction>&#160;million principal amount of term loans on the closing date (&#8220;Tranche A&#8221;) and (ii) a second tranche of $<ix:nonFraction unitRef="usd" contextRef="c-405" decimals="INF" name="soph:BorrowingFacilitiesMaximumBorrowingCapacity" scale="6" id="f-1759">35.0</ix:nonFraction>&#160;million principal amount of term loans that the Company may draw upon on or prior to March 31, 2026 (&#8220;Tranche B&#8221;), subject to satisfaction of certain </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1756-2" continuedAt="f-1756-3"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customary conditions. The term loans are scheduled to mature on the fifth anniversary of the closing date and accrue interest at Term Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;) (floored at <ix:nonFraction unitRef="number" contextRef="c-406" decimals="2" name="ifrs-full:BorrowingsAdjustmentToInterestRateBasis" scale="-2" id="f-1760">4</ix:nonFraction>% per annum) plus <ix:nonFraction unitRef="number" contextRef="c-407" decimals="4" name="ifrs-full:BorrowingsAdjustmentToInterestRateBasis" scale="-2" id="f-1761">6.25</ix:nonFraction>% per annum; provided that upon the occurrence and during the continuation of any event of default, the term loans will accrue interest at Term SOFR plus <ix:nonFraction unitRef="number" contextRef="c-408" decimals="4" name="ifrs-full:BorrowingsAdjustmentToInterestRateBasis" scale="-2" id="f-1762">9.25</ix:nonFraction>% per annum. Term SOFR means the Term SOFR reference rate that is two business days prior to the first day of the preceding calendar month. The Company has the right to prepay the term loans at any time subject to applicable prepayment premiums. The Perceptive Credit Agreement also contains certain mandatory prepayment provisions, including prepayments from the proceeds from certain asset sales and casualty events (subject to a right to reinvest such proceeds in assets used in the Company&#8217;s business within <ix:nonNumeric contextRef="c-403" name="soph:BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets" format="ixt-sec:durday" id="f-1763">180</ix:nonNumeric> days) and from issuances or incurrences of non-permitted debt, which will also be subject to prepayment premiums. The obligations under the Perceptive Credit Agreement are secured by substantially all of the Company&#8217;s and certain of the Company&#8217;s subsidiaries&#8217; assets and are guaranteed initially on the closing date by SOPHiA GENETICS SA and SOPHiA GENETICS, Inc. The Perceptive Credit Agreement contains customary covenants, including an affirmative covenant to maintain qualified cash of at least $<ix:nonFraction unitRef="usd" contextRef="c-403" decimals="-5" name="soph:BorrowingsCovenantCashAndCashEquivalentsMinimum" scale="6" id="f-1764">3.0</ix:nonFraction>&#160;million, an affirmative last twelve months revenue covenant of $<ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-5" name="soph:BorrowingsCovenantRevenueFromContractsWithCustomersMinimum" scale="6" id="f-1765">67.4</ix:nonFraction> million as of December 31, 2025. The last twelve months revenue covenant is tested on a quarterly basis beginning June 30, 2024, and negative covenants including limitations on indebtedness, liens, fundamental changes, asset sales, investments, dividends and other restricted payments and other matters customarily restricted in such agreements. The Perceptive Credit Agreement also contains customary events of default, including payment defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults to certain other agreements, judgments against the Company and the Company&#8217;s subsidiaries and change in control, the occurrence of which gives the lenders the right to declare the term loans and all obligations under the Perceptive Credit Agreement immediately due and payable. The Company was in full compliance with all covenants contained in the Perceptive Credit Agreement as of December 31, 2025 and 2024.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company issued to Perceptive Credit Holdings IV, LP a warrant certificate (the &#8220;Warrant Certificate&#8221;) representing the right to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-410" decimals="INF" name="soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-1766">400,000</ix:nonFraction> ordinary shares at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-410" decimals="4" name="soph:ExercisePriceOfWarrantRights" scale="0" id="f-1767">4.9992</ix:nonFraction> per share, with the right to purchase <ix:nonFraction unitRef="shares" contextRef="c-411" decimals="INF" name="soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-1768">200,000</ix:nonFraction> ordinary shares available immediately and the right to purchase an additional <ix:nonFraction unitRef="shares" contextRef="c-412" decimals="INF" name="soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-1769">200,000</ix:nonFraction> ordinary shares to be available upon the drawdown of the second tranche of the term loans. The purchase rights represented by the Warrant Certificate are exercisable after becoming available, on a cash basis, at the option of the holder at any time prior to 5:00 p.m., Eastern time on the tenth anniversary of the applicable date of availability. The Warrant Certificate contains customary anti-dilution adjustments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company drew down the $<ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-5" name="soph:ProceedsFromBorrowings" scale="6" id="f-1770">35.0</ix:nonFraction>&#160;million of Tranche B on June 25, 2025 and the right to purchase an additional <ix:nonFraction unitRef="shares" contextRef="c-414" decimals="INF" name="soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-1771">200,000</ix:nonFraction> ordinary shares became available under the Warrant Certificate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 23, 2026, the Company entered into an amendment (the &#8220;2026 Amendment&#8221;) to the Perceptive Credit Agreement. The 2026 Amendment provides for, among other things, $<ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-5" name="soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" scale="6" id="f-1772">25.0</ix:nonFraction>&#160;million of additional term loan commitments consisting of (i) an additional $<ix:nonFraction unitRef="usd" contextRef="c-416" decimals="INF" name="soph:BorrowingFacilitiesMaximumBorrowingCapacity" scale="6" id="f-1773">12.5</ix:nonFraction>&#160;million tranche of term loan commitments (&#8220;Tranche C&#8221;), which may be drawn subject to certain customary conditions, and (ii) an additional $<ix:nonFraction unitRef="usd" contextRef="c-417" decimals="INF" name="soph:BorrowingFacilitiesMaximumBorrowingCapacity" scale="6" id="f-1774">12.5</ix:nonFraction>&#160;million tranche of term loan commitments (&#8220;Tranche D&#8221;), which may be drawn at such time as the Company&#8217;s revenue for a trailing twelve-month period exceed $<ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-5" name="soph:BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger" scale="6" id="f-1775">85.0</ix:nonFraction>&#160;million and otherwise subject to customary conditions. Tranche C and Tranche D, if drawn, will have terms and conditions consistent with the Company&#8217;s existing term loans, will bear interest at rate per annum equal to Term SOFR (floored at <ix:nonFraction unitRef="number" contextRef="c-419" decimals="2" name="ifrs-full:BorrowingsAdjustmentToInterestRateBasis" scale="-2" id="f-1776">4</ix:nonFraction>% per annum) + <ix:nonFraction unitRef="number" contextRef="c-420" decimals="4" name="ifrs-full:BorrowingsAdjustmentToInterestRateBasis" scale="-2" id="f-1777">6.25</ix:nonFraction>% and will mature in 2029. In connection with the 2026 Amendment, the Company amended and restated the warrant certificate in order to issue to Perceptive Credit Holdings IV, LP the right to purchase an additional <ix:nonFraction unitRef="shares" contextRef="c-421" decimals="INF" name="soph:WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-1778">75,000</ix:nonFraction> ordinary shares, which right is exercisable immediately. The Warrant Certificate also grants Perceptive Credit Holdings IV, LP the right to purchase an additional (1) <ix:nonFraction unitRef="shares" contextRef="c-422" decimals="INF" name="soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-1779">100,000</ix:nonFraction> ordinary shares, which right will become exercisable upon the Company&#8217;s draw down of the Tranche C under the Perceptive Credit Agreement and (2) another <ix:nonFraction unitRef="shares" contextRef="c-423" decimals="INF" name="soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-1780">100,000</ix:nonFraction> ordinary shares, which right will become exercisable upon the Company&#8217;s draw down of the Tranche D under the Perceptive Credit Agreement. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Tranches A and B</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for each tranche of the term loans and warrants as <ix:nonFraction unitRef="instrument" contextRef="c-424" decimals="INF" name="soph:NumberOfFinancialInstruments" format="ixt-sec:numwordsen" scale="0" id="f-1781">two</ix:nonFraction> separate financial instruments: (i) a warrant obligation and (ii) a loan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i) The warrant obligation is presented in the consolidated balance sheet as a short-term liability given the warrants are not settled in the entity&#8217;s functional currency and thus are not considered to be settled in a fixed amount and can be exercised currently without restriction or right to defer. The warrant obligation was initially </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1756-3" continuedAt="f-1756-4"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measured at fair value using a Black-Scholes pricing model and is subsequently remeasured to fair value at each reporting date. Changes in the fair value (gains or losses) of the warrant obligation at the end of each period are recorded in the consolidated statement of loss. The Company determined the Tranche A warrant obligation qualified as a level 2 fair value liability as inputs to the fair value measurement are derived principally from or corroborated by observable market data by correlation or other means. Refer to Note 26 &#8212; &#8220;Financial instruments and risks&#8221; for the current fair value amount for the warrant obligation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii) The term loans were initially recorded at their amortized costs of $<ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="soph:ProceedsFromBorrowings" scale="6" id="f-1782">15.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-5" name="soph:ProceedsFromBorrowings" scale="6" id="f-1783">35.0</ix:nonFraction>&#160;million for Tranches A and B, respectively, less any capitalized expenses and fees payable upon the issuance (&#8220;transaction costs&#8221;) and after allocating a portion of the proceeds to the fair value of the warrant obligation. The loans are presented as a long-term financial liability in the consolidated balance sheet.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the allocation of transaction costs in accordance with IFRS 9 and determined the allocation to warrants was immaterial, as such the Company allocated the total amount of the transaction costs to the term loan. The transaction costs are presented net of the term loan on the consolidated balance sheet. The transaction costs are amortized as non-cash interest expense recorded to the consolidated statement of loss as the difference between the stated interest rate and the EIR. The EIR was determined upon the initial draw down at <ix:nonFraction unitRef="number" contextRef="c-404" decimals="3" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-1784">15.2</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-405" decimals="3" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-1785">12.4</ix:nonFraction>% for Tranches A and B, respectively, and reassessed based on changes in the variable interest rate from the Perceptive Credit Agreement. As of December 31, 2025 and 2024 the EIR was <ix:nonFraction unitRef="number" contextRef="c-425" decimals="3" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-1786">12.1</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-426" decimals="3" name="ifrs-full:BorrowingsInterestRate" scale="-2" id="f-1787">14.8</ix:nonFraction>%, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculated the fair value of the warrant obligation on issuance using the Black-Scholes pricing model. The warrant obligation for Tranche A was recorded at an initial fair value of $<ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-5" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-1788">0.7</ix:nonFraction>&#160;million on May 2, 2024 and the warrant obligation for Tranche B was recorded at an initial fair value of $<ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-5" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-1789">0.5</ix:nonFraction>&#160;million on June 25, 2025. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" id="f-1790" continuedAt="f-1790-1" escape="true">Key inputs for the valuation of the warrant obligation upon issuance were as follows:</ix:nonNumeric></span></div><ix:continuation id="f-1790-1" continuedAt="f-1790-2"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:34.006%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.674%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 25, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of May 2, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-429" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1791">5.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-430" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1792">5.00</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price in USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-431" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1793">3.17</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-432" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1794">5.08</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-433" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1795">4.24</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-434" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1796">4.53</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (annualized)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-435" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1797">72.98</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-436" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1798">71.77</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-437" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1799">10</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-438" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1800">10</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-439" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-1801">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-440" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-1802">&#8212;</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Black-Scholes value in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-441" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1803">2.37</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-442" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1804">4.06</ix:nonFraction></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of the warrant obligation on a quarterly basis. Key inputs for the remeasurement of the Tranche A warrant obligation were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of  December 31, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of  December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-443" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1805">5.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-444" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1806">5.00</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price in USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-445" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1807">4.67</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-446" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1808">3.07</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-447" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1809">4.01</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-448" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1810">4.51</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-449" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1811">68.39</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-450" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1812">72.52</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-451" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1813">8.34</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-452" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1814">9.33</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-453" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-1815">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-454" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-1816">&#8212;</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Black-Scholes value in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-455" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1817">3.35</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-456" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1818">2.22</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:10pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1756-4" continuedAt="f-1756-5"><ix:continuation id="f-1790-2"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key inputs for the remeasurement of the Tranche B warrant obligation were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:34.059%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.146%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.495%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of  December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-457" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1819">5.00</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price in USD</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-458" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1820">4.67</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-459" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1821">4.02</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-460" decimals="4" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="-2" id="f-1822">76.10</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-461" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1823">9.48</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-462" decimals="INF" name="ifrs-full:SignificantUnobservableInputLiabilities" format="ixt:fixed-zero" scale="-2" id="f-1824">&#8212;</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Black-Scholes value in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="number" contextRef="c-463" decimals="2" name="ifrs-full:SignificantUnobservableInputLiabilities" scale="0" id="f-1825">3.71</ix:nonFraction></span></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tranche A was recorded at an initial amortized cost of $<ix:nonFraction unitRef="usd" contextRef="c-404" decimals="-5" name="ifrs-full:Borrowings" scale="6" id="f-1826">13.3</ix:nonFraction>&#160;million on May 2, 2024. This amount represents the residual amount of the $<ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="soph:ProceedsFromBorrowings" scale="6" id="f-1827">15.0</ix:nonFraction>&#160;million draw down after allocating $<ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-5" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-1828">0.7</ix:nonFraction>&#160;million for the fair value of the warrant obligation and the $<ix:nonFraction unitRef="usd" contextRef="c-424" decimals="-5" name="ifrs-full:BorrowingCostsIncurred" scale="6" id="f-1829">1.1</ix:nonFraction>&#160;million of transaction costs to be amortized as interest expense over the life of the loan. Tranche B was recorded at an initial amortized cost of $<ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-5" name="ifrs-full:Borrowings" scale="6" id="f-1830">34.1</ix:nonFraction>&#160;million on June 25, 2025. This amount represents the residual amount of the $<ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-5" name="soph:ProceedsFromBorrowings" scale="6" id="f-1831">35.0</ix:nonFraction>&#160;million draw down after allocating $<ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-5" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="6" id="f-1832">0.5</ix:nonFraction>&#160;million for the fair value of the warrant obligation and the $<ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-5" name="ifrs-full:BorrowingCostsIncurred" scale="6" id="f-1833">0.4</ix:nonFraction>&#160;million of transaction costs to be amortized as interest expense over the life of the loan. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory" id="f-1834" continuedAt="f-1834-1" escape="true">The following table presents the allocation of the loan proceeds and any movements in the liability for the year ended December 31, 2025, (in USD thousands):</ix:nonNumeric></span></div><ix:continuation id="f-1834-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"/><td style="width:46.606%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.997%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-3" name="ifrs-full:Borrowings" format="ixt:fixed-zero" scale="3" id="f-1835">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Tranche A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="soph:ProceedsFromBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-1836">15,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-467" decimals="-3" name="ifrs-full:BorrowingCostsIncurred" format="ixt:num-dot-decimal" scale="3" id="f-1837">1,070</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Proceeds net of transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="soph:ProceedsFromBorrowingsNetOfCostsIncurred" format="ixt:num-dot-decimal" scale="3" id="f-1838">13,930</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant obligation at issuance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="3" id="f-1839">656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="ifrs-full:InterestExpenseOnBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-1840">1,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1841">1,152</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" sign="-" name="soph:BorrowingsForeignCurrencyTranslationGainLoss" scale="3" id="f-1842">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-3" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="3" id="f-1843">13,237</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Tranche B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" name="soph:ProceedsFromBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-1844">35,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-468" decimals="-3" name="ifrs-full:BorrowingCostsIncurred" scale="3" id="f-1845">437</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Proceeds net of transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" name="soph:ProceedsFromBorrowingsNetOfCostsIncurred" format="ixt:num-dot-decimal" scale="3" id="f-1846">34,563</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant obligation at issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="3" id="f-1847">474</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" name="ifrs-full:InterestExpenseOnBorrowings" format="ixt:num-dot-decimal" scale="3" id="f-1848">3,891</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-1849">3,521</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-409" decimals="-3" name="soph:BorrowingsForeignCurrencyTranslationGainLoss" scale="3" id="f-1850">37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-3" name="ifrs-full:Borrowings" format="ixt:num-dot-decimal" scale="3" id="f-1851">47,733</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:10pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1756-5"><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock" id="f-1852" escape="true"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the movements in the warrant obligation liability for the year ended December 31, 2025, (in USD thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.030%"><tr><td style="width:1.0%"/><td style="width:51.389%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.629%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.833%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.649%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Obligation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-469" decimals="-3" name="ifrs-full:CurrentWarrantLiability" format="ixt:fixed-zero" scale="3" id="f-1853">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-469" decimals="INF" name="soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" format="ixt:fixed-zero" scale="0" id="f-1854">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of warrants from Tranche A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-470" decimals="-3" name="soph:ProceedsFromWarrantLiability" scale="3" id="f-1855">656</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-470" decimals="INF" name="soph:WarrantsOrRightsNumberOfWarrantsIssued" format="ixt:num-dot-decimal" scale="0" id="f-1856">200,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-470" decimals="-3" sign="-" name="soph:AdjustmentsForFairValueOfWarrantLiability" scale="3" id="f-1857">370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-470" decimals="-3" sign="-" name="soph:WarrantLiabilityForeignExchangeGainLoss" scale="3" id="f-1858">158</ix:nonFraction></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-471" decimals="-3" name="ifrs-full:CurrentWarrantLiability" scale="3" id="f-1859">444</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-471" decimals="INF" name="soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-1860">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of warrants from Tranche B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-3" name="soph:ProceedsFromWarrantLiability" scale="3" id="f-1861">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-470" decimals="INF" name="soph:WarrantsOrRightsNumberOfWarrantsIssued" format="ixt:num-dot-decimal" scale="0" id="f-1862">200,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-3" name="soph:AdjustmentsForFairValueOfWarrantLiability" scale="3" id="f-1863">497</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-472" decimals="-3" name="soph:WarrantLiabilityForeignExchangeGainLoss" scale="3" id="f-1864">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-473" decimals="-3" name="ifrs-full:CurrentWarrantLiability" format="ixt:num-dot-decimal" scale="3" id="f-1865">1,412</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-473" decimals="INF" name="soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-1866">400,000</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revolving credit facility</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2024 the Company terminated its existing credit agreement with Credit Suisse SA for up to CHF <ix:nonFraction unitRef="chf" contextRef="c-474" decimals="-5" name="soph:TerminationOfBorrowings" scale="6" id="f-1867">5.0</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="c-474" decimals="-5" name="soph:TerminationOfBorrowings" scale="6" id="f-1868">5.5</ix:nonFraction>&#160;million). Additionally, the Company entered into a new credit agreement with Credit Suisse SA for up to CHF <ix:nonFraction unitRef="usd" contextRef="c-475" decimals="-5" name="soph:BorrowingFacilitiesMaximumBorrowingCapacity" scale="6" id="f-1869">0.1</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="c-475" decimals="-5" name="soph:BorrowingFacilitiesMaximumBorrowingCapacity" scale="6" id="f-1870">0.1</ix:nonFraction>&#160;million) to be used for cash credits, contingent liabilities, or as margin for OTC derivative transactions. Borrowings under the new credit agreement will bear interest at a rate to be established between the Company and Credit Suisse SA at the time of each draw down. On November 27, 2025 the Company terminated this CHF <ix:nonFraction unitRef="chf" contextRef="c-476" decimals="-5" name="soph:TerminationOfBorrowings" scale="6" id="f-1871">0.1</ix:nonFraction>&#160;million facility ($<ix:nonFraction unitRef="usd" contextRef="c-476" decimals="-5" name="soph:TerminationOfBorrowings" scale="6" id="f-1872">0.1</ix:nonFraction>&#160;million). On February 20, 2025 the Company entered into a new credit agreement with UBS Switzerland AG for up to CHF <ix:nonFraction unitRef="chf" contextRef="c-477" decimals="-5" name="soph:BorrowingFacilitiesMaximumBorrowingCapacity" scale="6" id="f-1873">0.3</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="c-477" decimals="-5" name="soph:BorrowingFacilitiesMaximumBorrowingCapacity" scale="6" id="f-1874">0.3</ix:nonFraction>&#160;million), intended solely for the issuance of bank guarantees. As of December 31, 2025 and 2024, the Company had <ix:nonFraction unitRef="usd" contextRef="c-478" decimals="-5" name="ifrs-full:Borrowings" format="ixt:fixed-zero" scale="0" id="f-1875"><ix:nonFraction unitRef="usd" contextRef="c-479" decimals="-5" name="ifrs-full:Borrowings" format="ixt:fixed-zero" scale="0" id="f-1876">no</ix:nonFraction></ix:nonFraction> borrowings outstanding under these credit facilities.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_307"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">24. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfRelatedPartyExplanatory" id="f-1879" continuedAt="f-1879-1" escape="true">Related parties</ix:nonNumeric></span></div><ix:continuation id="f-1879-1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related parties comprise the Company&#8217;s executive officers and directors, including their affiliates, and any person that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control, with the Company.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key management personnel comprised of <ix:nonFraction unitRef="personnel" contextRef="c-1" decimals="INF" name="soph:NumberOfExecutiveOfficers" format="ixt-sec:numwordsen" scale="0" id="f-1880">six</ix:nonFraction> Executive Officers and Directors and <ix:nonFraction unitRef="personnel" contextRef="c-1" decimals="INF" name="soph:NumberOfNonExecutiveOfficers" format="ixt-sec:numwordsen" scale="0" id="f-1881">six</ix:nonFraction> Non-Executive Directors for the year ended December 31, 2025. Key management personnel comprised of <ix:nonFraction unitRef="personnel" contextRef="c-4" decimals="INF" name="soph:NumberOfExecutiveOfficers" format="ixt-sec:numwordsen" scale="0" id="f-1882">six</ix:nonFraction> Executive Officers and Directors and <ix:nonFraction unitRef="personnel" contextRef="c-4" decimals="INF" name="soph:NumberOfNonExecutiveOfficers" format="ixt-sec:numwordsen" scale="0" id="f-1883">six</ix:nonFraction> Non-Executive Directors for the year ended December 31, 2024. Key management personnel comprised of <ix:nonFraction unitRef="personnel" contextRef="c-5" decimals="INF" name="soph:NumberOfExecutiveOfficers" format="ixt-sec:numwordsen" scale="0" id="f-1884">six</ix:nonFraction> Executive Officers and Directors and <ix:nonFraction unitRef="personnel" contextRef="c-5" decimals="INF" name="soph:NumberOfNonExecutiveOfficers" format="ixt-sec:numwordsen" scale="0" id="f-1885">seven</ix:nonFraction> Non-Executive Directors for the year ended December 31, 2023.</span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" id="f-1886" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation for key management and non-executive directors recognized during the year comprised (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.627%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and other short-term employee benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1887">5,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1888">4,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1889">4,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="f-1890">281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="f-1891">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits" scale="3" id="f-1892">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" format="ixt:num-dot-decimal" scale="3" id="f-1893">11,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" format="ixt:num-dot-decimal" scale="3" id="f-1894">12,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment" format="ixt:num-dot-decimal" scale="3" id="f-1895">10,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1896">18,000</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1897">16,786</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ifrs-full:KeyManagementPersonnelCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1898">15,059</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-52</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_310"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">25. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" id="f-1899" continuedAt="f-1899-1" escape="true">Commitments and contingencies</ix:nonNumeric></span></div><ix:continuation id="f-1899-1"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="usd" contextRef="c-6" decimals="INF" name="soph:FutureLeasePaymentsUnderShortTermLeasesNotRecognized" format="ixt:fixed-zero" scale="0" id="f-1900"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="INF" name="soph:FutureLeasePaymentsUnderShortTermLeasesNotRecognized" format="ixt:fixed-zero" scale="0" id="f-1901">no</ix:nonFraction></ix:nonFraction> commitments for future lease payments under short-term leases not recognize</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d on the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">balance sheet as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a minimum purchase agreement with a vendor related to computational and hosting-related costs. As part of the agreement, the Company has a total minimum commitment of approximately $<ix:nonFraction unitRef="usd" contextRef="c-481" decimals="-5" name="ifrs-full:ContractualCapitalCommitments" scale="6" id="f-1902">80.9</ix:nonFraction>&#160;million from the period beginning November 1, 2022 through October 31, 2029 and an additional one-year grace period to meet the minimum commitment by October 31, 2030. As of December 31, 2025 and 2024, the Company has remaining commitments of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ifrs-full:CapitalCommitments" scale="6" id="f-1903">58.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="ifrs-full:CapitalCommitments" scale="6" id="f-1904">56.9</ix:nonFraction> million, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024 the Company had&#160;<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="INF" name="ifrs-full:EstimatedFinancialEffectOfContingentAssets" format="ixt:fixed-zero" scale="0" id="f-1905"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="INF" name="ifrs-full:EstimatedFinancialEffectOfContingentAssets" format="ixt:fixed-zero" scale="0" id="f-1906">no</ix:nonFraction></ix:nonFraction>&#160;contingent assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is regularly subject to lawsuits, claims, arbitration proceedings, administrative actions and other legal and regulatory proceedings involving intellectual property disputes, commercial disputes, competition and other matters, and the Company may become subject to additional types of lawsuits, claims, arbitration proceedings, administrative actions, government investigations and legal and regulatory proceedings in the future. As of December 31, 2025 and 2024, the Company has concluded that losses are not probable and no provisions have been recorded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Guardant Health</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2025 Guardant Health ("Guardant") filed suit against the Company in multiple jurisdictions. Guardant filed suit in the U.K., and in the EU at the Unified Patent Court (the &#8220;UPC&#8221;) in Paris, alleging that the Company&#8217;s MSK-Access liquid biopsy test infringes certain of their patents and seeking remedies, including unspecified monetary damages and injunctive relief. In January 2026, the UPC Paris Local Division issued a final order rejecting Guardant's application for provisional measures and ordered Guardant to pay an interim award of costs of &#8364;<ix:nonFraction unitRef="eur" contextRef="c-482" decimals="-3" name="ifrs-full:LossesOnLitigationSettlements" format="ixt:num-dot-decimal" scale="0" id="f-1907">400,000</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="c-482" decimals="0" name="ifrs-full:LossesOnLitigationSettlements" format="ixt:num-dot-decimal" scale="0" id="f-1908">470,080</ix:nonFraction>), which Guardant has appealed. The U.K. proceedings remain pending. The Company continues to defend itself against these claims.  As of December 31, 2025, the Company has concluded that losses related to this matter are not probable and no provision has been recorded.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-53</span></div></div></div><div id="i949f8e5b3f184d2fadfac47a64e0acc8_313"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">26. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory" id="f-1909" continuedAt="f-1909-1" escape="true">Financial instruments and risks</ix:nonNumeric></span></div><ix:continuation id="f-1909-1" continuedAt="f-1909-2"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.</span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" id="f-1910" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds the following financial instruments (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.282%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.105%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets at amortized cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-483" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-1911">70,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-484" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-1912">80,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-485" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-1913">15,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-486" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-1914">7,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financial non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-487" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-1915">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-488" decimals="-3" name="ifrs-full:FinancialAssets" scale="3" id="f-1916">994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets at amortized cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-489" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-1917">87,285</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-490" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-1918">88,656</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets at fair value through statement of loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-491" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-1919">1,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-492" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:fixed-zero" scale="3" id="f-1920">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-1921">87,285</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:FinancialAssets" format="ixt:num-dot-decimal" scale="3" id="f-1922">88,656</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities at amortized cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-493" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1923">8,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-494" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1924">5,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-495" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1925">20,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-496" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1926">13,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-497" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1927">15,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-498" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1928">16,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-499" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1929">47,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-500" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1930">13,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities at amortized cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-501" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1931">92,716</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-502" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1932">48,467</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities at fair value through statement of loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-503" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1933">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-504" decimals="-3" name="ifrs-full:FinancialLiabilities" scale="3" id="f-1934">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1935">94,128</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:FinancialLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1936">48,911</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s exposure to various risks associated with the financial instruments is discussed below in &#8220;Financial risk management.&#8221; The maximum exposure to credit risk at the end of the reporting period is the carrying amount of each class of financial assets mentioned above. See Note 12 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Accounts receivable&#8221; for expected credit loss provisions on accounts receivable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the Company signed a stock purchase and subscription agreement to acquire a non-controlling minority equity interest in A.D.A.M. Innovations, formerly known as Genesis Healthcare, in two tranches totaling $<ix:nonFraction unitRef="usd" contextRef="c-505" decimals="-5" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="6" id="f-1937">2.0</ix:nonFraction>&#160;million. The Company acquired shares totaling $<ix:nonFraction unitRef="usd" contextRef="c-506" decimals="-5" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="6" id="f-1938">0.5</ix:nonFraction>&#160;million in September 2025 and shares totaling $<ix:nonFraction unitRef="usd" contextRef="c-507" decimals="-5" name="ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss" scale="6" id="f-1939">1.5</ix:nonFraction>&#160;million in October 2025. These financial assets are initially measured at fair value and subsequently re-measured at fair value at each reporting date. Changes in fair values for these financial assets are recorded through profit or loss in accordance with IFRS 9 Financial Instruments. As of December 31, 2025 purchase price approximated fair value and no changes in fair value had been recorded in the Consolidated Statements of Loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value measurement</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the carrying amount was a reasonable approximation of fair value for the following financial assets and liabilities:</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial assets</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Cash and cash equivalents</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Accounts receivable</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Other non-current assets&#8212;lease deposits </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial liabilities</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Accounts payable</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Accrued liabilities</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Borrowings</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1909-2" continuedAt="f-1909-3"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair value measurement methodology</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures financial instruments at fair value at each balance sheet date. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either in the principal market for the asset or liability or, in the absence of a principal market, in the most advantageous market for the asset or liability.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A fair value measurement of a non-financial asset takes into account a market participant&#8217;s ability to generate econo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mic benefits by using the asset or by sell</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ing it to another market participant.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses valuation techniques to measure fair value maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All assets and liabilities for which fair value is measured or disclosed in the consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1&#8212;Quoted (unadjusted) market prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2&#8212;Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3&#8212;Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets and liabilities that are recognized in the consolidated financial statements at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting period.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management determines the policies and procedures for both recurring fair value measurement and for non-recurring measurement with the involvement of experts and external consultants when needed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds money market funds which are classified as cash equivalents which are measured as a level 1 valuation. Refer to Note 11 &#8211; &#8220;Cash and cash equivalents.&#8221; The Company also has warrant obligations related to the Perceptive Credit Agreement, which are measured as a level 2 valuation. Refer to Note 23 &#8212; &#8220;Borrowings&#8221;. The Company also holds a minority equity interest in A.D.A.M. Innovations, which is measured as a level 2 valuation.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1909-3" continuedAt="f-1909-4"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recurring fair-value measurements</span></div><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" id="f-1941" escape="true"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory" id="f-1940" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2025 (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"><tr><td style="width:1.0%"/><td style="width:42.085%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-508" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1942">27,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-509" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1943">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-510" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Equity Investments: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-511" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1945">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-512" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1946">1,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-513" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1947">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-514" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1948">27,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-515" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1949">1,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-516" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1950">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perceptive Credit Holdings warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-517" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1951">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-518" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1952">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-519" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1953">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-514" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-515" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1955">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-516" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1956">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2024 (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"><tr><td style="width:1.0%"/><td style="width:42.085%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-520" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1957">39,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-521" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1958">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-522" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1959">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1960">39,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1961">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-525" decimals="-3" name="ifrs-full:FinancialAssetsAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1962">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perceptive Credit Holdings warrants</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-526" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1963">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-527" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="3" id="f-1964">474</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-528" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1965">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-523" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1966">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-524" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" scale="3" id="f-1967">474</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-525" decimals="-3" name="ifrs-full:FinancialLiabilitiesAtFairValue" format="ixt:fixed-zero" scale="3" id="f-1968">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2025 and 2024 there were no significant changes in the business or economic circumstances that affect the fair value of the Company&#8217;s financial assets and financial liabilities. There were also&#160;no&#160;transfers between categories.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial risk management</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial risks</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior management reg</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ularly reviews th</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e Company&#8217;s cash forecast and related risks. They also perform the risk assessment, define any necessary measures and ensure the monitoring of the internal control system.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s principal financial liabilities include borrowings and accounts payable. The Company&#8217;s principal financial assets include cash and cash equivalents and accounts receivable.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the course of its business, the Company is exposed to a number of financial risks including credit and counterparty risk, funding and liquidity risk, and market risk (i.e. foreign currency risk and interest rate risk). This note presents the Company&#8217;s objectives, policies, and processes for managing these risks.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1909-4" continuedAt="f-1909-5"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit and counterparty risk management</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Company is exposed to credit risk from its operating activities, primarily accounts receivable.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration risk arises when a number of counterparties are engaged in similar business activities, or activities in the same geographical region, or have economic features that would cause their ability to meet contractual obligations to be similarly affected by changes in economic, political, or other conditions.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy with regard to assessing and providing for expected credit losses on accounts receivable is set out in Note </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Accounts receivable.&#8221;</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk from balances with banks and financial institutions is managed by the Company&#8217;s treasury department in accordance with the Company&#8217;s policy.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial transactions are predominantly entered into with investment grade financial institutions and in principle the Company requires a minimum long-term rating of&#160;A3/A-&#160;for its cash investments and term deposits. The Company may deviate from this requirement from time to time for operational reasons. The highest exposure to a single financial counterparty within cash and cash equivalents and term deposits amounted to $<ix:nonFraction unitRef="usd" contextRef="c-529" decimals="-5" name="ifrs-full:MaximumExposureToCreditRisk" scale="6" id="f-1969">24.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-530" decimals="-5" name="ifrs-full:MaximumExposureToCreditRisk" scale="6" id="f-1970">26.1</ix:nonFraction> million as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other&#160;non-current&#160;financial assets include cash deposits for leases.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding and liquidity risk management</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Funding and liquidity risk is the risk that a company may encounter difficulties in meeting its obligations associated with financial liabilities that are settled by delivering cash or other financial assets. Such risk may result from inadequate market depth or disruption or refinancing problems.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company views equity funding as its primary source of liquidity only partly complemented with revenue generated from the sale of the platform, applications, products, and services and borrowings. The Company has </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-480" decimals="-5" name="soph:ProceedsFromBorrowings" scale="6" id="f-1971">50.0</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of outstanding term loans under the Perceptive Credit Agreement, see Note 23 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Borrowings&#8221; fo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r additional information.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Short term liquidity is managed based on projected cash flows. As&#160;of&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;the&#160;Company&#8217;s liquidity consisted of&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ifrs-full:CashAndCashEquivalents" scale="6" id="f-1972">70.3</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="ifrs-full:CashAndCashEquivalents" scale="6" id="f-1973">80.2</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in cash and cash equivalents, respectively. In 2025 the Company has sold, from its treasury shares, <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="soph:NumberOfEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1974">228,238</ix:nonFraction> ordinary shares for total gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ifrs-full:ProceedsFromIssuingShares" scale="6" id="f-1975">1.1</ix:nonFraction>&#160;million under the Company&#8217;s ATM program. In 2026, as described in Note 28 - &#8220;Events After the Reporting Period&#8221;, the Company has sold, from its treasury shares, <ix:nonFraction unitRef="shares" contextRef="c-531" decimals="INF" name="soph:NumberOfEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-1976">2,795,485</ix:nonFraction> ordinary shares for total gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-531" decimals="-5" name="ifrs-full:ProceedsFromIssuingShares" scale="6" id="f-1977">14.3</ix:nonFraction>&#160;million under the Company&#8217;s ATM program and signed an amendment to the Perceptive Credit Agreement which provided an additional </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-5" name="soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" scale="6" id="f-1978">25.0</ix:nonFraction>&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> available for draw. On the basis of the current operating performance and liquidity position, Board of Directors believes that the available cash balances will be sufficient for operating activities, working capital, interest, capital expenditures and scheduled debt repayments for the next 12 months.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1909-5" continuedAt="f-1909-6"><ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory" id="f-1979" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarizes the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted cash flows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:29.855%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Within 1 year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Between 1 and 5 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After 5 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1980">15,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1981">2,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-533" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1982">11,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1983">1,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1984">16,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-1985">8,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-3" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-1986">8,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-533" decimals="-3" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-1987">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-3" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-1988">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-1989">8,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="soph:AccruedExpensesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-1990">20,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-3" name="soph:AccruedExpensesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-1991">20,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-533" decimals="-3" name="soph:AccruedExpensesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-1992">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-3" name="soph:AccruedExpensesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-1993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="soph:AccruedExpensesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-1994">20,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-1995">47,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-1996">5,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-533" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-1997">61,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-1998">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-1999">67,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total contractual liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2000">92,716</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-532" decimals="-3" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2001">37,813</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-533" decimals="-3" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2002">73,797</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-534" decimals="-3" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2003">1,463</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2004">113,073</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:29.855%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.111%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Within 1 year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Between 1 and 5 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After 5 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2005">16,793</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2006">2,739</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2007">12,518</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-537" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2008">4,469</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:GrossLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-2009">19,726</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2010">5,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-3" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2011">5,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-3" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2012">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-537" decimals="-3" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2013">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2014">5,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="soph:AccruedExpensesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2015">13,217</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-3" name="soph:AccruedExpensesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2016">13,217</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-3" name="soph:AccruedExpensesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2017">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-537" decimals="-3" name="soph:AccruedExpensesUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2018">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="soph:AccruedExpensesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2019">13,217</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2020">13,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2021">1,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2022">20,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-537" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:fixed-zero" scale="3" id="f-2023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:BankBorrowingsUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2024">22,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total contractual liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2025">48,467</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-3" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2026">22,798</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-3" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2027">32,923</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-537" decimals="-3" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2028">4,469</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows" format="ixt:num-dot-decimal" scale="3" id="f-2029">60,190</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made adjustments to previously reported future maturities of borrowings as of December 31, 2024 to incorporate contractual cash interest payments of $<ix:nonFraction unitRef="usd" contextRef="c-535" decimals="-5" name="soph:BankBorrowingsInterestPaidUndiscountedCashFlows" scale="6" id="f-2030">1.6</ix:nonFraction> million within 1 year and $<ix:nonFraction unitRef="usd" contextRef="c-536" decimals="-5" name="soph:BankBorrowingsInterestPaidUndiscountedCashFlows" scale="6" id="f-2031">5.4</ix:nonFraction> million between 1 and 5 years to correct for immaterial misstatements.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market risk</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk includes currency risk and interest rate risk.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Currency risk</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency risk is the risk that the fair value or future cash flows of an exposure will fluctuate because of changes in foreign exchange rates.</span></div><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock" id="f-2032" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant exchange rates that have been applied to these consolidated financial statements are listed below:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Spot rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerCHF" contextRef="c-3" decimals="5" name="soph:ForeignExchangeSpotRate" scale="0" id="f-2033">0.79208</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerCHF" contextRef="c-6" decimals="5" name="soph:ForeignExchangeSpotRate" scale="0" id="f-2034">0.90740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerCHF" contextRef="c-1" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2035">0.83064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerCHF" contextRef="c-4" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2036">0.88064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerCHF" contextRef="c-5" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2037">0.89855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/EUR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerEUR" contextRef="c-3" decimals="5" name="soph:ForeignExchangeSpotRate" scale="0" id="f-2038">0.85092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerEUR" contextRef="c-6" decimals="5" name="soph:ForeignExchangeSpotRate" scale="0" id="f-2039">0.96530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerEUR" contextRef="c-1" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2040">0.88644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerEUR" contextRef="c-4" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2041">0.92455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerEUR" contextRef="c-5" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2042">0.92478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerGBP" contextRef="c-3" decimals="5" name="soph:ForeignExchangeSpotRate" scale="0" id="f-2043">0.74179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerGBP" contextRef="c-6" decimals="5" name="soph:ForeignExchangeSpotRate" scale="0" id="f-2044">0.79870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerGBP" contextRef="c-1" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2045">0.75887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerGBP" contextRef="c-4" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2046">0.78267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerGBP" contextRef="c-5" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2047">0.80428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/BRL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerBRL" contextRef="c-3" decimals="5" name="soph:ForeignExchangeSpotRate" scale="0" id="f-2048">5.49560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerBRL" contextRef="c-6" decimals="5" name="soph:ForeignExchangeSpotRate" scale="0" id="f-2049">6.17360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerBRL" contextRef="c-1" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2050">5.58911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerBRL" contextRef="c-4" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2051">5.39155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerBRL" contextRef="c-5" decimals="5" name="soph:AverageForeignExchangeRates" scale="0" id="f-2052">4.97372</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock" id="f-2053" continuedAt="f-2053-1" escape="true"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sensitivity of the Company&#8217;s income to possible changes in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign exchange rates is measured at the local entity level as it depends on the functional currency of each entity. As of December 31, 2025, 2024, and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-1909-6"><ix:continuation id="f-2053-1"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company was exposed principally to movements in four cross currency pairs. The sensitivity of the Company&#8217;s loss before tax to such changes was as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.012%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.012%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.012%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.996%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/CHF exchange rate by&#160;<ix:nonFraction unitRef="number" contextRef="c-538" decimals="INF" name="soph:SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent" scale="-2" id="f-2054">10</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-539" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-2055">2,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-540" decimals="-3" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-2056">2,101</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-541" decimals="-3" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2057">562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-542" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2058">562</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-543" decimals="-3" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-2059">3,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-544" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-2060">3,034</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in EUR/CHF exchange rate by&#160;<ix:nonFraction unitRef="number" contextRef="c-538" decimals="INF" name="soph:SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent" scale="-2" id="f-2061">10</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-545" decimals="-3" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-2062">1,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-546" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" format="ixt:num-dot-decimal" scale="3" id="f-2063">1,020</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-547" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2064">75</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-548" decimals="-3" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2065">75</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-549" decimals="-3" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2066">508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-550" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2067">508</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in GBP/CHF exchange rate by&#160;<ix:nonFraction unitRef="number" contextRef="c-538" decimals="INF" name="soph:SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent" scale="-2" id="f-2068">10</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-551" decimals="-3" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2069">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-552" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2070">36</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-553" decimals="-3" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2071">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-554" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2072">25</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-555" decimals="-3" sign="-" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2073">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-556" decimals="-3" name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" scale="3" id="f-2074">23</ix:nonFraction></span></td></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s exposure to foreign currency changes for all other currencies is not material. The Company does not use derivative financial instruments to hedge exposures and under no circumstances may enter into derivative instruments for speculative purposes.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sensitivity of the Company&#8217;s reported equity or net assets to possible changes in foreign exchange rates is measured at the consolidated level as it depends on the presentation currency selected for the consolidated financial statements. Such effects are reported not in income but in the currency translation account within other reserves. <ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock" id="f-2075" continuedAt="f-2075-1" escape="true">As of </ix:nonNumeric></span><ix:continuation id="f-2075-1" continuedAt="f-2075-2"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the sensitivity of the Company&#8217;s equity to such changes, measured against the USD, was as follows (in USD thousands):</span></ix:continuation></div><ix:continuation id="f-2075-2"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.012%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.990%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.012%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.994%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/CHF exchange rate by&#160;<ix:nonFraction unitRef="number" contextRef="c-557" decimals="INF" name="soph:SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent" scale="-2" id="f-2076">10</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-558" decimals="-3" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" format="ixt:num-dot-decimal" scale="3" id="f-2077">2,561</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-559" decimals="-3" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" format="ixt:num-dot-decimal" scale="3" id="f-2078">2,561</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-560" decimals="-3" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" format="ixt:num-dot-decimal" scale="3" id="f-2079">1,520</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-561" decimals="-3" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" format="ixt:num-dot-decimal" scale="3" id="f-2080">1,520</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/EUR exchange rate by&#160;<ix:nonFraction unitRef="number" contextRef="c-557" decimals="INF" name="soph:SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent" scale="-2" id="f-2081">10</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-562" decimals="-3" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" id="f-2082">663</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-563" decimals="-3" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" id="f-2083">663</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-564" decimals="-3" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" format="ixt:num-dot-decimal" scale="3" id="f-2084">2,244</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-565" decimals="-3" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" format="ixt:num-dot-decimal" scale="3" id="f-2085">2,244</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/GBP exchange rate by&#160;<ix:nonFraction unitRef="number" contextRef="c-557" decimals="INF" name="soph:SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent" scale="-2" id="f-2086">10</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-566" decimals="-3" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" id="f-2087">95</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-567" decimals="-3" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" id="f-2088">95</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-568" decimals="-3" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" id="f-2089">61</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-569" decimals="-3" sign="-" name="ifrs-full:ReserveOfExchangeDifferencesOnTranslation" scale="3" id="f-2090">61</ix:nonFraction>)</span></td></tr></table></div></ix:continuation><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Interest rate risk</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s&#160;cash&#160;and cash&#160;equivalents&#160;are subject to market risk&#160;associated with&#160;interest rate&#160;fluctuations. Fixed rate securities may have their market value adversely affected due to a rise in interest rates.&#160;The C</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ompany concluded that fluctuations in the interest rate did not have a material impact on the Company&#8217;s cash and cash equivalents balances.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company currently has $<ix:nonFraction unitRef="usd" contextRef="c-570" decimals="-5" name="ifrs-full:Borrowings" scale="6" id="f-2091">50.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-571" decimals="-5" name="ifrs-full:Borrowings" scale="6" id="f-2092">15.0</ix:nonFraction>&#160;million, respectively, of debt outstanding under the Perceptive Credit Agreement. Based on the terms of the Perceptive Credit Agreement, the monthly interest expense fluctuates based on the Term SOFR reference rate that is two business days prior to the first day of the preceding calendar month. Given the Company&#8217;s outstanding debt under this agreement, the Company is subject to interest rate risk related to debt obligations if the SOFR were to move significantly. Based on the borrowings exposed to floating interest rates at year-end, an increase in interest rates of <ix:nonFraction unitRef="number" contextRef="c-409" decimals="4" name="soph:SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage" scale="-4" id="f-2093">100</ix:nonFraction> basis points would cause an increase in cash interest costs on an annualized basis of $<ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-5" name="soph:SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings" scale="6" id="f-2094">0.5</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-426" decimals="-5" name="soph:SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings" scale="6" id="f-2095">0.2</ix:nonFraction>&#160;million as of December 31, 2025 and 2024, respectively.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_316"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">27. <ix:nonNumeric contextRef="c-1" name="soph:DisclosureOfCapitalManagementExplanatoryTextBlock" id="f-2096" continuedAt="f-2096-1" escape="true">Capital management</ix:nonNumeric></span></div><ix:continuation id="f-2096-1" continuedAt="f-2096-2"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers equity as equivalent to the IFRS Accounting Standards equity on the balance sheet (including share capital, share premium, and all other equity reserves attributable to the owners of the Company). Other reserves are comprised of comprehensive income/loss and share-based compensation.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary objective of the Company&#8217;s capital management is to maximize shareholder value. The Board regularly reviews its shareholders&#8217; return strategy. For the foreseeable future, the Board will maintain a capital structure that supports the Company&#8217;s strategic objectives through managing funding and liquidity risks and optimizing shareholder return.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i949f8e5b3f184d2fadfac47a64e0acc8_7">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><ix:continuation id="f-2096-2"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company&#8217;s cash and cash equivalents amounted to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ifrs-full:CashAndCashEquivalents" scale="6" id="f-2097">70.3</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="ifrs-full:CashAndCashEquivalents" scale="6" id="f-2098">80.2</ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted in Note 28 &#8212; &#8220;Events after the reporting date&#8221;, the Company also has access to $<ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-5" name="soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" scale="6" id="f-2099">25.0</ix:nonFraction>&#160;million available, of which $<ix:nonFraction unitRef="usd" contextRef="c-425" decimals="-5" name="ifrs-full:UndrawnBorrowingFacilities" scale="6" id="f-2100">12.5</ix:nonFraction>&#160;million can be drawn immediately, under the Perceptive Credit Agreement. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors believes that the Company has sufficient financial resources to meet all of its obligations for at least the next twelve months. Moreover, the Company is not exposed to liquidity risk through requests for early repayment of loans.</span></div></ix:continuation><div id="i949f8e5b3f184d2fadfac47a64e0acc8_319"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">28. <ix:nonNumeric contextRef="c-1" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory" id="f-2101" continuedAt="f-2101-1" escape="true">Events after the reporting date</ix:nonNumeric></span></div><ix:continuation id="f-2101-1" continuedAt="f-2101-2"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated, for potential recognition and disclosure, events that occurred prior to the date at which the consolidated financial statements were authorized for issuance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 23, 2026, the Company entered into an amendment (the &#8220;2026 Amendment&#8221;) to the Perceptive Credit Agreement. The 2026 Amendment provides for, among other things, $<ix:nonFraction unitRef="usd" contextRef="c-415" decimals="-5" name="soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" scale="6" id="f-2102">25.0</ix:nonFraction>&#160;million of additional term loan commitments consisting of (i) an additional $<ix:nonFraction unitRef="usd" contextRef="c-416" decimals="INF" name="soph:BorrowingFacilitiesMaximumBorrowingCapacity" scale="6" id="f-2103">12.5</ix:nonFraction>&#160;million tranche of term loan commitments (&#8220;Tranche C&#8221;), which may be drawn subject to certain customary conditions, and (ii) an additional $<ix:nonFraction unitRef="usd" contextRef="c-417" decimals="INF" name="soph:BorrowingFacilitiesMaximumBorrowingCapacity" scale="6" id="f-2104">12.5</ix:nonFraction>&#160;million tranche of term loan commitments (&#8220;Tranche D&#8221;), which may be drawn at such time as the Company&#8217;s revenue for a trailing twelve-month period exceed $<ix:nonFraction unitRef="usd" contextRef="c-418" decimals="-5" name="soph:BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger" scale="6" id="f-2105">85.0</ix:nonFraction>&#160;million and otherwise subject to customary conditions. Tranche C and Tranche D, if drawn, will have terms and conditions consistent with the Company&#8217;s existing term loans, will bear interest at rate per annum equal to Term SOFR (floored at <ix:nonFraction unitRef="number" contextRef="c-419" decimals="2" name="ifrs-full:BorrowingsAdjustmentToInterestRateBasis" scale="-2" id="f-2106">4</ix:nonFraction>% per annum) + <ix:nonFraction unitRef="number" contextRef="c-420" decimals="4" name="ifrs-full:BorrowingsAdjustmentToInterestRateBasis" scale="-2" id="f-2107">6.25</ix:nonFraction>% and will mature in 2029. In connection with the 2026 Amendment, the Company amended and restated the warrant certificate in order to issue to Perceptive Credit Holdings IV, LP the right to purchase an additional <ix:nonFraction unitRef="shares" contextRef="c-421" decimals="INF" name="soph:WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-2108">75,000</ix:nonFraction> ordinary shares, which right is exercisable immediately. The Warrant Certificate also grants Perceptive Credit Holdings IV, LP the right to purchase an additional (1) <ix:nonFraction unitRef="shares" contextRef="c-422" decimals="INF" name="soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-2109">100,000</ix:nonFraction> ordinary shares, which right will become exercisable upon the Company&#8217;s draw down of the Tranche C under the Perceptive Credit Agreement and (2) another <ix:nonFraction unitRef="shares" contextRef="c-423" decimals="INF" name="soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-2110">100,000</ix:nonFraction> ordinary shares, which right will become exercisable upon the Company&#8217;s draw down of the Tranche D under the Perceptive Credit Agreement. </span></div></ix:continuation><div><span><br/></span></div><div style="margin-top:10pt"><ix:continuation id="f-2101-2" continuedAt="f-2101-3"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2026, through its ATM program, the Company has sold, from its treasury shares</span></ix:continuation><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-2101-3">, <ix:nonFraction unitRef="shares" contextRef="c-531" decimals="INF" name="soph:NumberOfEquitySharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-2111">2,795,485</ix:nonFraction> ordinary shares for total gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-531" decimals="-5" name="ifrs-full:ProceedsFromIssuingShares" scale="6" id="f-2112">14.3</ix:nonFraction>&#160;million</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-60</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>exhibit11aoasgsanovember20.htm
<DESCRIPTION>EX-1.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i6276010608c047a88eaccdfbe1b1a35f_1"></div><div style="min-height:76.32pt;width:100%"><div style="margin-bottom:14pt;margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 1.1</font></div></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Articles of Association</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of SOPHiA GENETICS SA</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Statuts</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">de SOPHiA GENETICS SA</font></div><div style="margin-bottom:3pt;margin-top:3pt"><font><br></font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section 1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>Name, registered office, purpose and duration of the Company</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;margin-top:12pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section&#160;1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>Raison sociale, si&#232;ge, but et dur&#233;e de la Soci&#233;t&#233;</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 1</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 1</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Name, registered office</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Under the name SOPHiA GENETICS SA (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) exists a corporation with its registered office in Rolle, Canton of Vaud, governed by these articles of association (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Articles of Association</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) and the Swiss Code of Obligations (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">CO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">).</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Raison sociale, si&#232;ge</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Sous la raison sociale SOPHiA GENETICS SA (la </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Soci&#233;t&#233;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) existe une soci&#233;t&#233; anonyme avec si&#232;ge &#224;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Rolle, Canton de Vaud, r&#233;gie par les pr&#233;sents statuts (les </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Statuts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) et le Code suisse des obligations (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">CO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">).</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 2 </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 2</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Purpose</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The Company's purpose is the management, preservation and storage of archives of all types, in particular computer and paper archives, as well as the design, development, maintenance, sale and lease of systems, products and services in connection therewith&#59; the development, management and transfer of licenses and franchise agreements in connection therewith, as well as the preservation and archiving of data in the genetic field. The Company may carry out any financial, commercial or industrial activities, in movable or real property, in direct or indirect connection with its purpose.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">But</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> La Soci&#233;t&#233; a pour but la gestion, la conservation et l'entreposage d'archives de toute nature, notamment d'archives informatiques et de papiers ainsi que la conception, la r&#233;alisation, la maintenance, la vente et la location de syst&#232;mes, produits et services s'y rapportant&#59; le d&#233;veloppement, la gestion et le transfert de licences et contrats de franchise y relatives, ainsi que la conservation et l'archivage de donn&#233;es dans le domaine de la g&#233;n&#233;tique. La Soci&#233;t&#233; peut exercer toute activit&#233; financi&#232;re, commerciale ou industrielle, mobili&#232;re ou immobili&#232;re, en rapport direct ou indirect avec son but.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The Company may open branch offices and subsidiaries in Switzerland and abroad. It may also acquire participations or otherwise invest in other companies in Switzerland and abroad.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> La Soci&#233;t&#233; peut constituer des succursales et des filiales en Suisse et &#224; l'&#233;tranger et participer &#224; ou investir autrement dans d'autres entreprises en Suisse et &#224; l'&#233;tranger.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The Company may acquire, hold, manage, mortgage, exploit and sell real estate and intellectual property rights in Switzerland and abroad and may also finance other companies.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> La Soci&#233;t&#233; peut acqu&#233;rir, d&#233;tenir, g&#233;rer, gager, mettre en valeur et ali&#233;ner des immeubles et des droits de propri&#233;t&#233; intellectuelle en Suisse et &#224; l'&#233;tranger, ainsi que financer d'autres soci&#233;t&#233;s.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 3</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 3</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Duration</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The duration of the Company shall be unlimited.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:23.78pt">Dur&#233;e</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La dur&#233;e de la Soci&#233;t&#233; est illimit&#233;e.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section 2</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt">Share capital, shares, restrictions of transferability</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section 2</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt">Capital-actions, actions et restrictions &#224; la transmissibilit&#233;</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 4</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 4</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Share capital</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The share capital of the Company is CHF 4,466,061.- and is divided into 89,321,220 fully paid in registered shares with a par value of CHF&#160;0.05 each.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:23.78pt">Capital-actions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le capital-actions de la Soci&#233;t&#233; est de <br>CHF 4'466'061.- et est divis&#233; en 89'321'220 actions nominatives enti&#232;rement lib&#233;r&#233;es d'une valeur nominale de CHF&#160;0.05 chacune.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 4a</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 4a</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Capital Range</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Company has a capital range ranging from <br>CHF 3,319,908.20 (lower limit) to CHF 4,979,862.30 (upper limit). The Board of Directors shall be authorized within the capital range to increase or reduce the share capital once or several times and in any amounts or to acquire or dispose of shares directly or indirectly, until June 18, 2030 or until an earlier expiry of the capital range. The capital increase or reduction may be effected by issuing up to 33,199,082 fully paid-in registered shares with a par value of CHF 0.05 each and cancelling up to 33,199,082 registered shares with a par value of CHF 0.05 each, as applicable, or by increasing or reducing the par value of the existing shares within the limits of the capital range or by simultaneous reduction and re-increase of the share capital.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Marge de fluctuation du capital</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La Soci&#233;t&#233; dispose d'une marge de fluctuation du capital allant de CHF 3'319'908.20 (limite inf&#233;rieure) &#224; CHF 4'979'862.30 (limite sup&#233;rieure). Le Conseil d'Administration peut, dans les limites d&#233;finies de la marge de fluctuation, et ce jusqu'au 18 juin 2030 ou jusqu'&#224; l'expiration anticip&#233;e de la marge de fluctuation, augmenter ou r&#233;duire le capital-actions en une ou plusieurs fois, de quelque montant que ce soit, ou acqu&#233;rir ou ali&#233;ner des actions directement ou indirectement. L'augmentation ou la r&#233;duction du capital peut se faire par l'&#233;mission de jusqu'&#224; 33'199'082 actions nominatives d'une valeur nominale de CHF&#160;0.05 chacune, qui doivent &#234;tre int&#233;gralement lib&#233;r&#233;es, respectivement l'annulation de jusqu'&#224; 33'199'082 actions nominatives d'une valeur nominale de CHF&#160;0.05 chacune, ou par une augmentation ou une r&#233;duction, dans les limites de la marge de fluctuation, de la valeur nominale des actions nominatives existantes ou encore par une r&#233;duction et une nouvelle augmentation simultan&#233;es.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> In the event of an issue of shares, the subscription and acquisition of the new shares, as well as any subsequent transfer of the shares, shall be subject to the restrictions pursuant to article 6 of these Articles of Association.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> En cas d'&#233;mission d'actions, la souscription et l'acquisition des nouvelles actions, ainsi que tout transfert ult&#233;rieur des actions, sont assujettis aux restrictions &#224; la transmissibilit&#233; conform&#233;ment &#224; l'article 6 des Statuts.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">In the event of a capital increase within the capital range, the Board of Directors shall, to the extent necessary, determine the issue price, the type of contribution (including cash contributions, contributions in kind, set-off and conversion of reserves or of profit carried forward into share capital), the date of issue, the conditions for the exercise of pre-emptive rights and the beginning date for dividend entitlement. In this regard, the Board of Directors may issue new shares by means of a firm underwriting through a financial institution, a syndicate of financial institutions or another third party and a subsequent offer of these shares to the existing shareholders or third parties (if the pre-emptive rights of the existing shareholders have been withdrawn or have not been duly exercised). The Board of Directors is entitled to permit, to restrict or to exclude the trading of pre-emptive rights. It may permit the expiration of pre-emptive rights that have not been duly exercised, or it may place such rights or shares as to which pre-emptive rights have been granted, but not duly exercised, at market conditions or may use them otherwise in the interest of the Company.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">En cas d'augmentation du capital-actions dans le cadre de la marge de fluctuation, le Conseil d'Administration d&#233;termine, le cas &#233;ch&#233;ant, le prix d'&#233;mission, la nature des apports (y compris la lib&#233;ration en esp&#232;ces, les apports en nature, la compensation et la conversion de r&#233;serves ou de b&#233;n&#233;fice report&#233; en capital-actions), le moment de l'&#233;mission, les conditions de l'exercice du droit de souscription pr&#233;f&#233;rentiel et le moment &#224; partir duquel les actions donneront droit &#224; des dividendes. A cet effet, le Conseil d'Administration peut &#233;mettre des nouvelles actions par voie de prise ferme par un &#233;tablissement financier, un consortium bancaire ou un tiers et d'offre subs&#233;quente de ces actions aux actionnaires actuels ou &#224; des tiers (si les droits de souscription pr&#233;f&#233;rentiels des actionnaires actuels ont &#233;t&#233; supprim&#233;s ou n'ont pas &#233;t&#233; valablement exerc&#233;s). Le Conseil d'Administration est en droit d'autoriser, de limiter ou d'exclure le n&#233;goce des droits de souscription pr&#233;f&#233;rentiels. Le Conseil d'Administration peut laisser s'&#233;teindre les droits de souscription pr&#233;f&#233;rentiels non exerc&#233;s valablement&#59; il peut aussi ali&#233;ner ceux-ci, respectivement les actions pour lesquelles des droits de souscription ont &#233;t&#233; accord&#233;s sans toutefois &#234;tre valablement exerc&#233;s, aux conditions du march&#233; ou les utiliser autrement dans l'int&#233;r&#234;t de la Soci&#233;t&#233;.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">In the event of an issue of shares, the Board of Directors is further authorized to withdraw or restrict pre-emptive rights of existing shareholders and to allocate such rights to third parties, the Company or any of its group companies&#58;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">En cas d'&#233;mission d'actions, le Conseil d'Administration peut aussi exclure ou limiter les droits de souscription pr&#233;f&#233;rentiels des actionnaires actuels et les attribuer &#224; des tiers, &#224; la Soci&#233;t&#233; ou &#224; une des soci&#233;t&#233;s du groupe&#58;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(a)&#160;&#160;&#160;&#160;if the issue price of the new shares is determined by reference to the market price&#59; or</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(a)&#160;&#160;&#160;&#160;si le prix d'&#233;mission des nouvelles actions est d&#233;termin&#233; en fonction du prix du march&#233;&#59; ou</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(b)&#160;&#160;&#160;&#160;for raising equity capital in a fast and flexible manner, which would not be possible, or might only be possible with great difficulty or delays or at significantly less favorable conditions, without the exclusion of the pre-emptive rights of existing shareholders&#59; or</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(b)&#160;&#160;&#160;&#160;pour cr&#233;er des fonds propres de mani&#232;re rapide et flexible, ce qui ne serait pas possible ou possible qu'avec difficult&#233; ou tardivement ou &#224; des conditions nettement plus d&#233;favorables sans l'exclusion des droits de souscription pr&#233;f&#233;rentiels des actionnaires actuels&#59; ou</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(c)&#160;&#160;&#160;&#160;for the acquisition of companies, part(s) of companies or participations, for the acquisition of products, intellectual property or licenses by or for investment projects of the Company or any of its group companies, or for the financing or refinancing of any of such transactions through a placement of shares&#59; or</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(c)&#160;&#160;&#160;&#160;pour l'acquisition de soci&#233;t&#233;s, de partie(s) de soci&#233;t&#233;s ou de participations, pour l'acquisition de produits, de propri&#233;t&#233; intellectuelle, ou licences par ou pour des projets d'investissement de la Soci&#233;t&#233; ou de l'une des soci&#233;t&#233;s du groupe, ou pour le financement ou le refinancement de telles transactions par le placement d'actions&#59; ou</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(d)&#160;&#160;&#160;&#160;for purposes of broadening the shareholder constituency of the Company in certain geographic, financial or investor markets, for purposes of the participation of strategic partners including financial investors, or in connection with the listing of new shares on domestic or foreign stock exchanges&#59; or</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(d)&#160;&#160;&#160;&#160;pour &#233;largir le cercle des actionnaires de la Soci&#233;t&#233; dans certains march&#233;s g&#233;ographiques, financiers ou d'investisseurs, pour permettre la participation de partenaires strat&#233;giques y compris d'investisseurs financiers, ou en relation avec la cotation de nouvelles actions sur des bourses nationales ou &#233;trang&#232;res&#59; ou</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(e)&#160;&#160;&#160;&#160;for purposes of granting an over-allotment option (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt">Greenshoe</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) or an option to subscribe for additional shares in a placement or sale of shares to the respective initial purchaser(s) or underwriter(s)&#59; or</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(e)&#160;&#160;&#160;&#160;pour octroyer une option de surallocation (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt">Greenshoe</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) ou une option de souscription d'actions suppl&#233;mentaires lors d'un placement ou de la vente d'actions &#224; un ou plusieurs acheteurs initiaux ou souscripteurs&#59; ou</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(f)&#160;&#160;&#160;&#160;for the participation of members of the Board of Directors (or equivalent corporate body), members of the executive management, employees, contractors, consultants, or other persons performing services for the benefit of, the Company or any of its group companies&#59; or</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(f)&#160;&#160;&#160;&#160;pour la participation de membres du conseil d'administration (ou d'un organe &#233;quivalent), de membres de la direction, d'employ&#233;s, de co-contractants ou de consultants ou d'autres personnes exer&#231;ant des services au b&#233;n&#233;fice de la Soci&#233;t&#233; ou de l'une des soci&#233;t&#233;s du groupe&#59; ou</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(g)&#160;&#160;&#160;&#160;following a shareholder or a group of shareholders acting in concert having accumulated shareholdings in excess of 15% of the share capital registered in the commercial register without having submitted to all other shareholders a takeover offer recommended by the Board of Directors&#59; or</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(g)&#160;&#160;&#160;&#160;si un actionnaire ou un groupe d'actionnaires agissant de concert a acquis ou r&#233;uni une participation de plus de 15% du capital-actions inscrit au registre du commerce sans avoir pr&#233;sent&#233; &#224; tous les autres actionnaires une offre publique d'achat dont l'acceptation a &#233;t&#233; recommand&#233;e par le Conseil d'Administration&#59; ou</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(h)&#160;&#160;&#160;&#160;for the defense of an actual, threatened or potential takeover bid that the Board of Directors, upon consultation with an independent financial adviser retained by it, has not recommended or will not recommend to the shareholders to accept on the basis that the Board of Directors does not find such takeover bid to be (i) financially fair to the shareholders or (ii) in the Company's interest.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(h)&#160;&#160;&#160;&#160;pour se d&#233;fendre contre une offre publique d'achat hostile pr&#233;sent&#233;e, mena&#231;ante ou potentielle dont le rejet est, respectivement sera, recommand&#233; par le Conseil d'Administration, apr&#232;s consultation d'un conseiller financier ind&#233;pendant qu'il aura choisi, dans la mesure o&#249; le Conseil d'Administration estime que l'offre publique d'achat n'est pas (i) &#233;quitable d'un point de vue financier vis-&#224;-vis des actionnaires ou (ii) dans l'int&#233;r&#234;t de la Soci&#233;t&#233;.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a change of the par value, new shares shall be issued within the capital range with the same par value as the existing shares.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> En cas de modification de valeur nominale, les nouvelles actions &#233;mises dans le cadre de la marge de fluctuation du capital doivent &#234;tre &#233;mises avec la m&#234;me valeur nominale que les actions nominatives existantes.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">6 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the share capital increases as a result of an increase from conditional capital pursuant to Article 4b of these articles of association, the upper and lower limits of the capital range shall increase in an amount corresponding to such increase in the share capital.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> En cas d'augmentation du capital-actions en raison d'une augmentation conditionnelle du capital-actions conform&#233;ment &#224; l'article 4b, les limites sup&#233;rieure et inf&#233;rieure de la marge de fluctuation augmentent en fonction du montant de l'augmentation du capital-actions.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">7 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a reduction of the share capital within the capital range, the Board of Directors shall, to the extent necessary, determine the use of the reduction amount.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> En cas de r&#233;duction du capital-actions dans le cadre de la marge de fluctuation, le Conseil d'Administration d&#233;termine, si n&#233;cessaire, l'affectation du montant de la r&#233;duction.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 4b</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 4b</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Conditional share capital for employee participation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The share capital may be increased in an amount not to exceed CHF 1,069,162.35 through the issuance of up to 21,383,247 fully paid in registered shares with a par value of CHF&#160;0.05 per share through the direct or indirect issuance of shares, or through the exercise or mandatory exercise of rights to acquire shares or through obligations to acquire shares that were granted to or imposed on members of the Board of Directors (or equivalent corporate body), members of the executive management, employees, contractors or consultants of the Company or its group companies, or other persons providing services to the Company or its group companies.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Capital-actions conditionnel pour la participation des employ&#233;s</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le capital-actions peut &#234;tre augment&#233; d'un montant maximum de CHF 1&#8217;069'162.35 par l'&#233;mission de 21'383&#8217;247 actions nominatives au plus, d'une valeur nominale de CHF&#160;0.05 chacune, qui doivent &#234;tre int&#233;gralement lib&#233;r&#233;es, par l'&#233;mission directe ou indirecte d'actions ou par l'exercice ou l'exercice obligatoire de droits de souscription d'actions ou par des obligations d'acquisition d'actions accord&#233;es ou impos&#233;es &#224; des membres du conseil d'administration (ou d'un organe &#233;quivalent), des membres de la direction, des employ&#233;s, des co-contractants ou des consultants de la Soci&#233;t&#233; ou de l'une des soci&#233;t&#233;s du groupe, ou d'autres personnes exer&#231;ant des services au b&#233;n&#233;fice de la Soci&#233;t&#233; ou de l'une des soci&#233;t&#233;s du groupe.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The pre-emptive rights and advance subscription rights of the shareholders of the Company shall be excluded in connection with the issuance of any shares, options, other rights to receive shares, or subscription rights therefor. Shares, options, other rights to receive shares, or subscription rights therefore shall be issued pursuant to one or more plans, regulations or resolutions to be issued by the Board of Directors or, to the extent delegated to it, the Compensation Committee, and to the extent applicable, taking into account the compensation principles pursuant to article&#160;28 of these Articles of Association.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Such shares may be issued at a price lower than the respective market price quoted on the stock exchange and such rights or acquisition obligations may be granted below their intrinsic value.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Le droit de souscription pr&#233;f&#233;rentiel ainsi que le droit de souscription pr&#233;alable des actionnaires de la Soci&#233;t&#233; sont exclus en relation avec l'&#233;mission de toutes actions, options, autres droits &#224; recevoir des actions ou des droits de souscription qui y sont attach&#233;s. L'&#233;mission d'actions, d'options, d'autres droits &#224; recevoir des actions ou des droits de souscription qui y sont attach&#233;s est faite selon un ou plusieurs plans, r&#232;glements ou d&#233;cisions adopt&#233;s par le Conseil d'Administration ou le Comit&#233; de R&#233;mun&#233;ration, dans la mesure o&#249; cette comp&#233;tence lui a &#233;t&#233; d&#233;l&#233;gu&#233;e, et, le cas &#233;ch&#233;ant, en tenant compte des principes de r&#233;mun&#233;ration selon l'article&#160;28 des Statuts. L'&#233;mission de telles actions peut se faire &#224; un prix inf&#233;rieur au prix du march&#233; et l'octroi de tels droits ou obligations d'acquisition peut se faire &#224; un prix inf&#233;rieur &#224; leur valeur intrins&#232;que.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The direct or indirect acquisition of the new shares by persons listed in paragraph&#160;1 of this article 4b in connection with an employee participation program, as well as any subsequent transfer of such shares, shall be subject to the restrictions of article&#160;6 of these Articles of Association.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">L'acquisition directe ou indirecte de nouvelles actions par des personnes mentionn&#233;es &#224; l'alin&#233;a 1 du pr&#233;sent article 4b dans le cadre d'un programme de participation des collaborateurs, ainsi que le transfert subs&#233;quent de ces actions, sont assujettis aux restrictions &#224; la transmissibilit&#233; conform&#233;ment &#224; l'article 6 des Statuts.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The declaration of acquisition of the shares based on this Article 4b shall refer to this Article 4b and be made in a form that allows proof by text. A waiver of the right to acquire shares based on this Article 4b may also occur informally or by lapse of time&#59; this also applies to the waiver of the exercise and forfeiture of this right.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> La d&#233;claration concernant l'acquisition d'actions fond&#233;e sur le pr&#233;sent article 4b doit faire r&#233;f&#233;rence &#224; cet article 4b et doit &#234;tre faite sous une forme permettant d'en &#233;tablir la preuve par texte. La renonciation &#224; un droit d'acquisition d'actions fond&#233; sur le pr&#233;sent article 4b peut &#233;galement avoir lieu de mani&#232;re informelle ou par l'&#233;coulement du temps&#59; cela vaut &#233;galement pour la renonciation &#233; l'exercice et la d&#233;ch&#233;ance de ce droit.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 4c</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 4c</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Conditional share capital for financing, acquisitions and other purposes</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The share capital may be increased including in connection with an intended takeover in an amount not to exceed CHF 913,868.15 through the issuance of up to 18,277,363 fully paid in registered shares with a par value of CHF 0.05 per share through the exercise or mandatory exercise of conversion, exchange, option, warrant or similar rights or obligations for the subscription of shares granted to shareholders or third parties on a stand-alone basis or in connection with bonds, notes, options, warrants or other securities or contractual obligations of the Company or any of its group companies (collectively, the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Financial Instruments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">).</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Capital-actions conditionnel aux fins de financement, acquisitions ou d'autres buts</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le capital-actions peut &#234;tre augment&#233;, y compris en lien avec une future offre publique d'acquisition, d'un montant maximum de CHF 913'868.15 par l'&#233;mission de 18'277&#8217;363 actions nominatives au plus, d'une valeur nominale de CHF 0.05 chacune, qui doivent &#234;tre int&#233;gralement lib&#233;r&#233;es par l'exercice ou l'exercice obligatoire de droits de conversion, d'&#233;change, d'option, de warrant ou d'autres droits ou obligations similaires pour la souscription d'actions octroy&#233;s aux actionnaires ou &#224; des tiers de mani&#232;re autonome ou en rapport avec des obligations, effets, options, warrants ou autres instruments financiers ou obligations contractuelles de la Soci&#233;t&#233; ou de l'une des soci&#233;t&#233;s du groupe (collectivement, les </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Instruments Financiers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">).</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The pre-emptive rights of shareholders shall be excluded for the exercise of any Financial Instruments in connection with the issuance of shares. The then-current owners of such Financial Instruments shall be entitled to acquire the new shares issued upon conversion, exchange or exercise of any Financial Instruments. The main conditions of the Financial Instruments shall be determined by the Board of Directors.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Le droit de souscription pr&#233;f&#233;rentiel des actionnaires est exclu en relation avec l'&#233;mission d'actions &#224; l'occasion de l'exercice d'Instruments Financiers. Les personnes qui d&#233;tiendront alors de tels Instruments Financiers seront en droit d'acqu&#233;rir les nouvelles actions &#233;mises &#224; l'occasion de la conversion, de l'&#233;change ou de l'exercice d'Instruments Financiers. Le Conseil d'Administration d&#233;termine les principales conditions des Instruments Financiers.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Board of Directors shall be authorized to restrict or withdraw advance subscription rights of shareholders in connection with the issuance of Financial Instruments by the Company or one of its group companies (1) if the issuance is for purposes of financing or refinancing, or the payment for, the acquisition of companies, parts of a company, participations, intellectual property rights, licenses or investments, (2) if the issuance occurs in domestic or international capital markets or through a private placement, (3) following a shareholder or a group of shareholders acting in concert having accumulated shareholdings in excess of 15% of the share capital registered in the commercial register without having submitted to all other shareholders a takeover offer recommended by the Board of Directors, (4) for the defense of an actual, threatened or potential takeover bid that the Board of Directors, upon consultation with an independent financial adviser retained by it, has not recommended or will not recommend to the shareholders to accept on the basis that the Board of Directors does not find such takeover bid to be (i) financially fair to the shareholders or (ii) in the Company's interest, or (5) if the Financial Instruments are issued on appropriate terms. If the advance subscription rights are neither granted directly nor indirectly by the Board of Directors, the following shall apply&#58;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le Conseil d'Administration est autoris&#233; &#224; limiter ou retirer le droit de souscription pr&#233;alable des actionnaires en relation avec l'&#233;mission d'Instruments Financiers par la Soci&#233;t&#233; ou une des soci&#233;t&#233;s du groupe (1) si l'&#233;mission a pour but le financement, le refinancement ou le paiement de l'acquisition d'entreprises, de parties d'une entreprise, de participations, de droits de propri&#233;t&#233; intellectuelle, de licences ou d'investissements, (2) si l'&#233;mission a lieu sur les march&#233;s de capitaux nationaux ou internationaux ou par le biais d'un placement priv&#233;, (3) si un actionnaire ou un groupe d'actionnaires agissant de concert a acquis ou r&#233;uni une participation de plus de 15% du capital-actions inscrit au registre du commerce sans avoir pr&#233;sent&#233; &#224; tous les autres actionnaires une offre publique d'achat dont l'acceptation a &#233;t&#233; recommand&#233;e par le Conseil d'Administration, (4) pour se d&#233;fendre contre une offre publique d'achat hostile pr&#233;sent&#233;e, mena&#231;ante ou potentielle dont le rejet est, respectivement sera, recommand&#233; par le Conseil d'Administration, apr&#232;s consultation d'un conseiller financier ind&#233;pendant qu'il aura choisi, dans la mesure o&#249; le Conseil d'Administration estime que l'offre publique d'achat n'est pas (i) &#233;quitable d'un point de vue financier vis-&#224;-vis des actionnaires ou (ii) dans l'int&#233;r&#234;t de la Soci&#233;t&#233;, ou (5) si les Instruments Financiers sont &#233;mis &#224; des conditions appropri&#233;es. Si le droit de souscription pr&#233;alable n'est pas accord&#233;, de mani&#232;re directe ou indirecte, par le Conseil d'Administration, les r&#232;gles suivantes s'appliquent&#58;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(a)&#160;&#160;&#160;&#160;the Financial Instruments shall be issued or entered into at market conditions&#59; </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(a)&#160;&#160;&#160;&#160;les Instruments Financiers sont &#233;mis ou conclus aux conditions du march&#233;&#59; </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(b)&#160;&#160;&#160;&#160;the Financial Instruments may be converted, exchanged or exercised during a maximum period of 10 years from the date of issuance or contract conclusion&#59; and</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(c) &#160;&#160;&#160;&#160;the conversion, exchange or exercise price of the Financial Instruments shall be set with reference to, and&#47;or shall be subject to change based upon, the valuation of the Company's equity and&#47;or market conditions.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(b)&#160;&#160;&#160;&#160;les Instruments Financiers peuvent &#234;tre convertis, &#233;chang&#233;s ou exerc&#233;s durant une p&#233;riode maximale de 10 ans suivant la date de l'&#233;mission ou de la conclusion du contrat&#59; et</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(c) &#160;&#160;&#160;&#160;le prix de conversion, d'&#233;change ou d'exercice des Instruments Financiers est fix&#233; en prenant en compte, et&#47;ou peut &#234;tre modifi&#233; en fonction, de la valorisation des fonds propres de la Soci&#233;t&#233; et&#47;ou des conditions du march&#233;.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The direct or indirect acquisition of the new shares acquired through the exercise of Financial Instruments, as well as any subsequent transfer of such shares, shall be subject to the restrictions of article&#160;6 of these Articles of Association.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">L'acquisition de nouvelles actions acquises directement ou indirectement par l'exercice d'Instruments Financiers, ainsi que le transfert subs&#233;quent de ces actions, sont assujettis aux restrictions &#224; la transmissibilit&#233; conform&#233;ment &#224; l'article&#160;6 des Statuts.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The declaration of acquisition of the shares based on this Article 4c shall refer to this Article 4c and be made in a form that allows proof by text. A waiver of the right to acquire shares based on this Article 4c may also occur informally or by lapse of time&#59; this also applies to the waiver of the exercise and forfeiture of this right.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> La d&#233;claration concernant l'acquisition d'actions fond&#233;e sur le pr&#233;sent article 4c doit faire r&#233;f&#233;rence &#224; cet article 4c et doit &#234;tre faite sous une forme permettant d'en &#233;tablir la preuve par texte. La renonciation &#224; un droit d'acquisition d'actions fond&#233; sur le pr&#233;sent article 4c peut &#233;galement avoir lieu de mani&#232;re informelle ou par l'&#233;coulement du temps&#59; cela vaut &#233;galement pour la renonciation &#224; l'exercice et la d&#233;ch&#233;ance de ce droit.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 5</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Share certificates and intermediated securities</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Company may issue its registered shares in the form of single certificates, global certificates, uncertificated securities within the meaning of article&#160;973c or 973d CO, or intermediated securities. Subject to applicable law, the Company may convert its registered shares from one form into another form at any time and without the approval of the shareholders. The Company shall bear the cost associated with any such conversion.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:23.78pt">Certificats d'actions et titres interm&#233;di&#233;s</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La Soci&#233;t&#233; &#233;met ses actions nominatives sous forme de certificats individuels, de certificats globaux, de droits-valeurs au sens des articles&#160;973c ou 973d CO ou des titres interm&#233;di&#233;s. La Soci&#233;t&#233; est libre, dans les limites du droit applicable, en tout temps et sans l'approbation des actionnaires, de convertir ses actions nominatives &#233;mises sous l'une des formes ci-dessus, en une autre forme. La Soci&#233;t&#233; supporte les co&#251;ts d'une telle conversion.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> A shareholder has no right to request a conversion of the registered shares issued in one form into another form. Each shareholder may, however, at any time request from the Company a written confirmation of the registered shares held by such shareholder, as reflected in the share register.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Un actionnaire n'a pas le droit de r&#233;clamer la conversion d'actions nominatives &#233;mises sous une certaine forme en une autre forme. Chaque actionnaire peut toutefois exiger en tout temps que la Soci&#233;t&#233; &#233;tablisse une attestation relative aux actions nominatives qu'il d&#233;tient selon le registre des actions.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Intermediated securities based on registered shares of the Company cannot be transferred by way of assignment. A security interest in any such intermediated securities also cannot be granted by way of assignment.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Les titres interm&#233;di&#233;s fond&#233;s sur des actions nominatives de la Soci&#233;t&#233; ne peuvent pas &#234;tre transf&#233;r&#233;s par cession. Il ne peut pas non plus &#234;tre constitu&#233; de s&#251;ret&#233;s par cession sur ces titres interm&#233;di&#233;s.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 6</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 6</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Share register, restrictions on registration, Nominees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Company shall maintain, itself or through a third party, a share register for the registered shares that lists the surname and name (the name of the company in case of a legal entity), the address and domicile (the registered office in case of a legal entity) of the shareholders or usufructuaries. A person registered in the share register shall notify the share registrar of any change of address. Until such notification has occurred, all written communications from the Company to persons registered in the share register shall be deemed to have been validly made if sent to the address previously recorded in the share register.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:23.78pt">Registre des actions, limitations &#224; l'inscription, Nominees</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La Soci&#233;t&#233; ou un tiers mandat&#233; par elle tient un registre des actions qui mentionne le nom et le pr&#233;nom (la raison sociale pour les personnes morales), l'adresse et le domicile (le si&#232;ge pour les personnes morales) des propri&#233;taires et des usufruitiers. Si une personne inscrite au registre des actions change d'adresse, elle doit le communiquer &#224; la personne en charge de la tenue du registre. Aussi longtemps que cette communication n'a pas eu lieu, toutes les communications &#233;crites de la Soci&#233;t&#233; aux personnes inscrites au registre des actions seront valablement envoy&#233;es &#224; l'adresse inscrite au registre des actions.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Persons acquiring shares shall be registered in the share register as shareholders with voting rights upon their request if they expressly declare to have acquired these shares in their own name and for their own account. Subject to paragraph 4 of this article&#160;6 and article&#160;685</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt">d</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> para.&#160;3 CO, no person or entity shall be registered in the share register as a shareholder with voting rights for, and no person or entity may directly or indirectly, formally, constructively or beneficially own, or otherwise control alone or together with third parties voting rights (whether exercisable or not) with respect to more than 15% of the share capital as set forth in the commercial register as a shareholder with voting rights. This restriction shall also apply to persons or entities who hold some or all of their shares through Nominees (as defined in paragraph&#160;4 of this article&#160;6). </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Les personnes qui acqui&#232;rent des actions sont inscrites dans le registre des actions, &#224; leur demande, comme actionnaires avec droit de vote, pour autant qu'elles d&#233;clarent express&#233;ment avoir acquis les actions en leur nom et pour leur propre compte. Sous r&#233;serve de l'alin&#233;a 4 du pr&#233;sent article 6 et de l'article&#160;685d al.&#160;3 CO, aucune personne physique ou morale ne peut &#234;tre inscrite au registre des actions comme actionnaire avec droit de vote et aucune personne physique ou morale ne peut d&#233;tenir, directement ou indirectement, formellement, de fait ou comme ayant droit &#233;conomique, ou contr&#244;ler autrement, seul ou avec des tiers, des droits de vote (exer&#231;ables ou non), par rapport &#224; plus de 15% du capital-actions inscrit au registre du commerce en tant qu'actionnaire avec droit de vote. Cette restriction s'applique &#233;galement aux personnes ou entit&#233;s qui d&#233;tiennent tout ou partie de leurs actions par l'interm&#233;diaire de Nominees (tels que d&#233;finis &#224; l'alin&#233;a&#160;4 du pr&#233;sent article 6).</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Subject to Art. 652b para. 3 CO, this transfer restriction also applies in the case of the acquisition of shares by the exercise of subscription, option and conversion rights. The transfer restriction does not apply to acquisitions by inheritance, division of an estate or matrimonial property law.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Sous r&#233;serve de l'art. 652b al. 3 CO, les restrictions au transfert s'appliquent &#233;galement lors de l'acquisition d'actions dans le cadre de l'exercice d'un droit de souscription, d'option ou de conversion. Les restrictions au transfert ne s'appliquent pas lors d'acquisitions par succession, partage successoral ou en vertu du droit matrimonial.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The Board of Directors may, in its own discretion, register persons who declare in the registration application that they hold the shares as nominees (each, a </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Nominee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) on behalf of third party beneficiaries (each, a </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Beneficial Owner</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) in the share register as shareholders with voting rights. If, however, any Beneficial Owner should as a result of such registration being made or upheld, directly or indirectly, formally, constructively or beneficially own, or otherwise control or direct, alone or together with third parties, voting rights (whether exercisable or not) with respect to more than 15% of the share capital as set forth in the commercial register, the Board of Directors may cancel the registration of the Nominee holding shares for the account of such Beneficial Owner with respect to any shares in excess of such limit. The Board of Directors may make the registration with voting rights of the shares held by a Nominee subject to conditions, limitations and reporting requirements or may impose or adjust such conditions, limitations and requirements once registered.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Le Conseil d'Administration peut, &#224; son enti&#232;re discr&#233;tion, inscrire les personnes qui d&#233;clarent dans leur requ&#234;te d'inscription qu'elles d&#233;tiennent les actions en tant que nominees (chacun, un </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Nominee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) pour le compte de tiers ayants droit &#233;conomiques (chacun, un </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Ayant Droit Economique</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) en tant qu'actionnaires avec droit de vote. Toutefois, si suite &#224; l'inscription ou &#224; la confirmation de l'inscription, un Ayant Droit Economique d&#233;tient directement ou indirectement, formellement, de fait ou comme ayant droit &#233;conomique, ou contr&#244;le ou dirige autrement, seul ou avec des tiers, des droits de vote (exer&#231;ables ou non) par rapport &#224; plus de 15% du capital-actions inscrit au registre du commerce, le Conseil d'Administration peut annuler l'inscription du Nominee d&#233;tenant les actions pour le compte d'un tel Ayant Droit Economique pour les actions d&#233;passant cette limite. Le Conseil d'Administration peut soumettre l'inscription avec droit de vote des actions d&#233;tenues par un Nominee &#224; des conditions, limitations, exigences de rapports ou peut imposer de telles conditions, limitiations ou exigences suite &#224; l'inscription.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Legal entities and partnerships or other groups of persons or joint owners who are interrelated to one another through capital ownership, voting rights, uniform management or are otherwise linked, as well as individuals or legal entities or partnerships who act in concert or otherwise act in a coordinated manner or acquire shares indirectly, thereby circumventing the restrictions or limits pursuant to paragraph&#160;2 or&#160;4 of this article&#160;6 shall be treated as one single person, entity, Nominee or as a person acquiring shares, as applicable, for purposes of paragraphs&#160;2 and&#160;4 of this article&#160;6.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Les personnes morales et communaut&#233;s de personnes ou autres groupes de personnes ou de copropri&#233;taires qui sont li&#233;s par le capital, les droits de vote, la gestion commune ou de toute autre mani&#232;re, de m&#234;me que les personnes physiques ou morales ou communaut&#233;s de personnes qui agissent de concert ou de mani&#232;re coordonn&#233;e ou acqui&#232;rent indirectement des actions, et contournent ainsi les restrictions ou limites vis&#233;es aux alin&#233;as&#160;2 ou 4 du pr&#233;sent article&#160;6 sont trait&#233;s comme une seule personne, personne morale, Nominee ou comme une personne acqu&#233;rant des actions, selon le cas, aux fins des alin&#233;as&#160;2 et 4 du pr&#233;sent article&#160;6.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">6 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Board of Directors may grant exceptions from the restrictions or limits pursuant to paragraph 2 or 4 of this article&#160;6 for justified reasons with the majority vote of two thirds of all its members. A justified reason may include the situation where a person extends an offer to purchase with respect to all other shares of the Company, which the Board of Directors, after having consulted an independent financial advisor, recommends to the shareholders.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">6 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le Conseil d'Administration peut octroyer des d&#233;rogations aux restrictions et limites mentionn&#233;es aux alin&#233;as 2 ou 4 du pr&#233;sent article 6 pour des raisons justifi&#233;es, &#224; la majorit&#233; des deux tiers de l'ensemble de ses membres. Peut aussi &#234;tre consid&#233;r&#233;e comme une raison justifi&#233;e le fait qu'une personne &#233;tende une offre d'achat par rapport &#224; l'ensemble des autres actions de la Soci&#233;t&#233; et que le Conseil d'Administration, apr&#232;s avoir consult&#233; un conseiller financier ind&#233;pendant, recommande aux actionnaires d'accepter cette offre. </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">7 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Shareholders, other than Nominees, already being registered directly or through a Nominee with more than 15% at the time that this article&#160;6 takes effect remain registered with voting rights for such shares. Such privilege may not be transferred by an indirect transfer of shares.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">7 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Les actionnaires autres que les Nominees d&#233;j&#224; inscrits directement ou par l'interm&#233;diaire d'un Nominee pour plus de 15% au moment o&#249; le pr&#233;sent article&#160;6 entre en vigueur demeurent enregistr&#233;s avec droit de vote pour ces actions. Ce privil&#232;ge ne peut &#234;tre transf&#233;r&#233; par un transfert indirect d'actions.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">8 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">After hearing the registered shareholder or Nominee, the Board of Directors may cancel such person's registration in the share register with retroactive effect as of the date of registration if such registration was made based on false or misleading information or if such information becomes untrue or misleading. The relevant shareholder or Nominee shall be promptly informed of the cancellation.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">8 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le Conseil d'Administration peut, apr&#232;s avoir entendu l'actionnaire ou le Nominee, radier du registre des actions l'inscription qui a &#233;t&#233; faite sur la base d'informations fausses ou trompeuses donn&#233;es par l'acqu&#233;reur, ou si les informations deviennent fausses ou trompeuses. L'actionnaire ou le Nominee doit &#234;tre inform&#233; imm&#233;diatement de la radiation.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">9 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Board of Directors shall regulate all details and issue the instructions necessary to ensure compliance with the preceding provisions. The Board of Directors may delegate its duties.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">9 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le Conseil d'Administration r&#232;gle les d&#233;tails et prend les mesures n&#233;cessaires au respect des dispositions ci-dessus. Le Conseil d'Administration peut d&#233;l&#233;guer ses t&#226;ches.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 7</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Exercise of rights</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Company shall only accept one representative per share.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:12.00pt"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:23.78pt">Exercice des droits</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La Soci&#233;t&#233; ne reconna&#238;t qu'un repr&#233;sentant par action.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The voting right and the rights associated therewith may be exercised vis-&#224;-vis the Company by a shareholder, usufructuary or Nominee only to the extent that such person is registered in the share register with voting rights.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Le droit de vote et les droits y relatifs ne peuvent &#234;tre exerc&#233;s &#224; l'&#233;gard de la Soci&#233;t&#233; que par un actionnaire, un usufruitier ou un Nominee uniquement dans la mesure o&#249; celui-ci est inscrit avec droit de vote au registre des actions.</font></div></td></tr><tr style="height:4pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section 3</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt">Corporate bodies</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section 3</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt">Organes</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">A.&#160;&#160;&#160;&#160;The General Meeting</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">A.&#160;&#160;&#160;&#160;L'Assembl&#233;e G&#233;n&#233;rale</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 8</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 8</font></div></td></tr><tr style="height:30pt"><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Powers of the General Meeting</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The general meeting of shareholders (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">General Meeting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) is the supreme corporate body of the Company. </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:23.78pt">Pouvoirs de l'Assembl&#233;e G&#233;n&#233;rale</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">L'assembl&#233;e g&#233;n&#233;rale des actionnaires (l'</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Assembl&#233;e G&#233;n&#233;rale</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) est l'organe supr&#234;me de la Soci&#233;t&#233;. </font></div></td></tr><tr style="height:37pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The General Meeting shall have the following inalienable powers&#58;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> L'Assembl&#233;e G&#233;n&#233;rale a le droit inali&#233;nable&#58;</font></div></td></tr><tr style="height:34pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">1.&#160;&#160;&#160;&#160;the adoption and amendment of these Articles of Association&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">1.&#160;&#160;&#160;&#160;d'adopter et de modifier les Statuts&#59;</font></div></td></tr><tr style="height:54pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">2.&#160;&#160;&#160;&#160;the election of the members of the Board of Directors, the chair of the Board of Directors (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Chair</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) and the members of the Compensation Committee&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">2.&#160;&#160;&#160;&#160;de nommer les membres du Conseil d'Administration, le&#47;la pr&#233;sident&#47;e du Conseil d'Administration (le&#47;la </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Pr&#233;sident&#47;e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) et les membres du Comit&#233; de R&#233;mun&#233;ration&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">3.&#160;&#160;&#160;&#160;the election of the Auditors&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">3.&#160;&#160;&#160;&#160;de nommer l'Organe de R&#233;vision&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">4.&#160;&#160;&#160;&#160;the election of the independent voting rights representative&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">4.&#160;&#160;&#160;&#160;de nommer le repr&#233;sentant ind&#233;pendant&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">5.&#160;&#160;&#160;&#160;the approval of the annual management report and the consolidated financial statements&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">5.&#160;&#160;&#160;&#160;d'approuver le rapport annuel et les comptes consolid&#233;s&#59;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">6.&#160;&#160;&#160;&#160;the approval of the annual financial statements as well as the resolution on the allocation of profit shown on the balance sheet, in particular the determination of dividends&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">6.&#160;&#160;&#160;&#160;d'approuver les comptes annuels et de d&#233;terminer l'emploi du b&#233;n&#233;fice r&#233;sultant du bilan, en particulier de fixer le dividende&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">7.&#160;&#160;&#160;&#160;the determination of interim dividends and the approval of the interim financial statements required for this purpose&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">7.&#160;&#160;&#160;&#160;de fixer le dividende int&#233;rimaire et d'approuver les comptes interm&#233;diaires n&#233;cessaires &#224; cet effet&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">8.&#160;&#160;&#160;&#160;the resolution on the repayment of the statutory capital reserve&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">8.&#160;&#160;&#160;&#160;de d&#233;cider du remboursement de la r&#233;serve l&#233;gale issue du capital&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">9.&#160;&#160;&#160;&#160;the discharge from liability of the members of the Board of Directors and the persons entrusted with management&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">9.&#160;&#160;&#160;&#160;de donner d&#233;charge aux membres du Conseil d'Administration et aux personnes charg&#233;es de la gestion&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">10.&#160;&#160;&#160;&#160;the approval of the compensation of the Board of Directors and of the executive committee of the Company (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Executive Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) pursuant to article 26 of these Articles of Association&#59; </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">10.&#160;&#160;&#160;&#160;d'approuver la r&#233;mun&#233;ration du Conseil d'Administration et de la direction ex&#233;cutive de la Soci&#233;t&#233; (la </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Direction Ex&#233;cutive</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) selon l'article 26 des Statuts&#59; </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">11.&#160;&#160;&#160;&#160;the delisting of the Company's equity securities&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">11.&#160;&#160;&#160;&#160;de proc&#233;der &#224; la d&#233;cotation des titres de participation de la soci&#233;t&#233;&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">12.&#160;&#160;&#160;&#160;the approval of the report on non-financial matters pursuant to article 964c CO (if applicable)&#59; and</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">12.&#160;&#160;&#160;&#160;d'approuver le rapport sur les questions non finan-ci&#232;res selon l'article 964c CO (si applicable)&#59; et</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:35.47pt;padding-right:2.77pt;text-align:justify;text-indent:-32.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">13.&#160;&#160;&#160;&#160;the adoption of resolutions on matters that are reserved to the General Meeting by law or these Articles of Association or that are, subject to article 716a CO, submitted to the General Meeting by the Board of Directors.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:25.87pt;padding-right:2.77pt;text-align:justify;text-indent:-23.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">13.&#160;&#160;&#160;&#160;de prendre toutes les d&#233;cisions qui lui sont r&#233;serv&#233;es par la loi ou les Statuts ou qui lui sont soumises par le Conseil d'Administration, sous r&#233;serve de l'article&#160;716a CO.</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 9</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 9</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Ordinary and extraordinary General Meetings</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The ordinary General Meeting shall be held each year within six months of the close of the financial year of the Company.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Assembl&#233;es g&#233;n&#233;rales ordinaires et extraordinaires</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">L'Assembl&#233;e G&#233;n&#233;rale ordinaire a lieu chaque ann&#233;e dans les six mois qui suivent la cl&#244;ture de l'exercice social de la Soci&#233;t&#233;.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Extraordinary General Meetings shall be held if</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Des Assembl&#233;es G&#233;n&#233;rales extraordinaires ont lieu lorsque</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(a)&#160;&#160;&#160;&#160;the Board of Directors or the Auditors deem it necessary&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:28.82pt;padding-right:2.77pt;text-align:justify;text-indent:-26.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(a)&#160;&#160;&#160;&#160;le Conseil d'Administration ou l'Organe de R&#233;vision l'estime n&#233;cessaire&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.42pt;padding-right:2.77pt;text-align:justify;text-indent:-23.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(b)&#160;&#160;&#160;&#160;so resolved by a General Meeting&#59; or</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:28.82pt;padding-right:2.77pt;text-align:justify;text-indent:-26.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(b)&#160;&#160;&#160;&#160;une Assembl&#233;e G&#233;n&#233;rale le d&#233;cide&#59; ou</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.42pt;padding-right:2.77pt;text-align:justify;text-indent:-23.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(c)&#160;&#160;&#160;&#160;shareholders who hold, alone or together, shares representing at least 5% of the share capital or votes so request in writing, indicating the matters to be discussed and the corresponding proposals and, in case of elections, the names of the nominated candidates.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:28.82pt;padding-right:2.77pt;text-align:justify;text-indent:-26.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(c)&#160;&#160;&#160;&#160;des actionnaires repr&#233;sentant seuls ou ensemble 5% au moins du capital-actions ou des voix le requi&#232;rent par &#233;crit en indiquant les objets de discussion et les propositions, et, en cas d'&#233;lections, les noms des candidats propos&#233;s.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 10</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 10</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Notice</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Notice of a General Meeting shall be given by the Board of Directors or, if necessary, by the Auditors, no later than 20 calendar days prior to the date of the meeting. Liquidators and representatives of bond-holders are also entitled to call a General Meeting. </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:23.78pt">Convocation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">L'Assembl&#233;e G&#233;n&#233;rale est convoqu&#233;e par le Conseil d'Administration ou, si n&#233;cessaire, par l'Organe de R&#233;vision au plus tard 20 jours calendaires avant le jour de l'assembl&#233;e. Les liquidateurs et les repr&#233;sentants de d&#233;tenteurs d'obligations ont &#233;galement le droit de convoquer l'Assembl&#233;e G&#233;n&#233;rale. </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Notice of the General Meeting shall be given by way of a single announcement in the official means of publication of the Company pursuant to article&#160;35 of these Articles of Association. Registered shareholders may in addition be notified in writing.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> La convocation &#224; l'Assembl&#233;e G&#233;n&#233;rale a lieu par une annonce unique dans l'organe de publication de la Soci&#233;t&#233; selon l'article 35 des Statuts. La convocation peut &#233;galement &#234;tre envoy&#233;e par &#233;crit aux actionnaires inscrits.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The annual report, the compensation report, the Auditors' reports and any other reports required by law shall be made available to the shareholders no later than 20 calendar days prior to the ordinary General Meeting. </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le rapport de gestion, le rapport de r&#233;mun&#233;ration, les rapports de r&#233;vision et tout autre rapport exig&#233;s par la loi sont mis &#224; la disposition des actionnaires au plus tard 20 jours calendaires avant l'Assembl&#233;e G&#233;n&#233;rale ordinaire. </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The notice shall include&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt;padding-left:22.27pt">date, beginning, ending, mode and venue of the General Meeting&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt;padding-left:22.27pt">the agenda&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt;padding-left:22.27pt">the proposals of the Board of Directors together with a brief statement of the reasons&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt;padding-left:22.27pt">proposals of the shareholders, if any, together with a brief statement of the reasons&#59; and</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt;padding-left:22.27pt">name and address of the independent voting rights representative.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La convocation doit mentionner&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:22.27pt">la date, l'heure de d&#233;but et de fin, le lieu et la forme de l'Assembl&#233;e G&#233;n&#233;rale&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:22.27pt">les objets port&#233;s &#224; l'ordre du jour&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:22.27pt">les propositions du Conseil d'Administration accompagn&#233;es d'une motivation succincte&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:22.27pt">le cas &#233;ch&#233;ant, les propositions des actionnaires, accompagn&#233;es d'une motivation succincte&#59; et</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:33.37pt;padding-right:2.77pt;text-align:justify;text-indent:-30.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:22.27pt">le nom et l'adresse du repr&#233;sentant ind&#233;pendant.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">.</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 11</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 11</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">16 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Agenda</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Shareholders who, alone or together, hold at least 0.5% of the share capital or the votes may request that an item be included on the agenda or that a proposal relating to an agenda item be included in the notice convening the General Meeting. Such request must be received by the Company at least 45 calendar days prior to the General Meeting, specifying the agenda item and the proposals of the shareholders.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:23.78pt">Objets &#224; l'ordre du jour</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Des actionnaires qui repr&#233;sentent, seuls ou ensemble, au moins 0,5% du capital-actions ou des voix peuvent requ&#233;rir l'inscription d'un objet &#224; l'ordre du jour, ainsi que l'inscription dans la convocation &#224; l'Assembl&#233;e G&#233;n&#233;rale de propositions concernant les objets port&#233;s &#224; l'ordre du jour. La demande doit &#234;tre re&#231;ue par la Soci&#233;t&#233; au moins 45 jours calendaires avant l'Assembl&#233;e G&#233;n&#233;rale avec indication des objets &#224; l'ordre du jour et des propositions des actionnaires.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> No resolutions may be passed at a General Meeting on proposals concerning agenda items for which proper notice was not given. This provision shall not apply, however, to proposals made during a General Meeting to convene an extraordinary General Meeting or to initiate a special audit. Each request for inclusion of an item on the agenda shall include (i) a brief description of the agenda item and the reason for which it is to be discussed at the meeting&#59; (ii) the motions regarding the agenda item&#59; (iii) the name and address, as they appear on the Company's register of shareholders, of the shareholder proposing such business&#59; (iv) the number of shares of the Company which are beneficially owned by such shareholder&#59; (v) the dates upon which the shareholder acquired such shares&#59; (vi) documentary support for any claim of beneficial ownership&#59; (vii) any material interest of such shareholder in including the item in the agenda&#59; (viii) a statement in support of the matter&#59; and (ix) all other information required under applicable law and stock exchange rules.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Aucune d&#233;cision ne peut &#234;tre prise par l'Assembl&#233;e G&#233;n&#233;rale sur des objets qui n'ont pas &#233;t&#233; d&#251;ment port&#233;s &#224; l'ordre du jour, &#224; l'exception des propositions de convoquer une Assembl&#233;e G&#233;n&#233;rale extraordinaire et d'instituer un contr&#244;le sp&#233;cial. Toute requ&#234;te visant l'inscription d'un objet &#224; l'ordre du jour doit inclure (i) une br&#232;ve description de cet objet et la raison pour laquelle il doit &#234;tre discut&#233; lors de l'Assembl&#233;e G&#233;n&#233;rale&#59; (ii) les propositions relatives &#224; cet objet&#59; (iii) le nom et l'adresse, tels qu'ils apparaissent dans le registre des actions, de l'actionnaire proposant un tel objet&#59; (iv) le nombre d'actions de la Soci&#233;t&#233; dont cet actionnaire est l'Ayant Droit Economique&#59; (v) les dates auxquelles l'actionnaire a acquis ces actions&#59; (vi) les pi&#232;ces justificatives d&#233;montrant le statut d'Ayant Droit Economique&#59; (vii) l'int&#233;r&#234;t important de l'actionnaire &#224; l'inscription de l'objet &#224; l'ordre du jour&#59; (viii) une d&#233;claration &#224; l'appui de la requ&#234;te&#59; et (ix) toute autre information requise par la loi ou les r&#232;gles boursi&#232;res applicables.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">No prior notice is required to bring motions related to items already on the agenda or for the discussion of matters on which no resolution is to be taken.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">En revanche, il n'est pas n&#233;cessaire d'annoncer &#224; l'avance les propositions entrant dans le cadre des objets port&#233;s &#224; l'ordre du jour ni les d&#233;lib&#233;rations qui ne doivent pas &#234;tre suivies d'un vote.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 11a</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 11a</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Venue</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The Board of Directors shall determine the venue of the General Meeting, which may be held in Switzerland or abroad.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Lieu de r&#233;union</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Le Conseil d'Administration d&#233;termine le lieu de l'Assembl&#233;e G&#233;n&#233;rale, qui peut se tenir en Suisse ou &#224; l'&#233;tranger.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The Board of Directors can determine that the General Meeting be held simultaneously at different locations, provided that the contributions of the participants are transmitted directly in video and audio to all venues and that shareholders who are not present at the venue(s) of the General Meeting may exercise their rights by electronic means.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Le Conseil d'Administration peut d&#233;cider que l'Assembl&#233;e G&#233;n&#233;rale se tiendra simultan&#233;ment en plusieurs lieux, &#224; condition que les votes des participants soient transmis directement par l'image et le son &#224; tous les lieux de r&#233;union et que les actionnaires qui ne sont pas pr&#233;sents au(x) lieu(x) de l'Assembl&#233;e G&#233;n&#233;rale puissent exercer leurs droits par voie &#233;lectronique.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Alternatively, the Board of Directors may provide that the General Meeting will be held by electronic means without a venue.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Alternativement, le Conseil d'Administration peut pr&#233;voir que l'Assembl&#233;e G&#233;n&#233;rale se d&#233;roule par voie &#233;lectronique sans lieu de r&#233;union.</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 12</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 12</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Chair, vote counters, minutes</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Chair of the Board of Directors shall chair the General Meeting. In his absence, the Vice-Chair of the Board of Directors, another member or a person designated by the Board of Directors shall chair the General Meeting. If no member of the Board of Directors is available and no other person has been designated by the Board of Directors, the acting chair shall be elected by the General Meeting.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:24.92pt">Pr&#233;sidence, scrutateurs, proc&#232;s-verbal</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le&#47;la Pr&#233;sident&#47;e du Conseil d'Administration pr&#233;side l'Assembl&#233;e G&#233;n&#233;rale. En son absence, le&#47;la Vice-Pr&#233;sident&#47;e du Conseil d'Administration, un autre membre ou une personne d&#233;sign&#233;e par le Conseil d'Administration pr&#233;side l'Assembl&#233;e G&#233;n&#233;rale. Si aucun membre du Conseil d'Administration n'est disponible et aucune personne n'a &#233;t&#233; d&#233;sign&#233;e par le Conseil d'Administration, l'Assembl&#233;e G&#233;n&#233;rale &#233;lit son&#47;sa pr&#233;sident&#47;e.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The acting chair of the General Meeting shall appoint the secretary and the vote counter(s), none of whom need be shareholders. The minutes shall be signed by the acting chair of the General Meeting of and the secretary.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Le&#47;la pr&#233;sident&#47;e de l'Assembl&#233;e G&#233;n&#233;rale d&#233;signe un r&#233;dacteur du proc&#232;s-verbal et le ou les scrutateurs, qui ne doivent pas n&#233;cessairement &#234;tre des actionnaires. Le proc&#232;s-verbal doit &#234;tre sign&#233; par le&#47;la pr&#233;sident&#47;e de l'Assembl&#233;e G&#233;n&#233;rale et le&#47;la secr&#233;taire.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The acting chair of the General Meeting shall have all powers and authority necessary and appropriate to ensure the orderly conduct of the General Meeting.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le&#47;la pr&#233;sident&#47;e de l'Assembl&#233;e G&#233;n&#233;rale a tous les pouvoirs n&#233;cessaires et appropri&#233;s pour s'assurer de la conduite r&#233;guli&#232;re de l'Assembl&#233;e G&#233;n&#233;rale.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt"> </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The resolutions and election results shall be made available electronically within 15 calendar days after the General Meeting, stating the exact proportion of votes&#59; each shareholder may request that the minutes be made available to him within 30 calendar days after the General Meeting.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Les d&#233;cisions et le r&#233;sultat des &#233;lections, avec indication de la r&#233;partition exacte des voix, doivent &#234;tre rendus accessibles par voie &#233;lectronique dans les 15 jours calendaires qui suivent l'Assembl&#233;e G&#233;n&#233;rale&#59; chaque actionnaire peut exiger que le proc&#232;s-verbal soit mis &#224; sa disposition dans les 30 jours calendaires qui suivent l'Assembl&#233;e G&#233;n&#233;rale.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 13</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Article 13</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">19 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr style="height:42pt"><td colspan="3" rowspan="4" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Voting rights, representation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Each share shall convey the right to one vote. The voting rights are subject to the conditions of articles 6 and 7 of these Articles of Association.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:23.78pt">Droit de vote, repr&#233;sentation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Chaque action donne droit &#224; une voix. Les droits de vote sont soumis aux conditions des articles 6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">et 7 des Statuts.</font></div></td></tr><tr style="height:123pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">No shareholder or proxy may, directly or indirectly, exercise voting rights attached to own or represented shares that would collectively exceed 15% of the share capital as set forth in the commercial register. Legal entities and partnerships or other groups of persons or joint owners who are interrelated to one another through capital ownership, voting rights, uniform management or are otherwise linked, as well as individuals or legal entities or partnerships who act in concert or otherwise act in a coordinated manner, thereby circumventing the aforementioned restriction of voting rights, are deemed to be one shareholder for the purposes of such voting.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Aucun actionnaire ou mandataire ne peut exercer, directement ou indirectement, des droits de vote attach&#233;s &#224; des actions propres ou repr&#233;sent&#233;es qui d&#233;passeraient collectivement 15% du capital-actions tel qu'il figure au registre du commerce. Les personnes morales et les communaut&#233;s de personnes ou autres groupes de personnes ou de copropri&#233;taires qui sont li&#233;s par le capital, les droits de vote, la gestion commune ou de toute autre mani&#232;re, de m&#234;me que les personnes physiques ou morales ou communaut&#233;s de personnes qui agissent de concert ou de mani&#232;re coordonn&#233;e, contournant ainsi les restrictions ou limites susmentionn&#233;es, sont trait&#233;s comme un seul actionnaire aux fins de ce vote. </font></div></td></tr><tr style="height:138pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The restrictions of paragraph&#160;2 of this article&#160;13 shall not apply to the exercise of voting rights by (i) shareholders or their proxies, to the extent that their shares are registered in the share register with voting rights pursuant to article&#160;6 paragraph&#160;7 of these Articles of Association, (ii) Nominees, provided that Nominees' voting rights shall be subject to the same restrictions as set forth in article&#160;6 paragraph&#160;4 of these Articles of Association, and (iii) the independent voting rights representative to the extent that the latter has been appointed as proxy by shareholders.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Les restrictions cit&#233;es &#224; l'alin&#233;a 2 du pr&#233;sent article 13 ne s'appliquent pas &#224; l'exercice du droit de vote par (i) les actionnaires ou leurs mandataires, dans la mesure o&#249; leurs actions sont inscrites au registre des actions avec droit de vote conform&#233;ment &#224; l'article 6 alin&#233;a 7 des Statuts, (ii) les Nominees, &#224; condition que les droits de vote des Nominees soient soumis aux m&#234;mes restrictions que celles &#233;nonc&#233;es &#224; l'article 6 alin&#233;a 4 des Statuts, et (iii) le repr&#233;sentant ind&#233;pendant des droits de vote dans la mesure o&#249; ce dernier a &#233;t&#233; d&#233;sign&#233; comme mandataire par les actionnaires.</font></div></td></tr><tr style="height:138pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The Board of Directors shall issue the rules regarding the participation in and representation at the General Meeting and determine the requirements as to proxies and instructions. A shareholder may be represented at the General Meeting by the independent voting rights representative, its legal representative or, by means of a written proxy, by any other proxy who need not be a shareholder. All shares held by a shareholder may only be represented by one person.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Le Conseil d'Administration prend les dispositions relatives &#224; la participation et &#224; la repr&#233;sentation &#224; l'Assembl&#233;e G&#233;n&#233;rale et d&#233;termine les exigences applicables aux procurations et instructions. Un actionnaire peut &#234;tre repr&#233;sent&#233; &#224; l'Assembl&#233;e G&#233;n&#233;rale par le repr&#233;sentant ind&#233;pendant, par son repr&#233;sentant l&#233;gal ou, au moyen d'une procuration &#233;crite, par tout autre mandataire qui ne doit pas n&#233;cessairement &#234;tre un actionnaire. Toutes les actions d&#233;tenues par un actionnaire ne peuvent &#234;tre repr&#233;sent&#233;es que par une seule personne.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The General Meeting shall elect the independent voting rights representative for a term of office until completion of the next ordinary General Meeting. Re-election is possible.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">L'Assembl&#233;e G&#233;n&#233;rale nomme le repr&#233;sentant ind&#233;pendant pour une dur&#233;e de fonctions s'achevant &#224; la fin de l'Assembl&#233;e G&#233;n&#233;rale ordinaire suivante. La r&#233;&#233;lection est possible.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">6 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">If the Company does not have an independent voting rights representative, the Board of Directors shall appoint the independent voting rights representative for the next General Meeting.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">6 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Dans le cas o&#249; la Soci&#233;t&#233; n'a pas de repr&#233;sentant ind&#233;pendant, le Conseil d'Administration nommera le repr&#233;sentant ind&#233;pendant pour l'Assembl&#233;e G&#233;n&#233;rale suivante.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 14 </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 14</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Resolutions, elections</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The General Meeting shall pass its resolutions and decide its elections by the majority of the votes attached to the shares represented, unless required otherwise by law or these Articles of Association. In the event of a tie, the resolution shall be deemed refused.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">D&#233;cisions, &#233;lections</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Les d&#233;cisions de l'Assembl&#233;e G&#233;n&#233;rale sont prises &#224; la majorit&#233; des voix attribu&#233;es aux actions repr&#233;sent&#233;es, &#224; moins que la loi ou les Statuts n'en disposent autrement. En cas d'&#233;galit&#233; de voix, la d&#233;cision est refus&#233;e. </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Two thirds of the votes represented and the majority of the par value of shares represented shall be required for the General Meeting to adopt resolutions on the following matters&#58;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Une d&#233;cision de l'Assembl&#233;e G&#233;n&#233;rale recueillant au moins les deux tiers des voix attribu&#233;es aux actions repr&#233;sent&#233;es et la majorit&#233; des valeurs nominales repr&#233;sent&#233;es est n&#233;cessaire pour&#58;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27.72pt;padding-right:2.77pt;text-align:justify;text-indent:-24.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">1.&#160;&#160;&#160;&#160;the amendment of the purpose of the Company&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">1.&#160;&#160;&#160;&#160;la modification du but social de la Soci&#233;t&#233;&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">2.&#160;&#160;&#160;&#160;the creation of shares with privileged voting rights&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">2.&#160;&#160;&#160;&#160;l'introduction d'actions &#224; droit de vote privil&#233;gi&#233;&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">3.&#160;&#160;&#160;&#160;the restriction on the transferability of registered shares or their registration with voting rights and the cancelation of such a restriction&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">3.&#160;&#160;&#160;&#160;la restriction de la transmissibilit&#233; des actions nominatives ou leur inscription avec droit de vote ainsi que la suppression d'une telle restriction&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">4.&#160;&#160;&#160;&#160;the introduction of conditional share capital or the introduction of a capital range&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">4.&#160;&#160;&#160;&#160;la cr&#233;ation d'un capital conditionnel ou l'institution d'une marge de fluctuation du capital&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">5.&#160;&#160;&#160;&#160;an increase in share capital through the conversion of equity surplus, against contributions in kind, by set-off against a claim, or the granting of special benefits&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">5.&#160;&#160;&#160;&#160;l'augmentation du capital-actions au moyen de la conversion de fonds propres, contre apport en nature ou par compensation de cr&#233;ance, ou l'octroi d'avantages particuliers&#59;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">21 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">6.&#160;&#160;&#160;&#160;the limitation or withdrawal of pre-emptive rights&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">6.&#160;&#160;&#160;&#160;la limitation ou la suppression du droit de souscription pr&#233;f&#233;rentiel&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">7.&#160;&#160;&#160;&#160;the change of currency of the share capital&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">7.&#160;&#160;&#160;&#160;le changement de la monnaie dans laquelle le capital-actions est fix&#233;&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">8.&#160;&#160;&#160;&#160;the introduction of a casting vote for the person chairing the General Meeting&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">8.&#160;&#160;&#160;&#160;l'introduction de la voix pr&#233;pond&#233;rante du pr&#233;sident &#224; l'Assembl&#233;e G&#233;n&#233;rale&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">9.&#160;&#160;&#160;&#160;the relocation of the registered office of the Company&#59; </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">9.&#160;&#160;&#160;&#160;le transfert du si&#232;ge de la Soci&#233;t&#233;&#59; </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">10.&#160;&#160;&#160;&#160;the delisting of the Company's equity securities&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">10.&#160;&#160;&#160;&#160;la d&#233;cotation des titres de participation de la Soci&#233;t&#233;&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">11.&#160;&#160;&#160;&#160;the dissolution of the Company&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">11.&#160;&#160;&#160;&#160;la dissolution de la Soci&#233;t&#233;&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">12.&#160;&#160;&#160;&#160;the introduction of an arbitration clause in the articles of association&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">12.&#160;&#160;&#160;&#160;l'introduction d'une clause d'arbitrage dans les statuts&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">13. &#160;&#160;&#160;&#160;mergers, demergers and conversions pursuant to the Swiss federal act on merger, demerger, conversion and transfer of assets and liabilities (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Merger Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">)&#59; </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">13.&#160;&#160;&#160;&#160;une fusion, scission ou transformation conform&#233;ment &#224; la loi f&#233;d&#233;rale sur la fusion, la scission, la transformation et le transfert de patrimoine (la </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Loi sur la Fusion</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">14. &#160;&#160;&#160;&#160;the conversion of registered shares into bearer shares&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">15. &#160;&#160;&#160;&#160;the removal of any member of the Board of Directors or of its Chair before the end of his&#47;her term of office&#59; </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">14.&#160;&#160;&#160;&#160;la conversion d'actions nominatives en actions au porteur&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:28.97pt;padding-right:2.77pt;text-align:justify;text-indent:-26.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">15. &#160;&#160;&#160;&#160;la r&#233;vocation de tout membre du Conseil d'Administration ou de son&#47;sa Pr&#233;sident&#47;e avant la fin de son mandat&#59; </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">16.&#160;&#160;&#160;&#160;the combination of shares&#59; and</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">16.&#160;&#160;&#160;&#160;la r&#233;union d'actions&#59; et</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">22 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27.72pt;padding-right:2.77pt;text-align:justify;text-indent:-24.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">17.&#160;&#160;&#160;&#160;the amendment or repeal of the following provisions of these Articles of Association, with the exception of editorial amendments that do not effectively change their content&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(i) &#160;&#160;&#160;&#160;article 4a paragraph 1, 2, 4(g) and 4(h)&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(ii) &#160;&#160;&#160;&#160;article 4c paragraph 1, 3 and 4&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(iii) &#160;&#160;&#160;&#160;article&#160;6&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(iv) &#160;&#160;&#160;&#160;article 13 paragraph 2 and 3&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(v) &#160;&#160;&#160;&#160;article 14&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(vi) &#160;&#160;&#160;&#160;article 15&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(vii) &#160;&#160;&#160;&#160;article 18&#59; and</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(viii) &#160;&#160;&#160;&#160;article 35a.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">17.&#160;&#160;&#160;&#160;la modification ou la suppression des dispositions suivantes des Statuts, &#224; l'exception des modifications r&#233;dactionnelles qui ne modifient pas effectivement leur contenu&#58;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(i) &#160;&#160;&#160;&#160;article 4a alin&#233;a 1, 2, 4(g) et 4(h)&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(ii) &#160;&#160;&#160;&#160;article 4c alin&#233;a 1, 3 et 4&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(iii) &#160;&#160;&#160;&#160;article&#160;6&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(iv) &#160;&#160;&#160;&#160;article 13 alin&#233;a 2 et 3&#59;</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(v) &#160;&#160;&#160;&#160;article 14&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(vi) &#160;&#160;&#160;&#160;article 15&#59; </font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(vii) &#160;&#160;&#160;&#160;article 18&#59; et</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:49.77pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(viii) &#160;&#160;&#160;&#160;article 35a.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Resolutions and elections shall be decided by open ballot, unless the acting chair of the General Meeting decides that a secret ballot be held or that it be voted by electronic means. The acting chair of the General Meeting may at any time order that a resolution or election be repeated if he&#47;she considers the vote to be in doubt. The resolution or election previously held shall then be deemed not to have taken place. </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Les d&#233;cisions et &#233;lections ont lieu &#224; main lev&#233;e, &#224; moins qu'un vote &#224; bulletins secrets ou &#233;lectronique ne soit ordonn&#233; par le&#47;la pr&#233;sident&#47;e de l'Assembl&#233;e G&#233;n&#233;rale. Le&#47;la pr&#233;sident&#47;e de l'Assembl&#233;e G&#233;n&#233;rale peut en tout temps ordonner qu'une d&#233;cision ou &#233;lection soit r&#233;p&#233;t&#233;e s'il&#47;elle estime qu'il existe des doutes sur le r&#233;sultat. Dans ce cas, la d&#233;cision ou l'&#233;lection pr&#233;c&#233;dente est r&#233;put&#233;e ne pas avoir eu lieu.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">B.&#160;&#160;&#160;&#160;The Board of Directors</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">B.&#160;&#160;&#160;&#160;Le Conseil d'Administration</font></div></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 15</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 15</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Number of directors</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The board of directors of the Company (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Board of Directors</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) shall consist of not less than 3 and not more than 8 members.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;padding-left:23.78pt">Nombre de membres</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le conseil d'administration de la Soci&#233;t&#233; (le </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Conseil d'Administration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) se compose de 3 membres au moins et de 8 membres au plus.</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 16</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 16</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Election and term of office</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The General Meeting shall elect the members of the Board of Directors and the Chair of the Board of Directors individually and for a term of office until the completion of the next ordinary General Meeting. Re-election is possible. </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#201;lection et dur&#233;e des fonctions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Les membres du Conseil d'Administration et le&#47;la Pr&#233;sident&#47;e du Conseil d'Administration sont &#233;lus individuellement par l'Assembl&#233;e G&#233;n&#233;rale pour une dur&#233;e de fonctions s'achevant &#224; la fin de l'Assembl&#233;e G&#233;n&#233;rale ordinaire suivante. La r&#233;&#233;lection est possible. </font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">23 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> If the office of the Chair of the Board of Directors is vacant, the Board of Directors shall appoint a new Chair from among its members for a term of office extending until completion of the next ordinary General Meeting.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Lorsque la fonction de Pr&#233;sident&#47;e du Conseil d'Administration est vacante, le Conseil d'Administration d&#233;signe un&#47;une nouveau-elle Pr&#233;sident&#47;e parmi ses membres pour une dur&#233;e de fonctions s'achevant &#224; la fin de l'Assembl&#233;e G&#233;n&#233;rale ordinaire suivante.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 17</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Organization of the Board of Directors</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the election of the Chair of the Board of Directors and the members of the Compensation Committee by the General Meeting, the Board of Directors shall constitute itself. The Board of Directors may elect one or several vice-chairs (each, a </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vice-Chair</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The Board of Directors shall further appoint a secretary who need not be member of the Board of Directors.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Organisation du Conseil d'Administration</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A l'exception de l'&#233;lection par l'Assembl&#233;e G&#233;n&#233;rale du&#47;de la Pr&#233;sident&#47;e du Conseil d'Administration et des membres du Comit&#233; de R&#233;mun&#233;ration, le Conseil d'Administration se constitue lui-m&#234;me. Il peut d&#233;signer au besoin, un&#47;une ou plusieurs vice-pr&#233;sident&#47;e(s) (chacun, un&#47;e </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vice-Pr&#233;sident&#47;e</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Le Conseil d'Administration d&#233;signe en outre un&#47;une secr&#233;taire, qui ne doit pas n&#233;cessairement &#234;tre membre du Conseil d'Administration.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Subject to these Articles of Association, the Board of Directors shall regulate its organization and the adoption of resolutions in the organizational regulations.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Le Conseil d'Administration r&#232;gle en outre son organisation et la mani&#232;re de prendre des d&#233;cisions dans un r&#232;glement d'organisation, sous r&#233;serve des Statuts.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 18</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 18</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr style="height:40pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Reimbursement of expenses, indemnification</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The members of the Board of Directors shall be entitled to the reimbursement of all expenses incurred in the interest of the Company.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Remboursement des frais, indemnisation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Les membres du Conseil d'Administration ont droit au remboursement de tous les frais engag&#233;s dans l'int&#233;r&#234;t de la Soci&#233;t&#233;.</font></div></td></tr><tr style="height:279pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> To the extent not included in insurance coverage or paid by third parties, the Company shall indemnify and hold harmless, to the extent permitted by law, the existing and former members of the Board of Directors and Executive Committee, and their heirs, executors and administrators, out of the assets of the Company from and against all threatened, pending or completed actions, suits or proceedings &#8211; whether civil, criminal, administrative or investigative &#8211; and all costs, charges, losses, damages, and expenses which they or any of them, their heirs, executors or administrators, shall or may incur or sustain by or by reason of any actual or alleged actions, consents or omissions in or about the execution of their duty, or alleged duty, or by reason of the fact that he is or was a member of the Board of Directors or Executive Committee of the Company or the board of directors (or equivalent corporate body) or the management of one of its subsidiaries, or, while serving as a member of the Board of Directors or Executive Committee of the Company, is or was serving at the request of the Company as a director, member of the executive management, employee or agent of another corporation, partnership, joint venture, trust or other enterprise&#59; provided, however, that this indemnity shall not extend to any matter in which any of said persons is found, in a final judgment or decree of a court or governmental or administrative authority of competent jurisdiction not subject to appeal, to have committed an intentional or grossly negligent breach of his statutory duties as a member of the Board of Directors or Executive Committee.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Dans la mesure o&#249; la loi le permet, la Soci&#233;t&#233; indemnisera, &#224; concurrence de la portion non couverte par une assurance ou pay&#233;e par un tiers, sur ses propres biens les membres actuels et pass&#233;s du Conseil d'Administration et de la Direction Ex&#233;cutive ainsi que leurs h&#233;ritiers, masse en faillite ou masse successorale contre toutes actions, proc&#232;s ou poursuites, mena&#231;ants, en cours ou termin&#233;s, de nature civile, p&#233;nale, administrative ou autre, et tous les co&#251;ts, d&#233;penses, pertes, dommages et frais qu'ils (ou leurs h&#233;ritiers, masse en faillite ou masse successorale) subiraient ou pourraient subir en raison d'actions, consentements ou omissions, effectifs ou pr&#233;sum&#233;s, en relation avec l'exercice de leurs fonctions, leurs fonctions suppos&#233;es ou en raison du fait d'&#234;tre ou d'avoir &#233;t&#233; membres du Conseil d'Administration ou de la Direction Ex&#233;cutive de la Soci&#233;t&#233; ou du conseil d'administration (ou d'un organe &#233;quivalent) ou de la direction de l'une de ses filiales ou, sur instruction de la Soci&#233;t&#233; en tant que membres du Conseil d'Administration ou de la Direction Ex&#233;cutive, en raison du fait d'&#234;tre ou d'avoir &#233;t&#233; administrateur, membre de la direction, employ&#233; ou mandataire d'une autre soci&#233;t&#233;, entreprise, coentreprise, personne morale d&#233;nu&#233;e de la personnalit&#233; ou trust. L'obligation d'indemnisation s'&#233;teint d&#232;s qu'un jugement d&#233;finitif et ex&#233;cutoire d'un tribunal ou d'une autorit&#233; comp&#233;tente a d&#233;cid&#233; que la personne en question a viol&#233;, volontairement ou par grave n&#233;gligence, ses devoirs de membre du Conseil d'Administration ou de la Direction Ex&#233;cutive.</font></div></td></tr><tr style="height:162pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Without limiting the foregoing paragraph 2 of this article&#160;18, the Company shall advance costs and expenses idemnifiable thereunder to the existing and former members of the Board of Directors and Executive Committee to the extent not included in insurance coverage or advanced by third parties. The Company may however recover such advanced costs if any of said persons is found, in a final judgment or decree of a court or governmental or administrative authority of competent jurisdiction not subject to appeal, to have committed an intentional or grossly negligent breach of his statutory duties as a member of the Board of Directors or Executive Committee.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Sans pr&#233;judice de l'alin&#233;a 2 du pr&#233;sent article 18, la Soci&#233;t&#233; avancera les frais et les co&#251;ts indemnisables en vertu de la disposition pr&#233;cit&#233;e aux membres actuels et pass&#233;s du Conseil d'Administration et de la Direction Ex&#233;cutive, &#224; concurrence de la portion non couverte par une assurance ou pay&#233;e par un tiers. La Soci&#233;t&#233; peut cependant recouvrer ces avances de frais si l'une de ces personnes a &#233;t&#233; reconnue coupable de violation intentionnelle ou par n&#233;gligence grave de ses devoirs de membre du Conseil d'Administration ou de la Direction Ex&#233;cutive par un jugement ou une d&#233;cision final et ex&#233;cutoire d'un tribunal ou d'une autorit&#233; gouvernementale ou administrative comp&#233;tente. </font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">25 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 19</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Convening of meetings, resolutions, minutes</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors shall meet at the invitation of its Chair or, if not available, of the Vice-Chair or of another member of the Board of Directors as often as the business of the Company shall require or if a member requests it in writing or via email or another form of electronic communication, indicating the reasons.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Convocation, d&#233;cisions, proc&#232;s-verbal</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Le Conseil d'Administration est convoqu&#233; par son&#47;sa Pr&#233;sident&#47;e ou, en cas d'emp&#234;chement de ce&#47;cette dernier-&#232;re, par son&#47;sa Vice-Pr&#233;sident&#47;e ou par un autre membre du Conseil d'Administration, aussi souvent que cela appara&#238;t n&#233;cessaire ou lorsqu'un membre du Conseil d'Administration le demande par &#233;crit, par email ou par un autre moyen de communication &#233;lectronique, avec indication des motifs.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Unless the organizational regulations adopted by the Board of Directors or a board resolution taken with the applicable attendance quorum provide otherwise, the Board of Directors shall only have a quorum if a majority of the members of the Board of Directors is present. No attendance quorum shall be required for resolutions of the Board of Directors providing for the amendment and ascertainment of capital changes or a change in the currency of the share capital.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> A moins que le contraire ne r&#233;sulte d'une disposition du r&#232;glement d'organisation adopt&#233; par le Conseil d'Administration ou d'une d&#233;cision du Conseil d'Administration prise conform&#233;ment aux dispositions applicables au quorum de pr&#233;sence, la majorit&#233; des membres du Conseil d'Administration doivent &#234;tre pr&#233;sents afin de pouvoir prendre une d&#233;cision. Ce quorum de pr&#233;sence n'est pas n&#233;cessaire pour les d&#233;cisions de modification et de constatation du Conseil d'Administration en lien avec les modifications du capital-actions ou de changement de la monnaie du capital-actions.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Except as otherwise provided in the organizational rules adopted by the Board of Directors or in a board resolution taken with the applicable attendance quorum, resolutions of the Board of Directors shall be adopted by the majority of the members present, provided that those present form a majority of the Board of Directors. In case of a tie, the Chair shall not have a casting vote.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Sauf disposition contraire du r&#232;glement d'organisation adopt&#233; par le Conseil d'Administration ou d'une d&#233;cision du Conseil d'Administration prise conform&#233;ment aux dispositions applicables au quorum de pr&#233;sence, les d&#233;cisions du Conseil d'Administration sont prises &#224; la majorit&#233; des voix &#233;mises par les membres pr&#233;sents, pourvu toutefois que ceux-ci forment la majorit&#233; du Conseil d'Administration. En cas de partage &#233;gal des voix, celle du&#47;de la Pr&#233;sident&#47;e n'est pas pr&#233;pond&#233;rante.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Resolutions may also be adopted by way of written consent orelectronically, unless a member of the Board of Directors requests discussion thereof.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Les d&#233;cisions du Conseil d'Administration peuvent &#233;galement &#234;tre prises par voie de circulation ou par voie &#233;lectronique, &#224; moins qu'une discussion ne soit requise par l'un des membres du Conseil d'Administration.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The decisions of the Board of Directors shall be recorded in minutes. The minutes shall be signed by the acting chair and the secretary.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Les d&#233;cisions du Conseil d'Administration sont consign&#233;es dans un proc&#232;s-verbal. Le proc&#232;s-verbal est sign&#233; par le&#47;la pr&#233;sident&#47;e et par le&#47;la secr&#233;taire.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 20</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 20</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Powers of the Board of Directors</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors may pass resolutions with respect to all matters which are not delegated to another corporate body of the Company by law, by these Articles of Association or by regulations.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Attributions du Conseil d'Administration</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Le Conseil d'Administration peut prendre des d&#233;cisions sur toutes les affaires qui ne sont pas attribu&#233;es &#224; un autre organe de la Soci&#233;t&#233; par la loi, les Statuts ou un r&#232;glement.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> It shall have the following non-transferable and inalienable duties&#58;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Il a les attributions intransmissibles et inali&#233;nables suivantes&#58;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27.72pt;padding-right:2.77pt;text-align:justify;text-indent:-24.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">1.&#160;&#160;&#160;&#160;the ultimate management of the Company and the issuance of necessary instructions&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.32pt;padding-right:2.77pt;text-align:justify;text-indent:-21.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">1.&#160;&#160;&#160;&#160;exercer la haute direction de la Soci&#233;t&#233; et &#233;tablir les instructions n&#233;cessaires&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">2.&#160;&#160;&#160;&#160;the determination of the organization of the Company&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">2.&#160;&#160;&#160;&#160;fixer l'organisation de la Soci&#233;t&#233;&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">3.&#160;&#160;&#160;&#160;the structuring of the accounting system, of the financial controls and of the financial planning&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">3.&#160;&#160;&#160;&#160;fixer les principes de la comptabilit&#233; et du contr&#244;le financier ainsi que le plan financier&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">4.&#160;&#160;&#160;&#160;the appointment and dismissal of the persons entrusted with management and representation of the Company, and issuance of rules on the signature authority&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">4.&#160;&#160;&#160;&#160;nommer et r&#233;voquer les personnes charg&#233;es de la gestion et de la repr&#233;sentation de la Soci&#233;t&#233; et r&#233;glementer le droit de signature&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">5.&#160;&#160;&#160;&#160;the ultimate supervision of the persons entrusted with management, in particular in view of compliance with the law, these Articles of Association, regulations and directives&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">5.&#160;&#160;&#160;&#160;exercer la haute surveillance sur les personnes charg&#233;es de la gestion pour s'assurer notamment qu'elles observent la loi, les Statuts, les r&#232;glements et les instructions donn&#233;es&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">6.&#160;&#160;&#160;&#160;the preparation of the annual report, the compensation report and, if applicable, the report on non-financial matters pursuant to article&#160;964c CO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">and other reports as required by law, if any&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">6.&#160;&#160;&#160;&#160;&#233;tablir le rapport de gestion, le rapport de r&#233;mun&#233;ration, et, le cas &#233;ch&#233;ant, le rapport sur les questions non financi&#232;res selon l'article 964c CO&#160;et, le cas &#233;ch&#233;ant, d'autres rapports exig&#233;s par la loi&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">7.&#160;&#160;&#160;&#160;the preparation of the General Meeting and the implementation of its resolutions&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">7.&#160;&#160;&#160;&#160;pr&#233;parer l'Assembl&#233;e G&#233;n&#233;rale et ex&#233;cuter ses d&#233;cisions&#59;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">27 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">8.&#160;&#160;&#160;&#160;the adoption of resolutions on the change of the share capital to the extent that such power is vested in the Board of Directors, the ascertainment of capitalchanges, the preparation of the report on the capital increase, and the respective amendments of these Articles of Association (including deletions)&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">8.&#160;&#160;&#160;&#160;prendre les d&#233;cisions relatives aux modifications du capital-actions, dans la mesure o&#249; elles sont de la comp&#233;tence du Conseil d'Administration, ainsi que les d&#233;cisions relatives &#224; la constatation des modifications de capital, &#224; l'&#233;tablissement du rapport d'augmentation du capital-actions et aux modifications des Statuts qui en r&#233;sultent (radiation comprise)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">9.&#160;&#160;&#160;&#160;the non-transferable and inalienable duties and powers of the Board of Directors pursuant to the Merger Act&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">9.&#160;&#160;&#160;&#160;les attributions et comp&#233;tences intransmissibles et inali&#233;nables du Conseil d'Administration selon la Loi sur la Fusion&#59;</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">10.&#160;&#160;&#160;&#160;the submission of a petition for debt-restructuring moratorium and the notification of the court in case of over-indebtedness&#59; and</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">10.&#160;&#160;&#160;&#160;le d&#233;p&#244;t d'une demande de sursis concordataire et l'avis au tribunal en cas de surendettement &#59; et</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">11.&#160;&#160;&#160;&#160;other powers and duties reserved to the Board of Directors by law or these Articles of Association.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:26.32pt;padding-right:2.77pt;text-align:justify;text-indent:-23.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">11.&#160;&#160;&#160;&#160;d'autres attributions et comp&#233;tences r&#233;serv&#233;es au Conseil d'Administration par la loi ou les Statuts.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">In all other respects, the Board of Directors may delegate in whole or in part the management and the representation of the Company within the framework set forth by these Articles of Association and the law to one or several of its members or to third parties by means of organizational regulations or by adopting a resolution.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">En outre, le Conseil d'Administration peut d&#233;l&#233;guer en tout ou en partie la gestion ainsi que la repr&#233;sentation de la Soci&#233;t&#233;, dans le cadre des Statuts et de la loi, &#224; un ou plusieurs de ses membres ou &#224; des tiers conform&#233;ment au r&#232;glement d'organisation ou d'une d&#233;cision. </font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.2pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:5.62pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">C.&#160;&#160;&#160;&#160;The Compensation Committee</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">C.&#160;&#160;&#160;&#160;Le Comit&#233; de R&#233;mun&#233;ration</font></div></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 21</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 21</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Number of members</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The compensation committee of the Board of Directors (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Compensation Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) shall consist of at least 2 members of the Board of Directors.</font></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Nombre de membres</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le comit&#233; de r&#233;mun&#233;ration du Conseil d'Administration (le </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Comit&#233; de R&#233;mun&#233;ration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) se compose d'au moins 2 membres du Conseil d'Administration.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 22</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 22</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Election and term of office</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The General Meeting shall elect the members of the Compensation Committee individually for a term of office until the completion of the subsequent ordinary General Meeting. Only members of the Board of Directors may be elected. Re-election is possible.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Election et dur&#233;e de fonctions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">L'Assembl&#233;e G&#233;n&#233;rale &#233;lit individuellement les membres du Comit&#233; de R&#233;mun&#233;ration pour une dur&#233;e de fonctions s'achevant &#224; la fin de l'Assembl&#233;e G&#233;n&#233;rale ordinaire suivante. Seuls des membres du Conseil d'Administration sont &#233;ligibles. La r&#233;&#233;lection est possible.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">If there are vacancies on the Compensation Committee, the Board of Directors may appoint substitute members from among its members for a term of office extending until completion of the next ordinary General Meeting.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">En cas de vacance au sein du Comit&#233; de R&#233;mun&#233;ration, le Conseil d'Administration peut d&#233;signer des substituts parmi ses membres pour une dur&#233;e de fonctions s'achevant &#224; la fin de l'Assembl&#233;e G&#233;n&#233;rale ordinaire suivante.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 23</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 23</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Organization of the Compensation Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee shall constitute itself. Unless the organizational regulations provide otherwise, the Board of Directors shall elect a chair from among the Compensation Committee's members.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Organisation du Comit&#233; de R&#233;mun&#233;ration</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Le Comit&#233; de R&#233;mun&#233;ration se constitue lui-m&#234;me. A moins que le r&#232;glement d'organisation n'en dispose autrement, le Conseil d'Administration &#233;lit le&#47;la pr&#233;sident&#47;e du Comit&#233; de R&#233;mun&#233;ration parmi les membres du Comit&#233; de R&#233;mun&#233;ration. </font></div></td></tr><tr style="height:54pt"><td colspan="3" rowspan="2" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The Board of Directors shall issue regulations establishing the organization and decision-making process of the Compensation Committee, which may be part of the organizational regulations.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:15pt;padding-right:2.77pt;text-indent:-28.35pt"><font style="font-family:'Wingdings',sans-serif;font-size:7.5pt;font-weight:400;line-height:15.00pt"></font></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Le Conseil d'Administration &#233;tablit un r&#232;glement concernant l'organisation et le processus de d&#233;cision du Comit&#233; de R&#233;mun&#233;ration, qui peut &#234;tre int&#233;gr&#233; au r&#232;glement d'organisation.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 24</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 24</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Duties and powers</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee shall support the Board of Directors in establishing and reviewing the compensation strategy and guidelines as well as in preparing the proposals to the General Meeting regarding the compensation of the Board of Directors and the Executive Committee. It may submit proposals to the Board of Directors in other compensation-related issues.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Attributions</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Le Comit&#233; de R&#233;mun&#233;ration assiste le Conseil d'Administration dans l'&#233;tablissement et la r&#233;vision de la strat&#233;gie et des directives de r&#233;mun&#233;ration, ainsi que dans la pr&#233;paration des propositions &#224; soumettre &#224; l'Assembl&#233;e G&#233;n&#233;rale concernant la r&#233;mun&#233;ration du Conseil d'Administration et de la Direction Ex&#233;cutive. Il peut soumettre au Conseil d'Administration des propositions en toutes autres mati&#232;res relatives &#224; la r&#233;mun&#233;ration.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">29 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Board of Directors shall determine in regulations for which positions of the Board of Directors, the Executive Committee and other member of management (if any) the Compensation Committee shall submit proposals for the performance metrics, target values and&#47;or the compensation of the members of the Board of Directors and the Executive Committee, and for which positions it shall itself determine, in accordance with these Articles of Association and the compensation guidelines established by the Board of Directors, such performance metrics, target values and&#47;or the compensation.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le Conseil d'Administration d&#233;termine dans un r&#232;glement pour quelles fonctions du Conseil d'Administration, de la Direction Ex&#233;cutive et d'autres membres de la direction (si applicable) le Comit&#233; de R&#233;mun&#233;ration proposera au Conseil d'Administration les mesures de performance, les valeurs cibles et&#47;ou la r&#233;mun&#233;ration des membres du Conseil d'Administration et de la Direction Ex&#233;cutive, et pour quelles fonctions il aura la comp&#233;tence de d&#233;terminer de son propre chef, en accord avec les Statuts et les directives de r&#233;mun&#233;ration &#233;tablies par le Conseil d'Administration, les mesures de performance, les valeurs cibles et&#47;ou la r&#233;mun&#233;ration.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Board of Directors may delegate further tasks to the Compensation Committee.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le Conseil d'Administration peut d&#233;l&#233;guer d'autres t&#226;ches au Comit&#233; de R&#233;mun&#233;ration.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">D.&#160;&#160;&#160;&#160;The Auditors</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">D.&#160;&#160;&#160;&#160;L'Organe de R&#233;vision</font></div></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 25</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 25</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Auditors</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The General Meeting shall elect the auditors of the Company (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Auditors</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) for a term of office of one financial year. Their term of office ends with the approval of the annual financial statements of the respective financial year by the ordinary General Meeting. Re-election is possible.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Organe de r&#233;vision</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">L'Assembl&#233;e G&#233;n&#233;rale &#233;lit l'organe de r&#233;vision de la Soci&#233;t&#233; (l'</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Organe de R&#233;vision</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">) pour un mandat d'un exercice. Son mandat prend fin avec l'approbation des comptes annuels de l'exercice concern&#233; par l&#8217;Assembl&#233;e G&#233;n&#233;rale ordinaire. La r&#233;&#233;lection est possible.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The Auditors shall have the powers and duties vested in them by law.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> L'Organe de R&#233;vision a les pouvoirs et obligations que lui conf&#232;re la loi.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Board of Directors may mandate the Auditors at any time to perform special investigations, in particular interim audits, and to prepare a report on their findings.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le Conseil d'Administration peut en tout temps charger l'Organe de R&#233;vision de proc&#233;der &#224; des contr&#244;les sp&#233;ciaux, notamment des r&#233;visions interm&#233;diaires, et de lui en soumettre un rapport.</font></div></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section 4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>Compensation of the members of the Board of Directors and the Executive Committee and related matters</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section&#160;4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>R&#233;mun&#233;ration des membres du Conseil d'Administration et de la Direction Ex&#233;cutive et affaires connexes</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 26</font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 26</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Approval of the compensation by the General Meeting</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The General Meeting shall approve the proposals of the Board of Directors in relation to the aggregate amounts of&#58; </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Approbation de la r&#233;mun&#233;ration par l'Assembl&#233;e G&#233;n&#233;rale</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">L'Assembl&#233;e G&#233;n&#233;rale approuve les propositions du Conseil d'Administration en relation avec les montants maximaux suivants&#58;</font></div></td></tr><tr style="height:42pt"><td colspan="3" rowspan="2" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:28.52pt;padding-right:2.77pt;text-align:justify;text-indent:-25.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">1.&#160;&#160;&#160;&#160;the maximum compensation of the Board of Directors until the completion of the next ordinary General Meeting&#59;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:29.17pt;padding-right:2.77pt;text-align:justify;text-indent:-26.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">1.&#160;&#160;&#160;&#160;la r&#233;mun&#233;ration maximale du Conseil d'Administration jusqu'&#224; la fin de l'Assembl&#233;e G&#233;n&#233;rale ordinaire suivante&#59;</font></div></td></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:28.52pt;padding-right:2.77pt;text-align:justify;text-indent:-25.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">2.&#160;&#160;&#160;&#160;the maximum fixed compensation of the Executive Committee for the following financial year&#59; and</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:29.17pt;padding-right:2.77pt;text-align:justify;text-indent:-26.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">2.&#160;&#160;&#160;&#160;la r&#233;mun&#233;ration fixe maximale de la Direction Ex&#233;cutive pour l'ann&#233;e comptable suivante&#59; et</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:28.52pt;padding-right:2.77pt;text-align:justify;text-indent:-25.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">3.&#160;&#160;&#160;&#160;the maximum variable compensation of the Executive Committee for the current financial year.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:29.17pt;padding-right:2.77pt;text-align:justify;text-indent:-26.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">3.&#160;&#160;&#160;&#160;la r&#233;mun&#233;ration variable maximale de la Direction Ex&#233;cutive pour l'exercice en cours.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:0.6pt;padding-right:2.77pt;text-align:justify;text-indent:-0.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Board of Directors may submit for approval by the General Meeting deviating, additional or conditional proposals relating to the maximum aggregate amount or maximum partial amounts for the same or different periods and&#47;or specific compensation components and&#47;or in relation to additional amounts for specific compensation components.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le Conseil d'Administration peut soumettre &#224; l'approbation de l'Assembl&#233;e G&#233;n&#233;rale des propositions divergentes, suppl&#233;mentaires ou conditionnelles concernant le montant maximal total ou les montants maximaux partiels pour les m&#234;mes p&#233;riodes ou des p&#233;riodes diff&#233;rentes et&#47;ou des &#233;l&#233;ments de r&#233;mun&#233;ration sp&#233;cifiques et&#47;ou en relation avec des montants additionnels pour des &#233;l&#233;ments de r&#233;mun&#233;ration sp&#233;cifiques.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">In the event that the General Meeting does not approve a proposal of the Board of Directors, the Board of Directors shall determine, taking into account all relevant factors, the respective (maximum) aggregate amount or (maximum) partial amounts, and submit the amount(s) so determined for approval by a General Meeting.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Si l'Assembl&#233;e G&#233;n&#233;rale n'approuve pas une proposition du Conseil d'Administration, le Conseil d'Administration d&#233;termine, en prenant en compte tous les crit&#232;res pertinents, le montant (maximal) total ou des montants (maximaux) partiels respectifs, et soumet le(s) montant(s) ainsi d&#233;termin&#233;(s) &#224; l'approbation d'une Assembl&#233;e G&#233;n&#233;rale.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Company or companies controlled by it may pay or grant compensation prior to approval by the General Meeting, subject to subsequent approval.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La r&#233;mun&#233;ration peut &#234;tre vers&#233;e ou octroy&#233;e par la Soci&#233;t&#233; ou les soci&#233;t&#233;s qu'elle contr&#244;le avant l'approbation de l'Assembl&#233;e G&#233;n&#233;rale, sous r&#233;serve d'une approbation ult&#233;rieure.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">If variable compensation is approved prospectively, the Board of Directors shall submit the compensation report to the General Meeting for a consultative vote.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Si des r&#233;mun&#233;rations variables sont approuv&#233;es de mani&#232;re prospective, le Conseil d'Administration soumet le rapport de r&#233;mun&#233;ration au vote consultatif de l'Assembl&#233;e G&#233;n&#233;rale.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 27</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 27</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Supplementary amount for changes to the Executive Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the maximum aggregate amount of compensation already approved by the General Meeting is not sufficient to also cover the compensation of one or more persons who become members of the Executive Committee after the General Meeting has approved the compensation of the Executive Committee for the relevant period, then the Company or companies controlled by it shall be authorized to pay such member(s) a supplementary amount during the compensation period(s) already approved. The supplementary amount per compensation period per member shall not exceed 100% of the aggregate amount of (maximum) compensation of the Executive Committee last approved.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Montant compl&#233;mentaire en cas de changements au sein de la Direction Ex&#233;cutive</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Si le montant global maximal de la r&#233;mun&#233;ration d&#233;j&#224; approuv&#233; par l'Assembl&#233;e G&#233;n&#233;rale n'est pas suffisant pour couvrir &#233;galement la r&#233;mun&#233;ration d'une ou plusieurs personnes devenant membre(s) de la Direction Ex&#233;cutive apr&#232;s que l'Assembl&#233;e G&#233;n&#233;rale a approuv&#233; la r&#233;mun&#233;ration de la Direction Ex&#233;cutive pour la p&#233;riode vis&#233;e, la Soci&#233;t&#233; ou toute autre soci&#233;t&#233; qu'elle contr&#244;le est alors autoris&#233;e &#224; verser &#224; ce(s) membre(s) un montant compl&#233;mentaire au cours de la (ou les) p&#233;riode(s) de r&#233;mun&#233;ration d&#233;j&#224; approuv&#233;e(s). Le montant compl&#233;mentaire par p&#233;riode de compensation par membre ne doit pas d&#233;passer 100% du montant global de la r&#233;mun&#233;ration (maximale) de la Direction Ex&#233;cutive approuv&#233;e en dernier.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 28</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 28</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">32 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr style="height:63pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">General compensation principles</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation of the non-executive members of the Board of Directors may consist of fixed and variable compensation elements. Total compensation shall take into account the position and level of responsibility of the recipient.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Principes g&#233;n&#233;raux de r&#233;mun&#233;ration</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">La r&#233;mun&#233;ration des membres non-ex&#233;cutifs du Conseil d'Administration peut &#234;tre constitu&#233;e d'&#233;l&#233;ments de r&#233;mun&#233;ration fixes et variables. La r&#233;mun&#233;ration totale prend en compte la position et le niveau de responsabilit&#233; du b&#233;n&#233;ficiaire.</font></div></td></tr><tr style="height:102pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The compensation of the members of the Executive Committee may consist of fixed and variable compensation elements. Fixed compensation comprises the base salary and may consist of other compensation elements. Variable compensation may take into account the achievement of specific performance targets. Total compensation shall take into account the position and level of responsibility of the recipient.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La r&#233;mun&#233;ration des membres de la Direction Ex&#233;cutive peut &#234;tre constitu&#233;e d'&#233;l&#233;ments de r&#233;mun&#233;ration fixes et variables. La r&#233;mun&#233;ration fixe comprend le salaire de base et peut &#234;tre constitu&#233;e d'autres &#233;l&#233;ments de r&#233;mun&#233;ration. La r&#233;mun&#233;ration variable peut prendre en compte l'accomplissement d'objectifs de performance sp&#233;cifiques. La r&#233;mun&#233;ration totale prend en compte la position et le niveau de responsabilit&#233; du b&#233;n&#233;ficiaire.</font></div></td></tr><tr style="height:39pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The performance targets may include individual targets, targets of the Company, group or parts thereof or targets in relation to the market, other companies or comparable benchmarks, taking into account the position and level of responsibility of the recipient. The Board of Directors or, to the extent delegated to it, the Compensation Committee shall determine the relative weight of the performance targets and the respective target values.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Les objectifs de performance peuvent comprendre des objectifs personnels, des objectifs li&#233;s &#224; la performance de la Soci&#233;t&#233; ou de tout ou partie du groupe ou des buts en relation avec le march&#233;, d'autres soci&#233;t&#233;s ou d'autres rep&#232;res comparables, prenant en compte la position et le niveau de responsabilit&#233; du b&#233;n&#233;ficiaire. Le Conseil d'Administration ou le Comit&#233; de R&#233;mun&#233;ration, dans la mesure o&#249; cette comp&#233;tence lui est d&#233;l&#233;gu&#233;e, d&#233;termine le poids relatif des objectifs de performance et les valeurs cibles respectives.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Compensation may be paid in the form of cash, shares, options or other share-based instruments or units, or in the form of other types of benefits. The Board of Directors or, to the extent delegated to it, the Compensation Committee shall determine grant, vesting, exercise, restriction and forfeiture conditions and periods. In particular, they may provide for continuation, acceleration or removal of vesting, exercise, restriction and forfeiture conditions and periods, for payment or grant of compensation based upon assumed target achievement, or for forfeiture, in each case in the event of pre-determined events such as a change of control or termination of an employment or mandate agreement. The Company may procure the required shares or other securities through purchases in the market, from treasury shares or by using conditional or authorized share capital.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La r&#233;mun&#233;ration peut &#234;tre vers&#233;e en esp&#232;ces, sous forme d'actions, d'options ou d'instruments ou unit&#233;s sur base d'actions ou d'autres types de prestations. Le Conseil d'Administration ou le Comit&#233; de R&#233;mun&#233;ration, dans la mesure o&#249; cette comp&#233;tence lui a &#233;t&#233; d&#233;l&#233;gu&#233;e, d&#233;termine les conditions et p&#233;riodes d'octroi, d'acquisition (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt">vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">), d'exercice, de restriction et de p&#233;remption. Ils peuvent en particulier pr&#233;voir la continuation, l'acc&#233;l&#233;ration ou la suppression des conditions ou p&#233;riodes d'acquisition (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt">vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">), d'exercice, de restriction et de p&#233;remption, le versement ou l'octroi d'une r&#233;mun&#233;ration supposant l'atteinte des objectifs ou encore la d&#233;ch&#233;ance des droits, dans chaque cas lors d'&#233;v&#233;nements pr&#233;d&#233;termin&#233;s tels que, notamment, un changement de contr&#244;le ou la fin d'un contrat de travail ou de mandat. La Soci&#233;t&#233; peut se procurer les actions ou autres instruments des march&#233;s financiers requis par le biais d'achats sur le march&#233; ou d'actions propres, ou en utilisant son capital-actions conditionnel ou autoris&#233;.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">33 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Compensation may be paid by the Company or companies controlled by it.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">5 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La r&#233;mun&#233;ration peut &#234;tre vers&#233;e par la Soci&#233;t&#233; ou tout autre soci&#233;t&#233; qu'elle contr&#244;le.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 29</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 29</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Agreements with members of the Board of Directors and the Executive Committee</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company or companies controlled by it may enter into agreements with non-executive members of the Board of Directors relating to their compensation for a fixed term or for an indefinite term. The duration and termination are subject to the term of office and the law.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Contrats avec les membres du Conseil d'Administration et de la Direction Ex&#233;cutive</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">La Soci&#233;t&#233;, ou toute soci&#233;t&#233; qu'elle contr&#244;le, peut conclure des contrats de dur&#233;e d&#233;termin&#233;e ou ind&#233;termin&#233;e avec les membres non-ex&#233;cutifs du Conseil d'Administration en relation avec leur r&#233;mun&#233;ration. La dur&#233;e et la r&#233;siliation doivent &#234;tre conformes avec la dur&#233;e des fonctions ainsi qu'avec les dispositions l&#233;gales applicables.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Company or companies controlled by it may enter into employment agreements with executive members of the Board of Directors and other members of the Executive Committee for a fixed term or for an indefinite term. Fixed term agreements may have a maximum duration of one year&#59; renewal is possible. Agreements for an indefinite term may have a notice period of maximum twelve months.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La Soci&#233;t&#233;, ou toute soci&#233;t&#233; qu'elle contr&#244;le, peut conclure des contrats de travail de dur&#233;e d&#233;termin&#233;e ou ind&#233;termin&#233;e avec les membres ex&#233;cutifs du Conseil d'Administration et les autres membres de la Direction Ex&#233;cutive. Les contrats de dur&#233;e d&#233;termin&#233;e peuvent avoir une dur&#233;e maximale d'une ann&#233;e&#59; le renouvellement est possible. Les contrats de dur&#233;e ind&#233;termin&#233;e peuvent pr&#233;voir un d&#233;lai de cong&#233; d'au maximum douze mois.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The Company or companies controlled by it may enter into non-compete agreements with members of the Executive Committee for the time after termination of employment. Their duration shall not exceed two years, and consideration paid per year for such non-compete undertaking shall not exceed the average compensation of such member of the last three financial years.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La Soci&#233;t&#233;, ou toute soci&#233;t&#233; qu'elle contr&#244;le, peut conclure des accords de non-concurrence avec les membres de la Direction Ex&#233;cutive pour la p&#233;riode suivant la fin des rapports de travail. Leur dur&#233;e ne peut exc&#233;der deux ans et l'indemnisation par an vers&#233;e en contrepartie d'un tel accord de non-concurrence ne peut exc&#233;der la moyenne de la r&#233;mun&#233;ration du membre concern&#233; des trois derniers exercices.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 30</font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 30</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Mandates outside of the group</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The number of mandates on the Board of Directors, the Executive Committee or comparable functions at other enterprises with an economic purpose is limited&#58;</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Mandats en dehors du groupe</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Le nombre de mandats d'administrateur, au sein de la Direction Ex&#233;cutive ou de fonctions similaires aupr&#232;s d'autres entreprises poursuivant un but &#233;conomique est limit&#233;&#58;</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(a)&#160;&#160;&#160;&#160;for members of the Executive Committee, to 7 mandates, of which no more than 2 in a listed company&#59; and</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(a)&#160;&#160;&#160;&#160;pour les membres de la Direction Ex&#233;cutive, &#224; 7 mandats, dont pas plus de 2 au sein de soci&#233;t&#233;s cot&#233;es&#59; et</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(b)&#160;&#160;&#160;&#160;for members of the Board of Directors, to 15 mandates, of which no more than 5 in listed companies.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:24.07pt;padding-right:2.77pt;text-align:justify;text-indent:-21.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">(b)&#160;&#160;&#160;&#160;pour les membres du Conseil d'Administration &#224; 15 mandats, dont pas plus de 5 au sein de soci&#233;t&#233;s cot&#233;es.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:3.37pt;padding-right:2.77pt;text-align:justify;text-indent:-0.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Mandates in different legal entities being part of the same group or for the same group are deemed to be one mandate.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt;text-align:justify;text-indent:-1.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Les mandats dans diff&#233;rentes entit&#233;s juridiques appartenant au m&#234;me groupe ou assum&#233;s pour le m&#234;me groupe sont consid&#233;r&#233;s comme un mandat.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Mandates in associations, charitable organizations, family trusts and foundations relating to post-retirement benefits as well as mandates held at the request of the Company or companies controlled by it are not subject to the above limitations. No member of the Board of Directors or the Executive Committee shall hold more than 10 such mandates.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Les mandats dans des associations, organisations caritatives, fondations de famille et fondations de pr&#233;voyance professionnelle ainsi que les mandats exerc&#233;s &#224; la demande de la Soci&#233;t&#233; ou des soci&#233;t&#233;s qu'elle contr&#244;le ne sont pas soumis aux limites mentionn&#233;es ci-dessus. Aucun membre du Conseil d'Administration ou de la Direction Ex&#233;cutive ne peut exercer plus de 10 mandats de ce genre.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 31</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 31</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Post-retirement benefits</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company or companies controlled by it may grant to members of the Board of Directors and the Executive Committee post-retirement benefits beyond the occupational benefit schemes which do not exceed the annual compensation of the respective member of the Board of Directors or the Executive Committee last paid or payable for the first time.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Prestations de retraite</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">La Soci&#233;t&#233; ou toute soci&#233;t&#233; qu'elle contr&#244;le peut octroyer aux membres du Conseil d'Administration et de la Direction Ex&#233;cutive des prestations de retraite allant au-del&#224; du r&#233;gime de pr&#233;voyance professionnelle n'exc&#233;dant pas la r&#233;mun&#233;ration annuelle</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">du membre du Conseil d'Administration ou de la Direction Ex&#233;cutive concern&#233; vers&#233;e ou &#224; verser pour la premi&#232;re fois.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section 5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>Financial year, profit allocation</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section&#160;5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>Exercice, r&#233;partition du b&#233;n&#233;fice</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 32</font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 32</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Financial year, annual and compensation report</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial year shall be determined by the Board of Directors. </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Exercice social, rapport de gestion et de r&#233;mun&#233;ration</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">L'exercice est fix&#233; par le Conseil d'Administration.<br></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">35 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The Board of Directors shall prepare an annual report for each financial year, comprising the annual financial statements, if required, the management report and the consolidated financial statements, as well as a compensation report and any other report required by law.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> Le Conseil d'Administration &#233;tablit pour chaque exercice un rapport de gestion, qui se compose des comptes annuels et, cas &#233;ch&#233;ant, du rapport annuel et des comptes de groupe, ainsi qu'un rapport de r&#233;mun&#233;ration et tout autre rapport requis par la loi.</font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 33</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 33</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Allocation of profit shown on the balance sheet, reserves</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The General Meeting shall resolve on the allocation of the profit as shown on the balance sheet in accordance with applicable law. The Board of Directors shall submit its proposals to the General Meeting. </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Utilisation du b&#233;n&#233;fice r&#233;sultant du bilan, r&#233;serves</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">L'Assembl&#233;e G&#233;n&#233;rale d&#233;termine l'emploi du b&#233;n&#233;fice r&#233;sultant du bilan, sous r&#233;serve des prescriptions l&#233;gales concernant la r&#233;partition du b&#233;n&#233;fice. Le Conseil d'Administration lui soumet ses propositions.</font></div></td></tr><tr style="height:30pt"><td colspan="3" rowspan="2" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> In addition to the reserves required by law, the General Meeting may create other reserves. </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:14pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" rowspan="2" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> En sus des r&#233;serves l&#233;gales, l'Assembl&#233;e G&#233;n&#233;rale peut constituer des r&#233;serves suppl&#233;mentaires.</font></div></td></tr><tr style="height:57pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Dividends that have not been collected within five years after their payment date shall inure to the Company and be allocated to the general statutory reserves.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Les dividendes qui n'ont pas &#233;t&#233; per&#231;us dans un d&#233;lai de cinq ans apr&#232;s leur date de paiement sont prescrits et sont allou&#233;s aux r&#233;serves statutaires de la Soci&#233;t&#233;.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:83.82pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section 6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>Dissolution, liquidation</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section&#160;6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>Dissolution, liquidation</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 34</font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 34</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Dissolution, liquidation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The General Meeting may at any time resolve to dissolve and liquidate the Company in accordance with the law and the provisions set forth in these Articles of Association.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Dissolution, liquidation</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">L'Assembl&#233;e G&#233;n&#233;rale peut d&#233;cider en tout temps de la dissolution et de la liquidation de la Soci&#233;t&#233; en conformit&#233; avec les prescriptions l&#233;gales et statutaires.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> The liquidation shall be effected by the Board of Directors, unless the General Meeting appoints other persons as liquidators.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt"> La</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">liquidation a lieu par les soins du Conseil d'Administration, &#224; moins que l'Assembl&#233;e G&#233;n&#233;rale ne d&#233;signe d'autres liquidateurs.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">36 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The liquidation of the Company shall be effected pursuant to applicable law. The liquidators shall be entitled to sell assets (real estate included) in private transactions.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">La liquidation de la Soci&#233;t&#233; s'effectue conform&#233;ment au droit applicable. Les liquidateurs sont autoris&#233;s &#224; vendre des actifs (immeubles y compris) de gr&#233; &#224; gr&#233;.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Upon discharge of all liabilities of the Company, the assets shall be distributed to the shareholders in proportion to the share capital, unless these Articles of Association provide otherwise.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">4 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Apr&#232;s paiement des dettes de la Soci&#233;t&#233;, l'actif est r&#233;parti entre les actionnaires au prorata du capital-actions, &#224; moins que les Statuts n'en disposent autrement.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section 7</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt">Means of Publication, communications</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section&#160;7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>Organe de publication, communications</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 35</font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 35</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Notices, communications</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The official means of publication of the Company shall be the Swiss Official Gazette of Commerce. </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Communications, organe de publication</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">L'organe de publication de la Soci&#233;t&#233; est la Feuille Officielle Suisse du Commerce. </font></div></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">In particular cases, the Board of Directors may specify additional means of publication.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">2 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le Conseil d'Administration peut d&#233;signer d'autres organes de publication dans certains cas particuliers.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Notices by the Company to the shareholders may, at the election of the Board of Directors, be validly given by publication in the Swiss Official Gazette of Commerce or in a form that allows proof by text.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:12.00pt;position:relative;top:-3.5pt;vertical-align:baseline">3 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Les communications aux actionnaires peuvent, au choix du Conseil d'administration, &#234;tre valablement effectu&#233;es par publication dans la Feuille officielle suisse du commerce ou sous une forme permettant d'en &#233;tablir la preuve par texte.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section&#160;7a</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>Jurisdiction</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section&#160;7a<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt">For</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 35a</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 35a</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Jurisdiction</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">The exclusive place of jurisdiction for any disputes arising under, out of or in connection with or related to the corporate relationship shall be at the registered office of the Company.</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For exclusif</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:12.00pt">Le for exclusif pour tout litige d&#233;coulant de ou en rapport avec la Soci&#233;t&#233; se situe au si&#232;ge de celle-ci.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">37 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:76.32pt;width:100%"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Articles of Association of SOPHiA GENETICS SA &#47; Statuts de SOPHiA GENETICS SA</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.777%"><tr><td style="width:1.0%"></td><td style="width:10.273%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.453%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section 8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>Authoritative language</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Section&#160;8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:12.00pt"><br>Langue faisant foi</font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 36</font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:207.07pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.00pt">Article 36</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Authoritative language</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of discrepancies between the French and English versions of these Articles of Association, the French version shall prevail. </font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Langue faisant foi</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">En cas de conflit entre la version fran&#231;aise et la version anglaise, la version fran&#231;aise des Statuts pr&#233;vaut. </font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:3pt;margin-top:3pt;padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font><br></font></div></td></tr></table></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div><div style="margin-bottom:14pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:162%">Nyon, le 5 novembre 2025<br>Nyon, November 5, 2025</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">38 &#47; #NUM_PAGES#</font></div><div style="margin-bottom:14pt;text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>3
<FILENAME>exhibit21descriptionofsecu.htm
<DESCRIPTION>EX-2.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i86e8a716a2434b1798dc319a7a2bd586_1"></div><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.85pt;padding-left:185.35pt;text-indent:-153.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:114%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of December 31, 2025, our share capital as registered with the commercial register of the Canton of Vaud, Switzerland (the &#8220;Commercial Register&#8221;) amounted to CHF 4,466,061.00 and was divided into 89,321,220 ordinary shares, each with a par value of CHF 0.05 per share.</font></div><div style="padding-left:5pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unless otherwise noted, the following is a summary of the material provisions of our share capital and our articles of association that are in effect on the date of this prospectus.</font></div><div style="margin-top:9.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Changes in Our Share Capital During the Last Three Fiscal Years</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">In this section, share amounts are presented as of the date of the relevant transaction. Since January 1, 2023, our share capital has changed as follows&#58;</font></div><div style="padding-left:46.9pt;padding-right:38.25pt;text-indent:-21pt"><font><br></font></div><div style="padding-left:82.9pt;text-indent:-39pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:35.5pt">On June 26, 2023, our share capital as registered with the Commercial Register on June 29, 2023 was increased by issuing 10,500,000 ordinary shares&#59;</font></div><div style="padding-left:46.9pt"><font><br></font></div><div style="padding-left:82.9pt;text-indent:-39pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:35.5pt">On June 24, 2024, our share capital as registered with the Commercial Register on July 12, 2024 was increased by issuing 2,423,056 ordinary shares&#59; and</font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font><br></font></div><div style="padding-left:82.9pt;text-indent:-39pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:34.8pt">On November 5, 2025,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our share capital as registered with the Commercial Register on November 7, 2025 was increased by issuing 10,000,000 ordinary shares.</font></div><div style="padding-right:38.25pt"><font><br></font></div><div style="margin-top:0.2pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Articles of Association</font></div><div style="margin-top:9.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Ordinary Capital Increase, Capital Range and Conditional Share Capital</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Under Swiss law, we may increase our share capital (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">capital-actions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">) with a resolution of the general meeting of shareholders (ordinary capital increase) that must be carried out by the board of directors within six months of the respective general meeting in order to become effective. Under our articles of association and Swiss law, in the case of subscription and increase against payment of contributions in cash, a resolution passed by a majority of the shares represented at the general meeting of shareholders is required. In the case of subscription and increase against contributions in kind, by set-off against claims or to fund acquisitions in kind, when shareholders&#8217; statutory pre-emptive subscription rights or advance subscription rights are limited or withdrawn or where transformation of freely disposable equity into share capital is involved, a resolution passed by two-thirds of the shares represented at the general meeting of shareholders and the majority of the par value of the shares represented is required.</font></div><div><img alt="image_0c.jpg" src="image_0c.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-bottom:10pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of January 1, 2023 companies can no longer adopt, increase or extend authorized share capital (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">capital-actions autoris&#233;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). Instead, companies may adopt a capital range as further explained below. </font></div><div style="margin-top:3.8pt;padding-left:4.5pt;padding-right:8.4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Under the Swiss Code of Obligations (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">Code des obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">) (the &#8220;Code of Obligations&#8221;), our shareholders, by a resolution passed by two-thirds of the shares represented at a general meeting of shareholders and the majority of the par value of the shares represented, can&#58;</font></div><div style="margin-top:9.7pt;padding-left:46.9pt;padding-right:7.15pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;adopt conditional share capital (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">capital-actions conditionnel</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">) in the aggregate amount of up to 50% of the share capital for the purpose of issuing shares in connection with, among other things, option and conversion rights granted to shareholders, the creditors of bonds and similar debt instruments, employees, members of the board of directors of the Company or of any group company, or to any third parties&#59; and</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:52.7pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;may, in the form of capital range (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">marge de fluctuation du capital</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">), empower our board of directors to increase and&#47;or decrease our share capital by up to 50% of the share capital, by issuing or canceling shares, or by increasing or decreasing the par value of shares, including through the conditional share capital&#59; such capital range is to be utilized by the board of directors within a period determined by the shareholders but not exceeding five years from the date of the shareholder approval.</font></div><div style="padding-right:52.7pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our shareholders at the annual general meeting held in 2023 have adopted a capital range, allowing our board of directors to increase or to lower the capital in the limits as stated in Article 4a of the Articles of Association, as well as conditional capital in Articles 4b and 4c. The capital range and the conditional capital have been amended at the annual general meeting held in 2025.</font></div><div style="margin-top:9.5pt;padding-left:4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Pre-Emptive and Advance Subscription Rights</font></div><div style="margin-top:9.7pt;padding-left:4.5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pursuant to the Code of Obligations, shareholders have pre-emptive subscription rights (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">droits de souscription pr&#233;f&#233;rentiels</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">) to subscribe for new issuances of shares. With respect to conditional capital, shareholders have (i) pre-emptive subscription rights for the subscription of option rights and (ii) advance subscription rights (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">droit de souscription prioritaire</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">) for the subscription of bonds and similar debt instruments to which option or conversion rights are attached.</font></div><div style="margin-top:0.15pt;padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:8.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">A resolution passed at a general meeting of shareholders by two-thirds of the shares represented and the majority of the par value of the shares represented may withdraw or limit, or authorize our board of directors to withdraw or limit, pre-emptive subscription rights or advance subscription rights in certain circumstances.</font></div><div style="margin-top:9.7pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">If pre-emptive subscription rights are granted, but not exercised, the board of directors may allocate the unexercised pre- emptive subscription rights at its discretion.</font></div><div style="margin-top:9.55pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Our Capital Range</font></div><div style="margin-top:0.1pt;padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under our articles of association, our board of directors is authorized at any time, including to prevent takeovers and changes in control, until June 18, 2030 at the latest to increase our nominal share capital to a maximum aggregate amount of CHF 4,979,862.30 through the issuance of not more than 33,199,082 shares, which would have to be fully paid-in, each with a par value of CHF 0.05 per share.</font></div><div style="margin-top:9.7pt;padding-left:4.5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Increases in partial amounts are permitted. The board of directors has the power to determine the type of contributions, the issue price and the date on which the dividend entitlement starts.</font></div><div style="margin-top:9.75pt;padding-left:4.5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">With respect to our capital range, the board of directors is authorized by our articles of association to withdraw or to limit the pre-emptive subscription rights of shareholders, and to allocate them to third parties or to us or another company of our group, in the event that the newly issued shares are issued under the following circumstances&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;if the issue price of the new registered shares is determined by reference to the market price&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:15.45pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;for raising of capital (including private placements) in a fast and flexible manner, which would not be possible, or might only be possible with great difficulty or delays or at significantly less favorable conditions, without the exclusion of the statutory pre-emptive subscription rights of the existing shareholders&#59;</font></div><div style="margin-top:9.7pt;padding-left:46.9pt;padding-right:7.7pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;for the acquisition of an enterprise, parts of an enterprise or participations, for the acquisition of products, intellectual property or licenses by or for investment projects of the Company or any of its group companies, or for the financing or refinancing of any of such transactions through a placement of shares&#59;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><img alt="image_16.jpg" src="image_16.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-top:3.8pt;padding-left:46.9pt;padding-right:25.5pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;for purposes of broadening the shareholder constituency of the Company in certain geographic, financial or investor markets, for purposes of the participation of strategic partners, or in connection with the listing of new shares on domestic or foreign stock exchanges&#59;</font></div><div style="margin-top:9.7pt;padding-left:46.9pt;padding-right:25.45pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;for purposes of granting an over-allotment option or an option to purchase additional shares in a placement or sale of shares to the respective initial purchaser(s) or underwriter(s)&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:11.75pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;for the participation of members of the board of directors, members of the executive committee, employees, contractors, consultants or other persons performing services for the benefit of the Company or any of its group companies&#59;</font></div><div style="margin-top:9.65pt;padding-left:46.9pt;padding-right:9.85pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;following a shareholder or a group of shareholders acting in concert having accumulated shareholdings in excess of 15% of our share capital registered in the Commercial Register without having submitted to all other shareholders a takeover offer recommended by the board of directors&#59;</font></div><div style="margin-top:9.7pt;padding-left:46.9pt;padding-right:22.05pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;for the defense of an actual, threatened or potential takeover bid, that the board of directors, upon consultation with an independent financial adviser retained by it, has not recommended to the shareholders acceptance on the basis that the board of directors has not found the takeover bid to be financially fair to the shareholders or not to be in the Company&#8217;s interest&#59; or</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;for other valid grounds in the sense of Article 652b para. 2 of the Code of Obligations.</font></div><div style="padding-right:9.15pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the increase of share capital, our board of directors has the right to reduce the share capital to the minimum amount of CHF 3,319,908.20. According to the Articles of Association, our board of directors is entitled to determine the use of the reduction amount, to the extent necessary.</font></div><div style="margin-top:9.55pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Our Conditional Share Capital</font></div><div style="margin-top:0.45pt;padding-left:4.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Conditional Share Capital for Financing, Acquisitions and Other Purposes</font></div><div><font><br></font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nominal share capital may be increased, including to prevent takeovers and changes in control, by a maximum aggregate amount of CHF 913,868.15 through the issuance of not more than 18,277,363 ordinary shares, which would have to be fully paid-in, each with a par value of CHF 0.05 per share, through the exercise or mandatory exercise of conversion, exchange, option, warrant or similar rights or obligations for the subscription of shares granted to shareholders or third parties on a stand-alone basis or in connection with bonds, notes, options, warrants or other securities or contractual obligations of the Company or any of its group companies. Shareholders will not have pre-emptive subscription rights in such circumstances, but will have advance subscription rights to subscribe for such warrants, convertible bonds or similar instruments. The holders of such warrants, convertible bonds or similar instruments are entitled to the new shares upon the occurrence of the applicable conversion feature.</font></div><div style="margin-top:9.7pt;padding-left:4.5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">When issuing such convertible bonds, warrants or similar instruments, the board of directors is authorized to withdraw or to limit the advance subscription right of shareholders&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:12.1pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;for the purpose of financing or refinancing, or the payment for, the acquisition of enterprises, parts of enterprises, participations, intellectual property rights, licenses or investments&#59;</font></div><div style="margin-top:9.55pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;if the issuance occurs in domestic or international capital markets, including private placements&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:9.85pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;following a shareholder or a group of shareholders acting in concert having accumulated shareholdings in excess of 15% of the share capital registered in the Commercial Register without having submitted to all other shareholders a takeover offer recommended by the board of directors&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:9.3pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;for the defense of an actual, threatened or potential takeover bid that the board of directors, upon consultation with an independent financial adviser retained by it, has not recommended to the shareholders to accept on the basis that the board of directors has not found the takeover bid to be financially fair to the shareholders or not to be in the Company&#8217;s interest&#59; or</font></div><div><font><br></font></div><div style="padding-left:46.9pt;padding-right:9.3pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;if such convertible bonds, warrants or similar instruments are issued on appropriate terms.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.55pt"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-top:3.8pt;padding-left:4.5pt;padding-right:11.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">To the extent that the advance subscription rights are withdrawn or limited, (i) the convertible bonds, warrants or similar instruments are to be issued at market conditions&#59; (ii) the term to exercise the convertible bonds, warrants or similar instruments may not exceed ten years from the date of issue of the respective instrument and (iii) the conversion, exchange or exercise price of the convertible bonds, warrants or similar instruments has to be set with reference to or be subject to change based upon the valuation of the Company&#8217;s equity or market conditions.</font></div><div style="margin-top:9.55pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Conditional Share Capital for Employee Participation</font></div><div style="margin-top:0.1pt;padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our nominal share capital may, to the exclusion of the pre-emptive subscription rights and advance subscription rights of shareholders, be increased by a maximum aggregate amount of CHF 1,069,162.35 through the (direct or indirect) issuance of not more than 21,383,247 ordinary shares, which would have to be fully paid-in, each with a par value of CHF 0.05 per share, or through the exercise or mandatory exercise of rights to acquire shares or through obligations to acquire shares that were granted to or imposed on members of the board of directors (or equivalent corporate body), members of the executive management, employees, contractors or consultants of the Company or its group companies, or other persons providing services to the Company or its group companies through one or more equity incentive plans, regulations or resolutions to be issue by the board of directors or, to the extent delegated to it, by the compensation committee.</font></div><div style="margin-top:9.5pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Uncertificated Securities</font></div><div style="margin-top:9.7pt;padding-left:4.5pt;padding-right:11.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Our shares are in the form of uncertificated securities (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">droits-valeurs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">, within the meaning of Article 973c of the Code of Obligations). In accordance with Article 973c of the Code of Obligations, we maintain a non-public register of uncertificated securities (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">registre des droits-valeurs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">). We may at any time convert uncertificated securities into share certificates (including global certificates), one kind of certificate into another, or share certificates (including global certificates) into uncertificated securities. Following entry in the share register, a shareholder may at any time request from us a written confirmation in respect of his, her or its shares. Shareholders are not entitled, however, to request the conversion and&#47;or printing and delivery of share certificates. We may print and deliver certificates for shares at any time.</font></div><div style="margin-top:0.45pt;padding-left:4.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">General Meeting of Shareholders</font></div><div style="margin-top:9.5pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Ordinary&#47;Extraordinary Meetings, Powers</font></div><div style="margin-top:9.7pt;padding-left:4.5pt;padding-right:36.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The general meeting of shareholders is our supreme corporate body. Under Swiss law, an annual general meeting of shareholders must be held annually within six months after the end of a corporation&#8217;s financial year. In our case, this generally means on or before June 30. In addition, extraordinary general meetings of shareholders may be held.</font></div><div style="margin-top:9.7pt;padding-left:4.5pt;padding-right:36.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">A general meeting of shareholders may take place at different places simultaneously if the votes of the participants are immediately transmitted to all meeting venues (multilocal shareholders&#8217; meeting). If the articles of association so permit, a general meeting of shareholders may be held outside Switzerland. The board of directors may allow shareholders that are not present at the meeting venue of the general meeting of shareholders to participate and exercise their rights electronically (&#8220;hybrid shareholder meeting&#8221;). A general meeting of shareholders without a physical meeting venue but that takes place using electronic means (&#8220;virtual shareholder meeting&#8221;) may be held, subject to certain legal requirements and if the articles of association so allow. Our articles of association currently do not provide for general meetings of shareholders outside Switzerland or virtual shareholder meetings.</font></div><div style="margin-top:0.5pt;padding-left:4.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">According to our articles of association, the following powers are vested exclusively in the general meeting of shareholders&#58;</font></div><div style="margin-top:9.5pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;adopting and amending the articles of association, including the change of a company&#8217;s purpose or domicile&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:42.15pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;electing the members of the board of directors, the chairman of the board of directors, the members of the compensation committee, the auditors and the independent proxy&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:22.6pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;approving the business report, the annual statutory and consolidated financial statements and deciding on the allocation of profits as shown on the balance sheet, in particular with regard to dividends&#59;</font></div><div style="margin-top:9.7pt;padding-left:46.9pt;padding-right:43.8pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;approving the aggregate amount of compensation of members of the board of directors and the executive committee&#59;</font></div><div style="margin-top:9.7pt;padding-left:46.9pt;padding-right:13.8pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;discharging the members of the board of directors and the executive committee from liability with respect to their conduct of business&#59;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><img alt="image_16.jpg" src="image_16.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-top:3.6pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;dissolving the company with or without liquidation&#59; and</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46.9pt;padding-right:51.05pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;deciding matters reserved to the general meeting of shareholders by law or the articles of association or submitted to it by the board of directors.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In addition, the following powers are, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">inter alia</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, vested exclusively in the general meeting of shareholders by operation of statutory law&#58; (i) determination of the interim dividend and approval of the requisite interim financial statements and (ii) repayment of the statutory capital reserve (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">r&#233;serve l&#233;gale</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">). </font></div><div style="margin-top:0.05pt;padding-left:4.5pt;padding-right:11.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">An extraordinary general meeting of shareholders may be called by a resolution of the board of directors or the general meeting of shareholders or, under certain circumstances, by a company&#8217;s auditors, liquidator or the representatives of bondholders, if any. In addition, our articles of association require the board of directors to convene an extraordinary general meeting of shareholders if shareholders representing at least 5% of our share capital request such general meeting of shareholders in writing. A request for an extraordinary general meeting of shareholders must set forth the items to be discussed and the proposals to be acted upon. Further, the board of directors must convene an extraordinary general meeting of shareholders and propose financial restructuring measures if, based on our stand-alone annual statutory balance sheet, half of our share capital and statutory reserves are not covered by our assets and a contemplated restructuring measure falls within the competence of the general meeting of shareholders.</font></div><div style="margin-top:9.5pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Voting and Quorum Requirements</font></div><div style="margin-top:9.7pt;padding-left:4.5pt;padding-right:8.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Shareholder resolutions and elections (including elections of members of the board of directors) require the affirmative vote of the majority of shares represented at the general meeting of shareholders, unless otherwise stipulated by law or our articles of association.</font></div><div style="margin-top:0.1pt;padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Under our articles of association, a resolution of the general meeting of shareholders passed by two- thirds of the votes and the majority of the par value of the shares, each as represented at the meeting, is required for&#58;</font></div><div style="margin-top:9.55pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;amending the Company&#8217;s corporate purpose&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;creating shares with preference rights&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;cancelling or amending the restriction on the transferability of shares or their registration with voting rights&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;creating conditional share capital&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:14.5pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;increasing share capital out of equity, against contributions in-kind or for the purpose of acquiring specific assets and granting specific benefits&#59;</font></div><div><font><br></font></div><div style="padding-left:46.9pt;padding-right:14.5pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;limiting or withdrawing shareholders&#8217; pre-emptive subscription rights&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:9.5pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;changing a company&#8217;s domicile&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:7.7pt;text-align:justify;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;amending or repealing the voting and recording restrictions, the provision setting a maximum board size or the indemnification provision for the board of directors and the executive committee set forth in our articles of association&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;converting registered shares into bearer shares&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;removing the chairman or any member of the board of directors before the end of his or her term of office&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;dissolving or liquidating the Company.</font></div><div><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">In addition, a resolution of the general meeting of shareholders passed by two-thirds of the votes and the majority of the par value of the shares, each as represented at the meeting is, by operation of statutory law required for&#58; (i) a consolidation of shares (reverse split)&#59; (ii) a capital increase through contribution by set-off&#59; (iii) the introduction of a capital range (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">marge de fluctuation du capital</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">)&#59; (iv) a conversion of participation certificates into shares&#59; (v) a change of currency of the share capital&#59; (vi) the introduction of a casting vote of the chairperson at the general meeting of shareholders&#59; (vii) a provision in the articles of association regarding the holding of the general meeting of shareholders outside Switzerland&#59; (viii) a delisting of the equity securities&#59; and (ix) the introduction of an arbitration clause in the articles of association.</font></div><div style="padding-left:5pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The same voting requirements apply to resolutions regarding transactions among corporations based on Switzerland&#8217;s Federal Act on Mergers, Demergers, Transformations and the Transfer of Assets of 2003, as amended (the &#8220;Swiss Merger Act&#8221;). See &#8220;&#8212;Articles of Association&#8212;Compulsory Acquisitions&#59; Appraisal Rights.&#8221;</font></div><div style="margin-top:0.05pt"><img alt="image_4.jpg" src="image_4.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div style="margin-top:3.8pt;padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">In accordance with Swiss law and generally accepted business practices, our articles of association do not provide quorum requirements generally applicable to general meetings of shareholders. To this extent, our practice varies from Nasdaq listing standards, which require an issuer to provide in its bylaws for a generally applicable quorum and that such quorum may not be less than one-third of the outstanding voting shares.</font></div><div style="margin-top:9.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Notice</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General meetings of shareholders must be convened by the board of directors at least 20 days before the date of the meeting. The general meeting of shareholders is convened by way of a notice appearing in our official publication medium, currently the Swiss Official Gazette of Commerce. Registered shareholders may also be informed by ordinary mail or e- mail. The notice of a general meeting of shareholders must state the date, the starting time, the form and location of the meeting, the items on the agenda, the motions to the shareholders including a short explanation for these motions, the name and address of the independent representative and, in case of elections, the names of the nominated candidates. A resolution on a matter which is not on the agenda may not be passed at a general meeting of shareholders, except for motions to convene an extraordinary general meeting of shareholders or to initiate a special investigation, on which the general meeting of shareholders may vote at any time. No previous notification is required for motions concerning items included in the agenda or for debates that do not result in a vote.</font></div><div style="margin-top:9.65pt;padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">All owners or representatives of our shares may, if no objection is raised, hold a general meeting of shareholders without complying with the formal requirements for convening general meetings of shareholders (a universal meeting). This universal meeting of shareholders may discuss and pass binding resolutions on all matters within the purview of the general meeting of shareholders, provided that the owners or representatives of all the shares are present at the meeting.</font></div><div style="margin-top:9.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Agenda Requests</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:10.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pursuant to our articles of association, one or more shareholders whose combined shareholdings represent 0.5% of our voting rights or of our share capital have the right to request that an item including a proposal, or a proposal with respect to an existing agenda item, be included in the agenda of a general meeting of shareholders. </font></div><div style="padding-left:4.5pt;padding-right:10.5pt"><font><br></font></div><div style="padding-left:4.5pt;padding-right:10.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">To be timely, the shareholder&#8217;s request must be received by us generally at least 45 calendar days in advance of the meeting. The request must be made in writing and contain, for each of the agenda items, the following information&#58;</font></div><div style="margin-top:9.75pt;padding-left:46.9pt;padding-right:33.2pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;a brief description of the business desired to be brought before the general meeting of shareholders and the reasons for conducting such business at the general meeting of shareholders&#59;</font></div><div style="margin-top:9.5pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;the motions regarding the agenda item&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;the name and address, as they appear in the share register, of the shareholder proposing such business&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:14.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;the number of shares which are beneficially owned by such shareholder (including documentary support of such beneficial ownership)&#59;</font></div><div style="margin-top:9.5pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;the dates upon which the shareholder acquired such shares&#59;</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;any material interest of the proposing shareholder in the proposed business&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;a statement in support of the matter&#59; and</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;all other information required under the applicable laws and stock exchange rules.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">In addition, if the shareholder intends to solicit proxies from the shareholders of a company, such shareholder shall notify the company of this intent in accordance with SEC Rule 14a-4 and&#47;or Rule 14a-8.</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><img alt="image_4.jpg" src="image_4.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-top:3.8pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Our business report, the compensation report and the auditors&#8217; report must be made available for inspection by the shareholders no later than 20 days prior to the general meeting of shareholders. It said reports are not made available electronically, any shareholder may request delivery thereof.</font></div><div style="margin-top:9.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Voting Rights</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Each of our ordinary shares entitles a holder to one vote. The ordinary shares are not divisible. The right to vote and the other rights of share ownership may only be exercised by shareholders (including any nominees) or usufructuaries who are entered in the share register at a cut-off date determined by the board of directors. Those entitled to vote in the general meeting of shareholders may be represented by the independent proxy holder (annually elected by the general meeting of shareholders), by its legal representative or by another registered shareholder with written authorization to act as proxy.</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:113%">The chairman has the power to decide whether to recognize a power of attorney.</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:8.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Our articles of association contain provisions that prevent investors from acquiring voting rights exceeding 15% of our issued share capital. Specifically, if an individual or legal entity acquires ordinary shares and, as a result, directly or indirectly, has voting rights with respect to more than 15% of the registered share capital recorded in the Commercial Register, the registered shares exceeding the limit of 15% shall be entered in the share register as shares without voting rights (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">limitation &#224; l&#8217;inscription</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">). This restriction applies equally to parties acting in concert and to shares held or acquired via a nominee, including via Cede &#38; Co., New York (or any successor), as the nominee of The Depository Trust Company (&#8220;DTC&#8221;), New York, acting in its capacity as clearing nominee. Specifically, if shares are being held by a nominee for third-party beneficiaries, which control (alone or together with third parties) voting rights with respect to more than 15% of the share capital recorded in the Commercial Register, our articles of association provide that the board of directors may cancel the registration of the shares with voting rights held by such nominee in excess of the limit of 15%. Furthermore, our articles of association contain provisions that allow the board of directors to make the registration with voting rights of shares held by a nominee subject to conditions, limitations and reporting requirements or to impose or adjust such conditions, limitations and requirements once registered.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:11.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">However, any shareholders who held more than 15% prior to our initial public offering remain registered with voting rights for such shares. Furthermore, the board of directors may in special cases approve exceptions to these restrictions.</font></div><div style="margin-top:9.5pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Dividends and Other Distributions</font></div><div style="margin-top:9.75pt;padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Our board of directors may propose to shareholders that a dividend or interim dividend or other distribution be paid but cannot itself authorize the distribution. Dividend and interim dividend payments require a resolution passed by a majority of the shares represented at a general meeting of shareholders. In addition, our auditors must confirm that the dividend proposal of our board of directors conforms to Swiss statutory law and our articles of association.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Under Swiss law, we may pay dividends only if we have sufficient distributable profits from the previous business year (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">b&#233;n&#233;fice de l&#8217;exercice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">) or brought forward from the previous business years (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">report des b&#233;n&#233;fices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">) or if we have distributable capital reserves (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">r&#233;serve l&#233;gale issue du capital</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">), each as evidenced by audited stand-alone statutory annual or interim financial statements prepared pursuant to Swiss law, and after allocations to reserves required by Swiss law and by the articles of association have been deducted. </font></div><div><font><br></font></div><div style="margin-top:0.05pt"><img alt="image_4.jpg" src="image_4.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-top:3.8pt;padding-left:5pt;padding-right:9.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Under the Code of Obligations, at least 5% of our annual profit must be retained as statutory profit reserve (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">r&#233;serve l&#233;gale</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">). If there is a loss carried forward, such loss must be eliminated before allocation to the statutory profit reserve. The statutory profit reserve shall be accumulated until it reaches, together with the statutory capital reserve, 50% of our share capital recorded in the Commercial Register. In addition, we have to allocate, among other things, the net proceeds of share issuances to the statutory capital reserve. The Code of Obligations permits us to accrue additional reserves. Further, a purchase of our own shares (whether by us or a subsidiary) reduces the distributable reserves in an amount corresponding to the purchase price of such own shares. Finally, the Code of Obligations under certain circumstances requires the creation of revaluation reserves which are not distributable.</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:11.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Distributions out of issued share capital (i.e., the aggregate par value of our issued shares) are not allowed and may be made only by way of an ordinary capital reduction or within a capital range that (also) allows for a capital reduction (see &#8220;&#8212;Articles of Association&#8212;Ordinary Capital Increase, Capital Range and Conditional Share Capital&#8221;). An ordinary capital reduction requires a resolution passed by a majority of the shares represented at a general meeting of shareholders. The board of directors must publish a call to creditors in the Swiss Official Gazette of Commerce in which creditors are advised that they may request, subject to certain conditions, security for their claims within 30 days of the publication of the creditor call. A licensed audit expert must then confirm, based on the results of the call to creditors, that the claims of the creditors remain fully covered despite the reduction in our share capital recorded in the Commercial Register. If all requirements for an ordinary capital reduction have been met, the board of directors has to amend the articles of association in a public deed. Our share capital may be reduced below CHF 100,000 only if and to the extent that at the same time the statutory minimum share capital of CHF 100,000 is reestablished by sufficient new fully paid-up capital. An ordinary capital reduction must be completed within six months after the resolution of the general meeting of shareholders.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7.85pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Our board of directors determines the date on which the dividend entitlement starts. Dividends are usually due and payable shortly after the shareholders have passed the resolution approving the payment, but shareholders may also resolve at the annual general meeting of shareholders to pay dividends in quarterly or other installments.</font></div><div style="margin-top:9.55pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Transfer of Shares</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Shares in uncertificated form (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">droits-valeurs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">) may only be transferred by way of assignment. Shares or the beneficial interest in shares, as applicable, credited in a securities account may only be transferred when a credit of the relevant intermediated securities to the acquirer&#8217;s securities account is made in accordance with applicable rules. Our articles of association provide that in the case of securities held with an intermediary such as a registrar, transfer agent, trust corporation, bank or similar entity, any transfer, grant of a security interest or usufructuary right in such intermediated securities and the appurtenant rights associated therewith requires the cooperation of the intermediary in order for such transfer, grant of a security interest or usufructuary right to be valid against us.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:17.35pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Voting rights may be exercised only after a shareholder has been entered in the share register (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">registre des actions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">) with his, her or its name and address (in the case of legal entities, the registered office) as a shareholder with voting rights. For a discussion of the restrictions applicable to the control and exercise of voting rights, see &#8220;&#8212;&#8212;Articles of Association&#8212;Voting Rights.&#8221;</font></div><div style="margin-top:9.55pt;padding-left:5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inspection of Books and Records</font></div><div style="margin-top:9.7pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Under the Code of Obligations, a shareholder has a right to inspect the share register with respect to his, her or its own shares and otherwise to the extent necessary to exercise his, her or its shareholder rights. No other person has a right to inspect the share register. Shareholders holding in the aggregate at least 5% of our nominal share capital or of our voting rights have the right to inspect our books and correspondence, subject to the safeguarding of our business secrets and other legitimate interests. Our board of directors is required to decide on an inspection request within four months after receipt of such request. Denial of the request will need to be justified in writing. If an inspection request is denied by the board of directors, shareholders may request the order of an inspection by the court within thirty days. See &#8220;&#8212;Comparison of Swiss Law and Delaware Law&#8212;Inspection of books and records.&#8221;</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><img alt="image_7a.jpg" src="image_7a.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-top:3.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Special Investigation</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:8.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">If a shareholder has exercised its information or inspection rights, such shareholder may propose to the general meeting of shareholders that specific facts be examined by a special examiner in a special investigation. If the general meeting of shareholders approves the proposal, we or any shareholder may, within 30 calendar days after the general meeting of shareholders, request a court at our registered office (currently Rolle, Canton of Vaud, Switzerland) to appoint a special examiner. If the general meeting of shareholders rejects the request, one or more shareholders representing at least 5% of our share capital or voting rights may request that the court appoint a special examiner. The court will issue such an order if the petitioners can demonstrate that members of the board of directors or our executive committee infringed the law or our articles of association and that such violation is suitable to cause a damage to the Company or the shareholders. The costs of the investigation would generally be allocated to us and only in exceptional cases to the petitioners</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Compulsory Acquisitions&#59; Appraisal Rights</font></div><div style="margin-top:9.7pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Business combinations and other transactions that are governed by the Swiss Merger Act (i.e., mergers, demergers, transformations and certain asset transfers) are binding on all shareholders. A statutory merger or demerger requires approval of two-thirds of the shares represented at a general meeting of shareholders and the majority of the par value of the shares represented.</font></div><div style="margin-top:9.7pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">If a transaction under the Swiss Merger Act receives all of the necessary consents, all shareholders are compelled to participate in such transaction.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Swiss corporations may be acquired by an acquirer through the direct acquisition of the shares of the Swiss corporation. The Swiss Merger Act provides for the possibility of a so-called &#8220;cash-out&#8221; or &#8220;squeeze-out&#8221; merger with the approval of holders of 90% of the issued shares. In these limited circumstances, minority shareholders of the corporation being acquired may be compensated in a form other than through shares of the acquiring corporation (for instance, through cash or securities of a parent corporation of the acquiring corporation or of another corporation). For business combinations effected in the form of a statutory merger or demerger and subject to Swiss law, the Swiss Merger Act provides that if equity rights have not been adequately preserved or compensation payments in the transaction are unreasonable, a shareholder may request the competent court to determine a reasonable amount of compensation.</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:9.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">In addition, under Swiss law, the sale of &#8220;all or substantially all of our assets&#8221; by us may require the approval of two-thirds of the number of shares represented at a general meeting of shareholders and the majority of the par value of the shares represented. Whether a shareholder resolution is required depends on the particular transaction, including whether the following test is satisfied&#58;</font></div><div style="margin-top:9.7pt;padding-left:46.9pt;padding-right:16.65pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;a core part of our business is sold, without which it is economically impracticable or unreasonable to continue to operate the remaining business&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:27.15pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;our assets, after the divestment, are not invested in accordance with our corporate purpose as set forth in the articles of association&#59; and</font></div><div style="margin-top:9.7pt;padding-left:46.9pt;padding-right:7.65pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;the proceeds of the divestment are not earmarked for reinvestment in accordance with our corporate purpose but, instead, are intended for distribution to our shareholders or for financial investments unrelated to our corporate purpose.</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">A shareholder of a Swiss corporation participating in certain major corporate transactions may, under certain circumstances, be entitled to appraisal rights. As a result, such shareholder may, in addition to the consideration (be it in shares or in cash) receive an additional amount to ensure that the shareholder receives the fair value of the shares held by the shareholder. Following a statutory merger or demerger, pursuant to the Swiss Merger Act, shareholders can file an appraisal action against the surviving company. If the consideration is deemed inadequate, the court will determine an adequate compensation payment.</font></div><div><font><br></font></div><div><img alt="image_4.jpg" src="image_4.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-top:3.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Board of Directors</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Our articles of association provide that the board of directors shall consist of at least three and not more than eight members.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The members of the board of directors and the chairman are elected annually by the general meeting of shareholders for a period until the completion of the subsequent annual general meeting of shareholders and are eligible for re-election. Each member of the board of directors must be elected individually.</font></div><div style="margin-top:9.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Powers</font></div><div style="margin-top:9.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">According to our articles of association, the board of directors has the following non-delegable and inalienable powers and duties&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;the ultimate direction of the business of the Company and issuing of the relevant directives&#59;</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;laying down the organization of the Company&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;formulating accounting procedures, financial controls and financial planning&#59;</font></div><div><font><br></font></div><div style="padding-left:46.9pt;padding-right:37.1pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;nominating and removing persons entrusted with the management and representation of the Company and regulating the power to sign for the Company&#59;</font></div><div style="margin-top:9.7pt;padding-left:46.9pt;padding-right:19pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;the ultimate supervision of those persons entrusted with management of the Company, with particular regard to adherence to law, our articles of association and regulations and directives of the Company&#59;</font></div><div style="margin-top:9.7pt;padding-left:46.9pt;padding-right:15.95pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;issuing the business report and the compensation report, and preparing for the general meeting of shareholders and carrying out its resolutions&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;informing the court in case of over-indebtedness.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">By operation of statutory law, the board of directors has, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">inter alia</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">, the additional non-delegable and inalienable power and</font></div><div style="padding-left:5pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">duty to submit an application for debt-restructuring moratorium if needed.</font></div><div style="padding-left:5pt;padding-right:3.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The board of directors may, while retaining such non-delegable and inalienable powers and duties, delegate some of its powers, in particular direct management, to a single or to several of its members, committees or to third parties (such as executive officers) who need be neither members of the board of directors nor shareholders. Pursuant to Swiss law and our articles of association, details of the delegation and other procedural rules such as quorum requirements have been set in the organizational rules established by the board of directors.</font></div><div style="margin-top:9.5pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Indemnification of Executive Officers and Directors</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:10.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Subject to Swiss law, our articles of association provide for indemnification of the existing and former members of the board of directors and the executive committee and their heirs, executors and administrators against liabilities arising in connection with the performance of their duties in such capacity, and permits us to advance the expenses of defending any act, suit or proceeding to our directors and executive officers to the extent not included in insurance coverage or advanced by third parties.</font></div><div style="margin-top:9.7pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">In addition, under general principles of Swiss employment law, an employer may be required to indemnify an employee against losses and expenses incurred by such employee in the proper execution of his or her duties under the employment agreement with the employer. See &#8220;&#8212;Comparison of Swiss Law and Delaware Law&#8212;Indemnification of directors and executive officers and limitation of liability.&#8221;</font></div><div style="margin-top:9.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Conflicts of Interest, Management Transactions</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The members of the board of directors and the executive committee are required to immediately and fully inform the board of directors about conflicts of interests concerning them. The board of directors is furthermore required to take measures in order to protect the interests of the company. More generally, the Code of Obligations requires our directors and executive officers to safeguard the Company&#8217;s interests and imposes a duty of loyalty and duty of care on our directors and executive officers. This rule is generally understood to disqualify directors and executive officers from participation in decisions that directly affect them. Our directors and executive officers are personally liable to us for</font></div><div><font><br></font></div><div><img alt="image_4.jpg" src="image_4.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-top:3.8pt;padding-left:5pt;padding-right:8.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">breaches of these obligations. In addition, Swiss law contains provisions under which directors and all persons engaged in the Company&#8217;s management are liable to the Company, each shareholder and the Company&#8217;s creditors for damages caused by an intentional or negligent violation of their duties. Furthermore, Swiss law contains a provision under which payments made to any of the Company&#8217;s shareholders or directors or any person related to any such shareholder or director, other than payments made at arm&#8217;s length, must be repaid to the Company if such shareholder or director acted in bad faith.</font></div><div style="margin-top:9.7pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Our board of directors has adopted a Code of Ethics and other policies that cover a broad range of matters, including the handling of conflicts of interest.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principles of the Compensation of the Board of Directors and the Executive Committee</font></div><div style="margin-top:9.7pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pursuant to Swiss law, the aggregate amount of compensation of the board of directors and the persons whom the board of directors has, fully or partially, entrusted with the management (which we refer to as our &#8220;executive committee&#8221;) of the Company has to be submitted to our shareholders for approval each year. All of our executive officers named in &#8220;Management&#8221; are deemed to be members of our executive committee.</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:8.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The board of directors must issue, on an annual basis, a written compensation report that must be reviewed by our auditors. The compensation report must disclose, among other things, all compensation granted by the Company, directly or indirectly, to current members of the board of directors and the executive committee and, to the extent related to their former role within the Company or not on customary market terms, to former members of the board of directors and former executive officers.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The disclosure concerning compensation, loans and other forms of indebtedness must include the aggregate amount for the board of directors and the executive committee, respectively, as well as the particular amount for each member of the board of directors and for the highest-paid executive officer, specifying the name and function of each of these persons.</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">We are prohibited from granting certain forms of compensation to members of our board of directors and executive committee, such as&#58;</font></div><div style="margin-top:9.75pt;padding-left:46.9pt;padding-right:28.2pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;severance payments (compensation due until the termination of a contractual relationship does not qualify as severance payment)&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;advance compensation&#59;</font></div><div><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;incentive fees for the acquisition or transfer of companies, or parts thereof, by the Company or by companies being, directly or indirectly, controlled by us&#59;</font></div><div style="padding-left:46.9pt;padding-right:9.15pt"><font><br></font></div><div style="margin-top:9.75pt;padding-left:46.9pt;padding-right:58.2pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;loans, other forms of indebtedness, pension benefits not based on occupational pension schemes and performance-based compensation not provided for in the articles of association&#59; and</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:46.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;equity-based compensation not provided for in the articles of association.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Compensation to members of the board of directors and the executive committee for activities in entities that are directly or indirectly controlled by the Company is prohibited if (i) the compensation would be prohibited if it were paid directly by the Company, (ii) the articles of association do not provide for it, or (iii) the compensation has not been approved by the general meeting of shareholders.</font></div><div style="margin-top:9.75pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Each year, the general meeting of shareholders has to vote on the proposals of the board of directors with respect to&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:46.9pt;padding-right:30.1pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;the maximum aggregate amount of compensation of the board of directors for the term of office until the next annual general meeting of shareholders&#59; and</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.05pt"><img alt="image_10a.jpg" src="image_10a.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-top:3.8pt;padding-left:46.9pt;padding-right:31.6pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;the maximum aggregate amount of fixed compensation of the executive committee for the following financial year&#59; and</font></div><div style="margin-top:9.7pt;padding-left:46.9pt;padding-right:25.45pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8226;&#160;&#160;&#160;&#160;the maximum aggregate amount of variable compensation of the executive committee for the current financial year.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The board of directors may submit for approval at the general meeting of shareholders deviating or additional proposals relating to the same or different periods.</font></div><div style="margin-top:9.75pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">If, at the general meeting of shareholders, the shareholders do not approve a compensation proposal of the board of directors, the board of directors must prepare a new proposal, taking into account all relevant factors, and submit the new proposal for approval by the same general meeting of shareholders at a subsequent extraordinary general meeting of shareholders or the next annual general meeting of shareholders.</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">In addition to fixed compensation, members of the board of directors and the executive committee may be paid variable compensation depending on the achievement of certain performance criteria. The performance criteria may include individual targets, targets of the Company or parts thereof and targets in relation to the market, other companies or comparable benchmarks, taking into account the position and level of responsibility of the recipient of the variable compensation. The board of directors or, where delegated to it, the compensation committee shall determine the relative weight of the performance criteria and the respective target values.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Compensation may be paid or granted in the form of cash, shares, financial instruments, in kind, or in the form of other types of benefits. The board of directors or, where delegated to it, the compensation committee shall determine grant, vesting, exercise and forfeiture conditions.</font></div><div style="margin-top:9.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Borrowing Powers</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:10.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Neither Swiss law nor our articles of association restricts our power to borrow and raise funds. The decision to borrow funds is made by or under the direction of our board of directors and no approval by the shareholders is required in relation to any such borrowing.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Repurchases of Shares and Purchases of Own Shares</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:8.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The Code of Obligations limits our ability to repurchase and hold our own shares. We and our subsidiaries may repurchase shares only to the extent that (i) we have freely distributable reserves in the amount of the purchase price and (ii) the aggregate par value of all shares held by us does not exceed 10% of our share capital. Pursuant to Swiss law, where shares are acquired in connection with a transfer restriction set out in the articles of association, the foregoing upper limit is 20%. If we own shares that exceed the threshold of 10% of our share capital, the excess must be sold or cancelled by means of a capital reduction within two years.</font></div><div style="margin-top:9.7pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Shares held by us or our subsidiaries are not entitled to vote at the general meeting of shareholders but are entitled to the economic benefits applicable to the shares generally, including dividends and pre-emptive subscription rights in the case of share capital increases.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">In addition, selective share repurchases are only permitted under certain circumstances. Within these limitations, as is customary for Swiss corporations, we may, subject to applicable law, purchase and sell our own shares from time to time in order to meet imbalances of supply and demand, to provide liquidity and to even-out variances in the market price of shares.</font></div><div><font><br></font></div><div style="margin-top:0.05pt"><img alt="image_16.jpg" src="image_16.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-top:3.6pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Notification and Disclosure of Substantial Share Interests</font></div><div style="margin-top:9.7pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The disclosure obligations generally applicable to shareholders of Swiss corporations under the Federal Act on Financial Market Infrastructures and Market Conduct in Securities and Derivatives Trading, or the Financial Market Infrastructure Act (the &#8220;FMIA&#8221;), do not apply to us since our shares are not listed on a Swiss exchange.</font></div><div style="margin-top:9.55pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Mandatory Bid Rules</font></div><div style="margin-top:9.7pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The obligation of any person or group of persons that acquires more than one third of a company&#8217;s voting rights to submit a cash offer for all the outstanding listed equity securities of the relevant company at a minimum price pursuant to the FMIA does not apply to us since our shares are not listed on a Swiss exchange.</font></div><div style="margin-top:9.55pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Stock Exchange Listing</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares are listed on Nasdaq under the symbol &#8220;SOPH.&#8221;</font></div><div style="margin-top:9.55pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">The Depository Trust Company</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each person owning a beneficial interest in common shares held through DTC must rely on the procedures thereof and on institutions that have accounts therewith to exercise any rights of a holder of the shares.</font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transfer Agent and Registrar of Shares</font></div><div style="margin-top:9.75pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Our share register is kept by Computershare Trust Company, N.A., which acts as transfer agent and registrar. The share register reflects only record owners of our shares. Swiss law does not recognize fractional share interests.</font></div><div style="margin-top:9.55pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comparison of Swiss Law and Delaware Law</font></div><div style="margin-top:0.1pt;padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Swiss laws applicable to Swiss corporations and their shareholders differ from laws applicable to U.S. corporations and their shareholders. The following table summarizes significant differences in shareholder rights pursuant to the provisions of the Code of Obligations, by which our Company is governed (but see the introduction to this Exhibit 2.1 regarding the two-year transition period that currently applies), and the Delaware General Corporation Law applicable to companies incorporated in Delaware and their shareholders. Please note that this is only a general summary of certain provisions applicable to companies in Delaware. Certain Delaware companies may be permitted to exclude certain of the provisions summarized below in their charter documents. </font></div><div><img alt="image_4.jpg" src="image_4.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:0.15pt;margin-top:4.7pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DELAWARE CORPORATE LAW&#160;&#160;&#160;&#160;SWISS CORPORATE LAW</font></div><div style="padding-left:5pt"><img alt="image_17a.jpg" src="image_17a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:726px"></div><div style="margin-top:9.1pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Mergers and similar arrangements</font></div><div style="padding-left:50.3pt;padding-right:50.3pt;text-align:center"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.757%"><div style="margin-top:4.85pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Under the Delaware General Corporation Law, with certain exceptions, a merger, consolidation, sale, lease or transfer of all or substantially all of the assets of a corporation must be approved by the board of directors and a majority of the outstanding shares entitled to vote thereon. A shareholder of a Delaware corporation participating in certain major corporate transactions may, under certain circumstances, be entitled to appraisal rights pursuant to which such shareholder may receive cash in the amount of the fair value of the shares held by such shareholder (as determined by a court) in lieu of the consideration such shareholder would otherwise receive in the transaction. The Delaware General Corporation Law also provides that a parent corporation, by resolution of its board of directors, may merge with any subsidiary, of which it owns at least 90.0% of each class of capital stock without a vote by the shareholders of such subsidiary. Upon any such merger, dissenting shareholders of the subsidiary would have appraisal rights.</font></div><div style="margin-top:4.85pt;padding-left:5pt;padding-right:8.95pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.484%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.759%"><div style="padding-left:5pt;padding-right:8.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Under Swiss law, with certain exceptions, a merger or a demerger of the corporation or a sale of all or substantially all of the assets of a corporation must be approved by two-thirds of the voting rights represented at the respective general meeting of shareholders as well as the majority of the par value of shares represented at such general meeting of shareholders. A shareholder of a Swiss corporation participating in a statutory merger or demerger pursuant to the Swiss Merger Act </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">(Loi sur la fusion la scission, la transformation et le transfert de patrimoine</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">) can file a lawsuit against the surviving company. If the consideration is deemed &#8220;inadequate,&#8221; such shareholder may, in addition to the consideration (be it in shares or in cash) receive an additional amount to ensure that such shareholder receives the fair value of the shares held by such shareholder. Swiss law also provides that if the merger agreement provides only for a compensation payment, at least 90% of all members in the transferring legal entity who are entitled to vote shall approve the merger agreement.</font></div></div></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Shareholders&#8217; suits</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.820%"><div style="margin-top:9.75pt;padding-right:0.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class actions and derivative actions generally are available to shareholders of a Delaware corporation for, among other things, breach of fiduciary duty, corporate waste and actions not taken in accordance with applicable law. In such actions, the court has discretion to permit the winning party to recover attorneys&#8217; fees incurred in connection with such action.</font></div><div style="margin-top:9.75pt;padding-left:4.6pt;padding-right:9.2pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.358%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.822%"><div style="padding-left:4.6pt;padding-right:9.2pt"><font><br></font></div><div style="padding-right:9.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class actions and derivative actions as such are not available under Swiss law. Nevertheless, certain actions may have a similar effect. A shareholder is entitled to bring suit against directors, officers or liquidators for breach of their duties and claim the payment of the company&#8217;s losses or damages to the corporation and, in some cases, to the individual shareholder. Likewise, an appraisal lawsuit won by a shareholder may indirectly compensate all shareholders. In addition, to the extent that U.S. laws and regulations provide a basis for liability and U.S. courts have jurisdiction, a class action may be available.</font></div><div style="margin-top:9.65pt;padding-left:4.6pt;padding-right:9.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Under Swiss law, the winning party is generally entitled to recover a limited amount of attorneys&#8217; fees incurred in connection with such action. The court has discretion to permit the shareholder who lost the lawsuit to recover attorneys&#8217; fees incurred to the extent that he or she acted in good faith.</font></div></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt"><img alt="image_19a.jpg" src="image_19a.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-bottom:0.15pt;margin-top:3.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DELAWARE CORPORATE LAW&#160;&#160;&#160;&#160;SWISS CORPORATE LAW</font></div><div style="padding-left:5pt"><img alt="image_17a.jpg" src="image_17a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:726px"></div><div style="padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Shareholder vote on board and management compensation</font></div><div style="padding-left:50.3pt;padding-right:50.3pt;text-align:center"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.242%"><div style="margin-top:9.05pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Under the Delaware General Corporation Law, the board of directors has the authority to fix the compensation of directors, unless otherwise restricted by the certificate of incorporation or bylaws.</font></div><div style="margin-top:9.05pt;padding-left:5pt;padding-right:8.15pt"><font><br></font></div></div><div style="display:inline-block;max-width:1.514%;min-width:0.514%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.244%"><div style="padding-left:5pt;padding-right:8.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Pursuant to Swiss law, the general meeting of shareholders has the non-transferable right, amongst others, to vote separately and bindingly on the aggregate amount of compensation of the members of the board of directors, of the executive committee and of the advisory boards.</font></div></div></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Annual vote on board renewal</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.820%"><div style="margin-top:4.85pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unless directors are elected by written consent in lieu of an annual meeting, directors are elected in an annual meeting of shareholders on a date and at a time designated by or in the manner provided in the bylaws. Re-election is possible.</font></div><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:113%">Classified boards are permitted.</font></div><div style="margin-top:4.85pt;padding-left:4pt;padding-right:9.6pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.358%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.822%"><div style="padding-left:4pt;padding-right:9.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The general meeting of shareholders elects the members of the board of directors, the chairperson of the board of directors and the members of the compensation committee individually and annually for a term of office until the end of the following general meeting of shareholders. Re-election is possible.</font></div></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnification of directors and executive officers and limitation of liability</font></div><div style="text-align:center"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.820%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Delaware General Corporation Law provides that a certificate of incorporation may contain a provision eliminating or limiting the personal liability of directors and officers  of the corporation for monetary damages for breach of a fiduciary duty as a director or officer, except no provision in the certificate of incorporation may eliminate or limit&#58; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the liability of a director or officer for any breach of the duty of loyalty to the corporation or its shareholder</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the liability of a director or officer for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">a director&#8217;s statutory liability for unlawful payment of dividends or unlawful share purchase or redemption&#59; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the liability of a director or officer for any transaction from which the director or officer derived an improper personal benefit&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">the liability of an officer in any action by or in the right of the corporation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A Delaware corporation may indemnify any person who was or is a party or is threatened to be made a party to any proceeding, other than an action by or on behalf of</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the corporation, because the person is or was a director or officer, against liability incurred in connection with the proceeding if the director or officer acted in good faith and in a manner reasonably believed to be in, or not opposed to, the best interests of the corporation&#59; and the director or officer, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unless ordered by a court, any foregoing indemnification is subject to a determination that the director or officer has met the applicable standard of conduct</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">by a majority vote of the directors who are not parties to the proceeding, even though less than a quorum&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">by a committee of directors designated by a majority vote of the eligible directors, even though less than a quorum&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:13.8pt">by independent legal counsel in a written opinion if there are no eligible directors or if the eligible directors so direct&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">by the shareholders</font></div><div><font><br></font></div></div><div style="display:inline-block;max-width:0.358%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.822%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Under Swiss corporate law, an indemnification by the corporation of a director or member of the executive committee in relation to potential personal liability is not effective to the extent the director or member of the executive committee intentionally or negligently violated his or her corporate duties towards the corporation (certain views advocate that at least a grossly negligent violation is required to exclude the indemnification). Furthermore, the general meeting of shareholders may discharge (release) the directors and members of the executive committee from liability for their conduct to the extent the respective facts are known to shareholders. Such discharge is effective only with respect to claims of the company and of those shareholders who approved the discharge or who have since acquired their shares in full knowledge of the discharge. Most violations of corporate law are regarded as violations of duties towards the corporation rather than towards the shareholders. In addition, indemnification of other controlling persons is not permitted under Swiss corporate law, including shareholders of the corporation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The articles of association of a Swiss corporation may also set forth that the corporation shall indemnify and hold harmless, to the extent permitted by the law, the directors and executive managers out of assets of the corporation against threatened, pending or completed actions. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Also, a corporation may enter into and pay for directors&#8217; and officers&#8217; liability insurance, which may cover negligent acts as well.</font></div></div></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.820%"><div><font><br></font></div></div><div style="display:inline-block;max-width:0.358%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.822%"></div></div><div style="margin-bottom:0.15pt;margin-top:3.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DELAWARE CORPORATE LAW&#160;&#160;&#160;&#160;SWISS CORPORATE LAW</font></div><div><img alt="image_16.jpg" src="image_16.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:46.770%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moreover, a Delaware corporation may not indemnify a director or officer in connection with any proceeding in which the director or officer has been adjudged to be liable to the corporation unless and only to the extent that the court determines that, despite the adjudication of liability but in view of all the circumstances of the case, the director or officer is fairly and reasonably entitled to indemnity for those expenses which the court deems proper.</font></div></div><div style="display:inline-block;max-width:6.459%;min-width:5.459%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:46.771%"><div><font><br></font></div></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><img alt="image_16.jpg" src="image_16.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div><font><br></font></div><div><font><br></font></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div><font><br></font></div><div style="margin-bottom:0.15pt;margin-top:3.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DELAWARE CORPORATE LAW&#160;&#160;&#160;&#160;SWISS CORPORATE LAW</font></div><div style="padding-left:5pt"><img alt="image_17a.jpg" src="image_17a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:726px"></div><div style="margin-top:0.05pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Directors&#8217; fiduciary duties</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.820%"><div style="margin-top:9.7pt;padding-left:5pt;padding-right:2.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">A director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:40.4pt;text-indent:-17.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;the duty of care&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:40.4pt;text-indent:-17.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;the duty of loyalty.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:0.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:0.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">duty, a director must inform himself or herself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction.</font></div><div style="margin-top:9.75pt;padding-left:5pt;padding-right:2.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The duty of loyalty requires that a director act in a manner he or she reasonably believes to be in the best interests of the corporation. He or she must not use his or her corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties.</font></div><div style="margin-top:9.65pt;padding-left:5pt;padding-right:0.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Should such evidence be presented concerning a transaction by a director, a director must prove the procedural fairness of the transaction and that the transaction was of fair value to the corporation.</font></div><div style="margin-top:9.7pt;padding-left:3.5pt;padding-right:8.1pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.358%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.822%"><div style="padding-left:3.5pt;padding-right:8.1pt"><font><br></font></div><div style="padding-right:8.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The board of directors of a Swiss corporation manages the business of the corporation, unless responsibility for such management has been duly delegated to the executive committee based on organizational rules. However, there are several non-transferable duties of the board of directors&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:34.5pt;padding-right:19.75pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the overall management of the corporation and the issuing of all necessary directives&#59;</font></div><div style="margin-top:9.05pt;padding-left:33.9pt;text-indent:-17.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;determination of the corporation&#8217;s organization&#59;</font></div><div><font><br></font></div><div style="margin-top:8.1pt;padding-left:34.5pt;padding-right:18.65pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:117%">&#8226;&#160;&#160;&#160;&#160;the organization of the accounting, financial control and financial planning systems as required for management of the corporation&#59;</font></div><div style="margin-top:9.4pt;padding-left:34.5pt;padding-right:14.8pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the appointment and dismissal of persons entrusted with managing and representing the corporation&#59;</font></div><div style="margin-top:9.05pt;padding-left:34.5pt;padding-right:9.15pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;overall supervision of the persons entrusted with managing the corporation, in particular with regard to compliance with the law, articles of association, operational regulations and directives&#59;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:34.5pt;padding-right:16.45pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;compilation of the annual report, preparation for the general meeting of the shareholders, the compensation report and implementation of its resolutions&#59; and</font></div><div style="margin-top:9.5pt;padding-left:34.5pt;padding-right:9.2pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the filing an application for a debt restructuring moratorium and notification of the court in the event that the company is over-indebted.</font></div><div style="margin-top:9.25pt;padding-left:3.5pt;padding-right:8.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The members of the board of directors must perform their duties with all due diligence and safeguard the interests of the corporation in good faith. They must afford the shareholders equal treatment in equal circumstances.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:3.5pt;padding-right:8.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The duty of care requires that a director act in good faith, with the care that an ordinarily prudent director would exercise under like circumstances.</font></div><div style="padding-left:3.5pt;padding-right:8.65pt"><font><br></font></div><div style="padding-left:3.5pt;padding-right:8.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The members of the board of directors and the executive committee are required to immediately and fully inform the board of directors about conflicts of interests concerning them. The board of directors is furthermore required to take measures in order to protect the interests of the company.</font></div><div style="padding-left:3.5pt;padding-right:8.65pt"><font><br></font></div><div style="padding-left:3.5pt;padding-right:8.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The duty of loyalty requires that a director safeguard the interests of the corporation and requires that directors act in the interest of the corporation and, if necessarily, put aside their own interests. If there is a risk of a conflict of interest, the board of directors must take appropriate measures to ensure that the interests of the company are duly taken into account.</font></div><div style="margin-top:9.65pt;padding-left:3.5pt;padding-right:8.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The burden of proof for a violation of these duties is with the corporation or with the shareholder bringing a suit against the director.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The Swiss Federal Supreme Court has established a doctrine that restricts its review of a business decision if </font></div></div></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div style="margin-bottom:0.15pt;margin-top:3.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DELAWARE CORPORATE LAW&#160;&#160;&#160;&#160;SWISS CORPORATE LAW</font></div><div style="padding-left:5pt"><img alt="image_17a.jpg" src="image_17a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:726px"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.820%"><div><font><br></font></div><div style="padding-left:4.5pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.358%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.822%"><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">the decision has been taken following proper preparation, on an informed basis and without conflicts of interest.</font></div></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt"><img alt="image_19a.jpg" src="image_19a.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div style="padding-left:5pt"><font><br></font></div><div id="i86e8a716a2434b1798dc319a7a2bd586_4"></div><div style="margin-bottom:0.15pt;margin-top:3.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DELAWARE CORPORATE LAW&#160;&#160;&#160;&#160;SWISS CORPORATE LAW</font></div><div style="padding-left:5pt"><img alt="image_17a.jpg" src="image_17a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:726px"></div><div style="margin-top:4.65pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Shareholder action by written consent</font></div><div style="padding-left:50.3pt;padding-right:50.3pt;text-align:center"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.820%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Delaware corporation may, in its certificate of incorporation, eliminate the right of shareholders to act by written consent.</font></div><div style="margin-top:9.75pt;padding-left:4.25pt;padding-right:1.4pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.358%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.822%"><div style="padding-left:4.25pt;padding-right:1.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Shareholders of a Swiss corporation may exercise their voting rights in a general meeting of shareholders.  Shareholders can only act by written consents if no shareholder requests a general meeting of shareholders. The articles of association must allow for (independent) proxies to be present at a general meeting of shareholders. The instruction of such (independent) proxies may occur in writing or electronically.</font></div></div></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.7pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Shareholder proposals</font></div><div style="padding-left:50.3pt;padding-right:50.3pt;text-align:center"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.820%"><div style="margin-top:4.9pt;padding-left:5pt;padding-right:0.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">A shareholder of a Delaware corporation has the right to put any proposal before the annual meeting of shareholders, provided it complies with the notice provisions in the governing documents. A special meeting may be called by the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings.</font></div><div style="margin-top:4.9pt;padding-left:3.45pt;padding-right:10.3pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.358%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.822%"><div style="padding-right:10.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">At any general meeting of shareholders any shareholder may put proposals to the meeting if the proposal is part of an agenda item. No resolution may be taken on proposals relating to the agenda items that were not duly notified.</font></div><div style="padding-left:3.45pt;padding-right:6.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unless the articles of association provide for a lower threshold or for additional shareholders&#8217; rights&#58;</font></div><div style="margin-top:9.5pt;padding-left:34.5pt;padding-right:6.95pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shareholders together representing at least 5% of the share capital or voting rights may demand that a general meeting of shareholders be called for specific agenda items and specific proposals&#59; and</font></div><div style="margin-top:9.6pt;padding-left:34.5pt;padding-right:9.2pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">shareholders together representing shares with a par value of at least 5%, or 0.5% in case of a listed company, of the share capital or the voting rights may demand that an agenda item including a specific proposal, or a proposal with respect to an existing agenda item, be put on the agenda for a scheduled general meeting of shareholders, provided such request is made with appropriate lead time.</font></div></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt"><img alt="image_19a.jpg" src="image_19a.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div style="padding-left:5pt"><font><br></font></div><div id="i86e8a716a2434b1798dc319a7a2bd586_7"></div><div style="margin-bottom:0.15pt;margin-top:3.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DELAWARE CORPORATE LAW&#160;&#160;&#160;&#160;SWISS CORPORATE LAW</font></div><div style="padding-left:5pt"><img alt="image_17a.jpg" src="image_17a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:726px"></div><div style="padding-left:277.45pt;padding-right:30.75pt;text-align:justify"><font><br></font></div><div style="padding-left:277.45pt;padding-right:30.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Any shareholder can propose candidates for election as directors or make other proposals within the scope of an agenda item without prior written notice.</font></div><div style="padding-left:282.45pt;padding-right:9.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">In addition, any shareholder is entitled, at a general meeting of shareholders and without advance notice, to (i) request information from the board of directors on the affairs of the company (note, however, that the right to obtain such information is limited), (ii) request information from the auditors on the methods and results of their audit,</font></div><div style="padding-left:282.45pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(iii) request that the general meeting of shareholders resolve to convene an extraordinary general meeting, or (iv) request that the general meeting of shareholders resolve to appoint an examiner to carry out a special examination (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">examen</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">sp&#233;cial</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8221;).</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Cumulative voting</font></div><div style="padding-left:50.3pt;padding-right:50.3pt;text-align:center"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.738%"><div style="padding-right:1.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Delaware General Corporation Law, cumulative voting for elections of directors is not permitted unless the corporation&#8217;s certificate of incorporation provides for it.</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:9.8pt"><font><br></font></div></div><div style="display:inline-block;max-width:2.521%;min-width:1.521%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.741%"><div style="padding-left:5pt;padding-right:9.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cumulative voting is not permitted under Swiss corporate law. Pursuant to Swiss law, shareholders can vote for each proposed candidate, but they are not allowed to cumulate their votes for single candidates. An annual individual election of (i) all members of the board of directors, (ii) the chairperson of the board of directors, (iii) the members of the compensation committee, (iv) the election of the independent proxy for a term of</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">office of one year (i.e., until the following annual general meeting of shareholders), as well as the vote on the aggregate amount of compensation of the members of the board of directors, of the executive committee and of the members of any advisory board, is mandatory for listed companies. Re-election is permitted.</font></div></div></div><div><font><br></font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt"><img alt="image_19a.jpg" src="image_19a.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div style="padding-left:5pt"><font><br></font></div><div id="i86e8a716a2434b1798dc319a7a2bd586_10"></div><div style="margin-bottom:0.15pt;margin-top:3.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DELAWARE CORPORATE LAW&#160;&#160;&#160;&#160;SWISS CORPORATE LAW</font></div><div style="padding-left:5pt"><img alt="image_17a.jpg" src="image_17a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:726px"></div><div style="padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Removal of directors</font></div><div style="padding-left:50.3pt;padding-right:50.3pt;text-align:center"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.734%"><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Delaware corporation with a classified board may be removed only for cause with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise.</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:7pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.529%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.737%"><div style="padding-left:5pt;padding-right:7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">A Swiss corporation may remove, with or without cause, any director at any time with a resolution passed by a majority of the shares represented at a general meeting of shareholders. The articles of association may require the approval by a supermajority of the shares represented at a meeting for the removal of a director.</font></div></div></div><div><font><br></font></div><div style="margin-top:4.7pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Transactions with interested shareholders</font></div><div style="padding-left:50.3pt;padding-right:50.3pt;text-align:center"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.757%"><div style="margin-top:4.85pt;padding-left:4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The Delaware General Corporation Law generally prohibits a Delaware corporation from engaging in certain business combinations with an &#8220;interested shareholder&#8221; for three years following the date that such person becomes an interested shareholder. An interested shareholder generally is a person or group who or which owns or owned 15.0% or more of the corporation&#8217;s outstanding voting shares within the past three years.</font></div><div style="margin-top:4.7pt;padding-left:5pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.484%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.759%"><div style="padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No such rule applies to a Swiss corporation.</font></div></div></div><div><font><br></font></div><div style="margin-top:4.7pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Dissolution&#59; Winding-up</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.707%"><div style="margin-top:9.7pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Unless the board of directors of a Delaware corporation approves the proposal to dissolve, dissolution must be approved by shareholders holding 100.0% of the total voting power of the corporation. Only if the dissolution is initiated by the board of directors may it be approved by a simple majority of the corporation&#8217;s outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by the board.</font></div><div style="margin-top:9.7pt;padding-left:5pt;padding-right:10.35pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.583%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.710%"><div style="padding-left:5pt;padding-right:10.35pt"><font><br></font></div><div style="padding-right:10.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A dissolution of a Swiss corporation requires the approval by two-thirds of the voting rights represented at the respective general meeting of shareholders as well as the majority of the par value of shares represented at such general meeting of shareholders. The articles of association may increase the voting thresholds required for such a resolution.</font></div></div></div><div><font><br></font></div><div style="margin-top:4.65pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Variation of rights of shares</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.989%"><div style="margin-top:9.75pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">A Delaware corporation may vary the rights of a class of shares with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise.</font></div><div style="margin-top:9.75pt;padding-left:5pt;padding-right:8.15pt"><font><br></font></div></div><div style="display:inline-block;max-width:2.018%;min-width:1.018%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.993%"><div style="padding-left:5pt;padding-right:8.15pt"><font><br></font></div><div style="padding-right:8.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The general meeting of shareholders of a Swiss corporation may resolve that preference shares be issued or that existing shares be converted into preference shares with a resolution passed by a majority of the shares represented at the general meeting of shareholders. Where a company has issued preference shares, further preference shares conferring preferential rights over the existing preference shares may be issued only with the consent of both a special meeting of the adversely affected holders of the existing preference shares and of a general meeting of all shareholders, unless otherwise provided in the articles of association.</font></div><div style="margin-top:9.7pt;padding-right:8.15pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Shares with preferential voting rights are not regarded as preference shares for these purposes.</font></div></div></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt"><img alt="image_21a.jpg" src="image_21a.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div style="padding-left:5pt"><font><br></font></div><div id="i86e8a716a2434b1798dc319a7a2bd586_13"></div><div style="margin-bottom:0.15pt;margin-top:3.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DELAWARE CORPORATE LAW&#160;&#160;&#160;&#160;SWISS CORPORATE LAW</font></div><div style="padding-left:5pt"><img alt="image_17a.jpg" src="image_17a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:726px"></div><div style="margin-top:4.65pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Amendment of governing documents</font></div><div style="padding-left:50.3pt;padding-right:50.3pt;text-align:center"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.635%"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Delaware corporation&#8217;s governing documents may be amended with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise.</font></div><div style="margin-top:9.75pt;padding-left:5pt;padding-right:9.8pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.726%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.639%"><div style="padding-left:5pt;padding-right:9.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The articles of association of a Swiss corporation may be amended with a resolution passed by a majority of the shares represented at a general meeting of shareholders, unless otherwise provided in the articles of association.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">There are a number of resolutions, such as an amendment of the stated purpose of the corporation, the introduction of a capital range and conditional capital and the introduction of shares with preferential voting rights that require the approval by two-thirds of the votes and a majority of the par value of the shares represented at such general meeting of shareholders. The articles of association may increase these voting thresholds. The articles of association of a Swiss corporation may be amended with a resolution passed by a majority of the shares represented at a general meeting of shareholders, unless otherwise provided in the articles of association.</font></div></div></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:4.65pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inspection of books and records</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.757%"><div style="margin-top:9.75pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Shareholders of a Delaware corporation, upon written demand under oath stating the purpose thereof, have the right during the usual hours for business to inspect for any proper purpose and to obtain copies of list(s) of shareholders and other books and records of the corporation and its subsidiaries, if any, to the extent the books and records of such subsidiaries are available to the corporation.</font></div><div style="margin-top:9.75pt;padding-left:5pt;padding-right:9.7pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.484%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.759%"><div style="padding-left:5pt;padding-right:9.7pt"><font><br></font></div><div style="padding-right:9.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shareholders of a Swiss corporation holding in the aggregate at least 5% of the nominal share capital or voting rights have the right to inspect books and records, subject to the safeguarding of the company&#8217;s business secrets and other interests warranting protection. A shareholder is only entitled to receive information to the extent required to exercise his, her or its rights as a shareholder. The board of directors has to decide on an inspection request within four months after receipt of such request. Denial of the request will need to be justified in writing. If the board of directors denies an inspection request, shareholders may request the order of an inspection by the court within thirty days. </font></div><div style="margin-top:9.75pt;padding-right:9.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">A shareholder&#8217;s right to inspect the share register is limited to the right to inspect his, her or its own entry in the share register .</font></div></div></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:4.7pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Payment of dividends</font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.820%"><div style="margin-top:9.7pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">The board of directors may approve a dividend without shareholder approval. Subject to any restrictions contained in its certificate of incorporation, the board may declare and pay dividends upon the shares of its capital stock either&#58;</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:40.4pt;text-indent:-17.45pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">out of its surplus&#59; or</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41pt;padding-right:5.05pt;text-indent:-18.05pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:117%">&#8226;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:117%">in case there is no such surplus, out of its net profits for the fiscal year in which the dividend is declared and&#47;or the preceding fiscal year.</font></div><div style="margin-top:9.55pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Shareholder approval is required to authorize capital stock in excess of that provided in the charter. Directors may issue authorized shares without shareholder approval.</font></div><div style="margin-top:9.7pt;padding-left:4.6pt;padding-right:9.8pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.358%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.822%"><div style="padding-left:4.6pt;padding-right:9.8pt"><font><br></font></div><div style="padding-right:9.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend (including interim dividend) payments are subject to the approval of the general meeting of shareholders. The board of directors may propose to shareholders that a dividend shall be paid but cannot itself authorize the distribution</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:4.6pt;padding-right:7.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Payments out of a corporation&#8217;s share capital (in other words, the aggregate par value of the corporation&#8217;s shares) in the form of dividends are not allowed and may be made only by way of a share capital reduction. Dividends may be paid only from the profits of the previous business year or brought forward from previous or current business years or if the corporation has distributable reserves, each as evidenced by the corporation&#8217;s audited stand-alone statutory balance sheet prepared pursuant to Swiss law and after allocations to reserves required by Swiss law and the articles of association have been deducted.</font></div></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:5pt"><img alt="image_19a.jpg" src="image_19a.jpg" style="height:2px;margin-bottom:5pt;vertical-align:text-bottom;width:728px"></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:23.76pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 2.1</font></div></div><div style="padding-left:5pt"><font><br></font></div><div id="i86e8a716a2434b1798dc319a7a2bd586_16"></div><div style="margin-bottom:0.15pt;margin-top:3.6pt;padding-left:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DELAWARE CORPORATE LAW&#160;&#160;&#160;&#160;SWISS CORPORATE LAW</font></div><div style="padding-left:5pt"><img alt="image_17a.jpg" src="image_17a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:726px"></div><div style="margin-top:4.65pt;padding-left:99.65pt;padding-right:99.65pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Creation and issuance of new shares</font></div><div style="padding-left:50.3pt;padding-right:50.3pt;text-align:center"><font><br></font></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:49.820%"><div style="padding-right:0.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All creation of shares require the board of directors to adopt a resolution or resolutions, pursuant to authority expressly vested in the board of directors by the provisions of the company&#8217;s certificate of incorporation.</font></div><div style="margin-top:9.75pt;padding-left:3.45pt;padding-right:6.45pt"><font><br></font></div></div><div style="display:inline-block;max-width:0.358%;min-width:0.000%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:49.822%"><div style="padding-left:3.45pt;padding-right:6.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">All creation of shares require a shareholders&#8217; resolution. The creation of a capital range or conditional share capital requires at least two-thirds of the voting rights represented at the general meeting of shareholders and a majority of the par value of shares represented at such meeting. The board of directors may issue or cancel shares out of the capital range during a period of up to five years by a maximum amount of 50% of the current share capital. Shares are created and issued out of conditional share capital through the exercise of options or of conversion rights that the board of directors may grant to shareholders, creditors of bonds or similar debt instruments, employees, directors of the company or another group company or third parties.</font></div></div></div><div style="height:23.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8
<SEQUENCE>4
<FILENAME>exhibit81listofsubsidiaries.htm
<DESCRIPTION>EX-8
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i9d06224450f0490cb2d6e0f8cd7ded6b_1"></div><div style="min-height:36pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 8.1</font></div></div><div style="margin-top:0.4pt;text-align:right"><font><br></font></div><div style="margin-top:0.5pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Subsidiaries</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.252%"><tr><td style="width:1.0%"></td><td style="width:52.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.826%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.472%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of  Subsidiary</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS S.A.S.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS LTD&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS, Inc.&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware (USA)</font></td></tr><tr><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS Intermedia&#231;&#227;o de Neg&#243;cios LTDA</font></td><td style="padding:2px 0;text-align:left;vertical-align:bottom"></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS PTY LTD</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS S.R.L.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS GmbH</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>5
<FILENAME>exhibit121ceo302certificat.htm
<DESCRIPTION>EX-12.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i57742eb70d7a42fa851482a64e375a84_1"></div><div style="min-height:36pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 12.1</font></div></div><div style="margin-top:0.4pt;text-align:right"><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:74.5pt;text-indent:-54.95pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO RULES 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:13pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, Jurgi Camblong, certify that&#58;</font></div><div style="margin-top:9.5pt;padding-left:54.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.67pt">I have reviewed this annual report on Form 20-F of SOPHiA GENETICS SA&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:54.9pt;padding-right:16.05pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:54.9pt;padding-right:17.1pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9.75pt;padding-left:54.9pt;padding-right:11.95pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have&#58;</font></div><div style="margin-top:6pt;padding-left:96.85pt;padding-right:17.45pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5.75pt;padding-left:96.85pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:8.2pt;padding-left:96.85pt;padding-right:18.95pt;text-align:justify;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:13.23pt">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:96.85pt;padding-right:27.65pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9.75pt;padding-left:54.9pt;padding-right:29.15pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5.95pt;padding-left:96.85pt;padding-right:26.35pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:96.85pt;padding-right:57.5pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:13pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March&#160;3, 2026</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:13pt;padding-right:455.2pt"><img alt="image_03.jpg" src="image_03.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:363px"></div><div style="padding-left:13pt;padding-right:455.2pt"><font><br></font></div><div style="padding-left:13.5pt;padding-right:455.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Jurgi Camblong </font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; Jurgi Camblong</font></div><div style="padding-left:13.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; Chief Executive Officer</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>6
<FILENAME>exhibit122cfo302certificat.htm
<DESCRIPTION>EX-12.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i908b6cfb89a146c8a9006f2bcd89d2a7_1"></div><div style="min-height:36pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 12.2</font></div></div><div style="margin-top:0.4pt;text-align:right"><font><br></font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="margin-top:4.55pt;padding-left:74.5pt;text-indent:-54.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO RULES 13A-14(A) AND 15D-14(A) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:13pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, George Cardoza, certify that&#58;</font></div><div style="margin-top:9.5pt;padding-left:54.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.67pt">I have reviewed this annual report on Form 20-F of SOPHiA GENETICS SA&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:54.9pt;padding-right:16.05pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:54.9pt;padding-right:17.1pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9.75pt;padding-left:54.9pt;padding-right:11.95pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have&#58;</font></div><div style="margin-top:6pt;padding-left:96.85pt;padding-right:17.45pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5.75pt;padding-left:96.85pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:8.2pt;padding-left:96.85pt;padding-right:18.95pt;text-align:justify;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:13.23pt">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:96.85pt;padding-right:27.65pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9.75pt;padding-left:54.9pt;padding-right:29.15pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5.95pt;padding-left:96.85pt;padding-right:26.35pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:96.85pt;padding-right:57.5pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:13pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March&#160;3, 2026</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:13pt;padding-right:455.2pt"><img alt="image_02.jpg" src="image_02.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:363px"></div><div style="padding-left:13pt;padding-right:455.2pt"><font><br></font></div><div style="padding-left:13pt;padding-right:455.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; George Cardoza</font></div><div style="padding-left:13pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; George Cardoza</font></div><div style="padding-left:13pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; Chief Financial Officer</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>7
<FILENAME>exhibit131ceo906certificat.htm
<DESCRIPTION>EX-13.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i14b1a2cc163446fb8cda2f406b7880cd_1"></div><div style="min-height:36pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 13.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with SOPHiA GENETICS SA&#8217;s annual report on Form 20-F for the year ended December 31, 2025 (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, Jurgi Camblong, the Chief Executive Officer of SOPHiA GENETICS SA, certify that&#58;</font></div><div style="margin-top:9.5pt;padding-left:54.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.67pt">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:54.9pt;padding-right:16.05pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of operations of SOPHiA GENETICS SA.</font></div><div style="padding-right:16.05pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March&#160;3, 2026</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:13pt;padding-right:455.2pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:363px"></div><div style="padding-left:13pt;padding-right:455.2pt"><font><br></font></div><div style="padding-right:455.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Jurgi Camblong </font></div><div style="padding-right:455.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; Jurgi Camblong</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; Chief Executive Officer</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>8
<FILENAME>exhibit132cfo906certificat.htm
<DESCRIPTION>EX-13.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i948ec066fb8944359ff199d7d039ebc2_1"></div><div style="min-height:36pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 13.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certification set forth below is being submitted in connection with SOPHiA GENETICS SA&#8217;s annual report on Form 20-F for the year ended December 31, 2025 (the &#8220;Report&#8221;) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, George Cardoza, the Chief Financial Officer of SOPHiA GENETICS SA, certify that&#58;</font></div><div style="margin-top:9.5pt;padding-left:54.9pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.67pt">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:54.9pt;padding-right:16.05pt;text-indent:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:114%;padding-left:12.67pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;of operations of SOPHiA GENETICS SA.</font></div><div style="padding-right:16.05pt"><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March&#160;3, 2026</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="padding-left:13pt"><img alt="image_01.jpg" src="image_01.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:363px"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:129%">&#47;s&#47; George Cardoza</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; George Cardoza</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Title&#58; Chief Financial Officer</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15
<SEQUENCE>9
<FILENAME>exhibit151pwcconsentfy25.htm
<DESCRIPTION>EX-15
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i7a3c9853d84145cd8a665e77a7025fe0_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:0.1pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 15.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:115%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:115%">We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-258121, 333-258122 and 333-288625) and Form F-3 (Nos. 333-280060, 333-289266 and 333-289270) of SOPHiA GENETICS SA of our report dated March 3, 2026 relating to the financial statements, which appears in this Form 20-F.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; PricewaterhouseCoopers SA</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:112%">Lausanne, Switzerland</font></div><div><font style="color:#000000;font-family:'Georgia',serif;font-size:10pt;font-weight:400;line-height:112%">March 3, 2026</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>soph-20251231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c4318-4e70-7eba-b516-6c06258ef00a,g:b3ab9529-65b6-4117-b100-6d41f692b5c5-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:soph="http://www.sophiagenetics.com/20251231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.sophiagenetics.com/20251231">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-af-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd"/>
  <xs:import namespace="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full" schemaLocation="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="soph-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="soph-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="soph-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="soph-20251231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.sophiagenetics.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.sophiagenetics.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofLoss" roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss">
        <link:definition>9952151 - Statement - Consolidated Statements of Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>9952152 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets">
        <link:definition>9952153 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofChangesinEquity" roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity">
        <link:definition>9952154 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>9952155 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Companyinformationandoperations" roleURI="http://www.sophiagenetics.com/role/Companyinformationandoperations">
        <link:definition>9952156 - Disclosure - Company information and operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Materialaccountingpolicies" roleURI="http://www.sophiagenetics.com/role/Materialaccountingpolicies">
        <link:definition>9952157 - Disclosure - Material accounting policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segmentreporting" roleURI="http://www.sophiagenetics.com/role/Segmentreporting">
        <link:definition>9952158 - Disclosure - Segment reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.sophiagenetics.com/role/Revenue">
        <link:definition>9952159 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Costofrevenue" roleURI="http://www.sophiagenetics.com/role/Costofrevenue">
        <link:definition>9952160 - Disclosure - Cost of revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Operatingexpense" roleURI="http://www.sophiagenetics.com/role/Operatingexpense">
        <link:definition>9952161 - Disclosure - Operating expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Otheroperatingincomenet" roleURI="http://www.sophiagenetics.com/role/Otheroperatingincomenet">
        <link:definition>9952162 - Disclosure - Other operating income, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterestincomeInterestexpenseandForeignexchangelossesgainsnet" roleURI="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnet">
        <link:definition>9952163 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Incometax" roleURI="http://www.sophiagenetics.com/role/Incometax">
        <link:definition>9952164 - Disclosure - Income tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Losspershare" roleURI="http://www.sophiagenetics.com/role/Losspershare">
        <link:definition>9952165 - Disclosure - Loss per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Cashandcashequivalents" roleURI="http://www.sophiagenetics.com/role/Cashandcashequivalents">
        <link:definition>9952166 - Disclosure - Cash and cash equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accountsreceivable" roleURI="http://www.sophiagenetics.com/role/Accountsreceivable">
        <link:definition>9952167 - Disclosure - Accounts receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventory" roleURI="http://www.sophiagenetics.com/role/Inventory">
        <link:definition>9952168 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Prepaidsandothercurrentassets" roleURI="http://www.sophiagenetics.com/role/Prepaidsandothercurrentassets">
        <link:definition>9952169 - Disclosure - Prepaids and other current assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Propertyandequipment" roleURI="http://www.sophiagenetics.com/role/Propertyandequipment">
        <link:definition>9952170 - Disclosure - Property and equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.sophiagenetics.com/role/IntangibleAssets">
        <link:definition>9952171 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.sophiagenetics.com/role/Leases">
        <link:definition>9952172 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Othernoncurrentassets" roleURI="http://www.sophiagenetics.com/role/Othernoncurrentassets">
        <link:definition>9952173 - Disclosure - Other non-current assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accountspayable" roleURI="http://www.sophiagenetics.com/role/Accountspayable">
        <link:definition>9952174 - Disclosure - Accounts payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accruedexpenses" roleURI="http://www.sophiagenetics.com/role/Accruedexpenses">
        <link:definition>9952175 - Disclosure - Accrued expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Postemploymentbenefits" roleURI="http://www.sophiagenetics.com/role/Postemploymentbenefits">
        <link:definition>9952176 - Disclosure - Post-employment benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Sharebasedcompensation" roleURI="http://www.sophiagenetics.com/role/Sharebasedcompensation">
        <link:definition>9952177 - Disclosure - Share-based compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Borrowings" roleURI="http://www.sophiagenetics.com/role/Borrowings">
        <link:definition>9952178 - Disclosure - Borrowings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Relatedparties" roleURI="http://www.sophiagenetics.com/role/Relatedparties">
        <link:definition>9952179 - Disclosure - Related parties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Commitmentsandcontingencies" roleURI="http://www.sophiagenetics.com/role/Commitmentsandcontingencies">
        <link:definition>9952180 - Disclosure - Commitments and contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Financialinstrumentsandrisks" roleURI="http://www.sophiagenetics.com/role/Financialinstrumentsandrisks">
        <link:definition>9952181 - Disclosure - Financial instruments and risks</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Capitalmanagement" roleURI="http://www.sophiagenetics.com/role/Capitalmanagement">
        <link:definition>9952182 - Disclosure - Capital management</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Eventsafterthereportingdate" roleURI="http://www.sophiagenetics.com/role/Eventsafterthereportingdate">
        <link:definition>9952183 - Disclosure - Events after the reporting date</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MaterialaccountingpoliciesPolicies" roleURI="http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies">
        <link:definition>9955511 - Disclosure - Material accounting policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyinformationandoperationsTables" roleURI="http://www.sophiagenetics.com/role/CompanyinformationandoperationsTables">
        <link:definition>9955512 - Disclosure - Company information and operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingTables" roleURI="http://www.sophiagenetics.com/role/SegmentreportingTables">
        <link:definition>9955513 - Disclosure - Segment reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.sophiagenetics.com/role/RevenueTables">
        <link:definition>9955514 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingexpenseTables" roleURI="http://www.sophiagenetics.com/role/OperatingexpenseTables">
        <link:definition>9955515 - Disclosure - Operating expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables" roleURI="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables">
        <link:definition>9955516 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxTables" roleURI="http://www.sophiagenetics.com/role/IncometaxTables">
        <link:definition>9955517 - Disclosure - Income tax (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LosspershareTables" roleURI="http://www.sophiagenetics.com/role/LosspershareTables">
        <link:definition>9955518 - Disclosure - Loss per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandcashequivalentsTables" roleURI="http://www.sophiagenetics.com/role/CashandcashequivalentsTables">
        <link:definition>9955519 - Disclosure - Cash and cash equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableTables" roleURI="http://www.sophiagenetics.com/role/AccountsreceivableTables">
        <link:definition>9955520 - Disclosure - Accounts receivable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryTables" roleURI="http://www.sophiagenetics.com/role/InventoryTables">
        <link:definition>9955521 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandothercurrentassetsTables" roleURI="http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsTables">
        <link:definition>9955522 - Disclosure - Prepaids and other current assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandequipmentTables" roleURI="http://www.sophiagenetics.com/role/PropertyandequipmentTables">
        <link:definition>9955523 - Disclosure - Property and equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangiblesassetsTables" roleURI="http://www.sophiagenetics.com/role/IntangiblesassetsTables">
        <link:definition>9955524 - Disclosure - Intangibles assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.sophiagenetics.com/role/LeasesTables">
        <link:definition>9955525 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OthernoncurrentassetsTables" roleURI="http://www.sophiagenetics.com/role/OthernoncurrentassetsTables">
        <link:definition>9955526 - Disclosure - Other non-current assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountspayableTables" roleURI="http://www.sophiagenetics.com/role/AccountspayableTables">
        <link:definition>9955527 - Disclosure - Accounts payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedexpensesTables" roleURI="http://www.sophiagenetics.com/role/AccruedexpensesTables">
        <link:definition>9955528 - Disclosure - Accrued expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostemploymentbenefitsTables" roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsTables">
        <link:definition>9955529 - Disclosure - Post-employment benefits (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedcompensationTables" roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationTables">
        <link:definition>9955530 - Disclosure - Share-based compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsTables" roleURI="http://www.sophiagenetics.com/role/BorrowingsTables">
        <link:definition>9955531 - Disclosure - Borrowings (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartiesTables" roleURI="http://www.sophiagenetics.com/role/RelatedpartiesTables">
        <link:definition>9955532 - Disclosure - Related parties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrisksTables" roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables">
        <link:definition>9955533 - Disclosure - Financial instruments and risks (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails" roleURI="http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails">
        <link:definition>9955534 - Disclosure - Company information and operations - Summary of Wholly-Owned Subsidiaries (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyinformationandoperationsAdditionalInformationDetails" roleURI="http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails">
        <link:definition>9955535 - Disclosure - Company information and operations - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MaterialaccountingpoliciesDetails" roleURI="http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails">
        <link:definition>9955536 - Disclosure - Material accounting policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingDetails" roleURI="http://www.sophiagenetics.com/role/SegmentreportingDetails">
        <link:definition>9955537 - Disclosure - Segment reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueAdditionalInformationDetails" roleURI="http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails">
        <link:definition>9955538 - Disclosure - Revenue - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails" roleURI="http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails">
        <link:definition>9955539 - Disclosure - Revenue - Schedule of Revenue from Contracts with Customers Allocated to Geographical Areas and Revenue Streams (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingexpenseAdditionalInformationDetails" roleURI="http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails">
        <link:definition>9955540 - Disclosure - Operating expense - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails" roleURI="http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails">
        <link:definition>9955541 - Disclosure - Operating expense - Summary of Depreciation and Amortization have Charged in Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails" roleURI="http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails">
        <link:definition>9955542 - Disclosure - Operating expense - Summary of Employee Benefit Expenses, Social Charges and Share-based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestIncomeDetails" roleURI="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestIncomeDetails">
        <link:definition>9955543 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails" roleURI="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails">
        <link:definition>9955544 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofForeignExchangeLossesGainsNetDetails" roleURI="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofForeignExchangeLossesGainsNetDetails">
        <link:definition>9955545 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Foreign Exchange (Losses) Gains, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxAdditionalInformationDetails" roleURI="http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails">
        <link:definition>9955546 - Disclosure - Income tax - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails" roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails">
        <link:definition>9955547 - Disclosure - Income tax - Summary of Current and Deferred Income Tax (Expenses) Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails" roleURI="http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails">
        <link:definition>9955548 - Disclosure - Income tax - Reconciliation of Expected Tax Expense to Tax Expense Report in Statement of Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxSummaryofMovementinDeferredTaxBalancesDetails" roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails">
        <link:definition>9955549 - Disclosure - Income tax - Summary of Movement in Deferred Tax Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails" roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails">
        <link:definition>9955550 - Disclosure - Income tax - Summary of Unrecognized Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncometaxSummaryofNetOperatingLossCarryforwardsDetails" roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails">
        <link:definition>9955551 - Disclosure - Income tax - Summary of Net Operating Loss Carryforwards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LosspershareAdditionalinformationDetails" roleURI="http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails">
        <link:definition>9955552 - Disclosure - Loss per share - Additional information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LosspershareComponentsofLossforYearDetails" roleURI="http://www.sophiagenetics.com/role/LosspershareComponentsofLossforYearDetails">
        <link:definition>9955553 - Disclosure - Loss per share - Components of Loss for Year (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashandcashequivalentsDetails" roleURI="http://www.sophiagenetics.com/role/CashandcashequivalentsDetails">
        <link:definition>9955554 - Disclosure - Cash and cash equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableAdditionalInformationDetail" roleURI="http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail">
        <link:definition>9955555 - Disclosure - Accounts receivable - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails" roleURI="http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails">
        <link:definition>9955556 - Disclosure - Accounts receivable - Summary of Accounts Receivable and Lease Receivable Less Expected Credit Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails" roleURI="http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails">
        <link:definition>9955557 - Disclosure - Accounts receivable - Summary of Movement in Allowance for Expected Credit Losses in Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventorySummaryofInventoryDetails" roleURI="http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails">
        <link:definition>9955558 - Disclosure - Inventory - Summary of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventorySummaryofInventoryProvisionMovementDetails" roleURI="http://www.sophiagenetics.com/role/InventorySummaryofInventoryProvisionMovementDetails">
        <link:definition>9955559 - Disclosure - Inventory - Summary of Inventory Provision Movement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidsandothercurrentassetsDetails" roleURI="http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails">
        <link:definition>9955560 - Disclosure - Prepaids and other current assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandequipmentAdditionalInformationDetails" roleURI="http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails">
        <link:definition>9955561 - Disclosure - Property and equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandequipmentSummaryofPropertyandEquipmentNetDetails" roleURI="http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails">
        <link:definition>9955562 - Disclosure - Property and equipment - Summary of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsAdditionalInformationDetails" roleURI="http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails">
        <link:definition>9955563 - Disclosure - Intangible Assets - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsIntangibleAssetsNetMovementDetails" roleURI="http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails">
        <link:definition>9955564 - Disclosure - Intangible Assets - Intangible Assets Net, Movement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalInformationDetails" roleURI="http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails">
        <link:definition>9955565 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryofRightofUseAssetsDetails" roleURI="http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails">
        <link:definition>9955566 - Disclosure - Leases - Summary of Right of Use Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryofLeaseLiabilitiesDetails" roleURI="http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails">
        <link:definition>9955567 - Disclosure - Leases - Summary of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OthernoncurrentassetsDetails" roleURI="http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails">
        <link:definition>9955568 - Disclosure - Other non-current assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccountspayableDetails" roleURI="http://www.sophiagenetics.com/role/AccountspayableDetails">
        <link:definition>9955569 - Disclosure - Accounts payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedexpensesDetails" roleURI="http://www.sophiagenetics.com/role/AccruedexpensesDetails">
        <link:definition>9955570 - Disclosure - Accrued expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails" roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails">
        <link:definition>9955571 - Disclosure - Post-employment benefits - Summary of Additional Details on Defined Pension Plans Funded Status (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails" roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails">
        <link:definition>9955572 - Disclosure - Post-employment benefits - Summary of Movement in Defined Benefit Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostemploymentbenefitsAdditionalInformationDetails" roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails">
        <link:definition>9955573 - Disclosure - Post-employment benefits - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails" roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails">
        <link:definition>9955574 - Disclosure - Post-employment benefits - Summary of Movement in Defined Benefit Plans Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails" roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails">
        <link:definition>9955575 - Disclosure - Post-employment benefits - Summary of Defined Benefit Plans Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails" roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails">
        <link:definition>9955576 - Disclosure - Post-employment benefits - Summary of Pension Costs Recognized in Statement of Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails" roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails">
        <link:definition>9955577 - Disclosure - Post-employment benefits - Summary of Pension Remeasurement Recognized in Statement Other Comprehensive Loss (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails" roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails">
        <link:definition>9955578 - Disclosure - Post-employment benefits - Summary of Sensitivity Analysis for Funded Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails" roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails">
        <link:definition>9955579 - Disclosure - Post-employment benefits - Summary of Sensitivity Analysis for Unfunded Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedcompensationAdditionalInformationDetails" roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails">
        <link:definition>9955580 - Disclosure - Share-based compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedcompensationSummaryofStockOptionActivityDetails" roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails">
        <link:definition>9955581 - Disclosure - Share-based compensation - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedcompensationSummaryofValuationInputsDetails" roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails">
        <link:definition>9955582 - Disclosure - Share-based compensation - Summary of Valuation Inputs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails" roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails">
        <link:definition>9955583 - Disclosure - Share-based compensation - Weighted Average Fair Value of Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails" roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails">
        <link:definition>9955584 - Disclosure - Share-based compensation - Summary of Restricted Stock Units Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedcompensationMovementsinSharebasedCompensationReserveDetails" roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationMovementsinSharebasedCompensationReserveDetails">
        <link:definition>9955585 - Disclosure - Share-based compensation - Movements in Share-based Compensation Reserve (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedcompensationSharebasedCompensationExpenseDetails" roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails">
        <link:definition>9955586 - Disclosure - Share-based compensation - Share-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsAdditionalInformationDetails" roleURI="http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails">
        <link:definition>9955587 - Disclosure - Borrowings - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails" roleURI="http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails">
        <link:definition>9955588 - Disclosure - Borrowings - Schedule of Key Inputs for Valuation of Warrant Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails" roleURI="http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails">
        <link:definition>9955589 - Disclosure - Borrowings - Schedule of Allocation of the Loan Proceeds and Movements in Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsScheduleofWarrantObligationLiabilityDetails" roleURI="http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails">
        <link:definition>9955590 - Disclosure - Borrowings - Schedule of Warrant Obligation Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartiesAdditionalInformationDetails" roleURI="http://www.sophiagenetics.com/role/RelatedpartiesAdditionalInformationDetails">
        <link:definition>9955591 - Disclosure - Related parties - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails" roleURI="http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails">
        <link:definition>9955592 - Disclosure - Related parties - Summary of Compensation for Key Management and Non-executive Directors (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandcontingenciesDetails" roleURI="http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails">
        <link:definition>9955593 - Disclosure - Commitments and contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail" roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail">
        <link:definition>9955594 - Disclosure - Financial instruments and risks - Summary of Financial Instruments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrisksAdditionalInformationDetail" roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail">
        <link:definition>9955595 - Disclosure - Financial instruments and risks - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails" roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails">
        <link:definition>9955596 - Disclosure - Financial instruments and risks - Summary of Fair Value Measurement of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail" roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail">
        <link:definition>9955597 - Disclosure - Financial instruments and risks - Summary of Maturity Profile of Financial Liabilities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrisksSummaryofSignificantExchangeRatesDetail" roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofSignificantExchangeRatesDetail">
        <link:definition>9955598 - Disclosure - Financial instruments and risks - Summary of Significant Exchange Rates (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail" roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail">
        <link:definition>9955599 - Disclosure - Financial instruments and risks - Summary of Loss Before Tax To Changes in Foreign Exchange Rates (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail" roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail">
        <link:definition>9955600 - Disclosure - Financial instruments and risks - Summary of Equity To Changes in Foreign Exchange Rates (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalmanagementDetails" roleURI="http://www.sophiagenetics.com/role/CapitalmanagementDetails">
        <link:definition>9955601 - Disclosure - Capital management (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EventsafterthereportingdateDetails" roleURI="http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails">
        <link:definition>9955602 - Disclosure - Events after the reporting date (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="soph_AuditorAbstract" abstract="true" name="AuditorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_AdjustmentsForFairValueOfWarrantLiability" abstract="false" name="AdjustmentsForFairValueOfWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ForeignExchangeAndOtherGainLoss" abstract="false" name="ForeignExchangeAndOtherGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_CurrentAccruedExpenses" abstract="false" name="CurrentAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_TransactionsWithOwnersAbstract" abstract="true" name="TransactionsWithOwnersAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" abstract="false" name="NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" abstract="false" name="IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_NumberOfTreasurySharesIssued" abstract="false" name="NumberOfTreasurySharesIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="soph_NumberOfEquitySharesIssued" abstract="false" name="NumberOfEquitySharesIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="soph_AdjustmentsForFinanceExpenseIncomeNet" abstract="false" name="AdjustmentsForFinanceExpenseIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_AdjustmentsForCreditLossAllowance" abstract="false" name="AdjustmentsForCreditLossAllowance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_AdjustmentsForResearchTaxCredit" abstract="false" name="AdjustmentsForResearchTaxCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_GainLossOnDisposalOfLeaseLiability" abstract="false" name="GainLossOnDisposalOfLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_WorkingCapitalChangesAbstract" abstract="true" name="WorkingCapitalChangesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_CapitalizedSoftwareDevelopmentCosts" abstract="false" name="CapitalizedSoftwareDevelopmentCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_DisclosureOfCompanyInformationAndOperationsAbstract" abstract="true" name="DisclosureOfCompanyInformationAndOperationsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_DisclosureOfCompanyInformationAndOperationsTextBlock" abstract="false" name="DisclosureOfCompanyInformationAndOperationsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_SummaryOfMaterialAccountingPoliciesAbstract" abstract="true" name="SummaryOfMaterialAccountingPoliciesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_DisclosureOfCostOfSalesAbstract" abstract="true" name="DisclosureOfCostOfSalesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_DisclosureOfOperatingExpenseTextBlock" abstract="false" name="DisclosureOfOperatingExpenseTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_OtherOperatingIncomeExpenseNetAbstract" abstract="true" name="OtherOperatingIncomeExpenseNetAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract" abstract="true" name="InterestIncomeExpenseAndForeignExchangeGainLossAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_PrepaymentsAndOtherCurrentAssetsAbstract" abstract="true" name="PrepaymentsAndOtherCurrentAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_AccruedExpensesAbstract" abstract="true" name="AccruedExpensesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract" abstract="true" name="DisclosureOfInformationAboutPostEmploymentBenefitsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_DisclosureOfCapitalManagementExplanatoryTextBlock" abstract="false" name="DisclosureOfCapitalManagementExplanatoryTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfEventsAfterReportingPeriodAbstract" abstract="true" name="DisclosureOfEventsAfterReportingPeriodAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForCostOfSalesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock" abstract="false" name="DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutSubsidiariesTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock" abstract="false" name="DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="soph_SophiaGeneticsSASMember" abstract="true" name="SophiaGeneticsSASMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SophiaGeneticLimitedMember" abstract="true" name="SophiaGeneticLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SophiaGeneticsIncMember" abstract="true" name="SophiaGeneticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember" abstract="true" name="SophiaGeneticsIntermediacaoDeNegociosLTDAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SophiaGeneticsPtyLtdMember" abstract="true" name="SophiaGeneticsPtyLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SophiaGeneticsSRLMember" abstract="true" name="SophiaGeneticsSRLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SOPHiAGENETICSGmbHMember" abstract="true" name="SOPHiAGENETICSGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_DisclosureOfCompanyInformationAndOperationsTable" abstract="true" name="DisclosureOfCompanyInformationAndOperationsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_DisclosureOfCompanyInformationAndOperationsLineItems" abstract="true" name="DisclosureOfCompanyInformationAndOperationsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_IncreaseDecreaseInAuthorisedCapital" abstract="false" name="IncreaseDecreaseInAuthorisedCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_IncreaseDecreaseInNumberOfSharesAuthorised" abstract="false" name="IncreaseDecreaseInNumberOfSharesAuthorised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="soph_NumberOfConditionalSharesAuthorised" abstract="false" name="NumberOfConditionalSharesAuthorised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement" abstract="false" name="NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="soph_WorkflowEquipmentAndServicesMember" abstract="true" name="WorkflowEquipmentAndServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_CustomerOneMember" abstract="true" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_RevenueFromContractsWithCustomersPaymentTerm" abstract="false" name="RevenueFromContractsWithCustomersPaymentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_RevenueFromContractsWithCustomersExtendedPaymentTerm" abstract="false" name="RevenueFromContractsWithCustomersExtendedPaymentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" abstract="false" name="DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" abstract="false" name="DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_EuropeTheMiddleEastAndAfricaMember" abstract="true" name="EuropeTheMiddleEastAndAfricaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_OtherCountriesInEuropeMiddleEastAndAfricaMember" abstract="true" name="OtherCountriesInEuropeMiddleEastAndAfricaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_OtherCountriesInNorthAmericaMember" abstract="true" name="OtherCountriesInNorthAmericaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SOPHiADDMPlatformMember" abstract="true" name="SOPHiADDMPlatformMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_CostOfRevenue1Member" abstract="true" name="CostOfRevenue1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_ResearchTaxCredit" abstract="false" name="ResearchTaxCredit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ResearchAndDevelopmentExpense1Member" abstract="true" name="ResearchAndDevelopmentExpense1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SellingAndMarketingExpense1Member" abstract="true" name="SellingAndMarketingExpense1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_GeneralAndAdministrativeExpense1Member" abstract="true" name="GeneralAndAdministrativeExpense1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties" abstract="false" name="TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_DeferredBenefitAbstract" abstract="true" name="DeferredBenefitAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" abstract="false" name="TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss" abstract="false" name="TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember" abstract="true" name="DepreciationAndAmortizationRelatedTemporaryDifferencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_BadDebtReservesRelatedTemporaryDifferencesMember" abstract="true" name="BadDebtReservesRelatedTemporaryDifferencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_AccruedPensionRelatedTemporaryDifferencesMember" abstract="true" name="AccruedPensionRelatedTemporaryDifferencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_RightOfUseAssetsRelatedTemporaryDifferencesMember" abstract="true" name="RightOfUseAssetsRelatedTemporaryDifferencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember" abstract="true" name="LeaseLiabilitiesRelatedTemporaryDifferencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_UnrecognizedDeferredTaxAssetsGross" abstract="false" name="UnrecognizedDeferredTaxAssetsGross" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_NetOperatingLossCarryforwardsYearOne" abstract="false" name="NetOperatingLossCarryforwardsYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_NetOperatingLossCarryforwardsYearTwo" abstract="false" name="NetOperatingLossCarryforwardsYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_NetOperatingLossCarryforwardsYearThree" abstract="false" name="NetOperatingLossCarryforwardsYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_NetOperatingLossCarryforwardsYearFour" abstract="false" name="NetOperatingLossCarryforwardsYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_NetOperatingLossCarryforwardsThereafter" abstract="false" name="NetOperatingLossCarryforwardsThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_NetOperatingLossCarryforwards" abstract="false" name="NetOperatingLossCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_TradeAndOtherReceivablesTable" abstract="true" name="TradeAndOtherReceivablesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_TradeAndOtherReceivablesLineItems" abstract="true" name="TradeAndOtherReceivablesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_AccountsReceivableNonInterestBearingPaymentTerms" abstract="false" name="AccountsReceivableNonInterestBearingPaymentTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm" abstract="false" name="AccountsReceivableNonInterestBearingExtendedPaymentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_PercentageOfCustomerBalanceAccountReceivable" abstract="false" name="PercentageOfCustomerBalanceAccountReceivable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="soph_AccountsReceivableInAggregateAmount" abstract="false" name="AccountsReceivableInAggregateAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_LongTermLeaseReceivables" abstract="false" name="LongTermLeaseReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_NetLeaseReceivables" abstract="false" name="NetLeaseReceivables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_FinancialAssetsAccountsReceivableMember" abstract="true" name="FinancialAssetsAccountsReceivableMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_ProvisionOfInventory" abstract="false" name="ProvisionOfInventory" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ReconciliationOfChangesInProvisionOfInventoryAbstract" abstract="true" name="ReconciliationOfChangesInProvisionOfInventoryAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_ChangesInProvisionOfInventoryAbstract" abstract="true" name="ChangesInProvisionOfInventoryAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_InventoryIncreaseInProvision" abstract="false" name="InventoryIncreaseInProvision" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_InventoryCurrencyTranslationAdjustment" abstract="false" name="InventoryCurrencyTranslationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_CurrentGovernmentGrantsReceivable" abstract="false" name="CurrentGovernmentGrantsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_CurrentContractAcquisitionCosts" abstract="false" name="CurrentContractAcquisitionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_CurrentOtherAssetsMiscellaneous" abstract="false" name="CurrentOtherAssetsMiscellaneous" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_AmortisationCurrentContractAcquisitionCosts" abstract="false" name="AmortisationCurrentContractAcquisitionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment" abstract="false" name="CurrentAccruedExpensesOnPropertyPlantAndEquipment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ScheduleOfIntangibleAssetsTable" abstract="true" name="ScheduleOfIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_ScheduleOfIntangibleAssetsLineItems" abstract="true" name="ScheduleOfIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_NumberOfCashGeneratingUnit" abstract="false" name="NumberOfCashGeneratingUnit" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="soph_DisclosureOfLeaseTable" abstract="true" name="DisclosureOfLeaseTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_OfficeSpaceMember" abstract="true" name="OfficeSpaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_RolleSwitzerlandMember" abstract="true" name="RolleSwitzerlandMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_BostonMassachusettsMember" abstract="true" name="BostonMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_BidartFranceMember" abstract="true" name="BidartFranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember" abstract="true" name="ConsumerPriceIndicesInSwitzerlandAndFranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_DisclosureOfLeaseLineItems" abstract="true" name="DisclosureOfLeaseLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_NumberOfLeases" abstract="false" name="NumberOfLeases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="soph_LeaseTerm" abstract="false" name="LeaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_AreaOfOfficeSpaceLeased" abstract="false" name="AreaOfOfficeSpaceLeased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="soph_AreaOfOfficeSpaceGainedAccessUnderLease" abstract="false" name="AreaOfOfficeSpaceGainedAccessUnderLease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="soph_LeaseIncentivesAndExpectedRestorationCosts" abstract="false" name="LeaseIncentivesAndExpectedRestorationCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_LeaseDirectCosts" abstract="false" name="LeaseDirectCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ExpectedLeaseCommitments" abstract="false" name="ExpectedLeaseCommitments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_LeaseExpenses" abstract="false" name="LeaseExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_RightOfUseAssetsDiscountedPaymentsRate" abstract="false" name="RightOfUseAssetsDiscountedPaymentsRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="soph_LeaseLiabilitiesDiscountedPaymentsRate" abstract="false" name="LeaseLiabilitiesDiscountedPaymentsRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="soph_PrincipalPaidOnLeaseLiabilities" abstract="false" name="PrincipalPaidOnLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_InterestPaidOnLeaseLiabilities" abstract="false" name="InterestPaidOnLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_NonCurrentDepositsGuarantyAssets" abstract="false" name="NonCurrentDepositsGuarantyAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_NonCurrentContractAcquisitionCosts" abstract="false" name="NonCurrentContractAcquisitionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_EmployeeRelatedPayables" abstract="false" name="EmployeeRelatedPayables" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables" abstract="false" name="ValueAddedTaxesSalesTaxesAndOtherTaxesPayables" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_AccruedCompensation" abstract="false" name="AccruedCompensation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_AccruedProfessionalFees" abstract="false" name="AccruedProfessionalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_AccruedInventoryPurchases" abstract="false" name="AccruedInventoryPurchases" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_AccruedITSupport" abstract="false" name="AccruedITSupport" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_AccruedLegalFees" abstract="false" name="AccruedLegalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_AccruedOther" abstract="false" name="AccruedOther" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract" abstract="true" name="ReconciliationOfChangesInDefinedBenefitObligationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_ChangesInDefinedBenefitObligationAbstract" abstract="true" name="ChangesInDefinedBenefitObligationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_ServiceCostDefinedBenefitPlans" abstract="false" name="ServiceCostDefinedBenefitPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ActuarialGainsLossesNetDefinedBenefitPlans" abstract="false" name="ActuarialGainsLossesNetDefinedBenefitPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" abstract="false" name="TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" abstract="false" name="IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_SwissPensionPlanMember" abstract="true" name="SwissPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_FrenchPensionPlanMember" abstract="true" name="FrenchPensionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_NumberOfActiveMembers" abstract="false" name="NumberOfActiveMembers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="soph_DemographicAssumptionOfWeightedTurnoverRates" abstract="false" name="DemographicAssumptionOfWeightedTurnoverRates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="soph_FinancialAssumptionOfDiscountRates" abstract="false" name="FinancialAssumptionOfDiscountRates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="soph_LPPInterestRate" abstract="false" name="LPPInterestRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="soph_ExtraMandatoryPartEquivalentToDiscountRate" abstract="false" name="ExtraMandatoryPartEquivalentToDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="soph_AverageLifeExpectancyInYearsAfterRetirementForMale" abstract="false" name="AverageLifeExpectancyInYearsAfterRetirementForMale" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_AverageLifeExpectancyInYearsAfterRetirementForFemale" abstract="false" name="AverageLifeExpectancyInYearsAfterRetirementForFemale" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract" abstract="true" name="ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset" abstract="false" name="AdministrativeExpensesNetDefinedBenefitLiabilityAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_FrenchPlanMember" abstract="true" name="FrenchPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SwissPlanMember" abstract="true" name="SwissPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" abstract="false" name="IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ActuarialAssumptionOfExpectedInterestRatesMember" abstract="true" name="ActuarialAssumptionOfExpectedInterestRatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption" abstract="false" name="PeriodOfReasonablyPossibleIncreaseInActuarialAssumption" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption" abstract="false" name="PeriodOfReasonablyPossibleDecreaseInActuarialAssumption" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_A2013IncentiveShareOptionPlanMember" abstract="true" name="A2013IncentiveShareOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_A2019IncentiveShareOptionPlanMember" abstract="true" name="A2019IncentiveShareOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_A2021EmployeeIncentivePlanMember" abstract="true" name="A2021EmployeeIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_ShareBasedPaymentArrangementsVestingAxis" abstract="true" name="ShareBasedPaymentArrangementsVestingAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_ShareBasedPaymentArrangementsVestingDomain" abstract="true" name="ShareBasedPaymentArrangementsVestingDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_ShareBasedPaymentArrangementVestingTrancheOneMember" abstract="true" name="ShareBasedPaymentArrangementVestingTrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_ShareBasedPaymentArrangementVestingTrancheTwoMember" abstract="true" name="ShareBasedPaymentArrangementVestingTrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_ShareBasedPaymentArrangementVestingTrancheThreeMember" abstract="true" name="ShareBasedPaymentArrangementVestingTrancheThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_RestrictedStockUnitsMember" abstract="true" name="RestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_NumberOfShareOptionPlans" abstract="false" name="NumberOfShareOptionPlans" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" abstract="false" name="VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" abstract="false" name="VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis" abstract="false" name="VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" abstract="false" name="VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" abstract="false" name="VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" abstract="false" name="VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" abstract="false" name="VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" abstract="false" name="VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" abstract="false" name="VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" abstract="false" name="VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" abstract="false" name="VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract" abstract="true" name="ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" abstract="true" name="NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" abstract="true" name="ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" abstract="true" name="WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" abstract="true" name="ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" abstract="true" name="WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions" abstract="false" name="WeightedAverageRemainingContractualLifeOfExercisableShareOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_WeightedAverageFairValueShareOptionsGranted" abstract="false" name="WeightedAverageFairValueShareOptionsGranted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" abstract="true" name="ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" abstract="true" name="NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" abstract="true" name="ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" abstract="true" name="WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" abstract="true" name="ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" abstract="false" name="WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" abstract="false" name="WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" abstract="false" name="WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement" abstract="false" name="WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="soph_ReconciliationOfChangesInShareBasedPaymentsAbstract" abstract="true" name="ReconciliationOfChangesInShareBasedPaymentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_ChangesInShareBasedPaymentsAbstract" abstract="true" name="ChangesInShareBasedPaymentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_IncomeStatementLocation1Axis" abstract="true" name="IncomeStatementLocation1Axis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_IncomeStatementLocation1Domain" abstract="true" name="IncomeStatementLocation1Domain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SalesAndMarketingExpenseMember" abstract="true" name="SalesAndMarketingExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_PerceptiveCreditAgreementMember" abstract="true" name="PerceptiveCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_PerceptiveCreditAgreementTrancheAMember" abstract="true" name="PerceptiveCreditAgreementTrancheAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_PerceptiveCreditAgreementTrancheBMember" abstract="true" name="PerceptiveCreditAgreementTrancheBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_PerceptiveCreditAgreementTrancheCMember" abstract="true" name="PerceptiveCreditAgreementTrancheCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_PerceptiveCreditAgreementTrancheDMember" abstract="true" name="PerceptiveCreditAgreementTrancheDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_CreditAgreementExistingMember" abstract="true" name="CreditAgreementExistingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_CreditAgreementNewMember" abstract="true" name="CreditAgreementNewMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_BorrowingTermsAxis" abstract="true" name="BorrowingTermsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_BorrowingTermsDomain" abstract="true" name="BorrowingTermsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_TermSecuredOvernightFinancingRateSOFRMember" abstract="true" name="TermSecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_TermSecuredOvernightFinancingRateSOFRFloorMember" abstract="true" name="TermSecuredOvernightFinancingRateSOFRFloorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember" abstract="true" name="TermSecuredOvernightFinancingRateSOFRUponDefaultMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_PerceptiveCreditHoldingsIVLPMember" abstract="true" name="PerceptiveCreditHoldingsIVLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_CreditSuisseSAMember" abstract="true" name="CreditSuisseSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_UBSSwitzerlandAGMember" abstract="true" name="UBSSwitzerlandAGMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_WarrantTermsAxis" abstract="true" name="WarrantTermsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_WarrantTermsDomain" abstract="true" name="WarrantTermsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_WarrantRightsTrancheAMember" abstract="true" name="WarrantRightsTrancheAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_WarrantRightsTrancheBMember" abstract="true" name="WarrantRightsTrancheBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_WarrantRightsTrancheCMember" abstract="true" name="WarrantRightsTrancheCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_WarrantRightsTrancheDMember" abstract="true" name="WarrantRightsTrancheDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_MajorBorrowingTransactionsMember" abstract="true" name="MajorBorrowingTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_WarrantLiabilityMember" abstract="true" name="WarrantLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_BorrowingFacilitiesMaximumBorrowingCapacity" abstract="false" name="BorrowingFacilitiesMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets" abstract="false" name="BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_BorrowingsCovenantCashAndCashEquivalentsMinimum" abstract="false" name="BorrowingsCovenantCashAndCashEquivalentsMinimum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum" abstract="false" name="BorrowingsCovenantRevenueFromContractsWithCustomersMinimum" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" abstract="false" name="WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="soph_ExercisePriceOfWarrantRights" abstract="false" name="ExercisePriceOfWarrantRights" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="soph_ProceedsFromBorrowings" abstract="false" name="ProceedsFromBorrowings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" abstract="false" name="BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger" abstract="false" name="BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights" abstract="false" name="WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="soph_NumberOfFinancialInstruments" abstract="false" name="NumberOfFinancialInstruments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="soph_TerminationOfBorrowings" abstract="false" name="TerminationOfBorrowings" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_BorrowingMaturityTerm" abstract="false" name="BorrowingMaturityTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_RedemptionPeriodOfWarrantRights" abstract="false" name="RedemptionPeriodOfWarrantRights" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="soph_ExercisePriceMeasurementInputMember" abstract="true" name="ExercisePriceMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SharePriceMeasurementInputMember" abstract="true" name="SharePriceMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_ExpectedVolatilityMeasurementInputMember" abstract="true" name="ExpectedVolatilityMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_ExpectedTermMeasurementInputMember" abstract="true" name="ExpectedTermMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_DividendYieldMeasurementInputMember" abstract="true" name="DividendYieldMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_BlackScholesPricingModelValueMeasurementInputMember" abstract="true" name="BlackScholesPricingModelValueMeasurementInputMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_PerceptiveCreditHoldingsWarrantsMember" abstract="true" name="PerceptiveCreditHoldingsWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_ChangesInBorrowingsAbstract" abstract="true" name="ChangesInBorrowingsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_ProceedsFromBorrowingsNetOfCostsIncurred" abstract="false" name="ProceedsFromBorrowingsNetOfCostsIncurred" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_BorrowingsForeignCurrencyTranslationGainLoss" abstract="false" name="BorrowingsForeignCurrencyTranslationGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ChangesInWarrantLiabilityAbstract" abstract="true" name="ChangesInWarrantLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_ProceedsFromWarrantLiability" abstract="false" name="ProceedsFromWarrantLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_WarrantLiabilityForeignExchangeGainLoss" abstract="false" name="WarrantLiabilityForeignExchangeGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_WarrantsOrRightsNumberOfWarrantsIssued" abstract="false" name="WarrantsOrRightsNumberOfWarrantsIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="soph_NumberOfExecutiveOfficers" abstract="false" name="NumberOfExecutiveOfficers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="soph_NumberOfNonExecutiveOfficers" abstract="false" name="NumberOfNonExecutiveOfficers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="soph_GuardantHealthMember" abstract="true" name="GuardantHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized" abstract="false" name="FutureLeasePaymentsUnderShortTermLeasesNotRecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_CashAndCashEquivalentMember" abstract="true" name="CashAndCashEquivalentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_OtherFinancialNonCurrentAssetsMember" abstract="true" name="OtherFinancialNonCurrentAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_AccountsPayablesMember" abstract="true" name="AccountsPayablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_AccruedExpensesMember" abstract="true" name="AccruedExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_WarrantObligationsMember" abstract="true" name="WarrantObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_GenesisHealthcareMember" abstract="true" name="GenesisHealthcareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_CashAndCashEquivalentsAndTermDepositsMember" abstract="true" name="CashAndCashEquivalentsAndTermDepositsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_BankBorrowingsInterestPaidUndiscountedCashFlows" abstract="false" name="BankBorrowingsInterestPaidUndiscountedCashFlows" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage" abstract="false" name="SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings" abstract="false" name="SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" abstract="true" name="DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_CashAndCashEquivalents1Member" abstract="true" name="CashAndCashEquivalents1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" abstract="true" name="DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable" abstract="true" name="DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems" abstract="true" name="DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_AccruedExpensesUndiscountedCashFlows" abstract="false" name="AccruedExpensesUndiscountedCashFlows" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ContractualLiabilitiesUndiscountedCashFlows" abstract="false" name="ContractualLiabilitiesUndiscountedCashFlows" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="soph_ForeignExchangeSpotRate" abstract="false" name="ForeignExchangeSpotRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="soph_AverageForeignExchangeRates" abstract="false" name="AverageForeignExchangeRates" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable" abstract="true" name="DisclosureOfEffectOfChangesInForeignExchangeRatesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_FunctionalCurrencyMember" abstract="true" name="FunctionalCurrencyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_DifferencesOfCurrencyUSDAndCHFMember" abstract="true" name="DifferencesOfCurrencyUSDAndCHFMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_DifferencesOfCurrencyEURAndCHFMember" abstract="true" name="DifferencesOfCurrencyEURAndCHFMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_DifferencesOfCurrencyGBPAndCHFMember" abstract="true" name="DifferencesOfCurrencyGBPAndCHFMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems" abstract="true" name="DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent" abstract="false" name="SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="soph_PresentationCurrencyMember" abstract="true" name="PresentationCurrencyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_DifferencesOfCurrencyUSDAndEURMember" abstract="true" name="DifferencesOfCurrencyUSDAndEURMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_DifferencesOfCurrencyUSDAndGBPMember" abstract="true" name="DifferencesOfCurrencyUSDAndGBPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent" abstract="false" name="SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="soph_CapitalManagementTable" abstract="true" name="CapitalManagementTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="soph_CapitalManagementLineItems" abstract="true" name="CapitalManagementLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>soph-20251231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c4318-4e70-7eba-b516-6c06258ef00a,g:b3ab9529-65b6-4117-b100-6d41f692b5c5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss" xlink:type="simple" xlink:href="soph-20251231.xsd#ConsolidatedStatementsofLoss"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_019c4318-5179-7d38-bc09-10bb74b66043" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_019c4318-5179-7081-85f7-6e44b289f87c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_019c4318-5179-7d38-bc09-10bb74b66043" xlink:to="loc_ifrs-full_GrossProfit_019c4318-5179-7081-85f7-6e44b289f87c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_019c4318-5179-7e58-9eab-07456558abfe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_019c4318-5179-7d38-bc09-10bb74b66043" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_019c4318-5179-7e58-9eab-07456558abfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_019c4318-5179-7e26-a0da-f1d85d484cab" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_019c4318-5179-7d38-bc09-10bb74b66043" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_019c4318-5179-7e26-a0da-f1d85d484cab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_019c4318-5179-767f-8479-073957d13022" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_019c4318-5179-7d38-bc09-10bb74b66043" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_019c4318-5179-767f-8479-073957d13022" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_019c4318-5179-7d6a-aba3-19df21030005" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities_019c4318-5179-7d38-bc09-10bb74b66043" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_019c4318-5179-7d6a-aba3-19df21030005" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-79f6-9063-13075a51ecad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_019c4318-5179-790e-aeb3-6b63c3da13f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-79f6-9063-13075a51ecad" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_019c4318-5179-790e-aeb3-6b63c3da13f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ForeignExchangeAndOtherGainLoss_019c4318-5179-75d9-b963-098a6008130c" xlink:href="soph-20251231.xsd#soph_ForeignExchangeAndOtherGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-79f6-9063-13075a51ecad" xlink:to="loc_soph_ForeignExchangeAndOtherGainLoss_019c4318-5179-75d9-b963-098a6008130c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromInterest_019c4318-5179-7226-bc0a-0bc892171edd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-79f6-9063-13075a51ecad" xlink:to="loc_ifrs-full_RevenueFromInterest_019c4318-5179-7226-bc0a-0bc892171edd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpense_019c4318-5179-709d-ad50-c1df81c9f8aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-79f6-9063-13075a51ecad" xlink:to="loc_ifrs-full_InterestExpense_019c4318-5179-709d-ad50-c1df81c9f8aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c4318-5179-7870-af86-ce58530d2614" xlink:href="soph-20251231.xsd#soph_AdjustmentsForFairValueOfWarrantLiability"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-79f6-9063-13075a51ecad" xlink:to="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c4318-5179-7870-af86-ce58530d2614" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_019c4318-5179-7c74-91ba-6c802aced308" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-7eff-95d7-ca1c45c8ed75" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_019c4318-5179-7c74-91ba-6c802aced308" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-7eff-95d7-ca1c45c8ed75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-5179-7524-bfd5-ffad1baabef1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss_019c4318-5179-7c74-91ba-6c802aced308" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-5179-7524-bfd5-ffad1baabef1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_019c4318-5179-7672-b59f-f112c55c171f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_019c4318-5179-7999-8d97-3a084fa8d208" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_019c4318-5179-7672-b59f-f112c55c171f" xlink:to="loc_ifrs-full_ProfitLoss_019c4318-5179-7999-8d97-3a084fa8d208" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_019c4318-5179-7096-9858-c106f850f7c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-5179-71a8-b7da-8e914fd2d83a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_019c4318-5179-7096-9858-c106f850f7c5" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-5179-71a8-b7da-8e914fd2d83a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_019c4318-5179-7e10-9fd5-151a3859ce19" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit_019c4318-5179-7096-9858-c106f850f7c5" xlink:to="loc_ifrs-full_CostOfSales_019c4318-5179-7e10-9fd5-151a3859ce19" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="soph-20251231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_019c4318-5179-7435-94cb-901c6d54a608" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-7a4c-adb2-beee94c327b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_019c4318-5179-7435-94cb-901c6d54a608" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-7a4c-adb2-beee94c327b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-725a-9659-c537c1ca146d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncome_019c4318-5179-7435-94cb-901c6d54a608" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-725a-9659-c537c1ca146d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_019c4318-5179-7388-a3f0-0f30d6b70667" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_019c4318-5179-7825-81f0-72197ac4cde3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_019c4318-5179-7388-a3f0-0f30d6b70667" xlink:to="loc_ifrs-full_ComprehensiveIncome_019c4318-5179-7825-81f0-72197ac4cde3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-7bb5-ba05-173c3d73be3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_019c4318-5179-77ea-8265-cf8859efad03" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-7bb5-ba05-173c3d73be3f" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_019c4318-5179-77ea-8265-cf8859efad03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_019c4318-5179-7b59-ac45-aca639ba272a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_019c4318-5179-7be2-93b4-00f892a1e298" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_019c4318-5179-7b59-ac45-aca639ba272a" xlink:to="loc_ifrs-full_ProfitLoss_019c4318-5179-7be2-93b4-00f892a1e298" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_019c4318-5179-74a6-b9ea-af37dd35fcdf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome_019c4318-5179-7b59-ac45-aca639ba272a" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_019c4318-5179-74a6-b9ea-af37dd35fcdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-7d0c-80f4-0d92386c94b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-5179-7de9-8f08-e6360465e0b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-7d0c-80f4-0d92386c94b7" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-5179-7de9-8f08-e6360465e0b2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="soph-20251231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_019c4318-5179-7a59-b02e-1cf799630a44" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_019c4318-5179-7e43-9d4b-57b38db28910" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_019c4318-5179-7a59-b02e-1cf799630a44" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_019c4318-5179-7e43-9d4b-57b38db28910" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_019c4318-5179-7364-beb0-8943f951ac8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_019c4318-5179-7a59-b02e-1cf799630a44" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_019c4318-5179-7364-beb0-8943f951ac8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_019c4318-5179-7031-9775-5cc1f67ce423" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_019c4318-5179-7a59-b02e-1cf799630a44" xlink:to="loc_ifrs-full_RightofuseAssets_019c4318-5179-7031-9775-5cc1f67ce423" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_019c4318-5179-7c26-95f8-83e3f1352432" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_019c4318-5179-7a59-b02e-1cf799630a44" xlink:to="loc_ifrs-full_NetDeferredTaxAssets_019c4318-5179-7c26-95f8-83e3f1352432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_019c4318-5179-7527-928f-8fc810f5724b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets_019c4318-5179-7a59-b02e-1cf799630a44" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_019c4318-5179-7527-928f-8fc810f5724b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_019c4318-5179-789e-9df5-005b3bbda5e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019c4318-5179-7c31-810d-b17c4c5d7738" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_019c4318-5179-789e-9df5-005b3bbda5e8" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019c4318-5179-7c31-810d-b17c4c5d7738" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_019c4318-5179-73eb-913e-7468b7c394bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_019c4318-5179-789e-9df5-005b3bbda5e8" xlink:to="loc_ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents_019c4318-5179-73eb-913e-7468b7c394bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_019c4318-5179-7fce-bd98-6fe6a5244ff3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_019c4318-5179-789e-9df5-005b3bbda5e8" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_019c4318-5179-7fce-bd98-6fe6a5244ff3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_019c4318-5179-7010-bd9f-b832565ba05d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_019c4318-5179-789e-9df5-005b3bbda5e8" xlink:to="loc_ifrs-full_Inventories_019c4318-5179-7010-bd9f-b832565ba05d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-5179-7d9d-86b3-186fa48ff705" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets_019c4318-5179-789e-9df5-005b3bbda5e8" xlink:to="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-5179-7d9d-86b3-186fa48ff705" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities_019c4318-5179-7282-b9f6-d6f2527e31a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_019c4318-5179-71aa-9c5f-ed811b969c6a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_019c4318-5179-7282-b9f6-d6f2527e31a1" xlink:to="loc_ifrs-full_CurrentLiabilities_019c4318-5179-71aa-9c5f-ed811b969c6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_019c4318-5179-7438-b3c2-da62b3686b31" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Liabilities_019c4318-5179-7282-b9f6-d6f2527e31a1" xlink:to="loc_ifrs-full_NoncurrentLiabilities_019c4318-5179-7438-b3c2-da62b3686b31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_019c4318-5179-71d2-81f4-d74bfbb51630" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-5179-74ff-90bb-b55c23bf7070" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_019c4318-5179-71d2-81f4-d74bfbb51630" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-5179-74ff-90bb-b55c23bf7070" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentAccruedExpenses_019c4318-5179-7eb5-a46f-463779530322" xlink:href="soph-20251231.xsd#soph_CurrentAccruedExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_019c4318-5179-71d2-81f4-d74bfbb51630" xlink:to="loc_soph_CurrentAccruedExpenses_019c4318-5179-7eb5-a46f-463779530322" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_019c4318-5179-72fc-b9fe-b2f80128ab0a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_019c4318-5179-71d2-81f4-d74bfbb51630" xlink:to="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_019c4318-5179-72fc-b9fe-b2f80128ab0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_019c4318-5179-72a7-a163-575eaa349d07" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_019c4318-5179-71d2-81f4-d74bfbb51630" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_019c4318-5179-72a7-a163-575eaa349d07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentWarrantLiability_019c4318-5179-73e2-ae46-0e6d15490b4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities_019c4318-5179-71d2-81f4-d74bfbb51630" xlink:to="loc_ifrs-full_CurrentWarrantLiability_019c4318-5179-73e2-ae46-0e6d15490b4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019c4318-5179-7892-84b7-d5eb997cf42b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_019c4318-5179-72f1-9dba-7fa43cc3a322" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_019c4318-5179-7892-84b7-d5eb997cf42b" xlink:to="loc_ifrs-full_IssuedCapital_019c4318-5179-72f1-9dba-7fa43cc3a322" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremium_019c4318-5179-7b9c-a7f6-edd457bbd0e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_019c4318-5179-7892-84b7-d5eb997cf42b" xlink:to="loc_ifrs-full_SharePremium_019c4318-5179-7b9c-a7f6-edd457bbd0e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves_019c4318-5179-79f9-9c34-b1963a26b426" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_019c4318-5179-7892-84b7-d5eb997cf42b" xlink:to="loc_ifrs-full_OtherReserves_019c4318-5179-79f9-9c34-b1963a26b426" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarnings_019c4318-5179-740e-92f6-3ac0e84a07ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_019c4318-5179-7892-84b7-d5eb997cf42b" xlink:to="loc_ifrs-full_RetainedEarnings_019c4318-5179-740e-92f6-3ac0e84a07ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasuryShares_019c4318-5179-76c2-8875-e9f66751167b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasuryShares"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity_019c4318-5179-7892-84b7-d5eb997cf42b" xlink:to="loc_ifrs-full_TreasuryShares_019c4318-5179-76c2-8875-e9f66751167b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities_019c4318-5179-7320-aae8-830505a8e325" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities_019c4318-5179-7610-8964-0d63ea292e93" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_019c4318-5179-7320-aae8-830505a8e325" xlink:to="loc_ifrs-full_Liabilities_019c4318-5179-7610-8964-0d63ea292e93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019c4318-5179-7532-8cef-400753ccbe46" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities_019c4318-5179-7320-aae8-830505a8e325" xlink:to="loc_ifrs-full_Equity_019c4318-5179-7532-8cef-400753ccbe46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_019c4318-5179-70d0-ae86-6ba70dc4326a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_019c4318-5179-7928-8019-fefd40e9ea80" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_019c4318-5179-70d0-ae86-6ba70dc4326a" xlink:to="loc_ifrs-full_CurrentAssets_019c4318-5179-7928-8019-fefd40e9ea80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_019c4318-5179-7edb-9b54-0ab3cefcf327" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets_019c4318-5179-70d0-ae86-6ba70dc4326a" xlink:to="loc_ifrs-full_NoncurrentAssets_019c4318-5179-7edb-9b54-0ab3cefcf327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_019c4318-5179-774f-858d-9ac280e0031b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_019c4318-5179-7d93-98ec-f3cc63c504db" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_019c4318-5179-774f-858d-9ac280e0031b" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_019c4318-5179-7d93-98ec-f3cc63c504db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_019c4318-5179-78b7-8ef9-60806319518d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_019c4318-5179-774f-858d-9ac280e0031b" xlink:to="loc_ifrs-full_LongtermBorrowings_019c4318-5179-78b7-8ef9-60806319518d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_019c4318-5179-7269-97a8-62883d26e322" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_019c4318-5179-774f-858d-9ac280e0031b" xlink:to="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_019c4318-5179-7269-97a8-62883d26e322" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_019c4318-5179-73cc-be2c-a9fc44a01827" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities_019c4318-5179-774f-858d-9ac280e0031b" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_019c4318-5179-73cc-be2c-a9fc44a01827" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="soph-20251231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c4318-5179-7192-bec6-4505394f2306" xlink:href="soph-20251231.xsd#soph_AdjustmentsForFairValueOfWarrantLiability"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c4318-5179-7192-bec6-4505394f2306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForFinanceExpenseIncomeNet_019c4318-5179-7911-b21b-e33b3231c2bb" xlink:href="soph-20251231.xsd#soph_AdjustmentsForFinanceExpenseIncomeNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_soph_AdjustmentsForFinanceExpenseIncomeNet_019c4318-5179-7911-b21b-e33b3231c2bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_019c4318-5179-742c-98e4-4ca3d7116e22" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_019c4318-5179-742c-98e4-4ca3d7116e22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_019c4318-5179-7012-b9ed-b55944471188" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_019c4318-5179-7012-b9ed-b55944471188" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_019c4318-5179-7507-b29c-f79718bc1b33" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_019c4318-5179-7507-b29c-f79718bc1b33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GainLossOnDisposalOfLeaseLiability_019c4318-5179-7b95-aef1-ae274fe8cfd5" xlink:href="soph-20251231.xsd#soph_GainLossOnDisposalOfLeaseLiability"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_soph_GainLossOnDisposalOfLeaseLiability_019c4318-5179-7b95-aef1-ae274fe8cfd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_019c4318-5179-7599-9834-febdb8ac8264" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_019c4318-5179-7599-9834-febdb8ac8264" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_019c4318-5179-7a7a-8c40-8ca4229793fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_019c4318-5179-7a7a-8c40-8ca4229793fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-7c4b-93f5-8c48c6763557" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-7c4b-93f5-8c48c6763557" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_019c4318-5179-7964-ac00-b4587a7cdd09" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_019c4318-5179-7964-ac00-b4587a7cdd09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForResearchTaxCredit_019c4318-5179-7eda-95b4-df19373a30a1" xlink:href="soph-20251231.xsd#soph_AdjustmentsForResearchTaxCredit"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_soph_AdjustmentsForResearchTaxCredit_019c4318-5179-7eda-95b4-df19373a30a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForCreditLossAllowance_019c4318-5179-7e3e-b979-790f1b90a75f" xlink:href="soph-20251231.xsd#soph_AdjustmentsForCreditLossAllowance"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_soph_AdjustmentsForCreditLossAllowance_019c4318-5179-7e3e-b979-790f1b90a75f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_019c4318-5179-7679-b6b6-bd18c6259ceb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationExpense_019c4318-5179-7679-b6b6-bd18c6259ceb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_019c4318-5179-70bf-bb3d-705606dadd61" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_019c4318-5179-70bf-bb3d-705606dadd61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationExpense_019c4318-5179-7c40-917e-d1bd6a568cf7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationExpense"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-71f5-b649-54ee3f8e11f2" xlink:to="loc_ifrs-full_AmortisationExpense_019c4318-5179-7c40-917e-d1bd6a568cf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_019c4318-5179-70a2-8287-2d1d9fb65c1d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5179-7ee2-a8fa-f45b5b77dc67" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_019c4318-5179-70a2-8287-2d1d9fb65c1d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5179-7ee2-a8fa-f45b5b77dc67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-5179-7254-84a6-898c393017e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_019c4318-5179-70a2-8287-2d1d9fb65c1d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-5179-7254-84a6-898c393017e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c4318-5179-7776-947d-7c8be42f06b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_019c4318-5179-70a2-8287-2d1d9fb65c1d" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c4318-5179-7776-947d-7c8be42f06b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5179-7a50-8177-5a6c87845b82" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_019c4318-5179-745a-986f-3207bc91f62d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5179-7a50-8177-5a6c87845b82" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_019c4318-5179-745a-986f-3207bc91f62d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_019c4318-5179-7ee1-8e67-7ec68d283f88" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5179-7a50-8177-5a6c87845b82" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_019c4318-5179-7ee1-8e67-7ec68d283f88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CapitalizedSoftwareDevelopmentCosts_019c4318-5179-7eaf-bde6-841264ed5bac" xlink:href="soph-20251231.xsd#soph_CapitalizedSoftwareDevelopmentCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5179-7a50-8177-5a6c87845b82" xlink:to="loc_soph_CapitalizedSoftwareDevelopmentCosts_019c4318-5179-7eaf-bde6-841264ed5bac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_019c4318-5179-74af-8bba-ae722fc7d484" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5179-7a50-8177-5a6c87845b82" xlink:to="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_019c4318-5179-74af-8bba-ae722fc7d484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_019c4318-5179-7329-9ea0-9b93bd60596c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5179-7a50-8177-5a6c87845b82" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_019c4318-5179-7329-9ea0-9b93bd60596c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_019c66b9-b12a-7a79-b2b3-a2ae6666810f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5179-7a50-8177-5a6c87845b82" xlink:to="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_019c66b9-b12a-7a79-b2b3-a2ae6666810f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c4318-5179-7b1f-9011-dbbe931a39d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-75a1-a7af-723bd367c566" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c4318-5179-7b1f-9011-dbbe931a39d5" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-75a1-a7af-723bd367c566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_019c4318-5179-74a4-935e-7b59a135cc24" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c4318-5179-7b1f-9011-dbbe931a39d5" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_019c4318-5179-74a4-935e-7b59a135cc24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-5179-7973-b725-d1aaf241cf4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_019c4318-5179-7770-87ab-01e711d1d4a5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-5179-7973-b725-d1aaf241cf4c" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_019c4318-5179-7770-87ab-01e711d1d4a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_019c4318-5179-7f6e-a8e9-a8e4f973867f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-5179-7973-b725-d1aaf241cf4c" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_019c4318-5179-7f6e-a8e9-a8e4f973867f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_019c4318-5179-7e5f-881d-fe4bafc4acc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-5179-7973-b725-d1aaf241cf4c" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_019c4318-5179-7e5f-881d-fe4bafc4acc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_019c66bd-5b28-7196-94f9-aa214d5c2bb6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-5179-7973-b725-d1aaf241cf4c" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_019c66bd-5b28-7196-94f9-aa214d5c2bb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_019c66bd-5b28-7f1c-a7a5-5334642c90b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-5179-7973-b725-d1aaf241cf4c" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_019c66bd-5b28-7f1c-a7a5-5334642c90b8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpense_019c4318-517a-7603-a562-09220d547a02" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_019c4318-517a-7ec6-ac3d-1052a26588de" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnOtherFinancialLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_InterestExpense_019c4318-517a-7603-a562-09220d547a02" xlink:to="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_019c4318-517a-7ec6-ac3d-1052a26588de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_019c4318-517a-7019-91f3-a10754f646ca" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_InterestExpense_019c4318-517a-7603-a562-09220d547a02" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_019c4318-517a-7019-91f3-a10754f646ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts_019c4318-517a-756f-9f17-288734c4a00f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBankLoansAndOverdrafts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_InterestExpense_019c4318-517a-7603-a562-09220d547a02" xlink:to="loc_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts_019c4318-517a-756f-9f17-288734c4a00f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_019c4318-517a-7b56-911f-b50878c2aa11" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_019c4318-517a-7880-b1c5-f6f987b23667" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_019c4318-517a-7b56-911f-b50878c2aa11" xlink:to="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_019c4318-517a-7880-b1c5-f6f987b23667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_019c4318-517a-7c74-a77d-bf86f33603ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_019c4318-517a-7b56-911f-b50878c2aa11" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_019c4318-517a-7c74-a77d-bf86f33603ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_019c4318-517a-7722-bcb2-7bd726d522a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_019c4318-517a-7624-b30b-a9fa687554c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome_019c4318-517a-7722-bcb2-7bd726d522a3" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_019c4318-517a-7624-b30b-a9fa687554c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-70a5-a24b-82f5121810c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_019c4318-517a-7447-aba0-4c1b63826378" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-70a5-a24b-82f5121810c0" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_019c4318-517a-7447-aba0-4c1b63826378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_019c4318-517a-77b9-8460-75fb15a99ef4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-70a5-a24b-82f5121810c0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_019c4318-517a-77b9-8460-75fb15a99ef4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-722a-82de-4a0225a263ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_019c4318-517a-7966-bbed-64139d61416a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-722a-82de-4a0225a263ea" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_019c4318-517a-7966-bbed-64139d61416a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_019c4318-517a-71f3-b6f8-d510643450c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-722a-82de-4a0225a263ea" xlink:to="loc_ifrs-full_TaxEffectOfForeignTaxRates_019c4318-517a-71f3-b6f8-d510643450c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_019c4318-517a-7d79-9d8a-c6b34e24b29b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-722a-82de-4a0225a263ea" xlink:to="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_019c4318-517a-7d79-9d8a-c6b34e24b29b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss_019c4318-517a-7e49-be31-1c3733e1a011" xlink:href="soph-20251231.xsd#soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-722a-82de-4a0225a263ea" xlink:to="loc_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss_019c4318-517a-7e49-be31-1c3733e1a011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_019c4318-517a-7509-ba67-ae3d55b0ac10" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-722a-82de-4a0225a263ea" xlink:to="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_019c4318-517a-7509-ba67-ae3d55b0ac10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_019c4318-517a-7b2e-b127-243d603a2011" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-722a-82de-4a0225a263ea" xlink:to="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_019c4318-517a-7b2e-b127-243d603a2011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense_019c4318-517a-79c2-b677-4dfc5ed0c672" xlink:href="soph-20251231.xsd#soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-722a-82de-4a0225a263ea" xlink:to="loc_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense_019c4318-517a-79c2-b677-4dfc5ed0c672" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxSummaryofNetOperatingLossCarryforwardsDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwards_019c4318-517a-7927-a6d5-c4229c6b1b86" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearOne_019c4318-517a-7666-95d4-d9f623783a78" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearOne"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_NetOperatingLossCarryforwards_019c4318-517a-7927-a6d5-c4229c6b1b86" xlink:to="loc_soph_NetOperatingLossCarryforwardsYearOne_019c4318-517a-7666-95d4-d9f623783a78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearTwo_019c4318-517a-7fe9-a72a-7933e78e2fd4" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_NetOperatingLossCarryforwards_019c4318-517a-7927-a6d5-c4229c6b1b86" xlink:to="loc_soph_NetOperatingLossCarryforwardsYearTwo_019c4318-517a-7fe9-a72a-7933e78e2fd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearFour_019c4318-517a-76a1-917c-165093f9ea00" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_NetOperatingLossCarryforwards_019c4318-517a-7927-a6d5-c4229c6b1b86" xlink:to="loc_soph_NetOperatingLossCarryforwardsYearFour_019c4318-517a-76a1-917c-165093f9ea00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearThree_019c4318-517a-7342-bc2f-43f3d3418ebf" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_NetOperatingLossCarryforwards_019c4318-517a-7927-a6d5-c4229c6b1b86" xlink:to="loc_soph_NetOperatingLossCarryforwardsYearThree_019c4318-517a-7342-bc2f-43f3d3418ebf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsThereafter_019c4318-517a-7646-b2ac-7e24f29a5217" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsThereafter"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_NetOperatingLossCarryforwards_019c4318-517a-7927-a6d5-c4229c6b1b86" xlink:to="loc_soph_NetOperatingLossCarryforwardsThereafter_019c4318-517a-7646-b2ac-7e24f29a5217" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CashandcashequivalentsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#CashandcashequivalentsDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/CashandcashequivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash_019c4318-517a-740a-b919-aeda1b24358d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Cash"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BalancesWithBanks_019c4318-517a-7351-b9f0-332eb6610cc6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BalancesWithBanks"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Cash_019c4318-517a-740a-b919-aeda1b24358d" xlink:to="loc_ifrs-full_BalancesWithBanks_019c4318-517a-7351-b9f0-332eb6610cc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019c4318-517a-7734-bd59-67cd2b61e1ac" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash_019c4318-517a-7c71-a10c-22daa2cf32aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Cash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_019c4318-517a-7734-bd59-67cd2b61e1ac" xlink:to="loc_ifrs-full_Cash_019c4318-517a-7c71-a10c-22daa2cf32aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents_019c4318-517a-7c91-89aa-3d21b1edb163" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashAndCashEquivalents_019c4318-517a-7734-bd59-67cd2b61e1ac" xlink:to="loc_ifrs-full_CashEquivalents_019c4318-517a-7c91-89aa-3d21b1edb163" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents_019c4318-517a-7042-aab0-8a871f5cb5d5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_019c4318-517a-729a-afb7-360b68cf8f49" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashEquivalents_019c4318-517a-7042-aab0-8a871f5cb5d5" xlink:to="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_019c4318-517a-729a-afb7-360b68cf8f49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_019c4318-517a-7965-b95c-5e04bfad67e8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CashEquivalents_019c4318-517a-7042-aab0-8a871f5cb5d5" xlink:to="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_019c4318-517a-7965-b95c-5e04bfad67e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#InventorySummaryofInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_019c4318-517a-75d2-b72b-161443c758f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RawMaterials_019c4318-517a-70f9-9c9b-b34693d14ab7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_019c4318-517a-75d2-b72b-161443c758f2" xlink:to="loc_ifrs-full_RawMaterials_019c4318-517a-70f9-9c9b-b34693d14ab7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WorkInProgress_019c4318-517a-79d4-a3a5-88bd5ec1527c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WorkInProgress"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_019c4318-517a-75d2-b72b-161443c758f2" xlink:to="loc_ifrs-full_WorkInProgress_019c4318-517a-79d4-a3a5-88bd5ec1527c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinishedGoods_019c4318-517a-76cf-8957-7374ab6f3b06" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_019c4318-517a-75d2-b72b-161443c758f2" xlink:to="loc_ifrs-full_FinishedGoods_019c4318-517a-76cf-8957-7374ab6f3b06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProvisionOfInventory_019c4318-517a-767b-a5bf-764bbd52d4bc" xlink:href="soph-20251231.xsd#soph_ProvisionOfInventory"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_Inventories_019c4318-517a-75d2-b72b-161443c758f2" xlink:to="loc_soph_ProvisionOfInventory_019c4318-517a-767b-a5bf-764bbd52d4bc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PrepaidsandothercurrentassetsDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-517a-75a3-a8d4-27e03e477122" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepayments_019c4318-517a-703c-bf25-c4eedc95d53c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepayments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-517a-75a3-a8d4-27e03e477122" xlink:to="loc_ifrs-full_CurrentPrepayments_019c4318-517a-703c-bf25-c4eedc95d53c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables_019c4318-517a-7209-8f33-5d78dd92d0db" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-517a-75a3-a8d4-27e03e477122" xlink:to="loc_ifrs-full_CurrentValueAddedTaxReceivables_019c4318-517a-7209-8f33-5d78dd92d0db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentGovernmentGrantsReceivable_019c4318-517a-76a7-a990-81d001d0d07b" xlink:href="soph-20251231.xsd#soph_CurrentGovernmentGrantsReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-517a-75a3-a8d4-27e03e477122" xlink:to="loc_soph_CurrentGovernmentGrantsReceivable_019c4318-517a-76a7-a990-81d001d0d07b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentContractAcquisitionCosts_019c4318-517a-772f-b2ff-834f8133fed8" xlink:href="soph-20251231.xsd#soph_CurrentContractAcquisitionCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-517a-75a3-a8d4-27e03e477122" xlink:to="loc_soph_CurrentContractAcquisitionCosts_019c4318-517a-772f-b2ff-834f8133fed8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentOtherAssetsMiscellaneous_019c6753-8212-73e0-8cb0-c290b99e907a" xlink:href="soph-20251231.xsd#soph_CurrentOtherAssetsMiscellaneous"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-517a-75a3-a8d4-27e03e477122" xlink:to="loc_soph_CurrentOtherAssetsMiscellaneous_019c6753-8212-73e0-8cb0-c290b99e907a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#LeasesSummaryofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_019c89ba-4f59-7a11-918f-dfbf9faf8216" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_019c89ba-4f59-791f-9427-4412915f7fbe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_LeaseLiabilities_019c89ba-4f59-7a11-918f-dfbf9faf8216" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_019c89ba-4f59-791f-9427-4412915f7fbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_019c89ba-4f59-7b9b-86d1-0c046f7775aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_LeaseLiabilities_019c89ba-4f59-7a11-918f-dfbf9faf8216" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_019c89ba-4f59-7b9b-86d1-0c046f7775aa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#OthernoncurrentassetsDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_019c4318-522c-78fa-8434-c2b3309e9c38" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentValueAddedTaxReceivables_019c4318-522c-77a4-9129-4f3fad2eb387" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentValueAddedTaxReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_019c4318-522c-78fa-8434-c2b3309e9c38" xlink:to="loc_ifrs-full_NoncurrentValueAddedTaxReceivables_019c4318-522c-77a4-9129-4f3fad2eb387" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NonCurrentDepositsGuarantyAssets_019c4318-522c-785f-9d25-4936da100566" xlink:href="soph-20251231.xsd#soph_NonCurrentDepositsGuarantyAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_019c4318-522c-78fa-8434-c2b3309e9c38" xlink:to="loc_soph_NonCurrentDepositsGuarantyAssets_019c4318-522c-785f-9d25-4936da100566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_019c677d-abb8-7489-bb0f-518fc536fff5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_019c4318-522c-78fa-8434-c2b3309e9c38" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_019c677d-abb8-7489-bb0f-518fc536fff5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NonCurrentContractAcquisitionCosts_019c677d-abb8-7bb8-984e-8f4adb21c384" xlink:href="soph-20251231.xsd#soph_NonCurrentContractAcquisitionCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets_019c4318-522c-78fa-8434-c2b3309e9c38" xlink:to="loc_soph_NonCurrentContractAcquisitionCosts_019c677d-abb8-7bb8-984e-8f4adb21c384" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccountspayableDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#AccountspayableDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/AccountspayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-522c-7625-8e40-2263c340966b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_EmployeeRelatedPayables_019c4318-522c-7fe9-93f9-1c5836ef6ad3" xlink:href="soph-20251231.xsd#soph_EmployeeRelatedPayables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-522c-7625-8e40-2263c340966b" xlink:to="loc_soph_EmployeeRelatedPayables_019c4318-522c-7fe9-93f9-1c5836ef6ad3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables_019c4318-522c-7b4f-bac8-ce2fac0a9885" xlink:href="soph-20251231.xsd#soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-522c-7625-8e40-2263c340966b" xlink:to="loc_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables_019c4318-522c-7b4f-bac8-ce2fac0a9885" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_019c4318-522c-7db2-9523-435070cf6b2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-522c-7625-8e40-2263c340966b" xlink:to="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_019c4318-522c-7db2-9523-435070cf6b2d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccruedexpensesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#AccruedexpensesDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/AccruedexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentAccruedExpenses_019c4318-522c-7651-9bec-16e23c5a8580" xlink:href="soph-20251231.xsd#soph_CurrentAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedOther_019c4318-522c-7d31-96c3-138fefeb3e8d" xlink:href="soph-20251231.xsd#soph_AccruedOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_CurrentAccruedExpenses_019c4318-522c-7651-9bec-16e23c5a8580" xlink:to="loc_soph_AccruedOther_019c4318-522c-7d31-96c3-138fefeb3e8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedInventoryPurchases_019c4318-522c-73e6-bf9e-b14400df45c9" xlink:href="soph-20251231.xsd#soph_AccruedInventoryPurchases"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_CurrentAccruedExpenses_019c4318-522c-7651-9bec-16e23c5a8580" xlink:to="loc_soph_AccruedInventoryPurchases_019c4318-522c-73e6-bf9e-b14400df45c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedProfessionalFees_019c4318-522c-7abc-b5d4-b149c8a1d795" xlink:href="soph-20251231.xsd#soph_AccruedProfessionalFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_CurrentAccruedExpenses_019c4318-522c-7651-9bec-16e23c5a8580" xlink:to="loc_soph_AccruedProfessionalFees_019c4318-522c-7abc-b5d4-b149c8a1d795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedITSupport_019c4318-522c-76b5-a785-468136accbeb" xlink:href="soph-20251231.xsd#soph_AccruedITSupport"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_CurrentAccruedExpenses_019c4318-522c-7651-9bec-16e23c5a8580" xlink:to="loc_soph_AccruedITSupport_019c4318-522c-76b5-a785-468136accbeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedLegalFees_019c4318-522c-72ff-aa76-7bf656f7f2ff" xlink:href="soph-20251231.xsd#soph_AccruedLegalFees"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_CurrentAccruedExpenses_019c4318-522c-7651-9bec-16e23c5a8580" xlink:to="loc_soph_AccruedLegalFees_019c4318-522c-72ff-aa76-7bf656f7f2ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedCompensation_019c4318-522c-7744-b07d-d93b01bf9637" xlink:href="soph-20251231.xsd#soph_AccruedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_CurrentAccruedExpenses_019c4318-522c-7651-9bec-16e23c5a8580" xlink:to="loc_soph_AccruedCompensation_019c4318-522c-7744-b07d-d93b01bf9637" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SurplusDeficitInPlan_019c4318-522c-7566-be5a-d5ea02819cef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SurplusDeficitInPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-522c-7fd4-80b5-ae3e7e6fd394" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SurplusDeficitInPlan_019c4318-522c-7566-be5a-d5ea02819cef" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-522c-7fd4-80b5-ae3e7e6fd394" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_019c4318-522c-751c-a022-3ad7b5793472" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_SurplusDeficitInPlan_019c4318-522c-7566-be5a-d5ea02819cef" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_019c4318-522c-751c-a022-3ad7b5793472" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_019cb022-ae2b-7bf2-b20c-d6b4a93a0626" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_019cb022-ae2b-77d7-8e1e-3e7ae0014479" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_PlanAssetsAtFairValue_019cb022-ae2b-7bf2-b20c-d6b4a93a0626" xlink:to="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_019cb022-ae2b-77d7-8e1e-3e7ae0014479" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets_019cb022-ae2b-7506-8a9a-1fa84fbd95c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_PlanAssetsAtFairValue_019cb022-ae2b-7bf2-b20c-d6b4a93a0626" xlink:to="loc_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets_019cb022-ae2b-7506-8a9a-1fa84fbd95c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_019c4318-522c-71cf-8145-88d51b2858ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ServiceCostDefinedBenefitPlans_019c4318-522c-7703-97a1-31374b2da6fd" xlink:href="soph-20251231.xsd#soph_ServiceCostDefinedBenefitPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_019c4318-522c-71cf-8145-88d51b2858ec" xlink:to="loc_soph_ServiceCostDefinedBenefitPlans_019c4318-522c-7703-97a1-31374b2da6fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans_019c4318-522c-7f83-b12a-6ecab1eb60a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseIncomeDefinedBenefitPlans"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_019c4318-522c-71cf-8145-88d51b2858ec" xlink:to="loc_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans_019c4318-522c-7f83-b12a-6ecab1eb60a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-522c-7094-943f-2ef3fd5a528f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_019c4318-522c-790e-8d0e-577e8d1c5bb2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-522c-7094-943f-2ef3fd5a528f" xlink:to="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_019c4318-522c-790e-8d0e-577e8d1c5bb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans_019c4318-522c-7f97-8db7-a42054f502be" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-522c-7094-943f-2ef3fd5a528f" xlink:to="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans_019c4318-522c-7f97-8db7-a42054f502be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-74c5-8082-f32377047754" xlink:href="soph-20251231.xsd#soph_ActuarialGainsLossesNetDefinedBenefitPlans"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-522c-7094-943f-2ef3fd5a528f" xlink:to="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-74c5-8082-f32377047754" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7cdb-8144-ea29cdc9b454" xlink:href="soph-20251231.xsd#soph_ActuarialGainsLossesNetDefinedBenefitPlans"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7139-a6f1-748514ef576c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7cdb-8144-ea29cdc9b454" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7139-a6f1-748514ef576c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_019c4318-522c-7a3e-8ece-8f3972be1464" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7cdb-8144-ea29cdc9b454" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_019c4318-522c-7a3e-8ece-8f3972be1464" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7c4a-8d4d-ebab0b855922" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7cdb-8144-ea29cdc9b454" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7c4a-8d4d-ebab0b855922" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowingsNetOfCostsIncurred_019c81fd-0242-7606-8685-3a78a6e72a08" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowingsNetOfCostsIncurred"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowings_019c81fd-0242-7458-8a91-423249f5765a" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_ProceedsFromBorrowingsNetOfCostsIncurred_019c81fd-0242-7606-8685-3a78a6e72a08" xlink:to="loc_soph_ProceedsFromBorrowings_019c81fd-0242-7458-8a91-423249f5765a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingCostsIncurred_019c81fd-0242-7a81-95e4-598a19f14672" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingCostsIncurred"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_ProceedsFromBorrowingsNetOfCostsIncurred_019c81fd-0242-7606-8685-3a78a6e72a08" xlink:to="loc_ifrs-full_BorrowingCostsIncurred_019c81fd-0242-7a81-95e4-598a19f14672" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_019c4318-522d-7656-9982-6fbdf6312b52" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_019c4318-522d-7b03-b081-2724c44dd6f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_019c4318-522d-7656-9982-6fbdf6312b52" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_019c4318-522d-7b03-b081-2724c44dd6f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_019c4318-522d-71a4-8f7c-dcd9b2ffcce8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_019c4318-522d-7656-9982-6fbdf6312b52" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_019c4318-522d-71a4-8f7c-dcd9b2ffcce8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_019c4318-522d-75d8-8e23-33132e8594eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation_019c4318-522d-7656-9982-6fbdf6312b52" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_019c4318-522d-75d8-8e23-33132e8594eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"/>
  <link:calculationLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_ContractualLiabilitiesUndiscountedCashFlows_019c4318-522d-771a-ac64-d721e67bc266" xlink:href="soph-20251231.xsd#soph_ContractualLiabilitiesUndiscountedCashFlows"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_019c4318-522d-793a-86be-b990bd940f17" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossLeaseLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_ContractualLiabilitiesUndiscountedCashFlows_019c4318-522d-771a-ac64-d721e67bc266" xlink:to="loc_ifrs-full_GrossLeaseLiabilities_019c4318-522d-793a-86be-b990bd940f17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_019c4318-522d-7be2-a1f7-134e4dcff327" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_ContractualLiabilitiesUndiscountedCashFlows_019c4318-522d-771a-ac64-d721e67bc266" xlink:to="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_019c4318-522d-7be2-a1f7-134e4dcff327" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedExpensesUndiscountedCashFlows_019c4318-522d-7ce2-be54-af23ec7b4709" xlink:href="soph-20251231.xsd#soph_AccruedExpensesUndiscountedCashFlows"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_ContractualLiabilitiesUndiscountedCashFlows_019c4318-522d-771a-ac64-d721e67bc266" xlink:to="loc_soph_AccruedExpensesUndiscountedCashFlows_019c4318-522d-7ce2-be54-af23ec7b4709" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_019c4318-522d-74e3-8725-3e98ae398068" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_soph_ContractualLiabilitiesUndiscountedCashFlows_019c4318-522d-771a-ac64-d721e67bc266" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_019c4318-522d-74e3-8725-3e98ae398068" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>soph-20251231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c4318-4e70-7eba-b516-6c06258ef00a,g:b3ab9529-65b6-4117-b100-6d41f692b5c5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CoverPage" xlink:type="simple" xlink:href="soph-20251231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_019c4318-5179-7113-8165-67f7b6f10b87" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentInformationTable_019c4318-5179-7113-8165-67f7b6f10b87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_019c4318-5179-7fa5-964d-8e3164687908" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_019c4318-5179-7113-8165-67f7b6f10b87" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_019c4318-5179-7fa5-964d-8e3164687908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_019c4318-5179-7fa5-964d-8e3164687908_default" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_019c4318-5179-7fa5-964d-8e3164687908" xlink:to="loc_dei_AddressTypeDomain_019c4318-5179-7fa5-964d-8e3164687908_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_019c4318-5179-7003-b574-0d6e2b17eb8d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_019c4318-5179-7fa5-964d-8e3164687908" xlink:to="loc_dei_AddressTypeDomain_019c4318-5179-7003-b574-0d6e2b17eb8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_019c4318-5179-72ee-ae18-f31e3a55e327" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_BusinessContactMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_019c4318-5179-7003-b574-0d6e2b17eb8d" xlink:to="loc_dei_BusinessContactMember_019c4318-5179-72ee-ae18-f31e3a55e327" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019c4318-5179-7eec-a5cc-056ff9443599" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentType_019c4318-5179-7eec-a5cc-056ff9443599" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_019c4318-5179-7621-99a4-5aad13dbb637" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentRegistrationStatement_019c4318-5179-7621-99a4-5aad13dbb637" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_019c4318-5179-7b20-a2f6-b345d5591e58" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentAnnualReport_019c4318-5179-7b20-a2f6-b345d5591e58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019c4318-5179-75e3-951f-3d46ca791fe4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentPeriodEndDate_019c4318-5179-75e3-951f-3d46ca791fe4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019c4318-5179-737a-9653-70b2bf0d5679" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_CurrentFiscalYearEndDate_019c4318-5179-737a-9653-70b2bf0d5679" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019c4318-5179-77f4-9927-8d750dfc3249" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentTransitionReport_019c4318-5179-77f4-9927-8d750dfc3249" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_019c4318-5179-7e3a-89a5-be308baa5115" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentShellCompanyReport_019c4318-5179-7e3a-89a5-be308baa5115" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019c4318-5179-7af1-8c4a-07654a25ae05" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityFileNumber_019c4318-5179-7af1-8c4a-07654a25ae05" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019c4318-5179-7eb5-9b85-1516a5b55f51" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityRegistrantName_019c4318-5179-7eb5-9b85-1516a5b55f51" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019c4318-5179-7063-a13a-1f2bc7e1efe1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019c4318-5179-7063-a13a-1f2bc7e1efe1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019c4318-5179-73fe-a54d-72664b14a925" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressAddressLine1_019c4318-5179-73fe-a54d-72664b14a925" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_019c4318-5179-7457-92d0-942e0e5eaaa7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressAddressLine2_019c4318-5179-7457-92d0-942e0e5eaaa7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019c4318-5179-7ea4-a8f1-221fd735d1d7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressPostalZipCode_019c4318-5179-7ea4-a8f1-221fd735d1d7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019c4318-5179-7fcb-817f-695161f94e5b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressCityOrTown_019c4318-5179-7fcb-817f-695161f94e5b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_019c4318-5179-75ce-b52a-c24783f8ddf3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressCountry_019c4318-5179-75ce-b52a-c24783f8ddf3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_019c4318-5179-70a7-9d25-0d5f97d69d91" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ContactPersonnelName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_ContactPersonnelName_019c4318-5179-70a7-9d25-0d5f97d69d91" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019c4318-5179-73ad-b571-4b061ba6972c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressStateOrProvince_019c4318-5179-73ad-b571-4b061ba6972c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019c4318-5179-74da-8c45-9adc35ad2d65" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_CityAreaCode_019c4318-5179-74da-8c45-9adc35ad2d65" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019c4318-5179-7ca6-afcd-fcc70ce8943c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_LocalPhoneNumber_019c4318-5179-7ca6-afcd-fcc70ce8943c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019c4318-5179-7108-be42-309d2922f9d4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_Security12bTitle_019c4318-5179-7108-be42-309d2922f9d4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019c4318-5179-752c-83e7-dee01b04e286" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_TradingSymbol_019c4318-5179-752c-83e7-dee01b04e286" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019c4318-5179-7703-a65e-96ee4b027563" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_SecurityExchangeName_019c4318-5179-7703-a65e-96ee4b027563" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019c4318-5179-7b51-b5a2-a0cf2beb3a71" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019c4318-5179-7b51-b5a2-a0cf2beb3a71" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_019c4318-5179-7e0c-b241-596ba5b992c3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_019c4318-5179-7e0c-b241-596ba5b992c3" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_019c4318-5179-7981-9612-e399fe17860a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityVoluntaryFilers_019c4318-5179-7981-9612-e399fe17860a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019c4318-5179-7930-8e01-7c82fc4900f7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityCurrentReportingStatus_019c4318-5179-7930-8e01-7c82fc4900f7" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019c4318-5179-7a57-91ef-dce578156e5f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityInteractiveDataCurrent_019c4318-5179-7a57-91ef-dce578156e5f" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019c4318-5179-7cde-b8b8-034d713b7885" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityFilerCategory_019c4318-5179-7cde-b8b8-034d713b7885" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019c4318-5179-7bb7-85e7-ec560e5f6f3a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityEmergingGrowthCompany_019c4318-5179-7bb7-85e7-ec560e5f6f3a" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_019c4318-5179-76df-aac7-125ea38e87ab" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityExTransitionPeriod_019c4318-5179-76df-aac7-125ea38e87ab" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_019c4318-5179-72ac-b231-b3f7caf94259" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_IcfrAuditorAttestationFlag_019c4318-5179-72ac-b231-b3f7caf94259" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_019c4318-5179-7470-925e-187d44abd918" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_019c4318-5179-7470-925e-187d44abd918" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_019caf24-4e5c-7deb-be91-e71a7d782235" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_019caf24-4e5c-7deb-be91-e71a7d782235" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_019c4318-5179-74be-a714-5440a7d0fa10" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentAccountingStandard_019c4318-5179-74be-a714-5440a7d0fa10" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019c4318-5179-7f7b-abba-a7382d573c5c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityShellCompany_019c4318-5179-7f7b-abba-a7382d573c5c" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019c4318-5179-7d0d-9517-db323d57e61c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityCentralIndexKey_019c4318-5179-7d0d-9517-db323d57e61c" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019c4318-5179-7cd2-9216-cf06a6c78c75" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentFiscalYearFocus_019c4318-5179-7cd2-9216-cf06a6c78c75" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019c4318-5179-7896-8541-02c27cf75dc0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019c4318-5179-7896-8541-02c27cf75dc0" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019c4318-5179-7066-94f6-74c20b6fb474" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_AmendmentFlag_019c4318-5179-7066-94f6-74c20b6fb474" xlink:type="arc" order="38"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="simple" xlink:href="soph-20251231.xsd#ConsolidatedStatementsofChangesinEquity"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_019c4318-5179-7af8-a791-84c1b57b4514" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_019c4318-5179-7af8-a791-84c1b57b4514" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-7a5e-bf6d-a97893ff9b44" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_019c4318-5179-7af8-a791-84c1b57b4514" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-7a5e-bf6d-a97893ff9b44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-7a5e-bf6d-a97893ff9b44_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-7a5e-bf6d-a97893ff9b44" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-7a5e-bf6d-a97893ff9b44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-7a5e-bf6d-a97893ff9b44" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_019c4318-5179-7255-8b57-acc070c7d206" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:to="loc_ifrs-full_IssuedCapitalMember_019c4318-5179-7255-8b57-acc070c7d206" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasurySharesMember_019c4318-5179-748d-862e-e9272cfbd1c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:to="loc_ifrs-full_TreasurySharesMember_019c4318-5179-748d-862e-e9272cfbd1c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_019c4318-5179-77ac-9bfa-ea792361f8a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:to="loc_ifrs-full_SharePremiumMember_019c4318-5179-77ac-9bfa-ea792361f8a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReservesMember_019c4318-5179-71b7-b046-635c54959334" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReservesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:to="loc_ifrs-full_OtherReservesMember_019c4318-5179-71b7-b046-635c54959334" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember_019c4318-5179-7cfd-8be2-76123183eb99" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:to="loc_ifrs-full_RetainedEarningsMember_019c4318-5179-7cfd-8be2-76123183eb99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_019c4318-5179-7b1d-8f83-8b0c730effc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_NumberOfSharesIssued_019c4318-5179-7b1d-8f83-8b0c730effc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019c4318-5179-706d-a1cf-6b29920cd714" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_Equity_019c4318-5179-706d-a1cf-6b29920cd714" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_019c4318-5179-7003-9332-4544922243cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_ProfitLoss_019c4318-5179-7003-9332-4544922243cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_019c4318-5179-752c-a9dc-93928d363daf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_019c4318-5179-752c-a9dc-93928d363daf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_019c4318-5179-7565-87dc-3deb11669074" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_ComprehensiveIncome_019c4318-5179-7565-87dc-3deb11669074" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019c4318-5179-7f5f-805f-89412074c49b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019c4318-5179-7f5f-805f-89412074c49b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:href="soph-20251231.xsd#soph_TransactionsWithOwnersAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_019c4318-5179-705c-9500-d12edeb8b42c" xlink:href="soph-20251231.xsd#soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_019c4318-5179-705c-9500-d12edeb8b42c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity_019c4318-5179-71bd-9f9d-308a01016a63" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity_019c4318-5179-71bd-9f9d-308a01016a63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfTreasurySharesIssued_019c4318-5179-7056-8810-9e80a15132e2" xlink:href="soph-20251231.xsd#soph_NumberOfTreasurySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_soph_NumberOfTreasurySharesIssued_019c4318-5179-7056-8810-9e80a15132e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SaleOrIssueOfTreasuryShares_019c4318-5179-752d-b975-282ddc2fe327" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SaleOrIssueOfTreasuryShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_ifrs-full_SaleOrIssueOfTreasuryShares_019c4318-5179-752d-b975-282ddc2fe327" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquitySharesIssued_019c66a7-6861-7af8-b152-fc73215ea3c5" xlink:href="soph-20251231.xsd#soph_NumberOfEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_soph_NumberOfEquitySharesIssued_019c66a7-6861-7af8-b152-fc73215ea3c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_019c66a2-68f6-75a7-9656-c0a134582146" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_ifrs-full_IssueOfEquity_019c66a2-68f6-75a7-9656-c0a134582146" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_019c4318-5179-738e-baf8-a36d6cb8124d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019c4318-5179-715b-8325-5cde011fa651" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_019c4318-5179-760c-97d8-ed47bcecad36" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_019c4318-5179-7c6e-a427-c3b2b5d576eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_019c4318-5179-760c-97d8-ed47bcecad36" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_019c4318-5179-7c6e-a427-c3b2b5d576eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c4318-5179-7973-9b3e-31693ea3867d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_019c4318-5179-7c6e-a427-c3b2b5d576eb" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c4318-5179-7973-9b3e-31693ea3867d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-7973-9b3e-31693ea3867d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c4318-5179-7973-9b3e-31693ea3867d" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-7973-9b3e-31693ea3867d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c4318-5179-7973-9b3e-31693ea3867d" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsSASMember_019c4318-5179-7b28-8dd0-2da28a10cb98" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsSASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticsSASMember_019c4318-5179-7b28-8dd0-2da28a10cb98" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticLimitedMember_019c4318-5179-7e09-9be4-efb26308aec5" xlink:href="soph-20251231.xsd#soph_SophiaGeneticLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticLimitedMember_019c4318-5179-7e09-9be4-efb26308aec5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsIncMember_019c4318-5179-77aa-8b21-97cf3a65f4d6" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticsIncMember_019c4318-5179-77aa-8b21-97cf3a65f4d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember_019c4318-5179-727f-9f4b-44c8b5f151ea" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember_019c4318-5179-727f-9f4b-44c8b5f151ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsPtyLtdMember_019c4318-5179-76b8-81f1-129e4f9d2157" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsPtyLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticsPtyLtdMember_019c4318-5179-76b8-81f1-129e4f9d2157" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsSRLMember_019c4318-5179-7b1e-9d44-459b57342879" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsSRLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticsSRLMember_019c4318-5179-7b1e-9d44-459b57342879" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SOPHiAGENETICSGmbHMember_019c66c4-ddfc-7dd9-9fe2-98fd82af5be4" xlink:href="soph-20251231.xsd#soph_SOPHiAGENETICSGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SOPHiAGENETICSGmbHMember_019c66c4-ddfc-7dd9-9fe2-98fd82af5be4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NameOfSubsidiary_019c4318-5179-755c-bd41-3950e23a758a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NameOfSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_019c4318-5179-760c-97d8-ed47bcecad36" xlink:to="loc_ifrs-full_NameOfSubsidiary_019c4318-5179-755c-bd41-3950e23a758a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DomicileOfEntity_019c4318-5179-7281-ae17-a2bb253ab06c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DomicileOfEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_019c4318-5179-760c-97d8-ed47bcecad36" xlink:to="loc_ifrs-full_DomicileOfEntity_019c4318-5179-7281-ae17-a2bb253ab06c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#CompanyinformationandoperationsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-5179-7863-9eda-7b9834e043d2" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-5179-7863-9eda-7b9834e043d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-78bd-a60c-5bf1c0d4f7ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-5179-7863-9eda-7b9834e043d2" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-78bd-a60c-5bf1c0d4f7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-78bd-a60c-5bf1c0d4f7ef_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-78bd-a60c-5bf1c0d4f7ef" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-78bd-a60c-5bf1c0d4f7ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-7638-b261-6922b49ae746" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-78bd-a60c-5bf1c0d4f7ef" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-7638-b261-6922b49ae746" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_019c4318-5179-7f83-9de4-09b0724a175e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-7638-b261-6922b49ae746" xlink:to="loc_ifrs-full_IssuedCapitalMember_019c4318-5179-7f83-9de4-09b0724a175e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasurySharesMember_019c4318-5179-785d-baa3-e919d5314ec7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-7638-b261-6922b49ae746" xlink:to="loc_ifrs-full_TreasurySharesMember_019c4318-5179-785d-baa3-e919d5314ec7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019caf47-7dc7-7d4a-ab7c-7ce29a223f90" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-5179-7863-9eda-7b9834e043d2" xlink:to="loc_ifrs-full_RangeAxis_019caf47-7dc7-7d4a-ab7c-7ce29a223f90" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019caf47-7dc7-7d4a-ab7c-7ce29a223f90_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_019caf47-7dc7-7d4a-ab7c-7ce29a223f90" xlink:to="loc_ifrs-full_RangeDomain_019caf47-7dc7-7d4a-ab7c-7ce29a223f90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019caf47-7dc7-7a4f-8f6e-ffe22962bc49" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_019caf47-7dc7-7d4a-ab7c-7ce29a223f90" xlink:to="loc_ifrs-full_RangeDomain_019caf47-7dc7-7a4f-8f6e-ffe22962bc49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019caf47-7dc7-73e7-8bc3-1d828624b23e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019caf47-7dc7-7a4f-8f6e-ffe22962bc49" xlink:to="loc_ifrs-full_BottomOfRangeMember_019caf47-7dc7-73e7-8bc3-1d828624b23e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019caf47-7dc7-7b49-a54b-b54ba9302382" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019caf47-7dc7-7a4f-8f6e-ffe22962bc49" xlink:to="loc_ifrs-full_TopOfRangeMember_019caf47-7dc7-7b49-a54b-b54ba9302382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019caf47-7dc7-7ca6-b877-59540347c958" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-5179-7863-9eda-7b9834e043d2" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019caf47-7dc7-7ca6-b877-59540347c958" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019caf47-7dc7-7ca6-b877-59540347c958_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019caf47-7dc7-7ca6-b877-59540347c958" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019caf47-7dc7-7ca6-b877-59540347c958_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019caf47-7dc7-7cb7-9ec0-d1a29dcd0506" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019caf47-7dc7-7ca6-b877-59540347c958" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019caf47-7dc7-7cb7-9ec0-d1a29dcd0506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019caf47-7dc7-7011-a909-1be3b63316eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019caf47-7dc7-7cb7-9ec0-d1a29dcd0506" xlink:to="loc_ifrs-full_OrdinarySharesMember_019caf47-7dc7-7011-a909-1be3b63316eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_019c4318-5179-799a-a3d3-b23691123642" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_ifrs-full_NumberOfSharesIssued_019c4318-5179-799a-a3d3-b23691123642" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_019c4318-5179-7557-a938-2b5bdefb8684" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_019c4318-5179-7557-a938-2b5bdefb8684" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseInAuthorisedCapital_019caf47-7dc7-7296-ad70-2ca337f8ad97" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseInAuthorisedCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_IncreaseDecreaseInAuthorisedCapital_019caf47-7dc7-7296-ad70-2ca337f8ad97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseInNumberOfSharesAuthorised_019cb01f-c48d-75cc-a8cd-10151600a8c4" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseInNumberOfSharesAuthorised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_IncreaseDecreaseInNumberOfSharesAuthorised_019cb01f-c48d-75cc-a8cd-10151600a8c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_019caf47-7dc7-75e6-87fc-e965d05f9547" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_ifrs-full_ParValuePerShare_019caf47-7dc7-75e6-87fc-e965d05f9547" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfTreasurySharesIssued_019c4318-5179-748f-b72b-197049c8269d" xlink:href="soph-20251231.xsd#soph_NumberOfTreasurySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_NumberOfTreasurySharesIssued_019c4318-5179-748f-b72b-197049c8269d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfConditionalSharesAuthorised_019cad2f-01f6-75a9-ae16-2ceb08e31de2" xlink:href="soph-20251231.xsd#soph_NumberOfConditionalSharesAuthorised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_NumberOfConditionalSharesAuthorised_019cad2f-01f6-75a9-ae16-2ceb08e31de2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement_019caf53-cb59-7a9a-9b22-6251f6a309e7" xlink:href="soph-20251231.xsd#soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement_019caf53-cb59-7a9a-9b22-6251f6a309e7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_019cad2f-421c-705d-a93d-ce737200ff2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_ifrs-full_IssueOfEquity_019cad2f-421c-705d-a93d-ce737200ff2e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquitySharesIssued_019caf5d-567a-7deb-a5aa-3e90e82bce31" xlink:href="soph-20251231.xsd#soph_NumberOfEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_NumberOfEquitySharesIssued_019caf5d-567a-7deb-a5aa-3e90e82bce31" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_019caf5c-667d-74a6-8802-86058d778fa3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_019caf5c-667d-74a6-8802-86058d778fa3" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#MaterialaccountingpoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_019c66d3-3ecc-7d2f-8da2-4906f17fe76f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_019c66d3-3ecc-7e67-9730-57f0890b9d16" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_019c66d3-3ecc-7d2f-8da2-4906f17fe76f" xlink:to="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_019c66d3-3ecc-7e67-9730-57f0890b9d16" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_019c66d3-3ecc-7181-93be-001476529a3d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_019c66d3-3ecc-7e67-9730-57f0890b9d16" xlink:to="loc_srt_RestatementAxis_019c66d3-3ecc-7181-93be-001476529a3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_019c66d3-3ecc-7181-93be-001476529a3d_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_019c66d3-3ecc-7181-93be-001476529a3d" xlink:to="loc_srt_RestatementDomain_019c66d3-3ecc-7181-93be-001476529a3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_019c66d3-3ecc-7e64-b2f6-87bead60b545" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_019c66d3-3ecc-7181-93be-001476529a3d" xlink:to="loc_srt_RestatementDomain_019c66d3-3ecc-7e64-b2f6-87bead60b545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_019c66d3-3ecc-7357-9ef5-ae3d87f3f9ea" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_019c66d3-3ecc-7e64-b2f6-87bead60b545" xlink:to="loc_srt_RestatementAdjustmentMember_019c66d3-3ecc-7357-9ef5-ae3d87f3f9ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c66d3-3ecc-7034-91a1-4089f5797d35" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_019c66d3-3ecc-7d2f-8da2-4906f17fe76f" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c66d3-3ecc-7034-91a1-4089f5797d35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c66d3-3ecc-7552-bbd2-08361eed43ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_019c66d3-3ecc-7d2f-8da2-4906f17fe76f" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c66d3-3ecc-7552-bbd2-08361eed43ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c66d3-3ecc-7950-860e-9e0fa81f344c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_019c66d3-3ecc-7d2f-8da2-4906f17fe76f" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c66d3-3ecc-7950-860e-9e0fa81f344c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SegmentreportingDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SegmentreportingDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/SegmentreportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019c4318-5179-779b-a848-25f0a9375ccb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019c4318-5179-723f-910c-88f3dd6386f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019c4318-5179-779b-a848-25f0a9375ccb" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019c4318-5179-723f-910c-88f3dd6386f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_019c4318-5179-7205-a5d7-5c0c9b36a773" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019c4318-5179-723f-910c-88f3dd6386f6" xlink:to="loc_ifrs-full_GeographicalAreasAxis_019c4318-5179-7205-a5d7-5c0c9b36a773" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7205-a5d7-5c0c9b36a773_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-5179-7205-a5d7-5c0c9b36a773" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7205-a5d7-5c0c9b36a773_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-5179-7205-a5d7-5c0c9b36a773" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_019c4318-5179-710d-b78a-0121f53a2c13" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:to="loc_country_CH_019c4318-5179-710d-b78a-0121f53a2c13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_019c4318-5179-70ea-925a-6782c685c602" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:to="loc_country_FR_019c4318-5179-70ea-925a-6782c685c602" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_019c4318-5179-7116-b98c-3a2dfd8524ae" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:to="loc_country_US_019c4318-5179-7116-b98c-3a2dfd8524ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_019c4318-5179-72f1-9816-baafb875d27e" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_BR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:to="loc_country_BR_019c4318-5179-72f1-9816-baafb875d27e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_019c4318-5179-7577-bc40-5cdc62bcb544" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019c4318-5179-779b-a848-25f0a9375ccb" xlink:to="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_019c4318-5179-7577-bc40-5cdc62bcb544" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#RevenueAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPerformanceObligationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5179-75d0-88b3-aa5d6bc22e59" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPerformanceObligationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5179-75d0-88b3-aa5d6bc22e59" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-5179-71d3-bcb4-e72bb6e45645" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5179-75d0-88b3-aa5d6bc22e59" xlink:to="loc_ifrs-full_RangeAxis_019c4318-5179-71d3-bcb4-e72bb6e45645" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-5179-71d3-bcb4-e72bb6e45645_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_019c4318-5179-71d3-bcb4-e72bb6e45645" xlink:to="loc_ifrs-full_RangeDomain_019c4318-5179-71d3-bcb4-e72bb6e45645_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-5179-7397-bb4b-d5469e8b8853" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_019c4318-5179-71d3-bcb4-e72bb6e45645" xlink:to="loc_ifrs-full_RangeDomain_019c4318-5179-7397-bb4b-d5469e8b8853" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-5179-7c30-8428-aca26f4c801f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-5179-7397-bb4b-d5469e8b8853" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-5179-7c30-8428-aca26f4c801f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-5179-717a-b908-4a6e6d3135e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-5179-7397-bb4b-d5469e8b8853" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-5179-717a-b908-4a6e6d3135e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_019c4318-517a-75c6-8d68-4dd376a81840" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5179-75d0-88b3-aa5d6bc22e59" xlink:to="loc_ifrs-full_SegmentsAxis_019c4318-517a-75c6-8d68-4dd376a81840" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_019c4318-517a-75c6-8d68-4dd376a81840_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_019c4318-517a-75c6-8d68-4dd376a81840" xlink:to="loc_ifrs-full_SegmentsDomain_019c4318-517a-75c6-8d68-4dd376a81840_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_019c4318-517a-7f66-ba75-27881c40fcc9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_019c4318-517a-75c6-8d68-4dd376a81840" xlink:to="loc_ifrs-full_SegmentsDomain_019c4318-517a-7f66-ba75-27881c40fcc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WorkflowEquipmentAndServicesMember_019c4318-517a-74f5-9acb-80c3152cd84a" xlink:href="soph-20251231.xsd#soph_WorkflowEquipmentAndServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_019c4318-517a-7f66-ba75-27881c40fcc9" xlink:to="loc_soph_WorkflowEquipmentAndServicesMember_019c4318-517a-74f5-9acb-80c3152cd84a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersAxis_019c4318-517a-7b26-ab34-5d6a83cfb66d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5179-75d0-88b3-aa5d6bc22e59" xlink:to="loc_ifrs-full_MajorCustomersAxis_019c4318-517a-7b26-ab34-5d6a83cfb66d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersDomain_019c4318-517a-7b26-ab34-5d6a83cfb66d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MajorCustomersAxis_019c4318-517a-7b26-ab34-5d6a83cfb66d" xlink:to="loc_ifrs-full_MajorCustomersDomain_019c4318-517a-7b26-ab34-5d6a83cfb66d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersDomain_019c4318-517a-7de1-b2be-1ada3c421a74" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MajorCustomersAxis_019c4318-517a-7b26-ab34-5d6a83cfb66d" xlink:to="loc_ifrs-full_MajorCustomersDomain_019c4318-517a-7de1-b2be-1ada3c421a74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CustomerOneMember_019c4318-517a-7d1c-a48e-47fd0def5122" xlink:href="soph-20251231.xsd#soph_CustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersDomain_019c4318-517a-7de1-b2be-1ada3c421a74" xlink:to="loc_soph_CustomerOneMember_019c4318-517a-7d1c-a48e-47fd0def5122" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RevenueFromContractsWithCustomersPaymentTerm_019c4318-517a-7eeb-9922-104917925ad1" xlink:href="soph-20251231.xsd#soph_RevenueFromContractsWithCustomersPaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_soph_RevenueFromContractsWithCustomersPaymentTerm_019c4318-517a-7eeb-9922-104917925ad1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm_019c4318-517a-7b33-be63-577c3d7fdc15" xlink:href="soph-20251231.xsd#soph_RevenueFromContractsWithCustomersExtendedPaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm_019c4318-517a-7b33-be63-577c3d7fdc15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_019c4318-517a-7066-a3c3-66ca3a5bdb98" xlink:href="soph-20251231.xsd#soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_019c4318-517a-7066-a3c3-66ca3a5bdb98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_019c4318-517a-7ae2-b783-7404a0965aea" xlink:href="soph-20251231.xsd#soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_019c4318-517a-7ae2-b783-7404a0965aea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingLeaseIncome_019c4318-517a-7b8a-8cd8-e91b55f01520" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingLeaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_ifrs-full_OperatingLeaseIncome_019c4318-517a-7b8a-8cd8-e91b55f01520" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-517a-77e6-b201-6ffa4aee8c69" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-517a-77e6-b201-6ffa4aee8c69" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019c4318-517a-7572-95d1-592ee654882c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019c4318-517a-7dc4-a4fc-b9cf90ade251" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019c4318-517a-7572-95d1-592ee654882c" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019c4318-517a-7dc4-a4fc-b9cf90ade251" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_019c4318-517a-7b78-9cab-f164eabfd6a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019c4318-517a-7dc4-a4fc-b9cf90ade251" xlink:to="loc_ifrs-full_GeographicalAreasAxis_019c4318-517a-7b78-9cab-f164eabfd6a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7b78-9cab-f164eabfd6a4_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-517a-7b78-9cab-f164eabfd6a4" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7b78-9cab-f164eabfd6a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-517a-7b78-9cab-f164eabfd6a4" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:href="soph-20251231.xsd#soph_EuropeTheMiddleEastAndAfricaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:to="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_019c4318-517a-703f-b592-f81a7e08a729" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:to="loc_country_CH_019c4318-517a-703f-b592-f81a7e08a729" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_019c4318-517a-7b8d-b767-e557d2145bd4" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_FR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:to="loc_country_FR_019c4318-517a-7b8d-b767-e557d2145bd4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IT_019c4318-517a-7d06-80fd-43c92ea38272" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_IT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:to="loc_country_IT_019c4318-517a-7d06-80fd-43c92ea38272" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_ES_019c4318-517a-7c03-9b52-bdd9852aef91" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_ES"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:to="loc_country_ES_019c4318-517a-7c03-9b52-bdd9852aef91" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember_019c4318-517a-77a3-8e4e-33184edb6793" xlink:href="soph-20251231.xsd#soph_OtherCountriesInEuropeMiddleEastAndAfricaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:to="loc_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember_019c4318-517a-77a3-8e4e-33184edb6793" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_019c4318-517a-73bf-88e2-4f58e2f8e955" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:to="loc_srt_NorthAmericaMember_019c4318-517a-73bf-88e2-4f58e2f8e955" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_019c4318-517a-705e-a807-95eb2b089df2" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NorthAmericaMember_019c4318-517a-73bf-88e2-4f58e2f8e955" xlink:to="loc_country_US_019c4318-517a-705e-a807-95eb2b089df2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OtherCountriesInNorthAmericaMember_019c4318-517a-76d5-b68a-693449aab89f" xlink:href="soph-20251231.xsd#soph_OtherCountriesInNorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NorthAmericaMember_019c4318-517a-73bf-88e2-4f58e2f8e955" xlink:to="loc_soph_OtherCountriesInNorthAmericaMember_019c4318-517a-76d5-b68a-693449aab89f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_019c4318-517a-7b5f-b346-876ad125a8cb" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LatinAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:to="loc_srt_LatinAmericaMember_019c4318-517a-7b5f-b346-876ad125a8cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_019c4318-517a-7b62-87f8-8318ef127e2a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:to="loc_srt_AsiaPacificMember_019c4318-517a-7b62-87f8-8318ef127e2a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_019c4318-517a-7e41-86b8-a24e3104f5c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019c4318-517a-7dc4-a4fc-b9cf90ade251" xlink:to="loc_ifrs-full_SegmentsAxis_019c4318-517a-7e41-86b8-a24e3104f5c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_019c4318-517a-7e41-86b8-a24e3104f5c1_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_019c4318-517a-7e41-86b8-a24e3104f5c1" xlink:to="loc_ifrs-full_SegmentsDomain_019c4318-517a-7e41-86b8-a24e3104f5c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_019c4318-517a-7c50-a488-7097cbb8f3bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_019c4318-517a-7e41-86b8-a24e3104f5c1" xlink:to="loc_ifrs-full_SegmentsDomain_019c4318-517a-7c50-a488-7097cbb8f3bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SOPHiADDMPlatformMember_019c4318-517a-7c35-9b63-ab116142f1e4" xlink:href="soph-20251231.xsd#soph_SOPHiADDMPlatformMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_019c4318-517a-7c50-a488-7097cbb8f3bb" xlink:to="loc_soph_SOPHiADDMPlatformMember_019c4318-517a-7c35-9b63-ab116142f1e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WorkflowEquipmentAndServicesMember_019c4318-517a-755e-a6cc-fb07beb1bf83" xlink:href="soph-20251231.xsd#soph_WorkflowEquipmentAndServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_019c4318-517a-7c50-a488-7097cbb8f3bb" xlink:to="loc_soph_WorkflowEquipmentAndServicesMember_019c4318-517a-755e-a6cc-fb07beb1bf83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-517a-78e3-99aa-e86051efd5d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019c4318-517a-7572-95d1-592ee654882c" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-517a-78e3-99aa-e86051efd5d2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#OperatingexpenseAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c898a-d76a-7e2d-8422-3988c4e256d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c898a-d76a-7c0f-a765-e9a3cb8a4be9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c898a-d76a-7e2d-8422-3988c4e256d4" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c898a-d76a-7c0f-a765-e9a3cb8a4be9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c898a-d76a-7a35-bb3a-6b700d1ce147" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c898a-d76a-7c0f-a765-e9a3cb8a4be9" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c898a-d76a-7a35-bb3a-6b700d1ce147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c898a-d76a-7a35-bb3a-6b700d1ce147_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c898a-d76a-7a35-bb3a-6b700d1ce147" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c898a-d76a-7a35-bb3a-6b700d1ce147_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c898a-d76a-769e-8e8f-e384ebc5aa32" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c898a-d76a-7a35-bb3a-6b700d1ce147" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c898a-d76a-769e-8e8f-e384ebc5aa32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CostOfRevenue1Member_019c898a-d76a-7dd4-b0ae-6e416907806d" xlink:href="soph-20251231.xsd#soph_CostOfRevenue1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c898a-d76a-769e-8e8f-e384ebc5aa32" xlink:to="loc_soph_CostOfRevenue1Member_019c898a-d76a-7dd4-b0ae-6e416907806d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ResearchTaxCredit_019c4318-517a-778e-b1f4-f4e8ad31e5b8" xlink:href="soph-20251231.xsd#soph_ResearchTaxCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c898a-d76a-7e2d-8422-3988c4e256d4" xlink:to="loc_soph_ResearchTaxCredit_019c4318-517a-778e-b1f4-f4e8ad31e5b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019c898a-d76a-7474-8490-491c788dfa5d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c898a-d76a-7e2d-8422-3988c4e256d4" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019c898a-d76a-7474-8490-491c788dfa5d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-75da-b89d-5c2e1fa7e18e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7672-9884-737562b2e478" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-75da-b89d-5c2e1fa7e18e" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7672-9884-737562b2e478" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7a28-9f7a-ac88c95f9b2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7672-9884-737562b2e478" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7a28-9f7a-ac88c95f9b2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-7a28-9f7a-ac88c95f9b2b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7a28-9f7a-ac88c95f9b2b" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-7a28-9f7a-ac88c95f9b2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7a28-9f7a-ac88c95f9b2b" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSalesMember_019c4318-517a-7193-81d5-cf5f6537be22" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:to="loc_ifrs-full_CostOfSalesMember_019c4318-517a-7193-81d5-cf5f6537be22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-517a-7914-9427-e371ee470915" xlink:href="soph-20251231.xsd#soph_ResearchAndDevelopmentExpense1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:to="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-517a-7914-9427-e371ee470915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SellingAndMarketingExpense1Member_019c4318-517a-7fb3-80c3-17d46c48c1b0" xlink:href="soph-20251231.xsd#soph_SellingAndMarketingExpense1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:to="loc_soph_SellingAndMarketingExpense1Member_019c4318-517a-7fb3-80c3-17d46c48c1b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-517a-7361-904d-1e122432388c" xlink:href="soph-20251231.xsd#soph_GeneralAndAdministrativeExpense1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:to="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-517a-7361-904d-1e122432388c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationExpense_019c4318-517a-77dc-9b4e-a9a44686f82e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-75da-b89d-5c2e1fa7e18e" xlink:to="loc_ifrs-full_DepreciationExpense_019c4318-517a-77dc-9b4e-a9a44686f82e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationExpense_019c4318-517a-790f-9563-365dc1cb885d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-75da-b89d-5c2e1fa7e18e" xlink:to="loc_ifrs-full_AmortisationExpense_019c4318-517a-790f-9563-365dc1cb885d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-707d-9b4f-eafd8f65b226" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7da3-afca-07e46cf43086" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-707d-9b4f-eafd8f65b226" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7da3-afca-07e46cf43086" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7995-8638-8b8cd14c3de3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7da3-afca-07e46cf43086" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7995-8638-8b8cd14c3de3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-7995-8638-8b8cd14c3de3_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7995-8638-8b8cd14c3de3" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-7995-8638-8b8cd14c3de3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7995-8638-8b8cd14c3de3" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CostOfRevenue1Member_019c71bd-8539-7cac-8fbd-d1b3a170a3d1" xlink:href="soph-20251231.xsd#soph_CostOfRevenue1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:to="loc_soph_CostOfRevenue1Member_019c71bd-8539-7cac-8fbd-d1b3a170a3d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-517a-76a6-9b40-84fb0c3c4948" xlink:href="soph-20251231.xsd#soph_ResearchAndDevelopmentExpense1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:to="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-517a-76a6-9b40-84fb0c3c4948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SellingAndMarketingExpense1Member_019c4318-517a-7e60-adbd-47f141bddaa0" xlink:href="soph-20251231.xsd#soph_SellingAndMarketingExpense1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:to="loc_soph_SellingAndMarketingExpense1Member_019c4318-517a-7e60-adbd-47f141bddaa0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-517a-78ad-9468-921922ddd40a" xlink:href="soph-20251231.xsd#soph_GeneralAndAdministrativeExpense1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:to="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-517a-78ad-9468-921922ddd40a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019c4318-517a-7f8d-b1e8-7e8617fd423a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-707d-9b4f-eafd8f65b226" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019c4318-517a-7f8d-b1e8-7e8617fd423a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_019c4318-517a-716f-b9e5-84b12d85c1b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-702f-92ca-c5ac8d5845f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_019c4318-517a-716f-b9e5-84b12d85c1b4" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-702f-92ca-c5ac8d5845f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c7280-b2ba-7a35-88da-4448f3d8b53c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-702f-92ca-c5ac8d5845f5" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c7280-b2ba-7a35-88da-4448f3d8b53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c7280-b2ba-7a35-88da-4448f3d8b53c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c7280-b2ba-7a35-88da-4448f3d8b53c" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c7280-b2ba-7a35-88da-4448f3d8b53c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c7280-b2ba-74f0-8408-bd60e3aa2aa7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c7280-b2ba-7a35-88da-4448f3d8b53c" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c7280-b2ba-74f0-8408-bd60e3aa2aa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsSASMember_019c7280-d0dd-7e35-8bd6-aaa1c3299d35" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsSASMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c7280-b2ba-74f0-8408-bd60e3aa2aa7" xlink:to="loc_soph_SophiaGeneticsSASMember_019c7280-d0dd-7e35-8bd6-aaa1c3299d35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties_019c4318-517a-7c9c-835d-d3558a7d4421" xlink:href="soph-20251231.xsd#soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_019c4318-517a-716f-b9e5-84b12d85c1b4" xlink:to="loc_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties_019c4318-517a-7c9c-835d-d3558a7d4421" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsReceived_019c4318-517a-71cf-8e1f-60ffae30f720" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_019c4318-517a-716f-b9e5-84b12d85c1b4" xlink:to="loc_ifrs-full_DividendsReceived_019c4318-517a-71cf-8e1f-60ffae30f720" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxSummaryofMovementinDeferredTaxBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-744a-81c8-9ce174c2be1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7973-bb20-077884ea2f00" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-744a-81c8-9ce174c2be1e" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7973-bb20-077884ea2f00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-7418-bc6c-7caa2643f3ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7973-bb20-077884ea2f00" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-7418-bc6c-7caa2643f3ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-7418-bc6c-7caa2643f3ae_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-7418-bc6c-7caa2643f3ae" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-7418-bc6c-7caa2643f3ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-7418-bc6c-7caa2643f3ae" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember_019c4318-517a-7414-a5bf-9837f329ca20" xlink:href="soph-20251231.xsd#soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember_019c4318-517a-7414-a5bf-9837f329ca20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BadDebtReservesRelatedTemporaryDifferencesMember_019c4318-517a-71c7-a231-ac11c3ba6eab" xlink:href="soph-20251231.xsd#soph_BadDebtReservesRelatedTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_soph_BadDebtReservesRelatedTemporaryDifferencesMember_019c4318-517a-71c7-a231-ac11c3ba6eab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedPensionRelatedTemporaryDifferencesMember_019c4318-517a-7c26-9964-c660590070ac" xlink:href="soph-20251231.xsd#soph_AccruedPensionRelatedTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_soph_AccruedPensionRelatedTemporaryDifferencesMember_019c4318-517a-7c26-9964-c660590070ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember_019c4318-517a-7a33-821c-407b1ce81098" xlink:href="soph-20251231.xsd#soph_RightOfUseAssetsRelatedTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember_019c4318-517a-7a33-821c-407b1ce81098" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember_019c4318-517a-75ef-a32e-5f84c4950615" xlink:href="soph-20251231.xsd#soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember_019c4318-517a-75ef-a32e-5f84c4950615" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_019c4318-517a-776a-9730-dbd0f3321f6e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_ifrs-full_OtherTemporaryDifferencesMember_019c4318-517a-776a-9730-dbd0f3321f6e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_019c4318-517a-7b01-80d0-5025b7076df6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_019c4318-517a-7b01-80d0-5025b7076df6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-70b4-b96f-96de23113ca5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-744a-81c8-9ce174c2be1e" xlink:to="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-70b4-b96f-96de23113ca5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-70b4-b96f-96de23113ca5" xlink:to="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_019c4318-517a-7fbc-bf18-a72885e0b65a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_019c4318-517a-7fbc-bf18-a72885e0b65a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_019c4318-517a-76fc-b87c-dacd041250ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_019c4318-517a-76fc-b87c-dacd041250ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_019c4318-517a-7caa-b39d-0c8b4cac9277" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:to="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_019c4318-517a-7caa-b39d-0c8b4cac9277" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_019c4318-517a-7229-910f-8b4a89f1fbe7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_019c4318-517a-7229-910f-8b4a89f1fbe7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_019c4318-517a-708b-b23e-91e279780111" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_019c4318-517a-706d-b76c-a225fbbc50f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-70b4-b96f-96de23113ca5" xlink:to="loc_ifrs-full_DeferredTaxAssets_019c4318-517a-706d-b76c-a225fbbc50f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_019c4318-517a-7be0-ac07-cd7a4d1a2e36" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-70b4-b96f-96de23113ca5" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_019c4318-517a-7be0-ac07-cd7a4d1a2e36" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7f59-a23e-bda0c58459cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7bb1-acf7-6c35daa4765a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7f59-a23e-bda0c58459cd" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7bb1-acf7-6c35daa4765a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-701e-881f-5a1c36952038" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7bb1-acf7-6c35daa4765a" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-701e-881f-5a1c36952038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-701e-881f-5a1c36952038_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-701e-881f-5a1c36952038" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-701e-881f-5a1c36952038_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-76f5-a640-cfb8ba1fe7be" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-701e-881f-5a1c36952038" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-76f5-a640-cfb8ba1fe7be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceMember_019c4318-517a-755e-a62f-a302ec5f1d4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-76f5-a640-cfb8ba1fe7be" xlink:to="loc_ifrs-full_TemporaryDifferenceMember_019c4318-517a-755e-a62f-a302ec5f1d4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_019c4318-517a-723d-a4fe-c2c00dbb4d5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-76f5-a640-cfb8ba1fe7be" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_019c4318-517a-723d-a4fe-c2c00dbb4d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_UnrecognizedDeferredTaxAssetsGross_019c4318-517a-74a2-9987-65fa58c99887" xlink:href="soph-20251231.xsd#soph_UnrecognizedDeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7f59-a23e-bda0c58459cd" xlink:to="loc_soph_UnrecognizedDeferredTaxAssetsGross_019c4318-517a-74a2-9987-65fa58c99887" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfTaxLosses_019c4318-517a-739d-88f1-18a222d2b8f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7f59-a23e-bda0c58459cd" xlink:to="loc_ifrs-full_TaxEffectOfTaxLosses_019c4318-517a-739d-88f1-18a222d2b8f6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#LosspershareAdditionalinformationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_019c4318-517a-7148-955c-d2557494324e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareTable_019c4318-517a-783d-8bf4-4236217a19fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_019c4318-517a-7148-955c-d2557494324e" xlink:to="loc_ifrs-full_EarningsPerShareTable_019c4318-517a-783d-8bf4-4236217a19fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019c4318-517a-79db-8e12-e2403465477e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_EarningsPerShareTable_019c4318-517a-783d-8bf4-4236217a19fd" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019c4318-517a-79db-8e12-e2403465477e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c4318-517a-79db-8e12-e2403465477e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c4318-517a-79db-8e12-e2403465477e" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c4318-517a-79db-8e12-e2403465477e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c4318-517a-7867-9281-7a1d362a9587" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c4318-517a-79db-8e12-e2403465477e" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c4318-517a-7867-9281-7a1d362a9587" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019c4318-517a-7783-beff-245cf8153035" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019c4318-517a-7867-9281-7a1d362a9587" xlink:to="loc_ifrs-full_OrdinarySharesMember_019c4318-517a-7783-beff-245cf8153035" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_019c4318-517a-7132-8b53-4e116e3e300e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_019c4318-517a-7148-955c-d2557494324e" xlink:to="loc_ifrs-full_ParValuePerShare_019c4318-517a-7132-8b53-4e116e3e300e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#AccountsreceivableAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:href="soph-20251231.xsd#soph_TradeAndOtherReceivablesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TradeAndOtherReceivablesTable_019c4318-517a-7a49-808f-d0287622686d" xlink:href="soph-20251231.xsd#soph_TradeAndOtherReceivablesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_TradeAndOtherReceivablesTable_019c4318-517a-7a49-808f-d0287622686d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-517a-714c-a4da-ec81c5eb7816" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_TradeAndOtherReceivablesTable_019c4318-517a-7a49-808f-d0287622686d" xlink:to="loc_ifrs-full_RangeAxis_019c4318-517a-714c-a4da-ec81c5eb7816" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-517a-714c-a4da-ec81c5eb7816_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_019c4318-517a-714c-a4da-ec81c5eb7816" xlink:to="loc_ifrs-full_RangeDomain_019c4318-517a-714c-a4da-ec81c5eb7816_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-517a-70fc-9909-4f19bbc301ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_019c4318-517a-714c-a4da-ec81c5eb7816" xlink:to="loc_ifrs-full_RangeDomain_019c4318-517a-70fc-9909-4f19bbc301ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-517a-76d9-81e3-7d7e15f215e0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-517a-70fc-9909-4f19bbc301ee" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-517a-76d9-81e3-7d7e15f215e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-517a-7dee-aeb8-eef37f1b9e2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-517a-70fc-9909-4f19bbc301ee" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-517a-7dee-aeb8-eef37f1b9e2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsReceivableNonInterestBearingPaymentTerms_019c4318-517a-7264-bce7-9b4f5bbf0843" xlink:href="soph-20251231.xsd#soph_AccountsReceivableNonInterestBearingPaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_AccountsReceivableNonInterestBearingPaymentTerms_019c4318-517a-7264-bce7-9b4f5bbf0843" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm_019c4318-517a-7741-a03a-3683c436771f" xlink:href="soph-20251231.xsd#soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm_019c4318-517a-7741-a03a-3683c436771f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PercentageOfCustomerBalanceAccountReceivable_019c4318-517a-7537-810f-854e08e6317e" xlink:href="soph-20251231.xsd#soph_PercentageOfCustomerBalanceAccountReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_PercentageOfCustomerBalanceAccountReceivable_019c4318-517a-7537-810f-854e08e6317e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsReceivableInAggregateAmount_019c4318-517a-73c4-8cfa-94d71cc79b3d" xlink:href="soph-20251231.xsd#soph_AccountsReceivableInAggregateAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_AccountsReceivableInAggregateAmount_019c4318-517a-73c4-8cfa-94d71cc79b3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LongTermLeaseReceivables_019c4318-517a-706d-89cc-ce09d1ab9032" xlink:href="soph-20251231.xsd#soph_LongTermLeaseReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_LongTermLeaseReceivables_019c4318-517a-706d-89cc-ce09d1ab9032" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetLeaseReceivables_019c4318-517a-7b9d-bb93-503c065ffc4f" xlink:href="soph-20251231.xsd#soph_NetLeaseReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_NetLeaseReceivables_019c4318-517a-7b9d-bb93-503c065ffc4f" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-7c92-a8d2-99f2601d7bca" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-7f9e-830d-446a8bda69aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-7c92-a8d2-99f2601d7bca" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-7f9e-830d-446a8bda69aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eff-a3d5-c8b9abe219da" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-7f9e-830d-446a8bda69aa" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eff-a3d5-c8b9abe219da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7eff-a3d5-c8b9abe219da_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eff-a3d5-c8b9abe219da" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7eff-a3d5-c8b9abe219da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7ee0-8409-ee5503079f3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eff-a3d5-c8b9abe219da" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7ee0-8409-ee5503079f3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_019c4318-517a-7ba3-a3f1-a54ac489f44a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7ee0-8409-ee5503079f3f" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_019c4318-517a-7ba3-a3f1-a54ac489f44a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_019c4318-517a-757f-822a-e4b762dfea60" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7ee0-8409-ee5503079f3f" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_019c4318-517a-757f-822a-e4b762dfea60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-7964-bcf9-e1ded3612fb8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-7f9e-830d-446a8bda69aa" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-7964-bcf9-e1ded3612fb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-7964-bcf9-e1ded3612fb8_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-7964-bcf9-e1ded3612fb8" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-7964-bcf9-e1ded3612fb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-753a-a1f8-7b705f614efe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-7964-bcf9-e1ded3612fb8" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-753a-a1f8-7b705f614efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-7899-8e38-0c26bdd5367f" xlink:href="soph-20251231.xsd#soph_FinancialAssetsAccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-753a-a1f8-7b705f614efe" xlink:to="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-7899-8e38-0c26bdd5367f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivablesMember_019c4318-517a-784b-a2cb-393c7006fbc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-7899-8e38-0c26bdd5367f" xlink:to="loc_ifrs-full_TradeReceivablesMember_019c4318-517a-784b-a2cb-393c7006fbc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractAssetsMember_019c4318-517a-740b-98ba-83d32a32543b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-7899-8e38-0c26bdd5367f" xlink:to="loc_ifrs-full_ContractAssetsMember_019c4318-517a-740b-98ba-83d32a32543b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_019c4318-517a-7e44-bab5-60627b6e8a87" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-7c92-a8d2-99f2601d7bca" xlink:to="loc_ifrs-full_FinancialAssets_019c4318-517a-7e44-bab5-60627b6e8a87" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-719d-84e8-65677b336459" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-77fc-84f5-17af594f6285" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-719d-84e8-65677b336459" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-77fc-84f5-17af594f6285" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eb7-a267-87aa6f7da705" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-77fc-84f5-17af594f6285" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eb7-a267-87aa6f7da705" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7eb7-a267-87aa6f7da705_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eb7-a267-87aa6f7da705" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7eb7-a267-87aa6f7da705_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-517a-75d2-a5c3-07ecfe792af8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eb7-a267-87aa6f7da705" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-517a-75d2-a5c3-07ecfe792af8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_019c4318-517a-7fb3-935c-b6906b8ad834" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-517a-75d2-a5c3-07ecfe792af8" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_019c4318-517a-7fb3-935c-b6906b8ad834" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-751e-9cc5-9f7bb3cfd2d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-77fc-84f5-17af594f6285" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-751e-9cc5-9f7bb3cfd2d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-751e-9cc5-9f7bb3cfd2d9_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-751e-9cc5-9f7bb3cfd2d9" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-751e-9cc5-9f7bb3cfd2d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-7cff-9333-3b5e806af967" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-751e-9cc5-9f7bb3cfd2d9" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-7cff-9333-3b5e806af967" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-72ee-be5e-46822d15eb9a" xlink:href="soph-20251231.xsd#soph_FinancialAssetsAccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-7cff-9333-3b5e806af967" xlink:to="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-72ee-be5e-46822d15eb9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-719d-84e8-65677b336459" xlink:to="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_019c4318-517a-74f3-860b-af0801cd71b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:to="loc_ifrs-full_FinancialAssets_019c4318-517a-74f3-860b-af0801cd71b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_019c9dad-1368-7943-8743-2334266da6b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_019c9dad-1368-7943-8743-2334266da6b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss_019c7480-2efa-797a-8fd3-000aff610d38" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:to="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss_019c7480-2efa-797a-8fd3-000aff610d38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_019c4318-517a-7bae-a625-2f1e9dee8428" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughWriteoffFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:to="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_019c4318-517a-7bae-a625-2f1e9dee8428" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_019c4318-517a-7df7-88b8-e003b821de51" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_019c4318-517a-7df7-88b8-e003b821de51" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_019c4318-517a-750c-a5dd-c7e2cb87061b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PropertyandequipmentAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-517a-7f9e-9b02-52c3c3cf3d12" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-73c8-86f0-efc3533f04e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-517a-7f9e-9b02-52c3c3cf3d12" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-73c8-86f0-efc3533f04e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-517a-71a3-a3b8-a9d92b17b118" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-73c8-86f0-efc3533f04e3" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-517a-71a3-a3b8-a9d92b17b118" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-71a3-a3b8-a9d92b17b118_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-517a-71a3-a3b8-a9d92b17b118" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-71a3-a3b8-a9d92b17b118_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-517a-71a3-a3b8-a9d92b17b118" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerEquipmentMember_019c4318-517a-7b56-a2ec-06908253b25e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:to="loc_ifrs-full_ComputerEquipmentMember_019c4318-517a-7b56-a2ec-06908253b25e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MachineryMember_019c4318-517a-7f27-ab06-3fe7df75f650" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MachineryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:to="loc_ifrs-full_MachineryMember_019c4318-517a-7f27-ab06-3fe7df75f650" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_019c4318-517a-705e-ad2e-867c64478a26" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_019c4318-517a-705e-ad2e-867c64478a26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_019c6760-b497-7a93-9fa6-82af723677b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_019c6760-b497-7a93-9fa6-82af723677b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-517a-706c-951a-ddd2a7abb3e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-73c8-86f0-efc3533f04e3" xlink:to="loc_ifrs-full_RangeAxis_019c4318-517a-706c-951a-ddd2a7abb3e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-517a-706c-951a-ddd2a7abb3e4_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_019c4318-517a-706c-951a-ddd2a7abb3e4" xlink:to="loc_ifrs-full_RangeDomain_019c4318-517a-706c-951a-ddd2a7abb3e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-517a-7e38-8451-cbaec0a3c7bf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_019c4318-517a-706c-951a-ddd2a7abb3e4" xlink:to="loc_ifrs-full_RangeDomain_019c4318-517a-7e38-8451-cbaec0a3c7bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-517a-7121-bb0d-8f2f872b7141" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-517a-7e38-8451-cbaec0a3c7bf" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-517a-7121-bb0d-8f2f872b7141" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-517a-724c-bf72-5855087766d0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-517a-7e38-8451-cbaec0a3c7bf" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-517a-724c-bf72-5855087766d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_019c4318-517a-7561-8cf6-c8245f61113f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-517a-7f9e-9b02-52c3c3cf3d12" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_019c4318-517a-7561-8cf6-c8245f61113f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment_019c4318-517a-7b96-8840-5538fdaf808b" xlink:href="soph-20251231.xsd#soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-517a-7f9e-9b02-52c3c3cf3d12" xlink:to="loc_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment_019c4318-517a-7b96-8840-5538fdaf808b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConstructionInProgress_019c6760-b497-7cb5-a197-6b578c9fd282" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-517a-7f9e-9b02-52c3c3cf3d12" xlink:to="loc_ifrs-full_ConstructionInProgress_019c6760-b497-7cb5-a197-6b578c9fd282" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-522c-74bd-8f48-bf2088f3f751" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-7095-9698-c7debf1fa72c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-522c-74bd-8f48-bf2088f3f751" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-7095-9698-c7debf1fa72c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-780f-9cfe-f801dd77cd3e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-7095-9698-c7debf1fa72c" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-780f-9cfe-f801dd77cd3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-517a-780f-9cfe-f801dd77cd3e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-780f-9cfe-f801dd77cd3e" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-517a-780f-9cfe-f801dd77cd3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-522c-7f36-8717-6a7b6f9609bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-780f-9cfe-f801dd77cd3e" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-522c-7f36-8717-6a7b6f9609bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522c-75e3-9dfa-98c4a4cadb51" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522c-7f36-8717-6a7b6f9609bd" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522c-75e3-9dfa-98c4a4cadb51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019c4318-522c-7eaa-b7f6-7ac69963f2f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522c-7f36-8717-6a7b6f9609bd" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019c4318-522c-7eaa-b7f6-7ac69963f2f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-522c-7e7c-adc2-e167c890632d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-7095-9698-c7debf1fa72c" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-522c-7e7c-adc2-e167c890632d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-7e7c-adc2-e167c890632d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-522c-7e7c-adc2-e167c890632d" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-7e7c-adc2-e167c890632d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-522c-7e7c-adc2-e167c890632d" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_019c4318-522c-7aa1-9081-34717b36d108" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_019c4318-522c-7aa1-9081-34717b36d108" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MachineryMember_019c4318-522c-7ecd-ac3b-6ad27abed59b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MachineryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:to="loc_ifrs-full_MachineryMember_019c4318-522c-7ecd-ac3b-6ad27abed59b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerEquipmentMember_019c4318-522c-721f-a4a6-e00dfbef9e4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:to="loc_ifrs-full_ComputerEquipmentMember_019c4318-522c-721f-a4a6-e00dfbef9e4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_019c4318-522c-75c0-8142-128cd8807655" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_019c4318-522c-75c0-8142-128cd8807655" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-7a83-b087-b3227ca1027c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-522c-74bd-8f48-bf2088f3f751" xlink:to="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-7a83-b087-b3227ca1027c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-7a83-b087-b3227ca1027c" xlink:to="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_019c4318-522c-776f-ab68-d2631f21a61b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_019c4318-522c-776f-ab68-d2631f21a61b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_019c4318-522c-7cda-990d-c38102961af6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_019c4318-522c-7cda-990d-c38102961af6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_019c4318-522c-7963-9afb-c3b8c4a5f54b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_019c4318-522c-7963-9afb-c3b8c4a5f54b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_019c4318-522c-7c0c-a458-239a0b342154" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_019c4318-522c-7c0c-a458-239a0b342154" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_019c4318-522c-71a3-920e-309365147b89" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IntangibleAssetsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:href="soph-20251231.xsd#soph_ScheduleOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ScheduleOfIntangibleAssetsTable_019c4318-522c-752a-bf2c-d3f95acfbb1a" xlink:href="soph-20251231.xsd#soph_ScheduleOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_soph_ScheduleOfIntangibleAssetsTable_019c4318-522c-752a-bf2c-d3f95acfbb1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7a3f-9cb6-7f9227e7adde" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_ScheduleOfIntangibleAssetsTable_019c4318-522c-752a-bf2c-d3f95acfbb1a" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7a3f-9cb6-7f9227e7adde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7a3f-9cb6-7f9227e7adde_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7a3f-9cb6-7f9227e7adde" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7a3f-9cb6-7f9227e7adde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7825-9848-6d862f492068" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7a3f-9cb6-7f9227e7adde" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7825-9848-6d862f492068" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_019c4318-522c-74b1-8182-0c5e19f82145" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7825-9848-6d862f492068" xlink:to="loc_ifrs-full_ComputerSoftwareMember_019c4318-522c-74b1-8182-0c5e19f82145" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_019c4318-522c-72b1-b3de-2fdfd975b03a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7825-9848-6d862f492068" xlink:to="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_019c4318-522c-72b1-b3de-2fdfd975b03a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_019c4318-522c-71f1-8adb-6a0649f59e60" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_019c4318-522c-71f1-8adb-6a0649f59e60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_019c4318-522c-771b-8c08-8230c9557306" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_019c4318-522c-771b-8c08-8230c9557306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets_019c4318-522c-75dc-baf7-e575944c3048" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets_019c4318-522c-75dc-baf7-e575944c3048" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus_019c4318-522c-73c6-98d1-113b21556259" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus_019c4318-522c-73c6-98d1-113b21556259" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets_019c4318-522c-7bf9-81ec-57db768bc180" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets_019c4318-522c-7bf9-81ec-57db768bc180" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfCashGeneratingUnit_019c4318-522c-72f4-9e97-12a796565be5" xlink:href="soph-20251231.xsd#soph_NumberOfCashGeneratingUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_soph_NumberOfCashGeneratingUnit_019c4318-522c-72f4-9e97-12a796565be5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IntangibleAssetsIntangibleAssetsNetMovementDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_019c4318-522c-79f1-8de1-ed74d54e8e7c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019c4318-522c-72bd-b010-be45040e24cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_019c4318-522c-79f1-8de1-ed74d54e8e7c" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019c4318-522c-72bd-b010-be45040e24cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522c-7b4c-97ce-f2cbd60bfcb6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019c4318-522c-72bd-b010-be45040e24cd" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522c-7b4c-97ce-f2cbd60bfcb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-522c-7b4c-97ce-f2cbd60bfcb6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522c-7b4c-97ce-f2cbd60bfcb6" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-522c-7b4c-97ce-f2cbd60bfcb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-522c-707c-b39f-a9c45433975f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522c-7b4c-97ce-f2cbd60bfcb6" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-522c-707c-b39f-a9c45433975f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522c-721c-9a82-442f1585cc77" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522c-707c-b39f-a9c45433975f" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522c-721c-9a82-442f1585cc77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019c4318-522c-71d2-b0a5-b6f7dc7272bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522c-707c-b39f-a9c45433975f" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019c4318-522c-71d2-b0a5-b6f7dc7272bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7d11-85e4-3eeebc5f5a15" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019c4318-522c-72bd-b010-be45040e24cd" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7d11-85e4-3eeebc5f5a15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7d11-85e4-3eeebc5f5a15_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7d11-85e4-3eeebc5f5a15" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7d11-85e4-3eeebc5f5a15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7ae6-9896-4973cccc8015" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7d11-85e4-3eeebc5f5a15" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7ae6-9896-4973cccc8015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillMember_019c4318-522c-776d-8f13-83fe87f46540" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodwillMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7ae6-9896-4973cccc8015" xlink:to="loc_ifrs-full_GoodwillMember_019c4318-522c-776d-8f13-83fe87f46540" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_019c4318-522c-7029-ab3b-1c0fcce7a5d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7ae6-9896-4973cccc8015" xlink:to="loc_ifrs-full_ComputerSoftwareMember_019c4318-522c-7029-ab3b-1c0fcce7a5d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_019c4318-522c-7550-861b-5e50c6bf3fd2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7ae6-9896-4973cccc8015" xlink:to="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_019c4318-522c-7550-861b-5e50c6bf3fd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019c4318-522c-7e5a-9647-c9b505a7bc76" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_019c4318-522c-79f1-8de1-ed74d54e8e7c" xlink:to="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019c4318-522c-7e5a-9647-c9b505a7bc76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-522c-79ed-bd1e-842ce64fed06" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019c4318-522c-7e5a-9647-c9b505a7bc76" xlink:to="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-522c-79ed-bd1e-842ce64fed06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_019c4318-522c-7ba9-8c9a-e98056369c11" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-522c-79ed-bd1e-842ce64fed06" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_019c4318-522c-7ba9-8c9a-e98056369c11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_019c4318-522c-7a34-87ce-02d4e0244cf8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-522c-79ed-bd1e-842ce64fed06" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_019c4318-522c-7a34-87ce-02d4e0244cf8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_019c4318-522c-78d1-81fb-f4020ab3dbaa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-522c-79ed-bd1e-842ce64fed06" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_019c4318-522c-78d1-81fb-f4020ab3dbaa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_019c4318-522c-7d63-9eb2-ff3648df1e1d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#LeasesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:href="soph-20251231.xsd#soph_DisclosureOfLeaseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:href="soph-20251231.xsd#soph_DisclosureOfLeaseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522c-7fcd-a3ae-905da5c7d42d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522c-7fcd-a3ae-905da5c7d42d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522c-7fcd-a3ae-905da5c7d42d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522c-7fcd-a3ae-905da5c7d42d" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522c-7fcd-a3ae-905da5c7d42d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522c-7611-8d20-df8f9ff2955c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522c-7fcd-a3ae-905da5c7d42d" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522c-7611-8d20-df8f9ff2955c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OfficeSpaceMember_019c4318-522c-70af-b4fa-39c16c346ac1" xlink:href="soph-20251231.xsd#soph_OfficeSpaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522c-7611-8d20-df8f9ff2955c" xlink:to="loc_soph_OfficeSpaceMember_019c4318-522c-70af-b4fa-39c16c346ac1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e86-a149-ba57e2e7e742" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:to="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e86-a149-ba57e2e7e742" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-7e86-a149-ba57e2e7e742_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e86-a149-ba57e2e7e742" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-7e86-a149-ba57e2e7e742_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-780b-971d-0c6ce37b955b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e86-a149-ba57e2e7e742" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-780b-971d-0c6ce37b955b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RolleSwitzerlandMember_019c4318-522c-774c-a8ea-38147833bdd6" xlink:href="soph-20251231.xsd#soph_RolleSwitzerlandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-780b-971d-0c6ce37b955b" xlink:to="loc_soph_RolleSwitzerlandMember_019c4318-522c-774c-a8ea-38147833bdd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BostonMassachusettsMember_019c4318-522c-7d57-a6ca-0096546e53e3" xlink:href="soph-20251231.xsd#soph_BostonMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-780b-971d-0c6ce37b955b" xlink:to="loc_soph_BostonMassachusettsMember_019c4318-522c-7d57-a6ca-0096546e53e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BidartFranceMember_019c4318-522c-73d0-b74b-7fa41e4f9aa9" xlink:href="soph-20251231.xsd#soph_BidartFranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-780b-971d-0c6ce37b955b" xlink:to="loc_soph_BidartFranceMember_019c4318-522c-73d0-b74b-7fa41e4f9aa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-522c-7394-9bcb-b3c58acb2b08" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:to="loc_ifrs-full_RangeAxis_019c4318-522c-7394-9bcb-b3c58acb2b08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522c-7394-9bcb-b3c58acb2b08_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522c-7394-9bcb-b3c58acb2b08" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522c-7394-9bcb-b3c58acb2b08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522c-7bc3-85c3-bcffc809c70f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522c-7394-9bcb-b3c58acb2b08" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522c-7bc3-85c3-bcffc809c70f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-522c-73dd-9c54-146a486bb188" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522c-7bc3-85c3-bcffc809c70f" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-522c-73dd-9c54-146a486bb188" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-522c-7427-a511-122446766fa8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522c-7bc3-85c3-bcffc809c70f" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-522c-7427-a511-122446766fa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522c-7ce0-be85-a80d5ecc53c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522c-7ce0-be85-a80d5ecc53c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522c-7ce0-be85-a80d5ecc53c7_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522c-7ce0-be85-a80d5ecc53c7" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522c-7ce0-be85-a80d5ecc53c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522c-729b-9372-ad1544990180" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522c-7ce0-be85-a80d5ecc53c7" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522c-729b-9372-ad1544990180" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember_019c4318-522c-7a89-bb2d-dbab2f3ce97c" xlink:href="soph-20251231.xsd#soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522c-729b-9372-ad1544990180" xlink:to="loc_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember_019c4318-522c-7a89-bb2d-dbab2f3ce97c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfLeases_019c4318-522c-77f8-a372-021c3bb0b230" xlink:href="soph-20251231.xsd#soph_NumberOfLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_NumberOfLeases_019c4318-522c-77f8-a372-021c3bb0b230" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseTerm_019c4318-522c-7381-8100-78741392c56d" xlink:href="soph-20251231.xsd#soph_LeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_LeaseTerm_019c4318-522c-7381-8100-78741392c56d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AreaOfOfficeSpaceLeased_019c4318-522c-7a32-9e5f-bcf509fa4297" xlink:href="soph-20251231.xsd#soph_AreaOfOfficeSpaceLeased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_AreaOfOfficeSpaceLeased_019c4318-522c-7a32-9e5f-bcf509fa4297" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AreaOfOfficeSpaceGainedAccessUnderLease_019c4318-522c-75d9-bc2c-309a4573aca5" xlink:href="soph-20251231.xsd#soph_AreaOfOfficeSpaceGainedAccessUnderLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_AreaOfOfficeSpaceGainedAccessUnderLease_019c4318-522c-75d9-bc2c-309a4573aca5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_019c4318-522c-73f1-8237-0c1067486a29" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_ifrs-full_RightofuseAssets_019c4318-522c-73f1-8237-0c1067486a29" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_019c4318-522c-7cfb-bb2b-a619114885e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_ifrs-full_LeaseLiabilities_019c4318-522c-7cfb-bb2b-a619114885e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseIncentivesAndExpectedRestorationCosts_019c4318-522c-7925-9b7f-019d9070fcf4" xlink:href="soph-20251231.xsd#soph_LeaseIncentivesAndExpectedRestorationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_LeaseIncentivesAndExpectedRestorationCosts_019c4318-522c-7925-9b7f-019d9070fcf4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseDirectCosts_019c4318-522c-7ad3-9959-1ea7c59ae880" xlink:href="soph-20251231.xsd#soph_LeaseDirectCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_LeaseDirectCosts_019c4318-522c-7ad3-9959-1ea7c59ae880" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExpectedLeaseCommitments_019c4318-522c-7a33-9cf5-912ae948bd0c" xlink:href="soph-20251231.xsd#soph_ExpectedLeaseCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_ExpectedLeaseCommitments_019c4318-522c-7a33-9cf5-912ae948bd0c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseExpenses_019c4318-522c-784b-b744-1413b66f3fa5" xlink:href="soph-20251231.xsd#soph_LeaseExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_LeaseExpenses_019c4318-522c-784b-b744-1413b66f3fa5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashOutflowForLeases_019c4318-522c-7f52-b651-0214d7d48cc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashOutflowForLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_ifrs-full_CashOutflowForLeases_019c4318-522c-7f52-b651-0214d7d48cc8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RightOfUseAssetsDiscountedPaymentsRate_019c4318-522c-7581-a990-5bdca5932327" xlink:href="soph-20251231.xsd#soph_RightOfUseAssetsDiscountedPaymentsRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_RightOfUseAssetsDiscountedPaymentsRate_019c4318-522c-7581-a990-5bdca5932327" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseLiabilitiesDiscountedPaymentsRate_019c4318-522c-7627-9b57-4dc7e225b33b" xlink:href="soph-20251231.xsd#soph_LeaseLiabilitiesDiscountedPaymentsRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_LeaseLiabilitiesDiscountedPaymentsRate_019c4318-522c-7627-9b57-4dc7e225b33b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_019c89bb-0601-76e9-a859-b217894998a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_ifrs-full_AdditionsToRightofuseAssets_019c89bb-0601-76e9-a859-b217894998a9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_019c89bb-0601-7ded-b355-f4571f1c02e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_019c89bb-0601-7ded-b355-f4571f1c02e3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PrincipalPaidOnLeaseLiabilities_019c89bb-4570-798e-8a4f-aaca68bcae6f" xlink:href="soph-20251231.xsd#soph_PrincipalPaidOnLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_PrincipalPaidOnLeaseLiabilities_019c89bb-4570-798e-8a4f-aaca68bcae6f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_InterestPaidOnLeaseLiabilities_019c89bb-4570-7438-b1f4-46018f2c66f6" xlink:href="soph-20251231.xsd#soph_InterestPaidOnLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_InterestPaidOnLeaseLiabilities_019c89bb-4570-7438-b1f4-46018f2c66f6" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#LeasesSummaryofRightofUseAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfLeaseLineItems_019c9fdf-169c-7dfc-9d49-9a43488622a4" xlink:href="soph-20251231.xsd#soph_DisclosureOfLeaseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfLeaseTable_019c9fdf-169c-77b3-9b6d-be85a46ce413" xlink:href="soph-20251231.xsd#soph_DisclosureOfLeaseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c9fdf-169c-7dfc-9d49-9a43488622a4" xlink:to="loc_soph_DisclosureOfLeaseTable_019c9fdf-169c-77b3-9b6d-be85a46ce413" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_019c9fdf-169c-79c6-9a93-b191556e9c59" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfLeaseTable_019c9fdf-169c-77b3-9b6d-be85a46ce413" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_019c9fdf-169c-79c6-9a93-b191556e9c59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_019c9fdf-169c-79c6-9a93-b191556e9c59_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_019c9fdf-169c-79c6-9a93-b191556e9c59" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_019c9fdf-169c-79c6-9a93-b191556e9c59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_019c9fdf-169c-778b-b1d8-922e8ef43de5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_019c9fdf-169c-79c6-9a93-b191556e9c59" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_019c9fdf-169c-778b-b1d8-922e8ef43de5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OfficeSpaceMember_019c9fdf-169c-70fa-ab0d-e5bc818d22fd" xlink:href="soph-20251231.xsd#soph_OfficeSpaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_019c9fdf-169c-778b-b1d8-922e8ef43de5" xlink:to="loc_soph_OfficeSpaceMember_019c9fdf-169c-70fa-ab0d-e5bc818d22fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_019c9fdf-169c-731c-8c80-0be731371b4f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c9fdf-169c-7dfc-9d49-9a43488622a4" xlink:to="loc_ifrs-full_RightofuseAssets_019c9fdf-169c-731c-8c80-0be731371b4f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7617-964c-cebd9be0a056" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7bc7-bcb2-f99829e41f94" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7617-964c-cebd9be0a056" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7bc7-bcb2-f99829e41f94" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7f2a-8223-3360500096fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7bc7-bcb2-f99829e41f94" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7f2a-8223-3360500096fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7f2a-8223-3360500096fe_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7f2a-8223-3360500096fe" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7f2a-8223-3360500096fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-711b-af03-19f522bb9a15" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7f2a-8223-3360500096fe" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-711b-af03-19f522bb9a15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7826-ab9f-7a66edf3554f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-711b-af03-19f522bb9a15" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7826-ab9f-7a66edf3554f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-786a-a4f1-f7f6026f6352" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-711b-af03-19f522bb9a15" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-786a-a4f1-f7f6026f6352" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract_019c4318-522c-7320-8b8b-cc8403ae86a9" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7617-964c-cebd9be0a056" xlink:to="loc_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract_019c4318-522c-7320-8b8b-cc8403ae86a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:href="soph-20251231.xsd#soph_ChangesInDefinedBenefitObligationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract_019c4318-522c-7320-8b8b-cc8403ae86a9" xlink:to="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-522c-7905-a9ba-f336cc8975bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-522c-7905-a9ba-f336cc8975bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ServiceCostDefinedBenefitPlans_019c4318-522c-7811-b721-9adf8bbf0213" xlink:href="soph-20251231.xsd#soph_ServiceCostDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_soph_ServiceCostDefinedBenefitPlans_019c4318-522c-7811-b721-9adf8bbf0213" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_019c4318-522c-753b-8bb6-a58088b896a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentServiceCostDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_019c4318-522c-753b-8bb6-a58088b896a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans_019c4318-522c-7767-9861-bbb2041b3b1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans_019c4318-522c-7767-9861-bbb2041b3b1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_019c4318-522c-75fb-89bb-d889505760c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_019c4318-522c-75fb-89bb-d889505760c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7326-801d-2f53f0c69ce6" xlink:href="soph-20251231.xsd#soph_ActuarialGainsLossesNetDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7326-801d-2f53f0c69ce6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_019c4318-522c-7247-9322-3e44d4cfeff8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_019c4318-522c-7247-9322-3e44d4cfeff8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans_019c4318-522c-7b48-95e8-c95e85075bcf" xlink:href="soph-20251231.xsd#soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans_019c4318-522c-7b48-95e8-c95e85075bcf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans_019c4318-522c-7533-8e31-59dbe282fef6" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans_019c4318-522c-7533-8e31-59dbe282fef6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-522c-7cf6-a9de-312681bed9ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-76a9-b82d-a7c323f919c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-76a9-b82d-a7c323f919c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-76a9-b82d-a7c323f919c0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-76a9-b82d-a7c323f919c0" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-76a9-b82d-a7c323f919c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7db4-b8f7-528debf3062d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-76a9-b82d-a7c323f919c0" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7db4-b8f7-528debf3062d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7a2a-b6c6-0eb594d86747" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7db4-b8f7-528debf3062d" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7a2a-b6c6-0eb594d86747" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_019c4318-522c-7889-865a-f454b5bce146" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_019c4318-522c-7889-865a-f454b5bce146" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_019c4318-522c-7889-865a-f454b5bce146_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_019c4318-522c-7889-865a-f454b5bce146" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_019c4318-522c-7889-865a-f454b5bce146_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_019c4318-522c-7604-86cf-f5d705013274" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_019c4318-522c-7889-865a-f454b5bce146" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_019c4318-522c-7604-86cf-f5d705013274" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SwissPensionPlanMember_019c4318-522c-7082-a993-7767efee1013" xlink:href="soph-20251231.xsd#soph_SwissPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_019c4318-522c-7604-86cf-f5d705013274" xlink:to="loc_soph_SwissPensionPlanMember_019c4318-522c-7082-a993-7767efee1013" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FrenchPensionPlanMember_019c4318-522c-7069-9270-49e339476fac" xlink:href="soph-20251231.xsd#soph_FrenchPensionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_019c4318-522c-7604-86cf-f5d705013274" xlink:to="loc_soph_FrenchPensionPlanMember_019c4318-522c-7069-9270-49e339476fac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e5f-85f3-09fbed6c225a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:to="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e5f-85f3-09fbed6c225a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-7e5f-85f3-09fbed6c225a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e5f-85f3-09fbed6c225a" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-7e5f-85f3-09fbed6c225a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-737d-8258-a52cbf329434" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e5f-85f3-09fbed6c225a" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-737d-8258-a52cbf329434" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_019c4318-522c-71f4-804d-ec55f6e802d8" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-737d-8258-a52cbf329434" xlink:to="loc_country_US_019c4318-522c-71f4-804d-ec55f6e802d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c71d2-4074-7854-9cbf-ba64665d2df8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:to="loc_ifrs-full_RangeAxis_019c71d2-4074-7854-9cbf-ba64665d2df8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c71d2-4074-7854-9cbf-ba64665d2df8_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_019c71d2-4074-7854-9cbf-ba64665d2df8" xlink:to="loc_ifrs-full_RangeDomain_019c71d2-4074-7854-9cbf-ba64665d2df8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c71d2-4074-7cf0-a546-3b00244f1148" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_019c71d2-4074-7854-9cbf-ba64665d2df8" xlink:to="loc_ifrs-full_RangeDomain_019c71d2-4074-7cf0-a546-3b00244f1148" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c71d3-4c9f-7e7a-8bf7-815eb37a9738" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c71d2-4074-7cf0-a546-3b00244f1148" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c71d3-4c9f-7e7a-8bf7-815eb37a9738" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c71d3-920f-7608-bd50-6776300b7613" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c71d2-4074-7cf0-a546-3b00244f1148" xlink:to="loc_ifrs-full_TopOfRangeMember_019c71d3-920f-7608-bd50-6776300b7613" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfActiveMembers_019c4318-522c-7ba0-a9fa-ce0d56ab7720" xlink:href="soph-20251231.xsd#soph_NumberOfActiveMembers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_NumberOfActiveMembers_019c4318-522c-7ba0-a9fa-ce0d56ab7720" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans_019c4318-522c-7169-aa94-b8d908e222c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans_019c4318-522c-7169-aa94-b8d908e222c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DemographicAssumptionOfWeightedTurnoverRates_019c4318-522c-7faa-8ba3-dfbd60e46e8c" xlink:href="soph-20251231.xsd#soph_DemographicAssumptionOfWeightedTurnoverRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_DemographicAssumptionOfWeightedTurnoverRates_019c4318-522c-7faa-8ba3-dfbd60e46e8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FinancialAssumptionOfDiscountRates_019c4318-522c-7c2f-b4ae-ec3602e499f3" xlink:href="soph-20251231.xsd#soph_FinancialAssumptionOfDiscountRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_FinancialAssumptionOfDiscountRates_019c4318-522c-7c2f-b4ae-ec3602e499f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_019c4318-522c-716a-a94b-b704f82dd784" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_019c4318-522c-716a-a94b-b704f82dd784" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_019c4318-522c-7e31-91e4-de43c4632fa1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_019c4318-522c-7e31-91e4-de43c4632fa1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_019c4318-522c-7f5f-b6b6-82b7fdc2caa7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_019c4318-522c-7f5f-b6b6-82b7fdc2caa7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LPPInterestRate_019c4318-522c-7f64-ba2e-ff6f103d4437" xlink:href="soph-20251231.xsd#soph_LPPInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_LPPInterestRate_019c4318-522c-7f64-ba2e-ff6f103d4437" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExtraMandatoryPartEquivalentToDiscountRate_019c4318-522c-73bd-9913-d854eea257ff" xlink:href="soph-20251231.xsd#soph_ExtraMandatoryPartEquivalentToDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_ExtraMandatoryPartEquivalentToDiscountRate_019c4318-522c-73bd-9913-d854eea257ff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_019c4318-522c-7aa8-ad06-0136852ac740" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_019c4318-522c-7aa8-ad06-0136852ac740" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForMale_019c4318-522c-7792-a42a-84fc723ff004" xlink:href="soph-20251231.xsd#soph_AverageLifeExpectancyInYearsAfterRetirementForMale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForMale_019c4318-522c-7792-a42a-84fc723ff004" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale_019c4318-522c-7600-b1ea-a2d2b0f241b8" xlink:href="soph-20251231.xsd#soph_AverageLifeExpectancyInYearsAfterRetirementForFemale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale_019c4318-522c-7600-b1ea-a2d2b0f241b8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_019c4318-522c-7d57-a623-746bc4f7c2b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_019c4318-522c-7d57-a623-746bc4f7c2b2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_019c4318-522c-7900-9bd4-12606324ec60" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_019c4318-522c-7900-9bd4-12606324ec60" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c6790-95fa-7e0b-bf64-e52738a7c242" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c6790-95fa-7d6e-9435-6fea9761c84c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c6790-95fa-7e0b-bf64-e52738a7c242" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c6790-95fa-7d6e-9435-6fea9761c84c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_019c6790-95fa-799c-a249-53e792f24bb2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c6790-95fa-7d6e-9435-6fea9761c84c" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_019c6790-95fa-799c-a249-53e792f24bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_019c6790-95fa-799c-a249-53e792f24bb2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_019c6790-95fa-799c-a249-53e792f24bb2" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_019c6790-95fa-799c-a249-53e792f24bb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_019c6790-95fa-7824-9748-7ba00bf20b0d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_019c6790-95fa-799c-a249-53e792f24bb2" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_019c6790-95fa-7824-9748-7ba00bf20b0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FrenchPlanMember_019c6791-c120-7897-8db2-04a530f1f3ec" xlink:href="soph-20251231.xsd#soph_FrenchPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_019c6790-95fa-7824-9748-7ba00bf20b0d" xlink:to="loc_soph_FrenchPlanMember_019c6791-c120-7897-8db2-04a530f1f3ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SwissPlanMember_019c6792-811f-756a-acc7-114e1dab649e" xlink:href="soph-20251231.xsd#soph_SwissPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_019c6790-95fa-7824-9748-7ba00bf20b0d" xlink:to="loc_soph_SwissPlanMember_019c6792-811f-756a-acc7-114e1dab649e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_019cb022-0eb1-7f4d-8a46-0a914c161e13" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c6790-95fa-7e0b-bf64-e52738a7c242" xlink:to="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_019cb022-0eb1-7f4d-8a46-0a914c161e13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets_019c6790-95fa-7e52-8f06-6b03cfdfe815" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c6790-95fa-7e0b-bf64-e52738a7c242" xlink:to="loc_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets_019c6790-95fa-7e52-8f06-6b03cfdfe815" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_019c6790-95fa-7a46-bc68-5fdaf067ab1f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c6790-95fa-7e0b-bf64-e52738a7c242" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_019c6790-95fa-7a46-bc68-5fdaf067ab1f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7fab-a77d-c79f7ea87c14" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7474-8f4c-dfc438cab498" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7fab-a77d-c79f7ea87c14" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7474-8f4c-dfc438cab498" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7db2-a13e-581e80b713c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7474-8f4c-dfc438cab498" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7db2-a13e-581e80b713c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7db2-a13e-581e80b713c6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7db2-a13e-581e80b713c6" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7db2-a13e-581e80b713c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7249-b7c2-679b080dbac6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7db2-a13e-581e80b713c6" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7249-b7c2-679b080dbac6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7479-af59-de59925fc58c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7249-b7c2-679b080dbac6" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7479-af59-de59925fc58c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7b79-aeca-8291e96a76da" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7249-b7c2-679b080dbac6" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7b79-aeca-8291e96a76da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ServiceCostDefinedBenefitPlans_019c4318-522c-7235-8758-9cd2955e70de" xlink:href="soph-20251231.xsd#soph_ServiceCostDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7fab-a77d-c79f7ea87c14" xlink:to="loc_soph_ServiceCostDefinedBenefitPlans_019c4318-522c-7235-8758-9cd2955e70de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans_019c4318-522c-7178-8c25-dc9eefd80367" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseIncomeDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7fab-a77d-c79f7ea87c14" xlink:to="loc_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans_019c4318-522c-7178-8c25-dc9eefd80367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_019c4318-522c-7017-b4ec-9065e04c1063" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7fab-a77d-c79f7ea87c14" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_019c4318-522c-7017-b4ec-9065e04c1063" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7f56-bcac-bed1f6f41f1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7f56-bcac-bed1f6f41f1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ed-b2e5-e04bf846a249" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7f56-bcac-bed1f6f41f1c" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ed-b2e5-e04bf846a249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-71ed-b2e5-e04bf846a249_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ed-b2e5-e04bf846a249" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-71ed-b2e5-e04bf846a249_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-790a-9b06-5d33defe4e76" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ed-b2e5-e04bf846a249" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-790a-9b06-5d33defe4e76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7d29-8499-356eb13e385e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-790a-9b06-5d33defe4e76" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7d29-8499-356eb13e385e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7b5c-9746-502596015d65" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-790a-9b06-5d33defe4e76" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7b5c-9746-502596015d65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7236-92c0-01f228dc685c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7236-92c0-01f228dc685c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7562-a3a7-d7fa9a73bf5c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7562-a3a7-d7fa9a73bf5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_019c4318-522c-7334-a4e7-5d27c5ad9ccd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_019c4318-522c-7334-a4e7-5d27c5ad9ccd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7e22-adc8-0f1a772ac719" xlink:href="soph-20251231.xsd#soph_ActuarialGainsLossesNetDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7e22-adc8-0f1a772ac719" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_019c4318-522c-7da1-9da3-7dc4d6c92df5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_019c4318-522c-7da1-9da3-7dc4d6c92df5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans_019c4318-522c-7be6-816a-566624e4fac4" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans_019c4318-522c-7be6-816a-566624e4fac4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-522c-7ecd-bfb7-9c5cbb34c29e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-522c-7ecd-bfb7-9c5cbb34c29e" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7fc6-9370-afa5ba7f7cca" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7fc6-9370-afa5ba7f7cca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7fa3-965f-778e7185cc71" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7fc6-9370-afa5ba7f7cca" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7fa3-965f-778e7185cc71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7fa3-965f-778e7185cc71_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7fa3-965f-778e7185cc71" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7fa3-965f-778e7185cc71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7ebc-83e4-6163c0a6df4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7fa3-965f-778e7185cc71" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7ebc-83e4-6163c0a6df4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7be8-9f26-e094be137fcd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7ebc-83e4-6163c0a6df4a" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7be8-9f26-e094be137fcd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7b9e-9f01-841c35fde58b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7fc6-9370-afa5ba7f7cca" xlink:to="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7b9e-9f01-841c35fde58b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7b9e-9f01-841c35fde58b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7b9e-9f01-841c35fde58b" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7b9e-9f01-841c35fde58b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7b9e-9f01-841c35fde58b" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_019c4318-522c-73f5-8f05-b700fa284f05" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_019c4318-522c-73f5-8f05-b700fa284f05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_019c4318-522c-7f00-b23d-83c89aa9f2b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_019c4318-522c-7f00-b23d-83c89aa9f2b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ActuarialAssumptionOfExpectedInterestRatesMember_019c4318-522c-7a2d-b0ca-ba12a7fc8e68" xlink:href="soph-20251231.xsd#soph_ActuarialAssumptionOfExpectedInterestRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:to="loc_soph_ActuarialAssumptionOfExpectedInterestRatesMember_019c4318-522c-7a2d-b0ca-ba12a7fc8e68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_019c4318-522c-757e-b292-ad4e8c2dc8fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_019c4318-522c-757e-b292-ad4e8c2dc8fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_019c4318-522c-74e3-a74d-0ccc2c841a48" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:to="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_019c4318-522c-74e3-a74d-0ccc2c841a48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-726a-9146-33afe9dae5dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-726a-9146-33afe9dae5dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7c14-8270-85202dce8511" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7c14-8270-85202dce8511" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-77df-93f4-833ceb4c4469" xlink:href="soph-20251231.xsd#soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-77df-93f4-833ceb4c4469" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-71d8-937d-58c0d8782fb4" xlink:href="soph-20251231.xsd#soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-71d8-937d-58c0d8782fb4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-7e46-9ddd-75157f4ec6f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-7e46-9ddd-75157f4ec6f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7d2c-9be0-58de6697b093" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7d2c-9be0-58de6697b093" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7029-88fe-124f22be231b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7029-88fe-124f22be231b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ca-824f-548002c6f743" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7029-88fe-124f22be231b" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ca-824f-548002c6f743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-71ca-824f-548002c6f743_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ca-824f-548002c6f743" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-71ca-824f-548002c6f743_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7329-b8dc-caafa58e92e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ca-824f-548002c6f743" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7329-b8dc-caafa58e92e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7766-936f-74ed33fd3d21" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7329-b8dc-caafa58e92e7" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7766-936f-74ed33fd3d21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7e98-9aa8-9ed610af6334" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7029-88fe-124f22be231b" xlink:to="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7e98-9aa8-9ed610af6334" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7e98-9aa8-9ed610af6334_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7e98-9aa8-9ed610af6334" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7e98-9aa8-9ed610af6334_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7b34-b79b-761c3a5eaf21" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7e98-9aa8-9ed610af6334" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7b34-b79b-761c3a5eaf21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_019c4318-522c-792b-b0e4-30a20189114f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7b34-b79b-761c3a5eaf21" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_019c4318-522c-792b-b0e4-30a20189114f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_019c4318-522c-7f1c-809c-68f08caf250c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7b34-b79b-761c3a5eaf21" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_019c4318-522c-7f1c-809c-68f08caf250c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-7453-bd86-619eee6f91d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-7453-bd86-619eee6f91d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7a22-b861-9910e45258af" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7a22-b861-9910e45258af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-79da-a3f7-75eb17bf5489" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-79da-a3f7-75eb17bf5489" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-709c-85b8-8bb97d207d53" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-709c-85b8-8bb97d207d53" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c6be8-4cc5-78c4-b741-05d10a138e04" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c6be8-4cc5-78c4-b741-05d10a138e04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-78c4-b741-05d10a138e04_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c6be8-4cc5-78c4-b741-05d10a138e04" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-78c4-b741-05d10a138e04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-701c-84f2-712daca66776" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c6be8-4cc5-78c4-b741-05d10a138e04" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-701c-84f2-712daca66776" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2013IncentiveShareOptionPlanMember_019c6be8-4cc5-7e2e-9412-d3aa69db3da1" xlink:href="soph-20251231.xsd#soph_A2013IncentiveShareOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-701c-84f2-712daca66776" xlink:to="loc_soph_A2013IncentiveShareOptionPlanMember_019c6be8-4cc5-7e2e-9412-d3aa69db3da1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2019IncentiveShareOptionPlanMember_019c6be8-4cc5-7cda-82d9-d414536ce5e0" xlink:href="soph-20251231.xsd#soph_A2019IncentiveShareOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-701c-84f2-712daca66776" xlink:to="loc_soph_A2019IncentiveShareOptionPlanMember_019c6be8-4cc5-7cda-82d9-d414536ce5e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2021EmployeeIncentivePlanMember_019c6be8-a6f3-75dd-ade9-5d7d7b9ceeca" xlink:href="soph-20251231.xsd#soph_A2021EmployeeIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-701c-84f2-712daca66776" xlink:to="loc_soph_A2021EmployeeIncentivePlanMember_019c6be8-a6f3-75dd-ade9-5d7d7b9ceeca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementsVestingAxis_019c6be8-a6f3-7d6f-bcc4-6dfe72b2de89" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementsVestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:to="loc_soph_ShareBasedPaymentArrangementsVestingAxis_019c6be8-a6f3-7d6f-bcc4-6dfe72b2de89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7d6f-bcc4-6dfe72b2de89_default" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementsVestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_soph_ShareBasedPaymentArrangementsVestingAxis_019c6be8-a6f3-7d6f-bcc4-6dfe72b2de89" xlink:to="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7d6f-bcc4-6dfe72b2de89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7093-984e-7a7610b455e7" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementsVestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_soph_ShareBasedPaymentArrangementsVestingAxis_019c6be8-a6f3-7d6f-bcc4-6dfe72b2de89" xlink:to="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7093-984e-7a7610b455e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementVestingTrancheOneMember_019c6be8-a6f3-7701-9b8b-e299614afe82" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementVestingTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7093-984e-7a7610b455e7" xlink:to="loc_soph_ShareBasedPaymentArrangementVestingTrancheOneMember_019c6be8-a6f3-7701-9b8b-e299614afe82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember_019c6be8-a6f3-7cfe-8949-e48aab55aece" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementVestingTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7093-984e-7a7610b455e7" xlink:to="loc_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember_019c6be8-a6f3-7cfe-8949-e48aab55aece" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember_019c6be9-7ba8-74e9-945c-97625f00f31f" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementVestingTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7093-984e-7a7610b455e7" xlink:to="loc_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember_019c6be9-7ba8-74e9-945c-97625f00f31f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c7475-5943-73cb-8578-ea9d71e2d7be" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:to="loc_ifrs-full_RangeAxis_019c7475-5943-73cb-8578-ea9d71e2d7be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c7475-5943-73cb-8578-ea9d71e2d7be_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_019c7475-5943-73cb-8578-ea9d71e2d7be" xlink:to="loc_ifrs-full_RangeDomain_019c7475-5943-73cb-8578-ea9d71e2d7be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c7475-5943-70c6-85ab-c89ed602adad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_019c7475-5943-73cb-8578-ea9d71e2d7be" xlink:to="loc_ifrs-full_RangeDomain_019c7475-5943-70c6-85ab-c89ed602adad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c7475-5943-7ad9-b3cb-c826f404cb5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c7475-5943-70c6-85ab-c89ed602adad" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c7475-5943-7ad9-b3cb-c826f404cb5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c7475-5943-78f0-b2f3-05ed1e1ed2b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c7475-5943-70c6-85ab-c89ed602adad" xlink:to="loc_ifrs-full_TopOfRangeMember_019c7475-5943-78f0-b2f3-05ed1e1ed2b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019c6be9-7ba8-75ee-ba27-53bf23fe532d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019c6be9-7ba8-75ee-ba27-53bf23fe532d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c6be9-7ba8-75ee-ba27-53bf23fe532d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c6be9-7ba8-75ee-ba27-53bf23fe532d" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c6be9-7ba8-75ee-ba27-53bf23fe532d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c6be9-7ba8-7929-bac3-d64acc6c5e36" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c6be9-7ba8-75ee-ba27-53bf23fe532d" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c6be9-7ba8-7929-bac3-d64acc6c5e36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RestrictedStockUnitsMember_019c6be9-7ba8-70bf-82c2-d1383db89a18" xlink:href="soph-20251231.xsd#soph_RestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019c6be9-7ba8-7929-bac3-d64acc6c5e36" xlink:to="loc_soph_RestrictedStockUnitsMember_019c6be9-7ba8-70bf-82c2-d1383db89a18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_019c6be8-4cc5-7113-986f-71cf18c0042c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_019c6be8-4cc5-7113-986f-71cf18c0042c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfShareOptionPlans_019c6be8-7af3-7196-a0ff-1cb223db9e4a" xlink:href="soph-20251231.xsd#soph_NumberOfShareOptionPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_NumberOfShareOptionPlans_019c6be8-7af3-7196-a0ff-1cb223db9e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_019c6be8-a6f3-79d5-ab3d-3784ff1ce4b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_019c6be8-a6f3-79d5-ab3d-3784ff1ce4b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis_019c6be8-a6f3-79ad-bb74-053daa537a35" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis_019c6be8-a6f3-79ad-bb74-053daa537a35" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis_019c6be8-a6f3-76c7-8944-89233664f8a4" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis_019c6be8-a6f3-76c7-8944-89233664f8a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis_019c72cb-46df-79a3-934f-96b740c07ddb" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis_019c72cb-46df-79a3-934f-96b740c07ddb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_019c6be8-a6f3-7b9c-9fd3-34dc7c152a8b" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_019c6be8-a6f3-7b9c-9fd3-34dc7c152a8b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_019c72cf-56f9-70ae-b993-a7d59b628939" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_019c72cf-56f9-70ae-b993-a7d59b628939" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_019c6be8-a6f3-7d38-aead-c0f0ab7ca566" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_019c6be8-a6f3-7d38-aead-c0f0ab7ca566" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c6be8-d992-7fc6-9c51-65bde330aabc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c6be8-d992-7fc6-9c51-65bde330aabc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_019c6be8-d992-78d7-ba58-cfc7bf5da4e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_019c6be8-d992-78d7-ba58-cfc7bf5da4e7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_019c6be9-7ba8-7705-a13f-8eb334096b94" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_019c6be9-7ba8-7705-a13f-8eb334096b94" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019c6be9-7ba8-779d-b15d-ad363d306cb0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019c6be9-7ba8-779d-b15d-ad363d306cb0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_019c6be9-7ba8-73bd-9796-46b2cdfd173b" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_019c6be9-7ba8-73bd-9796-46b2cdfd173b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_019c72d8-a229-75bc-86b5-a2b223fffbd9" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_019c72d8-a229-75bc-86b5-a2b223fffbd9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_019c72dc-e136-7691-8933-89fe17e9f35a" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_019c72dc-e136-7691-8933-89fe17e9f35a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_019c72dd-3526-71cf-9ba1-8deb0fe63fb9" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_019c72dd-3526-71cf-9ba1-8deb0fe63fb9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_019c72e0-de9f-71fe-95b2-1ab865410c80" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_019c72e0-de9f-71fe-95b2-1ab865410c80" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_019c72e1-3027-7f8d-8f47-e05ff4bd8141" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_019c72e1-3027-7f8d-8f47-e05ff4bd8141" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationSummaryofStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc1-845b-3a9b7df1ce55" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7ed2-815c-57f46a0a2912" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc1-845b-3a9b7df1ce55" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7ed2-815c-57f46a0a2912" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7c06-b5b6-c675853bb6fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7ed2-815c-57f46a0a2912" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7c06-b5b6-c675853bb6fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7c06-b5b6-c675853bb6fc_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7c06-b5b6-c675853bb6fc" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7c06-b5b6-c675853bb6fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7812-a6b0-bb6960e0a23e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7c06-b5b6-c675853bb6fc" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7812-a6b0-bb6960e0a23e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2013IncentiveShareOptionPlanMember_019c4318-522c-77ae-a968-24480199fb0e" xlink:href="soph-20251231.xsd#soph_A2013IncentiveShareOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7812-a6b0-bb6960e0a23e" xlink:to="loc_soph_A2013IncentiveShareOptionPlanMember_019c4318-522c-77ae-a968-24480199fb0e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2019IncentiveShareOptionPlanMember_019c4318-522c-7a19-9852-d4ea42604efc" xlink:href="soph-20251231.xsd#soph_A2019IncentiveShareOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7812-a6b0-bb6960e0a23e" xlink:to="loc_soph_A2019IncentiveShareOptionPlanMember_019c4318-522c-7a19-9852-d4ea42604efc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-7a39-9830-89aa1fbb3858" xlink:href="soph-20251231.xsd#soph_A2021EmployeeIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7812-a6b0-bb6960e0a23e" xlink:to="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-7a39-9830-89aa1fbb3858" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7a9f-b00f-5bb7b190b172" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc1-845b-3a9b7df1ce55" xlink:to="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7a9f-b00f-5bb7b190b172" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7e3c-a43c-e350faa1b6ea" xlink:href="soph-20251231.xsd#soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7a9f-b00f-5bb7b190b172" xlink:to="loc_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7e3c-a43c-e350faa1b6ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:href="soph-20251231.xsd#soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7e3c-a43c-e350faa1b6ea" xlink:to="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_019c4318-522c-718e-bc4b-38cb2f68e7a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_019c4318-522c-718e-bc4b-38cb2f68e7a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_019c4318-522c-7f29-a5f5-49136f9a8996" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_019c4318-522c-7f29-a5f5-49136f9a8996" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_019c4318-522c-79a8-b6c4-3d421da1dfda" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_019c4318-522c-79a8-b6c4-3d421da1dfda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_019c4318-522c-71dc-98c8-ccf28fde1806" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_019c4318-522c-71dc-98c8-ccf28fde1806" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_019c4318-522c-7a8d-b2be-bd15d9c38eee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_019c4318-522c-7642-9ad8-bc09ac320344" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7e3c-a43c-e350faa1b6ea" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_019c4318-522c-7642-9ad8-bc09ac320344" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7143-9ef9-8c39641a622c" xlink:href="soph-20251231.xsd#soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7a9f-b00f-5bb7b190b172" xlink:to="loc_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7143-9ef9-8c39641a622c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:href="soph-20251231.xsd#soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7143-9ef9-8c39641a622c" xlink:to="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c4318-522c-7b04-b30a-ba64eae1314c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c4318-522c-7b04-b30a-ba64eae1314c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_019c4318-522c-7edc-9011-9a9499cd7e84" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_019c4318-522c-7edc-9011-9a9499cd7e84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_019c4318-522c-7261-8574-dccb47ec1c1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_019c4318-522c-7261-8574-dccb47ec1c1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_019c4318-522c-72b2-809d-4196eface8ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_019c4318-522c-72b2-809d-4196eface8ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c4318-522c-778a-bde8-150d45706442" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_019c4318-522c-777b-9509-6c8a0011cdbf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7143-9ef9-8c39641a622c" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_019c4318-522c-777b-9509-6c8a0011cdbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-76ad-8733-d6298208a571" xlink:href="soph-20251231.xsd#soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7a9f-b00f-5bb7b190b172" xlink:to="loc_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-76ad-8733-d6298208a571" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_019c4318-522c-7a3b-b88d-975963be6d3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-76ad-8733-d6298208a571" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_019c4318-522c-7a3b-b88d-975963be6d3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions_019c4318-522c-74b0-9c87-8606a333cab5" xlink:href="soph-20251231.xsd#soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-76ad-8733-d6298208a571" xlink:to="loc_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions_019c4318-522c-74b0-9c87-8606a333cab5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationSummaryofValuationInputsDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-78c7-b925-3593576f1991" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-78c7-b925-3593576f1991" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7da6-b854-246abe08864b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-78c7-b925-3593576f1991" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7da6-b854-246abe08864b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7da6-b854-246abe08864b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7da6-b854-246abe08864b" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7da6-b854-246abe08864b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7c7b-b9f3-a7c878d59795" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7da6-b854-246abe08864b" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7c7b-b9f3-a7c878d59795" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-757c-97ca-1326296436e2" xlink:href="soph-20251231.xsd#soph_A2021EmployeeIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7c7b-b9f3-a7c878d59795" xlink:to="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-757c-97ca-1326296436e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-522c-76a0-80f8-fa111cbfd44b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-78c7-b925-3593576f1991" xlink:to="loc_ifrs-full_RangeAxis_019c4318-522c-76a0-80f8-fa111cbfd44b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522c-76a0-80f8-fa111cbfd44b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522c-76a0-80f8-fa111cbfd44b" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522c-76a0-80f8-fa111cbfd44b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522c-75de-b2e5-3a39154ca26c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522c-76a0-80f8-fa111cbfd44b" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522c-75de-b2e5-3a39154ca26c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-522c-7f8d-a212-e7bff619da51" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522c-75de-b2e5-3a39154ca26c" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-522c-7f8d-a212-e7bff619da51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-522c-7e92-9cd3-dee12b15f16f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522c-75de-b2e5-3a39154ca26c" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-522c-7e92-9cd3-dee12b15f16f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_019c4318-522c-7130-b596-7d2885e57610" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_019c4318-522c-7130-b596-7d2885e57610" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_019c4318-522c-7caf-8465-218fe615fc6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_019c4318-522c-7caf-8465-218fe615fc6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_019c4318-522c-78fa-9de1-9bddf7afa16e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_019c4318-522c-78fa-9de1-9bddf7afa16e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_019c4318-522c-7e16-8ce3-d677dca6e573" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_019c4318-522c-7e16-8ce3-d677dca6e573" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_019c4318-522c-732a-a6bc-807bb59efb23" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_019c4318-522c-732a-a6bc-807bb59efb23" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc8-995a-76df69d2e701" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7d96-ba49-f535f1d2ece3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc8-995a-76df69d2e701" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7d96-ba49-f535f1d2ece3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7a81-b968-4c6fd9b0842a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7d96-ba49-f535f1d2ece3" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7a81-b968-4c6fd9b0842a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7a81-b968-4c6fd9b0842a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7a81-b968-4c6fd9b0842a" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7a81-b968-4c6fd9b0842a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-77dc-8437-f7871a30d057" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7a81-b968-4c6fd9b0842a" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-77dc-8437-f7871a30d057" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-783d-8bd1-68ea05ac7e0a" xlink:href="soph-20251231.xsd#soph_A2021EmployeeIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-77dc-8437-f7871a30d057" xlink:to="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-783d-8bd1-68ea05ac7e0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageFairValueShareOptionsGranted_019c4318-522c-7081-9edd-0c21314e7be6" xlink:href="soph-20251231.xsd#soph_WeightedAverageFairValueShareOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc8-995a-76df69d2e701" xlink:to="loc_soph_WeightedAverageFairValueShareOptionsGranted_019c4318-522c-7081-9edd-0c21314e7be6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7147-8abe-a73d08cb1361" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7fc7-b1a5-1b017d71d45c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7147-8abe-a73d08cb1361" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7fc7-b1a5-1b017d71d45c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-735c-86ad-3fbb87540bc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7fc7-b1a5-1b017d71d45c" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-735c-86ad-3fbb87540bc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-735c-86ad-3fbb87540bc2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-735c-86ad-3fbb87540bc2" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-735c-86ad-3fbb87540bc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-71b0-8454-2be8722f7da4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-735c-86ad-3fbb87540bc2" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-71b0-8454-2be8722f7da4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RestrictedStockUnitsMember_019c4318-522c-7642-85eb-358c3e11cb1d" xlink:href="soph-20251231.xsd#soph_RestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-71b0-8454-2be8722f7da4" xlink:to="loc_soph_RestrictedStockUnitsMember_019c4318-522c-7642-85eb-358c3e11cb1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7bf9-a100-38f77cf2caa3" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7147-8abe-a73d08cb1361" xlink:to="loc_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7bf9-a100-38f77cf2caa3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7fa8-a29a-1416ac67a27a" xlink:href="soph-20251231.xsd#soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7bf9-a100-38f77cf2caa3" xlink:to="loc_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7fa8-a29a-1416ac67a27a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:href="soph-20251231.xsd#soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7fa8-a29a-1416ac67a27a" xlink:to="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_019c4318-522c-7d72-b3c2-5b9cbca4f4a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_019c4318-522c-7d72-b3c2-5b9cbca4f4a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_019c4318-522c-7041-b458-359673379a8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_019c4318-522c-7041-b458-359673379a8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019c4318-522c-76f6-8c20-f640710b75f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019c4318-522c-76f6-8c20-f640710b75f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_019c4318-522c-7e1f-8304-4944e419bf94" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_019c4318-522c-7e1f-8304-4944e419bf94" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_019c4318-522c-73e4-9440-888ad915e08e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-764a-b082-9afc78ac1c4a" xlink:href="soph-20251231.xsd#soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7bf9-a100-38f77cf2caa3" xlink:to="loc_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-764a-b082-9afc78ac1c4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:href="soph-20251231.xsd#soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-764a-b082-9afc78ac1c4a" xlink:to="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement_019c4318-522c-7540-9ac6-00cee81137c9" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:to="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement_019c4318-522c-7540-9ac6-00cee81137c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_019c4318-522c-7c61-a1b4-195d6d1ef606" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:to="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_019c4318-522c-7c61-a1b4-195d6d1ef606" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_019c4318-522c-7272-bc34-a097c06cd103" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:to="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_019c4318-522c-7272-bc34-a097c06cd103" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement_019c4318-522c-7e85-914b-5adb77aaf63d" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:to="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement_019c4318-522c-7e85-914b-5adb77aaf63d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement_019c4318-522c-7ef9-954d-5d2d8143ba90" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationSharebasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7631-9898-f2d63476de91" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7469-b0a8-fe41939fec16" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7631-9898-f2d63476de91" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7469-b0a8-fe41939fec16" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncomeStatementLocation1Axis_019c4318-522c-75af-a69b-f462e1599cce" xlink:href="soph-20251231.xsd#soph_IncomeStatementLocation1Axis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7469-b0a8-fe41939fec16" xlink:to="loc_soph_IncomeStatementLocation1Axis_019c4318-522c-75af-a69b-f462e1599cce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-75af-a69b-f462e1599cce_default" xlink:href="soph-20251231.xsd#soph_IncomeStatementLocation1Domain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_soph_IncomeStatementLocation1Axis_019c4318-522c-75af-a69b-f462e1599cce" xlink:to="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-75af-a69b-f462e1599cce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-7b3a-b68c-a885e8e57f4f" xlink:href="soph-20251231.xsd#soph_IncomeStatementLocation1Domain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_soph_IncomeStatementLocation1Axis_019c4318-522c-75af-a69b-f462e1599cce" xlink:to="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-7b3a-b68c-a885e8e57f4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-522c-7f81-b475-70b5cd4b2cce" xlink:href="soph-20251231.xsd#soph_ResearchAndDevelopmentExpense1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-7b3a-b68c-a885e8e57f4f" xlink:to="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-522c-7f81-b475-70b5cd4b2cce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SalesAndMarketingExpenseMember_019c4318-522c-7d6b-b271-17ac60e91bb1" xlink:href="soph-20251231.xsd#soph_SalesAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-7b3a-b68c-a885e8e57f4f" xlink:to="loc_soph_SalesAndMarketingExpenseMember_019c4318-522c-7d6b-b271-17ac60e91bb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-522c-75a5-bc77-2ad1f3d7171f" xlink:href="soph-20251231.xsd#soph_GeneralAndAdministrativeExpense1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-7b3a-b68c-a885e8e57f4f" xlink:to="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-522c-75a5-bc77-2ad1f3d7171f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_019c4318-522c-77f1-ba17-0c84f058b268" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7631-9898-f2d63476de91" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_019c4318-522c-77f1-ba17-0c84f058b268" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#BorrowingsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019c758f-a4af-7c19-9bf7-6ef2fad9faeb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019c758f-a4af-7c19-9bf7-6ef2fad9faeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7c19-9bf7-6ef2fad9faeb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c758f-a4af-7c19-9bf7-6ef2fad9faeb" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7c19-9bf7-6ef2fad9faeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7a98-bc87-8b022fa59a7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c758f-a4af-7c19-9bf7-6ef2fad9faeb" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7a98-bc87-8b022fa59a7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7a98-bc87-8b022fa59a7a" xlink:to="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheAMember_019c758f-a4af-7738-ae3f-8a1edece0383" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheAMember_019c758f-a4af-7738-ae3f-8a1edece0383" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheBMember_019c758f-a4af-7b26-9eef-ff88eccadbb2" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheBMember_019c758f-a4af-7b26-9eef-ff88eccadbb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheCMember_019c758f-f3e1-757c-a557-e98818b7ebfa" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheCMember_019c758f-f3e1-757c-a557-e98818b7ebfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheDMember_019c758f-f3e1-7883-9feb-e57a5121e179" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheDMember_019c758f-f3e1-7883-9feb-e57a5121e179" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CreditAgreementExistingMember_019c7590-76cd-73d3-9a0f-617e364b0516" xlink:href="soph-20251231.xsd#soph_CreditAgreementExistingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7a98-bc87-8b022fa59a7a" xlink:to="loc_soph_CreditAgreementExistingMember_019c7590-76cd-73d3-9a0f-617e364b0516" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CreditAgreementNewMember_019c7590-76cd-7cac-bcf8-d2786f012ca6" xlink:href="soph-20251231.xsd#soph_CreditAgreementNewMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7a98-bc87-8b022fa59a7a" xlink:to="loc_soph_CreditAgreementNewMember_019c7590-76cd-7cac-bcf8-d2786f012ca6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsAxis_019c758f-c9f5-7427-b9b3-9b8d1aae5f11" xlink:href="soph-20251231.xsd#soph_BorrowingTermsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_soph_BorrowingTermsAxis_019c758f-c9f5-7427-b9b3-9b8d1aae5f11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7427-b9b3-9b8d1aae5f11_default" xlink:href="soph-20251231.xsd#soph_BorrowingTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_soph_BorrowingTermsAxis_019c758f-c9f5-7427-b9b3-9b8d1aae5f11" xlink:to="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7427-b9b3-9b8d1aae5f11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7747-b673-d58dd6021b48" xlink:href="soph-20251231.xsd#soph_BorrowingTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_soph_BorrowingTermsAxis_019c758f-c9f5-7427-b9b3-9b8d1aae5f11" xlink:to="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7747-b673-d58dd6021b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRMember_019c758f-c9f5-791e-8898-c85bd34284d9" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7747-b673-d58dd6021b48" xlink:to="loc_soph_TermSecuredOvernightFinancingRateSOFRMember_019c758f-c9f5-791e-8898-c85bd34284d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRFloorMember_019c81cd-0d43-7c11-8b00-fc08c0a373a3" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRFloorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7747-b673-d58dd6021b48" xlink:to="loc_soph_TermSecuredOvernightFinancingRateSOFRFloorMember_019c81cd-0d43-7c11-8b00-fc08c0a373a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember_019c758f-c9f5-7632-80bd-2836bbe5a999" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7747-b673-d58dd6021b48" xlink:to="loc_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember_019c758f-c9f5-7632-80bd-2836bbe5a999" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019c758f-c9f5-75f8-a4ba-5493c94dcc74" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019c758f-c9f5-75f8-a4ba-5493c94dcc74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c758f-c9f5-75f8-a4ba-5493c94dcc74_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c758f-c9f5-75f8-a4ba-5493c94dcc74" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c758f-c9f5-75f8-a4ba-5493c94dcc74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c758f-c9f5-78ac-8193-53c56bafbaf4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c758f-c9f5-75f8-a4ba-5493c94dcc74" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c758f-c9f5-78ac-8193-53c56bafbaf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019c758f-c9f5-77e7-b49c-cd14d6b1dc5d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019c758f-c9f5-78ac-8193-53c56bafbaf4" xlink:to="loc_ifrs-full_OrdinarySharesMember_019c758f-c9f5-77e7-b49c-cd14d6b1dc5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_019c758f-c9f5-7f07-9194-d5eb2fec0ec6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_ifrs-full_CounterpartiesAxis_019c758f-c9f5-7f07-9194-d5eb2fec0ec6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7f07-9194-d5eb2fec0ec6_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_019c758f-c9f5-7f07-9194-d5eb2fec0ec6" xlink:to="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7f07-9194-d5eb2fec0ec6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7b46-99fc-9afd426c1ed6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_019c758f-c9f5-7f07-9194-d5eb2fec0ec6" xlink:to="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7b46-99fc-9afd426c1ed6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditHoldingsIVLPMember_019c758f-c9f5-7011-957e-c40c873f30b5" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditHoldingsIVLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7b46-99fc-9afd426c1ed6" xlink:to="loc_soph_PerceptiveCreditHoldingsIVLPMember_019c758f-c9f5-7011-957e-c40c873f30b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CreditSuisseSAMember_019c7590-76cd-70d3-99cf-6bf8e8fcdb39" xlink:href="soph-20251231.xsd#soph_CreditSuisseSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7b46-99fc-9afd426c1ed6" xlink:to="loc_soph_CreditSuisseSAMember_019c7590-76cd-70d3-99cf-6bf8e8fcdb39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_UBSSwitzerlandAGMember_019c9691-cf99-708b-a5fc-40ceb2240687" xlink:href="soph-20251231.xsd#soph_UBSSwitzerlandAGMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7b46-99fc-9afd426c1ed6" xlink:to="loc_soph_UBSSwitzerlandAGMember_019c9691-cf99-708b-a5fc-40ceb2240687" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsAxis_019c758f-c9f5-7dc7-bede-5d8e60b09a90" xlink:href="soph-20251231.xsd#soph_WarrantTermsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_soph_WarrantTermsAxis_019c758f-c9f5-7dc7-bede-5d8e60b09a90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsDomain_019c758f-c9f5-7dc7-bede-5d8e60b09a90_default" xlink:href="soph-20251231.xsd#soph_WarrantTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_soph_WarrantTermsAxis_019c758f-c9f5-7dc7-bede-5d8e60b09a90" xlink:to="loc_soph_WarrantTermsDomain_019c758f-c9f5-7dc7-bede-5d8e60b09a90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:href="soph-20251231.xsd#soph_WarrantTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_soph_WarrantTermsAxis_019c758f-c9f5-7dc7-bede-5d8e60b09a90" xlink:to="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheAMember_019c758f-c9f5-709a-8a20-6999e1851252" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:to="loc_soph_WarrantRightsTrancheAMember_019c758f-c9f5-709a-8a20-6999e1851252" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheBMember_019c758f-c9f5-73f2-b831-2cb10327ddaf" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:to="loc_soph_WarrantRightsTrancheBMember_019c758f-c9f5-73f2-b831-2cb10327ddaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheCMember_019c81e4-a55a-74f9-b7de-1180c8b9304f" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:to="loc_soph_WarrantRightsTrancheCMember_019c81e4-a55a-74f9-b7de-1180c8b9304f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheDMember_019c81e4-e1d8-7a5a-9680-f0fbfc9ab816" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:to="loc_soph_WarrantRightsTrancheDMember_019c81e4-e1d8-7a5a-9680-f0fbfc9ab816" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c758f-f3e1-7423-9311-7f540fe728ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c758f-f3e1-7423-9311-7f540fe728ea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c758f-f3e1-7423-9311-7f540fe728ea_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c758f-f3e1-7423-9311-7f540fe728ea" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c758f-f3e1-7423-9311-7f540fe728ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c758f-f3e1-7062-ba15-dfab020f3fed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c758f-f3e1-7423-9311-7f540fe728ea" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c758f-f3e1-7062-ba15-dfab020f3fed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_MajorBorrowingTransactionsMember_019c89cd-d2e7-7c9a-a537-034ce92eb04e" xlink:href="soph-20251231.xsd#soph_MajorBorrowingTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c758f-f3e1-7062-ba15-dfab020f3fed" xlink:to="loc_soph_MajorBorrowingTransactionsMember_019c89cd-d2e7-7c9a-a537-034ce92eb04e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c7590-26c2-70f4-8f30-6e97c03c6515" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c7590-26c2-70f4-8f30-6e97c03c6515" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c7590-26c2-70f4-8f30-6e97c03c6515_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c7590-26c2-70f4-8f30-6e97c03c6515" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c7590-26c2-70f4-8f30-6e97c03c6515_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c7590-26c2-71e3-ae6b-46d36d07a46e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c7590-26c2-70f4-8f30-6e97c03c6515" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c7590-26c2-71e3-ae6b-46d36d07a46e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantLiabilityMember_019c7590-26c2-7a65-9575-bb643acc2454" xlink:href="soph-20251231.xsd#soph_WarrantLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c7590-26c2-71e3-ae6b-46d36d07a46e" xlink:to="loc_soph_WarrantLiabilityMember_019c7590-26c2-7a65-9575-bb643acc2454" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesMaximumBorrowingCapacity_019c758f-a4af-7d81-9475-eae8514d0e69" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingFacilitiesMaximumBorrowingCapacity_019c758f-a4af-7d81-9475-eae8514d0e69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_019c758f-c9f5-7738-b5ef-bb4affe47b0e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_019c758f-c9f5-7738-b5ef-bb4affe47b0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets_019c758f-c9f5-7694-a686-4cf9eebfcfef" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets_019c758f-c9f5-7694-a686-4cf9eebfcfef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum_019c758f-c9f5-72ce-9479-0138b27acdf8" xlink:href="soph-20251231.xsd#soph_BorrowingsCovenantCashAndCashEquivalentsMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum_019c758f-c9f5-72ce-9479-0138b27acdf8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum_019c758f-c9f5-79dc-b57d-252500631a4a" xlink:href="soph-20251231.xsd#soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum_019c758f-c9f5-79dc-b57d-252500631a4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c758f-c9f5-7907-b8cb-45437cd8edac" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c758f-c9f5-7907-b8cb-45437cd8edac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExercisePriceOfWarrantRights_019c758f-c9f5-766c-a1d0-6b87917253b1" xlink:href="soph-20251231.xsd#soph_ExercisePriceOfWarrantRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_ExercisePriceOfWarrantRights_019c758f-c9f5-766c-a1d0-6b87917253b1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowings_019c7590-4f90-71c3-989b-e3507a12ce8b" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_ProceedsFromBorrowings_019c7590-4f90-71c3-989b-e3507a12ce8b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c81d5-76eb-72e8-bd29-84c87df35b0c" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c81d5-76eb-72e8-bd29-84c87df35b0c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger_019c758f-f3e1-738a-9292-ac4294ccbe58" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger_019c758f-f3e1-738a-9292-ac4294ccbe58" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights_019c81e2-b38f-7c04-a103-ddaa075b7c69" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights_019c81e2-b38f-7c04-a103-ddaa075b7c69" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfFinancialInstruments_019c758f-f3e1-7b92-94cf-f7bd0f532209" xlink:href="soph-20251231.xsd#soph_NumberOfFinancialInstruments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_NumberOfFinancialInstruments_019c758f-f3e1-7b92-94cf-f7bd0f532209" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_019c7590-26c2-7c70-bb31-efb9fdddeefb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_ifrs-full_BorrowingsInterestRate_019c7590-26c2-7c70-bb31-efb9fdddeefb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c7590-26c2-7fbb-8a4e-e30bc7979603" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c7590-26c2-7fbb-8a4e-e30bc7979603" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019c7590-26c2-7620-8782-103a6b87bfac" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_ifrs-full_Borrowings_019c7590-26c2-7620-8782-103a6b87bfac" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingCostsIncurred_019c7590-4f90-79c8-8f60-4df9d919553f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingCostsIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_ifrs-full_BorrowingCostsIncurred_019c7590-4f90-79c8-8f60-4df9d919553f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TerminationOfBorrowings_019c7590-76cd-7a74-9d67-064d87ce6e86" xlink:href="soph-20251231.xsd#soph_TerminationOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_TerminationOfBorrowings_019c7590-76cd-7a74-9d67-064d87ce6e86" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingMaturityTerm_019c8222-2905-7bca-b644-f7ab5d405856" xlink:href="soph-20251231.xsd#soph_BorrowingMaturityTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingMaturityTerm_019c8222-2905-7bca-b644-f7ab5d405856" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RedemptionPeriodOfWarrantRights_019c8222-2905-75f6-9821-4c24a7a77d06" xlink:href="soph-20251231.xsd#soph_RedemptionPeriodOfWarrantRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_RedemptionPeriodOfWarrantRights_019c8222-2905-75f6-9821-4c24a7a77d06" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_019c4318-522c-7367-9a69-d05eac17b5fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-522c-783a-a2a7-c4692325b74b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_019c4318-522c-7367-9a69-d05eac17b5fb" xlink:to="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-522c-783a-a2a7-c4692325b74b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-7319-b00f-ef436be7ade0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-522c-783a-a2a7-c4692325b74b" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-7319-b00f-ef436be7ade0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7319-b00f-ef436be7ade0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-7319-b00f-ef436be7ade0" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7319-b00f-ef436be7ade0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7a91-b420-e85dd2524524" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-7319-b00f-ef436be7ade0" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7a91-b420-e85dd2524524" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantLiabilityMember_019c4318-522c-7eac-a76b-dcd57debe456" xlink:href="soph-20251231.xsd#soph_WarrantLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7a91-b420-e85dd2524524" xlink:to="loc_soph_WarrantLiabilityMember_019c4318-522c-7eac-a76b-dcd57debe456" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsAxis_019c4318-522c-76fa-a1a0-a2011ed01307" xlink:href="soph-20251231.xsd#soph_WarrantTermsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-522c-783a-a2a7-c4692325b74b" xlink:to="loc_soph_WarrantTermsAxis_019c4318-522c-76fa-a1a0-a2011ed01307" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsDomain_019c4318-522c-76fa-a1a0-a2011ed01307_default" xlink:href="soph-20251231.xsd#soph_WarrantTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_soph_WarrantTermsAxis_019c4318-522c-76fa-a1a0-a2011ed01307" xlink:to="loc_soph_WarrantTermsDomain_019c4318-522c-76fa-a1a0-a2011ed01307_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsDomain_019c4318-522c-71d3-adcc-2d852b616073" xlink:href="soph-20251231.xsd#soph_WarrantTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_soph_WarrantTermsAxis_019c4318-522c-76fa-a1a0-a2011ed01307" xlink:to="loc_soph_WarrantTermsDomain_019c4318-522c-71d3-adcc-2d852b616073" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheAMember_019c4318-522c-7041-a877-c41fb6f133a2" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WarrantTermsDomain_019c4318-522c-71d3-adcc-2d852b616073" xlink:to="loc_soph_WarrantRightsTrancheAMember_019c4318-522c-7041-a877-c41fb6f133a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheBMember_019c4318-522c-78af-a921-d1d18363b860" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WarrantTermsDomain_019c4318-522c-71d3-adcc-2d852b616073" xlink:to="loc_soph_WarrantRightsTrancheBMember_019c4318-522c-78af-a921-d1d18363b860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_019c4318-522c-76a0-a799-ec7090620895" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-522c-783a-a2a7-c4692325b74b" xlink:to="loc_ifrs-full_UnobservableInputsAxis_019c4318-522c-76a0-a799-ec7090620895" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-76a0-a799-ec7090620895_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_UnobservableInputsAxis_019c4318-522c-76a0-a799-ec7090620895" xlink:to="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-76a0-a799-ec7090620895_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_UnobservableInputsAxis_019c4318-522c-76a0-a799-ec7090620895" xlink:to="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExercisePriceMeasurementInputMember_019c4318-522c-78d8-81f7-c048adf12052" xlink:href="soph-20251231.xsd#soph_ExercisePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_ExercisePriceMeasurementInputMember_019c4318-522c-78d8-81f7-c048adf12052" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SharePriceMeasurementInputMember_019c4318-522c-781e-a985-fc5b051ad205" xlink:href="soph-20251231.xsd#soph_SharePriceMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_SharePriceMeasurementInputMember_019c4318-522c-781e-a985-fc5b051ad205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateMeasurementInputMember_019c4318-522c-7ccc-990c-be32323564c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestRateMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_ifrs-full_InterestRateMeasurementInputMember_019c4318-522c-7ccc-990c-be32323564c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExpectedVolatilityMeasurementInputMember_019c4318-522c-7e90-9f82-f0e626a643b8" xlink:href="soph-20251231.xsd#soph_ExpectedVolatilityMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_ExpectedVolatilityMeasurementInputMember_019c4318-522c-7e90-9f82-f0e626a643b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExpectedTermMeasurementInputMember_019c4318-522c-709d-a082-4462d037dad5" xlink:href="soph-20251231.xsd#soph_ExpectedTermMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_ExpectedTermMeasurementInputMember_019c4318-522c-709d-a082-4462d037dad5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DividendYieldMeasurementInputMember_019c4318-522c-7557-9a1e-a4531a01193b" xlink:href="soph-20251231.xsd#soph_DividendYieldMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_DividendYieldMeasurementInputMember_019c4318-522c-7557-9a1e-a4531a01193b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BlackScholesPricingModelValueMeasurementInputMember_019c4318-522c-7550-8be7-2a223eba0873" xlink:href="soph-20251231.xsd#soph_BlackScholesPricingModelValueMeasurementInputMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_BlackScholesPricingModelValueMeasurementInputMember_019c4318-522c-7550-8be7-2a223eba0873" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_019c4318-522c-7e9a-85c3-bd163b02bf10" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_019c4318-522c-7367-9a69-d05eac17b5fb" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_019c4318-522c-7e9a-85c3-bd163b02bf10" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7e1d-8806-ae422a3e791f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-7a37-99ce-a7ea5cdbe3d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7e1d-8806-ae422a3e791f" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-7a37-99ce-a7ea5cdbe3d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522c-755d-a20c-05d08e522c76" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-7a37-99ce-a7ea5cdbe3d3" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522c-755d-a20c-05d08e522c76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c4318-522c-755d-a20c-05d08e522c76_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522c-755d-a20c-05d08e522c76" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c4318-522c-755d-a20c-05d08e522c76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c4318-522c-7af7-8728-6a69fa934282" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522c-755d-a20c-05d08e522c76" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c4318-522c-7af7-8728-6a69fa934282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementMember_019c4318-522c-7f87-8520-48a0502236dd" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c4318-522c-7af7-8728-6a69fa934282" xlink:to="loc_soph_PerceptiveCreditAgreementMember_019c4318-522c-7f87-8520-48a0502236dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-71d6-89a3-1f2bc1db3e5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-7a37-99ce-a7ea5cdbe3d3" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-71d6-89a3-1f2bc1db3e5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-71d6-89a3-1f2bc1db3e5a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-71d6-89a3-1f2bc1db3e5a" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-71d6-89a3-1f2bc1db3e5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7d49-b61d-15e1e7cd6c48" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-71d6-89a3-1f2bc1db3e5a" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7d49-b61d-15e1e7cd6c48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditHoldingsWarrantsMember_019c4318-522c-7a96-8db9-b9831c113900" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditHoldingsWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7d49-b61d-15e1e7cd6c48" xlink:to="loc_soph_PerceptiveCreditHoldingsWarrantsMember_019c4318-522c-7a96-8db9-b9831c113900" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:href="soph-20251231.xsd#soph_ChangesInBorrowingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7e1d-8806-ae422a3e791f" xlink:to="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019c81f5-f809-7f1f-b40a-99b9daf3db49" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_ifrs-full_Borrowings_019c81f5-f809-7f1f-b40a-99b9daf3db49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowings_019c4318-522c-7be3-94a2-132d44762f17" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_soph_ProceedsFromBorrowings_019c4318-522c-7be3-94a2-132d44762f17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingCostsIncurred_019c4318-522c-781d-b7ed-fe76b8665f7e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingCostsIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_ifrs-full_BorrowingCostsIncurred_019c4318-522c-781d-b7ed-fe76b8665f7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowingsNetOfCostsIncurred_019c81fc-2005-7c46-bda2-48854ed35a9f" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowingsNetOfCostsIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_soph_ProceedsFromBorrowingsNetOfCostsIncurred_019c81fc-2005-7c46-bda2-48854ed35a9f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c4318-522c-7064-86ca-fe458b2325ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c4318-522c-7064-86ca-fe458b2325ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_019c4318-522c-72ef-9b96-41daef3dec70" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_019c4318-522c-72ef-9b96-41daef3dec70" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_019c4318-522c-7495-8e8b-a95e8f583ed5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_019c4318-522c-7495-8e8b-a95e8f583ed5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingsForeignCurrencyTranslationGainLoss_019c4318-522c-7e8e-bc2f-d00c7e675094" xlink:href="soph-20251231.xsd#soph_BorrowingsForeignCurrencyTranslationGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_soph_BorrowingsForeignCurrencyTranslationGainLoss_019c4318-522c-7e8e-bc2f-d00c7e675094" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019c81f8-9e0a-7113-b240-f92c71d332b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#BorrowingsScheduleofWarrantObligationLiabilityDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c750e-8771-7a8e-8e6b-cb48680379d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c750e-8771-7144-9c3f-7094f0dbef19" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c750e-8771-7a8e-8e6b-cb48680379d3" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c750e-8771-7144-9c3f-7094f0dbef19" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c8203-69e7-7e39-9698-4d2cd556d40b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c750e-8771-7144-9c3f-7094f0dbef19" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c8203-69e7-7e39-9698-4d2cd556d40b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c8203-69e7-7e39-9698-4d2cd556d40b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c8203-69e7-7e39-9698-4d2cd556d40b" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c8203-69e7-7e39-9698-4d2cd556d40b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c8203-69e7-71ec-8660-d1263067c1b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c8203-69e7-7e39-9698-4d2cd556d40b" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c8203-69e7-71ec-8660-d1263067c1b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditHoldingsWarrantsMember_019c8203-69e7-7f49-92fa-3a7afdd59b15" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditHoldingsWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c8203-69e7-71ec-8660-d1263067c1b4" xlink:to="loc_soph_PerceptiveCreditHoldingsWarrantsMember_019c8203-69e7-7f49-92fa-3a7afdd59b15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:href="soph-20251231.xsd#soph_ChangesInWarrantLiabilityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c750e-8771-7a8e-8e6b-cb48680379d3" xlink:to="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentWarrantLiability_019c750e-8771-7f8b-b205-dda0e3d9b1c8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_ifrs-full_CurrentWarrantLiability_019c750e-8771-7f8b-b205-dda0e3d9b1c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromWarrantLiability_019c750e-8771-786d-903a-0342eade71a5" xlink:href="soph-20251231.xsd#soph_ProceedsFromWarrantLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_soph_ProceedsFromWarrantLiability_019c750e-8771-786d-903a-0342eade71a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c750e-8771-74cb-86f4-92703a9258ce" xlink:href="soph-20251231.xsd#soph_AdjustmentsForFairValueOfWarrantLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c750e-8771-74cb-86f4-92703a9258ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantLiabilityForeignExchangeGainLoss_019c750e-8771-7a7b-ac1d-9f848fdb1754" xlink:href="soph-20251231.xsd#soph_WarrantLiabilityForeignExchangeGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_soph_WarrantLiabilityForeignExchangeGainLoss_019c750e-8771-7a7b-ac1d-9f848fdb1754" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentWarrantLiability_019c7510-3642-72ac-8761-5eb1cd74796d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7510-0426-7185-b414-82123624db5e" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7510-0426-7185-b414-82123624db5e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfWarrantsIssued_019c7510-0426-7c41-935a-32484c527efc" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfWarrantsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_soph_WarrantsOrRightsNumberOfWarrantsIssued_019c7510-0426-7c41-935a-32484c527efc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7511-5447-740f-86ce-218addb5eeb1" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#CommitmentsandcontingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_019caf67-919d-7f5b-99f8-26e012c47efe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_019caf67-919d-7f5b-99f8-26e012c47efe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019caf67-919d-7b5b-be59-024068013256" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_019caf67-919d-7f5b-99f8-26e012c47efe" xlink:to="loc_dei_LegalEntityAxis_019caf67-919d-7b5b-be59-024068013256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019caf67-919d-7b5b-be59-024068013256_default" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_019caf67-919d-7b5b-be59-024068013256" xlink:to="loc_dei_EntityDomain_019caf67-919d-7b5b-be59-024068013256_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019caf67-919d-721d-9d0d-16b9e3278773" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_019caf67-919d-7b5b-be59-024068013256" xlink:to="loc_dei_EntityDomain_019caf67-919d-721d-9d0d-16b9e3278773" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GuardantHealthMember_019caf67-919d-756b-a96a-96346c7ad6fa" xlink:href="soph-20251231.xsd#soph_GuardantHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_019caf67-919d-721d-9d0d-16b9e3278773" xlink:to="loc_soph_GuardantHealthMember_019caf67-919d-756b-a96a-96346c7ad6fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019caf67-919d-729e-95ee-f8bbd9053b65" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_019caf67-919d-7f5b-99f8-26e012c47efe" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019caf67-919d-729e-95ee-f8bbd9053b65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019caf67-919d-729e-95ee-f8bbd9053b65_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019caf67-919d-729e-95ee-f8bbd9053b65" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019caf67-919d-729e-95ee-f8bbd9053b65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019caf67-919d-7288-b7e9-590bb606039e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019caf67-919d-729e-95ee-f8bbd9053b65" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019caf67-919d-7288-b7e9-590bb606039e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommencementOfMajorLitigationMember_019caf67-919d-7a58-af46-323a8b2c02e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CommencementOfMajorLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019caf67-919d-7288-b7e9-590bb606039e" xlink:to="loc_ifrs-full_CommencementOfMajorLitigationMember_019caf67-919d-7a58-af46-323a8b2c02e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized_019c4318-522d-7f7f-b08e-799953df4c75" xlink:href="soph-20251231.xsd#soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:to="loc_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized_019c4318-522d-7f7f-b08e-799953df4c75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractualCapitalCommitments_019c4318-522d-75d4-894c-0ce5b6754cc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractualCapitalCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:to="loc_ifrs-full_ContractualCapitalCommitments_019c4318-522d-75d4-894c-0ce5b6754cc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalCommitments_019c4318-522d-79da-b161-b2e2147f5fc9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:to="loc_ifrs-full_CapitalCommitments_019c4318-522d-79da-b161-b2e2147f5fc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentAssets_019c4318-522d-7f1c-8055-4c446c8e2f29" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:to="loc_ifrs-full_EstimatedFinancialEffectOfContingentAssets_019c4318-522d-7f1c-8055-4c446c8e2f29" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LossesOnLitigationSettlements_019caf63-7e33-72a5-847f-443b727dba81" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnLitigationSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:to="loc_ifrs-full_LossesOnLitigationSettlements_019caf63-7e33-72a5-847f-443b727dba81" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7453-a1d5-4b388bb15b0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-7b5e-ba14-8a843d868589" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7453-a1d5-4b388bb15b0f" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-7b5e-ba14-8a843d868589" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_019c4318-522d-74ec-954c-48e25a8b086a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-7b5e-ba14-8a843d868589" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_019c4318-522d-74ec-954c-48e25a8b086a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_019c4318-522d-74ec-954c-48e25a8b086a_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_019c4318-522d-74ec-954c-48e25a8b086a" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_019c4318-522d-74ec-954c-48e25a8b086a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_019c4318-522d-7583-b769-4a168e656e11" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_019c4318-522d-74ec-954c-48e25a8b086a" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_019c4318-522d-7583-b769-4a168e656e11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_019c4318-522d-7768-9ca1-1ce502761908" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_019c4318-522d-7583-b769-4a168e656e11" xlink:to="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_019c4318-522d-7768-9ca1-1ce502761908" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_019c9fe2-bb76-7826-aeeb-72765b297cc7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_019c4318-522d-7583-b769-4a168e656e11" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_019c9fe2-bb76-7826-aeeb-72765b297cc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_019c4318-522d-75e8-919b-5738b8ffc0f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-7b5e-ba14-8a843d868589" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_019c4318-522d-75e8-919b-5738b8ffc0f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_019c4318-522d-75e8-919b-5738b8ffc0f4_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_019c4318-522d-75e8-919b-5738b8ffc0f4" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_019c4318-522d-75e8-919b-5738b8ffc0f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_019c4318-522d-74a2-a5e0-0158c2cab483" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_019c4318-522d-75e8-919b-5738b8ffc0f4" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_019c4318-522d-74a2-a5e0-0158c2cab483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_019c4318-522d-75a6-8744-1990ddfb3128" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_019c4318-522d-74a2-a5e0-0158c2cab483" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_019c4318-522d-75a6-8744-1990ddfb3128" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_019c9fe3-86b5-761d-b1b2-319d912b094c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_019c4318-522d-74a2-a5e0-0158c2cab483" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_019c9fe3-86b5-761d-b1b2-319d912b094c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522d-7f89-a850-fc6a8519e99e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-7b5e-ba14-8a843d868589" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522d-7f89-a850-fc6a8519e99e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7f89-a850-fc6a8519e99e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522d-7f89-a850-fc6a8519e99e" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7f89-a850-fc6a8519e99e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522d-7f89-a850-fc6a8519e99e" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CashAndCashEquivalentMember_019c4318-522d-7088-88ec-a2d81906a800" xlink:href="soph-20251231.xsd#soph_CashAndCashEquivalentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_CashAndCashEquivalentMember_019c4318-522d-7088-88ec-a2d81906a800" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-522d-7395-95aa-4c554ee0659e" xlink:href="soph-20251231.xsd#soph_FinancialAssetsAccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-522d-7395-95aa-4c554ee0659e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OtherFinancialNonCurrentAssetsMember_019c4318-522d-7caf-96c7-c50cce2e1cc0" xlink:href="soph-20251231.xsd#soph_OtherFinancialNonCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_OtherFinancialNonCurrentAssetsMember_019c4318-522d-7caf-96c7-c50cce2e1cc0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember_019c9dca-f13a-7d4f-8cbb-aabb3989fe48" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_ifrs-full_EquityInvestmentsMember_019c9dca-f13a-7d4f-8cbb-aabb3989fe48" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsPayablesMember_019c4318-522d-7f29-821e-3eb3a8138e06" xlink:href="soph-20251231.xsd#soph_AccountsPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_AccountsPayablesMember_019c4318-522d-7f29-821e-3eb3a8138e06" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedExpensesMember_019c4318-522d-7206-930b-c1821eb23b95" xlink:href="soph-20251231.xsd#soph_AccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_AccruedExpensesMember_019c4318-522d-7206-930b-c1821eb23b95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_019c4318-522d-7e63-b139-d809e494fc09" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_019c4318-522d-7e63-b139-d809e494fc09" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowingsMember_019c4318-522d-764c-90af-4e7152f1697d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_ifrs-full_LongtermBorrowingsMember_019c4318-522d-764c-90af-4e7152f1697d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantObligationsMember_019c4318-522d-7b0b-9ec1-af920e8aa7b0" xlink:href="soph-20251231.xsd#soph_WarrantObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_WarrantObligationsMember_019c4318-522d-7b0b-9ec1-af920e8aa7b0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_019c4318-522d-7da0-ba0f-bad93895b699" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7453-a1d5-4b388bb15b0f" xlink:to="loc_ifrs-full_FinancialAssets_019c4318-522d-7da0-ba0f-bad93895b699" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_019c4318-522d-747c-831c-a9a9e9dc30a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7453-a1d5-4b388bb15b0f" xlink:to="loc_ifrs-full_FinancialLiabilities_019c4318-522d-747c-831c-a9a9e9dc30a0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_019c6cc1-c55a-7a69-bd9d-393a22dca574" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_019c6cc1-c55a-7a69-bd9d-393a22dca574" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_019c6cc1-c55a-7a69-bd9d-393a22dca574_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_019c6cc1-c55a-7a69-bd9d-393a22dca574" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_019c6cc1-c55a-7a69-bd9d-393a22dca574_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_019c6cc1-c55a-77fd-9abe-de6b9206178a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_019c6cc1-c55a-7a69-bd9d-393a22dca574" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_019c6cc1-c55a-77fd-9abe-de6b9206178a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GenesisHealthcareMember_019c6cc1-c55a-7efd-bb14-fb5ed3cdefe5" xlink:href="soph-20251231.xsd#soph_GenesisHealthcareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_019c6cc1-c55a-77fd-9abe-de6b9206178a" xlink:to="loc_soph_GenesisHealthcareMember_019c6cc1-c55a-7efd-bb14-fb5ed3cdefe5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c6cc1-c55a-7d69-9ec9-eccd821a8888" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c6cc1-c55a-7d69-9ec9-eccd821a8888" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c6cc1-c55a-7d69-9ec9-eccd821a8888_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c6cc1-c55a-7d69-9ec9-eccd821a8888" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c6cc1-c55a-7d69-9ec9-eccd821a8888_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c6cc1-c55a-754b-8f3b-6a42c3296660" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c6cc1-c55a-7d69-9ec9-eccd821a8888" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c6cc1-c55a-754b-8f3b-6a42c3296660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember_019c6cc1-c55a-7ac8-aed4-233f72cf9f09" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c6cc1-c55a-754b-8f3b-6a42c3296660" xlink:to="loc_ifrs-full_EquityInvestmentsMember_019c6cc1-c55a-7ac8-aed4-233f72cf9f09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c6cc2-2395-74de-8292-04473a57542d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c6cc2-2395-74de-8292-04473a57542d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c6cc2-2395-74de-8292-04473a57542d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c6cc2-2395-74de-8292-04473a57542d" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c6cc2-2395-74de-8292-04473a57542d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c6cc2-2395-7a0e-8f69-209af2e47a2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c6cc2-2395-74de-8292-04473a57542d" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c6cc2-2395-7a0e-8f69-209af2e47a2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CashAndCashEquivalentsAndTermDepositsMember_019c6cc2-2395-73c7-b817-e2476b6ab88c" xlink:href="soph-20251231.xsd#soph_CashAndCashEquivalentsAndTermDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c6cc2-2395-7a0e-8f69-209af2e47a2d" xlink:to="loc_soph_CashAndCashEquivalentsAndTermDepositsMember_019c6cc2-2395-73c7-b817-e2476b6ab88c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019c6cc2-2395-7f38-9c1c-9d54409e2ac0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019c6cc2-2395-7f38-9c1c-9d54409e2ac0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c6cc2-2395-7f38-9c1c-9d54409e2ac0_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c6cc2-2395-7f38-9c1c-9d54409e2ac0" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c6cc2-2395-7f38-9c1c-9d54409e2ac0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c6cc2-2395-73a8-83be-5c10dc90a419" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c6cc2-2395-7f38-9c1c-9d54409e2ac0" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c6cc2-2395-73a8-83be-5c10dc90a419" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementMember_019c6cc2-2395-7f9f-87e4-22b4edd2ec22" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c6cc2-2395-73a8-83be-5c10dc90a419" xlink:to="loc_soph_PerceptiveCreditAgreementMember_019c6cc2-2395-7f9f-87e4-22b4edd2ec22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c6cc2-2395-7657-b056-77a632d186eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c6cc2-2395-7657-b056-77a632d186eb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c6cc2-2395-7657-b056-77a632d186eb_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c6cc2-2395-7657-b056-77a632d186eb" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c6cc2-2395-7657-b056-77a632d186eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c6cc2-2395-7bb9-8512-c574434e5edc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c6cc2-2395-7657-b056-77a632d186eb" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c6cc2-2395-7bb9-8512-c574434e5edc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_019c905e-74a8-7cd3-b5e1-7a2c48b6df09" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c6cc2-2395-7bb9-8512-c574434e5edc" xlink:to="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_019c905e-74a8-7cd3-b5e1-7a2c48b6df09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_MajorBorrowingTransactionsMember_019c89d0-324e-7ab6-9a60-979aeb2c2298" xlink:href="soph-20251231.xsd#soph_MajorBorrowingTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c6cc2-2395-7bb9-8512-c574434e5edc" xlink:to="loc_soph_MajorBorrowingTransactionsMember_019c89d0-324e-7ab6-9a60-979aeb2c2298" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-74fd-ad0f-e917be130084" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-74fd-ad0f-e917be130084" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-522d-74fd-ad0f-e917be130084_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-74fd-ad0f-e917be130084" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-522d-74fd-ad0f-e917be130084_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-522d-76f7-bc7b-1802332caf12" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-74fd-ad0f-e917be130084" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-522d-76f7-bc7b-1802332caf12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522d-78da-a8f1-7dce64e2828f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522d-76f7-bc7b-1802332caf12" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522d-78da-a8f1-7dce64e2828f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_019c89f3-8f1b-72fe-af6a-584d1e772c2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_MaturityAxis_019c89f3-8f1b-72fe-af6a-584d1e772c2b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_019c89f3-8f1b-72fe-af6a-584d1e772c2b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_019c89f3-8f1b-72fe-af6a-584d1e772c2b" xlink:to="loc_ifrs-full_MaturityDomain_019c89f3-8f1b-72fe-af6a-584d1e772c2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_019c89f3-8f1b-7201-8707-874c0f95e361" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_019c89f3-8f1b-72fe-af6a-584d1e772c2b" xlink:to="loc_ifrs-full_MaturityDomain_019c89f3-8f1b-7201-8707-874c0f95e361" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_019c89f3-8f1b-796b-84fe-af6da975ad63" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_019c89f3-8f1b-7201-8707-874c0f95e361" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_019c89f3-8f1b-796b-84fe-af6da975ad63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_019c89f3-8f1b-70df-a081-4292eaf1be1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_019c89f3-8f1b-7201-8707-874c0f95e361" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_019c89f3-8f1b-70df-a081-4292eaf1be1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_019c6cc1-c55a-7705-8ef6-3ad2c58f3572" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_019c6cc1-c55a-7705-8ef6-3ad2c58f3572" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_019c6cc2-2395-7d4e-9709-474b0fc2e244" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_ifrs-full_MaximumExposureToCreditRisk_019c6cc2-2395-7d4e-9709-474b0fc2e244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowings_019c6cc2-2395-707c-b76e-1c613a4899fa" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_ProceedsFromBorrowings_019c6cc2-2395-707c-b76e-1c613a4899fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019c6cc2-2395-7f37-a8f0-52707ad7c903" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019c6cc2-2395-7f37-a8f0-52707ad7c903" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquitySharesIssued_019c905c-836e-7bed-a906-8f92598182dd" xlink:href="soph-20251231.xsd#soph_NumberOfEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_NumberOfEquitySharesIssued_019c905c-836e-7bed-a906-8f92598182dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_019c6cc2-2395-7b22-a8f2-466b20dec3b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_019c6cc2-2395-7b22-a8f2-466b20dec3b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8217-2d83-71db-9c79-b4ef999ee9ae" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8217-2d83-71db-9c79-b4ef999ee9ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BankBorrowingsInterestPaidUndiscountedCashFlows_019c89f3-8f1b-7680-ab62-d8cd25278f2c" xlink:href="soph-20251231.xsd#soph_BankBorrowingsInterestPaidUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_BankBorrowingsInterestPaidUndiscountedCashFlows_019c89f3-8f1b-7680-ab62-d8cd25278f2c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019c6cc2-8c57-7805-933a-17084cca1952" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_ifrs-full_Borrowings_019c6cc2-8c57-7805-933a-17084cca1952" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage_019c8a00-3163-780b-b0ea-22523a64e2f8" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage_019c8a00-3163-780b-b0ea-22523a64e2f8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings_019c8a00-3163-7f56-aad4-1b15441c411a" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings_019c8a00-3163-7f56-aad4-1b15441c411a" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019c4318-522d-78c3-b7cd-d6fb0120a386" xlink:href="soph-20251231.xsd#soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:href="soph-20251231.xsd#soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019c4318-522d-78c3-b7cd-d6fb0120a386" xlink:to="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_019c4318-522d-73e2-a234-e68094e07f6d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:to="loc_ifrs-full_MeasurementAxis_019c4318-522d-73e2-a234-e68094e07f6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementDomain_019c4318-522d-73e2-a234-e68094e07f6d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_019c4318-522d-73e2-a234-e68094e07f6d" xlink:to="loc_ifrs-full_MeasurementDomain_019c4318-522d-73e2-a234-e68094e07f6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementDomain_019c4318-522d-7624-ae9d-66df81aaf915" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_019c4318-522d-73e2-a234-e68094e07f6d" xlink:to="loc_ifrs-full_MeasurementDomain_019c4318-522d-7624-ae9d-66df81aaf915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecurringFairValueMeasurementMember_019c4318-522d-7527-ad3a-e52422c3b758" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RecurringFairValueMeasurementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_019c4318-522d-7624-ae9d-66df81aaf915" xlink:to="loc_ifrs-full_RecurringFairValueMeasurementMember_019c4318-522d-7527-ad3a-e52422c3b758" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_019c4318-522d-7fb1-8f39-adec1720270d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_019c4318-522d-7fb1-8f39-adec1720270d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7fb1-8f39-adec1720270d_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_019c4318-522d-7fb1-8f39-adec1720270d" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7fb1-8f39-adec1720270d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7bf5-a91b-9a94dcbf5610" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_019c4318-522d-7fb1-8f39-adec1720270d" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7bf5-a91b-9a94dcbf5610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_019c4318-522d-7891-833e-16b0cec1a0b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7bf5-a91b-9a94dcbf5610" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_019c4318-522d-7891-833e-16b0cec1a0b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_019c4318-522d-79fb-9acc-8d50792eefcf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7bf5-a91b-9a94dcbf5610" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_019c4318-522d-79fb-9acc-8d50792eefcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_019c4318-522d-78b1-aa97-8501faaf88b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7bf5-a91b-9a94dcbf5610" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_019c4318-522d-78b1-aa97-8501faaf88b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522d-744f-9977-bfb35d220a97" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522d-744f-9977-bfb35d220a97" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522d-744f-9977-bfb35d220a97_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522d-744f-9977-bfb35d220a97" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522d-744f-9977-bfb35d220a97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522d-7e0e-8315-2fab24c5ac4f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522d-744f-9977-bfb35d220a97" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522d-7e0e-8315-2fab24c5ac4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CashAndCashEquivalents1Member_019c4318-522d-72a4-874e-1492e6081a26" xlink:href="soph-20251231.xsd#soph_CashAndCashEquivalents1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522d-7e0e-8315-2fab24c5ac4f" xlink:to="loc_soph_CashAndCashEquivalents1Member_019c4318-522d-72a4-874e-1492e6081a26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember_019c6c1d-649f-7410-9991-c40dea17ccbd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522d-7e0e-8315-2fab24c5ac4f" xlink:to="loc_ifrs-full_EquityInvestmentsMember_019c6c1d-649f-7410-9991-c40dea17ccbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522d-714a-bc0a-22f51853b3f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522d-714a-bc0a-22f51853b3f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522d-714a-bc0a-22f51853b3f2_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522d-714a-bc0a-22f51853b3f2" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522d-714a-bc0a-22f51853b3f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522d-7537-aa37-dd32cfa3b421" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522d-714a-bc0a-22f51853b3f2" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522d-7537-aa37-dd32cfa3b421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantLiabilityMember_019c4318-522d-7a5d-8de8-591105d31848" xlink:href="soph-20251231.xsd#soph_WarrantLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522d-7537-aa37-dd32cfa3b421" xlink:to="loc_soph_WarrantLiabilityMember_019c4318-522d-7a5d-8de8-591105d31848" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_019c4318-522d-72bb-9020-597b4314bce0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019c4318-522d-78c3-b7cd-d6fb0120a386" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValue_019c4318-522d-72bb-9020-597b4314bce0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c4318-522d-7360-9aa3-6eafd95fc036" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019c4318-522d-78c3-b7cd-d6fb0120a386" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c4318-522d-7360-9aa3-6eafd95fc036" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:href="soph-20251231.xsd#soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_019c4318-522d-736d-a554-ef0c47ad0170" xlink:href="soph-20251231.xsd#soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:to="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_019c4318-522d-736d-a554-ef0c47ad0170" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-7c80-8758-9fd4713bcae5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_019c4318-522d-736d-a554-ef0c47ad0170" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-7c80-8758-9fd4713bcae5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-522d-7c80-8758-9fd4713bcae5_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-7c80-8758-9fd4713bcae5" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-522d-7c80-8758-9fd4713bcae5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-522d-74b0-9f2d-c376400484bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-7c80-8758-9fd4713bcae5" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-522d-74b0-9f2d-c376400484bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522d-763b-b6f6-459efa6e4674" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522d-74b0-9f2d-c376400484bb" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522d-763b-b6f6-459efa6e4674" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_019c4318-522d-71d2-a5d7-1058aa9be8c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_019c4318-522d-736d-a554-ef0c47ad0170" xlink:to="loc_ifrs-full_MaturityAxis_019c4318-522d-71d2-a5d7-1058aa9be8c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_019c4318-522d-71d2-a5d7-1058aa9be8c9_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_019c4318-522d-71d2-a5d7-1058aa9be8c9" xlink:to="loc_ifrs-full_MaturityDomain_019c4318-522d-71d2-a5d7-1058aa9be8c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_019c4318-522d-7b3b-aa70-6b38ab561e4e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_019c4318-522d-71d2-a5d7-1058aa9be8c9" xlink:to="loc_ifrs-full_MaturityDomain_019c4318-522d-7b3b-aa70-6b38ab561e4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_019c4318-522d-7940-9cbb-cdd99b5304c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_019c4318-522d-7b3b-aa70-6b38ab561e4e" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_019c4318-522d-7940-9cbb-cdd99b5304c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_019c4318-522d-7e37-bca5-a37edd36885c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_019c4318-522d-7b3b-aa70-6b38ab561e4e" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_019c4318-522d-7e37-bca5-a37edd36885c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_019c4318-522d-7b7f-8708-781f8946f80e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_019c4318-522d-7b3b-aa70-6b38ab561e4e" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_019c4318-522d-7b7f-8708-781f8946f80e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_019c4318-522d-7a78-af79-b2eecd038c62" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:to="loc_ifrs-full_GrossLeaseLiabilities_019c4318-522d-7a78-af79-b2eecd038c62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_019c4318-522d-78b8-901b-d794ad5eb836" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:to="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_019c4318-522d-78b8-901b-d794ad5eb836" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedExpensesUndiscountedCashFlows_019c4318-522d-7f0a-ab67-719c07214b71" xlink:href="soph-20251231.xsd#soph_AccruedExpensesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:to="loc_soph_AccruedExpensesUndiscountedCashFlows_019c4318-522d-7f0a-ab67-719c07214b71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_019c4318-522d-7188-b4e4-bcadcb35773c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_019c4318-522d-7188-b4e4-bcadcb35773c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_019c4318-522d-7641-8072-526be42f8551" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:to="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_019c4318-522d-7641-8072-526be42f8551" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d03-ac5e-a5ad9032eaa8" xlink:href="soph-20251231.xsd#soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7352-a774-9985a5ed2571" xlink:href="soph-20251231.xsd#soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d03-ac5e-a5ad9032eaa8" xlink:to="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7352-a774-9985a5ed2571" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7396-adb9-92e1c1eb45b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrencyInWhichInformationIsDisplayedAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7352-a774-9985a5ed2571" xlink:to="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7396-adb9-92e1c1eb45b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7396-adb9-92e1c1eb45b5_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7396-adb9-92e1c1eb45b5" xlink:to="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7396-adb9-92e1c1eb45b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7d0f-9e84-eb1132ea3fc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7396-adb9-92e1c1eb45b5" xlink:to="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7d0f-9e84-eb1132ea3fc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FunctionalCurrencyMember_019c4318-522d-7453-b8c9-fd601d8640c1" xlink:href="soph-20251231.xsd#soph_FunctionalCurrencyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7d0f-9e84-eb1132ea3fc8" xlink:to="loc_soph_FunctionalCurrencyMember_019c4318-522d-7453-b8c9-fd601d8640c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_019c4318-522d-78ed-9466-2b0e68f18d6b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7352-a774-9985a5ed2571" xlink:to="loc_srt_CurrencyAxis_019c4318-522d-78ed-9466-2b0e68f18d6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_019c4318-522d-78ed-9466-2b0e68f18d6b_default" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_019c4318-522d-78ed-9466-2b0e68f18d6b" xlink:to="loc_currency_AllCurrenciesDomain_019c4318-522d-78ed-9466-2b0e68f18d6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_019c4318-522d-7598-ac61-749a84c31a66" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_019c4318-522d-78ed-9466-2b0e68f18d6b" xlink:to="loc_currency_AllCurrenciesDomain_019c4318-522d-7598-ac61-749a84c31a66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyUSDAndCHFMember_019c4318-522d-75de-bec5-6ec61d13a2d1" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyUSDAndCHFMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7598-ac61-749a84c31a66" xlink:to="loc_soph_DifferencesOfCurrencyUSDAndCHFMember_019c4318-522d-75de-bec5-6ec61d13a2d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyEURAndCHFMember_019c4318-522d-7a98-8e9f-4de9fd5a181c" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyEURAndCHFMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7598-ac61-749a84c31a66" xlink:to="loc_soph_DifferencesOfCurrencyEURAndCHFMember_019c4318-522d-7a98-8e9f-4de9fd5a181c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyGBPAndCHFMember_019c4318-522d-7ccd-81a2-c1fa2eff9c55" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyGBPAndCHFMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7598-ac61-749a84c31a66" xlink:to="loc_soph_DifferencesOfCurrencyGBPAndCHFMember_019c4318-522d-7ccd-81a2-c1fa2eff9c55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-522d-7899-88a9-5d96f5952a4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7352-a774-9985a5ed2571" xlink:to="loc_ifrs-full_RangeAxis_019c4318-522d-7899-88a9-5d96f5952a4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522d-7899-88a9-5d96f5952a4b_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522d-7899-88a9-5d96f5952a4b" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522d-7899-88a9-5d96f5952a4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522d-7ee7-859b-f5da1b5556d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522d-7899-88a9-5d96f5952a4b" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522d-7ee7-859b-f5da1b5556d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-522d-7b46-a954-cf71ef800810" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522d-7ee7-859b-f5da1b5556d7" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-522d-7b46-a954-cf71ef800810" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-522d-7bf0-ac3b-d9591a173fcd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522d-7ee7-859b-f5da1b5556d7" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-522d-7bf0-ac3b-d9591a173fcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent_019c4318-522d-7bc8-8411-f5447a8425b6" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d03-ac5e-a5ad9032eaa8" xlink:to="loc_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent_019c4318-522d-7bc8-8411-f5447a8425b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_019c4318-522d-71c9-b8ea-4dec294bcabe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d03-ac5e-a5ad9032eaa8" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_019c4318-522d-71c9-b8ea-4dec294bcabe" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d28-958f-19432737d269" xlink:href="soph-20251231.xsd#soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7171-8133-29e8b8ad9ec1" xlink:href="soph-20251231.xsd#soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d28-958f-19432737d269" xlink:to="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7171-8133-29e8b8ad9ec1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7e5d-bae9-b64379854d8f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrencyInWhichInformationIsDisplayedAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7171-8133-29e8b8ad9ec1" xlink:to="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7e5d-bae9-b64379854d8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7e5d-bae9-b64379854d8f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7e5d-bae9-b64379854d8f" xlink:to="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7e5d-bae9-b64379854d8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7814-8172-f49b2f02ea86" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7e5d-bae9-b64379854d8f" xlink:to="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7814-8172-f49b2f02ea86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PresentationCurrencyMember_019c4318-522d-7936-b3dc-d305ae4592f4" xlink:href="soph-20251231.xsd#soph_PresentationCurrencyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7814-8172-f49b2f02ea86" xlink:to="loc_soph_PresentationCurrencyMember_019c4318-522d-7936-b3dc-d305ae4592f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_019c4318-522d-76d7-be6e-9bb83b410b76" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7171-8133-29e8b8ad9ec1" xlink:to="loc_srt_CurrencyAxis_019c4318-522d-76d7-be6e-9bb83b410b76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_019c4318-522d-76d7-be6e-9bb83b410b76_default" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_019c4318-522d-76d7-be6e-9bb83b410b76" xlink:to="loc_currency_AllCurrenciesDomain_019c4318-522d-76d7-be6e-9bb83b410b76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_019c4318-522d-7602-96d7-f11a8253a670" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_019c4318-522d-76d7-be6e-9bb83b410b76" xlink:to="loc_currency_AllCurrenciesDomain_019c4318-522d-7602-96d7-f11a8253a670" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyUSDAndCHFMember_019c4318-522d-75c0-a390-5bd97ffa0b9b" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyUSDAndCHFMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7602-96d7-f11a8253a670" xlink:to="loc_soph_DifferencesOfCurrencyUSDAndCHFMember_019c4318-522d-75c0-a390-5bd97ffa0b9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyUSDAndEURMember_019c4318-522d-736f-bd9d-ad3e9bd66732" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyUSDAndEURMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7602-96d7-f11a8253a670" xlink:to="loc_soph_DifferencesOfCurrencyUSDAndEURMember_019c4318-522d-736f-bd9d-ad3e9bd66732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyUSDAndGBPMember_019c4318-522d-75a4-a501-06d3f6b5eda3" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyUSDAndGBPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7602-96d7-f11a8253a670" xlink:to="loc_soph_DifferencesOfCurrencyUSDAndGBPMember_019c4318-522d-75a4-a501-06d3f6b5eda3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-522d-7608-9c15-c3c7f003387c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7171-8133-29e8b8ad9ec1" xlink:to="loc_ifrs-full_RangeAxis_019c4318-522d-7608-9c15-c3c7f003387c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522d-7608-9c15-c3c7f003387c_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522d-7608-9c15-c3c7f003387c" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522d-7608-9c15-c3c7f003387c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522d-7261-94e5-cd0a58b175ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522d-7608-9c15-c3c7f003387c" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522d-7261-94e5-cd0a58b175ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-522d-71a3-b6db-22ed4f7949c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522d-7261-94e5-cd0a58b175ba" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-522d-71a3-b6db-22ed4f7949c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-522d-7041-b226-7a01319200b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522d-7261-94e5-cd0a58b175ba" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-522d-7041-b226-7a01319200b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent_019c4318-522d-71bd-a28c-2781254975b3" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d28-958f-19432737d269" xlink:to="loc_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent_019c4318-522d-71bd-a28c-2781254975b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_019c4318-522d-7ccf-84a7-f69ba13cdf81" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d28-958f-19432737d269" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_019c4318-522d-7ccf-84a7-f69ba13cdf81" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CapitalmanagementDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#CapitalmanagementDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/CapitalmanagementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_CapitalManagementLineItems_019c4318-522d-7dbe-ba67-a59d6e269746" xlink:href="soph-20251231.xsd#soph_CapitalManagementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CapitalManagementTable_019c4318-522d-72a8-beab-91a5c9863378" xlink:href="soph-20251231.xsd#soph_CapitalManagementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_soph_CapitalManagementLineItems_019c4318-522d-7dbe-ba67-a59d6e269746" xlink:to="loc_soph_CapitalManagementTable_019c4318-522d-72a8-beab-91a5c9863378" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522d-7948-8462-d69fb78e8869" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_CapitalManagementTable_019c4318-522d-72a8-beab-91a5c9863378" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522d-7948-8462-d69fb78e8869" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c4318-522d-7948-8462-d69fb78e8869_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522d-7948-8462-d69fb78e8869" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c4318-522d-7948-8462-d69fb78e8869_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c431a-006b-7bc5-ab53-6436d6440e37" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522d-7948-8462-d69fb78e8869" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c431a-006b-7bc5-ab53-6436d6440e37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementMember_019c4318-522d-7daa-80b0-4c2579c02295" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c431a-006b-7bc5-ab53-6436d6440e37" xlink:to="loc_soph_PerceptiveCreditAgreementMember_019c4318-522d-7daa-80b0-4c2579c02295" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c8219-0bea-7b76-8277-442ad27a8e89" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_soph_CapitalManagementTable_019c4318-522d-72a8-beab-91a5c9863378" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c8219-0bea-7b76-8277-442ad27a8e89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c8219-0bea-7b76-8277-442ad27a8e89_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c8219-0bea-7b76-8277-442ad27a8e89" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c8219-0bea-7b76-8277-442ad27a8e89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c8219-0bea-73d2-8e51-da31f5154b68" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c8219-0bea-7b76-8277-442ad27a8e89" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c8219-0bea-73d2-8e51-da31f5154b68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_MajorBorrowingTransactionsMember_019c8a01-a2d3-7437-ad89-ab9cea000b84" xlink:href="soph-20251231.xsd#soph_MajorBorrowingTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c8219-0bea-73d2-8e51-da31f5154b68" xlink:to="loc_soph_MajorBorrowingTransactionsMember_019c8a01-a2d3-7437-ad89-ab9cea000b84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019c4318-522d-7070-9917-b0ef09755fd1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_CapitalManagementLineItems_019c4318-522d-7dbe-ba67-a59d6e269746" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019c4318-522d-7070-9917-b0ef09755fd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8219-0bea-714d-8073-a68276d91908" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_CapitalManagementLineItems_019c4318-522d-7dbe-ba67-a59d6e269746" xlink:to="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8219-0bea-714d-8073-a68276d91908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_019c6cca-f0c5-7712-b41d-7ac2a8cca991" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UndrawnBorrowingFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_CapitalManagementLineItems_019c4318-522d-7dbe-ba67-a59d6e269746" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_019c6cca-f0c5-7712-b41d-7ac2a8cca991" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#EventsafterthereportingdateDetails"/>
  <link:definitionLink xlink:role="http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c7594-b052-7c51-af87-8081595ed66f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c7594-b052-7c51-af87-8081595ed66f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c7594-b052-7c51-af87-8081595ed66f_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c7594-b052-7c51-af87-8081595ed66f" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c7594-b052-7c51-af87-8081595ed66f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c7594-b052-78fe-bacd-0668f5341b3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c7594-b052-7c51-af87-8081595ed66f" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c7594-b052-78fe-bacd-0668f5341b3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_MajorBorrowingTransactionsMember_019c8a01-3737-727b-9f3a-76a06440cb9c" xlink:href="soph-20251231.xsd#soph_MajorBorrowingTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c7594-b052-78fe-bacd-0668f5341b3f" xlink:to="loc_soph_MajorBorrowingTransactionsMember_019c8a01-3737-727b-9f3a-76a06440cb9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_019caf5e-73a6-77b8-a875-d575e1ef902c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c7594-b052-78fe-bacd-0668f5341b3f" xlink:to="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_019caf5e-73a6-77b8-a875-d575e1ef902c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019c7594-b052-7c06-9de6-e78c28c3a8bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019c7594-b052-7c06-9de6-e78c28c3a8bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c7594-b052-7c06-9de6-e78c28c3a8bd_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c7594-b052-7c06-9de6-e78c28c3a8bd" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c7594-b052-7c06-9de6-e78c28c3a8bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c7594-b052-7013-8b27-3274359c6874" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c7594-b052-7c06-9de6-e78c28c3a8bd" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c7594-b052-7013-8b27-3274359c6874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementMember_019c7594-b052-7480-91d3-386d7128e802" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c7594-b052-7013-8b27-3274359c6874" xlink:to="loc_soph_PerceptiveCreditAgreementMember_019c7594-b052-7480-91d3-386d7128e802" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheCMember_019c7594-b052-7024-a470-b8f03159a999" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c7594-b052-7480-91d3-386d7128e802" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheCMember_019c7594-b052-7024-a470-b8f03159a999" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheDMember_019c7594-b052-79a8-947b-cc0279d9c7e9" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c7594-b052-7480-91d3-386d7128e802" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheDMember_019c7594-b052-79a8-947b-cc0279d9c7e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsAxis_019c7594-b052-70d0-82f0-5d6f64a8e956" xlink:href="soph-20251231.xsd#soph_BorrowingTermsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_soph_BorrowingTermsAxis_019c7594-b052-70d0-82f0-5d6f64a8e956" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsDomain_019c7594-b052-70d0-82f0-5d6f64a8e956_default" xlink:href="soph-20251231.xsd#soph_BorrowingTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_soph_BorrowingTermsAxis_019c7594-b052-70d0-82f0-5d6f64a8e956" xlink:to="loc_soph_BorrowingTermsDomain_019c7594-b052-70d0-82f0-5d6f64a8e956_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsDomain_019c7594-b052-75d1-97b7-b8f702f401f0" xlink:href="soph-20251231.xsd#soph_BorrowingTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_soph_BorrowingTermsAxis_019c7594-b052-70d0-82f0-5d6f64a8e956" xlink:to="loc_soph_BorrowingTermsDomain_019c7594-b052-75d1-97b7-b8f702f401f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRMember_019c7594-b052-7d09-98a9-ea46abda7d0b" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_BorrowingTermsDomain_019c7594-b052-75d1-97b7-b8f702f401f0" xlink:to="loc_soph_TermSecuredOvernightFinancingRateSOFRMember_019c7594-b052-7d09-98a9-ea46abda7d0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRFloorMember_019c8214-ed65-7d43-b307-4fc718bcb44c" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRFloorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_BorrowingTermsDomain_019c7594-b052-75d1-97b7-b8f702f401f0" xlink:to="loc_soph_TermSecuredOvernightFinancingRateSOFRFloorMember_019c8214-ed65-7d43-b307-4fc718bcb44c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019c7594-b052-7767-ba52-89f79736994e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019c7594-b052-7767-ba52-89f79736994e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c7594-b052-7767-ba52-89f79736994e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c7594-b052-7767-ba52-89f79736994e" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c7594-b052-7767-ba52-89f79736994e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c7594-b052-7228-ab5c-da612f4a96d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c7594-b052-7767-ba52-89f79736994e" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c7594-b052-7228-ab5c-da612f4a96d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019c7594-b052-7979-b872-1627c2bec897" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019c7594-b052-7228-ab5c-da612f4a96d9" xlink:to="loc_ifrs-full_OrdinarySharesMember_019c7594-b052-7979-b872-1627c2bec897" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_019c7594-b052-7ff6-984b-dbca0e707c1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_ifrs-full_CounterpartiesAxis_019c7594-b052-7ff6-984b-dbca0e707c1e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_019c7594-b052-7ff6-984b-dbca0e707c1e_default" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_019c7594-b052-7ff6-984b-dbca0e707c1e" xlink:to="loc_ifrs-full_CounterpartiesDomain_019c7594-b052-7ff6-984b-dbca0e707c1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_019c7594-b052-796b-b2b5-80b3dc49c1bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_019c7594-b052-7ff6-984b-dbca0e707c1e" xlink:to="loc_ifrs-full_CounterpartiesDomain_019c7594-b052-796b-b2b5-80b3dc49c1bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditHoldingsIVLPMember_019c7594-b052-7c7f-8c11-336c4d32507e" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditHoldingsIVLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesDomain_019c7594-b052-796b-b2b5-80b3dc49c1bc" xlink:to="loc_soph_PerceptiveCreditHoldingsIVLPMember_019c7594-b052-7c7f-8c11-336c4d32507e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsAxis_019c8214-ed65-7543-a628-e42832032eac" xlink:href="soph-20251231.xsd#soph_WarrantTermsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_soph_WarrantTermsAxis_019c8214-ed65-7543-a628-e42832032eac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsDomain_019c8214-ed65-7543-a628-e42832032eac_default" xlink:href="soph-20251231.xsd#soph_WarrantTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_soph_WarrantTermsAxis_019c8214-ed65-7543-a628-e42832032eac" xlink:to="loc_soph_WarrantTermsDomain_019c8214-ed65-7543-a628-e42832032eac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsDomain_019c8214-ed65-7166-b3a5-d1b27e4ab028" xlink:href="soph-20251231.xsd#soph_WarrantTermsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_soph_WarrantTermsAxis_019c8214-ed65-7543-a628-e42832032eac" xlink:to="loc_soph_WarrantTermsDomain_019c8214-ed65-7166-b3a5-d1b27e4ab028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheCMember_019c8214-ed65-79bb-ba6e-ef5ec44e52f4" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WarrantTermsDomain_019c8214-ed65-7166-b3a5-d1b27e4ab028" xlink:to="loc_soph_WarrantRightsTrancheCMember_019c8214-ed65-79bb-ba6e-ef5ec44e52f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheDMember_019c8214-ed65-7ba0-b251-83589c546866" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_soph_WarrantTermsDomain_019c8214-ed65-7166-b3a5-d1b27e4ab028" xlink:to="loc_soph_WarrantRightsTrancheDMember_019c8214-ed65-7ba0-b251-83589c546866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8214-ed65-78ad-8311-f42a829d2bcf" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8214-ed65-78ad-8311-f42a829d2bcf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesMaximumBorrowingCapacity_019c8214-ed65-7c82-b10a-4342aa591028" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_BorrowingFacilitiesMaximumBorrowingCapacity_019c8214-ed65-7c82-b10a-4342aa591028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger_019c7594-b052-7f09-bd1f-42ccfc2657fa" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger_019c7594-b052-7f09-bd1f-42ccfc2657fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_019c7594-b052-711f-8de5-a00bf3cc63b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_019c7594-b052-711f-8de5-a00bf3cc63b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights_019c8214-ed65-7d88-b051-6543b88f9690" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights_019c8214-ed65-7d88-b051-6543b88f9690" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7594-b052-7892-a6c5-757c62e4c9e5" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7594-b052-7892-a6c5-757c62e4c9e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquitySharesIssued_019caf5e-73a6-7edf-bb03-f19dd8219004" xlink:href="soph-20251231.xsd#soph_NumberOfEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_NumberOfEquitySharesIssued_019caf5e-73a6-7edf-bb03-f19dd8219004" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_019caf5e-73a6-7ece-bdb4-f895cb64c856" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_019caf5e-73a6-7ece-bdb4-f895cb64c856" xlink:type="arc" order="7"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>soph-20251231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c4318-4e70-7eba-b516-6c06258ef00a,g:b3ab9529-65b6-4117-b100-6d41f692b5c5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_soph_DisclosureOfEventsAfterReportingPeriodAbstract_019c7593-fafb-75b7-bee4-fbf0f65ae809_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfEventsAfterReportingPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Events After Reporting Period [Abstract]</link:label>
    <link:label id="lab_soph_DisclosureOfEventsAfterReportingPeriodAbstract_label_en-US" xlink:label="lab_soph_DisclosureOfEventsAfterReportingPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Events After Reporting Period [Abstract]</link:label>
    <link:label id="lab_soph_DisclosureOfEventsAfterReportingPeriodAbstract_documentation_en-US" xlink:label="lab_soph_DisclosureOfEventsAfterReportingPeriodAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of events after reporting period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEventsAfterReportingPeriodAbstract" xlink:href="soph-20251231.xsd#soph_DisclosureOfEventsAfterReportingPeriodAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfEventsAfterReportingPeriodAbstract" xlink:to="lab_soph_DisclosureOfEventsAfterReportingPeriodAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_019c66d3-3ecc-77c9-ad08-17b220256e3b_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpense_019c4318-5379-713f-86b2-564dc6788e8d_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_ifrs-full_InterestExpense_019c4318-5379-70b3-88c5-b3750e2e814e_totalLabel_en-US" xlink:label="lab_ifrs-full_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total interest expense</link:label>
    <link:label id="lab_ifrs-full_InterestExpense_label_en-US" xlink:label="lab_ifrs-full_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpense" xlink:to="lab_ifrs-full_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_019c4318-5378-71be-b15f-74987b2d378b_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-5379-7b62-bb2a-b361fc25d698_terseLabel_en-US" xlink:label="lab_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruemnts, In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_documentation_en-US" xlink:label="lab_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruments, In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:href="soph-20251231.xsd#soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:to="lab_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019c4318-52e4-7a0a-8962-3d4ffeb128b9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfFinancialInstruments_019c4318-5379-7014-b3b3-3237892e1ee4_terseLabel_en-US" xlink:label="lab_soph_NumberOfFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of separate financial instrument</link:label>
    <link:label id="lab_soph_NumberOfFinancialInstruments_label_en-US" xlink:label="lab_soph_NumberOfFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Financial Instruments</link:label>
    <link:label id="lab_soph_NumberOfFinancialInstruments_documentation_en-US" xlink:label="lab_soph_NumberOfFinancialInstruments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Financial Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfFinancialInstruments" xlink:href="soph-20251231.xsd#soph_NumberOfFinancialInstruments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfFinancialInstruments" xlink:to="lab_soph_NumberOfFinancialInstruments" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearOne_019c4318-52e4-748b-a82b-69e5ceba07cd_terseLabel_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">One year</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearOne_label_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Operating Loss Carryforwards, Year One</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearOne_documentation_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards year one.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearOne" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NetOperatingLossCarryforwardsYearOne" xlink:to="lab_soph_NetOperatingLossCarryforwardsYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ExercisePriceMeasurementInputMember_019c4318-52e4-739d-8d6b-e0129f567fc8_terseLabel_en-US" xlink:label="lab_soph_ExercisePriceMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price in USD</link:label>
    <link:label id="lab_soph_ExercisePriceMeasurementInputMember_label_en-US" xlink:label="lab_soph_ExercisePriceMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price, Measurement Input [Member]</link:label>
    <link:label id="lab_soph_ExercisePriceMeasurementInputMember_documentation_en-US" xlink:label="lab_soph_ExercisePriceMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExercisePriceMeasurementInputMember" xlink:href="soph-20251231.xsd#soph_ExercisePriceMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ExercisePriceMeasurementInputMember" xlink:to="lab_soph_ExercisePriceMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncome_019c4318-5379-75c8-9beb-002bf782fae7_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred income tax (expense) benefit</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncome_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-52e4-70c1-9af4-a8b7915ecb19_terseLabel_en-US" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Levels of fair value hierarchy [domain]</link:label>
    <link:label id="lab_ifrs-full_LevelsOfFairValueHierarchyDomain_label_en-US" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Levels of fair value hierarchy [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:to="lab_ifrs-full_LevelsOfFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BidartFranceMember_019c4318-53fc-7662-afec-9831d2e35614_terseLabel_en-US" xlink:label="lab_soph_BidartFranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bidart</link:label>
    <link:label id="lab_soph_BidartFranceMember_label_en-US" xlink:label="lab_soph_BidartFranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bidart, France [Member]</link:label>
    <link:label id="lab_soph_BidartFranceMember_documentation_en-US" xlink:label="lab_soph_BidartFranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bidart, France</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BidartFranceMember" xlink:href="soph-20251231.xsd#soph_BidartFranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BidartFranceMember" xlink:to="lab_soph_BidartFranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock_019c4318-52e4-728e-b7f3-23e10ea019be_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Expected Tax Expense to Tax Expense Report in Statement of Loss</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Reconciliation Of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of reconciliation of expected tax expense to tax expense report in statement of loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="lab_ifrs-full_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PresentationCurrencyMember_019c4318-5379-7ec6-a8ce-0955da060512_terseLabel_en-US" xlink:label="lab_soph_PresentationCurrencyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Presentation Currency</link:label>
    <link:label id="lab_soph_PresentationCurrencyMember_label_en-US" xlink:label="lab_soph_PresentationCurrencyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Presentation Currency [Member]</link:label>
    <link:label id="lab_soph_PresentationCurrencyMember_documentation_en-US" xlink:label="lab_soph_PresentationCurrencyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Presentation currency.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PresentationCurrencyMember" xlink:href="soph-20251231.xsd#soph_PresentationCurrencyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PresentationCurrencyMember" xlink:to="lab_soph_PresentationCurrencyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5379-7834-b13c-a384e25c9c6a_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash used in operating activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperations_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_019c4318-52e4-781f-90fd-c37f6557f803_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_label_en-US" xlink:label="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other tax effects for reconciliation between accounting profit and tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:to="lab_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_019c4318-52e4-7009-9318-9ec8d250d16d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Right of Use Assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about right-of-use assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-5379-7dc5-a37f-ba4ae7ed2f86_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Borrowings [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019c4318-5379-7061-94fd-b92addcd0226_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of instruments granted subject to four year vesting (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019c4318-5379-7b9e-b435-4e83c9200c6e_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments exercised or vested in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-5379-7d4f-82aa-b8356757dd45_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]</link:label>
    <link:label id="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_label_en-US" xlink:label="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]</link:label>
    <link:label id="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_documentation_en-US" xlink:label="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:href="soph-20251231.xsd#soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:to="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-52e4-73b9-9161-8a075674e01d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:to="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfCashGeneratingUnit_019c4318-5379-7c18-9cb0-e2d3f3122e44_terseLabel_en-US" xlink:label="lab_soph_NumberOfCashGeneratingUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash-generating units</link:label>
    <link:label id="lab_soph_NumberOfCashGeneratingUnit_label_en-US" xlink:label="lab_soph_NumberOfCashGeneratingUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Cash-Generating Unit</link:label>
    <link:label id="lab_soph_NumberOfCashGeneratingUnit_documentation_en-US" xlink:label="lab_soph_NumberOfCashGeneratingUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of operating segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfCashGeneratingUnit" xlink:href="soph-20251231.xsd#soph_NumberOfCashGeneratingUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfCashGeneratingUnit" xlink:to="lab_soph_NumberOfCashGeneratingUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-5378-7fb9-9da4-5e0c5708ce26_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [abstract]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c66ce-cdf1-70d6-81d8-00d4894ad537_terseLabel_en-US" xlink:label="lab_soph_SummaryOfMaterialAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary Of Material Accounting Policies [Abstract]</link:label>
    <link:label id="lab_soph_SummaryOfMaterialAccountingPoliciesAbstract_label_en-US" xlink:label="lab_soph_SummaryOfMaterialAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary Of Material Accounting Policies [Abstract]</link:label>
    <link:label id="lab_soph_SummaryOfMaterialAccountingPoliciesAbstract_documentation_en-US" xlink:label="lab_soph_SummaryOfMaterialAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Summary of significant accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract" xlink:href="soph-20251231.xsd#soph_SummaryOfMaterialAccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract" xlink:to="lab_soph_SummaryOfMaterialAccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsAndGoodwill_019c4318-53fc-7936-81e3-5e352c442bc0_periodStartLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsAndGoodwill_019c4318-53fc-7e83-b217-d4b84a7df766_periodEndLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsAndGoodwill_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets and goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of comprehensive income [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock_019c4318-5379-75ed-91f8-259c553a9960_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Pension Costs Recognized in Statement of Loss</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Pension Costs Recognized In Statement Of Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about pension costs recognized in statement of income loss explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-52e4-72a8-87d3-5f4bba04101a_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement Of Changes In Equity [Line Items]</link:label>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityLineItems_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_TerminationOfBorrowings_019c4318-5379-7fa9-bbc9-9bed1b8400d0_terseLabel_en-US" xlink:label="lab_soph_TerminationOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination of existing borrowings</link:label>
    <link:label id="lab_soph_TerminationOfBorrowings_label_en-US" xlink:label="lab_soph_TerminationOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Termination Of Borrowings</link:label>
    <link:label id="lab_soph_TerminationOfBorrowings_documentation_en-US" xlink:label="lab_soph_TerminationOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Termination Of Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TerminationOfBorrowings" xlink:href="soph-20251231.xsd#soph_TerminationOfBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_TerminationOfBorrowings" xlink:to="lab_soph_TerminationOfBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock_019c4318-52e4-78d9-b435-4e6910b4a5de_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Equity to Changes in Foreign Exchange Rates</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Sensitivity Of Equity To Changes In Foreign Exchange Rates [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity of equity to changes in foreign exchange rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_019c4318-5379-7679-8575-81bcf3e2aa7d_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Increase) decrease in accounts receivable</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_FunctionalCurrencyMember_019c4318-52e4-7693-8aef-5115a8d3f814_terseLabel_en-US" xlink:label="lab_soph_FunctionalCurrencyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Functional Currency</link:label>
    <link:label id="lab_soph_FunctionalCurrencyMember_label_en-US" xlink:label="lab_soph_FunctionalCurrencyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Functional Currency [Member]</link:label>
    <link:label id="lab_soph_FunctionalCurrencyMember_documentation_en-US" xlink:label="lab_soph_FunctionalCurrencyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Functional currency.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FunctionalCurrencyMember" xlink:href="soph-20251231.xsd#soph_FunctionalCurrencyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_FunctionalCurrencyMember" xlink:to="lab_soph_FunctionalCurrencyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccruedInventoryPurchases_019c4318-53fc-7c69-b07d-aae819c41cf7_terseLabel_en-US" xlink:label="lab_soph_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued inventory purchases</link:label>
    <link:label id="lab_soph_AccruedInventoryPurchases_label_en-US" xlink:label="lab_soph_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:label id="lab_soph_AccruedInventoryPurchases_documentation_en-US" xlink:label="lab_soph_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued inventory purchases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedInventoryPurchases" xlink:href="soph-20251231.xsd#soph_AccruedInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccruedInventoryPurchases" xlink:to="lab_soph_AccruedInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_019c4318-5379-7a15-8eff-5c9fbe198af7_terseLabel_en-US" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_label_en-US" xlink:label="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquisitions through business combinations, intangible assets and goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="lab_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_019c9fe2-bb76-7d41-8fcf-d6ab0c410efc_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through statement of loss</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through profit or loss, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentPrepayments_019c4318-5379-7dee-a69b-fdb4dc7b4df3_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentPrepayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayments</link:label>
    <link:label id="lab_ifrs-full_CurrentPrepayments_label_en-US" xlink:label="lab_ifrs-full_CurrentPrepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current prepayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepayments" xlink:to="lab_ifrs-full_CurrentPrepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_019c4318-5379-72e8-ad5b-58ad975240bb_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency Translation Adjustment</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets and goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of financial position [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory_019c4318-52e4-79b2-bc43-49ba3775d018_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income, net and Foreign exchange (losses) gains, net</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for interest income and expense [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherOperatingIncomeExpense_019c4318-5379-7516-b751-6843fb8c272b_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other operating (loss) income, net</link:label>
    <link:label id="lab_ifrs-full_OtherOperatingIncomeExpense_label_en-US" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other operating income (expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_019c4318-52e4-7a2c-a312-d86962e22747_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other interest</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense on other financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnOtherFinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities" xlink:to="lab_ifrs-full_InterestExpenseOnOtherFinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory_019c4318-52e4-7e5f-95f2-17569a4e4658_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Maturity Profile of Financial Liabilities</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis of undiscounted cash outflows to repurchase derecognised financial assets or amounts payable to transferee in respect of transferred assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantLiabilityForeignExchangeGainLoss_019c750e-8771-78cd-a0a3-4e884d1d3db2_terseLabel_en-US" xlink:label="lab_soph_WarrantLiabilityForeignExchangeGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange gain (loss)</link:label>
    <link:label id="lab_soph_WarrantLiabilityForeignExchangeGainLoss_label_en-US" xlink:label="lab_soph_WarrantLiabilityForeignExchangeGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Liability, Foreign Exchange Gain (Loss)</link:label>
    <link:label id="lab_soph_WarrantLiabilityForeignExchangeGainLoss_documentation_en-US" xlink:label="lab_soph_WarrantLiabilityForeignExchangeGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Liability, Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantLiabilityForeignExchangeGainLoss" xlink:href="soph-20251231.xsd#soph_WarrantLiabilityForeignExchangeGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantLiabilityForeignExchangeGainLoss" xlink:to="lab_soph_WarrantLiabilityForeignExchangeGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_RedemptionPeriodOfWarrantRights_019c4318-5379-78ae-8bfa-959eadf2df44_terseLabel_en-US" xlink:label="lab_soph_RedemptionPeriodOfWarrantRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise period of purchase rights on warrant certificate</link:label>
    <link:label id="lab_soph_RedemptionPeriodOfWarrantRights_label_en-US" xlink:label="lab_soph_RedemptionPeriodOfWarrantRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redemption Period Of Warrant Rights</link:label>
    <link:label id="lab_soph_RedemptionPeriodOfWarrantRights_documentation_en-US" xlink:label="lab_soph_RedemptionPeriodOfWarrantRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Redemption Period Of Warrant Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RedemptionPeriodOfWarrantRights" xlink:href="soph-20251231.xsd#soph_RedemptionPeriodOfWarrantRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_RedemptionPeriodOfWarrantRights" xlink:to="lab_soph_RedemptionPeriodOfWarrantRights" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock_019c4318-52e4-7909-8548-508c92cfa487_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in accounting policies, new standards, amendments to standards and interpretations</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Changes And New Standards [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for new standards amendments to standards and interpretations issued not yet effective.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansAxis_019c4318-52e4-7d3d-8635-8a2c71f657a9_terseLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plans [axis]</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansAxis_label_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plans [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis" xlink:to="lab_ifrs-full_DefinedBenefitPlansAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfCostOfSalesAbstract_label_en-US" xlink:label="lab_soph_DisclosureOfCostOfSalesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Cost Of Sales [Abstract]</link:label>
    <link:label id="lab_soph_DisclosureOfCostOfSalesAbstract_documentation_en-US" xlink:label="lab_soph_DisclosureOfCostOfSalesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of cost of sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCostOfSalesAbstract" xlink:href="soph-20251231.xsd#soph_DisclosureOfCostOfSalesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfCostOfSalesAbstract" xlink:to="lab_soph_DisclosureOfCostOfSalesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-7c9a-aff3-e64658f2b3ae_terseLabel_en-US" xlink:label="lab_soph_ChangesInWarrantLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes In Warrant Liability [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInWarrantLiabilityAbstract_label_en-US" xlink:label="lab_soph_ChangesInWarrantLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes In Warrant Liability [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInWarrantLiabilityAbstract_documentation_en-US" xlink:label="lab_soph_ChangesInWarrantLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Changes In Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInWarrantLiabilityAbstract" xlink:href="soph-20251231.xsd#soph_ChangesInWarrantLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract" xlink:to="lab_soph_ChangesInWarrantLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock_019c4318-52e4-7749-86cc-4f405188edb0_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Accounts Receivable and Lease Receivable Less Expected Credit Loss</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed information About Accounts Receivable And Lease Receivable [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of accounts receivable and lease receivable less expected credit loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets_019c4318-52e4-7eab-81e9-0df4c0804924_terseLabel_en-US" xlink:label="lab_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of business days for right to reinvest certain proceeds in assets</link:label>
    <link:label id="lab_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets_label_en-US" xlink:label="lab_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowing Facilities, Prepayment Terms, Business Threshold Days For Right To Reinvest Certain Proceeds In Assets</link:label>
    <link:label id="lab_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets_documentation_en-US" xlink:label="lab_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowing Facilities, Prepayment Terms, Business Threshold Days For Right To Reinvest Certain Proceeds In Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets" xlink:to="lab_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CashAndCashEquivalentMember_019c4318-5378-7cc7-9ed6-6d9860bfa64d_terseLabel_en-US" xlink:label="lab_soph_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_soph_CashAndCashEquivalentMember_label_en-US" xlink:label="lab_soph_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalent [Member]</link:label>
    <link:label id="lab_soph_CashAndCashEquivalentMember_documentation_en-US" xlink:label="lab_soph_CashAndCashEquivalentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CashAndCashEquivalentMember" xlink:href="soph-20251231.xsd#soph_CashAndCashEquivalentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CashAndCashEquivalentMember" xlink:to="lab_soph_CashAndCashEquivalentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-5378-7b7d-a8ac-ebb386848f19_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:to="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock_019c4318-5379-765a-8a2a-b7791ff2f345_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Wholly-Owned Subsidiaries</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Subsidiaries [Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock_019c4318-52e4-7cdf-8ace-b1fb775881ed_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Expiring Amounts of Unrecognized Net Operating Loss Carryforwards</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Expiring Amounts Of Unrecognized Net Operating Loss Carryforwards [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of expiring amounts of unrecognized net operating loss carryforwards explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AdjustmentsForFairValueOfWarrantLiability_019c4318-5379-7ec3-8759-1387a53b2e44_terseLabel_en-US" xlink:label="lab_soph_AdjustmentsForFairValueOfWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on warrant obligations</link:label>
    <link:label id="lab_soph_AdjustmentsForFairValueOfWarrantLiability_019c4318-5379-7e4b-b16c-fb16dd8c29bf_negatedLabel_en-US" xlink:label="lab_soph_AdjustmentsForFairValueOfWarrantLiability" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Fair value adjustments on warrant obligations</link:label>
    <link:label id="lab_soph_AdjustmentsForFairValueOfWarrantLiability_019c4318-5379-736d-8d93-fe2473a11414_verboseLabel_en-US" xlink:label="lab_soph_AdjustmentsForFairValueOfWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_soph_AdjustmentsForFairValueOfWarrantLiability_label_en-US" xlink:label="lab_soph_AdjustmentsForFairValueOfWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Fair Value Of Warrant Liability</link:label>
    <link:label id="lab_soph_AdjustmentsForFairValueOfWarrantLiability_documentation_en-US" xlink:label="lab_soph_AdjustmentsForFairValueOfWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments For Fair Value Of Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForFairValueOfWarrantLiability" xlink:href="soph-20251231.xsd#soph_AdjustmentsForFairValueOfWarrantLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AdjustmentsForFairValueOfWarrantLiability" xlink:to="lab_soph_AdjustmentsForFairValueOfWarrantLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_019c4318-5379-7930-a7b3-a380d8fea19f_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SharePremium_019c4318-52e4-753c-b55e-b5cff5af2d3e_terseLabel_en-US" xlink:label="lab_ifrs-full_SharePremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share premium</link:label>
    <link:label id="lab_ifrs-full_SharePremium_label_en-US" xlink:label="lab_ifrs-full_SharePremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremium" xlink:to="lab_ifrs-full_SharePremium" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019c4318-5378-7d48-be70-de219220d664_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-52e4-7200-8e74-387f900d0cdb_terseLabel_en-US" xlink:label="lab_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sensitivity analysis, period increase</link:label>
    <link:label id="lab_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption_label_en-US" xlink:label="lab_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Period Of Reasonably Possible Increase In Actuarial Assumption</link:label>
    <link:label id="lab_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption_documentation_en-US" xlink:label="lab_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Period Of Reasonably Possible Increase In Actuarial Assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:href="soph-20251231.xsd#soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="lab_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CurrentOtherAssetsMiscellaneous_019c4318-52e4-71a1-a9d4-de7ca2086964_terseLabel_en-US" xlink:label="lab_soph_CurrentOtherAssetsMiscellaneous" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_soph_CurrentOtherAssetsMiscellaneous_label_en-US" xlink:label="lab_soph_CurrentOtherAssetsMiscellaneous" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Other Assets Miscellaneous</link:label>
    <link:label id="lab_soph_CurrentOtherAssetsMiscellaneous_documentation_en-US" xlink:label="lab_soph_CurrentOtherAssetsMiscellaneous" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current other assets miscellaneous.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentOtherAssetsMiscellaneous" xlink:href="soph-20251231.xsd#soph_CurrentOtherAssetsMiscellaneous"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CurrentOtherAssetsMiscellaneous" xlink:to="lab_soph_CurrentOtherAssetsMiscellaneous" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-5378-7bc9-8c0b-bac70b870812_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of significant unobservable inputs used in fair value measurement of assets [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of significant unobservable inputs used in fair value measurement of assets [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:to="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-53fc-7607-b260-e6aeba3c8585_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of liabilities [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of liabilities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain" xlink:to="lab_ifrs-full_ClassesOfLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheBMember_019c4318-52e4-7e6e-a9a0-2e25db6e7d6a_terseLabel_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche B</link:label>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheBMember_label_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Perceptive Credit Agreement, Tranche B [Member]</link:label>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheBMember_documentation_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Perceptive Credit Agreement, Tranche B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheBMember" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PerceptiveCreditAgreementTrancheBMember" xlink:to="lab_soph_PerceptiveCreditAgreementTrancheBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncome_019c4318-52e4-7d60-9f29-412a73c343be_totalLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive loss for the period</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="lab_ifrs-full_ComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WorkInProgress_019c4318-53fc-7d78-8557-f54ce379327d_terseLabel_en-US" xlink:label="lab_ifrs-full_WorkInProgress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work in progress</link:label>
    <link:label id="lab_ifrs-full_WorkInProgress_label_en-US" xlink:label="lab_ifrs-full_WorkInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current work in progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WorkInProgress" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WorkInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WorkInProgress" xlink:to="lab_ifrs-full_WorkInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_019c4318-52e4-7a7c-a8ec-2bb6e6dd3e4b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BalancesWithBanks_019c4318-52e4-7444-bea4-620feb61bcf1_terseLabel_en-US" xlink:label="lab_ifrs-full_BalancesWithBanks" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash on hand</link:label>
    <link:label id="lab_ifrs-full_BalancesWithBanks_label_en-US" xlink:label="lab_ifrs-full_BalancesWithBanks" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Balances with banks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BalancesWithBanks" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BalancesWithBanks"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BalancesWithBanks" xlink:to="lab_ifrs-full_BalancesWithBanks" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EstimatedFinancialEffectOfContingentAssets_019c4318-52e4-7b60-8d91-0eb2d951f710_terseLabel_en-US" xlink:label="lab_ifrs-full_EstimatedFinancialEffectOfContingentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingent assets</link:label>
    <link:label id="lab_ifrs-full_EstimatedFinancialEffectOfContingentAssets_label_en-US" xlink:label="lab_ifrs-full_EstimatedFinancialEffectOfContingentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated financial effect of contingent assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EstimatedFinancialEffectOfContingentAssets" xlink:to="lab_ifrs-full_EstimatedFinancialEffectOfContingentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Assets_019c4318-5379-7ace-86dc-7e274cc87ee4_totalLabel_en-US" xlink:label="lab_ifrs-full_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_ifrs-full_Assets_label_en-US" xlink:label="lab_ifrs-full_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets" xlink:to="lab_ifrs-full_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OperatingLeaseIncome_019c4318-5379-7731-af9c-a237327c4ab7_terseLabel_en-US" xlink:label="lab_ifrs-full_OperatingLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues from payments from leased equipment recognized</link:label>
    <link:label id="lab_ifrs-full_OperatingLeaseIncome_label_en-US" xlink:label="lab_ifrs-full_OperatingLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating lease income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingLeaseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingLeaseIncome" xlink:to="lab_ifrs-full_OperatingLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_019c4318-53fc-7f4d-9184-b01257c2a91f_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for income tax [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CreditAgreementExistingMember_019c4318-5378-7b67-a150-b73618cc0060_terseLabel_en-US" xlink:label="lab_soph_CreditAgreementExistingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Existing Credit Agreement</link:label>
    <link:label id="lab_soph_CreditAgreementExistingMember_label_en-US" xlink:label="lab_soph_CreditAgreementExistingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Agreement, Existing [Member]</link:label>
    <link:label id="lab_soph_CreditAgreementExistingMember_documentation_en-US" xlink:label="lab_soph_CreditAgreementExistingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit Agreement, Existing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CreditAgreementExistingMember" xlink:href="soph-20251231.xsd#soph_CreditAgreementExistingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CreditAgreementExistingMember" xlink:to="lab_soph_CreditAgreementExistingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CostOfSalesMember_019c4318-5379-7e1a-b52e-56399fccdeb3_terseLabel_en-US" xlink:label="lab_ifrs-full_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_ifrs-full_CostOfSalesMember_label_en-US" xlink:label="lab_ifrs-full_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of sales [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSalesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSalesMember" xlink:to="lab_ifrs-full_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_019c4318-5379-7ae7-b7b9-2503f6631fdc_periodStartLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested at beginning of period (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_019c4318-5379-72f8-a088-a2f077e5057f_periodEndLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested at end of period (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments outstanding in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock_019c7523-dfc4-796b-a081-c6a41af48d79_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Warrant Obligation Liability</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Warrant Liability [Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement_019c4318-52e4-7b43-9303-12d46664e696_periodStartLabel_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement_019c4318-52e4-7834-8858-43281e12240f_periodEndLabel_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested at end of period (in dollars per share)</link:label>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value Of Other Equity Instruments Outstanding In Share Based Payment Arrangement</link:label>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted-average grant date fair value of other equity instruments outstanding in share-based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" xlink:to="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_019c4318-52e4-7a59-9345-78ac2a7c7a2b_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total current income tax expense</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax expense (income) and adjustments for current tax of prior periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019c4318-5378-786a-a6bf-b6e9d5427073_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DifferencesOfCurrencyUSDAndEURMember_019c4318-5378-742d-84cc-010472ca06a1_terseLabel_en-US" xlink:label="lab_soph_DifferencesOfCurrencyUSDAndEURMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">USD/EUR</link:label>
    <link:label id="lab_soph_DifferencesOfCurrencyUSDAndEURMember_label_en-US" xlink:label="lab_soph_DifferencesOfCurrencyUSDAndEURMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Differences Of Currency USD And EUR [Member]</link:label>
    <link:label id="lab_soph_DifferencesOfCurrencyUSDAndEURMember_documentation_en-US" xlink:label="lab_soph_DifferencesOfCurrencyUSDAndEURMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Differences of Currency USD/EUR.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyUSDAndEURMember" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyUSDAndEURMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DifferencesOfCurrencyUSDAndEURMember" xlink:to="lab_soph_DifferencesOfCurrencyUSDAndEURMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_019c6c18-0d07-7b9b-9ec3-00453a2d2793_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through profit or loss</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at fair value through profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019c4318-5378-7a5a-9081-e7aced26ecbc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AuditorAbstract_label_en-US" xlink:label="lab_soph_AuditorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor [Abstract]</link:label>
    <link:label id="lab_soph_AuditorAbstract_documentation_en-US" xlink:label="lab_soph_AuditorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Auditor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AuditorAbstract" xlink:href="soph-20251231.xsd#soph_AuditorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AuditorAbstract" xlink:to="lab_soph_AuditorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets_019c4318-5379-7f83-9060-78ec07b3edb7_terseLabel_en-US" xlink:label="lab_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance policies</link:label>
    <link:label id="lab_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets_label_en-US" xlink:label="lab_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Qualifying insurance policies, amount contributed to fair value of plan assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" xlink:to="lab_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_019c4318-5378-7425-bb10-5c53918d6a1c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfBorrowingsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of borrowings [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfBorrowingsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IssuedCapitalMember_019c4318-5378-788f-97b0-06dcc9e1a8cd_terseLabel_en-US" xlink:label="lab_ifrs-full_IssuedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share capital</link:label>
    <link:label id="lab_ifrs-full_IssuedCapitalMember_label_en-US" xlink:label="lab_ifrs-full_IssuedCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issued capital [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember" xlink:to="lab_ifrs-full_IssuedCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentLiabilities_019c4318-52e4-7d38-a077-051fd88f2bdc_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentLiabilities_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities" xlink:to="lab_ifrs-full_OtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherReservesMember_019c4318-5378-7064-86e4-c24e5141736b_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherReservesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other reserves</link:label>
    <link:label id="lab_ifrs-full_OtherReservesMember_label_en-US" xlink:label="lab_ifrs-full_OtherReservesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other reserves [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReservesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReservesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReservesMember" xlink:to="lab_ifrs-full_OtherReservesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LossesOnLitigationSettlements_019caf63-7e33-77ae-bcb1-8fd2c38c0fef_terseLabel_en-US" xlink:label="lab_ifrs-full_LossesOnLitigationSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation ordered payment of interim award costs</link:label>
    <link:label id="lab_ifrs-full_LossesOnLitigationSettlements_label_en-US" xlink:label="lab_ifrs-full_LossesOnLitigationSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Losses on litigation settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LossesOnLitigationSettlements" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnLitigationSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LossesOnLitigationSettlements" xlink:to="lab_ifrs-full_LossesOnLitigationSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock_019c727a-2a29-7396-95e4-edacc4dfdcf6_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative costs</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For General And Administrative Expense [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For General And Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019c4318-52e4-7d2b-ab3d-a0326f25cd73_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_019c4318-52e4-7cbd-b15c-906364042a71_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average share price at date of exercise (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average share price for share options in share-based payment arrangement exercised during period at date of exercise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-52e4-7561-b2a4-c79965a9a1c5_terseLabel_en-US" xlink:label="lab_soph_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Intangible Assets [Line Items]</link:label>
    <link:label id="lab_soph_ScheduleOfIntangibleAssetsLineItems_label_en-US" xlink:label="lab_soph_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Intangible Assets [Line Items]</link:label>
    <link:label id="lab_soph_ScheduleOfIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_soph_ScheduleOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ScheduleOfIntangibleAssetsLineItems" xlink:href="soph-20251231.xsd#soph_ScheduleOfIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems" xlink:to="lab_soph_ScheduleOfIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BorrowingFacilitiesMaximumBorrowingCapacity_019c4318-52e4-78be-b816-9e273c34d262_terseLabel_en-US" xlink:label="lab_soph_BorrowingFacilitiesMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum borrowings</link:label>
    <link:label id="lab_soph_BorrowingFacilitiesMaximumBorrowingCapacity_label_en-US" xlink:label="lab_soph_BorrowingFacilitiesMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowing Facilities, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_soph_BorrowingFacilitiesMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_soph_BorrowingFacilitiesMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit facility, maximum borrowing capacity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesMaximumBorrowingCapacity" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BorrowingFacilitiesMaximumBorrowingCapacity" xlink:to="lab_soph_BorrowingFacilitiesMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_IncomeStatementLocation1Axis_019c4318-5379-70d9-93f9-9edc4a6eca7c_terseLabel_en-US" xlink:label="lab_soph_IncomeStatementLocation1Axis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_soph_IncomeStatementLocation1Axis_label_en-US" xlink:label="lab_soph_IncomeStatementLocation1Axis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location1 [Axis]</link:label>
    <link:label id="lab_soph_IncomeStatementLocation1Axis_documentation_en-US" xlink:label="lab_soph_IncomeStatementLocation1Axis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Statement Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncomeStatementLocation1Axis" xlink:href="soph-20251231.xsd#soph_IncomeStatementLocation1Axis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_IncomeStatementLocation1Axis" xlink:to="lab_soph_IncomeStatementLocation1Axis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_019c4318-52e4-7dc9-a6a3-792988432f7f_negatedLabel_en-US" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Disposals</link:label>
    <link:label id="lab_ifrs-full_DisposalsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposals, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MachineryMember_019c4318-5379-70c3-91f3-e4145c94dcfe_terseLabel_en-US" xlink:label="lab_ifrs-full_MachineryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_ifrs-full_MachineryMember_label_en-US" xlink:label="lab_ifrs-full_MachineryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MachineryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MachineryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MachineryMember" xlink:to="lab_ifrs-full_MachineryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_019c4318-53fc-76d5-8c51-f78d860f48f6_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Tax at Swiss statutory rate</link:label>
    <link:label id="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_label_en-US" xlink:label="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax expense (income) at applicable tax rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:to="lab_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock_019c4318-5379-7195-ae0f-97d620219b8f_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Foreign Exchange Losses</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Foreign Exchange Gain (Loss), Net [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Foreign Exchange And Other Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AssetsAbstract_019c4318-52e4-7a9b-8c30-fff95c35f1a4_terseLabel_en-US" xlink:label="lab_ifrs-full_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_ifrs-full_AssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract" xlink:to="lab_ifrs-full_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfLeaseTable_019c4318-5378-7db2-9041-1e305c14107b_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfLeaseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease [Table]</link:label>
    <link:label id="lab_soph_DisclosureOfLeaseTable_label_en-US" xlink:label="lab_soph_DisclosureOfLeaseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease [Table]</link:label>
    <link:label id="lab_soph_DisclosureOfLeaseTable_documentation_en-US" xlink:label="lab_soph_DisclosureOfLeaseTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfLeaseTable" xlink:href="soph-20251231.xsd#soph_DisclosureOfLeaseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfLeaseTable" xlink:to="lab_soph_DisclosureOfLeaseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_019c4318-52e4-7b39-96f9-7354667166a7_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price at grant date (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average share price, share options granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:to="lab_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-5379-7cd9-92ad-03971069030b_terseLabel_en-US" xlink:label="lab_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining life in years</link:label>
    <link:label id="lab_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Life Of Equity Instruments In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_documentation_en-US" xlink:label="lab_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Life Of Equity Instruments In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:href="soph-20251231.xsd#soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:to="lab_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentAssetsAbstract_019c4318-52e4-7ca0-bcff-f504bd74a4a3_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_ifrs-full_CurrentAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_CurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssetsAbstract" xlink:to="lab_ifrs-full_CurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019c4318-5378-717c-999e-88c08cb2f260_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory_019c4318-53fc-7f65-9e25-ac537bd9127f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of accrued expenses and other liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccruedExpensesMember_019c4318-5379-79ec-983f-dca47024b6ee_terseLabel_en-US" xlink:label="lab_soph_AccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_soph_AccruedExpensesMember_label_en-US" xlink:label="lab_soph_AccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Expenses [Member]</link:label>
    <link:label id="lab_soph_AccruedExpensesMember_documentation_en-US" xlink:label="lab_soph_AccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedExpensesMember" xlink:href="soph-20251231.xsd#soph_AccruedExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccruedExpensesMember" xlink:to="lab_soph_AccruedExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssetsAbstract_019c4318-5378-7fa9-a25a-16e35ae99366_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c89a9-e5e3-75f3-b3f5-304d824dcd84_terseLabel_en-US" xlink:label="lab_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Presentation of leases for lessee [abstract]</link:label>
    <link:label id="lab_ifrs-full_PresentationOfLeasesForLesseeAbstract_label_en-US" xlink:label="lab_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Presentation of leases for lessee [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:to="lab_ifrs-full_PresentationOfLeasesForLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinanceCostExplanatory_019c4318-52e4-7d19-8c02-b4ba70bdd0ac_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income, Interest expense and Foreign exchange (losses) gains, net</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinanceCostExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of finance cost [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceCostExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinanceCostExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GeneralAndAdministrativeExpense_019c4318-52e4-771f-a088-0e2ccd4912b9_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">General and administrative costs</link:label>
    <link:label id="lab_ifrs-full_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_ifrs-full_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and administrative expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeneralAndAdministrativeExpense" xlink:to="lab_ifrs-full_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_019c4318-52e4-7ffd-a591-e95eb4c65b1a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of income tax [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_019c4318-53fc-7180-aabd-5fbea8bc6da1_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SellingAndMarketingExpense1Member_019c4318-5379-7c0d-9421-f73c959fe6c9_terseLabel_en-US" xlink:label="lab_soph_SellingAndMarketingExpense1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling and marketing costs</link:label>
    <link:label id="lab_soph_SellingAndMarketingExpense1Member_label_en-US" xlink:label="lab_soph_SellingAndMarketingExpense1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling And Marketing Expense1 [Member]</link:label>
    <link:label id="lab_soph_SellingAndMarketingExpense1Member_documentation_en-US" xlink:label="lab_soph_SellingAndMarketingExpense1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Selling and marketing costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SellingAndMarketingExpense1Member" xlink:href="soph-20251231.xsd#soph_SellingAndMarketingExpense1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SellingAndMarketingExpense1Member" xlink:to="lab_soph_SellingAndMarketingExpense1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_019c4318-5379-7469-895d-888ebf4bd554_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for recognition of revenue [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_A2019IncentiveShareOptionPlanMember_019c4318-52e4-7643-b00c-00798b8989d9_terseLabel_en-US" xlink:label="lab_soph_A2019IncentiveShareOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019 ISOP</link:label>
    <link:label id="lab_soph_A2019IncentiveShareOptionPlanMember_label_en-US" xlink:label="lab_soph_A2019IncentiveShareOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2019 Incentive Share Option Plan [Member]</link:label>
    <link:label id="lab_soph_A2019IncentiveShareOptionPlanMember_documentation_en-US" xlink:label="lab_soph_A2019IncentiveShareOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and nineteen incentive share option plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2019IncentiveShareOptionPlanMember" xlink:href="soph-20251231.xsd#soph_A2019IncentiveShareOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_A2019IncentiveShareOptionPlanMember" xlink:to="lab_soph_A2019IncentiveShareOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccruedITSupport_019c4318-5379-7ed4-89f7-510225d758d8_terseLabel_en-US" xlink:label="lab_soph_AccruedITSupport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued IT support</link:label>
    <link:label id="lab_soph_AccruedITSupport_label_en-US" xlink:label="lab_soph_AccruedITSupport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued IT Support</link:label>
    <link:label id="lab_soph_AccruedITSupport_documentation_en-US" xlink:label="lab_soph_AccruedITSupport" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued IT support.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedITSupport" xlink:href="soph-20251231.xsd#soph_AccruedITSupport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccruedITSupport" xlink:to="lab_soph_AccruedITSupport" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearFour_019c4318-52e4-788a-8d73-4888e29a02c0_terseLabel_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Four years</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearFour_label_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Operating Loss Carryforwards, Year Four</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearFour_documentation_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards year four.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearFour" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NetOperatingLossCarryforwardsYearFour" xlink:to="lab_soph_NetOperatingLossCarryforwardsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ProceedsFromWarrantLiability_019c750e-8771-756d-a33b-4a34327cce9f_terseLabel_en-US" xlink:label="lab_soph_ProceedsFromWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of warrants</link:label>
    <link:label id="lab_soph_ProceedsFromWarrantLiability_label_en-US" xlink:label="lab_soph_ProceedsFromWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Warrant Liability</link:label>
    <link:label id="lab_soph_ProceedsFromWarrantLiability_documentation_en-US" xlink:label="lab_soph_ProceedsFromWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issue of During the Value Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromWarrantLiability" xlink:href="soph-20251231.xsd#soph_ProceedsFromWarrantLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ProceedsFromWarrantLiability" xlink:to="lab_soph_ProceedsFromWarrantLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_019c66bb-486e-7f08-bad6-1f46f6ba54fa_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest paid, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_019c4318-53fc-7298-955f-ebf0a0331ff9_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Stock Option Activity</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of number and weighted average exercise prices of share options [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SwissPensionPlanMember_019c4318-5379-78bb-a90f-852adae8e680_terseLabel_en-US" xlink:label="lab_soph_SwissPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Swiss Pension Plan</link:label>
    <link:label id="lab_soph_SwissPensionPlanMember_label_en-US" xlink:label="lab_soph_SwissPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Swiss Pension Plan [Member]</link:label>
    <link:label id="lab_soph_SwissPensionPlanMember_documentation_en-US" xlink:label="lab_soph_SwissPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Swiss pension plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SwissPensionPlanMember" xlink:href="soph-20251231.xsd#soph_SwissPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SwissPensionPlanMember" xlink:to="lab_soph_SwissPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CapitalCommitmentsAbstract_label_en-US" xlink:label="lab_ifrs-full_CapitalCommitmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital commitments [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalCommitmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CapitalCommitmentsAbstract" xlink:to="lab_ifrs-full_CapitalCommitmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComputerSoftwareMember_019c4318-5378-7ac4-aff2-755d1955b121_terseLabel_en-US" xlink:label="lab_ifrs-full_ComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer software</link:label>
    <link:label id="lab_ifrs-full_ComputerSoftwareMember_019c4318-5378-7fa2-8272-70c0043e4721_verboseLabel_en-US" xlink:label="lab_ifrs-full_ComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Purchased software</link:label>
    <link:label id="lab_ifrs-full_ComputerSoftwareMember_label_en-US" xlink:label="lab_ifrs-full_ComputerSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer software [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerSoftwareMember" xlink:to="lab_ifrs-full_ComputerSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-5378-78c4-916c-8e4592cd388d_terseLabel_en-US" xlink:label="lab_soph_EuropeTheMiddleEastAndAfricaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_soph_EuropeTheMiddleEastAndAfricaMember_label_en-US" xlink:label="lab_soph_EuropeTheMiddleEastAndAfricaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Europe, The Middle East And Africa [Member]</link:label>
    <link:label id="lab_soph_EuropeTheMiddleEastAndAfricaMember_documentation_en-US" xlink:label="lab_soph_EuropeTheMiddleEastAndAfricaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Europe, The Middle East And Africa</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_EuropeTheMiddleEastAndAfricaMember" xlink:href="soph-20251231.xsd#soph_EuropeTheMiddleEastAndAfricaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_EuropeTheMiddleEastAndAfricaMember" xlink:to="lab_soph_EuropeTheMiddleEastAndAfricaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_label_en-US" xlink:label="lab_ifrs-full_ReceivablesFromContractsWithCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivables from contracts with customers [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract" xlink:to="lab_ifrs-full_ReceivablesFromContractsWithCustomersAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_019c72dc-e136-757f-bae5-0544abde9695_terseLabel_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSU vesting percentage on a quarterly basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_label_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On A Quarterly Basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_documentation_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On A Quarterly Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:to="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Cash_019c4318-5379-793e-85f6-a75b2eecf406_totalLabel_en-US" xlink:label="lab_ifrs-full_Cash" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash</link:label>
    <link:label id="lab_ifrs-full_Cash_label_en-US" xlink:label="lab_ifrs-full_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Cash" xlink:to="lab_ifrs-full_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember_019c4318-53fc-725a-bd93-3ce9a0a3c05a_terseLabel_en-US" xlink:label="lab_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ROU asset</link:label>
    <link:label id="lab_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember_label_en-US" xlink:label="lab_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-Of-Use Assets Related Temporary Differences [Member]</link:label>
    <link:label id="lab_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember_documentation_en-US" xlink:label="lab_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary difference ROU asset.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember" xlink:href="soph-20251231.xsd#soph_RightOfUseAssetsRelatedTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember" xlink:to="lab_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityInvestmentsMember_019c6c1d-649f-7bff-b4e3-83634c502fc5_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_ifrs-full_EquityInvestmentsMember_label_en-US" xlink:label="lab_ifrs-full_EquityInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity investments [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInvestmentsMember" xlink:to="lab_ifrs-full_EquityInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019c4318-5379-7758-9cb2-5075fd5d6922_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_019c72d8-a229-7ff4-8d56-bd2acd39b76b_terseLabel_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSU vesting percentage on an annual basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_label_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On An Annual Basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_documentation_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On An Annual Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:to="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_019c4318-52e4-7019-9114-677d49281c46_negatedLabel_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Actual plan participants&#8217; contributions</link:label>
    <link:label id="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_019c4318-52e4-741e-82bb-7e451492ead0_terseLabel_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_019c4318-52e4-74d8-8aec-db3d7a302b37_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk free interest rate (%)</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risk free interest rate, share options granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="lab_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_019c4318-52e4-7864-8fe6-d4771e309704_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for determining components of cash and cash equivalents [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SOPHiADDMPlatformMember_019c4318-5379-7f57-9099-5dd8e06b9e51_terseLabel_en-US" xlink:label="lab_soph_SOPHiADDMPlatformMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SOPHiA DDM Platform</link:label>
    <link:label id="lab_soph_SOPHiADDMPlatformMember_label_en-US" xlink:label="lab_soph_SOPHiADDMPlatformMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SOPHiA DDM Platform [Member]</link:label>
    <link:label id="lab_soph_SOPHiADDMPlatformMember_documentation_en-US" xlink:label="lab_soph_SOPHiADDMPlatformMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SOPHiA platform.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SOPHiADDMPlatformMember" xlink:href="soph-20251231.xsd#soph_SOPHiADDMPlatformMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SOPHiADDMPlatformMember" xlink:to="lab_soph_SOPHiADDMPlatformMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_019c72e1-3027-7c82-9a1f-dd4b8958760c_terseLabel_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSU vesting period on a monthly basis</link:label>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_label_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On A Monthly Basis</link:label>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_documentation_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On A Monthly Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:to="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019c4318-52e4-7c16-9402-20f4768acb03_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019c4318-52e4-71ce-9091-72a4a713035c_verboseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Movement in the period</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through share-based payment transactions, equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_019c4318-52e4-795e-a287-27b3efeb31c9_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AdjustmentsForFinanceExpenseIncomeNet_019c4318-52e4-79f8-8e14-9be1a32d1dd0_terseLabel_en-US" xlink:label="lab_soph_AdjustmentsForFinanceExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance expense (income), net</link:label>
    <link:label id="lab_soph_AdjustmentsForFinanceExpenseIncomeNet_label_en-US" xlink:label="lab_soph_AdjustmentsForFinanceExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for Finance Expense (Income), Net</link:label>
    <link:label id="lab_soph_AdjustmentsForFinanceExpenseIncomeNet_documentation_en-US" xlink:label="lab_soph_AdjustmentsForFinanceExpenseIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for Finance Expense (Income), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForFinanceExpenseIncomeNet" xlink:href="soph-20251231.xsd#soph_AdjustmentsForFinanceExpenseIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AdjustmentsForFinanceExpenseIncomeNet" xlink:to="lab_soph_AdjustmentsForFinanceExpenseIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssets_019c4318-52e4-7e5f-8d0f-7b790876d216_totalLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="lab_ifrs-full_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_019c4318-52e4-7e7e-8905-f7df21c34bb3_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, exchange differences on translation of foreign operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-52e4-71f9-965b-5a70cd3c027e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Defined Benefit Plans [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_019c4318-5378-7b96-9df9-bd8728ad022a_terseLabel_en-US" xlink:label="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Movements in Share-based Compensation Reserve</link:label>
    <link:label id="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_label_en-US" xlink:label="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Explanation of effect of share-based payments on entity's financial position [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions" xlink:to="lab_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_019c4318-52e4-75f5-aedd-5bbe9ed6f068_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other operating income, net</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other operating income (expense) [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-5378-792d-bbff-3db1fb2a8f14_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_019c4318-52e4-75bf-8a34-99b43da33ed7_verboseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total foreign exchange gains (losses), net</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_019c4318-52e4-758a-bb9a-7597de43cf9c_terseLabel_en-US" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange gain (loss)</link:label>
    <link:label id="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign exchange gain (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheAMember_019c4318-52e4-70b4-a52d-68ad1054f168_terseLabel_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche A</link:label>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheAMember_label_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Perceptive Credit Agreement, Tranche A [Member]</link:label>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheAMember_documentation_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Perceptive Credit Agreement, Tranche A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheAMember" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PerceptiveCreditAgreementTrancheAMember" xlink:to="lab_soph_PerceptiveCreditAgreementTrancheAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember_019c4318-52e4-7e6d-8226-fdd76f0ee5e8_terseLabel_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Tranche Two</link:label>
    <link:label id="lab_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember_label_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Vesting Tranche Two [Member]</link:label>
    <link:label id="lab_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember_documentation_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Vesting Tranche Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementVestingTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember" xlink:to="lab_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-52e4-73be-91a7-bb589c4caef2_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of property, plant and equipment [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsDomain_019c4318-52e4-7038-b6a6-a5a926dcec56_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial assumptions [domain]</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsDomain_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumptions [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain" xlink:to="lab_ifrs-full_ActuarialAssumptionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_019c4318-5379-7e3b-88dc-ac4772ae991b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019c4318-52e4-76c4-b878-a75b12760819_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019c4318-5379-726a-a275-42a4616e060b_terseLabel_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of changes in intangible assets other than goodwill [abstract]</link:label>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_label_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of changes in intangible assets other than goodwill [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:to="lab_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MajorOrdinaryShareTransactionsMember_019c6cc2-2395-7a03-9adb-f43b32c4dd2e_terseLabel_en-US" xlink:label="lab_ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major ordinary share transactions</link:label>
    <link:label id="lab_ifrs-full_MajorOrdinaryShareTransactionsMember_label_en-US" xlink:label="lab_ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major ordinary share transactions [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:to="lab_ifrs-full_MajorOrdinaryShareTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock_019c4318-5378-76d7-9560-899a6913b708_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Cash and Cash Equivalents</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Schedule Of Cash And Cash Equivalents [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of schedule of cash and cash equivalents explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_019c4318-52e4-71d6-9794-8b3c68e93bef_terseLabel_en-US" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange differences on cash balances</link:label>
    <link:label id="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_019c66b8-d313-70e1-9bd1-0d898fb67ed5_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest received</link:label>
    <link:label id="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest received, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_019c4318-53fc-7739-8d2c-afd202e80bd2_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for foreign currency translation [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CapitalManagementLineItems_019c4318-5379-7e93-8cb5-8fb4853dc28f_terseLabel_en-US" xlink:label="lab_soph_CapitalManagementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Management [Line Items]</link:label>
    <link:label id="lab_soph_CapitalManagementLineItems_label_en-US" xlink:label="lab_soph_CapitalManagementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Management [Line Items]</link:label>
    <link:label id="lab_soph_CapitalManagementLineItems_documentation_en-US" xlink:label="lab_soph_CapitalManagementLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capital Management [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CapitalManagementLineItems" xlink:href="soph-20251231.xsd#soph_CapitalManagementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CapitalManagementLineItems" xlink:to="lab_soph_CapitalManagementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_019c4318-52e4-7755-b314-9f16319c02a6_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-7af8-a878-c3adf6da5ca2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of contingent liabilities in business combination [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of contingent liabilities in business combination [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-5379-7e15-8592-cfee04181188_terseLabel_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sensitivity analysis, basis point increase</link:label>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_label_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of reasonably possible increase in actuarial assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_019c4318-52e4-7bff-890d-34d60d54f0f9_negatedLabel_en-US" xlink:label="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Return on plan assets, excl. interest income</link:label>
    <link:label id="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_019c4318-52e4-7b85-8290-8c901cb80663_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Return on plan assets</link:label>
    <link:label id="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ResearchTaxCredit_019c4318-5378-711d-b66b-acb31bc4ae02_terseLabel_en-US" xlink:label="lab_soph_ResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government grants for research and development and innovation</link:label>
    <link:label id="lab_soph_ResearchTaxCredit_label_en-US" xlink:label="lab_soph_ResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Tax Credit</link:label>
    <link:label id="lab_soph_ResearchTaxCredit_documentation_en-US" xlink:label="lab_soph_ResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research tax credit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ResearchTaxCredit" xlink:href="soph-20251231.xsd#soph_ResearchTaxCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ResearchTaxCredit" xlink:to="lab_soph_ResearchTaxCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-5378-7dab-b232-d4ffa12742e0_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Instruments [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract_019c4318-53fc-712d-8b78-9811dc4f5767_terseLabel_en-US" xlink:label="lab_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Defined Benefit Obligation [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract_label_en-US" xlink:label="lab_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Defined Benefit Obligation [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract_documentation_en-US" xlink:label="lab_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Defined Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract" xlink:to="lab_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GeographicalAreasDomain_019c4318-5378-7c4a-92bb-907d410b7c1b_terseLabel_en-US" xlink:label="lab_ifrs-full_GeographicalAreasDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical areas [domain]</link:label>
    <link:label id="lab_ifrs-full_GeographicalAreasDomain_label_en-US" xlink:label="lab_ifrs-full_GeographicalAreasDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical areas [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasDomain" xlink:to="lab_ifrs-full_GeographicalAreasDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_019c4318-5378-78d2-afc9-f94ae671aedf_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of other non-current assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentReceivables_019c4318-5378-7126-9105-05b816bf403f_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentReceivables_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other current receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentReceivables" xlink:to="lab_ifrs-full_TradeAndOtherCurrentReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_LPPInterestRate_019c4318-5378-762b-815a-fc0e2e8988ff_terseLabel_en-US" xlink:label="lab_soph_LPPInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LPP interest rate</link:label>
    <link:label id="lab_soph_LPPInterestRate_label_en-US" xlink:label="lab_soph_LPPInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">LPP Interest Rate</link:label>
    <link:label id="lab_soph_LPPInterestRate_documentation_en-US" xlink:label="lab_soph_LPPInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">LPP interest rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LPPInterestRate" xlink:href="soph-20251231.xsd#soph_LPPInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_LPPInterestRate" xlink:to="lab_soph_LPPInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_019c4318-5379-7193-b21a-456c12e26af1_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CustomerOneMember_019c4318-52e4-760f-810e-52a031e71410_terseLabel_en-US" xlink:label="lab_soph_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer One</link:label>
    <link:label id="lab_soph_CustomerOneMember_label_en-US" xlink:label="lab_soph_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer One [Member]</link:label>
    <link:label id="lab_soph_CustomerOneMember_documentation_en-US" xlink:label="lab_soph_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CustomerOneMember" xlink:href="soph-20251231.xsd#soph_CustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CustomerOneMember" xlink:to="lab_soph_CustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CapitalizedSoftwareDevelopmentCosts_019c4318-52e4-714b-8ef8-707a92745736_negatedLabel_en-US" xlink:label="lab_soph_CapitalizedSoftwareDevelopmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Capitalized development costs</link:label>
    <link:label id="lab_soph_CapitalizedSoftwareDevelopmentCosts_label_en-US" xlink:label="lab_soph_CapitalizedSoftwareDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Software Development Costs</link:label>
    <link:label id="lab_soph_CapitalizedSoftwareDevelopmentCosts_documentation_en-US" xlink:label="lab_soph_CapitalizedSoftwareDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized software development costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CapitalizedSoftwareDevelopmentCosts" xlink:href="soph-20251231.xsd#soph_CapitalizedSoftwareDevelopmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CapitalizedSoftwareDevelopmentCosts" xlink:to="lab_soph_CapitalizedSoftwareDevelopmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ActuarialAssumptionOfExpectedInterestRatesMember_019c4318-52e4-746e-b78b-358cd0a7eec6_terseLabel_en-US" xlink:label="lab_soph_ActuarialAssumptionOfExpectedInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_soph_ActuarialAssumptionOfExpectedInterestRatesMember_label_en-US" xlink:label="lab_soph_ActuarialAssumptionOfExpectedInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial Assumption Of Expected Interest Rates [Member]</link:label>
    <link:label id="lab_soph_ActuarialAssumptionOfExpectedInterestRatesMember_documentation_en-US" xlink:label="lab_soph_ActuarialAssumptionOfExpectedInterestRatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected interest rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ActuarialAssumptionOfExpectedInterestRatesMember" xlink:href="soph-20251231.xsd#soph_ActuarialAssumptionOfExpectedInterestRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ActuarialAssumptionOfExpectedInterestRatesMember" xlink:to="lab_soph_ActuarialAssumptionOfExpectedInterestRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-52e4-707f-a403-52fd61f7b19f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of attribution of expenses by nature to their function [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:to="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_TradeAndOtherReceivablesTable_019c4318-52e4-7db3-a0bd-53c56382b2a9_terseLabel_en-US" xlink:label="lab_soph_TradeAndOtherReceivablesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade And Other Receivables [Table]</link:label>
    <link:label id="lab_soph_TradeAndOtherReceivablesTable_label_en-US" xlink:label="lab_soph_TradeAndOtherReceivablesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade And Other Receivables [Table]</link:label>
    <link:label id="lab_soph_TradeAndOtherReceivablesTable_documentation_en-US" xlink:label="lab_soph_TradeAndOtherReceivablesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade And Other Receivables [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TradeAndOtherReceivablesTable" xlink:href="soph-20251231.xsd#soph_TradeAndOtherReceivablesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_TradeAndOtherReceivablesTable" xlink:to="lab_soph_TradeAndOtherReceivablesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CapitalManagementTable_019c4318-52e4-7d3c-b5f7-1d8b200d3e30_terseLabel_en-US" xlink:label="lab_soph_CapitalManagementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital Management [Table]</link:label>
    <link:label id="lab_soph_CapitalManagementTable_label_en-US" xlink:label="lab_soph_CapitalManagementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Management [Table]</link:label>
    <link:label id="lab_soph_CapitalManagementTable_documentation_en-US" xlink:label="lab_soph_CapitalManagementTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capital Management [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CapitalManagementTable" xlink:href="soph-20251231.xsd#soph_CapitalManagementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CapitalManagementTable" xlink:to="lab_soph_CapitalManagementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_019c4318-52e4-767d-a38d-722e1939b319_terseLabel_en-US" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Levels of fair value hierarchy [axis]</link:label>
    <link:label id="lab_ifrs-full_LevelsOfFairValueHierarchyAxis_label_en-US" xlink:label="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Levels of fair value hierarchy [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="lab_ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CreditAgreementNewMember_019c4318-5378-7d3f-a705-d678a174d116_terseLabel_en-US" xlink:label="lab_soph_CreditAgreementNewMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Credit Agreement</link:label>
    <link:label id="lab_soph_CreditAgreementNewMember_label_en-US" xlink:label="lab_soph_CreditAgreementNewMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Agreement, New [Member]</link:label>
    <link:label id="lab_soph_CreditAgreementNewMember_documentation_en-US" xlink:label="lab_soph_CreditAgreementNewMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit Agreement, New</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CreditAgreementNewMember" xlink:href="soph-20251231.xsd#soph_CreditAgreementNewMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CreditAgreementNewMember" xlink:to="lab_soph_CreditAgreementNewMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LatinAmericaMember_019c4318-52e4-7ddf-8c9e-3579f708f30f_terseLabel_en-US" xlink:label="lab_srt_LatinAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LATAM</link:label>
    <link:label id="lab_srt_LatinAmericaMember_label_en-US" xlink:label="lab_srt_LatinAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Latin America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LatinAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LatinAmericaMember" xlink:to="lab_srt_LatinAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_019c4318-5379-7f82-8b5f-96c59e7cbba7_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Life expectancy</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of life expectancy after retirement [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_019c4318-5378-7cff-9656-1e3e9ca32425_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material accounting policies</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of material accounting policy information [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:to="lab_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_019c4318-5379-7dd6-a406-4e8e8e1b7823_verboseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase of 25 basis points</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InventoryWritedown2011_019c4318-5379-7fa4-a826-9c764697c7c8_terseLabel_en-US" xlink:label="lab_ifrs-full_InventoryWritedown2011" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Write-off</link:label>
    <link:label id="lab_ifrs-full_InventoryWritedown2011_label_en-US" xlink:label="lab_ifrs-full_InventoryWritedown2011" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InventoryWritedown2011" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InventoryWritedown2011"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InventoryWritedown2011" xlink:to="lab_ifrs-full_InventoryWritedown2011" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SOPHiAGENETICSGmbHMember_019c66c4-ddfc-7f64-a8bf-70dcd9dd1453_terseLabel_en-US" xlink:label="lab_soph_SOPHiAGENETICSGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SOPHiA GENETICS GmbH</link:label>
    <link:label id="lab_soph_SOPHiAGENETICSGmbHMember_label_en-US" xlink:label="lab_soph_SOPHiAGENETICSGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SOPHiA GENETICS GmbH [Member]</link:label>
    <link:label id="lab_soph_SOPHiAGENETICSGmbHMember_documentation_en-US" xlink:label="lab_soph_SOPHiAGENETICSGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SOPHiA GENETICS GmbH</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SOPHiAGENETICSGmbHMember" xlink:href="soph-20251231.xsd#soph_SOPHiAGENETICSGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SOPHiAGENETICSGmbHMember" xlink:to="lab_soph_SOPHiAGENETICSGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_019c4318-52e4-7677-928c-5f956dac34d5_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities classification</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_label_en-US" xlink:label="lab_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense) And Foreign Exchange Gain (Loss) [Abstract]</link:label>
    <link:label id="lab_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_documentation_en-US" xlink:label="lab_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Income (Expense) And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract" xlink:href="soph-20251231.xsd#soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract" xlink:to="lab_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ShareBasedPaymentArrangementsVestingAxis_019c4318-52e4-7064-b8af-ec8e036c20d2_terseLabel_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementsVestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangements, Vesting [Axis]</link:label>
    <link:label id="lab_soph_ShareBasedPaymentArrangementsVestingAxis_label_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementsVestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangements, Vesting [Axis]</link:label>
    <link:label id="lab_soph_ShareBasedPaymentArrangementsVestingAxis_documentation_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementsVestingAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangements, Vesting</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementsVestingAxis" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementsVestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ShareBasedPaymentArrangementsVestingAxis" xlink:to="lab_soph_ShareBasedPaymentArrangementsVestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019c4318-5378-7511-8183-12d017cbabd0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_019c4318-5379-7941-9498-3bb898091563_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total items that may be reclassified to statement of loss</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ExpectedLeaseCommitments_019c4318-5379-7814-980a-f6f9e8363092_terseLabel_en-US" xlink:label="lab_soph_ExpectedLeaseCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected lease commitments</link:label>
    <link:label id="lab_soph_ExpectedLeaseCommitments_label_en-US" xlink:label="lab_soph_ExpectedLeaseCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected Lease Commitments</link:label>
    <link:label id="lab_soph_ExpectedLeaseCommitments_documentation_en-US" xlink:label="lab_soph_ExpectedLeaseCommitments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected lease commitments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExpectedLeaseCommitments" xlink:href="soph-20251231.xsd#soph_ExpectedLeaseCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ExpectedLeaseCommitments" xlink:to="lab_soph_ExpectedLeaseCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_019c4318-5378-7c45-aaae-89ef660edbad_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of cash and cash equivalents [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOutstandingShareOptions_019c4318-52e4-73e5-a29f-1d5fe7119fa7_periodStartLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOutstandingShareOptions_019c4318-52e4-7eb9-85ce-740ce5149489_periodEndLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOutstandingShareOptions_label_en-US" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AverageForeignExchangeRates_019c4318-5379-7a4f-b5a1-258c58e02748_terseLabel_en-US" xlink:label="lab_soph_AverageForeignExchangeRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average rate (in dollars per share)</link:label>
    <link:label id="lab_soph_AverageForeignExchangeRates_label_en-US" xlink:label="lab_soph_AverageForeignExchangeRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average Foreign Exchange Rates</link:label>
    <link:label id="lab_soph_AverageForeignExchangeRates_documentation_en-US" xlink:label="lab_soph_AverageForeignExchangeRates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Average foreign exchange rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AverageForeignExchangeRates" xlink:href="soph-20251231.xsd#soph_AverageForeignExchangeRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AverageForeignExchangeRates" xlink:to="lab_soph_AverageForeignExchangeRates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_019c4318-5378-7e17-aa21-47424d4cc5db_terseLabel_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Deferred Tax Liability (Asset) [Abstract]</link:label>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_label_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of changes in deferred tax liability (asset) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract" xlink:to="lab_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock_019c4318-52e4-704b-b362-4087a5f7b2a6_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Loss Before Tax to Changes in Foreign Exchange Rates</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Sensitivity Of Loss Before Tax To Changes In Foreign Exchange Rates [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity of loss before tax to changes in foreign exchange rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset_019c4318-5379-760f-af7f-9257e97a9a0a_negatedLabel_en-US" xlink:label="lab_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Administrative expenses</link:label>
    <link:label id="lab_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Administrative Expenses Net Defined Benefit Liability Asset</link:label>
    <link:label id="lab_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset_documentation_en-US" xlink:label="lab_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Administrative expenses net defined benefit liability asset.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset" xlink:href="soph-20251231.xsd#soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset" xlink:to="lab_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAndLiabilitiesAbstract_019c4318-5378-77ad-8ff0-d431870dabe2_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and equity</link:label>
    <link:label id="lab_ifrs-full_EquityAndLiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity and liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_019c4318-53fc-7e9e-b695-622feef5eee7_terseLabel_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of changes in property, plant and equipment [abstract]</link:label>
    <link:label id="lab_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of changes in property, plant and equipment [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:to="lab_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_019c4318-52e4-731e-8ee9-09162481d8bb_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_019c4318-52e4-702a-95e1-0bece5947702_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_019c4318-5379-775e-ba6e-fc35c570b4e4_terseLabel_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossFromOperatingActivities_019c4318-53fc-7fd6-a719-276716a99d8e_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_ifrs-full_ProfitLossFromOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) from operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantRightsTrancheAMember_019c4318-52e4-7fd7-aaf5-53b5c0a3be0e_terseLabel_en-US" xlink:label="lab_soph_WarrantRightsTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche A</link:label>
    <link:label id="lab_soph_WarrantRightsTrancheAMember_label_en-US" xlink:label="lab_soph_WarrantRightsTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche A [Member]</link:label>
    <link:label id="lab_soph_WarrantRightsTrancheAMember_documentation_en-US" xlink:label="lab_soph_WarrantRightsTrancheAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheAMember" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantRightsTrancheAMember" xlink:to="lab_soph_WarrantRightsTrancheAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock_019c4318-52e4-7114-bb7b-045801ff34f9_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Employee Benefit Expenses, Social Charges and Share-based Compensation</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Employee Benefit Expenses Included In Operating Expense [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of employee benefit expenses and social charges from the operating expense explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019c4318-52e4-7c30-a5f3-f40bc31585b2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_019c4318-52e4-703d-8f1d-86e33e5cc9b9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfLeasesExplanatory_019c4318-52e4-74f4-8b05-9d2dfe3dcbc2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfLeasesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfLeasesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of leases [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfLeasesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfLeasesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans_019c4318-5379-71e4-9551-6ed817e18d0c_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense (income), defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseIncomeDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans" xlink:to="lab_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_019c4318-52e4-7d13-ba97-3baae945b2b6_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movements in provisions and pensions</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for increase (decrease) in employee benefit liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_019c4318-53fc-7d46-b068-7c0dd8958433_terseLabel_en-US" xlink:label="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected employer contributions for next annual reporting period</link:label>
    <link:label id="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_label_en-US" xlink:label="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimate of contributions expected to be paid to plan for next annual reporting period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:to="lab_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of cash flows [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfCapitalManagementExplanatoryTextBlock_019c4318-52e4-7712-8fad-7abe5262fa7a_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfCapitalManagementExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capital management</link:label>
    <link:label id="lab_soph_DisclosureOfCapitalManagementExplanatoryTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfCapitalManagementExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Capital Management Explanatory [Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfCapitalManagementExplanatoryTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfCapitalManagementExplanatoryTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of capital management explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCapitalManagementExplanatoryTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfCapitalManagementExplanatoryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfCapitalManagementExplanatoryTextBlock" xlink:to="lab_soph_DisclosureOfCapitalManagementExplanatoryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccountsPayablesMember_019c4318-52e4-71e3-bc3b-e7bb1af8d54f_terseLabel_en-US" xlink:label="lab_soph_AccountsPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_soph_AccountsPayablesMember_label_en-US" xlink:label="lab_soph_AccountsPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payables [Member]</link:label>
    <link:label id="lab_soph_AccountsPayablesMember_documentation_en-US" xlink:label="lab_soph_AccountsPayablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts payables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsPayablesMember" xlink:href="soph-20251231.xsd#soph_AccountsPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccountsPayablesMember" xlink:to="lab_soph_AccountsPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock_019c4318-5379-7fa0-845f-0c184bf47fd8_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Inventory</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Inventories [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of detailed information about inventories.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-5379-7510-931f-fe837d8def57_terseLabel_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Funding arrangements of defined benefit plans [domain]</link:label>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_label_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Funding arrangements of defined benefit plans [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain" xlink:to="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_019c4318-5379-738a-aaab-64fa3e523ba8_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for current tax of prior periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:to="lab_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-5379-788b-b03c-18d1413789c8_verboseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Changes in demographic assumptions</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial gains (losses) arising from changes in demographic assumptions, net of tax, defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:to="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ExercisePriceOfWarrantRights_019c4318-52e4-7395-8d5f-0db64ddf1ebf_terseLabel_en-US" xlink:label="lab_soph_ExercisePriceOfWarrantRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price per share of shares available to purchase under warrant certificate (in dollars per share)</link:label>
    <link:label id="lab_soph_ExercisePriceOfWarrantRights_label_en-US" xlink:label="lab_soph_ExercisePriceOfWarrantRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Of Warrant Rights</link:label>
    <link:label id="lab_soph_ExercisePriceOfWarrantRights_documentation_en-US" xlink:label="lab_soph_ExercisePriceOfWarrantRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Of Warrant Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExercisePriceOfWarrantRights" xlink:href="soph-20251231.xsd#soph_ExercisePriceOfWarrantRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ExercisePriceOfWarrantRights" xlink:to="lab_soph_ExercisePriceOfWarrantRights" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-5379-71c9-abf9-b927eedd5e52_terseLabel_en-US" xlink:label="lab_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes In Other Equity Instruments, Number Of Other Equity Instruments, In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes In Other Equity Instruments, Number Of Other Equity Instruments, In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_documentation_en-US" xlink:label="lab_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Changes In Other Equity Instruments, Number Of Other Equity Instruments, In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:href="soph-20251231.xsd#soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:to="lab_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember_019c4318-52e4-7ce4-9c4a-7fd84c29f1f7_terseLabel_en-US" xlink:label="lab_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SOPHiA GENETICS Intermedia&#231;&#227;o de Neg&#243;cios LTDA</link:label>
    <link:label id="lab_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember_label_en-US" xlink:label="lab_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sophia Genetics Intermediacao De Negocios LTDA [Member]</link:label>
    <link:label id="lab_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember_documentation_en-US" xlink:label="lab_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sophia Genetics Intermediacao de Negocios Eireli.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember" xlink:to="lab_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock_019c4318-5379-74c2-98a4-4d048d07de8a_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Accrued Expenses</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Accrued Expenses [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about accrued expenses explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_019c4318-52e4-741d-9296-a04e3b47cb58_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total recognized</link:label>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Post-employment benefit expense in profit or loss, defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TaxEffectOfForeignTaxRates_019c4318-53fc-726f-b958-7ac193f747a5_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Effect of tax rates in foreign jurisdictions</link:label>
    <link:label id="lab_ifrs-full_TaxEffectOfForeignTaxRates_label_en-US" xlink:label="lab_ifrs-full_TaxEffectOfForeignTaxRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax effect of foreign tax rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfForeignTaxRates" xlink:to="lab_ifrs-full_TaxEffectOfForeignTaxRates" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AdjustmentsForResearchTaxCredit_019c4318-52e4-7cd4-8817-25e01a9d69ca_negatedTerseLabel_en-US" xlink:label="lab_soph_AdjustmentsForResearchTaxCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research tax credit</link:label>
    <link:label id="lab_soph_AdjustmentsForResearchTaxCredit_label_en-US" xlink:label="lab_soph_AdjustmentsForResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Research Tax Credit</link:label>
    <link:label id="lab_soph_AdjustmentsForResearchTaxCredit_documentation_en-US" xlink:label="lab_soph_AdjustmentsForResearchTaxCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for research tax credit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForResearchTaxCredit" xlink:href="soph-20251231.xsd#soph_AdjustmentsForResearchTaxCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AdjustmentsForResearchTaxCredit" xlink:to="lab_soph_AdjustmentsForResearchTaxCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentLiabilitiesAbstract_019c4318-5378-7a40-94ec-7add4b3c1897_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract" xlink:to="lab_ifrs-full_CurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_country_BR_019c4318-52e4-7e4e-acf8-72f6673ac436_terseLabel_en-US" xlink:label="lab_country_BR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Brazil</link:label>
    <link:label id="lab_country_BR_label_en-US" xlink:label="lab_country_BR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BRAZIL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_BR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_BR" xlink:to="lab_country_BR" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfActiveMembers_019c4318-52e4-7cb7-a57a-e78b90fe995a_terseLabel_en-US" xlink:label="lab_soph_NumberOfActiveMembers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of active members</link:label>
    <link:label id="lab_soph_NumberOfActiveMembers_label_en-US" xlink:label="lab_soph_NumberOfActiveMembers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Active Members</link:label>
    <link:label id="lab_soph_NumberOfActiveMembers_documentation_en-US" xlink:label="lab_soph_NumberOfActiveMembers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of active members.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfActiveMembers" xlink:href="soph-20251231.xsd#soph_NumberOfActiveMembers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfActiveMembers" xlink:to="lab_soph_NumberOfActiveMembers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_019c747b-4f3d-7c8c-9e6d-6b84a3df7d10_terseLabel_en-US" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Investment</link:label>
    <link:label id="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingCostsIncurred_019c4318-5379-7a68-bba0-0360cc9087d7_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs associated with loan</link:label>
    <link:label id="lab_ifrs-full_BorrowingCostsIncurred_019c4318-5379-791e-9688-5e55b1ff6e6a_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingCostsIncurred" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_ifrs-full_BorrowingCostsIncurred_label_en-US" xlink:label="lab_ifrs-full_BorrowingCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowing costs incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingCostsIncurred" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingCostsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingCostsIncurred" xlink:to="lab_ifrs-full_BorrowingCostsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccruedPensionRelatedTemporaryDifferencesMember_019c4318-5379-7852-8dcc-20ffe87e4fde_terseLabel_en-US" xlink:label="lab_soph_AccruedPensionRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued pension</link:label>
    <link:label id="lab_soph_AccruedPensionRelatedTemporaryDifferencesMember_label_en-US" xlink:label="lab_soph_AccruedPensionRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Pension Related Temporary Differences [Member]</link:label>
    <link:label id="lab_soph_AccruedPensionRelatedTemporaryDifferencesMember_documentation_en-US" xlink:label="lab_soph_AccruedPensionRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary difference accrued pension.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedPensionRelatedTemporaryDifferencesMember" xlink:href="soph-20251231.xsd#soph_AccruedPensionRelatedTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccruedPensionRelatedTemporaryDifferencesMember" xlink:to="lab_soph_AccruedPensionRelatedTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AmortisationExpense_019c4318-5379-7340-ba34-bcf09f0662c1_terseLabel_en-US" xlink:label="lab_ifrs-full_AmortisationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_ifrs-full_AmortisationExpense_019c4318-5379-7c37-9db9-f49d1874f2de_negatedLabel_en-US" xlink:label="lab_ifrs-full_AmortisationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_ifrs-full_AmortisationExpense_label_en-US" xlink:label="lab_ifrs-full_AmortisationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortisation expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationExpense" xlink:to="lab_ifrs-full_AmortisationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeAbstract_019c4318-52e4-7f54-ad34-243be565fa84_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income:</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock_019c4318-5379-7d19-828f-3800aea8febc_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Foreign Exchange Rates</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Foreign Exchange Rates [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Exchange Rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CH_019c4318-5379-7edc-8ba2-71169309d833_terseLabel_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_country_CH_019c4318-5379-7422-bf28-82b2ff46c9b3_verboseLabel_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Switzerland</link:label>
    <link:label id="lab_country_CH_label_en-US" xlink:label="lab_country_CH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SWITZERLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CH" xlink:to="lab_country_CH" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TemporaryDifferenceMember_019c4318-5378-7258-8342-5a2a97995ff6_terseLabel_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deductible temporary differences</link:label>
    <link:label id="lab_ifrs-full_TemporaryDifferenceMember_label_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary differences [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceMember" xlink:to="lab_ifrs-full_TemporaryDifferenceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_019c4318-5378-776d-9843-a4e3d965c753_totalLabel_en-US" xlink:label="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total contractual liabilities</link:label>
    <link:label id="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_label_en-US" xlink:label="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-derivative financial liabilities, undiscounted cash flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:to="lab_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DemographicAssumptionOfWeightedTurnoverRates_019c4318-52e4-7a87-93a5-169ec644eb3f_terseLabel_en-US" xlink:label="lab_soph_DemographicAssumptionOfWeightedTurnoverRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Demographic assumptions increase in weighted turnover</link:label>
    <link:label id="lab_soph_DemographicAssumptionOfWeightedTurnoverRates_label_en-US" xlink:label="lab_soph_DemographicAssumptionOfWeightedTurnoverRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Demographic Assumption Of Weighted Turnover Rates</link:label>
    <link:label id="lab_soph_DemographicAssumptionOfWeightedTurnoverRates_documentation_en-US" xlink:label="lab_soph_DemographicAssumptionOfWeightedTurnoverRates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Demographic Assumption Of Weighted Turnover Rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DemographicAssumptionOfWeightedTurnoverRates" xlink:href="soph-20251231.xsd#soph_DemographicAssumptionOfWeightedTurnoverRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DemographicAssumptionOfWeightedTurnoverRates" xlink:to="lab_soph_DemographicAssumptionOfWeightedTurnoverRates" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalDomain_019c4318-52e4-703c-9914-82f105ec8d1b_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of share capital [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of share capital [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain" xlink:to="lab_ifrs-full_ClassesOfShareCapitalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfShareOptionPlans_019c4318-5379-74e7-b10d-c0dbbb9edced_terseLabel_en-US" xlink:label="lab_soph_NumberOfShareOptionPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share option plans</link:label>
    <link:label id="lab_soph_NumberOfShareOptionPlans_label_en-US" xlink:label="lab_soph_NumberOfShareOptionPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Share Option Plans</link:label>
    <link:label id="lab_soph_NumberOfShareOptionPlans_documentation_en-US" xlink:label="lab_soph_NumberOfShareOptionPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of share option plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfShareOptionPlans" xlink:href="soph-20251231.xsd#soph_NumberOfShareOptionPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfShareOptionPlans" xlink:to="lab_soph_NumberOfShareOptionPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-5378-70cc-bb6b-23f12a4bad36_terseLabel_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sensitivity analysis, basis point decrease</link:label>
    <link:label id="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_label_en-US" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of reasonably possible decrease in actuarial assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AdjustmentsForCreditLossAllowance_019c4318-5378-7a1f-9375-c0d960a0eb34_terseLabel_en-US" xlink:label="lab_soph_AdjustmentsForCreditLossAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected credit loss allowance increase (reversal)</link:label>
    <link:label id="lab_soph_AdjustmentsForCreditLossAllowance_label_en-US" xlink:label="lab_soph_AdjustmentsForCreditLossAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments For Credit Loss Allowance</link:label>
    <link:label id="lab_soph_AdjustmentsForCreditLossAllowance_documentation_en-US" xlink:label="lab_soph_AdjustmentsForCreditLossAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments for credit loss allowance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForCreditLossAllowance" xlink:href="soph-20251231.xsd#soph_AdjustmentsForCreditLossAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AdjustmentsForCreditLossAllowance" xlink:to="lab_soph_AdjustmentsForCreditLossAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_019c4318-52e4-7fb4-84e0-f62285c03219_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Demographic assumptions increase in expected employee salaries</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of salary increases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccountsReceivableInAggregateAmount_019c4318-52e4-7007-a0a2-e70dbc7e31c8_terseLabel_en-US" xlink:label="lab_soph_AccountsReceivableInAggregateAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable in aggregate amount</link:label>
    <link:label id="lab_soph_AccountsReceivableInAggregateAmount_label_en-US" xlink:label="lab_soph_AccountsReceivableInAggregateAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable In Aggregate Amount</link:label>
    <link:label id="lab_soph_AccountsReceivableInAggregateAmount_documentation_en-US" xlink:label="lab_soph_AccountsReceivableInAggregateAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts receivable in aggregate amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsReceivableInAggregateAmount" xlink:href="soph-20251231.xsd#soph_AccountsReceivableInAggregateAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccountsReceivableInAggregateAmount" xlink:to="lab_soph_AccountsReceivableInAggregateAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_label_en-US" xlink:label="lab_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Information About Post Employment Benefits [Abstract]</link:label>
    <link:label id="lab_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_documentation_en-US" xlink:label="lab_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of information about post-employment benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract" xlink:to="lab_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum_019c4318-5378-73f4-91ba-e3c78666932e_terseLabel_en-US" xlink:label="lab_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum amount of qualified cash required to be maintained under customary covenants</link:label>
    <link:label id="lab_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum_label_en-US" xlink:label="lab_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Covenant, Cash And Cash Equivalents, Minimum</link:label>
    <link:label id="lab_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum_documentation_en-US" xlink:label="lab_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Covenant, Cash And Cash Equivalents, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum" xlink:href="soph-20251231.xsd#soph_BorrowingsCovenantCashAndCashEquivalentsMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum" xlink:to="lab_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfEquitySharesIssued_019c66a7-6861-7e44-b398-acb064b791a2_terseLabel_en-US" xlink:label="lab_soph_NumberOfEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from ATM offering, net of transaction costs (in shares)</link:label>
    <link:label id="lab_soph_NumberOfEquitySharesIssued_019c905d-217b-7e86-99f8-62d711a972ab_verboseLabel_en-US" xlink:label="lab_soph_NumberOfEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of shares sold under ATM program (in shares)</link:label>
    <link:label id="lab_soph_NumberOfEquitySharesIssued_label_en-US" xlink:label="lab_soph_NumberOfEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Equity Shares Issued</link:label>
    <link:label id="lab_soph_NumberOfEquitySharesIssued_documentation_en-US" xlink:label="lab_soph_NumberOfEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Shares Issued Of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquitySharesIssued" xlink:href="soph-20251231.xsd#soph_NumberOfEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfEquitySharesIssued" xlink:to="lab_soph_NumberOfEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_019c74b4-e84c-77ee-9638-d61ff6151b30_negatedLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of equity investments held at fair value</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of interests in investments accounted for using equity method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentShellCompanyReport_019c4318-5379-795f-8378-86b5c7aa852f_terseLabel_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:label id="lab_dei_DocumentShellCompanyReport_label_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport" xlink:to="lab_dei_DocumentShellCompanyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_019c4318-5378-7991-bf19-695fd9d8ede7_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjusted interest rate</link:label>
    <link:label id="lab_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_label_en-US" xlink:label="lab_ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, adjustment to interest rate basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:to="lab_ifrs-full_BorrowingsAdjustmentToInterestRateBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdditionsToRightofuseAssets_019c4318-5379-7547-9fae-a14d3c0ad428_terseLabel_en-US" xlink:label="lab_ifrs-full_AdditionsToRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions to ROUs</link:label>
    <link:label id="lab_ifrs-full_AdditionsToRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_AdditionsToRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additions to right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsToRightofuseAssets" xlink:to="lab_ifrs-full_AdditionsToRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-5379-7ad8-8491-98c673c95a03_terseLabel_en-US" xlink:label="lab_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price</link:label>
    <link:label id="lab_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price Of Equity Instruments In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_documentation_en-US" xlink:label="lab_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price Of Equity Instruments In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:href="soph-20251231.xsd#soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:to="lab_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_019c4318-5378-7ad1-98ed-b27d48db8267_terseLabel_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfNonExecutiveOfficers_019c4318-5379-7dfe-8c48-3892df17fb31_terseLabel_en-US" xlink:label="lab_soph_NumberOfNonExecutiveOfficers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of non-executive officers</link:label>
    <link:label id="lab_soph_NumberOfNonExecutiveOfficers_label_en-US" xlink:label="lab_soph_NumberOfNonExecutiveOfficers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Non-Executive Officers</link:label>
    <link:label id="lab_soph_NumberOfNonExecutiveOfficers_documentation_en-US" xlink:label="lab_soph_NumberOfNonExecutiveOfficers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Non-Executive Officers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfNonExecutiveOfficers" xlink:href="soph-20251231.xsd#soph_NumberOfNonExecutiveOfficers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfNonExecutiveOfficers" xlink:to="lab_soph_NumberOfNonExecutiveOfficers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LeaseLiabilities_019c4318-5379-73d7-b0c8-36e9c4cf03dc_terseLabel_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_ifrs-full_LeaseLiabilities_019c89ba-4f59-72cd-a41f-b79defa54f2b_totalLabel_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_ifrs-full_LeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_LeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities" xlink:to="lab_ifrs-full_LeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_019c4318-52e4-7fac-99e3-40e165183fc8_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimating the defined benefit obligation, the discount rates</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRates_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of discount rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:to="lab_ifrs-full_ActuarialAssumptionOfDiscountRates" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c4318-5379-7590-bc82-7655c7c54d19_terseLabel_en-US" xlink:label="lab_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares available to purchase under warrant certificate (in shares)</link:label>
    <link:label id="lab_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7511-7a0e-7852-9a62-d6f843abffe1_periodStartLabel_en-US" xlink:label="lab_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginnings balances (in shares)</link:label>
    <link:label id="lab_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7511-5447-7c5f-be2c-3afcbfa29f53_periodEndLabel_en-US" xlink:label="lab_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balances (in shares)</link:label>
    <link:label id="lab_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Or Rights, Number Of Shares Called By Warrants Or Rights</link:label>
    <link:label id="lab_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_documentation_en-US" xlink:label="lab_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants Or Rights, Number Of Shares Called By Warrants Or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" xlink:to="lab_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_019c4318-5378-7edb-a0f5-064918439892_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Restricted Stock Units Activity</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of number and weighted average exercise prices of other equity instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_019c4318-52e4-7ad8-8760-a09943e0446d_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for trade and other receivables [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent_019c4318-52e4-729e-b1e5-d9d39dce83d0_terseLabel_en-US" xlink:label="lab_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sensitivity analysis, change in exchange rate, percent</link:label>
    <link:label id="lab_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent_label_en-US" xlink:label="lab_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Foreign Exchange Gain (Loss), Reasonably Possible Change In Currency Variable, Percent</link:label>
    <link:label id="lab_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent_documentation_en-US" xlink:label="lab_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Foreign Exchange Gain (Loss), Reasonably Possible Change In Currency Variable, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent" xlink:to="lab_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IssuedCapital_019c4318-52e4-7bf9-8e77-b02af9ee4efe_terseLabel_en-US" xlink:label="lab_ifrs-full_IssuedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share capital</link:label>
    <link:label id="lab_ifrs-full_IssuedCapital_label_en-US" xlink:label="lab_ifrs-full_IssuedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issued capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital" xlink:to="lab_ifrs-full_IssuedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-5379-7b93-8f5e-97964da6ef39_terseLabel_en-US" xlink:label="lab_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in intangible assets and goodwill [abstract]</link:label>
    <link:label id="lab_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_label_en-US" xlink:label="lab_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in intangible assets and goodwill [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract" xlink:to="lab_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_019c4318-52e4-7f94-a2f2-624d52aaede9_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of financial assets [axis]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables_019c4318-52e4-7272-a57c-7251e59ce07b_terseLabel_en-US" xlink:label="lab_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">VAT, sales, and other taxes</link:label>
    <link:label id="lab_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables_label_en-US" xlink:label="lab_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Value Added Taxes, Sales Taxes And Other Taxes Payables</link:label>
    <link:label id="lab_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables_documentation_en-US" xlink:label="lab_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Value added tax sales and other taxes payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables" xlink:href="soph-20251231.xsd#soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables" xlink:to="lab_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_019c4318-52e4-7cdf-858d-f4f145256ece_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, deferred tax liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfSharesOutstanding_019c4318-5378-75c4-b411-532d8fce9608_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares outstanding (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesOutstanding_label_en-US" xlink:label="lab_ifrs-full_NumberOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of shares outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesOutstanding" xlink:to="lab_ifrs-full_NumberOfSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfLeaseLineItems_019c4318-52e4-7efe-90c6-dcb450410400_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfLeaseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease [Line Items]</link:label>
    <link:label id="lab_soph_DisclosureOfLeaseLineItems_label_en-US" xlink:label="lab_soph_DisclosureOfLeaseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Lease [Line Items]</link:label>
    <link:label id="lab_soph_DisclosureOfLeaseLineItems_documentation_en-US" xlink:label="lab_soph_DisclosureOfLeaseLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of lease line items.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfLeaseLineItems" xlink:href="soph-20251231.xsd#soph_DisclosureOfLeaseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfLeaseLineItems" xlink:to="lab_soph_DisclosureOfLeaseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PrepaymentsAndOtherCurrentAssetsAbstract_label_en-US" xlink:label="lab_soph_PrepaymentsAndOtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepayments And Other Current Assets [Abstract]</link:label>
    <link:label id="lab_soph_PrepaymentsAndOtherCurrentAssetsAbstract_documentation_en-US" xlink:label="lab_soph_PrepaymentsAndOtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaids and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract" xlink:href="soph-20251231.xsd#soph_PrepaymentsAndOtherCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract" xlink:to="lab_soph_PrepaymentsAndOtherCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-52e4-7d8b-a50e-0ba61bff347e_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfCompanyInformationAndOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Company Information And Operations [Line Items]</link:label>
    <link:label id="lab_soph_DisclosureOfCompanyInformationAndOperationsLineItems_label_en-US" xlink:label="lab_soph_DisclosureOfCompanyInformationAndOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Company Information And Operations [Line Items]</link:label>
    <link:label id="lab_soph_DisclosureOfCompanyInformationAndOperationsLineItems_documentation_en-US" xlink:label="lab_soph_DisclosureOfCompanyInformationAndOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of company information and operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems" xlink:to="lab_soph_DisclosureOfCompanyInformationAndOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SwissPlanMember_019c6792-811f-7af7-bc76-1c3d9d12f9cf_terseLabel_en-US" xlink:label="lab_soph_SwissPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Swiss plan</link:label>
    <link:label id="lab_soph_SwissPlanMember_label_en-US" xlink:label="lab_soph_SwissPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Swiss Plan [Member]</link:label>
    <link:label id="lab_soph_SwissPlanMember_documentation_en-US" xlink:label="lab_soph_SwissPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Swiss Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SwissPlanMember" xlink:href="soph-20251231.xsd#soph_SwissPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SwissPlanMember" xlink:to="lab_soph_SwissPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilities_019c4318-5379-7929-8bda-cb4bdab41064_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total financial liabilities</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilities_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilities" xlink:to="lab_ifrs-full_FinancialLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherTemporaryDifferencesMember_019c4318-5378-76dd-b7cf-88b97a411f7d_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_ifrs-full_OtherTemporaryDifferencesMember_label_en-US" xlink:label="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other temporary differences [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTemporaryDifferencesMember" xlink:to="lab_ifrs-full_OtherTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-5378-7a7b-bbce-3ed86f4436b7_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-5378-763a-8301-8b09a0cdb48a_negatedTotalLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total income tax (expense) benefit</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxExpenseContinuingOperations_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_GeneralAndAdministrativeExpense1Member_019c4318-52e4-736d-8ff3-bc1c551827f2_terseLabel_en-US" xlink:label="lab_soph_GeneralAndAdministrativeExpense1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative costs</link:label>
    <link:label id="lab_soph_GeneralAndAdministrativeExpense1Member_019c4318-52e4-778c-b10e-79b53cca60fb_verboseLabel_en-US" xlink:label="lab_soph_GeneralAndAdministrativeExpense1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_soph_GeneralAndAdministrativeExpense1Member_label_en-US" xlink:label="lab_soph_GeneralAndAdministrativeExpense1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General And Administrative Expense1 [Member]</link:label>
    <link:label id="lab_soph_GeneralAndAdministrativeExpense1Member_documentation_en-US" xlink:label="lab_soph_GeneralAndAdministrativeExpense1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">General and administrative costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GeneralAndAdministrativeExpense1Member" xlink:href="soph-20251231.xsd#soph_GeneralAndAdministrativeExpense1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_GeneralAndAdministrativeExpense1Member" xlink:to="lab_soph_GeneralAndAdministrativeExpense1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantUnobservableInputLiabilities_019c4318-5379-7d57-a91e-60928ef1b67e_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Key inputs for valuations</link:label>
    <link:label id="lab_ifrs-full_SignificantUnobservableInputLiabilities_label_en-US" xlink:label="lab_ifrs-full_SignificantUnobservableInputLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant unobservable input, liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantUnobservableInputLiabilities" xlink:to="lab_ifrs-full_SignificantUnobservableInputLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_019c4318-5379-70b7-b06b-f6b4525b6ac4_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Events after the reporting date</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of events after reporting period [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock_019c7279-35a7-7ede-b923-e4c639b0063c_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling and marketing costs</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Selling And Marketing Expense [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Selling And Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_019c4318-52e4-7f03-ae48-7df0c00dd4af_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SharePriceMeasurementInputMember_019c4318-52e4-7ba6-8385-fd5b34bb1d0b_terseLabel_en-US" xlink:label="lab_soph_SharePriceMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price in USD</link:label>
    <link:label id="lab_soph_SharePriceMeasurementInputMember_label_en-US" xlink:label="lab_soph_SharePriceMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price, Measurement Input [Member]</link:label>
    <link:label id="lab_soph_SharePriceMeasurementInputMember_documentation_en-US" xlink:label="lab_soph_SharePriceMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Price, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SharePriceMeasurementInputMember" xlink:href="soph-20251231.xsd#soph_SharePriceMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SharePriceMeasurementInputMember" xlink:to="lab_soph_SharePriceMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019c4318-52e4-751b-acd8-f1ef9516e467_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_OtherCountriesInNorthAmericaMember_019c4318-52e4-729d-85ef-f2454cc5fa16_terseLabel_en-US" xlink:label="lab_soph_OtherCountriesInNorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rest of NORAM</link:label>
    <link:label id="lab_soph_OtherCountriesInNorthAmericaMember_label_en-US" xlink:label="lab_soph_OtherCountriesInNorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Countries In North America [Member]</link:label>
    <link:label id="lab_soph_OtherCountriesInNorthAmericaMember_documentation_en-US" xlink:label="lab_soph_OtherCountriesInNorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Countries In North America</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OtherCountriesInNorthAmericaMember" xlink:href="soph-20251231.xsd#soph_OtherCountriesInNorthAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_OtherCountriesInNorthAmericaMember" xlink:to="lab_soph_OtherCountriesInNorthAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_MiscellaneousNoncurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Miscellaneous non-current assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousNoncurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract" xlink:to="lab_ifrs-full_MiscellaneousNoncurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties_019c4318-5378-77c8-a9c9-9c41c37e783c_terseLabel_en-US" xlink:label="lab_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax liability including interest and penalties</link:label>
    <link:label id="lab_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties_label_en-US" xlink:label="lab_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Liabilities That Have Not Been Recognised Including Interest And Penalties</link:label>
    <link:label id="lab_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties_documentation_en-US" xlink:label="lab_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrecognized tax liability including interest and penalties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties" xlink:href="soph-20251231.xsd#soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties" xlink:to="lab_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-5378-78aa-9d25-9cf091592da7_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Defined Benefit Plans [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019c4318-5379-755e-ab93-b10ca2ad7e86_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c6cc2-2395-7ef7-9c2e-07d5de924991_terseLabel_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [domain]</link:label>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_label_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaturityAxis_019c4318-52e4-7cc1-a828-ac04d5122896_terseLabel_en-US" xlink:label="lab_ifrs-full_MaturityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturity [axis]</link:label>
    <link:label id="lab_ifrs-full_MaturityAxis_label_en-US" xlink:label="lab_ifrs-full_MaturityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maturity [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis" xlink:to="lab_ifrs-full_MaturityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SaleOrIssueOfTreasuryShares_019c4318-52e4-7b98-9e3d-0c58e90e4d1b_terseLabel_en-US" xlink:label="lab_ifrs-full_SaleOrIssueOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of shares to be held as treasury shares</link:label>
    <link:label id="lab_ifrs-full_SaleOrIssueOfTreasuryShares_label_en-US" xlink:label="lab_ifrs-full_SaleOrIssueOfTreasuryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale or issue of treasury shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SaleOrIssueOfTreasuryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SaleOrIssueOfTreasuryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SaleOrIssueOfTreasuryShares" xlink:to="lab_ifrs-full_SaleOrIssueOfTreasuryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-5379-7c51-8eb2-75976ff01c41_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial instruments [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial instruments [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss_019c9fd9-32a3-79ef-93c8-664eb8a8ad57_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reversals</link:label>
    <link:label id="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reversal of impairment loss recognised in profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm_019c4318-52e4-76fe-a46d-ccf0d4b40381_terseLabel_en-US" xlink:label="lab_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Extended term of payment for non-interest bearing accounts receivable</link:label>
    <link:label id="lab_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm_label_en-US" xlink:label="lab_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Non-Interest Bearing, Extended Payment Term</link:label>
    <link:label id="lab_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm_documentation_en-US" xlink:label="lab_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Non-Interest Bearing, Extended Payment Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm" xlink:href="soph-20251231.xsd#soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm" xlink:to="lab_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_InventoryCurrencyTranslationAdjustment_019c4318-5379-785d-a343-9cbdc25f049d_negatedTerseLabel_en-US" xlink:label="lab_soph_InventoryCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustment</link:label>
    <link:label id="lab_soph_InventoryCurrencyTranslationAdjustment_label_en-US" xlink:label="lab_soph_InventoryCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Currency Translation Adjustment</link:label>
    <link:label id="lab_soph_InventoryCurrencyTranslationAdjustment_documentation_en-US" xlink:label="lab_soph_InventoryCurrencyTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inventory currency translation adjustment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_InventoryCurrencyTranslationAdjustment" xlink:href="soph-20251231.xsd#soph_InventoryCurrencyTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_InventoryCurrencyTranslationAdjustment" xlink:to="lab_soph_InventoryCurrencyTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019c4318-52e4-799c-8ad1-df597b729a79_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019c4318-53fc-73dc-85d5-cfdbbacc8eeb_terseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019c8cba-9b49-726b-9a8c-4963ff66c87d_verboseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Recast of employee benefit expenses</link:label>
    <link:label id="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_label_en-US" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense from share-based payment transactions with employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_019c4318-52e4-7bc8-b647-3f4998af83e1_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds upon maturity of term deposits</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) decrease (increase) in short-term deposits and investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:to="lab_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ResearchAndDevelopmentExpense1Member_019c4318-5379-7bfc-a19a-ca4a22094686_terseLabel_en-US" xlink:label="lab_soph_ResearchAndDevelopmentExpense1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development costs</link:label>
    <link:label id="lab_soph_ResearchAndDevelopmentExpense1Member_019c4318-5379-7477-873e-94847f9b119f_verboseLabel_en-US" xlink:label="lab_soph_ResearchAndDevelopmentExpense1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_soph_ResearchAndDevelopmentExpense1Member_label_en-US" xlink:label="lab_soph_ResearchAndDevelopmentExpense1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Expense1 [Member]</link:label>
    <link:label id="lab_soph_ResearchAndDevelopmentExpense1Member_documentation_en-US" xlink:label="lab_soph_ResearchAndDevelopmentExpense1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research and development costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ResearchAndDevelopmentExpense1Member" xlink:href="soph-20251231.xsd#soph_ResearchAndDevelopmentExpense1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ResearchAndDevelopmentExpense1Member" xlink:to="lab_soph_ResearchAndDevelopmentExpense1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-52e4-7a4f-a6b0-6ece1cc8983b_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial assets [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_country_ES_019c4318-52e4-7cf9-aedf-e45031da7549_terseLabel_en-US" xlink:label="lab_country_ES" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spain</link:label>
    <link:label id="lab_country_ES_label_en-US" xlink:label="lab_country_ES" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SPAIN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_ES" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_ES"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_ES" xlink:to="lab_country_ES" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossLeaseLiabilities_019c4318-5378-78d8-bd5c-e3aa3f2fafca_terseLabel_en-US" xlink:label="lab_ifrs-full_GrossLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_ifrs-full_GrossLeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_GrossLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossLeaseLiabilities" xlink:to="lab_ifrs-full_GrossLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus_019c4318-52e4-7f4c-bacf-1e6907c399ea_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exceeds the reported net assets</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill, revaluation surplus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeStatementAbstract_label_en-US" xlink:label="lab_ifrs-full_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit or loss [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeStatementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeStatementAbstract" xlink:to="lab_ifrs-full_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EarningsPerShareTable_019c4318-53fc-7a1a-8bc6-ca14ce0fc536_terseLabel_en-US" xlink:label="lab_ifrs-full_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_ifrs-full_EarningsPerShareTable_label_en-US" xlink:label="lab_ifrs-full_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareTable" xlink:to="lab_ifrs-full_EarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfAssetsAxis_019c4318-5379-7a6d-abbc-26ff2466289f_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of assets [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfAssetsAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of assets [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccruedOther_019c4318-52e4-7b6a-b841-fffe37f6a319_terseLabel_en-US" xlink:label="lab_soph_AccruedOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued other</link:label>
    <link:label id="lab_soph_AccruedOther_label_en-US" xlink:label="lab_soph_AccruedOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Other</link:label>
    <link:label id="lab_soph_AccruedOther_documentation_en-US" xlink:label="lab_soph_AccruedOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedOther" xlink:href="soph-20251231.xsd#soph_AccruedOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccruedOther" xlink:to="lab_soph_AccruedOther" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_019c4318-5379-74ed-a15f-c92a45b60a2e_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade payables</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="lab_ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-5379-7936-b0b0-70b3c3761caa_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [domain]</link:label>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_label_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5379-7fdf-a88e-974f892afd8c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPerformanceObligationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Performance Obligations [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPerformanceObligationsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPerformanceObligationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of performance obligations [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPerformanceObligationsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPerformanceObligationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsTable" xlink:to="lab_ifrs-full_DisclosureOfPerformanceObligationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights_019c81e2-b38f-7099-bf82-88bc19e8d9fa_terseLabel_en-US" xlink:label="lab_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional shares available to purchase under warrant certificate (in shares)</link:label>
    <link:label id="lab_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Or Rights, Increase (Decrease) In Number Of Shares Called By Warrants Or Rights</link:label>
    <link:label id="lab_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights_documentation_en-US" xlink:label="lab_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants Or Rights, Increase (Decrease) In Number Of Shares Called By Warrants Or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights" xlink:to="lab_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_country_FR_019c4318-5379-7d82-a25a-a6a659379223_verboseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">France</link:label>
    <link:label id="lab_country_FR_019c4318-5379-7afe-b5b0-c5b098737eab_terseLabel_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">France</link:label>
    <link:label id="lab_country_FR_label_en-US" xlink:label="lab_country_FR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">FRANCE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_FR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EarningsPerShareAbstract_019c4318-5379-7e12-b0cf-59c02585cbc5_terseLabel_en-US" xlink:label="lab_ifrs-full_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings per share [abstract]</link:label>
    <link:label id="lab_ifrs-full_EarningsPerShareAbstract_label_en-US" xlink:label="lab_ifrs-full_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareAbstract" xlink:to="lab_ifrs-full_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RangeAxis_019c4318-52e4-7d45-8416-93da3fb824b8_terseLabel_en-US" xlink:label="lab_ifrs-full_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [axis]</link:label>
    <link:label id="lab_ifrs-full_RangeAxis_label_en-US" xlink:label="lab_ifrs-full_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis" xlink:to="lab_ifrs-full_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock_019c4318-52e4-74dc-a4e9-e1df247f0dc8_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Movement in Defined Benefit Obligation Explanatory</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Movement In Defined Benefit Obligation [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of movement in defined benefit obligation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComponentsOfEquityAxis_019c4318-5378-7f68-8ca0-e3bc26403673_terseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of equity [axis]</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfEquityAxis_label_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of equity [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-52e4-7486-bbb8-4677d1641006_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheCMember_019c758f-f3e1-742d-beee-0f327dcd8e99_terseLabel_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche C</link:label>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheCMember_label_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Perceptive Credit Agreement, Tranche C [Member]</link:label>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheCMember_documentation_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Perceptive Credit Agreement, Tranche C</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheCMember" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PerceptiveCreditAgreementTrancheCMember" xlink:to="lab_soph_PerceptiveCreditAgreementTrancheCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossBeforeTax_019c4318-52e4-700a-a1fc-8051e94ef118_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_ifrs-full_ProfitLossBeforeTax_019c4318-52e4-73b2-ad41-fc064c3475b2_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss before tax</link:label>
    <link:label id="lab_ifrs-full_ProfitLossBeforeTax_label_en-US" xlink:label="lab_ifrs-full_ProfitLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss) before tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossBeforeTax" xlink:to="lab_ifrs-full_ProfitLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans_019c4318-5378-7c62-a957-a205483ab416_negatedTerseLabel_en-US" xlink:label="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans_label_en-US" xlink:label="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Net Exchange Differences, Pension Remeasurement Of Defined Benefit Plans</link:label>
    <link:label id="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans_documentation_en-US" xlink:label="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pension remeasurement currency translation differences.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" xlink:to="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-5378-76df-818e-b1ca6ad81928_terseLabel_en-US" xlink:label="lab_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Net Defined Benefit Liability (Asset) [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract_label_en-US" xlink:label="lab_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Net Defined Benefit Liability (Asset) [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract_documentation_en-US" xlink:label="lab_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Net Defined Benefit Liability (Asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="lab_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BorrowingsForeignCurrencyTranslationGainLoss_019c4318-5378-7425-b53c-36a08730604c_terseLabel_en-US" xlink:label="lab_soph_BorrowingsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_soph_BorrowingsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_soph_BorrowingsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Foreign Currency Translation Gain (Loss)</link:label>
    <link:label id="lab_soph_BorrowingsForeignCurrencyTranslationGainLoss_documentation_en-US" xlink:label="lab_soph_BorrowingsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingsForeignCurrencyTranslationGainLoss" xlink:href="soph-20251231.xsd#soph_BorrowingsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BorrowingsForeignCurrencyTranslationGainLoss" xlink:to="lab_soph_BorrowingsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AmortisationCurrentContractAcquisitionCosts_019c9dbd-a6c0-76e5-ab6e-1610331cb693_terseLabel_en-US" xlink:label="lab_soph_AmortisationCurrentContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current contract acquisition costs amortized</link:label>
    <link:label id="lab_soph_AmortisationCurrentContractAcquisitionCosts_label_en-US" xlink:label="lab_soph_AmortisationCurrentContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortisation, Current Contract Acquisition Costs</link:label>
    <link:label id="lab_soph_AmortisationCurrentContractAcquisitionCosts_documentation_en-US" xlink:label="lab_soph_AmortisationCurrentContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Contract Acquisition Costs, Amortisation Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AmortisationCurrentContractAcquisitionCosts" xlink:href="soph-20251231.xsd#soph_AmortisationCurrentContractAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AmortisationCurrentContractAcquisitionCosts" xlink:to="lab_soph_AmortisationCurrentContractAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccruedExpensesUndiscountedCashFlows_019c4318-52e4-7137-9ba5-18425e855542_terseLabel_en-US" xlink:label="lab_soph_AccruedExpensesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_soph_AccruedExpensesUndiscountedCashFlows_label_en-US" xlink:label="lab_soph_AccruedExpensesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Expenses, Undiscounted Cash Flows</link:label>
    <link:label id="lab_soph_AccruedExpensesUndiscountedCashFlows_documentation_en-US" xlink:label="lab_soph_AccruedExpensesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued expenses, undiscounted cash flows.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedExpensesUndiscountedCashFlows" xlink:href="soph-20251231.xsd#soph_AccruedExpensesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccruedExpensesUndiscountedCashFlows" xlink:to="lab_soph_AccruedExpensesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_A2013IncentiveShareOptionPlanMember_019c4318-52e4-7e8e-9dd3-32a7a1eb40ec_terseLabel_en-US" xlink:label="lab_soph_A2013IncentiveShareOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2013 ISOP</link:label>
    <link:label id="lab_soph_A2013IncentiveShareOptionPlanMember_label_en-US" xlink:label="lab_soph_A2013IncentiveShareOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2013 Incentive Share Option Plan [Member]</link:label>
    <link:label id="lab_soph_A2013IncentiveShareOptionPlanMember_documentation_en-US" xlink:label="lab_soph_A2013IncentiveShareOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two Thousand And Thirteen incentive share option plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2013IncentiveShareOptionPlanMember" xlink:href="soph-20251231.xsd#soph_A2013IncentiveShareOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_A2013IncentiveShareOptionPlanMember" xlink:to="lab_soph_A2013IncentiveShareOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccountsReceivableNonInterestBearingPaymentTerms_019c4318-5379-700f-95b6-0957b4db2ab1_terseLabel_en-US" xlink:label="lab_soph_AccountsReceivableNonInterestBearingPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of payment for non-interest bearing accounts receivable</link:label>
    <link:label id="lab_soph_AccountsReceivableNonInterestBearingPaymentTerms_label_en-US" xlink:label="lab_soph_AccountsReceivableNonInterestBearingPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Non-Interest Bearing, Payment Terms</link:label>
    <link:label id="lab_soph_AccountsReceivableNonInterestBearingPaymentTerms_documentation_en-US" xlink:label="lab_soph_AccountsReceivableNonInterestBearingPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts receivable balance non-interest bearing and payment terms.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsReceivableNonInterestBearingPaymentTerms" xlink:href="soph-20251231.xsd#soph_AccountsReceivableNonInterestBearingPaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccountsReceivableNonInterestBearingPaymentTerms" xlink:to="lab_soph_AccountsReceivableNonInterestBearingPaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-5378-78f7-a1f5-12bbbed4be40_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial instruments [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial instruments [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:to="lab_ifrs-full_ClassesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDepreciationExpense_019c4318-52e4-794e-b92e-a777b1535528_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDepreciationExpense_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for depreciation expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDepreciationExpense" xlink:to="lab_ifrs-full_AdjustmentsForDepreciationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_019c4318-5378-7309-9fa8-82f677f1fd63_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ProceedsFromBorrowingsNetOfCostsIncurred_019c81fd-0242-7fde-90bd-cfce4ddf8abb_totalLabel_en-US" xlink:label="lab_soph_ProceedsFromBorrowingsNetOfCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Proceeds net of transaction costs</link:label>
    <link:label id="lab_soph_ProceedsFromBorrowingsNetOfCostsIncurred_label_en-US" xlink:label="lab_soph_ProceedsFromBorrowingsNetOfCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Borrowings, Net Of Costs Incurred</link:label>
    <link:label id="lab_soph_ProceedsFromBorrowingsNetOfCostsIncurred_documentation_en-US" xlink:label="lab_soph_ProceedsFromBorrowingsNetOfCostsIncurred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net Proceeds From Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowingsNetOfCostsIncurred" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowingsNetOfCostsIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ProceedsFromBorrowingsNetOfCostsIncurred" xlink:to="lab_soph_ProceedsFromBorrowingsNetOfCostsIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets_019c4318-52e4-72c6-8c4a-49e0d3fca3f9_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated equity value</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill, revalued assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-5379-763c-a5b0-5d6c2d6f7dad_terseLabel_en-US" xlink:label="lab_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_documentation_en-US" xlink:label="lab_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:href="soph-20251231.xsd#soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:to="lab_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_019c72cf-56f9-7c69-a45d-5cc240a27014_terseLabel_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period on quarterly basis</link:label>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_label_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Period Of Share Based Payment Arrangement Option On Quarterly Basis</link:label>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_documentation_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Period Of Share Based Payment Arrangement Option On Quarterly Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:to="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_019c4318-52e4-79aa-9aee-127626ec9724_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment reporting</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageShares_019c4318-52e4-7ccc-8a4d-06f68649c38a_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of shares in issue, basic (in shares)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageShares_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average number of ordinary shares used in calculating basic earnings per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares" xlink:to="lab_ifrs-full_WeightedAverageShares" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_019c4318-53fc-7421-91b6-2c8f418effe6_terseLabel_en-US" xlink:label="lab_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred contract revenue brought forward</link:label>
    <link:label id="lab_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_label_en-US" xlink:label="lab_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue That Was Included In Contract Liability Balance At Beginning Of Period</link:label>
    <link:label id="lab_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_documentation_en-US" xlink:label="lab_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Revenue That Was Included In Contract Liability Balance At Beginning Of Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:href="soph-20251231.xsd#soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:to="lab_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_019c4318-5379-7b46-9e18-4f829b6065bb_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems" xlink:to="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum_019c4318-5379-7162-8762-cc8a3867b6e0_terseLabel_en-US" xlink:label="lab_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum amount of last twelve months revenue required to be maintained under customary covenants</link:label>
    <link:label id="lab_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum_label_en-US" xlink:label="lab_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, Covenant, Revenue From Contracts With Customers, Minimum</link:label>
    <link:label id="lab_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum_documentation_en-US" xlink:label="lab_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowings, Covenant, Revenue From Contracts With Customers, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum" xlink:href="soph-20251231.xsd#soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum" xlink:to="lab_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CurrentAccruedExpenses_019c4318-52e4-71f0-9b43-b28b3a9c8998_terseLabel_en-US" xlink:label="lab_soph_CurrentAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_soph_CurrentAccruedExpenses_019c4318-52e4-74fe-939f-bdaf788aa73e_totalLabel_en-US" xlink:label="lab_soph_CurrentAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_soph_CurrentAccruedExpenses_label_en-US" xlink:label="lab_soph_CurrentAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Accrued Expenses</link:label>
    <link:label id="lab_soph_CurrentAccruedExpenses_documentation_en-US" xlink:label="lab_soph_CurrentAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentAccruedExpenses" xlink:href="soph-20251231.xsd#soph_CurrentAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CurrentAccruedExpenses" xlink:to="lab_soph_CurrentAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_019c4318-52e4-746b-96e1-3040daaccf33_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Movement in Deferred Tax Balances</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_019c4318-52e4-72ae-8758-2e9b3bb7d5b7_terseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss, goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_019c4318-52e4-7a61-a4fe-0cb74c04cd0d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Intangible Assets [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherReserves_019c4318-52e4-7487-a43b-3b007df7f2c7_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other reserves</link:label>
    <link:label id="lab_ifrs-full_OtherReserves_label_en-US" xlink:label="lab_ifrs-full_OtherReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherReserves" xlink:to="lab_ifrs-full_OtherReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_019c4318-52e4-7fc0-ba4b-92ad2885523e_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, share-based payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis_019c72cb-46df-7847-8c55-745ff3351677_terseLabel_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting percentage on monthly basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis_label_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Percentage Of Share Based Payment Arrangement Option On Monthly Basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis_documentation_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Percentage Of Share Based Payment Arrangement Option On Monthly Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis" xlink:to="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Borrowings_019c4318-53fc-791a-a53c-57f1322663eb_terseLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings amount</link:label>
    <link:label id="lab_ifrs-full_Borrowings_019c4318-53fc-73f6-b3e0-2ce3481ceb3d_periodStartLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_ifrs-full_Borrowings_019c4318-53fc-7aa6-a0a8-b586c91b4756_periodEndLabel_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_ifrs-full_Borrowings_label_en-US" xlink:label="lab_ifrs-full_Borrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings" xlink:to="lab_ifrs-full_Borrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_019c4318-52e4-75a0-8f28-f5e153d72813_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_019c4318-53fc-73bf-88f3-b9fdfe763d5e_terseLabel_en-US" xlink:label="lab_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term investments, classified as cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:to="lab_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_RevenueFromContractsWithCustomersPaymentTerm_019c4318-5379-70f3-b400-20ca6a374764_terseLabel_en-US" xlink:label="lab_soph_RevenueFromContractsWithCustomersPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of payment agreements for products and services sold</link:label>
    <link:label id="lab_soph_RevenueFromContractsWithCustomersPaymentTerm_label_en-US" xlink:label="lab_soph_RevenueFromContractsWithCustomersPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue From Contracts With Customers, Payment Term</link:label>
    <link:label id="lab_soph_RevenueFromContractsWithCustomersPaymentTerm_documentation_en-US" xlink:label="lab_soph_RevenueFromContractsWithCustomersPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue From Contracts With Customers, Payment Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RevenueFromContractsWithCustomersPaymentTerm" xlink:href="soph-20251231.xsd#soph_RevenueFromContractsWithCustomersPaymentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_RevenueFromContractsWithCustomersPaymentTerm" xlink:to="lab_soph_RevenueFromContractsWithCustomersPaymentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansDomain_019c4318-52e4-74f1-9997-fb2c4af53d55_terseLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit plans [domain]</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitPlansDomain_label_en-US" xlink:label="lab_ifrs-full_DefinedBenefitPlansDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit plans [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain" xlink:to="lab_ifrs-full_DefinedBenefitPlansDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_019c4318-52e4-7b64-9291-9f5e0c7ad33f_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComputerEquipmentMember_019c4318-5379-73ef-8eec-9fc51b432c98_terseLabel_en-US" xlink:label="lab_ifrs-full_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer hardware</link:label>
    <link:label id="lab_ifrs-full_ComputerEquipmentMember_label_en-US" xlink:label="lab_ifrs-full_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer equipment [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerEquipmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerEquipmentMember" xlink:to="lab_ifrs-full_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MajorCustomersDomain_019c4318-5378-7841-8057-18c3370879ae_terseLabel_en-US" xlink:label="lab_ifrs-full_MajorCustomersDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major customers [domain]</link:label>
    <link:label id="lab_ifrs-full_MajorCustomersDomain_label_en-US" xlink:label="lab_ifrs-full_MajorCustomersDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major customers [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorCustomersDomain" xlink:to="lab_ifrs-full_MajorCustomersDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-52e4-73d0-b212-f08f613bc6b0_terseLabel_en-US" xlink:label="lab_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes In Other Equity Instruments, Weighted Average Exercise Price Of Other Equity Instruments, In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes In Other Equity Instruments, Weighted Average Exercise Price Of Other Equity Instruments, In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_documentation_en-US" xlink:label="lab_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Changes In Other Equity Instruments, Weighted Average Exercise Price Of Other Equity Instruments, In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:href="soph-20251231.xsd#soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:to="lab_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-52e4-70cf-8f46-746c4039796a_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash flow provided from (used in) financing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-52e4-7ea0-a5ae-bc82f08cb1de_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash flow provided from (used in) financing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AreaOfOfficeSpaceGainedAccessUnderLease_019c4318-5378-7100-95b0-309b2d0c2cb4_terseLabel_en-US" xlink:label="lab_soph_AreaOfOfficeSpaceGainedAccessUnderLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of office space gained access under lease (in sq ft)</link:label>
    <link:label id="lab_soph_AreaOfOfficeSpaceGainedAccessUnderLease_label_en-US" xlink:label="lab_soph_AreaOfOfficeSpaceGainedAccessUnderLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Area Of Office Space Gained Access Under Lease</link:label>
    <link:label id="lab_soph_AreaOfOfficeSpaceGainedAccessUnderLease_documentation_en-US" xlink:label="lab_soph_AreaOfOfficeSpaceGainedAccessUnderLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Area of office space gained access under lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AreaOfOfficeSpaceGainedAccessUnderLease" xlink:href="soph-20251231.xsd#soph_AreaOfOfficeSpaceGainedAccessUnderLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AreaOfOfficeSpaceGainedAccessUnderLease" xlink:to="lab_soph_AreaOfOfficeSpaceGainedAccessUnderLease" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CommencementOfMajorLitigationMember_019caf67-919d-77df-abab-23fa8633c334_terseLabel_en-US" xlink:label="lab_ifrs-full_CommencementOfMajorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major litigation</link:label>
    <link:label id="lab_ifrs-full_CommencementOfMajorLitigationMember_label_en-US" xlink:label="lab_ifrs-full_CommencementOfMajorLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commencement of major litigation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommencementOfMajorLitigationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CommencementOfMajorLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CommencementOfMajorLitigationMember" xlink:to="lab_ifrs-full_CommencementOfMajorLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CounterpartiesAxis_019c4318-52e4-77ab-9a1b-b12d2b5c90c4_terseLabel_en-US" xlink:label="lab_ifrs-full_CounterpartiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparties [axis]</link:label>
    <link:label id="lab_ifrs-full_CounterpartiesAxis_label_en-US" xlink:label="lab_ifrs-full_CounterpartiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparties [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesAxis" xlink:to="lab_ifrs-full_CounterpartiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_019c4318-53fc-7ef2-a367-be5515f30a5c_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets classification</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for financial assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_019c4318-52e4-78d3-b7a3-9693f593d3a3_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PlanAssetsAtFairValue_019c4318-5379-764d-ab77-b26de0a0c8b2_verboseLabel_en-US" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Plan assets, at fair value</link:label>
    <link:label id="lab_ifrs-full_PlanAssetsAtFairValue_019c4318-5379-748d-a2b9-dd118941ea31_totalLabel_en-US" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_ifrs-full_PlanAssetsAtFairValue_label_en-US" xlink:label="lab_ifrs-full_PlanAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan assets, at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlanAssetsAtFairValue" xlink:to="lab_ifrs-full_PlanAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TreasuryShares_019c4318-53fc-7a1e-9f78-e3e564a300b5_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_TreasuryShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares</link:label>
    <link:label id="lab_ifrs-full_TreasuryShares_label_en-US" xlink:label="lab_ifrs-full_TreasuryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasuryShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasuryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasuryShares" xlink:to="lab_ifrs-full_TreasuryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityTable_019c4318-5379-7916-b37f-8cc0778955cb_terseLabel_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement Of Changes In Equity [Table]</link:label>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityTable_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsAxis_019c4318-5378-74c6-92a8-ed5b954b89ac_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Actuarial assumptions [axis]</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionsAxis_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumptions [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis" xlink:to="lab_ifrs-full_ActuarialAssumptionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-52e4-7bee-b833-a953a4cd2c80_verboseLabel_en-US" xlink:label="lab_soph_ActuarialGainsLossesNetDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Actuarial gains (losses)</link:label>
    <link:label id="lab_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-52e4-7c73-ac25-e447b110e839_totalLabel_en-US" xlink:label="lab_soph_ActuarialGainsLossesNetDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total actuarial gains (losses)</link:label>
    <link:label id="lab_soph_ActuarialGainsLossesNetDefinedBenefitPlans_label_en-US" xlink:label="lab_soph_ActuarialGainsLossesNetDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial Gains (Losses) Net Defined Benefit Plans</link:label>
    <link:label id="lab_soph_ActuarialGainsLossesNetDefinedBenefitPlans_documentation_en-US" xlink:label="lab_soph_ActuarialGainsLossesNetDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Actuarial gains (losses), net defined benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans" xlink:href="soph-20251231.xsd#soph_ActuarialGainsLossesNetDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans" xlink:to="lab_soph_ActuarialGainsLossesNetDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_MajorBorrowingTransactionsMember_019c89cd-d2e7-772d-acc9-f9bf0ac83bc6_terseLabel_en-US" xlink:label="lab_soph_MajorBorrowingTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major Borrowing Transactions</link:label>
    <link:label id="lab_soph_MajorBorrowingTransactionsMember_label_en-US" xlink:label="lab_soph_MajorBorrowingTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major Borrowing Transactions [Member]</link:label>
    <link:label id="lab_soph_MajorBorrowingTransactionsMember_documentation_en-US" xlink:label="lab_soph_MajorBorrowingTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Major Borrowing Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_MajorBorrowingTransactionsMember" xlink:href="soph-20251231.xsd#soph_MajorBorrowingTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_MajorBorrowingTransactionsMember" xlink:to="lab_soph_MajorBorrowingTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NetOperatingLossCarryforwards_019c4318-5379-7c37-a8d9-cab40c9a4610_totalLabel_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwards_label_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Operating Loss Carryforwards</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwards_documentation_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwards" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NetOperatingLossCarryforwards" xlink:to="lab_soph_NetOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantTermsDomain_019c4318-52e4-7117-9f56-12adf41480d8_terseLabel_en-US" xlink:label="lab_soph_WarrantTermsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant Terms [Domain]</link:label>
    <link:label id="lab_soph_WarrantTermsDomain_label_en-US" xlink:label="lab_soph_WarrantTermsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Terms [Domain]</link:label>
    <link:label id="lab_soph_WarrantTermsDomain_documentation_en-US" xlink:label="lab_soph_WarrantTermsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Terms [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsDomain" xlink:href="soph-20251231.xsd#soph_WarrantTermsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantTermsDomain" xlink:to="lab_soph_WarrantTermsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ForeignExchangeAndOtherGainLoss_019c4318-52e4-72f7-a2df-38263c3e225c_terseLabel_en-US" xlink:label="lab_soph_ForeignExchangeAndOtherGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange (losses) gains, net</link:label>
    <link:label id="lab_soph_ForeignExchangeAndOtherGainLoss_label_en-US" xlink:label="lab_soph_ForeignExchangeAndOtherGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange And Other Gain (Loss)</link:label>
    <link:label id="lab_soph_ForeignExchangeAndOtherGainLoss_documentation_en-US" xlink:label="lab_soph_ForeignExchangeAndOtherGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign Exchange And Other Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ForeignExchangeAndOtherGainLoss" xlink:href="soph-20251231.xsd#soph_ForeignExchangeAndOtherGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ForeignExchangeAndOtherGainLoss" xlink:to="lab_soph_ForeignExchangeAndOtherGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CostOfSales_019c4318-5379-7b54-8564-e125062296d6_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_CostOfSales" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_ifrs-full_CostOfSales_label_en-US" xlink:label="lab_ifrs-full_CostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales" xlink:to="lab_ifrs-full_CostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfAssetsDomain_019c4318-52e4-7375-9888-0a0dfa0190cf_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of assets [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfAssetsDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of assets [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain" xlink:to="lab_ifrs-full_ClassesOfAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_019c4318-52e4-76ce-9281-186b4fb3b844_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashEquivalents_019c4318-5379-7afb-b646-25cee74c88f3_totalLabel_en-US" xlink:label="lab_ifrs-full_CashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashEquivalents_label_en-US" xlink:label="lab_ifrs-full_CashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashEquivalents" xlink:to="lab_ifrs-full_CashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts_019c4318-52e4-733d-a84b-e459d1f0ff0d_negatedLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest on loans</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense on bank loans and overdrafts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBankLoansAndOverdrafts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" xlink:to="lab_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock_019c4318-5378-7539-98e1-dc31075ad8be_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Current and Deferred Income Tax (Expenses) Benefits</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Current And Deferred Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of current and deferred tax (expenses) benefits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger_019c758f-f3e1-7eb9-b349-87b9826fdc97_terseLabel_en-US" xlink:label="lab_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trailing twelve-month revenue triggering draw down</link:label>
    <link:label id="lab_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger_label_en-US" xlink:label="lab_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowing Facilities, Threshold Trailing Twelve Months Revenue Threshold, Allowable Proceeds From Borrowings Trigger</link:label>
    <link:label id="lab_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger_documentation_en-US" xlink:label="lab_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowing Facilities, Threshold Trailing Twelve Months Revenue Threshold, Allowable Proceeds From Borrowings Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger" xlink:to="lab_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BottomOfRangeMember_019c4318-52e4-782d-8d74-75883269c6e6_terseLabel_en-US" xlink:label="lab_ifrs-full_BottomOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_ifrs-full_BottomOfRangeMember_label_en-US" xlink:label="lab_ifrs-full_BottomOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bottom of range [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember" xlink:to="lab_ifrs-full_BottomOfRangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_019c4318-52e4-70f7-abea-cb9fdb7c8d87_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities at amortized cost</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at amortised cost, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-52e4-7135-b13c-3fdbf6f37d3e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Borrowings [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_TradeAndOtherReceivablesLineItems_019c4318-52e4-7b22-aa3c-d1b0d692c956_terseLabel_en-US" xlink:label="lab_soph_TradeAndOtherReceivablesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade And Other Receivables [Line Items]</link:label>
    <link:label id="lab_soph_TradeAndOtherReceivablesLineItems_label_en-US" xlink:label="lab_soph_TradeAndOtherReceivablesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade And Other Receivables [Line Items]</link:label>
    <link:label id="lab_soph_TradeAndOtherReceivablesLineItems_documentation_en-US" xlink:label="lab_soph_TradeAndOtherReceivablesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade And Other Receivables [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TradeAndOtherReceivablesLineItems" xlink:href="soph-20251231.xsd#soph_TradeAndOtherReceivablesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems" xlink:to="lab_soph_TradeAndOtherReceivablesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IT_019c4318-52e4-7e1e-9731-e3256ed72355_terseLabel_en-US" xlink:label="lab_country_IT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Italy</link:label>
    <link:label id="lab_country_IT_label_en-US" xlink:label="lab_country_IT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ITALY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IT" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_IT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IT" xlink:to="lab_country_IT" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_TransactionsWithOwnersAbstract_019c4318-52e4-70ff-8f17-a9038d27cc3f_terseLabel_en-US" xlink:label="lab_soph_TransactionsWithOwnersAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transactions with owners</link:label>
    <link:label id="lab_soph_TransactionsWithOwnersAbstract_label_en-US" xlink:label="lab_soph_TransactionsWithOwnersAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transactions With Owners [Abstract]</link:label>
    <link:label id="lab_soph_TransactionsWithOwnersAbstract_documentation_en-US" xlink:label="lab_soph_TransactionsWithOwnersAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transactions with owners.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TransactionsWithOwnersAbstract" xlink:href="soph-20251231.xsd#soph_TransactionsWithOwnersAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_TransactionsWithOwnersAbstract" xlink:to="lab_soph_TransactionsWithOwnersAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLoss_019c4318-5379-7bd0-9385-7e4537cf358f_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss for the year</link:label>
    <link:label id="lab_ifrs-full_ProfitLoss_019c4318-5379-7b33-872b-dc2b6163c6b7_verboseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Loss for the period</link:label>
    <link:label id="lab_ifrs-full_ProfitLoss_019c4318-5379-7e78-a430-5d33311fa1c6_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss for the period</link:label>
    <link:label id="lab_ifrs-full_ProfitLoss_label_en-US" xlink:label="lab_ifrs-full_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="lab_ifrs-full_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssets_019c4318-53fc-79c1-b37a-8e1af338f01d_verboseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net accounts receivable</link:label>
    <link:label id="lab_ifrs-full_FinancialAssets_019c4318-53fc-7bb9-a2c7-a78e88551f45_negatedPeriodStartLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_ifrs-full_FinancialAssets_019c4318-53fc-7142-aded-04c4b8d1397d_negatedPeriodEndLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_ifrs-full_FinancialAssets_019c4318-53fc-73ef-8f91-5ede6ec81ad4_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total financial assets</link:label>
    <link:label id="lab_ifrs-full_FinancialAssets_label_en-US" xlink:label="lab_ifrs-full_FinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssets" xlink:to="lab_ifrs-full_FinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BlackScholesPricingModelValueMeasurementInputMember_019c4318-52e4-70a9-83d5-9f52b67d2a9d_terseLabel_en-US" xlink:label="lab_soph_BlackScholesPricingModelValueMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Black-Scholes value in USD</link:label>
    <link:label id="lab_soph_BlackScholesPricingModelValueMeasurementInputMember_label_en-US" xlink:label="lab_soph_BlackScholesPricingModelValueMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Black-Scholes Pricing Model Value, Measurement Input [Member]</link:label>
    <link:label id="lab_soph_BlackScholesPricingModelValueMeasurementInputMember_documentation_en-US" xlink:label="lab_soph_BlackScholesPricingModelValueMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Black-Scholes Pricing Model Value, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BlackScholesPricingModelValueMeasurementInputMember" xlink:href="soph-20251231.xsd#soph_BlackScholesPricingModelValueMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BlackScholesPricingModelValueMeasurementInputMember" xlink:to="lab_soph_BlackScholesPricingModelValueMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_019c4318-52e4-74ef-b062-fa2cd045d652_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options granted in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentLiabilities_019c4318-52e4-70ab-9d90-2c510fe5f91a_totalLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLiabilities_label_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="lab_ifrs-full_NoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_LongTermLeaseReceivables_019c4318-52e4-7fee-ae3a-0c345f0b63f6_terseLabel_en-US" xlink:label="lab_soph_LongTermLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term lease receivables</link:label>
    <link:label id="lab_soph_LongTermLeaseReceivables_label_en-US" xlink:label="lab_soph_LongTermLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long Term Lease Receivables</link:label>
    <link:label id="lab_soph_LongTermLeaseReceivables_documentation_en-US" xlink:label="lab_soph_LongTermLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long-term lease receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LongTermLeaseReceivables" xlink:href="soph-20251231.xsd#soph_LongTermLeaseReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_LongTermLeaseReceivables" xlink:to="lab_soph_LongTermLeaseReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentRegistrationStatement_019c4318-52e4-78d0-bd87-057c3152f561_terseLabel_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Registration Statement</link:label>
    <link:label id="lab_dei_DocumentRegistrationStatement_label_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement" xlink:to="lab_dei_DocumentRegistrationStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_019c4318-5379-7b6e-9304-aada17284eba_periodStartLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_019c4318-5379-7b5c-8550-b498b9e2acc5_periodEndLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_019c4318-5379-7919-9139-99c72e0a134a_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfSharesIssued_label_en-US" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of shares issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued" xlink:to="lab_ifrs-full_NumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DepreciationRightofuseAssets_019c89bb-0601-7937-b7f7-90672336240f_terseLabel_en-US" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation charges</link:label>
    <link:label id="lab_ifrs-full_DepreciationRightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_DepreciationRightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationRightofuseAssets" xlink:to="lab_ifrs-full_DepreciationRightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-52e4-7efc-9b19-a5f3702df390_terseLabel_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [domain]</link:label>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_label_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CapitalCommitments_019c4318-5379-7bd5-b3dd-7c190c99bdc8_terseLabel_en-US" xlink:label="lab_ifrs-full_CapitalCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining commitments</link:label>
    <link:label id="lab_ifrs-full_CapitalCommitments_label_en-US" xlink:label="lab_ifrs-full_CapitalCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalCommitments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CapitalCommitments" xlink:to="lab_ifrs-full_CapitalCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PerceptiveCreditHoldingsWarrantsMember_019c4318-52e4-7022-a2ae-82e4d276b6ae_terseLabel_en-US" xlink:label="lab_soph_PerceptiveCreditHoldingsWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Perceptive Credit Holdings Warrants</link:label>
    <link:label id="lab_soph_PerceptiveCreditHoldingsWarrantsMember_label_en-US" xlink:label="lab_soph_PerceptiveCreditHoldingsWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Perceptive Credit Holdings Warrants [Member]</link:label>
    <link:label id="lab_soph_PerceptiveCreditHoldingsWarrantsMember_documentation_en-US" xlink:label="lab_soph_PerceptiveCreditHoldingsWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Perceptive Credit Holdings Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditHoldingsWarrantsMember" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditHoldingsWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PerceptiveCreditHoldingsWarrantsMember" xlink:to="lab_soph_PerceptiveCreditHoldingsWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019c4318-52e4-7eaa-8caf-09c55f71b61e_terseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019c4318-52e4-7ab1-a1f1-c6c76ef50c3a_verboseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember_label_en-US" xlink:label="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated depreciation and amortisation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="lab_ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RetainedEarningsMember_019c4318-5379-7b90-b9ec-01f52ddbd5b4_terseLabel_en-US" xlink:label="lab_ifrs-full_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_ifrs-full_RetainedEarningsMember_label_en-US" xlink:label="lab_ifrs-full_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained earnings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember" xlink:to="lab_ifrs-full_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_019c4318-52e4-7f2d-a04a-58146ed53f95_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for leases [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans_019c4318-52e4-7a17-9ce4-d974e930a990_terseLabel_en-US" xlink:label="lab_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transfers (in) out due to (joiners) leavers</link:label>
    <link:label id="lab_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans_019c4318-52e4-7106-879c-04db07bc5960_negatedLabel_en-US" xlink:label="lab_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Transfers in (out) due to joiners (leavers)</link:label>
    <link:label id="lab_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans_label_en-US" xlink:label="lab_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transfers Out (In) Due To Joiners Leavers Defined Benefit Plans</link:label>
    <link:label id="lab_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans_documentation_en-US" xlink:label="lab_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transfers (in) out due to (joiners) leavers defined benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" xlink:href="soph-20251231.xsd#soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" xlink:to="lab_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity_019c4318-5379-7e89-a2b1-b1f56b6469f5_terseLabel_en-US" xlink:label="lab_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share options exercised and vesting of Restricted Stock Units</link:label>
    <link:label id="lab_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity_label_en-US" xlink:label="lab_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Exercise Of Options And Vesting Of Other Equity Instruments, Equity</link:label>
    <link:label id="lab_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity_documentation_en-US" xlink:label="lab_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Exercise Of Options And Vesting Of Other Equity Instruments, Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" xlink:to="lab_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_label_en-US" xlink:label="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Analysis of income and expense [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_019c4318-5379-7836-8734-9efbe83d09cc_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Sensitivity Analysis for Funded and Unfunded Plans</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of sensitivity analysis for actuarial assumptions [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_BusinessContactMember_019c4318-52e4-7a44-881b-f283f10c07c4_terseLabel_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Contact</link:label>
    <link:label id="lab_dei_BusinessContactMember_label_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Contact [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_BusinessContactMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ConstructionInProgress_019c6760-b497-74a7-bb8e-cdc79e36c172_terseLabel_en-US" xlink:label="lab_ifrs-full_ConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets under construction</link:label>
    <link:label id="lab_ifrs-full_ConstructionInProgress_label_en-US" xlink:label="lab_ifrs-full_ConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConstructionInProgress" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ConstructionInProgress" xlink:to="lab_ifrs-full_ConstructionInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-5378-7fd6-a816-d6930755136d_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Line Items]</link:label>
    <link:label id="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_label_en-US" xlink:label="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Line Items]</link:label>
    <link:label id="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_documentation_en-US" xlink:label="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for financial liabilities on contractual discounted cashflows.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems" xlink:href="soph-20251231.xsd#soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems" xlink:to="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsDomain_019c4318-52e4-7780-a1fd-307dca0a3923_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of financial assets [domain]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialAssetsDomain_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial assets [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:to="lab_ifrs-full_CategoriesOfFinancialAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_GuardantHealthMember_019caf67-919d-72c1-9649-b7e895641862_terseLabel_en-US" xlink:label="lab_soph_GuardantHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guardant</link:label>
    <link:label id="lab_soph_GuardantHealthMember_label_en-US" xlink:label="lab_soph_GuardantHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guardant Health [Member]</link:label>
    <link:label id="lab_soph_GuardantHealthMember_documentation_en-US" xlink:label="lab_soph_GuardantHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Guardant Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GuardantHealthMember" xlink:href="soph-20251231.xsd#soph_GuardantHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_GuardantHealthMember" xlink:to="lab_soph_GuardantHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CarryingAmountMember_019c4318-5379-76cb-95d4-769a9d43462f_terseLabel_en-US" xlink:label="lab_ifrs-full_CarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount</link:label>
    <link:label id="lab_ifrs-full_CarryingAmountMember_label_en-US" xlink:label="lab_ifrs-full_CarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying amount [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember" xlink:to="lab_ifrs-full_CarryingAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnobservableInputsDomain_019c4318-52e4-77da-88cb-b94609f0671f_terseLabel_en-US" xlink:label="lab_ifrs-full_UnobservableInputsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unobservable inputs [domain]</link:label>
    <link:label id="lab_ifrs-full_UnobservableInputsDomain_label_en-US" xlink:label="lab_ifrs-full_UnobservableInputsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unobservable inputs [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnobservableInputsDomain" xlink:to="lab_ifrs-full_UnobservableInputsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_019c4318-5379-71b5-a095-481f414a26cb_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Salaries and other short-term employee benefits</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, short-term employee benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019c4318-5379-788c-9e80-3810ff95edd8_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentServiceCostDefinedBenefitPlans_019c4318-5378-7277-ad45-c9a620c36cae_negatedLabel_en-US" xlink:label="lab_ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">of which current service cost</link:label>
    <link:label id="lab_ifrs-full_CurrentServiceCostDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current service cost, defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentServiceCostDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:to="lab_ifrs-full_CurrentServiceCostDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_019c4318-52e4-7510-94ee-c48557155d69_negatedPeriodStartLabel_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_019c4318-52e4-7661-a203-28e3c25a80a2_negatedPeriodEndLabel_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net defined benefit liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:to="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-5379-78b5-828c-cb57810e7b2b_terseLabel_en-US" xlink:label="lab_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in allowance account for credit losses of financial assets [abstract]</link:label>
    <link:label id="lab_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in allowance account for credit losses of financial assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:to="lab_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_019c4318-52e4-7b10-9e76-9b125eb2b259_negatedLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-52e4-7da1-8afd-c41c2780220f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [abstract]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-5379-7057-b3f8-aff3e4c9adcc_terseLabel_en-US" xlink:label="lab_soph_ChangesInDefinedBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes In Defined Benefit Obligation [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInDefinedBenefitObligationAbstract_label_en-US" xlink:label="lab_soph_ChangesInDefinedBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes In Defined Benefit Obligation [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInDefinedBenefitObligationAbstract_documentation_en-US" xlink:label="lab_soph_ChangesInDefinedBenefitObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Changes In Defined Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInDefinedBenefitObligationAbstract" xlink:href="soph-20251231.xsd#soph_ChangesInDefinedBenefitObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract" xlink:to="lab_soph_ChangesInDefinedBenefitObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_019c4318-5378-7ea6-9e28-e85eda5074f6_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Table]</link:label>
    <link:label id="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_label_en-US" xlink:label="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Table]</link:label>
    <link:label id="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_documentation_en-US" xlink:label="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of maturity analysis for financial liabilities on contractual discounted cashflows.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable" xlink:href="soph-20251231.xsd#soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable" xlink:to="lab_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SurplusDeficitInPlan_019c4318-5379-7f57-b9e4-71aec7ad0ac4_totalLabel_en-US" xlink:label="lab_ifrs-full_SurplusDeficitInPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net pension liability</link:label>
    <link:label id="lab_ifrs-full_SurplusDeficitInPlan_label_en-US" xlink:label="lab_ifrs-full_SurplusDeficitInPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Surplus (deficit) in plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SurplusDeficitInPlan" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SurplusDeficitInPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SurplusDeficitInPlan" xlink:to="lab_ifrs-full_SurplusDeficitInPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_019c4318-5379-7100-a250-77ab6ade1b9c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Valuation Inputs</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RightofuseAssets_019c4318-5378-7674-8083-6e68be49e26a_terseLabel_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_ifrs-full_RightofuseAssets_label_en-US" xlink:label="lab_ifrs-full_RightofuseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets" xlink:to="lab_ifrs-full_RightofuseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfCompanyInformationAndOperationsAbstract_label_en-US" xlink:label="lab_soph_DisclosureOfCompanyInformationAndOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Company Information And Operations [Abstract]</link:label>
    <link:label id="lab_soph_DisclosureOfCompanyInformationAndOperationsAbstract_documentation_en-US" xlink:label="lab_soph_DisclosureOfCompanyInformationAndOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of company information and operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsAbstract" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsAbstract" xlink:to="lab_soph_DisclosureOfCompanyInformationAndOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_019c4318-52e4-7ac3-8c8b-d53be0a247df_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected rates of salary increases</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_019c4318-52e4-731b-94e9-09751a4ac6df_verboseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Expected rates of salary increases</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of salary increases [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelName_019c4318-52e4-7f3c-af63-03495fced0a9_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:label id="lab_dei_ContactPersonnelName_label_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ContactPersonnelName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_019c4318-5379-7e40-9c2d-e1cbb262d98f_terseLabel_en-US" xlink:label="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term deposits less than 3 months</link:label>
    <link:label id="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-term deposits, classified as cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:to="lab_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_FinancialAssumptionOfDiscountRates_019c4318-53fc-76cb-84cb-816a675aedde_terseLabel_en-US" xlink:label="lab_soph_FinancialAssumptionOfDiscountRates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assumptions increase (decrease) of discount rate</link:label>
    <link:label id="lab_soph_FinancialAssumptionOfDiscountRates_label_en-US" xlink:label="lab_soph_FinancialAssumptionOfDiscountRates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Assumption Of Discount Rates</link:label>
    <link:label id="lab_soph_FinancialAssumptionOfDiscountRates_documentation_en-US" xlink:label="lab_soph_FinancialAssumptionOfDiscountRates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Assumption Of Discount Rates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FinancialAssumptionOfDiscountRates" xlink:href="soph-20251231.xsd#soph_FinancialAssumptionOfDiscountRates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_FinancialAssumptionOfDiscountRates" xlink:to="lab_soph_FinancialAssumptionOfDiscountRates" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ForeignExchangeSpotRate_019c4318-52e4-703f-a2f9-adca2ff32e1d_terseLabel_en-US" xlink:label="lab_soph_ForeignExchangeSpotRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spot rate (in dollars per share)</link:label>
    <link:label id="lab_soph_ForeignExchangeSpotRate_label_en-US" xlink:label="lab_soph_ForeignExchangeSpotRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Spot Rate</link:label>
    <link:label id="lab_soph_ForeignExchangeSpotRate_documentation_en-US" xlink:label="lab_soph_ForeignExchangeSpotRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign exchange, spot rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ForeignExchangeSpotRate" xlink:href="soph-20251231.xsd#soph_ForeignExchangeSpotRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ForeignExchangeSpotRate" xlink:to="lab_soph_ForeignExchangeSpotRate" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ProvisionOfInventory_019c4318-52e4-735c-b319-aedce6ec914f_negatedLabel_en-US" xlink:label="lab_soph_ProvisionOfInventory" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Provision</link:label>
    <link:label id="lab_soph_ProvisionOfInventory_019c4318-52e4-7f25-a61c-65763c9a91dc_negatedPeriodStartLabel_en-US" xlink:label="lab_soph_ProvisionOfInventory" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_soph_ProvisionOfInventory_019c4318-52e4-7145-9955-4f2af7ee60a1_negatedPeriodEndLabel_en-US" xlink:label="lab_soph_ProvisionOfInventory" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_soph_ProvisionOfInventory_label_en-US" xlink:label="lab_soph_ProvisionOfInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision Of Inventory</link:label>
    <link:label id="lab_soph_ProvisionOfInventory_documentation_en-US" xlink:label="lab_soph_ProvisionOfInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Provision of inventory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProvisionOfInventory" xlink:href="soph-20251231.xsd#soph_ProvisionOfInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ProvisionOfInventory" xlink:to="lab_soph_ProvisionOfInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_019c66d3-3ecc-7ad6-ac72-42fe960d8640_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of changes in accounting estimates [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of changes in accounting estimates [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:to="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_019c4318-52e4-7a6b-be4c-6f9a703effb0_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Revenue and Non-Current Non-Financial Assets by Country</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of geographical areas [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_019c4318-5379-7881-b1e9-822bc94c3433_terseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Items that may be reclassified to statement of loss</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_label_en-US" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValue_019c4318-52e4-7b52-805f-3f4795e23a29_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total financial assets</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtFairValue_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets, at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtFairValue" xlink:to="lab_ifrs-full_FinancialAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearTwo_019c4318-5379-7a19-9d36-410e264adc5f_terseLabel_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Two years</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearTwo_label_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Operating Loss Carryforwards, Year Two</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearTwo_documentation_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards year two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearTwo" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NetOperatingLossCarryforwardsYearTwo" xlink:to="lab_soph_NetOperatingLossCarryforwardsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BorrowingMaturityTerm_019c4318-5379-76b1-ba04-ef87f0c8a0f3_terseLabel_en-US" xlink:label="lab_soph_BorrowingMaturityTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit agreement maturity</link:label>
    <link:label id="lab_soph_BorrowingMaturityTerm_label_en-US" xlink:label="lab_soph_BorrowingMaturityTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowing Maturity, Term</link:label>
    <link:label id="lab_soph_BorrowingMaturityTerm_documentation_en-US" xlink:label="lab_soph_BorrowingMaturityTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowing Maturity, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingMaturityTerm" xlink:href="soph-20251231.xsd#soph_BorrowingMaturityTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BorrowingMaturityTerm" xlink:to="lab_soph_BorrowingMaturityTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnusedTaxLossesMember_019c4318-52e4-7ffe-8689-3b788f54ebea_verboseLabel_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_ifrs-full_UnusedTaxLossesMember_019c4318-52e4-7d2d-a7bf-f319c1d5f65e_netLabel_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_ifrs-full_UnusedTaxLossesMember_label_en-US" xlink:label="lab_ifrs-full_UnusedTaxLossesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unused tax losses [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnusedTaxLossesMember" xlink:to="lab_ifrs-full_UnusedTaxLossesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WeightedAverageFairValueShareOptionsGranted_019c4318-5379-76a1-b96f-28c2384ce2f7_terseLabel_en-US" xlink:label="lab_soph_WeightedAverageFairValueShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average fair value of options granted (in dollars per share)</link:label>
    <link:label id="lab_soph_WeightedAverageFairValueShareOptionsGranted_label_en-US" xlink:label="lab_soph_WeightedAverageFairValueShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Fair Value, Share Options Granted</link:label>
    <link:label id="lab_soph_WeightedAverageFairValueShareOptionsGranted_documentation_en-US" xlink:label="lab_soph_WeightedAverageFairValueShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average fair value, share options granted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageFairValueShareOptionsGranted" xlink:href="soph-20251231.xsd#soph_WeightedAverageFairValueShareOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WeightedAverageFairValueShareOptionsGranted" xlink:to="lab_soph_WeightedAverageFairValueShareOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PrincipalPaidOnLeaseLiabilities_019c8cc0-c8c5-7252-9a87-69569cb9356c_verboseLabel_en-US" xlink:label="lab_soph_PrincipalPaidOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Lease liability payments</link:label>
    <link:label id="lab_soph_PrincipalPaidOnLeaseLiabilities_label_en-US" xlink:label="lab_soph_PrincipalPaidOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Principal Paid On Lease Liabilities</link:label>
    <link:label id="lab_soph_PrincipalPaidOnLeaseLiabilities_documentation_en-US" xlink:label="lab_soph_PrincipalPaidOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Principal Paid On Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PrincipalPaidOnLeaseLiabilities" xlink:href="soph-20251231.xsd#soph_PrincipalPaidOnLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PrincipalPaidOnLeaseLiabilities" xlink:to="lab_soph_PrincipalPaidOnLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_019c4318-5379-75b7-9a32-cc6bbef01377_terseLabel_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated life</link:label>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalAxis_019c4318-53fc-7b47-9922-40e63401e926_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of share capital [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfShareCapitalAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of share capital [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis" xlink:to="lab_ifrs-full_ClassesOfShareCapitalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_019c4318-5378-780c-9350-dfc2136f829f_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share options exercised (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_019c4318-5378-73e1-b108-23a9563509a4_negatedLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_019c4318-5378-72aa-a1d7-f8a2181b9afd_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Expense not deductible for tax purposes</link:label>
    <link:label id="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_label_en-US" xlink:label="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax effect of expense not deductible in determining taxable profit (tax loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="lab_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock_019c4318-52e4-7496-9761-f973e285bce4_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Pension Remeasurement Recognized in Statement Other Comprehensive Loss</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Pension Remeasurement Recognized In Statement Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about pension remeasurement recognized in statement other comprehensive income loss explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Equity_019c4318-5378-7f5c-8724-695b17180874_totalLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_ifrs-full_Equity_019c4318-5378-729b-9cf6-11abe475ee6a_periodStartLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_ifrs-full_Equity_019c4318-5378-7c85-8069-1fd2b3be5eab_periodEndLabel_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_ifrs-full_Equity_label_en-US" xlink:label="lab_ifrs-full_Equity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity" xlink:to="lab_ifrs-full_Equity" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfCompanyInformationAndOperationsTextBlock_019c4318-5379-7cf7-bf11-1cc5c64d8081_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfCompanyInformationAndOperationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company information and operations</link:label>
    <link:label id="lab_soph_DisclosureOfCompanyInformationAndOperationsTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfCompanyInformationAndOperationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Company Information And Operations [Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfCompanyInformationAndOperationsTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfCompanyInformationAndOperationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Company information and operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsTextBlock" xlink:to="lab_soph_DisclosureOfCompanyInformationAndOperationsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_019c4318-53fc-7cac-84d0-0140a6078f33_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_019c4318-52e4-73aa-9f03-bb2de5ee8007_terseLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_019c4318-52e4-7f99-988e-713ff343a306_periodStartLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_019c4318-52e4-7e32-82cb-2efe58ecd680_periodEndLabel_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_ifrs-full_PropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossProfit_019c4318-52e4-7c2a-923d-38f9df5520c7_totalLabel_en-US" xlink:label="lab_ifrs-full_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_ifrs-full_GrossProfit_label_en-US" xlink:label="lab_ifrs-full_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit" xlink:to="lab_ifrs-full_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ShareBasedPaymentArrangementsVestingDomain_019c4318-52e4-7845-93e2-c8886964c0c5_terseLabel_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementsVestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangements, Vesting [Domain]</link:label>
    <link:label id="lab_soph_ShareBasedPaymentArrangementsVestingDomain_label_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementsVestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangements, Vesting [Domain]</link:label>
    <link:label id="lab_soph_ShareBasedPaymentArrangementsVestingDomain_documentation_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementsVestingDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangements, Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementsVestingDomain" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementsVestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ShareBasedPaymentArrangementsVestingDomain" xlink:to="lab_soph_ShareBasedPaymentArrangementsVestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ProceedsFromBorrowings_019c4318-52e4-7282-aee4-3b77308582d9_terseLabel_en-US" xlink:label="lab_soph_ProceedsFromBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Draw down of term loans</link:label>
    <link:label id="lab_soph_ProceedsFromBorrowings_019c4318-52e4-7775-af97-385f4da8cffe_verboseLabel_en-US" xlink:label="lab_soph_ProceedsFromBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gross proceeds</link:label>
    <link:label id="lab_soph_ProceedsFromBorrowings_label_en-US" xlink:label="lab_soph_ProceedsFromBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From borrowings</link:label>
    <link:label id="lab_soph_ProceedsFromBorrowings_documentation_en-US" xlink:label="lab_soph_ProceedsFromBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowings" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ProceedsFromBorrowings" xlink:to="lab_soph_ProceedsFromBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ChangesInShareBasedPaymentsAbstract_019c4318-5379-7d45-8482-f689e3d2c3e4_terseLabel_en-US" xlink:label="lab_soph_ChangesInShareBasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes In Share-Based Payments [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInShareBasedPaymentsAbstract_label_en-US" xlink:label="lab_soph_ChangesInShareBasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes In Share-Based Payments [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInShareBasedPaymentsAbstract_documentation_en-US" xlink:label="lab_soph_ChangesInShareBasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Changes In Share-Based Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInShareBasedPaymentsAbstract" xlink:href="soph-20251231.xsd#soph_ChangesInShareBasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ChangesInShareBasedPaymentsAbstract" xlink:to="lab_soph_ChangesInShareBasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantTermsAxis_019c4318-5379-71e1-b092-17124562c2d7_terseLabel_en-US" xlink:label="lab_soph_WarrantTermsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant Terms [Axis]</link:label>
    <link:label id="lab_soph_WarrantTermsAxis_label_en-US" xlink:label="lab_soph_WarrantTermsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Terms [Axis]</link:label>
    <link:label id="lab_soph_WarrantTermsAxis_documentation_en-US" xlink:label="lab_soph_WarrantTermsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsAxis" xlink:href="soph-20251231.xsd#soph_WarrantTermsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantTermsAxis" xlink:to="lab_soph_WarrantTermsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_019c7278-42ce-737b-b8a1-11c2459962ea_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for research and development expense [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_019c4318-52e4-764c-ace3-41a29e2d7618_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average modified duration</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average duration of defined benefit obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:to="lab_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_019c4318-52e4-78c1-8dc9-85801ac6ec95_terseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Items that will not be reclassified to statement of loss (net of tax)</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_label_en-US" xlink:label="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:to="lab_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Level1OfFairValueHierarchyMember_019c4318-52e4-7203-8d60-cde886b14390_terseLabel_en-US" xlink:label="lab_ifrs-full_Level1OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_ifrs-full_Level1OfFairValueHierarchyMember_label_en-US" xlink:label="lab_ifrs-full_Level1OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Level 1 of fair value hierarchy [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level1OfFairValueHierarchyMember" xlink:to="lab_ifrs-full_Level1OfFairValueHierarchyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_RolleSwitzerlandMember_019c4318-5379-7ab2-ba59-9a7647aec451_terseLabel_en-US" xlink:label="lab_soph_RolleSwitzerlandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rolle</link:label>
    <link:label id="lab_soph_RolleSwitzerlandMember_label_en-US" xlink:label="lab_soph_RolleSwitzerlandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rolle, Switzerland [Member]</link:label>
    <link:label id="lab_soph_RolleSwitzerlandMember_documentation_en-US" xlink:label="lab_soph_RolleSwitzerlandMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rolle.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RolleSwitzerlandMember" xlink:href="soph-20251231.xsd#soph_RolleSwitzerlandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_RolleSwitzerlandMember" xlink:to="lab_soph_RolleSwitzerlandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CurrentContractAcquisitionCosts_019c729c-b19f-7755-bbaa-1e12ecf539d7_terseLabel_en-US" xlink:label="lab_soph_CurrentContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current contract acquisition costs</link:label>
    <link:label id="lab_soph_CurrentContractAcquisitionCosts_label_en-US" xlink:label="lab_soph_CurrentContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Contract Acquisition Costs</link:label>
    <link:label id="lab_soph_CurrentContractAcquisitionCosts_documentation_en-US" xlink:label="lab_soph_CurrentContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Contract Acquisition Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentContractAcquisitionCosts" xlink:href="soph-20251231.xsd#soph_CurrentContractAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CurrentContractAcquisitionCosts" xlink:to="lab_soph_CurrentContractAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_019c4318-5378-75ca-a778-bab108c7b80c_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of share options granted (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_019c4318-5378-748d-9d09-ac1d65fbb9a9_verboseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of share options granted in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock_019c4318-52e4-7095-abc7-2880dfb1598c_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Interest Expense</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Interest Expense [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-53fc-7d6d-bf53-9893fc0b7e79_terseLabel_en-US" xlink:label="lab_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of options</link:label>
    <link:label id="lab_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Equity Instruments In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_documentation_en-US" xlink:label="lab_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Equity Instruments In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:href="soph-20251231.xsd#soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:to="lab_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-52e4-7817-8ff5-b4952562f470_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Property Plant And Equipment [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UndrawnBorrowingFacilities_019c6cc2-2395-71e9-8bc5-b46dcf598874_terseLabel_en-US" xlink:label="lab_ifrs-full_UndrawnBorrowingFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings that can be drawn immediately</link:label>
    <link:label id="lab_ifrs-full_UndrawnBorrowingFacilities_label_en-US" xlink:label="lab_ifrs-full_UndrawnBorrowingFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undrawn borrowing facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UndrawnBorrowingFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UndrawnBorrowingFacilities" xlink:to="lab_ifrs-full_UndrawnBorrowingFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Level2OfFairValueHierarchyMember_019c4318-5378-77be-a454-dd2699df3c04_terseLabel_en-US" xlink:label="lab_ifrs-full_Level2OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_ifrs-full_Level2OfFairValueHierarchyMember_label_en-US" xlink:label="lab_ifrs-full_Level2OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Level 2 of fair value hierarchy [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level2OfFairValueHierarchyMember" xlink:to="lab_ifrs-full_Level2OfFairValueHierarchyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FixturesAndFittingsMember_019c4318-52e4-706a-9dd0-43dc59878fca_terseLabel_en-US" xlink:label="lab_ifrs-full_FixturesAndFittingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_ifrs-full_FixturesAndFittingsMember_label_en-US" xlink:label="lab_ifrs-full_FixturesAndFittingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fixtures and fittings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FixturesAndFittingsMember" xlink:to="lab_ifrs-full_FixturesAndFittingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CashAndCashEquivalents1Member_019c4318-52e4-7f74-a6f7-8d029ea66176_terseLabel_en-US" xlink:label="lab_soph_CashAndCashEquivalents1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents:</link:label>
    <link:label id="lab_soph_CashAndCashEquivalents1Member_label_en-US" xlink:label="lab_soph_CashAndCashEquivalents1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalents1 [Member]</link:label>
    <link:label id="lab_soph_CashAndCashEquivalents1Member_documentation_en-US" xlink:label="lab_soph_CashAndCashEquivalents1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalents1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CashAndCashEquivalents1Member" xlink:href="soph-20251231.xsd#soph_CashAndCashEquivalents1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CashAndCashEquivalents1Member" xlink:to="lab_soph_CashAndCashEquivalents1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c6bdc-e091-73d6-b8ff-bfc0c7ce6e73_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement (in dollar per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c4318-5379-799e-984b-ca3e2c30725f_periodEndLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c4318-5379-7c3b-97c6-24c921e93875_periodStartLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_019c4318-5378-740f-b27e-a1380480daf0_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease (increase) in prepaids and other assets</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in prepaid expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_019c4318-52e4-75b2-ac07-066e4aeb84a7_totalLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Attributable to the owners of the parent</link:label>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_019c4318-52e4-72e0-af69-14f4e36f196c_terseLabel_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss attributed to shareholders</link:label>
    <link:label id="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent_label_en-US" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Profit (loss), attributable to owners of parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SophiaGeneticsPtyLtdMember_019c4318-5379-7fdc-b539-52bce6faeced_terseLabel_en-US" xlink:label="lab_soph_SophiaGeneticsPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SOPHiA GENETICS PTY LTD</link:label>
    <link:label id="lab_soph_SophiaGeneticsPtyLtdMember_label_en-US" xlink:label="lab_soph_SophiaGeneticsPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sophia Genetics Pty Ltd [Member]</link:label>
    <link:label id="lab_soph_SophiaGeneticsPtyLtdMember_documentation_en-US" xlink:label="lab_soph_SophiaGeneticsPtyLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sophia Genetics Pty Ltd .</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsPtyLtdMember" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsPtyLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SophiaGeneticsPtyLtdMember" xlink:to="lab_soph_SophiaGeneticsPtyLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SalesAndMarketingExpense_019c4318-52e4-7045-ba3d-318ba5385042_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_SalesAndMarketingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Selling and marketing costs</link:label>
    <link:label id="lab_ifrs-full_SalesAndMarketingExpense_label_en-US" xlink:label="lab_ifrs-full_SalesAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales and marketing expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SalesAndMarketingExpense" xlink:to="lab_ifrs-full_SalesAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-5378-7837-bfb9-f65acc25eef7_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-5378-74fe-8a34-56e91ea876a7_totalLabel_en-US" xlink:label="lab_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_label_en-US" xlink:label="lab_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current prepayments and other current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:to="lab_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MajorCustomersAxis_019c4318-52e4-7c4a-ba49-8b63f7ed79b3_terseLabel_en-US" xlink:label="lab_ifrs-full_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Major customers [axis]</link:label>
    <link:label id="lab_ifrs-full_MajorCustomersAxis_label_en-US" xlink:label="lab_ifrs-full_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major customers [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorCustomersAxis" xlink:to="lab_ifrs-full_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_019c66d3-3ecc-7d8b-b180-0fda93fe2bf2_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of changes in accounting estimates [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of changes in accounting estimates [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:to="lab_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantRightsTrancheCMember_019c81e4-a55a-7d12-b113-0e04149c01c0_terseLabel_en-US" xlink:label="lab_soph_WarrantRightsTrancheCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche C</link:label>
    <link:label id="lab_soph_WarrantRightsTrancheCMember_label_en-US" xlink:label="lab_soph_WarrantRightsTrancheCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche C [Member]</link:label>
    <link:label id="lab_soph_WarrantRightsTrancheCMember_documentation_en-US" xlink:label="lab_soph_WarrantRightsTrancheCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche C</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheCMember" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantRightsTrancheCMember" xlink:to="lab_soph_WarrantRightsTrancheCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilityAsset_019c4318-52e4-77b4-9504-8b8410c4709b_negatedPeriodStartLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability (asset) at beginning of period</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilityAsset_019c4318-52e4-7f8e-8d5d-020b2ec79a26_negatedPeriodEndLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liability (asset) at end of period</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilityAsset" xlink:to="lab_ifrs-full_DeferredTaxLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_GenesisHealthcareMember_019c6cbb-4ca5-7afe-8c8f-1425e9fc0884_terseLabel_en-US" xlink:label="lab_soph_GenesisHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Genesis Healthcare</link:label>
    <link:label id="lab_soph_GenesisHealthcareMember_label_en-US" xlink:label="lab_soph_GenesisHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Genesis Healthcare [Member]</link:label>
    <link:label id="lab_soph_GenesisHealthcareMember_documentation_en-US" xlink:label="lab_soph_GenesisHealthcareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Genesis Healthcare</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GenesisHealthcareMember" xlink:href="soph-20251231.xsd#soph_GenesisHealthcareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_GenesisHealthcareMember" xlink:to="lab_soph_GenesisHealthcareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentLiabilities_019c4318-5379-7978-bc34-6d3a65ef71b4_totalLabel_en-US" xlink:label="lab_ifrs-full_CurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_ifrs-full_CurrentLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="lab_ifrs-full_CurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DividendsReceived_019c4318-5379-76e4-b2a9-454ab6225310_terseLabel_en-US" xlink:label="lab_ifrs-full_DividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends payments received</link:label>
    <link:label id="lab_ifrs-full_DividendsReceived_label_en-US" xlink:label="lab_ifrs-full_DividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsReceived" xlink:to="lab_ifrs-full_DividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BadDebtReservesRelatedTemporaryDifferencesMember_019c4318-5379-718e-aa12-03887edcc2c4_terseLabel_en-US" xlink:label="lab_soph_BadDebtReservesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bad debt reserves</link:label>
    <link:label id="lab_soph_BadDebtReservesRelatedTemporaryDifferencesMember_label_en-US" xlink:label="lab_soph_BadDebtReservesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bad Debt Reserves Related Temporary Differences [Member]</link:label>
    <link:label id="lab_soph_BadDebtReservesRelatedTemporaryDifferencesMember_documentation_en-US" xlink:label="lab_soph_BadDebtReservesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary difference bad debt reserves.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BadDebtReservesRelatedTemporaryDifferencesMember" xlink:href="soph-20251231.xsd#soph_BadDebtReservesRelatedTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BadDebtReservesRelatedTemporaryDifferencesMember" xlink:to="lab_soph_BadDebtReservesRelatedTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherReceivablesAbstract_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other receivables [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="lab_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans_019c4318-5379-79b9-a7aa-4c79ab0b8cb4_verboseLabel_en-US" xlink:label="lab_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">of which past service cost including effects from curtailment</link:label>
    <link:label id="lab_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans_019c9105-a1eb-7e95-932a-adcf3aecc365_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Past service cost gain</link:label>
    <link:label id="lab_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Past service cost and losses (gains) arising from settlements, defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" xlink:to="lab_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxAssets_019c4318-52e4-79ac-974a-20255b3be45a_terseLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxAssets_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets" xlink:to="lab_ifrs-full_DeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Inventories_019c4318-5378-752d-ba1a-83fd5bd2d8bc_terseLabel_en-US" xlink:label="lab_ifrs-full_Inventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_ifrs-full_Inventories_019c4318-5378-7a67-aff8-1bcd5768da38_totalLabel_en-US" xlink:label="lab_ifrs-full_Inventories" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_Inventories_label_en-US" xlink:label="lab_ifrs-full_Inventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories" xlink:to="lab_ifrs-full_Inventories" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_019c4318-5379-7f0c-a6a5-beeaac9923b6_verboseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Decrease of 25 basis points</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="lab_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAccountingStandard_019c4318-52e4-78c8-b2fb-f2d2ac386bef_terseLabel_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:label id="lab_dei_DocumentAccountingStandard_label_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard" xlink:to="lab_dei_DocumentAccountingStandard" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantLiabilityMember_019c4318-52e4-7599-9fe5-4689b1fb7eb9_terseLabel_en-US" xlink:label="lab_soph_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant obligation:</link:label>
    <link:label id="lab_soph_WarrantLiabilityMember_label_en-US" xlink:label="lab_soph_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Liability [Member]</link:label>
    <link:label id="lab_soph_WarrantLiabilityMember_documentation_en-US" xlink:label="lab_soph_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantLiabilityMember" xlink:href="soph-20251231.xsd#soph_WarrantLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantLiabilityMember" xlink:to="lab_soph_WarrantLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions_019c4318-5379-743b-8447-0d370486a2d7_terseLabel_en-US" xlink:label="lab_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions_label_en-US" xlink:label="lab_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Contractual Life Of Exercisable Share Options</link:label>
    <link:label id="lab_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions_documentation_en-US" xlink:label="lab_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life of exercisable share options.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions" xlink:href="soph-20251231.xsd#soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions" xlink:to="lab_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_019c4318-5378-7921-a887-86b8da9b28cb_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_019c4318-52e4-7035-ac50-6ea9685e20cd_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock_019c4318-52e4-75d2-960f-d5b5d0ed01da_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Interest Income</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Interest Income [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Detailed Information About Finance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-5379-7385-aea7-58b10f0a2a94_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in financial assumptions</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial gains (losses) arising from changes in financial assumptions, net of tax, defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:to="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_019c4318-52e4-71b5-9fd0-6c9165a83cbb_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for share-based payment transactions [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_StatementOfChangesInEquityAbstract_label_en-US" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of changes in equity [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets_019c4318-5378-7d82-95a0-4fb0b43039ed_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity value</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill, revalued assets, at cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RetainedEarnings_019c4318-5379-7ac3-bf64-497c1b7877ca_terseLabel_en-US" xlink:label="lab_ifrs-full_RetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_ifrs-full_RetainedEarnings_label_en-US" xlink:label="lab_ifrs-full_RetainedEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarnings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarnings" xlink:to="lab_ifrs-full_RetainedEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MeasurementDomain_019c4318-53fc-7ad9-860e-abd3ac6efcf2_terseLabel_en-US" xlink:label="lab_ifrs-full_MeasurementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement [domain]</link:label>
    <link:label id="lab_ifrs-full_MeasurementDomain_label_en-US" xlink:label="lab_ifrs-full_MeasurementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementDomain" xlink:to="lab_ifrs-full_MeasurementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaximumExposureToCreditRisk_019c4318-53fc-7c87-a1ca-9bb33e39b532_terseLabel_en-US" xlink:label="lab_ifrs-full_MaximumExposureToCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum exposure to credit risk</link:label>
    <link:label id="lab_ifrs-full_MaximumExposureToCreditRisk_label_en-US" xlink:label="lab_ifrs-full_MaximumExposureToCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum exposure to credit risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaximumExposureToCreditRisk" xlink:to="lab_ifrs-full_MaximumExposureToCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-52e4-7a03-a7a9-dd868723bab5_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Financial Instruments [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock_019c4318-5379-7d51-bdb9-c4621e21422d_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Lease Liabilities</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Lease Liabilities [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of quantitative information about lease liabilities explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-52e4-7212-b3ee-030231681b8d_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</link:label>
    <link:label id="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_label_en-US" xlink:label="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</link:label>
    <link:label id="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_documentation_en-US" xlink:label="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of effect of changes in foreign exchange rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems" xlink:href="soph-20251231.xsd#soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems" xlink:to="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_019c4318-52e4-7c61-85ab-ecae4b69b7f9_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inflation</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of inflation [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_019c4318-52e4-717c-9c1d-0647b6dc5337_terseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_label_en-US" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_019c66d3-3ecc-771a-9823-6dfec11b2382_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revision of Prior Period, Adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_019caf67-919d-7f25-a071-01a70f7f91bd_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccruedLegalFees_019c4318-5379-718f-982e-1c2471a1cc94_terseLabel_en-US" xlink:label="lab_soph_AccruedLegalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued legal fees</link:label>
    <link:label id="lab_soph_AccruedLegalFees_label_en-US" xlink:label="lab_soph_AccruedLegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Legal Fees</link:label>
    <link:label id="lab_soph_AccruedLegalFees_documentation_en-US" xlink:label="lab_soph_AccruedLegalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued legal fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedLegalFees" xlink:href="soph-20251231.xsd#soph_AccruedLegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccruedLegalFees" xlink:to="lab_soph_AccruedLegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c4318-52e4-72ea-aa07-549d5ff2fd81_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiaries [axis]</link:label>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_label_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities_019c4318-52e4-710a-a7d5-4dbeba17b195_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest paid, classified as operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember_019c4318-52e4-7b11-8516-07b530898ca1_terseLabel_en-US" xlink:label="lab_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation &amp; amortization</link:label>
    <link:label id="lab_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember_label_en-US" xlink:label="lab_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation And Amortization Related Temporary Differences [Member]</link:label>
    <link:label id="lab_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember_documentation_en-US" xlink:label="lab_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary difference depreciation and amortization.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember" xlink:href="soph-20251231.xsd#soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember" xlink:to="lab_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_019c4318-5379-789f-8410-9c0729335865_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discount rates</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_019c4318-5379-720b-8f01-6d0218a331d0_verboseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Discount rates</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of discount rates [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DomicileOfEntity_019c4318-5379-78a8-b7b3-c603e5df8d71_terseLabel_en-US" xlink:label="lab_ifrs-full_DomicileOfEntity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Country of domicile</link:label>
    <link:label id="lab_ifrs-full_DomicileOfEntity_label_en-US" xlink:label="lab_ifrs-full_DomicileOfEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domicile of entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DomicileOfEntity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DomicileOfEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DomicileOfEntity" xlink:to="lab_ifrs-full_DomicileOfEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DeferredBenefitAbstract_019c4318-5379-7391-8931-2e6813805e5f_terseLabel_en-US" xlink:label="lab_soph_DeferredBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income tax (expense) benefit</link:label>
    <link:label id="lab_soph_DeferredBenefitAbstract_label_en-US" xlink:label="lab_soph_DeferredBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Benefit [Abstract]</link:label>
    <link:label id="lab_soph_DeferredBenefitAbstract_documentation_en-US" xlink:label="lab_soph_DeferredBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred benefit.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DeferredBenefitAbstract" xlink:href="soph-20251231.xsd#soph_DeferredBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DeferredBenefitAbstract" xlink:to="lab_soph_DeferredBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GeographicalAreasAxis_019c4318-5379-77cb-8654-9b4a5c3640c8_terseLabel_en-US" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical areas [axis]</link:label>
    <link:label id="lab_ifrs-full_GeographicalAreasAxis_label_en-US" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical areas [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasAxis" xlink:to="lab_ifrs-full_GeographicalAreasAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings_019c8a00-3163-7952-a065-c3cfe34d00a4_terseLabel_en-US" xlink:label="lab_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in cash interest costs</link:label>
    <link:label id="lab_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings_label_en-US" xlink:label="lab_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Borrowings, Interest Expense On Borrowings</link:label>
    <link:label id="lab_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings_documentation_en-US" xlink:label="lab_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowing of Increase in Cash Interest Costs on Annualized Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings" xlink:to="lab_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized_019c4318-5378-78c5-a99b-e5d697ab331e_terseLabel_en-US" xlink:label="lab_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future lease payments under short-term leases not recognized</link:label>
    <link:label id="lab_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized_label_en-US" xlink:label="lab_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Future Lease Payments Under Short Term Leases Not Recognized</link:label>
    <link:label id="lab_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized_documentation_en-US" xlink:label="lab_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Future lease payments under short-term leases not recognized.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized" xlink:href="soph-20251231.xsd#soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized" xlink:to="lab_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_RightOfUseAssetsDiscountedPaymentsRate_019c4318-52e4-785a-8cc7-4a8ce0d80bf6_terseLabel_en-US" xlink:label="lab_soph_RightOfUseAssetsDiscountedPaymentsRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets discounted payments rate</link:label>
    <link:label id="lab_soph_RightOfUseAssetsDiscountedPaymentsRate_label_en-US" xlink:label="lab_soph_RightOfUseAssetsDiscountedPaymentsRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-Of-Use Assets Discounted Payments Rate</link:label>
    <link:label id="lab_soph_RightOfUseAssetsDiscountedPaymentsRate_documentation_en-US" xlink:label="lab_soph_RightOfUseAssetsDiscountedPaymentsRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Right-of-use assets discounted payments rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RightOfUseAssetsDiscountedPaymentsRate" xlink:href="soph-20251231.xsd#soph_RightOfUseAssetsDiscountedPaymentsRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_RightOfUseAssetsDiscountedPaymentsRate" xlink:to="lab_soph_RightOfUseAssetsDiscountedPaymentsRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentLeaseLiabilities_019c4318-52e4-79ea-ab90-46f2401780c8_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities, net of current portion</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLeaseLiabilities_019c89ba-1c4f-72f4-8b27-9a03e8d7c8d1_verboseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Non-current lease liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_019c4318-52e4-70e2-8cdc-ca075fdd2e26_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of revenue from contracts with customers [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:to="lab_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_019c4318-5378-7452-a5e9-6fdecee41f38_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-5379-70c3-a921-d3ec9d50be48_terseLabel_en-US" xlink:label="lab_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes In Net Defined Benefit Liability (Asset) [Abstract]</link:label>
    <link:label id="lab_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_label_en-US" xlink:label="lab_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in net defined benefit liability (asset) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:to="lab_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_019c4318-5378-704e-8c1b-dd7a8337550e_terseLabel_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible assets other than goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_019c4318-5379-7abc-8d04-d4559e87d33e_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheDMember_019c758f-f3e1-7931-8f51-a03ece60a594_terseLabel_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tranche D</link:label>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheDMember_label_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Perceptive Credit Agreement, Tranche D [Member]</link:label>
    <link:label id="lab_soph_PerceptiveCreditAgreementTrancheDMember_documentation_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementTrancheDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Perceptive Credit Agreement, Tranche D</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheDMember" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PerceptiveCreditAgreementTrancheDMember" xlink:to="lab_soph_PerceptiveCreditAgreementTrancheDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SegmentsDomain_019c4318-52e4-7e80-944c-0d63d0da308c_terseLabel_en-US" xlink:label="lab_ifrs-full_SegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [domain]</link:label>
    <link:label id="lab_ifrs-full_SegmentsDomain_label_en-US" xlink:label="lab_ifrs-full_SegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentsDomain" xlink:to="lab_ifrs-full_SegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_019c4318-52e4-7ccb-b29d-78f20179e26a_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_019c4318-52e4-7873-9d92-a5a1d2389c59_periodStartLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at beginning of the year</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_019c4318-52e4-70ab-b444-5931a4cfe8c2_periodEndLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at end of the year</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_019c4318-52e4-7166-9c96-e7ccf3dc9b97_totalLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalents_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents" xlink:to="lab_ifrs-full_CashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_019c4318-52e4-77da-ac4f-702efd5aefe2_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_019c4318-52e4-7cad-b33e-31ac5f32f05e_terseLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase / (decrease) of equity in exchange rate</link:label>
    <link:label id="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_label_en-US" xlink:label="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve of exchange differences on translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:to="lab_ifrs-full_ReserveOfExchangeDifferencesOnTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CreditSuisseSAMember_019c4318-5379-7d29-9916-41a4861550e8_terseLabel_en-US" xlink:label="lab_soph_CreditSuisseSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Suisse SA</link:label>
    <link:label id="lab_soph_CreditSuisseSAMember_label_en-US" xlink:label="lab_soph_CreditSuisseSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Suisse SA [Member]</link:label>
    <link:label id="lab_soph_CreditSuisseSAMember_documentation_en-US" xlink:label="lab_soph_CreditSuisseSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Credit Suisse SA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CreditSuisseSAMember" xlink:href="soph-20251231.xsd#soph_CreditSuisseSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CreditSuisseSAMember" xlink:to="lab_soph_CreditSuisseSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_019c4318-5379-79ff-86d4-e21e0be8117f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Compensation for Key Management and Non-executive Directors</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_019c4318-5378-75f8-a9d4-cedc989e6653_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Allocation of the Loan Proceeds and Any Movements in the Liability</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about borrowings [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAndLiabilities_019c4318-5378-7d7e-8555-713312e81504_totalLabel_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_ifrs-full_EquityAndLiabilities_label_en-US" xlink:label="lab_ifrs-full_EquityAndLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity and liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="lab_ifrs-full_EquityAndLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_019c4318-5379-7ffc-9e0e-affeade194cd_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_019c4318-5379-7174-86ce-952863ecde1a_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-5379-739b-8331-6f6bdcbd8ab5_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPerformanceObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Performance Obligations [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPerformanceObligationsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPerformanceObligationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of performance obligations [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPerformanceObligationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems" xlink:to="lab_ifrs-full_DisclosureOfPerformanceObligationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BusinessCombinationsAxis_019c6cba-e8a3-7127-8536-f12a6a4191bc_terseLabel_en-US" xlink:label="lab_ifrs-full_BusinessCombinationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combinations [axis]</link:label>
    <link:label id="lab_ifrs-full_BusinessCombinationsAxis_label_en-US" xlink:label="lab_ifrs-full_BusinessCombinationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business combinations [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis" xlink:to="lab_ifrs-full_BusinessCombinationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_UnrecognizedDeferredTaxAssetsGross_019c4318-52e4-7cca-8037-176fc9158752_terseLabel_en-US" xlink:label="lab_soph_UnrecognizedDeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross amount</link:label>
    <link:label id="lab_soph_UnrecognizedDeferredTaxAssetsGross_label_en-US" xlink:label="lab_soph_UnrecognizedDeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Deferred Tax Assets Gross</link:label>
    <link:label id="lab_soph_UnrecognizedDeferredTaxAssetsGross_documentation_en-US" xlink:label="lab_soph_UnrecognizedDeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrecognized deferred tax assets gross.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_UnrecognizedDeferredTaxAssetsGross" xlink:href="soph-20251231.xsd#soph_UnrecognizedDeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_UnrecognizedDeferredTaxAssetsGross" xlink:to="lab_soph_UnrecognizedDeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent_019c4318-5379-7783-912f-c6356fcfb380_terseLabel_en-US" xlink:label="lab_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sensitivity analysis, change in exchange rate, percent</link:label>
    <link:label id="lab_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent_label_en-US" xlink:label="lab_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Reserve Of Exchange Differences On Translation, Reasonably Possible Change In Currency Variable, Percent</link:label>
    <link:label id="lab_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent_documentation_en-US" xlink:label="lab_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Reserve Of Exchange Differences On Translation, Reasonably Possible Change In Currency Variable, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent" xlink:to="lab_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BusinessCombinationsDomain_019c6cba-e8a3-7fb5-839f-c9010bbc659e_terseLabel_en-US" xlink:label="lab_ifrs-full_BusinessCombinationsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business combinations [domain]</link:label>
    <link:label id="lab_ifrs-full_BusinessCombinationsDomain_label_en-US" xlink:label="lab_ifrs-full_BusinessCombinationsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business combinations [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsDomain" xlink:to="lab_ifrs-full_BusinessCombinationsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfConditionalSharesAuthorised_019cad2f-01f6-7db8-b77e-d1c08eccd02a_terseLabel_en-US" xlink:label="lab_soph_NumberOfConditionalSharesAuthorised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of conditional share capital available for financing (in shares)</link:label>
    <link:label id="lab_soph_NumberOfConditionalSharesAuthorised_label_en-US" xlink:label="lab_soph_NumberOfConditionalSharesAuthorised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Conditional Shares Authorised</link:label>
    <link:label id="lab_soph_NumberOfConditionalSharesAuthorised_documentation_en-US" xlink:label="lab_soph_NumberOfConditionalSharesAuthorised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Conditional Shares Authorised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfConditionalSharesAuthorised" xlink:href="soph-20251231.xsd#soph_NumberOfConditionalSharesAuthorised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfConditionalSharesAuthorised" xlink:to="lab_soph_NumberOfConditionalSharesAuthorised" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_LeaseDirectCosts_019c4318-5379-7d3b-8d76-47cb2c397a39_terseLabel_en-US" xlink:label="lab_soph_LeaseDirectCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial direct costs to obtain lease</link:label>
    <link:label id="lab_soph_LeaseDirectCosts_label_en-US" xlink:label="lab_soph_LeaseDirectCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Direct Costs</link:label>
    <link:label id="lab_soph_LeaseDirectCosts_documentation_en-US" xlink:label="lab_soph_LeaseDirectCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Direct Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseDirectCosts" xlink:href="soph-20251231.xsd#soph_LeaseDirectCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_LeaseDirectCosts" xlink:to="lab_soph_LeaseDirectCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LongtermBorrowingsMember_019c4318-52e4-7431-b19e-50dbc2c3e5bb_terseLabel_en-US" xlink:label="lab_ifrs-full_LongtermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_ifrs-full_LongtermBorrowingsMember_label_en-US" xlink:label="lab_ifrs-full_LongtermBorrowingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-term borrowings [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowingsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowingsMember" xlink:to="lab_ifrs-full_LongtermBorrowingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestRateMeasurementInputMember_019c4318-52e4-7d13-a360-a7e2b9255f6e_terseLabel_en-US" xlink:label="lab_ifrs-full_InterestRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_ifrs-full_InterestRateMeasurementInputMember_label_en-US" xlink:label="lab_ifrs-full_InterestRateMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest rate, measurement input [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateMeasurementInputMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestRateMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestRateMeasurementInputMember" xlink:to="lab_ifrs-full_InterestRateMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DepreciationExpense_019c4318-52e4-76b9-85f3-61ce4b34b7c7_negatedLabel_en-US" xlink:label="lab_ifrs-full_DepreciationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_ifrs-full_DepreciationExpense_label_en-US" xlink:label="lab_ifrs-full_DepreciationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DepreciationExpense" xlink:to="lab_ifrs-full_DepreciationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-52e4-7637-80a9-39b50d9aa099_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Attribution Of Expenses By Nature To Their Function [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of attribution of expenses by nature to their function [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:to="lab_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-52e4-7a09-a36f-4a11682d9575_terseLabel_en-US" xlink:label="lab_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of RSUs</link:label>
    <link:label id="lab_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Other Equity Instruments In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_documentation_en-US" xlink:label="lab_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Other Equity Instruments In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:href="soph-20251231.xsd#soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:to="lab_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DifferencesOfCurrencyUSDAndCHFMember_019c4318-53fc-7fb0-bdcf-fc4c35ddcd10_terseLabel_en-US" xlink:label="lab_soph_DifferencesOfCurrencyUSDAndCHFMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">USD/CHF</link:label>
    <link:label id="lab_soph_DifferencesOfCurrencyUSDAndCHFMember_label_en-US" xlink:label="lab_soph_DifferencesOfCurrencyUSDAndCHFMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Differences Of Currency USD And CHF [Member]</link:label>
    <link:label id="lab_soph_DifferencesOfCurrencyUSDAndCHFMember_documentation_en-US" xlink:label="lab_soph_DifferencesOfCurrencyUSDAndCHFMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Differences of currency USD/CHF.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyUSDAndCHFMember" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyUSDAndCHFMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DifferencesOfCurrencyUSDAndCHFMember" xlink:to="lab_soph_DifferencesOfCurrencyUSDAndCHFMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_019c4318-5379-751a-bd7b-152ec85976ed_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Demographic assumptions increase in expected employee turnover rate</link:label>
    <link:label id="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_label_en-US" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial assumption of expected rates of inflation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CashAndCashEquivalentsAndTermDepositsMember_019c4318-5378-7fb1-887a-477d193453fa_terseLabel_en-US" xlink:label="lab_soph_CashAndCashEquivalentsAndTermDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalents and Term Deposits</link:label>
    <link:label id="lab_soph_CashAndCashEquivalentsAndTermDepositsMember_label_en-US" xlink:label="lab_soph_CashAndCashEquivalentsAndTermDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash And Cash Equivalents And Term Deposits [Member]</link:label>
    <link:label id="lab_soph_CashAndCashEquivalentsAndTermDepositsMember_documentation_en-US" xlink:label="lab_soph_CashAndCashEquivalentsAndTermDepositsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, term deposits and short-term investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CashAndCashEquivalentsAndTermDepositsMember" xlink:href="soph-20251231.xsd#soph_CashAndCashEquivalentsAndTermDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CashAndCashEquivalentsAndTermDepositsMember" xlink:to="lab_soph_CashAndCashEquivalentsAndTermDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NonCurrentDepositsGuarantyAssets_019c4318-5379-72fb-b4cd-8caecd464ee4_terseLabel_en-US" xlink:label="lab_soph_NonCurrentDepositsGuarantyAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantee deposits</link:label>
    <link:label id="lab_soph_NonCurrentDepositsGuarantyAssets_label_en-US" xlink:label="lab_soph_NonCurrentDepositsGuarantyAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Current Deposits Guaranty Assets</link:label>
    <link:label id="lab_soph_NonCurrentDepositsGuarantyAssets_documentation_en-US" xlink:label="lab_soph_NonCurrentDepositsGuarantyAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Current Deposits Guaranty Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NonCurrentDepositsGuarantyAssets" xlink:href="soph-20251231.xsd#soph_NonCurrentDepositsGuarantyAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NonCurrentDepositsGuarantyAssets" xlink:to="lab_soph_NonCurrentDepositsGuarantyAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm_019c4318-53fc-78ca-a8be-4dc528d2a84f_terseLabel_en-US" xlink:label="lab_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Extended term of payment agreements for products and services sold</link:label>
    <link:label id="lab_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm_label_en-US" xlink:label="lab_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue From Contracts With Customers, Extended Payment Term</link:label>
    <link:label id="lab_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm_documentation_en-US" xlink:label="lab_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue From Contracts With Customers, Extended Payment Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm" xlink:href="soph-20251231.xsd#soph_RevenueFromContractsWithCustomersExtendedPaymentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm" xlink:to="lab_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019c4318-5379-79e4-9e7b-2d5bcc375b2f_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SophiaGeneticsSRLMember_019c4318-5378-7cdd-843b-37f3e1967940_terseLabel_en-US" xlink:label="lab_soph_SophiaGeneticsSRLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SOPHiA GENETICS S.R.L.</link:label>
    <link:label id="lab_soph_SophiaGeneticsSRLMember_label_en-US" xlink:label="lab_soph_SophiaGeneticsSRLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sophia Genetics S R L [Member]</link:label>
    <link:label id="lab_soph_SophiaGeneticsSRLMember_documentation_en-US" xlink:label="lab_soph_SophiaGeneticsSRLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sophia Genetics S.R.L.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsSRLMember" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsSRLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SophiaGeneticsSRLMember" xlink:to="lab_soph_SophiaGeneticsSRLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_019c4318-52e4-7caa-a4f5-1162d7133dab_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Prepaids and Other Current Assets</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information Of Prepayments And Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information of other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock_019c7277-61bc-7771-9f2f-ad024f93f131_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Cost Of Sales [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Cost Of Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_019c4318-52e4-7ca8-b787-ed1617238e39_terseLabel_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful life of property and equipment</link:label>
    <link:label id="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Useful life measured as period of time, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_019c4318-52e4-73dd-8dd9-26b74fdb49e0_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of financial liabilities [domain]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial liabilities [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:to="lab_ifrs-full_CategoriesOfFinancialLiabilitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanFiveYearsMember_019c4318-5379-7334-b0a0-81948bd2c959_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">After 5 years</link:label>
    <link:label id="lab_ifrs-full_LaterThanFiveYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than five years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_019c4318-5379-7e6a-8ffe-f681fef5065d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related parties</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of related party [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="lab_ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-52e4-73ff-ba26-91990a62cdb9_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of financial assets [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfFinancialAssetsDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of financial assets [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_019c4318-5378-764f-b240-29d7000c490c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of intangible assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory_019c4318-52e4-7eb9-892b-61f2e17e1acc_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of cost of sales [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCostOfSalesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment_019c4318-52e4-7322-acdc-a0173ef2ebe0_terseLabel_en-US" xlink:label="lab_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses for property and equipment</link:label>
    <link:label id="lab_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment_label_en-US" xlink:label="lab_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Accrued Expenses On Property, Plant And Equipment</link:label>
    <link:label id="lab_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment_documentation_en-US" xlink:label="lab_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current Accrued Expenses On Property, Plant And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment" xlink:href="soph-20251231.xsd#soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment" xlink:to="lab_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Level3OfFairValueHierarchyMember_019c4318-53fc-7d7c-9f7b-cd9a3fe0c977_terseLabel_en-US" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_ifrs-full_Level3OfFairValueHierarchyMember_label_en-US" xlink:label="lab_ifrs-full_Level3OfFairValueHierarchyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Level 3 of fair value hierarchy [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Level3OfFairValueHierarchyMember" xlink:to="lab_ifrs-full_Level3OfFairValueHierarchyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentValueAddedTaxReceivables_019c4318-5378-7b95-a806-46457bed76c3_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentValueAddedTaxReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">VAT receivable</link:label>
    <link:label id="lab_ifrs-full_CurrentValueAddedTaxReceivables_label_en-US" xlink:label="lab_ifrs-full_CurrentValueAddedTaxReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current value added tax receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentValueAddedTaxReceivables" xlink:to="lab_ifrs-full_CurrentValueAddedTaxReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_019c4318-5378-7263-8d9b-b5cef7d15f1f_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Recognized in OCI</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income tax relating to components of other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:to="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_019c4318-5379-73b7-b023-2f01f0f33068_negatedLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnLeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense on lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SophiaGeneticsSASMember_019c4318-5379-7405-ac48-e1613d45287e_verboseLabel_en-US" xlink:label="lab_soph_SophiaGeneticsSASMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">SOPHiA GENETICS S.A.S.</link:label>
    <link:label id="lab_soph_SophiaGeneticsSASMember_019c4318-5379-726f-8be8-ec8158f947d9_terseLabel_en-US" xlink:label="lab_soph_SophiaGeneticsSASMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">French subsidiary</link:label>
    <link:label id="lab_soph_SophiaGeneticsSASMember_label_en-US" xlink:label="lab_soph_SophiaGeneticsSASMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sophia Genetics S A S [Member]</link:label>
    <link:label id="lab_soph_SophiaGeneticsSASMember_documentation_en-US" xlink:label="lab_soph_SophiaGeneticsSASMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sophia Genetics SAS.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsSASMember" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsSASMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SophiaGeneticsSASMember" xlink:to="lab_soph_SophiaGeneticsSASMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_UnobservableInputsAxis_019c4318-5378-7aa2-aad9-d62f5962165d_terseLabel_en-US" xlink:label="lab_ifrs-full_UnobservableInputsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unobservable inputs [axis]</link:label>
    <link:label id="lab_ifrs-full_UnobservableInputsAxis_label_en-US" xlink:label="lab_ifrs-full_UnobservableInputsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unobservable inputs [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UnobservableInputsAxis" xlink:to="lab_ifrs-full_UnobservableInputsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_019c4318-52e4-78d7-884c-afae72c80a66_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CostOfRevenue1Member_019c71bd-8539-7c0d-a8c5-2839a42fb78a_terseLabel_en-US" xlink:label="lab_soph_CostOfRevenue1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_soph_CostOfRevenue1Member_label_en-US" xlink:label="lab_soph_CostOfRevenue1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost Of Revenue1 [Member]</link:label>
    <link:label id="lab_soph_CostOfRevenue1Member_documentation_en-US" xlink:label="lab_soph_CostOfRevenue1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cost Of Revenue1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CostOfRevenue1Member" xlink:href="soph-20251231.xsd#soph_CostOfRevenue1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CostOfRevenue1Member" xlink:to="lab_soph_CostOfRevenue1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_LeaseTerm_019c4318-5379-7e4f-9096-2bcc953989bf_terseLabel_en-US" xlink:label="lab_soph_LeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_soph_LeaseTerm_label_en-US" xlink:label="lab_soph_LeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Term</link:label>
    <link:label id="lab_soph_LeaseTerm_documentation_en-US" xlink:label="lab_soph_LeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease term.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseTerm" xlink:href="soph-20251231.xsd#soph_LeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_LeaseTerm" xlink:to="lab_soph_LeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DecreaseThroughWriteoffFinancialAssets_019c4318-52e4-793e-a8eb-5d910d77cd77_verboseLabel_en-US" xlink:label="lab_ifrs-full_DecreaseThroughWriteoffFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Write-off</link:label>
    <link:label id="lab_ifrs-full_DecreaseThroughWriteoffFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_DecreaseThroughWriteoffFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Decrease through write-off, financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughWriteoffFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets" xlink:to="lab_ifrs-full_DecreaseThroughWriteoffFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019c4318-5379-7f9c-8661-3a7e79db3164_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantRightsTrancheDMember_019c81e4-e1d8-70e5-a00c-9f19df463f1b_terseLabel_en-US" xlink:label="lab_soph_WarrantRightsTrancheDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche D</link:label>
    <link:label id="lab_soph_WarrantRightsTrancheDMember_label_en-US" xlink:label="lab_soph_WarrantRightsTrancheDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche D [Member]</link:label>
    <link:label id="lab_soph_WarrantRightsTrancheDMember_documentation_en-US" xlink:label="lab_soph_WarrantRightsTrancheDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche D</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheDMember" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantRightsTrancheDMember" xlink:to="lab_soph_WarrantRightsTrancheDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_019c4318-52e4-7cca-9cbc-3aa9a3ac8f87_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other receivables [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccruedProfessionalFees_019c4318-5378-79f1-a4e3-7efef5319249_terseLabel_en-US" xlink:label="lab_soph_AccruedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_soph_AccruedProfessionalFees_label_en-US" xlink:label="lab_soph_AccruedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees</link:label>
    <link:label id="lab_soph_AccruedProfessionalFees_documentation_en-US" xlink:label="lab_soph_AccruedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued professional fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedProfessionalFees" xlink:href="soph-20251231.xsd#soph_AccruedProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccruedProfessionalFees" xlink:to="lab_soph_AccruedProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfLeases_019c4318-52e4-7458-a9b0-cb73b5a9687e_terseLabel_en-US" xlink:label="lab_soph_NumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of leases</link:label>
    <link:label id="lab_soph_NumberOfLeases_label_en-US" xlink:label="lab_soph_NumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Leases</link:label>
    <link:label id="lab_soph_NumberOfLeases_documentation_en-US" xlink:label="lab_soph_NumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfLeases" xlink:href="soph-20251231.xsd#soph_NumberOfLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfLeases" xlink:to="lab_soph_NumberOfLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_IncreaseDecreaseInNumberOfSharesAuthorised_019cb01f-c48d-7b6e-b985-e8db36917416_terseLabel_en-US" xlink:label="lab_soph_IncreaseDecreaseInNumberOfSharesAuthorised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized increase in nominal share capital issuance (in shares)</link:label>
    <link:label id="lab_soph_IncreaseDecreaseInNumberOfSharesAuthorised_label_en-US" xlink:label="lab_soph_IncreaseDecreaseInNumberOfSharesAuthorised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Number Of Shares Authorised</link:label>
    <link:label id="lab_soph_IncreaseDecreaseInNumberOfSharesAuthorised_documentation_en-US" xlink:label="lab_soph_IncreaseDecreaseInNumberOfSharesAuthorised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Number Of Shares Authorised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseInNumberOfSharesAuthorised" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseInNumberOfSharesAuthorised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_IncreaseDecreaseInNumberOfSharesAuthorised" xlink:to="lab_soph_IncreaseDecreaseInNumberOfSharesAuthorised" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GoodwillMember_019c4318-5378-7d75-b824-e6cf9204c9b2_terseLabel_en-US" xlink:label="lab_ifrs-full_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_ifrs-full_GoodwillMember_label_en-US" xlink:label="lab_ifrs-full_GoodwillMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodwillMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GoodwillMember" xlink:to="lab_ifrs-full_GoodwillMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_019c4318-52e4-70d6-b8b7-f4b7fec73199_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option life, share options granted</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_019c4318-52e4-7b53-bed8-20fb05788704_verboseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Life of option</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option life, share options granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:to="lab_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c4318-5378-7ad7-a076-4f60e475f177_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash flows used in operating activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c4318-5378-7ec1-9347-575ca42a6ecf_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinishedGoods_019c4318-52e4-79ff-864d-bd237046d8a6_terseLabel_en-US" xlink:label="lab_ifrs-full_FinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_ifrs-full_FinishedGoods_label_en-US" xlink:label="lab_ifrs-full_FinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current finished goods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinishedGoods" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinishedGoods" xlink:to="lab_ifrs-full_FinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock_019c4318-52e4-758e-b91d-595ad5debf6c_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting policies</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Accounting Policies [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for Accounting policies explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_019c4318-5378-7549-a060-321ac6734ec9_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_label_en-US" xlink:label="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of other equity instruments forfeited in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-52e4-77b1-b2e2-4d5443e4893d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfOperatingExpenseTextBlock_019c4318-5378-757a-83a9-f2637ecdd07c_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfOperatingExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expense</link:label>
    <link:label id="lab_soph_DisclosureOfOperatingExpenseTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfOperatingExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Operating Expense [Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfOperatingExpenseTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfOperatingExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of operating expense explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfOperatingExpenseTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfOperatingExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfOperatingExpenseTextBlock" xlink:to="lab_soph_DisclosureOfOperatingExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentLiabilitiesAbstract_019c4318-52e4-7d45-b7cb-9da61219bf3b_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current liabilities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="lab_ifrs-full_NoncurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NameOfSubsidiary_019c4318-52e4-7a7a-8c19-2ec25f74e0c6_terseLabel_en-US" xlink:label="lab_ifrs-full_NameOfSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ifrs-full_NameOfSubsidiary_label_en-US" xlink:label="lab_ifrs-full_NameOfSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Name of subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NameOfSubsidiary" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NameOfSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NameOfSubsidiary" xlink:to="lab_ifrs-full_NameOfSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_019caf67-919d-76b0-b48f-d6be996f39cc_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_019c4318-5378-785d-8aed-a3be3f2b5719_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of share-based payment arrangements [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement_019caf53-cb59-79a8-ac0f-d4a527d28e4c_terseLabel_en-US" xlink:label="lab_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of conditional share capital available for employee participation (in shares)</link:label>
    <link:label id="lab_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Conditional Shares Authorised In Share-Based Payment Arrangement</link:label>
    <link:label id="lab_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Conditional Shares Authorised In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement" xlink:href="soph-20251231.xsd#soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement" xlink:to="lab_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_019c4318-52e4-74b7-b02a-58e5b336cacb_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-52e4-7235-993d-1612fc5f9521_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments for non-monetary items</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile profit (loss) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory_019c4318-52e4-7fed-9e05-85d798dbe947_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of prepayments and other assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_019c4318-5379-7248-84fa-6c5e21f10381_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined benefit pension liabilities</link:label>
    <link:label id="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_label_en-US" xlink:label="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current net defined benefit liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:to="lab_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantsOrRightsNumberOfWarrantsIssued_019c7510-0426-78bf-8417-4edb1dc06595_terseLabel_en-US" xlink:label="lab_soph_WarrantsOrRightsNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of warrants (in shares)</link:label>
    <link:label id="lab_soph_WarrantsOrRightsNumberOfWarrantsIssued_label_en-US" xlink:label="lab_soph_WarrantsOrRightsNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Or Rights, Number Of Warrants Issued</link:label>
    <link:label id="lab_soph_WarrantsOrRightsNumberOfWarrantsIssued_documentation_en-US" xlink:label="lab_soph_WarrantsOrRightsNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issue of During the Shares Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfWarrantsIssued" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfWarrantsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantsOrRightsNumberOfWarrantsIssued" xlink:to="lab_soph_WarrantsOrRightsNumberOfWarrantsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_019c4318-52e4-75db-89e7-369628e303fe_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Financial Instruments</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NorthAmericaMember_019c4318-5378-7650-a3fe-c04f4f7b1933_terseLabel_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NORAM</link:label>
    <link:label id="lab_srt_NorthAmericaMember_label_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">North America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NorthAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NorthAmericaMember" xlink:to="lab_srt_NorthAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock_019c4318-5378-73c2-82aa-79e85f373362_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Going concern basis</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Going Concern Basis [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for going concern basis explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DifferencesOfCurrencyGBPAndCHFMember_019c4318-5379-7d72-9c66-1d02e0e3999d_terseLabel_en-US" xlink:label="lab_soph_DifferencesOfCurrencyGBPAndCHFMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GBP/CHF</link:label>
    <link:label id="lab_soph_DifferencesOfCurrencyGBPAndCHFMember_label_en-US" xlink:label="lab_soph_DifferencesOfCurrencyGBPAndCHFMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Differences Of Currency GBP And CHF [Member]</link:label>
    <link:label id="lab_soph_DifferencesOfCurrencyGBPAndCHFMember_documentation_en-US" xlink:label="lab_soph_DifferencesOfCurrencyGBPAndCHFMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Differences of Currency GBP/CHF.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyGBPAndCHFMember" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyGBPAndCHFMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DifferencesOfCurrencyGBPAndCHFMember" xlink:to="lab_soph_DifferencesOfCurrencyGBPAndCHFMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LeaseholdImprovementsMember_019c4318-5379-785c-ad36-3a0e66927556_terseLabel_en-US" xlink:label="lab_ifrs-full_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_ifrs-full_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_ifrs-full_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold improvements [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseholdImprovementsMember" xlink:to="lab_ifrs-full_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-53fc-78b3-abdc-1c110a17e6b5_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current income tax expense</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-53fc-7a5d-90c3-d5f3a3525d83_verboseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current tax expense (income) and adjustments for current tax of prior periods [abstract]</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax expense (income) and adjustments for current tax of prior periods [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-5378-706b-ab2e-0b31b3868116_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-5378-7107-a0c5-330bec59527f_totalLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current trade payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensation_019c4318-52e4-79f3-8f7f-673d0b929f1d_totalLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensation_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensation" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_EmployeeRelatedPayables_019c4318-52e4-7520-ada9-564842245796_terseLabel_en-US" xlink:label="lab_soph_EmployeeRelatedPayables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee related payables</link:label>
    <link:label id="lab_soph_EmployeeRelatedPayables_label_en-US" xlink:label="lab_soph_EmployeeRelatedPayables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Related Payables</link:label>
    <link:label id="lab_soph_EmployeeRelatedPayables_documentation_en-US" xlink:label="lab_soph_EmployeeRelatedPayables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee related payables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_EmployeeRelatedPayables" xlink:href="soph-20251231.xsd#soph_EmployeeRelatedPayables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_EmployeeRelatedPayables" xlink:to="lab_soph_EmployeeRelatedPayables" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ChangesInBorrowingsAbstract_019c8204-586b-7990-90e0-b1e2cea02535_terseLabel_en-US" xlink:label="lab_soph_ChangesInBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes In Borrowings [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInBorrowingsAbstract_label_en-US" xlink:label="lab_soph_ChangesInBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes In Borrowings [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInBorrowingsAbstract_documentation_en-US" xlink:label="lab_soph_ChangesInBorrowingsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Changes In Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInBorrowingsAbstract" xlink:href="soph-20251231.xsd#soph_ChangesInBorrowingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ChangesInBorrowingsAbstract" xlink:to="lab_soph_ChangesInBorrowingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfInventoriesAbstract_label_en-US" xlink:label="lab_ifrs-full_ClassesOfInventoriesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of current inventories [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract" xlink:to="lab_ifrs-full_ClassesOfInventoriesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_019c4318-52e4-7d88-87bf-6caa9ab8a707_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Defined Benefit Plans Assets</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of defined benefit plans [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OrdinarySharesMember_019c4318-5379-7a1e-aedc-4df64c425035_terseLabel_en-US" xlink:label="lab_ifrs-full_OrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary Shares</link:label>
    <link:label id="lab_ifrs-full_OrdinarySharesMember_label_en-US" xlink:label="lab_ifrs-full_OrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Ordinary shares [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OrdinarySharesMember" xlink:to="lab_ifrs-full_OrdinarySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage_019c8a00-3163-7696-ad76-5d105f846ae4_terseLabel_en-US" xlink:label="lab_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis point change in interest rate</link:label>
    <link:label id="lab_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage_label_en-US" xlink:label="lab_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Borrowings, Reasonably Possible Change In Interest Rate, Percentage</link:label>
    <link:label id="lab_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage_documentation_en-US" xlink:label="lab_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sensitivity Analysis For Borrowings, Reasonably Possible Change In Interest Rate, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage" xlink:to="lab_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_019c4318-52e4-7acb-9583-c3bfe3b3936a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss per share</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of earnings per share [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_019c4318-52e4-7b25-b0f5-40e1bbf72b54_terseLabel_en-US" xlink:label="lab_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share options exercised and vesting of Restricted Stock Units (in shares)</link:label>
    <link:label id="lab_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Share Options Exercised And Other Equity Instruments Vested In Share-Based Payment Arrangement</link:label>
    <link:label id="lab_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Share Options Exercised And Other Equity Instruments Vested In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:href="soph-20251231.xsd#soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:to="lab_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_GrossCarryingAmountMember_019c4318-5378-74c4-9d67-d82dd01eef2d_terseLabel_en-US" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross carrying amount</link:label>
    <link:label id="lab_ifrs-full_GrossCarryingAmountMember_019c4318-5378-754e-af35-39104a833300_verboseLabel_en-US" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net carrying amount</link:label>
    <link:label id="lab_ifrs-full_GrossCarryingAmountMember_label_en-US" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross carrying amount [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember" xlink:to="lab_ifrs-full_GrossCarryingAmountMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfInventoriesExplanatory_019c4318-5378-7e81-8dec-cbc98f8e956f_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfInventoriesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfInventoriesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of inventories [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInventoriesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfInventoriesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ShareBasedPaymentArrangementVestingTrancheOneMember_019c4318-53fc-785b-a002-83465d11e76d_terseLabel_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementVestingTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Tranche One</link:label>
    <link:label id="lab_soph_ShareBasedPaymentArrangementVestingTrancheOneMember_label_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementVestingTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Vesting Tranche One [Member]</link:label>
    <link:label id="lab_soph_ShareBasedPaymentArrangementVestingTrancheOneMember_documentation_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementVestingTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Vesting Tranche One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementVestingTrancheOneMember" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementVestingTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ShareBasedPaymentArrangementVestingTrancheOneMember" xlink:to="lab_soph_ShareBasedPaymentArrangementVestingTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_019c4318-52e4-7923-b3d9-e8209f8bbb26_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for intangible assets and goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019c4318-5379-71c0-94ad-82a4c10dc66b_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromIssuingShares_019c74af-f429-78b5-80e9-eff8f01bd8d6_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of common stock in at-the-market offering</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromIssuingShares_019caf5c-df0c-7915-8bc6-5a9d2cc35a66_verboseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gross proceeds from shares sold under ATM program</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromIssuingShares_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from issuing shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NotLaterThanOneYearMember_019c4318-52e4-79ae-97c3-aceaea798ba2_verboseLabel_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Within 1 year</link:label>
    <link:label id="lab_ifrs-full_NotLaterThanOneYearMember_label_en-US" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not later than one year [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ChangesInProvisionOfInventoryAbstract_019c4318-5379-7131-973a-93efae817a26_terseLabel_en-US" xlink:label="lab_soph_ChangesInProvisionOfInventoryAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes In Provision Of Inventory [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInProvisionOfInventoryAbstract_label_en-US" xlink:label="lab_soph_ChangesInProvisionOfInventoryAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes In Provision Of Inventory [Abstract]</link:label>
    <link:label id="lab_soph_ChangesInProvisionOfInventoryAbstract_documentation_en-US" xlink:label="lab_soph_ChangesInProvisionOfInventoryAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Changes In Provision Of Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInProvisionOfInventoryAbstract" xlink:href="soph-20251231.xsd#soph_ChangesInProvisionOfInventoryAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ChangesInProvisionOfInventoryAbstract" xlink:to="lab_soph_ChangesInProvisionOfInventoryAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsThereafter_019c4318-5379-73b6-bd23-3fb30f44537b_terseLabel_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter and unlimited</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsThereafter_label_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Operating Loss Carryforwards, Thereafter</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsThereafter_documentation_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards thereafter and unlimited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsThereafter" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NetOperatingLossCarryforwardsThereafter" xlink:to="lab_soph_NetOperatingLossCarryforwardsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_019c9fe3-86b5-7159-86fa-4325ae3d6209_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value through statement of loss</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities at fair value through profit or loss, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember_019c4318-5378-74a8-bdc2-039efe47a314_terseLabel_en-US" xlink:label="lab_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember_label_en-US" xlink:label="lab_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Liabilities Related Temporary Differences [Member]</link:label>
    <link:label id="lab_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember_documentation_en-US" xlink:label="lab_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary difference lease liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember" xlink:href="soph-20251231.xsd#soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember" xlink:to="lab_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LongtermBorrowings_019c4318-52e4-7202-aa21-3bdd18bbf9f8_terseLabel_en-US" xlink:label="lab_ifrs-full_LongtermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_ifrs-full_LongtermBorrowings_label_en-US" xlink:label="lab_ifrs-full_LongtermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current portion of non-current borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings" xlink:to="lab_ifrs-full_LongtermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_019c4318-5379-7fee-8ad1-a24eee3c0073_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Decrease (increase) in inventory</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for decrease (increase) in inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_019c4318-53fc-778c-be76-ad6f15510558_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for property, plant and equipment [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis_019c4318-5379-739c-b101-c18dc49ae2f6_terseLabel_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period on annual basis</link:label>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis_label_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Period Of Share Based Payment Arrangement Option On Annual Basis</link:label>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis_documentation_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Period Of Share Based Payment Arrangement Option On Each Anniversary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" xlink:to="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_019c4318-52e4-7dc1-a6b0-17eb0acdf970_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from borrowings, net of transaction costs</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from borrowings, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_019c4318-52e4-7a54-bb5e-fbd9f9341885_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments of principal portion of lease liabilities</link:label>
    <link:label id="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_label_en-US" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_019c4318-5379-76ce-8ed5-b0006de5b2e6_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentWarrantLiability_019c4318-5378-7233-8b82-a847c2f46592_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant obligations</link:label>
    <link:label id="lab_ifrs-full_CurrentWarrantLiability_019c7510-7ff0-7bc1-8568-f7041b0f8fd9_periodStartLabel_en-US" xlink:label="lab_ifrs-full_CurrentWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginnings balances</link:label>
    <link:label id="lab_ifrs-full_CurrentWarrantLiability_019c7510-3642-783b-a5dd-1cc6d7ed37f1_periodEndLabel_en-US" xlink:label="lab_ifrs-full_CurrentWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balances</link:label>
    <link:label id="lab_ifrs-full_CurrentWarrantLiability_label_en-US" xlink:label="lab_ifrs-full_CurrentWarrantLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current warrant liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentWarrantLiability" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentWarrantLiability" xlink:to="lab_ifrs-full_CurrentWarrantLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_019c4318-52e4-78be-a8a9-4ed065eb5b34_terseLabel_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase</link:label>
    <link:label id="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment loss recognised in profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_019c4318-5378-7204-be50-3d1d2754f939_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Additional Details on Defined Benefit Plans Funded Status</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of additional information about defined benefit plans [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccruedCompensation_019c4318-52e4-71b2-bb5d-b5a4d30f5594_terseLabel_en-US" xlink:label="lab_soph_AccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_soph_AccruedCompensation_label_en-US" xlink:label="lab_soph_AccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Compensation</link:label>
    <link:label id="lab_soph_AccruedCompensation_documentation_en-US" xlink:label="lab_soph_AccruedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued compensation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedCompensation" xlink:href="soph-20251231.xsd#soph_AccruedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccruedCompensation" xlink:to="lab_soph_AccruedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SophiaGeneticsIncMember_019c4318-52e4-704a-a691-acc8a8cde27e_terseLabel_en-US" xlink:label="lab_soph_SophiaGeneticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SOPHiA GENETICS, Inc.</link:label>
    <link:label id="lab_soph_SophiaGeneticsIncMember_label_en-US" xlink:label="lab_soph_SophiaGeneticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sophia Genetics Inc [Member]</link:label>
    <link:label id="lab_soph_SophiaGeneticsIncMember_documentation_en-US" xlink:label="lab_soph_SophiaGeneticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sophia Genetics Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsIncMember" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SophiaGeneticsIncMember" xlink:to="lab_soph_SophiaGeneticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_UBSSwitzerlandAGMember_019c9691-cf99-743c-aa81-806b27fe5f1a_terseLabel_en-US" xlink:label="lab_soph_UBSSwitzerlandAGMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UBS Switzerland AG</link:label>
    <link:label id="lab_soph_UBSSwitzerlandAGMember_label_en-US" xlink:label="lab_soph_UBSSwitzerlandAGMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UBS Switzerland AG [Member]</link:label>
    <link:label id="lab_soph_UBSSwitzerlandAGMember_documentation_en-US" xlink:label="lab_soph_UBSSwitzerlandAGMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">UBS Switzerland AG</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_UBSSwitzerlandAGMember" xlink:href="soph-20251231.xsd#soph_UBSSwitzerlandAGMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_UBSSwitzerlandAGMember" xlink:to="lab_soph_UBSSwitzerlandAGMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019c4318-5379-760e-8b58-2a8a28ee3bd5_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RawMaterials_019c4318-52e4-776e-be3e-aea5dec46e9a_terseLabel_en-US" xlink:label="lab_ifrs-full_RawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_ifrs-full_RawMaterials_label_en-US" xlink:label="lab_ifrs-full_RawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current raw materials</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RawMaterials" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RawMaterials" xlink:to="lab_ifrs-full_RawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BasicEarningsLossPerShare_019c4318-53fc-7fbe-be10-9f5e4cc8b818_terseLabel_en-US" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic loss per share (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_BasicEarningsLossPerShare_label_en-US" xlink:label="lab_ifrs-full_BasicEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basic earnings (loss) per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShare" xlink:to="lab_ifrs-full_BasicEarningsLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MeasurementAxis_019c4318-5378-7fdc-803b-cae79c21734c_terseLabel_en-US" xlink:label="lab_ifrs-full_MeasurementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement [axis]</link:label>
    <link:label id="lab_ifrs-full_MeasurementAxis_label_en-US" xlink:label="lab_ifrs-full_MeasurementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementAxis" xlink:to="lab_ifrs-full_MeasurementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DifferencesOfCurrencyEURAndCHFMember_019c4318-52e4-787e-bc1f-3ba2ade0c0cc_terseLabel_en-US" xlink:label="lab_soph_DifferencesOfCurrencyEURAndCHFMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EUR/CHF</link:label>
    <link:label id="lab_soph_DifferencesOfCurrencyEURAndCHFMember_label_en-US" xlink:label="lab_soph_DifferencesOfCurrencyEURAndCHFMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Differences Of Currency EUR And CHF [Member]</link:label>
    <link:label id="lab_soph_DifferencesOfCurrencyEURAndCHFMember_documentation_en-US" xlink:label="lab_soph_DifferencesOfCurrencyEURAndCHFMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Differences of Currency EUR/CHF.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyEURAndCHFMember" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyEURAndCHFMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DifferencesOfCurrencyEURAndCHFMember" xlink:to="lab_soph_DifferencesOfCurrencyEURAndCHFMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ScheduleOfIntangibleAssetsTable_019c4318-5379-7775-82a7-f9dc397f367e_terseLabel_en-US" xlink:label="lab_soph_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule Of Intangible Assets [Table]</link:label>
    <link:label id="lab_soph_ScheduleOfIntangibleAssetsTable_label_en-US" xlink:label="lab_soph_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Intangible Assets [Table]</link:label>
    <link:label id="lab_soph_ScheduleOfIntangibleAssetsTable_documentation_en-US" xlink:label="lab_soph_ScheduleOfIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of intangible assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ScheduleOfIntangibleAssetsTable" xlink:href="soph-20251231.xsd#soph_ScheduleOfIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ScheduleOfIntangibleAssetsTable" xlink:to="lab_soph_ScheduleOfIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustedWeightedAverageShares_019c4318-5379-791d-b500-477b5400f0a7_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average number of shares in issue, diluted (in shares)</link:label>
    <link:label id="lab_ifrs-full_AdjustedWeightedAverageShares_label_en-US" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average number of ordinary shares used in calculating diluted earnings per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearThree_019c4318-52e4-73f0-b0d6-3079196ea758_terseLabel_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Three years</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearThree_label_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Operating Loss Carryforwards, Year Three</link:label>
    <link:label id="lab_soph_NetOperatingLossCarryforwardsYearThree_documentation_en-US" xlink:label="lab_soph_NetOperatingLossCarryforwardsYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards year three.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearThree" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NetOperatingLossCarryforwardsYearThree" xlink:to="lab_soph_NetOperatingLossCarryforwardsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantRightsTrancheBMember_019c4318-5379-73fd-92b7-cb643a71f8c6_terseLabel_en-US" xlink:label="lab_soph_WarrantRightsTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche B</link:label>
    <link:label id="lab_soph_WarrantRightsTrancheBMember_label_en-US" xlink:label="lab_soph_WarrantRightsTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche B [Member]</link:label>
    <link:label id="lab_soph_WarrantRightsTrancheBMember_documentation_en-US" xlink:label="lab_soph_WarrantRightsTrancheBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Rights, Tranche B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheBMember" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantRightsTrancheBMember" xlink:to="lab_soph_WarrantRightsTrancheBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_019c4318-52e4-7468-b922-5cdca1df50b8_negatedLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Origination and reversal of temporary differences</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax expense (income) relating to origination and reversal of temporary differences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_019c66d3-3ecc-76cd-b499-6aedcdb7f72e_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_FinancialAssetsAccountsReceivableMember_019c4318-52e4-7bd0-bee9-4a92cfd8e170_terseLabel_en-US" xlink:label="lab_soph_FinancialAssetsAccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_soph_FinancialAssetsAccountsReceivableMember_label_en-US" xlink:label="lab_soph_FinancialAssetsAccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Assets, Accounts Receivable [Member]</link:label>
    <link:label id="lab_soph_FinancialAssetsAccountsReceivableMember_documentation_en-US" xlink:label="lab_soph_FinancialAssetsAccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Assets, Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FinancialAssetsAccountsReceivableMember" xlink:href="soph-20251231.xsd#soph_FinancialAssetsAccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_FinancialAssetsAccountsReceivableMember" xlink:to="lab_soph_FinancialAssetsAccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForSharebasedPayments_019c4318-5379-74f0-aa47-8c1611da5eb8_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForSharebasedPayments_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for share-based payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c81d5-76eb-727c-a8fe-316a64beb02f_terseLabel_en-US" xlink:label="lab_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional borrowings</link:label>
    <link:label id="lab_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_label_en-US" xlink:label="lab_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowing Facilities, Increase (Decrease) In Maximum Borrowing Capacity</link:label>
    <link:label id="lab_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowing Facilities, Increase (Decrease) In Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" xlink:to="lab_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_019c4318-5378-7757-a190-29152854d610_terseLabel_en-US" xlink:label="lab_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred contract revenue recognized</link:label>
    <link:label id="lab_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_label_en-US" xlink:label="lab_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Revenue From Performance Obligations Satisfied Or Partially Satisfied In Previous Periods</link:label>
    <link:label id="lab_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_documentation_en-US" xlink:label="lab_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Revenue From Performance Obligations Satisfied Or Partially Satisfied In Previous Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:href="soph-20251231.xsd#soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:to="lab_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-5378-7daa-8d7a-5b65dc04f23e_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BankBorrowingsInterestPaidUndiscountedCashFlows_019c89f3-8f1b-72d1-b8c3-494559014417_terseLabel_en-US" xlink:label="lab_soph_BankBorrowingsInterestPaidUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual cash interest payments</link:label>
    <link:label id="lab_soph_BankBorrowingsInterestPaidUndiscountedCashFlows_label_en-US" xlink:label="lab_soph_BankBorrowingsInterestPaidUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank Borrowings, Interest Paid, Undiscounted Cash Flows</link:label>
    <link:label id="lab_soph_BankBorrowingsInterestPaidUndiscountedCashFlows_documentation_en-US" xlink:label="lab_soph_BankBorrowingsInterestPaidUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Bank Borrowings, Interest Paid, Undiscounted Cash Flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BankBorrowingsInterestPaidUndiscountedCashFlows" xlink:href="soph-20251231.xsd#soph_BankBorrowingsInterestPaidUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BankBorrowingsInterestPaidUndiscountedCashFlows" xlink:to="lab_soph_BankBorrowingsInterestPaidUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_label_en-US" xlink:label="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Major components of tax expense (income) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:to="lab_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentValueAddedTaxReceivables_019c4318-5378-72ac-922d-b1d6768dc96b_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentValueAddedTaxReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research tax credit receivable</link:label>
    <link:label id="lab_ifrs-full_NoncurrentValueAddedTaxReceivables_label_en-US" xlink:label="lab_ifrs-full_NoncurrentValueAddedTaxReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current value added tax receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentValueAddedTaxReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentValueAddedTaxReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentValueAddedTaxReceivables" xlink:to="lab_ifrs-full_NoncurrentValueAddedTaxReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContractAssetsMember_019c4318-52e4-7bad-9c6f-44a367109382_terseLabel_en-US" xlink:label="lab_ifrs-full_ContractAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued contract revenue</link:label>
    <link:label id="lab_ifrs-full_ContractAssetsMember_label_en-US" xlink:label="lab_ifrs-full_ContractAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract assets [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractAssetsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractAssetsMember" xlink:to="lab_ifrs-full_ContractAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_019c4318-5379-779b-83af-d40a12025b36_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Post-employment benefits</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of employee benefits [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_019c4318-5379-719e-8abb-0a5315d63a09_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Intangible Assets Net, Movement</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_019c4318-5379-7c48-9a2f-d768fc8498dd_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_019c4318-5379-7018-945b-05e05fa58f69_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Currencies</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EquityAbstract_019c4318-5379-7ac3-97a6-7e247cb3eeb8_terseLabel_en-US" xlink:label="lab_ifrs-full_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_ifrs-full_EquityAbstract_label_en-US" xlink:label="lab_ifrs-full_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAbstract" xlink:to="lab_ifrs-full_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019c4318-53fc-7228-b2c7-2f50bedc8dfd_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock_019c4318-52e4-7c45-beab-6ea4656dafdd_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Other Non-Current Assets</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Non-Current Assets And Other Explanatory [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Non-Current Assets And Other Explanatory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-52e4-736c-be37-b05d586d95dc_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [abstract]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about financial instruments [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_TermSecuredOvernightFinancingRateSOFRMember_019c4318-5379-773c-bc8f-5320fd0d9437_terseLabel_en-US" xlink:label="lab_soph_TermSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term SOFR</link:label>
    <link:label id="lab_soph_TermSecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_soph_TermSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_soph_TermSecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_soph_TermSecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRMember" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_TermSecuredOvernightFinancingRateSOFRMember" xlink:to="lab_soph_TermSecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_A2021EmployeeIncentivePlanMember_019c4318-5378-7360-82e6-28c1e6daf119_terseLabel_en-US" xlink:label="lab_soph_A2021EmployeeIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021 EIP</link:label>
    <link:label id="lab_soph_A2021EmployeeIncentivePlanMember_label_en-US" xlink:label="lab_soph_A2021EmployeeIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2021 Employee Incentive Plan [Member]</link:label>
    <link:label id="lab_soph_A2021EmployeeIncentivePlanMember_documentation_en-US" xlink:label="lab_soph_A2021EmployeeIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Two thousand and twenty one employee incentive plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2021EmployeeIncentivePlanMember" xlink:href="soph-20251231.xsd#soph_A2021EmployeeIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_A2021EmployeeIncentivePlanMember" xlink:to="lab_soph_A2021EmployeeIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_019c4318-5378-70c7-942d-3b5f70ca0c3a_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Hierarchy for Financial Assets Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement of assets [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CapitalisedDevelopmentExpenditureMember_019c4318-52e4-78f6-ba8c-16efa8932f36_terseLabel_en-US" xlink:label="lab_ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalised development expenditure</link:label>
    <link:label id="lab_ifrs-full_CapitalisedDevelopmentExpenditureMember_019c4318-52e4-77de-96f9-cde3b2e90864_verboseLabel_en-US" xlink:label="lab_ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Capitalized internally developed software costs</link:label>
    <link:label id="lab_ifrs-full_CapitalisedDevelopmentExpenditureMember_label_en-US" xlink:label="lab_ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalised development expenditure [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:to="lab_ifrs-full_CapitalisedDevelopmentExpenditureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_FrenchPensionPlanMember_019c4318-5378-76f1-a451-78f9feab36c6_terseLabel_en-US" xlink:label="lab_soph_FrenchPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">French Pension Plan</link:label>
    <link:label id="lab_soph_FrenchPensionPlanMember_label_en-US" xlink:label="lab_soph_FrenchPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">French Pension Plan [Member]</link:label>
    <link:label id="lab_soph_FrenchPensionPlanMember_documentation_en-US" xlink:label="lab_soph_FrenchPensionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">French pension plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FrenchPensionPlanMember" xlink:href="soph-20251231.xsd#soph_FrenchPensionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_FrenchPensionPlanMember" xlink:to="lab_soph_FrenchPensionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ProceedsFromExerciseOfOptions_019c4318-52e4-7612-beb7-f37b5cf4ab59_terseLabel_en-US" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of share options</link:label>
    <link:label id="lab_ifrs-full_ProceedsFromExerciseOfOptions_label_en-US" xlink:label="lab_ifrs-full_ProceedsFromExerciseOfOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromExerciseOfOptions" xlink:to="lab_ifrs-full_ProceedsFromExerciseOfOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-53fc-795d-b758-124bedc8e6b3_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [abstract]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of transactions between related parties [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_label_en-US" xlink:label="lab_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subclassifications of assets, liabilities and equities [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:to="lab_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock_019c4318-52e4-7f93-a967-5afc34461245_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Historical cost convention</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Historical Cost Convention [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for historical cost convention explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_019c4318-52e4-7ab0-a692-5e573c2a79ab_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock_019c4318-52e4-7315-99e5-584204a82240_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Weighted Average Fair Value of Options Granted</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Weighted Average Fair Value Of Options Granted [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about weighted average fair value of options granted explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock_019c4318-52e4-7b45-bca7-523cda2dfd90_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Movement in Allowance for Expected Credit Losses in Accounts Receivable</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Allowance For Credit Losses In Accounts Receivable [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Allowance For Credit Losses In Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_019c4318-5379-73bd-8c90-1f85b8f0e4c2_terseLabel_en-US" xlink:label="lab_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_label_en-US" xlink:label="lab_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade and other payables, undiscounted cash flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows" xlink:to="lab_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ServiceCostDefinedBenefitPlans_019c4318-5379-73d9-9ffd-88f1b744821b_negatedLabel_en-US" xlink:label="lab_soph_ServiceCostDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Service Cost</link:label>
    <link:label id="lab_soph_ServiceCostDefinedBenefitPlans_label_en-US" xlink:label="lab_soph_ServiceCostDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service Cost, Defined Benefit Plans</link:label>
    <link:label id="lab_soph_ServiceCostDefinedBenefitPlans_documentation_en-US" xlink:label="lab_soph_ServiceCostDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Service cost defined benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ServiceCostDefinedBenefitPlans" xlink:href="soph-20251231.xsd#soph_ServiceCostDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ServiceCostDefinedBenefitPlans" xlink:to="lab_soph_ServiceCostDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_019c4318-52e4-7751-a560-3adfa88e55f5_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-5379-76c8-8549-aaadbe0864fc_terseLabel_en-US" xlink:label="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Funded</link:label>
    <link:label id="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_label_en-US" xlink:label="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wholly or partly funded defined benefit plans [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:to="lab_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract_019c4318-5379-7506-ab78-69d92cdd245d_terseLabel_en-US" xlink:label="lab_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Share-Based Payments [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract_label_en-US" xlink:label="lab_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Share-Based Payments [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract_documentation_en-US" xlink:label="lab_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Share-Based Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInShareBasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract" xlink:to="lab_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_019c4318-5379-7f27-b940-b29f057d49a3_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Key Inputs for the Valuation of the Warrant Obligation</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of significant unobservable inputs used in fair value measurement of liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-5379-7b5e-a43e-d256de24e4cd_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AccruedExpensesAbstract_label_en-US" xlink:label="lab_soph_AccruedExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Expenses [Abstract]</link:label>
    <link:label id="lab_soph_AccruedExpensesAbstract_documentation_en-US" xlink:label="lab_soph_AccruedExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedExpensesAbstract" xlink:href="soph-20251231.xsd#soph_AccruedExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AccruedExpensesAbstract" xlink:to="lab_soph_AccruedExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashOutflowForLeases_019c4318-5379-72be-8f29-6043f42c18ba_terseLabel_en-US" xlink:label="lab_ifrs-full_CashOutflowForLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash outflows related to leases less than 12 months</link:label>
    <link:label id="lab_ifrs-full_CashOutflowForLeases_label_en-US" xlink:label="lab_ifrs-full_CashOutflowForLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash outflow for leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashOutflowForLeases" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashOutflowForLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashOutflowForLeases" xlink:to="lab_ifrs-full_CashOutflowForLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock_019c727b-2c23-7478-9e46-8828cf4eba79_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other operating income, net</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Other Operating Income (Expense) [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Other Operating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of contingent liabilities in business combination [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-52e4-7a9e-9de5-0569a78ad8ab_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency in which information is displayed [axis]</link:label>
    <link:label id="lab_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_label_en-US" xlink:label="lab_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency in which information is displayed [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrencyInWhichInformationIsDisplayedAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" xlink:to="lab_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss_019c4318-52e4-7d85-aa41-65d87766244f_negatedTerseLabel_en-US" xlink:label="lab_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income not subject to tax</link:label>
    <link:label id="lab_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss_label_en-US" xlink:label="lab_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Effect Of Income Not Deductible In Determining Taxable Profit (Tax Loss)</link:label>
    <link:label id="lab_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss_documentation_en-US" xlink:label="lab_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax effect of income and expense not subject to tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:href="soph-20251231.xsd#soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="lab_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-52e4-7409-bd41-40aa9a23ba93_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_019c4318-52e4-7aa5-8d31-cca8214726fb_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_019c4318-5378-7123-8a78-80b787f1b355_terseLabel_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension costs</link:label>
    <link:label id="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_label_en-US" xlink:label="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Key management personnel compensation, post-employment benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:to="lab_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SharePremiumMember_019c4318-52e4-7253-91a8-ac3a68e55b4e_terseLabel_en-US" xlink:label="lab_ifrs-full_SharePremiumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share premium</link:label>
    <link:label id="lab_ifrs-full_SharePremiumMember_label_en-US" xlink:label="lab_ifrs-full_SharePremiumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share premium [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SharePremiumMember" xlink:to="lab_ifrs-full_SharePremiumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-52e4-7c89-b973-78f6687a05e0_terseLabel_en-US" xlink:label="lab_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average grant date fair value per share</link:label>
    <link:label id="lab_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price Of Other Equity Instruments In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_documentation_en-US" xlink:label="lab_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price Of Other Equity Instruments In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:href="soph-20251231.xsd#soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:to="lab_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WorkingCapitalChangesAbstract_019c4318-52e4-7240-a34b-342520c27490_terseLabel_en-US" xlink:label="lab_soph_WorkingCapitalChangesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Working capital changes</link:label>
    <link:label id="lab_soph_WorkingCapitalChangesAbstract_label_en-US" xlink:label="lab_soph_WorkingCapitalChangesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Working Capital Changes [Abstract]</link:label>
    <link:label id="lab_soph_WorkingCapitalChangesAbstract_documentation_en-US" xlink:label="lab_soph_WorkingCapitalChangesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Working capital changes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WorkingCapitalChangesAbstract" xlink:href="soph-20251231.xsd#soph_WorkingCapitalChangesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WorkingCapitalChangesAbstract" xlink:to="lab_soph_WorkingCapitalChangesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_019c4318-52e4-713e-b355-795b0bc6b4ff_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Revenue from Contracts with Customers Allocated to Geographical Areas and Revenue Streams</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_019c4318-5379-78b9-9006-eb53a154f61e_totalLabel_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Attributable to owners of the parent</link:label>
    <link:label id="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_label_en-US" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive income, attributable to owners of parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_LeaseIncentivesAndExpectedRestorationCosts_019c4318-52e4-7ba3-ab86-6d2b253f9915_terseLabel_en-US" xlink:label="lab_soph_LeaseIncentivesAndExpectedRestorationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease incentives and expected restoration costs</link:label>
    <link:label id="lab_soph_LeaseIncentivesAndExpectedRestorationCosts_label_en-US" xlink:label="lab_soph_LeaseIncentivesAndExpectedRestorationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Incentives And Expected Restoration Costs</link:label>
    <link:label id="lab_soph_LeaseIncentivesAndExpectedRestorationCosts_documentation_en-US" xlink:label="lab_soph_LeaseIncentivesAndExpectedRestorationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease incentives and expected restoration costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseIncentivesAndExpectedRestorationCosts" xlink:href="soph-20251231.xsd#soph_LeaseIncentivesAndExpectedRestorationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_LeaseIncentivesAndExpectedRestorationCosts" xlink:to="lab_soph_LeaseIncentivesAndExpectedRestorationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_Liabilities_019c4318-52e4-7555-bf65-02a88076a0ee_totalLabel_en-US" xlink:label="lab_ifrs-full_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_ifrs-full_Liabilities_label_en-US" xlink:label="lab_ifrs-full_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Liabilities" xlink:to="lab_ifrs-full_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DividendYieldMeasurementInputMember_019c4318-5378-7976-9292-3546624ce0bf_terseLabel_en-US" xlink:label="lab_soph_DividendYieldMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_soph_DividendYieldMeasurementInputMember_label_en-US" xlink:label="lab_soph_DividendYieldMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividend Yield, Measurement Input [Member]</link:label>
    <link:label id="lab_soph_DividendYieldMeasurementInputMember_documentation_en-US" xlink:label="lab_soph_DividendYieldMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dividend Yield, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DividendYieldMeasurementInputMember" xlink:href="soph-20251231.xsd#soph_DividendYieldMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DividendYieldMeasurementInputMember" xlink:to="lab_soph_DividendYieldMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale_019c4318-52e4-735e-b543-b6763b05b37b_terseLabel_en-US" xlink:label="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average life expectancy in years after retirement for female</link:label>
    <link:label id="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale_label_en-US" xlink:label="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average Life Expectancy, In Years After Retirement, For Female</link:label>
    <link:label id="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale_documentation_en-US" xlink:label="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Average life expectancy in years after retirement for female.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale" xlink:href="soph-20251231.xsd#soph_AverageLifeExpectancyInYearsAfterRetirementForFemale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale" xlink:to="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BorrowingTermsAxis_019c4318-5379-7825-a0c2-41948de1af56_terseLabel_en-US" xlink:label="lab_soph_BorrowingTermsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowing Terms [Axis]</link:label>
    <link:label id="lab_soph_BorrowingTermsAxis_label_en-US" xlink:label="lab_soph_BorrowingTermsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowing Terms [Axis]</link:label>
    <link:label id="lab_soph_BorrowingTermsAxis_documentation_en-US" xlink:label="lab_soph_BorrowingTermsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowing Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsAxis" xlink:href="soph-20251231.xsd#soph_BorrowingTermsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BorrowingTermsAxis" xlink:to="lab_soph_BorrowingTermsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_TermSecuredOvernightFinancingRateSOFRFloorMember_019c81cd-0d43-746c-9eb1-ba3bbf68273f_terseLabel_en-US" xlink:label="lab_soph_TermSecuredOvernightFinancingRateSOFRFloorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term SOFR Floor</link:label>
    <link:label id="lab_soph_TermSecuredOvernightFinancingRateSOFRFloorMember_label_en-US" xlink:label="lab_soph_TermSecuredOvernightFinancingRateSOFRFloorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Secured Overnight Financing Rate (SOFR), Floor [Member]</link:label>
    <link:label id="lab_soph_TermSecuredOvernightFinancingRateSOFRFloorMember_documentation_en-US" xlink:label="lab_soph_TermSecuredOvernightFinancingRateSOFRFloorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Secured Overnight Financing Rate (SOFR), Floor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRFloorMember" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRFloorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_TermSecuredOvernightFinancingRateSOFRFloorMember" xlink:to="lab_soph_TermSecuredOvernightFinancingRateSOFRFloorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_InterestPaidOnLeaseLiabilities_019c4318-52e4-7da2-a338-f3aa55504e63_terseLabel_en-US" xlink:label="lab_soph_InterestPaidOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on lease liability payments</link:label>
    <link:label id="lab_soph_InterestPaidOnLeaseLiabilities_label_en-US" xlink:label="lab_soph_InterestPaidOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid On Lease Liabilities</link:label>
    <link:label id="lab_soph_InterestPaidOnLeaseLiabilities_documentation_en-US" xlink:label="lab_soph_InterestPaidOnLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Paid On Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_InterestPaidOnLeaseLiabilities" xlink:href="soph-20251231.xsd#soph_InterestPaidOnLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_InterestPaidOnLeaseLiabilities" xlink:to="lab_soph_InterestPaidOnLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_019c4318-5378-78f1-8d5d-9758df78f1a9_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Significant Investments In Subsidiaries [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_019caf67-919d-7fa1-90d9-fc3b3741ce2b_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of contingent liabilities in business combination [table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of contingent liabilities in business combination [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PerceptiveCreditHoldingsIVLPMember_019c4318-5378-7b51-a4ae-8d77cbeb7b80_terseLabel_en-US" xlink:label="lab_soph_PerceptiveCreditHoldingsIVLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Perceptive Credit Holdings IV, LP</link:label>
    <link:label id="lab_soph_PerceptiveCreditHoldingsIVLPMember_label_en-US" xlink:label="lab_soph_PerceptiveCreditHoldingsIVLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Perceptive Credit Holdings IV, LP [Member]</link:label>
    <link:label id="lab_soph_PerceptiveCreditHoldingsIVLPMember_documentation_en-US" xlink:label="lab_soph_PerceptiveCreditHoldingsIVLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Perceptive Credit Holdings IV, LP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditHoldingsIVLPMember" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditHoldingsIVLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PerceptiveCreditHoldingsIVLPMember" xlink:to="lab_soph_PerceptiveCreditHoldingsIVLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_OtherFinancialNonCurrentAssetsMember_019c4318-53fc-7df1-8c9f-a3cc8d562b8b_terseLabel_en-US" xlink:label="lab_soph_OtherFinancialNonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financial non-current assets</link:label>
    <link:label id="lab_soph_OtherFinancialNonCurrentAssetsMember_label_en-US" xlink:label="lab_soph_OtherFinancialNonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Financial Non Current Assets [Member]</link:label>
    <link:label id="lab_soph_OtherFinancialNonCurrentAssetsMember_documentation_en-US" xlink:label="lab_soph_OtherFinancialNonCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other financial non-current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OtherFinancialNonCurrentAssetsMember" xlink:href="soph-20251231.xsd#soph_OtherFinancialNonCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_OtherFinancialNonCurrentAssetsMember" xlink:to="lab_soph_OtherFinancialNonCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DifferencesOfCurrencyUSDAndGBPMember_019c4318-52e4-76ca-b99d-92413d45f298_terseLabel_en-US" xlink:label="lab_soph_DifferencesOfCurrencyUSDAndGBPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">USD/GBP</link:label>
    <link:label id="lab_soph_DifferencesOfCurrencyUSDAndGBPMember_label_en-US" xlink:label="lab_soph_DifferencesOfCurrencyUSDAndGBPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Differences Of Currency USD And GBP [Member]</link:label>
    <link:label id="lab_soph_DifferencesOfCurrencyUSDAndGBPMember_documentation_en-US" xlink:label="lab_soph_DifferencesOfCurrencyUSDAndGBPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Differences of Currency USD/GBP.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyUSDAndGBPMember" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyUSDAndGBPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DifferencesOfCurrencyUSDAndGBPMember" xlink:to="lab_soph_DifferencesOfCurrencyUSDAndGBPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock_019c4318-52e4-7c86-bbe0-bfc48207cc08_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of consolidation</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Basis Of Consolidation [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for basis of consolidation explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock_019c4318-52e4-7fca-b11d-949af461b0ea_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of estimates</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Use Of Estimates [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for use of estimates explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForMale_019c4318-52e4-72b0-920d-026f6f6c5fef_terseLabel_en-US" xlink:label="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForMale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average life expectancy in years after retirement for male</link:label>
    <link:label id="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForMale_label_en-US" xlink:label="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForMale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Average Life Expectancy, In Years After Retirement, For Male</link:label>
    <link:label id="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForMale_documentation_en-US" xlink:label="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForMale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Average life expectancy in years after retirement for male.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForMale" xlink:href="soph-20251231.xsd#soph_AverageLifeExpectancyInYearsAfterRetirementForMale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForMale" xlink:to="lab_soph_AverageLifeExpectancyInYearsAfterRetirementForMale" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_019c4318-5379-7672-89a0-55189b0536ff_terseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency Translation Adjustment</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through net exchange differences, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement_019c4318-5378-777f-984f-efad0bc1d42e_terseLabel_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value Of Other Equity Instruments Forfeited In Share Based Payment Arrangement</link:label>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted-average grant date fair value of other equity instruments forfeited in share-based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement" xlink:to="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-52e4-790b-b656-50ec7f7b75ce_terseLabel_en-US" xlink:label="lab_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sensitivity analysis, period decrease</link:label>
    <link:label id="lab_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption_label_en-US" xlink:label="lab_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Period Of Reasonably Possible Decrease In Actuarial Assumption</link:label>
    <link:label id="lab_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption_documentation_en-US" xlink:label="lab_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Period Of Reasonably Possible Decrease In Actuarial Assumption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:href="soph-20251231.xsd#soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="lab_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_019c4318-5378-726b-b1cc-83e22ac85c27_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred contract revenue</link:label>
    <link:label id="lab_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current deferred income including current contract liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:to="lab_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LeaseLiabilitiesMember_019c4318-5378-747f-87d4-a48ae3e8d39e_terseLabel_en-US" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_ifrs-full_LeaseLiabilitiesMember_label_en-US" xlink:label="lab_ifrs-full_LeaseLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease liabilities [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilitiesMember" xlink:to="lab_ifrs-full_LeaseLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_019c4318-52e4-7a3a-b87c-46b3c209b90a_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options forfeited in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_GainLossOnDisposalOfLeaseLiability_019c4318-5379-7a9e-8eb2-62f4a374930d_negatedTerseLabel_en-US" xlink:label="lab_soph_GainLossOnDisposalOfLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on disposal of lease liability</link:label>
    <link:label id="lab_soph_GainLossOnDisposalOfLeaseLiability_label_en-US" xlink:label="lab_soph_GainLossOnDisposalOfLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Disposal Of Lease Liability</link:label>
    <link:label id="lab_soph_GainLossOnDisposalOfLeaseLiability_documentation_en-US" xlink:label="lab_soph_GainLossOnDisposalOfLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Disposal Of Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GainLossOnDisposalOfLeaseLiability" xlink:href="soph-20251231.xsd#soph_GainLossOnDisposalOfLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_GainLossOnDisposalOfLeaseLiability" xlink:to="lab_soph_GainLossOnDisposalOfLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValue_019c4318-52e4-79fd-9ce5-eafdf8c95c94_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total financial liabilities</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValue_019c4318-52e4-733d-a55a-b8ac5f6e9041_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Warrant obligation at issuance</link:label>
    <link:label id="lab_ifrs-full_FinancialLiabilitiesAtFairValue_label_en-US" xlink:label="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial liabilities, at fair value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="lab_ifrs-full_FinancialLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncome_019c4318-52e4-79f3-bc95-3fe062fa10a3_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_ifrs-full_CurrentTaxExpenseIncome_label_en-US" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current tax expense (income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncome" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c6cc2-2395-7253-a2f3-b8ef3b766165_terseLabel_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [axis]</link:label>
    <link:label id="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_label_en-US" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-adjusting events after reporting period [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_019c4318-5379-7adc-9ce0-2fa6767bbd2b_terseLabel_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Between 1 and 5 years</link:label>
    <link:label id="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_label_en-US" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Later than one year and not later than five years [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NonCurrentContractAcquisitionCosts_019c677c-a893-7871-99db-1040530b9349_terseLabel_en-US" xlink:label="lab_soph_NonCurrentContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non&#8209;current contract acquisition costs</link:label>
    <link:label id="lab_soph_NonCurrentContractAcquisitionCosts_label_en-US" xlink:label="lab_soph_NonCurrentContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non Current Contract Acquisition Costs</link:label>
    <link:label id="lab_soph_NonCurrentContractAcquisitionCosts_documentation_en-US" xlink:label="lab_soph_NonCurrentContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non Current Contract Acquisition Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NonCurrentContractAcquisitionCosts" xlink:href="soph-20251231.xsd#soph_NonCurrentContractAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NonCurrentContractAcquisitionCosts" xlink:to="lab_soph_NonCurrentContractAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TopOfRangeMember_019c4318-5379-7585-98a5-4dd89475c252_terseLabel_en-US" xlink:label="lab_ifrs-full_TopOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_ifrs-full_TopOfRangeMember_label_en-US" xlink:label="lab_ifrs-full_TopOfRangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Top of range [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember" xlink:to="lab_ifrs-full_TopOfRangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense_019c4318-5379-71fe-be2c-6c4b75ade514_terseLabel_en-US" xlink:label="lab_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized deferred tax assets</link:label>
    <link:label id="lab_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense_label_en-US" xlink:label="lab_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Benefit Arising From Unrecognised Tax Loss, Tax Credit Or Temporary Difference Of Prior Period Used To Reduce Deferred Tax Expense</link:label>
    <link:label id="lab_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense_documentation_en-US" xlink:label="lab_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Benefit Arising From Unrecognised Tax Loss, Tax Credit Or Temporary Difference Of Prior Period Used To Reduce Deferred Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" xlink:href="soph-20251231.xsd#soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" xlink:to="lab_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EarningsPerShareLineItems_019c4318-52e4-7b67-9f74-47329fa2200e_terseLabel_en-US" xlink:label="lab_ifrs-full_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_ifrs-full_EarningsPerShareLineItems_label_en-US" xlink:label="lab_ifrs-full_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareLineItems" xlink:to="lab_ifrs-full_EarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PerceptiveCreditAgreementMember_019c4318-53fc-768b-be09-deccadf47b3c_terseLabel_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Perceptive Credit Agreement</link:label>
    <link:label id="lab_soph_PerceptiveCreditAgreementMember_label_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Perceptive Credit Agreement [Member]</link:label>
    <link:label id="lab_soph_PerceptiveCreditAgreementMember_documentation_en-US" xlink:label="lab_soph_PerceptiveCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Perceptive Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementMember" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PerceptiveCreditAgreementMember" xlink:to="lab_soph_PerceptiveCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ResearchAndDevelopmentExpense_019c4318-5379-747a-997c-027386d18a27_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research and development costs</link:label>
    <link:label id="lab_ifrs-full_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and development expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherNoncurrentAssets_019c4318-52e4-76a4-950b-54ff2fb61d4e_terseLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentAssets_019c4318-52e4-7352-87fc-d6df52b3b70d_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_ifrs-full_OtherNoncurrentAssets_label_en-US" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="lab_ifrs-full_OtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TaxEffectOfTaxLosses_019c4318-52e4-7d5f-9270-6291d6e6800b_terseLabel_en-US" xlink:label="lab_ifrs-full_TaxEffectOfTaxLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax effect</link:label>
    <link:label id="lab_ifrs-full_TaxEffectOfTaxLosses_label_en-US" xlink:label="lab_ifrs-full_TaxEffectOfTaxLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax effect of tax losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfTaxLosses" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxEffectOfTaxLosses" xlink:to="lab_ifrs-full_TaxEffectOfTaxLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-5379-718f-b256-f12df904ee42_verboseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement of defined benefit plans</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-5379-7179-95af-5cc6886dbab0_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total recognized</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember_019c4318-52e4-78e4-8814-fd03d37f39c8_terseLabel_en-US" xlink:label="lab_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term SOFR upon event default</link:label>
    <link:label id="lab_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember_label_en-US" xlink:label="lab_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Term Secured Overnight Financing Rate (SOFR), Upon Default [Member]</link:label>
    <link:label id="lab_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember_documentation_en-US" xlink:label="lab_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Term Secured Overnight Financing Rate (SOFR), Upon Default</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember" xlink:to="lab_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SalesAndMarketingExpenseMember_019c4318-5379-7fa4-849b-7e71c4afc7cf_terseLabel_en-US" xlink:label="lab_soph_SalesAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_soph_SalesAndMarketingExpenseMember_label_en-US" xlink:label="lab_soph_SalesAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales And Marketing Expense [Member]</link:label>
    <link:label id="lab_soph_SalesAndMarketingExpenseMember_documentation_en-US" xlink:label="lab_soph_SalesAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sales And Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SalesAndMarketingExpenseMember" xlink:href="soph-20251231.xsd#soph_SalesAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SalesAndMarketingExpenseMember" xlink:to="lab_soph_SalesAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_019c4318-53fc-7b2b-952c-a7abe73f500a_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total items that will not be reclassified to statement of loss</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income that will not be reclassified to profit or loss, net of tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_019c4318-52e4-7414-955c-c43936a671c8_terseLabel_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_label_en-US" xlink:label="lab_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, amount contributed to fair value of plan assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" xlink:to="lab_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_019c4318-52e4-73fd-9a02-bc02d59b15fa_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for measuring inventories [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_019c4318-5379-75f2-ab1d-8a3e88a9dd2c_terseLabel_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total non-current assets other than financial instruments and deferred tax assets</link:label>
    <link:label id="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_label_en-US" xlink:label="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:to="lab_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_SophiaGeneticLimitedMember_019c4318-52e4-7bf5-b26f-f5f0af1a074f_terseLabel_en-US" xlink:label="lab_soph_SophiaGeneticLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SOPHiA GENETICS LTD</link:label>
    <link:label id="lab_soph_SophiaGeneticLimitedMember_label_en-US" xlink:label="lab_soph_SophiaGeneticLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sophia Genetic Limited [Member]</link:label>
    <link:label id="lab_soph_SophiaGeneticLimitedMember_documentation_en-US" xlink:label="lab_soph_SophiaGeneticLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sophia Genetic Limited.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticLimitedMember" xlink:href="soph-20251231.xsd#soph_SophiaGeneticLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_SophiaGeneticLimitedMember" xlink:to="lab_soph_SophiaGeneticLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-52e4-7392-8f2a-d8f03fd44b7b_terseLabel_en-US" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
    <link:label id="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_label_en-US" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_019c4318-52e4-7ce1-ac68-407c5a078510_terseLabel_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSU vesting period on an annual basis</link:label>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_label_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On An Annual Basis</link:label>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_documentation_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Period Of Share Based Payment Arrangement, Other Equity Instruments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:to="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsByNameDomain_019c4318-52e4-78b1-93c4-0890c262ccd8_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings by name [domain]</link:label>
    <link:label id="lab_ifrs-full_BorrowingsByNameDomain_label_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings by name [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameDomain" xlink:to="lab_ifrs-full_BorrowingsByNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-52e4-73d4-abbc-787252da2541_negatedLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Present value of defined benefit obligation</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-52e4-76c6-8062-463d647feb08_negatedPeriodStartLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">January 1</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-52e4-745e-aeaf-ee0090deaaad_negatedPeriodEndLabel_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">December 31</link:label>
    <link:label id="lab_ifrs-full_DefinedBenefitObligationAtPresentValue_label_en-US" xlink:label="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined benefit obligation, at present value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:to="lab_ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TradeReceivablesMember_019c4318-52e4-7a46-947a-1a5562373aee_verboseLabel_en-US" xlink:label="lab_ifrs-full_TradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Trade receivable</link:label>
    <link:label id="lab_ifrs-full_TradeReceivablesMember_label_en-US" xlink:label="lab_ifrs-full_TradeReceivablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade receivables [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivablesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeReceivablesMember" xlink:to="lab_ifrs-full_TradeReceivablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ExtraMandatoryPartEquivalentToDiscountRate_019c4318-52e4-789e-8405-aece3e5d90f2_terseLabel_en-US" xlink:label="lab_soph_ExtraMandatoryPartEquivalentToDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Extra mandatory part equivalent to discount rate</link:label>
    <link:label id="lab_soph_ExtraMandatoryPartEquivalentToDiscountRate_label_en-US" xlink:label="lab_soph_ExtraMandatoryPartEquivalentToDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Extra Mandatory Part Equivalent To Discount Rate</link:label>
    <link:label id="lab_soph_ExtraMandatoryPartEquivalentToDiscountRate_documentation_en-US" xlink:label="lab_soph_ExtraMandatoryPartEquivalentToDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Extra mandatory part equivalent to discount rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExtraMandatoryPartEquivalentToDiscountRate" xlink:href="soph-20251231.xsd#soph_ExtraMandatoryPartEquivalentToDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ExtraMandatoryPartEquivalentToDiscountRate" xlink:to="lab_soph_ExtraMandatoryPartEquivalentToDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RevenueFromContractsWithCustomers_019c4318-5378-72e1-b87f-b1e2aa2fd314_terseLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromContractsWithCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_ifrs-full_RevenueFromContractsWithCustomers_019c4318-5378-75b2-b059-50cf07320884_netLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromContractsWithCustomers" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Revenue from contracts with customers</link:label>
    <link:label id="lab_ifrs-full_RevenueFromContractsWithCustomers_019c4318-5378-76c8-8161-1157e29092c6_verboseLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromContractsWithCustomers" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_ifrs-full_RevenueFromContractsWithCustomers_label_en-US" xlink:label="lab_ifrs-full_RevenueFromContractsWithCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from contracts with customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromContractsWithCustomers" xlink:to="lab_ifrs-full_RevenueFromContractsWithCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-5379-7723-8a27-7864278b59f5_terseLabel_en-US" xlink:label="lab_ifrs-full_FunctionalOrPresentationCurrencyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Functional or presentation currency</link:label>
    <link:label id="lab_ifrs-full_FunctionalOrPresentationCurrencyMember_label_en-US" xlink:label="lab_ifrs-full_FunctionalOrPresentationCurrencyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Functional or presentation currency [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FunctionalOrPresentationCurrencyMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FunctionalOrPresentationCurrencyMember" xlink:to="lab_ifrs-full_FunctionalOrPresentationCurrencyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_019c4318-5379-71df-936a-1902ebbcd9cf_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Currency translation adjustments</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) through foreign exchange, financial assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilities_019c4318-5379-7302-a4af-53926dd3f112_negatedLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxLiabilities_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities" xlink:to="lab_ifrs-full_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_019c4318-52e4-79c1-8473-b424b3c38246_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Income tax paid</link:label>
    <link:label id="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_label_en-US" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income taxes paid (refund), classified as operating activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_019c4318-52e4-7e61-b64b-086eac6e62f0_totalLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive (loss) income for the period</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_019c4318-52e4-7c12-bb3b-30f6c95c0d09_verboseLabel_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_ifrs-full_OtherComprehensiveIncome_label_en-US" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other comprehensive income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome" xlink:to="lab_ifrs-full_OtherComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ExpectedVolatilityMeasurementInputMember_019c4318-5378-7eaf-854d-b6cb5f92e319_terseLabel_en-US" xlink:label="lab_soph_ExpectedVolatilityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility (annualized)</link:label>
    <link:label id="lab_soph_ExpectedVolatilityMeasurementInputMember_label_en-US" xlink:label="lab_soph_ExpectedVolatilityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected Volatility, Measurement Input [Member]</link:label>
    <link:label id="lab_soph_ExpectedVolatilityMeasurementInputMember_documentation_en-US" xlink:label="lab_soph_ExpectedVolatilityMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected Volatility, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExpectedVolatilityMeasurementInputMember" xlink:href="soph-20251231.xsd#soph_ExpectedVolatilityMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ExpectedVolatilityMeasurementInputMember" xlink:to="lab_soph_ExpectedVolatilityMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-52e4-7fe1-8f0f-5c08ea98a998_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of liabilities [axis]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfLiabilitiesAxis_label_en-US" xlink:label="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of liabilities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis" xlink:to="lab_ifrs-full_ClassesOfLiabilitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CounterpartiesDomain_019c4318-5378-7822-8c8d-0f588a3ed356_terseLabel_en-US" xlink:label="lab_ifrs-full_CounterpartiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparties [domain]</link:label>
    <link:label id="lab_ifrs-full_CounterpartiesDomain_label_en-US" xlink:label="lab_ifrs-full_CounterpartiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparties [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesDomain" xlink:to="lab_ifrs-full_CounterpartiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_OtherOperatingIncomeExpenseNetAbstract_label_en-US" xlink:label="lab_soph_OtherOperatingIncomeExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Operating Income Expense Net [Abstract]</link:label>
    <link:label id="lab_soph_OtherOperatingIncomeExpenseNetAbstract_documentation_en-US" xlink:label="lab_soph_OtherOperatingIncomeExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other operating income (expense), net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OtherOperatingIncomeExpenseNetAbstract" xlink:href="soph-20251231.xsd#soph_OtherOperatingIncomeExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_OtherOperatingIncomeExpenseNetAbstract" xlink:to="lab_soph_OtherOperatingIncomeExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TreasurySharesMember_019c4318-5379-75b2-b82d-9cddff3ed1f4_terseLabel_en-US" xlink:label="lab_ifrs-full_TreasurySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Share capital</link:label>
    <link:label id="lab_ifrs-full_TreasurySharesMember_label_en-US" xlink:label="lab_ifrs-full_TreasurySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury shares [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasurySharesMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasurySharesMember" xlink:to="lab_ifrs-full_TreasurySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_019c4318-5379-7e27-8f9b-8f7b081c576f_totalLabel_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Decrease in cash and cash equivalents</link:label>
    <link:label id="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_label_en-US" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash and cash equivalents before effect of exchange rate changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-5378-70b8-84ec-cbb9d72bd4aa_terseLabel_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
    <link:label id="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_label_en-US" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_019c4318-5378-7ab0-8777-d4cab8433997_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">APAC</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseOnBorrowings_019c4318-52e4-7639-a5d9-d2ff22fa1731_verboseLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseOnBorrowings_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense on borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnBorrowings" xlink:to="lab_ifrs-full_InterestExpenseOnBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019c4318-52e4-7ffe-a585-837722eb410d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_019c4318-52e4-7566-92bb-beeb4686ba77_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Significant Investments In Subsidiaries [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of subsidiaries [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:to="lab_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_019c4318-53fc-748a-9cbe-2dae1c35d3c3_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Hierarchy for Financial Liabilities Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of fair value measurement of liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_IssueOfEquity_019c66a2-68f6-7032-afbe-97a4888c6f2d_terseLabel_en-US" xlink:label="lab_ifrs-full_IssueOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from ATM offering, net of transaction costs</link:label>
    <link:label id="lab_ifrs-full_IssueOfEquity_019c905d-92a6-7f59-90a2-ce2fbabfe779_verboseLabel_en-US" xlink:label="lab_ifrs-full_IssueOfEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Aggregate offing price</link:label>
    <link:label id="lab_ifrs-full_IssueOfEquity_label_en-US" xlink:label="lab_ifrs-full_IssueOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issue of equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssueOfEquity" xlink:to="lab_ifrs-full_IssueOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_019c4318-52e4-78f4-98d8-754aba4fcf07_terseLabel_en-US" xlink:label="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows_label_en-US" xlink:label="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Bank borrowings, undiscounted cash flows</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:to="lab_ifrs-full_BankBorrowingsUndiscountedCashFlows" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-5379-7ee6-9240-2cd66e46fb5b_terseLabel_en-US" xlink:label="lab_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in property, plant and equipment [abstract]</link:label>
    <link:label id="lab_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in property, plant and equipment [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract" xlink:to="lab_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-52e4-7eba-9bf8-87f4c7c1f02d_terseLabel_en-US" xlink:label="lab_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unfunded</link:label>
    <link:label id="lab_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_label_en-US" xlink:label="lab_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Wholly unfunded defined benefit plans [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember" xlink:to="lab_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-52e4-7a85-8012-cea70d851149_terseLabel_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [domain]</link:label>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_label_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:to="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccountingProfit_019c4318-52e4-776f-b3f5-29af38478dfe_terseLabel_en-US" xlink:label="lab_ifrs-full_AccountingProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss before tax</link:label>
    <link:label id="lab_ifrs-full_AccountingProfit_label_en-US" xlink:label="lab_ifrs-full_AccountingProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccountingProfit" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccountingProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccountingProfit" xlink:to="lab_ifrs-full_AccountingProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5379-7e33-8b81-7235e90b077f_terseLabel_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiaries [domain]</link:label>
    <link:label id="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_label_en-US" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-5379-7ad6-bea0-09072480f3bd_terseLabel_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Funding arrangements of defined benefit plans [axis]</link:label>
    <link:label id="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_label_en-US" xlink:label="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Funding arrangements of defined benefit plans [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:to="lab_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsByNameAxis_019c4318-5379-7608-b5f6-cf5adde43f06_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowings by name [axis]</link:label>
    <link:label id="lab_ifrs-full_BorrowingsByNameAxis_label_en-US" xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings by name [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis" xlink:to="lab_ifrs-full_BorrowingsByNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans_019c4318-52e4-7355-b611-a84acffba983_terseLabel_en-US" xlink:label="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency translation differences</link:label>
    <link:label id="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans_label_en-US" xlink:label="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Through Net Exchange Differences, Defined Benefit Plans</link:label>
    <link:label id="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans_documentation_en-US" xlink:label="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency translation differences defined benefit plans.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" xlink:to="lab_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-52e4-733c-82e3-26e86f300092_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfCompanyInformationAndOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Company Information And Operations [Table]</link:label>
    <link:label id="lab_soph_DisclosureOfCompanyInformationAndOperationsTable_label_en-US" xlink:label="lab_soph_DisclosureOfCompanyInformationAndOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Company Information And Operations [Table]</link:label>
    <link:label id="lab_soph_DisclosureOfCompanyInformationAndOperationsTable_documentation_en-US" xlink:label="lab_soph_DisclosureOfCompanyInformationAndOperationsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of company information and operations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsTable" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsTable" xlink:to="lab_soph_DisclosureOfCompanyInformationAndOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock_019c4318-52e4-7dbb-bd87-1885bcf50081_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Movement in Defined Benefit Plans Assets</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Movement In Defined Benefit Plan Assets [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of movement in defined benefit plan assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-5378-7bf2-9f21-f54b6096fe7e_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Effect Of Changes In Foreign Exchange Rates [Table]</link:label>
    <link:label id="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_label_en-US" xlink:label="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Effect Of Changes In Foreign Exchange Rates [Table]</link:label>
    <link:label id="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_documentation_en-US" xlink:label="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of effect of changes in foreign exchange rates.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable" xlink:href="soph-20251231.xsd#soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable" xlink:to="lab_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_019c4318-52e4-79d9-8e43-4564664e5c55_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of trade and other payables [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfTreasurySharesIssued_019c4318-52e4-7970-bc6c-b5e2540a20a4_terseLabel_en-US" xlink:label="lab_soph_NumberOfTreasurySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of shares to be held as treasury shares (in shares)</link:label>
    <link:label id="lab_soph_NumberOfTreasurySharesIssued_label_en-US" xlink:label="lab_soph_NumberOfTreasurySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Treasury Shares Issued</link:label>
    <link:label id="lab_soph_NumberOfTreasurySharesIssued_documentation_en-US" xlink:label="lab_soph_NumberOfTreasurySharesIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Treasury Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfTreasurySharesIssued" xlink:href="soph-20251231.xsd#soph_NumberOfTreasurySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfTreasurySharesIssued" xlink:to="lab_soph_NumberOfTreasurySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ReserveOfSharebasedPayments_019c4318-52e4-7e1a-a179-856d5b2dccf9_periodStartLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_ifrs-full_ReserveOfSharebasedPayments_019c4318-52e4-73f2-8757-26d5c56fcaa9_periodEndLabel_en-US" xlink:label="lab_ifrs-full_ReserveOfSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_ifrs-full_ReserveOfSharebasedPayments_label_en-US" xlink:label="lab_ifrs-full_ReserveOfSharebasedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reserve of share-based payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPayments" xlink:to="lab_ifrs-full_ReserveOfSharebasedPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AccumulatedImpairmentMember_019c4318-5379-7a1e-92ba-0d2579b79f1a_terseLabel_en-US" xlink:label="lab_ifrs-full_AccumulatedImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected Credit Losses</link:label>
    <link:label id="lab_ifrs-full_AccumulatedImpairmentMember_label_en-US" xlink:label="lab_ifrs-full_AccumulatedImpairmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated impairment [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedImpairmentMember" xlink:to="lab_ifrs-full_AccumulatedImpairmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_019c4318-5379-7b0f-85b3-d6f2f94f6070_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial instruments and risks</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of financial instruments [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_019c4318-52e4-7762-8199-658fdd84800e_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of commitments and contingent liabilities [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_FrenchPlanMember_019c6791-c120-783b-86f0-9ae82376bab8_terseLabel_en-US" xlink:label="lab_soph_FrenchPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">French plan</link:label>
    <link:label id="lab_soph_FrenchPlanMember_label_en-US" xlink:label="lab_soph_FrenchPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">French Plan [Member]</link:label>
    <link:label id="lab_soph_FrenchPlanMember_documentation_en-US" xlink:label="lab_soph_FrenchPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">French Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FrenchPlanMember" xlink:href="soph-20251231.xsd#soph_FrenchPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_FrenchPlanMember" xlink:to="lab_soph_FrenchPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_019c4318-5379-7b4b-8f72-8d8eb4b97a37_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Property and Equipment, Net</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-52e4-7b77-afaf-fce3dbeaca4d_terseLabel_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Classes of intangible assets and goodwill [domain]</link:label>
    <link:label id="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_label_en-US" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Classes of intangible assets and goodwill [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_BorrowingsInterestRate_019c4318-5379-71ea-84ca-4692c5ad9375_terseLabel_en-US" xlink:label="lab_ifrs-full_BorrowingsInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_ifrs-full_BorrowingsInterestRate_label_en-US" xlink:label="lab_ifrs-full_BorrowingsInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowings, interest rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsInterestRate" xlink:to="lab_ifrs-full_BorrowingsInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5379-7f71-986b-b8f4d2336de3_totalLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash flow (used in) provided from investing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5379-7b2e-a961-22532e7b6366_terseLabel_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net cash flow (used in) provided from investing activities</link:label>
    <link:label id="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash flows from (used in) investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis_019c4318-52e4-7cd9-aa56-ef1938e2873f_terseLabel_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting percentage on annual basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis_label_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Percentage Of Share Based Payment Arrangement Options On Annual Basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis_documentation_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting percentage of share-based payment arrangement option on each anniversary over four year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" xlink:to="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_IncreaseDecreaseInAuthorisedCapital_019caf47-7dc7-7692-b70a-883b969d1d07_terseLabel_en-US" xlink:label="lab_soph_IncreaseDecreaseInAuthorisedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized increase in nominal share capital</link:label>
    <link:label id="lab_soph_IncreaseDecreaseInAuthorisedCapital_label_en-US" xlink:label="lab_soph_IncreaseDecreaseInAuthorisedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Authorised Capital</link:label>
    <link:label id="lab_soph_IncreaseDecreaseInAuthorisedCapital_documentation_en-US" xlink:label="lab_soph_IncreaseDecreaseInAuthorisedCapital" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Number Of Shares Authorised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseInAuthorisedCapital" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseInAuthorisedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_IncreaseDecreaseInAuthorisedCapital" xlink:to="lab_soph_IncreaseDecreaseInAuthorisedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_019c4318-52e4-7471-82c8-90bfb51da805_terseLabel_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value Of Other Equity Instruments Vested In Share Based Payment Arrangement</link:label>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value Of Other Equity Instruments Vested In Share Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:to="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_019c4318-52e4-743b-8c78-1916e397b3fb_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Intangible Assets [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_019c4318-53fc-7513-b1d8-d7f8c4247fe3_terseLabel_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Experience adjustments</link:label>
    <link:label id="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Actuarial gains (losses) arising from experience adjustments, net of tax, defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:to="lab_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BostonMassachusettsMember_019c4318-5379-7f56-9d7a-7ceff443cb86_terseLabel_en-US" xlink:label="lab_soph_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Boston</link:label>
    <link:label id="lab_soph_BostonMassachusettsMember_label_en-US" xlink:label="lab_soph_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts [Member]</link:label>
    <link:label id="lab_soph_BostonMassachusettsMember_documentation_en-US" xlink:label="lab_soph_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Boston.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BostonMassachusettsMember" xlink:href="soph-20251231.xsd#soph_BostonMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BostonMassachusettsMember" xlink:to="lab_soph_BostonMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_LeaseExpenses_019c4318-52e4-7d06-a603-7c1fc4fea66d_terseLabel_en-US" xlink:label="lab_soph_LeaseExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease expenses</link:label>
    <link:label id="lab_soph_LeaseExpenses_label_en-US" xlink:label="lab_soph_LeaseExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Expenses</link:label>
    <link:label id="lab_soph_LeaseExpenses_documentation_en-US" xlink:label="lab_soph_LeaseExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseExpenses" xlink:href="soph-20251231.xsd#soph_LeaseExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_LeaseExpenses" xlink:to="lab_soph_LeaseExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_InventoryIncreaseInProvision_019c4318-52e4-77da-95af-383c7b11736c_negatedTerseLabel_en-US" xlink:label="lab_soph_InventoryIncreaseInProvision" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Increase</link:label>
    <link:label id="lab_soph_InventoryIncreaseInProvision_label_en-US" xlink:label="lab_soph_InventoryIncreaseInProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Increase In Provision</link:label>
    <link:label id="lab_soph_InventoryIncreaseInProvision_documentation_en-US" xlink:label="lab_soph_InventoryIncreaseInProvision" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inventory Increase In Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_InventoryIncreaseInProvision" xlink:href="soph-20251231.xsd#soph_InventoryIncreaseInProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_InventoryIncreaseInProvision" xlink:to="lab_soph_InventoryIncreaseInProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentAssets_019c4318-5378-7ad4-b8e5-e231160aa068_totalLabel_en-US" xlink:label="lab_ifrs-full_CurrentAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_ifrs-full_CurrentAssets_label_en-US" xlink:label="lab_ifrs-full_CurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="lab_ifrs-full_CurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ContractualCapitalCommitments_019c4318-52e4-7f82-b687-2dbe599b7180_terseLabel_en-US" xlink:label="lab_ifrs-full_ContractualCapitalCommitments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum purchase agreement commitment</link:label>
    <link:label id="lab_ifrs-full_ContractualCapitalCommitments_label_en-US" xlink:label="lab_ifrs-full_ContractualCapitalCommitments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual capital commitments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractualCapitalCommitments" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractualCapitalCommitments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractualCapitalCommitments" xlink:to="lab_ifrs-full_ContractualCapitalCommitments" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsTable_019c4318-5379-7b40-a927-88865321474d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Operating Segments [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_019c4318-5379-7422-8172-16f4a78a4cf2_negatedLabel_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Recognized in profit or loss</link:label>
    <link:label id="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_label_en-US" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred tax expense (income) recognised in profit or loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_LeaseLiabilitiesDiscountedPaymentsRate_019c4318-5379-794c-9bee-f1dfa83e862e_terseLabel_en-US" xlink:label="lab_soph_LeaseLiabilitiesDiscountedPaymentsRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities discounted payments rate</link:label>
    <link:label id="lab_soph_LeaseLiabilitiesDiscountedPaymentsRate_label_en-US" xlink:label="lab_soph_LeaseLiabilitiesDiscountedPaymentsRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Liabilities Discounted Payments Rate</link:label>
    <link:label id="lab_soph_LeaseLiabilitiesDiscountedPaymentsRate_documentation_en-US" xlink:label="lab_soph_LeaseLiabilitiesDiscountedPaymentsRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease liabilities discounted payments rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseLiabilitiesDiscountedPaymentsRate" xlink:href="soph-20251231.xsd#soph_LeaseLiabilitiesDiscountedPaymentsRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_LeaseLiabilitiesDiscountedPaymentsRate" xlink:to="lab_soph_LeaseLiabilitiesDiscountedPaymentsRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_InterestExpenseDefinedBenefitPlans_019c4318-5379-72eb-b911-7d2e2784b8f5_negatedLabel_en-US" xlink:label="lab_ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_ifrs-full_InterestExpenseDefinedBenefitPlans_label_en-US" xlink:label="lab_ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest expense, defined benefit plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:to="lab_ifrs-full_InterestExpenseDefinedBenefitPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_SegmentsAxis_019c4318-5379-76bb-9991-0cf4f7732cc4_terseLabel_en-US" xlink:label="lab_ifrs-full_SegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [axis]</link:label>
    <link:label id="lab_ifrs-full_SegmentsAxis_label_en-US" xlink:label="lab_ifrs-full_SegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentsAxis" xlink:to="lab_ifrs-full_SegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock_019c4318-53fc-70e1-bc68-d9192883880a_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Inventory Provision Movement</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Inventory Provision Movement [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The disclosure of inventory provision movement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NumberOfExecutiveOfficers_019c4318-53fc-7d18-a753-bddd5e7bb99c_terseLabel_en-US" xlink:label="lab_soph_NumberOfExecutiveOfficers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of executive officers</link:label>
    <link:label id="lab_soph_NumberOfExecutiveOfficers_label_en-US" xlink:label="lab_soph_NumberOfExecutiveOfficers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Executive Officers</link:label>
    <link:label id="lab_soph_NumberOfExecutiveOfficers_documentation_en-US" xlink:label="lab_soph_NumberOfExecutiveOfficers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Executive Officers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfExecutiveOfficers" xlink:href="soph-20251231.xsd#soph_NumberOfExecutiveOfficers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NumberOfExecutiveOfficers" xlink:to="lab_soph_NumberOfExecutiveOfficers" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock_019c4318-52e4-7c97-bb56-ee25cfbfeda9_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Accounts Payable</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Accounts Payables [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of accounts payables explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract_019c4318-52e4-7070-b4ee-c17e31021ab4_terseLabel_en-US" xlink:label="lab_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Provision Of Inventory [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract_label_en-US" xlink:label="lab_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Provision Of Inventory [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract_documentation_en-US" xlink:label="lab_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Provision Of Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInProvisionOfInventoryAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract" xlink:to="lab_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember_019c4318-52e4-798d-97f4-053303dcde31_terseLabel_en-US" xlink:label="lab_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rest of EMEA</link:label>
    <link:label id="lab_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember_label_en-US" xlink:label="lab_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Countries In Europe, Middle East, And Africa [Member]</link:label>
    <link:label id="lab_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember_documentation_en-US" xlink:label="lab_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Countries In Europe, Middle East, And Africa</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember" xlink:href="soph-20251231.xsd#soph_OtherCountriesInEuropeMiddleEastAndAfricaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember" xlink:to="lab_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_019c4318-5379-7724-86af-c8aa69678ec1_terseLabel_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_label_en-US" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted average exercise price of share options exercised in share-based payment arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock_019c4318-52e4-778f-9d88-05c78dd33f03_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Depreciation and Amortization have Charged in Expense</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock_label_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Detailed Information About Depreciation And Amortization Charged In Operating Expenses [Table Text Block]</link:label>
    <link:label id="lab_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock_documentation_en-US" xlink:label="lab_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure of depreciation and amortization have charged in expense explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock" xlink:to="lab_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-5379-7f79-b701-4601d37a0446_terseLabel_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [axis]</link:label>
    <link:label id="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_label_en-US" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Attribution of expenses by nature to their function [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_019c72dd-3526-7b0a-b830-a2645515012b_terseLabel_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSU vesting period on a quarterly basis</link:label>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_label_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On A Quarterly Basis</link:label>
    <link:label id="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_documentation_en-US" xlink:label="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On A Quarterly Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:to="lab_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember_019c4318-52e4-7545-82f0-2488ff40d1b0_terseLabel_en-US" xlink:label="lab_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consumer Price Indices in Switzerland and France</link:label>
    <link:label id="lab_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember_label_en-US" xlink:label="lab_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consumer Price Indices In Switzerland And France [Member]</link:label>
    <link:label id="lab_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember_documentation_en-US" xlink:label="lab_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Consumer price indices in Switzerland and France.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember" xlink:href="soph-20251231.xsd#soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember" xlink:to="lab_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_019c4318-53fc-7df3-95cc-9d7ce4953f48_terseLabel_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial assets at amortized cost</link:label>
    <link:label id="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_label_en-US" xlink:label="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial assets at amortised cost, category [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:to="lab_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_019c4318-5379-70ef-8925-2ad3223c1941_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility (%)</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected volatility, share options granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="lab_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ParValuePerShare_019caf49-8d2a-7a74-b4f2-7b79c2bb11e6_netLabel_en-US" xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Par value (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_ParValuePerShare_019c4318-5378-714f-9003-26bf8115ab04_verboseLabel_en-US" xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Nominal value (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_ParValuePerShare_label_en-US" xlink:label="lab_ifrs-full_ParValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Par value per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare" xlink:to="lab_ifrs-full_ParValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_019c4318-5379-7b8f-8bcf-c9082fd28c0c_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_NetDeferredTaxAssets_019c4318-52e4-7df1-aae5-6f0ca671e78c_terseLabel_en-US" xlink:label="lab_ifrs-full_NetDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_ifrs-full_NetDeferredTaxAssets_label_en-US" xlink:label="lab_ifrs-full_NetDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDeferredTaxAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDeferredTaxAssets" xlink:to="lab_ifrs-full_NetDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_019c72e0-de9f-73a1-8e23-4a4ceb2651be_terseLabel_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSU vesting percentage on a monthly basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_label_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On A Monthly Basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_documentation_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On A Monthly Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:to="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember_019c4318-5379-7032-bc15-a680632619c2_terseLabel_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Tranche Three</link:label>
    <link:label id="lab_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember_label_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Vesting Tranche Three [Member]</link:label>
    <link:label id="lab_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember_documentation_en-US" xlink:label="lab_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Vesting Tranche Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementVestingTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember" xlink:to="lab_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_019c4318-5379-7462-9f43-140b3790296c_terseLabel_en-US" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield (%)</link:label>
    <link:label id="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_label_en-US" xlink:label="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected dividend as percentage, share options granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="lab_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_019c4318-52e4-74a1-9ce1-6db04b24de35_terseLabel_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Post-employment benefit expense, 401(k) defined contribution plan</link:label>
    <link:label id="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_label_en-US" xlink:label="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Post-employment benefit expense, defined contribution plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:to="lab_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019c4318-5379-78fe-b2b8-3ffca0d48317_verboseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ComponentsOfEquityDomain_019c4318-5378-7aaf-8a8d-33e2e18f00b3_terseLabel_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of equity [domain]</link:label>
    <link:label id="lab_ifrs-full_ComponentsOfEquityDomain_label_en-US" xlink:label="lab_ifrs-full_ComponentsOfEquityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of equity [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain" xlink:to="lab_ifrs-full_ComponentsOfEquityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019c4318-52e4-74a7-8ebe-dc248d2a672d_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Operating Segments [Line Items]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of operating segments [line items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-52e4-758f-aca4-c678a0fc5c32_terseLabel_en-US" xlink:label="lab_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in deferred tax liability (asset) [abstract]</link:label>
    <link:label id="lab_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_label_en-US" xlink:label="lab_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changes in deferred tax liability (asset) [abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract" xlink:to="lab_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_NetLeaseReceivables_019c4318-5378-77ba-b47d-802d6135978e_terseLabel_en-US" xlink:label="lab_soph_NetLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net lease receivables</link:label>
    <link:label id="lab_soph_NetLeaseReceivables_label_en-US" xlink:label="lab_soph_NetLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Lease Receivables</link:label>
    <link:label id="lab_soph_NetLeaseReceivables_documentation_en-US" xlink:label="lab_soph_NetLeaseReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Net lease receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetLeaseReceivables" xlink:href="soph-20251231.xsd#soph_NetLeaseReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_NetLeaseReceivables" xlink:to="lab_soph_NetLeaseReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_019c4318-5378-79dc-babc-1911bd27182b_terseLabel_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Post-employment benefits</link:label>
    <link:label id="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_label_en-US" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description of accounting policy for employee benefits [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_CurrentGovernmentGrantsReceivable_019c4318-52e4-7419-9480-389e993b9995_terseLabel_en-US" xlink:label="lab_soph_CurrentGovernmentGrantsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government grants receivable</link:label>
    <link:label id="lab_soph_CurrentGovernmentGrantsReceivable_label_en-US" xlink:label="lab_soph_CurrentGovernmentGrantsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Government Grants Receivable</link:label>
    <link:label id="lab_soph_CurrentGovernmentGrantsReceivable_documentation_en-US" xlink:label="lab_soph_CurrentGovernmentGrantsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current government grants receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentGovernmentGrantsReceivable" xlink:href="soph-20251231.xsd#soph_CurrentGovernmentGrantsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_CurrentGovernmentGrantsReceivable" xlink:to="lab_soph_CurrentGovernmentGrantsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-52e4-7073-988c-97264af039df_terseLabel_en-US" xlink:label="lab_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Equity Instruments In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Equity Instruments In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_documentation_en-US" xlink:label="lab_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Equity Instruments In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:to="lab_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock_019c4318-52e4-7491-b61f-02304ae00733_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of preparation</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Basis Of Preparation [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for basis of preparation explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-5379-7472-a60c-451acb56000d_terseLabel_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</link:label>
    <link:label id="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_label_en-US" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WarrantObligationsMember_019c4318-5378-78a4-89c8-b3700079624f_terseLabel_en-US" xlink:label="lab_soph_WarrantObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant obligations</link:label>
    <link:label id="lab_soph_WarrantObligationsMember_label_en-US" xlink:label="lab_soph_WarrantObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Obligations [Member]</link:label>
    <link:label id="lab_soph_WarrantObligationsMember_documentation_en-US" xlink:label="lab_soph_WarrantObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantObligationsMember" xlink:href="soph-20251231.xsd#soph_WarrantObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WarrantObligationsMember" xlink:to="lab_soph_WarrantObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_OfficeSpaceMember_019c4318-5378-7ab5-9d53-30b25d9c3280_terseLabel_en-US" xlink:label="lab_soph_OfficeSpaceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Office Space</link:label>
    <link:label id="lab_soph_OfficeSpaceMember_label_en-US" xlink:label="lab_soph_OfficeSpaceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office Space [Member]</link:label>
    <link:label id="lab_soph_OfficeSpaceMember_documentation_en-US" xlink:label="lab_soph_OfficeSpaceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Office space.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OfficeSpaceMember" xlink:href="soph-20251231.xsd#soph_OfficeSpaceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_OfficeSpaceMember" xlink:to="lab_soph_OfficeSpaceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-52e4-71c6-801c-12b7a6d760da_terseLabel_en-US" xlink:label="lab_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Other Equity Instruments In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_label_en-US" xlink:label="lab_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Other Equity Instruments In Share-Based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_documentation_en-US" xlink:label="lab_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reconciliation Of Changes In Other Equity Instruments In Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:to="lab_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RangeDomain_019c4318-52e4-760b-a7fa-f5a3ce46cf9b_terseLabel_en-US" xlink:label="lab_ifrs-full_RangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Range [domain]</link:label>
    <link:label id="lab_ifrs-full_RangeDomain_label_en-US" xlink:label="lab_ifrs-full_RangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Range [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeDomain" xlink:to="lab_ifrs-full_RangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_PercentageOfCustomerBalanceAccountReceivable_019c4318-52e4-7101-a35f-ee465b9f034e_terseLabel_en-US" xlink:label="lab_soph_PercentageOfCustomerBalanceAccountReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of customer balance account receivable</link:label>
    <link:label id="lab_soph_PercentageOfCustomerBalanceAccountReceivable_label_en-US" xlink:label="lab_soph_PercentageOfCustomerBalanceAccountReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage Of Customer Balance Account Receivable</link:label>
    <link:label id="lab_soph_PercentageOfCustomerBalanceAccountReceivable_documentation_en-US" xlink:label="lab_soph_PercentageOfCustomerBalanceAccountReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of customer balance account receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PercentageOfCustomerBalanceAccountReceivable" xlink:href="soph-20251231.xsd#soph_PercentageOfCustomerBalanceAccountReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_PercentageOfCustomerBalanceAccountReceivable" xlink:to="lab_soph_PercentageOfCustomerBalanceAccountReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_019c4318-52e4-7d1d-a218-f2b3bbc5364f_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on disposal of property and equipment</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for gain (loss) on disposals, property, plant and equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_019c4318-52e4-72d4-9dab-1524515bdd48_terseLabel_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in accounts payables, accrued expenses, deferred contract revenue, and other liabilities</link:label>
    <link:label id="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_label_en-US" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments for increase (decrease) in trade and other payables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RevenueFromInterest_019c4318-53fc-7d9e-a38d-df1cb20c01ae_verboseLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_ifrs-full_RevenueFromInterest_019c4318-53fc-74c0-882c-a6b211ca9e1c_terseLabel_en-US" xlink:label="lab_ifrs-full_RevenueFromInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total interest income</link:label>
    <link:label id="lab_ifrs-full_RevenueFromInterest_label_en-US" xlink:label="lab_ifrs-full_RevenueFromInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromInterest" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromInterest" xlink:to="lab_ifrs-full_RevenueFromInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_RecurringFairValueMeasurementMember_019c4318-52e4-7108-a814-fe4fb90339ed_terseLabel_en-US" xlink:label="lab_ifrs-full_RecurringFairValueMeasurementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recurring fair value measurement</link:label>
    <link:label id="lab_ifrs-full_RecurringFairValueMeasurementMember_label_en-US" xlink:label="lab_ifrs-full_RecurringFairValueMeasurementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recurring fair value measurement [member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecurringFairValueMeasurementMember" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RecurringFairValueMeasurementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RecurringFairValueMeasurementMember" xlink:to="lab_ifrs-full_RecurringFairValueMeasurementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_ExpectedTermMeasurementInputMember_019c4318-52e4-789b-9d16-fcc616fee1cb_terseLabel_en-US" xlink:label="lab_soph_ExpectedTermMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_soph_ExpectedTermMeasurementInputMember_label_en-US" xlink:label="lab_soph_ExpectedTermMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expected Term, Measurement Input [Member]</link:label>
    <link:label id="lab_soph_ExpectedTermMeasurementInputMember_documentation_en-US" xlink:label="lab_soph_ExpectedTermMeasurementInputMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expected Term, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExpectedTermMeasurementInputMember" xlink:href="soph-20251231.xsd#soph_ExpectedTermMeasurementInputMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_ExpectedTermMeasurementInputMember" xlink:to="lab_soph_ExpectedTermMeasurementInputMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_019caf24-4e5c-7cee-a81c-2da35989ab7e_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Restatement Recovery Analysis [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Restatement Recovery Analysis [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:to="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_019c4318-52e4-7272-89fb-4004a7c6d675_verboseLabel_en-US" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_label_en-US" xlink:label="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expense from share-based payment transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="lab_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_IncomeStatementLocation1Domain_019c4318-53fc-742f-9175-10e80c8d1486_terseLabel_en-US" xlink:label="lab_soph_IncomeStatementLocation1Domain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_soph_IncomeStatementLocation1Domain_label_en-US" xlink:label="lab_soph_IncomeStatementLocation1Domain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location1 [Domain]</link:label>
    <link:label id="lab_soph_IncomeStatementLocation1Domain_documentation_en-US" xlink:label="lab_soph_IncomeStatementLocation1Domain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncomeStatementLocation1Domain" xlink:href="soph-20251231.xsd#soph_IncomeStatementLocation1Domain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_IncomeStatementLocation1Domain" xlink:to="lab_soph_IncomeStatementLocation1Domain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_019c4318-5379-723c-9078-1938ea82eae0_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Address Type</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_019c4318-5379-7d7a-b83e-9c0e7b1a6de0_terseLabel_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_label_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value Of Other Equity Instruments Granted In Share Based Payment Arrangement</link:label>
    <link:label id="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_documentation_en-US" xlink:label="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted-average grant date fair value of other equity instruments granted in share-based payment arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" xlink:to="lab_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CurrentLeaseLiabilities_019c4318-52e4-7558-a5cc-e06e388d4ca0_terseLabel_en-US" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities, current portion</link:label>
    <link:label id="lab_ifrs-full_CurrentLeaseLiabilities_019c89ba-0aae-707a-832b-68afda4e056d_verboseLabel_en-US" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current</link:label>
    <link:label id="lab_ifrs-full_CurrentLeaseLiabilities_label_en-US" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current lease liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_019c4318-53fc-7c30-9442-54400068a781_terseLabel_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting percentage on quarterly basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_label_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Percentage Of Share Based Payment Arrangement Option On Quarterly Basis</link:label>
    <link:label id="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_documentation_en-US" xlink:label="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting percentage of share-based payment arrangement option on monthly basis over remaining three years.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:to="lab_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_019c4318-52e4-7e8e-843c-3e562f98ed06_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_BorrowingTermsDomain_019c4318-52e4-75c3-bb5c-06a25e99d720_terseLabel_en-US" xlink:label="lab_soph_BorrowingTermsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Borrowing Terms [Domain]</link:label>
    <link:label id="lab_soph_BorrowingTermsDomain_label_en-US" xlink:label="lab_soph_BorrowingTermsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Borrowing Terms [Domain]</link:label>
    <link:label id="lab_soph_BorrowingTermsDomain_documentation_en-US" xlink:label="lab_soph_BorrowingTermsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Borrowing Terms [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsDomain" xlink:href="soph-20251231.xsd#soph_BorrowingTermsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_BorrowingTermsDomain" xlink:to="lab_soph_BorrowingTermsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DilutedEarningsLossPerShare_019c4318-5379-70e5-a450-58089c353cc5_terseLabel_en-US" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted loss per share (in dollars per share)</link:label>
    <link:label id="lab_ifrs-full_DilutedEarningsLossPerShare_label_en-US" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Diluted earnings (loss) per share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShare" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_MaturityDomain_019c4318-52e4-7b9c-90af-b2387e0f8921_terseLabel_en-US" xlink:label="lab_ifrs-full_MaturityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturity [domain]</link:label>
    <link:label id="lab_ifrs-full_MaturityDomain_label_en-US" xlink:label="lab_ifrs-full_MaturityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maturity [domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityDomain" xlink:to="lab_ifrs-full_MaturityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019c4318-5378-75ed-850a-169b7708a07a_terseLabel_en-US" xlink:label="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</link:label>
    <link:label id="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_label_en-US" xlink:label="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</link:label>
    <link:label id="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_documentation_en-US" xlink:label="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:href="soph-20251231.xsd#soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:to="lab_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_019c4318-52e4-70bf-867c-fba32ad9f71f_terseLabel_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Categories of financial liabilities [axis]</link:label>
    <link:label id="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_label_en-US" xlink:label="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Categories of financial liabilities [axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:to="lab_ifrs-full_CategoriesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_AreaOfOfficeSpaceLeased_019c4318-5379-7365-a0ea-c5023b88b02b_terseLabel_en-US" xlink:label="lab_soph_AreaOfOfficeSpaceLeased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of office space leased (in sq ft)</link:label>
    <link:label id="lab_soph_AreaOfOfficeSpaceLeased_label_en-US" xlink:label="lab_soph_AreaOfOfficeSpaceLeased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Area Of Office Space Leased</link:label>
    <link:label id="lab_soph_AreaOfOfficeSpaceLeased_documentation_en-US" xlink:label="lab_soph_AreaOfOfficeSpaceLeased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Area of office space leased.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AreaOfOfficeSpaceLeased" xlink:href="soph-20251231.xsd#soph_AreaOfOfficeSpaceLeased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_AreaOfOfficeSpaceLeased" xlink:to="lab_soph_AreaOfOfficeSpaceLeased" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-52e4-7713-9312-b7644a647255_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_EarningsPerShareExplanatory_019c4318-5379-723b-a054-ad3529e92f40_terseLabel_en-US" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Loss for Year</link:label>
    <link:label id="lab_ifrs-full_EarningsPerShareExplanatory_label_en-US" xlink:label="lab_ifrs-full_EarningsPerShareExplanatory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings per share [text block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EarningsPerShareExplanatory" xlink:to="lab_ifrs-full_EarningsPerShareExplanatory" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_RestrictedStockUnitsMember_019c4318-5379-70bd-a6ba-4246396988a1_terseLabel_en-US" xlink:label="lab_soph_RestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units</link:label>
    <link:label id="lab_soph_RestrictedStockUnitsMember_label_en-US" xlink:label="lab_soph_RestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units [Member]</link:label>
    <link:label id="lab_soph_RestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_soph_RestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted stock units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RestrictedStockUnitsMember" xlink:href="soph-20251231.xsd#soph_RestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_RestrictedStockUnitsMember" xlink:to="lab_soph_RestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_WorkflowEquipmentAndServicesMember_019c4318-52e4-71d5-a6ec-736179f067e1_terseLabel_en-US" xlink:label="lab_soph_WorkflowEquipmentAndServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Workflow equipment and services</link:label>
    <link:label id="lab_soph_WorkflowEquipmentAndServicesMember_label_en-US" xlink:label="lab_soph_WorkflowEquipmentAndServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workflow Equipment And Services [Member]</link:label>
    <link:label id="lab_soph_WorkflowEquipmentAndServicesMember_documentation_en-US" xlink:label="lab_soph_WorkflowEquipmentAndServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Workflow equipment and services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WorkflowEquipmentAndServicesMember" xlink:href="soph-20251231.xsd#soph_WorkflowEquipmentAndServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_WorkflowEquipmentAndServicesMember" xlink:to="lab_soph_WorkflowEquipmentAndServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-5378-7702-9c3b-a6dbf3c7c437_terseLabel_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure Of Property Plant And Equipment [Table]</link:label>
    <link:label id="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock_019c4318-52e4-791b-83a0-79fc72ac1e93_terseLabel_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provisions and contingencies</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock_label_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Description Of Accounting Policy For Provisions And Contingencies [Text Block]</link:label>
    <link:label id="lab_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock_documentation_en-US" xlink:label="lab_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Description of accounting policy for provisions and contingencies explanatory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock" xlink:to="lab_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_019c4318-52e4-70d5-b566-5d5ffe33d70a_negatedTerseLabel_en-US" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisition of intangible assets</link:label>
    <link:label id="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_label_en-US" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019c4318-52e4-7ee7-ac88-60b52e93c2da_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>soph-20251231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019c4318-4e70-7eba-b516-6c06258ef00a,g:b3ab9529-65b6-4117-b100-6d41f692b5c5-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CoverPage" xlink:type="simple" xlink:href="soph-20251231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019c4318-5179-789e-b830-d8f303a14592" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_019c4318-5179-7113-8165-67f7b6f10b87" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019c4318-5179-789e-b830-d8f303a14592" xlink:to="loc_dei_DocumentInformationTable_019c4318-5179-7113-8165-67f7b6f10b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_019c4318-5179-7fa5-964d-8e3164687908" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_019c4318-5179-7113-8165-67f7b6f10b87" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_019c4318-5179-7fa5-964d-8e3164687908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_019c4318-5179-7003-b574-0d6e2b17eb8d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_019c4318-5179-7fa5-964d-8e3164687908" xlink:to="loc_dei_AddressTypeDomain_019c4318-5179-7003-b574-0d6e2b17eb8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_019c4318-5179-72ee-ae18-f31e3a55e327" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_BusinessContactMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_019c4318-5179-7003-b574-0d6e2b17eb8d" xlink:to="loc_dei_BusinessContactMember_019c4318-5179-72ee-ae18-f31e3a55e327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_019c4318-5179-7113-8165-67f7b6f10b87" xlink:to="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019c4318-5179-7eec-a5cc-056ff9443599" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentType_019c4318-5179-7eec-a5cc-056ff9443599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_019c4318-5179-7621-99a4-5aad13dbb637" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentRegistrationStatement_019c4318-5179-7621-99a4-5aad13dbb637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_019c4318-5179-7b20-a2f6-b345d5591e58" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentAnnualReport_019c4318-5179-7b20-a2f6-b345d5591e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019c4318-5179-75e3-951f-3d46ca791fe4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentPeriodEndDate_019c4318-5179-75e3-951f-3d46ca791fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_019c4318-5179-737a-9653-70b2bf0d5679" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_CurrentFiscalYearEndDate_019c4318-5179-737a-9653-70b2bf0d5679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_019c4318-5179-77f4-9927-8d750dfc3249" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentTransitionReport_019c4318-5179-77f4-9927-8d750dfc3249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_019c4318-5179-7e3a-89a5-be308baa5115" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentShellCompanyReport_019c4318-5179-7e3a-89a5-be308baa5115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019c4318-5179-7af1-8c4a-07654a25ae05" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityFileNumber_019c4318-5179-7af1-8c4a-07654a25ae05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019c4318-5179-7eb5-9b85-1516a5b55f51" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityRegistrantName_019c4318-5179-7eb5-9b85-1516a5b55f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019c4318-5179-7063-a13a-1f2bc7e1efe1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019c4318-5179-7063-a13a-1f2bc7e1efe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019c4318-5179-73fe-a54d-72664b14a925" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressAddressLine1_019c4318-5179-73fe-a54d-72664b14a925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_019c4318-5179-7457-92d0-942e0e5eaaa7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressAddressLine2_019c4318-5179-7457-92d0-942e0e5eaaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019c4318-5179-7ea4-a8f1-221fd735d1d7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressPostalZipCode_019c4318-5179-7ea4-a8f1-221fd735d1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019c4318-5179-7fcb-817f-695161f94e5b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressCityOrTown_019c4318-5179-7fcb-817f-695161f94e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_019c4318-5179-75ce-b52a-c24783f8ddf3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressCountry_019c4318-5179-75ce-b52a-c24783f8ddf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_019c4318-5179-70a7-9d25-0d5f97d69d91" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ContactPersonnelName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_ContactPersonnelName_019c4318-5179-70a7-9d25-0d5f97d69d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019c4318-5179-73ad-b571-4b061ba6972c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityAddressStateOrProvince_019c4318-5179-73ad-b571-4b061ba6972c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019c4318-5179-74da-8c45-9adc35ad2d65" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_CityAreaCode_019c4318-5179-74da-8c45-9adc35ad2d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019c4318-5179-7ca6-afcd-fcc70ce8943c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_LocalPhoneNumber_019c4318-5179-7ca6-afcd-fcc70ce8943c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019c4318-5179-7108-be42-309d2922f9d4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_Security12bTitle_019c4318-5179-7108-be42-309d2922f9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019c4318-5179-752c-83e7-dee01b04e286" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_TradingSymbol_019c4318-5179-752c-83e7-dee01b04e286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019c4318-5179-7703-a65e-96ee4b027563" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_SecurityExchangeName_019c4318-5179-7703-a65e-96ee4b027563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_019c4318-5179-7b51-b5a2-a0cf2beb3a71" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_019c4318-5179-7b51-b5a2-a0cf2beb3a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_019c4318-5179-7e0c-b241-596ba5b992c3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_019c4318-5179-7e0c-b241-596ba5b992c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_019c4318-5179-7981-9612-e399fe17860a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityVoluntaryFilers_019c4318-5179-7981-9612-e399fe17860a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_019c4318-5179-7930-8e01-7c82fc4900f7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityCurrentReportingStatus_019c4318-5179-7930-8e01-7c82fc4900f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_019c4318-5179-7a57-91ef-dce578156e5f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityInteractiveDataCurrent_019c4318-5179-7a57-91ef-dce578156e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_019c4318-5179-7cde-b8b8-034d713b7885" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityFilerCategory_019c4318-5179-7cde-b8b8-034d713b7885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019c4318-5179-7bb7-85e7-ec560e5f6f3a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityEmergingGrowthCompany_019c4318-5179-7bb7-85e7-ec560e5f6f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_019c4318-5179-76df-aac7-125ea38e87ab" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityExTransitionPeriod_019c4318-5179-76df-aac7-125ea38e87ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_019c4318-5179-72ac-b231-b3f7caf94259" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_IcfrAuditorAttestationFlag_019c4318-5179-72ac-b231-b3f7caf94259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_019c4318-5179-7470-925e-187d44abd918" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_019c4318-5179-7470-925e-187d44abd918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_019caf24-4e5c-7deb-be91-e71a7d782235" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_019caf24-4e5c-7deb-be91-e71a7d782235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_019c4318-5179-74be-a714-5440a7d0fa10" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentAccountingStandard_019c4318-5179-74be-a714-5440a7d0fa10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_019c4318-5179-7f7b-abba-a7382d573c5c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityShellCompany_019c4318-5179-7f7b-abba-a7382d573c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019c4318-5179-7d0d-9517-db323d57e61c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_EntityCentralIndexKey_019c4318-5179-7d0d-9517-db323d57e61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_019c4318-5179-7cd2-9216-cf06a6c78c75" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentFiscalYearFocus_019c4318-5179-7cd2-9216-cf06a6c78c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_019c4318-5179-7896-8541-02c27cf75dc0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_DocumentFiscalPeriodFocus_019c4318-5179-7896-8541-02c27cf75dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019c4318-5179-7066-94f6-74c20b6fb474" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_019c4318-5179-77de-ae7d-0ff237c9f309" xlink:to="loc_dei_AmendmentFlag_019c4318-5179-7066-94f6-74c20b6fb474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AuditInformation" xlink:type="simple" xlink:href="soph-20251231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_AuditorAbstract_019c4318-5179-7fd2-84f5-fbfe547476c0" xlink:href="soph-20251231.xsd#soph_AuditorAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_019c4318-5179-7788-ad9e-83b173315006" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AuditorAbstract_019c4318-5179-7fd2-84f5-fbfe547476c0" xlink:to="loc_dei_AuditorFirmId_019c4318-5179-7788-ad9e-83b173315006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_019c4318-5179-705d-a36d-c24c768dcc97" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AuditorAbstract_019c4318-5179-7fd2-84f5-fbfe547476c0" xlink:to="loc_dei_AuditorName_019c4318-5179-705d-a36d-c24c768dcc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_019c4318-5179-7a5f-9c64-3a8b67767483" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AuditorAbstract_019c4318-5179-7fd2-84f5-fbfe547476c0" xlink:to="loc_dei_AuditorLocation_019c4318-5179-7a5f-9c64-3a8b67767483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss" xlink:type="simple" xlink:href="soph-20251231.xsd#ConsolidatedStatementsofLoss"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-5179-7107-b514-d959a2e8d7c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-5179-7107-b514-d959a2e8d7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSales_019c4318-5179-7cb5-8cd9-f1ed970f03cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_CostOfSales_019c4318-5179-7cb5-8cd9-f1ed970f03cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossProfit_019c4318-5179-7fa0-bb39-71c53e5d4fd6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_GrossProfit_019c4318-5179-7fa0-bb39-71c53e5d4fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_019c4318-5179-7144-903a-caeb00ec5289" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_019c4318-5179-7144-903a-caeb00ec5289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SalesAndMarketingExpense_019c4318-5179-7278-84c6-e268b2380534" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_SalesAndMarketingExpense_019c4318-5179-7278-84c6-e268b2380534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeneralAndAdministrativeExpense_019c4318-5179-7583-95a4-933091cce298" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_GeneralAndAdministrativeExpense_019c4318-5179-7583-95a4-933091cce298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_019c4318-5179-7c31-a1c5-0c5875da1899" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_019c4318-5179-7c31-a1c5-0c5875da1899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_019c4318-5179-71ff-b2d4-d3a2d872c225" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_019c4318-5179-71ff-b2d4-d3a2d872c225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromInterest_019c4318-5179-703d-ac31-508bb12b2919" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_RevenueFromInterest_019c4318-5179-703d-ac31-508bb12b2919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpense_019c4318-5179-7f3a-945e-f08f34bf118b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_InterestExpense_019c4318-5179-7f3a-945e-f08f34bf118b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c4318-5179-7092-925a-e25ac261119f" xlink:href="soph-20251231.xsd#soph_AdjustmentsForFairValueOfWarrantLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c4318-5179-7092-925a-e25ac261119f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ForeignExchangeAndOtherGainLoss_019c4318-5179-7d27-8f58-2d5010abb508" xlink:href="soph-20251231.xsd#soph_ForeignExchangeAndOtherGainLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_soph_ForeignExchangeAndOtherGainLoss_019c4318-5179-7d27-8f58-2d5010abb508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-7842-8a49-5efcbeb74f3b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-7842-8a49-5efcbeb74f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-5179-71c1-93f5-2454336e4738" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-5179-71c1-93f5-2454336e4738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_019c4318-5179-72e7-89c5-d5e5a3c0b0c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_ProfitLoss_019c4318-5179-72e7-89c5-d5e5a3c0b0c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_019c4318-5179-7a51-bd05-62dbc06a92d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_019c4318-5179-7a51-bd05-62dbc06a92d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_019c4318-5179-7668-8805-4b6827514f26" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeStatementAbstract_019c4318-5179-7c6f-864c-a829c4cf6ead" xlink:to="loc_ifrs-full_EarningsPerShareAbstract_019c4318-5179-7668-8805-4b6827514f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_019c4318-5179-7f8c-9bcc-3059d756c257" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019c4318-5179-7668-8805-4b6827514f26" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_019c4318-5179-7f8c-9bcc-3059d756c257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_019c4318-5179-759f-9265-c3921105c3f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019c4318-5179-7668-8805-4b6827514f26" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_019c4318-5179-759f-9265-c3921105c3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="soph-20251231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_019c4318-5179-7afe-8162-73eaf2d8039e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_019c4318-5179-781a-bc7a-c2a6b322db59" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_019c4318-5179-7afe-8162-73eaf2d8039e" xlink:to="loc_ifrs-full_ProfitLoss_019c4318-5179-781a-bc7a-c2a6b322db59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_019c4318-5179-73a1-afcf-b27a01cddbc4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_019c4318-5179-7afe-8162-73eaf2d8039e" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeAbstract_019c4318-5179-73a1-afcf-b27a01cddbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_019c4318-5179-7ae7-8b9f-2e81fc898ad1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_019c4318-5179-73a1-afcf-b27a01cddbc4" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_019c4318-5179-7ae7-8b9f-2e81fc898ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_019c4318-5179-7720-840d-3e6dd5761949" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_019c4318-5179-7ae7-8b9f-2e81fc898ad1" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_019c4318-5179-7720-840d-3e6dd5761949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-7452-90d5-6a7a3c3bef90" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract_019c4318-5179-7ae7-8b9f-2e81fc898ad1" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-7452-90d5-6a7a3c3bef90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_019c4318-5179-7e9c-be9a-4b0643d6b463" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_019c4318-5179-73a1-afcf-b27a01cddbc4" xlink:to="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_019c4318-5179-7e9c-be9a-4b0643d6b463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-5179-782d-9882-27e5cb44e97e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_019c4318-5179-7e9c-be9a-4b0643d6b463" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-5179-782d-9882-27e5cb44e97e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-77c5-bd1a-f99340b374e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract_019c4318-5179-7e9c-be9a-4b0643d6b463" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_019c4318-5179-77c5-bd1a-f99340b374e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_019c4318-5179-7392-8709-7457344aeef7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_019c4318-5179-73a1-afcf-b27a01cddbc4" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_019c4318-5179-7392-8709-7457344aeef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_019c4318-5179-7bd8-8614-4c58e16bdb51" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_019c4318-5179-7afe-8162-73eaf2d8039e" xlink:to="loc_ifrs-full_ComprehensiveIncome_019c4318-5179-7bd8-8614-4c58e16bdb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_019c4318-5179-787c-89ea-163c0786afb5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_019c4318-5179-7afe-8162-73eaf2d8039e" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_019c4318-5179-787c-89ea-163c0786afb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="soph-20251231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_019c4318-5179-7c15-b6fc-d07adb722877" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AssetsAbstract_019c4318-5179-7e53-a23a-846d6300b11f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_019c4318-5179-7c15-b6fc-d07adb722877" xlink:to="loc_ifrs-full_AssetsAbstract_019c4318-5179-7e53-a23a-846d6300b11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssetsAbstract_019c4318-5179-7639-ab10-9a7cf94d331f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_019c4318-5179-7e53-a23a-846d6300b11f" xlink:to="loc_ifrs-full_CurrentAssetsAbstract_019c4318-5179-7639-ab10-9a7cf94d331f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019c4318-5179-7877-9051-4c102db64fa0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_019c4318-5179-7639-ab10-9a7cf94d331f" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019c4318-5179-7877-9051-4c102db64fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentReceivables_019c4318-5179-7810-86cd-00d39edddbf8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_019c4318-5179-7639-ab10-9a7cf94d331f" xlink:to="loc_ifrs-full_TradeAndOtherCurrentReceivables_019c4318-5179-7810-86cd-00d39edddbf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_019c4318-5179-7430-b4e3-8310b2219f0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_019c4318-5179-7639-ab10-9a7cf94d331f" xlink:to="loc_ifrs-full_Inventories_019c4318-5179-7430-b4e3-8310b2219f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-5179-753f-8698-9c4e206421c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_019c4318-5179-7639-ab10-9a7cf94d331f" xlink:to="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-5179-753f-8698-9c4e206421c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentAssets_019c4318-5179-700f-a47a-08b7f3133031" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentAssetsAbstract_019c4318-5179-7639-ab10-9a7cf94d331f" xlink:to="loc_ifrs-full_CurrentAssets_019c4318-5179-700f-a47a-08b7f3133031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_019c4318-5179-73fd-9c0f-71399b6761c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_019c4318-5179-7e53-a23a-846d6300b11f" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_019c4318-5179-73fd-9c0f-71399b6761c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_019c4318-5179-7e78-a7b1-4194e079ce9a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019c4318-5179-73fd-9c0f-71399b6761c7" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_019c4318-5179-7e78-a7b1-4194e079ce9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_019c4318-5179-75c9-acf3-e99fca1acb7f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019c4318-5179-73fd-9c0f-71399b6761c7" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_019c4318-5179-75c9-acf3-e99fca1acb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_019c4318-5179-745a-b14e-45236d780404" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019c4318-5179-73fd-9c0f-71399b6761c7" xlink:to="loc_ifrs-full_RightofuseAssets_019c4318-5179-745a-b14e-45236d780404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NetDeferredTaxAssets_019c4318-5179-72d1-a413-9ed8595d8b1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDeferredTaxAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019c4318-5179-73fd-9c0f-71399b6761c7" xlink:to="loc_ifrs-full_NetDeferredTaxAssets_019c4318-5179-72d1-a413-9ed8595d8b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_019c4318-5179-71a1-8e58-ff6b04c90d96" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019c4318-5179-73fd-9c0f-71399b6761c7" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_019c4318-5179-71a1-8e58-ff6b04c90d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssets_019c4318-5179-7db0-ab6e-5e922a17a8bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_019c4318-5179-73fd-9c0f-71399b6761c7" xlink:to="loc_ifrs-full_NoncurrentAssets_019c4318-5179-7db0-ab6e-5e922a17a8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Assets_019c4318-5179-7942-b474-26ad71cc32f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_019c4318-5179-7e53-a23a-846d6300b11f" xlink:to="loc_ifrs-full_Assets_019c4318-5179-7942-b474-26ad71cc32f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_019c4318-5179-7aae-a6ba-6f1d7ae4cc96" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_019c4318-5179-7c15-b6fc-d07adb722877" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_019c4318-5179-7aae-a6ba-6f1d7ae4cc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilitiesAbstract_019c4318-5179-7b58-8596-5228f8a7178f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_019c4318-5179-7aae-a6ba-6f1d7ae4cc96" xlink:to="loc_ifrs-full_CurrentLiabilitiesAbstract_019c4318-5179-7b58-8596-5228f8a7178f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-5179-7087-9d9e-b800dc4ad235" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019c4318-5179-7b58-8596-5228f8a7178f" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-5179-7087-9d9e-b800dc4ad235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentAccruedExpenses_019c4318-5179-790e-8ae7-a07001bf6c70" xlink:href="soph-20251231.xsd#soph_CurrentAccruedExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019c4318-5179-7b58-8596-5228f8a7178f" xlink:to="loc_soph_CurrentAccruedExpenses_019c4318-5179-790e-8ae7-a07001bf6c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_019c4318-5179-7f31-af06-6b9a9d367d54" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019c4318-5179-7b58-8596-5228f8a7178f" xlink:to="loc_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities_019c4318-5179-7f31-af06-6b9a9d367d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_019c4318-5179-752f-90c9-c9afd4f6a6c3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019c4318-5179-7b58-8596-5228f8a7178f" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_019c4318-5179-752f-90c9-c9afd4f6a6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentWarrantLiability_019c4318-5179-7c50-9b72-42581b4a5d5f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019c4318-5179-7b58-8596-5228f8a7178f" xlink:to="loc_ifrs-full_CurrentWarrantLiability_019c4318-5179-7c50-9b72-42581b4a5d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLiabilities_019c4318-5179-754d-8bdd-3b3b3bfb5c28" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentLiabilitiesAbstract_019c4318-5179-7b58-8596-5228f8a7178f" xlink:to="loc_ifrs-full_CurrentLiabilities_019c4318-5179-754d-8bdd-3b3b3bfb5c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019c4318-5179-7d9a-9b04-0784994ef4ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_019c4318-5179-7aae-a6ba-6f1d7ae4cc96" xlink:to="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019c4318-5179-7d9a-9b04-0784994ef4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowings_019c4318-5179-7e72-af15-69199964cf14" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019c4318-5179-7d9a-9b04-0784994ef4ea" xlink:to="loc_ifrs-full_LongtermBorrowings_019c4318-5179-7e72-af15-69199964cf14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_019c4318-5179-7d18-94f9-a90080366bb1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019c4318-5179-7d9a-9b04-0784994ef4ea" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_019c4318-5179-7d18-94f9-a90080366bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_019c4318-5179-7eef-ab02-4db005a15485" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019c4318-5179-7d9a-9b04-0784994ef4ea" xlink:to="loc_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan_019c4318-5179-7eef-ab02-4db005a15485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_019c4318-5179-7068-a6b1-f2fd3a860899" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019c4318-5179-7d9a-9b04-0784994ef4ea" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_019c4318-5179-7068-a6b1-f2fd3a860899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLiabilities_019c4318-5179-7263-8d3f-f314b31254e2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentLiabilitiesAbstract_019c4318-5179-7d9a-9b04-0784994ef4ea" xlink:to="loc_ifrs-full_NoncurrentLiabilities_019c4318-5179-7263-8d3f-f314b31254e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Liabilities_019c4318-5179-789e-ba96-a366944abb84" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_019c4318-5179-7aae-a6ba-6f1d7ae4cc96" xlink:to="loc_ifrs-full_Liabilities_019c4318-5179-789e-ba96-a366944abb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAbstract_019c4318-5179-77d3-a876-44e6580a0606" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_019c4318-5179-7aae-a6ba-6f1d7ae4cc96" xlink:to="loc_ifrs-full_EquityAbstract_019c4318-5179-77d3-a876-44e6580a0606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapital_019c4318-5179-7f67-ab19-951a2a44c5b3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019c4318-5179-77d3-a876-44e6580a0606" xlink:to="loc_ifrs-full_IssuedCapital_019c4318-5179-7f67-ab19-951a2a44c5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremium_019c4318-5179-76ba-95fe-638473e143e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019c4318-5179-77d3-a876-44e6580a0606" xlink:to="loc_ifrs-full_SharePremium_019c4318-5179-76ba-95fe-638473e143e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasuryShares_019c4318-5179-70c0-b5f8-c9da44255d53" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasuryShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019c4318-5179-77d3-a876-44e6580a0606" xlink:to="loc_ifrs-full_TreasuryShares_019c4318-5179-70c0-b5f8-c9da44255d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReserves_019c4318-5179-7982-a0ad-9cd0f7f7a807" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019c4318-5179-77d3-a876-44e6580a0606" xlink:to="loc_ifrs-full_OtherReserves_019c4318-5179-7982-a0ad-9cd0f7f7a807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarnings_019c4318-5179-7701-9c0c-0466e4553838" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019c4318-5179-77d3-a876-44e6580a0606" xlink:to="loc_ifrs-full_RetainedEarnings_019c4318-5179-7701-9c0c-0466e4553838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019c4318-5179-74fd-ad44-9bdc537743e0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAbstract_019c4318-5179-77d3-a876-44e6580a0606" xlink:to="loc_ifrs-full_Equity_019c4318-5179-74fd-ad44-9bdc537743e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityAndLiabilities_019c4318-5179-7bc9-8025-c3011513e0fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_019c4318-5179-7aae-a6ba-6f1d7ae4cc96" xlink:to="loc_ifrs-full_EquityAndLiabilities_019c4318-5179-7bc9-8025-c3011513e0fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="simple" xlink:href="soph-20251231.xsd#ConsolidatedStatementsofChangesinEquity"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_019c4318-5179-7177-8042-bf94eebfe927" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_019c4318-5179-7af8-a791-84c1b57b4514" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_019c4318-5179-7177-8042-bf94eebfe927" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_019c4318-5179-7af8-a791-84c1b57b4514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-7a5e-bf6d-a97893ff9b44" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_019c4318-5179-7af8-a791-84c1b57b4514" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-7a5e-bf6d-a97893ff9b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-7a5e-bf6d-a97893ff9b44" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_019c4318-5179-7255-8b57-acc070c7d206" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:to="loc_ifrs-full_IssuedCapitalMember_019c4318-5179-7255-8b57-acc070c7d206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasurySharesMember_019c4318-5179-748d-862e-e9272cfbd1c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:to="loc_ifrs-full_TreasurySharesMember_019c4318-5179-748d-862e-e9272cfbd1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SharePremiumMember_019c4318-5179-77ac-9bfa-ea792361f8a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SharePremiumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:to="loc_ifrs-full_SharePremiumMember_019c4318-5179-77ac-9bfa-ea792361f8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherReservesMember_019c4318-5179-71b7-b046-635c54959334" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherReservesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:to="loc_ifrs-full_OtherReservesMember_019c4318-5179-71b7-b046-635c54959334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RetainedEarningsMember_019c4318-5179-7cfd-8be2-76123183eb99" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-74cf-bab3-430612ad7a1c" xlink:to="loc_ifrs-full_RetainedEarningsMember_019c4318-5179-7cfd-8be2-76123183eb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_019c4318-5179-7af8-a791-84c1b57b4514" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_019c4318-5179-7b1d-8f83-8b0c730effc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_NumberOfSharesIssued_019c4318-5179-7b1d-8f83-8b0c730effc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019c4318-5179-706d-a1cf-6b29920cd714" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_Equity_019c4318-5179-706d-a1cf-6b29920cd714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLoss_019c4318-5179-7003-9332-4544922243cc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_ProfitLoss_019c4318-5179-7003-9332-4544922243cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_019c4318-5179-752c-a9dc-93928d363daf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_019c4318-5179-752c-a9dc-93928d363daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComprehensiveIncome_019c4318-5179-7565-87dc-3deb11669074" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_ComprehensiveIncome_019c4318-5179-7565-87dc-3deb11669074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019c4318-5179-7f5f-805f-89412074c49b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019c4318-5179-7f5f-805f-89412074c49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:href="soph-20251231.xsd#soph_TransactionsWithOwnersAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_019c4318-5179-705c-9500-d12edeb8b42c" xlink:href="soph-20251231.xsd#soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_019c4318-5179-705c-9500-d12edeb8b42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity_019c4318-5179-71bd-9f9d-308a01016a63" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity_019c4318-5179-71bd-9f9d-308a01016a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfTreasurySharesIssued_019c4318-5179-7056-8810-9e80a15132e2" xlink:href="soph-20251231.xsd#soph_NumberOfTreasurySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_soph_NumberOfTreasurySharesIssued_019c4318-5179-7056-8810-9e80a15132e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SaleOrIssueOfTreasuryShares_019c4318-5179-752d-b975-282ddc2fe327" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SaleOrIssueOfTreasuryShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_ifrs-full_SaleOrIssueOfTreasuryShares_019c4318-5179-752d-b975-282ddc2fe327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquitySharesIssued_019c66a7-6861-7af8-b152-fc73215ea3c5" xlink:href="soph-20251231.xsd#soph_NumberOfEquitySharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_soph_NumberOfEquitySharesIssued_019c66a7-6861-7af8-b152-fc73215ea3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_019c66a2-68f6-75a7-9656-c0a134582146" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TransactionsWithOwnersAbstract_019c4318-5179-7f08-8991-17d231c43052" xlink:to="loc_ifrs-full_IssueOfEquity_019c66a2-68f6-75a7-9656-c0a134582146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_019c4318-5179-738e-baf8-a36d6cb8124d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_NumberOfSharesIssued_019c4318-5179-738e-baf8-a36d6cb8124d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Equity_019c4318-5179-715b-8325-5cde011fa651" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_019c4318-5179-7a3d-9c6d-44ddbe324df9" xlink:to="loc_ifrs-full_Equity_019c4318-5179-715b-8325-5cde011fa651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="soph-20251231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_019c4318-5179-7e37-94da-10d48e0930a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019c4318-5179-7107-921c-b3eedbef69a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019c4318-5179-7e37-94da-10d48e0930a4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019c4318-5179-7107-921c-b3eedbef69a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-787b-98cd-9d00146b7c3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019c4318-5179-7107-921c-b3eedbef69a9" xlink:to="loc_ifrs-full_ProfitLossBeforeTax_019c4318-5179-787b-98cd-9d00146b7c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019c4318-5179-7107-921c-b3eedbef69a9" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDepreciationExpense_019c4318-5179-7804-af47-38d4ac2258ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDepreciationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:to="loc_ifrs-full_AdjustmentsForDepreciationExpense_019c4318-5179-7804-af47-38d4ac2258ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationExpense_019c4318-5179-7785-8e75-a44c14025a3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:to="loc_ifrs-full_AmortisationExpense_019c4318-5179-7785-8e75-a44c14025a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForFinanceExpenseIncomeNet_019c4318-5179-771f-a120-f5c92c885c4a" xlink:href="soph-20251231.xsd#soph_AdjustmentsForFinanceExpenseIncomeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:to="loc_soph_AdjustmentsForFinanceExpenseIncomeNet_019c4318-5179-771f-a120-f5c92c885c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c4318-5179-77e3-a142-0fc1a04de9c9" xlink:href="soph-20251231.xsd#soph_AdjustmentsForFairValueOfWarrantLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:to="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c4318-5179-77e3-a142-0fc1a04de9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForCreditLossAllowance_019c4318-5179-72ce-9d72-4a3e1faa7ec9" xlink:href="soph-20251231.xsd#soph_AdjustmentsForCreditLossAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:to="loc_soph_AdjustmentsForCreditLossAllowance_019c4318-5179-72ce-9d72-4a3e1faa7ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_019c4318-5179-7ab4-9666-716e3eab52e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_019c4318-5179-7ab4-9666-716e3eab52e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_019c4318-5179-7abe-8965-809c1a4fc2d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities_019c4318-5179-7abe-8965-809c1a4fc2d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForResearchTaxCredit_019c4318-5179-7e45-9165-968e34068833" xlink:href="soph-20251231.xsd#soph_AdjustmentsForResearchTaxCredit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:to="loc_soph_AdjustmentsForResearchTaxCredit_019c4318-5179-7e45-9165-968e34068833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_019c4318-5179-72d4-a79d-9b8b9c91b273" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:to="loc_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_019c4318-5179-72d4-a79d-9b8b9c91b273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GainLossOnDisposalOfLeaseLiability_019c4318-5179-768e-a2fc-921f58fc0418" xlink:href="soph-20251231.xsd#soph_GainLossOnDisposalOfLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:to="loc_soph_GainLossOnDisposalOfLeaseLiability_019c4318-5179-768e-a2fc-921f58fc0418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WorkingCapitalChangesAbstract_019c4318-5179-74b3-b3c6-f9a19db71c31" xlink:href="soph-20251231.xsd#soph_WorkingCapitalChangesAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_019c4318-5179-7a29-b439-5d340dd0da3b" xlink:to="loc_soph_WorkingCapitalChangesAbstract_019c4318-5179-74b3-b3c6-f9a19db71c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_019c4318-5179-7977-ac3e-7277bcdcdd02" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WorkingCapitalChangesAbstract_019c4318-5179-74b3-b3c6-f9a19db71c31" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_019c4318-5179-7977-ac3e-7277bcdcdd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_019c4318-5179-7dc0-bfbd-4f923072727f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WorkingCapitalChangesAbstract_019c4318-5179-74b3-b3c6-f9a19db71c31" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses_019c4318-5179-7dc0-bfbd-4f923072727f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_019c4318-5179-7277-88f9-df5f79010e45" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WorkingCapitalChangesAbstract_019c4318-5179-74b3-b3c6-f9a19db71c31" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_019c4318-5179-7277-88f9-df5f79010e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_019c4318-5179-703f-a4a3-910aeec228d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WorkingCapitalChangesAbstract_019c4318-5179-74b3-b3c6-f9a19db71c31" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables_019c4318-5179-703f-a4a3-910aeec228d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-7f5f-a9c0-0691c0be4d55" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019c4318-5179-7107-921c-b3eedbef69a9" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperations_019c4318-5179-7f5f-a9c0-0691c0be4d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_019c4318-5179-74d6-b783-7d720c3a4a44" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019c4318-5179-7107-921c-b3eedbef69a9" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_019c4318-5179-74d6-b783-7d720c3a4a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c4318-5179-7d5a-8770-2ed463afe7eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_019c4318-5179-7107-921c-b3eedbef69a9" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c4318-5179-7d5a-8770-2ed463afe7eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019c4318-5179-79cd-8c95-c34110e18ad3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019c4318-5179-7e37-94da-10d48e0930a4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019c4318-5179-79cd-8c95-c34110e18ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_019c4318-5179-70c1-b6bd-248394dce014" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019c4318-5179-79cd-8c95-c34110e18ad3" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_019c4318-5179-70c1-b6bd-248394dce014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_019c4318-5179-73ba-a696-3bca529867ab" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019c4318-5179-79cd-8c95-c34110e18ad3" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_019c4318-5179-73ba-a696-3bca529867ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CapitalizedSoftwareDevelopmentCosts_019c4318-5179-7e53-b040-7baa1c2aa26c" xlink:href="soph-20251231.xsd#soph_CapitalizedSoftwareDevelopmentCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019c4318-5179-79cd-8c95-c34110e18ad3" xlink:to="loc_soph_CapitalizedSoftwareDevelopmentCosts_019c4318-5179-7e53-b040-7baa1c2aa26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_019c66b7-a998-7777-8084-70bb3e3a183b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019c4318-5179-79cd-8c95-c34110e18ad3" xlink:to="loc_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod_019c66b7-a998-7777-8084-70bb3e3a183b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_019c4318-5179-7762-83fc-89463c8a7ffb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019c4318-5179-79cd-8c95-c34110e18ad3" xlink:to="loc_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments_019c4318-5179-7762-83fc-89463c8a7ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_019c4318-5179-727d-8a48-e9791d854458" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019c4318-5179-79cd-8c95-c34110e18ad3" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsInvestingActivities_019c4318-5179-727d-8a48-e9791d854458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5179-7159-98c8-f7ed71ded19f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_019c4318-5179-79cd-8c95-c34110e18ad3" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c4318-5179-7159-98c8-f7ed71ded19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019c4318-5179-7cb2-beae-c74a2f9e896a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019c4318-5179-7e37-94da-10d48e0930a4" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019c4318-5179-7cb2-beae-c74a2f9e896a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromExerciseOfOptions_019c4318-5179-7950-8a81-72ec3019c434" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromExerciseOfOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019c4318-5179-7cb2-beae-c74a2f9e896a" xlink:to="loc_ifrs-full_ProceedsFromExerciseOfOptions_019c4318-5179-7950-8a81-72ec3019c434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_019c66bb-486e-73ee-9e71-db6fdb2893f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019c4318-5179-7cb2-beae-c74a2f9e896a" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsFinancingActivities_019c66bb-486e-73ee-9e71-db6fdb2893f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_019c4318-5179-7c12-b499-8ea72adb2cf0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019c4318-5179-7cb2-beae-c74a2f9e896a" xlink:to="loc_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities_019c4318-5179-7c12-b499-8ea72adb2cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_019c74af-f429-7258-9c38-2802d4343dc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019c4318-5179-7cb2-beae-c74a2f9e896a" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_019c74af-f429-7258-9c38-2802d4343dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_019c4318-5179-7fe0-bd56-ad5018f3005f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019c4318-5179-7cb2-beae-c74a2f9e896a" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_019c4318-5179-7fe0-bd56-ad5018f3005f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-5179-78bb-995c-a2283feecb56" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_019c4318-5179-7cb2-beae-c74a2f9e896a" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c4318-5179-78bb-995c-a2283feecb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_019c4318-5179-7a5f-af67-79209222d14d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019c4318-5179-7e37-94da-10d48e0930a4" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges_019c4318-5179-7a5f-af67-79209222d14d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_019c4318-5179-771c-a5d6-e29c55a1ad12" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019c4318-5179-7e37-94da-10d48e0930a4" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_019c4318-5179-771c-a5d6-e29c55a1ad12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019c4318-5179-7311-9ab1-8892e720e129" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019c4318-5179-7e37-94da-10d48e0930a4" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019c4318-5179-7311-9ab1-8892e720e129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019c4318-5179-7fde-a08e-caa34a98ed3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_019c4318-5179-7e37-94da-10d48e0930a4" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019c4318-5179-7fde-a08e-caa34a98ed3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Companyinformationandoperations" xlink:type="simple" xlink:href="soph-20251231.xsd#Companyinformationandoperations"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Companyinformationandoperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsAbstract_019c4318-5179-7d80-a0cc-2fe2e1e1808e" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsTextBlock_019c4318-5179-7e5d-b152-5e5c817668bf" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsAbstract_019c4318-5179-7d80-a0cc-2fe2e1e1808e" xlink:to="loc_soph_DisclosureOfCompanyInformationAndOperationsTextBlock_019c4318-5179-7e5d-b152-5e5c817668bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Materialaccountingpolicies" xlink:type="simple" xlink:href="soph-20251231.xsd#Materialaccountingpolicies"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Materialaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-7602-9e1b-b8b298924e54" xlink:href="soph-20251231.xsd#soph_SummaryOfMaterialAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_019c4318-5179-7d43-bafc-8ebdec114698" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-7602-9e1b-b8b298924e54" xlink:to="loc_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory_019c4318-5179-7d43-bafc-8ebdec114698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Segmentreporting" xlink:type="simple" xlink:href="soph-20251231.xsd#Segmentreporting"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Segmentreporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019c4318-5179-74b1-92ee-484933f92e16" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_019c4318-5179-719a-afae-0a3d566cd290" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019c4318-5179-74b1-92ee-484933f92e16" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_019c4318-5179-719a-afae-0a3d566cd290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Revenue" xlink:type="simple" xlink:href="soph-20251231.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019c4318-5179-7907-ac61-233bd9ee07cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_019c4318-5179-7fe7-9d5d-fe2ca10addd9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019c4318-5179-7907-ac61-233bd9ee07cf" xlink:to="loc_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_019c4318-5179-7fe7-9d5d-fe2ca10addd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Costofrevenue" xlink:type="simple" xlink:href="soph-20251231.xsd#Costofrevenue"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Costofrevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCostOfSalesAbstract_019c4318-517a-77a9-ba88-1afb18dcd7ed" xlink:href="soph-20251231.xsd#soph_DisclosureOfCostOfSalesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_019c4318-517a-708c-a787-7068451cebee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCostOfSalesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCostOfSalesAbstract_019c4318-517a-77a9-ba88-1afb18dcd7ed" xlink:to="loc_ifrs-full_DisclosureOfCostOfSalesExplanatory_019c4318-517a-708c-a787-7068451cebee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Operatingexpense" xlink:type="simple" xlink:href="soph-20251231.xsd#Operatingexpense"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Operatingexpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_019c4318-517a-7886-a363-633bffbe9484" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfOperatingExpenseTextBlock_019c4318-517a-71ac-9985-7135bba5b151" xlink:href="soph-20251231.xsd#soph_DisclosureOfOperatingExpenseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_019c4318-517a-7886-a363-633bffbe9484" xlink:to="loc_soph_DisclosureOfOperatingExpenseTextBlock_019c4318-517a-71ac-9985-7135bba5b151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Otheroperatingincomenet" xlink:type="simple" xlink:href="soph-20251231.xsd#Otheroperatingincomenet"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Otheroperatingincomenet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_OtherOperatingIncomeExpenseNetAbstract_019c4318-517a-75f3-825a-dba7c08b367e" xlink:href="soph-20251231.xsd#soph_OtherOperatingIncomeExpenseNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_019c4318-517a-7fd3-9c27-89b34a229a79" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_OtherOperatingIncomeExpenseNetAbstract_019c4318-517a-75f3-825a-dba7c08b367e" xlink:to="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_019c4318-517a-7fd3-9c27-89b34a229a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnet" xlink:type="simple" xlink:href="soph-20251231.xsd#InterestincomeInterestexpenseandForeignexchangelossesgainsnet"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-70c6-b87d-d5a158260a21" xlink:href="soph-20251231.xsd#soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinanceCostExplanatory_019c4318-517a-7d24-a575-5e6750d827fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceCostExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-70c6-b87d-d5a158260a21" xlink:to="loc_ifrs-full_DisclosureOfFinanceCostExplanatory_019c4318-517a-7d24-a575-5e6750d827fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Incometax" xlink:type="simple" xlink:href="soph-20251231.xsd#Incometax"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Incometax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7508-8fce-eedca1edbaae" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_019c4318-517a-7873-a50c-bb2098ad407a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7508-8fce-eedca1edbaae" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_019c4318-517a-7873-a50c-bb2098ad407a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Losspershare" xlink:type="simple" xlink:href="soph-20251231.xsd#Losspershare"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Losspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7feb-ac1b-34c745f98b27" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_019c4318-517a-7e32-a7c8-48bb0d04df82" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7feb-ac1b-34c745f98b27" xlink:to="loc_ifrs-full_DisclosureOfEarningsPerShareExplanatory_019c4318-517a-7e32-a7c8-48bb0d04df82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Cashandcashequivalents" xlink:type="simple" xlink:href="soph-20251231.xsd#Cashandcashequivalents"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Cashandcashequivalents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_019c4318-517a-70a6-ae89-964e27cd24ec" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_019c4318-517a-7cb1-8f9b-e1f27cba9300" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_019c4318-517a-70a6-ae89-964e27cd24ec" xlink:to="loc_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_019c4318-517a-7cb1-8f9b-e1f27cba9300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Accountsreceivable" xlink:type="simple" xlink:href="soph-20251231.xsd#Accountsreceivable"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Accountsreceivable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_019c4318-517a-7e23-b2b1-bfbd02c1d0b7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_019c4318-517a-7f8f-9980-36534cd6c0dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_019c4318-517a-7e23-b2b1-bfbd02c1d0b7" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_019c4318-517a-7f8f-9980-36534cd6c0dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Inventory" xlink:type="simple" xlink:href="soph-20251231.xsd#Inventory"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Inventory" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7db6-82ad-74a67e43e8ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfInventoriesExplanatory_019c4318-517a-729d-98bd-b58bf351133b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInventoriesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7db6-82ad-74a67e43e8ff" xlink:to="loc_ifrs-full_DisclosureOfInventoriesExplanatory_019c4318-517a-729d-98bd-b58bf351133b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Prepaidsandothercurrentassets" xlink:type="simple" xlink:href="soph-20251231.xsd#Prepaidsandothercurrentassets"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Prepaidsandothercurrentassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-72a6-9df3-eac23059a3a3" xlink:href="soph-20251231.xsd#soph_PrepaymentsAndOtherCurrentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory_019c4318-517a-7e35-bb9a-69fbd55ac16b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-72a6-9df3-eac23059a3a3" xlink:to="loc_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory_019c4318-517a-7e35-bb9a-69fbd55ac16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Propertyandequipment" xlink:type="simple" xlink:href="soph-20251231.xsd#Propertyandequipment"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Propertyandequipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_019c4318-517a-7217-afc7-e90aa9a9009a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_019c4318-517a-7423-98eb-98c36d3274b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_019c4318-517a-7217-afc7-e90aa9a9009a" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_019c4318-517a-7423-98eb-98c36d3274b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IntangibleAssets" xlink:type="simple" xlink:href="soph-20251231.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019c4318-522c-7a88-966b-174cd007c73f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_019c4318-522c-7b9a-b1d0-1325746c6d0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019c4318-522c-7a88-966b-174cd007c73f" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsExplanatory_019c4318-522c-7b9a-b1d0-1325746c6d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Leases" xlink:type="simple" xlink:href="soph-20251231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c4318-522c-7a54-b883-0408b62c9adf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfLeasesExplanatory_019c4318-522c-7a12-8f6e-7a904275464f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfLeasesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c4318-522c-7a54-b883-0408b62c9adf" xlink:to="loc_ifrs-full_DisclosureOfLeasesExplanatory_019c4318-522c-7a12-8f6e-7a904275464f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Othernoncurrentassets" xlink:type="simple" xlink:href="soph-20251231.xsd#Othernoncurrentassets"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Othernoncurrentassets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_019c4318-522c-7cd2-ab4f-5eb01d32b82e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousNoncurrentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_019c4318-522c-71eb-8c66-53c934ce5982" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_019c4318-522c-7cd2-ab4f-5eb01d32b82e" xlink:to="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_019c4318-522c-71eb-8c66-53c934ce5982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Accountspayable" xlink:type="simple" xlink:href="soph-20251231.xsd#Accountspayable"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Accountspayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_019c4318-522c-7231-ba5c-d921a3ded8ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_019c4318-522c-7db2-ae16-30830f9f945c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_019c4318-522c-7231-ba5c-d921a3ded8ea" xlink:to="loc_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory_019c4318-522c-7db2-ae16-30830f9f945c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Accruedexpenses" xlink:type="simple" xlink:href="soph-20251231.xsd#Accruedexpenses"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Accruedexpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedExpensesAbstract_019c4318-522c-7094-af8d-fe84bc138f70" xlink:href="soph-20251231.xsd#soph_AccruedExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory_019c4318-522c-700c-a621-fa5a08df43a8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AccruedExpensesAbstract_019c4318-522c-7094-af8d-fe84bc138f70" xlink:to="loc_ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory_019c4318-522c-700c-a621-fa5a08df43a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Postemploymentbenefits" xlink:type="simple" xlink:href="soph-20251231.xsd#Postemploymentbenefits"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Postemploymentbenefits" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-782a-98bc-ac9329895038" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_019c4318-522c-7a88-aa9f-5a7c2a04ed46" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEmployeeBenefitsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-782a-98bc-ac9329895038" xlink:to="loc_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory_019c4318-522c-7a88-aa9f-5a7c2a04ed46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Sharebasedcompensation" xlink:type="simple" xlink:href="soph-20251231.xsd#Sharebasedcompensation"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Sharebasedcompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-777b-b4ae-0b6c2f23e5e5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_019c4318-522c-729d-bdef-421649d2cab0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-777b-b4ae-0b6c2f23e5e5" xlink:to="loc_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory_019c4318-522c-729d-bdef-421649d2cab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Borrowings" xlink:type="simple" xlink:href="soph-20251231.xsd#Borrowings"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Borrowings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-77af-8094-dbd05725f840" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_019c4318-522c-730b-a88f-ab44c4fec637" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBorrowingsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-77af-8094-dbd05725f840" xlink:to="loc_ifrs-full_DisclosureOfBorrowingsExplanatory_019c4318-522c-730b-a88f-ab44c4fec637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Relatedparties" xlink:type="simple" xlink:href="soph-20251231.xsd#Relatedparties"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Relatedparties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-7100-872b-a609ea7ce4e0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_019c4318-522c-7b66-b14d-342060bd69f7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-7100-872b-a609ea7ce4e0" xlink:to="loc_ifrs-full_DisclosureOfRelatedPartyExplanatory_019c4318-522c-7b66-b14d-342060bd69f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Commitmentsandcontingencies" xlink:type="simple" xlink:href="soph-20251231.xsd#Commitmentsandcontingencies"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Commitmentsandcontingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_019c4318-522d-7023-b24b-5b58659e8a8a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_019c4318-522d-7832-b081-a73644a97cf1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_019c4318-522d-7023-b24b-5b58659e8a8a" xlink:to="loc_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_019c4318-522d-7832-b081-a73644a97cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Financialinstrumentsandrisks" xlink:type="simple" xlink:href="soph-20251231.xsd#Financialinstrumentsandrisks"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Financialinstrumentsandrisks" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7d29-936d-c2951e1afeb8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_019c4318-522d-7794-9de8-f2dfa11805d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7d29-936d-c2951e1afeb8" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_019c4318-522d-7794-9de8-f2dfa11805d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Capitalmanagement" xlink:type="simple" xlink:href="soph-20251231.xsd#Capitalmanagement"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Capitalmanagement" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalCommitmentsAbstract_019c4318-522d-74e3-8a40-a45289bb1387" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCapitalManagementExplanatoryTextBlock_019c4318-522d-7b51-9954-19aa2768b378" xlink:href="soph-20251231.xsd#soph_DisclosureOfCapitalManagementExplanatoryTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CapitalCommitmentsAbstract_019c4318-522d-74e3-8a40-a45289bb1387" xlink:to="loc_soph_DisclosureOfCapitalManagementExplanatoryTextBlock_019c4318-522d-7b51-9954-19aa2768b378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/Eventsafterthereportingdate" xlink:type="simple" xlink:href="soph-20251231.xsd#Eventsafterthereportingdate"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/Eventsafterthereportingdate" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEventsAfterReportingPeriodAbstract_019c4318-522d-7c7c-9085-a7baedba2604" xlink:href="soph-20251231.xsd#soph_DisclosureOfEventsAfterReportingPeriodAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_019c4318-522d-72c3-8127-41ada0b172c5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEventsAfterReportingPeriodAbstract_019c4318-522d-7c7c-9085-a7baedba2604" xlink:to="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_019c4318-522d-72c3-8127-41ada0b172c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies" xlink:type="simple" xlink:href="soph-20251231.xsd#MaterialaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:href="soph-20251231.xsd#soph_SummaryOfMaterialAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock_019c4318-5179-7961-8697-f15730af2679" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock_019c4318-5179-7961-8697-f15730af2679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock_019c4318-5179-73c6-b506-7ddf7e8ecfde" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock_019c4318-5179-73c6-b506-7ddf7e8ecfde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_019c4318-5179-7bc4-974e-d2e6f0ba70ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_019c4318-5179-7bc4-974e-d2e6f0ba70ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock_019c4318-5179-7161-af11-86c638d2ea53" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock_019c4318-5179-7161-af11-86c638d2ea53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock_019c4318-5179-78ad-bc5e-d65c76668baf" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock_019c4318-5179-78ad-bc5e-d65c76668baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock_019c4318-5179-7d87-917b-f27e8ff9ec5c" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock_019c4318-5179-7d87-917b-f27e8ff9ec5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock_019c4318-5179-7ac5-a113-40dab07ea7a7" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock_019c4318-5179-7ac5-a113-40dab07ea7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock_019c4318-5179-7333-a633-fa2a3ace6383" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock_019c4318-5179-7333-a633-fa2a3ace6383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_019c4318-5179-7646-a2a5-001db5f74c47" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory_019c4318-5179-7646-a2a5-001db5f74c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_019c4318-5179-77af-bf25-1cfc4e5e2a1a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory_019c4318-5179-77af-bf25-1cfc4e5e2a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock_019c4318-5179-7f36-95d2-fb7fd8ce4a6c" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock_019c4318-5179-7f36-95d2-fb7fd8ce4a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_019c4318-5179-7875-b9bf-cbaa39d548f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue_019c4318-5179-7875-b9bf-cbaa39d548f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock_019c7277-61bc-75cf-bd3d-5ef00f1a798c" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock_019c7277-61bc-75cf-bd3d-5ef00f1a798c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_019c7278-42ce-7bd0-92a1-ce231e5324bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory_019c7278-42ce-7bd0-92a1-ce231e5324bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock_019c7279-35a7-74c7-aba1-a2b1a48f117d" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock_019c7279-35a7-74c7-aba1-a2b1a48f117d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock_019c727a-2a29-773c-aca9-f3979022f284" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock_019c727a-2a29-773c-aca9-f3979022f284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock_019c727b-2c23-759d-8c59-c5e98ca47658" xlink:href="soph-20251231.xsd#soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock_019c727b-2c23-759d-8c59-c5e98ca47658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory_019c4318-5179-77a1-b65d-75c45be59aed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory_019c4318-5179-77a1-b65d-75c45be59aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_019c4318-5179-798f-9df6-dadc2c913046" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory_019c4318-5179-798f-9df6-dadc2c913046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_019c4318-5179-7678-a05c-d7173bd53558" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_019c4318-5179-7678-a05c-d7173bd53558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_019c4318-5179-75ba-883a-78e40dfe10d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory_019c4318-5179-75ba-883a-78e40dfe10d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_019c4318-5179-7d08-b44f-b361f4c2d357" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_019c4318-5179-7d08-b44f-b361f4c2d357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_019c4318-5179-7250-b26f-836eb32efa4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_019c4318-5179-7250-b26f-836eb32efa4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_019c4318-5179-71d8-8b5d-c3b63aeccfa5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory_019c4318-5179-71d8-8b5d-c3b63aeccfa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_019c4318-5179-7baa-a5d7-9b4ab6f16067" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_019c4318-5179-7baa-a5d7-9b4ab6f16067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_019c4318-5179-70dd-9ef6-0b33b023bad8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory_019c4318-5179-70dd-9ef6-0b33b023bad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_019c4318-5179-758a-a6a5-ef26574eb378" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c4318-5179-770c-aa82-82d4709317d1" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_019c4318-5179-758a-a6a5-ef26574eb378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CompanyinformationandoperationsTables" xlink:type="simple" xlink:href="soph-20251231.xsd#CompanyinformationandoperationsTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/CompanyinformationandoperationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsAbstract_019c4318-5179-76f2-9214-b582c26b963c" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock_019c4318-5179-7cd0-b998-4c1d10951aec" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsAbstract_019c4318-5179-76f2-9214-b582c26b963c" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock_019c4318-5179-7cd0-b998-4c1d10951aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SegmentreportingTables" xlink:type="simple" xlink:href="soph-20251231.xsd#SegmentreportingTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/SegmentreportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019c4318-5179-7f61-bc39-32096cacdc72" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_019c4318-5179-7b6d-bc21-6a2226b161fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019c4318-5179-7f61-bc39-32096cacdc72" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_019c4318-5179-7b6d-bc21-6a2226b161fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/RevenueTables" xlink:type="simple" xlink:href="soph-20251231.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019c4318-5179-7403-bb74-f36cc906407e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_019c4318-5179-7412-8462-4b0bdd929cb0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019c4318-5179-7403-bb74-f36cc906407e" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_019c4318-5179-7412-8462-4b0bdd929cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/OperatingexpenseTables" xlink:type="simple" xlink:href="soph-20251231.xsd#OperatingexpenseTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/OperatingexpenseTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_019c4318-517a-7488-bcbf-75d3a939f9f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock_019c4318-517a-7377-b768-bb8cff49087b" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_019c4318-517a-7488-bcbf-75d3a939f9f1" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock_019c4318-517a-7377-b768-bb8cff49087b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock_019c4318-517a-7092-abfa-635ae68f4f76" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_019c4318-517a-7488-bcbf-75d3a939f9f1" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock_019c4318-517a-7092-abfa-635ae68f4f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables" xlink:type="simple" xlink:href="soph-20251231.xsd#InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-79d0-a035-f47f8da0bd82" xlink:href="soph-20251231.xsd#soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock_019c4318-517a-70c9-972b-d6325e5a7170" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-79d0-a035-f47f8da0bd82" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock_019c4318-517a-70c9-972b-d6325e5a7170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock_019c4318-517a-70a2-8b65-a259312a0642" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-79d0-a035-f47f8da0bd82" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock_019c4318-517a-70a2-8b65-a259312a0642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock_019c4318-517a-7882-b3b3-fa56c89fedbf" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-79d0-a035-f47f8da0bd82" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock_019c4318-517a-7882-b3b3-fa56c89fedbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxTables" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/IncometaxTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7822-90f3-7fcea9b4fdb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock_019c4318-517a-7d08-93c0-9379032ee577" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7822-90f3-7fcea9b4fdb4" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock_019c4318-517a-7d08-93c0-9379032ee577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock_019c4318-517a-76ac-a29f-362035ce81e0" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7822-90f3-7fcea9b4fdb4" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock_019c4318-517a-76ac-a29f-362035ce81e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_019c4318-517a-71c6-8840-804e5fd931fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7822-90f3-7fcea9b4fdb4" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_019c4318-517a-71c6-8840-804e5fd931fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock_019c4318-517a-75bc-8e4d-4c580cb42774" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7822-90f3-7fcea9b4fdb4" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock_019c4318-517a-75bc-8e4d-4c580cb42774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/LosspershareTables" xlink:type="simple" xlink:href="soph-20251231.xsd#LosspershareTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/LosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7e7c-8b38-c794a544c280" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareExplanatory_019c4318-517a-76ec-b17e-434a29914f83" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7e7c-8b38-c794a544c280" xlink:to="loc_ifrs-full_EarningsPerShareExplanatory_019c4318-517a-76ec-b17e-434a29914f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CashandcashequivalentsTables" xlink:type="simple" xlink:href="soph-20251231.xsd#CashandcashequivalentsTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/CashandcashequivalentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_019c4318-517a-722d-94ef-edb14842ce37" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock_019c4318-517a-7a7e-99ac-c61f5b65841b" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_019c4318-517a-722d-94ef-edb14842ce37" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock_019c4318-517a-7a7e-99ac-c61f5b65841b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccountsreceivableTables" xlink:type="simple" xlink:href="soph-20251231.xsd#AccountsreceivableTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/AccountsreceivableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_019c4318-517a-72bd-b844-27f631dd3f7b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock_019c4318-517a-72b2-802a-9b1e14577e31" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_019c4318-517a-72bd-b844-27f631dd3f7b" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock_019c4318-517a-72b2-802a-9b1e14577e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock_019c4318-517a-75fc-85ec-aebe40e4b1a7" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_019c4318-517a-72bd-b844-27f631dd3f7b" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock_019c4318-517a-75fc-85ec-aebe40e4b1a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/InventoryTables" xlink:type="simple" xlink:href="soph-20251231.xsd#InventoryTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/InventoryTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7dd6-8c77-4974e1c8f968" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock_019c4318-517a-7914-bfe9-bc3ac1d617af" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7dd6-8c77-4974e1c8f968" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock_019c4318-517a-7914-bfe9-bc3ac1d617af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock_019c4318-517a-75c9-8536-68e198e08b43" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7dd6-8c77-4974e1c8f968" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock_019c4318-517a-75c9-8536-68e198e08b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsTables" xlink:type="simple" xlink:href="soph-20251231.xsd#PrepaidsandothercurrentassetsTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-76a1-a79b-7dc0bdd8d24c" xlink:href="soph-20251231.xsd#soph_PrepaymentsAndOtherCurrentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_019c4318-517a-79f6-9507-de84c25c10b4" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-76a1-a79b-7dc0bdd8d24c" xlink:to="loc_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock_019c4318-517a-79f6-9507-de84c25c10b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PropertyandequipmentTables" xlink:type="simple" xlink:href="soph-20251231.xsd#PropertyandequipmentTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PropertyandequipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_019c4318-517a-7a9c-ba3b-a2f0a9ab2c66" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_019c4318-517a-7531-8eab-12c4d2e89e6f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_019c4318-517a-7a9c-ba3b-a2f0a9ab2c66" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_019c4318-517a-7531-8eab-12c4d2e89e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IntangiblesassetsTables" xlink:type="simple" xlink:href="soph-20251231.xsd#IntangiblesassetsTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/IntangiblesassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019c4318-522c-7f3c-8acb-730e33eeda59" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_019c4318-522c-7f77-83d0-1dd9024a1ac3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019c4318-522c-7f3c-8acb-730e33eeda59" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory_019c4318-522c-7f77-83d0-1dd9024a1ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/LeasesTables" xlink:type="simple" xlink:href="soph-20251231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c4318-522c-74f8-b9d6-8f35ec7344b0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_019c4318-522c-7c62-b21d-53b1b0459248" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c4318-522c-74f8-b9d6-8f35ec7344b0" xlink:to="loc_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_019c4318-522c-7c62-b21d-53b1b0459248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock_019c4318-522c-716d-887e-66640c7b1ae1" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c4318-522c-74f8-b9d6-8f35ec7344b0" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock_019c4318-522c-716d-887e-66640c7b1ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/OthernoncurrentassetsTables" xlink:type="simple" xlink:href="soph-20251231.xsd#OthernoncurrentassetsTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/OthernoncurrentassetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_019c4318-522c-7fe0-9837-b997d0c86fbf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousNoncurrentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock_019c4318-522c-76ef-bd7f-8423394edd0d" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_019c4318-522c-7fe0-9837-b997d0c86fbf" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock_019c4318-522c-76ef-bd7f-8423394edd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccountspayableTables" xlink:type="simple" xlink:href="soph-20251231.xsd#AccountspayableTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/AccountspayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_019c4318-522c-7f96-8cba-4567dcf85f79" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock_019c4318-522c-7088-8054-04f5d949ee3b" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_019c4318-522c-7f96-8cba-4567dcf85f79" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock_019c4318-522c-7088-8054-04f5d949ee3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccruedexpensesTables" xlink:type="simple" xlink:href="soph-20251231.xsd#AccruedexpensesTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/AccruedexpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedExpensesAbstract_019c4318-522c-777b-a4f0-08f5f7e8a38e" xlink:href="soph-20251231.xsd#soph_AccruedExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock_019c4318-522c-738d-b21e-94a09c5e8f77" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AccruedExpensesAbstract_019c4318-522c-777b-a4f0-08f5f7e8a38e" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock_019c4318-522c-738d-b21e-94a09c5e8f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsTables" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7414-a506-bc62f7607df2" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_019c4318-522c-7c33-a3be-9589afc136cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7414-a506-bc62f7607df2" xlink:to="loc_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory_019c4318-522c-7c33-a3be-9589afc136cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock_019c4318-522c-77fe-be05-642ba5f6ce5e" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7414-a506-bc62f7607df2" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock_019c4318-522c-77fe-be05-642ba5f6ce5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock_019c4318-522c-705d-add4-ee6a99c07ff5" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7414-a506-bc62f7607df2" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock_019c4318-522c-705d-add4-ee6a99c07ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_019c4318-522c-7b2b-accd-12203e1a691d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7414-a506-bc62f7607df2" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory_019c4318-522c-7b2b-accd-12203e1a691d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock_019c4318-522c-7e7d-848b-86f4ad9f7cf3" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7414-a506-bc62f7607df2" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock_019c4318-522c-7e7d-848b-86f4ad9f7cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock_019c4318-522c-7b68-a9ea-98a04a283e48" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7414-a506-bc62f7607df2" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock_019c4318-522c-7b68-a9ea-98a04a283e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_019c4318-522c-740d-b91a-97e6776c6e5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7414-a506-bc62f7607df2" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_019c4318-522c-740d-b91a-97e6776c6e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationTables" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7347-99f6-aabe93ec357c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_019c4318-522c-71aa-81ed-e60a6704e986" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7347-99f6-aabe93ec357c" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_019c4318-522c-71aa-81ed-e60a6704e986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_019c4318-522c-78ef-8dfd-1e896623da3b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7347-99f6-aabe93ec357c" xlink:to="loc_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_019c4318-522c-78ef-8dfd-1e896623da3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock_019c4318-522c-7210-bad8-666fe1d8ecdc" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7347-99f6-aabe93ec357c" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock_019c4318-522c-7210-bad8-666fe1d8ecdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_019c4318-522c-7172-bbe3-2968c76193db" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7347-99f6-aabe93ec357c" xlink:to="loc_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_019c4318-522c-7172-bbe3-2968c76193db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_019c4318-522c-7998-885c-91a820dcd565" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7347-99f6-aabe93ec357c" xlink:to="loc_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions_019c4318-522c-7998-885c-91a820dcd565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/BorrowingsTables" xlink:type="simple" xlink:href="soph-20251231.xsd#BorrowingsTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/BorrowingsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-7fe5-bcb0-cb75d88c2958" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_019c4318-522c-77bc-b125-c4afc5b6db96" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-7fe5-bcb0-cb75d88c2958" xlink:to="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory_019c4318-522c-77bc-b125-c4afc5b6db96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_019c4318-522c-7cc9-8af9-24ca8e9027ad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-7fe5-bcb0-cb75d88c2958" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory_019c4318-522c-7cc9-8af9-24ca8e9027ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock_019c7523-dfc4-76d2-a31b-809bc8c481dc" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-7fe5-bcb0-cb75d88c2958" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock_019c7523-dfc4-76d2-a31b-809bc8c481dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/RelatedpartiesTables" xlink:type="simple" xlink:href="soph-20251231.xsd#RelatedpartiesTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/RelatedpartiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-772c-82ab-5abfe62011b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_019c4318-522c-706f-8534-1a7a0090f724" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-772c-82ab-5abfe62011b6" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_019c4318-522c-706f-8534-1a7a0090f724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksTables"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7eb7-a124-ad41ea04ecad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_019c4318-522d-7d27-8462-bb9f11a23bfa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7eb7-a124-ad41ea04ecad" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_019c4318-522d-7d27-8462-bb9f11a23bfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_019c4318-522d-73d7-b730-51de471f4a0e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7eb7-a124-ad41ea04ecad" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory_019c4318-522d-73d7-b730-51de471f4a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_019c4318-522d-773a-9628-9e33c0b56229" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7eb7-a124-ad41ea04ecad" xlink:to="loc_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_019c4318-522d-773a-9628-9e33c0b56229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory_019c4318-522d-76b8-a35a-51cd79792387" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7eb7-a124-ad41ea04ecad" xlink:to="loc_ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory_019c4318-522d-76b8-a35a-51cd79792387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock_019c4318-522d-7d31-ac58-224340374f81" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7eb7-a124-ad41ea04ecad" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock_019c4318-522d-7d31-ac58-224340374f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock_019c4318-522d-7d5b-8540-eccb1a697569" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7eb7-a124-ad41ea04ecad" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock_019c4318-522d-7d5b-8540-eccb1a697569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock_019c4318-522d-7154-87d5-a08c598f5444" xlink:href="soph-20251231.xsd#soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7eb7-a124-ad41ea04ecad" xlink:to="loc_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock_019c4318-522d-7154-87d5-a08c598f5444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsAbstract_019c4318-5179-798b-8658-0657600385b6" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_019c4318-5179-7c6e-a427-c3b2b5d576eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsAbstract_019c4318-5179-798b-8658-0657600385b6" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_019c4318-5179-7c6e-a427-c3b2b5d576eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c4318-5179-7973-9b3e-31693ea3867d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_019c4318-5179-7c6e-a427-c3b2b5d576eb" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c4318-5179-7973-9b3e-31693ea3867d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c4318-5179-7973-9b3e-31693ea3867d" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsSASMember_019c4318-5179-7b28-8dd0-2da28a10cb98" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsSASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticsSASMember_019c4318-5179-7b28-8dd0-2da28a10cb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticLimitedMember_019c4318-5179-7e09-9be4-efb26308aec5" xlink:href="soph-20251231.xsd#soph_SophiaGeneticLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticLimitedMember_019c4318-5179-7e09-9be4-efb26308aec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsIncMember_019c4318-5179-77aa-8b21-97cf3a65f4d6" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticsIncMember_019c4318-5179-77aa-8b21-97cf3a65f4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember_019c4318-5179-727f-9f4b-44c8b5f151ea" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember_019c4318-5179-727f-9f4b-44c8b5f151ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsPtyLtdMember_019c4318-5179-76b8-81f1-129e4f9d2157" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsPtyLtdMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticsPtyLtdMember_019c4318-5179-76b8-81f1-129e4f9d2157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsSRLMember_019c4318-5179-7b1e-9d44-459b57342879" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsSRLMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SophiaGeneticsSRLMember_019c4318-5179-7b1e-9d44-459b57342879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SOPHiAGENETICSGmbHMember_019c66c4-ddfc-7dd9-9fe2-98fd82af5be4" xlink:href="soph-20251231.xsd#soph_SOPHiAGENETICSGmbHMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c4318-5179-787b-9ca3-1a340421af31" xlink:to="loc_soph_SOPHiAGENETICSGmbHMember_019c66c4-ddfc-7dd9-9fe2-98fd82af5be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_019c4318-5179-760c-97d8-ed47bcecad36" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_019c4318-5179-7c6e-a427-c3b2b5d576eb" xlink:to="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_019c4318-5179-760c-97d8-ed47bcecad36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NameOfSubsidiary_019c4318-5179-755c-bd41-3950e23a758a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NameOfSubsidiary"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_019c4318-5179-760c-97d8-ed47bcecad36" xlink:to="loc_ifrs-full_NameOfSubsidiary_019c4318-5179-755c-bd41-3950e23a758a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DomicileOfEntity_019c4318-5179-7281-ae17-a2bb253ab06c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DomicileOfEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems_019c4318-5179-760c-97d8-ed47bcecad36" xlink:to="loc_ifrs-full_DomicileOfEntity_019c4318-5179-7281-ae17-a2bb253ab06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#CompanyinformationandoperationsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsAbstract_019c4318-5179-7122-8c54-38faffb8e5c3" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-5179-7863-9eda-7b9834e043d2" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsAbstract_019c4318-5179-7122-8c54-38faffb8e5c3" xlink:to="loc_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-5179-7863-9eda-7b9834e043d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-78bd-a60c-5bf1c0d4f7ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-5179-7863-9eda-7b9834e043d2" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-78bd-a60c-5bf1c0d4f7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-7638-b261-6922b49ae746" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_019c4318-5179-78bd-a60c-5bf1c0d4f7ef" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-7638-b261-6922b49ae746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssuedCapitalMember_019c4318-5179-7f83-9de4-09b0724a175e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-7638-b261-6922b49ae746" xlink:to="loc_ifrs-full_IssuedCapitalMember_019c4318-5179-7f83-9de4-09b0724a175e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TreasurySharesMember_019c4318-5179-785d-baa3-e919d5314ec7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_019c4318-5179-7638-b261-6922b49ae746" xlink:to="loc_ifrs-full_TreasurySharesMember_019c4318-5179-785d-baa3-e919d5314ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019caf47-7dc7-7d4a-ab7c-7ce29a223f90" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-5179-7863-9eda-7b9834e043d2" xlink:to="loc_ifrs-full_RangeAxis_019caf47-7dc7-7d4a-ab7c-7ce29a223f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019caf47-7dc7-7a4f-8f6e-ffe22962bc49" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_019caf47-7dc7-7d4a-ab7c-7ce29a223f90" xlink:to="loc_ifrs-full_RangeDomain_019caf47-7dc7-7a4f-8f6e-ffe22962bc49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019caf47-7dc7-73e7-8bc3-1d828624b23e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019caf47-7dc7-7a4f-8f6e-ffe22962bc49" xlink:to="loc_ifrs-full_BottomOfRangeMember_019caf47-7dc7-73e7-8bc3-1d828624b23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019caf47-7dc7-7b49-a54b-b54ba9302382" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019caf47-7dc7-7a4f-8f6e-ffe22962bc49" xlink:to="loc_ifrs-full_TopOfRangeMember_019caf47-7dc7-7b49-a54b-b54ba9302382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019caf47-7dc7-7ca6-b877-59540347c958" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-5179-7863-9eda-7b9834e043d2" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019caf47-7dc7-7ca6-b877-59540347c958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019caf47-7dc7-7cb7-9ec0-d1a29dcd0506" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019caf47-7dc7-7ca6-b877-59540347c958" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019caf47-7dc7-7cb7-9ec0-d1a29dcd0506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019caf47-7dc7-7011-a909-1be3b63316eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019caf47-7dc7-7cb7-9ec0-d1a29dcd0506" xlink:to="loc_ifrs-full_OrdinarySharesMember_019caf47-7dc7-7011-a909-1be3b63316eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:href="soph-20251231.xsd#soph_DisclosureOfCompanyInformationAndOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsTable_019c4318-5179-7863-9eda-7b9834e043d2" xlink:to="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesIssued_019c4318-5179-799a-a3d3-b23691123642" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_ifrs-full_NumberOfSharesIssued_019c4318-5179-799a-a3d3-b23691123642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfSharesOutstanding_019c4318-5179-7557-a938-2b5bdefb8684" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_ifrs-full_NumberOfSharesOutstanding_019c4318-5179-7557-a938-2b5bdefb8684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseInAuthorisedCapital_019caf47-7dc7-7296-ad70-2ca337f8ad97" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseInAuthorisedCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_IncreaseDecreaseInAuthorisedCapital_019caf47-7dc7-7296-ad70-2ca337f8ad97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseInNumberOfSharesAuthorised_019cb01f-c48d-75cc-a8cd-10151600a8c4" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseInNumberOfSharesAuthorised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_IncreaseDecreaseInNumberOfSharesAuthorised_019cb01f-c48d-75cc-a8cd-10151600a8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_019caf47-7dc7-75e6-87fc-e965d05f9547" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_ifrs-full_ParValuePerShare_019caf47-7dc7-75e6-87fc-e965d05f9547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfTreasurySharesIssued_019c4318-5179-748f-b72b-197049c8269d" xlink:href="soph-20251231.xsd#soph_NumberOfTreasurySharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_NumberOfTreasurySharesIssued_019c4318-5179-748f-b72b-197049c8269d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfConditionalSharesAuthorised_019cad2f-01f6-75a9-ae16-2ceb08e31de2" xlink:href="soph-20251231.xsd#soph_NumberOfConditionalSharesAuthorised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_NumberOfConditionalSharesAuthorised_019cad2f-01f6-75a9-ae16-2ceb08e31de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement_019caf53-cb59-7a9a-9b22-6251f6a309e7" xlink:href="soph-20251231.xsd#soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement_019caf53-cb59-7a9a-9b22-6251f6a309e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IssueOfEquity_019cad2f-421c-705d-a93d-ce737200ff2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssueOfEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_ifrs-full_IssueOfEquity_019cad2f-421c-705d-a93d-ce737200ff2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquitySharesIssued_019caf5d-567a-7deb-a5aa-3e90e82bce31" xlink:href="soph-20251231.xsd#soph_NumberOfEquitySharesIssued"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_soph_NumberOfEquitySharesIssued_019caf5d-567a-7deb-a5aa-3e90e82bce31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_019caf5c-667d-74a6-8802-86058d778fa3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfCompanyInformationAndOperationsLineItems_019c4318-5179-7da0-90de-830461f455d7" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_019caf5c-667d-74a6-8802-86058d778fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#MaterialaccountingpoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c66ce-cdf1-7292-9b2b-b804ae7b4cb2" xlink:href="soph-20251231.xsd#soph_SummaryOfMaterialAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_019c66d3-3ecc-7e67-9730-57f0890b9d16" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_SummaryOfMaterialAccountingPoliciesAbstract_019c66ce-cdf1-7292-9b2b-b804ae7b4cb2" xlink:to="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_019c66d3-3ecc-7e67-9730-57f0890b9d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_019c66d3-3ecc-7181-93be-001476529a3d" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_019c66d3-3ecc-7e67-9730-57f0890b9d16" xlink:to="loc_srt_RestatementAxis_019c66d3-3ecc-7181-93be-001476529a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_019c66d3-3ecc-7e64-b2f6-87bead60b545" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_019c66d3-3ecc-7181-93be-001476529a3d" xlink:to="loc_srt_RestatementDomain_019c66d3-3ecc-7e64-b2f6-87bead60b545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_019c66d3-3ecc-7357-9ef5-ae3d87f3f9ea" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_019c66d3-3ecc-7e64-b2f6-87bead60b545" xlink:to="loc_srt_RestatementAdjustmentMember_019c66d3-3ecc-7357-9ef5-ae3d87f3f9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_019c66d3-3ecc-7d2f-8da2-4906f17fe76f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesTable_019c66d3-3ecc-7e67-9730-57f0890b9d16" xlink:to="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_019c66d3-3ecc-7d2f-8da2-4906f17fe76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c66d3-3ecc-7034-91a1-4089f5797d35" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_019c66d3-3ecc-7d2f-8da2-4906f17fe76f" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_019c66d3-3ecc-7034-91a1-4089f5797d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c66d3-3ecc-7552-bbd2-08361eed43ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_019c66d3-3ecc-7d2f-8da2-4906f17fe76f" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_019c66d3-3ecc-7552-bbd2-08361eed43ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c66d3-3ecc-7950-860e-9e0fa81f344c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems_019c66d3-3ecc-7d2f-8da2-4906f17fe76f" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_019c66d3-3ecc-7950-860e-9e0fa81f344c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SegmentreportingDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SegmentreportingDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/SegmentreportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019c4318-5179-7017-a91e-034f17b4e988" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019c4318-5179-723f-910c-88f3dd6386f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_019c4318-5179-7017-a91e-034f17b4e988" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019c4318-5179-723f-910c-88f3dd6386f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_019c4318-5179-7205-a5d7-5c0c9b36a773" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019c4318-5179-723f-910c-88f3dd6386f6" xlink:to="loc_ifrs-full_GeographicalAreasAxis_019c4318-5179-7205-a5d7-5c0c9b36a773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-5179-7205-a5d7-5c0c9b36a773" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_019c4318-5179-710d-b78a-0121f53a2c13" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CH"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:to="loc_country_CH_019c4318-5179-710d-b78a-0121f53a2c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_019c4318-5179-70ea-925a-6782c685c602" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_FR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:to="loc_country_FR_019c4318-5179-70ea-925a-6782c685c602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_019c4318-5179-7116-b98c-3a2dfd8524ae" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:to="loc_country_US_019c4318-5179-7116-b98c-3a2dfd8524ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_019c4318-5179-72f1-9816-baafb875d27e" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_BR"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-5179-7fbb-9e23-d107bbaa4225" xlink:to="loc_country_BR_019c4318-5179-72f1-9816-baafb875d27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019c4318-5179-779b-a848-25f0a9375ccb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_019c4318-5179-723f-910c-88f3dd6386f6" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019c4318-5179-779b-a848-25f0a9375ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_019c4318-5179-7577-bc40-5cdc62bcb544" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_019c4318-5179-779b-a848-25f0a9375ccb" xlink:to="loc_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_019c4318-5179-7577-bc40-5cdc62bcb544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#RevenueAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019c4318-5179-711d-843a-00f0e8dc68af" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5179-75d0-88b3-aa5d6bc22e59" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPerformanceObligationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019c4318-5179-711d-843a-00f0e8dc68af" xlink:to="loc_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5179-75d0-88b3-aa5d6bc22e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-5179-71d3-bcb4-e72bb6e45645" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5179-75d0-88b3-aa5d6bc22e59" xlink:to="loc_ifrs-full_RangeAxis_019c4318-5179-71d3-bcb4-e72bb6e45645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-5179-7397-bb4b-d5469e8b8853" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_019c4318-5179-71d3-bcb4-e72bb6e45645" xlink:to="loc_ifrs-full_RangeDomain_019c4318-5179-7397-bb4b-d5469e8b8853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-5179-7c30-8428-aca26f4c801f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-5179-7397-bb4b-d5469e8b8853" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-5179-7c30-8428-aca26f4c801f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-5179-717a-b908-4a6e6d3135e1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-5179-7397-bb4b-d5469e8b8853" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-5179-717a-b908-4a6e6d3135e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_019c4318-517a-75c6-8d68-4dd376a81840" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5179-75d0-88b3-aa5d6bc22e59" xlink:to="loc_ifrs-full_SegmentsAxis_019c4318-517a-75c6-8d68-4dd376a81840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_019c4318-517a-7f66-ba75-27881c40fcc9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_019c4318-517a-75c6-8d68-4dd376a81840" xlink:to="loc_ifrs-full_SegmentsDomain_019c4318-517a-7f66-ba75-27881c40fcc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WorkflowEquipmentAndServicesMember_019c4318-517a-74f5-9acb-80c3152cd84a" xlink:href="soph-20251231.xsd#soph_WorkflowEquipmentAndServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019c4318-517a-7f66-ba75-27881c40fcc9" xlink:to="loc_soph_WorkflowEquipmentAndServicesMember_019c4318-517a-74f5-9acb-80c3152cd84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersAxis_019c4318-517a-7b26-ab34-5d6a83cfb66d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5179-75d0-88b3-aa5d6bc22e59" xlink:to="loc_ifrs-full_MajorCustomersAxis_019c4318-517a-7b26-ab34-5d6a83cfb66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorCustomersDomain_019c4318-517a-7de1-b2be-1ada3c421a74" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersAxis_019c4318-517a-7b26-ab34-5d6a83cfb66d" xlink:to="loc_ifrs-full_MajorCustomersDomain_019c4318-517a-7de1-b2be-1ada3c421a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CustomerOneMember_019c4318-517a-7d1c-a48e-47fd0def5122" xlink:href="soph-20251231.xsd#soph_CustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersDomain_019c4318-517a-7de1-b2be-1ada3c421a74" xlink:to="loc_soph_CustomerOneMember_019c4318-517a-7d1c-a48e-47fd0def5122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPerformanceObligationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsTable_019c4318-5179-75d0-88b3-aa5d6bc22e59" xlink:to="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RevenueFromContractsWithCustomersPaymentTerm_019c4318-517a-7eeb-9922-104917925ad1" xlink:href="soph-20251231.xsd#soph_RevenueFromContractsWithCustomersPaymentTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_soph_RevenueFromContractsWithCustomersPaymentTerm_019c4318-517a-7eeb-9922-104917925ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm_019c4318-517a-7b33-be63-577c3d7fdc15" xlink:href="soph-20251231.xsd#soph_RevenueFromContractsWithCustomersExtendedPaymentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm_019c4318-517a-7b33-be63-577c3d7fdc15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_019c4318-517a-7066-a3c3-66ca3a5bdb98" xlink:href="soph-20251231.xsd#soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod_019c4318-517a-7066-a3c3-66ca3a5bdb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_019c4318-517a-7ae2-b783-7404a0965aea" xlink:href="soph-20251231.xsd#soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods_019c4318-517a-7ae2-b783-7404a0965aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OperatingLeaseIncome_019c4318-517a-7b8a-8cd8-e91b55f01520" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingLeaseIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_ifrs-full_OperatingLeaseIncome_019c4318-517a-7b8a-8cd8-e91b55f01520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-517a-77e6-b201-6ffa4aee8c69" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPerformanceObligationsLineItems_019c4318-517a-7162-87c1-3dd8da2cbb93" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-517a-77e6-b201-6ffa4aee8c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019c4318-517a-7d53-9a6e-ea18872eb926" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReceivablesFromContractsWithCustomersAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019c4318-517a-7dc4-a4fc-b9cf90ade251" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReceivablesFromContractsWithCustomersAbstract_019c4318-517a-7d53-9a6e-ea18872eb926" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019c4318-517a-7dc4-a4fc-b9cf90ade251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_019c4318-517a-7b78-9cab-f164eabfd6a4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019c4318-517a-7dc4-a4fc-b9cf90ade251" xlink:to="loc_ifrs-full_GeographicalAreasAxis_019c4318-517a-7b78-9cab-f164eabfd6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-517a-7b78-9cab-f164eabfd6a4" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:href="soph-20251231.xsd#soph_EuropeTheMiddleEastAndAfricaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:to="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CH_019c4318-517a-703f-b592-f81a7e08a729" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CH"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:to="loc_country_CH_019c4318-517a-703f-b592-f81a7e08a729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_FR_019c4318-517a-7b8d-b767-e557d2145bd4" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_FR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:to="loc_country_FR_019c4318-517a-7b8d-b767-e557d2145bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IT_019c4318-517a-7d06-80fd-43c92ea38272" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_IT"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:to="loc_country_IT_019c4318-517a-7d06-80fd-43c92ea38272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_ES_019c4318-517a-7c03-9b52-bdd9852aef91" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_ES"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:to="loc_country_ES_019c4318-517a-7c03-9b52-bdd9852aef91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember_019c4318-517a-77a3-8e4e-33184edb6793" xlink:href="soph-20251231.xsd#soph_OtherCountriesInEuropeMiddleEastAndAfricaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_EuropeTheMiddleEastAndAfricaMember_019c4318-517a-7c93-8582-5ebdd62da43d" xlink:to="loc_soph_OtherCountriesInEuropeMiddleEastAndAfricaMember_019c4318-517a-77a3-8e4e-33184edb6793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_019c4318-517a-73bf-88e2-4f58e2f8e955" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_NorthAmericaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:to="loc_srt_NorthAmericaMember_019c4318-517a-73bf-88e2-4f58e2f8e955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_019c4318-517a-705e-a807-95eb2b089df2" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NorthAmericaMember_019c4318-517a-73bf-88e2-4f58e2f8e955" xlink:to="loc_country_US_019c4318-517a-705e-a807-95eb2b089df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OtherCountriesInNorthAmericaMember_019c4318-517a-76d5-b68a-693449aab89f" xlink:href="soph-20251231.xsd#soph_OtherCountriesInNorthAmericaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NorthAmericaMember_019c4318-517a-73bf-88e2-4f58e2f8e955" xlink:to="loc_soph_OtherCountriesInNorthAmericaMember_019c4318-517a-76d5-b68a-693449aab89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_019c4318-517a-7b5f-b346-876ad125a8cb" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_LatinAmericaMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:to="loc_srt_LatinAmericaMember_019c4318-517a-7b5f-b346-876ad125a8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_019c4318-517a-7b62-87f8-8318ef127e2a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-517a-7920-9257-60b2c54dada9" xlink:to="loc_srt_AsiaPacificMember_019c4318-517a-7b62-87f8-8318ef127e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsAxis_019c4318-517a-7e41-86b8-a24e3104f5c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019c4318-517a-7dc4-a4fc-b9cf90ade251" xlink:to="loc_ifrs-full_SegmentsAxis_019c4318-517a-7e41-86b8-a24e3104f5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SegmentsDomain_019c4318-517a-7c50-a488-7097cbb8f3bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_019c4318-517a-7e41-86b8-a24e3104f5c1" xlink:to="loc_ifrs-full_SegmentsDomain_019c4318-517a-7c50-a488-7097cbb8f3bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SOPHiADDMPlatformMember_019c4318-517a-7c35-9b63-ab116142f1e4" xlink:href="soph-20251231.xsd#soph_SOPHiADDMPlatformMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019c4318-517a-7c50-a488-7097cbb8f3bb" xlink:to="loc_soph_SOPHiADDMPlatformMember_019c4318-517a-7c35-9b63-ab116142f1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WorkflowEquipmentAndServicesMember_019c4318-517a-755e-a6cc-fb07beb1bf83" xlink:href="soph-20251231.xsd#soph_WorkflowEquipmentAndServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_019c4318-517a-7c50-a488-7097cbb8f3bb" xlink:to="loc_soph_WorkflowEquipmentAndServicesMember_019c4318-517a-755e-a6cc-fb07beb1bf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019c4318-517a-7572-95d1-592ee654882c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_019c4318-517a-7dc4-a4fc-b9cf90ade251" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019c4318-517a-7572-95d1-592ee654882c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-517a-78e3-99aa-e86051efd5d2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromContractsWithCustomers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_019c4318-517a-7572-95d1-592ee654882c" xlink:to="loc_ifrs-full_RevenueFromContractsWithCustomers_019c4318-517a-78e3-99aa-e86051efd5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#OperatingexpenseAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_019c4318-517a-7816-9d28-8a8157be9336" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c898a-d76a-7c0f-a765-e9a3cb8a4be9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_019c4318-517a-7816-9d28-8a8157be9336" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c898a-d76a-7c0f-a765-e9a3cb8a4be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c898a-d76a-7a35-bb3a-6b700d1ce147" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c898a-d76a-7c0f-a765-e9a3cb8a4be9" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c898a-d76a-7a35-bb3a-6b700d1ce147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c898a-d76a-769e-8e8f-e384ebc5aa32" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c898a-d76a-7a35-bb3a-6b700d1ce147" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c898a-d76a-769e-8e8f-e384ebc5aa32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CostOfRevenue1Member_019c898a-d76a-7dd4-b0ae-6e416907806d" xlink:href="soph-20251231.xsd#soph_CostOfRevenue1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c898a-d76a-769e-8e8f-e384ebc5aa32" xlink:to="loc_soph_CostOfRevenue1Member_019c898a-d76a-7dd4-b0ae-6e416907806d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c898a-d76a-7e2d-8422-3988c4e256d4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c898a-d76a-7c0f-a765-e9a3cb8a4be9" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c898a-d76a-7e2d-8422-3988c4e256d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ResearchTaxCredit_019c4318-517a-778e-b1f4-f4e8ad31e5b8" xlink:href="soph-20251231.xsd#soph_ResearchTaxCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c898a-d76a-7e2d-8422-3988c4e256d4" xlink:to="loc_soph_ResearchTaxCredit_019c4318-517a-778e-b1f4-f4e8ad31e5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019c898a-d76a-7474-8490-491c788dfa5d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c898a-d76a-7e2d-8422-3988c4e256d4" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019c898a-d76a-7474-8490-491c788dfa5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_019c4318-517a-78ac-8670-f5874ecfda4d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7672-9884-737562b2e478" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_019c4318-517a-78ac-8670-f5874ecfda4d" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7672-9884-737562b2e478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7a28-9f7a-ac88c95f9b2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7672-9884-737562b2e478" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7a28-9f7a-ac88c95f9b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7a28-9f7a-ac88c95f9b2b" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CostOfSalesMember_019c4318-517a-7193-81d5-cf5f6537be22" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:to="loc_ifrs-full_CostOfSalesMember_019c4318-517a-7193-81d5-cf5f6537be22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-517a-7914-9427-e371ee470915" xlink:href="soph-20251231.xsd#soph_ResearchAndDevelopmentExpense1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:to="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-517a-7914-9427-e371ee470915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SellingAndMarketingExpense1Member_019c4318-517a-7fb3-80c3-17d46c48c1b0" xlink:href="soph-20251231.xsd#soph_SellingAndMarketingExpense1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:to="loc_soph_SellingAndMarketingExpense1Member_019c4318-517a-7fb3-80c3-17d46c48c1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-517a-7361-904d-1e122432388c" xlink:href="soph-20251231.xsd#soph_GeneralAndAdministrativeExpense1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-714e-9d94-1f1ff064fc67" xlink:to="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-517a-7361-904d-1e122432388c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-75da-b89d-5c2e1fa7e18e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7672-9884-737562b2e478" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-75da-b89d-5c2e1fa7e18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationExpense_019c4318-517a-77dc-9b4e-a9a44686f82e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-75da-b89d-5c2e1fa7e18e" xlink:to="loc_ifrs-full_DepreciationExpense_019c4318-517a-77dc-9b4e-a9a44686f82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AmortisationExpense_019c4318-517a-790f-9563-365dc1cb885d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-75da-b89d-5c2e1fa7e18e" xlink:to="loc_ifrs-full_AmortisationExpense_019c4318-517a-790f-9563-365dc1cb885d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_019c4318-517a-7ca4-b3c3-e0c770f716bf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7da3-afca-07e46cf43086" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_019c4318-517a-7ca4-b3c3-e0c770f716bf" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7da3-afca-07e46cf43086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7995-8638-8b8cd14c3de3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7da3-afca-07e46cf43086" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7995-8638-8b8cd14c3de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_019c4318-517a-7995-8638-8b8cd14c3de3" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CostOfRevenue1Member_019c71bd-8539-7cac-8fbd-d1b3a170a3d1" xlink:href="soph-20251231.xsd#soph_CostOfRevenue1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:to="loc_soph_CostOfRevenue1Member_019c71bd-8539-7cac-8fbd-d1b3a170a3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-517a-76a6-9b40-84fb0c3c4948" xlink:href="soph-20251231.xsd#soph_ResearchAndDevelopmentExpense1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:to="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-517a-76a6-9b40-84fb0c3c4948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SellingAndMarketingExpense1Member_019c4318-517a-7e60-adbd-47f141bddaa0" xlink:href="soph-20251231.xsd#soph_SellingAndMarketingExpense1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:to="loc_soph_SellingAndMarketingExpense1Member_019c4318-517a-7e60-adbd-47f141bddaa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-517a-78ad-9468-921922ddd40a" xlink:href="soph-20251231.xsd#soph_GeneralAndAdministrativeExpense1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_019c4318-517a-79bd-b368-960962b94fb4" xlink:to="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-517a-78ad-9468-921922ddd40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-707d-9b4f-eafd8f65b226" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable_019c4318-517a-7da3-afca-07e46cf43086" xlink:to="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-707d-9b4f-eafd8f65b226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019c4318-517a-7f8d-b1e8-7e8617fd423a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems_019c4318-517a-707d-9b4f-eafd8f65b226" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_019c4318-517a-7f8d-b1e8-7e8617fd423a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestIncomeDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-79b6-bc80-5f642b897ca3" xlink:href="soph-20251231.xsd#soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RevenueFromInterest_019c4318-517a-7861-9e19-dc7cb8dacb6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-79b6-bc80-5f642b897ca3" xlink:to="loc_ifrs-full_RevenueFromInterest_019c4318-517a-7861-9e19-dc7cb8dacb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-7161-9823-254b33017e4e" xlink:href="soph-20251231.xsd#soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts_019c4318-517a-72fc-a0e4-3b5adafd0230" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBankLoansAndOverdrafts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-7161-9823-254b33017e4e" xlink:to="loc_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts_019c4318-517a-72fc-a0e4-3b5adafd0230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_019c4318-517a-7925-89c9-43c8389db73f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-7161-9823-254b33017e4e" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_019c4318-517a-7925-89c9-43c8389db73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_019c4318-517a-7fb6-be48-40d24dab7fcc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnOtherFinancialLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-7161-9823-254b33017e4e" xlink:to="loc_ifrs-full_InterestExpenseOnOtherFinancialLiabilities_019c4318-517a-7fb6-be48-40d24dab7fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpense_019c4318-517a-7b72-8215-3d0e1b506c7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-7161-9823-254b33017e4e" xlink:to="loc_ifrs-full_InterestExpense_019c4318-517a-7b72-8215-3d0e1b506c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofForeignExchangeLossesGainsNetDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofForeignExchangeLossesGainsNetDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofForeignExchangeLossesGainsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-7c5e-bb07-f40ceeaa6470" xlink:href="soph-20251231.xsd#soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_019c4318-517a-75e9-b7c2-b6ecd50c2a96" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract_019c4318-517a-7c5e-bb07-f40ceeaa6470" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_019c4318-517a-75e9-b7c2-b6ecd50c2a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-72ea-b987-61f5e9a725da" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-702f-92ca-c5ac8d5845f5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-72ea-b987-61f5e9a725da" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-702f-92ca-c5ac8d5845f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c7280-b2ba-7a35-88da-4448f3d8b53c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-702f-92ca-c5ac8d5845f5" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c7280-b2ba-7a35-88da-4448f3d8b53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c7280-b2ba-74f0-8408-bd60e3aa2aa7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_019c7280-b2ba-7a35-88da-4448f3d8b53c" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c7280-b2ba-74f0-8408-bd60e3aa2aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SophiaGeneticsSASMember_019c7280-d0dd-7e35-8bd6-aaa1c3299d35" xlink:href="soph-20251231.xsd#soph_SophiaGeneticsSASMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_019c7280-b2ba-74f0-8408-bd60e3aa2aa7" xlink:to="loc_soph_SophiaGeneticsSASMember_019c7280-d0dd-7e35-8bd6-aaa1c3299d35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_019c4318-517a-716f-b9e5-84b12d85c1b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-702f-92ca-c5ac8d5845f5" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_019c4318-517a-716f-b9e5-84b12d85c1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties_019c4318-517a-7c9c-835d-d3558a7d4421" xlink:href="soph-20251231.xsd#soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_019c4318-517a-716f-b9e5-84b12d85c1b4" xlink:to="loc_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties_019c4318-517a-7c9c-835d-d3558a7d4421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DividendsReceived_019c4318-517a-71cf-8e1f-60ffae30f720" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_019c4318-517a-716f-b9e5-84b12d85c1b4" xlink:to="loc_ifrs-full_DividendsReceived_019c4318-517a-71cf-8e1f-60ffae30f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7a98-b0e9-5efb95833c03" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7cc4-9528-406b1ea92661" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7a98-b0e9-5efb95833c03" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7cc4-9528-406b1ea92661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_019c4318-517a-74d1-81e5-2938e947379b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7cc4-9528-406b1ea92661" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_019c4318-517a-74d1-81e5-2938e947379b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_019c4318-517a-7bec-99f4-40804f257a16" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7cc4-9528-406b1ea92661" xlink:to="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_019c4318-517a-7bec-99f4-40804f257a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_019c4318-517a-7cb6-bba9-3729f715558f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7cc4-9528-406b1ea92661" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods_019c4318-517a-7cb6-bba9-3729f715558f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DeferredBenefitAbstract_019c4318-517a-75e6-a312-ecfd8788d7f0" xlink:href="soph-20251231.xsd#soph_DeferredBenefitAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7a98-b0e9-5efb95833c03" xlink:to="loc_soph_DeferredBenefitAbstract_019c4318-517a-75e6-a312-ecfd8788d7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_019c4318-517a-7b81-b456-d387c0d09e84" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DeferredBenefitAbstract_019c4318-517a-75e6-a312-ecfd8788d7f0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_019c4318-517a-7b81-b456-d387c0d09e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_019c4318-517a-7171-b4d6-301dd3feaa64" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DeferredBenefitAbstract_019c4318-517a-75e6-a312-ecfd8788d7f0" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_019c4318-517a-7171-b4d6-301dd3feaa64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-7b22-b7b2-45edffe222d1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7a98-b0e9-5efb95833c03" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-7b22-b7b2-45edffe222d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7c9e-89e0-fe2f39520e35" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccountingProfit_019c4318-517a-7dc8-8725-fe241720be4c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccountingProfit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7c9e-89e0-fe2f39520e35" xlink:to="loc_ifrs-full_AccountingProfit_019c4318-517a-7dc8-8725-fe241720be4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_019c4318-517a-79d6-aac6-a5981f58902c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7c9e-89e0-fe2f39520e35" xlink:to="loc_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_019c4318-517a-79d6-aac6-a5981f58902c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfForeignTaxRates_019c4318-517a-7e9d-8dc1-8b4939d539c8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfForeignTaxRates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7c9e-89e0-fe2f39520e35" xlink:to="loc_ifrs-full_TaxEffectOfForeignTaxRates_019c4318-517a-7e9d-8dc1-8b4939d539c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense_019c4318-517a-76ef-8c34-b8f216668770" xlink:href="soph-20251231.xsd#soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7c9e-89e0-fe2f39520e35" xlink:to="loc_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense_019c4318-517a-76ef-8c34-b8f216668770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss_019c4318-517a-7f5a-abc2-eeeb88c836b6" xlink:href="soph-20251231.xsd#soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7c9e-89e0-fe2f39520e35" xlink:to="loc_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss_019c4318-517a-7f5a-abc2-eeeb88c836b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_019c4318-517a-7a86-926f-ac3e560a9799" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7c9e-89e0-fe2f39520e35" xlink:to="loc_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_019c4318-517a-7a86-926f-ac3e560a9799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_019c4318-517a-756f-b72a-488c69437e74" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7c9e-89e0-fe2f39520e35" xlink:to="loc_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod_019c4318-517a-756f-b72a-488c69437e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_019c4318-517a-7b2c-9f59-17fa3a68b4b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7c9e-89e0-fe2f39520e35" xlink:to="loc_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_019c4318-517a-7b2c-9f59-17fa3a68b4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-7370-b35c-219d2b4c2344" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-7c9e-89e0-fe2f39520e35" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_019c4318-517a-7370-b35c-219d2b4c2344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxSummaryofMovementinDeferredTaxBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-744a-b2b9-da5f202b4f9b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7973-bb20-077884ea2f00" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-744a-b2b9-da5f202b4f9b" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7973-bb20-077884ea2f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-7418-bc6c-7caa2643f3ae" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7973-bb20-077884ea2f00" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-7418-bc6c-7caa2643f3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-7418-bc6c-7caa2643f3ae" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember_019c4318-517a-7414-a5bf-9837f329ca20" xlink:href="soph-20251231.xsd#soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember_019c4318-517a-7414-a5bf-9837f329ca20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BadDebtReservesRelatedTemporaryDifferencesMember_019c4318-517a-71c7-a231-ac11c3ba6eab" xlink:href="soph-20251231.xsd#soph_BadDebtReservesRelatedTemporaryDifferencesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_soph_BadDebtReservesRelatedTemporaryDifferencesMember_019c4318-517a-71c7-a231-ac11c3ba6eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedPensionRelatedTemporaryDifferencesMember_019c4318-517a-7c26-9964-c660590070ac" xlink:href="soph-20251231.xsd#soph_AccruedPensionRelatedTemporaryDifferencesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_soph_AccruedPensionRelatedTemporaryDifferencesMember_019c4318-517a-7c26-9964-c660590070ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember_019c4318-517a-7a33-821c-407b1ce81098" xlink:href="soph-20251231.xsd#soph_RightOfUseAssetsRelatedTemporaryDifferencesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_soph_RightOfUseAssetsRelatedTemporaryDifferencesMember_019c4318-517a-7a33-821c-407b1ce81098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember_019c4318-517a-75ef-a32e-5f84c4950615" xlink:href="soph-20251231.xsd#soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember_019c4318-517a-75ef-a32e-5f84c4950615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherTemporaryDifferencesMember_019c4318-517a-776a-9730-dbd0f3321f6e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTemporaryDifferencesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_ifrs-full_OtherTemporaryDifferencesMember_019c4318-517a-776a-9730-dbd0f3321f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_019c4318-517a-7b01-80d0-5025b7076df6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-704a-9da1-83b60edeaecd" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_019c4318-517a-7b01-80d0-5025b7076df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-744a-81c8-9ce174c2be1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7973-bb20-077884ea2f00" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-744a-81c8-9ce174c2be1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-70b4-b96f-96de23113ca5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-744a-81c8-9ce174c2be1e" xlink:to="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-70b4-b96f-96de23113ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-70b4-b96f-96de23113ca5" xlink:to="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_019c4318-517a-7fbc-bf18-a72885e0b65a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_019c4318-517a-7fbc-bf18-a72885e0b65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_019c4318-517a-76fc-b87c-dacd041250ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss_019c4318-517a-76fc-b87c-dacd041250ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_019c4318-517a-7caa-b39d-0c8b4cac9277" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:to="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_019c4318-517a-7caa-b39d-0c8b4cac9277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_019c4318-517a-7229-910f-8b4a89f1fbe7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset_019c4318-517a-7229-910f-8b4a89f1fbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilityAsset_019c4318-517a-708b-b23e-91e279780111" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilityAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-7dc3-b739-ed48ded788db" xlink:to="loc_ifrs-full_DeferredTaxLiabilityAsset_019c4318-517a-708b-b23e-91e279780111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxAssets_019c4318-517a-706d-b76c-a225fbbc50f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-70b4-b96f-96de23113ca5" xlink:to="loc_ifrs-full_DeferredTaxAssets_019c4318-517a-706d-b76c-a225fbbc50f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_019c4318-517a-7be0-ac07-cd7a4d1a2e36" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract_019c4318-517a-70b4-b96f-96de23113ca5" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_019c4318-517a-7be0-ac07-cd7a4d1a2e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-791b-9100-546c18817035" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7bb1-acf7-6c35daa4765a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-791b-9100-546c18817035" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7bb1-acf7-6c35daa4765a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-701e-881f-5a1c36952038" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7bb1-acf7-6c35daa4765a" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-701e-881f-5a1c36952038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-76f5-a640-cfb8ba1fe7be" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_019c4318-517a-701e-881f-5a1c36952038" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-76f5-a640-cfb8ba1fe7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TemporaryDifferenceMember_019c4318-517a-755e-a62f-a302ec5f1d4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-76f5-a640-cfb8ba1fe7be" xlink:to="loc_ifrs-full_TemporaryDifferenceMember_019c4318-517a-755e-a62f-a302ec5f1d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnusedTaxLossesMember_019c4318-517a-723d-a4fe-c2c00dbb4d5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnusedTaxLossesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_019c4318-517a-76f5-a640-cfb8ba1fe7be" xlink:to="loc_ifrs-full_UnusedTaxLossesMember_019c4318-517a-723d-a4fe-c2c00dbb4d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7f59-a23e-bda0c58459cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_019c4318-517a-7bb1-acf7-6c35daa4765a" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7f59-a23e-bda0c58459cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_UnrecognizedDeferredTaxAssetsGross_019c4318-517a-74a2-9987-65fa58c99887" xlink:href="soph-20251231.xsd#soph_UnrecognizedDeferredTaxAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7f59-a23e-bda0c58459cd" xlink:to="loc_soph_UnrecognizedDeferredTaxAssetsGross_019c4318-517a-74a2-9987-65fa58c99887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TaxEffectOfTaxLosses_019c4318-517a-739d-88f1-18a222d2b8f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxEffectOfTaxLosses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract_019c4318-517a-7f59-a23e-bda0c58459cd" xlink:to="loc_ifrs-full_TaxEffectOfTaxLosses_019c4318-517a-739d-88f1-18a222d2b8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IncometaxSummaryofNetOperatingLossCarryforwardsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-76db-a7d8-48ae5fc40f43" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearOne_019c4318-517a-7bdf-897c-74c05fe03135" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearOne"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-76db-a7d8-48ae5fc40f43" xlink:to="loc_soph_NetOperatingLossCarryforwardsYearOne_019c4318-517a-7bdf-897c-74c05fe03135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearTwo_019c4318-517a-7627-81c4-102cf2420271" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-76db-a7d8-48ae5fc40f43" xlink:to="loc_soph_NetOperatingLossCarryforwardsYearTwo_019c4318-517a-7627-81c4-102cf2420271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearThree_019c4318-517a-760e-ba6f-cbb0cb59d57c" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-76db-a7d8-48ae5fc40f43" xlink:to="loc_soph_NetOperatingLossCarryforwardsYearThree_019c4318-517a-760e-ba6f-cbb0cb59d57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsYearFour_019c4318-517a-7f65-9e0d-00c6e6ea8050" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-76db-a7d8-48ae5fc40f43" xlink:to="loc_soph_NetOperatingLossCarryforwardsYearFour_019c4318-517a-7f65-9e0d-00c6e6ea8050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwardsThereafter_019c4318-517a-753e-bf3e-f498f9eb23ee" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwardsThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-76db-a7d8-48ae5fc40f43" xlink:to="loc_soph_NetOperatingLossCarryforwardsThereafter_019c4318-517a-753e-bf3e-f498f9eb23ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetOperatingLossCarryforwards_019c4318-517a-71f8-b72e-3ab04e10d209" xlink:href="soph-20251231.xsd#soph_NetOperatingLossCarryforwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract_019c4318-517a-76db-a7d8-48ae5fc40f43" xlink:to="loc_soph_NetOperatingLossCarryforwards_019c4318-517a-71f8-b72e-3ab04e10d209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#LosspershareAdditionalinformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7cd8-8902-08b076fe00ce" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareTable_019c4318-517a-783d-8bf4-4236217a19fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7cd8-8902-08b076fe00ce" xlink:to="loc_ifrs-full_EarningsPerShareTable_019c4318-517a-783d-8bf4-4236217a19fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019c4318-517a-79db-8e12-e2403465477e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareTable_019c4318-517a-783d-8bf4-4236217a19fd" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019c4318-517a-79db-8e12-e2403465477e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c4318-517a-7867-9281-7a1d362a9587" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c4318-517a-79db-8e12-e2403465477e" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c4318-517a-7867-9281-7a1d362a9587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019c4318-517a-7783-beff-245cf8153035" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019c4318-517a-7867-9281-7a1d362a9587" xlink:to="loc_ifrs-full_OrdinarySharesMember_019c4318-517a-7783-beff-245cf8153035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareLineItems_019c4318-517a-7148-955c-d2557494324e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareTable_019c4318-517a-783d-8bf4-4236217a19fd" xlink:to="loc_ifrs-full_EarningsPerShareLineItems_019c4318-517a-7148-955c-d2557494324e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ParValuePerShare_019c4318-517a-7132-8b53-4e116e3e300e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareLineItems_019c4318-517a-7148-955c-d2557494324e" xlink:to="loc_ifrs-full_ParValuePerShare_019c4318-517a-7132-8b53-4e116e3e300e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/LosspershareComponentsofLossforYearDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#LosspershareComponentsofLossforYearDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/LosspershareComponentsofLossforYearDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7c90-858a-b2ccab3d7843" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_019c4318-517a-7de8-9b60-4cf4ad7126c2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7c90-858a-b2ccab3d7843" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_019c4318-517a-7de8-9b60-4cf4ad7126c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageShares_019c4318-517a-72d5-a8e4-b91d87431458" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7c90-858a-b2ccab3d7843" xlink:to="loc_ifrs-full_WeightedAverageShares_019c4318-517a-72d5-a8e4-b91d87431458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_019c4318-517a-7798-a2e9-d0bbef6c72bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7c90-858a-b2ccab3d7843" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_019c4318-517a-7798-a2e9-d0bbef6c72bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BasicEarningsLossPerShare_019c4318-517a-77b9-b9d7-e37719d4d6f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7c90-858a-b2ccab3d7843" xlink:to="loc_ifrs-full_BasicEarningsLossPerShare_019c4318-517a-77b9-b9d7-e37719d4d6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShare_019c4318-517a-77ef-8dd6-223a13c467f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EarningsPerShareAbstract_019c4318-517a-7c90-858a-b2ccab3d7843" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShare_019c4318-517a-77ef-8dd6-223a13c467f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CashandcashequivalentsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#CashandcashequivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/CashandcashequivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_019c4318-517a-73f0-afcf-5de961652f9a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BalancesWithBanks_019c4318-517a-70be-94d7-1817d92f9af8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BalancesWithBanks"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_019c4318-517a-73f0-afcf-5de961652f9a" xlink:to="loc_ifrs-full_BalancesWithBanks_019c4318-517a-70be-94d7-1817d92f9af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Cash_019c4318-517a-7bcf-aa0a-922989c468f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Cash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_019c4318-517a-73f0-afcf-5de961652f9a" xlink:to="loc_ifrs-full_Cash_019c4318-517a-7bcf-aa0a-922989c468f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_019c4318-517a-7ee8-b5f5-8ee45c08f650" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_019c4318-517a-73f0-afcf-5de961652f9a" xlink:to="loc_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents_019c4318-517a-7ee8-b5f5-8ee45c08f650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_019c4318-517a-7eb3-a8c5-5f621ba83e9f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_019c4318-517a-73f0-afcf-5de961652f9a" xlink:to="loc_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents_019c4318-517a-7eb3-a8c5-5f621ba83e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashEquivalents_019c4318-517a-7c16-81bf-c52a14876580" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_019c4318-517a-73f0-afcf-5de961652f9a" xlink:to="loc_ifrs-full_CashEquivalents_019c4318-517a-7c16-81bf-c52a14876580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019c4318-517a-70f6-af9f-0920a50b1929" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_019c4318-517a-73f0-afcf-5de961652f9a" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019c4318-517a-70f6-af9f-0920a50b1929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#AccountsreceivableAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_019c4318-517a-7425-952e-fba8e4c7cdaa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TradeAndOtherReceivablesTable_019c4318-517a-7a49-808f-d0287622686d" xlink:href="soph-20251231.xsd#soph_TradeAndOtherReceivablesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_019c4318-517a-7425-952e-fba8e4c7cdaa" xlink:to="loc_soph_TradeAndOtherReceivablesTable_019c4318-517a-7a49-808f-d0287622686d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-517a-714c-a4da-ec81c5eb7816" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TradeAndOtherReceivablesTable_019c4318-517a-7a49-808f-d0287622686d" xlink:to="loc_ifrs-full_RangeAxis_019c4318-517a-714c-a4da-ec81c5eb7816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-517a-70fc-9909-4f19bbc301ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_019c4318-517a-714c-a4da-ec81c5eb7816" xlink:to="loc_ifrs-full_RangeDomain_019c4318-517a-70fc-9909-4f19bbc301ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-517a-76d9-81e3-7d7e15f215e0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-517a-70fc-9909-4f19bbc301ee" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-517a-76d9-81e3-7d7e15f215e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-517a-7dee-aeb8-eef37f1b9e2e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-517a-70fc-9909-4f19bbc301ee" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-517a-7dee-aeb8-eef37f1b9e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:href="soph-20251231.xsd#soph_TradeAndOtherReceivablesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TradeAndOtherReceivablesTable_019c4318-517a-7a49-808f-d0287622686d" xlink:to="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsReceivableNonInterestBearingPaymentTerms_019c4318-517a-7264-bce7-9b4f5bbf0843" xlink:href="soph-20251231.xsd#soph_AccountsReceivableNonInterestBearingPaymentTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_AccountsReceivableNonInterestBearingPaymentTerms_019c4318-517a-7264-bce7-9b4f5bbf0843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm_019c4318-517a-7741-a03a-3683c436771f" xlink:href="soph-20251231.xsd#soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm_019c4318-517a-7741-a03a-3683c436771f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PercentageOfCustomerBalanceAccountReceivable_019c4318-517a-7537-810f-854e08e6317e" xlink:href="soph-20251231.xsd#soph_PercentageOfCustomerBalanceAccountReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_PercentageOfCustomerBalanceAccountReceivable_019c4318-517a-7537-810f-854e08e6317e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsReceivableInAggregateAmount_019c4318-517a-73c4-8cfa-94d71cc79b3d" xlink:href="soph-20251231.xsd#soph_AccountsReceivableInAggregateAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_AccountsReceivableInAggregateAmount_019c4318-517a-73c4-8cfa-94d71cc79b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LongTermLeaseReceivables_019c4318-517a-706d-89cc-ce09d1ab9032" xlink:href="soph-20251231.xsd#soph_LongTermLeaseReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_LongTermLeaseReceivables_019c4318-517a-706d-89cc-ce09d1ab9032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NetLeaseReceivables_019c4318-517a-7b9d-bb93-503c065ffc4f" xlink:href="soph-20251231.xsd#soph_NetLeaseReceivables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_TradeAndOtherReceivablesLineItems_019c4318-517a-7c9d-846e-65ec6bda5562" xlink:to="loc_soph_NetLeaseReceivables_019c4318-517a-7b9d-bb93-503c065ffc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_019c4318-517a-70c9-bb47-64840dee6236" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-7f9e-830d-446a8bda69aa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_019c4318-517a-70c9-bb47-64840dee6236" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-7f9e-830d-446a8bda69aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eff-a3d5-c8b9abe219da" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-7f9e-830d-446a8bda69aa" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eff-a3d5-c8b9abe219da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7ee0-8409-ee5503079f3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eff-a3d5-c8b9abe219da" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7ee0-8409-ee5503079f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_019c4318-517a-7ba3-a3f1-a54ac489f44a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7ee0-8409-ee5503079f3f" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_019c4318-517a-7ba3-a3f1-a54ac489f44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_019c4318-517a-757f-822a-e4b762dfea60" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-517a-7ee0-8409-ee5503079f3f" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_019c4318-517a-757f-822a-e4b762dfea60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-7964-bcf9-e1ded3612fb8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-7f9e-830d-446a8bda69aa" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-7964-bcf9-e1ded3612fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-753a-a1f8-7b705f614efe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-7964-bcf9-e1ded3612fb8" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-753a-a1f8-7b705f614efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-7899-8e38-0c26bdd5367f" xlink:href="soph-20251231.xsd#soph_FinancialAssetsAccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-753a-a1f8-7b705f614efe" xlink:to="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-7899-8e38-0c26bdd5367f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeReceivablesMember_019c4318-517a-784b-a2cb-393c7006fbc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeReceivablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-7899-8e38-0c26bdd5367f" xlink:to="loc_ifrs-full_TradeReceivablesMember_019c4318-517a-784b-a2cb-393c7006fbc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractAssetsMember_019c4318-517a-740b-98ba-83d32a32543b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-7899-8e38-0c26bdd5367f" xlink:to="loc_ifrs-full_ContractAssetsMember_019c4318-517a-740b-98ba-83d32a32543b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-7c92-a8d2-99f2601d7bca" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-7f9e-830d-446a8bda69aa" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-7c92-a8d2-99f2601d7bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_019c4318-517a-7e44-bab5-60627b6e8a87" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-7c92-a8d2-99f2601d7bca" xlink:to="loc_ifrs-full_FinancialAssets_019c4318-517a-7e44-bab5-60627b6e8a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_019c4318-517a-7f9c-8ceb-ddfaa8d0e477" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-77fc-84f5-17af594f6285" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_019c4318-517a-7f9c-8ceb-ddfaa8d0e477" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-77fc-84f5-17af594f6285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eb7-a267-87aa6f7da705" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-77fc-84f5-17af594f6285" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eb7-a267-87aa6f7da705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-517a-75d2-a5c3-07ecfe792af8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-7eb7-a267-87aa6f7da705" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-517a-75d2-a5c3-07ecfe792af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_019c4318-517a-7fb3-935c-b6906b8ad834" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedImpairmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-517a-75d2-a5c3-07ecfe792af8" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_019c4318-517a-7fb3-935c-b6906b8ad834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-751e-9cc5-9f7bb3cfd2d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-77fc-84f5-17af594f6285" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-751e-9cc5-9f7bb3cfd2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-7cff-9333-3b5e806af967" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c4318-517a-751e-9cc5-9f7bb3cfd2d9" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-7cff-9333-3b5e806af967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-72ee-be5e-46822d15eb9a" xlink:href="soph-20251231.xsd#soph_FinancialAssetsAccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c4318-517a-7cff-9333-3b5e806af967" xlink:to="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-517a-72ee-be5e-46822d15eb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-719d-84e8-65677b336459" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable_019c4318-517a-77fc-84f5-17af594f6285" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-719d-84e8-65677b336459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems_019c4318-517a-719d-84e8-65677b336459" xlink:to="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_019c4318-517a-74f3-860b-af0801cd71b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:to="loc_ifrs-full_FinancialAssets_019c4318-517a-74f3-860b-af0801cd71b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_019c9dad-1368-7943-8743-2334266da6b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss_019c9dad-1368-7943-8743-2334266da6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss_019c7480-2efa-797a-8fd3-000aff610d38" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:to="loc_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss_019c7480-2efa-797a-8fd3-000aff610d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_019c4318-517a-7bae-a625-2f1e9dee8428" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DecreaseThroughWriteoffFinancialAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:to="loc_ifrs-full_DecreaseThroughWriteoffFinancialAssets_019c4318-517a-7bae-a625-2f1e9dee8428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_019c4318-517a-7df7-88b8-e003b821de51" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets_019c4318-517a-7df7-88b8-e003b821de51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_019c4318-517a-750c-a5dd-c7e2cb87061b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract_019c4318-517a-739a-a869-0a47b63e29cb" xlink:to="loc_ifrs-full_FinancialAssets_019c4318-517a-750c-a5dd-c7e2cb87061b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#InventorySummaryofInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7d4b-a975-946c64557fd1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RawMaterials_019c4318-517a-7841-bad6-90fbc5745b04" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7d4b-a975-946c64557fd1" xlink:to="loc_ifrs-full_RawMaterials_019c4318-517a-7841-bad6-90fbc5745b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WorkInProgress_019c4318-517a-7eb6-8757-af651bae8fe5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WorkInProgress"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7d4b-a975-946c64557fd1" xlink:to="loc_ifrs-full_WorkInProgress_019c4318-517a-7eb6-8757-af651bae8fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinishedGoods_019c4318-517a-7233-a75e-0f7a8681f820" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7d4b-a975-946c64557fd1" xlink:to="loc_ifrs-full_FinishedGoods_019c4318-517a-7233-a75e-0f7a8681f820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProvisionOfInventory_019c4318-517a-72c0-9de8-03bb321b24fc" xlink:href="soph-20251231.xsd#soph_ProvisionOfInventory"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7d4b-a975-946c64557fd1" xlink:to="loc_soph_ProvisionOfInventory_019c4318-517a-72c0-9de8-03bb321b24fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Inventories_019c4318-517a-752c-a3e6-3c3b1036b21a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7d4b-a975-946c64557fd1" xlink:to="loc_ifrs-full_Inventories_019c4318-517a-752c-a3e6-3c3b1036b21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/InventorySummaryofInventoryProvisionMovementDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#InventorySummaryofInventoryProvisionMovementDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/InventorySummaryofInventoryProvisionMovementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7666-a19b-782266fe7126" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfInventoriesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract_019c4318-517a-7eee-9198-84c7c4f80456" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInProvisionOfInventoryAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfInventoriesAbstract_019c4318-517a-7666-a19b-782266fe7126" xlink:to="loc_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract_019c4318-517a-7eee-9198-84c7c4f80456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInProvisionOfInventoryAbstract_019c4318-517a-7b04-a153-8347b52afef7" xlink:href="soph-20251231.xsd#soph_ChangesInProvisionOfInventoryAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ReconciliationOfChangesInProvisionOfInventoryAbstract_019c4318-517a-7eee-9198-84c7c4f80456" xlink:to="loc_soph_ChangesInProvisionOfInventoryAbstract_019c4318-517a-7b04-a153-8347b52afef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProvisionOfInventory_019c4318-517a-7f50-ae12-4619cf634137" xlink:href="soph-20251231.xsd#soph_ProvisionOfInventory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInProvisionOfInventoryAbstract_019c4318-517a-7b04-a153-8347b52afef7" xlink:to="loc_soph_ProvisionOfInventory_019c4318-517a-7f50-ae12-4619cf634137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_InventoryIncreaseInProvision_019c4318-517a-7659-a47f-f344e869e7ad" xlink:href="soph-20251231.xsd#soph_InventoryIncreaseInProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInProvisionOfInventoryAbstract_019c4318-517a-7b04-a153-8347b52afef7" xlink:to="loc_soph_InventoryIncreaseInProvision_019c4318-517a-7659-a47f-f344e869e7ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InventoryWritedown2011_019c4318-517a-754c-81d1-93fd6f334ac8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InventoryWritedown2011"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInProvisionOfInventoryAbstract_019c4318-517a-7b04-a153-8347b52afef7" xlink:to="loc_ifrs-full_InventoryWritedown2011_019c4318-517a-754c-81d1-93fd6f334ac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_InventoryCurrencyTranslationAdjustment_019c4318-517a-7a48-bbbc-5fc702ac7331" xlink:href="soph-20251231.xsd#soph_InventoryCurrencyTranslationAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInProvisionOfInventoryAbstract_019c4318-517a-7b04-a153-8347b52afef7" xlink:to="loc_soph_InventoryCurrencyTranslationAdjustment_019c4318-517a-7a48-bbbc-5fc702ac7331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProvisionOfInventory_019c4318-517a-7f63-8d70-7b3efafb3a85" xlink:href="soph-20251231.xsd#soph_ProvisionOfInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInProvisionOfInventoryAbstract_019c4318-517a-7b04-a153-8347b52afef7" xlink:to="loc_soph_ProvisionOfInventory_019c4318-517a-7f63-8d70-7b3efafb3a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PrepaidsandothercurrentassetsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-7b7a-b1f7-d121e2ba0402" xlink:href="soph-20251231.xsd#soph_PrepaymentsAndOtherCurrentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepayments_019c4318-517a-7e73-8813-b18791a87b53" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-7b7a-b1f7-d121e2ba0402" xlink:to="loc_ifrs-full_CurrentPrepayments_019c4318-517a-7e73-8813-b18791a87b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentValueAddedTaxReceivables_019c4318-517a-76af-afb4-896a40eb72cf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentValueAddedTaxReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-7b7a-b1f7-d121e2ba0402" xlink:to="loc_ifrs-full_CurrentValueAddedTaxReceivables_019c4318-517a-76af-afb4-896a40eb72cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentGovernmentGrantsReceivable_019c4318-517a-7a67-a1bc-cefdb89945ac" xlink:href="soph-20251231.xsd#soph_CurrentGovernmentGrantsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-7b7a-b1f7-d121e2ba0402" xlink:to="loc_soph_CurrentGovernmentGrantsReceivable_019c4318-517a-7a67-a1bc-cefdb89945ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentContractAcquisitionCosts_019c6753-13f0-7b55-b75d-6f0d78cf85d7" xlink:href="soph-20251231.xsd#soph_CurrentContractAcquisitionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-7b7a-b1f7-d121e2ba0402" xlink:to="loc_soph_CurrentContractAcquisitionCosts_019c6753-13f0-7b55-b75d-6f0d78cf85d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentOtherAssetsMiscellaneous_019c4318-517a-706e-bfca-891bbaeb207f" xlink:href="soph-20251231.xsd#soph_CurrentOtherAssetsMiscellaneous"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-7b7a-b1f7-d121e2ba0402" xlink:to="loc_soph_CurrentOtherAssetsMiscellaneous_019c4318-517a-706e-bfca-891bbaeb207f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-517a-722e-8a9a-97ada515a3ef" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-7b7a-b1f7-d121e2ba0402" xlink:to="loc_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets_019c4318-517a-722e-8a9a-97ada515a3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AmortisationCurrentContractAcquisitionCosts_019c9dbd-a6c0-74c8-a3e0-716ec3aaa06a" xlink:href="soph-20251231.xsd#soph_AmortisationCurrentContractAcquisitionCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PrepaymentsAndOtherCurrentAssetsAbstract_019c4318-517a-7b7a-b1f7-d121e2ba0402" xlink:to="loc_soph_AmortisationCurrentContractAcquisitionCosts_019c9dbd-a6c0-74c8-a3e0-716ec3aaa06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PropertyandequipmentAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_019c4318-517a-728d-91f6-427d7568683d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-73c8-86f0-efc3533f04e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_019c4318-517a-728d-91f6-427d7568683d" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-73c8-86f0-efc3533f04e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-517a-71a3-a3b8-a9d92b17b118" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-73c8-86f0-efc3533f04e3" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-517a-71a3-a3b8-a9d92b17b118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-517a-71a3-a3b8-a9d92b17b118" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerEquipmentMember_019c4318-517a-7b56-a2ec-06908253b25e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:to="loc_ifrs-full_ComputerEquipmentMember_019c4318-517a-7b56-a2ec-06908253b25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MachineryMember_019c4318-517a-7f27-ab06-3fe7df75f650" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MachineryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:to="loc_ifrs-full_MachineryMember_019c4318-517a-7f27-ab06-3fe7df75f650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_019c4318-517a-705e-ad2e-867c64478a26" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_019c4318-517a-705e-ad2e-867c64478a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_019c6760-b497-7a93-9fa6-82af723677b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-517a-7cfa-8dfa-d57f30194ee0" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_019c6760-b497-7a93-9fa6-82af723677b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-517a-706c-951a-ddd2a7abb3e4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-73c8-86f0-efc3533f04e3" xlink:to="loc_ifrs-full_RangeAxis_019c4318-517a-706c-951a-ddd2a7abb3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-517a-7e38-8451-cbaec0a3c7bf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_019c4318-517a-706c-951a-ddd2a7abb3e4" xlink:to="loc_ifrs-full_RangeDomain_019c4318-517a-7e38-8451-cbaec0a3c7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-517a-7121-bb0d-8f2f872b7141" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-517a-7e38-8451-cbaec0a3c7bf" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-517a-7121-bb0d-8f2f872b7141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-517a-724c-bf72-5855087766d0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-517a-7e38-8451-cbaec0a3c7bf" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-517a-724c-bf72-5855087766d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-517a-7f9e-9b02-52c3c3cf3d12" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-73c8-86f0-efc3533f04e3" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-517a-7f9e-9b02-52c3c3cf3d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_019c4318-517a-7561-8cf6-c8245f61113f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-517a-7f9e-9b02-52c3c3cf3d12" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_019c4318-517a-7561-8cf6-c8245f61113f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment_019c4318-517a-7b96-8840-5538fdaf808b" xlink:href="soph-20251231.xsd#soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-517a-7f9e-9b02-52c3c3cf3d12" xlink:to="loc_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment_019c4318-517a-7b96-8840-5538fdaf808b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ConstructionInProgress_019c6760-b497-7cb5-a197-6b578c9fd282" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ConstructionInProgress"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-517a-7f9e-9b02-52c3c3cf3d12" xlink:to="loc_ifrs-full_ConstructionInProgress_019c6760-b497-7cb5-a197-6b578c9fd282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_019c4318-517a-74c3-9a6d-db0d79ff2627" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-7095-9698-c7debf1fa72c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract_019c4318-517a-74c3-9a6d-db0d79ff2627" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-7095-9698-c7debf1fa72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-780f-9cfe-f801dd77cd3e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-7095-9698-c7debf1fa72c" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-780f-9cfe-f801dd77cd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-522c-7f36-8717-6a7b6f9609bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-517a-780f-9cfe-f801dd77cd3e" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-522c-7f36-8717-6a7b6f9609bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522c-75e3-9dfa-98c4a4cadb51" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522c-7f36-8717-6a7b6f9609bd" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522c-75e3-9dfa-98c4a4cadb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019c4318-522c-7eaa-b7f6-7ac69963f2f1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522c-7f36-8717-6a7b6f9609bd" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019c4318-522c-7eaa-b7f6-7ac69963f2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-522c-7e7c-adc2-e167c890632d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-7095-9698-c7debf1fa72c" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-522c-7e7c-adc2-e167c890632d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_019c4318-522c-7e7c-adc2-e167c890632d" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseholdImprovementsMember_019c4318-522c-7aa1-9081-34717b36d108" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:to="loc_ifrs-full_LeaseholdImprovementsMember_019c4318-522c-7aa1-9081-34717b36d108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MachineryMember_019c4318-522c-7ecd-ac3b-6ad27abed59b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MachineryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:to="loc_ifrs-full_MachineryMember_019c4318-522c-7ecd-ac3b-6ad27abed59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerEquipmentMember_019c4318-522c-721f-a4a6-e00dfbef9e4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:to="loc_ifrs-full_ComputerEquipmentMember_019c4318-522c-721f-a4a6-e00dfbef9e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FixturesAndFittingsMember_019c4318-522c-75c0-8142-128cd8807655" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FixturesAndFittingsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_019c4318-522c-771d-8488-e79f2b26673c" xlink:to="loc_ifrs-full_FixturesAndFittingsMember_019c4318-522c-75c0-8142-128cd8807655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-522c-74bd-8f48-bf2088f3f751" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_019c4318-517a-7095-9698-c7debf1fa72c" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-522c-74bd-8f48-bf2088f3f751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-7a83-b087-b3227ca1027c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_019c4318-522c-74bd-8f48-bf2088f3f751" xlink:to="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-7a83-b087-b3227ca1027c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-7a83-b087-b3227ca1027c" xlink:to="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_019c4318-522c-776f-ab68-d2631f21a61b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_019c4318-522c-776f-ab68-d2631f21a61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_019c4318-522c-7cda-990d-c38102961af6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_019c4318-522c-7cda-990d-c38102961af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_019c4318-522c-7963-9afb-c3b8c4a5f54b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:to="loc_ifrs-full_DisposalsPropertyPlantAndEquipment_019c4318-522c-7963-9afb-c3b8c4a5f54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_019c4318-522c-7c0c-a458-239a0b342154" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_019c4318-522c-7c0c-a458-239a0b342154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_019c4318-522c-71a3-920e-309365147b89" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract_019c4318-522c-734e-960c-a9db6e85dc93" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_019c4318-522c-71a3-920e-309365147b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IntangibleAssetsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019c4318-522c-7910-a364-d8844017bd33" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ScheduleOfIntangibleAssetsTable_019c4318-522c-752a-bf2c-d3f95acfbb1a" xlink:href="soph-20251231.xsd#soph_ScheduleOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019c4318-522c-7910-a364-d8844017bd33" xlink:to="loc_soph_ScheduleOfIntangibleAssetsTable_019c4318-522c-752a-bf2c-d3f95acfbb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7a3f-9cb6-7f9227e7adde" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ScheduleOfIntangibleAssetsTable_019c4318-522c-752a-bf2c-d3f95acfbb1a" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7a3f-9cb6-7f9227e7adde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7825-9848-6d862f492068" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7a3f-9cb6-7f9227e7adde" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7825-9848-6d862f492068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_019c4318-522c-74b1-8182-0c5e19f82145" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7825-9848-6d862f492068" xlink:to="loc_ifrs-full_ComputerSoftwareMember_019c4318-522c-74b1-8182-0c5e19f82145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_019c4318-522c-72b1-b3de-2fdfd975b03a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7825-9848-6d862f492068" xlink:to="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_019c4318-522c-72b1-b3de-2fdfd975b03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:href="soph-20251231.xsd#soph_ScheduleOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ScheduleOfIntangibleAssetsTable_019c4318-522c-752a-bf2c-d3f95acfbb1a" xlink:to="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_019c4318-522c-71f1-8adb-6a0649f59e60" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_019c4318-522c-71f1-8adb-6a0649f59e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_019c4318-522c-771b-8c08-8230c9557306" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill_019c4318-522c-771b-8c08-8230c9557306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets_019c4318-522c-75dc-baf7-e575944c3048" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets_019c4318-522c-75dc-baf7-e575944c3048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus_019c4318-522c-73c6-98d1-113b21556259" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus_019c4318-522c-73c6-98d1-113b21556259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets_019c4318-522c-7bf9-81ec-57db768bc180" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets_019c4318-522c-7bf9-81ec-57db768bc180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfCashGeneratingUnit_019c4318-522c-72f4-9e97-12a796565be5" xlink:href="soph-20251231.xsd#soph_NumberOfCashGeneratingUnit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ScheduleOfIntangibleAssetsLineItems_019c4318-522c-7659-98d8-21795cc36138" xlink:to="loc_soph_NumberOfCashGeneratingUnit_019c4318-522c-72f4-9e97-12a796565be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#IntangibleAssetsIntangibleAssetsNetMovementDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019c4318-522c-7ebf-8cbe-1dfdf3457890" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019c4318-522c-72bd-b010-be45040e24cd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAbstract_019c4318-522c-7ebf-8cbe-1dfdf3457890" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019c4318-522c-72bd-b010-be45040e24cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522c-7b4c-97ce-f2cbd60bfcb6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019c4318-522c-72bd-b010-be45040e24cd" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522c-7b4c-97ce-f2cbd60bfcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-522c-707c-b39f-a9c45433975f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522c-7b4c-97ce-f2cbd60bfcb6" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-522c-707c-b39f-a9c45433975f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522c-721c-9a82-442f1585cc77" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522c-707c-b39f-a9c45433975f" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522c-721c-9a82-442f1585cc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019c4318-522c-71d2-b0a5-b6f7dc7272bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522c-707c-b39f-a9c45433975f" xlink:to="loc_ifrs-full_AccumulatedDepreciationAndAmortisationMember_019c4318-522c-71d2-b0a5-b6f7dc7272bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7d11-85e4-3eeebc5f5a15" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019c4318-522c-72bd-b010-be45040e24cd" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7d11-85e4-3eeebc5f5a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7ae6-9896-4973cccc8015" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_019c4318-522c-7d11-85e4-3eeebc5f5a15" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7ae6-9896-4973cccc8015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GoodwillMember_019c4318-522c-776d-8f13-83fe87f46540" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GoodwillMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7ae6-9896-4973cccc8015" xlink:to="loc_ifrs-full_GoodwillMember_019c4318-522c-776d-8f13-83fe87f46540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ComputerSoftwareMember_019c4318-522c-7029-ab3b-1c0fcce7a5d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7ae6-9896-4973cccc8015" xlink:to="loc_ifrs-full_ComputerSoftwareMember_019c4318-522c-7029-ab3b-1c0fcce7a5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_019c4318-522c-7550-861b-5e50c6bf3fd2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalisedDevelopmentExpenditureMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain_019c4318-522c-7ae6-9896-4973cccc8015" xlink:to="loc_ifrs-full_CapitalisedDevelopmentExpenditureMember_019c4318-522c-7550-861b-5e50c6bf3fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_019c4318-522c-79f1-8de1-ed74d54e8e7c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_019c4318-522c-72bd-b010-be45040e24cd" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_019c4318-522c-79f1-8de1-ed74d54e8e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019c4318-522c-7e5a-9647-c9b505a7bc76" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_019c4318-522c-79f1-8de1-ed74d54e8e7c" xlink:to="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019c4318-522c-7e5a-9647-c9b505a7bc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-522c-79ed-bd1e-842ce64fed06" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract_019c4318-522c-7e5a-9647-c9b505a7bc76" xlink:to="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-522c-79ed-bd1e-842ce64fed06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_019c4318-522c-7ba9-8c9a-e98056369c11" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-522c-79ed-bd1e-842ce64fed06" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_019c4318-522c-7ba9-8c9a-e98056369c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_019c4318-522c-7a34-87ce-02d4e0244cf8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-522c-79ed-bd1e-842ce64fed06" xlink:to="loc_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_019c4318-522c-7a34-87ce-02d4e0244cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_019c4318-522c-78d1-81fb-f4020ab3dbaa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-522c-79ed-bd1e-842ce64fed06" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill_019c4318-522c-78d1-81fb-f4020ab3dbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwill_019c4318-522c-7d63-9eb2-ff3648df1e1d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract_019c4318-522c-79ed-bd1e-842ce64fed06" xlink:to="loc_ifrs-full_IntangibleAssetsAndGoodwill_019c4318-522c-7d63-9eb2-ff3648df1e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#LeasesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c4318-522c-7dbd-965f-1aeaf35c05a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:href="soph-20251231.xsd#soph_DisclosureOfLeaseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c4318-522c-7dbd-965f-1aeaf35c05a1" xlink:to="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522c-7fcd-a3ae-905da5c7d42d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522c-7fcd-a3ae-905da5c7d42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522c-7611-8d20-df8f9ff2955c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522c-7fcd-a3ae-905da5c7d42d" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522c-7611-8d20-df8f9ff2955c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OfficeSpaceMember_019c4318-522c-70af-b4fa-39c16c346ac1" xlink:href="soph-20251231.xsd#soph_OfficeSpaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522c-7611-8d20-df8f9ff2955c" xlink:to="loc_soph_OfficeSpaceMember_019c4318-522c-70af-b4fa-39c16c346ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e86-a149-ba57e2e7e742" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:to="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e86-a149-ba57e2e7e742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-780b-971d-0c6ce37b955b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e86-a149-ba57e2e7e742" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-780b-971d-0c6ce37b955b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RolleSwitzerlandMember_019c4318-522c-774c-a8ea-38147833bdd6" xlink:href="soph-20251231.xsd#soph_RolleSwitzerlandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-780b-971d-0c6ce37b955b" xlink:to="loc_soph_RolleSwitzerlandMember_019c4318-522c-774c-a8ea-38147833bdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BostonMassachusettsMember_019c4318-522c-7d57-a6ca-0096546e53e3" xlink:href="soph-20251231.xsd#soph_BostonMassachusettsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-780b-971d-0c6ce37b955b" xlink:to="loc_soph_BostonMassachusettsMember_019c4318-522c-7d57-a6ca-0096546e53e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BidartFranceMember_019c4318-522c-73d0-b74b-7fa41e4f9aa9" xlink:href="soph-20251231.xsd#soph_BidartFranceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-780b-971d-0c6ce37b955b" xlink:to="loc_soph_BidartFranceMember_019c4318-522c-73d0-b74b-7fa41e4f9aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-522c-7394-9bcb-b3c58acb2b08" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:to="loc_ifrs-full_RangeAxis_019c4318-522c-7394-9bcb-b3c58acb2b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522c-7bc3-85c3-bcffc809c70f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522c-7394-9bcb-b3c58acb2b08" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522c-7bc3-85c3-bcffc809c70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-522c-73dd-9c54-146a486bb188" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522c-7bc3-85c3-bcffc809c70f" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-522c-73dd-9c54-146a486bb188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-522c-7427-a511-122446766fa8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522c-7bc3-85c3-bcffc809c70f" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-522c-7427-a511-122446766fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522c-7ce0-be85-a80d5ecc53c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522c-7ce0-be85-a80d5ecc53c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522c-729b-9372-ad1544990180" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522c-7ce0-be85-a80d5ecc53c7" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522c-729b-9372-ad1544990180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember_019c4318-522c-7a89-bb2d-dbab2f3ce97c" xlink:href="soph-20251231.xsd#soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522c-729b-9372-ad1544990180" xlink:to="loc_soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember_019c4318-522c-7a89-bb2d-dbab2f3ce97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:href="soph-20251231.xsd#soph_DisclosureOfLeaseLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseTable_019c4318-522c-7b76-84c6-01a00fbe2f61" xlink:to="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfLeases_019c4318-522c-77f8-a372-021c3bb0b230" xlink:href="soph-20251231.xsd#soph_NumberOfLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_NumberOfLeases_019c4318-522c-77f8-a372-021c3bb0b230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseTerm_019c4318-522c-7381-8100-78741392c56d" xlink:href="soph-20251231.xsd#soph_LeaseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_LeaseTerm_019c4318-522c-7381-8100-78741392c56d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AreaOfOfficeSpaceLeased_019c4318-522c-7a32-9e5f-bcf509fa4297" xlink:href="soph-20251231.xsd#soph_AreaOfOfficeSpaceLeased"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_AreaOfOfficeSpaceLeased_019c4318-522c-7a32-9e5f-bcf509fa4297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AreaOfOfficeSpaceGainedAccessUnderLease_019c4318-522c-75d9-bc2c-309a4573aca5" xlink:href="soph-20251231.xsd#soph_AreaOfOfficeSpaceGainedAccessUnderLease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_AreaOfOfficeSpaceGainedAccessUnderLease_019c4318-522c-75d9-bc2c-309a4573aca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_019c4318-522c-73f1-8237-0c1067486a29" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_ifrs-full_RightofuseAssets_019c4318-522c-73f1-8237-0c1067486a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_019c4318-522c-7cfb-bb2b-a619114885e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_ifrs-full_LeaseLiabilities_019c4318-522c-7cfb-bb2b-a619114885e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseIncentivesAndExpectedRestorationCosts_019c4318-522c-7925-9b7f-019d9070fcf4" xlink:href="soph-20251231.xsd#soph_LeaseIncentivesAndExpectedRestorationCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_LeaseIncentivesAndExpectedRestorationCosts_019c4318-522c-7925-9b7f-019d9070fcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseDirectCosts_019c4318-522c-7ad3-9959-1ea7c59ae880" xlink:href="soph-20251231.xsd#soph_LeaseDirectCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_LeaseDirectCosts_019c4318-522c-7ad3-9959-1ea7c59ae880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExpectedLeaseCommitments_019c4318-522c-7a33-9cf5-912ae948bd0c" xlink:href="soph-20251231.xsd#soph_ExpectedLeaseCommitments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_ExpectedLeaseCommitments_019c4318-522c-7a33-9cf5-912ae948bd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseExpenses_019c4318-522c-784b-b744-1413b66f3fa5" xlink:href="soph-20251231.xsd#soph_LeaseExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_LeaseExpenses_019c4318-522c-784b-b744-1413b66f3fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashOutflowForLeases_019c4318-522c-7f52-b651-0214d7d48cc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashOutflowForLeases"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_ifrs-full_CashOutflowForLeases_019c4318-522c-7f52-b651-0214d7d48cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RightOfUseAssetsDiscountedPaymentsRate_019c4318-522c-7581-a990-5bdca5932327" xlink:href="soph-20251231.xsd#soph_RightOfUseAssetsDiscountedPaymentsRate"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_RightOfUseAssetsDiscountedPaymentsRate_019c4318-522c-7581-a990-5bdca5932327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LeaseLiabilitiesDiscountedPaymentsRate_019c4318-522c-7627-9b57-4dc7e225b33b" xlink:href="soph-20251231.xsd#soph_LeaseLiabilitiesDiscountedPaymentsRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_LeaseLiabilitiesDiscountedPaymentsRate_019c4318-522c-7627-9b57-4dc7e225b33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_AdditionsToRightofuseAssets_019c89bb-0601-76e9-a859-b217894998a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsToRightofuseAssets"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_ifrs-full_AdditionsToRightofuseAssets_019c89bb-0601-76e9-a859-b217894998a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DepreciationRightofuseAssets_019c89bb-0601-7ded-b355-f4571f1c02e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DepreciationRightofuseAssets"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_ifrs-full_DepreciationRightofuseAssets_019c89bb-0601-7ded-b355-f4571f1c02e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PrincipalPaidOnLeaseLiabilities_019c89bb-4570-798e-8a4f-aaca68bcae6f" xlink:href="soph-20251231.xsd#soph_PrincipalPaidOnLeaseLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_PrincipalPaidOnLeaseLiabilities_019c89bb-4570-798e-8a4f-aaca68bcae6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_InterestPaidOnLeaseLiabilities_019c89bb-4570-7438-b1f4-46018f2c66f6" xlink:href="soph-20251231.xsd#soph_InterestPaidOnLeaseLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c4318-522c-780a-8f06-b90960948e7a" xlink:to="loc_soph_InterestPaidOnLeaseLiabilities_019c89bb-4570-7438-b1f4-46018f2c66f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#LeasesSummaryofRightofUseAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c89a9-e5e3-7993-9c67-136e2da039bf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfLeaseTable_019c9fdf-169c-77b3-9b6d-be85a46ce413" xlink:href="soph-20251231.xsd#soph_DisclosureOfLeaseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c89a9-e5e3-7993-9c67-136e2da039bf" xlink:to="loc_soph_DisclosureOfLeaseTable_019c9fdf-169c-77b3-9b6d-be85a46ce413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_019c9fdf-169c-79c6-9a93-b191556e9c59" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseTable_019c9fdf-169c-77b3-9b6d-be85a46ce413" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_019c9fdf-169c-79c6-9a93-b191556e9c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_019c9fdf-169c-778b-b1d8-922e8ef43de5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_019c9fdf-169c-79c6-9a93-b191556e9c59" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_019c9fdf-169c-778b-b1d8-922e8ef43de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OfficeSpaceMember_019c9fdf-169c-70fa-ab0d-e5bc818d22fd" xlink:href="soph-20251231.xsd#soph_OfficeSpaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_019c9fdf-169c-778b-b1d8-922e8ef43de5" xlink:to="loc_soph_OfficeSpaceMember_019c9fdf-169c-70fa-ab0d-e5bc818d22fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfLeaseLineItems_019c9fdf-169c-7dfc-9d49-9a43488622a4" xlink:href="soph-20251231.xsd#soph_DisclosureOfLeaseLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseTable_019c9fdf-169c-77b3-9b6d-be85a46ce413" xlink:to="loc_soph_DisclosureOfLeaseLineItems_019c9fdf-169c-7dfc-9d49-9a43488622a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RightofuseAssets_019c9fdf-169c-731c-8c80-0be731371b4f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfLeaseLineItems_019c9fdf-169c-7dfc-9d49-9a43488622a4" xlink:to="loc_ifrs-full_RightofuseAssets_019c9fdf-169c-731c-8c80-0be731371b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#LeasesSummaryofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c89b9-77a6-7fe5-aacf-a38c9999102a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PresentationOfLeasesForLesseeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_019c89b9-db01-7835-9f46-74000dcf6bc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c89b9-77a6-7fe5-aacf-a38c9999102a" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_019c89b9-db01-7835-9f46-74000dcf6bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_019c89b9-db01-78db-bd4c-46f7b59af4df" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c89b9-77a6-7fe5-aacf-a38c9999102a" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_019c89b9-db01-78db-bd4c-46f7b59af4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilities_019c89b9-db01-7ab1-92b7-2b5ceba0a5c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PresentationOfLeasesForLesseeAbstract_019c89b9-77a6-7fe5-aacf-a38c9999102a" xlink:to="loc_ifrs-full_LeaseLiabilities_019c89b9-db01-7ab1-92b7-2b5ceba0a5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#OthernoncurrentassetsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_019c4318-522c-7de4-a058-718c3f831b6c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousNoncurrentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NoncurrentValueAddedTaxReceivables_019c4318-522c-7407-9ddb-1c5640a3067a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentValueAddedTaxReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_019c4318-522c-7de4-a058-718c3f831b6c" xlink:to="loc_ifrs-full_NoncurrentValueAddedTaxReceivables_019c4318-522c-7407-9ddb-1c5640a3067a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NonCurrentDepositsGuarantyAssets_019c4318-522c-7f15-a14e-c838b4adbff8" xlink:href="soph-20251231.xsd#soph_NonCurrentDepositsGuarantyAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_019c4318-522c-7de4-a058-718c3f831b6c" xlink:to="loc_soph_NonCurrentDepositsGuarantyAssets_019c4318-522c-7f15-a14e-c838b4adbff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_019c677a-dd30-782c-97b9-5e3211eae01c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_019c4318-522c-7de4-a058-718c3f831b6c" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_019c677a-dd30-782c-97b9-5e3211eae01c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NonCurrentContractAcquisitionCosts_019c677c-a893-71e5-b83c-5aa71dc930b6" xlink:href="soph-20251231.xsd#soph_NonCurrentContractAcquisitionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_019c4318-522c-7de4-a058-718c3f831b6c" xlink:to="loc_soph_NonCurrentContractAcquisitionCosts_019c677c-a893-71e5-b83c-5aa71dc930b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_019c4318-522c-71e4-aeeb-f07792454108" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MiscellaneousNoncurrentAssetsAbstract_019c4318-522c-7de4-a058-718c3f831b6c" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_019c4318-522c-71e4-aeeb-f07792454108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccountspayableDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#AccountspayableDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/AccountspayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_019c4318-522c-77f9-bca5-c4ff7674f55e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_019c4318-522c-7a5a-9e59-8b63c7e1d2f6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_019c4318-522c-77f9-bca5-c4ff7674f55e" xlink:to="loc_ifrs-full_TradeAndOtherPayablesToTradeSuppliers_019c4318-522c-7a5a-9e59-8b63c7e1d2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_EmployeeRelatedPayables_019c4318-522c-71d7-86d0-3b30c4405d8d" xlink:href="soph-20251231.xsd#soph_EmployeeRelatedPayables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_019c4318-522c-77f9-bca5-c4ff7674f55e" xlink:to="loc_soph_EmployeeRelatedPayables_019c4318-522c-71d7-86d0-3b30c4405d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables_019c4318-522c-7926-9115-c4ea0ea19334" xlink:href="soph-20251231.xsd#soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_019c4318-522c-77f9-bca5-c4ff7674f55e" xlink:to="loc_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables_019c4318-522c-7926-9115-c4ea0ea19334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-522c-75c9-9ffe-357c8e60003c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_019c4318-522c-77f9-bca5-c4ff7674f55e" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_019c4318-522c-75c9-9ffe-357c8e60003c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/AccruedexpensesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#AccruedexpensesDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/AccruedexpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedExpensesAbstract_019c4318-522c-7727-a133-59961ffbb54b" xlink:href="soph-20251231.xsd#soph_AccruedExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedCompensation_019c4318-522c-7d28-998a-fd2a6ca98ae5" xlink:href="soph-20251231.xsd#soph_AccruedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AccruedExpensesAbstract_019c4318-522c-7727-a133-59961ffbb54b" xlink:to="loc_soph_AccruedCompensation_019c4318-522c-7d28-998a-fd2a6ca98ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedProfessionalFees_019c4318-522c-775e-a12a-0c8da130ba3a" xlink:href="soph-20251231.xsd#soph_AccruedProfessionalFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AccruedExpensesAbstract_019c4318-522c-7727-a133-59961ffbb54b" xlink:to="loc_soph_AccruedProfessionalFees_019c4318-522c-775e-a12a-0c8da130ba3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedInventoryPurchases_019c4318-522c-7ec1-b824-092ed600a748" xlink:href="soph-20251231.xsd#soph_AccruedInventoryPurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AccruedExpensesAbstract_019c4318-522c-7727-a133-59961ffbb54b" xlink:to="loc_soph_AccruedInventoryPurchases_019c4318-522c-7ec1-b824-092ed600a748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedITSupport_019c4318-522c-718a-920b-c28bd314739b" xlink:href="soph-20251231.xsd#soph_AccruedITSupport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AccruedExpensesAbstract_019c4318-522c-7727-a133-59961ffbb54b" xlink:to="loc_soph_AccruedITSupport_019c4318-522c-718a-920b-c28bd314739b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedLegalFees_019c4318-522c-76e8-9271-230ad4c98132" xlink:href="soph-20251231.xsd#soph_AccruedLegalFees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AccruedExpensesAbstract_019c4318-522c-7727-a133-59961ffbb54b" xlink:to="loc_soph_AccruedLegalFees_019c4318-522c-76e8-9271-230ad4c98132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedOther_019c4318-522c-7749-9aa4-e7f2471cb303" xlink:href="soph-20251231.xsd#soph_AccruedOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AccruedExpensesAbstract_019c4318-522c-7727-a133-59961ffbb54b" xlink:to="loc_soph_AccruedOther_019c4318-522c-7749-9aa4-e7f2471cb303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CurrentAccruedExpenses_019c4318-522c-7c17-b16b-4a01d8aad457" xlink:href="soph-20251231.xsd#soph_CurrentAccruedExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_AccruedExpensesAbstract_019c4318-522c-7727-a133-59961ffbb54b" xlink:to="loc_soph_CurrentAccruedExpenses_019c4318-522c-7c17-b16b-4a01d8aad457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7627-91b9-4dd54179cc95" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-522c-76f9-8430-9bc5574eef5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7627-91b9-4dd54179cc95" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-522c-76f9-8430-9bc5574eef5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_019c4318-522c-7e18-acd1-918ddbde070a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7627-91b9-4dd54179cc95" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_019c4318-522c-7e18-acd1-918ddbde070a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SurplusDeficitInPlan_019c4318-522c-7ae0-85c2-628bc955b07c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SurplusDeficitInPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7627-91b9-4dd54179cc95" xlink:to="loc_ifrs-full_SurplusDeficitInPlan_019c4318-522c-7ae0-85c2-628bc955b07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-71d6-8ab4-e2ac393adf2a" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7bc7-bcb2-f99829e41f94" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-71d6-8ab4-e2ac393adf2a" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7bc7-bcb2-f99829e41f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7f2a-8223-3360500096fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7bc7-bcb2-f99829e41f94" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7f2a-8223-3360500096fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-711b-af03-19f522bb9a15" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7f2a-8223-3360500096fe" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-711b-af03-19f522bb9a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7826-ab9f-7a66edf3554f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-711b-af03-19f522bb9a15" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7826-ab9f-7a66edf3554f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-786a-a4f1-f7f6026f6352" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-711b-af03-19f522bb9a15" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-786a-a4f1-f7f6026f6352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7617-964c-cebd9be0a056" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7bc7-bcb2-f99829e41f94" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7617-964c-cebd9be0a056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract_019c4318-522c-7320-8b8b-cc8403ae86a9" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7617-964c-cebd9be0a056" xlink:to="loc_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract_019c4318-522c-7320-8b8b-cc8403ae86a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:href="soph-20251231.xsd#soph_ChangesInDefinedBenefitObligationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract_019c4318-522c-7320-8b8b-cc8403ae86a9" xlink:to="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-522c-7905-a9ba-f336cc8975bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-522c-7905-a9ba-f336cc8975bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ServiceCostDefinedBenefitPlans_019c4318-522c-7811-b721-9adf8bbf0213" xlink:href="soph-20251231.xsd#soph_ServiceCostDefinedBenefitPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_soph_ServiceCostDefinedBenefitPlans_019c4318-522c-7811-b721-9adf8bbf0213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_019c4318-522c-753b-8bb6-a58088b896a3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentServiceCostDefinedBenefitPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_ifrs-full_CurrentServiceCostDefinedBenefitPlans_019c4318-522c-753b-8bb6-a58088b896a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans_019c4318-522c-7767-9861-bbb2041b3b1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans_019c4318-522c-7767-9861-bbb2041b3b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_019c4318-522c-75fb-89bb-d889505760c4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseDefinedBenefitPlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_ifrs-full_InterestExpenseDefinedBenefitPlans_019c4318-522c-75fb-89bb-d889505760c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7326-801d-2f53f0c69ce6" xlink:href="soph-20251231.xsd#soph_ActuarialGainsLossesNetDefinedBenefitPlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7326-801d-2f53f0c69ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_019c4318-522c-7247-9322-3e44d4cfeff8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_019c4318-522c-7247-9322-3e44d4cfeff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans_019c4318-522c-7b48-95e8-c95e85075bcf" xlink:href="soph-20251231.xsd#soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans_019c4318-522c-7b48-95e8-c95e85075bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans_019c4318-522c-7533-8e31-59dbe282fef6" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans_019c4318-522c-7533-8e31-59dbe282fef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-522c-7cf6-a9de-312681bed9ff" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInDefinedBenefitObligationAbstract_019c4318-522c-77a4-a403-4405d9d19fd1" xlink:to="loc_ifrs-full_DefinedBenefitObligationAtPresentValue_019c4318-522c-7cf6-a9de-312681bed9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7d5a-a740-696153144396" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7d5a-a740-696153144396" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-76a9-b82d-a7c323f919c0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-76a9-b82d-a7c323f919c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7db4-b8f7-528debf3062d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-76a9-b82d-a7c323f919c0" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7db4-b8f7-528debf3062d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7a2a-b6c6-0eb594d86747" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7db4-b8f7-528debf3062d" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7a2a-b6c6-0eb594d86747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_019c4318-522c-7889-865a-f454b5bce146" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_019c4318-522c-7889-865a-f454b5bce146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_019c4318-522c-7604-86cf-f5d705013274" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_019c4318-522c-7889-865a-f454b5bce146" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_019c4318-522c-7604-86cf-f5d705013274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SwissPensionPlanMember_019c4318-522c-7082-a993-7767efee1013" xlink:href="soph-20251231.xsd#soph_SwissPensionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_019c4318-522c-7604-86cf-f5d705013274" xlink:to="loc_soph_SwissPensionPlanMember_019c4318-522c-7082-a993-7767efee1013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FrenchPensionPlanMember_019c4318-522c-7069-9270-49e339476fac" xlink:href="soph-20251231.xsd#soph_FrenchPensionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_019c4318-522c-7604-86cf-f5d705013274" xlink:to="loc_soph_FrenchPensionPlanMember_019c4318-522c-7069-9270-49e339476fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e5f-85f3-09fbed6c225a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:to="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e5f-85f3-09fbed6c225a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-737d-8258-a52cbf329434" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_019c4318-522c-7e5f-85f3-09fbed6c225a" xlink:to="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-737d-8258-a52cbf329434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_019c4318-522c-71f4-804d-ec55f6e802d8" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_019c4318-522c-737d-8258-a52cbf329434" xlink:to="loc_country_US_019c4318-522c-71f4-804d-ec55f6e802d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c71d2-4074-7854-9cbf-ba64665d2df8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:to="loc_ifrs-full_RangeAxis_019c71d2-4074-7854-9cbf-ba64665d2df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c71d2-4074-7cf0-a546-3b00244f1148" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_019c71d2-4074-7854-9cbf-ba64665d2df8" xlink:to="loc_ifrs-full_RangeDomain_019c71d2-4074-7cf0-a546-3b00244f1148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c71d3-4c9f-7e7a-8bf7-815eb37a9738" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c71d2-4074-7cf0-a546-3b00244f1148" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c71d3-4c9f-7e7a-8bf7-815eb37a9738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c71d3-920f-7608-bd50-6776300b7613" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c71d2-4074-7cf0-a546-3b00244f1148" xlink:to="loc_ifrs-full_TopOfRangeMember_019c71d3-920f-7608-bd50-6776300b7613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-754c-8f48-2d4897333295" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfActiveMembers_019c4318-522c-7ba0-a9fa-ce0d56ab7720" xlink:href="soph-20251231.xsd#soph_NumberOfActiveMembers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_NumberOfActiveMembers_019c4318-522c-7ba0-a9fa-ce0d56ab7720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans_019c4318-522c-7169-aa94-b8d908e222c1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans_019c4318-522c-7169-aa94-b8d908e222c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DemographicAssumptionOfWeightedTurnoverRates_019c4318-522c-7faa-8ba3-dfbd60e46e8c" xlink:href="soph-20251231.xsd#soph_DemographicAssumptionOfWeightedTurnoverRates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_DemographicAssumptionOfWeightedTurnoverRates_019c4318-522c-7faa-8ba3-dfbd60e46e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FinancialAssumptionOfDiscountRates_019c4318-522c-7c2f-b4ae-ec3602e499f3" xlink:href="soph-20251231.xsd#soph_FinancialAssumptionOfDiscountRates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_FinancialAssumptionOfDiscountRates_019c4318-522c-7c2f-b4ae-ec3602e499f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_019c4318-522c-716a-a94b-b704f82dd784" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRates_019c4318-522c-716a-a94b-b704f82dd784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_019c4318-522c-7e31-91e4-de43c4632fa1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_019c4318-522c-7e31-91e4-de43c4632fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_019c4318-522c-7f5f-b6b6-82b7fdc2caa7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019_019c4318-522c-7f5f-b6b6-82b7fdc2caa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_LPPInterestRate_019c4318-522c-7f64-ba2e-ff6f103d4437" xlink:href="soph-20251231.xsd#soph_LPPInterestRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_LPPInterestRate_019c4318-522c-7f64-ba2e-ff6f103d4437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExtraMandatoryPartEquivalentToDiscountRate_019c4318-522c-73bd-9913-d854eea257ff" xlink:href="soph-20251231.xsd#soph_ExtraMandatoryPartEquivalentToDiscountRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_ExtraMandatoryPartEquivalentToDiscountRate_019c4318-522c-73bd-9913-d854eea257ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_019c4318-522c-7aa8-ad06-0136852ac740" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation_019c4318-522c-7aa8-ad06-0136852ac740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForMale_019c4318-522c-7792-a42a-84fc723ff004" xlink:href="soph-20251231.xsd#soph_AverageLifeExpectancyInYearsAfterRetirementForMale"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForMale_019c4318-522c-7792-a42a-84fc723ff004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale_019c4318-522c-7600-b1ea-a2d2b0f241b8" xlink:href="soph-20251231.xsd#soph_AverageLifeExpectancyInYearsAfterRetirementForFemale"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale_019c4318-522c-7600-b1ea-a2d2b0f241b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_019c4318-522c-7d57-a623-746bc4f7c2b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan_019c4318-522c-7d57-a623-746bc4f7c2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_019c4318-522c-7900-9bd4-12606324ec60" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7625-b4e0-649e8d2314f0" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans_019c4318-522c-7900-9bd4-12606324ec60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7bdc-a6ad-3447f5be59fd" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7ca0-b2c4-0f0f76f62961" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7bdc-a6ad-3447f5be59fd" xlink:to="loc_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7ca0-b2c4-0f0f76f62961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7b97-acc7-d41ffed343a2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7ca0-b2c4-0f0f76f62961" xlink:to="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7b97-acc7-d41ffed343a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_019c4318-522c-79b7-a57c-70653f9ec0fd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7b97-acc7-d41ffed343a2" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_019c4318-522c-79b7-a57c-70653f9ec0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_019c4318-522c-7aee-80de-f6c7fc93bb20" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7b97-acc7-d41ffed343a2" xlink:to="loc_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_019c4318-522c-7aee-80de-f6c7fc93bb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_019c4318-522c-7db9-a5a7-ff934c256585" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7b97-acc7-d41ffed343a2" xlink:to="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_019c4318-522c-7db9-a5a7-ff934c256585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset_019c4318-522c-7809-aee6-98311ad78311" xlink:href="soph-20251231.xsd#soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7b97-acc7-d41ffed343a2" xlink:to="loc_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset_019c4318-522c-7809-aee6-98311ad78311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_019c4318-522c-7539-a956-ca9acc1528d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7b97-acc7-d41ffed343a2" xlink:to="loc_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_019c4318-522c-7539-a956-ca9acc1528d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_019c4318-522c-734d-a9cb-a5d5bfe3d33b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7b97-acc7-d41ffed343a2" xlink:to="loc_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_019c4318-522c-734d-a9cb-a5d5bfe3d33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans_019c4318-522c-7fc1-8410-e0f543d077f2" xlink:href="soph-20251231.xsd#soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7b97-acc7-d41ffed343a2" xlink:to="loc_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans_019c4318-522c-7fc1-8410-e0f543d077f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_019c4318-522c-70a4-892e-4944e2890d2a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7b97-acc7-d41ffed343a2" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_019c4318-522c-70a4-892e-4944e2890d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_019c4318-522c-753c-b313-946994c22b9e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract_019c4318-522c-7b97-acc7-d41ffed343a2" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_019c4318-522c-753c-b313-946994c22b9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7d03-8f58-93891618fccc" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c6790-95fa-7d6e-9435-6fea9761c84c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7d03-8f58-93891618fccc" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c6790-95fa-7d6e-9435-6fea9761c84c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_019c6790-95fa-799c-a249-53e792f24bb2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c6790-95fa-7d6e-9435-6fea9761c84c" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_019c6790-95fa-799c-a249-53e792f24bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_019c6790-95fa-7824-9748-7ba00bf20b0d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_019c6790-95fa-799c-a249-53e792f24bb2" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_019c6790-95fa-7824-9748-7ba00bf20b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FrenchPlanMember_019c6791-c120-7897-8db2-04a530f1f3ec" xlink:href="soph-20251231.xsd#soph_FrenchPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_019c6790-95fa-7824-9748-7ba00bf20b0d" xlink:to="loc_soph_FrenchPlanMember_019c6791-c120-7897-8db2-04a530f1f3ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SwissPlanMember_019c6792-811f-756a-acc7-114e1dab649e" xlink:href="soph-20251231.xsd#soph_SwissPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_019c6790-95fa-7824-9748-7ba00bf20b0d" xlink:to="loc_soph_SwissPlanMember_019c6792-811f-756a-acc7-114e1dab649e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c6790-95fa-7e0b-bf64-e52738a7c242" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c6790-95fa-7d6e-9435-6fea9761c84c" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c6790-95fa-7e0b-bf64-e52738a7c242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_019cb022-0eb1-7f4d-8a46-0a914c161e13" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c6790-95fa-7e0b-bf64-e52738a7c242" xlink:to="loc_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets_019cb022-0eb1-7f4d-8a46-0a914c161e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets_019c6790-95fa-7e52-8f06-6b03cfdfe815" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c6790-95fa-7e0b-bf64-e52738a7c242" xlink:to="loc_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets_019c6790-95fa-7e52-8f06-6b03cfdfe815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PlanAssetsAtFairValue_019c6790-95fa-7a46-bc68-5fdaf067ab1f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PlanAssetsAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c6790-95fa-7e0b-bf64-e52738a7c242" xlink:to="loc_ifrs-full_PlanAssetsAtFairValue_019c6790-95fa-7a46-bc68-5fdaf067ab1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7d30-bfdf-d912ba5a3bc4" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7474-8f4c-dfc438cab498" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7d30-bfdf-d912ba5a3bc4" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7474-8f4c-dfc438cab498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7db2-a13e-581e80b713c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7474-8f4c-dfc438cab498" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7db2-a13e-581e80b713c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7249-b7c2-679b080dbac6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7db2-a13e-581e80b713c6" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7249-b7c2-679b080dbac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7479-af59-de59925fc58c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7249-b7c2-679b080dbac6" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7479-af59-de59925fc58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7b79-aeca-8291e96a76da" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7249-b7c2-679b080dbac6" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7b79-aeca-8291e96a76da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7fab-a77d-c79f7ea87c14" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7474-8f4c-dfc438cab498" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7fab-a77d-c79f7ea87c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ServiceCostDefinedBenefitPlans_019c4318-522c-7235-8758-9cd2955e70de" xlink:href="soph-20251231.xsd#soph_ServiceCostDefinedBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7fab-a77d-c79f7ea87c14" xlink:to="loc_soph_ServiceCostDefinedBenefitPlans_019c4318-522c-7235-8758-9cd2955e70de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans_019c4318-522c-7178-8c25-dc9eefd80367" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseIncomeDefinedBenefitPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7fab-a77d-c79f7ea87c14" xlink:to="loc_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans_019c4318-522c-7178-8c25-dc9eefd80367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_019c4318-522c-7017-b4ec-9065e04c1063" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-7fab-a77d-c79f7ea87c14" xlink:to="loc_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans_019c4318-522c-7017-b4ec-9065e04c1063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7c62-ba9a-0f10cbe69644" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7f56-bcac-bed1f6f41f1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7c62-ba9a-0f10cbe69644" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7f56-bcac-bed1f6f41f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ed-b2e5-e04bf846a249" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7f56-bcac-bed1f6f41f1c" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ed-b2e5-e04bf846a249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-790a-9b06-5d33defe4e76" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ed-b2e5-e04bf846a249" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-790a-9b06-5d33defe4e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7d29-8499-356eb13e385e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-790a-9b06-5d33defe4e76" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7d29-8499-356eb13e385e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7b5c-9746-502596015d65" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-790a-9b06-5d33defe4e76" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7b5c-9746-502596015d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansTable_019c4318-522c-7f56-bcac-bed1f6f41f1c" xlink:to="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7236-92c0-01f228dc685c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7236-92c0-01f228dc685c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7562-a3a7-d7fa9a73bf5c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans_019c4318-522c-7562-a3a7-d7fa9a73bf5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_019c4318-522c-7334-a4e7-5d27c5ad9ccd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans_019c4318-522c-7334-a4e7-5d27c5ad9ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7e22-adc8-0f1a772ac719" xlink:href="soph-20251231.xsd#soph_ActuarialGainsLossesNetDefinedBenefitPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_soph_ActuarialGainsLossesNetDefinedBenefitPlans_019c4318-522c-7e22-adc8-0f1a772ac719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_019c4318-522c-7da1-9da3-7dc4d6c92df5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_019c4318-522c-7da1-9da3-7dc4d6c92df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans_019c4318-522c-7be6-816a-566624e4fac4" xlink:href="soph-20251231.xsd#soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans_019c4318-522c-7be6-816a-566624e4fac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-522c-7ecd-bfb7-9c5cbb34c29e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems_019c4318-522c-740e-9fab-9df2de56041e" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans_019c4318-522c-7ecd-bfb7-9c5cbb34c29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-75d7-bec8-daf750d51ff4" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7fc6-9370-afa5ba7f7cca" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-75d7-bec8-daf750d51ff4" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7fc6-9370-afa5ba7f7cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7fa3-965f-778e7185cc71" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7fc6-9370-afa5ba7f7cca" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7fa3-965f-778e7185cc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7ebc-83e4-6163c0a6df4a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-7fa3-965f-778e7185cc71" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7ebc-83e4-6163c0a6df4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7be8-9f26-e094be137fcd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7ebc-83e4-6163c0a6df4a" xlink:to="loc_ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember_019c4318-522c-7be8-9f26-e094be137fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7b9e-9f01-841c35fde58b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7fc6-9370-afa5ba7f7cca" xlink:to="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7b9e-9f01-841c35fde58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7b9e-9f01-841c35fde58b" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_019c4318-522c-73f5-8f05-b700fa284f05" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_019c4318-522c-73f5-8f05-b700fa284f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_019c4318-522c-7f00-b23d-83c89aa9f2b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_019c4318-522c-7f00-b23d-83c89aa9f2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ActuarialAssumptionOfExpectedInterestRatesMember_019c4318-522c-7a2d-b0ca-ba12a7fc8e68" xlink:href="soph-20251231.xsd#soph_ActuarialAssumptionOfExpectedInterestRatesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:to="loc_soph_ActuarialAssumptionOfExpectedInterestRatesMember_019c4318-522c-7a2d-b0ca-ba12a7fc8e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_019c4318-522c-757e-b292-ad4e8c2dc8fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_019c4318-522c-757e-b292-ad4e8c2dc8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_019c4318-522c-74e3-a74d-0ccc2c841a48" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7d25-9099-0ba96a91db14" xlink:to="loc_ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_019c4318-522c-74e3-a74d-0ccc2c841a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7fc6-9370-afa5ba7f7cca" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-726a-9146-33afe9dae5dd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-726a-9146-33afe9dae5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7c14-8270-85202dce8511" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7c14-8270-85202dce8511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-77df-93f4-833ceb4c4469" xlink:href="soph-20251231.xsd#soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-77df-93f4-833ceb4c4469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-71d8-937d-58c0d8782fb4" xlink:href="soph-20251231.xsd#soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-71d8-937d-58c0d8782fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-7e46-9ddd-75157f4ec6f9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-7e46-9ddd-75157f4ec6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7d2c-9be0-58de6697b093" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7fcf-879f-e408ecb9660a" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7d2c-9be0-58de6697b093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7788-8d95-73ca1051f138" xlink:href="soph-20251231.xsd#soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7029-88fe-124f22be231b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract_019c4318-522c-7788-8d95-73ca1051f138" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7029-88fe-124f22be231b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ca-824f-548002c6f743" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7029-88fe-124f22be231b" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ca-824f-548002c6f743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7329-b8dc-caafa58e92e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis_019c4318-522c-71ca-824f-548002c6f743" xlink:to="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7329-b8dc-caafa58e92e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7766-936f-74ed33fd3d21" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WhollyUnfundedDefinedBenefitPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain_019c4318-522c-7329-b8dc-caafa58e92e7" xlink:to="loc_ifrs-full_WhollyUnfundedDefinedBenefitPlansMember_019c4318-522c-7766-936f-74ed33fd3d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7e98-9aa8-9ed610af6334" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7029-88fe-124f22be231b" xlink:to="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7e98-9aa8-9ed610af6334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7b34-b79b-761c3a5eaf21" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_019c4318-522c-7e98-9aa8-9ed610af6334" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7b34-b79b-761c3a5eaf21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_019c4318-522c-792b-b0e4-30a20189114f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7b34-b79b-761c3a5eaf21" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_019c4318-522c-792b-b0e4-30a20189114f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_019c4318-522c-7f1c-809c-68f08caf250c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_019c4318-522c-7b34-b79b-761c3a5eaf21" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_019c4318-522c-7f1c-809c-68f08caf250c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable_019c4318-522c-7029-88fe-124f22be231b" xlink:to="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-7453-bd86-619eee6f91d8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-7453-bd86-619eee6f91d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7a22-b861-9910e45258af" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-7a22-b861-9910e45258af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-79da-a3f7-75eb17bf5489" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_019c4318-522c-79da-a3f7-75eb17bf5489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-709c-85b8-8bb97d207d53" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems_019c4318-522c-7d42-83ad-40fcc6d22dbd" xlink:to="loc_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_019c4318-522c-709c-85b8-8bb97d207d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7df4-9dad-93b02d7a08e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7df4-9dad-93b02d7a08e6" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c6be8-4cc5-78c4-b741-05d10a138e04" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c6be8-4cc5-78c4-b741-05d10a138e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-701c-84f2-712daca66776" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c6be8-4cc5-78c4-b741-05d10a138e04" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-701c-84f2-712daca66776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2013IncentiveShareOptionPlanMember_019c6be8-4cc5-7e2e-9412-d3aa69db3da1" xlink:href="soph-20251231.xsd#soph_A2013IncentiveShareOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-701c-84f2-712daca66776" xlink:to="loc_soph_A2013IncentiveShareOptionPlanMember_019c6be8-4cc5-7e2e-9412-d3aa69db3da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2019IncentiveShareOptionPlanMember_019c6be8-4cc5-7cda-82d9-d414536ce5e0" xlink:href="soph-20251231.xsd#soph_A2019IncentiveShareOptionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-701c-84f2-712daca66776" xlink:to="loc_soph_A2019IncentiveShareOptionPlanMember_019c6be8-4cc5-7cda-82d9-d414536ce5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2021EmployeeIncentivePlanMember_019c6be8-a6f3-75dd-ade9-5d7d7b9ceeca" xlink:href="soph-20251231.xsd#soph_A2021EmployeeIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c6be8-4cc5-701c-84f2-712daca66776" xlink:to="loc_soph_A2021EmployeeIncentivePlanMember_019c6be8-a6f3-75dd-ade9-5d7d7b9ceeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementsVestingAxis_019c6be8-a6f3-7d6f-bcc4-6dfe72b2de89" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementsVestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:to="loc_soph_ShareBasedPaymentArrangementsVestingAxis_019c6be8-a6f3-7d6f-bcc4-6dfe72b2de89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7093-984e-7a7610b455e7" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementsVestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ShareBasedPaymentArrangementsVestingAxis_019c6be8-a6f3-7d6f-bcc4-6dfe72b2de89" xlink:to="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7093-984e-7a7610b455e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementVestingTrancheOneMember_019c6be8-a6f3-7701-9b8b-e299614afe82" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementVestingTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7093-984e-7a7610b455e7" xlink:to="loc_soph_ShareBasedPaymentArrangementVestingTrancheOneMember_019c6be8-a6f3-7701-9b8b-e299614afe82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember_019c6be8-a6f3-7cfe-8949-e48aab55aece" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementVestingTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7093-984e-7a7610b455e7" xlink:to="loc_soph_ShareBasedPaymentArrangementVestingTrancheTwoMember_019c6be8-a6f3-7cfe-8949-e48aab55aece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember_019c6be9-7ba8-74e9-945c-97625f00f31f" xlink:href="soph-20251231.xsd#soph_ShareBasedPaymentArrangementVestingTrancheThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ShareBasedPaymentArrangementsVestingDomain_019c6be8-a6f3-7093-984e-7a7610b455e7" xlink:to="loc_soph_ShareBasedPaymentArrangementVestingTrancheThreeMember_019c6be9-7ba8-74e9-945c-97625f00f31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c7475-5943-73cb-8578-ea9d71e2d7be" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:to="loc_ifrs-full_RangeAxis_019c7475-5943-73cb-8578-ea9d71e2d7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c7475-5943-70c6-85ab-c89ed602adad" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_019c7475-5943-73cb-8578-ea9d71e2d7be" xlink:to="loc_ifrs-full_RangeDomain_019c7475-5943-70c6-85ab-c89ed602adad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c7475-5943-7ad9-b3cb-c826f404cb5b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c7475-5943-70c6-85ab-c89ed602adad" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c7475-5943-7ad9-b3cb-c826f404cb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c7475-5943-78f0-b2f3-05ed1e1ed2b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c7475-5943-70c6-85ab-c89ed602adad" xlink:to="loc_ifrs-full_TopOfRangeMember_019c7475-5943-78f0-b2f3-05ed1e1ed2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019c6be9-7ba8-75ee-ba27-53bf23fe532d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019c6be9-7ba8-75ee-ba27-53bf23fe532d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c6be9-7ba8-7929-bac3-d64acc6c5e36" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c6be9-7ba8-75ee-ba27-53bf23fe532d" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c6be9-7ba8-7929-bac3-d64acc6c5e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RestrictedStockUnitsMember_019c6be9-7ba8-70bf-82c2-d1383db89a18" xlink:href="soph-20251231.xsd#soph_RestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019c6be9-7ba8-7929-bac3-d64acc6c5e36" xlink:to="loc_soph_RestrictedStockUnitsMember_019c6be9-7ba8-70bf-82c2-d1383db89a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-756c-a2a3-6297a467a427" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_019c6be8-4cc5-7113-986f-71cf18c0042c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_019c6be8-4cc5-7113-986f-71cf18c0042c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfShareOptionPlans_019c6be8-7af3-7196-a0ff-1cb223db9e4a" xlink:href="soph-20251231.xsd#soph_NumberOfShareOptionPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_NumberOfShareOptionPlans_019c6be8-7af3-7196-a0ff-1cb223db9e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_019c6be8-a6f3-79d5-ab3d-3784ff1ce4b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_019c6be8-a6f3-79d5-ab3d-3784ff1ce4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis_019c6be8-a6f3-79ad-bb74-053daa537a35" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis_019c6be8-a6f3-79ad-bb74-053daa537a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis_019c6be8-a6f3-76c7-8944-89233664f8a4" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis_019c6be8-a6f3-76c7-8944-89233664f8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis_019c72cb-46df-79a3-934f-96b740c07ddb" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis_019c72cb-46df-79a3-934f-96b740c07ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_019c6be8-a6f3-7b9c-9fd3-34dc7c152a8b" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_019c6be8-a6f3-7b9c-9fd3-34dc7c152a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_019c72cf-56f9-70ae-b993-a7d59b628939" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis_019c72cf-56f9-70ae-b993-a7d59b628939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_019c6be8-a6f3-7d38-aead-c0f0ab7ca566" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_019c6be8-a6f3-7d38-aead-c0f0ab7ca566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c6be8-d992-7fc6-9c51-65bde330aabc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c6be8-d992-7fc6-9c51-65bde330aabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_019c6be8-d992-78d7-ba58-cfc7bf5da4e7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019_019c6be8-d992-78d7-ba58-cfc7bf5da4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_019c6be9-7ba8-7705-a13f-8eb334096b94" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_019c6be9-7ba8-7705-a13f-8eb334096b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019c6be9-7ba8-779d-b15d-ad363d306cb0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019c6be9-7ba8-779d-b15d-ad363d306cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_019c6be9-7ba8-73bd-9796-46b2cdfd173b" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_019c6be9-7ba8-73bd-9796-46b2cdfd173b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_019c72d8-a229-75bc-86b5-a2b223fffbd9" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis_019c72d8-a229-75bc-86b5-a2b223fffbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_019c72dc-e136-7691-8933-89fe17e9f35a" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_019c72dc-e136-7691-8933-89fe17e9f35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_019c72dd-3526-71cf-9ba1-8deb0fe63fb9" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis_019c72dd-3526-71cf-9ba1-8deb0fe63fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_019c72e0-de9f-71fe-95b2-1ab865410c80" xlink:href="soph-20251231.xsd#soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_019c72e0-de9f-71fe-95b2-1ab865410c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_019c72e1-3027-7f8d-8f47-e05ff4bd8141" xlink:href="soph-20251231.xsd#soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fe3-8903-bc0e122dceac" xlink:to="loc_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis_019c72e1-3027-7f8d-8f47-e05ff4bd8141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7ba5-ae02-f2c1413126e3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7ed2-815c-57f46a0a2912" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7ba5-ae02-f2c1413126e3" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7ed2-815c-57f46a0a2912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7c06-b5b6-c675853bb6fc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7ed2-815c-57f46a0a2912" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7c06-b5b6-c675853bb6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7812-a6b0-bb6960e0a23e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7c06-b5b6-c675853bb6fc" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7812-a6b0-bb6960e0a23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2013IncentiveShareOptionPlanMember_019c4318-522c-77ae-a968-24480199fb0e" xlink:href="soph-20251231.xsd#soph_A2013IncentiveShareOptionPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7812-a6b0-bb6960e0a23e" xlink:to="loc_soph_A2013IncentiveShareOptionPlanMember_019c4318-522c-77ae-a968-24480199fb0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2019IncentiveShareOptionPlanMember_019c4318-522c-7a19-9852-d4ea42604efc" xlink:href="soph-20251231.xsd#soph_A2019IncentiveShareOptionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7812-a6b0-bb6960e0a23e" xlink:to="loc_soph_A2019IncentiveShareOptionPlanMember_019c4318-522c-7a19-9852-d4ea42604efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-7a39-9830-89aa1fbb3858" xlink:href="soph-20251231.xsd#soph_A2021EmployeeIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7812-a6b0-bb6960e0a23e" xlink:to="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-7a39-9830-89aa1fbb3858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc1-845b-3a9b7df1ce55" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7ed2-815c-57f46a0a2912" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc1-845b-3a9b7df1ce55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7a9f-b00f-5bb7b190b172" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc1-845b-3a9b7df1ce55" xlink:to="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7a9f-b00f-5bb7b190b172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7e3c-a43c-e350faa1b6ea" xlink:href="soph-20251231.xsd#soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7a9f-b00f-5bb7b190b172" xlink:to="loc_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7e3c-a43c-e350faa1b6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:href="soph-20251231.xsd#soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7e3c-a43c-e350faa1b6ea" xlink:to="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_019c4318-522c-718e-bc4b-38cb2f68e7a9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_019c4318-522c-718e-bc4b-38cb2f68e7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_019c4318-522c-7f29-a5f5-49136f9a8996" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:to="loc_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_019c4318-522c-7f29-a5f5-49136f9a8996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_019c4318-522c-79a8-b6c4-3d421da1dfda" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_019c4318-522c-79a8-b6c4-3d421da1dfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_019c4318-522c-71dc-98c8-ccf28fde1806" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:to="loc_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_019c4318-522c-71dc-98c8-ccf28fde1806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_019c4318-522c-7a8d-b2be-bd15d9c38eee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7006-8179-0074c4ed9ef5" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_019c4318-522c-7a8d-b2be-bd15d9c38eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_019c4318-522c-7642-9ad8-bc09ac320344" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7e3c-a43c-e350faa1b6ea" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_019c4318-522c-7642-9ad8-bc09ac320344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7143-9ef9-8c39641a622c" xlink:href="soph-20251231.xsd#soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7a9f-b00f-5bb7b190b172" xlink:to="loc_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7143-9ef9-8c39641a622c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:href="soph-20251231.xsd#soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7143-9ef9-8c39641a622c" xlink:to="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c4318-522c-7b04-b30a-ba64eae1314c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c4318-522c-7b04-b30a-ba64eae1314c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_019c4318-522c-7edc-9011-9a9499cd7e84" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_019c4318-522c-7edc-9011-9a9499cd7e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_019c4318-522c-7261-8574-dccb47ec1c1c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_019c4318-522c-7261-8574-dccb47ec1c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_019c4318-522c-72b2-809d-4196eface8ee" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_019c4318-522c-72b2-809d-4196eface8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c4318-522c-778a-bde8-150d45706442" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-79b2-b7c7-722335941471" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_019c4318-522c-778a-bde8-150d45706442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_019c4318-522c-777b-9509-6c8a0011cdbf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7143-9ef9-8c39641a622c" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_019c4318-522c-777b-9509-6c8a0011cdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-76ad-8733-d6298208a571" xlink:href="soph-20251231.xsd#soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7a9f-b00f-5bb7b190b172" xlink:to="loc_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-76ad-8733-d6298208a571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_019c4318-522c-7a3b-b88d-975963be6d3c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-76ad-8733-d6298208a571" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_019c4318-522c-7a3b-b88d-975963be6d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions_019c4318-522c-74b0-9c87-8606a333cab5" xlink:href="soph-20251231.xsd#soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-76ad-8733-d6298208a571" xlink:to="loc_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions_019c4318-522c-74b0-9c87-8606a333cab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationSummaryofValuationInputsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7e1b-a6b6-48a46adb4b79" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-78c7-b925-3593576f1991" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7e1b-a6b6-48a46adb4b79" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-78c7-b925-3593576f1991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7da6-b854-246abe08864b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-78c7-b925-3593576f1991" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7da6-b854-246abe08864b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7c7b-b9f3-a7c878d59795" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7da6-b854-246abe08864b" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7c7b-b9f3-a7c878d59795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-757c-97ca-1326296436e2" xlink:href="soph-20251231.xsd#soph_A2021EmployeeIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-7c7b-b9f3-a7c878d59795" xlink:to="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-757c-97ca-1326296436e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-522c-76a0-80f8-fa111cbfd44b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-78c7-b925-3593576f1991" xlink:to="loc_ifrs-full_RangeAxis_019c4318-522c-76a0-80f8-fa111cbfd44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522c-75de-b2e5-3a39154ca26c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522c-76a0-80f8-fa111cbfd44b" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522c-75de-b2e5-3a39154ca26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-522c-7f8d-a212-e7bff619da51" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522c-75de-b2e5-3a39154ca26c" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-522c-7f8d-a212-e7bff619da51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-522c-7e92-9cd3-dee12b15f16f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522c-75de-b2e5-3a39154ca26c" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-522c-7e92-9cd3-dee12b15f16f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-78c7-b925-3593576f1991" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_019c4318-522c-7130-b596-7d2885e57610" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:to="loc_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019_019c4318-522c-7130-b596-7d2885e57610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_019c4318-522c-7caf-8465-218fe615fc6b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:to="loc_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_019c4318-522c-7caf-8465-218fe615fc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_019c4318-522c-78fa-9de1-9bddf7afa16e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:to="loc_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_019c4318-522c-78fa-9de1-9bddf7afa16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_019c4318-522c-7e16-8ce3-d677dca6e573" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:to="loc_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_019c4318-522c-7e16-8ce3-d677dca6e573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_019c4318-522c-732a-a6bc-807bb59efb23" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-716a-8e1e-747228e23325" xlink:to="loc_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_019c4318-522c-732a-a6bc-807bb59efb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7127-817e-ee1845a7e711" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7d96-ba49-f535f1d2ece3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7127-817e-ee1845a7e711" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7d96-ba49-f535f1d2ece3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7a81-b968-4c6fd9b0842a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7d96-ba49-f535f1d2ece3" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7a81-b968-4c6fd9b0842a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-77dc-8437-f7871a30d057" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-7a81-b968-4c6fd9b0842a" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-77dc-8437-f7871a30d057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-783d-8bd1-68ea05ac7e0a" xlink:href="soph-20251231.xsd#soph_A2021EmployeeIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-77dc-8437-f7871a30d057" xlink:to="loc_soph_A2021EmployeeIncentivePlanMember_019c4318-522c-783d-8bd1-68ea05ac7e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc8-995a-76df69d2e701" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7d96-ba49-f535f1d2ece3" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc8-995a-76df69d2e701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageFairValueShareOptionsGranted_019c4318-522c-7081-9edd-0c21314e7be6" xlink:href="soph-20251231.xsd#soph_WeightedAverageFairValueShareOptionsGranted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7fc8-995a-76df69d2e701" xlink:to="loc_soph_WeightedAverageFairValueShareOptionsGranted_019c4318-522c-7081-9edd-0c21314e7be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7e95-8482-673460e85190" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7fc7-b1a5-1b017d71d45c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7e95-8482-673460e85190" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7fc7-b1a5-1b017d71d45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-735c-86ad-3fbb87540bc2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7fc7-b1a5-1b017d71d45c" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-735c-86ad-3fbb87540bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-71b0-8454-2be8722f7da4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_019c4318-522c-735c-86ad-3fbb87540bc2" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-71b0-8454-2be8722f7da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RestrictedStockUnitsMember_019c4318-522c-7642-85eb-358c3e11cb1d" xlink:href="soph-20251231.xsd#soph_RestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_019c4318-522c-71b0-8454-2be8722f7da4" xlink:to="loc_soph_RestrictedStockUnitsMember_019c4318-522c-7642-85eb-358c3e11cb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7147-8abe-a73d08cb1361" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7fc7-b1a5-1b017d71d45c" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7147-8abe-a73d08cb1361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7bf9-a100-38f77cf2caa3" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7147-8abe-a73d08cb1361" xlink:to="loc_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7bf9-a100-38f77cf2caa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7fa8-a29a-1416ac67a27a" xlink:href="soph-20251231.xsd#soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7bf9-a100-38f77cf2caa3" xlink:to="loc_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7fa8-a29a-1416ac67a27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:href="soph-20251231.xsd#soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7fa8-a29a-1416ac67a27a" xlink:to="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_019c4318-522c-7d72-b3c2-5b9cbca4f4a1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_019c4318-522c-7d72-b3c2-5b9cbca4f4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_019c4318-522c-7041-b458-359673379a8b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_019c4318-522c-7041-b458-359673379a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019c4318-522c-76f6-8c20-f640710b75f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_019c4318-522c-76f6-8c20-f640710b75f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_019c4318-522c-7e1f-8304-4944e419bf94" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_019c4318-522c-7e1f-8304-4944e419bf94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_019c4318-522c-73e4-9440-888ad915e08e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7c07-87be-a2aa9f5d5264" xlink:to="loc_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_019c4318-522c-73e4-9440-888ad915e08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-764a-b082-9afc78ac1c4a" xlink:href="soph-20251231.xsd#soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-7bf9-a100-38f77cf2caa3" xlink:to="loc_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-764a-b082-9afc78ac1c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:href="soph-20251231.xsd#soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-764a-b082-9afc78ac1c4a" xlink:to="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement_019c4318-522c-7540-9ac6-00cee81137c9" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:to="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement_019c4318-522c-7540-9ac6-00cee81137c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_019c4318-522c-7c61-a1b4-195d6d1ef606" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:to="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement_019c4318-522c-7c61-a1b4-195d6d1ef606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_019c4318-522c-7272-bc34-a097c06cd103" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:to="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement_019c4318-522c-7272-bc34-a097c06cd103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement_019c4318-522c-7e85-914b-5adb77aaf63d" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:to="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement_019c4318-522c-7e85-914b-5adb77aaf63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement_019c4318-522c-7ef9-954d-5d2d8143ba90" xlink:href="soph-20251231.xsd#soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract_019c4318-522c-73fd-8439-fceac9942bbd" xlink:to="loc_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement_019c4318-522c-7ef9-954d-5d2d8143ba90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationMovementsinSharebasedCompensationReserveDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationMovementsinSharebasedCompensationReserveDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationMovementsinSharebasedCompensationReserveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-770c-8b34-fcb96e87c23f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract_019c4318-522c-7ea9-b7a1-e1b4eb29ca6b" xlink:href="soph-20251231.xsd#soph_ReconciliationOfChangesInShareBasedPaymentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-770c-8b34-fcb96e87c23f" xlink:to="loc_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract_019c4318-522c-7ea9-b7a1-e1b4eb29ca6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInShareBasedPaymentsAbstract_019c4318-522c-7acc-ab64-e030735a3fe5" xlink:href="soph-20251231.xsd#soph_ChangesInShareBasedPaymentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ReconciliationOfChangesInShareBasedPaymentsAbstract_019c4318-522c-7ea9-b7a1-e1b4eb29ca6b" xlink:to="loc_soph_ChangesInShareBasedPaymentsAbstract_019c4318-522c-7acc-ab64-e030735a3fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfSharebasedPayments_019c4318-522c-7769-b5e7-64446af70cc7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInShareBasedPaymentsAbstract_019c4318-522c-7acc-ab64-e030735a3fe5" xlink:to="loc_ifrs-full_ReserveOfSharebasedPayments_019c4318-522c-7769-b5e7-64446af70cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019c4318-522c-7620-9a9a-c95ed0e0198a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInShareBasedPaymentsAbstract_019c4318-522c-7acc-ab64-e030735a3fe5" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_019c4318-522c-7620-9a9a-c95ed0e0198a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfSharebasedPayments_019c4318-522c-7c13-be76-f75565b6d26f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfSharebasedPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInShareBasedPaymentsAbstract_019c4318-522c-7acc-ab64-e030735a3fe5" xlink:to="loc_ifrs-full_ReserveOfSharebasedPayments_019c4318-522c-7c13-be76-f75565b6d26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#SharebasedcompensationSharebasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7b83-a9ca-061f0097c25a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7469-b0a8-fe41939fec16" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract_019c4318-522c-7b83-a9ca-061f0097c25a" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7469-b0a8-fe41939fec16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncomeStatementLocation1Axis_019c4318-522c-75af-a69b-f462e1599cce" xlink:href="soph-20251231.xsd#soph_IncomeStatementLocation1Axis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7469-b0a8-fe41939fec16" xlink:to="loc_soph_IncomeStatementLocation1Axis_019c4318-522c-75af-a69b-f462e1599cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-7b3a-b68c-a885e8e57f4f" xlink:href="soph-20251231.xsd#soph_IncomeStatementLocation1Domain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_IncomeStatementLocation1Axis_019c4318-522c-75af-a69b-f462e1599cce" xlink:to="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-7b3a-b68c-a885e8e57f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-522c-7f81-b475-70b5cd4b2cce" xlink:href="soph-20251231.xsd#soph_ResearchAndDevelopmentExpense1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-7b3a-b68c-a885e8e57f4f" xlink:to="loc_soph_ResearchAndDevelopmentExpense1Member_019c4318-522c-7f81-b475-70b5cd4b2cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SalesAndMarketingExpenseMember_019c4318-522c-7d6b-b271-17ac60e91bb1" xlink:href="soph-20251231.xsd#soph_SalesAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-7b3a-b68c-a885e8e57f4f" xlink:to="loc_soph_SalesAndMarketingExpenseMember_019c4318-522c-7d6b-b271-17ac60e91bb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-522c-75a5-bc77-2ad1f3d7171f" xlink:href="soph-20251231.xsd#soph_GeneralAndAdministrativeExpense1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_IncomeStatementLocation1Domain_019c4318-522c-7b3a-b68c-a885e8e57f4f" xlink:to="loc_soph_GeneralAndAdministrativeExpense1Member_019c4318-522c-75a5-bc77-2ad1f3d7171f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7631-9898-f2d63476de91" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_019c4318-522c-7469-b0a8-fe41939fec16" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7631-9898-f2d63476de91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_019c4318-522c-77f1-ba17-0c84f058b268" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_019c4318-522c-7631-9898-f2d63476de91" xlink:to="loc_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_019c4318-522c-77f1-ba17-0c84f058b268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#BorrowingsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-7658-8523-dc3282cf9a85" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-7658-8523-dc3282cf9a85" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019c758f-a4af-7c19-9bf7-6ef2fad9faeb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019c758f-a4af-7c19-9bf7-6ef2fad9faeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7a98-bc87-8b022fa59a7a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c758f-a4af-7c19-9bf7-6ef2fad9faeb" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7a98-bc87-8b022fa59a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7a98-bc87-8b022fa59a7a" xlink:to="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheAMember_019c758f-a4af-7738-ae3f-8a1edece0383" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheAMember_019c758f-a4af-7738-ae3f-8a1edece0383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheBMember_019c758f-a4af-7b26-9eef-ff88eccadbb2" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheBMember_019c758f-a4af-7b26-9eef-ff88eccadbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheCMember_019c758f-f3e1-757c-a557-e98818b7ebfa" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheCMember_019c758f-f3e1-757c-a557-e98818b7ebfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheDMember_019c758f-f3e1-7883-9feb-e57a5121e179" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheDMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c758f-a4af-7918-a556-dbf2a7329cbc" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheDMember_019c758f-f3e1-7883-9feb-e57a5121e179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CreditAgreementExistingMember_019c7590-76cd-73d3-9a0f-617e364b0516" xlink:href="soph-20251231.xsd#soph_CreditAgreementExistingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7a98-bc87-8b022fa59a7a" xlink:to="loc_soph_CreditAgreementExistingMember_019c7590-76cd-73d3-9a0f-617e364b0516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CreditAgreementNewMember_019c7590-76cd-7cac-bcf8-d2786f012ca6" xlink:href="soph-20251231.xsd#soph_CreditAgreementNewMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c758f-a4af-7a98-bc87-8b022fa59a7a" xlink:to="loc_soph_CreditAgreementNewMember_019c7590-76cd-7cac-bcf8-d2786f012ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsAxis_019c758f-c9f5-7427-b9b3-9b8d1aae5f11" xlink:href="soph-20251231.xsd#soph_BorrowingTermsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_soph_BorrowingTermsAxis_019c758f-c9f5-7427-b9b3-9b8d1aae5f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7747-b673-d58dd6021b48" xlink:href="soph-20251231.xsd#soph_BorrowingTermsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_BorrowingTermsAxis_019c758f-c9f5-7427-b9b3-9b8d1aae5f11" xlink:to="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7747-b673-d58dd6021b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRMember_019c758f-c9f5-791e-8898-c85bd34284d9" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7747-b673-d58dd6021b48" xlink:to="loc_soph_TermSecuredOvernightFinancingRateSOFRMember_019c758f-c9f5-791e-8898-c85bd34284d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRFloorMember_019c81cd-0d43-7c11-8b00-fc08c0a373a3" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRFloorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7747-b673-d58dd6021b48" xlink:to="loc_soph_TermSecuredOvernightFinancingRateSOFRFloorMember_019c81cd-0d43-7c11-8b00-fc08c0a373a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember_019c758f-c9f5-7632-80bd-2836bbe5a999" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_BorrowingTermsDomain_019c758f-c9f5-7747-b673-d58dd6021b48" xlink:to="loc_soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember_019c758f-c9f5-7632-80bd-2836bbe5a999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019c758f-c9f5-75f8-a4ba-5493c94dcc74" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019c758f-c9f5-75f8-a4ba-5493c94dcc74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c758f-c9f5-78ac-8193-53c56bafbaf4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c758f-c9f5-75f8-a4ba-5493c94dcc74" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c758f-c9f5-78ac-8193-53c56bafbaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019c758f-c9f5-77e7-b49c-cd14d6b1dc5d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019c758f-c9f5-78ac-8193-53c56bafbaf4" xlink:to="loc_ifrs-full_OrdinarySharesMember_019c758f-c9f5-77e7-b49c-cd14d6b1dc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_019c758f-c9f5-7f07-9194-d5eb2fec0ec6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_ifrs-full_CounterpartiesAxis_019c758f-c9f5-7f07-9194-d5eb2fec0ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7b46-99fc-9afd426c1ed6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_019c758f-c9f5-7f07-9194-d5eb2fec0ec6" xlink:to="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7b46-99fc-9afd426c1ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditHoldingsIVLPMember_019c758f-c9f5-7011-957e-c40c873f30b5" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditHoldingsIVLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7b46-99fc-9afd426c1ed6" xlink:to="loc_soph_PerceptiveCreditHoldingsIVLPMember_019c758f-c9f5-7011-957e-c40c873f30b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CreditSuisseSAMember_019c7590-76cd-70d3-99cf-6bf8e8fcdb39" xlink:href="soph-20251231.xsd#soph_CreditSuisseSAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7b46-99fc-9afd426c1ed6" xlink:to="loc_soph_CreditSuisseSAMember_019c7590-76cd-70d3-99cf-6bf8e8fcdb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_UBSSwitzerlandAGMember_019c9691-cf99-708b-a5fc-40ceb2240687" xlink:href="soph-20251231.xsd#soph_UBSSwitzerlandAGMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019c758f-c9f5-7b46-99fc-9afd426c1ed6" xlink:to="loc_soph_UBSSwitzerlandAGMember_019c9691-cf99-708b-a5fc-40ceb2240687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsAxis_019c758f-c9f5-7dc7-bede-5d8e60b09a90" xlink:href="soph-20251231.xsd#soph_WarrantTermsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_soph_WarrantTermsAxis_019c758f-c9f5-7dc7-bede-5d8e60b09a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:href="soph-20251231.xsd#soph_WarrantTermsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WarrantTermsAxis_019c758f-c9f5-7dc7-bede-5d8e60b09a90" xlink:to="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheAMember_019c758f-c9f5-709a-8a20-6999e1851252" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:to="loc_soph_WarrantRightsTrancheAMember_019c758f-c9f5-709a-8a20-6999e1851252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheBMember_019c758f-c9f5-73f2-b831-2cb10327ddaf" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:to="loc_soph_WarrantRightsTrancheBMember_019c758f-c9f5-73f2-b831-2cb10327ddaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheCMember_019c81e4-a55a-74f9-b7de-1180c8b9304f" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:to="loc_soph_WarrantRightsTrancheCMember_019c81e4-a55a-74f9-b7de-1180c8b9304f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheDMember_019c81e4-e1d8-7a5a-9680-f0fbfc9ab816" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheDMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WarrantTermsDomain_019c758f-c9f5-7c1b-8c01-1bc2fabba938" xlink:to="loc_soph_WarrantRightsTrancheDMember_019c81e4-e1d8-7a5a-9680-f0fbfc9ab816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c758f-f3e1-7423-9311-7f540fe728ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c758f-f3e1-7423-9311-7f540fe728ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c758f-f3e1-7062-ba15-dfab020f3fed" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c758f-f3e1-7423-9311-7f540fe728ea" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c758f-f3e1-7062-ba15-dfab020f3fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_MajorBorrowingTransactionsMember_019c89cd-d2e7-7c9a-a537-034ce92eb04e" xlink:href="soph-20251231.xsd#soph_MajorBorrowingTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c758f-f3e1-7062-ba15-dfab020f3fed" xlink:to="loc_soph_MajorBorrowingTransactionsMember_019c89cd-d2e7-7c9a-a537-034ce92eb04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c7590-26c2-70f4-8f30-6e97c03c6515" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c7590-26c2-70f4-8f30-6e97c03c6515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c7590-26c2-71e3-ae6b-46d36d07a46e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c7590-26c2-70f4-8f30-6e97c03c6515" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c7590-26c2-71e3-ae6b-46d36d07a46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantLiabilityMember_019c7590-26c2-7a65-9575-bb643acc2454" xlink:href="soph-20251231.xsd#soph_WarrantLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c7590-26c2-71e3-ae6b-46d36d07a46e" xlink:to="loc_soph_WarrantLiabilityMember_019c7590-26c2-7a65-9575-bb643acc2454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-76f8-9ff5-ae725c118557" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesMaximumBorrowingCapacity_019c758f-a4af-7d81-9475-eae8514d0e69" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingFacilitiesMaximumBorrowingCapacity_019c758f-a4af-7d81-9475-eae8514d0e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_019c758f-c9f5-7738-b5ef-bb4affe47b0e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_019c758f-c9f5-7738-b5ef-bb4affe47b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets_019c758f-c9f5-7694-a686-4cf9eebfcfef" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets_019c758f-c9f5-7694-a686-4cf9eebfcfef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum_019c758f-c9f5-72ce-9479-0138b27acdf8" xlink:href="soph-20251231.xsd#soph_BorrowingsCovenantCashAndCashEquivalentsMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum_019c758f-c9f5-72ce-9479-0138b27acdf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum_019c758f-c9f5-79dc-b57d-252500631a4a" xlink:href="soph-20251231.xsd#soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum_019c758f-c9f5-79dc-b57d-252500631a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c758f-c9f5-7907-b8cb-45437cd8edac" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c758f-c9f5-7907-b8cb-45437cd8edac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExercisePriceOfWarrantRights_019c758f-c9f5-766c-a1d0-6b87917253b1" xlink:href="soph-20251231.xsd#soph_ExercisePriceOfWarrantRights"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_ExercisePriceOfWarrantRights_019c758f-c9f5-766c-a1d0-6b87917253b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowings_019c7590-4f90-71c3-989b-e3507a12ce8b" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_ProceedsFromBorrowings_019c7590-4f90-71c3-989b-e3507a12ce8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c81d5-76eb-72e8-bd29-84c87df35b0c" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c81d5-76eb-72e8-bd29-84c87df35b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger_019c758f-f3e1-738a-9292-ac4294ccbe58" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger_019c758f-f3e1-738a-9292-ac4294ccbe58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights_019c81e2-b38f-7c04-a103-ddaa075b7c69" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights_019c81e2-b38f-7c04-a103-ddaa075b7c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfFinancialInstruments_019c758f-f3e1-7b92-94cf-f7bd0f532209" xlink:href="soph-20251231.xsd#soph_NumberOfFinancialInstruments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_NumberOfFinancialInstruments_019c758f-f3e1-7b92-94cf-f7bd0f532209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsInterestRate_019c7590-26c2-7c70-bb31-efb9fdddeefb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsInterestRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_ifrs-full_BorrowingsInterestRate_019c7590-26c2-7c70-bb31-efb9fdddeefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c7590-26c2-7fbb-8a4e-e30bc7979603" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c7590-26c2-7fbb-8a4e-e30bc7979603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019c7590-26c2-7620-8782-103a6b87bfac" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_ifrs-full_Borrowings_019c7590-26c2-7620-8782-103a6b87bfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingCostsIncurred_019c7590-4f90-79c8-8f60-4df9d919553f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingCostsIncurred"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_ifrs-full_BorrowingCostsIncurred_019c7590-4f90-79c8-8f60-4df9d919553f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TerminationOfBorrowings_019c7590-76cd-7a74-9d67-064d87ce6e86" xlink:href="soph-20251231.xsd#soph_TerminationOfBorrowings"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_TerminationOfBorrowings_019c7590-76cd-7a74-9d67-064d87ce6e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingMaturityTerm_019c8222-2905-7bca-b644-f7ab5d405856" xlink:href="soph-20251231.xsd#soph_BorrowingMaturityTerm"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_BorrowingMaturityTerm_019c8222-2905-7bca-b644-f7ab5d405856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_RedemptionPeriodOfWarrantRights_019c8222-2905-75f6-9821-4c24a7a77d06" xlink:href="soph-20251231.xsd#soph_RedemptionPeriodOfWarrantRights"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7817-97c5-4c2d045ee2e6" xlink:to="loc_soph_RedemptionPeriodOfWarrantRights_019c8222-2905-75f6-9821-4c24a7a77d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-7e22-a80c-4168775baa04" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-522c-783a-a2a7-c4692325b74b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-7e22-a80c-4168775baa04" xlink:to="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-522c-783a-a2a7-c4692325b74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-7319-b00f-ef436be7ade0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-522c-783a-a2a7-c4692325b74b" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-7319-b00f-ef436be7ade0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7a91-b420-e85dd2524524" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-7319-b00f-ef436be7ade0" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7a91-b420-e85dd2524524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantLiabilityMember_019c4318-522c-7eac-a76b-dcd57debe456" xlink:href="soph-20251231.xsd#soph_WarrantLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7a91-b420-e85dd2524524" xlink:to="loc_soph_WarrantLiabilityMember_019c4318-522c-7eac-a76b-dcd57debe456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsAxis_019c4318-522c-76fa-a1a0-a2011ed01307" xlink:href="soph-20251231.xsd#soph_WarrantTermsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-522c-783a-a2a7-c4692325b74b" xlink:to="loc_soph_WarrantTermsAxis_019c4318-522c-76fa-a1a0-a2011ed01307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsDomain_019c4318-522c-71d3-adcc-2d852b616073" xlink:href="soph-20251231.xsd#soph_WarrantTermsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WarrantTermsAxis_019c4318-522c-76fa-a1a0-a2011ed01307" xlink:to="loc_soph_WarrantTermsDomain_019c4318-522c-71d3-adcc-2d852b616073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheAMember_019c4318-522c-7041-a877-c41fb6f133a2" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WarrantTermsDomain_019c4318-522c-71d3-adcc-2d852b616073" xlink:to="loc_soph_WarrantRightsTrancheAMember_019c4318-522c-7041-a877-c41fb6f133a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheBMember_019c4318-522c-78af-a921-d1d18363b860" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WarrantTermsDomain_019c4318-522c-71d3-adcc-2d852b616073" xlink:to="loc_soph_WarrantRightsTrancheBMember_019c4318-522c-78af-a921-d1d18363b860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsAxis_019c4318-522c-76a0-a799-ec7090620895" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnobservableInputsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-522c-783a-a2a7-c4692325b74b" xlink:to="loc_ifrs-full_UnobservableInputsAxis_019c4318-522c-76a0-a799-ec7090620895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UnobservableInputsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsAxis_019c4318-522c-76a0-a799-ec7090620895" xlink:to="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExercisePriceMeasurementInputMember_019c4318-522c-78d8-81f7-c048adf12052" xlink:href="soph-20251231.xsd#soph_ExercisePriceMeasurementInputMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_ExercisePriceMeasurementInputMember_019c4318-522c-78d8-81f7-c048adf12052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SharePriceMeasurementInputMember_019c4318-522c-781e-a985-fc5b051ad205" xlink:href="soph-20251231.xsd#soph_SharePriceMeasurementInputMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_SharePriceMeasurementInputMember_019c4318-522c-781e-a985-fc5b051ad205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestRateMeasurementInputMember_019c4318-522c-7ccc-990c-be32323564c6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestRateMeasurementInputMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_ifrs-full_InterestRateMeasurementInputMember_019c4318-522c-7ccc-990c-be32323564c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExpectedVolatilityMeasurementInputMember_019c4318-522c-7e90-9f82-f0e626a643b8" xlink:href="soph-20251231.xsd#soph_ExpectedVolatilityMeasurementInputMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_ExpectedVolatilityMeasurementInputMember_019c4318-522c-7e90-9f82-f0e626a643b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ExpectedTermMeasurementInputMember_019c4318-522c-709d-a082-4462d037dad5" xlink:href="soph-20251231.xsd#soph_ExpectedTermMeasurementInputMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_ExpectedTermMeasurementInputMember_019c4318-522c-709d-a082-4462d037dad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DividendYieldMeasurementInputMember_019c4318-522c-7557-9a1e-a4531a01193b" xlink:href="soph-20251231.xsd#soph_DividendYieldMeasurementInputMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_DividendYieldMeasurementInputMember_019c4318-522c-7557-9a1e-a4531a01193b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BlackScholesPricingModelValueMeasurementInputMember_019c4318-522c-7550-8be7-2a223eba0873" xlink:href="soph-20251231.xsd#soph_BlackScholesPricingModelValueMeasurementInputMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_UnobservableInputsDomain_019c4318-522c-7a70-943c-45b171220ebe" xlink:to="loc_soph_BlackScholesPricingModelValueMeasurementInputMember_019c4318-522c-7550-8be7-2a223eba0873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_019c4318-522c-7367-9a69-d05eac17b5fb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable_019c4318-522c-783a-a2a7-c4692325b74b" xlink:to="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_019c4318-522c-7367-9a69-d05eac17b5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_SignificantUnobservableInputLiabilities_019c4318-522c-7e9a-85c3-bd163b02bf10" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantUnobservableInputLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems_019c4318-522c-7367-9a69-d05eac17b5fb" xlink:to="loc_ifrs-full_SignificantUnobservableInputLiabilities_019c4318-522c-7e9a-85c3-bd163b02bf10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-7e0c-884e-9bdffbf71b6e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-7a37-99ce-a7ea5cdbe3d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c4318-522c-7e0c-884e-9bdffbf71b6e" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-7a37-99ce-a7ea5cdbe3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522c-755d-a20c-05d08e522c76" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-7a37-99ce-a7ea5cdbe3d3" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522c-755d-a20c-05d08e522c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c4318-522c-7af7-8728-6a69fa934282" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522c-755d-a20c-05d08e522c76" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c4318-522c-7af7-8728-6a69fa934282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementMember_019c4318-522c-7f87-8520-48a0502236dd" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c4318-522c-7af7-8728-6a69fa934282" xlink:to="loc_soph_PerceptiveCreditAgreementMember_019c4318-522c-7f87-8520-48a0502236dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-71d6-89a3-1f2bc1db3e5a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-7a37-99ce-a7ea5cdbe3d3" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-71d6-89a3-1f2bc1db3e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7d49-b61d-15e1e7cd6c48" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522c-71d6-89a3-1f2bc1db3e5a" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7d49-b61d-15e1e7cd6c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditHoldingsWarrantsMember_019c4318-522c-7a96-8db9-b9831c113900" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditHoldingsWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522c-7d49-b61d-15e1e7cd6c48" xlink:to="loc_soph_PerceptiveCreditHoldingsWarrantsMember_019c4318-522c-7a96-8db9-b9831c113900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7e1d-8806-ae422a3e791f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c4318-522c-7a37-99ce-a7ea5cdbe3d3" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7e1d-8806-ae422a3e791f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:href="soph-20251231.xsd#soph_ChangesInBorrowingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c4318-522c-7e1d-8806-ae422a3e791f" xlink:to="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019c81f5-f809-7f1f-b40a-99b9daf3db49" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_ifrs-full_Borrowings_019c81f5-f809-7f1f-b40a-99b9daf3db49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowings_019c4318-522c-7be3-94a2-132d44762f17" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_soph_ProceedsFromBorrowings_019c4318-522c-7be3-94a2-132d44762f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingCostsIncurred_019c4318-522c-781d-b7ed-fe76b8665f7e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingCostsIncurred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_ifrs-full_BorrowingCostsIncurred_019c4318-522c-781d-b7ed-fe76b8665f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowingsNetOfCostsIncurred_019c81fc-2005-7c46-bda2-48854ed35a9f" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowingsNetOfCostsIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_soph_ProceedsFromBorrowingsNetOfCostsIncurred_019c81fc-2005-7c46-bda2-48854ed35a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c4318-522c-7064-86ca-fe458b2325ea" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c4318-522c-7064-86ca-fe458b2325ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_019c4318-522c-72ef-9b96-41daef3dec70" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_019c4318-522c-72ef-9b96-41daef3dec70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_019c4318-522c-7495-8e8b-a95e8f583ed5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_019c4318-522c-7495-8e8b-a95e8f583ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingsForeignCurrencyTranslationGainLoss_019c4318-522c-7e8e-bc2f-d00c7e675094" xlink:href="soph-20251231.xsd#soph_BorrowingsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_soph_BorrowingsForeignCurrencyTranslationGainLoss_019c4318-522c-7e8e-bc2f-d00c7e675094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019c81f8-9e0a-7113-b240-f92c71d332b1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInBorrowingsAbstract_019c8204-586b-76ca-86f8-2d6a5de9ee2b" xlink:to="loc_ifrs-full_Borrowings_019c81f8-9e0a-7113-b240-f92c71d332b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#BorrowingsScheduleofWarrantObligationLiabilityDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c74ee-6f5f-7cc6-a7fa-6ee235e30c15" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c750e-8771-7144-9c3f-7094f0dbef19" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract_019c74ee-6f5f-7cc6-a7fa-6ee235e30c15" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c750e-8771-7144-9c3f-7094f0dbef19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c8203-69e7-7e39-9698-4d2cd556d40b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c750e-8771-7144-9c3f-7094f0dbef19" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c8203-69e7-7e39-9698-4d2cd556d40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c8203-69e7-71ec-8660-d1263067c1b4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c8203-69e7-7e39-9698-4d2cd556d40b" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c8203-69e7-71ec-8660-d1263067c1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditHoldingsWarrantsMember_019c8203-69e7-7f49-92fa-3a7afdd59b15" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditHoldingsWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c8203-69e7-71ec-8660-d1263067c1b4" xlink:to="loc_soph_PerceptiveCreditHoldingsWarrantsMember_019c8203-69e7-7f49-92fa-3a7afdd59b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c750e-8771-7a8e-8e6b-cb48680379d3" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c750e-8771-7144-9c3f-7094f0dbef19" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c750e-8771-7a8e-8e6b-cb48680379d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:href="soph-20251231.xsd#soph_ChangesInWarrantLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c750e-8771-7a8e-8e6b-cb48680379d3" xlink:to="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentWarrantLiability_019c750e-8771-7f8b-b205-dda0e3d9b1c8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_ifrs-full_CurrentWarrantLiability_019c750e-8771-7f8b-b205-dda0e3d9b1c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromWarrantLiability_019c750e-8771-786d-903a-0342eade71a5" xlink:href="soph-20251231.xsd#soph_ProceedsFromWarrantLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_soph_ProceedsFromWarrantLiability_019c750e-8771-786d-903a-0342eade71a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c750e-8771-74cb-86f4-92703a9258ce" xlink:href="soph-20251231.xsd#soph_AdjustmentsForFairValueOfWarrantLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_soph_AdjustmentsForFairValueOfWarrantLiability_019c750e-8771-74cb-86f4-92703a9258ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantLiabilityForeignExchangeGainLoss_019c750e-8771-7a7b-ac1d-9f848fdb1754" xlink:href="soph-20251231.xsd#soph_WarrantLiabilityForeignExchangeGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_soph_WarrantLiabilityForeignExchangeGainLoss_019c750e-8771-7a7b-ac1d-9f848fdb1754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrentWarrantLiability_019c7510-3642-72ac-8761-5eb1cd74796d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentWarrantLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_ifrs-full_CurrentWarrantLiability_019c7510-3642-72ac-8761-5eb1cd74796d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7510-0426-7185-b414-82123624db5e" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7510-0426-7185-b414-82123624db5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfWarrantsIssued_019c7510-0426-7c41-935a-32484c527efc" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfWarrantsIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_soph_WarrantsOrRightsNumberOfWarrantsIssued_019c7510-0426-7c41-935a-32484c527efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7511-5447-740f-86ce-218addb5eeb1" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_ChangesInWarrantLiabilityAbstract_019c8206-964b-749c-825a-ea91d8d0f6d6" xlink:to="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7511-5447-740f-86ce-218addb5eeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/RelatedpartiesAdditionalInformationDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#RelatedpartiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/RelatedpartiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-7a29-9652-075035050d9f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfExecutiveOfficers_019c4318-522c-7564-b307-209646eb9d5f" xlink:href="soph-20251231.xsd#soph_NumberOfExecutiveOfficers"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-7a29-9652-075035050d9f" xlink:to="loc_soph_NumberOfExecutiveOfficers_019c4318-522c-7564-b307-209646eb9d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfNonExecutiveOfficers_019c4318-522c-7f08-8ae8-6cf6ac14335a" xlink:href="soph-20251231.xsd#soph_NumberOfNonExecutiveOfficers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-7a29-9652-075035050d9f" xlink:to="loc_soph_NumberOfNonExecutiveOfficers_019c4318-522c-7f08-8ae8-6cf6ac14335a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-78c7-a08a-33f7fe94ff96" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_019c4318-522c-7604-bd0a-8922d2c4f715" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-78c7-a08a-33f7fe94ff96" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_019c4318-522c-7604-bd0a-8922d2c4f715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_019c4318-522c-7357-8fab-9c63d7a09fe7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-78c7-a08a-33f7fe94ff96" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits_019c4318-522c-7357-8fab-9c63d7a09fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_019c4318-522d-73f5-b702-9d840d3f0b63" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-78c7-a08a-33f7fe94ff96" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment_019c4318-522d-73f5-b702-9d840d3f0b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_KeyManagementPersonnelCompensation_019c4318-522d-7cd7-9cb1-e6b66e73a629" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_KeyManagementPersonnelCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract_019c4318-522c-78c7-a08a-33f7fe94ff96" xlink:to="loc_ifrs-full_KeyManagementPersonnelCompensation_019c4318-522d-7cd7-9cb1-e6b66e73a629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#CommitmentsandcontingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_019c4318-522d-7926-a864-acfa91c7b0b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_019caf67-919d-7f5b-99f8-26e012c47efe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_019c4318-522d-7926-a864-acfa91c7b0b8" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_019caf67-919d-7f5b-99f8-26e012c47efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_019caf67-919d-7b5b-be59-024068013256" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_019caf67-919d-7f5b-99f8-26e012c47efe" xlink:to="loc_dei_LegalEntityAxis_019caf67-919d-7b5b-be59-024068013256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_019caf67-919d-721d-9d0d-16b9e3278773" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_019caf67-919d-7b5b-be59-024068013256" xlink:to="loc_dei_EntityDomain_019caf67-919d-721d-9d0d-16b9e3278773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GuardantHealthMember_019caf67-919d-756b-a96a-96346c7ad6fa" xlink:href="soph-20251231.xsd#soph_GuardantHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_019caf67-919d-721d-9d0d-16b9e3278773" xlink:to="loc_soph_GuardantHealthMember_019caf67-919d-756b-a96a-96346c7ad6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019caf67-919d-729e-95ee-f8bbd9053b65" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_019caf67-919d-7f5b-99f8-26e012c47efe" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019caf67-919d-729e-95ee-f8bbd9053b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019caf67-919d-7288-b7e9-590bb606039e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019caf67-919d-729e-95ee-f8bbd9053b65" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019caf67-919d-7288-b7e9-590bb606039e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CommencementOfMajorLitigationMember_019caf67-919d-7a58-af46-323a8b2c02e9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CommencementOfMajorLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019caf67-919d-7288-b7e9-590bb606039e" xlink:to="loc_ifrs-full_CommencementOfMajorLitigationMember_019caf67-919d-7a58-af46-323a8b2c02e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_019caf67-919d-7f5b-99f8-26e012c47efe" xlink:to="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized_019c4318-522d-7f7f-b08e-799953df4c75" xlink:href="soph-20251231.xsd#soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:to="loc_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized_019c4318-522d-7f7f-b08e-799953df4c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ContractualCapitalCommitments_019c4318-522d-75d4-894c-0ce5b6754cc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractualCapitalCommitments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:to="loc_ifrs-full_ContractualCapitalCommitments_019c4318-522d-75d4-894c-0ce5b6754cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalCommitments_019c4318-522d-79da-b161-b2e2147f5fc9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:to="loc_ifrs-full_CapitalCommitments_019c4318-522d-79da-b161-b2e2147f5fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EstimatedFinancialEffectOfContingentAssets_019c4318-522d-7f1c-8055-4c446c8e2f29" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EstimatedFinancialEffectOfContingentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:to="loc_ifrs-full_EstimatedFinancialEffectOfContingentAssets_019c4318-522d-7f1c-8055-4c446c8e2f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LossesOnLitigationSettlements_019caf63-7e33-72a5-847f-443b727dba81" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LossesOnLitigationSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems_019caf67-919d-74a3-91cd-b5b1e171308d" xlink:to="loc_ifrs-full_LossesOnLitigationSettlements_019caf63-7e33-72a5-847f-443b727dba81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-72bd-b10c-fc058627b4f0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-7b5e-ba14-8a843d868589" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-72bd-b10c-fc058627b4f0" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-7b5e-ba14-8a843d868589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_019c4318-522d-74ec-954c-48e25a8b086a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-7b5e-ba14-8a843d868589" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_019c4318-522d-74ec-954c-48e25a8b086a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_019c4318-522d-7583-b769-4a168e656e11" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsAxis_019c4318-522d-74ec-954c-48e25a8b086a" xlink:to="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_019c4318-522d-7583-b769-4a168e656e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_019c4318-522d-7768-9ca1-1ce502761908" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_019c4318-522d-7583-b769-4a168e656e11" xlink:to="loc_ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember_019c4318-522d-7768-9ca1-1ce502761908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_019c9fe2-bb76-7826-aeeb-72765b297cc7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialAssetsDomain_019c4318-522d-7583-b769-4a168e656e11" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_019c9fe2-bb76-7826-aeeb-72765b297cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_019c4318-522d-75e8-919b-5738b8ffc0f4" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-7b5e-ba14-8a843d868589" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_019c4318-522d-75e8-919b-5738b8ffc0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_019c4318-522d-74a2-a5e0-0158c2cab483" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfFinancialLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesAxis_019c4318-522d-75e8-919b-5738b8ffc0f4" xlink:to="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_019c4318-522d-74a2-a5e0-0158c2cab483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_019c4318-522d-75a6-8744-1990ddfb3128" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_019c4318-522d-74a2-a5e0-0158c2cab483" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember_019c4318-522d-75a6-8744-1990ddfb3128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_019c9fe3-86b5-761d-b1b2-319d912b094c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfFinancialLiabilitiesDomain_019c4318-522d-74a2-a5e0-0158c2cab483" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_019c9fe3-86b5-761d-b1b2-319d912b094c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522d-7f89-a850-fc6a8519e99e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-7b5e-ba14-8a843d868589" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522d-7f89-a850-fc6a8519e99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c4318-522d-7f89-a850-fc6a8519e99e" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CashAndCashEquivalentMember_019c4318-522d-7088-88ec-a2d81906a800" xlink:href="soph-20251231.xsd#soph_CashAndCashEquivalentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_CashAndCashEquivalentMember_019c4318-522d-7088-88ec-a2d81906a800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-522d-7395-95aa-4c554ee0659e" xlink:href="soph-20251231.xsd#soph_FinancialAssetsAccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_FinancialAssetsAccountsReceivableMember_019c4318-522d-7395-95aa-4c554ee0659e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_OtherFinancialNonCurrentAssetsMember_019c4318-522d-7caf-96c7-c50cce2e1cc0" xlink:href="soph-20251231.xsd#soph_OtherFinancialNonCurrentAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_OtherFinancialNonCurrentAssetsMember_019c4318-522d-7caf-96c7-c50cce2e1cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember_019c9dca-f13a-7d4f-8cbb-aabb3989fe48" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_ifrs-full_EquityInvestmentsMember_019c9dca-f13a-7d4f-8cbb-aabb3989fe48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccountsPayablesMember_019c4318-522d-7f29-821e-3eb3a8138e06" xlink:href="soph-20251231.xsd#soph_AccountsPayablesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_AccountsPayablesMember_019c4318-522d-7f29-821e-3eb3a8138e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedExpensesMember_019c4318-522d-7206-930b-c1821eb23b95" xlink:href="soph-20251231.xsd#soph_AccruedExpensesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_AccruedExpensesMember_019c4318-522d-7206-930b-c1821eb23b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LeaseLiabilitiesMember_019c4318-522d-7e63-b139-d809e494fc09" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilitiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_ifrs-full_LeaseLiabilitiesMember_019c4318-522d-7e63-b139-d809e494fc09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LongtermBorrowingsMember_019c4318-522d-764c-90af-4e7152f1697d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowingsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_ifrs-full_LongtermBorrowingsMember_019c4318-522d-764c-90af-4e7152f1697d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantObligationsMember_019c4318-522d-7b0b-9ec1-af920e8aa7b0" xlink:href="soph-20251231.xsd#soph_WarrantObligationsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c4318-522d-7cd5-a527-289db00fbb99" xlink:to="loc_soph_WarrantObligationsMember_019c4318-522d-7b0b-9ec1-af920e8aa7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7453-a1d5-4b388bb15b0f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-7b5e-ba14-8a843d868589" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7453-a1d5-4b388bb15b0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssets_019c4318-522d-7da0-ba0f-bad93895b699" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7453-a1d5-4b388bb15b0f" xlink:to="loc_ifrs-full_FinancialAssets_019c4318-522d-7da0-ba0f-bad93895b699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilities_019c4318-522d-747c-831c-a9a9e9dc30a0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7453-a1d5-4b388bb15b0f" xlink:to="loc_ifrs-full_FinancialLiabilities_019c4318-522d-747c-831c-a9a9e9dc30a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7c9d-8600-19dc5aebbe4f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7c9d-8600-19dc5aebbe4f" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_019c6cc1-c55a-7a69-bd9d-393a22dca574" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_019c6cc1-c55a-7a69-bd9d-393a22dca574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_019c6cc1-c55a-77fd-9abe-de6b9206178a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_019c6cc1-c55a-7a69-bd9d-393a22dca574" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_019c6cc1-c55a-77fd-9abe-de6b9206178a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_GenesisHealthcareMember_019c6cc1-c55a-7efd-bb14-fb5ed3cdefe5" xlink:href="soph-20251231.xsd#soph_GenesisHealthcareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_019c6cc1-c55a-77fd-9abe-de6b9206178a" xlink:to="loc_soph_GenesisHealthcareMember_019c6cc1-c55a-7efd-bb14-fb5ed3cdefe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c6cc1-c55a-7d69-9ec9-eccd821a8888" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c6cc1-c55a-7d69-9ec9-eccd821a8888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c6cc1-c55a-754b-8f3b-6a42c3296660" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_019c6cc1-c55a-7d69-9ec9-eccd821a8888" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c6cc1-c55a-754b-8f3b-6a42c3296660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember_019c6cc1-c55a-7ac8-aed4-233f72cf9f09" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_019c6cc1-c55a-754b-8f3b-6a42c3296660" xlink:to="loc_ifrs-full_EquityInvestmentsMember_019c6cc1-c55a-7ac8-aed4-233f72cf9f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c6cc2-2395-74de-8292-04473a57542d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c6cc2-2395-74de-8292-04473a57542d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c6cc2-2395-7a0e-8f69-209af2e47a2d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsAxis_019c6cc2-2395-74de-8292-04473a57542d" xlink:to="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c6cc2-2395-7a0e-8f69-209af2e47a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CashAndCashEquivalentsAndTermDepositsMember_019c6cc2-2395-73c7-b817-e2476b6ab88c" xlink:href="soph-20251231.xsd#soph_CashAndCashEquivalentsAndTermDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialInstrumentsDomain_019c6cc2-2395-7a0e-8f69-209af2e47a2d" xlink:to="loc_soph_CashAndCashEquivalentsAndTermDepositsMember_019c6cc2-2395-73c7-b817-e2476b6ab88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019c6cc2-2395-7f38-9c1c-9d54409e2ac0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019c6cc2-2395-7f38-9c1c-9d54409e2ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c6cc2-2395-73a8-83be-5c10dc90a419" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c6cc2-2395-7f38-9c1c-9d54409e2ac0" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c6cc2-2395-73a8-83be-5c10dc90a419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementMember_019c6cc2-2395-7f9f-87e4-22b4edd2ec22" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c6cc2-2395-73a8-83be-5c10dc90a419" xlink:to="loc_soph_PerceptiveCreditAgreementMember_019c6cc2-2395-7f9f-87e4-22b4edd2ec22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c6cc2-2395-7657-b056-77a632d186eb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c6cc2-2395-7657-b056-77a632d186eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c6cc2-2395-7bb9-8512-c574434e5edc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c6cc2-2395-7657-b056-77a632d186eb" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c6cc2-2395-7bb9-8512-c574434e5edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_019c905e-74a8-7cd3-b5e1-7a2c48b6df09" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c6cc2-2395-7bb9-8512-c574434e5edc" xlink:to="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_019c905e-74a8-7cd3-b5e1-7a2c48b6df09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_MajorBorrowingTransactionsMember_019c89d0-324e-7ab6-9a60-979aeb2c2298" xlink:href="soph-20251231.xsd#soph_MajorBorrowingTransactionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c6cc2-2395-7bb9-8512-c574434e5edc" xlink:to="loc_soph_MajorBorrowingTransactionsMember_019c89d0-324e-7ab6-9a60-979aeb2c2298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-74fd-ad0f-e917be130084" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-74fd-ad0f-e917be130084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-522d-76f7-bc7b-1802332caf12" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-74fd-ad0f-e917be130084" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-522d-76f7-bc7b-1802332caf12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522d-78da-a8f1-7dce64e2828f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522d-76f7-bc7b-1802332caf12" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522d-78da-a8f1-7dce64e2828f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_019c89f3-8f1b-72fe-af6a-584d1e772c2b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_MaturityAxis_019c89f3-8f1b-72fe-af6a-584d1e772c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_019c89f3-8f1b-7201-8707-874c0f95e361" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_019c89f3-8f1b-72fe-af6a-584d1e772c2b" xlink:to="loc_ifrs-full_MaturityDomain_019c89f3-8f1b-7201-8707-874c0f95e361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_019c89f3-8f1b-796b-84fe-af6da975ad63" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019c89f3-8f1b-7201-8707-874c0f95e361" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_019c89f3-8f1b-796b-84fe-af6da975ad63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_019c89f3-8f1b-70df-a081-4292eaf1be1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019c89f3-8f1b-7201-8707-874c0f95e361" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_019c89f3-8f1b-70df-a081-4292eaf1be1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_019c4318-522d-78c7-ae21-f527a3bdf5fe" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_019c6cc1-c55a-7705-8ef6-3ad2c58f3572" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss_019c6cc1-c55a-7705-8ef6-3ad2c58f3572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaximumExposureToCreditRisk_019c6cc2-2395-7d4e-9709-474b0fc2e244" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaximumExposureToCreditRisk"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_ifrs-full_MaximumExposureToCreditRisk_019c6cc2-2395-7d4e-9709-474b0fc2e244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ProceedsFromBorrowings_019c6cc2-2395-707c-b76e-1c613a4899fa" xlink:href="soph-20251231.xsd#soph_ProceedsFromBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_ProceedsFromBorrowings_019c6cc2-2395-707c-b76e-1c613a4899fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019c6cc2-2395-7f37-a8f0-52707ad7c903" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019c6cc2-2395-7f37-a8f0-52707ad7c903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquitySharesIssued_019c905c-836e-7bed-a906-8f92598182dd" xlink:href="soph-20251231.xsd#soph_NumberOfEquitySharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_NumberOfEquitySharesIssued_019c905c-836e-7bed-a906-8f92598182dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_019c6cc2-2395-7b22-a8f2-466b20dec3b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_019c6cc2-2395-7b22-a8f2-466b20dec3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8217-2d83-71db-9c79-b4ef999ee9ae" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8217-2d83-71db-9c79-b4ef999ee9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BankBorrowingsInterestPaidUndiscountedCashFlows_019c89f3-8f1b-7680-ab62-d8cd25278f2c" xlink:href="soph-20251231.xsd#soph_BankBorrowingsInterestPaidUndiscountedCashFlows"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_BankBorrowingsInterestPaidUndiscountedCashFlows_019c89f3-8f1b-7680-ab62-d8cd25278f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Borrowings_019c6cc2-8c57-7805-933a-17084cca1952" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_ifrs-full_Borrowings_019c6cc2-8c57-7805-933a-17084cca1952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage_019c8a00-3163-780b-b0ea-22523a64e2f8" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage_019c8a00-3163-780b-b0ea-22523a64e2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings_019c8a00-3163-7f56-aad4-1b15441c411a" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_019c4318-522d-7179-b434-3e0ee5cc0a96" xlink:to="loc_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings_019c8a00-3163-7f56-aad4-1b15441c411a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7347-ada0-35d95b35869a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:href="soph-20251231.xsd#soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7347-ada0-35d95b35869a" xlink:to="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementAxis_019c4318-522d-73e2-a234-e68094e07f6d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:to="loc_ifrs-full_MeasurementAxis_019c4318-522d-73e2-a234-e68094e07f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MeasurementDomain_019c4318-522d-7624-ae9d-66df81aaf915" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_019c4318-522d-73e2-a234-e68094e07f6d" xlink:to="loc_ifrs-full_MeasurementDomain_019c4318-522d-7624-ae9d-66df81aaf915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RecurringFairValueMeasurementMember_019c4318-522d-7527-ad3a-e52422c3b758" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RecurringFairValueMeasurementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_019c4318-522d-7624-ae9d-66df81aaf915" xlink:to="loc_ifrs-full_RecurringFairValueMeasurementMember_019c4318-522d-7527-ad3a-e52422c3b758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_019c4318-522d-7fb1-8f39-adec1720270d" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_019c4318-522d-7fb1-8f39-adec1720270d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7bf5-a91b-9a94dcbf5610" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LevelsOfFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyAxis_019c4318-522d-7fb1-8f39-adec1720270d" xlink:to="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7bf5-a91b-9a94dcbf5610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level1OfFairValueHierarchyMember_019c4318-522d-7891-833e-16b0cec1a0b8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level1OfFairValueHierarchyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7bf5-a91b-9a94dcbf5610" xlink:to="loc_ifrs-full_Level1OfFairValueHierarchyMember_019c4318-522d-7891-833e-16b0cec1a0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level2OfFairValueHierarchyMember_019c4318-522d-79fb-9acc-8d50792eefcf" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level2OfFairValueHierarchyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7bf5-a91b-9a94dcbf5610" xlink:to="loc_ifrs-full_Level2OfFairValueHierarchyMember_019c4318-522d-79fb-9acc-8d50792eefcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_Level3OfFairValueHierarchyMember_019c4318-522d-78b1-aa97-8501faaf88b6" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Level3OfFairValueHierarchyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_LevelsOfFairValueHierarchyDomain_019c4318-522d-7bf5-a91b-9a94dcbf5610" xlink:to="loc_ifrs-full_Level3OfFairValueHierarchyMember_019c4318-522d-78b1-aa97-8501faaf88b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522d-744f-9977-bfb35d220a97" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522d-744f-9977-bfb35d220a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522d-7e0e-8315-2fab24c5ac4f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_019c4318-522d-744f-9977-bfb35d220a97" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522d-7e0e-8315-2fab24c5ac4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CashAndCashEquivalents1Member_019c4318-522d-72a4-874e-1492e6081a26" xlink:href="soph-20251231.xsd#soph_CashAndCashEquivalents1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522d-7e0e-8315-2fab24c5ac4f" xlink:to="loc_soph_CashAndCashEquivalents1Member_019c4318-522d-72a4-874e-1492e6081a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_EquityInvestmentsMember_019c6c1d-649f-7410-9991-c40dea17ccbd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_019c4318-522d-7e0e-8315-2fab24c5ac4f" xlink:to="loc_ifrs-full_EquityInvestmentsMember_019c6c1d-649f-7410-9991-c40dea17ccbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522d-714a-bc0a-22f51853b3f2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522d-714a-bc0a-22f51853b3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522d-7537-aa37-dd32cfa3b421" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfLiabilitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesAxis_019c4318-522d-714a-bc0a-22f51853b3f2" xlink:to="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522d-7537-aa37-dd32cfa3b421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantLiabilityMember_019c4318-522d-7a5d-8de8-591105d31848" xlink:href="soph-20251231.xsd#soph_WarrantLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfLiabilitiesDomain_019c4318-522d-7537-aa37-dd32cfa3b421" xlink:to="loc_soph_WarrantLiabilityMember_019c4318-522d-7a5d-8de8-591105d31848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019c4318-522d-78c3-b7cd-d6fb0120a386" xlink:href="soph-20251231.xsd#soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable_019c4318-522d-7e38-86ed-db283e453ca5" xlink:to="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019c4318-522d-78c3-b7cd-d6fb0120a386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialAssetsAtFairValue_019c4318-522d-72bb-9020-597b4314bce0" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialAssetsAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019c4318-522d-78c3-b7cd-d6fb0120a386" xlink:to="loc_ifrs-full_FinancialAssetsAtFairValue_019c4318-522d-72bb-9020-597b4314bce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c4318-522d-7360-9aa3-6eafd95fc036" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinancialLiabilitiesAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems_019c4318-522d-78c3-b7cd-d6fb0120a386" xlink:to="loc_ifrs-full_FinancialLiabilitiesAtFairValue_019c4318-522d-7360-9aa3-6eafd95fc036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-75d4-b761-14b324c6e87c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_019c4318-522d-736d-a554-ef0c47ad0170" xlink:href="soph-20251231.xsd#soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-75d4-b761-14b324c6e87c" xlink:to="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_019c4318-522d-736d-a554-ef0c47ad0170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-7c80-8758-9fd4713bcae5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_019c4318-522d-736d-a554-ef0c47ad0170" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-7c80-8758-9fd4713bcae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CarryingAmountMember_019c4318-522d-74b0-9f2d-c376400484bb" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_019c4318-522d-7c80-8758-9fd4713bcae5" xlink:to="loc_ifrs-full_CarryingAmountMember_019c4318-522d-74b0-9f2d-c376400484bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522d-763b-b6f6-459efa6e4674" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_019c4318-522d-74b0-9f2d-c376400484bb" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_019c4318-522d-763b-b6f6-459efa6e4674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityAxis_019c4318-522d-71d2-a5d7-1058aa9be8c9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_019c4318-522d-736d-a554-ef0c47ad0170" xlink:to="loc_ifrs-full_MaturityAxis_019c4318-522d-71d2-a5d7-1058aa9be8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MaturityDomain_019c4318-522d-7b3b-aa70-6b38ab561e4e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_019c4318-522d-71d2-a5d7-1058aa9be8c9" xlink:to="loc_ifrs-full_MaturityDomain_019c4318-522d-7b3b-aa70-6b38ab561e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_019c4318-522d-7940-9cbb-cdd99b5304c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019c4318-522d-7b3b-aa70-6b38ab561e4e" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_019c4318-522d-7940-9cbb-cdd99b5304c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_019c4318-522d-7e37-bca5-a37edd36885c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019c4318-522d-7b3b-aa70-6b38ab561e4e" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_019c4318-522d-7e37-bca5-a37edd36885c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_019c4318-522d-7b7f-8708-781f8946f80e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_019c4318-522d-7b3b-aa70-6b38ab561e4e" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_019c4318-522d-7b7f-8708-781f8946f80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:href="soph-20251231.xsd#soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable_019c4318-522d-736d-a554-ef0c47ad0170" xlink:to="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GrossLeaseLiabilities_019c4318-522d-7a78-af79-b2eecd038c62" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossLeaseLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:to="loc_ifrs-full_GrossLeaseLiabilities_019c4318-522d-7a78-af79-b2eecd038c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_019c4318-522d-78b8-901b-d794ad5eb836" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:to="loc_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows_019c4318-522d-78b8-901b-d794ad5eb836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AccruedExpensesUndiscountedCashFlows_019c4318-522d-7f0a-ab67-719c07214b71" xlink:href="soph-20251231.xsd#soph_AccruedExpensesUndiscountedCashFlows"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:to="loc_soph_AccruedExpensesUndiscountedCashFlows_019c4318-522d-7f0a-ab67-719c07214b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_019c4318-522d-7188-b4e4-bcadcb35773c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankBorrowingsUndiscountedCashFlows"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:to="loc_ifrs-full_BankBorrowingsUndiscountedCashFlows_019c4318-522d-7188-b4e4-bcadcb35773c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_019c4318-522d-7641-8072-526be42f8551" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems_019c4318-522d-7949-88de-c98762ee5ea7" xlink:to="loc_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows_019c4318-522d-7641-8072-526be42f8551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofSignificantExchangeRatesDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofSignificantExchangeRatesDetail"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofSignificantExchangeRatesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7aac-809d-a40fe60aac82" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_ForeignExchangeSpotRate_019c4318-522d-7a49-b0dd-e555377c0d94" xlink:href="soph-20251231.xsd#soph_ForeignExchangeSpotRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7aac-809d-a40fe60aac82" xlink:to="loc_soph_ForeignExchangeSpotRate_019c4318-522d-7a49-b0dd-e555377c0d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_AverageForeignExchangeRates_019c4318-522d-7066-bc28-d2bd8a8e38b3" xlink:href="soph-20251231.xsd#soph_AverageForeignExchangeRates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-7aac-809d-a40fe60aac82" xlink:to="loc_soph_AverageForeignExchangeRates_019c4318-522d-7066-bc28-d2bd8a8e38b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-742a-8d5e-a3a0daa94495" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7352-a774-9985a5ed2571" xlink:href="soph-20251231.xsd#soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-742a-8d5e-a3a0daa94495" xlink:to="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7352-a774-9985a5ed2571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7396-adb9-92e1c1eb45b5" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrencyInWhichInformationIsDisplayedAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7352-a774-9985a5ed2571" xlink:to="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7396-adb9-92e1c1eb45b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7d0f-9e84-eb1132ea3fc8" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7396-adb9-92e1c1eb45b5" xlink:to="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7d0f-9e84-eb1132ea3fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_FunctionalCurrencyMember_019c4318-522d-7453-b8c9-fd601d8640c1" xlink:href="soph-20251231.xsd#soph_FunctionalCurrencyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7d0f-9e84-eb1132ea3fc8" xlink:to="loc_soph_FunctionalCurrencyMember_019c4318-522d-7453-b8c9-fd601d8640c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_019c4318-522d-78ed-9466-2b0e68f18d6b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7352-a774-9985a5ed2571" xlink:to="loc_srt_CurrencyAxis_019c4318-522d-78ed-9466-2b0e68f18d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_019c4318-522d-7598-ac61-749a84c31a66" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_019c4318-522d-78ed-9466-2b0e68f18d6b" xlink:to="loc_currency_AllCurrenciesDomain_019c4318-522d-7598-ac61-749a84c31a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyUSDAndCHFMember_019c4318-522d-75de-bec5-6ec61d13a2d1" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyUSDAndCHFMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7598-ac61-749a84c31a66" xlink:to="loc_soph_DifferencesOfCurrencyUSDAndCHFMember_019c4318-522d-75de-bec5-6ec61d13a2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyEURAndCHFMember_019c4318-522d-7a98-8e9f-4de9fd5a181c" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyEURAndCHFMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7598-ac61-749a84c31a66" xlink:to="loc_soph_DifferencesOfCurrencyEURAndCHFMember_019c4318-522d-7a98-8e9f-4de9fd5a181c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyGBPAndCHFMember_019c4318-522d-7ccd-81a2-c1fa2eff9c55" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyGBPAndCHFMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7598-ac61-749a84c31a66" xlink:to="loc_soph_DifferencesOfCurrencyGBPAndCHFMember_019c4318-522d-7ccd-81a2-c1fa2eff9c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-522d-7899-88a9-5d96f5952a4b" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7352-a774-9985a5ed2571" xlink:to="loc_ifrs-full_RangeAxis_019c4318-522d-7899-88a9-5d96f5952a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522d-7ee7-859b-f5da1b5556d7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522d-7899-88a9-5d96f5952a4b" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522d-7ee7-859b-f5da1b5556d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-522d-7b46-a954-cf71ef800810" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522d-7ee7-859b-f5da1b5556d7" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-522d-7b46-a954-cf71ef800810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-522d-7bf0-ac3b-d9591a173fcd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522d-7ee7-859b-f5da1b5556d7" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-522d-7bf0-ac3b-d9591a173fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d03-ac5e-a5ad9032eaa8" xlink:href="soph-20251231.xsd#soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7352-a774-9985a5ed2571" xlink:to="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d03-ac5e-a5ad9032eaa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent_019c4318-522d-7bc8-8411-f5447a8425b6" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d03-ac5e-a5ad9032eaa8" xlink:to="loc_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent_019c4318-522d-7bc8-8411-f5447a8425b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_019c4318-522d-71c9-b8ea-4dec294bcabe" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d03-ac5e-a5ad9032eaa8" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss_019c4318-522d-71c9-b8ea-4dec294bcabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail" xlink:type="simple" xlink:href="soph-20251231.xsd#FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-70bb-8957-d107cb441f6e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7171-8133-29e8b8ad9ec1" xlink:href="soph-20251231.xsd#soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsAbstract_019c4318-522d-70bb-8957-d107cb441f6e" xlink:to="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7171-8133-29e8b8ad9ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7e5d-bae9-b64379854d8f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrencyInWhichInformationIsDisplayedAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7171-8133-29e8b8ad9ec1" xlink:to="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7e5d-bae9-b64379854d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7814-8172-f49b2f02ea86" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FunctionalOrPresentationCurrencyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis_019c4318-522d-7e5d-bae9-b64379854d8f" xlink:to="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7814-8172-f49b2f02ea86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PresentationCurrencyMember_019c4318-522d-7936-b3dc-d305ae4592f4" xlink:href="soph-20251231.xsd#soph_PresentationCurrencyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_FunctionalOrPresentationCurrencyMember_019c4318-522d-7814-8172-f49b2f02ea86" xlink:to="loc_soph_PresentationCurrencyMember_019c4318-522d-7936-b3dc-d305ae4592f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_019c4318-522d-76d7-be6e-9bb83b410b76" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7171-8133-29e8b8ad9ec1" xlink:to="loc_srt_CurrencyAxis_019c4318-522d-76d7-be6e-9bb83b410b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_019c4318-522d-7602-96d7-f11a8253a670" xlink:href="https://xbrl.sec.gov/currency/2025/currency-2025.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_019c4318-522d-76d7-be6e-9bb83b410b76" xlink:to="loc_currency_AllCurrenciesDomain_019c4318-522d-7602-96d7-f11a8253a670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyUSDAndCHFMember_019c4318-522d-75c0-a390-5bd97ffa0b9b" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyUSDAndCHFMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7602-96d7-f11a8253a670" xlink:to="loc_soph_DifferencesOfCurrencyUSDAndCHFMember_019c4318-522d-75c0-a390-5bd97ffa0b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyUSDAndEURMember_019c4318-522d-736f-bd9d-ad3e9bd66732" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyUSDAndEURMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7602-96d7-f11a8253a670" xlink:to="loc_soph_DifferencesOfCurrencyUSDAndEURMember_019c4318-522d-736f-bd9d-ad3e9bd66732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DifferencesOfCurrencyUSDAndGBPMember_019c4318-522d-75a4-a501-06d3f6b5eda3" xlink:href="soph-20251231.xsd#soph_DifferencesOfCurrencyUSDAndGBPMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_019c4318-522d-7602-96d7-f11a8253a670" xlink:to="loc_soph_DifferencesOfCurrencyUSDAndGBPMember_019c4318-522d-75a4-a501-06d3f6b5eda3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeAxis_019c4318-522d-7608-9c15-c3c7f003387c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7171-8133-29e8b8ad9ec1" xlink:to="loc_ifrs-full_RangeAxis_019c4318-522d-7608-9c15-c3c7f003387c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_RangeDomain_019c4318-522d-7261-94e5-cd0a58b175ba" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_019c4318-522d-7608-9c15-c3c7f003387c" xlink:to="loc_ifrs-full_RangeDomain_019c4318-522d-7261-94e5-cd0a58b175ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_TopOfRangeMember_019c4318-522d-71a3-b6db-22ed4f7949c7" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522d-7261-94e5-cd0a58b175ba" xlink:to="loc_ifrs-full_TopOfRangeMember_019c4318-522d-71a3-b6db-22ed4f7949c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BottomOfRangeMember_019c4318-522d-7041-b226-7a01319200b9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_019c4318-522d-7261-94e5-cd0a58b175ba" xlink:to="loc_ifrs-full_BottomOfRangeMember_019c4318-522d-7041-b226-7a01319200b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d28-958f-19432737d269" xlink:href="soph-20251231.xsd#soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable_019c4318-522d-7171-8133-29e8b8ad9ec1" xlink:to="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d28-958f-19432737d269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent_019c4318-522d-71bd-a28c-2781254975b3" xlink:href="soph-20251231.xsd#soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d28-958f-19432737d269" xlink:to="loc_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent_019c4318-522d-71bd-a28c-2781254975b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_019c4318-522d-7ccf-84a7-f69ba13cdf81" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfExchangeDifferencesOnTranslation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems_019c4318-522d-7d28-958f-19432737d269" xlink:to="loc_ifrs-full_ReserveOfExchangeDifferencesOnTranslation_019c4318-522d-7ccf-84a7-f69ba13cdf81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/CapitalmanagementDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#CapitalmanagementDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/CapitalmanagementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CapitalCommitmentsAbstract_019c4318-522d-7254-81ec-af788ff19c9e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CapitalCommitmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CapitalManagementTable_019c4318-522d-72a8-beab-91a5c9863378" xlink:href="soph-20251231.xsd#soph_CapitalManagementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CapitalCommitmentsAbstract_019c4318-522d-7254-81ec-af788ff19c9e" xlink:to="loc_soph_CapitalManagementTable_019c4318-522d-72a8-beab-91a5c9863378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522d-7948-8462-d69fb78e8869" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_CapitalManagementTable_019c4318-522d-72a8-beab-91a5c9863378" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522d-7948-8462-d69fb78e8869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c431a-006b-7bc5-ab53-6436d6440e37" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c4318-522d-7948-8462-d69fb78e8869" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c431a-006b-7bc5-ab53-6436d6440e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementMember_019c4318-522d-7daa-80b0-4c2579c02295" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c431a-006b-7bc5-ab53-6436d6440e37" xlink:to="loc_soph_PerceptiveCreditAgreementMember_019c4318-522d-7daa-80b0-4c2579c02295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c8219-0bea-7b76-8277-442ad27a8e89" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_CapitalManagementTable_019c4318-522d-72a8-beab-91a5c9863378" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c8219-0bea-7b76-8277-442ad27a8e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c8219-0bea-73d2-8e51-da31f5154b68" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c8219-0bea-7b76-8277-442ad27a8e89" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c8219-0bea-73d2-8e51-da31f5154b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_MajorBorrowingTransactionsMember_019c8a01-a2d3-7437-ad89-ab9cea000b84" xlink:href="soph-20251231.xsd#soph_MajorBorrowingTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c8219-0bea-73d2-8e51-da31f5154b68" xlink:to="loc_soph_MajorBorrowingTransactionsMember_019c8a01-a2d3-7437-ad89-ab9cea000b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_CapitalManagementLineItems_019c4318-522d-7dbe-ba67-a59d6e269746" xlink:href="soph-20251231.xsd#soph_CapitalManagementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_CapitalManagementTable_019c4318-522d-72a8-beab-91a5c9863378" xlink:to="loc_soph_CapitalManagementLineItems_019c4318-522d-7dbe-ba67-a59d6e269746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CashAndCashEquivalents_019c4318-522d-7070-9917-b0ef09755fd1" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_CapitalManagementLineItems_019c4318-522d-7dbe-ba67-a59d6e269746" xlink:to="loc_ifrs-full_CashAndCashEquivalents_019c4318-522d-7070-9917-b0ef09755fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8219-0bea-714d-8073-a68276d91908" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_CapitalManagementLineItems_019c4318-522d-7dbe-ba67-a59d6e269746" xlink:to="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8219-0bea-714d-8073-a68276d91908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_UndrawnBorrowingFacilities_019c6cca-f0c5-7712-b41d-7ac2a8cca991" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UndrawnBorrowingFacilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_CapitalManagementLineItems_019c4318-522d-7dbe-ba67-a59d6e269746" xlink:to="loc_ifrs-full_UndrawnBorrowingFacilities_019c6cca-f0c5-7712-b41d-7ac2a8cca991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails" xlink:type="simple" xlink:href="soph-20251231.xsd#EventsafterthereportingdateDetails"/>
  <link:presentationLink xlink:role="http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_soph_DisclosureOfEventsAfterReportingPeriodAbstract_019c7593-fafb-7050-9446-d9ef52b152ee" xlink:href="soph-20251231.xsd#soph_DisclosureOfEventsAfterReportingPeriodAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_DisclosureOfEventsAfterReportingPeriodAbstract_019c7593-fafb-7050-9446-d9ef52b152ee" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c7594-b052-7c51-af87-8081595ed66f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c7594-b052-7c51-af87-8081595ed66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c7594-b052-78fe-bacd-0668f5341b3f" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_019c7594-b052-7c51-af87-8081595ed66f" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c7594-b052-78fe-bacd-0668f5341b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_MajorBorrowingTransactionsMember_019c8a01-3737-727b-9f3a-76a06440cb9c" xlink:href="soph-20251231.xsd#soph_MajorBorrowingTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c7594-b052-78fe-bacd-0668f5341b3f" xlink:to="loc_soph_MajorBorrowingTransactionsMember_019c8a01-3737-727b-9f3a-76a06440cb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_019caf5e-73a6-77b8-a875-d575e1ef902c" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorOrdinaryShareTransactionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_019c7594-b052-78fe-bacd-0668f5341b3f" xlink:to="loc_ifrs-full_MajorOrdinaryShareTransactionsMember_019caf5e-73a6-77b8-a875-d575e1ef902c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_019c7594-b052-7c06-9de6-e78c28c3a8bd" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_019c7594-b052-7c06-9de6-e78c28c3a8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_019c7594-b052-7013-8b27-3274359c6874" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_019c7594-b052-7c06-9de6-e78c28c3a8bd" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_019c7594-b052-7013-8b27-3274359c6874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementMember_019c7594-b052-7480-91d3-386d7128e802" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_019c7594-b052-7013-8b27-3274359c6874" xlink:to="loc_soph_PerceptiveCreditAgreementMember_019c7594-b052-7480-91d3-386d7128e802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheCMember_019c7594-b052-7024-a470-b8f03159a999" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c7594-b052-7480-91d3-386d7128e802" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheCMember_019c7594-b052-7024-a470-b8f03159a999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditAgreementTrancheDMember_019c7594-b052-79a8-947b-cc0279d9c7e9" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditAgreementTrancheDMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_PerceptiveCreditAgreementMember_019c7594-b052-7480-91d3-386d7128e802" xlink:to="loc_soph_PerceptiveCreditAgreementTrancheDMember_019c7594-b052-79a8-947b-cc0279d9c7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsAxis_019c7594-b052-70d0-82f0-5d6f64a8e956" xlink:href="soph-20251231.xsd#soph_BorrowingTermsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_soph_BorrowingTermsAxis_019c7594-b052-70d0-82f0-5d6f64a8e956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingTermsDomain_019c7594-b052-75d1-97b7-b8f702f401f0" xlink:href="soph-20251231.xsd#soph_BorrowingTermsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_BorrowingTermsAxis_019c7594-b052-70d0-82f0-5d6f64a8e956" xlink:to="loc_soph_BorrowingTermsDomain_019c7594-b052-75d1-97b7-b8f702f401f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRMember_019c7594-b052-7d09-98a9-ea46abda7d0b" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_BorrowingTermsDomain_019c7594-b052-75d1-97b7-b8f702f401f0" xlink:to="loc_soph_TermSecuredOvernightFinancingRateSOFRMember_019c7594-b052-7d09-98a9-ea46abda7d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_TermSecuredOvernightFinancingRateSOFRFloorMember_019c8214-ed65-7d43-b307-4fc718bcb44c" xlink:href="soph-20251231.xsd#soph_TermSecuredOvernightFinancingRateSOFRFloorMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_BorrowingTermsDomain_019c7594-b052-75d1-97b7-b8f702f401f0" xlink:to="loc_soph_TermSecuredOvernightFinancingRateSOFRFloorMember_019c8214-ed65-7d43-b307-4fc718bcb44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalAxis_019c7594-b052-7767-ba52-89f79736994e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_ifrs-full_ClassesOfShareCapitalAxis_019c7594-b052-7767-ba52-89f79736994e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ClassesOfShareCapitalDomain_019c7594-b052-7228-ab5c-da612f4a96d9" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfShareCapitalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalAxis_019c7594-b052-7767-ba52-89f79736994e" xlink:to="loc_ifrs-full_ClassesOfShareCapitalDomain_019c7594-b052-7228-ab5c-da612f4a96d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_OrdinarySharesMember_019c7594-b052-7979-b872-1627c2bec897" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfShareCapitalDomain_019c7594-b052-7228-ab5c-da612f4a96d9" xlink:to="loc_ifrs-full_OrdinarySharesMember_019c7594-b052-7979-b872-1627c2bec897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesAxis_019c7594-b052-7ff6-984b-dbca0e707c1e" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_ifrs-full_CounterpartiesAxis_019c7594-b052-7ff6-984b-dbca0e707c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_CounterpartiesDomain_019c7594-b052-796b-b2b5-80b3dc49c1bc" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_019c7594-b052-7ff6-984b-dbca0e707c1e" xlink:to="loc_ifrs-full_CounterpartiesDomain_019c7594-b052-796b-b2b5-80b3dc49c1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_PerceptiveCreditHoldingsIVLPMember_019c7594-b052-7c7f-8c11-336c4d32507e" xlink:href="soph-20251231.xsd#soph_PerceptiveCreditHoldingsIVLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_019c7594-b052-796b-b2b5-80b3dc49c1bc" xlink:to="loc_soph_PerceptiveCreditHoldingsIVLPMember_019c7594-b052-7c7f-8c11-336c4d32507e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsAxis_019c8214-ed65-7543-a628-e42832032eac" xlink:href="soph-20251231.xsd#soph_WarrantTermsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_soph_WarrantTermsAxis_019c8214-ed65-7543-a628-e42832032eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantTermsDomain_019c8214-ed65-7166-b3a5-d1b27e4ab028" xlink:href="soph-20251231.xsd#soph_WarrantTermsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WarrantTermsAxis_019c8214-ed65-7543-a628-e42832032eac" xlink:to="loc_soph_WarrantTermsDomain_019c8214-ed65-7166-b3a5-d1b27e4ab028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheCMember_019c8214-ed65-79bb-ba6e-ef5ec44e52f4" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WarrantTermsDomain_019c8214-ed65-7166-b3a5-d1b27e4ab028" xlink:to="loc_soph_WarrantRightsTrancheCMember_019c8214-ed65-79bb-ba6e-ef5ec44e52f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantRightsTrancheDMember_019c8214-ed65-7ba0-b251-83589c546866" xlink:href="soph-20251231.xsd#soph_WarrantRightsTrancheDMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_soph_WarrantTermsDomain_019c8214-ed65-7166-b3a5-d1b27e4ab028" xlink:to="loc_soph_WarrantRightsTrancheDMember_019c8214-ed65-7ba0-b251-83589c546866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_019c7594-b052-791c-9054-c5eb1c8ec21a" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8214-ed65-78ad-8311-f42a829d2bcf" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity_019c8214-ed65-78ad-8311-f42a829d2bcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesMaximumBorrowingCapacity_019c8214-ed65-7c82-b10a-4342aa591028" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_BorrowingFacilitiesMaximumBorrowingCapacity_019c8214-ed65-7c82-b10a-4342aa591028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger_019c7594-b052-7f09-bd1f-42ccfc2657fa" xlink:href="soph-20251231.xsd#soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger_019c7594-b052-7f09-bd1f-42ccfc2657fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_019c7594-b052-711f-8de5-a00bf3cc63b2" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsAdjustmentToInterestRateBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_ifrs-full_BorrowingsAdjustmentToInterestRateBasis_019c7594-b052-711f-8de5-a00bf3cc63b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights_019c8214-ed65-7d88-b051-6543b88f9690" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights_019c8214-ed65-7d88-b051-6543b88f9690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7594-b052-7892-a6c5-757c62e4c9e5" xlink:href="soph-20251231.xsd#soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights_019c7594-b052-7892-a6c5-757c62e4c9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_soph_NumberOfEquitySharesIssued_019caf5e-73a6-7edf-bb03-f19dd8219004" xlink:href="soph-20251231.xsd#soph_NumberOfEquitySharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_soph_NumberOfEquitySharesIssued_019caf5e-73a6-7edf-bb03-f19dd8219004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_019caf5e-73a6-7ece-bdb4-f895cb64c856" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_019c7594-b052-7d04-a67b-c3332b3572fa" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_019caf5e-73a6-7ece-bdb4-f895cb64c856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
MB5!.1PT*&@H    -24A$4@  !V@    '" (   !"YXKZ    4DE$051X7NW8
M,1$   @#,?R;AI5B@63KU<%7 0    #P7B_W P    #@(>$8     ( @' ,
M    $(1C      !"A.,]      ! . 8     ( P#<H'I8''Y=     !)14Y$
$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_01.jpg
<TEXT>
begin 644 image_01.jpg
MB5!.1PT*&@H    -24A$4@  !V@    '" (   !"YXKZ    4DE$051X7NW8
M,1$   @#,?R;AI5B@63KU<%7 0    #P7B_W P    #@(>$8     ( @' ,
M    $(1C      !"A.,]      ! . 8     ( P#<H'I8''Y=     !)14Y$
$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_02.jpg
<TEXT>
begin 644 image_02.jpg
MB5!.1PT*&@H    -24A$4@  !V@    '" (   !"YXKZ    4DE$051X7NW8
M,1$   @#,?R;AI5B@63KU<%7 0    #P7B_W P    #@(>$8     ( @' ,
M    $(1C      !"A.,]      ! . 8     ( P#<H'I8''Y=     !)14Y$
$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_03.jpg
<TEXT>
begin 644 image_03.jpg
MB5!.1PT*&@H    -24A$4@  !V@    '" (   !"YXKZ    4DE$051X7NW8
M,1$   @#,?R;AI5B@63KU<%7 0    #P7B_W P    #@(>$8     ( @' ,
M    $(1C      !"A.,]      ! . 8     ( P#<H'I8''Y=     !)14Y$
$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_0c.jpg
<TEXT>
begin 644 image_0c.jpg
MB5!.1PT*&@H    -24A$4@  #M0    +" (   #:HA^S    T$E$051X7NW:
MV1& (!!$0?(/P1R)82W% U8+$NC^G$GAE0T             8"4B2MX
M         $:U5O$Q             +!03^)C             &"FE<?B8P
M          !@YBF/_^/C_@8             :')\G'\             @-,0
M'^<3             .#VQL?Y 0            #H7/%QG@$
H1D=\G#<             @(^(V $R1_Y7+O4??P    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_10a.jpg
<TEXT>
begin 644 image_10a.jpg
MB5!.1PT*&@H    -24A$4@  #M0    +" (   #:HA^S    SDE$051X7NW:
MV1& (!!$0?+/P" W!BS% [8L,(#NSYD47MD              %9JK25O
M          "CB! ? P             +<1(? P             SK3P6'P,
M            ,T]Y_!T?]S<             0)/CX_P#             )R&
M^#B?              "W-S[.#P            ! YXJ/\PP
F,#KBXPH             \,,.0_% FBCUS&D     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_16.jpg
<TEXT>
begin 644 image_16.jpg
MB5!.1PT*&@H    -24A$4@  #M0    +" (   #:HA^S    SDE$051X7NW:
MV1& (!!$0?+/P" W!BS% [8L,(#NSYD47MD              *8BHM9:\@P
M            T(F3^!@             6! ? P            !KK3P6'P,
M            ,T]Y_!T?]S<             0)/CX_P#             )R&
M^#B?              "W-S[.#P            ! YXJ/\PP
F,#KBXPH             \,,.DV%"DC@<?<4     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_17a.jpg
<TEXT>
begin 644 image_17a.jpg
MB5!.1PT*&@H    -24A$4@  #LL    (" (   "*D[=X    B4E$051X7NW:
MP0D (  #L>Z_M((*%5<P^10ZPR4              ,E8WA<
M^)/"&              HA3$             4 IC             *!.8;P'
M             & HC $           " F\(8             *@)R>G#?%[]
.M*<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>image_19a.jpg
<TEXT>
begin 644 image_19a.jpg
MB5!.1PT*&@H    -24A$4@  #M4    0" (   !<<8;5   !%4E$051X7NW:
MVPV (!!%0?OOP"*I01/P 1O-;@$S/R3<+>%L.P            ! YNBV^ T
M            L&JMZ8\!            @%SK],<             0&+$Q_IC
M             "#QQ,>__?%\ 0             P?/3'\00
MH(O]<=P!             &Y+?QQ'             (#)VQ_'!0
M  !@=?7'XP$             2.F/ 0           ( J_3$
M4*4_!@            "J],<             0)7^&             "H.@&B
3(0L Z&*[%     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>image_21a.jpg
<TEXT>
begin 644 image_21a.jpg
MB5!.1PT*&@H    -24A$4@  #M4    0" (   !<<8;5   !$TE$051X7NW:
MVPW ( P$0?KO($520R)!7EB)[ )F?I XE[!M!P            "H:?$#
M         ."'_A@             J-(? P            !5;0,
M    R.B/ 0           ("2WKO^&             #(]4%_#
M   D9GRL/P8             $G=\_-L?OR\              *:/_CB>
M           ,L3^..P            # 9>F/XP@             \/+TQW$!
M             %B=_?%\              !2^F,             H.H ^K8+
1 %*8?"P     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>image_2a.jpg
<TEXT>
begin 644 image_2a.jpg
MB5!.1PT*&@H    -24A$4@  #M0    +" (   #:HA^S    SDE$051X7NW:
M6PW (!1$0?P[J$@TW";0!]PT4 $SG[L63CD              '8BHN0-
M         &!6:Q4? P             ;M1$? P             KO3P6'P,
M            *T]Y_!T?CS<             0)?CX_P#             #13
M?)Q/             (";^!@             ^.6-C_,#             #"X
FXN,\ P            #,(N($(*L<]ZJ6'OH     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>image_4.jpg
<TEXT>
begin 644 image_4.jpg
MB5!.1PT*&@H    -24A$4@  #M0    +" (   #:HA^S    T$E$051X7NW:
MV1& (!!$0?+/P"")82W% U8+$NC^G$GAE0T             8"4B2MX
M         $:U5O$Q             +!03^)C             &"FE<?B8P
M          !@YBF/_^/C_@8             :')\G'\             @-,0
M'^<3             .#VQL?Y 0            #H7/%QG@$
H1D=\G#<             @(^(V 'CB1_K5FURTP    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>image_7a.jpg
<TEXT>
begin 644 image_7a.jpg
MB5!.1PT*&@H    -24A$4@  #M0    +" (   #:HA^S    S$E$051X7NW:
M6PW (!1$0?P[J$@TW";0!]PT4 $SG[L63CD              '8BHN0-
M         &!6:Q4? P             ;M1$? P             KO3P6'P,
M            *T]Y_!T?CS<             0)?CX_P#             #13
M?)Q/             (";^!@             ^.6-C_,#             #"X
DXN,              -@Y 1Z+/7"18):O     $E%3D2N0F""

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>soph-20251231_g1.jpg
<TEXT>
begin 644 soph-20251231_g1.jpg
M_]C_X  02D9)1@ ! 0  2 !(  #_X0!J17AI9@  34T *@    @  @$2  ,
M   !  $  (=I  0    !    )@       Y*&  <    2    4* "  0    !
M   #XZ #  0    !   "*P    !!4T-)20   %-C<F5E;G-H;W3_X0DA:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[
MOR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \>#IX;7!M971A
M('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)835 @0V]R92 V
M+C N,"(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2(B+SX@/"]R9&8Z4D1&/B \+W@Z>&UP;65T83X@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" \/WAP86-K970@96YD/2)W(C\^ /_M #A0:&]T
M;W-H;W @,RXP #A"24T$!        #A"24T$)0      $-0=C-F/ +($Z8 )
MF.SX0G[_X@TD24-#7U!23T9)3$4  0$   T487!P; (0  !M;G1R4D="(%A9
M6B 'YP "  ( "0 P #=A8W-P05!03     !!4%!,
M    ]M8  0    #3+6%P<&P
M                         !%D97-C   !4    &)D<V-M   !M    ?!C
M<')T   #I    "-W='!T   #R    !1R6%E:   #W    !1G6%E:   #\
M !1B6%E:   $!    !1R5%)#   $&   " QA87)G   ,)    "!V8V=T   ,
M1    #!N9&EN   ,=    #YM;6]D   ,M    "AV8V=P   ,W    #AB5%)#
M   $&   " QG5%)#   $&   " QA86)G   ,)    "!A86=G   ,)    "!D
M97-C          A$:7-P;&%Y
M
M            ;6QU8P         F    #&AR2%(    8   !V&MO2U(    8
M   !V&YB3D\    8   !V&ED       8   !V&AU2%4    8   !V&-S0UH
M   8   !V&1A1$L    8   !V&YL3DP    8   !V&9I1DD    8   !V&ET
M250    8   !V&5S15,    8   !V')O4D\    8   !V&9R0T$    8   !
MV&%R       8   !V'5K54$    8   !V&AE24P    8   !V'IH5%<    8
M   !V'9I5DX    8   !V'-K4TL    8   !V'IH0TX    8   !V')U4E4
M   8   !V&5N1T(    8   !V&9R1E(    8   !V&US       8   !V&AI
M24X    8   !V'1H5$@    8   !V&-A15,    8   !V&5N054    8   !
MV&5S6$P    8   !V&1E1$4    8   !V&5N55,    8   !V'!T0E(    8
M   !V'!L4$P    8   !V&5L1U(    8   !V'-V4T4    8   !V'1R5%(
M   8   !V'!T4%0    8   !V&IA2E     8   !V !$ $4 3 !, "  4  R
M #< ,0 Y $@ 0W1E>'0     0V]P>7)I9VAT($%P<&QE($EN8RXL(#(P,C,
M %A96B        #SV  !     18(6%E:(        &2'   S*@   0I865H@
M        :N0  +R7   1REA96B         G:P  $#X  ,!98W5R=@
M  0     !0 *  \ %  9 !X (P H "T ,@ V #L 0 !% $H 3P!4 %D 7@!C
M &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *, J "M +( MP"\ ,$ Q@#+ -
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MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\
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MIP  #5D  !/0   *6W9C9W0          0 !          $    !
M  $    !          $  &YD:6X         -@  IT   %8   !2@   G
M "<    /0   4$   %1   (S,P ",S,  C,S          !M;6]D
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]L
M0P ! 0$! 0$" 0$" P(" @,$ P,# P0&! 0$! 0&!P8&!@8&!@<'!P<'!P<'
M" @(" @("0D)"0D+"PL+"PL+"PL+_]L 0P$" @(# P,% P,%"P@&" L+"PL+
M"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+
M_]T !  __]H # ,!  (1 Q$ /P#^_BFNZ1J7D( '4FG5PVK:@UW.8T/[M#@#
MU/K32N)LV9_$-LAQ"I?WZ"J__"2?],?_ ![_ .M7+T55D3S,ZC_A)/\ IC_X
M]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6
MKEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X
M]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6
MKEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X
M]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6
MKEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X
M]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6
MKEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X
M]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6
MKEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X
M]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6
MKEZ*+(+LZC_A)/\ IC_X]_\ 6H_X23_IC_X]_P#6KEZ*+(+LZC_A)/\ IC_X
M]_\ 6J:+Q% QQ-&4]P<_X5R-%%D',STN&>*XC$D+!E/I4M>>Z??26,X<'Y3]
MX>HKT!65U#KT(R*EJQ2=QU%%%(84444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\
MP6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__ &RO
MH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6
MEW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH
M'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_
M (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'
M_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>
M+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__
M &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB
M\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/G
MO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2
M/%G_ (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?
M_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/
M_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\
MP6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__ &RO
MH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6
MEW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH
M'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_
M (+?_ME'_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'
M_#0/_4D>+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>
M+/\ P6__ &ROH2BB\>P6EW/GO_AH'_J2/%G_ (+?_ME'_#0/_4D>+/\ P6__
M &ROH2BB\>P6EW/GEOVC_#5@//\ %&@Z_HEOD SWU@R1CU.5+'CJ>*]VTG5M
M-UW38-8T>=+FUN4$D4L9RK*>XJY-#%<1-!.H>-P596&00>H(/4&OGOX+11^&
MO&GC3X::<-FG:/=VUQ:Q]1$M]&9&13_=!' QQGJ:=DTVN@KM-)]3Z(HHHK,T
M/__2_ONOO^/*;_<;^5><UZ-??\>4W^XW\J\YJXDR"BBBF2%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7>:+_P @V/\ X%_,UP==YHO_ "#8_P#@
M7\S2D5$U****@H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***X+X
MD?$;PY\+?"\GBKQ*S")6$<<:#+RRL"0BC@9(!/)  !--)MV0FTE=G>T5^5FE
M?\%-]"U/XLWOPOC\/EKC3K=;JX42D%8I"NTARNTMA@=N/Q%?IMX8\2:3XO\
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M:U86&I7VD7$UN25CO=-G>VN(CD Y25&&?NL,,I*L"?DO_@I[^UU;?L0?L/\
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MN^78[8WY5S;A7>:+_P @V/\ X%_,UP==YHO_ "#8_P#@7\S42-(FI117P/\
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MM :XX6;AS_ULW^A,\73C/DOK_P %+]3]^**_(_PO_P %6_AS\8M8M_AOX?\
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M%,?&/PU/);ZE#?6DT6EWJAB4FMY%$H0%,???8XP\;NK<?#7_  62_;N^"/\
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M2GNKW_\  6?*NM?M _M$?\&]OC#Q+^RO!X=U+XF?"GQNMS>?"!P6FEL=8N)
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MP^\!?$[P]+X1^)6AZ?XATF?!DLM3MH[NW?']Z.560_B*Z^BDG;5%-)Z,^6?
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M!1112*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 ?G9_P42_X*)^#?^"?OA'PI/>>%]4\<^+/'NK+HOASP[HX N;ZZ.W(W$-M
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M?#7P'?\ @SX2:CHWAK^PY(K":WT:ZN(;2 RBVF91%*\<LL^\([%69P><U-?
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MV\-Z'\4)O">I^#I&O;6.TUB;1<27$+Q0RM) 2Q?:T\:*9"#G:2P]S^-&D?\
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M=2,MZUK):1V\DPMUB; C *5]+_ ']GW3OAM\7OV1_BW\<?A7JVHZI%\$=/\
M#WVI]#NKN?3O%UF=)>UCOVCAD;3Y$07"B>Z$<<6)-[+AJ_H4^$WPH^'_ ,#/
MAMHOPA^%6G+I/ASP]:I9Z?9K))*(8(_NJ'E9W;'JS$^]>AU=7,'*4FEH[]==
M;_YF=++5&$5)ZJW32ZM_E^-S^0CX<_"[X\>,+'XD2^ /A?K'A)?'_P "/'-A
MKN@V?A/5M'M8_$\B6HLK.:\U&21M6U$>;/&MZH59QN$6X!@G]&'[,O[07@[Q
M0VA?L_P:?K%CK^E>!] \0R_VCITUE$;34$:%%!F5'6:-X766%T5T/!&0P7['
MKEM*\#^#=#\3ZKXUT?2K6UUC71 -1OHXE6XNA:J4A$L@&YQ$I(0$D+DXQDYR
MKXI55:4?0VP^$=%WC+U_X'S/Q^_92^->I_!2[^,OP:\0_#SQS<^)=8^(_C35
M=(0>%]7CTF_@O+F26U(U<6AL8X[@ !9FF"C<#GI7YC?!_P"%WQLU+P1\<+7P
M+\.=9\/:9XV_9_\ $4-]HNG^#M7T"S/BP)LBLE&HO-/J6HJD\D378&;K'R;@
MN%_KCHJHXWE;:CJ[7U[$RP/,HIRVO;3N?SC_ ++S?#[]F/XK:A^T;\)/AGXP
M\$_#SP'\);@?$2.ZT._L)M7\06TUK-!Y5O>K$]_=VT$5X9;Q#(A255\U@1C[
M(_X*@VNJ?$CX2?!/QSX.M_%CZ7:?$/1=<O+SPCI5SJ.LV&G&POLW*6UO;74P
MVF1%;,#;2P!&37ZD>-/!'@[XC>&;KP7X_P!+M=:TB]V"XLKV)9[>8(P=0\;@
MJP#*#@@@XYKIP !@< 5,L5>:J6U7GT_K]"XX2U.5.^C\NO\ EM^)_,S\'/@W
M\=+&$R^&/#WCG4_"5]\??"?B6QUKQAI\T'BG4+;[,B:E=:E#Y44L=I;O&D4$
MDT$ $*@%<*&:3]GOX/\ CW3/C5\,5MO GBK3/V@=+^(6K7WQ)\9W>G7D.FZA
MX:D:^+A]4<?8KRUN(WM5L+2*21K=D&(XC&YK^F.BK>/DTU;^K6U[_P"9FLNB
MFGS;?YWT[>3[?>?A9^P-^P;\0O$GPG^'GBK]I'Q3XCM],\#>+]?\3:/X%N;"
MVTVWM=075-1^RW-Q(;<7TRA)S<1(TJQL75B&4**^:/V9OV3?&GP T?\ 9X^-
M?@3X::U'XWN]5\>P>,D:*ZM[BZT^2QUF>QMKZ24$6\$EU'9BV,@6-'=3&,O\
MW]-5%2\=-N5]GT^__,I9?32C9ZKK]W?TM\S^2#X,_#3XY77@WXW)\/?AYK7A
MO3_&?P!\0QWFCZ;X.U?P_:CQ:J[8;-/[0>:XU+442>2(W:@-=$?)N"X7[3/_
M  3<^$FM_&GX9_#7Q%\.[V\\$/\ "GQ)>ZZ;A+IH;GQ3=3Z*BRZA,3^_U"1$
ME=/M#-(6B\Q1NB#+_0915RS";=XZ?/RL3#+8)6EK\O._XG\T/[-'[/GQ;_9[
M\+?!CXN>%/AUXCU/Q;XE^!7BC_A/[2[:]BNM6\06T.DSZ?9ZC<3;GM[R25KF
M&W,A62--Z1@(A4>)_"W2/$7PW^%7[2FN7O@^^\,_#_Q/\%2L^FQ>$=3\)Z7+
MXFD%];M:6\&IO+/<WCBXC@DN#M:Z8H0"%4U_657+^+_!7A+Q]I46A^-=.@U2
MSAN[2_2&Y02(+FPF2YMY,'C=%-&DB'LR@]J?U]MOF6_^=_\ @(EY<DERRV_R
MM^.[*GPYTK6]"^'N@Z)XEE\_4K/3K6"ZE_OSQQ*LC?BP)KLZ**\]N[N>DE96
M"BBBD,*^>_AS_P EZ^)'_<'_ /2=J^A*^>_AS_R7KXD?]P?_ -)VJX[2]/U1
M$]X^OZ,^A****@L__]'^^Z^_X\IO]QOY5YS7HU]_QY3?[C?RKSFKB3(****9
M(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %=YHO_ "#8_P#@7\S7
M!UWFB_\ (-C_ .!?S-*1434HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OGOX<_\
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M,XR>>22:Z>N\T7_D&Q_\"_F:+M;!9/<\/_X9^_ZG?Q9_X,O_ +71_P ,_?\
M4[^+/_!E_P#:Z^A**7M)=Q^SCV/GO_AG[_J=_%G_ (,O_M='_#/W_4[^+/\
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M?]3OXL_\&7_VNOH2BCVDNX>SCV/GO_AG[_J=_%G_ (,O_M='_#/W_4[^+/\
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M?]3OXL_\&7_VNOH2BCVDNX>SCV/GO_AG[_J=_%G_ (,O_M='_#/W_4[^+/\
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M?]3OXL_\&7_VNOH2BCVDNX>SCV/GO_AG[_J=_%G_ (,O_M='_#/W_4[^+/\
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MK]**BGM\W^9]?QO_ ,C&E_V#X/\ ]1* 44459\@%%%% !1110 4444 %%%%
M!1110 4444 %%%% '__4_ONOO^/*;_<;^5><UZ-??\>4W^XW\J\YJXDR"BBB
MF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7>:+_P @V/\ X%_,
MUP==YHO_ "#8_P#@7\S2D5$U****@H**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ***\]^+.L^//#GPRU[7_A?IL.L>(;*QGGT^QG8I'<7$:EDC)7G
MYB,#D9/&1U S6A1=6K&E%I.32U=EJ[:MZ)=V]CX9_9B_Y2(_M0_]R3_Z;)*_
M2BOYM_V8_P!O:X\9_MH>/=6^#OAXZEXB^+=]X+@2PNB\<=C;Z=I\BZK)(X&?
M]%(*KQ\WW@#C:?Z2*RI233MW?YGZ!XEY'C<NS&@L;#D<L/ADDVK^YAJ,)76Z
M2G&4;]7&5M@HHHK4_.@HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]7^
M^Z^_X\IO]QOY5YS7HU]_QY3?[C?RKSFKB3(****9(4444 %%%% !1110 444
M4 %%%?G5_P %2OV\A_P3F_9*U']HBTT'_A)-2-]:Z5IUE)*88#=7>[#SR $K
M&BHS' RQ 7*[MPNE3E4FH0W9G5JQIP=2;LEJS]%:*_"KP+_P4\_:N^$'[(/Q
M*_:M_;]^%^B:!I/@ZRL;S0;WPMK46H67B&347\J*"!HGNE3;*T:O-YC !\A"
M%)/B7P-_X+$?MH>'_C9\(/#'[>OP:TWP+X)^/<D5OX2UC2[\SS0SW7E_9DNX
MR\A!D,T0(80LHD#;3L=1U+ 57=JSMYK72^G>R.1YE17*I75_)Z:V5]-+O:Y_
M2%17\IWC#_@NO^W/X.?XL_&2T^"WA_Q!\)/@]XUN?"FMZA;ZHUIJ"+'=BVB<
M1R,Y8OOC!*1,H9N<*"1^B7[/'_!5ZV^-7[4OQH^#FLVND:)X:\ :%HNMZ!?7
M4Y@NK]-6LDO-LRR/L!4.!B/IWISR^M%.36GJO+_-!3S/#SDHIZONFN_X:/4_
M9^BOYU/V?O\ @J7\:_VH?A-^S5\9[_Q7X2^%\OQ)\;:AHFJZ#<V-Y?/K5M:7
M"0+;V$J)*()CNY:9HUW.K;L(R/U7CO\ X+3:UX0_X*OVG[#4'A>RG^'<>MZ=
MX3U#Q09)//BUW5;1YH(%&1'CSPL+ C(VN<],KZA6NXVU2;?R=GZ_(/[2H<JE
M?1M)?-77IIW/Z :*_.;_ (*9?M_6?_!/WX):9XQT7P[+XR\9>+M7@\/>&- A
M<QM>ZC<@[=S*KL$4#D*I9F*H,%MP\Y_9K_;)_:^\*> _'/Q#_P""JW@+P_\
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MYE^/^0<[_E?X?YGT)17SW_PKCX]?]%(_\H]O_P#%4?\ "N/CU_T4C_RCV_\
M\51RK^9?C_D'._Y7^'^9]"45\]_\*X^/7_12/_*/;_\ Q5'_  KCX]?]%(_\
MH]O_ /%4<J_F7X_Y!SO^5_A_F?0E%?/?_"N/CU_T4C_RCV__ ,51_P *X^/7
M_12/_*/;_P#Q5'*OYE^/^0<[_E?X?YGT)17SW_PKCX]?]%(_\H]O_P#%4?\
M"N/CU_T4C_RCV_\ \51RK^9?C_D'._Y7^'^9]"45\]_\*X^/7_12/_*/;_\
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M^99OC<PJJOC9RG-1C%-M7Y8)1BM^B7SW=VVSZ$HKY[_X5Q\>O^BD?^4>W_\
MBJ/^%<?'K_HI'_E'M_\ XJGRK^9?C_D<'._Y7^'^9]"45\]_\*X^/7_12/\
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MB#'':7$ LKO6YIQ:1++-&L<J&*V=P(7D6-F8$C(S_153(XXXHUBB4*J@  #
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M(I;'Q)\#](\7/<Z;XL'A._UG7YQ%%</)J+(\ER]M'LF-LK#>9S)('5<5Z3\
M?A?\3=>_X*'_  5UC]JSQ[JG_":O\(+J^N9]'U]DL-2O-.UFQCC1# 5AFBNH
M%2:Z@0>7-)EBO%5+ \MW*7?SVO\ Y$1Q[E91CV5]EK;_ #T/Z4J*_F,^%7[3
M_CC4OVP?@I\7_A;XD\4W7@?XJ>+]<T)[?Q5XN6\FU6R2"](EB\/0PB"PAM;B
M!?+E$D<X&R.6,F0D7?@I9_M.6?\ P34T3_@HK%\3O&OB[QIX>OO^$EU'2+C5
M)FTZ\\/Z)J$\5Y8+9J1&[/8K(YE</+),J_-@*%4L"XVO+>R^;NOT*CF"E?EC
MM=_))._XG],U5[NYBLK66\GSLA1G;')PHR:_.K]@WXL^(?V@[CXK?M93ZY=:
MCX%\2>(Y=/\ !ML)'DLTT7P]']C>[MH^QO;M;F4LJY=!'UP /R8_9[_:4\?:
MW^UQ\$_%G@+Q'XHO? OQK@\50_9_%GB]-6O=2M+33[B\M[P:)!"+;30DMN%4
MPR*VUS')&&Z9QPDFY*_P_P"5VOP9<\;&*@[?$]/O23]-4?T3_ /XV^!_VD?@
MSX;^/'PU:=] \56,>H6)N8_*F,,HRN],G:?49->NU_)9\)_B+XKMOV6OV._A
M.VM^-%\)ZY\-M9O;C2OAUJ!TW6Y]2T\V:6\TLZRP,;:+SW7RQ*%,K R(T:MM
M^G?AWX6_:$T_QA\ _P!B[]KWXI>*?"B:SX"U7Q5KFH6GB.:'4-9\2P36L9T\
M:J)#*([2WF>=H;>4(S9/S1@5K4P*3=I:7?W*_P#D8TLP<DKQULO2[M_F?T;5
MX5'^TG\&UU7Q5I6KZL=(_P"$-U*PTC4KC5();"U%YJ?E?98X9[A$BG,K31QJ
M8F<>8P3[Q /\_7PL^)G[0W[3'BCX&? J]^+/B:'PMJ/B[XF^'F\3Z-=BTO\
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M_96\9_M3Q^$K=-:T3QE?Z=:>&5NQ)9?:-/M'DM[F2XDD2<HIC FB$89MWR
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MC[P!XYM_#W]H:7I=YXM.DI'H-E<ZPT,=OYLTL\<S1^9/'')+#!+''(2C,&!
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MND!!&11;J%^@4444 %%%% !1110 5\]_#G_DO7Q(_P"X/_Z3M7T)7SW\.?\
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M3Y84U&SN?#LD4EK,LDD,D1D8QXE)B.\._ )R,.7_ ()Y? N7]AH_L!/=ZO\
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M4 %%%% !1110 4444 %%%% !1110 5WFB_\ (-C_ .!?S-<'7>:+_P @V/\
MX%_,TI%1-2BBBH*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^>_AS_P EZ^)'_<'_ /2=
MJ^A*^>_AS_R7KXD?]P?_ -)VJX[2]/U1$]X^OZ,^A****@L__];^^Z^_X\IO
M]QOY5YS7HU]_QY3?[C?RKSFKB3(****9(4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %<QJ/Q_P#A)X)O'\,>)]6^RWUKCS8OL\S[=XWK\R(5.58'
M@UT]=YHO_(-C_P"!?S-&G4->AX?_ ,-4_ 7_ *#W_DK<?_&Z/^&J?@+_ -![
M_P E;C_XW7T)12O#L_O_ . .T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^
MO_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X
M:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\
M;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2
MMQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]
M_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!
M?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_P
MU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@G
MSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^
M[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "
MT^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_
M / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447A
MV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"
M447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^
M-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)
M6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>
M_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^
MO_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X
M:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\
M;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2
MMQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]
M_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!
M?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_P
MU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@G
MSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "T^Z^
M[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_ / "
MT^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447AV?W_
M / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"447A
MV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^-U]"
M447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)6X_^
M-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>_P#)
M6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^ O_0>
M_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X:I^
MO_0>_P#)6X_^-U]"447AV?W_ / "T^Z^[_@GSW_PU3\!?^@]_P"2MQ_\;H_X
M:I^ O_0>_P#)6X_^-UG_  P_:&_X6/\ M$_%#X!_V1]C_P"%;?V)_IWVCS/M
MO]L6S7/^J\M?*\K;M^^^_.?EZ5]*4E*#V3^__@'7CLOQ6#J*EB$HR<832W]V
MI"-2#T;WA*+MNKV=FFCY[_X:I^ O_0>_\E;C_P"-T?\ #5/P%_Z#W_DK<?\
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MRHSGDC]:]KHH<E:R0*+O>3"BBBH+/__7_ONOO^/*;_<;^5><UZ;(@DC:-NC
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%4-4U72]#TZ?6-:N8
MK.TMD,DT\[B..-%Y+,S$!0!U).*!QBY-)+4_.;]F+_E(C^U#_P!R3_Z;)*_2
MBOS"_9RUW1-(_P""@O[3NHZK>06MO*_@6-)99%1&>;3I%C4,2 2[$!0.23@5
M^GM9T]OF_P SZ_CB+6846UI]7PG_ *B4 HHHK0^/"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#__T?[^**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \5\<
M?M$_!CX;?$SPW\'?&VNQ6'B3Q<672;)TD9IRAQ]]5*)D_*N]EW-PN3Q7X1_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+/ DGA'Q'XI_LGQ+9IJNCZ9K&@:;/>6>J?9IP421)(Q"[+M+I*58_=(^D_\
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M_BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%%%24%%%% !1110 4444 %%%% !1110 4444 ?_U_[^**** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN?$8&I1@IS:UZ=3IPV84J\W"FGIUMI_6O^1]66]O;VD*VUJBQ1H,*B *H'H
M.!4U%%<9W!1110!__]'^_BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 1N<9+$DFOMBBB6*K-W<W][\O\E]R[!'"4(JRIK[EY_YO[WW/S-^,7_!'?\
MX)R?'GP!X*^&GQ,^&\-YIGP\TZ/2/#[Q7]];W=II\7W;<W45PMQ+$,GY9I'P
M6)&&)-?>_P +_AGX'^#'PZT3X3?#.P72_#WARRAT[3;-7>18+:W4)'&&D9G(
F50 "S$^]=W143K5)+EE)M>I<*%.$G*$4F^R"BBBLS4**** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>soph-20251231_g10.jpg
<TEXT>
begin 644 soph-20251231_g10.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_X@'824-#7U!23T9)3$4  0$   '(
M  0P  !M;G1R4D="(%A96B 'X  !  $       !A8W-P
M                     0  ]M8  0    #3+0
M                                              ED97-C    \
M "1R6%E:   !%    !1G6%E:   !*    !1B6%E:   !/    !1W='!T   !
M4    !1R5%)#   !9    "AG5%)#   !9    "AB5%)#   !9    "AC<')T
M   !C    #QM;'5C          $    ,96Y54P    @    < ', 4@!' $)8
M65H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M     "2@   /A   ML]865H@        ]M8  0    #3+7!A<F$       0
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M,U=VA9BTUB,D07>6V/ R48BVN,$E)T)A@28X8G%RH?_$ !P! 0 " P$! 0
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MEKFI;UA3;?8+\08]3"QLMC<^XY7/:ZL=RW)V)WA?;?KCZ#J=1-QJ=T/URO*
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M<.-[N_\ 1^S_ &K&_::=CW"_Z04_[-E?^,3Z50^(S[? 1 1 1 1 1 1 1 1
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MX\K_ *>WYD=_X/W;B?\ 4T_/C]TOKC_2 I+^U:"?'P=XYOW'E?\ 3V_,CO\
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M?DO3_P!UIEG11EZ B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M B B B B B B B B B B B B<RP_-#'ZD;^#@8O[$_F^43)/9#\_R&9N(9-
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M&MR!J2GKU"@M*5F;Q'5@9MZV-1B9-JU6)58:Z;'Z=MCA$K?BIXN[D(J'PBQ
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M1GZ+=7BH]MM5M61TD!9[4K)#JJ@$LP5BX4;LQ3906(!P;1+K?ZN[.R/7+6.
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M5':!N=@3XR!XAO&PW)V&Y\9V[3MXMS[T]D>3V B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M+CCC(]1D7ACR>=EQQQQR:;SEGSQQQQSEV +,=@22 -@"2=AY!OXA[P@ #?8
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M$0$0$0$0$0$0$0$0$0$0$3,D?SOY_6J[\90(C[/\Z_W24>P_,W]\PT2R* B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M88@=@+!-R =@3V21?%PCTR;[# 0]3WOC_A)NG[_Q?QCQ<(],F^PP#J>]\?\
M".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7
M\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)
MOL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?
M'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q
M?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],
MF^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]
M\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[
M_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7
M"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL,
MZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".
MG[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ
M<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP
M#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\
M".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7
M\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)
MOL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?
M'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q
M?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],
MF^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]
M\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[
M_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7
M"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL,
MZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".
MG[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ
M<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP
M#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\
M".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7
M\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)
MOL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?
M'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q
M?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],
MF^PP#J>]\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]
M\?\ ".G[_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[
M_P 7\8\7"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7
M"/3)OL, ZGO?'_".G[_Q?QCQ<(],F^PP#J>]\?\ ".G[_P 7\8\7"/3)OL,
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M[I_.OS8Z[^1?,?3'FURKU/C_ +E<?C4.]:_=/YU^;'7?R+YCZ8\VN5>I\?\
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MZNKDM-(1-S:W(B#U:Y<K/)2I$I)JA0:647GGQDJL[*B*SN[!41069F8[*JJ
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MF]P^+3@9#49.6V9B8[7M;:E:XN051G:JM .:':L@'JOTRXYEP0!TQ!],GS2
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MS T[KWG%SJK;0QZ8R*S55<Y1B$-;'E6OA!!V,1MN Q]Q^ZG(OT'4-2Z&.,O
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M_K.B.S #<<NPE?\ 6  .T6+W2Z-F92X>/F![G)6O>JY$L8;^"CO6JDG;P=R
M_8$+$B<F[=6'0]FV'RU=5W7W6VRYLGK,]"V0F>/$=3V,K<\64B$'2QIC:U@Q
M??"_.34HXQ79MR!S)4MS@O2K4JD@K%>Y[5GPN_QB[8W2-X+6U*YI"\^J*V</
MP*^$.SDR[,H(()];NCT=,[U/.5OD]48Y"U7,@O+<.D;%0ISY^">WBK;AF!!
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MQU5B-4[UN.+UNR.NX/%D)5AN"0=B"-P2/(9MJW2U$MK;DEB*Z,-P&1P&5MB
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MU"@4*U+8UF%YJI$U)$[:2GXP8G1$A6'KC&A,HSTVJ'%SNYO&U&O!Q<*ZO.-
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M$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$E"H/GS(^QZ_\
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MG9$=Y]#S[-97Y+O_ 'O"G!_1#^PN+^5*/W3-GSPA]DGQN B B B B B B B
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M?_<,3_W1ZAZU_4^J?]OR_P#TQ^]I=1S^@!NS_NJ7K_R&'JYHO]<:7_W#$_\
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MS^@!NS_NJ7K_ ,AAZN:+_7&E_P#<,3_W1ZAZU_4^J?\ ;\O_ -,?O:74<_H
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M97P5^='^5/<__6N-Y[/F1^_6]*C^G#2?OF\_$H?Y+]T']597P5^='^5/<_\
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M"$24\W!*B3*%:C+'@E,0:=G@7EG6C6NE:#=['5$!( +.0J@DD ;DCM) 'C)
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ME)QR,//-RXP+PXYYRY[ [*NM[76NM2]CD*B*-V9CX@![9/M"< [I6C66,$1
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M.7!*8@DG# O'<HJHJHHV5%55!))"J  "6))V ':22?&23-,S,[,['=G8LQV
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M%G<SH=V39F6X"69%MK76,]V2R/8S<F9J3<:2"?&O3X;=G';LEHEVE^L3A?\
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MM1FO<%*DVNB(ED:>LSY,RSX*([GPIUO4=\+C>$737=\!!301C%R"0":B;0
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M75 S.M2D !%9P&.VVY[ -_%OVL=J U<V,!$!$FYQ^8:;ZFC_ ">(X9OJ]O\
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MD,[,7/82!X7@@^#M/[4W3_T\I"@9MJW7%&QUKH2R'-X>9U7+X[2R<MLG='Y
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M?&X"("("("("("("("("("("("(")]=OIV?0T="?M)M3OT(U\/SKK/V<U?\
M*FH?O5T_16C?8/2/R7I_[K3+.BC+T!$!$!$!$!$!$!$!$!$!$!$!$!$S-%\P
M<OK9;^.H&*?5Z_QE?[2SVSZVM_%6_LM*(;62R10+5W9*=1!S.9)9"Z#N*61A
MY3EISCVB11RO)$\,KF02K)4)33D#DC3*RRU*<]/GF5CB<2:7SEAE]!Q46S)Q
MT<<D>^I&':-U:Q0PW&Q[02.P@SYADLR8][J=F2FUE/9V,J,0>WL[" >WLG5.
MK[?#J6ZS:7ZB]3.R]JT6R=$77::ZOKAUYG%4PB//,5;4\VL.,EOD0LB+HDKZ
MN6JFJMW52FS,):T+,^.;66NC\M;^562;JK,#3<G-R],JQ#C7TU"RG)2YV5SP
MK?B]3DJ!O8H/C+*&V>L[;\XF9GX^)C:A9DC(IML*6T/4BLHY.O);%'(G:L[>
M(*Q7=7&^VSK9SKQ0.A;PN*MH5K=.;MKC6=YC,?V.N!DL"(1(J$/$@<>&Q0W0
MJ$/R,]TLA4R+^%+4Y8%.L:P*=VYSP-,)9$Y#^JUF+H5F113:^2E%F2K-C4M6
M[FQ5&X-CJ0M08;%>Q]U(/LMU&PR-82BVU$QWNKQV5<BT.J<&8[;(C#>P@]A[
M5 (/^J QBF"]5C;BP>K@Z:[P6B)-/-:5E<0T]GB"!P@K4M:8++YW7W"'=1=)
MU<5RE:J%'027)7$JL\G4HWE"_(,C.XNJ8PW&6S2\2O2!DO>J9(L?=B'(:Q*[
M-\$*'X!Q8A'5V/A*1OQ,C34<FS4S0E+/CFM-E!0<4=Z]LLMQY%.#@]/?Q,/;
M$SCSP15)]T<,K=KU.%VK)=]I=<E&U?$\BI!6,[5G8)L'I+3^:'*4+(!QD9@Y
MY2;%\+58L&9:C-EQ?S2HSG'Z@6BCD<A!E=[G)&)TWWZ8[>)NW""SVN'';EV<
MBOAS+U:KZNPH<XW6&/WSS4>&?;%6W+I^WRY \?\ 5Y'C)@)ZOTMLO:*?T!JA
MH]<&S4'IRR454W#>K#+V6(16(2LQX5,CH8W-CG'W0E\9&=8WN?)K@LD<?4+$
MK4N<D;>8T\M[@OB]2$JQ:\C+S:<9[JC;30R,[N@ 8;D,.+,"NP"MVL 2#N!+
MZIM9DO1C8EN0E5@KMN5PJHW(J=@5(91L>TLN^Q(&VQ.O[7+JA;@;'Q'JK,M\
M4G:C74E5P[:AP)F->3>!UU,=6T, KFP75'2*25L4'S<GBSC.6?AM9+/6D/6+
M0_MOA<YK7)..41M_)TS$QWTHX]])NM?%'"Q++$RC996#>49]A5V[M4./)3QW
M![92HU#*O741=58*ZTR3R1TK?&"5V$5!@A)L[-EL(.S#EL1V28J7ZK[#KUI]
MT^ZGIFCMA]N]B-B:ZET@K^II-:*"167E#HG+YPA<'Z<VKS">,''GG.-2'B-I
M&R"9D-D6BSB2[*VQ(PI5CO#=I39&7J%UU^-B8^/:JV7+65JYNJ$+75S[/9+R
M)<$NXXABQ"S5:D*<7"KJIORK[ZW-=36AK.",X+/;P[?8MQ 3L52"0%!,DN7R
M0#56-!T==,:UOM:5R&S=@'K6N=4LWN[<19=<6>QM3,Z&,S0@-:,T]@*'DM_:
M28VF+,BI[BI5]X+<6IV2KFU)&-!M[XOH;)I1:L=<E+R#TK*F+ ,3O]+ XMS)
MY<0-QR!!.9UJOH4W+18[67&AZ01U*[% /$#CX9/(<1X.Y.QV((%R>GIU(CMX
M)=L?5LVU^E>LURZT26-LTUK:7RM%+7 UNE?#_BUN.*U+'XURF6IE$<6%/#;@
M@6HT>"UF4(WIR)<<<B:>H:=WBN-:F0F33DHS):BE1NG'<;%F["&'$[@G9@5'
M'MM8.?WV^16]#8]N.RAD9@Q(;EL?8KL1Q.XV(&XV8[S9\-9-A 1 1 1)(K[^
M=_ZA_?1S^N_T7_C_ .#.H[F_Z;_RW^//.Z?-!7]5Y_!P-,OB'X!\DZ%O&?PG
MY9Z ]GD!$!$!$!$!$!$!$!$!$!$!$!$YEA^:&/U(W\' Q?V)_-\HF2>R'Y_D
M,\LB_CI7UKA^6/'B>(_A_N$]?QC\']YG5 ZO^\NS-,;ZU90CWM3..G]J*_U2
MEE#'L/!Z&3W3C,;+,7N!2U#)N##4[I@R1XY.C;W1BC*A0L;4IR1U?F%R;Y,V
MN#1]![G-*P,K2+\M,"K5]13(-;8=N6<7IT[+L4["O)P2RO8 &.ZJZM60WS[N
MCU7.QM6HPWU"W1].?'%B9M6&,KJ7[MN'[0X1" K)620-F="MBLEK9_U9E>IE
M1:<500YLW4SVPV!KUUFC;+:C?X/1U;3.'L*E[X5SIPDZTM\C$?SRY9W6/I4*
M-I(X<WB'R@YV1PU=PC8E&OI[GAJ&3J>00^AZ?AW+4U>2EN7?58X7:I47@[CP
ME<DL>*VUA6M&[C87=T)T_&TW'Y)KFHYE+6K9C/3B46UH7WM:P\JZ_8L@ 39F
MJL+"H[)*;;@=2MSVPK?I%WUKU*;9HY!974'C=4W'7K7-GB/N!;@P2J(MLHKV
M9*HFX-S;-HRH(6%."+!<3F@=6-Y2F.#.VKSU[2CV>FZ&NGW=T6)F5XV6:-'?
M(QKFJ5QQ>NUJ[JA8K-58"-CL=U=3Q9@%8ZW4M<;4*.YW+P[,C$%^L5X^32MK
MHP9+*ULIM-95;:R"&&XXLC#DJL646=N/Y(4JZK;LL^+L^M\^GNN5$6RWTO=>
MRS;/8HT\1F9GO6; ZFQ.IUJ ^13V/,KH0J3'O*-]:N#^2"3"TV!#JR'.=#&[
MCK[\6BQLVFG-R\=LG%P6IL;J5A>:BS(#!*G9=B%*-MN1ONK<;V3W848^5D5K
MA7786)D#%RLY;JUZ=I;@W3QR"]R(P(+!UWV'9LR%IGG76+?W;;6=:K:@:46Y
MN,93#_$XS>UEPN7LD,BE>NTI<RVK@E#X687E,]E-*SE<C7JGQWA:3E3'Y2J3
M'G1^/K7\5J>YI%TZK4-2U3&TWOE+'Q*+:VLLN6M2W;Q="A8;$!%M.SU@CFX2
M6K>Z1VU&W TW2\C4N]7KKR[ZK%JKI:Q@NPY(P;B>08NU0W2P@FM"\I7'NJ9N
MQ-^HGO9K5)=>K&/H*MX&X,AT8BDMK^(3+72/HH7@<JO918:2&*)(]9V&G_\
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M&NR5NR'Z=[*[69 I4! 6 K I) [/$C.+,*NOG6R+2ZV-HG#72?LED:^WM'*
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M?JI?X^(1/<G_ /$V_P"N3?R7 VFA_5;_ ,6O[4TG=']0QOQK_L2+ATDY* B
MB B B B B B B B B B B B3<X_,--]31_D\1PS?5[?[=G[9GTBOZWI_%U_L
M"8B/8@(@(@(@(@(@(@(@(@(@(@(@(@(F5<?.JL^QKI^*J'M'UW1^/I_;2897
MUCE?[-D?^-Y"HZ^<% 1 1 1 1 1 1 1 1 1 1 1 1 1):@?S'4_9([_A48YS
M6/KFO\0O_DMG6Z#]9V_[2_\ XJ9PHI39P$0$0$0$0$0$0$0$0$0$0$0$0$3(
MHY_&%'U''\?@1V>U^?\ NDE?M_F_OG&.GS05_5>?P<#-?$/P#Y)@WC/X3\L]
M >SR B B B B B B B B B B B B<RP_-#'ZD;^#@8O[$_F^43)/9#\_R&9N
M(9- 1 1 1.KI\EK_ $..E?MV:X_03LB.\^AY]FLK\EW_ +WA3@_HA_87%_*E
M'[IFSYX0^R3XW 1 1 1 1 1 1 1 1 1 1 1 1 1/KM].SZ&CH3]I-J=^A&OA
M^==9^SFK_E34/WJZ?HK1OL'I'Y+T_P#=:99T49>@(@(@(@(@(@(@(@(@(@(@
M(@(@(F9HOF#E];+?QU Q3ZO7^,K_ &EGMGUM;^*M_9:08.ZGS: B B B B B
M B B B B B B B B217W\[_U#^^CG]=_HO\ Q_\ !G4=S?\ 3?\ EO\ 'GG=
M/F@K^J\_@X&F7Q#\ ^2="WC/X3\L] >SR B B B B B B B B B B B B<RP
M_-#'ZD;^#@8O[$_F^43)/9#\_P AGED7\=*^M</RQX\3Q'\/]PGK^,?@_O,X
M$9S" B B B B B B B B B B B B>4C_ #Y/U4O\?$(GN3_^)M_UR;^2X&TT
M/ZK?^+7]J:3NC^H8WXU_V)%PZ2<E 1 1 1 1 1 1 1 1 1 1 1 1 1)N<?F&
MF^IH_P GB.&;ZO;_ &[/VS/I%?UO3^+K_8$Q$>Q 1 1 1 1 1 1 1 1 1 1
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M<?H)V1'>?0\^S65^2[_WO"G!_1#^PN+^5*/W3-GSPA]DGQN B B B B B B
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M=G9MBZ@ LP!R]7LW3=9[H6[VS-2QJ+*6*#(<48-*AN;@,MJISY#945>01F)
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MIB4FD#8A,5HDRHB1MQ>*9]P6O.#FS&-JO5WZ&P%%M&71D59&8F([U E:;+;
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M[.:O^5-0_>KI^BM&^P>D?DO3_P!UIEG11EZ B B B B B B B B B B B B
MB9FB^8.7ULM_'4#%/J]?XRO]I9[9];6_BK?V6D&#NI\V@(@(@(@(@(@(@(@(
M@(@(@(@(@(DD5]_._P#4/[Z.?UW^B_\ '_P9U'<W_3?^6_QYYW3YH*_JO/X.
M!IE\0_ /DG0MXS^$_+/0'L\@(@(@(@(@(@(@(@(@(@(@(@(G,L/S0Q^I&_@X
M&+^Q/YOE$R3V0_/\AGED7\=*^M</RQX\3Q'\/]PGK^,?@_O,X$9S" B B B
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MGR6O]#CI7[=FN/T$[(CO/H>?9K*_)=_[WA3@_HA_87%_*E'[IFSYX0^R3XW
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M.69*A.H)SP-(/*SS*-*SQ,+RRPRXYY](()!!!!(((V(([""#V@@]A!\4\!!
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M:MU;JCOXA7 V^%+ZX(<VAO)BV$G?'&T$*2,5\X.<"/@C2P2!.<N[Y:G=3O\
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MHV5(Z$LR_%-)D:?7?;0E6117D686*U6*$<&QAC(S<K%05)980Q4,Q+G8L5Y
MF.C.LHJO>VBZRBO,R%LR.:$(IO*CBA<V.B;@,0H"C?B#Q.UW[PZD+[6UG[&5
M56&I-PW^ZZO0N#V9:<CB$HK:,0YJ@$QAJN;<.1#K,9"VKG21DM;>Y\,\,C[2
M]O<CX:710FQ2)TQ>:BG1IRV58]MN73CC*L>JI72UG-B.$VV12 NY7=V957<
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MCGP7D?B@2'*N2<3.<<^"^3>"N<.,^<,^,.<NVYQR['8YJ(O-U7?;DRKOY.1
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M166MG<"@L[D^T*9\/D3! L8=%I:LB[$SK)=(&^/KEZ#C!M2-S&XK&!V.5.:
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M%=&W(1\+$Q@&#T69+N2!P(N-7'B0Q)(Z9Y;J -QL3V[7*Z'3+R;R5X75XZ*
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M.W PDQKFK:Q;\RTFLLR<<C,OR$ +*C;A+5##CL&! + !C<\:R;* B B B B
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MOV_S?WSC'3YH*_JO/X.!FOB'X!\DP;QG\)^6>@/9Y 1 1 1 1 1 1 1 1 1
M1 1 1.98?FAC]2-_!P,7]B?S?*)DGLA^?Y#,W$,F@(@(@(G5T^2U_H<=*_;L
MUQ^@G9$=Y]#S[-97Y+O_ 'O"G!_1#^PN+^5*/W3-GSPA]DGQN B B B B B
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MR?T%OS(_<T[&_P"@"[/[*IW\0AW]A?=F+_U%7SX[RS/N3)_06_,C]S3L;_H
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M@ =OD[>R8IW _P!!-]KS\@]B.X'^@F^UY^0(CN!_H)OM>?D"([@?Z";[7GY
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M>X*NI2(N3VFC+=*K;L")UQ''"2+$#DZ(X^B?)B[LS8J>U38S/#BF:B%1B\]
MU.2PI/DG0JC"K&/BY68YJQ,;(RK%0V-7CTV7N$!52Y2I68(&95+$; LH)W(W
MKY&5BX:"W+R<?%K9Q6MF1=70A<AF"![652Y568*#N0K$#8':N_[Y;TX_Z?\
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M$_\ ='[Y;TX_Z?\ I-_O5T5_SX'J'K7]3ZI_V_+_ /3'JYHO]<:7_P!PQ/\
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M_P"HJ^?'AEG]56WW<E_Q0[TR_N;(_0V?-CO["^[,7_J*OGQX99_55M]W)?\
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MP.X3('II7*.<<L^"$;BC4G<X8?+RRX*).SSYQQX^7EEQCV,?^WG@>%'4;LK
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M!:SJ+7:I7PDM].=.-48E;?37V0J&DJ-J6U([N4X5')G?7ZO,ZQA,C:LZMO\
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M<V]-RM3JU?0VR-2R,NO6<!K[J;-DIJ8TVV(*JE/34H5KW=55GV?EV-L.U0.
MGT. B B B B B B7 JWYQ&+_ &G^>7 :W(^K/_N_LK+E7U-?S_M&2 (9) 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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M9=A,[^Z?7,GI=;/9NAD)DU;48J%+JP51@4H4D ,P*,36P)YJVYE,MF=GKJW
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MP7;/AUFK&/3J^EUE.F5V->S^!X.]@9O;WW[9,<#$*Y"&K=<IQ9>.I;],</U
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M)C&[.V/<V1[N.4XRF9O6,S<6#EUS9E?#,_R)UCL?X2\OCIEP5%&EC3J>^O\
MK11_!*?N4%N5??513;9RJQ@RTKQ0< W'D.2J&;?BOLRVVW9MVR6O&IJLNMK3
MC9>0;6Y.W,KOMV,Q5=N1[%"CM]X2PXKR> B B B B B217W\[_U#^^CG]=_H
MO_'_ ,&=1W-_TW_EO\>5WG_SYR'[(9_DRQ2H^I)^ _*9N[/9M^&:U;4Z7NB%
MUW:5L-9FO49DMJ=_-KHYNYCQ+6YDDKHSXDX-KC+H6TR!!#)4M(P(+*4GOS"O
MR=B,<$[UX23E$E%[S'U[5L7%.'1FV5X^S*J\:V:M6WW%=K(;:QVG8(XXDDIQ
M/;-'D=S^D9>7W[?A5V9&ZLS%[52QE[%:VI7%5A'B)=#R'8_(  9LY:!ZDNZK
M9):X5-P>IV[3-"/88S&=641Q8*9A.4*&HK@I-,22HEPD-5'Y]M!L(SF?V_:J
M<CL<,,<8EU?44&$JY&PTXL<,=*@]$N &/;439N /JO/;VMI,VC::QSBV-N=2
M"#-^G7CK!"2OBM'2V)/U'I[^WO/$IZ?NHJMTI-Z45)P8YZZU>Z4S3:GQ\LW'
MQ/K5ZB[G#'.-\DX3/%/(>%,:>7)M\+RHI\?B>^>_$[H4O*(5%!K&HA<I.^/!
MS;URLD=*CZ9>EBVJ^_2W39T5N-91#ML5*[B>'1M-+8KG&\+"QVQ<4];(^E4-
M6U35[=79]ZV9>5@=QON&# $<*V]-W2YH@E%UHWTSWO"=:[&4VS2C+YHEKF^)
M=@*Y!Q*5#_X2/G1KO(^Z/V/"[P5+%[\R8=CO7!MQ1?\ 5QFVMZFUN5>V5O;F
MT#'RFZ...K2$Z83B*N*>!V<JPC^WRW[9BNAZ6M.'0N+M5@7G(Q$Z^0>E<;.H
M7Y&[E9N_A<;"Z>UQV[),U9:OT93EHW-=%<0?Q<LO8-R9W>WI)XRS!W\;G%@Y
M=,FE1X&?9 YL#!WIR].7/<HPU,I"COG_ *T4=W$CN56_/R\FC%QK[>=&&K+C
M)PK7IJ_'D.2(KOOP7ZHS$;=FVYWM8^GXF+D96513POS65LFSJ6MU63EQ/%W9
M$VY-V5J@._:#L-I]%27("("("("("("(")*%0?/F1]CU_P"3P%?)^I?[P_OD
MM/LQ^ SD+K^>IO\ ]7TGYQ=1YB_4V_MG]E9[?[,?V1\IFIK8;I9Z&;2V5E;U
MW4&TR:QEN+:0[R5MEL^A:J3%LZ,M$WER1+"I5'D#^H3-R1*AQ<'!(>[>#$"-
MNY7<MZ,E,7T.'K^KX%'>V+ELE Y%:VKIM%?([DH;:W9 6)/$$+R8MQY'><_F
M]S^CZA?WSEX:V7GB&L6RZHV<1L!8*K$5R% ')@6XJ%Y<1M)A9]*]7X];E8WG
M'JE:6"S*9JDJD*Q>6-YE3.T1"K",9%B3$F^%MS\F@YR8KB62#C!Q7QQ8\X^$
M<N>''LIT?*>LVIY[XU^(^0ST960<J]76MFLR#PWL:UD-H/TM/!5PO@^Q[3O:
M72M/3)Q\Q,94R,7'&)CNCV*M6..IM6M2N*2!U7\)JRWA>R[!M%:7I@Z-(J6B
MNO":C^YT]";;)O6,1#S2K?S\&6HG:U;,5*?& R?YRE;VK:N5)O ;@]JXYEW7
MNV;1DH++-PL'7=5.59FG*_SFW'.)99T,;PL<L&-?#H],>$H/,(']KEL2)7&@
M:2,2O"&)_FM62,NNKKY/@Y 4H+.?6ZA\%B.#.4[=^._;,U=-!=2GE9LFO<JG
M[Y5[>)VE)L0;X]643YH2=C.4*&LON:>9%%1/O4Y6HSYS@^$9S/[IVJG([''#
MC&)=7U%!A*N1L-.+'#'2H/1+@!CVU$V;@#ZKSV]K:2MH^FN<\MC;G4PHS?IU
MXZX0DKXK1T]B3]1Z>_M[SD&C1K5IBF6O%@-57=ZR[5*#95M03OX[6(?XA0K-
MC6QS)E[P4RTYLE/99G%8C\(S1%(W;CNW?'"[A664?ABVJY[U9E+9&]>H6]?+
M7I4CK6AP_/<5AJ_"4'C447LVVV[)ZNDZ>EN%<N/M;IU/0PVZMYZ-7 IPXFTK
M9X+$<K0[=N^^^QELL<L<N.,L<N,L>?\ )ECSQSQS_P#XYX[/'(U\V4_H1 1
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M<+4$%6SJ2K[H2P]D3L-JM6@Z33AWX%>&JXN3Q-Z=2TO:48.A:TV&W=& 9 '
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M\N UN1]6?_=_967*OJ:_G_:,D 0R2 B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M<YM?EY&F6*&JU3"R<<[[;I=34V5C6J=CX:74J%':#R[0=A-2HZ*<] 1 1 1
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MJ7(Q2;@E]Q\&G#R=-O&13GX.H778%SI796$YA<>]2+T5E94R!;39LI)4, H
M)\R<^[-Q=4QSCWZ=GZ=13GTK99587X<\C'8-18R,COCFF^ODP 8KNQ) VFUI
M-$=DUS +%;L,2V^?0F*S1"7@9W7 M'*6) ^)<,3>QCW3' A?ACB9VN/;\<<9
M=CCL]@:"^HT7W4GQTVV5'\-;E#\8G0T6B^BF]?8W55VCV^RQ X[?P&9L(I+
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MZS1I2JS-,7>9O6DT4F4^C7F'&G9F*6FHWR#,_!W.?.2A,@3J#.<SC3#<X-1
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MC"#5*E]7$GY(>,]/IP[]/U4V8S-E8N,,BK(-[A5!OIJX"A0JD[.Q+N[CM "
MC>8:C=FT:EI(JRE7$RLDX]V,**RSD8]]O,WL68#=% 1$0@C<N0>,Y*^-[7ZJ
MKIG5#5SK!:U^3BOZ<C-Z/YT-D$"C4<00)Z=)FV.1BYYFCZT<8/J R(<\,L=;
M4SL\RQ0X\DMB,HAJ<U9&.)I*9&+3EW9^/B579-F*@M2YW-RBHJ M2-X#=3PW
M8JM87=B2R@Y9FKOCY5N'1I^1F74XM>6YJ>FNM:6:U6+/:Z[.#5X"*&:PMLH
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MF?4MRVR_2%J^F>#V>$I/@\NSM\?9)+K+4BQX7L?8%P.CW"5$:E>D5%:UMR%
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MVW'89-@ FEKB"O?-UN0 ?&$L;Z5O[YJ"$_AFP$4)=@(@(@(@(@(DD5]_._\
M4/[Z.?UW^B_\?_!G4=S?]-_Y;_'E=Y_\^<A^R&?Y,L4J/J2?@/RF;NSV;?AF
MJ"I?-1JFX=_:9KF/0]QL:365%-L:6+LE[D,8KN3Q&YXK$X5,4CI(HO%Y<[MB
MB+V-5=A&N!*!@=5?)TABYYR<E&[\J4_0Y'>^1C:1DW/8M-=%FGY701++J[,:
MRRVHJEEE:L+*<BG8LZCP+-MRNQY[&[XQ\K6<6BNIK[+Z]1Q>N[UT65Y5==5H
M9ZZ[64UWX]Y8*C'PZ_$'W& ZU4CU&->*%NJ!-C7I>;8CY/[$MBIW<ZPKMD\2
MYE=M7"IG4K8)^VY51 W5*P,<:?'U)'G6/N:U>O?$S3X2;4J U6:7-G96BYN7
MBW,VIBE*:<?(44XM=G3Q\;I5O2W?%JEWL5"ZNH 0MQ8L!(<'$US"P\NE5THW
MO==DXS&[+LJZF3E&ZU+E[WI8(E;N*V1BQ<+R4*3MEVW5*;PVU=NOLUJ)@U3S
MA&N=F)[7CN=CVK;L<E4M>E]8R:"OK&]-,8I&8M#*UI5DM<5;2X(7]S5JDR!%
MRL1I#5)Y)$>G96EXV+F59+ZAU<V@X[]#'QGKK07I:CJUF76SL16 RE% ).Q(
M )EU+$U;)R\*W&33NC@WC(KZ^1DI98YHLI=76O$L5%!L)4AV)"C<*20)?8-=
MK,QVKM_860KH*F:K0U/JFERV-F=Y O<&NP(C(K'?I*ISY71AM3&P[+F9H4[&
MZXJ>7M;PF5YKX\V=H3PHKOFT>I^-AH+BV/J-^47944-38E*H.RQB+?I9+KMP
M&XV=NW:TF%?ZHY&:YI"WZ=CXO!6=F6ZJR^RP]M:@U?35"-OS.QY(O9O D T7
MMN*TGTQ*V<)%71SYI98L?E]I*T3M)C&E_;6JKK(A*DB 'GQ%.L=5V;K,&Q00
M7(D,53Y-Y"XTQ24I*3I%5N[5L:S*UVY4O":I2]>."M?)&:^FT&X"PA1QK8'@
M;#N0-MMR*=.DY->)H-#/07TN^NW((:SBZKCY%)%)-8+'E:I =:QQ#'<$ 'B8
M?H/<$>U0TPHE9):V-ENNFYT3V*FSDF=Y1E''6$L-]6-:2QKBRLV'E.:V4F1^
M7MJ-,A=FAD:<W@A<G-?"412=P4^V:OC/J&IY82_IYNF6X52E:^:VOB4XX:P=
M4J*P];$E6=N)!"$[J,*M'RDTW2\,V4&W!U2K-M8-9TVJKS;LDK634&-A2Q0
MRHO,$%P-F.&;B498T8SW]=F]8QN:OJ/(M5-4J58V-2[GR-M>S8U-*ZL1VFI*
MAC3M+0Q,D/DDCFW?C>[/7!L<C#SDOP;57"5,IETW+IL&CH0ZC1#J&H93N%",
MG.J^E:B'+,[VUI5LRIL]B\>0W(BU+#OK.LN"C'7!IVG8J(7-BN:[:+VM!0*J
M)58]VZL_TNMRP4[ [EVUO2-+<@:F\G%,@;$25O1)\/\ V"$B(@M,F)P__M*)
M+PPQ_P#VQX',LQ9BS'=F)8D^,DG<D_A,ZA5"JJJ-E4!0/( -@/S 3W1Y/8"(
M"("(")*%0?/F1]CU_P"3P%?)^I?[P_ODM/LQ^ SD+K^>IO\ ]7TGYQ=1YB_4
MV_MG]E9[?[,?V1\IFI>;)WVM^H5&)<A3)B6_9S5IWI:-/*LA8I8DEST))IC;
M43:Y60CR3'8II#!)[8"]">G5EJU*:"NS>7D2;FC,'15%;]&LK)).!GKE.H(#
MG%RZZ\>QJR=QNEU-((((!N5NT SG[0]&M5VJ!QS]/?%1R"4&5AV6Y-:V ;'9
MZ;KV4@[D4LO9V&1Y5^IM\3:_ZZN39B(ZN5JQTRS6,H8(/K+E*W JU;;M6+&U
M_*[5L)VE$-A*AL;FZ"KI"T1.)XE2AX)52QT7O$O49-Z$M1-?J.)5AWXV#9GW
MOE/0'MSNF#CXV/9UJ\>E:[;0S-<$:RSZ6I%:JM8Y':''T[,MS:,K/KT_'3%2
M\I3@&UN^,G)KZ-F3>UE5)55I+I77],;>UF:T\5WC6J=#-D4&&KM V]**<>=4
M--;%>+!KY]C;C,CKAMTIE99E&J3C4ZC*Z.-D5A!, :9HL.E#BS2V6<2I4S,9
M*)"V\G+ER:?(U?!/?^7C5Y*ZAJ="4W(ZU#&QRSU693U.+&LMZS5#@K5U],,^
MY8; P8VCYR^I^'E68KZ=I=[W4.C6G*R>"6UXB7(:UKIZ*VDV,EEG4*(%5=RP
M]JG-&-FH^JU2I&T9;3SEJYI-9[C9M:22,.,Q.N.US8VU3!AHQ@G$9<(VW12$
MEUVW3%2ID[@T2N6X2I6R,9*- W=V7+D_F3JV"XU'*QZ\E<_5,=:+T=:AC8_-
MJWRWJ<6-9;UVJ'!6KKZ89]RVP!8ND9Z'3L3(MQ6T_2LALC'LK:TY62:UM3#2
MY&K6NGH+:384LM%A1 JKN6&'5?TNK HJ5F[&U,]5NU;8F[>W#:LC>ETGFV$$
MM'6>X)TM4/-(S!65$5:]F6H8<:V2=AS01)];(]:S3RM3JUR1R/>2),C7J<NO
MO+(6]M/]3L;'1!75U<?.QJ@$RJAU &4VAD?E8C/0VQ *A#'1W/W8EISL9Z%U
M$ZGE9+NUEW1R,#*N)?$M(K)5A5QL0BIUKR%W!(8L+B:%)U4J;=E=B#T1Z5MV
M:V<FL_@9R[#,IQ<*I@D6A-%5X[J$YA99J5')6VJE4Q8R#>.3/ ,F;3L^>,CN
M<,-;JY%;8.$""V#@U4W;;<1D766Y=R@@D$UMD"IS[NMIL]'!L7/S2"%S\^VZ
MG<$,<>FNG#I8@^(6+C&U/_X6*9?@:B;B B B B B B B<@T_-5L^R"+_ (DH
M8O[!O[+?(9ZOC'X1\LMC/_XFW_7)OY+@3:']5O\ Q:_M35]T?U#&_&O^Q-4>
M\"=5!;(TDV;X0GK8Y1NQN42LK-+@88>T5SLO!I%0N<D,+)+---;(S9,LK%\?
M<2\.>]F-"X.9G/!+>9V>TPCSKS<;?9K\;G6#_K68UB9''\+5):J^5B![<X7+
M'"S$R-MUIOXV;>TF0C4<O$=PMCULP\@)]J1+9M']021[V5MLS%8OIQG7521&
MV*FC;5(+FNQOFLAKZTI1!78^3/C<W:^.S&SS)I;X03P4P()"ZLBA8O-)S?L"
M"L%.4M5^GK@VXSOF=2YZ;6*TTE%LJ6P<5)R S(2_LBH8 >Q]J164YK9E>0JX
MO3J6RI0UMH=J[&0EB!0RAP$\08KN?'(QDW3YV;<R+)U8;952F.C=M[;8;/26
M2K'*:EWTPQ)TM1EO>:4&Q0TB,FPM6C?+2:<B&>Q%4]3*6F'.CH4MB[FX%I$I
MDJZAC UY12_OZK$[V50$[W9Q4<=,AGYBP%:CNU8K(9U79P"3(VPL@A\<-3WG
M9E#(8DOU@AL%STA0O AK!LMG4!"D[J3L)+,\T6MJ403JRQAOD5=$N&^'*GS(
MCECM)2T<<[MKI%*BQ\T<PB(J#FCL25B6+<O%A/+^PQF)E7'97F&MA$->;4EF
ME.5LVP=NML%W;;)>[Z7X8W\%@/"*>%N/%VR1\.UDU)0U>^9]2W+;+](6KZ9X
M/9X2D^#R[.WQ]D]J]]';7M"54P]L$AKQ&CKK1/:'6![+>'62$*54]NR"5U%X
MJ\-6"*)N!1\0;U\0<CI O5G(7E*C/0F-S ZG&J$Z;RC-JJ2Y66PFS.Q<D;!2
M!70]K.#NX\,AQQ W4D'=AV;^W8EEC5,K(!7AY&.=RVY>U$52-E/@@J>1.Q V
MV4^US<6TPM%C?>DZYJGZ F)]$JKET&MS!.Z2'(Z1NS]J^VTHC45QB9%BL'=N
M+E2,UP4FR8R(*<(_D6J*2'./.35B?-J8:L MG^?VJ].X7P0N4;R+/#[#P.PX
M\QR[-]NV>KB6!M,)9-L*MTM[6\(MC=$=/P>T<NT\N'@]NV_9*QSC7*?P=_YU
MT>3H_)%^ZW5MRW&3D1A4\JT$<UMIA74-SRPV?*'1A:26Y\\.5/&8;FV-V;LW
M'/4]C!:!\5Y&+.$=E,FMU[X')1A:3WGNP4%LF[K4ITP&.Z\;F?<[':MMU'9O
M7:BRMC0>+',U/OH!22%QZ>C:Q?=0 >52H0"1O8NS'M WHC1S<0$0$0$0$0$0
M$3-[2^<$OZNT_@'%)]=6?V[?E:?1A]:T_BZOV!--_4097G]SVBM*/M"M_==:
MK@I?9PUC;L,C'1WBU*6$R2NR&YJ+PQS,.=%58$S0IO2E89&KE61:$KCNBG'G
MCHM&9._#0[!%SL;*P>9VXK9E4O70S;]@47FHDGV(\+VIHM;1^\AD(I=L#*Q<
M_@OLFKQ+TLO5?*QQQ: !VL?!]N1!M/1>S>U)DNA,-:]2VJC+@AK?$6W8Q:3,
M5VQT(IN;Q](CLZ/QV-*8<NCKP]2] Y2!/&'DB?Q)H;&AZX\+,*ET18JG"SI^
M7@Z?T[;&U!LO&M:PX0Z2X5N34Y-#O8+0ZI6RH;%Z-CLR>"X4[+7U##S]0-M5
M2Z<N)DU+4N<1:<ZG%M0#(1*S4:W:P,XK87U*JMX:%ANW&VWJ)LO"K&N.0:;.
MM*M\2V4H.OJ0G[=;SQ-FMSJM\JR/R*#0JU('E&8U)R)ERFKZ2&M"Z%O9L8X/
M?(_'W+*1'HE#@E2Y8^HX-M&,FIKE&S!R[LJEL9:F7(3(=+;<>[J65FK>Y PM
M06;([KP! )PR=-SZK\I],;%%>?ATXEZY3W*V.^.CTU9%/3KL%NU%A5JG->[I
M6W,@L!@BK0S9'7W&41S3"3TXJB%OZK4_K58:JZ'&9,3]!Y+2D,>:XBMWPXB)
MQV5HI4L7PE^5E/$%=5$;(RDC2QK\)&H;CER5+*-6P<SIOJ=>2+,;4,G.I&*M
M3I;7E6K?9BVFQZS6%M0<;5%AX,XX!MB83H^=A"RO2[,4U96G8V!><MK4>JS%
MJ:BO+J%5=BV%J7(>EC6.HJ'F5) ]*>='RM[.L&EFZ>*&]\I6BM#"]7(&J)>'
MUJLECMIL=DR:.V\B;$:'Q?S.8XZ:[O+6I6R)2:VS4U"J+85!:1.Y)LJ>Z2^B
MG*:D%,K+U8Y]P*HU#8[*2^.6)Y^$_%6 0<JN0+C<J?+NYFC(OQ!<5?$P]']3
MZ2&=<A,E6 3)"A>&Z(6=27/&X@],[!AGU5Q^]Y7M-J;!+W7Q6761IKKO9TPN
M>QX2I>UD2E4SNI<CJ2FEJ?)\C\?5(YK*(! K.F,W:"TF:!C7KLDK:L5MBYN4
MJ(<A\2O3]0MQ!971J>9CUXM%H065UXH.1E \'<&JNZZBNIB=W W8!@P$^.F9
M9J&G4YC5V7Z9A9%N5?47-5EN4PQL4@NB$6V4TY%MJ[%48[*2I4G;(.>G10$0
M$0$0$0$0$0$2X%6_.(Q?[3_/+@-;D?5G_P!W]E9<J^IK^?\ :,D 0R2 B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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M)<@(@(@(@(@(@(@(@(DH5!\^9'V/7_D\!7R?J7^\/[Y+3[,?@,Y"Z_GJ;_\
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M?)[CVV7([6X]F,RVV5A+&K8NJ,56U36S#A8/"4$A@/&/$3)/^7_(()/ 1 1
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M=]5V6#9>(*\.&QW9N6^_9MVV._\ 7W?\@I2] 1'9X_\ ?_ZY_P GW0B/_O\
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MN=V.YFN;&7#]0359>UF7J--F7;;?;8^0[:?DEF?FY4*6 /30+6-EV0<1M$-
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M@$[GC9R4]F_(@=IEH^G@;N3$=>M*Z\DE-U(52K3K/1B%[G[I<TL0W(T=K3+
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MUV6!=]B7!&YD&3EV:GI>K9[N_"C3M,P2FY"#*ZE65GDKOQYI99746VWV0@[
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M:NN\:4;JZ['L?5;"C(JK=<FSUUN %'$V  )L%[> &QVEC(LLJ.I"JQT5%TY
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MKQ\>GETJ*J^?8_3K1.0[>QN(&X[3V'L[3Y9AA>B^E9<+)KC'4G6[FOTTO4V
MFA.=*5T;%4\W6I6]O6RHAA-CN;82^JVUI:VI4XEIL5*AH;D+2=GFW)2$N&??
MV;S-O?>3U"@K-G7LYE!N0A;EOQ!8D#?8,2WC),Q[TQ.'3[VQ^ <N$Z-?$.0
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MYX_3^BD?_P!7+VN=].^BW@OJB)KF2]%G<KEMHQPP0?H8U-<E1US#U,'-&/\
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MZEK5FY-6YY! &/*])^9R:P=,8Y+)>LE2M]=+@V8Y/+FSD:ZR=J3)=B;.2-S
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MLD!+*:[#:BW BU%L4HZ)R)!X!M\0Y.=A 1 1 1)0J#Y\R/L>O_)X"OD_4O\
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M+\?'NZ]%#TFM::WY*BV6K<PX+NJ<B9[230&];$V/*LNS(EK%1T>>H==L+O\
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M,0 6"[[ D  D#<@#?Q2OQ4,7"J'("E]AR*@DA2VVY )) )V!)V\<Y(8S* B
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MJBJUK*H16L8 %V"*J@L20H"@[ "9*(Y) 1 1 1 1 1 1)0J#Y\R/L>O_ ">
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MQ=7[ E6!=D,!$!$!$!$!$!$!$!$!$!$!$!$!$N!5OSB,7^T_SRX#6Y'U9_\
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MF5)W%]S:G)I*;TJO%-FIR72[++J*ZKZ;*\FJZVC(\)*VZ*L;$<,H:MU*\6#
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MX1\LMC/_ .)M_P!<F_DN!-H?U6_\6O[4U?=']0QOQK_L2+ATDY* B B B B
MB B B B B B B B B9O:7S@E_5VG\ XI/KJS^W;\K3Z,/K6G\75^P)5@79#
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M7\]3?_J^D_.+J/,7ZFW]L_LK/;_9C^R/E,A\69# 1 1 1 1 1 1 1 1 1 1
M1 1.0:?FJV?9!%_Q)0Q?V#?V6^0SU?&/PCY9;&?_ ,3;_KDW\EP)M#^JW_BU
M_:FK[H_J&-^-?]B1<.DG)0$0$0$0$0$0$0$0$0$0$0$0$0$3-[2^<$OZNT_@
M'%)]=6?V[?E:?1A]:T_BZOV!*L"[(8"("("("("("("("("("("("(")<"K?
MG$8O]I_GEP&MR/JS_P"[^RLN5?4U_/\ M&2 (9) 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M1 1 1 1 1 1 1 1.KI\EK_0XZ5^W9KC]!.R([SZ'GV:ROR7?^]X4X/Z(?V%Q
M?RI1^Z9L^>$/LD^-P$0$0$0$0$0$0$0$0$0$0$0$0$3ZU^DGT*C1W[2;4']$
M59C\\ZI_I!JOY4U+]YOGZ(TC[ Z3^2]._=J)S(QEB B B B B B B B B B
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MC*+PI*(IV;94/U0LI#;* &.^QMVY>?;G)BXSI2+<6NT]2M6-)8!V8;C=F&W
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M:QR="TKL6@Y7+5R]I0M#FM5+S9:M:R:Z*Z+*<3)%*\:7R:>K94NP 53R V
M W!.P )( $BLTFA[K+DMR:#<=[4HMZ:6'<DEAQ)[222-]MR2 "23:Y'H342/
M=Q/OMQ*;/4W(141-,> E;Y&3Z]/C))!:?AT4MG,/XE9TD-Q+X,.7<S+A"8;E
MGGRU\=MV.*IS[CA' XU=$W=;D%;J<O)OSX<?>X;^_+/>=7???O*SJ]+I<=UZ
M?'R[<>7+W^>WO3K&[0:T;]L>[6^UEUQ5?4!KN<V]8);MKS)--W]MPHB=-[$S
M*V&#R.[Y4ZRLI>S*5*7O%V=T28XLV/*7R7,J!M9VWO4L=+BY. V%@566Z?97
M361D+F*W7K+,'=:$";-L=P#MX7%"2QWG/Y&/FC+S72O.K>VS>AL5AT7 !5&N
M8MV;C8D;CCR=0 -A-YM$=/":6<AZ?VS&]5B6"\;JZFP][P<<8M((-E#7ITDS
MP\+4K=8/!,-=E$E?(]&UK.Q.[Q$Y.T(G1[;%[E@N=BU7"Y3I+]02HZAC8-=8
MPLMUVYK9S 4 ;U[NO%68%E5T)"D @$;#<4X3V#"OS'<Y>,AWXLG$EB>RSP3R
M95V!96 + G<[[GE2.C/K GUUVNUEPG=]<P/<*V&>XK,=\Y17O,N8I,R35AG:
M5#!5_%78LS8Q&.\>1)E"60,$G<,VTU426YE*LR5A'GJQE=\8F3TZ.IAU&FH<
M;.#*U;5DV#J\BW%B0591OMV;=D]]2\?H9./SNX95HML/).2L'5P$/3V"[J!L
MRL=M^W?MFI?J,Z9W_%-P-<'6LZRW;<*#H[2N$:YUY=&D[BROE\N#M#'5;@@9
M;-2JW2.,+8T%(SLU;JL;H^P)'14O1N1"I;BW\,K!MM.S:'Q,D6VX0OOS7R+*
M,T$8X6Q1NU6P9F8GL +-L!L0-^3:S.Q+DRL<UIF&FG#2BNW$(:[="0!8-U &
MQW)"J#N""=MEVX='F';Y1#6V2X[Z26:/,M>;)=7.JFBTGUIE%KQJKN6MJ(;4
ML_?VDY7B<ZN#F4X.!+4XKU[NTEFF8+34?"DEH;-1J[X+Y*]X*BHM2BTU*5J:
MW<DFM2!V $#<  [=@[.1V>F)F)0W?C.6-A-8L8/:M>PV#L-]R3N=B21OV[>Q
M&V4:J;* B B217W\[_U#^^CG]=_HO_'_ ,&=1W-_TW_EO\>20.?G40$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
M$2/[2^<1]_V9^>6\38_U9/\ >_9:1V_4V_-^T)3=2K2HBN3UBE.D(XRQQY.4
MG%D%<99<]C''DPW+##C++GY6/'9[///RN..1LP">P D^0#>4B0!N2 /*3L/.
M9ZGAIGYR<\.'9LYS9,<<GG#O]+VS1CD1WSCDYX]U[*#')-QRHQY5<%<<D<=U
MXY[G_"'O%O!\%O"]CV'PNW;P>SM[>SLW[>R><E\+PE\#V?:/![-_"[?![.WM
MV[.V><EQ;U*$MT3KD9[8:GX5E.)*H@U"8DYP[IPJ+5X9Y)\T_)?\/@[$SDOG
M#^%QEVORQYQ8-Q*GEOMQV/+?R;>/?WIZ&4CD""NV_($;;>/??Q;;=N_BGKHG
MQD<F[AW;GAK7M//&?/#HB<$BINYX+R[0SGA:0<8FYXPR_@Y\]U_@Y?P<NQS\
MH>E'4\65E;W)4@]OB["-YX'1AR5E9?=!@1V>/M!VE5]UMN(_IUK7:.PAK FL
M@^LVN&/)L ;Y4BCSH\-DRL"+P)*O+<<FY]S0H2%$EQ78+,F=4G6<HLD1>9>9
M_!Y5_2].?4LZC##F@7M:O6:LNJM739<1QY)N2*]MN0(WW]K::_5=233,#(S>
M O-"U-T5L",ZVW5TA@W%]@#9RWXD';;V]Q,].6HVVW4E0VEPE)C>=MUI!+'0
MQI6Z)UJUL*F\7:Y*6T\*NXHN7,QMQ<^$1BPE$FQ4YD9'8IB.,^Y85<FAL?(R
M*-^?>]]M)<*0&-5C)RVW/'EQWV).V^VYEK%R!DXV-D;"OOFBF\5E@Q7JUK9Q
MWV7EQY;;\1OMOL/%)%X=FKERR9>'-OY>,$V*W-IX6IN7+%'EESABKR0<&]]8
MILL^.<,3^2N"N<N.<>,^SQV!%Q;CRXMQWVY;'COY-_%O[V\FY+RX\EY;;\=Q
MRV\NWCV]_:5PC6WU)2S:"Q-0F=[<3+FJZ&,DYEB$]MY(8"6>08QTQN3(7S-1
MW%<[YE2EG--;"B>#BBSC.>>>>2<N!=LTW*KP:=1= ,:^UJJR&W<LG/D2FVZK
M]+;PCV'LE*O4\2S4+],5V[ZQZDNL4KL@5^'$!]]BWTQ-U W&_O2SXH2_ 1 1
M 1 1 1+;US_)PV_6SU^=',46^NU_&5?_ $D[?6MGXJWY'D<#MI\XC_U_Z^[P
M$1V>.?\ )SV?\O'_ /'CGL<\?_PY^5S_ /N$1_\ ;_*$3%9U)\(3"9C,S$>3
MCA$HM(9-DWXG\)<U^+ T+';)%@IR*/X3Y*L4G)/!_)!W!/.?=.2C.,><.<D7
MFZ)OMS95W\>W(@;[>WMO,7;@C-MOQ5FV\O$$[?%*E=/'=%#O[K#%]E&^O5=7
MII+(9@P<1!;)29:>CSB3\J9,U7+V0QQTM1BNY3=\XE<-1/*?C/N/.9W:]URM
MZAA' RGQC8+2JHW,+PWYJ&VX\FVVWV\?;*V#E=^XZY'3Z?)G'#ESVXL5WY<5
M\>V_B[)=_P#^_P#D%*6Y6"^-O:8UQL;76J[,<7U+,-I+ .K6IDC0R'.J9=)4
MZA@2G^&511I>#.W$GR9GP,7&XFX\<J>>>TYXPR%FC$NR*\BVH*4Q:Q9:2P!"
MGEMQ'^L?!/9[TKW955%E%=A(?(?IU #?=MU';Y .0[??EGQ6EB B B B B B
M217W\[_U#^^CG]=_HO\ Q_\ !G4=S?\ 3?\ EO\ 'DD#GYU$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$
M!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$C^TO
MG$??]F?GEO$V/]63_>_9:1V_4V_-^T)U?/DAKZ&K-O\ O1J;_P"9.1W?<=]G
M*?Q&1_XS.'[M?L%;_M&-^W-/;%T]J%5]4JC-653E:YU1;#Z8L-Q70W>:A*"W
MNQYLJ8YA)URN5OY:K%<[(5TSB++,U#8=EPAPD*4M2F(3DEEI\>D;6<L:#EZ@
M%Q^^<+4WQL5NA64IJ#U5@5IMLI%5C5AAV\#L29S*:+AGN@P]/+9)QLW2TRLI
M>^+.5]Q6VPFQ]^3*;:TM*GLZ@!&P[)$U/WI HQT1?$:\8'(+D8OWP-YJFLHS
MC8SW5L2;#$D$BMD<XV!,&8WA:5">^GZ8J5S"E,1F+SG/A6D<6)0U<2%LLY.)
M=9W4]7%M3&8:0N1?8:5R+&!NLH^DUL-NKLE85R#MQV*N&X-5Q<RE.Y3HY=+Y
M2>K38^/7UVQZUVIJR/IUJ]O2W>TE!L26Y!D*\UQG5ER51"D^M;34:D==.%8H
M]?6^6M;+2TSF,]I9 ^IW\ENY/KN33M4LD;VA3H7<UB6R%P4JU+[DT)3,G)T0
M(FM7SEJ %F5W,9+I<MYS36SY555.4R<=]KJZ0$4DJ'"* $Y'95+,)AI[&K%[
MJL6MZ#CC#%JIBVVW8H<6!=Z'N)L<!6X&QB2_ 'DRA3+8OFG]3U3T$+/V?;LY
M5(KPOBB]>4<XF<IDKF[\EQ1MV%J,J*0IA:U!^3<S1Z),K''V%I)3$]\>#V9$
M08?WJG2)$E!-2R,CNMHP&Z:8N)EYIJJK15^F'#R>I:[ <F>QG=VW.V[$@;DD
M[)],QL?N.R,]>H^7F8F$+K;+&;Z6N=C"NI%)XHE:(B* -^**-]@ '2==GMSV
M]0J]QXLX<;6DZ4U<Y=.Y!+CT&-?EU(S5LL2LA,':RS5I*25/$82$.I:W%3FM
MX_\ S8-<DK?(LEF!KN@5%TTKIEB^I_JG>NLM7RZQR&O!<VMV;UK82I&W'ZWX
MDU@1W.LS:F#JE1]4?4K';1185Z/>R4$(*E'+:QJQR#;D_7/(+9RWUM:L,-FV
M[8<)M8BV:!KO<Q#N$S+W:QKHV!L:&;)2B1JW%$VF5T95:Q*KB"^*/+HL\&'K
MD[%RMY5EKH:].21E-R8AN\]Z,:FW'.-F7Z8=-8+3BX=%N"B %NMWP"+!8JCD
M 7VVVM4%QSFBT],C*OJR1DX=.J#4T9K\K,NJSK+"RKT.]B#6U3LW$D)OR!J=
M@FZ3:74^O&G$#Z_NPD*MQ*VPU$P.=77%K.DDT\DS#B\;%2I;2D[1> 5Y[\FY
MEKN^3*4RM4U0MP4.;:L-[[:4+/D0U8(TN@R,S4[>Y##MQRUI=<C&SBE*.5PJ
MQE4GF AZ:K576&M 5AV,6!;<]#CX6F5=V6;5DA:@C8^5@"RZQ.>=8<2X<"7'
M59[K+"M1+*?"4+LNP[=X^=3Z3 1 1 1 1 1+;US_ "<-OUL]?G1S%%OKM?QE
M7_TD[?6MGXJWY'E ]^SSDVB6ZJE,<:G4)]2MCCTZ@@S,HX@XJG9D84<2:7SB
M84:49CCF69AECGAGCQECSQSQQR/H.!VYV%O]UXW_ )DGR[-[,+,V^Y<C_P 3
MSH[LFOO@JA>C+L*QW;L.Q6QM[=E@4%94M:;:?DCM':S(NI'4""/UDMQXY40Q
M&CAIKH3RE+,<$:M<[*3E28U*6F1%=LV1O?K..:,9J<2BO(J0TJ5:WHFXM:/$
MY+['?8$ #8[[D\DM'TG2KQ;>MN5=918XL.ZU]84A:SXT 3?L[023OV; ;4=&
MG&):-7OUTZ'*>;=>-9Z-K$RPR&!EF+QG9;<61&I+F\KH9+2U:)4P3)P;9(8F
M,F9!J)P+4LL>?'%PX,8BU&&JS0^=1H=_&H9-]IK+,B](^&H'--B&0%=^&Q&Q
M90#RVFQPRF'?K%(-IQZ:S8%5SU!LK;E&W'%R&VY[@^"I)\'>:T.GC922(=2W
M0:>44YM4 8=A'-[C5BUXU[)26_;)=F%9F_Q_,[952M9(_'6R8/W.),B9HZWM
M* M+X*:I)S'(VM\'9'[/4*R^F9]=X-C8X5J[#C+CU!AQ;;&')G*+VJ6)._)E
MY.-Y1P; F?AO20BW[K96,AKK"-F7_."0JACV,JA1ML&XJ=I=_IJZDPW9!7U"
M[^MZ;6?)E>K>R%_/%)5YS,5Y-=1F;+V"1+'J<+6 SE26YO;@C:HLU%<8YHB$
MJ..I^ZXK<LTW>%'4LM\8:?CTI4@RL;'%]G =1T#*%K#>TH)9CXR2W81V[V\#
M&2\YUUKV,<?(O-*<STU<ABS\?$6("CVNQ1OOV;:\NFU*'9WEG3O@N[225Q_I
MZYVM<#32)J!>4SUA/-C3'Y*YY*KES)7&K'9@3/\ (6>)X$NI38QXI<3",,3H
M]YJ!RS8ZD@5-1LPBK:ATJ6O!&]M>,%VVI[-@W%2^XW;?_P#ET@*. S%L%,OD
MN#U+13L0M;W\M][>W<KR8+V[+MV>QZN]C>J8\61=/5'VGJ:[I=!8LP5U633^
MY@+O'8B1:\5K7*59$8HX-]F5VM2-YC#,IPJ>USHZGLJ\WC-^5E.S%SFY91I
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M8]0=/]S;^E/HCQ*8_0U/NC+R!ZL9ONJ_T8],>H.G^YM_2GT1XE,?H:GW1EY
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H0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$3_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>soph-20251231_g11.jpg
<TEXT>
begin 644 soph-20251231_g11.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (4!*@# 2(  A$! Q$!_\0
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M_D>C_AXO^SU_T4 _^"74?_D>OQ.HH_LZEW?]?(/[0J]E_7S/VQ_X>+_L]?\
M10#_ ."74?\ Y'H_X>+_ +/7_10#_P""74?_ )'K\3J*/[.I=W_7R#^T*O9?
MU\S]L?\ AXO^SU_T4 _^"74?_D>C_AXO^SU_T4 _^"74?_D>OQ.HH_LZEW?]
M?(/[0J]E_7S/VQ_X>+_L]?\ 10#_ ."74?\ Y'H_X>+_ +/7_10#_P""74?_
M )'K\3J*/[.I=W_7R#^T*O9?U\S]L?\ AXO^SU_T4 _^"74?_D>C_AXO^SU_
MT4 _^"74?_D>OQ.HH_LZEW?]?(/[0J]E_7S/VQ_X>+_L]?\ 10#_ ."74?\
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MU^)U%']G4N[_ *^0?VA5[+^OF?MC_P /%_V>O^B@'_P2ZC_\CT?\/%_V>O\
MHH!_\$NH_P#R/7XG44?V=2[O^OD']H5>R_KYG[8_\/%_V>O^B@'_ ,$NH_\
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M\/%_V>O^B@'_ ,$NH_\ R/1_P\7_ &>O^B@'_P $NH__ "/7XG44?V=2[O\
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M4?\ Y'H_X>+_ +/7_10#_P""74?_ )'K\3J*/[.I=W_7R#^T*O9?U\S]L?\
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M35^K/_!5K_DWCP[_ -C5;_\ I)=U^4U?1X'^"O5GSF._C?)!1117>< 4444
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MS1HL+[T6WHSX8A^$%CX1_:#A^'7Q U^WT?3[35ET_5M7L&9XHDXW,C.@P/\
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M'^=-"8RBBBJ)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ^,/\ @JU_R;QX=_[&JW_])+NORFK]6?\
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MVVMD?"&>/?&<>W/^?S]*7!R>"<5^PWPZ^"GA#XX:!K>C^*_V9-/^%^B20?\
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M(=3)/O;(+1L N>?NDU]2_P#!+&\N=>^"WQ0\/:ENFT".X4QI(1L'G0.LRX/
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MYS1G_.: "BC/^<T9_P YH **,_YS1G_.: "BC/\ G-&?\YH **,_YS1G_.:
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M5\8T4?5:/8/K5;N?9W_#UKXM?]"[X+_\ ;O_ .2J/^'K7Q:_Z%WP7_X W?\
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M_P"'2?PB_P"AC\;?^!UG_P#(M?;5%'UFM_,P^K4OY4?$O_#I/X1?]#'XV_\
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M444 %%%% !1110 4444 5?\ F(?\!JU57_F(?\!JU02@HHHH*"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &2_ZMOI
M4-A_Q[+]34TO^K;Z5#8?\>R_4T$]2S11104(>E?@+^TK_P G&_%3_L:]5_\
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M#9-?R,DQ>2..39P68' 4 ;L8!XK.,JJ@[2?3N:-4G-77?L>?Z-%^R;K7Q>\
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M@W!P I'O7>>9QT_*DTUN4FGL/HIGF"EW4ACJ*2EH **** &2_P"K;Z5#8?\
M'LOU-32_ZMOI4-A_Q[+]303U+-%%%!0AZ5^ O[2O_)QOQ4_[&O5?_2R6OWZ/
M2OP%_:5_Y.-^*G_8UZK_ .EDM>OEOQR]#Q\Q^&/J>;T445[QX04444 %%%%
M!117N?P _8S^)/[1VGSZIX;M++3]"A=H3JVL3F&!Y%QE$"J[L0".0NT'@D&H
MG.,%>3L5&$INT5<\,R?7]:.<8KWCX_\ [%GQ(_9RTB'6?$D.F7^AR2+#_:>D
MW?F1+*P)"%9%20' /.S;QUKP?L<\8ZYXQ3A.-1<T7<)PE3=I("?QZ]3Q1C&.
M^/7TH^O'^]Q1TQDX!^M5N1=(.WKZYYSZ4$9SDDY[]Z,''^?UH/ )["CK>X^E
MK"YY]O0<4G;'X5]':G^Q\FF_LGVWQJ_X3O3IFF*?\2)+?H6G\KRQ/YG,JCYB
MFSC##)QD^8ZC\ _'FE?"BP^)=UH7E>"KZ016^J?;(#O8NR >4)#(/F1ARO;Z
M5DJL'HGY&CIS6K1Y_1^7KSZU]&_"O]D"+XF?LX>+/BJ?'NFZ4VA"Y;^QY+?>
M7\I P627S%\IG)PHV-G*G^+CYR_05491FVEK84HRBD^X#C'MTS0. 1^'L:![
M_+ZD]J^C?CO^Q_'\$_@GX+^(*^.].\0GQ$85&FVMN$V>9"9"T4GF-YRJ1M)V
MKU![XHE4C%I2W8*G)IN.R/G+J>23[DYHR<Y[]CZ?TKT'Q_\  /QY\+O"7A_Q
M-XGT+^S=$U^-9--NA=P3>>K('!VQR,R_*P/S@>AYKSX GIS],FJ4E)733):<
M79H.G3@44F<D8[^_^?\ (I:8@HHHH **** "BBB@#[8_X)*?\G'>(O\ L5+G
M_P!*[.OUJ/2OR5_X)*?\G'>(O^Q4N?\ TKLZ_6H]*^:Q_P#&?HCZ3 _P?FQ:
M***\\]$**** "BBB@ ICY /].]/IA.,]30M&+<^ ?@6_P%U'PIXZF^-3>&?^
M%D2ZYJ":Z/%TD8OUQ(WEBV\T[U41[0/)P01@<@5?^'%YJGQ6_8B^+7@S1]?G
MT]/#VI7VC:=J.NR/:.NFQ.DR1SO)@Q@P%HB6QM7@@ 5WOQ$_:;^!NE^-M0_X
M2+P-<7GQ1TB[DMM-TR[\*F75+YXVVQ/:S>6PV/@,C;P<<XZ \=K7P4\;Z=^R
M+>7.K:#-JWB+7/%D?C/Q3X7LE\V6[MGN5DDLPH&781I&2GJK*,\ ^A=/5]6C
MS>5K1=/(\NT?Q]\&_C;9?#_PG\)/A_%X+^*L.L6<D-[;00P/IR6[![B9KM3_
M *4FQ7 5B6?()4-BOTT7[@'&*^!_V@OC3\,?VD/!6G>%_ACHE_KGQ9MY[5=$
M2UT::TN]!>.9&+/.\:K"B!2" Q7('(QN'U7XX^..C_"GQ%\/O"^OVVIWNL>+
M;@V%K/IMIYL*3*$W-(=P*J2X^Z&(&20 ":QK+F2LM36B^5N[,?XR_#[X/^#?
M"?BKQ_XI^'7A/4GL;>;4+NYNM%M9)[J0#.TNZ$L[MM49/)85C?LV_L_Z'X>^
M$-R/$7A31/[1\9,NJZYI"Z;"MG'OPT5H( NSRX5VJ!CE@SGEC6/^WG?&X^&7
MA/PT64P^*/%^E:1<(P)#PF;S&!]LQK^%?2L:A54# &. .U9N35-:[FJC%U&[
M'R/\>?@I\-];\;^"_A7X<^'?A/2M3\122:AJVIV.AV:3V&E6Y4RLC! R/,Q6
M%77E<L1R!7=_%6RM/"7QK^ )$<6F^%;.YU'2X44;((;N2RV6<8'0$JLR+]<#
MK6-\.;[_ (2?]NKXL7<I60^'/#VF:/;[E.Y%F)N'V\]-W7UX].?H77_#FE>*
MM)GTS6M-L]7TR=<36>H0)/#(.N&1P0?QJG-QLGKI^9,8*=VE;4^97^(DG@GX
MI_'CQ!H$*:F]U=Z+H.E6D;?N[O7C T9CR <%1)!YA_A5&S]VN@^'?Q1\*_![
MPD^D?8M;U71=(U)K'Q!XY2VB%@^K22#[3)+F7SF!FDPTBQM&A.TN-IQJ_#[P
M]IGC/XK3ZCI.G6FE>!_A\9]#T&PL8%AMVU!\"]N$10 HB!-NN!P6N/6O%[C5
M[;P_^S)X]^#MZ=WQ)NK_ %73+/06'^EZ@UW>2/!=1(?F>';,K&4950C98%3B
MVE+0A.4=3[A4Y4$'.:6J.A64FFZ)I]I,_FRV]O'$[YSN95 )_2KU<AVK8***
M*!A1110 4444 %5;+[TW^]5JJME]Z;_>H M4444 %%%% !1110 4TIG/.,_I
M3JH:WK=IX<T:^U74)?L^GV,$ES<3;6;9$BEF;"@DX )P 30!\1_#/X(:9\#O
M^"@UEI^G:WKOB!]6\'W.I7-]XANTN;EI6N-A^=47C$:XSD]>:]$_:#T:#XP?
MM/\ PL^&&M1B[\(VUC=^)]1TXL1'>21GRX%D'=%;)QT.\@C%>,:M^V1\(+K]
MM?0O'T7B[=X3MO!TFERZA_9EX-MR;EW">68=Y^4@[@I'O7K_ ,>O$<?@_P")
MGPH^/^F6=[K7@F'3I[#69["V=IH+"Y19(+DQD!O+5B2P(!&1QGBN^2;DFUK;
M\3SHR2BTGI?\"MKG@G1/@#^V+\+I/!.F6?AS2?'-CJ.E:MI.EP+;VLK6T2RP
MS"),(&#$ D '&>>3EOPW\!:#^T+^TC\8?$_CC1[+Q/9^&;^'PSHNGZI$MS:V
MJ1Q[YV$3@J79V#;B.,G%,T#QQ8_M8?M.>!/%7@M+J^^'_@&TO9YM>GM)+:*Z
MOKF,1+;Q"159BJ@,W QCGJN8/^%E:3^Q_P#M ?$J3Q\M[I7@;QO<P:UI.O16
M<MQ;+="+9<6\GE*S+(2-P&#\H!.,U.MK?:L/3I\-S?\ V5+%/AI\:OC;\+-,
M8Q^%M$OK+5=*M-Q*6:WD)DDB3).$# 8'U/4G._\ MR^)=4T/X$3:5HMPUEJ'
MB?5+/P\MS&VUXTN)0LFT^I0,O_ O:N6^ &L7(U/XV_M ZUI.HZ=X?UT13:79
MO;$7<^G6-NP$XBSG,@'R@XSMST()O_&Z[F_:F_9+M_%O@+3K]]0CFM_$.D6%
M_!Y-S)):SY,84$C<RK(%P2&)7!(.:E_Q4WY7]2U_#:7G;T.._:I^ W@KX#?
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M-%DU&ZTMN*[BW;>YW.H?&;XN?%;Q%KT'P7T/PFGAO0;Z33)]>\937(34+J/
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MLLOB5X?\/W\,USK,UG;:?;6,S./-/F1(D3QE4C.[>X'0GCFW^TK\2O"&O_\
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M?+_\31_PK?Q;_P!"MK7_ (+Y?_B:^B_^'F?QM_Y_M%_\%B_XT?\ #S/XV_\
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M7\: "BBB@ HHHH **** "BBB@#[/_P""4O\ R</XB_[%6X_]*[2OU9K\IO\
M@E+_ ,G#^(O^Q5N/_2NTK]6:^<QW\;Y(^CP/\%>K"BBBN [PHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<YYXX'IW[(>@^'_V=/V._$_QR&BVNO>+66Y,,\QSY<<<QMXXU/)12X+N5PS
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MS"BBB@ HHHH ****!!1113 **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\Q_6)J*B?4WP-^.G[/\ HOPPLO"?Q/\ A->ZM?V5S)=)KVCS@W5Q(S9^9Q+
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MZMN..LIVJN#P%'P5SGT^O.*,8Z<5#PM)RN6L344;7#K11176<H4444 %%%%
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MX\^^&/[5WA?XD>+K;PO<:%XH\$Z_>P-<Z=9>+M+^Q-J,2@EGMR&97  )/(.
M2 0#7AVKWMQXS\*?L<:=J\C7-G?W=K>W?F?,L\UO9JT8;/4G)XSR3T/&/1OV
MTHAI\GP9UZ#Y-3LO'VFP0W )R(Y0XE3/HP50<>U-4HI\KW=R?:R?O+9=/4^E
M.F<\8Z^U>'?$3]KOPGX \8ZAX9M]!\5^,M4TJ-9=6'A723>QZ8I&X&X;<H7C
M)XSC!S@\5[B>!TSCG [?A7S;^P= MW\*O$>O3@2:KK?BG5+O4)&&7:3SB@#$
M=<!0<'U.*R@HV<I:FLW*ZA ]ATCXP>#];^&0^(-IKEO)X0-H]X=2.0JQID/N
M4_,"I4@KC(88QFO,O!7[:?@GQCXCT72YM%\5^&;77I/)T36O$&D&UT_5G)^5
M;>;<<EN"-P7.0.I KY;UU#;?!/XF>"XW>#P[)\8UTAX@WRQ6C3H[)SQMW*#C
MCD]^E?2O[?&FVT7[*_B&YB007&CSV%W921X3[/*MU$BLOIA685O[*$6H]S#V
MLY1<D]$=_P")/BUK \<:MX6\'>&(/$VH:)90WVK/=ZI]A2$2[C%#%^ZD,DS*
MC-A@B %<N,\:.E_&OPUJ?P@3XD^=-:^'OL+7TBW$>)XMN0T+("?WH<%-H)RW
M )R*\XTO4=1^%'Q:\;>(K_0-<UK2?&.G:=?6=QH>G37Q%Y! 87M9%C5C$7'E
MLKR 1\G<XQ7ENG/<^ ?AK8:#XGM_,TCP!;3>,/%MC!*&5]1GFDN;'3-XR&VO
M()&() V0]G^:53B]"G4DM3Z]\%ZOJ7B'PGI&IZOI/]@ZE>VT<\^F&8S&V9@#
MY1?:N6 // P16S7B^E?$SQMX8\6^!].\=6VAM9>,?,A@.CP30R:9=K"9EMI&
M>1Q.&577S0(_F3&SGCV@=.WX5SS5CIA*X4445)04444 %%%% !1110 4444
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M6KV4-[$C_>174-M/N.1^%8SA;8WISYCH:***R-0HHHH **** "BBB@ HHHH
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M# *BJ!M(SD^G/M'_  2VO'U7P'\9[V:.%);BYAF9((4BC4M#,2%10%5?10,
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MC\HV \U[K1QG./T_KUHHE)R'&*B%%%%24%%%% !1110 4444 %%%% !1110
M4444 %%%% ',?$NZ\76?@V^G\"VVF7OB:,QO;VNL2.EO,H=2Z,5/#,FX*>F2
MN37@>J^$?BY^TKX@\/Z=X^\&6/PT\ Z/?PZE?:>-8AU.ZUB:([H8]T2A4AW8
MW!L'(X[8^H_Q([\&@ #''3]*N,^5;:F<H<SWT/(_BKXP^+_A'Q/%+X*^'VF?
M$'PU+9JIMEUE--OH+G>VYBTP*-&5V8  .0<G%9GP"^%7BO2_%GBGXD_$22Q'
MC;Q(D5LNG::?,M]*LHP3';J^,LQ)RY'&0,>I]O/(P1D>_-!Y^OJ>:?.[62#V
M:YKMGE/AW7/B_J@^)4.J>'O#VC2VL\D?@^Y>X:2.\0*_EO=*C,RC.PG 4G+?
M*, GRCQGIGQZ_:'T0> ?$/@C3/AEX:O&2/7M?AUR+4)+RW!4O':Q(,QERO\
MRUS\IP3US]6_GCZ]![4']?I353EV0G34MVSSSXCMXT\%>#=(3X9>'])UR33I
M(HI=%U"Z-IY]FJ,OEP2'Y$DSLP7&W :O,/#G@7XF_&KXL^&?&7Q.\/67@3P]
MX2=[G2?"\.HQZA<7%ZR;1<33(-FU03L P0WXY^DOSQTQG_.?QH''_P!;BDIV
M5K Z:<KW9S/Q*N/$MMX(U7_A$+(7_B62(0V"S.B)%([!1,Q<@%8\[R.2=FT
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MV'PD^$'A:\\)>"DVBY;4-HF9!(7\I0LDG!?YV<N6;H>ISN:#^V]\+/BG\+M
M\+?M ?#[4?%=[H4:Q6NK:0X\V90 N]CYT+QL0J;P&*N5S@< ?#Y (Y%!.<]\
M\\DUM]5I\MC'ZS/FO_PQ[M\0OCQX3T?XT^'/&OP7\'/X!MO#RQB&"ZF\S[8R
M$Y>9 3MW*QC8>8Q8=P:^B/&'[:O[.?Q<O--\6>/_ (-ZMJGCFRM?)54='M'Q
MDA'?SD\U<DXWQ-MSTKX!Z'CCZ4=.PIO#4W:UU8E8B:OMJ?8G[(7[7_@+]GG2
M/B38ZEH.OK:^(KE9=-MM/$-U]EB59 $EDDDB+$"11N"\XSQTK+_9'_:R\(_
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3J* &[%_NC\J-B_W1^5.HH ;L7^Z/RHV+_='Y4ZB@!NQ?[H_*C8O]T?E3J*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3(/1]K>U85M^PC\0;SP?XYU^WU3PU<GP9/=6^JZ9;7\DUVKP('<($B*-E3D
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MO!_B;\:/B)JGQ9NOAM\(]"T*\UK2[&+4-9UGQ5-*MA:++GRH@D/[QW8*3D<
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MJ<49 E1%E_>))'N4D-G(R>!C/M6N:Y;>'-$O]5OF,=G8V\ES.X&=J(I9CCZ
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M+_JV^E0V'_'LOU-32_ZMOI4-A_Q[+]303U+-%%%!0AZ5^ O[2O\ R<;\5/\
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M"]I%K4%3E'8]>'04M)2US'6%%%% !1110 4444 ,E_U;?2H;#_CV7ZFII?\
M5M]*AL/^/9?J:">I9HHHH*$/2OP%_:5_Y.-^*G_8UZK_ .EDM?OT>E?@+^TK
M_P G&_%3_L:]5_\ 2R6O7RWXY>AX^8_#'U/-Z***]X\(**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *.X^N>.***-]
MP6FP9_'V[4444]!:GVQ_P24_Y..\1?\ 8J7/_I79U^M1Z5^2O_!)3_DX[Q%_
MV*ES_P"E=G7ZU'I7S./_ (S]$?2X#^#]XM%%%>>>B%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5;+[TW^]5JJME]
MZ;_>H M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %5[[_CW/U%6*KWW_ ![GZB@3)H_]6OT%.IL?^K7Z"G4#
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@"K_ ,Q#_@-6JJ_\Q#_@-6J"4%%%%!04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R7_5M]*AL/^/9?J:F
ME_U;?2H;#_CV7ZF@GJ6:***"A#TK\!?VE?\ DXWXJ?\ 8UZK_P"EDM?OT:_
M7]I;C]HWXJ9_Z&O53_Y.2UZ^6_'+T/'S'X8^IYO11_GBBO>/""BBB@ HHHH
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M#GD]6O0\O'3Y(QT3]3Z(_P"%7?L3?]%@\:?^ <O_ ,K:/^%7?L3?]%@\:?\
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MXT_\ Y?_ )75\8<>E''I1[%_SO\ KY![:/\ (OZ^9]G_ /"KOV)O^BP>-/\
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M #O^OD'MH_R+^OF?9_\ PJ[]B;_HL'C3_P  Y?\ Y74?\*N_8F_Z+!XT_P#
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MU^IK-K3L?^/<?4TF,L4444AB'I7X"_M*_P#)QOQ4_P"QKU7_ -+):_?H]*_
M7]I7_DXWXJ?]C7JO_I9+7KY;\<O0\?,?ACZGF]%%%>\>$%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M]G_\$I?^3A_$7_8JW'_I7:5^K-?E-_P2E_Y.'\1?]BK<?^E=I7ZLU\YCOXWR
M1]'@?X*]6%%%%<!WA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M* "BBB@ HHHH *** "3C'?% !12 Y&1S].<TI^4\D?R_G0 44'@'VZ\&C&*
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MUV'\^G:OULUKXD>/OBEHNC>)?@1XB^'FK^';F$&Z_P"$ECO#+$_7[T#_ "L
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MUIJGQ%MO!,>K:IXFUC7X(KKQ=K6K/%YR:) 6\FR588XXHTGF+(0B LHG9BV
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M91GCV(K@_CW\#?AS\&O@KJEV/%WBKQ7;:C9-8^$_">J^(&O-/^U2KL@:UM@
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MUI6/_'NOU-2QHLT444BA#TK\!?VE?^3C?BI_V->J_P#I9+7[]'I7X"_M*_\
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MS1K3Q)HU_I6H(\MC?0/;7"1RO"S1L"& ="&7@GE2",]<TRT\/Z;8:!%HD%C
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M0I;WGV>\N+:._B7[L=U'%(J7"#G"RA@ 2!P37;10QV\*111K'$@"HBC"JH&
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MUFUI6/\ Q[K]34L:+-%%%(H0]*_ 7]I7_DXWXJ?]C7JO_I9+7[]5^ O[2O\
MR<;\5/\ L:]5_P#2R6O7RWXY>AX^9?#'U/-Z***]X\(**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[/
M_P""4O\ R</XB_[%6X_]*[2OU9K\IO\ @E+_ ,G#^(O^Q5N/_2NTK]6:^<QW
M\;Y(^CP/\'[PHHHK@.\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "M*Q_P"/=?J:S:TK'_CW7ZFI8T6:***10E?@)^TJ1_PT;\5?
M;Q7JN?;_ $R6OW[Q7!W7P*\ 7U]=WESX-T"ZNKJ>2YFFN=+AEDDDD<N[,[*6
M)+,3UQSTKLPM=8>3;5SAQ-!UTDG8_GY_"BOZ O\ A0/PZ_Z$;PS_ ."6V_\
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MBABC%7_[.7^^?RH_LY?[Y_*BX6*&*,5?_LY?[Y_*C^SE_OG\J+A8H8HQ5_\
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$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>soph-20251231_g12.jpg
<TEXT>
begin 644 soph-20251231_g12.jpg
M_]C_X0#H17AI9@  34T *@    @ !@$2  ,    !  $   $:  4    !
M5@$;  4    !    7@$H  ,    !  (   (3  ,    !  $  (=I  0    !
M    9@        !(     0   $@    !  B0   '    !# R,C&1 0 '
M! $" P"2A@ '    $@   ,R@   '    !# Q,#"@ 0 #     0 !  "@ @ $
M     0  !"J@ P $     0   C:D!@ #     0          05-#24D   !3
M8W)E96YS:&]T  #_X@TP24-#7U!23T9)3$4  0$   T@87!P; (0  !M;G1R
M4D="(%A96B 'Z@ " !H $P ( !)A8W-P05!03     !!4%!,
M            ]M8  0    #3+6%P<&P
M                                 !%D97-C   !4    &)D<V-M   !
MM    ?IC<')T   #L    "-W='!T   #U    !1R6%E:   #Z    !1G6%E:
M   #_    !1B6%E:   $$    !1R5%)#   $)   " QA87)G   ,,    "!V
M8V=T   ,4    #!N9&EN   ,@    #YM;6]D   ,P    "AV8V=P   ,Z
M #AB5%)#   $)   " QG5%)#   $)   " QA86)G   ,,    "!A86=G   ,
M,    "!D97-C          A$:7-P;&%Y
M
M                    ;6QU8P         G    #&AR2%(    6   !Y&MO
M2U(    6   !Y&YB3D\    6   !Y&ED       6   !Y&AU2%4    6   !
MY&-S0UH    6   !Y'-L4TD    6   !Y&1A1$L    6   !Y&YL3DP    6
M   !Y&9I1DD    6   !Y&ET250    6   !Y&5S15,    6   !Y')O4D\
M   6   !Y&9R0T$    6   !Y&%R       6   !Y'5K54$    6   !Y&AE
M24P    6   !Y'IH5%<    6   !Y'9I5DX    6   !Y'-K4TL    6   !
MY'IH0TX    6   !Y')U4E4    6   !Y&5N1T(    6   !Y&9R1E(    6
M   !Y&US       6   !Y&AI24X    6   !Y'1H5$@    6   !Y&-A15,
M   6   !Y&5N054    6   !Y&5S6$P    6   !Y&1E1$4    6   !Y&5N
M55,    6   !Y'!T0E(    6   !Y'!L4$P    6   !Y&5L1U(    6   !
MY'-V4T4    6   !Y'1R5%(    6   !Y'!T4%0    6   !Y&IA2E     6
M   !Y !, $4 3@ @ %  ,@ W &@ +0 Q #   '1E>'0     0V]P>7)I9VAT
M($%P<&QE($EN8RXL(#(P,C8  %A96B        #S4@ !     1:^6%E:(
M     &^D   X]@   Y%865H@        8I0  +>&   8VEA96B         D
MG@  #X0  +;"8W5R=@        0     !0 *  \ %  9 !X (P H "T ,@ V
M #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *,
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M>&YXS'DJ>8EYYWI&>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>
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M.="ZT3S1OM(_TL'31-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N
MW 7<BMT0W9;>'-ZBWRG?K^ VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_G
MJ>@RZ+SI1NG0ZEOJY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G
M]#3TPO50]=[V;?;[]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M__]P
M87)A       #     F9F  #RIP  #5D  !/0   *6W9C9W0          0 !
M          $    !          $    !          $  &YD:6X
M-@  H]<  %1[  !,S0  F9H  "9F   /7   4 \  %0[  (S,P ",S,  C,S
M          !M;6]D        ,*X  &&O 0$!&P
M    =F-G<        P    )F9@ #     F9F  ,    "9F8    ",S,T
M  (S,S0      C,S- #_VP"$  $! 0$! 0(! 0(# @(" P0# P,#! 8$! 0$
M! 8'!@8&!@8&!P<'!P<'!P<(" @(" @)"0D)"0L+"PL+"PL+"PL! @(" P,#
M!0,#!0L(!@@+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+
M"PL+"PL+"PL+"PL+"__=  0 0__  !$( C8$*@,!(@ "$0$#$0'_Q &B   !
M!0$! 0$! 0           0(#! 4&!P@)"@L0  (! P,"! ,%!00$   !?0$"
M P $$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G
M*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%
MAH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35
MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^@$  P$! 0$! 0$! 0        $"
M P0%!@<("0H+$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R
M@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(
M24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JB
MHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR
M\_3U]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3I0 M
M%)5;[9;?:/LFX>9C.WVH M45QWB/QUX6\)6;W>N720K&,D=Z^==0_;#^&-O=
M):V2S2J7VL^T */7KTJHP;V1,IJ.Y]=T5\_ZA\6X=<LUE^'5W:WTKC(CSA@/
MIBO+M?\ BS\2Q9_8M+>R-\YVA58#:??.*:IMDNHD?:-%?FWJGQZ^,VFI+H^L
M7%A;S)\A<.=P/_?->,^)?BU\2]/@CFA\3_:I9"=R0Y^7^5:K#29F\3%'[%45
M^'+>-_BMJ5PD1OKUI)ON8R,YZ8KT3P[X>_:0U6;RM.^W+V+2-A:KZK;=HE8F
M^T3]@J*^&O!WP\^/=I:%?$VO_9P>@4EB/Y5[5X:\/>(M%8R:CXAN+S/\)7C^
M=8NFNC-HS;W1[W17%?V_<A=H6E'B&Z[J/RI>S9=T=I17$-K]V8\ 8:G#7+A@
M-X_*CV;"YVG2D+*.I%< VHW)?<#QZ56DN)I&W,QHY!<QZ-YD8'44SSX_4?G7
MG/F2'J:G$L/HU/V8<QZ'O3L13Z\\^TH.@/YU:35Y4^[FIY N=S17,)KY(_U9
M/TJQ%J%Y.V$BQ1RE&_15>)I^DH%6*D HHHH **** "BD)"CFDW"@!U%1^9'C
M.1BHS=6Z]6% %BBH4N(7P$85-0 4444 %%%-9MHS0 ZBH#<(#MP:DW"@!]%5
M'N-K["IX[XXJ3SOF"[: )Z*B60LY7&,5+0 4444 %%-SSBG4 %%%1M($7<W:
M@"2BLM-5MV. #Q[5;CNX)!E3Q18"S12 @C*]*!0 M%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]#^_BBBB@ HHHH
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M(/ASJIT_5HOW).(IA]QQ[5QFGZKJND2>9IES);D]XV*_RINA%Q#ZQ*,M4?T
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MZ**^N/CM\5/A1^RK\'O$/QN\<O!IFD:#:O=W$F "Q X4>I8\8%?Y67_!1?\
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M0R,-P' H CHI2I7[PQ4T*H0Q(SCM0!!14V(&X&13'B*GVH 911L..AHQCB@
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M4M%%0,**** "BBB@ HHHH **** "BBB@ HHHH **** /_];^_BBBB@ HHHH
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MK"[E+#)\R6%&8'W!/->]?V'I_P#S_)^5?G9_P3.O)+W]A[X?/+P4TR*/\$4
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M U?PSJDNCZU"\,T3%2'&"<5UT:<)'%6J3AHC=\<?$/Q#\0==_P"$@UZ7$P
MV<!0.F*=HWB^&.[MWU^$7"P'<KKQ)D=*X/I4D2&6184&2Q  ^M=G(K6.+FE>
M[/0=<LM+\275SKNAS;0%WR1.,%?QKSG*XSVKUDVJ>%(!H4M@]U<W2J[=1T[
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MD^,?[#'Q9^&=K&9+C6?"NJ6T  R?->W=4('J#C%?Y!^H6K6%_/8/]Z"1D/\
MP$XK_:WGBBGC,4RAE;@J1P17^1+_ ,%)_P!G#4OV4?VV?'_P6OH?*MM/U.66
MQ.,"6TE;,;CV-?3<.5=9TCYCB*C\%3Y'PM12FDKZH^6+D7^K%25!'(BH :?Y
ML?K7GSA+F>@']4_BCXV?LY^#?V>)/!?_  65\5>$_CIXM72$A\.:1X,MEN/&
M&D'8/(2\\1VS06T2Q?QV\PNWZ'#!3&?A_P#X)S6D?[%O[)?Q-_X*H>(E$/B&
M%)/ /PQ#C#'Q!JD)%Y?QY_Y\;0MM;E&9F0\BOPX\V/UKN=6^)_Q%U[P/I/PR
MUSQ#J5[X:T"2>;3-)GNI9+&RDNCNF:W@9C'$TI&7**"QZUR+!2Y>5;/?33T2
MZ'=]<O)2MJEIW]6_+H?U=_ SX>_M(_$[2_\ @FMXW_9EL=4U'PCX>O[G^V;G
M3$DDMM/O4UG=J[WK1C;%YMOOR9,>8FX#.:]<_: \%_%_XV>(/V5?%?[!EE?:
MIX2T/XW^/YKV;08W>VL+J7Q49K>>\,(VI&; YC>3Y1!E> <'^1_X>?M/_M&_
M"/P=J7PZ^%/Q!\1^&?#^LEC?Z9I6J7-G:71=0C&6&&14?<H"G<#E>.E'PO\
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M$U]UHT\O+-P..:QJ63LD=%--J]S"DU!-.TPZCK;I;+&FZ5L@*N*\$\6?M*^
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M110 4444 %%%% $1B4U_%U_P=4?L$WFMZ3H'[=7P_LVE?3-ND^(O+7.+=O\
M43/CHJ,/+^L@K^TJO+/C-\*/"'QQ^%^O?"7Q_:)>:/X@LY+.YB=<@JXX./53
MAE]"!73@\2Z%6-1=#DQN%5>BZ?W'^,&>M)7Z(_\ !33]@#XD?\$\/VFM4^$'
MBNVD?0KEVNM!U$#]U=V3DXP>S(0493@_+G&""?SOQBOT2G4C."G#9GY[4IRA
M)PENA****L@4'%&:2B@84N:2B@0N?2DHHH *448KV/X!? CXF?M+?%O0_@C\
M(-.?4]>U^Z2U@B0':FXX,CD#Y8T'S.>R@FE*2BN:6R&HMOE6Y^ZW_!MU^P3J
M'[37[8D?Q[\5V?F^$/AKBZD++\DNHRY6"/W&T2,1V*BO](](UV5\'?\ !.']
MB'P1^P)^RYH7P&\'JDMQ"@N=4O H5KJ]D \R0X^F!]*^]1P*^ S+&?6*SDME
MHC[[*\']7H*+W>YY-K_P4\ ^)?$/_"4:W:^?>;2I8DC*XQCBOC#Q;^R9]M^)
MC:9H5S'9Z;.@E52V7'J .M?H7K_B;0O#5C)?ZY<QVT<:[OG(' ]!7X__ !2^
M,>N>(OBA-XP\.W+0+#^ZMV4X^1:PH<[T1OB.1+5'US9_L1^$89TDGU&=T4C*
MY'./PKZ]T+0O#_@W2H]-TJ%((XE PH )Q7Y%Z5^T9\7;/4XKPZJ\H# %&^Z1
MZ5^GVE:E/K&EVVIW/WYXE<_B*=6$].9A0E#[".Y?Q%&&(1,U7_X2&93]P8KG
MJ2LU%&]S?_M^ZW] %-*VL7/VOT4?E6'&,L!4D8%S<;<A1G&:.5!<[JXLK34[
M4V]_$DT;CE6 (_*O#X?V>? VE>.+7QQX?B^PSV[EF2/[C9]NU>ZVBI'"L:'(
M%6JR4FMAN*>Z&J,"AE##!I?:EI%'AOB[X):'XE\96OCF&0P7MLR'@#:RKC@C
M%>O0>41Y2.,IUP>>*U*XO5O FAZN_F2[XF+!R8FVDD?2FVV))+9&#\3/AUH/
MQ$T%M(UN+>!AD*#YL^V*^*]>_8OU&+Q-;)X>N=^EN1YOF, Z#OC^E?HO8V$=
MA"((B2%_O<FK]7"K**LC.=&,MS\T/B)^QIJFFQ)>> 9C=9(#12GD>X-7?"7[
M%5U>Z*)_%EX;6]9A\D>"NSTK]&YXFFC\L';[BHA&+:(L[<#J:OZQ.Q'U:%[V
M/SGT?]DS1;J9I=7FFMA'*P\K/51TYQ74:1^R;X)LM2^V7T\MQ #\L1.!^.,5
M]&Z-XBD\1_:-0-OY$0E*1Y_C [UT*1L1GH*T=25MQ*A!=#RS3_@?\+=(7_1]
M)B9FZELGC\Z[3PWX4\/^&4DM="@%K'+@[%^Z#712LIP%[#%1#[U1=M:FBBEL
MA7C*-M:KEM?W%JP*M\H[5#<?ZS\!BH*0SI6U_P Q<"/G]*P9[@W#E\;?85!1
M0DD NX]JE\P,NUQGT(J&D/2F!*\95@JBI ?(7'&[WIS2R180<<55H Q;;PWX
M=L=7DU^WLXTO)<AI0,$YK<-R[$ < >E-J"1_+C>8@D*.@Z\4 K+0\*\?_'.Y
M\(>*'\-V%BK2I&'W2\>9GLM?'GQ.^,6K?$2_32?&-@EI#$V$ 7#1YXSGO5_]
MI?QOI_BGQA;Q:3-OBLX]IPN&5\G(.:RVN/#]S\/K74M7MS?M'@2MD!QG@8KI
MA%*S..<G*\4>::OX$U.P NM,_P!-MGQM>/GKZ@5F7'A+6K6#SY8N%&64') ^
ME;-OXH31(F3PHDL.3EG8Y('IQ716EOIL^E7'C]&*,N4>$<Y<C&>.U:WMN<]D
M]CQZBGR$,Y?UYIE49A1110 4444 %%%% !1110 4444 %*#BDHH TM*U6_T7
M48=6TMS%<6[!HW'\)%?0_@"X^)OQV^(5NLNIS0M G[R:-MFU!Z 8%?,ZG%>\
M_ OXU-\'M5FDDLA=6]V ),'#J!Z5%3;1:FM*5G9['ZU>"O"G_"):2-,^US7A
MSDR3MN:M[5].@U+3Y;&=%=94*X89'(QTK$\&>+])\;^'+?Q'HS;H+A<@=U/H
M<5UNTUY;W/65K:;'XC_$SPOKOPH^(<UJLGDS(WG0O%\ORD\8K]1/@%\48OB3
MX(@N)W#7ML/+N!WW#O\ C6)\4_V>?#'Q)\56OB;69O($2['4?\M/05Z9X)^'
M'A;X<VGV/PQ;B%'^^?6NBI4C**[G-2I2A)]CT)I GWB *Q]0UG3((C')<1AF
M4[5W $X]*^<?C-XDU[QE*WPW^'UU#',[ 7,OF@,@] *^6[+X;^&(?$<>@>(]
M:O=1OMWDEK8-M@D]R<<5$*5]V:3JM:11Q7QK^-_B/Q@LO@EP$L;29E/]YRAX
MS2?LM^)!X:^)\,D[.EM<(86Q]W)QC/Y5Z7\/?V<?^$@\3:UX9\6VTT,5O(?)
MNL_-[8]<U]F^"_@/X(\&::MA:0B4C:2[#YBR]#71*<(PY$<T:524N9GM,1W(
M"*DJ)<1@)Z "CS5KA.\EHKY6^-'[<'[(W[/.F7NI_&'XAZ%HPT[BX@>\CENH
M_P#MWB+S?DE?G#X\_P"#BW_@D]X-M4GTOXB/K[L3NBL--O R =SYT$2_D36M
M/#U9_!!OY&,\31A\<TOFC]QZ*_G"T_\ X.C/^":-W>BTN&\0VT9SB9[$%./]
MURWZ5]7>!_\ @OM_P2A\=)90V?Q5M[2\O2$%M<Z??1LC$XPS_9_+'UW8K26"
MKQ5W3?W$1QN'>BJ+[T?L?17E7@'XY?!KXK*[?"_Q5I'B/RDWR#3+V&[*+_M"
M)V*_CBO3XYED4, <5S-6T.A-/8FHIH8'I3J!A1110 4444 %%%% !1110!__
MTO[^**** "BBB@ HHHH **** ()(59>E?FK^VM_P2?\ V,?V\])G'QH\*I;Z
MV49(=;TO%K?Q$C&[< 4D/0?O4? &!7Z8T5=.I*F^:#LS.I1A4CRS5T?Y]G[5
M7_!J9^U-X N[G5OV6_$UAXUTPR3/':WX^P7<, R43<#(L\F,#Y5C!/8=*_!W
MXS?\$XOVY_V>K!]4^,7PPUW1;1'*?:)K8^6Q']TC.1^%?Z^; %<51\O<<&O:
MH\05X+EFDSQ:W#]"6L&T?XLLW@KQE;@&XTB]3/3=;N/_ &6I3X#\<+RVC7P'
M_7N^/_0:_P!</]LGP6VJ^%;#5K.R\Q+.7=,ZIG8AZGZ5VNNQZ)K/[.L\GA,Q
MS8LE 95&[C&>W%=_]O\ NI^S_$\_^P/>:Y]O(_RI?A;_ ,$_OVQ?C%:PZCX"
M^'^JWEC.ZJ+LPE8%SW9NP_"OUH_9U_X-\OBYXCU&UOOVC-=BT6VW8EL-+ FE
M>/'43M\L9^L3<5_4G#>W=LGDQR,@[@' XJ;^UM3;AIW.>.O:G5S:K)6@K#I9
M717Q:GS_ / ?]AWX(_LK>'OL'PB\/6EM(B@3WF[S[J7'\3.PR,]PN%XZ5[@W
M7=WZ5J:+>SZ?J"30':&.UQC@J>H-;%[X:O+C7'MK./9"V75S]P)ZYZ8%>7.;
MD[R>IZ,(1C&T%9'(GK16UJ>AS:=$MTDL<\+'&^,Y&?2L6D  >E&*LVMM)>74
M=G;\R2L$4#U/ KWJR_9D^+E[ITVI#3]@B'"L0&8>PI-I;E*#>Q\^8H ]*ZW4
M? WB[1KU=/U/3;B*9AD*8S_A7V#\,OV1](\6^'K?7=:OYH99!\]N, J?0XZ5
M,IQBKLJ%*4M$CX2P:3!K]&]?_8FT:/1YWT"^D:\49B#_ '?I7SOXL_9C\>^#
M/!C^+M4V-Y6/,ACY95Z9XI1JP?4IT)KH>!:)HNH>(-5AT72XS)/.P5%%?J1\
M$OV8M!\#1P^(/$BB[U,88!ON1GT ]J^4/V0;/3KGXJ"2] \R.!FBSZY%?K,N
M O%<^)J->ZCIPM)6YF-6,#Z5+117&=H4444 %%%% !1110 4444 %%%% !36
M4,,4ZB@#\\_^"C/_  3S^$'_  4.^ E]\)OB%;B#5(D:32-5109K*XQPP]5/
M&Y>A]J_S!?VV?V%/C[^P1\7KOX0_'33C%+&Q-I?Q*?LM[".DD3>A';M7^P"Z
MAN#7RE^UQ^QE^S[^VS\++GX2_M!:%#K.GRY:WE=<7%I-C D@E&'C8=#M(R,J
M>"17JY;FDL,^5ZP/(S+*X8A<T=)'^/#BC'I7](__  43_P"#</\ :I_9:FO/
MB!^SG!/\2O!BL\FRS3?JEK&"-JO;J \N<G'DJ^ OS8XK^<O5=,U#0]3N=$UB
M![6]LI'@G@E4I)%)&=K(RG!5E(P00,$5]IA\32K1YJ;N?&U\-4HOEJ*QF444
M5N8!1110 4I4CK32Z1#?(=JCO7[+?L!_\$.OVV_VY]0LM<B\/S>#?!DK1M+K
MFLQFV1X6&=UO&X$DP8#"M&K+G&3BLJM:G2CS5'9&M*C.I+EIQNS\O?@W\%_B
M;\?_ (BZ;\*/A'I%QK>O:K*L%O:VZ%F+-P,XZ >OI7^DK_P1=_X(V^$_^"<'
MP\7QS\15M]:^*>N0@:C?HN8K&-AS;6V>R]&DZOSPJG:/J7_@G)_P2I_9E_X)
MR> QI7PMT]=0\2W:_P#$R\0WB!KVY;^Z&_Y9QCM&F%[XR37Z?1C:H':OC\SS
M=U_W5+2'YGUV690J'[RK\7Y @V_*HP*RO$.M67AW1KC6M0<)#;H78^PK9!!Z
M5X+^TAJ^BZ7\*=235Y!'Y\92(=V;L,5XL5=I'MR=HW/RQ^)WQ*\0?$7Q'<:K
MJ=PQBW$11J<(J=N*\RQR.*VM&\.ZUX@G^R:):2W+CLBYKV[X??LY^,O%>I^5
MKL#Z=:QX+.XP6]A7J^[%'DVE.5['._#OX'>,/B' ;[3\6UM_#+(.#].E?IEX
M'TS6M%\+VFDZ[(DMQ;H$W(,+@=*E\'^%=/\ !6@0>'-,+-!;C"EN^:ZBN6I/
MF.^E14!:***S-15)4Y%2F-6PT??C%0U/ P&[/;D4 6HM1N+-1'$V<>U7;;7Y
M]^)QD?E6">3FBIY4.YZ:CJX!4TDK^5$7]!7G4=U<0G*.16K_ &])]G,<@!)X
MS4<C'<237;PME<*/I6S;:Y;2X20;6/Y5Q/#"IXFPX[57(A7/15GA;A6%2Y Z
MUYF6<-G[I]JM#4;P)Y>\XJ>0=SOA/"6V!AFN9\9ZBFG>&KJX\P(=A53[FN>5
MG+C!Y]:Y?Q]X;D\8>&;SPU=2%#,A"MG[IQQ34-0YC3T]K+3=$B:;Y4BCR6.
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MGI7PX^,/Q5^$&K)K?PL\2:CX?NDD23?87+P LA!&Y5(##(Z,"/:OZ4/V&/\
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M&*=7.=(4444 %%%% !1110 4444 %%%% !1110 4F*6B@"*5%:,J0"",8KX
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MT^PTE;-W/^S<&YEVX_ZY&O[* H%&T54\[Q<M.:WHD@ADF$C]F_JS\C_V5O\
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M@*X<TM]4J>AWY7_O5/U/]$N/-2U%'WJ6OS\_00HHHH **** /__6_OXHHHH
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M@,KN&.*J#2>I,EIH<O\ #+XA>$/'%HTGAJZ$[+RZ=&7/3(_"O5N0>E?GK?\
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M4Y&:6JMM<Q3Q!T-600>E04+1110 4444 %%%% !1110 4444 %%%% !1110
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M:/\ AB[]CW.[_A5'@W/K_85E_P#&:K^UX^?X=K=B%DLEMR_<^]_^!Z'X ?\
M!N-IGP5TGQU^TSI7[.VJSZ[X&M_&4,>AZA<R/+-<62QL(I&9U1B63!R5!]J_
MJ35 !R*\V^'?P9^$_P (HKFU^%/AC2/#,%XRO/'I-C#9+*RC +B%4#$#@9'
MKTVO'Q-;VM1S]/RL>SA*'LJ2AV&A0HP*=116!TA1110 4444 %%%% !1110
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M"OD<PS6>)]U:0['UF7933PWO2UE^7H-4;5P*<*6BO*/6"BBB@ HHHH ****
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MG+H4D.HHHK,H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3_\ @B;<Z9\5M6^+'[&7Q9UCX1R:V6:YL+$2F(>8<NL<L-Q!(L6>1&P<*>A
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MW[,?QC\/?%WX:^,VT&&:]T.R6RU75;J2SNX8;>!Y/+B@27=<02;7'SVNP,H
MD)V( N2/<KVDOY3];1R,BEJ*(_*%]*EK(W$P*6BB@ HHIF["Y- #Z*B\S]*^
M;OCC^V!^S+^S9"LGQT\=Z%X6>12T4.I7\-M+*!UV1NZLW_ 10E=V0G))79]+
M45_/;X]_X.:O^"7'@^:[LM&\1:GKES:;EV6NEW021EXPDABV$'L<XKY=O_\
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M_];^_BBBB@ HHHH **** "BDZ55EE1/F;Y1^5 %NBLZ&[MYR?+D5L>A!JZC
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M#=7#D?@'%?R18K[[*/\ =*?H? 9K_O=0***>BAF"FO1;LKGG'TG^Q_\ M/\
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M^\M?122/Q3_8TT3X\?%K]ISQ+XA^(_P_\,77A1F"2ZQ-9I+/(DJB14BFP%F
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M[.\/Q89\&20\LQK"M5459'10H<SUV.L\)>&M*\):'!H.C1B*"W4* /:NFI
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MO-N(KRU8D)(AZ'I@X[U\9<8K] A-3BI1V/@)P<).,MT)1115$A1110 4444
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M4 ?GG_P4,_X)R? S_@HK\')?AK\6[*./4;-7?1]611]IL)F R4;KL; WKT;
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M HHHH **** "BBB@ HHHH **** "BBDR!0 M%(,$<4M !1110 4444 %%%%
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M10!__]7^_BBBB@ HHHH ***3(H 6BDRM&5H 6BLR/6M&EU&31HKN%KN%%>2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*K-:6[@JZ@@\=*LT4 0PPI @BB 51P *FHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@"G=6<%T%24=*CM]-M;:02QK@]
M*OXI: L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ?_]#^_BBBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#_T?[^**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /_2_OXHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>soph-20251231_g13.jpg
<TEXT>
begin 644 soph-20251231_g13.jpg
M_]C_X  02D9)1@ ! 0  2 !(  #_X0!J17AI9@  34T *@    @  @$2  ,
M   !  $  (=I  0    !    )@       Y*&  <    2    4* "  0    !
M   #]Z #  0    !    ]P    !!4T-)20   %-C<F5E;G-H;W3_X0DA:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[
MOR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \>#IX;7!M971A
M('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)835 @0V]R92 V
M+C N,"(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2(B+SX@/"]R9&8Z4D1&/B \+W@Z>&UP;65T83X@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" \/WAP86-K970@96YD/2)W(C\^ /_M #A0:&]T
M;W-H;W @,RXP #A"24T$!        #A"24T$)0      $-0=C-F/ +($Z8 )
MF.SX0G[_X@TD24-#7U!23T9)3$4  0$   T487!P; (0  !M;G1R4D="(%A9
M6B 'YP "  ( "0 P #=A8W-P05!03     !!4%!,
M    ]M8  0    #3+6%P<&P
M                         !%D97-C   !4    &)D<V-M   !M    ?!C
M<')T   #I    "-W='!T   #R    !1R6%E:   #W    !1G6%E:   #\
M !1B6%E:   $!    !1R5%)#   $&   " QA87)G   ,)    "!V8V=T   ,
M1    #!N9&EN   ,=    #YM;6]D   ,M    "AV8V=P   ,W    #AB5%)#
M   $&   " QG5%)#   $&   " QA86)G   ,)    "!A86=G   ,)    "!D
M97-C          A$:7-P;&%Y
M
M            ;6QU8P         F    #&AR2%(    8   !V&MO2U(    8
M   !V&YB3D\    8   !V&ED       8   !V&AU2%4    8   !V&-S0UH
M   8   !V&1A1$L    8   !V&YL3DP    8   !V&9I1DD    8   !V&ET
M250    8   !V&5S15,    8   !V')O4D\    8   !V&9R0T$    8   !
MV&%R       8   !V'5K54$    8   !V&AE24P    8   !V'IH5%<    8
M   !V'9I5DX    8   !V'-K4TL    8   !V'IH0TX    8   !V')U4E4
M   8   !V&5N1T(    8   !V&9R1E(    8   !V&US       8   !V&AI
M24X    8   !V'1H5$@    8   !V&-A15,    8   !V&5N054    8   !
MV&5S6$P    8   !V&1E1$4    8   !V&5N55,    8   !V'!T0E(    8
M   !V'!L4$P    8   !V&5L1U(    8   !V'-V4T4    8   !V'1R5%(
M   8   !V'!T4%0    8   !V&IA2E     8   !V !$ $4 3 !, "  4  R
M #< ,0 Y $@ 0W1E>'0     0V]P>7)I9VAT($%P<&QE($EN8RXL(#(P,C,
M %A96B        #SV  !     18(6%E:(        &2'   S*@   0I865H@
M        :N0  +R7   1REA96B         G:P  $#X  ,!98W5R=@
M  0     !0 *  \ %  9 !X (P H "T ,@ V #L 0 !% $H 3P!4 %D 7@!C
M &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *, J "M +( MP"\ ,$ Q@#+ -
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MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\
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MIP  #5D  !/0   *6W9C9W0          0 !          $    !
M  $    !          $  &YD:6X         -@  IT   %8   !2@   G
M "<    /0   4$   %1   (S,P ",S,  C,S          !M;6]D
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]L
M0P ! 0$! 0$" 0$" P(" @,$ P,# P0&! 0$! 0&!P8&!@8&!@<'!P<'!P<'
M" @(" @("0D)"0D+"PL+"PL+"PL+_]L 0P$" @(# P,% P,%"P@&" L+"PL+
M"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+
M_]T ! ! _]H # ,!  (1 Q$ /P#^_BBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB@ HHHH **** "BBB@ HHHH BG@AN87MKE%DCD4JRL,JRG@@@]0:_+_X;_\
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M5?M6IB%D-_Y"IF0YP_E [?ER/ES@XHO=+\1S^%#I%GJGD:IY"Q_VAY"M^]
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MS%TF/,#<#+<C)YSZTUL+J=-1112&%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!EZU_R#9/^ _S%<'7>:U_R#9/^ _S%<'5Q)D%%%%,D****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOS1R(Q1QG!#!E'V_6-2G*$G":LT;TZD:D5.#NF%%%%06%%%% !1110 4444
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MF>_2OT4KS#T0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,O6O\
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M;C_@FY^U#H?[&7_!N3X;_:4ULQLWAC1_$$ME#(?EGOY=9O8K2$]\27#QJ<=
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MD>XVVLL3I&LD4:R.S;1N7([C];ZHZGIFFZWIMQHVLV\5W9W<3PSP3()(Y8Y
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M)\:?V7_:S2+_ &3J$&I0^60,S09VAL@Y7DY P?>G&U]12O;0Z^BBBD,****
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MC&K%WO?3T\]NFU[GGRS&G&M*C-6M;73K;IO;7>UEU/Z3Z*_G"^,'_!POX?\
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MWA6'KFC:7K/V/^U&=?LES'<0[)&CS+'G:#M(W#GE3D'N*W*\6^,_AW7/$/\
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M5_$^EPZSX4^&'PZUW1O%.LPWEN8;74]8?4[C[,D,DBW$R(]XD2ND10@9.!G
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M$>@%%%% !1110 4444 %%%% !1110!EZU_R#9/\ @/\ ,5P==YK7_(-D_P"
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M#EI))'B+.S'DLQ)-?8-%-5)IW4G<ETH-*+BK>AX/\'OV6_V:OV>X=5MO@/X
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M>/?V?]3U75=)\37>DQ:A#<2ZU*DURIL7F"1H'C7RU+R*%W!@Q<L.,_X*@?\
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M^"@'QNOOC7>VGA;4_"&FQKHMOH4B:?JMK/93-<S0R2O<2""YE",_S*Y#%VP
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M5?$<WP[L=1+ZRLKPFW,$J_/#EG&\H$X"DYS@]LUJ5236Y#:>S"BBBF 4444
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MHO\ R#8_^!?S-:E9>B_\@V/_ (%_,UJ5#-$%%4YM0L+>[AT^XGC2>XW&*-F
M>38,MM'4X!YQTJY2&TU:X4444""BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /_U/[^**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110!WFB_\@V/_@7\S7F/QZ_X7E_PJW5/^&<_[+_X2WR_]#_MC?\
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M?N[_ )L=:Z^BFHVZGEYIG?UV$8?5J5.SO>G#E;\GJ] HHHJCQ HHHH ****
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M>O?[R?F?\*[*BCF861QO_"/7O]Y/S/\ A1_PCU[_ 'D_,_X5V5%',PLCC?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>soph-20251231_g14.jpg
<TEXT>
begin 644 soph-20251231_g14.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" //!RD# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,P5<F@!U%49-357VA2:DCO0X^9<&@"U130X8<&E!![T +1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRTHM(E.=HJ:B@",P1D<H*ADL(G4X&T^U6J0]* ,*X@:"0C''K457=38M( >
M*I4 %%%% !1110 4444 %%%% !1110 4444 %%%2I;&1-P(SZ4 1#((QU'-7
M[:2:0J0P.T_=J&*W.2'B+'VJ[;V2* V"I],T 6 X#D;3GN:EI!TI: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!,"EHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBDZ4 -DD$2%CT%4+C4\\1_G1J5R?\ 5@8%9Z(78*!D
MF@"8W<[D#<<DXJU';7,H&Z0@5/:62PJ"PR_\JMT 41I@8Y>0M4T=C%&<A>:L
M44 (!@4M%)G YH 6BF+*K$@'FGT %%%% #22'Z<>M.I"<9S5=K^%3@MS0!8)
M ZG%037D4 Y;)]!44FH0L,9)'M6=.Z.^8P1]: +K:L.R57EU&1S\OR#VJK10
M!86]E5MV[-))>RN"-W%044 &<T444  .*7)/<D4E% !CW-.21H_NL13:GM[4
MS\[@%[T 26]]+O Y<5K(VY0<8SVJHK16JX!!/>FI?Q[BV2/:@"_155=1A*Y)
MP?2D_M*'UH MT572^A<@!N34^X>HH 6BD]^M56OU1RK CF@"W159;^ _Q@5(
MES%)]UP: )/I44RR-&=IVGVJ;K10!G&XNH?O+N'K3!>S,Y*J2/2M/'8T@0#H
M!0!0^W3CGRN*M6UP9URR%#[U*0<\8QWJ%[@H^T1D@=Z 'M*4_A)^E-^TKZ$?
MA3HYUDXY!J3:#VS0 V.02#BGT@ %+0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6D4,8R<E<CI5@=*XO4]!,6BBB@84444 %%%% !44\@CC).?PJ6D(!&",B@#
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M_P"'%;*HJ]!BG4 9T.E*.9#D^E78X$B VC%244 %%%% !1110 4444 %%%%
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M:D&H(ZJKG#GCFO./6(FTG)X?BG"UALAO<[L=*<WG1997#KUJ"34!+&5>,$T
M$NINS#9@+Z5%/?&>+8PY]:K'DT4 .#LO\1_.FDY.:** "BBB@ HHHH ****
M"BBB@ HHHH *L6UV;<$ =:KT4 /EF:9B6/X4RBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ***EMX?M$FP'!H BHK472DV\L<U6N[)H
M"N6'<T 5TB>0$JNX"F$8.#UK0TT/N(&-HZBFW]D4/F)]WN* *-%%% !1110
M#CI5JVN)D/RY9?2BRM!<9+''M6K%"L* * * (;>]\P[74HU6J;M!YP,TZ@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CVOYI.X;,?=J2BB@ K!U
M36M0ANS;VFG/+S_K2?EK>HH$8/B$:DWAZ0VB_P"G;>%7MGK7D!\ ZQ<I<7VJ
M-]F55+M)(>I]*]ZD+!#M4,W8$XKD=;\*7WBMU6]NC;6H/^HC[UI"5C*4+G@O
M4G!R!WHKTO4O@^XU3R[27%KMW%Y.,>U<AKNA6FB"6-[P2W*G 6/D8^M=2DGL
M8.#6YATH&>@))XP!FI(+2>[<+# TC$X&T9%>B>#_ (?7&FWEO?:FB+"<?NW/
M/Y4G)(2C?0XK3_"VJZHZ+!:.P?[I(P!771>"[+PK;BZUD&ZE(R+>(Y(^M>QQ
M11+&!&BJN.-HQQ55-#M!,96B$DA[OSBL'59NJ:1X]"FL>*)EATNU;3K0="J[
M2:NP?#'6[Z:-=0NG>!'SM<Y)%>PQQ)&,(JJ/88I]3[1E<B,NTT6"UT]+>*",
M;%V@LOZUPGBSX6OJ5P)[-P)VZXZ8KT^BI4FBN5'AQ^$&L $AT/H*RIO FJ:7
M>(MS:-)$.20<"OH:H+JTBO(7BE4,C @YK3VKZF;I+H?/=Y!8W=I>.H=;FWQM
MC!R!6';P2W+!8T+'\A7=^)O"4OASQ&6L[1[BSE'&>@)IH\-7LTT,<=N+:V9=
M[D=_85LI(R<3B[K3;FQ16F38K\!A5:MV_ GTZ>'#1FVE) ?KCTK"'3TK0S"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#2\/Z)-XA
MU2*SA&=Q^8^@KWGPOX.LO#-N@B0-/CYI2.:\I\ >*M,\*K))/&SW<A"@@=%)
MKW"UN!=6\<RC"NH89]ZYJLGL=%.*)>M+116!N%%%% PHHHH *C=Q&I8D!1DD
MGIBGGI7PS^WW^T%\0?AVO]A:'ITNGZ1=(5?5HP2&![9[5O0HRQ$U3CN<N)Q$
M<-3=270\D_X*6^/]"\5^)M'TS2=36]GL2RSI&^0ISR*^*?TJ2YNYKZYEN+B5
MIYI26:21LDD\FHZ^^H450IJFNA^9XJN\15=1JUPHZ=^1SD44AST'7]:Z#F6Y
M],?L+> M>^(OQ7LQ!K=W8Z3IS>;/'&YP_L*_7*ULS90P00,!!&N"&Y)K\H/V
M7?VD_#_[/>I6=GIQ?4H-3VK?/<)L$+'&<'N!7Z&^(?VJ/AQX;\+1ZW/XAM9(
MY(O,2"%PTAXSC%?(YE3JU*WNQTZ'W64U:-.A9RU/4M7U:TT/3;B_OYEM[2!"
M\DCG@ 5QWP_^+.G_ !$N97TYLVF2L;$<MCO]*_/']H#]O34?C$H\-^&[&6RT
M>5P)#&2TDXSTKZ:_9[U2;1-&T"6.S^RAT$;I+\K]!VKCJ8*5&ESU-WT.ZECH
MUZW)2U2ZGUD#QFG4U"&0'L1FEKS#UA:***!A1110 4444 ,>,2+AAD5%)9Q2
M C;CZ58HH Q7L)0Y 7C/%7[&U^SIEA\YJW10 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 44UV"J2QP!R3TQ5:#4K:Y25XI5=(_O,O04"
M+1SVI#T..N*YD_$31B[QK,[R*=I5%SS6]83&XMUD^8AN06&#19H$[CK0R,K>
M:I#9_.K%(.E+0,*\G_:0^&?_  M/X>7>CI?MI,[?,EZK[?+QSUKUBLOQ!H]O
MKND7-G<P"YB<$^26(W$<@9K2G)PFI(RJP4X.+/Q ^.?ABP\&^*XM&M=2FU:^
MM4*7ES(V=SYXV^U>=9[U[5^U1X+\3Z;\3M;U75/#$NB63SE(]@+1,.VUJY#X
M4?!3Q5\8/$,&E:)ITS*Q'F7#(0J*3UK] IU8JDIRD?F-:C*59PC'Y'+Z/X;U
M#Q!#=26$!N!;+OE"_P *^M>@^"KFY\/_  NUR2]OEM=/OUV6\(^_*U?HQ\!_
MV$/#GPMT:^CU6Z?5[G4K8Q7,;+\B$CG;7YZ_M0Z=!X0\?WOA"TTI]+L=,F98
M0Q/[U1_%7)2Q<,54=.'3J=M7 U,'356?7H>-KT_QI2,C'?K2TAX^GK7J^:/%
M/I/]GK]M_P 6_!#3[+0?L\6H^'8GX@*Y=<GG!K]2/AA\3H?BQX(L=?TJ)K?S
M@-\4PY0XY%?G)^RY^PK>?%S1['Q=J>HI;:,TBO!&IRTFTY((K]0?#'AVT\+:
M%9Z7:(JPVT:Q@JH&<=S7QV9/#\_[O?J?=Y3#$\G[Q^[T,[QKX&L/'-A'#?(P
M9.4VGH37@NO_  "UZRO95T]/M$ /R8/:OJ''?I47FY9D .<=:Y<)F-?"+E@]
M#JQN48;'2YJBL^Y\WZ/^SEJ]] KWETEDQ/*D9P*[;2_V=-$AB1KR9YYA]XJ<
M UZ3)]J9F^\1TJ',T+ '*_6M:V;8NK]JWH8T<BP-%64+^;$M= LM!L([6T5(
M(XP!@#DU'4UQ(SD9YXZU#7DRDYOFD]3WXQC"*C'1(****DH**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHJ]IUJ')=U!6@"C16]]FCQC8*#;QDYVB@#"YS
M@"G>2^,[3BML6L0.=@IX48QC@4 <]@^AJWIQ43_,<&M.2$2*<8!/?%58M+5<
MEFR?:@"\""*" 1@\U'#"(1P3^-2T ,2-8\[1C-4M3E*J%!P#6A63J@'FCUH
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M10 4444  !) '4UM6,/DP@'J:R($:250O7-;ZC"@>U "T444 %%%% !1110
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M8Y&S*S2@C!5NE6R:44Q6*\-A;6Z[8X40>@%6!P*6BD%@HHHH&%%%% !1110
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M(XD1QD..C>]*JEW '#$=Z^16)K)M\Q]V\'AY))P.5^&_PWTGX7>&HM*TM2Q
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD]9B4/Y&LJE2G"/ONR.BC2JU&G35V>\_#;]L;POK^GBWURV&C36T>V-8S\A
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MC0C9;]SYFOB)5Y7>P9SR>M%%%=1S!1110 4444 %%%% !1110 4444 %%%%
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MQ]C#%4*GP3.VHH1DF&Z*1)E_O1-N'YT5S?(Z[A1110 44JC<14PM]K<\J.U
M$:1%^1@#WI3"1_$*260LQ'W:90 XQD<XS[TVG)(4Z=/0U(9(SU7!H AHJ4SX
M.%48%)YV1AUR/:@!PPT.T$ ^AJ-E*]:?NCVC"G--D??CVH 91110 4444 %%
M%% !1110 JL4/'%/(#C(X/I4=*"0<B@ VG'3I25*9S@<#_&CS$)SLYH BHJ8
M2!P0RC':F-&5&30 RBBB@ HIZ1[^3P/6G?NEXP7]Z (J*DPA.,XI'B*$8Z4
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M#6.IV0QU*6DM#]+Z*\L^#O[2_P .OCO:;_!_B:VO[Q5W2Z;,##>1<<[HG ;
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M-ID4T1FLI-X')B/WEK.(QP00?>BX6"BBBF2*H#$ D =23Z?Y%?GQ^U=\1?\
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MID[<"=?2,D@./^!#E2&_8:&1)HD>-@\; ,KJ<@@]"#7\W_Z?C@U^I'_!,O\
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MVJ.O+]$^*%Q8Q"*^C-TB]&7[WXUV^@>+=/\ $7[N!Q'<8SY+=:3IM#51,V:
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M?&7]EVATVV?%S*/F8'E17C&3G).3U)-=-./4YJDN@=****Z3 ****0!1110
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M 4444 %%%% !1110 4T@&G5SOC[QSHGPU\(:KXF\1WR:;HVFPF:XN).BC.
M!R6)(4 <DD =:+-O03LEJ97Q=^+GAGX(>"+_ ,5^*[_[%IEJ JJHW2W$ISLB
MB3^)VP<#IP22 "1^,'[4/[5?BC]IKQ9]KU-VTWPU:.QTW0HY"T=NO3>_'SR$
M'E\=\# I?VK/VHM=_:;\>MJ5UYMAX;L2T6D:.7P((\CYVQP97 !9NV !P*\1
M_6OHL+A%27-/XCYW%8IU7RP^$,8Z]:***]0\ST"BBBD,**** "BBB@ HHHH
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M5^<OCCP#X5L/%NJ6<FKW.D7RRLQM)8< 9/.#7Z+^,OBO\+K#50UAXNT\W!W
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M6Q]A45F^&=4.NZ!:7SD&21?G /0UI5\1.#IR<'NC]'I5(U8*<=F%%!P 6)
MZL>U$-U#,I,7S@'!;M4I-ZFC:6X#)Z#-!!'48J7?&JY7(:D64@?, P]Z0R.B
MI/._V!0)A@_(M &5XCT9-?TB:U<?/C,9]#7AU[92Z;=26\R[98SCGN*^ATVM
MD\!L$^W3BO"/%4TT_B"Z,Y4ONP<>G:NBD^ASU5U,FBCI170<X4444 %)M!/0
M?E2T4 "$Q.&0F-AR&7BNGTCXB:KI8BCDE$T"D ANN*YBBDTGN--K8][T76(-
M>L$NK<CG[R>AJ[7A>@>(KSP[="6V<["?FC/0BNP7XML67=:J%[X'-<TJ;OH=
M,:BMJ>B45Q"?%G32/GMI@?:D;XLZ<'XMIMM3[.78KVD>YW%%<_I'CK2-7R/-
M^RL!G$IZUO0RI=1"2*19$/0J:AIK=%II[,=12X.:IZCJ]EI"%KN=(CU"$\FE
M:X[ENFS0I<PO#,H>)U(8'C KF3\2-(''SGGK6;K_ ,3;064D%E&S32*5WMT%
M:*$C-S1QWB_2[+1-7>'3[@F,C)"'&WVK"^M*268LQ+,3DY]:2NM*R.1N["BB
MBF(**** "BBB@ HHHH *FL[V;3KF.X@<HZ,#QT(J)59B  3[XKL/!'@VZO=3
MCFO+8+9J-_[SH_TJ6TD4DVST3PUKB>(=+BN$YDP X'/..:TZ?X=\.V>D"1K1
M/+1R<BMB2RBE.<8KC=KG9&]C-L(S).,#@5M5'#"D*X48J2I*"DI:9CWH ^-/
M^"E'@2'Q9\++75K$1/J6D7'F/(C#S$C[].G-?#'PR_:\^)GPN18]-UM[BU
M,%S^\&!V&:^Q/VK_ (:>)O'_ ,5[FPN]6'A'PE+:@)?.2(+B0G[K>]>?:Q_P
M3&OI_"5M?^'O$4.H7CQ[V&?D?TVU]7A:E"G04*ST9\9C*>(J5W5P\;6-KPC_
M ,%0IKV\T*QUS1A9(;A5OKR/YLQ^R]N:^_/"OBC2O%^D0:GI-TEW:W""164]
M,^H[5\$_L;?LA)I/B'7K/XE>&RU]",VK3#Y'7/WUK[Y\+^$=)\&Z<ECI%G'9
M6R_P1BO)QZPRG:BO\CV<N>)<.:N_\S9HHHKRCV@HHHH **** "BBB@ HHHH
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MH_[)&H:C^T/H7PQ/B.UEM->LWU+2/$EA!Y\%]:?9Y)XI41G7&XQ%""V%8'J
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MC<NPU>]2>C[G5E^;XO#<M*GJK['K?Q*\=ZI?:S+H^BHTL,# NT?5N?Y5L_\
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MY4<7WV/<>E>YR1F2,#=@^M9?ASPS:>&;8P6HX8Y)-;%<<Y<S.R$>56&-&L@
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MCRFCD(R2">0/PJM^VG\:K;X0?"#4?+G":OJ2-;VL8/S'(Y/Y5^17A#XA>(_
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MAK5_[?30O[)O1KCW"VBZ8;=S<F8MM$0BQNWDD +C)/%?67QG^(OBSX%_L_?
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MW\#OCYX[^,6L?'73O%GB"ZU;1;OP/K%VNDS,?L=J\2KY7D1=(MH)'RXSU;)
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M7RU.5,TA3&TL<8&.,UTTG*[BW<YZJCRJ25AE%%%=+.<^A/V&-;_LOXZ16I;
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MT@\(ZPWB?PO97GVF*[G,>)/*8';CITK\I>F,'![8."*]@_9HU[Q>WQ%MM/\
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M=W124M<9U(****8PHHHH **** "BBB@ HHHH **** "BBB@ I#2TA-(#\O\
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M?B'J):U<K;Z%K-T_,1/"VDK'^'H$;M]P\;<>'B\':]2F>UA,7M"H?I?G-+2
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MG7?%/A[]L."7P=(DU[I]B_BO4#JPW<QV[62$L,,0A;C ^8HH^40Y5;15[?\
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MN-P_LY<\-F?0X/$>TCR3W1ZC12"EKRT>H%%%%, HHHH **** "BBB@ HHHH
M::_ ;]I'P#_PK'X\>._#*Q^3;V6JS_9E]+=V\R'_ ,ANE?OW7Y9_\%9?A)_8
M?Q \.?$*TAVVNM6YT^^=!TN8>49O=HCM'M":]+ 5.6KR]SS,?!RI\RZ'P111
MTHKZ0^="BBO1?@9\%M1^./C"?2;74;31--L+.74]4UG4#_H]A:Q@;Y&'4]0
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M%'P+/J\T>HV*E[@X1HP./K6[\.O"DGAG22)\?:)>6QVKKJ*OG=N5F?(KW$)
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ME)6=BXNZN3TUU5U*L-RG@@C(J/R,^668Y0=CP:FJ2AD<:QH$0!5'0#I3Z**
M"D-+3&QSGM0!\J_\%%/VA)/@K\%GTG2+HP>)_%)?3[5HS\\$&/W\H[@[6" ]
M0T@(^[7XTU[]^W#\<I/CG\?]<O8)C)H.CNVE:6JME6BB8AI1V_>/O8'K@J.U
M> _YXKZC"4?94U?=GRV+J^UJ.VR"BBBNTXPHHHH **** "IK&SFU&]M[2VB:
M:XN)%BBC49+.S   >O/0?7FH:]__ &$OAFGQ1_:=\(V=Q'YFGZ7*=8NACC;
M Z ]L&3RP<]C43ER1<NQ<(\\E'N:_P :_P!@#XD? GX<77C77M0\/7NEVC1)
M/#IMS/)/'YCA 2KP(I 9E!^8]>AZUR?[-_[)WB_]J$Z^/"VHZ+8?V)Y'VC^V
M)Y8]WFF3;L\N)\_ZMLYQU'6OTBT3QC;?M,Z]^TW\*[F03V=K)':63<':QMO)
M8K@_P7%ON'N>OIXI_P $B[6>QO/BW;3Q-#<Q-IT<D3CYD8&Z!!]Q_G%>6L34
M5*7-NK'I/#P=2/+LSQKQ9_P2Y^,WAG1+C4+>7P[XCD@4NUAI%]*;AP.?E$T,
M:L>.!NR>G-?,W@7P'JWQ"\=Z-X1TJ)5UG5+Q+&%)\JL<C-@E^,@+U/!. >*_
M1S]@W]FKXG_L_P#Q$\6^)_'T<?A3PHVG2*]M/JD$L=P_F*XE<1R,BB-5?YF(
M(W\9RV.!_8T\.Z/\8_VZOB%\1=.0MX;TBZOM4LYF! :2XD=(G(/W<H97P>F!
MZ5<,3-*?,[V6Y$L/%N%E:[V/GW]HG]BGQW^S-X;TW7?$]_H>HZ??7?V)&T:X
MGE:.38SC<)(DZA&QC/(Z"O(? 'P^\1?%'Q78^&_"VE3:SK5ZQ6&UM]HS@$EF
M8D*J@ Y9B !WK]*=4\2+^U_^QM\90$>[O=!U[4KW3-H!<QQ2FZ@"\]XG>,>W
MKU/*_P#!+;0=-\,_"SXH_$,P1W&L6I:T7/WDAB@$Q4>@=F7/^X/2G'$R5%N7
MQ+3[P>'BZJ4?A>OW'C][_P $L_C3:^'SJ,<WAJZN_+#G2H=2D%SD_P  9HEB
MR/\ KICW-?(^HZ?<Z3J%U8WD+6UW:RM#-"_WHW4D,I]P0173WOQ=\:W_ (SU
M'Q;)XHU6/Q'J'F"YU&&Z>.5DDSOC!4\(0<;!\H' &*Y#I792517YVF<=1TW\
M"L%%%%;F(4444 %%%% !7UI_P3D_:"D^$GQGM_#&I77E^&/%CI9RK(?E@N\D
M02CTRS;">F'!/W:^2Z?#-);S)+$[QRHP=7C;:RD=P>QZ8/:LJM-58.#-:51T
MYJ2/Z/5Y I]>+?LB_&L_'WX#>'O$MRZ/K"(;#5%3C%U%@.V.V\;9 .PD%>T#
MD"OD91<&XL^MC)32DMA:***DL**** "BBB@ HHHH **** "O$OVQ?@J?CO\
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M,<1>-F);<Z.&((' '.?LY4TW'5_@6IQFUS:(D_:-\46.A^&?AQ\)[6^_MM_
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MR/I14EW;_9;F6'._8QY_&HZ[D<04444 (>>!U/'ZU]#?#NP^P>%K53P7&_\
M.OGDD@;AU'/ZU]"?#G4&U'PM;.PP4R@_"L:NQM2W.HHHHKE.H***0G SZ=Z
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M!P&&1ZT ,HJ0QAN5/X5&>#S0 5(G,;U'4D)VAN ?K0!&>M%2>=_L+1YW^PM
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MT_:QY;FM*I[*7,?I'^SI_P %.?$?CWXMZ3H/Q%M_"7ASPO>K*DFIP)-;_9Y
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MB,#CY3GXCHK/ZI37,MD^A7UJ;4>K1]ZWO[)O[,5EXCOO$]Y\?M,D\&,'N(M
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M$TOV96^)'CX_$77[,OX8\.2@V22IE+N^ RN/41<.?]HQCG#"OUI P*YOX?\
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M"*]WI ,$U49R@[Q=B)PC-6DKGY&?%W_@EM\3?!3SW?@^ZLO'.FJ25BB86EZ
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M<@Z#/UH,>]=RD#V- $=%'2B@ HHHH 53AOKQ2N,.:13\P-.F^_GUH 91110
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M-QX?U%;ZYF4DKP@KT8=*YJD^B.BG#JP%+117.= 4444P"BBB@".90\;*?2L
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MF:BH **** "COBBG1@%AF@!YS%& .&//%1L=QR:=,<N?;BF4 %%%% !1110
M4444 %21<;CZ"HZF@)"NWH* &)$SJ3BI+=I('W@$>M,:=F4#/'6FM(S'K0!L
M07:2<?=/H:G(RI'J*PTF.1N/T-:5I=%L1OU'0^M &7,FR5E]Z95S4XPDX8=3
M50 DXQDT )14ZV4K8^7&?6KD.EKM!D.6H HQ6[S<(M6XM+/!<_A6A'&L:A5&
M *?0!'%$L*[5&!4E%% !1110 4444 %%%% !1110 4444 %%%% $<L:S(R,
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MI4UK^R1KF@?'O0?A]XIUWPSI<>H10:C;ZM/JA33]0M6<!1;S;,L[X=%7:I+
M>H)V/C9(X_8P_9S0$A#-K[% >"1> #]"?SKKOBU-'!<?LAW,\@0)HNG&29V
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M6O*S%_NTNYZF7QO4;['M0'2EI :6OGD?0A1113 **** "BBB@ HHHH ****
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MQ*[YV'_<"U[2:,'/6N*>)JU-)2.R&'I4]5$3^'ICVI12T5S'2%%%%,84444
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M#'<"N4[ADA!VX.<5H:4/W1;-9\,#S-M4<>M:]I;"VCQG)[T 6**** "BBB@
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MO2[W3M3NA&%:[-G<>4DKXQER"<GOQTQBOF3&..OXYKV[]IGXJ^&O%X\'>#/
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M8M;S3Y!:!&W28ZM7<T4TVMA-)[C(U*QJK'<0,9/>O-/B1H*Z5)+K<,7G2/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;J._MXPM[#;L<[1_$!7QMX=_:]^*GAO5XKD^)KJX$<H:6";H<'!!_6OVHO\
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MR3X-V7V2>>YE_=F9<1@]Z]<KCDDF=D'=!1114EA1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%(#S0 M4M2D58@I[U=K/U-E&,KF@"D FT\9Q2(49L%>*0R *0
MJX!I@.#D=10!*Z(&Z$"EC5!(&#?G0C,P)<X7'2H* 'R,7<TKG"(/Q-,'44^8
MY(^E $=%%% !1110 4444 %.3.X8&33:E4^7&&ZD\ T ). &'KWJ.C)/7K10
M ^$D./0TTC!(J13Y29_B-14 %%%% "I]X4Z3_6-34^\*=)_K&H 8>M306SSM
MA1QZTMK;-<28'"CK6Q%$L2!5'% $5I9K;#U;UJS110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 9>O>'[+Q'9_9+Z,RQ;@X 8@@CH<U'J&FVMQHDFDW\RR17,1MSYA
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MS&QN/H*M@[L$=Q7RS\)?"WC?XV>.H?&_Q#L[G0K+36SI^C;L1L?[S#N:^IU
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MI<6EVACDC(]OIR"."*_HOKRGXZ?LV> ?VAM(^P^+M'2:[C0I:ZK;8CO+7/\
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M!.3W9F.2S'J6)R3UKIQ2T5XK;;NSVDDE9!1110,**** "BBB@ HHHH ****
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MSQ$==T"*ZN702X^?L!6_%,DZ[HW5U]16#31NFF24444AA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !2 <TM% ",0H)/05BWD_GR\?=%;7KFL?4(#%-D#Y3S0!5HI0">G-2+"2
MF3P?2@ B;<I4U$1@XJ9(B@9FX %1*NY@* '1QEFST I)#N<FG3';\BGCO4=
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MHR!PU97V9N=Q QZT 0ER>"<TL0S(M2B% P!;DTUF$2E4'/<T 1O]]OK2444
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MFY:UU2UE0D,L@Q[\U]-VDWVBUBDQC<H.*YJJLSHI.Z)J***Q-PHHHH ****
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MD5I0:DCC$GRFLNK%FB23!7Z=J -4NSIN0@CM566[G3 ,?-78XUC0*O04[ H
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MD(*@H>XJ6- @P#Q0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "DSBEJ-R%R>OK0 C$*,]N]?G[^V9_P483PC<7W@CX5W4-UJR;H;
M_P 2+B2*U;H8[<='?J#(<JO0 GE>/_;X_;PGU*ZU#X:?#?4O*T^+=!K6NVKX
M:=N0UO PZ(.C..6/RCC.[\\_KUKV<+@T_?J'BXK&/X*99U34[S6M1N=0U&ZG
MO[VY=I9[FYD,DDKL<EF8\DDDDD\DU6_6BBO<\DCQ/5A1110 4444 %%%% !1
M110 4444 %%%% !1110 H;801D,.A!P1WX/X#IT(K[Y_8[_X*.:CX7N;#P;\
M5KZ34M#;$-KXDDRUQ9GHHG/62/H-^-P[[A]WX%HK&K2C6CRR1M2JRI2YHG]'
M5C>V^IV<%W9SQ75K/&LL4\+ATD1AE65AP00001UKD?BMX,3QAX8GC5 ;N$%X
MFQR,5^6_[#W[<E_\$-4M/!WC&[EO?A_<R;(II,O)I+L?OIW,63\T8Z<LO.0_
MZZV5[;:I86]W:SQ75I<1K+%/"X=)$895E8<$$$$$=17SSC4P592739GO7I8^
MC*$UH]T?#-Q;RV=Q)#,ACDC)#*>U,KV#X]?#UM)U!M=M1NM[E\2*!]UO6O'\
MYY%?I.%Q$<5252)^-XW"3P5:5&?3\@H(S1179Y'$=!X3UNVTHS07:LT,G/RU
MZ1X4T+3_ !M;RG3KL1S1GF*3KCUKQ>NG^'&NW6@>*K22V5I/,8(\:]&!KP\P
MP$*\95(?$?393FM3#3C0G\%SZ%\-^![+1$6291<7(ZDC*CW%=+U(SQGBD#;E
M5^FX [?2BOSIMWU/UJ*5E9'COQ%MF@\3SL2=K@;37,U[7XI\)P^)K<9PMQ&/
MD85YQ?\ P_U?3H'E:(.$ZA.>/6NF$XVL<TX2O<YNBE(*D@@@C@@TE:F04444
M %%%% !1110 4444 %%%% !1110 4444 !.*] ^&O@--;;[??+FV4_(I[FN*
ML-)N=3EC2&%G5FP64=.:^B_#6D+H>C6]J#DHH+'W[UE4G96-:<+NYHPP)!$L
M<:A$4  "I***Y#K"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "DZTM-9@@+$X H R=24)/QU-5
M*GO9A-,6'([5!0 4444 %*I 89Z4E&,T 3NJ,WWQ2& ;00?SJ((3C@U)+E=H
MSCB@!CH5/M3<<5*)2!\P#"E$RN-I&%[&@!LGRQA?7FHZF*K@*QX[-3)45'PO
M(H 94D(&&8]0*CJ5!MB<G@=J $8%HUP*;L8#.#BI-^R#'4MWI@G<=Z $2-G8
M@"G>4 <LV/:@S,PP3U]*CH T],;<6Q]P5H5G:2?OBM&@ HI,?-F@'UH 6BBB
M@ HJ#[4HN/*[U/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4@I:* "B
MBB@ HHHH 3%+110 4444 -(!&#R._%5[;3K:S9V@@CA:0Y<QJ!GZU:HHO85B
MK<Q3&UD6W?$S?=9^0*R[#PK:1R)=WL,5YJ('_'Q(@)'L/:MZBFFUL)I/<15"
MJ !@ 8 %+112*"J.KZO9Z%I\][?3I;6L0W/*_115ZN:^(,N@P^$]0?Q')&FD
MK&6F\U]H( Z545=I$3=HMHS= ^,7A'Q9<&WT768-3N-A<1P9)(_*IM,^*OAG
M5=?ET1-2CBU6+[UK+\K?AFOB+P_^W-\*?A;XFU*W\-^$OL]CEA]J0Y9VR>GH
M*^>/VC/VJ;CXL^.['Q!X;MF\.RV8PLD!VM+]<=:]FGELZDOA:7=G@5,UA3C>
MZ;['[)#IG]:<.17Y)?#S_@HG\0?!>FV]E?JFLHC#+R]2*]Q\)?\ !3VVUNYF
MM=2T,:>Y0"!E;<7D/ &/K653*\13V5T;4LWPU2UW9GWYTI:Y'X7^)M2\7^"]
M/U;5;'^S[JY3?Y)Z[>Q([9KKJ\J2<79GLQDIKF051UG4X]&TN[OI?]7;Q-*W
M..@S5ZOE3_@H7\5=4^'GP>>STMD1]68VTL@DQ(J^PK:C3=:I&"ZF6(JJC2E-
M]$=W^S;^T=!^T!)XE>WLOLD.E7/V<<_>ZC^E>WCI7YG?\$O/'7]G^+-:\.2W
M1'VT><(]OWV ZYK],1TKHQM!8>LX+8Y<OKO$T%4>XM%%%<!Z0A4'J,U&;=/,
MWXP?:I:* $ P*"P'6EI" >* %HHHH **** $ZTPQGS P./:GX YI: "BBB@!
M!G-+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4F<YI:3&*  ]*^!/
M^"CG[8TW@:TG^%O@N^\O7KN+_B=7\#?-9PL.($(^[(X.6/\ "I '+97Z!_;&
M_:0@_9M^$EWJ]NT4GB;46-GHUK)A@TQ'S2LIZI&OS'L3M7C=FOQ#UG5[[Q#J
MM[J>IW<M]J-[,]Q<W5P^^261F+,S$]2222?>O4P6&]H_:3V1Y.-Q/LU[..Y3
MZ4445]!Z'@>H4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*^]?^"<_[8TWA#6+/X5^,K_=X>OG\O1+VX;_ (\IV/%NQ/\ RSD).W^ZQ'9B
M5^"J4$JRL#@@@@^GT/7_  (K&M2C5ARR-J565*:DC^B3QEI=OJ_AJ^@N8Q)&
M8V.,=#BOB^YB^S74\0X6-R!GTS76?\$\OVHYOCK\/9_"OB6\%QXR\.Q*CRRG
M+WUIPJ3'/WG4X5SWRA/+UVWQC^$,EA-/KFECS(';,MNHY7W%1E%=82K+#5G:
M^QR9_A)8RE'%45>VYXQ10<J<,"K=P>HHK[;?4_-K-;A70_#YUC\9::S-@!ZY
MZNW^#UA#?>-;83CA#E1CO7-BI*%";?8[L#%SQ5-+NCZ9[*>N1UHH8 ' & .*
M*_)GO<_=$K)!2YX(X]\TE% SGM>\#Z=K:'""VFZED[UQ/B?X>2:)9_:H)1)$
M/O ]:]7K*\4(9/#]Z ,GRSP!6L9R3L92@FCPP'(SZT4BC  (P1VI:ZSD"BBB
M@ HHHH **** "BBB@ HHHH *#THH/2@#VOX06L8\/&0QKO+<G%>@5Q'PCG67
MPM&@&"C'-=O7#+XCMAL%%%%26%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%(3B@'- "T444 %%%% !1110 4444 %%%% !6=JDQ " X!
MK0]ZQ;Y_,N&]N* *]%%% !1110 4Z(?.?4#--J2#[_X4 (96SUIK,7/-(>M%
M !1110!)'* ,,-P[4V63S'SC':FXS3UC&W<> .U $>.U3RH1$O'RXIOG!<A0
M!2+*P)SR/>@!5(=-AR&]*81@D'J*D=B55NA%),<D$]2* (Z*** -#2NK5IUF
MZ4K98]JTJ "DP*6B@ J"YN1;KDC-2O(L8))Q6/>W(N'^4\"@!C3E[GS.G/%;
M:'<H/J*Y\9SP. <UO0-NB4^U $E%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %(>E+7,^/OB'H/PUT&76/$%_'8
M6,75W/)]@*:BY.R)E)07-+8WKF[@L87EN)5AB7JSG %<;H_QH\'Z[XOO?#-I
MK=L^L6I&ZW\P?-G^[ZU^77[0O[8_C/QSK^M:3INNF3PU-(?LQA780G;D5X?X
M#\8ZGX?^(6D:\NHS)=07"/+<E\DJ#W]>*]^GE,G3YINS['S%7.XQJJ$%==6?
MO6S"-"6(  R3T K\ZO\ @HY^T=:ZBL?P_P!#N2[(P>[GA;C/]VO3M%_X*+>
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M56:IP<GT/SG_ &R?VAKC]HKXRZCJT,K?\(WII:PT: GY?LZL?WI']Z1OG/'
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M>(-.\PPF\TK2;BYBWC!*[T0KD C(]Z_6_P",.HV?[2_@3]H#X86OE2ZAX8,
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MC1@X[TB@L0,9)H 2GQ0O,P"C/O5V#2Q@&0_A6A'"D0PHQ0 VWA$$87O4M%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRUU1^C8''T\9'3==#K@<TM(*6O-/6"BBBF 4444 %%%% !114<LHB +=">M
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MB@ HHHH **** "BBB@ IK ,"#WIU% &%=P&"8CL>:AK4U508@3UK+H ****
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MG4'5K<P*]BW\1?N*]\2/=+L) &>I]._\JUJ4Y4VKF%*K&JG*'0917SR?VX?
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M(\\]<5ZS7C'P7E?^V+B,(=FPG?7L]<<]SLI_"%%%%9FH4444 %%%% !1110
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M>WY;Z#NM%!ZT5[9\Z%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4=*O);*X4#H\;E&Q[94U[N73O%P/"S"%I*9CT4#IZ?2BO8/("BBBB]@M<WO
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MYU]179UR_P 1IIX?"MX;==Q*X;V%9Q^)&LMCQ#0D8I<.C8=4(V>U90Z5IZ,
MB7-P2<!2,>]9HZ5VHX0HHHI@%%%% !1111:X;@ 2<#DG@"MJ7&AZ;L7"WTW4
M]U6J&FND4K2NN_RU+*O8FLJW\<P:OJ3PZC +:(L565#RI[5UTL)5Q$'.GLCS
M\1CZ&%J1IU-Y%HDDY/7WHJW=Z<]O&)$99X3_ !)SBJE<K3CI)'<I*2O%W05-
M8VCW][#;QC+2,%_#-0UVOPJT5]1\1I<F/,$ R2?6I;LKFD5S,]:\+^&K;P[I
MZ111A92OSL!U-;E(.E+7!N[G:E;0****!A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5B^*] C\4>'-2TF5VCBNX6B+H<$9K:IAYR*:=FF2U=69^
M,5O\8?'7[+/Q$\0>'] O0EO#=R?NYQN##=U-:GC/]O/XF>-_"MWHUW=0VJ71
MR\]LFUP/0'TKL/\ @I%\*)/"/Q8B\4PQ$6&K(!E1T<=:^0ATK[NA"CB(1K..
MI^<8FK7PU25!2T)9[B:[F:6XE>>9SEI)#DD_6HZ**]$\EMMA1110+U.C\ >
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M0?C7H&N?%6TB?=X6CTZ6*"29%+201WC.49Q@C;M!&"&"X)'>?%KXAZ1\*O\
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M>?FG^ZR^7YGIY1_O<3]#*^)?^"M?_)N?AO\ [&NW_P#2.\K[:KXE_P""M?\
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M44 %%%% !1110 4444 %%%% #)'\L9P3]*53D9Z9IU% !1110 4444 %%%%
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MGAJJJQD]!>@KYN_;L^ /B?\ :/\ A-I'AGPI)81W]KKD.HR'49FBC\I8)XV
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?.G
M[<7Q53X8_!C4<6RW4NH@VZJ3TSWKZ+KQ[]I7X"Q_M!>#$T"2\2QC$F\S%26'
MTKHP\H1JQE/9')BHSG1E&&[/Q2TK1=0\179M]-L9K^Y=B?+@0L02:^^_V-?V
M%1BR\:>-(9()T;?;6$B $'KEJ^I/@+^REX/^!>DQ)9VB7VI[=LE[.H+,>^*]
ML"A5    XP*]C%YHZB]G15D>'@<H5-JI7=V-AB2")8XU"H@"J!V Z5(*0&E'
M-?/^I],O(6BBB@84444 %%%% !1110 44QF"*6)"@=23BN?U?QWI&DHV^Y62
M1?X$/--)O83=CHZR->\2V/AZV:6ZE56 .U,\DUYEK_Q=O-0)M]+A,2MQDCYJ
MPH?!WB3Q)B:9)7!Y4R&M(PZR9DY]D)XD\=ZGXHO'AMVDC@8X2)>IKH?!_P )
MY;O9=ZJ2D?!$7\1^M=EX*\%V^C:9%]IM4-X#EG8<BNN'04Y3MI$2A?616M+"
M"PM4MH(PD*# 0#BK"*$&%&![4ZBL3<**** "BJL]\(KF.$1M(S]2.@JU0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S3X
MQE>;Q5K!D8N5NY5&XY^4.< ?2L>M;Q9_R-6L_P#7[-_Z&:R:[ELC@>X5ZQ\#
M)'*:RA8^6IA(4G@$[\_R%>3UZO\  KKK?T@_]J5-3X2Z?Q'JPZ5\Q_M_?%;Q
MS\)/A1X:OOA]JITC7]2\36VE"7[/!/YB207!\O$RLHRZ1G.,\=>M?3@Z5\=_
M\%/+AK7X0> IDP&C\<6#@^A%O='I^%8T$G4BF:5VU3DT>Q?LF_%^7XX_ ?PQ
MXGOI!)K9B-GJN%5"+N(E)&*J %WX#X   <5Y+_P4%_:/\5_!3PYX;T?P!?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)>)LDSM[@<4^WMTM8EBC&$7I4M% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 52U2QCU"REAE4.""0".]7:2@#Q_P 77!T+2+54A:TN'EY13C(!KF]5@G\5
M7$=]!(C@K@JQPP/]:]@\6>&K?66M[BX#.EOGY%'7->(^)[,:3K4B0"2.#.Y
M3C/-=,&FCFDFC+N+=[6=XI1MD7J*FTG3SJNI06BML:5MH;TK0N((M<"W,<ZQ
M3@!760X!QWJ.#3[FPF2X@NX1+'AA@Y/6MKZ&-M3W?PAX6C\*Z=]F20RDG)8U
MO5SG@_Q$^L:?']J0PW0 W!OXO>NCKA=[ZG;';0****1044AX%5VF<RD*"5'4
MT 6:*K0O*S\C"U9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBL7BHTJEK,]\Q@5@^+O''ASP#I\6H>*/$.E^&["686Z76K7D=K$\I#,$#2$
ML0K' .<*3V-;XY KXD_X*U#_ (QT\.'/_,UV_7I_QYW@KY2G'GFHOJ?=U)<D
M')'TYI?Q_P#AAKMVMKIOQ&\)ZA<M]V&TUNUE<_15<DUWJD$ @Y!&1S7SMXF_
M8$^!?BC39+9_ MMIDK(5CNM+N);>6(XX<;6VDC.0&5ATR#7C_P"R_P"(?$O[
M-W[2>I_L[^)]8N]?\/7UJ;_PI>W1W,B*C2%!_=0HDH(Z!X3M'S$UK[.,D^1Z
MKN8^UG&SFM&?4?CW]H+P%\,?&_ASPCXEUY--U_Q%(L>G6S02N)"S^6I9E4J@
M+_*"Q )SV!(](SD9KPGXR^.OA7X?^,_PQT?QGX:75O&6IW./#VHFPCF^R2>8
MBY+E@R?,5((!P1D8(%==\;/CWX/_ &?O#,.M>+K][=+F3R;2RMHS+<W<G]V.
M,=>HR20HXR1D9APNHV6K-5.W-=Z(](!S17S=X'_;I\$>+?%^E>&=5\/^+O!&
MK:O-Y&G1^)]':W6Z<D!51D9QDY'7 R0,\BO(/^"F?[0FE:1X OOAI:#58/$D
M\UI=-=1P%+98MQ?;YN1ECM^Z >AIQHSE)0MJ3*O!0<[Z'WC3>OTKY^_9Y_:Y
M\(?'#5X?"VB:;XAM-2M--^U22ZG8"&$JAC0X;>V6RXP/0$]JN^(?VR/AMX3U
M?Q_8:W?W6ER^"C FH-/ ,3R3 ^6EN VZ1C@\8&.2> 2)=*:ERVU12JP<5*^C
M/4_'/CG1?AOX2U3Q-XBOETW1=,A,MS<NC.$7.!A5!9B20  "22 .M9?@OXN>
M&?B-\.8_'/AN_.J^'Y8)IDFCB9'/E;@Z['"D,"K##8]>F#7E^C?M->!_B_\
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MNO6J6[2DHKAD"N^1M=#SC[W?K7J@Z"DTXNSW*BU)76PM%%%(H**** "BBB@
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M()4;E1FW8 .>>+_X*O\ _)M>D?\ 8S6O_I/<UY]\?/%TW[=NJ^ =!^'7P_\
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M$#+$@D;G8 D#->>? #PIKFF?M_\ QLUF\T;4+72+RP"VVH3VKI!,=UMD)(0
MW0\ GH:MR3E4<>Q"BU&FI=S[.7VZ4ZFK3J\\]%!1110,**** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"<4 +12=:6@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&!(P#@TB+M !Y
M-.HH **** "D(R,&EHH 0* *6BB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
)** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>soph-20251231_g15.jpg
<TEXT>
begin 644 soph-20251231_g15.jpg
M_]C_X0#H17AI9@  34T *@    @ !@$2  ,    !  $   $:  4    !
M5@$;  4    !    7@$H  ,    !  (   (3  ,    !  $  (=I  0    !
M    9@        !(     0   $@    !  B0   '    !# R,C&1 0 '
M! $" P"2A@ '    $@   ,R@   '    !# Q,#"@ 0 #     0 !  "@ @ $
M     0  !$>@ P $     0   DRD!@ #     0          05-#24D   !3
M8W)E96YS:&]T  #_X@TP24-#7U!23T9)3$4  0$   T@87!P; (0  !M;G1R
M4D="(%A96B 'Z@ !  T "  T !]A8W-P05!03     !!4%!,
M            ]M8  0    #3+6%P<&P
M                                 !%D97-C   !4    &)D<V-M   !
MM    ?QC<')T   #L    "-W='!T   #U    !1R6%E:   #Z    !1G6%E:
M   #_    !1B6%E:   $$    !1R5%)#   $)   " QA87)G   ,,    "!V
M8V=T   ,4    #!N9&EN   ,@    #YM;6]D   ,P    "AV8V=P   ,Z
M #AB5%)#   $)   " QG5%)#   $)   " QA86)G   ,,    "!A86=G   ,
M,    "!D97-C          A$:7-P;&%Y
M
M                    ;6QU8P         G    #&AR2%(    8   !Y&MO
M2U(    8   !Y&YB3D\    8   !Y&ED       8   !Y&AU2%4    8   !
MY&-S0UH    8   !Y'-L4TD    8   !Y&1A1$L    8   !Y&YL3DP    8
M   !Y&9I1DD    8   !Y&ET250    8   !Y&5S15,    8   !Y')O4D\
M   8   !Y&9R0T$    8   !Y&%R       8   !Y'5K54$    8   !Y&AE
M24P    8   !Y'IH5%<    8   !Y'9I5DX    8   !Y'-K4TL    8   !
MY'IH0TX    8   !Y')U4E4    8   !Y&5N1T(    8   !Y&9R1E(    8
M   !Y&US       8   !Y&AI24X    8   !Y'1H5$@    8   !Y&-A15,
M   8   !Y&5N054    8   !Y&5S6$P    8   !Y&1E1$4    8   !Y&5N
M55,    8   !Y'!T0E(    8   !Y'!L4$P    8   !Y&5L1U(    8   !
MY'-V4T4    8   !Y'1R5%(    8   !Y'!T4%0    8   !Y&IA2E     8
M   !Y !$ $4 3 !, "  4  R #< ,@ P $0 0W1E>'0     0V]P>7)I9VAT
M($%P<&QE($EN8RXL(#(P,C8  %A96B        #S4@ !     1:^6%E:(
M     &^D   X]@   Y%865H@        8I0  +>&   8VEA96B         D
MG@  #X0  +;"8W5R=@        0     !0 *  \ %  9 !X (P H "T ,@ V
M #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *,
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M>&YXS'DJ>8EYYWI&>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>
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M.="ZT3S1OM(_TL'31-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N
MW 7<BMT0W9;>'-ZBWRG?K^ VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_G
MJ>@RZ+SI1NG0ZEOJY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G
M]#3TPO50]=[V;?;[]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M__]P
M87)A       #     F9F  #RIP  #5D  !/0   *6W9C9W0          0 !
M          $    !          $    !          $  &YD:6X
M-@  H]<  %1[  !,S0  F9H  "9F   /7   4 \  %0[  (S,P ",S,  C,S
M          !M;6]D        $*P  -#\,4-$3
M    =F-G<        P    )F9@ #     F9F  ,    "9F8    ",S,T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **3(Q5>:[M+9HTN)4C,K;4#$#<WH/4^U %FB
MBB@ HHHH __0_OXHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR?+\&/\ L>O#O_IP@H _W2:*** "BBB@#__2_OXHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **AFN+>V4-<.L8)"
MC<0.3T%34 %%?$O_  4@F_:&M_V$OBI+^RC'=2_$,>'KO^Q%L/\ C[^T;?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M _NNUG_@C--\6_!_Q07]J;XOZU\0_&'Q-\.V?A.379].LK)=/TBSF%QY,%K
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6-44#>['.,G/7 &/\IJO],C_ (,HO^4?WQ._['M__2&VH _LPK_%V_X+R?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7Y55^JO_  0Y_P"4O7[.W_8\:5_Z,% '^U'7\-/_  ? ?\F]? 7_ +&+6/\
MTFAK^Y:OX:?^#X#_ )-Z^ O_ &,6L?\ I-#0!_G.U]7_ +!G_)\OP8_['KP[
M_P"G""OE"OK#]@S_ )/E^#&/^AZ\._\ IP@H _W2**** "BBB@#_U_[^****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\FC?%'_L4]9_])):_P )B@ K_6O_ .#3?_E"AX _[#/B'_TX35_DH5_K7_\
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M_I3!7^B]7^=#_P 'P/\ R<!\ _\ L7M9_P#2F"@#^&6OU5_X(<_\I>OV=O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4YWL-3T2_OI[C3KNT+1;8[VQC:,>6$5) \BE^%:OZ6:_B)_X)3_\'5'[0_\
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M,]?[FU?X9/\ P4-_Y/\ ?CE_V4#Q-_Z<9Z /CVO],C_@RB_Y1_?$[_L>W_\
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MZ_9V_P"QXTK_ -&"ORJK]5?^"'/_ "EZ_9V_['C2O_1@H _VHZ_AI_X/@/\
MDWKX"_\ 8Q:Q_P"DT-?W+5_#3_P? ?\ )O7P%_[&+6/_ $FAH _SG:^L/V#/
M^3Y?@QC_ *'KP[_Z<(*^3Z^K_P!@S_D^7X,?]CUX=_\ 3A!0!_NDT444 %%%
M% '_T?[^**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M (/%?^40L7_8\Z+_ .BKJO\ *RH T-)_Y"MM_P!=4_F*_P!Y+X$?\D/\&?\
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MTR/^#*+_ )1_?$[_ +'M_P#TAMJ_S-Z_TR/^#*+_ )1_?$[_ +'M_P#TAMJ
M/[,*_P 7;_@O)_RF&_:%_P"QOO/_ &6O]HFO\7;_ (+R?\IAOVA?^QOO/_9:
M /R0K^X[_@R!_P"3C_CO_P!BUI/_ *525_#C7]QW_!D#_P G'_'?_L6M)_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$_\ V+FA?^B*_F9H _JG_P"#/'_E+M_W)FL_S@K_ %4:_P J[_@SQ_Y2Z_\
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MY-&^*/\ V*>L_P#I)+7^$Q7^[/\ MD?\FC?%'_L4]9_])):_PF* "O\ 6O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJHT ?YB?_!ZU_P I.?AW_P!DOT__ -.NJU_'G7]AG_!ZU_RDY^'?_9+]/_\
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M-ND_\A6V_P"NJ?S%?[R7P(_Y(?X,_P"P%IW_ *3I0!^;O_!>_P#Y0Y?M"?\
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MWA?V8/CAIW[3?[-/P\_:2TBPDTJT^(7AG2?$L%E,XDDMH]6M8KI8F90 S()
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M_!(7QCX8^(_C_3;#QW;R>(I+Z*:UFU.]M$NM4NU>$L@NFFD9X4(90SKN7;G
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M],]]0!_L0U_$-_P>\?\ )JGP0_[&N_\ _2.O[>:_B&_X/>/^35/@A_V-=_\
M^D= '^<!7Z(?\$D/^4GWP"_['K1/_2E*_.^OT0_X)(?\I/O@%_V/6B?^E*4
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M/^46/[-/_9*O!O\ Z:+6O?/VMO\ DU;XE?\ 8K:O_P"DLE 'Y$ZG_P %K?\
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MOZM/^#.C_E+;<?\ 8DZO_P"C+>OY2Z_JT_X,Z/\ E+;<?]B3J_\ Z,MZ /\
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M*KNF_P#(1M_^NB?S% '^\;^S[_R03P1_V --_P#2>.OQW_X.:_\ E"-\;?\
MKWTC_P!.EI7[$?L^_P#)!/!'_8 TW_TGCK\=_P#@YK_Y0C?&W_KWTC_TZ6E
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MO^Y,UG^<%?ZJ-?Y5W_!GC_REU_[DS6?_ $*"O]5&@#_,3_X/6O\ E)S\._\
MLE^G_P#IUU6OX\Z_L,_X/6O^4G/P[_[)?I__ *==5K^/.@#]W/\ @V:_Y3B_
M C_K[UK_ -,U_7^PY7^/'_P;-?\ *<7X$?\ 7WK7_IFOZ_V'* /X=_\ @]\_
MY-G^!7_8S:I_Z2I7^<?7^CA_P>^?\FS_  *_[&;5/_25*_SCZ /J;]AG_D]C
MX/?]COX>_P#2^"O]U$=!7^%=^PS_ ,GL_!W_ +'?P]_Z7P5_NHCH* /Y5?\
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M/^#*+_E']\3O^Q[?_P!(;:@#^S"O\7;_ (+R?\IAOVA?^QOO/_9:_P!HFO\
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MCK\=_P#@YK_Y0C?&W_KWTC_TZ6E?L1^S[_R03P1_V --_P#2>.OQW_X.:_\
ME"-\;?\ KWTC_P!.EI0!_CVT444 ?[?'_!)S_E%C^S3_ -DJ\&_^FBUKWO\
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M0!_F)_\ !ZU_RDY^'?\ V2_3_P#TZZK7\>=?V&?\'K7_ "DY^'?_ &2_3_\
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M\E"O]:__ (--_P#E"AX _P"PSXA_].$U '])-?X9/_!0W_D_WXY?]E \3?\
MIQGK_<VK_#)_X*&_\G^_'+_LH'B;_P!.,] 'Q[7^F1_P91?\H_OB=_V/;_\
MI#;5_F;U_ID?\&47_*/[XG?]CV__ *0VU ']F%?XNW_!>3_E,-^T+_V-]Y_[
M+7^T37^+M_P7D_Y3#?M"_P#8WWG_ ++0!^2%?W'?\&0/_)Q_QW_[%K2?_2J2
MOX<:_N._X,@?^3C_ ([_ /8M:3_Z524 ?Z-5?Y,'_!VC_P IF_%W_8!T/_TG
M%?ZS]?Y,'_!VC_RF;\7?]@'0_P#TG% '\TU?U:?\&='_ "EMN/\ L2=7_P#1
MEO7\I=?U:?\ !G1_REMN/^Q)U?\ ]&6] '^J)7^=#_P? _\ )P'P#_[%[6?_
M $I@K_1>K_.A_P"#X'_DX#X!_P#8O:S_ .E,% '\,M?JK_P0Y_Y2]?L[?]CQ
MI7_HP5^55?JK_P $.?\ E+U^SM_V/&E?^C!0!_M1U_#3_P 'P'_)O7P%_P"Q
MBUC_ -)H:_N6K^&G_@^ _P"3>O@+_P!C%K'_ *30T ?YSM?5_P"P9_R?)\&/
M^QZ\._\ IP@KY0KZP_8,_P"3Y?@Q_P!CUX=_].$% '^Z11110 4444 ?_]#^
M_BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M )2Z_P#<F:S_ .A05_JHT ?YB?\ P>M?\I.?AW_V2_3_ /TZZK7\>=?V&?\
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M#'_8]>'?_3A!0!_NDT444 %%%% '_]'^_BBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK.U;5;#0M*N=;U6
M3RK6SB>>9\9VQQC<QP/0#M0!/<7MG9F);N5(C,XCC#L%W.>BKGJ<#H/2FW>H
M6%AL^W31P^8=J;V"[B!G SUX!.!V%?PB>(O^"W?[/G[77_!6'X"_&_4/B\FD
M?#[P;XRUC2['P4FFZCOBMGTRZMX]8OIA;^5)-<W#+%##$9/)A<%BI+XW=/\
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M!KG_  4;^.[?\%(/&?P#\9?'OP[\+O"F@>--/\/Z3HVJ>"+B_P#[4CGA@E,
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M?8=5A2-_-F^9QA%!^5?B!\<?VMK;]J#XG_M_Z/XXT#X4ZC^S_P#"'PO=^'_
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M -DRL?\ TZZG0!_'37[K_P#!L_\ \IPO@/\ ]?NL_P#IGOJ_"BOW7_X-G_\
ME.%\!_\ K]UG_P!,]]0!_L0U_$-_P>\?\FJ?!#_L:[__ -(Z_MYK^(;_ (/>
M/^35/@A_V-=__P"D= '^<!7Z(?\ !)#_ )2?? +_ +'K1/\ TI2OSOK]$/\
M@DA_RD^^ 7_8]:)_Z4I0!_MT5_*U_P 'B/\ RB"'_8[Z)_Z+N:_JEK^5K_@\
M1_Y1!#_L=]$_]%W- '^595W3?^0C;_\ 71/YBJ57=-_Y"-O_ -=$_F* /]XW
M]GW_ )()X(_[ &F_^D\=?CO_ ,'-?_*$;XV_]>^D?^G2TK]B/V??^2">"/\
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MO_!C=_QY?M)?[_A7^6I5_?E0!_DV_P#!V[_RF8\3_P#8N:%_Z(K^9FOZ9O\
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M^)?@?XL>,!='5OA[/?7.D&"<QQ*^H6[6LWF(.''E,0 >AK_/D_X/,_BO\4O
M7_!1#X;Z9X%\2ZKHMM+\.K65X;"\FMHV?^T]0&XK&R@G  SC. /2OY!_^&D/
MVB/^A]\1?^#2Y_\ CE '^TAX%_X)J?LS_#2'X2OX'BU/3[[X+->KX=OH[QOM
M1M=2+&YM+E\?O[:5F#&)AC<BD8*BOT K_(F_X-Q_C=\9_%?_  6G^!F@>*/%
MVM:E83W^JB6VNK^>:%PNDWI&Y&<J<$ C(K_79H _FH_X.&O^"U?Q_P#^"/UE
M\,;GX&^%?#_B4^-WU);L:ZMR?*%D(=GE_9YH>OF'.[/08K^9;_B-F_X* ?\
M1*OA]_WQJ/\ \F5]J_\ !\-_R"?V??\ KKKW_H-K7^?E0!_>E^Q=_P '>_[<
M'[2W[6WPV_9\\6?#7P-8:9XT\1:?HUU<6B7XGBAO)EC9H]]VR[@#QE2/:O\
M0FK_ !"_^"4'_*3/X"_]CUH?_I5'7^WI0!_+#_P>%_\ *'Z3_L==$_\ 0;BO
M\J6O]5K_ (/"_P#E#])_V.NB?^@W%?Y4M %FS'^EQ#_;7^=?[Q'[.'_)O'@+
M_L7=+_\ 2:.O\'>S_P"/R+_?7^=?[Q'[.'_)O'@+_L7=+_\ 2:.@#V>BBB@
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M _V(:_B&_P"#WC_DU3X(?]C7?_\ I'7]O-?Q#?\ ![Q_R:I\$/\ L:[_ /\
M2.@#_. K]$/^"2'_ "D^^ 7_ &/6B?\ I2E?G?7Z(?\ !)#_ )2?? +_ +'K
M1/\ TI2@#_;HK^5K_@\1_P"400_['?1/_1=S7]4M?RM?\'B/_*((?]COHG_H
MNYH _P JRKNF_P#(1M_^NB?S%4JNZ;_R$;?_ *Z)_,4 ?[QO[/O_ "03P1_V
M --_])XZ_'?_ (.:_P#E"-\;?^O?2/\ TZ6E?L1^S[_R03P1_P!@#3?_ $GC
MK\=_^#FO_E"-\;?^O?2/_3I:4 ?X]M%%% '^WQ_P2<_Y18_LT_\ 9*O!O_IH
MM:]\_:V_Y-6^)7_8K:O_ .DLE>!_\$G/^46/[-/_ &2KP;_Z:+6O?/VMO^35
MOB5_V*VK_P#I+)0!_A%T444 ?ZT/_!I9_P H6/!7_8=\0?\ I:]?TKU_-1_P
M:6?\H6/!7_8=\0?^EKU_2O0!_@<?$3_DH&N_]A"Y_P#1C5QU=C\1/^2@:[_V
M$+G_ -&-7'4 ?Z7O_!DY_P F$_%3_L>__;"VK^SNOXQ/^#)S_DPGXJ?]CW_[
M86U?V=T ?XP?_!?/_E,9^T%_V-=Q_P"@I7Y!U^OG_!?/_E,9^T%_V-=Q_P"@
MI7Y!T ?Z W_!C=_QY?M)?[_A7^6I5_?E7\!O_!C=_P >7[27^_X5_EJ5?WY4
M ?Y-O_!V[_RF8\3_ /8N:%_Z(K^9FOZ9O^#MW_E,QXG_ .Q<T+_T17\S- ']
M4_\ P9X_\I=O^Y,UG^<%?ZJ-?Y5O_!GC_P I=O\ N3-9_G!7^JE0!_F)_P#!
MZU_RDY^'?_9+]/\ _3KJM?QYU_89_P 'K7_*3GX=_P#9+]/_ /3KJM?QYT ?
MNY_P;-?\IQ?@1_U]ZU_Z9K^O]ARO\>/_ (-FO^4XOP(_Z^]:_P#3-?U_L.4
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M_P )BO\ =G_;(_Y-&^*/_8IZS_Z22U_A,4 %?ZU__!IO_P H4/ '_89\0_\
MIPFK_)0K_6O_ .#3?_E"AX _[#/B'_TX34 ?TDU_AD_\%#?^3_?CE_V4#Q-_
MZ<9Z_P!S:O\ #)_X*&_\G^_'+_LH'B;_ -.,] 'Q[7^F1_P91?\ */[XG?\
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M\F]? 7_L8M8_])H:_N6K^&G_ (/@/^3>O@+_ -C%K'_I-#0!_G.U]7_L&?\
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M -)XZ_'?_@YK_P"4(WQM_P"O?2/_ $Z6E '^/;1110!_M\?\$G/^46/[-/\
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M(7_9/;K_ -+[*O\ 3CK_ #'/^#*O_E)#\0O^R>W7_I?95_IQT ?YE'_!Z_\
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MZOPHK]U_^#9__E.%\!_^OW6?_3/?4 ?[$-?Q#?\ ![Q_R:I\$/\ L:[_ /\
M2.O[>:_B&_X/>/\ DU3X(?\ 8UW_ /Z1T ?YP%?HA_P20_Y2?? +_L>M$_\
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MKN/_ $%*_(.OU\_X+Y_\IC/V@O\ L:[C_P!!2OR#H _T!O\ @QN_X\OVDO\
M?\*_RU*O[\J_@-_X,;O^/+]I+_?\*_RU*O[\J /\FW_@[=_Y3,>)_P#L7-"_
M]$5_,S7],W_!V[_RF8\3_P#8N:%_Z(K^9F@#^J?_ (,\?^4NW_<F:S_."O\
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MG_D]GX._]COX>_\ 2^"O]U$=!0!_*K_P>*_\HA8O^QYT7_T5=5_E95_JF_\
M!XK_ ,HA8O\ L>=%_P#15U7^5E0!H:3_ ,A6V_ZZI_,5_O)? C_DA_@S_L!:
M=_Z3I7^#;I/_ "%;;_KJG\Q7^\E\"/\ DA_@S_L!:=_Z3I0!^;O_  7O_P"4
M.7[0G_8J3_\ HR.O\7^O]H#_ (+W_P#*'+]H3_L5)_\ T9'7^+_0 5_M\_\
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MUGJ.GZ[XL\.F33AK6GRLXU2RMVV6UU.KQQ^5<R1!3.B[E$F2K$'CZPK\Q?\
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M==>_]!M:_P _*@#]!/\ @E!_RDS^ O\ V/6A_P#I5'7^WI7^(7_P2@_Y29_
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M[$?L^_\ )!/!'_8 TW_TGCK\=_\ @YK_ .4(WQM_Z]](_P#3I:4 ?X]M%%%
M'^WQ_P $G/\ E%C^S3_V2KP;_P"FBUKWS]K;_DU;XE?]BMJ__I+)7@?_  2<
M_P"46/[-/_9*O!O_ *:+6O>_VMO^35OB5C_H5M7_ /262@#_  C**** /]:'
M_@TL_P"4+'@K_L.^(/\ TM>OZ5Z_FH_X-+/^4+'@K_L.^(/_ $M>OZ5Z /\
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M?>M?^F:_K_8<K_'C_P"#9K_E.+\"/^OO6O\ TS7]?[#E '\._P#P>^?\FS_
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M>_\ 0;6O\_*@#]!/^"4'_*3/X"_]CUH?_I5'7^WI7^(7_P $H/\ E)G\!?\
ML>M#_P#2J.O]O2@#^6'_ (/"_P#E#])_V.NB?^@W%?Y4M?ZK7_!X7_RA^D_[
M'71/_0;BO\J6@"S9_P#'Y%_OK_.O]XC]G#_DWCP%_P!B[I?_ *31U_@[V?\
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M\I/O@%_V/6B?^E*4 ?[=%?RM?\'B/_*((?\ 8[Z)_P"B[FOZI:_E:_X/$?\
ME$$/^QWT3_T7<T ?Y5E7=-_Y"-O_ -=$_F*I5=TW_D(V_P#UT3^8H _WC?V?
M?^2">"/^P!IO_I/'7X[_ /!S7_RA&^-O_7OI'_ITM*_8C]GW_D@G@C_L :;_
M .D\=?CO_P '-?\ RA&^-O\ U[Z1_P"G2TH _P >VBBB@#_;X_X).?\ *+']
MFG_LE7@W_P!-%K7O?[6__)JOQ*_[%;5__262O!/^"3G_ "BQ_9I_[)5X-_\
M31:U[Y^UM_R:M\2O^Q6U?_TEDH _PBZ*** /]:'_ (-+/^4+'@K_ +#OB#_T
MM>OZ5Z_FH_X-+/\ E"QX*_[#OB#_ -+7K^E>@#_ X^(G_)0-=_["%S_Z,:N.
MKL?B)_R4#7?^PA<_^C&KCJ /]+W_ (,G/^3"?BI_V/?_ +86U?V=U_&)_P &
M3G_)A/Q4_P"Q[_\ ;"VK^SN@#_&#_P""^?\ RF,_:"_[&NX_]!2OR#K]?/\
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MOG_@D[_RBR_9I_[)5X-_]-%K7^(-7^WS_P $G?\ E%E^S3_V2KP;_P"FBUH
M]N_;(_Y-&^*/_8IZS_Z22U_A,5_NS_MD?\FC?%'_ +%/6?\ TDEK_"8H *_U
MK_\ @TW_ .4*'@#_ +#/B'_TX35_DH5_K7_\&F__ "A0\ ?]AGQ#_P"G":@#
M^DFO\,G_ (*&_P#)_OQR_P"R@>)O_3C/7^YM7^&3_P %#?\ D_WXY?\ 90/$
MW_IQGH ^/:_TR/\ @RB_Y1_?$[_L>W_](;:O\S>O],C_ (,HO^4?WQ._['M_
M_2&VH _LPK_%V_X+R?\ *8;]H7_L;[S_ -EK_:)K_%V_X+R?\IAOVA?^QOO/
M_9: /R0K^X[_ (,@?^3C_CO_ -BUI/\ Z525_#C7]QW_  9 _P#)Q_QW_P"Q
M:TG_ -*I* /]&JO\F#_@[1_Y3-^+O^P#H?\ Z3BO]9^O\F#_ (.T?^4S?B[_
M + .A_\ I.* /YIJ_JT_X,Z/^4MMQ_V).K_^C+>OY2Z_JT_X,Z/^4MMQ_P!B
M3J__ *,MZ /]42O\Z'_@^!_Y. ^ ?_8O:S_Z4P5_HO5_G0_\'P/_ "<!\ _^
MQ>UG_P!*8* /X9:_57_@AS_REZ_9V_['C2O_ $8*_*JOU5_X(<_\I>OV=O\
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M_!X7_P H?I/^QUT3_P!!N*_RI: +-G_Q^1?[Z_SK_>(_9P_Y-X\!?]B[I?\
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ML1^S[_R03P1_V --_P#2>.OQW_X.:_\ E"-\;?\ KWTC_P!.EI0!_CVT444
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MHCH*_P *[]AG_D]GX._]COX>_P#2^"O]U$=!0!_*K_P>*_\ *(6+_L>=%_\
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M_P#Y1,:[_P!E%UC_ -(M/K^LV@#_ !)O^"P/_*4CX^?]COJ__H]J_."OT?\
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M^/#0 5_MX?\ !)/_ )16_LU?]DM\(?\ IJMJ_P 0^O\ ;P_X))_\HK?V:O\
MLEOA#_TU6U 'TC^U)_R;-\0_^Q:U7_TEDK_!^K_>!_:D_P"39_B'_P!BUJO_
M *325_@_4 %?[!__  ;+_P#*%?X.?]<-1_\ 2V>O\?"O]@[_ (-E_P#E"O\
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M^595W3?^0C;_ /71/YBJ57=-_P"0C;_]=$_F* /]XW]GW_D@G@C_ + &F_\
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MU4: /\Q/_@]:_P"4G/P[_P"R7Z?_ .G75:_CSK^PS_@]:_Y2<_#O_LE^G_\
MIUU6OX\Z /W<_P"#9K_E.+\"/^OO6O\ TS7]?[#E?X\?_!LU_P IQ?@1_P!?
M>M?^F:_K_8<H _AW_P"#WS_DV?X%?]C-JG_I*E?YQ]?Z.'_![Y_R;/\  K_L
M9M4_])4K_./H ^IOV&?^3V?@[_V._A[_ -+X*_W41T%?X5W[#/\ R>S\'?\
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M#_.=KZO_ &#/^3Y?@Q_V/7AW_P!.$%?*%?5_[!G_ "?+\&/^QZ\._P#IP@H
M_P!TFBBB@ HHHH __]+^_BBBB@ K^-[_ (/7_P#E'#\,_P#LI-K_ .FO4:_L
MAK^-[_@]?_Y1P?#/_LI-K_Z:]1H _P RBM'1_P#D+6O_ %U3^8K.K1T?_D+6
MO_75/YB@#_?GK\,O^#D__E"=\<_^P?IW_IQM:_<VOPR_X.3_ /E"=\<_^P?I
MW_IQM: /\=2BBB@#_;G_ ."1/_**C]FS_LF'A/\ ]-EO6U_P52_Y1D_M"_\
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M#/'_ )2Z_P#<F:S_ #@K_51K_*N_X,\?^4NO_<F:S_."O]5&@#_,3_X/6O\
ME)S\._\ LE^G_P#IUU6OX\Z_L,_X/6O^4G/P[_[)?I__ *==5K^/.@#]W/\
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M7X,?]CUX=_\ 3A!7RA7U?^P9_P GR_!C_L>O#O\ Z<(* /\ =)HHHH ****
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M&O\ 8>_X.7?^4)7QP_Z\]+_].5I7^/#0 5_MX?\ !)/_ )16_LU?]DM\(?\
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M^4+'@K_L.^(/_2UZ_I7K^:C_ (-+/^4+'@K_ +#OB#_TM>OZ5Z /\#CXB?\
M)0-=_P"PA<_^C&KCJ['XB?\ )0-=_P"PA<_^C&KCJ /]+W_@R<_Y,)^*G_8]
M_P#MA;5_9W7\8G_!DY_R83\5/^Q[_P#;"VK^SN@#_&#_ ."^?_*8S]H+_L:[
MC_T%*_(.OU\_X+Y_\IC/V@O^QKN/_04K\@Z /] ;_@QN_P"/+]I+_?\ "O\
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M?^DJ5_G'U_HX?\'OG_)L_P "O^QFU3_TE2O\X^@#ZF_89_Y/8^#W_8[^'O\
MTO@K_=1'05_A7?L,_P#)['P>_P"QW\/?^E\%?[J(Z"@#^57_ (/%?^40L7_8
M\Z+_ .BKJO\ *RK_ %3?^#Q7_E$+%_V/.B_^BKJO\K*@#0TG_D*VW_75/YBO
M]Y+X$?\ )#_!G_8"T[_TG2O\&W2?^0K;?]=4_F*_WDO@1_R0_P &?]@+3O\
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M3-^+O^P#H?\ Z3B@#^::OZM/^#.C_E+;<?\ 8DZO_P"C+>OY2Z_JT_X,Z/\
ME+;<?]B3J_\ Z,MZ /\ 5$K_ #H?^#X'_DX#X!_]B]K/_I3!7^B]7^=#_P '
MP/\ R<!\ _\ L7M9_P#2F"@#^&6OU5_X(<_\I>OV=O\ L>-*_P#1@K\JJ_57
M_@AS_P I>OV=O^QXTK_T8* /]J.OX:?^#X#_ )-Z^ O_ &,6L?\ I-#7]RU?
MPT_\'P'_ ";U\!?^QBUC_P!)H: /\YVOJ_\ 8,_Y/E^#'_8]>'?_ $X05\H5
M]7_L&?\ )\OP8_['KP[_ .G""@#_ '2:*** "BBB@#__U/[^**** "OXWO\
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M $":_P _;_@QP_Y"/[1__7/PO_/4*_T": /\H/\ X.[_ /E,EK?_ &*NA?\
MHIZ_F#K^GS_@[P_Y3):W_P!BKH7_ **>OY@Z /[%?^#*O_E)#\0O^R>W7_I?
M95_IQU_F.?\ !E7_ ,I(?B%_V3VZ_P#2^RK_ $XZ /\ ,H_X/7_^4C_PS_[)
MM:_^G34:_C>K^R'_ (/7_P#E(]\,_P#LFUK_ .G34:_C>H _=#_@VH_Y3??
M;_K_ -6_]-%[7^Q17^.O_P &U'_*;[X#?]?^K?\ IHO:_P!BB@#^!3_@^&_Y
M!/[/O_777O\ T&UK_/RK_0-_X/AO^03^S[_UUU[_ -!M:_S\J /T$_X)0?\
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M^(?_ &+6J_\ I+)7^#]0 5_L'_\ !LO_ ,H5_@Y_UPU'_P!+9Z_Q\*_V#_\
M@V7_ .4*_P '/^N&H_\ I;/0!^]-?X'_ ,3?^2D^(?\ L)7?_HUJ_P!\"O\
M _\ B;_R4GQ#_P!A*[_]&M0!P]?Z6/\ P9+?\F*_%K_L>E_](+>O\TZO]+'_
M (,EO^3%/BU_V/2_^D%M0!_:/7^(S_P5Q_Y2>_'K_L>-9_\ 2AZ_VYJ_Q&?^
M"N/_ "D]^/7_ &/&L_\ I0] 'YVU_?U_P8W_ 'OVD?IX6_\ <C7\ M?W]?\
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MHLOV:?\ LE7@W_TT6M?X@U?[?/\ P2=_Y19?LT_]DJ\&_P#IHM: /;OVR/\
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M0!_L0U_$-_P>\?\ )JGP0_[&N_\ _2.O[>:_B&_X/>/^35/@A_V-=_\ ^D=
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M^F5 '^YQ7X9?\')__*$[XY_]@_3O_3C:U^HS?M9_LV(Q4^,],XXXER*_'?\
MX+Z_%7X??'G_ ()(?&'X3?!74D\5>)]8L;%+'2M+5KF[N&2^MW81Q(I9L(I8
MX'04 ?Y"U%?67_#!G[;O_1(?&/\ X)+O_P"-4?\ #!G[;O\ T2'QC_X)+O\
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MX)G:Q\-?VDO-\"^()O'>J7J:=K<,EE<M;26EBJ2B.15;8S(P#8P2I]*_I?\
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MM2:5?_#[^WAX<_L[^WK2:Q^U?9OM_F^5YJ+NV;TW8Z;A0!_?57^3S_P=S_\
M*97Q#_V+.A?^B37^G[_PUK^S7_T.>F?]_?\ ZU?YJ/\ P<Z?!#XU?M.?\%6=
M<^*/[/'@[7/&OAN7P]HUO'J>C:=<7=HTL,1#H)(XRNY3P1GB@#^3ZOZFO^#/
MO_E+[;?]BAK7\HJ_!;_A@S]MS_HD/C'_ ,$EW_\ &J_HT_X-<?@M\9/V7_\
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M /\ $ HKZP'[!O[;A4,/A#XRY_Z@EY_\:I?^&#/VW/\ HD/C'_P27?\ \:H
M_P!/#_@TL_Y0L>"O^P[X@_\ 2UZ_I7K^7O\ X-FO'/A?]FK_ ()+^$OA3^T%
M<'P7XEM-9UR6;2]9B>SNXXYKMVC9HI%5@K+@J<8(Z5^_@_:T_9L)"_\ "9Z9
M_P!_<?TH _PP/B)_R4#7?^PA<_\ HQJXZOMKQS^PO^VG?^-=8OK+X2^,)89K
MVX>-UT6[*LK.2"/W70CI7+?\,&?MN?\ 1(?&/_@DN_\ XU0!_H&?\&3G_)A/
MQ4_['O\ ]L+:O[.Z_BZ_X-(;D_LE_L7_ !'\&?M.P7'@'5M0\9?;+6SUVWDL
M9IK?[% GF(DJJ2FY2N0,9&*_J\_X:U_9K[>,],_[^_\ UJ /\@S_ (+Y_P#*
M8S]H+_L:[C_T%*_(.OWT_P""T_[+7[3'QF_X*H?&_P"*/PE^'OB3Q)X;UKQ+
M/<6&IZ=I5S<6MS"54!XI$C*LO'!!Q7Y>_P##!G[;O_1(?&/_ ()+O_XU0!_:
MI_P8W?\ 'E^TE_O^%?Y:E7]^5?P/_P#!GUH?B+]D&U^/D?[4NEW_ ,/CKS>&
MSIPUZTEL?M0MA?\ F^5YJ+OV>8F['3<*_M7_ .&M?V:_^ASTS_O[_P#6H _R
M]O\ @[=_Y3,>)_\ L7-"_P#1%?S,U_5O_P '-?P.^-G[3/\ P5;\1?%/]GKP
M;KOC3PW/H6C01ZGHVFW%W:-+##AT$D<94E3P0#Q7\_7_  P9^V[_ -$A\8_^
M"2[_ /C5 '[Z?\&>/_*7;_N3-9_G!7^JE7^7M_P:T_!GXQ?LO?\ !3T?$W]H
MWPEK7@?P]_PBFJVO]HZUI\]E;>?*8=D?F2(J[FVG [XK_2!_X:T_9L_Z'/3/
M^_O_ -:@#_.;_P"#UK_E)S\._P#LE^G_ /IUU6OX\Z_M'_X.U_A9\4/VL?\
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MQXTK_P!&"OES_A@S]MW_ *)#XQ_\$EW_ /&J_2'_ ((^_LI?M/\ PB_X*A?
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MWVE6,.WRUL+V]DF@==K-@2*V[#'=S\P!H ^WZ*** /$O$?[2W[.O@_XMZ5\
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M_LNCVNL:C;V,M_-P/+MTF=#*V2!A >2!W%>TU^'/_!1C0/B9\)O$7Q;^-/\
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M16#"@#^P"BBB@ HHHH *_ '_ ()X?\IU_P#@HK_W2+_U'IZ_?ZOP!_X)X?\
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MQ JJ9HQ'*RJJJK,0H"XH _7^BBB@ K\ ?^"AW_*=?_@G5_W5S_U'K>OW^K\
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MVB_%OPW^"FF:+)!>^$_!,QTJ_O-4,H(FEN\O'+&T>!MEA?RC&-B_O'8?F/\
M\$//BA^T7^S_ /\ !4W]IW_@EWXR^*.M_%WX5?"C3K;4])UWQ)<F]O-.N7-N
M6M3.W(^6>5)$'[L26Q**F6! /ZZJ*_A__8W_ &<OVIO^#BS1OBC_ ,%!_B;^
MT%\0?A/X:7Q-?:)\+/#GA'43I]EIMMIZJ8[J[B3(F<^:J2%#%*SHY\P)Y:K]
M'_\ !.'XC?\ !2#_ (*I?\$C?&W[*8^-%U\./C?\+/'DO@;7/&\<37%_=Z;I
MS1N^V>-X98[DH[1_:!B23R?F8-*TB@']>-%?PJ_M7? #X_\ _!"S]O+]E*]_
M9=_:$^(GQ(7XT>,8_#WB3PIXUU;^TXM2BDN+.&:6.(+'&N[[40'=6DBD*%7(
MW"OZ/?\ @H]_P2RNO^"B?C/PSJOB;XZ_$+X9^$?#NG7D-WH/@O44TR*^NY61
MH;J64HXS$ RLKQN""NPQ8?S #];:*_DJ_P"#<SX^_M)P_M6?M1?L!>.OB1J7
MQG^''P8UF&V\->+-4F:]N(R\]Q";9KIBQ?<L6=FXHC1/Y>$(K^M6@ HHHH *
M_ '_ (+Z?\V5_P#9U7PX_P#;ZOW^K\ ?^"^G_-E?_9U7PX_]OJ /W^HHHH *
M*** "BOG?]K3X>?&[XL_LU^-/AK^S=XR3X?>.=:TN6UT;Q"]O]J%A</CY]F1
M@E<J'&3&2' 8J%/\3/\ P5=_8J_:9_X(:?LV^!_^"@7P:_:R^)?BSXJCQ/IN
MF:S:^)M6>\TC7)IX9I9%2S;+-'^YYBN))\QY^8,%- ']]U%?S5_\%U?VQ_VJ
M=$T+]G;]@3]E36+CX=?$W]J#7H])N]<MC_I6@Z7 +<7S1.K*\<JM=)B1&#B.
M*0(5<JP_/KXP_!3]HW_@W_\ VZ?V</B#\-OCKX]^)_PB^,WBJ'P5XRT3QOJ?
M]I;+R_:-5NH056-6^9YE9565?)V&1TD84 ?VLT5_+Q^TW_P0Y_:*^/?C/XM_
MM-?M0_MC_$+29([J_P!4\&6WAB^?1=$\/:;%%OB%Q:YD!\H I(T#1,ZIYC.7
M<@>\_P#!LG^U_P#M)?MI_P#!+?2?B3^U'J5QKVOZ-K^I:%;:S>?-=:E8V@B:
M.:9_^6CHTCP%S\S>5ELMEB ?T'45_#;_ ,'+7_!<7XD^&;C5/V$OV"=3O[9_
M#=_8P_$CQGHSO&-+GGD)M](ANHL>5/(8V-P58, AA'295_N2H **** "BBB@
M#\ ?^#7+_E!1\#/^YF_]2#4J_?ZOP!_X-<O^4%'P,_[F;_U(-2K]_J "BBB@
M HHK\)/V[?\ @D3^T)_P4#_:MF\:?$?]I;QKX'^#-KHMO;Z9X-\#7!T>X74T
M),D]S/\ O8KA2?G4O"7&=B[ FYP#]VZ*_D1_X(-_M5_'KX/?%W]L[]DKX]_$
M75_BS\-?V9]2>32?$NKRF[U&&WMVOA-;O-(Q9SY=IPF[9&\;A<*P ^5_V.OV
M)/VYO^"Z_P"S#XI_X*A_%#]H[Q_\-_%OBS4M7/PQ\/>%]6DT_P /Z/!ISO:P
MB6*/YRK3Q-$[0F*0A#([2,V  ?W+45_)/^PIX^_;Z_X+B_\ !%GP;HOAKXV:
MA\(_B%X?\7/X;\=>)M.@V:GJ=AI;JSK!-;O$]M<-;S0,[ICS9(V5MJ2-7RMX
MJ^$GQY_X(H_\%C/V6_@%^S?\=O'GQ0\)_'6^FL/%'A?QIJG]J&*W66**2\"A
M(HTXEDFB=4$BFW=2S*2" ?W T5_#_P#\%F/$G@_QC_P7J\-? C]I/]HWQ;\
MOA-_PJ2'5[J^T#Q(VAQG4(KR^$8"OOA>24 +@1&1@H Z5^\7_!'']F;]FGX-
M^!O%GQ3_ &6OVD?%W[1GA_QA)96[WOB7Q+#XB@TZ;3?.)CM_*CC^SR2"X'G(
M_P Q"1\#'(!^SU%%% !1110 4444 %%%% '_T?[^**** "BBB@ HHHH *_)S
M_@LS_P %-/"W_!+;]B_5_C0BQ:CXYUMO[%\&:.PWM>ZQ<*?+8QCYFAMQ^]EQ
MC(41@AG2OUCK\0O^"F?_  0<_9F_X*K?&;PY\:OVA?B#\0M%NO"-@+'1]/\
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M(?LVI^+_ !G?C4M5>W8HS1(Z1Q(J.R*6.TR-M 9R   #]?**** "BBB@ K\
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MLFGVFJ_:/#'PCT2Y&?[-T. O#)<K_M$&2$,N \LETV K)5C_ ()]:]8?"O\
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MF\.?&K]H7X@_$+1;KPC8"QT?3_#>HV-I869\PRO/&D^GW$BSR-LWR"3D1Q@
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MHH **** /P!_X-<O^4%'P,_[F;_U(-2K]_J** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
&**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>soph-20251231_g2.jpg
<TEXT>
begin 644 soph-20251231_g2.jpg
M_]C_X  02D9)1@ ! 0  2 !(  #_X0!J17AI9@  34T *@    @  @$2  ,
M   !  $  (=I  0    !    )@       Y*&  <    2    4* "  0    !
M   #T* #  0    !   "(@    !!4T-)20   %-C<F5E;G-H;W3_X0DA:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[
MOR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \>#IX;7!M971A
M('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)835 @0V]R92 V
M+C N,"(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2(B+SX@/"]R9&8Z4D1&/B \+W@Z>&UP;65T83X@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" \/WAP86-K970@96YD/2)W(C\^ /_M #A0:&]T
M;W-H;W @,RXP #A"24T$!        #A"24T$)0      $-0=C-F/ +($Z8 )
MF.SX0G[_X@TD24-#7U!23T9)3$4  0$   T487!P; (0  !M;G1R4D="(%A9
M6B 'YP "  ( "0 P #=A8W-P05!03     !!4%!,
M    ]M8  0    #3+6%P<&P
M                         !%D97-C   !4    &)D<V-M   !M    ?!C
M<')T   #I    "-W='!T   #R    !1R6%E:   #W    !1G6%E:   #\
M !1B6%E:   $!    !1R5%)#   $&   " QA87)G   ,)    "!V8V=T   ,
M1    #!N9&EN   ,=    #YM;6]D   ,M    "AV8V=P   ,W    #AB5%)#
M   $&   " QG5%)#   $&   " QA86)G   ,)    "!A86=G   ,)    "!D
M97-C          A$:7-P;&%Y
M
M            ;6QU8P         F    #&AR2%(    8   !V&MO2U(    8
M   !V&YB3D\    8   !V&ED       8   !V&AU2%4    8   !V&-S0UH
M   8   !V&1A1$L    8   !V&YL3DP    8   !V&9I1DD    8   !V&ET
M250    8   !V&5S15,    8   !V')O4D\    8   !V&9R0T$    8   !
MV&%R       8   !V'5K54$    8   !V&AE24P    8   !V'IH5%<    8
M   !V'9I5DX    8   !V'-K4TL    8   !V'IH0TX    8   !V')U4E4
M   8   !V&5N1T(    8   !V&9R1E(    8   !V&US       8   !V&AI
M24X    8   !V'1H5$@    8   !V&-A15,    8   !V&5N054    8   !
MV&5S6$P    8   !V&1E1$4    8   !V&5N55,    8   !V'!T0E(    8
M   !V'!L4$P    8   !V&5L1U(    8   !V'-V4T4    8   !V'1R5%(
M   8   !V'!T4%0    8   !V&IA2E     8   !V !$ $4 3 !, "  4  R
M #< ,0 Y $@ 0W1E>'0     0V]P>7)I9VAT($%P<&QE($EN8RXL(#(P,C,
M %A96B        #SV  !     18(6%E:(        &2'   S*@   0I865H@
M        :N0  +R7   1REA96B         G:P  $#X  ,!98W5R=@
M  0     !0 *  \ %  9 !X (P H "T ,@ V #L 0 !% $H 3P!4 %D 7@!C
M &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *, J "M +( MP"\ ,$ Q@#+ -
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MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\
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MIP  #5D  !/0   *6W9C9W0          0 !          $    !
M  $    !          $  &YD:6X         -@  IT   %8   !2@   G
M "<    /0   4$   %1   (S,P ",S,  C,S          !M;6]D
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]L
M0P ! 0$! 0$" 0$" P(" @,$ P,# P0&! 0$! 0&!P8&!@8&!@<'!P<'!P<'
M" @(" @("0D)"0D+"PL+"PL+"PL+_]L 0P$" @(# P,% P,%"P@&" L+"PL+
M"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+
M_]T !  ]_]H # ,!  (1 Q$ /P#^^Z\O(K*+SILD$XXZYK+_ .$ALO[K_D/\
M:/$/_'DO^^/Y&N-JDB6SLO\ A(;+^Z_Y#_&C_A(;+^Z_Y#_&N-HIV0<S.R_X
M2&R_NO\ D/\ &C_A(;+^Z_Y#_&N-HHL@YF=E_P )#9?W7_(?XT?\)#9?W7_(
M?XUQM%%D',SLO^$ALO[K_D/\:/\ A(;+^Z_Y#_&N-HHL@YF=E_PD-E_=?\A_
MC1_PD-E_=?\ (?XUQM%%D',SLO\ A(;+^Z_Y#_&C_A(;+^Z_Y#_&N-HHL@YF
M=E_PD-E_=?\ (?XT?\)#9?W7_(?XUQM%%D',SLO^$ALO[K_D/\:/^$ALO[K_
M )#_ !KC:*+(.9G9?\)#9?W7_(?XT?\ "0V7]U_R'^-<;119!S,[+_A(;+^Z
M_P"0_P :/^$ALO[K_D/\:\COO'?@C3/%5IX%U+6;&WUN_C,MMI\MQ&EU-&-Q
M+1Q%@[*-C9(4CY3Z&J?@[XE_#GXASZG;> /$&FZY)HMTUCJ":?=Q736ETGWH
M9A&S&.1>Z/AAZ4^32]B>=7L>T?\ "0V7]U_R'^-'_"0V7]U_R'^-<;7$^#OB
M7\.?B'/J=MX \0:;KDFBW36.H)I]W%=-:72?>AF$;,8Y%[H^&'I1R]1\_0]H
M_P"$ALO[K_D/\:/^$ALO[K_D/\:XVBE9#YF=E_PD-E_=?\A_C1_PD-E_=?\
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MJM*Z;BKK7YA1116!T!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:5XB>:]EF@GLK:[6UCACA9O+BC6*9_E0 %CN.6 -?Z!ZVMLEPUVL:B5U"LX
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M0.4U#1OC)X5T'XC_ !K^%?PEO] ^%_Q(^+.D7^FV6H^#I=8U3P_86VD^1?\
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MKC1K9-+TV?5;*\OA!;B8(EM]H6!U3R\ES"P7:05%?#WB+P+?_M&?"?XL>%_
M_D:'\=_&/PVT;1-!\&V7@W5?!\.H:/X:O$N-1$3ZO%&EW<W,$[6K1Q-M2$JA
MWH2P=/ TY1YN9V=OEMOZ7_ 53,*D)<KBKJ_SWM;UMY[G]:GPL^./P4^.>FW>
ML?!/QAHGC&TL)C;74^AZA!J$<,P_Y9R- [A7_P!DD&JNO_M ? ;PK\2+#X-^
M*/&V@:;XOU55:RT.ZU*WAU*Y5N%,5L\@F<$]-JG-?E#_ ,$S_AQH.I_'[Q-^
MT'IT_C&TU"X\+:?X?O=/U[P)_P (19!;:XDEA4(L,,=S<VH+QEH]ZI'(%#D
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M+5;+XH>!=1UC3[6U_M%=.M4NXVORY1& MH5R)9#B/8,L<4_JM.%2',[J[O\
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MB\?,N*I82G&/-*7?_AT0\;4G+EA&VW_#/^D?OSX^^,_P>^%/_)4?%FC>&_\
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M\T?WZI8.E=1<]=.W5V_#J+Z[6LY*&BOWZ*_X]#^@KPK\<;EO%/Q*A^)S>']
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M?]G5>Z_J_P"BOZ6%_:=+L[Z?C9=^[MZW/Z:*X;P/\3OAS\31JY^'6NV&N_\
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M_P %MM%\<ZS^R1H47@SQ/-X;0^/O!D5SY-M!<>=YNM6:PD^>K;?(FV3C'#E
MKY0D4OJ>L(N6LFT_+1?Y^@_KVE22CI%)K;767GMIZGZB:)\5?A[XC^(NO?"3
M1-5AN?$GABWLKO5+!<^;:P:EYOV9WR,8E\F3;@G[ISBO0*_FL\2^#?VO_#/[
M9G[36M?"+XO_ -C:YX*^&O@W4M1U2XT*RNI];O+.'6)8%D1E%O;P-LD$XAA$
MAW*8WCVG?-XQ_P""A_[7'[0'C/P)\.?@E<:_X3N-2^$7AWXB74OA7P]9:_=7
M6H^(58K%*FH/LBL(#'M8Q#S7=]HD3:,MX%NW))6LK[Z72?;ST_$2S!)/GB[W
M:6VMFUW\M;V\C^A2T^)WPYOOB+>?"&RUVPE\5:?8Q:G<Z0EPAO8;.=VCCG>$
M'>L;.K*&(P2,4_XD>!-.^)_@75/A_J][J.G6VK0-;R7.DWDVGWL2MU,-S R2
MQ/Z,C BOYTOB[^WG^V1\/O!'Q5^)'BG2[+P5X_\ "_P!\,^*Y[)]/MWFLM?G
MU"_ANE9W5Y'@_= QPR2.B9R/F+$_JMXZ^(7[0'[%_P"P;\1OV@/C3XE3XG>,
M/#.B:EXF5$L(M.L89(;42+90QVZB0VD<J,1),TDY1B6<X $3PLH.+35VTEZZ
M?+KW+AC(34KIV2;>G37SOT?0^M?@?\#_ (7_ +.'PNTKX,_!O2UT?P[HR.MM
M;AWE;=*[2R222RLTDDDDCM))([,[NQ9B2:]8K^?GQ5\6/^"BOP>UCX>?#G_A
M:]G\0-?^/?@[Q+/H[KHEC:+H/B+2M*_M*UELQ"A%Q82-^X=+H2OEHV\SYBM>
M*Z)_P6F^(DOBW1OVA-4EM1\'%^'20ZG"T*!E\>G0YO$KP^=@.NVTA^S"$-AI
M).F[;5_4:L[R33Z]?/NNZ9']H486A)./3IIHNSZ)K[S^G"OSFN?^"6_[,%YJ
M>HVMW-XED\):OK,GB"\\&G7;O_A&YM0FN#=R.UB)-IC>Y)F>W+>0S\F,CBO@
MCP[\1_\ @I=\2_B;%\ 9OBU;^#=:T'X+^&O&NLW*^'K&[N)?$=]+?I/$!(@B
MBMRT*I*OE,VV-?+,;%RWOWQ%_;A^,UQ_P0_;]O;PI+;Z3X\F^'MGXB$JP)+;
MQZC)%&966*0,IC+EBJMG"D#J,T*A5IM*$UJTM+]=@EB:-1-U(/1-ZI=-^OYG
MW/\ '_\ 8]^&'[0OC+P]\3=9U#7?#?BOPO!=6FGZWX;U.;3+U;2],;3V[M&=
MDL,C11L4D1@&0%<'.>]^ 7[//PO_ &:?!$W@3X66MQ%!>WUQJE_=7MU+?7U_
MJ%V0T]U=7,[O+--(0-S.QP %&%50/Q_^,O[0'[:_['GQ1U/X=^.OB=;_ !&'
MBOX4^,O%UBYT2STZ3P_K'AF"&6.2)( ?,LIC/M6.Z,T@>,9E89!\@\6_M7_M
MY^ O O[/GA7Q/X^U/6O%'[1EI<:_/=^%O#6G7-QH5GIVG0WCV.EVMP%CFDF-
MPA>>\:;:D4C)& 0JTL-5E%1YUR]-_-OITL_T)>+HPG*3IOF6^W6R77K=?KL?
MTFUPW_"SOAR?B6?@S_;MA_PEPTS^VO[&^T)]O_L[S?(^U>1GS/)\W]WYF-N_
MY<YK\)/A_P#M.?\ !1/XI^-/AE^QIXVU6Y^%OBCQ'<^+KZ[\8:CHEFFKZEH7
MA][863V^GRF>RANKI;M3< K(D8A8HF&&/<_%?CG]L7P1^U+X@_9_\!ZSI7CC
MQYIOP)NM9TC4=0TNUT]K_P 0#4Y8;8S/& 8XFP@:$2K 7!?"9R,G@VG9R7W^
M=K[6M^)JL<FKQB[:+;K:]M[W_ _6CQ]\3OAS\*]/LM6^)>NV&@6NI7]MI=I+
MJ%PEND][>/L@@0N0&DD;A$')/2NYK^:W3/VQ_C99?#W0O!/Q*\9ZUK/Q$M?B
M9\-],U_P]XY\*:;IFH:3;:YJ0@G> VL1M+FWG*O]ENH"\D1C)\W<01V?Q>_:
M^_;4N?AC^T)^V]\/_'^G^'O#?P&\6ZOH-GX%GTNVFM-6M?#CQ+=-?7L@^V1W
M%Z68VXMWC2-3'E9-Q-5]1EM=?CY6Z=;^A']HPU=GM>VE]+WOKTMMO^G]#]%?
MSC?'S]JW]O2\@_:F^-?PG^(UMX8\/_ )M/U/2/#MQH-K<O?12:'9:G<6M[<2
M9D6,F20)Y0297<YE*!4'Z&_\% _V@_C5\/?V=/A_XR_9WU2V\.>(/&_C3PAH
M,=S?VBZA!!!X@O(K>3S(24WA5DYVNC''RLIYJ'A))Q5UKZZ:)ZZ=GTN:K&P:
MF[/W?375K37NNMC]+**_FK^)'QE_X*:?#N/]J+0K+XWV=\O[-ND6OBRPO+GP
MQ8"[UR*\TQM1:QO1&%AB@B%O+&C6\23L9 S2_+M-KXU_M]?MM_&7XX?$'P+^
MRDOB'1YOAUX:\.ZGINF:'X=LM<M]6U/7M/&I(FJ3W<B26]H=RVR?90DF5ED,
MAVA*M8";VDK=]?+R\T9O,H+>+OM;37>_7IRO]#^B7QGXQ\,_#SP?JWC_ ,:W
MB:=HVA6<^H7]U+G9!;6J&261L G"(I8X!.!7BD_B;]EO]H_Q!H7A&[O]$\5:
MIHT6G>.--TV25)IX(I0XL=1^SD[@N68PR.F%?###JI'X;_'_ .-?[8?[9'PC
M_:DCB\8K\*="^$W@DV-_X0CTJUO[F_N[_P /C4;X7T]P&EBC'G-;0?9GC.8S
M(2V-IQ]?_;C^+'[*GPZUG6/ ]KI5TWA?]G_X:WVDB]M8U6+4M<U"73!-<W"*
ML[VT.Z.5HC)L 1BNTLS5<,#*VC][3\;6Z>9$\PC?6/N:[K>U[]?+J?T;_$3X
MG?#GX1>'/^$P^*>NV'AW2?M%O:?;-2N$MH//NI%BACWR%5W22,JJ,Y)-=S7X
MO_M61?M8?LG?LDZGXP^(_P 58_BAJ-YXH\$6EN^J>'-,M8[3[9K=I;7@2.&+
MRW21)1Y/F(TL#+N$K-@K\O?'C]K7]O'POX,_:7_:?\(_$BSL?#?P \=G2['P
MN=#M91J=A#;Z=/<0W5V^9579=MY+0B.17!+NZE53.&#<TG&2WMU\O*_4TJ8Y
M4V^>+VO;2ZW\[=.A_2#17\YO[2/[;7[>7C#]I;XT^ ?V4(_$"S?!N?3K'2="
MTGPY9:K8ZU>3V4=\XU:ZN9%N+>*X,ODP_9/+*HOF%G)VC^AKP[J-[J_A^QU;
M4[1["YNK>*:6UD.7A=U!:-B."5)P?I6-7#RIJ+DUK_P_ZF]'$QJRE&*>G^;6
MGW&Q1116!T!1110 4444 %%%% !1110 5Y_J_P 5?A[H'Q(T7X0ZQJL-OXE\
M1VEY?:;I[9\VYM]/,0N'7C&(C-'NR0?F&*] K\5_VYO!GQ4\??\ !3C]GCPU
M\(?&;> M3F\(^.S+J\-A!J-Q';J^D%EACN@T"R,=HWR1RJ%S\A)!&U"FIRY6
M[:-_<FS#$573AS15]4OO:1^M_B;XG?#GP7XFT#P7XOUVPTS5_%4\MMHUE=7"
M13W\T$9ED2W1B&D9(P68*#@<FNYK^=GX2_MM_M!ZU\4/A1X ^*U]I_BF_P##
M?Q6^(?@?5M8M],MTEUJW\-:+>75O<PH%86D[L$CE%LR@LCI]PE:F^$7[7_[:
MEM\,/V?/VW_'_C_3_$'AOX\^+=(T&\\"P:7;0VNDVOB-Y4M6L;V,?;)+BR*J
M;C[0\B2*),+'M!KHE@9KJO\ /?;3RZG-',(/H_\ +X=]?/H?T045_,KX@_:I
M_P""D4W@BX_:#\*_%72K>Q'QPOOA=9^'KKPY;368TZYUR72;>YN)D>.YEGMB
M\;*(I($=(P)-SEG/M^I?M9?M#?!R_P#C5^S;\9/B[<7.O^$/$7A*P\,>);#P
MM;7VMZE_PE%LUPNFV^F6XCMGN@T,JQ2LC(L?SRAMK&AX"?22?W]TNWF@68PZ
MQ?X=F^_6S/W[KS^S^*GP]O\ XH7WP7L]5AD\4Z9IMOK%UIPSYT=C=R2PPS'C
M&UY(9%&#G*FOYVK/]O+]O"S^ 7BSP!'K-Q8_$CPW\:/"W@2RU7Q;I.G1W3Z7
MXE^Q/$-0M-,DDM!(HNFW-;.C&/;Q')N \O\ VH?VF?C-^P?^W;XF\,S^([KQ
M?XY\0_##PGIEQX[U+28TT[0K6Y\0:I'-K&HP6,201V]BMS$B(% D;9YA(\QZ
MN.72;<;J_3\-=MM?7R(GF<$E*SMUOTWTWWNO3S/ZM:*_G*_:(_:^_;MU']HS
MXG?L[_LUZOXEN]1^"^@Z"+1]'\,Z=J\?B36-3L?M@EU:25H?LMK,=L*K8I$P
M82N'PJQU]$_!?XY_MK?&_P#:_P#B3;>)/$,WA+P9\*],\*:S=>#=.TFUO-6O
M;O6-(6\NM-:XF4E42575?+(F:1@!(B+@Y/!24>9R6U_RMTZW7ZV-5CX.7*HO
M>W3I>_7I9_I<_:RO/O ?Q6^'GQ/N_$-CX!U6'5)O"FK2Z%JRPYS::C#'%,\#
MY ^=8YHV.,C##FORK^/'[9/QT^+?Q8^#7[,OP,CUSX)ZA\4=4\0+>:UXET:W
M;4X++PY90WCI8VMPT]N\ER9U19)0X18I3L) K\T?!'[1O[0O[)/@[XG_  S\
M,:[>:[XS^(/[3-_X5N?$]EH]M/?+'_8.GW,DUOI[.EHUY*L BC1OW6YF?80H
M2JIX&4HW;UZ+RO:[^Y^9-7,(QEHM%HWYVO9:^:\C^FCXV_'CX0_LX^ IOB=\
M;M>M_#VAPRQ6YN;C<Q>>=ML<4<:!I))';A(XU9V/05/\*?CC\(?CEIEYJWPB
M\16/B"'39DMKT6DH>2TGDB2813Q\/#+Y<B,8Y%5USR :_FK^/%]^W9\8M&^#
M/ACXU>(?$'A631OCWI.G^']=U;0--L]1U6TNM-FN+:]N+-5EMEN+&=+B$"-5
MAF5E=H]RJ1] >+_VK/VJ=(G\8>$/A1XCTO0M;O?VE+#X<1:I+HUM,HTN]T:U
ME=YH8Q#Y\PE<R"1G#G:J%]@VU;P/NJTE?UTW]/Z[$?VA[S;B^7TUO:_?^NY_
M1117\XGQ7_;X_:[_ &6_!_QE^"'B;Q)_PG7B[PIX^\'>$]"\5G1[9+B*S\96
M\$_FRV%N8+::>TW2I"N8TE<Q[SC<#6U;]L;_ (*)_#70)?A#XGGU?3Y?'GC[
MPEX.\&^//&WA^RT^^MD\0)=M?-+86;"TN)+3[(%MCLC61[E X.W!A8"HU>Z_
MSV=]O/U\BWF5-.W*_P -'JK;]UZ>9_0'H/Q6^'GB?XB>(/A-H.JPW7B/PI!8
MW.K6"9\VTBU(2FU9\C&)1#)MP3]TYQ7H-?BO_P $_O!?Q+\ ?\%(_P!J+PS\
M5_&DWC[58="^'9_MBZL;;3[B2)HM8*K)%:+' 67D;DCC!&,KD$GY;^*W[5?[
M>GASX)?M#_MG:)\5;.ST?X'?$#6M(T[PC-H=D;35--TJYA'V:[O"IN1)*DWE
M0O 8F5@"WF%N%]3O/DA);1[[R2\N[']>Y:?/.+WEM;11;\^RZ'])E<[XF\7^
M%?!?A[5/%WB[4K;3-+T2UEO=0N[J58H;6VA0R22RNQ 1$12S,Q "@D\5_/U^
MVY^WG^T%\*/B)XG^*OP#\8^(/$'ASX=>(?#^G^(=!LO#&G+X=L$O);..[L;_
M %:[E%W+>E+G>OV#/D-)&DD8&YZR[&S^.O@+]J']O;XIVOQ#FO+7PGHUO>IH
M]SI5A):W)D\-R7-DDI:$N4L]PC SB=5_?!R6RXX%\O-*2V\^ZTV\T*6814N2
M,6];=.TG??7X7YG]#_ACQ-X=\:^&M/\ &7@^^@U32=6MHKVRO+6198+BVG0/
M'+&ZDJZ.A#*P)!!!%;E?S&:O^W/^VK\4-?L?@Q^S_=:[H=]X0^%WA+Q#CPMX
M8T_5UU76->LVG NUNFC2UT]/*6)4M$5]S.1(H14/J^I_M#_\%'?C1XL^*-CH
MGC6W^$=W\-_A?X3\9W6A-H=KJ,\>NZI97MQ<V4DUQOVVPEM6CE 5I?NF.2/#
M!QX":WDE]_E;IYB68P>T6_NZ7OUZ6?Z']"YGA$PMBZ^85+!<_,5'!./3)%2U
M_.E\'_$/QQ_:9_X*4_ OX[VWCRY\-1>+/@%:^+[C2[;3[.:$6]W?Z1+>:>'F
MC=Q'<NP9I0WG1[0$8"O>OV[OVLOVC=._;/T3]C;X#7WB+P[&O@F3QE>:EX5T
M&R\0:G<227K64,/DZ@P@CMHBA>=U5I&,D:*T>2QEX.7,H*2O:[WT_KR+6.CR
M.;B[7LMM?Q_,_;.BOY_/AU\;/^"E_P"TC\:/!7[/?B#Q9'\$M?NOA,GBGQ%$
MNA6FH7::S#JD]ANB2Z,B113JL<K(_F[4PJ;6)<<O\,_VQ?VW_P!KBP_94\*>
M /&UE\/KWXM>"_$^J>+=2M]*M[^5;G0)K&$36,5RKQI))(\@"R!HECE8E&9$
MP_J,OYE^.FC?;R>UQ+,(/[+\MM=4N_FM[']%=?/UW^U3^SU8?;_MGBJSC_LO
MQ1:^"KK._P#=:_>^3Y%D?E_ULGVB''\/SCFOQ!\9_MF_MLZ5^SQ\2O\ @HGI
M7C^TB\-?#+QM?>'T^'LNDVIBU#3-'U--+G%S>;1=Q:E<G=-$(F6%&9$\I@<U
MY9XZ_P":F_\ 9YW@S_W7ZTA@-???EIWTNMO,SJ9AI[B\]>UG9Z/R]3^I*BOY
MKOVB/VL_^"@_ASP=^T9^TG\-?B5IVGZ-\#?B/;>']+\,7.@VT\&I6<BZ69HK
MVZR)P@%\3&8#%*&5MTC!E\OJ/VAOVYOVPO\ @G^WQW\'?%#Q9:?%'4?#/@7P
MUXP\.ZC-I$&FK8W&NZK/HTT<D%LRB6V@E5+A \GF>6K(\I)WB%@)NUI*[Z:^
M7E;JBWF--7YHM)==//SO]EG]%--=TB0R2$*JC))X  K^:3XC_M>_\%*_@'\"
M_BSXHU"X\0W]CI&B:%J/A_Q3XU\,Z?H\UOJ]QJT%G=V)MK%C#/;26\PDB9@)
M4^=2[$*]=C^T_P"-_P!L7P7H/[2O[(7Q0^*?_"4E?@E<^/M+UR+1+*PGLV1[
MRVO; 0QJR/;SI %C>0O/$LC?O"ZJU"P$K_$OQ\K].EP>8QM\#_#SMUZV?=']
M!GB7Q7X8\&^%M0\<>+=0M],T;2K66^O;ZYD6*WM[6!#))+)(Q"K&B LS$X &
M3Q7DOPQ^&?P7F^(&M_M6_#.1+^_^)>DZ,MQJEM<FXM;VPT])GL7APQCVE+IV
M#I]\,"2<"OA_X8?\+.^"_P#P2"O?%>N^*V\7:OI_PRGUC3KJ_L+2-+>--'$L
M%NT$48AFCB*XS*K&0'#[A7R1X8^,_P"W)\=?'^G?"3X0?$VS^'NG:;\"_"/C
MEVM] LKR235]0^V(Z()5\J&VD\E!)&L3%551"8OF+*.&;4N66BT;UM^5RIXI
M)PYHN[U2TO?7K>VUS^@QIX4F6W9U$C@E5)Y(7&2!WQD9^M2U_,_\-O'G[0'[
M8'[7_P"R!\?7\?3^%+OQ=\(M7UVYL[+3K.:".??I!U"*/SXY&\N];;R27A6,
M>602Q/5']M3]M'_AG _\%-AXZLO^$2_X3W^PO^%9?V5;>5_8W]O?V#Y?VW;]
MM_M/_EYW>9Y.?D\G%-X"2LN97^>]VDOP]"5F,=7RNRUZ;63;WZ76FY_1M7EG
MB'XW?";PEX[_ .%9^*-?M-/UP:+=^(VMKA_+*Z58R1Q7%TSL BQ1/*@<EAC=
MGIDU\._M@_%[X]ZK^U5\*OV+_@1XJC^'C^.--UW7]4\2_8H+^\2UT3[,BVMC
M#=K);&:5[D-(\D<FR-,A23Q\O_$6W^(WPQ_X* Z&OC?Q$GBSQ+HO[//C22;6
M);&&U6[FAU73721[5-T*\!0R@;&(/R@' BGAKI.3W3=NO7Y=#2KBN5M16S2;
MZ:V\[[/T/VN\%>-?"'Q(\(Z;X_\ A_J=KK6AZS;1WEC?V4JSV]S;R@,DD<B$
MJRL#D$&LW5/B=\.=$\?:5\*M9UVPM?$VNV]S=Z=I4MPB7EW!:;?/DBB)#NL>
M]=Y4$#/-?@M\!OC5^VS^TKKWP8^"'PO^)5G\-[/7OV?_  ]X\U&[LO#UC=R'
M5KF00,+>*51;P0L74M&(V0(FV-4)W#!\(_\ !2CXQZEX ^ W[2?C+3=/U&\U
M#X._$3Q;KEG!:1"2[U'PPEE@6\Q1IH(YG$A,<;!6W+N!V+C3ZC*[2?\ 5FUT
M\G_P#)9C"R;36VOS2?7S7_!/Z0*X#XI_%+X?_!/X>:O\6/BKJD.B>'=!MVNM
M0OKC/E00KC+MM!.!GL#7Y3>!/'G[3GPY_8QN?VU?VDOVA+1+#Q'X-MM8$</A
M:UN--T2_U7R)+8V"6Q2[O%3S?L\<,\LSW$CHP*_<;\Q/VDOVEOVD_%_[(O[7
MW[-O[0MWXDU2WTCX<Z7XGT&[\6:1IFBZL+?4IKBWG22WTMVC\DR6ZM#YR1W"
M_.LBGY6*I8)RE;F5DTGOW2=KKI<*V8*$;\KNTVKV[-J]GUL?UF/<V\4(N)75
M(SC#,<#YC@=?4D 5/7XX_P#!:C1?'.L_L=^'(O!GB>;PVA\=^"HKGR;:"X\[
MS=9LEA)\]6V^1-LG&.'*!7RA(I;;Q!^VMXB_X*&)^R3IGQ;^Q>%/!W@/P[XH
MUF__ +$L'U/5KV?4;Z"6)<Q>1;Q7,4 $Q2,LFQ?)V%G:LXX;FI\_,NO?I;_,
MVGBN6I[/E;V[=;^?D?JI\-OB=\.?C)X*LOB1\)==L/$OA[4O,^R:EIEPEU:S
M^4[1/LEC+(VV1&1L'AE(/(J#5_BK\/= ^)&B_"'6-5AM_$OB.TO+[3=/;/FW
M-OIYB%PZ\8Q$9H]V2#\PQ7X'_"_]K;XR>-?V'_@7:^%O&^J>'OB#X[7Q#<+I
M'@7PIINHZIJ,.G7LD9DBCNO+TRQMX,IYTLR!9'D4!E8G=R'[-7[1/QM_:?\
MC/\ LK?&GQ9#;O\ $*?P%\6=.F6ZC2WAFU/1M1L=/#S);NZ1B62V#R+$[*NX
MA"0!6WU%IR;>BNON3\MM#!9@FHI+5\K\M7&_5Z^\M#^E^BOQT_X)J_'WX_\
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M9.,9.?NBBK]O4U]YZ^9G]7I:>XM/)?UT7W'RV/V+/V9QX+'P]'AK_B3CQ?\
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M[T6*6:=;9X"_DX$MQ*V\()#NP6P% ^@J*7M9_P S^_\ KLON*]C3_E7W>O\
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M;_9;H6Q$)WK-&=JL4W+S^HM%'UNKW_!>7EKLON!X.EV_%^?GIN_O/SM^!?\
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MM?L@_LG?LZ:;^TS/XDL/&^@:SJ<6EZ</#6HV=XUY*7"3-"WG+'(MOD&8JQV
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:3IAUN=+RQO--1],#!#>0R7L$"7%LK$!IH6>-21EAD5P/PS_ ."IW["?Q?\
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MXL76-5LK-=2^SRV=W9-<6+N(Q=6QNH81=6Q<A?/MS)%EE&[YAG(^.'_!0O\
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M[$C2LR33KED8*S*49]8T,.WS2:]+KM^&ID\1B4N6*?JXM]?QTZ;]C[-\%?\
M!1&#XN?\%%O%_P +K#Q['X4^&OPQ\-:?J]W:7>A3Q?VLUY;7=Q=376H7<2+8
M0V4<<#J#L,OS\L P7[(^%W_!2+]BOXRZ?XBU/X?^-DN$\+:+)XDU!+JQO;&;
M^QX06>^@BNH(I+FU '^NMUDC)( )+ 'X&^-/[$7[0_[3Y_:T232&\&+\;? W
M@RR\/MJ-U;RD:CIEO>O<VER+2:8H(Y98X)G&Y&#L8C(HS7*_&#X(?ME_ML>+
M!\0O$_PA?X5'P-\+?&GAFTL;G5=.NIM<UKQ-9Q6T=K;-:3R1I86YAW)-</$6
M=U_=J Q$RI4)6UM9+JNR?;6[;7EZ:%1K8B%]+W;Z/^9KOI9)/SOIKJ??Z_\
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MZ6T:6EV]H=1MD,DMDMZL)M'O$4'=;+,9P?EV;N*_-+XM_ C]L;0?C]HWCO\
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M_0%\?_VE?@9^RSX0M/'W[0/B.V\,:-?WT>F07=TKF-[N5'D2+Y%8AF6-]N<
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M/&MYJ!?6[/P]<:-%J<%F=2DS)')-=N+9;MF\P*^T,&(-4OC-\:?CY\,OA?\
MM'? 7X&_%CQ!J6C> /&WPUT_POXON[TZKJ>G3^(M0M%U+3WO9"3>+;94E)V=
M@EP892PXJG@ISDN:=V[=]FTOUV)CCZ<(M1A9*^BMNDW;\'KW/ZD:\O\ B_\
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M<>X,JR[C,HD&?U+1/FT>VC\_\C3Z_JUR:K?5>5OS1_2+17\GOC5OVB_@_P#
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MUM[8.,C:AD8;FYVCG!KQS]D?X7?##X5QZGIWP\^+/B'XF/J-GI]Y,/$'B/\
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M?_MQ#S&S:</^'O)/_P!)9_4+17X,_"O1_P!I+X\_M\Z#\//CU\2=>TB#PO\
M"'P3XHUO1/"FJ-::9J'B62\ODN)?-@P6M7,;!XHRL=PGEA]RHJGX7_9^^+'Q
M.TS]G+]G']J?2OCEXL\5?$WQM\2;#PQJ'AN^UW[=IU]IEQJ4UI>6S::/D1K:
MR7[0;EE,T97<[X( A8&_VM=/Q3:_(IY@E]AVU[=&D]/GL?UG5ROC7QSX-^&_
MAJY\9_$#5;31-(LS&)[R]E6"",RNL:;G<A1N=E5<GEB .37\N_C3XH_M._#O
M]BSX[?MK6?Q,\7:IKVF_$OQ!X,TZ"34BFF>'_#S^)19RS1P,KQ-/!"9!%=3K
M)]F0J% CCP?.OVNOAS^T2G[$WQC_ .%D>*];@^'%L_@C6M)AN?'?_"3:E;W<
MVK);W;2WL865M/GMY$GBCF9D2>'S(\;>-(9?=I.>E[?E_F9SS*T6U!WM?Y6=
MK_=^7R_KWKE9?'/@R#QM!\-9M5M%\0W5C+J<.FF51=264$D<4DZQ9WF)))8T
M9P,!G4$Y(K^>[]O_ ,4KX3EN_P!GWX(^/?'D^M^ OA[/XGEU>Y\?GP]IEG;R
MW%RL%[<WOESWFIW)EB9!"RR6X2-4?86R>9^ =N_[1/\ P4(_9R_: ^*?C'7]
M*UCQG^S[I_BN2&SUB:QM;G4_M>DRRVJQ(RH]O/N+SVP&R4@,PXJ(X+W.=RTL
M_P KHTEC_?\ 9QCK=>F]G]Q_0C\&?C!X)^/GPUTSXM?#IKM]&U;SC;F_LKC3
M[C]Q*\+[[>ZCBF3YT;&]!N&&&5(->H5_+O\  +XV?&#]H#X=_LG_  5^-?Q/
M\1>&/#GQ"TSQIJ6LZ]8ZK)I^J:UJ>CWWEV6G_P!I*PGB ADDE*QNKRK$%!PI
M%5?AU\6OV@?C9XO^%7[.,/Q<\4-X5;XR>._!=MXLTN]6/4M?\-Z)HTUW!YMV
MJ%)W2=9+4W2*')B,B,LH#BI8!IOWMK_<K_Y$QS%-1]V[=OO?+]R]Y?U8_J2H
MK\QO^"8/B;Q]/X8^,/PE\<^)-4\60_#/XFZSX6TC4=;N6O-1;3(;:RNH4N+A
M_GF>,W3)YCDLR@9.:_3FN*K3Y).-SOHU/:04[6"BBBLS0**** "BBB@ HHHH
M **** "BBB@ HHHH ***_'[]L?Q+X@^(W[?GPS_9&\:>/M:^&WP_UGPEK?B(
M7&@ZD^B7FNZS97%M"EB+Z,K,BV]O+)<M%"Z,_!;*K@:TJ?/*U^[^XRK5?9QY
MK=4OOT/V!HK^83_@H)\7IK#PYXK\&?LV_$SQMJFJ_"'X;VNM2^))?'D6@Z/$
MTBW36=VYMX'EUN]N6@*RQ,AM7VI'OBDD)KTIO'>H?M4?M:0Z'\;OC-XE^&GA
MFX^!?A3QJUAX?\0G0(1J%[-?&YN]Z[7Q"@7>%81L GG*X5 .I8%\O.WI_P -
MT^9R/,%S<B6OKIUZ^5C^C&O%;WX^> +#]HC3OV8+AKC_ (2G5/#UYXG@419@
M^P6-S!:RDR9X?S+B/"XY&3GBOYL--_:?^+?[1W[*WPA\,>+O%/B^/XD7/PXU
M+Q9?:A:^+%\ Z,-*@O)+2TUB^NXX)+F:>58HY5ACCDAVN6E0*RDZ'P?\03_M
MG?'K]ESQK\>?B%K/@W4O$_[/NHWNI:EH>K?V'>:G=I?:;YD9N8]LJ"0JURZP
M-&V8^OEAU-K+W&[F]K_A?_+R,WF2E94UO;?SM_GYG]'_ ,0/BC\+;+QMI_P"
M\=6\U[=^+M+U*Y2U?3YKJQGLK-46Y2>81M;)N64 1RN#("0 >E? G[&>D_\
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MG/XR/AK4=:\0Q/:6_P!G@U J?L]O;Q%KB/3;3RHRTF2&52IM8!NWO;_DE?\
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MMP>17\JG[='B[_A?_P *?VW_ !#\<?BWKWA35OA>;_PYX<\%V>M?V7IITO\
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ME,^Y2A)/!2]Z526U_P VOQY?R"&/A:,:<-[?E%_AS+[F?U*T445YYZ04444
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MW;U&J<4K):'F6L_!3X-^(HO$\&O^$M&O4\:QQP^(1/802#5HX8_)C6\W(?M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH _];^_BBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?^K7?_+V_P#O+1_Q'._]6N_^7M_]Y:_D!_X1OP[_ ,^%M_WZ7_"C_A&_#O\
MSX6W_?I?\*/]6I_\_%]P?ZV4_P#GT_O7^1_7]_Q'._\ 5KO_ )>W_P!Y:/\
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M+77VM'-N(%"-N9I!M/RD!B%(\BBMZ\=K_+OOMYC7$4GMAY;V^?;;?R/Z!_\
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M^2G_ -MJO]9:G_/M?B1_JI1_Y^/[D?YH?_#&_P"UY_T2KQA_X([W_P",T?\
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M*KT;PU'XEBTT1^*C:&Y#$#[&KK$$XP,.2<]?:O\ -=_X?>?\%3O^BO:A_P"
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M4N-.@U"%---O?)!@"X@(B(:*0D[&!((&<]JX#QS_ ,%3/^"E7@_PM=>(M/\
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MW5/C7\,K[P+I_BGP]X]F\5WWAG2UT_[4[-I,MI!'96K3Q1+)MF<+*L<.\J%
MZ%A*#4I+5+SVWO\ @K]3FEC,1%QC+1ONM]K=.K=NA_1]^SO_ ,% /AK^T+\2
M+;X5?\(IXK\$ZOJ^C-XBT-?%.GI8KK.E1O&DEQ:%)IC^[,T1>*813JLBDQXS
MCX/_ &COVK?VB)?V^_$O[,4/QET/X!6.FZ5I5QX'CU_1(KRV\975W&S71:[N
MI(D"6\VRW\BVD2=B2PSC!]2_X)]_L*?$?]GOQWI_B/XS?#OX?:9J7AS1)=*M
MO$_AK5-2O-1U"64PAY#:WEO'%:1RQQYF19929 -N%'.U^W9^SY^WC^TCH?C?
MX#Z'HOPK\7_#KQC:_9M-G\4+?6^HZ \L'E/,88X+N*\DB?=-!(DEJZNP' 7=
M6$%1C6:C:UNMGUW5[K;H_/9F\W7E03E?FOLKJ^FSM9K7JO+=7&^+/B;^V5^T
MI^UUXM_9:^ ?CK3OAKI'PET71IO$^OQ:-%JEUJ.NZW$UQ%;6UO=2M'#:QP()
M)"Q:4F0(&_CKY*\5?M\_M;:G\(_"/PMUOQ3I/@3XDZ3\<E^$OB[Q#:V$,]C/
M:+IMW?QWUO;7;.L0N8A;.59OE<.HPO%?27AW]BC]K_\ 9!^(=K\3?V-M8\.>
M-7USP?X=\,>+-/\ &US=:>UY?^&;;['::K#=6L-VPDDA)6X@>/#!01)NXKAI
M_P#@E!XW\6?#;P1I?QFO_#?C3Q!?_&4?%?XC)?6S_P!DW@EL+JR>RL;:6.??
M% CVT4*7&T.L;.S*QVUI"5!6NU;2VFM[:W^??RL9SCB'>R?-K?5VM?2WG;JM
M=[]#YO\ $/\ P4U_:(^$&E?%'PGXI^(WAKQGIGPN\<_#O3G^(.GV,-G93Z7X
MFNE&IVUT@EGM4GLX58/+"^%5U9@CC%?7'CC_ (*;_"_XH_M:>$?A%^RW\4]$
M\1>%;KP3XSUCQ'-X;EL]5NK*YTR.S:RE4Y=4=1).R(_R2%<,"!7T[^U7^Q%I
M/Q'^ 7AOX'?LY:/X>\'V&C>-?#7B22RBMUT^Q^S:1J4%Y<JD=K"R^;)'$50%
M K-@,RCD9?[2_P"QIXT^+G[2O@[XQ^ Y=(T_2_#_ (+\9^'+N*8O%/)=>(H[
M-+5T6.%U,:&W?S2S!E!&U6R<0JF'E9N-GKV[*UU;J]5V+=+$QNE*Z]WO_,[V
M=^BLG?='QY^TW^VI^T3X:_88^![?L8ZY+XI^)OQ1T$>(-.U'Q!I]NMS>Z3I.
MCOJUW-<6L'[B.:XQ;VVV/Y4DN1M)(!/V5;?&GX@?&/7/@Q^UI\+=9N-,^#-S
MX1U7Q/XJ#BVDM9[>[LX);*,C#78N8'+R9C C")(KY8JM?)?P7_X)*:GK>N?#
MS_AL:ZM-8T;X5?"OPYX%\/6GAW6-3LG74[:/_B;W;R6_V*0),T4$<(WMOC3<
MZ(P K[$_8C_9:^*_[(7[,7B/]FNTN]'O+#1=8U[_ (0(2O<7<4&AWLKW%A;Z
M@'6.0M \KQ2+&[@Q*NU\G"JK*@HVA9R3?3H[_DK=-'<=&.(<KU+J+2Z[.-OS
M=[ZZJQZ#^R9^V7H?[7NBIXL\)>!?%WAG0K[3[;5M)U7Q!906]GJME=Y,4ML\
M%S<'YEP_ES"*4*02@!KEX/V_OA_KWQYU+X%?#7P9XP\9)X?UF#P_KOB+1--2
M?0])U.;86M[B=YTD9H5D1K@P0RK &_>%<''S?^P/^Q7\?/V>/VA/$WQ/\2Z3
MX5^&_@O5M$2Q/@OP5JM_J.CW6L_:/-DU5+>[MK6*P)CS$L%O&0P8EV)4$]-\
M'OV>/VV?V7?C7XVT'X,KX,U[X8_$'QS=>-9[W6;N]MM9TO\ M>5)=2MDMH+:
M2&ZW,'-K(UQ%LW8D#!0#G*G1YY*+Z::_?KW_ *\C6%2OR0<EK?73[M--'Z?Y
MGM'AW]OWP5JGQ^T/X!>*/ GC7PG)XJO-0T[0=<U[2TLM*U.\TV*2>6&%FG-R
MC-##))$9K>)944E"W&?&/#'_  5Y^ 'B:]T?4F\'^.--\(:QXD?PBOB^]TA(
MM"@UA;M[%(99Q<&39)<)Y:SI$\"NP5Y$<,J_%7PD_P""5_[5VC_M"?##XM_%
M@>"=6U3P!XTOM?U?QO)J&HWWB?Q%974-['&A6>V$5DD0GA4V<4K0,8]R-&(U
M63R;]C3]G?\ :W_:V_8W\.? B[_X132/@Q_PLS7-<U'5%NKN3Q#<6VC>*[R]
M-DMH;<6R-+>0#_2/M)"PG'E%P=W0\/A[7OII?7UV\[):?\,<RQ.*ORM:N]M.
MW+H^RNW=_CU/V4\3_M^^"?!'QPTKX.^-? GC71]/UOQ GA:Q\5WNEI!H,^K2
M[A#"DCSBY*S.I2*86WD2-@+(00:_/O\ 99_X*BQ?#O0_&MK^TMI'C74M%T[X
ML>)_#4GC9M.630-)BDUJ6TT^WFN&E27RD#11>9%#)%$657=6R!Q'CC_@EA^U
M=\0?VB;+XC^+QX)UUM'^+6F^/+;QEJVH:C<^(?[!LM3CNTTFVM6M3;6'D6R>
M4/(E,4VU0RH6:1>EU#_@G9^W1XG^%_C+]C?Q%>>"+;X5_$+XBZKXNU77+6\O
MI-<ATB]UHZI]ABM'M$MVN)0L:&<SA(@S@(Y57<C3PRC9M:VOK][7^7X!*KBG
M)R47I>VGI9/;[_Q.T^+O[3?CN+QSIVG?#SQ_K]Z+?]I31/!6J6]Y:VMG':V4
MNGI<3:=;M;C=<6C"6-_,F_>EB0>%!,'Q7_X*->-_@'X1O=<^'B>)?BC<7_QX
M_P"$$N4N]*LD_LRV-Y;13Z;9B">W\W]V[)I\TY+O*3YQ  KJ_&/_  3R_:!;
M5/$/B[PQ>:#=WMQ^T#IGQ:T^UGNKB&.32K2QM;*2WFD%LYCN?W4CJ%62,@*"
MX).VKX[_ ."=O[17_"F_&-EX$U'P]/XM;X[+\8/#T%Y<7$=A/;V][!=16=W*
MMN9(9'2-U8QQRJK8PQ!)!%X?W;VZ!)8GWN5.^I[AH'[<OP[\ ^*_C?\ $SXN
M>(/$]EI7@VT\)7%QX7U72[57T6?6[-6AL[/[&9)[JZNYI$22.1WV7!"1-L.:
MEU'_ (*P_ WPSX<\02_$/P?XS\+^*]!OM%T\>#]3TZ!-<OI?$4K0::;18[F2
MUD2XECD0.;E1&T;"38< _-_QI_X)C_'+]J#PU\?+WXG:AH'AS7/BT? ^KZ3#
M8W-SJ-K8ZMX4@0R17+/;VK26TDZ>6'1=YB8OM5P%H\*?L _%NQ^$?BW3=5^!
M/P:36?$*Z;87NDS:OJVI6&KZ=:/-+,LMU<6(DM'69HY;/;!/Y3;BQW$%8]GA
MFKMZZ=5V7_!_S[VZF*3M%::[IOK+_P"U_1=%^H&D_M%7NJ_ #5_CG=^ ?%6D
M7.D0W<DGAO4;2&+67:TSE4C2X>"3?C*.DY1AR&K\\OV:O^"M*>,/V0_A;\6?
MC3X"\32>/_B-%!;Z5X?T/3HFF\07?V;[3<W&EQ/>,HLH8P6>:ZFA$8QN.2,_
M3/[!'[,/QC^ 7[-FM_"/XX:Q%<2ZMJ^IW6F:=9ZA=ZO;Z!I-X%6WTV"]OE2Y
MN4MP&8/(BX+E5&U17P-\'OV"_P!OKX1_#;X&7]@G@:Y\:_LW1:AH&BPOJ=Z-
M-\2:#JELEO<-<.+'S=/NE$,#Q;%N4W*P8A6J(0H>_%VWTU\G^MD_Z9=2>(]R
M2OMKI?JOQM=K[K=#]<OV:/VI/AK^U/X%U'QIX%AU#2Y]!U.YT76])UFW^QZC
MI6I6FTRVUU%N95=5='!1W1D965B#FOR@^-7_  4Z?XU>,?@5#^S3I'C/2O"7
MB;XL:5I'_"7S6"6V@^(--5;N.XAMY?-:9HI)$5D,L$2RB,E"VTU]X?L<?LK?
M$7X7^&_B=XK_ &A[[3KKQG\8O$%SKNMP:"TITZPC>UAL8+6VDF2.27RH(%W3
M/&C/(Q.T "OSU^%O_!/K_@H+X<\%_ K]FGQMJ/@.Y^'_ ,!/&FFZY9:U;W-^
MNL:MIFF">.WC>U-KY%O.D,Y#XFD61@,,@!9G2C04Y.^VU_1W]=;+\0K2Q#A!
M6WWLO-6]+J[?W'V^W_!4CX%O\0(?"VG>&_%EYX>OO$,WA'3_ !?#IT?_  C]
M]K\+O#]@@N&G65G>X1K:.4PK;/.-@E/6N]\.?\%$_P!G;Q7\-_A%\3M$DOY+
M+XSW$EOHL#0QI<6WV6VGNKR2]5I L,=DEM(MRP9]C@ !LYK\YOV=_P#@DYXP
M^ 'QEM]#U+P/X"\:^"=-\7S>)M)\4:EJ>I0>(;&&2\>^CB:P2WDM)KFVF<"&
M?SXU*H&9-W%>N?![_@EGXJ\,?M-?$CQ%\2-;L;SX57=GXDMO 6DV3RB]T@^.
M'CN-<:17C6*+$R,MKY3R?NI6W!3Q3G3PJO9_\'_@WMVTN*G5Q;MS1W?W?\"U
M[;ZV/24_X*A?"GXL^';KP_X,T/Q;X9/B_P -ZWJ?@;Q%J^G+9Z;X@73K62X:
M2P<2O,"(E^T1BXA@9XAO4$=>8^ O_!1"P\$?LH?L^Z%XOTCQ5\5?BEXY^&VC
M>*+S3/#5I'?:DUM]CM_M.HW3336\,<;3R;06D#RR$K&K$$#Y]_9&_P""4WQ*
M^"MCIGPW^)7@OX>W4?A31-1T;2O'NGZAJ;ZW.+FRDL8)FTV:#[-;RM#(RW)6
MYD4AB$'.:[/X/?L1?MS?LTV7PB^+GPDB\%:OXY\(_"^R^%?B31=6U*]@TNXM
M-(F,EC?V=[%923"3.YIH9+8 K(5#[D5C<H8;6,7^.^_7HMK^?8SA4Q3M*:];
M+;:^G5[VWT[GU#J7_!5G]GJXTCX<7WPOT#Q9X^O/BII^K7^@Z=X>TL2WA;0Y
M88+V"Y2>6!;66"278_GLD:M&ZEPVP/[A\-/VW/A5\6OV9/$?[4'@W3-;DLO"
M*ZLFL:%-9B'7+.]T3?\ :[&2V:0*+I"A 3S-K$KAB"#7XL0_L[?M+_L>?M5_
MLT_#WX3/X<\:?$6;0?BAK^M_VM<7.E:5=7>M7^FWMXMM)##=20K'),%AW0L&
M1/F"ELC]C/V#OV9?'?[.'PH\1P?&74;#5O&GQ \4:OXQ\1MI:N--BOM7<%K>
MU\T"1H(8DCC5I &?:6(&<#*O2H0@I1Z[:[J[7Y):_P!+7#UL1.;C/2V^FSY8
MO\V]/Z<VK?M]? VTMOAW<^';?6/$A^)WAG4/%^C0Z)9&^G.DZ=:17;RO#&QE
MW2>?##$D:NTDTBH!U(\ZTS_@IK\*(O#WQ,U7XD^#/&/@74?A9X8_X3'4M'\0
M6%O!?W>B;9R+FS6&ZFCD4M;R1E7DC97 5PN:^)/A+_P2C_:7^%7@GXS^'_#/
MC^PT?4[OPS>^"/A%J-A)<"X\/^'[B_N]16.Z<Q*4F,EQ#;M);[RD-M&R'>H
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MZ/J&M67AO68 +Z"WTMX$NA.T#2P1LAN8<*9<L&X&58#\D/V7O@)IGQ>_;_\
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M3=6U7FM3^F#P9XNT'X@>#])\>>%9C<:7K=G!?V<I5D,EO<H)(VVL RY5@<$
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MCCKTXZ4G?H=>$^J_O/K/-\+Y>6WQ].:_V=[VU['RUJ=Y87;S_#;Q%XK\._\
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M#L .!4M% %>.SM(FE:.)%,QS(0H&\XQEO7CCFGPPPVT*V]NBQQH JJHP !T
M Z"I:* (([6VAEDGAC5'E(+L  6(&!D]\"N9\:>#].\:^"-9\"W3-;6VM6=S
M9RO" '5;I&1V&01N^8GD=>M=;133MJ)J^AXY^SU\%?#O[.GP,\&_ CPM/+>V
M/@S0M.T&WN[D*+B>'38$MXWE*!5+E4!. !DG  KEOV4?V:O"/[)/P'T#X">#
M+NXU*Q\/1W$<5Y>A/M,BW%Q+<D.455PK2L!@#CWKZ,HJG4D[IO?7^OO)5.*L
MTME9>G])$/V>W^T?:_+7S=NS?@;MN<XSUQGM4U%%0606]K;6B&*UC6)22Q"
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M ?9?_#07P(_Z#5O_ -^9/_B*]3\.:OX9\7:-#XA\./'=6=QN\N54P&V,5/!
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M "BBB@ HHHH **** "BBB@ HHHH _]7^_BBBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)!P1CZUYEH7[1'P[BT.SB\3:PL^I+!&+N2UT^[B@><*/,:-'1V1"V2JL[$#
M+$\UZMITL<_C"^GB.5>PLF!]07N*-"JE^=ZI^FWR\OD>-:EXO^,-Y\,O%7B<
MZ=;1R6NEZ@VGVW[^QN9+J%&,09Y PC1B/]8 <9! .,5](Z18?$#PKX;/A?1=
M(TF*WM@ZV\=M=M ((9';8B116:J%B0A5QRVW^]S45S;6]Y;R6=Y&LL4JE'1P
M&5E88((/!!'!!JK\-O'-EHT ^'_BRX4ZM81O+<7*VYA2Y4[Y7NWV((8P_65\
MJOGEU 'R[FGIL$8RE>,>ODNE_G_5WL?)7[>?[07Q/^&GP^@\#Z-IVF_;?$\D
MMI/LO)6DAL#$1+(I\F+#%V0!N?E+@*67(_#?3K?6=.LK:SM+2W,<$:Q1DW+N
M2BC !8Q$G@=2>37T3^T)\5-1^.'Q?U7XAZ];K;I#++9:;$SI*;>PA?" 2)D?
MO=@G<*S*'<@,P537CNE:5K^JZF-%TJ-[Z]OI1%900C=+(S=$ P 7W$A1W &3
MU-*_D4Z<W)4D[_E=_A\_+>UC[J_X)_\ C#XI/\0KWPA)IR3>'1;O/)-]OF"V
MLKX#%+<H(I2YCC4G :,'<K ,X?\ 0;P=X@^-WB>RM]8N[/3;"W>3$D-S%<PW
M 16P3L;H2/NYZU3^ OP7;X0:3+I,PFMW39OA2[$UK-/)!!]HN-B1QG>TD8C
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M&<;L:/G&23C/3)K_ $4*S- HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>61YG(7.!ND9FP,D@9P"21U-?SG_ /$4A_P3B_Z!GC'_ ,%T'_R31_Q%(?\
M!.+_ *!GC'_P70?_ "31_9F+_P"?;#^UL'_S]C]Y_0;\1] UKQ1X,O-"\.SI
M;7D_E^7([R1J-KJQRT1#C(!'!^O&:\WM_P!G[PU?^&H],\3W-Y<7K_9WFN%N
M9&>-D_UT<$C[I(HKA2\,H4AGA8J3SFOPZ_XBD/\ @G%_T#/&/_@N@_\ DFC_
M (BD/^"<7_0,\8_^"Z#_ .2:%EF+6JIL7]K8/_G['[S]HV_93^&5O;W-GI&D
M:1:Q&96M2+)G:* !BT3 S;&P[?(R)'M0*A#$;JFM?V1_@G%XDTSQ>=)6UU'2
M+M;JVDT^:XM 1]E:V>"4+,3-;R>9([PRED<LN\-L!K\5O^(I#_@G%_T#/&/_
M (+H/_DFC_B*0_X)Q?\ 0,\8_P#@N@_^2::RW%K:F_N*><X1JSK+[]_7O\S]
MJ_"_P'U8_:F\<ZO=,QDS!]@OKE!L_P!L.QY_W>*^F:_F[_XBD/\ @G%_T#/&
M/_@N@_\ DFC_ (BD/^"<7_0,\8_^"Z#_ .2:7]F8O_GVQ?VM@_\ G['[S^D2
MJ&J?\@Z?_<-?SE?\12'_  3B_P"@9XQ_\%T'_P DU7N_^#HK_@G%<VTEN--\
M8C>I&?[-@[_]O-']F8O_ )]L/[6P?_/V/WG[[6FI6>DR&_OFD6-!SY4;2OSQ
MPJ!F/X"N:_X6&_\ :_D_V:OV#S,>=LO/.\O/WO+^P;=V/X?,Q[U^ ?\ Q$S?
M\$Y?^?/QA_X+(/\ Y*H_XB9O^"<O_/GXP_\ !9!_\E4?V9B_^?;#^UL'_P _
M8_>?D/\ \'IFI6FK2_LV7]B9&B<>,<&6-HGX_L@<JX5A^(K_ $5Z_P I3_@Y
M/_X*9_LY?\%%O^%+_P##/\.L0_\ "'?\)']O_M:U2VS_ &A_9WE>7LEDW?\
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MVJ[RP\!>)+&7XE:3X#E\-6/BSQ3:ZYK.HW'AZ\N9[U9YOM<T-M*8_+V1"40
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M_M(^+/$'@;2H8M"\0_L_>*?A]%J#SPQQ)K6IW5NUI \8;S=@02-Y@C,:#(W
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M&9E?S %8#K[NR_:;^+FC_MK_ +(_P(^%<GBB+XF?$75=$/BF?4K&VTS2'O\
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M\0N7_!"C_HAG_ES>(?\ Y9T?VQC/^?GY?Y!_8>!_Y]+[W_F?Y0'_  OG5O\
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M6"XU2"YOUGRD4D[%(5FE0 LP7/:OB/Q1\3_V@+W]E3X'_M2^/OB!XD\0>#=
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MOB5XJT[XL>*M$/AW5_%#1Q&VAO(R+MQ<^8@N63:7G*[Y0>3S6)^V'\5_C/\
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M<)]G$/D;6<*@E+>0 @-92PEH.IS:=//;_,WCC>:HJ:@[]?+?_(_=6BOY;O\
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M%$,$Y6:E^#VO;\WL$\>H.TH_BM[7_);]]#^IFBOY9OBU\/\ X]> U_;)\/\
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M?VM:_P#79/YBIA/8GH_Z'_"KVG7>GPZA!-(^%216)P> "/:BS"Q^]-%?/O\
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M/@A_T (?^_DO_P 72_\ #-WP2_Z $7_?R7_XNO<**+ON!XD/V<?@H.F@Q?\
M?R3_ .+IX_9U^"XX_L&+_OY)_P#%5[511=]PL>#ZI^S+\$-7L9-.NM$V1R8R
M8+FX@DX(/#QR*XZ<X(R.#P37.6'['G[/FGW*W<6D7<A7(VSZI?SQG<"#E)+A
MD/7C(.#R.0*^FZ*.9]Q61YY\-/A1\/?@]H,OACX:Z9'I5A/</=R0QL[AII
MS9=F.2%'?'%>AT44AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__5
M_OXHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH _];^_BBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME57&#\QBGRS%0 21D_)YUK]G?4/VDOB];_M.:I\0 +?Q1?+I:^$)(615^U7
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M /A3X\:U8?VKX+\176J7']E(]U;ZAI]RT#FT=YEMW3)A^]L8*&; .<C0UO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]'^
M_BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
6**** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>soph-20251231_g3.jpg
<TEXT>
begin 644 soph-20251231_g3.jpg
M_]C_X  02D9)1@ ! 0  2 !(  #_X0!J17AI9@  34T *@    @  @$2  ,
M   !  $  (=I  0    !    )@       Y*&  <    2    4* "  0    !
M   #T* #  0    !   !P@    !!4T-)20   %-C<F5E;G-H;W3_X0DA:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[
MOR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \>#IX;7!M971A
M('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)835 @0V]R92 V
M+C N,"(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2(B+SX@/"]R9&8Z4D1&/B \+W@Z>&UP;65T83X@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" \/WAP86-K970@96YD/2)W(C\^ /_M #A0:&]T
M;W-H;W @,RXP #A"24T$!        #A"24T$)0      $-0=C-F/ +($Z8 )
MF.SX0G[_X@TD24-#7U!23T9)3$4  0$   T487!P; (0  !M;G1R4D="(%A9
M6B 'YP "  ( "0 P #=A8W-P05!03     !!4%!,
M    ]M8  0    #3+6%P<&P
M                         !%D97-C   !4    &)D<V-M   !M    ?!C
M<')T   #I    "-W='!T   #R    !1R6%E:   #W    !1G6%E:   #\
M !1B6%E:   $!    !1R5%)#   $&   " QA87)G   ,)    "!V8V=T   ,
M1    #!N9&EN   ,=    #YM;6]D   ,M    "AV8V=P   ,W    #AB5%)#
M   $&   " QG5%)#   $&   " QA86)G   ,)    "!A86=G   ,)    "!D
M97-C          A$:7-P;&%Y
M
M            ;6QU8P         F    #&AR2%(    8   !V&MO2U(    8
M   !V&YB3D\    8   !V&ED       8   !V&AU2%4    8   !V&-S0UH
M   8   !V&1A1$L    8   !V&YL3DP    8   !V&9I1DD    8   !V&ET
M250    8   !V&5S15,    8   !V')O4D\    8   !V&9R0T$    8   !
MV&%R       8   !V'5K54$    8   !V&AE24P    8   !V'IH5%<    8
M   !V'9I5DX    8   !V'-K4TL    8   !V'IH0TX    8   !V')U4E4
M   8   !V&5N1T(    8   !V&9R1E(    8   !V&US       8   !V&AI
M24X    8   !V'1H5$@    8   !V&-A15,    8   !V&5N054    8   !
MV&5S6$P    8   !V&1E1$4    8   !V&5N55,    8   !V'!T0E(    8
M   !V'!L4$P    8   !V&5L1U(    8   !V'-V4T4    8   !V'1R5%(
M   8   !V'!T4%0    8   !V&IA2E     8   !V !$ $4 3 !, "  4  R
M #< ,0 Y $@ 0W1E>'0     0V]P>7)I9VAT($%P<&QE($EN8RXL(#(P,C,
M %A96B        #SV  !     18(6%E:(        &2'   S*@   0I865H@
M        :N0  +R7   1REA96B         G:P  $#X  ,!98W5R=@
M  0     !0 *  \ %  9 !X (P H "T ,@ V #L 0 !% $H 3P!4 %D 7@!C
M &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *, J "M +( MP"\ ,$ Q@#+ -
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MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\
M3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4VU4H5755
MPE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N56^5<-5R&
M7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=C
MZV1 9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/
M:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S
M77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC
M>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$
M'82 A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6B_R,8XS*
MC3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4])5?E<F6
M-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY GJZ?'9^+
MG_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4JC$J3>I
MJ:H<JH^K JMUJ^FL7*S0K42MN*XMKJ&O%J^+L "P=;#JL6"QUK)+LL*S.+.N
MM"6TG+43M8JV ;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]%;V/O@J^
MA+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_R#W(O,DZ
MR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'31-/&U$G4
MR]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N W 7<BMT0W9;>'-ZBWRG?K^ V
MX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJY>MPZ_OL
MANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[]XKX&?BH
M^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M__]P87)A       #     F9F  #R
MIP  #5D  !/0   *6W9C9W0          0 !          $    !
M  $    !          $  &YD:6X         -@  IT   %8   !2@   G
M "<    /0   4$   %1   (S,P ",S,  C,S          !M;6]D
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]L
M0P ! 0$! 0$" 0$" P(" @,$ P,# P0&! 0$! 0&!P8&!@8&!@<'!P<'!P<'
M" @(" @("0D)"0D+"PL+"PL+"PL+_]L 0P$" @(# P,% P,%"P@&" L+"PL+
M"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+
M_]T !  ]_]H # ,!  (1 Q$ /P#^_BBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ-_X-[K_ ..T?\-/_M+?]%$\3?\ @WNO_CM>&44>SCV#VD^[/<_^&G_VEO\
MHHGB;_P;W7_QVC_AI_\ :6_Z*)XF_P#!O=?_ !VO#**/9Q[![2?=GN?_  T_
M^TM_T43Q-_X-[K_X[1_PT_\ M+?]%$\3?^#>Z_\ CM>&44>SCV#VD^[/<_\
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M[8M>T[S$7/WI[-MRC_OV\A_"OW_KP\90A&J[)'TF Q,YT8MR=UIN>Y_\-/\
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M?M*4W?9K\G^A]@4445\P?7G_T?[^**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *_G _P""P/\ R<MH?_8LVW_I5=U_1_7\X'_!8'_DY;0_
M^Q9MO_2J[KNR_P#C?(X,R_@_-'Y34445[Q\\%%%% !1110 4444 %%%% !11
M10 4444 %!&>#110!_(M\?\ P'_PK'XV>*/ BIY<6G:C.D Z?N&;?$?QC937
MD%?II_P5.\!?\([\>['QK;IMA\1:=&SM_>GM3Y3?E'Y5?F77T=&?-3C(^1Q-
M/DJRCYA1116IB%%%% !17UGX8_8'_;I\;^%;+QUX+^"WCO5]$U*W2[M-1LO#
MFH7%I<6\@W++'+' 4=&7D,I((Y!KY,J8SC+X7<N5.4;.2M<**Z7P7X/\2?$/
MQCI/@#P;:F^UC7+R#3[&V5E4S7-RXCB0%B%!9V RQ &>2!75?&?X,_$S]GGX
MHZS\%_C)I3Z)XG\/3_9M0L9)(Y6@E*AMI:)G0_*P/RL1S3YE?EOJ+E=N:VAY
MA1113)"BBB@ HHHH ]T_9E\>_P#"LOC]X3\:2/Y<-KJ,23MTQ!.?*E/_ '[=
MJ_K4K^+>OZYOV?/'G_"SO@CX6\=._F3:AIT#3G.?WZ+LE_*16%>7F,/AE\CV
M\HJ?%#YGL5%%%>6>R%%%% !1110 4444 %%%% !1110 4444 %?EU_P57\!?
MV]\%-(\>6Z;IM U$([?W8+Q=K?\ D18Q7ZBUX?\ M*^ O^%F_ 3Q9X*1/,FN
M].F:!>N9X1YL7_D1%K6A/EJ1D88FGSTI1\C^2>BBBOHSY(**** "BOL72/\
M@G;_ ,% ?$&DVNO:#\"_B%?6-]"EQ;7-OX8U*6*:*4!D='6W*LK*058$@@Y%
M<'\5/V2_VCO@?\-?#WQ=^+WA*]\.Z!XJO-2T_3)KX)%++=:1,;>\B: MY\3P
M3*8W66-#N!':LU5@W925_4U="HE=Q=O0^=J***T,@HHHH **** "BBB@ HHH
MH _J!_8'\>_\)[^RUX:EE??<:2CZ7,.NW[*VV,?]^O+/XU]CU^,7_!)'Q[NM
MO%WPPN'^XT&J6Z9_O#RIC^D5?L[7SV)ARU9(^KP=3GHQ?]:!1116!TA1110
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M_0]HHHKX _2C_]+^_BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MEGQM_P )'_Q[_P!G-L_Z[[E\C_R-LK^56O:R^5Z=NS/GLU@E53[H****[CS
MHHHH _MF_;.^//ASX-_\$^?V8D'[1OCGX0^(IO@II4^E^'O"UK<266KSQV,7
ME&ZFBEC6+?)B+)#%5R>F*YW]B/\ X)"?L:?&G]D30O ?QN^&^G^%/B3XY^'E
MQXKT?6;OQC=7'B.654!AOHM&MX5M(M/;S%?]],9.?+9&8%Q^''PN_P""]/\
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MA]^WIX$U#XK:I\6O%7B[3;:^EU>XLOLE[JFL3_:;VX,#++<RO(\> 77J[YW
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MKOQ(\?6_A>\\7W=[IMGIS6+W$QO;29X/+#+(%()0EF)4 E5&2V:]=^&G[/\
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M"OQ8_P""MW@+$GA'XH6Z=1/I=P_T_>PC]9:_:>OSX_X*;_V#_P ,M77]K_\
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MM>V5^7R5FT?L$7=)G__3_OXHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K^<#_ (+ _P#)RVA_]BS;?^E5W7]']?S@?\%@?^3EM#_[%FV_
M]*KNN[+_ .-\C@S+^#\T?E-1117O'SP5]=? K]H#X,_#CPS'X?\ B7\,K/Q3
M<V=[]OM-3BO9;"]208VJ\B!BR*0,*-JCJ5))-?(M%3*"DK,N$W%W1^FNI?\
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M3?AM\/M+^(/QMT/P;\8_C!H+^)?!/@>YT^><7NGK";A3<WJ.%MW>(;]OE.5
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M+XCDA??;Z0T>EP\YQ]E7$@_[^F2NW 0O5OV//S.IRT;=SXTHHHKVSYL****
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MLN-<DATN+W\YMT@_&)'%?S+UZ^70M%R[GA9M4O.,.P4445Z)Y 4444 %%%%
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MC_AF#]I;_HG?B;_P477_ ,:K^O/_ (2&]_NI^1_QH_X2&]_NI^1_QH_M&?\
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M!_T;]\2?_"4U3_Y&K_5!_P"&@_&?_/M9?]\/_P#'*/\ AH/QG_S[67_?#_\
MQRC^WJW_ #[7WL/]6L/_ ,_']R/\K[_AV=_P4@_Z-^^)/_A*:I_\C4?\.SO^
M"D'_ $;]\2?_  E-4_\ D:O]4'_AH/QG_P ^UE_WP_\ \<H_X:#\9_\ /M9?
M]\/_ /'*/[>K?\^U][#_ %:P_P#S\?W(_P K[_AV=_P4@_Z-^^)/_A*:I_\
M(U'_  [._P""D'_1OWQ)_P#"4U3_ .1J_P!4'_AH/QG_ ,^UE_WP_P#\<H_X
M:#\9_P#/M9?]\/\ _'*/[>K?\^U][#_5K#_\_']R/\K[_AV=_P %(/\ HW[X
MD_\ A*:I_P#(U'_#L[_@I!_T;]\2?_"4U3_Y&K_5!_X:#\9_\^UE_P!\/_\
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M@A<DXX!)/ZTW_A(;W^ZGY'_&O-J9K.<W)Q1ZU')Z=."@I.R/Y#/^&8/VEO\
MHG?B;_P477_QJC_AF#]I;_HG?B;_ ,%%U_\ &J_KS_X2&]_NI^1_QH_X2&]_
MNI^1_P :C^T9_P J-/[,A_,S^0S_ (9@_:6_Z)WXF_\ !1=?_&J/^&8/VEO^
MB=^)O_!1=?\ QJOZ\_\ A(;W^ZGY'_&C_A(;W^ZGY'_&C^T9_P J#^S(?S,_
MD,_X9@_:6_Z)WXF_\%%U_P#&J/\ AF#]I;_HG?B;_P %%U_\:K^O/_A(;W^Z
MGY'_ !H_X2&]_NI^1_QH_M&?\J#^S(?S,_D,_P"&8/VEO^B=^)O_  477_QJ
MC_AF#]I;_HG?B;_P477_ ,:K^O/_ (2&]_NI^1_QH_X2&]_NI^1_QH_M&?\
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M><K'&TC&-K+ZUT8;.*E.3M!.YRXO(Z=:*YIM)'^3'_P[._X*0?\ 1OWQ)_\
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MEPW04TU4>GDC^4[_ (9@_:6_Z)WXF_\ !1=?_&J/^&8/VEO^B=^)O_!1=?\
MQJOZ_+S6[NWNG@14PIP,@Y_G5;_A(;W^ZGY'_&O-_M&?\J/6_LN'\S/Y#/\
MAF#]I;_HG?B;_P %%U_\:H_X9@_:6_Z)WXF_\%%U_P#&J_KS_P"$AO?[J?D?
M\:/^$AO?[J?D?\:/[1G_ "H/[,A_,S^0S_AF#]I;_HG?B;_P477_ ,:H_P"&
M8/VEO^B=^)O_  477_QJOZ\_^$AO?[J?D?\ &C_A(;W^ZGY'_&C^T9_RH/[,
MA_,S^0S_ (9@_:6_Z)WXF_\ !1=?_&J/^&8/VEO^B=^)O_!1=?\ QJOZ\_\
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M_P"?:^]A_JUA_P#GX_N1_E??\.SO^"D'_1OWQ)_\)35/_D:C_AV=_P %(/\
MHW[XD_\ A*:I_P#(U?ZH/_#0?C/_ )]K+_OA_P#XY1_PT'XS_P"?:R_[X?\
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M#[K\$_\ ),+#_K@O_H5,I_@G_DF%A_UP7_T*F5Q]6=G1!1110 4444 %%%%
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M=37EG=)/?:A'Y,DNU)(PN]R028]KX,B[OTFT/XB^-D_X.4OAKX-EUF[.D_\
M" 16B6;SL8%B?19KED6,G: TR+(0!RPR>:)8ZKRMQL[<SOK9V2>FOG;KL$<!
M2YDI<RORJVEU=M:Z>5]EN?S.:S_P2T_;'_9M\5_#7QC^UG\*-7M_!GBWQ'I>
MEM;VUY:+=7?VJ9<VFY)G^R7$T898S<",!N3T.,CXA_L,?%7XZ_MW^//V;?V*
MOA7X@M'T2_F6/P[J-Q!-=Z7!#M1Q=W9E-LJ^8?E=IRIW*H=SR?U:_P""<_Q
M\9>/O^">/B*]\?:O=:Q<O^T!X&O1-?3-/*US=7EL9I-[DL7DVY8YR>3ZU]>7
M.EZ]\:_BO_P4/_9 _9_U:WTKXR>-];T^YT2WDN4L[C5=/L9F:\M()'*@%HBZ
M,"P!$WS$+N8$L74C*2E:ZTZVWCJU?I<%@Z4HQY;V>O2^TM$[=;?\!G\]Z?\
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M /8R1?\ HN2O]4GQ#_Q^K_N#^9K_ "MO^"*?_*57X'_]C)%_Z+DK_5)\0_\
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MPJW?%'_(S:C_ -?4W_H9K"KM1QO<****!!1110 4444 %%%% !1110 4444
M%%%% 'W7X)_Y)A8?]<%_]"IE/\$_\DPL/^N"_P#H5,KCZL[.B"BBB@ HHHH
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MU.26O9]T?8X#&PQ5+VD='LUV84445R':%%%% $]K_P ?,?\ O#^=>1?M%_\
M'[I7^Y+_ #6O7;7_ (^8_P#>'\Z\B_:+_P"/W2O]R7^:U=/XD*?P,^;:***Z
M3D"BBB@ HHKY'_;D_:T\)_L3?LT>(?C_ .*(A=RZ=&L&G61;:;R_G.V"'/4
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ML8^TINZZ]T>IE><_6)>RJJTNCZ/_ ()^XU%%%>,>\%%%% !7O_[/7_(S7O\
MUZ_^SK7@%>__ +/7_(S7O_7K_P"SK45/A9I2^)'O&J?\A"7_ 'JH5?U3_D(2
M_P"]5"N8Z6%%%% @HHHH **** "BBB@ HHHH **** "BBB@#2UK_ ))WJO\
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M_+]3Y?B3_EU_V]^@445]B_\ !/W]F.W_ &R?VS/A]^S5?W,EG9>*-3$=[-"
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MN'CK7?%W_!,RYT'5W9X/"_C+5=,L@W18)(;6\('MYMU(?J37^=2JLS!5&2>
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M^QM:?%3P?;-=ZE\-;YM3GC0;G.F7">7=%0/^>9$4K'LB,>U=V6SC'$P<MO\
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M_P!+B,57A/V4(7<MGT\[^GXGR6%P>'J4_;5*EE'XEU?;E]?P/PE_;D7]G_\
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M?\(XO_/8_P#?/_UZ/^$<7_GL?^^?_KUY5T>K9G*T5U7_  CB_P#/8_\ ?/\
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M_#.ME_T%7_[]#_XJC_AG6R_Z"K_]^A_\51[6'</92/EFBOJ;_AG6R_Z"K_\
M?H?_ !5'_#.ME_T%7_[]#_XJCVL.X>RD?+-%?4W_  SK9?\ 05?_ +]#_P"*
MH_X9ULO^@J__ 'Z'_P 51[6'</92/EFBOJ;_ (9ULO\ H*O_ -^A_P#%4?\
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M_P">Q_[Y_P#KT?\ ".+_ ,]C_P!\_P#UZ+H+,YRU_P"/F/\ WA_.O(OVB_\
MC]TK_<E_FM?0<7A]8Y%D\TG:0>GI^-<I\0?AK!X^GM9IKMK;[,K* J;L[L>X
M]*J$DI)L4HMQ:1\*T5]3?\,ZV7_05?\ []#_ .*H_P"&=;+_ *"K_P#?H?\
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M 'Z'_P 51[6'</92/EFO?_V>O^1FO?\ KU_]G6NG_P"&=;+_ *"K_P#?H?\
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M?\_<W_?QO\:/[;UC_G[F_P"_C?XUF446079I_P!MZQ_S]S?]_&_QH_MO6/\
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M\_\ ?;\ZBHH$2^?/_?;\Z//G_OM^=144 2^?/_?;\Z//G_OM^=144 2^?/\
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M44[]?5F<JLFN5[>B"BBBM#,**** /JW]AO\ Y.V\!_\ 837_ -!:OZN?$/\
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M$^G'PMH6E:];JVF1W#W!&CRD6]Q#++(<RO);L_F.0JF4EE1!M4?ZRU?XYGP
M^%&N_';XY^#O@MX9B::_\5ZS8Z5"JC)W7<RQY/H%#9)Z  D\5_L9UXO$<8J5
M-K>S^[I^I[_"TY.%5/:Z^_6_Z!1117S9]6%%%% $]K_Q\Q_[P_G7D7[1?_'[
MI7^Y+_-:]=M?^/F/_>'\Z\B_:+_X_=*_W)?YK5T_B0I_ SYMHHHKI.0****
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M)7[=>G?LZ0W#+H?PUT>V_P!&!^4ZCJJ+<RRD>I@:W09Z;3C[QK^9>OW_ /\
M@Y>^%.O> ?\ @J;XB\;ZE$PL_'.C:/JUG)CY66WMDL' /3(>T.1U (/<5W7[
M#O[!O[.W_!9K]G*\\%?"Z_L/AK^TG\.+*-9HRGEZ/XITI,1PW4T,:EH+F,[8
MKB>%&W-MDD1WE++]YA:U.A@Z4G\-E=]K]_F?G&,H5,1CJT$_>N[+NET7G8_G
MU\ ^ /&_Q4\::9\.?AMI-UKNO:S<):V.GV,33W%Q,YPJ(B@DD_RYZ5]P_M=_
MLS?#K]A[08_V??'-W;^)OC5="&X\1K9SF33O"L?#KIZ/&VVZU!Q@W3Y,,"_N
MD#N3(G]&?Q^TG]F?_@VS_9J3P#\&+JT\9_M9?$/36CD\1S1J_P#8=C+E9)[>
M)L^3%N!6!6^>XD4R292,1#^,[6=9U?Q%J]UX@U^ZEOK^^F>XN;FX<R2S32L6
M=W=B69F8DLQ)))R:VP]>6(?/'2FMN\O/T_/TT.?$X>.%C[.>M1[]H^7F_P O
M75?W^_\ !J_^TMX@^*O[&GBGX ^)KA[J3X9ZS&+!G.3'IVK*\L<7/.%GBN"/
M0, .!7]0-?R*?\&DGPHUW0?@9\7_ (TWL31V'B;6=,TJU9A@.VD0S22%?49O
M5&>F01U!K^NNOCLV45BZBCM?]-?Q/N\EE)X*DY[V_"[M^ 4445YQZ@4444 :
M6M?\D[U7_KSN?_0&KX%K[ZUK_DG>J_\ 7G<_^@-7P+6U'J95N@4445L8!111
M0 5_F ?MN_M!:Y^U%^U;XY^-VM3M.FL:K.+(,<B*PA;RK6,>R0J@XZG)ZFO]
M/^O\L_QEH7B;]ES]I/5?#=_96UQJG@77Y[=[74K=+JUF>QG*[9H9 4EBD"_,
MK JZ'T->_D27-4?6R_K\CYGB1ODIQ^S=W_#_ ()X/7U3^R'^QI\=_P!MSXI+
M\+O@;IJSO;1&[U35+Q_L^F:38IS)=7MP1MAA0 DDY9L816; K^CSX6?\$'OV
M<?\ @JAX.\%?M@?L!>,H? /A'Q#=?9_&WA34?,OIO#M[$H-U#82<M*,E3#%<
M,N8W63S,$1CQG_@KM^V'^SK^Q]\*KK_@C]_P3,A33/"VG2>7\0O$<#B2]UO4
M(^'M);E0#*$8?Z21A=P\A%2-&5O3_M!5)>RH+W^M_L^OZ);]SR/[,=*+KXA^
MYTL_B[6_5M:=C\'?VE4^ ?@GQ[;_  __ &9+N?6=-\+;H9O%DV^";6[X,#)<
MPP;B+:U5EQ:IS+L^>1RSA(_]$7_@GU\>-3_::_8M^'/QMUY_-U+6=(C6_DZ>
M9>VC-;7#X[;IHG;';.*_S':_TCO^"1WPTUGX2_\ !.'X4>#_ !!&T-T^DOJ3
M1N,,JZI<2WJ CJ"%G&0>1TKCSN"5&%W=W_34[^'JDI5ZEE9-;=-]/U/T:HHH
MKYD^N"BBB@ K].*_,>OTXKGK]#HH=0HHHKG.@__6_OXK^&>O[F*_AGKULK^W
M\OU/'S;['S_0*]H_9VU/QUHOQO\ #.J_#33O[6UN"^1[:SZ"8\[E)X"J4W98
M\*/F/ KQ>M_POXI\1^"M>MO%'A&^FT[4;-M\-Q;N4D0]#@CL1D$="#@\5ZLE
M=-'DQ=I)G[^_$?X2^"?VI?!?BWQ5KGAC7/A]XQLK/R[R:YWP0W1A0LBLZDP7
M<(,8!8#<H"D8XKTWP4VM_";PW\)?A[\&/#,&H^%O$4!_MN]2%F$2M!&XF=U(
M4-*S,2T@(.-HY(K\/O&_[:_[3GQ$\*3^"O%7BB273KI#'.D4$%NTJ'@JSQ1J
MQ4C@C.&!YS5/X?\ [8_[2/PP\(IX%\&>)I;;3(05ABDAAG,*GM&TJ,RCT .!
MV KSWA*CC:Z]-;;'I+&4U*Z3]=+[G[,>%D\-_ JQ^/>J?#VQM7MM"NDU*"S=
M,VZ7 L8[@IM!&%64G 4C;T&,5WE_\=]6LYO@UXEBTG3_ +=\2(K:+4)S&?,B
MBEMUGV1-NW!1))D!BPP.F3FOY]M#_:&^,GAWPYXB\)Z7KDGV'Q:TC:LLL<4[
MW33*5=FDD1I 6!.2K ]^M:MQ^U!\=+J+PI!/KI*>"0@T4"V@'V;RT6->D?[S
M"*!^\W^_4Y;P;;NW?_AK?F)8Z*5DFO\ A[_D?M_\.O!GB7P)\:_C!XO\+O8:
M9H,>I6K/(-.>^OC,UK#<SI$D)5]K&92!A\L?E7.37;^*M5B\)?ML^#?["MH8
M3XTT2^M]19H]LL@L5\Z(]B'!^4Y!.W@]!C\-M"_;7_::\.>(M9\5:5XF9+W7
MWCDO6-M;LCR0QK$CB,Q;$8(JJ2JC( SFN7\3_M3_ !]\9>+M#\>>(O$4LVK^
M'-PTZY6&&)X=^-V?+C4/NQAMX;(X.032^IS;NVMK?A_F/Z[32LD][_C_ )'[
ME?"SQ[\2?%_[37Q*T?Q[8"RM=#L'M-*<0/%YUIY[E7W,2'R,?,N!7C'PHU'Q
M7\!/V%_#7Q _9Q\,P^(?$.LSQOJ)6WDN)&#O('9EB(D81E5B !PN<XZU^;%[
M^W?^U-?:P=>?Q*J71MFLRZV5KS"S;BI!A(Z]^H[=ZXCX3?M5_'OX(:-+X<^&
M_B"2RT^5S)]GDBBN(U<]2@E1]F>^W /?)I_59VZ=-.F@OKD+]>NNE]3SGXK:
MYXL\2_$K7==\=VHL=9NKV9[RW$7DB&;<=R;.J[3QSSQR2>:\_KI/%_B[Q)X]
M\2WGC#Q?=O?:EJ$AEN)WP&=CQG   X&    .!7-UWQ5DD>;)W;84444Q!111
M0!]6_L-_\G;> _\ L)K_ .@M7]7/B'_C]7_<'\S7\HW[#?\ R=MX#_[":_\
MH+5_5SXA_P"/U?\ <'\S7CYC_$7H>YEG\*7J8-%%%>>>@%%%% !1110 4444
M %%%% !1110 4444 %=1X;_Y;?\  ?ZUR]=1X;_Y;?\  ?ZTGL-;GP9XH_Y&
M;4?^OJ;_ -#-85;OBC_D9M1_Z^IO_0S6%7:CC>X4444""BBB@ HHHH ****
M"BBB@ HHHH **** /NOP3_R3"P_ZX+_Z%3*?X)_Y)A8?]<%_]"IE<?5G9T04
M444 %%%% $%S;6U[;26=Y&LT,RE'1P&5E88((/!!'!!K_-Y_X+1_\$7/B;^P
MO\3=7^-?P4TBXUCX-ZQ</=6]Q:H96T)I6R;6Z R5B4G$,Q^4KM5FW]?](VH+
MFVMKVVDL[R-9H9E*.C@,K*PP00>""."#7=@,?/"SYHZI[H\[,LMIXRGR3T:V
M?8_R.-1_;]_; U;]DZT_8<U#QU?2?"VRN?M,6A[8PF=YE$;3!!.T*R'S%A:0
MQ!\,%R 1\B6MK=7UU'964;333,$CC0%F=F.  !R23P *_P!4#XK?\$4?^"67
MQHUZ7Q+XW^#6C1WDS%Y&TF2YT=78]24L)K="2>22N2>M>Q?LY_\ !,[]@K]D
MS5H_$?P!^%VB:'JL/^JU%XVO;^+UV7-TTTR9[[7&>]>\L_P\8ODIN[UZ)7]?
M^ ?-OAK$SDO:54TM.K=O3_@G\^/_  ;V?\$7?'?P,\1V_P"W3^UII#Z1XA%N
MZ>%= NTVW-DMPA22]N4/,<K1L4BB;YD5F9P&VA?Z]:**^<Q>*GB*CJ3_ .&/
MJL%@Z>%I*E3V_-]PHHHKF.L**** )[7_ (^8_P#>'\Z\B_:+_P"/W2O]R7^:
MUZ[:_P#'S'_O#^=>1?M%_P#'[I7^Y+_-:NG\2%/X&?-M%%%=)R!1110 5X)^
MT]^SKX _:P^!/B+X!?$R,MI?B&V,1E0 RV\R$/#/'GC?%(JNN>#C!R"17O=%
M.,G%J2W1,XJ47&2T9_F3?MB_L2?M#?L$?%I_!WQ2L9H(4G,FD:[:AA9WR1G*
M2P2C[KC@M&2)(SU&,$Y7[6'[>/[6O[<5_H.H_M3>-;OQ:_ABS^Q::LZ10QPQ
MG&]MD"1JTLFU?,E8&1\#<Q &/]+_ ,=?#_P)\3_#-QX+^).BV/B#1[L8GLM1
MMTNK>3'3='(&4X[<<5^<^L?\$6/^"8>NZP=<O?A3:).S;MMO?W]O#G_KC%<I
M&![;<5]#2SFF[.M#WEU5OZ1\Q7R"JN:.'J>Z]T[_ *7O8_SWOA=\*OB1\:_'
M%A\-?A-HMWX@UW4G$=O9649DD8]R<<*J]6=B%4<L0!FO] O_ ()*_P#!.2R_
MX)^? R>V\5R0WOCWQ6T5UKMS#\T<(C!\JTB;^)(=S%F_C=F/W0N/NKX(?LR_
ML^_LV:/)H?P'\':5X5@F $QL+98Y9L=/-EP9)".Q=F->YUQX_-)5UR05H_F=
MV69-'#2]I-WE^""BBBO)/;"BBB@ KW_]GK_D9KW_ *]?_9UKP"O?_P!GK_D9
MKW_KU_\ 9UJ*GPLTI?$CWC5/^0A+_O50J_JG_(0E_P!ZJ%<QTL****!!1110
M!^-/_!:3_@EK8?\ !2S]GJWMO!DD%A\1_!K37?AV[G.V*<2@>=93-_#'/M4J
M_P#!(JG[I<'_ #N_"GBG]KO_ ()J?M/1>(=%&I_#?XE^#YI$VW,"B6/S%*,&
MCE5XIH94)ZJ\<BG(R,&O]=JOGG]H#]DS]F?]JK1(_#_[1?@;1O&%O "(&U*U
M26:#=U\F; EB)[F-U)KV,OS9T(>QJQYH?U]Z\CPLSR58B:KTI<M1=>]MO1^9
M_DE_&_XX_%C]I'XJ:S\;?CAKEQXB\4^()_M%]?W. \CX"J JA41$4!41%5$4
M!5   KZ2_8,_X)Y_M'?\%#?BW;?#3X'Z3)]@BE3^UM=G1AIVEP,>7FDZ%\9*
M1*3)(>@P"1_H6:'_ ,$$_P#@DCX>UQ?$-A\&[*2X5MX2YU+4KJ#/7F&:[>(C
MV*8K]1_A[\-?AW\)/"=KX#^%>@Z?X:T2R&+>PTNVCM+:('KMCB55&>^!S7I5
MN((*'+0AKYVLODKGET.&*CJ<V)J)KK:[;^;L>3?LD?LO_#7]C3]G?PO^S=\)
MXF71_#-H(!-(!YMS.Y+S7$N./,FE9G;' )P,  5]'445\O*3DW*3U9]?""C%
M1BK)!1114E!1110!I:U_R3O5?^O.Y_\ 0&KX%K[ZUK_DG>J_]>=S_P"@-7P+
M6U'J95N@4445L8!1110 5_+A_P %RO\ @DOXS^,.OS_MD_LR:8^IZX8$3Q+H
MEJNZXNU@4*EW;H.9)%0!)8U^9@JLH+;L_P!1]%=&&Q,Z%15('-B\)#$4W3J?
M\,S_ #'?V:?V\/VQ?V)=*\7>#OV</&E_X-M_&%O]AUF"&.,LWE[E#+YJ.T$Z
M!F42Q;)5R<,.,?'DDDDLC2RL69B223DDGN:_TW?CQ_P3X_8L_:9U237_ (V?
M#G2-8U.;_6WZQM:7DGION+9HI6QVW.<=J\L^&G_!(W_@G!\)=9C\0>#_ (4:
M2]U"P=&U.2XU558="$O99U!'4''!Z5[L,ZH*\O9M2>^VOS/FI\/XAVA[5.*V
MO?3Y?\$_DO\ ^"2O_!);XA?MC_$+2_B[\7=+GTKX4Z5.EQ--<(8VUEHSD6]N
M#@M$Q&)91\H7*J=_3^^:WMX+2!+6U18HHU"(B#"JHX  '  '04EO;P6D"6MJ
MBQ11*$1$&U55>  !P !T%35XV-QD\1/FEHELCW\!@*>%ARQU;W?<****XSO"
MBBB@ K].*_,>OTXKGK]#HH=0HHHKG.@__]?^_BOX9Z_N8K^+W_A1'QP_Z$S7
M?_!=<?\ QNO5RQI<]WV_4\C-8M\EEW_0\IHKU;_A1'QP_P"A,UW_ ,%UQ_\
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M_"B/CA_T)FN_^"ZX_P#C='/'N'LY=CRFBO5O^%$?'#_H3-=_\%UQ_P#&Z/\
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MD?\ "C[-<_\ /-OR/^% 69!14_V:Y_YYM^1_PH^S7/\ SS;\C_A0%F045/\
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M_P"$7\3?] ZZ_P"_+?X5M1>YC63T,*BMW_A%_$W_ $#KK_ORW^%'_"+^)O\
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M&?\ /S\%_D?VP?\ $8=_U;M_Y=W_ -Z:/^(P[_JW;_R[O_O37\3]%']CX/\
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M&?\ /S\%_D?VP?\ $8=_U;M_Y=W_ -Z:/^(P[_JW;_R[O_O37\3]%']CX/\
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M:S[GTY_PT;_U!O\ R8_^UT?\-&_]0;_R8_\ M=?,=%'LH=@]K/N?3G_#1O\
MU!O_ "8_^UT?\-&_]0;_ ,F/_M=?,=%'LH=@]K/N?3G_  T;_P!0;_R8_P#M
M='_#1O\ U!O_ "8_^UU\QT4>RAV#VL^Y].?\-&_]0;_R8_\ M='_  T;_P!0
M;_R8_P#M=?,=%'LH=@]K/N?3G_#1O_4&_P#)C_[77H'P\^*G_">:G/IWV#[)
MY,7F;O-\S/(&,;5]:^(Z]_\ V>O^1FO?^O7_ -G6IG3BHMI%PJ2<DFSZ9NM=
M^S7#P>5NVG&=V/Z57_X23_IC_P"/?_6K&U3_ )"$O^]5"L+(V;.H_P"$D_Z8
M_P#CW_UJ/^$D_P"F/_CW_P!:N7HHL@NSJ/\ A)/^F/\ X]_]:C_A)/\ IC_X
M]_\ 6KEZ*+(+LZC_ (23_IC_ ./?_6H_X23_ *8_^/?_ %JY>BBR"[.H_P"$
MD_Z8_P#CW_UJ/^$D_P"F/_CW_P!:N7HHL@NSJ/\ A)/^F/\ X]_]:C_A)/\
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M?_:Z/^&C?^H-_P"3'_VNOF.BCV4.P>UGW/IS_AHW_J#?^3'_ -KH_P"&C?\
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M HHHH **** /NOP3_P DPL/^N"_^A4RG^"?^286'_7!?_0J97'U9V=$%%%%
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MD MQ,9O+\_B(!?+$GE]]N[FO$J**U44MD8N3>["BBBF(**** /U%_P""*?\
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M_H5,I_@G_DF%A_UP7_T*F5Q]6=G1!1110 4444 %%%% !1110 4444 %%%%
M!1110!/:_P#'S'_O#^=>1?M%_P#'[I7^Y+_-:]=M?^/F/_>'\Z\B_:+_ ./W
M2O\ <E_FM73^)"G\#/FVBBBNDY HHHH **** "BBB@ HHHH **** "BBB@ K
MW_\ 9Z_Y&:]_Z]?_ &=:\ KW_P#9Z_Y&:]_Z]?\ V=:BI\+-*7Q(]XU3_D(2
M_P"]5"K^J?\ (0E_WJH5S'2PHHHH$%%%% !1110 4444 %%%% !1110 4444
M :6M?\D[U7_KSN?_ $!J^!:^^M:_Y)WJO_7G<_\ H#5\"UM1ZF5;H%%%%;&
M4444 %%%% !1110 4444 %%%% !1110 5^G%?F/7Z<5SU^AT4.H4445SG0?_
MU?[^*_FN_P"(5?\ X)C_ //]XV_\&T'_ ,AU_2C16]'$U:5_9R:N85L-2JV]
MI%.W<_FN_P"(5?\ X)C_ //]XV_\&T'_ ,AT?\0J_P#P3'_Y_O&W_@V@_P#D
M.OZ4:*V_M'$_\_&8_P!FX7_GVON/YKO^(5?_ ()C_P#/]XV_\&T'_P AT?\
M$*O_ ,$Q_P#G^\;?^#:#_P"0Z_I1HH_M'$_\_&']FX7_ )]K[C^:[_B%7_X)
MC_\ /]XV_P#!M!_\AT?\0J__  3'_P"?[QM_X-H/_D.OZ4:*/[1Q/_/QA_9N
M%_Y]K[C^:[_B%7_X)C_\_P!XV_\ !M!_\AT?\0J__!,?_G^\;?\ @V@_^0Z_
MI1HH_M'$_P#/QA_9N%_Y]K[C^:[_ (A5_P#@F/\ \_WC;_P;0?\ R'1_Q"K_
M /!,?_G^\;?^#:#_ .0Z_I1HH_M'$_\ /QA_9N%_Y]K[C^:[_B%7_P""8_\
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M?&<G/3\*O44KA8\>O?@AX,U"]FO[AKGS)W:1L. ,L<G^&JO_  H3P-_?NO\
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M\#?W[K_OX/\ XFO:Z**3DWN-12V"BBBI&?_6_OXHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"[1_0C15_7ZETVKV5NMNG2]NGH9_V;3LTG:[OTOUZVOU]5W"BBBN$] ****
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M7P[^)OPW^+WA2W\=_"?Q!IOBC0[O<(-1TF[BO;64J<'9+"S(V#P<'BN$\/\
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M<;7"AAYTI,DF#\[DLV3S54L+35[Z]OFX?_)"K8NJ[6T[_)3V^<3^B?Q1\?\
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M (=V-/\ #S4= B\5KHGA:WBN]92WF@2UMM.6.\AC:Y1X$F68() P#E054YW
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MIP.@'0'\.2H\#1PR:U_;[1_+*&,8N% N, $,8Q!D'/%==JWCKP?J/B'6]4\
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M])_^G)'\N'_!S/\ \BI\'O\ K[UO_P! M*_DNK^M+_@YF!_X1/X/GM]KUO\
M] M*_DMK]JX6_P"192_[>_\ 2F?T1P]_N%/Y_P#I3"O7+/X&?$[4/@C=_M$V
M&FM-X2L-671;J\1E8PW;QB50Z [E1E8 .1MW$+G) /D=?H7\%/V@_#?PC_9J
MTCP_JYBU>QU+Q9JT'B/P_P":%EO-$O+&R1^.2C"2/?;RX/ESQ*XY2O8Q-2I!
M)TU=W_#^MCU*\YQ2<%=W/BKQS\/O$_PZO=/T_P 50K#+J>FV>K6X5P^ZUOXE
MFA8X)P2C D'D=#7$U^^,'BG]EC3_ !OKFD>!/$.D>)-:T_PWX-L= U:]N=,L
M(Y=/L[%X[Y%?6+>ZLX;G?]G\Z)PLN%=$?AT?@?!%E^RU\1?C#X'\1Z*_@OPS
MH'A3XL7M_P"(K/4=0M4ADT2Y&DB/R?/C@-Y:&6VO-L4<16%9/F1(V+5PPS-V
MO.F]KW^5]M]=EYZ')''.UY0>WZ7VWUV7F?B97N'A+0?%_P 3_A]XAL]*>UAL
MO VCIK%WYI99);=+Y;=5CPK R"74LX8JI0'G( /W?\/OC!\(=*O/AMX+F7PK
MY%KX*N;J)[^PM9;5/%I>^2T?4Y?*:1U16C CG9H%8QO(NT,U;WB_XH_"RX\/
M>*1\0;SP[_PFFH_#TV/B&7PP+6WL[^[_ .$BTZ>&*(6BI9R7@LHV:5K8&,JH
MR2ROBZF+FY*/)U7YVOMV^YM%SQ,[J/)U_7T_JZ/R"HK]T?$7Q._99U3Q6]M\
M;D\#W?PWC\5:5)X+M_#=G!'J%IHRW!,XO_LJ)>>1]EP+J.]8W$DV#$#AFK&\
M0>)-+\'_  R\-^._VB(?!'BJTO?&MUHNHS>%+73I,:%>Z>8G"/8PHBR0B4S6
MJM^^B=4W!,**2S*3M^[U]=]+Z:;K9]GIJ)8V7\FO];:?)[69^(]%?8_[:?A7
MPQ\(?B)I_P"S5X7:TO'^'5E_9FJZG:Q!#?ZO+(]Q=NS$!V$+R"U4-T6#@ DY
M^.*]"C552"FMGMZ=/O1V4YJ<5-;,*_T*?^"-O_*-/X6_]>E]_P"E]S7^>M7^
MA5_P1N!'_!-3X6@_\^E]_P"E]S7R?&G^YP_QK\I'SG%7^ZP_Q+\F?IM7Y?\
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M94^Z)_,O^R1_P3F^,WC_ .(FF^(OB[HMQX<\,Z=.EQ<K?KY5Q=>60WDI"?G
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M_P!HSX;ZY/IJ^&KW6[1)"L%WID3723(<[6V1;G3('(=00?J"?,_^&<_VA/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
=HHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>soph-20251231_g4.jpg
<TEXT>
begin 644 soph-20251231_g4.jpg
M_]C_X  02D9)1@ ! 0  2 !(  #_X0!J17AI9@  34T *@    @  @$2  ,
M   !  $  (=I  0    !    )@       Y*&  <    2    4* "  0    !
M   #/* #  0    !   !XP    !!4T-)20   %-C<F5E;G-H;W3_X0DA:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[
MOR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \>#IX;7!M971A
M('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)835 @0V]R92 V
M+C N,"(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2(B+SX@/"]R9&8Z4D1&/B \+W@Z>&UP;65T83X@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" \/WAP86-K970@96YD/2)W(C\^ /_M #A0:&]T
M;W-H;W @,RXP #A"24T$!        #A"24T$)0      $-0=C-F/ +($Z8 )
MF.SX0G[_X@TD24-#7U!23T9)3$4  0$   T487!P; (0  !M;G1R4D="(%A9
M6B 'YP "  ( "0 P #=A8W-P05!03     !!4%!,
M    ]M8  0    #3+6%P<&P
M                         !%D97-C   !4    &)D<V-M   !M    ?!C
M<')T   #I    "-W='!T   #R    !1R6%E:   #W    !1G6%E:   #\
M !1B6%E:   $!    !1R5%)#   $&   " QA87)G   ,)    "!V8V=T   ,
M1    #!N9&EN   ,=    #YM;6]D   ,M    "AV8V=P   ,W    #AB5%)#
M   $&   " QG5%)#   $&   " QA86)G   ,)    "!A86=G   ,)    "!D
M97-C          A$:7-P;&%Y
M
M            ;6QU8P         F    #&AR2%(    8   !V&MO2U(    8
M   !V&YB3D\    8   !V&ED       8   !V&AU2%4    8   !V&-S0UH
M   8   !V&1A1$L    8   !V&YL3DP    8   !V&9I1DD    8   !V&ET
M250    8   !V&5S15,    8   !V')O4D\    8   !V&9R0T$    8   !
MV&%R       8   !V'5K54$    8   !V&AE24P    8   !V'IH5%<    8
M   !V'9I5DX    8   !V'-K4TL    8   !V'IH0TX    8   !V')U4E4
M   8   !V&5N1T(    8   !V&9R1E(    8   !V&US       8   !V&AI
M24X    8   !V'1H5$@    8   !V&-A15,    8   !V&5N054    8   !
MV&5S6$P    8   !V&1E1$4    8   !V&5N55,    8   !V'!T0E(    8
M   !V'!L4$P    8   !V&5L1U(    8   !V'-V4T4    8   !V'1R5%(
M   8   !V'!T4%0    8   !V&IA2E     8   !V !$ $4 3 !, "  4  R
M #< ,0 Y $@ 0W1E>'0     0V]P>7)I9VAT($%P<&QE($EN8RXL(#(P,C,
M %A96B        #SV  !     18(6%E:(        &2'   S*@   0I865H@
M        :N0  +R7   1REA96B         G:P  $#X  ,!98W5R=@
M  0     !0 *  \ %  9 !X (P H "T ,@ V #L 0 !% $H 3P!4 %D 7@!C
M &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *, J "M +( MP"\ ,$ Q@#+ -
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MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\
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MIP  #5D  !/0   *6W9C9W0          0 !          $    !
M  $    !          $  &YD:6X         -@  IT   %8   !2@   G
M "<    /0   4$   %1   (S,P ",S,  C,S          !M;6]D
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]L
M0P ! 0$! 0$" 0$" P(" @,$ P,# P0&! 0$! 0&!P8&!@8&!@<'!P<'!P<'
M" @(" @("0D)"0D+"PL+"PL+"PL+_]L 0P$" @(# P,% P,%"P@&" L+"PL+
M"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+
M_]T !  T_]H # ,!  (1 Q$ /P#^_BBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO,<=Z +M%4_,D]:=YST 6J*K^>>XIPG4]10!-13!(GK3@0>E "T444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__T/[^**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHK#U?Q)H>A*3JERD38W;"<L1[*.:"H0E-\L5=FY1
M7BNK_&2PA)CT6V:8@D;Y#M7Z@<D\^N*\NU;X@^*]7RLMT84./EA^0<>XY_6I
M<T>K0R3$U-9+E7G_ )'U/J.MZ/I"%]2N8X<#.&8 GZ#J?PKSS4OB]X;M05T]
M);INQ V+^9Y_2OF<DL2S')/4TE0YL]BCD%&.M23E^"_KYGKE_P#&+Q!."MC!
M#;@]"<NP_/ _2N'U'QAXGU7B]OI6!!!53L4Y]EP*YNN,\(?$?X>_$&;5+?P%
MKVG:W)H=Y)IVHK874=R;2\BQO@F$;-Y<JY&Y'PP[BE[SU/2IX3#4FE&"3_'_
M #.T)+$LQR3U-)114G6%%%% !1110 4444 %?1?P7<G1[R/L)@?S4?X5\Z5]
M$?!?_D%7O_75?Y5<-SRLZ_W27R_,]8HHHK4^("N/TWXA^ -9\8ZC\.](US3[
MOQ!H\<4M_ID-U')>6J3 -&TT*L9(U=2"I90&!!%=A7\DGBK]J'7?V4OV[O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?-%J=^B3F15BMXH"TC8)+!&8/M-?UZS(\D3)&VQF! 8#.">^#QQ7YJ_LC_\
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M %%%% '_T_[^**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;?SR^!/C']L#XFW/AG_@HOX>^&$OQ5'Q-T#5OAO\2M%TAH[:+5IK%C;VNH<
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MZJ )4Y%64E#<-P: )J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6=_IUCXAN'\[[9?ZDLWF0B.$J#$JL0%SP&.?S8\0_P#!1?\ :L_:9U3XB?\
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M86I^U7>[T,<6XIGU?:/>OYK_ (U?M^_M.?'#SK'6M??2-+ER#8:3FTA*GLS
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M"26)9CDGJ:2L7*Y]M@L#3PT.6&_5]PHHHI':%%%% !1110 4444 ?D-\ _\
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M'%?*E%%<K;;NS^E\ORW"X"A'"X.DH4X[**LO^'[O=]0HHHI':%%%% !1110
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M^&& X?A'$5;5<5UFUI'R@GMVYOB?DG8****Q/T\**** "BBB@ HHHH ****
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M\Q)5<4>QG:_+_7](;KT[VYE_PUO\S[SHJO9W4-]:17MMDQS(KKN4J=K#(RK
M$'V(!'>K%9&H4444 %%%% !1110 5;M;V:T;*'*GJIZ54HH [:UNX;M-T9Y'
M4'J*M5P4<KPN)(S@CO756&I)=?NY,+)^A^E2T6F:=%%%2,**** "BBN6UG6=
MF;.S;GH[C^0II";#6=9V9L[-N>CN/Y"N0HHJR !QR*]!T/7!=@6EV<2CH?[W
M_P!>O/J5696#*<$<@BDT-,]GHK!T35UU"+RI3B9!R/4>M;U06%%%% !1110
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M<@BN-)N;**W=))"OE%9L.A4,67[V!@&K?[;OQ6_99^/_ .T_\.Y?AIJKZ?\
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M5)4)5HFU9?L0<,.5*&;<&&=N,X;&#]BVUM;65M'9V<:Q0Q*$1$ 5551@  <
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M&@MG4Y%L#P[@_OCP/W?,GP7^S%^TW%\1X8? 'CV8)XA0;;>X8X%\!V/I./\
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M[B/)>1BTCZ0:49/KM]__  -/F95$Y2BNF_W;?CK\CZ1HHHK,U"BBB@ HHHH
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MS46CYDHHHJ3UPHHHH *_HN_X(#?=^+/UT'_V_K^=&OZ+?^" _3XL_P#<!_\
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M$U6PS#>QP7L)FL]*LYRI\N>Z7$UQ-&1);VVW8R231LO4?\.X_P!@:Y_>Z_\
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MJ_7F6A:D=/N]LAQ%)PWMZ&O30<\BL6C9,****0PHHHH **** "BBB@ HHHH
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MQJS=L5_FW?$CXB>,/BWX^UCXG?$"]?4=;UZ[EOKVYDZR33,68XZ #.%4<*,
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M56OX-=T?ZP\!\>93Q=E-/-LIJ7B])1?Q0EUA-=&ON:LTVFF%%%%<9]F%%%%
M'WQ_P3.\<>$OAS^U[HGB[QOJ%CI>G6VG:P'GU*9(+;?)87"HCM(RK\[D(!D%
MB<#DU[/^TQ\=O!WQX_84\&M\.I/#O@N30];E7Q)X,TN."Q-U>M'M@U."+/G2
MIY1,<G+;6.#PN:_*"BM%4:CRGR./X/PV*SBGG4IM58>SLMU:'M;W3T=_:NSW
MBXQ:>]_Z$/ /[6/P:M/%WPB^ OQ+URQO/ 6O_#SPQ:ZC<1W$;IH?B'3+B>6W
MFD;)$+QL%2=6*D1LI?Y5KPSX8?$CX+>$/^"C_P 7OVJ_%&L:7J&E>#+CQ!KN
MAP"]B5=9OI9'CM8K9LL)-_F%P\8?;M#8(K\8J*KVSTT/$I^&F"IK$JG6DE7I
MNG-*R34I)SDNTI02IMKHD]T?JS^U#\9/@K^TS^QAX5\3>%H8_#/B7X>Z[=:4
MNC7^K+J&HW>F:D/M)N%=TBDE6.?*8"$1@GG!K\IJ**SE+F=V?79#D=+*</+"
M8>3=/GE**DVW'G?,U=MM^\Y.[=];= HHHJ3VPHHHH ^EM2_XJ?\ 9&TR^/S3
M>#_%%Q9NQZB#6[99H$XSPLEC<L,[>7.-W.SYIKZ6^"/_ !47PP^)OP[^]+/H
MT&MVB?WKC2+F-G/'/RV<MVW4KQR,X9?FFJET9Y&5^Y4Q-#I&;:])I3;].>4_
MN\@HHHJ3UPK^BW_@@/T^+/\ W ?_ &^K^=*OZ+?^" _3XL_]P'_V^KHPO\5?
MUT/R'QX_Y(7,?^X7_I^F?T5T45X3^U)XPB^'O[,GQ&\?3R^0FA^&-7U!I?E^
M06UI+(6^?"\;<_-QZ\5[,8W:1_G'*7*FWT/(O^"<P^T?L*?"KQ#T_P"$@\.6
M6N[?[O\ ;"?;MN.VWS\8R<8QN;[Q^TZ\C_9_\'S?#WX#>"? -Q%Y$FAZ!ING
MM'\WR&VMXXROSX;C;CYAGUYK\U/@M_P4\?XN67P+\.V:69\5?$+Q-=:1XBMA
MIM_!;6UI;Z=JMUOM)I<1&3SK.!>99@49\+T9-W3E4E.<%I=_J_T,(U8THPA-
MZV7Z+]3]AZ^3?V*? ?B;P3\!X-4\>V4VG^)/%NJ:KXIU>WN6)FAN=;O);L0L
M"6*"WBDC@2,LQC2-4+,5W'X(O_\ @H=\9+?]KN_^!^CZIX2U;[-\1+7PA'X.
MM]-O/^$C?1Y8+.6YU;[8M]) ([07,DL@>R1#'$5$@<BNU^,?[:'[2WPK\:?&
M/XC6L'AO4?AO\'?$VB:-J&DFRN8M;GL-1T[2[RYNX[_[8UN9(&U!V2 V2ATB
MV^8&;-:+#5+<G>S_ $_7T,WBJ3?/KI=?J_R]?(_72OB;X-VUM\3?VN_B=\;7
MC5[;PI!8^ -*D( ;=;*-1U*5".J2375O;MN/RR63;54$M)]+_%OXD:%\&_A3
MXG^+WB@XTSPKI-[K%V<[<06,+S2<GI\J'FO%OV)?A-XB^#7[,?A?PSX\CC3Q
M7J,<^O>)3%NVOKNMS/?ZB07)<K]JGE";CD( .  !A'2$I=]/U?\ 7F;SUJ1C
MVU_1?UY'U711161L%%%% !117SO^T)^U-\'_ -ES1[3Q%\9'UFVT^\)5;K3-
M U368(FWQQJ)Y-.M+E8"[RHL8F*&1CA-Q!Q48N3Y8J[)G.,5S2=D?1%?'/[5
MWQ&\;3Q:7^S7\#KCR_'/C[S+9[R"8)/X>T4JRW>M8VMEK?*QVJL,2W<D2GY!
M(5[[P7^U7\#_ !Y\0])^$>D:C>6?BG6]$G\1V>D:MI=]I-ZVFVUS]DDE:&]M
MX'C(F('ER!9"I#A2A#5Y;!^WA^R#<>"/#WQR\,ZO=:WIWCF\O-%TF[T30=3U
M2\U"717NO/C6"SM)KEH[=HKE@Y3R\;G5BK9.L*<U*_(W\OZ[/[C&I5@XVYTO
MGZ?YK[T?3'PF^&/A7X+_  ST+X3^"4D72O#UE#8V[3OYL\BQ* 9)I#S)-(<O
M+(WS2.S,Q))->A5P'PM^*7@'XU^ -,^*/PNU*/5]!UB,RVEU&K('"L48%'57
M1T=61T=59&!5@""*[^LI7N^;<VA;E7+L%%%%24%0W-S:V5K+?7TJ000(9)99
M#M1$7J23T I+N[L].LYM1U*9+>VMT,DLLAPB*.I)K\U?CI\=[SXCW3>'O#Q>
MWT*!\A3\KW++T>0>@_A7MU//32G3<F9U*J@KLL?';X]77Q"G;PQX89X-"A;G
M/RO=,O1W'91_"GXGGI\T445W1BHJR/-E-R=V%%%%42%%%% !1110 4444 %?
M17[._P 4AX'\2?\ "/:U+LTG5&"NS?=AFZ+)[ _=?VYYVBOG6BIE%-694).+
MNC]J64JQ5N".#7"?$KX8_#OXR>"KWX;_ !7T2R\1:!J0C%WIVH0K<6TPB=9$
M#QN"K!756 (Z@5YK^SI\2?\ A-_"9\/ZI)NU/1T56)/,MOT1_<KPC?\  3U)
MKZ$KSVG"7FCTTU./DS^2/XS1^'-)_;<\&Z%_P5T^+^D:/#X3U)-9^'OPO\'V
MTMKH-M':3-#IMWJ5V4\JW$K(%19GPH;#211ED/\ 0A^Q#^V1H'[9OPSU7Q.F
MAW/A/Q/X4UBZ\.>)_#U[(LTVEZM9$"6'S4PDT9#!HY5 #J>@(('PO_P5D_8"
ML/CA8S?M'>$?']M\(WM="O-$^(/B"6"2[^V>#%CDGFMS;@^5(Z2@,A*J^#\K
MY54;\HOV4?B'\;=#_9[O_A-_P2.\,GX4?" 7$NH^(OCA\5)8X9;Z5@L<MW;0
MR 1'Y4"QML>, 8=87)8^S*$,104D[-?)+_A_G)GAQJ5,+B)1DKQ=WWE+M]W?
MW8H_I#_X*%_LV>-OVO?V-O'7[.GPZ\22>%-9\3620V^H)N"_NI4E:&39\_E7
M"H89=O.QSPPRI_G;_91^(O[4OP/^&/A/Q59>$_!W[%/P%\*75G-XBU'7XVNM
M<\7SV9'G1I'<I%=R+<A2$W*LP5OW<D@&ROZ-/V)?VH/A%^U'\&(M:^%'CNV^
M(TGA>5- UG7+6U>RCN]4M(8C/*L+_=24N)%VED(;Y68#-?DQ_P %/OV7O@?X
M&_:#TS]JKQ#\'?&'[2WC_P 9RII7AGPG-<-<^%](GM8$W/-$P988I0#(RR))
M"S*[$1G+UC@Y\KEAJB_#K\VEMUE>W8WQM-24<52?2V_3U5WOTC:_>R/WC^$W
MQ3\#_'#X9:#\8?AI>?VAX?\ $UC!J6GW)1XC);W"AT8I(%=3@\JR@@\$9KT*
MOPE_X)#SR?LH:5>?L:_M)^/O#L7Q1\5:OJ7B32OAYHUZ;U/#&FNB2'3XSNE\
MI(L,ZQ%RH7)0OAWK]VJX<125.HXIW71]T>AAJSJ4U*2L^J[/^OF=IX5O_O:?
M(?\ :3^H_K7:5X];3R6LZ7$7WD.17K=M/'=0)<1?=<9%<S1UIDU%%%2,****
M "BBB@ HHHH _]7^_BBBB@ HHHH **** "BBN9\8^)(/"7AJ[UZ;:3!&3&K'
M >3^%?Q/ISBFE?0#Y(_:'\4MJOBJ/P[ ^8=.7Y@#D&60 G/'4# [XY]Z^?*L
M7=W<W]W+?7CF2:9VD=CU9F.23]35>NZ*LK'#*5W<*\H^-^L?$;1OA?K$OP<7
M2IO%\MNT>C0:S.]O9S79^ZCM'\_(S@+@DC&5&6'J]?S3_P#!47X/^'/VN= U
MG]KO1]6/Q!^'_A.'3O#^F6WAF>:>ZTNZCU1?[:ODAC BED6V'EH2SIMPY7:J
MM75A:2J5$I.R^_\ R_,X\96=.FW%7?K;U?7\CY4_9"_9GT>T^)&A? KP]=>,
MOV<?VH=%@EENM0D$NJZ1XG@B9I9IGRS0NI /<09 '[UN!_7MIUC#IMFEI#CC
M+,P54WNQ+.Y"@#<S$LV ,DDU^6?_  2/\+?%R#]G!O&GQ5\2:_XAT[4-1O5\
M)P^*;9(]5L-#CF>.#S)3F5S<QI'*0QVJ H0;<$_JS6N/K.=1I]/Z];>6MNAA
MEM!4Z2DE:_\ 732_FK7ZA117Y(?\%EOVVG_8Z_9-O++PC=_9_&GCGS-(T8HV
M)($*_P"DW2]QY,; *1TED0],US4:4JDU3CNSLKUHT:<JD]D?S,_\%O/VZF_:
MO_::E^&/@B\\WP1\/))K"T,;9CN[_.VZN>.&&Y?*B/(V(64_.:_%2BBONJ%&
M-*"IQV1^;8BO*M4E5GNPHHHK4Q"BBB@ HHHH **** "BBB@ HHHH DAFEMY5
MG@8I(A#*RG!!'0@CH17ZS_LQ_M.1?$F*'P#X]F">(4&VWN&X%\!V/I./_(G^
M]][\E*DAFEMY5G@8I(A#*RG!!'0@CH17GYEEM+&TO9U-^CZI_P!;H_1/#3Q+
MS;@K-HYEELKP=E4IM^[4CV?9K[,MXONFT_Z-**^,OV8_VG(OB3%#X!\>S!/$
M*#;;W#<"^ ['TG'_ )$_WOO?9M?E>.P-7"572JK7\&NZ/]8> ^/,IXNRFGFV
M4U+Q>DHOXH2ZPFNC7W-6:;33"BBBN,^S-SPUXAO_  IKMKXCTN.VEN+1_,1+
MRUAO8"?]N"X22*0?[+HP]J]Y_P"&K_BA_P! OP;_ .$9X?\ _E=7S5134FMF
M<.*RS!XF2GB:,9M:7E%-V^:9]*_\-7_%#_H%^#?_  C/#_\ \KJ/^&K_ (H?
M] OP;_X1GA__ .5U?-5%/GEW.;_5_*_^@2G_ . 1_P CZCTS]J75+J_B7XB^
M#/!_B+3=V)K1= L=(9HVX<+<:7#:3*Q7[K;SL.& R*Y;XE_#[PS-X2MOC5\*
MA,OAJ_O&L;FRG)DFTB^*F1+>27 $L<L89[>7"M((Y%90T9)\%KZ-_9U\2V<N
MJ:O\%_$MTEKHGC^V33)II<".VO8Y!+8W))^Z([A561AR())1WIIWT9RXK 4\
M!'ZW@8<JC;FC&ZBX?:M!:<R5Y)Q2E)I1;LV?.5%:>M:-JOAS6+OP]KMN]I?6
M$TEO<02#:\<L3%71AV*L""/6LRH/H(R4DI1=TPHHHH&?1G[)%Y;0_M&>%=&O
MVV6OB"Y?0+EL$[;?6XGL)3QGI'<,>C#U5A\I^?;VSN=.O)M/O%V30.T;KD'#
M*<$9''4=J+*\N=.O(=0LVV30.LB-@'#*<@X/'4=Z^A_VNM-AMOVAO$>O60 M
M/$LL7B*V"-O00ZU$E\J*P)W"/S]F<GE2"<@U7V3R+^SS3_KY3^[V<OU]K^!\
MW4445)ZX5_1;_P $!^GQ9_[@/_M]7\Z5?T6_\$!^GQ9_[@/_ +?5T87^*OZZ
M'Y#X\?\ )"YC_P!PO_3],_HKKXL_X**G[5^Q'\1_#74>)-);P\RCJRZVZ6!5
M1U+,+C"JI#,2 I!((^TZ^+?VZ3_:/PS\(^#$^_KOQ"\%0X[-'9ZU9W\R,.A5
MX+61&!(!!/WCA6]VA_$CZH_S?Q'\*?HS[2K\KO$B_L4_L\3_  P_9QU/Q3KN
MI^(/@_J!\4:9HNBV-SX@UEOM-K?60>]M-+LKB80&._F96$47S*AW;0P;[A_:
M7^+5Q\"/V?/&?QBT^V6^O?#NCW=[96CYQ=7B1G[-;\%3F:;9&/F'+=1UJ']G
M7X%Z%\ OAG8^$K5OM^MS1QSZ]K,WSWFKZFRC[1>7,I :2263<1G"HN$14C54
M%4WRQ<GMY?UY_B357-)1C:Z[^ORZK\#\X;S7OV.;GQ4_CNTLOBY9ZV/&X\=P
M7]O\//%"S6]\]I#8SVT9.@D?8[FUB\J>)PS,'8AU81LG.>(M$_9,^*_QB\0>
M)_$E]\9;C1?'FOZ3KNK>$IO &OVV@76I:7;V=I:O/(?#J78A46-N\D<EZ+=F
M4EUV$BOTF^%?Q.\5>/OCY\4_"TCQGP]X)N=(T2W54 <:E+9)J-V68_,V8+ZS
MQ@; !P2QD"_2-:NMROK>W=>3[&,:'.NEKOH]U=?S'PQ^VL\?Q N/AU^RW RL
MWQ#\2VTNI1^:8)!H>@$:G>LKKSB1X+>T8+\Y%UP4P98_N>OBSX:?\73_ &R?
M'7Q2_P!9IG@#3;?P3IDB_-&UY=^7J.K,K-_VX0N(@%$ENRN[NGEV_P!IUC4T
M48?/[_\ @6.BEJY3[Z?)?\&X4445B;!1110 5\E?MR?#+QQ\8OV9M;^'OPYL
MO[1UB\O-'EAM_-CAW):ZC;3RG?*R(-L4;MRP)Q@9) KZUKY4^+'[3-]X5^(4
M/P8^#?A.]^(/B\QK/?VME/#:V6CP3*Q@EU&[F;; LS*1'&B2W#J&=(F"\Z4N
M;G3CNM3*MR\C4MGI]Y\9_MI_L;_M!?'+]I-/B]\#;R#PYJNE>%[32M,URXE
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MP;K7[+_[1'B?PMI/Q.\7Z_J_C2U^'FA7L<P\.Z==^4S6D40DD,<:2%G5%9D
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MZ/JG_6Z/T3PT\2\VX*S:.99;*\'95*;?NU(]GV:^S+>+[IM/^C2BOC/]F/\
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M &C<H8;3]XN&C'GO'EQR@^;M5<MU""Z_J[?H2I)2J3?3]%?]3A/V!_\ B>_
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M?&?]FKQ_\-O&UKHNBZ_XIT;5-*T^&RO)[NT@%Y:-#$9[A[>%V/F,6<I;C:N
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MOQ/_ &[$T7Q?^S7X4\%+X%CM])MKR;7]:LWU%9M'CO((@D4=W9RNL*7D<T7
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MX^J_T(5Q8B@Z4N5_I?YVV9WX;$1K0YE^MOE?=>9WWA:\$MJUFY^:,Y'^Z?\
MZ]=57EFBWALM1CD_A8[6^A_SFO4ZY6=:"BBBD,**** "BBB@#__7_OXHHHH
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M?2:9=7=O)%!>Q(CR6TK*0DR+(&0M&V'4,I7(&017\-O[0_PC\ Z/\:;WP%\
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M]LSP!XR^)OPE@^"6AZ=-<VGC?5K'1M;E096#1))/-U%G!(0K+:Q26^')0M,
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M2#J>KNQZ(@_B8]A^)XS7Y:_%KXMZ]\5M<^V7N;>PMR1:6BG*QJ>Y_O.?XF_
M<8%73I.3\B:M507F2_%WXOZY\5M:$UQFVTVV)%K: Y" _P 3?WG/<_@.*\AH
MHKN225D>;*3;NPHHKRWXI_&7P!\'-,M;WQK=LMQJ4IM].L+=&GOK^XQD0VT"
M R2N1V484<L0N2*2;=D3*22NSTB]O;+3+*;4M1F2WM[=&DEED8(B(@RS,QX
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M+("#V-?/WC?PGXIN_AY\$+&UTVZEFTG7M$FOHTA<M;1PV4RNTH S&J,0K%L
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MVG_V,]'^%_[3GQF\4_!W0/A7\7M;L[S5/ OA6VCM]4TW3M:#2R:HRP(9Y98
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MA^]UES@6L$DHSZJ"0.<<D\ =Z_+IF9V+.<D\DFOOOX\ZJVF_#FYB1MK7<D<
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MU0@9#,,9H:A\,OAK^SQX,UW]H?XGW&J^.M8\+:=>ZS<:KJKI=WB):PM+*+&
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MP-TGX4?#WX<+#)#IXF-MJ&C:?J<)FTVV: Y^TO)LD>><;3N?YE5NO[!?MB_
M_6/VEOV5/B'^S_X>U(:1?^,= O\ 2K:\;.R*6YB9%,FW+&,D@2 <E"0**D70
MQ5UIK?>]D_3R"G)8C"6=WI9Z6NUOOYGY%_L12_\ !*ZT_P""CNH^*?V _B5X
M9TR:_P#!\OAW4? VA6SVUKJ-Y:W2W*:A#*2L$[Q0JZ$0(QVDN7P6K^@:OY'_
M !1\:?\ @CC\%?#OP"^%6K>)]%TCXM?!?6M$OKU_AMH[W_VS4+"/R;VUDOA
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M_P"*IVJ=U]S_ ,PO1[/[U_D>PZC^Q9^V-H]F^HZO\)O&5K;QXWRS:#?(BY(
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M61_PQ5^QM_T23P9_X(;'_P",T?\ #%7[&W_1)/!G_@AL?_C-3[2-TVWIY?\
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M9;D^"?P_\8WWC.#X8^(-7\)SS:II_P#9E]9RZ?<-BUFAW,3Y:.A21CN>-E+
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M (+%_$;Q#X"DU"[U"%[ZUC#M:ZI#<"..SE:2&<6UO"N]%'D;%V@$QCFO[?\
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M5_Q,;ZP^S_;_ "?/_P"/*X@W[_(B^_NV[?EQDYRHXVC3QL<0G)Q\[7V:-:^
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MVW^85:L6V7T+^CJ?UJK3D8HX<=CFN<Z3V:B@'/(HK,T"BBB@#__6_OXHHHH
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MT?\ $(!^TA_T6'PU_P" %U_C7][U%']NXS^;\%_D'^KN!_D?WL_FK_X(M?\
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M!W\4-_X!?_;J</V$K;OXG;_P#'_QVOT!HH^L5.X?5Z?8^ /^&$K3_H9W_P#
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MT)_T!O#O_@/<_P#R57YH4^**2>1885+NY"JJC))/0 4?VAB/YV'_ !$+B/\
MZ#I_A_D?I9_P]2_:$_Z WAW_ ,![G_Y*H_X>I?M"?] ;P[_X#W/_ ,E5\/R^
M ='T"X-AX\UJ/3KQ=PDM+>)KN:!E/W9=I6-6]5#LZD$.JGBL'6_!EYI6GIK6
MG75OJU@0N^YLM[)"[D@)*)$1XV.T[=Z@. 2A8 XIXW%+[;.N?&G%4$W+&3TW
M7-%M>L5JK=;K3J??W_#U+]H3_H#>'?\ P'N?_DJC_AZE^T)_T!O#O_@/<_\
MR57Q<OPLLM$%O_PL?7;70)KA!)]C,<MS>1HZAD:2.-=L>X$$*\BO@@[<$&L7
M7/A\UGHLOB?PQJ,&NZ; ^RXDM4E22U#-MC,\<J(4\SC:RETR=N[=Q3>,Q2^V
MRY\8\5QBW+&2NMUS1YEWO'XE;K=:(^Z_^'J7[0G_ $!O#O\ X#W/_P E4?\
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M:Z6[[?Y')2HUM85?\^C1A4445\L>F%%%% !1110!^P/PS_Y)OX?_ .P;:?\
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M-&.*X9PE.DZW.X\M/VCBY1D[<TZ:M*.C]^,$^RG>WNL_."BBBOI#X4*_5_\
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M&^4BOE?XA_LO_M'_  D\(6?Q ^*/@37O#VB:@RI;WVHZ?-;0.SC<J[Y$ !8
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M@3_P4]^&6/\ J-?^FF\IRV8H?$C_ $!Z***Y#N"O&OVC/^3>_'?_ &+NJ?\
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M_#-/[.7_ $('AO\ \%5K_P#&Z/\ AFG]G+_H0/#?_@JM?_C=:_\ $4L+_P!
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M[2!+:VMK:+.V.**,!54$L<#J22>37]?/_#-/[.7_ $('AO\ \%5K_P#&Z/\
MAFG]G+_H0/#?_@JM?_C=<]+Q%RZDTZ>#::O;5==^G4[<1X+9U74HULS4D[73
M4M;;=>G0_C#HK^SS_AFG]G+_ *$#PW_X*K7_ .-T?\,T_LY?]"!X;_\ !5:_
M_&ZZ?^(I87_H'E]Z_P C@_X@#CO^@V'_ (#(_C%1'D<1Q@LS'  Y))K^C/\
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M$61&(Q(7)'"\_P!(>A?LB?LG^%]4BUSPS\,/"6G7L#!HKBUT2SAE1AW5TB#
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MW_T(?AW_ ,%=M_\ &Z/[#J?SH/\ B!6._P"@R'_@,C^3RBOZP_\ AG/]GO\
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M<KF67X1^"V9CDDZ!8DD_]^:^[P7&?)2C"O3O)=4]S[#"\4\M-1K0NUU3W/\
M,[HK_3!_X8B_8P_Z)#X*_P#!!8__ !FC_AB+]C#_ *)#X*_\$%C_ /&:Z_\
M7:A_SZ?WHZ/]:Z7_ #[?WH_S/J*_TP?^&(OV,/\ HD/@K_P06/\ \9H_X8B_
M8P_Z)#X*_P#!!8__ !FC_7:A_P ^G]Z#_6NE_P ^W]Z/\SZBO],'_AB+]C#_
M *)#X*_\$%C_ /&:/^&(OV,/^B0^"O\ P06/_P 9H_UVH?\ /I_>@_UKI?\
M/M_>C_,^HK_3!_X8B_8P_P"B0^"O_!!8_P#QFC_AB+]C#_HD/@K_ ,$%C_\
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M_BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
? "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>soph-20251231_g5.jpg
<TEXT>
begin 644 soph-20251231_g5.jpg
M_]C_X  02D9)1@ ! 0  2 !(  #_X0!J17AI9@  34T *@    @  @$2  ,
M   !  $  (=I  0    !    )@       Y*&  <    2    4* "  0    !
M   "V: #  0    !   !S0    !!4T-)20   %-C<F5E;G-H;W3_X0DA:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[
MOR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \>#IX;7!M971A
M('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)835 @0V]R92 V
M+C N,"(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2(B+SX@/"]R9&8Z4D1&/B \+W@Z>&UP;65T83X@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" \/WAP86-K970@96YD/2)W(C\^ /_M #A0:&]T
M;W-H;W @,RXP #A"24T$!        #A"24T$)0      $-0=C-F/ +($Z8 )
MF.SX0G[_X@TD24-#7U!23T9)3$4  0$   T487!P; (0  !M;G1R4D="(%A9
M6B 'YP "  ( "0 P #=A8W-P05!03     !!4%!,
M    ]M8  0    #3+6%P<&P
M                         !%D97-C   !4    &)D<V-M   !M    ?!C
M<')T   #I    "-W='!T   #R    !1R6%E:   #W    !1G6%E:   #\
M !1B6%E:   $!    !1R5%)#   $&   " QA87)G   ,)    "!V8V=T   ,
M1    #!N9&EN   ,=    #YM;6]D   ,M    "AV8V=P   ,W    #AB5%)#
M   $&   " QG5%)#   $&   " QA86)G   ,)    "!A86=G   ,)    "!D
M97-C          A$:7-P;&%Y
M
M            ;6QU8P         F    #&AR2%(    8   !V&MO2U(    8
M   !V&YB3D\    8   !V&ED       8   !V&AU2%4    8   !V&-S0UH
M   8   !V&1A1$L    8   !V&YL3DP    8   !V&9I1DD    8   !V&ET
M250    8   !V&5S15,    8   !V')O4D\    8   !V&9R0T$    8   !
MV&%R       8   !V'5K54$    8   !V&AE24P    8   !V'IH5%<    8
M   !V'9I5DX    8   !V'-K4TL    8   !V'IH0TX    8   !V')U4E4
M   8   !V&5N1T(    8   !V&9R1E(    8   !V&US       8   !V&AI
M24X    8   !V'1H5$@    8   !V&-A15,    8   !V&5N054    8   !
MV&5S6$P    8   !V&1E1$4    8   !V&5N55,    8   !V'!T0E(    8
M   !V'!L4$P    8   !V&5L1U(    8   !V'-V4T4    8   !V'1R5%(
M   8   !V'!T4%0    8   !V&IA2E     8   !V !$ $4 3 !, "  4  R
M #< ,0 Y $@ 0W1E>'0     0V]P>7)I9VAT($%P<&QE($EN8RXL(#(P,C,
M %A96B        #SV  !     18(6%E:(        &2'   S*@   0I865H@
M        :N0  +R7   1REA96B         G:P  $#X  ,!98W5R=@
M  0     !0 *  \ %  9 !X (P H "T ,@ V #L 0 !% $H 3P!4 %D 7@!C
M &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *, J "M +( MP"\ ,$ Q@#+ -
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MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\
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MIP  #5D  !/0   *6W9C9W0          0 !          $    !
M  $    !          $  &YD:6X         -@  IT   %8   !2@   G
M "<    /0   4$   %1   (S,P ",S,  C,S          !M;6]D
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]L
M0P ! 0$! 0$" 0$" P(" @,$ P,# P0&! 0$! 0&!P8&!@8&!@<'!P<'!P<'
M" @(" @("0D)"0D+"PL+"PL+"PL+_]L 0P$" @(# P,% P,%"P@&" L+"PL+
M"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+
M_]T !  N_]H # ,!  (1 Q$ /P#^_BBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MPW]Y=:7>6,5TL$,0D+./)ED**?,\K$C*JM7UMJGP6\5:9_P5*L_'/[=GP?\
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MTF\+^([RZ\4Z=>ZC'KEII[2Z'9K98S%=W>X"*63/[M=IW$@$@LN?P@_X*#?
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M$)U?B:N_F%%%%<YTA1110 4444 %%%% !1110!__T?[^**** "BBB@ HHHH
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MA837LNFQ3QM<PJKR1!@717SM++G(!P<$CG!JY0-IK<****!!4%Q<16L1EF.
M*F)"@L> *X'4KYKZ<D?<7A132N)NQ/>ZS<W1*QGRT]!U/U-8]%%61<**** -
MBRUFYM2%D/F)Z'J/H:[&WN(KJ(2PG(->;5HZ;?-8S@G[C<,*3129W]%("& 8
M<@TM04%%%% !1110 4444 %%%% !1110 4444 ?_U?[^**** "BBB@ HHHH
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MW!?]4<_\K=?I112Y/-G3_K=_U 8;_P %?_;'X[_'_P#X>0?\*8\1_P##0/\
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MO5CX<:*WM[66VE,*2%)-SA;M!Y\8QM", &/:;_AZO^V?_P!&6?$;_P "+?\
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M** "BBB@ HHHH **** "BBB@#__6_OXHHHH **** &2RQPQM-,P1$!9F8X
MZDFO,/ OQ2LOB)J]Y%X;L;A](M5PFIN-D,\H."L8/S,!_>Z<8],]EXCU7P]I
MUK#8^))$6'4YEL420%EEDF! CQ@_>&>O%:6FZ;I^C:?#I6E0I;VUN@CCCC&%
M55X  JM+$N]RI8_\)#_:U]_:7V?[!F/['Y6[SL;?WGFY^7[WW=O;KS7FNL']
MH+_A))#H"^'O[(\T>6+@W/VDQ<9R5&P-UQ@8'O7L=%"?D-J_4SM2.K"*+^QU
MA9_.C\SSBP BW#S-NT'YMN=H/&>O%<_XV/Q _LI!\.1IYOO,&\ZD9/*$>#G'
ME?-NSC';&:[&BDF#1QG@@_$+^S)!\2!IWVWS3Y9TTR^5Y>!C/F\[LYZ<8Q1J
M":N]HTNKK"&6>01^26(\DGY"VX##8 W8XSTKLZK7EN+JV> _Q#CZ]J+ZW"VE
MCSBOYH?V-?\ @H5^SA^P[XW_ &B?A'^TJWB#0M<U'XU>,M<M8HO#VI7L<VGW
MUPA@F22WMY$*R!"5^;E<$<$$_P!,#HT;E'&"#@BFUU4:L8J49QNGYVV^3.2O
M1G*49PE9J^ZOO\T?@#^TW_P4Y_X)(_M<?"&_^"OQEU+Q1<:7>/'<0SVOAC6[
M>\LKNW;?!=6LRV>Z*>%_F1Q[@@J64_GOJ7[6GPM\9:$_PG^)W[:7Q2U;X>SI
M]FN-/MOAY/8:U<VA&##+K$>GF=MR_*[A [@G)YK^F+]K/X/?M"_&KX?67AG]
MF[XKS_"'68+Y+B?5H-(MM9:>V5'4VYANF55!=E?>IW#9CH37YY?\, ?\%6O^
MCX=1_P#"$TG_ ./5Z&'JT%'>WDW?YK]V[?(\W$T<0Y_#?S2M?R?[Q7^:,WX2
M?\%>O^"4_P "OAIHGP>^$]SKNB^'/#MI'9:?90>$];V10QC@9-F69B<LS,2S
M,2S$DDUXCK?[:GP/_;E_X*G_ +*=U^SA_;>K6W@J;QO<:U<7>B7^G0VD=]HK
MQ0%GNH(@=\BE1@GYB >2,_MS^S9\.?C#\*?A'8>"?COX_E^)WB6VDG:X\03:
M=!I3SI(Y:-?L]N3&OEJ0F<DMC)ZU[Q7,ZU&$I.,6WJK\W=-7^%/J=2H5IQBI
MR25T[<MGHT[?$UT\PK"U>/XQK(DOPU&C?9V&)O[3\_?O'3;Y7&,'OSFM]$:1
MPB#))P!7HMG;BUMD@'\(Y^O>N&]CT;7,33SXO'A93JHLSK?D-N$1<6OG8.,$
MY?9G&>,XJ;6#XG_X1Z4Z MK_ &KY0\H7!?[.)?\ :*C?M^@R?:MZBHN58\S\
M#'XQ_;9Q\2QHWV?8/).F&??OSSN\WC&/3G-=W =6.IW N5A%F$C\@J6,I?YM
M^\$8 ^[MP2>N>U:-%#=P2L>/>*C\?_[=E_X0D>'_ .S/E\K[<;GSSP-V[RQM
MZYQCM7IVI-K(T_=HZPF[RG$S,(\;AOY4$YVYV\=<9XK3HH;!(Y?Q@?&O]BM_
MP@ LCJ.Y=O\ :!D\@+_%GR_FSCI69X%/Q-^S7 ^)@TOSMR^0=,,NW;CG?YO.
M<],5W=%%]+!;6YG6!U8RW/\ ::PA/._T?RBQ)BVK]_(&&W;N!D8QWS7EKG]H
M+_A*,Q+X>_L7[2.";G[5]GW>N-GF;?;;GVKV.BA.W0&KF=J!U8/;?V6L++YP
M^T>:6!$6#DI@'+9Q@' QGFN0U6(Q:A*/4[OSYKT"N:\06A95NT'W?E;Z=J$#
M/Q._X+U_"3QI\9?^"5GQ0\/^ XI+F^TR&RUE[>,$M+;:9=17%QP.3LA1Y,=]
ME?:7["W[0?PS_:@_9*\!_&/X474,^EZAH]K&\,+ FSN88U2:V<#[KPR H1[9
M'!!/UC+%%/$T,RAT<%65AD$'J"*_ 3XA?\$,+OP-\2]7^*7_  3D^-OB3]GQ
M_$,QN=2T338S?:)+*?XH[7SX!'U.%8R*G1 B\#T*4Z<Z7L:DN6SNGNM;73MK
MT/-K0JTZWMZ4>9-)-7L]&VFKZ=7=:'[I>/-.N]7\$:SI>GIYEQ<V%S#$O +.
M\; #)XY.*_)O_@@K\&/BM\!/^"9O@SX<_&KP]?>%]?M[[6)I=.U*%K>YB26]
MF9"\;@,NY<,N0,J0>A%?./\ PZU_X*X?]'T:Q_X3B?\ R91_PZU_X*X?]'T:
MQ_X3B?\ R96JA25-T_;1LVGM+I?^[YF,JE5U8U?82NDUO#K;^]Y']#U?SG?\
M$?+_ $/QG_P4:_;4^)_P:*O\.=2\2Z7;VUQ!S:76K0+<F\DA8?*V9&9V9>&$
MB')!%.U;_@CE_P %#/BE82>"OC[^VQXJU?PI? Q:C8:7I(T^:Z@;AXC,MXP5
M6'!#1R*1P5(K]H?V4OV4?@C^Q9\$]+^ 7P TH:5H.F;I"7;S+BZN),>9<7$F
M 9)9"!N;@  *H5%51#=*E2G&,^9RLM$[+6_5+70M*M6JPG.'+&-WJTVVTUT;
MTU[GT> 2<#J:9X-3XRQ:S)%XZ&B_V6L;"'[ 9_M 8$;=WF#:1MSG&.>E;.C6
MAN;L.1\L?S'Z]J[FO/;Z'II=3.4ZO_:S!EA^P>2NT@MYWG9.<C&W;MQ@YSG-
M>;>,3\=3K)_X5\-!&G;%Q_:!N#,7_B_U7R@>G4UZU14IV*:N8ERWB,>'RUFM
ML=5\D85V86_G8YY +;,^V<5%XH/BH:'/_P (6+0ZG\OD_;2X@ZC.[R_FZ9QC
MO70447"QYWX$/Q8W7(^)HTC;A/LYTLS9SSNWB7\,8]\UV=J=6-]="^6$6P9/
MLQ0L7*[1NW@C .[.,$\=>:T:*&[@E8\;UD_M!?\ "1RGP^OA[^R/-'EBX-S]
MI,?&=Q4; W7&!@>]>IZF=6$4?]CK"S^='YGG%@/*W#S,;0?FVYV@\9Z\5HT4
M-^0)>9Q_C4^/_P"RD_X5R-/-]Y@W?VD9/*$>#G'E?-NSC';&:9X'/Q#_ +,E
M'Q(&G?;/-/EG33+Y7EX&-WF\[LYZ<8Q79T47TL%M;F!LU>?3KI-66$-YDAB\
MDL08@<INW 8;'W@,C/0UQU>H5YYJ%HUG=-%_#U7Z4TQ-%*OY>/\ @JW\4/''
M[0'[9NI?LK^#]%^%=A%\(_!W_";S:K\3=.AOWU!G.XVMF9E81P;0HF8#[P.2
M-H!_J'KXT_:A_P"">W[&/[:&L:3XB_:;\ :?XKU'0U\NSNYFE@G2+=N\MI()
M(W>+<2?+<LF23CDY[,'6A2J<\U_7X'#CJ$ZU+D@^OI?YZV/@?X9?\%A]%TO]
MC7X.?'?Q5\&/'FLW'Q T>>9K+P#H)U.RT^33I3:NI+2Q>5'(R[[=,L?*QD\9
M+/\ A^E\//\ HW3X\_\ A&K_ /)=?M/X5\*^&? WAG3_  9X+T^WTK2-*MX[
M2RLK2-88+>"%0J1QHH"JJJ     !6_3=:A=OV?5]6)4,19+VO1?978^=_P!E
MS]HS3/VI_A';?%[2/"GB;P9!=7$]N--\6Z<=,U)3 VTNT.^0;&ZHP8@_4$5]
M$445S2:;;2LCK@FDE)W9GZI'XX>TW_#X6/\ :",#_P 3'S/)V'@_ZKYL^G:O
M0[4^)O\ A&T-ZMK_ &Q]G^8(7^S?:-O8D;]F[VSCWIVAVAM[4S.,-)S^':MN
MLV^AHD8.KGQ/_P (]*=!6U_M;ROW8N"_V<2_[14;]N?09/M7(^!O^%Q_;9A\
M2AHWV;9^Y.F&??OS_%YO&,>G.:],HI7TL.VMS.A.K'4[@7"PBR"1^05+&4O\
MV_>", ?=VX)/7/:O+_%1^/\ _;LO_"$#P_\ V9\OE?;C<^>>!NW>6-O7.,9X
MKV&BA.P-7,O4FUH:<6TA8#=Y3B9F$>-PW\J"?NYV\=<9K+\8'QH-$;_A 19'
M4=R[?[0,@@"Y^;/E_,3CITKJ**+@T<'X%/Q.^SW ^)@TOS=R^0=,,NW;CG?Y
MO.<XQBNKL#JQENO[36$)YO\ H_E%B3%M7[^0,-NW<#(QCOFM&BANX)6/&Y#^
MT%_PE&85\/?V+]I'!-S]J^S[O7&SS-OMMS[5Z7K/_"0_Z)_PCWV?_CX3[3]H
MW?\ 'OSO\O;_ ,M.FW/R^M;-%-N_0$CF/$D=PPAE7;Y2[@W][<<8QVQP<_A7
M+5Z/>6XNK9X#_$./KVKSIT:-RCC!!P130I(;7X;>(/V%_P!LG]B'XI^(_BS_
M ,$LM5T*^\(>+[U]4UOX9>*C)#IT=_+_ *RXTJYBYMFDP,Q/MB'J5"(G[DT5
MM2K2IWMJGNGLSGK4(U+7T:V:W7]?<?E?H5W_ ,%&?B]^QU\2M%M? &A? 'XL
M7?G_ /".2V^I6^LVMQ<3!7DN9#!&$BDD;>@=Q(P8B1E.,'^<?]D7QKXW_83\
M-Z]^T3^SO<ZO;?$#X;PG_AH+X4>,]0#7>JK&Y>77M.G?"L_[PLK(&RK*"7W#
MS_[B*^$?VI?^"9O[$'[:/CG1?B3^TCX#M?$.MZ$HC@N_.GM7EA5MZPW'V>2/
MSX@W(27<!D@8#,#VX?&PCS0J1]U]ORU>WST>J.#%8"I/EG3G[\=%?3YZ+1_*
MS6C1]4?![XH^&/CA\)?"_P :/!/G?V-XNTFRUFP^T)Y<OV:_A6>+>N3M;8XR
M,G!KT:J.EZ7INB:;;Z+HUO':6=I$D$$$*"..**,!51%7 55    P ,"M!$:1
MPB#))P!7G.U]-CU(WLK[EG1H_%RZ_%+:"S_L5HV$^_?]J\T?=V8^39SSGFNL
M_P"*A_X2'_EW_LG[/_M?:/M&[_OCR]G_  +=[5H6=N+6V2 ?PCGZ]ZLUFV:)
M6/)/&'_"]_[:;_A /[!_L[:NW^T/M'G[OXL^7\N,]*[:7_A,?^$3_<_8_P"W
M/LX^]O\ LGVC'/\ M[,].^*Z6BGS>0N7S.9\1_\ "9?\(X__  B/V+^U]J;/
MMF_[-NR-V=GSXQG'OC-<UX&_X7#]KG_X67_8WD;!Y/\ 9GG[]^>=WF\8QZ<Y
MKTNBE?2P[:W,:POM7N-4OK2^L?L]M;M&+:X\Q7^T!ERQVCE-K?+SUZBMFLG7
M[&YU/0KW3;*9[::X@DCCFC.'C9U(#*>Q!.0:X#X(:_K/B?X4Z+K/B$/]M>$Q
MS&0$.S1,T>YL\Y;;D^N:=M+BOK8]5HHHJ2@HHHH **** /_7_OXHHHH ****
M .7\3^+M#\)?V=_;CLG]IWL-A;[5+9GFSL!QT'!Y[5U%<!X]\"1^.CHGFW)M
MAHVJV^J#";O,-ONPG48SNZ\].E=_3=K(2O=A1112&%%%% !1110!S^KZ4;C_
M $FW'S]QZ_\ UZY @@X/!%>GUG7FEVM[\SC:_P#>'6J3$T<!16_-X?ND/[EE
M<?D:J_V+J73R_P!1_C3NB;,RJ4 DX')-;T/A^Z<_OF5!^9KH+/2[6R^9!N?^
M\>M#8<I0TC2C;_Z3<#Y^P]/_ *]=!114%A1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M  =H_P#!9^]:-;+X8_"N8S*'C":5K#;E:3R@1C5^09/D!'\7R]>*U_L[%?\
M/M_<8_VIA/\ G['[S_2.HK_-Q_XBT?\ @L^9+B(?#'X5[K1F2<?V5K&8F569
M@_\ Q-_E(5')!Q@*Q[&LK_B+N_X+"?\ 1/OA)_X+M6_^7%']FXK_ )]/[@_M
M3!_\_8_>?Z4=%?YKG_$7=_P6$_Z)]\)/_!=JW_RXH_XB[O\ @L)_T3[X2?\
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MQ7]>E<DX2A)QFK-'93J1G%3@[I]0HHHJ"PHHHH **** "BBB@ HHHH ****
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M[;+>Y\__ + G[5/BKQK\-M2_:3^*/[2GACXE>"](\.3:GXJT]-$ATG4/#5]
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MM3/)-?I7X[^$?PX^)NJ^'];\>:5%J=SX6OUU32VE9L6]XBE5E"@A6*@G;O#
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M_P H[OAY_P!Q;_TYW=?I17YK_P#!(3_E'=\//^XM_P"G.[J'\:]'^A]?@O\
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M(7_@MK_P3Y9N@MOC%VS_ ,RY!V'-??\ 9>,O \%N(KQYYY 6)?\ LNY7())
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MD]Z\G2Q_9PLO$FH^"6\5V0\0V1M_M.FSW<*RP27B>9"K*5+()%((^4\8-4M
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M6ZA(H+>! D<:*.%5% 50.@%;E8_7GM;3UU^S_P#(HV_L];WUWVT^U_\ )/\
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MS?*LKX"[FW=[X!E\?2^./%+>,=/MK6V^THNGS6^<RVB+^[:1C&-SDE]P$CA
M!@+N(JI:NZ9=&K"-*M#DT=K>]MK>[6G,[:=$KWML9/C3X=_ :U\<ZIXZN+O0
M(?%E^NFO-#*MLE[,]H@\M'9V#EG38J,1E%^Z#G%>1VO@K0/$>H0^(K/Q/H&G
MV,6F7UM/IES'9BWE:ZN1(MREPI9B( HC:,QA2SY+9'/T-=?$;QO8WGB**'5K
M=+;3-5M["UC_ .$?U.5H8VTZUN61Y4EV7),DS.L\"K"JGR#F:&4UT7P[\?\
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MVN+J]9(I'+;E=H5@EQY!:0KR-^=IX.Y&.#L_Z_K^KGYF?MO_ !_N/&'BRX^
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M:;:7-LT4()<6\VR-3,9/M# ,FP_7GC;_ (*,_&CP?^T%X:_97;X4Z6OCO5-
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M8?AK6M,\0Z+#K&CHZ6TV[8LD;0L-K%3E& (Y!ZCGK5=&3;5,W****DH****
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M;_HA_P /_P#PF=._^,4?\.]OV!O^B'_#_P#\)G3O_C%'U_\ Z=0_\!#^SO\
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MNIPY(J-V[=]PHHHJ"PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU]%T47 Q/#8\2#0;4>,#;'4_+'VDV880&3OL#DL%],G-;=%%( HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ K&\/:K<ZWH\.IWEE-ITDN[-O<;?,3:Q'.TD<@9&#T-;->?
M_"SQVOQ+\!V'C9;;[&+WS?W)??M\N1H_O8&<[<]*=M+BOK8] HHHI#"BBB@
MHHHH __3_OXHHHH **** ,[4-/-^UNPN)H/L\PEQ$VT28!&Q^#E3G)'J!6C7
MF'Q)D\00WOA>?0(9Y@NM0BZ$()"V[Q3(S/C^!2P))XSCOBO3Z;6B$GJPHHHI
M#"BBB@ HHHH **CEECAC,LIPHZFN3O==FD)2T^1?7N?\*:0FSK7DCC&9&"CW
M.*A^VV><><G_ 'T*\Z=WD;=(2Q]3S3:?*+F/3E=7&4((]J=7F<4TL+;XF*GV
M.*Z*QUY@1'>\C^\/ZT<HU(ZJBD5E90RG(/2EJ1A1110 4444 %%%% !1110
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MWE8D,H^9B6^9BQ/S$]^.E/H*VIT%%%%(84444 %%%% '_]3^_BBBB@ HHHH
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MZ<]_[KIG=C][G'E\U^9'_!.3_AM/_A"O$'_#.W_"L_[?^U1?\)9_PDW]O?\
M"0?;?WGE_;]_&[_6;?+_ '>=V/FW5E*I:7+8_1,HX!6-R*KG3QU*/+)1Y&]8
MW=KU7_R[3^QI+F=EH?TC45^:_P#QN"_ZHY_Y6Z/^-P7_ %1S_P K=5S^3/*_
MU1_ZC\-_X-_^U/THHK\U_P#C<%_U1S_RMUM^&O\ AZ__ ,)'I_\ PF'_  J7
M^R/M,7V[['_;'VG[-N'F^5O^3S-F=F[Y=V,\4<_DR9\)\L7+Z_AW;M5U_P#2
M3]#:***L^2,W5V*Z=*1Z ?F17 UZ#JD9DT^51Z9_+FO/JN),@K\._@-_P0F_
M9L^ O[98_:9TC6+_ %/PIHMQ/JGA/P/> RZ9H&KWI7[1=0%I&#?<3RD,:F,J
MK%G*1E?W$K^*+]N+_@H=^V?\-/VU/BA\%_AC\6]?MO@?#XRT>U\3^-8=!-Q+
MX)FN&*SZ?;3* IB!4 DKEBNU<DN9O1P%.M4<X4I6NM?/\]=?T/*S*K0IJ%2M
M#FL]/)[]UIIZ=7L?U6?MC>$/VP_&GPNMM*_8F\7:)X,\5KJ$4EQ>Z]9&^MWL
M@D@>-% ?:Y<QD,4;A2.,YKY'_9>^$'_!8KPK\:M*US]JWXN^"O%'@6%;@:AI
MNE:,UO>3%HF$7ER^5%LVRE&))(*@C:<\:W_!6KXB_#SX<_LQ:1K?Q$^/6M?
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MM445-QA1110 4444 %%%% !1110 4444 %%%% !1110!_]#^_BBBB@ HHHH
M**** "BBB@ HHHH **** .(^)GQ'\&?!WX;^(/BY\1KS^SO#WA73;O6-4N_+
M>;R+*QB::>3RXE>1]D:,VU%9CC !/%?%'[+7_!5S_@G[^VAX^/PL_9P^(MOK
MOB+[*U['I]Q8WVFSS6Z<L\*WUO;^: .3Y>XA<D\ FO3O^"A?AGQ)XU_8$^./
M@WP;I]SJVL:M\/\ Q-96-C91-/<W-S/IUPD4442 O))(Y"HB@LS$  DU_+-^
MQU^R!_P4#^'/QO\ @_K/QCM/%6LW]O\  W4M/^&&IKH?V"R\$^(KJP>+^SM9
M$=ONC:,$K'/=NI9F4$$Y">CA<+2J49RG*TEMKY7[?JCS,7BZU*M"$(WB]]/.
MV]]/N>O;<_M9HK_/T_9>_9O_ &FOA'^SU^T%XV^*5AXY\%ZU;_!_Q9;>+;;6
M?#NHV>GZMJ1#-%<2:M=:A<0W=X"2\4L%O&##NY&?G[3]A_\ 9]_:Z\;:1J_Q
M%_X)[>#_ !Y\/TU7]GV*R\0:QXBDN;:W\3>,;J-9$N-*EN9G5S)&5-K/$R)$
MO:+<"_1+*HI2?M59=;:?G^5SFAG$VXIT7=]+Z_E]][']Z]>2?$SX[_"/X.:W
MX5\-_$S7(-(OO&^JIHFAPRARU[?R*76%-JM@E5)RV%]Z_AP^%G[+/[4X^"/Q
MCM/V;?A)\3? _A:Z^"EGI'BG1O$=K?-=>(/B&ES"UQ=:=;2/)+,60.1)"B@+
MN&Q-X%?5'[8?_!*GX;?"KX"_LK_&2#X1^,O'(36]/U3XLV]D^J:KXANCJ-C;
MF[DF@$WG1L)(=C>4(O+8!?E+<S_9U)3495-^R7:^NH_[4K2@Y0I;:ZMVWMI[
MNI_:%17.^$/[-/A/2SHUM-96?V2#R+>X1HYHH]@VI(C_ #JZC 8-\P(P>:Z*
MO(9[:"BBB@ HHHH **** "BBB@ HHHH *\W^,'Q=^'7P#^%VO?&CXN:FFC>&
M?#-E+J&I7KH\@AMX1N9MD:O(Y[*B*SL<!020*](K\1_^"Z?@G]HKX_\ [.7@
M_P#8Y_9Q\-W>M7?Q4\6Z;8:U>FVN9-*T[2+)Q<RR:A<6T;FWA:9(02<%TWA<
MD8K;#TU4J1A)V3W].IABJKITI3BKM+1>?3\3]2OV=/VC?@O^UG\'M(^/G[/F
MN)XB\):[YWV*^2&:W\PV\KP2 Q3I'*A62-E(=%/&>A!/MU?Q"^*?V=_^"GWP
MQ_9 _:)_8HMO ^K^3IOQ(TSQE(O@:VOHM.UCPSKJM/J>F:%<RQH\JV\H@W0*
M6DPTB,&PP/9?'SX&_#_6M$^ =Y\/?V=/B]%^R5HVI>(5\4?#R&RU*/7WU:>)
M3:WUQ:?:VNY;4R%/*?SPJ".0#&X(_HO+8.7NU-+NVSTM==5J]E^9YD<TJ<OO
M4]4E?=:WL^CT6[=[I=&?VD45_##_ ,%'/V7?VGOB5^U3H'B'0?!WQ%T7X93>
M!O#L'PU.D^'=2UW4O"EQ;Q0F6WDBM=2M18ZBDJN99KEIMR\9.-P^@_B#\#_C
MMX;_ ."SEM\6])\!>/\ XE27MU96FK:WJ6BZAIT6C6UIIPBFU#0]3@NQ92Q,
MY=DM+J'F90@4MM>I_LV/*G[3=-[=K:;V_P""5_:D^9KV6BDE>_>^MK7]--4[
MZ']C=>2?#3X[_"/XQZYXJ\-?#/7(-7OO!&J/HNN10AP;*_C4.T+EE +!6!.T
MD>^:_FL_X-\_@Q\6/@E\=?B7X=U[X;^)K#PY/I4,Z^-_&&E:CH&M7]])<M(U
ME=VEU=W%K<2QJ[$W-J.B ,[!U ^&8OV&/CK\%K#]MWX-?LP_"_QEX=^*6LW]
M[<>"_$-K%?#3K[P3-J-E-/I]I?M*8)+N6!"54[IW57C#[MRT++Z?M)TW4VM9
MZ=7K?7H#S*I[.%54]^:ZUOHG9+36]O0_N4HK^:7_ ((:?!WXC?#_ /:!^+GB
M?X9_#[QM\)_@)J.F:)#HOASQVMQ#>OK\,*B_N88;J22149Q)YD@.V0LN/N;$
M_I:KAQ-%4JC@G?;^NOYGH86NZU-3<;;_ (/?9:/T04445@= 4444 %%%% !1
M110!YU\7?BOX#^!/PPU[XR_%&\?3O#?ABQFU+4[M()KHP6MNI>23RH$DE8(H
M+'8C$ $XQ7R[X]_X*.?LF> _!G@#QB-<O-<;XKZ3>:SX*T[1],O+W4-=@LK1
M;V1;>".'<DGDNF$N/)^=@IPV0/L#QMX.\/?$/P9J_@#Q;;B[TK7;*XT^]@;I
M+;W2-'(A]F1B*_BQ_8__ &+/VU+Z'XF>!OCMX'\0P6?[,_PF\<^!/ =W/IUS
M&=?U/6Y]0$5UII9 +@&SQ;H+??E3$<_. >_"8>E4C*4Y6M^NWXVOY,\[&XFM
M2G&-.-[^NEK7_"]O-']DOP4^*5G\;OA+X>^+FGZ-JWAZ#Q%8Q7R:;KMJ;+4K
M591D1W$!+>7(.XW$>A(YKU"OX+_V@?V:_P!H^/X9_LL:_!\*/B#XZ\9>$/ &
MCZ8_@[4]!U5=!-W)>2M*QO[.ZM9],U*%"#*UPGEF(1[FPI6O1/CQ\*_VT-(^
M(?Q7_9XL_A!X_P!1N-?_ &BM-^(]KKFF:9/=Z*OA^:5EPMU'G>R&1=R(A555
MV8J$-=+RR#?NU%U_.W?4Y5FTTO>I/I^*OVT/[C*_-KX6?\%0?@I\;+'P]JOP
ML\*>,M<LM?\ &]]X#>YL])\Z'3K_ $\ RW%ZR2L(+3Y@!*<GJ2H )'\U/C[X
M<?ME:W_P6;T;XV^!?@YXQ\&G2_C-9:=JFKZ;INLWEIJ7A6>Y1);VZU.6[DM!
M:RQ*S?9[>TC@@C)+R X#:G[.O[/W[4_AKQK\(OA[?_#?QC83>#?VG-:UK6;@
MZ1=BR72+T0F*\\]4,;6IV-^^)\OISR*<<NIJ-Y3N[7]-'YOR)EF=5SM&%DFU
MZZKR5NI_;/7!_%'XG^ O@K\.]9^+/Q2U.+1O#OAZUDOM1OI@QC@MXAEG8*&8
M@#L 2>PK^*?X#_"[4[/]J']H?]H30?V7_BKHM_J?A_Q!IOP]\-SZ5K5CIDL<
MEI,;F\O-2FD$J7MZ-RP0P$;6?RXCYAC<?/\ \!/V(?VL_BE\ /VE?AH_PH\7
MZ'X>\2> =,\2>'O#]SI&KZ1IX\36,R-)%8QW]W=RSSJIG4>9,9+GAS$ R4EE
M<$_>J:*W1==^KV&\WJ->[2NWS=7TV^RM_OV[G]O"?M4^#[[XP>!?A1X;T#Q#
MK-K\0-$GU[3_ !)8Z<\F@P6T2+(BW5V2/)DF5@8D*'.0#@D _3E?QQ_ 3X"_
M&63XJ?LXZA^Q_P##/QI\.H-&^$WC/2[B;Q!I=_:0:=XMN+*9%DN9+O>L:S7K
M!X=[A64C8H'RCY)_9)_9:_:]TF_U-?AK\+/B;X.UFW^$OCG3OB[=^)([QH/%
M7B&[L[Q-.%@)99!=SF=H&1H%R5Z Y+.I9=3:=JEK+KZO?73;I?5_,<<TJ)J]
M.]WTOVCMIKN][:+Y']Z5%?R,_P#!+/\ 9 ^.'[,O[9'[.GCG3_"'C+1;/Q?\
M(;F/XB7.JQZC);+K$#N;:"[-UNCM9HU2)(H/W>U% 5!DY\3_ ."MW[-_[5WC
MC]N'XNZ[=?#CXB^.?$.N6/AE/@9XA\)M<_V3X;N+<Q?VC]IEAF2*T=G$C%Y@
M>[_(&5US67P=7V?M-+7O\[=_GOMJ:RS*:H>U=)WO:U_*_;Y;;Z7ZG]-6H_\
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MX))^,/CE^P%HL'_!.CXW_L]>.=8\5+XWO+AO&VDZ3'/X=O+6^E)&JSZE)(B
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MNW_!"BBBN$] **** "BBB@ HHHH **** "BBB@#_T?[^**** "BBB@ HHHH
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MNK=)%MV\J1!&QR"BC*CTK_@J?\2/VR?V.OVE/#O[+FE_'/Q?X4\#:+X,>_\
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MS$#D#/I4M?Q2>#/V^?\ @L1XQNO!VC)\;M#MW^(GP:O?B;#-_P (G9LVF/I
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M.3<I/5CC%12C%62(O)A\[[1L7S-NW=CYMO7&?2I:**DHBC@@BD>6)%5I""Y
MP6(XY]>*EHHH **** "BBB@ HHHH **** "BBB@#_]/^_BBBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'7[(WARSLM.\/?"SPA86^G:M;Z_:16^AV420:M:J$@O8U6$!+F) %CF7$B*
M P%?1U%'M9VMS,7LH7ORK[CP/6/V4_V8/$/A7Q)X&UOX<^&+K1?&.H/J^O6,
MFDVK6^IZA(P=KJZC\O;/<%@&,T@:3< =V16!H/[%/['7A;QMH_Q+\-?"GPAI
M_B+P];PVNF:G;:+9Q7EG#;((H4AF6(/&L<8"(%(VK\HP.*^FZ*/:SVYF'LH7
MORK[@HHHJ#0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
>*** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>soph-20251231_g6.jpg
<TEXT>
begin 644 soph-20251231_g6.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" =9##X# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M::WQ1UJ8%& 4?W@_2BYT+*,2SU)9HM^UF%.:XC!P)!7BL_BWQ#/.73490/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH$TPI"P!Q2
MD@=33-Y/4"@$F.+ <$TFYB>*8TB+]YQ^=1F_LHVVR72*<="X%%B^61/E_?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** YT
MAA5F>G D<;<4M% [W LY.,\>N*;L 4D\GVIU%!/+J-'SKC:1]:  !G!X[4ZB
MB['RL0G>O"%3]:6%Y8593(Q!' #=***:;%*%.2M-%W2_$FN:4A2TO2JYZ'FM
MK2_B?JEMM6[1I#W(KF*%;:P)''>GS,XJV"P]79'H^G?%BQE8+<1%?4ENE=%I
M7B72-9426-ZCX^\%->*'=$QD494]:FTZ^O[(LUC<-&K=<'%"EJ>95R.,U>+L
M>Z?:$/W6%+O;UKQ[3O'>MZ=]Z<R#/\35T%A\62$4728/L*O0\RKE5>FM-3T$
M%NU.!.!GK7.Z'X_T?6I?*CFV87+%^/YUM6^HV=VG[JX1O<,#2//G2J0=FB=F
M(. :3>WK1E"00V>*1F.. M!DW87<YZ?RI1N)PW2D#$=*?0)23$P@/_UZ6F-P
MW I]!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*** "BBB@ HHHH **** "BBB@ HHHH'H%%%% @HHHH'=IZ!1110*[>X4444
MK!2,-PV^M+10/00%E'E@9!I71, JV<=0**/>@3M81<[3MXYH92Q7><TM% K!
MOD#[2Q  ['%6].\0:OI#$V-PP$G4'G%5*,GUH,Y8;#U/B1U-G\4-4M]HFD+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M68U'PUKMIJ%OG'GV5RLJ9],J2*NR.L0)<] 2:AQ<9\KW+]I%PYT] ;CYLTK
M-%D_>/WA7Q'XO_X+U_L0^"_%FI>$=8E\0?:]+O9+6YV:8Q7>C%6P?3(KZ _9
M0_;*^$G[8OAJ?Q=\*7O?LT2JS?;;<QG!Z8S6\\+7IPYI1T.&&8X6M4]G"5V>
MM-,R F-,)MP?K20NCQJH;*D?-CO7YO\ _!;_ /;8^,_[-"CPY\.)1##?VR1O
M.&963>HR01WYKQ/_ ((S_P#!2[]H?XB?&'P[^SWXSM+K5=-G;R7U:2.25E &
M<R/C /U-;4\!.I1]H<=7.*=+%^P:/V."[V*$97%(NUR8W^0)T![TU5(0$OR?
M0UY)^W+^T?+^RG^S;KGQM@M%F;2(U*HZ;@V2>H%<L:52<^5,]:52G2H>UELC
MUWS78;_,!P<$>U+N!) CPQ^X<]:_'P_\'(VOQC:GA2USG_GS;_"OLG_@F[_P
M4Z\,_MR6]Y9O9/!J5E(D;HEN50,5SQD>]=E;+:U"FIM'EX;B#!8JO[&+U/KI
MFW1\KAAU%*&#("!0FX-D8+9YSZ4I )+C@$]*\\]V*N)10>.M .1FE= [6N@H
MH R,@C\Z#P0.N1VHU>PHM-Z 7:20HHVX')I,-CY>WZT.Q\O;C##[V/2LSQQ?
MW&C^"]4U:T/[VVTR>6(9[K&Q'ZBK@N>7*C*M+D3;Z&HTD@^1EY[&FQKB3S&/
MS#M7X#:O_P %LOVK[;XCWWA^,VGDP:O/"A,C9VK(P';VK]N?V5?&^K_$C]GG
MPCX]\0!3>ZIHT<\^SD;CG-=M?!.C!.:L>9@<YIXNNZ4.AZ%R3O/?M12*<C)I
M0-REO3M7!R6>AZLJ7-*Z844 Y_\ KTA;!Q@_6JU:N:7=M6+10<*"2>@YKF]6
M^+OPKT*]_LW7/B9H-E<9QY%WJ\,;Y^C,#3C"<_A1C4K4Z7Q.QTE )4[O(+ C
MJ*J:/K&F:[:+J&BZG!>6[_<GMY@Z-]&7@U:RS-L)P.Y-3*+B[,M5(VNF*JF+
M;Y9P['YAZ4@E ^;S !G!?WKA?VA/VB?AA^S3\.-3^)?Q)UZ*WLM-MS-)")5\
M^4#J(T)RQ]A7P)\7?^#B_P"!NF^)K"V^%6FWMQIKR1_;GOM.8,!N&XCCTS75
M3P=>I'F43S<1FV#H3Y9S29^FH2/SBCC=Z2"E#;OOG+#@#VKYZ_8Z_P""DWP'
M_;8NM0TKX1Q:IYVG1HUR;VR:,#=@<$]>:^A7 >$$@!A_=K"I3E!V:.W#XF%:
M'-!W0449YQ1U. *CE=KG19A111@XS26NPGHKA12@$]*-C4)WV"]Q**4J0.:3
MFA*[L-)MV"BBBC804444+4KE84444$A1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110'*F%%% SW% ^5) >1B@#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+8?M>?$N^CU/PQX[N](A1B7BR&WCTZUX7^V>X'[67Q!0J./%5T3]-YK]!O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MYD#'M[U^./QP^!GQ'_9R^)E]\._'6E3VE[I5X8Q<B-ECD92/F1C]X9[BO?\
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MM<_<.**-(MEO&%"\# X'M7YK?\%^OV.]?^(_PM3XT^%O#3W7]A"6ZU:6)/\
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MGZNYBDYK^<O]BWP'IWQ._:H\#^!]:@D>RU#7XHKORUR0ASFOZ9KKP3HWPX^
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MIT<%&&'4Y,SKYA5QN82A1T1\&_MU?M*>&OVHOC7??$7P[X873([C;\JR!@<
M\<?6OT4_X-K3CPKX@X_YBA_] -?(G_!8']GCX*_L\_&%?"WPBU6*>-9 )%CF
M5BHVGKM/'-?7?_!M63_PBOB#(_YBA_\ 19KJQDW/ V2T/.RE<N<-7UN?=?\
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MG)V/G/\ ;/N?B!^Q=_P2JU.T\)>*)+?7_#^DHD&H*OS%MQYP:_/_ /X)_?\
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MX[)9FZQ@>HK\COA#^R=^V]_P4YT>77K'4Y)K?0AY<<VNW+J'##=\A;J.>U>
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8?A/X7^-_P .-4^%GC.-GTK5[8PW:Q_>*D__ %J_*/\ ;*_X-[/&FO>-A?\
M[-FHV46G-%\Z:G=8(;/IFM\OQU/V'LIG#GF18RCC_K%#4Z_]I?\ X.$/ 5[\
M([G1/A=H4<VK7MJ5CDANOFMV]>M?D@3K7Q@^*ZO%:O<7OB+6Q^[!R6DEDZ?F
M:^V(O^#=']MV)AC6_#>6Z;KSC^=?6O[!_P#P04T3X->++/XA_&S41<ZE92+)
M%%9W6^,2*<@XSZBNI8G"8&,FNIY4\!FV:8N'MUHCZ?\ ^";G[.<O[)W[+.D:
M'XQT[^SKY; #4(9!@QD>M?AY_P %3_B'X1^(_P"U7JVI^#];COH+>1X99H^B
MNKD%?PK^COX@VTDG@R\L((&<M"1M49)X[5_,S\??V;?C\_QG\6ZK'\'?$ALF
MUV[D6<Z1+M*^:QW9V],=ZX\KK495I3D]ST^(L)5A0ITJ<=K'[(_\$"MQ_91L
M,-DM8QX]Z^]6RS",IM Y^IKX7_X(2>'M<\._LHV":UH]S:,UC'Y8GB*Y^F:^
MZ%9P=S8P5Z&O,QTU.N^5Z'UN0J='+4FNA^.W_!RA\4_ WB?Q%X6\%:1KT4NI
M:9%/%?6R_>A;<>#7B/\ P;W_  G^'WQ9_;"O[;QYHL6H+I>B?:['S?\ EE,K
M'##W&*@_X+UKC]K742YR/MTN.:]A_P"#;'X&>,;7XK:O\?':V_L:ZTR73TC#
M?O1(K')QZ5]!#DH95ON?!)5*W$#<HZ'ZI_M9?$OP5\'O@-KOC?XA:Y%IVE6=
MJ1/>3?=7(('ZU_,7J=QIGB?XZWMW XGL;_Q-/+#+VDC>9F'Y@BOZ"?\ @M[&
ML/\ P3C\?H&SF&/=GMR:_GV^!/A35/'/Q=\.>$M&:/[3?ZO%##YAP S-@9KG
MRBU.C.9KQ)-UL7"DHZ'](O\ P3M\#^$/!'[(OA";0-+CM/M&CJ]QM'WB"W)K
M\D_^#@3XF>!_''[4DMOX5UB&XEM].MTF2/JI5<']:_9W]G?X<Z[\*?V==#^&
M_B5XS?Z7I!AG:$Y4L-QX/XU_/=_P5<7/[7>LB-R=J#)8]?F:C+7[7&2D=>?0
M6%R:G"*WL?='_!L2V?#?C\D[@VKP9'_;):_7$ JNTKCO7YA?\&XWP-\7> ?A
M=XA\=:K-;FUU^[AN;-4;D)Y87D=CQ7Z?,$7Y023WKR<WE?%.Q])PO%K+8MB4
M445Y9](%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 784444!=ATH(
M!ZBBB@   X%&.]%%  !@ #M0P9D(QFBCG'!_6B[*:4HV9:T?6=1T1]]FY4>E
M=-H_Q6O8I@+U3(N/FRW3WKCL28QD?G2A1R">W44TW<\ZM@:-96:/8M \8:3K
ML0^Q72N_=0>E:RODX#=J\,TK5+K3)O,@+*0>-M=GX=^*I1EM]43CH"%JSY_%
M955I:P5ST'<2.6Q2AUQ][-4M/UO3]13=!.A_X%5LLK=!^5!Y$H3@[20XL.,-
M2A@>AIN#V%&".<4$6'D$]#BFX?UI0X/6@,I[T#U%HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;=8U ^@%7U(Q@\'/3M7%5JNM4<I'?E^%^J4% 6BBBLCN"BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>DHI*-F3UN&&VX+=1R:.2<D?C115MW&W<****0@HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****!/8
M***#R.: 04QFW#&*4$@XSP*9(S9W$@+V]:!DJ]!]*:^U?F8U%<7=M:0>;<2!
M$[LQQBN8U3XAV-U->:7HK>;):PAVE7E6SV%3RE4U[25D=#?ZS9Z?$7N)0H ]
M:XSQ!\541VMM-C#'^^#7'ZSKVJ:K<^;=W#<9^56(_,52&)26/447:/I,%E,9
M+FEJ7-6\0:KJKD7,K2*3G:3TJJJXR>AQTIHW$[NPXI:3=SWZ.'I4HVL&8VB(
M*8(/6BBBD6[;(****!\O4****!!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 KB$$]&Q0[8'$>:6B@=KC-IQN$0)]*5EW,%,GRG^'WIQY&,XK8\%:.=4
MU3>R@QQC<2>G%5%'+BZD:-%W.E^']F^@:.]YYYS< -&N.E=78:]'<85FY[\U
MA7,[R!DB"A8^(@!VI@9XP"IY[XK6R/A<1452JV=D&60<&E4 #@YKF;+79K?
M;)^M;6FZE#=PB1W ;.,9I-6,?=OH7:*0'C/7Z4H)/:I&%%%( 1U- "T444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH!:A1110-JP4444[,+!11119@U8****0@HHHH
M$G=V"BBB@IIH****!!1110%KA1110*]F%%%%!25PHHHH$%%%% !1110-JP44
M44[7!*ZN%%%%)Z E<****!= HHHH **** "BBB@=@HHHH%=!1110"U"BBB@'
MH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110.VH$9(/I1
M2C!^7N>E(PQP&YI7U%JF C,I$8[UW_A_2X-"TI(D.)).6..<&N7\%:;_ &AJ
M2O-"VR-OG/:NVNI!(ZC:,( !BM8+0^8SK%Z^SB0LB[]RR8 Z"CYCSNI3@G)[
M]:.E:JQ\S"]O> #%.1Y8OWD38(/:F@X.:"<G-2]1Q23-73/$;1$17)S]:V(;
M^&< JPY[5R6!UQ4MO=SVS[XG_.IY67S(Z_/&11G%9.G^( X"7##/M6G%-',N
MY&!HLT%T/HHSZTGS;NO%(8M%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4BMDXQ2U&""VT'GTH DHX/!I 0
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MQ]:XY*SL??T:D:M-,**#QQWQ12*?NL****"K75PHHHH$%%%% !1110 4444
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M102 .HSZ4C': <9SZ=J'%LGE<GHA:*"",X&<4*"_0?A2Y&)P:E8** <YXZ4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !102!U-)N'K0 M%(&!. :&) R* %J,*!ERH5CQFE>XAB7?+(%'<
MFN&\;_&?1O#=TVG62M<2 9$L9!4&JBKLER2.OU+5K'2[<R7UT%P,G)YKS'XB
M_'%99?[,\+2Y1#\\ZG!]Q7#^+/'&L^*;YKJZN6"@_*JD@5C%&))WBMHT^YC*
M9:UC7-3U^YWZC<M*W_+-G/0543Y4\LGD'I371FC*%L>XIR'*5M&*B8N3>@M&
M >HHHJKW%RL, =!1110(**** DK- N\-N3TJ:PU.;3+M;R"=E=#D8JNZ@\G.
M:=&H6/>,;FXY[42B7'22D>E7TEGXC\.P^(+"Y+O$@2X3'\9K#RPPMQSNX4U!
M\./$J:9<MHUXP^SW&=^?[W0?SK2UO3!I-VUK(X=.L;@\<UPU8M2/L<FQOM(J
M+>I7!RVX]N!]*2E4^9%L7[W8^U)6-T?25$K7"BBB@F#;B%%%%!04444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU@_\-N?'QH0A\11_+_L'_&H^L*Y[-#P=SN4/>:/UYO?%OARP'VB[U.' '5Y
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVAE."PZM3@E\@HHHJ3KCAJ4?LK[@HHHH-N2"V#)/4T444!9!1110.R"BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** M<***0L!UH*414+*2&0<_=.:FTNUFU&^2T
M\H$EA^55G99$*,#CUS79^"M!6PLAJ]U$?,/RJ#Z543@QV(CAJ37<W(XTTZRB
MTQ%QY(P<5&3DYI7.^0RG.6ZY-)6JV/@JDKU7)]0HHHIDA1110 4444 %%%%
M!1110 4444 %%%% !QT-/@N9;9MR']:9QCWI S#[PZT ;>EZ\LL@BN&XQ6NK
MB4!XY.#7&A1]Y6P1[U=L-9GMF"2O\M)HI,Z=L8P32U!:7D-Y&"K G'K4]04%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#GL*6B@!
M"?O''THX!P1@=R*6E!P.E $]CJ,UA*"K$IGDUT5GJUI> +$Y)/K7+*05*D?G
M3K6YFM7W(W2DTF-.QV.1C.:.E9.EZX)\12-S6HORKN'/TJ6K#YAU% Z44B@H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;BUJ@HHHH)5D%%%% K:A11104^7H%%%% @HHHH **** "BBB@ HHHH ****
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MN"0,T@+$9*D?6@22OJ+11103:7-8****=D.7*M@HHHI""BBB@ HHHH ****
M"BBB@ HHHH';0* ,T4C D<'% M6*&S@$=*W/ NCQZAJ1FE4@("<E>.*Q[*TG
MNKA+6,@LYP#BO1+*R@TBPCLH<?,H9R.NZM(^\>-FV+5.ERK<=<$/,S!CM_A'
MI3<@#@=:**T6A\:FY.[ 9QR****!!1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@4444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7PU?#3Y:D6F.HH?]V0'X)]:&#*1D<'O08V8449&<#D>M% EJ%%%% [,****
M3W"D;G 'K2T-@)D^M*Z""W8V=0Q+H>>U=CX T6.UM&UB[4[CE5!'J*YC2+%[
M_4(;=$)RWS"O0E"06R6D:;0JC(]ZM1=SYW-L5R)Q3&GJ60G<.M \P_O!C'0\
MT')(.?K0?1>!U(]ZV2L?*S][7J%%%% MXZA1110""BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXDF2 &29P% R2S8 KB/B=^T+\.OA;I,VK^)==MU"KD)%*K,?H,Y-?$?[0?\
MP54USQ-!<^'/AM82V&V9E%^) RRIG' SW_K7RCX_^*_CCXDW"77BO6I;DQY\
MF/<1UK.I6C'0_7.&_"7,<R<:N+]R)]8_M'?\%2]8UC6)=%^$-NK::(]K7-RC
M)('Z''M7R9XT^*GC?Q[J=QJ?B7Q#=3"Z;<T3REE%<Z P!)^1CU0GG%"Y:(AA
MMQ7'.K*;/W[(.",GR2DHQIIM=12' R@'7FB@[2-\8Q[T5DTS[2$:5-6@@HHH
MH+:<_B"BBB@:2CHGH%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\N[1U[A1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW[;?C2R^&$VN7FI?:+T.VT9$.\XWD9Y%:8BG&]V]#+#UY6LEJ?JO_P $PO\
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M !?ES6!H>LE&^SS-P?>MU7C)&T]:EH:W'T445)84444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>3!]#WKZ'"91"BU*IJSY_%9M*L^5;$]_J%]JMV]]J=W)/-(Y>265LLQ/4DU
MR@OO4;2/2EHKUU&%-6BCQY5I1J6B?HK_ ,$K/VRM"\8?#:__ &.OCA--=6$O
MFWFE790R3K<8(CC!/1<XXJ?XC^$)?A]XUOO"UZDBFSEV^6XY_*O@?X1?$O5_
MA#\2-)^(FD,WF:=?1321(<>8B,&*_CBOU@^/<^@?M/? #PI^V-X$\)?9KO7K
M-KKQ.B,&-H<D#>:^,XBP37[R"/ZV^CWQ_+ Y@LNQ$O=EM?N?/9SU/?I10 P^
M\<T5\8FV?WW"<:D%);,****904444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4HY(7ISUI*5
M0""&/'>@+V&ET4X8'KU XIQ&":1=[<=0.B4I9F.&^4#[H/>@24$O>EJ)1110
M*"G:R8#@YH(!)8CK1123M*XYQ]RR=V(J[>A/6G;OF5L#*^E)2!@3BAW;N%.G
MR0NQ1Q^=(1G/;-+124G$<?>=FKL0J#VY]:5?E! /7O110WS*Y,91C6LUH!SN
M+9ZC%-5-L@&X#/3WIU(ZQL/G&2.E5JMB&J5[M!*K+A6ZYR-O>A5&<<EZ<K,2
M (B@7G>:#(NTLGWCT;UH<G+8T?)&+3V$=-J\=/\ 9I'("A0.3UP.M!<P/MW8
MR/FIP<KCRSA<<CUI>]LC)QIN.HU59I,@#&.]+C?E03N!Q[4;VV!)!L^;.: &
M+%T.]<]15-M*R-N6$J2[H,8&,8]J "!MW&BBDF^A*E)Q26P+A<\=12;<'*DC
MZ4M%.<^=#]G2<N8.,8(S]::$ !&>#VIU%"DX["2IQU:!0%0)C(!I-HYQQ]*6
MBB,N5W"48-WE$!P,*,?2D*@L&/;M2T47TL3"-&*YF&/FR./84@ 7I2T4KLT:
MN^8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF.$K/!U73/Z&CA3M4\C[P'0UR?Q!^"7PU^*%I+#XT\)V5[),GEO//;*[A.F
M36WX6\1Z5XKT.WUW1KM9;:X3=%*O20>M:-?/RG.E/0^ABJ5:%VCQ;P)^P/\
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M3ZUT<$\=R@DC:DT',R2B@'(S14EH**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **#TYII957).0>E #J:S'/!X[T@(
M49)Z]!7-_$CQY9^"]+,A8&Y=?W,.>6'K32NR9.Q'\0?B-IOA*P>.20/.ZD1*
MO.#[UX3K^NW^O7YU'4)69R> IXHUO7KS7[Q[_4'+[V/S$]!Z54 ( Q]W^$^U
M=,(&$YB-MX<#&>V*4@KC!SGK[445NK)'.[MA1112&%%%% !1110 4444 %%%
M% !1110 444AD\OH-Q/\-%V@LGN+[T8)X4C\:0!C&61-V?X?2N5\=_&OX:_#
MB<V_B_Q+!92I 96BD;^$#DU4:;GMN3*HH;G5$*R@*3A/OY[U\_?\%*_B3!\,
M_P!F+6-;DL[^;[3!);(NGQ,S*S(0&..@&>36M\/_ /@H#^R]\2=<U/0O"_Q.
ML9YM,Q]KC1N8\],U<_:OT^3XI_LY:];>"B+\RZ7.T?E<_P#+,UTT:$X37,<U
M:O3G!\I^"W[!?A3P-\2_VL/#VD_%;6&ATVXU'%U/+,%^7W)-?OVO[.GP(\7?
M#>/PM9>#])FL)=-$"W45K&7*E,;MP'7%?S7>)-+\2_#'QE/IMY%)::I93GSE
M/#(<U^R/_!-C_@K/\#=<^$&F^ OBKXAMM#URW=+:*TGERTJ* H?\:]G&0K22
MG \7"SHJHZ<]SXD_X*F?\$T?%/[*WC2[\?>%;/SO"=[(\EJT?SM#&/[^.%KG
MO^"0_P"T7X]^!_[3%E!X7NQ-9ZKMLY[2X8M&H=L%@O0-SUK]#/\ @LQ^U?\
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M/+!_6@KG<I6L&1W-% ,62'3KW]Z%567RMV2*;B[$Q=)Z)Z@01U%%*6:3Y\Y
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$=U,-K<?+Y8'X5^:7Q$_9M^.7P:\8/X>UCPEJ\5[;G*36MM( <'@@@5^U/\
MP1E_:HTWX^_LX6OA2Y\3_P!H:UH5FBZK&Q^: DC&?SKZ>\;? KX7_$+4EUCQ
MCX3M[^Z$803RCD*.U<;QDL-4Y9ZHZEA(5_?AHS^=3X;_ +,_[3W[2NM#1HM)
MUFZ:%PIEU&.5ECSZ$]*_;3_@F]_P3[\#_L@> +6\M[8MKMY;A[RY<AF&]<LN
M>N,D\5] > ?A)\/OAD)_^$)\.06/VG'G&(?>Q71JH4$ 8!KDQF-57X=CLP^
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M^";G[4VFVDM[=?#BY6.&)G8[AT S6+PV(M?E=C[G$\9<.X'$>PK8B,9>;2/
M ,,5'3M6IX1\(:UXZUB+POH%L9;B9QC"YZG%/\5^ O%7@RZ,'B.PDMI Q!C<
M=#7T7_P32^!?CWQM\4+?QKHNAO+I\#[)9@> 0>:*%.56KR(RSWBG"9=DD\=2
MJ)Q2T=]+GC?QH_9U\=? :.Q'C4Q*M]GR$B;YEQ_>K@EP6R3T' K](O\ @JE^
MRE\6?B/JECKW@[PW+<6MF7:X=",*,5^<>K:9/I6HS:?<G$MO(8I5/\+#@BE6
MIRA6=.QY/A_Q9#B;)U7J23FMTGL0EMWS8 SZ4@8$XKT?3/V6/B]JGPO/Q;T_
MPS-+HPA\W[4,;=OK7G36\R7)MO+)D#;2@]:/934E%H^QPN<Y;C%/V51/D=GK
ML)17J-O^Q[\<KGX71_%Y/!UP-&F@\Y;D#Y0OK7F1MKA9FLY(]LJN4V^XJ91G
M"7*T98'/\IS&4U0JQER[V=[$=%>B77[,7Q>T[X:1?%2[\)S#2)8!*ET>C+ZU
MYY,/(8ASWP?:AQDG9FV#S?+\=&4J-1-1=G9]4)17HGPE_9=^,GQF"R>!/",]
M[$^-KIP*[76?^"<'[4FA:7/K-[\/KH10(7<9' %:1H5IJZBSQ\5QIP[@\5["
MKB(J7JCP:BK_ (E\,ZYX7O!INO:<]I*,A@PKJ/A3^S]\2OC#;W-WX&\/RWR6
MT1:3R^P'!-33A*H[(]*OGV78;"_6)U$H/K?0XBK6BV/]I:O;6;$!))0'R>U>
MQ>&OV /VEO%-J]WI?P_N71#\S9 Q7%^+OA#XU^#7Q"M?#?CK1GL[M9$8Q2'D
M ]#71"C-V;5D>'BN+LFQ.&G3PM>,II;)J_W'T#\8_P!A#X;> /V8M/\ C787
ME\;VZLTE:,S'9DLPZ?A7R1<($D*<D!C@"OTU_:? /_!.[0R[X7^RH?Q^=Z_/
M'X;_  G\;_%GQ$= \#:++>S,_2,>I-*M3;J\L4?&^'O$]2MEU>ICZND9RU?9
M,Y:BN_\ C#^S=\4/@:5_X6%H$MD7&463N,XKSY&>7)V8VC)'M7/*+B[,_6<!
MF&$S+#*OAYJ47LUJ.HH!!&114G>E=7"BBB@3T"BBB@ HHHI7 ****8/0*,J#
MD@Y'W<44 D$,.HZ4!)>[<VOAE((/B/H<SNH"ZM;LQ<\#$JU]Q_\ !3SQ3HVK
M_#30X],U.WGD6)MRI("1\M? D,TMO<)=0N5DC<,C#L0<@UL>(?B'XQ\51)#K
M^N2W"1_<#GI73[=?5G2:/SK.N$*F9\0T,QC*WL^G<R+1C%/$S[6S,O3MS7WQ
MX_\ %&B/_P $V;+1(]4A-PNDN!")!G.?2O@- (VWH,$GK6W<?$/QE=>'T\+3
MZY*UA&NU+<] /2G3KPAA)T;;FG$W"4\^Q^'Q"E;V3OZF3"[><I*# >OO[3?%
MNBQ?\$Q+_2/[5@^UG1@!#Y@SG/I7Y^Y8+A36S'\1/&2^''\)#6Y1I[IL>V_A
M(]*G#58THR4E>ZL/BCA2IGU+#PC*WLY)_<9.]DN@Y _UF<CZU^CWP#C\-_'G
M]A)_@O:>)+&VU)M-6)/M%RJ '/?FOS?!P..M;'A;XB>,_!"LOA?6Y;4/U$=7
MA:\:%%P:T9Q<7<%U<^P-*-"7+4IV:?H=3\=OV;_$OP%U9M/U_6["[+OE&L[@
M.,$\=#6G^R#^T7??LY_%6S\23DG3O.S=+&,EATKS_P 4^.?%?C1Q-XEUB2Z8
M#K)62%&P(>@Z5G3JJE.\3W*>0U\=D/U',6I-JS:/TH_:-^#?P?\ VY/#=MXZ
M^'?BBQM-;>! ZW=VD:C"CJ,^M>7_  7_ .";6G^ _$"^*?CQX[T633[-]Q73
M]10DC\Z^0_"WQ%\9>"PW_",ZY+:;@0WEGK5W5_C?\4->TY])U7Q7<36\@P\;
M'@UU_6Z'Q<NI^:KP[XFP=\)@\3:@^_Q)>I]!_P#!1'X^?#;Q/=VGPV^&>G6_
MV2PCB'VB&)?FVJ%/S#KTKV+_ ()N^+?#NC_ K6[6^U6**4P+M624 GY#ZU^>
M7))8G))R3[UN^'_B5XU\+V;V&A:Y+;Q.,,B'@UA3Q/+)R:W/?QWANJ^24\#3
MJ.\6FV]2#QY-YWCC69D*E?[5N&##H?WK5]_?\$Z_&/A_2OV>M<AU'5((I)(!
MA7D /^K/2OSMGE>X=Y)CDR,6<^I)R:VM ^)'C3PQIS:5H>N2V]NXPT:'@U%"
MLJ3=T>OQ!PA5S?(Z> C*SCRZ^C16\:L'\::NX;(;4[@J0>"#(U?7G_!(_P 1
MZ3HOB'5GUB_@M\2$1^8X7(\L>M?&4TLD\K32MN9V+,3W)[UI>&?&GB;P?*T_
MAS59+5VZM&:6%J*C5YF=F=\+O-.'O[/4K/EM<]/_ &\]1M+_ /:,U2_L;M)8
MGA0*T; @G+5ZI_P3:_:NT7X=:M<?#+QQ.J:?JF<O)T4;-O4].M?)^N:W>:[?
MG4]4OS/<-]YVZFOLS_@G[^S?^S_\=?"%_'XHT*SNM7C7$#2#YE;83Q^.*UP"
ME+$R['R'%^783)^#8X;%IRC%):=//Y%[X[_\$XK#XE>+'\8_!CQUHD-A>OOE
M%YJ* C.2<<^IKZ@_8:^$GPM_9_\ #K^!]*U>"^UN>W9[^6"=9$$BJ0<$?6O@
MCXH_"O\ :K^$'BRZ\%:&]_'8QS,UJJ=-K$X _ "OI_\ X)^_#KQQ\)?!^L_%
M/XTM);22*SP2W/7:8S_45W4HT%?V:MW/Q?/(YABLIC3GBE4A]F*W\K]SY'_X
M*'7<8_:FU>5-V?*CVD=N6KZ6_8N_:B^&'Q0^#<GP"^,5U%%%M6*WDG*J,*I
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MV<?!<WAG6Y;)Y)T5VC/WAY*<5ZF&]G"BYR5['\\>)V+SVMG5# X*LZ?.^AT
M_P""2G['#'<GQ#N0WOJP_P :X[XX?\$>? Q\)_VG\ /%#7EXA8W N;_>NW'&
M,'KG-?$Y_:.^-2YDE\:70 ^Z^[M7TA_P3D_;-^*=A\6[3P3K_B*XU"RU:9+=
M8Y'P$)8Y-:*5'$Z1C8^:S3ASCWA7#+,/KG/&.K39\L?$7X;^)OA1XFN/!_BR
MU*7%O(4+[3@X]#6 JL9"N>%YYK[Q_P""FOP!UKX@_M#:/X7^'.A&ZU+4K&>=
MX(ARY5ADU\^Z/_P3]_:9U?6;C1;;X>W37$,8:1"0, FO,G1J1J.*1^K\->(F
M4ULKIUL754)65TV>(+NR2Q!&>,4M>G?$G]D/XW_"K4[;1_%/@R>WGNUS#&<'
M/./YFNF\/?\ !.S]J#Q'ID>J6?P\NO+<;E.X<BDJ-5NW*SZ>KQOPY&E&J\1'
ME>SNK'A=%>E?%+]DOXX_"-U/C+P9<6JM&6!;D8]>*\T)*,T3<L#@Y_AJ*D94
MW:2/7RW/,MS6'-AJJDO)W%I&W(#(H&2.:ZGX;_![X@_%B\&G^"/#TMV^[:6C
M'>O4M1_X)O?M4:?IQU*;X=7015W.<C@5O&E4Y4['DYEQAD66S=&M7C&6NC:/
M1/@I^P5\-/B'^S[??%._O;];VWA+A1/A,^6S=/PKY&U&W-G?2VRD$1RLJ_@<
M5^I/[.'A/7/"W['^O:'KMFT%Q;V[I(C#D$0OFORYUH1'5KH],7,F#Z?,:UK<
ML%%):GYUP'Q%C,VS7%J=7F@I/E[)>1]3?#G]C7X)>*/@'<_$C4_$TT>J10%E
M@^V  G83TSZBOE6YB2"XD@3D)(P!SV!KVGPI\%?VJ-3^&4OB/P[IU[)H B+2
M2J1MQM)_EFO$Y$>*9X[C@JQ$CFL*FB5U8^TX6E4_M+%<U=5%S:)._+Y"4$!A
M@UH>%_#>L>,-631]!L6N)WXCC0?>]Z]GT7_@G'^U)X@TJ+4;7X=77ERKE#D<
MU,:%6IK%7/=S#BG),HG;$UHQ?F['A&[^%N/<UH^$/"NL^-O$%KX:T. RW5T^
MR-0N>:W_ (J_ ;XH?!ZX^R^.O"\UH%.-S^N:]P_X)P?LY_$KQG\9_#WQ%TC0
M))-+M+M9+J4$8"]*JE2E4J<G4\;/^+\%@<DJ8ZA43LKIWT/#_B_\$?&'P6U.
MWT;QCY0DN(%F18SR >F:X\[Q+P04[5^@?_!3C]C[XR^./B##XR\*>$I9]/M=
M+43W"$84J 3^@KX%U72KG1]0DT^[3$D#8D4]JFM'DJN-CFX%XLAQ/EBJRFG-
M;I'T/^R+^RM\)/C9\-]2\5>.-?DM;RU,WE1K=! =H..,^U>%?$GP_IOA?QIJ
M.A:1*9(;67;"^[.X?7O7H'P)^$?[1/CCPI>:K\)[*[?3H_,^T/ 1C@'=7FWB
M72-?T_Q-<:+K\;+>I)MF+]0:UJ^[3BN4,EK55Q#B7+$*2O\ #?X?^',S+,=S
MX!]!2UZCJ'['WQMT[P,OQ'NO"$ZZ88\BY/0C&<_E7ERJZ@[ES[^E85*4X;H^
MOP.<9?CZLE0J*7+H[.]F@HKO?A3^S;\5_C#HMQKG@CPU->6]N&,DB=!MZUR'
MB7PYJWA36I?#^L6ABNH7VR1GJII<LDEIN31SK+:^)G2C47-'=7V*-%>B?"C]
MEOXS_&FX-IX&\'SW.Q=[.G<?C7;:U_P3B_:CT6QDU"Z^'ET(HQEFR.E:_5J_
M)S*+L>37XUX<PV(]A/$14NUT>"T5H^)O"VN^$-4DT?7]/>WGC.&1QTK..<#*
M8_K6)]%A,9A\;252C)->04444'4%%%% !1110M1-M.P44'D;0<$]Z4IO8!3C
M'7WIM6*M9V8TC)! &<\9Z5UWP=^'U_\ $+QK:69LI9($E'FM"I(!!'I7*1Q2
M74JPP1;F<X51W-?=G[%7P2L?A[X$&MW\XDNM1VSHS)@P@@@K[UV82BY5+L_)
M?%;C%<,Y'-0?OR32/7/!7ANQ\)^';;1M-BVQ1QK@8YS@9K6/J:2/:BXW]>![
MTM?0*/LXG^=>.QU;,\=/$5'JW<****M:HX6W)WZ!1110(**** "BBB@ H S1
M1G%  >****:=A-"853YA)X]*50Q?<#A@,J0>E%  !R.M#LP5T>A?"OX_^)/
MH32[AA<69P)/-&YE'^SFOH/P]XK\->,+2.72-0C,SH&:+S!D9'I7QUD+R6Q[
MUI^%O%>N>$;T:MHUXUO+TW*>HKEJ4>9W1U4ZR2LSZ_FA:$^2X((ZFFCI7G7P
MK_:(T7Q99?V9XVN5MKR/"QRR-DW!]:](,?R":'YXG0%9![USN#1T*:8RBA%8
MJ0.?0T;77EUQ6=TC2VEPHH+J>G%%-:B"BBBFU8 HHHI %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 APWR_K5[2]5DL9 KGY3ZU2QF@\\&I:95T=A:W,=S&)$/4
M5)7,:7JTEE)M=_E/ %=';SK<Q"2-_K2M8.8DHI <C-+2&G<****!A1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_8+N!=_M(6UP%V,[9*>GS5S\R^MIQ/M,AP68+A'%T,QIVBF^5-IV5OT/I?\
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MU1=KG[+D'#F4X'A)8B-->TY=7U>A^IOQ4^&WB3XF_L,^&?"7AJS::>[TV':
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M/^S=_P )I#K=H=3;PX(P?-7=O\KIZ]:_&G8F>?F'H16Y_P +)\=?V-_PC_\
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M\<_\\E_[Y-9__"\/BI_T.5U_WT*7_A>/Q5'(\9W6?]X4?[-V9CR\5?SQ+_\
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MZ_[Z%.^&[,+<4_SHT/\ AG[QY_SR7_ODTA_9\\='DPK_ -\FJ/\ PO/XK?\
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M5/><30_X9^\=_P#/!/\ ODT?\,_>._\ G@G_ 'R:S_\ A>GQ9_Z'6Z_,4?\
M"]/BS_T.MU^8HOANS*4>*?YD:'_#/WCO_G@G_?)H_P"&?O'G_/)?^^36?_PO
M3XL_]#K=?F*/^%Y_%C.?^$TN_P Q1_LW837%27Q(T/\ AG[QY_SR7_ODT?\
M#/WCO_GBOUVFL_\ X7G\5^_C.Z_,4?\ "]/BQV\:77YBC_9NPHKBI_;1H?\
M#/WCS_GDO_?)H/[/WCO',2_]\FJ!^.?Q7/\ S.EW^8I/^%Y_%?&/^$TN_P Q
M2_V;L)OBI?:1>'[/OCL](D_[Y-(?V?/'?_/)/^^35'_A>7Q7Q_R.5U_WT/\
M"C_A>7Q8_P"ASNO^^J;]@T.;XJ;TDB])\ ?&]O$;J6--J#+?*:XF='M;F2W=
M<2)(5.1Z5TMQ\:_BG<)Y,GC"Z*-PZY%<S-+-=7+37,Q9G)9I#U)K*2H]CV<N
M6:Z?66F-YSR1GOBBCC)PHSW;UHJ-.A[CY;Z!1110(**** "BBB@ HVL1E2!C
MUHH(''&?44(.7GT-OX?2QP^,M-F>15 G0L3_ +PK[2_X*;^*] \0?L[>#+/3
M-5AFEBN4WHL@)'[E!7PE&[6]P+J#Y64Y7%:VN^.?%?BBTBL=>UJ6XA@YBBD/
M"GI71[7EP[CO<_.\]X0JYMGM#'<UO9O[S)HHHKGD[K0_0XP@H:+8^@?^"9NM
MV'A_]JG2]0U*\C@B6SG!DE; &0O<UI_\%/M>T?7OCY=76C7J3J8(AYD3@CH?
M2OG?0]=U3PY>C5-&O&@N5R$E3J >M+KOB'6/$MRU]K5\\\Q',C]3715KJ6'4
M+:K4_/*_!E2KQ<LT<O=<>6WS/KW_ ()S?MJZ-\/[:X^#OQ,<'3M1R%EP,(NW
M;@D]/O5M?M!?\$\?"GQ.\2OXT^!OQ#T:VM+YMTJ7]^#C/)QSZFOAQ'9"'089
M>E='I/Q>^)>C:>NGZ=XON885^[$I&!71#%1JT>6:U1\[G7ASF%+.)X_*:O)*
M7Q=4_D?=WP&^!'P+_8R\/W'C/XC^)M,U/6A;OY4<5RDB'*D'"G/?%?%O[0OQ
MA@^)WQ9O/&NBV2V\(D_T=(H@@&"1G KE/$WC?Q9XQ*MXCUR:Y,:X7S#VK)Y4
M;%[_ 'C65;%N3BDM$>IPQP-B\-B:F*S"KSU)JS[6]#]#_P!F+]H7X3?M _ )
M_@U\6]0AMY8U2* S.J9(4@$9]S7G1_X)EV^F_$./6[CXE:#_ ,(RD_FSQ_;Q
MYWEG/0Y^E?'-G<3V-PMW:3%)48%&'45TES\9?B?=0_8[GQA=-"Z[9$)&"OI6
MTL30DE)QU/!QWAQG&"QTYY96Y(5'JM_N['ZQW_C?X,>&_P!FC4O!?@K7+?R[
M.P>$YG4EV$;#/O7X^ZPYDU6Z\LC;]H<@G_>-:UG\3?'MK9S:7;>)KA;>4G>@
M(P>*P3^]+"0#=USZFLL37C.K&3V1ZG!? .)X<=:56?,ZE_Q/TQ^ WCGPK8_L
M3W^F7>N6ZSM9L!$9AG/E-VK\T]39SJ%Q)$5QYS%?S-:MG\0_&EAI;:-;^(9D
MM67!MP>#6*JAQO9L$GYE]:PQ-2-6:G'0]WA?A67#V/Q564KJJ[GV3_P3<_:Y
M\,^#+2[^#GQ*N'&GZC'(?-E;A2RE0,GIUK1^,/\ P3GTWXA_$2;QA\-OB/H,
M&BWDNY8[B^&\+^!KXE#2!@Z/M*L"N*Z?3_C'\2]*M%L+'Q=<QPH,*JD<5V+$
MT:JC[57L?+YSX=9A'-9XS*:OLW/XET/O3XJ_%WX1_LB_LXR?"_P?J45YJ5S'
MY=RUK('RS*58C';FOC?]E#QW:>'?VC/#_C/7[G9%#?\ F,[M@XYZDUYOK6N:
MOX@N_MVK7[S2]V;O54NQD293M93U':L'B+XQ32T1Z^2\ T\%E%:A7DY5*OQ/
MNS]"OV\?V:[?]I6XM/BAX&\>Z1$L&EH'CGO &.U03P#[5\ ^)=(OO#>L3^';
MV2*62!MK2P<J?H:V(/C!\2;6R&EVOBRY6#;MV C&.F*YZZN[J[N7FNIV9W/+
MGO4UZD*M5RM8VX'X8S3ARE.C5FI0OHNQ]]?\$OO&7AS0/V>]?L-3U>"WE<W6
M$FE )RK>M?%_QYF2^^*VL36TZ/&;CY64]:Q]"\;^+/#=H^GZ/K,MO#)G>$/7
M/6LNZN+B_E:>YD+2,<LYZM3J8B-:DHVV.G)>$:V5Y_B,>Y7]JT[>AH>!M:N?
M#OBRPUN"0H;>Z1V.>P:OUU^#WQ9^$'CGX.>'OB?X@U.T;5=(L2T#22+N!.<Y
MSS7X\,2YSNQA<8]:W-*^)/CC1M%_L'3/$4\-H5VFW4\8K3#XQ4:;C:]SSN/>
M 5Q7*G44N5Q=V^Z['5_M3?$FY^)GQAU/76N_-59WBC8MGY0QQ^E87P7^)E_\
M)?B)I_C6Q;$EG+D%>]<M(Y9FD?YW=B68]R::0H*@("I'(_NUR4JKIU5+J?78
M3AW"4\CC@)+1*Q^FWCI/V>/V_P#X5V_VC7+>Q\16]JOEO-<K&V]4 &[N5R*\
M2^&O_!,BZ\.>-+?6?B7\2O#LNCP/NFCM+T!R/SKY&\-^*O$'A&^;4O#VI26L
MS+L+QGG%;EW\;_BC>1-:S^+KID<?-EA7HRQ.$TFX>\?D\_#?B#+*DJ.7XCEH
MR>SUM?S/JK]OC]H_X3:)X0MO@=\)=.MI)+95^TWJ0HRE2H4@,!UXKXJ"E%5-
MP( X(Z_C3IF><M)<3F1W8EF/7FF+&L8V)T'>O/JU?;5'.VY^H\*<,4^&\#[/
MF<I/5MN^HM%%%0?5A1110 44*0QP*4*2< 4$NJGI8!@YRWW><>M>S_L>?!NY
M\<_$:VU+6=-F&G1*S&0K@;N"O/X5Y1X4\.R^+O$%IH-LI5II@ID49(S7Z-?
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M<'IW/K713@CGG(5W\UO,'X_6B@9/(Z45NE8Y[W"BBBF 4444 %%%% !1110
M4444 %%%% !1113]Y[#7*MQ#M!&Y2>>@IS#T(*GTZBFL6 RK8(Z&N6\4?&7X
M=>"-9@\.>(_$<-M?7>&BB+C+<X]?4TE3JR?D#G3BCDOVPOVG-$_95^$NI^/]
M8A:5K:U:2U5%!RPQV/7K7XV^ ?\ @L/\</#O[3O_  M7^US)I=S>-&;*=2R+
M#(P!^4\9 SSCBOVJ^/OP'^'G[2GP\NO!7CC28+VWNK<K%)(N[R]V.17X-?\
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M\"OY7BG2&MO]ZL_0]!U7Q'?+IVB6;W$C=%45FO:.=DB?[0PLJ'M>9<O<I (
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MB0/&!T%%(O0?2EK+N?6T?X4?1!1114K8T"BBBF 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ H.>U%%4FD !_*Z5L:)JY!$,K?2L<J&XQ2QLT!W
M9Y'2IW&F=B" -P.0:5>F?4UEZ)JZS*(I6Y[9K30<9SUZ5#5BQU%%%( HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?X>7.B:0VI*_E!S:-RWUW5X)^VK^P79_"#3Q\2/AYJ+7FEWK!XHQ&%6-6^8
M8] :NIAW[.ZZ'R^5^*6"Q^,6%Q%"=/F^%R5K^AR/[ 'P,\(_'3XJ1Z-XOBD:
M*.8!5C?;N&,TG_!1?P#H7PW^/W_"+>'[18+6'2X2JJH&3MQVKZF_X)*^(?V<
M/[/T[3CIUJ/%4<:BXD\H[]^.><U?_P""F?B;]CZWUJ^L/$6EV3^+6T\>0[P$
MN 5^7G-:8BDJ>'31\)2XTS&/B-[)4YN%K6Z;[GYG@L025.#TQ0I5F 8=.:<[
M'SU2%N&. O:OLK]DC]ASP)#X(/QN^/E[Y6F(K-]DFA#(57G/KR#6.'I2J1/V
M7B/BS!<.8*%?$)MO:*W9\:H )"Z_+Z!N]-+/OW28/KM]*_1>R\4?\$K?%%Z-
M!T[0M(^T2 I&WV-A@G_@5>$?ME?L/Z#\'-*3X@^ ?%'V_3[U]T40"J(U8;@!
MCG@'%.I0G&'->Z/F<F\3\/F&80H5</*DY[<RT9\P(R>82/EYX#4 _P +C#>G
MM2-]]%=<L1^5*/F7<YRW3<?2N8_4U>Z?1A11105'<**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M ****%N W_EG7M/Q!_Y(-I'_ %YI_,UXM_RSKVGX@_\ )!M(_P"O-/YFMJ/4
M^/XF_B4_4\77H/I2T#H**R[GUE'^%'T04445*V- HHHI@%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C@E>%)]<=J6@L0,
M"0KGC [T74=0>@@RR JP  []Z51&PP WN*LZ)H]QKFIP:5;*6>5PJHH]3BON
M?X*_L9_ /]G[P<GQ3_:9U**ZCU"W"Q:;>0!EBX#!AC!R0:Z:.%G47/+1'Q?%
M?&>$X=483BYSEHHQW9\'@A%99%.TGCUI 4 V.I)S\I'2OTH\!_\ #K_XN:['
MX*\+Z'I/V^Z1A!_HC#'XEO>OF7]O[]C7_AF?Q%%KFBS-+HNH2 6;; H!(W$
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M4&<;VU"BBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M  .E%%=UW:QR-7>H4444K6 **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCG_@DEXRD\0ZCX@^#OQ$TJ?2(IMUA"LK/,J8X!(/)KQCXU> /VD_!.B?V/\
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M@<5RY+D[5(^;[W%(<*=F<GU-* 4&X')KKC&QS2D&,<>E%%%60%%%% !1110
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M.\<E@.22_P FWFOB^(,!KSQ1_6/T?/$">68]99B)^[+:[/$B ,G<.*,' 8C
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M:"5-RR*V:4,,%2O-<W+RG3S<P44=\YHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D
MQSGVI:* $*@\]Z4 $Y)P>QHH(+<"@$:6C:M)!*(96R.U= '5T#@9S7&1ET;=
MGD=*W-%UH-B&9OSJ6C0V:*.M%2 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=O\ T(8_\"__ +&DL*NY?_$PV+_Y]HW?^$W\,CKJ\/\ WW1_PF_AC_H+0_\
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M^_\ UJ?)1[A_:/%+5G07WF1_PICXJ?\ 0B:C_P!^:/\ A3'Q4/'_  @FH_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7^=21313Q++!(K@GJK9!'K4.-1^\6IICSSS12L5#GRN5/KVI*GF<MQA1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M::T.CM+/3-.@%MIME'"@4*$B0*!CV%2S"0*JR2+N/*L!T%.S&PR@_$BD9-[
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MRH^RW/\ S[M^5>J-HVFYP;*/'TI1HVF @"S3'TI@TCRK[+=?\^[?E1]ENO\
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MJWE2QAT(23D'G^_7K/\ P4+)'[=6@'O_ &L<D_[IK])_A< / .D@KUL(NO\
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MU]I#DY^A].T5^=^J?\%0/VY=%TTZSJ7[,^BK;)@NRW<Y('TV5[E^QG_P4?\
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M6'NM:F]#*Z4I<R>A\\_L$_\ !-[X+?L::6=>\.:,?^$DU&R2/4[V24NA7A@
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 49
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M:EHGSY_P0/\ @I\8-#T"_P#C3XV\5R3:9JUG]DLM)FWEX61L[\DD8((Z5^E
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MUHJ4H1E),SUG8^U!^SE\(4T0Z"OA"V^SF+R\>4F<8QUQ7YV_MT_#ZY_X)O\
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M79&=(;(@$MCO7LGAG]E/X0^$]9B\1:'HKPW,2@!S+GI^%<+_ ,$PBQ_8W\)
M$%#:GKUZU]"LVQ/F7Z"N*M)\S.FEL.3[HYSQ7"_M-?\ )!/%W_8O77_HMJ[I
M>G(KA?VFO^2">+O^Q>NO_1;5SIW9NMS^4R?_ ).4N_\ K\/\J^AK'_CVC_W1
M7SS/_P G)W1_Z?3_ "KZ&L?^/:/_ '17'B-S^S?H_P#_ "+YC_XV^M+2?QM]
M:6N2&Y_2LM@HHHH*84444""BBB@ HHHH#<***,,Q"HI)/0 4+<BI)1@V>O\
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MH%]%8:_8(QM+Q@?E8GJ0O)KY9T&P_P""K_PJLO\ A"_".JR26-HY2"4Z3N#
M<#DOZ"OTWXP"P^8^E"A%4AF.X]!VIT<1R*S1-6@ZCNF?G7\(?V#/VDOVC?B3
M'\4_VJO%<;&SF#G3Y;5HVDSR< $@5]:_'C]D;P+\:?A*GPWO[!(_LMN$LYR?
M]6X0*#P,]J]?*\?*/G'^L)[4A#R ,'^4>M54Q4WLK6"GA*:UD[GY?:5^S?\
M\%#_ -DG6[SP_P# OQ6UUIIEPCBP:5< <8W,,5JZ9^RU^W7^UWXNMK/]ICQ1
M]GTNU=99(WL6B$H'!4;6/:OTKVX.\J#Z ]#2!'4[F&<GG-53Q+WDM13H-.T7
MH<!X!^ '@[P%\)8?A/I-C&MG'9^0H4=>N"3CGK7P#X[_ &$/VN?V8?BW>^-_
MV=M:6<WTQD_T>S9P@9BV#DCIFOU "8X_O=_2F8)^9V)8?RK-8F:JNH]QU,/"
M,%".Q^<.G?"?_@I9^TW<+X&^,GCA--TF7B>233&C! YZJQ/<UE>%_P#@F_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPLJ^QPXK'*@^1[,_0G]M#_@B-H7[3'QE'Q.\'^+[/1+:58Q=VMTCNTC#[Q!
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MQ# FH-:(]W:7#+'\Q W!03D\YKLOB)^RW\!/BC<IJWC;X8Z3J4T8(C>ZM Q
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MQAAZ5252-1;7/EG_ (*Y<_MH>,!_U&9>/P6OG_X6 'XC:*&&0;].M?0'_!7
M@?MG>,3U_P")S+U^BU\__"AF;XCZ*/34$J,!&/U&-CLS>4IXP_8+_@I#IEA%
M_P $J-!N(K*%'_LFWRZQ '[[]\5^2?[.J*_QR\-(X!!U9,@CCJ:_77_@I*,?
M\$HM P/^83;?^AO7Y&_LY+GXY^&1CKK"?UK/!R<ZDTQXJ*5.%C]Y/VI?BO\
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MJ%%%%,84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %'7K110&Y[#^R%,_B?QA=?#'6'#Z1=Z;<W4T'0F6./Y3
MG\:\FU>-8=6NXK8\)=2*%]@Q K1^'VN:AX>\8Z??Z9?R6TCW4<3R1M@E&8!@
M?8BN_P#VR?#VD>'_ (SSQ>&M/BALVT^W</ OR,Y3+8(X)SUKKE:>'370_/Z5
M=Y)Q4XU=57V\K?YW/* 5"XVX)ZTE'4[F)SVHKDCIJ?H<8-ZW"BCK12,[W=@H
MHHIC"BBB@ '45XC^U/\ ZM/JU>W+U'UKQ']J?_5I]6K:C\1^/>,/_),R_KH?
MM3_P;G_\F[2?]?3?^@FOTH'WC7YK_P#!N?\ \F[2?]?3?^@FOTH'WC7HK8_S
M^G\;&88L?DP,5A77P]\+7?B*+Q5<V6;^%]T<F[O6\V<XR>:;M)!4#+#H30I:
MD)-(_)+_ (+N?M_?M+_LY>-=/\-_">:XLK3? XE$0(=B1QU%8?@#P]^W=_P4
M?_9B\,>)K'QG+HUY!9AIY9K9CYI8_P"PU?J%\9?V4_@C\>YHKCXE>!K#4GA9
M65KJV#D$=.M=-\.OA;X-^%GAV+PQX%T.WL;.% L<,$>U0/I7HK$QC2LD<;I2
M<S*_9Z\$>(?A_P#"G1_#'BK4EN[^VL(4N)@A&Y@@!//O7;!1G:7&3]T4XH5
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M0HHHI%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4BG/:C 7)S0=P'R@4 (TBJ.3^=>:?&WQ_+I]LNB:/>J'D)6<#KC%
M=CXY\2V7AG0IKZ[F .-J@=<D<5\ZZGJ-WJMY)>W<I?YB=S'G%;4X7,9SLR*1
MG=]UP<N>_K0&(S@]::"2,]0>03U%+74HV1S.5V!Y7;1UHHIMW%:P  =****0
M!1110 4444 %%%% !1110 4$9X-%% '+_%WX4^&/C%X%O_ OBJS$UK>V[QD$
M]-PQFOQH_P""@7_!%[QU^SY!>?$GX23C6=$^:06-E VZT7LK,V,]*_;X]0,]
M?6JFNZ!I/B;3YM"UJPAGM91B2&1<JX]_6N[#XN5!*QQXO"4\33UW/Y@?A'\8
MO'?P.\>VWBKPUJ=Q:WNG70,D0D/5&Y7&<=:_8_\ X)^?\%H/ ?[1,EI\//BG
M#_8^M1A8FO+V=<73=V55SCKBL+_@J!_P1\\+?%+2)/B5^SWH-O8:U$-UWIT"
MK%"R*.6'<L3FOR3\=?#?XL?LY^+TC\1V5SI-_;N1%,BLA)'=20,UZZC2QM._
M4\5RQ&#=OLG])WQ=^#OP_P#CQ\/KKPAXHTBWN+34;1A%*4'1QP0<9Z5^-W_!
M07_@C)\0?V<H[GQ_\,I?[7T-R9?LME V;1<X"LS8R>,UL_\ !.3_ (+.>)_@
MHY^'O[0^JW.HZ.$+6>H/NGG#D_=/HH&*^[-8_P""KG[('C>XT/P'K6IR75IX
MELW:5;BU!5.2N&R>#]:P@L3AI66QM-X?%1YNI^'OP2^,/Q#^!_Q'LO%7@_4;
MF*\L[P PI(>64_=QG'6OZ(OV'OC;XM^//P#T/QQXTT2>TO[FQ1YVGQ^]8D\C
M!.*^<_"/_!&_]D/XF?$FT_:$\,^)-0,"W@N4TQ8$^S2$'=@C=T.:^W_#GAO1
M/">E1:'X?TF"SM+=-D,%NFU57T KFQN+IRT2U.O X6K%W;T+X)!R#3=S;L'O
M3J*\Q035T>JYM:,****D HHHH ****'J-.PC8VGY<GM028U#E21C! [4%06!
M9B #VH5E3<[YVYX '6G"%Q2G87=&)!Y<H=>Q%?)__!1/_@II\+OV0/ =]I^A
M:O#JOB2YC:&'3;68"6+>"N\AN,*2":[;_@H5^T]I/[+_ .SQKOB73-8M!K<M
M@XTFTDN%#^:,'E<Y'&>U?SS_ !8^+/C;XT^,KOQOXXU.2XN;F9G*O(6$>>PS
MVKUL#@_:._0\C'XQ0A9;C_C%\9/'7QQ\;WGCGQ]K$E[>74I<EB<*,G QGWKE
ML?+M[48R2%'S#OVH&>^/PKZB,(4H6B?,2G*L[R%+L5"D\"DHHIJS5R-M HHH
MH&%%%% !1110 4444 %%%%$[.'F*:M8*^H_^"6?[<>I_L;?&N.^O[I_['U$+
M;W41?"JK,=S'/UKY< !.&) ]J55(<INPRC<K$T<OM:?),T4FH<RW/Z _CC^R
MW^P?_P %4O"EOK7A+Q+I*>+[F$M9W,<K$PL22=RJO-?.^F?\&P>JZ=KD6H:K
M\?\ 1KC3X;CS+BW6RF!,>?NYV^E?EGX _:"^-/PQD2Y\"_$#4]->+[AM+HH1
M^5=G)_P4 _:^E5HY?CUXD"L,$#4FY^M>-+"XB$OW>B/6I8NA*"557/V%\6>/
M/V(_^"3GP4U+PQ\*K_3Y/%$T&V]6*XS(\H!7(W*,<8KXX_X)!?&+7?CK^WQX
MI\>:[=-++<V(*EN2(_-<K^AK\^O&_P 2/'GQ'O9+SQKXLO=0N)6W-)<S%B?Q
M-.^'7Q0\>?"G6)-;^'?B:ZTJZ>,1R7%G,4=@.Q(K2EELN652H]6C.OF,;*%.
M-DF?0/\ P5R8?\-H>+Q#\X.L2YQ]%KP#X5*5^)6B([8'V]*H^,/''B7Q[K-Q
MXB\6:S=7U]/)NGN+ABS,Q[DU1LKNXT^=+JUF9)HVW1OG!4^M=.!P\L+AU%ZF
M>-Q,<7)270_:3_@I.7_X=3Z!&1LSI%OASW^=Z_(_]G$.WQW\-#/ U>/!]3S2
M^)_VCOC;XQ\(1> _$OQ&U2]TJ) L=C<79:-0,X 'XUQNEZGJ&B:E%J=C<O#-
M"^Z"1#AE;UJ:5!TZLGW%4Q'/"-^A^P7_  6O8-^Q1X0VC&-'AW'T/F-7Y(_#
MMP?'VD;1N_TM1N%;/CO]H'XS?$K0X?#7C3Q_J6HV-N@2*VNKHNB@'.,5QUO<
MW=A-%):OLD5LHZGE31A:$J4Y/N+%UXUE'R/VM_X*%E1_P2'T3G&+*RZ]_FDK
M\4)&4NQ*X!<@KZ5W'B?]I'XW>+?!:> ?$GQ%U2[T: *B6$UV6C &<87\:X12
MB*TCDDL. 11AL/*-9SD.MB%.CRH_;7]FAF7_ ()*ZJNTJ#';[6/0_NI:_%KQ
M8'3Q)>LR[A]LD^8=OF-=5I7[27QOT7P:W@/3?B3JL6D2@;M/6[(CX! ^7\37
M$RRN\GS2%VD8EBW<GFKC1=/$N?<B=92PL8/<_3G_ ((R?MN_#VT^&VN?LI?&
MK58H;?779K*]N9=J18B9%7')/+5R'QW_ ."'WQQ\0_%VZU+X2EM3T&_FWVVI
M6EJQBPQ+'DX/<5^?>F:MJV@Z@FHZ3?/;31'*2PO@@YKU+1OVZ?VK-#L!ING_
M !T\1PQ1+B**/46 'X5CBL+-5E4I;LNABU[/V=39'ZA^+;[X(?\ !,C]AS4/
MAG'X@TZZ\6:JJ?;;9!B59&1D;AAVW>M?G9^P-\:/#?@_]KS1/''C26-+9M9$
MDTLI 5%^8Y/YUXKX]^+7Q#^)UV=1\>^+[_4YV.2;N8OG\ZY]+BYM)1=VLI1T
M.49#SFM,-AJE+F<WJPQ.*I5.7E6Q^U'_  5+_8:^*O[=-GH/QB_9\\4/?V,.
MFQPM8V".QY(.>PX KY\_99_X)5:Y\%?B18?$S]K7Q]%X8TW2)UGM8-:20?;2
M/O(A&[! .>?2OBKPI^VK^T]X*T:/1_#'QJ\06=N@ 6W@OV51^%4?B)^U;^T-
M\3;6*V\<?%76=1A@),<=U>LX7/7 -<E+ U*/,KWN;U,=1K-<VEC]G?\ @M1X
M9T[QO^P/8S?#VZ2[TZVGM##)!R&1>0?IBOS&_P""1:B/]L?PVC/\PU5 /?K7
MC&L?M0?'W7?"2>"M8^)^K7&D*H LI;PE!@<#;7*>#_&WBSP)K<7B/PEK=QI]
MY$^^&YMI"KHWKFJPF#JX>4D^HL3C*=;EY>A]Y_\ !PUN3]I/0B4(_P"*=C_F
MM?GNJX 8=#71?$?XL_$'XMZG'K7Q(\77VK3PQB..>]F+L%[#)[5SJ%A(X(^7
M^&NS!T)X6#3ZF&.Q$<1)/L+11174< 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% ",H9MQZTZ.::"9+B%L.C J?0BDHJ7[[MT+C4]G57*?I?^QK^
MU'X*_:%_8]B_9P\7>%[B7Q)X2\Z^M]9EN 1,9-JJ@')X /6N4NX)+&X:PFB/
MFQG##N#7QY^S!\74^"OQIT/QIJ.HW$>F6]\CZI!""1+$,_*5'7Z5^A_QQ^$M
MW_8]A\=_#]S:S:'XIMQ?VWV2=7,"N<*CJN=AX/!YKX+/\!*E5YXK0_M[Z.W'
M\8P_LW%SWVN>7HK",,[?-GE?2BE"D("S9;/.*2OEK6T/[24E-*2"BBB@8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% #H9&BGCE1L,K@@_0U['\6GD\1?L_^&M:B'G72WLHN9!R=H48S
M7C6/XL\BO9O ^/$/P(U#3XV$CZ=;/*RG^ $@9K>G\#CW/C.(Z7L\91Q7\AXR
M, $@=>M%)DJ=A'6EK&2LN4^MPU1SHQFNJ"BBBCH;NR=D%%%%(04444 "]1]:
M\1_:G_U:?5J]N7J/K7B/[4_^K3ZM6U'XC\>\8?\ DF9?/\C]J?\ @W/_ .3=
MI/\ KZ;_ -!-?I0/O&OS7_X-S_\ DW:3_KZ;_P!!-?I0/O&O16Q_G]/XV&%Z
M4O6FK]\TZBR)$V+0,*,4M(5#=:&T*VMP)4G\*;E0/N].WK0ZX&0?KFN7\5_%
M[P-X,O5L==UN&*1SA5:51^>3513>PGRK<Z<=?,*XSVH,F\E2-I'0FN;;XK^"
M%U./1_[?M3-+$LB1BX3=M;D'&>E1VWQ>\!7?B<^$DUR'[:C%3$95Y(_&CDJ+
MH3[2FW8ZCAQG<!CK2%U=B4?(!Y K#T_XC>#=3>XCL=;MY/LRL9F692JXZY(/
M%16_Q1\$7-A/JL.OVGV>W($TPN$V#_@6<4^60^>$3HDY/F'CMS2D@G(.?>LW
MPWXIT/Q9IG]JZ%?1W$)<J'B<,,CKR*K>+?'7AOP3:B[\0ZA'"I&0"X!/YTK-
MRL$IJ*N;81L?>&:6,G)4CG/7UK&\+>-/#WC+3/[5T#4$FAR1N5P>1]*Q_$7Q
MM^'_ (8O6T_6/$-M!,IP4DG0'/XFA)N5C:C1J5_A5SL"IW<"AHQPP'(KSX_M
M(_"P?\S;9?\ @2G_ ,51_P -(_"S_H;;'_P*3_&GRZV.K^SL;+:#._&,[1U'
M:G+M9< \UYZG[1OPO:0!?%EE\QQ_Q])_C7::)K6GZ]91ZEI]PLD4BY1T((8>
MN13E"R,:F#KX=7FFB^J@KSZ\4,O/ [4@ZCZT^L>8P&@ #YCUHPGK^M*ZDCBF
MA23R*?,Q"X^;('%*$4<8[T;E7BE!SR*:N]QB  '(%+@9S110TF*^H@4#H*"B
MD8(I:*-$AB  '(%* !THHI<J)NT-D7)!QTI0H':EHJM$--L:G/7M3J:@(SD4
MZI5QATKA/VFO^2">+O\ L7KK_P!%M7=UPG[37_)!/%W_ &+UU_Z+:J".Y_*9
M-_R<G=?]?I_E7T-8_P#'M'_NBOGF?_DY2[_Z_#_*OH:Q_P"/:/\ W17%B'=G
M]G?1_P#^1?,?_&WUI:3^-OK2UR0W/Z5EL%%%%!3"BBB@04444F3*]M H!(.0
MN3Z448)X!YH?NHN#2W%6)[AA&C8=W VD=Z]G\>W3^!?V;]&\'PS"'4I;^5KP
M#AGB95*@^W6O+/!.FP:SXEM=.E8A3*I=N^017=_M2:J\7C6+PLB P06,#I)W
MR5_^M79'W:?,CXC.K8_.*-%[)ZGER*54 C! [THXZ=Z,;?ESG'K17(W<^SA3
M4(JG'H  !R***.U!4&XOE"BBB@44T%%%%!04444 %%%% !1110 4444 %%%%
M !1110+FE%,0G'\.:5@H3_6C<>WI1@'J::$#AE7&3]W-"CS2"I-2M<EM;:YN
MYX[1(&\R5PJK]:^W_P!B#X$2_#SPQ+XHUVXC,NIA9(59,-'QC'Z5\V_LH?#'
M5?B1\2((X;+S4LRLTC2KA"H/(STS[5^A5E90V=LEC:V\:1(,(BCA17LX&A9\
MS/Y+\>>.O8Q_L[#2WW)5&26'([4O7G% )D3=C;CCBD&,<5[$_?6A_'CJ<Z<^
MHM%%%*^ABISD%%%%!04444 %%%% !1110 4444 %%%% !0"N?+9MI/(8T5A?
M$7Q'_P (KX/U#Q"B,TMK;2/&FW()"$C^5)MK8:2>C%\9_$?P/\.K9;OQOXFM
MM.BDXC>X) )_ 5@:7^TQ\"M;O$L-(^)>FW$\A 2".0[FS^%?FMX*M_'/_!0[
M]IK6](\<_%"YT72;.5/]$@U!4"J6*G8K$9->R_$__@D)!X(\)R^)?A%\9/$5
MUJT(W0">X"J0!GJ#[5W0PZA%2?4X95I<S2Z'W[%-'<KY]NP92,@#O5?5M9T[
M0[-]0UBY6WA09:20\ 5\M_\ !.+7_C_HOA"]\#?'>*0MI,0^RW\LC.\Q+ ?,
M2!VKYV_:G_:.^,7[67[0X_9W^%&K36.GV\I2^N+:8QR?(X#?48S4O#NK5Y47
M[>*I\S/ORV_:;^ UW?KIT/Q-TQIV;:(1(V2?3I7:V=_:W]NMW:SAXI!NC=>C
M"OS^\9?\$?UT+X>3^-/#7Q@\22:]%;^9# TXVE_KFMC_ ()@?M#?&"'Q=J'P
M!^*>EW\YLI)FBO[R&0Y5,@ ,1BM%0I<KB]T9O$U(M=F?:_BGQ_X.\%M"/%7B
M"WL/M)(@$Y(W$>E9/B'X^_!OPG,D/B;X@:?8O+$)(HYW.74]","OCO\ X+6^
M,M>\(>&?#>J^'[Z6&0-*4"L5SP>M<+^S'_P3E\6?M0?#N+XC_&CXK:]:W<D8
M%E#:7(9?+QE>I&.U9X;"QDG-EUL1*+26[/T4\'^/?"?C[3QJGA+6H;VW(R)8
M6R"*7Q=X\\(>!=-&J^+-?M[& N%\V<D#/I7D?A+PKHO[$'[-YM[K5Y;O^R+3
M]Y<71!9\'OZU\4> /"?Q_P#^"EOQ/O\ 6M1\57^D^%K2ZDA5+*Y*J=C'G!QS
M@4Z=%U)-PV"I6E32YMV?HCI/[2WP*UW48]*TCXF:;<7$IPD4;MG/Y5VT,JS1
MJT3A]X#(PZ$&O@OQ_P#\$=[?PCX9G\1_"SXS>))-8ACWVJ3SA 6]SFH_^"<O
M[7'Q&T#Q[>?LX?&.\-Q<6DDA@O;B4O*<,5"Y/;BK>&]HO<)6)=/XS[[=MF0Z
M[=GWLUQ&O?M'_ [PQJ1TG7?B5IMO,APZR.05/ITKYK_X*6?M>^)/A\UG\'/A
ME<L=<UH-&9(F.Z-@?4=*X3X-_P#!)'5OBOX0C\9?'+XN:_::O>GSO)LKH.@C
M;YAR2.>:SAA[TVWL7/$.,UW/NCP7\4/ /Q&2:;P/XGMM2B@($DELQ(7/U%;5
M]=VVG6LE_?3K##$A9W?H *_,/XV?L\?&S_@G?X@A^(7PR\?:IJ?AV*3?/%>W
M?^L7.!N5<U]K>#?C1IWQL_97OO'FFW1+G1WCF _AD$8W?KFJJX>U+GAT%0Q"
ME.TMV>A:'\9OA?XFFGMM$\:V4TMN<3(C$E#[\5ES_M/? 2"__LV3XG:8LX?8
M8S(V=V<8Z5^2GP&B^-WQ4_:)UOX9>#/$UU#:ZCJ&+BX2Y*O" H^[^%?4_P 1
M?^"/^G:+X"N?&'A_XQ>);C68K9IWCGF 7S,9/.?7-6\/"$8N75&=/$2J2DET
M9][:5K.GZW91:GIEPLMM.NZ&9#PX]16)\7?#'@#Q1X/N-*^([H=*EB9;@NY4
M!2.<FOS_ /\ @E)\>_B9X:^+VM? +XB^(;G4?+OA%;FZF,AA"H"0OIUK[!_;
M@N[BU_9_UF:UN7B<64IW*<$?**C$4(Q@FC2A7E*<E(L_LM_"K]FKX:Z9J=K^
MSU/;BWN+A6OFBG+@N%XZ@8XKTKQ%XG\/>$]-.JZ_J\5K N=\TIPH KXE_P""
M+&LZKK'A#Q:=3OY;CR]2B"&5LD?NQ7L?_!2K4;[2_P!G;4;C39C$X@EPR'!^
MZ*SKN4)QCWL:4%"4)2['LEK\8/AG>Z(_B2W\96;6$>-]V&.P9Z=JS-&_:0^!
M^OZD-'TGXD:=/<LVU(T<Y8^G2OS"_86^$WQJ_;+TAO#>M>,]0TOPYII$%S-8
M76'D)&02#UZFO0?VL?\ @F7J7[-_@(_$?X2?%WQ#=WEH6EN/MEP%V@ 'C!]3
M6\Z,:=N;J<U/%5*MW'H?IA#-%/#YZR *>C>M/..BN#[U\K_\$L/VC=8^.WP9
METGQ3<M->Z"T=K+,S$EVVELDGO7<_MV?M"W/P ^#5]K-@46^N8)([0 \[P 1
MC%<^)HN$DEU.C#8AU(MOH>C^,OC3\+/AY>QZ?XW\;66G32J6C2X8@L!]!3=&
M^-_PI\1Z9-JVC>-K*:WMT+S3(YVJOKTK\\/V<OV%/BW^VG!_PMGXZ?$O6;"P
MO/WEFMI=[F5&&0 &Q@9%9'[8/[''Q;_8T\-7NM?"KXAZMJ>AW$!2?[==_,JC
MDG:,^U=#PE.$5&3U,88VI4<I16A^FO@OXC^"/B':S7/@KQ#;ZC';2>7/);L2
M$;&<'-;=?!7_  0Q\2:OXE^%OBF\UG49II?[;CXD8D#]VU?>M9X[#1P\U%=B
M\!B95Z;OW"BBBN--\J1UVLPHHHH **** "BBB@ HHHH #R-IZ4A!"X6EHHW!
M.QZG^SU\:G\%W \,:TQ-C,Y.6;@,:^@Y_LE[;+J^E3J]K*-R2+TQ7Q25E&)(
MF (/&37N'[,WQ2L%,OA/Q)JDO[S"P^:?E7\3TKEJT['52J7W/7PNTX<88CH>
MX]:6I[FRGA E<!E891P<_+VJN>#NSQ7,SJ3N+1112 **** "BBB@ HHHH6X!
M11151J*4K,E4^5W8H^5" >:B>UM?^/F>UC9U'RN4&1^-/!)&32-F2,J:F3DJ
MJ47H-J+C=[GXQ?\ !QM^W9XJT'Q''^S1X,\8"T,!674K:,G=Y4B<9Q_NU^6O
M[-?[,OQ0_:L^)=GX&\ Z+<WTUU,!+=1KO"#(R3SGH<U^DG_!R#^PSJ2?%8_M
M4^&(;Z\FU)([;4(5B+10Q1(2&XSCEN]<7_P;;^)/#FF_'^;3=9TYC<222>2R
MP%L#8.I[5]90JTJ6#NMSY'$TZ]?&J,MC]&O^"=O_  19_9[_ &0O!FE>)?%.
MA0:SXW0":ZUA,A.0"J[&'!4DBJ?_  4'_P"")/PI_;6\6:?XZ\/W]CH&I6TJ
M?:Y98F(F3S SKA!U(&,U]R7=]86%DU]J-XEO&L>YI)'"HH]23P!7P+_P4B_X
M+6_"3]G+P!K7A?X2:K#JGBF,FU"D!HEW JS!U)Y&017D4ZF*KUKQV/;E1P>'
MH:[GK?\ PE_['7_!)OX+:3X$AOK/1+&,%!!<7)R\FT%SG'<C->8?\%=M)^+W
M[3G[!\7C/]GGQ+YVFZNMM<QZ?:Q%Y)U.[YE;CC'\Z_ ?XP?M*?'3]H35S%X^
M\;ZQK9FO'DM;229IB"Q/RJO7H<5^SW_!OA\2_P!HSQC\*[KX8?&+PK-/X:MI
MU2SDU:*020HJ':BJZC ZUUU,/"C-5'N<5/%5*\?91V/SA_X)I_!C]J#PQ^WQ
MX*L+WP7KD*Z?XACDUI)'XAB(?#,-W0FOZ9=*$@TZ$2CYO+&[-<UHWP.^$?AO
MQ-)XIT3P)I\&I2X\Z\CM@'('3FNM&WHO0=J\W%XE5WHCUL+AGAXZA1117 D=
M:>FH4444P"BBB@ HHHH **** "BBB@ H  .1110 L;M&VY3BNFTG4%O(PH/0
M8-<Q5G2[]K"8)G@FID5$ZO(SC-%16\JW,0D0\XJ6I*"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD4,.II.X 6QTY-0WEU'
M9VCW$LH547)8]JE?/4CCUKSKXR?$1]'L)= LPIDF7:Y] :N$6]R)RY4<1\6/
M%[^(=5-I#=;X4)!P>#7(%5*J-O*]*7<[_/(<L>IHKLC%)'))ML"2>6ZT445=
MV0E8****5K%-W"BBB@04444 %%%% !1110 >QH'S-A>?4T!F V1@%CW;TH!*
MMY4@QZLM"U0;,&*C[K9.>0*#D, 5X/\ %0PCC&Y"23QS6)X\\5Z5X'\+WGB+
M6M02"VMH29)I7"JO'J>*=-<\K!6<:4.8\J_;)_;E^$O['_A*76/&FIPR7X3,
M&F>;MDDXR,9XYKX8B_X.3?#4SY;X ZH "-I^WQ\#\Z^(OVV_C9XE_:O_ &EK
MO2]"UN[U")]1:SLX9W)3>)"HQ[<5L_%;_@E_\9O@W\ [OXU?$&;3;&.UA5Q:
M-?JLLF3_  QG!;\*^BP^74E#FEN?-U\=5E5:B?K9^R-_P5;^ ?[4%_'X>DU2
MVTO4)XQMM+B<,S,>-G%;'[>W_!-WX5_MJ>!Y+5K&WT[Q';1%=,UAD^6#)).5
M4<YK^>[POXI\2^"-2CU;PMK,]C=1.&6:UDVL,>XK]'_^">'_  6R?X=^'W\!
M?M#:C=W4D<D<6GWGEM,\J\99SV.32K8.I07/29>'QT*\?9U4?,7[47_!,?\
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M,CL<=*\9.[&%.*3*!_+9FX^[3J^JH4H4H6BCY2M6G6GS2!A\H2/A3]\>M
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M44 "]1]:\1_:G_U:?5J]N7J/K7B/[4_^K3ZM6U'XC\>\8?\ DF9?/\C]J?\
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MG*]V!SN^4X7THX[445K'W59'S*T5D%%%% ^9I6"BBB@04444 %%%% !1110
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MGP]^$45[>J\+"[G2U8QHC#KN7(ZUGC8NIB5)%8*<885Q.@_X(8+&GPX\81P
M!%U],8[_ +LU]\5^?_\ P0:23_A4WBQK@GS!KL8;Z^6U?H!59FKU(OR,\L^"
M7J%%%%><]CT>H4445(PHHHH **** "BBB@ HHHH6@/40J'P&Z YJ2.YGM)1)
M#*00<KM.,4S(Z48!&#2:4MQQ;CL?0_P!^->I>*[5?!WB28R3Q+F&X/ VCHN*
M]-O+:2WE\N1",U\;^']<U'PYJD6J:;.5>)PP&[&<=C7U%\(_C%I?Q1TM+/5'
M2'4$4"55X!;VSUKDJTU%Z'92J7CKN="/D.UN/3-+3I%D29D9 << GTIM8.R-
ME=A1112*=@HHHH$%%%%-.S ****3U=PW XSQ2Y&,8Y]:2BA*VP/5W.7^+7P?
M^'_QJ\%W?@+XDZ%'?:9J,30W43@?,AZX...E?+/[,G_!-S]F3_@G!JOB[XW7
M=U9P6<M^UQI%PS,!80%/]421R21UK[/#8'(! [&O#O\ @HC\"/&W[0_[+.N_
M#CX?70BU"YVRH6FV#"*V1G\:ZZ-:46H2>C.7$4DUSM:GY<?\%/?^#@63Q?8Z
MQ\!?V>M/G@MGC>"ZUZ"X5HYU/&T#(((*_K7Y6^&=!^(OQU\>)X=T*&[U75]4
MN 6C1BS-D@$X)]Z]Z\)?\$HOVL/'OQTN/A5%X0DCN5O#YUS.KK%M9V .\KCM
M7[B?L'_\$O?V=OV%?@M#X@\;Z+I=WKZVZW.J:EJ@C/V:15)9(Y">AQGZBOH?
M;X; T5[/5L^<EAL1BJMZCT1\H?\ !+[_ (-^+;P->Z-\=_V@[Z":ZBD2>TT*
MXMV62!ASN)P0<@U^L?@SX?>%/ =G_9WA;18;6(C)2) .?7@5^/\ _P %2/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M36Q^3[.V#(?7D^E?<7_!._\ X)J>$OVB/@IKWQS\:ZO!-;6-C*\&G-&=P9&
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MFOX1?M!1VEK\5?#2ZDMD2;9BY&PGK75^%?"NC^"]#@\-^'[<0VEM&(X4'.%
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M4<9XKPKQ9_P3)_8Y\::U+XBUSX7![N8DR.ER5!R?05[%_P +0^&O_10=$_\
M!K#_ /%4?\+1^&O_ $4#1/\ P:P__%5*G5Y;%M4WJS@?@Y^P]^S?\!KJ;4?A
MIX#CLII6#2,\F\L1]:].U?P_I^N://H%_$&M+B$QRQ]-RD8(K/\ ^%H_#7_H
MH&B?^#6'_P"*H_X6C\-?^B@:)_X-8?\ XJIE[24;$P]FI7..^%7['_P'^#/B
M2[\5^ ?!ZV5Y?2^;<R"0G<V,9_2O2;^TMM0M'L;J#?%(NUDSVK&_X6C\->WQ
M T3_ ,&L/_Q5+_PM'X:_]%!T3_P:P_\ Q5.ISS2OT+INE"]NIQ/@[]C7X!>
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MX4[H[WW"BBBF(**** "BBB@ HHHH **** #'.?:DV;GYZ4M% !MRV">,5L^
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M)N)()S7[0_L2?\&WOP=\,>&[/Q3^U UOXBEN[<22Z7Y31/;L1]TG'8U\#_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBFN2#P: '44P;FZ']:?0
M4'ITHI&Z&@".3<1PN[_9KD/BOX['A+2/(M1ON9LJH4\QG'6NBU_6K;0=,DU2
M[8K&@P>.]?/GCGQ')XDUZ6]\]S$?N@]JTIQNS.H[(S+V]N;^XDO;IMS2MF0G
MUJ/:5X7[O:D7&WCH?6E[<5V1]TXY-R8?+V/UHH Q11>X6L%%%% !1110 444
M4 %%%% !1113MH 44G&2305!ZTEJQ-V&R0J\1C$>0W#$],5\M_\ !2+]B?\
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MACX6>';*XOF:&*XTBR99X\G@J57(/%<4:T%6?*=*HMT$V?HX_P */B!\-/\
M@FM>> OBM;RB]L;&.-1<+R L<F:_G[\90QQ>+-0CC'RK>2Y?M]\U^_'@C1_B
MG'_P30OM5^*E_<W&I7]A',1=R,SI^ZDR/FY%?@1XUWCQ;J*3C&;V7@?[YK#
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MF= H498\BNG*>7V+26IS9O[3ZPI7T/VS_:E6#XD_\$L='UG57$TUK:HJ,PY
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ML+*C6=]#_4?PHXQP_%/#=*TO?BDGZC:*0L@P,TOTK@/U;FDY:A1110,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7EN7YA3E]3?O1Z=S[FW?[?Z4;O\ ;_2LGPKXDL/%FCPZQIMPLD4L89&5L\$
M]JTR0JENI[BL'&Q\Q4IRI2<9;H?N_P!O]*7#?WOTJE>ZM86*[KNZCB ZEW _
MG3]/U6QOUWVDZR*?XD;(HY0=.:AS6T++*0,YY[TU3ALD<>M!P.YP:0.2-J@
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MM+<^NRIRRG"O&R7O/X?4\;^#OQJ\6_L@?$&+X0?%FZD;199%ATZ_G.U/4X_
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MX ?[A/Y#_P"-OK2TG\;?6EKDAN?TI+8****"F%%%% @H]L9SV]:*/F_AZ]J
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M5:5VC]6?V2O^"P/[/OC;]GZW^ 7[6?A:"6RL8(X U]=8$RJ#SC/O1J'[6/\
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M!<77B>PN//T>6]FSY-I#&S,B,W('3@5\OQ#@(U8>T@?T/X&<=RX=SN-"I/\
M=R9S*[5.&CP.Y]:#C/%3ZG:OI]]<:<WWHG9<_0XJ < "O@)73L?Z1X'%T\;A
M8U8]5<****1U!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,N2/UKUHJIP?>DFCCE4JR\'J/6B,[,\C"8N>!K*I3=FCY!_8S^/-[\/=7F^
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MZ*U/#I9:_:>TK/0^>M$_X(U_L Z7X+3P;)\"K$6S6XCN(RQ^<X&3^)%?@_\
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MQ4R14=BR"#T-%(J@<C-+4E!1110 4444 %%%% !1110 4444 %%%% !1110
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MIW@] R"V3-CW]3Z4M#+D@$# YHIII(;;>KW"BBBE<+,****!7"BBB@ HHHH
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MGW]K.I> O@AX#GUC4KN#3-#TJW#7$I&$@C&!D_I7R9^R]_P6C_9M^-7CG7/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO#/_  51^+WC"[CTK]KE9OB1X;8XNM"OY B3IW4D8KY9^4-OY)]#TH#[V9V
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M@_\ 06A_[[%?R3_\-6_M0?\ 17/$W_@WG_\ BJ/^&K?VH/\ HKGB;_P;S_\
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MM:'_ +[%"^*M '']KP_]]BOY(U_:V_:5_P"BS>)/QUF;_P"*IQ_:U_:5Z?\
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M6PWBOP^1D:K#G_?%(GBS0@/FU6'\7%?R4?\ #5O[4'_17/$__@WG_P#BJ/\
MAJW]J#_HKGB?_P &\_\ \52YHKJ)97C^76D_N/ZV/^$MT#_H*P_]]BC_ (2W
M0/\ H*P_]]BOY)_^&K?VH/\ HKGB;_P;S_\ Q5'_  U;^U!_T5SQ/_X-Y_\
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M;L;SJQI61]LQY0N67:&.0* 41=V<;NE?*/P-_P""HGP\^(FO_P#"+^+M&O\
M1;MY0L4>IV_DENG0,!ZU].WOBG1+#0SXCGO8DLUA$OFNX  QGK^-:5*4X05T
M9PK0G.R=C0+;0&E?Y>YH5%;@)E#T:ODWXQ_\%4OAWX*\3-X7\$Z!J.NW$983
M+IMKYXW#TV@UA>#O^"LWAJ[UN*T\:^ ==T>"5PJ37VG-"F?JP%)49R2YD+VL
M(M\K/M$G^''"\"DK"^'WQ"\+?$KPY!XF\*:K#=03QAB8I0VS/8XZ&MVHG2G2
ME:1=.K"JKQ DCD+GVH9@<;6VY[4UV"J6+8 Y)]!7A/[2/[>/PO\ @#.='DG:
M^U#H+.TQ)(3C.-HYJ$I5):&DG&"U/>GQ&F1+N)[4T%I!LD.UDY^M?#UO_P %
M<429;B]^$7B>&V,@!FET9PH!/7)6OH_X"?M7_"_]H&U$GA;5D%RJ O!)( P)
MXQBNOZN^3F.;ZS'GLSU12I4R%LD<8IBEP<;\&N&^-WQ_\#_ CP[+X@\7ZA''
MM7]W$' 9R1Q@=Z^6+W_@KI%</))H?PC\3W5LK$)<0Z.[*P]B%YK"G3E4D:SG
M"G'5GW"K!3\LV3WIPPS8:'(;[U?)/[.O_!4_X6_&7Q-_PB.I6ESI=YYA0Q7\
M0B8-TQ@@=Z^KX9X[JW%S;2;D90<@]JJK1E15V33JQK2]UDH,8)1SMY^7BD*H
MO5LFOD_Q1_P5+^&/A'XD:CX URUG26Q$J+^Z WLO0#U)-8?@K_@J:WB_QI9^
M&+;X6^(8X[Z?RX;F727$?UW;<44Z3E3NP==1FHLZ[_@IA\;_ (F_!CX6Q^(/
MACXJFTV\-W$AFAZ[2>17=?L&_$3QI\5/V:O#_CCQUK\M]J5W 6N9Y>KG/>O#
M?^"M>I-JG[/ECJR(4\^ZMV96&",D5ZM_P3,W#]D7POMZ&V.?SK>E3BL-)F->
MLYXJ-CZ!&5^93AOZ4;U$B&4[@QYS7BG[5?[7&F?LS/8'6=-GECO;N*#S(H=P
M7>P')[=:]/\ A[XTTSQ_X2M/$^CRJ\%Y'NC?.17,Z?M(<QTU)\DU'J;0*,^Q
MSA<\4[!C/EJV5[&O&_VJ?VNO#O[-5A9OJT#2SWMW'!''''N)+D <?C7H/PL\
M9O\ $'P%9>*VM)(&NXM_ERIM9?J*;I_N[L<ZB5511T8?>,L,'THI3G@L.<4E
M9(JR3T"BBB@ HHHH *?!--;2K<P.59#D,.U,I&*J06SCO1*.@T[,^E?V<_BS
M?>,=(/AKQ'>&6[A4E)G/)7HH_2O0+NU>S<[GSGJ*^.="\1:OX6UF+5=+N&1X
MB& #'!QV-?6'PY\<6'Q)\(VVHO.GVY(A]IC0@?,<]JX:L'<[:50T@01Q0,Y.
M?PI95,3;<=*09/:L$W<Z&D%%%%/<D****-@"BBB@ HHHIZ6$[VL%(&S$V4X!
MZ4M+\S?=QTZ5*<G8I)<FA^+W_!S5\;/B3X>GT'P#I?BF>+2KR^DBELU^ZZ^6
MQQ^E?G3^QC^P/\5_VV-5FL?AU;SW3P;PZQ)NQM&37[>_\%GO^"7;_MI?#D^.
M?!L\G]O:,LEQ!"\I",Q&T #OUK\F?V#OVS_B1_P2@^.]]X?^(7A*2*T1IDN4
MEL3YDC$;=R9'*\U]1@YQ^JVAN?*8N,XUVY;&=X=U3]JW_@C/^TY:7VL6%_;V
M$%VAO+)FV+?JH)V$]O6OK'_@J+_P46_9*_;7_8QLM5^Q6#^,O/M2UOYI:2$
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M.E+2MRE74@HHHI[BV"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@FBX-IW/M2UU+1_$FDQ^(M#NQ+#+P=O9L<TS)9A@X8#Y1ZUXQ^S9\9WTM$\
M:T%:VD?]RP7YMS'UKV[4+5;5@JJ=K<HV.@KAE!Q.V$^;<@/7FBBBH1H%%%%
M!1110 4445,KVN.^@4JJ2=J-G(R6]*2AC&B9.[!/)%:<R=,E1:W#/F PH3_M
M'^]7X=_\'+/PFTO1?&FG>-=.^&R6\KVR(^L)G.6<97\:_<5B1"T3#Y,<%>M>
M8_M+?LH?"C]JGPE:^$/B=I"SV]KJ,%Y'(J#>6B<.JDG^$D<CO71@,1.A4YGL
M<^,P\,12<>I_,!^R]^PM\?\ ]JOQ/:Z+\-O MW=VLT@6>]1,>6I[\U^U'[#G
M_!O?^SM\&;/2_&GQTTJS\5:E$L=P+>]MMIM9Q\R\C'W6 /X5]G^.KW]G']D'
MX>7'CJ\\.Z%H=II]MN;[/:10/*%P/EP!DU^<'_!0#_@XB\+:#X9OO /[.,#O
MJ&HV4D#W=Q"'2.-U*,5(Z, <@]B*]J>*Q.*DHTUH>+'#X7"1;GN??_[1?[:_
M[-O[&7@R9?&?BJRL/LL.+6R+]<#IQ["OQ@_;B_X.#?VBOC;<ZIX.^!^L7GA?
M2G:2V:>SNMPNH#E6R#V9<_G7PAK'C[XQ_&76ETG4/%6O>(+F]G;RK22]EN'<
MDDX52374:O\ L6_M(Z/X)?QQ??"C6TLHS^\']FR!E7&2QXZ =:ZZ.7T83YJC
MNSDKXVO5A:"T.)\*>#/'_P :_',/AWPM83ZMK.K3[;>%%.9'/.,U^JW[ G_!
MO9\5(_%'AWXJ?$_Q?<Z#-97$&H+;26H;=L8/LSCOC%>)?\$=/^"AO[._[*>O
M1>%/BS\/+6[FNW2--1GTR)V@(/)#LI*].N:_H$^$OQ-\$?%7P99>,/ >K6EY
MIUU;*Z&UD5O+)&=IQT(]*PS/&5Z*Y(QT-\LPE&L_:2>IT%I'Y5M'%_=0#/T%
M24B@ 8%+7S+5W='TT922L%%%%)Z#NWJPHHHI %%%% !1110 4444 % QGFBB
M@ .,\59TN]%K/D_E5;!ZXH^E!43L+>=9HED09W#/6I,=P*Q_#E]N0PN>G2M<
M9WD]L5F4+12 YS]:6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'5#!)Q>H03AA[5^CO[1/[5WPG_9E\.+KOQ$UF%"\JHMJ)5$IW'&<'M7XH_\
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MM%A*PVL(16?[Q SU/>M$[&35S31%CX08XQ2C@Y%%%1*1<8@231114E!1110
M4444 %%%% !1110 4444 %!=$&7;%% )'(4'U!%#=M1I7=C\R/\ @J;^SY^T
M/XU^.,'C3X0^&KF>6WNB\%U V"AVGFO+K#Q5_P %A=+L8M(M/%WB*"&&,+&B
MRC"@=!TK]@+C3M.NV$TNGPR$'DR1 FFG0-$)W_V/9XQWMU_PKJH8SV:M8YJ^
M$YW>Y^/>J>%O^"J_QMA_X07XA>(]=N=.NAY<R32 J5/X5]6_\$__ /@F'IWP
M0U1?B;\3_P#3=69"$M;B( IGD-D>AK[7BT31;<F6WTFW#]RL*_IQ5H H0 %Z
M>G K26-2^%&$,$^K/CK_ (*P_!GXA_%GP7H]EX!\//>O;K() A^[G.*^@OV:
M- U?PS\'M%T;7;4P7,-A"LD9Z@A *[V[TVUN9!'<01S;OOAE# ?3-2(D46$M
MD55 Q@CI6,:]H-/J;U*"=2+70\5_;<_9?L_VF?A7<^'< 7@A(M)-F2ISVKY*
M^%/CS]O7]D82?#JX^&]]XJL(&)M)IKG8%3HH 'H*_2';L8E>5'K5:32-&N':
MZN],AD8C +Q G]11A:ZIMI[#QE)U$N4_.KXL:G^VS^W!';^ M5^&]YX5TM_D
MOO*N/,$H)SR#7L'BO_@F3X,U3]FRW^&-A!''J,#?:5E$/S&?:.?KFOK>STRS
MM$$MMI]M&<?*4A4']!4SQJQR 2W?'2K>)<)>Z1[%RBN8_-/X0>)O^"@'[',E
MQ\-/^$(U#Q;H]HPCTZ&:XV+ @[#'K5OXD#]MS]N'4X?!.O>![WPGHRLK7*QS
M>8KKT8$'UK]&9]+T6Z/^DZ7$[-U=X@3^>*=!INFVK?:;+3H8WQC*1 9'X5:Q
M2EJUJ9O#2CML>0?!G]E#PK\+OV>8OA#;0)O-B(KJ39@RL <$C\:^&-)^!/[7
M7[$7QMU'Q7\*_"-WJ]A>SNYMDD"*59V;^M?J=^\(5FVX8?,*KW-AIUP0US80
MS#=UDC#']:R6)E&KS&[PZG2Y6?!?B+XX_MX?M)Z>_@32/AA>^$C<#9+?V]UO
M('?@Y[&O&/AK^P]^T%\ OVL;#79-$N=3M998)KN_?"_,Q+/G'N:_5J'3-*LG
M::TTVWC8G@QP@']!2RZ5IKR>?<VD3R+SO9 3^=;?7.5:(YWA)2=F]#P/]MG]
MEIOVH?A-':PKY6J6\(-M($RR$,6X_&OF;X4_%G]OO]EFU?X<7_PKO?%5G;DB
MVNI[G9M7.  !Z "OT;6-05**-K#[M5Y]%T6YEW7NF0.QZDQ FL88AMZHV>&2
M6C/SH^*-K^VC^W;J%EX*\1^ +SPOHL9 O(DG\Q9L-G)S[$BOIVV_8>\#0_LQ
MK\"&@CVB)V1S%TE=5W''U%>^VVFZ?9Y^R6$$0'1HX@#^E3JV],;0J_PY'.:)
MXG71!##77O,_,7P9\)_VV?V!/&UQ9_#70+_7_#EU*7.GB01QOC 4\>G-=+\3
MOC)^W?\ M+Z/_P *SM?A)>>&H+L&.[N(;K?O1AC!!^E?H=-IVFWBM]NLDE=3
M\OF(#_.HK71]+@Q/;Z9;1NIR&\E03^E:K%*2]Y&7U1Q?NL^?_P!@C]BJP_9:
M\$S2ZO*+O6-5D6XN9I(]K1MM((KZ+4-G@\^M&T#Y\Y+<D#M17+4J<SN=5*CR
M(J:UI%GK>EW&DWT(>*XB9)%;N""#_.OSN^/G[!GQE^ GQ@D^-O[,EU<B%IQ+
M-IMF@57 R<9QZFOT<SCDTV>W@N(3!]G5U[B10<T4ZO*QU::FCX"G_;1_;VU'
MPS_PC4'[/%S'>.@A.H"].[)XW_KFM']CW]@SXG:C\7)OV@OVA[Z>;59V22/[
M6@+9!.!D>@-?<4>A:&P\P:-;*0>OD+_A5I4C@7RHHQAA@!1P*Z%B%!JR.5X>
M33NS\[/VW?V,?BWX ^-=G\=_V>-/FGDC.ZZAM@%W,7!()^@K>B_:_P#V]/$N
MD+X+M/V?+JQNKB,0QZFMZ2T)P/G _#]:^])K2WFB,=U;1RC^ZZ C]:KQZ)HJ
M2>9_9-LI3E2D*@_RIK%7BU)&CPMFG%GY,_M ?L#?M9>(-;T[XQ^,+R_UK5X]
M1@D6VG S''Y@8C..V*_3/]FR3Q&WP8TE/%&GM;WBP[9H6.2, 5W%U9VMR@6>
MTB< \!T!P/QJ6.*&V&;.)4C_ +@& *FOBG4H<BV(I85QK\[9^=?PU_9T^+^D
M_MX7WQ"O/"DJZ6\L^VY)XP6&*_1& X0-*NW*C ]>*0:;IJRFY^Q19/5EC&[\
MZE"HI^7[O;/:LJM55*"@C2E2Y:SDSY5_X*A_"WQS\4?A''H_@;0WO+C[=$Q1
M#S@'FN^_X)^^"O$OP\_9B\.>&/%FEM:7MO 1-$QY!S7L]S8VMRF)[=)#G@.H
M(_6G100VZ>5!$J!?X57 'X5<*_+0]FC2K2O4YQ[[6'S#'.<U^8W_  68^#.H
M+X]TWQCX54I<:I-(UQY8Y<@'&:_0?XR?&[P;\$_#1\0>+I&6 . 2& YKXE\5
M?%"#]N[]I71+3P7I4[Z#H]Z?M,LD>5*L/4<=Z6$]W%*1GB6W0Y3Z?_8*^"MK
M\%_@-IFF0H!)?PI=3';@[G4$_P Z]LV+Z53\.:5%H>@V>DP@!;>V2, =L#%7
M:K&3]K7=@P:Y*>H9(&W/'I1117*=&O4**** "BBB@ HHHH !P=PZ^M'0EL<G
MK11@G@''UH"]B2QO+W2;R/4K*8QR1/NC8'E3ZU]-_ KXNS_$/1%T+6ES=P*%
M$K-DR=\U\OG&2/O*!SBN@^&7C$>!_%MMK[2R^5'D&-6ZY]JQJ0N:TI'UI-&\
M+FWDCQ(#DCVIA",1'YFU_2G:/K&F^,O#\/BG26+)(NUCGI@#-,DS@+'C)_B-
M<4E8[X:BY!Z449<\OC/M12&]PHHHH$%%%% !0>5VGIGI110%V+N([]::PXX&
M/4TM'"_,HRWH?2J2;V$TC\SO^#B/X(_&WQK\"D\9>"/%%Z^C:9'--J.F0H"@
MCQC!XSU(K\+]2^!OQ \/^,/#_@_Q3HTEC>>(YK=;&-QS(DKJ@;\V%?UYZYH.
MA>)--?3=?T>TOK:5<36UY LB./0JP(-?S]?\' FAZM\+_P!M;POXY\+^%UL;
M32+6&XM6CM D*R1S(Z+@#&,KTKW\JQ,I1<4M3P,VPT9R3N?;G_!,+_@@YX!_
M9ZO-#^-OQ9D34M=A*7-O97-L ;1L9R&'J#7Z%^//!?PUC\!ZII_BS2[9='_L
M^;[:DIPIAV'<#_P'-?D5\&/^#G>WT[X;Z;I/Q@\*7$VO6\(2YETVQ58FP !@
M8]*\8_X*-_\ !>OQ7^U9\,?^%7?"D7FCVTTJ/<2A##*P'WEW+@X(SQ3]CC*V
M(W)6)PE/"\B6I\C_ /!2#3/@=I'[87BRQ_9UM+6U\)I>?\2NWLUQ&!SG'XU^
MX?\ P;N7EQ>_L3SBZN2S1ZR<,?0 \5^ 7P6^"/Q._:4^(MKX)\#:;<:A?ZC.
M$:X*-((R>[&OZ7?^"4/[(WB+]C;]F6V^'GB>XCEO+V5;N38Q(4LO(YZ=:Z,R
ME3AA^5N[,,KC5J5G)*R/IP2HYWH,^H]*"40X9^H_*O.OC]^U+\'/V=/"MUXF
M^)/B^PM#:QES9O<JDLN.R@]37YT?M*_\''?@_P +^/=&\)?!*Q$D$VJ0#4KF
M\MUD46Y<"3!QP<9KY^AAJ]>#:1]!5Q5'#JS>I^KH&!UR.S>M%<)^S[^T-\.O
MVD?A[9?$7X>:W!<VM[")/)24,\6?[P'2N[KGE"4'9F\)JI'F04445)04444
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MVOB+P]XQU2UN+69)%>&_D0G:P.#AN1Q7!#*:^(7/.=F>E/,:&'J<D8W/M/\
MX*B?\$7_ !M^Q!;-XX\(W\^M^&<O(U]Y058XP"<\"O@S=AL$\=J_7CPS_P %
M?/AA\9?^"<FJ? [XZV4FJ>(O[&:&&155G9R1T+ G.*^:/V6/^"./Q?\ VF[N
MZ\>:H\'A[PQ*SRPW&K!H@$Y8'=D<8KHPU:OAKPJ/1'-B(4L3:5-:L^(""H9C
MT6D1T?G-?I]<?\$#/ ^L1OIW@W]IOP;J&H.,6UE;ZUOD=O0 -S7Q/^UY^P_\
M:OV.O%3:)\0M E^Q,?W.H1P,(FR>!N-=E#,*$YV1RSP-5PN^AXSE<;\\>M*=
MR#+C'I7UC_P3/_X)A^)?^"A<7B4>'M9M[8Z L99)I2I;=CI@^]>S>&/^""WB
M;2O$-U8_&;XL^'_#5O%*Z0-JUZ8-X!^4@D\YK2IB</1FXU'J91PE6M3BX'YT
M JWW3UZ4#I@_>';VK])OC7_P;]>./#7PMF^)/PB^(NB^)888#(K:3=M.&'M@
MU^<_BSPQJ_@W7[G0-<MGBO+2=HI49<<J2#Q10Q6%Q/N1>I5?"5L/%3EL41@J
M&SP:/FW8*X!Z'->X_L<_L"_&K]LCQ0NG> ="F2V\P"6]E@8Q*#WR.@K[3C_X
M( >"[%(-#\2_M,^#;357"[K.76MK[S_#C=US1B,51P[M)DT\/6Q.L%HC\N_E
M.Y0?F3J*0'+$'CBOK[]MO_@D)\</V4=/NO%T;1:MH4&6CO\ 3U9T9?7=DYKY
M4\):!+XG\56/A=_EEN;M8 3Q@DXYJJ%6A5CS185J%2#7.C-1793Q\W\(]:,X
MZU^B^K_\$ OB]<_!?1?BEX5U2"X.L6@GV([MY8W$<C/'2NC\'?\ ! KPKK]O
M;Z5>?M'^$$U:55W:<=8Q*'('R[=V<YR*Q>986+:OJ..!Q,[2:T/S%<,"%49)
MI WS$'L*^V?CA_P1#_:>^%?QBM?A_I>D-J&GWKN8-4M87>&-%.,LV:]?\#?\
M$$/"GB2VM]/O_P!I+P=%J\R@-I[ZQB4,1]W;NZYXJ7F%""Y[FCP5>I)1:T/S
M&,@X ZFOJW_@DQI_[)]Y\==2M/VP=$T^\T0:=&;:'4$+('+')X(YQBJW[?7_
M  2U^,W[$>I&Z\0PK?:+)EH=0LD9HPH.!EOKFN>_X)U_L9^)?VVOBQ??#OP[
MKZ6$UI9I,TKSLA(+$8R"/2M(8NCC*4N5V'4PE7#U(W6AD_\ !0&U^!EE^TAK
M]O\ L^Z?:VOA@:A)_9\5FI""/C;@9^M>*.CKAMOR?PGWKT_]L#]GS5/V9_C?
MK/PHUG4Q=7.F7SPM.92X;;CN3[US/P>^"_COXZ^,X/ WP_TJ>\O9G5=D<9;9
MNZ$@=N*,+*$HNSV%BH2]HDEJ<J'C8$JV<'#>U .\G9R .37Z8^"?^" DVG>%
M+#4/C+\:?#7AG4;^%7CL]6U$P.W.#A2WK7F/[9O_  12^,'[.?AN;XB^$=9L
MO$6AI"7-UI#-*N ,DYS[BLWF&$]LHL<<!B9TW/J?#A91U/7I2GAPN>#WKN_@
M+^SC\1_V@_B+;?#KP5HTT]]*^UD6(G8 1G('IFOO[3_^"!'AS0=,@M?BC^T3
MX2T74Y(U>2QOM7\J6/< >5+<5MB,;0H>[)Z,QI82M5]Z/0_,;;)YA7;QZT@8
MN 8ANYYK] _VD_\ @A)\3?ASX0/Q ^$7C;2O%.F6\!:>71YVN .">H)[ U\#
M:SI5_P"'=3ET/4[5XI[>1E=2,$$'']*,-B<+4?+!E8G"UJ45,K*0P)4]#@T4
M=1G@>U%=*5CE;3"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH /PHHHH .
M1T.*%+1MNC;&?O\ ^U112V=P?PG5?"+XL>(?A'XNA\1:/,S0%P+^S#86ZBSS
M&Q]#7MW[8'P0\!^*/ &@_M*?!/4%GBUVR-WXGT:W3"Z),6(6$'JV0 <^]?,]
M>S?L@?&"Q\(>.(_!OCR<S>&]2#"\@E;=AL87&[( KFQ$'&2JQ.BA/GARR/&&
MR9#P05'-"<Y;'6O3?VC_ (&:K\+?%4VK:7$;K0+^0S6>J0 M"6<EO+W=-P!
M(KS(%SRQ'M@5O":JI2,90Y'86BBBK)"BBB@ HHHH **** "BBB@ HHHH *,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HRO<T4JNT;_,HY[D4+<%\2
M&[2X  Y/:O;OA9J/_"DO@5?_ !1MT%Q/XD$VD2VS_+Y:_P!_WZUXS8JTNJ0P
MF)G5I!C8/>O6OVDIH['1-,T2.58T6WAD%JAP 2@^;:.,^]=5!\LG,^(XI?\
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M((./6GVTS6LZR*._(IE#?-R: .KTR]%Y!NP 1V%6<C.,USN@7QAE\EVZFN@
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MY*^$_P#@W+B1?VQ/$2!>1I<:C\)6K[=^/^\?\$+M'D/W/[!MN/\ @<E?$O\
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MY9510.6=L#]:IWFIVVC:*^K7T@5(HBS'IT&:_/7X_P#[9?QK_:E^*5S^S_\
M &46]FK^7>7(A^90258AU((Y%8QI.I5=SJ=14:2;ZGZ%CQ!H32>4-9M2WI]H
M7_&K:31MAT<$=B#FOS3F_P""37[1^D60\1VGQJU![V(>8(SK=R5W#G!&_P!J
M[3]E[]N3XX> ?C O[/G[120F2)(X;.XCM1'OR2JY)Y/"TUAO:W4.A#Q/)9O9
MGMG_  4E^)OB7X?? ;4-1\)>*&L;HE!F*0!L$D'BL[_@E7XL?6_V6[.^US6X
MY[F;5KK<TLR[R=P/2O _^"N?[,OBSQ%I0^,.F^,YTLHD.^S%[($;<QQ\H.#T
M]*Y+_@F=^P_\1_%V@Z3\;+'XBW,&G0ZDX;3EU&54.P\_(&V\Y]*WPM*FZ+<]
MT<^*JS59*&S/U&7;M!4Y'K399X88_.FF1%_O.P _6LV]O[3PIX<:^U!VV6EN
M6D8MUP":_/;XX?M;_&_]KGXJ7?P&^ ,QL]+C8)>W1C.Y5)*DAU((Y6N)1=2>
MB.UR]G"[/T23Q!H;Y UBUR#C'VA?\:MHZ2J6C8$ 9R#VK\U)_P#@E#^TKX=L
MU\6V/QIOY;N#$T<#:S<L"1S@KOYZ5W?[)O[<OQD\/?%QOV?_ -HR*-+F)8X;
M*>.V\H.22!DGD\+6L\-_+N8+%<KN]C[P+ #)/%0W&JZ7:2>5=ZE!$W]V295/
MZFO&/VT/VKH/V;/A<WBJR*2W<NQ;50H;);('!]\5\4^$?V;_ -KG_@H+=R_&
M#Q;\09]%AG/^BPVEU-:KA3@?*C =#44L-.?O/8WJ8F"A:.Y^GUOJ%A=G%K>1
M2^OER!OY5S_Q<UJ7PY\/=7U.TU 6T\5H6AD+@$-D=,U^;W@WQE^T;_P32^+%
MKX)\9>(Y=7\/ZO<AIKF[=YRK,P10'D)P.3Q7UE^V;\+M?_:8^ !UWPAXFDLD
M2S,TC0W+Q[@0./E(]:*M*%."E>YG0JU).TD?/'_!.;XP^,_B%^U;K]U\0/&;
MWWV2ZN8;7[5,N%3'05^B]O-!-&&2170_<VG(/XU^(G['7[(7CKXS_&B_\&>'
MO'%SI]QIU\_G7"7\D9DV8)Y5@3FOV.^!'P^U7X6_#2P\%ZOJC7<UJI#SRRL[
M-T_B;)KLK4H**;['+0G6G)V[GFG[5G[%_A']HOQMI'BS7?&8TZ737B:. JIW
M;'##K]*]M\,Z-#H&CP:3;S^8D,04/ZX KX*_X*P^*?$>A_&SPA::)K]_:))<
M6F];:[>-6_?IU"D9K[F^&$LK^"=.FGD9I!;J6+'.?E%<:?-2E9'7)6JQCU-Y
MF55WL<#/4U7FUO1H'\J;5[56]#<+_C7R/_P4!_;H\9?"#68OA#\'_)GUW5H@
MH8P"4(KD(>.H(W5X1X3_ ."87[4/Q>TA?B!XI^,5_97^H#?-;C5[B)5^BA\"
MB&';IJ<MC2O5<5RQW/TSM[VSN^;6ZCD'K&X(_2I"P4D$].M?F7\)/C;^T?\
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MP*@]J4L00&^\>A'3%?$.;E+4_P!!J4U7H*2ZA11G/(%% TFE8****!A1110
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MG7KWK@F*G[HXJZDKKTT//X;PL5@G66\G?[Q****P2LCZ6+NO>"BBBF 4444
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MWDT\XEFFN61E7S6/:OUP^+G@S_A/_AM?^&449NH#C([X-?F)^S=XWU']A/\
M:>U;0/BAHC1:7J4I6*YFA 0;Y&.<MGL12PTE*K)21>*@Y4H\K/>3^V/_ ,%
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M1>$I^AG2C)8N=B5]JG:5PW\Z2C)R03_C17FGHNP4444""BBB@ HHHH ****
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MT#$K*%B)X7@-ZT_89,<@8I& SA>2.]$YN<5'H@4$FY=6+@D;L9'K24BJ0.)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?\,9?L\?]%TO_P#P&C_QH_X8R_9X_P"BZ7__ (#1_P"-?-/]LZQ_T%;G_O\
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M?^_[?XT>RK_S![:G_*?2X_8R_9V[_'6__P# :/\ QI?^&,OV=?\ HNM__P"
MT?\ C7S,=8U<]=5N?^_[?XT?VMJW_04N?^_[?XT>RK_S![:G_*?3)_8R_9UQ
MQ\=;_P#\!H_\:;_PQE^SQ_T72_\ _ :/_&OF@:OJP.1JMS_W_;_&E_MG6/\
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MVQ&S[UT0G"6S,Y0L%%('!)5>2/2EX(# Y![BM3,**** "BBB@ HHHH ****
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M% Y&<44X\L=3K3YY:!1114)W!M7"BBBF(**** "BBB@ HHHH **** "BBB@
MHH[9)P/6EP,CYN#T-*^H3J\J2L)10,G)*XQZT=\'BF$HMI,**.-^P'\:*2=Q
MR=XV05ZW^RM>Q:Q?:O\ "1'VW'BR!+. CJ#G=_2O)*Z3X.^.8OAC\3=)\?/
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MC^S--_Y\(?\ OV*+T^P?O>YXC_PTI\8O^B76G_?YZ/\ AI3XQ?\ 1+K3_O\
M/7MW]F:;_P ^$/\ W[%']F:;_P ^$/\ W[%%Z?8/WO<\1_X:4^,7_1+K3_O\
M]'_#2GQB_P"B76G_ '^>O;O[,TW_ )\(?^_8H_LS3?\ GPA_[]BB]/L'[WN>
M(_\ #2GQB_Z)=:?]_GH_X:4^,7_1+K3_ +_/7MW]F:;_ ,^$/_?L4?V9IO\
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M>)?!\.GQA"PECD8DGTYKT"HX+.UMCFWMT3_=4"I*B5KZ&D;VU"BBBI&%%%%
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M0!]*[/\ 9A_X)G_M2?M80IXA\*>$+VWTVXVM;ZM=VC/%.I_B!!YK]:_V*O\
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M_9FT3Q4^ABX\V(@*D:YX13WKLHT(SAS,_(O$?C'.>':M"CET5*=1VU/SU?\
MX)K_ +6A(W^"HO9?M7_V--N/^";O[6"AIIO L"JHYQ=?_6KZ0;_@ME;2-E?
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M#+>2!L%&]!@YXKYI\(:"GB7Q%::3,^%EN41AGL6 /\Z_33X9^#;#X:_#'3/
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MM($& 1D<]#2U#=RTK!1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%% !1110 4444 %%%% !1110 4444 %%%% !37W A8QG<<-[4ZD.X*<<Y[4
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M(\,_8;_8S_X:"U.;Q!XDN9+?1[-'>:95!R4&2.>W%>Z^,OBU^P3\$KH> O\
MA6>D:O<6)V7%Y/9$ESZY5L&NJ_8UW^%/V'_$.JZ9;_OI8;A=Z#D Q-SFOS:U
M.XNKN]FDO+PREI#N=V)/7N34U*JPRC&*UZGO83"8KCSB+%*O5:ITG9)-K6WE
M8_7_ /8O\"? ;5[F?XH_!R9+>&:T=9+*"$*J,02>,DU^<?\ P4("-^UWXOC.
M<&_Y/KQ7TC_P1J\6:K%J&H:%]J=K<P3-L8D\X-?-W_!0P+-^UOXO$K@!;_\
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MXN<N(:ZSN<HI/W'K9+I\/ZGFW[:/[+OP9C^'4GQN^#VNVZ6TD1F>PC9$V#L
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M,KGGU%*WSX+<XZ9H)8_>[=..U%?1M/1(^;5[78'DY-%%%42E8****!A1110
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MLC()*CWKY+!.2#(&QZ5G3G[70NK#D0M*HR<&DI"VWD'FKC:#9FDTD*I90?+
M;_>H&Y5  !)^]GM2 J@PX.&[BOH[_@GA^P%XI_;E\<7/AW1-2BM[;3W073RQ
M,1AOI2KU(TJ?.72@ZE3D/G+CH#DTGWU)!P1VKL_CY\,'^#OQ2U7P*\H<Z==R
MVY90<':Q7//TKC=O =3UZTL-5C6AS!7IRHSY0+!N0,49XQ@445I>Y&P4444
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MIX;DW?=G@X#@[B6OQ!ALQJTXPA%[1Z'-?L,_%NU^$WQUT_5KY$6&\FC@E+'
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M\,+GX>QZ7-.MRDBB6(KCYB/6O#?$_B6;Q!XRNO%@A>-KFZ\XY/(/'^%%:O\
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M-[I/IL?1GP-\7>+-1_8_EUC]HQ4D#:<"9+V7=))[L#BORK\=2Z?+XTU>XT@
MP'49C$N, +O.,5[#^T7^WC\3_CO;3^'8KK^S]&?*BT6(*54]LJ:\())E+#(/
M5B3UKS\14A4JWCL?6>&/"..R)5L1BM)5'\*V0;=ZK..=W7/:EI6X.5/RMT%)
M6!^O7<%:VH4444%<SFKL**** "BBB@ HHHH **** "BBBDVD%ELA5*D[3299
MOW@7@=:1V"IRA//44I+0G<IW.1R!VIK4F2L[+9"PP2S2K# H9IG"HI]3Q7Z#
M_L%_"MO@Q\*)_%%S%NU3Q%;FWNHWZ1(&#*0>]?)/[*_P"\2?&?QO!<KI<O\
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M,67BCQ);27Q(8Z<L^V3:?XN1TK.5&2G8T5:/)<]D&U4(N"1G^[SBC.]L19)
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M  *^]OVWO^"4_P $?VIM$O/$%CI?V+Q.X+1ZE+*2@[D;0.YQ7Y)_'#_@D_\
MM8_"KQ/+H>@?#74_$,'F$1WFGVV$QS_>-?04L32Q=)*6Y\[.C6PE5R@C]$OB
M/_P7&^ VJ_L^:KJ6C7\RZ_<0-;PVHM6"KO1AN!SV.*_-_P#8 USQ7\3?^"AW
M@3QAK/V[4GE\5B2YNO*:38A$F-Y ^4<XYKGM+_X)X_MK:EJ$&F7'[/GB.))9
MEC,K0+M0$@;B-W09S7ZM_P#!(_\ X)I^(_V0[C4_&7CV[M+J^U6RB41M:$/
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M]ID-CXCU;0(6N[DQJ69R9$)Z9Z8[UO+&K#X)32NY:'-'!^UQ;@WHM3Y-N?\
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M$XQL)@9SCFE.<Y!Q]***:;2L).,8V2#D# //K00N[<JX^E%%*7O;B?+)ZH0
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M ']I36[KXD_L^^/K*&W);[2]O/(V9CSU &*X,,K5FGL>EBW+ZNFEJ>E?'O\
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M[*$-LZ_-ZE&Q7P__ ,$4)DF^(GC-[<@J80>/^NU9X2K*<9MEXF,*<H+N<_\
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MJ'PN^._B*/4+^*U>9)HX1& "Q"C&3V%<];"5\1352?0Z<-C*$).,#M/VB_\
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M9IM[9;'* =3CK7YB6]Q<6]XEQ#=;71LJ5XKHRIJ=%QEN<V<1<*D:L-3]S/\
M@OIX#UKXC?L+^#O&/AF22XACBL2XB^90HB0D\5^%QBDE80HI+ X QS7ZZ?L,
M?\%9O@A\:_@0G[+G[9(CBLD@-O:ZG?7"I'$ NQ2< DX %2:?_P $]/\ @D-I
M'C5?&5[^V;X)NM,BD\QM,CN)P[ =L^7BL<--Y;B9J2NGL;Z9CA5KJCU/_@C?
MX(U;X3_\$JO&'BOQ@TEHET-2$4=Q\N0RD@@''K7Y@?LSZE!JG[>&FZI;-N63
M4\J1^%?9G_!1'_@KQ\)%^!P_9@_99TAK72+;]PUU;W"LDJA0A88P<'&:_/\
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MO\K^X/\ 6_(?^?T?_ D>=45Z+_PR3^TG_P!$=UC_ +]+_P#%4?\ #)/[2?\
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MM8_>CSL!=A5O2D))&PCCUKT0?LE?M*9X^#FL?]^E_P :4_LE?M*=_@YK&?\
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MJR61G#N"0#C@8KZ&QM?&_/%>/5H5J<GS,]K#U*=6/NBT445@;!1110 4444
M%%%% !1110 4444 % (SM/?I129 R?[HS0!K>&KQEF-JYX.36\N<<UR-C<FV
MN%E'<@5UD$@EB#CTJ9%1'T445)04444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% GL%%%%1+<:$Y!Y P*\<
M^/'B&&6^73$NI,  A<<9KUK5M1M=*LVU&_N5AAC&9'?H*^;O%VKRZUK\]W<7
M8G3S"(BOIGBNBE"YC4=C./F9_>GYN_-%!# X?KWHKK.4**** "BBB@ HHHH
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M?#+Q3/9ZA%&T:,SEEV-@,-I..E:_Q'^.<_QF^(5IXX\86S+JSS+]MOY" KJ
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M!).3)5O;B/\ =QW4C(1_&?TJ+8PW'/5N>:*/QJ:<*<=RJDIR@HK0:ZN9 JX
M'5@:F-_=KA8[J0JG')J.BG.-*<%%]!1=2,KIA/(\@W33,?44B,BCS"<#'&/2
MEHI<L%\.@^:;=V"JRKQ]WM1116EGT,FFF%%%%&VXTF%%%%2VA6L%%%%-:L H
MHHHEH] "BBB@ HHHH ****%H-O70,GM2,5QCO]*6BA:$JZ=V-1"!P<D^M?3/
M[!WQRUJ;48_@'J5SYNGZA.1IT$K_ "BYD. <=N<<U\SN0JY(K2\'^+-?^'_B
MNQ\;^%[SR+[3;A)[20#.R13D'WKBQN&6(HN)])PSGF(R',Z>(I2LTT?H1\0O
M ^O?#GQC?>"?$T21WFG3&*9(FRI/7K6-[5VEOXZA_:;^ VD?&^\7?XE@L@_B
MZ^!XNKAB<-@?=XQ7%*=S94;^.HK\NQ]"6&Q#B?ZI>'G%-+B7AVE63O*VHM%*
M67;C:=PI <C)KFV5C] <>5!1112$%%%% !1110 4444 !)*[!U-;GA?XD?$#
MP?!]G\(^*KRP4\.+:;;Q6'1DCH:J-2I%Z,Y,5@L-C8<E:/,NS.R'[0_QP;YD
M^*.L +PW^E'DTO\ PT/\;B/^2H:Q_P"!1KC**V6*K_S'C_ZI</WO[!'9?\-#
M_&__ **?K'_@4:/^&AOC?_T5#6/_  *-<;11]:Q'\PO]4LA_Y\K[CLO^&AOC
M?_T5#6/_  *-'_#0WQO_ .BH:Q_X%&N-HI?6L3_,'^J>0_\ /E?<=E_PT-\;
M_P#HJ&L?^!1I?^&A_CA_T5#6/_ HUQE QGFCZUB?Y@_U3R!?\N%]QV?_  T/
M\</^BH:Q_P"!1H_X:'^.'_14-8_\"S7&,,$%3FD8;F!)I/%XE?:'_JED'+=4
M%?T.T_X:'^.'_14-8_\  HT?\-#_ !P_Z*AK'_@4:XRBFL5B/YA1X3R!QNZ"
M^X[/_AH?XX?]%0UC_P "C1_PT/\ '#_HJ&L?^!1KC**/K6)_F'_JGD'_ #X7
MW'9_\-#_ !P_Z*AK'_@4:/\ AH?XX?\ 14-8_P# LUQE%'UK$?S!_JED'_/A
M?<=G_P -#_'#_HJ&L?\ @4:3_AH;XW_]%0UC_P "C7&T4?6L3_,+_5+(/^?"
M^X[+_AH;XW_]%0UC_P "C1_PT-\;_P#HJ&L?^!1KC:*/K6(_F#_5/(?^?*^X
M[+_AH;XW_P#14-8_\"C1_P -#?&__HJ&L?\ @4:XVBCZUB?Y@_U3R'_GRON.
MR_X:&^-__14-8_\  HT?\-#?&_\ Z*AK'_@4:XVBCZUB?Y@_U3R'_GRON.R_
MX:&^-_\ T5#6/_ HTH_:%^.#<?\ "T=8'_;V:XRBFL5B;_$-<)Y!_P ^%]QV
M4O[0WQNV+_Q=+6/O?\_1KK_$'C?X\:-X,M?%C_%36"MQ$' ^V'N37CG5*]I^
M(/\ R0?2/^O-/YFM(8C$2^T?-9YP_DN%JPY**U.+'[0_QP'3XH:O_P"!1H/[
M0_QO/7XH:O\ ^!1KC!R**CZWB/YCZ&'">0SI1?L%?T.R'[0WQO[?$_5__ HT
M?\-#?&__ **AK'_@4:XVBI^M8E_:-/\ 5/(?^?*^X[+_ (:&^-__ $5#6/\
MP*-'_#0WQO\ ^BH:Q_X%&N-HH^M8G^87^J>0_P#/E?<=E_PT/\;_ /HJ&L?^
M!1H_X:(^-_\ T4_6/_ HUQM%-8O$?S!_JED/_/B/W'9?\-$?&_\ Z*?K'_@4
M:/\ AHCXW_\ 13]8_P# HUQM%/ZWB/Y@_P!4LA_Y\1^X[+_AHCXW_P#13]8_
M\"C2_P##1'QP_P"BH:Q_X%FN,HH^MXC^8:X3R#_GPON.S_X:(^./_14=8_\
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M$&<]<]J:ZHXW.Q#+P *\<_X> _L:?]'$>'_^_K__ !-'_#P']C3_ *.(\/\
M_?U__B:'!M6L$)J/4]C+[L#:#Z9I0&"D'[N>?K7C?_#P']C3_HXCP_\ ]_G_
M /B:/^'@/[&G_1Q'A_\ [^O_ /$TE"::$Y0<KL]D.V1E0,1SSBDD$0.T@@CN
M!WKQS_AX#^QK_P!'$>'_ /O\_P#\31_P\!_8T_Z.(\/_ /?U_P#XFGRR4KI
MY1>Y['B7A2JY[8I71@?F4 >U>-_\/ ?V-?\ HXCP_P#]_G_^)H_X> _L:?\
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MO6D(^?(^5O:O'/\ AX'^QGV_:%T ?]MG_P#B:/\ AX#^QK_T<1X?_P"_S_\
MQ-').]TA)QN>QD#&2@)[G%(X+?*"5/?;Z5X[_P / ?V-/^CB/#__ ']?_P")
MH_X> _L:?]'$>'_^_K__ !-)PFXV+E4A(]C(&S9;<N.[4@7G+=>_UKQW_AX#
M^QK_ -'$>'_^_P __P 31_P\!_8T_P"CB/#_ /W]?_XFA1JV2$I4U&UCV.D;
M/W0Q&>.*\=_X> _L:?\ 1Q'A_P#[^O\ _$T?\/ OV-1T_:%T!OI,_P#\32G"
MI-#56*1[&X7 AD48[,.M'SL#'(!P.W<5XY_P\#_8V_Z.!T'_ +_/_P#$T?\
M#P/]C8\?\- Z#_W^?_XFJY9<MK$\Z/8P H^5B/\ 9[4K^8#\D:E?>O&_^'@/
M[&G_ $<1X?\ ^_K_ /Q-'_#P+]C7_HXGP_\ ]_G_ /B:.6?8:J12L>R-][!X
M!["A@B#(=@?05XW_ ,/ ?V-/^CB/#_\ W]?_ .)H_P"'@/[&G_1Q'A__ +^O
M_P#$TO9SM:P*HCV,E_\ 6&-?;'?ZTFW8P:0DDG[O:O'?^'@/[&G_ $<1X?\
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M6FFM&L2YY(.#QVK\R?VPO^"7G[0?[*EQ'JUWX<EU/2KN4Q6[Z>&N) P&265
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M&ZY'0T&.16VLW!]#3]QQC--  Z5]-=)V/FF[JXM%%%!(4444 %%%% !1110
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M&#_V;O\ H^CPK_X#2_\ Q%'UB/8/J\^Y\K45]4']@[]G#/'[<_A7_P !YO\
MXFD_X8._9Q_Z/F\*_P#@/-_\32^L+L'U>7<^6**^I_\ A@[]G'_H^;PK_P"
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MV<?^CYO"O_@/-_\ $T?\,'?LX_\ 1\WA7_P'F_\ B:7UA=@]A+N?+%%?4_\
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MO0C ;!S6G,H*Q#30M%&"&" 9/\Z,@GA<>M);7$%%%%, HHHH **** "BBB@
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M $1C0/\ P 6O0J*/:R#V*//?^&4/V;O^B,:!_P" "T?\,H?LW?\ 1&- _P#
M!:]"HH]K(/8H\]_X90_9N_Z(QH'_ ( +1_PRA^S=_P!$8T#_ , %KT*BCVL@
M]BCST_LH?LV?Q?!C0/\ P 6D_P"&4?V:O^B,:!_X+UKT.BCVL@]BCSP?LH?L
MU_P_!C0/_!>M+_PRA^S=_P!$8T#_ , %KT*BCVL@]BCSW_AE#]F[_HC&@?\
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M'_1%O#W_ ( +7H=%'M9![%'G@_9._9O[_!?P_P#^ "TO_#*'[-W_ $1C0/\
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M8:W.JTBX-S:!V[5:K$\.7I+>0QX]*VAG=R?I4%BT444 %%%% !1110 4444
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MVFY_Y^'_ .^J/M-S_P _#_\ ?5,HH]E3[![2?<?]IN?^?A_^^J/M-S_S\/\
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MVL0IS[C_ +3<_P#/P_\ WU1]IN?^?A_^^J910Z4%T#VDUU'_ &FY_P"?A_\
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MF7M^7F;T.K+714N6VI[_ !JP)B0 ;.,TX%/,,39WX^;TQ0RH%6-CAB/NTK
M\MQC@^IKYQRD?21C&2T# '"].U%& .!12#8**** "BBB@ HHHH **** "D)
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M7++EN1%3C=(N:%X>\1^([G[%X8T*\U&<_P#+"SMFE;\E!-)KNA:[X;O/[/\
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MXR.QJC0XR5 ].:RDF5%GU1H$'@W]NVWATB\72/#OC&&!(@?-2VM90H"J[.Q
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M*_-L@!0$7'K7V-^Q'^TSX-;X4S? SXI>(8K:&W>6XT@7#?>N'/ 'OP*^<SS
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M-GI<C;H(%ZI(%/W9,8S7K@5$ $8_$T%5C(1$[<D>E.8*HP@I-Z#BA%./O"C
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ML48[U)) _E3:N[$N5DF>A44*0PRISBC(QG/%%TM&%V]@HI2/D\S/R^M("#@
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M$1'YV^4YK**!\(R[B.1793C8XYNXM%%%7(@****%L 4444 %%%% !1110 4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M)I/[6G[/:^*M/TNR@\;Z0Z120VB!?M-L@R\KXY9R!UKY9.YD0%MY'0>E=/\
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MU]-ZC+-#H5U<IG<MK(R/Z$*37P'\!_VI?CAXE_;<U3X;:QXTFFT:&2(0VQ'
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M8\.W7V2ZPQX:NE!R0P/!K,T'44@4 YI: "BBB@ HHHH **** "BBB@ HHHH
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M.4)(^,_A!^S-\3?BYX7N/'W@?1GO[;3M5@M+NW@C9Y=[D8(4<[0.M?O_ /\
M!/7X&WOP*_9IT7PKKVCVEMJ.TRRFWC .'52 ?>OSR_X-Y[7Q4_B+5YK1G?2/
MMO\ IJ[<J9/+^7/ZU^OP1!)^[7.1R!VKS,SK1J,]7+*4H(4Y/WN:*" #P**\
M=2NCV+>]<****E;#>X4444Q!11136CN'2P5Q7[0WQ8TCX'?!S7OBMKY?[)HM
MF9YA$,M@$#C\Z[4G S7P3_P7F_:'UOX4_L[P?#G2[)FA\8136EU(KXVJ!NR?
M7I73A(.M61S8NHJ%$_(']JOXVWOQ[^,VK>.KE?W4U[)]C&.?++9&?>O.RNQB
MA/(ZT$[L/&O(&":"HP&'.?XO6OLJ<5""1\94DYS;"BBBM#,**** "BBB@ HH
MHH *%PO:D.>U!^\*+V#R/1OV1P#^T1X3/_4<M\?]]BOTF_X.%B!\,_AP[C)&
MC2X [?O6K\N_@IXVA^'7Q2T;QG=1[TTS4([AESC<%.:^K?\ @IO_ ,%&_"W[
M:'A3PKH?AKP^EH^B6#PSLD^[>2Y.?UKS<QHRK5Z;1Z.45%AYS;/C"TO[K3;Z
M.^L)F22,@I(IP0?K7Z]_\$;_ /@H!X;^+_A-/V1OC?<I<"YA%O8FZ 92H7N6
M]VK\?@T:-Y1.T=D]ZZ7X2_$G7_A+X_L/'7A?4'M[NRE#++&<$#(R/TKLEA:-
M?#.$EKT.6.+JT:_/':^I^M6G_P#!)#PQX-_;V?6=7TU)?##^3>68< QR2.[,
M5]",$<5D?\%*?^"DWQ[_ &/_ (KQ_"KX*>!K33M)LO,BB!L#&KJIX*X&".>U
M-TG_ (. ? .J?#/2](\6^!X[O5M(C1HKM[O#;U0*#U]JY_XB_P#!7+]B3]HV
M*PU3]H3]G33]:U"T@*17-S>X(!.3W]:^>6'Q=*K:2O%'T,J^$KTTUI)G _LP
M?M0?MV?MR_M)^&;V]GU:PTBRU.&6]ET_SH[=T!(()& ?<5ZK_P ').CWFGR>
M!XI!)*8=$D$DS9.3YIZFO,]0_P""T/P]^!\D/A;]E'X4Q>&]%63<\=E<Y7)^
M\>3ZUR/_  46_P""H7@K]M?X(Z1X>O/#L:Z]8V2Q->&?<S'>23C\155*-2K6
MA4@M+DTJ]*C1G&;W1[W_ ,$)?B]H/C?X%^*/V<;F_AAN_P"RY7@29PN]I' P
M,]>E?GW^W5\!?'_P>_:(\1:=KOANYBCN-2D:U?[.P611@9!QS7'?L\?M >.O
MV</B':_$+P/JTMG/;R*\@B;!D"DG;^M?H-?_ /!7/]DSX_:!INJ?M2_ *RU_
M6;"V$<5W>7>&Y.2>#ZUWU85Z&(56*/.P\Z%>FZ<F4O\ @WR_9?\ 'NL?&"_^
M*&LZ-/::9!:Q-;RSQ,F]E<Y SUZUXE_P6OC1/VO-21<DFXG*D]OF6OH+P7_P
M7-\$?"KQA9>&OA/\.8]&\)6<RO\ 8H+KY'!^\,Y]A7Q5^W_^TWIG[5?QSNOB
M/X>TP6T,LDA\I9-V-Q!Z_A6,(8C$8GVLT=%&>'PN&E3@SZ*_X-^!(_[3&L;<
M K9P'!_WS7E/_!8%G/[7.M':,B\GS_WTM9?_  3/_;#\/_L<?%J\\<ZYIJWB
M7<,<85I-N-K$UQ_[;W[06G?M*?&[4?B-I.FBVBN+B1UC#[OO$'K^%=%2E*IB
M8OL<M.M&&&E%=3]%/^"!OQ;\*^/?@YXK_9]O[Q8;L:3B-)F"^87E7@9Z]*_/
M_P#X* _ +QG\&OVB]>L=6\/7445WJ,LEJYMV"NF0,@XYKB/V<_VB?'_[-WQ#
MM?B%\/\ 79;2>&56ECB.-X7H*_0"]_X*X_LE_M Z!97O[57P!LO$6L65N(4N
M[R\PVWJ>A]<4L71G1Q"J1+P5>%3#.E,\8_X(Q_LH>._BA^T]I'Q#N-!G@TCP
M]>Q7<UW/"RQNO*D!B,'J*U_^"]7Q@\/_ !%_:4T_0= F$B:1I[VLA3! 977T
MKN_B1_P6F^'WPN^&*_#7]D'X81>&;64.C&QNL[0>>Y]17YX_$;XB>)OB?XPO
M?&OB[47N+R]G:1WD/.6I1]MB<5&I-;#:I83"2A3>Y^B7_!N4%3XI>,P3EAI]
MOMS_ -=!7RE_P4RVG]JKQ'*RG<-2GZ#_ &JZ[_@EK^W1X<_8E\7Z[XC\3:&M
MZNJ6T<<:O-L^ZP->.?M7_&:Q^/'QEU3XBZ3;"WAO;J2180V<;CGK6U2DWC7(
MYZ55+!*/4^T?^#<UO-^/VL21D@@0</\ [PKP;_@KI@_M<:QLSN^T3<GI]^I/
M^"7/[;_AS]BCXE7_ (N\4:,M['<B/:CR[,;3FO-_VV?V@=)_:1^,]_\ $72K
M 6\%S*[+$'W?>;/6BI2;QL9ETZZ6 E![W/H;_@@[&Y_:_P!'D8C<=1BP%-8/
M_!6P0K^W!&'W9^VC./\ KJ*\Z_X)Q_M9:'^R'\=-.^)>MZ6MS#;W22%&DV\#
MWJC^VK^T[HO[1O[0H^*VCZ>L$(N _E*^[^,-U_"HQU%U<9&:-,#6C2PDX/J?
MIW^T!N3_ ((TRJQPO_"//C/4\BOR*_9Y\5VW@WXTZ%K5\^V./5X"Q/8>8#FO
ML'XG?\%3_!_C/]A!_P!F%?#2+??V8ULMU]HYR2#G&:^!5DD$GVA'W2"3*L/X
M>:*-!JLV3B*\94(KL?LE_P %A/@]>?M1?L@^$_C3\.T;4(=#L)9KE+/YV8'(
M& N<]:_*+X*_![Q9\4?BCIO@6'P]=EYK^.*9%MVW*I< D\<5]2?L/_\ !7+Q
M=\ ?"D'P?^(NFR:[X72,126TTX5 G<5[)IO_  5 _8-^'&I77C_X5?LT:;8>
M(Y8V87T-YE]YYSU]:RC'$82<G%;F_/A\9ATF_>1R/_!2_P#8C_9__8^_9_\
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M<N6ST%/&-WR]>]5<^'KX[$XEWJ3;?F[@D4<:[54"D90*<6 ZTWYFI'*K]1P
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M+*CC8>_T:V/R[_:$G.@^$-!\&6CX2QC99(7/SI]1VKR5.GF,WM@5]Q_MO?\
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M?M-^)+C6/$-S+::)IE^Z0QQ,4,SQL0,CNIQ7NUE86NG64=M8VL<,,8Q%%$N
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBGHT"6MSC?C_\
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M4ERTK2W/EK]AWQ-\4?"O[&7CH^+M(U73&L[R.*RBO[=XB(S$V=H8#CZ5K?\
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M=O\ @LI^[\/Z$0<DZQ:X/_ EKZ@_8O _X9R\-1L<DV?-5&2C0E8RFG+$1;/
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MVEM2T"\U.9[33+C-K;[SL0D$' Z"OV'_ ."BG[3</[*7[,NK?$B6W#FX;[#
MI?;L>52JL/H2#7\[7Q"\=Z[\2O%][XW\4:@]W?7<I9YI.I&3BO=RC#V]YG@Y
MOB+^ZC%8F/ ]>M*XV_*#P.E*FV1=\G![4TY/S9ZU]"]7<^>6BL%%%% !1110
M 4444 %%%% !1W!]***3U5B7[NH@7#%P>2,4K?,H4#&!VHHII)M7-(S:C= A
M"Y^4'(ZFD"@#BEHJ7%N5T*%HQU#CL,?3O0^'4J1U/Y444U4@I6>H.G+EYDQ
MHQC I0 .@HHI>[S\J&N;DYFQ H\ORR,\YR:%15.>OL:7ZT52;O9D\J2O$#R
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MXN[)DN4****:2E<5Y10H4L#C@C^]2 @KN!''7%>C?L]?LE?'_P#:KURX\/?
MKP)<^(+NUMGGN(+?JL:C+'GTP:Y7XF?#3Q?\'O&E]\/?'N@2:=JVFR^7?6$G
MWHV]#64JL55]AU-(4I2H^V,/@]**5CGD>G3TI*TV(W"BBB@ H!!94P<MW[4
M G!&1Z4&78=HX [?W:<4G*PF^57%,94E68$CGCTI <C->M_!G]A7]J7X]?#Z
M]^*/PH^%UYJ^BV*2-=W\)&V-4^\3]*\MUC1M1\/:G-HNKP&*YMWVS1MU4UBZ
MT85?9=C6-&4Z*JE:BBBMFEN9INX444A&1BD J_+T%'':@<#DT4:, 8;FWDG-
M*3EPX&"!CBDHJ6K,(Z@Q"#<W3VI2R* 64_-T-)@@97G/45W7P)_9K^-'[3/B
M=?!GP5\&W&MZB59EM;?KA>35SFHPN.$>:5CA6#1N8GZ@9.**[#XY_ ;XK_LY
M>.I_AO\ &3PE-HVM6J*T]G.?F4,./Y5QX.1FLJ4^>-RJD>25@HHHK0@****
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M[? C_@D3\%OA\FGZQXBMY+N\LI/,,<K!T<^A!ZBOL.QTFQMDQ%:JN.F!UJR
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M10M?N[/=2D8.&.<'Z5JM$9R?-(ZGPOX?LO"OAZV\.::#Y-G$L46[KM%:'<G
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M;@ _PMAO[_I7PS_P7$_8C\-_M)?LUZCXZLM.2/6/#5O)?S7BQ[FDC1!A:]'
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MHAPQY''M2,54X&<=LTM(RDXKL6B.-NXH&>]!XH' Q10 4444 %%%% !1110
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M4?\ #+7[2>/^2&^)_P#P3R_X5ZS_ ,/@?^"BO_1RVN_]_!_A1_P^!_X**_\
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MEM=_[^#_  IJ.-74KGPO8\F_X9:_:3_Z(;XG_P#!/+_A0/V6OVD_^B&^)_\
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M*5P>ZH37U9^S#^P[XI_;4_;#U;P1I"2+:_;YY;J98]P5$(+9_#-?;OQNNO\
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M=KL<U# SJ4N=NUS\DYH)[>3RKB%D;T88IHY.!7[%_M+?\$U_V.?VR?V>KO\
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MG\*'7!!0< T.6W*B)EEX(H.X/]G,F#U)I)6U03B]&#J2C2$Y)Z"E9^ 57KU
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M$DJ.E>.?!/\ ;(^&_P =_B!>>#_A[-%=PV:R+-<QL>)$)!7'X5[(BEERK;5
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M#?)T- "FODC_ (+#?M/^&O@7^RGKO@J_N+R+5?%FGR6FD7-BY5H91ALDCD<
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MBM\!?C%JOPE\9>%+NTU#3[SR'@$18!N.,@>]&$4:>.:EN:5Y^UR]*CL?H/\
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M(->8H5&68;??UKNIS31R5(.+'?UZ441Y*$,V<_=/]VC\:U,]@HP3T%%*%9B
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MX4YR"/WC[2._J*\]^-OQQT?X=-9>$M,F%SK^NN8="T]>L\HYVY'3@&J2)<C
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MU_P2W '[8_B7_KI>_P S7-!>TK2&W[&A'S/TR^TP6J":X=50=6?I7S]\?/\
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M9="LG%J6Z*_Q-_X*Q_LZ?#;Q;=^#KNVO]2>RE,9N],P\;^X('-6_@Y_P5/\
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ME/2LYT;X=5$%.K[.NZ4B_1117$=@4444 %%%% !1110 4444 %%%% !1110
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MH;/N*:JA01Z]:4  8%>\]58\%:2N%%%%*.BL#U84444P"BBB@ HHHH ****
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M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/<)!>JYZ;N:EJXT['6 8HI(V#(&'<4M26%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4C+D8'K2TUCD8!^M)JX'!?'C5;FST!;2+_5SAED&.U>)
M ,.OX5Z?^T%K$QE33D;*@GC/M7F 8$#!S@<UV4M$<E0****U,@HHHH ****
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M%9<J>N*4YVB(,.N<CT]*/OCRUZGOZ4 "0D0_= Y]S6GM%%<K!14E<]$_9_\
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M\Y-(HSNR>M*B%!@MD^M2;BA0#FEHHH$WJ%%%% PHHHH **** "BBB@ HHHH
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MI[S'!*G'EL0ZAI]GJ-N8;VTAN(W^]%+&'4_@>*Q8?A1\+ED\\?#K0?,SG/\
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MERNQWQ=T0J%VC':EH8(C8SUZ44B@HHHH **** "BBB@ HHHH **** "BBB@
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MT?\ "\?C=_T63Q5_X4-S_P#%UR]%'LJ787MY'4?\+Q^-W_19/%7_ (4-S_\
M%T?\+Q^-_P#T63Q5_P"%#<__ !=<O11[*EV'[>1U'_"\?C=_T63Q5_X4-S_\
M71_PO'XW?]%D\5?^%#<__%UR]%'L:787MY'4?\+Q^-W_ $63Q5_X4-S_ /%T
M?\+Q^-W_ $63Q5_X4-S_ /%UR]%'LJ78:KR.H_X7C\;O^BR>*O\ PH;G_P"+
MH_X7C\;O^BR>*O\ PH;G_P"+KEZ*/8TNP>WD=1_PO'XW?]%D\5?^%#<__%T?
M\+Q^-W_19/%7_A0W/_Q=<O11[*EV#V\CJ/\ A>/QN_Z+)XJ_\*&Y_P#BZ/\
MA>/QN_Z+)XJ_\*&Y_P#BZY>BCV-+L+V\CJ/^%X_&[_HLGBK_ ,*&Y_\ BZ#\
M<?C=V^,?BK_PH;G_ .+KEZ*3HTNPU6D=1_PO'XW?]%C\5?\ A0W/_P 72/\
M''XW 9'QC\4YSW\0W/\ \77,4V7&T;FP,]:ATJ:Z![:1U0^.GQM0[E^,'BKV
MSXAN<?\ H=-_X7?\;"V__A<GBD$_P_\ "0W/_P 77;_LX_#GP3\9GO/AM<7:
M0>)-018O#\+  33$]"Q.%XS7G/COP3K/P]\47OA?7K)X[BRN'B=F4X)4XX/0
MU*C2YK6'[6HE<T/^%X_&[_HL?BG_ ,*&Y_\ BZ#\</C=@Y^,7BG_ ,*&Y_\
MBZY<,"H;L>E+^&?:M'AZ3Z"]K49Z?\+?VQOCQ\*M4&KZ?XNFUER0?)\2RO?0
M\?[$I(Q7J%O_ ,%%;CQZ1'\;_A_HLT ^Y_8FB0P'=VY5:^8 -[[C\JG^#L*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;?\ ^AB\/_\ @N_^O1YW[;__ $,7A_\ \%W_ ->O?:*OVE]R?9)'@7G?MO\
M_0Q>'_\ P7?_ %Z/._;?_P"AB\/_ /@N_P#KU[[124DK@X6M8\"\[]M_MXB\
M/_\ @N_^O1Y_[;^?^1B\/_\ @N_^O7OM%)3]WE*=**DFCP+SOVW_ /H8O#__
M (+O_KT>=^V_G_D8O#__ (+O_KU[[134U&-@]FFSP(R_MP#_ )F+P_\ ^"[_
M .O1YW[;_?Q%X?\ _!=_]>O?N/44AQGBE&H[B=)'@7G?MO\ ;Q%X?_\ !=_]
M>CSOVW^_B+P__P""[_Z]>^T57/J3[,\"\[]M_P#Z&+P__P""[_Z]'G?MO_\
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MLHY[MBJR=B0,9KX0^#__  6 _:G^&NB#2[WQ7>:JRX'GW-UAFQ]!7U7\ O\
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M***->H!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 *"%(<J3@]J^MOV;_%C>
M*_ 8@NKZ-Y(\QJ@/(4#%?)(..68A1]ZO9/V1O%:67B*30)(50LC.&!ZYKGKQ
MNCHHR29[C?V_V2X-IG(C. :AK4\2VO[Y9T7'4L?6LNN%+4[FU8****HD****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML5?!30/VA/VB-#^%OB"\$%IJ+L)G:0KTQW%='\;?^":W[67[/GPAL/C?\4O
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M?E6!@8HI "!R:6O4BVXZGER24G8****HD**** "BBB@ HHHH **** "BBB@
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M\RZD(P9'/5C[UU) 9MRC..Y[4-V!+4  .E%%%06%%%% !1110 4444 %%%%
MTKA0#S@KN'<#K12,Q/*_(!U84"%'"^8HPO=>](HZ2;LYZ*.M,NKB"VC'G7*H
M <LSL "*\6\??M8>%=7\4W/P8^%4ES=^+O-,<4)MV6($?>Q)TX!IK<ERL>D_
M$/XK>#OAOI+:EXIUF"W=LB""1]K2MV5?>O*;:V^-7QRO1-+JL%IX6O&\Q+8P
ME9RO;YP?K6OX+_9L77;I?$'QJOI-?ESNAL=04,EM)_>4C'(Z?A7K>E:79:-8
MQZ9I4"QP1+MC11@(/053=B=S,\&?#WPOX'T](=+TFUCN67;)<1P*)''NP&36
MV&*,$8=J0!<[R<D4K,)#N%+VEM#10%R.O3Z4G?-%%38 HHHH **** "BBB@
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MJH%48 [4ZO'L>TM4%%%%%D,****8!1110 4444 %%%% !1110 4444 %%%%
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ME<*OXDG KX%^#/\ P7*\)>,OVB[GX,?$3P[9Z;9?VJ]CIM_8[Y&FE$A1 <\
M'CGWK>G3JSCS1,)5:4'RRZF%_P % /\ @BEJOQY\>ZG\5?A[XU@L+N]D>>Y7
M4&DE!./X1GBOR \3^%[SPQXPU'P9.XGN=.OY;5WC'#LCE"1^(K^I;Q#?Z;9:
M3/<ZU>Q6]NR$/-,X55!&.IX%?GOXH_X(B?!_Q-\?;;XRV7C]VM9=5%Y<::@B
M,4^7+L#SD@YKVL#CG1IM31XF,P//5]Q[GX[VOB+QUX/G2*TU[4;#8P(2*[=
M2/8&OIGX#_\ !8+]J?X3ZFL^J>)X[NVCLUMX8S;9(51@$Y;GCO7ZQ_%S_@DU
M^RY\4-0.HP>#[/3#AML5I9@CGZFOE+6_^#=/PO=W=Y>:?\2M47?,[0PB&,*
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M_*#_ (.'_CCH>N6WA[X0V^E3B[T;4))I+EG!1@\9 &.O:OU:U*X:TL9KI?\
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MRWDFXX P!TKG,)NW% FW[P%=V!P\\/2<:G<\[,,93Q-6/*?T%?M!_L[^&?\
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M7\9Z'IWV2TO[^::"W( V*TC,!QQP"*Y,9+8=Q]:[?]I#P9IGP^^,>N^%-*C
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;0-)9RN?L\BC.?7..E=M&M;<XJU*[N>?9&< Y/I0,DD =.M!:2%>8%+GWI
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MC*WL:J08@N,'/8US5:%/#PM+<WI5YXFI>.Q['J6KZ=H\#W>J7:00HI9I9#@
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MY2#G+8R,^M?O*>RX&#U/I328Q&0S84<Y-=M#%3HT^5*YQU\+"M44F[6/@O\
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M[D#H:^>?^&>OC7_T3+6__!5-_P#$5UGP$^$7Q+\*_&[PK?\ B'P/JEI$=9B
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MU,\S]L\1'V>Q]]?\'''PO\->(/@YX6^.MM91)J-S96,,DJ( 6#*I/05\F?\
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M ((O^+-:\-_MH>&XM-OW027G*QL0#P.H!YKZ _X.>& _;%TX2#!_X16QZ?\
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M+?C'-XT^,O\ PM+4[,%FOC<R1J@ 9BQ8\=.]?O-^S_XU_97_ ."EW[ OA[X
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M;&*AL SCFBBBDE8&KA1113&%%%% !1110 4444 %%%% !1110 4444 %%%%
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M'H>PIPH3DEK9G*_\$;+.TM?V>]0-K!@MJ:EC_P !-?7UV-D;>4P''0U\D_\
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M7J3YE8QO^"/ *?LU2Q@[1_:\IP>N<FO,_P#@M)<X/AZ*Y.(7W[\GC[U>G?\
M!'FWGM_V:YEFCD!_M>7_ %JD'J?6MW_@I;^S'J7Q\^$$TWAJV$VJ6<!-JO3)
MR3UK*O-4\7!OR+P\'/#SCZGL_P"SU#IO_"F_#ITPJ5_L>VR4Z9\I:O\ Q(\:
M?##P)IIU'XF:MIEI:@9,VHH"H'X@U\#_ +&/_!3'1/@-X:D^%/[3%CJM@^F2
MO%#/!ITDK$(=JCG''%<[^U=^T;??\% _'NG_  K^ ]E?SZ3+*4FN+FU>'*YR
M,Y!%5BTZF+C*.Q.&:I89P9^A>M^,O!?C7X1:OK'@76+6]L&T^14FM/N9"]!Q
M7Y^_\$W8\?MC>+ !@?VN-V?]Q:^ZOA[\)+'X;_L]KX TNU$;/I 24(O_ "U,
M8#'\\U^<'P*^-OA;]CS]LWQ//\5X-2@LSJ_RSPV#2;P%49[9J::IK$.*8ZCG
M/#*=NI^M@PL?ELP((XKY*_X*Z"7_ (9YN5W# C4<CK\QKZ(^#GQE\$_'3PA%
MXT\ 3SRZ=(Q57N83&^X=?E-?//\ P5NCN)O@!=16\#2*$7)522/F/3%<51<M
M5KS.Z'OT5Z%O_@D:J?\ #*=J(@01JEQEB>O(KP/_ (+&%'^*'A$ZBK"U!_>9
M.!GSN*]]_P""2D$T'[*ULLD;QC^T[CAUP>H[&JO_  5!_9;UKXX?#B/Q!X1L
MQ+J6FQAH4SC.&+&N^O.,<7"?H<.%IMX6</4^C/A$]FWPUT$:<5$0TNVV@>OE
M+7GW[>4FCK^SCKHUI1Y6!N!.,G#8KY._8[_X*C:%\&O##?#7]I/3M3LI-,+1
MQW$.G22NP4[0.<<8%8W[:_[>D'[6NEV_PA_9MTG4+^UU$@7-Q=6,D+(=W'8C
MH:BM!U<3SK:Y>%FJ5!I[G1_\$3_MDBZY][[+YL_EXZ?ZTU@_\%)[2WNOVQ/!
M<5Q'N7RG*C_MLM?47_!.[]ERZ_9O^#MKI>NI_P 3:[9Y9\D' ?# 9'XU\R_\
M%&;2]G_;(\%E;60A87WLB$@'SE[U4JD:F91DO(YL)2G'!3Y_,_1'PB#'X5TU
M N"=/A ]OD%?GM_P611!X]\*' &)X<D]_P!^M?H7X2F1O"^GJ$/RZ?#R1S]P
M5^?/_!8:RU"X\=^%7ALVE7[1"<A2<?OU]*4G_P *M[G:DEEG+;<^\/A&&?X;
M:-VSI\(Y'_3-:Z9RH@\KJ >37,?" G_A76C9W9%A#N!'3]VM=.S=4 X)SFL,
M4U]9D+!)K#:GRY_P5?6]'[..H"T5BOV:7S,>F!7+?\$9CH8^ M\;/!F^VQ^9
M@]]C5]&?M+?!Z'XW_";5_ Y7,UW9M'"3CJ<>OTK\Y_V:_C5XX_X)P?%C4?A]
M\7_#]PGANXNGD6ZMH7F.!@+P!CN>]7@9IPE!]0QL&E&H?JI=+"T7[X@!!GGO
M7Y<_ @VW_#R_6/\ A'$8@W-X9RIR-V5KV;X]?\%?_@WJW@.?3/@9'J^H:O=P
ME(DN-)DCVMQC!&:Y_P#X)??LO>.KGQOJ/[0_Q,LY+>XU.XDEC5N6Q(,\@@$=
M*VPB5%3YV9XN3K4X\A]"?\%&G4?LA^*%((8:,V3^*UXY_P $4<O\)M21AQ]O
MSG_@)KVG_@H]&TO[*GBE(X"Q&DN%15SGE:\6_P""+<-Y:?"C4S<VSQYU'@,I
M'\)]:SH>]"4D]+E25N5/<^X@Y.2I "]5(YHVX.3U/2E<(I)7J1Z49W 'VKDJ
MVYCLIO2P4445DM4:;!1113)"BBB@ HHHHV"UP.[^$@'U-?2W[(GBF[O- DT6
M1?D1V;&*^:0,G KUO]DKQ'<P>,Y-):0+&8B1SU-<]:/,KG12?*['T%K<3"Z>
M9ONN<[>]4JUO$L# K/MX%9-<2=W8[;:7"BBBF(**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** 'V[%)T<#HPKK+
M.;SX%D]17(J<,#73Z+)OLD'H*A[E1+3 C ![TZFM]\4ZD4%%%% !1110 444
M4 %%%% !1110 5XU\?\ 6H;F^33R?G !'T!KV1_NG)KY[^+^J6NK>*V6'.8<
MHQQ[UI3W,YO0YA@W! ZT4O(QM.12'K78<CW"BBB@04444 %%%% !1110 I8(
MI&-Q/8=JYWXK>+8/ GPSUSQK?0-*NF:;-<LB'!8(I.![\5OGYF* D$_K7RY_
MP5A_:DC_ &=_V:-1CT^&TN9];C?3Y(;B7#*LBXW #GO71@Z<IUM=C#&5%3H:
M;GXP_%/]LSQQXF_:ZU/]H+X?:O?Z7%>ZJ)[6VN;IG6%3@$$ X-?NO^SM^V;^
MSK\4_!N@Z%X?^-6BZEK8T6V?4+6"8ETD\I=^1C^]FOY[_@'^SG\5?VF/B!:?
M#GX5:$;K4+URL)F)2(''\3X(6MKXC?"G]H_]A_X@/I.N276A:H(QON-/E)5E
M/;?@ U[U;#X>K&RW/!HXC$4I7>Q_2Q)%I>MV8CGC@O+:897S$#H1[@]:\L^,
MO[)_[-?Q.G35/B=X2M$ PJ/$JQ D=.BUX7_P1L_:!\5?&']GB-?'.O->76G6
MB 333[G?C))KXT_X+ _\%&?BM=?%23X1?#GQ+_9]G8[7-WIEW\Q<<%3CCM7F
MX?"UY57!,]*OB:"I*;6I^H?P(^ G[-WP2OY;;X1VD5K<W;AFQ-NW$#'3 KUG
MZG-?S8_"O]N3]J/X:>--/\9R_$G6[U;>0%;>]N&$<@)'M7[Q_L+?M*R?M/\
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M&]0HHHH ***-Q5AD<=Z:5Q.]M!"P!P:3>/2M'PK90ZIXCL;&4#$MW&C ]P6
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M!?\ @A!\(_$L7PP\7>+M9FU6U(M9GB\,I(AD4["2XDQU%:7[7G_!%O\ 9O\
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M=^%S+$TJ?(EH?NN/^#H#]CC'/['%U_Y)_P#Q->;?M"_\%SOV;?VP;GPO\,O
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M0.0I*'!ZGM7Q<I8#KUZT=*YGE="FT[_>SI_M/$RJ7L*[M(YD<Y+')-)2 @G
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK-*(-D  W';G YQ7ZWI(C'?C[IKYV_X**_L3:'^V3\'Y_#5O L>LVY,MA<
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M#7[8/_!)#6_AOH-Y%-JRZ+<I%:E@'#$Q@<9SVK\./BS\$?B%\-_B)J7@R_\
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M)+_LM#I_P52^&'_@-=?_ !%*?^"2_P"RT>O_  52^&'_ (#W7_Q%?"N!Z"C
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M=?\ Q%!_X)+_ ++)/_*5+X8?^ ]U_P#$5\+X'I28%#PM62UFP^M1>\4?=/\
MPZ6_99'/_#U'X8?^ UU_\13?^'3/[+.?^4J'PP_\![K_ .(KX9(!&,4FQ?2F
M\')JW.Q/$0C*\8H^Z1_P29_9:(X_X*I?##_P&NO_ (BE_P"'3'[+?_25+X8?
M^ UU_P#$5\*A5'048'H*2P<OYV.>(A)_"?=#_P#!)C]EK_I*G\,,_P#7O=?_
M !%-'_!)C]EO_I*E\,/_  &NO_B*^&2JGM1M4=J:PE1?;8/$0EIRH^YA_P $
MF?V6\_\ *5+X8?\ @-=?_$4__ATO^RW_ -)4OAA_X#W7_P 17PMM7TI3@]11
M]4G;XV)5X;<J/N=O^"3/[+(.#_P51^&'_@/=?_$4T_\ !)C]EK.?^'J7PP_\
M![K_ .(KX9*J>HHVKZ41PD[:S94\3"+]V-S[F'_!)C]EOJ/^"J?PP_\  >Z_
M^(I5_P""2_[+9_YRI?##_P !KK_XBOA@(HZ+0%4=!2>&K1TC-V$J\'JXH^Z1
M_P $EOV6L<_\%4OAA_X#77_Q%(/^"2W[+F<'_@JC\,/_  'NO_B*^%]H]*4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4DA(0D-CCJ:6D9
M0PPW2@#G/B-X/T_QUX4NM#U&W+B2%MF#_%M.#7YY^)OV2K+P3\5Y_$?B>*29
MK.??81,YVJ>^0>#7Z6,55MISC%>6?M)?!U?'FB_VSI*!+NU4M@<>:?>NBC5Y
M'9G-7IMJZ/E!$V%7A0*@&-H'2G;49]C2 9/%2W=G/97,EM(N&B<I(I/<5$QB
M<$ ?CBO1OS1T//2LQ6.3C(XXXI* >.!THJ5<TT"BBBF0%%%% !1110 4444
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M&=K:[CNT )STJ6G<:=CJ\[F!Q3Z9 _FQ+(5&2,T^I+O<**** "BBB@ HHHH
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M"634I[I&20")$P #D?=_6OA#2-7O-&OH[ZP<K+$X9'7U!S415<;1^)I @4$
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$<@C@U#M?]V_D4F^6U1&!XBT+6O"FIOHFN:=):W438DAE'S*?>OW5_X-Q_\
M@FRGAOX<R_M(?&?X;W>F:S-<_P#$BEO  ;BT="1(H&<KTKX__P"";/@#PA_P
M4:^*>E^#?'OPY@@:VN$.HZA9618LK<99B,5_1)\+_A]I?PN\ :1\/="'^AZ1
M8I:VV1CY5&!7AYKCY.*IK<]S*\O][G>QMQQ-$%6,@*HP1ZBI!N!I5C"C&<TH
M4 YS7S2YG*[/J$E&-D+2!LDC%*>!FD '4=Z;L)6%HHHIC"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+/J. Q/>NVI!<CTT1QJ<TDV]38_:Y_;'\#_LP>%VOM747.I2H%M;%)0LCD\
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M)FU?6=4CMX(4+/-)TXK\P?@IH<'PY_X**:EH.@1K#;3*LA6/C[TC$\5]-_\
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M_P"$2\7_ /0JZC_X R?X4O\ PB/BW_H5=2_\ 9/\*KGIIH482E%W1GT5H_\
M"'^+O^A6U+_P!D_PH_X0[Q=_T*VI?^ ,G^%2JBC="5-WNC.HK1_X0_Q;_P!"
MMJ/_ ( R?X4?\(=XN_Z%;4O_  !D_P *INDTFRE"I?0SJ*T3X0\6CKX6U+_P
M!D_PI/\ A$?%G_0K:E_X R?X4G*E\5R.2MS*-M3/HK1_X1#Q8?\ F5M2_P#
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M ***,CUH"X4444 %%%% !1110 44447 **** LPHHHH **** "BBB@ HHHH
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M@YQQ6+DD;VN(_(X%"[N_2C=QDTM"5W<>P44450!1110 4444 %%%% !1110
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M^T?^SCX2_:.\&/X6\4Q87YO*E5061B,9&:YZ]>"K1E'9*QTX>ES4FGN]2_\
ML\>/M#^(?PET7Q%H6HQS+-9*SJASC)->%_\ !57XMZ#X-^!,_A]+E4NKY98D
MB+<DE17BEG^P7^W_ /!+6;O0/@'XJMKO0))<VW]IZV(VC0#  7M6W\//^";'
M[0WQ3\<IXJ_:X\3!H;?:T%E8ZB)XRPSU'TJ72A7KJ;V,H5)T.:%CNO\ @CS\
M+O$'@7X$7>MZQ:.AUN6*YM]RXW+M(R*\&_:N91_P5(LRO#%K+*]^CU^D?@CP
M;IG@3PI9^%/#\"Q6UA (HE08^45\A_'7]A7XW_$/]MZW^/V@6^G_ -A1?9MS
M2W@67Y V[Y?QK1XJFL5=;6L/ZK4>%L^]S['\,1A/#]HY8$&$?N^]?G;_ ,%-
M-G_#6O@HNA&-;C(4_P#7-J_1;2+66ST>"UN  \<8!(]:^1_VTOV*OC1\<_CY
MX:^(O@>WT]M/TO4TGN3<W81MH0C@'KUKDA*V,4WL=%2+>&Y.I].^ KM]/^&.
MGWBVK2;-.\P(IZX!.*^9)_VT_@[\<OC1>_L_?%;X4R6%Q"RHLEY,AW[B1QC)
MZ"OJGP7HU[H_A*ST6_"F6"W$<H!R,]\5\Q_MD?\ !.Q/C!XC/Q3^%NHR:=XE
MA(DA,4@B61@, ,WIR:=2I!8KF"%.]+E1>^*W_!+?]FGXHK%J>GZ+%;E8#Y92
M0CWSP*^,K/PEXC_8Z_;:L/AY\/\ QD]YIU[?10S6D;L?+7#-SN^E>PP_LT_\
M%7K:R72;+4]%-NB>6)6\0 -MZ9Z=:],_9<_X)NZIX0\30?%SXXZY+J/B@RA[
MB.2<31(1TVMGW-=BNE>3T9QS3F^5+4^-OB%\/]%\ _MK6VL?&/2#!I>N.\VZ
MX.%<NZ@'OZU^C'A']C+]DOQ7X?AUK3/!$,T4T*E)4DX)P/:G?M:?L1> _P!I
MOPZMO>J;2_M8@+*Z@4!U9>5&3T&<5\LZ%^QW_P %./ABC>&O ?B#3KO2XR1:
M27NO@/C/<=J4:ZJ4?9IV9I4HNE-3:NK'H_[6VC_L;?LK:7;W][\*UU2]GFCB
MAL8+A5=B[!1U'J:^A?V2]5T76_@MI>L>'/ T_AVWG0E=-N'#-&..XXKY;^#?
M_!-GXU^._&">./VMO$AFNK6<-;65K?BXA(!# GWR*^XO#N@V'AO1X]$TV%8X
M+= $51BE5K>SH>S;NPIKVU122LD:*+%N <?PU\!?\%I]\6@:&S2C899>W3Y3
M7WX"?+R17SW^WY^R/?\ [4GPT?1?#,JC4XHG^R>;($7<?4GI7GT?XT3OJP7L
M9/R/1OV9)H_^%#>%BHW Z-;_ ##_ '!6A\;?"]]XQ^&&K>';5=\MS;%5"CFO
ME7]D#]G;]OGX2>)K32?B7=Z8_AZSA\N(1:N)&"CI\OTK[50F1 YZX^8'I6^/
MLZUT<^!J^SP_+8_+3_@F5X]A^$'[4GB'P1XO<6DDM[=")9N,DN0*_4:34K>&
MV^V3WBK&BY9CV%?)7[7/_!-J/XH>(?\ A9OPBU%]+\01L'402B%'8'/)]S7D
MMY^RQ_P53U;36\,W6M:5'9RKL^T)X@'F8]:VJOZW32OJ94T\+-R74X[]L/QY
M#^T3^WGH6@> [I;Z#37MS<-!\P5HY!N!_*OT[\-V36&CV]J1@H@&VOFS]D;_
M ()T^$?@#JB^-O$>H3ZEKT\1:ZEN2' D;D@-GD9KZ?B5N'EP&/0#I4U)1IT/
M91"G2E4K>TEL*A(R#U[ U^>__!9EO*O_  Y+,NT ODGM\QK]!T8L2S#Y@>GM
M7SA_P4%_8W\0?M3>!3:>#98QJ]M&?L/GS!%)))Y)Z5R89N%=7.^ND\/+T/8O
M@4T,OP@\.>2P8_V-;=#_ -,EKH]>)31KF1CAE@?KWX-?('['_P !/V\?A7XB
M@T[XK76F/HMM"L4?D:L)&"KP./H!7V'J=O-?Z;+;0@&1XF5 QX)([UIF:YY/
MDZG'E[:HZ]#\MO\ @G<=O[:'BC,H^:_NL_\ ?]Z_4J]0)!)%(V08VVGTXKXC
M_9)_8&^._P %_P!H?6_B?XRMM-&G7]Y.\!@O0[8:5F&0/8BOMV^5I('A ^>1
M"%/X5IBI.I@TENC2A>EB^8_,;PB?*_X*7WP*$$VT0!/^^U?0'_!7/P!J_BOX
M SW^F:9),;:(;R@Z_,36/HG["7QRTW]L^X^-]S;Z<=%EAC52+P&3AB3\OXU]
M?>+_  CHOC?09_#6O6JSVUPA5D=<C%54K1EAJ=]T9.A)XF<ELSX _P""7'PS
M_9@^,7PC_L/Q;X=@;7K:\F$Z22_-M#8'&/8U]1>*OV-?V3/"6C3:YK'@:&*&
MWB9FE>3 . 3Z5\[?%7_@E_\ &7X=>-)O'/[*'B0PW%S(6EL[F_$$0!))_4UE
MR_L=?\%*_B7-'X9^)_B/3[319N+R6PUT-(![#OWKIJ/VZ4DSGI4IT$SL/V0/
MC9^SKXZ^--_X6^$?P'N;5K!RKZPETC1MM=EZ=>H_6N!_X*N93X_^#45]VX9W
M8^[^^'%?6'[(G[%_@C]EW0/LVGR/<7LQ9KFZE4%RS')Y'OFO*_VZOV*OC+\?
M_BOX?\8?#Z&P>QTP_P"E&ZNQ&W^L#< ]>*FG67UJ*?1%NE;"3;ZL^K? HSX+
MT;:,O_9=OD_]LUKF_P!H_P"(=]\+/A'J_BVPA:66&(@;3R"5//-=;X6L;G2O
M#.GZ5<*HFMK&**;![J@!Q^(JKXX\'Z=X[\+W?A;5HED@NXV5PPSU!&?UKS:U
MY5KG=1M"@HL_+S]DSX0:E_P4!\=ZOK7Q9\=EX[>9S%!O==H$A4#Y?:OI>X_X
M)P?LR? [1K_Q-XG=988[.5E,]TY!;8<=1[5Y+KO_  3,_:O^"GQ$O]>_9;UN
MV;3KURS+?ZH(2"6+$8Y[FNE\.?L.?MK_ !9E_LO]H_QDMAI@[:1K E+#L"./
M>O2O"K25G:QP-3IU&Y+<^?/^"<NH^&=2_;1U:7PM:""Q$R1PQ[L])'&:^BO^
M"T]RMIX(TZ[:$MY,L+C'H),U0^%W_!,KXP_ O]JB/X@?#W[#)X7)@\^6>]59
MCMW%CM'?)%6_^"T=M-/\/M,MI2/GE@1CGGF3%.I7IRE3Y=[BITJD8U92V:/<
M/^";_P 7O#?Q'_9OT?\ L_4XA<1EEEM=V60#:,FG_P#!1/XN>%OA_P#L]ZI#
MJ.HQB[G(BAMRV&8,&&?SKY.^#'[%?[3^C_"[3?'7[,OB-/,OABXM+[4A#$@
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MX[&N0ZA**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5I9G9I2Y<L_5B3SFOHLI@U$^<S:=Y"8QVY[GUHHSGKU[T5[QX(4444 %%%%
M!3-ISBGT4  &!BO1/@'\=U^"=S?3MH9O?MBJ,#'RX^M>=TH[Y]*F45-6949.
M#NCZ5_X> 18 '@8_FE!_;_B_Z$9OS2OFG'&:,5A]5ILU^MS['TK_ ,/ (O\
MH16_-*#_ ,% (_\ H16_\<KYJHI?5:0?6ZG8^E3_ ,% (\_\B*W_ (Y1_P /
M (_^A%;\TKYJHI_5:;#ZU/L?2O\ P\!C'_,B-_XY1_P\ C'_ #(K?FE?-5%'
MU:D'UNIV/I7_ (> Q_\ 0B-_XY1_P\ C_P"A%;\TKYJHH^JTP^MU%T/I7_AX
M!'V\"M_XY1_P\ B_Z$5OS2OFJBE]5I#^MU'T/I7_ (> 1C_F16_-*/\ AX!'
M_P!"*WYI7S513^JTA?6ZG8^E?^'@,?4>!&Y_W*#_ ,% 8_\ H16_\<KYJHH^
MK4^X?6ZG8^E?^'@$8/\ R(C?FE'_  \ C_Z$1O\ QROFJBCZK3!8NHNA]*_\
M/ (O^A%;\TH_X> 1?]"*WYI7S511]5IA]:GV/I7_ (> Q]/^$%;_ ,<H_P"'
M@$9_YD5O_'*^:J*/JM(/K=3L?2O_  \ C_Z$5OS2C_AX!%U_X05OS2OFJBCZ
MK2!8J?8^E?\ AX!%_P!"(WYI1_P\ B_Z$5OS2OFJBCZM3[A]:GV/I7_AX#'_
M -"*W_CE'_#P"/J? K?FE?-5%'U:FNH?6IVV/I4_\% (C_S(C?\ CE'_  \
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MU"BBBE&*OS/<J4[KD04444Y2E+0(J"5NH4444.R5NHE%M^04444>S:5P<DM
MHHHH2ON3SN+"BBBDTV[(IVO=L****=ZBTL4U3<;W"BBBA)2T9GS-;;!11157
MA#0IQD]4%%%%+XM$*,WO(****5G'0JZ>H4444[K85G>X4444@"BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?VW_ ,%,/^A,\$?^#(?X4<B#G9](45\W_P!M_P#!3#_H3/!'_@R'^%)_;?\
MP4P_Z$SP1_X,A_A1R(.=GTC2;5/:OF\:W_P4R[^"_!'_ (,A_A2C7/\ @I@/
M^9,\$?\ @R'^%'(@YV?2  '2BOF\ZW_P4P/_ #)G@C_P9#_"C^V_^"F'_0F>
M"/\ P9#_  HY0YSZ0P3T%%?-ZZY_P4Q'(\%^"/\ P9#_  H.N?\ !3 _\R9X
M(_\ !D/\*.1!SL^D*#GO7S?_ &W_ ,%,/^A,\$?^#(?X4?VW_P %,/\ H3/!
M'_@R'^%/E#F/I#!/045\W_VW_P %,/\ H3/!'_@R'^%']M_\%,/^A,\$?^#(
M?X4N0.<^D*\#_P""BMC?:E^SUJ5K8P-*Y@DPB]?NBLO^V_\ @IA_T)G@C_P9
M#_"JFK-_P49UNV>PUGX<^!+J&1<-'-?*P_E2<7S1?F4I^Y)>1S7_  1_T34M
M'^"DL.I6[02[8OD<<]*^P"6/#I@CO7R]H%A_P4/\(V/V#PU\,/A_9PG&5M[Y
M5_D*T1K/_!3/:'/@SP1C_L)#/\J[,;)3K*2.'!Q]C1Y7U/I"@\@U\W_VW_P4
MP_Z$SP3_ .#(?X4?VW_P4P_Z$SP3_P"#(?X5QJ%X\QV<[B['T>BD#I0ZDCI7
MSA_;?_!3#_H3/!'_ (,A_A1_;?\ P4P_Z$SP1_X,A_A5*+0<Q](#@<T5\W_V
MW_P4P_Z$SP1_X,A_A1_;?_!3#_H3/!'_ (,A_A2Y YV?2%%?-W]M_P#!3#_H
M3/!'_@R'^%)_;G_!3/\ Z$OP1_X,A_A1R!SL^DJ1AGG;FOFX:W_P4RSSX+\$
M?^#(?X4[^V_^"F'_ $)G@C_P9#_"CD#G9](  #I17S?_ &W_ ,%,/^A,\$?^
M#(?X4?VW_P %,/\ H3/!'_@R'^%.S%S'TA2%0>HKYP_MO_@IA_T)G@C_ ,&0
M_P */[<_X*88Q_PA?@C_ ,&(_P *7)8?/<^D, C&*  .@KYN&N?\%,,_\B7X
M)_\ !B/\*=_;O_!3#_H2O __ (,1_A1RW$I6/H^BOG#^W?\ @IA_T)7@?_P8
MC_"D;7?^"F../!7@C_P8C_"CD'SL^D" >#2;5]*^;QKG_!3 CGP7X)_\&0_P
MI?[;_P""F'_0F>"/_!D/\*.6XN8^D!&.H6E (_AKYO\ [>_X*8_]"9X(_P#!
MD/\ "C^WO^"F/_0E^"/_  9#_"FHV'SGT@>O3%)7S>=<_P""F!.3X,\$?^#(
M?X4?VW_P4P_Z$SP1_P"#(?X4N0.=GTA17S?_ &W_ ,%,/^A,\$?^#(?X4?VW
M_P %,/\ H3/!'_@R'^%'('.SZ0HKYO\ [;_X*8?]"9X(_P#!D/\ "C^V_P#@
MIA_T)G@C_P &0_PHY;@IV/I"BOF_^V_^"F'_ $)G@C_P9#_"C^V_^"F'_0F>
M"/\ P9#_  HY YV?2%&">@KYO_MO_@IA_P!"9X(_\&0_PH&N_P#!3$=/!G@C
M_P &0_PHY YV?2.#Z&DP1VKYP_M[_@IC_P!"7X(_\&0_PI&UW_@ID1@>"_!'
M_@R'^%-1:#G/H\J#U% 0=A7S>-;_ ."F7?P7X(_\&0_PI1KG_!3 ?\R7X(_\
M&(_PI<H<^ECZ0HKYO_MO_@IA_P!"9X(_\&0_PH_MO_@IA_T)G@C_ ,&0_P *
M.1!SL^D,C&,4$ ]17S=_;7_!2_K_ ,(7X(_\&0_PI?[;_P""F(X_X0OP3_X,
M1_A2G"UD@C4LG<^C_*W D'  Y]Z^&_\ @L=H>JZWX3TM-+L7DVW-OG:,_P#+
M45ZK_;7_  4R)VCP9X(YZ_\ $R'^%97B#2?^"AOBB(0^(_A3\/;^-6!5;F]5
ML8Z=16L$E7@^Q$FW1G#NCTS]B*TN[3]G31+>[MF1E#?>^BUZNV\'H:^:-.N_
M^"CVDP+I^E?#_P #6\"CY(8K\!5^@Q5@ZW_P4R[>"_!'_@R'^%.O[]9R(H>Y
M1C%]#Z/7>3TKYR_;._;GN_V7W&DZ?\+KS6WN[8[)+:95V.WR@\GL335US_@I
MEW\%^"/_  9#_"L?Q%X8_;[\82+_ ,)'\(/AW?NOW6NKM6Q^8J8Q1HY.QPW_
M  3_ /AYX^^,?Q+U']I?XH>'+BS^VA'LH[E1G*MT!&>QK[@6.1&R3A3T4U\S
M:0G_  4>\-6*:9HWPY\ VT$?^KA@OU"C\ *LC6_^"F!.$\&>"2QY.[41@?I5
MU+<EC.G=3NSZ19HV)A=\G^&E))(\P88<#/I7@W@35O\ @H'-XOL8?B%X0\'P
MZ(9A]OFL[\-,L>.JC')KW>-G*KO!SM^8GUKE:L=2=QU% YI<>AI7L,2BBB@
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M "BBB@ I&) XI:" 1@T (N2,DTM &!@44 (Q((Q2T44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !03@9HHP#U% #58EJ=2!0#FEH *1R1TI:" 1@T
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M1[XMZX./>L=P0[*>S$5YC^(]2'PB44451(4444 %%%% !1110 4444 %%%%
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M7M\?]_5KS"O3OV.\_P#"_P#PZ1_T%[?_ -&+45/X;*@VIH_=/]O?_@F1?_\
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M+XLO]:UW]HYC<7%U(\V[Q%#D,6)(Y?U-;8K$.=7V78Y\-0Y*#JK<9\._ O\
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M]*?@%XI_X)X?\%/_  -J7@6/X9Z?X)\3(6&EZ;/<^;).JH3O&,]\#\:_-O\
M;9_9:\3?LE_''4OAIKEHZPQ.#;3,FT,&R1@?05I?\$]/%FI^#/VF] O],GF0
MO*$(A)S@NH/2ONG_ (.)_"/AZ3PCX&\=VMJJZA?7)%S*R@,P$&1GO6&*C++Z
MT6GHS3#S68T)1MJCYY_X(:AF_:]M ><:?<<?@*R/^"W 9_V[?$GF#(5(=O\
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M((Y/[3$Y_P"H9+_6O+/^"Q__ "?MXZ_["I_E794FHYHH+L<^&IN> =1HH?\
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MI^H?[*?_  3U^ O[*W[,T?[2O[4VG6U[>3(T]IIMV"C2J5#H <=P163\/?\
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M.#V-\PHVIPJ=;GZ2_P#!P 0?@!X*=>#LM?\ TG2OR%[>_>OUZ_X+_?\ )O\
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M** #&>/6NB\.!1:[1V'6N=)P,UM>%IF92O/-3(J)L@Y&:6D0$#D4M24%%%%
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MR6=FCA)8]R:JGCL1%/FB9SP&'?PR/YMA\%OBI=W"1/X9NW=V"KN.<9K]L/\
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M-UJ:TF@?=^YF*DGWQ7VKX4_X+O\ QITSPU!HGBSX<>%=<>",*MSJNF+/)@#
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M4/\ Z,DKZ=QW8U^?U4^=GWU+E]DABQC);.?3VK\V?^#F54C_ &0=%*C[VIW
M/_?M:_2A2!DU^:__  <T<_LA:)@?\Q.X_P#1:UT8'F6(BC#&<BH2/YPU#JN0
MW3C%9_BH!?#MP.WEGCTK1'05G^+/^0!<_P#7(U]QB^986_D?$4)1^L_,_KN_
MX)/D#_@G+\'LG_F2[;G_ +ZKZ&VJ#G%?/'_!)\ _\$YO@\/^I*MO_9J^ABQW
M8'K7Y_43<V?>4&O9H^$?^#C$E?\ @FEKIQ_S'K'^;U_,;<DFX?:,?,?YU_3E
M_P '&9S_ ,$T==_[#UC_ #>OYC)O^/F3_>-?4Y!?V;/G<]3>PUL@#G.37]0G
M_!O!E?\ @EKX& &0);G'_?2U_+VW;ZU_4+_P;O\ _*+3P+_UVN?YK6.?M\T1
M9#'E3/MR96.&[>E.C!"\FE?I^-"?=%?-GU*V%I"">AQ2T4"Z#&0#Y@O-?GI_
MP5._X(<WG_!1KQU9>-+;XTQ^'?LD[2&%[,R;L@C&<'UK]#J/K5TZDJ3O$SJ4
MHU5:1^'_ /Q"):M_T=?#_P""L_\ Q-!_X-$M7'/_  U?#_X*S_\ $U^W_P N
M>U(V,8V_CBNQ9IC-E(X'E6%>MC^6;_@J3_P26N_^";=]:VEW\5D\1+<QQME;
M4QXW8]0/6OC0A0 0.O6/TK]H?^#J;_D-:7Q_RSMOYBOQ?*_.37U^75JM3!J3
M>I\ICX4Z59I(^@/^";7[#4O[?WQ^D^"]IXT7P^R:<US]L:$R=.V,&OTC;_@T
M5UDLLK?M9PL>_P#Q*FY_\=KYC_X-KQ_QGY. /^9>?^9K^EM4 7DUX.8X_$T:
M[C&1[&68*C7H7:/Q"'_!HGJP^9?VL(!S_P! L_\ Q->O?L$_\&UU]^QG^UOX
M4_:=N_VBHM8'AN=I/[-73RAER,8SCBOU@11@\4<8V]Z\F>/Q%:-I2/8I8"A2
MDFEJ-& !QVQ7\YG_  <S,W_#55D=W FGPOKS7]&C#  K^<K_ (.91C]JRQ!_
MY[3_ ,Z[<D4?K:.?-F_JS1^:2 -'C'X5^O'_  :H93X@>+%4\?VG%Q_VS6OR
M(BQ@_2OUX_X-4@?^%A>+/^PG%_Z+6O<SGF^K79\]E7LUBE8_>L =1^51D-OS
MG@]O2I5Z#Z4P@DG KXJ1]OT!HU#[U')[U^,7_!UK&$MO" 48W:3(3[_O6K]G
MV[?6OQB_X.N@6M/!PSC_ (E$G_HXUZ.67^MQL<&9_P"ZL_#A3GOG%(_ W%N*
M'WK)N<8('/H:J:I>?8[F.1V&&' [5]_*;BES,^"C3O*R+,@22+;Y.,\,_J*_
MH@_X-E?C)\.->_9JU;P)HGBN&XU.UO8$FM5;+1L(SD?K7\\$!#D\\NHZ]*_5
M'_@UP_:1^'W@C]HZ\_9NU.TO3X@\232WUA)'$3 (XHP&W-V/(KP,]H1G#F/;
MRG$.%?E/Z$E4G +=Z_,__@Z$^,/PVT__ ()]ZE\#-1\80V_B;6-6LKS3],W$
M230QNX=A[#(_.OTP;+#DXK^?_P#X.??VCO ?C[XX:#\.])MKM=0TS3)8)GEB
MPA82*3@U\[EV'C4Q44?2XVNX8>3/R;M0$A6+'*@9IQ(+8#TCJJ1%V)R!QBJN
MF7@NI7"G(5L&OO%%1:BF?G\VZDG-HNNIVD$=J_;#_@U$/F>'_$PF^;;JS;3Z
M#RS7XG,V!@@\U^V'_!J"<^'?$Q_ZB[?^BS7E9VK8=IGLY-.+KJQ^V)YZGBH[
MFY@LX'N[F4+'&A9R>P R:E"Y&:^>O^"G'[:?P\_82_9.U[XR?$FWOI+2XC;2
M[06$)=UN;A&2(D#H Q&37QD8\]101]=*?LX.;/R#_P"#B[_@H=XG\9?%:\_9
MO^'/Q.:;1[20IJFGP-QY;*>#^(%?D]$A7+M\P' )KH?BE\2->^+GQ U3Q_XF
MN6EO-2N&<R,23M+$KDGV-<VWEIG9N)Z8]Z^^R["PPN&UW/BLPQ+KU[(O:#H.
MJ>*-7@T#1K=I[ZX?;! GWI#Z"OTA_8$_X-P?VBOVE-'LO''QTFNO ED;R.>&
MVOK3>+ZV!W<$ X# 8_&O2/\ @VG_ .">*_$#Q-J'[1/Q5\/6=YI2)%-H<5S$
M'.X, VY6]C7[TZ=86.F6L>GV%LD,42!8XHU 55'0 5X.8YI6]HX19ZF RB#7
M/(_/.'_@W!_8;CB42^ -/+*H!.P\G'7I7S/^TM_P:N:?=+J_CSX3?&&'3X+/
M3IIK30(; DS.JEE0''?&/QK]JFW9XS22)')$8I8\JRX8$<&O+CF.)@_B/6J9
M7AZBM8_C!^*WPC\?? _QG>> ?B?X<FTK5+&4QSV=P/F0US9+E,K+M&>O]*_H
MK_X+X_\ !+[X8?%W]G+Q/^TGX.\-W!\7>';%[JSMM,@YNI#QAE7E^M?SK36=
MYIMQ+9WD)CN8)2D\,JX*,#@@@]"*^OP..ACJ?*SY7,,OE@I\T3ZS_P""8W_!
M53XR_L"_$NRGTV:YU3PPTZ?VAH2R[5G0=%R3Q7]0?P6^)VF_&3X7Z+\1M-C"
M+J^FPW30!L^49$#;,^V<5_&-.5$BL'968\%.U?TJ?\&\'[4GAWXV_LD1>&[*
MZU">ZTR[:!GO,G C&, GMQ7@9OA/8RYTCVLFQCJ14&?H<J )C;C'0>E?@%_P
M=0J/^&G;!6&1_8UKC_OD5_0!PR_6OY__ /@ZCX_:=L#_ -0:U_\ 017-DTD\
M;&YVYM'FPLC\G, @*>@K:^$WA&7XH_&+PO\ "A+X6G_"1:W!IXNBN?*\Q@N[
M'?&:Q:[;]DK_ )/&^%H/_0[V'_HU:^MS&I*E1?*SY#!4:=:NHR/UP3_@T7U@
MG<?VL(?_  5'_P")JIKO_!H_X@LM,FOK+]J&*YEBC+0VRZ8<R,.WW>]?N.H7
M;S3<)YF/YU\<LRQ47I(^N65X9QM8_E(_:@_X(X?MT_LR/K_B?Q'\%=6D\)Z/
M/M7Q&T06*5".&QV[U\L3I+!*UO*OS(Q5P>Q'!K^T?QWX&\-_$;PQ=^$?%>DP
M7EC=1E)H+B,.IX]#7\T/_!>#]BGP)^R%^U'=6'PZL[J.POH(KDF1?W8>7+LJ
MXXX)Z5[>6YO4J5.29X^89/3I4^:!\,Z=J5_HVI0ZGIETR30.&B9#@J0<U_0Y
M_P &XW_!0!OVCOA#)\%?'?Q'74O%VAQR33:;(W[V*UW;(V/MA:_G=<;U!'W6
M'.*^@?\ @E[\=_&'[/O[:/@W6_#&MK86VKZU;6>L2M-L4V^XD@GTY[UTYS@X
M5*7/%'+E&+G2JJ#9_7&Y&WZTB,", U0\.:_IOBC0;?Q#H]['<VMU&)()X'#*
MZ^H(ZU?4YR%Z8ZU\5:SL?;7O&X2DA>.M4]6U?3]"TJ;6M6N5AMK="\TK=%4=
MZM. XV,WUP>:\ _X*6_M(:!^S1^R=XH\::EK=C:WK:5,ND17LRJ+B=0#L /W
MC@]!54:3J5E$FI45.FVS^>;_ (+?_'_3_CE^V?K+:3XS35[71;R>VAV=(%)4
M[:^-E6.?GR\A>2*V_B=\0-2^*?Q%U?XC:K;HE[KEZUU.D:X0,<9P/PK#-KJ&
MH7*V&E6LDT\APD$*%FD/H .IK]#PJ6&PZBCX+&3=?$-"E@Y"E^!]T>@KM_V9
MO'FM?"O]H?P?\2M"NGM[O1]82XMG0X*L >?UKC+K1->\/S"W\1Z/<V<K#*Q7
M,+(WY&F SP-]K@F*[>593A@?:IQ5.5?#M$86<<-B4?V/?LI?$^?XM_L_^%_'
MFI:C]HO+_28I;R3OYC9SFO1 R$8!Z]*_+3_@V/\ VMO%/QQ_9NUOP/XWU6W:
M;P_JD5GIL+R?O7A$;'.#R>:_4C&T\C\J^"Q%)TZC3/O,/456DFB0;3G::X7]
MI%"?@?XE#G_F&MSZ?,*[=<A]Q/'I7%_M(Y_X4=XE'_4-;_T):FF[31=2/NL_
MD&_:6 /[1WC9)/G \0SX/XUQ<A?854XXKM/VE/\ DXWQO_V,,_\ Z%7%M]TU
M]_3ES82WD?GU2+>*:\S]Z?\ @TG7_C%KQ@R]O%C9'K\C5^O.T[L$U^0W_!I)
M_P FM>,?^QL;_P! :OUYR0V2*^&Q?\=GV^ C:@AXX&*;@[\]J&8]OSI5^Z*Y
M;ZG:E86BBBF,**** "BBBDU<"&_MEN[5[9UR'4@U\@_M&^"+WP=XZENI].9+
M>ZE)MI3T8>HK["D0..2>.>*\D_:P\!0>*/!K>)%25I]-B)BC0=<^W>MZ,N65
MC&M#F5SY7#.5PW-5=7UO2M#M#=:O=+!;J/GD;H*\.\=_M$?%KQQXCG^&'[//
M@Z6V\06+E[J[\1V+1VC1 D$*[#!;@T_PO^SE\2_&TBZ_\;O$\D.H2_->6VEW
M9$ ;N%&<8KUJ<5):GDU).,M#K/&O[6_P1\&&31;OQS:'4]FZVT\MAI2?N@?6
MO,K+XZ_M7_&OQ!_PA.@_!34O"FDWK'[/XU:0/&B#^+;GOT_"O8_"?[/_ ,./
M#-JL$FAV^H2(Y=;F_A620>VXUV=M:6UI"L%K L<:C"QHN OX55U%$KWF>.:9
M^R-87DHNO'FO#5I6 \]F4CS/6O0/A]\'OA[\,(9X/!GAZ*U2Y8-,HYR0,#K7
M3T5,IW5BU3L[AC$>T8^@%+P@ 'S ]1FDHJ+LJR 8 S&-K YSZ^U+C<PF9N?[
MM)11=A9 >3FBBBD,**** "BBB@ HHHH **** "BBB@ HHHH>P!10:#P,T+87
MV@!R"PZ#K7C?Q%_X* ?LD?"?Q _A?Q_\9--TZ^3.ZWF8Y%>Q(ID'RL%SU#&O
MD/\ :"_X)(?!O]H#Q[+XV\4:OJ4=Q)GBWN,#KGUJZ;5R:B=CO1_P5(_849MH
M_: TC/\ OFD_X>E?L)DD#]H'2..OSFOC/]L3_@DI\'_@#\(-1\?Z%J^IO<6E
MN9(UEGR,C\:SOV'/^"5/PC_::^$LGCCQ3J^I13I>M$!;W&T8'KS7HTL/AYKF
MN>75Q.(IRY4C[V\#_P#!0O\ 9 ^)&MP^'/!GQHTR^O9VQ%!$QRQK>\,?M?\
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MY\_\O=EQ_P!M4K] /!!9O#%CLX_=#G\*V]E'ZLIKN92K2AB>2QM$;02W&.M
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M?\6OA_\ &7PROC#X;>(X=4TYY6C6Y@/REAU%='@YQZUYK^RW\"?!WP"^'">
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M*M*K.23.3%TE2HQ9#8Y_M>SE0Y"ZA#S_ ,#%?V5_LXG'[/\ X&/7_BCM,_\
M22.OXU-/XU:R(/!OX<_]]BO[+?V<0/\ AGWP-Q_S)VF?^DD=>#GO,ZB/6R!+
MWF=ENW<-7YY_\''BD?L86A/_ $$9?_0%K]"R!R?2OSS_ .#CXD_L8V?/749?
M_0%KR<$W]9C;N>UCDO8.Y_-2OW16;XJ _L:XS_SS-:? &!69XFYT6XS_ ,\S
M7W6-4OJ[?D?$T%!US^MK_@C1@?\ !+SX)G_J2H?_ $9)7TZ>E?,?_!&H@?\
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MLK$D'L>*^@/^"T'PLT?X)?'OP_\ ";099'M?#^CRV=J\SY8HKKU/<U[,J_\
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M>OZ?:2ZIH.HN;.^T-9=BO+,R(LI/^SDU_5;X>U5=<T*RUH1[/M=I'-LSG&Y
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MORW_ &>#<>!/^"B6I^']#*QVSRPETCX!R[DCBHPTHU5.-@Q-.=+EFGH>Z?\
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M\=;[PRU]+OLK9X _F1,,A@<50\<Z;^V%^P5\0+*Y7QQJ'BK1[J?;<S!/+4H
M3[5YS\._C?\ MU?L:W-SX4@\'W%_9:8[01O)922QD*, @XQBO;?@Q_P5R\$>
M+OL_AW]J+X<2K?W#;(91I0$*-ZDL, 8S7J1BZ=G'<\MR]HVGH?5WBW]I/3/
MG[/=O\6?$KK&\NFK+Y3M@^84)"Y^M?$G@/Q%^U__ ,%&?%\^HZ!XLU#PSX:C
MES;S*HD15)P37;?\%6_BUI>O?LWV5[\.[R V,]Q;&-+=AM4%A\I XZ=J\/\
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MHHH **0Y[4.X4A0ISW/:E=7!IV%HH(YR#Q15-$IO8****E%MW"BBBF(****
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M8]/.N?\ T):QS^]XCR"UI'W$<8YHXS359BW4$>U.'2OF=3Z?H%(N .#2TC'
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M*1<R+N0\ \YI3@G@<5UG*] HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>H2J]W=8PJ%WRV?H":_0#X:_M9_ SXE^&8?%&A^,;6:"XCW)(#UKH?B[\$/
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MAHVC/<6ZW$09"P91R._6N+,ZSPU%-=3LRNBL17<9'YH-_P $//\ @H^Z;3\
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M@Y5G&">*^*S"M[;$ML^URZ@J6&5@C((^4<4ZD"[>E+7 G<]'8****8!1110
M4444 %%%!(')- GJB*Z(,1'M7\</[7?/[6/Q)_['._\ _1S5_8[<D%,#O7\<
M7[71!_:S^)( _P"9RO\ GM_KFKW<C_WAG@9VU[(\]VLH5EY:OZ(_^#4T!O\
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MZ_\ 71:^3RV?/CKGU>/CR8%(^%68L3GTK]L?^#3_ /Y%SQ.?^HNW_HLU^)[
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MM[*V2&! .B*, ?D*^9S?'.O/E1]#DV#="'-):EHMNY'X5^ 7_!U%Q^TY8?\
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M*;J*<D?8:*$Y Z5Y3^W!\5%^#7[*OC?XDKIZ7;Z5H,]PMJ[[?-*@?+FO5V8
M!17XW_\ !SK_ ,% &\*>&]/_ &4/ (O[76%N/.UN<Y$,UK+&,(,=3D'BOFL+
M3E6Q"BD?3XBI&C1=S\3_ (O_ !'/Q@^*FN_%J31%LI?$-\UW]D#;O*R ,9_"
MN<E?RUW2MQ_*E(VIU'/IVKH/A7X<N/%_Q/\ #_@O3[)KF;4]12".%5W-(3V
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M?C?_ ,%3_P#Q-/V2#VDCZ,8 G"'#=S2@J@Q)S7SE_P /$M%[? /QO_X*F_\
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MW7X!^-_PTIO_ (FCV;BA<]GH?1QD"<(*4^6R[@.>]?.(_P""B>CC@? /QO\
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M3T;_ *('XW_\%3?_ !-/V3[CY^6W4^CGX^Z>.XII"H1L_&OG(?\ !1+1P?\
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M^)4W_P 33=&X^>Q]&E0?FS0%C/('-?.8_P""BFB@_P#) _&^/^P4W_Q-#?\
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M?$/_  3[_P""D'P;U/Q'K7PXT/PEX@LK61;>RBS(<K&S!LL?4"O1/BW\'_\
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M,3NQTSFOQU##)+J<=,"D$<49,BY)'0$\4J^%A.K[7J3A,9.@O9/8_6;X2?\
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MM1_%CQMIGP_\&_#.[N-4U27R["#:1O;KU(XK]9_^"9W_  ;7VO@KQ)9?&?\
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MW\)>(;B74/#,<6E1^'88 1<+-)DR%L9&-O3WK\3#^R3^T%<A<_#^\ Z_</\
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M0!AL4N%4 *#C/ -5R\VY5FMCZ!'_  4)^+(&!+)_W^-+_P /"?BS_P ]9?\
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MBBB@ HHHH ,#THHHH " >M &.!110 4$ ]1110TF 8 Z"C ZXHHHL@"BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@!DES:09-S=)'QQO8#^=,M[^TO!MAN4.SNC@[J^+?^"P7Q8\=_#+X=6]]X
M/U9[>5[J)=T3$=2/0UY/_P $EOVI_B'XS\?W/@CX@:S),;B2-(?.8Y[9ZDUT
MX;"O%T7)=#FQ&)6%:OU/TPVN!G;SZ4CS)M/S %>N3@"D5T # G@?>SQ7B?[>
M7QFF^#_P)U?6["\6*[-L3 0<'.:PY>6T.IU1:E'FZ'M*:EID[;!J$0;IM1P3
MFI4!SY;=>QK\D_\ @GI^TY\8/'W[1TFE^*-;N)+>0LZ1N[8P6..":_6L.SPQ
M\?,!S715PKH1YV<6'Q<*U1P["@@C;W%%*?FYS2 @]ZY;WCL=DE)R] HHHH34
M8V?4'KJ@&:0LH8*6Y/04M&">1CBB%.\[=!2JQO8%\S<9)8P!T !J(WELC&(W
M$9D/1"XR/PI[,9E\S)&.WK7Q?X@L_P!HV;]MF.XM;2^'AL7,NY_+?RP/EQSG
M'K5TE&<W'L353A&_<^T7<I*$C&X,.?:G2J8P$)Z_Q"J]AYJV,+R#+^6NX>^*
M^9_%_P"W@D'[45I\ ?#&F31R%I4O);A REE(Y'H,&A4W*=HC=51I*3/I\\T5
M%93-/:12O]YHPS8]2*EI3BXRLQ1G?6(4444-)JS+YVMPHHHJ>90T)]^H^9;"
M@<TF5P4C.YL]#VI< G&[ ]33=S#)&#C@$5+=EH6O>:N,>\ME<123QJ^?N%P#
M4F0>17QC\;[+]HL_MI:-+X;M+YO#IU&/[0\:/Y83:V<G..N*^QM,$JV423_?
MV#=]:V=)JDI&;JKZPXEBCGM1QBC([&LTG+0T2LFPHHHII)Z,5Y2CH% -%%)Q
MYGH#O=(****&[#LF%%%&#Z4DP:"BBBF*]PHHHH **** "O4_V2R1\0IO^O<?
MSKRRO4_V2_\ DH,W_7L/YFL:WPFM!ZGU'KX!TI\BN9KI]>_Y!3_05S%><MST
M?LA1115DA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !2CY2&8<4E))S$R]^U &AX?N$AO<GHPP*Z6N0M 1<PA3_&,U
MU]3(<=PHHHJ2PHHHH)>Z&N 2,C/I[5!K!QIEP,?\N[_^@FK#=1]:K:Q_R#;G
M_KW?_P!!-$-9#E\)\PWH_P!.F.>/-;C\:CJ6]_X_)?\ KJW\ZBKOCL<,OB"B
MBBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I)" A)I:1\[3@9]J /F#_ (+=C/\ P2N\9>6,EM=L"/S>OYYMP4?O.#VK
M^AG_ (+>/C_@EEXR&,K_ &Y8[E'4'+U_/,P9'"JZXSWKZ/)_X3/F,W_BH7CM
M10>O!S17N_9/'^V%%%% @HHHH .E*P) 91P:2ABJJS'KCD4FH]0Y5+<4[6XC
M;)]Z:8R&^8X/M3XX([V:&Q=]HD=1OSC;D]37TU\,?^"<>C_$?P;:>,)/VM/
M>DFZ7/V'4+AA+'_O<UC*M&&R+C21\R'&.#25]=C_ ()5Z*?^;V/AK^-RW^-
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M_P"CVOAM_P"!3_XT?6EV#ZO+N?(V#[?G1@^WYU]<_P##J;0_^CVOAM_X%/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !32H'+'\:<>E(N1P: .1^,Z%O
ME_L7<?L[CI[5\5!60;77!'45]W^+[6WO?#=Y%.F5,#<'Z5\1^,K:*S\37EM
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MU",C[^^,?Q)\0?#7X<3^,?#WAM-3NX;4RQVCN0&. 0..>]?C]K?[6?Q2D_;
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MTYI?6)PTD@]C"6J9\I>8O/L<4I8#K7W-)\8_^"%JRK$W[*_Q-VE<Y_X2E/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBBDW8!'^
MZ:^.OVCO^2FZC_U\-7V,1D8KY\_:?^#.H:IKT&N^%-*FE>97>]91N&[^G%;T
M))2U.>NFT?/R?ZH?6BN1\4?%K3_"6MS:#J6DSB6$G*[@.^*S!\?]$QDZ7/\
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M@_8E_P""QO?X^>%/_":D_P#CE/FI]PY:G1'NU!9%&6)!]0*\*_X8E_X+&?\
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M<?%]\5Z8&IS=?SI>UHKJ'+5[%?\ X2;PY_T,%C_X%I_C1_PDWAS_ *&"Q_\
M M/\:LC_ ((<>#N_C.]_\&<W^-._X<<>#/\ H<[[_P &<W^-1]8HC]G59BZ_
M\2?!WABS.IW^MV[QH,LL4JN3^ -<V?VF_A5$NV36KD[CC'V<\?K7IF@?\$5/
M"&@WJWD7BJXE93D+-?2N/R-=)_PZ7\/#D:Q;],<EJ%B*!2HUFCQ+_AI/X4H
MBZO.??R.OZT?\-*?"K_H+3_]^/\ Z]>V+_P24\.J,?VU!S_M-0/^"2_A\?\
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MT-UA_P!^F_QJ7C8+1(?U.<M6S\[_ /A=7_!3!N!^S%X5_P#!])_\31_PN?\
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M$KM(,'>?YUUY0;<#H*YO7=JWQSC&.U81=MS>2T*-%+E2/E%( >ZFJ)"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **1C@9I
M5#$9(_2@ I4^\*0\=!2A2/XA2;L-*X1_ZT5UFF?\>,?^[7*1K^]'-=5I?_'C
M'_NTF[C2L6****DH****35P&N"V IZ5@?$K0M1\2>&9-)TY TC,#RV.E= 1P
M<=32*@')IK03U/!S\"O'1&!:IU_YZ_\ UJ/^%$^._P#GUC_[^U[U@>E%7[5H
MCV=SP7_A1/CO_GUC_P"_M'_"B?'?_/K'_P!_:]ZHP/2G[9B]FCP7_A1/CO\
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M@;32!N]#7TC]EMO^?>/_ +X%(;2U/_+NG_? H]LQJDNI\8_M[?\ !(+X:?\
M!1;2= G\??$75M!DTK3S;K%IULCAP6W9.XCFOEP_\&D?[-!?S/\ AI7Q8#Z?
MV;#_ /%5^N:1A/3';%+M'8"M*>/Q-*-HR,*N PU5W<3\C?\ B$C_ &:,Y_X:
M4\6?^"V'_P"*I#_P:1_LTXY_:5\6?^"V'_XJOUT' H(!&#369XUR^-D?V7@[
M6Y3\BQ_P:1?LT'_FY3Q9_P""V'_XJC_B$A_9I_Z.4\6_^"V'_P"*K]<_E04;
MQZ&K>98W^=DK*\';X3\C/^(2+]FC_HY/Q9_X+8?_ (JC_B$A_9H_Z.4\6_\
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M ."V'_XJOUSWCT-&\>AH_M+&_P [#^R\'_*?D9_Q"0_LT?\ 1RGBW_P6P_\
MQ5'_ !"0_LT_]'*>+?\ P6P__%5^N>\>AHWCT-']I8W^=A_9>#_E/R,_XA(?
MV:?^CE/%O_@MA_\ BJ/^(2']FG_HY3Q;_P""V'_XJOUSWCT-&\>AH_M+&_SL
M/[+P?\I^1G_$)#^S1_T<IXM_\%L/_P 51_Q"1?LT?]')^+/_  6P_P#Q5?KG
MO'H:-X]#1_:6-_G8?V7@OY3\C/\ B$A_9I_Z.4\6_P#@MA_^*H_XA(?V:?\
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M6_\ @MA_^*K]<]X]#1O'H:/[2QO\[#^R\%_*?D9_Q"0_LT_]'*>+?_!;#_\
M%4?\0D/[-/\ T<IXM_\ !;#_ /%5^N>\>AHWCT-']I8W^=A_9>#_ )3\C/\
MB$A_9H_Z.4\6_P#@MA_^*H_XA(?V:?\ HY3Q;_X+8?\ XJOUSWCT-&\>AH_M
M+&_SA_9>"_E/R,_XA(OV:/\ HY/Q9_X+8?\ XJC_ (A(?V:?^CE/%O\ X+8?
M_BJ_7/>/0T;QZ&C^TL;_ #L/[+P?\I^1G_$)#^S3_P!'*>+?_!;#_P#%4?\
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MYHV=/UIU% 7&[.#]:7:.>/I2T4!<3;SR.U)LZ?K3J* N-*<<>M+L'/'TI:*
MN(%&>1VI O3(^M.HH"XTIQQZT%.N!]*=10%QNS^5 7ID?6G44!<;L]N]!3K@
M?2G44!<;L_E0$Z9'UIU% 7&A..?6@KUP/I3J* N(5&>!VHV#CCZTM% 7&A..
M?6C9U_2G44!<0KSP.U 4 =*6B@+A@>@HP/0444!<,#T%&!Z"BB@+A11122L%
MPHHH&><^M%PL%%%%,$%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@6H4444!=A1110%V%%%% 78
M4444!=A1110%V%%%% 784444!=A1110%V%%%% 784444!=A1110%V%%%% 78
M4444!=A1110%V%%%% 784444!=A1110%V%%%% 784444!=A1110%V%%%% 78
M4444!=A1110%V%%%% 784444!=A1110%V%%%1DDG)H&244U6SQBG4 %%%% K
MH****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M%)W=:=A/\F@*!R!2*NA:*** "BC(/0T4 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 F&W9
MSQ2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;V]:-[>M #Z*9O;UHWMZT /HIF]O6C>WK0 ^BF;V]:-[>M #Z*9O;UHWMZT
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M +[;_"OGORH?^>='E0_\\Z7^I>2_\^P_U\S_ /Y^,^A/^'MG[0?_ $(VC_\
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M^^V_PKY]\F(](Q0(5_N4O]3\C7_+L<>/,^:UJ,^@_P#A[=^T)_T(NC_]]O\
M_$TO_#VS]H/_ *$;1_\ OMO\*^>_*4#'EC\J/*A_YYT+@W));4Q?Z^Y]?2HS
MZ$_X>V?M!_\ 0C:/_P!]M_A1_P /;/V@_P#H1M'_ .^V_P *^>_*A[QBCRH?
M^>=/_4O)?^?8?Z^9_P#\_&?0G_#VS]H/_H1M'_[[;_"C_A[9^T'_ -"-H_\
MWVW^%?/?E0_\\Z/*A_YYT?ZF9+_S[0?Z^9__ ,_&?0G_  ]L_:#_ .A&T?\
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M"=I*$Y^4#]:_7+1-6TO7M-AUC1KI;BUND#PS(>&7U%?G&+P=7!5/9U%J?KV
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M[6G_ $2/PO\ ]_'_ /B:_/WRT_NBCRT_NBCDB'M)]S] O^(D7]K3_HD?A?\
M[^/_ /$T?\1(O[6G_1(_"_\ W\?_ .)K\_MH]*,#T%')$/:3[GZ _P#$2+^U
MI_T2/PO_ -_'_P#B:/\ B)%_:T_Z)'X7_P"_C_\ Q-?G]@>@HP/04<D0]I/N
M?H#_ ,1(O[6G_1(_"_\ W\?_ .)H_P"(D7]K3_HD?A?_ +^/_P#$U^?Q53P0
M*3RT_NBCDB'M)]S] O\ B)%_:T_Z)'X7_P"_C_\ Q-'_ !$B_M:?]$C\+_\
M?Q__ (FOS]\M/[HH\M/[HHY(A[2?<_0+_B)%_:T_Z)'X7_[^/_\ $T?\1(O[
M6G_1(_"__?Q__B:_/WRT_NBCRT_NBCDB'M)]S] O^(D7]K3_ *)'X7_[^/\
M_$T?\1(O[6G_ $2/PO\ ]_'_ /B:_/WRT_NBCRT_NBCDB'M)]S] O^(D7]K3
M_HD?A?\ [^/_ /$T?\1(O[6G_1(_"_\ W\?_ .)K\_?+3^Z*/+3^Z*.2(>TG
MW/T"_P"(D7]K3_HD?A?_ +^/_P#$T?\ $2+^UI_T2/PO_P!_'_\ B:_/WRT_
MNBCRT_NBCDB'M)]S] O^(D7]K3_HD?A?_OX__P 31_Q$B_M:?]$C\+_]_'_^
M)K\_?+3^Z*/+3^Z*.2(>TGW/T"_XB1?VM/\ HD?A?_OX_P#\31_Q$B_M:?\
M1(_"_P#W\?\ ^)K\_?+3^Z*/+3^Z*.2(>TGW/T"_XB1?VM/^B1^%_P#OX_\
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M/PO_ -_'_P#B:_/WRT_NBCRT_NBCDB'M)]S] O\ B)%_:T_Z)'X7_P"_C_\
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MH7QV/_,EZ7_WVW^%+_P] ^._/_%&:5Q_MM_A7B1A4]4_2D\A?[GZ4_[9QO\
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M]"7I?_?;?X5XGY2_W/TH\I?[GZ4O[9QO\P/CK/?^?C/:_P#AZ'\=O^A+TO\
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MP[H_67X7_&/P5\7- 7Q+X,U-;JU=0R2(P.0?H:ZB.0LFYL9]J_&!O&G[4OP
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MU7RQ?8-UDV#_ )#] /\ B(\_:R_Z)9X:_P"_K_\ Q-'_ !$>?M9?]$L\-?\
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M /Q-? %%'^K&6?R!_8V#_D/O_P#XB//VLO\ HEGAK_OZ_P#\31_Q$>?M9?\
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MRS^0/[&P?\A]_P#_ !$>?M9?]$L\-?\ ?U__ (FC_B(\_:R_Z)9X:_[^O_\
M$U\ 44?ZL99_(']C8/\ D/O_ /XB//VLO^B6>&O^_K__ !-'_$1Y^UE_T2SP
MU_W]?_XFO@"BC_5C+/Y _L;!_P A]_\ _$1Y^UE_T2SPU_W]?_XFC_B(\_:R
M_P"B6>&O^_K_ /Q-? %%'^K&6?\ /L/[&P?\A]__ /$1Y^UE_P!$L\-?]_7_
M /B:/^(CS]K+_HEGAK_OZ_\ \37P!11_JQEG\@?V-@_Y#[__ .(CS]K+_HEG
MAK_OZ_\ \31_Q$>?M9?]$L\-?]_7_P#B:^ **/\ 5C+/^?8?V-@_Y#[_ /\
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M*][\/_MV_&O4;*.:^\&:>DC+EE!;C]*YR+3[*%=L%O$BCL(Q4AC2-=R(O/3
MK\KQGB;G-65H/E/I:7#V$AI.-V=@/VV?BY_T*UA^;?X4#]MGXMYY\+6'YM_A
M7'&$?\\12>2/^>-<*\0.(;:U&;+(<O\ Y#LS^VS\6ST\+6 _%O\ "D_X;8^+
MG_0KV'YG_"N-\D?\\:/)'_/&C_7_ (A_Y^,/["R_^0[+_AMCXN?]"O8?F?\
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M&V/BY_T*]A^9_P *XWR1_P \:/)'_/&C_7_B'_GXP_L++_Y#LO\ AMCXN?\
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ME_\ (=E_PVQ\7/\ H5[#\S_A1_PVQ\7/^A7L/S/^%<;Y(_YXT>2/^>-'^O\
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M'9?\-L?%S_H5[#\S_A1_PVQ\7/\ H5[#\S_A7&^2/^>-'DC_ )XT?Z_\0_\
M/QA_867_ ,AV7_#;'Q<_Z%>P_,_X4?\ #;'Q<_Z%>P_,_P"%<;Y(_P">-'DC
M_GC1_K_Q#_S\8?V%E_\ (=E_PVQ\7/\ H5[#\S_A1_PVQ\7/^A7L/S/^%<=Y
M(_YX"CR5_P">/Z4?Z_\ $/\ S\8O["P'\AV/_#;'Q=[>%K#\V_PH/[:_Q> R
M?"VG_FW^%<:8E R8:<L2'),(]N*/]?\ B'_GXP_L++_Y#K9/VW/B^@)'A33S
M@>K?X5P/Q0_X*-?M/^%=-N+KPS\-M)NI$'[I7+\_7"UH&&/.3"/KB@6=O)+Q
M&A!^]E0=U;8?Q%SVE57--M$OA_!3>D3F_P!B+_@J'^T[\5_CCJ/@[]I+X;Z-
MX?\ #=MI9GM=0LV<.\N3\IW*!TQWK[G\!?$_PG\1[1[WPKJ*SQQ8WL"#U^AK
MXG\1>"/#7B>S.GZK8((\_>C^4_F*\_\ B'I?[2_PH^'.J6O[+?QEB\,SR%6A
M\ZU:8@#M^5?H/#WBA"K65/%JU^IX>8<.S@[TD?IR')YX_.@N>N/I7YX?\$[_
M /@J?XY\4_$^3]F']J+2YX-6AM1+;>,;IE2"^E8X$*H"2&XSSZU^A\))0 G.
M!UK]EP6.P^.I*=*5TSY>M0GAY\LAN2Q*G@'N*^)?^"Q7Q"\%^,OV>;OX&+XB
MNK35[O4K:>/[*<,T<;'<,YZ'-?4/[2OQGC^ 'P*\3_&<Z*^I#PYI3WAL(7"M
M/M(&T$].M?C]XD_:MA_;V\6Q?&R'P)=>'A9(T)L+F<.6WD-NR"1QBOL.&LKG
MF./CIHF?$<7YW#*<KDXO5HSO WP[T#P;:H-,MUSY8!)7[Q]371J2?O*!Z8[4
MD:+&@16R!W%+7] T,)3P\(PBK'\L8S&3QE5U)O5L.<;2Q(]:%P'YZ8HHYKJY
M(K8QES,#T "CKS111^-)M$\K"BCMUI.<<'\ZFP[-=1:*.:!GO2MYA=A11S2<
M]J+(+L6BCFCFBR[A=A11S1S^M%@NPHH.:#GM19=PNPHHYI.>]%D%V+10<T'/
M:BR[A=A11S2<]Z+!=BT+\S;12<TI7?QFFHMO1B<DMQ2,=Q^%(03WII"@;%7)
MIZKQN\DG;R>:=DMPM)[#0H(ZFE4C;C<:N:3H>LZ_.(-*TQYF/]SM75:#\!OB
M#K$A>XT6>WC(P)&3AO:N2MCL/05I21V8?*\3B-8Q9Q-%>RZ'^R)J.H1AM0\8
MPV?M)$:U$_8NTTG#_%>R7_M@W^%>=4SO!TWU/2AD&.D>#%."V[H>F::.H!+#
M/<U[G?\ [&R6<3367Q MKEE. J1-S[]*Y?Q%^S1XUTX;=.W7F>J1Q]*VH9O@
MZBWMZF57(<;#97]#S;&!USBDW< @'DUL:UX \5^'6)U719K<1\%W'?TK'S/'
MN,L!/'3^[[UZ,,32JKW7<\ZM0JT%RRC8""1\IZ4@5NY_6G?( "&&2.?:@$'H
M:VNK7L<T9)Z,!D#&3111SVJ7)38U'E>C"BDY[4O-*R[CNPHH&>]'-%@O(**3
MGM2\T67<+L**.:.:+!>044<_K0<T67<+L**.?THYHL%Y!12<]Z4YHLNX7844
M'/:CFBP7D%+GC&33>>YI::4+ZB:E+J&3ZTH(SAAD8Y!I**:E&+T&Y65F-,8;
M&YS\IR/\*66,3D$KVY'K2T @<D42:GNAPERZIG)>)_A;X6UO6D\370>&:(@B
M6)/F0CN*_6?]@WXK>$OB!\!]'\/^&M5ENI-"LH[6\>8_-OY//X5^8%[$+FU9
M$?+R?*WTKHOV7_\ @H9:_L$_$*'X0CX77GB ^-+U+EKRWN55;8@B/!#$9ZYX
MK\SXYR*#H?6*:U/UWPYXEJ1Q:PE5[G[&-UIRXQQ5/0-377="LM9\KR_M=K'-
MY9/*[E#8_#-6U.&Q7X\TMC^@$TU=#J***>PPHHHH **** "BBB@ HHHH ***
M* "@]**#T- '+_%;XG^$OA!X,O?''C2_^S6%E$7GDR %'XU_-9^UY=>'_B1^
MT'KOC6QU:748Y]2F>"6=@V$,A( ]L5]^_P#!:W_@K#IK>(/&'_!/P?"B]6>Y
M)L3XE6[41KWW;<YK\Q;*S^S1B%7(Q_&QSFMH)'/4DRP@CC&(XE '3CI0Z[SN
M\UL^M&0PR&S[T5L<O,[@0I&2>>^*&SG*,11105J(!CN:6BB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HH"LWW:1MIZT +0.<\]* X88C?\*4[0 9(\$]<T (#E=P'%%*=P
M8;1A<4A.3D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !2C '4TE% "
M$9.2QI< <8_'O110 $\EP,$]ATJMJ.EVNL0>3>1+CT'>K!ZXS0S*A&_IGKZ4
M^6Z&FTS]'_\ @WE^,_@#X/\ B?Q'X \2^*+A9];2&'2[*5AL1@02%!/M7[&V
MT\-Q$DT!RKKD$5_+E\(OC-#^S=\7-%^/%SI4NJ1^';H7+:?!+L-QCC:">*_?
M3_@EA^WUI_\ P4)_9\E^*NG_  _N/#:Z=J)L#9W4ZR,Y4'YLJ3Z5S3C8ZJ<N
M8^GJ* 0>AHK,U"BBB@ HHHH **** "BBB@ HP.N*** "BBB@ IK@XR3QZ4ZN
M+_:%^*H^"/P:\1?%<Z.^H?V#IDEW]BC8!IMN/E!/2E)J*NR*DU"+;Z'S?_P5
MD\=^#_$OP'N_@A+K]U::EJ=S#-";3AMJ,=PS^-?$O@3X9^'/ UDDFD0!F>,!
MV9>2?7ZU-J/[7-I^WKXIB^+3^ KGP[_9:M#]DNIPY??\V>"1VK>13"/EC*Y&
M!GM7Q&=XY5I61_/?'>?3Q6,="#T0L;%0-J#D=3U%* (B!%SSR31\QY8Y/>BO
M!BHJ%S\SDZDG9@YWG)X^E  !R6-%%2E="3D&3G.32Y/J:2BG8=V+D^II-H_O
M&BBBP<S0;1_?:C)' )HHHL',^PN3ZFD/S=6-%%%@YO(-H_OM1M']]J**+!S/
ML&T?WVHVC^^U%%%@YV&T?WVHVC^^U%%%@YGV#:/[[4;1_?:BBBP<[ #;T8TN
M3ZFDHHL%VQ<GN32;5_OFBBBP>\)M7KO-*"<<$T$9'6@# Q2:2W"TF+D^II,Y
MZL:**5X@XR0;5/\ &: H!R)#111[K#WA<)GJWYT80=S^=)15<@7D+_VT-(5!
M.3(:**.02C(-B_WS1M7^^:**.0.2:#&.CFD(R<[C2T4N0/>0FW_:/YTNT?WV
MHHI\MA\S0;1_?:ER>Q-)118.9]A<GU-(1NZL:**+!S>0;1_?:C:/[[4446#G
M8;1_?:C:/[[4446#G?8-H_OM1M']]J**+!SL-H_OM1M']]J**+!S/L ^7HQI
M<GU-)118.;R#)/!)HVC^^U%%%@YGV#:/[QHQP3N.3112=T2^:3T!,J &YQ02
M0,*._-%%/]TMRI.?VADEO%.K13#*'C'K7GFK?![P[:?&/P1\2(]4NM-&B^)8
MKN\>R^7S8U_A;U%>C54UK2TUC3I=.=,B9"N?3/>NG"8J=*NFMCV\FS2I@,7"
MI%[,_5CX7?$SPS\4_#D?B3PK<F6!T#!CQG-=-'AER./:OS6_X)U_\%"[30?C
M]H_[#_\ PJV\9KF*11KQN5\M?* _ASGG-?I4AW8(K]%PM=5J*9_4F58V&.P,
M*T7JTA4^]3MN1@FEP!16[V/4OJ X&****:V ****8!1110 4444 %%% SDY_
M"@35PIBG!P: Y[TDA"Y8C@=:E)\X)W0%MQKPG]OC]HOX<_!'X2W6E^-M>:RG
MUB!H[$HP!9AR<9->T>(-8/A_P]?:\T1E%G:23^6."VU2V/TK\"?^"P/_  4/
MMOVX/BK;_!^P^'EYX??P'=R&2]FN@RW6\$<!3QC/>O4RK!/&8R,>ESORW#2Q
M%=(^4/&FE:;?_%/Q!XG@N'N/M6J3R1S2<DJ6)ZTU5584\O@'\Z;;Q+&BINP%
M')/<TX-RS[<'^$5^T8+#4\-248(_2L+AU1A9"C*]&-(JA) ZMP*7.>2**ZK5
M(JYO'GY_>$ .23ZTM%%)*35RV]= HHHI\LA7"BBBCED%PHHHHY9!<****.60
M7"BBBCED%PHHHHY9!<****.607"BBBCED%PHHHHY9!<****.607"@#-%&>U'
M+(-6+CWHQ[TF:,XZ4N606D+M]Z,>])1D^M'+(+2%Q[T8]Z3)HSCI1RR"TQ=O
MO1M]Z2BGRR"T@/%%%%'+(+L****.607"BBBCED%PHHHHY9!<****.607"BBB
MCED%PHHHHY9!<****.607"BBBCED%PHHHHY9!<****.607"CY3PRC Z"BBBR
MOJQ2<FM 4$R9;IC@4(I",-Q.?O9HHW.2$49SU]J.2SO<*<I-6D9GB'P_::OI
M[I,FUMI\MT'S*<<$5^X'_!!S]HCX?6'[&?A#X&WOBJ:[U^R,BS+<N"YW$8SS
MFOQ2*"3Y/XQT/M7H?[*?[:]G^P5\48_C'?>$KGQ (Y5D&G6]P(S\O;D@5\EQ
M'EE/$X=SBM4?/9SEJJ4G-']..X$Y]>:4L2>":X_X#?$V/XU?!SPW\6%TUK,>
M(-(AOELW8$PAUSM)'7%==O5F(':ORFW*W%]#X!Q<9M,D7IR:,X&32,?E H8Y
M -9QN[BZCNM%(IR*6K&%%%% !1110 4444 %-/\ %3CP,TP'+YI-70"CE#FF
MX!ZT]<8*@TP@J<9_#UH7NJP)W0U5&,D]#Q7Q+_P4!N/AU^T)XQM_AX-:O!<:
M3N@N[=%^1FW;N>?>O=?VWOVL4_9#^$I^)0\%3Z\/,=?L=M*$;@ ]21ZU\@?"
MG5[#XWF+]I9=(?3'\6C[?_9<S[GML_+L)'!^[7YSQ]GJRW RIP>K/<R3!/$8
ME-K0Z7X>?#KP_P##_P .QZ-H=N(T3N%QS70A1A=IZ#EN](V1&%04JC"U_+&)
MQ,\3B7.H]3](A1]DK0 _?PH^7N: !OY/RXHHK.>LDS7EDM6)@L<DG\Z-O^T?
MSI:*&VQ;B;?]H_G1M_VC^=+12NP$V_[1_.C;_M'\Z6BB[ 3;_M'\Z-O^T?SI
M:*=V FW_ &C^=&W_ &C^=+12NP$V_P"T?SHV_P"T?SI:*=V FW_:/YT;?]H_
MG2T4KR 3;_M'\Z-O^T?SI:*+L!-O^T?SHV_[1_.EHHNP$V_[1_.C;_M'\Z6B
MB[ 3;_M'\Z-O^T?SI:*$VP$V_P"T?SHVG^\:6BG>VXFGT$VG/WC05('WC^=+
M0,>G([U//*3L59VU$5<_Q$?4TO(;&3]:4033OF.,L/05:A\/ZW(NU-,D?O@#
MI71'"8BI'W%<QE.,7=LJLK$9+?K3<#.-QJ\_AW6E&7TR1<>M598;FU?;-;D=
MJF>#Q%*-YQ:!5Z3>XP)G^/\ 6D"MCAJ5%#.>:3?M8IFN>#3=C1>SD &1D,?S
MHV_[1_.E!R,T5I=W&)M_VC^=&W_:/YTM%%V FW_:/YT;?]H_G2T4KL!-O^T?
MSHV_[1_.EHIW8";?]H_G1M_VC^=+12NP$V_[1_.C;_M'\Z6BB[ 3;_M'\Z-O
M^T?SI:*+L!-O^T?SHV_[1_.EHHO(!-O^T?SHV_[1_.EHHNP$VG^\?SHV_P"T
M?SI:*+R'<3;[FC;_ +1_.EHHNPN QGD\4A .Y0<#^$BEHI-RN'O-W0I;<,,H
MZ8-1RV]M*I22-7&,!6'!^M/I"B.0$< _Q'THA7<=>J%%.H^5GA'QY_9K\,:Q
MX_\ !WQ)@U"[TUM#\2PWUW)8#!DC0@E6]5K]-?AG\4O"WQ0T-=<\+7#20,H(
M+#'6OC;Q!I,>N:3/I=U,NR:,H"1ZUUO[#'QD@T"S\0_#BU\(SJ/#]TEL;DR#
M$_R@[@.W6OW;PXXIG.E]7J/8^)XARUQG[1'L7[<.DQ:Y^RGXZT>928[G094(
M YZBOQZ^!W@JU\#Z++96>]49P2K#':OV9_:R4GX!^*$]=*?^8K\FH8!$"%'4
M]!7]I>'=+FE4EV/Y;\4Z\HJ--;$H*MRHP*6CZT8[U^K6;U9^(IKL%%%%4M%H
M&H4444*Z8!1113]16"BBBE[O8+(****?N]@L@HHHH]WL%D%%%%'N]@L@HHHH
M]WL%D%%%%'N]@L@HHHH]U*X[(*,'KBB@$JV7?*$8"^]3LKM HIO0*0A0V[)R
M:252ORE]OHM=%X ^&VN^/[]K73+=_D7+.%SQ7/B,12H1YF['3A<-+$5.1(Q;
M'3M3OY1'I^G33<X)CB+8_(5Z7\-O@!'KLQNO&-\;* KE1Y@5OQ!Q7K/P\\!^
M#O@3H2WWB'6K>\N+F+S'MBN&B8 C::\3^*WQIOO&.M2MI5D]I"CE50-U .,\
M5X']HXS,Y.%%6CW/H89?A<M2G5=WV/9X/"_P6^!NF)X@\,ZV;Z^P"\%RZLF?
MSKG/$G[</BNTF.EZ;X0T<PH,QL(^2?P%> W&H7%XY:[NFSZ,QJ(;F?(!49ZY
MZT\-D-"<[XA\[\Q5^(:Z]VA'E1Z?K_[4OC37V+2Z?;0'T@&*PY?CCXT<$*R?
M]]&N+8A6.).:%)5"S\UZ\<MP=.2CRGDSSC'SBWSGH6E?M&^-K"9'$$+[%QM<
MG!KK/#_[<7CS17VMX4TJ5CQF2/./TKQ%) X&!BG5AB,FP59N+CH;4<]S&E%/
MG/J?1O'WPX^.-L+3XA-#8><-\K6F 0WMG%<G\4OV<?AO_9SWOPT\2RW-P0=T
M4TR].V #7@BS30',<K#Z&MOP7\0M3\'ZY;:JUTTL<4@)BW=:\Z655L(^>C-V
MZ1Z'IPS;#XU<E>&O61!K/@3Q-X>4B]TF?:#\S^4V,_7%9)22-]CJ5/H1BOJG
MP=\9/!/QOT@^!-4TR/2Y91Y@OI6!'RCI@>M>8_'?]G^[\$*?$^F:HNH6LI.#
M$F @'>M<'G,_:^QK*S,,9DM)T_:T=4>39&<9HIH!Y9FRV>*'=A\JU]$FG'F/
MF^6,9\K'44)D??%'-5[EM"%9NR"BBBDK=BFD@HHHI^[V%9!1111[O8+(****
M/=[!9!1111[O8+(****/=[!9!1112]WL%D%&!113NET&M H) ZFBBBZ"R G'
M-(YP.*7I2,,C&:6MK![J=["J\:Y..,<\5R\OPUL/&'QP\,ZQ=HY-O(NQE7)'
M[Q373A<#!K?^%%JDGQ"TTX'%PF./]H5Y6<4HU<#-2['L\/UI4,UISCW1^N_@
MA!'X2TN)>B6$*_DBUK%<'<*S/!P_XIFQ'_3G'_Z *TE.&VU_-=1)5&?U_AI.
M5"+\D.HHHJ%L= 4444 %%%% !1110 4444 %%%% !1UHHH _G=_X+5^%XC_P
M42\5:TL9RNJ%F./:OG#>6QM48'<U]<_\%I4!_;>\5G'_ #$#_*OD<#' KHIK
M2YR5785CN;. /84E%%:LRBDE<****0/4**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHJ;@%%%%4 4444 %%%% !1110 A
M8+USSZ5<TCP[KNOW:V6@Z5/=2.<!886<_H*IMOQA/QK[Y_X)Y_!+1/A]H>C?
M'#Q1)%=6=S;?:#:NF.W3/X4#2N?)>F?LM_%F_M1=_P!@M"IZB6-E/ZBN<\3?
M"KQ]X,GG&M>&[U(4;Y9VM7V$?[V,5]9_'#_@I1HUUXCGT7P_\,WMTL[]UW+,
MN'56(]?:O=-/\9^"/VU/V>M*\$Z5X=CTO59]-)DG;#'<,GM23N4XGY;D2F/,
M@Q\V,4=.!6M\0-%;PUXQU#P_))O:SO)8S(!C.URO]*R00PW ]:9+5@HHHH$%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4#'H#[&BBFG8=T9_B.
MPCU'1)K64'YTPX _E7[7_P#!MSH46B?L6:M;PH0&\32'YA[&OQ?(!8<=:_;W
M_@WP&W]D#5!C_F8I/Y&L:FJ-J3/O$,5Z4\=***P.D**** "BBB@ HHHH ***
M* "BBB@ IJODX(H<]J5/NT"OI<7O7F'[86G)K/[.7C#2)02MQHDJ$#W KTUS
MVK@OVDAN^#VO*1G.G2<?E65;^#+T.#,Y.&!J279GY#? OX?V/P_T>ZLK%&!G
ME5BKCI@5WZYV@,<\^M-6!4D8[<<U(0H0?6OS3%R4JC1_)V;UYU\;)RWN)]:*
M**Y[VT/,YFU<****3C85D%%%%*S[A9!11132L-:!1113'=A1110%V%%%% 78
M4444!=A1110%V%%%% 784490'+T*'WL[CY?6B-F]0E*$8W84A.!Q^%.1'D81
MX+L3@#T%=UX$^!6M^+4%S>RFSA."DKKD,/6M:5*55Z';A<'+%OW#A[>SO[O_
M (]K*63_ *YQ%OY58_X1_7F'&BW?_@,_^%>X6-AX/^!4'VV?4(=9+_*8HQM*
MG\::?VN_!D$K6T?PX+$'M*M=2PM%;RU/6IY5AJ<K5IV9XB= UU?O:+=_C;-_
MA4$]G=VW_'S:R1_[Z$?SKWB#]J_P?JK>1+\.##GC>95XIFH^'/!'Q67[6NNV
M^G%AG8XSD_A1+!PMHRJN4X:;M1G<\&/7!HKL?B+\(=0\%,)DO?M<3-A)%7 -
M<>058I+&59> M<<X<G0\/$8:6'G:0E';-"E@/GY(Z+5G2M&U+6Y?*M(&*[PK
MX'0FG3BY[F5&C.O4LD5@CR B-2W^Z,U/!HVL3 -#I5RZ]BL#$?RKVGP3^S'8
MVFEQZUXA\:P6GF#F&2(YQU]*[ >-_AK\.($TX6\.H&)>60XW8^M=L,(OM,^E
MI9%&,%.K*R9\UMX>\0@9_L&\_P# 5_\ "HGTC6HN9=(N5Q_>@8?TKZ*'[7'@
M)V:W/P[X'1O-7FIF^)OP^\=VIWZ=%8%QM^=LXS5U,'2BERSN:SR;+Y+]U5NS
MYHPP.UE((Z@BBO8?&W[-R@#6/#'B>.]\XY,,49R!U[UY7K7A[5M"N9+/4;5H
M61L#<*YJN&G35SQ,;EM3"Q<GL4L'THH#!5\L2AG'WS[45R7N>7%JV@4444!*
M5F%%%% 784444#NPHHHH"["BBB@+L**** NPHHHH"["BBB@+L**** N'/8T4
M4460KR[A0R@J<L0<<8HH(R,55U;0:;3+?[#'PUM(OV[M"\;&%O.B2?#[?4+W
MK]9X?]4K#J1S7YQ?L26P7]HG2),#/ER<X]A7Z/PX,0!'\-?=9&W/"W9_2'AS
M7G5RB\NCL/!Z>]+SGVIL?>E<D#BO;78_0GNA:*!R**8PHHHH **** "BBB@
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M/!.@6^AZ1 )7DL(X92AQ@[ ":^=V)<$-SGK7J5:L,+!0CN?1X^O2P%!4,/\
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M\D8K+VXXQ7LX2NZN'4NYX6,H_5\2UT"BBBM[*.YC+6S"BBB@D**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!1T/TKH_A#_R/MA_U\I_Z$*YP<Y^E
M='\(?^1]L/\ KY3_ -"%>=FG^Z3]&>GDW_(QI^J/UU\'?\BW8_\ 7G'_ .@B
MM$??_&L[P=_R+=C_ -><?_H(K17&XDU_-%3^)(_L3!_[M#T0ZBBBLEL=(444
M4P"BBB@ HHHH **** "BBB@ HHHH _ G_@M)_P GN>+/^PB?Y5\BU]=?\%I/
M^3W/%G_81/\ *OD6NF&QQ5@HHHK5[(E?"%%%%2(**** "BBB@ HHHH ****
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M-=3PU.HDY=#:-%5/>GT'['??);PO(Q)+?+D"NM^"7CM/AQX^M/$,VXK"ZL5
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MP4445J]D2OA"BBBI$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 'UI D;L=N0WJ:7I2H&?#D_3WI/8%J6-*U'6M+N!)H5]<12],Q.0<?A6
MOJ'BWXAS0@WVMZKL'W0\S[:^J_\ @FM_P3'UG]LO2[KQI+XL;2[&RNS"\OD;
MANQD#I[5]A>.O^""UOJ7ALP:=\6O,FB0[(Q9<N?3I4729T1CIH?CL]Q>W<K7
M%Y.9),$;F;-,4LB"6-AE3GZU[C^W+^Q3XE_8R^($'@O7+Y[HWEO]H21X]ORD
MX_K7D_P[\&7GQ!\:6'@G2XBL]_/Y<>T9P<5:DCG<7S"Z9XK\>6JAM'UO4E^3
M;L@F? 'T%5]7U_Q5>1QPZSJU[(#T%Q*Q_G7ZK? K_@A$9O#%CXDU/XL>3)>6
M*N\!L\["R_2N0_:R_P""&>M>#/!4OC7PS\1GU!;*-I)HTM,8'Y5',N8UY78_
M,5$216#,>O>IM+O;_3I#-H]W-%*IZHQ&:F\5Z-<>'=?NM$NA^]M+AHFR.NTX
MKZ+_ ."<O[ NK_MN^+=1TZT\0MIEOI;)]HN!%O"AL<_K5MJQDE*YX5)XL^)9
M@VSZ]JQC*\AIWVXK"N[R]OF!OKF1_P"[O<FOV1UG_@@_IUWX7.EVWQ:'FI#A
M9!9_>('3I7P-^WY_P3I\6?L42Z9>ZOKLE]!J6\QNT.T*%S41<>8UFFXGS")"
MQ*E1L QTYS4MM9W\Z!+>U>0N.-J$D58\,Z'/XC\16>A68/F7ERD28]6.,U^I
M'[+_ /P0RNM?\":3X[U[XG&UFNX!)+9/9Y*'TSBKG+0F$&?E?-IUS9KMN8G5
M2>=P(YJ+#)^Z@&X'NU?JO^T9_P $'+O2O!=YXD\-?$IKI[2-YVA2TQP!GTK\
MP?''A:\\">+;[PA?,?.LI?+=B,9-$)W6A%2$DS'POW!U') HI(Q@DJ<'N?6E
MIWN)7L%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#/P]?VL.6;3=T@'KN->Y*2EA.7L?H5;DQ65.CUBKH^>GPR@H?K2;?DQGFGO
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M5?Y"O(*]?_9C_P"/+4O^NJ_R%?5<(_\ (T7HSQLY_P!U^9W7[6'_ "0?Q/\
M]@M_YBOR<7[Q^M?K'^UA_P D'\3_ /8+?^8K\G%^\?K7^D7ASM5/XV\5?XL!
MU%%%?J:V/Q=!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^PB?Y5\BU]=?\%I/^3W/%G_81/\ *OD6NF&QQ5@HHHK5[(E?"%%%%2(****
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M_=/E)M1E9;!11124=3-P;C="@[#Y@P2O(![UVGP \*S>,/B!%8F-"&B=SN'
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M!_N?S/Z*\-/^1*_46/O2OT_&DC[TK]/QKW%N?I#W0J]!]**%Z#Z44R@HHHH
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M\>6I?]=5_D*\@KU_]F/_ (\M2_ZZK_(5]5PC_P C1>C/&SG_ '7YG=?M8?\
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MPK]O/^#?+_DT'5/^QBD_D:RG\)M2V/O.BBBL#J"BBB@ HHHH **** "BBB@
MHHHH ;)VI4^Z*23M2I]T4$_9$D[5PG[1W_)(M=_[!\G]*[N3M7"?M'?\DBUW
M_L'R?TK*M_!EZ'GYK_R+JGH?F-+_ *UO]Z@_<'UHE_UK?[U!^X/K7YCB?XK/
MY*S'_>Y^HVBBBL9;HX%\(44453W*"BBBD 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "D'WC2T@^\: $?K^%.IK]?PIU+J);&-\0O\ D2=7_P"P9/\
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MKZX/6NJLOV9O&E]J?V 6[D@G@D5ZEX-^#FF? 30[SQYXUL8DNU@SITK$%HI
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M?^A"N<7O]*Z/X0_\C[8?]?*?^A"O.S3_ '2?HST\F_Y&,/5'ZZ^#O^1;L?\
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MU9FFWN%%%% PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH 5/O"OV\_P"#?+_DT'5/^QBD_D:_$-/O"OV\_P"#?+_DT'5/^QBD_D:R
MG\)M2V/O.BBBL#J"BBB@ HHHH **** "BBB@ HHHH ;)VI4^Z*23M2I]T4$_
M9$D[5PG[1W_)(M=_[!\G]*[N3M7"?M'?\DBUW_L'R?TK*M_!EZ'GYK_R+JGH
M?F-+_K6_WJ#]P?6B7_6M_O4'[@^M?F.)_BL_DK,?][GZC:***QENC@7PA111
M5/<H****0!1110 4444 %%%% !1110 4444 %%%% !1110 49'K11@4F[:H&
MW+1!G S360J/-# ;CD =12\@<#.*!L^\YY;MZ5HII;&L9ZIQ>J/</V>_$UCX
MRL7\)>(;L,8D+*;M\@=AC-<?\:?A;J/AGQ!=7UI:A[::0M"T2_*5]JX?3=5U
M+1[@OIURT4F.77J1Z5[I\%?BGX?\0Z4-%^(DRWRQ*(XA<'[F>P_&O2HNE7C:
M>Z/J\)4H9IA_85':7<\$C+QRC>HR#SD=*^N_V1_'>GZWX4;1[I@_V.,)F3D#
MC/&:\1^/?PE/@[&J6-D([:YDWH4Z$-R!^1KA_"_COQ;X0C>+PUK$UGYG+1Q'
M[U%"M+!5G?86 Q,\@QEI[([C]I/5(-3\22F&4';,1C/H37F0!51P>E3ZEK%_
MK+_:-0NFED+DN[=:A#%L_OCC/"UQ8B2KRYSP,TQ<<1B7-+1B444'IS7/(\^R
MC$#E#N;&WVI2IQN4@@]* 0(]JG<I]:GT^SFOKN*UB@.2X7"C.>:NG3N:8:A4
MKSLA=(T;4-=NC::?:R2D#D1KG%?1_P )/!&C_"OPFVI^+OLIDN;<RQ+( 67Y
M3Z].:F\.Z+X#^"/@F#6M=TBWBO;A?GF)^8C (KPGXB?$_P 0>,M>N9#KLLMD
M)"+:,GA$]!7?'EH0/J:,:.44^>6LF4/'_B-_$WB2YNQ+(4+D+N8\#)Z5C$ @
M>PQFD4D]#N']_P!:6O.E4G*=WL?-8K$*OB'+JQ,#CVI:**';H<UY-ZA1112&
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!^Z?I10?NGZ
M4+<%N>M?L1?\G!Z3_P!<I/Z5^C</^H'^[_2OSD_8B_Y.#TG_ *Y2?TK]&X?]
M0/\ =_I7W>0?[G\S^BO#3_D2OU%C[TK]/QI(^]*_3\:]Q;GZ0]T*O0?2BA>@
M^E%,H**** "BBB@ HHHH *0?>-+2#[QH 1^OX4ZFOU_"G4NHEL8WQ"_Y$G5_
M^P9/_P"BVK^;?]MG_DY+Q'_U\_XU_21\0O\ D2=7_P"P9/\ ^BVK^;?]MG_D
MY+Q'_P!?/^-?<\%?[W+T/J>&?X\CRBBBBOTP^X"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "E"%> />DHP6/RFIDT
MMPO8U]'\<^*O#PCBT[7KN"-#\JPW#*!^ -=UX=_:)U.PMO+U74KV>3/#-,S?
MSKR[S"WRNOYTFQ!T6L9TJ4EHC"5/G9[1%^TW'MP6N>.O-#?M-P_WKK\Z\8
MZ"@; ?F.*(X:ER78I89*+9]G^'OC!9>.O@Y9W6D6\KSZ9$SWC(O.#P,UX_JG
M[2T-M?RVQ%R"CD$$^E=)^PIJ&GQ^!_'>G:D%9IK",6H;UW#I7@WQ!TJXT?Q9
M>6]W"<R3LZ ^F>*\^C2C&NT]CGC2CS';^,?CQ'XETQK-#<#<"/G)KS:"]2VU
M5+Y@^!('R.N<YJN6/67BD5L@_O/I7I*G"$CMC3ARGN/@C]JJQ\,(BWT5U*$
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M_75?Y"O(*]?_ &8_^/+4O^NJ_P A7U7"/_(T7HSQLY_W7YG=?M8?\D'\3_\
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MX4ZFOU_"G4NHEL8WQ"_Y$G5_^P9/_P"BVK^;?]MG_DY+Q'_U\_XU_21\0O\
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MT;_R*A_WC_*OF2OYG\5/^1H??\,?P&%%%%?DA]4%%%% !1110 4444 %%%%
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M$*@G@GCUI:**U3TL8I24G<****"@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH!;BKW^E='\(?^1]L/^OE/_0A7.+W^E='\(?^1]L/
M^OE/_0A7G9I_ND_1GIY-_P C&'JC]=?!W_(MV/\ UYQ_^@BM'LWUK.\'?\BW
M8_\ 7G'_ .@BM'LWUK^:*G\21_8>$_W6'HAU%%%9+8Z@HHHI@%%%% !1110
M4444 %%%% !1110!^!/_  6D_P"3W/%G_81/\J^1:^NO^"TG_)[GBS_L(G^5
M?(M=,-CBK!1116KV1*^$****D04444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 ?6C&<JOIQNHHH 1E1@,[L@>M:7A7Q9KGA;4DOM)U2XM6#9
MW6TS(?Q((K.I,^E%KC3L='\1OB-KWQ#O8+W7]8N[N2"$1H]S<,Y ]!N)XK'\
M/:U)H>N6^JPM(C0R;@\;88?0U5Y]?THY[4[(3;N?J9^S[_P7*^'7P_\ !.F^
M$==\/ZK,]C8I$TA((+*N.I%<!^V[_P %@M _:%\*Q>&/"-AJ=EA760[]H?/K
MMQFOSR' Q14VU+4M"74[N74=4GU&5R3+*SG)Y.37O/[ G[8-K^R/\0F\77L-
MX\$LJM)#;/C<!ZCH:\!HH:N1>S/UYU[_ (+^?"ZZ\+3V%IX8U-99K8H&VKD,
M1C/2OSR_;$_:NG_:3U>QN!/>F&T9ODNI2W!],UXDPW#%($ .<THJQI*3<2?3
M+HV5_%?Q,RF*0,I!P01Z5Z+XJ_:-\9>)?":^&CXFU3RUCVA)+V0K^6<5YK13
M:3(4M!9W,SF29F9B<EL]32!'V[@W3L:**8-MA@,-S=<]J***!!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 *GWA7[>?\&^7
M_)H.J?\ 8Q2?R-?B&GWA7[>?\&^7_)H.J?\ 8Q2?R-93^$VI;'WG1116!U!1
M110 4444 %%%% !1110 4444 -D[4J?=%))VI4^Z*"?LB2=JX3]H[_DD6N_]
M@^3^E=W)VKA/VCO^21:[_P!@^3^E95OX,O0\_-?^1=4]#\QI?]:W^]0?N#ZT
M2_ZUO]Z@_<'UK\QQ/\5G\E9C_O<_4;1116,MT<"^$****I[E!1112 **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *%9U8!,;3][(HHHVU#
M4'VLVY,@=P:;Y<BMY@<@C[FTXQ3J!CS!D\8H4O:.Z'%N-1.]CU7X'?&S3O"B
MR67C2.2]C9,1B0[PO_?6:W=?^$UC\8KU]<\(SP1";++&.,>Q KPP*RN05^4]
MZW/"GQ"\8^#G"Z#KT]LA8$F,XP*[J.*4ER5#Z3#YI2JQ5.OJCO-,_9;\4V3_
M &O6)XH8MY"^8",XKM[3XQ^ OA1HQ\-#38I[F.(I+)%&I^;&,YQ7FWC?X_\
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M^-)'WI7Z?C7N+<_2'NA5Z#Z44+T'THIE!1110 4444 %%%% !2#[QI:0?>-
M"/U_"G4U^OX4ZEU$MC&^(7_(DZO_ -@R?_T6U?S;_ML_\G)>(_\ KY_QK^DC
MXA?\B3J__8,G_P#1;5_-O^VS_P G)>(_^OG_ !K[G@K_ 'N7H?4\,_QY'E%%
M%%?IA]P%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]:6BN6_NFX#(&W-%%%9QV ****H HHHH **** "BBB@ HHHH **** "BBB@
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M=C+($/&3S7VM_P %6"3\+8@O7[=%A3]17R-^RU\7H?@U\3;#Q3?7#+'!<!I
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M^P9/_P"BVK^;?]MG_DY+Q'_U\_XU]SP5_O<O0^IX9_CR/*****_3#[@****
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M:?P)\.>%?A!\*SXV3285O501BXV_,=RFOEO]H;XZ_$+7_B#>QP^);F.T+_+
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M<_7%? 'Q9_9L_P""F'Q%\1W5QJ>I:E+;+<NT%N][E4&3C'R>E+F#E/K/6?V
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M\9X#:>&_"NL&YF4^7C6,C./0+7S'^T'\'O\ @IU\3?$M^DVJZBU@]](\%O\
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MCXZ5^T9H*-KD\4L5R9',A*_+MYP*_-CX(^ M.^'/[9\WA32(1%':ZN8TVC&
M'3BO2P.;5)X6I&3U2.RACI+#S5];'HW[>_[ ?[/'P)\+ZE?> =&OH+BTTQ)T
M-Q?%_F*@^E?GEEP-@(&>=QK]@/\ @K(J'P7K.$!8Z)'DG_<%?C\"QE!/(48V
MGI7JY#BJM;!<T]3NRJO*KA6Y'Z'?\$XOV!/V?OVB/AEHGB7XA:1?375[.R7#
MV]Z8U('3 QQ7RY^V;\%_!/P?_:"U#P#X.MIH[""XD5$EFW-@, .:_1+_ ((R
M<?!;PV2O#73@+Z<U\.?\%)&"_M<:NJCI>3?^A"O/I8NJ\UJ03TL<U+%5)8V4
M;['UI^QK_P $J_V;?CI^QWIOQ3UW0=2DUJYCD+/'J!5&(( PN*ZSPO\ \$_O
MV&?@Q&=+^(/A_51?3'S(R=6VC;]"M=]^Q_XQU?P9_P $I8]>T2X>"XM].G:.
M:-L%#N7D5^3OQG_:D^/7C+Q]?7FM_$O4Y_)N'CA628':F>W%<.&IXO'U:E-R
MTYCEP]+$8NI-7V9['^V1\._@1=?&6_\  /P>L+A&F81V(DNO,PV._ S7O7[#
MW_!'CP/X]\*#Q)\:]&O9)VN!Y;07#1#RS[<U\N_\$ZM*/Q2_:S\/77C>]>^#
M:DGFRW')(P:^T/\ @J-_P4%\;_LP^,M.^#_P>Q:6TVCB1KF"8HR/P.!SZUOB
MYXR$EA*;U[FN*=>E:C39[VG_  2^_89T?'@R/PQJI90%*G5>1_X[7B?[5_\
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MZQMYI3F$-\N*^,RJAB<UQ\:4]53/N\]KX?*<%*K#3VAY'/>7&H3F:X.3ZT,
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MW3M5_9!;G#_M"?\ !9']K2S\>3Z3X/\ $NCQV5M(R!3I*L1Z9.:]._X)T?\
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M#?+_ )-!U3_L8I/Y&OQ#7[PK]O/^#?+_ )-!U3_L8I/Y&LI_";T=C[SHHHK
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M448!TR?@_P"\E?CIXZ*KXTU/^'_3'!)^M?K=^SS\2?"5C_P2J;0Y[XB8:9,
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M3LAC8A%4\<<5U5I4.'\I>&<KMF<8U,PQJJVLD=M^S,<O.0W\? _"JG[2*O\
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MMIM8XY5)N?.]]SJ-9^+WC;Q)X83P?JM\AL8PN%$>.G3G-<LF7.6&$7E2:&6
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M'FIQ6]Q?1".X>2+>&4'..O'6N/D&2&=R !RH[TJ A2R]",?2J"[.N^,7QO\
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MC2.9&.2!DG/K69;W5Q;3"2R<JRG)8>M-WG.QF/7.:"%5E(<C/WL4Q<VI[?\
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M_'WB/P)=-=>&IU1F7!)7-)XO\?>)O&TPN==N%=QV"8K''F1H!M ^;M2&1F)
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M%% !1110 4444  .#D4$E'#D<&DSE@HIROR49>E/G25A/<EL[NXL+U;VT/S
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M'&1G)IT:N[9\P8'ZUYC\&?V@O"OQ.E;2K"Y)NK=O*FCV\!U.TC/U!KTXAQ*
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M3=.MM-MDMK:(*H'"@< 5:W8.VOO\+1C1I\J/Z@R[!PP&!A22V%"G."*4;3D
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MGXX?"W6;G[!9>-[&696*2HCG*,."#QZUNVOB?0+X,UIJL3A3C*GK7P-\%O\
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M6LBB@#7^V6O_ #V6C[9:_P#/9:R** -?[9:_\]EH^V6O_/9:R** -?[9:_\
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M9KOP,=*3_EI3JRO<Z+6"BBB@3V"BBB@%L%%%% PHHHH **** "BBB@ HHHH
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M5119!R1.U_MW2O\ G]3\Z/[=TK_G]3\ZXJBBR#DB=K_;NE?\_J?G1_;NE?\
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M'6K5*TKR8&)2V\]<4H!XR>E+17.9!1110 4444 %%%% !1110 4444 %%%%
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M079W_P#PD.C_ //_ !_G1_PD.C_\_P#'^=<!11RH+L[_ /X2'1_^?^/\Z/\
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?0E!M'0>M"]!]**_<Z.'I82"ITU9(^0JU)U*EY,__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>soph-20251231_g7.jpg
<TEXT>
begin 644 soph-20251231_g7.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" -!!6$# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]_**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHSS10 4449H *#T
MZ5'-=6UNNZXG2,9QEVQ69>^//".GJQN-=@^5MK+&V]@?HN307&G4J:13?HC7
M' Z4'.17'WOQE\.0[TM+2YG*G"G8%5O?).1^59=Y\;+XEQIVAQJ/X&FD)Q]0
M,?SHNCLIY9CJFT'\]#T3/M1D#@FO(]0^*'C*^=C'J"6ZLN#'!" ![@G+ _C6
M;<^)?$5XH2ZURZ<*<C=,:7,CMIY#BI?%)+\3VIIX5^5IU!_WA6;<^./"-G$9
M)O$-J=O!$<P=OR7)KQJ1Y)I#-/(TC-U9VR328I<QU0X?C]N?W(]6N_BKX.MM
MIBO9)MW7RH6X^N<53F^-&@)(4@TRZ=1]U\*,_F:\UHHYF=,<CP<=[OYGH%U\
M;K=7'V'P_(Z]_-N N/R!JI>?&S59$46&APQ-N^9II3("/H O\ZXJBCF9M')\
M!'[/XLZJX^,'BR>(QK%9QM_STCA;(_-B/TJM_P +1\9_]!)/_ =/\*YZBINS
M=9=@8_\ +M'02?$_QHZ%/[27YAC*PJ"/TJK_ ,)YXQQQX@G_ $_PK)YHZT79
M4<'A([4U]R-;_A//&/\ T,%Q^G^%>E?#K4+W5?"5K?:A<--,YDW2-U.'8#]*
M\?Z5ZU\*O^1'L_K)_P"C&JHGCYW1HT\/%PBEKT7D=%1115'S(4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4449..E !12-P-Q.*R]8\9^&]$D\G4-6C61?O1*=S=,X('3
MVSUH*C"=1VBKFK0>G2N&U7XTV$:M'HVFR3/T628[5Z=<#D\]N/K7-ZK\3?%V
MIAE%^MLK<;;9=O;UZ_K2NCTJ.3XVMNN7U_R/5;S4]-TY=]]>Q0CG;YD@7/TS
MUK#U#XI^#[(-Y=^]PP&=L$9;/T/ _6O*;BYN;Z9KJ\N))I&^])*Y9CQCJ:;T
MZ"ES'J4LAI+^)-OTT.\U#XV2,2NE:+M&[ :XDY/X#I^9K"U#XG>,=10Q?VBL
M"E<-]GC"D_CR0?H16!^%%+F9Z5/+,#2V@GZZDEU>WE](9+V[EF9N6:60L3V[
MU'M'7%%%([(QC%62 ;N]%%%!04444 %%%% !1110 4444 %%%% !1110 5ZU
M\*O^1'L_K)_Z,:O):]:^%7_(CV?UD_\ 1C543PL^_P!VCZ_H=%1115'R@444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%! ZFJ.K>(]$T./S-4U&.'Y<A6;YC]!U/2@J,92E:*N7J"P'4
MUP.M_&B+<8_#^FLW4>=<<#/J .W3T_"N5U?QIXGUMC]NU:0(3_J83L7KTXZ_
MCDTKH]3#Y-C*VLO=7GO]QZEK/C;PUH*9OM5CW?\ /*-MSGC/0=/J<"N2U?XT
MW3EH]#TI5])KELY_X"/P[UPH SFEI<Q[.'R3"T]:GO/[D:&J>*_$>M;O[1U>
M9E;[R*VU>F.@P*SE&*6BI/5ITZ=.-H)+T#Z"@9QS110:!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5ZU\*O^1'L_K)_Z,:O)<\9
MQ7K7PK_Y$>S^LG_HQJJ)X6??[M'U_0Z*BBBJ/E HHHH **** "BBB@ HHHH
M**** "BBB@!&=44N[;57DD]JX;X0_M1?LS_M!W%W:_ 3]HCP+XWET\*;Z/PC
MXLL]2:V#9VF06\C[,X.,XS@^E?%O_!Q;_P %%-+_ &//V-[SX&>"/$\MO\1/
MBQ97&EZ3#9(&EL]+("7UTS$$19CD\E&^^7E+1X,3/'^</_!)OX ^-_V(_P#@
MOS\,/V==2U.^L=0D\&EO%MB+EP'EN_!\FI2VL@*(2D=R4(1E^5H5Y)4-7I8?
M+_;86563MHVEWMO^9Y>(S#V.*C2BKZI-]K[']%5%>*_M(?\ !0_]CG]D7XF>
M%_A!^T9\:+?PQK_C1=WARUNM)O98[D>8(LM-#"\4(WD#]XZ=:];N?%'AFPU>
MP\/7OB&Q@U#5(Y7TRQFND6:[6,*9#&A.YP@92VT':&&<9%>>X2C%-K?8])5(
M2DTGMN7Z*X?]H#]I+X&?LK> %^*7[0WQ+T[PKX?;5+73QJNILPB^T7$@CB0[
M02 6.2Q&U%5G<JJLPZ+P'X[\&_$_P;I?Q#^'?B2SUG0M:LH[S2=6T^8207=O
M(NY)8V'#*P(((HY9<O-;0.:/-RWU-:BBBI*"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***,XH *** 0>E !1SWJ*ZO+6R
MA:>[N(XXU&6>1@ /SKD-<^,6DV8>#0[1KJ0+\DC?+'G^9_3-!O1PU?$2M3BV
M=FSJJ[F;BN<UKXI>%M*&R"Y:ZDR1MM^0/J3QCZ9KSG7/%OB#Q"[?VCJ+^6Q_
MU$9VH/;'?IWS6;TX%3S'O8;(5O7E\E_F=-K7Q6\3ZH#':,MG&<_ZGEL<\9/\
MQC\*YN262>1IYI6D=FRSNQ))]:8?6E.>U2>Y1PU##QM3BD%%&1C-%!N%'-&:
M&.T%B: ,'XA?%+X9_"/1(_$OQ6^(FA>&=-EN5MX]0\0:M#90/,RLPC#S,JER
MJL0N<D*3V-;D$\-U"ES;RK)'(H:.1&RK*>A!'45^0?\ P<-_M"_L2?M"?#?2
M?#?PQ^.^@ZU\2O /B41W&GZ4CS))97$.)XUNDA:&1XY! 2BS (1,&!==H^\O
M^"4'[3H_:Q_8/\!_$C4)6;6M/TQ=#\2>9,9'>^L@('F9O+09F58[@JH(3S]F
MYBI->A6P,Z6#C7=]79IJWH>'A<ZHXG-ZF"5GRI--.]^Z\FNQ]&9STHHHKSSW
M HHHH ***,T %%%% !1110 449HH **** "BBB@ HHHH **** "BBB@ KU#X
M.?\ (J-_U]O_ "6O+Z]0^#G_ "*C_P#7X_\ ):J)X^>?[C\U^IUE%%%4?'A1
M110 4444 %%%% !1110 4444 %9WB_Q7X=\">%-3\;^+]4CL=)T;3YK[4[Z;
M.RWMXD,DDC8YPJ*2<=A6C2,,C!% '\ZUWX1_;+_X+X_\%1?'7[3G[&?C+0=#
ML?A/?Z?/X(USQE>7*VMA:VUVYTTI']DGQ+/)#-=^2\(0'S0Y8CY\OQ5'_P %
M$/AA_P %R/V;=4_;Q.EZ+\4-2\0^$X;G6O"<EI;SZSI4NK26+27DE@0DLLL(
MN+63.-UNB1%=F ?Z&/A?\&/@_P# _1)_#7P7^%/AOPCIMU=&YN=/\+Z';V$$
MLY54,K) BJSE45=Q&<*HS@"OG7]MO_@CM^S1^W9^T=X-_:K^(OCWX@>&_&7@
M>SM;72+[P7KEO:ADMKM[N N)K:8JZ32R$/&8V^?DG:I7VZ>:4^;EE%*"BTM+
MM:=_-GA5,JJ<O/&3<^9-ZV3U[>2/S4_X*(:?-^US_P '/WP_^ LGA&[:V\'W
MWANPN_L=_E[JWAMAK<UT 5'E!([AE*Y;(MRV?FVK=_X.+Y?$?[6O_!5KX$_L
M-^#/&>HVI6QL["1K+26G;2;C5KY4N+P*I1IU6V@MY&7S H6 \IEFKV#_ (*-
M?\$8?^"B7CK_ (*=7?\ P4,_81^./A_1]2U_[&JW5U=-9WGAXQZ5#I<I!9)%
MN$DA1VR &'F,NWY0[<;^R#_P23_X*0>&?^"TWA[]I']LW6=;\>:#X9A%T_Q6
M&J6:0WUVNEXC@2W:5IU@2>1X1^ZC+A/,(CWD#HIUL/&,*BFO<@U;KS?/3=G-
M4HXF4ITG!^_--OI;Y'@O_!RQXB_:7^'_ .U-9_LF2?&ZRD^%_B*QTSQ!X+^&
M.B0RV]OHL4< TV$2*T8C1#):S[(HI6C!5Y#%"TGS?I1_P3'_ &B_VHOV</V*
M_$S?\%1O@_X?^#_ASX.V-I8:'J]O;QVMO?:>@>,$1Q2.A8$00HL8!D9UP"S@
M5\$_\%,OB%\,O@Y_P<Q>#?BS^V/>:Y9?#WPZWA_5=.OIH;EX[:*"S:2UN(%3
M+/;1ZHC/((@REDN 59MZG4_X.E_VBKCXX^&OV>=*^$GCK[=\/?&FE7?B+2WD
MW6=O>S,88[>XD\\1[,13/CS0NP2,3MR:'3^L4:&'Y4E)7<K??;SLM0C4^KUJ
M^(4FVG91O^?E=GWM\-?^#B/_ ()0_$_QKI_@73/VB9M+N-1F\J&\\0>';RQL
MT;L))Y8PD8)XRQ R>2.M?;P.>:_"_P#X. OV,/V+/V0/^"8?P/\ "GP9\!>%
M-+\96_B:QM(M8A^R_P!M:YI_]EW3WMS/)$%:\4W'V1GEP8T>6,)L615,G_!1
MC_@HA^TS\,O^"(7[+_AJ?XE^*M%^)GQ*LDN[SQ!;W5W9ZI+I>GJ DQGCD20M
M,L]BV]]_GH[ODD[CQ2R^G6C"5!M<S:U\NNG2QVQS&I1E.->SY4GIY]#]S*0D
M@U^$GQF_X*G?\' '_!._X>?"?XM?M6^"/",7AS6+%[!=#U[3DDOM6EB5F,NI
M&.;S[>Z>.17'E,B+Y2!X@?,1_LK3?^#GW_@ES+-IMCJOBKQ9!->6MI)>30^%
MY9+>RDFB1Y(V?Y6;R6=D=E0@F-BNX8)PJ9;BHI."YD[ZQUV.FGF>%DVI/E:M
MI+3<_1*BJ'A7Q3X:\<>&--\:>#-?LM6T?6+&&]TG5--N5FM[RVE0/%-%(A*R
M1NC*RLI(8$$'!J_7 >AN%%&:* "BC-% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTM]2N]'%VSV]Y:32PW$&]MB.ACSMD1P2<,O!!^!?C/XT_P""Q7[2'[*NI?\
M!4]/VG]0\*> T5;>Q\(^"?&.I:?.+6&\^Q/<+:V:"(XG\UI)99%<B-S@1B-:
M>&RRIB(*;DHINVN]^Q.8<14,#6=*-.4VH\SM:W+WN?M3\1/CI\%_A%>:=8?%
M3XK^'?#EQJ]Y':Z7#K>M0VK7<TA(2.,2,"[,58 #J0:9\8?CQ\)?@+\)]2^-
M_P 5?'-CI/AC2['[5<:I-,&21",HL0&3*[\!$3+.S *"2!7XGZK^QGX^_P""
M@?\ P3H\;?\ !47XO?&WQ)XF^)VES32-9R6D L_[-T_*31I%$J+$/*/FDH J
M^2YVL9&-?0_["?P>UC_@K)_P1-_X9L\3>,I-#U7P/XW;2M#\03PK<1M]E6"Z
MBWQ($)06]ZUOC<6R@D+-]RMZF6X>E%2<[\LN66FWH<=#B+&XJHZ<:*3G!SIW
M?Q>3['J?PL_X.&OV<_BU\9=+^&OAO]GSXE-IGB#4X=+\.ZU'IUO))>7\AA7R
M3 LN$VF4DE9'8*JG;\^!^@G0=:_%&?XO?\%;?^"+WP^\-^&_CI\._!WBCX8Z
M3XH73]!U"Y%M=YQOE,5M<QE;F'S(T?RVN8RR)$JJJK&$'[$?!?XH:-\;O@_X
M4^,_ARPNK73O%WANQUJPMKU5$T,-U;I.B2!2RAPL@!P2,@X)'-8YEA:='EG2
M7NO2][W_ ,CIX?S+$8SGI8F3]HK-Q<>6R?;NNS.FHHHKRSZ4**** "BBB@ H
MHHH *]0^#G_(J/\ ]?C_ ,EKR^O4/@Y_R*C_ /7X_P#):J)X^>?[C\U^IUE%
M%%4?'A1110 4444 %%%% !1110 4444 %%%%  3CK67IGC7P;K>LW?AO1O%N
MFW>HV'%]86M_')-;<X_>(I+)SQR!7YT_\'!W_!6?7_V(/AK=?LM_#7PMXNTO
MQE\1?!<L^@_$32Y8[>UTO-VD$L<,IRYN!")R6CVO 9;9T;=(&C^/_P#@W#_8
M!_9A_:5\8Z7^UIKW[1_BC5OB%X!\1+JOB+P##975K9PL'E&G//>9!NV\V%;K
M:KE#A8I$9=X;T*> ;P;Q$W9=-+W_ ,NQYM3,$L8L/35WUUM;_,_>JBFB1&.T
M-3J\\](\W^/'['G[*_[4,MI<?M#_ +/OA+QE-8J%L[CQ!H<-Q)"HW8579=P4
M%W.W.,L3C)-><_\ !0?_ ()B_L\?\%#/V;;;]GKX@64FAMH*H_@CQ!H\8\[P
M_,BJ@\N/(22)HU\IXFX9#\I1U21/HZBM(5JM.2<9/3;R,YT:-2+4HK7?S/QU
M^!O_  :G&[\?:9J?[:/[8FK>-O"_AY((-'\-Z''- TEK'NQ:--.[FW@XC!6%
M0VTN%:,[7')_\%&?V,_C'^W;_P %T?AE\.]>_9;\2:7\%_"ZZ/X;;7/^$5O+
M32K_ $JR\W4;N!+F%@JJX>:VCDB:/8"F "N3^VU&!UQ79',L3[3GD[NS2Z6O
MU5NIPRRO#>SY(Z*Z;ZWMTU/PQ_X.*?'^I_MJ_P#!37X-_P#!-#X:ZC-+_9=U
M8V^MJCS(D&IZM-'C>#$5Q#9>3-YR"10MRX.#&RUB_P#!T)\/?A+\/?$OP&_9
M=^!'PBTVUUR/3;R5I-#TNWCNM2\UK:UMXI$@C5I)6>)B"1\Q<X'6OV,OOV#?
MV/[S]I?1?VQD^ >@V?Q,T&2\DL_%VEPO9W,SW5NUM.]R(&1+UC"[(&N%D*!C
ML*DYKYS_ &E/^"+6F_M,_P#!3[P;_P %"_''QZ:ZTKPK)I[+\/[[PK;S1%+-
M2T,*3[E^0W#/,QE21\R%5955 O5AL?1IRIWNE!/YR?H<N(R^M4C4M9N<E\HK
MU,']M#PA%\%/^"?GP<_8UTC_ (*H^%_V??'W@O0-#LSXCOO$2:>VLP:?IBV<
M\7EF9)!$S/'*.N"B ^H^)?V3/^"AW[;_ .Q=_P %/?AK^S?\4?V]M)_:-^'/
MQ8U#3K!=4T7Q NJVZK>WT^G6\T<[@M:SPW*%I84=E>+ ;<Q0Q\Y_P4<_9R^,
M_P %O^"U/B?]JG]H+_@GUXJ^/'PYU;5$O_#FDZ;;7'V+4!#9VRPK(UM'.-D$
M@57AF39,%;>A5V%<5_P2._9O\&?M>?\ !="_\967[/3?#_PK\/?$E]XLNOA_
M'<221Z#?6DP6VM/-C,6P17Y20*%\O]QY138<5UT:%..#E*;4DXN6T=WTOOH_
MD<=:M6EBXQ@G%J26[V76VVJ/N3_@N#_P7KUK]D#4?%_[''[-FA^(= ^+&FW&
MC26_C:^TFSFT^"SGB6[FDMTN!*L[;/*M_GBVYEG(*M I?[6_8I_:=\<_'G]B
M30?C-K.N^!_'?Q$D\(G4=:T/X:ZU;_8VU K(R:>DC7,T<<@9/L[2M*8C+'(R
ME4P!^0G[7?A/Q1_P61_X.'V_9IN](O)O /PXU!=%UJWEFDM?LNCZ:P;4YF:)
MI-KSW;R0Q2*%+"6T5_+(++[%_P %@]&^ 7_!$7]AV;]G+_@G]XL\0>!_&GQB
M^(2:O+<:;XLOEU33]+M@7D:&YC<210HXMK9%D<M(DTQ+2LCL.:>$H2IT:$5:
MI*S?7?N]UIK8ZJ>,Q$:E6O-WIQNETV[+KKH?8_\ P2 _X*&?M9?MYVWQ-7]J
M;]DZ3X93>"=>M['2Y/L-[ MXTKW1EM66Z7)GMDBMUD93AFG#;(@56OM"OA?X
M2_MVZ9_P3;_X)>?"_P"*O_!3_P"/6J:QXSUOPM'<V]G/I_F:WJ4C6XGBL!$4
MB>6XCB:&*6:X*XF;,TWS>8=3]B3_ (+Z_P#!/3]N?QW9_"?P1XLU[PEXMU2]
MDMM'\.^/-*CLY=0*HC PS02S6Y+EBJ1F42LT;83&TMY];#U9RE4IP]U/I=K0
M]"AB:-.,:=2I[S76U]3[4HHS17&=P4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%!8 9)KF?
M%7Q.T3P^?LUFRWEQWCA?Y5^K?7MUH-:-&K7ERTU=G17$\5O$TT\@1(UW,S-@
M >N:XKQ1\7[6%#:^&$\Z3I]HD7Y%^@ZD_I7'>(?%NN>)IB^I76(_X;>,D(OX
M9Y_'-9M3S'T>#R2$;2KN[[=/F6-5UG5==N/M6JWTDS9^7<W"^P'057HHJ3WH
MQC3CRQ5D%&:.O%&0*"@HKSG]K/\ :5\%?L@?L\>)OVC?B':W%QI?AFTCEDM;
M-29;F269((85X."\LJ)N/RKNRQ !(_,[6?\ @MW_ ,%5-'^$%K^V3=?L8>!X
M?@QJ'B@V=AJ<D=V;EH/.=1&9!>[E.$:+[6;40&48"Y(C/9AL#B,5'FA:U[:N
MUWV1Y.89U@<MJ*%5N]KZ)NR[OLC]19/V@_@E'\98?V>(OB?HTWCB;3Y+T^%K
M>\62\AMXUC8R2QIDP@K*A7S-N\$E=P!Q\3R_\%X/"?AO_@HGJG['_P 5OA='
MX=\*Z5KUYX=_X2J&^>^FN-26X2.WF= D?V>W8"164"9@SQG<%5C7RU^WKX,\
M-_M#?#30_P#@N%_P3VU"\T'5M+U0_P#"SM/AUC;=:5?1R11QS[%P1+ME59E5
MBKQ2PNJ;3([\SI%C\$/^"K'[>\MMXF\5I9:M^T+\&H;RWATNSBF/@_Q9I:^4
M87+.SB)H-&GDYV2/!J"+@;EEKUL/EN&C3<ZEVK-/O&2_K0^7Q_$&83K1I4+1
M?,G'M.#VU?6^CMW/>?V8/%7C/X0?\'(GQ+^&?C3QEJGC)_%&BZG8Z;J&J7T@
M.C65S%;:_#:Q)(TN8H%3[*L:LBX/F (/W=?$_P"Q[X\_;(_8P_:'\<?L9>#/
MCAX1^#FM>(=233O%OB;QQ)%!9V4FG_:&B=;F6-U1)!,^QPI6594(."IKTK]C
M;1_VP]7_ ."L'PK\#_&#P+XRN/%WPEOE\/\ B[5C%<7#)I44DIBFN9%4@0^5
M=(@F+F*6%X""0P9_U+_;+_X)#?L6?MOZN_C#XE^#K_1/$TTBM<>*_"-VEI?7
M  1=LN^.2*;Y4507C9E&=I&3GIJXC#X*JH5+-2BM59ZK9V_$\_#8#'9QAG5H
M-QE3J2:3;5U*S<;[Z;7]3Y>_X)8?#G_@F_\ LD_M&:I^R;\+OVK[CXK?$+XA
M>%)H;[Q!HL,0T1X(Q+<&TMV@DF59_(!=B99 /);YD8^73O\ @BQ^QY^VG^Q7
M^UY\5O GCGX=:E:?"NXDGLK74I+Q/LMU>12J]G>P"1E>6)K9I(V=$)W21JV#
M&X3[+_9%_P""<G[(G[$227?P#^%L=GJUQ;>1>^(M1NGNK^X3"!E,LA.Q6:-7
M*1A$W9(49Q7N?.>E>5B,PYI5%"\E-*[EW75);'U&!R'V<:,ZMH2I-M*%[6?1
MMZOS/._V@_V3OV<?VK-$L_#W[0_P=T3Q7;Z>[MITFI6O[^S+E"_DS(5EA#^7
M'O", X10V0 *=^SY^RC^SE^RIH-UX<_9Y^#NA^%+>^=6U"33+7$]X5+E/.F8
MM+-L,DFP.S! Y"X!Q7H5<7\?OVA/@[^R]\,+[XR?'?QK#X?\-Z=)%'=:A+;S
M3$/)(L:*D4*/)(Q9APBL0 6.%4D>=&I6E'V:;MV_X![LZ.$IU'B)12:6LK*]
MO4[3!HKB?V=OV@OA?^U-\'-&^/'P9UF;4/#>O+.=.NKBSDMW?R9Y+>0&.0!E
M(EB=>1@XR,@@F[\3_CE\%?@EI\.K_&;XO^%_"-K<S"&WNO$_B"VL(Y9"&8(K
M3NH9B$<X'.%8]C4^SJ<_)9W[=33V]'V2J\RY7K>^EO4ZF@FO"_V6?^"C7[*/
M[9VJ^+[']GKQW<:O:^";2SN-7U2ZTN:R@>.X$Y!C%RL<A">0X<LB@97!(.:_
M.>Q_X*-_\%</^"D/Q7\=77_!/G[+H/@GP7"MY9VW]CVT<]S''.TMM%+-<"8O
M>7 38849(62,AE4%RW71R_$5I23M'EM=O3?8\K&9]@<+3A*-ZCG>RAJW;?[C
M]<_'OQ$\ ?"KPI=>._B?XXT?PWH=D4%YK&O:E%9VL&]UC3?+*RHNYV51DC+,
M .2!7SI\0/\ @KS^R%X/\=?"[P!X=U;6/%-Q\7-0LX/"MYH.G?Z-Y-Q?R6 N
M9'G:/:BW$3*R@%\<A2*^5_V!OVW/'G_!6S]FOXM?L ?M2P6\WQ$C\)WEQ8:J
MNG):?;8A,$5I8Q"88);:ZDMER%4E60A2\;N?%_\ @VS\#? GXA_M ^.O^%N:
M):ZYXV\*Z'I]UX!CU6&2X33[6.YF6\FA# Q1NDTECM)Q(ID8Q_\ +0CLAEU.
MC3J2KWO#HNJ>SN>35X@KXS$8>G@[*-6_O2W3C\2:[VV\SZ$^#_[7_P .?V1?
M^"KNJ?\ !.OX4_LF> _A;X9\6:DT-]XFCOB+R_U%[22>QG4DK&L$A>."&Q ^
M62=MC R&,_ 7[8W[(OQ$^&W_  4C\.?#G]N3XCV=]=?$K4K#5?$6O>#;&.&9
M+6[O9;4OY0A$:W'[AG;"R*6;<6D8L3]7_P#!Q#\-_$_P(_:L^#_[?O@-XH)K
M>:ULYI(K.#,.I:;=&]M9VW$F=I$=DPR%56S4,Q#*H]>_X+;?L=?%+]N/]GGX
M??M5?LR^%[C5/$'A?3CJ)TG3[B1M0GT^YCBF M4CRLLT;*&VK\[=$W-A3Z&&
MK4Z+I5%HJD;-O^9>IX>886OBHXB@TY2H34HQ6B<):M67D8?_  6A_8E\&_!K
M_@D3X7\&Z1XQU+6G^#OB"S_L37?%$<=YJ<UC<RR6QL!<*$\F%?M%OA57;LL(
M$V_*K+Y_X0_9=^!'QY_X-V6\8> _A9H[>*?".EZGK\FM26,<5U'?6URK:A*)
MV!<[[.U52 0)!!"O\"@>R_LG/_P4T_X*&_LR_$CX%_MU?!R/P+X;UCP"FB>&
M]>O-,DTK4KC5HB<W$]G.'E99,HTD@6&(>4%AC)=S'[G_ ,$Q_P#@GWK_ .Q#
M^REK7[.'Q;\=Z?XTCUS7KV\N(8K-S9Q6MQ;Q0-:A)L[D;RW=@5"DS,,'DGEE
MBGA</R2G><9J6CW3WV/1IY=',L=[:G2:I5*3A[RLXM:+1Z^C/A7]DCQWJ'[7
M7_!O=\9O@'XD\9QV^I?"VWN)[:1H9;B8Z9:/#K-LDF^0#YY(+FU0H0(HXD.P
M[</U_P#P2+U*^_:<_P"",'Q>_9?O/[8NYM BUFRTN&QMT:0QW5L;N*W@"AF=
MC<&8D%229L+G@#[U_9$_X)__ +,7[#_AC6/"GP"\&75G!XBCMQK\FIZI->-J
M#0HZ*[B5BBDB1\JBJIW?=   ]2\$_#WP%\--';P]\.? ^D>']/:9IFL=%TV*
MUA,A !?9$JKN(49.,G ]*YZ^94Y*<:<=')27EW^\[\%P_B82I5*\U>--TY)7
M=T]M?+T/SU_X(5?L[?&2#]AOXF_LS?M6_!KQOX9T;Q%J5U!:V_B6WDL3/I]]
M9_9KF*WBE(FA*E'9F,:J3.C*6.[;>_X)%?\ !+']I#]DWX/?%SX>?'W7M/T5
M?BIH<5A%>>$?$#MJNBO''>0>;&PA\I7*W7F)(LC%&C7*G)V_HI17/5S&M4E.
MR24VF_5'H87(,)AXT>9N3I)Q3VNGO<_-OP1_P;?_  DMO%-C#\9/VJ_''C3P
M3X;NF;P=X)FC6VBTZW>X:>:W>0R2*RRLV7,$=MN<L_5N/T6\,>&O#_@SPWI_
MA#PEHEKINE:5916>FZ=8P+%#:V\:!(XHT4 (BJH4*    !5ZBN>OBL1B;>T=
M['=@\MP67W]A"U]WJW][NPHHHKG.X**** "BBB@ HHHH *]0^#G_ "*C_P#7
MX_\ ):\OKU#X.?\ (J/_ -?C_P EJHGCYY_N/S7ZG644451\>%%%% !1110
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M?-[&&R[FH>VISO):[:::VOW/D\PS_P!GC/JF(I6IS;BW?WK/3F:Z)O8^EO\
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MFRVN@^!;C3XI;72'DMTMVFAN&)EW;!(-S9<B9]SL6)/Q7_P6._8H_;4^!_\
MP5FT'_@J7\*/A!J_Q1\(6FJ:-KK:3H,$TLNC'28+9);695#E(Y?):9)$7;NE
MD!4,N7_;CI1^%=E+'UZ=;GE[VEM>QQU<OP]2C[.'NZWT[GXH?\'/G[5'CCXD
M?L+_ +-=G%X4F\-Z9\5(V\7ZYH6H>9]ML+B'3[1H;*1OD!"?VG,)%9,F2&,C
M9M(/#?M^_P#!0O\ 96\$?\$&/A'^Q!^S/\6M%U3Q-XF\+:#;^,=!T>^^V2Z6
M(X(KW4!<EU?R6:](79O1@2P0;(W5?VJ_:+_9=_9\_:W^'LGPJ_:1^$FC>+]!
M:;SH[/5K;<UM-M91-!(I$EO*%9U$D;*X5V&<,0?BG]I__@V=_P""?7QKT+PU
MH/P7TN\^%*Z#JEQ=WTGAY/MTFKK.UH'CGDO7DE(2*U=85#^7$]Q(^QMSJ_9A
M<9@XTZ<*J:Y9-Z:I]K]?(X<5@L:ZE2=-I\R2UW7>Q\T_'K43_P $P/\ @V?\
M-_"'0HK72?&WQLM4AU:1$M//G75<W-](XQ(L_P#Q+E6R\P'>B/"P96C7%/\
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M*@A0ZYQD5J9&,UY)[ 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#5T\,:6UY#97"_>@>4,$,BGAE4ML8,C;65E'D'_!7S]MKX[:+^R]\.OVQ_\
M@GC^T'I=QX*M_$1'BF^T7R+C[0TJ1-:),LBDJJ,LL<T#!7#3('4;3M^?/^"%
MG[)/[$7[9G[,OQ(^'_QO\!V&L>-6U9EFU"XN(3J5C9RP*L5S9G;YD.V3<2[;
MU,@&1C*GG/\ @C=\*/$?Q+UO]I;_ ()6?$OQ-8W7AO4O#MX;B]TNXEGAL]9L
MKV.S2^M&#QK)&7:.0[@/-%K #M7<K>I'!X/#5')7;IM<U]FGU1\U/-LUS##P
MA)I1KJ7(X-J491U2;\^ISOCG_@F)%^T;_P $Q[K_ (*@>'OB9KWBSXH:K<7W
MB+QI9RWT2Z>]K'>7"W@AC>W2430(FY@92A$,@C#9C4_H5_P0B_:_U7]J3]B'
M3] \;ZLUWXG^'MU_8.I7,TS/+=VJH&M)W)0?-Y1\H_,[,;<NS9DP/#?^#=C3
MOVF_ VB_%']F;XW_  QURU\':7J+-8S:M9'[)!J6?)O;.*7:5E#KY3E5D9!M
MWJ/WK,WO7_!-3_@DK#_P3Z^,'COXJV_QKNM8A\5>;9V'ARST\6UC;V?V@30R
M2J68O.@S&I!"HLDGWMXVQF%>G*G4H5)7<6G!^3Z:&V0X.M3K8?&8>#2G%QJI
MZ:K[6NKNSS'_ (."_P!@C]H/]K7P1X)^*/[/_AZ;Q%<>!8]475O#5K,3=30W
M MW$UK">)77[.RLBGS'W1A%8C%>/ZM_P2K_X*(?\%6?'=K^U-^V]XXT3X2ZI
M#IME9>'=%L?"_P!HEM]/5[JXPT'VI7AD261"$FD:0B=MQ0Q!&_7K ]**\^CF
MF(HT%3BEI>SMK9[H]W%<-X+&8V5>I*5I6O&^C:T3[Z>IY[X\_9G^$?QN^'>C
M^ /VCO NB^//[)@M\WFNZ5&S/<QB,M.F<F(NT8+*K8(^5MRD@^0_\%!?^"8G
MP_\ VXOAKX-\)^&_'5U\.-:^'5VLO@76O#]B&ATJ/]RK0K;))"-H6WA\LH\;
M1-$A4[0R-]08Q17'3Q%:G)2C+;8]2O@,'B*<J=2":DDGW=MM=SXG_9Y_X(D?
M!+P7XDL_B;^US\5O$WQ\\9:?Y::?JGCVYEDLK2&.5Y(XX[22:8D;GRRRRRH2
M"0J!G#?; &.!0?K116Q%;$2O-W*PF!PN!ART8VOOW?J]V%%&<]*,UB=045#=
MW]EI]O)=W]W'!#$A>26:0*JJ!DDD] !WKRKXJ?MS_LL?!V9[#Q?\7=/>]53_
M ,2_2U>\FW; X5A &\O((P7*@YZ]:-M6=F#R[,,QJJGA:4JDGTC%M_@CUN@G
MBOB?QO\ \%H_AS:+-#\//A'K%\WD@V\VJ74=LID]&5-YQ[@_A7B_Q%_X*[_M
M0>+8)K#P=9:!X7A:96M[BRL#<W4:CJA:=FC;/<^4#Z8ZUFZU-=3[[+?"7C?,
M+-X?V:?6<DOPU?X'Z?/)'&,NZK_O&N-\;_M&? 7X;7$EAX\^,7AO2KJ.V^T-
M9WFLPI.T?/S+&6WMG! P"21@9-?D#XT_:0^/OQ#N/M/C+XP^(;YOWFU6U214
M <Y8!5(4 ^@& . *XD #M63Q*Z(_0,O\ ZSUQV,2\H1O^+:_(_5WQ3_P5._8
M[\.>0-/\<7VL>=NW?V;H\_[K&/O>:J=<\8ST.<<9\N\9_P#!:CP#8G9X!^"N
MK:DRSLK-J>J1VBF,9PZ[4E.3_=(&,]>U?GG14/$5.A]I@?!/@W"ZU?:5?\4K
M?^DJ)]8>,_\ @L-^TQKXO+3PKX:\+Z%;S39LYH[*6XNK>/<"%+R2>6[8&TMY
M0!R2 IQCSWQ)_P %%_VQO$MU'=2_&6ZL_+CV^7IMG#"K<YR0$Y/O7B-%9NK4
M?4^PP? 7!N!M[+ T].\>;_TJYW&M?M,?M$^(-0FU/5?CEXL>:X;,WEZ]/&IX
MQPB,% ]@ *X? ]***B4I2W9]%A\OR_!JU"C&'^&*6VVRZ!1112.Q)+8****
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M>0<C(HI%&T;:6O+/6"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **,T4 &><51USQ)I'AVU
M^UZK=B,?PKU9OH.]9/C/XBZ9X95K.V9;B\P0L*MPAQP7]/IU_G7E^K:MJ&N7
MIO\ 5;III2, M_"/0#L*&['K8#*JF*]^>D?Q?I_F:WBWX@:OXHW6JG[/9[L^
M0A^_Z;CW^G3-8&T&EHK,^LHT*6'I\E-604444&P4444 %%%% !7A?C'_ ()X
M?LT_$3]LG3_VW/'G@J'4_%FBZ/96NB0S1A;>VN[:6=TU!T7'GW(66-$:7<(Q
M;1%0&5&7W2CZU<*E2G=Q=KZ&-;#T<0DJD4[.ZOW74#STH P.M (/(HR,XJ-6
M:RDHJ[*.I^(]!T2[L['6M<L[.;4KK[/IT-U<K&]U-L9_+C#$%WV([;5R<*QZ
M T[7]?T3PMH5YXG\2:M;V.G:=:R7-_?74PCBMX8U+/(['A55022> !FOQK_X
M.1/B38^ OVT/A+XO^'<.K:3X]\+>'TU)=>D6-K?RX[[SM/:!6+9DBG2[+[E
M.Z,?-@@?4/\ P2<\._M.?MG_ ++/C+XE_MM?'"W\<>!_B]&RZ?X>L;JYM[C3
MUCDEM;JWWPF);>!Q$JM;Q[UD^?>1OE$OJ2R]0P<,2Y:/===^A\[3SZ5;-JF
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1V>EZ?;(6GO+ZX6.- !GDL?04%0A.I)1@FV]DM6:5-FGAMXVFGE5%5<LS-@
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MNG^---L=-^)FA+K,EU!%J2%)8D,A=3<6[B*- JHB*UFC@ R )Z5^W?\ LW_
MO_@IM_P3(\*_ME?LG:5IMKXF^'/AB.*3P_X?TQ2PM8(U^U:,\:$R0O;9::$?
M."N0 RW"2K[6#PV"H0IU9^]S.U^D7YKU/D,VS'-L96K8>B^3V:OR]9Q>[3Z:
M=NI\Y?&O]F7]I[_@@!^TKX)_:"^'WQ%F\9>%=8<VM]J5KISZ=#J2*RO<:5=H
M6G2(R( \3EG),9D5<PL!ZS_P4>_X)K>/?C9\8O"O_!2?_@G]X8B^*&C>.[BV
M\0:MX;U"SMKBWCG3R'B+PRNOVB"8!DEMV3]V8I%<GS-J>M?L37]M_P %F?\
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MS^3\*\*XK(W]4<G0KTE33<G=T^:<U:ZNG><M7K:QZ_\ LW?M%^#?AYX-\4_
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M$:ZK<1W)@AL;=5G%EF!&,TLDDA=890&59?)/B/\ P0T_X)C?"W]JWP9\2/\
M@IO_ ,%,M'L/$&A^*+J^N-,E\577V6SED^TR3ZIK-P2L:@"5-B2+((U'VH.I
M(4ITU%A:\/:SNX07*GUD^_R.:G+&8>?LH64YOF:Z17_!/VP^%_QD^$7QNT*;
MQ1\&/BGX<\7:9;WC6MQJ/AG7+>_@BG"JYB:2!V4.%=&*DY =3C!%=)7\_O\
MP;7>!3XD_P""L/Q)^(_[.&GZM;_"?0]*U>.-KJ290FGW5YC2X+@G(>8I$6"N
MQ8^3(PSL8C^@*O*QN&CA:WLT[Z)_?T/6P.*EBZ'M&K:M>MNH4445R'8%%%%
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MGX>&&@;PGK&I7S:I]LW"Y^U,#L\O8-FW'7<<^U=S>?M>_"KXCZ7X=U;]H?\
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M%_MO:#_P3\_9WF_:$\1?#W4/$]O'K%IIRZ3IETD,SO.Q52&8$<$=,9.:[_\
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M5!CU DQ;Y#/DN'V-P,5+P\8KF<O=LG?R>VGWE+$2E+D4??NU:_5:[_-'UO\
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M(G2XTW5K42)\R-&70_>C?:[@2(0R[C@BOC?_ (+4?LJ_M+:__P $RI/V7/\
M@G/\(]%_L6V$%OKGA32'^S78T6#]Z8;",,L<KET7?&Q+R+N"*\CBOO+'>BM:
M-:5&<9+6SO9[&-:A"M!Q>EU:ZW/E+_@CC_P3UT;_ ()V?L8Z'\-]0T-;?QOX
M@CCUCXB7#3)-(VIR1J#;>8A*F.!0(E",4RLC@DR,S?5M%%*I4G6J.<MV51IP
MHTU""T04445F:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2]'_ .0M:_\ 7PG_ *$*^^OVV?BQ_P $Z/#O[3'B+1OC7^RGXH\1>)X(=/\
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M_F?GV4\69A.M[/&TE[^+J4(.,ME",Y)OW5_);S;OI:Q\ZT YYK[4A\ ^!O\
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M6UAT?3+B1D&RZ8(!-Y<4>(GN"PW,^XN6 JE1<9)-V>OX?UH<-;Q"CBL+.='
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MA,4]G=1AE8P3QGRV9264'(5\;3]!44?6*W-S7UO?YD_5J/+:VEN7Y'R+\/\
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M[&2W_P#2<5^7M?J%_P $#O\ DD7CS_L9+?\ ])Q75A/XOR/Q7Q__ .3;UO\
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M6?\ P3^$?_E#1_PSC\8?^C^/BS_X)_"/_P H:]:HH]I+^D@]G'S^]_YGDO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M  W\,(;'P_X>CU!M'V_:3YCAX9-@DS@$ 9V'KBO?/V5_C]8_$OP!\3OB-/\
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MX%\;?#FUO+2W:[M$1YK&YM;N:=T;8^Y95DVMD#:,$CF_V8_VL_\ @HA^UO\
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M,5.Y3@CH: .TS16=H.L?;XO(N&_?+_X\/6M&LS0**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHILLL<$33S2*B(I9F9L!0.Y- $.K:K8:'
MILVK:G/Y=O;INEDP3@?A7SY\2?'UW\0-<^W,KPVL*[+2W+?=7/WB,XW'OCL
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M<#3A*#O\+NMNS6MEKO\ @ Z=****XSN"BBB@ HHHH **,^U% !1110 4444
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M'^&G_!0;]DZX\6_#^_\ $6F>&O&VEWEKI>J*S6%\B;GB6[A:-RT?S+O1L@\
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M HR/6K6AZ>FK:W9Z5)(56ZNXX68?PAF"Y_6OLW]HS]I_Q]^RK^U$O[,WP?\
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M /7JE_Z55"OU"_X('?\ )(O'G_8R6_\ Z3BOR]K]0O\ @@=_R2+QY_V,EO\
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M'8?%7X%?!+XZZ;9Z-\;O@[X5\8V>GW7VJPM?%7A^VU".VGP5\V-9T<(^"1N
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M2%!.!F@'-5=;UK1_#FC7?B'Q%J=O8Z?86TEQ?7EU,(XH(44L\CL>%55!))X
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MGH/W;?TK:K,T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_@LA_P %*Q^VK\4(?A=\)=8N/^%:>%+HM8ED"#6-07>C7^.OEA&*1!N=K.Q
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MO_$0O&F<MYJD3?*<]1P..G KCOV.;;7-6_91_:"\/_#CS'\67'A[3'AM[/\
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M?@?-9VWQ-T*TL9-0$GV>.WUNSO&RF-ZN+>60Q,"PRK[3STK[0^#7C7Q/K?\
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MZ5,BHDU%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,/B=XMO/'?C_ %^?5-7U!D-Y?7.-\I5%12< #A54=.U;'_"]OBW_ -#K<?\
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M!TSSSFM+_A>WQ;_Z'6X_[]Q__$T?\+V^+?\ T.UQ_P!^X_\ XFIO'JWKY?\
M!.Z&%S"FXN.%H+E;DK2>DI7YFOW6CE=W>[N[[G*VEW=6%W%?6-U)!/#(LD,T
M,A5XW!R&4CD$'D$=#7H'Q$_:W_:6^+7@J'X=?$?XU:]K&BP^7C3[R\W(^S[O
MF$ &3& ?G)Y&>O-9/_"]OBW_ -#K<?\ ?N/_ .)H_P"%[?%O_H=;C_OW'_\
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MOC&]L=6U"VN+>^U!9-TL\<_^M5F;.=_<GDUSW2NN_P"%[?%O_H=KC_OW'_\
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MO_Z3BML)_%^1^6^/_P#R;>M_CI_F??5%%%>D?P">2_L6_P#)']9_[*UX^_\
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M+Q='J%KNLYL22):^:IE,<)&)RP'ELNY&"2.ZL&44[]L?]BG]E[]K2ST+Q/\
MM/Z?)-IW@7[7>V\S:PUG;0Q.(GG:=@0/+VVZDDD  -R.M?"_[7GQ!_X*]?LS
M?M!:[^VQ\*_%*^._A+J2O?Z38^']0EU;0;?0E5)8I9;56'DY@ =[J+CF5A($
M(-=^%HTZKBXOWEO?9]DC@Q5:I24N9>Z]K;KNV>7_ /!*#]O/]F7]FOP_XC_8
MT_;+^"R:/9^)O&5W>7&HZUI0N+'3_/M8+<V-Y;W(::.("$KO;S/]=B0*H>2O
MI+1?^"(7[,NO?M ^!_VI?V6?C'-;^"T\1/JFIZ7INJ+/"T:&5T6QN(U;Y1<+
M'"\3DXB\SY]Z[7\VT+]HC_@E7_P5MT&/3_VI/"FD_"GXO7L<ENWB!;E;87,R
MP!(I1>D(EPN%39#<_,I01*6!4O\ <O\ P3W_ &&?!_[ OP&7X0Z!X@CU[4[K
M4IK[7?$G]EBS?4)68B/,?F2%%CB"(%WL,AF&-Y Z\56=*\HWC)Z-;I^:9R8.
MBJMHNTH+9[->3/:;WPYX>U*^AU/4M"L[BZM\&"XGM4>2/!R-K$9&#SQWJZ,=
MA117C79[5DM@HHHI %1W5Q;VEO)=W<ZQ1Q*7DDD8*J*!DDD] !WJ2OS]_P""
M[/\ P4(U7]F_X60?LS_";7I+'QGXWT_S]0U"VDDCGTS2#(R&2)@-H>9XI(<[
MMRJ)" &*,NV'HRQ%90CU,<17CAZ+G+H?%?\ P6L_X**?\-9_&<_!KX2^+FN?
MASX/FV0S6-R_V?6[_:OF73*57<(F+PQD[E(5G0XEY^'1]*!P**^THT88>FH1
MZ'Q=>M/$5'.74****V,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]*_
M9_\ C_J'PKOUT+79'N-!N)<R1X+-:,?^6B>WJO?J.>OU=I>IV&LZ?#JNE7L=
MQ;7$8>&:%@RNIZ$&O@?\*]*^ '[0&H?"R_70M=EEN- N)#YD8^9K1C_RT3VS
M]Y>_)'/7Y;/,C6*3KT%[_5=_^#^9_5G@1X[5.%ZE/(,_J.6$D[4YO5TF^C_N
M?^D[K0^MO>BJ^EZGI^LZ=#JVE7<=Q;7$:R0S1ME74C((-6*^ :E&5F?Z"4JU
M.O3C4IR4HR2::U33V:?9A1110:!1110 4444 %%%% !15SP]H&L^+/$%CX6\
M.V#76H:E>1VMC:QD!III&"(@R0,EB!R<<UH?$CX:^//A#XSO/AY\2_"]UH^M
M:>RB\T^\4!X]RAU/!((*L"""00:=G:YSO%X6.*6&<U[1KF4;KF<4[-VWLGI<
MPZ*W/$GPU\<^$?"N@^-_$?AR:UTOQ-#/+H-Y(ZE;Q(7\N0J 21M8XY K#R/6
MDTXNS*P^(P^*I^THR4E=JZ=U=-IK3JFFGV:L%%%%!L%%%% !1110 4444 %!
M]ZW/AS\-_&_Q;\86G@#X<^'IM4UB^W"TL8&56DVJ6;!8@< $]>U8?U%%G:YC
M'$495I45)<\4FU?5)WLVNSL[=[/L:UAXH2#P9?\ @V]LFFCN+J&[L95DV_9I
MURK'&/F5HV((R.54]B#DT?A10VWN%'#T</*;@K<SN_6R7RVUMUUW8445L> ?
M 'C#XH>,+'P#X T.74]8U*1H[&QA90TK!2Q +$#[JD\D=*$G)V15:M1P]&56
MK)1C%-MMV22W;?1(QZ*FO[&[TN_GTS4(&BN+:9HIXVZHZG!'X$5#05&4914E
MJF%%&:*"@HHHH *ZRZ'VGX&V,DYW-9^*KA+?_862VA+CWR8TZYQCC&3GDZZ[
M2_\ 2/@5KGG?-]C\6:7]G_V/-MK_ ,S_ +Z\F+_O@8[YTI]5Y/\ S/'SC2-"
M?558?B^5_>FT_)LY&N]\1HI_9A\&SE?G_P"$[\21[N^T6>AL%^@+L<>K'U-<
M%7=:K<P:C^S+H-G92>9)H_CS5WU)1_RP6\LM,%L3Z^8;&[QC./).<97)3^&7
MI^J,\X_C81]JJ_&$U^+:1PM?J%_P0._Y)%X\_P"QDM__ $G%?E[7ZA?\$#O^
M21>//^QDM_\ TG%;83^+\C\Q\?\ _DV];_'3_,^^JH^*-;'AKPSJ/B,VWG?V
M?8RW/D[MN_8A;;G!QG&,X-7JYOXQZA8:3\(_%.J:I>PVUK;>';Z6XN+B0)'%
M&L#EG9CPJ@ DD\ "O4CK)(_S_D[1;,?]EO16\._LW>!-(>X$QB\)V'[P+MSF
M!&Z?C7>5R_P2L+_2O@QX1TO5+*:VNK;POI\5Q;W$922*1;:,,C*>58$$$'D$
M5U%$G>381^%(AU+3;#6=.N-(U6SCN+6ZA:*XMYEW+)&PPRD'J""017#_ +-/
MP%T[]F;X3V?P8\.>)[[4]$T>ZN!X?74%7S+"Q>5I(K/</]8D(8QHQYV*H.<9
M-KQ]\;?#_@WQ$O@/1M$U3Q)XF:RCN_\ A'O#]J)IH+>1Y(XIKF1F6*TBD>*9
M8WG=!(8)MF_R9=G/7OQ&_:ZU:47'@C]F#PQ:VBKMDC\<?$YK"[,G4E(]/T[4
M(C%@KAFF5RP<&, *SU&,U%]F3*4')7Z'JN,=!1@#M7DO_"9?MV?]&Y?"7_P]
M.I__ #.4?\)E^W9_T;E\)?\ P].I_P#S.4N1]U]X>TCY_<SUH #H*.!SBO)?
M^$R_;L_Z-R^$O_AZ=3_^9RC_ (3+]NS_ *-R^$O_ (>G4_\ YG*.1]U]X_:1
M\_N9ZUTHKR7_ (3+]NS_ *-R^$O_ (>G4_\ YG*/^$R_;L_Z-R^$O_AZ=3_^
M9RCD?=?>+VD?/[F>M8'I17DO_"9?MV?]&Y?"7_P].I__ #.4?\)E^W9_T;E\
M)?\ P].I_P#S.4<C[K[Q^TCY_<SUKWQ7G/\ PSGH%_\ M._\-/\ B3Q!>:CJ
M5AX8_L/PUI<J*MMH\,DGF74L>.6EF81AG/1(E4<9SE_\)E^W9_T;E\)?_#TZ
MG_\ ,Y7H7@.]\?:CX7M[SXG>&M'T?6F9_M>GZ#KDNI6L8#D)LN);:V=\IM)S
M"NTDJ-P&XGO0]Y/^F+W:BY6OP[:FQ1114&@4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4449H *=##+<2B*),L:(H9;B58H5RQ[5X_P#M
M!_M")HJ3_#SX=:C_ *5\T>K:M"?N=C%&?7KEATZ#G.*C&4Y61,I1A&[#]H/]
MH2+2(;CX=_#K4%:9U,>K:K$?N=C%$?7U8=,X!SR/ :**[Z=.-.-D<$ZDJDKL
M****L@**** "BBB@ HHHH **,T4 %%%% !1110 4444 ;WPV^(&J_#/Q=;^*
MM+W-Y>8[JWW[5N(3]Z-N#P< ]#@@'J*^J])UK2/$VC6OB;P]-OLKZ$20[B-T
M?K&V"<,IX(R>1WKXVKUC]F#XH3:-XAC^'6O:@W]F:I)LLE;YOL]TS *5XZ,?
ME(R!DY]:YZ]/F7,CHH5.5\K/>**=-%)!*T,JX93AA3:XSL"BCFOR9_X*M?MN
M_P#!6SQ_^UIK'_!.[]B;X'ZUX<,&E17Z^*/#+22:AJ>G3)*OVT7C+'%I]N3F
M(,IWI/ RK.7(C7HPV'EB:G*FEW;.?$XB.%I\S3?9+N?7G_!0?_@L!^R/_P $
M]M)U+0_&_BN/Q!X^M[%)M/\ A[HTV;R=Y-OEB>0*R6:%6\PM)SY8)19"55N/
M_P""-O\ P5>UG_@I=X;\:/\ $'P5H_AK7- U=3I^FZ;JT<GVBP:*,%A$S^>?
M+D(WRE!&3/&JL2& _+O_ ()*?LW?\$^G^/WQ(G_X*P?$G3])\9>!M6F2/PGX
M^UP6=GJ4RLZW4TYF"M<SI*!MA\S,F\MY<F#C?\1_&3]G3XG_ /!;KX4^*?\
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M8KBVN(P\,T+AE=3T((JQ7P+3B[,_T$HUJ=>E&I3DI1DDTT[II[-/J@HHHH-
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M;WX^5CUR,G (KKJ^3OAG\0-5^&GBZW\4:;^\6,E+JV9CMGB8892 1G@Y&>C
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M33?#=\=-MKA(O*>6^O9(0/+M(!M988U9L]%FD:)!@^,?#G_!2G_@WO\ BO\
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MTKX ?'^_^%E^NA:\TUQH,[_/&/F:T8G[Z#T]5[]1SU^5SS(UBDZ]!>_U7?\
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M!_XUN_ \G_HF.C_^DD==5!QA1G-Q3LXK7SYO\CEKJ<ZT(*35U)Z>7+_F1?\
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MZ2O9WUT\O/U/L2BBBN4[ HHHH **** "G0PS7$HBA7+&B*&2YD6*$98UX_\
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MT^\T/4FO]-OEN[B2X2X,;1[FE>1GE 1W"HY95W,5 ))KM='^$?P[T+XE:O\
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M110 4444 %%%% !1110 4444 %%%% !113;B>&U@>YN)%2.-2TCL<!5 R2:
M/,_VCO%!MM.M?"=M-AKEO.NE'4QJ?E!YZ%N>G5?:O(:U/&WB*3Q5XJO===V*
MS3'R0W\,8X4=!V [?7FLNNVG'EC8XJDN:5PHHHJR HH)QR:H>)_$>G>$?#.H
M>+-62X:TTNQFN[I;.TDN)3'&A=@D489Y&P#A%!9CP 20*+-A<_//_@OS^VA\
M$="^!.J?L96_B;5[CQQK'V&_GL=&*BWLX$G254OG8<B1072%/GRD;MM4IYG#
M?"3]D;_@C+_P41^#6@>!O@OXNB\%_$C3?#MC%?'3[B:UOC<"$JRRVUV3#? S
M29>6',A(C7SE& ?$? W[;_[,'Q4_X*=^)/CQ_P %!/V=1H^CZSX?72FT+7M+
M_M*'1;J*"-$EN+>6#S"62/:&5 R-(#]W)7W?XD?\$*?V7/VA_#4GQD_X)V_M
M'0Z>DC;]+M)-3;4=-28*T@B^T(6N+<X>'[WFNBC)5BPQ] HPPM&--N47O=:J
M[Z'S[E/%5I32C);6V=EU/:?^"7W_  35_:1_8>^)OB#_ (6=^T4^O>![>Q$?
MA'PYI>I7<=L]U*P::ZFMF(2-D 9%3,BL9FD.UE6ON*N3^!GPUG^#WP?\._#&
M[\5ZMKUQHNDQ6UYK6N:K/>W5].%S+,\L[,YW.68+G:BD(@5%51UE>+B*TJU1
MRE^5CVL/2C1I*,0HHHK$V"BC-<Y\7OBGX.^"'PPU[XN?$'5X;'1?#NES7VH7
M4S8 2-2=HP"69CA54 LS,JJ"2 7&+E*R%*2C&[/@K_@X$_;COO@]\([7]D;P
M'-"NK_$#3VF\0W0F/G6>E+*!M0*X(,[QO&2P*F-95 ).5_%\=*[[]J']HOQY
M^UA\=_$7Q[^(UPK:EKUV&6&-55+6W1!'! H4 82)$7.,L06;+,2>!YK[/ X?
MZKAU'KU]3XO&XEXK$.?3IZ!11178<@4444 %%%% !74?!/X-?$3]H?XM^'_@
M?\)M ;4_$?BC5([#2;-7"[Y7/5F8@(BC+,Q("JI)X%<O7WQ_P;6Z=X?O_P#@
MJGX9EUN*%YK7PWJTVFB;'%P+? *Y_BVE^G;-9UJGLJ,ZEK\J;^Y7+IT_:5(P
MO:[2^]G9?%3X$_\ !%G_ ();>(5^!?[4/@KQA^T?\5(;6,>,[+0_$DVC:+X=
MN""_DPO;O%+)+M*AE=Y0!@_NVR@Q_B9^P;^PC^W;^RKXV_;(_P""75GXF\$Z
MW\.;6.Y\=?!;Q1J#7R06@C^:YLKJ1WE8%4>0^8[[F5U C 53\:_MDZMXDU[]
MK?XG:MXP,G]IS^/=6:\\UB6#_:Y!C\*X71M2\4Z9;7K>'-0U"WA-N#J1L9I%
M7RBP3]YMXV[G"_-QE@.IKS:.&K5,/&LZCYVD[W]WO:VUNG<]&M6HT<5*BJ:<
M$VK6][M>^]_P\CZ^_9R_:?\ ^",O@CX*:!X7_:-_X)D>)O&WC2SM&3Q!XHLO
MBAJ5C%J$OF,0ZP17*I'\I5<!0.,U]9_MW^%/^"#W["EW\.K7Q/\ \$M_$/B
M_$3X?VGBJT:Q^+6M0_8XIV8"!]]Z=S#;]X<'-?C\,;>*_1?_ (.&/^0S^S'_
M -FWZ-_Z,EJ<9AU]8IM2DN>3O:3MLWIKIJ/!5FZ=1.*]V%U=*][Q6O?1GQE^
MUEXY_9M^(OQOU+Q7^R7\$+[X=^!YK>W73?"NH:Y-J4MM(L2K,YGF=W;?(&8
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M &_;=8^*GBF.[$8P@%AJUSI,&T=O]&T^WW<G+[VX!"BH_ V$OC2/5****S-
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MDD;//S+@YYR<\Y!KCQ$+/F1UX>=URLZ.BBBN<Z3\T_\ @Y3_ &&OB_\ M1_
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M4?"NL1W7V.1]J7D'W9K=CCA9(F="<9&[(Y KSBBC?1@?I[^UA^RI_P $XO\
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M;==]_N1/ID>FS:C;Q:U=W%O9M,HNI[6W6:2.//S,B,Z!V R0I=03QN'6NO\
M[!_9P_Z*OXX_\-[9_P#RVKB:*J,E'=)_?^C,,7@Z^)DG"O.G;I%0L_7FA)_<
M=O\ V!^S?_T5?QQ_X;VS_P#EM1_8/[-__16/''_AO;/_ .6U<1FM+P;J.CZ1
MXKT_4/$6EQWVGK=*-0LYNDMNWRR*" 2K%"V'4;E.&7D"K4XMVY5^/^9Y]?+\
M=1HRJ+&5963=DJ-W;HOW6[.D_L']G#_HJ_CC_P -[9__ "VI?[ _9O\ ^BK^
M./\ PWMG_P#+:N:\9>&YO!WBW4O"L\ID;3[Z2 2%0/,56(#8!.,C!QDXS6;0
MY1B[.*_'_,,/@<1B*,:M/'57&233M2V>J_Y=';_V!^S?_P!%7\<?^&]L_P#Y
M;4?V!^S?_P!%7\<?^&]L_P#Y;5Q%%+VD?Y5^/^9K_96,_P"@VK]U+_Y4=M_8
M/[.'_15_''_AO;/_ .6U+_8/[-__ $5?QQ_X;VS_ /EM7$44>TC_ "K\?\P_
MLK&?]!M7[J7_ ,J-[Q#X!N]'TP^(=)UW3=8TM9%C>^TVX),3'.!)$X66/..&
M9 I/ )((&#]*U/!GBFX\'>(K?64@2XMU=5O[&9=T5Y;[@7@D7(W(P'J"#@@@
M@$2_$+PLG@OQIJ'ANWD>2WMYMUC/)SY]LZB2&4' #*\3(X8#:P8,."*4DG'F
M1IA:^(H8OZIB)<S:<HRM9M)I--+2ZNM59.^B5C4^(O\ I7A'P3J,7^J'AV2U
MS_TTCOKIF'TQ(O-6?V=@;SXO:;X9CXF\16M]H%G(WW8[C4;*>QA=^X19+A&8
M@$A0V 3@&KXH+7GP?\)ZB@PMOJ&J6#*>I9#;SEOIBY4?53[5<_9D_P"3D_AY
M_P!CUI/_ *615K'^/'Y?H>)6=N$\;'K%8A/_ ,"F_P FF</7ZA?\$#O^21>/
M/^QDM_\ TG%?E[7ZA?\ ! [_ ))%X\_[&2W_ /2<56$_B_(^$\?/^3:U?\=/
M\S[ZKS36C_QF'X;_ .R:ZW_Z<-*KTNO)/!F/^&ZOB/\ ]DF\%_\ IS\4UZL.
MK\O^ ?Y_SZ+S_P"">MYKR7]@O]_^Q/\ "?6)OGN]6^'ND:IJMTW,E[?7=I'<
MW5U*W62::XEEFDD8EI))7=B68D[7[5MS!;?LR_$!9WV_:/!^H6T/!^:6:W>*
M-?;+NHR>!G)(&37:>'[::RT&RLKF/;)#9QI(N0<,% (X]Z?_ "[^8?\ +WY?
MG_PQ<HHHK,T"BBB@#S?]KW]HWP_^R3^S5XQ_:)\2V374'A?1WN8;%6VF\N6(
MCM[<'L9)GCCSVWYKXK_:D^.'_!9#]EW]BS5/VU=9^+7PSUIY=)CO-6\!6?@E
MX&\+17$J"*6VO&G?[<T6^,2)-$@*F3#,55J^M/\ @H=\(?A]\>/V*_B'\*OB
ME\0]+\)Z/JF@L9/$VM7T=M9Z7<1R)-;W$TDC*JHD\<1.2 0,=Z^&_P#@HW\8
MOV_/%?\ P2M\3?#/QS^RUH_AG3K;PY8V_B#XD1^/]/U#3=:MUN8(XCI<%L[W
M#M='RL>>D01)'Y+!<]V!BI26B;YXIWVY6U_P;]=CCQ4N62NVERR>G==_*WRW
MN?0'[>W_  42USX%^*/AA^S9X$^*'@3P/XL^)&F-J6J?$+XC7T,&D^&M-B5?
M,G\N66);BXD<E8H2ZJQ1LD<5SO[,_P#P4,\7Z+^U]X6_92^(G[9?P<^/.D_$
M"ROI/#WC'X:S6MK?Z7?6T(F:TO;*VN[F-87C5S'*&!9@P/0 :G[;?[$'Q$^(
M?Q5^$/[9/PJ^#_AOXD:MX!\.R:-XD^&/BO[,D6MZ;.BDFWEN@88[F)]S+YN%
M;=C<N.=+]G_X*?&WQ;^T_P"'?B@_["7@/X!^"?"UG>&\L3I_A^_UW7[V6,)$
M4GT])5LK>(,_*3+)(258!<;M8K#JF[I?:OMY\MNO:UM^IQ\V*ERN[VA;?ROY
M/K>^W0XKX2?'+_@IA^UY^T+\?/A1\)OCKX+\!^'OA?\ $2?2M%U[4O ?]JW-
MV/+S'9&/SX45%'SO.2[Y90%P#GO_ -DG_@HSXF\4?L!>-_VGOVG=!L8->^%.
MK:YI'C"/P\K1V]_<:;(4WP"0DIYHV#!. Y)  PHW?^"?O[._QB^"/QG_ &CO
M%GQ/\'_V7I_CSXP3ZWX3N/[0MYOMU@T"()ML4C-%\P(VR!7]JX/]EG]@7XFZ
MC^Q1\?/V7OC[HK^&)/B9\2?%E[I5PEY;W1^PWTP:UNOW,C@9P&\MBK@#!"DU
ME*5&5"4;+2,&N]].;]3JY:L:T97>LI)]K6=M/6VIXK;?\%-_VD]2^!S?M:P_
M\%'_ -ENSU:32VUFW_9WN-2L&F6VV;UL'U+^T%G^V^7U3R /.^3@<#UCXS?M
M]_M,?&+Q1^S/H7[$U]H.BQ?'[P[J=W=7?BC3#?)HB0VT,[W&U"AF>%//"Q[D
M6239N(7(KB/!'[.'[6OP]_9ZM?V:X_\ @DO\)]6\>:3HHT32_C)/-X=?1)F2
M+RX=5GMI5-\[@ .\1@;?(",[6)'MEU^R3\;=!_:F_99\6PZ38:MH_P ,?#/B
M&R\;Z_I=M8Z;;07-SIRQ1M%91>7A'FW +#$0@QNVCFNBI]551<J5KZ;:JSWM
MKO;?6YQQ>,]F[MWMKOO=?+OMT.Q^)6J?M^?!K]F/2O"O@N31_BM\6M6\1?V;
M)XK_ +%CTK2M+M)9Y"-2N+03%MD-N$!B1W9Y2.2N:\2E_:J_;$_9,_;[^%/[
M+/QZ_:H^'?Q:TSXH-<6EYI^D^%8M#UKP[,D320W#6T5U.6@DQM$CX#%7 "D
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MO@/\8/%VL>&TLKY_BEX@NKK2;IO-6&7R(6:%CQO .5/3(]*Z+X9_M?S^#?\
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MUI>D^4C2QB%(UN;QEEAG8,T8D/FI&%"J@KU7_@FI_P %,?A!_P %,OAAKGQ
M^&?A76- O/#>M&PUC1=856>-6!>WF66/*.LD8Y'#(ZNI!4)))\$?!#]B+]E_
M_@@'-X=_;1_;@_:6UWQ!\1]2EGT_2_"G@/"VUVLR)%.@2=XWOHHA)YKRRF%
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MJ-2,G9Z/L3*#CKNC.HHHK0D**** "BBB@ HHHH **** "BBB@ H-%% 'I7P
M_: U#X6WZZ#K[S7&@SM\\?WFM&)^^@]/[R]^HYX/U?INI6&KV$.J:7=QW%O<
M1K)#-$VY74C((-? QKTKX ?M :A\*]0&A:ZTEQH-Q)F1.2UHQ/,B#N/[R]^H
MYZ_*YYD:Q2>(H+W^J[_\$_JWP(\=ZG#%2GD&?U&\))VIU'JZ3?1]X/\ \E]#
MZVHJ#3=3L-8L(=4TJ[CN+>XC#PS0R!E=3T((ZBIZ^!=XNS/] Z-:G7IQJ4Y*
M49*Z:=TT]FGU04444&@449KWS1/V?O@'\+O@1X4^-G[36L^++J;QU-<-X?\
M#G@ZXM;>:&TA?8UU-+<12J03C:BJ#A@2PY%7&G*=^ECQ\XSK"Y+3INK&4I5)
M<L(P5Y2=FVDKI:)-MMI61X'17K?CKX"_"+3_ -H31?AQX _:#T6^\(Z]':W$
M?BN]NHD&F0R@ETN@&"I-& <KD9.W@$X'J/P7_9<_8Z_:8\?:M\#_ (+ZY\2E
MUVSTVY;3/%^I264FDWMQ"A(9[=(%E@BEVN4S*S 8!W'-5&C.6WGIZ;GBX[CC
M)\OPL,14C4<)04VU!^Y%NUYWLUK>Z5Y:/0^4\T9KZ"^#_P"SI^SQ>_L=ZA^U
M+\:?$OBR.;3?'K:''HOAV6V4WL?V6&555I8F\I\R.3(2R[5 "$G-8_[2'P$^
M$7A/X.^!OVA?@3KOB"3P_P",I+RUFTGQ1)!)>6%W;/M=3) B(Z-U!V XQGKP
MI4Y1C?T?WVM^:-,/QIE&)S%82,9J]25)3<;0=2,>9Q4K[\J;3M;I>^AXK1FO
MI/6/V;?V5O@6O@_P;^TQXQ\9_P#"4>+M&M=3OI/#,UI%9^'(;D#RO/6:*1[A
ME!W.$:, *0"<@UG?#+]C3P7XI^)7Q"?5/BC+K/@'X;QQW%]KW@RU6\N-7CED
MVV\-JHW*)9,,-QRJ%23D"J]A/FMZW\K;F,>/,B]A.O)35-*\9.#Y:BYE#]V_
MM-R:23LW=-::GS[FBOHS6_V4?A=\1_@[XL^)GP)T+XAZ#J/@>Q74-6T+Q]'#
M*M]8[@'F@N(8(55HQN9HV4D@9![5>^+G[/'[(/P&^$/P]\7^.=7^(.J:]X^\
M!V^LQV.DZA90P6,[QY+.9+=F>(N0 @PP"L2[9&)E1E%7?E^/_#$T^/,GJSA2
MIPJ2JRFX<BBG)245-W][EMRNZ:;3VWT/F6B@'(HK,^V+.C:O?^']8M->TN14
MNK&ZCN+=V4,%D1@RG!Z\@5O?%W1M+TWQK/J_AH-_8NN*=4T/<Q+):RNV(GSS
MOB</"QZ%XF*EE*L>8KL/LZ>*_@HU\MPK7WA+5ECDAZR-IUV"5< =(X;B,JS'
M^*_B7(R =(^]%Q^?]?+\CQ<P_P!EQU#%]&_9R])/W7ZJ=DNRE+N<?11169[0
M4444 %=9I8-Y\"]:$OS?V?XJTUK<#^$3VUZ)"?4$P0CGI^-<G7<?!F\AET?Q
MYX-4-]JU[P+-%9-CY%-I>6FJ2[SU ,%A.%P#ER@. 2PTI_%;R?Y'BY])T\"J
MJ^Q.G+Y*<;_A?Y%7X4L;FT\6:(_^IOO"-QYS+]X>1-!=KCZR6Z Y!^4L!@D$
M<BKLC!T8AEY!7M76?!8>?XONM);B.^\/ZI#,P^\%%E+)Q[Y0=CQFN3[4/X(O
MU_K\2:'NYIBZ?62A+Y.+C]]X/\#K/CHJK\6]<95QONP[<?>9D5F8^Y)))[DY
MK]%O^"!W_)(O'G_8R6__ *3BOSJ^.1\WXGZA?(/W5Y#:WELW]^&:VBEC;VRC
MJ<'!&<$ Y%?HK_P0./\ Q:/QY_V,EO\ ^D]=%'_>9?,_'?&)I^#L/^X*^:LG
M^)]]5YG^RU_R)_B;_LI7B;_T[7->F5YG^R/B3X'V>H2?-/>ZUJ]Q=3'[TLSZ
ME<EG8]R3U->FOX;^7ZG\(O\ B+T?Z#?&UK;:K^US\/;'4+>.XAL? _B?4K6&
M90RV]XMSHULER@/"2B"ZNX1(,,([F9 =LC@^G5YGI1^W_M>ZU/:?.NF_#S3X
M+UNGER37MT\8YZY6)SQD#;SC(SZ93J=%Y!#KZA111G'6LS0*Y'X[_$Z\^#OP
MEUOX@Z1X8_MS5+.U$6@>'Q>"V.L:I,ZP65@)BK+";BZDA@$K*4C,NYOE4FNN
MKR_XOW<7C'XW_#WX.Q980W%UXLU; RJ6]AY<4"MUP[W=W;NBLN&6VF965HAF
MH+FEJ3.3C'0WOVAL_P##/_CC(_YD_4__ $EDKY/_ &?OAUXX^+O_  0$\/?#
M/X:+(VOZY\!_L>DQQ-M:2=[0A4!R.6/R_C7V]=6MM>VTEE>VT<T,T92:&1 R
MNI&"I!X(([&H=$T+1/#6D6^@>'='M=/L;2,1VME96ZQ0PH.BHB@*H'H!BJ]I
M:C*'=Q?W7_S(=.]:%3^5-??;_(_(WX0?%#]D#3_V!+&+XF_\%8/C7X<U30?!
M:Z'XC^"$7B3P_;:M!=PVXMYM*MM-FTK[0Z%@8T/S#:1N?AB.Z^('Q#U+]E:U
M_9E_9B^'_C32?@#IEU\.M0NK'XS?'CPSI^J:MHRKL8Z(9&:WM[:9E9#,"Z _
MNE W*0WZ/77P@^$=]XP7XAWOPP\.S>($D5TUR718&O%8# 83%-X(' .>!5SQ
MCX!\!?$334T;X@>"](UVSCD$D=KK&G174:N 1N"R*0#@GG&>:[IXSVDKN+U=
MVM+;-=M;7OKZ=SBA@73CRJ6RLGUW3[Z:*VGKV/S'_8L^)'A[QK_P6MTV\MOV
MN]4^--U_PH_5;"^\=2:/;V6CW-^FHP2R6NDK;IL-O'&5<[99QN=B)"#@>R_\
M$.OB-\/T^'/Q1^!C^-M)'C31_C5XKO-4\)G4(_[1MK9K\*L[V^[S!$6(42;=
MI) SGBOM&P^'/P[TNYTN\TSP+HMO-H=NUOHLMOID2-80L,-'"0O[I2."JX!%
M+I_P]^'^D^*[SQWI7@C1[77-0C\N_P!9M]-B2ZN4^7Y9)0H=Q\J\$D?*/05G
M4Q,:E-PY79QY>G23=]O,JGA9PFI\ROS7_P#)5%K\#X0_8H_;'_9J_9)\0?M*
M?#']I'XO:/X/\26/QV\1Z[#X?UJY$5]J=A>N)K:6R@/[R],B@@) ';.,@;ES
MF?L,ZNVO?\$#/B'KCZ=<6;7NA_$2=K2ZC*RP%[O4FV.IY##."#R"*^_M4^&7
MPTUOQ9:^/=9^'VAWFN6046>M76DPR7< &<!)F4NN,G&",9/K5BP\$>"M*\.S
M>$-,\):7;Z3<"47&EP6$:6\HE),H:,+M.\LQ;(^8L<YS6<JT9491Y7>2BO+W
M?\S2-&2JQ?,K1E*7G[W^1X=^R3X3U'Q!_P $N/A_X*\&2+9WVH?!.PM--D1M
MHBFDTM%1LCIAF!S7P%^P?KOP!^#/[(\?PW_:*_X*J_%CX(^,_AT]YI_BSX6O
MXDT/3Y+2X2:1S]AL[G3)+B[20,'4QM,69S@G(K]>],TO2]$TZ#1]&L(+.TM8
M5BM;6UB6..&-1A455 "J , #@"L/Q#\'_A'XM\10^,/%7PO\.ZEJUL4-OJFH
M:+!-<Q;#E-LCH67:>1@\'I51Q/[RHVM)V?FK7MOIU9+PO[FE&^L-/)W23VUZ
M(_+W1?AK^P_X ^$G[/=M\0/%?QX^"$.HQ:SJGP[^-7B#Q'IVG76FO<W7VE].
MU*9(/LT<5P"DR)+"J,F1N!W"O</^";?[27[0&L_M:^(OV6]1_;&\/?M(?#_0
M_ \.J+\4]!T.&W_LW47N-JZ?+<6TLL%T[Q,7RKL5\O!V$%:^Y/%/A'PEXXT6
M3PWXU\,Z=K&G3,IFL-4LX[B%R#D$HX*G! (R.#4?@_P-X(^'ND_V#X"\(:5H
MEB9FE^Q:/I\=M#YAQEMD:@;C@9.,G JY8KFC).+=[^FNW3=>6C)C@W&4>625
MK7>STWZZI^=[&M11D>M%<!Z 4444 %%%% !3HH9+F18H1N8TB(TK>6B[F;@"
MO(/V@OV@HM%AN/AU\/+]6N6_=ZIJT+?ZOUAC([]F;MR!SR*C&4Y61,I1@KL7
M]H+]H--#CN/AW\.]0/VK)CU;5H6_U?8Q1D?Q9ZMVQ@<]/ ***[Z=.-.-D<%2
MI*I*["BBBK("BBB@ HHHH **** "BBB@ HHHH \Z^./[3_PR^ E]I?A_Q+#K
M6K:]K7F-I/AGPMHLVI:E=1Q@>9*L$(+;%SRQP/3.#6;\&_VQ_A#\<]/\3-X)
MM_$$>K^$5;^W_"NJ:#-;:M;'!*K]F<;F9MI"J,G. <$C/E?QL^-'B"U_;C;X
M9?"O0_AKX;\4:?X%BNKCQU\1K6:22\LWG;%G:K#-"Q56RS$N1G<-O>N&_8,\
M2ZCXB_X*)_%Z[USXOZ?XVOI/"NFBYU[2=+BM+.61&VM% L9/F1PG]T)"S,2A
M#$D9KLI4(RI-O>S?W?IH<=2O*-:RVNE]]O\ ,](_X)O?M8>-?VD=$\60?$'1
M_$[7UEXLU$VNHZEX;>TLHK195CBM%DVA//0??B^^IR37TKJ6HZ?I&GSZMJU_
M#:VMK"TMS<W$@2.*-1EG9CPJ@ DD\ 5\Q?\ !*[6-(_X5CXZ\-#4[?\ M*U^
M+'B%[C3_ #E\Z)?M0&YDSN SW(KT3]OSPKXR\;_L9?$;PQ\/[:>XU6Z\,SBV
MM[529)U7#21J!R69 R@#KG'>L<1R\RY5;2/Y+4VPW,XOF=]9?FSQ;]K'_@HQ
M\)/%7[,/C9/AIJ?C/2'U#0KR'PGXV?P]>6&FZA=(#A+2^*JID.UMN"I)4@<X
M!]+\<^+/ ]GI'P'?XA_$CQGINI:KJUBFCQ^'[[;#J]XUF&,.H9!,D!&6(R"6
MYS7C_P"U+\=?V;/$'_!)J;3=+\4:/>+?>#+*QT?1X9D:X2^C$8V^4OS*T3QL
MS$@!1&Q/%;W[2F/MG[)/_8\:?_Z;Z[/90B^5)_'%7[[_ -?<<?MIRCS-IW@W
M;MM_7WGOGQR_:?\ A?\  "XTO1_%IU;4M;UQI!HOAGPWI$VH:E?!,>8\<$(+
M%5!R6.!]3Q5/X"_M=?"#]H;5M<\+^$9M8TO7O#>PZYX;\4:-+IU_9H_W9&BE
M .TXZ@G'&0-RY\G_ &@?C)K>F_MM:7\,OAGX?^&^@>*H/ \E[_PGGQ&MYI/,
MM&FVFQM5BFA8G=\['?@!6^4]1XC\)[WQ_P#$/]M3X[:3IWQJTSQAXJU#X*W%
MI::QH&GI:6<5]]U+>W",Q=(7(02.S/E2&)*UC3HQE1N^S?W7_#0Z*E:4:UEW
MBOOM^.I]):I_P4W_ &8=)EU#49'\53>'=-O)+.?QM;^$[I]#:Z1<F!;S;Y>\
MMA!D@%B.=IW5UGCO]M'X%_#7X*>$_P!H'QIK-Y9>&/&<MFFDWCV9+1_:H&GC
M:50<H-B-G&2#P 2:\'T+XY?L[Z3_ ,$GY- UOQ)H\!L_A]-HM]X;EN$%TFIB
M!HVM3 3O\XS<XQG)W=.:Q_B5I]EJO[#/[)=AJ-LLT,OC#P8)(Y!E6']G2GFM
M/J]/FY;/248W[IWN_P #)8BIH[K6,G;M:W^9]"?#;]N7X,_$GXHVOP?&D>+/
M#VN:E:R7.AP^+O"EUIJZM"F<R6QF4>8N!N[9'OQ5_P",G[87PE^"_C6U^&5[
M9>(O$GBBZM#>?\(SX+\/3ZK?0VN<>?+% "8TSP"V,]ACFN'_ &Q8(O\ AIO]
MG*Z\L>8OCS4$63N%.G2$CZ' _(5S'[/GB?PU\+?^"@7QTT7XMZO:Z3J_B)]+
MU'PW>:M<I$M[IB0%"L+.0&",5# '@]1Q64:=.24DNDM.]G;_ ()<JM2G)Q;_
M )=>W-_6A[]\#_V@_A7^T1X,D\;_  P\0-<6UM<-;:C;7=N]O<Z?<* 7AGBD
M :-USR",=P2.:\UU+_@I5^SAILEYJJV7C*\\+Z?>M:WOCW3_  5>W&@Q.K;7
M/VQ$*E5?Y=RY!/3(()Y']E#6- \>_M7?M"_%/X?6;ZCX+OI-,LH[C3\-#JE_
M!9E;HP8(5SGY"P."W.><UXS\/O[2^%_P#U+XA_LF_MF:*OP_TW^TI[SX1?&?
M1;64V;(6WV,C1N)T/F;B%5@#N7.\EB7&C3Y]=K)^E^__  P2K5.73NU?O;L?
M6/@;QK\+/$/[7VOV7AKXF>*=0UJ3P+I]Y)HK7PDT&.QD<F*ZME _US_Q,"05
MQ5/QU^WW\$?!?C#6?"&G^'_&GB9O#4GE>)M2\'^#KK4K+2),;F2XGB4HC*OS
M,,G:,@\@@>,?L2?$2\^+/[;VJ_$?4/!(\-RZQ\#="N#HBKM6T!G?"*,#"8 *
MC ^4BLC0?#9M_BC\2?$?[(O[8\GPWO(_&DTGCCX<_$S2;.:SEN\!I;A S&1+
M>90H#(0Q ;YQA0M>PC&HHRZ)_A)KIT_4E5IRIN4>K7_I*?7J?:?PZ^(G@OXL
M^"=-^(WPZ\0V^K:)J]JMQI^H6Q.V5#[$ J005*D!E8$$ @BMJO$_V ?C3J_Q
MX_9VM/&>L> -'\/R0:I>6*Q>&X6CTV\\J4@W5JK<B*1MS#))SGD]:]LKFK4_
M9U7$ZJ-3VE-2"BBBLC0**** "O5OV3_&_P#8OC:;P7J%VRV>N0>7$FW*K=*<
MHWMD;EXZDKGIQY33[:[N;&YCOK.=HYH9%DBDC;#(P.01[@U,X\T;%0ER23/L
M^2-XG:*0896PP]*;57PYXJL_'WA73_'5@@1=0AS-"&W>3,.'3/U''0D=A5H9
M[BO-/2"ODK_@K7_P5.\&?\$R/A)8:C)X3FUOQKXPL]07P+ITD1^PM<6WV</)
M=.K*PC0W43E%(:0!E#(3O'UK7A?[?7_!/+]GW_@HY\*K'X4?'Q=8M8=)U9=0
MTG6O#MU%!?V4H4HZH\L4J;'0[71D8'"GAD5EWPTJ,:R=7X>IAB8UI49*E\70
M_)_]D?\ 8L_9_P#C+\>-7_;"_P""V7[;_P /(/%T][!J#?"_6/B/IMM?&01J
MXBU2W:026R1IL1;% KC;M?:H,;_KM^R1^VG^R1^V#X>U%_V2_B;9>(=-\+M!
M:7T5CI-S9I9;D/E1A)X8_EVH<;00 ,<<5^;/[2/_  2^_P""#/\ P2KTM?%_
M[6WB'XB>.KK7+?R] \$ZAXB\R\GVR*'N($TU+(J%!.YYY1%@%5S)M4]Y_P $
MH/VW_P#@A-X)^-M]\.OV.? ?B3X6>)O&R6]A&WC:ZO9(-8=#(\<$<LM]=Q0N
M#NQO,6]G5%+L0M>OBX+%T74AS-+;2T4>1@YRPE54Y\J;WUO)GZD5D^/?#5UX
MU\"ZUX/L?$NH:--JVDW%G#K&DR(MU8M+$R">$R(Z"1"VY2R,H91E6&0=:BO!
M3L[GNM<RL?AS9?L*?L4?\$2/@<WQO_X*-^"M#^+WQ:UC6I!\// =AJ3M836\
M*PL'DCEBV@++N,LTB2H$:)%C9BZMV?P4_P"#E;XE^'!%XU\9?\$ZO^$?^ ::
MII_A[P_JWA.2X6+P\R0#S;8W)MEM+QPBEXK:-+5HXUV_/C?5O_@X,\"VG@G_
M (*1?LW_ +4'QDTRXU;X5PSZ;I?B2QFL3+9P"UU9KFY63S"(<SV]QC:Q4LMJ
MV20!CQG]HSX?_M+?LA?'#]H#_@F1^R3^SC-\0/!?[0']GZUX%,%G]HCTRTN
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M54/8X5-[RU_R/D<UK^VQ32VCH%%%%>D>:%%%% !1110 4444 %%%% !1110
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MLT>$=>C_ -3KFFMK-HK?>2"^E>\B5_1Q'.@8 D!@P!88)]>?PUQ_Q^_^0_\
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MMIXP\,T+[E=3W!%6*^#]Z$NS1_?THX7,,*KVG3FD^CBUNGV:ZG7?\+S^)O\
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M:B_:8O&@^$/PCU"^M8Y-MSJEWMM;2'$FQLRS%58JV<HFY_E;"G::_13X!_\
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MO[FNXQC@44>TETT'R1ZG$_\ #.WPC_Z%^\_\'M[_ /'J/^&=OA'_ -"_>?\
M@]O?_CU=M12YY]PY(]CB?^&=OA'_ -"_>?\ @]O?_CU'_#.WPC_Z%^\_\'M[
M_P#'J[:BCGGW#DCV.)_X9V^$?_0OWG_@]O?_ (]1_P ,[?"/_H7[S_P>WO\
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MQ%K%SJ>J31PB-9+FXE:61@J\*"[L<#@=!7MY+1YJLJCZ:'B9U6Y:4::Z_H9
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MK_$VXD^Q-)X.\/[5\FZ>'?K%Z>=W[N5/*LD5@ "PG:4,?E@V@R=/X0\%^'/
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M  F/A[Q;IE_I&QW_ +4LKZ.6VVIG>WFJ2N%P<G/&#FO._P!I_P#:M\%?L_\
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ML7=UI=TN^"[,;(425.CH'VOM8$$H,BB.'A-Q:;LW)?\ @*N5*O*%TUJE%_\
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M<(@'4DDL['JS,2S$DL223731P_-[TMC^?O%'QNPO"\YY7DUJF*6DI/6%-_\
MMTUVV3WOJCR3]BS_ ()Z? W]BSP_N\'Z>VI^)KJU\G6/%-\#Y]T-Y;:J;BL*
M#(&U ,A%W%B-U>]# ^4445W;:(_B_,\TS#.<;/%XZK*I4F[N4G=O_@+HEHEH
M@HHHH. **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M48QITTDK!11169H%0ZA?V6EV,VIZE>0V]O;Q-+<7%Q($CB11EF9CPH !))X
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MH^U-ZPJ@D\M"^XJ".JHHI-M[E6ML%%%%( HHHH **** "BBB@ HHHH ****
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MCG_^%\_ W_HLWA/_ ,**V_\ BZ/^%\_ W_HLWA/_ ,**V_\ BZZ#_A']!_Z
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M444 %%&:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *#R***
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MW\.PZ#J_B+[4T>F221?:XK:!Y66.';'JL<SP(%!G@!/S1D;'[+7[)5E^Q/\
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MEXSTKY4^!O[-W[+O_!93]GGPW^UW^TM\"[/2?&6H-<66IWWA74Y[7[2MK/+
MF[YB6&T#&_<X 5=Y55 ]+!U%2HS<[\KTNMUU/-QD75K0C"W,M;/9H^2O&.E?
ML)1_\%:_@;I?_!.>PFFM4\6V%QXLDT&>YGT]I6NQ,QMS*S, D'F&4)B%$"@
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MS$\D]:P?$W[,7P"\9^/[SXH>*OA;I>H:WJ6BG2=3NKJ-F6]LCUAFB)\N5?\
M?4D87!^48]3Z_P#[1*3NXWNEZ.Z^7_#GE_4?W*2MS:IOUNOO[?<?-/[2_P /
M_B=J]S\-Q\=_VO/ L9D\;Z?<>"_^$;^&-Q]ONKI3E4@>.^E98W3(9PNP C)Z
M5J6_@3XI']H;XJ>(OV(OVC/#*ZU<:Q WCCX>^/\ PW+Y*7OEQJ)TN443K&T(
M^4JLD1+''8CV?X0_L._LF? 7Q9_PG7PF^!FBZ3K.QDBU)5DFFA5@0WE-*S>5
MD$J=FTD$@Y'%2_&C]BG]EC]H?Q%#XN^,?P5TG6M4A@\E=0?S(9FC[*[PLAD
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MH9M"\+LJGJ5^S3#/TSQFOH*QL+'3+&'3=-LXK>W@C6."WAC"I&@& J@<
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M%?1%W&8;J2(KC;(1CTYK@K:5&=U%WIHCHHHK(V"BBB@ HHHH **** "BBB@
MHQWHHH Z+PO*7TS:1]R0C^1_K6E6+X1D.V>(O_=(7/UR?Y5M5#W-%L%%%%(
MKC/CWJ$=E\.+BV>-F-Y<10J1_"0V_)_!"/QKLZ\U_:4NYDT#3K-'_=R7C,ZX
MZE5X_F:JG\:)F[19X[10!CH**[CA"BC/M67XW\6:=X#\&:OXXUB":2TT;2[B
M^NH[909&CAC:1@H8@%B%.,D#/<=::5W9 W;4\J_;O^&/C_X[?L_ZI\%?@]\<
MK7P'XHUFXM39ZQ)J#P2")9U9T4Q$2?. 5^7UQ7YN>%_^"5/_  61_9#T?7=+
M_98^-MF^FW%U'.VF^&_%GV-]1< )YHBNE2)'"GDM(I*H!DD**Y;]FC]@S]I?
M_@L-JWBO]L?XE?M!3>'5_P"$AG@\.27-K<W1CD#M/Y5L&E'D6T#2(B*KL1AA
M\NT%OJO_ (-_/V@?C9X]^&WQ%_9X^-UUJ%U>_#+7;6&UFUB5FO+5;DW*R64F
MX;L12VDA&XE@9F7A44#V^6I@Z#4)*5K737<\/FAC*\7.+C>_*T^QZ1_P3&O?
M^"I+^*/%6B_\%#8O)L;'2;'_ (1N-X=.9I9'>4._GV(9)"%B&Y6D+KN4E0'4
MG["HHKQZU3VM1RLEY+8]BC3]E34;M^;"BBBLS0**** /Q)_X.,_BBWBW]L_0
M/AK8>)IKFS\)>"+<7&FLC+'9ZA=3S2RD9 #,]N+(EE)&%49RK ?G[7U)_P %
MH?&\/CG_ (*0_$2ZATYK?^S;BSTU@TF[S&@M(HR_08#8SCM7RW7VV!CR82"\
MCXG'2Y\7-^84445U'*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M #/K6SX%^(OQ"^%VN?\ "3_#+QYK7AS4O):'^T-!U2:SG\MB"R>9$RMM.!D9
MP<"L:BDXJ6XTVMCTM?VK_BG?LJ^-M/\ #'BB'/SP^(O"-E.6!^_^]$2RJSCA
MI%=9.X8-@U;G^('[)/C6!F\5_L\:]X/U*;]VMY\/O&3RZ9:J.DG]GZI'<W$\
MAY##^T8E/!4)@AO*:,\XQ67L*?33TT+]M4ZZ^NIZ5_PJ[]G[7SYGA7]J"UTD
M-\WE>-O"E_;E5Z;=VGQWN7SSC 7'\6>#-XE_8Y^/^B:;_P )!X=\*6?C+25M
MVN)M6^'>NVGB*&TA W![O^SI9FT\LOS".[6&3"ME 4<+Y?@^M3:9J6I:-J$.
MK:3?S6MU;2K+;W5O*8Y(G4Y#*RG*D'D$<BCEJKX9?>O\K!S4WO'[B35]%UGP
M_=_8->TBZL9]H;R;RW:-]IZ'# ''%5:]$\/?M8_M#>'T%K)\2[G6K'<6DTGQ
M=:0:W8S,1UDM=0CF@DP<,N]#M8*RX8 B_??'3X,^,(E'Q!_9*\,V]TS>=>:Q
MX%UJ_P!'NKVX/WW>&66ZL88V)9C#:VENB-M$8CC7RR<U:.\;^C_SL'+3EM*W
MK_P+GEE&:].M?#/[(_BJZCL['XL>-/"<UQ(((6\0>%8-1L8F)P+BYN;6X2>*
M$$_.(;2XE549D65B(A)J?[)7CR\OG_X5)XV\'_$33N#;:EX/\1)YDRX^=SI]
MZ+?48$1\QEY[6)2P!4LDD3N>WIK1Z>JM_P  /92Z:^AY;16_X[^%7Q,^%\L$
M7Q&\ :QH?VII!9R:IITD,=ULQO,3L LH&Y?F0D893G!&<#/I6L91DKID.,HZ
M,**,<YQ13$%%%% !1110 4444 %%%% !1110 5UW@'X\?%KX::-)X4\*^-;I
M=!N+IKB\\,WVVZTNZE951I)+.8-"[E$5"Y3=M&,XKD:*F48RT:N.,I1U1ZC=
MZS^S#\4H4DU+PUJ?PW\03<W=]I-PVH^'Y7Z I9NOVNR!"[G(GN@9';RXX8]L
M:?0?_!*[_@F%J'[6W[=O@7P!JFN>'_%7P\2.?Q'X@USP]JR/!<Z;830I/;R0
MW")<P.UQ-;P-#-!'*R3K*JF%UF/Q61GBOZ&/^#5?]DC1?AA^Q?JW[5NJZ"%U
M[XF:U-!8W\DBLQTJQE>!%3#G8#<BYW JK,44G<HC(\O,ZTL'A'*+WT77?SW/
M3RRC'&8M1DMM7\C]3  HP****^%/O HHHH "<<T9XS12,,KC% 'BDW_!2K_@
MG1;2M;S_ +?7P522-BLD;?%+2 RL#@@C[1P:;_P\P_X)Q?\ 1_\ \$__  ZF
MD?\ R17\C'C)Q'XJU9R/NZC.3_WV:_0OX%_\&Q7[?/[0?P1\'?'OP7\5_A%;
M:/XW\*Z?K^DV^IZ_JB7,5M>6T=Q$DJIISJL@210P5F4,#AB.3]'5R? X>*=6
MM:_D?.T\WQU:4E2I<UC][_!O[?G["?Q%\26O@SX?_MI_";7-8O=XL]*T?XC:
M9=7,^Q&=]D4<[,VU%9C@'"J2> :]7L[VSU&TCO\ 3[J.>":-7AFAD#)(I&0P
M(X(([BOY2?\ @H=_P1O_ &S_ /@FGI6E^+_CMI7A_5O"^K2QVMOXM\(:L]S8
MQWS^<PLI%GBAG27RX3)DQ>4RL LC,KJGU)_P;)?\%&?C#\./VO=,_8>\:^*Y
MM5\ _$&SN4TBTU2_XT+5+:T::*2!G)Q'+%;M;F 8!=H&7;L99.;$Y53CAG7H
M5.:*-\/FU26)5#$4^5O8_H6S[5F^,/&?A#X>>%M0\<^/_%>FZ'HNDVKW.J:Q
MK%]':VMG"HRTLLLA"1H!R68@ =:TJ_*O_@Z]_:FN_AA^QOX7_9>T2_BCN/BE
MX@\W5K>2U+-+INFO#<MABA5,7361X97.WC*^8*\S"T)8G$1I+JSU<16CAZ,J
MCZ(^[--_X*/_ /!/+6-1M](TC]O'X,W5W=SI#:VMO\4-)>2:1V"JBJ+@EF+$
M  <DG KVBOXFUEEB<26\\D<B,#')"Q5D8="".00>AK^M;_@DW^V2?V[OV"?
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M_P <KN**/<\P]\X?_AIG]F__ *.!\$_^%59__'*/^&F?V;_^C@?!/_A56?\
M\<KN**/W?F'OG#_\-,_LW_\ 1P/@G_PJK/\ ^.4?\-,_LW_]' ^"?_"JL_\
MXY7<44?N_,/?.'_X:9_9O_Z.!\$_^%59_P#QRC_AIG]F[_HX'P3_ .%59_\
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MQ)))R:@K[RG'EII=DCX&I+FJ-]V%%%%62%%%% !1110 4444 %%%% !1110
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M % )).!7++&8BE3KQ;4G32=TM->C5]T=,<'1JRH22:4Y<K3>NEM4^WZG#_\
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M-D,_\/9_#&?^A3UO_P!)35XJM[; XA]G;[DC/"T?98S#>>OWMG[W_P#!3_\
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M1;:9V7?S"OV&W"D(,,[@LV5"_L-7+F7-]>J<W<WROE^H4^7L?'?QG_X(0_\
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M6ECJ-2-N6"2?R/7/^"G_ /RC7_:"_P"R)^*O_33<U_,O_P $C_\ E)Y\!_\
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M_!#QU\7CXW\(V/P/\ 7W@=]5_L?3_&MCJTGAR^4[&O;2U@.8$=7)"+$(R\:
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M_&7A[QSJ6M>,-0^(-G]D\7>(_$5XKWMY %*QQJ8U1(5CR2BQJH!P<9 KKO\
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MA^+K'Q==ZIXRU+QY:_9?&&O>*KE9KK4K<(R+ ?+5$BC56;:L:J 3GJ!CI/\
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M_"WA5)(_#'AK3]-68@S+86:0B0CH3L SC)Z^M:%%%3=E!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !
M /6BBB@ HHHH *]>_8JS_P +8O/^P#-_Z.AKR&O7_P!BG_DK%Y_V 9O_ $=#
M6=;^&S2C_$1[G*K)*R.N&5B"/2FU-J7_ "$;C_KLW\S4->>>@%%%% !1110
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MZ/\ B',_X(X?]&AM_P"' \0?_)]'^L6$_EE^'^8?ZO8S^9?C_D?R\45_4/\
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MQ!_\GT?ZQ83^67X?YA_J]C/YE^/^1_+Q17]0_P#Q#F?\$</^C0V_\.!X@_\
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M\&>,4@T_]H68QML:;PJJMMX) U?(^HR/S%?9_P#Q#F?\$</^C0V_\.!X@_\
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M.HHHJ1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^(L<3]J?_@+_ ,S]"O\ A[=^S%_T+_C3_P $*_\ QVC_ (>W?LQ?]"_XT_\
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MW_0O>+O_  2+_P#'*/\ AZ-^SM_T+_B[_P $B_\ QROA?FBO-_UBS#M'[O\
M@GRW_$4^)>T/_ 7_ )GW1_P]&_9V_P"A?\7?^"1?_CE'_#T;]G;_ *%_Q=_X
M)%_^.5\+T4?ZQ9AVC]W_  0_XBGQ+VA_X"_\S[H_X>C?L[?]"_XN_P#!(O\
M\<H_X>C?L[?]"_XN_P#!(O\ \<KX7HH_UBS#M'[O^"'_ !%/B7M#_P !?^9]
MT?\ #T;]G;_H7_%W_@D7_P".4?\ #T;]G;_H7_%W_@D7_P".5\+T4?ZQ9AVC
M]W_!#_B*?$O:'_@+_P S[H_X>C?L[?\ 0O\ B[_P2+_\<H_X>C?L[?\ 0O\
MB[_P2+_\<KX7HH_UBS#M'[O^"'_$4^)>T/\ P%_YGW1_P]&_9V_Z%_Q=_P""
M1?\ XY1_P]&_9V_Z%_Q=_P""1?\ XY7PO11_K%F':/W?\$/^(I\2]H?^ O\
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MY<33L &E9I"?G(')ZFH*_1L#P30]G?%3;;Z+2WYGV6%X8H\EZ\G?LM#]Q/\
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M_P"2*/\ B(M_8#_Z GQ$_P#"9B_^2*_#NBC_ %+RGO+[U_D'^K.7]Y??_P
M_<3_ (B+?V _^@)\1/\ PF8O_DBC_B(M_8#_ .@)\1/_  F8O_DBOP[HH_U+
MRGO+[U_D'^K.7]Y??_P#]Q/^(BW]@/\ Z GQ$_\ "9B_^2*/^(BW]@/_ * G
MQ$_\)F+_ .2*_#NBC_4O*>\OO7^0?ZLY?WE]_P#P#]Q/^(BW]@/_ * GQ$_\
M)F+_ .2*/^(BW]@/_H"?$3_PF8O_ )(K\.Z*/]2\I[R^]?Y!_JSE_>7W_P#
M/W$_XB+?V _^@)\1/_"9B_\ DBC_ (B+?V _^@)\1/\ PF8O_DBOP[HH_P!2
M\I[R^]?Y!_JSE_>7W_\  /W$_P"(BW]@/_H"?$3_ ,)F+_Y(H_XB+?V _P#H
M"?$3_P )F+_Y(K\.Z*/]2\I[R^]?Y!_JSE_>7W_\ _<3_B(M_8#_ .@)\1/_
M  F8O_DBC_B(M_8#_P"@)\1/_"9B_P#DBOP[HH_U+RGO+[U_D'^K.7]Y??\
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M /9T?\-M?"G_ *%[Q-_X)_\ [.OGVBC_ (B_Q7VI_P#@+_S#_5;+>\OO_P"
M?07_  VU\*?^A>\3?^"?_P"SH_X;:^%/_0O>)O\ P3__ &=?/M%'_$7^*^U/
M_P !?^8?ZK9;WE]__ /H+_AMKX4_]"]XF_\ !/\ _9T?\-M?"G_H7O$W_@G_
M /LZ^?:*/^(O\5]J?_@+_P P_P!5LM[R^_\ X!]!?\-M?"G_ *%[Q-_X)_\
M[.C_ (;:^%/_ $+WB;_P3_\ V=?/M%'_ !%_BOM3_P# 7_F'^JV6]Y??_P
M^@O^&VOA3_T+WB;_ ,$__P!G1_PVU\*?^A>\3?\ @G_^SKY]HH_XB_Q7VI_^
M O\ S#_5;+>\OO\ ^ ?07_#;7PI_Z%[Q-_X)_P#[.C_AMKX4_P#0O>)O_!/_
M /9U\^T4?\1?XK[4_P#P%_YA_JMEO>7W_P# /H+_ (;:^%/_ $+WB;_P3_\
MV='_  VU\*?^A>\3?^"?_P"SKY]HH_XB_P 5]J?_ ("_\P_U6RWO+[_^ ?07
M_#;7PI_Z%[Q-_P""?_[.C_AMKX4_]"]XF_\ !/\ _9U\^T4?\1?XK[4__ 7_
M )A_JMEO>7W_ / /H+_AMKX4_P#0O>)O_!/_ /9T?\-M?"G_ *%[Q-_X)_\
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M:ZYX1UB6UF7B1%;,<JY!VNOW77('!!' ]*[#XD^!?#OBOPM+\;OAG"MMI[W
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ME9UPW1D;;)C &!'R!D"IE3ISCS4^FZ9C5P^%KTG5PS:MJXO>W=/JOQ.-HH'
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ML)!(H#%<%2 =N"9?!V@^,_CYI^JW6A?M2^*[F'0;%K[7(?$GVA6M[",CS;A
MMU*) BL6V95CM8 =,\\L16Y%.R2\]3&5:IR\ST1P5W^SK\4[:+?;Z3:WS_\
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M_P#T4*]SK\$Q24<5-+N_S/R7$+EQ$TN[_,****YS$**** "OEK]MOX>VM_\
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M_P"CUK[ZKX%_X)(?\E=\4?\ 8NK_ .CUK[ZK\#X\_P"2EJ^D?_24?U!X8_\
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M!^,-Y\6/BS]GBOWS##9VD)CCM8@QQ$H8EOE'R_,2>.237V=_P;]>'_V5M?\
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MRLQV[LG!&!7L8S"XS-,1[:F[\_,TMK1B[==-CDHU*6&I\DM+6N^[9A@?[-!
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M?[='BG4+;X3:CI^E6NBHLE]K&K33QPQL60"-6BBD_>$-N ..%8YXYXO]J_\
M9;^*/[(GQ?OOA)\5HH&U"W9I(;RT\PPW4>X@2(TB(S!@,YVC@BO9O^"9_P#P
M5$\2?\$_;G6M!N/A]#XD\/Z](DMS:?VA]DDAG4@+()!#*6 3>-F!DL#GC!\]
M_;V_;:\6_MT?&J3XI>(?#L.D6L$;0:5ID,PF\B'=P&DV(7.T*"2HZ9P,XH][
MF#W>7S._^)'_  29_:7^$?[*'_#2?Q!\5^'=,TM2T[^';J\NTO$Q&QP8VMPG
MF'80!OQTY]/E+&.E?0G[7_\ P4R_:9_;3\-:?X(^*6M6<.AZ?*D\>F:?8QQJ
M]PN\>:S!0V=K[=N=O XS7SW3CS=12Y>@4444R0HHHH **** "BBB@ HHHH _
M43_@V:_Y'3XO?]@O1?\ T9>5^ME?DG_P;-?\CI\7O^P7HO\ Z,O*_6RN:I\;
M.RC_  PHHHJ#0**** "O.?VMO^3</%__ &!Y/Y5Z-7G/[6W_ ";AXO\ ^P/)
M_*L<3_N\_1_D>?FW_(KK_P""7Y,_,T=**!THK\M/X["BBB@ HHHH **** "B
MBB@ K0\+^)];\&ZW#XB\.WTEO=09\N2-RO4$$<$'H3WK/HIQE*,KHNG4J4JB
MG!V:V9Z5/X.T;XCZ5<?$7X6W,EGK5CNNM4T4,%,07)\VWV G:-H)W8P7 R>M
M>;/(\KM+(Q9F.69NI/K5O0->U7PQJ]OKFBW/DW-K(LD+[01N!R,@]1D5WMMI
M/A7XYVLTND16NB^+%8S7$<UZ%@U0M]XKYA58FWG.T%LAN  I)ZWRXKX=)=NC
M]/,]>2IYM%>SM&KUCTD^ZZ*7=;/IV/-@"S!%&2QP!ZUZ9IOA?PG\&=#T_P ;
M^-UBU37KR-;C3/#_ ,IACA=<"2X# ,"/G("@C<J<]<-NX_"_P'@MVLYK76?%
MQ?SEN8;@-!I)4C8 $+).Q/S<D 8 (.:X#7=<U3Q-K%SK^MW/G75W,TDTFT+E
MB<G ' 'L*FT</OK+\O\ @D\M+*HMSM*MT6ZAYOO+RV777077]>U7Q1K-QX@U
MN[DN+JZ?=+)(Q8GC &22<   >@ JG1CO17-)N3NSR93E4DY2=VPHHHI$A111
M0 4444 %%%% !1110!^DG[$__)L/A7_KUD_]'/7JE>5_L3_\FP^%?^O63_T<
M]>J5^H83_=8>B_(_L#)?^1/A_P#!'_TE!11170>H%%%% !7Y0_\ !SM_K?@E
M_N^)/_<77ZO5^4/_  <[?ZWX)?[OB3_W%U]!PO\ \CVC\_\ TEGL9#_R-:?S
M_)GY2T445^R'Z0%%%% !1110 4444 %%%% !1110 8S1110!ZEX@O#X[_94T
M.]9/*;P%K#:7Q_R\?;Y+BYW'K]WR=O;KWKE/AO\ !WX@_%::X'@WP_-<6]FN
M^^OO+?R;5,C+2,H.T?,.W>M+X3QZIXF\*^+/AO8(TS7NDQ7MC:(OS/=074)+
M#N<6[7)QTQSV%0ZIX@UG3O@?HOANPO6CL;_6KN[O(D _>31JD:$MUX21QC.#
MG.#@8XUS4[PAWT\D]?\ ,YUS1O&/?\]?\SL=0L/"OP ^&'B#PQ)\0M'\2:YX
MHCAAMX_#=Y]HM;2*/S!(;@NL;*Y68&/"L,JV<8&?&QTHR3R:*WIT_9W;=VS2
M$.6^MVPHHHK4T"BBB@ HHHH **** "BBB@#^D7_@F;_R8!\(?^Q$T_\ ]%"O
M<Z\,_P""9O\ R8!\(?\ L1-/_P#10KW.OP/&?[U4_P 3_,_)L5_O,_5_F%%%
M%<Y@%%%% !7@?[9/_(;T/_KUF_\ 0EKWRO _VR?^0WH?_7K-_P"A+7Y[XH_\
MD7B/6'_I<3V^'?\ D;4_G^3/%Z***_DT_30HHHH **** "BBB@ HHHH *U/#
M&H6.G'4);QCNDTR6.WQCEVPO\B:RZ*VP]>6'K*I%:KN14@JD>5G4?#/YDU95
M[V*_^C%JU\.+I]#T"ZUJ\\77FGVLEQY*P6?)D?;G)!91T[YS5;X8<S:DO=K(
M?^ABF_#;Q9J6B2W&EQ^+ETJUF7S'=K!9PSC  P>G!/>OJ\KKT:$<*ZG::7DW
MM?WHZ?-'F8JG*?M$EV_K9_D=)'X[T175C\0]:X.?]4G_ ,>K,T[6]*U_Q=XB
MU?1;#[/;3:!>>7&4"D?NNX!('YFMR/QFP=2?C/#U_P"A=3_XJL.SU#0=1\6>
M(KSPW%LLWT&[\K.>?W77GD5[F)K<TZ*52+][:VOPRU7OST77;IN<-.*Y9^Z]
MM^FZ_NK]3"^&^L6N@^,+34[R98XTCF5F8XQNA=?YFLF_\G[?-Y#;D\YMC#N,
MU%P.12"OSRIBIRPJP[6D9.2[W:2?Y(]^-.*JNIU:2^[_ (<6BBBN4U"BBB@
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M12HDDKB.-&9C]U5&<TZ6WN()/*F@=&'564@B@!E%!# 9(ZT ,WW5- !1110
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M5=?^ _@']G_Q!\,?!7CR'5-2W8FO"P1;QC%,08TWMP-^TX)Y],XKSWQ3XO\
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M79=%\D%%%%8G$%%%% 'Z2?L3_P#)L/A7_KUD_P#1SUZI7E7[$W/[,7A4@_\
M+I)_Z.>O5:_4,)_NL/1?D?V!DG_(GP_^"/\ Z2@HHHKH/4"BBB@ K\H?^#G;
M_6_!+_=\2?\ N+K]7J_*'_@YV_UOP1_W?$G_ +BZ^@X7_P"1[1^?_I+/8R'_
M )&M/Y_DS\I:***_9#]("BBB@ KJ/@A_R6CPA_V-&G_^E,=<O70?"75+'1/B
MKX9UG5+A8;6S\064UQ-(V%2-9T9F)/0  FHJ?PWZ,FI_#?H?I!^TY^U_8_LH
M_MTVL'C;PU#K?@OQ=\.=%L/%FD7%NLZRQI8V\D,BQNZQLZR8P7S@,V.33?V
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M/-9EN+/Q!9R#.E7&^1TG*A?WBEU@X+J  3D\UTWQ&\)? ;X!?#KQ%XP\1?\
M!2G3?B1?S:-<VWAOP_X6T^S63[<\9\B:1H+J<B-7&&4I@@C)%&)IXYXR2G=/
M3D=I.RLMK.RUWN%:.*^L-2>NG+HWIY6T];GCNC_"'PKX3_8Y^.T.K^&M-N];
M\*^,-)TZSUB:QC:X@"W]U%)Y<I7<@<( 0,9  /2NZ_X)E_"SX9>._P!E_P"/
MVO>-OAWH>L7VC^#;B?2;S5-)AN);*019#Q.ZDQL#W4@U@_L!>+/V?_BC\,?B
MK^S%^TK\6K7P:OCB33+[1?%&H%/)@N+6XFGD$@:2)3O#X&77!/ /2O=/@W-^
MQ7^Q'^SK\8/@WH_[6N@>.?$7B[P?=FUU33Y((+=3L$:6B!+F999&;+<,&P!\
MI!S75C:U:%.KA[2YW.+5D]O=N[[6WN=&)J5(PG2UYG)-:/;3J<C\&%^!7P9_
MX)7:7^TGK_[/7A7Q3XLL?&^H0V,NMZ%;S1SK]HM$"W#,I>14#Y5<X&6'&:H_
M ?1OA7\4?AE\0/\ @JE\=/A3X::'P?J;Z?H/P]T?2(8M)O=05+5HA-;NI5XO
M]*RV&#83(!(&>'U+XX?"Z;_@DC9?!&/QC8GQ1'XTOKIM'^U)YXA>YLV5]F=V
M"$<YQV-<_P#L4_M*^ -.^%?BC]BO]H#4FT_P'X[EDGCUZ--S:)JC+ L5XR#:
M947[/&"AD1<$DD8YKZKB)8>K42ES>T=][\E]4O\ @?(?L*KIU)J]^=][\M]4
MCW3X _M'_ 3_ (*7_$./]D'XK?LD> ? [>(+.YD\.^)O >@V]K>6EQ;0O<K&
M92A*QND3*P4$G@="2'?L9?#VX^$O[.O[7/PINKGSI?#-GJNE23?WVMYXHBW0
M==GH*Y?X3Z#^Q=_P3R\1R?M.>&_VJ-/^*?BC3;.X@\(^&])L$M/+FN8V@:XE
MDCN;C 2&60[&CPQP,@\UF_LD?M4>!_\ A0'[1U[\7?'.GV?B;XA:??75K;S7
M$<;7MW<212.$4D9RV_A1VK"M1E*G/ZM&7LKPLFG\2DKV3UVWZ?B95:;E3E[!
M/DO'1WWNKVOJ3?L[^$?V;?V1OV+M&_;2^*GPVM?'7C#Q9J%Y!X5\-Z_8V]SI
MD8M91&TDB2+NSF:,Y4G&WZ5Z#\ ?''[+O_!5Z;5/@5\1/V;?"WPW\70V,MWX
M=UKX>Z):VOG"%/-,4CE2Y^5)<J!C&/>O&?V<OC9^S=\</V9;?]C;]J?Q')X5
M;0KJ>;P-XT6,SQV4EU(7G66$&)2NZ.#EY>F[IS7<_#KQ=^QG_P $T]%U3XC_
M  H^.L'Q9^)%Y;-!H+Z?9BSM=/AEQ%(6*37*,WE&?A@#\Z], U>(HU.:HFI^
MWYGR-7M:^FOPI6WOYE5J<^:=U+VM_=:O:W3RMWN9OPM^&'PM_8:_8PT/]MWQ
MQ\-]&\=>,_%FN7&C:!X;\46$5WI=FD=S=Q2W$D4B!MX%G\C*209.0 3CT3]D
M/XU_!O\ ;EL_B9<_$K]D+X9Z/KGAGP*USIMYX?\ "-M%#(LEY;J[2*RD^:N$
M",#D+),.-W/F/[.'QQ^!7[5W[+4/[#/[57Q(M_!4^AZE)JO@KQQ>!6@MYFGG
MFFBF0O"F'%U,H+2\';@'I7OW[%/[._[+O[._A+XM:9\*OVG=.^)GB:\\"@WU
MYHMK'':V-HMY#E2T5S.CL[LF.5($9ZY.,,9+V=.I]84O;<RLUS6Y>96LUI:V
M_F9XA\D9^VO[3F5GK:UUUVM8^;?A#\(/!?[67_!-_P 7:CX<\$:/IWCKX+WL
ME_<:AINFQPS:GH\MJ9F:XD53)-(C6<X7.U0&Z\G&M^RA\-_AG\ _^"?OQ%_:
M\^+?PVT'Q%K6J7\>A^#]*\2:1#=QJI-D7N8EE7*.$NY#N5LYC'''/E?_  31
M^/\ JOP0_:BT'2#9M>:+XUU"U\.^(M/49,]I=3+ ^,*6W!)9,!<$ENH.*]8_
MX+-?&[P?>_$/P[^RW\'76/PCX%TO]Y9^;O>+4C-.DH8D;@1$L VD\8Z5WU:>
M*^N+!J_)-J=[[)?$OG+\SJJ1Q'UGZLK\LFI7[+JOO_,^)@<\TM%%?4'N!111
M0 4444 ?TB_\$S?^3 /A#_V(FG_^BA7N=>&?\$S?^3 /A#_V(FG_ /HH5[G7
MX'C/]ZJ?XG^9^38K_>9^K_,****YS **** "O _VR?\ D-Z'_P!>LW_H2U[Y
M7@7[9)']N:&,_P#+I-_Z$M?GOBC_ ,D7B/6'_I<3V^'?^1M3^?Y,\8HH&>]%
M?R:?IH4444 =%\(A_P 7*TC/_/S_ .RFO0KG5=+\0_$3Q-\*O$K[;?4M1+Z?
M,V/W5P4"+USC)*]!GBO-_AKJ5GI'CS3=2U"=8H8;C,DC-@*-IYJ7XF:U;WWQ
M,U/7M$NQ(C7WFV\\9# XQ@^G45]SE&;4\KX=3TE^^]Z#^U!PLTUV?YGBXK"R
MQ.8-:KW-'V=U8Z_Q;J]CX%N+#X2^%9PT:WD+ZM<+P9)A(H*\8X!C4\CO2ZGX
M/C\9?'S5;.>!YH[.%+I[>/!:8)'%\G/J2!7G6FW\C^(K?4M0GW,;Q))I&P/X
MP2:[:]^(>FZ3\:K[Q%:7(FTZ^5+:ZDB8'="T<8;!YZ%>WI79A\XP.8J,L5:-
M%5X)0Z1@HR2T[)VNS">#K8>ZIZS<'=]W=?CV.EB3Q7<WW]D7W[/MFNE[RJM%
MI*"<*.C9Z;NF?J:K>&].M/A-\8X_!EMHME?0WEY"UO=7L(>:!?-*@JV.#WX[
M@42Z7X#%ZVO#XT1C3G8NFGK#'YR@]%_UF[C/IVKAM+\7:?IWQ,M?$JRR26-O
MJ,;*9/O")9 WIUZU[F88[#Y=B,/4FUS^T5I<U.34.ND%\+Z7U70XZ%"IB*=2
M*6G*[JTE[W3=[^A?^+'CN+6]6U#0T\&Z/:M%?RI]LM+-4F?$G4L.I..?J:[?
M0=-\<#2(Y%^#OAN.W_Y:0S:?F:9<\X^7&2.G-<9\0="\*:5K'_"::+XXM-2-
MU?&Z^PQ!=T:EPVTD.3G!]!TKI?&^G?#SQOKX^(C_ !1MXH%VNVG-&GG*$ZHH
M\P-DXX^7OWK#!?6EF6+KUYIU+JR4J:O!MOFN[JR5KI:ZZEUO9_5Z4(*T;.[:
MD_>5M+>?_#&9\3/ VF^$/&^CWNGVK6O]I+YLEGM 6!MB$J !P 6/Y5M?%_XE
M6/@[QS-8V'@K2KYG3?<3ZG:+(Y.]@54]EXS]363\6?&/A76M9\-S:'JBS06=
MN4D;<-R#9&!N]#QWK2^(&B?"_P"*/B:37;/XE6>EF/\ =S1W&UA+\Q.]29%]
M>@S]:ZL1+E^O4LHJ0C)U(.*O%77+[W+?3=NYG3CS>QEBHR:46GH^^E[:F/XR
M^'>@:X_A_P 2>%8VMX=>E47ENJ@+ Q,9(0 < >8>.P%3:W\2?!/@35Y/"GAW
MX<Z5?6=N0DUUJ%HCS2YZ\@<C&.M9_C_XE:3;7>D:%X"!-EH+ K.Q_P"/B12G
M/(.!^['<]:L:KH'PD\;:B?%%KXZ72(Y,-=:?-;[V!'7:S2*3D8[5YU:M16(K
M+*94E6O#F;Y4FN7WN1RTMS?%;Y:&\*<_9P^M*3A9V6K>^E[:[;$7Q!\,^&(?
M^$=\>>$HGAM]9N?WEJ54+$Z,H(4+P!D-6W\6K2VOOC]H]I?6Z31206ZR1R*&
M5AO?@@]:Y?QSXUT#4+G1?"_AB)DTG19OW<TC<RLS*6?!'R\[NYK8^(7C'P[J
M?QMTGQ!8ZI#)9P1PB2=9 57#-GG/O2J8K*Y0KQIRA9UL.VE;E;2?.TNU[^0X
MT\4G3<D_AJ6OO9M<J?G8S_#VA>%KSX]7VB:U#%%8QZQ=+;V^T",LLK>7'C&-
MN<#&.E7OB?=^++'2Y;#Q3\*](LH=VV#4+&Q\O:V#C#8Y]:P7N?!&L?%/6+GQ
M/<R?V=>:E=-#=0-D+N=MC\=1R#UQBNXM=:\/^ O"^J6FH_%6WUZVNM/F@MM-
MMXHQ^\9" Q*NQ'I497&AB,OQ5+GC"+G4;DG#;HI1EJX_R\O=AB/:4ZU*=G)J
M,=&G\[-:7[W.;\-W>@>&_AG#XHN/"]C?7B73"+[5;JZGYROS<9. >/<"M>;6
M_#6K_#Y?BK?^!]-6^M;_ .R+:0VJ+;R?*7W.N.>E<G<ZYI3_  N32([A%N/M
M3-Y 895?,S_*K-MXAT=/@9-X=:]C^VMKGFB#<-VSRF&<=<9KGPN:4Z-)4%*'
M*J',E:/\1;/;XK[&E3#.4N=IW<[;OX7O\C8\6+H/CSX2?\)U'X=L=-U&TNA'
M(-/MUC216)'.!DGY/PR:\S%=QIGB/1H?@C>>'Y+^-;R2Z1E@WC<0&DYQG/<5
MPXZ5\_Q-6HXJ>'KQ:<Y4XN;5M97>]NIZ&6QE352#O92=K]M-@HHHKY@](***
M0G:,EOQJH?&A2^$^M:*-P]:*_J8_+#\;?"6F^/?#=A-X(^+.CQZ9XNT&X:Q\
M4:/'J$%TVGW@57,+20221E@DD;?*[###FM89[U]<_P#!3/\ 8A_:5\>?'G1/
MV@/V9_!]GXHTW4-(@T?QAX1M[JSL+R"6.YEDCU.%[AHH[C<ERZ3AYE=5M8/*
M24NX7X[U'6;/0=6;PYXH+Z1JB[BVFZLAM[C 9D+!'P73<CJ'7*$J<,<5_:'#
M?$6$SC P4II54K276ZZ_,_C_ (PX3QV0YE4<:;=%MN,DKJSUL^S6Q;HJ$7]B
M>1>1_P#?P4?;K+_G\C_[^"OI[H^,Y9=B:BHOMUE_S^1_]_!2?;K+_G\C_P"_
M@IW0<LNQ+@@\4N.U1?;K+_G\B_[^"D^W67_/Y'_W\%*Z%ROL38I"#Z5']NLO
M^?R+_OX*/MUE_P _D?\ W\%.Z'RR[$M%1?;K+_G\C_[^"C[=9?\ /Y'_ -_!
M1=!RR)3G'%(%/7-1?;K+_G\C_P"_@I?MUE_S^1?]_!1=!RR[$I&:*A^W67_/
MY'_W\%+]NLO^?R+_ +^"E=!RR[$N.]#9(P*B^W67_/Y'_P!_!2?;K+_G\C_[
M^"BZ#ED>W?#KQ-^R/XP^']GX+^,>A:AX?U'3V!_M[08UWW8V@;9,QRDG.X]!
MVIOQA^,/PHT+X<_\*5_9TAO/[(O)/,UW5-27%Q?,KK)'RJQ_=(*\IT_.O$Q?
M6?\ S]Q?]_!0;ZR_Y_(O^^Q7C+)</]9565232?,HN5XW[V_+L>__ &_BOJ;H
MQIPC)KE<U&TG'M?SV;W9]$_!#XM?LP_ 7PS:_$G08]4U3QT--$+6%_"&MK:<
ME2TB$1*0?E('[P\.>M?/]U=W>H7<M_?3-+-/(TDTDC99V8Y))]2:K?;;''_'
MU'_W\%'VZR_Y_(O^^Q73@\OHX.M4K*3E*>[;OHMDNR5SCQV9XC'8>E0<5&%.
M]E%6NW:[?=NR)J*B^W67_/Y%_P!_!2?;K+_G\C_[^"O1NCS.678FHJ+[=9?\
M_D7_ '\%)]NLO^?R/_OX*+H.61-1FJMUKFC6,?G7VK6T*?WY9U4?F36OX$^$
M/[1'[1>FW5K^RI\+Y/$UPOV:-M:N+Z"STNQ6YDDBCNI)YW4SPQM%*T@M%N)5
M6(CRF9HT?CQF88++Z+JXB:BEW9WY?E689KB%1PM-RD^R_-]#Z0_X(\:9X^UK
MX\>-O'>F:/%<>"+/P^NBRZU#J$#>7KB3I-+9-")/-5EMY8)-Q0(1( &)R!^A
M^!G->9_L?? _5OV=_P!G/PO\*_%-YI]YKUCIR/XBU#3+<)#=7[C=,ZG8AD4'
MY%=E5F2-2P!X'IG.>E?SKGF92S;-*N)MI)Z>BT7X']:<-Y/'(LEHX.]W%:^K
MU?XA1117DGN!1110 5YK^V?X*\;_ !*_8\^+'PZ^&>B?VGXDU_X:Z[IOA_3?
MM$</VN^GT^>*"+S)65$W2,J[G95&<D@ FO2J* /Y35MKRQ>33-36-;NSGDM;
MZ..99%CN(G,<J;D)5MKJRY!(R.":=GVK](/^"OG_  2._:WU_P#:R\2?M._L
MT_#>Q\5>!?$^GPWVK:5I%]965UX=N+2QCAF/D3-")X95MTE4PM+,TLLP:-0$
M9_S=O9&TO4'T;6;>?3[^-4:;3]2MWM[F'<H==\,@5T)5E8!E!P0>]=49*2.*
M<'%CJ!GO3?/@_P">R_\ ?0H\^'_GLO\ WT*H@=SFCG--\^'_ )[+_P!]"CSX
M?^>R_P#?0H =13?/A_Y[+_WT*//A_P">R_\ ?0H =1VIOGP_\]E_[Z%'GP_\
M]E_[Z% #AQQ0,]Z;Y\/_ #V7_OH4>?#_ ,]E_P"^A0 ZBF^?#_SV7_OH4>?#
M_P ]E_[Z% #J",BF^?#_ ,]E_P"^A1Y\/_/9?^^A0 X9H]\4WSX?^>R_]]"C
MSX?^>R_]]"@!U &.E-\^'_GLO_?0H\^'_GLO_?0H =SCK01FF^?#_P ]E_[Z
M%'GP_P#/9?\ OH4 .HIOGP_\]E_[Z%'GP_\ /9?^^A0 OS4M-\^'_GLO_?0H
M\^'_ )[+_P!]"@!U%0S:A8VR[[B\BC7^\\@ KUK]G+]@O]L_]LZ*7_AF+X,3
M:E9PW=G;WGB36[Z'3M,L4N0WEW9>=EDNH%"LSFSCN' 7 1F*JR;MN5&+EL??
M7_!LKX%^("WOQ:^+<VAQGP?J TW1]-UB.^A?S=2M7N'NK<Q*YD0QI/;DLR*I
M\S"EBK ?K%7G?[)WP'LOV9OV</!?P-MY+2>X\-^&;#3]3U&SM$A&H74-M'%+
M=,%5<M(R;BQ&3WKT2N:4N:5SLC'EC8****DH**** "O+_P!M7PU\2/&'[*?C
MOPU\'_#;:QXHO/#T\>AZ6MU% ;FX(^5/,E=$3/JS*/>O4*#SQBIE%3BXOJ95
MJ,<11E2EM)-/YGX\>&?$>A^+-#M_$'AS5[>^L[A28;JUF$D<F"5.&'!P01]1
M5^O5_P!L+]D?]I;X8?'KQ9\4/!OPR@\0_"O4[5]7CG\-2VL=QX86VM4^TQ3V
M;&*29'*[X1:+<R.5E#I&?+$GC$/BCP[+?S:1_;-NEY;R>7<6,T@2>%_[KQMA
MD/(X8 \U^<8[ UL'6<6G;H^Y_*G$7#>89#CYTZD'R7?+*VC70T**B^W67_/W
M%_W\%'VZR_Y_(O\ OX*X#YSEEV):*B^W67_/Y%_W\%'VZR_Y_(O^_@H#ED2T
M'..!47VZR_Y_(O\ OX*/MUE_S^1?]_!18.61+147VZR_Y_(O^_@H^W67_/Y%
M_P!_!0'+(E&>]%1?;K+_ )_(O^_@H^W67_/Y%_W\%&H<LB7FCOFHOMUE_P _
MD7_?P4?;K+_G\B_[^"@.5]B6BHOMUE_S^1?]_!1]NLO^?R+_ +^"@.61+]11
M47VZR_Y_(O\ OX*/MUE_S^1?]_!18.61=T6]MM-UJSU&^L([J&WNHY)K:096
M9%8$H1QP1P?K7M23_L1>(GA\4ZO>Z]I-VJJ\VBV<8^SL_4J/]';C)(^]T'7O
M7A'VZR_Y_(O^_@I#>V1&/MD7_?P5U8?$2H77*GZH]3+\RJ9?&4?91FGK[T;V
M:ZH]4^(7QE\,?&?XJ6-]XTM+C3?"]G&(+>UL %D@CV=0,.,[\GA>A]:N?&'X
MA_"'3OAU:?"SX$37SVLU\;G6=0O%VRW( /EQL0B;E4NV 5/0<^OC_P!MLN]Y
M%_W\%!O;/_G\B_[^"J>,K24KI7EN[:^B\C>6>8V<*W-%.=3>5O>2TT3Z+2WH
M345%]NLO^?R+_OX*/MUE_P _D7_?P5QGB<LB6BHOMUE_S^1?]_!1]NLO^?R+
M_OX* Y9$M4_$&OZ-X7T:X\0>(M4@L;&UCWW5W=2!(XE_O,QX J.X\5^&K6\A
MTV77;7[5<2K%:V:S*TT\AZ(B#YG8]E4$GL*]>_9>_8]_:D^+'QP\&^//$'PV
MM?#OPLL_LVM:CJ'B2XMI+GQ!#)&98+>VLE,LB#*IYPNUMG1)EV!W5T3NP.!K
MXRLHQ3MU?8^AX?X=S#/<="E2@^2ZYI6T2ZNY]D?L">%/BUX(_9!\$^&/CEX2
M;0_%EKI\@UK26O8;@VTAGD(7S(9)(V^0J?E=ASCKD#V(9[T<#@"BOTB$53@H
MKIH?U9AZ,<-AX4H;122^2L%%%%4;!1110 5^5O\ P<Y_#[XCZGX;^#_Q9T?0
M%D\)>';K6K'Q+JTE]!&+2ZO6TU;&/RW<22F5H9P#&C!=GS%=RY_5*N#_ &G?
M@7H_[2_[/GC3X#:W=QV:>+/"]_I5OJC64=P^G37%M)"EW&D@VF2(OO7/=17=
MEN,E@,=3Q"^R_P -G^!U8+$O"8J%5='_ ,.?S!T5Z]^T9_P3P_;?_8SLOM?[
M2GP::#3OMUQ;6WBKPWJ$6I:;>+#%YCW(,1\^V@V!CONH;<_*<@'BO&[?4;"[
M3S+:]AD7^]'(&'Z5^U83'87'4U4HS31^G8?%8?%0YJ<DR:BF^=#_ ,]5_P"^
MJ/.A_P">J_\ ?5=?,CHN.HIOG0_\]5_[ZH\^'_GJO_?0HYD%QU%-\Z'_ )ZK
M_P!]4>?#_P ]5_[Z%'-$+CJ*;YT/_/5?^^J/.A_YZK_WU1>(7'44WSH?^>J_
M]]4>=#_SU7_OJCF07'44WSX?^>J_]]"CSH?^>J_]]4<R"XZBF^?#_P ]5_[Z
M%'G0_P#/5?\ OJCF07'44WSH?^>J_P#?5'G0_P#/5?\ OJCF0'TQ^RK\1?V!
M-:^$]Q\$?VNO .J:1<-=?:;7X@>%X5^W)M>1O)<M%.2I#A>(^B#D=3VGQ8_:
M@_8Y_9O^!.M?!3_@GY<>(-2U+QDT<'BCQEXFCVW264>YA#"R0VQ4F0JW*L,)
MSSBOC/SH3_RV7_OH4GFP _ZQ?^^J\RIEE"I7]I*<FKWY;^[?T.&6!ISJ<SD[
M7O:^ESZS_83^*7_!/OX":!#\;_C!#XDU3XD^&[^2ZT'0#"DFG7$J+%);R'_1
MB0RS1G&9EQN_&OG/XP_$34/BW\5?$7Q/U0MYVO:U<WS*Q)*^9(S!>IZ @=>U
M<SYT)/\ K5_[ZH\^'_GJO_?0KHHX2E1Q$JW,W*6FKV79>1K3P\*=:52[;??H
MNR'44WSH?^>J_P#?5'G0_P#/5?\ OJNOF1TW'44WSH?^>J_]]4>=#_SU7_OJ
MCF0#JAOKF&TMS-//'&"RHK2R!5W,0JC)X&20/QIUM.M]?QZ1ID<EY>S$BWL+
M&%I[B9@"=J11@N[8!.%!/%?HI_P2)_X)*_M<3_M2>$/VF?V@?A38^&?AQH>G
M?VK96OB&\L[JY\2&\LI4@5+2)I6@6+S!)*+H02*QB"HY\SR_)S;-\+EN&E*4
MES6T75L\_,,PH8&BY2:YK:+N?J+_ ,$^/AS\1?A'^Q'\+?AG\7?#ITCQ1H?@
MJQL]>TLW44_V6Z2("2/S(7>-\'C<K,I[$U['1CC&**_%*DY5)N3W;N?F,I.<
MG)]0HHHJ20HHHH *^5OV]==\2>%OB]X&U?5X+>T\'ZA876E-K%UJ$,8?6I9H
M6M+-(VD$CO)$ERP*H5'E$%@2 ?JFN*_:&^%U[\8_@OXB^'^B7=G9ZO?:5<)H
M6I7EJDRV%Z8V6&<!E;!5C]X*2 3@'I7A\2Y/'/LCK8%NW.M'YK5?BCLR_%/!
M8R%;L_PZGR>N<4M<S97GQG^%NCV^E?M8?#*7PAJT:W"-JT5Y;W>D:BMJ8HYK
MV&X@D8V]N[RHT8O$MIF1QF)6614V+#Q+X=U6'[3I>OV5S'_STM[I'7\P:_CG
M,LGS+)\0Z&+IN,EW6C\T]F?JF'Q6'Q5/GI231>HJ$:CI_:^A_P"_@H_M'3_^
M?Z'_ +^"O.Y9=CHN3=Z*A_M'3_\ G^A_[^"C^T=/_P"?Z'_OX*.678+DP&**
MA_M'3_\ G^A_[^"C^T=/_P"?Z'_OX*.678-";'O14/\ :.G_ //]#_W\%']H
MZ?\ \_T/_?P4<L@N345#_:.G_P#/]#_W\%']HZ?_ ,_T/_?P4<L@N34<U#_:
M.G_\_P!#_P!_!1_:.G_\_P!#_P!_!1RR[ 3<T'..*A_M'3_^?Z'_ +^"C^T=
M/_Y_H?\ OX*.678"8Y[4'D8J'^T=/_Y_H?\ OX*/[1T__G^A_P"_@HY9 34$
M9J'^T=/_ .?Z'_OX*/[1T_\ Y_H?^_@HM+L!,,]Z*A_M'3_^?Z'_ +^"C^T=
M/_Y_H?\ OX*.607)L#TH(R,5#_:.G_\ /]#_ -_!1_:.G_\ /]#_ -_!1RR#
M0FHJ'^T=/_Y_H?\ OX*1M1T[&3?0_P#?P4<L@N3Y]JY3XQ^(-<TGP7+I'@J.
MWN/%&N/_ &;X/TNXU"*V;4]4D1C#:I),Z('?:<;F4<$Y&*O:A\2?!5A+-:1Z
M_#>WD,#S-INEYNKHH@RS"&(-(0..=N 2/45Z9^Q]\"OVD;S]H'5/BO\ '?X:
M6OA7PIHFFSZ;X7\.ZM=V-[?WU\UQ#)_:I^RO/'!$L40CB_?"8M+/OBC"QL_V
MO!O".8<0YI3O3:HIIRDUI9:V7=O8\?-LTHX'#RM)<[6B/<?[&^(O_0M-_P"!
M47_Q=%>A[%]**_JS^RL'V/S3VU01^OX5^'W_  7W_P"4O7@[_LAVF?\ IVUN
MBBOLN%_^1S3]3Y#C/_D0U?0Y*V_U*U)117[Y'X4?RW+X@HHHJNA(4444 %%%
M%'4 HHHH0!1110 4444 %%%%" ****.@"#[QI:** "BBBCJ 4444 >>?M)?\
MD]F^I_\ 037ZT?\ ! #_ )1#_!C_ +!&H?\ ITO***_+?$#>F?M?A9\-0^Q^
M]%%%?F9^RA1110 4444 %!Z444 (O2OYC_\ @LY_RFO^.'_82T?_ -,>FT45
M=/XC.I\)X^GW!]*6BBM3C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH Y7XL?\BXW^\/YBOZ6O\ @BO_ ,HH?@'_ -DWT_\
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IRF@C_P"R<Z]_Z,T^OV33[M%%?U=P)_R3U+T/S3./]^D+1117V1Y1_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>soph-20251231_g8.jpg
<TEXT>
begin 644 soph-20251231_g8.jpg
M_]C_X  02D9)1@ ! 0  2 !(  #_X0!J17AI9@  34T *@    @  @$2  ,
M   !  $  (=I  0    !    )@       Y*&  <    2    4* "  0    !
M   #^J #  0    !    MP    !!4T-)20   %-C<F5E;G-H;W3_X0DA:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[
MOR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B \>#IX;7!M971A
M('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)835 @0V]R92 V
M+C N,"(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O
M,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z1&5S8W)I<'1I;VX@
M<F1F.F%B;W5T/2(B+SX@/"]R9&8Z4D1&/B \+W@Z>&UP;65T83X@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" \/WAP86-K970@96YD/2)W(C\^ /_M #A0:&]T
M;W-H;W @,RXP #A"24T$!        #A"24T$)0      $-0=C-F/ +($Z8 )
MF.SX0G[_X@TD24-#7U!23T9)3$4  0$   T487!P; (0  !M;G1R4D="(%A9
M6B 'YP "  ( "0 P #=A8W-P05!03     !!4%!,
M    ]M8  0    #3+6%P<&P
M                         !%D97-C   !4    &)D<V-M   !M    ?!C
M<')T   #I    "-W='!T   #R    !1R6%E:   #W    !1G6%E:   #\
M !1B6%E:   $!    !1R5%)#   $&   " QA87)G   ,)    "!V8V=T   ,
M1    #!N9&EN   ,=    #YM;6]D   ,M    "AV8V=P   ,W    #AB5%)#
M   $&   " QG5%)#   $&   " QA86)G   ,)    "!A86=G   ,)    "!D
M97-C          A$:7-P;&%Y
M
M            ;6QU8P         F    #&AR2%(    8   !V&MO2U(    8
M   !V&YB3D\    8   !V&ED       8   !V&AU2%4    8   !V&-S0UH
M   8   !V&1A1$L    8   !V&YL3DP    8   !V&9I1DD    8   !V&ET
M250    8   !V&5S15,    8   !V')O4D\    8   !V&9R0T$    8   !
MV&%R       8   !V'5K54$    8   !V&AE24P    8   !V'IH5%<    8
M   !V'9I5DX    8   !V'-K4TL    8   !V'IH0TX    8   !V')U4E4
M   8   !V&5N1T(    8   !V&9R1E(    8   !V&US       8   !V&AI
M24X    8   !V'1H5$@    8   !V&-A15,    8   !V&5N054    8   !
MV&5S6$P    8   !V&1E1$4    8   !V&5N55,    8   !V'!T0E(    8
M   !V'!L4$P    8   !V&5L1U(    8   !V'-V4T4    8   !V'1R5%(
M   8   !V'!T4%0    8   !V&IA2E     8   !V !$ $4 3 !, "  4  R
M #< ,0 Y $@ 0W1E>'0     0V]P>7)I9VAT($%P<&QE($EN8RXL(#(P,C,
M %A96B        #SV  !     18(6%E:(        &2'   S*@   0I865H@
M        :N0  +R7   1REA96B         G:P  $#X  ,!98W5R=@
M  0     !0 *  \ %  9 !X (P H "T ,@ V #L 0 !% $H 3P!4 %D 7@!C
M &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *, J "M +( MP"\ ,$ Q@#+ -
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MUTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I- DU*39--W$XE3FY.MT\
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MIP  #5D  !/0   *6W9C9W0          0 !          $    !
M  $    !          $  &YD:6X         -@  IT   %8   !2@   G
M "<    /0   4$   %1   (S,P ",S,  C,S          !M;6]D
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M]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0 M1$
M @$"! 0#! <%! 0  0)W  $" Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S
M4O 58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC
M9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.T
MM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]L
M0P ! 0$! 0$" 0$" P(" @,$ P,# P0&! 0$! 0&!P8&!@8&!@<'!P<'!P<'
M" @(" @("0D)"0D+"PL+"PL+"PL+_]L 0P$" @(# P,% P,%"P@&" L+"PL+
M"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+"PL+
M_]T ! ! _]H # ,!  (1 Q$ /P#^_BBBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT*DJ->#C.+LTTTT^S35TSTRBN?TS61<$6]UP_8]C_P#7KH*@@**** "BBB@
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M(L44:CJ69B !^-;\LC32M*_5B3^=?S.?\'&WB#6=+\'?#33+.YE2TNKK4#-
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M=;L+^![:[CEC26WN48%)%>,@JRN,Y4@@@XZ5^&WQY_X(_P"H_ _QK<_M(_\
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M7X ?LG+XOT^2U\*>)D5;FU;8UC(I+K<^$MK?ZXG&V(H>>#<XY.PU]?\ B?\
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MO7R3:OJ]]J]MX>TT00QJ?[0@T5DNKII!+O@C1@P,3D9&X'\%O WQ,_:9O/\
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MJ<=LUI+.$Y\_L^W7LV][>=C.&225/D]IWZ=TEM?NKG\*O_!;3QQ_P3P^(O\
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M6WPVMJMN5V]3_.Z_X*3/\8=<_P""H/QDTO\ :,\=6?PZ\56VL:;)\,M;UO\
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M6H:5IWAF\<0M>W&G16D,RW4<_ERF0,BX:=L F,@^G_\ !8JY_9A\(^$_@/\
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M]\/_  <\$6_@AFN]06R%AJ-VYOWNK=6#>=<QSPS0>6,;@@R1Q7!>"_B%X?\
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MA#X2O+*3P;K6E?%G5O!?C#2;.^-]97#6WA/4]4B6.X\JW:XMW#V=RA>&)@X
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MXDV]SJ^H>%%U>R:36IF5/^)2\]Q AMI;2-HI99&5%+S^6"?+8G[.U7_@KO\
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MC@8SI3HQ34U?5/\ K7^O(UK4Z\VG!VT:_P NGZKYGGVN_M[:UI'Q9OM(M_!
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M>C^(_B-8^&'T/QCHGCJ^T>VTVVNH[JSN?!UTL*?:99;ETGCNHRS,L<431,H
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M?E+XO_:^_:+^ .I?M8?%WQ+J>F^)_#_P[UC1[30-%^Q3P26K:IIVE20O)/\
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M/@GPI%<ZO+?7-J5URPM=T[P"Y"(8?,X2W$*R;?GRY,E<+X4_::_:[^)_Q_\
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M%]<S3"S29)8[M&B6<./W"%"K?L+IGP?^$NBG0SHWA;2+3_A&!<+HWDV,,?\
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MX(T'4=9\2:9_8NKWUSIUO-<7^FY!^RW$CH6F@R!^[<LO XX%=*KT5]C^M/\
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MJ&LO%)J%U#"D<UV\*"*-IG4!I"D:A%+$E5  P!BM^N2<DW=*QVTXN*LW?^M
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M".H(-+ZS!W3@K?+_ "]/6P?59JS4WMYZO3S]?2Y^+O\ P3:_;3UOXB>$M?\
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ME )V=&AOS=?P_K_+<P5?$6MR:V\][_UU\]C]2M<^+_P(T[XIV?PPU;Q'H/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
K "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>soph-20251231_g9.jpg
<TEXT>
begin 644 soph-20251231_g9.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_X@'824-#7U!23T9)3$4  0$   '(
M  0P  !M;G1R4D="(%A96B 'X  !  $       !A8W-P
M                     0  ]M8  0    #3+0
M                                              ED97-C    \
M "1R6%E:   !%    !1G6%E:   !*    !1B6%E:   !/    !1W='!T   !
M4    !1R5%)#   !9    "AG5%)#   !9    "AB5%)#   !9    "AC<')T
M   !C    #QM;'5C          $    ,96Y54P    @    < ', 4@!' $)8
M65H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M     "2@   /A   ML]865H@        ]M8  0    #3+7!A<F$       0
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M-#8W.DA)M<@G='6S*3,U4G%Y@;1"1$549F>%_\0 '0$!  (" P$!
M      4&!P@#! D" ?_$ ',1  $# P$"!PD(!A(,#0($!P ! @,$!08'$1(3
M%QA5E=36"!05%B%45I;5(C%7DZ2FT_ E*4%1I>8C,C=$6&%F9W&!@X:CI[2V
MP](),S4V0G5VA(61M<8D-#A%1D=28G-TL\3%<K(F4X*AHK%#DF/1X?_:  P#
M 0 "$0,1 #\ W^
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MYT
M
M
M
M
M
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MQ<
M
M
M
M
M
M                       >HY\GC7K'+@[:<J%RBJJKTT><D$E2M-&>>5&U
M;+9E:VY/",8QC"DD;T:9)1E_S24:-.26$)980,#9DU&Y)<D:B(BK2NV)]]U#
M3.<O[*N557]-3/.&N5V-VU7+M5&U3?VF5M2QJ?M-:B?M%TA6"S@
M                 &D_\L/_ /AV?[7'_P!,9E#3;_GK_1W_ +\Q?J3_ ,R_
MZ1_]@:3YE Q>
M
M
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MCIIGPM2/:LBK*UBQHC$1=]5=L;L7;LV&!#MG4
M
M
M                                            !ZB'R=7^9PT\_P!H
M+_O2YN,#YG_?+<O\S_D%*9XPS^]JV_YY_+ZHNP*N6@
M         TG_ )8?_P##L_VN/_IC,H:;?\]?Z._]^8OU)_YE_P!(_P#L#2?,
MH&+P
M
M
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MKGL]?+0U"H]S$:^.5J*C)HGIM9(U%\J;?*US=J[KVN;M79M6&))D8
M
M
M                                                        >HA\
MG5_F<-//]H+_ +TN;C ^9_WRW+_,_P"04IGC#/[VK;_GG\OJB[ JY:
M                     #2?^6'_ /P[/]KC_P"F,RAIM_SU_H[_ -^8OU)_
MYE_TC_[ TGS*!B\
M
M
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M4;MGE6W,15^^B5-3L_U;5_UFJN7\H
M
M
M                                !ZB'R=7^9PT\_P!H+_O2YN,#YG_?
M+<O\S_D%*9XPS^]JV_YY_+ZHNP*N6@                           TG_
M )8?_P##L_VN/_IC,H:;?\]?Z._]^8OU)_YE_P!(_P#L#2?,H&+P
M
M
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MJ])I9-K4BEF16['HFU7(NU%\FS8JTG%H*N
M
M
M                                     >HA\G5_F<-//]H+_O2YN,#Y
MG_?+<O\ ,_Y!2F>,,_O:MO\ GG\OJB[ JY:
M  #2@^6'PCY.';'R1\D([;PC'_DA&/JR>2'E_P!<?)'R?Z_)'_490TV_YZ_T
M=_[\Q?J3_P S?Z1_]B:3QE Q>
M
M
M
M
M
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M1?*BHOD5%]X_(_3\
M
M
M
M
M
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MCH6NWN]H6L<[[CI%VOE<B?<1TCGN1/?1%1%VDL"/)
M          %<>QW"-X<&V=VK+]SOJACZY[X=*L5+U=]NK[QQ?<MPJX_YUURO
M>*;FLEQN5?-+\VG,O?E#BLFI24J,:\:5*G))-4617JW1I%27":.)OD;&](YX
MV)]YC*ADK6)^DU$3;Y=FTA:W';+<)%EJ[?#)*[\M(Q9()'K]][Z=\3GK_P!Y
MRJNSR;=A&OHZO!PY/?B"VE\;CO>.>2\Y?(Z#JIT?$S&N;?EE?UH='5X.')[\
M06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,
M:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE
M\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-O
MRROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</
M'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_
M6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+
MSE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.C
MJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD
M=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X
M<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.J
MCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^
M(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F
M-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2
M^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFW
MY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'
MCGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_
MK0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\E
MYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1
MU>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R
M.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<
M.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'5
M1XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_
M$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S
M&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI
M?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;
M\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#
MQSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?
MUH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2
M\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#H
MZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y
M'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.
M')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#J
MH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?
MB"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9
MC7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06T
MOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM
M^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;A
MXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORRO
MZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)
M><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT
M=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\
MCH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'
M#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U
M4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GO
MQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,
MQKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:
M7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V
M_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P
M\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97
M]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGD
MO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z
M.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^
M1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#
MAR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@Z
MJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3W
MX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF
M8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M
M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;
M?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X
M>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK
M^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR
M7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH=
M'5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?
M(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!
MPY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=
M5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[
M\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3
M,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"V
ME\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-
MORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC<
M/'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65
M_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY
M+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.
MCJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><O
MD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@
MX<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.
MJCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]
M^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)
MF-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;
M2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKF
MWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN
M'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*
M_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\
MEYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'
M1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7
MR.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP
M<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'
M51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>
M_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$
MS&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@M
MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US
M;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW
M#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE
M?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>
M2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#
MHZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+
MY'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X
M.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#
MJH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/
M?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B
M9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06
MTOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:Y
MM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;
MAXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORR
MOZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/
M)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6A
MT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE
M\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\
M'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UHAYMCP*>%9C/\ 0']"=6OH3Z;_
M $J^D_\ [-VQKEZ3]&_HYZ%_^5\O+_,^9]/5_P#F_FO.>=_X7SGFZ7S)*WY9
M?Y^&X6OW]S@]W_@M$W9O;^W\K3)MV[$]_;[WD(VX8G8(.!X*@W-_A-[_ (56
MNV[NYL_+5*[-FU?>V>_Y28?1U>#AR>_$%M+XW$;XYY+SE\CH.JDEXF8US;\L
MK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QS
MR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH
M='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y
M?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO
M!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0
M=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')
M[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\
M3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"
MVE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7
M-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC
M</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^6
M5_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXY
MY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT
M.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><
MOD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7
M@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH
M.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D
M]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>
M)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!
M;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QK
MFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7Q
MN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+
M*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<
M\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:
M'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.
M7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.K
MP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T
M'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR
M>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/
M$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@
MMI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8U
MS;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+X
MW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?E
ME?UH='5X.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.
M>2\Y?(Z#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M
M#HZO!PY/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G
M+Y'0=5'B9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5
MX.')[\06TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z
M#JH\3,:YM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY
M/?B"VE\;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'
MB9C7-ORROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\0
M6TOC</'/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:
MYM^65_6AT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\
M;AXYY+SE\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-OR
MROZT.CJ\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'
M/)><OD=!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6
MAT=7@X<GOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+S
ME\CH.JCQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ
M\'#D]^(+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH='5X.')[\06TOC</'/)><OD=
M!U4>)F-<V_+*_K0Z.KP<.3WX@MI?&X>.>2\Y?(Z#JH\3,:YM^65_6AT=7@X<
MGOQ!;2^-P\<\EYR^1T'51XF8US;\LK^M#HZO!PY/?B"VE\;AXYY+SE\CH.JC
MQ,QKFWY97]:'1U>#AR>_$%M+XW#QSR7G+Y'0=5'B9C7-ORROZT.CJ\'#D]^(
M+:7QN'CGDO.7R.@ZJ/$S&N;?EE?UH_V'R=;@X0C"/J>0_5'R_KV!VEC#]7^N
M$<W1A&'_ #1A&$?^4>.>2\Y?(Z#JH\3,:YM^65_6B?\ K#HOJ)IBVN#;K%@'
M'^(YG>C33/+VQMRAQO!\249Y:E!$^7U<2MYO1Z0)ZLL*R="Z/RM(GKS3UZ-&
M2K4J3S0]==;C<W(ZNK)JG=\K6O=LC:J^^K(F(V)JK[RJUB*J>15V(3%#:K=;
M6N;0T<--O>1SF-VR.3[B.E>KI'(GW$<]41?*B$L"/)
M
M
M
M
M                            K[WL_99_7?\ P@3%I_/'[E_2$/=OSO\
MNO\ 1E@A#DP
M
M
M
M
M
M
M  5][V?LL_KO_A F+3^>/W+^D(>[?G?]U_HRP0AR8
M
M
M
M
M
M
M                                *^][/V6?UW_P@3%I_/'[E_2$/=OS
MO^Z_T98(0Y,
M
M
M
M
M
M
M  %?>]G[+/Z[_P"$"8M/YX_<OZ0A[M^=_P!U_HRP0AR8
M
M
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M.K:C8J][SLX*9S43:JL3:YDFQ-JJD;W*U$57(B>4M/( G@
M              :Q7RHW<Z^M==/\<X#QP\K;:?=MKFNZWKL?6U152N$<28\:
MV)5?5MHU*>:G730NQTO.SF=WJ25?F++7GN%C44:J9YJQIWK [9%6W*:KG:CV
M6Z.-\;7)M;WS,YR0O5%\B\&V*5[4V>1Z,<FQ6E&SRYS4-MAI8'K&^XR21R/:
MNQW>\36K,Q%3RIPBR1L<J+^45[5_+'G:&9C#
M
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M\$H\+450
M
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MO(:[RRR32233/=)+*]TDDCU5SGO>JN<YRKY5555553KY]GP
M
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M /AV?[7'_P!,9E#3;_GK_1W_ +\Q?J3_ ,R_Z1_]@:3YE Q>
M
M                                                 #VP#5\V@
M !Y"_$L_G&M_OZ;&U7]^M^&QEC_N+9_\5V_^20FN=\_NU>/\:7#^5S$)R4(L
M
M
MVB/DEG\XUFG^A/D;^_76\H>H?]Q:7_&D'\DK2^:>?W:JO\5S_P KHCT.##9F
M0K[WL_99_7?_  @3%I_/'[E_2$/=OSO^Z_T98(0Y,%)_RBK^9PW#_P!GW_O2
MX1+1AG]\MM_SS^0515\S_O:N7^9_R^E/+O,\&!P
M
M                                        >HA\G5_F<-//]H+_ +TN
M;C ^9_WRW+_,_P"04IGC#/[VK;_GG\OJB[ JY:
M     #2?^6'_ /P[/]KC_P"F,RAIM_SU_H[_ -^8OU)_YE_TC_[ TGS*!B\
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M\C4:KT>YFUJHJU5E@(
M                          'M@&KYM     #R%^)9_.-;_?TV-JO[];\-
MC+'_ '%L_P#BNW_R2$USOG]VKQ_C2X?RN8A.2A%@
M                    V6N"+P4, \3W!F7\I9=RKF&P7C'>6*-@-;?CBM9=
M-L6ME6T&*XHK%\+FM1_51705.M:A"*=103^CTZ4(T?.?/J34?*<HJ[%5TU/3
MT]-,V:GX9SI^%WD=PKV;$X.1B;-C47RHJ[5]\O&+8O27VDJ:BHJ*F%T-1P+6
MP\%NJW@V/VKPD;UV[7*GD5$V)[Q:_D+Y(E@1R:5<V(-PLLV\\R)54J*;(5D6
M9?336<Z,*LE.BKFMBOCY4E2Q4R0H*IZ7IBA+"%6>6C7J20H35^'46K:Y.^;;
M3O;M3;P,LL3D:NSRIPB3(J[/*FW8B^3RI[Y8)M.J1S5[VN50Q^Q=G#112M5R
M>\B\&L*HFWR+LVJGWE7R&HOO=H5L!P[LWJ,&[ M#32=U+11N:T+NM9:H=;*O
MZTU2Q8@3W#;#FK1-JV:C*N0+$+@V.K<VO+4LH34ES?2I5D==5D6TW>CO-*E7
M1N=NHY8Y(Y$1LL,B(CE9(U%<FW8Y%1S7.8Y%\CE5%1,=7:T5EFJUI*QK=Y6I
M)')&JNBFC55:CXW*C5V;6JUS7-:YJIY4V*BK"XDR,       !NY_)Q>'+I#M
MMHID')>Q^N=B9:OMJV?OVS&^Y;FB^?2"6UVS&F''A S4_HUX0)_1$KF_O*RG
M\ZC-5\ZX5_G5)I?F2R8MS6]76W7:&"BK9J>%U!#*L<>[NK(Z>I:KEVM5=JM8
MU/?]YJ&4L*LMJN-IFGK:*&HF;7S1)))O;R1M@IG(U-CD38CGN7WO?<IIQYY8
MVFV,Y9GMI@0T6QBM[+&16-E;4_S_ $=O:6F[WA W(:'G)IZGF4B-/13TO.3S
MS_,IR_.FFF\L8Y)HWNDI*61ZJY\E- ][E]]SG1-<Y5V>3:JJJ^0QI5-:RJJ6
M,1&M9/,UK4]Y&MD<B(GZ2(B(8H.R<                 -@'A*<"1WXI6#L
MB9OALK1P4U6-E97BI(UU,.5,E3/[@W6C:MW.3A!PERA8,K=*E3W>U)O0_0E\
M:D9HUXJJ<(PI0J&198VP5<-+WBM6Z6G2H5W?/ ;C7221M39P$V]M6)R[=J;/
M>V+[Y<,=Q-U_I)JKOY*1L50M.C>]N'WW-BBE<N]WQ#N[$E:FS=7[^WR["A)[
M;8LST[L\:WI$6IT<&V*B%/S4*\4*NJE\]YKY]3S7G?-?/\WYRI\SYWS?GS>3
MYT;:QV^QKMFS>:UVSW]F\B+LV^3;LV_>*B]NX]S=NW=<YNWWMNZJIMV>79MV
M??.+/H^0                                        ;1'R2S^<:S3_
M $)\C?WZZWE#U#_N+2_XT@_DE:7S3S^[55_BN?\ E=$>AP8;,R%?>]G[+/Z[
M_P"$"8M/YX_<OZ0A[M^=_P!U_HRP0AR8*3_E%7\SAN'_ +/O_>EPB6C#/[Y;
M;_GG\@JBKYG_ 'M7+_,_Y?2GEWF># X
M              -]BR_DGVEURV-9]T+MD-FT2RY;7MQYKTJ:O%$$E!<^-:)9
M%/0A6QW&K-2@I5^93TYZTU:I#YDGG)JDWSHXDEU"N;)9(TH:%49(]J>2HVJC
M'*FU=DVS;L3:J[-AEN+3VV/BCD6NKD5\;'+Y:?8BO:B[$VP[=FU=B)MVD*]P
MODG63,>V&[WSI]GN.;7QCH+7!1B+(UKHK+NE[;DM":O!/9UWM+LX6^\7)5FE
M\TF9'QGM1"L\L8TGZ13YE"HE+;J%!-,V*Y4G>K'JC4J8)%EC8JKLVRQN:CVL
M3[KV.D5/^QLVJD9<M/9X8G2VVK[Z>Q%<M-/&D4CVHFW9%*URL=(OO(U[8VK_
M -M%V(NH(M1+&Y8K;W!(I0+T"FNB7(5M"JE6(EB6K/04I%::O)3K)U*>M)/1
MKT*TDE6C5DGIU))9Y8PAD9%14145%14145%VHJ+Y45%3R*BIY45/?,<*BHJH
MJ*BHJHJ*FQ45/(J*B^5%1?(J+[Q\Q^GX    #?*SSPR-"[8X#M#9IAUEQ\V9
MYFT(PGD^;)B>+_\ I!&_KBQWC]V>[GCYQZG0?2+BXNC@K4?\2]'\ZJJ?,H22
M_-EEQ)27V[ORSO%]=,ZD\+U,' +N;G LGE:V/9N[=UK6HB>7;Y$\IEFML=IC
MQ)*YE#"VK\$TD_#IO[_"OB@<^3RNV;SE<Y5\FSRKY#0U,MF)@
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MG#3S_:"_[TN;C ^9_P!\MR_S/^04IGC#/[VK;_GG\OJB[ JY:
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M;Z22F=325/#ND@IX=_?X)K=W@)9%<B*QZKO[NS:FQ%VKLU\2XE/
M                               !M$?)+/YQK-/]"?(W]^NMY0]0_P"X
MM+_C2#^25I?-//[M57^*Y_Y71'H<&&S,A7WO9^RS^N_^$"8M/YX_<OZ0A[M^
M=_W7^C+!"')@I/\ E%7\SAN'_L^_]Z7"):,,_OEMO^>?R"J*OF?][5R_S/\
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MX:>?[07_ 'I<W&!\S_OEN7^9_P @I3/&&?WM6W_//Y?5%V!5RT
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M6IY?R62:*H<F[MV.5((H5;M\J*]R)LV^7:\VJR3MU<.MMLY=X9:;7+,=ZO\
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MQU0LSD5/(K53W_?6FLLI60
M        >V :OFT     /(7XEG\XUO\ ?TV-JO[];\-C+'_<6S_XKM_\DA-<
M[Y_=J\?XTN'\KF(3DH18
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M\S_O:N7^9_R^E/+O,\&!P
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MI*B[3"CFN8YS'(J.:Y6N1??1S5V*B_IHJ;#X3]/P
M                      ]1#Y.K_,X:>?[07_>ES<8'S/\ OEN7^9_R"E,\
M89_>U;?\\_E]478%7+0                           :3_P L/_\ AV?[
M7'_TQF4--O\ GK_1W_OS%^I/_,O^D?\ V!I/F4#%X
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M+I>(XXJ^=DD<3^$8QD,,2(_=5BO5S&(]55JKM17;OEVHU/)LKJ)HA0
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M-//]H+_O2YN,#YG_ 'RW+_,_Y!2F>,,_O:MO^>?R^J+L"KEH
M               -+KY81;KNIMO0*[**.K.PLKWLQ;KDOA+-&@F=[H08)<F1
M'4G\GS9:JY':#_6HRQC":>1OKQEA&$DWDR;IN]J27>)5]V]E"]J??;&ZK:]?
MVEE8G[9C+4B-RQVB5$]PQ]=&Y?O.D;2N:G[:1/\ ]1I"&4S%@
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M3[B?<#Y))7;TCWR.][>>YSW;/O;7*JG7S[/@
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MRSOE8O[;'M7]L@82Y$
M                 _9.H4)%%!4EKUDRI-6I*$RE/5GHJ$ZBC/+4HUZ%:G-+
M4I5J5266I2JTYI9Z<\LL\DT)H0C J(J*BHBHJ;%1?*BHOOHJ?=10BJBHJ*J*
MB[45/(J*GO*B_<5#EWFZ+FN*5/)<%Q/K[(EFJ3)9'EW<'.5--6A)"K,GE6J*
M\*,U6%.G"I&G"6,\))(31C"67R?#8V,V[C&,V^_NM1NW9[VW8B;=A]ND>_9O
MO>_9[V\Y7;-OO[-JKLVG!'V?
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M>5Z_M,8Y?VCRU#/9@0
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M8UK&IY$:U$:U$^\B(B(G[2'RYSGN5SW.>Y??<Y5<Y?V5555?VSC#Z/D
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M[A/RKY%1K=S>:Q'[^^V_8MAT]-417*[-2-\*I)2T>\U[DE38K)IW-56MX/\
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M&)J,BB8R.-C?(C&,:C6-3])K41$_8.TG&<@
M
M
M
M
M                  *^][/V6?UW_P ($Q:?SQ^Y?TA#W;\[_NO]&6"$.3
M
M
M
M
M
M
M                                                 !7WO9^RS^N_
M^$"8M/YX_<OZ0A[M^=_W7^C+!"')@
M
M
M
M
M
M
M                    K[WL_99_7?\ P@3%I_/'[E_2$/=OSO\ NO\ 1E@A
M#DP
M
M                                       8ULW,F*\B77?-D6'?MLWA
M=&,_H&6_FJW'.@[S6I7N6=\D9D+NK0QK($[FJFMQYA5:_2IG%!!'\YP2I95*
M2-?C9+'(Y[6/:]6;-_=\J)O;R(F\GN57:U45$55;L\J)M0ME^P3,<7LV/9!D
M>-W:QVC+/"*XW5W6DDH4O,=I2WNKZBB@J$CJ9*2)+K0*RL6%M+4\/LI9IEBF
M2/)1R%3
M
M
M
M             ,<Y)R]C'#J*VW/*=\6[8+5=UUHK(8'>Z7"FTM"VZG%K>'E
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M0M-6TTU)4)!6TT-;1S+#.R.1(JNCJ(*NFD5NY/33PSQ.?%(Q[N2/TZ@
M
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MY ?A5VF[^#ORX>:_P$_]8<E#N%OT2G\<>C_9P>TLXR'(#\*NTW?P=^7#S7^
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M"KM-W\'?EP\U_@)_ZPY*'<+?HE/XX]'^S@]I9QD.0'X5=IN_@[\N'FO\!/\
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M&4:S.I:;@-M+#"LLRR9+.0J8
M
M
M
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MYSG*KG.555553] ?  *^][/V6?UW_P ($Q:?SQ^Y?TA#W;\[_NO]&6"$.3
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MU+84C@=4OF?!#!$YD,>7SD*0
M
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MJY*A88U=O=[T<&UM-04C5\L='10T]+%[T<+4\ADLY"I@
M
M
M
M
M                            %?>]G[+/Z[_X0)BT_GC]R_I"'NWYW_=?
MZ,L$(<F
M
M
M
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M8XU>J&"Z6ZUNH;73W2*K=+<GR1QRHZK@CAX.-8U5Z*[>5%3=12V D#3
M
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M2M@ANT<]ON]G=.]%6.!]ULE9<:"GJ)4:YT5-53PU,B->K8EW';)3G8,.@
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M3743964E3+&R.198&SM9,V-4D1$21J.VHOD,O'*4<
M
M
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M9#V__C<?[#__ +''K!_9"/\ DYW#_*[%OY14FZ&6,\%P
M
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MJ0JN,[<\(UWHOSE;<W+ZTM)N4=6*ZOWOR:-BMV^58D<BM_3W7.?O>7[FUO\
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MK90I)P]PIY:&E6*BCFJXYW\"Z%8\_**/_/=1/_M7._\ ]^P\<=V]^#]B3_\
MFPR;_8OO^+ZV_P#C:=?_ &9P7'\-C_01U>_ZK&C_ />5IWJ'_BD/[#O_ +W&
MC/=7?\HS5W_*ZJ_D],3?.V:]@
M
M
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M^R$(O)SN/D][+L65?TD[YJ$VK^VJ)^RINB%C/!<
M
M                        K[WL_99_7?\ P@3%I_/'[E_2$/=OSO\ NO\
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M
M
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MFV5"(V&:9]/'5R[0).GD0
M
M      5][V?LL_KO_A F+3^>/W+^D(>[?G?]U_HRP0AR8
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M.\:C@
M
M
M
M
M                         %?>]G[+/Z[_ .$"8M/YX_<OZ0A[M^=_W7^C
M+!"')@
M
M
M
M
M
M                                                         K[W
ML_99_7?_  @3%I_/'[E_2$/=OSO^Z_T98(0Y,
M
M
M
M
M
M
M                            %?>]G[+/Z[_X0)BT_GC]R_I"'NWYW_=?
MZ,L$(<F
M
M
M
M
M
M                                                          "O
MO>S]EG]=_P#"!,6G\\?N7](0]V_._P"Z_P!&6"$.3
M
M
M
M
M
M
M                                !7WO9^RS^N_^$"8M/YX_<OZ0A[M^
M=_W7^C+!"')@
M
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M)V@<L][1Q=Z?^@N'>K%DZB.-?5+X2L_]<LB]HCUY-UN<':3M Y9[VCB[T_\
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M1'KR;K<X.TG:!RSWM'%WI_Z"X=ZL63J(XU]4OA*S_P!<LB]HCUY-UN<':3M
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MZB.-?5+X2L_]<LB]HCUY-UN<':3M Y9[VCB[T_\ 07#O5BR=1'&OJE\)6?\
MKED7M$>O)NMS@[2=H'+/>T<7>G_H+AWJQ9.HCC7U2^$K/_7+(O:(]>3=;G!V
MD[0.6>]HXN]/_07#O5BR=1'&OJE\)6?^N61>T1Z\FZW.#M)V@<L][1Q=Z?\
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M4PNWHJBFJ8FS031N_P )DL3VO:OW6N0YXZQV@
M   #6&^4F/;BG8=0+;I*)Y6EV=\XO:Y+":,*=9QM]'BA UJ)Y/\ R9ITR:YG
MBG3FC#RRRJZL(>2$\WEV][D^FB=59Q6*U%G@I\>IHW[/*V*JDO,LS47WT1SZ
M.!53[NXGWD-#^[AKIXZ#3BVM<J4U769172LV^1T]OAL4%.[9[RJV.YU2(OW-
M]=GOJ:K!N6>>X
M
M
M
M                          +C.$Q^W[^RO_>.:I]TY_T(_?+_ / &\G<8
M?]9/[SO]Z2G,VL-&P
M
M                     ;]_!V?'*X>&YK*O=5$ZE2G:,AL=*I4FC--*VVQF
M#(5MLZ>$9HQC"1(T-*%)3E_S2TZ,DLL(2PA"'FCKK314FJV710M1C'U%LJ51
M$V(LM;8[963N\GW7SSR/5?NJY57RJ>PO<UUL]PT1P.>H=O21T=VHFKM5=D%L
MR&[VVE;Y55?<4U)"S9[R;NQ$1-B%F)B4SF
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M:>)JJB.DGGDCBC3:FU[D3;Y3,>Q.KF=]4+N:K&S[8"NP;E?&!/<S0DJN]O7
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MEBRRAGN%L2VU514O9!3Q4$LB5:3T=*D4BMN-.C6QNF:JI*BN1&M5\/"]&-
M
M
M
M                                  "XSA,?M^_LK_WCFJ?=.?\ 0C]\
MO_P!O)W&'_63^\[_ 'I*<S:PT;
M
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M2ONJP5#E"K;ZMWA"1G5.[<Y)*=.=E=U4?0$#PUN#DG].F3IE\B"HO;X*M@L
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MKL<$TUWM-%=%I:RE6G1SIXN$JF)21/C:QSG^$JBVM:C'(JHY$1:1384U6
M
M
M
M                           +C.$Q^W[^RO\ WCFJ?=.?]"/WR_\ P!O)
MW&'_ %D_O._WI*<S:PT;
M
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MB^147RHI_!^GX
M
M
M                                         "XSA,?M^_LK_P!XYJGW
M3G_0C]\O_P  ;R=QA_UD_O._WI*<S:PT;
M
M                                     !OL<%O^;0UK_MC_ +_LJ'FS
MK]^:WEG^@?YLV8]>NY=_,*P;]\W\\,@+2##IGX
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MGJI=QJ-9PD\KI9-QJ>1K=YZ[K4\B)L3[AQ)SG7
M
M
M
M      !<9PF/V_?V5_[QS5/NG/\ H1^^7_X WD[C#_K)_>=_O24YFUAHV
M
M
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MU5UD:^ZWF>&=M6SA8V3U21,=7-2LGGFJZB>H?'2QQQT,%/P$M/QG0UK
M
M
M
M                                !<9PF/V_?V5_[QS5/NG/^A'[Y?\
MX WD[C#_ *R?WG?[TE.9M8:-@
M
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MOLU?!%%<I86MVN>M*^EHJJ5B(J][0SR>_&B+I<&_AY;
M
M
M
M                                                         N,X
M3'[?O[*_]XYJGW3G_0C]\O\ \ ;R=QA_UD_O._WI*<S:PT;
M
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M?>^T(Y%FEO/^?]*X[V5'1VM*>M#:3WUQ-X)#E2:@<SX=T?>^T(Y%FEO/^?\
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M;2>^N)O!(<J34#F?#NC[WVA'(LTMY_S_ *5QWLJ.CM:4]:&TGOKB;P2'*DU
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M]]H1R+-+>?\ /^E<=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_/\
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M'1^&KK.ZXW-D;V[KV4\LC6PT;9&[4E[R@IW2M56RJ]NQJ3[,:F6P
M
M
M
M
M                                    "OO>S]EG]=_\($Q:?SQ^Y?TA
M#W;\[_NO]&6"$.3
M
M
M
M
M
M
M      !7WO9^RS^N_P#A F+3^>/W+^D(>[?G?]U_HRP0AR8
M
M
M
M
M
M
M                                      *^][/V6?UW_P ($Q:?SQ^Y
M?TA#W;\[_NO]&6"$.3
M
M
M
M
M
M
M         !7WO9^RS^N_^$"8M/YX_<OZ0A[M^=_W7^C+!"')@
M
M
M
M
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M=[(XE"OO>S]EG]=_\($Q:?SQ^Y?TA#W;\[_NO]&6"$.3
M
M
M
M
M                             !Y_G%@SG<^<=Z\\U'MP45F;%MZON&K.
M:9ZD\4;(RXW=5EN+Z:.C-&,M.9WN1&]OZVI_Y556YU(>6%&G0ITO3'13'*3'
M=.<<[WB:VHO-!3WZOG1J))43W2%E5"LCD3:J04CZ>GC3WFLB1?RSG*OCUW1F
M75V6:M96VHG?)1XY<:G&;93[7<%2P6>9])5)&Q5V(^HN,=742O1-KW2(W:K(
MXT2N(RN8,
M
M         -F7Y.AG.YX7YG'6Y:X*%EHJ;*IYEM]OKU)YZ#&],MPV[9MRU$$L
M8_-HRW FNFW9EU.$/FS56)-5IPDGG435=1NZGQRD\'X[ED438ZUM>ZPU<K6H
MCJB">FJ:ZC2543:Y:9U'5I&JKMW:AS5VHUJ)OCW%&75RW'*\&GG?+0>#F9-;
MX'JYS:6>"KI;;<EAVJJ,95)74#I&)L3A(-]J;SY%7:[-,#T'*^][/V6?UW_P
M@3%I_/'[E_2$/=OSO^Z_T98(0Y,
M
M
M
M
M            'G![R?Z:VX/]*38'^]F[3U7T[_,_P7_([&/]B4)XC:L?FI:E
M?Y?YE_.*Y$6RXE
M
M               +[/D[7^FME#^BW>O][.$C6SNI/S/[/_EC;_\ 8F0FWO<6
M?FI7_P#R NO\XL5-S0T*/3LK[WL_99_7?_"!,6G\\?N7](0]V_._[K_1E@A#
MDP
M
M
M
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M44]+/-!3[4VIP\L;'1Q;4\J<(YOD\OO'7SM'3
M                                              +[/D[7^FME#^BW
M>O\ >SA(UL[J3\S^S_Y8V_\ V)D)M[W%GYJ5_P#\@+K_ #BQ4W-#0H].ROO>
MS]EG]=_\($Q:?SQ^Y?TA#W;\[_NO]&6"$.3
M
M
M
M
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MI*F2Y5U;5OJZ._UT,R543:=[ZN6K2":2.IJ)W[U;432+,R&#L&]7\R%P]/\
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MI7T4KGT=;>H+.YL<U+55RQ4=?!<*:MGM[JI5AKZ9'HQC&M:L2]ZOYD+AZ?\
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M::@H8;Y=+;34KH[57W"..CM-LI)Z>6:94I59#)7U$<DLK:J6D6*5CJ>>5B9
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M,:UD3)&QL1&M0K7,LF#0
M                           7V?)VO]-;*']%N]?[V<)&MG=2?F?V?_+&
MW_[$R$V][BS\U*__ .0%U_G%BIN:&A1Z=E?>]G[+/Z[_ .$"8M/YX_<OZ0A[
MM^=_W7^C+!"')@
M
M
M
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MK[_BO'_]DTQ4(9R-;0
M                         7V?)VO]-;*']%N]?[V<)&MG=2?F?V?_ "QM
M_P#L3(3;WN+/S4K_ /Y 77^<6*FYH:%'IV5][V?LL_KO_A F+3^>/W+^D(>[
M?G?]U_HRP0AR8
M
M
M
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MC0
M         7V?)VO]-;*']%N]?[V<)&MG=2?F?V?_ "QM_P#L3(3;WN+/S4K_
M /Y 77^<6*FYH:%'IV5][V?LL_KO_A F+3^>/W+^D(>[?G?]U_HRP0AR8
M
M
M
M
M                                          /.OXBUG/5C;V;9L[ZE
MJI%;AGC(]XI9*U.:G&JRY!N1=?5OJI(30A\^DJ9+B;Z]*I+Y9:DE2$TL8PB>
MI.E=?!<M.,*GIWM>R+'+70/5JHN[/:Z6.W5+%V*NQS)Z61KD7RHJ>\>+6M]I
MJ;-JYJ'2U3'L?497>+M%OM5N_37NKDO%*]NW\LQ8*Z-$<FU';%]Y=J)"\OYB
MP
M
M V&/DY]FO2S9W-^0:*6K-;UN8'K6:X+84YO,4WJ]<@V4]LR6-7R?,A5KH;!?
M:LM/R_.C(GGF\GDE\IJ]W5%P@CQ'';6Y[>^JO(TN$<>U-]8+?;*^GF?N^_NI
M)<Z=JKLV;7(ANCW$]IJ9<XRV^M8_O.AQ3P3))NKP??-UN]MK(&;_ +V^D5FJ
M';OE78NU=B;-NX0:,'I.5][V?LL_KO\ X0)BT_GC]R_I"'NWYW_=?Z,L$(<F
M
M
M
M
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MDWL8<EW73T&^<V']H![%OB7\M?WQX!\5!Q_:2>EGX!R;V,.2[KIZ#?.;#^T
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MO]&6"$.3
M
M
M
M
M
M                                                           !
M7WO9^RS^N_\ A F+3^>/W+^D(>[?G?\ =?Z,L$(<F
M
M
M
M
M
M
M                                "OO>S]EG]=_\($Q:?SQ^Y?TA#W;\
M[_NO]&6"$.3
M
M
M
M
M
M
M  !7WO9^RS^N_P#A F+3^>/W+^D(>[?G?]U_HRP0AR8
M
M
M
M
M
M
M                                  *^][/V6?UW_P ($Q:?SQ^Y?TA#
MW;\[_NO]&6"$.3
M
M
M
M                                                           !
MP-SW3;-DL#I==Y7"R6I;#&EG7/-Q7(ZH61D:4=/R0G5.+JY5TR%&GEC-++&J
MHKTY/G32R^7YTT(1[-)1U=?4PT=#2U%95U#TC@I:6&2HJ)I%]YD4,37R2.78
MJ[K6JNQ%7[AU:VNHK;2SUUPJZ:AHJ6-TU365D\5-34\3?RTDT\SF11,;]USW
M-:GWRNQ\XQ/#<MYR4-2_9IH4*4T\U.I58\>9@N=NFFEC&6,4[Q;>/79H5R1C
M#_)J)%U:G-#R32SQEC",<HTVA6JU7$V:+$:AC'HBHE3<['12HB^7W4%9<X)V
M+]]'QM5%\BHBF%JWNE-$;?.ZGGSRCDD;MVNHK3D-S@78JI[FJMMHJZ9_E3R;
MDSMJ;%3R*BG$>VDX:',I]SF?O"L['$#JWZ)_A[&?;)U.5%H7Z<_-G,.SX]M)
MPT.93[G,_>%8X@=6_1/\/8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?H
MG^'L9]LCE1:%^G/S9S#L^/;2<-#F4^YS/WA6.('5OT3_  ]C/MD<J+0OTY^;
M.8=GQ[:3AH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.93[G,_>
M%8X@=6_1/\/8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LCE1
M:%^G/S9S#L^/;2<-#F4^YS/WA6.('5OT3_#V,^V1RHM"_3GYLYAV?'MI.&AS
M*?<YG[PK'$#JWZ)_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P]
MC/MD<J+0OTY^;.8=GQ[:3AH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX
M]M)PT.93[G,_>%8X@=6_1/\ #V,^V1RHM"_3GYLYAV?'MI.&AS*?<YG[PK'$
M#JWZ)_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P]C/MD<J+0OT
MY^;.8=GQ[:3AH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.93[G
M,_>%8X@=6_1/\/8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]L
MCE1:%^G/S9S#L^/;2<-#F4^YS/WA6.('5OT3_#V,^V1RHM"_3GYLYAV?'MI.
M&AS*?<YG[PK'$#JWZ)_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$
M_P /8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LCE1:%^G/S9
MS#L^/;2<-#F4^YS/WA6.('5OT3_#V,^V1RHM"_3GYLYAV?'MI.&AS*?<YG[P
MK'$#JWZ)_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P]C/MD<J+
M0OTY^;.8=GQ[:3AH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.9
M3[G,_>%8X@=6_1/\/8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L
M9]LCE1:%^G/S9S#L^/;2<-#F4^YS/WA6.('5OT3_  ]C/MD<J+0OTY^;.8=G
MQ[:3AH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.93[G,_>%8X@
M=6_1/\/8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LCE1:%^G
M/S9S#L^/;2<-#F4^YS/WA6.('5OT3_#V,^V1RHM"_3GYLYAV?'MI.&AS*?<Y
MG[PK'$#JWZ)_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P]C/MD
M<J+0OTY^;.8=GQ[:3AH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)P
MT.93[G,_>%8X@=6_1/\ #V,^V1RHM"_3GYLYAV?'MI.&AS*?<YG[PK'$#JWZ
M)_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P]C/MD<J+0OTY^;.
M8=GQ[:3AH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.93[G,_>%
M8X@=6_1/\/8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LCE1:
M%^G/S9S#L^/;2<-#F4^YS/WA6.('5OT3_#V,^V1RHM"_3GYLYAV?'MI.&AS*
M?<YG[PK'$#JWZ)_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P /
M8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LCE1:%^G/S9S#L^
M/;2<-#F4^YS/WA6.('5OT3_#V,^V1RHM"_3GYLYAV?'MI.&AS*?<YG[PK'$#
MJWZ)_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P]C/MD<J+0OTY
M^;.8=GQ[:3AH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.93[G,
M_>%8X@=6_1/\/8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LC
ME1:%^G/S9S#L^/;2<-#F4^YS/WA6.('5OT3_  ]C/MD<J+0OTY^;.8=GQ[:3
MAH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.93[G,_>%8X@=6_1
M/\/8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LCE1:%^G/S9S
M#L^/;2<-#F4^YS/WA6.('5OT3_#V,^V1RHM"_3GYLYAV?'MI.&AS*?<YG[PK
M'$#JWZ)_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P]C/MD<J+0
MOTY^;.8=GQ[:3AH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.93
M[G,_>%8X@=6_1/\ #V,^V1RHM"_3GYLYAV?'MI.&AS*?<YG[PK'$#JWZ)_A[
M&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P]C/MD<J+0OTY^;.8=GQ
M[:3AH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.93[G,_>%8X@=
M6_1/\/8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LCE1:%^G/
MS9S#L^/;2<-#F4^YS/WA6.('5OT3_#V,^V1RHM"_3GYLYAV?'MI.&AS*?<YG
M[PK'$#JWZ)_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P /8S[9
M'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LCE1:%^G/S9S#L^/;2<
M-#F4^YS/WA6.('5OT3_#V,^V1RHM"_3GYLYAV?'MI.&AS*?<YG[PK'$#JWZ)
M_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P]C/MD<J+0OTY^;.8
M=GQ[:3AH<RGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.93[G,_>%8
MX@=6_1/\/8S[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LCE1:%
M^G/S9S#L^/;2<-#F4^YS/WA6.('5OT3_  ]C/MD<J+0OTY^;.8=GQ[:3AH<R
MGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.93[G,_>%8X@=6_1/\/8
MS[9'*BT+].?FSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LCE1:%^G/S9S#L^/
M;2<-#F4^YS/WA6.('5OT3_#V,^V1RHM"_3GYLYAV?'MI.&AS*?<YG[PK'$#J
MWZ)_A[&?;(Y46A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P]C/MD<J+0OTY^
M;.8=GS#^5]TM9]OOH#U=LE?RA_R>?2GZ8?\ B=?]I?0_Z6_1WZ/_ /IS:ML_
M2'TA^C+W_P#DOTWT3T+_ ([Z-Z2D](AKO@&6X-WOXTVGP7X4X7O'_A]LK>'[
MRX+OK^YU;5\%P7?=/_;N#W^$_(]_<?NV?'-4<%U)[\\2KYX:\"][^$_L9>+=
MWMX1X?O/^ZUOH.&X;O"K_P"+\+P?!?DNYOQ[^8/;2<-#F4^YS/WA63/$#JWZ
M)_A[&?;)6.5%H7Z<_-G,.SX]M)PT.93[G,_>%8X@=6_1/\/8S[9'*BT+].?F
MSF'9\>VDX:',I]SF?O"L<0.K?HG^'L9]LCE1:%^G/S9S#L^/;2<-#F4^YS/W
MA6.('5OT3_#V,^V1RHM"_3GYLYAV?'MI.&AS*?<YG[PK'$#JWZ)_A[&?;(Y4
M6A?IS\V<P[/CVTG#0YE/N<S]X5CB!U;]$_P]C/MD<J+0OTY^;.8=GQ[:3AH<
MRGW.9^\*QQ ZM^B?X>QGVR.5%H7Z<_-G,.SX]M)PT.93[G,_>%8X@=6_1/\
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MCVTG#0YE/N<S]X5CB!U;]$_P]C/MD<J+0OTY^;.8=GQ[:3AH<RGW.9^\*QQ
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MEGQ/([7?&P(BU$='4)WU3H[9NNJ**5(ZRG:Y5V-=- QKEVHU55%1)!E9+<
M
M
M                                     :1W&QW0O3..S-W8#:'M<@PW
M@5[J6K2MQ(IJ44-R9#;*<M&[;H?D]*>%-<L:76=9;+%351K4FM$VJ5:*1*J>
MW2%7T%[GW ;?CV)463ST\<M^R2#OSOI[$=)1VN5R]YTE,YR;8VSPHRKJ7,V+
M,^5D;U<R"+9Y:=U5JC=<GSBX85254L&,XG.VC?1Q2*V*XWJ-C7UM;6-:[9*M
M),]:*DCDWFP<!+,Q&R5#]E*!L&:I
M
M                               %QG"8_;]_97_O'-4^Z<_Z$?OE_P#@
M#>3N,/\ K)_>=_O24YFUAHV
M
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M1SPM<OE<UB.5$551)!E9+<
M
M                                                           #
MSA-Y(QCNON#&,8QCZT>P$/+&/E_5#+%VPA#]?_)"$(0A#_DA"$(?J@>J^G:(
MFG^#;$V?_@[&5_;6RT2JO[:^5?TSQ'U855U3U*5555\?LQ3:J[?(F0W%$3R_
M<1$1$3[B(B)Y$(M%Q,?@
M
M                      %QG"8_;]_97_O'-4^Z<_Z$?OE_^ -Y.XP_ZR?W
MG?[TE.9M8:-@
M
M                WV>"W&,>&AK7&,8QCY,Q0_7'R_JAGW*<(0__ $0A"$(0
M_P"2$(0A^H\V=?41-6LLV)L_N$O[:XU9E5?VU\J_IGKUW+RJNA>#;55?)DJ>
M7R^1,PR!$3]A$1$3[R)L+1S#IGX
M
M
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M<Z31PU-'6<''(]L-3 QD[8Y74DU2V&9T<!C)9B
M
M            N,X3'[?O[*_]XYJGW3G_ $(_?+_\ ;R=QA_UD_O._P!Z2G,V
ML-&P
M
M        ;['!;_FT-:_[8_[_ +*AYLZ_?FMY9_H'^;-F/7KN7?S"L&_?-_/#
M("T@PZ9^
M
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MK.^4>SO2*WTC5@J:ES9**38TU+
M                                                        +C.$
MQ^W[^RO_ 'CFJ?=.?]"/WR__  !O)W&'_63^\[_>DIS-K#1L
M
M                                                    &^QP6_YM
M#6O^V/\ O^RH>;.OWYK>6?Z!_FS9CUZ[EW\PK!OWS?SPR M(,.F?@
M
M
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M9%5+7M98[SLFE9'44EK; ^6%[YDUGS;8T6
M
M    +C.$Q^W[^RO_ 'CFJ?=.?]"/WR__  !O)W&'_63^\[_>DIS-K#1L
M
M
M&^QP6_YM#6O^V/\ O^RH>;.OWYK>6?Z!_FS9CUZ[EW\PK!OWS?SPR M(,.F?
M@
M
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MHFJD$U.[@W2)O;RM<SJ8-JUD>G^/YCC=FHK)4T.;T*V^ZRW.FKYJNGA=15]
MKK?)2W*BABEX&XSN1U3!5LX5D3MS=:]CX6E_,7F3,,Y5N'!N6,=YBM)&S.-S
M8SN]BO5A0W$G7*V)6ZV^OHN").[I6UQ:'"NWU:U"25521NB!3/2C-+25T9XP
MGA$7^RTN166Z6&MDJ(J.[T-1;ZF2E?&RI9#4QNBD= ^:*>)LJ-<JL=)#*Q%V
M;S')Y"=QC(*W%,BLN36Z*EFK[%<J2ZT<-:R62DDJ**9L\3*F.":FF?"Y[$21
ML51"]6[4;(Q=BIWK:;9:^MN<V71GC)#3:3)=]VI+=1N3;9"!X;;;H4K9MYLM
MI!,B1OS]<KG3J5D+4GJJXUWA3+45SUJE&5/1FDH4X[#<2MN#X_1XW:9ZVHH:
M)]5)%+<9():MSJNJFJY$DDIJ:DA5&R3.:S=@8J,1J.5SD5RRVH&<W;4?*KAE
MU\I[=2W*XQT44\%JAJ8*%C:"B@H85BBK*NNJ&JZ&G8Z17U,B+(KE:C&JC&Y,
MU4WKR[J!9V=[(QI;^.GQGV%MMKM>]*M\L]R.:]L0M+7>30F46Q68+MMFBB6S
M);X=YJT[JG>DT]:@WSR):<E%1351&9Z<6/.:_'+C=JJZT\^,54U70);IZ2&.
M:2::@G>RL;4T56Z2-'V^!&I"^G>C72HKU5S59/:>ZM9)IM;,NM-BH[+5TV9T
M,%!='7:FKIYH(J>GN=-&^@?1W&@;%*L=UJ5<M0RJ8KF0JD:(UZ2?C@C>;+NO
M6 \^ZZ64Q8]<;(V+:')FO9SN9GN%==#4E=;:6VJLJ6JN;+J9FI$HG;%]6:2=
MX97VG3524JLM*$D*E*I]9)IU8\HR7&LIN%3=(KCBL\51;XJ.>ECHYWPU<=;&
ME;'-15$TC4FC1%2"HIE5BN:KMNQR?.(ZL9)AF'YAA5KI+-/:LUIIZ6ZSU]-6
MRW"GCJ*&6WRK;Y:>X4M/$]8)7*BU-+5M21&N1NS:UW(YPWWS%GC6[">J]PV[
MC:U\5X*I6_\ HU2L=EN5L>K@6VW;"FU6]VO%6\7>_MSBYSI'!V<%E=J:62DI
M>'AQ6S4(2U*-"AQ8[IK8<;RO(,RI:J[5EYR-:KOMUQJ*2:GI8ZNL96RP4#(*
M&FEBA1\4$4;9IJAS(((HT=M1SG<V5ZOY-EV#XKI]6T5CH,?Q)M%WBVU4M=!5
M5LM!0/MT%3<Y*FY5D$]0L<U3-*^GIZ1KZFJGE5B(YC&0ZMU_=K4N!BNA@656
MY]MMX;']E<*$?)60.S.MH.+:LHQ_Y*J58FHUZ<?^2>G O=52P5M+4T=3&DM-
M5T\U+41._*R05$;HI8W?I/C>YJ_I*8SHJRIMU927"CE=!5T-53UE+,W\M#4T
MLK)X)6_]Z.5C7I^FB$M=T]XLH;UWK:-_Y9M#%]LW)9UKU+/1J<:LESL\CFR1
M=ECRFHO/Z37C>%=3.WKG%RG0>BUT5*C*X*X3T:L]2$\M)P#3NSZ<V^NMEDKK
MQ5TE?6-KI&7:HHYUAJ$A93O=!WG04+6)+'%$DF^V1SEB9L<U$V+D;5'5>_ZM
M76VWG(K;8*"NMEO=;(I+'2U],D]*M1+51LJN_P"YW)[UAEGG6'@WQ-:DTFUK
ME=M2*]G7E=F/;H8[VL6XWFT;OMIPHNC!<EO."EJ>6APH>6%-4A7HZE)10J?-
MFGI5(2S_ #*U&I5H5I9Z-6I)-<J^@HKI1U-ON5)3UU#5Q.AJJ2JB9-!/$[WV
M21O16N3:B*FU-K7(CFJCD14Q];+G<;+<*2ZVFNJK;<J&9M11UU%-)3U5-,S;
MNR0S1.:]CMBJU=B['-5S'(K7*BW=V1\H,V_8&) U7GC[!F2'-K3T)$EU.]N7
M,R/JE9233)IW)TI,%U(V&HL4?.C/6BRLK#2_X513ITZ=*K)+2UZN'<Q8-4U,
MLU!=,CM,,SG*^B@JZ2HIV1N>CDAA=54<E2D;=B(G?%14N\C55RJU57:JU=V3
MJ51TD-/<[/B=\GIV,2.X5-#7TE7)*V-8W3U#:.XQ4;I7[55W>M+1M3>D:UJ-
M<B-@[D[B6;0YAV,QCLCD!\8'M\PY=C/=^.,<_1[LBQ+;2YF7)G"5,FM=$_)W
M2M3<E"6E!Y=%5Q5KF<4\E%)5?X)43?129$M&DN'V+%;OBELIZJGI[]13T-UN
MO"P27NKCGC=$KWUDE,Z%JQ->[@(64K:2)RN>E,KY)7/Q1?M<\^R7-K#G%YJZ
M.KJ\9N-+<K)9$AJ8L<H9J66.=&1V^*L;4.;421M[ZJ)*Y]?.Q&1.K.#B@;%-
MQS^4*[MKDJBBDL'6=D65Z<*<KLUV'D.JXT(2QC&6-*#SEMV;Y_FQFC&654@4
M4X1C&,)/UQ,>Q=R_I[&]KGW/+:AC55>!FN5K2)VW9MV\!9()4V[$VJR1J_IF
M59^[-U4EC>V.SX+2R/1&I44]HO3IF;-NS=2IR.HA79M5422%Z)][RJ5=;+;>
M;";<W4FNO.^0W*[J[92FH,+%1I)V>T;;HSRRRUI6"UFJFE9V]0JA)3]/<I4L
M[JY>:H_2*Y5YBCYO,.)8/C&#T;Z+&[7%0MF5'5-2YSYZZK<BJK>^:R97SRM9
MM7@HE>D,.UW!1LWG;<!9UJ1F>H]PCN.77J>Y/@:K*.D:UE+;:%BHB.2CM].V
M.EA?(B-X:=(UJ)]UG#S2;C-W*5R<0/,[WI];FD31;N,[#PZRK$*UX760R7,W
M7M?M9&YJGY1"^7ATO!Y:G.1UN.NFN!T@VL#//67M+2G3SI6A)%LJP])IE8*?
M.JK4*>KN]ROM0R6.".XU%)+;[:V2)E,WP=!#0T\T*P4K7TL/"U,Z-BFF<Y'S
MOX9+!7:QY15Z:T.E5-16*T8S2RPRU,MJI*Z"ZWAT4\E6]+M4U%RJJ>=*BN?'
M6U' 4=*KIJ:G8Q8Z:-:=WTZR\0W-FKV(\K8'M^W,8Y*Q'F"FKDN6Q\N,=SW
MSH)W5GKL+_7M^2V[RM"L@JW$V3(:+MZ567TIJC.UJD--"JI*:RKXR[2['LPO
MEFR2JJKO:;Y8UC6DN-CJ*.EGE2"=M33-JEJZ"N25M+,DCH-Q(E1)YF2+(Q6-
M9]X)K1E6 XWD.(T5%8;YCF2ME2NM.1TE?64T*U%,^CK'T:4-SMKH75M.L+*G
MA'3-5U+3R1-BD;(Z2!YD@Q&
M                                                     7&<)C]O
MW]E?^\<U3[IS_H1^^7_X WD[C#_K)_>=_O24YFUAHV
M
M                                              #?8X+?\VAK7_;'
M_?\ 94/-G7[\UO+/] _S9LQZ]=R[^85@W[YOYX9 6D&'3/P
M
M
M                        /.-WP1*F_=S;Z@LHST*M39K.2V22I+&6:9*Y
MY+N5Q0UH0C"$?F*42M.HIS?YIJ=62:$8PC")ZIZ;RLFT]P9\;D<U,2QZ)53[
MCX+320RM_99)&]J_IHIXF:OT\M-JMJ1',Q6/=G.4U#6K[ZQ5=ZK:JG?^Q)!-
M'(GZ3D(HEU,=
M
M               %QG"8_;]_97_O'-4^Z<_Z$?OE_P#@#>3N,/\ K)_>=_O2
M4YFUAHV
M
M           #?CX,Z%4W\-;6F@LHSIZU1)E1=)3J0C+-,E<\X9+<D-:$(_\
M\"E$K3J*4?\ --3JR30_5&!YJZ\RLFU9RU\;D<U)+/$JI]Q\&/6F&5O[+)(W
MM7]-%/8#N9:>:FT.P6.9BL>Z&_5#6K[ZPU>47NJIW_L2031R)^DY"STQ"9X
M
M
M                                    !K"\93A79(R/D!TVRUKM=5>K
MC<*!'#+^-&*CYZYZKJSH:+<EOBT6JG#SC_!P:TB-)<+"W23O4'%'3>4"1VBZ
MND6S;O0?66U6BVPX5EE8R@AII9%L=VJ'*E(R&>1TK[?73+M2F2.9[Y*6IDV0
M<'(Z"5\*10K)HGW37<^WK(;M-J'@U"ZY5E3!$W)+%3(BUL\M+$V&*ZVZ'R=]
M2/IHXX:RDC5:ASH8YX(YWRS(W5P?+??K9<5#/<C([V^[I*DU)6UOC:L:7%+5
MDC&6>FH0KZ*=31J2S0C":2I2EFEC",(PA$W%IJNEK8FST=33U<#T1634TT<\
M3T7RHK9(G/8Y%3RHJ*J*>?\ 76^OMD[J6Y4-9;ZEBJCZ>NIIJ2=JIY%1T,[(
MY&JB^1=K4V'$'8.F
M
M                 "XSA,?M^_LK_P!XYJGW3G_0C]\O_P  ;R=QA_UD_O._
MWI*<S:PT;
M
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M(60Q(YVQ-]ZM8CI'K[J217/=M<Y3O9'$H
M
M
M
M
M                "OO>S]EG]=_\($Q:?SQ^Y?TA#W;\[_NO]&6"$.3
M
M
M
M
M
M
M                                              !7WO9^RS^N_P#A
M F+3^>/W+^D(>[?G?]U_HRP0AR8
M
M
M
M
M
M
M                  *^][/V6?UW_P ($Q:?SQ^Y?TA#W;\[_NO]&6"$.3
M
M
M
M
M
M
M                                                 !7WO9^RS^N_
M^$"8M/YX_<OZ0A[M^=_W7^C+!"')@
M
M
M
M
M
M
M                    K[WL_99_7?\ P@3%I_/'[E_2$/=OSO\ NO\ 1E@A
M#DP
M
M
M
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MR=1'&OJE\)6?^N61>T1Z\FZW.#M)V@<L][1Q=Z?^@N'>K%DZB.-?5+X2L_\
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M)V@<L][1Q=Z?^@N'>K%DZB.-?5+X2L_]<LB]HCUY-UN<':3M Y9[VCB[T_\
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M1'KR;K<X.TG:!RSWM'%WI_Z"X=ZL63J(XU]4OA*S_P!<LB]HCUY-UN<':3M
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M)V@<L][1Q=Z?^@N'>K%DZB.-?5+X2L_]<LB]HCUY-UN<':3M Y9[VCB[T_\
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M1'KR;K<X.TG:!RSWM'%WI_Z"X=ZL63J(XU]4OA*S_P!<LB]HCUY-UN<':3M
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MFJ8FS031N_PF2Q/:]J_=:Y#GCK':
M
M
M     !YS6_SXXW#O'MVO=%$ZE2GV-S"QTJE2:,TTK=;-]O=MLZ>$9HQC"1(T
M-*%+3E_S2TZ,LLL(2PA"'JAIE314NG>#Q0M1K'8K8ZE41-FV6LMU/63N_9?/
M/(]5^ZKE5?*IXHZRUL]PU9U'GJ';TD>:9%1-7:J[(+9<ZBW4K?*JK[BFI(6;
M/>3=V(B(B(1$+P8U
M
M                   +C.$Q^W[^RO\ WCFJ?=.?]"/WR_\ P!O)W&'_ %D_
MO._WI*<S:PT;
M
M                !OW\'9\<KAX;FLJ]U43J5*=HR&QTJE2:,TTK;;&8,A6V
MSIX1FC&,)$C0TH4E.7_-+3HR2RPA+"$(>:.NM-%2:K9=%"U&,?46RI5$38BR
MUMCME9.[R?=?//(]5^ZKE5?*I["]S76SW#1' YZAV])'1W:B:NU5V06S(;O;
M:5OE55]Q34D+-GO)N[$1$V(68F)3.8
M
M
M       /.#WD_P!-;<'^E)L#_>S=IZKZ=_F?X+_D=C'^Q*$\1M6/S4M2O\O\
MR_G%<B+9<2@',V];MP7:]MMM6HQ/-S7&]*J:%G8+>;%KT]NRVKY?-(VUJ;:"
ME<O55/)'S:=+0JUI_)'YLD?)$X*JJI:&GFJZVIIZ.DIV+)/554T=/3P1I[\D
MTTKF1QL3[KGN:U/NJ=FBHJRY54%#;J2JKZZJD;#34=%3RU554RN_*Q04\#))
MII'?X+(V.<OW$,ZWOI[M=C6WIKMO_6W.5G6Q21U%ZNX+AQ=>;8T-J2C+-/5J
MO"]2SR)F7S=.2>I/3=JB*K+2EFJQDA3EC-"MV[.L+NU4E%;,LQVOK'/2-E-2
MWB@FGF>Y41K8(V3J^HVJJ-18$D17*C=NWR%MNNFNH=BHEN5YP?++90-B=-)6
M5M@NE/301-15<ZJFDIFLI=U$5SFU+HG(U%<J;$52.):RDF?L<:I[-Y?:/TAQ
M;K]F2_[>C1KUZ=P6GCB['IAKRIIZE.M32O*)JJMBM3+5I5:4J1,JJJJM6E4I
M4J,]22:6%9NN:8C8Y^];QD]AME5O-:M-6W6BIZEJNV*BO@DF26-FQS55[V-8
MUJHYSD1=I<+)I[G>2TW?N/X;DUXHMU[DK+=9+C54CT8KFN;'514[H)'HYKFI
M''(Z1SFN:UJN143%=Y6+>^.GRM;&0;.NJQ+D34Y*RBWKRMYWMA\H4:DU22G5
MK-+VC0KZ5.I/2JR23SIY99IJ5266,8R30A,T%RMUUIVUEKKZ*Y4CU5K:J@JH
M*RG<Y$15:V>GDDB541S55$<JHBHJ^^A7[G:;K9*M]!>;9<+17,:CGT5SHJF@
MJV-<JHUSZ:JBBF:U5:Y$56(BJU41=J*=DQ[A+,V6Z+HHQ3B/)V3J#'4247JO
MCVP;JO2BSUE\JB=#2=*EMM+E(WU%LB55.DD5S49E,J91-1A/"C4C+U+ID-@L
M;H67J^6>SNJ$>ZG;=+G16]T[8U:DCH4JYX5E2-7L1ZL1R,5[4=LWDV]ZS8KD
M^1MJ'X]CE^OS*1T;:I]FL]PNC:9TR/6)M0ZAIYTA=*D<BQI(K5>C'JU%1KMG
M/W5K1L=8K8I>KVU_S;9S.CH5%*MVNK%-]V\V)4U*$8U5"E>[L*-+0H4X0C&I
M5JU9:<D(1C--"$#K4>78I<964]OR?'J^>1R,9#1WJVU4KWKY$:R."I>]SE7W
MFHU57[B'<N&"YO:8'U5UP[*K931L622HN&/7>B@C8W\L]\U31QQL8W[KG.1$
M^ZIBE@M]^NM[:K:M=D=[DN-]7)FMD8&!M6/#V\.:RK+12-S4U-U%2N<%RJM-
M+23)$E"LHKU9I:=*G--&$(S5354U%3S5=9404E)31OFJ*JIFC@IX(8T5SY9I
MI7,CBC8U%<][W-:U$555$*]1T=7<*JGH:"EJ:ZMJYF4]+1T<$M355,\KD;'!
M3T\+7S332.5&LCC8Y[W*B-:JKL/NN^S+PQ_<*^TK]M2Y;(NMJ]'@Z6S=[$Z6
MU<+;%8EHKDD%[*\I43DC]*1*4ZQ/Z0FI^?2J**BE\ZC5ISS<=#7T%TI8JZVU
MM)<:*;>X&LH:F&KI9=Q[HW\%44[Y(I-R1CF.W'KNO:YJ['(J)RW*UW.S5LUN
MN]NKK5<*?<[XH+E25%#6P<+&R:/AJ6JCBGBX2*1DK-^-N_&]CV[6N15Y>T,6
M9.R"UW0^6%CF_+W9;(14W.]'>T+0N"Y6NT&VLG<%=%PNAP9FY:D8$55*TNJF
MFK=JR2A.G;'"M+4C31*9J7!77FSVR:CIKE=;;;ZBXR+%;X*ZNI:2:NE:Z)CH
MJ.*HEC?52-?/"Q60->Y'31-5-LC$7LVW'[]>:>X5=HLEWNM+:8FSW2IMMMK*
MZGML#V32-FN$U+#+'1Q.CIJA[9*AT;',@F<CE;$]6Y?Q+IOLKG3%F1<U8IQ8
M[7?C/%,CE&][F2.ENHI&^JS,]"X7=(W-;J\(7FXU[8Q*4SJN06XW.RQ.D4I8
MST85%:6G6@[WGF)8Y>;5C]ZO,%#=[TL*6^D?#52+*E1.ZE@?+-#!)3TD4U0Q
MT,<M7+!&Y[7[';K'JVR8[IEG.68_>\IQ['ZFY6''DG6ZU\5111)"ZEI65M3%
M!3U%3%5UTT%)(RHEAH8*F1D;X]K4=+&U\9"W%$,F7YA;,>*T;.XY/Q-DS'#?
M<,U>5@77Y8ETV>C?)DU*A74RLZFX6INH.<R>@J35J\$4]>-*DHH5*D)9*M.,
MT1;<@L-ZDGBL][M%VEI4:M3';;E15\E,CW.:Q9V4LTKH4<YCVMX1&[SF.1-J
MM79.W?%LFQ^*FFO^.WVQPUJO2CEN]HN%MBJU8UCWI325M/ R=6,D8YZ1*_=:
M]CEV(Y%7&9+D$ #)CYA;,=LV4TY*N3$V3+>QR_RMTS%?[Y8ETM-E/4KNGJ*V
MF9INI>U)V)RE=$E*JJ;HHU]:"U/2J5DT:M.2::$13Y!8:RX3VBDO=HJKK3+*
ME3;*>Y44]PIU@>D<Z3T44SJF)87N:R7A(F\&]4:_8JHA.U>+9-06JFOE=CM]
MHK)6) M)>*NT7"GM54E2Q9*9::X34[*2=*B-KI(%BF=PK&J^/>:BJ8S)<@@
M
M                                    7&<)C]OW]E?^\<U3[IS_ *$?
MOE_^ -Y.XP_ZR?WG?[TE.9M8:-@
M
M                               WV."W_-H:U_VQ_P!_V5#S9U^_-;RS
M_0/\V;,>O7<N_F%8-^^;^>&0%I!ATS\
M
M
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MK@1K4:2JCI.]6E6H('-KKO;)%93E;U3JE<52%(K^\$U@QS.;A462.EN=CO\
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M!)XYI61NFX-]+4,IZI=L+5D6HIHZJA8BQLDJV32Q1OK],G&'
M
M"XSA,?M^_LK_ -XYJGW3G_0C]\O_ , ;R=QA_P!9/[SO]Z2G,VL-&P
M
M                                                          ;[
M'!;_ )M#6O\ MC_O^RH>;.OWYK>6?Z!_FS9CUZ[EW\PK!OWS?SPR M(,.F?@
M
M
M                                     ><'O)_IK;@_TI-@?[V;M/5?
M3O\ ,_P7_([&/]B4)XC:L?FI:E?Y?YE_.*Y$6RXE ),:L[<YRTYR%-D7!]T2
M,R]:FI-UR6^ZI?I:T;Q::-:->FUW.R35:$%=&C5FJ5$:Y&I0/39/643M3HAF
M4J)JM2S+!\=SNUI:LAHUGBC>LM)50/X"NH)W-W5FI*A&NW'.:B))'(R6GF1K
M4FADW&;MZT_U'RS3.]+>\4N"4TTL;8*ZBJ(^^+;<Z9KM]M/7TBN8DK6.55BF
MB?#54ZN>M/40K(]7;$F%-V=(^+*],.OFWVN3/9>=KG1*6FR;_M^IYVFY.:-
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M:V:XM6@M[VMI8EI;A4TB.8G"M572I DCU5J>Z<J>5$VFR&M7="RX'J)><73
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MEK=)L*T8U)P.CU=H<T2^6^MK[';I+554+J6[Q4K98(*1CI*QBK5U])0RIM?
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M=J.25E/2U%=$M8D4EO?/4P4;[C#3OJ(YZ&IJJ:K;3*^29LC8V+5T9B,!
M
M        %QG"8_;]_97_ +QS5/NG/^A'[Y?_ ( WD[C#_K)_>=_O24YFUAHV
M
M
M    #?8X+?\ -H:U_P!L?]_V5#S9U^_-;RS_ $#_ #9LQZ]=R[^85@W[YOYX
M9 6D&'3/P
M
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ME-)4MD>L%%IL6:F
M                           %QG"8_;]_97_O'-4^Z<_Z$?OE_P#@#>3N
M,/\ K)_>=_O24YFUAHV
M
M                       #?8X+?\VAK7_;'_?]E0\V=?OS6\L_T#_-FS'K
MUW+OYA6#?OF_GAD!:08=,_
M
M
M\X/>3_36W!_I2; _WLW:>J^G?YG^"_Y'8Q_L2A/$;5C\U+4K_+_,OYQ7(BV7
M$H
M
M     !<9PF/V_?V5_P"\<U3[IS_H1^^7_P" -Y.XP_ZR?WG?[TE.9M8:-@
M
M
M  WV."W_ #:&M?\ ;'_?]E0\V=?OS6\L_P! _P V;,>O7<N_F%8-^^;^>&0%
MI!ATS\
M
M                                           #0ZXQNL5V8 W/R5=R
MMK4QQ_GNX7C*]DW'+0G^CUSC<:F5SOECG40A&C3=V.ZER^=0B\Y&O!H<61RG
MDDIN-.67T?T'R^BR7 ;50,F9X3QJFALUPI5<G"QPTS5BMU2C5V.6"HHXXVMD
M1-WAXIXMNV/R^2?=.X#<<0U.O-W=3O\  F854U]ME:V-4@?552I)=J-[T]RV
MJ@KG2S.C5=YU/44\VSW;D2J0S2:Y@
M
M                               %QG"8_;]_97_O'-4^Z<_Z$?OE_P#@
M#>3N,/\ K)_>=_O24YFUAHV
M
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MKBDSHW5-HM4;*YT6S@EN-5++77'@U3\M'W]55&X_WWMV/5$5RH2K*:7T
M
M
M                                 &)LTX+Q'L18J_&V:;$8L@6:X3RU
MYVIZH5/.(EU.2I3H.C,YI*J9U8GA-3K5J:9W9ER%QH4ZU:E34RTZU62>:L&1
M7O%[C%=K!<JFV5\2*U)Z=R(CXW*BNAGB>CH:B!ZHBO@GCDB<J-56*K45(#)<
M6Q[,;5/9,FM-'>;94*CGTM9'O(R1J*C)Z>5JMFI:F/:O!U--)%/'M7<D3:NV
MH-\^3V:..SDH7(+PV-MA-6GFGIL['?EB*&Y)+&,8PIIZMR8MN%WFDEA'YLL5
M;JIJ1A"'SJDTWEFCG&F[I[42")L<M%BU:]J(BSU-MN+)7JGW7)1WBD@15]]=
MR%B;?>1$\AK96]QKI-5SNF@K\TMD;MNREHKQ;)(&>55]RZY6*X5*[$\B;]0[
MR(FW:NU5XCH[6E/6AM)[ZXF\$CL<J34#F?#NC[WVA.IR+-+>?\_Z5QWLJ.CM
M:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\ /^E<=[*CH[6E/6AM)[ZXF\$A
MRI-0.9\.Z/O?:$<BS2WG_/\ I7'>RHZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA
M'(LTMY_S_I7'>RHZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_S_I7'>RH
MZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_P _Z5QWLJ.CM:4]:&TGOKB;
MP2'*DU YGP[H^]]H1R+-+>?\_P"E<=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O
M?:$<BS2WG_/^E<=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_/^E<=
M[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_ #_I7'>RHZ.UI3UH;2>^
MN)O!(<J34#F?#NC[WVA'(LTMY_S_ *5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[
MH^]]H1R+-+>?\_Z5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\_Z
M5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\ /^E<=[*CH[6E/6AM
M)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_/\ I7'>RHZ.UI3UH;2>^N)O!(<J34#F
M?#NC[WVA'(LTMY_S_I7'>RHZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_
MS_I7'>RHZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_P _Z5QWLJ.CM:4]
M:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\_P"E<=[*CH[6E/6AM)[ZXF\$ARI-
M0.9\.Z/O?:$<BS2WG_/^E<=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2
MWG_/^E<=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_ #_I7'>RHZ.U
MI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_S_ *5QWLJ.CM:4]:&TGOKB;P2'
M*DU YGP[H^]]H1R+-+>?\_Z5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]]H1R
M+-+>?\_Z5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\ /^E<=[*C
MH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_/\ I7'>RHZ.UI3UH;2>^N)O
M!(<J34#F?#NC[WVA'(LTMY_S_I7'>RHZ.UI3UH;2>^N)O!(<J34#F?#NC[WV
MA'(LTMY_S_I7'>RHZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_P _Z5QW
MLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\_P"E<=[*CH[6E/6AM)[Z
MXF\$ARI-0.9\.Z/O?:$<BS2WG_/^E<=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/
MO?:$<BS2WG_/^E<=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_ #_I
M7'>RHZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_S_ *5QWLJ.CM:4]:&T
MGOKB;P2'*DU YGP[H^]]H1R+-+>?\_Z5QWLJ.CM:4]:&TGOKB;P2'*DU YGP
M[H^]]H1R+-+>?\_Z5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\
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M;2>^N)O!(<J34#F?#NC[WVA'(LTMY_S_ *5QWLJ.CM:4]:&TGOKB;P2'*DU
MYGP[H^]]H1R+-+>?\_Z5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>
M?\_Z5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\ /^E<=[*CH[6E
M/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_/\ I7'>RHZ.UI3UH;2>^N)O!(<J
M34#F?#NC[WVA'(LTMY_S_I7'>RHZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA'(L
MTMY_S_I7'>RHZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_P _Z5QWLJ.C
MM:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\_P"E<=[*CH[6E/6AM)[ZXF\$
MARI-0.9\.Z/O?:$<BS2WG_/^E<=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$
M<BS2WG_/^E<=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_ #_I7'>R
MHZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_S_ *5QWLJ.CM:4]:&TGOKB
M;P2'*DU YGP[H^]]H1R+-+>?\_Z5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]
M]H1R+-+>?\_Z5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\ /^E<
M=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_/\ I7'>RHZ.UI3UH;2>
M^N)O!(<J34#F?#NC[WVA'(LTMY_S_I7'>RHZ.UI3UH;2>^N)O!(<J34#F?#N
MC[WVA'(LTMY_S_I7'>RHZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_P _
MZ5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\_P"E<=[*CH[6E/6A
MM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_/^E<=[*CH[6E/6AM)[ZXF\$ARI-0.9
M\.Z/O?:$<BS2WG_/^E<=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_
M #_I7'>RHZ.UI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_S_ *5QWLJ.CM:4
M]:&TGOKB;P2'*DU YGP[H^]]H1R+-+>?\_Z5QWLJ.CM:4]:&TGOKB;P2'*DU
M YGP[H^]]H1R+-+>?\_Z5QWLJ.CM:4]:&TGOKB;P2'*DU YGP[H^]]H1R+-+
M>?\ /^E<=[*CH[6E/6AM)[ZXF\$ARI-0.9\.Z/O?:$<BS2WG_/\ I7'>RHZ.
MUI3UH;2>^N)O!(<J34#F?#NC[WVA'(LTMY_S_I7'>RI_L/D[6E$(PC')^T<8
M0C"/DC>V)_)'_FCY,)0CY(_YH^2,(_ZHPB%[J34#8OV(PY/TTM]ZVI^GY<@5
M/]:*GZ03N+-+$5%\/9^NQ?>6ZX[L7])=F+(NQ?TE1?O*A/#5/AG:CZ>.GZ48
MLL-6[7_"A52TLCY <_TKO!$FKTIJ"BDSUIDJ!EMV*FC/5H*U%NLC2K6IZU5*
ML45TLT*,N-LSU:S?.H>\[U<VQ6W>:];5;8>\J%[VKO-=.Q'R3U6XNQS&U4\[
M(W(CV-:]-XS%I_H?ISIK.M=CEE5]V<QT?AJZSNN-S9&]NZ]E/+(UL-&V1NU)
M>\H*=TK55LJO;L:D^S&IEL
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
L                                                       __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SOPHiA GENETICS SA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">V8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">La Pi&#232;ce 12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">CH-1180<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Rolle<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary shares, par value CHF 0.05 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SOPH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">68,486,338<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag', window );">Document Financial Statement Restatement Recovery Analysis [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001840706<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">401 Park Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 505<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">George Cardoza<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">982-1210<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtRestatementRecoveryAnalysisFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AuditorAbstract', window );"><strong>Auditor [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers SA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Lausanne, Switzerland<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AuditorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Auditor</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AuditorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue</a></td>
<td class="nump">$ 77,271<span></span>
</td>
<td class="nump">$ 65,173<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 62,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of revenue</a></td>
<td class="num">(25,194)<span></span>
</td>
<td class="num">(21,236)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19,458)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">52,077<span></span>
</td>
<td class="nump">43,937<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">42,913<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development costs</a></td>
<td class="num">(34,216)<span></span>
</td>
<td class="num">(34,366)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(36,969)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Selling and marketing costs</a></td>
<td class="num">(36,118)<span></span>
</td>
<td class="num">(29,369)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(28,423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative costs</a></td>
<td class="num">(52,563)<span></span>
</td>
<td class="num">(46,953)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(53,301)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating (loss) income, net</a></td>
<td class="num">(86)<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">954<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating loss</a></td>
<td class="num">(70,906)<span></span>
</td>
<td class="num">(66,568)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(74,826)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Interest income</a></td>
<td class="nump">1,872<span></span>
</td>
<td class="nump">3,362<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,547<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest expense</a></td>
<td class="num">(4,554)<span></span>
</td>
<td class="num">(1,913)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(588)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AdjustmentsForFairValueOfWarrantLiability', window );">Fair value adjustments on warrant obligations</a></td>
<td class="num">(497)<span></span>
</td>
<td class="nump">370<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ForeignExchangeAndOtherGainLoss', window );">Foreign exchange (losses) gains, net</a></td>
<td class="num">(3,402)<span></span>
</td>
<td class="nump">3,479<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,628)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before income taxes</a></td>
<td class="num">(77,487)<span></span>
</td>
<td class="num">(61,270)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(78,495)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="num">(1,512)<span></span>
</td>
<td class="num">(1,223)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(486)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the year</a></td>
<td class="num">(78,999)<span></span>
</td>
<td class="num">(62,493)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(78,981)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Attributable to the owners of the parent</a></td>
<td class="num">$ (78,999)<span></span>
</td>
<td class="num">$ (62,493)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (78,981)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per share (in dollars per share)</a></td>
<td class="num">$ (1.17)<span></span>
</td>
<td class="num">$ (0.95)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (1.22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share (in dollars per share)</a></td>
<td class="num">$ (1.17)<span></span>
</td>
<td class="num">$ (0.95)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (1.22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2025-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AdjustmentsForFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments For Fair Value Of Warrant Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AdjustmentsForFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ForeignExchangeAndOtherGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Exchange And Other Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ForeignExchangeAndOtherGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Statement of comprehensive income [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">$ (78,999)<span></span>
</td>
<td class="num">$ (62,493)<span></span>
</td>
<td class="num">$ (78,981)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Items that may be reclassified to statement of loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation', window );">Currency translation adjustments</a></td>
<td class="nump">11,292<span></span>
</td>
<td class="num">(9,679)<span></span>
</td>
<td class="nump">15,037<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Total items that may be reclassified to statement of loss</a></td>
<td class="nump">11,292<span></span>
</td>
<td class="num">(9,679)<span></span>
</td>
<td class="nump">15,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract', window );"><strong>Items that will not be reclassified to statement of loss (net of tax)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Remeasurement of defined benefit plans</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax', window );">Total items that will not be reclassified to statement of loss</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive (loss) income for the period</a></td>
<td class="nump">11,996<span></span>
</td>
<td class="num">(9,352)<span></span>
</td>
<td class="nump">14,825<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the period</a></td>
<td class="num">(67,003)<span></span>
</td>
<td class="num">(71,845)<span></span>
</td>
<td class="num">(64,156)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Attributable to owners of the parent</a></td>
<td class="num">$ (67,003)<span></span>
</td>
<td class="num">$ (71,845)<span></span>
</td>
<td class="num">$ (64,156)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [domain]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 70,289<span></span>
</td>
<td class="nump">$ 80,226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentReceivables', window );">Accounts receivable</a></td>
<td class="nump">15,001<span></span>
</td>
<td class="nump">7,436<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventory</a></td>
<td class="nump">6,351<span></span>
</td>
<td class="nump">5,868<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets', window );">Prepaids and other current assets</a></td>
<td class="nump">7,438<span></span>
</td>
<td class="nump">5,875<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">99,079<span></span>
</td>
<td class="nump">99,405<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">5,665<span></span>
</td>
<td class="nump">5,209<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">35,891<span></span>
</td>
<td class="nump">28,998<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">12,382<span></span>
</td>
<td class="nump">14,168<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">1,831<span></span>
</td>
<td class="nump">1,767<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="nump">8,183<span></span>
</td>
<td class="nump">5,762<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">63,952<span></span>
</td>
<td class="nump">55,904<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">163,031<span></span>
</td>
<td class="nump">155,309<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Accounts payable</a></td>
<td class="nump">8,960<span></span>
</td>
<td class="nump">5,220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_CurrentAccruedExpenses', window );">Accrued expenses</a></td>
<td class="nump">20,736<span></span>
</td>
<td class="nump">13,217<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities', window );">Deferred contract revenue</a></td>
<td class="nump">16,720<span></span>
</td>
<td class="nump">5,732<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities, current portion</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="nump">2,190<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentWarrantLiability', window );">Warrant obligations</a></td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">444<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">50,528<span></span>
</td>
<td class="nump">26,803<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Borrowings</a></td>
<td class="nump">47,733<span></span>
</td>
<td class="nump">13,237<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities, net of current portion</a></td>
<td class="nump">12,587<span></span>
</td>
<td class="nump">14,603<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan', window );">Defined benefit pension liabilities</a></td>
<td class="nump">4,162<span></span>
</td>
<td class="nump">3,839<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">876<span></span>
</td>
<td class="nump">337<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">65,358<span></span>
</td>
<td class="nump">32,016<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">115,886<span></span>
</td>
<td class="nump">58,819<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">4,814<span></span>
</td>
<td class="nump">4,188<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SharePremium', window );">Share premium</a></td>
<td class="nump">473,675<span></span>
</td>
<td class="nump">472,244<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury shares</a></td>
<td class="num">(1,218)<span></span>
</td>
<td class="num">(702)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherReserves', window );">Other reserves</a></td>
<td class="nump">89,150<span></span>
</td>
<td class="nump">61,037<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Accumulated deficit</a></td>
<td class="num">(519,276)<span></span>
</td>
<td class="num">(440,277)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">47,145<span></span>
</td>
<td class="nump">96,490<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">$ 163,031<span></span>
</td>
<td class="nump">$ 155,309<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current warrant liabilities. [Refer: Warrant liability]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharePremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharePremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_CurrentAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_CurrentAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Share capital</div></th>
<th class="th"><div>Treasury Share capital</div></th>
<th class="th"><div>Share premium</div></th>
<th class="th"><div>Other reserves</div></th>
<th class="th"><div>Accumulated deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Balance at beginning of period (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,398,164<span></span>
</td>
<td class="nump">2,166,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at beginning of period at Dec. 31, 2022</a></td>
<td class="nump">$ 200,130<span></span>
</td>
<td class="nump">$ 3,464<span></span>
</td>
<td class="num">$ (117)<span></span>
</td>
<td class="nump">$ 471,623<span></span>
</td>
<td class="nump">$ 23,963<span></span>
</td>
<td class="num">$ (298,803)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">(78,981)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78,981)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income (loss)</a></td>
<td class="nump">14,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the period</a></td>
<td class="num">(64,156)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,825<span></span>
</td>
<td class="num">(78,981)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">15,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TransactionsWithOwnersAbstract', window );"><strong>Transactions with owners</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement', window );">Share options exercised and vesting of Restricted Stock Units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">999,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity', window );">Share options exercised and vesting of Restricted Stock Units</a></td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">223<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfTreasurySharesIssued', window );">Issuance of shares to be held as treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SaleOrIssueOfTreasuryShares', window );">Issuance of shares to be held as treasury shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 584<span></span>
</td>
<td class="num">$ (584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Balance at end of period (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,898,164<span></span>
</td>
<td class="nump">11,667,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at end of period at Dec. 31, 2023</a></td>
<td class="nump">151,442<span></span>
</td>
<td class="nump">$ 4,048<span></span>
</td>
<td class="num">$ (646)<span></span>
</td>
<td class="nump">471,846<span></span>
</td>
<td class="nump">53,978<span></span>
</td>
<td class="num">(377,784)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">(62,493)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(62,493)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income (loss)</a></td>
<td class="num">(9,352)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,352)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the period</a></td>
<td class="num">(71,845)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,352)<span></span>
</td>
<td class="num">(62,493)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">16,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TransactionsWithOwnersAbstract', window );"><strong>Transactions with owners</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement', window );">Share options exercised and vesting of Restricted Stock Units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,456,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity', window );">Share options exercised and vesting of Restricted Stock Units</a></td>
<td class="nump">405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="nump">398<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfTreasurySharesIssued', window );">Issuance of shares to be held as treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,423,056<span></span>
</td>
<td class="nump">2,423,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SaleOrIssueOfTreasuryShares', window );">Issuance of shares to be held as treasury shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
<td class="num">$ (140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Balance at end of period (in shares) at Dec. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,321,220<span></span>
</td>
<td class="nump">12,634,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at end of period at Dec. 31, 2024</a></td>
<td class="nump">96,490<span></span>
</td>
<td class="nump">$ 4,188<span></span>
</td>
<td class="num">$ (702)<span></span>
</td>
<td class="nump">472,244<span></span>
</td>
<td class="nump">61,037<span></span>
</td>
<td class="num">(440,277)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Loss for the period</a></td>
<td class="num">(78,999)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78,999)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income (loss)</a></td>
<td class="nump">11,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive loss for the period</a></td>
<td class="num">(67,003)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,996<span></span>
</td>
<td class="num">(78,999)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">16,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TransactionsWithOwnersAbstract', window );"><strong>Transactions with owners</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement', window );">Share options exercised and vesting of Restricted Stock Units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,571,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity', window );">Share options exercised and vesting of Restricted Stock Units</a></td>
<td class="nump">346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">338<span></span>
</td>
<td class="num">(88)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfTreasurySharesIssued', window );">Issuance of shares to be held as treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SaleOrIssueOfTreasuryShares', window );">Issuance of shares to be held as treasury shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 626<span></span>
</td>
<td class="num">$ (626)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfEquitySharesIssued', window );">Proceeds from ATM offering, net of transaction costs (in shares)</a></td>
<td class="nump">228,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Proceeds from ATM offering, net of transaction costs</a></td>
<td class="nump">$ 1,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">1,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Balance at end of period (in shares) at Dec. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,321,220<span></span>
</td>
<td class="nump">20,834,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Balance at end of period at Dec. 31, 2025</a></td>
<td class="nump">$ 47,145<span></span>
</td>
<td class="nump">$ 4,814<span></span>
</td>
<td class="num">$ (1,218)<span></span>
</td>
<td class="nump">$ 473,675<span></span>
</td>
<td class="nump">$ 89,150<span></span>
</td>
<td class="num">$ (519,276)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SaleOrIssueOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity resulting from the sale or issue of treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SaleOrIssueOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Through Exercise Of Options And Vesting Of Other Equity Instruments, Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Shares Issued Of Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Share Options Exercised And Other Equity Instruments Vested In Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfTreasurySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Treasury Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfTreasurySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_TransactionsWithOwnersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transactions with owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_TransactionsWithOwnersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Loss before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (77,487)<span></span>
</td>
<td class="num">$ (61,270)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (78,495)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments for non-monetary items</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationExpense', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,976<span></span>
</td>
<td class="nump">4,575<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5,508<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,553<span></span>
</td>
<td class="nump">4,021<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,828<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AdjustmentsForFinanceExpenseIncomeNet', window );">Finance expense (income), net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,127<span></span>
</td>
<td class="num">(5,210)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,934<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AdjustmentsForFairValueOfWarrantLiability', window );">Fair value adjustments on warrant obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">497<span></span>
</td>
<td class="num">(370)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AdjustmentsForCreditLossAllowance', window );">Expected credit loss allowance increase (reversal)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57<span></span>
</td>
<td class="num">(523)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,205<span></span>
</td>
<td class="nump">16,488<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15,242<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities', window );">Movements in provisions and pensions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">649<span></span>
</td>
<td class="nump">1,617<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">308<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AdjustmentsForResearchTaxCredit', window );">Research tax credit</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(977)<span></span>
</td>
<td class="num">(726)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,129)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment', window );">Loss on disposal of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">28<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_GainLossOnDisposalOfLeaseLiability', window );">Gain on disposal of lease liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(733)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WorkingCapitalChangesAbstract', window );"><strong>Working capital changes</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">(Increase) decrease in accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,603)<span></span>
</td>
<td class="nump">5,892<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(6,500)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses', window );">Decrease (increase) in prepaids and other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">334<span></span>
</td>
<td class="num">(1,157)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,375<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Decrease (increase) in inventory</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(874)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables', window );">Increase (decrease) in accounts payables, accrued expenses, deferred contract revenue, and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,930<span></span>
</td>
<td class="num">(7,385)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">6,871<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperations', window );">Cash used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(35,693)<span></span>
</td>
<td class="num">(43,979)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(52,423)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income tax paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(200)<span></span>
</td>
<td class="num">(536)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(801)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash flows used in operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(35,893)<span></span>
</td>
<td class="num">(44,515)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(53,224)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Purchase of property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(574)<span></span>
</td>
<td class="num">(244)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,494)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Acquisition of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(108)<span></span>
</td>
<td class="num">(195)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(263)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_CapitalizedSoftwareDevelopmentCosts', window );">Capitalized development costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,938)<span></span>
</td>
<td class="num">(7,737)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(7,469)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod', window );">Purchase of equity investments held at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,885)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments', window );">Proceeds upon maturity of term deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">17,546<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities', window );">Interest received</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,835<span></span>
</td>
<td class="nump">3,421<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,655<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash flow (used in) provided from investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,670)<span></span>
</td>
<td class="num">(4,755)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">12,975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromExerciseOfOptions', window );">Proceeds from exercise of share options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">346<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities', window );">Interest paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,953)<span></span>
</td>
<td class="num">(1,728)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities', window );">Proceeds from borrowings, net of transaction costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34,563<span></span>
</td>
<td class="nump">13,930<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Proceeds from sale of common stock in at-the-market offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,093<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments of principal portion of lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,872)<span></span>
</td>
<td class="num">(2,750)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(3,043)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash flow provided from (used in) financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,177<span></span>
</td>
<td class="nump">9,857<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2,823)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges', window );">Decrease in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14,386)<span></span>
</td>
<td class="num">(39,413)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(43,072)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Effect of exchange differences on cash balances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,449<span></span>
</td>
<td class="num">(3,612)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5,018<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at beginning of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">80,226<span></span>
</td>
<td class="nump">123,251<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">161,305<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at end of the year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 70,289<span></span>
</td>
<td class="nump">$ 80,226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 123,251<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash from (used in) the entity's operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 102<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of interests in investments accounted for using the equity method. [Refer: Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AdjustmentsForCreditLossAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for credit loss allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AdjustmentsForCreditLossAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AdjustmentsForFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments For Fair Value Of Warrant Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AdjustmentsForFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AdjustmentsForFinanceExpenseIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for Finance Expense (Income), Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AdjustmentsForFinanceExpenseIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AdjustmentsForResearchTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AdjustmentsForResearchTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_CapitalizedSoftwareDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized software development costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_CapitalizedSoftwareDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_GainLossOnDisposalOfLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposal Of Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_GainLossOnDisposalOfLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WorkingCapitalChangesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Working capital changes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WorkingCapitalChangesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company information and operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCompanyInformationAndOperationsAbstract', window );"><strong>Disclosure Of Company Information And Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCompanyInformationAndOperationsTextBlock', window );">Company information and operations</a></td>
<td class="text">Company information and operations<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General information</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOPHiA GENETICS SA and its consolidated subsidiaries (NASDAQ: SOPH) (&#8220;the Company&#8221;) is a cloud-native software technology company in the healthcare space, incorporated on&#160;March 18, 2011, and headquartered in Rolle, Switzerland. The Company is dedicated to establishing the practice of data-driven medicine as the standard of care in healthcare and for life sciences research. The Company has built a cloud-native software platform capable of analyzing data and generating insights from complex multimodal datasets and different diagnostic modalities. This platform, commercialized as &#8220;SOPHiA DDM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; standardizes, computes, and analyzes digital health data and is used in decentralized locations to break down data silos. The Company collectively refers to SOPHiA DDM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Platform and related products and solutions as &#8220;SOPHiA DDM Platform.&#8221;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, the Company had the following wholly-owned subsidiaries:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Country of domicile</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS S.A.S.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS LTD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS Intermedia&#231;&#227;o de Neg&#243;cios LTDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS PTY LTD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS S.R.L.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS GmbH</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Board of Directors approved the issue of the consolidated financial statements on&#160;March&#160;3, 2026.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issued share capital</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, the Company had issued 89,321,220 shares of which 68,486,338 are outstanding and 20,834,882 are held by the Company as treasury shares. As of December 31, 2024, the Company had issued 79,321,220 shares of which 66,687,085 are outstanding and 12,634,135 are held by the Company as treasury shares. All shares were considered paid as of December 31, 2025.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Range</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Under the Company&#8217;s articles of association, the board of directors is authorized, at any time and including for anti&#8209;takeover and change&#8209;of&#8209;control purposes, to increase the Company&#8217;s nominal share capital until June 18, 2030, within a capital range extending from CHF 3,319,908.20 ($4,192,193.63) (lower limit) to CHF 4,979,862.30 ($6,288,042.55) (upper limit). Within this capital range, the board is authorized to increase the Company&#8217;s nominal share capital by up to CHF 4,979,862.30 ($6,288,042.55) through the issuance of up to 33,199,082 fully paid&#8209;in ordinary shares, each with a par value of CHF 0.05 ($0.06). In addition to the increase of share capital, our board of directors has the right to reduce the share capital to the minimum amount of CHF3,319,908.20 ($4,192,193.63). According to the articles of association, our board of directors is entitled to determine the use of the reduction amount, to the extent necessary.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Treasury shares</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2023, the Company issued 10,500,000 registered shares to SOPHiA GENETICS LTD pursuant to a share delivery and repurchase agreement, which were immediately exercised, and repurchased the shares to hold as treasury shares. During the third quarter of 2024, the Company issued 2,423,056 registered shares to SOPHiA GENETICS LTD pursuant to a share delivery and repurchase agreement, which were immediately exercised, and repurchased the shares to hold as treasury shares for the purposes of administering the Company's equity incentive programs. During the fourth quarter of 2025, the </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company issued 10,000,000 registered shares to SOPHiA GENETICS LTD pursuant to a share delivery and repurchase agreement, which were immediately exercised, and repurchased the shares to hold as treasury shares. The Company held 20,834,882 and 12,634,135 treasury shares as of December 31, 2025 and 2024, respectively. The issuance of the 10,000,000 shares in 2025 was made out of the Company&#8217;s capital range in accordance with the board of directors&#8217; authorization under the Company&#8217;s articles of association.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury shares are recognized at acquisition cost and recorded as treasury shares at the time of the transaction. Upon exercise of share options or vesting of restricted stock units, the treasury shares are subsequently transferred. Any consideration received is included in shareholders&#8217; equity.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conditional share capital</span></div><div><span><br/></span></div><div style="margin-top:0.05pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Conditional Share Capital for Financing, Acquisitions and Other Purposes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may increase its share capital for anti&#8209;takeover and change&#8209;of&#8209;control purposes through the exercise or mandatory exercise of conversion, exchange, option, warrant or similar rights granted to shareholders or third parties, whether issued on a standalone basis or in connection with other securities or contractual obligations of the Company or its subsidiaries. As of December 31, 2025, the conditional share capital available for financing, acquisitions and other strategic purposes consisted of 18,277,363 ordinary shares with a par value of CHF 0.05 ($ 0.06) each, compared to 21,599,082 ordinary shares as of December 31, 2024.</span></div><div style="margin-top:9.55pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Conditional Share Capital for Employee Participation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may issue registered shares to employees, agents and members of the Board of Directors under its stock option and other equity&#8209;based incentive plans. As of December 31, 2025, the conditional share capital available for employee participation consisted of 21,383,247 ordinary shares with a par value of CHF 0.05 ($ 0.06) each, compared to 18,061,528 ordinary shares as of December 31, 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ATM Program</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2025, the Company established a new at-the-market (&#8220;ATM&#8221;) offering program pursuant to which  from time to time the Company may sell ordinary shares having an aggregate offering price of $50.0&#160;million. For the year ended December 31, 2025, 228,238 ordinary shares were sold for total gross proceeds of $1.1&#160;million under this program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfCompanyInformationAndOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of company information and operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfCompanyInformationAndOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfCompanyInformationAndOperationsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Company information and operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfCompanyInformationAndOperationsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_SummaryOfMaterialAccountingPoliciesAbstract', window );"><strong>Summary Of Material Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory', window );">Material accounting policies</a></td>
<td class="text">Material accounting policies<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of preparation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with International Financial Reporting Standards</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of the Company have been prepared in accordance with IFRS Accounting Standards and interpretations issued by the IFRS Interpretations Committee (&#8220;IFRS IC&#8221;) applicable to companies reporting under IFRS Accounting Standards. The consolidated financial statements comply with IFRS Accounting Standards as issued by the International Accounting Standards Board (&#8220;IASB&#8221;).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary is an entity over which the Company has control. The Company controls an entity when it has the power to direct its activities and has rights to its variable returns. Subsidiaries are fully consolidated from the date on which control is transferred to the Company and deconsolidated from the date that control ceases.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the consolidation process intercompany transactions, balances, and unrealized gains on transactions between companies are eliminated. Unrealized losses are also eliminated unless there is evidence of an impairment of the transferred asset. In order to ensure consistency with the accounting policies of the Company, the accounting policies of subsidiaries have been changed where necessary.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign currency translation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Items included in the consolidated financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic environment in which the entity operates (&#8220;functional currency&#8221;). In individual entities, transactions in foreign currencies are translated as of transaction date. Monetary assets and liabilities in foreign currencies are translated at month end rates. The Company&#8217;s reporting currency of the Company&#8217;s consolidated financial statements is the U.S. dollar (&#8220;USD&#8221;). Assets and liabilities denominated in foreign currencies are translated at the month-end spot exchange rates, income statement accounts are translated at average rates of exchange for the period presented, and equity is translated at historical exchange rates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On consolidation, assets and liabilities of foreign operations reported in their local functional currencies are translated into USD. Differences arising from the retranslation of opening net assets of foreign operations, together with differences arising from the translation of the net results for the year of foreign operations, are recognized in other comprehensive income under currency translation adjustments. Gains or losses resulting from foreign currency transactions are included in net income.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company selected the U.S. dollar as its presentation currency for purposes of its consolidated financial statements instead of the Company&#8217;s functional currency, the Swiss franc, because of the global nature of its business, its expectation that an increasing portion of revenues and expenses will be denominated in USD, and its plans to continue to access U.S. capital markets.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with IFRS Accounting Standards requires the use of accounting estimates. It also requires management to exercise judgment in applying the Company&#8217;s accounting policies. The Company&#8217;s significant estimates and judgments included in the preparation of the consolidated financial statements are related to revenue recognition, capitalized internal software development costs, defined benefit liability and share-based compensation.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosed in the corresponding sections within the footnotes are the areas which require a high degree of judgment, significant assumptions, and/or estimates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going concern basis</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared on a going concern basis (See Note 27 &#8211; &#8220;Capital management&#8221;).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Historical cost convention</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared on a historical cost basis except for certain assets and liabilities, which are carried at fair value.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material accounting policies adopted in the preparation of the consolidated financial statements have been consistently applied, unless otherwise stated.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions and contingencies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions comprise liabilities of uncertain timing or amount. The provisions and liabilities are recognized when the Company has a present legal or constructive obligation as a result of past events, it is probable that an outflow of resources will be required to settle the obligation, and the amount can </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be reliably estim</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ated. Provisions are not recognized for future operating losses. Provisions are measured at the present value of management&#8217;s best estimate of the expenditure required to settle the present obligation at the end of the reporting period, unless the impact of discounting is immaterial. The discount rate used to determine the present value is a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. The increase in the provision due to the passage of time is recognized as interest expense.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent liabilities are possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not fully within the control of the Company.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The likelihood of occurrence of provisions and contingent liabilities requires use of judgment. Judgment is also required to determine if an outflow of economic resources is probable, or possible but not probable. Where it is probable, a liability is recognized, and further judgment is used to determine the level of the provision. Where it is possible but not probable, further judgment is used to determine if the likelihood is remote, in which case no disclosures are provided; if the likelihood is not remote then judgment is used to determine the contingent liability disclosed.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial assets classification</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon recognition, financial assets are classified on the basis of how the financial assets are measured: at amortized cost or fair value through income.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification of financial assets at initial recognition depends on the financial asset&#8217;s contractual cash flow characteristics and the Company&#8217;s business model for managing them. Except for accounts receivable that do not contain a significant financing component, the Company initially measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through income, transaction costs. Accounts receivable that do not contain a significant financing component are measured at the transaction price.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business model for managing financial assets is defined by whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets held in order to collect contractual cash flows are measured at amortized cost. Financial assets held both to collect contractual cash flows and for sale are measured at fair value through other comprehensive income/loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases or sales of financial assets that require delivery of assets within a time frame established by regulation or convention in the marketplace (regular way trades) are recognized on the trade date, i.e., the date that the Company commits to purchase or sell the asset.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial assets measured at amortized cost</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets initially measured at amortized cost are subsequently measured using the effective interest rate (&#8220;EIR&#8221;) method and are subject to impairment. Gains and losses are recognized in income when the asset is derecognized, modified, or impaired. The Company&#8217;s financial assets at amortized cost include cash and accounts receivable.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial assets&#8212;derecognition</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Company&#8217;s consolidated balance sheet) when:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the rights to receive cash flows from the asset have expired or;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material delay to a third party under a &#8216;pass-through&#8217; arrangement; and either;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Company has transferred substantially all the risks and rewards of the asset, or;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Company has neither transferred nor retained substantially all the risks and rewards of the asset but has transferred control of the asset.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risks and rewards of ownership.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control of the asset, the Company continues to recognize the transferred asset to the extent of its continuing involvement. In that case, the Company also recognizes an associated liability. The transferred </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">asset and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continuing involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that the Company could be required to repay.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial assets&#8212;impairment</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For cash and cash equivalents, the Company invests in short-term highly liquid assets where it has never incurred and does not expect to incur credit losses.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounts receivable the Company recognizes a loss allowance based on lifetime estimated credit losses (&#8220;ECL&#8221;) at each reporting date. When estimating the ECL the Company takes into consideration: readily available relevant and supportable information (this includes quantitative and qualitative data), the Company&#8217;s historical experience and forward-looking information specific to the receivables and the economic environment.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 12 &#8211; &#8220;Accounts receivable&#8221; for further information about the Company&#8217;s accounting for trade receivables.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial liabilities classification</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial liabilities are classified upon initial recognition as financial liabilities measured at fair value through income or at amortized cost. The Company&#8217;s financial liabilities include accounts payable and debt (including borrowings and lease liabilities), which are measured at amortized cost, and derivatives, which are measured at fair value through income.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest-bearing borrowings are initially recognized at fair value less directly attributable costs and subsequently measured at amortized cost using the EIR method. Gains and losses are recognized in income when the liabilities are derecognized as well as through the EIR amortization process.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortized cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included as interest expense in the statement of loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial liabilities&#8212;derecognition</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A financial liability is derecognized when the obligation under the liability is discharged or canceled or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized in the statements of loss.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in accounting policies </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Statement of Cash Flows - Interest Classification</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2025, the Company revised its accounting policy regarding the classification of interest paid and interest received in the Statement of Cash Flows. Interest paid was reclassified from Net cash flows used in operating activities to Net cash flows used in financing activities, and interest received was reclassified from Net cash flows used in operating activities to Net cash flows used in investing activities. The Company assessed the change in accounting policy under IAS 8, in accordance with the guidance regarding a voluntary change in accounting policy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification of interest paid was elected to provide a more cohesive presentation of payments related to the Company&#8217;s borrowings and lease liabilities. Prior to the change in accounting policy, interest paid on borrowings and lease liabilities were classified as operating cash flows, while proceeds from borrowings, net of transaction costs and payments of principal portion of lease liabilities are classified as financing cash flows. The change aligns interest payments with their associated transactions. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company reclassified interest received to investing activities, as the majority of interest received relates to interest earned on cash and cash equivalents and short-term investments. The Company believes this updated classification better reflects the nature and source of these cash inflows and provides more relevant and reliable information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the voluntary change in accounting policy did not have an impact on basic and diluted earnings per share under </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IAS 33 - Earnings per Share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applied the change in accounting policy retrospectively and has recast prior period comparative information within the Statement of Cash Flows to ensure consistency and comparability with the current period presentation. As part of the retrospective application, cash flows changed as follows for the year ended December&#160;31,&#160;2024: Net cash used in operating activities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $1.7&#160;million, Net cash flow used in investing activities decreased by $3.4&#160;million, and Net cash flow provided by financing activities decreased by $1.7&#160;million. Cash flows changed as follows for the year ended December 31, 2023: Net cash used in operating activities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $4.6&#160;million, Net cash flow provided by investing activities increased by $4.7&#160;million, and Net cash flow used in financing activities decreased by less than $0.1&#160;million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New standards, amendments to standards and interpretations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">New standards, amendments to standards, and interpretations issued not yet effective</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2024, IFRS 18, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Presentation and Disclosure in Financial Statements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued to achieve comparability of the financial performance of similar entities. The standard, which will replace IAS 1 impacts the presentation of primary financial statements and notes, including the statement of profit and loss where companies will be required to present separate categories of income and expense for operating, investing, and financing activities with prescribed subtotals for each new category. The standard will also require management-defined performance measures to be explained and included in a separate note within the consolidated financial statements. The standard is effective for annual reporting periods beginning on or after January 1, 2027, and requires retrospective application. While IFRS 18 will not change recognition criteria or measurement bases, it might have a significant impact on presenting information in the financial statements, in particular the income statement. The Company is currently assessing impacts and data readiness.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other IFRS Accounting Standards or IFRS IC interpretations that are not yet effective and that could have a material impact to the consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of material accounting policy information applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 176<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_176&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_SummaryOfMaterialAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_SummaryOfMaterialAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Segment reporting</a></td>
<td class="text">Segment reporting<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a single operating segment. The Company&#8217;s financial information is reviewed, and its performance assessed as a single segment by the senior management team led by the Chief Executive Officer (&#8220;CEO&#8221;), the Company&#8217;s Chief Operating Decision Maker (&#8220;CODM&#8221;). As announced in January 2026, the Company&#8217;s President will be promoted to CEO in 2026 and become the CODM.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2025 and 2024, respectively, the Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.&#160;An analysis of the location of non-current assets other than financial instruments and deferred tax assets by country is as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total non-current assets other than financial instruments <br/>and deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53,938</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48,375</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract', window );"><strong>Receivables from contracts with customers [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting estimates and judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sales transactions may consist of various performance obligations that are satisfied at different times. It requires judgment to determine when different obligations are satisfied, including whether enforceable commitments for further obligations exist and when they arise. Depending on the determination of the performance obligations and the point in time or period over which those obligations are fulfilled, this may result in all revenue being calculated at inception, and either being recognized at once, or on contract completion or spread over the term of a longer performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for contracts that contain promises to deliver more than one good or service, management has to determine how to allocate the total transaction price to the performance obligations of the contract. The total transaction price of a customer contract is allocated to the distinct performance obligations under the contract based on their standalone selling prices (&#8220;SSP&#8221;), the determination of which can require significant judgment from management. The best evidence of this is an observable price from the standalone sales of the good or service to similarly situated customers. However, where standalone selling prices are not observable, it requires judgment to estimate the cost of satisfying a performance obligation and adding an appropriate margin to that good or service. In some cases, SSP is not available and the residual approach is used to determine the stand-alone selling price of certain performance obligations. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue represents amounts received and receivable from third parties for goods supplied and services rendered to customers. Revenues are reported net of rebates and discounts and net of sales and value added taxes in an amount that reflects the consideration that is expected to be received for goods or services. The majority of the sales revenue is recognized: (i)&#160;when customers generate analyses on their patient data through the SOPHiA DDM Platform, (ii)&#160;when consumables, namely DNA enrichment kits, are delivered to customers at which point control transfers, (iii)&#160;when services, namely&#160;set-up&#160;programs, are performed and (iv)&#160;over the duration of the software licensing arrangements for the Alamut software offerings.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products and services are sold both directly to customers and through distributors, generally under agreements with payment terms typically o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f 30 to 60 days and in rare cases with payment terms extended up to&#160;180 days.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Therefore, contracts do not contain a significant financing component.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all contracts with customers the following steps are performed to determine the amount of revenue to be recognized and when it should be recognized: (1)&#160;identify the contract or contracts; (2)&#160;determine whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (3)&#160;measure the transaction price, including the constraint on variable consideration; (4)&#160;allocate the transaction price to the performance obligations based on estimated selling prices; and (5)&#160;recognize revenue when (or as) each performance obligation is satisfied.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SOPHiA DDM Platform</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the SOPHiA DDM Platform revenue is derived from each use of the SOPHiA DDM Platform by customers to generat</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e analyses on </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their patient data. Analysis revenue is recognized as analysis results are made available to the customer on the SOPHiA DDM Platform. The Company recognizes accrued contract revenue in accounts receivable for any analyses performed by customers that have not been invoiced at the reporting date and where the right to consideration is unconditional. Any payments received in advance of customers generating analyses are recorded as deferred contract revenue until the analyses are performed.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers use the SOPHiA DDM Platform to perform analyses under three different models: dry lab access; bundle access; and integrated solutions.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For dry lab contracts, customers use the testing instruments and consumables of their choice and the SOPHiA DDM Platform and algorithms for variant detection and identification. In these arrangements, the Company has identified one performance obligation, which is the delivery of the analysis result to the customer.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For bundle arrangements, customers purchase a DNA enrichment kit along with each analysis. Customers use the DNA enrichment kit in the process of performing their own sequencing of each sample. Customers then </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">upload their patient data to the SOPHiA DDM Platform for analysis. In these arrangements, the Company has identified two performance obligations: the delivery of the DNA enrichment kits and the performance of the analyses. Revenue is recognized for the DNA enrichment kits when control of products has transferred to the customer, which is generally at the time of delivery, as this is when title and risk of loss have been transferred. Revenue for the performance of the analyses is recognized on delivery of the analysis results to the customer. Refer to&#160;"&#8212;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with multiple performance obligations&#8221;&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for how revenue is allocated between the performance obligations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract revenue balances relating to analyses not performed</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within 12 months from the date of the delivery date are recognized as revenue. This policy is not based on contractual conditions but on the Company&#8217;s experience of customer behavior and expiration dates of the kits associated with the analyses.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For integrated arrangements, customers have their samples processed and sequenced through selected SOPHiA DDM Platform partners within the clinical network and access their data through the SOPHiA DDM Platform. The Company has identified one performance obligation, which is delivery of the analysis results to the customer through the SOPHiA DDM Platform.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sells access to its Alamut software application (&#8220;Alamut&#8221;) through the SOPHiA DDM Platform. Some arrangements with customers allow customers to use Alamut as a hosted software service over the contract period without the customer taking possession of the software. Other customers take possession of the software, but the utility of that software is limited by access to the Company&#8217;s proprietary SOPHiA database, which is provided to the customer on a fixed term basis. Under both models, revenue is recognized on a straight-line basis over the duration of the agreement.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also derives revenue from the SOPHiA DDM Platform by providing services to biopharma customers who engage the Company to (i)&#160;develop and perform customized genomic analyses and/or (ii)&#160;access the database for use in clinical trials and other research projects.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does enter into biopharma contracts that contain multiple products or services or&#160;non-standard&#160;terms and conditions. The biopharma contracts are generally unique in nature and each contract is assessed upon execution. Contracts may contain multiple performance obligations or performance obligations that are recognized overtime, at a point-in-time, or a combination depending on the Company&#8217;s ability to satisfy the requirements to recognize revenue over time and reasonably estimate the amount of revenue to recognize. See "&#8212;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with multiple performance obligation</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s&#8221; below for further discussion on treatment of biopharma contracts.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the primary performance obligation in these arrangements is the delivery of analysis results in the form of a final report, resulting in revenue being recognized, in most cases, upon the issuance of the final report or successful recruitment of clinical trial participants.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Workflow materials and services</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from workflow materials and services includes all revenue from the sale of materials and services that do not form part of a contract for the provision of platform services. These include the provision of&#160;set-up&#160;programs and training and the sale of kits and tests that are not linked to use of the platform.&#160;Set-up&#160;programs and training are typically combined with a customer&#8217;s first order prior to the customer beginning to use the SOPHiA DDM Platform.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from services is generally recognized when the services are performed. Revenue from materials is recognized when control of the goods is transferred to the customer, generally at the time of delivery. This category of re</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venue also includes the revenue from the sale of DNA sequencing automation equipment accounted for under IFRS 16,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;IFRS 16&#8221;), leasing </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the fees charged for the maintenance of this equipment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Arrangements with multiple performance obligations</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells different combinations of analyses, consumables, and services to its customers under its various SOPHiA DDM Platform models.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the stand-alone selling prices for services and DNA enrichment kits are directly observable. For&#160;set-up&#160;programs and training sold along with dry lab arrangements or bundle arrangements, the stand-alone selling price of these services is determined on a time and materials basis. For DNA enrichment kits sold as part of a bundle, the SSP is based on an expected cost-plus-margin approach of the kit portion of the bundle.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the SSP for the analyses, in both a dry lab arrangement and bundle arrangeme</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nt, is highly variable and therefore a representative SSP is not discernible from past transactions. As a result, the residual approach is used to determine the stand-alone selling price of the analyses in dry lab arrangements that include services and in bundle arrangements that include DNA enrichment kits and, in some cases, services.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For bundle contracts with a fixed term that also include providing the customer with DNA sequencing automation equipment, the Company determines if there is an IFRS 16 leasing component. In these arrangements the Company provides DNA sequencing automation equipment to the customer over the fixed term and at completion of the contract term the customer takes possession of the equipment. If the Company has determined that it is a dealer lessor, provision of this equipment to the customer is classified as a finance lease. Over the term of the agreement, the minimum lease payment is deducted from the proceeds of the bundle sales in order to reduce the net investment in the corresponding lease receivable over the contract term and interest income is recognized as the discount on the lease receivable unwinds. The remaining proceeds from the contract are accounted for under IFRS 15,&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;IFRS 15&#8221;), using the policies described above.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses biopharma contrac</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ts upon execution of each contract given their unique nature. The Company establishes each performance obligation within the contract and determines the appropriate value to be ascribed to each performance obligation. When relevant the Company utilizes previous established SSPs of its dry lab and bundle solutions or other service. When the performance obligation is specific to only the contract the Company utilizes all available information to reasonably estimate the correct value allocated to the performance obligation. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract balances</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Deferred contract costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract costs comprise deferred fulfillment costs related to biopharma, prepayments on contracts, and prepaid maintenance costs relating to DNA sequencing automation equipment.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs are incurred to fulfill obligations under certain contracts once obtained, but before transferring goods or services to the customer. Fulfillment costs are recognized as an asset, provided these costs are not addressed by other accounting standards, if the following criteria are met: (i)&#160;the costs relate directly to a contract or an anticipated contract that the Company can specifically identify, (ii)&#160;the costs generate or enhance resources of the Company that will be used in satisfying (or continuing to satisfy) performance obligations in the future and (iii)&#160;the costs are expected to be recovered.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The asset recognized from deferring the costs to fulfill a contract is recorded in the consolidated balance sheet as deferred contract costs within other current assets and amortized on a systematic basis consistent with the&#160;pattern of the transfer of the goods or services to which the asset relates, which depends on the nature of the performance obligation(s) in the contract. The amortization of these assets is recorded in cost of revenue.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition and billings can result in accrued contract revenue, which is presented within accounts receivable in the consolidated balance sheet and deferred contract revenue which is presented on the face of the consolidated balance sheet.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accrued contract revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued contract revenue relates to revenue recognized from satisfied performance obligations prior to invoicing and is primarily related to Dry Lab to be invoiced for the most recently completed month and some portions of biopharma contracts. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Deferred contract revenue</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract revenue relates to prepayments received from customers before revenue is recognized and is primarily related to SOPHiA DDM Platform analyses invoiced in advance of the customers performing the analyses, deferred Alamut software revenue, and progress payments received as part of biopharma contracts.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract revenue brought forward as of January&#160;1, 2025 and 2024 amounts to $5.7 million and $9.5 million, respectively. During the twelve months ended December 31, 2025 and 2024, the Company satisfied the performance obligations associated with that deferred contract revenue to the extent that revenue was recognized of $5.7 million and $9.5&#160;million, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the platform revenue is derived from contracts with</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an original expected length of one year or less. There are also certain biopharma and Alamut contracts in which performance obligations extend over multiple years, however, these contracts are immaterial. The Company has elected to apply the practical expedient not to disclose the value of remaining performance obligations associated with these types of contracts.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregated revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When disaggregating revenue, the Company considered all of the economic factors that may affect its revenues. The Company assesses its revenues by four geographic regions Europe, the Middle East, and Africa (&#8220;EMEA&#8221;); North America (&#8220;NORAM&#8221;); Latin America (&#8220;LATAM&#8221;); and Asia-Pacific (&#8220;APAC&#8221;). Additionally, the Company assesses revenues generated in its domiciled country and any country with significant revenue. The following table disaggregates the Company's revenue from contracts with customers by geographic market (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of EMEA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EMEA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55,576</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46,929</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43,958</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of NORAM</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NORAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,400</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,300</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,726</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LATAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,086</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,890</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,990</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,054</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,697</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,271</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,173</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62,371</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue streams</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue from contracts with customers has been allocated to the revenue streams indicated in the table below (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA DDM Platform</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,915&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,546&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,904&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workflow equipment and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,271</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,173</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62,371</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Workflow equipment and services includes revenues from payments from leased equipment recognized under IFRS 16, Leases. During the years ended December 31, 2025, 2024, and 2023, the Company recognized no revenue, $0.1&#160;million, and $0.1&#160;million, respectively related to leased equipment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Major Customers</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from one customer, a distributor for the Company, represented approximately $8.7 million and $8.2 million of the Company&#8217;s total revenues for the fiscal years ended December 31, 2025 and 2024, respectively. The Company did not have revenues greater than 10% from a single customer in the fiscal year ended December 31, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue from contracts with customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g105-109_TI<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g110-129_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReceivablesFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cost of revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCostOfSalesAbstract', window );"><strong>Disclosure Of Cost Of Sales [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCostOfSalesExplanatory', window );">Cost of revenue</a></td>
<td class="text">Cost of revenue<div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue comprises costs directly incurred in earning revenue, including computer costs and data storage fees paid to hosting providers, manufacturing costs, materials and consumables, the cost of equipment leased out under finance leases, personnel-related expenses and amortization of capitalized development costs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCostOfSalesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCostOfSalesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfCostOfSalesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of cost of sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfCostOfSalesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expense<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfOperatingExpenseTextBlock', window );">Operating expense</a></td>
<td class="text">Operating expense<div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs consist of personnel and related expenses for technology, application, and product development, depreciation and amortization, laboratory supplies, consulting services, computational and data storage fees paid to hosting providers related to research and development, and allocated overhead costs. These costs are stated net of government grants for research and development and innovation received as tax credits and net of capitalized costs.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Government grants for research and development and innovation received as tax credits</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company receives government grants in France for research and development and innovation by way of tax credits. Total government grants for research and development and innovation recognized in the statement of loss amounts to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.0 million, $0.7 million, and $1.1 million f</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or the years ended December 31, 2025, 2024, and 2023, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and marketing costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and marketing costs consist of personnel and related expenses for the employees of the sales and marketing organization, costs of communications materials that are produced to generate greater awareness and utilization of the platform among customers, costs of third-party market research, costs related to transportation and distribution of products and allocated overhead costs, and commissions to sales employees. The Company also records increases to, reversals of, and write-offs of the allowance for expected credit losses to selling and marketing costs.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company pays sales commission to its employees for obtaining contracts. These costs are expensed as part of employee compensation in selling and marketing costs. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The portion of commission payments to employees where the amortization period is greater than one year are capitalized and expensed as the associated revenue is recognized, see Note 14 &#8212; &#8220;Prepaids and other current assets&#8221; and Note 18 &#8212; &#8220;Other non-current assets&#8221; for the amounts capitalized.</span></div><div><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and administrative costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative costs consist of personnel and related expenses for executive, accounting and finance, legal, quality, support and human resources functions, depreciation and amortization, professional </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services fees incurred by these functions, general corporate costs and allocated overhead costs, which include occupancy costs and information technology costs.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expense</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization have been charged in the following expense categories (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5,266)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,524)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,099)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,649)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Selling and marketing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">General and administrative costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(497)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(3,976)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(5,553)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(4,575)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(4,021)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(5,508)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(2,828)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table presents employee costs by function,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which consists of &#8220;Employee benefit expenses&#8221;, &#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Social charges&#8221; and &#8220;Share-based compensation&#8221; (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93,657</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86,149</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90,181</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made adjustments to previously reported employee benefit expenses for the years ended December 31, 2024 and 2023 to include $2.2 million and $2.7 million, respectively, of employee benefit expenses included in cost of revenue to correct for immaterial misstatements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfOperatingExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of operating expense explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfOperatingExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other operating income, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_OtherOperatingIncomeExpenseNetAbstract', window );"><strong>Other Operating Income Expense Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory', window );">Other operating income, net</a></td>
<td class="text">Other operating income, net<div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records income and expenses that are not regularly occurring or normal business income and expense to other operating income, net. Other operating income, net consists of gains and losses related to the disposal of tangible assets, write-offs of intangible assets and other operating income (expense).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_OtherOperatingIncomeExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other operating income (expense), net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_OtherOperatingIncomeExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest income, Interest expense and Foreign exchange (losses) gains, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract', window );"><strong>Interest Income (Expense) And Foreign Exchange Gain (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceCostExplanatory', window );">Interest income, Interest expense and Foreign exchange (losses) gains, net</a></td>
<td class="text">Interest income, Interest expense and Foreign exchange (losses) gains, net<div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists of interest income earned on cash and cash equivalents, short-term investments, and lease receivables. Interest expense consists of interest expense incurred on lease liabilities and loans, which includes interest on commercial borrowings. The foreign exchange gains and losses arise principally on intercompany receivable balances in the parent company, whose functional currency is the Swiss Franc.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest income</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table presents interest income (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,872</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,362</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,547</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table presents interest expense (in USD thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,953)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,554)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,913)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(588)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign exchange gains (losses), net</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e table presents foreign exchange gains (losses), net (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains (losses), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total foreign exchange gains (losses), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,402)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,479</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,628)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceCostExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceCostExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income (Expense) And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income tax</a></td>
<td class="text">Income tax<div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to taxes in different countries. Taxes and related fiscal assets and liabilities recognized in the Company&#8217;s consolidated financial statements reflect management&#8217;s best estimate of the outcome based on the facts known at the balance sheet date in each individual country. These facts may include but are not limited to change in tax laws and interpretation thereof in the various jurisdictions where the Company operates. They may have an impact on the income tax as well as the resulting income tax assets and liabilities. Any differences between tax estimates and final tax assessments are charged to the statement of loss in the period in which they are incurred. Taxes include current and deferred taxes on income as well as actual or potential withholding taxes on current and expected transfers of income from subsidiaries and tax adjustments relating to prior years. Income tax is recognized in the statement of loss, except to the extent that it relates to an item directly taken to other comprehensive income/loss or equity, in which case it is recognized against other comprehensive income/loss or equity, respectively.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current income tax liabilities refer to the portion of the tax on the current year taxable profit (as determined according to the rules of the taxation authorities) and includes uncertain tax liabilities. The Company determines the taxable profit (tax loss), tax bases, unused tax losses, unused tax credits and tax rates consistently with the tax treatment used or planned to be used in its income tax filings if the Company concludes it is probable that the taxation authority will accept an uncertain tax treatment.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Otherwise, the Company reflects the effect of uncertainty using either the most likely outcome or the expected value outcome, depending on which method the entity expects to better predict the resolution of the uncertainty.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes are based on the temporary differences that arise when taxation authorities recognize and measure assets and liabilities with rules that differ from the accounting policies of the Company&#8217;s consolidated </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements. They also arise on temporary differences stemming from tax losses carried forward. Deferred taxes are measured at the rates of tax expected to prevail when the temporary differences reverse, subject to such rates being substantively enacted at the balance sheet date. Any changes of the tax rates are recognized in the statement of loss unless related to items directly recognized against other comprehensive income. Deferred tax liabilities are recognized on all taxable temporary differences excluding non-deductible goodwill. Deferred tax assets are recognized for unused tax losses, unused tax credits and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If the amount of taxable temporary differences is insufficient to recognize a deferred tax asset in full, then future taxable profits, adjusted for reversals of existing temporary differences, are considered, on the basis of the business plans for individual subsidiaries in the Company. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impact of a transaction or item can be uncertain until a conclusion is reached with the relevant tax authority or through a legal process. The Company uses in-house tax experts when assessing uncertain tax positions and seeks the advice of external professional advisors where appropriate. The assessment of the uncertain tax position is done by first making a determination of whether it is more likely than not that a tax position would be sustained upon an examination, and then by calculating the amount of the benefit, of that tax position that meets the more likely than not threshold, that should be recognized in the financial statements.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, and 2024, the Company recorded a provi</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sion of $0.2 million and $0.2 million, respectively,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for unrecognized tax liabilities including interest and penalties. The Company records interest and penalties related to income tax amounts as a component of income tax </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Uncertain tax positions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates and is therefore subject to tax examination by various taxing authorities. In the normal course of business, the Company is subject to examination by local tax authorities in Switzerland, France, Italy, Brazil, Australia, Germany, the U.K. and the U.S. In 2022 a tax assessment examination was rendered by the French tax authority during an audit of the Company&#8217;s 2018 and 2019 tax returns. In 2023, a tax assessment was rendered by the French tax authority during the review of the 2022 tax return with no additional tax liabilities resulting from the review. In 2024, a tax assessment was rendered by the Swiss tax authority regarding the Company&#8217;s 2019 through 2023 tax returns. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is not aware of any additional issues that could result in any other significant payments, accruals or material deviation from its tax positions. There are no tax examinations in progress as of December 31, 2025.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records tax liabilities or benefits for all years subject to examination based upon management&#8217;s evaluation of the facts, circumstances and information available at the reporting date. There is inherent uncertainty in quantifying income tax positions, especially considering the complex tax laws and regulations in each of the jurisdictions in which the Company operates.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of income tax (expense) benefits</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the current and deferred income tax (expense) benefits (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:56.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,115)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,542)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,270)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(255)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred income tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Origination and reversal of temporary differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred income tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(231)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,223)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(486)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reconciliation of the expected tax expense to the tax expense report in the statement of loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(77,487)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(61,270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(78,495)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at Swiss statutory rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of tax rates in foreign jurisdictions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tax effect of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Unrecognized deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,542)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(8,879)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Income not subject to tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expense not deductible for tax purposes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2,085)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,512)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,223)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(486)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Movement in the deferred tax balances</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, the Company recognized deferred tax assets for its foreign subsidiaries due to intercompany transfer pricing arrangements that will assure realization of their respective deferred tax assets in each country. The following table presents the changes in the Company&#8217;s deferred tax assets and deferred tax liabilities (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Depreciation &amp;<br/>amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net operating loss<br/>carryforward</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(136)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(897)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,047</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,150</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,767</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in profit or loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(402)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">570</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">517</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,143</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,831</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Depreciation &amp;<br/>amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net operating loss<br/>carryforward</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(761)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">794</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">696</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,010</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,720</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Recognized in profit or loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Currency translation differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(136)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(897)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,047</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,150</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,767</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">2,867&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(897)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(1,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized deferred tax assets</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company recognized deferred tax assets to the extent that it was probable that they would be realized.&#160;The following table consists of the gross tax loss carryforwards and the deferred tax assets that have not been recognized because it is not probable that there will be future taxable profits to use these benefits (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:43.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax effect</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax effect</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductible temporary differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">451,324</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60,885</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">352,156</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,205</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net operating loss carryforwards</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company had various net operating loss (&#8220;NOL&#8221;) carryforwards in Switzerland, the U.K., the U.S., and Brazil that are available to reduce future taxable income and income taxes, the majority of which will expire at various dates through</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2032.&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company had the following expiring amounts of unrecognized NOL carryforwards (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Two years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Four years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter and unlimited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">443,992</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">347,533</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future realization of the tax benefits of existing temporary differences and NOL carryforwards ultimately depends on the existence of sufficient taxable income within the carryforward period. As of December 31, 2025, the Company performed an evaluation to determine the likelihood of realization of these tax benefits. In assessing the realization of the deferred tax assets, the Company considered whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company considered all available evidence, both positive and negative, which included the results of operations for the current and preceding years. The Company determined that it was not possible to reasonably quantify future taxable income and determined that it is not probable that all of the deferred tax assets will be realized in Switzerland and Brazil but has recognized deferred tax assets in France, Italy, the U.K. and the U.S.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unrecognized deferred tax liability on retained earnings of subsidiaries</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews its plan to indefinitely reinvest on a periodic basis for each one of its foreign subsidiaries. In making its decision to indefinitely reinvest, the Company evaluates its plans of reinvestment, its ability to control repatriation and to mobilize funds without triggering basis differences, and the profitability of its Swiss operations and associated cash requirements and the need, if any, to repatriate funds. If the assessment of the Company with respect to any earnings of its foreign subsidiaries&#8217; changes, deferred Swiss income taxes, foreign income taxes, and foreign withholding taxes may have to be accrued.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not provide for foreign income and withholding taxes, Swiss income taxes or</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> tax benefits on the excess of the financial reporting basis over the tax basis of its investments in foreign subsidiaries to the&#160;extent that such amounts are indefinitely reinvested to support operations and continued growth plans outside of Switzerland, or if the Company has determined that no tax liability would arise in case of distribution. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, the Company plans to indefinitely reinvest any undistributed foreign </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">earnings for all its foreign subsidiaries except France. During the year 2025, the Company received a dividend payment from its French subsidiary in the amount of $3.5 million, paid on August&#160;28, 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the year 2024, the Company received a dividend payment from its French subsidiary in the amount of $3.3 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">repatriation of foreign earnings from France does not trigger a tax liability, based on the application of Swiss Participation Exemption rules and exemptions provided by the Double Tax Treaty signed between France and Switzerland, based on which </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dividends are exempt from withholding tax. The total amount of temporary differences associated with the other investments in subsidiaries is not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Loss per share</a></td>
<td class="text">Loss per share<span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s shares comprised of ordinary shares. Each share has a nominal value of $0.06&#160;(CHF&#160;0.05). The basic loss per share is calculated by dividing the net loss attributable to shareholders by the weighted average number of shares in issue during the period excluding treasury shares, which are owned by the Company.&#160;The table presents the loss for the year ended December 31, 2025, 2024, and 2023, respectively (in USD thousands, except shares and loss per share):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributed to shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,999)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,981)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of shares in issue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,539,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,062,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,750,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic and diluted loss per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.17)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.95)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2025, 2024 and 2023, the potential impact, on the calculation of loss per share, of the existing potential ordinary shares related to the share option plans and warrants are not presented, as the impact would be to dilute a loss, which causes them to be deemed &#8220;non-dilutive&#8221; for the purposes of the required disclosure, for additional details refer to Note 22 &#8212; &#8220;Share-Based Compensation&#8221; and Note 23 &#8212; &#8220;Borrowings&#8221;.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory', window );">Cash and cash equivalents</a></td>
<td class="text">Cash and cash equivalents<div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash on hand, deposits held at call with external financial institutions, money market funds, and short-term deposits and other short-term highly liquid investments with original maturities of three months or less. They are both readily convertible to known amounts of cash and so near to their maturity that they present insignificant risk of changes in value because of changes in interest rates. Amounts held in money market funds are classified as cash equivalents and are measured as level 1 fair value financial instruments. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the allocation between the Company&#8217;s cash and cash equivalents (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash on hand</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,459</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,783</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term deposits less than 3 months</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,302</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,857</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32,830</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,443</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70,289</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80,226</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">Accounts receivable</a></td>
<td class="text">Accounts receivable<div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable-trade balances are&#160;non-interest&#160;bearing and payment terms are generally under agreements with payment terms typically between 30 and 60 days with payment terms extended up to&#160;180 days. The Company&#8217;s customers primarily consist of government-owned or government-funded hospitals, laboratories with low credit risk, and biopharmaceutical companies. The Company has had minimal instances of actual credit losses and believes that this will continue to be the case.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted the simplified method indicated in IFRS 9,&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;IFRS 9&#8221;), to build its allowance for expected credit losses (&#8220;ECL&#8221;). The Company uses a matrix based on a calculation of collectability rates according to historical accounts receivable. Allowance is made for lifetime expected credit losses as invoices are issued or when accrued revenue is recognized. The amount of allowance initially recognized is based on historical experience, tempered by expected changes in future cash collections, due to, for example, expected improved customer liquidity or more active credit management.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the trade receivable</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, accrued contract revenue,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and lease receivable less the expected credit loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for expected credit losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,001</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,436</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records increases to, reversals of, and write-offs of the allowance for expected credit losses as &#8220;Selling and Marketing&#8221; expenses within its consolidated statements of loss. The following table provides a rollforward of the allowance for expected credit losses for the year ended December 31, 2025 and 2024, that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,181</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-off</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">366</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company&#8217;s largest customer balance represented&#160;15% and&#160;18% of accounts receivable, respectively. All customer balances that individually exceeded&#160;1% of accounts receivable in aggregate amounted to $8.3 million and $5.0 million as of December 31, 2025 and 2024, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded no long-term lease receivables as of December 31, 2025 and 2024, respectively. As of December 31, 2025 and 2024, the Company recorded no net lease receivables, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInventoriesExplanatory', window );">Inventory</a></td>
<td class="text">Inventory<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials and finished goods are stated at the lower of cost calculated using the first-in, first-out (&#8220;FIFO&#8221;) method and net realizable value. Work in progress is stated at the lower of its weighted average cost and net realizable value. Cost comprises direct materials, direct labor, and an appropriate proportion of variable and fixed overhead expenditure, the latter being allocated on the basis of normal operating capacity.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,868</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory provision movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,084)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(554)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-off</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,443)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,084)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInventoriesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS02_g36-39_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInventoriesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and other current assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_PrepaymentsAndOtherCurrentAssetsAbstract', window );"><strong>Prepayments And Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory', window );">Prepaids and other current assets</a></td>
<td class="text">Prepaids and other current assets<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents prepaids and other current assets (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grants receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current contract acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,438</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,875</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2025, $0.2 million of current contract acquisition costs were amortized through Selling and marketing costs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of prepayments and other assets. [Refer: Other assets; Prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_PrepaymentsAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaids and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_PrepaymentsAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Disclosure of detailed information about property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property and equipment</a></td>
<td class="text">Property and equipment<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment include leasehold improvements, computer hardware, machinery, and furniture and fixtures.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are shown on the balance sheet at their historical cost. The cost of an asset, less any residual value, is depreciated using the straight-line method over the useful life of the asset. For this purpose, assets with similar useful lives have been grouped as follows:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Leasehold improvements&#8212;Shorter of the useful life of the asset or the remaining term of the lease</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Computer hardware&#8212;<span style="-sec-ix-hidden:f-909">Three</span> to five years</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Machinery and equipment&#8212;Five years</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Furniture and fixtures&#8212;Five years</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Useful lives, components, and residual amounts are reviewed annually. Such a review takes into consideration the nature of the assets, their intended use, including but not limited to the closure of facilities, and the evolution of the technology and competitive pressures that may lead to technical obsolescence. Depreciation of property and equipment is allocated to the appropriate headings of expenses by function in the statement of loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reviews of the carrying amount of the Company&#8217;s property and equipment are performed when there is an indication of impairment. If any such indication exists, then the asset&#8217;s recoverable amount is estimated. The recoverable amount of an asset is the greater of its value in use and its fair value less costs of disposal. In assessing the value in use, the estimated future cash flows are discounted to their present value, based on the time value of money and the risks specific to the country where the assets are located.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company rec</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ords property and equipment under</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> accrued expense for amounts to be paid within the next 12 months. F</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or the year ended December 31, 2025, $1.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was recorded in accrued expense for property and equipment, an</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d for the year ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2024, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no amounts were recorded.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Computer hardware</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,456</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,861</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,361</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,244</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,922</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,285</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,557</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,466</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,216</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,524</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,615)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(973)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(955)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,713)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,810)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(399)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,943)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,658)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,218)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,040)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,859)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">899</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">248</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">176</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,665</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Computer hardware</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,855</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,975</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,460</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,310</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,600</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(485)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(815)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,456</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,861</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,361</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,244</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,922</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,576)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,935)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,615)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,170)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(973)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(955)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,713)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,841</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">691</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">388</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">289</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in leasehold improvements and machinery and equipment are </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.1 million and</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$0.3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively, related to assets under construction that have not yet been placed into service and begun depreciating as of December 31, 2025. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assets are primarily related to a lab expansion that was completed in early 2026.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible Assets</a></td>
<td class="text">Intangible Assets<div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill impairment testing</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as&#160;a single cash-generating unit (&#8220;CGU&#8221;). As a single CGU, goodwill is tested by considering its recoverability in terms of the entire business. Management assesses the recoverable value of </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">goodwill by comparing the Company&#8217;s equity value, either from observable market prices or based on discounted cash flow </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forecasts, to the net assets as reported in the Company&#8217;s consolidated financial statements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment testing is performed on an annual basis as of October 1. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized internally developed software costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized costs are based on the employment costs of individuals working on software development and based on timesheets. Special attention is paid to distinguishing between costs incurred on developing new software or software upgrades, which typically are eligible for capitalization, and costs incurred in maintenance and in the correction of problems, which are not eligible.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgment is required in identifying whether individual projects meet all of the criteria required to permit capitalization, in particular, whether the software will generate probable future economic benefits.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is initially measured as the difference between the aggregate of the value of the consideration transferred and the fair value of net assets acquired. Goodwill is not amortized but it is tested for impairment annually, or more frequently if events or changes in circumstances indicate that it might be impaired and is carried at cost less accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment testing</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are allocated to CGUs for the purpose of impairment testing. The allocation is made to those CGUs or groups of CGUs that are expected to benefit from the business combination in which the goodwill arose. The CGUs or groups of CGUs are identified at the lowest level at which goodwill is monitored for internal management purposes, being the operating segments. As the Company operates as a single CGU, the Company has only a single cash generating unit for impairment testing.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assesses the recoverable value of goodwill by comparing the Company&#8217;s equity value, either inferred from the public prices of share issues based on the fair value less cost of disposal (&#8220;FVLCOD&#8221;) method or based on discounted cash flow forecasts, with the net assets as reported in its consolidated financial statements based on the value in use (&#8220;ViU&#8221;) method. The discounted cash flow approach involves key assumptions that leave considerable scope for judgment. The Company typically compares the two methods and utilizes the greater recoverable amount for the purposes of its impairment testing. Impairment testing is performed on an annual basis as of October 1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchased software</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs of accessing software services are not capitalized if the Company does not have any contractual right to take possession of the software at any time during the term of the agreement and it is not feasible for the Company either to run the software on its own hardware or to contract with a third party unrelated to the vendor. Such costs represent software as a service costs and are expensed as incurred.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does capitalize software implementation costs, such as fees paid to outside consultants to set up a software arrangement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For cloud computing costs, the Company capitalized costs for certain configuration and customization costs paid by a customer in a cloud computing or hosting arrangement. IAS 38 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible assets (&#8220;IAS 38&#8221;)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aligns the accounting treatment of these costs incurred in a hosting arrangement treat</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ed as a service contract with the requirements for capitalization and amortization costs to develop or obtain an intangible asset.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased software and associated capitalized costs are amortized using the&#160;straight-line method&#160;over an estimated life of five years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized internally developed software costs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in the internal development of software are capitalized as intangible assets when they satisfy the criteria required by IAS 38 as set out below.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software development costs consist entirely of capitalized internally generated costs that are directly attributable to the design, testing, and enhancement of identifiable and unique software applications and products controlled by the Company and incorporated principally within the Company&#8217;s SOPHiA DDM Platform. They are recognized as intangible assets where the following criteria are met:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">it is technically feasible to complete the software so that it will be available for use;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">management intends to complete the software and use or sell it;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">there is an ability to use or sell the software;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">it can be demonstrated how the software will generate probable future economic benefits;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">adequate technical, financial, and other resources to complete the development and to use or sell the software are available, and;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the expenditure attributable to the software during its development can be reliably measured.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directly attributable costs that are capitalized as part of the software comprise principally employee costs. Capitalized development costs are recorded as intangible assets and amortized from the point at which the asset is ready for use on a straight-line basis over its expected useful life. Capitalized software development costs are amortized using the&#160;straight-line method&#160;over an estimated life of&#160;five years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased software</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capitalized internally developed software costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total intangible assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,046</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,321</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,709</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,556</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,748</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,616</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53,920</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,466)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,711)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,563)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,755)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,029)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14,000)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18,029)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,556</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">719</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,616</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,891</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased software</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capitalized internally developed software costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total intangible assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,999</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,162</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,367</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34,528</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,751)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,046</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,321</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,709</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,001)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,021)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,245)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,466)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,711)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">801</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,855</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,998</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill arose from the Company&#8217;s acquisition of Interactive Biosoftware (&#8220;IBS&#8221;) in June 2018. Through this acquisition the Company added Alamut (a genomic mutation interpretation software) to its existing SOPHiA DDM Platform.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is tested for impairment on an annual basis as of October 1 and at the occurrence of a potential indication of impairment. A triggering assessment is performed each quarter to ensure no occurrence of impairment triggering events. As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively,&#160;no&#160;impairment charges were recorded related to the Company&#8217;s goodwill.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 1, 2025 and 2024, respectively, the Company utilized the equity method (&#8220;FVLCOD&#8221;) to perform its annual assessment. The estimated equity value of the Company as of October 1, 2025 was $301.9&#160;million, which exceeds the reported net assets of the Company of $60.7&#160;million at that date by $241.2&#160;million. The estimated equity value of the Company as of October 1, 2024 was $242.5 million, which exceeds the reported net assets of the Company of $113.5 at that date by $129.0&#160;million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the basis of the analyses performed, the Company concludes that the recoverable amount exceeds the carrying amount of the goodwill and&#160;no&#160;impairment is needed as of December 31, 2025 and 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Presentation of leases for lessee [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfLeasesExplanatory', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses at inception of the contract whether a contract is or contains a lease. This assessment involves determining whether the Company obtains substantially all the economic benefits from the use of that asset, and whether the Company has the right to direct the use of the asset. When these conditions are met, the Company recognizes a&#160;right-of-use&#160;(&#8220;ROU&#8221;) asset and a lease liability at the lease commencement date, except for short-term leases of 12 months or less, which are expensed in the statements of loss on a straight-line basis over the lease term.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, the ROU asset comprises the initial lease liability, initial direct costs, and any obligations to refurbish the asset, less any incentives granted by the lessors.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ROU asset is depreciated over the shorter of the duration of the lease contract (including contractually agreed optional extension periods whose exercise is deemed to be reasonably certain) and the useful life of the underlying asset.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ROU asset is subject to testing for impairment if there is an indicator for impairment, as for owned assets.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that is not readily determinable, the incremental borrowing rate (&#8220;IBR&#8221;) at the lease commencement date. The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. Lease payments can include fixed payments; variable payments that depend on an index or rate known at the commencement date; and extension option payments or purchase options that the Company is reasonably certain to exercise.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease liability is subsequently measured at amortized cost using the effective interest rate method and remeasured (with a corresponding adjustment to the related ROU asset) when there is a change in future lease payments due to renegotiation, changes in an index or rate, or a reassessment of options.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s leases include options to extend the lease, and these options are included in the lease term to the extent they are reasonably certain to be exercised.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases out laboratory equipment to certain customers. These leases are classified as finance leases as the Company transfers substantially all the risks and rewards incidental to ownership of the asset to the customer. Refer to Note 4 &#8212; &#8220;Revenue&#8221; fo</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r disclosure of revenue recognized from leased laboratory equipment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the commencement of the lease term, the Company records revenue and the associated costs of sales, being the sale proceeds at fair value of the asset (computed at cost plus a margin) and the cost of the asset, derecognizes the leased asset from inventory, and recognizes a finance lease receivable on the balance sheet equal to the net investment in the lease. The Company notes these lease agreements ended during 2023, and as of December 31, 2025 and 2024, the Company did not have any leases of laboratory equipment. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company leases</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, the Company entered into&#160;one&#160;office lease as described below.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rolle office</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2021, the Company entered into a&#160;120-month lease for office space in Rolle, Switzerland primarily to support the expansion of the research and development department. The lease in total is for approximately&#160;65,860&#160;square feet, including an additional 21,258 square feet based on a lease amendment as described below, with the Company gaining access to areas on prescribed dates. The Company gained access to&#160;38,761&#160;square feet on July 1, 2021,&#160;5,840&#160;square feet on January 1, 2022, and the remaining&#160;21,258&#160;square feet on February 1, 2023. The&#160;expected lease commitments&#160;are linked to changes in the Swiss Consumer Price Index as published by Swiss Federal Statistical Office.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2022, the Company entered into an amendment to the lease for office space in Rolle, Switzerland. The amendment provides the Company with an additional floor of approximately 21,258 square feet with lease commencement initiating on April 1, 2022. Upon commencement of the lease, the Company recorded a right-of-use asset of $4.5&#160;million and a lease liability of $4.5&#160;million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company makes fixed payments and additional variable payments depending on the usage of the asset during the contract period. Upon commencement of the lease, the Company recorded a ROU asset of $7.7&#160;million and a lease liability of $8.5&#160;million. The difference between the ROU and lease liability of $0.8&#160;million is driven by lease incentives and expected restoration costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Boston office</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2024, the Company entered into a 73-month lease for office space in Boston, Massachusetts primarily to support the expansion of the Company&#8217;s growth in the United States. The lease in total is for approximately 12,807 square feet. The Company makes fixed payments and additional variable payments depending on the usage of the asset during the contract period. Upon gaining access to the space in September 2024, the Company recorded a right-of-use asset of $2.0&#160;million and a lease liability of $1.9&#160;million. The difference between the ROU and lease liability of less than $0.1&#160;million is driven by initial direct costs to obtain the lease. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Bidart office</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2023, the Company entered into a 108-month lease for office space in Bidart, France primarily to support the expansion of the research and development department and the Company&#8217;s administrative functions. The lease in total is for approximately 13,509 square feet. Upon commencement of the lease, the Company recorded a right-of-use asset of $2.3&#160;million and a lease liability of $2.3&#160;million. The expected lease commitments resulting from this contract are $0.1&#160;million in 2023 and $0.3&#160;million per year from 2024 onward.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, lease terms for office buildings are between <span style="-sec-ix-hidden:f-1144">one</span> and&#160;ten years. Any leases with terms less than 12 months and/or with low value are expensed in accordance with the IFRS 16 practical expedients for short-term leases and&#160;low-value&#160;leases. These expenses amounted to $0.1&#160;million,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> less than $0.1&#160;million, and $0.1&#160;million for the years ended December 31, 2025, 2024, and 2023, respectively. The Company had cash outflows related to leases less than 12 months and/or with low value of $0.1&#160;million, less than $0.1&#160;million, and $0.1&#160;million for the years ended December 31, 2025, 2024, and 2023, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has lease liabilities amounting to $12.7&#160;million and $12.1&#160;million for the years ended December 31, 2025 and 2024, respectively, that are linked to consumer price indices in Switzerland, France, and the United States.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future cash flow in relation to short-term leases and leases of low value assets is disclosed in Note 25 &#8212; &#8220;Commitments and contingencies.&#8221;</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future cash flow in relation to leases accounted for under IFRS 16 is disclosed in Note 26 &#8212; &#8220;Financial instruments and risks.&#8221;</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has several leases with extension and termination options. Management determines, on the basis of the business needs, whether they expect to exercise these options.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that is not readily determinable, the IBR at the lease commencement date. The IBR is the rate of interest that the Company would have had to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. On the basis of this policy, the IBRs used by the Company to discount lease payments outstanding at December 31, 2025 and 2024, respectively, in the countries in which it has recognized&#160;right-of-use&#160;assets and lease liabilities have been in the range of&#160;to&#160;2.76% and 11.42% and&#160;2.76% to&#160;11.42%, respectively. The Company notes the variation in IBRs used is due to the timing of lease commencement as well as geographical differences based on the physical location of the lease.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presen</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ts the ROU assets (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Office space leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,382</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,168</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2025 and 2024, the Company had additions to ROUs of $0.4 million and $2.2 million, respectively and depreciation charges of $2.2 million and $2.6 million, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the lease liabilities (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.909%"><tr><td style="width:1.0%"></td><td style="width:51.083%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.891%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,587&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,603&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,793</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2025 and 2024, the Company made payments of $2.5 million and $3.3 million, respectively, of which $0.7 million and $0.6 million was interest, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Section Presentation<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g47-50_TI<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS16_g51-60_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other non-current assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousNoncurrentAssetsAbstract', window );"><strong>Miscellaneous non-current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory', window );">Other non-current assets</a></td>
<td class="text">Other non-current assets<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets consist of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantee deposits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non&#8209;current contract acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,183</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,762</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other non-current assets. [Refer: Other non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousNoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousNoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory', window );">Accounts payable</a></td>
<td class="text">Accounts payable<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable consist of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade payables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related payables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT, sales, and other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,960</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,220</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedExpensesAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory', window );">Accrued expenses</a></td>
<td class="text">Accrued expenses<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued IT support</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued legal fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,736</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,217</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of accrued expenses and other liabilities. [Refer: Accruals; Other liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccruedExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccruedExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract', window );"><strong>Disclosure Of Information About Post Employment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory', window );">Post-employment benefits</a></td>
<td class="text">Post-employment benefits<div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting estimates and judgments</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability or asset recognize</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d on the balance</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation at the end of the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by independent actuaries using the projected unit credit method.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms approximating to the terms of the related obligation. In countries where there is no deep market in such bonds, the market rates on government bonds are used.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the statement of loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remeasurement gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which they occur, directly in other comprehens</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ive income. The remeasurement gains and losses are included in retained earnings in the statement of changes in equity and on the balance sheet.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in income as past service costs.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For defined contribution plans, the Company pays contributions to publicly or privately administered pension insurance plans. Employee contributions to these plans is voluntary and these contributions are matched by the employer. The Company has no further payment obligations once the contributions have been paid. The contributions are recognized as employee benefit expense when they are due. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in the future payments is available. Contributions are charged to the statement of loss as incurred.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates defined benefit and defined contribution pension plans. Funded schemes are generally funded through payments to insurance companies or trustee-administered funds, determined by periodic actuarial calculations. A defined </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity (a fund) and has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods. A defined benefit plan is a pension plan that is not a defined contribution plan. Typically, defined benefit plans define an amount of pension benefit that an employee will receive on retirement, usually dependent on one or more factors such as age, years of service and compensation.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual return on plan assets, excluding interest income measured at the discount rate, is recognized in other comprehensive income/loss within defined benefit plan remeasurements.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a funded defined benefit plan in Switzerland, an unfunded defined benefit plan in France, and a defined</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contribution plan in the U.S. The Company has no occupational pension plans in the U.K. and Brazil.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Swiss pension plan</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracted with the Swiss Life Collective BVG Foundation based in Zurich for the provision of occupational benefits. All benefits in accordance with the regulations are reinsured in their entirety with Swiss Life SA within the framework of the corresponding contract. This pension solution fully reinsures the risks of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disability, death and longevity with Swiss Life. Swiss Life invests the vested pension capital and provides a&#160;100% capital and interest guarantee. The pension plan is entitled to an annual bonus from Swiss Life comprising the effective savings, risk and cost results. As of January 1, 2025, the Company switched from Swiss Life Collective BVG Foundation to Profond for the provision of occupational benefits. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the amount of ultimate pension benefit is not defined, certain legal obligations of the plan create constructive obligations on the employer to pay further contributions to fund an eventual deficit; this results in the plan nevertheless being accounted for as a defined benefit plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">French pension plan</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In France, the bulk of pensions are paid by national pension schemes, which are unfunded. In addition, French employers are obliged by law to pay a retirement indemnity. Its amount depends on the last salary of the employee and on the period of activity with its employer. Rights to this benefit are acquired during the service life with the same employer on the condition that the employee will be with its employer at retirement date; it means that the rights are only vested on retirement date. This indemnit</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y is in substance a defined benefit plan.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional details on the defined benefit plans&#8217; funded status (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of defined benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,429)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net pension liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,162)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,839)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the movement in the defined benefit obligation (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,147)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(52)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,199)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(22,972)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,013)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,827)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,841)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">of which current service cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,841)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,683)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">of which past service cost including effects from curtailment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(942)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(942)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual plan participants&#8217; contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers (in) out due to (joiners) leavers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28,345)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(84)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28,429)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,147)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,199)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The service cost and interest expense are charged to the statement of loss as research and development, general and administrative costs, selling and marketing, and interest income, net, respectively. Actuarial gains (losses) are credited or charged to other comprehensive income (loss) as defined benefit plan remeasurements.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s of December 31, 2025, the Swiss and French plans had&#160;210&#160;and 89&#160;active members, respectively. As of December 31, 2024, the Swiss and French plans had&#160;209&#160;and&#160;84&#160;active members, respectively.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the reduction in conversion factors, the Company incurred a past service cost</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gain including curtailment of $0.9&#160;million </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the year ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the movement in the defined benefit plans&#8217; assets (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,360</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,927</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on plan assets, excl. interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers in (out) due to joiners (leavers)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,587)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,644)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,485)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,360</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the defined benefit plan assets, which include the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,895</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,360</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">French plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swiss plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,360</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Profond, and previously the Swiss Life Collective BVG Foundation, to which the Swiss pension plan is affiliated, manages its funds in the interests of all members, with due attention to the priorities of liquidity, security, and return. The Company&#8217;s pension plan benefits from the economies of scale and diversification of risk available through this affiliation. The Company has no influence over the investment policy.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the pension costs recognized in sta</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tement of loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.935%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,827)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,841)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,625)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,637)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,311)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,321)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,851)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,867)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,648)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,661)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,724)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,735)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the pension remeasurement recognized in statement of other comprehensive loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.328%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in demographic assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in financial assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">185</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">180</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">401</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">403</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">709</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">704</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">326</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(216)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(212)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demographic assumptions had no impact for 2025</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as these assumptions had no significant changes from 2024. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The positive impact of changes in demographic assumptions in 2023 was due principally to an increase in the weighted turnover f</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rom&#160;15.80% to&#160;19.50%. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The positive impact of changes in financial assumptions for the funded plan in 2025 was due to an increase in the discount rate from 0.95% to 1.10%.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The negative impact of chan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ges in financial assumptions in 2024 was due to a decrease in the discount rate from 1.50% to 0.95%.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The negative experience adjustments for the funded plan in 2025 was primarily due to actual effective salary increases exceeding the assumed rate as well as by departure-related payments that were lower than expected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The positive experience adjustments in 2024 was due largely to the surplus between the additional defined benefit obligation attributable to new joiners and the assets that they transferred into the plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key actuarial assumptions by plan</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Discount rate</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In estimating the defined benefit obligation, the discount rates used were, for the Swiss plan, 1.10% and&#160;0.95% and, for the French plan,&#160;4.05% and&#160;3.55% for the years ended December 31, 2025 and 2024, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Expected rate of salary increase</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">T</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he expected rate of annual salary increase was assumed to be, for the Swiss plan,&#160;2.50% and&#160;2.50% and, for the French plan,&#160;3.00% and&#160;3.00% for the years ended December 31, 2025 and 2024, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Pension plan modified duration</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average modified duration of the Swi</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ss plan is 13.7 and&#160;13.6 years and of the French plan 15.1 and&#160;15.3 years for the years ended December 31, 2025 and 2024, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Interest rates</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the Swiss plan, the interest on old age accounts is 2.30% for the year ended December 31, 2025. For the year ended December 31, 2024 the interest on old age accounts is based, for the LPP account, on the LPP interest rate, which was&#160;2.30% and, for the extra mandatory part, is equivalent to the discount rate, which was&#160;2.30%.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Inflation</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected annual rate of inflation was assumed to be, for the Swiss plan, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.75% </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.00%</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for the French plan </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.00% </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.00%</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the years ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exp</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ected annual rate of inflation for the Swiss plan is based on the inflation forecast of the Swiss National Bank. and for the French plan is based on the inflation forecast of the European Central Bank.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Mortality tables</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions regarding future mortality experience are set based on actuarial advice provided in accordance with published statistics and experience and are based on the mortality generational tables BGV 2020 (Swiss) and TH/TF&#160;00-02&#160;(French). For the Swiss plan, the average life expectancy in years after retirement of a pensioner retiring at age 65 (male) and 65 (female) on the balance sheet date is, respe</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ctively, 23.07 and 24.81 and 22.82 and 24.59, for the years ended December 31, 2025 and 2024, respectively.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sensitivity analysis</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables demonstrate the sensitivity of the defined benefit obligations to changes in the discount rate, expected rates of salary increase, interest credited on savings accounts (interest rate), inflation, and life expectancy at retirement age.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the sensitivity analysis for the funded plans (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of 25 basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(763)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(682)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 25 basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected rates of salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of 25 basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 25 basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of 25 basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 25 basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inflation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of 25 basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 25 basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Life expectancy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of 1 year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 1 year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the sensitivity analysis for the unfunded plans (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of&#160;50&#160;basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 50 basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected rates of salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of&#160;50&#160;basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 50 basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above sensitivity analyses are based on a change in an assumption while holding all other assumptions constant. In practice, this is unlikely to occur, and changes in some of the assumptions may be correlated. When calculating the sensitivity of the defined benefit obligation to significant actuarial assumptions the same method (present value of the defined benefit obligation calculated with the projected unit credit method at the end of the reporting period) has been applied as when calculating the pension liability recognized on the balance sheet.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The methods and types of assumptions used in preparing the sensitivity analysis did not change compared to the prior period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future employer contributions</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected employer contributions to the Swiss defined benefit pension plan for the year ending December 31, 2026 amount to $1.3&#160;million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defined contribution plans</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. pension plan</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a multiple employer 401(k) defined contribution plan in the U.S. The expense recognized in respect of the defined contribution plan in the U.S. was $0.3&#160;million for the years ended December 31, 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Section Scope<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS19_g2-7_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of information about post-employment benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory', window );">Share-based compensation</a></td>
<td class="text">Share-based compensation<div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting estimates and judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-based Compensation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2025, 2024, and 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company granted share options under one plan - the SOPHiA GENETICS 2021 Equity Incentive Plan (the &#8220;2021 Equity Incentive Plan&#8221; or the &#8220;2021 EIP&#8221;). Under this plan, directors may offer options to directors, employees, and advisors. The exercise price of the share options is set at the time they are granted. Options, once vested, can be exchanged for an equal number of ordinary shares.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measuring the cost of share options</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options under all plans are measured at each grant date using the Black-Scholes option pricing model, taking into account the terms and conditions upon which the options were granted.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For options up to September 2020, the fair value at grant date is independently determined using an adjusted form of the Black-Scholes option pricing model that takes into account the strike price, the fair value of the share at grant date, the expected life of the award, the expected price volatility of the underlying share, the risk-free interest rate for the term of the award, and the expected dividend yield.&#160;For options granted on and subsequent to September&#160;2020 until July 22, 2021, the fair value at grant date is based </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on a probability-weighted expected returns method that takes account of both the value derived by using an adjusted form of the Black-Scholes </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">option pricing model, as described above, and a discounted estimate of the price that might be achieved in a future transaction.&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For options granted on and subsequent to July 22, 2021, the fair value at grant date is determined by using the Black-Scholes option pricing model.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has used an independent valuation firm to assist in calculating the fair value of the award grants per participant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key inputs used in the valuation model, for the stock options granted in the years ended December 31, 2025, 2024, and 2023, respectively, are outlined below. Stock options were only granted under the 2021 Equity Incentive Plan (&#8220;2021 EIP&#8221;).&#160;No&#160;grants have been made under the 2019 Incentive Share Option Plan (&#8220;2019 ISOP&#8221;) since 2021 and the SOPHiA GENETICS Incentive Share Option Plan (&#8220;2013 ISOP&#8221;) since 2019.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Company&#8217;s IPO, the price of the ordinary shares at grant date, which represents a critical input into this model, has been determined on one of the following two bases:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">B</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y reference to a contemporaneous transaction involving another class of share, using an adjusted form of the Black-Scholes option pricing model as described above, and considering the timing, amount, liquidation preferences, and dividend rights of issues of other classes of shares.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">On the basis of discounted cash flow forecasts, where there was no contemporaneous or closely contemporaneous transaction in another class of share and the time interval was too large to permit an assumption that there had been no significant change in the Company&#8217;s equity value.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the IPO, the price of the ordinary shares at grant date, which represents a critical input into this model, has been determined on the most recent close price of the Company&#8217;s stock price on the date of grant.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has&#160;three&#160;share option plans for directors, employees, and advisors which are accounted for as equity-settled share-based compensation plans.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options granted under these plans is recognized as an employee benefits expense, with a corresponding increase in equity. The total amount to be expensed is determined by reference to the fair value of the options granted:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">including any market performance conditions (e.g., the entity&#8217;s share price);</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">excluding the impact of any service and non-market performance vesting conditions (e.g., profitability, sales growth; targets and remaining an employee of the entity over a specified time period), and;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">including the impact of any non-vesting conditions (e.g., the requirement for employees to save or hold shares for a specific period of time).</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total expense is recognized over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied. At the end of each period, the entity revises its estimates of the number of options that are expected to vest based on the non-market vesting and service conditions. It recognizes the impact of the revision to original estimates, if any, in income, with a corresponding adjustment to equity.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating fair value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including the share price, or the fair value of a share, the expected life of the share option, the volatility of the share price, the risk-free interest rate, the dividend yield, and making certain assumptions about the inputs. The assumptions used for estimating fair value for share-based payment transactions are disclosed below.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The volatility used in the estimation of fair value is calculated utilizing a mix of the Company&#8217;s own share price volatility and the volatility of the share prices of a set list of publicly traded peer companies based on a defined proportion. Share price volatility is calculated for each tranche of share options on a historical basis over a </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period of time equal to the average life of the share options granted in each tranche. In the event that a company used in the volatility calculation has not been publicly traded for the requisite amount of time, the entirety of its trading history was used.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the shares are not listed, estimating their fair value also requires determination of the most appropriate valuation model, such as:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">By reference to a contemporaneous transaction involving another class of share, using an adjusted form of an option pricing model above, and considering the timing, amount, liquidation preferences and dividend rights of issues of other classes of shares;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">On the basis of discounted cash flow forecasts, where there was no contemporaneous or closely contemporaneous transaction in another class of share and the time interval was too large to permit an assumption that there had been no significant change in the Company&#8217;s equity value;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Share based compensation expense is measured at the fair value of the options at the grant date and recognized over the vesting period. Share based compensation expense is presented in the statement of loss and allocated to the various expense categories based on the functions of the employees to whom the options are granted (e.g., research and development, selling and marketing, general &amp; administrative).</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the cost of the Company&#8217;s share option grants and of the fair value of the ordinary shares at the grant date requires the selection of an appropriate valuation model and is based on key assumptions that leave considerable scope for judgment.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recognizing the cost of share options</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each reporting date, the Company recognizes expense for the vested options granted and for partially earned but&#160;non-vested&#160;portions of options granted. This results in a front-loaded expense to the statement of loss. The Company accounts for these plans as equity-settled transactions. The charge to the statements of loss therefore results in a corresponding credit being booked to &#8220;Other reserves&#8221; within equity.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The plans</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has&#160;three&#160;share option plans: the 2013 ISOP (launched in&#160;September 2013), the 2019 ISOP (launched&#160;March 2019), and the 2021 EIP (launched&#160;June 2021). Under these plans, directors may offer options to directors, employees, and advisors. The exercise price of the share options is set at the time they are granted. Options, once vested, can be exchanged for an equal number of ordinary shares. Under the 2021 EIP, the Company can grant restricted stock units (&#8220;RSUs&#8221;) which represent the right to receive ordinary shares upon meeting specific vesting requirements. RSUs are able to be granted to directors, executives, and employees.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The options have a life of&#160;ten years.&#160;Options under the 2013 ISOP vest&#160;50% on the second anniversary of the grant date and a further&#160;50% on the third anniversary of the grant date. Options under the 2019 ISOP vest&#160;25% on each anniversary of the grant date over four years. The options under the 2021 EIP vest&#160;under one of five methods, i) 25% on the first anniversary of the grant date and the remaining&#160;75% vesting ratably on a monthly basis over the remaining three years, ii) 25% on the first anniversary of the grant date and the remaining&#160;75% vesting ratably on a quarterly basis over the remaining three years, iii) on the second anniversary of the grant date, iv) annually over four years on each anniversary of the grant date or v) 50% on the first anniversary of the grant date and the remaining 50% vesting ratably on a monthly basis over the remaining year. Refer to&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Restricted Stock Units&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">below for the vesting schedules of the RSUs under the 2021 EIP.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2021, the Board amended the 2019 ISOP to the effect that, in the event of a successful IPO or public listing of the Company&#8217;s shares, only those unvested options that otherwise would vest within six months following the effective date of the IPO or such public listing should become fully vested immediately as of such date (accelerated vesting). The remaining unvested options (i.e., unvested options that would only vest after the six-month period following the effective date of the IPO or public listing) would not be subject to accelerated vesting and, subject to certain conditions, would vest on the basis of the original vesting schedule. Additionally, the Board instituted a black-out period, irrespective of a successful IPO or public listing of the Company, in which no options could be exercised from May 1, 2021 to January 19, 2022, and to accelerate the vesting of options that would otherwise vest during that period.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2013 ISOP</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2025, under the 2013 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">560,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.03</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.54</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">480,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.73</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">480,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.73</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2024, under the 2013 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">606,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.49</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">560,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.03</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.54</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">560,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.03</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.54</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2023, under the 2013 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">657,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.92</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.24</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">606,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.49</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">606,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.49</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding as of December 31, 2025, under the 2013 ISOP expire between&#160;2026&#160;and&#160;2029 and have exercise prices between $2.96 and $3.34.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average share price at the date of exercise were $3.48, $4.72, and $4.82 for the years ended December 31, 2025, 2024, and 2023, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 ISOP</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2025, under the 2019 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,308,760</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.40</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,373)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,253,387</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.42</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,253,367</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.42</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2024, under the 2019 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,402,510</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.30</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,308,760</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.40</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,033,490</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.80</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.31</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2023, under the 2019 ISOP was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,629,516</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.96</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.21</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,402,510</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.30</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,651,493</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.64</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.03</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding as of December 31, 2025, under the 2019 ISOP expire between&#160;2028&#160;and&#160;2031 and have exercise prices between $3.16 and $6.31.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average share price at the date of exercise were $4.61, $4.70, and $4.65 for the years ended December 31, 2025, 2024, and 2023, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 EIP</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2025, under the 2021 EIP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,044,607</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.69</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.40</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,280,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(909,956)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,385,514</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.72</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.98</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,989,270&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.11</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2024, under the 2021 EIP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,708,059</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.84</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.74</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,840,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454,420)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,044,607</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.69</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.40</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806,356&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.37</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2023, under the 2021 EIP was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,624,297</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.32</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.88</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(645,310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,708,059</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.84</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.74</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155,231&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.57</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation inputs for the 2021 EIP grants were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December&#160;31,&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (in USD)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;$3.04 </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.73</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.40</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.53</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.72</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of share options (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.60%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.96%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.03%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.40%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.67%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield (%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options outstanding as of December 31, 2025, under the 2021 EIP expire between&#160;2026 and 2034 and have exercise prices between $2.06 and $18.00.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average share price at the date of exercise were $4.14 and $4.59</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the years ended December 31, 2025 and 2024, respectively; and no options were exercised for the year ended December 31, 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share options granted during the year</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December 31, 2025, 2024, and 2023, respectively (in USD):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 EIP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the 2021 EIP, the Company initiated granting of RSUs, which represent the right to receive shares of ordinary shares upon meeting specified vesting requirements. In the year ended December 31, 2025, the Company granted&#160;1,136,975&#160;RSUs under the 2021 plan. Under the terms of the 2021 plan,&#160;103,374 of the RSUs granted are subject to a four-year vesting schedule with&#160;25% vesting on the first anniversary of the grant date and the remaining&#160;75% ratably on a quarterly basis over the remaining three years, 864,681</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are subject to a two year vesting period on the second anniversary from the date of grant, and the remaining&#160;168,920&#160;of the RSUs granted to non-executive members of the Company&#8217;s board of directors are subject to a vesting period </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">set to be completed upon the Company&#8217;s 2026 Annual General Meeting.&#160;The activity for the year ended December 31, 2025 was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,053,076</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.69</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,434,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171,196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,584,209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.04</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the year ended December 31, 2024, the Company granted 1,373,816 RSUs under the 2021 plan. Under the terms of the 2021 plan, 1,168,896 of the RSUs granted are subject to a four-year vesting schedule with 25% vesting on the first anniversary of the grant date and the remaining 75% ratably on a quarterly basis over the remaining three years, and the remaining 204,920 of the RSUs granted to non-executive members of the Company&#8217;s board of directors are subject to a vesting period set to be completed upon the Company&#8217;s 2025 Annual General Meeting. The activity for the year ended December 31, 2024 was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,335,268</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.77</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,331,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,053,076</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.69</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the year ended December 31, 2023, the Company granted 2,658,150 RSUs under the 2021 plan. Under the terms of the 2021 plan, 2,260,649 of the RSUs granted are subject to a four-year vesting schedule with 25% vesting on the first anniversary of the grant date and the remaining 75% ratably on a monthly basis over the remaining three years, 107,647 are subject to a two year vesting period on the second anniversary from the date of grant, and the remaining 289,854 of the RSUs granted to non-executive members of the Company&#8217;s board of directors are subject to a vesting period set to be completed upon the Company&#8217;s 2024 Annual General Meeting. The activity for the year ended December 31, 2023 was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,865,433</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(927,155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,335,268</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.77</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-based compensation expense</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Movements in the share-based compensation reserve were as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,075</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,317</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,805</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73,010</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by financial statement caption for all stock awards consists of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,070&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,370&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,205</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,488</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,242</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract', window );"><strong>Disclosure of detailed information about borrowings [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBorrowingsExplanatory', window );">Borrowings</a></td>
<td class="text">Borrowings<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Perceptive Credit Agreement</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 2, 2024 (the &#8220;closing date&#8221;), the Company and its subsidiary SOPHiA GENETICS, Inc. entered into a credit agreement and guaranty (the &#8220;Perceptive Credit Agreement&#8221;) with Perceptive Credit Holdings IV, LP, as lender and administrative agent, pursuant to which the Company may borrow up to $50.0&#160;million principal amount of term loans, including (i) an initial tranche of $15.0&#160;million principal amount of term loans on the closing date (&#8220;Tranche A&#8221;) and (ii) a second tranche of $35.0&#160;million principal amount of term loans that the Company may draw upon on or prior to March 31, 2026 (&#8220;Tranche B&#8221;), subject to satisfaction of certain </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customary conditions. The term loans are scheduled to mature on the fifth anniversary of the closing date and accrue interest at Term Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;) (floored at 4% per annum) plus 6.25% per annum; provided that upon the occurrence and during the continuation of any event of default, the term loans will accrue interest at Term SOFR plus 9.25% per annum. Term SOFR means the Term SOFR reference rate that is two business days prior to the first day of the preceding calendar month. The Company has the right to prepay the term loans at any time subject to applicable prepayment premiums. The Perceptive Credit Agreement also contains certain mandatory prepayment provisions, including prepayments from the proceeds from certain asset sales and casualty events (subject to a right to reinvest such proceeds in assets used in the Company&#8217;s business within 180 days) and from issuances or incurrences of non-permitted debt, which will also be subject to prepayment premiums. The obligations under the Perceptive Credit Agreement are secured by substantially all of the Company&#8217;s and certain of the Company&#8217;s subsidiaries&#8217; assets and are guaranteed initially on the closing date by SOPHiA GENETICS SA and SOPHiA GENETICS, Inc. The Perceptive Credit Agreement contains customary covenants, including an affirmative covenant to maintain qualified cash of at least $3.0&#160;million, an affirmative last twelve months revenue covenant of $67.4 million as of December 31, 2025. The last twelve months revenue covenant is tested on a quarterly basis beginning June 30, 2024, and negative covenants including limitations on indebtedness, liens, fundamental changes, asset sales, investments, dividends and other restricted payments and other matters customarily restricted in such agreements. The Perceptive Credit Agreement also contains customary events of default, including payment defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults to certain other agreements, judgments against the Company and the Company&#8217;s subsidiaries and change in control, the occurrence of which gives the lenders the right to declare the term loans and all obligations under the Perceptive Credit Agreement immediately due and payable. The Company was in full compliance with all covenants contained in the Perceptive Credit Agreement as of December 31, 2025 and 2024.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company issued to Perceptive Credit Holdings IV, LP a warrant certificate (the &#8220;Warrant Certificate&#8221;) representing the right to purchase up to 400,000 ordinary shares at $4.9992 per share, with the right to purchase 200,000 ordinary shares available immediately and the right to purchase an additional 200,000 ordinary shares to be available upon the drawdown of the second tranche of the term loans. The purchase rights represented by the Warrant Certificate are exercisable after becoming available, on a cash basis, at the option of the holder at any time prior to 5:00 p.m., Eastern time on the tenth anniversary of the applicable date of availability. The Warrant Certificate contains customary anti-dilution adjustments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company drew down the $35.0&#160;million of Tranche B on June 25, 2025 and the right to purchase an additional 200,000 ordinary shares became available under the Warrant Certificate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 23, 2026, the Company entered into an amendment (the &#8220;2026 Amendment&#8221;) to the Perceptive Credit Agreement. The 2026 Amendment provides for, among other things, $25.0&#160;million of additional term loan commitments consisting of (i) an additional $12.5&#160;million tranche of term loan commitments (&#8220;Tranche C&#8221;), which may be drawn subject to certain customary conditions, and (ii) an additional $12.5&#160;million tranche of term loan commitments (&#8220;Tranche D&#8221;), which may be drawn at such time as the Company&#8217;s revenue for a trailing twelve-month period exceed $85.0&#160;million and otherwise subject to customary conditions. Tranche C and Tranche D, if drawn, will have terms and conditions consistent with the Company&#8217;s existing term loans, will bear interest at rate per annum equal to Term SOFR (floored at 4% per annum) + 6.25% and will mature in 2029. In connection with the 2026 Amendment, the Company amended and restated the warrant certificate in order to issue to Perceptive Credit Holdings IV, LP the right to purchase an additional 75,000 ordinary shares, which right is exercisable immediately. The Warrant Certificate also grants Perceptive Credit Holdings IV, LP the right to purchase an additional (1) 100,000 ordinary shares, which right will become exercisable upon the Company&#8217;s draw down of the Tranche C under the Perceptive Credit Agreement and (2) another 100,000 ordinary shares, which right will become exercisable upon the Company&#8217;s draw down of the Tranche D under the Perceptive Credit Agreement. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accounting for Tranches A and B</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for each tranche of the term loans and warrants as two separate financial instruments: (i) a warrant obligation and (ii) a loan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i) The warrant obligation is presented in the consolidated balance sheet as a short-term liability given the warrants are not settled in the entity&#8217;s functional currency and thus are not considered to be settled in a fixed amount and can be exercised currently without restriction or right to defer. The warrant obligation was initially </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">measured at fair value using a Black-Scholes pricing model and is subsequently remeasured to fair value at each reporting date. Changes in the fair value (gains or losses) of the warrant obligation at the end of each period are recorded in the consolidated statement of loss. The Company determined the Tranche A warrant obligation qualified as a level 2 fair value liability as inputs to the fair value measurement are derived principally from or corroborated by observable market data by correlation or other means. Refer to Note 26 &#8212; &#8220;Financial instruments and risks&#8221; for the current fair value amount for the warrant obligation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii) The term loans were initially recorded at their amortized costs of $15.0&#160;million and $35.0&#160;million for Tranches A and B, respectively, less any capitalized expenses and fees payable upon the issuance (&#8220;transaction costs&#8221;) and after allocating a portion of the proceeds to the fair value of the warrant obligation. The loans are presented as a long-term financial liability in the consolidated balance sheet.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the allocation of transaction costs in accordance with IFRS 9 and determined the allocation to warrants was immaterial, as such the Company allocated the total amount of the transaction costs to the term loan. The transaction costs are presented net of the term loan on the consolidated balance sheet. The transaction costs are amortized as non-cash interest expense recorded to the consolidated statement of loss as the difference between the stated interest rate and the EIR. The EIR was determined upon the initial draw down at 15.2% and 12.4% for Tranches A and B, respectively, and reassessed based on changes in the variable interest rate from the Perceptive Credit Agreement. As of December 31, 2025 and 2024 the EIR was 12.1% and 14.8%, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculated the fair value of the warrant obligation on issuance using the Black-Scholes pricing model. The warrant obligation for Tranche A was recorded at an initial fair value of $0.7&#160;million on May 2, 2024 and the warrant obligation for Tranche B was recorded at an initial fair value of $0.5&#160;million on June 25, 2025. Key inputs for the valuation of the warrant obligation upon issuance were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:34.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 25, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of May 2, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.00</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price in USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.17</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.08</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.24%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.53%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (annualized)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.98%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.77%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Black-Scholes value in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.37</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.06</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of the warrant obligation on a quarterly basis. Key inputs for the remeasurement of the Tranche A warrant obligation were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of  December 31, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of  December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.00</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price in USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.67</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.07</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.01%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.51%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.39%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.52%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.34</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Black-Scholes value in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.35</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.22</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key inputs for the remeasurement of the Tranche B warrant obligation were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:34.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.495%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of  December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.00</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price in USD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.67</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.10%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.48</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Black-Scholes value in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.71</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tranche A was recorded at an initial amortized cost of $13.3&#160;million on May 2, 2024. This amount represents the residual amount of the $15.0&#160;million draw down after allocating $0.7&#160;million for the fair value of the warrant obligation and the $1.1&#160;million of transaction costs to be amortized as interest expense over the life of the loan. Tranche B was recorded at an initial amortized cost of $34.1&#160;million on June 25, 2025. This amount represents the residual amount of the $35.0&#160;million draw down after allocating $0.5&#160;million for the fair value of the warrant obligation and the $0.4&#160;million of transaction costs to be amortized as interest expense over the life of the loan. The following table presents the allocation of the loan proceeds and any movements in the liability for the year ended December 31, 2025, (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"></td><td style="width:46.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Tranche A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Proceeds net of transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,930</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant obligation at issuance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,237</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Tranche B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(437)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Proceeds net of transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34,563</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant obligation at issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,521)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,733</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the movements in the warrant obligation liability for the year ended December 31, 2025, (in USD thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.030%"><tr><td style="width:1.0%"></td><td style="width:51.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.649%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Obligation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of warrants from Tranche A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of warrants from Tranche B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,412</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revolving credit facility</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 23, 2024 the Company terminated its existing credit agreement with Credit Suisse SA for up to CHF 5.0&#160;million ($5.5&#160;million). Additionally, the Company entered into a new credit agreement with Credit Suisse SA for up to CHF 0.1&#160;million ($0.1&#160;million) to be used for cash credits, contingent liabilities, or as margin for OTC derivative transactions. Borrowings under the new credit agreement will bear interest at a rate to be established between the Company and Credit Suisse SA at the time of each draw down. On November 27, 2025 the Company terminated this CHF 0.1&#160;million facility ($0.1&#160;million). On February 20, 2025 the Company entered into a new credit agreement with UBS Switzerland AG for up to CHF 0.3&#160;million ($0.3&#160;million), intended solely for the issuance of bank guarantees. As of December 31, 2025 and 2024, the Company had no borrowings outstanding under these credit facilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related parties</a></td>
<td class="text">Related parties<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Related parties comprise the Company&#8217;s executive officers and directors, including their affiliates, and any person that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control, with the Company.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key management personnel comprised of six Executive Officers and Directors and six Non-Executive Directors for the year ended December 31, 2025. Key management personnel comprised of six Executive Officers and Directors and six Non-Executive Directors for the year ended December 31, 2024. Key management personnel comprised of six Executive Officers and Directors and seven Non-Executive Directors for the year ended December 31, 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation for key management and non-executive directors recognized during the year comprised (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and other short-term employee benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,000</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,786</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,059</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract', window );"><strong>Disclosure of contingent liabilities in business combination [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory', window );">Commitments and contingencies</a></td>
<td class="text">Commitments and contingencies<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has no commitments for future lease payments under short-term leases not recognize</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d on the </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">balance sheet as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a minimum purchase agreement with a vendor related to computational and hosting-related costs. As part of the agreement, the Company has a total minimum commitment of approximately $80.9&#160;million from the period beginning November 1, 2022 through October 31, 2029 and an additional one-year grace period to meet the minimum commitment by October 31, 2030. As of December 31, 2025 and 2024, the Company has remaining commitments of $58.2 million and $56.9 million, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024 the Company had&#160;no&#160;contingent assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company is regularly subject to lawsuits, claims, arbitration proceedings, administrative actions and other legal and regulatory proceedings involving intellectual property disputes, commercial disputes, competition and other matters, and the Company may become subject to additional types of lawsuits, claims, arbitration proceedings, administrative actions, government investigations and legal and regulatory proceedings in the future. As of December 31, 2025 and 2024, the Company has concluded that losses are not probable and no provisions have been recorded.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Guardant Health</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In 2025 Guardant Health ("Guardant") filed suit against the Company in multiple jurisdictions. Guardant filed suit in the U.K., and in the EU at the Unified Patent Court (the &#8220;UPC&#8221;) in Paris, alleging that the Company&#8217;s MSK-Access liquid biopsy test infringes certain of their patents and seeking remedies, including unspecified monetary damages and injunctive relief. In January 2026, the UPC Paris Local Division issued a final order rejecting Guardant's application for provisional measures and ordered Guardant to pay an interim award of costs of &#8364;400,000 ($470,080), which Guardant has appealed. The U.K. proceedings remain pending. The Company continues to defend itself against these claims.  As of December 31, 2025, the Company has concluded that losses related to this matter are not probable and no provision has been recorded.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of commitments and contingent liabilities. [Refer: Classes of contingent liabilities [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risks<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Financial instruments and risks</a></td>
<td class="text">Financial instruments and risks<div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds the following financial instruments (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:71.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets at amortized cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financial non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets at amortized cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87,285</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88,656</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets at fair value through statement of loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87,285</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88,656</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities at amortized cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities at amortized cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92,716</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48,467</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities at fair value through statement of loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94,128</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48,911</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s exposure to various risks associated with the financial instruments is discussed below in &#8220;Financial risk management.&#8221; The maximum exposure to credit risk at the end of the reporting period is the carrying amount of each class of financial assets mentioned above. See Note 12 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Accounts receivable&#8221; for expected credit loss provisions on accounts receivable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2025, the Company signed a stock purchase and subscription agreement to acquire a non-controlling minority equity interest in A.D.A.M. Innovations, formerly known as Genesis Healthcare, in two tranches totaling $2.0&#160;million. The Company acquired shares totaling $0.5&#160;million in September 2025 and shares totaling $1.5&#160;million in October 2025. These financial assets are initially measured at fair value and subsequently re-measured at fair value at each reporting date. Changes in fair values for these financial assets are recorded through profit or loss in accordance with IFRS 9 Financial Instruments. As of December 31, 2025 purchase price approximated fair value and no changes in fair value had been recorded in the Consolidated Statements of Loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair value measurement</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the carrying amount was a reasonable approximation of fair value for the following financial assets and liabilities:</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial assets</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Cash and cash equivalents</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Accounts receivable</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Other non-current assets&#8212;lease deposits </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial liabilities</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Accounts payable</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Accrued liabilities</span></div><div style="padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Borrowings</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair value measurement methodology</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures financial instruments at fair value at each balance sheet date. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either in the principal market for the asset or liability or, in the absence of a principal market, in the most advantageous market for the asset or liability.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A fair value measurement of a non-financial asset takes into account a market participant&#8217;s ability to generate econo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mic benefits by using the asset or by sell</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ing it to another market participant.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses valuation techniques to measure fair value maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All assets and liabilities for which fair value is measured or disclosed in the consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1&#8212;Quoted (unadjusted) market prices in active markets for identical assets or liabilities.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2&#8212;Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3&#8212;Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets and liabilities that are recognized in the consolidated financial statements at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting period.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management determines the policies and procedures for both recurring fair value measurement and for non-recurring measurement with the involvement of experts and external consultants when needed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds money market funds which are classified as cash equivalents which are measured as a level 1 valuation. Refer to Note 11 &#8211; &#8220;Cash and cash equivalents.&#8221; The Company also has warrant obligations related to the Perceptive Credit Agreement, which are measured as a level 2 valuation. Refer to Note 23 &#8212; &#8220;Borrowings&#8221;. The Company also holds a minority equity interest in A.D.A.M. Innovations, which is measured as a level 2 valuation.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recurring fair-value measurements</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2025 (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"><tr><td style="width:1.0%"></td><td style="width:42.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Equity Investments: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,528&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perceptive Credit Holdings warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2024 (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"><tr><td style="width:1.0%"></td><td style="width:42.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perceptive Credit Holdings warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">474</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2025 and 2024 there were no significant changes in the business or economic circumstances that affect the fair value of the Company&#8217;s financial assets and financial liabilities. There were also&#160;no&#160;transfers between categories.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial risk management</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial risks</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior management reg</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ularly reviews th</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e Company&#8217;s cash forecast and related risks. They also perform the risk assessment, define any necessary measures and ensure the monitoring of the internal control system.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s principal financial liabilities include borrowings and accounts payable. The Company&#8217;s principal financial assets include cash and cash equivalents and accounts receivable.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the course of its business, the Company is exposed to a number of financial risks including credit and counterparty risk, funding and liquidity risk, and market risk (i.e. foreign currency risk and interest rate risk). This note presents the Company&#8217;s objectives, policies, and processes for managing these risks.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit and counterparty risk management</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Company is exposed to credit risk from its operating activities, primarily accounts receivable.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentration risk arises when a number of counterparties are engaged in similar business activities, or activities in the same geographical region, or have economic features that would cause their ability to meet contractual obligations to be similarly affected by changes in economic, political, or other conditions.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy with regard to assessing and providing for expected credit losses on accounts receivable is set out in Note </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Accounts receivable.&#8221;</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk from balances with banks and financial institutions is managed by the Company&#8217;s treasury department in accordance with the Company&#8217;s policy.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial transactions are predominantly entered into with investment grade financial institutions and in principle the Company requires a minimum long-term rating of&#160;A3/A-&#160;for its cash investments and term deposits. The Company may deviate from this requirement from time to time for operational reasons. The highest exposure to a single financial counterparty within cash and cash equivalents and term deposits amounted to $24.4 million and $26.1 million as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other&#160;non-current&#160;financial assets include cash deposits for leases.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding and liquidity risk management</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Funding and liquidity risk is the risk that a company may encounter difficulties in meeting its obligations associated with financial liabilities that are settled by delivering cash or other financial assets. Such risk may result from inadequate market depth or disruption or refinancing problems.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company views equity funding as its primary source of liquidity only partly complemented with revenue generated from the sale of the platform, applications, products, and services and borrowings. The Company has </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$50.0&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of outstanding term loans under the Perceptive Credit Agreement, see Note 23 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8220;Borrowings&#8221; fo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r additional information.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Short term liquidity is managed based on projected cash flows. As&#160;of&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;the&#160;Company&#8217;s liquidity consisted of&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$70.3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$80.2 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in cash and cash equivalents, respectively. In 2025 the Company has sold, from its treasury shares, 228,238 ordinary shares for total gross proceeds of $1.1&#160;million under the Company&#8217;s ATM program. In 2026, as described in Note 28 - &#8220;Events After the Reporting Period&#8221;, the Company has sold, from its treasury shares, 2,795,485 ordinary shares for total gross proceeds of $14.3&#160;million under the Company&#8217;s ATM program and signed an amendment to the Perceptive Credit Agreement which provided an additional </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$25.0&#160;million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> available for draw. On the basis of the current operating performance and liquidity position, Board of Directors believes that the available cash balances will be sufficient for operating activities, working capital, interest, capital expenditures and scheduled debt repayments for the next 12 months.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarizes the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted cash flows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:29.855%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Within 1 year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Between 1 and 5 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After 5 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,083&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total contractual liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92,716</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,813</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73,797</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,463</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113,073</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:29.855%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Within 1 year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Between 1 and 5 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After 5 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,793&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total contractual liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48,467</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,798</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32,923</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,469</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60,190</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made adjustments to previously reported future maturities of borrowings as of December 31, 2024 to incorporate contractual cash interest payments of $1.6 million within 1 year and $5.4 million between 1 and 5 years to correct for immaterial misstatements.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market risk</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk includes currency risk and interest rate risk.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Currency risk</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency risk is the risk that the fair value or future cash flows of an exposure will fluctuate because of changes in foreign exchange rates.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant exchange rates that have been applied to these consolidated financial statements are listed below:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Spot rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.79208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.88064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89855&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/EUR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.96530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.88644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.92455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.92478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.79870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.78267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/BRL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.49560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.17360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.97372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sensitivity of the Company&#8217;s income to possible changes in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign exchange rates is measured at the local entity level as it depends on the functional currency of each entity. As of December 31, 2025, 2024, and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company was exposed principally to movements in four cross currency pairs. The sensitivity of the Company&#8217;s loss before tax to such changes was as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/CHF exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,101)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,034)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in EUR/CHF exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,020)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(508)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in GBP/CHF exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s exposure to foreign currency changes for all other currencies is not material. The Company does not use derivative financial instruments to hedge exposures and under no circumstances may enter into derivative instruments for speculative purposes.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sensitivity of the Company&#8217;s reported equity or net assets to possible changes in foreign exchange rates is measured at the consolidated level as it depends on the presentation currency selected for the consolidated financial statements. Such effects are reported not in income but in the currency translation account within other reserves. As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the sensitivity of the Company&#8217;s equity to such changes, measured against the USD, was as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/CHF exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,561)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,520)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,520</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/EUR exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(663)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,244)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/GBP exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Interest rate risk</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s&#160;cash&#160;and cash&#160;equivalents&#160;are subject to market risk&#160;associated with&#160;interest rate&#160;fluctuations. Fixed rate securities may have their market value adversely affected due to a rise in interest rates.&#160;The C</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ompany concluded that fluctuations in the interest rate did not have a material impact on the Company&#8217;s cash and cash equivalents balances.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company currently has $50.0&#160;million and $15.0&#160;million, respectively, of debt outstanding under the Perceptive Credit Agreement. Based on the terms of the Perceptive Credit Agreement, the monthly interest expense fluctuates based on the Term SOFR reference rate that is two business days prior to the first day of the preceding calendar month. Given the Company&#8217;s outstanding debt under this agreement, the Company is subject to interest rate risk related to debt obligations if the SOFR were to move significantly. Based on the borrowings exposed to floating interest rates at year-end, an increase in interest rates of 100 basis points would cause an increase in cash interest costs on an annualized basis of $0.5&#160;million and $0.2&#160;million as of December 31, 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Section Scope<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalCommitmentsAbstract', window );"><strong>Capital commitments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCapitalManagementExplanatoryTextBlock', window );">Capital management</a></td>
<td class="text">Capital management<div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers equity as equivalent to the IFRS Accounting Standards equity on the balance sheet (including share capital, share premium, and all other equity reserves attributable to the owners of the Company). Other reserves are comprised of comprehensive income/loss and share-based compensation.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary objective of the Company&#8217;s capital management is to maximize shareholder value. The Board regularly reviews its shareholders&#8217; return strategy. For the foreseeable future, the Board will maintain a capital structure that supports the Company&#8217;s strategic objectives through managing funding and liquidity risks and optimizing shareholder return.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company&#8217;s cash and cash equivalents amounted to </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$70.3 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$80.2 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted in Note 28 &#8212; &#8220;Events after the reporting date&#8221;, the Company also has access to $25.0&#160;million available, of which $12.5&#160;million can be drawn immediately, under the Perceptive Credit Agreement. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors believes that the Company has sufficient financial resources to meet all of its obligations for at least the next twelve months. Moreover, the Company is not exposed to liquidity risk through requests for early repayment of loans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalCommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalCommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfCapitalManagementExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of capital management explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfCapitalManagementExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events after the reporting date<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEventsAfterReportingPeriodAbstract', window );"><strong>Disclosure Of Events After Reporting Period [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Events after the reporting date</a></td>
<td class="text">Events after the reporting date<div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has evaluated, for potential recognition and disclosure, events that occurred prior to the date at which the consolidated financial statements were authorized for issuance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On January 23, 2026, the Company entered into an amendment (the &#8220;2026 Amendment&#8221;) to the Perceptive Credit Agreement. The 2026 Amendment provides for, among other things, $25.0&#160;million of additional term loan commitments consisting of (i) an additional $12.5&#160;million tranche of term loan commitments (&#8220;Tranche C&#8221;), which may be drawn subject to certain customary conditions, and (ii) an additional $12.5&#160;million tranche of term loan commitments (&#8220;Tranche D&#8221;), which may be drawn at such time as the Company&#8217;s revenue for a trailing twelve-month period exceed $85.0&#160;million and otherwise subject to customary conditions. Tranche C and Tranche D, if drawn, will have terms and conditions consistent with the Company&#8217;s existing term loans, will bear interest at rate per annum equal to Term SOFR (floored at 4% per annum) + 6.25% and will mature in 2029. In connection with the 2026 Amendment, the Company amended and restated the warrant certificate in order to issue to Perceptive Credit Holdings IV, LP the right to purchase an additional 75,000 ordinary shares, which right is exercisable immediately. The Warrant Certificate also grants Perceptive Credit Holdings IV, LP the right to purchase an additional (1) 100,000 ordinary shares, which right will become exercisable upon the Company&#8217;s draw down of the Tranche C under the Perceptive Credit Agreement and (2) another 100,000 ordinary shares, which right will become exercisable upon the Company&#8217;s draw down of the Tranche D under the Perceptive Credit Agreement. </span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2026, through its ATM program, the Company has sold, from its treasury shares</span>, 2,795,485 ordinary shares for total gross proceeds of $14.3&#160;million<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of events after reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At SOPHiA GENETICS, cybersecurity risk management is an integral part of our enterprise risk management program. Our cybersecurity risk management program is derived from the ISO27001 family of standards and </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">underpins our Information Security Management System (&#8220;ISMS&#8221;) framework. This determines how we design our polices, guidelines, controls, and best practices to manage the organization&#8217;s information security risks while permitting us to leverage NIST, STRIDE, and SANS frameworks to inform our handling of cybersecurity threats and incidents. Additionally, we are certified in accordance to and maintain our cybersecurity framework consistent with ISO 27001 standards. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The scope of applicability includes our globally accessible cloud-native solution offering along with all physical associated geographical locations: Switzerland, the U.S., and France. This is designed to achieve comprehensive global risk coverage across operations, application development, wet-lab analysis, and R&amp;D. Many of these capabilities are delivered in-house, however third-party services are engaged in a modest capacity to support specific activities, such as security operations center capabilities and annual penetration testing. Where engaged, the organization has vendor management procedures in place that require cross-functional participation from the areas of Quality, Procurement, Regulatory, Legal, and Cybersecurity. These procedures are also interlinked directly with cybersecurity&#8217;s ISMS.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our framework includes tools and processes to identify and assess the severity of cybersecurity threats and incidents including, but not limited to, data loss, theft, and system penetration. Additionally our framework allows us to identify if the threat or incident is associated with a third-party provider, dynamically implementing cybersecurity countermeasures and mitigation strategies and informing management and our board of directors of material cybersecurity threats and incidents</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The cybersecurity team is further responsible for assessing our cybersecurity risk management program and communicating these risks to senior leadership and the Board. Although the assessment is solely performed within the cybersecurity team, external engagements influence such determination e.g.:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Annual penetration testing and Tabletop exercises </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Quarterly phishing exercises results</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Monthly SOC read-out calls</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">External threat feeds</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Cyber insurance evaluation</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">External Audit activities (ISO 27001, ISO 27017, ISO 27018, ISO 13485)</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Board and Executive team feedback</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The cybersecurity team is also responsible for providing all employee training, awareness, and education. It performs this by carrying out:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Quarterly phishing exercises </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Digital awareness campaigns through intranet posts, email updates, digital presentations </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt">Reach-out engagements to cross-functional teams aligned to their delivery schedules.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At SOPHiA GENETICS, cybersecurity risk management is an integral part of our enterprise risk management program. Our cybersecurity risk management program is derived from the ISO27001 family of standards and </span></div>underpins our Information Security Management System (&#8220;ISMS&#8221;) framework. This determines how we design our polices, guidelines, controls, and best practices to manage the organization&#8217;s information security risks while permitting us to leverage NIST, STRIDE, and SANS frameworks to inform our handling of cybersecurity threats and incidents. Additionally, we are certified in accordance to and maintain our cybersecurity framework consistent with ISO 27001 standards.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text">Our board of directors has overall oversight responsibility for our risk management and delegates cybersecurity risk management oversight to the audit committee of the board of directors. The audit committee is responsible for ensuring that management has processes in place designed to identify and evaluate cybersecurity risks to which the company is exposed and implement processes and programs to manage cybersecurity risks and mitigate cybersecurity incidents. The audit committee also reports material cybersecurity risks to our full board of directors.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The audit committee is responsible for ensuring that management has processes in place designed to identify and evaluate cybersecurity risks to which the company is exposed and implement processes and programs to manage cybersecurity risks and mitigate cybersecurity incidents.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The audit committee also reports material cybersecurity risks to our full board of directors.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text">Management is responsible for identifying, considering and assessing material cybersecurity risks on an ongoing basis, establishing processes to ensure that such potential cybersecurity risk exposures are monitored, putting in place appropriate mitigation measures and maintaining cybersecurity programs. Our cybersecurity programs are executed under the direction of our Chief Technology Officer (&#8220;CTO&#8221;), who has over 20 years of technology leadership, receives reports from our cybersecurity team and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents. Our dedicated personnel hold a multitude of certifications, including but not limited to Certified information systems security professional (&#8220;CISSP&#8221;), Certified Ethical Hacker, and experienced information systems security professionals and information security managers with many years of experience. Management, including the CTO and our cybersecurity team, update the audit committee on the company&#8217;s cybersecurity programs, material cybersecurity risks and mitigation strategies and provide cybersecurity reports annually that cover, among other topics, such as, key performance metrics, developments in cybersecurity and updates to the company&#8217;s cybersecurity programs and mitigation strategies.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">Management is responsible for identifying, considering and assessing material cybersecurity risks on an ongoing basis, establishing processes to ensure that such potential cybersecurity risk exposures are monitored, putting in place appropriate mitigation measures and maintaining cybersecurity programs. Our cybersecurity programs are executed under the direction of our Chief Technology Officer (&#8220;CTO&#8221;)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">Chief Technology Officer (&#8220;CTO&#8221;), who has over 20 years of technology leadership<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">Chief Technology Officer (&#8220;CTO&#8221;), who has over 20 years of technology leadership, receives reports from our cybersecurity team and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_SummaryOfMaterialAccountingPoliciesAbstract', window );"><strong>Summary Of Material Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock', window );">Basis of preparation</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of preparation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with International Financial Reporting Standards</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of the Company have been prepared in accordance with IFRS Accounting Standards and interpretations issued by the IFRS Interpretations Committee (&#8220;IFRS IC&#8221;) applicable to companies reporting under IFRS Accounting Standards. The consolidated financial statements comply with IFRS Accounting Standards as issued by the International Accounting Standards Board (&#8220;IASB&#8221;).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock', window );">Basis of consolidation</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of consolidation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A subsidiary is an entity over which the Company has control. The Company controls an entity when it has the power to direct its activities and has rights to its variable returns. Subsidiaries are fully consolidated from the date on which control is transferred to the Company and deconsolidated from the date that control ceases.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the consolidation process intercompany transactions, balances, and unrealized gains on transactions between companies are eliminated. Unrealized losses are also eliminated unless there is evidence of an impairment of the transferred asset. In order to ensure consistency with the accounting policies of the Company, the accounting policies of subsidiaries have been changed where necessary.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory', window );">Foreign currency translation</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign currency translation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Items included in the consolidated financial statements of each of the Company&#8217;s entities are measured using the currency of the primary economic environment in which the entity operates (&#8220;functional currency&#8221;). In individual entities, transactions in foreign currencies are translated as of transaction date. Monetary assets and liabilities in foreign currencies are translated at month end rates. The Company&#8217;s reporting currency of the Company&#8217;s consolidated financial statements is the U.S. dollar (&#8220;USD&#8221;). Assets and liabilities denominated in foreign currencies are translated at the month-end spot exchange rates, income statement accounts are translated at average rates of exchange for the period presented, and equity is translated at historical exchange rates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On consolidation, assets and liabilities of foreign operations reported in their local functional currencies are translated into USD. Differences arising from the retranslation of opening net assets of foreign operations, together with differences arising from the translation of the net results for the year of foreign operations, are recognized in other comprehensive income under currency translation adjustments. Gains or losses resulting from foreign currency transactions are included in net income.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company selected the U.S. dollar as its presentation currency for purposes of its consolidated financial statements instead of the Company&#8217;s functional currency, the Swiss franc, because of the global nature of its business, its expectation that an increasing portion of revenues and expenses will be denominated in USD, and its plans to continue to access U.S. capital markets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock', window );">Use of estimates</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with IFRS Accounting Standards requires the use of accounting estimates. It also requires management to exercise judgment in applying the Company&#8217;s accounting policies. The Company&#8217;s significant estimates and judgments included in the preparation of the consolidated financial statements are related to revenue recognition, capitalized internal software development costs, defined benefit liability and share-based compensation.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosed in the corresponding sections within the footnotes are the areas which require a high degree of judgment, significant assumptions, and/or estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock', window );">Going concern basis</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going concern basis</span></div>The consolidated financial statements have been prepared on a going concern basis<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock', window );">Historical cost convention</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Historical cost convention</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements have been prepared on a historical cost basis except for certain assets and liabilities, which are carried at fair value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock', window );">Accounting policies</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The material accounting policies adopted in the preparation of the consolidated financial statements have been consistently applied, unless otherwise stated.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock', window );">Provisions and contingencies</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions and contingencies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions comprise liabilities of uncertain timing or amount. The provisions and liabilities are recognized when the Company has a present legal or constructive obligation as a result of past events, it is probable that an outflow of resources will be required to settle the obligation, and the amount can </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be reliably estim</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ated. Provisions are not recognized for future operating losses. Provisions are measured at the present value of management&#8217;s best estimate of the expenditure required to settle the present obligation at the end of the reporting period, unless the impact of discounting is immaterial. The discount rate used to determine the present value is a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. The increase in the provision due to the passage of time is recognized as interest expense.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent liabilities are possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not fully within the control of the Company.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The likelihood of occurrence of provisions and contingent liabilities requires use of judgment. Judgment is also required to determine if an outflow of economic resources is probable, or possible but not probable. Where it is probable, a liability is recognized, and further judgment is used to determine the level of the provision. Where it is possible but not probable, further judgment is used to determine if the likelihood is remote, in which case no disclosures are provided; if the likelihood is not remote then judgment is used to determine the contingent liability disclosed.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory', window );">Financial assets classification</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial assets classification</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon recognition, financial assets are classified on the basis of how the financial assets are measured: at amortized cost or fair value through income.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The classification of financial assets at initial recognition depends on the financial asset&#8217;s contractual cash flow characteristics and the Company&#8217;s business model for managing them. Except for accounts receivable that do not contain a significant financing component, the Company initially measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through income, transaction costs. Accounts receivable that do not contain a significant financing component are measured at the transaction price.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s business model for managing financial assets is defined by whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets held in order to collect contractual cash flows are measured at amortized cost. Financial assets held both to collect contractual cash flows and for sale are measured at fair value through other comprehensive income/loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchases or sales of financial assets that require delivery of assets within a time frame established by regulation or convention in the marketplace (regular way trades) are recognized on the trade date, i.e., the date that the Company commits to purchase or sell the asset.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial assets measured at amortized cost</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets initially measured at amortized cost are subsequently measured using the effective interest rate (&#8220;EIR&#8221;) method and are subject to impairment. Gains and losses are recognized in income when the asset is derecognized, modified, or impaired. The Company&#8217;s financial assets at amortized cost include cash and accounts receivable.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial assets&#8212;derecognition</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Company&#8217;s consolidated balance sheet) when:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the rights to receive cash flows from the asset have expired or;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material delay to a third party under a &#8216;pass-through&#8217; arrangement; and either;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Company has transferred substantially all the risks and rewards of the asset, or;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the Company has neither transferred nor retained substantially all the risks and rewards of the asset but has transferred control of the asset.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risks and rewards of ownership.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When the Company has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control of the asset, the Company continues to recognize the transferred asset to the extent of its continuing involvement. In that case, the Company also recognizes an associated liability. The transferred </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">asset and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continuing involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that the Company could be required to repay.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial assets&#8212;impairment</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For cash and cash equivalents, the Company invests in short-term highly liquid assets where it has never incurred and does not expect to incur credit losses.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For accounts receivable the Company recognizes a loss allowance based on lifetime estimated credit losses (&#8220;ECL&#8221;) at each reporting date. When estimating the ECL the Company takes into consideration: readily available relevant and supportable information (this includes quantitative and qualitative data), the Company&#8217;s historical experience and forward-looking information specific to the receivables and the economic environment.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory', window );">Financial liabilities classification</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial liabilities classification</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial liabilities are classified upon initial recognition as financial liabilities measured at fair value through income or at amortized cost. The Company&#8217;s financial liabilities include accounts payable and debt (including borrowings and lease liabilities), which are measured at amortized cost, and derivatives, which are measured at fair value through income.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest-bearing borrowings are initially recognized at fair value less directly attributable costs and subsequently measured at amortized cost using the EIR method. Gains and losses are recognized in income when the liabilities are derecognized as well as through the EIR amortization process.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortized cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included as interest expense in the statement of loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Financial liabilities&#8212;derecognition</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A financial liability is derecognized when the obligation under the liability is discharged or canceled or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized in the statements of loss.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock', window );">Change in accounting policies, new standards, amendments to standards and interpretations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in accounting policies </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Statement of Cash Flows - Interest Classification</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2025, the Company revised its accounting policy regarding the classification of interest paid and interest received in the Statement of Cash Flows. Interest paid was reclassified from Net cash flows used in operating activities to Net cash flows used in financing activities, and interest received was reclassified from Net cash flows used in operating activities to Net cash flows used in investing activities. The Company assessed the change in accounting policy under IAS 8, in accordance with the guidance regarding a voluntary change in accounting policy.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reclassification of interest paid was elected to provide a more cohesive presentation of payments related to the Company&#8217;s borrowings and lease liabilities. Prior to the change in accounting policy, interest paid on borrowings and lease liabilities were classified as operating cash flows, while proceeds from borrowings, net of transaction costs and payments of principal portion of lease liabilities are classified as financing cash flows. The change aligns interest payments with their associated transactions. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company reclassified interest received to investing activities, as the majority of interest received relates to interest earned on cash and cash equivalents and short-term investments. The Company believes this updated classification better reflects the nature and source of these cash inflows and provides more relevant and reliable information.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined the voluntary change in accounting policy did not have an impact on basic and diluted earnings per share under </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IAS 33 - Earnings per Share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applied the change in accounting policy retrospectively and has recast prior period comparative information within the Statement of Cash Flows to ensure consistency and comparability with the current period presentation. As part of the retrospective application, cash flows changed as follows for the year ended December&#160;31,&#160;2024: Net cash used in operating activities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $1.7&#160;million, Net cash flow used in investing activities decreased by $3.4&#160;million, and Net cash flow provided by financing activities decreased by $1.7&#160;million. Cash flows changed as follows for the year ended December 31, 2023: Net cash used in operating activities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased by $4.6&#160;million, Net cash flow provided by investing activities increased by $4.7&#160;million, and Net cash flow used in financing activities decreased by less than $0.1&#160;million.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New standards, amendments to standards and interpretations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">New standards, amendments to standards, and interpretations issued not yet effective</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2024, IFRS 18, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Presentation and Disclosure in Financial Statements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was issued to achieve comparability of the financial performance of similar entities. The standard, which will replace IAS 1 impacts the presentation of primary financial statements and notes, including the statement of profit and loss where companies will be required to present separate categories of income and expense for operating, investing, and financing activities with prescribed subtotals for each new category. The standard will also require management-defined performance measures to be explained and included in a separate note within the consolidated financial statements. The standard is effective for annual reporting periods beginning on or after January 1, 2027, and requires retrospective application. While IFRS 18 will not change recognition criteria or measurement bases, it might have a significant impact on presenting information in the financial statements, in particular the income statement. The Company is currently assessing impacts and data readiness.</span></div>There are no other IFRS Accounting Standards or IFRS IC interpretations that are not yet effective and that could have a material impact to the consolidated financial statements<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue', window );">Revenue</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting estimates and judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s sales transactions may consist of various performance obligations that are satisfied at different times. It requires judgment to determine when different obligations are satisfied, including whether enforceable commitments for further obligations exist and when they arise. Depending on the determination of the performance obligations and the point in time or period over which those obligations are fulfilled, this may result in all revenue being calculated at inception, and either being recognized at once, or on contract completion or spread over the term of a longer performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accounting for contracts that contain promises to deliver more than one good or service, management has to determine how to allocate the total transaction price to the performance obligations of the contract. The total transaction price of a customer contract is allocated to the distinct performance obligations under the contract based on their standalone selling prices (&#8220;SSP&#8221;), the determination of which can require significant judgment from management. The best evidence of this is an observable price from the standalone sales of the good or service to similarly situated customers. However, where standalone selling prices are not observable, it requires judgment to estimate the cost of satisfying a performance obligation and adding an appropriate margin to that good or service. In some cases, SSP is not available and the residual approach is used to determine the stand-alone selling price of certain performance obligations. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue represents amounts received and receivable from third parties for goods supplied and services rendered to customers. Revenues are reported net of rebates and discounts and net of sales and value added taxes in an amount that reflects the consideration that is expected to be received for goods or services. The majority of the sales revenue is recognized: (i)&#160;when customers generate analyses on their patient data through the SOPHiA DDM Platform, (ii)&#160;when consumables, namely DNA enrichment kits, are delivered to customers at which point control transfers, (iii)&#160;when services, namely&#160;set-up&#160;programs, are performed and (iv)&#160;over the duration of the software licensing arrangements for the Alamut software offerings.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products and services are sold both directly to customers and through distributors, generally under agreements with payment terms typically o</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">f 30 to 60 days and in rare cases with payment terms extended up to&#160;180 days.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Therefore, contracts do not contain a significant financing component.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all contracts with customers the following steps are performed to determine the amount of revenue to be recognized and when it should be recognized: (1)&#160;identify the contract or contracts; (2)&#160;determine whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (3)&#160;measure the transaction price, including the constraint on variable consideration; (4)&#160;allocate the transaction price to the performance obligations based on estimated selling prices; and (5)&#160;recognize revenue when (or as) each performance obligation is satisfied.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SOPHiA DDM Platform</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the SOPHiA DDM Platform revenue is derived from each use of the SOPHiA DDM Platform by customers to generat</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e analyses on </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their patient data. Analysis revenue is recognized as analysis results are made available to the customer on the SOPHiA DDM Platform. The Company recognizes accrued contract revenue in accounts receivable for any analyses performed by customers that have not been invoiced at the reporting date and where the right to consideration is unconditional. Any payments received in advance of customers generating analyses are recorded as deferred contract revenue until the analyses are performed.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers use the SOPHiA DDM Platform to perform analyses under three different models: dry lab access; bundle access; and integrated solutions.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For dry lab contracts, customers use the testing instruments and consumables of their choice and the SOPHiA DDM Platform and algorithms for variant detection and identification. In these arrangements, the Company has identified one performance obligation, which is the delivery of the analysis result to the customer.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For bundle arrangements, customers purchase a DNA enrichment kit along with each analysis. Customers use the DNA enrichment kit in the process of performing their own sequencing of each sample. Customers then </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">upload their patient data to the SOPHiA DDM Platform for analysis. In these arrangements, the Company has identified two performance obligations: the delivery of the DNA enrichment kits and the performance of the analyses. Revenue is recognized for the DNA enrichment kits when control of products has transferred to the customer, which is generally at the time of delivery, as this is when title and risk of loss have been transferred. Revenue for the performance of the analyses is recognized on delivery of the analysis results to the customer. Refer to&#160;"&#8212;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with multiple performance obligations&#8221;&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for how revenue is allocated between the performance obligations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract revenue balances relating to analyses not performed</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> within 12 months from the date of the delivery date are recognized as revenue. This policy is not based on contractual conditions but on the Company&#8217;s experience of customer behavior and expiration dates of the kits associated with the analyses.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For integrated arrangements, customers have their samples processed and sequenced through selected SOPHiA DDM Platform partners within the clinical network and access their data through the SOPHiA DDM Platform. The Company has identified one performance obligation, which is delivery of the analysis results to the customer through the SOPHiA DDM Platform.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also sells access to its Alamut software application (&#8220;Alamut&#8221;) through the SOPHiA DDM Platform. Some arrangements with customers allow customers to use Alamut as a hosted software service over the contract period without the customer taking possession of the software. Other customers take possession of the software, but the utility of that software is limited by access to the Company&#8217;s proprietary SOPHiA database, which is provided to the customer on a fixed term basis. Under both models, revenue is recognized on a straight-line basis over the duration of the agreement.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also derives revenue from the SOPHiA DDM Platform by providing services to biopharma customers who engage the Company to (i)&#160;develop and perform customized genomic analyses and/or (ii)&#160;access the database for use in clinical trials and other research projects.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does enter into biopharma contracts that contain multiple products or services or&#160;non-standard&#160;terms and conditions. The biopharma contracts are generally unique in nature and each contract is assessed upon execution. Contracts may contain multiple performance obligations or performance obligations that are recognized overtime, at a point-in-time, or a combination depending on the Company&#8217;s ability to satisfy the requirements to recognize revenue over time and reasonably estimate the amount of revenue to recognize. See "&#8212;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Arrangements with multiple performance obligation</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s&#8221; below for further discussion on treatment of biopharma contracts.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, the primary performance obligation in these arrangements is the delivery of analysis results in the form of a final report, resulting in revenue being recognized, in most cases, upon the issuance of the final report or successful recruitment of clinical trial participants.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Workflow materials and services</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from workflow materials and services includes all revenue from the sale of materials and services that do not form part of a contract for the provision of platform services. These include the provision of&#160;set-up&#160;programs and training and the sale of kits and tests that are not linked to use of the platform.&#160;Set-up&#160;programs and training are typically combined with a customer&#8217;s first order prior to the customer beginning to use the SOPHiA DDM Platform.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from services is generally recognized when the services are performed. Revenue from materials is recognized when control of the goods is transferred to the customer, generally at the time of delivery. This category of re</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">venue also includes the revenue from the sale of DNA sequencing automation equipment accounted for under IFRS 16,&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;IFRS 16&#8221;), leasing </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the fees charged for the maintenance of this equipment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Arrangements with multiple performance obligations</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells different combinations of analyses, consumables, and services to its customers under its various SOPHiA DDM Platform models.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the stand-alone selling prices for services and DNA enrichment kits are directly observable. For&#160;set-up&#160;programs and training sold along with dry lab arrangements or bundle arrangements, the stand-alone selling price of these services is determined on a time and materials basis. For DNA enrichment kits sold as part of a bundle, the SSP is based on an expected cost-plus-margin approach of the kit portion of the bundle.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that the SSP for the analyses, in both a dry lab arrangement and bundle arrangeme</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nt, is highly variable and therefore a representative SSP is not discernible from past transactions. As a result, the residual approach is used to determine the stand-alone selling price of the analyses in dry lab arrangements that include services and in bundle arrangements that include DNA enrichment kits and, in some cases, services.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For bundle contracts with a fixed term that also include providing the customer with DNA sequencing automation equipment, the Company determines if there is an IFRS 16 leasing component. In these arrangements the Company provides DNA sequencing automation equipment to the customer over the fixed term and at completion of the contract term the customer takes possession of the equipment. If the Company has determined that it is a dealer lessor, provision of this equipment to the customer is classified as a finance lease. Over the term of the agreement, the minimum lease payment is deducted from the proceeds of the bundle sales in order to reduce the net investment in the corresponding lease receivable over the contract term and interest income is recognized as the discount on the lease receivable unwinds. The remaining proceeds from the contract are accounted for under IFRS 15,&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(&#8220;IFRS 15&#8221;), using the policies described above.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses biopharma contrac</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ts upon execution of each contract given their unique nature. The Company establishes each performance obligation within the contract and determines the appropriate value to be ascribed to each performance obligation. When relevant the Company utilizes previous established SSPs of its dry lab and bundle solutions or other service. When the performance obligation is specific to only the contract the Company utilizes all available information to reasonably estimate the correct value allocated to the performance obligation. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract balances</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Deferred contract costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract costs comprise deferred fulfillment costs related to biopharma, prepayments on contracts, and prepaid maintenance costs relating to DNA sequencing automation equipment.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs are incurred to fulfill obligations under certain contracts once obtained, but before transferring goods or services to the customer. Fulfillment costs are recognized as an asset, provided these costs are not addressed by other accounting standards, if the following criteria are met: (i)&#160;the costs relate directly to a contract or an anticipated contract that the Company can specifically identify, (ii)&#160;the costs generate or enhance resources of the Company that will be used in satisfying (or continuing to satisfy) performance obligations in the future and (iii)&#160;the costs are expected to be recovered.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The asset recognized from deferring the costs to fulfill a contract is recorded in the consolidated balance sheet as deferred contract costs within other current assets and amortized on a systematic basis consistent with the&#160;pattern of the transfer of the goods or services to which the asset relates, which depends on the nature of the performance obligation(s) in the contract. The amortization of these assets is recorded in cost of revenue.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition and billings can result in accrued contract revenue, which is presented within accounts receivable in the consolidated balance sheet and deferred contract revenue which is presented on the face of the consolidated balance sheet.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Accrued contract revenue</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued contract revenue relates to revenue recognized from satisfied performance obligations prior to invoicing and is primarily related to Dry Lab to be invoiced for the most recently completed month and some portions of biopharma contracts. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Deferred contract revenue</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract revenue relates to prepayments received from customers before revenue is recognized and is primarily related to SOPHiA DDM Platform analyses invoiced in advance of the customers performing the analyses, deferred Alamut software revenue, and progress payments received as part of biopharma contracts.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred contract revenue brought forward as of January&#160;1, 2025 and 2024 amounts to $5.7 million and $9.5 million, respectively. During the twelve months ended December 31, 2025 and 2024, the Company satisfied the performance obligations associated with that deferred contract revenue to the extent that revenue was recognized of $5.7 million and $9.5&#160;million, respectively. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the platform revenue is derived from contracts with</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an original expected length of one year or less. There are also certain biopharma and Alamut contracts in which performance obligations extend over multiple years, however, these contracts are immaterial. The Company has elected to apply the practical expedient not to disclose the value of remaining performance obligations associated with these types of contracts.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock', window );">Cost of revenue</a></td>
<td class="text"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue comprises costs directly incurred in earning revenue, including computer costs and data storage fees paid to hosting providers, manufacturing costs, materials and consumables, the cost of equipment leased out under finance leases, personnel-related expenses and amortization of capitalized development costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory', window );">Research and development</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs consist of personnel and related expenses for technology, application, and product development, depreciation and amortization, laboratory supplies, consulting services, computational and data storage fees paid to hosting providers related to research and development, and allocated overhead costs. These costs are stated net of government grants for research and development and innovation received as tax credits and net of capitalized costs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock', window );">Selling and marketing costs</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and marketing costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and marketing costs consist of personnel and related expenses for the employees of the sales and marketing organization, costs of communications materials that are produced to generate greater awareness and utilization of the platform among customers, costs of third-party market research, costs related to transportation and distribution of products and allocated overhead costs, and commissions to sales employees. The Company also records increases to, reversals of, and write-offs of the allowance for expected credit losses to selling and marketing costs.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company pays sales commission to its employees for obtaining contracts. These costs are expensed as part of employee compensation in selling and marketing costs. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The portion of commission payments to employees where the amortization period is greater than one year are capitalized and expensed as the associated revenue is recognized, see Note 14 &#8212; &#8220;Prepaids and other current assets&#8221; and Note 18 &#8212; &#8220;Other non-current assets&#8221; for the amounts capitalized.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock', window );">General and administrative costs</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and administrative costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative costs consist of personnel and related expenses for executive, accounting and finance, legal, quality, support and human resources functions, depreciation and amortization, professional </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">services fees incurred by these functions, general corporate costs and allocated overhead costs, which include occupancy costs and information technology costs.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock', window );">Other operating income, net</a></td>
<td class="text"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records income and expenses that are not regularly occurring or normal business income and expense to other operating income, net. Other operating income, net consists of gains and losses related to the disposal of tangible assets, write-offs of intangible assets and other operating income (expense).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory', window );">Interest income, net and Foreign exchange (losses) gains, net</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists of interest income earned on cash and cash equivalents, short-term investments, and lease receivables. Interest expense consists of interest expense incurred on lease liabilities and loans, which includes interest on commercial borrowings. The foreign exchange gains and losses arise principally on intercompany receivable balances in the parent company, whose functional currency is the Swiss Franc.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory', window );">Income tax</a></td>
<td class="text"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to taxes in different countries. Taxes and related fiscal assets and liabilities recognized in the Company&#8217;s consolidated financial statements reflect management&#8217;s best estimate of the outcome based on the facts known at the balance sheet date in each individual country. These facts may include but are not limited to change in tax laws and interpretation thereof in the various jurisdictions where the Company operates. They may have an impact on the income tax as well as the resulting income tax assets and liabilities. Any differences between tax estimates and final tax assessments are charged to the statement of loss in the period in which they are incurred. Taxes include current and deferred taxes on income as well as actual or potential withholding taxes on current and expected transfers of income from subsidiaries and tax adjustments relating to prior years. Income tax is recognized in the statement of loss, except to the extent that it relates to an item directly taken to other comprehensive income/loss or equity, in which case it is recognized against other comprehensive income/loss or equity, respectively.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current income tax liabilities refer to the portion of the tax on the current year taxable profit (as determined according to the rules of the taxation authorities) and includes uncertain tax liabilities. The Company determines the taxable profit (tax loss), tax bases, unused tax losses, unused tax credits and tax rates consistently with the tax treatment used or planned to be used in its income tax filings if the Company concludes it is probable that the taxation authority will accept an uncertain tax treatment.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Otherwise, the Company reflects the effect of uncertainty using either the most likely outcome or the expected value outcome, depending on which method the entity expects to better predict the resolution of the uncertainty.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred taxes are based on the temporary differences that arise when taxation authorities recognize and measure assets and liabilities with rules that differ from the accounting policies of the Company&#8217;s consolidated </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements. They also arise on temporary differences stemming from tax losses carried forward. Deferred taxes are measured at the rates of tax expected to prevail when the temporary differences reverse, subject to such rates being substantively enacted at the balance sheet date. Any changes of the tax rates are recognized in the statement of loss unless related to items directly recognized against other comprehensive income. Deferred tax liabilities are recognized on all taxable temporary differences excluding non-deductible goodwill. Deferred tax assets are recognized for unused tax losses, unused tax credits and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If the amount of taxable temporary differences is insufficient to recognize a deferred tax asset in full, then future taxable profits, adjusted for reversals of existing temporary differences, are considered, on the basis of the business plans for individual subsidiaries in the Company. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impact of a transaction or item can be uncertain until a conclusion is reached with the relevant tax authority or through a legal process. The Company uses in-house tax experts when assessing uncertain tax positions and seeks the advice of external professional advisors where appropriate. The assessment of the uncertain tax position is done by first making a determination of whether it is more likely than not that a tax position would be sustained upon an examination, and then by calculating the amount of the benefit, of that tax position that meets the more likely than not threshold, that should be recognized in the financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div>Cash and cash equivalents include cash on hand, deposits held at call with external financial institutions, money market funds, and short-term deposits and other short-term highly liquid investments with original maturities of three months or less. They are both readily convertible to known amounts of cash and so near to their maturity that they present insignificant risk of changes in value because of changes in interest rates. Amounts held in money market funds are classified as cash equivalents and are measured as level 1 fair value financial instruments.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory', window );">Accounts receivable</a></td>
<td class="text"><div style="margin-top:12pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable-trade balances are&#160;non-interest&#160;bearing and payment terms are generally under agreements with payment terms typically between 30 and 60 days with payment terms extended up to&#160;180 days. The Company&#8217;s customers primarily consist of government-owned or government-funded hospitals, laboratories with low credit risk, and biopharmaceutical companies. The Company has had minimal instances of actual credit losses and believes that this will continue to be the case.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has adopted the simplified method indicated in IFRS 9,&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;IFRS 9&#8221;), to build its allowance for expected credit losses (&#8220;ECL&#8221;). The Company uses a matrix based on a calculation of collectability rates according to historical accounts receivable. Allowance is made for lifetime expected credit losses as invoices are issued or when accrued revenue is recognized. The amount of allowance initially recognized is based on historical experience, tempered by expected changes in future cash collections, due to, for example, expected improved customer liquidity or more active credit management.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">Inventories</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials and finished goods are stated at the lower of cost calculated using the first-in, first-out (&#8220;FIFO&#8221;) method and net realizable value. Work in progress is stated at the lower of its weighted average cost and net realizable value. Cost comprises direct materials, direct labor, and an appropriate proportion of variable and fixed overhead expenditure, the latter being allocated on the basis of normal operating capacity.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">Property and equipment</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment include leasehold improvements, computer hardware, machinery, and furniture and fixtures.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill impairment testing</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates as&#160;a single cash-generating unit (&#8220;CGU&#8221;). As a single CGU, goodwill is tested by considering its recoverability in terms of the entire business. Management assesses the recoverable value of </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">goodwill by comparing the Company&#8217;s equity value, either from observable market prices or based on discounted cash flow </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forecasts, to the net assets as reported in the Company&#8217;s consolidated financial statements. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Impairment testing is performed on an annual basis as of October 1. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized internally developed software costs</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized costs are based on the employment costs of individuals working on software development and based on timesheets. Special attention is paid to distinguishing between costs incurred on developing new software or software upgrades, which typically are eligible for capitalization, and costs incurred in maintenance and in the correction of problems, which are not eligible.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Judgment is required in identifying whether individual projects meet all of the criteria required to permit capitalization, in particular, whether the software will generate probable future economic benefits.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is initially measured as the difference between the aggregate of the value of the consideration transferred and the fair value of net assets acquired. Goodwill is not amortized but it is tested for impairment annually, or more frequently if events or changes in circumstances indicate that it might be impaired and is carried at cost less accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment testing</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are allocated to CGUs for the purpose of impairment testing. The allocation is made to those CGUs or groups of CGUs that are expected to benefit from the business combination in which the goodwill arose. The CGUs or groups of CGUs are identified at the lowest level at which goodwill is monitored for internal management purposes, being the operating segments. As the Company operates as a single CGU, the Company has only a single cash generating unit for impairment testing.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assesses the recoverable value of goodwill by comparing the Company&#8217;s equity value, either inferred from the public prices of share issues based on the fair value less cost of disposal (&#8220;FVLCOD&#8221;) method or based on discounted cash flow forecasts, with the net assets as reported in its consolidated financial statements based on the value in use (&#8220;ViU&#8221;) method. The discounted cash flow approach involves key assumptions that leave considerable scope for judgment. The Company typically compares the two methods and utilizes the greater recoverable amount for the purposes of its impairment testing. Impairment testing is performed on an annual basis as of October 1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchased software</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs of accessing software services are not capitalized if the Company does not have any contractual right to take possession of the software at any time during the term of the agreement and it is not feasible for the Company either to run the software on its own hardware or to contract with a third party unrelated to the vendor. Such costs represent software as a service costs and are expensed as incurred.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does capitalize software implementation costs, such as fees paid to outside consultants to set up a software arrangement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For cloud computing costs, the Company capitalized costs for certain configuration and customization costs paid by a customer in a cloud computing or hosting arrangement. IAS 38 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible assets (&#8220;IAS 38&#8221;)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> aligns the accounting treatment of these costs incurred in a hosting arrangement treat</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ed as a service contract with the requirements for capitalization and amortization costs to develop or obtain an intangible asset.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchased software and associated capitalized costs are amortized using the&#160;straight-line method&#160;over an estimated life of five years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized internally developed software costs</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in the internal development of software are capitalized as intangible assets when they satisfy the criteria required by IAS 38 as set out below.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software development costs consist entirely of capitalized internally generated costs that are directly attributable to the design, testing, and enhancement of identifiable and unique software applications and products controlled by the Company and incorporated principally within the Company&#8217;s SOPHiA DDM Platform. They are recognized as intangible assets where the following criteria are met:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">it is technically feasible to complete the software so that it will be available for use;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">management intends to complete the software and use or sell it;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">there is an ability to use or sell the software;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">it can be demonstrated how the software will generate probable future economic benefits;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">adequate technical, financial, and other resources to complete the development and to use or sell the software are available, and;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">the expenditure attributable to the software during its development can be reliably measured.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Directly attributable costs that are capitalized as part of the software comprise principally employee costs. Capitalized development costs are recorded as intangible assets and amortized from the point at which the asset is ready for use on a straight-line basis over its expected useful life. Capitalized software development costs are amortized using the&#160;straight-line method&#160;over an estimated life of&#160;five years.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">Leases</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessee</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses at inception of the contract whether a contract is or contains a lease. This assessment involves determining whether the Company obtains substantially all the economic benefits from the use of that asset, and whether the Company has the right to direct the use of the asset. When these conditions are met, the Company recognizes a&#160;right-of-use&#160;(&#8220;ROU&#8221;) asset and a lease liability at the lease commencement date, except for short-term leases of 12 months or less, which are expensed in the statements of loss on a straight-line basis over the lease term.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, the ROU asset comprises the initial lease liability, initial direct costs, and any obligations to refurbish the asset, less any incentives granted by the lessors.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ROU asset is depreciated over the shorter of the duration of the lease contract (including contractually agreed optional extension periods whose exercise is deemed to be reasonably certain) and the useful life of the underlying asset.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ROU asset is subject to testing for impairment if there is an indicator for impairment, as for owned assets.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that is not readily determinable, the incremental borrowing rate (&#8220;IBR&#8221;) at the lease commencement date. The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. Lease payments can include fixed payments; variable payments that depend on an index or rate known at the commencement date; and extension option payments or purchase options that the Company is reasonably certain to exercise.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease liability is subsequently measured at amortized cost using the effective interest rate method and remeasured (with a corresponding adjustment to the related ROU asset) when there is a change in future lease payments due to renegotiation, changes in an index or rate, or a reassessment of options.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company&#8217;s leases include options to extend the lease, and these options are included in the lease term to the extent they are reasonably certain to be exercised.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases out laboratory equipment to certain customers. These leases are classified as finance leases as the Company transfers substantially all the risks and rewards incidental to ownership of the asset to the customer. Refer to Note 4 &#8212; &#8220;Revenue&#8221; fo</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">r disclosure of revenue recognized from leased laboratory equipment.</span></div>At the commencement of the lease term, the Company records revenue and the associated costs of sales, being the sale proceeds at fair value of the asset (computed at cost plus a margin) and the cost of the asset, derecognizes the leased asset from inventory, and recognizes a finance lease receivable on the balance sheet equal to the net investment in the lease. The Company notes these lease agreements ended during 2023, and as of December 31, 2025 and 2024, the Company did not have any leases of laboratory equipment.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory', window );">Post-employment benefits</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting estimates and judgments</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability or asset recognize</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d on the balance</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation at the end of the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by independent actuaries using the projected unit credit method.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms approximating to the terms of the related obligation. In countries where there is no deep market in such bonds, the market rates on government bonds are used.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the statement of loss.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Remeasurement gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which they occur, directly in other comprehens</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ive income. The remeasurement gains and losses are included in retained earnings in the statement of changes in equity and on the balance sheet.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in income as past service costs.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For defined contribution plans, the Company pays contributions to publicly or privately administered pension insurance plans. Employee contributions to these plans is voluntary and these contributions are matched by the employer. The Company has no further payment obligations once the contributions have been paid. The contributions are recognized as employee benefit expense when they are due. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in the future payments is available. Contributions are charged to the statement of loss as incurred.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates defined benefit and defined contribution pension plans. Funded schemes are generally funded through payments to insurance companies or trustee-administered funds, determined by periodic actuarial calculations. A defined </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity (a fund) and has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods. A defined benefit plan is a pension plan that is not a defined contribution plan. Typically, defined benefit plans define an amount of pension benefit that an employee will receive on retirement, usually dependent on one or more factors such as age, years of service and compensation.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual return on plan assets, excluding interest income measured at the discount rate, is recognized in other comprehensive income/loss within defined benefit plan remeasurements.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a funded defined benefit plan in Switzerland, an unfunded defined benefit plan in France, and a defined</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> contribution plan in the U.S. The Company has no occupational pension plans in the U.K. and Brazil.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Swiss pension plan</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracted with the Swiss Life Collective BVG Foundation based in Zurich for the provision of occupational benefits. All benefits in accordance with the regulations are reinsured in their entirety with Swiss Life SA within the framework of the corresponding contract. This pension solution fully reinsures the risks of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disability, death and longevity with Swiss Life. Swiss Life invests the vested pension capital and provides a&#160;100% capital and interest guarantee. The pension plan is entitled to an annual bonus from Swiss Life comprising the effective savings, risk and cost results. As of January 1, 2025, the Company switched from Swiss Life Collective BVG Foundation to Profond for the provision of occupational benefits. </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the amount of ultimate pension benefit is not defined, certain legal obligations of the plan create constructive obligations on the employer to pay further contributions to fund an eventual deficit; this results in the plan nevertheless being accounted for as a defined benefit plan.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">French pension plan</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In France, the bulk of pensions are paid by national pension schemes, which are unfunded. In addition, French employers are obliged by law to pay a retirement indemnity. Its amount depends on the last salary of the employee and on the period of activity with its employer. Rights to this benefit are acquired during the service life with the same employer on the condition that the employee will be with its employer at retirement date; it means that the rights are only vested on retirement date. This indemnit</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y is in substance a defined benefit plan.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory', window );">Share-based compensation</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical accounting estimates and judgments</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-based Compensation</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2025, 2024, and 2023</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company granted share options under one plan - the SOPHiA GENETICS 2021 Equity Incentive Plan (the &#8220;2021 Equity Incentive Plan&#8221; or the &#8220;2021 EIP&#8221;). Under this plan, directors may offer options to directors, employees, and advisors. The exercise price of the share options is set at the time they are granted. Options, once vested, can be exchanged for an equal number of ordinary shares.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Measuring the cost of share options</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the options under all plans are measured at each grant date using the Black-Scholes option pricing model, taking into account the terms and conditions upon which the options were granted.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For options up to September 2020, the fair value at grant date is independently determined using an adjusted form of the Black-Scholes option pricing model that takes into account the strike price, the fair value of the share at grant date, the expected life of the award, the expected price volatility of the underlying share, the risk-free interest rate for the term of the award, and the expected dividend yield.&#160;For options granted on and subsequent to September&#160;2020 until July 22, 2021, the fair value at grant date is based </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on a probability-weighted expected returns method that takes account of both the value derived by using an adjusted form of the Black-Scholes </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">option pricing model, as described above, and a discounted estimate of the price that might be achieved in a future transaction.&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For options granted on and subsequent to July 22, 2021, the fair value at grant date is determined by using the Black-Scholes option pricing model.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has used an independent valuation firm to assist in calculating the fair value of the award grants per participant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key inputs used in the valuation model, for the stock options granted in the years ended December 31, 2025, 2024, and 2023, respectively, are outlined below. Stock options were only granted under the 2021 Equity Incentive Plan (&#8220;2021 EIP&#8221;).&#160;No&#160;grants have been made under the 2019 Incentive Share Option Plan (&#8220;2019 ISOP&#8221;) since 2021 and the SOPHiA GENETICS Incentive Share Option Plan (&#8220;2013 ISOP&#8221;) since 2019.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Company&#8217;s IPO, the price of the ordinary shares at grant date, which represents a critical input into this model, has been determined on one of the following two bases:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">B</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y reference to a contemporaneous transaction involving another class of share, using an adjusted form of the Black-Scholes option pricing model as described above, and considering the timing, amount, liquidation preferences, and dividend rights of issues of other classes of shares.</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">On the basis of discounted cash flow forecasts, where there was no contemporaneous or closely contemporaneous transaction in another class of share and the time interval was too large to permit an assumption that there had been no significant change in the Company&#8217;s equity value.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the IPO, the price of the ordinary shares at grant date, which represents a critical input into this model, has been determined on the most recent close price of the Company&#8217;s stock price on the date of grant.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting policies</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has&#160;three&#160;share option plans for directors, employees, and advisors which are accounted for as equity-settled share-based compensation plans.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of options granted under these plans is recognized as an employee benefits expense, with a corresponding increase in equity. The total amount to be expensed is determined by reference to the fair value of the options granted:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">including any market performance conditions (e.g., the entity&#8217;s share price);</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">excluding the impact of any service and non-market performance vesting conditions (e.g., profitability, sales growth; targets and remaining an employee of the entity over a specified time period), and;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">including the impact of any non-vesting conditions (e.g., the requirement for employees to save or hold shares for a specific period of time).</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total expense is recognized over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied. At the end of each period, the entity revises its estimates of the number of options that are expected to vest based on the non-market vesting and service conditions. It recognizes the impact of the revision to original estimates, if any, in income, with a corresponding adjustment to equity.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimating fair value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including the share price, or the fair value of a share, the expected life of the share option, the volatility of the share price, the risk-free interest rate, the dividend yield, and making certain assumptions about the inputs. The assumptions used for estimating fair value for share-based payment transactions are disclosed below.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The volatility used in the estimation of fair value is calculated utilizing a mix of the Company&#8217;s own share price volatility and the volatility of the share prices of a set list of publicly traded peer companies based on a defined proportion. Share price volatility is calculated for each tranche of share options on a historical basis over a </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">period of time equal to the average life of the share options granted in each tranche. In the event that a company used in the volatility calculation has not been publicly traded for the requisite amount of time, the entirety of its trading history was used.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the shares are not listed, estimating their fair value also requires determination of the most appropriate valuation model, such as:</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">By reference to a contemporaneous transaction involving another class of share, using an adjusted form of an option pricing model above, and considering the timing, amount, liquidation preferences and dividend rights of issues of other classes of shares;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">On the basis of discounted cash flow forecasts, where there was no contemporaneous or closely contemporaneous transaction in another class of share and the time interval was too large to permit an assumption that there had been no significant change in the Company&#8217;s equity value;</span></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">Share based compensation expense is measured at the fair value of the options at the grant date and recognized over the vesting period. Share based compensation expense is presented in the statement of loss and allocated to the various expense categories based on the functions of the employees to whom the options are granted (e.g., research and development, selling and marketing, general &amp; administrative).</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of the cost of the Company&#8217;s share option grants and of the fair value of the ordinary shares at the grant date requires the selection of an appropriate valuation model and is based on key assumptions that leave considerable scope for judgment.</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recognizing the cost of share options</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At each reporting date, the Company recognizes expense for the vested options granted and for partially earned but&#160;non-vested&#160;portions of options granted. This results in a front-loaded expense to the statement of loss. The Company accounts for these plans as equity-settled transactions. The charge to the statements of loss therefore results in a corresponding credit being booked to &#8220;Other reserves&#8221; within equity.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for income and expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 46<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 170<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_170&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 170<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_170&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for Accounting policies explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for basis of consolidation explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for basis of preparation explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for new standards amendments to standards and interpretations issued not yet effective.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description Of Accounting Policy For Cost Of Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description Of Accounting Policy For General And Administrative Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for going concern basis explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for historical cost convention explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description Of Accounting Policy For Other Operating Income (Expense)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for provisions and contingencies explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description Of Accounting Policy For Selling And Marketing Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of accounting policy for use of estimates explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_SummaryOfMaterialAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_SummaryOfMaterialAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company information and operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCompanyInformationAndOperationsAbstract', window );"><strong>Disclosure Of Company Information And Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock', window );">Summary of Wholly-Owned Subsidiaries</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025, the Company had the following wholly-owned subsidiaries:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.052%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Country of domicile</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS S.A.S.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS LTD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.K.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS Intermedia&#231;&#227;o de Neg&#243;cios LTDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS PTY LTD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australia</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS S.R.L.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA GENETICS GmbH</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Germany</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfCompanyInformationAndOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of company information and operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfCompanyInformationAndOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory', window );">Summary of Revenue and Non-Current Non-Financial Assets by Country</a></td>
<td class="text">An analysis of the location of non-current assets other than financial instruments and deferred tax assets by country is as follows (in USD thousands):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,777&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,282&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazil</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total non-current assets other than financial instruments <br/>and deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53,938</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48,375</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of geographical information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract', window );"><strong>Receivables from contracts with customers [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory', window );">Summary of Revenue from Contracts with Customers Allocated to Geographical Areas and Revenue Streams</a></td>
<td class="text">The following table disaggregates the Company's revenue from contracts with customers by geographic market (in USD thousands):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Switzerland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">France</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Italy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of EMEA</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EMEA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55,576</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46,929</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43,958</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,872&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,323&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of NORAM</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NORAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,400</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,300</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,726</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LATAM</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,086</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,890</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,990</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,054</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,697</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,271</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,173</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62,371</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue streams</span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue from contracts with customers has been allocated to the revenue streams indicated in the table below (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SOPHiA DDM Platform</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,915&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,546&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,904&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workflow equipment and services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77,271</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65,173</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62,371</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReceivablesFromContractsWithCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReceivablesFromContractsWithCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock', window );">Summary of Depreciation and Amortization have Charged in Expense</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization have been charged in the following expense categories (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Depreciation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(5,266)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(3,524)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,099)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,649)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,961)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Selling and marketing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,468)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">General and administrative costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(497)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(1,546)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(3,976)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(5,553)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(4,575)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(4,021)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(5,508)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(2,828)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock', window );">Summary of Employee Benefit Expenses, Social Charges and Share-based Compensation</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table presents employee costs by function,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> which consists of &#8220;Employee benefit expenses&#8221;, &#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Social charges&#8221; and &#8220;Share-based compensation&#8221; (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,543&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93,657</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86,149</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90,181</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of depreciation and amortization have charged in expense explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of employee benefit expenses and social charges from the operating expense explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest income, Interest expense and Foreign exchange (losses) gains, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract', window );"><strong>Interest Income (Expense) And Foreign Exchange Gain (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock', window );">Summary of Interest Income</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table presents interest income (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,872</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,362</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,547</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock', window );">Summary of Interest Expense</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table presents interest expense (in USD thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on loans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,953)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,339)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(573)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,554)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,913)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(588)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock', window );">Summary of Foreign Exchange Losses</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e table presents foreign exchange gains (losses), net (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gains (losses), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total foreign exchange gains (losses), net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,402)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,479</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,628)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Foreign Exchange And Other Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Detailed Information About Finance Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income (Expense) And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock', window );">Summary of Current and Deferred Income Tax (Expenses) Benefits</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the current and deferred income tax (expense) benefits (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:56.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.107%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current income tax expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,115)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,542)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,270)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(255)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deferred income tax (expense) benefit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Origination and reversal of temporary differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total deferred income tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(231)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total income tax (expense) benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,223)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(486)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock', window );">Summary of Expected Tax Expense to Tax Expense Report in Statement of Loss</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reconciliation of the expected tax expense to the tax expense report in the statement of loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before tax</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(77,487)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(61,270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(78,495)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax at Swiss statutory rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of tax rates in foreign jurisdictions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(893)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(833)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tax effect of:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Unrecognized deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,542)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(8,879)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Income not subject to tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Expense not deductible for tax purposes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,857)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2,263)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(2,085)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(567)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,512)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,223)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(486)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory', window );">Summary of Movement in Deferred Tax Balances</a></td>
<td class="text">The following table presents the changes in the Company&#8217;s deferred tax assets and deferred tax liabilities (in USD thousands):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Depreciation &amp;<br/>amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net operating loss<br/>carryforward</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(136)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(897)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,047</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,150</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,767</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in profit or loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognized in OCI</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(402)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">570</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">517</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,143</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,831</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(402)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Depreciation &amp;<br/>amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrued pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU asset</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lease liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net operating loss<br/>carryforward</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(19)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(761)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">794</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">696</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,010</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,720</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Recognized in profit or loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Currency translation differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(136)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(897)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,047</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,150</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,767</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Deferred tax assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">670&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">2,867&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Deferred tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(136)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(897)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(1,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The following table consists of the gross tax loss carryforwards and the deferred tax assets that have not been recognized because it is not probable that there will be future taxable profits to use these benefits (in USD thousands):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:43.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax effect</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Tax effect</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductible temporary differences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,332&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,623&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,871&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,544&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">451,324</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60,885</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">352,156</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,205</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock', window );">Summary of Expiring Amounts of Unrecognized Net Operating Loss Carryforwards</a></td>
<td class="text"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2025 and 2024, the Company had the following expiring amounts of unrecognized NOL carryforwards (in USD thousands):</span><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,446&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Two years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Four years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter and unlimited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,756&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net operating loss carryforwards</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">443,992</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">347,533</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of current and deferred tax (expenses) benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expiring amounts of unrecognized net operating loss carryforwards explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of reconciliation of expected tax expense to tax expense report in statement of loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareExplanatory', window );">Summary of Loss for Year</a></td>
<td class="text">The table presents the loss for the year ended December 31, 2025, 2024, and 2023, respectively (in USD thousands, except shares and loss per share):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributed to shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,999)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,981)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of shares in issue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,539,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,062,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,750,886&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic and diluted loss per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.17)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.95)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Summary of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the allocation between the Company&#8217;s cash and cash equivalents (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash on hand</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,459</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,783</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term deposits less than 3 months</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,302</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,857</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32,830</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,443</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70,289</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">80,226</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of schedule of cash and cash equivalents explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock', window );">Summary of Accounts Receivable and Lease Receivable Less Expected Credit Loss</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the trade receivable</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, accrued contract revenue,</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and lease receivable less the expected credit loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,404&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for expected credit losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(366)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,001</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,436</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock', window );">Summary of Movement in Allowance for Expected Credit Losses in Accounts Receivable</a></td>
<td class="text">The following table provides a rollforward of the allowance for expected credit losses for the year ended December 31, 2025 and 2024, that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected (in USD thousands):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,181</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(463)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-off</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">366</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">394</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of accounts receivable and lease receivable less expected credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Allowance For Credit Losses In Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock', window );">Summary of Inventory</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,526&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,321&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,868</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock', window );">Summary of Inventory Provision Movement</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory provision movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,084)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,134)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(554)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-off</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,443)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,084)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of inventory provision movement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and other current assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_PrepaymentsAndOtherCurrentAssetsAbstract', window );"><strong>Prepayments And Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock', window );">Summary of Prepaids and Other Current Assets</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents prepaids and other current assets (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepayments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government grants receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current contract acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,438</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,875</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information of other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_PrepaymentsAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaids and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_PrepaymentsAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract', window );"><strong>Disclosure of detailed information about property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Summary of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Computer hardware</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,456</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,861</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,361</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,244</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,922</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,285</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,557</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,466</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,216</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,524</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,615)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(973)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(955)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,713)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,810)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(399)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,943)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,658)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,218)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,040)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,859)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">899</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">248</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">176</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,665</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Computer hardware</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,855</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,975</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,460</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,310</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,600</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(485)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(815)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,456</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,861</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,361</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,244</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,922</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,576)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(993)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,935)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,615)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,170)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(973)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(955)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5,713)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,841</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">691</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">388</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">289</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangibles assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract', window );"><strong>Disclosure of detailed information about intangible assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory', window );">Summary of Intangible Assets Net, Movement</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased software</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capitalized internally developed software costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total intangible assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,046</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,321</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,709</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,556</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,748</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,616</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53,920</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,466)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,711)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(290)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,563)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,755)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,029)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(14,000)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(18,029)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,556</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">719</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,616</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,891</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purchased software</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Capitalized internally developed software costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total intangible assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,999</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,162</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,367</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34,528</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,932&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(657)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,751)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,046</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,321</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">39,709</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,001)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,343)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,537)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,021)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,245)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(7,466)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(10,711)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net book value at December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">801</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,855</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28,998</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the reconciliation of changes in intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Presentation of leases for lessee [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory', window );">Summary of Right of Use Assets</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presen</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ts the ROU assets (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Office space leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,382</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,168</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock', window );">Summary of Lease Liabilities</a></td>
<td class="text"><div><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the lease liabilities (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.909%"><tr><td style="width:1.0%"></td><td style="width:51.083%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.888%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.719%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.891%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,587&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,603&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,793</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of quantitative information about lease liabilities explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other non-current assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousNoncurrentAssetsAbstract', window );"><strong>Miscellaneous non-current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock', window );">Summary of Other Non-Current Assets</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other non-current assets consist of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research tax credit receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,013&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantee deposits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity Investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non&#8209;current contract acquisition costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,183</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,762</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousNoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousNoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Non-Current Assets And Other Explanatory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock', window );">Summary of Accounts Payable</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable consist of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade payables</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related payables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT, sales, and other taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,960</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,220</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounts payables explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedExpensesAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock', window );">Summary of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,781&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued IT support</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued legal fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,736</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,217</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccruedExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccruedExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about accrued expenses explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract', window );"><strong>Disclosure Of Information About Post Employment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory', window );">Summary of Additional Details on Defined Benefit Plans Funded Status</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides additional details on the defined benefit plans&#8217; funded status (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of defined benefit obligation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,429)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net pension liability</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,162)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,839)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock', window );">Summary of Movement in Defined Benefit Obligation Explanatory</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the movement in the defined benefit obligation (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.996%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.948%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,147)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(52)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,199)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(22,972)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(41)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,013)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service Cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,827)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,841)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,625)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,637)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">of which current service cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,827)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,841)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,683)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">of which past service cost including effects from curtailment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(942)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(942)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(229)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains (losses)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,342)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual plan participants&#8217; contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,461)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,295)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers (in) out due to (joiners) leavers</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,738&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28,345)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(84)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28,429)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,147)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(52)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(23,199)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the sensitivity analysis for the unfunded plans (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of&#160;50&#160;basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 50 basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected rates of salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of&#160;50&#160;basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 50 basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock', window );">Summary of Movement in Defined Benefit Plans Assets</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the movement in the defined benefit plans&#8217; assets (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of January 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,360</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,927</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on plan assets, excl. interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,390&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,295&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transfers in (out) due to joiners (leavers)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,587)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,644)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,485)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,360</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory', window );">Summary of Defined Benefit Plans Assets</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the defined benefit plan assets, which include the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance policies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,895</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,360</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">French plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swiss plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">19,360</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock', window );">Summary of Pension Costs Recognized in Statement of Loss</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the pension costs recognized in sta</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tement of loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.935%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,827)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,841)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,625)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,637)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,311)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,321)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(414)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,851)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,867)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,648)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,661)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,724)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,735)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock', window );">Summary of Pension Remeasurement Recognized in Statement Other Comprehensive Loss</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the pension remeasurement recognized in statement of other comprehensive loss (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.328%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Funded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unfunded</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in demographic assumptions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in financial assumptions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(901)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">606&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total actuarial gains (losses)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">185</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">180</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">401</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">403</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Return on plan assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,668&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(654)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation differences</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total recognized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">709</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">704</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">326</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(216)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(212)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory', window );">Summary of Sensitivity Analysis for Funded and Unfunded Plans</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the sensitivity analysis for the funded plans (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount rates</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of 25 basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(763)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(682)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 25 basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected rates of salary increases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of 25 basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 25 basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of 25 basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 25 basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(258)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inflation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of 25 basis points</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 25 basis points</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Life expectancy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase of 1 year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease of 1 year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of additional information about defined benefit plans necessary to meet the objectives of IAS 19. [Refer: Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 137<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_137&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of defined benefit plans. [Refer: Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 138<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_138&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 204<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_204&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 204<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_204&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [domain]; Defined benefit obligation, at present value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 145<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_145&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of movement in defined benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of movement in defined benefit plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about pension costs recognized in statement of income loss explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about pension remeasurement recognized in statement other comprehensive income loss explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of information about post-employment benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory', window );">Summary of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2025, under the 2013 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">560,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.03</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.54</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">480,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.73</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">480,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.18</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.73</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2024, under the 2013 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">606,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.49</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">560,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.03</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.54</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">560,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.03</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.54</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2023, under the 2013 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">657,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.92</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.24</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">606,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.49</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">606,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.49</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2025, under the 2019 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,308,760</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.40</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,373)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,253,387</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.42</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,253,367</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.42</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2024, under the 2019 ISOP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,402,510</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.30</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,250)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,308,760</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.40</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,033,490</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.80</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.31</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2023, under the 2019 ISOP was as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,629,516</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.96</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.21</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,006)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,402,510</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.97</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.30</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,651,493</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.64</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.03</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2025, under the 2021 EIP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,044,607</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.69</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.40</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,280,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(909,956)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,385,514</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.72</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.98</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,989,270&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.11</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2024, under the 2021 EIP was as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,708,059</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.84</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.74</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,840,087&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,119)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(454,420)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,044,607</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.69</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.40</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806,356&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.37</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for the year ended December 31, 2023, under the 2021 EIP was as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average exercise price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average remaining life in years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,624,297</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12.32</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.88</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(645,310)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,708,059</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.84</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.74</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,155,231&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.57</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory', window );">Summary of Valuation Inputs</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation inputs for the 2021 EIP grants were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December&#160;31,&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at grant date (in USD)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;$3.04 </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.73</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.40</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.53</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.72</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life of share options (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.50</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.00</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.60%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.95%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.96%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate (%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.03%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.40%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.67%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield (%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock', window );">Summary of Weighted Average Fair Value of Options Granted</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average fair value of options granted during the years ended December 31, 2025, 2024, and 2023, respectively (in USD):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 EIP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory', window );">Summary of Restricted Stock Units Activity</a></td>
<td class="text">The activity for the year ended December 31, 2025 was as follows:<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of January 1, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,053,076</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.69</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,434,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171,196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,584,209</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.04</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The activity for the year ended December 31, 2024 was as follows:<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,335,268</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.77</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373,816&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,331,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(324,277)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,053,076</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.69</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The activity for the year ended December 31, 2023 was as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average grant date fair value per share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,865,433</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,658,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(927,155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,335,268</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.77</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions', window );">Summary of Movements in Share-based Compensation Reserve</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Movements in the share-based compensation reserve were as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,075</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40,317</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,805</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Movement in the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,205&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73,010</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by financial statement caption for all stock awards consists of the following (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,070&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,370&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,205</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,488</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,242</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information about weighted average fair value of options granted explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract', window );"><strong>Disclosure of detailed information about borrowings [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory', window );">Schedule of Key Inputs for the Valuation of the Warrant Obligation</a></td>
<td class="text">Key inputs for the valuation of the warrant obligation upon issuance were as follows:<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:34.006%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.425%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.674%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of June 25, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of May 2, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.00</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price in USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.17</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.08</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.24%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.53%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility (annualized)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.98%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.77%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Black-Scholes value in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.37</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.06</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of the warrant obligation on a quarterly basis. Key inputs for the remeasurement of the Tranche A warrant obligation were as follows:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of  December 31, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of  December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.00</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price in USD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.67</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.07</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.01%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.51%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.39%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.52%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.34</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.33</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Black-Scholes value in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.35</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.22</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key inputs for the remeasurement of the Tranche B warrant obligation were as follows:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:34.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.495%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of  December 31, 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise price in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.00</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price in USD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4.67</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.02%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.10%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.48</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Black-Scholes value in USD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.71</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory', window );">Schedule of Allocation of the Loan Proceeds and Any Movements in the Liability</a></td>
<td class="text">The following table presents the allocation of the loan proceeds and any movements in the liability for the year ended December 31, 2025, (in USD thousands):<div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"></td><td style="width:46.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.097%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Tranche A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Proceeds net of transaction costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,930</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant obligation at issuance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,152)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,237</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross proceeds from Tranche B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(437)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Proceeds net of transaction costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">34,563</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant obligation at issuance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(474)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,521)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,733</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock', window );">Schedule of Warrant Obligation Liability</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the movements in the warrant obligation liability for the year ended December 31, 2025, (in USD thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.030%"><tr><td style="width:1.0%"></td><td style="width:51.389%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.833%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.649%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Obligation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of January 1, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of warrants from Tranche A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(370)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of warrants from Tranche B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of December 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,412</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,000&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of significant inputs for which market data are not available and that are developed using the best information available about the assumptions that market participants would use when measuring the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Warrant Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory', window );">Summary of Compensation for Key Management and Non-executive Directors</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compensation for key management and non-executive directors recognized during the year comprised (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and other short-term employee benefits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,784&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,000</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,786</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15,059</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 18<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_18&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risks (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory', window );">Summary of Financial Instruments</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds the following financial instruments (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:71.282%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.105%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets at amortized cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,001&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financial non-current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets at amortized cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87,285</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88,656</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets at fair value through statement of loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87,285</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88,656</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities at amortized cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,220&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities at amortized cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92,716</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48,467</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities at fair value through statement of loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">94,128</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48,911</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory', window );">Schedule of Fair Value Hierarchy for Financial Assets Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2025 (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"><tr><td style="width:1.0%"></td><td style="width:42.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Equity Investments: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,528&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perceptive Credit Holdings warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2024 (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"><tr><td style="width:1.0%"></td><td style="width:42.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perceptive Credit Holdings warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">474</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory', window );">Schedule of Fair Value Hierarchy for Financial Liabilities Measured at Fair Value on a Recurring Basis</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2025 (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"><tr><td style="width:1.0%"></td><td style="width:42.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;Equity Investments: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Equity investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,528&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,977&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perceptive Credit Holdings warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the Company&#8217;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2024 (in thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"><tr><td style="width:1.0%"></td><td style="width:42.085%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,586&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant obligation:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perceptive Credit Holdings warrants</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total financial liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">474</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory', window );">Summary of Maturity Profile of Financial Liabilities</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below summarizes the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted cash flows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:29.855%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Within 1 year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Between 1 and 5 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After 5 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,960&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,083&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total contractual liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">92,716</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37,813</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73,797</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,463</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">113,073</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:29.855%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net carrying amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Within 1 year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Between 1 and 5 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">After 5 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,793&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,739&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,217&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,027&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total contractual liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48,467</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,798</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32,923</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,469</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60,190</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock', window );">Summary of Significant Foreign Exchange Rates</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant exchange rates that have been applied to these consolidated financial statements are listed below:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Spot rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average rate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/CHF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.79208&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90740&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.88064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89855&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/EUR</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.85092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.96530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.88644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.92455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.92478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/GBP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74179&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.79870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.78267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD/BRL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.49560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.17360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.39155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.97372&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock', window );">Summary of Loss Before Tax to Changes in Foreign Exchange Rates</a></td>
<td class="text"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sensitivity of the Company&#8217;s income to possible changes in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">foreign exchange rates is measured at the local entity level as it depends on the functional currency of each entity. As of December 31, 2025, 2024, and </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company was exposed principally to movements in four cross currency pairs. The sensitivity of the Company&#8217;s loss before tax to such changes was as follows (in USD thousands):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.996%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/CHF exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,101)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,101</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(562)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,034)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in EUR/CHF exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,020)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(508)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in GBP/CHF exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock', window );">Summary of Equity to Changes in Foreign Exchange Rates</a></td>
<td class="text">As of <span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2025 and 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the sensitivity of the Company&#8217;s equity to such changes, measured against the USD, was as follows (in USD thousands):</span><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.012%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/CHF exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,561)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,561</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,520)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,520</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/EUR exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(663)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,244</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,244)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase / (decrease) in USD/GBP exchange rate by&#160;10%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about financial instruments. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35K<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35K&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 43<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 43<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value measurement of assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of the fair value measurement of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of a maturity analysis of the undiscounted cash outflows that would or may be required to repurchase derecognised financial assets or other amounts payable to the transferee in respect of transferred assets, showing the remaining contractual maturities of the entity's continuing involvement. [Refer: Undiscounted cash outflow required to repurchase derecognised financial assets; Other amounts payable to transferee in respect of transferred assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 42E<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_42E_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Detailed Information About Exchange Rates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity of equity to changes in foreign exchange rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity of loss before tax to changes in foreign exchange rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company information and operations - Summary of Wholly-Owned Subsidiaries (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsSASMember', window );">SOPHiA GENETICS S.A.S.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure Of Significant Investments In Subsidiaries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">SOPHiA GENETICS S.A.S.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DomicileOfEntity', window );">Country of domicile</a></td>
<td class="text">France<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticLimitedMember', window );">SOPHiA GENETICS LTD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure Of Significant Investments In Subsidiaries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">SOPHiA GENETICS LTD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DomicileOfEntity', window );">Country of domicile</a></td>
<td class="text">U.K.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsIncMember', window );">SOPHiA GENETICS, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure Of Significant Investments In Subsidiaries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">SOPHiA GENETICS, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DomicileOfEntity', window );">Country of domicile</a></td>
<td class="text">U.S.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember', window );">SOPHiA GENETICS Intermedia&#231;&#227;o de Neg&#243;cios LTDA</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure Of Significant Investments In Subsidiaries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">SOPHiA GENETICS Intermedia&#231;&#227;o de Neg&#243;cios LTDA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DomicileOfEntity', window );">Country of domicile</a></td>
<td class="text">Brazil<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsPtyLtdMember', window );">SOPHiA GENETICS PTY LTD</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure Of Significant Investments In Subsidiaries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">SOPHiA GENETICS PTY LTD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DomicileOfEntity', window );">Country of domicile</a></td>
<td class="text">Australia<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsSRLMember', window );">SOPHiA GENETICS S.R.L.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure Of Significant Investments In Subsidiaries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">SOPHiA GENETICS S.R.L.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DomicileOfEntity', window );">Country of domicile</a></td>
<td class="text">Italy<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SOPHiAGENETICSGmbHMember', window );">SOPHiA GENETICS GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems', window );"><strong>Disclosure Of Significant Investments In Subsidiaries [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">SOPHiA GENETICS GmbH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DomicileOfEntity', window );">Country of domicile</a></td>
<td class="text">Germany<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DomicileOfEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The country of domicile of the entity. [Refer: Country of domicile [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 141<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_141_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B18<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B18_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 138<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_138_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DomicileOfEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NameOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The name of a subsidiary. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NameOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsSASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsSASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsSRLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsSRLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SOPHiAGENETICSGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SOPHiAGENETICSGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company information and operations - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="6">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>SFr / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th" colspan="2">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCompanyInformationAndOperationsLineItems', window );"><strong>Disclosure Of Company Information And Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Aggregate offing price | $</a></td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,107,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfEquitySharesIssued', window );">Number of shares sold under ATM program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,238<span></span>
</td>
<td class="nump">228,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Gross proceeds from shares sold under ATM program | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,093,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCompanyInformationAndOperationsLineItems', window );"><strong>Disclosure Of Company Information And Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value (in dollars per share) | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfConditionalSharesAuthorised', window );">Number of conditional share capital available for financing (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,277,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,277,363<span></span>
</td>
<td class="nump">21,599,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18,277,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement', window );">Number of conditional share capital available for employee participation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,383,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,383,247<span></span>
</td>
<td class="nump">18,061,528<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,383,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCompanyInformationAndOperationsLineItems', window );"><strong>Disclosure Of Company Information And Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseInAuthorisedCapital', window );">Authorized increase in nominal share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,192,193.63<span></span>
</td>
<td class="nump">SFr 3,319,908.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCompanyInformationAndOperationsLineItems', window );"><strong>Disclosure Of Company Information And Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseInAuthorisedCapital', window );">Authorized increase in nominal share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,288,042.55<span></span>
</td>
<td class="nump">SFr 4,979,862.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Maximum | Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCompanyInformationAndOperationsLineItems', window );"><strong>Disclosure Of Company Information And Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseInNumberOfSharesAuthorised', window );">Authorized increase in nominal share capital issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,199,082<span></span>
</td>
<td class="nump">33,199,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value (in dollars per share) | (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCompanyInformationAndOperationsLineItems', window );"><strong>Disclosure Of Company Information And Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,321,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,321,220<span></span>
</td>
<td class="nump">79,321,220<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">76,898,164<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">89,321,220<span></span>
</td>
<td class="nump">66,398,164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesOutstanding', window );">Number of shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,486,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,486,338<span></span>
</td>
<td class="nump">66,687,085<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">68,486,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfTreasurySharesIssued', window );">Issuance of shares to be held as treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">2,423,056<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">2,423,056<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember', window );">Treasury Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfCompanyInformationAndOperationsLineItems', window );"><strong>Disclosure Of Company Information And Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,834,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,834,882<span></span>
</td>
<td class="nump">12,634,135<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,667,605<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">20,834,882<span></span>
</td>
<td class="nump">2,166,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfTreasurySharesIssued', window );">Issuance of shares to be held as treasury shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">2,423,056<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,500,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Aggregate offing price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfEquitySharesIssued', window );">Number of shares sold under ATM program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,238<span></span>
</td>
<td class="nump">228,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfCompanyInformationAndOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of company information and operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfCompanyInformationAndOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_IncreaseDecreaseInAuthorisedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Shares Authorised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_IncreaseDecreaseInAuthorisedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_IncreaseDecreaseInNumberOfSharesAuthorised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Number Of Shares Authorised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_IncreaseDecreaseInNumberOfSharesAuthorised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfConditionalSharesAuthorised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Conditional Shares Authorised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfConditionalSharesAuthorised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Conditional Shares Authorised In Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Shares Issued Of Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfTreasurySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Treasury Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfTreasurySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_TreasurySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material accounting policies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">$ (35,893)<span></span>
</td>
<td class="num">$ (44,515)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">$ (53,224)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash flow (used in) provided from investing activities</a></td>
<td class="num">(8,670)<span></span>
</td>
<td class="num">(4,755)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">12,975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash flow provided from (used in) financing activities</a></td>
<td class="nump">$ 30,177<span></span>
</td>
<td class="nump">9,857<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2,823)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems', window );"><strong>Disclosure of changes in accounting estimates [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash flow (used in) provided from investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,400)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash flow provided from (used in) financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,700)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (100)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment reporting (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure Of Operating Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts', window );">Total non-current assets other than financial instruments and deferred tax assets</a></td>
<td class="nump">$ 53,938<span></span>
</td>
<td class="nump">$ 48,375<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_CH', window );">Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure Of Operating Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts', window );">Total non-current assets other than financial instruments and deferred tax assets</a></td>
<td class="nump">49,777<span></span>
</td>
<td class="nump">44,282<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure Of Operating Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts', window );">Total non-current assets other than financial instruments and deferred tax assets</a></td>
<td class="nump">2,574<span></span>
</td>
<td class="nump">2,184<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure Of Operating Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts', window );">Total non-current assets other than financial instruments and deferred tax assets</a></td>
<td class="nump">1,584<span></span>
</td>
<td class="nump">1,906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_BR', window );">Brazil</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure Of Operating Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts', window );">Total non-current assets other than financial instruments and deferred tax assets</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets and rights arising under insurance contracts. [Refer: Deferred tax assets; Classes of financial instruments [domain]; Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_BR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_BR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPerformanceObligationsLineItems', window );"><strong>Disclosure Of Performance Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm', window );">Extended term of payment agreements for products and services sold</a></td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod', window );">Deferred contract revenue brought forward</a></td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="nump">$ 9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods', window );">Deferred contract revenue recognized</a></td>
<td class="nump">5,700<span></span>
</td>
<td class="nump">9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">77,271<span></span>
</td>
<td class="nump">65,173<span></span>
</td>
<td class="nump">$ 62,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=soph_CustomerOneMember', window );">Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPerformanceObligationsLineItems', window );"><strong>Disclosure Of Performance Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">8,700<span></span>
</td>
<td class="nump">8,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=soph_WorkflowEquipmentAndServicesMember', window );">Workflow equipment and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPerformanceObligationsLineItems', window );"><strong>Disclosure Of Performance Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OperatingLeaseIncome', window );">Revenues from payments from leased equipment recognized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Revenue from contracts with customers</a></td>
<td class="nump">$ 2,356<span></span>
</td>
<td class="nump">$ 1,627<span></span>
</td>
<td class="nump">$ 1,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPerformanceObligationsLineItems', window );"><strong>Disclosure Of Performance Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_RevenueFromContractsWithCustomersPaymentTerm', window );">Term of payment agreements for products and services sold</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPerformanceObligationsLineItems', window );"><strong>Disclosure Of Performance Obligations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_RevenueFromContractsWithCustomersPaymentTerm', window );">Term of payment agreements for products and services sold</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPerformanceObligationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPerformanceObligationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OperatingLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of operating lease income. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 90<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_90_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 125<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_125&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 125<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_125&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OperatingLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Revenue From Performance Obligations Satisfied Or Partially Satisfied In Previous Periods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Revenue That Was Included In Contract Liability Balance At Beginning Of Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_RevenueFromContractsWithCustomersExtendedPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contracts With Customers, Extended Payment Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_RevenueFromContractsWithCustomersExtendedPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_RevenueFromContractsWithCustomersPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contracts With Customers, Payment Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_RevenueFromContractsWithCustomersPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=soph_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=soph_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=soph_WorkflowEquipmentAndServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=soph_WorkflowEquipmentAndServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Schedule of Revenue from Contracts with Customers Allocated to Geographical Areas and Revenue Streams (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">$ 77,271<span></span>
</td>
<td class="nump">$ 65,173<span></span>
</td>
<td class="nump">$ 62,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=soph_SOPHiADDMPlatformMember', window );">SOPHiA DDM Platform</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">74,915<span></span>
</td>
<td class="nump">63,546<span></span>
</td>
<td class="nump">60,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=soph_WorkflowEquipmentAndServicesMember', window );">Workflow equipment and services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">2,356<span></span>
</td>
<td class="nump">1,627<span></span>
</td>
<td class="nump">1,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=soph_EuropeTheMiddleEastAndAfricaMember', window );">EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">55,576<span></span>
</td>
<td class="nump">46,929<span></span>
</td>
<td class="nump">43,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_CH', window );">Switzerland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">1,776<span></span>
</td>
<td class="nump">1,494<span></span>
</td>
<td class="nump">1,432<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">11,317<span></span>
</td>
<td class="nump">10,333<span></span>
</td>
<td class="nump">10,076<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_IT', window );">Italy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">10,805<span></span>
</td>
<td class="nump">9,983<span></span>
</td>
<td class="nump">8,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_ES', window );">Spain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">6,027<span></span>
</td>
<td class="nump">5,788<span></span>
</td>
<td class="nump">6,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=soph_OtherCountriesInEuropeMiddleEastAndAfricaMember', window );">Rest of EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">25,651<span></span>
</td>
<td class="nump">19,331<span></span>
</td>
<td class="nump">17,384<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember', window );">NORAM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">13,400<span></span>
</td>
<td class="nump">11,300<span></span>
</td>
<td class="nump">10,726<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">10,872<span></span>
</td>
<td class="nump">9,323<span></span>
</td>
<td class="nump">9,465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=soph_OtherCountriesInNorthAmericaMember', window );">Rest of NORAM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">2,528<span></span>
</td>
<td class="nump">1,977<span></span>
</td>
<td class="nump">1,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_LatinAmericaMember', window );">LATAM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">3,086<span></span>
</td>
<td class="nump">2,890<span></span>
</td>
<td class="nump">3,990<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_AsiaPacificMember', window );">APAC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Total revenue</a></td>
<td class="nump">$ 5,209<span></span>
</td>
<td class="nump">$ 4,054<span></span>
</td>
<td class="nump">$ 3,697<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=soph_SOPHiADDMPlatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=soph_SOPHiADDMPlatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=soph_WorkflowEquipmentAndServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=soph_WorkflowEquipmentAndServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=soph_EuropeTheMiddleEastAndAfricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=soph_EuropeTheMiddleEastAndAfricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_CH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_CH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_IT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_IT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_ES">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_ES</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=soph_OtherCountriesInEuropeMiddleEastAndAfricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=soph_OtherCountriesInEuropeMiddleEastAndAfricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=soph_OtherCountriesInNorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=soph_OtherCountriesInNorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_LatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_LatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expense - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ResearchTaxCredit', window );">Government grants for research and development and innovation</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Total</a></td>
<td class="nump">93,657<span></span>
</td>
<td class="nump">86,149<span></span>
</td>
<td class="nump">90,181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_CostOfRevenue1Member', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Total</a></td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="nump">$ 2,247<span></span>
</td>
<td class="nump">$ 2,660<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ResearchTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ResearchTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_CostOfRevenue1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_CostOfRevenue1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expense - Summary of Depreciation and Amortization have Charged in Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="num">$ (3,976)<span></span>
</td>
<td class="num">$ (4,575)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (5,508)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortization</a></td>
<td class="num">(5,553)<span></span>
</td>
<td class="num">(4,021)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2,828)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortization</a></td>
<td class="num">(5,266)<span></span>
</td>
<td class="num">(3,524)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,099)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_ResearchAndDevelopmentExpense1Member', window );">Research and development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="num">(1,649)<span></span>
</td>
<td class="num">(1,961)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,494)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_SellingAndMarketingExpense1Member', window );">Selling and marketing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="num">(1,226)<span></span>
</td>
<td class="num">(1,349)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,468)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_GeneralAndAdministrativeExpense1Member', window );">General and administrative costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation</a></td>
<td class="num">(1,101)<span></span>
</td>
<td class="num">(1,265)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,546)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationExpense', window );">Amortization</a></td>
<td class="num">$ (287)<span></span>
</td>
<td class="num">$ (497)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (729)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=ifrs-full_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_ResearchAndDevelopmentExpense1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_ResearchAndDevelopmentExpense1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_SellingAndMarketingExpense1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_SellingAndMarketingExpense1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_GeneralAndAdministrativeExpense1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_GeneralAndAdministrativeExpense1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Operating expense - Summary of Employee Benefit Expenses, Social Charges and Share-based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Recast of employee benefit expenses</a></td>
<td class="nump">$ 93,657<span></span>
</td>
<td class="nump">$ 86,149<span></span>
</td>
<td class="nump">$ 90,181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_CostOfRevenue1Member', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Recast of employee benefit expenses</a></td>
<td class="nump">3,200<span></span>
</td>
<td class="nump">2,247<span></span>
</td>
<td class="nump">2,660<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_ResearchAndDevelopmentExpense1Member', window );">Research and development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Recast of employee benefit expenses</a></td>
<td class="nump">31,638<span></span>
</td>
<td class="nump">31,321<span></span>
</td>
<td class="nump">31,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_SellingAndMarketingExpense1Member', window );">Selling and marketing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Recast of employee benefit expenses</a></td>
<td class="nump">25,089<span></span>
</td>
<td class="nump">20,038<span></span>
</td>
<td class="nump">20,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_GeneralAndAdministrativeExpense1Member', window );">General and administrative costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems', window );"><strong>Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Recast of employee benefit expenses</a></td>
<td class="nump">$ 33,730<span></span>
</td>
<td class="nump">$ 32,543<span></span>
</td>
<td class="nump">$ 36,067<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_CostOfRevenue1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_CostOfRevenue1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_ResearchAndDevelopmentExpense1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_ResearchAndDevelopmentExpense1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_SellingAndMarketingExpense1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_SellingAndMarketingExpense1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_GeneralAndAdministrativeExpense1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=soph_GeneralAndAdministrativeExpense1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract', window );"><strong>Interest Income (Expense) And Foreign Exchange Gain (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Total interest income</a></td>
<td class="nump">$ 1,872<span></span>
</td>
<td class="nump">$ 3,362<span></span>
</td>
<td class="nump">$ 4,547<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income (Expense) And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract', window );"><strong>Interest Income (Expense) And Foreign Exchange Gain (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts', window );">Interest on loans</a></td>
<td class="num">$ (3,953)<span></span>
</td>
<td class="num">$ (1,339)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Interest on lease liabilities</a></td>
<td class="num">(573)<span></span>
</td>
<td class="num">(567)<span></span>
</td>
<td class="num">(545)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnOtherFinancialLiabilities', window );">Other interest</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Total interest expense</a></td>
<td class="nump">$ 4,554<span></span>
</td>
<td class="nump">$ 1,913<span></span>
</td>
<td class="nump">$ 588<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnBankLoansAndOverdrafts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnBankLoansAndOverdrafts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnOtherFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnOtherFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income (Expense) And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Foreign Exchange (Losses) Gains, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract', window );"><strong>Interest Income (Expense) And Foreign Exchange Gain (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Total foreign exchange gains (losses), net</a></td>
<td class="num">$ (3,402)<span></span>
</td>
<td class="nump">$ 3,479<span></span>
</td>
<td class="num">$ (7,628)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2025-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income (Expense) And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties', window );">Unrecognized tax liability including interest and penalties</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsSASMember', window );">French subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends payments received</a></td>
<td class="nump">$ 3.5<span></span>
</td>
<td class="nump">$ 3.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized tax liability including interest and penalties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsSASMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=soph_SophiaGeneticsSASMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax - Summary of Current and Deferred Income Tax (Expenses) Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract', window );"><strong>Current income tax expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current year</a></td>
<td class="num">$ (1,458)<span></span>
</td>
<td class="num">$ (1,115)<span></span>
</td>
<td class="num">$ (215)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod', window );">Uncertain tax positions</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods', window );">Total current income tax expense</a></td>
<td class="num">(1,542)<span></span>
</td>
<td class="num">(1,270)<span></span>
</td>
<td class="num">(255)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DeferredBenefitAbstract', window );"><strong>Deferred income tax (expense) benefit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences', window );">Origination and reversal of temporary differences</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="num">(231)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Total deferred income tax (expense) benefit</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="num">(231)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Total income tax (expense) benefit</a></td>
<td class="num">$ (1,512)<span></span>
</td>
<td class="num">$ (1,223)<span></span>
</td>
<td class="num">$ (486)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 80<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_80_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 80<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_80&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 80<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_80_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DeferredBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DeferredBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax - Reconciliation of Expected Tax Expense to Tax Expense Report in Statement of Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AccountingProfit', window );">Loss before tax</a></td>
<td class="num">$ (77,487)<span></span>
</td>
<td class="num">$ (61,270)<span></span>
</td>
<td class="num">$ (78,495)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Tax at Swiss statutory rate</a></td>
<td class="nump">10,475<span></span>
</td>
<td class="nump">8,222<span></span>
</td>
<td class="nump">10,453<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfForeignTaxRates', window );">Effect of tax rates in foreign jurisdictions</a></td>
<td class="num">(1,197)<span></span>
</td>
<td class="num">(893)<span></span>
</td>
<td class="num">(833)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense', window );">Unrecognized deferred tax assets</a></td>
<td class="num">(8,542)<span></span>
</td>
<td class="num">(6,025)<span></span>
</td>
<td class="num">(8,879)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Income not subject to tax</a></td>
<td class="nump">260<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Expense not deductible for tax purposes</a></td>
<td class="num">(1,857)<span></span>
</td>
<td class="num">(2,263)<span></span>
</td>
<td class="num">(2,085)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod', window );">Uncertain tax positions</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome', window );">Other</a></td>
<td class="num">(567)<span></span>
</td>
<td class="num">(358)<span></span>
</td>
<td class="nump">595<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Total income tax (expense) benefit</a></td>
<td class="num">$ (1,512)<span></span>
</td>
<td class="num">$ (1,223)<span></span>
</td>
<td class="num">$ (486)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AccountingProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AccountingProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 80<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_80_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfForeignTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfForeignTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax Benefit Arising From Unrecognised Tax Loss, Tax Credit Or Temporary Difference Of Prior Period Used To Reduce Deferred Tax Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax effect of income and expense not subject to tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax - Summary of Movement in Deferred Tax Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at beginning of period</a></td>
<td class="nump">$ 1,767<span></span>
</td>
<td class="nump">$ 1,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Recognized in OCI</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Currency translation differences</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at end of period</a></td>
<td class="nump">1,831<span></span>
</td>
<td class="nump">1,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">2,255<span></span>
</td>
<td class="nump">2,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(424)<span></span>
</td>
<td class="num">(1,100)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember', window );">Depreciation &amp; amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at beginning of period</a></td>
<td class="num">(136)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="nump">148<span></span>
</td>
<td class="num">(123)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Recognized in OCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Currency translation differences</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at end of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(136)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(136)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_AccruedPensionRelatedTemporaryDifferencesMember', window );">Accrued pension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Recognized in OCI</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Currency translation differences</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at end of period</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_RightOfUseAssetsRelatedTemporaryDifferencesMember', window );">ROU asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at beginning of period</a></td>
<td class="num">(897)<span></span>
</td>
<td class="num">(761)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="nump">531<span></span>
</td>
<td class="num">(166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Recognized in OCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Currency translation differences</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at end of period</a></td>
<td class="num">(402)<span></span>
</td>
<td class="num">(897)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(402)<span></span>
</td>
<td class="num">(897)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at beginning of period</a></td>
<td class="nump">1,047<span></span>
</td>
<td class="nump">794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="num">(523)<span></span>
</td>
<td class="nump">287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Recognized in OCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Currency translation differences</a></td>
<td class="nump">46<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at end of period</a></td>
<td class="nump">570<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">570<span></span>
</td>
<td class="nump">1,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at beginning of period</a></td>
<td class="nump">603<span></span>
</td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Recognized in OCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Currency translation differences</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at end of period</a></td>
<td class="nump">517<span></span>
</td>
<td class="nump">603<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">539<span></span>
</td>
<td class="nump">670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember', window );">Net operating loss carryforward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract', window );"><strong>Changes in deferred tax liability (asset) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at beginning of period</a></td>
<td class="nump">1,150<span></span>
</td>
<td class="nump">1,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss', window );">Recognized in profit or loss</a></td>
<td class="num">(36)<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome', window );">Recognized in OCI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset', window );">Currency translation differences</a></td>
<td class="nump">29<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilityAsset', window );">Deferred tax liability (asset) at end of period</a></td>
<td class="nump">1,143<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="nump">1,143<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph ab<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_ab&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 90<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_90&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in deferred tax liability (asset) resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Deferred tax liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_AccruedPensionRelatedTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_AccruedPensionRelatedTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_RightOfUseAssetsRelatedTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_RightOfUseAssetsRelatedTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_OtherTemporaryDifferencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income tax - Summary of Unrecognized Deferred Tax Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract', window );"><strong>Current tax expense (income) and adjustments for current tax of prior periods [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_UnrecognizedDeferredTaxAssetsGross', window );">Gross amount</a></td>
<td class="nump">$ 451,324<span></span>
</td>
<td class="nump">$ 352,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax effect</a></td>
<td class="nump">60,885<span></span>
</td>
<td class="nump">47,205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_TemporaryDifferenceMember', window );">Deductible temporary differences</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract', window );"><strong>Current tax expense (income) and adjustments for current tax of prior periods [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_UnrecognizedDeferredTaxAssetsGross', window );">Gross amount</a></td>
<td class="nump">7,332<span></span>
</td>
<td class="nump">4,623<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax effect</a></td>
<td class="nump">1,014<span></span>
</td>
<td class="nump">661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract', window );"><strong>Current tax expense (income) and adjustments for current tax of prior periods [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_UnrecognizedDeferredTaxAssetsGross', window );">Gross amount</a></td>
<td class="nump">443,992<span></span>
</td>
<td class="nump">347,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxEffectOfTaxLosses', window );">Tax effect</a></td>
<td class="nump">$ 59,871<span></span>
</td>
<td class="nump">$ 46,544<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfTaxLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfTaxLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_UnrecognizedDeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized deferred tax assets gross.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_UnrecognizedDeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_TemporaryDifferenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_TemporaryDifferenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis=ifrs-full_UnusedTaxLossesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income tax - Summary of Net Operating Loss Carryforwards (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract', window );"><strong>Major components of tax expense (income) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NetOperatingLossCarryforwardsYearOne', window );">One year</a></td>
<td class="nump">$ 27,446<span></span>
</td>
<td class="nump">$ 15,853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NetOperatingLossCarryforwardsYearTwo', window );">Two years</a></td>
<td class="nump">56,969<span></span>
</td>
<td class="nump">23,958<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NetOperatingLossCarryforwardsYearThree', window );">Three years</a></td>
<td class="nump">78,915<span></span>
</td>
<td class="nump">49,729<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NetOperatingLossCarryforwardsYearFour', window );">Four years</a></td>
<td class="nump">89,906<span></span>
</td>
<td class="nump">68,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NetOperatingLossCarryforwardsThereafter', window );">Thereafter and unlimited</a></td>
<td class="nump">190,756<span></span>
</td>
<td class="nump">189,107<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NetOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 443,992<span></span>
</td>
<td class="nump">$ 347,533<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NetOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NetOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NetOperatingLossCarryforwardsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards thereafter and unlimited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NetOperatingLossCarryforwardsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NetOperatingLossCarryforwardsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards year four.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NetOperatingLossCarryforwardsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NetOperatingLossCarryforwardsYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards year one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NetOperatingLossCarryforwardsYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NetOperatingLossCarryforwardsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards year three.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NetOperatingLossCarryforwardsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NetOperatingLossCarryforwardsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards year two.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NetOperatingLossCarryforwardsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Loss per share - Additional information (Details) - Dec. 31, 2025<br></strong></div></th>
<th class="th"><div>SFr / shares</div></th>
<th class="th"><div>$ / shares</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Nominal value (in dollars per share) | (per share)</a></td>
<td class="nump">SFr 0.05<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per share - Components of Loss for Year (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EarningsPerShareAbstract', window );"><strong>Earnings per share [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Net loss attributed to shareholders</a></td>
<td class="num">$ (78,999)<span></span>
</td>
<td class="num">$ (62,493)<span></span>
</td>
<td class="num">$ (78,981)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of shares in issue, basic (in shares)</a></td>
<td class="nump">67,539,835<span></span>
</td>
<td class="nump">66,062,205<span></span>
</td>
<td class="nump">64,750,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of shares in issue, diluted (in shares)</a></td>
<td class="nump">67,539,835<span></span>
</td>
<td class="nump">66,062,205<span></span>
</td>
<td class="nump">64,750,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic loss per share (in dollars per share)</a></td>
<td class="num">$ (1.17)<span></span>
</td>
<td class="num">$ (0.95)<span></span>
</td>
<td class="num">$ (1.22)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted loss per share (in dollars per share)</a></td>
<td class="num">$ (1.17)<span></span>
</td>
<td class="num">$ (0.95)<span></span>
</td>
<td class="num">$ (1.22)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BalancesWithBanks', window );">Cash on hand</a></td>
<td class="nump">$ 37,459<span></span>
</td>
<td class="nump">$ 13,783<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Cash', window );">Total cash</a></td>
<td class="nump">37,459<span></span>
</td>
<td class="nump">13,783<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents', window );">Money market funds</a></td>
<td class="nump">27,528<span></span>
</td>
<td class="nump">39,586<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents', window );">Term deposits less than 3 months</a></td>
<td class="nump">5,302<span></span>
</td>
<td class="nump">26,857<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Total cash equivalents</a></td>
<td class="nump">32,830<span></span>
</td>
<td class="nump">66,443<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 70,289<span></span>
</td>
<td class="nump">$ 80,226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="nump">$ 123,251<span></span>
</td>
<td colspan="2" class="nump">$ 161,305<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BalancesWithBanks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash balances held at banks.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BalancesWithBanks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of cash equivalents representing short-term investments. [Refer: Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TradeAndOtherReceivablesLineItems', window );"><strong>Trade And Other Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm', window );">Extended term of payment for non-interest bearing accounts receivable</a></td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_PercentageOfCustomerBalanceAccountReceivable', window );">Percentage of customer balance account receivable</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccountsReceivableInAggregateAmount', window );">Accounts receivable in aggregate amount</a></td>
<td class="nump">$ 8,300,000<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_LongTermLeaseReceivables', window );">Long-term lease receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NetLeaseReceivables', window );">Net lease receivables</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TradeAndOtherReceivablesLineItems', window );"><strong>Trade And Other Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccountsReceivableNonInterestBearingPaymentTerms', window );">Term of payment for non-interest bearing accounts receivable</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TradeAndOtherReceivablesLineItems', window );"><strong>Trade And Other Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccountsReceivableNonInterestBearingPaymentTerms', window );">Term of payment for non-interest bearing accounts receivable</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccountsReceivableInAggregateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable in aggregate amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccountsReceivableInAggregateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Non-Interest Bearing, Extended Payment Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccountsReceivableNonInterestBearingPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable balance non-interest bearing and payment terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccountsReceivableNonInterestBearingPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_LongTermLeaseReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-term lease receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_LongTermLeaseReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NetLeaseReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net lease receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NetLeaseReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_PercentageOfCustomerBalanceAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of customer balance account receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_PercentageOfCustomerBalanceAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_TradeAndOtherReceivablesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trade And Other Receivables [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_TradeAndOtherReceivablesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts receivable - Summary of Accounts Receivable and Lease Receivable Less Expected Credit Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Net accounts receivable</a></td>
<td class="nump">$ 87,285<span></span>
</td>
<td class="nump">$ 88,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=soph_FinancialAssetsAccountsReceivableMember', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Net accounts receivable</a></td>
<td class="nump">15,001<span></span>
</td>
<td class="nump">7,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Trade receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Net accounts receivable</a></td>
<td class="nump">14,404<span></span>
</td>
<td class="nump">7,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Accrued contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Net accounts receivable</a></td>
<td class="nump">963<span></span>
</td>
<td class="nump">742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Expected Credit Losses | Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems', window );"><strong>Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Net accounts receivable</a></td>
<td class="num">$ (366)<span></span>
</td>
<td class="num">$ (394)<span></span>
</td>
<td class="num">$ (1,181)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=soph_FinancialAssetsAccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=soph_FinancialAssetsAccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_ContractAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_ContractAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts receivable - Summary of Movement in Allowance for Expected Credit Losses in Accounts Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Changes in allowance account for credit losses of financial assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance at beginning of period</a></td>
<td class="num">$ (88,656)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance at end of period</a></td>
<td class="num">(87,285)<span></span>
</td>
<td class="num">$ (88,656)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=soph_FinancialAssetsAccountsReceivableMember', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Changes in allowance account for credit losses of financial assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance at beginning of period</a></td>
<td class="num">(7,436)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance at end of period</a></td>
<td class="num">(15,001)<span></span>
</td>
<td class="num">(7,436)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Expected Credit Losses | Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract', window );"><strong>Changes in allowance account for credit losses of financial assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance at beginning of period</a></td>
<td class="nump">394<span></span>
</td>
<td class="nump">1,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss', window );">Increase</a></td>
<td class="nump">520<span></span>
</td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss', window );">Reversals</a></td>
<td class="num">(463)<span></span>
</td>
<td class="num">(637)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DecreaseThroughWriteoffFinancialAssets', window );">Write-off</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(213)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets', window );">Currency translation adjustments</a></td>
<td class="nump">70<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance at end of period</a></td>
<td class="nump">$ 366<span></span>
</td>
<td class="nump">$ 394<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DecreaseThroughWriteoffFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in financial assets resulting from write-off. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35I<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35I_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph IG20B<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IG20B&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DecreaseThroughWriteoffFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 126<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_126_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 129<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_129_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 250<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_250_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 250<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_250_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in financial assets resulting from foreign exchange. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph IG20B<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IG20B&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 126<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_126_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 129<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_129_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 250<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_250_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 250<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_250_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=soph_FinancialAssetsAccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=soph_FinancialAssetsAccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory - Summary of Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfInventoriesAbstract', window );"><strong>Classes of current inventories [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 5,543<span></span>
</td>
<td class="nump">$ 5,526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WorkInProgress', window );">Work in progress</a></td>
<td class="nump">2,047<span></span>
</td>
<td class="nump">1,321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinishedGoods', window );">Finished goods</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ProvisionOfInventory', window );">Provision</a></td>
<td class="num">(1,443)<span></span>
</td>
<td class="num">(1,084)<span></span>
</td>
<td class="num">$ (2,134)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Total</a></td>
<td class="nump">$ 6,351<span></span>
</td>
<td class="nump">$ 5,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfInventoriesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfInventoriesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WorkInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WorkInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ProvisionOfInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provision of inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ProvisionOfInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory - Summary of Inventory Provision Movement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInProvisionOfInventoryAbstract', window );"><strong>Changes In Provision Of Inventory [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ProvisionOfInventory', window );">Balance at beginning of period</a></td>
<td class="num">$ (1,084)<span></span>
</td>
<td class="num">$ (2,134)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_InventoryIncreaseInProvision', window );">Increase</a></td>
<td class="num">(554)<span></span>
</td>
<td class="num">(284)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InventoryWritedown2011', window );">Write-off</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">1,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_InventoryCurrencyTranslationAdjustment', window );">Currency translation adjustment</a></td>
<td class="num">(159)<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ProvisionOfInventory', window );">Balance at end of period</a></td>
<td class="num">$ (1,443)<span></span>
</td>
<td class="num">$ (1,084)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryWritedown2011">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryWritedown2011</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ChangesInProvisionOfInventoryAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes In Provision Of Inventory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ChangesInProvisionOfInventoryAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_InventoryCurrencyTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory currency translation adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_InventoryCurrencyTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_InventoryIncreaseInProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventory Increase In Provision</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_InventoryIncreaseInProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ProvisionOfInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provision of inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ProvisionOfInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaids and other current assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_PrepaymentsAndOtherCurrentAssetsAbstract', window );"><strong>Prepayments And Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepayments', window );">Prepayments</a></td>
<td class="nump">$ 3,154<span></span>
</td>
<td class="nump">$ 3,786<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentValueAddedTaxReceivables', window );">VAT receivable</a></td>
<td class="nump">1,385<span></span>
</td>
<td class="nump">1,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_CurrentGovernmentGrantsReceivable', window );">Government grants receivable</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_CurrentContractAcquisitionCosts', window );">Current contract acquisition costs</a></td>
<td class="nump">2,002<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_CurrentOtherAssetsMiscellaneous', window );">Other</a></td>
<td class="nump">758<span></span>
</td>
<td class="nump">835<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets', window );">Total</a></td>
<td class="nump">7,438<span></span>
</td>
<td class="nump">$ 5,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AmortisationCurrentContractAcquisitionCosts', window );">Current contract acquisition costs amortized</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments. [Refer: Prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current value added tax receivables. [Refer: Value added tax receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AmortisationCurrentContractAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Contract Acquisition Costs, Amortisation Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AmortisationCurrentContractAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_CurrentContractAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Contract Acquisition Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_CurrentContractAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_CurrentGovernmentGrantsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current government grants receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_CurrentGovernmentGrantsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_CurrentOtherAssetsMiscellaneous">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current other assets miscellaneous.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_CurrentOtherAssetsMiscellaneous</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_PrepaymentsAndOtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaids and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_PrepaymentsAndOtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure Of Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment', window );">Accrued expenses for property and equipment</a></td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer hardware | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure Of Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life of property and equipment</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer hardware | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure Of Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life of property and equipment</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure Of Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life of property and equipment</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConstructionInProgress', window );">Assets under construction</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure Of Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful life of property and equipment</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure Of Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ConstructionInProgress', window );">Assets under construction</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ConstructionInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenditure capitalised during the construction of non-current assets that are not yet available for use. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ConstructionInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Accrued Expenses On Property, Plant And Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment - Summary of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="nump">$ 5,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="nump">5,665<span></span>
</td>
<td class="nump">$ 5,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="nump">3,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="nump">4,342<span></span>
</td>
<td class="nump">3,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="nump">691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="nump">899<span></span>
</td>
<td class="nump">691<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember', window );">Computer hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="nump">388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="nump">289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">289<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="nump">10,922<span></span>
</td>
<td class="nump">11,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">1,515<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(488)<span></span>
</td>
<td class="num">(80)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency Translation Adjustment</a></td>
<td class="nump">1,575<span></span>
</td>
<td class="num">(815)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="nump">13,524<span></span>
</td>
<td class="nump">10,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="nump">6,456<span></span>
</td>
<td class="nump">6,855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">1,110<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(252)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency Translation Adjustment</a></td>
<td class="nump">971<span></span>
</td>
<td class="num">(485)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="nump">8,285<span></span>
</td>
<td class="nump">6,456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="nump">1,861<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">403<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency Translation Adjustment</a></td>
<td class="nump">293<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="nump">2,557<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Computer hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="nump">1,361<span></span>
</td>
<td class="nump">1,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency Translation Adjustment</a></td>
<td class="nump">158<span></span>
</td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="nump">1,466<span></span>
</td>
<td class="nump">1,361<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="nump">1,244<span></span>
</td>
<td class="nump">1,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="num">(181)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency Translation Adjustment</a></td>
<td class="nump">153<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="nump">1,216<span></span>
</td>
<td class="nump">1,244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="num">(5,713)<span></span>
</td>
<td class="num">(4,131)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="num">(1,810)<span></span>
</td>
<td class="num">(1,935)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">488<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency Translation Adjustment</a></td>
<td class="num">(824)<span></span>
</td>
<td class="nump">339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="num">(7,859)<span></span>
</td>
<td class="num">(5,713)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="num">(2,615)<span></span>
</td>
<td class="num">(1,576)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="num">(1,181)<span></span>
</td>
<td class="num">(1,182)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">252<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency Translation Adjustment</a></td>
<td class="num">(399)<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="num">(3,943)<span></span>
</td>
<td class="num">(2,615)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation | Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="num">(1,170)<span></span>
</td>
<td class="num">(993)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="num">(303)<span></span>
</td>
<td class="num">(269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency Translation Adjustment</a></td>
<td class="num">(185)<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="num">(1,658)<span></span>
</td>
<td class="num">(1,170)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation | Computer hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="num">(973)<span></span>
</td>
<td class="num">(831)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="num">(180)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency Translation Adjustment</a></td>
<td class="num">(120)<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="num">(1,218)<span></span>
</td>
<td class="num">(973)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract', window );"><strong>Changes in property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at beginning of period</a></td>
<td class="num">(955)<span></span>
</td>
<td class="num">(731)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="num">(146)<span></span>
</td>
<td class="num">(276)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment', window );">Currency Translation Adjustment</a></td>
<td class="num">(120)<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Balance at end of period</a></td>
<td class="num">$ (1,040)<span></span>
</td>
<td class="num">$ (955)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_MachineryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>unit</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ScheduleOfIntangibleAssetsLineItems', window );"><strong>Schedule Of Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill', window );">Goodwill impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets', window );">Estimated equity value</a></td>
<td class="nump">301,900,000<span></span>
</td>
<td class="nump">242,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus', window );">Exceeds the reported net assets</a></td>
<td class="nump">60,700,000<span></span>
</td>
<td class="nump">113,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets', window );">Equity value</a></td>
<td class="nump">$ 241,200,000<span></span>
</td>
<td class="nump">$ 129,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfCashGeneratingUnit', window );">Cash-generating units | unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ScheduleOfIntangibleAssetsLineItems', window );"><strong>Schedule Of Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember', window );">Capitalised development expenditure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ScheduleOfIntangibleAssetsLineItems', window );"><strong>Schedule Of Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -Clause v<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_d_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets other than goodwill that would have been recognised had the revalued intangible assets been measured using the cost model after recognition. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 124<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_124_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 265<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_265_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 265<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_265_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets other than goodwill that are accounted for at revalued amounts. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 124<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_124_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 265<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_265_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 265<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_265_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revaluation surplus that relates to intangible assets other than goodwill. [Refer: Intangible assets other than goodwill; Revaluation surplus]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 124<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_124_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 265<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_265_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 265<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_265_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfCashGeneratingUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfCashGeneratingUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ScheduleOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ScheduleOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Intangible Assets Net, Movement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="nump">$ 28,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="nump">35,891<span></span>
</td>
<td class="nump">$ 28,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="nump">8,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="nump">9,556<span></span>
</td>
<td class="nump">8,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Purchased software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="nump">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="nump">719<span></span>
</td>
<td class="nump">801<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember', window );">Capitalized internally developed software costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="nump">19,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="nump">25,616<span></span>
</td>
<td class="nump">19,855<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="nump">39,709<span></span>
</td>
<td class="nump">34,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Additions</a></td>
<td class="nump">8,206<span></span>
</td>
<td class="nump">7,932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency Translation Adjustment</a></td>
<td class="nump">6,005<span></span>
</td>
<td class="num">(2,751)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="nump">53,920<span></span>
</td>
<td class="nump">39,709<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="nump">8,342<span></span>
</td>
<td class="nump">8,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency Translation Adjustment</a></td>
<td class="nump">1,214<span></span>
</td>
<td class="num">(657)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="nump">9,556<span></span>
</td>
<td class="nump">8,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Purchased software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="nump">4,046<span></span>
</td>
<td class="nump">4,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Additions</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency Translation Adjustment</a></td>
<td class="nump">594<span></span>
</td>
<td class="num">(311)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="nump">4,748<span></span>
</td>
<td class="nump">4,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount | Capitalized internally developed software costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="nump">27,321<span></span>
</td>
<td class="nump">21,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Additions</a></td>
<td class="nump">8,098<span></span>
</td>
<td class="nump">7,737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency Translation Adjustment</a></td>
<td class="nump">4,197<span></span>
</td>
<td class="num">(1,783)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="nump">39,616<span></span>
</td>
<td class="nump">27,321<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="num">(10,711)<span></span>
</td>
<td class="num">(7,343)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Additions</a></td>
<td class="num">(5,563)<span></span>
</td>
<td class="num">(4,021)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency Translation Adjustment</a></td>
<td class="num">(1,755)<span></span>
</td>
<td class="nump">653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="num">(18,029)<span></span>
</td>
<td class="num">(10,711)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated amortization | Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency Translation Adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated amortization | Purchased software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="num">(3,245)<span></span>
</td>
<td class="num">(3,001)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Additions</a></td>
<td class="num">(290)<span></span>
</td>
<td class="num">(484)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency Translation Adjustment</a></td>
<td class="num">(494)<span></span>
</td>
<td class="nump">240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="num">(4,029)<span></span>
</td>
<td class="num">(3,245)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated amortization | Capitalized internally developed software costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract', window );"><strong>Changes in intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Beginning balance</a></td>
<td class="num">(7,466)<span></span>
</td>
<td class="num">(4,342)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Additions</a></td>
<td class="num">(5,273)<span></span>
</td>
<td class="num">(3,537)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill', window );">Currency Translation Adjustment</a></td>
<td class="num">(1,261)<span></span>
</td>
<td class="nump">413<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Ending balance</a></td>
<td class="num">$ (14,000)<span></span>
</td>
<td class="num">$ (7,466)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets and goodwill resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CapitalisedDevelopmentExpenditureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 27, 2024 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 01, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Feb. 01, 2023 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jan. 25, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jan. 01, 2022 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jul. 01, 2021 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 03, 2021 </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfLeaseLineItems', window );"><strong>Disclosure Of Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,382<span></span>
</td>
<td class="nump">$ 14,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,287<span></span>
</td>
<td class="nump">16,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_LeaseExpenses', window );">Lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Cash outflows related to leases less than 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_RightOfUseAssetsDiscountedPaymentsRate', window );">Right-of-use assets discounted payments rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.76%<span></span>
</td>
<td class="nump">2.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_LeaseLiabilitiesDiscountedPaymentsRate', window );">Lease liabilities discounted payments rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.42%<span></span>
</td>
<td class="nump">11.42%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Additions to ROUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Depreciation charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_PrincipalPaidOnLeaseLiabilities', window );">Lease liability payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_InterestPaidOnLeaseLiabilities', window );">Interest on lease liability payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember', window );">Consumer Price Indices in Switzerland and France</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfLeaseLineItems', window );"><strong>Disclosure Of Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,700<span></span>
</td>
<td class="nump">$ 12,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=soph_OfficeSpaceMember', window );">Office Space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfLeaseLineItems', window );"><strong>Disclosure Of Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfLeases', window );">Number of leases | lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,382<span></span>
</td>
<td class="nump">$ 14,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=soph_OfficeSpaceMember', window );">Office Space | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfLeaseLineItems', window );"><strong>Disclosure Of Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_LeaseTerm', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=soph_OfficeSpaceMember', window );">Office Space | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfLeaseLineItems', window );"><strong>Disclosure Of Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_LeaseTerm', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=soph_OfficeSpaceMember', window );">Office Space | Rolle</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfLeaseLineItems', window );"><strong>Disclosure Of Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_LeaseTerm', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">120 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AreaOfOfficeSpaceLeased', window );">Area of office space leased (in sq ft) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,860<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AreaOfOfficeSpaceGainedAccessUnderLease', window );">Area of office space gained access under lease (in sq ft) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,258<span></span>
</td>
<td class="nump">21,258<span></span>
</td>
<td class="nump">5,840<span></span>
</td>
<td class="nump">38,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_LeaseIncentivesAndExpectedRestorationCosts', window );">Lease incentives and expected restoration costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=soph_OfficeSpaceMember', window );">Office Space | Boston</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfLeaseLineItems', window );"><strong>Disclosure Of Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_LeaseTerm', window );">Lease term</a></td>
<td class="text">73 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AreaOfOfficeSpaceLeased', window );">Area of office space leased (in sq ft) | ft&#178;</a></td>
<td class="nump">12,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_LeaseDirectCosts', window );">Initial direct costs to obtain lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=soph_OfficeSpaceMember', window );">Office Space | Bidart</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfLeaseLineItems', window );"><strong>Disclosure Of Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_LeaseTerm', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">108 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AreaOfOfficeSpaceLeased', window );">Area of office space leased (in sq ft) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ExpectedLeaseCommitments', window );">Expected lease commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AreaOfOfficeSpaceGainedAccessUnderLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of office space gained access under lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AreaOfOfficeSpaceGainedAccessUnderLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AreaOfOfficeSpaceLeased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of office space leased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AreaOfOfficeSpaceLeased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfLeaseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of lease line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfLeaseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ExpectedLeaseCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected lease commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ExpectedLeaseCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_InterestPaidOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Paid On Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_InterestPaidOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_LeaseDirectCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Direct Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_LeaseDirectCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_LeaseExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_LeaseExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_LeaseIncentivesAndExpectedRestorationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease incentives and expected restoration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_LeaseIncentivesAndExpectedRestorationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_LeaseLiabilitiesDiscountedPaymentsRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease liabilities discounted payments rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_LeaseLiabilitiesDiscountedPaymentsRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_LeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_LeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_PrincipalPaidOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Principal Paid On Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_PrincipalPaidOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_RightOfUseAssetsDiscountedPaymentsRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-use assets discounted payments rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_RightOfUseAssetsDiscountedPaymentsRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=soph_OfficeSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=soph_OfficeSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=soph_RolleSwitzerlandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=soph_RolleSwitzerlandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=soph_BostonMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=soph_BostonMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=soph_BidartFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=soph_BidartFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Right of Use Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfLeaseLineItems', window );"><strong>Disclosure Of Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">$ 12,382<span></span>
</td>
<td class="nump">$ 14,168<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=soph_OfficeSpaceMember', window );">Office Space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfLeaseLineItems', window );"><strong>Disclosure Of Lease [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">$ 12,382<span></span>
</td>
<td class="nump">$ 14,168<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfLeaseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of lease line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfLeaseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=soph_OfficeSpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=soph_OfficeSpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PresentationOfLeasesForLesseeAbstract', window );"><strong>Presentation of leases for lessee [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="nump">$ 2,190<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current lease liabilities</a></td>
<td class="nump">12,587<span></span>
</td>
<td class="nump">14,603<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 15,287<span></span>
</td>
<td class="nump">$ 16,793<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PresentationOfLeasesForLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PresentationOfLeasesForLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other non-current assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousNoncurrentAssetsAbstract', window );"><strong>Miscellaneous non-current assets [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentValueAddedTaxReceivables', window );">Research tax credit receivable</a></td>
<td class="nump">$ 4,013<span></span>
</td>
<td class="nump">$ 4,244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NonCurrentDepositsGuarantyAssets', window );">Guarantee deposits</a></td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">1,518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Equity Investment</a></td>
<td class="nump">1,977<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NonCurrentContractAcquisitionCosts', window );">Non&#8209;current contract acquisition costs</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Total</a></td>
<td class="nump">$ 8,183<span></span>
</td>
<td class="nump">$ 5,762<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousNoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousNoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentValueAddedTaxReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current value added tax receivables. [Refer: Value added tax receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentValueAddedTaxReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NonCurrentContractAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non Current Contract Acquisition Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NonCurrentContractAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NonCurrentDepositsGuarantyAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Deposits Guaranty Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NonCurrentDepositsGuarantyAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts payable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">$ 5,315<span></span>
</td>
<td class="nump">$ 1,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_EmployeeRelatedPayables', window );">Employee related payables</a></td>
<td class="nump">2,840<span></span>
</td>
<td class="nump">2,630<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables', window );">VAT, sales, and other taxes</a></td>
<td class="nump">805<span></span>
</td>
<td class="nump">658<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Total</a></td>
<td class="nump">$ 8,960<span></span>
</td>
<td class="nump">$ 5,220<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_EmployeeRelatedPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee related payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_EmployeeRelatedPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value added tax sales and other taxes payables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedExpensesAbstract', window );"><strong>Accrued Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedCompensation', window );">Accrued compensation</a></td>
<td class="nump">$ 15,853<span></span>
</td>
<td class="nump">$ 10,781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedProfessionalFees', window );">Accrued professional fees</a></td>
<td class="nump">1,778<span></span>
</td>
<td class="nump">1,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedInventoryPurchases', window );">Accrued inventory purchases</a></td>
<td class="nump">420<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedITSupport', window );">Accrued IT support</a></td>
<td class="nump">701<span></span>
</td>
<td class="nump">570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedLegalFees', window );">Accrued legal fees</a></td>
<td class="nump">824<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedOther', window );">Accrued other</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_CurrentAccruedExpenses', window );">Total</a></td>
<td class="nump">$ 20,736<span></span>
</td>
<td class="nump">$ 13,217<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccruedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccruedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccruedExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccruedExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccruedITSupport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued IT support.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccruedITSupport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccruedInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued inventory purchases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccruedInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccruedLegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued legal fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccruedLegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccruedOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccruedOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccruedProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued professional fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccruedProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_CurrentAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_CurrentAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-employment benefits - Summary of Additional Details on Defined Pension Plans Funded Status (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract', window );"><strong>Disclosure Of Information About Post Employment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Present value of defined benefit obligation</a></td>
<td class="num">$ (28,429)<span></span>
</td>
<td class="num">$ (23,199)<span></span>
</td>
<td class="num">$ (23,013)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Plan assets, at fair value</a></td>
<td class="nump">24,267<span></span>
</td>
<td class="nump">19,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SurplusDeficitInPlan', window );">Net pension liability</a></td>
<td class="num">$ (4,162)<span></span>
</td>
<td class="num">$ (3,839)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PlanAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PlanAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SurplusDeficitInPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SurplusDeficitInPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of information about post-employment benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits - Summary of Movement in Defined Benefit Obligation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInDefinedBenefitObligationAbstract', window );"><strong>Changes In Defined Benefit Obligation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">January 1</a></td>
<td class="num">$ (23,199)<span></span>
</td>
<td class="num">$ (23,013)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ServiceCostDefinedBenefitPlans', window );">Service Cost</a></td>
<td class="num">(1,841)<span></span>
</td>
<td class="num">(2,637)<span></span>
</td>
<td class="num">$ (1,321)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostDefinedBenefitPlans', window );">of which current service cost</a></td>
<td class="num">(1,841)<span></span>
</td>
<td class="num">(1,695)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans', window );">of which past service cost including effects from curtailment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(942)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseDefinedBenefitPlans', window );">Interest expense</a></td>
<td class="num">(229)<span></span>
</td>
<td class="num">(294)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ActuarialGainsLossesNetDefinedBenefitPlans', window );">Actuarial gains (losses)</a></td>
<td class="nump">180<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Actual plan participants&#8217; contributions</a></td>
<td class="num">(1,461)<span></span>
</td>
<td class="num">(1,295)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans', window );">Transfers (in) out due to (joiners) leavers</a></td>
<td class="nump">1,587<span></span>
</td>
<td class="nump">3,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans', window );">Currency translation differences</a></td>
<td class="num">(3,466)<span></span>
</td>
<td class="nump">1,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">December 31</a></td>
<td class="num">(28,429)<span></span>
</td>
<td class="num">(23,199)<span></span>
</td>
<td class="num">(23,013)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember', window );">Funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInDefinedBenefitObligationAbstract', window );"><strong>Changes In Defined Benefit Obligation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">January 1</a></td>
<td class="num">(23,147)<span></span>
</td>
<td class="num">(22,972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ServiceCostDefinedBenefitPlans', window );">Service Cost</a></td>
<td class="num">(1,827)<span></span>
</td>
<td class="num">(2,625)<span></span>
</td>
<td class="num">(1,311)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostDefinedBenefitPlans', window );">of which current service cost</a></td>
<td class="num">(1,827)<span></span>
</td>
<td class="num">(1,683)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans', window );">of which past service cost including effects from curtailment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(942)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseDefinedBenefitPlans', window );">Interest expense</a></td>
<td class="num">(227)<span></span>
</td>
<td class="num">(293)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ActuarialGainsLossesNetDefinedBenefitPlans', window );">Actuarial gains (losses)</a></td>
<td class="nump">185<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Actual plan participants&#8217; contributions</a></td>
<td class="num">(1,461)<span></span>
</td>
<td class="num">(1,295)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans', window );">Transfers (in) out due to (joiners) leavers</a></td>
<td class="nump">1,587<span></span>
</td>
<td class="nump">3,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans', window );">Currency translation differences</a></td>
<td class="num">(3,455)<span></span>
</td>
<td class="nump">1,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">December 31</a></td>
<td class="num">(28,345)<span></span>
</td>
<td class="num">(23,147)<span></span>
</td>
<td class="num">(22,972)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember', window );">Unfunded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInDefinedBenefitObligationAbstract', window );"><strong>Changes In Defined Benefit Obligation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">January 1</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ServiceCostDefinedBenefitPlans', window );">Service Cost</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentServiceCostDefinedBenefitPlans', window );">of which current service cost</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans', window );">of which past service cost including effects from curtailment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseDefinedBenefitPlans', window );">Interest expense</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ActuarialGainsLossesNetDefinedBenefitPlans', window );">Actuarial gains (losses)</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Actual plan participants&#8217; contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans', window );">Transfers (in) out due to (joiners) leavers</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans', window );">Currency translation differences</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">December 31</a></td>
<td class="num">$ (84)<span></span>
</td>
<td class="num">$ (52)<span></span>
</td>
<td class="num">$ (41)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentServiceCostDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentServiceCostDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ActuarialGainsLossesNetDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial gains (losses), net defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ActuarialGainsLossesNetDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ChangesInDefinedBenefitObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes In Defined Benefit Obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ChangesInDefinedBenefitObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency translation differences defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ServiceCostDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Service cost defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ServiceCostDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfers (in) out due to (joiners) leavers defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>member</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>member</div>
</th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans', window );">Past service cost gain</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DemographicAssumptionOfWeightedTurnoverRates', window );">Demographic assumptions increase in weighted turnover</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.50%<span></span>
</td>
<td class="nump">15.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_FinancialAssumptionOfDiscountRates', window );">Financial assumptions increase (decrease) of discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.95%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AverageLifeExpectancyInYearsAfterRetirementForMale', window );">Average life expectancy in years after retirement for male</a></td>
<td class="text">23 years 25 days<span></span>
</td>
<td class="text">22 years 9 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale', window );">Average life expectancy in years after retirement for female</a></td>
<td class="text">24 years 9 months 21 days<span></span>
</td>
<td class="text">24 years 7 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans', window );">Post-employment benefit expense, 401(k) defined contribution plan</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=soph_SwissPensionPlanMember', window );">Swiss Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfActiveMembers', window );">Number of active members | member</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Estimating the defined benefit obligation, the discount rates</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases', window );">Demographic assumptions increase in expected employee salaries</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average modified duration</a></td>
<td class="text">13 years 8 months 12 days<span></span>
</td>
<td class="text">13 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_LPPInterestRate', window );">LPP interest rate</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ExtraMandatoryPartEquivalentToDiscountRate', window );">Extra mandatory part equivalent to discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation', window );">Demographic assumptions increase in expected employee turnover rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan', window );">Expected employer contributions for next annual reporting period</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=soph_FrenchPensionPlanMember', window );">French Pension Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfActiveMembers', window );">Number of active members | member</a></td>
<td class="nump">89<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfDiscountRates', window );">Estimating the defined benefit obligation, the discount rates</a></td>
<td class="nump">4.05%<span></span>
</td>
<td class="nump">3.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases', window );">Demographic assumptions increase in expected employee salaries</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019', window );">Weighted average modified duration</a></td>
<td class="text">15 years 1 month 6 days<span></span>
</td>
<td class="text">15 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation', window );">Demographic assumptions increase in expected employee turnover rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember', window );">Funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans', window );">Past service cost gain</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_FinancialAssumptionOfDiscountRates', window );">Financial assumptions increase (decrease) of discount rate</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 144<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected rate of inflation that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [domain]; Defined benefit obligation, at present value; Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 144<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [domain]; Defined benefit obligation, at present value; Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 144<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_144&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimate of the expected contributions to be made to a defined benefit plan for the next annual reporting period. [Refer: Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 147<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_147_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 148<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_148_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 211<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_211_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 211<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_211_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 203<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_203&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 203<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_203&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 147<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_147_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AverageLifeExpectancyInYearsAfterRetirementForFemale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average life expectancy in years after retirement for female.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AverageLifeExpectancyInYearsAfterRetirementForFemale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AverageLifeExpectancyInYearsAfterRetirementForMale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average life expectancy in years after retirement for male.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AverageLifeExpectancyInYearsAfterRetirementForMale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DemographicAssumptionOfWeightedTurnoverRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Demographic Assumption Of Weighted Turnover Rates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DemographicAssumptionOfWeightedTurnoverRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ExtraMandatoryPartEquivalentToDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extra mandatory part equivalent to discount rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ExtraMandatoryPartEquivalentToDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_FinancialAssumptionOfDiscountRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Assumption Of Discount Rates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_FinancialAssumptionOfDiscountRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_LPPInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>LPP interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_LPPInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfActiveMembers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of active members.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfActiveMembers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=soph_SwissPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=soph_SwissPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=soph_FrenchPensionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=soph_FrenchPensionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits - Summary of Movement in Defined Benefit Plans Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract', window );"><strong>Changes In Net Defined Benefit Liability (Asset) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Balance at beginning of period</a></td>
<td class="nump">$ 19,360<span></span>
</td>
<td class="nump">$ 19,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset', window );">Interest income</a></td>
<td class="nump">203<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset', window );">Return on plan assets, excl. interest income</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">1,668<span></span>
</td>
<td class="num">$ (654)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset', window );">Administrative expenses</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset', window );">Employer contributions</a></td>
<td class="nump">1,562<span></span>
</td>
<td class="nump">1,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset', window );">Employee contributions</a></td>
<td class="nump">1,461<span></span>
</td>
<td class="nump">1,295<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans', window );">Transfers in (out) due to joiners (leavers)</a></td>
<td class="num">(1,587)<span></span>
</td>
<td class="num">(3,644)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset', window );">Currency translation differences</a></td>
<td class="nump">2,809<span></span>
</td>
<td class="num">(1,485)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Balance at end of period</a></td>
<td class="nump">$ 24,267<span></span>
</td>
<td class="nump">$ 19,360<span></span>
</td>
<td class="nump">$ 19,927<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 141<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_141_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 141<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_141_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 207<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_207_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 207<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_207_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 206<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_206_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 206<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_206_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [domain]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_141_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 207<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_207_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 207<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_207_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Administrative expenses net defined benefit liability asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfers (in) out due to (joiners) leavers defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-employment benefits - Summary of Defined Benefit Plans Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets', window );">Cash</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets', window );">Insurance policies</a></td>
<td class="nump">24,267<span></span>
</td>
<td class="nump">18,895<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="nump">24,267<span></span>
</td>
<td class="nump">19,360<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=soph_FrenchPlanMember', window );">French plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=soph_SwissPlanMember', window );">Swiss plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PlanAssetsAtFairValue', window );">Fair value of plan assets</a></td>
<td class="nump">$ 24,267<span></span>
</td>
<td class="nump">$ 19,360<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount cash and cash equivalents contribute to the fair value of defined benefit plan assets. [Refer: Cash and cash equivalents; Plan assets, at fair value; Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 142<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_142_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PlanAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PlanAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount qualifying insurance policies contribute to the fair value of defined benefit plan assets. [Refer: Plan assets, at fair value; Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 142<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_142&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=soph_FrenchPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=soph_FrenchPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=soph_SwissPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=soph_SwissPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits - Summary of Pension Costs Recognized in Statement of Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ServiceCostDefinedBenefitPlans', window );">Service Cost</a></td>
<td class="num">$ (1,841)<span></span>
</td>
<td class="num">$ (2,637)<span></span>
</td>
<td class="num">$ (1,321)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans', window );">Interest cost</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="num">(414)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans', window );">Total recognized</a></td>
<td class="num">(1,867)<span></span>
</td>
<td class="num">(2,661)<span></span>
</td>
<td class="num">(1,735)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember', window );">Funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ServiceCostDefinedBenefitPlans', window );">Service Cost</a></td>
<td class="num">(1,827)<span></span>
</td>
<td class="num">(2,625)<span></span>
</td>
<td class="num">(1,311)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans', window );">Interest cost</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(413)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans', window );">Total recognized</a></td>
<td class="num">(1,851)<span></span>
</td>
<td class="num">(2,648)<span></span>
</td>
<td class="num">(1,724)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember', window );">Unfunded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ServiceCostDefinedBenefitPlans', window );">Service Cost</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans', window );">Interest cost</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans', window );">Total recognized</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseIncomeDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseIncomeDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 5<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_5&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ServiceCostDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Service cost defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ServiceCostDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Post-employment benefits - Summary of Pension Remeasurement Recognized in Statement Other Comprehensive Loss (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans', window );">Changes in demographic assumptions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans', window );">Changes in financial assumptions</a></td>
<td class="nump">434<span></span>
</td>
<td class="num">(1,908)<span></span>
</td>
<td class="num">(903)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans', window );">Experience adjustments</a></td>
<td class="num">(254)<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ActuarialGainsLossesNetDefinedBenefitPlans', window );">Total actuarial gains (losses)</a></td>
<td class="nump">180<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset', window );">Return on plan assets</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">1,668<span></span>
</td>
<td class="num">(654)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans', window );">Currency translation differences</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Total recognized</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="num">(212)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember', window );">Funded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans', window );">Changes in demographic assumptions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans', window );">Changes in financial assumptions</a></td>
<td class="nump">439<span></span>
</td>
<td class="num">(1,908)<span></span>
</td>
<td class="num">(901)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans', window );">Experience adjustments</a></td>
<td class="num">(254)<span></span>
</td>
<td class="nump">566<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ActuarialGainsLossesNetDefinedBenefitPlans', window );">Total actuarial gains (losses)</a></td>
<td class="nump">185<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset', window );">Return on plan assets</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">1,668<span></span>
</td>
<td class="num">(654)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans', window );">Currency translation differences</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Total recognized</a></td>
<td class="nump">709<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="num">(216)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember', window );">Unfunded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems', window );"><strong>Disclosure Of Defined Benefit Plans [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans', window );">Changes in demographic assumptions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans', window );">Changes in financial assumptions</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans', window );">Experience adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ActuarialGainsLossesNetDefinedBenefitPlans', window );">Total actuarial gains (losses)</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset', window );">Return on plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans', window );">Currency translation differences</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans', window );">Total recognized</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDefinedBenefitPlansLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDefinedBenefitPlansLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [domain]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [domain]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_141_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 207<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_207_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 207<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_207_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ActuarialGainsLossesNetDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial gains (losses), net defined benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ActuarialGainsLossesNetDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pension remeasurement currency translation differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-employment benefits - Summary of Sensitivity Analysis for Funded Plans (Details) - Funded - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember', window );">Discount rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Sensitivity analysis, basis point increase</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Sensitivity analysis, basis point decrease</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase of 25 basis points</a></td>
<td class="num">$ (763)<span></span>
</td>
<td class="num">$ (682)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease of 25 basis points</a></td>
<td class="nump">$ 826<span></span>
</td>
<td class="nump">738<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember', window );">Expected rates of salary increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Sensitivity analysis, basis point increase</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Sensitivity analysis, basis point decrease</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase of 25 basis points</a></td>
<td class="nump">$ 262<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease of 25 basis points</a></td>
<td class="num">$ (261)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Sensitivity analysis, basis point increase</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Sensitivity analysis, basis point decrease</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase of 25 basis points</a></td>
<td class="nump">$ 265<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease of 25 basis points</a></td>
<td class="num">$ (258)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember', window );">Inflation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Sensitivity analysis, basis point increase</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Sensitivity analysis, basis point decrease</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase of 25 basis points</a></td>
<td class="num">$ (46)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease of 25 basis points</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember', window );">Life expectancy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Sensitivity analysis, period increase</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Sensitivity analysis, period decrease</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase of 25 basis points</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease of 25 basis points</a></td>
<td class="num">$ (182)<span></span>
</td>
<td class="num">$ (171)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period Of Reasonably Possible Decrease In Actuarial Assumption</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period Of Reasonably Possible Increase In Actuarial Assumption</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=soph_ActuarialAssumptionOfExpectedInterestRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=soph_ActuarialAssumptionOfExpectedInterestRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Post-employment benefits - Summary of Sensitivity Analysis for Unfunded Plans (Details) - Unfunded - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember', window );">Discount rates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Sensitivity analysis, basis point increase</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Sensitivity analysis, basis point decrease</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase of 25 basis points</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease of 25 basis points</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember', window );">Expected rates of salary increases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems', window );"><strong>Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Sensitivity analysis, basis point increase</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Sensitivity analysis, basis point decrease</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase of 25 basis points</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease of 25 basis points</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis=ifrs-full_WhollyUnfundedDefinedBenefitPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">48 Months Ended</th>
<th class="th" colspan="1">72 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 22, 2021</div></th>
<th class="th">
<div>Jan. 19, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>shares </div>
<div>year </div>
<div>plan </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares </div>
<div>year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares </div>
<div>year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfShareOptionPlans', window );">Number of share option plans | plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2013IncentiveShareOptionPlanMember', window );">2013 ISOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Option life, share options granted | year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Share options exercised (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,000<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="nump">$ 3.03<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="nump">$ 2.92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019', window );">Weighted average share price at date of exercise (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.48<span></span>
</td>
<td class="nump">$ 4.72<span></span>
</td>
<td class="nump">$ 4.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2013IncentiveShareOptionPlanMember', window );">2013 ISOP | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.96<span></span>
</td>
<td class="nump">2.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2013IncentiveShareOptionPlanMember', window );">2013 ISOP | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.34<span></span>
</td>
<td class="nump">3.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2013IncentiveShareOptionPlanMember', window );">2013 ISOP | Vesting Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis', window );">Vesting percentage on annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2013IncentiveShareOptionPlanMember', window );">2013 ISOP | Vesting Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis', window );">Vesting percentage on annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2019IncentiveShareOptionPlanMember', window );">2019 ISOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis', window );">Vesting percentage on annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis', window );">Vesting period on annual basis</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Share options exercised (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,373<span></span>
</td>
<td class="nump">38,250<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">$ 4.97<span></span>
</td>
<td class="nump">$ 4.97<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">5.00<span></span>
</td>
<td class="nump">4.96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019', window );">Weighted average share price at date of exercise (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.61<span></span>
</td>
<td class="nump">$ 4.70<span></span>
</td>
<td class="nump">$ 4.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2019IncentiveShareOptionPlanMember', window );">2019 ISOP | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.16<span></span>
</td>
<td class="nump">3.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2019IncentiveShareOptionPlanMember', window );">2019 ISOP | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.31<span></span>
</td>
<td class="nump">6.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of share options granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,280,275<span></span>
</td>
<td class="nump">3,840,087<span></span>
</td>
<td class="nump">3,734,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Share options exercised (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,412<span></span>
</td>
<td class="nump">49,119<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.72<span></span>
</td>
<td class="nump">$ 6.69<span></span>
</td>
<td class="nump">$ 7.84<span></span>
</td>
<td class="nump">5.72<span></span>
</td>
<td class="nump">5.72<span></span>
</td>
<td class="nump">$ 12.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019', window );">Weighted average share price at date of exercise (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.14<span></span>
</td>
<td class="nump">$ 4.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,136,975<span></span>
</td>
<td class="nump">1,373,816<span></span>
</td>
<td class="nump">2,658,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Option life, share options granted | year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.50<span></span>
</td>
<td class="nump">5.50<span></span>
</td>
<td class="nump">5.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.06<span></span>
</td>
<td class="nump">2.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Option life, share options granted | year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00<span></span>
</td>
<td class="nump">7.00<span></span>
</td>
<td class="nump">7.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP | Vesting Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis', window );">Vesting percentage on annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis', window );">Vesting period on annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis', window );">Vesting percentage on monthly basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP | Vesting Tranche One | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis', window );">Vesting period on annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments granted subject to four year vesting (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,374<span></span>
</td>
<td class="nump">1,168,896<span></span>
</td>
<td class="nump">2,260,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis', window );">RSU vesting period on an annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis', window );">RSU vesting percentage on an annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis', window );">RSU vesting percentage on a quarterly basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis', window );">RSU vesting period on a quarterly basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis', window );">RSU vesting percentage on a monthly basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis', window );">RSU vesting period on a monthly basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP | Vesting Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis', window );">Vesting percentage on annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis', window );">Vesting period on annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis', window );">Vesting percentage on quarterly basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis', window );">Vesting period on quarterly basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP | Vesting Tranche Two | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments granted subject to four year vesting (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">864,681<span></span>
</td>
<td class="nump">204,920<span></span>
</td>
<td class="nump">107,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis', window );">RSU vesting period on an annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP | Vesting Tranche Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis', window );">Vesting percentage on annual basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis', window );">Vesting percentage on monthly basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP | Vesting Tranche Three | Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Number of instruments granted subject to four year vesting (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price at the date of exercise for share options that are exercised in a share-based payment arrangement. [Refer: Types of share-based payment arrangements [domain]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfShareOptionPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share option plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfShareOptionPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Percentage Of Share Based Payment Arrangement Option On Monthly Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting percentage of share-based payment arrangement option on monthly basis over remaining three years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting percentage of share-based payment arrangement option on each anniversary over four year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On A Monthly Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On A Quarterly Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On An Annual Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Period Of Share Based Payment Arrangement Option On Each Anniversary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Period Of Share Based Payment Arrangement Option On Quarterly Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On A Monthly Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On A Quarterly Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting Period Of Share Based Payment Arrangement, Other Equity Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2013IncentiveShareOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2013IncentiveShareOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ShareBasedPaymentArrangementsVestingAxis=soph_ShareBasedPaymentArrangementVestingTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ShareBasedPaymentArrangementsVestingAxis=soph_ShareBasedPaymentArrangementVestingTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ShareBasedPaymentArrangementsVestingAxis=soph_ShareBasedPaymentArrangementVestingTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ShareBasedPaymentArrangementsVestingAxis=soph_ShareBasedPaymentArrangementVestingTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2019IncentiveShareOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2019IncentiveShareOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=soph_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=soph_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ShareBasedPaymentArrangementsVestingAxis=soph_ShareBasedPaymentArrangementVestingTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ShareBasedPaymentArrangementsVestingAxis=soph_ShareBasedPaymentArrangementVestingTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Summary of Stock Option Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1">48 Months Ended</th>
<th class="th" colspan="1">72 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 19, 2022 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2013IncentiveShareOptionPlanMember', window );">2013 ISOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract', window );"><strong>Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560,980<span></span>
</td>
<td class="nump">606,980<span></span>
</td>
<td class="nump">657,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68,000)<span></span>
</td>
<td class="num">(32,000)<span></span>
</td>
<td class="num">(39,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,000)<span></span>
</td>
<td class="num">(14,000)<span></span>
</td>
<td class="num">(12,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,980<span></span>
</td>
<td class="nump">560,980<span></span>
</td>
<td class="nump">606,980<span></span>
</td>
<td class="nump">657,980<span></span>
</td>
<td class="nump">480,980<span></span>
</td>
<td class="nump">480,980<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,980<span></span>
</td>
<td class="nump">560,980<span></span>
</td>
<td class="nump">606,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,980<span></span>
</td>
<td class="nump">480,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract', window );"><strong>Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruemnts, In Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at end of period (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="nump">$ 3.03<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="nump">$ 2.92<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.96<span></span>
</td>
<td class="nump">3.16<span></span>
</td>
<td class="nump">2.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.17<span></span>
</td>
<td class="nump">1.75<span></span>
</td>
<td class="nump">0.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.03<span></span>
</td>
<td class="nump">3.00<span></span>
</td>
<td class="nump">2.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="nump">$ 3.03<span></span>
</td>
<td class="nump">$ 3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract', window );"><strong>Weighted average remaining life in years</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 23 days<span></span>
</td>
<td class="text">2 years 6 months 14 days<span></span>
</td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">4 years 2 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions', window );">Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 23 days<span></span>
</td>
<td class="text">2 years 6 months 14 days<span></span>
</td>
<td class="text">3 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2019IncentiveShareOptionPlanMember', window );">2019 ISOP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract', window );"><strong>Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,308,760<span></span>
</td>
<td class="nump">2,402,510<span></span>
</td>
<td class="nump">2,629,516<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(40,373)<span></span>
</td>
<td class="num">(38,250)<span></span>
</td>
<td class="num">(32,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,000)<span></span>
</td>
<td class="num">(55,500)<span></span>
</td>
<td class="num">(195,006)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,253,387<span></span>
</td>
<td class="nump">2,308,760<span></span>
</td>
<td class="nump">2,402,510<span></span>
</td>
<td class="nump">2,629,516<span></span>
</td>
<td class="nump">2,253,387<span></span>
</td>
<td class="nump">2,253,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,253,367<span></span>
</td>
<td class="nump">2,033,490<span></span>
</td>
<td class="nump">1,651,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,253,367<span></span>
</td>
<td class="nump">2,253,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract', window );"><strong>Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruemnts, In Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at end of period (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">$ 4.97<span></span>
</td>
<td class="nump">$ 4.97<span></span>
</td>
<td class="nump">$ 4.96<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.49<span></span>
</td>
<td class="nump">4.12<span></span>
</td>
<td class="nump">4.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.06<span></span>
</td>
<td class="nump">5.46<span></span>
</td>
<td class="nump">4.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.97<span></span>
</td>
<td class="nump">4.97<span></span>
</td>
<td class="nump">4.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">$ 4.80<span></span>
</td>
<td class="nump">$ 4.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract', window );"><strong>Weighted average remaining life in years</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 5 months 1 day<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">6 years 3 months 18 days<span></span>
</td>
<td class="text">7 years 2 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions', window );">Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 5 months 1 day<span></span>
</td>
<td class="text">5 years 3 months 21 days<span></span>
</td>
<td class="text">6 years 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract', window );"><strong>Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at beginning of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,044,607<span></span>
</td>
<td class="nump">5,708,059<span></span>
</td>
<td class="nump">2,624,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,280,275<span></span>
</td>
<td class="nump">3,840,087<span></span>
</td>
<td class="nump">3,734,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29,412)<span></span>
</td>
<td class="num">(49,119)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(909,956)<span></span>
</td>
<td class="num">(454,420)<span></span>
</td>
<td class="num">(645,310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,385,514<span></span>
</td>
<td class="nump">9,044,607<span></span>
</td>
<td class="nump">5,708,059<span></span>
</td>
<td class="nump">2,624,297<span></span>
</td>
<td class="nump">11,385,514<span></span>
</td>
<td class="nump">11,385,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,989,270<span></span>
</td>
<td class="nump">2,806,356<span></span>
</td>
<td class="nump">1,155,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,989,270<span></span>
</td>
<td class="nump">4,989,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract', window );"><strong>Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruemnts, In Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at end of period (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.72<span></span>
</td>
<td class="nump">$ 6.69<span></span>
</td>
<td class="nump">$ 7.84<span></span>
</td>
<td class="nump">$ 12.32<span></span>
</td>
<td class="nump">$ 5.72<span></span>
</td>
<td class="nump">$ 5.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.29<span></span>
</td>
<td class="nump">4.78<span></span>
</td>
<td class="nump">4.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.78<span></span>
</td>
<td class="nump">2.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.69<span></span>
</td>
<td class="nump">5.37<span></span>
</td>
<td class="nump">6.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.69<span></span>
</td>
<td class="nump">7.84<span></span>
</td>
<td class="nump">12.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Exercisable (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.97<span></span>
</td>
<td class="nump">$ 10.22<span></span>
</td>
<td class="nump">$ 14.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.97<span></span>
</td>
<td class="nump">$ 7.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract', window );"><strong>Weighted average remaining life in years</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 11 months 23 days<span></span>
</td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
<td class="text">8 years 8 months 26 days<span></span>
</td>
<td class="text">8 years 10 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions', window );">Exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 1 month 9 days<span></span>
</td>
<td class="text">7 years 4 months 13 days<span></span>
</td>
<td class="text">7 years 6 months 25 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruments, In Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual life of exercisable share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Life Of Equity Instruments In Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2013IncentiveShareOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2013IncentiveShareOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2019IncentiveShareOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2019IncentiveShareOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Summary of Valuation Inputs (Details) - 2021 EIP<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>year </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>year </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield (%)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Share price at grant date (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.04<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="nump">$ 2.53<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Life of option | year</a></td>
<td class="nump">5.50<span></span>
</td>
<td class="nump">5.50<span></span>
</td>
<td class="nump">5.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility (%)</a></td>
<td class="nump">73.84%<span></span>
</td>
<td class="nump">72.86%<span></span>
</td>
<td class="nump">69.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate (%)</a></td>
<td class="nump">3.68%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.45%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019', window );">Share price at grant date (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.73<span></span>
</td>
<td class="nump">$ 4.96<span></span>
</td>
<td class="nump">$ 4.72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Life of option | year</a></td>
<td class="nump">7.00<span></span>
</td>
<td class="nump">7.00<span></span>
</td>
<td class="nump">7.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility (%)</a></td>
<td class="nump">77.60%<span></span>
</td>
<td class="nump">74.95%<span></span>
</td>
<td class="nump">74.96%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk free interest rate (%)</a></td>
<td class="nump">4.03%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.67%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>153
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Weighted Average Fair Value of Options Granted (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember', window );">2021 EIP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageFairValueShareOptionsGranted', window );">Weighted average fair value of options granted (in dollars per share)</a></td>
<td class="nump">$ 2.26<span></span>
</td>
<td class="nump">$ 3.27<span></span>
</td>
<td class="nump">$ 2.91<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WeightedAverageFairValueShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value, share options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WeightedAverageFairValueShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_A2021EmployeeIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Summary of Restricted Stock Units Activity (Details) - Restricted Stock Units<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract', window );"><strong>Changes In Other Equity Instruments, Number Of Other Equity Instruments, In Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Unvested at beginning of period (in shares) | shares</a></td>
<td class="nump">3,053,076<span></span>
</td>
<td class="nump">3,335,268<span></span>
</td>
<td class="nump">1,865,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Granted (in shares) | shares</a></td>
<td class="nump">1,136,975<span></span>
</td>
<td class="nump">1,373,816<span></span>
</td>
<td class="nump">2,658,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement', window );">Vested (in shares) | shares</a></td>
<td class="num">(1,434,646)<span></span>
</td>
<td class="num">(1,331,731)<span></span>
</td>
<td class="num">(927,155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(171,196)<span></span>
</td>
<td class="num">(324,277)<span></span>
</td>
<td class="num">(261,160)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement', window );">Unvested at end of period (in shares) | shares</a></td>
<td class="nump">2,584,209<span></span>
</td>
<td class="nump">3,053,076<span></span>
</td>
<td class="nump">3,335,268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract', window );"><strong>Changes In Other Equity Instruments, Weighted Average Exercise Price Of Other Equity Instruments, In Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement', window );">Unvested at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="nump">$ 4.77<span></span>
</td>
<td class="nump">$ 5.20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">3.30<span></span>
</td>
<td class="nump">4.71<span></span>
</td>
<td class="nump">4.42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">4.84<span></span>
</td>
<td class="nump">4.95<span></span>
</td>
<td class="nump">4.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">4.10<span></span>
</td>
<td class="nump">4.56<span></span>
</td>
<td class="nump">4.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement', window );">Unvested at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.04<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="nump">$ 4.77<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes In Other Equity Instruments, Number Of Other Equity Instruments, In Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes In Other Equity Instruments, Weighted Average Exercise Price Of Other Equity Instruments, In Share-Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average grant date fair value of other equity instruments forfeited in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average grant date fair value of other equity instruments granted in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average grant date fair value of other equity instruments outstanding in share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Grant Date Fair Value Of Other Equity Instruments Vested In Share Based Payment Arrangement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_RestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=soph_RestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Movements in Share-based Compensation Reserve (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInShareBasedPaymentsAbstract', window );"><strong>Changes In Share-Based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfSharebasedPayments', window );">Balance at beginning of period</a></td>
<td class="nump">$ 56,805<span></span>
</td>
<td class="nump">$ 40,317<span></span>
</td>
<td class="nump">$ 25,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Movement in the period</a></td>
<td class="nump">16,205<span></span>
</td>
<td class="nump">16,488<span></span>
</td>
<td class="nump">15,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfSharebasedPayments', window );">Balance at end of period</a></td>
<td class="nump">$ 73,010<span></span>
</td>
<td class="nump">$ 56,805<span></span>
</td>
<td class="nump">$ 40,317<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity resulting from share-based payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ChangesInShareBasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes In Share-Based Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ChangesInShareBasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based compensation - Share-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based compensation expense</a></td>
<td class="nump">$ 16,205<span></span>
</td>
<td class="nump">$ 16,488<span></span>
</td>
<td class="nump">$ 15,242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncomeStatementLocation1Axis=soph_ResearchAndDevelopmentExpense1Member', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based compensation expense</a></td>
<td class="nump">4,070<span></span>
</td>
<td class="nump">4,370<span></span>
</td>
<td class="nump">3,440<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncomeStatementLocation1Axis=soph_SalesAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based compensation expense</a></td>
<td class="nump">1,230<span></span>
</td>
<td class="nump">1,357<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_IncomeStatementLocation1Axis=soph_GeneralAndAdministrativeExpense1Member', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Share-based compensation expense</a></td>
<td class="nump">$ 10,905<span></span>
</td>
<td class="nump">$ 10,761<span></span>
</td>
<td class="nump">$ 10,536<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_IncomeStatementLocation1Axis=soph_ResearchAndDevelopmentExpense1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_IncomeStatementLocation1Axis=soph_ResearchAndDevelopmentExpense1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_IncomeStatementLocation1Axis=soph_SalesAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_IncomeStatementLocation1Axis=soph_SalesAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_IncomeStatementLocation1Axis=soph_GeneralAndAdministrativeExpense1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_IncomeStatementLocation1Axis=soph_GeneralAndAdministrativeExpense1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>157
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Additional Information (Details)<br> $ / shares in Units, SFr in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 23, 2026 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 27, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 27, 2025 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Jun. 25, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 02, 2024 </div>
<div>USD ($) </div>
<div>instrument </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 23, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 23, 2024 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 20, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 20, 2026 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantTermsAxis=soph_WarrantRightsTrancheAMember', window );">Warrant Rights, Tranche A | Warrant obligation:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantTermsAxis=soph_WarrantRightsTrancheBMember', window );">Warrant Rights, Tranche B | Warrant obligation:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary Shares | Perceptive Credit Holdings IV, LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights', window );">Number of shares available to purchase under warrant certificate (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ExercisePriceOfWarrantRights', window );">Price per share of shares available to purchase under warrant certificate (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.9992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary Shares | Perceptive Credit Holdings IV, LP | Major Borrowing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights', window );">Additional shares available to purchase under warrant certificate (in shares) | shares</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary Shares | Perceptive Credit Holdings IV, LP | Warrant Rights, Tranche A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights', window );">Number of shares available to purchase under warrant certificate (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary Shares | Perceptive Credit Holdings IV, LP | Warrant Rights, Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights', window );">Number of shares available to purchase under warrant certificate (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary Shares | Perceptive Credit Holdings IV, LP | Warrant Rights, Tranche C | Major Borrowing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights', window );">Number of shares available to purchase under warrant certificate (in shares) | shares</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary Shares | Perceptive Credit Holdings IV, LP | Warrant Rights, Tranche D | Major Borrowing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights', window );">Number of shares available to purchase under warrant certificate (in shares) | shares</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity', window );">Maximum borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets', window );">Number of business days for right to reinvest certain proceeds in assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">180 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum', window );">Minimum amount of qualified cash required to be maintained under customary covenants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum', window );">Minimum amount of last twelve months revenue required to be maintained under customary covenants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ProceedsFromBorrowings', window );">Draw down of term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000<span></span>
</td>
<td class="nump">$ 15,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.10%<span></span>
</td>
<td class="nump">14.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total financial liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 474,000<span></span>
</td>
<td class="nump">$ 656,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,733,000<span></span>
</td>
<td class="nump">13,237,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingMaturityTerm', window );">Credit agreement maturity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_RedemptionPeriodOfWarrantRights', window );">Exercise period of purchase rights on warrant certificate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement | Major Borrowing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity', window );">Additional borrowings</a></td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger', window );">Trailing twelve-month revenue triggering draw down</a></td>
<td class="nump">$ 85,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement | Term SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Adjusted interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement | Term SOFR | Major Borrowing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Adjusted interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement | Term SOFR Floor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Adjusted interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement | Term SOFR Floor | Major Borrowing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Adjusted interest rate</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement | Term SOFR upon event default</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Adjusted interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheAMember', window );">Tranche A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity', window );">Maximum borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ProceedsFromBorrowings', window );">Draw down of term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfFinancialInstruments', window );">Number of separate financial instrument | instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs associated with loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheBMember', window );">Tranche B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity', window );">Maximum borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ProceedsFromBorrowings', window );">Draw down of term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRate', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs associated with loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheCMember', window );">Tranche C | Major Borrowing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity', window );">Maximum borrowings</a></td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheDMember', window );">Tranche D | Major Borrowing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity', window );">Maximum borrowings</a></td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_CreditAgreementExistingMember', window );">Existing Credit Agreement | Credit Suisse SA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TerminationOfBorrowings', window );">Termination of existing borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="nump">SFr 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_CreditAgreementNewMember', window );">New Credit Agreement | Credit Suisse SA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity', window );">Maximum borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_TerminationOfBorrowings', window );">Termination of existing borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">SFr 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_CreditAgreementNewMember', window );">New Credit Agreement | UBS Switzerland AG | Major Borrowing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity', window );">Maximum borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="nump">SFr 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest and other costs that an entity incurs in connection with the borrowing of funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to the basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsAdjustmentToInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing Facilities, Increase (Decrease) In Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit facility, maximum borrowing capacity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingFacilitiesMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing Facilities, Prepayment Terms, Business Threshold Days For Right To Reinvest Certain Proceeds In Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing Facilities, Threshold Trailing Twelve Months Revenue Threshold, Allowable Proceeds From Borrowings Trigger</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingMaturityTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing Maturity, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingMaturityTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingsCovenantCashAndCashEquivalentsMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Covenant, Cash And Cash Equivalents, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingsCovenantCashAndCashEquivalentsMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Covenant, Revenue From Contracts With Customers, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ExercisePriceOfWarrantRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise Price Of Warrant Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ExercisePriceOfWarrantRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Financial Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ProceedsFromBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ProceedsFromBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_RedemptionPeriodOfWarrantRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption Period Of Warrant Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_RedemptionPeriodOfWarrantRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_TerminationOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Termination Of Borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_TerminationOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Or Rights, Increase (Decrease) In Number Of Shares Called By Warrants Or Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Or Rights, Number Of Shares Called By Warrants Or Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantTermsAxis=soph_WarrantRightsTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantTermsAxis=soph_WarrantRightsTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantTermsAxis=soph_WarrantRightsTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantTermsAxis=soph_WarrantRightsTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=soph_PerceptiveCreditHoldingsIVLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=soph_PerceptiveCreditHoldingsIVLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantTermsAxis=soph_WarrantRightsTrancheCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantTermsAxis=soph_WarrantRightsTrancheCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantTermsAxis=soph_WarrantRightsTrancheDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantTermsAxis=soph_WarrantRightsTrancheDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingTermsAxis=soph_TermSecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingTermsAxis=soph_TermSecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingTermsAxis=soph_TermSecuredOvernightFinancingRateSOFRFloorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingTermsAxis=soph_TermSecuredOvernightFinancingRateSOFRFloorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingTermsAxis=soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingTermsAxis=soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_CreditAgreementExistingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_CreditAgreementExistingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=soph_CreditSuisseSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=soph_CreditSuisseSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_CreditAgreementNewMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_CreditAgreementNewMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=soph_UBSSwitzerlandAGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=soph_UBSSwitzerlandAGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>158
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings - Schedule of Key Inputs for Valuation of Warrant Obligation (Details) - Warrant obligation:<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Jun. 25, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>May 02, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Exercise price in USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Share price in USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.08<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Expected volatility (annualized)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7177<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Black-Scholes value in USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.06<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche A | Exercise price in USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche A | Share price in USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">4.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche A | Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">0.0401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche A | Expected volatility (annualized)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">0.6839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche A | Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">8.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche A | Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche A | Black-Scholes value in USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">3.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche B | Exercise price in USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche B | Share price in USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">4.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche B | Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">0.0402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche B | Expected volatility (annualized)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">0.7610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche B | Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">9.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche B | Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember', window );">Warrant Rights, Tranche B | Black-Scholes value in USD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems', window );"><strong>Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantUnobservableInputLiabilities', window );">Key inputs for valuations</a></td>
<td class="nump">3.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantUnobservableInputLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of significant unobservable input used in the measurement of the fair value of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantUnobservableInputLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=soph_ExercisePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=soph_ExercisePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=soph_SharePriceMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=soph_SharePriceMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=ifrs-full_InterestRateMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=soph_ExpectedVolatilityMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=soph_ExpectedVolatilityMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=soph_ExpectedTermMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=soph_ExpectedTermMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=soph_DividendYieldMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=soph_DividendYieldMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnobservableInputsAxis=soph_BlackScholesPricingModelValueMeasurementInputMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnobservableInputsAxis=soph_BlackScholesPricingModelValueMeasurementInputMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantTermsAxis=soph_WarrantRightsTrancheAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantTermsAxis=soph_WarrantRightsTrancheAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantTermsAxis=soph_WarrantRightsTrancheBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantTermsAxis=soph_WarrantRightsTrancheBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>159
<FILENAME>R116.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Schedule of Allocation of the Loan Proceeds and Movements in Liability (Details) - Perceptive Credit Agreement - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 02, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInBorrowingsAbstract', window );"><strong>Changes In Borrowings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,237<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ProceedsFromBorrowings', window );">Gross proceeds</a></td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ProceedsFromBorrowingsNetOfCostsIncurred', window );">Proceeds net of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,563<span></span>
</td>
<td class="nump">13,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Warrant obligation at issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(474)<span></span>
</td>
<td class="num">(656)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnBorrowings', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,891<span></span>
</td>
<td class="nump">1,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities', window );">Interest paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,521)<span></span>
</td>
<td class="num">(1,152)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingsForeignCurrencyTranslationGainLoss', window );">Currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,733<span></span>
</td>
<td class="nump">13,237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Holdings Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInBorrowingsAbstract', window );"><strong>Changes In Borrowings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingCostsIncurred', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (437)<span></span>
</td>
<td class="num">$ (1,070)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest and other costs that an entity incurs in connection with the borrowing of funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowings, Foreign Currency Translation Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ChangesInBorrowingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes In Borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ChangesInBorrowingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ProceedsFromBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ProceedsFromBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ProceedsFromBorrowingsNetOfCostsIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Proceeds From Borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ProceedsFromBorrowingsNetOfCostsIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_PerceptiveCreditHoldingsWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=soph_PerceptiveCreditHoldingsWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>160
<FILENAME>R117.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings - Schedule of Warrant Obligation Liability (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInWarrantLiabilityAbstract', window );"><strong>Changes In Warrant Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentWarrantLiability', window );">Beginnings balances</a></td>
<td class="nump">$ 444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AdjustmentsForFairValueOfWarrantLiability', window );">Change in fair value</a></td>
<td class="num">(497)<span></span>
</td>
<td class="nump">$ 370<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentWarrantLiability', window );">Ending balances</a></td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">444<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_PerceptiveCreditHoldingsWarrantsMember', window );">Perceptive Credit Holdings Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ChangesInWarrantLiabilityAbstract', window );"><strong>Changes In Warrant Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentWarrantLiability', window );">Beginnings balances</a></td>
<td class="nump">444<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ProceedsFromWarrantLiability', window );">Issuance of warrants</a></td>
<td class="nump">474<span></span>
</td>
<td class="nump">656<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AdjustmentsForFairValueOfWarrantLiability', window );">Change in fair value</a></td>
<td class="nump">497<span></span>
</td>
<td class="num">(370)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantLiabilityForeignExchangeGainLoss', window );">Foreign exchange gain (loss)</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentWarrantLiability', window );">Ending balances</a></td>
<td class="nump">$ 1,412<span></span>
</td>
<td class="nump">$ 444<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights', window );">Beginnings balances (in shares)</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsNumberOfWarrantsIssued', window );">Issuance of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights', window );">Ending balances (in shares)</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current warrant liabilities. [Refer: Warrant liability]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AdjustmentsForFairValueOfWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments For Fair Value Of Warrant Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AdjustmentsForFairValueOfWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ChangesInWarrantLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes In Warrant Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ChangesInWarrantLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ProceedsFromWarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issue of During the Value Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ProceedsFromWarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantLiabilityForeignExchangeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Liability, Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantLiabilityForeignExchangeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Or Rights, Number Of Shares Called By Warrants Or Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantsOrRightsNumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issue of During the Shares Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantsOrRightsNumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_PerceptiveCreditHoldingsWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=soph_PerceptiveCreditHoldingsWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>161
<FILENAME>R118.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties - Additional Information (Details) - personnel<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfExecutiveOfficers', window );">Number of executive officers</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfNonExecutiveOfficers', window );">Number of non-executive officers</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfExecutiveOfficers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Executive Officers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfExecutiveOfficers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfNonExecutiveOfficers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Non-Executive Officers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfNonExecutiveOfficers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>162
<FILENAME>R119.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties - Summary of Compensation for Key Management and Non-executive Directors (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract', window );"><strong>Disclosure of transactions between related parties [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Salaries and other short-term employee benefits</a></td>
<td class="nump">$ 5,784<span></span>
</td>
<td class="nump">$ 4,206<span></span>
</td>
<td class="nump">$ 4,234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits', window );">Pension costs</a></td>
<td class="nump">281<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment', window );">Share-based compensation expense</a></td>
<td class="nump">11,935<span></span>
</td>
<td class="nump">12,327<span></span>
</td>
<td class="nump">10,597<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Total</a></td>
<td class="nump">$ 18,000<span></span>
</td>
<td class="nump">$ 16,786<span></span>
</td>
<td class="nump">$ 15,059<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 227<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_227&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 227<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_227&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>163
<FILENAME>R120.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and contingencies (Details)<br> &#8364; in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2026 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2026 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 01, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems', window );"><strong>Disclosure of contingent liabilities in business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized', window );">Future lease payments under short-term leases not recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContractualCapitalCommitments', window );">Minimum purchase agreement commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CapitalCommitments', window );">Remaining commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,200,000<span></span>
</td>
<td class="nump">56,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EstimatedFinancialEffectOfContingentAssets', window );">Contingent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=soph_GuardantHealthMember', window );">Guardant | Major litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems', window );"><strong>Disclosure of contingent liabilities in business combination [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LossesOnLitigationSettlements', window );">Litigation ordered payment of interim award costs</a></td>
<td class="nump">$ 470,080<span></span>
</td>
<td class="nump">&#8364; 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CapitalCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of future capital expenditures that the entity is committed to make.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CapitalCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContractualCapitalCommitments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContractualCapitalCommitments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EstimatedFinancialEffectOfContingentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the estimated financial effect of possible assets that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within control of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 260<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_260&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 260<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_260&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EstimatedFinancialEffectOfContingentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LossesOnLitigationSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LossesOnLitigationSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future lease payments under short-term leases not recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=soph_GuardantHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=soph_GuardantHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_CommencementOfMajorLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_CommencementOfMajorLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>164
<FILENAME>R121.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments and risks - Summary of Financial Instruments (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets</a></td>
<td class="nump">$ 87,285<span></span>
</td>
<td class="nump">$ 88,656<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">94,128<span></span>
</td>
<td class="nump">48,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember', window );">Financial liabilities at amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">92,716<span></span>
</td>
<td class="nump">48,467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember', window );">Financial liabilities at amortized cost | Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">8,960<span></span>
</td>
<td class="nump">5,220<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember', window );">Financial liabilities at amortized cost | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">20,736<span></span>
</td>
<td class="nump">13,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember', window );">Financial liabilities at amortized cost | Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">15,287<span></span>
</td>
<td class="nump">16,793<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember', window );">Financial liabilities at amortized cost | Borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">47,733<span></span>
</td>
<td class="nump">13,237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember', window );">Financial liabilities at fair value through statement of loss | Warrant obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total financial liabilities</a></td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember', window );">Financial assets at amortized cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets</a></td>
<td class="nump">87,285<span></span>
</td>
<td class="nump">88,656<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember', window );">Financial assets at amortized cost | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets</a></td>
<td class="nump">70,289<span></span>
</td>
<td class="nump">80,226<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember', window );">Financial assets at amortized cost | Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets</a></td>
<td class="nump">15,001<span></span>
</td>
<td class="nump">7,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember', window );">Financial assets at amortized cost | Other financial non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets</a></td>
<td class="nump">1,995<span></span>
</td>
<td class="nump">994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember', window );">Financial assets at fair value through statement of loss | Equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total financial assets</a></td>
<td class="nump">$ 1,977<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35H<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35M<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35N<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35I<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 71<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_71&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_AccountsPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_AccountsPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_AccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_AccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_LongtermBorrowingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_LongtermBorrowingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_WarrantObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_WarrantObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_CashAndCashEquivalentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_CashAndCashEquivalentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_FinancialAssetsAccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_FinancialAssetsAccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_OtherFinancialNonCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_OtherFinancialNonCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_EquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=ifrs-full_EquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>165
<FILENAME>R122.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risks - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th"><div>Jan. 23, 2026</div></th>
<th class="th"><div>May 02, 2024</div></th>
<th class="th"><div>Mar. 03, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Oct. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,289<span></span>
</td>
<td class="nump">$ 80,226<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 123,251<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="nump">$ 161,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfEquitySharesIssued', window );">Number of shares sold under ATM program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Gross proceeds from shares sold under ATM program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,093<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Within 1 year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BankBorrowingsInterestPaidUndiscountedCashFlows', window );">Contractual cash interest payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Between 1 and 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BankBorrowingsInterestPaidUndiscountedCashFlows', window );">Contractual cash interest payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,400<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember', window );">Major ordinary share transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfEquitySharesIssued', window );">Number of shares sold under ATM program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,795,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Gross proceeds from shares sold under ATM program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ProceedsFromBorrowings', window );">Draw down of term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,733<span></span>
</td>
<td class="nump">13,237<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage', window );">Basis point change in interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings', window );">Change in cash interest costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement | Gross carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Borrowings amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement | Major Borrowing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity', window );">Additional borrowings</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_CashAndCashEquivalentsAndTermDepositsMember', window );">Cash And Cash Equivalents and Term Deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaximumExposureToCreditRisk', window );">Maximum exposure to credit risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,400<span></span>
</td>
<td class="nump">$ 26,100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=soph_GenesisHealthcareMember', window );">Genesis Healthcare | Equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure Of Financial Instruments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss', window );">Financial assets at fair value through profit or loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaximumExposureToCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that best represents the maximum exposure to credit risk without taking into account any collateral held or other credit enhancements (for example, netting agreements that do not qualify for offset in accordance with IAS 32). [Refer: Credit risk [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35K<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35K_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaximumExposureToCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BankBorrowingsInterestPaidUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Bank Borrowings, Interest Paid, Undiscounted Cash Flows</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BankBorrowingsInterestPaidUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing Facilities, Increase (Decrease) In Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Shares Issued Of Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ProceedsFromBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From borrowings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ProceedsFromBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing of Increase in Cash Interest Costs on Annualized Basis</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis For Borrowings, Reasonably Possible Change In Interest Rate, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_CashAndCashEquivalentsAndTermDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialInstrumentsAxis=soph_CashAndCashEquivalentsAndTermDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=soph_GenesisHealthcareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=soph_GenesisHealthcareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_EquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_EquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>166
<FILENAME>R123.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments and risks - Summary of Fair Value Measurement of Assets and Liabilities (Details) - Recurring fair value measurement - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total financial assets</a></td>
<td class="nump">$ 27,528<span></span>
</td>
<td class="nump">$ 39,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 1 | Warrant obligation:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 1 | Cash and cash equivalents:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total financial assets</a></td>
<td class="nump">27,528<span></span>
</td>
<td class="nump">39,586<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 1 | Equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total financial assets</a></td>
<td class="nump">1,977<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total financial liabilities</a></td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 2 | Warrant obligation:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total financial liabilities</a></td>
<td class="nump">1,412<span></span>
</td>
<td class="nump">474<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 2 | Cash and cash equivalents:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 2 | Equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total financial assets</a></td>
<td class="nump">1,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3 | Warrant obligation:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Total financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3 | Cash and cash equivalents:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember', window );">Level 3 | Equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems', window );"><strong>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Total financial assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial assets. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_RecurringFairValueMeasurementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level1OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfLiabilitiesAxis=soph_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=soph_CashAndCashEquivalents1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=soph_CashAndCashEquivalents1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_EquityInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_EquityInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>167
<FILENAME>R124.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial instruments and risks - Summary of Maturity Profile of Financial Liabilities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems', window );"><strong>Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">$ 16,294<span></span>
</td>
<td class="nump">$ 19,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows', window );">Accounts payable</a></td>
<td class="nump">8,960<span></span>
</td>
<td class="nump">5,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedExpensesUndiscountedCashFlows', window );">Accrued expenses</a></td>
<td class="nump">20,736<span></span>
</td>
<td class="nump">13,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings</a></td>
<td class="nump">67,083<span></span>
</td>
<td class="nump">22,027<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total contractual liabilities</a></td>
<td class="nump">113,073<span></span>
</td>
<td class="nump">60,190<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember', window );">Within 1 year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems', window );"><strong>Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">2,992<span></span>
</td>
<td class="nump">2,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows', window );">Accounts payable</a></td>
<td class="nump">8,960<span></span>
</td>
<td class="nump">5,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedExpensesUndiscountedCashFlows', window );">Accrued expenses</a></td>
<td class="nump">20,736<span></span>
</td>
<td class="nump">13,217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings</a></td>
<td class="nump">5,125<span></span>
</td>
<td class="nump">1,622<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total contractual liabilities</a></td>
<td class="nump">37,813<span></span>
</td>
<td class="nump">22,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember', window );">Between 1 and 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems', window );"><strong>Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">11,839<span></span>
</td>
<td class="nump">12,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows', window );">Accounts payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedExpensesUndiscountedCashFlows', window );">Accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings</a></td>
<td class="nump">61,958<span></span>
</td>
<td class="nump">20,405<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total contractual liabilities</a></td>
<td class="nump">73,797<span></span>
</td>
<td class="nump">32,923<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember', window );">After 5 years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems', window );"><strong>Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,463<span></span>
</td>
<td class="nump">4,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows', window );">Accounts payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedExpensesUndiscountedCashFlows', window );">Accrued expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total contractual liabilities</a></td>
<td class="nump">1,463<span></span>
</td>
<td class="nump">4,469<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Net carrying amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems', window );"><strong>Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">15,287<span></span>
</td>
<td class="nump">16,793<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows', window );">Accounts payable</a></td>
<td class="nump">8,960<span></span>
</td>
<td class="nump">5,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AccruedExpensesUndiscountedCashFlows', window );">Accrued expenses</a></td>
<td class="nump">20,736<span></span>
</td>
<td class="nump">13,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankBorrowingsUndiscountedCashFlows', window );">Borrowings</a></td>
<td class="nump">47,733<span></span>
</td>
<td class="nump">13,237<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows', window );">Total contractual liabilities</a></td>
<td class="nump">$ 92,716<span></span>
</td>
<td class="nump">$ 48,467<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankBorrowingsUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to bank borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph IG31A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IG31A&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph B11D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B11D&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankBorrowingsUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 58<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_58&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph B11D<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B11D_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 119<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_119&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 119<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_119&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to non-derivative financial liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 72<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_72_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 72<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_72_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contractual undiscounted cash flows in relation to trade and other payables. [Refer: Trade and other payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph IG31A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IG31A&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph B11D<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B11D&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AccruedExpensesUndiscountedCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued expenses, undiscounted cash flows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AccruedExpensesUndiscountedCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of maturity analysis for financial liabilities on contractual discounted cashflows.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>168
<FILENAME>R125.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risks - Summary of Significant Exchange Rates (Detail)<br></strong></div></th>
<th class="th" colspan="12">12 Months Ended</th>
<th class="th" colspan="3"></th>
<th class="th" colspan="3"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / SFr</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / SFr </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / SFr </div>
<div>$ / &#163;</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / R$ </div>
<div>$ / SFr</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / SFr</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / SFr </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / SFr </div>
<div>$ / &#163;</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / SFr </div>
<div>$ / R$</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / SFr</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / &#163;</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / R$</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / &#163;</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / R$</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / &#8364;</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / &#163;</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / R$</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract', window );"><strong>Disclosure of detailed information about financial instruments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_ForeignExchangeSpotRate', window );">Spot rate (in dollars per share)</a></td>
<td class="nump">0.79208<span></span>
</td>
<td class="nump">0.79208<span></span>
</td>
<td class="nump">0.79208<span></span>
</td>
<td class="nump">0.79208<span></span>
</td>
<td class="nump">0.90740<span></span>
</td>
<td class="nump">0.90740<span></span>
</td>
<td class="nump">0.90740<span></span>
</td>
<td class="nump">0.90740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.85092<span></span>
</td>
<td class="nump">0.74179<span></span>
</td>
<td class="nump">5.49560<span></span>
</td>
<td class="nump">0.96530<span></span>
</td>
<td class="nump">0.79870<span></span>
</td>
<td class="nump">6.17360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_AverageForeignExchangeRates', window );">Average rate (in dollars per share)</a></td>
<td class="nump">0.83064<span></span>
</td>
<td class="nump">0.88644<span></span>
</td>
<td class="nump">0.75887<span></span>
</td>
<td class="nump">5.58911<span></span>
</td>
<td class="nump">0.88064<span></span>
</td>
<td class="nump">0.92455<span></span>
</td>
<td class="nump">0.78267<span></span>
</td>
<td class="nump">5.39155<span></span>
</td>
<td class="nump">0.89855<span></span>
</td>
<td class="nump">0.92478<span></span>
</td>
<td class="nump">0.80428<span></span>
</td>
<td class="nump">4.97372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_AverageForeignExchangeRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Average foreign exchange rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_AverageForeignExchangeRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_ForeignExchangeSpotRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange, spot rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_ForeignExchangeSpotRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>169
<FILENAME>R126.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risks - Summary of Loss Before Tax To Changes in Foreign Exchange Rates (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gain (loss)</a></td>
<td class="num">$ (3,402)<span></span>
</td>
<td class="nump">$ 3,479<span></span>
</td>
<td class="num">$ (7,628)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_FunctionalCurrencyMember', window );">Functional Currency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent', window );">Sensitivity analysis, change in exchange rate, percent</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_FunctionalCurrencyMember', window );">Functional Currency | USD/CHF | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gain (loss)</a></td>
<td class="num">$ (2,101)<span></span>
</td>
<td class="num">(562)<span></span>
</td>
<td class="num">(3,034)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_FunctionalCurrencyMember', window );">Functional Currency | USD/CHF | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gain (loss)</a></td>
<td class="nump">2,101<span></span>
</td>
<td class="nump">562<span></span>
</td>
<td class="nump">3,034<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_FunctionalCurrencyMember', window );">Functional Currency | EUR/CHF | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gain (loss)</a></td>
<td class="num">(1,020)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
<td class="num">(508)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_FunctionalCurrencyMember', window );">Functional Currency | EUR/CHF | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gain (loss)</a></td>
<td class="nump">1,020<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_FunctionalCurrencyMember', window );">Functional Currency | GBP/CHF | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gain (loss)</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_FunctionalCurrencyMember', window );">Functional Currency | GBP/CHF | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss', window );">Foreign exchange gain (loss)</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2025-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of effect of changes in foreign exchange rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis For Foreign Exchange Gain (Loss), Reasonably Possible Change In Currency Variable, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_FunctionalCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_FunctionalCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=soph_DifferencesOfCurrencyUSDAndCHFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=soph_DifferencesOfCurrencyUSDAndCHFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=soph_DifferencesOfCurrencyEURAndCHFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=soph_DifferencesOfCurrencyEURAndCHFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=soph_DifferencesOfCurrencyGBPAndCHFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=soph_DifferencesOfCurrencyGBPAndCHFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>170
<FILENAME>R127.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial instruments and risks - Summary of Equity To Changes in Foreign Exchange Rates (Detail) - Presentation Currency - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent', window );">Sensitivity analysis, change in exchange rate, percent</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_PresentationCurrencyMember', window );">USD/CHF | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Increase / (decrease) of equity in exchange rate</a></td>
<td class="nump">$ 2,561<span></span>
</td>
<td class="nump">$ 1,520<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_PresentationCurrencyMember', window );">USD/CHF | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Increase / (decrease) of equity in exchange rate</a></td>
<td class="num">(2,561)<span></span>
</td>
<td class="num">(1,520)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_PresentationCurrencyMember', window );">USD/EUR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Increase / (decrease) of equity in exchange rate</a></td>
<td class="nump">663<span></span>
</td>
<td class="nump">2,244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_PresentationCurrencyMember', window );">USD/EUR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Increase / (decrease) of equity in exchange rate</a></td>
<td class="num">(663)<span></span>
</td>
<td class="num">(2,244)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_PresentationCurrencyMember', window );">USD/GBP | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Increase / (decrease) of equity in exchange rate</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_PresentationCurrencyMember', window );">USD/GBP | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems', window );"><strong>Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation', window );">Increase / (decrease) of equity in exchange rate</a></td>
<td class="num">$ (95)<span></span>
</td>
<td class="num">$ (61)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfExchangeDifferencesOnTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2025-01-01<br> -Paragraph 52<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_52_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 218<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_218_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfExchangeDifferencesOnTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of effect of changes in foreign exchange rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis For Reserve Of Exchange Differences On Translation, Reasonably Possible Change In Currency Variable, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_PresentationCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrencyInWhichInformationIsDisplayedAxis=soph_PresentationCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=soph_DifferencesOfCurrencyUSDAndCHFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=soph_DifferencesOfCurrencyUSDAndCHFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=soph_DifferencesOfCurrencyUSDAndEURMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=soph_DifferencesOfCurrencyUSDAndEURMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=soph_DifferencesOfCurrencyUSDAndGBPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=soph_DifferencesOfCurrencyUSDAndGBPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>171
<FILENAME>R128.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital management (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jan. 23, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_CapitalManagementLineItems', window );"><strong>Capital Management [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,289<span></span>
</td>
<td colspan="2" class="nump">$ 80,226<span></span>
</td>
<td colspan="2" class="nump">$ 123,251<span></span>
</td>
<td colspan="2" class="nump">$ 161,305<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_CapitalManagementLineItems', window );"><strong>Capital Management [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UndrawnBorrowingFacilities', window );">Borrowings that can be drawn immediately</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement | Major Borrowing Transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_CapitalManagementLineItems', window );"><strong>Capital Management [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity', window );">Additional borrowings</a></td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UndrawnBorrowingFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UndrawnBorrowingFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing Facilities, Increase (Decrease) In Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_CapitalManagementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital Management [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_CapitalManagementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>172
<FILENAME>R129.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events after the reporting date (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 23, 2026</div></th>
<th class="th"><div>Mar. 03, 2026</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><sup>[1]</sup></th>
<th class="th"><div>May 02, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfEquitySharesIssued', window );">Number of shares sold under ATM program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,238<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Gross proceeds from shares sold under ATM program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,093,000<span></span>
</td>
<td colspan="2" class="nump">$ 0<span></span>
</td>
<td colspan="2" class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary Shares | Perceptive Credit Holdings IV, LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights', window );">Number of shares available to purchase under warrant certificate (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity', window );">Maximum borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement | Term SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Adjusted interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">6.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember', window );">Perceptive Credit Agreement | Term SOFR Floor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Adjusted interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember', window );">Major Borrowing Transactions | Ordinary Shares | Perceptive Credit Holdings IV, LP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights', window );">Additional shares available to purchase under warrant certificate (in shares)</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember', window );">Major Borrowing Transactions | Ordinary Shares | Perceptive Credit Holdings IV, LP | Warrant Rights, Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights', window );">Number of shares available to purchase under warrant certificate (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember', window );">Major Borrowing Transactions | Ordinary Shares | Perceptive Credit Holdings IV, LP | Warrant Rights, Tranche D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights', window );">Number of shares available to purchase under warrant certificate (in shares)</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember', window );">Major Borrowing Transactions | Perceptive Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity', window );">Additional borrowings</a></td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger', window );">Trailing twelve-month revenue triggering draw down</a></td>
<td class="nump">$ 85,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember', window );">Major Borrowing Transactions | Perceptive Credit Agreement | Term SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Adjusted interest rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember', window );">Major Borrowing Transactions | Perceptive Credit Agreement | Term SOFR Floor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis', window );">Adjusted interest rate</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember', window );">Major Borrowing Transactions | Tranche C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity', window );">Maximum borrowings</a></td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember', window );">Major Borrowing Transactions | Tranche D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity', window );">Maximum borrowings</a></td>
<td class="nump">$ 12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember', window );">Major ordinary share transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure Of Detailed Information About Borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_soph_NumberOfEquitySharesIssued', window );">Number of shares sold under ATM program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,795,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Gross proceeds from shares sold under ATM program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refer to &#8220;Note 2&#8212;Material Accounting Policies&#8212;Statement of Cash Flows - Interest Classification&#8221; for details on change in accounting policy.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsAdjustmentToInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The adjustment to the basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsAdjustmentToInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing Facilities, Increase (Decrease) In Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingFacilitiesMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Credit facility, maximum borrowing capacity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingFacilitiesMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing Facilities, Threshold Trailing Twelve Months Revenue Threshold, Allowable Proceeds From Borrowings Trigger</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_NumberOfEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Shares Issued Of Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_NumberOfEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Or Rights, Increase (Decrease) In Number Of Shares Called By Warrants Or Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants Or Rights, Number Of Shares Called By Warrants Or Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>soph_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=soph_PerceptiveCreditHoldingsIVLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=soph_PerceptiveCreditHoldingsIVLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingTermsAxis=soph_TermSecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingTermsAxis=soph_TermSecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_BorrowingTermsAxis=soph_TermSecuredOvernightFinancingRateSOFRFloorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_BorrowingTermsAxis=soph_TermSecuredOvernightFinancingRateSOFRFloorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=soph_MajorBorrowingTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantTermsAxis=soph_WarrantRightsTrancheCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantTermsAxis=soph_WarrantRightsTrancheCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_soph_WarrantTermsAxis=soph_WarrantRightsTrancheDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">soph_WarrantTermsAxis=soph_WarrantRightsTrancheDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=soph_PerceptiveCreditAgreementTrancheDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NonadjustingEventsAfterReportingPeriodAxis=ifrs-full_MajorOrdinaryShareTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>173
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>174
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>176
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>571</ContextCount>
  <ElementCount>522</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>146</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>19</UnitCount>
  <MyReports>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - Consolidated Statements of Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss</Role>
      <ShortName>Consolidated Statements of Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity</Role>
      <ShortName>Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Disclosure - Company information and operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Companyinformationandoperations</Role>
      <ShortName>Company information and operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Material accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Materialaccountingpolicies</Role>
      <ShortName>Material accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Segment reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Segmentreporting</Role>
      <ShortName>Segment reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Cost of revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Costofrevenue</Role>
      <ShortName>Cost of revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Operating expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Operatingexpense</Role>
      <ShortName>Operating expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Other operating income, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Otheroperatingincomenet</Role>
      <ShortName>Other operating income, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnet</Role>
      <ShortName>Interest income, Interest expense and Foreign exchange (losses) gains, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Income tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Incometax</Role>
      <ShortName>Income tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Losspershare</Role>
      <ShortName>Loss per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Cash and cash equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Cashandcashequivalents</Role>
      <ShortName>Cash and cash equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Accounts receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Accountsreceivable</Role>
      <ShortName>Accounts receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Prepaids and other current assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Prepaidsandothercurrentassets</Role>
      <ShortName>Prepaids and other current assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Property and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Propertyandequipment</Role>
      <ShortName>Property and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9952173 - Disclosure - Other non-current assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Othernoncurrentassets</Role>
      <ShortName>Other non-current assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9952174 - Disclosure - Accounts payable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Accountspayable</Role>
      <ShortName>Accounts payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9952175 - Disclosure - Accrued expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Accruedexpenses</Role>
      <ShortName>Accrued expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9952176 - Disclosure - Post-employment benefits</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Postemploymentbenefits</Role>
      <ShortName>Post-employment benefits</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9952177 - Disclosure - Share-based compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Sharebasedcompensation</Role>
      <ShortName>Share-based compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9952178 - Disclosure - Borrowings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Borrowings</Role>
      <ShortName>Borrowings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9952179 - Disclosure - Related parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Relatedparties</Role>
      <ShortName>Related parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9952180 - Disclosure - Commitments and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Commitmentsandcontingencies</Role>
      <ShortName>Commitments and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9952181 - Disclosure - Financial instruments and risks</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Financialinstrumentsandrisks</Role>
      <ShortName>Financial instruments and risks</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9952182 - Disclosure - Capital management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Capitalmanagement</Role>
      <ShortName>Capital management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9952183 - Disclosure - Events after the reporting date</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/Eventsafterthereportingdate</Role>
      <ShortName>Events after the reporting date</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Material accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies</Role>
      <ShortName>Material accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Company information and operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/CompanyinformationandoperationsTables</Role>
      <ShortName>Company information and operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Companyinformationandoperations</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Segment reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/SegmentreportingTables</Role>
      <ShortName>Segment reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Segmentreporting</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Revenue</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Operating expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/OperatingexpenseTables</Role>
      <ShortName>Operating expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Operatingexpense</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables</Role>
      <ShortName>Interest income, Interest expense and Foreign exchange (losses) gains, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnet</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Income tax (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/IncometaxTables</Role>
      <ShortName>Income tax (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Incometax</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Loss per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/LosspershareTables</Role>
      <ShortName>Loss per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Losspershare</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Cash and cash equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/CashandcashequivalentsTables</Role>
      <ShortName>Cash and cash equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Cashandcashequivalents</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Accounts receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/AccountsreceivableTables</Role>
      <ShortName>Accounts receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Accountsreceivable</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Inventory</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Prepaids and other current assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsTables</Role>
      <ShortName>Prepaids and other current assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Prepaidsandothercurrentassets</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Property and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PropertyandequipmentTables</Role>
      <ShortName>Property and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Propertyandequipment</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Intangibles assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/IntangiblesassetsTables</Role>
      <ShortName>Intangibles assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Leases</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Other non-current assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/OthernoncurrentassetsTables</Role>
      <ShortName>Other non-current assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Othernoncurrentassets</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Accounts payable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/AccountspayableTables</Role>
      <ShortName>Accounts payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Accountspayable</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Accrued expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/AccruedexpensesTables</Role>
      <ShortName>Accrued expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Accruedexpenses</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Post-employment benefits (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PostemploymentbenefitsTables</Role>
      <ShortName>Post-employment benefits (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Postemploymentbenefits</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Share-based compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/SharebasedcompensationTables</Role>
      <ShortName>Share-based compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Sharebasedcompensation</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Borrowings (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/BorrowingsTables</Role>
      <ShortName>Borrowings (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Borrowings</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Related parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/RelatedpartiesTables</Role>
      <ShortName>Related parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Relatedparties</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Financial instruments and risks (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables</Role>
      <ShortName>Financial instruments and risks (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Financialinstrumentsandrisks</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Company information and operations - Summary of Wholly-Owned Subsidiaries (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails</Role>
      <ShortName>Company information and operations - Summary of Wholly-Owned Subsidiaries (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Company information and operations - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails</Role>
      <ShortName>Company information and operations - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Material accounting policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails</Role>
      <ShortName>Material accounting policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Segment reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/SegmentreportingDetails</Role>
      <ShortName>Segment reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/SegmentreportingTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Revenue - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails</Role>
      <ShortName>Revenue - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Revenue - Schedule of Revenue from Contracts with Customers Allocated to Geographical Areas and Revenue Streams (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails</Role>
      <ShortName>Revenue - Schedule of Revenue from Contracts with Customers Allocated to Geographical Areas and Revenue Streams (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Operating expense - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails</Role>
      <ShortName>Operating expense - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Operating expense - Summary of Depreciation and Amortization have Charged in Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails</Role>
      <ShortName>Operating expense - Summary of Depreciation and Amortization have Charged in Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Operating expense - Summary of Employee Benefit Expenses, Social Charges and Share-based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails</Role>
      <ShortName>Operating expense - Summary of Employee Benefit Expenses, Social Charges and Share-based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestIncomeDetails</Role>
      <ShortName>Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails</Role>
      <ShortName>Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Foreign Exchange (Losses) Gains, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofForeignExchangeLossesGainsNetDetails</Role>
      <ShortName>Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Foreign Exchange (Losses) Gains, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Income tax - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails</Role>
      <ShortName>Income tax - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Income tax - Summary of Current and Deferred Income Tax (Expenses) Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails</Role>
      <ShortName>Income tax - Summary of Current and Deferred Income Tax (Expenses) Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Income tax - Reconciliation of Expected Tax Expense to Tax Expense Report in Statement of Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails</Role>
      <ShortName>Income tax - Reconciliation of Expected Tax Expense to Tax Expense Report in Statement of Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Income tax - Summary of Movement in Deferred Tax Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails</Role>
      <ShortName>Income tax - Summary of Movement in Deferred Tax Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Income tax - Summary of Unrecognized Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails</Role>
      <ShortName>Income tax - Summary of Unrecognized Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Income tax - Summary of Net Operating Loss Carryforwards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails</Role>
      <ShortName>Income tax - Summary of Net Operating Loss Carryforwards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Loss per share - Additional information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails</Role>
      <ShortName>Loss per share - Additional information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Loss per share - Components of Loss for Year (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/LosspershareComponentsofLossforYearDetails</Role>
      <ShortName>Loss per share - Components of Loss for Year (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Cash and cash equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/CashandcashequivalentsDetails</Role>
      <ShortName>Cash and cash equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/CashandcashequivalentsTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Accounts receivable - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail</Role>
      <ShortName>Accounts receivable - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Accounts receivable - Summary of Accounts Receivable and Lease Receivable Less Expected Credit Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails</Role>
      <ShortName>Accounts receivable - Summary of Accounts Receivable and Lease Receivable Less Expected Credit Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Accounts receivable - Summary of Movement in Allowance for Expected Credit Losses in Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails</Role>
      <ShortName>Accounts receivable - Summary of Movement in Allowance for Expected Credit Losses in Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Inventory - Summary of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails</Role>
      <ShortName>Inventory - Summary of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - Inventory - Summary of Inventory Provision Movement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/InventorySummaryofInventoryProvisionMovementDetails</Role>
      <ShortName>Inventory - Summary of Inventory Provision Movement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - Prepaids and other current assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails</Role>
      <ShortName>Prepaids and other current assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - Property and equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails</Role>
      <ShortName>Property and equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - Property and equipment - Summary of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails</Role>
      <ShortName>Property and equipment - Summary of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9955563 - Disclosure - Intangible Assets - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails</Role>
      <ShortName>Intangible Assets - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9955564 - Disclosure - Intangible Assets - Intangible Assets Net, Movement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails</Role>
      <ShortName>Intangible Assets - Intangible Assets Net, Movement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9955565 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9955566 - Disclosure - Leases - Summary of Right of Use Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails</Role>
      <ShortName>Leases - Summary of Right of Use Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9955567 - Disclosure - Leases - Summary of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Summary of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>9955568 - Disclosure - Other non-current assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails</Role>
      <ShortName>Other non-current assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/OthernoncurrentassetsTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>9955569 - Disclosure - Accounts payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/AccountspayableDetails</Role>
      <ShortName>Accounts payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/AccountspayableTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>9955570 - Disclosure - Accrued expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/AccruedexpensesDetails</Role>
      <ShortName>Accrued expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/AccruedexpensesTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>9955571 - Disclosure - Post-employment benefits - Summary of Additional Details on Defined Pension Plans Funded Status (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails</Role>
      <ShortName>Post-employment benefits - Summary of Additional Details on Defined Pension Plans Funded Status (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>9955572 - Disclosure - Post-employment benefits - Summary of Movement in Defined Benefit Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails</Role>
      <ShortName>Post-employment benefits - Summary of Movement in Defined Benefit Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>9955573 - Disclosure - Post-employment benefits - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails</Role>
      <ShortName>Post-employment benefits - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>9955574 - Disclosure - Post-employment benefits - Summary of Movement in Defined Benefit Plans Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails</Role>
      <ShortName>Post-employment benefits - Summary of Movement in Defined Benefit Plans Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>9955575 - Disclosure - Post-employment benefits - Summary of Defined Benefit Plans Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails</Role>
      <ShortName>Post-employment benefits - Summary of Defined Benefit Plans Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>9955576 - Disclosure - Post-employment benefits - Summary of Pension Costs Recognized in Statement of Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails</Role>
      <ShortName>Post-employment benefits - Summary of Pension Costs Recognized in Statement of Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>9955577 - Disclosure - Post-employment benefits - Summary of Pension Remeasurement Recognized in Statement Other Comprehensive Loss (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails</Role>
      <ShortName>Post-employment benefits - Summary of Pension Remeasurement Recognized in Statement Other Comprehensive Loss (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>9955578 - Disclosure - Post-employment benefits - Summary of Sensitivity Analysis for Funded Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails</Role>
      <ShortName>Post-employment benefits - Summary of Sensitivity Analysis for Funded Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>9955579 - Disclosure - Post-employment benefits - Summary of Sensitivity Analysis for Unfunded Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails</Role>
      <ShortName>Post-employment benefits - Summary of Sensitivity Analysis for Unfunded Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>9955580 - Disclosure - Share-based compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails</Role>
      <ShortName>Share-based compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>9955581 - Disclosure - Share-based compensation - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails</Role>
      <ShortName>Share-based compensation - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>108</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>9955582 - Disclosure - Share-based compensation - Summary of Valuation Inputs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails</Role>
      <ShortName>Share-based compensation - Summary of Valuation Inputs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>9955583 - Disclosure - Share-based compensation - Weighted Average Fair Value of Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails</Role>
      <ShortName>Share-based compensation - Weighted Average Fair Value of Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>9955584 - Disclosure - Share-based compensation - Summary of Restricted Stock Units Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Share-based compensation - Summary of Restricted Stock Units Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>111</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>9955585 - Disclosure - Share-based compensation - Movements in Share-based Compensation Reserve (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/SharebasedcompensationMovementsinSharebasedCompensationReserveDetails</Role>
      <ShortName>Share-based compensation - Movements in Share-based Compensation Reserve (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>112</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>9955586 - Disclosure - Share-based compensation - Share-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails</Role>
      <ShortName>Share-based compensation - Share-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>113</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>9955587 - Disclosure - Borrowings - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails</Role>
      <ShortName>Borrowings - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>114</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>9955588 - Disclosure - Borrowings - Schedule of Key Inputs for Valuation of Warrant Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails</Role>
      <ShortName>Borrowings - Schedule of Key Inputs for Valuation of Warrant Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>115</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R116.htm</HtmlFileName>
      <LongName>9955589 - Disclosure - Borrowings - Schedule of Allocation of the Loan Proceeds and Movements in Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails</Role>
      <ShortName>Borrowings - Schedule of Allocation of the Loan Proceeds and Movements in Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>116</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R117.htm</HtmlFileName>
      <LongName>9955590 - Disclosure - Borrowings - Schedule of Warrant Obligation Liability (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails</Role>
      <ShortName>Borrowings - Schedule of Warrant Obligation Liability (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>117</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R118.htm</HtmlFileName>
      <LongName>9955591 - Disclosure - Related parties - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/RelatedpartiesAdditionalInformationDetails</Role>
      <ShortName>Related parties - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>118</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R119.htm</HtmlFileName>
      <LongName>9955592 - Disclosure - Related parties - Summary of Compensation for Key Management and Non-executive Directors (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails</Role>
      <ShortName>Related parties - Summary of Compensation for Key Management and Non-executive Directors (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>119</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R120.htm</HtmlFileName>
      <LongName>9955593 - Disclosure - Commitments and contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails</Role>
      <ShortName>Commitments and contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Commitmentsandcontingencies</ParentRole>
      <Position>120</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R121.htm</HtmlFileName>
      <LongName>9955594 - Disclosure - Financial instruments and risks - Summary of Financial Instruments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail</Role>
      <ShortName>Financial instruments and risks - Summary of Financial Instruments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>121</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R122.htm</HtmlFileName>
      <LongName>9955595 - Disclosure - Financial instruments and risks - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail</Role>
      <ShortName>Financial instruments and risks - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>122</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R123.htm</HtmlFileName>
      <LongName>9955596 - Disclosure - Financial instruments and risks - Summary of Fair Value Measurement of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails</Role>
      <ShortName>Financial instruments and risks - Summary of Fair Value Measurement of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>123</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R124.htm</HtmlFileName>
      <LongName>9955597 - Disclosure - Financial instruments and risks - Summary of Maturity Profile of Financial Liabilities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail</Role>
      <ShortName>Financial instruments and risks - Summary of Maturity Profile of Financial Liabilities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>124</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R125.htm</HtmlFileName>
      <LongName>9955598 - Disclosure - Financial instruments and risks - Summary of Significant Exchange Rates (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofSignificantExchangeRatesDetail</Role>
      <ShortName>Financial instruments and risks - Summary of Significant Exchange Rates (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>125</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R126.htm</HtmlFileName>
      <LongName>9955599 - Disclosure - Financial instruments and risks - Summary of Loss Before Tax To Changes in Foreign Exchange Rates (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail</Role>
      <ShortName>Financial instruments and risks - Summary of Loss Before Tax To Changes in Foreign Exchange Rates (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>126</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R127.htm</HtmlFileName>
      <LongName>9955600 - Disclosure - Financial instruments and risks - Summary of Equity To Changes in Foreign Exchange Rates (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail</Role>
      <ShortName>Financial instruments and risks - Summary of Equity To Changes in Foreign Exchange Rates (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>127</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R128.htm</HtmlFileName>
      <LongName>9955601 - Disclosure - Capital management (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/CapitalmanagementDetails</Role>
      <ShortName>Capital management (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Capitalmanagement</ParentRole>
      <Position>128</Position>
    </Report>
    <Report instance="soph-20251231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R129.htm</HtmlFileName>
      <LongName>9955602 - Disclosure - Events after the reporting date (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails</Role>
      <ShortName>Events after the reporting date (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sophiagenetics.com/role/Eventsafterthereportingdate</ParentRole>
      <Position>129</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" isDefinitelyFs="true" isIfrs="true" isUsgaap="true" original="soph-20251231.htm">soph-20251231.htm</File>
    <File>soph-20251231.xsd</File>
    <File>soph-20251231_cal.xml</File>
    <File>soph-20251231_def.xml</File>
    <File>soph-20251231_lab.xml</File>
    <File>soph-20251231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>soph-20251231_g1.jpg</File>
    <File>soph-20251231_g10.jpg</File>
    <File>soph-20251231_g11.jpg</File>
    <File>soph-20251231_g12.jpg</File>
    <File>soph-20251231_g13.jpg</File>
    <File>soph-20251231_g14.jpg</File>
    <File>soph-20251231_g15.jpg</File>
    <File>soph-20251231_g2.jpg</File>
    <File>soph-20251231_g3.jpg</File>
    <File>soph-20251231_g4.jpg</File>
    <File>soph-20251231_g5.jpg</File>
    <File>soph-20251231_g6.jpg</File>
    <File>soph-20251231_g7.jpg</File>
    <File>soph-20251231_g8.jpg</File>
    <File>soph-20251231_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="45">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="1">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
    <BaseTaxonomy items="1577">https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>179
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "soph-20251231.htm": {
   "nsprefix": "soph",
   "nsuri": "http://www.sophiagenetics.com/20251231",
   "dts": {
    "inline": {
     "local": [
      "soph-20251231.htm"
     ]
    },
    "schema": {
     "local": [
      "soph-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/rol_ifrs_ea-dim_2025-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2025-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-af-sub-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "soph-20251231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "soph-20251231_def.xml"
     ],
     "remote": [
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/dim_ifrs_ea_2025-03-27_role-995000.xml",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/dim_full_ifrs_2025-03-27_role-995000.xml"
     ]
    },
    "labelLink": {
     "local": [
      "soph-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "soph-20251231_pre.xml"
     ]
    }
   },
   "keyStandard": 348,
   "keyCustom": 174,
   "axisStandard": 35,
   "axisCustom": 4,
   "memberStandard": 58,
   "memberCustom": 82,
   "hidden": {
    "total": 9,
    "http://xbrl.sec.gov/dei/2025": 4,
    "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 1,
    "http://www.sophiagenetics.com/20251231": 4
   },
   "contextCount": 571,
   "entityCount": 1,
   "segmentCount": 146,
   "elementCount": 992,
   "unitCount": 19,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 1577,
    "http://xbrl.sec.gov/dei/2025": 45,
    "http://xbrl.sec.gov/cyd/2025": 15,
    "http://xbrl.sec.gov/ecd/2025": 1
   },
   "report": {
    "R1": {
     "role": "http://www.sophiagenetics.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.sophiagenetics.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss",
     "longName": "9952151 - Statement - Consolidated Statements of Loss",
     "shortName": "Consolidated Statements of Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:CostOfSales",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "longName": "9952152 - Statement - Consolidated Statements of Comprehensive Loss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets",
     "longName": "9952153 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:TradeAndOtherCurrentReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity",
     "longName": "9952154 - Statement - Consolidated Statements of Changes in Equity",
     "shortName": "Consolidated Statements of Changes in Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "ifrs-full:NumberOfSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "ifrs-full:Equity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "9952155 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ProfitLossBeforeTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:AdjustmentsForDepreciationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.sophiagenetics.com/role/Companyinformationandoperations",
     "longName": "9952156 - Disclosure - Company information and operations",
     "shortName": "Company information and operations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfCompanyInformationAndOperationsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfCompanyInformationAndOperationsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.sophiagenetics.com/role/Materialaccountingpolicies",
     "longName": "9952157 - Disclosure - Material accounting policies",
     "shortName": "Material accounting policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.sophiagenetics.com/role/Segmentreporting",
     "longName": "9952158 - Disclosure - Segment reporting",
     "shortName": "Segment reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.sophiagenetics.com/role/Revenue",
     "longName": "9952159 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.sophiagenetics.com/role/Costofrevenue",
     "longName": "9952160 - Disclosure - Cost of revenue",
     "shortName": "Cost of revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfCostOfSalesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfCostOfSalesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.sophiagenetics.com/role/Operatingexpense",
     "longName": "9952161 - Disclosure - Operating expense",
     "shortName": "Operating expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfOperatingExpenseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfOperatingExpenseTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.sophiagenetics.com/role/Otheroperatingincomenet",
     "longName": "9952162 - Disclosure - Other operating income, net",
     "shortName": "Other operating income, net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnet",
     "longName": "9952163 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net",
     "shortName": "Interest income, Interest expense and Foreign exchange (losses) gains, net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinanceCostExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinanceCostExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.sophiagenetics.com/role/Incometax",
     "longName": "9952164 - Disclosure - Income tax",
     "shortName": "Income tax",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.sophiagenetics.com/role/Losspershare",
     "longName": "9952165 - Disclosure - Loss per share",
     "shortName": "Loss per share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.sophiagenetics.com/role/Cashandcashequivalents",
     "longName": "9952166 - Disclosure - Cash and cash equivalents",
     "shortName": "Cash and cash equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.sophiagenetics.com/role/Accountsreceivable",
     "longName": "9952167 - Disclosure - Accounts receivable",
     "shortName": "Accounts receivable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.sophiagenetics.com/role/Inventory",
     "longName": "9952168 - Disclosure - Inventory",
     "shortName": "Inventory",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfInventoriesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.sophiagenetics.com/role/Prepaidsandothercurrentassets",
     "longName": "9952169 - Disclosure - Prepaids and other current assets",
     "shortName": "Prepaids and other current assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.sophiagenetics.com/role/Propertyandequipment",
     "longName": "9952170 - Disclosure - Property and equipment",
     "shortName": "Property and equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.sophiagenetics.com/role/IntangibleAssets",
     "longName": "9952171 - Disclosure - Intangible Assets",
     "shortName": "Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.sophiagenetics.com/role/Leases",
     "longName": "9952172 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfLeasesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.sophiagenetics.com/role/Othernoncurrentassets",
     "longName": "9952173 - Disclosure - Other non-current assets",
     "shortName": "Other non-current assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.sophiagenetics.com/role/Accountspayable",
     "longName": "9952174 - Disclosure - Accounts payable",
     "shortName": "Accounts payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.sophiagenetics.com/role/Accruedexpenses",
     "longName": "9952175 - Disclosure - Accrued expenses",
     "shortName": "Accrued expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.sophiagenetics.com/role/Postemploymentbenefits",
     "longName": "9952176 - Disclosure - Post-employment benefits",
     "shortName": "Post-employment benefits",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.sophiagenetics.com/role/Sharebasedcompensation",
     "longName": "9952177 - Disclosure - Share-based compensation",
     "shortName": "Share-based compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.sophiagenetics.com/role/Borrowings",
     "longName": "9952178 - Disclosure - Borrowings",
     "shortName": "Borrowings",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfBorrowingsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.sophiagenetics.com/role/Relatedparties",
     "longName": "9952179 - Disclosure - Related parties",
     "shortName": "Related parties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.sophiagenetics.com/role/Commitmentsandcontingencies",
     "longName": "9952180 - Disclosure - Commitments and contingencies",
     "shortName": "Commitments and contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.sophiagenetics.com/role/Financialinstrumentsandrisks",
     "longName": "9952181 - Disclosure - Financial instruments and risks",
     "shortName": "Financial instruments and risks",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.sophiagenetics.com/role/Capitalmanagement",
     "longName": "9952182 - Disclosure - Capital management",
     "shortName": "Capital management",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfCapitalManagementExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfCapitalManagementExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.sophiagenetics.com/role/Eventsafterthereportingdate",
     "longName": "9952183 - Disclosure - Events after the reporting date",
     "shortName": "Events after the reporting date",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies",
     "longName": "9955511 - Disclosure - Material accounting policies (Policies)",
     "shortName": "Material accounting policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.sophiagenetics.com/role/CompanyinformationandoperationsTables",
     "longName": "9955512 - Disclosure - Company information and operations (Tables)",
     "shortName": "Company information and operations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutSubsidiariesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutSubsidiariesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.sophiagenetics.com/role/SegmentreportingTables",
     "longName": "9955513 - Disclosure - Segment reporting (Tables)",
     "shortName": "Segment reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.sophiagenetics.com/role/RevenueTables",
     "longName": "9955514 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.sophiagenetics.com/role/OperatingexpenseTables",
     "longName": "9955515 - Disclosure - Operating expense (Tables)",
     "shortName": "Operating expense (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables",
     "longName": "9955516 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net (Tables)",
     "shortName": "Interest income, Interest expense and Foreign exchange (losses) gains, net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.sophiagenetics.com/role/IncometaxTables",
     "longName": "9955517 - Disclosure - Income tax (Tables)",
     "shortName": "Income tax (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.sophiagenetics.com/role/LosspershareTables",
     "longName": "9955518 - Disclosure - Loss per share (Tables)",
     "shortName": "Loss per share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:EarningsPerShareExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.sophiagenetics.com/role/CashandcashequivalentsTables",
     "longName": "9955519 - Disclosure - Cash and cash equivalents (Tables)",
     "shortName": "Cash and cash equivalents (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.sophiagenetics.com/role/AccountsreceivableTables",
     "longName": "9955520 - Disclosure - Accounts receivable (Tables)",
     "shortName": "Accounts receivable (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.sophiagenetics.com/role/InventoryTables",
     "longName": "9955521 - Disclosure - Inventory (Tables)",
     "shortName": "Inventory (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsTables",
     "longName": "9955522 - Disclosure - Prepaids and other current assets (Tables)",
     "shortName": "Prepaids and other current assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.sophiagenetics.com/role/PropertyandequipmentTables",
     "longName": "9955523 - Disclosure - Property and equipment (Tables)",
     "shortName": "Property and equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.sophiagenetics.com/role/IntangiblesassetsTables",
     "longName": "9955524 - Disclosure - Intangibles assets (Tables)",
     "shortName": "Intangibles assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.sophiagenetics.com/role/LeasesTables",
     "longName": "9955525 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.sophiagenetics.com/role/OthernoncurrentassetsTables",
     "longName": "9955526 - Disclosure - Other non-current assets (Tables)",
     "shortName": "Other non-current assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.sophiagenetics.com/role/AccountspayableTables",
     "longName": "9955527 - Disclosure - Accounts payable (Tables)",
     "shortName": "Accounts payable (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.sophiagenetics.com/role/AccruedexpensesTables",
     "longName": "9955528 - Disclosure - Accrued expenses (Tables)",
     "shortName": "Accrued expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.sophiagenetics.com/role/PostemploymentbenefitsTables",
     "longName": "9955529 - Disclosure - Post-employment benefits (Tables)",
     "shortName": "Post-employment benefits (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.sophiagenetics.com/role/SharebasedcompensationTables",
     "longName": "9955530 - Disclosure - Share-based compensation (Tables)",
     "shortName": "Share-based compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.sophiagenetics.com/role/BorrowingsTables",
     "longName": "9955531 - Disclosure - Borrowings (Tables)",
     "shortName": "Borrowings (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.sophiagenetics.com/role/RelatedpartiesTables",
     "longName": "9955532 - Disclosure - Related parties (Tables)",
     "shortName": "Related parties (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables",
     "longName": "9955533 - Disclosure - Financial instruments and risks (Tables)",
     "shortName": "Financial instruments and risks (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails",
     "longName": "9955534 - Disclosure - Company information and operations - Summary of Wholly-Owned Subsidiaries (Details)",
     "shortName": "Company information and operations - Summary of Wholly-Owned Subsidiaries (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-44",
      "name": "ifrs-full:NameOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutSubsidiariesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-44",
      "name": "ifrs-full:NameOfSubsidiary",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutSubsidiariesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
     "longName": "9955535 - Disclosure - Company information and operations - Additional Information (Details)",
     "shortName": "Company information and operations - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-60",
      "name": "ifrs-full:IssueOfEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-60",
      "name": "ifrs-full:IssueOfEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails",
     "longName": "9955536 - Disclosure - Material accounting policies (Details)",
     "shortName": "Material accounting policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-61",
      "name": "ifrs-full:CashFlowsFromUsedInOperatingActivities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.sophiagenetics.com/role/SegmentreportingDetails",
     "longName": "9955537 - Disclosure - Segment reporting (Details)",
     "shortName": "Segment reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails",
     "longName": "9955538 - Disclosure - Revenue - Additional Information (Details)",
     "shortName": "Revenue - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:RevenueFromContractsWithCustomersExtendedPaymentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:RevenueFromContractsWithCustomersExtendedPaymentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails",
     "longName": "9955539 - Disclosure - Revenue - Schedule of Revenue from Contracts with Customers Allocated to Geographical Areas and Revenue Streams (Details)",
     "shortName": "Revenue - Schedule of Revenue from Contracts with Customers Allocated to Geographical Areas and Revenue Streams (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-104",
      "name": "ifrs-full:RevenueFromContractsWithCustomers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails",
     "longName": "9955540 - Disclosure - Operating expense - Additional Information (Details)",
     "shortName": "Operating expense - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:ResearchTaxCredit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:ResearchTaxCredit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails",
     "longName": "9955541 - Disclosure - Operating expense - Summary of Depreciation and Amortization have Charged in Expense (Details)",
     "shortName": "Operating expense - Summary of Depreciation and Amortization have Charged in Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DepreciationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:DepreciationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails",
     "longName": "9955542 - Disclosure - Operating expense - Summary of Employee Benefit Expenses, Social Charges and Share-based Compensation (Details)",
     "shortName": "Operating expense - Summary of Employee Benefit Expenses, Social Charges and Share-based Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-115",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestIncomeDetails",
     "longName": "9955543 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Income (Details)",
     "shortName": "Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:RevenueFromInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R71": {
     "role": "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails",
     "longName": "9955544 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Expense (Details)",
     "shortName": "Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Interest Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:InterestExpenseOnBankLoansAndOverdrafts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:InterestExpenseOnBankLoansAndOverdrafts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofForeignExchangeLossesGainsNetDetails",
     "longName": "9955545 - Disclosure - Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Foreign Exchange (Losses) Gains, Net (Details)",
     "shortName": "Interest income, Interest expense and Foreign exchange (losses) gains, net - Summary of Foreign Exchange (Losses) Gains, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R73": {
     "role": "http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails",
     "longName": "9955546 - Disclosure - Income tax - Additional Information (Details)",
     "shortName": "Income tax - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "soph:TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "soph:TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails",
     "longName": "9955547 - Disclosure - Income tax - Summary of Current and Deferred Income Tax (Expenses) Benefits (Details)",
     "shortName": "Income tax - Summary of Current and Deferred Income Tax (Expenses) Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails",
     "longName": "9955548 - Disclosure - Income tax - Reconciliation of Expected Tax Expense to Tax Expense Report in Statement of Loss (Details)",
     "shortName": "Income tax - Reconciliation of Expected Tax Expense to Tax Expense Report in Statement of Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:AccountingProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:AccountingProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails",
     "longName": "9955549 - Disclosure - Income tax - Summary of Movement in Deferred Tax Balances (Details)",
     "shortName": "Income tax - Summary of Movement in Deferred Tax Balances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "ifrs-full:DeferredTaxLiabilityAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-23",
      "name": "ifrs-full:DeferredTaxLiabilityAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails",
     "longName": "9955550 - Disclosure - Income tax - Summary of Unrecognized Deferred Tax Assets (Details)",
     "shortName": "Income tax - Summary of Unrecognized Deferred Tax Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:UnrecognizedDeferredTaxAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:UnrecognizedDeferredTaxAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails",
     "longName": "9955551 - Disclosure - Income tax - Summary of Net Operating Loss Carryforwards (Details)",
     "shortName": "Income tax - Summary of Net Operating Loss Carryforwards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "soph:NetOperatingLossCarryforwardsYearOne",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "soph:NetOperatingLossCarryforwardsYearOne",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails",
     "longName": "9955552 - Disclosure - Loss per share - Additional information (Details)",
     "shortName": "Loss per share - Additional information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-58",
      "name": "ifrs-full:ParValuePerShare",
      "unitRef": "chfPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R80": {
     "role": "http://www.sophiagenetics.com/role/LosspershareComponentsofLossforYearDetails",
     "longName": "9955553 - Disclosure - Loss per share - Components of Loss for Year (Details)",
     "shortName": "Loss per share - Components of Loss for Year (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ProfitLossAttributableToOwnersOfParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:WeightedAverageShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails",
     "longName": "9955554 - Disclosure - Cash and cash equivalents (Details)",
     "shortName": "Cash and cash equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:BalancesWithBanks",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "soph:DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:BalancesWithBanks",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "soph:DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail",
     "longName": "9955555 - Disclosure - Accounts receivable - Additional Information (Detail)",
     "shortName": "Accounts receivable - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:AccountsReceivableNonInterestBearingExtendedPaymentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:AccountsReceivableNonInterestBearingExtendedPaymentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails",
     "longName": "9955556 - Disclosure - Accounts receivable - Summary of Accounts Receivable and Lease Receivable Less Expected Credit Loss (Details)",
     "shortName": "Accounts receivable - Summary of Accounts Receivable and Lease Receivable Less Expected Credit Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:FinancialAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-160",
      "name": "ifrs-full:FinancialAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails",
     "longName": "9955557 - Disclosure - Accounts receivable - Summary of Movement in Allowance for Expected Credit Losses in Accounts Receivable (Details)",
     "shortName": "Accounts receivable - Summary of Movement in Allowance for Expected Credit Losses in Accounts Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "ifrs-full:FinancialAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-169",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails",
     "longName": "9955558 - Disclosure - Inventory - Summary of Inventory (Details)",
     "shortName": "Inventory - Summary of Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:RawMaterials",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:RawMaterials",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.sophiagenetics.com/role/InventorySummaryofInventoryProvisionMovementDetails",
     "longName": "9955559 - Disclosure - Inventory - Summary of Inventory Provision Movement (Details)",
     "shortName": "Inventory - Summary of Inventory Provision Movement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "soph:ProvisionOfInventory",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:InventoryIncreaseInProvision",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails",
     "longName": "9955560 - Disclosure - Prepaids and other current assets (Details)",
     "shortName": "Prepaids and other current assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:CurrentPrepayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:CurrentPrepayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
     "longName": "9955561 - Disclosure - Property and equipment - Additional Information (Details)",
     "shortName": "Property and equipment - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "soph:CurrentAccruedExpensesOnPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "soph:CurrentAccruedExpensesOnPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails",
     "longName": "9955562 - Disclosure - Property and equipment - Summary of Property and Equipment, Net (Details)",
     "shortName": "Property and equipment - Summary of Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-205",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails",
     "longName": "9955563 - Disclosure - Intangible Assets - Additional Information (Details)",
     "shortName": "Intangible Assets - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails",
     "longName": "9955564 - Disclosure - Intangible Assets - Intangible Assets Net, Movement (Details)",
     "shortName": "Intangible Assets - Intangible Assets Net, Movement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "ifrs-full:IntangibleAssetsAndGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:IntangibleAssetsAndGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
     "longName": "9955565 - Disclosure - Leases - Additional Information (Details)",
     "shortName": "Leases - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:LeaseExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails",
     "longName": "9955566 - Disclosure - Leases - Summary of Right of Use Assets (Details)",
     "shortName": "Leases - Summary of Right of Use Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R94": {
     "role": "http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails",
     "longName": "9955567 - Disclosure - Leases - Summary of Lease Liabilities (Details)",
     "shortName": "Leases - Summary of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:CurrentLeaseLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R95": {
     "role": "http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails",
     "longName": "9955568 - Disclosure - Other non-current assets (Details)",
     "shortName": "Other non-current assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:NoncurrentValueAddedTaxReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "soph:DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:NoncurrentValueAddedTaxReceivables",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "soph:DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.sophiagenetics.com/role/AccountspayableDetails",
     "longName": "9955569 - Disclosure - Accounts payable (Details)",
     "shortName": "Accounts payable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "soph:DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "soph:DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.sophiagenetics.com/role/AccruedexpensesDetails",
     "longName": "9955570 - Disclosure - Accrued expenses (Details)",
     "shortName": "Accrued expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "soph:AccruedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "soph:DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "soph:AccruedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "soph:DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails",
     "longName": "9955571 - Disclosure - Post-employment benefits - Summary of Additional Details on Defined Pension Plans Funded Status (Details)",
     "shortName": "Post-employment benefits - Summary of Additional Details on Defined Pension Plans Funded Status (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:DefinedBenefitObligationAtPresentValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:SurplusDeficitInPlan",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails",
     "longName": "9955572 - Disclosure - Post-employment benefits - Summary of Movement in Defined Benefit Obligation (Details)",
     "shortName": "Post-employment benefits - Summary of Movement in Defined Benefit Obligation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "ifrs-full:DefinedBenefitObligationAtPresentValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:CurrentServiceCostDefinedBenefitPlans",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
     "longName": "9955573 - Disclosure - Post-employment benefits - Additional Information (Details)",
     "shortName": "Post-employment benefits - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-23",
      "name": "soph:DemographicAssumptionOfWeightedTurnoverRates",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails",
     "longName": "9955574 - Disclosure - Post-employment benefits - Summary of Movement in Defined Benefit Plans Assets (Details)",
     "shortName": "Post-employment benefits - Summary of Movement in Defined Benefit Plans Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R102": {
     "role": "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails",
     "longName": "9955575 - Disclosure - Post-employment benefits - Summary of Defined Benefit Plans Assets (Details)",
     "shortName": "Post-employment benefits - Summary of Defined Benefit Plans Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails",
     "longName": "9955576 - Disclosure - Post-employment benefits - Summary of Pension Costs Recognized in Statement of Loss (Details)",
     "shortName": "Post-employment benefits - Summary of Pension Costs Recognized in Statement of Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:ServiceCostDefinedBenefitPlans",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:InterestExpenseIncomeDefinedBenefitPlans",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails",
     "longName": "9955577 - Disclosure - Post-employment benefits - Summary of Pension Remeasurement Recognized in Statement Other Comprehensive Loss (Details)",
     "shortName": "Post-employment benefits - Summary of Pension Remeasurement Recognized in Statement Other Comprehensive Loss (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R105": {
     "role": "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
     "longName": "9955578 - Disclosure - Post-employment benefits - Summary of Sensitivity Analysis for Funded Plans (Details)",
     "shortName": "Post-employment benefits - Summary of Sensitivity Analysis for Funded Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "c-317",
      "name": "ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-317",
      "name": "ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails",
     "longName": "9955579 - Disclosure - Post-employment benefits - Summary of Sensitivity Analysis for Unfunded Plans (Details)",
     "shortName": "Post-employment benefits - Summary of Sensitivity Analysis for Unfunded Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "c-327",
      "name": "ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-327",
      "name": "ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
     "longName": "9955580 - Disclosure - Share-based compensation - Additional Information (Details)",
     "shortName": "Share-based compensation - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:NumberOfShareOptionPlans",
      "unitRef": "plan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:NumberOfShareOptionPlans",
      "unitRef": "plan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R108": {
     "role": "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails",
     "longName": "9955581 - Disclosure - Share-based compensation - Summary of Stock Option Activity (Details)",
     "shortName": "Share-based compensation - Summary of Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "108",
     "firstAnchor": {
      "contextRef": "c-342",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-333",
      "name": "ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R109": {
     "role": "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails",
     "longName": "9955582 - Disclosure - Share-based compensation - Summary of Valuation Inputs (Details)",
     "shortName": "Share-based compensation - Summary of Valuation Inputs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "109",
     "firstAnchor": {
      "contextRef": "c-362",
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-362",
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R110": {
     "role": "http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails",
     "longName": "9955583 - Disclosure - Share-based compensation - Weighted Average Fair Value of Options Granted (Details)",
     "shortName": "Share-based compensation - Weighted Average Fair Value of Options Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "110",
     "firstAnchor": {
      "contextRef": "c-362",
      "name": "soph:WeightedAverageFairValueShareOptionsGranted",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-362",
      "name": "soph:WeightedAverageFairValueShareOptionsGranted",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R111": {
     "role": "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails",
     "longName": "9955584 - Disclosure - Share-based compensation - Summary of Restricted Stock Units Activity (Details)",
     "shortName": "Share-based compensation - Summary of Restricted Stock Units Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "111",
     "firstAnchor": {
      "contextRef": "c-380",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-392",
      "name": "ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R112": {
     "role": "http://www.sophiagenetics.com/role/SharebasedcompensationMovementsinSharebasedCompensationReserveDetails",
     "longName": "9955585 - Disclosure - Share-based compensation - Movements in Share-based Compensation Reserve (Details)",
     "shortName": "Share-based compensation - Movements in Share-based Compensation Reserve (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "112",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "ifrs-full:ReserveOfSharebasedPayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "ifrs-full:ReserveOfSharebasedPayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R113": {
     "role": "http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails",
     "longName": "9955586 - Disclosure - Share-based compensation - Share-based Compensation Expense (Details)",
     "shortName": "Share-based compensation - Share-based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "113",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R114": {
     "role": "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
     "longName": "9955587 - Disclosure - Borrowings - Additional Information (Details)",
     "shortName": "Borrowings - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "114",
     "firstAnchor": {
      "contextRef": "c-427",
      "name": "ifrs-full:FinancialLiabilitiesAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-427",
      "name": "ifrs-full:FinancialLiabilitiesAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R115": {
     "role": "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails",
     "longName": "9955588 - Disclosure - Borrowings - Schedule of Key Inputs for Valuation of Warrant Obligation (Details)",
     "shortName": "Borrowings - Schedule of Key Inputs for Valuation of Warrant Obligation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "115",
     "firstAnchor": {
      "contextRef": "c-429",
      "name": "ifrs-full:SignificantUnobservableInputLiabilities",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-429",
      "name": "ifrs-full:SignificantUnobservableInputLiabilities",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R116": {
     "role": "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
     "longName": "9955589 - Disclosure - Borrowings - Schedule of Allocation of the Loan Proceeds and Movements in Liability (Details)",
     "shortName": "Borrowings - Schedule of Allocation of the Loan Proceeds and Movements in Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "116",
     "firstAnchor": {
      "contextRef": "c-426",
      "name": "ifrs-full:Borrowings",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-409",
      "name": "soph:ProceedsFromBorrowingsNetOfCostsIncurred",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R117": {
     "role": "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails",
     "longName": "9955590 - Disclosure - Borrowings - Schedule of Warrant Obligation Liability (Details)",
     "shortName": "Borrowings - Schedule of Warrant Obligation Liability (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "117",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "ifrs-full:CurrentWarrantLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-472",
      "name": "soph:ProceedsFromWarrantLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R118": {
     "role": "http://www.sophiagenetics.com/role/RelatedpartiesAdditionalInformationDetails",
     "longName": "9955591 - Disclosure - Related parties - Additional Information (Details)",
     "shortName": "Related parties - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "118",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:NumberOfExecutiveOfficers",
      "unitRef": "personnel",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "soph:NumberOfExecutiveOfficers",
      "unitRef": "personnel",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R119": {
     "role": "http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails",
     "longName": "9955592 - Disclosure - Related parties - Summary of Compensation for Key Management and Non-executive Directors (Details)",
     "shortName": "Related parties - Summary of Compensation for Key Management and Non-executive Directors (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "119",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R120": {
     "role": "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails",
     "longName": "9955593 - Disclosure - Commitments and contingencies (Details)",
     "shortName": "Commitments and contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "120",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "soph:FutureLeasePaymentsUnderShortTermLeasesNotRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "soph:FutureLeasePaymentsUnderShortTermLeasesNotRecognized",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "soph:FutureLeasePaymentsUnderShortTermLeasesNotRecognized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "soph:FutureLeasePaymentsUnderShortTermLeasesNotRecognized",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R121": {
     "role": "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail",
     "longName": "9955594 - Disclosure - Financial instruments and risks - Summary of Financial Instruments (Detail)",
     "shortName": "Financial instruments and risks - Summary of Financial Instruments (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "121",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:FinancialAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:FinancialLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R122": {
     "role": "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
     "longName": "9955595 - Disclosure - Financial instruments and risks - Additional Information (Detail)",
     "shortName": "Financial instruments and risks - Additional Information (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "122",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-535",
      "name": "soph:BankBorrowingsInterestPaidUndiscountedCashFlows",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R123": {
     "role": "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails",
     "longName": "9955596 - Disclosure - Financial instruments and risks - Summary of Fair Value Measurement of Assets and Liabilities (Details)",
     "shortName": "Financial instruments and risks - Summary of Fair Value Measurement of Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "123",
     "firstAnchor": {
      "contextRef": "c-514",
      "name": "ifrs-full:FinancialAssetsAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
       "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-514",
      "name": "ifrs-full:FinancialAssetsAtFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory",
       "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R124": {
     "role": "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail",
     "longName": "9955597 - Disclosure - Financial instruments and risks - Summary of Maturity Profile of Financial Liabilities (Detail)",
     "shortName": "Financial instruments and risks - Summary of Maturity Profile of Financial Liabilities (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "124",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:GrossLeaseLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:GrossLeaseLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ifrs-full:DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R125": {
     "role": "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofSignificantExchangeRatesDetail",
     "longName": "9955598 - Disclosure - Financial instruments and risks - Summary of Significant Exchange Rates (Detail)",
     "shortName": "Financial instruments and risks - Summary of Significant Exchange Rates (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "125",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "soph:ForeignExchangeSpotRate",
      "unitRef": "usdPerCHF",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "soph:ForeignExchangeSpotRate",
      "unitRef": "usdPerEUR",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R126": {
     "role": "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail",
     "longName": "9955599 - Disclosure - Financial instruments and risks - Summary of Loss Before Tax To Changes in Foreign Exchange Rates (Detail)",
     "shortName": "Financial instruments and risks - Summary of Loss Before Tax To Changes in Foreign Exchange Rates (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "126",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "soph:DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-538",
      "name": "soph:SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R127": {
     "role": "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
     "longName": "9955600 - Disclosure - Financial instruments and risks - Summary of Equity To Changes in Foreign Exchange Rates (Detail)",
     "shortName": "Financial instruments and risks - Summary of Equity To Changes in Foreign Exchange Rates (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "127",
     "firstAnchor": {
      "contextRef": "c-557",
      "name": "soph:SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-557",
      "name": "soph:SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true,
      "unique": true
     }
    },
    "R128": {
     "role": "http://www.sophiagenetics.com/role/CapitalmanagementDetails",
     "longName": "9955601 - Disclosure - Capital management (Details)",
     "shortName": "Capital management (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "128",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "ifrs-full:CashAndCashEquivalents",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-425",
      "name": "ifrs-full:UndrawnBorrowingFacilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "unique": true
     }
    },
    "R129": {
     "role": "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
     "longName": "9955602 - Disclosure - Events after the reporting date (Details)",
     "shortName": "Events after the reporting date (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "129",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "soph:NumberOfEquitySharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "soph-20251231.htm",
      "first": true
     },
     "uniqueAnchor": null
    }
   },
   "tag": {
    "soph_A2013IncentiveShareOptionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "A2013IncentiveShareOptionPlanMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2013 ISOP",
        "label": "2013 Incentive Share Option Plan [Member]",
        "documentation": "Two Thousand And Thirteen incentive share option plan."
       }
      }
     },
     "auth_ref": []
    },
    "soph_A2019IncentiveShareOptionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "A2019IncentiveShareOptionPlanMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2019 ISOP",
        "label": "2019 Incentive Share Option Plan [Member]",
        "documentation": "Two thousand and nineteen incentive share option plan."
       }
      }
     },
     "auth_ref": []
    },
    "soph_A2021EmployeeIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "A2021EmployeeIncentivePlanMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 EIP",
        "label": "2021 Employee Incentive Plan [Member]",
        "documentation": "Two thousand and twenty one employee incentive plan."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccountingProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccountingProfit",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss before tax",
        "label": "Accounting profit"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r240",
      "r241"
     ]
    },
    "soph_AccountsPayablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccountsPayablesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payables [Member]",
        "documentation": "Accounts payables."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccountsReceivableInAggregateAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccountsReceivableInAggregateAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable in aggregate amount",
        "label": "Accounts Receivable In Aggregate Amount",
        "documentation": "Accounts receivable in aggregate amount."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccountsReceivableNonInterestBearingExtendedPaymentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccountsReceivableNonInterestBearingExtendedPaymentTerm",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extended term of payment for non-interest bearing accounts receivable",
        "label": "Accounts Receivable, Non-Interest Bearing, Extended Payment Term",
        "documentation": "Accounts Receivable, Non-Interest Bearing, Extended Payment Term"
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccountsReceivableNonInterestBearingPaymentTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccountsReceivableNonInterestBearingPaymentTerms",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of payment for non-interest bearing accounts receivable",
        "label": "Accounts Receivable, Non-Interest Bearing, Payment Terms",
        "documentation": "Accounts receivable balance non-interest bearing and payment terms."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccruedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccruedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails": {
       "parentTag": "soph_CurrentAccruedExpenses",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Accrued Compensation",
        "documentation": "Accrued compensation."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccruedExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccruedExpensesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Expenses [Abstract]",
        "documentation": "Accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccruedExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccruedExpensesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Accrued Expenses [Member]",
        "documentation": "Accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccruedExpensesUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccruedExpensesUndiscountedCashFlows",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail": {
       "parentTag": "soph_ContractualLiabilitiesUndiscountedCashFlows",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Accrued Expenses, Undiscounted Cash Flows",
        "documentation": "Accrued expenses, undiscounted cash flows."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccruedITSupport": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccruedITSupport",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails": {
       "parentTag": "soph_CurrentAccruedExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued IT support",
        "label": "Accrued IT Support",
        "documentation": "Accrued IT support."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccruedInventoryPurchases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccruedInventoryPurchases",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails": {
       "parentTag": "soph_CurrentAccruedExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued inventory purchases",
        "label": "Accrued Inventory Purchases",
        "documentation": "Accrued inventory purchases."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccruedLegalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccruedLegalFees",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails": {
       "parentTag": "soph_CurrentAccruedExpenses",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued legal fees",
        "label": "Accrued Legal Fees",
        "documentation": "Accrued legal fees."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccruedOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccruedOther",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails": {
       "parentTag": "soph_CurrentAccruedExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued other",
        "label": "Accrued Other",
        "documentation": "Accrued other."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccruedPensionRelatedTemporaryDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccruedPensionRelatedTemporaryDifferencesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued pension",
        "label": "Accrued Pension Related Temporary Differences [Member]",
        "documentation": "Temporary difference accrued pension."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AccruedProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AccruedProfessionalFees",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails": {
       "parentTag": "soph_CurrentAccruedExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional fees",
        "label": "Accrued Professional Fees",
        "documentation": "Accrued professional fees."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated depreciation",
        "verboseLabel": "Accumulated amortization",
        "label": "Accumulated depreciation and amortisation [member]"
       }
      }
     },
     "auth_ref": [
      "r17",
      "r549",
      "r558",
      "r563",
      "r564"
     ]
    },
    "ifrs-full_AccumulatedImpairmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccumulatedImpairmentMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails",
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected Credit Losses",
        "label": "Accumulated impairment [member]"
       }
      }
     },
     "auth_ref": [
      "r162",
      "r169",
      "r303",
      "r395",
      "r549",
      "r558",
      "r563",
      "r564"
     ]
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Acquisitions through business combinations, intangible assets and goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Total for all business combinations [member]; Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRates": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfDiscountRates",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimating the defined benefit obligation, the discount rates",
        "label": "Actuarial assumption of discount rates"
       }
      },
      "en": {
       "role": {
        "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfDiscountRatesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discount rates",
        "verboseLabel": "Discount rates",
        "label": "Actuarial assumption of discount rates [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the discount rates used as actuarial assumptions. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "soph_ActuarialAssumptionOfExpectedInterestRatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ActuarialAssumptionOfExpectedInterestRatesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Actuarial Assumption Of Expected Interest Rates [Member]",
        "documentation": "Actuarial assumption of expected interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfExpectedRatesOfInflation",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Demographic assumptions increase in expected employee turnover rate",
        "label": "Actuarial assumption of expected rates of inflation"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected rate of inflation that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [domain]; Defined benefit obligation, at present value; Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfExpectedRatesOfInflationMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inflation",
        "label": "Actuarial assumption of expected rates of inflation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the expected rates of inflation used as actuarial assumptions. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreases",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Demographic assumptions increase in expected employee salaries",
        "label": "Actuarial assumption of expected rates of salary increases"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [domain]; Defined benefit obligation, at present value; Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r552"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected rates of salary increases",
        "verboseLabel": "Expected rates of salary increases",
        "label": "Actuarial assumption of expected rates of salary increases [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the expected rates of salary increases used as actuarial assumptions. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfLifeExpectancyAfterRetirementMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Life expectancy",
        "label": "Actuarial assumption of life expectancy after retirement [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the life expectancy after retirement used as actuarial assumptions. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r553"
     ]
    },
    "ifrs-full_ActuarialAssumptionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actuarial assumptions [axis]",
        "label": "Actuarial assumptions [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "ifrs-full_ActuarialAssumptionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Actuarial assumptions [domain]",
        "label": "Actuarial assumptions [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all actuarial assumptions. Actuarial assumptions are the entity\u2019s unbiased and mutually compatible best estimates of the demographic and financial variables that will determine the ultimate cost of providing post-employment benefits. It also represents the standard value for the 'Actuarial assumptions' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails": {
       "parentTag": "soph_ActuarialGainsLossesNetDefinedBenefitPlans",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Changes in demographic assumptions",
        "label": "Actuarial gains (losses) arising from changes in demographic assumptions, net of tax, defined benefit plans"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions]"
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails": {
       "parentTag": "soph_ActuarialGainsLossesNetDefinedBenefitPlans",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in financial assumptions",
        "label": "Actuarial gains (losses) arising from changes in financial assumptions, net of tax, defined benefit plans"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions]"
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails": {
       "parentTag": "soph_ActuarialGainsLossesNetDefinedBenefitPlans",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Experience adjustments",
        "label": "Actuarial gains (losses) arising from experience adjustments, net of tax, defined benefit plans"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments]"
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "soph_ActuarialGainsLossesNetDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ActuarialGainsLossesNetDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Actuarial gains (losses)",
        "totalLabel": "Total actuarial gains (losses)",
        "label": "Actuarial Gains (Losses) Net Defined Benefit Plans",
        "documentation": "Actuarial gains (losses), net defined benefit plans."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions",
        "label": "Additions other than through business combinations, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r247"
     ]
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionsToRightofuseAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions to ROUs",
        "label": "Additions to right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r128",
      "r211"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Address Type",
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustedWeightedAverageShares",
     "presentation": [
      "http://www.sophiagenetics.com/role/LosspershareComponentsofLossforYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average number of shares in issue, diluted (in shares)",
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "soph_AdjustmentsForCreditLossAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AdjustmentsForCreditLossAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected credit loss allowance increase (reversal)",
        "label": "Adjustments For Credit Loss Allowance",
        "documentation": "Adjustments for credit loss allowance."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForCurrentTaxOfPriorPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForCurrentTaxOfPriorPeriod",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails": {
       "parentTag": "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails",
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Uncertain tax positions",
        "label": "Adjustments for current tax of prior periods"
       }
      }
     },
     "auth_ref": [
      "r363",
      "r412"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease (increase) in inventory",
        "label": "Adjustments for decrease (increase) in inventories"
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Decrease (increase) in prepaids and other assets",
        "label": "Adjustments for decrease (increase) in prepaid expenses"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for the decrease (increase) in prepaid expenses to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Current prepaid expenses; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Increase) decrease in accounts receivable",
        "label": "Adjustments for decrease (increase) in trade accounts receivable"
       }
      }
     },
     "auth_ref": [
      "r567"
     ]
    },
    "ifrs-full_AdjustmentsForDepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDepreciationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Adjustments for depreciation expense"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "soph_AdjustmentsForFairValueOfWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AdjustmentsForFairValueOfWarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value adjustments on warrant obligations",
        "negatedLabel": "Fair value adjustments on warrant obligations",
        "verboseLabel": "Change in fair value",
        "label": "Adjustments For Fair Value Of Warrant Liability",
        "documentation": "Adjustments For Fair Value Of Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "soph_AdjustmentsForFinanceExpenseIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AdjustmentsForFinanceExpenseIncomeNet",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance expense (income), net",
        "label": "Adjustments for Finance Expense (Income), Net",
        "documentation": "Adjustments for Finance Expense (Income), Net"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss on disposal of property and equipment",
        "label": "Adjustments for gain (loss) on disposals, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movements in provisions and pensions",
        "label": "Adjustments for increase (decrease) in employee benefit liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in employee benefit liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in accounts payables, accrued expenses, deferred contract revenue, and other liabilities",
        "label": "Adjustments for increase (decrease) in trade and other payables"
       }
      },
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r569"
     ]
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments for non-monetary items",
        "label": "Adjustments to reconcile profit (loss) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_AdjustmentsForResearchTaxCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AdjustmentsForResearchTaxCredit",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Research tax credit",
        "label": "Adjustments For Research Tax Credit",
        "documentation": "Adjustments for research tax credit."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Adjustments for share-based payments"
       }
      }
     },
     "auth_ref": [
      "r568"
     ]
    },
    "soph_AdministrativeExpensesNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AdministrativeExpensesNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Administrative expenses",
        "label": "Administrative Expenses Net Defined Benefit Liability Asset",
        "documentation": "Administrative expenses net defined benefit liability asset."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r451",
      "r462",
      "r472",
      "r505"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r454",
      "r465",
      "r475",
      "r508"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r539"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "currency_AllCurrenciesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/currency/2025",
     "localname": "AllCurrenciesDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Currencies",
        "label": "All Currencies [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r466",
      "r476",
      "r500",
      "r509",
      "r513",
      "r521"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AmortisationCurrentContractAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AmortisationCurrentContractAcquisitionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current contract acquisition costs amortized",
        "label": "Amortisation, Current Contract Acquisition Costs",
        "documentation": "Current Contract Acquisition Costs, Amortisation Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmortisationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AmortisationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization",
        "negatedLabel": "Amortization",
        "label": "Amortisation expense"
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "ifrs-full_AnalysisOfIncomeAndExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AnalysisOfIncomeAndExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Analysis of income and expense [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_AreaOfOfficeSpaceGainedAccessUnderLease": {
     "xbrltype": "areaItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AreaOfOfficeSpaceGainedAccessUnderLease",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of office space gained access under lease (in sq ft)",
        "label": "Area Of Office Space Gained Access Under Lease",
        "documentation": "Area of office space gained access under lease."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AreaOfOfficeSpaceLeased": {
     "xbrltype": "areaItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AreaOfOfficeSpaceLeased",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of office space leased (in sq ft)",
        "label": "Area Of Office Space Leased",
        "documentation": "Area of office space leased."
       }
      }
     },
     "auth_ref": []
    },
    "srt_AsiaPacificMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "AsiaPacificMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "APAC",
        "label": "Asia Pacific [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r111",
      "r113",
      "r191",
      "r194",
      "r310",
      "r311",
      "r337"
     ]
    },
    "ifrs-full_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Attribution of expenses by nature to their function [axis]",
        "label": "Attribution of expenses by nature to their function [axis]"
       }
      }
     },
     "auth_ref": [
      "r575",
      "r577"
     ]
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Attribution of expenses by nature to their function [domain]",
        "label": "Attribution of expenses by nature to their function [domain]"
       }
      }
     },
     "auth_ref": [
      "r575",
      "r577"
     ]
    },
    "soph_AuditorAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AuditorAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Abstract]",
        "documentation": "Auditor"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.sophiagenetics.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r434",
      "r435",
      "r458"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.sophiagenetics.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r434",
      "r435",
      "r458"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://www.sophiagenetics.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r434",
      "r435",
      "r458"
     ]
    },
    "soph_AverageForeignExchangeRates": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AverageForeignExchangeRates",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofSignificantExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average rate (in dollars per share)",
        "label": "Average Foreign Exchange Rates",
        "documentation": "Average foreign exchange rate."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AverageLifeExpectancyInYearsAfterRetirementForFemale": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AverageLifeExpectancyInYearsAfterRetirementForFemale",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average life expectancy in years after retirement for female",
        "label": "Average Life Expectancy, In Years After Retirement, For Female",
        "documentation": "Average life expectancy in years after retirement for female."
       }
      }
     },
     "auth_ref": []
    },
    "soph_AverageLifeExpectancyInYearsAfterRetirementForMale": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "AverageLifeExpectancyInYearsAfterRetirementForMale",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average life expectancy in years after retirement for male",
        "label": "Average Life Expectancy, In Years After Retirement, For Male",
        "documentation": "Average life expectancy in years after retirement for male."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r516"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r517"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r515"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r513"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r513"
     ]
    },
    "country_BR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "BR",
     "presentation": [
      "http://www.sophiagenetics.com/role/SegmentreportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Brazil",
        "label": "BRAZIL"
       }
      }
     },
     "auth_ref": []
    },
    "soph_BadDebtReservesRelatedTemporaryDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BadDebtReservesRelatedTemporaryDifferencesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bad debt reserves",
        "label": "Bad Debt Reserves Related Temporary Differences [Member]",
        "documentation": "Temporary difference bad debt reserves."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BalancesWithBanks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BalancesWithBanks",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails": {
       "parentTag": "ifrs-full_Cash",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash on hand",
        "label": "Balances with banks"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash balances held at banks."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "soph_BankBorrowingsInterestPaidUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BankBorrowingsInterestPaidUndiscountedCashFlows",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual cash interest payments",
        "label": "Bank Borrowings, Interest Paid, Undiscounted Cash Flows",
        "documentation": "Bank Borrowings, Interest Paid, Undiscounted Cash Flows"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BankBorrowingsUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BankBorrowingsUndiscountedCashFlows",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail": {
       "parentTag": "soph_ContractualLiabilitiesUndiscountedCashFlows",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "label": "Bank borrowings, undiscounted cash flows"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to bank borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r400",
      "r404"
     ]
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShare",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss",
      "http://www.sophiagenetics.com/role/LosspershareComponentsofLossforYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic loss per share (in dollars per share)",
        "label": "Basic earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54"
     ]
    },
    "soph_BidartFranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BidartFranceMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bidart",
        "label": "Bidart, France [Member]",
        "documentation": "Bidart, France"
       }
      }
     },
     "auth_ref": []
    },
    "soph_BlackScholesPricingModelValueMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BlackScholesPricingModelValueMeasurementInputMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Black-Scholes value in USD",
        "label": "Black-Scholes Pricing Model Value, Measurement Input [Member]",
        "documentation": "Black-Scholes Pricing Model Value, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingCostsIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingCostsIncurred",
     "calculation": {
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails": {
       "parentTag": "soph_ProceedsFromBorrowingsNetOfCostsIncurred",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs associated with loan",
        "negatedTerseLabel": "Transaction costs",
        "label": "Borrowing costs incurred"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest and other costs that an entity incurs in connection with the borrowing of funds."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "soph_BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/CapitalmanagementDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional borrowings",
        "label": "Borrowing Facilities, Increase (Decrease) In Maximum Borrowing Capacity",
        "documentation": "Borrowing Facilities, Increase (Decrease) In Maximum Borrowing Capacity"
       }
      }
     },
     "auth_ref": []
    },
    "soph_BorrowingFacilitiesMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BorrowingFacilitiesMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum borrowings",
        "label": "Borrowing Facilities, Maximum Borrowing Capacity",
        "documentation": "Credit facility, maximum borrowing capacity."
       }
      }
     },
     "auth_ref": []
    },
    "soph_BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of business days for right to reinvest certain proceeds in assets",
        "label": "Borrowing Facilities, Prepayment Terms, Business Threshold Days For Right To Reinvest Certain Proceeds In Assets",
        "documentation": "Borrowing Facilities, Prepayment Terms, Business Threshold Days For Right To Reinvest Certain Proceeds In Assets"
       }
      }
     },
     "auth_ref": []
    },
    "soph_BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trailing twelve-month revenue triggering draw down",
        "label": "Borrowing Facilities, Threshold Trailing Twelve Months Revenue Threshold, Allowable Proceeds From Borrowings Trigger",
        "documentation": "Borrowing Facilities, Threshold Trailing Twelve Months Revenue Threshold, Allowable Proceeds From Borrowings Trigger"
       }
      }
     },
     "auth_ref": []
    },
    "soph_BorrowingMaturityTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BorrowingMaturityTerm",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit agreement maturity",
        "label": "Borrowing Maturity, Term",
        "documentation": "Borrowing Maturity, Term"
       }
      }
     },
     "auth_ref": []
    },
    "soph_BorrowingTermsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BorrowingTermsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowing Terms [Axis]",
        "label": "Borrowing Terms [Axis]",
        "documentation": "Borrowing Terms"
       }
      }
     },
     "auth_ref": []
    },
    "soph_BorrowingTermsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BorrowingTermsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowing Terms [Domain]",
        "label": "Borrowing Terms [Domain]",
        "documentation": "Borrowing Terms [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Borrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Borrowings",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings amount",
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ifrs-full_BorrowingsAdjustmentToInterestRateBasis": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsAdjustmentToInterestRateBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjusted interest rate",
        "label": "Borrowings, adjustment to interest rate basis"
       }
      },
      "en": {
       "role": {
        "documentation": "The adjustment to the basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsByNameAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
      "http://www.sophiagenetics.com/role/CapitalmanagementDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings by name [axis]",
        "label": "Borrowings by name [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "ifrs-full_BorrowingsByNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsByNameDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
      "http://www.sophiagenetics.com/role/CapitalmanagementDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings by name [domain]",
        "label": "Borrowings by name [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "soph_BorrowingsCovenantCashAndCashEquivalentsMinimum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BorrowingsCovenantCashAndCashEquivalentsMinimum",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum amount of qualified cash required to be maintained under customary covenants",
        "label": "Borrowings, Covenant, Cash And Cash Equivalents, Minimum",
        "documentation": "Borrowings, Covenant, Cash And Cash Equivalents, Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "soph_BorrowingsCovenantRevenueFromContractsWithCustomersMinimum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BorrowingsCovenantRevenueFromContractsWithCustomersMinimum",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum amount of last twelve months revenue required to be maintained under customary covenants",
        "label": "Borrowings, Covenant, Revenue From Contracts With Customers, Minimum",
        "documentation": "Borrowings, Covenant, Revenue From Contracts With Customers, Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "soph_BorrowingsForeignCurrencyTranslationGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BorrowingsForeignCurrencyTranslationGainLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation adjustments",
        "label": "Borrowings, Foreign Currency Translation Gain (Loss)",
        "documentation": "Borrowings, Foreign Currency Translation Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BorrowingsInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsInterestRate",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Borrowings, interest rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The interest rate on borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "soph_BostonMassachusettsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "BostonMassachusettsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Boston",
        "label": "Boston, Massachusetts [Member]",
        "documentation": "Boston."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Bottom of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r115",
      "r139",
      "r151",
      "r232",
      "r387",
      "r388",
      "r573"
     ]
    },
    "ifrs-full_BusinessCombinationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BusinessCombinationsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combinations [axis]",
        "label": "Business combinations [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r292"
     ]
    },
    "ifrs-full_BusinessCombinationsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BusinessCombinationsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combinations [domain]",
        "label": "Business combinations [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r163",
      "r292"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r435",
      "r458"
     ]
    },
    "country_CH": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "CH",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails",
      "http://www.sophiagenetics.com/role/SegmentreportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Switzerland",
        "verboseLabel": "Switzerland",
        "label": "SWITZERLAND"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CapitalCommitments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CapitalCommitments",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining commitments",
        "label": "Capital commitments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of future capital expenditures that the entity is committed to make."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "ifrs-full_CapitalCommitmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CapitalCommitmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital commitments [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_CapitalManagementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CapitalManagementLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/CapitalmanagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Management [Line Items]",
        "label": "Capital Management [Line Items]",
        "documentation": "Capital Management [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_CapitalManagementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CapitalManagementTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/CapitalmanagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital Management [Table]",
        "label": "Capital Management [Table]",
        "documentation": "Capital Management [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CapitalisedDevelopmentExpenditureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CapitalisedDevelopmentExpenditureMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalised development expenditure",
        "verboseLabel": "Capitalized internally developed software costs",
        "label": "Capitalised development expenditure [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets arising from development expenditure capitalised before the start of commercial production or use. An intangible asset shall only be recognised if the entity can demonstrate all of the following: (a) the technical feasibility of completing the intangible asset so that it will be available for use or sale; (b) its intention to complete the intangible asset and use or sell it; (c) its ability to use or sell the intangible asset; (d) how the intangible asset will generate probable future economic benefits. Among other things, the entity can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset; (e) the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and (f) its ability to measure reliably the expenditure attributable to the intangible asset during its development."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "soph_CapitalizedSoftwareDevelopmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CapitalizedSoftwareDevelopmentCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capitalized development costs",
        "label": "Capitalized Software Development Costs",
        "documentation": "Capitalized software development costs."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails",
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail",
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]",
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r15",
      "r67",
      "r68",
      "r76",
      "r77",
      "r78",
      "r79",
      "r80",
      "r162",
      "r169",
      "r170",
      "r246",
      "r249",
      "r269",
      "r270",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r294",
      "r303",
      "r304"
     ]
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails",
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail",
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying amount",
        "label": "Carrying amount [member]"
       }
      }
     },
     "auth_ref": [
      "r15",
      "r68",
      "r76",
      "r78",
      "r79",
      "r162",
      "r169",
      "r170",
      "r249",
      "r270",
      "r276",
      "r278",
      "r279",
      "r294",
      "r303",
      "r304"
     ]
    },
    "ifrs-full_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total cash",
        "label": "Cash"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "soph_CashAndCashEquivalentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CashAndCashEquivalentMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash And Cash Equivalent [Member]",
        "documentation": "Cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/CapitalmanagementDetails",
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "periodStartLabel": "Cash and cash equivalents at beginning of the year",
        "periodEndLabel": "Cash and cash equivalents at end of the year",
        "totalLabel": "Cash and cash equivalents",
        "label": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r104",
      "r233",
      "r335"
     ]
    },
    "soph_CashAndCashEquivalents1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CashAndCashEquivalents1Member",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents:",
        "label": "Cash And Cash Equivalents1 [Member]",
        "documentation": "Cash And Cash Equivalents1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails": {
       "parentTag": "ifrs-full_PlanAssetsAtFairValue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash",
        "label": "Cash and cash equivalents, amount contributed to fair value of plan assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount cash and cash equivalents contribute to the fair value of defined benefit plan assets. [Refer: Cash and cash equivalents; Plan assets, at fair value; Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "soph_CashAndCashEquivalentsAndTermDepositsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CashAndCashEquivalentsAndTermDepositsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash And Cash Equivalents and Term Deposits",
        "label": "Cash And Cash Equivalents And Term Deposits [Member]",
        "documentation": "Cash and cash equivalents, term deposits and short-term investments."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails": {
       "parentTag": "ifrs-full_CashAndCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total cash equivalents",
        "label": "Cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value."
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds upon maturity of term deposits",
        "label": "Cash flows from (used in) decrease (increase) in short-term deposits and investments"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow (outflow) due to a decrease (increase) in short-term deposits and investments."
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flow provided from (used in) financing activities",
        "terseLabel": "Net cash flow provided from (used in) financing activities",
        "label": "Cash flows from (used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r89"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing activities",
        "label": "Cash flows from (used in) financing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flow (used in) provided from investing activities",
        "terseLabel": "Net cash flow (used in) provided from investing activities",
        "label": "Cash flows from (used in) investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r89"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing activities",
        "label": "Cash flows from (used in) investing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash flows used in operating activities",
        "terseLabel": "Net cash used in operating activities",
        "label": "Cash flows from (used in) operating activities"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r89"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating activities",
        "label": "Cash flows from (used in) operating activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperations",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Cash used in operating activities",
        "label": "Cash flows from (used in) operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash from (used in) the entity's operations."
       }
      }
     },
     "auth_ref": [
      "r380",
      "r383"
     ]
    },
    "ifrs-full_CashOutflowForLeases": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashOutflowForLeases",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash outflows related to leases less than 12 months",
        "label": "Cash outflow for leases"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for leases."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r210"
     ]
    },
    "ifrs-full_CategoriesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialAssetsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Categories of financial assets [axis]",
        "label": "Categories of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r300"
     ]
    },
    "ifrs-full_CategoriesOfFinancialAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialAssetsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Categories of financial assets [domain]",
        "label": "Categories of financial assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r300"
     ]
    },
    "ifrs-full_CategoriesOfFinancialLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialLiabilitiesAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Categories of financial liabilities [axis]",
        "label": "Categories of financial liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r300"
     ]
    },
    "ifrs-full_CategoriesOfFinancialLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfFinancialLiabilitiesDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Categories of financial liabilities [domain]",
        "label": "Categories of financial liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated categories of financial liabilities. It also represents the standard value for the 'Categories of financial liabilities' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r185",
      "r300"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ifrs-full_ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ChangesInAllowanceAccountForCreditLossesOfFinancialAssetsAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in allowance account for credit losses of financial assets [abstract]",
        "label": "Changes in allowance account for credit losses of financial assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ChangesInBorrowingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ChangesInBorrowingsAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes In Borrowings [Abstract]",
        "label": "Changes In Borrowings [Abstract]",
        "documentation": "Changes In Borrowings"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ChangesInDeferredTaxLiabilityAssetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ChangesInDeferredTaxLiabilityAssetAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in deferred tax liability (asset) [abstract]",
        "label": "Changes in deferred tax liability (asset) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ChangesInDefinedBenefitObligationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ChangesInDefinedBenefitObligationAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes In Defined Benefit Obligation [Abstract]",
        "label": "Changes In Defined Benefit Obligation [Abstract]",
        "documentation": "Changes In Defined Benefit Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ChangesInEquityInstrumentsNumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]",
        "label": "Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]",
        "documentation": "Changes In Equity Instruments, Number Of Equity Instruments, In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ChangesInEquityInstrumentsWeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruemnts, In Share-Based Payment Arrangement [Abstract]",
        "label": "Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruments, In Share-Based Payment Arrangement [Abstract]",
        "documentation": "Changes In Equity Instruments, Weighted Average Exercise Price Of Equity Instruments, In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ChangesInIntangibleAssetsAndGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ChangesInIntangibleAssetsAndGoodwillAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in intangible assets and goodwill [abstract]",
        "label": "Changes in intangible assets and goodwill [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ChangesInNetDefinedBenefitLiabilityAssetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ChangesInNetDefinedBenefitLiabilityAssetAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes In Net Defined Benefit Liability (Asset) [Abstract]",
        "label": "Changes in net defined benefit liability (asset) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ChangesInOtherEquityInstrumentsNumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes In Other Equity Instruments, Number Of Other Equity Instruments, In Share-Based Payment Arrangement [Abstract]",
        "label": "Changes In Other Equity Instruments, Number Of Other Equity Instruments, In Share-Based Payment Arrangement [Abstract]",
        "documentation": "Changes In Other Equity Instruments, Number Of Other Equity Instruments, In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ChangesInOtherEquityInstrumentsWeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes In Other Equity Instruments, Weighted Average Exercise Price Of Other Equity Instruments, In Share-Based Payment Arrangement [Abstract]",
        "label": "Changes In Other Equity Instruments, Weighted Average Exercise Price Of Other Equity Instruments, In Share-Based Payment Arrangement [Abstract]",
        "documentation": "Changes In Other Equity Instruments, Weighted Average Exercise Price Of Other Equity Instruments, In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ChangesInPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ChangesInPropertyPlantAndEquipmentAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in property, plant and equipment [abstract]",
        "label": "Changes in property, plant and equipment [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ChangesInProvisionOfInventoryAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ChangesInProvisionOfInventoryAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryProvisionMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes In Provision Of Inventory [Abstract]",
        "label": "Changes In Provision Of Inventory [Abstract]",
        "documentation": "Changes In Provision Of Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ChangesInShareBasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ChangesInShareBasedPaymentsAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationMovementsinSharebasedCompensationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes In Share-Based Payments [Abstract]",
        "label": "Changes In Share-Based Payments [Abstract]",
        "documentation": "Changes In Share-Based Payments"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ChangesInWarrantLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ChangesInWarrantLiabilityAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes In Warrant Liability [Abstract]",
        "label": "Changes In Warrant Liability [Abstract]",
        "documentation": "Changes In Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfAssetsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails",
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of assets [axis]",
        "label": "Classes of assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r62",
      "r114",
      "r130",
      "r213",
      "r265",
      "r312"
     ]
    },
    "ifrs-full_ClassesOfAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfAssetsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails",
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of assets [domain]",
        "label": "Classes of assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r114",
      "r130",
      "r213",
      "r265",
      "r312"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails",
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of financial assets [axis]",
        "label": "Classes of financial assets [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r178",
      "r179",
      "r201",
      "r202",
      "r320"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails",
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of financial assets [domain]",
        "label": "Classes of financial assets [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r141",
      "r178",
      "r179",
      "r201",
      "r202",
      "r320"
     ]
    },
    "ifrs-full_ClassesOfFinancialInstrumentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialInstrumentsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail",
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of financial instruments [axis]",
        "label": "Classes of financial instruments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r172",
      "r174",
      "r175",
      "r303",
      "r306"
     ]
    },
    "ifrs-full_ClassesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail",
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of financial instruments [domain]",
        "label": "Classes of financial instruments [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r169",
      "r172",
      "r174",
      "r175",
      "r303",
      "r306"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of intangible assets and goodwill [axis]",
        "label": "Classes of intangible assets and goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsAndGoodwillDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of intangible assets and goodwill [domain]",
        "label": "Classes of intangible assets and goodwill [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "ifrs-full_ClassesOfInventoriesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfInventoriesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of current inventories [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfLiabilitiesAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of liabilities [axis]",
        "label": "Classes of liabilities [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r312"
     ]
    },
    "ifrs-full_ClassesOfLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfLiabilitiesDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of liabilities [domain]",
        "label": "Classes of liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r312"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of property, plant and equipment [axis]",
        "label": "Classes of property, plant and equipment [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r250"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of property, plant and equipment [domain]",
        "label": "Classes of property, plant and equipment [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r250"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of share capital [axis]",
        "label": "Classes of share capital [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r315",
      "r348"
     ]
    },
    "ifrs-full_ClassesOfShareCapitalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfShareCapitalDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Classes of share capital [domain]",
        "label": "Classes of share capital [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r315",
      "r348"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_CommencementOfMajorLitigationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CommencementOfMajorLitigationMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Major litigation",
        "label": "Commencement of major litigation [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the commencement of major litigation."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r410"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r497"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of equity [axis]",
        "label": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "ifrs-full_ComponentsOfEquityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfEquityDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of equity [domain]",
        "label": "Components of equity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Items that may be reclassified to statement of loss",
        "label": "Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Items that will not be reclassified to statement of loss (net of tax)",
        "label": "Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive loss for the period",
        "label": "Comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r94",
      "r102",
      "r262",
      "r282",
      "r322",
      "r351",
      "r385"
     ]
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Attributable to owners of the parent",
        "label": "Comprehensive income, attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r322",
      "r353"
     ]
    },
    "ifrs-full_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer hardware",
        "label": "Computer equipment [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "ifrs-full_ComputerSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComputerSoftwareMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer software",
        "verboseLabel": "Purchased software",
        "label": "Computer software [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "ifrs-full_ConstructionInProgress": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ConstructionInProgress",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets under construction",
        "label": "Construction in progress"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expenditure capitalised during the construction of non-current assets that are not yet available for use. [Refer: Non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "soph_ConsumerPriceIndicesInSwitzerlandAndFranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ConsumerPriceIndicesInSwitzerlandAndFranceMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consumer Price Indices in Switzerland and France",
        "label": "Consumer Price Indices In Switzerland And France [Member]",
        "documentation": "Consumer price indices in Switzerland and France."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contact Personnel Name",
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContractAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContractAssetsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued contract revenue",
        "label": "Contract assets [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for contract assets. [Refer: Contract assets]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r173",
      "r302",
      "r305",
      "r395"
     ]
    },
    "ifrs-full_ContractualCapitalCommitments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContractualCapitalCommitments",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum purchase agreement commitment",
        "label": "Contractual capital commitments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of capital commitments for which the entity has entered into a contract. [Refer: Capital commitments]"
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "soph_ContractualLiabilitiesUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ContractualLiabilitiesUndiscountedCashFlows",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer contributions",
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from resulting from contributions to plan by employer"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Actual plan participants\u2019 contributions",
        "terseLabel": "Employee contributions",
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan by plan participants"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "soph_CostOfRevenue1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CostOfRevenue1Member",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost Of Revenue1 [Member]",
        "documentation": "Cost Of Revenue1"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cost of revenue",
        "label": "Cost of sales"
       }
      }
     },
     "auth_ref": [
      "r321",
      "r359"
     ]
    },
    "ifrs-full_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of sales [member]"
       }
      }
     },
     "auth_ref": [
      "r575",
      "r577"
     ]
    },
    "ifrs-full_CounterpartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CounterpartiesAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparties [axis]",
        "label": "Counterparties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "ifrs-full_CounterpartiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CounterpartiesDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparties [domain]",
        "label": "Counterparties [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "soph_CreditAgreementExistingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CreditAgreementExistingMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Existing Credit Agreement",
        "label": "Credit Agreement, Existing [Member]",
        "documentation": "Credit Agreement, Existing"
       }
      }
     },
     "auth_ref": []
    },
    "soph_CreditAgreementNewMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CreditAgreementNewMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Credit Agreement",
        "label": "Credit Agreement, New [Member]",
        "documentation": "Credit Agreement, New"
       }
      }
     },
     "auth_ref": []
    },
    "soph_CreditSuisseSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CreditSuisseSAMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Suisse SA",
        "label": "Credit Suisse SA [Member]",
        "documentation": "Credit Suisse SA"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CurrencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CurrencyAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency",
        "label": "Currency [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrencyInWhichInformationIsDisplayedAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrencyInWhichInformationIsDisplayedAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency in which information is displayed [axis]",
        "label": "Currency in which information is displayed [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "soph_CurrentAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CurrentAccruedExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/AccruedexpensesDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total",
        "label": "Current Accrued Expenses",
        "documentation": "Accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "soph_CurrentAccruedExpensesOnPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CurrentAccruedExpensesOnPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses for property and equipment",
        "label": "Current Accrued Expenses On Property, Plant And Equipment",
        "documentation": "Current Accrued Expenses On Property, Plant And Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r341",
      "r385"
     ]
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAssetsAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_CurrentContractAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CurrentContractAcquisitionCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current contract acquisition costs",
        "label": "Current Contract Acquisition Costs",
        "documentation": "Current Contract Acquisition Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentDeferredIncomeIncludingCurrentContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentDeferredIncomeIncludingCurrentContractLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred contract revenue",
        "label": "Current deferred income including current contract liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current deferred income including current contract liabilities. [Refer: Deferred income including contract liabilities]"
       }
      }
     },
     "auth_ref": [
      "r579",
      "r582"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "soph_CurrentGovernmentGrantsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CurrentGovernmentGrantsReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants receivable",
        "label": "Current Government Grants Receivable",
        "documentation": "Current government grants receivable."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails": {
       "parentTag": "ifrs-full_LeaseLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets",
      "http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities, current portion",
        "verboseLabel": "Current",
        "label": "Current lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r342",
      "r385"
     ]
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLiabilitiesAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Current liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_CurrentOtherAssetsMiscellaneous": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CurrentOtherAssetsMiscellaneous",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Current Other Assets Miscellaneous",
        "documentation": "Current other assets miscellaneous."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentPrepayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentPrepayments",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayments",
        "label": "Current prepayments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current prepayments. [Refer: Prepayments]"
       }
      }
     },
     "auth_ref": [
      "r417",
      "r425"
     ]
    },
    "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentPrepaymentsAndOtherCurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets",
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaids and other current assets",
        "totalLabel": "Total",
        "label": "Current prepayments and other current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current prepayments and other current assets. [Refer: Other current assets; Current prepayments]"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ifrs-full_CurrentServiceCostDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentServiceCostDefinedBenefitPlans",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "of which current service cost",
        "label": "Current service cost, defined benefit plans"
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails": {
       "parentTag": "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Current year",
        "label": "Current tax expense (income)"
       }
      }
     },
     "auth_ref": [
      "r362",
      "r411"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total current income tax expense",
        "label": "Current tax expense (income) and adjustments for current tax of prior periods"
       }
      }
     },
     "auth_ref": [
      "r544"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriodsAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails",
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails",
      "http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current income tax expense",
        "verboseLabel": "Current tax expense (income) and adjustments for current tax of prior periods [abstract]",
        "label": "Current tax expense (income) and adjustments for current tax of prior periods [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentValueAddedTaxReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentValueAddedTaxReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails": {
       "parentTag": "ifrs-full_CurrentPrepaymentsAndOtherCurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VAT receivable",
        "label": "Current value added tax receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current value added tax receivables. [Refer: Value added tax receivables]"
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "ifrs-full_CurrentWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentWarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant obligations",
        "periodStartLabel": "Beginnings balances",
        "periodEndLabel": "Ending balances",
        "label": "Current warrant liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current warrant liabilities. [Refer: Warrant liability]"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "soph_CustomerOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "CustomerOneMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer One",
        "label": "Customer One [Member]",
        "documentation": "Customer One"
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r443",
      "r532"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r443",
      "r532"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r445",
      "r534"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r445",
      "r534"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r447",
      "r536"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r445",
      "r534"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r438",
      "r527"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r439",
      "r528"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r439",
      "r528"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r437",
      "r526"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r437",
      "r526"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r437",
      "r526"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r440",
      "r529"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r442",
      "r531"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r442",
      "r531"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r443",
      "r532"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r446",
      "r535"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r444",
      "r533"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r441",
      "r530"
     ]
    },
    "ifrs-full_DecreaseThroughWriteoffFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DecreaseThroughWriteoffFinancialAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Write-off",
        "label": "Decrease through write-off, financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in financial assets resulting from write-off. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r393",
      "r394",
      "r403",
      "r415",
      "r416"
     ]
    },
    "soph_DeferredBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DeferredBenefitAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income tax (expense) benefit",
        "label": "Deferred Benefit [Abstract]",
        "documentation": "Deferred benefit."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred contract revenue recognized",
        "label": "Deferred Revenue From Performance Obligations Satisfied Or Partially Satisfied In Previous Periods",
        "documentation": "Deferred Revenue From Performance Obligations Satisfied Or Partially Satisfied In Previous Periods"
       }
      }
     },
     "auth_ref": []
    },
    "soph_DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred contract revenue brought forward",
        "label": "Deferred Revenue That Was Included In Contract Liability Balance At Beginning Of Period",
        "documentation": "Deferred Revenue That Was Included In Contract Liability Balance At Beginning Of Period"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r242",
      "r336",
      "r338"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred income tax (expense) benefit",
        "label": "Deferred tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r243"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncomeRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncomeRecognisedInProfitOrLoss",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Recognized in profit or loss",
        "label": "Deferred tax expense (income) recognised in profit or loss"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r243"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails": {
       "parentTag": "ifrs-full_DeferredTaxExpenseIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Origination and reversal of temporary differences",
        "label": "Deferred tax expense (income) relating to origination and reversal of temporary differences"
       }
      }
     },
     "auth_ref": [
      "r364",
      "r413"
     ]
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred tax liabilities",
        "label": "Deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r242",
      "r336",
      "r338"
     ]
    },
    "ifrs-full_DeferredTaxLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Deferred tax liability (asset) at beginning of period",
        "negatedPeriodEndLabel": "Deferred tax liability (asset) at end of period",
        "label": "Deferred tax liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r242"
     ]
    },
    "ifrs-full_DefinedBenefitObligationAtPresentValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DefinedBenefitObligationAtPresentValue",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails": {
       "parentTag": "ifrs-full_SurplusDeficitInPlan",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Present value of defined benefit obligation",
        "negatedPeriodStartLabel": "January 1",
        "negatedPeriodEndLabel": "December 31",
        "label": "Defined benefit obligation, at present value"
       }
      },
      "en": {
       "role": {
        "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]"
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "ifrs-full_DefinedBenefitPlansAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DefinedBenefitPlansAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit plans [axis]",
        "label": "Defined benefit plans [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r252"
     ]
    },
    "ifrs-full_DefinedBenefitPlansDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DefinedBenefitPlansDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit plans [domain]",
        "label": "Defined benefit plans [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r252"
     ]
    },
    "soph_DemographicAssumptionOfWeightedTurnoverRates": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DemographicAssumptionOfWeightedTurnoverRates",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Demographic assumptions increase in weighted turnover",
        "label": "Demographic Assumption Of Weighted Turnover Rates",
        "documentation": "Demographic Assumption Of Weighted Turnover Rates"
       }
      }
     },
     "auth_ref": []
    },
    "soph_DepreciationAndAmortizationRelatedTemporaryDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DepreciationAndAmortizationRelatedTemporaryDifferencesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation &amp; amortization",
        "label": "Depreciation And Amortization Related Temporary Differences [Member]",
        "documentation": "Temporary difference depreciation and amortization."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DepreciationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DepreciationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation",
        "label": "Depreciation expense"
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DepreciationRightofuseAssets",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation charges",
        "label": "Depreciation, right-of-use assets"
       }
      }
     },
     "auth_ref": [
      "r125",
      "r208"
     ]
    },
    "soph_DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting policies",
        "label": "Description Of Accounting Policy For Accounting Policies [Text Block]",
        "documentation": "Description of accounting policy for Accounting policies explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of consolidation",
        "label": "Description Of Accounting Policy For Basis Of Consolidation [Text Block]",
        "documentation": "Description of accounting policy for basis of consolidation explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of preparation",
        "label": "Description Of Accounting Policy For Basis Of Preparation [Text Block]",
        "documentation": "Description of accounting policy for basis of preparation explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in accounting policies, new standards, amendments to standards and interpretations",
        "label": "Description Of Accounting Policy For Changes And New Standards [Text Block]",
        "documentation": "Description of accounting policy for new standards amendments to standards and interpretations issued not yet effective."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DescriptionOfAccountingPolicyForCostOfSalesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForCostOfSalesTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Description Of Accounting Policy For Cost Of Sales [Text Block]",
        "documentation": "Description Of Accounting Policy For Cost Of Sales"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Post-employment benefits",
        "label": "Description of accounting policy for employee benefits [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for employee benefits. Employee benefits are all forms of consideration given by an entity in exchange for services rendered by employees or for the termination of employment."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialAssetsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets classification",
        "label": "Description of accounting policy for financial assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial assets. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities classification",
        "label": "Description of accounting policy for financial liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial liabilities. [Refer: Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation",
        "label": "Description of accounting policy for foreign currency translation [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for foreign currency translation."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "soph_DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative costs",
        "label": "Description Of Accounting Policy For General And Administrative Expense [Text Block]",
        "documentation": "Description Of Accounting Policy For General And Administrative Expense"
       }
      }
     },
     "auth_ref": []
    },
    "soph_DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Going concern basis",
        "label": "Description Of Accounting Policy For Going Concern Basis [Text Block]",
        "documentation": "Description of accounting policy for going concern basis explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Historical cost convention",
        "label": "Description Of Accounting Policy For Historical Cost Convention [Text Block]",
        "documentation": "Description of accounting policy for historical cost convention explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax",
        "label": "Description of accounting policy for income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for income tax."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets",
        "label": "Description of accounting policy for intangible assets and goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income, net and Foreign exchange (losses) gains, net",
        "label": "Description of accounting policy for interest income and expense [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for income and expense arising from interest."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Description of accounting policy for leases [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Description of accounting policy for measuring inventories [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r34",
      "r229"
     ]
    },
    "soph_DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other operating income, net",
        "label": "Description Of Accounting Policy For Other Operating Income (Expense) [Text Block]",
        "documentation": "Description Of Accounting Policy For Other Operating Income (Expense)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Description of accounting policy for property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "soph_DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provisions and contingencies",
        "label": "Description Of Accounting Policy For Provisions And Contingencies [Text Block]",
        "documentation": "Description of accounting policy for provisions and contingencies explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRecognitionOfRevenue": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForRecognitionOfRevenue",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Description of accounting policy for recognition of revenue [text block]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Description of accounting policy for research and development expense [text block]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "soph_DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling and marketing costs",
        "label": "Description Of Accounting Policy For Selling And Marketing Expense [Text Block]",
        "documentation": "Description Of Accounting Policy For Selling And Marketing Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Description of accounting policy for share-based payment transactions [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Types of share-based payment arrangements [domain]]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Description of accounting policy for trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "soph_DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of estimates",
        "label": "Description Of Accounting Policy For Use Of Estimates [Text Block]",
        "documentation": "Description of accounting policy for use of estimates explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Description of accounting policy for determining components of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r234"
     ]
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility (%)",
        "label": "Expected volatility, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfOptionLifeShareOptionsGranted",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option life, share options granted",
        "verboseLabel": "Life of option",
        "label": "Option life, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The option life of share options granted."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate (%)",
        "label": "Risk free interest rate, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "soph_DifferencesOfCurrencyEURAndCHFMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DifferencesOfCurrencyEURAndCHFMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EUR/CHF",
        "label": "Differences Of Currency EUR And CHF [Member]",
        "documentation": "Differences of Currency EUR/CHF."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DifferencesOfCurrencyGBPAndCHFMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DifferencesOfCurrencyGBPAndCHFMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GBP/CHF",
        "label": "Differences Of Currency GBP And CHF [Member]",
        "documentation": "Differences of Currency GBP/CHF."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DifferencesOfCurrencyUSDAndCHFMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DifferencesOfCurrencyUSDAndCHFMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "USD/CHF",
        "label": "Differences Of Currency USD And CHF [Member]",
        "documentation": "Differences of currency USD/CHF."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DifferencesOfCurrencyUSDAndEURMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DifferencesOfCurrencyUSDAndEURMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "USD/EUR",
        "label": "Differences Of Currency USD And EUR [Member]",
        "documentation": "Differences of Currency USD/EUR."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DifferencesOfCurrencyUSDAndGBPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DifferencesOfCurrencyUSDAndGBPMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "USD/GBP",
        "label": "Differences Of Currency USD And GBP [Member]",
        "documentation": "Differences of Currency USD/GBP."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShare",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss",
      "http://www.sophiagenetics.com/role/LosspershareComponentsofLossforYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted loss per share (in dollars per share)",
        "label": "Diluted earnings (loss) per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r53",
      "r54"
     ]
    },
    "ifrs-full_DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Accruedexpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Disclosure of accrued expenses and other liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of accrued expenses and other liabilities. [Refer: Accruals; Other liabilities]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "ifrs-full_DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Additional Details on Defined Benefit Plans Funded Status",
        "label": "Disclosure of additional information about defined benefit plans [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of additional information about defined benefit plans necessary to meet the objectives of IAS 19. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Attribution Of Expenses By Nature To Their Function [Line Items]",
        "label": "Disclosure of attribution of expenses by nature to their function [line items]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Attribution Of Expenses By Nature To Their Function [Table]",
        "label": "Disclosure of attribution of expenses by nature to their function [table]"
       }
      }
     },
     "auth_ref": [
      "r575",
      "r577"
     ]
    },
    "ifrs-full_DisclosureOfBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBorrowingsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Borrowings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "label": "Disclosure of borrowings [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "soph_DisclosureOfCapitalManagementExplanatoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfCapitalManagementExplanatoryTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/Capitalmanagement"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capital management",
        "label": "Disclosure Of Capital Management Explanatory [Text Block]",
        "documentation": "Disclosure of capital management explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Cashandcashequivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Disclosure of cash and cash equivalents [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "ifrs-full_DisclosureOfChangesInAccountingEstimatesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfChangesInAccountingEstimatesLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of changes in accounting estimates [line items]",
        "label": "Disclosure of changes in accounting estimates [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfChangesInAccountingEstimatesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfChangesInAccountingEstimatesTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of changes in accounting estimates [table]",
        "label": "Disclosure of changes in accounting estimates [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the changes in accounting estimates."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r236"
     ]
    },
    "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Commitmentsandcontingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies",
        "label": "Disclosure of commitments and contingent liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Classes of contingent liabilities [domain]]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "soph_DisclosureOfCompanyInformationAndOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfCompanyInformationAndOperationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Company Information And Operations [Abstract]",
        "documentation": "Disclosure of company information and operations."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfCompanyInformationAndOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfCompanyInformationAndOperationsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Company Information And Operations [Line Items]",
        "label": "Disclosure Of Company Information And Operations [Line Items]",
        "documentation": "Disclosure of company information and operations."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfCompanyInformationAndOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfCompanyInformationAndOperationsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Company Information And Operations [Table]",
        "label": "Disclosure Of Company Information And Operations [Table]",
        "documentation": "Disclosure of company information and operations."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfCompanyInformationAndOperationsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfCompanyInformationAndOperationsTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/Companyinformationandoperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company information and operations",
        "label": "Disclosure Of Company Information And Operations [Text Block]",
        "documentation": "Company information and operations."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities in business combination [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesInBusinessCombinationLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of contingent liabilities in business combination [line items]",
        "label": "Disclosure of contingent liabilities in business combination [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesInBusinessCombinationTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of contingent liabilities in business combination [table]",
        "label": "Disclosure of contingent liabilities in business combination [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to contingent liabilities in business combinations."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r160"
     ]
    },
    "soph_DisclosureOfCostOfSalesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfCostOfSalesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Cost Of Sales [Abstract]",
        "documentation": "Disclosure of cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfCostOfSalesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfCostOfSalesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Costofrevenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Disclosure of cost of sales [text block]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Defined Benefit Plans Assets",
        "label": "Disclosure of defined benefit plans [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of defined benefit plans. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r20",
      "r252"
     ]
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Defined Benefit Plans [Line Items]",
        "label": "Disclosure of defined benefit plans [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDefinedBenefitPlansTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Defined Benefit Plans [Table]",
        "label": "Disclosure of defined benefit plans [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to defined benefit plans."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r252"
     ]
    },
    "soph_DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountspayableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Accounts Payable",
        "label": "Disclosure Of Detailed Information About Accounts Payables [Table Text Block]",
        "documentation": "Disclosure of accounts payables explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Accounts Receivable and Lease Receivable Less Expected Credit Loss",
        "label": "Disclosure Of Detailed information About Accounts Receivable And Lease Receivable [Table Text Block]",
        "documentation": "The disclosure of accounts receivable and lease receivable less expected credit loss."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccruedexpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Accrued Expenses",
        "label": "Disclosure Of Detailed Information About Accrued Expenses [Table Text Block]",
        "documentation": "Disclosure of detailed information about accrued expenses explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Movement in Allowance for Expected Credit Losses in Accounts Receivable",
        "label": "Disclosure Of Detailed Information About Allowance For Credit Losses In Accounts Receivable [Table Text Block]",
        "documentation": "Disclosure Of Detailed Information About Allowance For Credit Losses In Accounts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about borrowings [abstract]",
        "label": "Disclosure of detailed information about borrowings [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Allocation of the Loan Proceeds and Any Movements in the Liability",
        "label": "Disclosure of detailed information about borrowings [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Detailed Information About Borrowings [Line Items]",
        "label": "Disclosure of detailed information about borrowings [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Detailed Information About Borrowings [Table]",
        "label": "Disclosure of detailed information about borrowings [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      }
     },
     "auth_ref": [
      "r573"
     ]
    },
    "soph_DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Current and Deferred Income Tax (Expenses) Benefits",
        "label": "Disclosure Of Detailed Information About Current And Deferred Tax Expense (Benefit) [Table Text Block]",
        "documentation": "The disclosure of current and deferred tax (expenses) benefits."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Depreciation and Amortization have Charged in Expense",
        "label": "Disclosure Of Detailed Information About Depreciation And Amortization Charged In Operating Expenses [Table Text Block]",
        "documentation": "Disclosure of depreciation and amortization have charged in expense explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Employee Benefit Expenses, Social Charges and Share-based Compensation",
        "label": "Disclosure Of Detailed Information About Employee Benefit Expenses Included In Operating Expense [Table Text Block]",
        "documentation": "Disclosure of employee benefit expenses and social charges from the operating expense explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Expiring Amounts of Unrecognized Net Operating Loss Carryforwards",
        "label": "Disclosure Of Detailed Information About Expiring Amounts Of Unrecognized Net Operating Loss Carryforwards [Table Text Block]",
        "documentation": "The disclosure of expiring amounts of unrecognized net operating loss carryforwards explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Financial Instruments",
        "label": "Disclosure of detailed information about financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about financial instruments. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r167",
      "r172",
      "r180",
      "r295"
     ]
    },
    "soph_DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Foreign Exchange Losses",
        "label": "Disclosure Of Detailed Information About Foreign Exchange Gain (Loss), Net [Table Text Block]",
        "documentation": "Disclosure Of Detailed Information About Foreign Exchange And Other Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Foreign Exchange Rates",
        "label": "Disclosure Of Detailed Information About Foreign Exchange Rates [Table Text Block]",
        "documentation": "Disclosure Of Detailed Information About Exchange Rates"
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Interest Expense",
        "label": "Disclosure Of Detailed Information About Interest Expense [Table Text Block]",
        "documentation": "Disclosure Of Detailed Information About Interest Expense"
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Interest Income",
        "label": "Disclosure Of Detailed Information About Interest Income [Table Text Block]",
        "documentation": "Disclosure Detailed Information About Finance Cost"
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutInventoriesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutInventoriesTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/InventoryTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Inventory",
        "label": "Disclosure Of Detailed Information About Inventories [Table Text Block]",
        "documentation": "The disclosure of detailed information about inventories."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/InventoryTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Inventory Provision Movement",
        "label": "Disclosure Of Detailed Information About Inventory Provision Movement [Table Text Block]",
        "documentation": "The disclosure of inventory provision movement."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Lease Liabilities",
        "label": "Disclosure Of Detailed Information About Lease Liabilities [Table Text Block]",
        "documentation": "Disclosure of quantitative information about lease liabilities explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Movement in Defined Benefit Obligation Explanatory",
        "label": "Disclosure Of Detailed Information About Movement In Defined Benefit Obligation [Table Text Block]",
        "documentation": "The disclosure of movement in defined benefit obligation."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Movement in Defined Benefit Plans Assets",
        "label": "Disclosure Of Detailed Information About Movement In Defined Benefit Plan Assets [Table Text Block]",
        "documentation": "The disclosure of movement in defined benefit plan assets."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/OthernoncurrentassetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Other Non-Current Assets",
        "label": "Disclosure Of Detailed Information About Non-Current Assets And Other Explanatory [Table Text Block]",
        "documentation": "Disclosure Of Detailed Information About Non-Current Assets And Other Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Pension Costs Recognized in Statement of Loss",
        "label": "Disclosure Of Detailed Information About Pension Costs Recognized In Statement Of Income (Loss) [Table Text Block]",
        "documentation": "Disclosure of detailed information about pension costs recognized in statement of income loss explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Pension Remeasurement Recognized in Statement Other Comprehensive Loss",
        "label": "Disclosure Of Detailed Information About Pension Remeasurement Recognized In Statement Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Disclosure of detailed information about pension remeasurement recognized in statement other comprehensive income loss explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Property and Equipment, Net",
        "label": "Disclosure of detailed information about property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r16",
      "r250"
     ]
    },
    "soph_DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Expected Tax Expense to Tax Expense Report in Statement of Loss",
        "label": "Disclosure Of Detailed Information About Reconciliation Of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "The disclosure of reconciliation of expected tax expense to tax expense report in statement of loss."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/CashandcashequivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Cash and Cash Equivalents",
        "label": "Disclosure Of Detailed Information About Schedule Of Cash And Cash Equivalents [Table Text Block]",
        "documentation": "Disclosure of schedule of cash and cash equivalents explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Equity to Changes in Foreign Exchange Rates",
        "label": "Disclosure Of Detailed Information About Sensitivity Of Equity To Changes In Foreign Exchange Rates [Table Text Block]",
        "documentation": "Sensitivity of equity to changes in foreign exchange rates."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Loss Before Tax to Changes in Foreign Exchange Rates",
        "label": "Disclosure Of Detailed Information About Sensitivity Of Loss Before Tax To Changes In Foreign Exchange Rates [Table Text Block]",
        "documentation": "Sensitivity of loss before tax to changes in foreign exchange rates."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutSubsidiariesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutSubsidiariesTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Wholly-Owned Subsidiaries",
        "label": "Disclosure Of Detailed Information About Subsidiaries [Text Block]",
        "documentation": "Disclosure Of Detailed Information About Subsidiaries"
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Warrant Obligation Liability",
        "label": "Disclosure Of Detailed Information About Warrant Liability [Text Block]",
        "documentation": "Disclosure Of Detailed Information About Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Weighted Average Fair Value of Options Granted",
        "label": "Disclosure Of Detailed Information About Weighted Average Fair Value Of Options Granted [Table Text Block]",
        "documentation": "Disclosure of detailed information about weighted average fair value of options granted explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/PrepaidsandothercurrentassetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Prepaids and Other Current Assets",
        "label": "Disclosure Of Detailed Information Of Prepayments And Other Current Assets [Table Text Block]",
        "documentation": "Disclosure of detailed information of other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Revenue from Contracts with Customers Allocated to Geographical Areas and Revenue Streams",
        "label": "Disclosure of disaggregation of revenue from contracts with customers [text block]"
       }
      }
     },
     "auth_ref": [
      "r117",
      "r204"
     ]
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Line Items]",
        "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table]",
        "label": "Disclosure of disaggregation of revenue from contracts with customers [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r204"
     ]
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Losspershare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss per share",
        "label": "Disclosure of earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "soph_DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfEffectOfChangesInForeignExchangeRatesLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]",
        "label": "Disclosure Of Effect Of Changes In Foreign Exchange Rates [Line Items]",
        "documentation": "Disclosure of effect of changes in foreign exchange rates."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfEffectOfChangesInForeignExchangeRatesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfEffectOfChangesInForeignExchangeRatesTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Effect Of Changes In Foreign Exchange Rates [Table]",
        "label": "Disclosure Of Effect Of Changes In Foreign Exchange Rates [Table]",
        "documentation": "Disclosure of effect of changes in foreign exchange rates."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEmployeeBenefitsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Postemploymentbenefits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Post-employment benefits",
        "label": "Disclosure of employee benefits [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for employee benefits."
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "soph_DisclosureOfEventsAfterReportingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfEventsAfterReportingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Events After Reporting Period [Abstract]",
        "label": "Disclosure Of Events After Reporting Period [Abstract]",
        "documentation": "Disclosure of events after reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Eventsafterthereportingdate"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Events after the reporting date",
        "label": "Disclosure of events after reporting period [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]",
        "label": "Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]",
        "documentation": "Disclosure Of Fair Value Measurement Of Assets And Liabilities [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]",
        "label": "Disclosure Of Fair Value Measurement Of Assets And Liabilities [Table]",
        "documentation": "Disclosure Of Fair Value Measurement Of Assets And Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfAssetsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Hierarchy for Financial Assets Measured at Fair Value on a Recurring Basis",
        "label": "Disclosure of fair value measurement of assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r312"
     ]
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Hierarchy for Financial Liabilities Measured at Fair Value on a Recurring Basis",
        "label": "Disclosure of fair value measurement of liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the fair value measurement of liabilities."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r312"
     ]
    },
    "ifrs-full_DisclosureOfFinanceCostExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinanceCostExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income, Interest expense and Foreign exchange (losses) gains, net",
        "label": "Disclosure of finance cost [text block]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of detailed information about financial instruments [abstract]",
        "label": "Disclosure of detailed information about financial instruments [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Financialinstrumentsandrisks"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial instruments and risks",
        "label": "Disclosure of financial instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Financial Instruments [Line Items]",
        "label": "Disclosure of detailed information about financial instruments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Financial Instruments [Table]",
        "label": "Disclosure of detailed information about financial instruments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r172",
      "r180",
      "r295"
     ]
    },
    "ifrs-full_DisclosureOfGeographicalAreasExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGeographicalAreasExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/SegmentreportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Revenue and Non-Current Non-Financial Assets by Country",
        "label": "Disclosure of geographical areas [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of geographical information."
       }
      }
     },
     "auth_ref": [
      "r199"
     ]
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Incometax"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax",
        "label": "Disclosure of income tax [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Valuation Inputs",
        "label": "Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "soph_DisclosureOfInformationAboutPostEmploymentBenefitsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfInformationAboutPostEmploymentBenefitsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Information About Post Employment Benefits [Abstract]",
        "documentation": "Disclosure of information about post-employment benefits."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Disclosure of intangible assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Intangible Assets [Line Items]",
        "label": "Disclosure of detailed information about intangible assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Intangible Assets [Table]",
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r271"
     ]
    },
    "ifrs-full_DisclosureOfInventoriesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInventoriesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Inventory"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "label": "Disclosure of inventories [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for inventories."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "soph_DisclosureOfLeaseLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfLeaseLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Lease [Line Items]",
        "label": "Disclosure Of Lease [Line Items]",
        "documentation": "Disclosure of lease line items."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfLeaseTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfLeaseTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Lease [Table]",
        "label": "Disclosure Of Lease [Table]",
        "documentation": "Disclosure of lease."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfLeasesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfLeasesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Disclosure of leases [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for leases."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136"
     ]
    },
    "ifrs-full_DisclosureOfMaterialAccountingPolicyInformationExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfMaterialAccountingPolicyInformationExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Materialaccountingpolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material accounting policies",
        "label": "Disclosure of material accounting policy information [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure of material accounting policy information applied by the entity."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r316",
      "r327"
     ]
    },
    "soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Line Items]",
        "label": "Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Line Items]",
        "documentation": "Disclosure of maturity analysis for financial liabilities on contractual discounted cashflows."
       }
      }
     },
     "auth_ref": []
    },
    "soph_DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfMaturityAnalysisForFinancialLiabilitiesOnContractualDiscountedCashflowsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Table]",
        "label": "Disclosure Of Maturity Analysis For Financial Liabilities On Contractual Discounted Cashflows [Table]",
        "documentation": "Disclosure of maturity analysis for financial liabilities on contractual discounted cashflows."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Maturity Profile of Financial Liabilities",
        "label": "Disclosure of maturity analysis of undiscounted cash outflows to repurchase derecognised financial assets or amounts payable to transferee in respect of transferred assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a maturity analysis of the undiscounted cash outflows that would or may be required to repurchase derecognised financial assets or other amounts payable to the transferee in respect of transferred assets, showing the remaining contractual maturities of the entity's continuing involvement. [Refer: Undiscounted cash outflow required to repurchase derecognised financial assets; Other amounts payable to transferee in respect of transferred assets]"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Restricted Stock Units Activity",
        "label": "Disclosure of number and weighted average exercise prices of other equity instruments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Stock Option Activity",
        "label": "Disclosure of number and weighted average exercise prices of share options [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r149",
      "r289"
     ]
    },
    "soph_DisclosureOfOperatingExpenseTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DisclosureOfOperatingExpenseTextBlock",
     "presentation": [
      "http://www.sophiagenetics.com/role/Operatingexpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expense",
        "label": "Disclosure Of Operating Expense [Text Block]",
        "documentation": "Disclosure of operating expense explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Segmentreporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment reporting",
        "label": "Disclosure of operating segments [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "ifrs-full_DisclosureOfOperatingSegmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/SegmentreportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Operating Segments [Line Items]",
        "label": "Disclosure of operating segments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/SegmentreportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Operating Segments [Table]",
        "label": "Disclosure of operating segments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to operating segments."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOtherNoncurrentAssetsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Othernoncurrentassets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current assets",
        "label": "Disclosure of other non-current assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other non-current assets. [Refer: Other non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Otheroperatingincomenet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other operating income, net",
        "label": "Disclosure of other operating income (expense) [text block]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "ifrs-full_DisclosureOfPerformanceObligationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPerformanceObligationsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Performance Obligations [Line Items]",
        "label": "Disclosure of performance obligations [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPerformanceObligationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPerformanceObligationsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Performance Obligations [Table]",
        "label": "Disclosure of performance obligations [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to performance obligations in contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r206"
     ]
    },
    "ifrs-full_DisclosureOfPrepaymentsAndOtherAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPrepaymentsAndOtherAssetsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Prepaidsandothercurrentassets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaids and other current assets",
        "label": "Disclosure of prepayments and other assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of prepayments and other assets. [Refer: Other assets; Prepayments]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Propertyandequipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Disclosure of property, plant and equipment [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Property Plant And Equipment [Line Items]",
        "label": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Property Plant And Equipment [Table]",
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r250"
     ]
    },
    "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Right of Use Assets",
        "label": "Disclosure of quantitative information about right-of-use assets [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r130",
      "r213"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangiblesassetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Intangible Assets Net, Movement",
        "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of the reconciliation of changes in intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails",
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]",
        "label": "Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails",
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [table]",
        "label": "Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in the loss allowance and explanation of changes in the gross carrying amount for financial instruments."
       }
      }
     },
     "auth_ref": [
      "r169",
      "r170",
      "r303",
      "r304"
     ]
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Relatedparties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related parties",
        "label": "Disclosure of related party [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Disclosure of revenue from contracts with customers [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122"
     ]
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Sensitivity Analysis for Funded and Unfunded Plans",
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [domain]; Defined benefit obligation, at present value]"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Line Items]",
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Sensitivity Analysis For Actuarial Assumptions [Table]",
        "label": "Disclosure of sensitivity analysis for actuarial assumptions [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the sensitivity analysis for actuarial assumptions."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Sharebasedcompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Disclosure of share-based payment arrangements [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Significant Investments In Subsidiaries [Line Items]",
        "label": "Disclosure of subsidiaries [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Significant Investments In Subsidiaries [Table]",
        "label": "Disclosure of subsidiaries [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to subsidiaries."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r51",
      "r109",
      "r308"
     ]
    },
    "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]",
        "label": "Disclosure of significant unobservable inputs used in fair value measurement of assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of significant unobservable inputs used in fair value measurement of assets [table]",
        "label": "Disclosure of significant unobservable inputs used in fair value measurement of assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to significant unobservable inputs used in the fair value measurement of assets."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Key Inputs for the Valuation of the Warrant Obligation",
        "label": "Disclosure of significant unobservable inputs used in fair value measurement of liabilities [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of significant inputs for which market data are not available and that are developed using the best information available about the assumptions that market participants would use when measuring the fair value of liabilities."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Movement in Deferred Tax Balances",
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r244"
     ]
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]",
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails",
      "http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table]",
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r244"
     ]
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [abstract]",
        "label": "Disclosure of terms and conditions of share-based payment arrangement [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items]",
        "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table]",
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r290"
     ]
    },
    "ifrs-full_DisclosureOfTradeAndOtherPayablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherPayablesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Accountspayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Disclosure of trade and other payables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/Accountsreceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Disclosure of trade and other receivables [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      }
     },
     "auth_ref": [
      "r574"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of transactions between related parties [abstract]",
        "label": "Disclosure of transactions between related parties [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/RelatedpartiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Compensation for Key Management and Non-executive Directors",
        "label": "Disclosure of transactions between related parties [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r260"
     ]
    },
    "ifrs-full_DisposalsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisposalsPropertyPlantAndEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Disposals",
        "label": "Disposals, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r13",
      "r248"
     ]
    },
    "soph_DividendYieldMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "DividendYieldMeasurementInputMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield",
        "label": "Dividend Yield, Measurement Input [Member]",
        "documentation": "Dividend Yield, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DividendsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DividendsReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends payments received",
        "label": "Dividends received"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends received."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Accounting Standard",
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r435",
      "r458"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r435",
      "r458",
      "r501"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r435",
      "r458",
      "r501"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Registration Statement",
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Shell Company Report",
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r435"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DomicileOfEntity": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DomicileOfEntity",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Country of domicile",
        "label": "Domicile of entity"
       }
      },
      "en": {
       "role": {
        "documentation": "The country of domicile of the entity. [Refer: Country of domicile [member]]"
       }
      }
     },
     "auth_ref": [
      "r224",
      "r317",
      "r328"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r490"
     ]
    },
    "country_ES": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "ES",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spain",
        "label": "SPAIN"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings per share [abstract]",
        "label": "Earnings per share [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EarningsPerShareExplanatory",
     "presentation": [
      "http://www.sophiagenetics.com/role/LosspershareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Loss for Year",
        "label": "Earnings per share [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of earnings per share."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "ifrs-full_EarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EarningsPerShareLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Line Items]",
        "label": "Earnings per share [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EarningsPerShareTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Table]",
        "label": "Earnings per share [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to earnings per share."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange differences on cash balances",
        "label": "Effect of exchange rate changes on cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r83"
     ]
    },
    "soph_EmployeeRelatedPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "EmployeeRelatedPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/AccountspayableDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountspayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee related payables",
        "label": "Employee Related Payables",
        "documentation": "Employee related payables."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Addresses, Address Type",
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r543"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r93",
      "r110",
      "r111",
      "r113",
      "r261",
      "r281",
      "r310",
      "r311",
      "r319",
      "r337",
      "r345"
     ]
    },
    "ifrs-full_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity",
        "label": "Equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and equity",
        "label": "Equity and liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "ifrs-full_EquityAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAndLiabilitiesAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and equity",
        "label": "Equity and liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityInvestmentsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity investments",
        "label": "Equity investments [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for investments in equity instruments."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r405"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r451",
      "r462",
      "r472",
      "r505"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r448",
      "r459",
      "r469",
      "r502"
     ]
    },
    "ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EstimateOfContributionsExpectedToBePaidToPlan",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected employer contributions for next annual reporting period",
        "label": "Estimate of contributions expected to be paid to plan for next annual reporting period"
       }
      },
      "en": {
       "role": {
        "documentation": "The estimate of the expected contributions to be made to a defined benefit plan for the next annual reporting period. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r29",
      "r31",
      "r256"
     ]
    },
    "ifrs-full_EstimatedFinancialEffectOfContingentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EstimatedFinancialEffectOfContingentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingent assets",
        "label": "Estimated financial effect of contingent assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the estimated financial effect of possible assets that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within control of the entity."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r267"
     ]
    },
    "soph_EuropeTheMiddleEastAndAfricaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "EuropeTheMiddleEastAndAfricaMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EMEA",
        "label": "Europe, The Middle East And Africa [Member]",
        "documentation": "Europe, The Middle East And Africa"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "soph_ExercisePriceMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ExercisePriceMeasurementInputMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price in USD",
        "label": "Exercise Price, Measurement Input [Member]",
        "documentation": "Exercise Price, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ExercisePriceOfWarrantRights": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ExercisePriceOfWarrantRights",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share of shares available to purchase under warrant certificate (in dollars per share)",
        "label": "Exercise Price Of Warrant Rights",
        "documentation": "Exercise Price Of Warrant Rights"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield (%)",
        "label": "Expected dividend as percentage, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "soph_ExpectedLeaseCommitments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ExpectedLeaseCommitments",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected lease commitments",
        "label": "Expected Lease Commitments",
        "documentation": "Expected lease commitments."
       }
      }
     },
     "auth_ref": []
    },
    "soph_ExpectedTermMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ExpectedTermMeasurementInputMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (years)",
        "label": "Expected Term, Measurement Input [Member]",
        "documentation": "Expected Term, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ExpectedVolatilityMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ExpectedVolatilityMeasurementInputMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility (annualized)",
        "label": "Expected Volatility, Measurement Input [Member]",
        "documentation": "Expected Volatility, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation expense",
        "label": "Expense from share-based payment transactions"
       }
      }
     },
     "auth_ref": [
      "r157",
      "r291"
     ]
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "verboseLabel": "Recast of employee benefit expenses",
        "label": "Expense from share-based payment transactions with employees"
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Movements in Share-based Compensation Reserve",
        "label": "Explanation of effect of share-based payments on entity's financial position [text block]"
       }
      },
      "en": {
       "role": {
        "documentation": "The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's financial position."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "soph_ExtraMandatoryPartEquivalentToDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ExtraMandatoryPartEquivalentToDiscountRate",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extra mandatory part equivalent to discount rate",
        "label": "Extra Mandatory Part Equivalent To Discount Rate",
        "documentation": "Extra mandatory part equivalent to discount rate."
       }
      }
     },
     "auth_ref": []
    },
    "country_FR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "FR",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails",
      "http://www.sophiagenetics.com/role/SegmentreportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "France",
        "terseLabel": "France",
        "label": "FRANCE"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails",
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net accounts receivable",
        "negatedPeriodStartLabel": "Balance at beginning of period",
        "negatedPeriodEndLabel": "Balance at end of period",
        "terseLabel": "Total financial assets",
        "label": "Financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r166",
      "r169",
      "r170",
      "r174",
      "r303",
      "r304",
      "r306",
      "r395"
     ]
    },
    "soph_FinancialAssetsAccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "FinancialAssetsAccountsReceivableMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails",
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Financial Assets, Accounts Receivable [Member]",
        "documentation": "Financial Assets, Accounts Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialAssetsAtAmortisedCostCategoryMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets at amortized cost",
        "label": "Financial assets at amortised cost, category [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets at amortised cost category. [Refer: Financial assets at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r183",
      "r298"
     ]
    },
    "ifrs-full_FinancialAssetsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialAssetsAtFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total financial assets",
        "label": "Financial assets, at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialAssetsAtFairValueThroughProfitOrLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets at fair value through profit or loss",
        "label": "Financial assets at fair value through profit or loss"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial assets that are measured at fair value and for which gains (losses) are recognised in profit or loss. A financial asset shall be measured at fair value through profit or loss unless it is measured at amortised cost or at fair value through other comprehensive income. A gain (loss) on a financial asset measured at fair value shall be recognised in profit or loss unless it is part of a hedging relationship, it is an investment in an equity instrument for which the entity has elected to present gains and losses in other comprehensive income or it is a financial asset measured at fair value through other comprehensive income. [Refer: At fair value [member]; Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r181",
      "r296"
     ]
    },
    "ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assets at fair value through statement of loss",
        "label": "Financial assets at fair value through profit or loss, category [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets at fair value through profit or loss category. [Refer: Financial assets at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r181",
      "r296"
     ]
    },
    "soph_FinancialAssumptionOfDiscountRates": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "FinancialAssumptionOfDiscountRates",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial assumptions increase (decrease) of discount rate",
        "label": "Financial Assumption Of Discount Rates",
        "documentation": "Financial Assumption Of Discount Rates"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total financial liabilities",
        "label": "Financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Classes of financial instruments [domain]; Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtAmortisedCostCategoryMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities at amortized cost",
        "label": "Financial liabilities at amortised cost, category [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial liabilities at amortised cost category. [Refer: Financial liabilities at amortised cost]"
       }
      }
     },
     "auth_ref": [
      "r184",
      "r299"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total financial liabilities",
        "negatedTerseLabel": "Warrant obligation at issuance",
        "label": "Financial liabilities, at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial liabilities at fair value through statement of loss",
        "label": "Financial liabilities at fair value through profit or loss, category [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the financial liabilities at fair value through profit or loss category. [Refer: Financial liabilities at fair value through profit or loss]"
       }
      }
     },
     "auth_ref": [
      "r182",
      "r297"
     ]
    },
    "ifrs-full_FinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails": {
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Current finished goods"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r418",
      "r426",
      "r557"
     ]
    },
    "ifrs-full_FixturesAndFittingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FixturesAndFittingsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Fixtures and fittings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r366"
     ]
    },
    "soph_ForeignExchangeAndOtherGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ForeignExchangeAndOtherGainLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange (losses) gains, net",
        "label": "Foreign Exchange And Other Gain (Loss)",
        "documentation": "Foreign Exchange And Other Gain (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ForeignExchangeSpotRate": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ForeignExchangeSpotRate",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofSignificantExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spot rate (in dollars per share)",
        "label": "Foreign Exchange Spot Rate",
        "documentation": "Foreign exchange, spot rate."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r466",
      "r476",
      "r509"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r466",
      "r476",
      "r509"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r466",
      "r476",
      "r509"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r466",
      "r476",
      "r509"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r466",
      "r476",
      "r509"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "soph_FrenchPensionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "FrenchPensionPlanMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "French Pension Plan",
        "label": "French Pension Plan [Member]",
        "documentation": "French pension plan."
       }
      }
     },
     "auth_ref": []
    },
    "soph_FrenchPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "FrenchPlanMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "French plan",
        "label": "French Plan [Member]",
        "documentation": "French Plan"
       }
      }
     },
     "auth_ref": []
    },
    "soph_FunctionalCurrencyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "FunctionalCurrencyMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Functional Currency",
        "label": "Functional Currency [Member]",
        "documentation": "Functional currency."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FunctionalOrPresentationCurrencyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FunctionalOrPresentationCurrencyMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Functional or presentation currency",
        "label": "Functional or presentation currency [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member indicates information displayed in the functional or presentation currency. It also represents the standard value for the \u2018Currency in which information is displayed\u2019 axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "ifrs-full_FundingArrangementsOfDefinedBenefitPlansAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FundingArrangementsOfDefinedBenefitPlansAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Funding arrangements of defined benefit plans [axis]",
        "label": "Funding arrangements of defined benefit plans [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "ifrs-full_FundingArrangementsOfDefinedBenefitPlansDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FundingArrangementsOfDefinedBenefitPlansDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Funding arrangements of defined benefit plans [domain]",
        "label": "Funding arrangements of defined benefit plans [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all defined benefit plans when disaggregated by funding arrangements of defined benefits plans. It also represents the standard value for the 'Funding arrangements of defined benefit plans' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "soph_FutureLeasePaymentsUnderShortTermLeasesNotRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "FutureLeasePaymentsUnderShortTermLeasesNotRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future lease payments under short-term leases not recognized",
        "label": "Future Lease Payments Under Short Term Leases Not Recognized",
        "documentation": "Future lease payments under short-term leases not recognized."
       }
      }
     },
     "auth_ref": []
    },
    "soph_GainLossOnDisposalOfLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "GainLossOnDisposalOfLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on disposal of lease liability",
        "label": "Gain (Loss) On Disposal Of Lease Liability",
        "documentation": "Gain (Loss) On Disposal Of Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofForeignExchangeLossesGainsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total foreign exchange gains (losses), net",
        "terseLabel": "Foreign exchange gain (loss)",
        "label": "Foreign exchange gain (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r38",
      "r257",
      "r329"
     ]
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "General and administrative costs",
        "label": "General and administrative expense"
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "soph_GeneralAndAdministrativeExpense1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "GeneralAndAdministrativeExpense1Member",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative costs",
        "verboseLabel": "General and administrative",
        "label": "General And Administrative Expense1 [Member]",
        "documentation": "General and administrative costs."
       }
      }
     },
     "auth_ref": []
    },
    "soph_GenesisHealthcareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "GenesisHealthcareMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Genesis Healthcare",
        "label": "Genesis Healthcare [Member]",
        "documentation": "Genesis Healthcare"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GeographicalAreasAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeographicalAreasAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails",
      "http://www.sophiagenetics.com/role/SegmentreportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical areas [axis]",
        "label": "Geographical areas [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r367",
      "r389",
      "r391",
      "r408"
     ]
    },
    "ifrs-full_GeographicalAreasDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeographicalAreasDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails",
      "http://www.sophiagenetics.com/role/SegmentreportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical areas [domain]",
        "label": "Geographical areas [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r367",
      "r389",
      "r391",
      "r408"
     ]
    },
    "ifrs-full_GoodwillMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GoodwillMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r373",
      "r414"
     ]
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail",
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross carrying amount",
        "verboseLabel": "Net carrying amount",
        "label": "Gross carrying amount [member]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r67",
      "r77",
      "r80",
      "r162",
      "r170",
      "r174",
      "r246",
      "r269",
      "r277",
      "r280",
      "r304",
      "r306",
      "r395"
     ]
    },
    "ifrs-full_GrossLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GrossLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail": {
       "parentTag": "soph_ContractualLiabilitiesUndiscountedCashFlows",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Gross lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to lease liabilities before deducting finance charges. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r131",
      "r214",
      "r399"
     ]
    },
    "ifrs-full_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross profit"
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "soph_GuardantHealthMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "GuardantHealthMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guardant",
        "label": "Guardant Health [Member]",
        "documentation": "Guardant Health"
       }
      }
     },
     "auth_ref": []
    },
    "country_IT": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "IT",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Italy",
        "label": "ITALY"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r434",
      "r435",
      "r458"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase",
        "label": "Impairment loss recognised in profit or loss"
       }
      }
     },
     "auth_ref": [
      "r57",
      "r60",
      "r263"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossGoodwill",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment",
        "label": "Impairment loss recognised in profit or loss, goodwill"
       }
      }
     },
     "auth_ref": [
      "r161",
      "r293"
     ]
    },
    "ifrs-full_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_IncomeStatementLocation1Axis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "IncomeStatementLocation1Axis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location1 [Axis]",
        "documentation": "Income Statement Location"
       }
      }
     },
     "auth_ref": []
    },
    "soph_IncomeStatementLocation1Domain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "IncomeStatementLocation1Domain",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location1 [Domain]",
        "documentation": "Income Statement Location [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss",
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails",
      "http://www.sophiagenetics.com/role/IncometaxSummaryofCurrentandDeferredIncomeTaxExpensesBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income tax expense",
        "negatedTotalLabel": "Total income tax (expense) benefit",
        "label": "Tax expense (income)"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r4",
      "r5",
      "r47",
      "r107",
      "r190",
      "r238",
      "r240",
      "r241",
      "r354"
     ]
    },
    "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Recognized in OCI",
        "label": "Income tax relating to components of other comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r239",
      "r355"
     ]
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income tax paid",
        "label": "Income taxes paid (refund), classified as operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r375"
     ]
    },
    "soph_IncreaseDecreaseInAuthorisedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "IncreaseDecreaseInAuthorisedCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Authorized increase in nominal share capital",
        "label": "Increase (Decrease) In Authorised Capital",
        "documentation": "Increase (Decrease) In Number Of Shares Authorised"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Decrease in cash and cash equivalents",
        "label": "Increase (decrease) in cash and cash equivalents before effect of exchange rate changes"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents before the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r233"
     ]
    },
    "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Decrease of 25 basis points",
        "label": "Increase (decrease) in defined benefit obligation due to reasonably possible decrease in actuarial assumption"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Increase of 25 basis points",
        "label": "Increase (decrease) in defined benefit obligation due to reasonably possible increase in actuarial assumption"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "soph_IncreaseDecreaseInNumberOfSharesAuthorised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "IncreaseDecreaseInNumberOfSharesAuthorised",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Authorized increase in nominal share capital issuance (in shares)",
        "label": "Increase (Decrease) In Number Of Shares Authorised",
        "documentation": "Increase (Decrease) In Number Of Shares Authorised"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation differences",
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from changes in foreign exchange rates, net defined benefit liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "soph_IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share options exercised and vesting of Restricted Stock Units",
        "label": "Increase (Decrease) Through Exercise Of Options And Vesting Of Other Equity Instruments, Equity",
        "documentation": "Increase (Decrease) Through Exercise Of Options And Vesting Of Other Equity Instruments, Equity"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughForeignExchangeFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughForeignExchangeFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Currency translation adjustments",
        "label": "Increase (decrease) through foreign exchange, financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in financial assets resulting from foreign exchange. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r393",
      "r403",
      "r415"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Currency translation differences",
        "label": "Increase (decrease) through net exchange differences, deferred tax liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in deferred tax liability (asset) resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Deferred tax liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "soph_IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation differences",
        "label": "Increase (Decrease) Through Net Exchange Differences, Defined Benefit Plans",
        "documentation": "Currency translation differences defined benefit plans."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency Translation Adjustment",
        "label": "Increase (decrease) through net exchange differences, intangible assets and goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets and goodwill resulting from the net exchange differences arising when the financial statements are translated from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r560"
     ]
    },
    "soph_IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Currency translation differences",
        "label": "Increase (Decrease) Through Net Exchange Differences, Pension Remeasurement Of Defined Benefit Plans",
        "documentation": "Pension remeasurement currency translation differences."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency Translation Adjustment",
        "label": "Increase (decrease) through net exchange differences, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.sophiagenetics.com/role/SharebasedcompensationMovementsinSharebasedCompensationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Movement in the period",
        "label": "Increase (decrease) through share-based payment transactions, equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r466",
      "r476",
      "r500",
      "r509",
      "r513",
      "r521"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r436",
      "r525"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r436",
      "r525"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r436",
      "r525"
     ]
    },
    "ifrs-full_IntangibleAssetsAndGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsAndGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Intangible assets and goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets",
        "label": "Intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r68",
      "r270",
      "r331"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity value",
        "label": "Intangible assets other than goodwill, revalued assets, at cost"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets other than goodwill that would have been recognised had the revalued intangible assets been measured using the cost model after recognition. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r273"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated equity value",
        "label": "Intangible assets other than goodwill, revalued assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets other than goodwill that are accounted for at revalued amounts. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r272"
     ]
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillRevaluationSurplus": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwillRevaluationSurplus",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exceeds the reported net assets",
        "label": "Intangible assets other than goodwill, revaluation surplus"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of revaluation surplus that relates to intangible assets other than goodwill. [Refer: Intangible assets other than goodwill; Revaluation surplus]"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r274"
     ]
    },
    "ifrs-full_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": -1.0,
       "order": 4.0
      },
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss",
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "totalLabel": "Total interest expense",
        "label": "Interest expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of expense arising from interest."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r189",
      "r196"
     ]
    },
    "ifrs-full_InterestExpenseDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseDefinedBenefitPlans",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest expense, defined benefit plans"
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "ifrs-full_InterestExpenseIncomeDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseIncomeDefinedBenefitPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails": {
       "parentTag": "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest cost",
        "label": "Interest expense (income), defined benefit plans"
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseIncomeNetDefinedBenefitLiabilityAsset",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)"
       }
      }
     },
     "auth_ref": [
      "r22",
      "r254"
     ]
    },
    "ifrs-full_InterestExpenseOnBankLoansAndOverdrafts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseOnBankLoansAndOverdrafts",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails": {
       "parentTag": "ifrs-full_InterestExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest on loans",
        "label": "Interest expense on bank loans and overdrafts"
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "ifrs-full_InterestExpenseOnBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseOnBorrowings",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest expense",
        "label": "Interest expense on borrowings"
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseOnLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails": {
       "parentTag": "ifrs-full_InterestExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest on lease liabilities",
        "label": "Interest expense on lease liabilities"
       }
      }
     },
     "auth_ref": [
      "r126",
      "r209"
     ]
    },
    "ifrs-full_InterestExpenseOnOtherFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseOnOtherFinancialLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails": {
       "parentTag": "ifrs-full_InterestExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other interest",
        "label": "Interest expense on other financial liabilities"
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "soph_InterestIncomeExpenseAndForeignExchangeGainLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "InterestIncomeExpenseAndForeignExchangeGainLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income (Expense) And Foreign Exchange Gain (Loss) [Abstract]",
        "documentation": "Interest Income (Expense) And Other"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestPaidClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestPaidClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest paid",
        "label": "Interest paid, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "ifrs-full_InterestPaidClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestPaidClassifiedAsOperatingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest paid",
        "label": "Interest paid, classified as operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "soph_InterestPaidOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "InterestPaidOnLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on lease liability payments",
        "label": "Interest Paid On Lease Liabilities",
        "documentation": "Interest Paid On Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestRateMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestRateMeasurementInputMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Interest rate, measurement input [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an interest rate used as a measurement input."
       }
      }
     },
     "auth_ref": [
      "r386"
     ]
    },
    "ifrs-full_InterestReceivedClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestReceivedClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest received",
        "label": "Interest received, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as investing activities."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "ifrs-full_Inventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Inventories",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets",
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "totalLabel": "Total",
        "label": "Current inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r35",
      "r230",
      "r333",
      "r423"
     ]
    },
    "soph_InventoryCurrencyTranslationAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "InventoryCurrencyTranslationAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryProvisionMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Currency translation adjustment",
        "label": "Inventory Currency Translation Adjustment",
        "documentation": "Inventory currency translation adjustment."
       }
      }
     },
     "auth_ref": []
    },
    "soph_InventoryIncreaseInProvision": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "InventoryIncreaseInProvision",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryProvisionMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Increase",
        "label": "Inventory Increase In Provision",
        "documentation": "Inventory Increase In Provision"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InventoryWritedown2011": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InventoryWritedown2011",
     "presentation": [
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryProvisionMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Write-off",
        "label": "Inventory write-down"
       }
      }
     },
     "auth_ref": [
      "r36",
      "r231",
      "r357"
     ]
    },
    "ifrs-full_InvestmentAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InvestmentAccountedForUsingEquityMethod",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Investment",
        "label": "Investments accounted for using equity method"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]"
       }
      }
     },
     "auth_ref": [
      "r108",
      "r192",
      "r309",
      "r332"
     ]
    },
    "ifrs-full_IssueOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssueOfEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from ATM offering, net of transaction costs",
        "verboseLabel": "Aggregate offing price",
        "label": "Issue of equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital",
        "label": "Issued capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r427"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share capital",
        "label": "Issued capital [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Key management personnel compensation"
       }
      }
     },
     "auth_ref": [
      "r44",
      "r259"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationPostemploymentBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationPostemploymentBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension costs",
        "label": "Key management personnel compensation, post-employment benefits"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationSharebasedPayment",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "Key management personnel compensation, share-based payment"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails": {
       "parentTag": "ifrs-full_KeyManagementPersonnelCompensation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/RelatedpartiesSummaryofCompensationforKeyManagementandNonexecutiveDirectorsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Salaries and other short-term employee benefits",
        "label": "Key management personnel compensation, short-term employee benefits"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "soph_LPPInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "LPPInterestRate",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LPP interest rate",
        "label": "LPP Interest Rate",
        "documentation": "LPP interest rate."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanFiveYearsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "After 5 years",
        "label": "Later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r134",
      "r140",
      "r217",
      "r221",
      "r398",
      "r401",
      "r404"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Between 1 and 5 years",
        "label": "Later than one year and not later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than five years."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r220",
      "r397",
      "r404"
     ]
    },
    "srt_LatinAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "LatinAmericaMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LATAM",
        "label": "Latin America [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_LeaseDirectCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "LeaseDirectCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial direct costs to obtain lease",
        "label": "Lease Direct Costs",
        "documentation": "Lease Direct Costs"
       }
      }
     },
     "auth_ref": []
    },
    "soph_LeaseExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "LeaseExpenses",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease expenses",
        "label": "Lease Expenses",
        "documentation": "Lease expenses."
       }
      }
     },
     "auth_ref": []
    },
    "soph_LeaseIncentivesAndExpectedRestorationCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "LeaseIncentivesAndExpectedRestorationCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease incentives and expected restoration costs",
        "label": "Lease Incentives And Expected Restoration Costs",
        "documentation": "Lease incentives and expected restoration costs."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "totalLabel": "Lease liabilities",
        "label": "Lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "soph_LeaseLiabilitiesDiscountedPaymentsRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "LeaseLiabilitiesDiscountedPaymentsRate",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities discounted payments rate",
        "label": "Lease Liabilities Discounted Payments Rate",
        "documentation": "Lease liabilities discounted payments rate."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseLiabilitiesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Lease liabilities [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r381",
      "r384"
     ]
    },
    "soph_LeaseLiabilitiesRelatedTemporaryDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "LeaseLiabilitiesRelatedTemporaryDifferencesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability",
        "label": "Lease Liabilities Related Temporary Differences [Member]",
        "documentation": "Temporary difference lease liability."
       }
      }
     },
     "auth_ref": []
    },
    "soph_LeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "LeaseTerm",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term",
        "label": "Lease Term",
        "documentation": "Lease term."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold improvements [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Level1OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Level1OfFairValueHierarchyMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Level 1 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r63",
      "r64",
      "r111",
      "r266",
      "r311"
     ]
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Level2OfFairValueHierarchyMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Level 2 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r111",
      "r266",
      "r311"
     ]
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Level3OfFairValueHierarchyMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Level 3 of fair value hierarchy [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r111",
      "r266",
      "r311"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Levels of fair value hierarchy [axis]",
        "label": "Levels of fair value hierarchy [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r111",
      "r311"
     ]
    },
    "ifrs-full_LevelsOfFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LevelsOfFairValueHierarchyDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Levels of fair value hierarchy [domain]",
        "label": "Levels of fair value hierarchy [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r111",
      "r311"
     ]
    },
    "ifrs-full_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r111",
      "r113",
      "r191",
      "r195",
      "r310",
      "r311",
      "r337"
     ]
    },
    "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LiabilityAssetOfDefinedBenefitPlans",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedPeriodStartLabel": "Balance at beginning of period",
        "negatedPeriodEndLabel": "Balance at end of period",
        "label": "Net defined benefit liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r21",
      "r253"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "soph_LongTermLeaseReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "LongTermLeaseReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term lease receivables",
        "label": "Long Term Lease Receivables",
        "documentation": "Long-term lease receivables."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LongtermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LongtermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "label": "Non-current portion of non-current borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ifrs-full_LongtermBorrowingsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LongtermBorrowingsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings",
        "label": "Long-term borrowings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for long-term borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r381",
      "r384"
     ]
    },
    "ifrs-full_LossesOnLitigationSettlements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LossesOnLitigationSettlements",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation ordered payment of interim award costs",
        "label": "Losses on litigation settlements"
       }
      }
     },
     "auth_ref": [
      "r358"
     ]
    },
    "ifrs-full_MachineryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MachineryMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment",
        "label": "Machinery [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing long-lived, depreciable machinery used in operations. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "soph_MajorBorrowingTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "MajorBorrowingTransactionsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/CapitalmanagementDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Major Borrowing Transactions",
        "label": "Major Borrowing Transactions [Member]",
        "documentation": "Major Borrowing Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MajorComponentsOfTaxExpenseIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorComponentsOfTaxExpenseIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Major components of tax expense (income) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Major customers [axis]",
        "label": "Major customers [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_MajorCustomersDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorCustomersDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Major customers [domain]",
        "label": "Major customers [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r200"
     ]
    },
    "ifrs-full_MajorOrdinaryShareTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorOrdinaryShareTransactionsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Major ordinary share transactions",
        "label": "Major ordinary share transactions [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for major ordinary share transactions. [Refer: Ordinary shares [member]]"
       }
      }
     },
     "auth_ref": [
      "r360",
      "r409"
     ]
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity [axis]",
        "label": "Maturity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r133",
      "r134",
      "r137",
      "r138",
      "r139",
      "r140",
      "r165",
      "r177",
      "r203",
      "r207",
      "r218",
      "r222",
      "r301",
      "r340",
      "r371",
      "r398"
     ]
    },
    "ifrs-full_MaturityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaturityDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity [domain]",
        "label": "Maturity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r133",
      "r134",
      "r137",
      "r138",
      "r139",
      "r140",
      "r165",
      "r203",
      "r207",
      "r218",
      "r222",
      "r301",
      "r340",
      "r371",
      "r398",
      "r402"
     ]
    },
    "ifrs-full_MaximumExposureToCreditRisk": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaximumExposureToCreditRisk",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum exposure to credit risk",
        "label": "Maximum exposure to credit risk"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that best represents the maximum exposure to credit risk without taking into account any collateral held or other credit enhancements (for example, netting agreements that do not qualify for offset in accordance with IAS 32). [Refer: Credit risk [member]]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_MeasurementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MeasurementAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement [axis]",
        "label": "Measurement [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r79",
      "r110",
      "r279",
      "r310"
     ]
    },
    "ifrs-full_MeasurementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MeasurementDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement [domain]",
        "label": "Measurement [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r79",
      "r110",
      "r279",
      "r310"
     ]
    },
    "ifrs-full_MiscellaneousNoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MiscellaneousNoncurrentAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Miscellaneous non-current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "ifrs-full_NameOfSubsidiary": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NameOfSubsidiary",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Name of subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The name of a subsidiary. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r50",
      "r95",
      "r96"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "ifrs-full_NetDeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetDeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Net deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r545"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "soph_NetLeaseReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NetLeaseReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net lease receivables",
        "label": "Net Lease Receivables",
        "documentation": "Net lease receivables."
       }
      }
     },
     "auth_ref": []
    },
    "soph_NetOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NetOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net operating loss carryforwards",
        "label": "Net Operating Loss Carryforwards",
        "documentation": "Net operating loss carryforwards."
       }
      }
     },
     "auth_ref": []
    },
    "soph_NetOperatingLossCarryforwardsThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NetOperatingLossCarryforwardsThereafter",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails": {
       "parentTag": "soph_NetOperatingLossCarryforwards",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter and unlimited",
        "label": "Net Operating Loss Carryforwards, Thereafter",
        "documentation": "Net operating loss carryforwards thereafter and unlimited."
       }
      }
     },
     "auth_ref": []
    },
    "soph_NetOperatingLossCarryforwardsYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NetOperatingLossCarryforwardsYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails": {
       "parentTag": "soph_NetOperatingLossCarryforwards",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Four years",
        "label": "Net Operating Loss Carryforwards, Year Four",
        "documentation": "Net operating loss carryforwards year four."
       }
      }
     },
     "auth_ref": []
    },
    "soph_NetOperatingLossCarryforwardsYearOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NetOperatingLossCarryforwardsYearOne",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails": {
       "parentTag": "soph_NetOperatingLossCarryforwards",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "One year",
        "label": "Net Operating Loss Carryforwards, Year One",
        "documentation": "Net operating loss carryforwards year one."
       }
      }
     },
     "auth_ref": []
    },
    "soph_NetOperatingLossCarryforwardsYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NetOperatingLossCarryforwardsYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails": {
       "parentTag": "soph_NetOperatingLossCarryforwards",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Three years",
        "label": "Net Operating Loss Carryforwards, Year Three",
        "documentation": "Net operating loss carryforwards year three."
       }
      }
     },
     "auth_ref": []
    },
    "soph_NetOperatingLossCarryforwardsYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NetOperatingLossCarryforwardsYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails": {
       "parentTag": "soph_NetOperatingLossCarryforwards",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofNetOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Two years",
        "label": "Net Operating Loss Carryforwards, Year Two",
        "documentation": "Net operating loss carryforwards year two."
       }
      }
     },
     "auth_ref": []
    },
    "soph_NonCurrentContractAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NonCurrentContractAcquisitionCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non\u2011current contract acquisition costs",
        "label": "Non Current Contract Acquisition Costs",
        "documentation": "Non Current Contract Acquisition Costs"
       }
      }
     },
     "auth_ref": []
    },
    "soph_NonCurrentDepositsGuarantyAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NonCurrentDepositsGuarantyAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantee deposits",
        "label": "Non-Current Deposits Guaranty Assets",
        "documentation": "Non-Current Deposits Guaranty Assets"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r455",
      "r466",
      "r476",
      "r500",
      "r509"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/CapitalmanagementDetails",
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-adjusting events after reporting period [axis]",
        "label": "Non-adjusting events after reporting period [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r237"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/CapitalmanagementDetails",
      "http://www.sophiagenetics.com/role/CommitmentsandcontingenciesDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-adjusting events after reporting period [domain]",
        "label": "Non-adjusting events after reporting period [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r237"
     ]
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current assets",
        "label": "Non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r341",
      "r385"
     ]
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current assets",
        "label": "Non-current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/SegmentreportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total non-current assets other than financial instruments and deferred tax assets",
        "label": "Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets and rights arising under insurance contracts. [Refer: Deferred tax assets; Classes of financial instruments [domain]; Non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r198"
     ]
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails": {
       "parentTag": "ifrs-full_LeaseLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets",
      "http://www.sophiagenetics.com/role/LeasesSummaryofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities, net of current portion",
        "verboseLabel": "Non-current lease liabilities",
        "label": "Non-current lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total non-current liabilities",
        "label": "Non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r342",
      "r385"
     ]
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLiabilitiesAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-current liabilities",
        "label": "Non-current liabilities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentRecognisedLiabilitiesDefinedBenefitPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentRecognisedLiabilitiesDefinedBenefitPlan",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined benefit pension liabilities",
        "label": "Non-current net defined benefit liability"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current net defined benefit liability. [Refer: Net defined benefit liability]"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ifrs-full_NoncurrentValueAddedTaxReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentValueAddedTaxReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research tax credit receivable",
        "label": "Non-current value added tax receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current value added tax receivables. [Refer: Value added tax receivables]"
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "ifrs-full_NonderivativeFinancialLiabilitiesUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonderivativeFinancialLiabilitiesUndiscountedCashFlows",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total contractual liabilities",
        "label": "Non-derivative financial liabilities, undiscounted cash flows"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to non-derivative financial liabilities."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r307"
     ]
    },
    "srt_NorthAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "NorthAmericaMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NORAM",
        "label": "North America [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NotLaterThanOneYearMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Within 1 year",
        "label": "Not later than one year [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r134",
      "r140",
      "r215",
      "r219",
      "r339",
      "r398",
      "r404"
     ]
    },
    "soph_NumberOfActiveMembers": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfActiveMembers",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of active members",
        "label": "Number Of Active Members",
        "documentation": "Number of active members."
       }
      }
     },
     "auth_ref": []
    },
    "soph_NumberOfCashGeneratingUnit": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfCashGeneratingUnit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash-generating units",
        "label": "Number Of Cash-Generating Unit",
        "documentation": "Number of operating segment."
       }
      }
     },
     "auth_ref": []
    },
    "soph_NumberOfConditionalSharesAuthorised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfConditionalSharesAuthorised",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of conditional share capital available for financing (in shares)",
        "label": "Number Of Conditional Shares Authorised",
        "documentation": "Number Of Conditional Shares Authorised"
       }
      }
     },
     "auth_ref": []
    },
    "soph_NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of conditional share capital available for employee participation (in shares)",
        "label": "Number Of Conditional Shares Authorised In Share-Based Payment Arrangement",
        "documentation": "Number Of Conditional Shares Authorised In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "soph_NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfEquityInstrumentsInShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options",
        "label": "Number Of Equity Instruments In Share-Based Payment Arrangement [Abstract]",
        "documentation": "Number Of Equity Instruments In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "soph_NumberOfEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfEquitySharesIssued",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from ATM offering, net of transaction costs (in shares)",
        "verboseLabel": "Number of shares sold under ATM program (in shares)",
        "label": "Number Of Equity Shares Issued",
        "documentation": "Number Of Shares Issued Of Equity"
       }
      }
     },
     "auth_ref": []
    },
    "soph_NumberOfExecutiveOfficers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfExecutiveOfficers",
     "presentation": [
      "http://www.sophiagenetics.com/role/RelatedpartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of executive officers",
        "label": "Number Of Executive Officers",
        "documentation": "Number Of Executive Officers"
       }
      }
     },
     "auth_ref": []
    },
    "soph_NumberOfFinancialInstruments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfFinancialInstruments",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of separate financial instrument",
        "label": "Number Of Financial Instruments",
        "documentation": "Number Of Financial Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Number of other equity instruments granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r155",
      "r572"
     ]
    },
    "soph_NumberOfLeases": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfLeases",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of leases",
        "label": "Number Of Leases",
        "documentation": "Number Of Leases"
       }
      }
     },
     "auth_ref": []
    },
    "soph_NumberOfNonExecutiveOfficers": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfNonExecutiveOfficers",
     "presentation": [
      "http://www.sophiagenetics.com/role/RelatedpartiesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of non-executive officers",
        "label": "Number Of Non-Executive Officers",
        "documentation": "Number Of Non-Executive Officers"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of instruments granted subject to four year vesting (in shares)",
        "negatedTerseLabel": "Vested (in shares)",
        "label": "Number of other equity instruments exercised or vested in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Number of other equity instruments forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "soph_NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of RSUs",
        "label": "Number Of Other Equity Instruments In Share-Based Payment Arrangement [Abstract]",
        "documentation": "Number Of Other Equity Instruments In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested at beginning of period (in shares)",
        "periodEndLabel": "Unvested at end of period (in shares)",
        "label": "Number of other equity instruments outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r572"
     ]
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOutstandingShareOptions",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in shares)",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "label": "Number of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r147",
      "r151",
      "r283",
      "r287"
     ]
    },
    "soph_NumberOfShareOptionPlans": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfShareOptionPlans",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of share option plans",
        "label": "Number Of Share Option Plans",
        "documentation": "Number of share option plans."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable (in shares)",
        "label": "Number of share options exercisable in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercisable in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r288"
     ]
    },
    "soph_NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share options exercised and vesting of Restricted Stock Units (in shares)",
        "label": "Number Of Share Options Exercised And Other Equity Instruments Vested In Share-Based Payment Arrangement",
        "documentation": "Number Of Share Options Exercised And Other Equity Instruments Vested In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share options exercised (in shares)",
        "negatedLabel": "Exercised (in shares)",
        "label": "Number of share options exercised in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r286"
     ]
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Number of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r285"
     ]
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of share options granted (in shares)",
        "verboseLabel": "Granted (in shares)",
        "label": "Number of share options granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r284"
     ]
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "periodEndLabel": "Balance at end of period (in shares)",
        "terseLabel": "Number of shares issued (in shares)",
        "label": "Number of shares issued"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "ifrs-full_NumberOfSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfSharesOutstanding",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares outstanding (in shares)",
        "label": "Number of shares outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r226",
      "r314",
      "r347"
     ]
    },
    "soph_NumberOfTreasurySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "NumberOfTreasurySharesIssued",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares to be held as treasury shares (in shares)",
        "label": "Number Of Treasury Shares Issued",
        "documentation": "Number Of Treasury Shares Purchased"
       }
      }
     },
     "auth_ref": []
    },
    "soph_OfficeSpaceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "OfficeSpaceMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office Space",
        "label": "Office Space [Member]",
        "documentation": "Office space."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OperatingLeaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OperatingLeaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues from payments from leased equipment recognized",
        "label": "Operating lease income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of operating lease income. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r223"
     ]
    },
    "ifrs-full_OrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OrdinarySharesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares",
        "label": "Ordinary shares [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive (loss) income for the period",
        "verboseLabel": "Other comprehensive income (loss)",
        "label": "Other comprehensive income"
       }
      }
     },
     "auth_ref": [
      "r103",
      "r324",
      "r350",
      "r356"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive (loss) income:",
        "label": "Other comprehensive income [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency translation adjustments",
        "label": "Other comprehensive income, net of tax, exchange differences on translation of foreign operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r356"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Remeasurement of defined benefit plans",
        "totalLabel": "Total recognized",
        "label": "Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) on remeasurements of defined benefit plans, which comprise actuarial gains and losses; the return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). [Refer: Other comprehensive income; Defined benefit plans [domain]; Plan assets [member]; Net defined benefit liability (asset)] [Contrast: Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r356",
      "r550"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total items that may be reclassified to statement of loss",
        "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r428",
      "r429"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "ifrs-full_OtherComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total items that will not be reclassified to statement of loss",
        "label": "Other comprehensive income that will not be reclassified to profit or loss, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r428",
      "r429"
     ]
    },
    "soph_OtherCountriesInEuropeMiddleEastAndAfricaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "OtherCountriesInEuropeMiddleEastAndAfricaMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of EMEA",
        "label": "Other Countries In Europe, Middle East, And Africa [Member]",
        "documentation": "Other Countries In Europe, Middle East, And Africa"
       }
      }
     },
     "auth_ref": []
    },
    "soph_OtherCountriesInNorthAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "OtherCountriesInNorthAmericaMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of NORAM",
        "label": "Other Countries In North America [Member]",
        "documentation": "Other Countries In North America"
       }
      }
     },
     "auth_ref": []
    },
    "soph_OtherFinancialNonCurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "OtherFinancialNonCurrentAssetsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financial non-current assets",
        "label": "Other Financial Non Current Assets [Member]",
        "documentation": "Other financial non-current assets."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets",
      "http://www.sophiagenetics.com/role/OthernoncurrentassetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current assets",
        "totalLabel": "Total",
        "label": "Other non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherNoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherOperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other operating (loss) income, net",
        "label": "Other operating income (expense)"
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "soph_OtherOperatingIncomeExpenseNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "OtherOperatingIncomeExpenseNetAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Operating Income Expense Net [Abstract]",
        "documentation": "Other operating income (expense), net."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "ifrs-full_OtherReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherReserves",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other reserves",
        "label": "Other reserves"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]"
       }
      }
     },
     "auth_ref": [
      "r419",
      "r427"
     ]
    },
    "ifrs-full_OtherReservesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherReservesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other reserves",
        "label": "Other reserves [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings]"
       }
      }
     },
     "auth_ref": [
      "r228",
      "r326"
     ]
    },
    "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Other tax effects for reconciliation between accounting profit and tax expense (income)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r240"
     ]
    },
    "ifrs-full_OtherTemporaryDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherTemporaryDifferencesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other temporary differences [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences that the entity does not separately disclose in the same statement or note. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r453",
      "r464",
      "r474",
      "r507"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r456",
      "r467",
      "r477",
      "r510"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r456",
      "r467",
      "r477",
      "r510"
     ]
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/LosspershareAdditionalinformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Par value (in dollars per share)",
        "verboseLabel": "Nominal value (in dollars per share)",
        "label": "Par value per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r225",
      "r313",
      "r346"
     ]
    },
    "ifrs-full_PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "of which past service cost including effects from curtailment",
        "negatedTerseLabel": "Past service cost gain",
        "label": "Past service cost and losses (gains) arising from settlements, defined benefit plans"
       }
      }
     },
     "auth_ref": [
      "r550"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments of principal portion of lease liabilities",
        "label": "Payments of lease liabilities, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r379"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r500"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r493"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "soph_PercentageOfCustomerBalanceAccountReceivable": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PercentageOfCustomerBalanceAccountReceivable",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of customer balance account receivable",
        "label": "Percentage Of Customer Balance Account Receivable",
        "documentation": "Percentage of customer balance account receivable."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PercentageOfReasonablyPossibleDecreaseInActuarialAssumption",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sensitivity analysis, basis point decrease",
        "label": "Percentage of reasonably possible decrease in actuarial assumption"
       }
      },
      "en": {
       "role": {
        "documentation": "The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sensitivity analysis, basis point increase",
        "label": "Percentage of reasonably possible increase in actuarial assumption"
       }
      },
      "en": {
       "role": {
        "documentation": "The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "soph_PerceptiveCreditAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PerceptiveCreditAgreementMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
      "http://www.sophiagenetics.com/role/CapitalmanagementDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Perceptive Credit Agreement",
        "label": "Perceptive Credit Agreement [Member]",
        "documentation": "Perceptive Credit Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "soph_PerceptiveCreditAgreementTrancheAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PerceptiveCreditAgreementTrancheAMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche A",
        "label": "Perceptive Credit Agreement, Tranche A [Member]",
        "documentation": "Perceptive Credit Agreement, Tranche A"
       }
      }
     },
     "auth_ref": []
    },
    "soph_PerceptiveCreditAgreementTrancheBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PerceptiveCreditAgreementTrancheBMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche B",
        "label": "Perceptive Credit Agreement, Tranche B [Member]",
        "documentation": "Perceptive Credit Agreement, Tranche B"
       }
      }
     },
     "auth_ref": []
    },
    "soph_PerceptiveCreditAgreementTrancheCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PerceptiveCreditAgreementTrancheCMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche C",
        "label": "Perceptive Credit Agreement, Tranche C [Member]",
        "documentation": "Perceptive Credit Agreement, Tranche C"
       }
      }
     },
     "auth_ref": []
    },
    "soph_PerceptiveCreditAgreementTrancheDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PerceptiveCreditAgreementTrancheDMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tranche D",
        "label": "Perceptive Credit Agreement, Tranche D [Member]",
        "documentation": "Perceptive Credit Agreement, Tranche D"
       }
      }
     },
     "auth_ref": []
    },
    "soph_PerceptiveCreditHoldingsIVLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PerceptiveCreditHoldingsIVLPMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Perceptive Credit Holdings IV, LP",
        "label": "Perceptive Credit Holdings IV, LP [Member]",
        "documentation": "Perceptive Credit Holdings IV, LP"
       }
      }
     },
     "auth_ref": []
    },
    "soph_PerceptiveCreditHoldingsWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PerceptiveCreditHoldingsWarrantsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Perceptive Credit Holdings Warrants",
        "label": "Perceptive Credit Holdings Warrants [Member]",
        "documentation": "Perceptive Credit Holdings Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "soph_PeriodOfReasonablyPossibleDecreaseInActuarialAssumption": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PeriodOfReasonablyPossibleDecreaseInActuarialAssumption",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sensitivity analysis, period decrease",
        "label": "Period Of Reasonably Possible Decrease In Actuarial Assumption",
        "documentation": "Period Of Reasonably Possible Decrease In Actuarial Assumption"
       }
      }
     },
     "auth_ref": []
    },
    "soph_PeriodOfReasonablyPossibleIncreaseInActuarialAssumption": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PeriodOfReasonablyPossibleIncreaseInActuarialAssumption",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sensitivity analysis, period increase",
        "label": "Period Of Reasonably Possible Increase In Actuarial Assumption",
        "documentation": "Period Of Reasonably Possible Increase In Actuarial Assumption"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PlanAssetsAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PlanAssetsAtFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails": {
       "parentTag": "ifrs-full_SurplusDeficitInPlan",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Plan assets, at fair value",
        "totalLabel": "Fair value of plan assets",
        "label": "Plan assets, at fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of defined benefit plan assets. Plan assets comprise assets held by a long-term employee benefit fund and qualifying insurance policies. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r483"
     ]
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PostemploymentBenefitExpenseDefinedBenefitPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total recognized",
        "label": "Post-employment benefit expense in profit or loss, defined benefit plans"
       }
      }
     },
     "auth_ref": [
      "r550",
      "r554"
     ]
    },
    "ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PostemploymentBenefitExpenseDefinedContributionPlans",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Post-employment benefit expense, 401(k) defined contribution plan",
        "label": "Post-employment benefit expense, defined contribution plans"
       }
      }
     },
     "auth_ref": [
      "r32",
      "r251"
     ]
    },
    "soph_PrepaymentsAndOtherCurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PrepaymentsAndOtherCurrentAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayments And Other Current Assets [Abstract]",
        "documentation": "Prepaids and other current assets."
       }
      }
     },
     "auth_ref": []
    },
    "soph_PresentationCurrencyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PresentationCurrencyMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Presentation Currency",
        "label": "Presentation Currency [Member]",
        "documentation": "Presentation currency."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PresentationOfLeasesForLesseeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PresentationOfLeasesForLesseeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Presentation of leases for lessee [abstract]",
        "label": "Presentation of leases for lessee [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_PrincipalPaidOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "PrincipalPaidOnLeaseLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Lease liability payments",
        "label": "Principal Paid On Lease Liabilities",
        "documentation": "Principal Paid On Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ProceedsFromBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ProceedsFromBorrowings",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails": {
       "parentTag": "soph_ProceedsFromBorrowingsNetOfCostsIncurred",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Draw down of term loans",
        "verboseLabel": "Gross proceeds",
        "label": "Proceeds From borrowings",
        "documentation": "Proceeds From borrowings"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from borrowings, net of transaction costs",
        "label": "Proceeds from borrowings, classified as financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r378"
     ]
    },
    "soph_ProceedsFromBorrowingsNetOfCostsIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ProceedsFromBorrowingsNetOfCostsIncurred",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofAllocationoftheLoanProceedsandMovementsinLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Proceeds net of transaction costs",
        "label": "Proceeds From Borrowings, Net Of Costs Incurred",
        "documentation": "Net Proceeds From Borrowings"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromExerciseOfOptions",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of share options",
        "label": "Proceeds from exercise of options"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r566"
     ]
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromIssuingShares",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of common stock in at-the-market offering",
        "verboseLabel": "Gross proceeds from shares sold under ATM program",
        "label": "Proceeds from issuing shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      }
     },
     "auth_ref": [
      "r377"
     ]
    },
    "soph_ProceedsFromWarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ProceedsFromWarrantLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of warrants",
        "label": "Proceeds From Warrant Liability",
        "documentation": "Stock Issue of During the Value Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLossAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss for the year",
        "verboseLabel": "Loss for the period",
        "terseLabel": "Loss for the period",
        "label": "Profit (loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r92",
      "r94",
      "r191",
      "r193",
      "r262",
      "r282",
      "r323",
      "r349",
      "r385",
      "r390"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss",
      "http://www.sophiagenetics.com/role/LosspershareComponentsofLossforYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Attributable to the owners of the parent",
        "terseLabel": "Net loss attributed to shareholders",
        "label": "Profit (loss), attributable to owners of parent"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r352"
     ]
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss before income taxes",
        "terseLabel": "Loss before tax",
        "label": "Profit (loss) before tax"
       }
      }
     },
     "auth_ref": [
      "r164",
      "r406",
      "r407",
      "r420",
      "r421"
     ]
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating loss",
        "label": "Profit (loss) from operating activities"
       }
      }
     },
     "auth_ref": [
      "r372",
      "r584"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets",
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r15",
      "r249",
      "r330"
     ]
    },
    "soph_ProvisionOfInventory": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ProvisionOfInventory",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails": {
       "parentTag": "ifrs-full_Inventories",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails",
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryProvisionMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Provision",
        "negatedPeriodStartLabel": "Balance at beginning of period",
        "negatedPeriodEndLabel": "Balance at end of period",
        "label": "Provision Of Inventory",
        "documentation": "Provision of inventory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Acquisition of intangible assets",
        "label": "Purchase of intangible assets, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "ifrs-full_PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of equity investments held at fair value",
        "label": "Purchase of interests in investments accounted for using equity method"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of interests in investments accounted for using the equity method. [Refer: Investments accounted for using equity method]"
       }
      }
     },
     "auth_ref": [
      "r565"
     ]
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of property and equipment",
        "label": "Purchase of property, plant and equipment, classified as investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r376"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "ifrs-full_QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails": {
       "parentTag": "ifrs-full_PlanAssetsAtFairValue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance policies",
        "label": "Qualifying insurance policies, amount contributed to fair value of plan assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount qualifying insurance policies contribute to the fair value of defined benefit plan assets. [Refer: Plan assets, at fair value; Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r551",
      "r556"
     ]
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range [axis]",
        "label": "Range [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r115",
      "r139",
      "r151",
      "r232",
      "r387",
      "r388",
      "r573"
     ]
    },
    "ifrs-full_RangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangeDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Range [domain]",
        "label": "Range [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r115",
      "r139",
      "r151",
      "r232",
      "r387",
      "r388",
      "r573"
     ]
    },
    "ifrs-full_RawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RawMaterials",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails": {
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Current raw materials"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r418",
      "r426",
      "r557"
     ]
    },
    "ifrs-full_ReceivablesFromContractsWithCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReceivablesFromContractsWithCustomersAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables from contracts with customers [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReconciliationOfChangesInDeferredTaxLiabilityAssetAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation Of Changes In Deferred Tax Liability (Asset) [Abstract]",
        "label": "Reconciliation of changes in deferred tax liability (asset) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ReconciliationOfChangesInDefinedBenefitObligationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ReconciliationOfChangesInDefinedBenefitObligationAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation Of Changes In Defined Benefit Obligation [Abstract]",
        "label": "Reconciliation Of Changes In Defined Benefit Obligation [Abstract]",
        "documentation": "Reconciliation Of Changes In Defined Benefit Obligation"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ReconciliationOfChangesInEquityInstrumentsInShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation Of Changes In Equity Instruments In Share-Based Payment Arrangement [Abstract]",
        "label": "Reconciliation Of Changes In Equity Instruments In Share-Based Payment Arrangement [Abstract]",
        "documentation": "Reconciliation Of Changes In Equity Instruments In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsIntangibleAssetsNetMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of changes in intangible assets other than goodwill [abstract]",
        "label": "Reconciliation of changes in intangible assets other than goodwill [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ReconciliationOfChangesInNetDefinedBenefitLiabilityAssetAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation Of Changes In Net Defined Benefit Liability (Asset) [Abstract]",
        "label": "Reconciliation Of Changes In Net Defined Benefit Liability (Asset) [Abstract]",
        "documentation": "Reconciliation Of Changes In Net Defined Benefit Liability (Asset)"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ReconciliationOfChangesInOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation Of Changes In Other Equity Instruments In Share-Based Payment Arrangement [Abstract]",
        "label": "Reconciliation Of Changes In Other Equity Instruments In Share-Based Payment Arrangement [Abstract]",
        "documentation": "Reconciliation Of Changes In Other Equity Instruments In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReconciliationOfChangesInPropertyPlantAndEquipmentAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentSummaryofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of changes in property, plant and equipment [abstract]",
        "label": "Reconciliation of changes in property, plant and equipment [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ReconciliationOfChangesInProvisionOfInventoryAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ReconciliationOfChangesInProvisionOfInventoryAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryProvisionMovementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation Of Changes In Provision Of Inventory [Abstract]",
        "label": "Reconciliation Of Changes In Provision Of Inventory [Abstract]",
        "documentation": "Reconciliation Of Changes In Provision Of Inventory"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ReconciliationOfChangesInShareBasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ReconciliationOfChangesInShareBasedPaymentsAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationMovementsinSharebasedCompensationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation Of Changes In Share-Based Payments [Abstract]",
        "label": "Reconciliation Of Changes In Share-Based Payments [Abstract]",
        "documentation": "Reconciliation Of Changes In Share-Based Payments"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r448",
      "r459",
      "r469",
      "r502"
     ]
    },
    "ifrs-full_RecurringFairValueMeasurementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RecurringFairValueMeasurementMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recurring fair value measurement",
        "label": "Recurring fair value measurement [member]"
       }
      }
     },
     "auth_ref": [
      "r110",
      "r310"
     ]
    },
    "soph_RedemptionPeriodOfWarrantRights": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "RedemptionPeriodOfWarrantRights",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise period of purchase rights on warrant certificate",
        "label": "Redemption Period Of Warrant Rights",
        "documentation": "Redemption Period Of Warrant Rights"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Research and development costs",
        "label": "Research and development expense"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r275"
     ]
    },
    "soph_ResearchAndDevelopmentExpense1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ResearchAndDevelopmentExpense1Member",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development costs",
        "verboseLabel": "Research and development",
        "label": "Research And Development Expense1 [Member]",
        "documentation": "Research and development costs."
       }
      }
     },
     "auth_ref": []
    },
    "soph_ResearchTaxCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ResearchTaxCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government grants for research and development and innovation",
        "label": "Research Tax Credit",
        "documentation": "Research tax credit."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReserveOfExchangeDifferencesOnTranslation",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase / (decrease) of equity in exchange rate",
        "label": "Reserve of exchange differences on translation"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r39",
      "r258"
     ]
    },
    "ifrs-full_ReserveOfSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReserveOfSharebasedPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationMovementsinSharebasedCompensationReserveDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Reserve of share-based payments"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity resulting from share-based payments."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "srt_RestatementAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementAdjustmentMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revision of Prior Period, Adjustment",
        "label": "Revision of Prior Period, Adjustment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revision of Prior Period [Axis]",
        "label": "Revision of Prior Period [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r449",
      "r460",
      "r470",
      "r503"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r450",
      "r461",
      "r471",
      "r504"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r457",
      "r468",
      "r478",
      "r511"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RestatementDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/MaterialaccountingpoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revision of Prior Period [Domain]",
        "label": "Revision of Prior Period [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_RestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "RestrictedStockUnitsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units",
        "label": "Restricted Stock Units [Member]",
        "documentation": "Restricted stock units."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RetainedEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RetainedEarnings",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained earnings"
       }
      },
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r427",
      "r429"
     ]
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained earnings [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r326",
      "r422"
     ]
    },
    "ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Return on plan assets, excl. interest income",
        "negatedTerseLabel": "Return on plan assets",
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [domain]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r23",
      "r255"
     ]
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromContractsWithCustomers",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss",
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "netLabel": "Revenue from contracts with customers",
        "verboseLabel": "Total revenue",
        "label": "Revenue from contracts with customers"
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117",
      "r204"
     ]
    },
    "soph_RevenueFromContractsWithCustomersExtendedPaymentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "RevenueFromContractsWithCustomersExtendedPaymentTerm",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extended term of payment agreements for products and services sold",
        "label": "Revenue From Contracts With Customers, Extended Payment Term",
        "documentation": "Revenue From Contracts With Customers, Extended Payment Term"
       }
      }
     },
     "auth_ref": []
    },
    "soph_RevenueFromContractsWithCustomersPaymentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "RevenueFromContractsWithCustomersPaymentTerm",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of payment agreements for products and services sold",
        "label": "Revenue From Contracts With Customers, Payment Term",
        "documentation": "Revenue From Contracts With Customers, Payment Term"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RevenueFromInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss",
      "http://www.sophiagenetics.com/role/InterestincomeInterestexpenseandForeignexchangelossesgainsnetSummaryofInterestIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest income",
        "terseLabel": "Total interest income",
        "label": "Interest income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income arising from interest."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r188",
      "r196",
      "r577"
     ]
    },
    "ifrs-full_ReversalOfImpairmentLossRecognisedInProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReversalOfImpairmentLossRecognisedInProfitOrLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofMovementinAllowanceforExpectedCreditLossesinAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reversals",
        "label": "Reversal of impairment loss recognised in profit or loss"
       }
      }
     },
     "auth_ref": [
      "r58",
      "r61",
      "r264"
     ]
    },
    "soph_RightOfUseAssetsDiscountedPaymentsRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "RightOfUseAssetsDiscountedPaymentsRate",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets discounted payments rate",
        "label": "Right-Of-Use Assets Discounted Payments Rate",
        "documentation": "Right-of-use assets discounted payments rate."
       }
      }
     },
     "auth_ref": []
    },
    "soph_RightOfUseAssetsRelatedTemporaryDifferencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "RightOfUseAssetsRelatedTemporaryDifferencesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ROU asset",
        "label": "Right-Of-Use Assets Related Temporary Differences [Member]",
        "documentation": "Temporary difference ROU asset."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets",
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/LeasesSummaryofRightofUseAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets",
        "label": "Right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r129",
      "r212"
     ]
    },
    "soph_RolleSwitzerlandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "RolleSwitzerlandMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rolle",
        "label": "Rolle, Switzerland [Member]",
        "documentation": "Rolle."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r520"
     ]
    },
    "soph_SOPHiADDMPlatformMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SOPHiADDMPlatformMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOPHiA DDM Platform",
        "label": "SOPHiA DDM Platform [Member]",
        "documentation": "SOPHiA platform."
       }
      }
     },
     "auth_ref": []
    },
    "soph_SOPHiAGENETICSGmbHMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SOPHiAGENETICSGmbHMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOPHiA GENETICS GmbH",
        "label": "SOPHiA GENETICS GmbH [Member]",
        "documentation": "SOPHiA GENETICS GmbH"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SaleOrIssueOfTreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SaleOrIssueOfTreasuryShares",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of shares to be held as treasury shares",
        "label": "Sale or issue of treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase in equity resulting from the sale or issue of treasury shares. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "ifrs-full_SalesAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SalesAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Selling and marketing costs",
        "label": "Sales and marketing expense"
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "soph_SalesAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SalesAndMarketingExpenseMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing",
        "label": "Sales And Marketing Expense [Member]",
        "documentation": "Sales And Marketing Expense"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ScheduleOfIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ScheduleOfIntangibleAssetsLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Intangible Assets [Line Items]",
        "label": "Schedule Of Intangible Assets [Line Items]",
        "documentation": "Schedule of intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "soph_ScheduleOfIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ScheduleOfIntangibleAssetsTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule Of Intangible Assets [Table]",
        "label": "Schedule Of Intangible Assets [Table]",
        "documentation": "Schedule of intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r433"
     ]
    },
    "ifrs-full_SegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SegmentsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [axis]",
        "label": "Segments [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r118",
      "r191",
      "r205",
      "r368",
      "r392"
     ]
    },
    "ifrs-full_SegmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SegmentsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [domain]",
        "label": "Segments [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r118",
      "r197",
      "r205",
      "r368",
      "r392"
     ]
    },
    "soph_SellingAndMarketingExpense1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SellingAndMarketingExpense1Member",
     "presentation": [
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofDepreciationandAmortizationhaveChargedinExpenseDetails",
      "http://www.sophiagenetics.com/role/OperatingexpenseSummaryofEmployeeBenefitExpensesSocialChargesandSharebasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling and marketing costs",
        "label": "Selling And Marketing Expense1 [Member]",
        "documentation": "Selling and marketing costs."
       }
      }
     },
     "auth_ref": []
    },
    "soph_SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in cash interest costs",
        "label": "Sensitivity Analysis For Borrowings, Interest Expense On Borrowings",
        "documentation": "Borrowing of Increase in Cash Interest Costs on Annualized Basis"
       }
      }
     },
     "auth_ref": []
    },
    "soph_SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis point change in interest rate",
        "label": "Sensitivity Analysis For Borrowings, Reasonably Possible Change In Interest Rate, Percentage",
        "documentation": "Sensitivity Analysis For Borrowings, Reasonably Possible Change In Interest Rate, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "soph_SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sensitivity analysis, change in exchange rate, percent",
        "label": "Sensitivity Analysis For Foreign Exchange Gain (Loss), Reasonably Possible Change In Currency Variable, Percent",
        "documentation": "Sensitivity Analysis For Foreign Exchange Gain (Loss), Reasonably Possible Change In Currency Variable, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "soph_SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sensitivity analysis, change in exchange rate, percent",
        "label": "Sensitivity Analysis For Reserve Of Exchange Differences On Translation, Reasonably Possible Change In Currency Variable, Percent",
        "documentation": "Sensitivity Analysis For Reserve Of Exchange Differences On Translation, Reasonably Possible Change In Currency Variable, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ServiceCostDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ServiceCostDefinedBenefitPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails": {
       "parentTag": "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Service Cost",
        "label": "Service Cost, Defined Benefit Plans",
        "documentation": "Service cost defined benefit plans."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ShareBasedPaymentArrangementVestingTrancheOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ShareBasedPaymentArrangementVestingTrancheOneMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Tranche One",
        "label": "Share-Based Payment Arrangement, Vesting Tranche One [Member]",
        "documentation": "Share-Based Payment Arrangement, Vesting Tranche One"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ShareBasedPaymentArrangementVestingTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ShareBasedPaymentArrangementVestingTrancheThreeMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Tranche Three",
        "label": "Share-Based Payment Arrangement, Vesting Tranche Three [Member]",
        "documentation": "Share-Based Payment Arrangement, Vesting Tranche Three"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ShareBasedPaymentArrangementVestingTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ShareBasedPaymentArrangementVestingTrancheTwoMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Tranche Two",
        "label": "Share-Based Payment Arrangement, Vesting Tranche Two [Member]",
        "documentation": "Share-Based Payment Arrangement, Vesting Tranche Two"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ShareBasedPaymentArrangementsVestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ShareBasedPaymentArrangementsVestingAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangements, Vesting [Axis]",
        "label": "Share-Based Payment Arrangements, Vesting [Axis]",
        "documentation": "Share-Based Payment Arrangements, Vesting"
       }
      }
     },
     "auth_ref": []
    },
    "soph_ShareBasedPaymentArrangementsVestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ShareBasedPaymentArrangementsVestingDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangements, Vesting [Domain]",
        "label": "Share-Based Payment Arrangements, Vesting [Domain]",
        "documentation": "Share-Based Payment Arrangements, Vesting [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SharePremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SharePremium",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share premium",
        "label": "Share premium"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r427"
     ]
    },
    "ifrs-full_SharePremiumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SharePremiumMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share premium",
        "label": "Share premium [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "soph_SharePriceMeasurementInputMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SharePriceMeasurementInputMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price in USD",
        "label": "Share Price, Measurement Input [Member]",
        "documentation": "Share Price, Measurement Input"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShorttermDepositsClassifiedAsCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails": {
       "parentTag": "ifrs-full_CashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term deposits less than 3 months",
        "label": "Short-term deposits, classified as cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "ifrs-full_ShorttermDepositsNotClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShorttermDepositsNotClassifiedAsCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of short-term deposits held by the entity that are not classified as cash equivalents. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "ifrs-full_ShorttermInvestmentsClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShorttermInvestmentsClassifiedAsCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails": {
       "parentTag": "ifrs-full_CashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/CashandcashequivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Short-term investments, classified as cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of cash equivalents representing short-term investments. [Refer: Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r570"
     ]
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails",
      "http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiaries [axis]",
        "label": "Subsidiaries [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r51",
      "r109",
      "r308"
     ]
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails",
      "http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiaries [domain]",
        "label": "Subsidiaries [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r51",
      "r109",
      "r308"
     ]
    },
    "ifrs-full_SignificantUnobservableInputLiabilities": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantUnobservableInputLiabilities",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Key inputs for valuations",
        "label": "Significant unobservable input, liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The value of significant unobservable input used in the measurement of the fair value of liabilities."
       }
      }
     },
     "auth_ref": [
      "r112"
     ]
    },
    "soph_SophiaGeneticLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SophiaGeneticLimitedMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOPHiA GENETICS LTD",
        "label": "Sophia Genetic Limited [Member]",
        "documentation": "Sophia Genetic Limited."
       }
      }
     },
     "auth_ref": []
    },
    "soph_SophiaGeneticsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SophiaGeneticsIncMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOPHiA GENETICS, Inc.",
        "label": "Sophia Genetics Inc [Member]",
        "documentation": "Sophia Genetics Inc."
       }
      }
     },
     "auth_ref": []
    },
    "soph_SophiaGeneticsIntermediacaoDeNegociosLTDAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SophiaGeneticsIntermediacaoDeNegociosLTDAMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOPHiA GENETICS Intermedia\u00e7\u00e3o de Neg\u00f3cios LTDA",
        "label": "Sophia Genetics Intermediacao De Negocios LTDA [Member]",
        "documentation": "Sophia Genetics Intermediacao de Negocios Eireli."
       }
      }
     },
     "auth_ref": []
    },
    "soph_SophiaGeneticsPtyLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SophiaGeneticsPtyLtdMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOPHiA GENETICS PTY LTD",
        "label": "Sophia Genetics Pty Ltd [Member]",
        "documentation": "Sophia Genetics Pty Ltd ."
       }
      }
     },
     "auth_ref": []
    },
    "soph_SophiaGeneticsSASMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SophiaGeneticsSASMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails",
      "http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "SOPHiA GENETICS S.A.S.",
        "terseLabel": "French subsidiary",
        "label": "Sophia Genetics S A S [Member]",
        "documentation": "Sophia Genetics SAS."
       }
      }
     },
     "auth_ref": []
    },
    "soph_SophiaGeneticsSRLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SophiaGeneticsSRLMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsSummaryofWhollyOwnedSubsidiariesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SOPHiA GENETICS S.R.L.",
        "label": "Sophia Genetics S R L [Member]",
        "documentation": "Sophia Genetics S.R.L."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement Of Changes In Equity [Line Items]",
        "label": "Statement of changes in equity [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement Of Changes In Equity [Table]",
        "label": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of comprehensive income [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r452",
      "r463",
      "r473",
      "r506"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subclassifications of assets, liabilities and equities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_SummaryOfMaterialAccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SummaryOfMaterialAccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary Of Material Accounting Policies [Abstract]",
        "label": "Summary Of Material Accounting Policies [Abstract]",
        "documentation": "Summary of significant accounting policies."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SurplusDeficitInPlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SurplusDeficitInPlan",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofAdditionalDetailsonDefinedPensionPlansFundedStatusDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net pension liability",
        "label": "Surplus (deficit) in plan"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]"
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "soph_SwissPensionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SwissPensionPlanMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Swiss Pension Plan",
        "label": "Swiss Pension Plan [Member]",
        "documentation": "Swiss pension plan."
       }
      }
     },
     "auth_ref": []
    },
    "soph_SwissPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "SwissPlanMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Swiss plan",
        "label": "Swiss Plan [Member]",
        "documentation": "Swiss Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "soph_TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized deferred tax assets",
        "label": "Tax Benefit Arising From Unrecognised Tax Loss, Tax Credit Or Temporary Difference Of Prior Period Used To Reduce Deferred Tax Expense",
        "documentation": "Tax Benefit Arising From Unrecognised Tax Loss, Tax Credit Or Temporary Difference Of Prior Period Used To Reduce Deferred Tax Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Expense not deductible for tax purposes",
        "label": "Tax effect of expense not deductible in determining taxable profit (tax loss)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r240"
     ]
    },
    "ifrs-full_TaxEffectOfForeignTaxRates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxEffectOfForeignTaxRates",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Effect of tax rates in foreign jurisdictions",
        "label": "Tax effect of foreign tax rates"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r240"
     ]
    },
    "soph_TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income not subject to tax",
        "label": "Tax Effect Of Income Not Deductible In Determining Taxable Profit (Tax Loss)",
        "documentation": "Tax effect of income and expense not subject to tax."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxEffectOfTaxLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxEffectOfTaxLosses",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax effect",
        "label": "Tax effect of tax losses"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r240"
     ]
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxReconciliationofExpectedTaxExpensetoTaxExpenseReportinStatementofLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Tax at Swiss statutory rate",
        "label": "Tax expense (income) at applicable tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r240"
     ]
    },
    "soph_TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax liability including interest and penalties",
        "label": "Tax Liabilities That Have Not Been Recognised Including Interest And Penalties",
        "documentation": "Unrecognized tax liability including interest and penalties."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TemporaryDifferenceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TemporaryDifferenceMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deductible temporary differences",
        "label": "Temporary differences [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for differences between the carrying amount of an asset or liability in the statement of financial position and its tax base. Temporary differences may be either: (a) taxable temporary differences; or (b) deductible temporary differences. [Refer: Carrying amount [member]]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r244"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails",
      "http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Temporary difference, unused tax losses and unused tax credits [axis]",
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r244"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails",
      "http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Temporary difference, unused tax losses and unused tax credits [domain]",
        "label": "Temporary difference, unused tax losses and unused tax credits [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r244"
     ]
    },
    "soph_TermSecuredOvernightFinancingRateSOFRFloorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "TermSecuredOvernightFinancingRateSOFRFloorMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term SOFR Floor",
        "label": "Term Secured Overnight Financing Rate (SOFR), Floor [Member]",
        "documentation": "Term Secured Overnight Financing Rate (SOFR), Floor"
       }
      }
     },
     "auth_ref": []
    },
    "soph_TermSecuredOvernightFinancingRateSOFRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "TermSecuredOvernightFinancingRateSOFRMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term SOFR",
        "label": "Term Secured Overnight Financing Rate (SOFR) [Member]",
        "documentation": "Term Secured Overnight Financing Rate (SOFR)"
       }
      }
     },
     "auth_ref": []
    },
    "soph_TermSecuredOvernightFinancingRateSOFRUponDefaultMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "TermSecuredOvernightFinancingRateSOFRUponDefaultMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term SOFR upon event default",
        "label": "Term Secured Overnight Financing Rate (SOFR), Upon Default [Member]",
        "documentation": "Term Secured Overnight Financing Rate (SOFR), Upon Default"
       }
      }
     },
     "auth_ref": []
    },
    "soph_TerminationOfBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "TerminationOfBorrowings",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination of existing borrowings",
        "label": "Termination Of Borrowings",
        "documentation": "Termination Of Borrowings"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail",
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofEquityToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofLossBeforeTaxToChangesinForeignExchangeRatesDetail",
      "http://www.sophiagenetics.com/role/LeasesAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Top of range [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r115",
      "r139",
      "r151",
      "r232",
      "r387",
      "r388",
      "r573"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r491"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r498"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.sophiagenetics.com/role/AccountspayableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountspayableDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "totalLabel": "Total",
        "label": "Current trade payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      }
     },
     "auth_ref": [
      "r424",
      "r582"
     ]
    },
    "ifrs-full_TradeAndOtherCurrentReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Trade and other current receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]"
       }
      }
     },
     "auth_ref": [
      "r318",
      "r334",
      "r344"
     ]
    },
    "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesToTradeSuppliers",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/AccountspayableDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountspayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade payables",
        "label": "Trade payables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business."
       }
      }
     },
     "auth_ref": [
      "r582"
     ]
    },
    "ifrs-full_TradeAndOtherPayablesUndiscountedCashFlows": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherPayablesUndiscountedCashFlows",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail": {
       "parentTag": "soph_ContractualLiabilitiesUndiscountedCashFlows",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofMaturityProfileofFinancialLiabilitiesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Trade and other payables, undiscounted cash flows"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contractual undiscounted cash flows in relation to trade and other payables. [Refer: Trade and other payables]"
       }
      }
     },
     "auth_ref": [
      "r400",
      "r404"
     ]
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivables [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_TradeAndOtherReceivablesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "TradeAndOtherReceivablesLineItems",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade And Other Receivables [Line Items]",
        "label": "Trade And Other Receivables [Line Items]",
        "documentation": "Trade And Other Receivables [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_TradeAndOtherReceivablesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "TradeAndOtherReceivablesTable",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableAdditionalInformationDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade And Other Receivables [Table]",
        "label": "Trade And Other Receivables [Table]",
        "documentation": "Trade And Other Receivables [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeReceivablesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeReceivablesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountsreceivableSummaryofAccountsReceivableandLeaseReceivableLessExpectedCreditLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Trade receivable",
        "label": "Trade receivables [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r168",
      "r173",
      "r302",
      "r305",
      "r395",
      "r577"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.sophiagenetics.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "soph_TransactionsWithOwnersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "TransactionsWithOwnersAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transactions with owners",
        "label": "Transactions With Owners [Abstract]",
        "documentation": "Transactions with owners."
       }
      }
     },
     "auth_ref": []
    },
    "soph_TransfersOutInDueToJoinersLeaversDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "TransfersOutInDueToJoinersLeaversDefinedBenefitPlans",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitPlansAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transfers (in) out due to (joiners) leavers",
        "negatedLabel": "Transfers in (out) due to joiners (leavers)",
        "label": "Transfers Out (In) Due To Joiners Leavers Defined Benefit Plans",
        "documentation": "Transfers (in) out due to (joiners) leavers defined benefit plans."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "ifrs-full_TreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TreasuryShares",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury shares",
        "label": "Treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r419",
      "r427"
     ]
    },
    "ifrs-full_TreasurySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TreasurySharesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/CompanyinformationandoperationsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofChangesinEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Share capital",
        "label": "Treasury shares [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r326"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Types of share-based payment arrangements [axis]",
        "label": "Types of share-based payment arrangements [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r290"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Types of share-based payment arrangements [domain]",
        "label": "Types of share-based payment arrangements [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r290"
     ]
    },
    "soph_UBSSwitzerlandAGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "UBSSwitzerlandAGMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "UBS Switzerland AG",
        "label": "UBS Switzerland AG [Member]",
        "documentation": "UBS Switzerland AG"
       }
      }
     },
     "auth_ref": []
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "US",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails",
      "http://www.sophiagenetics.com/role/SegmentreportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "verboseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UndrawnBorrowingFacilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UndrawnBorrowingFacilities",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/CapitalmanagementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings that can be drawn immediately",
        "label": "Undrawn borrowing facilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of undrawn borrowing facilities that may be available for future operating activities and to settle capital commitments. [Refer: Capital commitments]"
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r518"
     ]
    },
    "ifrs-full_UnobservableInputsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UnobservableInputsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unobservable inputs [axis]",
        "label": "Unobservable inputs [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r571"
     ]
    },
    "ifrs-full_UnobservableInputsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UnobservableInputsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unobservable inputs [domain]",
        "label": "Unobservable inputs [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all the unobservable inputs. It also represents the standard value for the 'Unobservable inputs' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r571"
     ]
    },
    "soph_UnrecognizedDeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "UnrecognizedDeferredTaxAssetsGross",
     "crdr": "debit",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross amount",
        "label": "Unrecognized Deferred Tax Assets Gross",
        "documentation": "Unrecognized deferred tax assets gross."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UnusedTaxLossesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UnusedTaxLossesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/IncometaxSummaryofMovementinDeferredTaxBalancesDetails",
      "http://www.sophiagenetics.com/role/IncometaxSummaryofUnrecognizedDeferredTaxAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net operating loss carryforward",
        "netLabel": "Net operating loss carryforwards",
        "label": "Unused tax losses [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r244"
     ]
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://www.sophiagenetics.com/role/IntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated life",
        "label": "Useful life measured as period of time, intangible assets other than goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r268"
     ]
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "presentation": [
      "http://www.sophiagenetics.com/role/PropertyandequipmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful life of property and equipment",
        "label": "Useful life measured as period of time, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r245"
     ]
    },
    "soph_ValueAddedTaxesSalesTaxesAndOtherTaxesPayables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "ValueAddedTaxesSalesTaxesAndOtherTaxesPayables",
     "crdr": "credit",
     "calculation": {
      "http://www.sophiagenetics.com/role/AccountspayableDetails": {
       "parentTag": "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/AccountspayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "VAT, sales, and other taxes",
        "label": "Value Added Taxes, Sales Taxes And Other Taxes Payables",
        "documentation": "Value added tax sales and other taxes payables"
       }
      }
     },
     "auth_ref": []
    },
    "soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting percentage on monthly basis",
        "label": "Vesting Percentage Of Share Based Payment Arrangement Option On Monthly Basis",
        "documentation": "Vesting Percentage Of Share Based Payment Arrangement Option On Monthly Basis"
       }
      }
     },
     "auth_ref": []
    },
    "soph_VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting percentage on quarterly basis",
        "label": "Vesting Percentage Of Share Based Payment Arrangement Option On Quarterly Basis",
        "documentation": "Vesting percentage of share-based payment arrangement option on monthly basis over remaining three years."
       }
      }
     },
     "auth_ref": []
    },
    "soph_VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting percentage on annual basis",
        "label": "Vesting Percentage Of Share Based Payment Arrangement Options On Annual Basis",
        "documentation": "Vesting percentage of share-based payment arrangement option on each anniversary over four year."
       }
      }
     },
     "auth_ref": []
    },
    "soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU vesting percentage on a monthly basis",
        "label": "Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On A Monthly Basis",
        "documentation": "Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On A Monthly Basis"
       }
      }
     },
     "auth_ref": []
    },
    "soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU vesting percentage on a quarterly basis",
        "label": "Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On A Quarterly Basis",
        "documentation": "Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On A Quarterly Basis"
       }
      }
     },
     "auth_ref": []
    },
    "soph_VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU vesting percentage on an annual basis",
        "label": "Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On An Annual Basis",
        "documentation": "Vesting Percentage Of Share Based Payment Arrangement Other Equity Instruments On An Annual Basis"
       }
      }
     },
     "auth_ref": []
    },
    "soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period on annual basis",
        "label": "Vesting Period Of Share Based Payment Arrangement Option On Annual Basis",
        "documentation": "Vesting Period Of Share Based Payment Arrangement Option On Each Anniversary"
       }
      }
     },
     "auth_ref": []
    },
    "soph_VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period on quarterly basis",
        "label": "Vesting Period Of Share Based Payment Arrangement Option On Quarterly Basis",
        "documentation": "Vesting Period Of Share Based Payment Arrangement Option On Quarterly Basis"
       }
      }
     },
     "auth_ref": []
    },
    "soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU vesting period on a monthly basis",
        "label": "Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On A Monthly Basis",
        "documentation": "Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On A Monthly Basis"
       }
      }
     },
     "auth_ref": []
    },
    "soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU vesting period on a quarterly basis",
        "label": "Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On A Quarterly Basis",
        "documentation": "Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On A Quarterly Basis"
       }
      }
     },
     "auth_ref": []
    },
    "soph_VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSU vesting period on an annual basis",
        "label": "Vesting Period Of Share Based Payment Arrangement Other Equity Instruments On An Annual Basis",
        "documentation": "Vesting Period Of Share Based Payment Arrangement, Other Equity Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "soph_WarrantLiabilityForeignExchangeGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantLiabilityForeignExchangeGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange gain (loss)",
        "label": "Warrant Liability, Foreign Exchange Gain (Loss)",
        "documentation": "Warrant Liability, Foreign Currency Translation"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantLiabilityMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails",
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFairValueMeasurementofAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant obligation:",
        "label": "Warrant Liability [Member]",
        "documentation": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WarrantObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantObligationsMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/FinancialinstrumentsandrisksSummaryofFinancialInstrumentsDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant obligations",
        "label": "Warrant Obligations [Member]",
        "documentation": "Warrant Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WarrantRightsTrancheAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantRightsTrancheAMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Rights, Tranche A",
        "label": "Warrant Rights, Tranche A [Member]",
        "documentation": "Warrant Rights, Tranche A"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WarrantRightsTrancheBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantRightsTrancheBMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Rights, Tranche B",
        "label": "Warrant Rights, Tranche B [Member]",
        "documentation": "Warrant Rights, Tranche B"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WarrantRightsTrancheCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantRightsTrancheCMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Rights, Tranche C",
        "label": "Warrant Rights, Tranche C [Member]",
        "documentation": "Warrant Rights, Tranche C"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WarrantRightsTrancheDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantRightsTrancheDMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Rights, Tranche D",
        "label": "Warrant Rights, Tranche D [Member]",
        "documentation": "Warrant Rights, Tranche D"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WarrantTermsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantTermsAxis",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Terms [Axis]",
        "label": "Warrant Terms [Axis]",
        "documentation": "Warrant Terms"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WarrantTermsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantTermsDomain",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofKeyInputsforValuationofWarrantObligationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Terms [Domain]",
        "label": "Warrant Terms [Domain]",
        "documentation": "Warrant Terms [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional shares available to purchase under warrant certificate (in shares)",
        "label": "Warrants Or Rights, Increase (Decrease) In Number Of Shares Called By Warrants Or Rights",
        "documentation": "Warrants Or Rights, Increase (Decrease) In Number Of Shares Called By Warrants Or Rights"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails",
      "http://www.sophiagenetics.com/role/EventsafterthereportingdateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares available to purchase under warrant certificate (in shares)",
        "periodStartLabel": "Beginnings balances (in shares)",
        "periodEndLabel": "Ending balances (in shares)",
        "label": "Warrants Or Rights, Number Of Shares Called By Warrants Or Rights",
        "documentation": "Warrants Or Rights, Number Of Shares Called By Warrants Or Rights"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WarrantsOrRightsNumberOfWarrantsIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WarrantsOrRightsNumberOfWarrantsIssued",
     "presentation": [
      "http://www.sophiagenetics.com/role/BorrowingsScheduleofWarrantObligationLiabilityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of warrants (in shares)",
        "label": "Warrants Or Rights, Number Of Warrants Issued",
        "documentation": "Stock Issue of During the Shares Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageDurationOfDefinedBenefitObligation2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageDurationOfDefinedBenefitObligation2019",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average modified duration",
        "label": "Weighted average duration of defined benefit obligation"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average duration of a defined benefit obligation. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "soph_WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WeightedAverageExercisePriceOfEquityInstrumentsInShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price",
        "label": "Weighted Average Exercise Price Of Equity Instruments In Share-Based Payment Arrangement [Abstract]",
        "documentation": "Weighted Average Exercise Price Of Equity Instruments In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsInShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average grant date fair value per share",
        "label": "Weighted Average Exercise Price Of Other Equity Instruments In Share-Based Payment Arrangement [Abstract]",
        "documentation": "Weighted Average Exercise Price Of Other Equity Instruments In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable (in dollars per share)",
        "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r148",
      "r288"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Weighted average exercise price of share options exercised in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r146",
      "r286"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Weighted average exercise price of share options forfeited in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r145",
      "r285"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Weighted average exercise price of share options granted in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r144",
      "r284"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average share price at date of exercise (in dollars per share)",
        "label": "Weighted average share price for share options in share-based payment arrangement exercised during period at date of exercise"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price at the date of exercise for share options that are exercised in a share-based payment arrangement. [Refer: Types of share-based payment arrangements [domain]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price of share options outstanding in share-based payment arrangement (in dollar per share)",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "periodStartLabel": "Outstanding at beginning of period (in dollars per share)",
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r143",
      "r147",
      "r283",
      "r287"
     ]
    },
    "soph_WeightedAverageFairValueShareOptionsGranted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WeightedAverageFairValueShareOptionsGranted",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationWeightedAverageFairValueofOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average fair value of options granted (in dollars per share)",
        "label": "Weighted Average Fair Value, Share Options Granted",
        "documentation": "Weighted average fair value, share options granted."
       }
      }
     },
     "auth_ref": []
    },
    "soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Weighted Average Grant Date Fair Value Of Other Equity Instruments Forfeited In Share Based Payment Arrangement",
        "documentation": "Weighted-average grant date fair value of other equity instruments forfeited in share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Weighted Average Grant Date Fair Value Of Other Equity Instruments Granted In Share Based Payment Arrangement",
        "documentation": "Weighted-average grant date fair value of other equity instruments granted in share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested at beginning of period (in dollars per share)",
        "periodEndLabel": "Unvested at end of period (in dollars per share)",
        "label": "Weighted Average Grant Date Fair Value Of Other Equity Instruments Outstanding In Share Based Payment Arrangement",
        "documentation": "Weighted-average grant date fair value of other equity instruments outstanding in share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "soph_WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofRestrictedStockUnitsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Weighted Average Grant Date Fair Value Of Other Equity Instruments Vested In Share Based Payment Arrangement",
        "documentation": "Weighted Average Grant Date Fair Value Of Other Equity Instruments Vested In Share Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "soph_WeightedAverageRemainingContractualLifeOfExercisableShareOptions": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WeightedAverageRemainingContractualLifeOfExercisableShareOptions",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable",
        "label": "Weighted Average Remaining Contractual Life Of Exercisable Share Options",
        "documentation": "Weighted average remaining contractual life of exercisable share options."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding",
        "label": "Weighted average remaining contractual life of outstanding share options"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "soph_WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WeightedAverageRemainingLifeOfEquityInstrumentsInShareBasedPaymentArrangementAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining life in years",
        "label": "Weighted Average Remaining Life Of Equity Instruments In Share-Based Payment Arrangement [Abstract]",
        "documentation": "Weighted Average Remaining Life Of Equity Instruments In Share-Based Payment Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageSharePriceShareOptionsGranted2019",
     "presentation": [
      "http://www.sophiagenetics.com/role/SharebasedcompensationSummaryofValuationInputsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price at grant date (in dollars per share)",
        "label": "Weighted average share price, share options granted"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageShares",
     "presentation": [
      "http://www.sophiagenetics.com/role/LosspershareComponentsofLossforYearDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average number of shares in issue, basic (in shares)",
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ifrs-full_WhollyOrPartlyFundedDefinedBenefitPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WhollyOrPartlyFundedDefinedBenefitPlansMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforFundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Funded",
        "label": "Wholly or partly funded defined benefit plans [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for wholly funded or partly funded defined benefit plans. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "ifrs-full_WhollyUnfundedDefinedBenefitPlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WhollyUnfundedDefinedBenefitPlansMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofMovementinDefinedBenefitObligationDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionCostsRecognizedinStatementofLossDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofPensionRemeasurementRecognizedinStatementOtherComprehensiveLossDetails",
      "http://www.sophiagenetics.com/role/PostemploymentbenefitsSummaryofSensitivityAnalysisforUnfundedPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unfunded",
        "label": "Wholly unfunded defined benefit plans [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for wholly unfunded defined benefit plans. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r369"
     ]
    },
    "ifrs-full_WorkInProgress": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WorkInProgress",
     "crdr": "debit",
     "calculation": {
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails": {
       "parentTag": "ifrs-full_Inventories",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.sophiagenetics.com/role/InventorySummaryofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work in progress",
        "label": "Current work in progress"
       }
      },
      "en": {
       "role": {
        "documentation": "A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]"
       }
      }
     },
     "auth_ref": [
      "r418",
      "r426",
      "r557"
     ]
    },
    "soph_WorkflowEquipmentAndServicesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WorkflowEquipmentAndServicesMember",
     "presentation": [
      "http://www.sophiagenetics.com/role/RevenueAdditionalInformationDetails",
      "http://www.sophiagenetics.com/role/RevenueScheduleofRevenuefromContractswithCustomersAllocatedtoGeographicalAreasandRevenueStreamsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Workflow equipment and services",
        "label": "Workflow Equipment And Services [Member]",
        "documentation": "Workflow equipment and services."
       }
      }
     },
     "auth_ref": []
    },
    "soph_WorkingCapitalChangesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.sophiagenetics.com/20251231",
     "localname": "WorkingCapitalChangesAbstract",
     "presentation": [
      "http://www.sophiagenetics.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Working capital changes",
        "label": "Working Capital Changes [Abstract]",
        "documentation": "Working capital changes."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r485"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2025-03-27"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "ab",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_ab&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2025-03-27"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_viii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2025-03-27"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "137",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_137&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_140_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "141",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "141",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "141",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "141",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "145",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_145_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "145",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "147",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_147_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "148",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_148_d_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI",
   "URIDate": "2025-03-27"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS02_g36-39_TI",
   "URIDate": "2025-03-27"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "52",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "18",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2025-03-27"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2025-03-27"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "126",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_126_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "126",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_126_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "129",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_129_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "129",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_129_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "130",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "130",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "e",
   "Clause": "iiA",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_e_iiA&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "89",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_89&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_124_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_124_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_124_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2025-03-27"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "32A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_32A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44H_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "46",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "19B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B16&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI",
   "URIDate": "2025-03-27"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI",
   "URIDate": "2025-03-27"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "58",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_58&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "90",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_90_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS16_g51-60_TI",
   "URIDate": "2025-03-27"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Section": "Presentation",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS16_g47-50_TI",
   "URIDate": "2025-03-27"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2025-03-27"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_j&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "Clause": "v",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_d_v&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35K",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35K_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35K",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35M",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_36&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "39",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_39_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_8_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_8_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_8_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_8_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_8&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B52",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B52&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "Scope",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI",
   "URIDate": "2025-03-27"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2026-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "30A",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_30A_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "107",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_107&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_108_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "141",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "164",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "164",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "164",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "168",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_168_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "169",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "170",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_170&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "176",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_176&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "184",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_184&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "190",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_190&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "192",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_192&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "203",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_203&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "204",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_204&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "206",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_206_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "207",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_207_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "207",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_207_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "211",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_211_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "218",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_218_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "218",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_218_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "227",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_227&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "230",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_230&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "250",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_250_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "250",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_250_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "250",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_250&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "e",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_e_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "260",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_260&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "265",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_265_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "265",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_265_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "265",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_265_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "266",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_266&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "269",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_269&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "271",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "271",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "273",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "274",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_274_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_34_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_37_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "43",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_44_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_44_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_44_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_44_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_44&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "64A",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_64A_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "71",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "71",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "72",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_72_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "89",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_89&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iv&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B13&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B18",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B18_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2026-01-01",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.49",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.49&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_138_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_o&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_56&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_69&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "90",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_90&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "98",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "98",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_99&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "22",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "22",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22_j&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "80",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "80",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "142",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_142_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "127",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_50_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI",
   "URIDate": "2025-03-27"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI",
   "URIDate": "2025-03-27"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "B36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_B36_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35I",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35I_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11D",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11D_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11D",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11D&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG20B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_IG20B&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG40B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_IG40B&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "191",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_191_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "191",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_191_j&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "193",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_193_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "193",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_193_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "193",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_193_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "251",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_251&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_70_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "102",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_102&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_68&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_70&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "80",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r545": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r546": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r547": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r548": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r549": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r550": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r551": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "142",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r552": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "144",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_144&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r553": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "145",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r554": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "5",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_5&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r555": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r556": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_8&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r557": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r558": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r559": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r560": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r561": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r562": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r563": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r564": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r565": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r566": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r567": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r568": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r569": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r570": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r571": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r572": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r573": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r574": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r575": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_104&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r576": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r577": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r578": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r579": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r580": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r581": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r582": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r583": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r584": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard",
   "URIDate": "2025-03-27"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>180
<FILENAME>0001840706-26-000006-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001840706-26-000006-xbrl.zip
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M;_?;<@)\J@D7_WHGM]?Q3CA<-P&:-3^)WIU5M]WS<+/=8'M$#Q)=RM?+S::
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M4P--VZ1^5G0;S98 Z6;A4[);J_H2#4@H383]FPJHT*"PPRE],:=TF\)VBAJ
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MB1K9CD^Z0J\CE[NUU0I]D&C[MP)MZQZ/Y2#MV>]4+3#_#P;J^G9GJ.L^96R
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M@//;*@8#_Q[X]RX#_U[@W[O?>(%_+_#O!?Z]EV$M_9[*CXN]9!.B'\5AZO6
MO\M!L]&-BLFBF(Q=(<ZA6JURDZ'R*].W;M19D2\CM<S)@T3'!N\U#KIX]"IU
MAE?LG+W[.GHA8?RX$<A]YX*#6'JN8ND3"1$4@\'C<0X1[+U[.VOP:T14Z0F*
MI$8O3/S \PRA)1X:SEF65S=:5:=<B#5X>_+WEB:R+=]S'YY=J+X*^=YG.8F0
M[WV>BNLKTG3O7][N#QOIJ392R/<.6=I_+^8J,_^KVC[7 Q0[[GT50U)E5U_K
M!V;(9/^<R?Q]QF#'4('/^?:RPX#$Z\S*OJ)_+$U9:@WJF0%2F3NB# "2EJ:L
M2HV(@DYG0@HS<#W(:21AG6>PHLEJO^$;W9A8GS*OC8U>:3+.)]%3M[G%6O\/
MIL$K^O3O^?7HJLDJSZJB1/O,)J8C+!Z(N]PN\BC3CDQGJN_LV/FTS,'/.^"Y
M#WW@SNT6Q_OXUC%HA%TEQ;<]WN1-)ID=,^!)Q2$4P?O?/[13"F=S.^%/:L05
M"]"@/[D>Z55]3VE,LRT,9'6M3FA6E3GE1NM7'Y?Z+/HQ%=:?=JBH +A^JBV)
MQ$D[;)0+Y-[HB@0H:Y<ALJ%7]G7TBM1.7#6_?NH:AUKO#+V O:BA+:0'W3"=
M!H]1673B=5!*KFP$ ;*))^Q.P+8$TB*W&6)M+2Y@R(:\8XQT=W?6P"+YW(3O
M$8;'/U?37QAWF=_5A6NKY5SH>44/RW8SF<,M5\^;[2K)Z]9=18NZTF22-FS]
M1M7CX8J0>PNYMR!<CE*X;-._K%LO/L[3EO:U3+O:\@LTMR5?T@=RM93+K@J=
M)85C+NQR32;@*JS:H[-:3D[:PT[H1E7=E8.>[T:WFWJ$#%C(@#W/280,V/-4
M'U^1N+A^>;L_;*2GVD@!X@^(_U6 ^ >(?X#X!XC_(T/\>W+U:I"EM<AO#U:=
M/:T4^4F;Y;0JK'B&:"3_!0ED;2>HP-/+K&[<>'R&0<@SC1:=WUU47K?-H7UA
MRE0G+B@:%?T=P^7J;M?0IHFKHD##&8EDFHQ4K19.NA9G7\A4']HVWUU@+*=Y
M_?JY!KQ0IA$7]DB%1<A3/W0Y.":4%,@/JHJD1G?;H,&+!4.E;!^2,G,U=R%(
MB5NF)R9S6>?")1+'*.QVCU%>O/^P0Y#R96_&(PRM_RRJB>O:2D9+D1Y*JT3T
MD,EL5:@,37MRX-+FC%%;*9,(,,Z0[ENAH2&LGC:QK.A ;P<)9\HB3^E_5+$$
MN^K$*T5WYY4N&''' Z?J=N*^I$.!:CO'N;+4Q8ZL+C]\T7&%Q6^P?!.?0S1%
MA/^A.6B^RO^FQ?J8XULT4G)W4=9R>Z@N?:Y4#N*7<T5+54;2S:U X[A,)Q-Z
M*BD6S M?*4@/*-V[:7Q;298S6A5YK#6GPLC=O+XX/_\8W2XTH]MB<V/22107
MAB:GZ*\V-^4-OP^3W: ATUP^\ /PO!B,:-%@/*:5G^,UI;EE(S512\4?<-,_
M;X7<+DR\P$.N,3(>4IYY.1E;.5S66SAY^_0%X(ULUS"TD8XC&G1->6CZ7UHG
M*VXW[D/+4BG^%?U8S]L+Q<2<F:Q5OC36^HPO+IYRORO>+/S*:R0H33:IRO6D
M/63]0>?V^/5,,6N0*B/87GRK6W24NA,ZB"L'=EM_KSBTZ@ G\RMT"/P-95,I
M3D*<%ZN\0 Y\FB?KU_Z'2Y71Z_*6(Z-%9YPEM]74FL2H@@]A7DSP#N']Z^*&
MC\[#/<2DM3#U\*6S;7^K-HU5N;E_U$EO&KJ^8?-PM+/HG.1KS3N;/G26,DDF
M/@UN<3C[!LF3D2A8F-4D^H4QH#=T?06035E4F W=BW^'UF'%JC!62X-:.G$W
M:&DY(:ET"\CM1-X]B33KQ5;IQ1BDHA3^0FCAL9:*5@<'SYT7=TXL!"-),LO;
M$R7$59; OHNXF(YV]R]5,I=W6* =9B%+K.BYJH(_G$/.9KC$G87N:5=5N<@+
M3(U^!I&B67K^4M&C)4; ;IBN;> 8:K72D!N^I63L7BZ=KXR=C,QA)7#W@H1#
MNHXR/2?UA)$1]J,'I+MA92Q'P?)BC8-D0.3Z.S97 &1L!%4N@O,6++U'LO2X
M_2)0$)IL.A([Y !<?> ZWS0W$3>0)/NJG Q377L?E8S NJTFJ64.6< ^%/^"
M9+,301E$&I: RY&Y]IAL*&=, HNJUAZ'*]]')$_8=J@*+ETF";V"GS0U.A-W
MIR:/)D-!ITPJO:(Q:]?G+F0N)B@R"1_]\,4A/D0JP7XS$1=X,T)VX?PGXZ:U
MA 4(A,E,F30U)3^$?&BK&-C-G!'$M"9 H)32"+.V8&#A"92$>XRB'AO6'S0V
MR7J%K\X_J@R&FN:E*_@ZL$\8AP^%R::C3$&_B55(:LZUZ23QK3<MPPKJ LI0
MEXW3&./%OSW_B%LYT(L/6Z[PNO Q26B8AOB=^)C<Z!.62O7[EN<U%).A(5D%
MRCJX?_$7& $W!*[VI&_^L7W RU+;@/1HLQE>Z$R6M>XXNJS7#"/J_[^]+^UQ
M&TFV_2L$!NBR ;F>ERHO8^ "C9[N03]X%HQGWON<(E.E[*9(-9-4N>;7WU@R
MN8FDJ'*5)$H!W#M=EB@R269&QG+BG-AA"#<Z)*BXSD+C)BW=SL(WPL_:'\"X
MUK#,W5REJ]3&6.#](BRHPNO" 3!TTB%MKJ!1@7^Q:Y[V4='C+XM^!OL7-*S"
MP:*T&UKI=+ZLKAR55R8</9$&:%J1"Q.#(:)GP,L40YZLJ [N&A<*TB*K *ZL
M)WD"L\<^_]H3@5<\*X'5S;OV_F?U6,$WC11!M^D):EY4@6W?*@X,OB G$^=L
M_5_L$\)O5VPEW,)+BAH9 YI//@PVC-IK)4_V.OARE<YCBO%H<31RAH%U_0ZY
M1B<X\I:&%8]_*US<X*X*GB@LVP6N;ET]VM3?(%S0S MR"(OJCM'I=&-"M]-?
M#A5Y:TJ^[H_ $664MPVOC,(#6H3!QJ2Q?V8;V/>2O,2]T\Z ?BAZJL[PL2L:
MPF/$61AI?+>VDKOXONFT!TCO_5M)@#VC6W0DH?'_;R"B*E!''*(2#&@I&9!F
M^B[%?\%L5# ;U\O@+0<XL!LJQ@^P(.:;CUV9+Q5M7-K,YK:983&N-D@E>@Q.
M-02)$#Z5^; G3'FUDFSCTGMN[-LI/N[']#>*N1T7/,,.2R? O7Y9_9YOWBPD
M/#Z1\%A ;6( MPS@5XP+O><,"] [QE<P/K<#*S!^4<V]QIFO2N!>3\2HR ID
MJEZJRELA2%7ZG.,7X";@TZE<4>N?9'GMT+LAN-B_/6M,^)QQ+O$>;S\SZN8,
M-98-T&E&LUIL,LQ[XCW2 R7/AQ\G!*RE@XY?>'<+C4[SO'BB)"G0NA5KVGC@
M)^B&\:,HS5Q"I&+."6NY7\XI<\' $[MA_N&4OBK\@NZLWI;A-HG'^JUW]*(2
MS;L'Q\?-[:/EV0KM="\F]58PJ8))%4RJ8%(/BTF51CEIE)O2(*11[CQ#P4?T
M-WVZO-DO$^E0$TFH(KM\:@A'-SHA_-T"HE1B[K.S.FO(+( 0 2NU,B7/%W4]
M2"*(T\)CV$RR,7D9=B&VSG%)9C/,8F/B6&V4B3$FF?E\;L602&BS"JJV,^VK
M,-C+=8)_$#2PL#!VNX4R]<PX?Q28ZD"\YZ+**CO<G87A$APMXR(&'+4Q*M K
M&"X#.7E06%"@7B5D1LO2Q(24\"X2UZI$S0CTMZN$,$A2^!$G;013_W*;+"<-
M6,HKN/^YBJ?W.,40CF\_&9:E"'&J_%'X7+3*D$B'4DVVAPT1D2"(5P(+%EUI
M3I[>? Z79:]*R*J&H<YS3!UGB='9*\_!,VM?HY?USZ>DB\2A+W;GG&=PI+4&
M*7H0%$R0A!#>$!;\5$:(JX^?\S;Y'EXH)J4/S"B/R&Q3*ATA(IS"=F<#*\PW
MYPQP>_3I@R;(3,/V>@E'9YEAP#-&+'F33# ;"[]&O).P_IV;+9D@IO0_"?;R
M["#>8\H^CR?HJX KUQI1>>=!KGZ'97)O\B7WX*S7,=P\9I$1?H\ELE##NDZS
M8N4!_0SWOR?0U6![;IK$#USP5_X4[%:IWTH P3@-:91KAD&#C;D._IYV#*WL
M!W8N'*M'U[D+^T_.MX7.F*<[5V!:(S*OU.!C0Y@2RB2^,214:X/8B'"I$H1P
MTI/E?_C&8E?++&\1QH>(4OZA@/*%)5&,\22-\8_@&9C$.A [(]')ITETR5%8
MQ+F'L=;1%>#A##(=L@FO.89#C-5E^;U9O!_RH@@FBR/&^-219).)*[[5QVEK
M>X#%WFAG88G+L<2F(%(T+BUYR;X]KO4Z2LVF2<!<1[W 19THVAK<2L08>P[)
MK?N]#G[2?>,+DBN2M]XF?V:EMKB#D!*]QJBD%''H%6(&5_E.\GMTTF.C/0*>
MG,CJ9/1$G/U_Y5#W#K+!.X?WYO&I(C[9Z(Y?B$,J-O#H8#:G#8.I->\(EKV>
M?131!1F3,3XJ(56_QTV=C73[2I>Q-:P^[]0YH+/J7ETW:TKW3U]R[F_;P^T0
M0PE^I9C>@6]SXYQISG)6/;'.?88C*5VX2;M5'R=08#J)08BQF9BQ^:J*1<.-
MJERN\W.H.ER2@>M;? \T"%L3E-UVR<"'^N;R7BLZF)]%3;FV[GW-R#W:%-Q>
MN4B-=6F]XMNKT'"W1))W7&E /"/XV>4O*8&78P^$P[W"WN"'.,/4X2A]F,JS
M\R-?ITGDY5Z&=7'%3;HXRW5S',OUKYH7@GT\*K9IR]VX5^0A8$$QIY9DZL$%
M+Z@J'8(?\( J090#'-'G4M8JP0*%!77P<@-4NA"_05;?Q:R^+_OMI6M=E"D)
MVI;:$E%NG\6M$S8K;@<Q6>CR[[[Z1%]UE)C<]NQS1SXWY!<H*E@A$QTEKZUV
M4FI%,C:C(ON=K+AJQ=T>9\4A!"C2?K&-B+NQ82IS.0,'$>/N5_>/ZD@2?BL#
M=,R%02A,PJVE9%4I2RJ[G*RYBUES>^YR%#&BEPF#+]E6O S3-DZ)1!FW/R8<
M2W4*%TY2;(9MFUT1&[6,UH]J"3:*C)-TIYSG(*0[Y3PWE/V;"MZ^OKS9+Q/I
M4!-)6N:Q9?Z]M,Q+R_Q^YY.6>6F9W[ME_N2WJ\-:B7^F]X/X7=GN]TI$3*KA
MI:?S#RM>R!+5 .,0?@<^6'M>.&P.))IW+XJ *&F$O40ZUG<JUXX-ODE,SZS]
M[18^KVG!64*K@]Z]RRD3/*=J_<5FS0_LGN1$2)7ORGQ-[SF* 7J*CCOB>AN0
MH$>&94<C3N"<Q0*SD5BB,UR42QAGHGB>E3E35\\KF\T<XW,?03/E/HD#GD$^
MWD,F K86B$EJ>>>VFB;8YO!K[HIO!#]EMMXX3N^Q[I:D\/PSN,!"9XS 3;"$
MIQ#[SK2'Q,OZPY]N/WZ61B=I=!(+,$D+$ ?,*JOJ+I9):.63- 2SR>:\]+U$
M!GUH4?(@R?MM@.QGHT;_X9H3MN.F<\L6W%Q_VK8%SSYOWEPS8_OV_^(F4L2Y
M66'\UA1::XB9.3P'S+""^7T7X(E1ZU;V4%?#L"0R-LUJQDD,XD"3^(83W(^;
MQ&^N;T]J$I.JC29G?@F>OVXIN72*LWA0(>:,#0/OZ].XW9W8.Z_%:(X:_?OO
MF6_OCC+?W@X:S4BS0E59>&GWU[5,J-A%F:>'GJ<+\PVM8K/]JL<BBGV[M'GS
M;M"^\5989(8Y)!GA&Z9%0BA?^V!S%$;V"L)@!Y/0(/D*7#F#MT$>X]:WZU@E
MR$HIQE F]:$GM3.&U%AI8#JN64\D5J1] 6Z@J;3GD&*BX+D,G]S<?([+60SG
MJ MFTI2NOA,K>FD3[F;0BJKU&L6Y2]*JR%"6!I5:V#9Z33"43(2[TA%78VN1
M./X,U12)R:#+LV09^WIDSKP.W&)(D'!63BTEPL3\RFHX]&I(TA7J^8%E=1T&
MR+?I#7*IWA0NX8%4/1!DGN^<>F:I6H6KH6J-'_1J:]=SA3RZ9!!EV-@7U5:'
M6.Y+FZNWXY*BMH#IN6'>B;%&FY0=23H26U&)/6=C]+V79HP-6>J2-X< ,H/H
MF%F359)V$DIQ;?HS4Q,PI"<Q"%DA^Z^0K8RK+;*--G%,$]L6^]AUXGVS5Z0=
M"*=,TERM5LQ;?(74([ 6YG /&\=OTH9K\#^::(U2;[&1THU@+'X,8NXO;3*_
M'S3WX%\C-W;=O59)4A"=+TI>,@T8Z>HF+I'&7Z Q)HV$BDYHYN0#Z&N6RGQ5
MY4 \LG)=9.BQ,^*R+JO\Z?U-&/STC^<L,/<VLQRG7Y9R180EY8=& A$E9;!'
MD+*:LNQV8B .;2!:E<(@P[ ^H_C!;6*SUL<NYE@5B>>_XJ-T3D<BZY:K+RZ=
MSG"2-\[AMU"B#>*"9%KFF;R*@ VLCI&)_\I+$CO;X3;IP8M%5P22M/Z2%O77
M[[Q\<(6-E)WRTA;"AWUWRK_J1&>PM?V-A:8JM B$.JPY7%<6JK4>B#&7.7SH
M.5R2$ZJ,BJ,09>O5//92Y7]UF#EOMV/=4MV&']DMR/J@D;SX_M\/TO\K_;_[
MG4_Z?Z7_]\G[?\47G=P^_G&XO(JDK<[P->CEG=P/B_]TB?U@U@4_A%O$O")Q
MQMLB7 9K;)I&9:.-ILR^8\[?[J7E+$^?"I$3(>*#.ESF*CM$ W6#,DF(JI-Z
M5KK0KBW7;&KR1[ZE>Z"9]@6<*2[P+5//+CV5E^)MRRH]]"KU79X=).K>T;5$
MS;Y+E67&C'A(<*ZQ4!"DB,SY]#G@$@'UA%9P'I>Q(<698:7$&I9G8(05D7M3
M=V9;3J9<S"6];'Q5RQ]AL$&<^$65+KI2Q5T5)7<(TNB\ZQ'5.E:Q,58G#:DC
MN,:+3$7.'N S0:K<7AL@.^BYKLU/@SOHR+91^GB]@T^D4=+ 0_ZFLSO83'\,
M<]EZ9'H?>GIOM4GJO+TWC&V='&1OY12\"KZDAM/V*OBEP U$;.VE34:(A <Q
M]<6<)AJ' 2I8@V-.<P@53B,]SU^!NU_#W:^05B?-3+$JXX$$%9"]$IZSQ&%:
M9#AK2^&J%-X$/8HY1#")MIR>Q'-,T_J=Q"!DUC]BUL>E<M.:@?2YUW-RRN$1
MH84LQ-O@6"/QO"+F:<+O7*F-(6DFLN$H6*=+P2(, >#W>>X5(7""ZURL[27-
MN_Z.8$:3.(>5X)+LQB**/MLP?UF/$\MPDX UI_M3+")H(%/ZH%.ZQ&OL]&E+
M<'RV*2&7:DAEI\1Z(/55#5HII%=/0@0T07J;(\E*_IH0^:3' E+JV^70>\@L
M/2,ENK_WRS363JP6P?=.-[;12>5R[_W=5(3*=TG_1:96^C[-?H<@CT1D\^5N
M'DM_%=Q$8)=)$QJ2U1N"R#@,C%>OQ5T&=R(#]T;] IHVH)56+-;3%NRM-0$P
M7R970!!S4RN R-XD]N$L[<//*.D&F^!L4#26Z"5=V.%P/7?8:@;1 [)*XB:G
M77M.HQ&A5@O8J\G,ER8P]>\9+7UFOFQ:H[:%BJ 2E>GBPAH-P0_%,S5).?C.
M'8AG@D%FME//=H?.;K=V[G70OZFW<$D7+^JSA_<X?<,W^4'02[N]?O]T;^T,
M-7U6)HIB_4SK]0346'[JC9_^[7R\LG\'_K%"A5]]>4M%9MVA9AW18*]JPN_!
MOSI;0T9ORF]?/_.F?!(3]&0] QG$$[VB,]Q;)TB3_ B9LS>7-]5E(AUJ(HF0
M4U>[Q]\+S!9B/M#E#67B/2)Y].]V W_H X !2-L+_/PHK?C#L<I!G]Q+)SM!
M&M668.X*^344_/VVRF7W/<16.OJPTVMRCM&)+^0#6[X44Z(8-KGDZ/0>V E8
MOB]D^.I!:#<_P2#.\45\/$,X/GX^M%WD+26%_V)]/EBE)K'.)F;#P-'>XOK%
MMPM_E'9A:1?>[WS2+BSMPB?5+GP^#M\II0S>3C/M<Q*#D(FT8R))[JG+=_@Y
M=DI*A&O3V8I@:8N%"?>OFQ[]T8E\[YCHQNN'MVF]. FD8Y()7^IVXJ<[8168
M!-ZDB0KX[0,U.JG6- I04R0N^369K: D;2CF5O]1$+E"!N\3Y>9:X[H._I'$
M#[O34(07G6N^ 1U=!__2K[2?W<8&\'*H!U!TQR=OJTB_(_.47A'JY";<2S^]
M1R@V:ZS-^C*"R\VA0DU>VB7DCR#X9%R#8%+>9D3:B<FK"639/=^0V#I<:A1>
MK9%(+ R#24<,F*T>ML1Y_=;KX*LN8B: &)%G8FH,?]]WU.5\'7Q1/@?HOO$K
MQ^:#AE#:/Z:\G+]+\?A(+2&TG:-Z#?S_1H6DLU0R/'7['(,=(TZ2ASR+W.1(
M7N]=AT66K@*U2L'7J3=I=#HM1!R%;]>Y+]NN2P*']#LMHL$N&NQBD:9HD7XN
MF]#9'*&P5@!;;S+::QC?OH+R1#JCK;ZT5T3.O3*-EI%CN"'21W)6L(63>& G
M,8BG?VM2<#B%_>@1>>)WES?[92(=:B))P:'+@?Y'K>5].+4L,_)\<WG]W7HU
M+*H+WR%6U_'B.OA/$FMK:<(,\":LLW1CP.LEDHE[8_NS!?5ZAT(R:9/54P3]
M$_.JS!U(+6':9LC6<)&/Z^([\8<J%FET=6%D)R=C0MDX06Q=F%?$VG#S>:6O
M@Q\=0M2)QP\3."17.D'%<(*7$OD3:\L.)0^J^@;*"=Y\^ QA?DED83 91I_J
M/2H<E&QX3'%D#ZJ)VYNN%$&6WO/?;\5,3F-%?U<Z[RC9O.#?0YN_L;;0#?=!
M6^9Q7QKG M1=#:8:U,RT\FJE?L>#P.$(T2\9]&5GP?W2A$N/42#Z*O>#?E]&
MB@AB*<12',Q2?-FY[Y)IR)'?J;6S([FMSA),O\?-39Z$JKV-**BLT.!KVJ.H
M@"H05#Q@?P/\!:0W=P18S@?821LUH;2^9,\E<7T1]O01^<:;RYO],I$.-9$D
M<=V5(/A+6RE')M[Y9H-VYJ=MP>I>/;EEDS0C29PUF=X8?>_CR@95!?F9^NZ!
MCKLK3$2W#I/-!O<:KJ;HC*PSZ$\ /B4\3Q5;3W;?QO-#)*FRJ/-Z_2!Z3V_\
M\S<=%J1+6-[Y=?!K3@$LZ9SDVP/H?@[,]ER__"MZ_2B^B.&W)-$G:Q)_K%'5
M3^]9B35\\MRXLD@@HP=3V$RFW"6:B+%RB5O?N/"8V)7IQR[2-9I9ER&6)C-#
M HZ]G!=U"4BO,%F3B*]T'MF:&<X".@R=38N5SC'0+K4>=T/IZKD ]1@FCI)3
MFLTH?O1SI4\/MPN&..9,0#7 (0&(K=MS3-FD&T&:$RLXD+,&F>[6Q>R^#R&Y
MZ".Y^"0D%T)RL=_YA.1"2"Y.BN3BO%WEZ99'CM,7,5A(C33V3\'/,.*KUU.Q
MN8I+GY7[T1M]SOI"3PI+.9!DY!6195;2/R_, @YY>#G4J.[C]E;LNF E./"G
M,E3@H(8/\*DR$^)P8&J!.[91<<&I']I7W"^Z(NK=7>H# ?:,ONQZ8C!B5[ F
M+%SUN&?XO%5(RHHX<E0W&BE@U!A^+>=0YBT@0&<UI,XW90L<X7<]M.>H;]\<
MRGZ)817#^F3TC?VAFU?^8^-*$>QV^9G:P_Z@5G=;:PH;"#)G.T),"D*](F$)
M#*.?1.5/7D!<K=;K&!XF.*$O.>H?A3DCZZLS-1BV,B8-E6#ITC5;,Z/OP,"0
MO%+HE;W9SA1#8??(GOJ=(?@,#^EY['!"5<"]P<];VHVUZK][HQF)0[E' F%\
MN-2+&<;G;-,#M=%A7;*1\03C4A]UT(*V+ /9/]5FS_"\A6% S.O11>5Z_-:&
MNN2BR,BYS)7]O2QG=/N1(KXH:^=BULZ0:](GPUBZ#>@'O'W_&;8TIT\\!E,^
M'7C:R48/@IL[Q4$(>$^$Y/[G+X/RA3\6D4'?Y/(6A\RS0\VS+U?4^:AK6S!7
MVD6A<!J[OPSBB5[1&6Z?$PR<'@%9OKV\J2X3Z5 32;#OG>";QWJF1W].D\WX
M'!KG6<N6[B*&5VXVU%N>5?)P1#'%]OP\Z"-[V<T@BW^!G[TP"7+:PN-\T"J[
MQGYTDVVQS2:1+6OW6%/+T@W\PCU?E20%_*LZD\U53I6_\A5DVJZY(-2ZH"_A
M][/K"TW^F1GK*L#+=@1X)_[8Q';OF:W?BR#?-:IO3Q17^OZ:AL95D%W6_D5\
M=13KOB-C<6!C[[AX$7X6*41)P-_ZF\Y",.37\-3*;]:91C@7 K2HBG]%=GU>
M(1$0'4 @?+#O.F9\Q94_E>\C<,^>JO<__.GCVS<?/N]!YRM* &*])D*_4<^
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M*;AFQ(R@*Y7 ]D;H+'<=#^C"EL0T-MB;%/6<K=:5I;JB83H7(<Z(2-1]Z >
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M.*7(_S-/HP?XSS)?Q?_SOU!+ P04    " #E-6-<]_R<./\'  !D)   '@
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M[K"%'&VSY;FO/#^WNO#^M<;<? F@#JTVSGE (CIE1+$I9S-0XRSBFM DR:F
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MWTAK>U4@G S6^IN'E9&0)X #DK4*OP.D@CD\5FO/>1*"+M&,0S\\\44>0)^
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M,3(R8V9O,S R8V5R=&EF:6-A="YH=&W5FFU3X[86Q]_W4Z@P=\O.)-G8>8
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M&2\J=+LPF7L-\,=": ;XBC6 ?]CH[KX&"'?-W%)-742WR3!U6%G!V2?;[+U
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M(.U6Z[%\;M=$X[%O6MY+9MGN8):=Y\TRGODO668%=L*\Z=_8F25!5=VF[U.
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M<'=C8V]N<V5N=&9Y,C4N:'1MS571;MHP%'W?5]Q1;5TE DD@D*8I$H/ D-J
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M,#1G\ 5=Y[%0'QK0C[,J>Q*\OTMH^IU )()?7)?V6R^\6AFR=G(X#5#TVAI
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MH(X58W.7)_0"D5)FB'YNJCN22# 8V\ZLE1!:NQ&U6.W[%<.VL-(_SF4],1S
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M5L"WL[S7 Z#<#;L*&"9! Y)-[=5I_A>LW6Y13TS9HH_8^A:GN<-CT6T FH
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MH*SG,-OP4B51Z)-O2&TV&(,D@2&O-1[KO*:YYI"[&)1"*XM!55"\U7!+.#4
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MK;P@! $Z?@T+0L-(W$!:T^WD+,FJQ'VC^<8BIQ /-?QN18,3:4U H';J&=1
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MOZ*%KG554]*PUQ]VK5[J/=RXY5WLN#\@Y_8OT5*[53&63H.-OB73;24G]@Z
M 7LT%NYK0<91J0'/F2G#</6L=OI&P2>K[M'4T@W["'P&[B>:6*R#UC=WL)J)
MB20G*=D\,(0%_JW7D U*QX/*N4&W/K[*"M8G4 F>'X/9;(>W5_<N.FR#[:G(
MN,%=>K$A:? W2W>+<B3+58(UGM;"'YL7#UN_O6Z1CMIQ;O[9TW/.7NS8NM&
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MW?-=2^N9>GFB8&5B<P"Y?3UA^VR:_*WI*T!723:@7N!NVIO7MGC]FXWB0H^
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MT]C;UX J56DPC7W]!53Y(^3?!G[XA.W2)OCE6>#>,_[H.5LZAJ_5U-CIUXM
M5>DUC;U_O0A4D8IK:8P"?+;_#/EY$L4AN/MY,JG/;H+M[%O<:FD, 6A E8J4
M64MC . LCKG73V+X^&9P^7T"5[#H_?2+'2></80/(^;QJR1P\(+9=I'G813?
M#.YM?UO-A);&"$$]"%>5Q&D,(=2#<%69%1JC#"\G'!UO.)C3YLX(3,(+]LC\
MD Q$^?O6EBI.C6&).I*Q*C6J,8Y11S)6I50U1CM^DHSWS/>]8 A4_&SS;RR&
MOV^Y1M48$*D=#2M2IVV-,9/:T; B7=K6&&'Y21KBO$IN^UA-YHZ]P(MB;L?>
M(]MNA=K>*E!&!T)6I56W"J31@9!5J=:M FT$M$UXS1TX&D&RM8IT^R";C9*M
M*K6Y?1#-1LE6E9+4&))Y8.-)R&T^O? & \99X+"O01(Q]\'^_BG$\6-PHJ6?
MG'/F>H4H^@6;<.9X-I$5SKYQR&/O/_3/.^;#EKD+[E";,66MML8PS&M)=^8X
M/&'NK5AY*ZBE,>#R6FK=><,1:,JO$3N#B^-H&^C5T1A<>2V]/C$[8I\\N^_Y
M7NRQ[:"7QD#**^B5&Z:)%>'U)I'&$$DI))KY17T(HS'DL2U&H ZN=4=C1*3&
M%J,6I-48-:FU>:D%<37&5FIMBVI!W.U$8"HQ7+6@YW;",ANT<K6@XA;#-;J8
MQ.N9^=GJ;C%RHP<N6BJUMA.WJ=YP71>]MA/$J=X671>]MA/;J1H7+95$VPG+
M5(.+EDJ8+095-#0".V62;HLA$SV,P%*IM9T8B%9&8*GTVDZ,0RLCL%1Z;2>:
M4;416":)#K<3M:C&""R5,%L,4.AB!.J0P'RXQ<"&+L'QJDB[G1A(]>:E%L3=
M3O2D>EM4"^)N)P)3?7"\*GIN)RQ357"\*BIN)USS["+;F>9PN)U 3I64K$HF
M-89X[KUA@/,%P >_#AY9%.,*T75PG_0CS_5L''&7;P("?W@V%JW'GA/=G]UO
M)\5Z&B,^YS;G4VS$,L81A. ^)N.$3,\"8D!P0:30@^OQQ/8XW@K^\8&#A,ZL
M,B.:"R[Y :%?\@*^C1KB9G#E!78 #^P+]VA./W#;97?,8=ZCW5]+&\0UQ29[
M&L-2AGO6P3UE5OST- :[=H9[SH$FW'9B\6U]-(_&:)KA'<WUCL9@W29X)[=J
M]M--<0\9U[/?. X^9Y0=8O710QIC@X:7UL]+I>HEC7%)[0E1JE!K#"UJ3XA2
M)4)C9-!HU_7S4IDI-#V-L4G#2VOB)1W"&T<[#K$:QJL(VS_2&9U55+OE(;Q4
M/+WU;6*H;-K@'-@PGB0QX^D%Y;'0G1T,V>S]WH=Q'(YO!O3EEFHFG0%8[1GD
M(9QL-W?H#+&^F#L^V\[("QB?;BFQ=,8T7TRL*^\[=D7&W(HK+\8!'%O:X>-(
M9_CPQ62C3-%1Z*.=Q\-'1AD6)5IZ6L95]$%+CNJ 'Y:NL T#E<= =< ]=; '
M#2/]@)%TQFTW8(T85BJ/E78<MJTS[8YU1CZ-=;LF9M+!KSK>*NC3F,*:<YO!
M40W7;9[KM@J?-49V;?A.9ZC9$+I$0AMP>@<Y;TTYE<<&G#8,]"H&,N"T8:12
M&,F TX:52F(E T[7EG8G!IS6BYF6K:I:0HJ%:Q/\.#$0M.&ILGG* ,V&M];%
M6P9.-MRU/N[:<=!XV\AIH&'#7W2M!G&*$P,M&P:LE $--&T840M&--"V845-
M6'''H?$=IGV[::!UPXPSWF>)H9MVTT#KAJ?*YBD#K1O>6A=O&6C=<-?ZN,M
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MN]9HD#X,V=88XC4,N=GXM$9<:1#H&HF$)M$0'3S#MH&T=YQQ5U/F+T#4ZN,
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M,N ?H%^> NL1=C!,(BM63PND$$FV(H<!-]^>3'S5;+-!GR0!S_J4I#^%+[W
M\1-*B<#:EM79#[Z^N/A<HH;K'1RNHJ_G#V<DQGZ'?CUK2-D1$X?)0YE/NB*]
M9G?MS+?'2;QD+Q]$EU0[=D9+KL#H."P^)Z/RZ_.+[TN^.7NR0>N [E)?(S^
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MH=@?V#4<B"Y;J0M=2*1/:5 H/EU(A]Q9D,JLS&S![$B29\Q)LA-<A(G70=K
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M)I9:=BQUHQPL3 \!7DE8C]+G#JS;,.0KGB&SWJ"$&8O8(O[(ERU<U*>(;49
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M)^\1-UTH?Z0:5I*)C1P02!#%N;;@8=Z[L_'L<)=YE#D8X>4'Y4 >&3(C$L_
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M,@F# B V]YC]Q!VR6$7AJ8M .D==G/Z4-"0!?=1.LL&(&J,B+ *2AYGCWW9
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M-TOY"=LA)7@DY\GI9/!JJ@":GYF$9 R'K8L)3".C9Q^?0YC-P+DL*_'U^G[
M._.%F;P=*]Q!F5?H4LLW"=-I2H[UH_#N1"D6V8W<NSO9Y;<NWVNNR0_.:6[+
M)*E]Z_<HI?9?-03&[);;<&C$Y)JRU]FG"85=_,W3G\EA>Z>#R.&+RW3FH3IY
MWI3\"UXAM?Z%!5'P4I,P"9^TS(:G40[71R(3X&O/*8A66_)70?^&'A-*=9A
ME&NJC3G"I^ORY_!,/]3S^.CZQD]_>&?O&M[F+UUW%<[49ZMN5\6%9N1^[E/]
M%:OQ^4YRP7XWRAHE.UR! .0R<] KI99#PUO,PL,5Z2-IK&W;>H$_N]>6@B^G
M!VBG\UUBB6E4:!O5TXI[2TF[.NWHT"H.H )YUUKY]C1I"7FTHS. XN:\[TK4
M&19]K:&@"ALA7QUF.41:6ZN.)S8QKFU"+B]8<"T5=]\9YIDB.4T&20%CUZK:
M:*U!B^5V?-XG?W0+\;;E^WC1,3N@)]ZC4>MV@W"IC5K.=6/%DA@38G+(9X)0
M,<!RA81$STO)597?4OJ\#5G 5W6:V#&TM2>G4@?2-RZ]5:ZL"$4F:K4%1@1T
MWI*;TF'4? VL$M+9(7B1\')(QEP(@)EZ?L<)-KSFB)-SD<W ;9T=HE/G8.8D
MMF,NU68",/ ^#@32(@8+QS/"<WC02<<O [],!ZXM&2^,E\KR5]%*DQ$,<]$.
M5E^"X%$^$IJ[LCY"P0BL8N\]?V?<@9^8V/@B\O2?2L[^0/B1@* P]J =$T8]
M]ZE/^[B#UJ@H9\R4&'Q;9/PUPL"]N.(KI)R.W:RL;NC;D?W B224DW<Y29LM
M0UO8LE!26976C4B'3KZILV CHR,_+B\+O5J.0=-TX[%:MYR9 H%Q,W-H_L&1
M3J54W0&Q=8:;6YAS''5F-BY=LD;BTQ$]].JF=M8JR]U-+8]P:Z$RR;W_[=U2
MS+K#U0I%$F.XS^/;KZ-3DSX&=:?\[PZ)7W?RX5@M!VDY%NX6NRK<+>$(.<E%
M^O;  H@VDB=^^+"9=RMU:A%\@S920$>+.]:?)H0U]<&UVMCQJ"7?%,S@^/2
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M7C&83/F+O'[UF+M(QG8\F\);I /.1P"^.S&Q:3S@7X3KZES,UV(X\3W4R%B
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M+R^J'F20$Z>=X_@X]LYW5O*9URH*E/#7811Q+VJ7BH66D08,A_GZS=C*(FH
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M9FADA8:IN4&]8*_KDQQOZJ\"XIZYY\CT4$)G@$5J$%_.:8W-A+3N8D$:R M
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MSM)K8!*+N5X/MZ]1]FZVKN&6"TKA(&KT5./V6^V<2S(^Z,4E.#0%,!W3LY*
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ML([\#-@9]0);IEPX44F'UYG>G,M B+"[XUCQS=]F+J=1K5.!&H_6R_]Y_M;
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M+$%@.575X':E\X'Q..-/N#W2'JZ46)U[1IN?)R.!P4*!\_ _RO G>(LD'X&
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M'9K*&F"M"!+O?9[F1_,U:8J5ZL+(LJ/+$)S(#7,?32$9'3M)F+3-C@X[UI\
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M% TD;FGTI'RR)7AK D1N[\,#EB\@-!'^A>LGYD*C:H,Q#A21O-IO[K59\3E
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MEKQB2A#2MTXBMB1>!:JLK_(]G1<1V,:#HO0:J[#Z8$.2KNO)[HYPI7R&6V$
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M..!WI_O_LV\1LBJ\$_M*I"@G%NP47?/@T!BO/7L>')IICO.=U(;=38/_TJL
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MTF6L?=%Q!AAY.E+ <JSR=(4_?$7SZ5U%\ZZB^4EW\@ZM__ HT=/TZD)4SZ*
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MOB_784P6+X&KE-J'E $HB0#R)A>7I\7"=;WO9MALI947= 7_.#T[3?O9,FL
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M/8#Z9'5<O^D7:3OENH:8>"&O*@J-EWE;MKPR'<KD)G]/LW2 *+>.$E9R=9%
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MV3['?BD]F3$ D ]MBTVG(H)Q,/J*ZG;X.LU\12V?*1'5[:A/?J4"V#$<Z;\
M_$&G^@TKYKU6AG*9"H5L/%5C%Z\MHI0)DN>4\0XEGF=\6)L[8E8=AT2D2?LE
MGE3[O"1H0/@PLD/":7T]^I)5"2,GN?:#)[Q^X9J%K- B9@+CMY3X6\,[2</&
MM>^Z@:D_M&?UH5CH^5=/\\ 0+&'VMFNE3ZS?SSMM;8O@7GL,3G=)L]MTX7@X
M/0G:/9>&H'Z[M2!_=D:0M!@,;&;/,K5=N>GSQBV:EC)^YZWZ^]O[0846^=K\
M+1.<K_*FN0YS?@5]LK"VSL*D_CL$1J@^C FW8M4S9=Q20\HM.\=KQ!JB[0H;
M9BLI%GK]A;R_=G!;6_G[#X=7IU9D9LS9^76YE(9 )@T@L(AVT.5O95V39T9"
M$85:'6V,XC_Q0TA'#[^".N=E.\C#49=V# ]F5@&,80@E2B9]Y [81LY=4ML)
M ]A038O1:I4X7;=Y#00Z$>@EOZ3GB)BO45EBYC$URF"Z%=W!].'P<'TC#J4K
MZ3?%95E<J2\O6*+P-6%@$]UYPBB%:WC]#WMS_($&N-5X%KT9X;=HW-_4VLRF
MOYYX;/C&Z5 -I_JY2K4B@2W^-#02"A6K=C-Y^-FU%L M2D(<)_PT\U9@=LX_
M%9LG>]W//KKRFMB51Z..^2?%+N+*($6_5$O[F,V8>[6XC8JA#5](BC=<H!H*
MA9\YP_#/?GW.A[K!(U-*1IQ]UAB.E3,AM3W,8@--PMUM6J*P_ JVBW]T;D#E
M YGI&LPZP%J8P1S&:9QOITH[,5&,]2ZS8'NA]F.6<P ADRVTI!X\<69%PI3_
M')X@M>_P?%03L@,/10]&&'W8=G1]X-_UZL05B2-&+4JG%6CC]$DND S\OB:M
M'/H$34&63 #-Q^3MMY2'8\G$ZF3-03>**EH,NQ=38*C9GBPE%;*C#^#R]\=7
MK=.RJ>>P'4#TY#S <[1<_)E!#[="EIDM(/4HD2.ZJ]K27I,MF0(MJ)-49J_U
MBV%@#D\7SQR'B%:=]=P@!:8=G^N &E#7-1EFI%7"!^"_.MM* $+RAB-N2ZL,
M+5K,JHE#R?% LTL:84[85*6Q@L3Y,+0;LC9%^&QW:XKTW]\4OW@K3*+8Q G&
M0%A\!-[>=E[2)BHR2IR>5F5'G[P!VW&KIH,C,>_\Z$**6TDI4\$T'MLP2M>@
MG)HY)JAIV[)@A5&JIE;"]"[J72MT7@I3;UY%'MHU)6Z:3$RX2EC6]KWKV*O*
MC?D;R@5G6E;\_L6/+UZ_?'ZV.'MF^? H3F87X2HX9('UO*"T:ZW2SW$60?VC
MS K(!\K;AY__\#7$QW<UQ+L:XB==0[R5!8.V\S9*53A#Q7DNKGVPF^,.(11-
MN&+1"F)5?F#>"?=)$@&XHAS>P!"ZR-\93CF)AI\U$BHV5"7I\&6,@0:$,\(8
M;S1VR%;Z,M\ 9R-L5>XTT!Y0<?-&##_+]ST)/"]#>*:^82KOQ/H+E#]'#:=@
MN6"J'7Y#'E1[$0ZPGA(KSZA7(Z=N ;OZ-TW^[Q*_"5.SS1:O^^8-?6-;-CDN
M^SRO\G7\AA0/-\@:>$2X\RP37]SRS7ZF]"Q8F!R8L:R[43G0V_B.JGN&.!WP
MH0R1F P/]7[4H74Y.(2#F]5&9-)H:4S[3%J11F+C)MK;X_2D7@\'K9V:\NF-
M3+@_%UON6+!Q&%@N0$TO-06&!%0&K%)_58)O>Q(F1N*Q/]_62VJK5&0;BEI<
M"&_UF?$L5 [W#]1=#-S#$+=O%?,]T3N64#--K,;P5JP#@ @,5Z9'04V9JL 2
M8(Z[7F"01/F5^BVX!L$X 1J"BV(-=5'8:M4\\!3_HJP362/AZ8N7/V.,'3A$
MA]=/GFR!X2P7D8AQ_'QNZ2>!QB&<0VZ]N:+SPQ)$UU,7U6PE(AG:Y" 1I%WO
M'W^ P9ZE8GUO,_.)Q(RW2=]=@,*,@#:\OHJ\\R@C.N_2%0LQYB*,?7TMG<)5
M06A.@J,<;ZY/-4.;HA-^>WUPJT+R.P%IVL;<6[ 2? B0 ,^2,?&\0FULT.S-
M6)K6.O?XJ^'(+C>T0W2Q&]\MF=7IOVG@VKI;T.#B,'%]H\GSYJ NQUW=?$C!
M\65BXI[%Z3[KPKPB6WU/R-=>/CL3 K/[BX=?90P:^$V<ZMFU/#V'+^1M%]_(
MM'U\3Y\'PXU4&"$=K,-,\U8K(,%&?1&=J%@@]AL38&(L/"9Z%4'IM6ERTPE%
M4\R>?88^[4=?GC[FI]1F;3 SA4AK'5M(^<&'7<WTC)R0:#7!_$\^)WT!NZNY
MN*$BY3@'M<D#2Y42C:0L">C>&O%#I;U+REC]\/3A@_\X7?P#BY-?,N9^FWZK
MR"HB@I1N=\^7%Q.%YTW=[WD;Q?-$,5\9-@M;/)\%U.YQ+O[D32&=8"B5$[[@
M-70K\S*XU.&@PA;:B+81,LA:QS>[P&,)L@1Z #U?Y]_LY7>OSJ;W(=4:]]1"
M#?^!/29/T5AZL<GYR[AY'1ARK)EU'1YDV.VCG7 YB74[HHQXJ<%K$]P-?4OQ
M-V'$ZRME[+ FY@'7(K>1V?J77';$1N DT8X3CA*X.ZH<45+N6-FY@+]@65\.
M P#"*RMT'HD+%G;=CZ1L\.BAT$?*7OYY^DQKE<M1#\JPA(1*\W!\J81QP5O:
MML455Y$K?H-GO!=>P22<+OZJ.JK2716CCM'"Z;B.2\UXBM_)K3#$,V1%Z62Z
MRW;0[6IK6E!>5A/"9+,!VC'+:F0SHMTGJHF1326Y3810ZI9UBT<OR7669G ]
M$OZ5 TPSV?[2L3@#^ _ +MB^FL .9APIS+)]3Z2*9B6Y%G<(I_)[>G3S2=FC
M4QJ*5*V?B+?\^D*CRL--F)0'".LL[$P2V2 FTV#LLX4/5K6X<CW($66+RYJ6
M\58)G'UO])H_I<W#$Z0'1^E<O_22N]J618FRIB24^3K)K$UE9 X--I^LMYF5
M*5%8R+@,;TE-;C5$IFL^7F%'=-2W86+5!@5;(N<#+?#%=_P1/1-:%DW/1+KU
M,%^%RW;\Y;:S^/6>K&EU?D*XVK]\$38(9\Z)<Z+J_G+R^.E'GFF\^=/?)AHX
M5"](QN'QH]//Z;V%-QEJ#5$R>ZKW>BZ<'_5D?WTW,Q]B9@QZPC ]DM<*7OMU
MP@N^NOZ-".COYO"#S*&I\U ^4>)2)HU2E(\0TFD1H D!TT88.H27XVYVCW5V
M@:LD%>GS8>G"":69REC;]>O#BA'ST_)'@0H\N8,*W$$%/C14X,Z('3)B3+^6
M^[02:U"$B,SKVA,_,9%'4:S ,=HA(GG7P<PRWAG5W*@6V8@P&WXD[[\I[ES&
MWVHN9[FT!TH.KD&$OU)V=U/RP:;$30C.5,8'16&FA- \E6MP_6TZ97 :@S\I
M?>\N:XE/)-(<\>MWT_E!IM/)K7HH3\(U[%'YC@I(.6H'?*[*2ZM-\G<N_,</
MT*S"8UT 7&D$>'^"ZR[LZ+KOA-MSR,]KY/["^7LW41_*CJIZJ K]Z8^;T1Q0
M3K(@33^9,-MD7(W5KHUS4B'R'"$3TTG)Y7,!X7661+V;U0^3?5Q[.;XU(>W!
MYD]S^J:XIA;PMJZJ8GLWWA\L8['/VU;T'K?!_6BW QVNF2-. %\B0W!GY'Z+
MZ9DJZR2=>@9>H)VQ*H)9 CPJ<K,RA-IQOZ/%_FYZ/LCT0#AAKG"6LN)Z)3QX
M^\!34ZZW96%:V4##JPA]%N^MUBB7\%'L3B_2>3>M'V1:76OH6"9V,[!TWM,?
MM)\J@SQ,ZT5!^O KL)@* J@-GD@AB@MW,_>!9TYU>U3,F8IDBC*/TWFTI?_(
MF<8KJ5Z]T5<9X23F0 &"B4"[;B(J/(Q$W=J,6F,&F\7-6P QKWSW)YI[JG,8
M--T+P@:1W"T5)TJ9W,6'YL8;(XQ(P.1Z<31?1D2$MZW;G'0Y&+ZY9>0:_?,"
MBCKARLQS)'2+!)X45'\\/3<U >R$H+ZLF0PJCE]DFN"9 &)":/8!<R 28__.
MUI=#YN+0\+(Z'7)M!P$>[KZ#YVH**LR@$P9ZSS8L;B2&A/F>I"CR%X%"KU-2
M26%2C/R07<<M%UK;JEEFG0E+T'($.?*$ 0O(M(202YL_*.$5'J[=7#MV!Y8,
M:8NNVQ;N^3^5OH#O&)\D>DH2E>[KME5D)<DLI)_9# C+(COH/!AGU'-Q(]KG
M**V<'ZUW'(@XN*+^HA!-)#GYBF@E!"MG)N.F:@XJ."#']"U04*>+GX:* 9P@
M (M1VS.1I^@2PV8QW9N4^Y5&7=MTVN"N)2CL5WU8[P^?/'%@7;>1GQ&'I-<@
M%Y"X7-U!<;$9@WGH=PJ$(Y%X9'_S;9'HA+GNTP[-6]3.V$TQ8\,N-109$L_#
M>O89A;AM<IRXL0CB[_QUJ''-$'DP4%G84N.9((.W:0I:^AA#1;KQ0,A$@AN/
M[L7R26[@9&1N-PR_%$J!4>]Q:( !,FR5$^9^"]]L:J)R Z]2.%')"=?2OW2F
M@O(&S^.4T-B4]Q6UR&C3PZNS?UA[")L_>(@;CA)6$ FB9126J%)5"N7N.AA;
M:?R+VCC3ECZ&*X-)0D#BMD*IR!0HF4"\Q)^+A)0>>!1Y4_=2CEA+,P*GMX')
M-E^L*"A?8$R#/G9A?LVQ!9AYX(EY9]I6OZ,E)&Y'MH'&2$S#+2V 9>I'Q;0I
MT7!=?9RA'XFO\[].@A%Z0^LA[J(4YWJ 4>@X+?H_TCZ&+)U@[4L U>,^[/QB
MQ[I=47*7IG_5E 28AUI-0X/<Y<3Z5'+HI2/;IB,JL7 <21.,'P7>_"7JPF8V
M7^9W'#T-DYI)M\%$MX_KS="50?M!SS+1H@6PWEH1!(D,:B*BIV)'*M(C47>[
M;.N$T&DPD',?FU)6D1Q#H=!^KL;+NU]%NYXR;K+TY;50N6$\] SS\>[R6J3A
MZ >,2M*$H;X@^W;QV&!JK@W/D7\#I=B^D;6[0P]%B$W$Z0=]WJ$7"1?\PV.I
M/K_#4MUAJ3XTENJC+F'SHP%GP%'!OK_:J$9/Z[&Q(6OA;<V"N\?H(^EES4Q2
M4!_=MFS$-N*I5KE[:F"D<:W40J?4\V:<);<P?J5,R8ZOJ 'THMQ'MC4EA8:&
MY&T]@M\_1E:WNJ(CD1FMUXG6L'(TO-7L%&F"TNS%CSGNBK9@?F5VF8[3+3HK
MZ0"C_^S3H I\V#0"R>N=+EX(%83X@8ZG85OD: 3SJ:'(6;@N6V[]PY"P&I10
M^AD%!JT?5; 5Q0"ZNR>4'$D6RY3$AA"$T$*"1I-XS7&/GR-JG=W:FU)_=DN/
M5;87Q=H$"UOB1=BQY\>J%7H!2Q0-XE&Z"8$+ZY8T&S4+$+7G9<CB<YC*!Z=)
MJ(6:N J<6%E-Y,H8/8FD%CCY%J+8 J=1J!R&+)[.%TH&+3PADJN0WU;51N\-
M>3(,+XG)4M]7'O&3B&&X NR BOC0&*3:P>H[^C!XU!(^[D.'!BZE39M>7N$=
M7."SHM">KY==L5L\?'"Z>!91B"]C"D,:B'\HPFN%R_;<U_#,7?B9N[ VC;V^
M20F84I-XX788Q9%Y<7OO&?Q\RFM?JR0Z)$>92+JA((RH]W69*G$TQ323B2IF
MN;TVUF=,J.^65R7+0;R)=;LMW] -621:6(Z5_1^</Z(!N \!C S)K;K_/I&S
M@L[4&-+5L180@5=( ;07A')%/Q2+_'J&K4CD"HQ6LD^)[CMO1<*.+W3@X[=0
M--6-0&!FL@J2<4J$3H_SD*(=I$\M^9"YFK1HEIL05@;AZPL_U AL&3''N9=;
M3N,01Q>U@2EEY%2[58U#+W!UH9H,X<OKX"Z= TX^4YA_YU4S?J);+(9T"_/<
M3^HA36GOLLP$0&OJZZQREJQX!X7=Z4>8&LK6#>:*9;5H. 48I" XM* U3AA$
M-PW/-7%9M,I$0 9TH.(X*P ,@D/+8-*RO*UTK[8.N-T6'NR=MMKO;^A>^SS+
M.#4JO.61T1O'39*<&6>(K+;)S&F1F$TC(A"0?3J,\KGQM; ^ _R*GWHOV)!O
MPL)L.,KR;WW -<'Z\0/#WV,A,RO01C=/^MC3O^D###4YN,O^P,0JA%]ZYTOC
M#Z66P2*FOZ?=U!N7!4XCQS(T7"9<]-7+)7"R3WW1*%8@E9LG]V_=,W_]S*"6
M<QQE+'D+"%;D-RS:.+-B'[/1-&=#6C$K$+64R+1/49:9Z$]S9D(E#G]J 5X2
MQ-\0?V(00^BPE]4<F> M8*-M(,<FR-.X!KV5+&H;Y:Q:P6KH42&4Y_IFED5/
MUU@FXAN.E29-42N\VJYTZ@92W' <W[$N/MH;--X783P*$"P6UM$<EOVZB#E_
M(VT$H[UL]JEY!0J"F(%^&MY)RE,H8TE03DTTG9"N;$J1%2M5IP6$-Z@CLU0$
MR!(L%WWX05CM(0=Q43 EN0AZ)7>$S/0ZW^7G(KY)"=G5!4_WI@R18$DG8%C)
MUX#E@(ZGXT+O=/6%,#+EKC7D2R[FY8!UB?<=WU44";%:&&&Z1/&K<XWLHOB"
M01]K-T&+1A-PAI:Y\:%*<NYVY2I,R7K@2_7#XA/Y*O+:,ANI\5-JS["BF#;+
M7@)UGY:KG[=[(6;&RD- UO#&[G>[G)797(79$XY=8R\0C4D>V9F&-%9,K?5;
M!LY6FYKG$841B-O7E"R%^W3 1^K5HR:!*O/'H: ZQG?S;:=#/X= :.'4(*[5
MO+W B:[I7YQ5T3N@RT7+^:FXAB-K553_K*\MB:.U4QHU\@>BR.^ T2TI5F>"
MQ4@SK[%LQO OD^W2$C=D$H_SO(\KAB*WYE(,)T :E\0_?)V.8E0L-N=1VX H
MB!3.H2D3Y$R?JJT A\>G:C=26QMP9P_RE>D,B$9H/.SI;.^#'?G#%R^?WA4O
M[XJ7GW3Q4O(5ZFNP9>(@PUNFTX3U,P)JV\A!F;K)%\4N'+%D\. DPR/#22K6
MZ=_%G#-%GTM4RG%AM?8J8C^9C8C73K[#SRA.A  CYUUR"G$HN>;H"+S+JK8[
MFXH=B,]5GL%H,#]_\!\:(<F]TX>3$A"(/C5_Z*_!X7KRJTP].BZR7( 16F7:
MUGUCEKK?<ZAPR9H$HM\L<QT"I^(JQM+):'+,7G+:BO^7/#$N096J'\U.=GZ9
M!T]'VX7H1'>GL_<+*?7F*CXBE$ZTJ6^E")DD->)OJ>Q*\FT@RR\8B[76$L5,
M"L7/SWEP&2F=Z_!44X5ZU+Y%,VX8]$4,&+TD%<,2S)<"<@>[Q)AWE9 \IZU&
MZ$SG!ED''1?Q7);$H[!L#8>8BJ(?2B=:^+LBBH:P//S#@&2U3M(D\\X :R=X
M=\5AI#P?&%(*LG(C''_>R1,Z@#*EYV_(G>-(ZYPXZ(O4,73.C R<$9T;?_O
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M7]P:W'LXQ1C_]&;:3=KV*\5"\'I*'M%:+VYZR$)HZHE?OA :92.LM<[;E.&
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M/HYPYK$BF5'1R\3\^O'W)C.95Q(04*@^]>14%S4%3^=AW]_[[/N_TB6*72F
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M:4/_1M-Z[S=9^;.]X=-O00W%__-_/'K\^.N._R=,15U=[XJ/ORWO.YD&PAZ
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M4J>TQ445Y]KPYPB.IM,()H6I3MU\'B;/#@XI%;B'G7C9=8>Q??/KN0"'.WZ
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MM=1D@)F'XQ<?V"PPYU)5.N'7QE/U.(C+@BG+R8[%(,J;>%5^H*LHCQ'ZP9C
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M"-/+4Q_5(@[:L\&C%UGW4AQ?Z8UR#:?T7)&K[$,;C%OH)6=H5H[I7Q9;0 A
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MPXD<_[J[_80! 6-SJ=U-U%N3"M#B/!.@O?Z5[-T,D;$QMX25LBGA[@Y_T0U
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MIV&)%NTTLSVD@!@/#[9:^'DE8N)3V-(L?9.A4HH91&0[F59<9-9'?&C.CY$
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M4&0YY:/CG\<\&$$QFQ'Y(]<S!I2 %KSA.N*\U"GV78=?(:>:Y73$ F+3:F0
M[=CN+V7K6*/C.&\H8X*GONN3)7H7\LS\6PLS#M?A);"5)N@(HWY8D9L=;WQR
MLCC$GZTFQXK C7'/XKZ=3I%6+F]I:]F4H$(BA0S[DY,Y_K5(IY>-B[FZ)VW_
ME^'.Q,4+;IVX*W++&P,(O35'(/ 3*7(R'72X_!G$7MA(/CCZ']?2+Y.%'^3Q
M>N ^2U1 H)(\!4K4SBRCB^96FDV>/\8V:%JH8%JR_*KC:<?/<40,T8S$XLQ>
MBX!@5S^!]UH27A),):IWUTDG5D-#EQ&M,[O;<%'M#:*^T(TSJ6E[1N6J_N[4
M;Y<P.X@ UERBHA9&Z'UHGS&'._65-ZIL+U7N<(LF:X49 A$#EX0MEO78]2-'
MMJ68?1R=ZW5E]4F<,BF8T=LS&WLR#R<N5A2:H0-UU/:2IB:N7:(T=2^#%TW@
ME98I=RF%K;0>;C:<,1B8$33.=W$S^B<,^J7SSE7355OA&IH*1CPN(L7G<>)_
M2[WSE?A2+5*(SE?%'%\,N5L8=5.L5^?G58TU=]L%''C%)!9M\/*I8&EY;K1B
MR'86? 6E,H^>Q)_I+[+)+]55->G\8*LS'WJ&6%,(FB]8!UVGE@G"/)IE(B*V
M"&B)]V!*1S09T)%SV[&RTN\Q#F]SM,LPE!(M+C+6_6$=%D0*UHEL$BG3*Z=R
MU( KAPS;+;YDSTU'FM=>K=$_82)/%Z[3B0=]I5X 2UR,]#[__V/OW9O;QI(L
M\:^"F)F=L2,@E26_RN7=B9!ENZRN<MEKV5WQ^_T'DJ"$-@BP\9#,_O1[\V3F
MO7D!4++=FBJZK8W8Z3)%XG$?>?-Q\AP1C<'^"F>M=>#D'?TU^'D#3,G3X!=-
MV_F>?P[2=0M3=M*G]3:<?%KD<\@B:)\OC!Z7S[+H&7U,&EGA?:J8N3DO*BCQ
M+@8'2)0'I!)?I;VT1.1!9QKQ@D 8PNI*V!N;?"B?MA0""Q&W^\6&S@P>FT6=
M1[Z].=K,.(60BF=F^!B(\\LB[^%2LE/$V"^S0 *)4E@J[-.0S ,>)\P[&G)0
M=M'1YT05W[FU(X#Q03E9O1EO?F5JVL^?&W-"ZI+BEY@<%^OB:"(DVLKDX%2!
MDIY'8D]=!#7C\5KC>1B%N.#WIN[]J/_\!] &D*TW-P^Q2^^.E')JAP:[#!]L
MF(\AO@"K4!)ZQ7G+N,=@K01+D^'?@3 E[AM;R#*8: +8-+>D6;N<_,VL*'N6
M?-5 _ESV;DNTBN;Q[K1W;TN9![>ES-M2YC?;+KP]6:G.WB[G*-]?ZY3"$Z<C
MC$DP /\Y=UL/9IQ_L1FAOGSM]@M\>&FUK6H3'@0B+9P\'MK29%3Q$<28+3<Q
MM&5)ITB :%[S@I<4(=C#;? ][UG@"Y0!C8XSNJO8>1?9@#5?<AP+=_PY+U=O
M+\>_Q#G1-4CM3_4(5-,-_M* EC;.HRF$C4[UD%JC?_5M/HA"1-$ O$CU@DG)
M2$2HOD0Q<G_;((&/C\9T9A@/$YA@#@76'1^\$O]=5634&)!='U-R-(Z(3:08
M9^T;JE&0!W(D/LD?;R;C9.2?.1:[;/9"0WRTA@?.H_$%ZTH5=X9B;>K4;XOA
M!LYHVR^9_K3SC&T==OV:?MMMR4KZQ*;;7E)7/D//QB!5BDA"$A;A5X/,JLFG
M#E5?53FO6G"6U"3)8D:'@Q\EH=EYNY:)+MMH$#-+2F3RI55<.*6,#.<U:Y(J
M;D65;I YX&PGC591@\62&0Z><P6X.R]\F,5?&><I"7]A)!YM8IJYQILHZHF*
MRJ5S0!>>\&"1>A.L-T #"^*SOT%+TU/=BLT3D^91 :D^DN:#_5]\5"=<D#DO
M,;E@@=SI:M57.!$LXF0WLTC/@-*08$T$8-PYM^'@&K5 ]RA(O++6 '8':A*Y
M3)T&S[S"<-I2Y]O<>1\1BQE*[V'%"Q387\T,K&W0H?2.W;?T8VG&$LX2+GN9
MUC#]'&E?=QM/G#Q@HP.1A_]NV$B2.9VA)B@3..P:DHTR&A,!8'1>H*A5PN+X
M]\1KO.SI'(:;L\H^,O:"\SX[FG)\J\7>46P?;V<QRR9KXC.V$W"1*1@)!>0Q
M@G#B6C'*Q,/ !UJ.;\!G4UJBC5 :&J8E NJ(BS@J3%M7ZM91(@Y"ISS3]+J0
M*Y@RAW&V"?*A*:-R=)M=DR59LO['1A)L[2T+QTVW*[\/KCA-I:J3GA-S+YCV
M; +\.C#0;4__S<V)+TD2BB34'QGCI8G)V&JTJKC*:(Z^:O*RX"P)E3Z#BV?1
M [H!;^?NQN8NMLNF+"<F6O5I:+.1CQ#32X8JWRTKPXU-R['0G17LRTTGZM=U
M6<"#!8=<O597FS(7EO;3(@N,QTY;=C?]%E.Q$680G](0\-DRNZ@;%HV(8C*.
M&P1CI7F?"U\GPTCY3VG]\N=\E3+C[RREAM:W/:?;:K #H%SH)0Z";\I9.FW,
M7^5=I T)4:,<L-DR\AY\>/D[Y\T6G-&B.HFY=NAVE]H[8V<8.69@K:$;;QS7
M:C 55=]E0)0T#_DZCZV(^=5#^BL=8L'-D]+TZ,4UG(/O-)0U"!3!@X>QI3I_
M7D\M@('>^:1?67 /!=FL;8MEY-!I4$3'CXR9^_W>:+D$/Q$I/=I?(6G!.=NP
MS9CD=N+P X.\ KO24+J=9VT>XC-]/#DJX91*<5&I'U=N?9[C%G!TZ3*2OC!W
M$A]?"'P]4D_Q:E(W]?!/ _;W&CNR]RA&6S39927<]>$:"(TZ]0:0M]949T!Y
MZ_DB7:SYIS4#W0EEH(*S0)U#MW8C;9UFYVF:.F!2,1,Z4!Y[VE*RI*. 4+G-
M2;.Y4%T2AG7AFYY,<]"9XW?!;II)$A,9; >L OJ,W*52%>2"P LOG!A<4D\$
M9QY833\3JC/O#[@Y&:B<\/<7K-D&TJU2>#@CE@,WUX6T^R[0H!MH#SSDB$-_
M19>XOU&V/H=ZHN_,Y6@,_0ZP"9/08S^IW71?R?YHG#AKIB=EG$P/4-W-.A_E
MLUK&'##_S2AQEW^21*$ OL(]:3N%KH_HFJ%[WGN^SEHI#:IO\I57GU.2+RQ@
M_^Y#:\E-TQNVFIL(Y^%>8JKIQ!HN;&MM[ZA)[5%;LTUJQ2W_O)S ^U09@"@R
ME@-(SFWU_O"V>G];O?^F&Y%/*I.6GB@"@>O6.XS67XRSD1&K L@7($)(2EO4
MQNL/>LHMP))MZ^X5UNE@$Z6#,%2AI':ZUZ_#U?BC-E%?1%N-S]PILFZ%6SEX
M(^QRL5VE#"272XJY<%?8AC2UA"8[0F(Y;!+KUC."2"D]@/ZM5CK93D[7J\"A
M2M S=W1P/%&6IK3F'KFFVUO;.'6C2FFA-3N>$$V\CSUP5A:&BQ5/D D./)ST
M:QK%?8?O-*63<SJ<GZNIYLHX%0.VHPFR(^K;2S[7C[(U_*W^%"8\\X%%'LE/
M(1:P2/[1+R?=,/ T\4$?]6)&K9]IPBQ_M4)8<?JVT_MF4@EW-[$ OKOH/?M^
M.^F*GTQHWKC5.B.LB+<DZNFQ/\@.+DN3#D-#NUW4_1OP+DVGA+PS5YFV6TGW
M\.^8)8;6O[)/GCQ_H=R3,>3ZM%X95GM-Y4H_/#,BX/T\9*7:BQ">1?M1H2I,
MT:8_1/R5&1=='N'@X*DVR63+90%7^&+HB;O?N:]'%FB0YC]X6M.XZ+!'C0@9
MY\ :IH2D373R[ED8OQCFN@WYHST:6UZ6WA#3RA8Z9?(,YJ<+$28?>E&/A<*?
MKGI#EHYGV+1\2]LII-C'A<NY5L(G5Q@;^.%=-(<E2T[0Y@8ZQ1U+RK? >E[:
M(CY4WJ/$0$G6CHHSOJ>6X1>HU- [Y6W< U.IDC!GD%1G0RY)AV#M-C(NX;O!
MD:-KJ82PK_0'U'(_W%-\< _GS!:3&*I1<U_Y>'0(P#>1*-!<%SL0_A$#*T'.
M71>@^FKRZ!IV;-TZ;!-YX:GJZKZAFS7[ )DLBN/472@@IT%C[]-LS$-JUL;P
M#DJ>-9"]\DFXJ.HIZTZ\I 'W(13;:QKL2Y)MET'GJ)Y8-()$+"<26W1[>6C@
MK#! D+AG4=:3N@8\,IE% JD?E&N$25Z>*?Q97\,]\YP8&8D2M+!7I )'&[?
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MF;H=^QLI=C;%JA 8%'%C [;]C6"'CR*DMEL]@B,^J9*_%EWC_BU0@^<^+XT
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ML0UQ*&LHQOFX99.M\LNZ^0AR"_<KN!H?!'9UQ$5/ZHYUX_=082.S?.Y^!<
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M1Z_)\T6]:JU]TEF[M3TW-CU&]%"K=/$I.)8]=%\F/JKSP/ F^!U_SEA:'*Y
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MT]"Z0>-I_T@GR8T.7V16+S81S6VV7!:?\*OC%V!8(_]P)T,URI3XF0UG_1H
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M@3-QAMR[T]CP^W_AJOC>JD4_WE:+;JM%.U8MFH:[2<28''&4[JP'!8EO\P9
M#$L5N&,@^;%"A8^<U^'IX=X$T#S0V,)+,=M$-?X)&/(HB3;+S;7,9?![&<C@
M)4#,0GT\3@GHEU0YPP+#:[19]Q6[CPK["9D!=X4->VI@AM,2CIIJBM<)>1
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M(MLTY#J+CFDP/=N0O:(O3/=K7)9X=\:7AN4FF^6<=JK@"06,,VGN[$$*- 0
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M>JJ7#&)DZ-]W#T%/>);3MEF?NXL\C5I;G*G..SR@-['FNP/'POPE$9I?]=[
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ME*WJ_*X]WE)UV^U)FV( 08B%G4K/FF3?\Z*=T_;:I)9YD!_Y.3 72)2W7<:
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MZM&<3XH]4(<K3Q%(B2'?BAS,/T425U=JC-JB;AL%-\)=3U=>!9IF&>)H?>3
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M%$=EHHC&V0SPGLT MQG@3<\ WQA&.HWGBSBB<#'LTQ<)J M_2E37!^P]MV-
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MI T++)#$Z^R7U?C5E/[OQ=TR.^6%[K5I1X=M$%5+Z=!;\(((;C[ESB03,7D
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MGSFV^OE3\SS?(X\JB27=X]MDIS33EG.ZU7,D&.4K"*E,5R6BY(>#.B18KKD
M'7C"%@O0!K8<G=-<PV!*5V2*#)94WH;*,P( NS2;^DE#MH@*%XU=N7[,]T7(
MCGD%MGBI^R(5-C!ML3&*F$X#[,/JJ[:;F*P!-CC'93']B)VE1 V9]UT2#8I&
MX#IT,@4^)KX K%=1(BX^)#^,<YSS-/'0>D4ZQ4YI9%,&<V[,+N>)TO6<?'E
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M44[3AE'T).(\2S,O0DK>EQ*\-Q*>^;6"9WX+YY8Z!^^!%D3ZO+DXGU>'7*O
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M.O:B[[K[M5O3^IIG1(_A'S%IH-0Y^Y!Z(LS@Z$!'Y,,I[0G=&+!B@9+0*O%
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MD?.//!(.NK-(,!!2CO$CRLR%MTWRD-T$=#E$T2YDFN%MCF"KDQ3I1'H%5M8
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MHN;.\4JX #@3YPO>#[=4]@^OQ%;0(==%L>K;S+*O+571G0BPWSK:@0"/FD&
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M4 JL<$MWH_D19%L9']19"*2I8N?L@*%7LB 5$]DEC$T,[(TF?GASL/Q^61_
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M@(K#;ZVS%@B*,/22YVH ;(Q,?<&9/(((",1X+G50;S@GFDD]T-(]U&[/61G
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M%V8DZN6Q4-9)*M'%JZN*;-!& H]NX?,L'X-1$255+6Z.5"D0#;5>H:):X-M
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M-K&EO<P+Q;(G=T/%X8O>F-E-EA=." ]+,Z&=52S.BK1;Z*#,HCM<-J.)E?#
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M7U+2@PM ;VJR754E.F_,-#D\H T95 =8^3GZ\2<T4IK2F+-Q.Q5W:@" /?4
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MTQE5=OXPY^4<@I&D>#SF3G,>*T*:[:"0.\I6JG]0MJO;D]GRSIKX00W? ,_
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M>-S68F*"TM3A#N\_W#*7[*>3R\FFD0LS+HT\/M<8R6;RL!@.'9R6@_;X$&H
MWR1QB>@8$,&%:8QXLNC#?Q !"-Y.8F*YE">H3+.0?!YBCH954(_13."!8,,)
M."7_EA!5+)F)<,<)W=5+B(ZMZIDUIN@1J,DTE?#=FQGL?96/S(RTZWM"AK_
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MM=JR!/=V7&6W8I4GTY(LJ84KJ^E,.CTYI#6@./XXV>%R! OMLL/+9+)A;\;
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M8TA!UN&U'[GD%30X&DLO5\Q+>_*(5D?,U_V="KUD#BGH*ZMH,P@5)JYQ3=A
MS&OYZ6I917>V,.,KN9N]UC#6\UD /  ^0U9B!@0?=S7,!NM36&1I4+MY:6!5
M.$0=O,!V7 S/F.O@^K6Q EVZZ#Q'^%B+&653XQ46]0&RD,T"74S]BL'[X]?S
MMFN1D9XK(B8+;6>*"5\3Y:(^F5:85D2C-^&CH2;J[[.E)LO(12B&-U?IFJ,T
MH['ENAU3UQ9";DI!E%LW+REM=4Q>H:L-UNV/) %1+C,>,@C'39BPADYYB9*7
MQ0N5ZL')X9%O\AIX/OA/M<]B_C1;C@3]PX0M#[=ARVW8\I/#EIL@P47UB!F$
MJ"?$7M2&@Y=+.'G<D6F).%$?$1 P#/Z[+A&42@>UG&&&[4M,0B.$Q)@2#X(T
MJUFPIJ'>..5&P V$.,>:-E-3.O75GM@6["I.G%&\I!%\Y3!K K!!@(^SC<8N
M-CCS]D%@/6H=01="[%@(W2X MH!FKZS&@#U.$X/UKV5 ?9Z,I!;@7ZZLI+69
MXQ]:CTD/*212?YF:$QA3=^P)[>94@$7<5FNL5;;@>731D&7;+2/)MO;WDS^W
ML;_#DV1,W-S>'34@"H.2I38@&^$.#T_V7I!1_8%T!&N[R9+?9/4X^P?7<O4!
MI:'9H5BU&6N&PL#T1*&!(2Y^7!3$'(D752!I[CQ'=*W*1LJ;W7#W-SB14/"W
MZ=>OA=^[%54Z,!#91Z8>.R$7CG=MY"5$FMF $=!<FV44O]+^\+ZBON[*"AM4
MJ]IYT2=97O7:/ RQT]Z9-Z''FRDLUKUOQ#M%PV?CO[<U*\ETV;@:<.H=X<%\
M@VX4A: 1PHKQ_;GWQUUV?8+)]!<<KZ1G1.S *V>+)@8:L/X6I>C\W75Q67.3
MEVWM8^?J,58.Y4IG#IXO2APN)XI!*G#'Y+?"P:R7&F=N^^!AG!0LZCB2;;$(
MVM9'C2V4IU_T;,A/:$DM+03%-KHVLX[0&6"J?3(6+QC/;N#W/4KZ)F?(V7J.
MJSFOBT/M!@X&![$.'7H=?WV7'GJAB8Y]Z?W#O*UZ=4)-QU5+[OKH:6)=1Q2F
MCM]QW6LQV);)XV6&^V9RWZB6Z%J>H]"I.H<GVG<I*JL HY1WP,6IU6%%%^$4
M3-?>B).N.PZ;WL%X)#IWZ>I@]'VCJCCP'!'>AI["A/.O!.-G<ZOU#!STW*ZU
M4W&[4TXXNB4(U39@,=E-21OFL A+O'(]?#AJX=O(4.ACL\% ]A%IA7(!F" [
M807*RSK'8Y$:L+691W-L,E *JF&T(7EM ^*V.ZP(IKW+Q5[PI\HF;AQ3>OU/
M0^I6WV-.O:QC 6E\Q!FC8_;:CW6@1G.#,[YI2$.1@P2=%0:B LKC2Z*EY.GC
MH\.PC(] K#R9*0V.$Q_8/!7_4]B\B7/_8$>D$NE4+^XD+^C)93&(RG!-><LV
M(DX3H;C<<MAGQ2[DSXJ WF1Y82.@@X5SN;I F&P=;:H3+ZL2N8"W("HWO!3>
M]^!<HU@UORQV8W<$7LOMGP54N<89B*F'J/=&7J">@E?>SI8[1RVB(10]61@>
M#>P!WBA_(T!]UEE:&? E@=81;^'*UBTW-O ;F-4^ NQR:,*@-/TFNC<NCX1!
M#G4M,G"ZVY->+;%G/R_^=DB#O>N.6%C;-TW&^1 $"\G412 )ZQ%526P;I?*.
MEH3O0C(7XUE8TN^BV.)<.0@@#;MO2!DL =FA6Z@I7E9C$6V6'5A==T4_S^Z3
MDT('BG,'2 ,%]<64NR9W. U5'I[X\DA_WK>(&)<0,:4NR:T#'0$P;VBLI="7
MNW?P>TFX"!GG>[YC];\^M]321NX;129+W#P$U'<1$2+\.X914*JGKXR $RO_
MC5EPGXEV*9<=*LP>><Z?P[%[7+<S8\=YUU11'+)1T<6#8TU(NV! 82D[$(3L
M= O8+AEE*)G<V I%TF<..*HF*/')*_Z$";-?@\%HY=STF0,K>:0LU':CM%>8
M-_=M&2.=,<HV%U'HP2,_0PK @NN!%;/6J\Y*'M=N$JKZB!F/XR.S :Q&MD:R
M[F6W)FV!CD %]^J[8\^6G;% \^_:N1#(QWNG5TN*.G% 93F/^\,$6H^V@=9M
MH/6[#K2^>__VXMW9\P_G?SM3;O'VU8LS$DP7O[S]]=6+Y/G;-Q>_OOJ0?/CE
M[/Q]\N'T?R>G+_YV?O&6?O'^[.?3]R_.W_R,+_F'9__]Z]F;YV<7R=N7R=M?
MWR?OWGXX>_/A_/25B+"+#Z<??J4OWR2G;Y+S-W\[N_CPFKZG?R9O,=#I^_^A
MUYZ^/[OX7M2G#S8H3#3V(HP@;Z0.!9,EZN:U/+TE]A0,PHHW.:K=LRK4'-%8
MYSG)_.3I?M"F-M"#65 >_9B<[G/#MK+(QYFKZ^1;([_E,,>J$5Y$#=CM7\D[
M&G&T<,%OY')*,0_O132_6PV% ]\]A--P$[0>CEN&'AI"$NY\M,:VVTH[/V0G
M<[]'?!IVTK(N51J#,7[]=_63+'J R2!TXUW<<:1&YB)-7SFO2=M"PO<P(IM2
MBS635@8EN;8%#+E:C&#.79*=$,/26GNDZ(QRLL;KW?WD)R-:F#\FJ$0"APR2
MA^VD!M^^[NLXH\*>/0XPWLE0AY> EVB5HK5&%FVXC?N<_UR77%.98VD#B18^
M?F_#>1+V%[0X?QV5XW%U>'R,R5:!_/00Q67G)0YRXU$5'E;@ B>RE0Y+,M-F
MX1-N91H"<7U=H@[.-'1#IB'\4RK#-1J;P>$#GAE%H'VAZM!G+UC.N.]8UX;9
M3-890%O9(>NV6=*'Q2YB ]L"<&%4V=;';3=D+\6+/+7'Z%U7*C1Z2<P.M$S5
MGI1<ZQY[G_+M* H@Z56_=.2YYY"J6G*)""UH("W.\:!E7-1WHHUJ/>PGGM<[
M8&U@0@[C8&V,7>X;5]]9T;N/9SOO;5EW.P60&^\1WT/I8(\VU,@;#8+FUU%W
M$SN496[B@>PE(3M03P>TW%F,9E(R2#EHAZ-K23N5]6ZOC8H5#JM*8S^F*'@^
MM4E/8QN6!Y-6+ K^'R<^GG?(2G+)ES[<F;2;7>QP4I^? R9YAX$'L-B::J[/
M##,#BZ*(KT8\0T66GW8<G M)T;ACW/LMU[LL.BO>3(YT,<C" V]'*GF^KK+C
M#>2:9->"R7.*P[);M;PC9I]S>4['@:6P*%Q/GNX &R^7@\LA_&Z3/]E]AH]=
M0/%R$8C/75L2("BKEW$4N)>6=Z</K,@UN"<\0O1W:2D2M@WW]?_ZD8C/BB]V
M2MM-PC>N5002*FV1FY;UU56%"SOQ#=K"5#%=-+P/)PJ?CZ<1MVY9](X]E2+X
MTWG;Z+IRC^FP74<#+2.0((/$&BJ#178+1%6$*1B:([?U,]DXVH?!X],&O[@J
MDG-\W1E)E&C6F*O6I[=%P9'OQ/:^4+R9&&(O8KS96WL?+_@^;B1C^\.8XS^'
MP@I]=Q@VR F2443G$W"$5HOY_]E[]^>TL2QQ_%]1,;/[3:ID@L3;F765XSC=
MGDG'V=@]_=F?MH1T,=H(B99$'/=?_SWGW*L'2!@)! BX4S5I#'K<>^YY/Q>4
M;_&J5(KI:*6BOB1#"U:E$65EU@+::I+:[;E1P>YB1_RHCG75+O/TXX65TH88
M&D("2\:1;C9BX3-CJX7=<F9H-GQ&RV 65R3%9 B^DOC8(F4I67&V0G6QGTU:
M^6@JGU<83$D^*2'&2ENQ6./FQ&IS:#0-'4DD>Y<G0N=E85%Y2':=O-.(PU;^
MOMR"Y)7U%5R.2"/-XL"" P7?$]E("Y>.>3;&<JO?I%45HENFZ6RT)WP$GX28
MVE.4CY 2:S(6U&G+6)",!=4]%K15>@BEM(K^[A\,\_M\IOR!)A&7C[54/;YR
M-T+ "\'3_G@4P$'2[B#N/$Z)0&CI"1F9&8HE&F_&7DWBO#PCTUH8Q8W"@46M
M.5)VP:* 2.=Q^!&(N>HB3,'4Q2,.]><$ZG$Z 7:B6$Y#L)>&6J2F7_ !EB!U
M[9DMO.C4F$+LFK?9&^>^</DM<7HVO8OR9D#0S(P77 &.I+#'4?*8.Z?&]]3O
M"\"'GEP!>CMN'?CJ=NNIX&9=<-F5<Z>!$3NV,IV0TAT3GJ-*$R&MMW8!Q/A$
M?5O0=!4K  XZQZ24V!T1=P"*/5QI#(4SBG*:Y[YK!Y.D[P)F91^)Z9AF:Y03
M]"W)"8I:#R>1O6MJL%9+Q+M)\:"%=$9D,NDV$6]$YI&@5Z[E+PSSBMA9-&8V
M]D0M>CHIC6F19^$C> .==)\).S=,N> KB5_YTV0S[AUYD_;&)#_P5,PE:X5<
M<>A=YQ-U@S@RQVV(-']>X,L!;)"'U-XVE8>EJ P''Z9E17WT$EQ?31993HUS
M$EW#0>?;4KNMY41&RQ.QI3A++N\5KZ9[9?+:XCRN(">DL%A4D#E+D7-+$6D'
M,XM7);UETA"!.5"EPY9U"3R4D,RZH!W LQWV9 >.$&1Q:>-S-&PQ-74FG:B\
MO@;-MOZKL5Z%U/1.8PWUZSNC_GPV]FM3^>B9<Z'@N.0#<XR70Z7%:SJLZ0^V
MK. L(1DE0RZ6?> 5MU% Z1J'^2WDKC\S3AI1[0(>--=B[&4^CD]ZN+U9=.HN
M%#[ E91RJ[<N/HDNW8L_]"[^Q6UB>$[,4:B@E$],82&.5,&P\'_^3>NU=C/U
M:J4\RP?Z\_-S,V!F\\G[L5>+AE[.P<#[HGH"6@*HI%;\Y,I'^JR"Q52:G,,4
MK6EYX13YQWW/!2UR(8,93H@J")*0P,RW?U! $N>;\ Z5E+K M=TD:)O&-E+,
M5-3?L-.D"$!B#@=GN=S/.O.YHS7B44(B1-:0R6U*1&:^XV2'7)6GW)"?S)Q3
M_-,;@T9,Q8H\S]SSHX012@7!J3U)P5R0W@(ID=SW%)#;F.>8D/OL!P,NEQJ#
M(TZ#.^$>1(A!Z^537#P;R!A1J1U)7WRE'8V.BFD+5\IY-.[E-\,',:#Q458]
MWF<VVI_@R=$6\[JJ$'/ *8A^8OTHWLC!=HZI>$FR_#?&V[P=+-?N+?"8* 4=
M"3Q0VJK".SYW572#!7/#C=?RJU#6DP$4M+: .!((0G(B(-* <#=%MDP\STL
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MU6QSV01O=Z(.NG\?M)KZTM=$(;$FW-:X)AP-5NFHD7M*-!I,QG6@.NK;(ND
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M"]$SF '/XMGR8^Q5$-!^32 !V"Y#EN8BN:(US F+.'ANK@6]/Z(LT/9X]$/
MXUG4E]%C4TP+, Y5GY #)Q^D3:Q]5+#<>X%I&2/TF:32%D"- W$48&H0B]JX
M4>U*NZG\"R@TE5 K6JQ^;"J(4\HG@[1^\>TWVN@W3*[G[!SEQ(?H%)#T[EQK
M#J?Q(FY83.)",% V$54.FR\*)JJ;$_2;<?8Q=Y-J?DJ_F:*NB7T$*(.2X/C&
M0GRU1Z@<OH5S<O%(12J> AKJ=\K*I.N5-Y@- 4@!!.E-T:FGDBP3B:@?O8=W
M'^&?MYB+XU@"=RB#+TX<@I_(S1>]   +[!V^<"@5<JR0))YC85VJ>9MCQ[EZ
MZFKGW]E4+FBR<D%6+FQ6N5 3L3PQ_&GD&!GY//T6'9HF2BMFO4,VA+9JP"+;
M5!1K??SX&Y:5AI22SW5RSCRCW._%).J ^EU8<U,(C2C%N!EUUZ1<,3O2Q(1B
MAOKA)WR!WKKX)!L+=_5*&@L/V[*QL.126S86SLZ0V&OGC*_7WQZ5N[N[S6NK
M>_5L!M('U3=6Z!]"8*E3CA/ULNET/F1^4>G6!D([SMM!Q.DW/[%A/4]L<$0G
MA@&4Q%X,XL4N=H6(*JJS31]4901FM4O^;^QDAB&H3Q?:QCUYP-S..U38GGD!
M_ 6K#R^#^11 ]O+^D">M\*,>-N..&?4]7NKOC0=D>>;\E=-=.-@%3:MPAVS8
M'(WJ2%0JF@L"FW2,6< NHP_OL1N+8[Q<VBXMFFZ*#E3H8:A.+(T%(1'#?TXT
MC6:+:QMB_)=XL_BY"3^]RWX_;+:Z6NXOK6;9[SNM7JD[5JVI7<=%]9HMO6YK
MTO1F:R 75711W5<?M69R7C2^IX7#>U:/(-OC9;J6N:[P%#/..JKAP(-"XY3N
MW*B+)+HK1R_ 7<6P@X412P5/H<8;%6)0^>(U%W96"2+4>-\?66#Z]FPALW_K
M?5<XN&__$$&MH0 HUN_QI(&$[2^*T<IY ZH<7SEO6 %2H9K_$8RX/.FRY!UM
M<W5]-W"L#-SR/4?RGLU5F+Q)R_#&?5*.UM3VHK6LWFI5OO*U^RWL*E_PN3#.
MAM\?9E7"?2X6H6F&9P1/\"+O!S4.UUO-20B<]CK57_]:]+ @W_D1[XGTRN/>
M A['4D='Y>$Z'=00$8;**.\,+RLOX^NQ;GG9*<E17<K1XY&CNF8ES@MOC+EK
MG&&G?!K$N^.^V9)G2YXM+SLQGMUI:G^33+OV3'L2AK/@\MV[Y^?G)BRN^>3]
M>'?MFQ.LK7G'K"?#?X<9Q^]@<=J@T^JW>O11&[8UO:O#._H]??C.TEI:O]>S
MV$_XP+G][4_3F5,OU,^VR=R *==//A,%RF/EJQ'RD#%V-14YY]&8YJQ6S_M9
M>M/?;Y4O5 EAO2B_NS:5=&([S+LO#[???L/Q%&XP!E2 6U2:"/TK<WU;^<#,
M/^?,9XYR R_U^?P._#EY!@U_\N;P]N@%U+B16<IO!H!#T8:JH@,(=BFK"OL
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M4M*941,4JDHUJQAQ>H0X_6P+C9*B5F)/?1C0NCRV7>!1OW'55WNZ])[M4-/
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M,2V=P1&%H7W6\2SZ(KR(,$0H]@]B.1UB.?V#*POG _IH!U>#FT/$GPIP8Z#
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M!-2#!&1IK61(=8G&W:S!M+&AU E:)[&A' MDHZO;H=X=957?QI)2$WB=M&Q
M-: :HZ=G-#RX<7!C3]D2]I6/E@_,7VAKK!F*T>4K[K$ H\!P_1^?+].\*A/+
MQ/5,[ET'[NJFW>H#WGS7MDP-]_!\N,:1HEP07I]M]\G_[+G+/P!F7YQ[ 3+7
M*<TG>NVKVVY?'XPKB&;9=]/.0 5_??C;7RBJ%G^=J]M>5Q\/*T@@KQ'^]AE*
M@\WJ34?58M/ $OQZ[Z J_"? YD4;FMPEIU)-Z%QL;$&[[H_!K/,:.,-.,Y%
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MM%/JX93&<&"-!D:K>_B.G'CXH&<-=&,TTML]H]7/<G;8D?5J%>Y(2_M3T%&
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M:<]00<!'&E,>*J%3=^Z(ZAT!+!*(:T(( C#X@60?N'(\5QR$>TA>1V>+W(D
MEMP7.]?2_EC!DQ0[BNPH[DJ400!A\I'[@>R9@]7L/&M*=6<"=_J= .KK\JG9
ML6,>/\B7P F!Y]%K9]P#7@LZ/%6S$$X\L84P"6YA%(OE2X^0J)A!CT,VR*/-
M%S)KC;5N$"N$I2IMHBXWY!Q,HLVN>E3N7_&RO5T,C$^<&(ZFO)VHEX0-['7M
M+@*R*+UQ#R#RM >IM=1A:W<&90&/VT0V2"S-E#0A'N[.3-C1(RKUX,V.R8 ?
M;A*T"[?#\WVR?:EFI+JD99!%F.>A! .W^Q:L!_.$&=37YOB],(;%R4TC51(5
M?:QC:J$U^VG!:9^DW(>F,5D;QW8=X-?,M^@V[&[O.@X7YQCQ<Y=N]/D4M$I\
M&%Y&\P56M(;5<B>@KLER.,DS@QZ(JQLK"U(4NB)UTFD1 6KLD<'44?S'[9E%
MB&1I1,H!!UC<:FY-HTTAQN53Q:M9Z3-[M,^9'2.C0YT872PV/-*-X5#OYMA3
MTPZ+:ET519,MY13HM8M=%<7#VN:KJ&98G2)?!?E\1)4HY@FR*HN2HHBC8Z&D
M![JET='[1:ZN-$KRI=W>7F+5N-4_WR/LTW)ENQO.M0>2+*U5?@G!^AY7%!^<
MJ_9R.34L:S87S8N "RYIAT.6G!-_+(1O8M D%(KS)L9"A;@FC[@)$Z700G.C
M#;.KB)NK&8CS2FW.R_+K+PY]\Q-.^X%MT"QPYY'2@Q]+TVF7Z+0[ZNI&;WB6
MW+Q73V[>KS$WKQA# Y((V@/@]T9.)/2S>7U-U*]MS/WNVZ_:@W!PU&'X^3S[
MBZ/=K>=KT.ZS*0-A&514]S6'/X&&?PT77,,!^YT'8<U7F&A8Z]7%FJ%43E[,
M/&',%!9*$<I(5@+T<=._J9/#Y[:=P<:"/8HH9#@RYG"J@*@<?YTLSUHJXF"0
ML.]=YU0N(1O6_>P3'2LAP <1P(=7MWT@YH*VA[!/-MD^/DM7&7;EPRY]L*0Y
M!U!)8N_L0^MBZ(=8Y'J8!&" 7)^7RY Y!=#^[*,IF;R#+IZ<<\_U?43$E'/3
M+[U+G5V;]""?_!F A5,$0'R5"Y;=,-116D5-3N5^A48^RU= ;NWC>MRW</AH
M5^%PX\2%PXU]"X?'DN-BA455[XJH=05UKHB7$__T Z4OLB.$>]'/J2'>SZDA
M'K;&2+>KL/CSJH?W<ZN']X7;JT1M51BF9Y$(>C]+SQTH_B<T4=S/'CP.QSD-
M(%M=M5^#ZJKYF/A)&%AF0 'A^%_*E%VH<1791$$ZMR+[/M5B<9@4ZZ,F +_S
ME>L1G+[*HLOUC%KZME^"9=*2!><EUR:<.W(#A8T[[?KX\OGWK_&6,^%"R'P)
M6#BX/9#&,FF+DVDT=.^7U"7P^J45!* 9*?E 7/8AE!'8"C9G2IH4" "B[KM%
MA=#5;@CV6S@TX=':O2!4X7RS<YZ9:270DGN/4$W#"=Y]_4G-+N><B'.GRIE+
MU-XBG[T8+\A>2E)MR'"F\3G5DB#O(@,QM0^ ]U*8YT8CJ[L0=)/$Z&O2XIZN
MLTY?QA_QM ":M8(P@'A%.2<8/4IV$#)_H-3R*&S;U/( +I4&=DQG@'\>&<P2
M20PH<^VAV2->Y9M<9B*F/$E&))K#.TV2KATY$^4KL/RX:RWJL"*SZ;!I -_R
MO&#!@O!94_1DY+0AJ\/VQJ+1$E@4,JSO"[ZH.E;$G)R^KDV8C=Q5%NQ?.QZ7
M%?CGS'*H_5;\>F#0P1/RZ(@-XM9PS&=Q< E;VA_1(T#>\N45( R[L<O@138.
M#(U@G**.'RV32W\_MHF#IUN>ZAT6NF;E1C)X;$!A[U3A@2QT#HIVH3W+F6XB
M5WF.&)8Z?/1MUR7ZB$2GE/ AF0A_>'%1P'-&W&MB &\_7X^;&, F!K#2&$!2
MAO)4I.Z^*E),5=PARL#_8)C.AS4P(V TWY SV<5:8_=\1!HY,VTJIR:XKEU?
MP>8+R,[)H)@]B[O,1/99000623;J<%M2] Z>67YXRJKUD?>O/&N)HA5*$UB$
M!Q[P:'FN0P>8Y<0$+"5V43LQ[$LE9?+9VIE*"5X]/!31\:"S'%AQR\1H #4X
M/7DRPVMFR>U3$U";R%4U@-A]).FTM%]=!S0BC-?TPX9*H)%.+-$\:<^'!]H2
M=FR!!D.-II>0'</5C12G]#IF(N%V;J0E9$XL"ZN9V,;$"Y?TCZ\?HR6\RY\7
MR!RN$DGVG2/EON$\KW&>_LH-PH@2,6O1^VO)HW$JT2+O<2!0>$S=2L!4#POS
M%8 V7&S'PWT\K&5DK,I.\%//6X#\XWI8NBHUK'K*KO=.4F;5BR (*Z.V)VK&
M)[$4DK[E4><H6\O24\YF@ECL:@"3EO91-@^;TD66'Y8P$,EN,3:(XX#W.W@%
MT(P:;>[H,"MN+J*"2!@UM[TE]0[\"I\/F[ZV@RAYA2SR!6]+!45BSBV]'(5U
MCX.:YJ-;68)3&"WR.+W&S+_6?B#Z+FL_"SW 4]*\&% X]%GND:&8DF@J%W%G
MG)%X?SW1&%=U?8X=Q63<>9S!H 4F\!4]2D>ZFC[N4SS!*-.6,)^-.:"T,+.(
M#^:<#D)E^?ID^=@?#YX(JAR?LEB.YMQV0;D#Z29 S4@.98*'&&@J.OW%?V#8
MM9@!:;O4H9NB]H06Y"DX>OR1@V ER!)O<WSRH=LVO#;-1H&D]+ G(T4Q",N9
M$,XH3V!*>BFMJ@I8$&ZZ-)LZGD7J#Q\]97X 1W>0UT@,\[;/17#[0VP[5[-Y
M)G$5EA<]/M7%K/9)FUHQR>!%Z+ A(]1VHZF'IR4%\T1YS#%U/UPWD+4"8:L(
M[UB"0"^B"<C.H&)*_UJ;<R7>H85XD\H?C,+LLU:%?+'(!S9*K=#AH>& B(S4
MN[*2;FK5]A-^Q3%AJ_:ADK35R2$.84F4\APA [,=]?(TX1;;7='\,=8>V(G)
MX5UHE.8.? K"HUO8V<C;>BT"G/ T O9Q4++!"P%5.A'CFH:'N2NN*'KD<WGL
M/:FR+BC$B=;T4OB@G'Q@KU(ED"C3&(AM<Q 0..9'X4ZJ+=<3L !A8[U<J=/>
M,=]A9%>(W5,QSI]=^.N#"V*,YY 1/(=W]G.4\7[655I?CDJ3Q#G@+$7T]O;U
MK8D$4V@@P=7?TS.7XXJC</9YWIJD#9K:FZ\ 8>QIKAE#ZA3:Z;Q7'4,_A&>]
M8JH%CJCJT/JO4!_Z )SJ ^8!. 7.I\'YP#.:E4AVFH;SJJU<_7S<+5*3%;D4
MH-WR54 "-^ Q8'@0YZJ.*M=41,=ZGB44Y1FS9.CGR3AGZJO<_K68NEC/"(N[
MO'"6FH)MN24&!_1;=Q4<*$3%'$'*YX2I?!0L@"8:Z> B!?P)!4:ZUSP9U!X\
M]]'"?"?_SC$_$(.>"RM(#N1&.:?UZ)#3^GCR64D^&2V#R"V++\1YR9ZQF9 ]
M!S&5LH^M'<4( W2TSM%J(^HS"8UCE5R,^-TITQ'Y]-,! 4R9/#2;SS$MC;+4
M?, &I6['TM0TNEI8BB@DBP'71C4C(,.#)N(4)R*F1MH=W'4PL]TGF4SKKKUI
MS, @Y621A\>#P!:B=/1&86\@\5J4(P-Y63N]RXJ&BNMJ;X1@GC>$%P*0<,_'
M"0+]UFX0WW=*_%L+@Y$P+ **A.$O<VOH%Y$V<06.,)LB*>21CCOA?J3<*F9+
MYB33HK<6;+1Z=AQB@72HA%:SR*\@+.9Z+,J (@JF@4B8]\,C 3.JE^JL$$2B
M?B:C.=H*<BJA):=J2=*X#M@/<1=AVN,S-"#ZTF072 ,7"2F^GXB!HZCR:-U<
MAV]"/ .A?_<UK(^ 6J *8@G5:UDN(4RU54>:W"K-% 8W^A+>C)X&?"F^T/(3
M*?0R3(1V2!CXFEB&/6(9.NTFF*$)9J@ZF*&;&\S0VZ+?H[Q6?RDFE$2#C/@!
M).];M%>Q='<A'9"P0^ZFF"1!'/)IX?IX@HB@+QX*#&@:Q@ RU"#A+):ALNY4
MND^H4@#PLNOX-S,-$_6QA(#K\9@P)0]$^58\,44H8LS*IZ($D_Z;,[-N?J-S
MY3O(+PO7I5,UN3JK EDZN96AX5R:V94ELZ7]5V@R]Q,V]M0!:\U2XF 851')
MA3$!4L<="[$S60>T0^K7EO:G"#$,DO>PF($Z<0X*07*&-?VX%[/R^P6B@(VF
M\"@.1*Y0ZK5%H]/W?)$UDX=^N#DTYJ4;<#V*+YFB ."X),&(5!=)6#@JDYOO
M\Y\C1$!\%O[H[#'GG)W?J+?FJKA)*:'J<"REGHL8C]P8K'$..QU?A((;98=(
MX]?4A@_D,#C &OA"'(A*+B7\4+/T],B()Z<H[(-4#4O%XB^ 99#;)>\^I;'<
M4-S-$I6%O\DAY5/IE\@@&!:7.2Q6X07Y>!(%%#"261'T7<(R8Z6Q:,F!U%$;
M\]7*IFZ+AV:%]6F \2PTXM;3!<,O8=R@XTW]4(E)^SI5& (<M287Y2-(6Y1.
MU&5+^Q19=\/@*5$(*[(:F"XQ+QP*67\3OK*P?@V92^!DIRK5\2J\8O)PD$M<
MH!J7FBXM$D;?1-!8V6N*\!*<4)98S]Z( TL8F5.82D3O"2=J2_FN#Y]IKH(>
M?R$E()\AKLL *8-XRX_<U)NP8%.(7FENDF8K$C=A0JC#2[=7%O" !$S^#FL!
MI]Y(L@GHM(N6EN'35)K2BJ4PR'<5O"BSHTG^5?0"?/D^#W>$[<=G-L^\*0?#
MQ7%E[]!:=&; >I E1BG,#9? SV68TJHC//9AA5-1/1%_#YLBD75EYH$<DRA*
M )CS^'RM8OR\F--.\1-A(@(!!B3N-^)B3WMB%%5G<O]MVDXKF33]2J&\P)E:
MO*6GDICB;&]*"8\4D1669<5I8PT#LI]2<DWM,F?+&BDRY%!,.^<%ULS$,N=8
MSA2S-2=SHMKY;":*L$:&0+)FJH#J3U]^#Y-BE\ [07U OB$?_1>R%\SF"U.W
M5.PH^1JB5+!DA*J,1@T=#N+T)$X=5\J O9/ 1QQ5O *MV7E'0IZ@DUH-&48E
M."#-(7OPUH^''8TV:.F,]^&*GY_B<)>1O]ZXGBYS\Z($;ET4? KR13:T(X0_
MXB16E/XG"T*F8?56&!0P\0-FD8"K]D8P8=2J'^-II5OS&V0FI@9G!0_>$D7<
M[+L+JIWU-?:NOAD:JJ&U!9ON!#?7W<&)??#$* ;O3VUG3:Y#UVA1.3WA1E'I
MQK*<;ES\"3=( (%\^_S'BFQ3KO>^V86J=B'N3HYG]*) 4F:'@%3)(XWQD'C>
M.7'/($HV;"-=@K)T<NQ19-$%80?%-:S"'8:*@$B'MV$5^ZBVZT8F2C 1RC9X
MCUZT:RD'AR6WHY)C[T6$O(4"<@.<HP,'99H *PF3 ,2D#"M\IJ( ^!,%@$L#
M+:%';VCZ6%OC". GML@!8L5Z*Z1W/V>_R&R>WOB4Q^4@K>6%A)8_\X)LRG-%
MYB29(CG!578;T^+\*LZH*!"'HUI/>0;63(;08-T[%LA&;KHJ[!%N8.%VN4\.
M]_R%M;J$77@&CE40R@[6@T_9A6,]I; +QX4"@1 R\XMBI-KP1?EG^ 0*>'$>
M7?N1"_7LB\SZ0BMF\IW2/2??Y4N,48L(;J:#3^*C:")&]H@8Z301(TW$2-41
M([W<B)'^EHB1\5E$C$@_C(KNS.%"28,U90P(?V R#"^F!5(![G242?H,4+S^
MS,ZS#[G,7DZ1?9<YD)@W*0T=:T8]+KBH!99_K%A^QILD6LO+8\N%A:6NXYA?
M0:F045?@2(Y3F[AD/U*=@Y,-;W)LUFOT923#0S%JOX8A-L>VTD7VU=I-??NY
MYWJ1O94^X%Z"_"FBPI.>6>RLY(L>1ZX77&/P"65(@JQE6W";&?I<5)B-D-H0
MP99#04O".&VZ7$2XB%1W,E#C[]H4KL T51';?'Y+F>\4C]8P+KS1+%%(=9_(
MPBCR<('0;&O&R5FE0K+-Y+I$IO\/OT3U, -1.R<*MQ8U9$B0E@]2+@6X+S$J
MP8!(,TF0_ T\C9EH1XW:%H#H!^J)(]B&OU[AV^@'*RK3J[VAHL?2GN]C%U:L
MCD,B(]T'7]CJ;Q@F>YM 6FB(311-P>AQBGF37E$4XZ]MU_TN>&KT\G10=K05
M4>1#7DF@O8HSUQF 889GQTAG>.:$,$CDR.0"$>\67T8V03/<CMSYF=";S,0J
M/R=I]!F!9;]$X8UYT658EOV,XLB>?P[%PSS/.<PL?T:IR++UBMSRV0 I%G<Q
MQA^P(V9">CJ1=V>C-[8[,I.EN(3O,CP 0 HBMBCJF4X"[8VX!*EFXGJ>^P2?
MI!>6<D1B3WL;SXTM=A_K\N$>T!VR4K_HMDL)H?LB'>#7$\Z\]$)232/E<T\V
MH8S-GS*/1 E</-:"P+,F:W& 4;27/-;R7/)9AW7DI/_TY7?I?'^6>ST-^(3;
M$LM28!@(2W;7PU?*\23*RI[9GMZE8@"PT:H]78LZ*!.23<0!+^H3D6J",DN8
M$(;^88\O+=!<D W$^HV2H,!5XSX_"/,6N*BH%/"Y!V2LO,MR40759U8WWN4S
M)RE+A0I%Q>7@B?4,NCKN$71940N)=(0$58:T&W-Q1EU]D_<!5!<P4W);8PKL
M%&1H^BR\V;Z4TK%X-Z;,)*,D4QD1%(5&E,$<$>\7.F%]#&VS.0T"Y>"$,5Q5
MN0.1#M0V$0-)5@7\2]9W#M^>-.(D'Q3%_/AK/&N<J* A)>F847RS)=K[RA*7
M%/P6AT7&3)&L3B1E]_C5HH%0RM =U>]31!@UKDY;/BC:]/1&PR3W3_ )OX!1
MY!2R*>[W5%V!@@^TDUB=X#?^%%;JRA8G&.2T/AET\G,W7KB-QR+>L#M==.)%
MFVJ5XL2@W\7/E@]HJ_E,_L9K30E&VH?M\G]M.H9]"H,:_XN!?NUMM$3_Q,A<
M\FCYTN6:WCT*VV6>&5;_S>16A&?TBEEFU(F$(BC#YMV"' N6MA6M+#WCB0S0
M,76$>.]O/(B[?]>R$EF4JA_KLP!23,'E4;Y =+E>,.ICCD.8^9*7)[M-B%1Y
MZ76>%I*7BM'Y<O=5&^EY;6/P_OG:$M]$N\FT1]>&)R$LMCR^%OW\BG,BHOTI
M0B3N8EC-U%4)@3!]RG2=N@M.$?R)BJ94MF,C#HY8M<#<;)X=6B:6CK"HO=JN
MC=13 X=Q['JX:.$60RC6N Z!&,_4 )75YE%?-T)R]'2=BM.FJF-'FEJX%I0(
M"P*ZM4*)/JJ0FAT8RXPKEJD3CDMV!Q)K0EYI/[X(\JT*Q987=X'%:^VVGN-[
MWXKCU^>8-QK'?..8K]HQO\4%+^38'.G6.(H\NZNU*D;XB;3;E"<I8F)9"8$\
M:MF#7%>*V)+]!6I7L$F<2N'=XF01;:!"0P?S'.&?*O07RJ*RH6]0C$!6+(]+
M$!-N6_R1G-Z8SKX2H?:I\W+" WA*,E) ELVF]U#1 :E#^C( SW*BS#EYGOKB
M.$WXK60UJ(33JN;BA%JZ,.=?B%][24J@(IOD;J40>MG("<LNB7*A4V%'MO 4
M,&F?Z5R'TUHV+Q=RW%%(NJ0*A+)DMPL:SZ?X**E/Z^DY3OILKRMD9/7#G>(Z
M=E1PE>7$WD0]X?@4Z[NL2%J4;2]$=W$F\](BKV&L^DJ1NIK?%TS4+J&'2AM0
MJ"*H2EW)CAN":+4[/V' 3<Q!Y1BIXMFAKJ.ZA*'PY]HB:+>XM[+HZMOMZ.(#
M]A*_B;2G;6I6E9@TRIV"IX.:JG)&1LERG;-W-F5&V!!JL"OS']19_EZM\UVX
MS#D=F@<&=F@>;N_0K"=UX*TJ, ZTLFEBG0#XM-=\OZC!;)]O]^JVV^KMFB]2
M67+.J@P-SBK/!/%B\_ZL!K-]WKT]]KDEV,]S:%_U5>\V%%\)Q1O'HWB0Z'NM
M03F*CZ,_E^I//-4]B7V 4]W)W++$OLW6F"1T6:$3$'7@I(] \J!SMEN='21?
MNU()^=Z)W_@3^H*$FP6V#.0E4]B6L-3JMC;:M9M@62O'?E/7\^:N>FVC3K,!
MA(<U$FI9^1QT^#L0GFT\1WJZZ(?3&>FU4*@>XL9E7.F/89DZ9!21BS^4YBL]
MXO9;0)U,Y7+/*0YD@>:#E+X@-8#(<P['!BDFLE"B*AF@.C4*DX0"FHJ=DL6&
M1+$75#<[4EOVXS6&(V.\[#&9W]+'(8C*WH,R^"L3)0)G$+;F40%#,G@Z:N6<
M5VU;E3KV18U\M'X$?.YZLN2XC"^*=04C&2<46/3HL).5%?,.!%+ \$U3SYJ(
M[+K !6 )@8FBC=$=+U^]2:ZG&':\H&2L\O2U*O@4WZ*PWA?,;T*9_K;(ZA,,
M(&JQQ*)IX^JF*GYN[Q"0&B0VK A=D535S''6%%F8+%J--;*!?U!_05$EB(S,
M*>_E4)?6)5EKLU 9Q8 /]'I(5B#6BDJ)R<Z0L; '6'S*A*?H"K%$A!P,%Q=U
MVY=(*M*VDRA!%IEY)%[2H=)6NII<M%#DL$/-VII2N:-@$?8H#"]*&O6LL*:V
MK7R$]#Y)/61C8@$3,>5.-E+M@(#KEVG>(RS"WT0U$ZK:+BMP%7<\<^6/7SYD
MCK0P-BUSJ,EH&&I[CQDW<J?#"@ERFY4?;Q<)9!=ZGXW8[I/"%=GM+#!ZF-JV
M]6PV*MO;WE[=4[HMK72 >GA"WL]"U>0K%[W@<B/1<QIY#'(:><AG1,PGZRU,
M!?WDHK)DR>G3V2'#]LJR5J(SM^,-#7P^SS"5G*CK!/_R*42$/ZD*P=3:,G:F
MA*$*U/I"OE*^2)6?!L9HJ0*%,BN/LZ5FR_A3' R(&S/MTP\^71,]WL^ P?*H
MI_&'3_<J#R<_D44\( 0+6A=$'X!?V??X<^X__AIOCHRGD8L5K^G84V<-'#2#
M_->@,&=A 8Q09@#9 DL(D\P H\3'X.VT5A-.W)P>!"^N9^O7SS'3C%]@F^G3
M=(1P'87^V9NDPVS!3*R[L-CXE% D3D05,XC]_8A="PEJ'> ZJD3]!1Q8_X:E
M!W9+V/T* L??H,7 6V^TS]CE5>;I_P%'-HR/1&6IN/SDL;\MNR5TTT,XS<_<
MG7MLM<#!WZ&>GLMI<BHJ#W(J*M^AK,_LC2S/*Q)'HS 5+,&NC.ZJD[(HO( &
M@3@I8IN92-8%J4ZDIV++#7GC9",7E@2$F-'MC6A)JV&Y'T"(Z;^]>1Z_VR-A
M6@3XAR$06-L30XIMMO+YC?KPWK1\6-+-C>40#NFF]_)A,FX"8P8>.0I%S)8Q
M$:3ABI^C<()66X04!![\WU1OEC^WX*=WV>^'_59_,,C]J=WJE/R^UR[WI*)!
MC5OC0?XO+SLF8^N3WM&ZB[6'[444_7]7W:LH5H2*YMRTM0[ X]VS+AMG+C-6
M/_#"]YEXF31B!%A.U22.@'A'=)YQ:(4$%I@G6;3H,DF$1*,KT&-18M5P]N_/
M83GQT$FLW7,G>>FKU"N#L&R^QW3*00O:-EFL>W72J6;$%)IJ3"38!Q>[)AJ'
MQ:Y[]L-(6ZOOXOTCO60533D^52HQ4H.YEG*F=!/.E&Y60/S-=:2<)KILW*.4
M]@V$M-!N^R42T3Y*Z>P;^R&N?G#]@"]7MDO1K#^)%N'BISO'_)V*LL"446OZ
M \WV7S!J Z5=#/3#"?A7FM#%8$P_@AMGO;PV73+WXYA#UTTWE$^'[:O;WE@?
M#HM\5\=! OY4"A'%#+FAW(9R]Z#<WL51+NA8O9YNC(S:4VYI*4-FE=9?RA"V
MAF<)&*DYYLJ=1KDURF5,9TFM_8NC5@.D;[T_+(H'VYM8\TGC:(=I@](M*!U<
M'$J[B-+.J"XHO5SU-&&8KEI!W8LR<Y;J<BAS>'&4B5&U>O]PRLRGD)=0QAJ4
MCBX.I7U$Z;A=%/-[:I3N.#^4>PD&RHM!_?)77:[^))RQC?Y4-6<9UY^S9)G'
MX.JV6Q/!LP'AX2 <ML\1A,/Z@/ 2M)]\/^0W#%I^5E +13L61+:\D)]/!J)T
M5]A^>(UA+60T/2=?0OXN/=>7<-B"O"S;RU^),FSO\ER$HZO;?E<?=T<9OGC2
MQ).VZ.IU@&OC(&#6VV79,*&&"<45@(MC0N.KV]Y([P[[#1-ZCACYCF)GB_-)
MFHYC5-BL6US8K$Q232],JFG*H37ET+:50ZM)TE7OL*2KW_DC=]8<ZP:$'/Y/
M*UA\6/O  KB7FQHQ:F=3(T;M;&J$?/C.5(0J6YK\'J5[AK.+!IY3BVZ45VFY
M(#]"3#)GZD8].J)L+][L673,Q*M5J:Y((N?DK[4Y3Z2EURI]*2^5S6?8B2A>
M)%1;LHTJAH6<XY%YEKM.9K)E&N-197;XPA=E3(-XA7=KB>GM7X(H%5DM$R:"
MA27D1!'[Z+[X.Q*/C^>OPSUD-N&8AS?ELG7&<FF)0G^)?D+Q!U)Q>=HR53H?
MJ\M;/F]I'_F*.Z;,K19EXL4(PXPD2KTO6 U5*W[E6ICS[-#TM:A4&370$\G]
MP<+U>6::0*,SR[9QFE2/$'<#UFQMT],8U0,@FM0F7%2)#1M4,+QDRE=!6'!%
MMJ@55R;;D+B4*.92<?ZI9%R4YV]S,4\XO5>8'1WK^<=50T#;=>;<*UB$&M<N
M_.*D^T6IJ?LJI]G!CHZ4JFCY(OW?Y+:%2T"5&\D^YP):YZY+71-@)(\6+F4L
M99.:-,>AO7"?J%2$38EMLC$O&0+CE817P+^YRIPN IC$GQJW;*];\"S:K*D\
MB:)MMOQP*&'!9I.Z+4R#PA='_23"YX1-XD3585'(P,;5\;EM4\$"'$;4(^[K
MUX=D;FJ&M@1I3&&15:&&> V!D'%08>9HQ<4J3*@R*)90<E0M3HMZ+."637"C
MB#^(I8D:5<1&3<Q0KG!J@ZD.C"C:86_@4[ 694+5,=_2_N4^87-!7=;,*%X-
ME5<?C8DJ)^2R1W6^R(47+%FP0M%)HF"_B/R%]D2=F5> :'@]/DD<06+? ?*I
M>5++9Q]S<:>BI@/L&:XA#CAJO!>UQ/ M$VM4T NP"(<EB[<G\!^N\W7.@E!S
M3]#@B.[RP9=3W++6DL)=MKE#72>0SRBEW(?9_Z)8AQ_V+ GK\HKJ(F%G24E0
MEF>*2AU<G+X(+Y]Z,U+93RJ6*Y"&CT*>(L 2(R3Y<M6K"NL/8'DE47K=XY-0
MW%)MEV1Q&RZ)0_56%$VV@ B$JT3F^CNJIVRV]6].BUFLR4)M0<4H)SR:?S2[
MB'ID29=X06/1#,>FZ8I%I4(!ZBR^T=Y8;X55A421<!VT.7>H1(',CD;.I#CM
M"D:(#()*F,3[<'V]?_B7=:=]_/BK]@!" =*2#B](O@%FN5Y2<T2=M /@9Q]_
MNP,9"JAQ08SGNX4U5T3S+SK\4GN$ H3@U$+.41WJ55=@GUZ:>*M:(/5*\9//
M@^OU2GP&!C+WV%*^6'(""9DWUJ-\6"B-F&LO(9'Y[BQXPCN!WKA#U5Z8YV$%
MFT@4Q.ON;+9<!]'E+@J<6+VW?LVQ=A3+<LVUJF43DA1)RBYV0G:#1=1;+KEY
MQ+P%:/#8IZYS+FZ:@!PV5A*G/9M[G,>Z"\A> [)/4[!9H3H$5[NG-RG,MFOM
M_62GH9U:^H.8V3>86,(^"\.;W@#43!;3WD%9[;;32CFN\?8A&4<<4O?J=I =
M$ERBRO5I'O6:P#,];R]AF**>Q7H%$RE3(6*_R7R2SR\U*0S\'.7/JI6'N!>B
M1(VJ+L%D0(Z+] G3%46TI$:1+(85Z_(!*A>(1)F.OW5G/]1@&K31:,*$JHC+
MB!;R6%Z#ZND$?.6G&'M&1(R:O:NC,CQR0\U5J>P@,/N+J.=[[#CMR)."BL]8
MLTU29XGK?.^U-X:\.&&&D)$87*F!9O:<CT\E+:WF&2BDA2&F9T5%XI"JTGH=
M#*TKAR;KK FE,:WBI8OYX>$.%^&A#)>@[4;:1&*2#3R[)Y^=U$C+ZJ*A_A?U
M!D^J.N_%X=V7;PNW*=Q?VLHW""7_K2CB5Z#.6'YD #J7<JHYPMAYT7B>*)LS
MJ;A@2PV 50\PVM"US[?=BR5Y(I[A*JGW] )%4LZNT?&2%?E;VITJF)2K4U"!
ML>@*-!X*AK7$YNB1%J^*]"D#D31XYFQ3LKAB^"9JA.>MJ5^NY*_A@)RH_71<
M2Z2REIMHK:/C((D$5+ZHMB >HA/.J1"^:TV%]5+8'E193%-H2::TO-"/5(82
MQ=Z$3H?6"0>^$DULF(TKN8DW,8LZ\3'S415KS>ADPJHB9Z Z*GNR&V\8GI=9
M$S0)V.*DB]\<+L&9B0"A<$<T7D3@6"!63#":M;(E8J6SR.*_=$';]&\TT]MH
M %#$#_?A#)G Y38/_U0EF.>>.''0KTY&HO-:/12@U$Q#B42/84TM:B +P:<+
MG,7T>,E@@4U,%T@CH7TN;T/(,FAC?=Y@L11Z,<D)R%Q "IJ&YD,I0(5E8K\X
MLKM17*].U[7SP]M(-"@2'E2%8TNUXB4S0WC*I+A7FE.=X58K$">6+MKLU=J;
M+K [(,NQQ6AH-9T+ 9O.5+4\+2U+@SFW2U%3]F2G,L]B4Z34"+AQG]!$@VWF
M22N!2^A%/D.'4/PU 4ILNTJTYO0+?GT!-;WB@)HF-*8)C7E&I\!1;B_ D>@%
M6!QQ8>1&7'1K%7&1OSCKE>TR,]?H[1:>;T+$5 RR_*$5/+E%&N]-[F&58SR/
MX@"29?_CLE_HZ$@)[\I0G?=89< G:[LHUR^,P.1REM9W+_+JJ@,F=MQ&-EXI
M1XL(A5DX+=F64;A.17B$%4B?GV?YWU6/>"&>DV@>>W,T*S6/+4N0FCF@=H<@
MX&<D 7C=#&5):;.\HL@6X_UI];="PT ^K._B?@DZU9<P-VME%YI:I-<\&7U;
M P*=<.SD@SN-(0XQ932*+YCPX(ES9YLAJ9[5GC\6ZG$39N,49--K$J+<"-.H
ML(8J78WV2K6FZ!B@:3G!PH]B($B!EA074J#0JCV>,BS(14"+ .RS[-8H P1"
M@Z!:,@P-"-5M'X3@0!D9TH%HZ&7U+)[2N $]P&4LXNC4/L22BKQ)3F Y9,%Q
MHY[78;/&D-6>G[X0TW"+= ;BOS+TAN1T7XGXH:.=!'H>N?M\U>(][^!$M[V#
M#X[W,('14<RC V3L>M^%]DB:N'SU/C[HI/GH.4IBV7-AYXC."Q'QY:,V-FAG
M]\.-<*DT?-JS'>OQ$D9@B6M4$-;N??M*K7LRYU7,F8P>GJ0)%S51.1;J=+#
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M7@"W2*V9I"<RQ,NB$,J?E7G!VGFR'%,Z_3R^E.=].,%PRN$ *)BBT(#2WV)
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M4,)IV'1M$-6>!3[4;PTS'=>T)<K<4OXN-9?>R\UE<'4[;F6[QZFY4 (*:NF
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MNQDANQD/LCGP#;NI"VPJ1LV![&;<L)LSP4U)=K.SPV(%[&;01J6A-S[$EM7
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M;5<0 M/09T.?#7U6?7ZB1UP?&>=+GV2L?D>M7Y[=__WXC80^R>Z5/W&'SZQ
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MC[GO0+CA0>MZD@M)%OG(['5X#.L K!5W","N8B1+#NMMBKN  <.+Q,V^V.@
MD(A!M7@"JL/*M==Q6HH-\LPVXV/RB,*3+2&I +L&OL&\Y(E+F(6S!1@PB -.
M+MU'3)DH;LD9ZB!%HAE1GN E]'#Q-G&6X3A85L95B[]5ADON1E95W!*\+]>I
MAZ')*]>W\(8;<6P^\B@B^3^3&H+4D-O1+6Q"<"F^)1, =BI7KD@'N#;:J56*
M_7?A15&O<WX] 9[S_9K-8) WS'YB&Q^5]#C( >'QA4O/N7!FLUG%,Q-&!A-
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MM1TLL$,+X0"GF+2LW#..#-@!&12YSLCO4P/A+ATO\,T"-RT<-Z"*A/:"E$W
MP (\+YX=[VVL,0T5&*]SV'7@2S[^VP>^1 ZTZ3>]9Q>H;;&9LLI!E+'7(P"3
MR:;;U_IN?#:=?V8R.#"0._ 8+ !9P#]8<_#U@->%@F91&/EQN::88JSLDD6E
M0S]>*@.XB?37;P#N\D'\6:G<C,LK(:7A@84'[S1HG^Z$.@M0QY[I]EQ0<BZK
M8C9;Q"2_PX"V^(D U=972@J9*'I5?;%5$G%G#1.F>V45_#/:NG2(_90#<&G1
MYDY8H=\B><9:QR-,,L1*@LF*69^7=^'E7;8&Q<N[U'(3WE%E-EMN]G+U7;I
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M>T%*=]D-*P='=VM%_BNH^@%QTVU7$GN3&3 ]:_&Q6Z7@\#D,/G\DN^;FEI*
M:#<B"JS<$R-"PE[/'!&G1,2'0L6I&B#4LP-";@(0[5#NOF?4'*;A>B[3=G$A
M4ET,#.((XR11Z?/)BTU>40=RP99RG-5 ^!:9<\&(?Q%"XP?H3+8+TAW6"MY
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MS<B\19%HR;Y5IB-G/* ;<0.>C>P49L)2Z ,LJM.P5HF"1H^/A4U'(#M$IBY
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MSF 7[KJ&<Q>>,]@1S?\TB1"[]?]Q<T5"VN-CXF#+J__G3" <J[V)K.:;/7-
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MR0QMN-2E& 6Q FO$NEN?RM&B;\R-6-]#:J!1:-FPTX:;KR'L+0/A7W-"=_.
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M75$ROGH.]6/@9%J)JT=7^,, $TA0*("D<@ EIRP[SVCED;P!$0J-)]@!\N@
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ME$HHTYQ3*P 5]^2KTB<9Z\RHZM2H ZY+Z%%3Y<MEBIH,5A,SY==6/#P0P%?
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MU7<2P[_DS?6X_CB8$UGR";P2?K(@8WR%]]J7REI[LK6'9.+&L/@@S.XC@(W
M#X+Y(B0SV"BNAGT%^_A;W-.$X5]Z9 3 VKB$L'4G6H9L<D=_!5B* =[O_#9=
M;BOA-OJ5$:(D$U"1)76@&C)%TK<7%]$#]_P9PV0S>L*1-',F242KC)O-Z=OR
MSK8-^^#NM\\; 3N@3/C0_?26(N=7^HIU%'>085 Z,"BEK!,@+K?RPO1F%F;T
M1E:>:R;KHI^6V JB')$4WH-^HGLPFMDN1M,'I?OUCUV=V<SJAH7>UP,NX\)X
M!B #U[_T*,-'O !/7;*S=GT\74P"QW]-8=L!;A<?^@#,U?%?D:UBQC$P__S0
MW/;9$941F5F]F?&\N+N_UDEA,MJ;"F5F<&CU1H-^&97 P7FXCZ*3/A.@0%VD
M 'D%A4$B_@2@T3X.<IR0HP/:8A!XL0@\UU]2]7N#920?U UX\R*(7'S@74@\
MJF"]?W$G\2S->\E\*M&7!^N/.(^@'2_C\H]D=.,Q0:VLK:0=>B2?;S S;^-4
M,G_.PG05"^>)W#R&Q/E^XTQAD>\<[\5YC5!ES_)98++9@]O><^G.IM.&=\9,
M#N A04CO]AU@C83X%*S$.?,*I%F(C.XOKJW;4XL8C]I4L?2).G4FP.GUH6/J
M9.",Q]:_010^H"V$+!1[:2#[^OM/SN@,_+T()5L$M&*=BHYF;_(K,KF-5S_6
M5WEBB3V73Y'.Z P?W6@,5@,8!??3CP3E"9G<^<PL1GOY,5C&OP;/E*W?^7F^
M3ON'1/0$'^ [?O:"\?<,@P<I0X#O+Y *PR7I\:\SH&TY#3PO>$$92\UD:<%\
M!A'E_?/D-%"!P'\7F5JK+ID./1YLX"']_NTC/!\L87&3Z.V["IH46\2*_U''
M !R"YRPB\B[]R_N)&\%7O[YS?;HI^J'WR<L2IHD,8\LO0$F(_7K-2_H#QD^2
M#+GDFY-?]^%7/^5_/E3ZFJH7_FK05RK^7!^8E3Y1MBA%[0^LJE_>RJ*TG:_:
MDY^X,^'UP,?LW&,%7E(F+CGP#J8Z#],,0?'9\+:U<%P9__:AGCDN#Q(]&(<D
MAN[=9-=/2:^"L M.&&;>E7\XH&"$K]*YDH:O,(1SB4&:6C&:4@?#9C,ZU$/K
M5QS8V*?:EC4S[PMM5;.GQW9<'X N!&X%77>.KM5<)E.[A*U0PK8+QF4+PNYN
MZX^[S6BJZ/31<+E@U7G4=_0:]O:5+:!?%=7K_.AA46EZJ="I.EGV>.A@]LVP
M]I@[44.ZY_*_DG@9^A)<.TT;83Y,62(_QEY_.ZU%=!X^-2,NU:[8-=W[:S?\
M,32E8PXJ+ZW+!(!.P(Z;!%!599VV)C'-VG7_HC7>OG%MF^F)20ZDZ(C7UAPC
M-O-PXQ(2=><HKFSV1J;H;=<-Q.SJQ-(<8H: & ZZV'57*_XT7WC!*TV]KCOY
M4J@O3<^)2R^G<06&];8W:W?&$@HR-P@[;J32R1#&AAG;M=T:0D4^C($3,;J8
M0P9^XHEEV$^Q9-"G<#Q?*M*XG(V'[<Y*9N,)/W6S6%D/R'-]Z4VPC-^F _*2
M^7C2FV0^7LX,$DK4*?T@;8S=P/9D)6.G*I=B"ZV< T"=>XX+EN"6S'%I'5#=
M5<+%"!?>U/&29M ?:!_HZ,[_'(3PW7[:&?JK$Q_@H*Q*>EBV+ENE!=-".^<#
M>/48>FD@D@L(TE"E;G$0=>F"QKZKV$#T*.<N:;E[_:1J]51M,Z,9FWJ,5%U6
MS8O/:!8=Z 3'N Z.<=;B)FTP[$IQ$X_=[PYJGI!I-;C102%WN9]^8!*M$P?A
M:^8"K>[U12AL.9?F#K_,W/$LZ5U$Z./K=UU'<P3=+O[5,7T(U,;Z$%1\54N+
MVMU&0C1'$,T13G.0HCG"U39'*/%6.]%,=$2H>FK=K)QN8*CGWGP%@-NM/\'_
M?/ISZ3Z#W@_:U>T<CBQ>Y3*0R4/PV7%#VL'Z?KHNWM@T(Z;N#S*Y^0\)@X(.
MH-K 1L7=4A7U?4-Y9UTP\@7-=8[F]G:*KTMS>>M<&?1&>D'U!F]TU=T@\YT/
MYKCCC\%"A>,:NR*LW+XL^Y\E[&/Z"AM?W<:7Y#*.$V@'^,44I=23?OEQY'J4
M>8D8V\N[SX(Q3#NS9*L@O[-S1E&Q_?<0Q(XGK**V BU\:V@G"+[F^L^OB/4V
M7M%P=;K5NA)E%2:6(&">"'BOF&Z(@/6N!#U/9\NE*TC7JK,0V7FTT&,_GSFE
M[;CP)2VM"PI@,?@SDY9$74W3=O5@V  [+7#^9CFIT;3SEP/]0R 'DTI.C1R3
M-^1TUXG))ML=S62%\W(7J=@MZ:S##CLDKQ8]RJ E]%BE%H\H)>^.3U.DEHO4
M\C/X0^VN^$-%U8E@#=?!&EKRM*J=F9W#8WD)[X4>7\( 'IK(=*CZ(B3/;K",
MO-?,M/5_NE.<D>UY;"RX]/._?I$^XSII-P<9&_"P>H_U1["OJ9LVE'<CR9E.
M7<]U8@+?,W=\YXE$DAM'TA3>$J63-=-6\[1HV/&\]4SR%S>>T5X_3HP#6_'-
M\*7XF47H!J$;NX1^R'/_7+H3-WZ5I8B,ER']&^XKI*VO^]+#>MIW,K)S:ZU)
M-0NL+ SF]!L(T&0P3[Z $@]](UPKCA*? BSH>N"7H1M]EYQGQ_5HC4K,JMKA
MOYD#@$<W5B'-G$CR ]C[%$@74Y@">&]R',]P&'3T*$UKVI[&WNS0UR_L%'#B
M=_05]OSD X;@J6\QW!HNXG[*!CG@,/"2^:^:JG2OSBF%!PZ!CP!(Z=$@:J/8
M:7]N,+L."G>XBFLHI^)RK.NPKUF\S;^U^T;%-YU^36;?UIHKA1-W)^Y.W-VA
M=V><N[#24+:+X!)Q<8%U<&<ONU2,[E04GK#NLDO'I(MC.N28-%$!?=S9?09S
MBTQ$#?2^<_K=GXJ3:C2R=A6'(<A+D)<@+T%>@KPNY*3RY-6%')B2A$,2/KMC
M0AW;HKROZNEULSJH@3;0.)JPO+-_ CH,,S71&5&E0R$LM8&A$%W('Q'TU$5Z
M*LGS/XB>"DA& Y)I8.:%H!=!+SS2RZY!14U+'YU*'[W.'%Y!33P@3%!3J?0I
M*9TY"3T9.!;&5.O,Y!#TQ /&!#V5EJ*5%!,=J\V9((+RTZH%O0AZZ02][)H2
MV+3T&5+IHPE?@J"FCE(3=DQLCYXL.NE>$=:1H*?.TI/:K#9G \GDJ[ $O0AZ
MZ02]&.U)'VU I8_*M?3I;C>;NZ26[_CH\K6U)&DFR)H=LLMNX-,/K& CK'CO
M0#FDT<;:YY^,*[!RR@!B0UA1 2L"*IV R@'#XVL !3LRFP(IG4!*:5RH(:SH
M@!5-8*436"F->32$%0,T?0&53D"EQ-W?$%!,H=5V!BFEKNR&L#+LC71%2*"N
M@*7$3]L06"PA@;H"E1(794- L9&K<"""NE#5LJ.")].F231Y;?9\12?'4SEL
MOP113.8++WC%_EX)*TFX3!,1$9U&1"RCN8B(Z,0JZ/=JZ'?_M(VJ]%M H@J0
M:!T7J:!/09]729][G0$GEZZL$K6@O;J@7D&]@GKK1I-.3K\:S?[6+4&_@GX%
M_38>X6M".\9RVSHN>4&?@CZODC[WAE5/+EU99:\I?$^">@7U-A_J/CG]8IFQ
M/*R5/2'H5]#OE=+OWNR#)K3C(9"HD*^"/@5]-IWR<7+I2BNEAUIS?6]X'(2'
M_\:#=_VEPX8+9B93);>GXQBI11"Y^,"[D'@.3IQ;3X_ZV^9$L62;@_5'G$?8
MU#(N_TBNZVQ;J4AT=M?G&VPOD5PI.Z7,G[,P7<7">2(WCR%QOM\X4UCD.\=[
M<5XC/.GL."_7O\D>W/:>2W<VG3:\,X84@'@0TKM]A_V&0WP*5N*<>072+$1"
M_XMKZ_;4(L:C-E4L?:).G<G4&>M#Q]3)P!F/K7^#"*6C[7"XV@?D$7X<_?TG
MI]TQF!0H4A%*M@@HY1^JHJ.%G_R*3&[CU8^-WHGF!'XE<^+@D\@1B^<%QC,2
MXI3#D,SP,\]D__Q W>[N_, P>V+Y.8+KJ7X!'AS<4^;DKF?2G]:W!V+BV/XU
M\3EQ3%-Y.R=Q=^+NKN'N+#'I3TSZX^\DQ:0_,>E/3/KCX>S$K"0Q*^D$E59B
M%)D@+T%>@KP$>7%Q3H*\CB>O+M1$%Q? ?Y@Y_A.)T-,\(?/@*706,W<L.5&T
MG"_0LQ^)^7]5S_2:>KPV7.A\.XZ7#J[J%\?U(XP'D0A6&<$9? Z#>8+6.__C
M&JNW:ZC^1N+[Z8/S8V_@?>K^().;_Y P*(JY&X/>Z+_^8JF*^CX7=6=^'W[:
MQ J"% 19@R#W5B[S09"*($A!D%= D'N3N?D@1U60HR#'*R#' VJ/^2!(31"D
M(,@K(,@#BHGY($A=$*0@R"L@R+W5PWR0HR'(49#C%9#C >7 )R3( L(S>Z/A
M(#^U3A"=(+H.$=W>&EX^I.!02$%!D%= D'N+=MN5@=9ER,#N#IS,Y#C C3G^
M&-Y8.\/AVB8EG"G0_SF]L!H$B),5-+LN 8I)'"?%5]V6VQ&L&_YV5J29@]ZH
M3J,& 3%N6%AC=G03L%*0@>7[:PD&QA.ZZG8U;I^!56Q%8](VYO:@3AMD@4%N
M.%R#L;1:R-OMM#";"VT+[/'#_W)Q(_ZYGRZX7Y<06! JX<*$,'HC>R F1G8%
M9+G0 !<@PVG' F*=@%C.V<T%P(;(Q3@8D=S=PCWL,1JZQ!\3R9G\L8SB.>M(
MV&RQWD'T57!FW:&O E_VL12VOK+;]8U5I2P+6+?10*]U#B*TG017N_57U2%5
MP?2VF\X7$)CC@*$U9O8TP<Z& \'.N(96N^4RC4!*Z8T,,S\I5["L2\55?4_U
M*<7DL/%J2(&Y\V.N;F%#(YQ,$YRL6ZBJGY_?"*[TWL@<Y!V  E>7BZNZ*>B-
MX,KHC6IGJ0A4<8.JNGG4C6#*1%[%BPSL0H[TCIYWDI->J/2$-RJ]\>B=YJSQ
M-L,V->HT>!DYUDCN-!W#4T1Q0%&'$A/. ;3R&:JMSC"B)W)<ZL[YZXT$ID^4
MK]T$NJU&LJ\%R/@!60,9VTT RT:VF:_@$FQ3(/K$;'-?EGAE=%?,>K0&F/6H
MZ0UD"PD4\H/"1KSOM;"WVZ=N[6CX*;BNP/M)N>Z^W/23\UQ5\-P.8K"1.$$#
MVJRE]49Z08:YX*L"TZ?%=$F,H@E,ZT4)[0+1 M&G1'1)?*0)/&,DK2!_7B"Z
MNPG]7TF\#'T),+< 6&!_&G+>?/Z+HN:3-*TIS8QE=W7O(P'?THO*T?8_7>?1
M]=SXE?Z^D,C-WLA0FPJ8GU^("-B=J ;@"+15<+5<5U= @<0&"@.:87^68'\"
M=%4:X=3D@X>XWC#2)YMFOLF#0.4UH?* BH.3"F7[NB80"B0VT"CG]-S15@1W
M["HFZ_;..8F*:*N]D=E$=:A &C](:[BNX;1R^+H&JUT9$NOUV3D-Q].YYWA=
MJ($HZ1._#$/BCU^E.(2W> [%Q,2=3@G^F(@^\:WUB:<AM#M_'!(G(A\)^^_#
M# [F:094]>G'F#:K^KB^FR_$C^#KOI(Y/+H,"=8:W4]KIJ'9S<T-:ZB?E4#=
M"3WNO*#.%*CK'NIV)71Q@+GFHD "<]Q@KK0A#R^HLP3JNH>Z N=Y40;UJ>!7
M #.,Z@B =09@!R7HMP8OV(^ 5Y?@M;\S?-L 4WHC;2@0UB&$[6L+WS;"U*+\
M>0&P2P78OJ;P;<-+ P;&RP#&+F20[^KA$Y)Q\.3#QR9-)X\?&'-@.W^GP=U,
M@N6C1UC<X9+F+1>?[['SENL=R*57R1PP#/8^GI'P0S!?A&2&?.:9 &\*YB3M
M%9:IH;G?9$'1X3Q(QS',>2;$?4E-@U@Z4UA9\ W!-TX\Y+<5#F+4ZR\E"%D0
M<E<(N=%1RJT0KXGB/Y]8(\2_X!J":W#(-0X8)M(*WQCV1IJ:[S\L^(;@&X)O
M<,@W#BC=:H5O6$5!0<$U!-<07(-#KK%WW$\K/,-&72,?Z!5<0W -P35X=%'N
M3Q5IEX,H.$Y3R5LKPDDI2/GZ2+GA2M-6"%@I&J$E% #!-037X%$!V)=HU3+W
MP#0^I4[?\#,3,LW-^BEVX*O@OQ/W>93NY;?E'*YS//H[_#!=_MP)GUR?K0/N
M=@LEI0ED)^.<*L+G(YD'3Z&SF+EC[.&YG"_P"B)IYDPD/Y#<^0(N!6MD)'6@
M&JUR=KH^6)0$4(Q(T>H0O>X4KL:/)98"&$G3,)CC6O6^M((1O1G>;^)A1J1%
M$+DQT%IZ[L%TM2_7!](MOBOX%6Q8DU[@K"9+>$OH^F-WX7C>JQ0'$NS,37(G
M\5$X38DMA$PD[ $0 +ZE:?M7"Q>5R.TR#N8OYX\DS 5H-U0??2-)- /GV]4)
MW4__-]GO0[+=KTY,UBSI1LWP)*TW4HQ^P?BDO\%9'K5>53OE>G58K]TW"M9[
M- &<&^<@/!P , YXS* <>1!B=PJ$"<BE78<9\HT5\HO1/G&C,9!S+(5PC(Q!
M5+U">\<=?DZ7F[W!C\EW[K@YHS<:].U\B@X"K>H"M8'2_ )-@%9?*4+6Y7%6
MGSPY!8AKG^OMQ#C#L[Z!9[S6IN%\ C3CK,Y"-G0$FLWFEV>5$=NQ6&X1LF0U
MF%ARUI.)]S)$4 -@"["B%92PR;\G@<9,QO3%D>,YX>N*7T;P3:!0HTI,7TR1
M"6^F.(,7OA /X2H]PAO)P@E!>2 W(?$<U"06SBM;5CQS8G@T))(7P'_PWS[=
MPA@>X_>T5R*IY+2W21-.[HDP!0O/"JR?A;>$LR'Q"R&,4-&Z0)#!F4^8102_
MIB:1%#R"*<$Z]CAQ'+J/2VI%X-M\\B+]$<#3803";)+>!$F/%OZ=M/R9DC"$
M=[I^L@9$P-D.F+[GG1N#C33>;;;2(_]_L(GU^.8L#P1TX4:X$S&E&RS"%#,B
M@8D%(;WE=TBC(3X%)E>6?W-)#W= L%$,W"-.64$Y?N6\3(JD903/(@^05USJ
MVXL;1?1FY>K*3;&\*ICL7E$JV&4:#E+>4<J^-C!.LU9U4*HNPEK7Y_P9"^!F
M[*"/W(%^HAV@L[@_*-G!D6LM5A7JKU7MC;2^4;36]*!?B0,<FE#9^Y&,":Y/
MTA29"6#DW"@O9"DDT8+)6^^5/^Y<E7E]2@0Y4PI B][2(;ACV[L%?_OZ_XRL
ME*'5&3J^CXK9UE%252/5P4#$/Q9STR,)YRB6FMX^)9S[Z3>ZX+0PMX22M-Y(
M+38,6N:QQRQ>W[7X\S/=8[9D(&<;-'L?1W'A8Q9OEB[^NMER4N_.C,!Y,'&G
M+NQ_LF1/7AA3SCJHG6<2.D\DOR?DFPDG;)^))[Q7<J-4ETT"/KDP?4%@/G7N
MWK*M?4PVM!TVNU^IV.H %-5LGS)8]O@=' 1B/4,<Z(+1^L/M&%2.KLO66D"X
M)UNK1==JYM;*R!?)-+G?#&O==]9&B^NW:9A .?JLS?;6J@WH6K62LVZ0<>(7
MX$9=4&=8)DB&UR0$I!M 8<S9 BR,>H_@5>]?W$D\2Q-A,I]*8KJ#]4><QRCP
MEG'Y1S+QVS&!4P];M9T_WVC6UJED_IR%Z2H6<,4WCR#KOM\X4UCD.\=[<5XC
M#"MG&31PY^S!;>^Y=&?3:<,[VR5]_NZ<>072+$3"^HMKZ_;4(L:C-E4L?:).
MG<G4&>M#Q]3)P!F/K7\#CWR@GC9@+Q^0)GV<6NFTF[/$(MM%*-DBH)2&547'
MW(WD5\ BXM6/S=Y%*BQW2)@D2AQ&7'K!/A=XKO#?;KIT5$(\4%% /0%LH4,A
MRF@$!VO/RHYHS#^_?$E/"M7D0J584]!(T?8IQ66LO2]]WO^4?M#.'T%QSUA%
ML/CTUS)^)/V9F[U[67J9N2#@P=@]SOA0BBVGPX]/+3V^#1L/OC)TI#G\S(D#
M,-,Q "+CKLF?2_<97NO':3!@PQMZT@U^PD7]FJ[I"RSITVHU#T'6SU6\=ZUL
M[_R%>!MD/5/O0LVBE><H\1BE#B0WW=*!/B.I?7%W%@?5ZJJ+T:^C2WU8Y.0M
M.I\SW3MJWA=P74VXY/9<EX'1FB+G#T>W5>@3O(3[:\+_N.?^3!0VA<X[CB[P
M0LBM"8_KGNL:EEU7D\>C5K.5. !(D;^D?< <[*'AZ>@2%:;]T]JC-.4UI)4U
MD]HM&P^3L1/%&0<T?.@W)\GT^=GQO_?I910)@L-?^VD9!@L"'_D JGR8OOCB
M Q6_!B&^)'Z5:,+3L9;_F0!\F\E3"LF3$])<N>D2,^&D^6IKV10R^$5$XO6M
M9Y*>)L_N&+/U@V=W0O.XJ+4<3AS\X(L; V:6CYX;S0B6P,!11K$[9L[Q[#?
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MX</M#-+R(HDGI.G\^'#SR8BER8>[TZ%.G_7D/ ;/12E.8!@[(4$.S@:).\F
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M-ZH=@)6DV^-V,5/V?JKN!;XS=*E:=#^]'=/T4I"27P)@A:^?@S"WOP?87L1
M5K(_NVA_=GY_934BR6$4G9'*5>E(,:(^A"ZU!,%*2$\3-L[T *:2_K&</,U)
MS@7&B=S.PN[#!NPX%'*?#V%L<L+5$OZF-5E!I1ZT3/D,15MQ1OX_ =&B0AWA
MW4I!:@5A51J8=H0)YQNF5=]_^6_W5OKETV^?'NX^?,,#4Z1/?R[1*+KST4L,
M4D%" 26]P>?_ZR^6J@[>ES]&'U#>2\E-;3Q_]R7Y[=N^]#M=#?4 X')DL+Q
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M7\P"[2&9.ZZ?F#XKSI-0/(.,!*8,,&\)_6Z@]V%J/RJ32?T$Y?T"0&?G!7D
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M'I%>W'BVY[K+<AB'Y;)GO?4D&:21[1<DB5@:2*F"0O351@/&&Z9N&,62X_O
M=L((&4URWYG9+!@ H&PJG>?([[G\SQ*8,PF]UQTGH_=&!;SA;UB ";+R%4_&
MD?Y,7R0]XINDX#GA#*M#:!_SVYL["/5&;Q3/L-"4QGJV<2]7#J@.+=Z9F=D;
M6:8N U>[SB![5>9L\<"<AP#3ET#:R9L7=$TIYX)7!<"8LJQK&@;SC8P:RL3D
MR@RL#/HV[] '(Q_^E&VUK*:N2)@#1N#!&_*#C)<8VP7U$C>Q4G\2Y9"F' [?
M1])CX(03_"4;@AO DSG(;5W9IBJ?G\6;4>X3*.L8X5T$D8L/O L)MAAX)NO
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M U,((WQ74J:_P?FI=C >@\Z*^@KH+1$H*+'T@%_SC8R7J,C<PPM\7)V4C V
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M[OA46D2A=67L10?Z($_Q&E2C@I*M_K";'8F:(6(0/I2.BE1YEGTZRW2?U?W
MK/0K7!J.4E#;Z991?UN':/-Y/.QMXIL1/RTB%BGY/93/W![!"[=8)+G^CP1-
MD.;NKFEMB;8#Z^LJJ;4-LK6B&/*1%OUG(+X-YMYX=_#.?^(K,W6DX=5(;N=-
M+HB2-];;:H1L=\=)?*SM)'(BZ(>=A(8GL2L?83-)[+!>-(_&LT6!,,O[8<66
MU3T9;C^ :=Y;T9J_Q$;;PRRQK<PN-IJ<X1C0Y'07F_]FJ]!.#$TG!(J>U#DS
MP$Q"-2(>LEAT-Q@/[G[8KR$.7U[6JG<VQ#GN/'%-:_>U?MEQXEVU+5<WVAHD
M5"6/ @Q6M8H>U6WW!R<?N)V^K,E#?;D2L\91"K1E/I^=):3&&YE=')9ID.9
MV28_'C_5-@RDP/TEIM"=&)'RABV659!WY6!MD[H)P9H5*-4Z5Z->.R-=X! (
MOSD(=>4:(:04@= EM/;/&9\XY]Z? YE/D=E@AYW7&:-OIT;T19]UNY,VR*J
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M//PZWER\GR(M/MI27=!6CP-MY;C0+K2K2J#=K1[::GW0[AT'VNIQH5UH5Y5
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M8Q1ND@SS%9\6+ J#C^X: I@1R+[I1$BE566M>S7J=%I:-Z\BX935Q *S3N@
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M$VT"/XVWX>D_X;"7I@Y'PPQ2L8WP-8:%RS;#C80>A>B1\5-LIQ7>!A*&(2R
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ME(T^ 7SXE"3PWO9SDS1K5'20"KTY'K_N<+6.C))0*0/UY\4@FD+U!VB&GUE
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MV=Z<.>'7!F_C8=F>M- ]ALOCA>-A'?K49OQKWV4 6\=XH884TLRP=+A=-R4
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M_C>"<A +H:@'L#(0BUI;ND?ZMBS&EQ^!?%UF;IC$^#$"S,( #JDI4[K@57<
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MJ^.3-T+>G6G(C+8=#0IN2QI*[;-*&29(^9EO2T9JP:W)2"!;D5$^[!KJ0@&
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M9*\.)L_E#MNZTDGAFCY*L9! C4HAO^39T[XFGD9]&.U#"T]7336J.U![.M6
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M2T63_HPFHD5?FTT<6=_)\B%[?UD]='6I.#4G07D57"%*S!Z[Y5_TTZ712+0
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M2"RIUR@0BH/)3TR$-S3 S]B-Q+X:GQ&&W9"RKF^-]=Z_T4*,SRYO%HK.;P[
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M&__V$+]Q]NG(E>7/6\E@2<6 $2M& RD4EK)1X,E;:?!0*W@PE;P;X:SE.'G
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M=.&NJ[KJEDG@3_X +"X"D#1^!P513#A$(,;E+-9QL$.H1+\=*N54749&7<8
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M_VM2!A7>!_E>+U*?@?=7WB]'[WL\?M@T^QQ' &?;U_BUJ>VJ3;'\153RLJ=
M'>V/@=@#9(-0BA.H*2VV!.RBR^+"WOAV^36Q=7E1NQ_^<U6M#^WV=O H <I1
M Y@P1+IT]AO!DA[M?ICS6L1&L6>O=YM!.7EKY&/T69F%W\BW7B[C"EW_V#3N
M<URE>PDP3H'Q!@*I* F*(6UEN3/53\*=E_N;F3UYE97S($Z:S2:L.K]?3D@0
M4$(PP*Q%@0OK*2Z7T]I%-Z\C.)DY,DH5&2D1_:OH/?DHF(M>UGXL%G.@6)!
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MU0&R3!+N ]>.#%I,#@PP+^]T,J(\6EARS'4>:_+(7_;=>YWD3-_=SL'ZAT,
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M,<HT'ABEH'&*PH#*=:W?"W$._N.D%.DOB.-5-74SQT%2&X^!1D$ 1*BGSH9
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MJCI=RP?ZE][^];KX^G,<Y^?*0M5?UJ;:$'9@](WUDLWJLS9SOSLCA B0B#/
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M$40:6%LU70_*\2">ZC&(MSSW0YBSQZ&.G\=8L:IA-=)+DCT(/E-Q<N6!]#(
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M"4[S.UPJ!:0G$D"+N7&.$2ZZG7YV''#48LL$-!4#VWB8=-GJ7'CKY'8/+FJ
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M/:NN"/^JYW?50[5SL]QFP^XL,#H(X)E@BE)+(,VW0>@YF>F),2.Y@YSV'IS
M!O ZYGUU5WZ9W]5 $\LKDR& $#$8,<8QRW?J<<($7IX*>Y(XT*'P48_.Q>IU
ML3SX )F@XG[*6\"$,X)+8Y',YRHFF=++4V=RHA.> J]M]-M=9<#+\%HO;W[Q
M"U_J*H7[]\A+;;<5*%!>"8"P%HHSSHS?";/L.<':/\9$!)'2DGNO],UPR+W[
M]6]^]>M]25G"H^X.HPQVX'WL# =I0]A9?*K:/#J/@'>".D:]]!G+#CI!3MMT
ML-.Y'C8.&(@@,)XR2*''U.9KS' 0[C@M!M-HJKVS8']VSNAX?OCN39N7.;5
M">M!P-8X#DVP)E\\9=H-!1/H<8P^@H=U,5ISMT94/_H(CJZ'D[J\=2)S-*E!
M88$A*@ =O\TH(4JP?!<^O*P^@D,IK)7#<?L(8A1GJR4&E.* F(Q;-R&RR>O9
M]1%L9_+T/H*M-)Q='T'D</05- .&!^&LP)7WD*\0;0)]!(_4T6!DC9;ZUK3R
M.A2W7,Q30+SWQK+ -,J8H'2F*;T9??HA>!NVB>#1&3>-6']D]B;+LFS70L(L
MRTY$GEEFK_;5"9OB@"I!;/P_"<]L@7N6F;W9--?*WS!^_#V>YE>[X%43&$2
M),%+$2AG--]1YU-LSROQLIW)NA]_.@W#9/!VRBR&6 %MB '(PF"M%YJY?%D9
M4TCX/E(F"6@9*,YT4MXP8Q!(C@Q@GD'+32#!9;R\;XH)W\<*:@#BAKG5?E\W
MJ8.9'_L:#7BF@>)4 *L,@TP+8T6^ Z'^\QF[I=Q0!YV9F1ZVHUR;H[D'K?)Q
M3^V0!Y)BZSD-WF5,_#X&^5EUE1M('?N[RZ6F-DMB^!;(VK&$5D!:I8%7$C).
MN+(HW]TM+4!'[5^3G.6#J8NG4C1,GSG[7W>SY:;G6$NKL2/FH D%LCK]@MA1
M#S&E-N2K+>@_GXFK,3/A ]4;'-$3ZHB95*GK$@4# H48QAV6,SI??6JJ64U<
MP*.0GZ5XH06<J]KM>8-!"(13Z0+R*-]YZ4&Q#9 QO;YM(WDSL Z?FBPC^M@9
MI&C\M;U_6X^_=],FH08R0 Z,@M4E=#1NVKJUR=H_1J_ZB-K'-AY(&L'C.F$Y
M@$A#&(S'@:/38.=KZI6(E2=%$ G,=48YP@_AL/OUI>&()E17IQ#M@8+,:6:%
MHV-<$O@=X"B-N5*POO\XZT3K#WM&N@'5' QMA#7>6?PVU-&/W4\E\Y \>C Q
MGE!X=<#K, 0NR*!"P(JQ$:[A&UX@W8_(\^JCE8"$NEBODI<AS*R_^J+MO@,T
M'8"A00.B+.*64*YM-R^B]M&CGAZ=;O$BF;D&B:__XHOK4D>_VNKY1;7-:[P(
M4G*@$57 :"8\]L(+FN]TL1'B=)R"_@P,$OJIP=IS46P3L.R.P1ZP8[D&"2@]
M+),>? R3_]0-H(0&J.I"-FBY]428N%KFNWXBJU .N@@CZJ25AM1NPJ=B/O=7
M?\Q6_^W+N5ZX/;E9U (M?7SY242%),0XQSOY"LV?/X;#D,3Z15K3)?0;UI!>
M%<M5L?@U>D;:WMQ%OVC?Y;R.":"YU0!"Q1GEGA%/.A&Z=XA)<)K&@*D?TE<S
MI\O5NU(O]GFGQ$%@!#5QXZ(I\C0HK54W/FN?/0TB^YELF/2NZF"FZ3U"% 7*
M6 ,,L4QJ:[#)>)/Y(ZSI..ZG67J8:V'7IW&-:FX$D]U!WP(XEE-^(EW-M/>P
M]2#.=PLH8PF0+/YA; A60F4%S%>5/CCQ!YWL#+RWFG@0OE\5JU5Q>QG6H/:]
M>AQ0EE& *-=4<F.0S+?>-P <)<GQ5-)J]/>U^"#1N\_%EU9$%$<'DB$$$,:4
M<L%YT/DTL(ON>0N@EZV'/9!Y-UM$%W1693XL5^5==53<&$JPOJHOEBSN%:%C
MWEI&;+X.$@?A3L<U3,O,(-<DMD)L?F :08YW"+P?^.A'PFEH/TY6/3C+OSHU
M@\4J[KR)P$ [Q"A5"N;L!SR:L+H?)9^/KEJI2AV:>ETLEA%,^;&<6?]^X6;K
MA-.MJ.C%PK5%8;14P!CL@#/:X$"L5[M-1_<$KHX=>=1#ZE3L%;E,GSHR_="O
M>),06@N2!PET-6F(D27&0(,)[*2"IY^;N</S$#F-/0R5FK.-S^7+V]IN2E9I
MXA#&>0F*B,*6<=>)KL>/G !3IYDG]0)<1<LOPU;ZRAJ6JQ>H8* \"]6.BD$5
M-,5*=*)LSP 3(#"%Z1(>%#1C^B6:QKL+&Q?WY>^+.,(:9*U6W<6UW,:_$:@T
M98)HJ[NUR^\XX!3I3F#:88X,9M<WJR+<+7WSE0VDJC7'1 !H$>2"2JYQOHXD
MN^B>MS(267V0.,#]]+29S:-%Z\Z #:9RX S0'"F$J)1L]Q!_0!WLHIN*#GI9
M?>]]&GU<L/?1A5^L9E]]5716M2VQ*^\^^67\=^M*JNJ:EWI#BNI23","B-]W
M"@H8;*#=?;1.8SYORH<T<%T'O+\.WLS*B*P1C'8$*,440%X+RY3V<C<\T\;V
MUB=/A=-3C55G3O1B[D%.:U"OB]O;V6J]^Z][F1%4=#"!0EC[.#OC8+= R+X1
M)L!D$N/5&97]G\5U]ZB&#;JDILHJJ@X:$3&<!Q(Z.N)//G8"W)UNICIA*D7W
MMN7-Y=TJS(L_WA5E<W0E, P,9ZB*KE G')76YCN3;4+XO'60T/H-89-^P:VU
MNW\9?G]P]ZNI5YW&O?NHOZT7F4]Z5=\,2@2T4A PX^(V4!%,<+<P2K?QGC??
M0QFV@?Q^0;-='[\;1HY%]/B8 -19X3%FAA#3?6T_.-X$R!_ L WD)\C%?6A)
ML?Q<-&[\I3(&0 Y11.<5T#*ZBP8C(1552N[F5@_9S&D_T.>ME_1<-"@E031N
M^ZJ(0_!<U<:', 8"90(%9"'.&)%I0SH5K21CHT$L_>ZV_5C.%G;V1<\_ZIF[
M7#2&D=;@(A@(A)(>2$T#T-KJZMI=[7GH]#(Y,-#S9CJY*1MX[A>2>Q_?9J5?
MKKIAHT0"@P(%-$I2!FSC7J=;Y5S[.!-@.:$A&TCF W?ENKJ[O=7EMR+<KT+?
M_=V^G;D.?G+B[ES'S21#ARX57 "(JZK,+EB@'%5 :4JHE!QCW2V*G;]#UQ9L
M84AT:+E;9WIIRJVGJ%MYY?EVZ.K*2M<.75W-=?X=NK9FHBR/1E$D+E4*,1;=
M5<LR7A9Q_AVZ.K/>N4-75^MG;KQT"-:/#EV]R#RB ].Q3(PG%"%-1.8D4!A[
MZ0,ESH]PL]49=^@:6!^M!.3IT+6%!@8-M($.>&:L1-)A'+JE69YYAZ[.%C_<
MH:NKN0:I\6L,0&PA(L@":24$T/CX!1'(T(SUO6<= CK6G4QD];TZ&&"C^+%8
MQNE^F1?KR+>)/P^SU??MUJ_%U[6'.EN\J0;U[M7F-R[-?';=M\ESLK&3;3:'
ML4;/[>A68'%+KD\1?)SKQ?Z+?S@2U<TJ%EAOG#(>:LCRW633%76",'C[2,VE
MF58 8ZN.[4I)K*)_'Q0]%]MDV5@/K*^&^'AJFLYG^_WN;N&J"\'+LJKT7A\F
M-LZQL9TKUD!B3  A'#)8-6T*/IL2CT%^'A=CIY%.39V#43C(GJTKVCW=H)OP
M9M_U'S>'L<(!P^GB9 GV(/4,Q8B0 3I$@2 5XG>,43KCG=GG(,*#(8=GH\%6
M+@?1WM]OBOG\VV7Y49>K^;<*?763:@UN<YFQQ#QNRU4 0G/N72",9=P$'P5]
MC"C)D%JH"6\X(@>)KVS@_KX(1P+E&F@:$ @B<(AYX(3EZXG>$?0+T5I:\I)W
M/]YWT>J^&,2^^]L(AD ::8"UDD*B?9Q&M_ZK)T,8^VKDY)O8C(RD[I1P,DJA
M:51[?*8HA<PI%Q\MU^T2CC/424X"B\&M/X@GM1?AZF/IEW%!_G<]OZOMLA5D
M0"NC08C^932'$LSD:\S?#7-FF0W$>4.^:7+"4K_$KGSY=69]5>K8L";7WJ\(
M 2,P DJ[((T)$'=,36H?9U+\I[;K(.W$7]^5913@<3 9,7%5-=&39Q+*N+XJ
MKO-EJ'>"/"DE#4G7(,U'/NKE-L:+A?M05,?X5;.4Y44Y6\8-Q+MHP2N_6FU"
M_,L.\Q \.H"2QT?$& PI,L2@?/'W-'.:J"Y'('R0;BD/Z>3W)<=='JX0'ZXJ
MP]Q)J1AD@D.;[WCR,-Z)"BXQ4:E;KES8U9TN9WJ^?@ VS\)OOLMB33 '$B('
M<& D0,N5]=UJ/;J/.2E-#&GOA!U8MM[AQ6)5SLS=?;5BA>K5M^K/*J ZJTJ6
MXNI8 _]0U?)MG:]4:_A)XTI), ;$4^JH#3Z$C$T'$LQH4IH<D>S4K6<^E_&A
M";Y<7MZMHK7N_.?B_RDBU'+YP>NO\3\=GC%#)5#,2V"K/QF,&UG;K4SQE-$G
MI:0\'*3N;O-^8<MU_R2_^>_GF[*XN[Z).G_[IUW;Z\TLQ GYA?5=P#-"@/0$
M ::<\5CB*/FN!9#]D$Q/3%FY&:0+SVGA-!OB!E@Y#PC"7"+CG0KYCI"/B7]F
MRR)^Z)E0=10/17D[3+YPZR@#9P9WG^'X.<!1.89Z"#A57KIH4QKR78YPWCG
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M$^8&?D?^T9<VPM'7_C)\BN_L8J'-_-O'8KF<F;E_>)&_7S3,L%8YPS50B')
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MH_M]"E[ES/-0'4,[0H(C#N<[#)MLL]9V_E,U:VTE;]0J%Z\D4%K'/[SC".K
M"1DWM?RENG-)&!NYRJ41VX\JET3<]JA8Z$3,R%4NAE!@A#) <&2)9EZ'C&^X
M9UOE,IAF6ODXJRH7A0TPT%- H,802840#3^J7!*RG:S*I96J,Z]R019(J"S@
M,D!IHWT8'*%%][2J7%+(+CF9P]SEFBZKDS("C),<<*2\]SPHY/+EE+_L7-XC
M#QQRL7[NN;P:X[C/Y@@HA>+RSS"3.M\K^F7G\B:5;#K6!UEE\V8W*:>!)D$
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MBG8N>%_P@$\=AL^ZE.?I%' 444:X]<S#;!WL&>R<=5#2SA76 XS>K-[.>?^
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M7%LN-!:'=45_'K(\%4ET]4=OQF?I;7./_6K,S\+X_8OT_6.M56".84ZS]-H
M[$B=Z=KII[/UT8F07^7\T3^+[&K:6SD= @-#+ ;,*&NLIH'J=@'=0I,:JYS^
MJ>AM=X?VAF*IJOIU])USVG511A$PE,E4"X(+0E(+Y'8OT0Y%_U/'+>FO\B"H
MWV@/S5VNYG_&(^FA?8]Y2&]', 2!4R@0-(*%]JURBTSMI]1/1CA5'AWU3^?(
MOM\>!2 )I( J2CU%*IYP3D7_)]X,_IGJOH90JG3WJ>1Q$4]!G ($4DKM%&(>
MRA$:R9=TSX<EKFUT7BDI7$XU,%"FQN3!"JDMLC0O %4/XV6'I4Z$^]*-=_98
MM=VL27 IMU6!8+VV2E%L3-X5TFA3.*E>5.T4>$"XZT3D4[D?RNK ]UHO']-F
M\[>I'=/<*BP5MUVE+0<06N\E0D18=<Q^4 'K:;F1IR*YGKUC;+V<S.?PM!-S
MYM0L1W'+-A0@Q1QWR <.CWH"4!CGS\^@VF=07B>5^Q?F3^U)!"5S9CB%OBVA
M0$,5C[C<.@3SLBBJPOSY 53[ (JKI&"<;=C,-H,JF9/SD@&%J %,.R.$UH&3
MO--";:0_OX)J7T$-K10,P(WDZJ7&P8I1!YC#3B)*C%;PI(X&[=[Z/?STU=I/
M4SVJZ<*7?^.7,UKMMWT'S_BTW_1Q@H"22H* '2=4<.>?2:>Z7T_X31_E"ABH
MHU73_0-1P5O$GX55S^%-7Z^F&[SIZV5_[#=]JXWHW32N:?[C,NX]*TNF/QTG
MB[J>6C =@.;*@$ Y]H@I9>W>!7SO*&?TY*Z?[ED-LY<.*.T"MJ/H?A>T[@=U
M!RICC =PA9G)X7N 6<=EWA -#)<6Z%2%7GHF @TGR_B.UV<G0WBO-2N\+?/Q
MMWV)J]UK_]U?S[XEA/>.*]K5#"5ET D&!#3,.FIP[M*?,UKC@WM);F8U#5OZ
MO<Y'?>W3)O>;GO\GGG&FG^^Q=4-SW "#!0)(:,MA])R,05F<]X]S)FP7-&;I
M+_R7>(2=Z^L([H7[&JV;PD:I"%6_%)EFP%@A -8.!>($$BAO2<\;[TQXKV#<
M*BG(]WC>1JML.;*?HA^[T';EY[Z;_NO+Q'[Y939SBZOY1S__/K%^\<%;'R?E
M7D_<[[/E?[_1UY-P^W8V3ZE!G^]Y6[Q8+/QR:Y,4(2YI&@D K:0!,FDPE\V.
MO,VF?38O6 \\))^FKEI6.WLYF\]G?\45?_'"W9E>7[^;AMG\ZVJ%&1#MS/S-
MQ2*;Q\RD2A3S;J1TO? P^ LSNUD^ MPI7QD5H81E@%KL(&7>X\VZA(TB; =,
MHFRD<O_ G>$*'B10(3"@O<#,(B19P\*Q1TQ@G&AD+6WVQQ]K<#IVQ/%QIH^S
M>'G[N_[ZV-%5,!F/V#2>LX5%"B@3!. ^X*"="MJW>[37A? T0I55E-'1(74@
M0Y4ZY3Y%M>;,[\/5O,Y7-]:Q:GH-YW.O1 :0,:)8=/1\C94"2 -Q!,B4WBPX
M<B8BV5N#:S2-]')0.CJR:HGU+1W97\U]]'I??)[[U?ZV=G)?PZ;B"JH9X\"9
M@+4@.+UYSPJ+[!EHC -D"3IFE6Q9.MJY$ULZI=HO_D4W1D$B1D\"D!IY%X^K
MD,B\%,_, 1O'P8I2E,7] /LV^];O,;[LQF@P!\K[ $*0TENKG3&XB 9>7I8&
MCK%OZ03Q?1A?;6(,Q",@F+#)" )X)2621G@3\MZ!9@YX*1HXQKZEDZ3W87S=
MC5%*$L],W@#/A(XL(X]$WMNOS $O10/'V+=T?O &LC?1N4W7=D^0*1@/RM8!
M05Q$IF$ ' E/.#60;>;M[7H3VS?,.?A\Y>Q8O/S?4V2_^[^Z05EMXUR#! X+
MR0-$V.JCR'T8X0QY/<YZI3?OATG>77<].9!:%1@0% M@E(DR,](AK3T+*"]-
M8?MWGW^ KX11ZW*\*>,>0 =E&G:-,D)^X5#;[^9Q@.%*+\0YP 2-P+@@P#'I
M'(<8&2I/C,F^O,'61/;:JS2!"<=';^-RY*Z^^_DTO59Z.YE&7RZ"_*"7_N/5
MVP^;/MT=3H4\D"F=P$IF'*%84I?G,Q\P:&._>3@_LP;&+1U R\+Y]GHVFZ^!
ME2CZ"-!1DD+%*'D=$ 0+I86:"))9<O[0D<]?#L>:>92%X8]O*7=DM<-TRY@3
M#"0T#F!)N#&>::4*KA%;XY^_/H:9O$H"XJMKO5@\]/1XI;]-EOJZ:Y]DT7'5
MU&C J")646>M:%?/<2?,\S\,E.:J2@G13FC=WU0GN.;W_CV Q[K\+T1OGFP&
M<%,E#>  D%);()$B@!'+N-$A_M_(*]&H"0$GH)M>2JKHY6KNXNXZOUUA6W3O
MIL+'W9LJ"ZQ#U'&#G&6NF5"Z$(X1@2Q&XY9 !G-0\"RT-M_9S73IY]_T?#GQ
MG4?^  502-'HU7F#@[?0VW;)R-OX+LJ'&<9.E7K03S%U?QJ=J-I[+1U(1W-7
M!C*Y1QH#:*CCH&2@,Y0#I8)-=6$=Q=PB[\9:6,9U2<;01J_U:^<L_7-VG<H]
M+=[]^>O[[IT0(@04$QY8"JT4)!!HV%%I"MMCC>)7#*:D+S=AH#U+1UGO0'V\
MF417ZN.+[BM7F&[1E0V FR"]#-89DA<OZ_KMSY_2P38K_<W^\?+CQ[\FR__M
MY]=ZZE[\L@9)<86 #4I%2-( S>($HZSBTH0IY%)DT=C]^Y\_D07L5KR>K$YO
M9I<[;_6<C<<.[SQ@3GH.#5391?\V?O/Y.^?##;K-+BO&;K=X.^$<E&FP/<8(
M>0;#K+Z+OP$F*U[Z?"\LBPR0%B* C,5!&Z,5R<LP:,5@7WY!2P)[+56)N _I
M'FNQZZW O2.F-) :0\"54CXN,0BSO#S\GD%:]PX9:/T.)@>;KK0/VX5K*_7_
M#A<)&!A)$,#6($BP<$[G59GI&>3,*#W&="V^TE=/$A \3<GA&@@:%# BKD31
M"8CG):,(S*P%US/(F5%ZC.DJ>;9/<+W>Q.61DT#H"$YQ"4& P02KM)&9Z>\]
M@YP9I<>8KDZ3S=E4NW_?K++PWWQ/5<)?A'A$^^"_S>;I9^_]?#)S3WV(N_<7
M%,<S,D'QGP*C,$1/7OIV;Y_S<9__2:DZF]O*XZV4M_GQ]:!M?NUQR S&N@ZI
MI8@CI3> SCK-X0>@AARGFF(,N+C\0PP#";[=/?[XXMM[W?(LM-?+8FG'^#?]
M[]G\,<-SK>+=NC^@K ,.>Q&=C'@0TXR(J !JO<+>0)I7.G??2&.$?^O1-*ME
MXSJI(#]27WZ=:#.YGFQ<1BH(,+<XSCE0( .)QW"?6D$1RQEBS1:872@OR9\J
MPM2VAD0=#3WY<OJQC9?8NH5W]+S60=QF268 ,76S6O=B1)[$3X4;0+DCW$&A
M*6_7/+ZU:/)S6L?23"\?E<)X/T#=;MZ5WT'2G*6$!P:,X91H:S%E-,M'Z?[]
MHR:C#B2@(^PSQ'JE0^T/F^-;;>]G^9O^>_+UYNO#?WFEO\7_MKS=+ 7@) (J
M]1KPVDN&J(.>YV61'##HV&6Q:U=KK4I"%5=UO<AS\MQ795EF[U(6AU\LTP.R
MEWJQ?;^8ZG09YD-4=00>/!4&MMLV,D&?N]KJLECMV?_C9_%^[K_=UX9/<?B7
M-XMHC\7B4Q30XLOLVKW6MZFYZ"JP_FGVP4^FW^-T7OEYM.OT_7QFO7>+=].U
MBO#K;QH5!9I+'DT8E/<FV.#S+IYJ(SUW79X>W=6*DBQ>S;[[:?0"7NE%:NV3
M_I;:LG[7URG\\5MD-J[[FUBQ]6F95P B(@T6VKIP8'6+O($O2VD5R"A=:FX;
MZP<?_WZSZICQ:C9=M7!>_&NR_/(J+N.SKWZ^"[9R-J[=P@',,(.0$Q1=B",U
ME(OA0N54A:+B#:[O3B.+J[OU<_'[3;+L_>N[Q2M]'>WV\G;S3VU!A@(8:>/I
MAU$BK)/>Z;QZQL>-?Q&*:D!-Z4S8C8;T3S(<MG9>;H%&#@)NI%!(8$8R6\'U
MC7(1RBAFYH(7^'?/8NZ]K;3F/<[X,;9!0WI*@2Q)S:$,\(1!H5'<2J7)8K[[
M]U\$YP5,6_#"89>O_FYJYUZG7O5W?W\W[8UA2.221+V)_I2/ATJ'%9#42N$"
M80;F;2&#8%R$=MH1M2TQ65IB#^>^3_-HN725^Y>__NY_BR[6E\6]S_7P9UY<
M7\_^2A=^W9_/I_GD\^?M$L)$:J"PPD!;BA6UUGAVX$&K*MY+%>W8U&^K6Q5U
MOK<_R@-\/HD\!H;(U$\%TKCG0P*<TQH*9H3-#,J70G01"AV%OH[XZK#+GQ\8
M[\N_I6:-B^7\)L7;MO*O3/PPXD<1_U48!P,C&,,\8?6-<A%B*6;F#@$4[6NU
M'O[?O)6T @)C" (^&!6<<S[^PPCW-^L8SUT]13GJ$$^!JHP/FEY/?UB^U9/Y
MG_KZ9@MA, 9(37T\I$!CA1**0]),17O 7HZ<2K+6H:L"CU"ZSKEW8#B&0 J)
M0=PF=8ILF+ 9<&RR$%V.6H[DHD,8!4I@/1Y29XN5WW4SGWNW&0R)3A60@<=_
M=4$YA11C)+07R1.,%RB8XSGJ$,^P^'2Z0(ZK7IKU5>A2]%V9%RTH4(X+ #EU
M4EC/O<Q[J;AC@'-GO9AQ.Q@?%I%^P/&;7M[,)\O;A/+NP(4Q!EC!5%O&:F X
MI='?UH8Y"IED>7QW_OJ+8'NX83NX'A:/_N"=__HM3??NQ4C7S<@:.!8X4!*C
M-%>JHRZ%@WFL[QGH(O@O:>P.)=R'C?_O?VS8,"+_S^H_K'Z>;/3!A_^6_O['
MAW</]OSKK[_^*Z&<Z,]^ZI<3N_@O._OZCY5)'ZWPT7[Q[N;:S\+_YV_?3;_=
M+!?18,GY7=EL]F-&5^9Z\GGUHSO++I[B7DR^?KO>^_JJQ+#_>)SY4XO<C_U$
M4TUMX/]>^JF+[LU0SVY=QQ\GGZ>3,+%Q^#^F,[/P\^\IGGN'\H]%$OC#:>4W
MK]/_*(53KL)=JM=.D9.X^2C-%7"0>6V1,*QA%*/&#(=[U 51=3ZPDD0#C;4
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M6_R,HHG3GYJ%NVAV_,-K/1?NJO<OGDYE>*N" 4B:=#(H9:F!C0Y6,GWR)73
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M4%5EJSL4J0D,:(4,4%I19^._<M2N*N<X8MKK$)V4EGH9JJ<AU(5PQ[-#%0U
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MZR=OGD-Z\[SSDU!4 1FW5F"5%!Q[S[P667Y)393%WN$4 M9Y2B;< <T8!3Y
M2X5V$ DXENG&><$SJCIW/N\9C?33>?O3JD:_E1!(P210P5&!B+':M\O^/Y>.
M,2>DX-'ZR_0J:;2F'YVH?O:7&5T/1W7_R")S-*E1$X\/(?Z3)8)3"*FDIEVO
MAPOL+U-!8;T<CMM?AA,## \<4*:BXKFG7+0KF_OL^LOT,WE\?YE>&MKTEUF/
MP#L<?0$G (),:JV,E[9E ]+Q^LN<LLMU-&-5,D [2N'OP_.S&\V!O.5T(CG4
MZ*VZT:QG/\?%36L! 3=$:L,X\K1=5XG3[$932P.]MAZA&\V3J$W<.ZTQP#JG
ME&$$4MLN(?S4N]%D<WA@-YI< DZE&\V3?*/4S$\SH(GPSA$N);/-!/,LN]$<
MKZ**5-5YQ)2)S(B0FO)(("0*4E$>)!RAI='9RF6(^:LXIJLSUZ^I+/2:?[Z5
M.2(DT"'56\3>6P>)M+Q=@F@GQ!'OT$_BOJ8D@U4VLT]S[7Q<%J^67_S\O;Y-
M1[K%[E+23][G2: @,L!%4VC'O)$-<S?R<?^48&6N2R<9OK!V?N/=?9G7/( !
MZE377,2#A[)08$2-V,A*W7$_G3/:I4NH#BU5-LJG]?&S0"(I4^<$FGP]9PUA
M0I!V'GD&X$N77SUVJSP'_GTVC;]J\ETOHQ?99:TLW)PB(.,G$_^5&T]QD(RU
MR[,_;@X_A=I0 SL?$8V599FZ:[[T83;WG_3?GV9W#0 6DVFDPD\^3]_\;5<_
M28T :B=;'@&E;<[E4%N53KU\$X*WRZMP#^1=)Y"='T<\J !MF0>:::<@P5[K
MO <?QV,HEC:9-6SW51?#0 M!@5*2:>8=9IE.YW'C-T]YK*B*G0F-E>@XH73%
MF_G<3^WMN^F_ODSLEW?3N I\7>5VO%M$0WR[UK?>=1;651QH9Q10V".+O*',
M-,P_S(4]^NUV+05M9\E48;).F_.;J4W ]/75_/W<+U(7GO3O/Z;0'>?LQ-G\
MPCL/^V@Y@G5$L/U IQZ#)Z0X!P-07E+@#4)IQR#!MJL-.:;2]J<*GK30>HDK
M'2%\A-@/BC("C+0*!,<A<I)3:/,<M%TCC''%58.066EK%KR<6,R7#V+OTK/T
M#BC*.< &>BX#DH[W)0\'O3 K!N(O7BT/__#7RT7ZMQ7Q=Z1OC'GN3LP@&Q<,
MW-I[#/_SQ?4/]>U\:-^)*<,;67C[7Y]GW__Q8ZP[#?SXMT<-]&%IZUT,8V=6
MR;0%5_%#L#$EXS&2H[@ *2VI)4CSOGO&TZ5[QQ;?G.U>BY;>JU]/XDJ6X*1B
M&C^F^<?'UZE:VS_?[NC:X3PPWC+ ?83I$-'8Y096]H_6;@\O1\JLID5+[MT[
M ;[YXT,?0!VG+[T*@+KX5\<TDBBO+WC.:&=)^1"+-OG*?WGYO@^@M0ZDTHO
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M@KY(V%.FX(_YK)_$II_F>KJX7MV_?/!V]GDZ67CW;KJJG;>\FJ?_[58&JE7
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MMB_,[&;Y&#EZJC'!%(U;#,.I3A"-:X4PP!)"<.H2BD.[_,8C)S%\U3ILX,=
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M3]U(T"#_KFO]9PX#/<VM_\* (6 $G -?(H UH IH BK *3#\,HCTC3VT4<
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M3O%9?2AQ$Y'GU"-Q^ZNUV:FZ9:F]*Z0ZO=/D7BC69@&5OY<_ME&KOG7]2LR
MZX;4XM'"$'ZSRYSGD:]Y"AZ9C44J<0Y^OXK)._E>7,*FVSSDF7!NMN7F7NL!
MKX?*+77S(">K.M^@!>+PYF#:,I%]"<Z48(:-SL<Q=&MG\'>EUK@,Q'O'7UXT
M#5'X;KTBIKQ:_8S=(PN!M?>8;5PTN=&\04-FVB)P06>3M!-L/$Z<6CSE<31
MD>WQBT_O<[/$CX[$6-=(V1LE!:I)VB:DDP4ZDE+<$@QE[/9R9\N+?5Y;3033
M+ WW%O/@$0-ZTMCH%U$=4'H/MY6"QH"7%E=P[M,EG5B)4/&W:O4IS+;<T0OW
M:&)EM:QN+;1HKL_ATCZ](_3H2=I;F'_:L6ET,Y_\;AZ??EIW4#%$##;]Q"^9
M4Y;AOOX9*_>C4'YPP:=F4T%"@"[0Y'5456N +2FXS7U9?EB@XV4F)9%[96I%
MJ)C(:;(7TG&CNP5R3$$"YY;?1^+?,AFKV17)R%#<W-A$.4Z_@%UBD[G'+GCG
MK42X7.E+G<FGYO>=Q^Y>T4%XZ C^5.$.LKGE)%GYNFNS*_]'XA"ZF#_6%9PC
MM>S;1?1=V78CZFMRB296G3>_Z:2[OIAT*CL;&MVN[+D>5%XGB^?$YAOA&; &
M/4CJ3LV(T]\>HVO8+#\'ARA&/UR^8=$*BXS3N.6V_H(E&/!Y!,A-!.4Z="Q/
M;V0>.&I@_OLQX+CIZ(DR+D>0L- =Q@.(AORA!11A"/)ROR_3975IJ)AML<#-
M\GBPB\XE@GP%:V^?# 9UW,<P[-K;=YO '>-'SPK37K=RK?:RRNAHENSHX4NZ
M.$G->MI$8[S"$O0J2O-J2&G+C:%BCO4$]6HF,>=S[9&_HDO#?Y1=FQZ$Q7[:
M[0,8?UC$90]!9NV<2$5@A,YVW#])-\\L21 OAUX>ZF=9<X7%?NW4Y(G9'I(S
M_F!=KVQR*^.5[9>O437B*8]R@VJ1F1G?4V^Z?ONQ@;] TBY!RF43N5HQ^_U5
M"HZ8P<>88CX\@]L44;0Z-J57<UYRC/[QT4:Z6\B'$GF&,(ET"3'3K_ZUXLG6
M-S4^.#XB J#/N;/2Q4;*UZ./]1O@AZ23Y1,L<5)]K P#OSX6WUKW1G:EC<8[
MW<S?#U:;Q%U3(U\T= SPC;J8TR+;56$[U;I+$M-K,]]#[I8?%#?\=.QU:=T@
M87]1  S;C2YUXE$L/"-)[L>\5GVA[4L]]M%)3$EK*TJ" '.S".+BJ%*Q$OW*
M>;*J\JGT]**Z$EY6J=OU(QMFXWOO:88!"/LN/-6%':?WL"36VRIKR:9UY'.E
M651TXS"MPXI@M:AHV?SH]=NUW>/RITWV8+$%L#B$N]N^R8HD]P'H?&F[224)
MSC@(F0E91AY!'%?:%7+!*1(]8J+4M]D3]]QT7,:]TZ2,408#<&9#]I?&GUDO
M$\%XY'HA7G-)LX> R((R)7$1S7!';U2^SO4?#BHQA-AKAL'$FZAASYP66Y4?
M?"M:?G*U0R3-S.!ZH%- A;G,Y75IKXI7@Q9$\[7/)(62+GJ\'6A@Q_&\.#\'
M?#QF VHY%9D)6SQ1L2A$/S]VOBF+J6G.NX]Y.-X[B79X&0P6C#-$<RZ("W5[
M:WDP0]$O/!IY!Y%4L;!%2%]IY8)+[-C@%EI!@_WR=?2JRI!DS_VQC]W-!#7C
M[Q]IBR7OMRS7VV)W'7 (D!F\S?0*./T,684H( R/!,HM(K(76DVNZM$17<;(
M- %)W#BK?K;C[@'!M5\"A#E>PF;6U<KN]"INGFL\DRKPICJGI!$F+L.8890$
M)X,[I,6]N29!F/2XTQM'6-3K;.T2QUIE$/4K9[^XN+[W1<!+W(PEVEZW11'.
MV[H,B!T$'.O+G,4UT;_"7,(,DRXO_#B'BUS2@X$7%#JE<1*^!"E.5 *Q*SX"
ME^[4BH=C* !U@@'V69<L-JMT<8[3HVM,7KPED0-U; %E737_IC\D5TE1QO.H
MB^G^X(N9.D4\*UA;#+=90]!/X"451=8=Q5<-S?/CRGOGH /AL07!JJ,LA(=U
MW\:6TLA1::M:HBUI.JEZJ/K^#W>YV5.LS1!V5353H,DF=9BO#B/6=J&A_G4W
MB*<)2;%RY_&DIT0:G,DUW2#,*5W[N!<!J*-M=0$!OF6!,067PZWDE>L??2E5
M4WXK81P4FW?>UKKU. XR;;<D-:!T&X$UR]19@F;NOJ^Q&K#](2S:EF@9,Q?J
MV_*JT^E!:Z6L-&0S+26E(/OD&'R0 GQ][_3@5/B0&P0#WX$ZOJ@;V,)+(8A<
M[WN1'$EL"9QX7UR=%<[]X2*")Y9GS"9]0%CL)4^!>T?<<R<CC1?8"VI%WEP'
MRZIF7&%O'N:>B.QS_+S @$270VF35&-G];'/'V+J>/WWA-4:NL83(#6!!8YW
MR_%Y"U89PS)C>S#)OI-GGL?FQHK&>0GD.'D]PC9[H<)FR6P'T+:T(L5[I3QE
M2"+;CL>5S:3,$8^'.6"0I*\&2;6)[<.HQNH,(EB)SI#KNU9<_BD#V@DN<<C&
M1AN!C\'+PR>K>N3KX6E1:;[S3.=\IH:*&X>(7-E+(0\3"=()/%.=XHML_,6W
M%Y@V=$T66;WF)V4V0^"HA7,L88)U48S;BP'?XD='\MX/O(0\L#=AL'E. 6H*
M24QY&KD!'H@=V"XT\45=3QU>B@(0N;[->Z0(<^ 3"6=7R"KCZDH<^+7^)*Y6
M7.9\\6/V9IY)>%YOW\:YU<T%/]-%DRS>FZH'P2(YSB8KV1OJ!*]8FCWO":(<
MNL;$<"K!>W%+X&,$3PIF^ BJ;+XL.L]4HNT!4]EU/LPUYW.Y,%EI^2<^C\Z/
M]XYGD!XW3V%EBQ0?K1!@*^5+GW^-IA$=2>G0$.AME[H>2"J$1S< XR$4B]JV
M2B\Z\;DID?J]!6?@K\1'BL(" :/.7M<G=:(<C .>FTY@KZ7ZTGMD%6,=XM2@
M*5 F/7'B$2Q;JGK8$OPV'/T:;MXVMD@>'?-[&;#4^3)7/([?Y,7)_H1KW\PX
M94\I[$=8,=@5YX@Y:.2+%28AGA),C)+BB3#0:Z7&ZF 84JLC%VX7']6-+_MQ
M<FZ%/W$_M7S4*]MX+*2YE/E,/N?I-SG7WX<)JKZ'<WT>DI$>OA/VB]W)\E')
MW=PO/VZ9OFWF?0E& W2WN&S.T/U7$P*R@#V?J@=1VIA=>EJ+Z#%*L,&>6"-+
M%A)9RYV#;&<#/'!*+8-#3>,B5TE/O)9;C%\%F)ZZ?)=T=>J@ ]'CA?15RD:V
MP(F\=Q>_]RC--.I3@)MW^W=F_5M3??>J@G3[X$]7OAGO*)8E*]UC[TDHZIZJ
MNJ=O7MU6YE,R]W.SXWFVE%9A)M_VT,,VR>!XO8\G?V1K8DQ(DN\'%_"*. @%
M4 C:9=BSF.@2(IJ0[A,]L0*8_ V_2O)(DOS8KM4&(3/PEX+Y@LUHT\IBVHR#
M&K+ME=*1B!.+WE',EW121*9P[S%U^!-#&Q5+;*@A>U**K@X:V91@.R(65Q=I
MM2% NYVKE7L)&A!T+7 ZR^BR?/].UI-KF\B&E'4P:J<SPRL0$@,AU$A?-[$E
M8_QW=+IS"/RRR'CD!Z/ M^PYOKF+$=YA A*XS=0"H^ O%;)AFXO*][XS0()&
MP9 _8,'P<>>P -5#QSXO4??'<EIO71?S*A8"-'DF6H+<'I*H\!%HJ7Y",4J\
M7_N(N_I$S7++&"9FTD%C(>R5L:'AP=6$-G0(-*8LD0T<"36.H:]&J6^!58\5
M/[LW!EXO+EEQQR(L.I'(L:9X-]N 76GU4YSKVW.L>MOS6C,)J<+JH:/!A5+,
MCM"'+FQ$+@B9)0YGLG=M"G$1F8Q@T^7UQ.6;\'IMK"O(BR*;ML_J)I^J57*%
ML?(7W\]A.LABNLA(#$>2KD/1I="FXHW72VPS51Y8TD):DL9T=4'Y;07X;KJ,
M(N,L9U-VG/KGUCL;!8H\E[2T:)9%0B\VO!J]>V]5<BKR9V)4>TM'<=@@6=S[
M5:;GDGM:L];9@B9Q@7<JYI;8#-\XK85<XDN4[-#Z]T)L*3EW>0DTHMAL"I#7
M3* "N8 M@E9SPZHNFY7\A2Q&>OX=M"O;M9A;NT$6+HP*G!MY<4@'Y.NVVYU^
MQZZ^@' ^4J:Z1I;I/*PX#?(Z:?)XD@@IO9,%C6Q-@&&;["PJ_2D 2H,]CBG$
MFP/29!;:,MST[I%$M67LIZ/0!)!1SL"O4P ."N 'Q\LA!B#7/?A^+JPC./'P
M;O['STM]OQN%??V@KB!Q?T<D3BR$<5DHY774DK^^]>-*-]1>4_2!7#'KM3I-
M=]XRWWCWG85O&Q&$[R5I<E^M7C)+EUS]#^E@"S-,S*]+A>PS4(#1Z+JG<M^1
M*=!M]RX)Q!?0WLU0M3JPL5U#J]A?Y(Q?'&G2+^0IX_^C._28)&FB#G9_8"LY
M20QOL;BE29 :X/>=SXG?B]DN(YQ>MSA2*!A>4_]I<CVN=C7M&2K&4*V@4>^0
M0H*,JT='[QCXKJ['L@JEZSH6V%[;'%05.+K&Z^C2E--9HY8SQ&COE*MF[[1H
MT_OU4>X5JGU2@B]!+^F-(X*J2X]HC_\.S28:+=[$%R;"KQ3HU81]FUZA%J(
M'<WN[V(V^&C82Y1TPA&Z"'1I,=9#:::*S+2$:U>:63N/W:Q:@G*Z&M!]JN%Y
M+&%M4#X47F(Z4G06]F'D_MV+UD^/FX5:,C@V5-VN'#^]<AHQO#F]M#?^LLFN
M8M,H@.R1]'US+LDTZ2,4:[MPVT,8B2Z%<"$\/\(QQN68.7$,49/#%9\;)U3:
M1M"M[Z^1".8HD?P<H5#OS->@&!IN3K9&]-B"2XZ$<'8)$!GPFKC"/;KF5M#
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M)RANZRC1K6\U0-^3<&9[EZ(Q5B#2LCI^=XZ X<>V'O$'C_.T[8&$#950V/9
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M  '/AQ4,E+>G6F@)O[_Y[D+-[39[DT.*KZ..,,**V"*N[;AC+1?A9ZA<%0F
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M[]3E1-;:Y&5^;>E#SQVR:WS)"P\X00_JJ7H:!E\/[:3P$1&"8WB:;CS69\P
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M5PT%R,*$ -B=3S=3;5(HWVO&/G8$_4DY%:Q^ZM&XNRF?#-&(^*3W.5B^"<N
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M]2'+1F_C!-VGA$;9@(L4D@&^754YM-VU7??.V]MLK>55@*3RBD.7NUA]$E=
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M66FT$4,QL$QV3+*#P/1$Z%?(A'94U!ZXK>_P^_$;HZM$7*6&[2;^Q_T,_4_
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MG'%O5[9-^)IGW-*GNY.WUKU]KA>?,.?WO?Y@:]\QFD/]H#,+]!+-G*+6\K-
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MPH?[P[Y%6E^V8H_E%Z?MQAM>00Z#C]8?<)R %[4[BK;WR<_VXNF.T,K4Y8*
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MLP:H>OSE<_)M*L-;37SZ&\Y=[MJ7AVD7MA!]/]PB988VF,)+I-UDC K;&&!
M,BT>3_QRP!'+,@#,\"@>,G4Q324Z2FZLLK(^*\%2BG"+/FS\9:K2M^FF/%B=
M(R&;B:1FMB4G."I^PTUVD\9J&7S XBX>= +SF+"1&/B"JD]1C*NK_=3ZJR:7
M\+WG*L^+4SY?U:0'$Z!D[#BW[8A7B>*7%5PZ>Y'_3@"24(GQ3].VF[-76>Y3
M/PXXE/*UD\-EJ.82H0<<A Q.(+K,0C2RZD/FW+S&P &'4)9;U/)OI_"&EUK=
M3H&'F!%;IY[[)W5T@-DK,)<0!&(K_V?.:GBPP,XMA"89Q>OLC'!J=BC9T@B#
M!N S+IP]X#"2OT?,2%XP?^6B/;^(+O.@JB4G+E',_;G6N.>M\\_,-<1_NX7@
M.2O-[TEN,I<F[A_]>RS;D[@O^NR.D>)+LR>D1"Y\B%5G\F11EW@C4VBJ*RA$
MK=V*YY$GZ]IGPZ//P"(K-E[A@[[K I5:=WJ>&_Z27@I=EPN72*LH7]M?:MPR
M^XMBST)AW/7,H&-H"O&O._. 8^& (W6Y:2^"3? G 2LR6H#5ER^@C'JFUV>X
M^RU/%!BM<OZCK3T$RM5U)"R3)R=>2Z1\$$AK3S5?!K>,@XZ!O%?+F Y^LG_T
M,!Z2?F#2;])34Y--%C@S2J<?0I8!M"&D 7QR-.[+;F=\<@SQI"8J$D1-8=J-
M!_:I=31WY:AFRC?D!'N5OA.YX!XG,]U=7VAKS/WN^Z/'KQA_P?+O6LC/F /U
M/T8_UXTV2\(Z<CD9[3C^ !F>%7?+_IQ21\*/>PM!'8)%C^?<W/PZ7SRX_\@,
M_E\/3OW70A=AW& #I@Y[UCLT6=;< <?>W5$_@DM^^?G0[O%MCU__EO/P^-_W
M=VBG:<?IJ\^U<BYU&EX9@0;D7NW1[XWOG4P]?O[.O/_WA8>F=Z_>JB+\Y:'_
MV4_ 2K"(X-JH&H8&TP8W$M"J9IM!F'->?JX<)&#I=3;CZI&*HNJ%#J6+1Z4O
M?[L\E!V?:O/"^4ZYS@7M8T&#,@X3X(F5C,LK(6X]_M!_XI6M\6U#QG[I[D_>
MW. Z&Q&NM&77"6H<[[028-ZBE8;CW 8BLC,[5;1)?5M>+F='AQ_6#4$/..K(
M-^3HMDI^3=7K9VT?OI6Y*&)4B_3+K\5YP%[E\>]G(8\!-G0D]>AXD+C::XT)
MC18=6+'0HQYAGCJ-I,-EKB.4A_<''US@0)Z!/&<Z[&<PN6C1=">:]"N:GN7(
M#E@,B.ARX:99=;2JAMTU<#%X;NX[5__U:V/4W T-F^^#T_+M>+'[SF"8YG!T
M*?=M<PCA@",O^X##Q4Q5H7+^3&-IJ,,JM'YXB>6Q#HL'>8(CP+QU52<8\W:Q
M ?F''P&Q]QPFX='WZFN^!F<]J#LA[?SE=F3XY]CW'@6RG!]IW10!!HAYM35,
MFVR5A#$@K;[[W1A;.+*C!S%S4-,./F'K(!R5XQKL*A96ZOL/Y.]GH(AJ1G_S
M&:CEBL5!6L#",Y.(ZX %"<8_O:)K%3'<M76CC.!T2]/9,#!)*59%/GL%K.,6
M:VS=U(/HTMJ7G0--A'?!Q)C^P_I!<SD''")3!(0P-2@*H5,)1-]2"0U5P>9^
MZO27O/L'-12O4O,U24'UB\],/V&4=+$D"-0RJF*@^K0FW>VO*S]NL#7,![F(
M, =6J69SHY%19314EZY,I$J@PU$M&XAX8FM"T%5)J1J-]5=3*>V_M\S)N"3B
M$29W65LA?+[+43HQ-(">TG&,7@2#*2=_4B\I+[^U8C^M[_OY)0C^O>WY@_$M
M331"'-@EP001YX%HVI0%[28<X@B(D?)/3%MZS-62&57:=N$JA,CTA8@;FIU%
MTUE" 85GG8=[GVOQAJ$9TL@NNO3A_2\:,(%5K.@HPNPC7'TN.5(#=A*2=W'8
MD;NH.6KS+X'3PS1.8J)PT_:!M5OL+4G.!2ONNU=:TKMYH>:]Z3=G2U<;8AD6
MK'YI>9IJS=S 2<1UZFQ!)3R$V[?>B0=J.^:4<^;< 8>#/-[B'#P%%/O^@LO.
M/+%V@/*7H8H<9#.:IEJ2M!#M67KI'X)\YV]=]-0.SRVB51)A/=0X>]7GY^?.
MYU""O;@I^*J"K=0WIL9^)D*;-DP6I<0R#("MSCR.<:;&GCLQSH?I7.@(B(#X
MX>".7V ONU#ESLE&(9?*-#/^C3Y\QI!6Q^N@AX;N,FWHN#W46O <[O6L"!!*
MME1S!K1IU@P'6FLN+E*:LK'=M,/GL.:[E@HW:?C<4$@6RSB>;5W$*PQU')PK
M0P?V.ALZH0?#_O0\.RW3VOL1!XI$]^T/+.SK@I'#Q%K;3&K7U/RS4AI_AQ:+
M%_/&!(;NK7#\F*7\^LUIU81P$9^R,R?OWMA&7]JO 7G#L1S(3D.-_2JD2"*H
M\PH0:A(&MIH"9;G#BR1N90@&R1[I.(?&ZZ$G&:2D+"I++;%!](!#^.RH+R8P
MF!RF:!]!JDST*O7VN!/U(RB_ ^=^5;-DS<SSK5.!>M&77K$.[0FP9$ R06C>
M@WFJM%-7-,Y0RC""=L21&C9RI#U$)$?N*O?1M<^5NB'!J?@M8T$;V);^G07^
M2]Z&57>O1K2.7[V[AP*/Q5LL[S2GOAZM''&R'=_;!,>/$4N#<'5!':A3</XN
M1V(;6@#P[]0E1E3Z?FRIL7PV<ZZA)5PAY0DVBQ?G:MT;'2RT"\FXY!?7]W6_
MPI";":(JOL;<8!@! ^UYG*,(FX]3LV:0X&I"%2:U1Q 3[Z5?=;PY5BS&X?[U
MP([''J?_>C&,6+V-R./['YA0*)6'M-WL$1T(FNS [QUWYK'P7%L:E6UZ[>#(
M?_YR8N "!GL'O"IF\?B4TE;T?'*T;R4S4+$M6<C+FF!&1KV4YJ..Q\+4$/+E
M\.J-&ZJ-GUC&XCXP^4B\-V^.*K-&KKSZRL*;4;9IOZ@=1H%6?U_Z^N--ZUA+
M, JLOEL/FBL@<FUO$)+M 1OR@##<U8*J@HO8!@MX816^CCZ.F]U<LL6T-FQ:
M>[RY/B_RX6.7,KZQ)&S?#^UIFRT!Y*W3C]=-S&E;O=B\].WSL5FWJT)U9\$Y
M+_R20NQ(=NT;+W%'_G.\OL(!:"+!>(SF\Z,:#S@.UTDIMK/.M@SSCC7JK=>K
MZ5YP3STKLE!T)6O^D+MS1T@"^0L"2@73(V@PYBG7;S(G#CA((J,[5D*>+!EJ
M&B3O=+;8V9&-.HK"XIC%C'X[26Y+FJ!@=>%E/^=/P8DK^@;:%XHIY59+^Y"]
MTU9"]TTM*Y85JG[3_VZ#GC!5& ]8/Z5U!F%,\[G\6&F1,0W*)8)3[U2%U-,A
ML@3$\^ZD?/I\>KJL48?>J7*X0JLY!C97/ZZ"N4QH?3."ALJ-J%#X\$C$6,II
MNUS9F:9"ZS]BWR[Q7%!, ?_4QK>".D#UR=W$9$.!_7=8R979D\TTT;5YOU+[
M94)U.$NJ"=?*\%D]8^%EK7,F;"HPY>U%M_;4.'%L)C49#XM'B8.\#CAX$&"J
M8AL[-'=#2*!PI,+@3\-+@Z5#E1N!\ZHYYY=?3U^ Y19>V7 3^*']U]1*U;+X
MLWG@\AC!*^!4MW:1W7C)SMC/_7NT)4HRU0%Y$F%.6_IVP"$*]^]J'NCHX[H_
M6EVWKVT33BO(Z)\U3U$5F36%1WR!+G%5ZZ!UJ=V4,C\8*5>&#.K4"SMB3"WI
M[K!0D_(63:SLE&)J!YFH^S8(EC=.QOB8!0QS#*6(S$R/DQ1?&HHC?X$%,8$'
M'-RJ$209X3;#6JI9%U9BM I$X@0?_Y,AGOM3! TKGOS0F!1\TZKI_E*VVW/<
M5W_&G&$78$/U(,O@#S@$_PQI1^P\'-[AGWPQW"$V6C=9=<[96R\<YYI)N5)8
MTOYY9@%[1E62[ZMF\><Z<CUJ?,Z#U]FA570'V 4YLY$5-L5%#]NOQ' 5P ?8
M0!1;U\NH@IC5C[D-SF,;\JT_QRU>^WUEYL;1+V>*8W[4_#AYLZDKQ*X5CNJ2
M%J ]R]*J)SG;#MC4-F:'>GG4Y2K$*C3X2P[6GCNK[UM97;Q@?^H?$]3EQCR5
M4?:;B!/:<]&4)BKLFR,V8G[@5;-!Z2M]NP+O;.4]E?Z/>YV1#?GGCWV-DZE?
M&[7^\2"=IP+J]_ZWW;)B)VYBGHQ["9I+E#Z[GXSD[I'?31)JLR%\_]7SQ=GL
M01-GF!GD-V(W%3/G-I>E<VWQ2T5DN/?0%U_"]@;@P.SS)"]=:.FBF.X%#ENU
MSB"2_3_O8PW%X4OT=JK'VC(5#*9N)&A @V[2.$O+O77O%IW>FGCT9\BA\.:L
M<5(LYE'38^!)G6MK*)1(26<HJ;W&V,U+\9-EHG9R8$<)K6-US<@JKW_HWA\H
M#N&WC>^L:9U]4[UX]B2$YM^N/8;4WR_3YZ-YT)WW\Q W2/'\W$Q%VHLTS:0F
M4FR=A,Z.2H.E1[&%<HT"54SZ\D]>'REFPW-YGCG4$98@$P*TT&I-Q_@C,$;"
MCL1VF=/P(*?Z%JHR4H!*SRV[H[S0.$1)J1IR$)%XV2;7E.TY\?$Q(O8E&S=:
MP!9JHZR8'E=O%<'6V=P&)P0QB_&7BJ-3]M,-%5C]!!D*B&UQ_9$%@)-]?5VV
MPXZE=?^ATND9IVX_NEZ3_KRPW7VY.+D8[(+A]#BVEW;$9 PK9D53)[72<]$.
MYJ6]8:73W2'A[7\NB1C1B[<$GC[5><MYXNH_?N!^7"0"0LY5HZOOO\?* #:D
M9RVD3PAM*&?T//0I+#I(%]M8Z+WW(NVHWEJE0CWL\FS?.XE[]J6Q-RF/+1 X
M]P..-CU#280-E:V+M;M0O)@G'U8)[MN.R4GGA^IFO-N4ZX4\ H.#Y!OW-#%>
MQZ_&:E^:^O Z8__79)WMP\\U<<^MJJH6T'^1"G5^_N_?BC.T<7GY2T#(U ;Z
M)'(4=:(.]3I/BK;1?<!Q&F[3%I)4462_,OZ/(0ZB\M8BQ- VBD*0S^;\IU>X
M[:9Y<J;F'VF#_4*0QP%'I./=-#3S'FT\&J/]!'U*HS?7QJ:A-FK[\]%@?HVX
M+[\ORS[1%U@%Q\G4!*UE!58SO8!SH30&"=/HB(K&/</Q_WF.;2VN-7*OB!U4
M59&@"%#BUHSMS07P!3R'+ULB(C\RE6FE[<2)W;GH^ VFRGR5.ID8@>$J]PP)
M2QQXM:[_L'!%9-A%QU+B?MT5C;'4[V>CW3JK&MJGOZ^FB^[<]K6U9N7NAP:O
MFXU?^N3<7;H ,QGO==TSHW9W3<438U"GZO+/:$5\!,!MOY8;M9HK'7_:]%.=
MI\064_>(WF&1LMWK6;_]-%"88]<[$9T,8_8',#<\!I>=PQQP_%OV!'P&L""+
ME$ J_FC9."P3.ELW,B$5W@W- ;67Z],GCG=VW0"I4@^MQC&3]DL14K3[+ [D
M*%8'P,VUH'FF@>H.DGY#,^+%VMC5E1<TA]C*JJ\\H<*BX#^;;4?4?WS X_2J
M@G<3]&7G9 A<I.XNE1,==W3'.]5BLC<Z*%:V5)?\N3ZGF_;Z!B7>=*W-OM,-
M18<'_(4N!&&RS#(*'EP^=$2B-*(T\"(TL('X[( CAX'YN3+O+4>26IMMV5!R
M6G>69CFR%3=.&.0+FXP@H==VY]4(CN-=NJ!8?;VY>*<L]-W$3X09]>FIHFNU
MID+'6:-*JM_)'M;]UZO#9::TZ7?!')Y@H?KD6!>180VP0+Z250MFS(<4%3S"
M1^V6M:Q92/AL9_ST 16R*4JOW'^#L"B##]/KJ* V6'3?R<1YF8AL_9 '(KI!
M:4]0U9-2#P7UGI^Z.7Z_Z^F]3T&?W/JO*OT$>3H1#\-SOK$. _M4I6^S^M2-
M) U^KMD_>\C\0"IAP^[7CMF[KG%QR_V(*6[H0C;\ 4_=Y7.F3^53GA?*1I;*
M5<[B?N<OC0S!?]3X+K.S7X\&I='"$V61L2NRFT&;(=SZTGDIVNRFF(.]VRFS
MHP*_1D:79+A@3+MRQ'EJ=>E\G[C,24BFKD%"<U*:KY')DQ?4@NR9XW.5J@["
M29?K_^PL:7JX#M]=(9D(6Y_YO\1T<.$!QW<M$""ZI=DV_G_?:!0_L+Q]H?!#
M41JM.QG!0^UNWT5> ]*K[.&A)I_O[>I&E?I+E51>NL71HUSYZ4,JI[GD>)8W
MJMYLK:.0>;46&*U$F%%;2R,"Q8YJ96\3.HM#W#8%32?6L^_S-#Q(4$IKVT:_
M!LV5YG&-;S!A5-EYD::Y?3.R3$=^-$NU:01C1Z)<ZMFQ2%7\G#?;Q;3_X-'D
M))$E8FIL%L@54D;PV\3A^2Q(VZAZ[0[^*=%[P$5R_$"$B(L4S3 66F(VMYJ!
M&60:H4)A('IE]J7KOAD&-X\OQ/H:#N 4=U\9A8=Z/2FZ4!I4Q::+Y97^$Q-E
MIM9Q%A8P9,/X('C#F7]X(X98[Y8GN?\1R<64H#ZP%>]_1?,EXK55RDVTLP55
MSO<K?7*9*5+0=D#\%/D-;3O] ]DKTV@6SE)DX;&G]]$XSU:[FT"H%UJB^&L&
M:T]/Q5#L7$O>C+!EP,I5LO)<@WF_TJ83W0H0I>60K#HW)AN[D;)4K482^KC5
M?'*<-L$ESL<]A:E2!.0B^A2&-J\]'.NS5Y*J?'A.52#N\WFL"Y78!B:HM>6S
M49(=7L7AR1VS%X8#^*-4YL.X\&-C+$'8*; G(7=_&0+96,LBO6AZ1>(_TQRN
MHU_W)EU.S\YN]*+&A_R! XXC.[,]DCCG\IR<Y-[&MN7Z*08+/&H6C_.T>HGB
M9\E,,AUH2TGZH$*XW7V!'$NV/]HT- PO"?$-OEN72WD:MOJ#XIKR'<WY^8 C
M_#7R1W8IQ<B+H>@UJS;D03M9\(&PVN!O]HF@6?^]-;,WG'!>@2C_,\;6+?'>
M>F1ZV[E(I"+B,L!7A.P%"QGR(9[3B!$(+YK2'"4C<?Z",K1:_]P_XRRQ\<"^
MAVK'>CU/M0]/.0V<Z.,]IM(3*V9TE%=I!<V[S.*DHIC"4]_ DD4 J/J/(1]M
MO(-/NV-/PHQD[E<,$6FN3'I#-(/R1EBZU:=>E<OI-4X\KEQP7$Q?7C/,:7#J
M8QEE=32[TMW!R;C>;K7(B5X_D[F=/(*>;)S?1+A2%>)!B4O4]=QYE=L_YN_G
M&_^J_Q[X=:A?J4PE UZ:^%3=^#;'T/'PXI*B'G>V(9UFC>37JKW<=H() O-D
MM2@-J"Z=#M6:76'8U36$0Z8\KO3Y)LL5.'I."\/;E"LO7]=DKL#-2$$4*\9%
M9'M^[0;%GQI-&HC1A,7F\ZL@'I*JG-I_>=6BO!\MYYW/HU"84T_S?'O#;BI)
M1*2WM_?OZU2#NL$UHGCTI"AY*5R#7](([9UW)(?D7!KY<2P Q,4O^3=D:V;:
M&<)M\"&*#/$KL_)?"BN0Q5>]?O:74VGEP70^KF0FLRAHX_<8(V5GI?P$=>S'
MQJB287QSJ&/W=B/#A&E#TVX'ASLVXC<X'#WWJ@O<Z3;0DXT5"O&EMU45D\Z[
M80/2S_^5_.)^<O=$Q+%7%5C%_6*<!_@HD 3B@@]TSTH.:0:C37.D$M<KH+#G
MNU7BMU7PUK<D?[AF: N\:G&M<.7E9G[9+T-YY(O\05&-<V"3XR3G_!BF,^JC
MIXM([>>&EL]O5I^W0<*>DI[5):@7?VZ/_GG]Y+=H_<.0113!AJ[3"D23\H$+
MVO'U,E'JJX;R- U;U_:@Q"+,;G/T!-/ 8X%/UTJY1ZL7__CH4=;?V_NDN!\9
MXF\S6U6KD%><F5-:57$5HNO=A:C7.9/!\FQIQ( QO)"]V=V4E##&^4>KXD^!
MW1M#4,WCV:$5US<4BN3Q4'=?7FQPLW&C8-^I&S'%B4T#TJ_0K!'<,<5A?5@)
M4Y.&BF::D=%'O1HS&_=4\DJ.]<U4$(JTIMZ=3RF)\3UT=^&H4%+]WRL5@&@G
M5HCM,^% FM,(YER%$P1T&BGD&6(7K?\06C#MXN0 SQNM/Y9;O3X7V?GVNV(L
MP3SA\8>NM9=*9/Z)9+HC#5E0P);79DEU1 EX$%FM?8 ;B+B58YKYK:QD&>8?
M7-+GH6N![CP5M2>1]=Z*)WA3?^A3RDN?>L_/;[,7%R?5>L'IVZSZWM7T!TW!
M0;#>ZGP]O;_YU<2CN+D"T"FLTFK^B6TOC$&)$PZO%GZ5:9/SLSD4_F%$H&['
M":S3$4,9F)((J*S\(2PI;1+F7H(<!Q_7EZ&&MH$$0%YH4<#HFWAT@L8JY&O!
M5QI?D7V?QF!E0D;0\[J+06=FM7K$26_#KYW-[SC@F-SZ1A1:@X(\5F?,VO+D
MZVT8EU?SCF1Y#*)E0ZU.321>:\W]47>C:H;5K9WJ?J(V_?#5J4R0)##>,:M
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M]U-34-:OBRSTX_&O6[I_PVA]R%5X(UT0N$)&34:WH;Z4)':5%O[)YW?_Y1O
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MHLK[RPI6*O^>E_XY]X_.TV:\(NU#9,V:\*$+'$&2=3F-&7UA%L7(GR ND,\
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M[?%Y\SD^SCE'+Y.CF;X_,V<=WN9DNOA4#KF4M PP^A#LJ/"II\?0F#9%-8O
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M-PDM*5V/[8(18HTIZZN%$+(UQ?U'R(YUTY!RH*&8N*B")B?L&L+V+*$O&;W
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MB^XV+P_WET;+ME+G;]XJIXQ,U2?'7Z?E/CV;VLL\SL8=+[8YAY&\N.E<=SD
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MD]9K+)7VE6!Y\VVU2I'']STH.CP_SV#K]W6[V6B[>97 4:)7 WU[V3^X-76
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M_&B7/*?4;.:WH:E-<CA6'&K%7+>^*/NVR[Z^\@1MA!'<T!R&Q9IM-U+IM$1
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MF*,(< :  )R/%C?@-8 +P/^P!)!^[,Y_+?U5R;]:!]+#5P N^I-HE$5D)%S
M$UPD9%RDAQX U>,I/7GR!!D)Z3_Z'0W]Z3-4#&24YT_^(CCC  !/GSP6H[W
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M)2O)'!GGC<B^@@A%FQ\5[M+24J\8S?[)?S.@_)O!9/$K+O"&]9CJ-J$YB$<
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MX+]9<\)3[*0W/"-KQ'Z<V\=_EY8B37N1_(Y'=)YF-UFKF;5*G#EJ/0 2[A\
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M)6WO[CH.-%+G5#FG3S9<"0DX#1K5,=B%M\N)IIL+U-2C#7+9$;AK[^:K5&;
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MS?=2J].V]A1D;710(J26&DAYM#LY_$Q'@:,KE8(>S[XW[;:9#/NY=-.F9YL
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M>599 X%!L2-P:<:_*<],;<!^AU*P7>S/4>5DQE%L?S_=G]7?:'T ^'W+H)K
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MYJ0!6MBKD\6:%KH.5O=W9L*T AM*81]MIJ9>/4^,5 +;Z@5:SAOWNK-1?$Q
MZ A'ZM$3O$AX]_S/.RM<E(N[^2F\;D-</N.F'"<('7B_##'24\H<J-:NFH"R
MY4 I@,@&LPRX"X?+*P<U0W-D;S">P_QC.HC'),3A4O9C[?SEN0<Z+U$IQ[.5
MR !FZM#5D=^L(=3!-D+R4O@AP3O]S"1U(L$.S^&)H7;T0P8+\&(#L(XOT&X=
MX/&07-OD'D?JFMR1+53ZA2./43TS@R,J--:(26_LMIGL:#!AG"VUV2%8IS%P
MFT8QK611T@ZEYM_6R=VK[D(&>%+(&\;J:^Z<"4)6VG-99,4@DJP*!&]-G2%6
M#D%G8P2>D9R&$R]Y*"(+'(XL(]R[@I"M;3(@>07C )@8N&>OH9XWD /*4H.G
MN.4R,:QB ^:$@+&ODY,SBM<BT0<(W9(S4MGIL??5'S[%E2<)6Q[E"\RL6$"!
M]\M3F%(ID(+)NQNO=VP,E1QJTVD\?A7.L-AX-.D7)>(6EX['"BKK<-8D/%:V
M^H31L)5?C^M/3A<#53<(#X0^?HN'F@F./SEO!;C3Q8_:48#N\[QP.,LO68'=
M.(0>+NFVS#_R>RW(O^@%/#ILEJOK?N;O7O\PECO&;/ZA%$R2+,_'T&?4/NU]
M0QDEE$3DHX_X!W;=^*IA6<JQ"0DCT?3UQ9\%,F5IMZP:\S^*0*6KGNWHS7'(
M5I6M_A(=$5OA473OR6DRZ"PS29+/8$A7TPK"RBJQ+DAGZAD'!IW.-58*"^]I
M'EY+;L-N;,??!EP3V>X]*&*(F)P- (SVTY:GTN:OS#+B$XC'ZT]3:RTG\$?J
MT>X.U<&G'_U]#1&M4RHV@FU?(.)-75H2C5ZBE#8:>JTR0 UX;C(C.1J8'0HI
MK;LP&#)$E6_C!,>F!H:;3K&!3D"KDS!]8+8$Z@;YSC;"V0]3L$S6-24S[F0K
M3?QPSI'V;?[ K+ZP>9[_(<\SP3&T#F^6A,_)41:#W!IY.-EPBVL3DGD]$B5P
MO, O(F"1.Q!@Y[+9+,V(E,& >$',A_4_8;AMZI:=BH2.E/@/?<(OB8)Y5W#F
M)PD1-M(BSMZ>#FO':M>@LI-Z>3'\QW<=<AM 58>7ISFKX$4F0#)JJ>1(0\Y3
MR]%=<]S=NOO[#MX-<''PUS'1:?Q<EF>P8&;D83SRZ:"G6AQ7-T@, XRKZ/2-
MW_FQ+1OJ-11%H[80P)J:;@BC# C*/^D%RGT.83M1BYT*=4J3\5%D:!SN3CP>
MF@PTG*^'2]_)XV2< \<R784_B'E:?:#[OL5(U$[3YK5%OT:5>#I5K7^\TH6E
MP8WI:H% 593>=1ZQH0JLW0_)K%4%DJ59"\SSMV3H@7+4]4R=*5W!I'Y1 TC?
M9"4![G:WZGDL64T5^X1PZ4BGMP&%1M2Q)MX;[!Q<M\X^\^!$1;WY4)KUD5L+
M5^>ZV?"GU(##< /@*P+MAI[!)R>J*Q^52\9X;/F.6"HI+%<@IU(F?RNK0]K+
M78),KHZ?-#CHF:(07!#E7GAGK^W["P'R5:=:6D\J$!TN W_QY6#3DCB^XZ"
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M(LO=0GN?Q;G*9G$ [G38#]72UMEE!EH2=NV=/Z^7D-N Q%H[^UE^9LYX?_H
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MMM71R^!*3U>&>B;D3^ZIC@;RPLK2;IV[BR(12=E+^+W=HL;N<XF\&-U!IWM
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MXFXQ0#J_L@6,6[N&9R.45;H8^C1M]^YQM,N+W(1AYH$"49$W@[%;'#_<)F+
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MX&*TODVR]/PJ[&)MYILW&[8%?QK/,JYZW"!3I;A2.R'V" OJ3>QP5:$@5_?
M8:G6SX/S:1ZB2J,!FOD%LW*W6H9WE1KMO3/G!/ <U>G7E>6OCJ!C_:*Q(_1<
MU</$2O$7I)NV"&^NK]S0&FRJUV7NY?I59TV_?'XL8%75A]GR-.4KFR%0#RN5
M<Z^MIN5?NC#OC5D9ZB(&H[IB(D*C!3UC6LMCRQ6.?@39]8,BU5>[#.P/#\SE
M^B%BU9U:>"IE$-[6\@\3W@@QDHMEF''4D;VT%::7C]'7JN9%2YXYYR)N61QS
M=:D[8D(._NJ$OT\8USRCOPN9G*]5"\73LEHKA@%W:2%5:1^DSGFJ#ZGH[2<L
M,(+,+L8U4?H$*:6V#:O3S^-:^/ \4Y@-7QG4[DU5Y6H36(3U9Q2QMQD9?TXW
M(],7T(AOR=_Z,JQ,LJ=88RM$Z0,G/!LV7U 02J^R_(R%#WG)]IGLYZNCD'UA
MSTOY -I=E.74AY6R4H]57 SN(/B6HB7_NV&":2O=+)?IWI*G>LYH=C_/[50>
MLUT'ZU/P*L^9^Y-?T!UC4062*KOT.<[,?A<88XW M7XCE#&*)CE;VFY]>#>#
M6)Y.@^<S8J*R/'>F:$(O+@I3;*8%VB+KN%UR((\YM.W+$S2;T54I-&]E+#KA
M?$<P^C/OW%LLH)37$O%9$##>01,.+U28M<,0+"\0$G3'I<TM1)K(6QKCVTK+
M^O0O-L8?RKJ3[EI./V949.5G\0@?0WBH<B?!^DN>9?9&FU7SL?LE=D@)#FI>
M4; >J>V:2S"^4YB:5_E8B28=@3,5H7US^GHGH2AGH!1<)JT*85WZ99HEG>7#
MT 0Y-1X7I:7_[-?O84R-.9. \J%A=(K2L+)4E[^'D([-A9Z9]OF,95DK_=)D
M3W<#+F3MV_'+6LDT[R>&DM? ZJB&A3CC&6B%G.4O&7[KMV2,&:>O_+PUXYC^
MTM&ULSO)>]HR(Q^_;Z#R/L8=4IN;162\R2VS_QF<P:KHWYHZ^<AFJO4/EF#'
M?J^8YBN%*\9PCB$D^;[5 ?0#GW)PY5+CFDJ[;_4TR5-4NVKWH3BLGU<ZHC&G
M^<$5*L]P=X[Z?5T?V#!\>!W'A%8(%6+%T$B4QSDA;EL%9QYY/@](GDE>5.6+
MK0KM,];-MN#(9FJ"MPEXD7MR"W@5/&QO<[D,.G2I_T(47_IQNG+0J@!/ILM0
M!*T,9&.,7F%>-Y^)K=BS_V3!?9=V3>(^UU)#G Z33NZ2W7IK,.ZOBJIBHF2X
M)7MN::&7>@#F<M,AR*47S:?0@8M(+G\7Q2J-IS\1>2$]L;L? PN\-FHAO01=
M6+Z=K?B#->@7T^186_-[*? W)YNQ9,&P&O^B"B0>P,'=PN3A*UG,_U;'I=)%
ML)FC3H)#?."$I:SB76F5(%[8XW"*FC1>HETQ.['U[YACX_!'SV9-?$HQCJ[K
MC]J [/8^_8%^7GT2ME@S=43&48V@$)+WWL2M3V@+,-9@_PEA_RSYQ"R*O+?M
M;;('.HYH%H70#4X\#^G>3IQA,Y$:@@7ZGZBQ#'T[KBQ+:58$BPTK,6RP>EO?
M80+7>3:(CZ\:S4!0-*C9J+SG35;_)#T4\[FVF3U5\)7"C\*=O!Z6FGA[O]*6
M@+0*N_D\]\NY(CA01SOKPRS#)+@9H"NMH<"S&&F-W< 27#M'?C./H <J'P0J
MPI9/J2D(91IMLXCUJJL=9K]-$RSY(B3>:YJ;886A&SU4A?2FDR?K?*Q!#(N6
M>M,<A\06N=V%D-D?U.PZ&HJ3(UM/Y6X>D[EHO%!,$TG*L<C;):*-2X(.DU?A
MYS8["0D&5<E+=#;'^KB/$ -JO/O&P O2#)D#4+36F%JD-)!!JR;TJ0<_K0/.
M"^?;RH'.]R@AWG#1X>\MX"S*"N=]BB4%GFC"F.?.=7>D&P>%C7--";*>Z$.G
M2GI=+EL^29=R,Z+&&S"B7/G58\L$5D!S"J]9FCSS!?WD:<[QADCO9V1.T:&]
M4AR/$@G&.979P<E-.4AAF=12QS7;0;L0$\#JH!P7S@=2F=(_U@!.1ZEPAN)"
M>:>96@4K=M*U)*.=6UL,5<E4SC_QX5$@1D1W2R>Y'>QY%+EA=V7"3SGQ$2V,
MG/P87"OZ:NY&Q=_EKJ!!^$$+Z;)="7HV[6/ 6Q'KVO.^BX_GZLIK"8]>?MSX
M0,<2O<@P 9#-7<I6XP*(X P8E0*#'8[M-W-P\K9WY\GUK:1XK00M"5SH,;:N
M6I2L$,HD=673SQ!P'4XD)W;>0OYPX+N9?;2 P-&)SM.5V"B7E>"#J^GIVT>$
M*.Y5B)4,6Q*1(G%&)-\[SQZ=G[X),[RP0FCC(/RA\N5G?-_!::R+M&BYQ4-:
M#=N6>IYW"%_S(6X!%AM<*QOKQA=1?>N#?A=Y^0+KCB5;2V677 &&CS5FLZ-4
M1%ZY6=::0QX]2+T(]E-BS=&=VD$#JI ][0<**\K$0QF/S1#6+*A*2W?:UW@(
ME1."J@L"[\_;ESIQIFT:< <B@*P#30?E(]9]<?638:8X^<,4B(/NL@Y\D-8"
M%+4>72C/RB_</T?C[ER)G1:E5C.*J \- W:2Y.;I-(_<J=^ LJN%91IRU?1A
MXJ8QUQ6V\PV\/$*Z(Z&Z7TG;,K/48Q?JZO-WW.YJ6_+T954D-6/AYEPS5J;%
M(;"6EM W,;9:3G8N[QPXL1IU(K0),PSFSZ1R2S&CYN7F#1>Y&L+'9(0_;VDD
M986HSI\P=X,)KKLYFZ!,S+)3C4RVLN=\/@:+*R'#K]3):-3-@#UEK93-=_;3
M:!BL9GS(#Z3*186.9/=K6+?!8UTUN3%UZ8O6#$J@9*<Z@,"&#V*X<-W\# S\
MWY(+U+<9)#E8&_(_;3?,1"'LQ<UJP87[+I!!G&-:03G?E&G.^<)-%#'9(Q-T
M@R+X>\DZI1#$1+]!\;:_N:<NJ:%&=^EYI#PC&W_+\!/?P=K3>0MFZ""D/3<3
MIJ Q) 2A7RB< N3T#]<(\LZ,^^F[0/N0Y0RA!@L* N&PWGKQ:;+$C5"7)0-2
M*';]3;G;G*B'J>EDML_F2I21MLPU9:L)&J7-9>BH)EO;K*YVN=Z78K(:4VTT
MCBY;J!?W?G>Q7!NVZT?AUH!VJ^#A6WK@D$,$-E55BH,8Q";*7F]<S-&="ZX9
M4:<61=2U;+UV/.HJ95+D_#BT=AH+6CR0DH)[Y/DW-ZKSS["]:#ON:Z8H?FWT
M9'907F.$UM!'N9?4CKN2V6C[Q.6-OCNW3ZU-,XR6EJG3Q4<7+<[%[[:OTR3Z
M4T9N26NKE@+7.G.L]#P#7KVOL$SHH*KRX9<(15:QO=,@.$.'M;\5KL^\)9]8
M.S 7[2_^GM7!S%:<X??M*XUD1#\MF9)&LMF/BM>HP5.4;S:R#^4&M3T!06@U
MN,4L"6Y00F8-;@X/GN6U1$8*XU1X)??4(\L]U9(RRC!SPF9H!^UT\J:U'''*
MJO#O\877LQ7M;)Z O%VZ"/H!ANI:]_"&39KQVEO50!%,;-EC57328(^!G6&Y
MZZ-=L>=KYB]5:>*U&B2POX_N+XODJ]K]J&\9CQK.1!*,<0]XNQ9),.6H-M^/
MKK-Z4#RBM25?2O%%C><H@]Z#2X2E9$0TNHR[U(=5X0L!E>5=Q+\*EH25,ZGG
MP\UVIC5BXM.KO'3TF[%W#72,),\6#5,\3:J\;HRV=CZL#L=S%-W;5_D>6H#!
MZIOA=IB+O*^1@QM:%_K7K"FM2EPZ#?A3;0@ZBB7'E!;10G'9D^F!PL=>\),?
M^FQ: X1J$1+IVUD-RCK-?GY*M"=U52/:/;#ZUDXNF>IS7PJX!W^59JBVB1\O
ML(+9"U7O\\E=3RSK:C9+RY1\M!I9W@:MJT):5.V36U3%#QFB">(E/*P,+XZ"
M?QE*WM3:]V_;>[R6?ZBHP74EK"X&EUZ2714NZ!<NPP_FGD68DN"]'AI>C1X0
M$2I].K^1S- ;)JTBGZ<E)Q^;F$(7&Z-[$(BGU(TIS8Z;<:I,8=92W+FDI>)[
MBCXXLQ>Q%&XF;@D5)IOCC5FB"(#D3?B<S=MLN4CQ-V#.:61L>T4()0CO7I*'
MR1'L]?69J'2'Q.>5_'<=6JF<3PH$I) U=_G8':JHSN47*RSE<PG?+6MIKO^9
M!XU-1S5YYH;.K68!;A 0[/'1LT!Z'*YGG'QX?TC@%/CQ;6U39QK[_92P.V '
MB!8J*%L(&*Z3%T)0#,@*ZPL]CI;+I./^;6<1MW>LSOW004[K=-3=U.PF6F'E
MK7:4OGV4[2:'W&\U<)-..K,_GO$/6J H;Q;R\9'1PK/I^#H>TY+*%ZKE0=!)
M?$##QBW0X^[RW<S,1^J!*VGA-@RF:J)F&PL1$X)SEM,< 8QDLEQPI%Z!]1C=
M*QOZQ'U ');%M]B-TA?2'/W!<NJ-[B(A\UMBVN<=$V!!)I\RIJZ2A@CS?\Q>
MMN#5L!'A8-RU>*(J'PU<E4YU,6,Y.W[#,@$:F1%T=4'X]?;7'MBN[8&_DBO<
M9 C.#L5H^<Y61"L<XY@UNIQ/3X-[?AS5'KO%L@U6@- ;T2-;5K[B;F!MZ#XH
M1]MP\=&&JKDQ7S+^"FLI315D'H>AHU!D$SH[^B@#%!>G!RCUB /(F3Q[ XW=
MAY!_,]I.P4WA2,Z(>= 5>>X%>./416G4S,F8K_XLO;SIGB6\L  JQ=+DM3<]
M4S[AD^:N".4=>4#@ ?Y6#PGJ:Y[]EAPZVNA! \M[B_-)J05V0FX+5VL))XH]
MFWZFF:CK""JMMF 6.*J*?/ ]VV3''$VB/*7@:L<]5&G>!K8;8UX@JP=OE8\Q
MT;69]:3,Q%1'%L2:I+%PL9Y-V@C:7F10G:;8+6A@4!%K_Q=S;_G5!N-TB](B
M;:'00G$MQ=V*2Z&X:P($*002) 1/D )/"\6MN+?%(<$AP=V]N 4H7MR=]CF_
M]WPZZZYS[UWKKG7O>_^"^32S9_;,WO/UP:A"=PJV2.6_;+;1QO**C:*OEH7U
M56E/.[.S<8[]D1'V>459S*?8OE_G,F3-T$A7I6/OX?[A<MA O\_NV;/AD"=K
M-@Q/JK5J1)L:G]A5TR1>[\\0U;)E0O#1%PIBJJ;^#MB9HE%5VVJ^%.D8_4,
M*O)S*:Q.P'$WS.3KR&H 7-XX^4<%>WKJ-BBEH3_Y^DHU"=5SI+7(8MST!S32
MC)&7>6 0J*4]5VL!M([T<XRVR-@(.(0'*VY+X X][\M1%U,\^9J5%#EBAOD*
M3>A!1B9'B00-PYC@BL#WH,[Q+MR)[)6G2%O+Q<X1MAU9T[$[1Y4\Y*I)JLH6
M/<!P7+\MBRP:*RY?KZ(\X)?(@GO']!HZS!CF;[JZ'"0,6+LZR#./"UF(.;I
M]$(89!,'99#,W_4P$,0&IY99.+D%"UN;8,WDL5++(?C)T[)CMY>Y*"HQ$3?8
M42W##./H^T/Z9O[!6OJA92\F48_FE:C=IQDD&BOUXFD0$W2:*)8!8$+F*7*F
M!5R'Y[8=-O8U='-<"-R31"DR8RXRNJ["N>_YY:O_Y#;V4GV/,8?JQ>N5;.GW
M#-6:$FO%[G+J<F=%Q/N^#C7?</"@[<=_Q9R]!!ONQ@ZG"4^755S5B)"J&W@
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MWX0P60\+MA.-*"#6RR6,K)Q-L,629OD%&-Z\BTZ\QW0:KY;5FQ:]3JM/B1(
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MNEI/:VJ=B^YNSLM3NX9'J7MQ*.%#-2 #"_FK%4 [I8B%JHJS,S/TA==A;$D
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M75T"WXC+=O>ZX($;F9K/^L!P$G')M@-E6C:H:HU>[]F\O=.\N6_($RXFP5Z
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MT$LB?\MS.A[D[".PUZG ;0>PI9&0=&F&'O=<H7^OA*9)WM$ ;LF*XKHK;U!
MJ>F/E^8E&V\3]=$-:N_5FRQ?@LV*L4*-Y]WNQH&=\VB>>;>Z>4=0.UHJU7K:
M!U.WJ2 _?;Z-GY=/1(#*B0C$LKD/=7OB<8'Q=27=_Y=,^[^2VUA(U'RRK.)1
M_>"D2L]Y\BS+59?"MW:7L<0%J3S8RR.$[]$M.L9^@9HJL@QU-HX K;2* GZ;
M<)FEAPPO&@;.SYD&R<<"9B1Y#Y1K>>;CQAV#GQ&\5'ZL1$#!V<[&G(URZ1\H
M=RWZ'^R]951<S;8NW DD)$ (">[! XT$"(U#(+A;-ZZ-:[#&(4&#NSL)KMW0
MN+L3W"TX-"2XP\W^]M[GG'%_W6_<.^[9YYYWC/5KU9C/FL]<LVI6U9IKUM2Z
MJ1T/A,Q_X<#OV1/I-R6  5' L)?%BJP>;,R3<JUJU=;6/M;RM/[R^J ;JG:(
M$W^F>JCCRE0,"^9#GS:T/GPV]4WPK KZW#RZI0#L[Y3)]TU6G^3017^'RT6;
M WYH)IY?303H[V6DEEFA3F"N"%K]S+P4\XRE\;59FLRA*Y9T*Y F00.QK_NC
MVR"1C>MH@43KH+JEZ[6=H%[[SR7_VJ"/8R_S;IRN9<18H8?LA91XK71Z6V.5
M^:Z,)B6?'*@-/,ELB,-'MBJ;< Z?,@Z#]"*W4_@(1GF=8@X+]-Y:\RWDJ :X
MEE/!:4/(+EKNV88O5E:6#07B?Z"%/7TZ0LPK=):&^K*!LW12&U5K6W-1DS*<
M,LY>8-MJP]ZPW3!%YIS5U)+&$,/\D3Y3:I;^Y7961[<B@M?&0W4&%P99;6Q@
M=Q_^R"@H#2F$Y(IVYEM-'MN\=Y4H78>6L_*-5.=B_L#/6ZY&,RR"3D^_59EM
M%/D,>-YK5#U',;R3PL>:!'MBZ]2JTH?8D*/R'A22,9[LC@K8*)AXSC"BDY*!
M8E>(8)AW)U.O.?E&FL_Y]NZ37WXDNQ)3ID1<SZHMVPA[!,L0"_RY'!::2IF=
MXLA3:ICLI$[[<_SDJ8Y[;8%GO&$O=:;>O2KI&K2*^<6'\\)Y5G\++&EN#70U
M'"AI2&26WJQEFP/9!>99$;+6NX59YV&%!VBY&#%!S-7%B[LD?@XMO%-NHQ2L
M.U<R'$DGU31#KA7Z& W+G%WTX".FE,UVY<\RY$J+2&/!>+2>*5RR:=M*2N3)
M&4QF9<ZQQ>\VI'_4I"R <B2C@TNTLWP]OJW(._&2=I?IL1 BGKU-X+95K;"<
M97X1PHH*H=^C3/PDF;8<^JX^[ 70=$"[313G/"_,B<=P$1G\Z7$6.H#.IOI"
M][C9VC9QJQ&UE/#"#BRA-^QEE^'P\\Q-C _HKO*+B#?NZ#7L0%6>SN12ZRAP
M^(3]V85\^A4W#?9X^UZBO8>!__0#@+N_:6-)0[$"YZ<U_=7I==B"-N7;O<R7
M\ /;[3,NC):CDP:J;<UJ;"O6/;U5Y2>A>,%J^4N)LWS\7)?Z@W!8U>/PUO_L
M%>?_:R?(>OG:4UDYASHW=)=G$WZWD@^57\T<"BF-JU3\669[Z,[;+I"+KP0D
MB?!4MR*_.</"[.6FV ]%QV%A8.H?Q F6]^9V?#;%U(+R!'(7Y;9%@<,'>Y:G
M/[1_$ KLB+A@OG%(%5+AYNG!D&T)=53MA@=)F'75(%\,E'<[YH50Y&!1U 6)
MN;]0<AZ:?-$6"+DQK6?["L3TM>4A2$Y 'O"]J<AWB7!5;>I=,FG"+Q[TVQA;
MZYEZ3>3?#]ML1N-"="EXF1S$537LZGQYZT'AI#IAVZHT@;\25[!;AIQC<M%8
MBBXOFI-8K'LG\42&);MFL%L"ZN,D.L'-7#B)!!%?-D3FIXV%GNI$27)]TX*W
MQ*9/-F;JBG%@-3HZ63_9YO>Q,%=MUEW0"3I LMB*>E6 $CUR?1$O/G%/QUYY
MU*H_+YUQ6R9HT-@; ?T82"Y*"+ LMUS,5-CHH4&\C3M13V_"7RNUNF;PR8@(
MBY+,33)49>JP#N(M97H//!O01W5-*0Z I8)<::%SF6'?]AM\\N*28GQ23ZV(
MR*H2XZ)M69Y^U/CQ,DH[FW"E\?%]FVT]+50]PX//A88! WY*KG@R5<,,M/TS
M<"59$HR"@.E3D>]66#\R19K]V+!Y7IE7DKB5G&["87S\(8E>WC8$3^[8VMN+
M@_[L,$Y\WW!S+B3SR@-&_(W\CM[*D[1*+SVI=.')XN^J:A1*P2N&9X;'B72U
M0 "GJ5F(@YMEPD?*]L!QN@8++\Q9_37L]SX*/?>1/8:/P&NKW0P^?_O#KRCR
MITI/!_PF7TC)E(7-&V30H6M'E:2LU=(IP ^:<]!EU%6T7=)'O^UG@%F3N)D/
M-UN2Y=R;8L.>7,-FF&NEIRH/RY=O)Y%XZ20$./Q/:TE[)*&&E:_&/F5#.HW3
M:BT78 TOIJSY)6U!:LL>9JGO9!MY^QP33-7+BY&D?4(F+ JAKCAN&<%,(GE;
MT?/S2E1SD!)54?T^?-VTYW0UM"0SAP@I5>5>RE?T\@EXYZJ\Z6KO*]S,)+TR
M4YIJQ7G71@03-^P%3Z((S@[4J-2]&'KEHJ%&&E'F6BHRSG2QZ2Q5S@<HUJX'
MP*TX/-M2BU35O/SC^#80-)1ZS0I](@D W.Y7F*,.L/I\;\/GE7^,^/V+'<,[
M0[21]7:_^/Z'1RB%N-IYQ R;[<(.=DH/4%7C>)!2>H5,2M[@P)H.2W-M^"6;
MI=;K^J:J6B87(2:+9_I[\^%3Q(6Z\56>^FN<\$]G7FF.QPY'UK:@O>FAL)(<
MK/1TT#/*:3 ;6,O/OQZSZ\67A=##7T1 +NF>$CPR6N;NR2)X26_^X.*;GB'5
M36:(X9<4=3C9XX'GBQ'7]#[G22JC.X\:10Z+/!X ?="]^W*+UAE2@[M.O >
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M ")\-"13*J7&CYFKN*APP>APX>6VQ^9$_]8O6"XB#>:I'@!1^6IG<FB'J0^
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MN$Y^M/U'P:3'6%:(1"PK?&,^ &S13QJC,LOFU55>JGT)M=R$\6Q.:*+>.3:
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MP&!NBC=OSZ0&^NU&!&.,TB7H@F*_GEV2S%=O:2W&YCFI8/W*3TLRR[(K+"S
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MO5'&(;P/AH(U2FB?!USY^N5?40^58R.\@9)[RM$X2V#("S!JK]%\HN93L/W
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MO,HD@F$S7M70V0.1K&NHT)]G01J1YF4^9"<*C V0R413Q".^L'GIF+FQ^Y8
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M$D$X58R[)+C+@V*\8G-&R\&>&+GG]JT:QB@H-&FLCEHP,#^K,7>94C_I1-L
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MWC!BIBIM^RY;KUA<:3$D#"O/ 72IH@P6])?LZ.=,<"*?US6P!9#3$1OBESC
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MJQ*_J?ME3?I+IXW^E_78B1:-)-KQ>-W:@]A5Y^_+_PB>N]EM2#1QGZ+N#_I
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MOMIYA.8]4R^6O^<U_MO$B,6JEDU2GDQ'T7^>8*:I%$L29W^G.Z43\;#<\=;
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MTV9#M?;'Q]K!S/D#+1X8!M\&3&&$>00YM8_@<OFYP612#/"EH(;USE@9;4B
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MZ9*HX:[9KG::;U4NY#C3@&D_4_R[\K0\*PIA#0G]8#NJLP0[':?5('^+L1R
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M9>;UIA G)KDUZND0KR-FWRL6PQ-N3U_F''M.K6@K:[\O-Q]%Z3I62KEKFB0
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MX5C5AU)+U+%KA_*-*$&5_)24</2W<NI"5[D>9T$&U\!*%+Q%KV!712(@M\8
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MW3!GL#(C 0'K&_WWI<(;G\;*G@'SMY]CS_5;'7=0600X&@?7UT<8DTU0#ZQ
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M>+WT#[M3KUQ5&\\OS'_K(%@:] F\?C-G\%L$]D=G^JU?2U#D1,?W?9K$7P^
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MV#UQ,^V+G0J4,CYX_RCO<YOI%G:2>+TJ>6&39.9A4C(<#L'K;2Z.:VVJ-,W
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M[V6T(ZSLN!W !90:(4J+_"2?U+K),ZDI7722)UN\X,(V<W%'^'T!IF)GY&A
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M8$2K70=,10L71^GP7N,==<Q1^.9SQ3@^3'T?'+?/-=&85E;(X(#9:>3PJR[
M7T:MK[S1\=)(&K3?"]I9351M&LQRX9G1).LDWF*(X1]Z::4"4IQOI.-X/ZPJ
M;#M1%:'V'G&W@L.Y+P?W"JG6%?-^]2S0:3N,)2$D/L]&8:')L(OJ0BBB&WGM
M[]) WS_17V@F/F-BNJ1%%\4]]\+EE JMQ,X7T%#2K$LNE;:*GZ*'P-@.B#2*
M[^B@B_8H/O\6UD@.?"SSSM! Z,ZYU3GX^?8H;4'VI;GMX4A)N,<[%V[7T0P8
M QQ#S*PX&KM&&'5KZ@(LC,V;_38^/$MJ'?/L\<%H%V/VIP"#]7P1-ZN!HNI/
MA,HJ7_9\I. ([]*4\CW+#Y,]@S/#H\ZA?J7\[(.H>0XU3C/S?-6WC0*MUF2?
ML(V*[WB64#_]/2LRY)U-M]^:'78$N0N!T.MIPTO[,R8=/65]26TMWS)U^M:6
M2.M84K425!-Q:>NB_8TOGB[N?9X+]Q%TVO/14K1G[3)H-,^ --L ^=Z"# R,
M>V+F7#RL6SS ;_+)4!DVV\0#O!XB6WL^,G8^TU='0GL\*A[6*]!6UF/*Z<](
MN<^C4;0GBL]QXFY/'53_D"&O_+I<DE>(_UYTZ.\F$MC ZW%?#*MW-Y*-E8'C
M/<UN^S C/U?24,Q0W"_CI!J<].G; WH5'YU)R?.$9HNYNB;#F01Q\[RC$$/N
M/#NXGW'8Z7#/J(A\EY4+]YX.,)LP+:D4421 GW'6(7>"0G%A!MH>GQL=@ -$
M5QIY62[X<\"T5QO_2P/=OG'P>YMKIH\X3RANV"X#BVSSAX(_?IGDBKT]LC#=
M^F4S&+TM$_D[[/K>YL='OSRWN^'I(#6$S?TPASW&KU58R<$<(/[J\-U(3KHJ
MV]T"YQ?KWRF=@XA4I>P-?H=XOGRM0/$EU3C1%ERS 5V!MWY>>Q.:9\L^PFF%
M.X2W(V*9RQ&/-]*Y8:RHHPFXZ'D/61L;@)(N/:39^!I_93#>J?^G6BS"-O]G
MOYEDGHQ419\P*-XNPW+Q_I=]#A$HABV^AOE*"2OU8L]&2:)CVB'XE$YX_K0
M]1>6,V1X^4QGUDO"<U_)'8YDNLF-.*R9&^;W](NC(PM;Y(I/0^W_Q,ZG6LP5
M%%MJ3DYM=O_HSZ+\]==5YZ%G'%1+Q'AL<)*JE8H*NZ2?\BPALQGO%OYYU-&[
M0[69#9S6_ *Y&X(-6[VI22G;>G_K1XF#3T-#!6U@J2=AN*@$8D/NO,QBWQ*T
MOTH>76X[>22!K67JY6;<76Q<T]ZD^_K-I^6:JI]^]<]H4U"]&,X/E20?B;#Q
MNM^M/T<H1O_()#:R7UAU%R!P3*&P7]#7I05177+]$>MJ_7Z'6$2%5WJ+O^!
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MF_D+RZO,9$K1_)]03EE%OT(SYD<_TLGV2]=8[ #^E.8O73=UQ33?F+X-114
M_VD,L]'&Q%]8LS*="1_!#[%_8;V^IYKU$?DC\@"Z]SOX'RZ?]2]PFB?WOY1\
MW^DG_^%%(X'>2_G7E32WHI1==3(Y>R3,-_*7]Q%^MA:#JG<++T?I);6([F56
MV6IV7H?^'MM4]'C^[W/98[K_)6/ >W[^/'_W+ZS;G(\+K ]J(8W?'V ?MQ=N
MRE)0,A4VP<)_85DK]);DIOX35ZIU<)_:M;+X/I\IPA6V\J=-QGFRQ.BZ0R:V
MYN9IGU+=/Z&1.'<.#!P6%[3Z]:6*CU$RK[4P);V 8]J:&^?$>U<&G84)O'\
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ML>R8>"\(!:?W%>+%FW$)D'WO5M<O<5#^KB9PHZ>27C$?ULAB0F*4[DC&99!
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M-<<_LIY56^4@5$16JF5(N4P^=48XC)NW$+?_E,>S:W1IR#?L<*55-0\'4X0
M%K-K5W.$AP3S<[NQ:9[):$X+>H2J0^IC;H\<0P2V[%T!I6L61]-E>NY"\'.&
M /KXJL%AJ)^%4N<9K17VNY&^"I)) :[/!J[JM@HHO!!V32CF^@3^V,5Q48N#
MQ2G$-49I-K]J)X<.(N/&$?\UV(0IC;[[6X(!/J$PDBHE.( G:7LPWQZXZ1.?
MRF7H0)WRJH[5S2P?9^V9BDF24,.C23QU[D+BUT=C<B\?F^F]D3IP?&T\D:Z\
MV455EVU4MXW9K.7O>]&]9'D]/C!W=G@ZLR8#:$3Y'>4=SR'4@5JDO+ )M]:,
MN$J2'^[^#%S#WES5/:NE9XI]"&K]<FI*E@5:+2U$^D/(P1,#132Y-:>C*^UO
M$7OI(4))YM1JZPAN)!--SDNP]P:K83:"V%*#IC*]O#JD6-UO.$Q)N_;IR[,'
MD3;F(=ZF T*XZ=_?L)N+N]]85?3=LUU!JGC<?'!]WU>K.7,PUB"H114CNV8H
M,%>HIU=V^"V*Q.MSUMY)70SN0,BC;S,\A2XK%FXP?])J^B,KAU?K^@N7#\)-
M<\>^4/-%:M@;8,:%H4,,''K-UO.<":UI,1,/G4-9E[M%\-(8AK0X5-" 0/SR
M':MW<SRKO/DL@SA0Q*JNA5X,<_:618+JX8J9WZ;_RH'OZ-9LG?.H:5Y1K8XI
MF"$/PH'81>!B/?"J1]Y#6KZVZ_6H:V1\U_GO/N41A'&81,/T>;K".NJ;E!>K
M]@Z-;%M>-A;E"N9W4Y3(5\3P#))P[[PKA1CJFL?3]]'\T,1V2%'T63H>/(!7
MBHF1;$ > 6M4>YXKZVYB*=.VXE_[%TL.-ME-N6'*0-5+W25N@SH=/>%C$YV<
MR;2=X\*%!P_+=I9&W+2?'K84Z7@!,1U#X;"Y8^>^;X#U"Y7GT,0WS!,3GAP"
MAKG1S&EQ&'"2!;^=Z,IJG*,77RSFT-ZENR:$#\);4/2KF6-(=:YK.D3,DV'5
MP%5^<-@D1(S@8=U!MO.X\)>L#J%&W&H@_$M_S9F.J/<CPER(-:U9HO\!)JIH
M2,(U9M]EQI[?QFB?><?:H!FE3&=)8[)S)F7W)%98*92ZJVG8D<P5D?GN\(A5
MG#3)#XK(G2#'(VPIJ@("_&?&2(^]=CO!1IQMGCC5T1;(A2W4@7X5M9]%&Z/R
MLE<=<R3K4,>2_$]X,7W::*^)@7*D_[F6':P/]4/V<5C*IIM LLV"J#]:.[NH
M2W:J!=GOBJ19S13L\$Q]7TY.]HL%(T!QVAF-YGD]DA6L.(T9;GV5,*&5EX6]
MK5/P#4R;)'!<3,RX GS"I^=J$K#^^>WP2--C1T-#ZN1S04G7=\.?VA*Z<&T/
M[RW[T6<[2!")&#ZD346P15IJ_0??(N8D;A1Q)Z42B!$/)YE2K="<:*6$DJ=?
M?%#VAJGTCGM-1%V*1#7W)%WV2+_<X5TN\,;XBU4FCJ$#EC,YCS8W9=<V\LG=
MGXPA;PSR/?B>:ZZ1S"13HXM" $TNLS"',CW31(M?.K>D0<:K?."'=/+;"N4;
MS\(S$?#:&I.\ER&<U$P&I!E(!5;(%RIS.D*D]54US71RL(#ZKL!U404-P !=
M;9"97\[0<:/?CR"91):Y]C 4OS>$VPIE/[(N2\"EJ!+,[SN,Q427+[J#W:7)
M*M?S!(H9*VS2@"&D5.\L;2'X_CA01T,'2\<R/-:QHV6BD1IKL<%J4XWQZ]R"
M'RNS&60) ?A0ZN>?#!(R"U@$JFH6=9PIUD=5,K;R,V+[AY@.G=@5U4+#W%G9
MQ7A3GR7PM<8JZJ[K$^8L 9#GS&[]+7N5[N=BTD\<WV"8FS"/@\!^/_4F7I#6
M'W!7<Y(;R+\-V'( +<F:3A(\J5ZX3B,E<'D>GG8H<MB:M"PI\YF:LU4^$6F^
MQR6,,^"H=$BQ[J3+-+5KQYW 9J>8;V)6>AQ$39+-ZHS.&1QM9_KTN#QFK+=H
M.?V]*?K5FE[-P#<?>QUP2O,K\UEIP6S>LQ83A9B\5L)]B;>'9:HO;:GK8>"J
MX!)+)7&C%TS$#/#:,@_U+#Q";B/87C<TN\58F(4PF@O"SK7LWP]S^_^0C91G
M7R_>;'-__'=&R2Q7OX'*7O;YKA+&8#M!Q?A5KXTY4FI@<2)3<9&N["FK\./
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M)1CIEJO()=)\*:2=?W/#+'=D\O4+)%?0TN)J*3R\TODR,$=_#[=8;]W>R5[
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M[T,7IC\T.8RS!2@*@:P[Y9V(BU[9?A-_5UOM9L$[2C3<;HG= 8E=:4%I^?2
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MS,J+&4LH0@L+2HJ6 QAT$B=D9S?K2B_9Y"N[:^S6MQS%(,343)Q]K^V,4C7
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M)"VX"&G3GB@4"Q51L.J=8:!O]GL\U1&XBI"LI;J%G1/Q]'EP)T"&-IJ*(RC
MVJ13J.6WQ=-H]:]-M67"=L>-C2,CFF%-95;OC"@&J<X&0$9SU@<MZ-EX@&&
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M,&J1Q@S[X'Y_0Q%9VZOE.ZL=((IU'3G8E_0WC?#</'+-U90G:D7FQ9D1N&^
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M3%.0</#$J%_H$9A%4C0KX"X0_%O[7U(WZ7+=XOZ?!W*;OEZZGIM9Q:YX$=$
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MH#G=P#,7LGT7A9H40E'\*^[P=+GY47F8!T;![ECIJZ',9BU(>0600E.5]X^
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M2#F-]E<8)LUYM8!^(?RZQ-U6R_Q$J1??L )8IZ%,N6?3=IL(Y,%!AX/K#"Q
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M@O>GBA?A6Q<VO8ZVM BG_+PZ?8==<):+BH)?4C12L:+T6<7%QVYC.*<H\=E
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MN0R4!\2/KK:)W*L)^7=9JFX:TO]KZF]SOB=*O1#@:7J/F?;YPW_#@!M^O+\
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MT2GA]JN9?IMKS^N%L7$[EI&U7!"I&>+]9OBW#W-^OH=3]&M)<<?L#&J7Y13
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M\X9 F(['G[1>H<':!-UBLYHLX$*)'9J>(IE<\MMP[LZ>\>ADLQ./:9X(/8J
M5,^P=LEE7]+39.?T;@9@-$JF550"?9YZPD:&^XQ'+;RNX@+GTU7OPA5(KZ\S
M[(I\X+_'X'YV_AX9,:_EE'.=G)V.ENJ3'D7#4<2B_KNT@_B-M99CF5J=7:7$
M.1I&[-FDQY9_3>_1M@ TA+?X"_5YI Q+E3-"=($[3.@!JZIH9D*F:\)?@._
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M&^5W1,T!/#DKE .B "L]+G++F+3DK JM H]YT>TY%E*/&H5,'FA+HSJY8LP
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M_7%L:#!G2OZS7.=>;KL^5.>@1$7\!#2Q?>7,>C(C)1^5P+I2QQ@^E10%1=?
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MH+2\S]J5=SB/%"'VEM?7^D<18XMZGK+-O*9.L+]? *]BZ$=&8E\?Z\X'+VK
M(97J\\U@0=HE02@9RDYZ'UVAEJ_F/0 !@?3?C"#?]'S030(PD0TA)]&0"C1_
MMU:UN(-)>#OC1\FG:B]B'(-P&5P>?_$@@):JTZ:)GM>50E-\<4:JTELTD/YM
M^G&FS"O@R2+G8"Z"5?18Z\JI?10=3%2\QS4]WMWIE+0G=S(]-;)_->0*6N-D
MK$-?+L\Z;#GO#"<$/7X(7XMJ;535(B27,>O^<?K\\%[+N>\!IKHJ?/X7^TYW
M59_G8O-E4.[ $(#$G,/D.@#(43M'[2'V;%"4*F>;1Q7/RS$G_8T7N>%^^;&
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MH?4GT-HE9WK'LL#$I?K=V/'M$UL:,;>Y<-*E9-+C_=;P*M ?P/T?P!I)'MJ
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M&R[J@OJ^K6ZR/H[&KC^CF%J?B,!4=95^:9\=%+)G9WY/^.6+>%(=J5C9ZA_
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M)^7D^5!(<"2QS<6D,,M=LUO;P' [>"DUC%CKJ1H\.O ;04/\,S*BRN2%@K/
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M\/R'-7_O@^?EB0SKN\B.NX?I5/8:!/'N6Q%J^S[J4';RQEE!-*OL3)%>B/F
M<2$L\>X"SEKE<9;PN_#B!<A&^R.O\W-#(@1UTKU4T7?*1DP2O":F0M?^'@ZD
M8$KN5.&21"(-\&IBBYKR\,=I;.:8CRYJ?<FHAJ.L[C^'$,B_A"J1_R9=^4]O
M_^=Y:T;@)A$<L1U;1 <4[@4-T"U.0-*CI@_<BQX%J@8U#ESM7T^U?K,7^]?&
M[_X.,MR[]*%^<RF0!A"RHDX@$W5"*Q06?0;W RXYO9I]7I<V_A^*OI7T:?-'
M&/U",OD_)];_T]?__;X&1 AT.L:#T;_;:3[6'$QX1EJ/V_3+H_:AK%1-[\>I
M#@-4N[C2F"/8)=Z=CKF6H;]^L$.40Q!OSA]IIP</2@P(=USQD.6#5H/4:_6?
MMW'XW-%G^F=.G;@Q%F2<I<!Z(@&MVUU!%UE3_71Q&U+ML$.?RND4+'DU[]P+
M&V.;X\:"U@S_A<3: \3=0!YHIG#3 -,3 31 86;(@27X'>@?Y9H^H7+L>0VZ
MHY*V#8T%[</;!&V, 7]-^K7,5:7R^0D7Z._/,0O:F+G]X4$2OSXVGW*U;5>.
M3!H#Y"?(OX],D"\\2W_S^P-@%UE#[YE<Q/95E%<*22B6&E^+3-17_(/8RI'3
MZ<26VNU&1R0_Q:P2_/$='1\X-UP&RR&?WWCUUI\V_B4IQ-$KP")H0S[$)!-S
M#8U/F9;NK5,C%.!6E<>C!6TN,/_K%&%.!\=I&B"]? 2^WD'7L$99!_ZMA?11
M<0_>/^&-VD,_HCNV=',F!FD4D!URCN)]J9=+Z.)W0YW^1<'\I\MK5"5X_W4\
M@A*#A.\^FE)PZD2;!!-?V1@+&?T;;_^+!/2B 0:5>2A)(-)U^QXA IR,6:1?
M^C$:H,X8ZG9S'+90-N&\<4@_U45.WL98$/"?2 RS4'X:(&U@487$,PU?O6B_
MR^E) TAAUWP/#HDGZ<K[31N8 'Q/ XP^1:X(?Z'J]XY/1;\BV^A_;4*G>CS(
M?S*:@!_R<.I%4*"(+>"RLU *Z/  - \:S!(0,Q:\P?^O!L%_*D'I'<OL1.\
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MS6JB?Q;1V>VO49CHG"^)_"^/L!?"*TF=P!<F@Q#W%6W,!_BMK=G>#CA++4*
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M';.;TCN_/-<9!AW6RMH^)P\_)1CB*&5^4C=^-DJ+@\V] 0W?UL74014QOC0
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M&LLJH%.434I^JR29?=A >I:XT 6<#KX;,SZC,NTOMQ,J._<IYE0/9_+'0<@
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MK+78\M*L2Y3_:+BV\"WY?-DZ JGV(#]A2^N,H(TQXQ\$Z?=O@E33 '(W\FF
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MM_;UJS&6C899YT/![1GRN.IB5>L"BVM?K\]$WB2_7!9G5^5@#Z!+U@0PJ#E
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M<%(*)X<*S\NVE-%SX<G;<3P<6-D0L5MBMPX4Y$(?SR!SN?2X=A,S'RX<S5J
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M=57ZQ;#7E]OOE_M+MFT+17C7M$VYK?_J>S+:02W.G*B9EA[.8;?A>2&23J>
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M-K$I@1;XC5&P$SB&5::9>^R#6R%6MQ3;?S$U(0'EFO%293Y!^- WAIB*KR?
MB>9X/VQ =S/[T(?]U.%]Y)5U_[I>F3<?%EAV']M7?T5JD_<5BMX+?+5MPK8G
MM83$&Y-$3@'O+,S/M#8,1=0!8BJ(%J< E;K:4T#H$0*?>2Q&XG'$UI,0^Q B
MBQC^;.KHI7[?70-/B9%H68FN4RL5Q+(=D+LYN(^TN*KW7V^OYA^VY[2"/&ON
MDCGP7ZW]J[5_M?:_L+7OX/FT-XP3(#!!!1^Z:#CD=U'^9Z.8%T=O@ OVJFV
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M[<67XS7!ZF+5ZU]<']A*OO?^*.Q-7C(@>4E5?-%?HP*FB=\CW%S/I([Z )+
MF)@D=G(T-2;1>-RP<'4U22&9=[ $&DL61)#9 !:YSKDNQNWMKVWLQ%#?U3H<
M4.;>]9DX-DB[X)T!7K^"E.M^>;QW1KCN-C \E_8@-P+"T'@G$(V@L#IZSU1Y
MI6;HUMNCRH\*;V]:K-*Q229W9\<W#>03O(G<(\T Z,Y"0)@2< /./'Q *URF
MP^>1(=DSHJZ<N3QKLSZ=(/_-OW0>PP1C'@A6:D3'V18QT]-J?5LNUU'C?"P_
MI,8\[AW^WRW#3)*)_B?%C60$A4GU6>'1G[5"^0S3OW#GKS?FT#+/%)O=?1RV
M)_'0\RY_G$F%21\8\S"7$AKT\"0;9(M6J*#6_H2]F,I29>$R/-DUX2DPA>8T
ML)$M/IKCO:SD<'!G.-,@,RYN79;-2F!8QKRV:3O^4DE#3TWZ3_> !RJ;*N\^
M=LNQ4;]Q;1$!N^]$!IC'N4\YQE0T7A>9^)&/;>I*^/JN\?,4X-//E[1>R<\]
M?9Y+G2$FYPJ##8V3V$9]+X>^:MG(:R]2-SXJ<WE,$\I;"+ZX>BQMZY<'P"K=
MVG?7OV@73D%%XNZ72A#*='X1O7+6.?E0TN6VW',FMD+W@T1C5HO.]D3&PMR+
M65H4UB3Z@')DWU6:<GG*\E45F1&3=U_'/-GQD\7!9C;2V"PK/@F]X4$[XV0E
MB-%%!9$_7ANW$ATF=4S%W:=QK+_Z^C& !A3V7/-,F7*7S<Y !]MRJ[IRRGHF
M9 (._>OKX8Y]U?T>#A5L3P\$!.)V]52[%#EQPU'.NS#VB;='T@IB0.=*54^:
MGH2'Z$>#^90/O;9T#&)@R #OX/+<QCI+1;U">4>0+;(6&M"A-[73!@=@$]XM
M9 53=\(EQVX7CUN:0DVT9*O68M3GW3F]PQ<%XA:IY4 FG]Y0/UC,OC07#ILF
M4-^M1UQHU$#J4F1^J$?G&.P\3(JP+-B+ 73XM3ST#-85%A2<_&:>V?]M_;)B
MI":^=?[$8^$E/LSY@\77!7*GPTB#.Q>JWJMN&^Z=*]04CHM@ZW+M:V0F..,%
MNI3XAGP_UT"8\0X35BE?AZ21EYVI)O3&LG/3W%9FO"U"92D'[J[?1:8?C,K,
M49!N0$5EH2 %@2[I81[>N5O&\?(* B"WF;>+"7KPM'WD%O;]M!I!&!^QPG_Y
ML=/>#\M)+1[&S=V*4<WRYE?&UA8$0;7B0W%<=>KCE*$S2!6M).)*WLU1'][(
MO1 %TBEV2G\XYS(84!H<?I5A6T*5=;M \L&WN!]/HL@>?QKDD(=TH2ZZ(,XS
MHO5RI)&1S6T3PR(=T#<BGR_2\@H<OFO5>9M=#\B.V8L7TQ^%,\',L?51R/V+
M/N;#,-LBYXGQ  Z>'&DLZ\N[UD%F+-*V5[R6/S8^U_@ZL\B\_,5G!D^]4!$1
MA@Y"2&EB*&MFQ;%N<0P1)J..F=I9W%+0'C<D;U(4_\67.$2FD5S3!3_^6J4F
MC!6R!!K9]DR]J&P-_$,^;:O&9_ ]>US7Y"OR9=:IST_H0717+*31QR8=@YQ0
MV\YFZI%&/[=WM1EQL)XG\B!&U1NO_2M?IT^I!W+ILAM-])\#OY:H?J/XUG<+
M;P(:2WAU?T&-Z5'J?Y8[R =U68GW%Y"VD:\8GW6VE9\YQ#_)6LDY F53&G%5
M,]R]0*4%,DG'<^):,&=$#=\[R4>$H ?)9]97W9.\T#]Y?TRON\6%A^KTL26%
MDG4% "1U;W9O^<V+7<'O+/@E89I>F \@WVW(F$\Y,_1<AMQB<'=2%F#G31E\
M1YXLW'(*<$$E*%W#9V XC8+$PI5N8G)QTLOQ^U/(V(KT%HN!C"LO6&+8,P-N
M^2^YD6E]_54[HIMMSVR;7JBE;IZK0;0X*81)8%(@59C]3/<F]""SE8J[+>8P
MW'<O&':5FLHX3OQ"T[,WGIH]%.-S;>#X9G;\2(&5Y2^] ->@HEY<L+;&&*_,
MQ!0,-9-YS;LHK*>'_S)-:W<,-,4 "SGKVI1 !_"R !Z!Q"^V\]P<*G=[311Q
M$?.H(421]:ESMVS:!+#T<,NCB\]P,R0*I$KP<'D6?_AB%1/^H7[^U39$KR$-
M_L-8X>W+?N^2MOO*]N?9HQ[;A;T4&DX4MHPVLN_+6@\V^N":B8CP==VR,&J,
M:']0%?Y!U/W]4PTF%QH'VU^ ?JA,^/]A[[VCFHJVO=$@3:1)!RE! 0'IO8A$
M5#H80>E-1:0)D1X@! $!Z0("TD&Z-)'>I8OT+ITDTD$2Z@9">'C/N>>=<[][
M[QOGC7O?^.X;WQ][[*QD9^^]]E[S-\N::_Y.70 &X_&J<U"U78;HL))<D<X7
M8Z#69,1R4;W!4_YN_&_Y.;? 'UE/?Y5Z^5>5=YP]1I=_RV0%S![87?REFIT^
ML8^'5)/36#ZR%IKJO*A29WNIQ1=(QZ5V+BB>I2L]7IHM#\S@'Y%AA]'TIZ0O
MM#HG-LADA=.;:M@*ZW1I!8872K9Y@U[F?^"1V;#0_$$S3[>_V!43J<P&B*!L
MIA"ZGM@VX2(G1R<GMD3TKN?@S^Q(URV7V0+>):HI06SC829VJ'.(,9-RZ!.0
MU*;,#]<=J(E"GXG_-+>\1S[ RUTI%#"HYO64(9)JZCV0J8,K*\<6'[H!\?EP
M'TQ7T@)S;4W+A+0\],0<-V#W;NQ!P8Y&*US,_,N^3#"N%GW8BF._,)G(JOO$
M0EJXL<$9F1A?(;L=)9-+)E;]>V0FU\/GI.0^/*(?[*1A!,VA$P2:%>,V>F_O
M;_FVOD-"'&0?P[O/0?>Q,8?GH& \IY39IMQFX3OGC =1-NE.(O@:!F^-#L_C
M&[TDHEM&!IB8"%/86\*U@HB2;"<7F/5;>V;9[=!QV\Q+"XSR\J(FWCS+;+S/
M=.'#,5: _2>\-?:5)>/DP8!V9T,>(0]UO"5L:::]6-.M;.+,Z&U(>!(<Y-V?
M*4#J];*^=O*W$F<>X)U3&]%IZM5A5Z)T_9-9Y?$C!R1OLOZ,)N733-%Y\,N[
MIT,";"]8%6[\;,Z-4VZI\LZM#O[]W-B9ZFDOA[.%0<4>J)/J#;R76#DH3]O2
M  5[9WES5/F6ZA*$[1STPM)BX]KCC9F7Q3FFO8Z,+4_"X[\-]PKG2A['?GD-
M/(521AI]GA*.#YM@SKVPS',?_7M.P-^,A'"\^EDQ7F*)EG4>;MAS%V<4C5>Q
MH1_P?[9T)K#8'/[EQW&/:S#_,+TWVZ7FSRVZ(PAU=/ET.;JGLW/\0O0*NE/$
M(F2R2]93>MZ^8CYH@;=_%&5L^'C(Q$WO,D5,8EB%85Z4B#+1$G3-P"TM1BU0
MXJ8ZZO$N^8[O:6E,<V.\W=P^IO1W2]W0*9&,S(FCE>>.#!3JKQ*;C?F6TIU7
M<%;\ .<9@&I6LPGLZ6H8#)\\N3-6T4Z2Z=*-26.^0D:C-15F1V#$97;UE<\4
MMTO8O8?;&DS>&-U9&M7=^/Y^KDG9-HDWB&)%HZ)L5S([-:Z#R@<2ULK6I(W)
MG![J4J:N!P31?K2/:K!;1446FX?K]CFFE[/Y<D-<._N-[ 0*@X19WI,Y9NO%
MR$1[F1I"*P[?*8 .AI2,XA%_#U&>C?\*41>#[F\8);EMV:PQ2,$&FER]< :*
MK!PAQ$BPE8-*,/Z$*;[_!6^%]25Z*"*C-0H^%5F.@&+Y#Q-QD!CV;Y;<N,5@
M)6B>R0P%X@*7Q$INOA'?3;G )<1OD?>*'EW/+JLG%PROI2W_2(.^ %1QM1U6
MU]Q39TLI?F_#JHZ10X5K,[ED,R?MSKW2.DA][U_T%/I$\O)+2D:G=H!41P;O
MQ'XI1 7G%;&];Z*CV%*!2N=8,+8O4092'G6PDVD[44?2C=.9@]O+F>&AG?XU
M*T6%EL!#3#OSS&+ Z'+5:?V3!<4>CZ]L97J2/!\"-QA<;M7U#MX-6AJ*Q-N?
MRMF;)G6D&Z'$(A!ZR(;FY>[44L!S4J'J%%A)R%7/\/0PIAT(:I4'V>8Y;>6P
ME.4K3^K:^4Z]0RK"?7I090D8SBLJZ @+9_1"GWK@C[LAARM>%!R^F43B;JU>
MM^CJ>)_G8J%=E/-6W3,Q@7C=["[4.8C1U$2]J(LS ==<U5CM*=@BF"+_\8-+
M]42.N;,Y,[G,KFV[&"V\P AX5FX^NR8D,Q70(MQ7HIYMKQ]V_SX[;979K,05
MUH)T'E'9$*$W1/+E^KC,R(/[N'M':.68[(U'),-&[9;LM9/"-A6I!A/.920?
MKSXLOJ7.DIB7/O$D^'UD\,T/184+ CR&#T=MZ^!6:'&<5PP"FKU^XI^<!_?O
MK:F;5-J)TUXE79AF<*9-8@M+KO7X("I_LU'Q./-;PU0D0NH3O/$^]I;=U&$&
MN1M7@4>)JG22\HT)4PDWN-[D ^9C;_F7)DC;[N%/S8NHU2CA%AXX^UV<6EI)
MHFGS![D*GK-?1H]FH76_D$R1**>H]:&/:W:?PK^/_Z=5"J/KR^P);"/EU4Z&
MNT+4DC^8Z^H;TFMR]0KYDF.>@@8LRZ7.\I!@ATPF91*@KWWF>LRIV:,*P5=Q
M->.Q$QUO>;%R3K-#1R&O!;L$-6_J9 J;J5-D(^>0)),R(I!M4_Z(*EKJ#2EA
M9F6127>CVI'?Z=%7>4^CY3B6OA:R*@A9!N!",8LAR"NSZ_;%^=F?-Z]5A8C(
MW1O>UIT_VR-*W,TA>4$5&7?WEUN<T"HL;/$O4CIU(:4-@!#:B>&/E/86S?^C
ME#XIE/B<U4?ZBRA%Y":N//@W@1QOS44[CG?+[UGZ6)5NVJ$>L7TMJO)[T8TY
M=3KN>J0*,?G.B_VRVH>W6^M^&?!]/1W*0M(AAPEL0(=?X;JA9TI/J))F 7?B
M7D<+[]=3YFPJG;LF5"_>?W=5,)2?JV^[T2QKHG]Y09--7YHT^>,2B$Q388T4
MX>*+8^CDDCLK0UYQ7/TV4Q D+%;JX72'Q6J6IL#K\IO;;%GW%I[8G6J%/C=.
ME.=@./"*EA9L@BX-^*O6)HLXRU!2;&$2 .-IC UY=,=K?JZ$* V!NN-4_<)?
M>;_@B'-0K=4;GJ8,.W<K5BNXULS2K#E\<NR^M[3Q1]E1G>.YN_)LE]5Y-BT[
MT.>@<$MFK-@;9R7[$D?98?A+=H]Z%EQ=+)]Z3Z+U;/II+]'=#8TNQ 2V&"T6
MB6?'IFH#ZD7XJSAI L_8_N'HM0V-&S$=>VJ,V8G:H[,&)@]7B%C3WA/Q,WT'
MV-N5Q8'DTTN(.XHB@8ZF4Z'5[N/9HWE)=N-/JYH^7%:!&71+3;O,J[Y:5ZTZ
M%#=X$6^6L;<$FR5OMY3 /4S.VKA&'J%$YU:<WJ#:$^$>9 W[+"O)3"$G_ESM
M,CG;'*A7OBRU,Y.Y.@ 39=:^0(/MY+HY+JTM *LV:IP@#;_'-_<\1%CU>MS+
M)R\[2.Y>6>YV7+&:J<0DO4/RX<DGN'I0T/ FP;,8;VL_V6+TYHLOS'MYG<](
M/X6\3._CK&>_J^_J(^*KFO>[ !N#88F1.;O?T;!2F@>T]$";JI(>C*VT"GK#
M*(*W>8T3(E5#+^RJX,A?OY_=+P"_<\AM8?3A2L*5=RAFMI, \:NZCJB=+]7[
M$2Y<_!'.]^]]ISA;>_W8CE_D&_^-!BCIQDG2.P1_KH-/2_Q94)'EK+K2R;./
M_4[);Y3U_(H307O?VIAVF=..E"\!CL^R@(S%_E$E(B>Y2"4S:Y+LA .VE;B5
M'IT%27;'[[S/*8A?W,E<.=P60MM&-4F@%XG7%Q1KAF?ZNI5?B'-R463'ZS0:
MZ_0Y\2A%\U-]WEP) /=_G!YB^Y&>&%)1Y%6TS?A(T1,O4.:6]?>2+Z350[@S
MM>$H6U7BCYE'YN=%,5^@A>I_2?5/*WU"[Q^?&%?9?NT<U$G+#L1!*>'$]^V9
MO;='$.N1+CL?BK_<D%$5&IR<TP2Y6(D83;56Q&SG9>/IL&65V-.>$\K-C,L3
M+[UK9^_%]S)H?5*@-S8/3KP)<AE_5O?JC4(%#7+@]([%8*1B:-792GBW53<L
M(+.R*ZF]^!S$@A<#6KT_+QAKO>=D,*T=Z)J+AM,5A9.K5$G!!/IV,U01I=V*
MN VA?2@&NF6/#45/M:7;7EC3Z8\OM/(T5MM;-)4J^K#VDLP>7R1O:U/@HX);
MK5Z_R[ZQO]Z'7<&K!:%8\ RV;2U2,!K[C)M-HS>BS2B=3.3:F/HLE5SZU2A^
ML/ 'LG]YEC;%Z\)18=:[,.G#J=]1K[G-Y+B&?&R+_Y/-I^Z_ZY^ S,*;_['W
M9XD/R>N 9#0G?8\6+N3]5UW2B3A,']SVYT9PV-.XF\A[/2L\19>:>SI:B94>
M8XE122%-=[#:FECHX<<K'LU&72'+7-@E^H[O]_I-(JS=GH$,KJBK"SOEE'C4
MY00U>OIX01B037Z^CQY"+&\3#$Y\3Q\1?B@SX#*WS;"N_-6U(RS=8 ?"PM<Q
M9>,51XW.WT^"]:G>?.Q;8GC329PV<9;?ZD09,VV&ED*(8,%O$#+@$.D^ <(8
MZ7S)NZ]-%3N7)-AO!7=0Q7%4S(^6/D\[?L+C^3V1[7[RH"G/<LRT2:LM?%^,
M^1S4OJ7[8"/@T3HU[+ TU;,%!7[OLO*;YPS6>^0_4[9Y2'Z6I$2+*UOLSA#!
M[;O- ]8=;?JW&>O@#W)SFF*$KE-=^E3(KC$(+5 >.0>1U#3Y&7WS9]MY&<V8
MB%YA2^8.OA&E?5_BNMY= RM58M!3(@L8GJ$1\["^!-E'$*I)F8(^P3Z05"U@
MQ2#ZE8KXSP[-?]^.5K9H\MTS/_@\X%98V[!YS"EMKUJGP/?9#R*U.D0)Q!\*
M3!VT,IH[<+'@:$/<JRJ"W?L<>W=>>-_D>A:+V7WY(?1V#DAC5CP+ESC4)7GL
MR./]XMU73]BWV[ZVU<AB9!N$R0,6?17O@LMO=+*Q_^R@/YW\:2QVE&G:D=?:
MSO,E^!;5<HS"NJ7N16]6 744)2Q$60$80%O<$+NZ"$=JCO[X 3=4N5Q;:[+P
M0/^RI"SV<Z>-)VZR+-U+/>7(UT,JG=:QSU$L%OLPZ1"R?1NZ#:[RMPV+WX;8
M]*0N_V*9SI"SEA]BZW:QNH\<.[0BDFEV:Y.%$&$:-9W[[A?ML-C(-797$!W&
MQW/S[=7^6A]T=$.W;H^ARV<49U6QD_6H<AK[R<W2V?G[7M:O!I1<A*(J0F/3
MBGK9TV7C(Y]>4CFE/>P#\HH1/&?Y2!*'!IGJA(&!G9G]>N9CSMCG&8[&<X5&
MCYN(VP;OJ!2GF^RI;9HIY[9_4+"QS4^G#8(XQDP_)?P@W!R6#D+# ,WHXI=3
M+_4*SN)[9TX]M_=>S&^FA6-5AN[=V3P0(UQQ.E4#8E#-Z;4= Y)]6G4C"(,<
MG=K*A?M"<SW)5Y!K)0'JQ!#):I<%_D9(M1&>P6'Q\5-GO,F2B<%+_IV*VG:)
M(:N4&57KC6\'>5 &F8>BGT8JQCM4QN/R#]17107*A\5F&Q]!@\"5_.UB@8=Q
MO%XP1Z;?^;%1V?CJ7[%K8]]W#J);(6X9_NF>(T7;1C+1BE5G\7^HVFO^S-C\
M2QKW?TTXML^JYDYF5VM8RU4<I".& B](F!GQ$-C&E]/'T)FJ[ G'_NC8&G5R
MON+4^VQ*>>) A.3291[N _*4.FALOJV\6S$7Y]+\[6XK5@(#/+X-3*\,AG1L
MVN]WC2ZEW'%>U/=]/R(I'?2#N$_@WA?JM-]<"<MR7'1GGV0NO!(]/%,+MBS*
M)C_5?90?B& N9^\\I SF$^[FV].Y#Y-G&P)=5?^Y&A\_P+FW./[:$>HPYMRG
MS\DX:N3#Q80K/_1OGE)FAD-TL)Q=S:'O\.1NMGZHPU9(?6QI_--P?84KFVFQ
MD5<5:=+R6H,(0LAA"!V"KA"ACK7)[&BEA"OO.Z#;[UB*:/GI'ZO=>/K\V#I,
MDY\Z_J?M[=!Q<,%HS-ZZIH&=<YQMQIKI8J=C3"3RQIB'%>VZYR+U4F6XKI!Q
MR*K'<E<;13,G)0=(^QQTY2GI<JT+AAG)!/2<WH87='M":)OH"A J6/]WU6S5
MJ<RI)N'M%C?0K]CT5?A/OM<^_5PNSZDB7_[9U<]_Z'@_RR4:6,F7N;86, HM
MGCN.[CE4;:X[^UA]#B+>F.FGQCCY$*!7YS=&?JEP?1XM^:SFO3O>_>ZAY-WG
MH$$AVDXD/8 Y55TWY7^#\%]JEFIK8:UM",%T7CLHJ^"<GN0)#O(V/%S?>\!K
M\_BTHUMJW EB3B.QN:FR6KXYM%=LD*GGRS22?+(]L9*<M3AGG^*[<1+<7-E<
M_5:_Y"7Z;KUQA\(5.0ZJ.-".Y;US$*BLNG5ZMG.!=@+&<PYZ6]EEN+?@<)+Y
MQ$_M*6LM>'?@2L^U@("O,DS;"^F0H>,S7>+H-#]Y/+SD0\K/D3:I]FSL8A2!
M'SZ&ZIH*:Q)?8/Z*17QUD!O3]B5!$TZWMB]1ZC%4[*HG\\0+1,7\D"4>\"WE
ML)4_@Y2;"GQ("V4MO!BX^O]9U("H'Z'=@//(#((58$5JDGW1=OTPF&.)QCI,
M,E1_K0M*U5LGN!Y7+[/D4_X6*8H<;>'&$M(Q.V3&>&DL38P_39Y?0=1SSH>;
MQBD\#:Q'#[+U.7_.L9/S1/\\B<'QM)*] ?5P0K3JAA*<BM*R^X^&=R'A+>)
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M D]"/>7(VKYC:I0_3)7#W,]H'S6,21]-'%QV^A4WTZ[ +%OW7M3PSN"],DQ
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MLM)DL$K4Z2+NGGT$>:78=V/ITD/RIXZH5Z<9]4H'Y3D(N5,?A"[6MBT"$K+
MJ<MR;TQ$)&521']P$EH;_/*E6_/R"ZK9V97+EP?5+I-5%(560VRAY<B0]^4^
M&:,%#^>UP+7J7:I Y:D6\.ED9LE\W<<\2..K^ZNB:'!",O3U:#*[<D@3V8>*
MEW.=%8.:_/$:BD8V\I]?ZZF+:+H-?+\PG;[^K5[P'P[S#ZV[KPE_"@8;7@P\
MK6VA@Y>M@JW_SK<M;IQX6)QR##&>::,]7*",N.F?Y23ZG[3]TY%3@99;%ZI(
M25D0H0548EH9[5FXP+IRACCF @_G6KFOO '7=LV=]>C:\+H^<(IN^OCX-6]C
M0,LE1LP-]5EH$W4!A'7 =W6\']SZ'$1&?P["I4!04V VR.IF!Q@03SH'14Y5
M'X1;]<//04;%^(+OTD93B]C-F,C,O0-4#)[U0D=W_V'?,T>\. =EEE/Y+[5;
M$:34)P7]Q?TLRW<SN4>LK/P[RI0E_8>F0B#89V+G(+8< J<++IZ ;)*X0!P*
M?V  ;)QW84;ZM/Y !*GZ^9V#:.J WG,0Q)+UHF=O6_$O8P"/GF[H\0FVAT#%
M=P["2/L]3]HCG[B 9<%=:J:#([PB!L.//_N/NS#RIP?@_W/__W^_?[M_+VZ&
M4#BE)G0CE<_2"2(."SPXG1/I%+_),-'T:^M34.$,1RB,^[M$83>/,R'-S<IE
MSY)&5,L#QO7]Z(O+ZT\?FMK#Q?T$VO;+I+X(Y)"/1H*U0/^->VG].E)&MW4U
MVCSQ*Q<7O?CAS7_KOIKXB][%Q5B5/US^_Z!W?]VWR%]\# AF?'JB%[1^-_ O
MS_="+_PW[?\*I)6.?Y"U9WS\:^S+<(%<"2&L]N'[*0\A_QDP^H.> XN>6LNM
MB7N?=+[1[O?Z4$WM>" O(?]-'KKKK[1E9$_LQYIL=@YU/&]*[1FIF#_V^L4(
MC@$T9?Q/KEA>J+7[YZ H6SW+LR3KML;?%^.Q7;/X'#2L?W0.N@3&7[3?QE]@
M=U;>#H$$ DQZ,)IX4K:LQ%R<K/4_/IEJTM/_<ZK_^:?RZ[I0MMD3L&KP#'^G
MA(7EG+F:DI!K&U]"&O%AX\/7FFR_IC9P>FN06_BD/]R3%P[6WY-/?A):P<T8
M>BHGD<Q^*KO915C#%_YLG0<G*(;O#=UU_OLVZ'_C5MM%]TKMLE->!1PUWYK_
M5PI,6;$C]66U/T<6C3\B]OR?U'ID67B5'D1^HV3BK[5MZ+N+E\N)L[:U*_P;
M(+=X_EJ]@VS+ZG?,CZB(LY'CQX7_8UI74M5G<0%1U;;/ST'N2 .KOU2F51'X
MAY=ZA?U?>OHO[_#AIS?_^[9X8N]&U7'>N27$\&?-[C^4V"%-$?CTYK]@/=(_
MN?W7\:;\U]>JT1D=_FL \@.HZM^D>_^5=M8@_*^\8@(,-__"(Y;Z%QI:XO_E
MNH)2VG^W:OE#U;\[R_,?5C[^9Q;U_G>Q'W'Z'O54D\>L9QR<N/NCV"\0VHO0
MK\R"XXL)V9(Y!X6U\!IW6"[V]+MJ@E,VC!%H@>Z)GR6-J6F!CE/%1M,F?)Y#
M-]/%'#WGXR 2/D%;4A:BJ=BAKI.I$.<F]0+@L7DK]B!_SZ78S'Y,T_ZR2M*B
M@$5QU=6'4-!*JX8RNZ,/.9ZQ>*D\PDG)".4GI Y$9;U)3.EZ:_/@U<8 <8Z$
M+44]FZ6LL#@1.3\E>,MW*=WJ0M5@H9GO+)E&2Y5'2A>'/O\TFVTL\<VWT[N7
M^/S2WEQL3*EK'S.&I;]DK%+1.K@I/J+!#M]RAOQ@- 9F\U_*!#,AK\!O8+I2
MDD>J2V^-DS<1NAOC-)W>+\$\XN1WLV+C&BO2,HAXB ^19^$$7N3(B<Q@)>J[
M^[;4_4"UMPZF QT=C%]%Y6Z0J'OR\/ [*T;^HK- SF2*061#Q2J*!GJ=H&2?
MFBO1Y5N^."$4?Z<N>9O7B5--18GCUF,M0D\] Q^*=?Y-F\6E^%Z/1R!^WDN.
MHP>+P$WR[BB&=M=-#6GJARL"32LC6[!<Q\'D6W(/>%X2?W'+".)G>]C,&^\Z
MQW0MFO"[IY?1J!)_]2P>[WAZ%S#K:E@,SAO3P,ZL^%(6\;$8">O-6P?3RU*M
M]MTB9OH54^K#U(-GB$&_3"V$J^M.5&=>L6NH#5O0*-D_[3N.K.CE$!'*#9'G
M=&6"SK]DVWE0/!91:?WDEN;-3XA259_NO%-I>*OV658.<)OG)R0\MS%ZY*4F
M[^GU1=;W&JQ9K@'LO%N#1$N3!6&M+R!<:U8<U@"T($JNBTM$G*^_..?A-NE7
MR9W^KUJQ6^W;SS5Z!K/H']YJ+I%M3>8:]&R.8?C4DONG8@ )!JC%YK2QM @V
M*G+5%_R\YPR[,5+V*\[NAE[2^Y)8[NOJ_/:\H(?B4N;D6P>G-X%ST&%B?8LR
M4W5U]9CPP[XHJR>QGZHU)6)9;0Q?(MR"'T=&S;I*)C@X*_TP95P;UU]>'M\[
MDT)E1LJ44UG XZ'8_'I_U*;N"L:P>BP_;O1JD%C+HT8C4* KG%QF -FJ=?8<
MF]0F1D\8:OT"Z5J\#!0)SSX*GWI2%XZ!I@U0X>Y\?3:>8,@18BX9M+O*$605
M_U/X&U7%G5#3P2C8J^69Y8F<K0^^/Z%]ROM($E^NZE-[K&R'%G!G"1)L12;C
M:#RE-XF_[>WF02.IM$S7JPBVZ$9;YF0*3V%6.\M#&F+>* MM$LB9]RP<KB$+
M;F:22-Q<%Z4YJW#2&Z^[=9?3[;'ZU<\_M"8K#%[_3GL^UFC+J>KGC3H' 7Q#
MW5%N';$;\;6A[HYA5[]+-ZL15%SO$.VBW4E.6# M"CWQ>*:S.,(-A"^.K" ?
ML(96R\Y8M-6T3/QV_F#<P2T_PZ>[X.P3(PQAO7.9W\8TM;6I2O*02=J\,4-.
MU;>U)_/G6 ^DLKDG-+ZS=H9TSF=Y:%K$9DPL&<?/-A<==G.DSB9!*_*-!I]*
M,>[H4 ,7NK5:!K?6PHGF?+*<@P>G.UEI9=C37:ER0 Q)\O*</<\@6KK&9*<U
MZ1LVFM)8TQ.F9_4 KWX6TN2%;46K!R@Q?=Y8X*J;4+*^;?93U\;M=@>=H>I-
M_>$B8E'EC5J?#78"13K.<^&H,\S;!35+??O^.ZV3ZJY?[9-KWO?4=R4H8FN(
M _O#&X- FH_#3KI$P+++OE=23AO!_'I6:GC:LT"D -X;F\9U<R1);=2=/7W1
MIGFB/#PBJN3[J2%O;,BD/@VV-<H%7$6^-82!35=:5HXA+& .PXL\=S)R"K1L
MJNLHHU#&G[_<,GXA&?1=OHVLR#!_^4=&;H,,HW?*\&Z*T$9Y2"M6%Q9I18<7
M@Y6Q5L$HVUP#C46J3XN>U\5>_NX4JWI=)VCDL+;ZF1FR'7(5I@3&I",7GV G
M>K$OC@Q/RI*=_'FG'+#<7I?I;T0E*(#JE*[>??I$K$2_T7R6:>N6R6UGQ+*J
MKUA;^;15ES^[$BEZB,W>)SHBUX[KFJ%C7[JEM_5B#8_0.WQ=)M^32VXQ3:VA
M48:Q:2]F+*C2S/5A1?\<4>WO?R&J57U#H%T08=2S]%[[OQ=7/M9^_H9Z#AVX
MY+%D]&,2S$&0QUO632)4L,7MEG07S@2[;G/*X'R3GH?BHN--%B$>E67.6$&;
M6_G0Y[X!HU;(J41!+!D$; QX[L*NZA:6!8"#\Q(,[0[<Q#XX69R V(7-.,IH
MB.1+_3Y$WJF"9FM;'^L'O:=&M)Z#*&LQ8NTBVFKC+1* 8_O]-I_F.5FQ(KC6
MBIMHA' ),X]G)8<BL\V]D33B^/@$\G5\YL-;-EQFWDD41?.>EY8XO+)J:QQ7
M6J\B[(%:' .:/QRA@/6ZB_ULCV2J9U:,KL6PE9$8R:7>5Q)7A^U=>A-9^1I:
MP+9%H,/;3+8(PZ%=AOIV7^#6:/50OOB'K2,[^7NEV8V[1_=O[B]G(8HO*72[
MI%TR*^ MZ_RLNA;S?. ZPO.P/![AA6F=B4&UOI6Q8M@\LB+9VO>3G"]SODEL
M_)S1\Y'R'L,;T*\X4G<7A!J07&3O3Z$D@F9S/P=1P#'= QX>1>9KD[XAJ?8D
M-PVCI>OLC89NH^Z9*P9:+<LS3LA.]!Y^/JS8]TH>DG;&"_406! J$TY-SW ,
M;4BA"88G\>TW)W=%/.$Y@9I;SC?LZ<J8+O6L\*@*"(>'WWU<_="M' OI)%S'
MK8;N-%F4] ^OIVR/- R[=X<]FK%ON]<^Z!EB^X%88N[AR(W"[C']I1$'^XQD
M5>XU00?J?S"J_G,.70&BO/:#' _OUIZ=2"$L%+4_LV7ZI.%WL8L736K>NI[&
MU?D%G=GGD16GQ1F:6T3E N>@X%E<$HHF+\?!BK5)!B4&W#OPK7L%UL<F]!.<
MH_[RCM,4F6_EY2QQ9+AFK5]SZE[K'=<RM!U#50PY4+[V(T6<X:0PT,X[1NBN
MH0[_MS[,P=ZE]IX2#HJ#E>BB/#-*U23E)]>OGV$:2?EY HXQCDO^W;"K\/+.
MAG-0@#*W76(+%Q"<U44]OEZ@8U,Q+O*"EV^B O;QYM*38M=Z\[0XHJT9H^>'
M88T\TT=Z#?7@\',0W?X?TC4:A J&6E\A_^NHB"D*]1:QFW'ITVJCA%ZFO];Q
MX2HFLV>'"' 5>Y<ABP4'0SM0U\P7[17YYG;*[!-+>Q/OG8/JXY\N)XA[$ZY2
M7)&>2QA>UE.=SC3^?9@[OVTIA:O%S"\&2HN1=RREWQ!C!@JZDRB=LF8U(4FO
M^I:/HY3*I_J>'-?]^N6^:3X4K"S]9RU,IQ@M_#%&.1A5^ RG5.J8"P]M9WCX
MJFM8OWW2O>YXXJ?@3$?@:Y!2K%9:"D,QXU".7/C]FU+=R@5,>WZ+,4I>&#\(
MNCP<+X.&;9G!R!SD4IR3LJLCZ6<6F].TQE)KW24)N[H;+=I=%7?Y70;<"6)
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MBTX3S1Z?,]>D_A*9S)-0J[Q[B;K'[47Y@D(O?@OP/S7'6P(F2SN :I,8QG%
M[I[%@D7Q?:H5SFE>M5T>)6O>-$&..)^4[T#0J2I>#2A:FN=O;Q'&J78W?K)W
M#2NU;@SA$7\=&9#Q-%"3AO.K1:I";V\)H=A@?#5^>.2Y_2U$D;ORUL7#3$&(
M SDXAJX%HB:L<WP)/*9C>#:6T51:_Z%(N4[R7IIZ^INR?HW79&/?R\4O#O>
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M;@9H+-<JB#&YZ4LKB,SJ>Z0J*A86L5V]?41))7)@>8LSAE(%LYBA(GU^R(X
M237]2GU%INWZQD3:&^@_E(G+G0?OL [-;R4"S@9\RHT1"]G[M_<(>4>J,,(7
M@$A>Q=VD;;I[Y$E)H?1WO;(.\>N?RD-CSN,A0S_QZ]MZGE+9(NR&ZNR* I0C
M"4K#]2IRCS3(0<M$ .Q@9X"#"%!YKN((R'WY]7"-F0XR=.<,0H,<5E$$?Z2I
MOM'['[A3#X(5E0'7LD4 N0DMU0ZA@=3FEG$B[S&3<=ZD96AAY;5X?2,!,N@4
M=4=D;12FOK6AM768UWLFAJIG,EMFXE6KZD*3X</Z_YC%(S\\VB+I^,/CA\?
M T)PD^'Q"5UU4T>O2![)4\?<?:3!^W9+BV-++33F;L(R?7=Z]IOKAWLCL=Z
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M1  CF'62P ^FQDR4($_<:2MO%$24L3,R ]B>G'X3+S#97=%^6/8J*>:X%!N
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M*MMFYY;'5"_C'F'($<#VKRWB3HN<X'M(2::-- 'S,=EYMPVA[WLH:M[[=G6
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M%D5^E(/16SOZ>BAMU,D/.(@;?L-(1948Y7R/M*'BH&#(;EBM+LX9-/)]QBS
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MXQ'CL>HIZ9GN"??2\"KV!GF;>3?[4**)TA=?3M]HWS4_6;]L/Z2_H7]= %F
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M>-,-D-W"$,7BQ@3=!3#(0)ADH)M^4#YZ'K'_CO"?9-%Q8F'CX-["PR<@!3!
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M^D /3F7E-8Y/S2:\=@_Q.Z6_,OI_EE#D_U5&?Q+ZD\_-/$"("4+?,$PR0 Y
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MU5"<@_ A2;01YI&M"5X$)F\]'MP]T N=Z11$B.W]6LO#WBDP1W2VOZ@\]\3
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MK/%F$\3DGHZ4YY10KGKQ(%)1-"J#711.'DMSR]IL'_/2+2TR$1A=^BA*)XC
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MUXA]2*Z0E#:[UI18,%-U913J##5M^#HE5"N=X/T.O-,U )U7Z3/'&:=7GS@
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M\M]E5N#)K>IKO2QSY_-D.KESKCERYW)-]P6@_0_CSL/=+-Z4X4&]L5J3CI
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M>MFS&9$K&4 N1=U"F<%((O_W7GJO^7LIP]^1%)>#[5[4NF-F_L?U+Y^07!<
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ML3Z3K0\O_FW7NI*?4W[_7:14DM:U!9F^HRV(79@E(>0<<+69Q2<_]V"-7]6
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MTLI"N=F"+L>7M.P4AJ<C@G6N)B%,,I X?KZ]XB9";DES]=W;G%*7>UX"AA]
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MLQP/1_.S^:/8.IVGKEVK!JHE^YT#CLNV>G9B:E.+,1#GU];P&KW/1?=V!>+
M,N%Y[U_0 RF4J7F>U89)HJ8)^1KU4Q)/[P9=YO14HL0T7K/)^(AQ<L6K'E$"
M1)K[IRU:4PI_.G.P8:E=.PO/ 069Z>%08#T[1>QW_2])O)KL%D[4PGI6Y7)*
MZE8^^_=9!022!H\J_A9F</T\Y@./UOX"? -:X2@0/IZO@H< QJZ#=H(C#CYV
MH#,](C7695<.*]VU2 F[\0 ?+]<5*&O5ISB0RB_._)@'C+)9Q& Z/RI)CJ(P
MCZ4J'^:LE-I)ZOH+F9C:H!R) 7 /U(SW"FC'\^P! 8$/)>1>L7UXOQ&:G^G5
M_;W^IT,Z[<ESA =%<H3'>N0D>G2#3-_PSX)2-)Y$T%(7(]ZH?2L=R\?Q)M/T
M)1ISK[^_WK%M'G'\_$B15YPXW:R[G WO4";M1Q&-W"3?YA8/_+*Q_EFD)."O
M>*.TG1/5,N@STF4*^=&@W;:N*.KPIPX?PFENHADBG/,?AP7T:%PI1,]\#"A5
MZ4X1>&528JLT;':1U]\[ DU=^U<Z@%'WT.<.9&X&4\KW_%#AT:,^+L5!H$G_
MI2(S$W!J9YQ-=AZLZ!S0C@9AC>CW9U7PK;6$F%5K5C(U(50"?+*N^2-(X<:Z
M.%R#298<"21G7NVMI@45AEF?49*[%AG0]LB9WD<$2NSH@EJ]VX8[QZO[2:>G
M]ZF2E?[H L0V/L3FUX57?$Y0 ;>M/UVL>+(.H9L^VVF@^C)N;D?2IK,20:D>
M:?R?\K+_*6>P*.+$[>C-\V<1H.$S,IW*\O!T.>0"F!-A8VG\=:C8_6:%4LP6
MMQ_4ZKIXC+WU8$?2OBZ5CPX/@Q"P/B'D%.:]:<=P\?@SA3<@%]$ZT#ONBI 4
M,HHN3/.=G2&'7DT? Y:"YM:-(,0/]0ER2H[8A01P1O-NFT'3>D',8?*5[F#%
M0Z_]HTSK]-^]!J.Z7(X),_(_+]#L&KD72DD&@B)?*L.[8@?/ 7%334;W3&(1
M+7FVE7D-CFVE'_5,?1N)H8OHP5_G *5WJA070Z%"78:4MYRVHE5.0A:+\#,Y
MG7GV!$!.]\F(]%!X!<M811C]Q5/5O3N3HT3MB4AWLSYUP<10GW, Z[L&QJ)%
M$O^)S7/R_@_4D9/W=!->]847P61I+ 'TF_J"T?2XG@/>2I$0?DUDH':DWS8I
MZI\?W=%UJQN$P(9GU_1O-TC/G2V2:7,)%TVA675#4OLC>6%CRN"=W;+A*@+W
M8H]Q;^X?#EG5&AM+B1>W$M,G.%,?\Z308M"E\O=I;S7/+B^V(]^< R[G?:\C
MF"W'"W3>L9-MQFW=NS,C49$/^!9E+$/Y*K$-98#B9[/&C/L=$2M"%?7X!I*B
M'7(UXN@"V"UH=?XGM*+OY'E?UZ,9_&2__1Q -[PJ[LV#R:UO;5 2NEFK>XRR
MSLOP?"',/BQ(Z%_*-.*"WG,5Y&^M)1'5,\?YZ@CEY38+-NZFI+H3926(0RQI
M"1?6JOT6Y?QS_@M(H %(4"AM2"^9TPO^@2)NH^A.>13KJJVX#)JW9 \<[3NQ
MJ*8C9LQJYV2(9EUJ>='PQJ/8.,?9A@3%W^!V\QT9HGB9B9%?3K8V+V(&R4Q8
M[52_-7)CJM(K/X'K@_H,)XW)IF: *Z[OM<X[)[7+6Y XOFNIULBK3]U.V!0;
MDE;D Q8T=B7D(#777G9[NS!<Q;Z+Y>#[5&7U84VE9'Q#,]+PP??JT?R%3&)%
M_$+.1!^T>(7Y33.+ZTGC[HY/\'WROH"/^J>*W7#&ZSI[*XVNZ\Q<-R2# H,^
MS/=PRQ' PQ F\HTM),L16Y4;U%A0YFL0YY9=XCJGN39+.U 6H9$OJ8K0GFN)
M5VX&=V'J\PLWO]H^K1>D H3+/5VX2B@S,6B(F:,R02H4T;8X>44)A=-JFM9]
M>XMG__8J4B"NE%<&[':)3B3O_TJ*\6\F%-PMR4Z1 B_2A,J-1!?ZFE74U[S(
MAO(P%X8 35J_)N E$5/59>\WNT8Z#!]@!@"<N\86^WA>#'GWY8-]*Q9"" /C
MCM%H[?JCZ75U!UI>1JVL.RN-W_T%#WZ\K*=U;W JL+:.^*F@T"+ULOKG0Q<?
MZ4?[W> THZ8H_;Y/EUHNBYA$<;+W"UA>S?>_^[UW(#A%[6KU#K6[C>M43O#3
M,?'IV.>G8?A?89VH0K L,/;]FN@<LUZ4%AZCG.&II YFW#*_-6BPAA01N>%C
M?#=N+C#OR>Q-RF)W%HHS(H7.Y<W2+E=B,=]XJY46*'AJ]!.5YSILZ]N1/,5U
M0[$V5W;[FT*)&4I:M(,(B!X 9:@E4[]67/O4IG1X-']Z7N8^FZ*%P=9LW0,+
MD[#D&- [_Z+:^\CY+(0[ *6OQ^;3QGX<1;HC\NOR']?IWL,-OM>)<?2]POPI
M=_8^[E(*'K%3E.9CWF>B[B*;;/M68P=&/:D+OQFM[%OE%SH*^TYVC&@"!?ZU
M;_(ONW'@("'H1!W],+9[:DG6\JU)%O>FVV4J^S'##M?V7ZQ/ZM7M5^N\1P&
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MR"P:A:P@.A$A9]V7\9A!.Q_*S?;:C:Q^*:7IZY&.0MD1AF':O^=<#8WHFJ.
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M]6;<7]'Q/;%C[..LB8_/S\GKO6+$$YECY#X5\7KV)<1!GZ<@G"9W">0K:E
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M&GZ6W,I";P1[WJK P_QOGY<+5[39 F]0_M"[4C!P$OZGPE]%5M+=_56)BNT
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M*4S765!%4$]E;C>Z)'+F$[PC*:@.L+J"7[P,$XK3\%]9_.<QU:*QX"IHD/L
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M:6<VG)?I<+.:T_B$R>UR%\::)0C;6\<UD.!]XFV >,:-6%!)8B9+5U$GJ<*
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M=]U@PH+\NZ[Q[SGT=+QF_)<.7 6T@>N$@Q\P!F0!)4 &N$0(O[2"7<)_KE%
MR\\_(M##S3V87Y.PRUSX]7V=I"3X92_*R@' SSW[QY+8__QK+Q*Q4_Z=YYP(
M '*$P(V(^N\\SZ\ T)Y'V'X?_LX3]2(X#0T >&?M%!(8^D?>+[="!E ##  K
MP GP H* &"!)&)\BH I<)HSX&F $W 2L 0? "7 '?(! ( R(!NX""4 *\!#(
M ?*!8J ,> 54 ;5 $] .= ']P!#P"9@"X, 2L 9L 0@ !6"(B(@HB.B(6(@X
MB?B(A(G$B62)E(DTB+2)KA.9$ED3W2)R(_(E"B&*)HHG2B'*(LHG*B%Z351#
MU$+41?2>:(QHEFB9:)-HC^B$F(28EIB5^"RQ"+$TL3*Q)K$!\4UB>V(WX@#B
M2.)[Q.G$CXE+B2N)&XF[B(>(IXB7B+>(#TD $AH2=A(!$DD291(M$B,2&Q)7
MDD"26))DDER24I)JDE:2 9()DB62;9)C4G)2%E)^4DE255(]4G-2)]( TEC2
M5-)\TE>DC:2]I!.DRZ0(4AP9'1D/F3B9"ID^F169&UD860)9+ME+L@:R/K(I
MLC4R%#DY.3NY*+D2N1ZY-;DG>11Y*OE3<BCY._(Q\E7R0PH*"DX*<0IU"B,*
M1XI@B@2*)Q25%#"*<8HU"C0E#24?I2RE#J4-I2]E'&4NY1O*3LIQR@U*#!4C
ME3"5"I41E3-5!%4&U7.J5JI1JC4J##43M2BU.O5-:D_JN]2/J:NI^ZB_4._3
MT-"<H[E$8T+C07.'YC'-6YI!FF6:8UIFV@NT6K1VM"&TZ;3EM.]H9VGWZ>CH
M1.@NT]G0!=.ET[VFZZ%;H$/3L]!+T>O3.]-#Z OH&^G'Z7\P4#$(,V@R.#!$
M,N0RU#&,,FPS4C&*,&HQ.C+&,A8PMC#.,!XRL3#),!DQ^3"E,KUA>L_TC9F"
M6819F]F9^1YS&7,/\RH+"8L@BQ:+$TL\RW.6/I8U5G)6459]5D_6%-8JUH^L
M"#9F-GDV"[9PM@*V#K8E=A)V$79]=F_V#/9:]FGV$XZS')H<+AQ)'-4<XQQ'
M9[C/7#[C<B;Y#/3,U)D33GY.;4XOSDS.)LYY+E*N"UPF7&%<15Q]7-O<K-RJ
MW$[<R=RUW',\Q#P7>$QYHGC*>(9Y#L_RGM4]ZW_VR=F>L]N\[+R7>3UY'_%V
M\F[RL?!I\'GP/>*#\7WG9^/7Y/?F?\S?RX\0X!'0$P@1*!'X*( Y)WK._%S<
M.>BY>4%J065!5\%'@MV"""$^H1M"T4(50G/"5,+*PN["><(#PD<BHB*6(HDB
M32+?1,^(ZHM&BE:(?A&C$P.)!8B5BDV>)S^O?-[K_-/SGRX07U"XX'ZAX,*H
M.+&XHKB'^%/Q,0DRB4L2OA*E$C.2M)*:DJ&2%9++4NQ2UZ7BI)JD?D@+2=M(
M9TH/2.,N*ESTOOC\(ER&6>::3)Q,J\R>[ 59)]D"V4DY.CD=.8A<LQQ27ES>
M1;Y(_K,"B\(-A42%;H53127%0,5JQ4TE(:5;2H5*,\JLRL;*J<J#E\@N7;D$
MN=1^Z5A%4258I59E5U52U4OUC>HW-5$U%[7G:JOJY]0=U4O4ES3X-6YI/--8
M @F '$&EH)7+@I>=+[^\O*%Y7M-3LU+SQY6+5P*O-%PYTE+1BM%Z=Y7DJN[5
MY*L?M9FUS;7SM1=TSNFXZ53H('05=*-TW^F1Z1GH9>K-Z)_5=])_K8^XIG0M
MYEJO :V!F4&^P<KU"]<#K[?>(+YQ[4;VC2^&PH:^ADU&@)&^4;;1O+&H<8!Q
MFPFYB;%)@<FZJ8QIM.F &8L9V.R-&>KFE9L9-^'F8N8AYMT6#!9V%J\MCBRO
M6F99+EE)6\58#5ES67M8-]M0V%C8O+0YM-6VS;%=LU.P2[";MA>U#[=_[\#E
MX.W0 68 .X+K;I'=LKSUYA;6T<BQU/'PMO[MPML()RVG/*<MY\O.CYPW7=1=
MLEPV7-5=LUR_N:F[9;MMNH/<<]VW/;0\\CV0GGJ>Q9Y'7D9>Y5YX;TMOJ ^E
MSRV?%E]F7R_?7C]>OW"_,7]Q_P3_I0"5@)P 1*!!X,L@HB#[H.9@5@(Y&@X1
M"[D?LARJ$5H0B@ZS"*L+9PKW#1^.N!"1%+$1J1/Y(HHTRBFJ.UH@^F[T<HQF
M3$DL4>SMV&Z((.0>9.V.[IU7=ZGO>MT=B;L8EQ5W$&\9WWKO[+T[]U;OZ]ZO
M2*!/"$R8251-+'Y ^L#CP<<DN:0G2;ADY^0/*1=3<E.PJ4ZI'])DTAZGX=-=
MTS]F*&84/21_Z/MP.A.4^2J+*2LR:S7[1G;C(_Y'R8\.<L Y[W/E<XOSJ/-"
M\I8>7W_<_$3HR<,GV'SW_*F"*P700I["I,*CI\Y/QXLN%U47GRU.*3YYYO'L
M<XEN26.I2&EN&7E9:-GZ<XOG R^47[Q^R?4RY>5IN6_YTBO35[VOE5Z_?L/S
M)J."N"*D8K/2KO)3U=6JYFK)ZA(H.S3E+? VY.WWFELUT[4&M=UURG75]<+U
MA0TL#<F-1(T1C8@F]Z:E9NOFL99K+=VMJJT-;5)MY>T"[04=;!T9G=2=]SKQ
ML$C8X3O_=]M=;EVKW>!N>(]5SV2O2>_'/H.^P7Z=_IX!S0'8H/I@^WN5]RT?
ME#\T#2D.-0XK##>,*(PT?%3\V#BJ--K\Z=*GUC&UL<YQT'C7Q-6)_DG]R:$I
MPZFQ:?/ISS-V,TN?G3]_F_6>1<Z%SF'@=[Z0?4F>9YS/7>!9*%T\OPA=4ESJ
M6+ZZ/+QBM@)?=5K=^AKT%;MV;YUN/7>#;^/U-]EO[9LZFY^^VWY?V_+?PFPG
M[##M%/X0^U&_>WEW&&&%6$,&(O%[J?N<^^4'\@?=A\:'"R@?%.8H&<V)?G6L
M?#QP8GFR@0G#4F ?GYX_;<49X+[@??!X?\= QU]4X.<#7V)75P#8*R?$#=8
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M<DJ:_[+@YPD,^C)^#J E(2(L)A(F  3@<&*ER<#_G?3*_KM%KIMW5>X!3SX
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M\B)<NSP4QMXP4^Z07X:)+X6E\,WMXZ@);HN,"VV&*.L*C25'=Z@M,AT4)]B
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M.:F-EI:] NU.%@D4U+LVQ<V:?<78>D4Z\9TON49-:7V:]0L7T:.CQ5VY'*[
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M?4'^J:XYQN*E@+,2[LI+YTL]QY=WC@,U[)964N:E>X/0QIOLD>69;R)H?N[
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MD&'I-0>EI>'GT7"YL^OUO9,)HIM"-UJB9&RR4TLXZPZ[VBC@G[LOW:)L _;
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M3\30!(+)T91L(HIL54,!4K7-KM(>4CK*["DZK;T>\BD^8EAH1M3(ZU,GO2/
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M2U\47F&!J$_FM';BW.S6\9J?-,MVB9IO3<CT1X^#)_;O#M 4B:!V"8YJ2DT
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M'Z9JB70]>F@1J^)Y>*!QP6"<_:]GTQ,.(?=RI44BIEZ-';^^S<-4@)3MHVE
MQ(8@]VM9^K<M]Y(ZAZ8Y0VSWIVW/C[5RJ0MNB9<5,HF4.?PR-!NNS(^">[LX
M^#3;UGQJ/G&RDZ>AZ)/V,;98G;:ZF:$*-@'J X),HV))#'H8W>;.\L$@5B0U
MS,9WK^2YC3!" 5O##/RE')>W=5(23D"%>0GQ.M[WBV\$'EE&+WA$7<]+P#0;
MG#IZZHS6I;R1E4K[C/33P5VC^6:\UYMY+)P7P%<8JKS0>IQ/O5QZK70G<5%0
M%G5H'HS-3]>(RS>4]P;/.].-W.%X3?X !Z4E>>=2.><"QT(Y+H6FS4OXYQP1
M/VVJ^.ZPR!Q;2.0W[_U^: R\DAU4#V+25%ECY%TI873BQ\+RQ(OR,M%77Z6*
M>GZY(W!C1A4QP7;&B<M*R( #JS=OJN,F'6=DK/H!0:CWJ%K;C'# *KZL6>5O
M)U44:3Y93KG<Z^7.VC%=<_?A^;>R^ZFS(TUY?MT^KRRR#"/"YM19B(%3N*;<
MI' PH_,EDH41F\3N@]LW"^K U48]H"]T\*KO1+JDQ&@Z:.:,=.7HI:&;QK M
M_(@J4\#GN).^9XMG<U\P"_.3D')$@Q9XJ.#)X3GZ%"I9%UK?*H+8,W\]/2E/
M;0_5OR' QB%>EG9]-BX_!:5IOUQ9\BX\JS;[9X7IF9]7<[J#7W*\^![3)L!H
MYX="@_@)@A]HPD3+^I+"R%CSZ[#++-]8S\C-$OO>)AWO&UM:1/#5X=@AYXF7
MNP_#L;]"KA:[1$HR,6SYJK>%P)WIY:%>.LZF\;PVMD0860,^,>R:\D=$!3DZ
MY=<K;M]20NX>;SNLTOVL_%I'!;F+@#4B\N-85[W9]]K;"4F>QW(W&^,\JK_K
M'XGY-DGJ<C82&9I53ND43PM[\J_ROORW:O4+>\-1$"G"3D.T"TVFDB*0&M.^
MJ:P.5V._WG!< ^9L?01B2)!I*E^S)>CM8(T[OW_=?:!97.MS ,@SZGX18)_1
MO.YZ<MZD9%MM3Y+O+AVO\GL"73*ZYFOAJJ7E?&8^=P&NU:]3N%_*2W8(D<+)
M0,%JB.P>6N;M <!>+B@%NEU5BA^?PU/&'%12-6L^J8I6:12&H0>I-WXXRILU
MYW3-*>TW8.J4B]QCZR_Z,?$ -EYHK"01<4WK1ZF*(9@9]##NF6ZIW8?=!SKE
MF73$-<Z/L/7^D3;1^%+7Q[?8Y.(D4M#OX?3E3YCU-PC:J/-G;MU==Z'N[^RR
MRUFI @7FYL"/7GI0'5=/;7AWB7$T"]YNGE."*LL4<F*IQ_EJO2()Z(CD(BS@
M60C0YL0YU'MU<.Y^&FFI5%-H=$&OZ4A (4!%H!5I4$UDA3W--R,'K+G&)X:T
M#Q'Q-M4W&8*OU]4)9_/@$]VD'']_B1E4L _;E.&GVI ]"!,T 05T(FPDJQS6
M%0E)L&VWC9A7>J(JL)+UN]IFJH>=_%3=)NWQ+N;YAXVK6)Z7!9^Y\4_X0MB<
M'R.&?^W&XH/T$\/FX6A!?H-#)_-B6(@H20%CJ/N1M"R^,E?TVK<9'A)"H1[.
M'\P%N3$$_J5^,2<(L6ZC,[=[3FL#(?]RD0EJ#D$&LM Q4.-9&-KZS.+Z-"<A
MIXN6$C>]E(89N]UY7WG5E5(7X0 :7+"2)A,)Z76)LRE\1*M#-Q-KEKYQ.88!
MK24>ZB^X]<6B]V*%:*X#TO#Q("Z<JF8W94W60R"4EU)NCNUBN6E+=1=+7U=]
MTN+N C:#Y FX$"J(=H6HU#.:)SQ::1E!GKAN'<O@IB/PLX@E/2NM&E>'X@()
M4N^6EY<0]%-)HU)&YH9SNH*_Q]BVPRJ6,)44MC.+>YG906DC7;4+>HY#<\J_
M1NPL5]H _$CU<^NWPBV^_Z<_;U:"8R0G%]YOMU&!N2N">OCB3!X;BCJ^I+Z>
MQ[05?-_#*B.?_%Z+,%<-#.B<N.?9)5 ID#?Z^6$)4SNKO%_/C8FD<(O4*V)%
MRHX(F1:A,U0APHQ^N#$Q>6$$OQ#3KK4Q<:^6&2ULK,% RO3CFP:_ 8F,ZOTD
M2V_B?V%1\<+^[H+<$3/L$C$M&=(F+M@;FY*8O>2:\Y%I]%L2.7S9%S?].YP\
M1/.R7*1'GZEX[[[J9O/X%,B[T04DA9'I_?U%=M$?4N_ ?@RM]MA/\4C@QA_U
MB!!?J%#)3)MHU==QZWF>5E B=,:)5S_5)L/YG+_G\@-%XY62*)*F])WK%Y[>
M4)^N  M03<E00I^N8[4KE'2YZM0SP4>?UY@C#@"YQFCY:WV&[K9 >G2P92X9
M3X!%4)5F\D^KZTQ9P$O,U.3SD@3D[T\2IBQ@&3I9?E6-&.0[\)3\K_)-Q?YS
M/0O/GU+*-\OQ%X#<ZC:*9J&]?896&E-@&)RYV@/1.(5D6<8YUWR3BP)?LNVN
M,]U8Y'AR=&#XA\[TZ4L"P3(L;<HRF:_7V*7R.[5O%HQ'5K.KB"F._</Q)$JV
M5[L0RZ;>-W:9><EP+T-M*AV;4M4_VNYR?V(UY/9FJG5!EA)A[Z6I8O2HNKD&
MC9=9Q7LOK#ZE9#"&NPK[WNCG(670@R=/2<R"GJ;GM;((B&HJV:S:)>?QKOFS
MVS$)I0K!>&(Q'E"FRF^CU$X6F@$W6G_8^U8)?J,D4_JXD2>AORU._<(%!^FP
M:]%H3RUZ1'?HQ)8YC)7*/BB&=[FM-,9MNM441JG:PUQ.YTK[\$<7+S@MZJL-
M)Y"32"'D6Y-X'^AI,LR$HH0O.*)-ZU' 7V7@SSFO?O9WHK/4(AW<<AT*>Q_3
MD-/)+#=^HZ9$!QTV\E ^D*X\W(KVHZD;;KJL8[XYP0K$EM!:(<<# /80CT6S
MOA;X)PD:)!>]?GLJ4' @K[XXJC!L\P!P!/* (-947 $]A@LJ-OMR+GA9NW2]
M&T<WDVZVNTM;2+J=C#?C,^.!29?AP-&UXT.6GQE/1UWO.<5Z1Y-5RNVUCL9#
M99>VVJM^0#,BC"IL/5+/1C*N<?C94U-*FS]-*:AOFWUB;(LJ-JEO]281FA+1
M,G'0(N[:'O#>;ZS/V@9I>T:U.2"Y\QK%):[(7._D4@=_R/3EFW8.*B-&1:^8
M5%N5C#U\;2?DC>^-_A?? _B0#^U?)17[;Y+C&Q#Z+N49UV8+0\H-#BL;1IRP
MEU&/L<HDJ_/<42?,U#]J:?P3C#7_9\+D_Q?*%[. OWC74[V,Y_5=;S9,K F
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M-P#8 ??%+NZELVOWYL3,.(_SUDK!: 7"B;@N&=CUVM1*0METJYH$W!U')K^
M9;',&>B<A76"IAK;U*2XGL-/U+\-"T"B7^B;M+MG)3;HR.^CH(#.^,@?O8]
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M;5IHS<!*RRJU=51VL615YU0D>4\(#^*)GGUDMTGS(=F(4<RGB.AS 8?WIY>
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M,NKO8NE$AKX9NVTZ,Z\O\<EU\(JH'6)Y)TT>AM3F<M'8PF,O2_=M>^7%K4^
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M'8@;M6W0-M<&K%T3N[C3?V2T%Z:Z:3\V8.$)HHGW+(0]O<ZY!=C]P@\8O03
MT0H7_HKNSWXJU?:LKFZT5+TB(@-94+F-*=_K%] 8HN3FXFWPZ:TIX!IG"Y^4
MX_BV#I#*MK\ ;\!P5& $M)NL;O=2?1$]'IX_>,42]S3=:[F(O:E+:_SN8VNZ
M+CRX#-2.=3D?27;XD&,L;9X5%865&]+*W3U^3BE8V)LA4KS\VRQ;P!N6<0L8
M%SW0^GDSJ^]U5GW-G;^;'96->G<4#:;*\O5U</9C+6A^;.CE)T+6^,-NS(J3
M^9,NJ]Q4!Z2U)>MFRSCJ^V934W*4]+38MHN&"F<SL)Z:>K\[@[M<CD5M3\/Q
MV%SA/[2)$>3C^*[S@>PXFN^,W2P",VZMNE(WG5/><]&^6_3"8<!<UQT%_P&4
MU U1.\0#M0NG%B&KIGA]"W"TM1UGG3,@Y+LOP?'0IB82-YO77&:^J[?&J2ZM
MH&JL?!/:=@_-V'T+H#P5F9/FAAGL7T+.LH;-'^M<S]$/BY?%DY549==#9< D
M0%ZOVO5;0 3;?!MKE:FM3R+"\'#AXW=H\]-'^@KC4@8LJQ>PZ;A%WQLB/<1X
MQ+0AU@E)K']#@>9;B&56,(D!'EZZ.YI;^-SGT+2^&P*C:"!RN][9B[..%:.6
M6=P9;_S<QR\BIM18*=DV/?T7>'_[)UP2>SPH_(908K\D.G:BO9F6)9/F$Y4R
MAE$N+N^))3286U\T6@::53_FJ[A_Y_$QY/@MYAJKXK .C@"EK8[5I::E5-VX
M+ S03)1.M3/1L-"E921Z2&?T4$KS"WCQ9NOB)-$?C?J2SR,XT3!,KZ<GR>\(
M:Q83_!_XHD?PA^[\VG_?;^Q%FI?0L88W'5LT"#'BTWX=4ROG5&*RW UTXN%6
MK?)E AT0'-!6[3%L']P""L1RK!(-AK3X5FHCCP80,E\DIJ5QM<QG:5FCY2RI
MY3B>AJ8K/42:X9]80]#\4ENLK_=IIA)%OT4:YPIU1_WA&@_Z%H![FGI?HM)(
M3]9Y_C.D[ZS=\&Q4WW?H/H/\]%3;-U=CG>4T(P,,&-_K9AH<R\@Y K+-V,ZW
M:#4'O_!RU?'G-&AHCOXL3[R)@?E/MUD6[FFS"ZUR9KWBD-JJR> ;M1O>ZS^D
M^H(LV;OL:XBQGZ<5H'A.2E9Z6A%C%G+9C<X.<Y V1&2^586'6-<WA^2[F6=$
M@\C%^Y6RL'(V-NT/WXOY7,V1'/6N&JU!6JWCE6O\<C;^Z%=')[4(?<V;YU4B
M7'<*6<.;.+63?@&UO 508(M>*/:^#R.(/&4&(01#Z]M=E>>LZZ8#>BR"A]OB
MH05XDD3K1:Z?#H[.OVUE.%K;MM6^^#:?Y[@.,O[ZNU6"6M)YDFV-SWV<;&\I
MZ)M%D)W2H-4'>F2E6&K!KN1IRT@J4&VJ]^G2: A>AU^0RI-D-6UA,<1P!M$L
MFGB>A*/9>_.3Y=!%S0N#E^(SJZHR<2 T;9^_E&I";@.K?3SQ'[-DS1XH+?\9
M89&IG/ZL$E=/NQ=B7UF7):]\D5W0]LCU%RN2-,%%XR=VTL?%CK:OY14K,/<A
ML?NH%TO?*57K'68>_T3!I=J=MV_W'52(&Y+XT*?#;M0.;%R%<?CUWK(])-80
M&86*SF?TBC[^TV8EQ[32&7/"<;S5=1PC561/XC<SIFWS<FJ4%ZAY5DAG^K7_
M[I'<69\A D2\',@$X,*KISJA_*S1$Z?-_;^7F?_G:SU:256+W+'-W_Z#%*+K
MXM4Z0\@0<<#'"?POMOE;'Z^Y2!@:=#]@1A44 ,K34F*N<?8NC6F?>EB22>C[
M "H8FVW\ET5U']M!5 3FDS&R8X,]) LY]]FM-3)E;-T6UNI@W & )1GN-U\^
MTUDI )04I'/,OTK[Z/P76Y(#@[-5-W%R:%)^HMWU*\KA'FP<8)9]K;<A9=M0
MP7L>Q]_]@>!*EG B9I778QJI'_.)<BR^^["'FYF[25FUP'!&2VO9I ?Z*&5-
M+TUL\Y%W*<_#?T@Y9WT3S5%3E:_>SMG=[Y@-1Q^&X4)Z HFN'))3IU3Z(6:[
MNSL#=T+]>1FD2MG&R#@K%=K^\&<P '9\B.R;+&.1-18S[%& 8Q[?B((G-M&X
M]AU\U4@8Q*61ZX&LN+/^O^^\@(V-H)"?ZDZZMWE&&S2\XL!RJ87O@ZLNC.]N
MMC!9VF?ALK,OP@GMX(>[NM_5;(B?0^35*-['_Q(L!-C&!LO8_M/:;7L'#YGR
M_ZV?&Z^VCP]^/&TMZ5 Z\2A':.BL^+^(-_7@->JOYY19/_?0GY;K:OT@EZ--
MN.N\+?6*_@PFB1V;%$@BPG58BK_VKAKOHYTW<HQQ=K;.W9:++[!NT^F]$6+A
M_!$CZ#!L3\X*SQ  )E=0KXY8'U2XS+R3U#*UX?JO:LZX9DEB;MP/;QZB5[^N
MT27Z7F@O& Q<#;C&?26M1U)O_*H7[.U:%PP%Z>N?\S-OE5X5*D@'KI51F7IS
ML4DFI["0YN\X!2S< AI2PCON2Q*$9/%KU7_P6G.7..Y<G]_*879=V4KUB[Z/
MX9/C))AOI\;0?11Y_F,S F4P8H)VE]C\"ZW<,_Z53HV C'/@GJ7?57DY@T\^
M;?'%LS+'Z%97-\_\0=;7AE0)?)#29K\7(1OB"PZ&6AQ%WHC7&+?^S3W/D^8L
MWMTHUI1J9[ =M;+EQ?#4,[C-+A[)DL _.CW<O_1JG.</C1&M\[4T&!]\=6AB
M?[/\8W$_#9Y>G!ZE__7A1])(J7DIU[\$^!1;3KC,D5GP(>[K6\FBC4/#DYM.
M.#T_PDX6P:JD>R_<,$S3R>A83YHBR>\G^,6*>RVI;K-9EI*7K..^L.PF$91'
M%M%:,8#KTOQM!K*[HO,S[@!T(9H-;.BE+><Z K&$?Y=8G#DZ<A"-8S:)>FN;
M\<*NTRJ;(%>D3 E?57HT6;7(2M^D5/28RPN"@<U)6SU6I^Q*]5S/;$5$QPM#
M=G_=\X+HH^\GV7E6+,>P&"=DUPSUP!!F96GB7V[(=B:7;%O4Z]L&?D=R33A9
M[JESAOC) MO+.RHK?GZ?O_^2NN:1!PROTNLMUKD&F!)"]..&[^+[@A=8.>K-
MY/N&*(]9$]Q:?64:H!,6<@MP B_G=E!5CO?\ IBQ>;7H]A>6O9&'6N6R[DTW
M9BE)R'YZ],D@IDUW=[CNPB+VLIY-E6E*4G-9'',^#<2O'/B"8\8XN Y4%*B9
M'#5.WV&BQ\M.D^]G&^QW64V&/\-9;:A[(EDC!-V/*.P;)<>J?:Z*VUK]1U8\
M\/,".]\!F %X-8Z.UNW-*4@D* L)$E;ABS;,C!ABSU+AS$B+[4@G"XMYL.BT
M<I&&C0 EKW5E'/M,*E#/N/X?/8T9.R8W;L+ E4-6 _W BN4"MJ+L(61$V"U#
MG-RZ>;A%DX79D9K9Y]Q;0$H"*4&*-\ O+*;X+*XG@'T*9YYKL"_)?\I0E.S[
M*&WM>+%G@(?E"_G\-+,"5-+]-/7 \^K#/KP6'&$Q#2M(UT61'/0<+EF[S/6>
M-07+,-T9/OWT_-,KWDWD#WO/3-'2/82S2TBN3-SR/6GM.?$0/ZU"K_F>I8#F
M/+!\Z2XMJ@)S_DE,6]?Q2T!.\* T"^2]&_6Z827]45%6B1%7@0CQ")J==EZ2
MX\#G8QXC)N:+P ! ]N/\[]1>P47(!KP?'#$?W/NN+D\B6LOTYTTAI6QG0/)E
MU]QG0-6*&(\!I*E24Y8Z.)2?0SP7-=_CA'TF'GKZ\^4FVJR0_W#GR;#<^8M=
ML#E6IUL,3(;C<,C;B;_;6!?W065:VK,JC E9M@<J&EYH>9(HWUWR!R*YD-84
MYI/87$C,P21\O?+16RGN-(Y\/U'Q9/E)C+=>7+WWX>^,!G$2JGP(3,L,YHL8
MI]Q?.G!9T<"D.,QJ=>R4;F.E(,X>5HF'*^+O5FUUM/2M7DI(Y??? AA.R4([
M2$P5,22OC4.XBI\^#W#DA8&#+P6F6T<L?+<J30WLUNY.5%G5/)4(0KQERIC8
M*LQC"(YJE5RTB;UW;X'K,.ML$TQ9__;0 _%QO<&],2JIM51T7#"FREV!W-Y5
M61&IM^'4>J0G^D!PB]_5P9]CDPU[_GYC]XWYSW)"C<LG(N6ZTT\<7J_7B/#7
M*1T9TNI<%VT9^CBQS[5C:IU*;*N7E/>9CYDNO!E7?.;H=HV-2V/3[U&]@U;=
M>TYL<PNH-(H>]<R]\%KE4Q__46HYY? Q-]9WL=_$RAP_"3N=BWYJW#\I_S'O
M&:+&1;FT"2,D3*;Q5?] S,BCDI+QDX,5LUZ,+GRBN,X473-.?B.ZE>9)J>A
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M,CG;&F@B&]U!9[9/.VVZ;"+ F,WE/.K]I[EP'\CL3'*0V%_Q<CN(U^HNQEI
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ME%8ID OY%PD7H"=LX.U^^)5^NFAH^*$C_QGKHU^:$*G4Q/M?OTK/YX9UCC7
MWGA[50QG,1\7CHQ/\[_H-V.<$V,D(]\]276(I/B8 DQ>6#1NB%;OZ^NNN9,<
M82Q5?NR$B$TJA72\G'([?/;[</M%1>#71 !!QOP><TIE\77*TO0[./CP@:5>
MR@:6^?, M5=TQR=HBTG_RX]S&6<5%P$VKR]70U;"#FFX*1JU,T>?)!*\&RJB
MI'V]UG'VTQXH_&-ZV_; XDH+_]K5?]K !3NNEW4RJN*!I_@4W'K:!WG+!=.6
MGJIY#LM&_&42XDDX,O+K=FF;8J.=%J70T\/76EZ'6R;+I/>GISJXWU&]!RW"
MZ[8C;U@U_:DZN*J3M- "(P\J-*:B;F;]+IQ8>V0<12/8.B;_&*>D>8L_AAF3
M48>%L:FAJW4N5Z[S[,"Y6P6?A7TFY$N&%!]>(TE\I-.R/^,X>(:*%TT@#-&<
M+J-L ;]_^%;Z;USQ[8,?PFWA &!2.=;U;1V:V("RCTG.L'-'/Q);_%H:5YGW
M:4$T/+5V6R7[VUY7/RC-Z&H#TW\=*<+ZP.O%#04,S^Y<T),I>U=_N2:*M6H)
MRQJO_+&<E(XE9Z[)3TWH^79@+.]#'4*@:J"RHNU=EC"1^BGGF..O&&K'<3WX
MM"+?414_Z$DU546^K-JL]JL]9XT@SK\I)9#!SC2HK(23/8.(0=U>N_T46'8=
M"Q3#R<]V\-D%,/[-9(F*TX5=B;RAB*\>L)DA+]?^Z4C<G^O,6\![&-6#.EE&
M]<J!O%]*/"8<K<'-\>\WCF$3"_+AEH;&?F4Y+WRRC; 5P[HV^J??+TEUB"8*
M[4O<J;3,)/[$Q@'?]TDJ627_L'^^;,!R)L3-LYD)P^W@,6U%NO;K[*K_YUHK
M,JIT<C<FINT\LE4!R1](!E+["2UD[GVP6^.>%F7<K7SBPAF] 4%G%RHAFP2?
M37**N=!9R66_5O"*--$DZ5%E_Y#!8L+B:M3-M/1=PZ^%57[P=X=IJ_-2/DQP
M$LAE8M#[M"-Z]>FIU=6O&(]+@BBW6P!YP!\"\A5+X%OW@MTZ4:T7UI^5C^3H
M..NIO^>@>4E#TT9,<"MIJO]#G5B.+;>84/AYC[MP)"#^P;BV I=0E4_C7%[>
M9Y9CO%9=!Y:O@<.G(DM<^)3]:2%GH9&.?+^/UUZDG%-O^13'GLE8#+VW.8X_
M5I:!S(O&2+@["" GOSU)_D2'J>+S8X^@!AV^7\?UZJ.^.I1&;_#N>#?_C?=#
MYP4PK0ZLCB5_D['*$G?GD.<F T(4_G"/X:%0\Y>+5^NJ[22.15D#4E&Q6^I4
M6KK*)8>4%>%]IAKRI+-SBWX:L_Q/8L45FA9QZFO-#-PB61OJE7%:DQW<1FNJ
MU6 YC,/*?8WL& _]QD]@I2UCM5JEO>*7L*PQH6#C#DJT2 =CA_Z]K-D.G/<U
MA%Y'?V))E/E,IB9R&X'&1 @3B#\55O0@'\14V9A@B[D2\J?)7^/WQ@)1%;J,
M8JZ1,@R1HZBULLL_,?<V8"FC72Q%=65BW%)Q0?)497*5U0U(IK.[^@_VC5,L
M:7:/7HW,-/*Z_T@,J[<OVD3$^N^F"CF9=OK]'*4YYWW>_VFC)(=PIZ#P_\[D
M=F)*\SB+U_DKK!TBZHC<*ULO6&FR(M5O'G1WW0=P_ZW0#K4<9PX5^W(-I9W]
MZ/9[86.Z:]Y-P27C&R+1=5@PU'Y2^JDY>B!*ATNA[7MU74!V>W+ %7YVHG36
M [XP:O3YH?,MX!X!FJQ_JQ4U'VRTW0-\,!2K2-)PI V^M)>[8),]&6'Q7C&6
M4AHX.T"@Q.O*K@=BP,Q.'JEK/M!^IR404G"@?"N][^9I4UL-60>_P,J%V+NL
M90N=NG4H^4_?K/JMO_XW8TG'JV#((E+(+36T&O*/%?S'GD-@=HFIG?C$VL*J
MNHTW?L33K+77B8H]N=H/V/;!-@'CK"B=.$8_Z:QY5>R7&J_EG@U"S%27.Z/[
MS?DWKV]WLEBW)%A?]O,BRWAYOIKK&=G.9=I->0;+YL3]Q:,,?HSHUIZWE5@I
MDV"#.@"AY6M]B W;G[?T%PGMX=L-2J(K&.;]BVVL$_H?+8,'.#T(4I9P[YQ!
MK/P.X"V^7XV B];,;U,R>GV">)F8@-J (=G&QE"X+=VAGP22G""TS0MD6\_?
ML/SNL<O<P4KH'PM'_X?$">L6SUT*CY1T?6>$$LH+3FWFO) I:<U]DFTS/O+L
M[C'TRR%:B9#MHW @&_#Q?(&51"A368#[#BNUG]5UJJW;LDW?2/[6>V\M,Z&D
MC*2DF213D8V9K5*!P*E(KJJDOX[._9\J 6&M$PGQ>ST:?#TKR],-SLK%VD/"
MLG((V78'*LWU,H&[AX[Y7$#T<O"12@QU27E:F]#RGO# H^[@1)F]3%DA;R:R
M ;(P8=P[U+W^. AGL@_KJ!)G<.PL"MI+%FC&AW4@4B\S2*VSC)-\TD1T+5#F
MLQ5EAS1]YB]P0^X,>;FD&[VQ YGHWN (,VDGXZ7_',K[ZTII\]>WCKIU5W"A
MC^Q!W#H)^<T\1]G%%WH:WNQOK,=_]X/AIK_C,9HL\NA(Y*K\(0G0D"P9CY0<
MLAQJKNBXS"JAPPM3-YL'ZE>5(SPQ=1UB/QHG$HRUTUZ%&WK>/1,]] #_^!5A
M=$G5,EL)'#'P#O%Z[-GGSXTJ7F<-Z2!?KC5\)5C_NO.ZQCD1+J_:(1EM,6.Z
M@%JTLAN5*&>#= ;@176A*W\O^S>:?2?(=G\\QLA,Q9*M>M38YB,2BY!7QCW>
M/:OH-AR2,ES(UH T3;0Q>B(KGU@(I=M$XQ*;UB,O[).9,A<Q=;LE @;Y(2\?
MCE/OR9*X[R FK.IC=2-10#U-QA!]Z'U;(-4S4R.4R4CPC<R&S'[&S(>ZF2([
M$0CC-X&H3TJK?19+"35MFHZU<YM-:2_-9N<4]W[UF-P"8J5=(8@YL3FL^%0\
MJ^UOI4J7+.:)-O. =15W_CIFJ!>D=5J:T(;^Y.P>;6/8D3)N3DQ+3'UP?D*@
M;RO)B:=5Y>O=5G?10BV%NQ[HNQ'4C]R(>#1FDSQ%%V)MY]Y809OD[H(V;@$X
M*E?,9\WP6P U:^<E^^A?9Q@(L?$J6%HT3L<YI/SESB87X389$4(]H)WS0P=T
MA^!G5OSZ6P E6V#Y(/S]5+[31MO7Y_*Q5P"[!W_81+'J(E,F:L<_V=[R11NN
M+CM;>+-G;:^U1W<D_ZJWB?NFYVPVY$[_UZ!A;JA_)FW_V[06]<ZO6B@N@[-'
M\(J^[M<U=^S7S"3_,&J/5-<Q6]C"KZ5?F$#L!BH=>3^U$">$=;@%$,9& --2
M:6GA"Z#Y-9,M0ZJB*T\].EWYNI,3FUSJ8_&#??3;/E8Z^'I>!SV:++HNW?]A
M[X=5PS4[S-S4<C@#+^$&S^3PP7"/XP/+&99[GZ9[AYVW?N_ZCRTB-@A=N-T;
M!OK<0#LP'#4$4><S.Q!T\\2.G#&8O=;+\;1;6*WDCX69U*:)8 <5"(Y[C85"
M4*DWA+< I.;=GM]1HXS=(4XT0L?7>0K"J@$Q3UQ/165-XMBM'#Z 9GZ/<_U"
MR#+LP.:@BSW]9GPH AQEL"*:(+!.$*LBK6,M .PKO(Z%P*0;2I_*_LE[LOQ@
M;(5%[&1B?@A<;W.H@*Y%@CY7X'C1XHA#>+#(S_0N3R>1-/[#+[72KS9Y352'
M.PGOOR(HV=3K>;2G^TEK>21B0G>]>!3+^FP27 A':<*K_>Y=IXD>13*L/&6?
M/]N7HMMDV[KB:HI=]EP_'H/^=1@O01S5 "(=RXA);)W+C;,*BSBTF&'[0(=G
MQ6)2?C9,('LVE2%$Y.Z?V6&1PMR?6@<?O!".E!VG CGW4OVCBOC/N:,CEK)_
M"=X#I=NYX9RH4J^"%9H4CK9E*JX'[),6*@^RY=Z-[,[[FCP;1CO\!_H*?A?(
M9Y?-!*2U91&9"DMU*NUD4'[H"/&6X^6S635Y?@Y@.5N;_[V-HTC?^#'19ECA
M)S!3W%=5VZH]=<Y"LR7"XF9YO3,C?EWM9'0MS\R[B:9JCU&B;I3?0YWYUXMR
M-M5I*;AF/OG'QDRV8W "TEH%HBWQM:2Z:3N[W)7,O6= \*S;4!WDPD'@90I;
M<"QNUBQYQD\!_G:<8E4PM1[IT#H0 $FMVEP&O312^?MT:HKGH97ON?FFADME
M5^76RAMB/%U+)55':*6'!_"7:BNI1%<D'.#/M^K;WOJ_,"WCBZT^P$_J\9VA
M:O@+<1]LVMV=!"MG6R6=?\"_^>'+L''4P>C%PVQYF")I+-TM*SB2\KKSYGZ#
MF1V[GKXU%]R-Y>M:<&QRGDOLR)A6=+W]]G><ZG6Z'P?:^GA8)?6*YA"HF#7K
MO$7VB7<3')%-+$V 6NZGE919:_89_QB "(Y0FE^#:]]0>5D,&)W\<=PX8:!A
MO+-K\JMW?-&X!TPA[2!06&;W*6'S(&+6BY.U[\@LE)(!(6#X4WYXX+TE%T]\
M;'$?M"8@J?AGJ<D^30OQN]T2HH:"PZN^<36B2P(]U"FJY2?@RH0"-[PC@3\Q
MMQT,I%Z($)#F+JKP,3(<?*5()WSR:ZZU $M99K=!(]FM1'\UN+J_@XC,#TF%
M2XGYA9@P^UG42SKT2YIZ2F>KHQKRRXE["&-DVQ\O\83%'"&P*GFC51#'\M\"
M[PUNWA\M6+</;W<N907GK/#/_)2&#->XW6^;[E\CF K@\'(T)3!>^YA=D) A
MW"#;WV2_->4N88FZ8$EA?5)4>C*,N['9$H_&:;IN"%+92XY./C..H.\<>QVG
M.F!%4$7B<_1W0XK[L@C1SW(=BNT\&5+B'*5G6EE7SF%/'X=:L1$7$Y-9FF5P
M$A:LCS^KE)A.TC$*!S#S%F(]-V3 G6;/IT75&?;>&A=FNM9M> VNSXLKLW,-
M#_=*9I0RQUU0:T<FUBZ$J_2KJNP%C&#G-\;B4/,(SC!I>21VRM??C#IVCX6P
MBRE>Z@P6WD9R)82%8HJP T@9^6YMS3PLG1]Z_/>9ZQ ^NDI ,R+Q9D(L@ I5
M=^E86OYK=Y*CSF-N@ ?+MG4)V@-U.MTQ\I/!.A7:_=AUWM7Q?C5*)$!Z!/6Y
ML,]&91/\1+\XV(5V9RJ,I;('G)S ,6'7H?5D=WJ*EKQ>:+;._0DX[$60C1^!
M1?X&,T-D7$@J>LDK3BVEVY!*F)Z6:&WVZJ=;#!]%@4/-ZP)>'R9WV CK\OXZ
M*,I/T)<@P@FG)!LN4EXZ;+STG ]5?;I1Z/;^!>%L8K'6_LK62,V@=G"YNNSK
MXH/96\#=ZU8L+'<)F]1KE+W@%O7UUUV/;;Y;@!;8WD_H.JJ# 2?,+=,1GSJ?
M3[*] M!0RH%ERYKO.\5<LGX1Y$_KLIPP>L&1 #?SM/S<L<I[$!<FN*&/VH='
M!_1=%YD@/O93<3KU-PG-[I\,2^^M*16FFI?XOAR:/F\;3>U]P(]\%S_0G1<-
MD-)UJZ 3'U4Q8P,&\OY;O8-;R_,'2S'5'3[B6+&7TJ=/ZQP.V*(_9/9>3E=6
M)#XB%7;6]\*?^LQV)?)F^_VH]9[8SX=X&8[EJ:GJCG?TB&7LJ3J,D^J*-"L!
MUI/Z KT6:OW^,<X=$M@0FW7E/-IW*GQ)T/+E:=%*'AV8J ;1X3<03).,0#N_
M1DE/P8NF_.J5_3SQO>0VK3>DBNA1#Y:'V$7S2F%C^Z;:II<LYE>A[:K?-00R
M)%8<O>IJ5ZCML\:$+[+2%<0DM+UZ$R1_TF\*,P5KP.B+,M. @2*ST__^ ,=_
MJ )]@I/[*938BF.>#;O2N4G0527U!K"']6BQISY287>:3)IK8J7U@K]%RP21
M._!YV@:\]K&H_V+L::V36*T(#?<9':V(;UO\U?5>"B0R8AAAF:BA4L!\CWHF
MT9BILK%)M\$SR>Z<U]EQBSO^MX&NK@[Y8<!#-"4V2>FDJ"OM1?VXJW%QI3=9
MD+0Y:VATM29](B&I2WN,I\<MX)&;;\C*M+?$P>S02ZE,Y[3JR4G#!B#'5#W]
MW7=@Q6.6J"R(6JG1:%$+@RDP[R^J#?U?N]6U5DPX"EO'>1UB))X%4F@'IHW6
MH)^E!N1T^=)S9A:<5MF L2EI5@<-&/O:D(T1YCME6DF4:49I+7\A5=TU84$4
MB>B4\V^6>ZYA2/>&2AMGAU*#LMYACSOC,N4A,[#?LTX?FM-9/H;%\]2[E2@P
M5;E\!#UNI:;3]F()2HS\E]; OZ>GTI5R<"4#]D;+J)3/'8]G]0G9">GHWY.)
M9 4V+^"X9QF,WZ9SLE> A6T:(&V[)MMA?K2LH?4JA8W9[JW1'QWK)[/4G4=7
M,W^H/Y'KNM]PR.CW $*NN(5?Z?0Z_:G6X3L#G'-DH>CW*^4$0FV?!%!9Y>6*
M: 5R,=E&*)OOQ^#JL@AATF/SC),C3>J3JO0K':5U.*MX4 "[,=1\CQ@Z6:_(
MZ%"EFX$GL[\C)34H6+F1M::71OMN>-#E@0P)1%*[N$6HV(A:</A,(9*KQ)%=
MJ'A8N/>T(F:(OGM#9G>6RE8UF)-?>^(_-QW_G[C4'S.XNW8 T6,1J/EN!EA$
MFY)?FF-,4;=U4U-27O0Z@( CXLDKIL17S+:U3G)2'*7):$_D=FC  Z^GMX"^
M %[X%<UW>[RRDE7^WF*IIQ&R$<L$^,5W$P'L <\#9F3KP9&R=C :?YB.Q[2?
MJ.V!VRJ1Q$,EQW9Q.*OT%Q8P,^HY-]1^?"G*]+H(Y[.4/)]NCFBEF+1CD/![
MP#9XL<Q$;P(P;'U_IQ-&?@W9^=&DH.*JB01Z4D>Z@_F C_HES_(B>6>DQU_]
M?>W$_Z>Q7QYCX]**JKRFQA1ESI YY=\1D2W/)8@?G(I24QE=/F]OD-6&FL.7
MKZ5]+CU[?D6 +&0IQ?A/5UUT0F9>7EBD7]4Z]["P[P0XM9^31;3)$X2YE3IR
M.,/M%@J.^^&9;AZQ;]RM];4?6.T)[?AL7UC 7\.M;@%+:U?(P^3L8)Q-B<C-
ML^HPJ\+-"M<2Q9SKC>E1O3U-OOL^6VTF&J3C68P>,AEB+S14_OCSE^VY0AB^
M-"95V[A\(K,O5S+BC?%FCAOYKXR)4+NJ-D"BZ@>(OEL,+.75UOLNSK$_IIS)
MFBW%@ P8IF9HML]/L@ %G</MV8>@Q)_76U17C(2"BU^\B(+Y5';UX=6(X.\P
M"RMF/3(16(G1TI*)L6&ID]2=@B08RU?3Z"^[U=#Q3NKW)L9VY!;$)B:-(+:0
MB@S+N&T%FD<76XE;\NP5AG!5*RH=Y7MZGN_#"[_'XL5")G#BJ%@'[3FI]*'H
M.^' =\SEX@C'!-)BV$7BC^N!$?+6^=;\^^] =(>1W:YVBXS=A.6U#S50^DG%
MK\,;2GX[GSP?4[=?>:4]]J913VGI]7O+#+TRWJP_6[BR@3@[5F)19C H\4@_
M/MRO6YE3JGR6[S3]+=V&LL.&:3 @A+Z\3L?%A<HB/KB0GTHWA>I[88DCA_*3
M1$,Z=MN'+RB[ ]<"Q2V/?]X0=:$A5[Y(FS#</3NQ?=/[,VMK/%F-.I_U-%MZ
MRY3J^CO(^GEKL*,;0QU<?B"T9^1OEPW]F>WF.%>;CVK;PYIY.0JLJAN0_4^G
MU\FBE)OEXTNZ+G_#?0OQ?S\N:F?$.-T"DKY@_UJ&I5CZ+:!0:#YC+BX4)U_B
MI=0K:=9<L.*?I#OMF-]6EVT/3Q;Y2,\*P2.EPQ]38HK6'37C?YISR+YXF7_E
MXJ=^G==&B995K,7*VR 9X\B&"MCG^0N\'$2Y0L8SN202<N)#E]@N7*<)F+8Z
M=*_C^7&FK(<GB"@XL]U2:#HR\_7&.WA[G$XU1"+S=UV3Y9/P,H>[B8KW)=9!
M0K< ,LKK7.5MY%^RU"60>0L8/-N>A];!>]./HO3AE#;H9[< )J.^W_)E_J$+
M#IK\>0-?V8YO-FHVJ[PQU-LZ/3-?F,525DDODQ'<I47G>P%Y6$[#"> SOX_8
M(51K;_EV'^)O8MF]X9GN#0LA2IEZ23\&2!96*AC=-WF3346[(7@0>*6$;:$W
M,N8]U-%^^\R:W3^-U]<6T2GKR56F?&8)_F[V')N+S&;V^JF+MJZN&)<-%WU^
M;_6PI;)6%2^D?R&H2JR,&'!G0+09 5]Z.'!#AK4JQ\E,B=X":KSD]>T8SC6N
M.-JRG-WU7+?JK.7B(U^RT0UN%>]IYL]K8CFNG3_.NYZ^70]HWX 20[N$W58U
M$3.>T]CN>QD+SS(M!&TLW$&@14(0V3'M^+#ST :3GR;ZW.PZ]X;+P':>E?H4
M3)'.#/0(&M[602U,6\0:1N*USM'-U'Y\=X>S>*X6R!RPF$W708D%#G2O4:,C
MIMP8F6\48!C3C&7Q5BF_J=<C+B,#B3[H0&WL3\S\7SN[XF74?.35Y<X+X=T1
ME?(R5JU^E_J\8V?A\+-C5]?2HLX*0\F[4L(3]GKH"PG]XI<N#:<WK=DY8*8V
M?I0E8OS@$'6"(.MS8MPSHZP->F 3=\5 D&+<G&NB:NS0ULGYG=OQU3:=- /R
M+_V^I E!!V,L4#:]MP"B7V*UQ;NT1-7V_(QLHW:R?[Y_$PXB2TOXU.GN>!]R
M<H[<'F!EQ'G,?:P',^W'5/TR[,(8>P-'B8D2_O#7L2N7J? /L64):P JF<4Q
MB=B8 AQG.B*S,?PO\P[_SJXT55#3F,3SQS1H</+[?8,4NH_!@X7$[.L;4OO^
M;U-X*#1HI@:^3[[:G0>>@DKBGO]/P9O_T\+.#9,7\@I1'-<FA:P4R6[8.4>M
M*39W)EENYLJNFB>S3<9 Y0)HT,QQT=*B!?LM'_+\I73J(H_7P$=*3PET+LC!
M8S$!_7^-6KCCB6P,U-J87]@[.M6,J2-;C2/6>!AI$#?!UTIPE;QI_;Q-3V'B
MK.8RQ3%]SQ^BZRYC/ZX2I.)H$X-'?,@GSMI=%9RPV^<UW\>/=[ /=&_V3DCU
M!01L\?9$MLZ<LQ_$8L:1BF'N>$.8S.\;$%+[0WB,B&_*4FKU#2?U2>."HW3^
MXY &TN*I/"8W]@!1>(TB<#9;[1;0K5#D'0EW"..?WJ;:=8^2<V"/<*4\U#DW
MH$R[2'4EC?V5^99D9>*1MK49=I1ER)/,_C)%=+^H=0[V#/JU+2SXK.QQY S#
ME(GEH?[.X2U 1FBHU+QMJLJ*?.456CZN+=M7M,QCHN]<F)I^@8=7RH/HA=%&
MUU)7O7%<=7-,B_.H/5:2&4A&L2S^?9M7)421'N:K=^<5/H T.6/[9VZ!^4B5
M7PL&)';"HW(WX6=6B.]\_DXVF8"??'&/S&4X.X!DK8QWQE$DBK?Y39*Q$OOG
MS1>"HA\!90 Z_'KKO<;JO&*',?MM!";.O;BRW)@+\/[E?K81.HX!^P$+-H!8
M<2#,OUKNFO55>/55X%0<"MGY_,:J>#09L )DM(8AUD(FG%P;%PQLG+0>%)$0
M^4$<V8:='YO+QL\3A\+'SSF+VWT#HJJ,O()&'1U,)-W8)BY!XT:80$_$\K23
MQS>V?(SH!$X4[1; U&$KH'(EC?/E/BO/T$T5?BK<V#(6AE3J:5VLMY66SV,]
M'604Q$-O$>VX,5LX:$S)-G0Z.+VZWK0I=/>8QYR_*TA0BXV9"%;HS[PWR)Y#
MMAAB4DU:**I1UMY@386*C#'4*S@<;=EQO<R,]@G][DPU/,HRY7P4B5(Y7'4L
MBK TK\L2F@!-D5F*:+G?)265FE-?2RY<O)@_D:<RTZ84J?DD=O[LQY<+YH1Y
M;1Z? R_V&-'1D-\UBHTD[&I!]"]7'DAL7X*V!6.E\1'&9#1[*2[VYY(*Q\,C
M#AQA@ \GP>"\&V$L#-72HT=BCCR47F'N?,-Z8V09>#&_!1XPM03-=W!":"^W
M[O764-++'7]E=2N]!$W_3DASO&3E2!].CX3HO\22]>1Y9<E2>#=\MK;F#1):
M\)FM1WM^/MVG=YM%5<-7/BT%J\FS^H'2?OLK8T;=UBBQ#D@PBX0ZF5)SAQIN
MG.(#&7BJO9D]>>L4Z"B<9/\\MG@%BM* AC$88:=UT7KA:6^5&A>)U$GO.F2-
MKL'?**FB88NRW9@;4BQO[FY")^:<7.DFB2F?F/TH#:,UU4%+KS=7L2RKU#FI
M:\L>5.,GCW#@[-/?O5]I27*JU>1N.//\KH]^NQ+?+M&6T@,9 V13U?3$D?VE
M4,K<I.&K^"Z&/@J2LO#G@$,=TF3P(:;W,Z>&CWG+;.!4F.\>T<\W2OPU:@^L
MMN=JJBI&FP64CP?0++/U6F\IQJ)C<[^>W0\\>(]7D1N,5YQ[5GQ@T8S/-I>#
M#LFW:[F?ZVM)*=/7WBK]"?;ZE0SOL2$4<A0))@-R[)UOW6PA%ZN,&?Q10&T!
M'[+N5M2"BD62\RJ+(R\C,9LJ1#&@4;N<ZO&I**KD'Z%N.YA#,3EB5W^S^-*)
M5> (P[LK^#F[+BRD [CS[$CMF^&>4&:-@4:GQ#G^5%$#:3O=B0:'U@!B?^@U
MA4Q'MZNTDHP2M>UG11)+(Y-TP^<^+'D-Y+,SU!+4W3[W2%XO!CFJ):Q")$QR
M7\I <A^31W_0XVWEPC6^!]J_MP*E^?E, 9<17D>S+IC*SP'UNS>@<@"$L>_R
MW:R?*/3CAFRK#:N6:1-/5>Q32NF#[J!><WL=_^_'C^FHOFVR*$KZS&7%()97
M7:XK#I\*JQ'>)?UL4^G3<C,><JIK[J&CP^;*R_K5%[1SAJY[CM%)V=ZD^]A(
M&:4^&1N.D*9%L^FA8J;N96[56D@/KFQ'GD/((LU8VJ<IT']Z#:\F3Q]?\VYG
M4V%Y=5!?RAK1B \[&X7O+?>Q#$A8JGDUII2UG26%5JS?*C5?L,64K(02>0L(
M^6"1=W$2Y&U67X[(9M@%\I_0=&^*E,ZR!BF54!^;FDV*EE?B:X<>CPZK14NR
M/!AUUAVT/9:U$?0Z+4$K0&W;*T""QJSF6H8=]+.DK3E&8(G[*K3;@%/10C#Y
M2TF73[[YISYZ;/I$SHLA5$P @WC WD#]HU5YX23:L3M=CK/<XJ7Y=H[XG#FC
M=\EG+ I_,52!GI32:!.,X)/YR+/E%9S %Z@(0\D&Z^XD(V7H1:^?0D"LP!?T
MIZ*(^0;MW49MXY%6J^B-+&1'F'IE4N='RL/I2%0<M;K(S>.6%\F"K00LF>5Y
M23NNLZ9J:5R["FY,B'^IH==13@3HUKT#?.E%Q'];<*'WJLI6QD:4[5IP;7Y5
MQXM_X-A491&ISMDT#;%<.S6U(/'I$J@<W#[BS"VO1_@0A,.DI=PX&EQ_9*>]
MF(@\H$4NTYC.E=%V$(B.\CA>,@N55);N? 4]RJ9QFP+ZV@5B"IRB)#\%\!<M
MZQS\7H#9L6P[*[A>*L76Q8#91J]X[V2H^LR="A?.O%8N,'QTRF// '$SLCL8
MT'H;G%9<LH<Q>DW3FOE4YC7E4"$D]G?+QXG"$4'B819.;3J6Y[S?92E$ @?&
MO/<-_U+^WF4Y*W8:K5KUI\EKJ_=L<]G$19S7!*<.ZM1-$=-_"*.CX\,8_<L?
M[JNJ6//UUE(F91NI[JL.;CH>_,4&%O^+OE7:&,9!<DLJG"D_'W_@-0^'O@7@
M[A6RE>RNE]C>N4XLY.?[!GOQFY/\:QYC%:JDCZ>:)) ()+, [Y<M-<"ZZYA$
MI20TS$_*IH"085*ZSL6%U^(M5Z%$/V_,TO8')TNQ[A?L&_B!QGI,SPMX0^A*
M>52)5(VL97;P-S2QW$J!3] VW3]-C7K?7*8D.&])A_>,*%^=[H[Z":%^8MJP
MWU'--#+BQKY1[P#/36Y0[SWH8=6R]K> T*QGZ+\,VC?]8;N!EU*W]M+GU#'E
M(.3K@'W?^6P(*TH-LHOC<( BCLCE2\RD?1=L-J'J]6=>1E^Y)]Y5G-KT6W(C
M>4#NG]#U,; '?_'-NZ+VMHD*]U$ZPR=->AUM<5LC 3^7TZY.NCNXIMK !7*E
MN^(JGI!/00I6,B_VI$!=LM6-!U_2-,/=]V4CS!CY_1^,EJL!E4RNSV =?H((
M9LZN%A>#71KG16-!E"+OT$"%<&8)[%@FHQEI(E$./Q&SS8L\CK/]_T662^BM
M D!QA0*:'" /[9*'0BS1Y?V<72QT;>-!;E)![&EB%Z*,7<??"9GHIN.#F_E6
M@H0P9#@J,":9]3Z01CSD% (7[.O@BCE$"HF/V]F=6Z?'ZF8<Z.R-*'&#XZ@/
MUI_OWF# ;'T#%JRH//KQ6X!9)!?L$_H_5>BOW)6L7PLL7;(W\N]9 ANIULI+
MVY PEJ[0!<B?E7W5VF,)VY,].$'73&^  _-G@,JB/_E_[.E'3+)OD^9?Q04I
M%3VX83ACLHS$U5QG!PB,HR!(T90JPV75=)JEZ(=C.X2;@:NI8<S8@=>0,X;^
M8Q+%X;4_<Q^:ZK-$4[CS)4"*]/H$38^#S9X]3:U-27^QW#.+J9YW\>'*:];(
M^<].4!H;E_)M4;SQ:,(,BLK,E;MZGZ\HDKW+YOKG<S:O\Z?^&=#,9]K(N"1*
M<"CR_Q81#FT.G)F;#VD3]*S<=S:F,Q-1O/]::;7@=,;.=$&$[,$*)'+L;6='
MH>0\N-"/19RR?-1##; 9)"&ZYQ.039,-81(J0P#H!XSJ3<;R;52+8IW>HFB2
M"ZEMV:S,<<8M\_)4$&+[J$E%'E7>9\LKL^S_2%+_=WE0&/UUM;039\^OQ53D
MLUKB+/7.J;4I[CM=*IQ/[YG_(<Z)<S8;!3/\M73=-@T1S<4R$E$P607$8VXD
MN/2-(0<GRG8BX&E#/HM/=42(MXMVDNR3DGP<6L$?*K_I$T(%FKH%U"K&Y/K)
M8-4WX#%+<S%62.._I-?$>->'-+GTV16X4758[9@3[6TOSW6V&LU<:.&Z"1(@
MW[(9I0*U8L\Q(]@0M&57&CQ4VDW$B=IP]5#,U=3.65XL];&5 V;\P6O2.SJM
M'J#'FQ]8=)"T77%8.2"EGS@:CAE8AB.$(S&:/_Q3?UYQ+OXFWP@XV7(<<ZVS
M9-YCTRIH+PII>G8]JODBKWW^W?77>C$TJ%N0S/9RAB&E$/U0)5@WZE!L:XE7
M\(6'WK<7M$1EO?%W7B)4.HO]5+$DJ(UN2;=&%A8LHM"K:*O_1HI?H^L4$O4V
M/#G;<@BO]GDS82A[*3Y^Z3KY7,C!-QZ=U2QR!?_LJ[<X,JP$ AS\]^F/ZF#A
M&(^6&JSS'[?3!E0%6@5I8<5AG:C@M-(H!?5M^BQ%RALQ!?W 2FH;0(=:W>XC
MBTH#]YAZ]GKL>Q?MO+!+-!OY(7O9+$#/K-#D"'_^V#613CAZ[AFIN.?5=\<O
M,\U:)Z+41Y*T!U%(0KA=.CC89RN7)J'$)*(@6"^(M4Y.Y*T3._HM'5]K<O>]
M,<4I#440];*7)X9N2MK7KL+.C 0[A!@GQY[(QUC-BGRH37O(Z\;?H&2,5!TN
MS4C19=OM=]3;K2I0C%%Q [[+ZPA!_SJH1QR^0(BU;D#Q<;I3-X^+0_\\;I@_
MJ!39=5#/30[B[?W3JY8^AG^H]T2%H*3B%H!W,Y;%D-[%H!D9\ RG7H.UL:QR
M<F"9K/M^)O5S,#GR>[30(XOP'^^K?OG:=?83:K11><.PSS$OG%(&0K3,KO-O
MAAA"\Z_D=\#$FN&'5G7S%;^TIZ15S FR[YT5+VYF<6O1SS-&*SS@#WGO\_FA
MW2ZX!AB(9*6WZR"?[."SO2R".Y",CD?@,H'F-KE=>*'?YS8S&U^.3?ZXD_ 3
M(,P]%[1'%/U+?FN/=SZ $\>&X@QQ.(4<$?B93ODY%Z^M^<=NJA29V,V+V<"^
M3:@T??M\\_^P]M[A<$??_^ D)*)'C3Y$CQ:]#R)Z$"($82(B6O3.F(E>H@L2
M;1*]=T8?O0;1>QM$'68(!H/-Y[N[O]_N/KO[?)]G]X_[]WV_S[WGO,[KWG-?
M1R$& 6#Z Q7#$6G@;#?V5REW0$\G\1X%G2QZZ:/? .'/!LJ&GOX2RUM#6U]L
MDL:J"4A>4#UQEL]4HSL $>/ F&V41K@@1QTN\5%(JQO"9B3B2_DO)ION(Y=T
M@;GS!U]Y5GCTS)6DGIQ'(&WU'_DR;_ATQS+W6;**[J;_0=C0M4U\.SP0R;'_
M+368#'$G+^1VUR3\<,< ;5W";YA<J_ L^OKN=9X$, I*,J'@H0"L5>J6%[F3
M:[&PL'\&94,$[ @1>^HD;^FW2QEU7X1+DJAK$D1?Y*[']XL007@P%G7T,%(%
MI0T@_=*2O(-_6@RZ[^>GJI"KQO(?]Y[;LJ1Q)7E,O1-^6;&G,JA^"Q#7,GR9
MKIO-KQ88L3'V^1_5^'+U"L+S&Z^8APBMJV39I9=;*<UYM@7ML/B0Y+LQ,/21
MKR:7X%[MYZ?W9T,@.IC)LZ_8V2CH0S.\$ 89)L@V@87P5^Y@&$[YMAMB%Z2;
MX+)9%@91A+;52]!W*YPE)H<D$>ICD47YGG;+*8TV,DIFVGO- 2PK/\%06"<G
MQ(4[K4>$Q5<K[[KO9T%_<8[HF@)UY"@H9P-^KI$/(0*_@'7*MNK> AZLHFW7
M9;+PC5XRSF5<2D?*AR%83Q7<K/ 3A:D/<9D230Z]\'IE-YQ) MZR!:XW@\X+
M=L_?8"]T..USC?[53W)?2_+D7SKE9.H%I]'=JA+MTR98:/^8U )*SZT1L+_,
MN!!;6J)Z#%".].2IL@AI><I N'VWH5[ :U+B&SNW&>I54X._=YE*1T7^TI_
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MY?I^TY*I#MM/J)S3U3<(T9P\K*S(HS(W?WZBPW%#^](T?E/@X@\N"#6/#]Q
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MLCZ9^"'0D>'7I!83V8.,^@-78^^DU145Q[M'V?;T$F\W/*COQOS=@Y&<CRT
MSV1F;P$?D1'9=+.M.F5F(Z7[/F*=PLFV;'_K2(*"Q ^9%[.5WU+TS";[_@$2
MFE^'*]U?]@UYR2YOL;R?BC%+TJ$4LH[FY^X@G8X)%55XL@%WPB7> GA8,2$W
M?:SF_]AUF2V_A_J8^H@5P_'0_L\-V(,;NGTP(SZ@$&>NJO;H$5?K["O;@=H@
MOR1[<YRUVB#7.3N%YI@-UN/,N0U#V5^J'W8#G.[_4GETT]-@$KQXT.[Q-J=F
M2Z?AM_2I4 Q9=JA),UX&9Y^S^V]K$?J[A(($(5*8HYA6AY]X'3\4)8U0_G1Y
MY!]%D,RTZ5=1V:]9>1OV%(W]Y;ZE'3,K=/_<+@0OBF6=C<)+0]*P*H4%WVV+
M+M*J--,=N=QUJ, IK T'G[(6([3_I'*?M"A6_AQGD=L$"^EG**A>/=KEU,7J
MQH?<"-C=2&"WPYPLSTTQ;15PP3O4HE?8>]W4M5\5WCTYZ>SLJ$R[!;!<S4X#
MJRWA)7,W\]3U-[C%%[KO=6TV&=Z,O_O.)<9BI?%M2"P "Q;2,QKA>.$DZ!84
M)VXAD5F!6A[U+U$HT7IC0VM@(;@-"KT.ET0>(.,2S5([INKVO[Q#K@A$P;ZJ
M(]4$CE?/WK5(P8#XAUU@/L7+CK>9;H]KJ"Y$\?NGAAM:30W]0]Q$-WZ9-UZ;
MUG0E;.WD*]_UHI,/)BDOK'FW],/[ J*><;U@N(PA69>/Y"M7PFD<$J!7J92.
MI@5:3 4+[/(!3S>MVP1BPO_?><<DYB;(#25PVO#9+;&IC6_1(&^E5\#<U*50
M\UUL?N+HW2#+P361"-?=&74+[67N1E>*6<9>9YQYIS&("6&16+JTL?TUSC&7
M]9[[:/Z9' >IPX!3.7M-I!JA#BUL627HU;C:>^?_1WV]362]2Q 8I72PBR50
MB2)#T-@;CA&^"]S]V3->B<(659H5/!W@G)TI$=M*2GO/RV;7"!^YIEO%!^)\
M>+O L99BF-RN=_$OIK;BYBD#O)TP0!SMIPAL!<"3[DP4,OX"MRML*O%OGI?!
M+2XA2 :(%D:ZWQ@J@&GK<7.@7^OGHBG "?_\Y!+^>D P1O[#0V7VX#L5/-&Z
M_ *B!:C#^+Q3X )\_3IRR@O\ '\/<Q2.MPZ@360U"U37N9(ABWX>2QX3R1&S
MEDFA_)<S9!3"?IU?WDJYQJK3 9+"O([OB;]KL1S8S/KD&'WPI[:IC[133D B
M(.(EX"A86@H"BNZ?>Z4]R'1ECPC([L8BS[YDH"K@ZR,$*AATX6<\Y7H'.A\'
MT_]>0#74[S'"E7<_Z9G'R4.9P;U?^L5[0(1E?)$O7 /[:_6!A"F4;X&[SH2-
M'_XR<<:*;=J>>JHPC27?A)3CA,2Z\6Z[3D[$LZRF3R1UDVUCOI-(!_TJB!&N
M?D,)I^YS"^@*S-N3 \\AZT3/*.OI0!]O 2+G&5)_%UIJIQV3<& L_(8.\1G*
MY>MX!;S2N*%A!0D ZZY+AZ]X4[?.G>8@O[:9W9%F)]I/VC*E;NIX%W1@X)[S
ML8C5.F3$7Y<0[UL !<0#,S'9OV"9$2B<F_>6U=B<^--6 NN\:"FCB=MR70*%
MJTI'/_.&2PP<\PW/B/-8 Q[ :F!=;)<A,+O 7-C"S?33M&O+SEIGT?,,V;'A
MB=:9:#J^PI$3(D/#Z*C=&T'<JG04B HOAGG=_NW2IC_X8WNVD)G R)CK+$U4
MT(.'#$-T:^&?3C?R_<,15V"<?'_7K#EVNY.5M!?^\!U",Z,'O)"\H.HY\(,K
MC=X-D,P&8$?(=)#\N'-RC[8ME*T!V) TSM:)06YHA+2*Y.RE V-!U';9<A/"
ME68WJ\.M&7JM=0F?%>J:XR'A@GS7\[Q3LP8E-S/^+I'M0CB?'O_9;B&B5QC;
M"(F^"<_*>\,\^W;LW4XBG*4NKGH^8DYKKI0C8/EQC>H0GVO5A1$!&LO1-&D$
MC0:)N097S#Z9WR(#+X>ZE@RKK&S%Y)IM+R7.\!9 KR"[ 3X80\<?^"W JBYN
M-+*^+8LB'9VNEKVSX;&N=<9)T4E;'QUT0=:+2K;_TJ1L)IPTEN@--KP6<PVQ
M*5Z2#91I+W.ZG_EKU'22"K0+>D?7-_&-R[TC J^/0V+2^MJ9ISDP_\BE%D0(
M%3!(_P%+N"+:-F4I?4(@+^%>,2LH???-IO.(;Q@=O#I"6GK/'IT_/ 0,5RS*
MB9X;^*^:@+^<-\1T:Z;""B8;8XQR5'3Y7^6>B\RGFU /$#4^[(6?AT$#9@^.
M\#2P]:ELP'5:G7G&-TC&V,,EG;)&JY!J3"+P9YR$U<VI'V[WV,"Q:34H0O+#
M%?!E:_3GY*[/6KQQ ANK"QHW).0YD"?3(A*4Y(ODUF:?Z>SU13EAIZ432I\J
M8V: Q%"J/8Z*%V85N<PJ=M'0]VYCDKAQQ1X$@GI)GU-7H<)BTR/)W6.F:KA*
MM")+.\.3;%8TE;7$"+'W;[O2MTOXEF[HM7OI4Z]*=M^_GFZ&)RF=J[E.&=)$
M7^YTJKAWF@*IY)**+O(.>ROMKN/J!SR!\0N$)\TYLJ);<;(\C;> ?TBK\!IK
M:Z 32*J?%!"XSMU(XOUCC!=368>7OP40=H7W'\B%9DNFKEPJ)GV-5G!R)F:L
M5**+RGW0J&=6.]%I)4J37OQ@)[[EHT5E3$B'+"M_BFKW@O5.-MNDY_Q'QV(A
M*RJ)L9D7;LDF^^M,.FK5EX9.I6U=_Q']*.Q2=DO^;/_U)4&>8>P8-$6H;7$1
M(TO;^UAM82GQ]P276M0V"1^!Y0J6VR"Y[FKJYOTV<[CCO:6'=SUI,^82?)@
M.W9EC@$75"E:0R'F).YW6,D!0K2OWJ(-W3)?WDT";*+26<U_WJ^N<,XV94ZZ
M[\"W]>&=*DV<FS(K.1V<K>3!1=K]<C77I(*#H-,?Q$4%I02__V0IWZ,-7?/H
M9;=1N$L.D&N"1R(>&=^03X.ZW+RQ#!LNSWQ'/*?'<!4H4=:VVN./SD03)7**
M#])U3;/=,$KKBH5=JP\T:#1HFWLGZV9]HI].I,H";KQV!L(NT/O/J=_3&EMF
MOJ_UBJ>U;^;%0Y?S &0'8THI%OEF_@(-MOZ^_OXM7(XR5#PFF>=%^F8GL?H;
M*U'6GD)HE&,1Y4I&@1+)(J:_9YFF5VA+U;5JZ1;@;GGGTL0(PY#NMNWZ>Z,P
M_=V>_GQ73M.,@0:KRH B.5V'O\Y4$@_0J^F5%M='\<EH&T6NQ<Y-IOMBT9 O
M]35R3#;_)US3='W/N+^06VRU*9;MB\IACZO[KVXE+^]P^4^4I/TOE+UW4%-A
MU"8>BJ" 1#I("0HJ14!Z[])%>A<"@E(BO04(04% :B@""@+2I!,10N]=$)#>
M2^B=A!)"7]S??CN[WWZ[,[\_WCMWDKEW[KSON><\SSWO>8Z$KNFYR:-E<)0<
M-=[=SQFR)/N:56YM^=/26^;:_<B"SM\;9<]7&8M_3YY&X?#XKWEX5_5S?L12
M6KI )R;6V=ENIE:G -F?MGV>;KRG53R5&O#UI5W\6:(5^OS=%N[^-:![5_]$
MNUE;<VQ)*5'5@Q0%U0Z<)XG,49(=[#_DV6MZ:#RYUW07&B$COX0W-J.6L%]-
MM3T@!#(AAX&WM^\N!9%/607^X*W] TWLM?99SM>\R-N,9F&;E'C8&()SF&BP
M6J!RKKP& +?US9D83H+?SM8'+-Z/=F$R>K4YW57KPS>44N%T(J_V[BB"__7A
MBCLQ\:+Z9;]4(/W6N!(&(4H;7):^50Q^>>:,RCWP*PL1>L8X/[FRO*U2E>5I
MAUZ*VR/*6C'I-?L16.>+&L@XFW>EVH!X,KU)'7/GU!Y%F*\\4],+V8!4U&)I
M1S;6(.SWT8EVO5$SXS5_]C@S&W1$!5E*;N;?[,'_#[EF0JK-B8*'C5%HG>AD
MW*BCB7;$TC7 N!L?G@<]MA@NNYMWH5_2-1N2^8QBM^"S7[Q>"J]<YJ[6JY00
MF(IG05O\JU^#F?5"&<WFVY"8[A3E<NFM!R7;&@(Q%]M"[%6@K9XMB&;:8.F=
M$),MSMAR[K=HA96) 7G48,<" ]Y>H6+H@MD%/E5<^+R.3,-@,]/_3$H]V71:
M;-74.G*@[F])V:[Q'?981=#9KZT[!KOFP]\<^S4U-[HJ'^E3"OK8K^>W#$YC
MC\"?C)N ^*_H/G+F>GOZ:\"TE?%C:OM]P6[1:FSWXD*'3E1FI?G&A/G8+-NM
M<5LS@YV=YX^?R6=J8C.G]]%7S;E70Y!BN02[G]4)3/?5PWS+L(>@=7 A')BZ
MH(]IBO&^3_ACF"\T90W$?E$\TV$80VD^.M&!R&S7S^!( ^I="'CVP,GAO:G@
M=A#!-IQZ%&DW(1*C.&7,',:IQK0[Z+_11'0U*/6DA=G2>$0Y68//]<VAT9OS
MW[M'2-,KP^88: 72V'<M8"_@;_MP.*\6>I+4R5RPDRC/\XSUX3!H(#DN4Y,$
M@'UA&XTK$UX:[ *2P:@Q>=V?&L#%*GF;V/3R8MCPK)Q$+%?WG[U P"+A2P G
M7!<^ L;H9K+ W!,.U3!'%5#Q5D3MK;R2+_7U.F:KK)\&;%\(2#PJ3]W*"4OW
MW2NEU)S\HFO>J%/7[""/YPIO1P0GSCG>MXM9=J513H+P\>OA',#GOV8]:$-&
MV7T86PF;I>#B5[.9=$T2VJ*-\[5/PKV><-X%*<>79O,$J"_N)\9FQ<Y+$#;!
M+[F0\&3J)+ZQJ<6QSM&BW0#V;15:$]>L[JW_C(*]%RCA_/@1-%N1*(@4GZ+[
ME]_7Q<:1^V"5X\I?U2-6]@M5]XN)^4S"YL7B"(&I(V3D])//LP\F*I\_"A37
M<OV&T!]*W$DZK5?Q'&L?*<9R^)M&?FYB @T!@V7\T/L1;*Q5$S#!$O/M5.W>
M->EB2>5"^3G9L7!O=JJ_[R%9@ZR\IV=X1>Q(5S-A@Y(H@@3BN9DH"') R<NB
M>A'H9.$DN 0I(!JCN-9L$O0&.-/=UEPIHNM@WAV/1K#:.H[D)IXPU+"@*A(3
M D[MDED6?Q(CR)HHO1HWMA ^84)T@5,.@T7"G7SLDK2H=;9_0O)=_S<N '.\
M!MPRJX,$3:5V"9[88^^6.!_=&UCH5X$K9Z#."6[^U*TX-]EI9?DR.'4\H^'O
M7U+XKYQI^1I@?B9#BH';]]^<1AV0<64W<@S,SF,$8H__2<+QC%RHH=/UG4'F
M/Q,#&V<YW^@H,8HI<Q,'EY#]Y+0EI=L]6]@=679^V:<?*-QV=0>#_.0MD<H\
M2 L-4J*?KD3CX[Y>M >W%P-N#RB2$L-65>QY=!/7'&I&/YOPR$8M+NPJ+X%#
M,AC&8<*4$>AF!CS$N$:K]@A!M]F%&WU90VBDL"%^CY9E75JQY6$N/O3< J:(
M3X*@5<9<WF758YIR'N?G+9C.G.K/]&C2*M0*EKB?.E 9D0@.Z(@NB_*5YDZ<
M/)NQ4'[4V;%7WDFA:3D7T4*@9C#(R%2($]GO?]U8LMOGN2% ?37+)C[1(%VZ
MB8.S8>S#4-H^<Z7>KE0.4NRHT>/;:0]5DG6[]]<Y"XC9%.E",!.X,JQ\.R)<
M",IZ(8]V98!ZNYB?#<]TWK>?OFJ7)B1O\2TPYDQ,H+S#:<L)DL.:M#7?QU/V
MSA]V- $G+F0=I7<B RU>I(X]<JDWRM6]L_^JD6OXQT1=4CCWJ([GC!S]U7C3
M4[S-8A(&-BT0!G-'.[C<G?N1M+0KO/MW6O.EEI)XH;[&$Z8N#7:*;VA\/BX&
MFQD#?[:Q0'5<N.N**F5;FPX@-Z#2XO4*5N1TXW12-#T<):K9<_'0D .KZ.<1
M[\7SETQ7V!="P;@([)./5W*O8*\J?PVO8%E.)GQW(3)"S HGY ]["".(%N]8
M@"0YHA--,^]>\4% % (76KYY,Y.#CYMSYAQ\E8Y9DR5< -1"SC;A  J[))QH
MAY[1SE(=S<!Y!@ICC_N*!;=:,AO_+2DY<J6&@HUL'JV'RVB_P?7=>00@>)(2
M'];"]."G3YGBM" P(LBAU+<CB/J";_F?1&ZV%OKK8N:+81%+/N>G#P[R#I4^
M*[%^;M+HLT\,%K8R477?WR ].%G+GU*4LT/Q3O=O3"W,7'A@7Z9CL[>7PM)$
MJU*6HF)4 [5C&A2_FWRI3F-4X_O2$S]!G!CLMV^9WZ$S?=AI)8N1RT'S"MS%
M*[=,RQ4_U"I20[.RFU;E]GHT!>R_>S\ISP\L4U7Q\XVZ8H.FM!!IRCT<<CD*
M'>.CONHLRYGF9[<FJ\/)JK&J>%8V)DE"7!7/-;JUTD\ZD3'FZUUO,2,0'W_+
M?!QE$GT\Y#+-<64O5(J!2=)%YP50A4ERT2$;I:%F]W;N1%2&%WG#(/F6M(7-
MKOI'CH-^ON*\!EB/61_NNHA]VTF6B>GQI\I0%#T2*S_WA4@-AG)@Y@;;P*&@
MR>0KVQDS@;"%7E3"B_T$SL/>G&^7B\(9M<BO#B6KFC2./36CW^CB@A*OV"ZE
M?8Z0"O@8;'-')K4<ISET:6/&4>HXV_Q10YU^@Q*'2V2YU-[;!UTM4X-67TCI
MUH^,:CKK*S4_E^;(A6"[=QN7!UFA.F;#('5,57A@F4+5V<0G+VUV"Z?47 6
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M.C+[2AS>GTD/<SVWT5@"46[ZGC7%EVTE3Y<E+O4]?%,>.?IE6O)NVZI!GQ&
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M$XCBL=Q8J91+2:UM;8QY>0Z;W[M 4A68J^<UX)8DYK7?V[LDCB&V3X+FCDO
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M/P8_JW2[^)[7X)07[*% 6N9N]?D:\/,D!*;X. L-IG3,9'AZ84$L=)G2D?$
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M9[\::J8RP%'C;][Q\+ME<UMRH%'@I/-@NNU]/[W./T'\##'M% $)CM< YFN
M XCZJCN#_5]']VM F%CJV]!L1W^CO/%\OLZ/OD+;B?V,?E:^\9Z5*XC/Q=Z
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M"X5*9'\C[Q@:5?#8\:0KSYO]Y?9=SR?;$:<W2]T@,6O.(.<KQJ2^-DY?+(=
MK2/G[Y93*9]C2ZWXH&R[+"X*47XKW((1D/&F4KOPVV8[U^ER2?1$DX^'9@^
M,KL:^ZM81]>,;:<0=_*_YE>EA1GRTXTR*]:[5UIH&FMS:'M.GGWGZEI D8X5
M+*^:*GZL?FSA&CQ?9BN%?\EM/<V5](JWBT'8Q&<^$[XZFJ1(V_(\%YX<DWX0
M ,6<=6()Y;Y2JF?X)'J<[3 EL!'<ZMX0<4TBD$OTS4_-4VA9K>B[;&UOP0BE
M7)R\]5%56%3RD3<F$$=0%-PEI!-#;XPC>"Q&G_@TLKC'@1(3TO("F\]!(:TV
M9;59.(;, ^]\(CJ;-D=W9JNU>50 )P6CT8>.[Q5).1- )^:)O79]R_*/823O
M],9KV$]9S7"W-OK4A5FA^6&[)W&\H3@B9:5.O[=51OXX,RW*O\?KQ/@O/ ">
M/@"@*JB)3FXX&?\-=8&Q7[BZE<@[-^&AF,[#9+8I E\)?]>_$!_(GZD&1O3Y
MW1=69>OY%_DXE'B@4HWMUH"1UI<7]Y4&_7O]LU>?,N/'WK[D_>,MYW^!LZ'_
MK6C8,Z!'N-UBTSQXG0R1N-U%BLB0G7%/Q%GZ('"\IL)>M1?'_G,:%VJ]OK+8
M7V KRBY-51UB6V$_<U6[^Z.2,WO$9/ 0^.OPK[9$.##>G_M0C*C?.."1EUOO
M=3FG<EEWLO%]MG1HP09S?1T6B\>96,U>V\;2*>0!\-B?PG^J"_@BO%\*=\56
MDJ%EIE%"\I=#6OGC,886[U3*X8:ZH9TGCR"[A^G(G/P?1<'!B$]=<L4BPROK
M"S]/VAW@\8/^(G';&@M(YRVZ@-=\]?AJBOK96Q@3F,]CY/U*[H!@,UCXKZ4[
M(&)BP&X+2*@!Q]!*-\XPQ?.3%6I+MF9L5FS6)SE9MW3%)H2,2^]U2916EL@*
M,I15=O&SZWW:.9*8F.594D7A"7K";2"M5:%P(W-<+PT5,5\-!W#,_)OVO#DC
M-N]]*U$]9K3@LW1XSE+T52RL^E<6?&:+*-C=^,[4&%I<&?"LI]SN P]#"(<S
MJ^;N[_58FM"W11'=V[NBB+BHB:.4!;XER5 _>T?%<L7UYJXZYU\#5EOBIZ3K
M8/\99I@%3DNT=$UKL\-!$!4>G>F.8SOTE3@\*',G)TQPQ1=?S1Y%QWFF)O<Z
MSE/5>#CWS,RV[TF5-IL=$XZ3.G]4@;RC2F894NM'JDJ4K\)_#R?*DVEV!C65
M; 3 E+NBS1=18G#AOM%AN&/%2JS* "7L!2.-)<9:@:CDY,*1O#\::IQ>\@$0
M:@[?[NYDM0-G^-+I 1LZ7:(])4TV;@B6N_P7<JNS!OO2JH7=#EQOSK5V?W&3
M:9J]._I[F,Z_&JN+JI(M*:C\*@U!5>(_N?%(,/Z1^8>HWS)7L4+P!2FK-FEP
M\W:FJVY;JC5&:76O,YF7A3;,/.*2&]^X+JE/;Z;$UZ'<,(R*3AU7<O6C(G97
M_A'"&(4G=\?\!Z1@YI""V-Y;PM63GU"G%CXZ-U\N?0 8\,XK#>[]H#UYXP=Z
MRK0TFF3,_Q,"O2_TWFZ5XNBBG9*&B!S*^U'DG:_G_3^)'9(? >OCN]6<KR(1
M624(<Q5#AH;GK+/NY+):(XO ;#G4@I7YEC5&G-(W91EA[G#*'P(%/RXTD*2J
M5U;.D?224L3N=WPH2MA.[A)S64I;)P97O"8%8< R;]S'WBXCZ>XJ9^@#($C
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M\ETL"X!#E#DY6?F?B!FA8 XKSB[.(MKX\QE(\A>NSZ$-%3DB,K(B0^.(D/0
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MRY$9?Q5YY&;.[Y\ZHZ+EJ;5&>_FLP(;^#U'6@\C$W*)P@/M% =+ ^HUH\\$
M#!!&]0C*<0P5:??\MX9A>Q%)P#:T_.8!4+TLA6##B5@QNT]JYR+-'"X>\W[_
M4]T5JZ\5I7(DA7?F1OZ;@[[*G&==).>-IA*1BM'-^<9?TDF]_[,L,M])79QT
MOJ@08HMQ=H?"P[][ GRLY@>7@J(RU>.9!&[7XQWH3^MX=ZO>:SX GL?#2Z%$
M8]=NS>=WR,NQ ,5IA;H"IL A&<R7F_$!]LBY^Z8'P&:VJZ&J[_9&J)B#\H?^
MT3(OZSE)VWB]M"5%W=\6M,$C\+/JQA"(\;4[$2E%R-VGB?%6#D,57CVM&$*\
MFAZ<R2B5J^M%N./.OY-C_X>9Q<+X-RFBNVPU* ?^L'L\ X$6SH7TF-QH8\KQ
M &^N[;AP/#YC3#1M#O87=A]$!L:6Q;\!\?S)O9*W%>,$3O&\C 9.&\4':<^8
M/DMMI>GU+$>]5+X%/&( KL0O-5^YPTY_K<"N_F 4ON@L61.ULJ.JKVE78-?!
M*?W\7*ABV?/7 ?6>O\:@4DOE/:.%MB_ORW4RN>S%9H\PK^N(S-3[:4^D/XH>
M*;,M#,J8"T<-B$VDB0,50WN_<Z4;!QYPV.:W7_@P_E-O"%TT3S4B6Y1,[&6/
M]GK+O3[4.K94?)A6@0IWVVY;<%E33:B)I?!:T@E.$7**%/:"J^&W,^Q::?;0
ME5,PE?C<)AV-XR_^=(/4,6Z&D?<?FS\26),I3%M+7]=.^M[E*3A%W?&31;5V
M2T!?OLH+7W^*S<K7(UVRT]*"B3P:.\?3_644EQW]ZVU;.BZ=&5Z[7RRAR%O3
MH98F-]KRU4_E7U L<X(<^!.>C!:#(ZMZ(TB>!8(ORZ"\&7&B]2KKHW%?JAAA
M7@&^N._W=EP2X7;/>&E61\B2F6-<DM<;?G]P_#3Q0CR$FY?J+9%*I84%")'.
MQX3K2M=AC^K4\C4H29/W[3FK,=N>SQK(FP=+PGYGE0:4>*NU\D-^.RPX;BHE
M?A0=W#7!Z6VS=$0GW2L^VTF9$#R(Z@.@<R4YKXMM)D4<<83)XV"%V?4$';B]
ML>7^BXXS4E$*-+S!DGL/&NL9*N<4*J6SFWV#02^8 .@3F.#@DS1*__J1?5&1
M)6 3WU1UH.98F-%::9NSEF\';ZWQSP/8F@S8X#F+?F#8:W"+>N.@;U28I+^X
M'T>?8FPOWI;J>+&BJLA#T.XB>C24JU.W\GR1.9O3K(/#06AE+:,P+9)XX$FH
M$NUU2901!QF9M@%4@^JJ,/*ZRJ4I$/C_,?/CCX58!SZ-DDGG8_\;I'%426MI
M%(GEMG],R,S$ PPD["[&?1-83G8E#)8R>NR[X)H@$0M0E*?[QV[&T@Z[A:ML
M$]J1(;MGBN]N+O\C)?>'<25W"!5%1ZRBR-#(_S6&(84R)*H4U'?I/EZ=R0P^
M"YKI /#]TS=@(.W.[\\OBD.98?QCRE(DP-Q<W-)_[0F$V);T2[I?Y3[B_KJ2
M==<4OV]T=1:Y38@M44ZB^&)0LC&O2#G%DJU$ ,W)5L]K68A*#TOI2O#L%,(3
M>N8E>66J-=<^)KFG_H3HTG)AMGM'CRT2+(H3*;"2H9JXI\APH]L5<AMU44,Y
M#.4L\:/?CTZW@OUD;Y&XY=]S@^F;IT/FC\;T=E^0>A#1N(W)N\.,!X3@SD_?
MRZUB5Q<^KPS+L<+Z7LN%AS5\&L?I-SC?(9R]13K%12\+S62*VG,4]Y14G07C
M5QUJEJ\N*I7^?$).!4@VET8*P 2;0P78C92T5 ^_^+95,X'BBSSX.%]G,,N[
M9&8&#7#LPRZJP&8.^A0:2[_<-_DX1:BK*F]"^?C=F:<UY;T49TB(LD&>Y$"V
M1M/:^O,OWB+TJ;EIM1!<7-%</*$T?(%WF9GS2>RQLG'!4>2R<=A8_VLM0#+&
MH"3_(3:=PL8;71I+FD<8'=X=OAO])\Q'_E1?\YV]_%V.N+H72D0G.CRT/2.'
M-0VC_Y%;)W\_W;MU.<<868CU>8<0VW:F])&-E63!QQICB&7J$"7Y"3T X4L?
MBF>ZSGHWS8>&HB[;E H7I@?.ZMWN63%7XW)-A:OLE4E&')005F!Q_RUFIRG_
M\J^'8OHF!QGQXP+ U#Z1/N[O=A]X[Y>UA#K<V8K+VY$1P'?'3!AJ2X1,$[54
M?_V#/>@#<!V<9)_6M;#D?Q3! "W,S]_Z%-IX,J-2AQ#7?4*WJ"!?&[<0':UC
M)K<8WX7:- MZDN_F5K^]J,9-:?V>HF;=%8>65KEFVX7AZCRX"#IN;J*,4MH_
MJ*M]_#=68VLZ>8)2;:TFPX&"/><]=@>>UU?V"8NS&"'6*CS75 GF"PE\?<1,
M^3$UC<'PW0\#\ QC3U4PE&= F3&=CDTWL9#0A>R76_"AF;A>0WE/B;W>PBO+
M5]"(6^J=RB_0?16=;8(K<=A-$RMEQ%R6P@-@Z$Z6C;&.< F'V2=J+DJ&$YUH
MOF6#P"MM84!,1[AINLQ#9H\!E%=Y\(**QM7MJ+A+L.R1=G)(6NE]5*K!_.=,
MLYC)UKK/EW@:)"J=<?S*-A98(9*Z[>_9;T_(F4DK>ZU\KLL<^-_\J]R<N.X0
MKC?MK!'X#[7J:U(0&5,K:^&(V_IN*#T]4DB(MA<H5&;[CX5"N1UL/MX5<RK5
M 'Y7M1:<(XGR=CMN59":[\H/!U&CW!J/K>L6W&D\[B97AZENPYYU9#9[T[^P
M:%#Y\U)]PR/(%\',B()*,"4BO,!KL.\$>)7][<5EW$<CT3=E^I'=.V%:W=N)
M"8HB3/'YR<KE?\\=+'/7B'P U!-6;U&![:3ZNJC9(EC=/'E"MKN:4'V^GUUU
M1E$MC!\R =A\Z$$#;@'H*!""I\](O[_ZD==UG^=@-TJ86.D*16%%00VN5;&,
MD&4#D]%T14;>8,M9!I]?DH?7Q&:J=31DO+[5WF(;/ WS-*^?N^[=0/<R-YHZ
MT38+UF[JF#/C*.F4CZA(6FT5><3((JVT8*L[_BO9E*BO*[X+($GAE3VSQ18.
M(MIVY!H4\AAGF&2<>^9(;&,[PGO^->-SB1M=(=]Y;*'^L([6;;OH!_IEM=5;
MKLT'P&  @*U/@]8+?RL[MEHM'Q&L&V\2=]W+2NSF[%J(GL?**/2$%VDPO,U,
M7KL9$"]%P",)M,]Y+/G,R[=?[$O@B:!=(\_C(Z-7D['&*H2#US;>9X6/7ZHK
MHWUK<4ZI'FO0OB)>"&B7:(CW0.S"5_HDV6 V89*T2)$IG@NB\%:R4[\' *D=
M\6DCS2 E_T1#*B5F(-EV\HJM\9_+#P!;9T*OC:N^&4FN)4-[%R^/%>WI:K/Y
M+68*:W'+$"6A2+R=&[7X'-J8!!_PI;R.+41JP46EHNC>0S((IGB"!=T@0"UY
MFC^MJKA4!@D+_0@HPS?(CUF[T8Z412^6S@A*<+H9HMU,+X>);^^'@SB@74^]
MB+:>!GEO287[,W]SVHG62+7HJ&G5#FT)J<4SII'1$Q$Q<VD1#M%4GHJ.#5Y1
M5MDO 1O-^A-3-I2;AU'K1S.=67I7"TJ1KTE;?WT"B'T?\@'MH]*'SZXRF&_G
M]T^(X>5].10!ML<3P*6#9L]LVG35IWY<NL\>.9%0OE=F<B-MFD094A$DE(#H
MN09LO\>REPL>J):QY5V&1<+_P,KX7@FN@>7J/BD\Q#@1.2):.4=%S*/##__P
M*>_/EW<JI,][E"A)"%V&M<UHMKEMH&O[?>8XAE[.TG,"#P#JY9OM?NK4-<B=
M[\_$76^[ELV@;/22O(VLOJ#\%#L%ZF)A/:VI@DI8_$ .)0)'9NZ3,P$B^<WD
M!T']V&IMM9PA[RML/&KY/L>^FF5<[6P9!GU6VE.")&/1X7TVJ6J$EJ;1657$
MQ+=KR9J%3G$P%J*O<A&QO:4? K:AB)NGI-!L@IW,-5^9E3&S?Z_:DV6.X?O^
MN2P&;39;7>C+W=N^"K +_#0*9 %-#-C<H%UZ %@Y4!/$]##'S<E6:-# 'D^%
MX+ Y;9G3N HAI^3=[LWP]M:7?8#28!W$W"8^,"06-@I]&E]MAP+..B]HS3>:
MDX&P;V]? 5O#G^QB*O=YB&+$[.3D3&C+DS<PY%;$E @+>_P]BLR\Z@$ 4_'=
M:/3_V3QE(V4-)Y\UL8CIPW@ _+J\(3:OW( ICUH'7SG.KUYD#%#PO5 0N1/\
M_@ 0%-RW>  $GTL\QH%W*BX'WTY/$QVKF@O$%_W%+_[7/(G ];:4D3L+@Z3L
M?6779DXV+>+T:H+$2[,2R;M=/#K,NFIDS_T 4)N3X7P 7$S)@+)Z6IC.RK>^
M] (ID%3PY^D4,0WB64^1EH/[+RRRW&+A2B4?HB?>*-'!I[ORQ'903,B7L.:!
M:D*-7$3SJ\8%@6%OXM5B(R'4A>-UXN!U2O"$T<5'Q-*T2=T<O2.8EO-N:BIG
M0M&(ZX)_NPM)DJPY$PLI@1484:<PO1"@>]?OQM.@'4A\'QPZZ,':20IO[ML@
M00K-6TZ#M7./J+%S0X*< YRFTJ@@^DR/1:%!#%?5/JD^[OHM$X25>"E9Q7'^
M45)&7 '\_T-'5$K*_ 'P)A<]+O!OW0=)L5O]22"&U+N-J!S:G;"]T5>..#*N
M/^;=&VV?64ELFSBG$*^159?CW=/<9P=L9G<1^N.8&-LO?Q:.!6D34KG3Z;&<
M,;H@W_2,E!W(\7I@6A*;N+M\.G1O$^=XQZE[: D6OGL9T ,"V\#SMR:,X2:>
M](0PX_<:8I8KOEX= 6XT?I.*R :GEPJ3VX*W/V 34.<P22(O]84^?^)IAJF+
MC("OBD]&51" 829ZTW%LPS@ONL"JEL?Q,NK5.9616395:_$^<=1D>AD18EI3
M\JY9_YMT*EI<]+/4MU0:;Q3L<1M6C+T?)ZY X@(B=3#T2G,QR2%(&=@K?^9Z
MX2>!7Q+/* D+IMO$7ML<JHGS&76&CZ7#'!XQU>PQX=X,=E@^KL7C^^FON4$E
M>)K-@7 N0:2YB;*NNUUGX1B-3'>2&1\*]T(+[U2J.6EJJU(U#?8^K0V!R:$Z
MDR<%/^RR]A-E5G)2+/6U]SK=6E#NO-$)\?2K'X5F_"?"&7;8]P7'U];&"RLJ
M%'^LU2?9>[VN$1'MOBY%SF'@MD@VS&(KD[OU"#(),R;_C!&N5-8< 'ZAU%PN
M_+?]Y9@2G*%IU8Y^[FZ.I&EI:TU*A9\$\W2WZL,>%:8RZ2;)I;V;G9DIS;HE
M#5)5(K2S>_R_*:O\.[-CFT[UT9KZ>S?A>I%_*5VE<(SNIG/0J[^D<6-\W.43
MR,^A<_+69W9KUG&WVUDE$FI[.XD9B#,:EYU],7V@S^+OE"*+_QNPS53T2H&0
M'5U#@ ?-J^ G<(V<C@R-+2,>2K;@>)+N^(_"O5T%_RP.>*\R2PM&A^#.ZLLN
M=C+ ;J1R#YA6Z\.KHY7.5,H/3^P-R5ZN2U$#9 ^(UHK;,UIH\1Q%23W]Q=,!
MCN0O%@=I(J^+&UZYEGR\) .,<!CQ%23*?E[#MD5CAZB)CWYX *BXR@YBQN;2
M%P>B@QNV/]N+I7T41A<U^U9:^O<"*NAD+U% >Y<.\/ZI&2AB,4%.0S?(FL4[
MFN/$D?+?U IT$EU:;O'BB@,3JM8_!U(F\I>)E'$O*P&],'UFJ#VL,$#NQ0TQ
M@Y6 #S(>22[7&GEE0R.)1UP$K*(T\9/SJ453'Q3N%>6.I:G<6(<-_0Y3W;1C
MF*'AVKH YFTJ 4"*SK$5E\4NQ,]^1\SH!%LN+1>/U[A]]=E<2T-]CQM"+\2E
MPIY< 5 RB>GRJJ9JCI*<Y=_S.DQ72#T3$T WC-!A_S1"DMJ9\#B^4:DIXWF(
MGX_^9",$K#VE4 ;]8:EYM^C_UJ]<29Q?M+R@YR#7#:%I&DY)G_JK"^?$T5PN
ML;W13A4\$.HUS\<UB\*S9Z 959 \-IQ%J'$@%<LOR A3&O2I%O\K2J*<#C"2
MS<W^7/ 9^@*-W2TX6&L2S22^W[N*&R3H)]A@YO!UR!WB5=7Z?<,8O]PS)G!$
M!I-^JZ%$4-W>T0RB^_9H)H6T\38'?VAEUU7_W?"-GT09UZR_$()U16:.H;TV
M O)%K;8 N%ZEK8/PK+2]Y;FJG$47EXM)7LA.O0U];,K94""^?,<$-U%';Z2>
M"=;?%4TWYYYXQL8TRU&5#-T/S1G(?O9Y8_>E@MP(D8NYJB)4@IXRB;PF@A,@
M>;#W@W<I"T260NLTCFQF*?\ZXTZ6HKG5A>94%-[OMM*2^M[VO"'F\<*DBY,R
M#KG*J/+,Q4W[P?/M*!,+U[@YORK"7X29^GW;<,V!^:M$/2GE$9A;]^05?RIR
M4)&WJ>5&G0*TUZ03]L;/ =NY4_EHKK*D\\Y]GUD_TV?W^[]P,79[O3W3BH)T
MIVQPB=<B>,U!IO/P.W&WVJA8%U2:HF>HZ+OO7DR:E#!"!ZYDV4,Y %"5)PLN
MR\5N5L])#9 (H!!HGI+D\II13_10MJDT6ZF[)<N:C?]S9MDC!>];V_E 7'<&
MX%>-C\Y,S+EOMQ'MB()OM0\ ],1PJ%F3*9=:P=!/)B]6+PDR?]%K,OU.K[^K
MC,QU#L3,0P*L>3[3$\.+.S;'N 8WGH ^UIL<>O@SQ$P4VS6QZ\H- T32%(>8
M2G"HL-1/4\M_$=$@,'3NB[JL3D-1###R D2X"4PPXX#Z=]#;Q\TUQ<@>OG["
M/3W\G!32<Y>LV#C[":C:DKEV?ORRG>DB'!C3]?0/%;.?4&RM0;CD>]'T)U Q
M=6;T,:PLFD)D(VH=@FM[-M+T1"=$10;S[7)J*/I5CPD$G2ZK<6W]669/0G=S
M0AI-+64JU,-_GX2_ \ G:P;_*D=/G.Y\C,C9S*[<!-(@9:<L85?!+[JP/[@_
ME_-CUE2*9[I/K64=^S&\$I-)ZV1R%P Y76K>FHB3^L !EH.>O'@ Z$^[GVAM
MZ$Z##2U?-_$:)=,H,K:8?/>VS\4:8F98QF42&2EA216VND;&6A#Z65>A3K^=
M.W_NQ/#*@32C1&OEFZ9YD#3%IO:ME<7?+:/DE7 -F71UG#-)KXUM+Y^5(=@V
M4?7;&^B(C0$?O[$8(\^0MY^W;KG*:-4X?^Y2C*#A92N*OANL]*LL=#"R&3!?
M[KO*J(.EP.RUC_T).F<N#C:M\/W<:-\H,D3L8*\>+3IO]7S83C^O#@7BM)O"
M1J]>(^X"MM:>[O?9Z,[\TIH>U9+#6HTFGV=.'OH@EOLBEQ? "[(.-UV>4 O_
MI:_F":KO =9VQ;0[PQX ?2A1ZHW0!B)<^\./&RM&J._/3WZE<Q@Q)->S>HIS
M.>+2NIQ;%*DYW#$[I.,,=N! KZ/<-QX?NAP1RY2N',T<A0K<R\YE8CT]_S J
M#IW2MT_J]OGL(2FDM'WU\CYSDN3)6'6MM!>S&4!*-D#LN)-;C98"6$?W\PSS
M4?XA1#DKL)=[^<S@ @#L2Q<]DFP5_QPB,.- NW]"=<=FB%#<!IL!80&12%I'
MP8TG@P5VG<#Z>:N6CFGD-+G_?*CAMDEB\A?0Q8GN1<Y2,"0'"\6 D#U[ !C
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M=)V97O"/XQ09%8+BC0 #G^1O(BQ.E63%G$0'.TP[FE$@<.ZGBH6$FI48(A5
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MG*"_\*S)A5/M_5%5V$VU$'>B/BT^KZ3B*7Q*6N21[R>HWD 'VDSQS*/0-F:
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MBH. X^!OX7I>]T7\TX[]\LDM!>[E\Q.PP4!R@%N<8? 6,&4=KR+FJ)BK[S
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M-R#BF1060M\;<QXVM-QSJ)L>1MKW]FB8TXQ$(AO]^X1Z[>"'[ZM88&1DCXD
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M&IZ1 0H'52Z:<LH["H7YLSRB/!4)&D"0=7"MM%B%,[11K^X4U8CW$6I <R^
MI<N;6,CZ*?IFVA]PP5O#'OA5G4]W^30!3'O]7X^,F7RDCTFSB.3=!-WH9;UE
MYX4=6J(JS\S"NM]P4R,?&QCU9-G[80^D,<-]JZV6$O7<:V6-?T9-Z-7=Z*R/
MZYATNZQ&"'31]PAT>).S3<ZM%HSQV]^ATJ^GG,P0<]S&U=_NI.QKS5%FO;51
MT$UP5I?:$>_$CBHVQ:STKA9384*AO]'L4S;+(98Y2D%-%P)-=G!>8ULX%+WW
MPTA+MQG?7H&;EB9R/@;)$&0P[%20T82Y,%GV6Y+%C[O*YG#[YINM["S)\ZGE
M(G_B8@V!5=D%18,%O$&4X\MJ?)JU1/R"/-"'4391&2JX"27K75 'E973BOXH
MYICM=[[HSTKBT5O^P$>CFMKI@AHP2^AMLIF<I/\&*#NWN:TM?4B'/':R?9:"
MZ&$!_-4Y2C.BH?PW]"[-CTQ(R41\S6_TF6WNX_EU>:7B"T"C=B;T3%[E[VA]
M,W()_B3J ?;6XV3>^)LZ!SC,]XUVO<0[?C;;K,O[^O$O@"VM)=NSM2\-L>\U
M;,LH-K2F*2'R[>)B=I_OEQ54/;D:: I!OR(+C&Y],FZ/MRS"<U>Y7!N%S</?
MI %Q4E9_S=WGN#P*0+A_Y>KT^M@Y,->#J59),^V$8%6[4OC3BN3 #::Y5*N6
M\2/_WY]CV2#J&_6?IR4($J<(U%1G\>0;.:0K1E"(Q)(U(WFW0;:S5L26C>,-
MD[Y8#'!??]J_ER%\KVV1W4#[(; \J(L\[%7(6J$,=1_*20#\[0.ZOXA\TTHS
M4-KJ#/JH*VFW0$$%IM)/'M ]^W0\8$H)$3G7VGMVF=1]3LCZ$AC,SH=(D7J7
M_N#X N@6-A+WD]K"[GD2*IB1X2$ICF"><=&[D).SS2\+\/YTZP5,W12JH&!9
M;_LE*&CX]@6 B[Q?B8^5HM5RX+E.E1?-^'],^6C5/(^^ .I$(D6L<BB+XHK"
M:Z?MT(;+K4]^RDG'.R+?%MB[@UR2/#$^/X^] &IOHSNM<H@P>21C3G1IRTMG
MKUNVZ4C5!4_)>8:DI+N'!P5$Z3HMA=%]B2"#70'P2S"UGGGSM0%<0YV=]T6M
M*;&<X,8W^[9878#7%Y)7<X5J0>:WI^WIGDT#S4+6T 68"^3V,TQMHQ+8TT%:
MJX=)JA Q$D[E/%AJ8?*H.";W[DR&:U85:UU6]V[^[,P/5U/SE=D3_Y<=Q?^9
M4)'A=/Q.WG/&2WRN.LNAU\]'\2U\V9EC.4C@BK:P@*B?&>&_27L'<<6*)P=E
M?LU4-X\FKS#TL.NNHN1D&?LO.[\)&6TC?15*R8%2S5EZ-F$"2K]!60WDNI>:
M/S..-HOX>(G+*&AAFY6>88_5B;W658Z!;A17K9*E%EN<9K%>A)V7X\UJ5R!O
M'0-O_*>"U,F,XJQ-)RZ_%#UY-P)G@P][! +3'O&R",D)NL63CKU'P+"B!!T9
M.?57N53 +4RDZP5/OR;HHQD,\W?>U+740GY896*F($R[UB%6E^3Y9/^CU&V8
MN3!%$(M\_1S_,",I<>51I,5.^*[^CB5T3RR1)#/(X-KS76+9>)X1[6JCX-SU
M&7"ZLH-I\<];K_D+KQU_2/S/"OHW$Y$*M*4K0X<8V!^+;<44M_P$%J)@'2\
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MCN*9K R^)I5AI@W>G 66 DJ^P1%<+Z)-$BBJEPGD8/XT?B[5Y"HII[_+*0M
MZ[1Y ;QYGL;ECO-R0 I*^QS9]!'![D329_99$,95XFF0\2#M/OOQUD&->)2U
MT%_N<#EL(M$/:3<3A#3&0FQ BAQ+\B3PE!E@+X+I62Q1-^/6[\=H2_56?_5O
MXY>X0&2*:]4X_9;+S>L(]<^N'!+#T;<68"FPR)L_:MSMFP7!-SQRHPZ)H2&(
M";I7GZ:T4(NLJ'5;JN<Y?0Y>[4/A![.DMWTE/EH>1L#(% N5$7ZCWS<_I!6S
M:%';5D!.-@+Z\Y6"0D7ZUH0S']]]9[1(C <0Y!L2/%@W%G36-44KIE4LP+__
MWNZ^GS&2Z;67>_]+,Z>N:*^5(F+S/-J?#,J28^=A5=*_JR@MG]-NB WM[5,]
MZN"P9+:/_2X9B!05#[R\W$@X972!+$\8L.J';VN +W2I(FYK>)IRQ]V3GU>T
M4 F6ZJ?53A52F](,W8,_)9\!3]D\&5YEF41YS=V9"*46N=22@(07I;3P3Y>=
M^@?T7%[S(^NB]HKA#4HTZS7:;#*A3-I<'5ZLP6B8D31L?]L.3RWC@MG:*TT'
MH](.:"Z8(W:JLT8/J]SJ).+J.<KH[YNO\SM6@,7Z(?FPE_/UILVW;(AC*F;>
MS;0$5=K@PD)TVF?WD$Q;4\:T^!#H>9]LFI^R'L5? "B@ 0<,:\R2QG1$#[D]
M?<8N!"%,KRDBHBN0_M,/?V2>P<XHY0,E#C$+W+MDZ7:G$YND)J:"NZS$@RE5
MM_R1JC/_A4/=L,;2XI5577W:U3\UX3+?=WBI*_6()SQ!)#!T"*L:C"[]'4)?
M$_]$;.\MCL$G$\(9KAQH[U9ZM+*U(3$L('^XT@9HO;(7"<6(".0X-D(X22ES
MGO$PF 0_U<4)6\<8#K;=%(!"A"FM11H"0CF;5>U8F+4%SHP]>6KCM[G6C@/J
ME08<D M!-\6]Q&>WL1PK\3P^FN#N80%)F<<)S^V\N5U4UL1KC6>01>&/C@4W
M@LZ,%;PQ6WOAX,J0-D0/@HO)'B-TS_5MB_C?T,X^ 8$LM%$%V\-[[A/)P8<Q
M@8S[+%$-  9<5[_+7%&IL-YJEJLU?_G/<NIP6!A41 %B6)YWT,3AQ;/\MVAM
M=7)5/.023^N95/?O(LSN:]O<]GP5KA:S&ZD]64X;3"O:?[Z5^8I'EP)48)5T
MS+\]9%?!G ))\K#UWE@H\)\T)(KI"<!FKG@L+V$ESM KJ5IAJ<W6QK;=:TCY
M4%)*332A6K%U3Y&UG):AC85:6"7>K!L7[J*JZI$K#[.X:7L!!#M;&>$9O@#Z
M.S'SFZ;^:-$=5KDF^;8)24S( )<9];+]C\DLK&@3=CNC!9DK/(&&[=-N3]S'
MTG,GF87]A<M$.[$)#L54\2B@@XX_Q=O%)TL;E,NDT@_8,?6N&6><C#9E*]\$
M1O5? ,[R9+&7-4&J7MT?V@6%N=73/UY+_8SLELS?"X]]Q+V_OLGKJ'S*?0%L
M9!F]?<96<BOQ]%\S(O?\)CC4Y&T=4-C5>36/D<9+KL.#X>P$[E#S7*8W=6,X
M<J^MI@H6^/JJ)[*T-;1"!!EGLGBLWC/D14^-_<\AGW;"3>R3V^T70'S&]P:(
M0_A9 Z_&S;A_[VA]X#:OUR^TX@Z.) &2GS)BAN*Q^EEY"?S'"4-P1KK^PP'5
MR%$=@D+%D8^*])#!(!FL9(+^^;R.[T!X>,J[@ZX$T;^G#\@W5J]K:><IL,G;
M,/_HLN.YTH\:H6V:P.^7'TN9Q$W9_M5;(-8##67<[T?T6P)U0.Y7 '"@SZ2J
MQ<IOORZBJ^%<_2'>8G.A-P#+EQ%2F!XA""P4RS^8+X\\W4#<N34W21KS3J.G
MN:[*5)TV!-JUU2W+T)J^6@^$_W#$_#^#Z$VYSQNX+<B)\X5%.=;<LPH&VKN/
M'"63_/JB-4,]:Y]__C#Q5S(Q8)HH,F+-6AP79#A6+,],R3JQ4,1"6_C'F-_9
M?VG0.?PL!&NY4L+VBY__FDZ(C.23>FY88\3W#&[<L?%VC8Q=?X]LR76\JYZO
M14@T!.$8J<L/_A5A@$U$III?;]="EH]UY&A)%5^?\_,>[8EY*1^ZZF]>%5:A
MKVOS;H8S2=&ER89;K&KW.J?11J'( !_C>$^";1OYH6' TOW#PC.=A]1H,&L&
MV_J DTXZ3ZW^:ON ;(W=",?(I:&;+[.@FE7^8L]VV4:*:6&;$)9V-C$:?ZJU
MF=BFP)V@E WSGZ#=/Z&FPCX^\Q$WMB.1ILNQZV[:3T>P:)C55,EAN^\DN+IY
M1+N,J6QFR#_=G;G*W^G'#BG9/9IYOMD->C(1WV?VXEGW A\^8U-:Y\KI,*7*
MX3T#B<4*,07G!@L;\N%28-$_&N<0_4\R*6$@F@&A$/SH5V*E0J-2UIIWHLBO
MY;?Q HBL6U\R6#UZK[H&E[0Z[KFY5XFIZ%IMP^:$3M8(Y,$?5;6\)4??<D^L
M_$OD.UDWO#*V07*4VQJ]8\Z(*W94S'4QA:3H["P0HKO,$WW-_,:8MKV7S6C#
M)%&GU2!.PW ?7*_%MS'YEMQ#-/IH=THN(:>:H!-_F/\L;FYA5A.3TS[#-$7E
MOYYN^<^"B@P\+8K2QT!S11#C)9+#2NFJN5!E0ZD<V,\M>J?$":<9K8QZ."Y=
MG?13D%(6\,%N1'WVR]>M(NGH-^8;<"I,9U\9X*8'=.JFT&2P]NFR/JU<,&ZW
M2_T//X$FH+9$7(V/-V#U/L$WBY=L=LL*54#9[C #$#+BX# 1A.<$CI+!\BHZ
M$ZX'W*E7<:C,S&N244CPEE6/9/LQP#,Q'"Y4X@/*>UGG"R\R](+SVR6C#8+C
MBQI.3F-ETAZNX#[BH% O,^G^DS*'OXX5"\ZE,?SDU)JFS_.2+DZ9-W)NK6FH
MX-=2+QP>\9%OK(TB.]!? *&=HDUQ7'Z,\LDTLL@YE*HR%*E7@_TB$=6^LI"^
M5KVQ^;H(7#''@O"X;N0/558WB=892),1YY/+)$ G*\?!_.#FR5V#>J96W#CI
M=LW]-W1)?9_5B^H/_-^44E$J.]H8]7P:%(GF'+)GB<O*3$?=E\8BT**FB3[N
MM#0"O !Z&F"]6PKO&):835K<0QP'A[/G]DU]$J] ';&IVG2-%GM),?DJ_6<)
M?Q/"F^YI%T)=,3EZEL>+2I$J+$T_R:.'=8W:D2T4E? 2P*X?4'Q-:V!2T-
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M*BJJP6)#I29BCAMPX>>BA*Y#@-@6LHRIDDW1Q##R,ME_ZN,!)-29J3+T9*E
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M3*+N=?J+TTN/J)6J!T=LHY!=^-$WO_!+@"AY*:]0^<[ZDL,S&OHF=H*:KF>
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M'S/5 ]L^:V=]6F['/:!N;Q:;B8#H:R8]_<F>'>*<L:MIO;#R'[.';([9K0<
M:[2]JH^&47GUZYA!>B3E24Z#Z4/6<)?W (0 6F.I];YUT5P F_VIE=SK7>,T
M,1UV!:-4S?&H"C69C[;_*(7L,2W%LQE.J_]X*_]@>4##]#UO]*DRJI11/H.
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MW_QQ0_\,X@!1R6<VU_ &:22YIGF2M:L1G1/I?H[I+.Z55/SE-+)ZA1+12?S
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M"_D#KQ^?GHKH[SA-79=CRE4H^S"BDSP8N24XA\;X$UV>3TMZ:8);?/Q&K[:
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MR2]>5R2'#E 5J@#CF:J1D+-D%+@U@E7WS]Z^ )C<PTS'D7LS!*-J?C;[B U
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M4QRYR)U$)B)OV\:=B?>3[B)DN)A!-S$#Z<FE5I6[=09^6J)&\>83CG7$7TF
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M97]EGI]!$#NV*.WS[9O1',-,K;KB:_]#3U:GOQ*V_XMFPG^76;R^?H9F"TH
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MA;_2=MTMVT'4G60^09O*X5L_99XY;2^V+">LBNW/(-:2NM:SR.?MFKP#Z9'
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MY0.<:QE4&3SH@ SA/[@HDTE4Y*.YKU7..[U?EW&2@E$D?,; [<D, S6N[9_
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M]Z\)!)'_9[R:QEM"(1\*P"XGGIK)/WRV_3_*-#-"X):T.QCZ)J]L ]]6'J[
M=[,#:%[9XO)4WQ??GT(V*3<[V5$V%5G7YNUE.MXR&9*5L1J[SY?4GPGWKY'#
M>/T%!]=L&C&[N0_-!C(RQJH]GH18^!IMUKB>U:SU!1&XP*B,^4\<Z?)U6K//
M@$ 46!.QF.8(.@(:.L/:<JT^"^BD7TC> NZA)>,4Y#TA<;P+?_"O82M?(K0I
M +(5_I-SPDYM>03_%./_%T]#T& KL97Y=Y65J@$NBP8*CD4=P6?7XIA(1[:.
M*7V48I%#:\+HKRSJ6E579A6XN'9AJNJ@_M5,$$K7C_86D-7Q#(-1O@7T&^I6
M4*1\W_F^'3-7"2'<J[X%+ %O*DS6$,4-6I?7T^"C7T%H10\F"H1!4EC$S[I4
M7Y+!R0/I^^];!@7P*LK3IUXJ*I%(UW]BY-Y,0G$]_BL%O1YTS5@5=)J]VSG$
MR!V.:D'8]G;1-VB E9&>\:T1$1%HOV*RH?>(C'Q1SY?+X0_[$WHDMA=+T]/9
MBL^YJLP*I[WE F\Z/ Y<NG5]B#9MPZL25KO6K^<:FF/T"Z0F?Q-;BTD^D@0
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MDRBWAOB!KGK%//YKKD@1":>#S)%XX%,MAS8X:(EYHRG\+ @T[^A]86+622C
M5CC5+2B3AO6[I)FD54E"YI55J@]VC$=IR8B3CEH5@SZT2%9K2$YR(I >I:Z/
M%(^&9FE,> R_:!+GB]^@EJ QP/F0^A1P7_41*2QKO2LNG_8.:&^!&5#.Z-U.
M4"9!J6I13,IX1K/4_OMB :X^DB2+#Z*_K\0/1->#XFX!6!!7>(=5S]5!4]BI
M3W&<[M>YTS]AY@.U9OM)/UYU%U7\BB<7S(=-HB7GVA_#+1=J9+6Z3;0G9%A=
MBU=@$4D+LUCD20)B.JJ 3&+W5%5)EJW*U#7R72W9U21U.G#]Q5 7$#.QBI,V
M$$A7-[WO\:L]M7_@RQ"#NXNBK@H!<SQD$U4_%WN&,X@3^"ZP;PT&"@F\'S@Z
ML;/XZR(;&NT":VNI;B A73LPG&3/>K"L]XA#6I/H*QX>(ZE<+8KLV@HBA[H%
M5"W_,9&96^2/X9UN^Y-]T-S48H/%HXUK _$&_")5&3 P$8ISXB43J1Q4Y90U
M/ESA&%3T]4[HL@LB0N'!A\([F1Q2=DF@/GG>1@T/*A5PC2#[1I2_M:S,+?NU
M&'>ZB&6 U3Z51@_%/A8OR:X,-VI/OK/0G&&Y'T37E['"[>PT5K5R+N7WU$T%
M*C@99 <BW@-CS<$;'NPR][%-JO?0-JYXUK+8#1]/YWMS=F//_26M?0MPZB)$
M&9Y'HP;@HQ;C_7-^6M%O870!,%A6'@\1TYG<&]\/FH2S7XLX2R?GOWL6X69<
M@#4B.6K(+>,[J;ZB#.V1U"^[,-V(@=%PDZB\BB0NE<GGQ%^&A=3SNM_1LC;3
MLA@&F]X">EY@J&3AHH-Q\&M97%5L>^AH,;"67%,XY3$D@"*_W>/'8.[O.I$,
M(\6%^KW69Y-U$'&X!O\@'65F_6<'JJO2#%^:S-7C67D6W8I#_/731Q?01TCJ
M@Q3$6J])5S\)V*2K=8H%H1,BBML<_,;[ XB7M_O-I&#/ON WF?O/RU7;'G]W
M53O(WQOD@'*C\.XN*;6;3S+@\MTKY:BS&]S%[WO[5:UG7TP;BC\W6Q,>I<!^
MGB1UK%7[%?[A%('O7W#QJIJ_XZ7042G\#SBX>_C#0U"'7VC+#6E><\IBF#W^
MGPF$X?*<J6JP/,54_4-#.>\9"#WKE\I%-3ZA?LKK$D%##,CNIZ4#M:HW5L//
M3SX_D6D6U7!+7'GX_50"DU6[2]VP^.LY=KZH:I37YH_QI:)Y[Z\T=]\MP<.]
M--&62"@!&N/9<7^+O06FPF/R@F\SD_; HJQT5]OA/4^R"BC1=;%=SWAV?:X(
MO$BVW"?:\GW#YWQ4OFS/+Z\@R[-X3$LB XCTTV\VIRA[ZW] V?,']'^U=Z5!
M32=9_,\M 0QR&#EE",< 9D4$D3,0Y%!ND%) 0"XQ<LFA 8D$," ,(B @8Q@)
MRGTHA1)0CH1+4%"10T$P$124FP1(C)+DOW&JYN/6[E0Y5;-;^^%7U=75'[KZ
MO=?]>^_5>RWC/"@\WE"5ACJO HLEK$0:[6E4W_3\*>ZZ;="8;XEV+%5K9-&J
MDL\X_B6=/3(]/A=K\;.@CT[== 9Z_#\GPNY#ID<,GHN1CE]V=DRWSG,Y: 5;
MJ%AV_($=@2[7GOUKNS?^E2B9'*OMS &P)SX.?U4UMP6!0*5<KN+K=%\>,N<#
M8R+3:[Q<Q2[N:7=W?B82I2=(.5DV\2"C$S:7+)]UK;-Y:PD$]!LO<HMQ;]@%
MB]$@0 KO":>"0.A<) U^N7H(&2;0U U_/KPI_RE,RER9''!K>>Y ^%XILU*6
MY?IL@"RNVP<$YJCFQB 0[$?AY=-.3,/7>/*, 8X\O*?M?38/8"</6X^L,]O[
M&(:R%N3;D1IK-8BH[J :<8@X4&J:6FJ+W;F7W83TZL-![">??=E-5F!/VI%
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MW//ERP3LS51ISAG-1ZF\DS2S[$3(GO[@P7;I/<; 1/ L0JF?V)*["I]%9A)
M ,_<+\(Y2#?CEA]M>5U^X!2-*NHMWY,G+C*J/CF8*NWF*&/OZ&(4ZMZY,V2L
M<H]F+89%!('"%-XPD?D4!!:>A;\'@8CHKT;#6126"/'KB<QDFJ4DXTPJ0VDV
MH-\5L@"SU'3=0<VO/>E])['C]L*@E9LO6C7HAH#$(]ENHUL,1U8Z(W?5FWZU
M_WL)'7VB3]&%J%5LMD28R%K%0^ .0R12<TRQP?!/ C 5XY#4;H6:QTDFB)L@
MD%A>K/=;@%_N&6X:;F[44@4W40$"WSR-$M97[) ?$2" !H%M*2)7KZTQDINY
M%6ECQ;W9(52]=!-F&LHY]%#\7K3ZV<IK)5DN"K["YZT;2^)!0':)TM2Z&LWP
M]&9H7\%:U[/-^L<DAA">J ?;#IN*-FK^92&&#W0\;$)T@%K1PLN?/?0:O^([
M)\<*%GGV-MN89_O[D%-B,ZX][8M^YHBZ)=2V1ZL4*2JER$WG\)+T,3'DQL1B
M0,@YLM0K)A'B.IO]0GTT&OHBG&4\YJ2KMG%Q=1=>6020#*X2U9NG3%V=O4_9
M1F&1[#@&;K;_5E+@1Z+4((&445"'0JR%9CYH1RT,"-J>'4]_N>,? F;I'F0N
MF4FUZ1U%*R*[795!H&<H 6_C^'C,H3DMN)]5L%XHEE]XZN.-3O3AP0JU.Z\J
MQK6-+2NCV5JEM9B[4YR3;(SFNU9"&-[\"'VR^>KY(YA;"EY7@TY3<T]HL^OS
MV<@9*;[2T#V&LV&77M2]EQ(7+0\3[HUWC,N$>WN["I=AX*_R[*W]F=N[L,!K
MG@C6@(R3&PQE$#/7B9ZO,Y@QLJ6[+89ZI0WZTNP^GQ87,OI,!,QU[J.)?'^T
M_\693;MQ1'SV$- RA?_=6'WYQ@I0H4!IQKUG)L=C5E#9[E65[[9-+K=YUM:[
M-)ION?V9/[5U*JV%5:U7T.-\O@T"5U<N*"4&WA 1M,X(W6/T$DV4W-=<LADC
MW.#&F&]5;S^G4VO4M%-G+<1WL3[ZO/JA)7IPAE!*N#O\^._9F"WWI*)P/F]P
M^"$UKPYVULS*NRGZ:T%Y3C-SWSR#TYR7-Y3#C-I3%^U$ (DO]J-_+L7S/PV!
M=CD0V,&IF:10]Q:9_H*1+PYLAVV7;U1"Q*Q$$')I3W5,1T>L^KJV_@B5.@7Q
M3T_@@./W#U3X0\ )>NS +SX_ Q7?EZ1 G(0<;0&Y7U4+F]T$CGZ?__%[1L58
M2=AJ^_Q],Y__Q[^'G? UH2L.V<U HN'2'_%*N"A?GZS*(#Y_ Q?@OPA0\.T_
M 5!+ P04    " #E-6-<"1<Z65GA  !>B $ %0   '-O<&@M,C R-3$R,S%?
M9S$U+FIP9^R["SQ4W=\WO,?YV!!RBJD<2TCE4&24)$E(2*K)*224B$JS15&.
MI:)4!ATH:7(N9)RE$Y%S,4@Y9D:,S>S9\R[7];^Z[ONY>@[O\WD_[_.Y[^=>
M[.;7LO;:OW7Z_K[?M==PN[@#T(A%F.]1"+*Q@=9 $"0$">"60KS PH$?"*<
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M!.<_=+9SH>?>*$6W.HFM7&',A;*%M(9%%F@L,5!X&-$#A3MCX)D!?@@NLP$
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MW<9TP4EAW8GY(3^2U&>E]7.V;?I32T<7U.H[8S8J<O9G=;L>,QPQV*I=?<T
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M[$89%_I\^REP5XNSSX<7K0,/GJ7.6S77TMAJ"S!V+^0 9C*^& >B.FC#&D3
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M,-_<A2)0>C-Q6+N4P%(=6]P([J/=*/O'6[ ,_.SVWVX=RF!Q[?\\_!!!C#[
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MY=_9!^+I/NK/).K,B=]LJK<(?OIC3Z*Q>NK?[4G0:LK_()S=B/&_)YQV@M.
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M/6M*&PV^24@Z\'2>R6*-1TF#R]E3KU1[_3!/XWW7@=WP&$6>(52K WV19P@
M+PELX]48,+\W)8%9NW'?4;/F>["T-.+ (_MZM5(;*K1+4@U]]-KM"X>Y'+DL
M^RY?(V9(H1$_?\?F,ILX:"#XUMVHD+5A@,[U-(&.I>Z-D[KG[#>Z1N5KGFNG
MQ*]PB>2OHWQS:LL@=_S +0"I/Q#!J=9,8/HD=*6[8)7R<6Z/]SVI-'&3U)$3
MYVSI4T$_^1!^<>7"C-WW#F8,S-K?R;U)E]X"MV(/U0XP %OC;NLQJ".Q2<;X
MW_4TMONCQ0M9T$L'U7R!WLW'K-S)Y7N +,QE DT;O7XURIY#(=Z!^]B*ULY"
M>T%-K> OB\P(Y&XMPJ;A(\V ;,Y2J&S8ET=>Y#81@4;_ERQ=5V'KOR-+MZ<R
MJ"=)]Z]4&13X<V40K>.++-UE/V?I_BN; 7##H1UH$+^UF2<WQ+\C(BVG;O<X
M> LSS^CB/TU\6K;1<W+HV1DG[@\?XW_YA^K+C Q(9"\H?U'%:+E2>= =6"1#
M4G:+ N'"O81U8>U5;'_,^PWKMS]8$E6S=,'.I&/SN)33 ^A[#MG0N F,=L]J
M&C8E/EILG@8G> *CP<6J_[MZ09]JT;."Q*>;*C;W>4HD^GI\>'S4I"#L?FET
M<V'LIA7M[# *6>=G2MQ('8IO %+OA+6.C_I*LK@D97")R#WUNVD'PPL;JZ:.
M?>9:7COC:M^M02,NJHUD/8^D^G+;]@,1\JB;4CLM%:BV>ZX*P3H1+=%#<ZO)
M075@Z>1A@636%44V:CB%W!PK \L[P!I<;YHDD!BYPWG&Y%IWV27%( K&P,+^
M- A6V2I \%.!$-U#+E\O$I"Y(6SRBM<<,(]S?AEW_MLXA9P3VP636D#2GJ_T
M [S#?0_P;$E7,;8,?MQ-$0%1B4</$$($LPF2N::"=3:&6S62I/J =;82 [>^
M&:@K\BQ/TJ[*J45M9RES"M.;5Q^(#YU/+C\H&D#FQ $D6;R<!95?0T.XF*4M
MN:PWU.S]!NI8_PI9F8C'(6E54-LQQ2^E O5X[2.@YECCC^#)QXQ$9/6<EZN,
MGP"CY_E" ?G8L!UPLAA]T(J?<>B-E*H#J"GT:1(+R$% >IT?YP=T&??@./ J
M0D/D0^3@;>;V%MD2K!D"PO TJC!4/Z#2>>;9 EE7(=31L-V&5EV^8#A8_7Z(
M,GNT_LP>;)EV(D),.)<RC.PW&R#2O2\MOE8D,1D/3\X$ F/YSX2"+51L)#(!
M$FUWQ:]N3H,E^F)-,O0ILK@3?XND17':CK"!TO+.I,F<.@EZ@28VRN\[ %J'
MXH%9, ^LC85FNXM+\:^'WJJ18:BR0X*<"BD1Q%XU\EM$!$/2):XM&HHIS"']
M0Z2:,)>C/&A#JP>TUL<<R0EKF4 "AD="HV!!"**&BC9[X_N9A7 KQI"ZK2*D
MCII2P)-*[@AWV595"%&@V0G(H0]81WGKT8]+2I#+VF2,&;E*(')EXU$\LD9A
M)LS[R\)"3TE/#RWTT,(?UQ'_"WLRM"&GW[@-\QLAMISC$"#$#OW(]WAV,H-A
MVGM78]S=JF)^75?_^T3A%JF5#[?.P!,SA%NT@:6HA[6+7:N2V2FT.\S<#</%
MKH?V<M3B$F_(UE<\B#WI_,#KQ_8%VXKX44GI)BNGZ_IT[=+MA=[N3YHA;J:8
MY70A6 Q/Y0M]!)*]/*9FDUY4G;_7I5=ZSL_-+@R=S2^<;]"Y.CGO:/8N7T>-
MUI,<D2VUO-VN"-W>JKXM=898,U-K>O:&0:*MARICCYMT+#42I'*\'N$)B3I5
M[QIVL=^)AZ(7F-)5.<U=^#!=R7I,(%=O(J<19\TNV></]9NZEI')U!5?:9:T
M"?)WWQHE6.LV_ML(Y_,71@RMO&XL?KB^;!VC/1E 4)JBQ<$U-2XB_ @VQ=FF
MKNEDWZ?@R3-%#KC.8L]CVX5H(*^BCT-@4]1%K1;<^VA-([SMV;)1RYK+)$SI
MZX^ED=3W;F"2V;]VZ;@3&YOP"/"EB'0)]QC2O+8 [; #JWRFDJ>&6QNJVGO3
M#O92  ^JG8 "%=-\<2W2P%O![:CZ>GR-0MZOB*16WU3E3(&/:,O!5NJ3#^3*
MKE2P(W@?@7BZ>4#AM=^D1XY!A5ULJ9F#/TUB!AZ_01_Q-,/G \E.:W/C -)P
M1\'VF:.H*NI/ 'GDOPC)<TA50TH[KR$-BQEU!YG'D+3Q4*VA@((V^P(JB3)2
M)Q[3E7TJO$Y[.(^'&P"\, *_95'/D4WYP(+R[L<WH&U#P#S$'\>SEL<^]L0/
M@W?0= V9:D-K'?G'$ +?H_T)GCFO1EHE*'R#R3GXT#WDLLU?%+ZX5W13W'="
M+I['80D=3*3,?H*/H>JK/*5FGL?!Z[[JS  _M=9('1^GV%G=%"<:-N,!Z7A/
MR)4/P@*Z*?8;T"A?T@T2%N9+Y^7XH\T6553"Q)<,J?^OC*?<5(JG&'^5F _>
MV5RX\;H-[0. ',TX).][)IC+,M.B;DI'4PQ/7 >7NJI.K:(P/R+*)5UH#IO4
M DKJ?!7>%\SR4S#A2WB=9,9Y-04#*7-)$S$*4HJS=*AUFC=/!UOWGN@ F8-0
MD08_;;)Q7"17%*^JQ<IP-1RHL[0JM.W8&K1Y_QND8U4Q$A*"Q'CB!G2PK(^<
M)'.NZ(+%OIXA7>O8YV@P8'!G3UDCYR5#GNL';O,<39@O5]LND'T?0FH]_LWD
M*D?-#ZW*2(+RU54&66PT5%5SN>-S>SI&]72,4NH89?@;':.^//QAP2^'/_PC
MNYS$0SG=E,&6PT2Q:;YAF? Q653JR:O;2EJ]#AS<5S7KAZ-3S[W,B=3^$&%)
MW$)<6X\.]9DCR*F@WRNLPP*\M-F!HT/8G-L.TSQ7^8\>D)S;/K7\\(8UAVP,
MNA;X) <@VTR/6%MC66 WL%)UWAI49QGT/I'NX?8V;;+[SO#PZ>5GQXT^O;0Q
M*'-'^>[7L[C;?\EG5?J'9KJ2_8&PG&2%=2H2UQ2Q+RK<\@JN F)" V#I^0C<
M5P&/BJT3&$E]S2=)5)C=37DJ7T18FG13'NF1:NYRF4+(DETMXSI$R63--G4Y
MR6WS4>G0,/@'.30$7S@NPGYR:!CW.#3^"0Z-\U#C:L4F#UTL<L#&U^'7<KXT
M$)^2)>^8>8*A:/-/%X$)ZING0/V20%)K,KBKR3YT,B-U-+A3'K=A QK.5D$.
MX(_4V<<X;8YF GG?=<#BR8Z?\X3VU0 +*NPB!UX&-]4/NPW>EH L=69(O.%L
M0WP$D!@3AXE7D#DH<3>)V_R1!653552?-W6VJZY)5T._#G7\=KGY1 %FX4VN
MF%J%R'5GF!)#X)>OD"4"T;Y6_.;F3+!.IVR#96/1BV!5W_X<YTC^.<ZQ6*D6
MO-Z1(;L%Y-5Q1>P1;@OF!"(2^PZPM.8T)N+[>8KT!U7P8$-[PA'MX.'1ND);
MXF 3+-N*<B6CN.)JE7X."@+TNHK\BFZ*+56Y3)QR<.EGSX6?P:\\%W2<CF[D
M2*TX :C$ CL 9D[([5JF#P2HL7(N-=QX267B]4JUJS? 6EY=3CZ.;M<FV^!>
M4$T@-IU\YN1-!D<A 3O/*A@"5LD0Y]6D3U2F5W E+)6%X@5J< LPXWM? 7^Q
MEOD*DBQ.&0DL@9/@Q0QV4^GO*-!,9BK[+[HI^Y#R<>32D55LXH1O/GG.'JZ<
M"C D#L'U@,8V<A1I$D?]@!4>W2\6/Z_*V6%#*URJHOB[F[+'354V1H>:N 6Y
M:8N/ *_-B,3 _6\N!YM2*Q&Y^%3E. 79JJV<4 VW#%.1?)V@)AVCJOB;6YFM
MG(]A0ZLOAFO2P%QN4P3W<" +?]"G=E/LLI [A*I^^7@10P4>().\""<D[0JM
M+;2<+1_JA1 C/&UHC<=5^R[HA&ZL<F]D"C(P404=,&I7,164.@BI-84?)!-L
M/09Y"DC)MUXJJK_)VE@5^1@SU,@]B3]Y+G*_\%Q(YRDU1[:A?0S^J9Y-\__>
MH.1!HL?JC'F%\5Y/5SL8E[PVC'#-WI?SS;L<]8)!;]6LLEJN7#R^LW;1J=?C
M3EEHO*N[%N][>5! X27O6VO6[)#O?9/Q0?_V4_^/HUW5K7QZ"_=IXV-]3I(#
MO.763!XL6DUCH2,[J2=S;_A9BSQ/)09-R4FSN]EH495T<%ICA=4FV4;/6CNS
M5QF3'3.&!.<>2=MT(]5\;S<%,Z&FL<L1LO\KD6N5L=]J]O>BHYSXIE3]-Y::
M!I=N37[3K[DF.6 YRGD^V"JK!EMT[=3C\LRYKKU3*=!#I)]/1OH&:U%G\DF_
M ;?Y[G-6"2<.>#'B7%6%XXW;9>.WQ%+FCC*XKOV&UP8V2Q\9^2YU%A$)9%Q?
M9JYUOXN6$RJ1(TQ:*F=5P,I[$-]@XJ-+RR*F3KPRCC9Y#7_:^= %[UHFE1W.
M=N@\:T,[21,MYV+&.Z_*Z7ZK,40^$^]3"%6.%P<>MW2H+#<=NKYWNX?E[.N-
M7<=[O=AS6L>=&VZQ9=;K =4# MKZ !31&(E]%(B64T?@ZN*P''00/D5T\U#U
M4BA#]GU0C,]80%/RY;,K_5=02HZ\G5G2ON3UFVS]$>>%PHX[2+DIJ561B!V)
M=Z<-0USS3Z':+<!6& D@88G8X=B.+>+ THYGQ_<&6;T<8@L6&&WU&2-GG4W9
M)L?4TD_(.))ZX@KBF<^7"HG3=W#=RH/FE>X^E^:]C1:_?WV_:\[MHAG[KS[>
M44I<M$L]MVA?/\OW+/V*MVH\9AY'M'RJX;$4.U%1=5*T5Q6DZP[K^"VMI/7?
M/L?ELN?>QQN"C7K9#=6V22JY329]V'"1<F^3!O,MK]U4=)($LE-<)]FF.)0"
M//I ;.SDG*R@/54+8[UNK7GG=@[9VF2M\;9FKF2UP5K[ Q=8NGWG#76QB4J*
M@&ZNG/Q\1':A[;A"%L068+,4')O03<G^QN^@R#T;T4P=NPZGBJ# UU'N,3Z[
M/<*^+S%KN5K]\*V+^T,7O8.!JXZ,0V9Z7LP>,E?*J-+,H?'YY9)(C"-'ZLE9
M!=;#&R' F.FT >\QY!EI7?@#^O3MC*:F<7OV#%PRI:C9Q,MRZ_NZQ&E/DIZ_
MI@!=ZXHF.)Q$MK;VQR>G)A.QB9Z#&JP'E$R]^1Y\QXH]'AXWWUT\-%;3?,F]
MV;NB:ZQL+'?#''BX CC3^I'F6&P&<Q:64X7Z6QN56!J<S;FVP<TW_KB7V8GO
MYH^=5[AX<<PT_YA9RZ=1(JG//(,XB0XY]8BGP, GKKD3"01RR=+30Y3>3:D*
M/+5W^V'?L, [\2U;ICI-V9?;>_KK!OUB?J^"N4_4["K0\C[!^H?GK$]P<NYG
M$CI^\%T/83:%[[WGR6GI!]2\$^('D'T[X]?YW*Q>@X6(_#\ZC'):L+%JV,Q'
MUQ\5>VR</VK7^ZV>@H7'LE;!HWO9:,L&"->;IOD:^B=<&5>9N?J,#[/B]?"B
MS7?+):L2^EI>'90?_*(LZ!)S_<.<X6K%/_5*^OF?VFL?8#CK8$CE4OL<ZUEO
M33JNC+1-"FV321HR'9W+GT75G+/=H;'*T<Z0I8',,9BAT)J-!N.(,TPC9@FL
MYD>_R=^^00L[><V'9A>6/33_9ODZ?N-]YX5>]/NQ'YQMK-]\X#YW./?D6)UZ
M)YWL;RL?C!5)9-@(5]'\='0HUUJO/"?&V<W\ ;\A278-MMWF'94B6D<V5+;W
M>C*NST*^^J11C)JNYD3Y>&89YQZ!ME"K(;Y#AF]8BX5''-9E^W9OT-"E] S9
MCO!K3N7\Z^ZKQ3M/]PX5[,Q,GFB*=0UD3=_*LK[R!A%>@Q.B\4F"H_"0SH/V
ME:['.3GPL+W<OE8"EI=%G/?B]=-$WYX_7NN\VC[1I7[5V873M)CW<5TBDAS"
M+)#MC(OW&U$R;$-1PM+%U;:/4I(7RJ>F)'@$VPX_,N]%[5W^JQ$NS[-]N+6V
M.9#('N6S)3>Q@]56Z_VTXOQT"E--<<\"/WOBY/6*M>7NUK2".SNRHHKE9BDW
M^T9?//]\^<1](P-[?T"!72X,@ZG65LQ\J-<4: MTVMK >193^WW2\<K\P?RX
ME-418PK>[DQX,OC9W*.5CE+O16\BI]UVR4ND,,,8V"FP=M<AM8:H =KL Q#D
M:A/Q*!9?B CCH;9@ 1N66 )MZ-BA)BV'!3S\&T$7NIT6?03M&@<_,T$06+09
MJ2!N,"-T & &41"DF'2 1-X0?I.1"4DFU\.R\3Q9!D-J"7[E73>E[2(\&&C!
M!U>1^F ;VDL/9 4L<A7@49)R,DO+7;H ?F'R]1!0VT_A#T ':\8C>?:I *C*
MIMU3^*ZBX88<^(/%3Q\PO_C AI:SE-FD:%0$?O&R*8"U3KG""Q A0_O35=EF
M;]7(3!5.6;+"'3L*M'<%5%-LW1<IY2' VM^K1N[2EH$=W_L,^!:.7R]%K?UW
MX/+SW-<R90\N,';V,MJ [-8\!H!F="!Q6F9(GGS$;0Q5,LXH2(C+^B*D9AQ0
M6^N'24]$,?8*I'T!</&^(S>QH KS/TYW0S=!?R)SSD@=/[#MDUO5DZW2PA*T
MN0F&@G<Y[W/(F.&OPEQ3E?N&+7C3$UG^,Y%E:5J/K[;'5]OCJ_U/ZN[_=_?C
M2LFI7AJ6%6=?:7BLHY65'+Z/4VW7T5#]9DJBB_<]_\XSQR)<3ND8Q?G;:$8O
MIDACVLG^_>36ABW)P$+7CG(;<+#:WG30.Y^P-6U7_(*,"X<>TJE$C]JI?^SW
M=O0[G[&I3 Q(!8T#1 2R37 $-4@U8;Z2\*PGODG5R#(*;YLO<?;8X+/C59G.
MG567Y[,&+UZAU75>.PT*$MQ%FQ4)]'0B%!)&0UH[K*W+_<QX.SQ33*LFX<NJ
M#O9_X13>Q9!O>3.C#=ZPGC.ILY]+6>WM?OV?Q=_68T4>/!GM-T6\-6@/^(JA
M10GY V'GM>Z#YQJ<'#ASFJU^E6'@\M%)&QW[V6RLK9I<>;0BQ5&SQ?69)W\<
ML.CUF*-\#+-6O-I^HXDY7=3).;;IC5:A_9Y1NLOHEP>.FS/&(W7KLWX=#? \
M1EL7F.=%V'QQEV0N=GN[$"TW3J_.-IB$Q0FO#%LEZJ:PCUZ< 6V^7Q1W_3AN
MMO?A)!?)Y#MG6&.<_5]G^3USEQV.I*IA7&"MF6&OQ.:5O"SNB+@WQ:2N6YA3
MZM$?+F3IO:MPLG<Q# \XKIM[\=F*@LN%^ KB4NI(?",6)D1.&GRK:[L:.V#5
M^?K,#Y=SAJ9>W5GR8/^Q6;MKIU(,CJ+YP21U.L85VS^#1<NH1V6NA_SL8^J3
M"O$YB2&5=U/"^3.1%BN;G?211H:4@=6SU O1,PBVG<H?1P8*AB#"0J#23H-5
MN\A'E^QW6SX=GQ%82<<,3!P<4K')O-C*\OK6D2T+><LG[_28 M/0I) +4X\?
M-1][UO\::D/'CZ/"=TB08 0.]IM&-#8BTN=Z%K\D:J,5&3,AZ3$:L6W=E&#?
MA36NQKMLQHU%>5M94#@;F^5.#F"(NRED7\)%E%TG]#SB!U6MJ/9^&]KL'ONC
MW]4M8\IJB8AMOM) BP<%F]"+GEC0);(_V(_?Q59V$>); *)<#BKZ&F0@SPT5
M#!+_N(L,<(?K:FUH%6'-Z\$G!\AWM(3D%@]1N<1/[)H!JZ_9'C%#K,.YOGZ=
MTP0LPLASXIJRZX)]+QZJ9Z]DNP&P /\&H]@$3?Q&OM"48#O1R!!;N*7!AO:"
MBAL M6'$#"9SU@-=._<AMRV*VZD(=P/3J)9:B)0V74/JS;7)E0EJ6U\B49E0
M.5P'MPZ1ST)R4WP&D%GOP?*VN\X5>0/Z8S]'!:H^C:2Z7CMA1 '_U%^3)GX,
M[*!H>F5\HOA 57STH*!* =7)[@"R?S;_[/S!N=9U=]7/[=)@3F)C4P09I0"V
M+X#U*5H^ 4.X;CI=3J&/-D?Z_)A>8=>Z<]CB<RYV.\L<XVXP5TY<^SZ[-&ST
MSM'J':ZXMCK9KTX^CRF 12PG/P.LPGI8 ]FO&$J*OA>6,;-B?,+;UDJ^Q_B(
M ;>KCH26'MU[^KNSENE<UO,;S/WD2\$]N.6%J(GLFR6WQ=6Q]S$56%UVQ11K
M<P-:T:"@[3?6T9+W-T8XE3]_#H#N/!%E/J2VWW>;:^?:T*+#\UNRJBUH)Y$'
MW@&\I45Q"9Q3_"E1L6YM+^&#8:5WQJ8L&_!QU8"+?3<U,I=ETS]" :A>J@ZS
MP+IW$L81;79*%NL&<@T6M20.F.=4L7G \,TCA9J.SX)>A,P2\MI?R0$.I\U@
MSF&^8PXASI,::]R88T6#KESSV;SRGGAA\K7A=LT#PY=\&W='ZMFY(B]U78QZ
M'T?&J1IF-I)FZ86<6D[FD?HBVQR!!O=0"D-88ZW_]$'BD3%%\= #Y,>P??01
MQDG)?6/'NZ?9[#N;13GX%$XO>0*6VB._:2(R>7_D!F:^WJ6EFRU#/Z[(W.UA
M,DQ[UJMCU:=G:1.%/(R& WU[+KB*)N\'5F=]R>>P_+&JU.% 33UI%&#+,KHI
MSU<18*&EC4"%\:DT@.WI?MIB.!O1PO2JGYWQ<7;2HSN]$\3)EV3WK:L8,>:P
M4<:A4P8AY+159"@DVI*,7XC.XLH-PKHIBTQNJ<MMN>(1B@8Z@/D<F%9 92DT
MV7R>?(\* ZM>O3T)1;G85+2560@Y#$ ^+D193DIQ+@I TM@O$US6*!)<N)U'
MO\[=W?PIU,6"+O#)FZ@P'Y7:MR03)_1X;2?04*>OAUA0L2_Z<@])70?T:"AN
M#CC!9;,B<?%[M.BTZ@]8T.D8 I@0 4!KU\Z"@6!HZ@*T5&35R1S.^(CB(R&
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MCZBP<. R*FX N&T2#=L*-5X"+-90M(Q;[<N"]D)"/ENZM.N9IZR;4HQVO#D
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MJOG 72)@%O'H5]E:9W_)UOJI[S)=W"H1$8\@#[2T>KF8FAU+.V*@_Y;9U\?
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MU5!]3V,_Y<9^P,CZ56>_A3V=_7HZ^_WW&]?_*Z50/YU20&_K(OL#0:ZQ#(/
M[9W':)%^WEA1I%O$Z"++N?$3 P;.<0BI&]_F_&K7B)2290]V#)PU^_4L[EMC
MTAS]1'NVFH#V)LU$9>YOM_5BXPOOR7LA;V:(N;7@5G-B#@!U9"OI\^CAZ3)K
M/:Q@Q#=&544HK9V/ODQ-V(M(!SA]/MF#!0DBT(&H$,RU=)YW#B37;!#(=B=R
MW_'Q:>")@X'T[R< =-%,BP9+KX0%Y2S_=,0>$(?^0!_E&4-;\^43#8:!]>?R
MU -)6XG6CH 23(E@11I(PV-?!?=_A_SA94! 4AL5\K]4D]0ZKD :OS'=%.\5
M8%X;FKHJ@& 2EG*D\P D=7E!Q)0(]&"].CZ$_,H,X$7Z@95P+KH*EO>O0.H_
M<*%(:B<P:0*F@\<8IM=*G%\/$&91@HQ\X"Z=IG)\FSINAPKO0FWGV6R.Q$(1
MJK>*!4(80)3R* M*[:9@4S/(>5 "0NP1H>UOZ40O=YQ A3E4:5_R#4"$_/1N
M2KXCMZ,?4-% <06D0+73G 3$B<>ZY E?\H<FF9_R8+VZ7%ME%98B\VL$ ,!)
M8Q3I?ELD@$;LFV.)6>!EY$$J3 !N<Z#J8".%*%!=AX6<1O&1R\ OI&):W118
MEDR&F[H3)XS4L>'@#RK1FF%R:X2W'LCQN8G<]C9NAY:JX4AJ@8-RPP>X2E=U
MX9:1NG2CBIX/B60LK%2XQ9I<]CL56#S,XO<^+M"L<54%]NY$("JL;97.8^10
M9>V%0/C4;H>K,Q0=A@+QH0[D,F>Y&5)F(@HDP^-B\?E-1 H@.*3MA* LELSU
M/ QU%'O8T!;]7CCLTD_AL'.Y/X7#O%6$P[)5$;T-[:G9WQ\.\_L9T?E?AL.^
M+-OZ9X7#<I3#89V_ZA.W[7,X;.3?%PY#5$3#>"J&"S3%Q3W!L/];, S%P[F9
M7/GO'3'&^1PQ^_DB%I0^1:$/% X Y8-'N1^NJZ)Y%O2LNLH0/Z_E3:;K0K*I
ML:?C<W[]_Y'4CJ?@"PVAFG2F,5(*UD.23C%QA2<^KJIH*Y(J!I+57PJ>=S.T
MS52N]Q'J&,Y]/H?P4S4*WH*-Y]<YC;$*::>4_,B"<I/)0>_! [STX9!9KQ2&
M**-].EQDKERUQ8)BD*^./%_&;8O_*?L1_5OV(_C]J9"JD\3(#$BY;JM>O6N/
MRGYO(:0EHLSRD=1* 4D%SQWLB@$5LGDF,"9NW(;K:' ]D'>:J4CN QS<Q;U+
MX/T5KN2VLR.IMS_A.3M \"L\1XYX?VH0]T#D_66#N$AJ+4-53F,LL4(Y_Y$U
M8\;OG#?*%7G\?@T7"S)'A& 9M 6:\H>1679@6V[Q(DT[R0*:: -0=?/#%-[@
M33<4V71SNBFZ,@I=1>,WN$KK-W">(FE5PG/X8[Z*-G%&%-6MWY!S1U31_"UU
MF1U7E L6'Q!+N23^(U"]AZH\B5GY\$</N!(PE098;<$$5MM-<5'/!+P5P;*V
MXG8\!S]AA-;2!,/0Y@,(,2:)VVZN8C22VIRN(JO1G;CFKI0 R8+&T^5 8@2,
M1FJJ20M%^OT-A:LN!)_%ZP+&81\;<(<Y"D/_GCMXP86WC=0)O5CE \6XG1R5
MY5LL*-Q-J22+"]:[\N%CP%Y>1E?F<^1:IZI^<6 AAZJHR,)C5)T[QH+XI]&C
M',Q:G5S:!(CCE%,.&3P??I>(:$$B/TW\$N\9+/\FD4U,/,J"7N]3Q+X^X?EF
M,O!G9K?^?6;_Z>P..B90U 2#93"*!HS=YAM\\-?<9=QF?S2H%;-"R&5IHGPR
M;RF7#.]4;/1I)]X !JPQ<?^\R%_'Z=/(>26?4GN!9*_C9IABLR'2\8HXGTR3
M>9.7/=R[9JJ@<2#@WG[*3W\$*/0LK>T$N^P!F1MX&.R(,D]G6+0*DBYT4-AO
M6ZHSP6[8&7$/$9Z%_O@R%I0A^T3S0!T&;$)J^POZ(N_?@LL?^Q)=W&<<;":=
M=(P5!1"O@,UL'\T5N(%GZHV<A-I6XO;=E(W.^<2HXKK.>II2NA^8%N%+\!#?
M98-;=M%5Y)A:6:-W^.025.4X^-ZAGMAD*AXUKKJ.."U#2;8;$*'@Y2D-1E);
M494I>]T4R%,)Q@'/ ^ 4ME*E2T*3P5J,5Q1;1* 7YI <2,4HA<Q"A'FHU(Z:
M:2HW3(9EL,NGSK.S?Z-B2#'';,PJ@%QN!28^-Y%+7C'3(\UCY4#I!Y1"M>,$
MBF7ROU0;!-3,5C#!X./-Y)&?&[ ]%V"SO4G'$'$&F=*!$K.=&)B()Z<B:2_0
MML/<T[3..L47Y16B.4<_'19)Q<9S\&O)$H"B]YTKJ829,P,+Y,E] 'J!O:>-
M/F 0Y\!:;8CALZS/?BHM(G\I+9H10E*+21&DW$4!?#,08=A,F'3DBO:0#]T@
MF;,5PC[RW]4688:*M@C_E^/R5'4_X'94]YR7]R]HB_!U3]M?CLO[LB^"2T]?
M!$5?!,&OVR)$P;7.2@V95ZJ1FQ"1+P^_40=T^SD"4A3&Q2$&7L111(4#O4#S
M8YVJPWOIN(]BB7]=<F1#RT!5-4! WV2H9'$;V@I5-43=E/ZMBM-^786MOSKM
MUX:6QU719YFA."A0J2<S9=MVJ$T;V,[QM_$L)"7L&5LZA@0ZZ*X.X-\;#;"P
M_'<<Z13F3O"5R@T0FHA(2 6)=U!4G]^+9NJI+#I*4&L1*%41H>\YJ@[[=53[
MC0-\NRD35-<=.6IV!*N&:_0=7U7;!(K? ;@!6,9]EB%Y4*HA4BH!.VN^!_S!
M4]6P#:WLB(J^RSSY=SRE%LT4YB*&2KJF8[M5=DUPU)29,:3?(FE\J.TBJHN4
M:BI<8[OA)DBU%YV"S"A6\HS#>>N1U1R1JRT>E51-9EX!KV^A<X&F[)K*:B*P
MBAI5G/D+UK*)LF-<6[H*CD%%\SE2>UYSB^(LMQ" ]!H4)%%?&;'11V[*/1,H
MR.46Y5*B5$?N'>CS0;]@\.HO]45C?ZDO>O,S>%>H!N^C/X-WQK\%O$U5@/>?
MX/,_ &\V-M.0=(P3!1+O?P)OW[\?O)_\#-@FOP;O7X__5X*W8IW\ \F;HY*\
M.7\U\E:NRI<JXL"F2-[0U%D(+R*LFQ)-!^O#0 ^LH%9E(%?$/0&]]P82Z?QJ
M\A4LL5?$8&[&*MHWRU1"N:-FX2?,-O\)LR<H,!NMT)3<^*3T A7R+18(]$(&
M!@&!KBHOA2L6<27 !@]P4?A6P.U"34>!(HAZ4*#9N@H!<C)3()VDZ(IS-T1
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M,@L[#B!&'6CSNT?RR5-NU;'WOAZYI4Z8(DKGG7CAFY"T8$[;1D@;:@:45C[
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MQYSO4("0B>2Y"S0#/9OEE3_Y6/P:\)_[A#X$TBI94GTT]PGQN=IUQ):C*&'
M@\SM[<1%6V7)I1<3&(GE^5VN/E.?G(=1C^7V+?CD<]8ILW<"X\5HMZY_:_N&
MC8P8)$XJH076$7-ITW"6! YX@\N$>10D, 3:T@T9;^ NO(,5IJ+F/HYGV+=5
MB:8U5<OH4]<1Q]^DKXTI%ZRHGCP1F:EPJ43(Z')^QJO\YZ*L\M\Y6XL>/_-O
M%N4D\>]%WS#?TF!%P\)WK"/*=.;6X5S8 H!:]. )((QE.([F]5BU*\5X5>4]
MON'M?G5W+^$_<'\=<8[X.XZ@Z'_)9<0?9R!AE=,P=L\+5=XVQZ;Y&K#3YDI8
M0.@+;/393 ;_5I+]M"HU](K5;]PWK5="9"J#^G]P67NA/Q:<$['\PF0<8!-P
MDDQ[G H=B(7$P%++WI]$\1_!P6GG?PQYBFPW#.7]*/\FCN?NLU2EL*TW;9B2
MZO.>3*T)R.1?31_[7^8WSW6!NL$MNNKS&^!%C!M/FJ,N82>:,;1'T^+ <)6"
MAI/#+T$3?UE+-475-\%JI_=K*+/&@3^XK+3_OVE/ GU''^",''%3/3EFIB^(
M;;&Z<MR2H3B&V STP8UP2XK E*/F5G)P*%K>_9=@I67E^_*>5W+I2O>]Y5]L
MDS1MVRRXH?;;_Y>RTNL(%Q2HJM3J"R>4))'RD+Q#7QRW>_ 27?SN"H'?W"=_
M.AT_O5#BYBG?:"RUZ?-8O<TO@S],,>P>^G.QO-:)OVNY=803!MR=-<]!<Q^O
M9 G?9P!@,)VS6;M*N_892X>6EU$PO7JGR<\SV#MWQ%A3H[5>PTRZT/H<Q[G]
M'ISSR+]7M9Z?9EZ >M<1'+CSS ,X(UI7%.N\RZT"+UG) 9]BGV?^2^::%;W[
MY/9(JGPV0 03Z#6HU[[S[PSDQY'Q,(X6_-.N%/UI5O?[EC_9E3Q?EK3)1!</
MOH-(,T-MP2FQGZE91NA9N+Z<3;',G14\FO'53.LG05KSW+[7 B\TGEY*-$8
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M#17[Z:;)#UV/WCWT#-G@]<>):07,W]O.X(2S(Q*K#I/.6YTV8GP5>=[PN1>
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MR)QY72\_;2!K!NLU1@H[4U\%NXP![6G5;7@4'=9)>QJTBI5.]1<O$ *^7[[
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M+'_TAVZ5'1-]R*7\@6MF5.2L@:PJW9N1S,[$<SAY5 6WH66P0$,IF/+-UO/
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MIL_"6_GXT+Y2A_9]6EW#F?9 695&>?UMDN!>9\DO6Q"WDHU%ST%CYM7<Q<Z
MZK>$9 > 6QX!B7!,0)O9+V 83(I%;5]9O /PXX)AM;D=6]3X0JTT9YKTL':
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M<3;%^\[$6CSS.Y_'Z7%J?\-]8Q=XW1Z?*UJV82-)!QR*]*:K@IVUE.B&:AH
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ME+GR&WHY2TORRUV0DP> GV?VCY X^/SK+))P4/]5YQ(/ /)$XD9"^U>=YRH
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M@RK;V<3JX#@Q#<L%M!/7,1DK(1'N2^ISBM^D2^KSIK\UEFX9D5,$]_N--3T
M>RUW-<Y5/7:/:6P5'0ZH&;]& &(1.FOT?F&>$P_SC2HM6H,1J]^U9D\*0;<1
M&(F<)"T L[U2-)A^IY-[PG*X=_)XXUXEK*&_+L<4,NN;!)<SRN#,\<XM*+W
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M=R, F'/P7;$EUY-GDGBUD/3NH/LX7^3+327='LL)VYG-IM5$GT;]^=/CDUS
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MD:2@BM#9Q#E'XT?X&N!W%8TY)GH1--Y"S9-2->N%ZM.?UM,N2F6J"*5^8",
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MG2M1R%M2B^-"TM@"[-L)-LQV@+G?65AUV&*X=7SX"Z+J1Z-B!#MQ70]/ZB-
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M&4GB94%)/Z7W&Q:N?E@U/7\U8_9 0DY7XH(U 4C)B-U+PNF<="+<YSB73-)
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M$1T:=&U6_%EM[%/U5U33F#-/[!9K* X*O8LKNR#=?CL9AR*C=]]ZU&'H)6Y
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MHWH!?66+]<+;([HF;QR<_'2PAY[/OCHUKEBJ</2#$_JGW8N<2&0ZVW0<8<B
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M8$F$&[ ZLYJ86@S +@/@\@72_8!<P_T"?U]L66,)_CI*3N*=V)7#?*_.'HK
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M1%,9IO>'/6PA6^]Y7NTKCG&WQ)B B# )94SYD!%D^C'6)\)9)G24?0V1:-C
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M7%X5[/E!3$;-1O1WVJ%Z^X]ZSZI*"$W4K_1SK!RD,N,DNTN&7Q/,7XJ/U)-
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MW^&!&?N:)&D;]1-!$R7/>HV^*!MN HYTE/]*E/U@<U0@*?PDOCB0*G)M&I*
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MY%17P9]C-.?0:-WL4KL@-MW;P6][[8I34&*80I9<H2\X5&OKJ.$N<Q9.81,
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M41LP$T9=S=%BJA!ZKRE_)M;+53]+U]=*_6D=U'S1M%9%%O(<1\ T _\;.>O
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M?;,$!Q,6'-4F*AIQQ*[[P;\SK&MD<G:/D9+^@GB' UH@6#5*&R0&1)C]@I#
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M0TZ%[<?QGX&3>LE78T;F*F??F _84QVUO[F/?S)DJ3YH(;H_DKWLU;4,=PM
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M$+YYGV3P^._9_STC-_B_J2ERH, ^I1Y.J$CB9C3?3.#-*\.C#-B06+*F)Z_
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M##5UV%D)0;<;$C5%W\=9T:9G_%*O[4@Z(174[/%U9Z.D:RW'9)'/OXJ>W 0
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M4IKK<W'O>PIJJR:#)_O'9L4F:U/XC6"101A6_EV.\!1?W@M?7PO!> S\YO&
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M\O1K=I%[-=4D%9PM*TQN-_84.'>:<.'8@%HZU''4RB%GYGW(F[T$:HJ"*1!
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M(4&&)35NG?@E=7JL<?;UJ2,3(2V->J8I\P;Q;$-'Y<R/5;;72A]]E<?/RJI
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M5:/5, $6"D.A4?)BOZ]'A<KUE^X$5&_7?FHH#<3JS1^"3OTKI5'N26_$K;O
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M,<;-;)%RJN-Z^COW:\O#ZZ?:4[3)?TM^YU_X8!\LH'[TQZT36%V6+$,#EZ]
M>;<AX@3F,,$PP5]!U!0H)Z-XC&9=<>DF;$:Q)I[V)KK3L,@TF<UWJN;!R7K2
MYB*6@58_SA@F0F;2P=6!G6"";!\9$M?SVG]LB*G@T:)=0TTO_>JIH7N>V58Q
M,MMH(DL8+36ICDKVRGZP*:-L4JUW6<1#-'\$,O,)76L8PQ0%^F@:5.&%URR6
M9-P&XKX!C99X!1_%//SY847_W&]AD?*&5<8!=>^ON+M=>Q-][56BI>,/7,?%
M\>I2#&8:OX<\<KFN4$Y&-'^M,#]U8H-ABB-OK&G,UC7Y%GH0^;11F.DX%,'B
M#L6JR"<8!G,[6_J^(<3!I-"^NF[JA7N[#?%7UFY^#/O;8VU4*)-+;1;U"LG?
MC->5E(M!7IR$,H)8"2PP=W6[6)KYJT8C?<BL8#Q:KG8+%;":B<"E;%S2?0'B
M6F:PS-BQS8//]H^H?'%-RL&?IZ8GD8,WW+I*=<="BZ.=4^]5E5=7I$Q['*_\
ML([RE_IJF:)R]/5,:@TFD44LG[!5UHQ+V-/C08+FE&VF@D]B'S6B8]#)P<'P
MB4YS\ZJHN>W4SYKYN\_\$D;C7_S\]J?CE-$Q)_!4<\.Q=+GI.=/];-)GY"26
ME\%&QB8<@@1UKP9%=-+LK"/@VC(O7I#"K(VKK8?<QE9'<RHKZ6(IH<7%]7EW
M4C3/TAQ.):MW9&:P7.#K[PP>RD"4]BW%3@@[,-#.E!_TJ7+4#H)8X#Z;O-R'
M\M\;]"@8<JY/&;M3EZYY2K/>7,*@W20*Q"!2"YF<2=0^VF<*OJ>/&$.(#"?U
M^Y*'*+J8O YG7]^OA#_+TT+A)Y,=*B<(5>G#IMDV?H[SLHK5#L=SV]'?^;H:
MP6^0"CA_:#CD1*HME6NI1K3A/J&EM,C&<]\_M_]*G\)H5W3*T)AKHKW.=[,Y
M=7+/B^/.XZ3,QI"ET0 H!370W/ A;TVXH+%@OX^%*P>B^OOA><PAZP9,*P]T
M]A/Q%<(RSV'IU%2O7.2.Q-VG8XZEU]+N#I-F4I$JB:GOG_SP9&P>9+*4_*59
MOG$^DD\7.D'W*%4U&P(D"(GL6T=MZ]R0S>H41;G23?J[,P2G5>(N.A_/AA7E
M\,=[:TI![C/;P)5\W9!7T$K76DK2;&2Y<&=##:9HRB/3/SLGL'AB4=QDQK(6
M][BYY5%]O?%SL8@?<:_G'L'-H6PLG'Q]"/+!O$'QM)R _I$++T/ Z!KZ7]W%
MKR@632=H=&;R%GFE[_(\)_?TX];?Z[%UE7M;O/S^5/C;>2Y)AF,M#BJW/PY9
MRG@8E/3R'AV6OX_IQL/6:_5V^FCN!T4LV3G"/#Z"\)BQ\>>Y&L9N43_DWRQG
M6TN7S,WWM,JZ7X,W]W:QMO1[;CXE)F9K$Y')^ R,_OOQ252"DS(@S+>*RPL:
MN$?)B&FYXF%GR)#9LI&IB2#SJ%FM:T7#Y[;L7&.-^&U/?K]3$=U[>\(DC$0_
M@_Q)Y$>* C[DP%B6? U=N['2C3K==,NW;.6YN\(E7(E4J(W7X^J:E&>)1HBO
MYQQQVNX#4H)5(/DM/,F'(;C"Y.(F#1QG<!UD(N!? =X%EM%K-1/W:)A+K_;Q
M139TEQ9XO Y:FPVU@/VU__WNMQ[90\2 [>0K$;=[JD)_-VKPVX$[8WU4KN'.
MZ[?LPU:;1INOEA$GPUJ(E$=)X3[4HV!NCVD)JLM"%*9)3^.-WR%(M*/0\!#$
M<4##<C=!'K\F%=K:3I/$"9KWY;VV$EY;C#42>5%M=_[]<[<P0P/0IVK=26$:
M*\;O"M@O?E=5SN^J'8<7-C2E[-C=_-[S+'U8H>]$6"+H2&4F8_Y?L)])S58"
MCE#3B7HC37PSBN* G D5,2T[C# O\@QY+WF^/-*XIR51]KMQL()L?<W'UDB4
MKMKE\(\:+YSJ*:%,3C<RYB02!Q70UJ=*V9<W 9:!;F1CGR,>ZF87FX?Y$B6U
M$E[D62<\C1.44L"\WT0N6TT*44W]*-]H* IJ9GJJJJYHM*O1US!P%]5:O=92
MHR,#F?D*Y4)> 0)6.I@G!QGVI%3R(8AG)00=WJ1?O-3G5@"$^ZW87A4W9A=H
M:HW.6../BW[L%NWSP-#)>4:1(72[HPU<$;5*SPG"WJ5:=T%CG30!>&[0EZW[
ME-&\0$*J?5@B<>U& LY$K4FY&]=;)?).NT*@O/C4S;U=F@$+7"P0]P!YYP*$
M!I V@XVJ-0<L[HSXP>5[&I Y12VUU^LK4KHYLTPR^2KM?P[^Z'MI-:]_/OK6
M;U@EH$/G1TX2*TTRVA7CT)P7*%:8630'0[$"L":;B%J-8!X/KRNHQL2G:] "
MRVV-E%*U,MV?U8!*WNJMZSN_C)2PZ6)J;>"_$)AA\20+H;5+&'N%FI9/3C2B
MZ<+(C0R&L!LMI&Y8]PP4H3BH;3N[,A";B2Q%?5Z:EASNK'U;I?GD-8W[?;:-
MR)B-=(;SWFIRL<&R@WHKDT3!T28!2RJ,]HP*7KLU,W7-/J6O7;Y8MCS'Q/4\
M_LJ&GPF+[LM3QO.XKK[+.:+=7W*/%'T.3^Z$5-:N*=(ED:.H2K,.XIL!TH X
M0C_K%I"#64$1\*(WK-+\ TNA2[6U<7!II2DCKA[IMB=3W"?N[+U._W$0?Q"!
M=86>9?X&<VD;LG<[&G1840L[^80\F<I4"0_/69-8NO5SNVE\_U&#UZ=3KH_F
M'4%[/#WQ7 5S[\VY?,E&6$,C-,7N$&3LH.-U9WY61Z$E2]<&V]\,*50OI8<A
M>*IJ@$!?TD28<V<4.3#2GT]T<7 QW6#?-V]I+-FQ"7/2RV5*#GU26=IS37KX
M\I&1I!LXR$P!ENL"9;>SWYIL%J'M/.-H2'*+A)"41ZI0IVSLVU"!7^#_Q&6I
M12Z[_WTXMFE@^3<AK=6:.Q-()2DR!))H&8#E##J>":8,)*VJAIEN=&BT< #Z
M7_\8/;^J#2'1X^C-^LX-O@+O/_2^X&DT\FG*4Q^J.+L,VD+SH=I8DLS=.%I7
MV?/[(I@/">ZC@DDG<BC[.+/!G;.&#Q2^33:J."UKX*T\U+H/_@3?T_[ZK3A&
MN:'4O'VY'EM\"$K/+BZT\:>&Z)IE]#%&]]WW5WR:M,7HS]W!8%U=AAB*$YO
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M4!"J&\E!14=J0TG]$+-1->YF79K)T44'L[-SD^GF1ER3SOP<:Y.%U/+?UN%
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MG*425MTT*/\7/>KRJO\IADN\AX4T\])P_Y*?L@KAEQ3'M3JE9:/9TU*GO]'
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M62(G )M-S"I:+IY=DW0;B4K8J=V\BIR ?>O0+A")D;[TXEBV321$X9CT,X7
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MYPZ/0L?)/W\\ME ]756+K@GW5/2U4^O?)\3V3S)'9FF>0SMH0D /[4-C\W>
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M0K*5C0WU=8X<[A4H=]GR^<;CMT+@72E];RUJ5V>]"=1#T!\FG68_QA1$]F=
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MF>#!T:T@S/F)4ZUZK"N/%\?>D\1L'2"$6<LI_:,AD<4?-0:>R$^<GEY4&#3
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MI2#F^UO$\X#3ZPE5Q4XOSGTO2E<77IY.N??/KLK);:B_>_+[%50A^N^G-$#
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M,IOU<OZA=9NB[._>!%ZB']^CV\];%9+/ Y;5)"KGB,L$KREDE8P[I,=T@=?
M/5GK:ICL?CGL(VS@C6:V,=K[OKGS_2>31=CMJ>ELE1?U?Z:3!@_EV;9 S#1
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M>,>.<L@C<U93JLX$#?#5C?)H"K1R"42*2LDZMJ,!3C<2>_#09>?M_@X58EB
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M/'<TF2N.&I:G0'^,#Y"<ID_6O4)7 TL#?'*.A^/LF&@ \9^4+'HR1;P$-=3
M#PB@0(KH8\@(^E]UI $X#.!=:J@_ LM ,I\.'5UE^(OG-,#Z//O.2R"9DK0(
MUQ/,2W*M>$DR'>VP]UH9$[_E-3/L-/90Z:-?)9)X]Q!QO!-" X3-@,A^J#PP
M,?8N]3P=K]MC_/3:L(6=:DC'-)F.J1?\AU(_B"A'#P"I+O\94N#<+] Q"=A&
MC:(;!?LX?+WAB,KTA ; STU-*$-9)0/KV>P?> 0Z!GZ,'#V[(9##*![V\93A
M)6.X.KW/_Q0.9\GZ/U20W &*!W=PVQON@:#,U<$]<;>;+;7#]^[&O]%GVNJ'
MCNS0?6R/%4)TNZ74>Z2:R8<D^&=C/!R=$](H/J\,2$6QTI'R+/D&SI&Q::-0
MW-:_T(]NLT6@I8^00Q9\$I7Y$PVPDLUK'6=3_A+RGS6F%'K.@C'I[>TC>2E%
MKKRU NE5!E^<73XQQ-WK'*FMV=E7% ]^=/UBKT=9%=P1'NX5D/8 'SAN,?-X
M7&YZ<\Y8&QIW6W_69G;IO4SOB*=DEEB;8H:^3&O/R[,H'A16BITHR4=AU'*@
MB_6/"R7]7P>EY,N"S5P.*39PE*-"8W@//8/Z3JG H3I#K"AE;=X5OY4$E)A^
MR5<_>DD#O-04@?_&=F0AU_;^[VD*F?V .B;T4:KH'1"UI+$-SG^;W8*,6OZ+
M09H*1A$UI.D">KM?_3H!>ZY:)D =B4!1VO[/HT?:<2VSWE 4(JVE..B,I0O=
M)^.[/[T O:F&4GF%: #H,6BV@L"N).(W/*8Y/+:X3^UJ\@-%?Q]H#V6@ 7H?
MT$DAY/@ 'TUEODP7LQR$E? D2LJ3CXGTF'(F&;YO#OS?!>\AV=*E CD<(>C*
MXH)>%+M6&)%N0GYE"4J**'1EW(PA4@>%*R*?$6/I9500#2 %)JJ#J!><2>KP
M+ET4QHA>+8!Z*N_2:88_61SN29UN,**CZ )W#K2W'W+\30.([+6J#5SR'CAI
MF+EJ8UHJ>;Y"V<^DXD*-:<DNXE%!K+32[8+8:X!_=2%'0?/LA"1*22@P])^U
M9: 7J-G$@1XN-P3'MA88?FLF5GMFY;;RZ2^^9B2QLV?!#3?$*QQ<!F#41,M5
MSYTF$M<"=1K>:-F9Q!6 NM<ZV0$DZM_'O[?9&<FHDDN7;>\O%?DH,^-;-=(^
M45ER7H=C]S;?T8?3SH6L0SN@P ;$RLY\V4C<.@'>NKAU8+DWON;<!2)>3^J!
M0B+MQ?'L.[7:Z;AE>YQGD@HH6G7'V4L[OQCM=N+^N7WD?0''%>NJ?1.IBT9K
M\ND15\RUQY:!Q.NJVU*XDW6C.GQ3(JKNZI0RR=BLJC_K\Y7:+RBUIIS'-( >
MG?>Y&9(E2(/+>>G+""'X4P0+T08^.]:)^((.>_FR[0KN .MC+S4MFQ^0XKXD
MZ)<O9&_@(7X@)T%Z\&,U+/5YKZJN> !3/R(<TK#7C7X'KT=%:G.3I2 Q+98[
M0BS@$JB#:6U]A%&>L91RF?M?J]WBQ!>-;_37>]T+/WY12'+QMKN>(>*Q9738
M8N<^XZZRL.+K9;;L7%7?GK,1FM'1XKX66FY(L@T=329"L7QQZWCC^B#/[L++
M>+/1U,\3;_W*@IO#;H^+V0ZFZN&9K!FZ>;4L8XB6A%&B_R=D/WL,G(]ZF1@D
MSQAP8<_8R>=+:TWSN"QRVWW71'KMJSA8:PTCR!-^ QY0FZYXJ?" '>M)YF(F
MQ/R$>>&6EY)Z!@MF0@4"UKL[6'&HOG;CZN=AM4M\L0:E^\5>RJ5F3:R.V*NO
M/W,/1:ZU(.= A$N4\C;;:K(?,09'ZK&8RUU \Y!9\<P]&L:_=]H>!21.]-S4
M"'IB4\?W[.SQY72^'08&'Y/0.X(?71[-(^ /-V!Y-("L'W>M6@YD=K,]V) \
MC=:L&BNB,L&['FB+D!TH5:%2&W/^L9<;B8^7V$^YS%'ZIBN>:2?)1J[V]>%:
M@E-"N+D*SHE&=OHPNBXTLT)>AH[2 (V0[=\DBR>;<_#.,8Z;98'Y,IQHZ]_6
M=AM-7G?]^+M44X)9..L5(SWEG.X*+>TXQ)(?4S[!'8'S#H3#29 +.Z\;FGV-
M^(AZBQB",1;K\7([:4A?F-@4 4YYJ$A&K6]S/;C,Q5F[+E>@SLC[NT.9%$$X
M300N,P/CL]$#Z#@4.SD$(\\+9)\G!B)A4&P<^\68)3[V5SC;D-C =[%2VCX9
M.@*>"C41']/__%AY#39WYP(7D$YV&B+8(1P[W([U_E,E+:B6.<_VL>(TZ@59
M$N_0\AX'64E$LT&P*2+SL3M,I?W;O*M1,1^?Q/Y*M^Q.X[9[WLNXM3</@OMT
MEA#$:T?;=GBF+NUKQ C,GF!1D&<XIK%Y6I>2L(OP=C^S,>\N/UN]%(LUV!5:
M#5M.R+# ,(M('Z#ZT3@P>Q*$DP9X1@/,52S=BLQMBB*;XD%8BSHLDGU,!O\2
MU6 TK-FJI)RL]&%ZR9;?((U=L.G[)Z\G5Z,[@?.*8 "1M)S4A6: Z>"B^UU]
M+DGW3!_1F>^+E*J%A8V>QT8)=^8?)(.U. R%M:$V"W;7KZ3>W6<S9F:/AAI"
M?9KL;78:D>,] 1_O!_48J=8=3(0<VLX=_3A9)] #?W@:$?B($MTA3H91$F%W
MFD(OXV0):<]\>8M+GLPN6(^$!$,%K"OW,.%/Q<.?_ZS3;PA;*,*B#*DW8/9$
M7QP[)J\.GX1=+%*&LP:$+OQVXZOB3I.Y&,[@9Y"^$)9G8!HVM"1(=5>!_-(G
M]..CN\?FJO=[.NW%:S.Q%FE+ZC 5!^P8]]Q6]FBA%V9K.&O/(K!C1OGF^ =R
M>\KY>P#%TT_OEH<N$L<(H!_:BAN+-]KQJ!C8DY>AHBZJ+<8T0-3?2P;@XMF^
M<MMCQ>LVGUVF#7J$>5+>O$PV4"^KNO_VY?MZ5%JPOK&VTZ.J=P@EK^E%5_M]
MRYF6VBU5&J!!?IM4 C.=HEZ !)2,@KA=M(5%Y%"UQ\,Z!9D*E+*/\IDUBON,
MO(!P/0'#XZ,^!,X,]4NZ<T!76Y(8>:8M:#?]677?]5G[89[&G/)K4*.<#;$F
MQYI8IZ>#,PF R^O%H><7Z 1'&;54G'>%\O$0 83:"-^ .>,?S(#8R"9E97/
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M,OH--3C'[8:7PJ3)G'5#L_-7O)/L\@>."U"LH=/Y"VQ0#%()WN*$8X,BK<P
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M/^.%JMGIPQQPACM8 D_<1_/&?K74-E=/Y*>OD>[ECF[\_JKY/K'7UM&(9S\
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MN9/]2L-K<Y3_$PT]JYKN8Z\'4Y?RW6# RZI"SZ)BA5JA?S)#"K ^#_Y,X'
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MQ8$!OEB/I?\0B(D&%Y ]"4D'.69H.RT>%7QI:8@5&5#Z>\QT.3TV4"9$\E4
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MJ=[Q4DM\Q62T!.)0*<;F33FK6:_ULP>CY8*E;-0JOZ1A].P2>8Z$"4<]!,6
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MZU]]?M\!H#$#/'X?_^J3@8-!0Q\ 6NS=PX*O_='W*ZPP *P )\ +' 9$ 0E
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M89AK^M>RKA'"+X571G!%!$3T1AZ+3(A<B#**RH^FCW:/;D,<0=Q 8&).Q;Q
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M)Q_D0!7-HQ)H*^48K6]JT=L2.4&'AC9#E=:,B=PD!0)1<BIF- &AX7H5,;-
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MW[L<W(_Y[/>_-N1OFNW\*(D/U@*;F&9031%U+%BJXC@C4;OCTNA40@52^4_
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M?&2ZXNHB/'MAXX?DZ;T7T+.HI3UQS-EWMQNU.8ZF/ONK]2(ATWY&3*4Q4+&
M7-F!?N:PF.L :(WFL" 6'K"-K<9?"PM%,PPWJQ+,]O^^^S\VG4Q!D?92NF:(
MGND4[K#"TOL[%CQ)G8N*["%W)Q.B3XV(X0ORLSJTMA[!],IAVK<"'%KTXPZX
M?%U2#!$>X!5;<#&CU5<N,^W*91['DZN#5SA2Z%M.G!41V>^.]CX</?E!-%<:
MJE@7Z?-JJE,)F8QI1DGX7*2Y$A?]$8H]"&'&C4ZT*@P]PROL/0*[$9"[<"?*
M*Z<!?YP8U2BVS<6!ZD<%D<AS"YHF(7-^1I[!%P)P/"A&"-%T[N]EP C^KHZY
MG@U+YTQ'1P\0\$5)@G:?*U,Y9PK9DN %&/(U]% CP!Y#MT=@O431H .Q*B;7
M^N@S46-:IT@>=4Z?AQV4S<N4!F@R0H M@CA8DN3M_TI,I0B6 J=)>S#XV<;
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M[F'HROU/?UD)X%<7L-,>TZRP_S<L:;RJN[Y3&UB]D6>9_L]V,'')_@(BU_I
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M>5=?E]WA[1+B8OQ8Z1F+]+_*JF1G4@[IXFV>(O^20.9&FK+_E?3]?X^U#B/
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MUOZ_7W])J35#[?@C0#!:#(:-6_<@YV:=F9Q]_.YI/^#M;W]?!OGEHS[W<Z(
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MKT[X'(YRW&;/.19O'OCVJ9E$0=U]R8Z.1M3N."H+X<(T=A;O3"HHUR5""%H
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MXPX@V521[3"DY1RRR$D*J)#JXW939U^O3#3JMU_$:S*10\CRQ#Y: HR' H)
MCI)U\%1_@B4",5R+^$%=@:ETR.R9S8,J3V(MFC (;2&Q(QRIEMTB9I8"ZH%4
MEB"WM['0^?^0E,ZOE)K_A]"?"+T&KYE20+07**!FA]#A4%K22\2,#A56ZA00
M759N#0*?1A1%PPCG?CAAYJG2NQF],2=XFP0[R!WR0WPT/+6U]R/ 696<0C;]
MIR52X'C/\+S+'QROG3,(VMO63!!O'49IFQ1L#&ZMU7*B9T0IH+<0@"K-K!,
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MR;'^-4J$.T!U^Y JC;H!XCJ$*U0%S I$X'E)'\F"0)<G#Y!F"X1+A*&(#N^
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M+%]F.T5,F^!\O>>6TE,YY+5M<,8IM(]-1QBR]5X GX&DVVW1[S1 "_IGX]Y
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M_SC0@5LNKF-\J!S)QJ.]U.S3X2A4-X'T9L7\,;E<.7K0GW-%<"9D0^C6M4Z
M7E^;2SU<?O"]_./:7V14*-2AZ ^F>L-S)<O>"+=J^G2>Q:U"+/5J0U12N/9>
MW\S/XYP=?DO[?OXG"6+?B9'XTX95L0]&%><T,9A3M<JY]4GLI\27+&X"GJ5T
M!HO&JFFM&($[?R^S_H[VEO:\9!\\X]8QTO/+L+AS7>WVMZ*X N>$W2M/U<M^
M+(JX&F TT).N)Q^5[74IL+,BR)+G&;JA2&$)'9ZCQ-GN,S4-B;IR\XXUT:^
M0 /N=R_#]WHL^:7+?NR<;1)I1$=1E<::X,N-64$GZ\M+PE&Q6-9DWI++]X B
M*VG7<ZZDA"^>6P(&F55-^M@ 931CKI>SG*,!-'.(8M[D/),E;TH0&+X1,@C/
M1L*_FI#9452S(AR*VBR+/FA9;P'%@6:7J(K'>L?94C2 7R0Q?75H-(B,IA3
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MH,'\3O!9AM ;8C$ZS_4NA35=2'U+ [ ZD&0H*0_'0$O.$.OMD]LYWJ7N'#3
M"[L7-=^;NI-\Y /KXIFKU.IMWD'C\M?1&;M$B8!WL OD>\2WN-)NV#_$2MR)
M[$4BVX\[@^&_0Z&22Y(UZL';Z3SZ7(2,@<'BV<I@0V2\R4('RT!%;];V>,#B
M$!W2\_U9P&GNAF84=:C[/"#J^U48??%8P*7-;AB6V!M6M +GZ-KK4?I5?WNJ
MY'W!6/0_%1WGZ[15#$\;RU6GS,DT+I ;;K3H_.H>_Q#XP6IPI\%^;;)T8QUN
M!KY O496(C8O&<*%R1+XLYG+<1=V7X:9C7@M-R,_E+1.2TOW3*D)B0#?X6@
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M\$,F'&=12T)S2'RT>.4E>75T=268[@?!;_\>9V]SI;,-XGW&#E&L!VC[;(W
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MF0VC>)?3 !KI\T/=NT0K. ?H#W@,C>, _TT0^7]<HA\_SZ->(K!10XN.+M$
M]EOPH8*C:CR)RIW3D7#">RA+9DC_FU+3F:A% A$;;?'"%8CE1A4%RIT)[=0)
MOVGQ F--!K4W)@_OKA0IGJAH^Z]1.=>FH/>!EN62Q8U[C>+8A?Y^K?.ZW,M2
MYB_?<=EO%9MI<Y^4[+5J<YF>^K<?X]^B3O^WDT+^7TE$.?V_ %!+ P04
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MHV/TR>DOO8@ $J*_Y/]2+T:"7L2DI"2D%+_T(B(.^]6 D93LPF5R)C5C"J<
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MRR7'>&7%Y=TXOKJ4!P40!_'W8]4&SX3['TW?;;]C;2&F/'DEX@D'=8F%YNW
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M0[@+A+-3RB%F&(2T6$B)3($O?L1(O7:(NH(4AB=M5ZQ,'D:[?N;A,K(5W4;
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MTZP!].$CYW2ADO/$<-U%3Z?ZJ.]6:<"#A 6Z(CYCFOCJ<W7*UQR%V?T#FM6
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M)T$Y/[6T@W982/WBZ%0V15(>;]3+MUNO["R>:@^XF"G9+Z-^6V?E<5<2K>@
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MY7DR/8G%]W-4MQXRZJG*>#E;)]N$()2;0L EO$5Z\N2*8#)20E(9<UQW/+Y
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MIZS[0D+$U<^<>Y9J=9&JCO*2?]$;-#2H*@VZZ9BF2V++?O7>J."])KJAAQR
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MA:AU+X-*O())P>E(W=C.DN +%JY^VT92?^K=+9V"N>5VLW&@KBW>T*/%W]U
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MX7 SY\@>^A/&O4R8J^^D<G8Z\TVYDYW<%N>L.FD7OK1DX9UNXNTD?,XUF Z
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M_!Q#GV1'*%.TG[TC[^<G,:F9*"1NX(Y=0I'2"@Z,+@T:D6!9Y[M.Q^9:HG6
MGHAH;)W#FB;V/-I;Z71H]?":W81]_YK=]&YSF37B7G1PK8+\Z,7,=S9,J@VN
M*=T!>I>HZ6BO$29RVBV"1R+T/!EA,J5K*IAM7-4RIKC0."%Q0JHB+S1J\&/@
M^TYVRZ(;DDBK>IP/3;_LM6^SY>IA2"L:V"[61 <0[B,$*9(H:MS>5@SP3! X
MVC2OCP@5,6\_].B<V=VJ0T=_'@>[U#5,/*IU#1A+^I9Z[9<[=PWSU<<C0W3
M<3]U4!*68(X 0/@9X5<(#<>!XULX%W-<'8GJE<UX@1:5Z4>'<LI%WBGF<KTD
M>)4\SRW+BSL]MKR)F\QH((V5UH40:E.$CNF3[(CR%A1MHII]$*F,L2N>AO _
M?VZ+L;4U*>F3)!:T3%\6FE(AXID5!8T7?C5MO6;<]*]9 "=4EJ),#N% X>B
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M^XTS(NGIK -3>ZUBG=JZ-'$B4P=FQKYR11+\_=A$E2Y ZU(F<NU0*?J9'<4
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M![&AHZ&B@Y%R[C7U#=.5TU(/[/3&:AQF2DX$=+EDZ;]Q[-$WL&<(CT]MLG3
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MA=*[UU<?=C^A%?EY:FI[&Q2W#8-#[LUK$H=1BT9QOK,VZ,969?&.3PTI^1C
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M4(1!7.R@Y#L$6(_],>I&BS;NG]P05GGNTIIV^Z;/>TE[F DZSLM=G-D%\'L
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M!+CZ,%<M^ER^:CM$]U#6-*W:<7HS#[)5-O+#<!J1<-UB%W88#1N7?@JTJ+]
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M,0'=<J]_F6-N) 1$1;#=^J*^_F/S00%O_W5CHTC A(P<I/#HWT,R5^U201#
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M6*^QONDN1NU=1[=/2CW3V1Y0S,3]8Y!J^85-$Z+HH-C1_&V\1BHN:B.?:2@
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M6)*4!!X,_'JFUK$8) I(G+IO)<1U6O46'($WV$0M1L75KJF>&X5@;TY@:.?
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M2KD#4S%WG#WD7A082/8Y!+C/6L:%CM3Q7^ _4S+:?+GQ^_>B=DHP ]W A^R
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MM9"@AJ\<^%UELH3/G#72TM[TI^9_&G"#5X.)N=DEN"%/:2<F? (-'EH+5?Y
M1A-3B7K'YR\S?Y7_"G20./D<292G2X#:6"Z+6=6*Y.E]QYA%7:NK?W;BDX7[
M'7;V((684/%;T0_75F@5C$ Q9E\I,%2(RG7&O,?B+9 ]-1'T<.0%1O))6&FY
MQ@,EYO9H^H;61K1OVZ7G0%,(-<QG8QDJ7&?_;.)JK);X"&]Z[4WU1R7BKT:^
M'\#<NZ//@BC2@>]79ND8$@NB5,+(6%F3;^!:)ENU;7R^6F9S0S0YH- ^SHYP
M*DLR^H^"W-^<3Z<Y+F.XJ8\_,G\C1:GMA#41ZCS-V+SO7#I11H8X$UDH)YM7
M$SWR0SCM4V(DL;!*)JHR:=)^TC+'7L3S*@L2;DDJ[*:'TRVF-8@X@'G15G?(
M5QUHSR:YMT.]/;Q^/7^.)OV <\$6I*=A($WIL" =HKU*(2A9<+Y2S]U[/5Y=
M2-U3ELZ,1.TSRS78-D\Q[0*_+\M#\H"7^U$,)6+4W;WP3/_J[PE-1=L_B=8_
M_1W6V10,9K]9\KW5YRA#F)&Z8QLT%[#<#1)TK3*P^#NJ[E)1ZX6\=T%F/NC"
M3<YG;U8LS_KQ=I8DG5/S2--S8$&.))+*F"$-2F#XAUK@])(LIH@TWHG!CG!B
M0<(P;[ [#F87R\>KD_?><?RS-[_C.W%[!U<R/<JQ,NB#.4!G!\]Z-<70GK8@
MA5CI%;[]2BQR+(^2%5^'RG=JO(Y*CM=Y)6*/Y;[,'J&%AXY4$3@B0,D!Y:.;
MU/5-NQEY,_D%(@L'!T6R@G(C5HB:!9%%9Q(%0R2T3S_C-/Y3,9C]O^F?\5@1
MB)=TOB".W+=K+,A+1!D>]A(FHGF,=IZZ@8=&EAMH6F/<TL4JHWZM!<<;J_0/
MGL&M>,X9B;G6(!9K5,=YKR\7_SC_1]5 2L8 W9I E5<QYIZPN8''<1OZCMYD
M7@M*)1J^,(!XGZ[<N'?^7$R9?/+;N*11[[N@\))$R( \AHEF04@59&$61&;O
M]<%;5$L6Y!I<A 7!NQ'DF0]Z$Q_46]-A4['*3B?YZ<"4N DIJ[%!KI($#6.>
MI**;O?V?3)N2!6HF\W(Q(UV%B?6I7-^G*U5+N_B;DL^,\L7'R*^)M=6^*9@\
MT(<P)!40/%N,HZK$>; E/5MAO;W2^EG%UF_?MGY-OR+*5I;Z]'.3XQ\=7I7X
MM^Z2(9^ELO_;3OY>:L1U=W3W"UXH" C8L2[&C1;@I=X@E?VE=4D1$?<FWJL4
MN+V?J:T*7SV4&7FVH^X8/?[3H^K;_$$ONA =4VLCRZTU>C%,83>[\Z3<+"_A
M< 3,R4'AS<)0I!MPM&W;17R9/]NP):X^J@U_=9_IR]#%;JHC)@R]*4A&,X4:
MSH 2( ;Z'Q-#PDH!=3$P$&CD['F7TSG8@"7QG"#COMF>:*H!VC!"SN)")24-
MY#MI%*,S2S]'!:O3"7/]>F$** 7#B7=G*Q6GKBRFT*A!0YW8_VAY$Q:!/H@X
M36JBS($.\DLA=DR<BFDKQ+@&UD"XD3>Q-6EW=TLA^E,?S'VD1&0G&%J:71>:
M3(*D W=W M(Q.@+FY_!_;TRSN+W2H8">LJU![SA\NA-*;@:L*)])\!$C>G>(
M!00TIF5W%[;6[[0[5&^1=I_@5& X]0:$?/:_-ID #_'V?1.'%58S<SX/WDR]
M;, DL" 7RRS+KNXM#["&_JGT4.3M\"($'"^-Y1Z]?2I^_B'WMS]4:TH6EPY*
M%V>F^/8;P6],HZE/;/V8(7\ N*-,%3%L&>Q-R-S)6R.H+&D>,J;T4Z'6EVC&
M.^.W6'P*PH(%@5'0U+U/FAS3HRL91[$@\\P^%@3*@A#<B*+G*;T\#L<(:]0G
M:$$6I)N1QP355TO_/6:7G>+Q=?FGJ4/>^C#*#;B;B5[E'T''T7\"Y6HK.F2I
M:=@WJ!A=O-?'2/7G<FLZM'_3V4/2Q>JR([8RGMUWOV;BO:D_KGS#S%KAF$?W
M,W*M-"?H=J0F6*:E[27Z+]PL'"<K.!31218X9CJ!F?%Z5/I!]72^60QQKGLJ
M@GD:PLB&+13O:3&('+8-17U]@/('"Y+9C,?0(34LB"AS^U,1BCCNM('DHL?"
MM_P.T%%K3J0;+ CO2V0O=//!W@+$2V'XM![]^CZ:/M!C#TH_B"T0 P3UFS!J
MHYF>C< ?0,%7Z P0! N!_D?S, (OS^@-YEN><"QI_S+=C3:9^;>U4(;M-Q9$
M@C9"YP7== I:'L$0@AX%IMB']F38OYF'3VX) ![3L%02? :ZM,JQ YW\;X>7
M1?,3H>-"0/')@E@\@WUG4@ V&/D0!_$T"Z(3T0RG[O-A*@/_VH&A[7H=Z-C7
M[CFZ\ [';NTKIMYV&14\_\U5F O/KHSVWJLY7!ARUK]W %N_=)XYT0:H36&_
MPP;&>=9A]>A&GG]S'?3?C*LPUDST**M*.UAVYC5FT100QUAA'@+^U7/._V$<
MLQ88!:OR0G=1Y==Y_G\5N#D,\U %R(ORU!SP;PTC0].87- ^J=Z+N'^P%C_4
M<Z:JCY@;-NU7'?)\Q?&R!._T@0\IS,3SF74K=\[E!-!NQ:YL7?IJY1^(_!E?
M"A92Q>K_U9.=_W;P'*/.DUXQ%:D>?5=CZ2YS@S,V >'R:J>DY12JO;;+/E P
MR0#^=9$&-0T@'6%!R*,,[LR*&)=62Z4+/:_39E#=IVF<1KA6+G"8<$;-!YB]
MB 8U&Y@"B<(#\[OF N-1WG-DH7'5'#((:#Y4Q3@*VP'%W%@^V"9LR94%^0%E
MXN 9 B9;46G-2_TTI--\-_T2""B_>P$26%A5W<?B7S]:(X3^HWGLM?-9RX(:
M$0/Y%!B,8T62 Q!08^X#*$O/&*\+:ZEI6-(1 .SAODS4%]-5J$7>,/4 \_BM
M/F8X6"]^4V!!VEU NRO8A2< G0U*]VU@_G4BK*!O!7$09F_(LROB")X(:MGV
M"SA24XHGP/\#-)S%@L1:X$S_T<=-&O0 S["%X1K! " ) .2?SQAA+]*9$J".
MWP?62F\Q]0O_Z.(B1?LPR)2"8"XL./S]:PZTN/(MKN4^6&FH@\[TV<X1" K\
M1ZL'02KA<K:EZ\"8!S LB/ MF'TP!_:-!VRM"3S3;#OF?Y]YB&<8WCQ!OP9J
M9J3PWB>B@&8NJC<S=!NV/0M0/],JH[3J[^"W H-1KT%^#M<$4_ :#4U;QT[?
M@1:WAVLL#\&W9V%M#4N9*,_[7X/MT YX@&J/YO(;*L*N]0(Q&LSC;DW!6V-8
M&B5Q6^5OL^*RI+&I@8AF>0XC_,F+%,/L%&(1_8?I?JXSN9<T$-5T-[#3KV]-
M,X/D9X"VVL_2:JH3(YE1M[[CVU\_;E="T>99$(PAJ/*CT1OC  [&""0NY/AJ
M2+P!K](UWEF%K:&9]>=);P&!*> ;L+LU9J(S;"D&IY^!;I)!_P,44Z )! MC
M*!5LZ+%MCH!M6-S1.CN=NF?':A^%=1>Q&^D(A/_CC?3?_Z2]8RWI9W_70?$T
MG*!_^I*&K,:=L%4YIW=XB5B%)(=-:(S[T)PP7;"J91<#JLK'SB\F5&^(!?ZJ
M=GG\?%_;PFMO8U0NU90IN#![G*=HVADO[Q$@B>S 3/G7Z8'1?#SK_Z$Y^7W?
MVWA;G,YBD,V.-:&;+J1F^[;EV /Z,5)7UN+O:M/:@<[HC5?TZ^=3M%Y2V(>G
MBW@$9[ D*F94C1GVU_U.W%L,TP#S(U!Z]S"*?:9_*F/K!7%@ MO)O-Q"S6C9
M^GPKJ^VGVJ) O)V!-9/'MWL01458$$^P(-?!Q&)!UEJ'6)"S>[5Z%",+6("3
M< PJB%DS*?3D3!!73!4]=]E1!+"DXY.*Q"YH[VT24@C]#_-93*C@WI+9;RP>
M2R/[@%-294=>![H4;L2"7"VAWV">,3X&_$: 5M9A5C \&5[NR>!B@IW "L/I
M"7IT;6E*# N2 30#VX1E%B3>#>\N@4]'X;/8D&KE]8,J8W^VD*A!1C^[Q)X>
MD)[X+M@9P,9W^/0?^1W*EC8S$XA[1A?QFS3C@PM6@2VM=IRRCFF-)V^H=);J
M\V Z88>G;=02C$:3N!4W1A 5M5L5:.\^A&=+/R$GLC.'1]J63CPA-:'669,%
M"O?_SC74_2?]\/(Q)U:TS_;JA7F@7V-[1RT+0\4WQFZO7V';<G:TS8H[D2[=
M37>8(CI]V_W14_$QVE+(62JL[KO<J81W25)BBI<6 D/_N/KP:B^::Z8T^6QQ
ME.+*[J[R*)"R9&^-NIS)2RG?$+ESPO9%<(J748"+4V%J&<P8G(?_L^/6[:(6
M_G?8P,G=8D#PW.5!XYEZR_]Y-DB$$:W('NRF/-632;<%UHV0ACUZNQD)P&\9
M "2D-PDMN$THK)F.&@; 4#<Z-BA:+\7] /7AX86J)$MQ1]\G02[Z%+_XQ_1>
M[%/ :6V4 []&E"3M0M_ >)XX\'F>FQM]R$;I>\D9>Y53I)&-5__A<VEJ.V88
M2I4 (K>L/6,:SI,<GT.+)Q>>4/0W&I,&_>.XM:[_(C081U_6D,]+[F_%7UB_
M([H8I!)\'Q[EM #6P\D?S'^=GQV)@;O=*7 SQ0@_Z3.2S!E(\5NM RDW\'PF
M]A@L_WI&=75E:67\^KI.U/%WM;5_?/Z<=3;>'\)MH**"? H.!%[GC:%KL" A
MGO1[9.'P7&>YG)**OH[\1MXEBS^L;N\3+[D]3<Y-G'@]D=C]TW@4Q^2^V*<I
M/.V&8T/^L!,N(PL6H:5OCJX6KW-9A]\/>5@5F>6+HI4J1UD7?;MDW 8G\TL1
MT6 : 2%8DA"-!4EPVR%FUFA]"!*+_5*+_IU,OQE) VO'W^@I#)V] 4RI41CA
MK/$8C EB+3LP);O-@IP;VAC3T=:G")<G>^_R@Z&(@X$=WSU&!^7PRRH</57O
M/QMA!CEGQ6N%CAI6,SB!%GUT)<#@9(+\\<UZC6F4Q3QSDU$&\H@QR8*Y'P>L
MNP-:Y28_Q!N)DN/,U]C_L _F/=^9O??>-J6HTB#S>&)W5+'IH[O8J8B593PF
MRNK<VP""$7+Y5AW9HX$IVG.FO*]U17=7N>K1=JQ3Y,?7J9]>.O<Z272ZHVN;
MB_0IHA_0][=0_]$'Z/^-J]9>*%3?"#&=#HUK_YK;-X.R#S+P@V7(4R./[7W:
M(@/6"*=R!8,04_X?8\3,5T9=D1C6RJY%]]P!X8E#$CDHM)M]CYKZ;9*_MO2(
MYG#AO?5)<[A.W.H3,^W9$XOP7HX5'G#,7%0U&I*N54V6?\EO)&7;>_A<8:;M
MY0"BU>T5'Z]7,O(A0E<Y3H6;:5KL=%BL6-!Y0]M!Y@V#366+'R.M)BCIN1&"
M3EH;-USUCS_^9;;VKA["T.-U\,7'[.Y<>2:3G<RM3YE1\^HA4=+=2#G_V.5&
MW&&$,6&9]_:H>4)0P'$.EPDVN6D.#K'8KY=SI!S'%#%6RBYWOE"BW'<EO:?0
MHW#F8:5,A!199[X9%Q[XR,VJ*.U"^.K<;-1H\T4Q37N+(RO9@@Z)AX.?Z2!"
MI>B"QI27B@H1.J3U#"GG2S;Q'$_1Y=',ZUCE50\/>;FS=75Q.4GF<JLS94H*
M/\ZF&TC%&]V G[90:KECE&_I"XO=,!:X'"KX)LWJ0?*=HXO'1\[6R!;1Q\"<
M0X+2H[D?ZVR\>\ ?5$+[5H&=BRAJ8#*1$X1X3VY0C&B!T9&TF L31%/")79&
M0(IMN4Z [7+O@<\B0-<RI(#I]5$M B")@[_%?P+!)Q_Y&[UYD+3&/##.@JR;
M(9WO$Z(,9A[8WUN=N?@Y.M[X*CMT]#AJ?H]^N$"27U#?XY\<-&E+?O08\^7D
M23#N06CFK2RF> [M.O#[1#.6RN,-IH89B=ZPKV>3*]1^NLM52YWLQRDK2W"K
M_O@8YFN;XV"^=7=EZ1KW9_\O)ST;DU/,TU,&TWP\"Q[PUJX^K2J]OJK/>3Z.
M;]JAG#CY\3);QD/N"]->AL2R(H1+ZUVC#A$M-9L>]\!6U\+!Y3MY.-S_W!?R
M<[I,:0\[EBX3[#MT-07/AG90Z/ .$%4/UXV_//0TZ!6;]'=,"/<XKYNP#14Q
M&"C3($5JRSI8F_N-)G>VPN">X=VN2B7-YYD"&Y='?]HJ^JY.M*I%M\I7=J"/
MDVT>C9?$UTQXZ[WWJT-*>E192:QB_S,H)B"'W6-DP!:.XG%TCFH0*S[3?V=F
MT6[PT5?P(+:$M0";)_=@OA>DP/_R:A3QB-Y&\?]Y<5^J//4BIMU_-6[K*,^U
M) CR1:STFW'4$S5N#L:ZVR:68L<H0;#3#*PJ8SQ/+"(ERE\]KBE-/F'S3&3J
MH<$+MNC5?>$!Q^>P[P-WY2GZ9)7M,)@+G'U)B%]1I:W TY$&1&E4\A9KQAX*
M7&QZXI-X,T\Z-UB-TS\MS:3S4U^;A8_+G5N*]RHC:VVU^JPI3EL:.@(6 ^C!
MO]X$(NC1!=R87#=(?109L@WV(%+,A6M:7NQJU%")\J11;%K=09WW_4J:.?J>
M%Q3"8$JAK4@5 Q ]0/@+^_&VD<G%E;ZOLD$*"J]$S<)#L7R:('D8DRE59(G6
M^RIM>1B<C:OP/84?+D4VW^>E)F*\*G8'N<*?*>?KJES8,"P([NY]5GV0/TU%
MI#G%UAJ6 :5&\OP%9#?^!K)^$,@ $,@.B_\3R.Y@YFNBEIG?.EB0^9_JL))B
M^,8B]#>*?C/B+\3/^!OQET#:@(&P'<;S3]26LMB8T($.BP#TG6N,&+!.1^LS
M7P/_?A(84+[3S#UH/^__3VA7QQ[05,%['O/OMHQH;N#M*_*QO3Y%D';33W&Q
MH9W9;SQK%\/1&*.KI3U_;\BG4-XXZO>G]Z_C<=E!/[CF#.P%^[V23KTL52\Y
M-67^_(?B\,)"0?SZA_T]O7I$S_^FTP3?#%)F\QU#WVJR*GI?7;3A4SGWM<*6
M!9Q/EHOL=0&/7YT%2U>+0"G.0Q9^G1WF,P;(:;RTXISV2>%,]#]W(4M6[*4X
MI^XI<1[-^[$&2?6?,"U"]U\!ZXO0>C29'_H7OT3\S2\@[+P!J_,],A70_">9
MIL&[?02!O]RF S@\Q,[W_O=A@A4KLB [ZZ&T$^PLB'8<X[#>/S+G56,RF#G2
MZ5<K&SC S$'/PDNQI#MPJBQ/L_&8<:L70H2*RI8/17BI*UG>+ L85(_]9CDH
M_/!+?!A[7=XO4T21L2!=VN(Q:6V/:IIYH,YH?DUI)>NE0/:MA@RW,Q\$4T9:
MWCS7ZK<XIQ;^3,7EEO+B>D>6[2^$^;77^49MO+/)NJ@MN<PHZ?7[&P_W;N2U
M-,@B/'XW")]Y\&?,:H[BFJ&/>X8%[=?P9?%0$5@AHE&*Z#--F&G-6URJ?V7
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MYN,DH<OS#NQ/CRY]VV<-?4H]X(_8[MNB'9@4J*FJAC=V*O!J?VX)3%DOP'_
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MQ,AM-T7AKTQ[&*U7..=]-&?@;Q 5MLI5U'V8F7+?OSQVO8N;(Z537XP]K[:
M8!CWTIU7^O3N'!LG%57U'0 ?369* :?1\CZ$R2502X<_'RGZ%=3D6U;\%/_T
MQ&7(N:PO0Z(Z3L1*H=H<O;ZY[;7>8M&^(##BL3)VE'8ERC6B<K6'_W7IZ9+;
M1:]A3K\R'XPQ(GM[QBTE\G [Z@E:,.9!.OO]+=/SYQ1W_'MNMX#4L?(A2ZY<
M@H\FY)Z@RV\U-'RVM'#_))8,?O;TQ4>%Z[^?& 6X'95&6;T=?C!J^'BR]G.M
MLX2/LD7N_O1O;>_P]/V;/JR.%Z]>>Z.T:UG9_^8NY&=^TW2_9,J35C.8@HR[
M</=478EW+;AQ6)VG;;O$Q*JLM>EP$\K7I<HQOB/AHS%N]YUZT2CY)_\E<P96
M\1K_#PF@=R$]?%^GC$[>-3ODS<U.N]PSFI">Q]*J/+OZP8?V;A]7C[YU&@P5
M(SK0G-!-O/6E6>]X(W<&]/H15&"&AO?&-66D!35\:0C8=4\P?&]O9ZF5/4H'
M^$L@6=N.0U+ZTT<>\8&7+[G3'W2Y[$<S!R2X%,=6;B5H]0^WS%A(^@3LZ$UM
M/Q2=]] <W4LY/<NXK<H!49/)*QR5?):@X6"TSR- 8S@^!_7IOJ>B:_>1V4&1
M%Z/&O.6;(;)/.&>7W[)]Y7-M?J/]G!_5K\\P_#8PUC4%]R[0H0B,-IOP1IJ)
M[TF6\T<@<_B4>.,*X1Q<']H?1KO8_$;OS<MG=J9MI+1/9A;/PAUH:RWG7"3P
MH!RBK@9EY7-N U]"_WV2P5*S WAZA\1#!E2X%9 BS7>W\=IB9(!7%ND2Z0G!
ME9G@?(88%,J.W),"_N-,:M%5CUF%):J>73X,_0M<8)[TG1)&@>.O8YR",]]^
M,L>]W#*3F?4--)F4-=&E9S:DLV:-E!B+T@G(B;H[L+%24?L&'!+@<QM%9*]?
MG!TD<4/,EGD8<8R="M9,V$\?SE[EV:\IE>U=SPWO^'5\7XV3H1?5,$.:5['
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MP#7@!N ,N *>@#<0 (0",. !$ 7$ 4^!5" #0 *Y0!%0#E0##4 +T [T /W
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MZ7F)(O([G#3F,#/CI-[G;738Y?<^03(Q7*[H(^@^+\$@S!K[F5CO@_)MU;B
M7+)(R,<M@GH.=?6*8?)AWRDI[Q9[]&O6N=.B%D^IBY=^F+;TXK_Z?U=7VO#
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M;P,Q3DQZAC1!>OPM:/#5YZ\^AV?!0^ -RAEC8Z&XXBMS,A"%)/513&KV/;+
M&FU+^]#/XMO &G@2>&OW(*P2DF3Q-@KK=$E&PN%EJI7IA?M;Q5EO7AT7=UO@
M[C%W+'ZL;SL[:! ;MN)Q/(1;Z;IV$#&V0=ON%6G#.;-V8BJZU?<[A7'7Z0,?
MQE?/3*8Z5XN@HL,IK -S0L?%N3=TK\*^_(Z!_.SL]*3]QWOW3G:RR@R;2CPM
MB<V53 X#CIFJ$0YPOPI2!(%/Q6F,@$ '+ITJ1.M@_4>VMU1GA2S11XP$LZ6"
MVD">"?^O#>HA,V-IRLBSXM&VXIM$?V+CGH5 6#I6!M>^.!]=*K$^06*>V-Q;
MB>&6<#)S5>[B%MY2/ <.)[008U41T_++H00N.RPE?47?(Q@-P<4<UZ9%6BLJ
M]=_D%92EF'M%L;SHJ'G '9?_[,6F5,UHZ':GE*!/3MU6ZERQY^P1H7;K[KN"
M%1NKT+I7U4.M5O7KAO>"-^ZB.@<GC7N:)A[OHV+!Z,O@:?S2J?(E,)/71)/"
M;$-"G4KE#SOMBHSW%I! VG','<FG!4$W %O6^VCHWD,24S_>ET)@ZY4Z$Q &
MN/(W[(RP:[C XOH'R^: ^K<Z5)+.[?O)73..= J<_4'NK(L&#4NA!$[K17X"
MC]61DA#N80>(/TA!HWT:W+T9 .*!J.#N22-MFB*OL^T]'6BUIWOG*"<#:M+=
M'6X[(#[SJ,+8$?AFL#D81&>F_L/"L(B.(Z-&7=!/]XE;\:F.B8(F+K8)^%SJ
M8VS!M]X@($RF&KQ!1^56-4.^@2D,5RO=-;N[3:=*?_POYMXSK,FN6Q>-+TA7
MBE01H@*B5.G2$A$!$1$1D1(@*AT$1'I+1)IT 0$!(2(@2I4N-2!-NH"T4$+H
M+9  AD#:R;O6_M;ZUM[?.M<^/\ZU]X_G8H8KF7,\<XYRWT_&&#GTW+9PAPSL
M@WWH?A,_\F+7UW!P\A*DS-D+@ZK;?O\/L%F1E[]KS?9?6/=_7IRTR?_D/0[5
MO1P>RH/<7/Q.]J\ 6X:5UW'RW=+R;[);5^R$J[Z'79YXD9V3^';DZ@UI0;#2
M*<KN!_MQ[<PW?Z"<KI/?IHFIMRW]U#.Z>6Y:.:8^N9DL" YTKN0K^KS9!$LL
M[BQR?5#46M?$LIRD$&5N!_BKU(AG[V51,ED<C)I"HZ#.)"9[$C"]>;@'O1#4
M> P[FI^=K519:^J@?$1BQ-]NL&/V=I*5@YXMSE$*NWM>/GI^9DI04/3/CN\#
MQ%L4TDSSH<:W./D=ORC$</+@03S@\IS64+/.<?VZBQ9=AA'B-/DFM5\'M^*Z
M1AH4'BYTV(\,5.]-/_ <5I@5JNB),XPP$%J,P+.3%'7P%UW1'@<F&;[C\NFK
MB_8@+\V:O _VO&ZLI:T%1J5EES*"&&&&S[128;=F7W4^.3.]K"U=4S*5L;0U
MLPCNNG%"^'0R)UN4?*-R+8:@0@<V4;!AX+>]Q+^3F"+AM:6!$;>F5(")=HI3
MLL_B.U'I.SZN1U,L3[+$&QI2V'YRI1\WVG!W,-( ]\XF"K_S?GV6Y?.4^?FJ
MN'?.PL7K'FWW5BKU7[YS9K4JW:U$#@%?@6O19-YU*JL8R2;T$I(HC<]\B-?K
MR0S$S^EJ5T:K-(<,2#?[HT]/E TX-UW#P+,NA+QFRS [WOL*FT2PASKF@W_
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M,%7M.PO]I Q?%[)-$_DABAV\\S@QDG1$*1T"!CB!C#\<Y+F7T0!Q,50>X'$
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M5"X%$6G,"%%\!-NX!$9%8,+6PZER<[4+RK_BYX/V*SKAQ<;24O<C $"IF[]
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M=FK%7%L:HY]2L"G6T? SN[:I<(>'.C9?:,EJ^FJ_3/'X"=^6#6=.O8_!O^]
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MHX:XE8!8K0&!,>E8)V#U*WVF/F2V]^[+;HA'S\)VA$)9AEMY^>4]A,R">K3
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MF&L3E>:?2(:4;9,PE,[*G]U3&5,4^>E)#\05)-Z8#'J!XE (.^D&JOY](4^
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M)R08/U\!D=@MT-%%KPPN/>P;,E^!EPL>M+C-9@QD$2O'Y*U[-M$]7 1^+ U
M$0N3'5VMKJJ=D!.VA14&W$S>;!/RN<6O4>DH':ZOZ@JT"L5BF&$A[0$[-J2
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M5\&8U-BZ'=00QQWS;L+O&)FHI!J'[H6L5[AL[D_KPPW(=G![@@TI&ZO0:28
M-R7%H*KTIE]RKD"%X)H)/9H],7RZ,Z&ERHE-@ZQO,E#-X*LGF')^7X^\6%$)
M<M].1G*TGOU;AY1B0M@@>A"2*?*LM@9X^\'Y[*6S6_(7C"8?PSW C2]FC<6$
M-H 54F<OJ=2>E:CVJ_@92/Q"$L?/TL\'"\C)+"FB(UCR%5S^"39(B08X3WJ.
ML:W)WI2Y#\W?*:[,D(TZ%UAB+'?W9.+'2YJ8"#JZR,T[@7>E< 73 -2S78[E
M\\8%'@Z"D]76^^]$M9^Y3MD$>5_5-:Y5/C[NZ$TY56-U-N?<U/7/^B.32GE3
M:X&M\6#][65'M[&*H#_C/O-D#?D+%68/LG8;%K04Z0?^'=R(9("E :*1K!2?
M!7N>,!E8AW[#M-.XO\(%]%K6P]9,YV4#XKL:Z;+PP^GK=TIXJ@,V Z&_^F,<
MZ@?YJ2Q7D=S*[%'S B06/''VX20%\7Y^ ^PR33&"O'^?;8)*,VD8WY2$%<=1
M]Z^*O(Z9Z(R23^5EIOAK7:=/[4+Q)0S -4C?%H5BJ'Q-I!*Z#[[;@%^;V 9>
MN;JG::63TSD ]2\:"!NJ$GL=J]>IJHA]]]VDP-&6F$+_]C-*X/$'*N,L=>BH
MN-.,J0N;/2=0/6<SA3@QVW=9-;5/MN_3FDSFZ''4AN=+BQ [F>MR$:N_;#(G
ME5J:J0J@#HC7BO'1:@MDKZYC>?KC_)'R3_1Q!LH=@UY=M*)PRRZAVMB%8)93
M"J=@U\F&M=4Y'M^ 69Z!ZH'H*\Z1\O=7R=[+Z1W&U"33MOISR%,$%"Z]B#J
MPM]')&>HCLS!BCL=1,:T+KM16?&)+;U)H1:6+=2?IV_"?Q0HOL@WSH[B%TU4
M53&=!$$H_,?Q8:)PQN/29AT"ZKN#9MQ&&U5YO!H"Y7 ++L^:MGDS'<P:30RM
MZ>2+^]4MNLNAOUN:,;;EI'%GN__0#'>*?M"R2!9D/;@/*9=\&X:RO$"5)B1%
M?G#/NS@IO_E] B@=^L%8OC-P*E/0V_YWO<I6[P6%#-;(=TZ>=SV>',Y1>;FK
M6X_ .PB%Z\MF7)O3"IV%DB6VRK)A'M,;O^%!9(^PGV"^L-/NR.KB.(0K3O9^
M=(_#Q8FPRVB/<7LZGMMK$I\2C0UTK\U4&>06SKRPZYEXM]NL^MJY;/;I/!6Z
MDA(H;G@$CA%;,6/?RKT&66JQN!7=R3O%2[U:-S[2HSDQ-0 M-%;^Q)?>?J:Y
M[\&9"]?Z69PF0)QTFW^K)4IJ64A./#)+:A65A=  ?'(4,9>)S3T?A@ ^9.25
M>.?^V9J)<,/5^DCG:U"3F+M/9K>G5''&=('L'I> /!%1URA2)"S!L3VST>$#
MA%O]G1F#='UE?9*+;^!',XG\'6L[I3"[D&55?FM@)TMN^IU'+OF%4-5MA%P8
M66/M ]O%3PUW5'<<MG>-*-DFD,]D+KT'7ZOMM;KY&0+?:/-U"^K_VN1VE#,S
M#\E;*9O.",;^NT+2#O)D("S:CF#5AA-R((AWS#D,$Y.O6Y$':X.X70%^]QA#
M3)Z0(#;C0)W\CE*W/VM>*KAX,2\6UM('RQ=/JC%]6BVSTC>IN?OK/[/A_ O+
M]T*S+Y8?PS/\P<3Q>6V/T:0(ZGF_;;!^4D($P^.O82TE+:6XV[/WZB&^3Y[+
M=_HRO>%F7]$_T?]<_U<J&[:WRVT<JFW[/Y(K4^51"QL(],8B>%.$;!'6C:QQ
M;3O$UA*$(A'8IZ&I1@NV;Z=Q4UGV.>\28UC?KCZ^#@,2*WHQ3'3_.$L#5/_(
M$ZA#",$JJ0)VV[OC9O@AI/S7PZ2Y1/$QM4.551DMSY<]RM0$!(_620HK:0/B
MZDAH:@OF37@_GON[.MENO&R?^^5OP W]J^?;+P!.6EWZ/@CKH6C,$D_3 /E"
M=#]!3S1R-6B !"L]H(%84)#%OI6KLITJL*'A=W5-6B7=G8%>VD.H;'/'[WD-
MFJ!LI*:'H;=T1&ILD2QKG\]FN_\4<VYR.6/+'\/P<H3+KBB=!F "4T?.8AGL
M=3HSOT(0KD_[>*/\#KT8VY@^*J,-'>6'YQC8-#>.&1'8><Q7U6..?S HD>ZN
M82A/DTF!=9NL-(#NWVNA5"[U0!K@8LG1+-60;L52R9\K#@\5*&>1JYABNF1^
MHJK%\K@,)N%&(6R-7D._XSOXX+7A2Y>?)*+5D@- KR[[;-N!XOXR2F-FE=:"
M/5M/3XGPEE<*W);%,8]T\<.;&*X;7'42"O%QNNOS(JABCSY'=$C8=\R>#E6(
MGL#>*$80XD#_?8E9W4K;FTLTP(M4O'1)B!%]?(-#% W0:4T#T%W6$8L;O:,H
MO7?2?7HX<J6O4X\&^"-/C^(+24)4-?#:"7IN33Q^B?H330']?4IB2@,L<2,Z
M6E"/H4<B] R4/LR[<12I"SQ- ZQ-@/"<H"K4VB;]4U$*A@98E*,/+X4Z9JRF
MYU4=-$#/7Y;D*OK@^33 WH51>C<#^@B7*S:GB;W'$:"GV:!X'YU"BC#>N53'
M[-5FQ.W*V!L-A^C7+[,.#:@7;8GJ=!NPP"I0N&QH ,*7BG(:8+P>L0#"ZQWG
MH5;_,>O?6C__9H:/U"O#?W-<&F#$UH"^R\L@RG-4*?05#? U<]-5M4N!5<\7
MG]VVTXTN>^L7>F$T_<V/!H:+7[4%M!>F<=/_SOS,81N(@4^(!6&ZR1V%@"AT
M4*A*WVP\B,JL0 -H>]&5PO",OLI^T'\3@NRQ\+_1U+\SID(ZP#_R9Z<P(&8P
M>T0$Z3R5CB,(%Q 4;C U' VBGJ%W77J#^._:M#JZ]6^4)(3?AO[DI\8@Z*N@
M2/AM4Q4-_I?:.*A#-$ Q76[?DW?#H"0-52JSS/K]&GLA)GH6PGD305IV0G1:
M"N'OL1^=^4.?1#S^'Y/<_7\ZR2)]BZST#N$OX8_IKZ\1;=Z4AX2.);NI\?5&
MJ^\;.&:)FAI;73*0CXI\]CZ_ZF2@'6@P[ZU "9D&J. @V9*OAPVB3OG;Y@8N
M%'=@6&%:1SL*5Q:7=,>\_ Z=8SAF!182+V4^8W(7<W)I::U?-\LRM30>=VS,
M4;OR,0"'>?;_*5WV$N74DI?DHL(K'-#Q0T$L)&C%T_J%E:!MY>47ANO%J#N;
MLA$DYP5;1%3KF6]XD[(.>P/GE46K>X7-?7RF+_*ROYD9!\7;'@HL_\L-5:9_
MK4NPRQZK)3X!5 W!!E0&/&B=^E"5^\#5SU?O6AOQ' ^*>>]H:$)9PTNY; KK
MY.A[+1)8C[Y[XZ2VUWN<@YICI,"@VWB(B/S/?ZUZ\&_9W'9P&U3TLW5"1['!
M0G;\:9]6=T'JI706P13&E$>1;2MZ?4LO!T/U]*X!S^B1[Q\@VU$'Z]MTF[!X
M!:YA"J+(TP!A]--)6@Z9X[9CCP@3HPZ!+U&E89%PXT4!'=TX[)-' ;.EZ]GW
M4F]Z]0"/ID^"GE;$"NR;W* !KM MG.?HB9[6XV^'D]CM&:Y%:-0^6>B\M4>P
MA=D3'YX?3SJ[C#O;7@A+W>Q=9;":R%= &S=3^6@ E!688A\2R5W.%!M# [AA
M%K,[$ ?K&S1 ?"FK*1@]I7E;RL\-**K\\<2*B5+=M]Y7:;G?OMST/'?^':]D
MDOKTJ-_]9XI %:"A$O_]I5.>_B"YT(*9*(Y+&IMLQHQ[?8->H__^L?;_ZZT;
M3TQ"GTYF2ST(Y%V1QZ :?<2&&^+A/P!#-U[VW))U:38C^D> :TFJ'SL6_7,5
MHM' 4=]Z8VJK25.=[X%/ K'K8;5G]GH*[LU]/2/M_S"@?ZG-T#;5;%#LIJKN
M7T9=0!>.5+WZU,MY<5Z[*>_$^11,JFQP_38O27VZ:\>=TVY8C,EPXLH$UT#/
MT*BLE$4.I=AG2*V\.R]\XO_7M4'H(BSQ+?N#7P_,L' ?,VY2.>"'=Z([?:M3
M>B]=U&3UG$92Y AHBC%>(#HQ8W;SZ<'@<5\H&=[ !VIYF8,;OO//6D(GXZ0*
MKOU'<8OQ?ZT,HK0;-K5Y52)B<_>L#Y<7Y^/SWTAJ%CDIZXQNTV_A1FF='/,D
MA]"3EU98RFY??27\NG:;N_<'B<HH=U8R8:E5=GRM)I\S^.M_RK\^+6?<=+S>
M_^SCYW+3 _NLV^;CO\$.JQ3I HFAFM])BN\N2AW<_!0VZYH3U$<#A#+O%@>F
MU!D:"UD,JB"E&I)-K:PNW3Y#++9ZUZ7TM9;T]C/Q9GE<C\-CW<#FY&WV#0.I
MB:0O<7K.SN>*A?<*/__O"D;_O3U0J#DC9Z$P(!BG/BWB_V7>GI/%$ZRWF'7;
M<TNL/EPT5L!JW<?$MLGJIM&]XXM6V:-F;^QZ/MUW\(6&^'OXLKS6U A[.+EV
M],-*5P_4)_G'74EIL/%_J#?\C_;Z]6D37W14_3<NUJ)+T9:;LF_SUA=_;^4.
MA 9;W.=R?<\_H'?3_1[B>Z3QY9$!:EE'*!ODQYJV\&^+95[%M3TK5O?2N=G7
M8EI/CU3!0XUDXUX%QUT1T/U?YF[N&9_^1_LL,KJB&V7$QNTO\4+(Q%7WTG/
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MNVR2JSS&&H.+=R%[&E_WC_,#XTW<QO?,BC^/_,F*C=-VES[DWR(+45O\]U<
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M!ZZ671@[8-F "'3QY#I"0J&:$YF9^EB)3+C4?:L^DR\J)T_;KC!6!JT*E/Q
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MF! =7V<#XJ%>_X)8%/M1+I@O5K/!H9;E*CLX\1OOG& B&LL^B]<Z8>2XUL5
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MO2X.EO9]D="X4[6'5<8@;1&;&]UV\@3$:]^(17;^/PW!2N%] MJK1[Z-;_2
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M-G/\-=6G$:]?;^A(C3>J%6!'T?:K@34_N)*-:MTT0I0QX"[Z\F_4 H7$12L
M07!8)CJ+N%S'4 +HBA+[A<!BB\D6@_Q 9+LENILJ=R:#Y ;-+W(K+3YOHU('
M,(#X-^:N2"F\FH*;T1+A'D,S#Q9U$I40T2!>=<,E((+L< P D*<"#^OB2EG7
MWJK?]?+"5W#&J,A\KY[N$&]PBT!]C/S\RMTE]9'*05H,J(U$-6]S10=UB3LS
M)B!T C._O>-"LK'"MJ$*R' ]]&3]1LF+%R^>A<1E945?U+I@?/+'UN;]LK)P
MJQC B13[-1Q%$]ZN?0SP8(4L'. O/V/4&'/ ,44>\FVZXC#2E'BZI[;,]:C
M.B&A_/288/_77@FK@DN][E&G'.J?U+S#@,E12Z0JHETDL9-D-0&3(1_T^MO)
MT3(VVR2N0%!=!WH5>B0?C<*R7@YFEY<(41,;X57=#[EBB7\:W^O+CF3:CQP#
M;MU>>_D><DZ%IA9* C6R\EL-4W7RL8'1G9,O<>L'A%YO3Q^(\,"%G_VYR;JS
M>A;:)BR?13E>W:Z4HH8S\(8K,&(AX"UH/N,8P,:_ $E4LA<0R\EP<"O3K'PU
M*5?HGF1E<SY;@76XQZ&A[H6T/&N[4?PMIDQ:*$JA%>1B8K0Y9,-NB35->/1G
M@:'LM=O_TV(Y%]G@&'#V--2;G$ X2](E\,31KP;B'I.A$$W1W]:PXO+?/NJ6
MQNNU6KZC\=<<A,->?W>Z^KCDM$VA9W3>G[$$Q8.;79-F;OKEUB('[K%T]AE2
M/>VS%]P9<ID]#,X/]2Z':L*Q3)V:? 0A1'W,2KIYZRCJ>@M/4I]HWT5THQ[W
M;$LIAW;OM;SXDCT460K>A9@1)ZG2"M75*+)_V^3V"V FU[8+(8R\)#=VV5UK
MB[)U>))&7,G>WJJHF^D9<XR#OT^3$S"N8'FMGWPJ)[S?<37W1]4VKA S!+'K
M_;#[04+U8V+_K*7%,8!59<9KC82W Q)[23%D.8KR[V"=&$V5C>% 6*_].-Z7
MG]E93_3R'Y7FEK> !(&HT(3PN\:)NJA!$ +)RR"-<D$.V@>HYR+X#%FMXRCR
M1\8\>Z-;)@E1,AA4^FOC>8=XZL*H8)^#T^6,3*[=*TT/^R]UG]V-((*6TMOM
MKS*J^MLP0:C5*.PV&;<X@?E$U2<'H*A:]CQ@/Y^S4;+6:KBZPAH]K[@+PJ'?
M!OB_:SZF0[(-7*(&9@T=]UKK)N$#JQZQW\?52BI?S*$]#ZFMX&V36 9>^C#0
M3Y",.P:P)_Y4M'\CJ$F,0N9A>@SD3F[8\4W6%Z-KFD8A7B)A YZ%A6_\TQKB
MFQ/J4 %BWS/FSIP "FVN4-R@[I!X9!WXC1\"R]0U)]YR#'CSH O;AERR,6BF
M8-@"?:4W!$YNWTT'V\2=_Z KR=N@((';*4 "605-328Q#X_V;UF-B\N:H>M'
MB_=_HVLIK.1#B@&5@Y:^Q\K3+71U?YE BWY;7PYB6]_INS#*7 _<Z3CGS:)K
M">M1FSIEQ.Q\LLV&7,IXBA>,,/>'<I$K*Z$<9 11M6>@6U# PW=L\WE],UH9
MY2-M)-PGRJ%W!:+@.IX.,_5_ F 6ZD_OV)XQ6"+E4[A^6Z A74)\&]8_$,29
M=E5&21V[!=7QKE@/[N(Q>J*X7OQD .*I>G?H2G*(&W1()E-3VQ]UN<H-?A'C
MC + )C"<,&ZJ%M&OH?H9D?*(T/G/41:\\*X<M-/[CM;] YF$RAMW@3US^RT*
M'XK=$^9(H^-!FG][[AK_K'I*FNA/M+4A!NT=*%04-WF<\I#*0\OVA-X)(>;;
M1=^+ZT:O%$?5166(>ON5X<[>M$&E(:+>:4_)1%Y9CJ4_T)3Y6Y6,,2[VF 9?
M2*PF/H(#[-W@'+[9H(ZY*^-*:AN&0A:$L9%-<T-EG&%38[.*]]4A/YGOSCSB
MJ>=3R;M+ ;TH0:HKK6Q/!DA*)Z<L3M.!KJ Z.L(5R;85W[<P"^Q4'N6L:VU\
MT[E<4:2G_O[]/X*/<=XZLZL"I4X*GCX&VJCB?7+F^(^\%*/$QH8V>U02/6+/
M6"MPK>D_[FZ AE+NPG#(ZF/ 9B-1I!-WEJX>N#AZEPB*S5=8S_30TNCN&O8"
MKBJT"^0\<4H-"U*6E)H2=^N&OQ$B&(&GMI<F&A?@K% )8FM#.7Q)XR2$TY40
MFK-XYLN(YVKRG T"]S#'NF!85:&OOMUT9RF3RDO+HW/CNAFX! @\Z,6ZQ*OK
M.804P(8.YB3K##RV924*PQV<&V)/.EJMT42[SH'<-9VW%U"#\&F*+3F2B%D$
M;=+\B.Q=1SODK$65S97%61[]"<\M4;[4K7+/4G?3PA:5TT\.V_YQ+Q#TY\A/
MLR8]2S=)50(V3ZOL&N(ALFN1ZC\JW)MVRFT+=]P@L,9->( F#]$RD@KY9!-8
MWAZ<6H4JG"L-"1F03%Z<,S\5;J([ +P0KL"\;+$/SVD,@[N!8X7.8.93D*=\
M0=.=B^FQ+_;X$=R_UG&<7IAZK[I50L7&,4 P&*KRTNH)N&CZ%^NNFA9GP3=Y
MY(?*T''",6!1'%](N1<81Y*F9:MK4>YO?&8(0TX1(JVA>!%QAG'[<X6%ZU+B
M#7)*XY7-2B/2AB=G-3Z_9,]LCG/\OI.AO8TT:$/D0?:HL<79VA9/$DD(<U*F
M?19UF.9$E:85MIV#>A"/ 8F:/-";DRGFDVT"]MU%@8G#SS)O.?FI\EX\KQN;
M['3O,-_%Z-ZI<'F[=?NNLWAVR@/8N-TI8F\/*DKS)!FU."OA!A)J85H LFKY
M28JU1#QJKFY--/]%2:5V<D*DT.^3WD%,;I?9\V+<M[%#\V<W#XB]\]_(G8MX
M4UVR#W%;BS!)FLLMO]+R !0-R6]RPX,:E)__3(NY\N3=VP].5RYP(*<?62RG
MD:B>]&>TFCRDNETZ56YM&FXC],N)BWK 0%-1J T1?4!G'B>J+.*BVR3!Q*Q%
MF:[,\1[$,[]%D47O0K G4T-&<9_\UUVD?-T,S$KE)'"'B<Z\07&&C6O*DS&%
MCP/5%K<1FM=Q[G VJ$T9U&ZT1?L&=]NEB<T%M#+H.?L% V=Z\,/PVQ_B+P52
M2F,'"F8?%K3B-NC\S2I!!29%O^PQZW,XC?U-Q)9FFROY-<6!_MW^@B_B-#FB
MNTWA,U] EV$PHTIZM?6]=;^57OYJ2."E:,. U(46K\)?94#)"U\GB7]=9F<9
MI94;!!NR=+9#* IT@:Y!U2=.H):0I\AE<K%IEBJC2IBHEA(7A'Y3==KC^^VO
M1L[I?E1,'.$:6.B?%*.<@]JCR::42[ !028RF*C212!78USEV'_;W2;43=9J
M>>8_\"MQMWF1WR@IE,ZZ_.!'$\(G.MW[!8>9;TM^:KVD+8H^LS6SMGO'PN]'
MRIL7V?N>&E_\MPOJ)[61#I3]/$ST$ ML&M<P.(D_*/IM2M4CUF$$Q,DX\>AZ
MN4B( (X0?X^P=R*K.Z)O!V"N;LNL\N$8$)*HW@.>WB ET#[7802A K0\/T2"
MX*V)RUV8.MMC0"=PB.T/7TR6EB>+U?OYKP-?5NWEP]6:7QB5O;Z_F]7OG-[3
ML+M[#) 9M/ YL_GI8&?G&*#1"&K2!Q[^=2Z["QL7XE3W8]"%/!'7 1&DFA!!
M/;K;+^H3'K&:#)FA&>05 ([T&A9N;!Z&2'\*55W5J'C[_'U/ )YEOARQH=I4
M_=CE/C0Y5#9@GFC<9;H6VU#Y=TFNU^B_-;Y'_LU)AAT@Z2WC1F1A_9@Z3(_<
M%:HML:=YD7*%+JR<,R?Q<V_0^-K(OFE17N_9S 2F'Q\>LCR\U7-N3^EH0\M#
MOVZ]N7TZPR+W4=E**7_^V4XZ#^$@4E%&I=/N:FWL2*=N8^)(/Z>0-,?#UQ<O
MJX=QGCYBF<N+[5]M$-ZYMDL?K88.-@<LK<Y,\F[$CQ;&WLEW=3;Z_37*@O>4
M8)?I[T]GU+W[>"/'%"Z&%SA>7(\5CKWM\/B9T=NPT^97 &QA+*&<)P2,.D^^
MC[Q_TH C7R E&7[9Y-\X@'C;\9)3"!L]Z*WZ!?A9CR/_RE*REV_].%YZ*R\G
MA'G9=N/J=]?N7'_[#\!(T5=G@*;=,%E"<1CU3M 2N\ ?_TS9I.(>)W1;6X8,
M_E.\GYO8NS)A2O5)# *28-]X%J]"X%F"X"_!7=0&F3K0LY.]J#-D7?NB",=!
MC9Q2MY#5\QU)HHWB4-V EAQ7_G#5-%'J_K^6</$4)VH@+1JF3/\!JI/KLH%<
M'")D+=U(6HBK-&'EGNNE>'7@=[W$PF\P\TROQAM$SF(BG6__"G5U,GF?ORV:
MW8RS"0HZ4+=:NQCOY*HB!IL8H<-L$5O #LV;!'@7^((5>>!K<&5.<]X?X\.&
MQHG+A>.572X)PP.\CGZ:9;J5G4Z.GA,_.Z)$>\:PR@FM-U6]9T8PL<< +#^=
MQ9SB1.\1E"%G$ 86,%W@<V0#,"UCIITN.$(7;(Q^45%(Q)'">]+37VKQ6M;?
MUVMZ_$(GG?-1^<[\+1IF20Y[0&>Y110AY=$J?;>C[2]YJK//(Z=G.B=@PHW#
MRS\KME%;SFT_"YL3OP])+8@8O+73$Q76NU7/<^Z1L)63UK8/$#+9/PMJ:6D9
M%,DRA:2G[MK-@EIAS2&H4&@#J-CXU$F'5Q>A'2?3>K_?7;YP9%9/-0F\13ID
MA'!78,]&.U8!ZO43CUL4;R_'Q7P>/ :<R\Y2_G!T]V-68-1\C9X?R6_7^;VB
MVRHF'3#U9916"IIO0-;[%6\.$^"+[!V0M\9DGT6V4L*"NEO5;^_?JH[HT+64
M +'R0:6M0C_F!!?7)SIN3A<:3[=M$V)1F[$M_5)ZN,FA@;X46KV65E^/_EPF
MOJ'-E?Y3WN/9"W#?!?GPWKRRUWV:898R\^QO,>QT(%E_M!=WWF\6U(7FHA\#
M:MU5S<<"TE*"O!S@LJY620WHF@;FSI/LUR9W' C%2^EX=F(*_?SI>5#LG"(9
MY;&@)B<(&T*SQW[ZN3:*Q_;OS!@GS[G5Z7('W=PQ>.F<[777(RSV.2!O,IP^
M^-=(20CKH,-0JXZXUXR"NB5@06YZ]Q$YW6TI 6Q![#IB0W*G>QV)T;93W%AS
M'[]XKO#>&.C)AI>J25Z.!M6L>(JBBD,54T*5&N4,HDDM<A6V]?C*CR8;A8?H
M*?JO^<;&>K 45BGAE0T+@%<]I;>TPA#>/<=)*,B$VDF,X14GQJM&.K[9_O,N
M*^L+D\(#[AV5_OYX<Q[I^\EGSV#>R479$\P@9,ET?$@1;&B.FQRZ)*/VMUP4
M^3HG.^[G>:^./U1?<@NJHO$U=NN<2T^GJLV;:]4Q!LWGIDYS[8$CX(Z(&!#!
M%C-53 JDU=!%J/>;"* XQ0&;0R70YAB:^RAU#EFBY\GTP7/;TR'L1>*:3T>Y
MIDN'?FSS/P:ROIL;@V(A:K8S\!_?FYS=RSS8S\Q6H9S@4<> 5\F_Z(6N%7@A
M_9J?OG&V[/]<:)@P*KAXUC\I7#O74G:Y5H#-*D:\5'0B(:BX[#_9#.WRX,$4
M$>IU6K6ZS,+06:JC06\MH?%MA;KQ<^FUG2OVZ\W4Y#76+Z# F71,9:B:EMF-
MQ<.\S;Z/(HI+8KXZG/(V/==?WQ<F<&D#J))BX<RDPV^HZ@C9A8\W?^LTE7KL
MLO_=1#E*BJ&E81PC*(]@/PXZ> C<S87N.2+5%$45<6/"08YP:Z.]TI4>_V\U
MO!SE9?E/8\O,9O5*9*:5RLI>INK4C-'4RRJ?/2?T>1%R$TT,2HVCQ$M%VD(W
M#C7)$0Q(,J<5,(AHNK?[7PMD$H8+&D*+XMWE*&:H%'V(0,HHZ?/.72^5OF%\
M(U<IM>+YG_DSR8L[ 1P5+[@>/5)/GS\&4+GLZ2R&E$=0!=H'JM \A.]W#@\Q
MN@MWA=S9CB4U8+4J:77#ZS>Q+3QQ)U-XTSBS9[EY+7@=S6<_]''-U: ;5M'4
MX!LX\(U6\)TU3DA_2FC#!%YLLG)T,I?F1PY9%.H$7P[$V!)T(I4&;QE-4E4]
M)ZU&\;+/TW:Z?N4&GA[3[=&-?WM>9_7$%VU+X>;'\^&2@H^3S NN?6$Z_78)
M:0<D4XB-^%PBD/20W$UY;D5.[U7.%(]M48,3FCM);3(C+4*%@^7N1ZETI/R7
MY,  JZ_;MV/U1%0L!;4^]Q=?,6VGWF: #!K>KDT7H?_(X2 ,%L?OE0L)VL)^
M*MNSN! OKP>'+ENJ>M*^,$O_M-83R_J6<G6E8O7Q+PGFZR962)*Y-HJ[LAA6
MJCGC#B9UBQXZ\83Z-^HIX4(UV/$GSUUK>'OO11P?6VP^P"4GO!"U$$VJHU6
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M[NU$7'!?ZQER$W]KO:M7GU'O\OF4=?V2HN,OI2;1^X[2#G0!"U@"Y2KLVYQ
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MJVLL%;GQ10NPQ.0AJ+N'[@F5)GC1VWZ_B'#WES]L;F:_6>)*H4#MR7!7>ZW
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M)?I_ IE;&-5''R<VYWI@C9K8 K&(\"A30^$^EH)XEJT[\,%@\9^3\E?Q9]D
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MULST&<8\I61HMX#NPMAYR7-;,E_596B$AY^4=_IPAP*S'XS'Q+SQG'GAS%'
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MZ75/(!NG69%-3TX*FJM+$Z.3V\L3B/>\8>28M#;V5<8?-^]DIS/K9H7[' /
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M=3638"I$!33MTF8P\GXQ15W&QWKZ'UENR"C\Z4>$XG/4DKPH   I1%9T2@8
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M-2;^'@K<-DF)\/0N!.0\ HRH](SB51^H.W1AYS#@X#T?-.L1@*P#%<RW*?4
M7QV*&QP/(BT/5X3H+E O?!6$$6'=T(N*H=O&WYX^ K9-T' G3(:#2]?YLAF*
MOQ]MP*@W;_DJ=4YR/'*@[ )%JB,;HBHY?\#P3\K!)+"U'@'?L28> 8A4,/M-
MR3X,1YA-08V&2- 6'AAD%;  [W#8'/#@==TCH"OB$4#V&MZ1T#E4(#C$@.K.
M.PA2'6Z3?Z3!XJW0RV4QT1(/(\+6 E$BUO_'I^4> :%==A7A$2$<O#'6)]@/
M_. &!/TX@I#+[^\+T'M4R*,7;\,&GLKB1V>NU3!<Q<7:OE#_G-<D=&_/NOZ
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M&5,2L-=%:P:OJJ- ,**7F\:KU1M9[[*;/!X!:,<=F$'=:A(8_EH04O#J:N%
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M(U1.):5>76.7;K;P4[&R068M D@16]PF+W%*@?/[,D4).69^(8&&E_EN[ 4
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MS1Q<2X@C*,.'RE=8;?/%[B?Y8Q8ZB_<:W$GB?@O)4.#5,!1[*Y9G.@BJ1^;
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M;0HE<AVGUJTQ[-Z$]-EJ=1+L5/V:3'CB]Q)F.G?9R3,P;_3#F<8S+HA;ET3
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M.(LRF,A^>S<JH!G2O<1G6T "6KD)X)9"+?*;DE&:6\W.*RBU2<!#1T15Z;C
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M-KKM]9-5</+&6,KW2^9+MD4$CN)W*L_"_A">!_4[0UFO8\74/>HVU](E,NS
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MP?A.O%H/88+6++'L'%.F4N4X_0LJ\/]/4.3#IV;V"O29 T<6TE8#&W%GI*8
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M,=F%2V?H1I @,O63/ E(OW*FE#-A?*OSD%IEF("X/0-#=<.(Z<VB%PN)NP4
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MI8[FZ3 ]N<A/Z3?9$S5?!;Q$?>P"$]BD8AI/B4@>%"?S>.?T_MAX(B\,>HV
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M9"#\=&0GM>Y<S@%./EU&4Q6M]91%_MA5()45]WT3UY,IPB;)GG%>5H)YL(G
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MDM&IF4HA8LD;TUJWF<1X^X/7$M5L!(>@O6OHX '1VTY$EEG?US?X>3(D%R9
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MS71W T9>W4U_M.D7FA3R9,/+SJ^D'<C2$D8/Q8Y':).RZOI\> RNY2=2A 4
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MPWT6HB%V,]:U&QG9_$1V3/Q-->>F;XP-2^FJJ\!N2J+" 2,C5J9*NMO>2*5
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M (^NHO3KOEB"EC-P<$/6.1<W3T8%FLE_GEU7^&.FM\4;+LJ,>\Y4TP&KS<\
M?^BM8@6$5@2$LM_A.P?,V=Z_3\W $H<5SI^Q(X\9PP6^-^.9L9?6;6N3),VB
MLW1NPC54_%F7L^OW=YO*833X,H]2$],:I\#\02_N/NH7\YVT6:%;5K(K0.#.
M$@/1G3'R2+0W:O7G;E],!)6"[*E+ 10O3:9A(DC$WK:+/:Y0G?'+;AZ\<]N-
MO/J]0%O^)Q/""2B;;2W9S/CER?V.,\"E4FV=W'&O3+R>Q;G'NP?^,L CY;:T
M)P;CP1BN))\!6%NES/T-9.>KH:(ZY#\>V6,H-6N\UZI$6#9&=PYYS3^U/Z>Y
MOBI#$?3\00RD!X0!BZ;K0&<+^?S;+@$!IVM>I@4TGY.+1K*N_=K1$/CEX8^H
M4P UGZ)PW[ JP[NA&"08'X1!M!OT!P30JD^_F7&SDQ_RHT@8:S7$0/8@!!.\
M2_?S'<7PI!*++GM>;^9'?%_C0??;T07!+008^7<K$$]98C+G KI24?>G@)_V
M1Y%H/>UT*%1.@LCJL-(I=TSZ7'MX!G!W)<O6:<=5WIG'Z7P]F%?@'@>F#I5_
MXYTU0+7.HE:'M4G%K=SX<Q=(2AI'IQ2%,7P*3 7+5,D6A[W;&J'8@2I>Y,62
M^?Q1'=G<MS!QV<52YFS_1BW>PE]#2HFZYX:,]^]<!;?I[%/_@=:<.C7*[GU]
MVA3W)X%SLY(:24<*^7ME:>^VZQLV&R7;HJ)!"^+ CE,7X5G$E<_B3-TCOYQF
MA5M?S/H:DQ@+S@#+%=D\Y%OX)Q;CWE"&[>HG++]V[I3'4+"KIOS;0GAX%$.U
M$)XSJ1"QV[M:VRY["/P]]W1@K R,KBH!^X\3GYS*'WKBT5]I=I@LZ5KS5YFO
MS?IK)U.F?(&P&&RX%;6<D25:BX_%0$SQ#RH;4F^_3C#/ <7",HN(,A.59P G
M64S N"U3/--KR5H'56AF#$G2*N%"/XY/<+_H,H,SNWRB='O"S4@[J0> +*M#
MS(1Y+\T]4G9U=\J4)MP63W-%B1/_ROX9<M9C-1@%4F38.'3 'D5VJK#:KK7X
MG@'X_OC#9)=IW=]'8N385Q93PUG"ON-PR#[7!RNI7_T(>F> #AZ5Z+TSP/LO
MH;>>Q$L,\1UT!V<6D,<K_ B()7_9?'H[WF*;>B5\CV@AJ(;Z.ZG:O+<_[\I8
M7.JGJY8HB<]ZJ\XN E;Y+A5(FU5YA'3/FT%EG3+O'5$DY$<'HOU9LU$A3 *O
MED^\,_HP4K5O=#?&)@^HC=_$.>(A'E@$^N:GE5J:D>C/BSM^C[^L!;M,@)8+
M43<->Q' .OI+BX_6G!Z N?U?AS#*0LC47X(<; @/>WRN&D%B'[O]]>-LUV/%
MNNLR$6YJO>]:YZ96?N8^K*^@>N*\.8&H!_:H<.% ^( BF"@>6OC$Q2?@]<,?
M)@_?O,A>I90]F&Y'X86HNI>N^>,6SP!=BD5S]^Q3#'"TN9;/ C8I&@8#'8@W
M);0G7^&3"K;9KJ11F3Z[',=BWWH_G%J\,B_DOJW?F^M!D\UJ1E$N138#*^(<
M_=*JS*D2+,FE_7)SBYM_0'N'F-#V,P ;'+"%JO5[6UM<D;HZ,.PX=A\5$&]]
M5(K":&CNP<=+U1#<;M&O5R;>(CYL-(%8S2W^0#'/>,0'3&RX*_+4JKB0B\[G
M.PG//Y#+>%V7>G.WQNL,0"D[^K\Q]]9Q;7_+HF@HM!0I5' O[A0K3FKX#RU>
MW*6X6])"D:(M%&BQX)0B*>X$UP+%W:$X)$@(D(07]MGGO'W/V?M^WOW<\^Y[
M?\R'?$*^WS4S:V;6S%IK9EXFTJ3RN98'"_RER%E'.-TI54<SL:DY< W(Z07-
M7P-JKP$)WK X:=A[62(1PSF'NC+"0^K!I3MWN5Q%IUJ]$7[=4,I@4U22_1J8
M2J-2(_C[Q^<]%!8@\2!DU3<;3&ZS\1ACU^ZO-]@+X[5@;G9YMJH'T/ZM<O6
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M,^8Z4LT))E!!K*)_MKUG,_&*/H',6J_*0^"#JT-E4'(?;@&Q>7=#AOM\XVV
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M)2"=IP_.!I7+'\?W.++%OV[S>'2_<UE,UL5);W\-6#Q6'-F84K1NCGYH@#Q
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M'4VYDC_+\R-8XD7X(R0WRG4.VG'/=_P-PF4B\<US8N54X7;6=R^E3]YG1%]
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MR^WD<YU(HU&@(R042?>!KJPBX:\I_D/('_M0<2...1DJ4B^S^X\(5'Z?WVF
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MUN9OLGR$]>?ZK[+\#X(%IA*%H-0%KP'"."6P%.]6"5;^_5_PA>&8:UI8=0W
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MP_>^*;092[G)1 '?;Q5$W"X,>UM@[!CZC<(F=GI[NFTYLA9(#F(VW/%X:NM
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M.Q3<(17SZ!6)+S3H=DJCBVH01"9^B&'^PU,J@Z":@"+[ ,8JMBJ;I+/\VZ:
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M+&A7U$70IF-4Z;)-VOT^O8 1*,N49*!.\2.D&=O:+VHRBQSS^^EN#F6SB!\
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ML57]8K^ N15);>FTY3EH2Y6??(@$944F<\?>ZD]4<JUFNQ56&VA?$\*&(_
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M:Y5?1TA WOU.9>N0TXNQN"S'8WQSQ6#%D<M3OC/7+%-FP$%@QHEG$.J"."+
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M2#!H#.N->;I1.[XP/XB=!1XZ"*(3-&ZXMK.20F"<^5J0P@\OJYV"F:MZ"RJ
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MZ!YU5M#^)SRPF=B[#3^[-KDHK$A/SZ2_ G6%G_!G29\#JH*W+\I::AKXGCR
M$8U,]XGM3 ?_OE0<>@@B9.8OG4'X5L'WK,\!_370O5AD#]_LDLXYX(3])Q13
M/Y66@IO?-K![OT!,3?N'P2#!Z)O_G!)!QVWH<_L>G_1/-G-_%;@SYFP3+;*S
ME!T8S'Z@H'=,TS87UPU\4&+.[<^VFD4Y,MR(++5EN\TS5OI<88!#\*AB"0N;
M7"0X\D6_%]1R=V<1(CDF$A$9&P5G7T4$5ZH1.--?Q2N6F)HDN:'ZVXXBE3RB
MN2H<ZB&CUJ&J?S7&:"?&+K*>:LO"_S\3NWE<^H6"_;,OI7SZT.:Q!TH56W:*
M;5U9I-KOR:BQ4?BH]=N*G%;NOL"Z&O>C:(TT<@;Q27D]WGS\]5#N2<@-@J:]
M85>_ZU.*WQ[O4M]'#"8%X_>&+Y>7F_Z^K"\>3^80@)<CL%7C#):OAXB\<EWE
M]54C:]@#[");A>A?_SD(";8:71$]N+M^@D*N7YM TF-](N&7ZTF&2**&$/A_
M+&/"L2?Z+9I,<_,7:]3K+5?UI_8\SL\A=M#.>\IG3010TBEM/3'<_2AW!4IX
M&VQ\%H$\!XQH0=Q(:';_9JS,?*YFFBL;F[]9FN]K#;.%Z0U$-X@#IRU#MBE@
MS.::'7?Y#=4I,.ECR'2^T>TT6XXL!^&'T4YS:E=I;KQ9R-U_K0+_10K]I9[G
MNXO$ ]7SYA?$FI2FXDM4WS3Z@(,"MU$!W=XQ3:RG:_7(^1OTKHV$+WF^)U3P
M09DD$%NM\7P(=GC\,?IKKG'AC%U/9$DFFQXUZ'W9+6O7DH4Q51_E3P:TR'IU
M.>QJ.!8T*[BR8 7_/&T<MIM8Z -O;7]V31.M=N>R"I?']:2S:C;,$H$MH@O5
M!:(&\F7?XS"NGF^*=%C(P#-A3;H(S"./C8RQ3A3U),(-7^T710CQ*!6SCZQ)
M[TC><]EO)LQ2#%'6!<R6?J]QPL]=Y5FR]0T'Q3_' [W!X)T34N2D<?89J+,L
MH2[7HZI5$.?C5>I]L_8DR4?\4DK7D3+<"(?'FQ(1&3(]HFVT!-OQT$V9FRZY
M>(L/LICI-2%Z2U"O,4[8>*<:KQEH1(7>C>>BSNAR:A_=?=CLY$PM9:?L*O,8
M=7/B2-:D[8;\0(LZVAC+@EO"4"&0Q!A?UK8;'WZ.AL6> UP6H+-TL2?-1-I]
M3/A@-S(IADBW &YM2_>:2EY8,R5[6T3A%$)[")J+P 9AX 26::1V1%'H;5QQ
MT99EPHVSGX<E=>2.E%;"%<0E&YZ_;S7$ N50.@GR,(VNO6ZCZ%VGNX-0OZCJ
MDVE[56DWAM9$5ZN/W*GU&A]Q='@72"^(&L)C'0@VF*C)#PEY4;ZF'_\K8LNR
M 3[OCJT\>Z^A&"K=6#L&/UHIT;JNT/+^9\G\:Q2'S5_O-TO?8W:",'(K;:G(
M,)&5PIB]C+T9-22E9*%($4.O$LI[YQR 9PJE1_=D26!@7;^H1!U-]</BKRES
M+GL-E)1+JI6E&*WHL]D+[^=<I*7I+,41Q7&U:%M;M-!<@__H79L9W0Z8E+YS
M2E:0@O/*^HYL-N$J[C@$DX*-Q-7G@6].Y,W>$VCZ-(Q]\G66^Q)E,/7.7PQH
M6?$SVMN.%.:2=U[93&NFB!>H= D=,U_^B]#'C2\OQ6B(0#OO0]3<;=@3-,3=
M@HW2GTE&*^]*LZ;."\K0SNQ0BNE\N;9:B9S+<:[ZN]\+GU/#VHP .0/.\I'E
MC(%S5)<_1/%H\BW"?RW-@GJ:Y&'U]Z>SR-LT"Q?M;U )OM?\@/ (GIYN8B)<
MC5GN[U*$]4(4<+VEVVFO1IK#4FQB95E""SE/6DO_R,RV$YE]\&$*]6^^)?)H
M2'S*31!X6/I!,"+1#6WT!2[:ZB?7VXA7;H#9DQ09K,$;>-A[#J O\X=2N4ZS
MR\Y^4YAX41& O-O?GETA@=4@191?((@V'K0?F)'@OW+Y*.2K(A!87W!+Z$F4
M.G41G.32NO'-.:Z .QHDY;UCK\&E"G+Y"'A.EK3Y@6'*E\%_=Q3P-XAC#I2J
MZ3% I<)'#-JWNXA=LP]*K,EAK=,9ZX7!OAFVURUJ=35;1^^9CX(>+\U+F'['
M2-<6SZKO%O,YVZHAI*H;E-!P8.SRA<IEJ=;A=-#7=='.4=Y"X<,'SG7:AWHW
M0FO[C,?92 1U,@26D_:G,HSSH9HX34R$1>;]'V.V"TU:PWNO+^EQ6QC/W;/#
M('8I\8PX R1UK,=J4%FM^X<7+WY]O*]%\<="^Z-36JM>ZB.M5E7>*CP;<0Q6
M9=4!BSSULU)*$[%IKM=3>.0E;?'N"P5O:>\K:(W2;CG^6J@5SK48]_2O^=B<
M:_FCQ[*#L?>X@Z7LSV*(5)!^,">1PB4] ;U_MVFBW,,QR>3V//S36&:R3[-P
MJQR2>B<.SQ6JC.Y=B@,:H',UH^E<#!K=34:"GS66R]HE!N<"Q8LVFOF$2!/%
MJR']VS;4;EJ#<R.C.%V[H379UB] YJ#$)SS$%US@]JCML<0J= ;1S_==)S'4
M_54[62B-]S-?1XENJ0DNUWCR^ _-0G[P$L<..]H_??)K\)GM3C&W&-_?L7P?
M#DY-[!2_JUDF7MC?6]E)*.(NJQ.*M]6E]HAN9EN#.=2@!>>,9)U(]PG7GA5P
MKGYA&&:<Z]ZDE"#_<2I43;7-ZK9 Y@?P-68VB*GU>JX?VURH *ZZF* TS=PZ
M7AM7>?@^Y2#IB5VMJ[N?WUBQX^:29.X5F<$P!N$]6K+#X-%\=RZ=Q".7XW+&
M#5EQ.G[@Z5'^[&N.I$_^%=J9CR;R?]YDE>WL5'?9_R_G=C-<:4JC1!<G] %[
MA<5Y>?Q7&46M;!FV:H&EV/2S^#8RXC0OMS$]P0T= IXOBWH3U?/2K_]WI\(0
M\1<4_:!]E@7[@*4?';&R]+[>B%>G_8,S_YLWX4/]^G_7GGOP?CK*%PF\\9IO
MJCY1NL2N./.@<^Q+XXD%"<_'2?J@HX>9$B/%1L81<S9)S)H>54NVFE<TG*Y(
MLUEH X!9[IC]SJ4:^*X@7G$SH[\KC*G'RD9?3_&7:1_*Q^E%0__ODT!UB5-9
M4D=YQ#D0/>AYTBRJQP;2CDRJ=E>M^"Q5]Y6>0JXL2M,L_D^8#_AG'3P$R1?'
M=Z6@]>V"&U=T-:3YG>GP3H^TD<3F[7Z3\59#D\-'^<HF)8V\A>603M!W6%R[
MA\P<2&=TOT4VH&1C?.N=<.O-HHZ#1U]\$%XATT?'>)6+.JH,YX#G^]%- =WP
MZ#FR[^,>NVGRD>_M4,H+,YS Z1]@M!8")_P2TKMT60"7CA$G:")Y;'[JJ>>J
M?GKRIG)C'M?9_9))_P@\%T"D8\,+0G[6UW.!WQ%<)?]:?@_RS?_:\(D**S[9
M&5]NRZ9DE#%R5&F.Q@6[^2MIU-)J&^2^5%8IB."_#NAOA80$@HB,DF?O"/;(
M+TP,.DC#NXK-#5=R-=(&&S7RZBC#<M!6V 2<!>8<8!SFOM+_#MD2>_6:!6/S
M&T%U,N&6V ;5H]H,=5''#?/02C5X.K?_OA8_$);.>]2X^VB0,<]/Z:7)@F@N
MM3*K^=Q@;T,-JXG6I?]R1^AZ_%&^8RK E.^AJ!UJ+9O.YADAS?0@4($$&_D3
M-T:;?>V22 HH/C:JP!YM0E'>6>2ZD#<<92N88:,EWOT2197VX?_9F;__ETW[
MSI9+@=RU;.K,*[]TDND84(7D8^EK3V)11,G O:'N)GGLK>$!_]MLVB8_%$SL
MAGL&9KD+^YGX'CSCDDX-Y 2<;>7\N:6PNJSWDNC7L[XP4<_.8J\_S6Y:G:XB
M;63D&EE%IO5*F[OH3^:7QT';<_'KF:,U<*IXQ]AO%"I;##+!HKGI1?^E NIN
MRQ[YMC89[U-ZLHD1@+J;Q*R-VB/IX"!=_>R-A8#<],\S,H-?A *>OK#F50LV
M-XUV$;)U?>U\]_*6ID [+VBY$(:V])[CT\=]. ?0QG6EU9URJQHN?_4^VBYX
MY Q .6+&8_$I1)HG>&M<+O83CL&Y"/?[U]/FRKH$+^D9V.^J]9N)<O:IMWX/
M)W_H-;Y::-)#."0IX1"Q%\8+%,'<74?NI-AMS4EUP??YM6>9+%4&^CGA,4R]
M3+Q*T4Q1CAB&F4I:]@&6N@4FC^FCZR0L$!TE"@4BL"Z3-;#(+-:QXY/G]9]E
MKAV@>.^'! 5B(]*Q\.[]F*5*Y_[VMQH4&./X&A@M@BO0<I._)=;?2?I10&AV
MA;5C ]R=S#)SHZBZI_]NGOLBWWT2UC-!: @4F,(^.10XEJA8ZZD]:7'T5<K+
M0<74WS=:F>-QF,1?,DM.Z*N'5ZFHM#7AJ^V=&HJ8Z4XFGO[RP&!DF)I)9<.0
MYTW.V)1.5('[\2&6Q&SX7*@8!AIS!(X!<=322/E_VE7\];+R&GVW4/*?-UGN
MW*^NV_;[ELKTN \);LK,5V.OX,SP=@29UI%:*-TW=^;[!ZX!'P!?A/D!1J-I
MW'[P[O:Y="PC#H,7W6K &,=4Y%5%&U9MO6/\<;H<@!!N?]CN"<-)*X5#:+:X
MO!+0&F/S=LTAJ<0Q_--4W16)KX-6*BJ[#KUX4>(H'\7%%0H@6B_O4(MEY7V&
MR _]4$IL5I?L#<KHKJ7 D"F_DJ<O1O\FB)MV/W6S$4' T'<N+@S@D%>_= Y
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M3L]4T0*G0TCJM3Z_\Y*R\>?D[^I?S]#X18="2M^+O5EO$#=UH+<CJ?_C\;F
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M7,@ODFE>RE:QO!<CQRY'-5\X(-_MET721!F  :)4PZ-=7MKX9$G,'M(5;8I
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M34726Z+K"C#F%K@.T6/%)[46;M[4$:/^G$XUP\?@9=;.-J7/';PT',\_/C'
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M)=5R[8(Q)H]G$<]).NBDVN&T$P 5%ZH <\_<% .+RTL#866C"T>)E&X@C$F
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M!O7 ^+<"LVW6<D1QI=/W6TM8ZCH6A/LSW&P^53OY>07VBND0^?&(%9)(]PF
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M25>(2U TROU_:Y7')S87AFHM$ ?VCA^R(]V3 =IERK>NCG,FTQH(=1YNWGD
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ML4;6IB^5HQ!$;D\R_2QF'F>D"Y4G7IARK]NE/>"J_<Y]2Y)!<U"Y)B*[GG+
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MGM@<HX*5_2@U[J" (=11-F^U7-Q5"_0@LL+TBXHYIZNZ&:1<KWB19O98\03
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MU$?&[K6V)%ZXG>4%R@,9_7#SG XIW;Y4@-+Z4I(NI/3>U^KNL#BUTGJ[O*'
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MPA&.R\QX<\NDX9;:B>[[[3=\7 5MM.E]K.>96-U!SG:(";EM(8'[#>,'^-X
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M$)Z6N:#4];1+^%:/^*\R"S^@G:H@F=N/B=FM\F'?&-$)V!<AEF,/JCR#U">
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MK(D$331M!^<[&6+>72E!!4EEU$QX.F8G%Q@9(A7N#&8BG!NMP6NV&LD,K7P
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ME;\(O.C>RC8D65OA\31^>GRV*%UG[6P$:!?^#8@3\2%<-ESD+5Z2PFF< %R
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M""4P]9T .H=.2X#@R2MRZ/)IYV"7$\"BAZ6'E^-2K$!-5=<?.$%1%&2 =J<
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M"P;((2*RKXW[^#3KYWVE7.G"I[G37J3^^2N=R+8:8'<UF"3_VRI?5'Y>1LU
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MB3R*# =^K!A''F5[5!93&/4J)6!J'TY0VR31L)X ="^50>?%=/^X90'^1AZ
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MZ6S8D#TZ:*OY6:LV&58!4?,A:Z[O[0_>4F&7@K*YG*Y0N9/I/:/F9]6:@+N
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M^<C[_=B=H:!PW^B^%N![J5EI'9A!Z-2BL9A8;XBA>ND=I #(!1[S$6]*G.$
MAQ-XUM$_?J#9?DMZT']G8I0\JG3FEA^\Z5VGALO O##5/7TX/._SRW5F!X5M
M>H(X$;Y/,I<E2 V8]PI4&;;-24F,9L86$Y@N =T.*_&SAUU+G+'L1G-SJF0M
M<?4GD-VD3BC5R .2^6^"CL@L8S)MWI=,>W[LQWT2]E;D)-(P6Z'GD<&'H,C7
MJ;G:WOCG\>-WFH S-T]:+Q+;^#'GRYW^,=X<W#\U.S"_DPZLUZW_Z#KMP.=D
M5RF[XR,4[GHCF9WYLL?.-*[83R8  [L[[+$@ N.#$T=<>Y$Y] G.J6([;=HT
MJ0[K9_I1(PSTDX+I:*/0X]6VG$%:NFR?@4/_SQUEJ:#OL-K&O0$!>&P'.ZY_
M;&I[?$/A/4/H3\U??HB_ZZQ?"$_;<$YVJ.'9(@A;\\=K)2W-6RV,7XOYQZ^T
MS:^Z[C[&:P3U^G,0=#"GO5\BZFMXK,V*BOF% 4>BK<QK<)X._FUX/6^TXD,L
M+_JV0<^;(9<B\X6GU![!HESG^&D7-H.2_8#,R0U]R;7ZSZ>(W=15V(SH"F4/
M#=V=@3Z.-QPQ&(F3BLYG4K\4;IK;[>'1\3/YJY3!=["RD03CXEC_(9IYBSR;
M7Y-G1@U!S+ N7I@-+R^.5P=KD1Y-T+GM,T)%7E2S!LL2[$7B;KON0C#+/36X
MR+XE<:S6G%JQ;Z #QDUI2-5/:%)#2%!$C!."T83/\;_$-6(X]KM<W<:'43.,
M<\*#'KV5GGM351V\L"X0%(9&SGD?K@+[3P/*5)-E7N_2 BK['A&N5PZ>"&*,
M=Z?QRE!I+&MT$-G@U\%7:P)-R7I-A^0WVEQ X=#Q<BCXHA"V4@!A.0:2X0SZ
M=/(=6I[]M$[J]FFPG5F3%U(+VGN:MV$YNNM U>(;,-A\3HF-U,;1H"X!D8T-
M\!O_U#2.M4705LX:= W 3 F=%TD2BB 4[WP&>ARUUMWQ16DLY0;F^OUJA,\(
MR9(2X4QK695$*<*;R;?O?/-MDX3JSS[>HCV@F1Z&U_*^5Q1< <]_ADJN?-FJ
MO.M2:0V^CW;9-='H/,09-7E)^(LMQ!B\C4HM#PRX!%Q+JL:Z+'<'B*F &Q/K
MCF)U?CN-7UCMX(P@NP_PUD$#<ZP]#R%7E[- Z@$VBWQOLL:X*$ ?F8^&]QBP
MKBL;(5([$#KHRRK-BF,YC9A?4=_(!/P6E)S6+P&<L"[N2X!=_ =_<Z(L[B7"
M,>TT(_2SU6Q)33<-M/,5EW5&#]!055J@L+O $9PVG#L#A5S$(NTN ?,/C,<[
M!*'WL"Z%X4N9/5X+#!&V HT^YT;&!"8$6K<, SQQ'"?0%._\LFNA<Q#KE!//
MDQXX0*02'Q"_P>KB=WE=7;$2ZKAX3['"VC*EIHD"WV^+BS[6]:Y!LR"F-G4\
MF-A'9,1]+C=ML)ZZ$[';QS/&(C=B6_E]TG137EY$0@>L1K*+H 5B'X0"2N:Z
MBN#T_=7MRNCH7CY]7YN'A^56!&3$.#]H$GX39@6.O030N-:9[;,Z5/AQT4^)
M/T_F>D^6:.F$%R)!:@G0F^5XWFM'$#8SW'"OA)_[F_A2==?R>R8%\JL 0IMW
MY6GO,D8-.<O;/<?=7UN.J^VC<7%A\'M9G]Y)COW:YZ!GL:G&;/FEH?P0A..?
M[M]9%!UHV>\R.6YH']?-T4GI77%^RM9)<#I*DOAD0W&@+@JY&=0- X"LD5<(
M>LT31 I'T\G)BP($UYC%TF?KA4>_8-3X-Y_U9%1C$B.4)X?CDY+CA<?3^_76
MFWN#1CH>ND:0X+F7*_. 1,K(?$N9W9]J-9)4!Y$SJ[WPJT3AH!&%QC[DG%U?
ME6)#;60-:UGF_6\]84?2YX_Q3IOI<Z>[I^5;+6^<#]A.[Y$+ACL2ADE"] \:
MN 1<A=GOLSEU<..*$=MI/D8_A[B\6=<9?[[A9Z/,N(_K$C;WBTY.<0[$HX%S
MVB=,6(H0B0B)-HNB[PZW5:\ZMY&%@BJ@\B@(!T$&QXI_]U(%<[.W>BC'L>6]
MWB>QB ERVH'COL#G)!CV='G6 33E"^\+<$]0JQ;$36?-!/7"JD#=P#D:G5$^
M+.N'/VTJ=MZQ5UV^IE/_YGI[]6C'0HHCI?SD?BDKAT_U$G'Z$E ST'L)F*M%
M@R/JIQU>8W[*C+8O/+V2=,_+"M[)<:[2#:=7O@D5Q%Q5,/=F\9Z2N7%EY5[G
MRA4G-.\\Y4D5+AE+B19+WT5@Q ESIFUF=DT)J:DO3>BY/"CHC$= *\F@NLI6
M*2#:-7;N<W4ZG2<'+M2Y)C$3F)T[)]M2P[U0D+:11%R&8X9;6/=T2$Z!$4J6
M,7HG@PC<D]NCD/UAI_,39GIACM/S/H_O:5?>6_LG>_)^8) >)!'2R+I;C6D]
M>8,;1 &!OK*]Z=/3XPMSVE!7B9\#L.R0ZB2=H 8H6R!)5>N:^?19=P>G$8O,
MA4'&H>OW<X75F9U,"(43'<Q;,!;82JZQ)>]4^52 R3'5G3=6"5K?Z((J['DI
M"90%6S+/S7R]V<8F*6<S@4WND"\D;6$V(%(_+M%L%!QJ7B5>%3V^,\$_U\LI
M-Z<,T17-T-?KMN!FROMJS9&(;22P4%^_A>.^5M]"R"/2!KUN?TBD^EP/>P.D
MSN,]\U92KE^'84S4*5<*'/,+":!?[:)$JE2>_5GR[M\\03]A62)4PY3W>GN2
MV>GUXPE,7U!RN%C,G8.37[SW Z[8Z5-HS,C:'55"B%0"V%*H)QXTY\O_O/E0
MHNZA6RV%XN^,<]B )4\MUOB]M-@5](WO/C9W54U\;/C/I]<A7: /-X-ZX76-
MT036DEJ5-^D:U?N;G?ZVU=T!(^]BJ]W3%1W]LA![897%>]QX)WL8[=''H%&[
MHL#L]5=MX;X+=F?&F^"(=R7O8CFX[\\^*1>BN!84".L2#^)U!#$1Q7#QJU,=
ML2+*95[,K=^3PY=ZK:7/[QC=GW^^PC'/E"+<S>W_::P-2P]S>[OXRU]/A2YV
MK625_4[4X>RF]*O_;U<FGZS#8"GJ'M7W/=U=RC</X$6BC3ANK @P,NCV34N&
MW]\N 3*ZE(5N/0G/O0H$))M#?IP;>83:-\ED#=>+>8GQ]F8\"^(;^=-;-=@U
M/UL]]$#@TRM4\)EZA>_ [BPVZZ@.#'!Z;#JG?C%X[:Q1\ACQ=D+,:#+T:U;%
M#QD%:E0*E^X,^(L'^72&4%XNQ[^L%1N(SJUVA&A]U9R+S8Q).RK(C;'__+ *
M?-LH\_NX@&I%C_*K>[F@/=Y]8]0R@:L6\T5[%.I0[#NMBW-..VBOX=^ARES+
MM(%Q7/2]?BIV$YC,Q;QC:8W7#OK!2PURA%.9XE30W@FU\W/;]RS5^7*63 7I
MOVH2&=7YV]^]DKR9:_!YUW/U'J97WWT;=H^WYG17#'L)."G#*E5&8^8[&WV\
M:S58 B:>^3D&'$+J>:LV")S+^(=0]MHQ@@-V7*L6:U3(.. FMN_2\.7EP,^V
MF, I )'Y!!:'@-GQSE*BU@;B$(H/<^V],P(;UO%*!<\5<]V4S<F2(9F\F.=
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M">,4^A:U7<(L3T3'=/3349?O:<N:C<"%<M%S=Z-@H4=D_OYNHIK6^CB]]_?
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M?:V)U\70+J*]LD8@]HZ[.%B/$59KB]QQNHANA3<E%"Q?(?+:[<AV56_;ADO
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M%+: &N!8OQ)8L;8%TUA?[Y^P;B4GR4M O+HWNY"21H53F8.+>$'ME_W>-=W
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M&S>W%6[I=U06$,2?'&@I 8&NAM"YI.+O)"EI<IZ $N8/U#3A7=3O$341W2-
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M0;:U<S.8MGAQ/@4^A;7?:./",;9=E$,T?<AKJELG"YK<&)^_LE.Y3>S,AV0
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MIM2$-,F)+>,?9=L'U?&!9E$X(FS$BNB'Q7K5NLJ5/DCS-NSNPC/NF9O<#'Q
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MY6&NP&A."FRAY[D4Q&2R^P=CZ0I?BF9R"J_Z<%>FV<9 98JI#EIQ@[[$Z,1
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M0Z/\%<JB))]/WZE9-8VX[9Z_[M1-X+!2?F8Z,Q -:.7J0*Q$D,-S#B_VZS[
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M61/WF_;FV%0P<SV[ %B0 5[['6B; P1'ZBL6[BG<5Z=68RA2>!58]?2-?DK
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ME[OY@X9QJ[GYZW'%D(1:UT8,$5FR.M8S;[J(!1$I'%_E2B##S?^QQS3Z?+\
M?)J_?E7P7$A]Z?Q%1F>%4\'!RB=-/WY9XT!5BI8C&'6_55)C+KT:4HDNPE]C
M/1/!>9T7OB(H3SKL?D'7W&ZU.IY<E]GO52FG7WB4@S<\O !0*]) ^+#TZW4?
M<+($S6_]7.&:3^@$I+G[YR#_E\K*2*TWG*^[!+F)AF ]8*P@',<$QW1,R-LB
M@"$K7)-W(<+T6@K9I44.)5N-0]H_#&O%9<A6VJGDG5^XL/](E*.5E?;9F"G;
MN0 <I%T KNJ<9T%?PJZ;:WSR&UXX-'D,LJ^OM\UZ8#W-I(KHI+T K'V$HHS@
MK/@EV;X@5M3WJ>=8)\[$C4<\5\6IKRT$I?U2BSA.C &SR1NZK!U2=U3!=IL.
M&U?@!Z(2*4"K@8[M\ZC+Z 6XGFSP_4 +^ND03LK!I+QN^N"Y.1);2_/(<IG-
MQ)Q=/V\[VK11@*G%NN8KM)LTZ#KN$3KQ8&]=-,J4)C)/FT>E%>32ZFU+SD+E
M&<>&?_?!2%W7Q(.!Y(]Q:% /\+-OK^A<XKI*60A.M%2)OV!#:-?WQX<_U>T4
M*>+"JXP1]X0'OSG!&76'A1\'/+<5\C,U3_&/56$PSF#8.$=.&D5<KM%4)R,5
MOF_5?Y-3ZN%5Q4G]JV.X\S$5\>3LS16Y/ >2ZIKF,W-*;AED5HZ[21Y[&Y]V
MBWQJLIGW'??+39;2\W\GO_[_:*3-<B%4GCL$\3[K4J]#LV0.%XNK?U+>6[UO
MU'M#?'G0'WV8R'4G(+9_0C<Q'<!+T2Q<RW\LO[6[%;"8T=Z26_R&6DML[\F0
M@,^;$ENAUT6;>#;-_9A:&=Z?O20RA*V;\B\>,@YDS.WB0Q?2JM>L)*DJ#"^I
M2W/L%2TT4HQ_/[;RN-:3-U C'_C!CQV,:CA/3/3:,\L5<O9H0EN&;+8%]KY,
M$'9Y^_*MW_L4<1:NJWZ#.(:[SMG0N52$RG+;(4/T>@6D+#[FLUQ& 6,#Z;)!
M<OP;T(M%-60^CF$+B9$'LSF9 KO>\]1.O_KY3=O9YB43/5S::E#R2 UW&Q93
M@Q6"(^C\%$^.1X98K;)6%M1>&%<_M!3*Z*TT0(OVQ5/#+=X(F.6:+@O<W:@C
M$0I+":P\U<4JH=C706\5;^PH7AEO$[![=?6MVR:<6&;I:W%.V@FLI#(ZG2GK
M2\N1UVM4_W?[HUQ4(B89BSX#[5*L$*%G*HL'.2='%'+T6/K><L61PWD2!SHU
M0;8T6-'PB KW$C]G9%[JU2S-/<;OT^R;MBQG2\@\X<D+ &$S8V^Y=<.CZ'<[
M:?%,IOR9;S :U:[6*:IN#YZ5=#P#D$CW!\GL@LCQ-^<@6F[A1GF,;8%O#MDH
M723I?U?/2W?!7POQ[(LE;:6'&QA^]I;AJ3D7A'!AUU'ZR('X\Q84LH_I]\?M
M6P*VS]4'/#^+2:XHN5VO?15ZKVC<>%L'1_L(PX[>[F[>PM:@G9]\?W52\(7=
M+& H1^CQK@<%G9+BR>E]2R[A])P_+^ !5"T[9;S\WW=B=/L9C'D2]:NT/ORC
MU.(_W-7)"5<!/,/1M) $&;EF@/_LABB.>1#3--L0[S^[EOBVS0!M8EK_>>^!
MSQ0N@R?'C7/O^!'F^/PC1.J,#T?1AMZ.$EFQ]F*;7%+CUN.U159!Y<%<08*K
M$"=LR4?(X^DK>^<EKU_^VDKE-6Y*M^;8_N:762J<(E^.G+XKWK(]K=<$#UU"
MECKP):X<3"5,&T_4'ZO_:0BP"-G8F%!A?/S?+]7Q=^UZ:X0&W.JJC%4S;T;4
MAF?(%&,GJA;>:QJ9\.I.&UA6K6SH'C/U03#S'K@12@IZL8J5VC; NA?O<DEA
MTXI+RT3>ZOA7(9CU>&]3NF^BQYRS:>--U%?3ZOPE.!U-?^#N+MY\Q7O'UWLX
M3["53\#Y<9>OG/.I)%:?8!&])^B]'!#OF"V=MW7=L))HXH/Z\S?9PU_A,DKF
ML]&@M;S+)*>@MR>.7CIT?D=:M6U-+U(6X0@!JK<<-Z"^N\)#^(68C!ZXKBV=
M>_L$[K>XYML0YF%05!R;\ D)GN+@3(:@WPO@F2 \%F",&#HP'%]O)>!2_6D*
MLICX(JQ1^!?.0P:F119C4G[$9S/6MY['.?^Y,$:X?O._/..KU$:GO$'=O*OX
MKN$ ]-GWK>)5ORE,Z(0$>(%&-V:U=PI\:U6^[GW7$XY?1"4B-R:W?.2?_Y*Q
M4E4#Q*@ ;G/G!5XZ (3M>VGF5M?S^P^ VN<)#7O.H[<L."TQ6@&]]Y[7BE\3
M4MC;^/Q479QTL,3^:="L\FYO,J5FD0!I2E+CBM)6]8,P.T>)I(_/E7YUN?TN
M9T]["* +P@3H$9??6UMOC3F5PU];/R/R*\-LHOOAD5[:FL(!+@KC%O(U8BQN
M)4(G/)KY,EX?=@TV%#V0'V0D\@,UR*[X5,.1V[UD6#FTEB%*>)AC9]9C,?W9
M:Y\:\Z/C:BDWHNF3/:WK1I(%WQAWAN/^//SL^K"?%<G"H&MJN?'J'TR2FD 9
M8@\'PD81-*#STPL,+M9KV0.[0KOY\33X[@L @P20"7YFC4V9[-F=>>*PZMAY
M[R>7D1_1TR"GF)2-^)&W;TIL$+POKZ1HR*RK?[A_GPY)-FZLCZY\BDJ/1\N9
M3,F3R2IF7#^N?+E[%A*GWJVN@.WWF'_F/IWW25"_XG7.&Y-Z7>W7?3-Q[W]*
M;U0ON!V*)4S'S*T=EVUP143T<5L")-KRRD"FMXNS ,ARCM\$'O_S/XN=$=M&
M+Y!M&WE5F>F/2SJ[N*FT!SBWRA@Y!T1ET[!7?+7^>=U8;LESPC]@HL$B;'N$
MYVQY5X +ZEO@M3L6;WO[&*2FR(![,05RZ@PV%?G>OY&Q(C[^"HT0>;H)#0P4
M!K;S0&DWO!C#A8881EWW(E1OHA<9CQ+W^=!XT= + .N=C'Y?8AVJW?LAE694
M@N]L2*C\C>?RN119=X&4\F JWV_RN2^&%52'?) WODE]^+T6@_L-ZI)E;$'6
MX(//N2!*99E61A;1&>V<"7>NLOYZ7YMPT%U<\"[LRU.=5SZ%'>["P.\[J\_^
M$U9!%-!+HL@WE:ASC'T#/(PYISMO,0?M>Z]O1(4J*WI> ,QG.F6\]GK+G&XX
M47A897((>(;2',/\L*-GKBL0 ZRN->K[L5GXV6WN%N$$ YH="X-=%>LRYFE<
M67PME9UC[MK>I*E^VNJ2'RT5X!71X$/'!Z[<&L$M:V%?BV^S7\__(O/T^%8I
M^M9-%8%*MHVWAE)V\.E[]9M:UUC^ "V@W4(=#W[D$6-3\$PS,"86-[J'O$G(
ME-:'VWNF4)0>;-X7(5+6%YL?:\E0']#^X(Q*I=6M"Y!''+8'YMC)2L/$EZM]
M=&RZF_J(VZ\X.JJ;C*<DT!#EB:=(11Z28Z%XVL.H4[^9FS'W/HLF90(MYN&,
M>ZK57%Y%%+DT/=BFT*-7=P//8<%Q]M 8453-QFK=[_TIM!D2&F<U_LDK^^LM
MNC"YI;Z)\(>J"$J:)[,%04N@NL'>_. ;I@ZG4M&;;9VIMQ#\AG^HES"2"WY-
M>(K!3XKA(OG!$!ZNS$#N/ZY!(TS$R.1?:[/#0+H.?FP38C;&51Z,Y-0H:V]^
MU3)$B:5"FV,K=#54\TK;I)+1_/8Y:NQQ96P&R$D%<%[D="=*8S7>%!@,\02%
MG<1N1HL69ER_": ;-J#6:0>B]$#SB0BF1+3X(0(6X6+[9:J!>85I53282(&!
M[0^]UO>3Z^S/PDRF[N8M.#LR3O32'I$D3S6J!.JCLO$4V<A5RA]AC[#Q9?Q-
M=*I,=(T[O\Y][27KRQ[1/Q7+=NP;C)&6DNC>ADMU*3TE;'#;V89$P?/<"X =
M32R00]Z>--J^Q&)Q\4](-6]+?-%",&YN24&XY;P%:@^+N   5F9[3\EB^-NF
MKPF[TQ>N4RO$^^#%".*@;H]9EC<=2-W&E:6R5ZTX/C/!)09?[H<4H)D1:K%X
M06PZE!D[HNN<O=>X+!<7CB/UJX88:GI9I2EHBU.%1=7%S=N(32.?OC/NY8+!
M'QTF8@5H$HYUHD" !EC8_=6/8//>US>5>W,&NKQ/9P<ZN3KM1*.A5^5M?=</
MM'HS] >WDE+,>B9)L.75;NOV_8<<.';T+;_4+M/,QE;#[CN45+Y(R1.=<(+2
M_NDT"^N_,#5H29UH,%UHKN,E\J(W'\ND[75D[4X;MRMW/Y\]V5V':EO27>:)
M08&Q4>ZQ?3.T^S;(KI,>IX J@<?+/[=KA'NZW8QXX);M+,C#O1:#+<)3,.GC
MV0;[W;\JVG7(A^2@+5L*""+,M"VP#)ONO!@OAN]#U:HY4CF$*^V,(SH<L.MH
M36@<B*'!+8KF%5JQ1/&\UBH-5TGU>.?IJ$)D5XY<W_N@.Y7OMS3N.BP^6@6M
MI>CR7@#JO=)_K@I@G*T3S;=+_$$XQEB,+?I=WMT,1%!(6<-RT_M?3Y-P^Z U
MH6NP=*@=S0(I$N.#/O);H&3EMR&*??62!#[3/@/""I/%LP\8RZ97?F@8RY#/
M?'"D'!^R V=LT'A6J2R8DTDPT]!/@;%YCL$:)8&LV]":Q/TB-#VBJ6]9SB)#
M)6]R\.D7C<T4Q'W@TJL\E@#C6@*:QAUW'#)\9\#7Z[/7A4WN)&O4;[L)C,^0
M]8&Q0JLQ)R#J!VFHD=Z:'[-T=+S-#R;6*O9^NX,%_48&% 6P(0CG?$9LT3,I
M*5\]MW2E'/LYGT]BAN\<RO6FCVN? A$<9Z $QRP5E4?K6IV>BZ"U'#::T(;#
MQ)EQ;,=MR]NA"LWO:4ZRFP=T3$]U\!21:#), DH@YLY^!]/R+I.L#=FO52T[
MO@B_KQ3NX/P\!K11S1KTQ@(VH]?8Q<W347R$=NAL;<-^VGC.DHVPA%OV!GN-
M%J!]HN10)TLU%OKEP#R%3X$/7R&^"!H5HMJJZG$)BHKK3TZ?']SII;FJ=^UY
M_^X7KSJ9_'G0>N>!TID*[NFD_".D&YU3W<Z""\[SJ[<,A8V-9^_M8]@'T%JM
MOWRR'XE:UOS;"C>'KGLR9-N*:4>S?:M8(5#_=3MK%]3D "?=(LFH:MV3SX>A
MS9]HXB\ 3=55Z-ZU45AO)^U.'?MB@#5K:V"KQI#,H.5)KNF[LHB-Y=_V8<%K
M/_E@?2RO!JJD>V@#U I&@WI!3 =!]!#OJ1/G#96(7PYK[VJZ5)9G.@AV<6@9
MY-JTO)NS+1K>?:/A9Y:5?695Q.\1L0%&S[PTE'9;G=EP!K%R";N0<5C6J=H:
M,XX!BF#N2:2!A<OK [[7C[RFFYDO,!(*JQ')^5U19A3O%#10--6"6;+HS?PN
MCTAW3Q<>HQA5+/7=!YWQ83.0S'VM@8_ZN8#I(G?[9QPG?]'%W@KU(+<2ML=3
MB);A^%%-?>00/A2R=^;!BSE9\^S_@[3W#&HJ^MI'HR!50*4C$!60+B"]1D1
M1$"*= @(2 <1Z24" DH5$%!:4 2D!J2$'CH"(M)[24*1$D@H(9(0;GQG[LQO
MWON^\[]S[X>33SES]MEK/7L]S]EKKR4W\/-Z!\OGZFR4+HG=M[<%'@]]1/!'
MNHS?$3(1RK,9B*;;.D!U&.(4$QI6>(*C-_OX;W3(+MD-;QCJ@<).7Y7W_LJ4
MYS*9L=-#[D(3_&V7-I03U_2LM!5]38^*R/2P$'G$;FF5'O=\]S3:?;0)!H4\
M1\QW;*[&8_2JW L$.@+'&_@,8J=1AERQQ@-HV_A.J078$X(0MGL3N1MJ.U$U
M]/"+90)Z0V"Z3;&7+)3;RW^W!><0B_;,A2FM';  D=H>YP ,VSI_?'8\=KM#
MBCNU0$RT/+T-_(,((C,$$16V#G0]<<.=TSN2C5\27*2C8B]0L?9#VL%,:Y^Z
M'$G"$BHS$RH@$MNM]0Y:Q2X$AYOL2N^S5X<OV^FHHD-X&?[6F337IY_:Y*O0
MQ"VMB++F90*M-_M4_*O7F5(;L"?T^>L?11UJ%S2)L):ME^QBFV*1MB?%MA?U
M_K"P75*>_\42'F4@OBEP0YW9,U^\?G1<3/E14M%:),7+NF[#A;N7?,7:9GF=
MSP&-XLB5>0YCVH$55D,6\2I5X+=;[8SX9V>-/N< UU'ZI3]/MC)LKW][[/Q
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MOJ]@^F4)E\Q(-YJNZS7,?VRF7O #WR3UQM_R.?NAU]A\L?;W+:=C13)]$5(
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M$DC FPLM ,X\&C-*Y]Q"[3I22[6_,[J9*\V,W>NLH+Z\Q_;UF,?@\\.NKB+
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MJ(!GVPQ7ZT,_?$^/:;Y^;\\/G [A!:UFG ,:4KMAK,.?_P"9 D!7NC:N\FU
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M@A%/<\UP/@G6;K!JLONU(9DW28HG][CZ(B/$:#Y9Q5-5A8)V8;@)2P(+[N5
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M-"J!L%0@_L99_3G N5W7&+?2#7O[\G'-C8"$A\X?%%BX%F>K!Y!03!_:=UX
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M0&-JXEXUB18](DUXYPQRRZ+/O3GZC='2--$2'F$\)77RM+K4OYP\!*X%]B(
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M\6%UZ?\I*6;?_,BF']YA=L/;:;#\@RS;A>PJ0*";6>J'XXVLLBT+C8ATC1
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MY@MU?<$4SB(VOBGA-TP\R?V4X(%WN\C.F65U:T>V@ *B Q%]\<K8[?F]B$=
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M@'L91CT0*G,"UD(&Q&Z5C%HF\AE)7 (%E*&:#Y\NHX X 2H4D#/D@'^LC42
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M'EA%<$KR!EI4X(-F-UGLU=XZNYVI[$^=DU34[7(8CB2N?D_W/,3S=-T.O<Z
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M\]W%UZ8+T0'QE^SP],5- ]4*TIS7:Y7YE\#XL].1L,-$."GB%EX^SQ=R.<6
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M/RK%#) ?$5P]"U[[LNQPO'9SZX=XP+3EQU:PSQ'PG]DLP,NJO]GI 5Y0RZK
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M5-%K,MR^B%]NB).H8F#A_8H-+=#<U(ZCIM4N2GRB5O ,X"8RR=4)C9PC+S-
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M2M439!=B>T=ASJZ#T4>\3C*HT9M1Z&?L]X<!^/?,S <5=QXR1&\,]/_)ZG.
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MW9V8&_7@:0F_U_%12,!C#_QUY@J ,@/-/5['A!7MPNK$?HF(0E_\^'F[QR_
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M$:V)@=\J,?H'MK\18W8!4Q,D_<7OC;?7\#T"2WY@#0JG2JZ7068>T3+\1_;
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MV$($9A %WA]8>V<95.93ID6Y8!%/+AJJZC<L':OSQM/0JK9"=#2]W7:%(=B
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M.#]JC=4K#GZ!@G<-+NPI:'4AG>L!;[8%0%$!H/VE-3";'DX3Z]B12;8QS=Z
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M<.YIO>S($A-8>%N5X1OQ[D2'9#QV&[.!@(_C^-TW9&XZ; VO;SY7,)TW\72
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MD=R26W"O>M9$;*C(3"L4.D9] %I3\OQ.CJV.8IQYW[Z7Z:;V&68H9G\5FD!
MO[O\5!:(\KLIX3E^ZOSUA6T'%&Y.]@^7 B85$=E)#Y+/ :O9E6B1'Z)[;T2
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M6@@R!UKO%(D4M91D)TA/GO"H'&#\(NX_EI)5S#-Y4ZHK%V!@F;,FHK=0X:-
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M2J,GK2+C7N]Y2=_26Q6TA)O>.+9ZR@//@CTG^]@/WY S(.3M5G[]0*9ES@S
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MRNTE_R@Z"UU?'%[Z>JQ0)J+976Z7OF[SJK375IXKCM68^!EJ>O8F#D>X\!)
M"EVUN* %45\"8/(>EX#>Z7L*SS?'TS=']5UGMC7[*>/?*_6!J!&7 %WRX4L
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M%U<EO$X SR+5"^$A7K+!^V"SD=:N$D*6CP44BG[/*"R'U1F0Z#42*].ON';
MZB&95K"ZW"/I-*+Q<E_U]#/L,]#)4\EP$H[(5)7X,ETM$N5?M,:0/F!:5S\^
M-_ZP[$MA3<?8I6*51JWPP9]2L4"GK^'WP^>#H/7FW5#6A7:3->40Y_+O3C%I
M3WDW'?(;[Q]\Q%& =0@)C4,-WOP>F)#X=X;Q+PM?"-P9\W.?P[/*;+A$ )V/
MEDCVC5U5W-UOWC7'0P<S/,FWWT(N(!$F<I&5GC3:F N(%A3WBJ0*\1Q?X@QS
M5G><LLVR5HK>9;OR: ]SLO\*=9^HK&U0GA\OVE]J65]#Z3$MW$=N#\)20VY\
MO/JAU@)KYZ:\-&KVPTTH1A=1N_50<>Z8:[U#6A;(-/_+?;_GQX^;Y$I.3?UT
MN?D=XD@#K)!QWUI]-&/=^_65_&7SY8D"WGK6,2X8]'NE@GECZJ>1G9L3^AOE
MA0E_4G64*-E8$\1L# Q)FT="5%1O7<GH.%2MTJ9D$Y!VAIXJU"KE!H>1?P+O
M72VJ6'++2E^SC2B/_\ 98MH?.J3WN[_^CSJ1D1'[M]P-RBC1><FZ]5YI\?CJ
MMX>_N>]O0 ?@ B$GL$H(HF:-_Z!3BCAE/LM]/\'+V_-5BTA3NECV)3EZQHD#
M>W'S.83;S<DGV&4PH?$"G@?QVOW#I59[H;M?@N+ >#5S=OU;R2>"Y/2:NQPF
M*3@KX*',?*[YWNF^$ E!,&#%<;K$,2N#?CCGKB?=ZE)PAD!3*R6^ZC=/;Y0Z
MDH>K+O7XZP 0\1#^R8 <--4OP A!Q'(?)2ES(,63[YLTH%I"K4><R9">O6_U
M@EN*MWFO^01.'XV(35;$_W3?O@Y$+$(7]#@/T"&>I]-K>/%\+ D"71[$2\TJ
MTX&AE&!/CZO-/R&%.OZ@WX7-7S?N_76L@'1KG@,\-^&Y HL>?;^BC"L+U\-
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MA)Z_:HB47K(W=Z+Z5C.%%'EZ2*@AEM.V&%8.*PV_3NQ*!\%[6< NA(QVDW,
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M@\AKV)+Z?L,%^2P,A;3HMF[VG-H=)RCJM"G\*JJYNXND<QW,\RLG&Y'Y#$A
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M%H=&X2L!]#@N@ ]O$!]-[?;Z*9[%'_$DG[T1PH.-N<?PI'3O8V)F4GW&F&B
MBP%]:4=! _IJQ5"8-<(^28">>,/JXSF #/1C\&DS0\.HF^3/L9)7H9'#=FJ_
MM$+P?=@_J*H!DB4U@'#/@WK7(:F2-U#?FR<D5B+RS*1;!L)-QQ[DG.T- AN)
M<67$83WTF,;7L0]E'SRGH\B$V?:>3>_\R=!BGA5Z=&+/"P[$/D#]6 M*#1?<
M:35<!N!LEH+Q5<EH^P-IE!32/O*>GG@7G.TXSS@P^A*=Y:D<Y!;6$:-.R%>V
M)\DYV6P ,![*@;<,DTS(R:R@+'[_BH+%'(#L$, 47?C:6> 94.Q'?9#(LYG1
MS%GF#S=B%^\]$"T-F6DU+-#1.!S.NA;@H<0KA6=128.[P=CO;@HTK?X.N=)1
M=<RT49J'RGB*BIEI'K#579W2=B+L9[/LV\)MN/%;I*[%&_?P+V?UB_?_I/EO
MRP2L9.2<P8BT3< -GGLJZ5<%G%YN-\NB&_[>[.E#%*_H9JMD8 (FPVE=B70@
M52KWIE,K@T6+[*:/(4>',I&V?[ZE]8F\BXJ>4ZG:A&"%LS9PLC^*T@@P*='F
M&\UP1 F\H;8*1;4N.X$-1)06!-$PM];1,_H.W)*6]JI^;L9B5B*F&E<'6L-D
M8^E0N^< G QI:]@;DN^"+SFV?EV$O+-"B0ZF1L/9+(M0''T,2J;4:HXN<OLA
M@; XH!,<*]IX#CA@6(]&NV!2T)0_"3\^[<^B;&\-797[F\VGQ/WS'.#&M#"%
MI-H70G,/#D(N>0?0''\HD_)_1N%T0R;BSJ<<=A%]N#B5F6FY0FW<+]'!<\";
M57H44Z^G_D;_JFC3E-GC^Q;\;G+I_:!NV.C8O-+&:2^,@3AC=PW-D:PJ8M7]
M0JZ<>W$7L_GNQ2+\50XN%0GKA=,3)Z'UKZR@29XVNCFW]$>N*\<KEXC".L(#
MB/WV7\Q[80G0!N<VA&>XH.?M1B%>EV]4Y*XJ,N8/F9.#N9 >>N/);5"8*@O:
M.Q;O62KU1EF\LC_,[=JZI.?238\,PB=96-0B[+53W(89S-NS%!&<;B#7/3=W
MN:F3'2P[3F3%ZC)1_7II_(,U<_'K-GDC>(4D:*\L!O<)KWHC?]8N,\*E:V^U
M3H\?%8GNUXZ!L32E>($)/!4?K%M%DZZ#5W\_W7JDW9LHZ2/>G 4J5+_]^Q9C
M<<Y?#R+-57;@"Q[O>\..E38.*:$),%*W]PD5 ?91_(!4-53C<.K3Z;=TSN:+
MFA8PJR56O6]?HJ1[=>\6;H5F)P'=F1;. >O$PE<0;K#YI.Q2">"]9*U<LXK2
M4R(-H5B5 J_5(F=W&5M4O.L?'<U0C7LO\*U3G) -1^28GP.XE>6A;! W)N85
M^]V02,DTFYC,VRY;3_B5N <),/BS#GN,WB3KQOTN >85*Y%$<5MU@,7,L!=V
M^)>XANZ5B4.G7?WBVB:@MOJE@KKN7Q[OT.:#3*]7J6?74=L)[<%E\VO+40Z-
M^2^5(GS?2N_9&9 4[%]")0\F$WO?,ZQR/<#:'%0K3/'VX3/_C%U_>RX2K'.0
M#-BS7U3JJ5A_U[_?=/CFV[SX![6A>PF%L]+&SG +XY(?J1- #N(4' "F5+0&
M#2)KT\IT!"G-MC;<!).B)VM!K!NGW?#XWPU )N(UM]9Z\6<QN4MU9^8C M1
MQ/N<^WW>9#MG:X,&;';N(4GCU= =HZH#XT_E5"D#G7[8-=2(S05A($Z<Z1WU
M0EEL)3/*EU/EEEX;Y&@\Z,*,!AHPZ3U7R;F39Y62W0"T9+(C&W3<4QO>]Q#M
MYF[SR.>8.GF^^;?)2'OAY"8-,:"2+_.#@?Z[[=FR_4UDX$-8XVLGR9^B9/4V
M8RGA,F!QK M'WL81G]N9\=G*2%,=T"TU$6-/3F3:)2J^396;'2V.MV[A)&T0
M_I3P4949KW51D@ZL/JT<BK[?E^W8^WE%4<N=5Q&@:1Y%55!SYWA%(VC<(AZG
MD@H_!B[185Z@)4OX4PO KN.'M26>=0\8)FX?_)*'J==/5Y^(^]Y[/7+SV3LG
MY>>=HMB+^L%I*-6/B+^-1]&MHP/0VH5'3E_2J4UI,CYMBZ[6D>0$TBB0BD0?
MEN 4\:;3U[].OY2\KM&:8SOV9H#Z%U7(W(*8QM=C:<P7/07^%I+@BF$74*<]
M:_5S\>UBP1MMXK;.>WJ@C<]N;]XM"48 COK!<Z0WIF+C</>QUCVG!VBE_E;V
MSC+_\N?4C6K51U^9 <ME%?VA0#P[#\861974R;2WQM%(3^@<Z"^-25++ZR6O
M#=O;/L**S.T_1M5O0%Z7HE,3A2^',NC12VQ>_AG^;/HL88F*$R>WD"+IG_?H
M?U#WGD%-1U^[: "E"@B"TD%1BC1!>HNH@(!TZ24JTCL(! @)B(!T 0&E5Q$I
MD=X)'10ITCN$*CVAA& *)_SO^^&<.>=^>>?,W+D??L-,,K^P]]JK/&OOO9Z5
M]"\8>0'8X[>[\=?P4=K8M8+Y/!/^&3(SGYZL. "85:?['W=NY,F = OD,]*@
M"CU.7AG:JR,'9^V-;I"-\F"7X7XB^-6I$%WP(Z%OQ*L@1OC#Y:GA T9+U6RG
M@E!%QD@>H3J49T+M!8!Y<;XVVE/ AE]>#&2_H)>!B*HXI;;CTZ4=8#D%A+HB
MS8?OFHYH4+8/8A56?RJ[HX[HZB/L'N2%/3Z;D[0VF6[U-PABO/+RZNY?):.Q
MD2NC-FP6_NV!12J!Y0RA_YUJ&SZH=+B7T4,==8 +UA;9/O;:%R^#R/'>ML[)
M5%+SCPC^*/+]/)QB=RK_P-K_EA<P6XS/0-CY_]1-SG2"O D8IUCT#Q2^D3'Y
MXS=2?\W&/C!]G^K[R-5DYQVH9C?384:CR$!T&R-O".YW^>R"LZ8V"W-13D',
M@167Y^K_DE->67$D_>%Y@O.%7$>;[;/B),&%R%OO\(^DAS3-:V?=P0'0O?!<
M)-_T6O]> $E-J@G?ZV!S!5T2M\ /#?Z4*RN55XSO6L:7'E7V&&UM\&V)Q<7]
MFSX4WFMD4]$OEO[<\^;A*TT%F?DGK(K2YT9-_2 ZVDF6S+K$=Y=4BC#>5BL4
M8N4NB*%5+O@N#=RR*@>L97K5?.W*=77H:[ @D3869XE5O #H,F$W[,/UG#KB
MNK2$/@.X&@3)$9X(9T38<@U\7\?;$\GXP5:H6JY>K5#GB>CS7_KNQ6&'H-L0
MJPM .*2='5QB&^+99:LXX7X;W)' ">:GU=^RF7'YQ$'8[HPOL?752W\2>GE(
M3W5M1U%FL1O_"A5R\"UAI4>,0QX3YSLM<XK8(QG(U41""E%UAA1_/\@,0'A6
M-5[43<'5 OC6^)T.0>F\)'W#,]5@J@BY%:?+W'-@![I#VNWDQ)J%_H#VU:<J
MC&G? ^'IE]TYYKM^\UJBVO/=<.WZ4L/J?,0[S;:<-#;!S5R[K+&%$L'&_R)0
MZ3V' .SFV+P1"A:][\?F:1Q26W^8ZG?*VL1_ZU7<&S\^/_C ,I;/?:OGD!U<
M\&^W-T=Z<F[D:>.S\K>DR#/I=I]!@<ML]Z,!E39:\D7;IW//_#WD_>;:IG^Q
M$:^.R-N;\H0,P]0IN,MR,*::.F8!EY4>;/_% D-YR>1FI2;H_Q*O,U$TIDQ3
MOO.,P?VD)=J,IXR3"5]VGD?X"A7>0; 195QSY*:][J5MKU)X,##-,*3B2+*Y
M"L6.K\+"$%4>=:LDB0['!M];O]GXT%U X4D9-!5_MK P" N4+?22TY(>X@_?
MZ0=.M8<+%?]J:LE5R9S<A+1],/,5#R*;2XOHCO3[RW@GYFR]R1#Y>.RR:X8:
M\#^6+K20QU4J6"]4$&O-[/Z74EF<(CS'&?+3!! 7MINDI2ZLK<V#FON4>]_.
MA#9YV$?E*J#A?G?X>,*G'2&]F\P^=94"D\.G5Z[9\4Y]NF5ZU$!>4L+2T<-A
MM)[PJ6"L4>BGTH'0W?BVL+68M#G,KGZ+SB#[;V,-G\JB\-RN KTOA4[#.PK9
M^W]2#35399HP\+T:THSK",47 $<XK43XH1^;GP[UIW*OQ=GR#H;PPY2Y-JH^
M7I07HC\>U&VF:!8)42K>;I"C"?-S+U1C!^63T.F.Z'<&Y'S<6''V2JB-IL=>
M**3_U1R08[/L7=?@DK=E-@M:_IN2+48Q-P[(T7X'XH-V(TI@(^!:@8%*R;8:
M;F198>]T?1+R?Q0QU?HFG&A6 2%LC1X/@CF2IY:"!\.<KSP_DNSZ+JY5F:4B
M-!91X&A:9SG>VB=)&_"@HS^(;&#Q]B)A5,0,A+H5#Q%V2;?E1RUN%!F]+$HW
M'6%[&<@F2@DN__BKV^>MBE"\N8G'[R]&&S_RDLGEE-<Y;+[#6\)W#[747UBZ
M#'V1GS-UDDWUV5E(2BPF,X%J<B;Z"!7F6LKY<UA94SL:T852 2W5[5<ESQB7
M1JS'I,OBPWQ"G$?GK1>'T](^LG/_N_].S]F5RO^F'H8I5>LH^CR8XW%^$6W3
MKYB9:2@/=J0+D^02M!4E4?'R$_% I\PLWBH.90YPY6/6V\_C2#5BSHEKT#,L
M*AJER'%V8MM7=W75_OU33^J5.OL6BZGWEOM?I^2Z&9)JGQ=HUYB1-.G]1$Z$
M_*PU29GN'50;N;NP&*K+!+L(X$C^4%OBR\S7\DK2)Y+_RZX;_TT*GSC'&$LM
MFN/W+X_CUNI>V'QAY3!P/&$BN<1@;.YW"#<)#3@O@7%/Y9NJQU?>#HPH64VU
M&Z 3\5P_<?I.1.$):?"C6== 42UB9#;KP"D&7@A<R:B7F\O%,WM:5HWO+3DO
MZX;>];[]&FKZ]RI4&J)!R%5]J+/6]MH<RK'K5E&Z\(!?)Y-*J@''>N0A?=]!
M"M,V4E*PVRVBE[.US(N^T;"O32F;"#N1)N&3\Y'5Z?U]- 7F+Z&R57 -SF.W
MS_^BWN"Y&O3@T5_7K5RL(SP>=O*\#H%GU27E]V86J!O(6ST(6KP'JH+DW2",
MWRV?^GT.3=[L>F%-L'@$?QW)>U6O05K,-VINK41[K"UQ%H$59=SG7 6%+Z-T
M#QFPQMV6*58++LVB>F_B/CYCV GR!;WS5[T_5;L(!F?T_7O3IO5[$/@YP$-0
MQ3?G%$?R4%<AA,Q6'70*D:8%.<*,M=(/+FN3T(BXXM3DQLZ= +@RC11/1,'[
M,\YB5E'^\<C@;0G[QB-3@3HON3>)^B['U3^12W<*<OW]'%1GD;<'3DV!_E!:
M5T^<":R3UX,D >[?#6/;<W[-7^ZROWS\;%%/%TJ'_=4K#;OE8@E1+@H8RZ/X
MP>!Z%J4Q5DB((L6ACVXY"DTQX\:3;W'^R4-%G&>L24%>(4IF*\NQ,L!]WANV
MRZE4(VUISQ/ C@+-#VY:1*ASQU6E@&:K?*!H' +')P7',XV;W'] 7]&N=H@K
M=46#D/#("H@-[KDYV!2C/+^,#5OU4XV8(P6L-[PI1.JMLLCS&G?W. QAH@Z;
MOP)GU5P!S3%/]QHC?MI5MI;W_V"8^!'?SVTD;&TRGV9Q!?J3A,*MB'R[P!I'
M_(TGW<!K$#)^BXJE3 =;)U5;"L6/SSK7.? JXQ"=RFW+!2C_^"E[8:L6I"?I
MS>WPH"T%^"(C5E@N[ #H2D)HMF%KGE$#Z6?U02$YV(K,X&^#-6_$GZV8K5)&
MHPK[+4<^(%'9B5&>2P=6*<P2L[Q*U4'H?7WQC00!E^J)\CX96\K<&L?#Z3TD
MNL862\H=KT1/>$">B";KEYCW>FX^\[$ZD^*:1B9VP6GGL&N8S'&(7!"%9@A<
MV8ABG#V(L(:51'$:8R_/F9);QOP:?RVZ*+H9#W'F&)Q+D3-N@<)Y&2 @QQ7&
M.4U]-#0/Y[XGTY^F89@C)X>=DA>\&O<-6?]UYO,D\5<4T/<?VR6;I!WC!]BM
M"\!+& .> RN)!CY'!>N4S'VIK'P)>6"@QGN;ZJ,W*.OP D YA'=J:G5M KJ"
M:-EG8]FA_:JK6J?#KONP^4P#; 7ZF$B3FX^=Q[Q&[V]4%KO:.QP2TKVNA %$
M.\)21LU6$TIP%L2E.;T2@11@[P6 K1RM;?+G2R>;/''?>ZS8U&1]MG5!V![M
M1!B^5*?7<$[BX')U22R4 0_&[A9@OTY9B926]S ]4_[!YU6X)=@$'[H 8._!
MH]SP<B13T*W_(UWRY$K0/S<A>>4ZO^5JQKU"G"TDD/ 9KX:>7S/;-UG3)1_[
M_>S'?.8G\K='7T+O/&*4[V?=1* T9L: 6*&I]&L<Z_\24ROZKBX.R_U\URW(
M.A]:*/^]HCVNJ]A\(I]>,3L SY6+WNIM%R24O!TAT_PVPI/K612*V;U-:V'^
M<H7+C 3&.MGQ)F5@7\PHJC8(FB_MZOM=XY[Y.M^#SAVRS99EK+S96UB]-0/4
M0='W] ( ,4LGO7&;'+Z?BQ2FU!'__ME(_J_SAG2A,;W,75\'O[MEQC5UB26P
ME2TENF<7 &=>.IMR6AY/VL>_!QYHW0N:1&!E]9&>D1!C=%D/C^*T^YA6+=4[
M)_8H6BURTJJ&9QT!G?1IGO4<(]D>[I^YI.,Y]=$U73Q7L,>E>."TA.G#59J\
MR(="'6[7 W]BRCI=WY5N^!;R_D+79AZI7A9MUD-'H9+8:9R9ZY_=H(DC*^>
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MD;O2<\11Q<DLV;4QB=^)H^^D%,U^P5#/$F?T^C&_"7EN;_5OJH7PI-)/P)S
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MC^MOTA1JT^55>6+65V\M(P03VVRS28H4V)"SC'']XI#P"%:W<0&P+.(IF6J
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M52E,8L&]AX<: W^/L/NK2@]FQ"1>]JG:R.&6_74!&/@\/W?>\RR959Z=)Y5
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MAWSJERJ0WHK25;N8@KW?+J^*'SNW)4X>8B5&HI25BH@](#IX;1OYV)RSQ(=
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M/WR1E(+?V@;ES,4N@6MZ'^H7S R,+]NTJ),?]?LR \I7S6_[=7;VT=N@B%7
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M>XAO^KYSPE(&6^1_V9=P_W+/E"_<L&21MO]*T'0E<6R9JDZ?9D=B383ZQ<S
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M<FP7?DSG0\P*:3XH;T.Z07:?JW=\5=*4G:\]71C6/CFXVM/[YHML1Z5<44\
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MZ"['LU\_ M,&#=*_>Q5WDWC5 #']'5#R1Z/(&!YA5-[@<<.;OZ2T(-7@C7'
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MK*UYWWP#BO] #U3R8PU7-)6XL3OZ:!,,@\231Q6V9IVR-U9@!5ZKAYF.,V<
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M10P<8PZM@?4U<\BTPI8+:TO9/_1L&3\5.#B!3':.=D\&9-N(L;S-K=4X,D<
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M<=6 D]K9VQC]EC!!V*QB_#WT6K[6%Z<3):NA%W/OJC8B#\"%4)0>#"N2V'U
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M$4 ,D'4&@K73%HX6O9>$76JZR!I!@8D-_I9IX74$$@V[]#IL90MZ+CP6O17
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M'H7)Z9>:%3Q<)^,8S>=8FG(6;ZB)O]U4-"X2==\]15!.+B^37R[)LC\T#0N
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MN'Z\*NY_\H^RCRV"P /&HS*YK1_$VLZ"]W==OXD,H>SKCT#-QX>^@'?8JXY
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M'C+DP9TD][?;J*ED>T6IPR]@K'4\_O(44^I>-7;@\/8LYA;D3T#(D8J(?[I
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MSC:UNDH =1$U-WC3A)1"O*_+C3@GR].P8+8V\ZTRV*QO)"S/,&=98B2DZ++
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M9-"%BT81$*2(@'2B@M*;B!2!J(@(*$T!I45!I82.%#$D*E5:1)K4*+U'>I6
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MP49I.3;'KE4_>Y*/?BS,<44I;]WX]3/Z$-^GM8+Y-7T)O^:PQI\T+_NX+<P
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MT_NKW3I)AD_>Y5.XB['A'[3/P3#-C"3Z.M$^Z'1\+;G0 XW^^CD.58C:#%]
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MCFK(A;8553SA!,# 2TVD_95K),+PBJ!]"6?DL:$(-"FH#V?>G__;[:U()O$
MU6],4J/ZPSHM,LH+>H/IVL"*RB;]S3&5LDMW*03'SD3G,&B?*_D$<-MJ%V]E
M_VW<9ZJSCFJ+['OH.@6SU]^"J+:W<NO6KS+W2FA7Y_QD?$TJ.0&TIR[2ZE/)
MKOXW"I2Q3FI!+X!C712N F8ZKMA">6:O<W[\_A>^F9.XOV!V6PQA=11/.TO'
M5,DFDB0SE<7D!+#6+;,^[>\ 1HX:9R"##),G+T?Q=[NN#F/0-^'S*^9T?'HI
MPE- QF2T@ YQD/WO#P14CE G .8;/N3+3E^!>]QU= N&V/*+OHJ(5.STEKX
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M0" P?BTG@!%!NH"^P]L7KZ_IZNZW,KCRZS<EO>62U)H,9$$UY!4IFQ#UZP3
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M_HKANT+]FH3]%QLR6U+GU98RU;%-\<0?>!Y123PD(,[, ODHXFOVG7'MF<W
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M8JY/R8:VU*AL=EV=,W-*0<B=+T;,FA8C7A/.'7./!4D:!&<]'<+V.80@Q8*
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M-=8?.FL_^?SXZ<N7D;Z\2)F5>CKFF/L"_A/DOA[<K9:; T/& /04,2&OT;%
MS"HSL8(4WPG'5OZ/"/?6ZJ$].E8!L[1-+8&).]+";YT J,*C.Y['*QV!HDQ^
MN(=[ P;"])5UQ-+'@:QLF OKJ_BW81R_8SD.KT170LM20'"5MH+77A?8N"AZ
MN4$X?#S1ARY]%4A7M@L79UQV%]Q+*%#:TT@;J:DOH,1WI./RL"L*?_"*GXF%
MV?/F8L\E5KMFM*O)Q?0!*H(-7_,(#<S?:CL!G,T;J#W4B!NAS-9++$V!0Z-"
MHVN&NVQ8J?21#/:&.Z$O4FY22Z9:CN6J*S&S$S_B<A"RJDK,R,ZZO4"#,F"*
M&$JN<*O<)G\#3A&6(>LA@D'E1K7SEQ<\:E 1KOQO9U]KEN;0?"E_IV?/]79[
MC F+QX(]ZM4[8,-T.3L"K )'W^A%LE&$/V(FJW"Z$K'/V-YZGM+B=*$\L3#C
M3%#Z,+!?V.U<\"+].#ESQ+M=,KN6](JL"HR!G1NGN $_=7Q9T_6W>ONN::9-
MZYVE@%S61 ]1*8/V,/1<+$D-U0AZ#IX<_J7QKQ3$WJ)JIW54,0(G<E4N]88^
M[.$/D>*%4NOE,?D6T.[,"6!?S'9">JA87?SO0]NK!M'/V&/AU5O+.I\;0C1/
M "T=\%?PRD]=6W0S=!BG2>*43P#Z8JC%Q\:+%A67\!X+_52B#%F.FG[[!! 6
MA%<%[OV+@.N+!*CO*!<@K"\9SCJ^:O1G!V?"\5[8.#*_%?<)X(X ?)\1-5#!
M+#&$IO_%_"+6>,O!L=_V/IAZ"M+=JGKP=:H>Y_"%R+&Z9X9^8^$1^9[66==/
MV5/);^'G3<&ZO[&./@'T*X-]8\R.&V%Z[0,FOOV;$-K9P0__TH&0KL$W#.B4
M_;X^V"@S<0](X2KX[W5).CU.D092!:X&W6Q/_(WJEZ[%"1R.)&]GW6 +[H"Y
MPEO[&&A*S/?HPOAK1A<MRHHJ00.N@E-/ 'B?6USDRTX.M<3<?]?G6/H.(M))
MOSL6<OI7>6%K)2< WA/ [].KM'K!01&UDG[>O>^V;"> 7C&P3X3W<=E/1-BW
MK'*P\C'^!/#1.!K>J@[C6*6%-/X+:X>R!*>/]X/Q!J=. (++)+IKV-O6[KD<
M"WSZ?3S>,H*^I4V+2;P!O?POG'T"Z+E1O7 ",-T$KAQ0.O\H>9X =N@]'$ZF
M"#N> "0'Q^%;6@Z46?37;J/-9!"._M%_0]W*.*;R-:W-XU"Z70> EB]F,IX
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M@7%GLGXT;#!3M9_*1B?!&MBY[50J:T825R PTP(]EM&(_ G".RL *^:B?4X
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M^+V:J:]#%[7:@'H*K\R,[\@^M2LN)H%']?>3I']PDHT"U+]2Z&*[O%,#7FI
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MF<[,-V*O% F&G'U$7!^R-KS*C&OKB4\H&E@X)>.M \@ X;]H-X5F)2-B[*7
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MAE$M9.<  &3$U-#38/URAS=#(A%TL_\:N56:?@WEG!>(CCT 7!$\/$ :?'A
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M1<3/="'HD-L'Q*^<,_H5 FF)Z" YI[%ER#-FJ(["']!MR%WTBNT# '_OW.L
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M'5_:?GUOV';LK:H3+Q:-=&OC_>OW44M9L9#G_Q4OZ7$\%.'U/$>EQXN<1F?
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MPC^;0)]R\RJ7NW[1XJEUYL&[;&56%IF1A.W<3T=?Q)'^V"MZ\[J]_M%A7MY
ML*:<[*>RWO8YX(<[8L;DU[/LZFP+U?U+-*^R23&*,\""6?2T;[HJ[P9;/4Y5
M/P[!B;R7T+/S,'N&L_+[8%)6^V"PT"2TBK<.DJX=.SN:$C&1]/Y8#RQ81H6?
M>WN)QUSG]+^70N*\N.6;%WKI8K89D[&7><W0=FRY[@I27NC97=&[T,9W!M!<
M]*(>E<V/:-L.!8*'.PUT(O!K6W#>S^4BU;71!P+,^A-8<!\FSU3(U1HA09!O
M*K9IS)>/]YW0=#[V>FQSF2AX"AP5O%/-%3[Z,4-@4=O'NCJU:RM'U!LZ(^Z4
M\/;BF@[(0R"OM4CN;O[ON3( _;ZWI9M F[30^\*"^UML<@'U.3&_XL4D[];0
M0.B70 X-1XR1KV.#>V(PN'CUON1W=Y2Z.EM%DRT45WJ>CLTE)-) 9V+M_ ZN
M(9>N89"8>QL)#D</<S"XK$JX!3GVG79^H=LI6],@UTJ62Z<?"$RVA8TV?YO1
MP<^A=(/OZK7$^8> L4VHB6?S+S.&+A",!^Q0."C>H?: ']FNA713B(,(UM1O
MHQCL8HW<"U6JDQ/E3!$ZB"0 0["P(]O5[]28'JC!/*T63\EAH'N<#?TQ,()W
MY.K7(C+8C :*\"6K^10$1N>>[9B;-XQVY/:7JV76<3(2C'ZI&-_7K L&KPF]
M2BS7#"D.!-\2Y3U\K>E]G#_5=EFY7ZZ@&9=K9L($'SL(H.@< B$+E[6_VIB6
MT3;#W[D_^M[TC9.&XD,)\YS<!  7(7%O(+6+7=#))BK;"4UWHI@Y]TW?NR2]
M8^>?^QVTR/1#<<W!I,(RQ(\ TDF3+KGU_E>%"2Q?W+]&<#<3H[6$IK='S[Z\
M4+Z>HB%T']=/EO'JCI<!\AA;*_\DV:IO4FI=Z8QC]Q6N8_*<JR3F%BSI#1E_
MP(EL5]C^HQ N"B;+Y9&G;,-O!B=EUQB?Y'PSJ>.#(GAI1Q;8D*&=K0JA$X@9
MCO"5R$F5>V+6[1B".8;'753FL$S3W*?$2)*"%)8M(-K_D"<.8HLK%P<72EZF
MGS6RW#8E^9$/#ICIBR)J*OD0,-TPIFTHJ_M"0U5-7$U!<D>%^$Z?# "#2(>'
MR;70\:_S.V.1GF7?]I\Z7*CZV73K_787@#4J^Z.54!R(06V^YJ'U7^%]M8_+
M[CUMRO@F+.R''D"355'&PTIR8NW:4LJA,E.O78+&/[(+Y]36NO:S.%RR57$Z
M+_SZF^RK]/>[&/+9C;7[>$@,D@E=8ZR FTE_-:GSLER1\*US.NC1U3Y3P9X_
M,&YDNS7&"QT)X]4T1E/XAV@@%P\5O=9/;]]Y/!6*<$G:F;ZJB@:\*2PD%!+Q
M4Z8O<-CK:COI$67_L*G0%?-(@>\UK[YZ\J]N[R['Y6<WW;UGWO*</W^'/\1"
M$XUMY)V-KITR9NY7D)O^PW/:3SR;[=#Y\ T-Y B;@)'.'N8HTD"33J2BFJK&
M'RY5_,JCGPB;Q4E7Q$2Z$%[4[DS[CY4'!F3=,;/;KK/V=<<+O'>[$+_I8T,T
MT$.%\=FYL4B*&H Z)\%SO-VQ[FZ/EMT].&L\+'1D#;Z$,GQL[BXTY)GGV7'A
M.Y(M<]LGO0=K@Z3P.9'NCE)<6UE' "(PX*[\?K\%Y3(O<=58;]&'*L$^-E""
M&80LJ=#F%0NK_H,8@U;%V.;)?9J45YP2N%"5+BDH*?E<IC"6RHH",'50S,5?
M<!=41!\2+[.X-S;0>ISHLLI_H$[]WMC3 0-18#6M59G#CMCW[NY/L(^R&>HS
MMQ[]?.4X'*!UWMC06+$,<09^C'SY(\6)W%1(N5#U":G^Q]S([<O'FT$>Q9MG
M,7<UO7'(<7<JJQ)!F8^8$;:-Y@G\O<Z4K%A:<[%FM:"4^XNN.MM>,?58#SZ1
M+3"1M$O46DP3)@TT?^*[RQ"!&%C@(EM+ MF[A^A?BT;\V,]Y&R*>)R3SV2E:
M.)NA?:[)^Q):DLU[+_N.C6^^X(C+$+0:1N$)($$.T9K6?@2?>9;5L5RR.L<U
M!DY4<*IFJV^9_D3HM'?,WC,J6RW _5[=81K<W6UN%F3C@@W^YN7M)FN^IC^@
M/,"RX/X+%IY1O0PY41-BV&W .]^J:U\>T>=.4J&R";EYS:/)X@^3YS GKI0_
M\RJPC9)X@PQD2+FY&532K5O$;5;"OV+%W2)K)\FJ9SF_03X]BX4QPBT/"_Q:
M6'I.":N'-RY?Y$GP3BIH.CXV.EO75WEP%-FNH>D4,J_?*KST4YIH/+TF5Q2F
M7O.,/Q_4EO":A8@&8!CN)T998=*K4^)(KD0BEW@"<E0IR(O"I]=IDQ@%=6]Y
MRG'MMZZM^U[*B6_ZC+]*NPW]O"_&*4XNW/NABG^@G#@ &T^=1Z[Z ,+4'_1+
M#&\<:^/@QZIW^I^+>]*D;WZWKF0!9;C5/RG9!JE 4;AMS;+NI+8'F\93;FML
M5 QZSE_D2=2XPVRA_L2]#8J;+?%T/"SSXXUX>)W$'G)@H@*^6/_1A\J>_,%^
MECJZ.^O>D-QYLJ^R5$U#]U>9NT6:[&/I+=?O%3M.FL(KFRN)@.@=9R<M29<!
MJ/;JCCN$#:YW '7-X?WQH*KSHHZ8_IWJ>YP&V^AOLV2IQ-690L0W3 U?(<Z>
M6XEO[C>LFLG^W8D3%Z#JVU[DLZ1BGV+J6"-TXK>S45:]6)*,DYB</9C"?_\T
M;+(AV4GLK \*]M;MQ\N*\?$N+<$<[@)O5?4$\Q]B2V"R6&([-,)!\_!5\]VR
MP.(._[%/YF[<EXRDU%B^.;AOV9)BAA]O>\7_%!OV_?,@YECM76[5L5SA>]8K
M*,J)W:>(GM;+OIH &Y_'J(WE" ?JH.A-&J@&T;29VN1POFU;[;X]3]&O1/<\
MGGOI-HLC!T945J"^.-I+ '?U'YNA#D)%?MT@',:)!NOY@)P]RAC!O8"=SE+9
MWAX(PR7(@&.RV6*151$OWB^1,F".(7;3C<1Z^57/;7$J[RJ5T3TQ<I:@)^*
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M($U >*D$HH?[1H>I*$61L!$M1WF GR@3M;_[1K-+[,GF=T3UIW;T2QP.?G&
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M_ZUG@@Q=NI+LW^UO%[4LN(5U':@C^HH[_&8)1J9D"727EPC<I9J<192\$J*
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MU=NHI]==57W63I3/.J/<B&_["@LW2BNOK7\[<2U$W>+HN?B0H<%Y)W2V*SU
MKHJ>[&NK(Z3!._B20ZLDEJ&6N_8>>NQ.CI$&;]@6\5#*AROKA$G=MDPV[FUP
MELSN$QJ2[S6DRN]/@FMMNPI6^.Z'O=%[ZY9Z7'S:Y,L7/Q!#E%KOW0[F"ZRY
MK@.[GX5-KO$DTZDO2LUWX20C6F)\I[I6B;[N4_@>@=0 5<=E*E'6M$8T7N-N
M?"T/GD'>^2Q>'=Y@(2=S"/<8IS<9\=@.:YO-\:PJ_-+B46_99.5-9F\A%D!0
MS8%J95B56E1K5TA*G6#/W+2^ID2.=ZXP5:@E!*--!@VW-?C"CIC.<#_9AI>[
M?4S^_DEJG$JXWDZ+"9R/>@UUE1E&3U6TP,/]4Z(*<);#%AY"UU^756BW2[[3
M$G8N]# VSCS/^ZSOE>Y>PL6NQV00#X$=BVPZBBNI3\NRL310U100B':.Q@^F
M!8^0066[^7AQ/Z>)9C[XX[4RPW/7!ZY6)B>).S4H^S/L@TGT*ECV%B%&7 LJ
M$%*'CANQ:K]VQ/&&+K44RT*W>1Z\P3GY)NY*_,G5TO>G5_=.N11J)KV]G.KT
M5;P_GT_6,),.R(LG42/XD='<1IG'*77"5<+\0^D69C<.WSM\;R%R#S;4L9N!
M0^!U_>YO66%130K*JAZW#]_@>7.?>3,1F5;31Z)7Q$@UID%71W-Q*(L>Z77/
MC9OQCBGSG(%YPH@:YB#[;)R/!F;6>]3EX*:1Z$9M,RL-+X%&V5%2+F-5D^N>
MI%+)?%<4#&,D[3N%6M-[3>H<&#]46AUABM:#K_&*V2U579\%W1FI2RM+UWF7
MLM1-)U%]VWW+=[< 2*#?I/,@1!C?-5Z=0>YXPK(_>B-6GZ0X*=7$'E&^^TZR
M8H?G$\N2 Y^J'JX"L,)?2G$J>%W;0&ZL>6CA\=Y;-LI$V%<?X6N=!M\GMXOT
MIB$$3O3T?>0[[0GZ.FHK]Y%+V0KH=(NX.,5%E8)&M"LX/ 7.0=E!;HQSN'8M
M@+?L"->JYM!G3C>B' ;1T!4QSH6)%A(HQI2%/)5^K/;)E?^LM4-BK'MN0HSR
M*3<=Z[2$PHNDSM-MCTFM2(S)!&-P[U[4%)S;)6[1<O\8O"3[5/ -?\>8H,LJ
M8[4UX#MR(69'J\^N@CZAOH"CZ\#O<>H  S*8!<)QX\)WW&G3I^*:-O/Y>;9Y
M.'<WUCRQ-PS#)DIB,Z<?F[-]=>DNH.ZNN47U;J7G\5)^7^]<7Z&D0JJNVZYR
MVVX&8-C9?LZ3I+KQ(SCSJ<5 _:+LI(1/'6_#5^4EBD3J(1AS)"^S53MN F,[
MVG3?D'6SR#[!0E8,@U)]4P7'B3HW"$*F>=&XGID"=;CO63:U01&_=KAFEP,,
M1NJ!EJ";$$_AS/<\+NXU7<B7=-U2!M-\/&9^1'>3KO#J-R85A7RI<M;D6QI.
M4SF($\0TZ.1K^8E2^5:BWM0]5,CJY/N29#;F2U+ATL*W9]DC#^K.SGNIR,*2
M8!A=%*T-CGH7-1!X-N^7KO-EJVXMS])).P?5\T?E66//]D:;2=[)YCW]>LJM
M/_F!QO91-JWCD2"0G;'MK6]OXA<O7[_0&"G^]H0;9:[FQ[>&;7/P)R^H'OL%
M'&"/Z*PIK]7;-1PE@Q@/Z7\!;=+*[KPK"#Q9JBJR;!- 4C=,FY?*&^BUN&4K
MQ_GE3)R JL+Y^<(NK=6G&AQF"?]D%>#O2R73G=C2I/R],)#.C>&:Z!E<?5&-
MU\5!2"X9U#8+W^DVMS<]UD:9BM0#DI)'MHN: J%+9F7I<M4I:[N^9%"W_O7
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MZ^:E+,N[M]7VXW"@"&P?*>P)H"5A>)@5&13>AUM![C, 1$SRD$%\T*E2TD7
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M@R0?X1*:2\?W#<QB60),Q&.\GXI<&*\2%)>D_RJAF/V<YE$(8IHW*_*TTN.
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M4G6$M&V;#2 A^0CHHAV0(M67_GA9?1*S0&3B@N*XD#,6Z6#*(74XAQ9:8Y^
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MZX_G*?B^;Q/ELU>QOQBK+7N>'& A!*0BSJ'!2"]0J='^LR,Q^U_^Y.HALP<
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M)O+'2UGA%-]9WC#4(#]G2&[+SZMUY[;6X--Q'CN\L-0\H!M*9WP:9%[MNVH
M?QDO%<=3)YX%B.)T?Y:U12#:98QWY[(8[;L;1)!8&Z%V#NB0$+[+2N#Y@E6-
M#I[0W8N'%RX8$<^5@W7KO^AJYZNZC\:NX8P05RM$6#]8THP(ZB@5!]2%Q%7;
M]3CMTZ=N_YGUO:\& $OK!=?_++72C@1##7A!(X[*?L]2EM!/""MOY"D7^^[4
M;AQ+Q58H>/W$_#XQWOT #R[\KFW_M6M*?,S4IM@G=0.X"'A'<5N4U&S9RV[
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M%#V&[XYLQ7Z#!0!"_ ["_H]B#LUM4:7^\T[HRXI'A/[O4^#_I7[Q/V+]CUB
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MCV]%S:F3#CIJ(G];)8_:?V>5$7CU+VH7K YSE<4F?F]5T0:T>BL:':&?H:+
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M?62(IH3IJ BN(WG([=X"T0<F<K&)S'&JW9T^Z(X[=[]FO/>6ZI)8?^0WE^8
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MLS'WOUF[2-V JX8&[*L0E3#XX%.-JE&(K0=SR(0KQCB:1YUQHHHI0(G2T^8
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MQ6[-Q):P#3$$XK#5,B/0CQ>H,93> Q[^^-\]93G8TTSN.WL_>DPUP#6%DM=
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M8NO_'_;>.ZCIKUL?#:* @-)[B0I($U&*%(&(" @H2)<:!:FA%^F)"$@1B(*
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M^@^< X&;TQ]#T1&**?H2L>Y1X%W!=1+@D!Y! JA7P.Z0 )7]A+24*!)@8X4
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MWUQ\8L>3>;\[I"DG4=\7-[K)N9[1G?$YP?^T_99C\FT\^*%[QB^E7.7^X]Z
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M-NY$EKBJW1+JT]_Y8V#<VZ9$?W!KBJGW.9.%Y27+^)[6E8.2!^<\B6/:+2Q
M![.L[IY\C7@5OVTA5J8WDX$#V;<G&61?/]X.P.E]?OPZD>*SD[+3/2$=VU"M
MW;+S#,^&#2V'9,)M"K/6X./E)F4#J(L'= NL=PZH<24,A[D#URIP2K,"59%'
M?MMV)AW6GGK8Y8.Q4!5V<\NK@KT^QWSR\K)#!*^AN38T/4$9!KELAIH9I-BH
M'JL1%7VN$ 3\8K+49J<+?UJ4M9+7(B("17V&/G)(#?IQ[=,['P/5W&W =@<;
MIDKP"*3XP5EU\IZBMSJ?8TY0C*G.GX8+<CF1_!;KY]TX^ZUG4:%].+<6VD";
M-U/5MY7BDR0*N=S>2;G;/Z.N,+K:_T+1)T<TNTIYY_!&><JC$=^@G^^4:B08
M-4*.3.'!^C5[1$$(4)+0V'A9?))P50ETD<AMCH\Q4VB\$9YQ9Y&JGJ--,7^D
M7M.OH) <$=)*W2W'BLPM449ZQ;T.FUZKAALV86XTA8TH+\6A#X"+*FF&D$XM
M42#_U(<;Y"7FTP[Z4ZT9]?^S.__E.)\\H+0G)FS@S[8#JU0_&WV+V8E4?)EX
M.T:A7KAV^<F\M#L;1M&XYV5*M%)DA/+&%,CUJN"D7,M4-C4#)C@6UB@>\RVU
M\$.EPKJ33#\MG6"):K^R^!3:Z?'+G19NAM>HG<NS_?;"V(6&9@N%>UOONSH,
MK27=/<JZ$[4_T7B'S?ZIK",J#-;;<KS1390J^_XK7"H"Y/M=OMBY(W74G$.D
MW4N3PCLD*$@A>7=7B_=LH>^Q&DIA@H?WX'?2_82G?KRI!PRAY+Q"HPX'NU^-
M>^$GX9HWT;_<[UE^55>:$/JUR.>+S]O4.$&/1EZL7(R2H2^]XLMHCS7Q>;TE
MOC!<6Q P#/0<P>:?V[)UI"(Z>*-3?G?;/8EG]WIM'7B2!;.S>88IQQ[IE$5:
MI?8^Y%"M3!:>K'=88.B8L6WG;AK>GS(I,V#8-MZS?)<>N!/$&]=7]%W9@<@W
M42Q/ B1$8^9AFV((@K'5+]@\8C(R$FEJ/!P<@CG^$KO\SMEQ I@>3%YQ1H(E
M@9SF=->L[1F 6B6Y7$5\"YXR]<M:=[ ?)91)?;'R588<?L,=OL\V<YJC5P)Z
M70L1_6C5\.F<@BJO5P,D%2]PJN ,XMJ/ENTD:.5-NE;O=L]:%=Y6J1;."4CO
M79J,S=W>MMD\LSPJ,G>(ENWE"DZ7>^+/BL#L6&@DZ>KYKKL5&"T-G-P$XX7M
M:]\V0*_Y!PFDQ1F#\(5]P[!G2.;[F(YX'[.[+YP?PHK]OP8_P 6[E)84BS-"
MW5-1+BHW\3&34G"OG;"N&;/NY)MB:T6?%.6CBC(*W$^I\?%:CRXM7F+SXZ5R
M5;U']$6[8YG[YZDC2]R4-!?XKN^^C/YT*7WRX;A _)MZS2?XWH6[GV&B=N\\
M=]-'^N?PZ%;N?/<*9]T?L;P9LTFW<DRRZIYS^SK3XTQ0O@WV"YMWI>XN4_(G
MF;3_UA'/SYUMRO+H-MIO,\..12*#M0I;<IRPY3^EGW.I!RG#-V5QS!*\D%KT
M)R?GKH:<%[R7:XK3_>_S?I_^91(K\%.@$'\I4.4&00!GW%YOOH7ZH$HW39B2
M/IO>1Z96=)HHVZ\QW0E/_T$9'SXV@2:'[Z8M@18@5; G?]S"0</-LN,OMNVS
MXHLD /?:5@[^Z^&LYLSGR!7B>0BOLKI8R@/]U,1:*4UC+^^,FFREM(%[XF46
MG)D^2(VCA+O\^60'Y+YP_MM?)M6J?U1S9'?B8('7&^BKPDZ<24/;2(!=")&*
M!"CSFB(![B$-D!)G;TF I3'")1+ 9KF*&&J= PZS(0%FA=>AAE%$I88'1%!S
M*@G@/X2&8W/1L[)]1[?Y_TCQ.#)/]!_]0Z!^3US+R8;5.E)8?#DQM-W1_0]Z
MERS8DA%H![@,EC(=@J'<"3&19XN$HM_:1 ><(5$C<@[;@>4DNY_CJP>J?]/]
M_(]AZ#;/ZIWA]*V'@?5<:QIN0UMFX>!%G?!+43$-Z9/ARI24RNSBX@EU 5X5
MT1/KMRKYIZ[#5?)K5D)53?U,<Q%3-AL9?K85@7A>*D6OE=>.OY$QF3D%$;D;
M)_6F.FZ2.0J>:34=YOMZT;4A%;/O+S7_8(KXSOQR/A%E(D40(I*_I=:8KZ3
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M8G!A1]9G6^S[+YO#)1,]M_=><0G,0 KPUR*(HHYE5Y>L&98@'XU;0SR\!^M
M$X.]2**<?V"O1G"OJBHA+N2.DP&KU^]3H&32I-GKLG58A70XUOO!XN]3;=^3
ML?[S'UP;D[;)*(^J^#(B'_UFZ73JB *A9LU8>._X9)1+;:5%-*M*V<E&G8QC
M@_0P)BH!XI7-?TV^/J'S-$4/UH+"0;LJX["Q;MCJ_9JVG7_4W"#ORI  /H@L
M9:7/1(U;!YH;R##TDD49&5^34<L^D[GRYXU_+C,Z="_^'P(;)>'3;_]38*/Z
M_[3 9NI> >K8@">I^EW<I^,/)T8R'Q\WI4MY-P<.!EUTA [!F@!*$,P4<H($
ML!K(JGYS-WFTZL:#5ZT7E!;0]R1ONKA*Q,V,=,;+MYM]*A4_7CH+ [D7&QY*
MX.A345!F;I3!=F\!XAG/&VF\Z0B:Z<_]PW1(5OQ]&(,9@>]A=G54YCLPLRIA
M0XZN/#<M*582+R_9;LTUVBCM. E-RE?UE#R\;_^0]\[TK?GW8"YBI^)L>F9P
M"'9K-+];P +[*"[V,D-@SUFFBKPS"*AD'VQ1-/[1XCG=Q>#%M(,2:;41-QE7
M73YSMJM?7+LI<@N^*RSVP)X :2JL[AKBO;,LG8YNUU8BF'B>\M\9DSLU]2]O
M:>3%"Y?<J<E7HX&HE=EYR)U)CZ(EB!=@30$5P @H8RFV@HQ4AFO9[^C0?$(^
MG*GPS*AH)DX L4^+O0^SL<,JO!5X'YG.19,+HZN5!*(L+_QCE:SM$BC6[\X8
M"<!Z4+=QA^K.<*Y=OV?UV!J0P).WT,\POIYQ9PAI'R_^-N?5@^^,%Q7XQ'<W
MGM2XFCY))OK\E$Z>##(M);8#*[;S3H7P6_6N3IB=+1DGXZ57/U&,XJ;4MB)=
MEL3W=K4Q(L%#U\(I;_3XMT&?P9J:H;+8AI4()87L\?5;EKTWO"F6.GF>=^VO
M6?:5DP#4#%TP3+2//Y2NG=_"EJL-=ZQEZ5 <+'JJ3QP^&=L2SY^<FW%Z,R)!
MQYAAO_G[>RQ?K[!0MR>(:GL+10+$$'D;&SR7U8M^6%!G7E8<V\\Z5?*/5,=Q
M-%_B,!PL6?#/J;B@E'L>FD1H-YOY3#>.+/XZB:MVB:\W7:7>)-O#A9IA$L"!
M!'AS(M>R,1>QD:^>/145-S63M*>,2QW-!HK*K(LC2L&<%6? ^WB[XAGGR5@F
M#9DUV&@G%=2P0Y8P2QQ1K,BMP!VU!E9FV-[9G6.__[&)D^U@94O]SV7>(\2[
M_C=A5..$FU9*>NE#$A/N'V(#QYH4*[/.R@L:OTCM['WV5)O,32U=UY+Z7L*Y
MHK2G\Y"+!(A:R> 83$95Q$IZ_$WVYO^K# XUYQ+0Q:0JG*#EB=G(J8YYJ>'
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M<V^9;H,??]0]W8"<'/D?'8M:E@D#N\RKY"U]+N@OSS"IMQ$YK,!:Z >))K?
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MZ(P1I"]_6GD@$! ;48D;K1\SP8=@%?="]H$<"QKOMF_3@+2C3 HX\[\+]/;
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M"9QNS/2OE4&M=Z3^B/P$&:2JMQ5=A@<BL%+N:E1G_H(NG CJO!69V;6C=DA
MYII-%M_5+LF_%B"&AT-9!QX,PLNSRY N-Q[R#R8)%<+5(VFHO59'+4PZX!DF
MEH!3*H'0\\TZU W@S>36Y)2@L<\P^^6HPF!6;I3#GHP$[NE%Y=+<;T9_\G^2
M,Q'ZW:Y89"O\R:#UANT>T)N4=P_0_S,&(?N_,0A!-MT,JT,0,7XX]X 9IGO
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M<:-LI@8\,%]+C.>5;4 VN!Q;9[>TU<R.T-#*[SW>H31-@(1G<J OEF4F$J?
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MDJ+K?]+F]=\^7PN(0T,6G@RQRDS4I2EC0D=WU.6[I<NS,6A;CYML715BGM"
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MKYAO7I\Y&SQ5K*U%JB"P61/$*!8PB::7A@VG)3QW0WH9\OW E>#.>14<K"X
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M-F1+S/V9FC%%4+L>S/+@?'5B]+>H]B(I]CL2<D\2'T%V4.$L0(9OO=33-B>
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M(^UL[_A7VBY_1*LNA=E7T6FLI-9HJV]DB[?B$;$4M^"2.UZ7N:B5KX^N.6,
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M&0O8.KOY"_2 #,*"*+S<G?9R,?V&I!*Q"/3,(['V2/ZE?N[$>YN/_B J^;:
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M4_$I/X4Y@MG( A03]5M-+)$"CY@V2U^*'.RM/:6X3KS#"3_I5,]3+T]_,VS
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M9#/6/E)BP6/#_,?IDPDO)K9'"Z<6"7V%?P,(\/OV,?#6!?@=@E8$3])]9F\
MG:&_\1C.@])WP4P0S0:8&MW2^S '%Z#(#< G^0+> >487\.R9NF/8.W+28]W
M#6:MJ[='BEO_8)R&WM$SD[M_L^A)8S.YG47<&<5A7HVWQ'#%O&7KE'#R>>6T
MX+U4I]+7^XR7A&@ULI_Y&.),%FX'^UL(.#8,1LMWDSQVN[M6]DT)(3WRT,[6
MO-F6U56&(@<2^.FG9H<Y[J]-VMKE-\O#>>NH'4F-M[_4\BF/4H:/@KL"V?Y^
M:>T:%_Q[!SK>2E?[NUF)L\OYGN(PTPOD>X"KH"IX5F?M.*9F3XJM\:-)=+!.
M_I91(!MA1<QIE,7X9@/-\.Y+%>K+$E3;YX));.W!.PW@7+F3QZ%UVWY61"MK
M5'18E=WH=$O3K3,,:*7$<;4D*O^V5ZYCDA"7D&88FPF SLZ7IN4BA7F'U(9F
M4;GV&G&%9B/$\M_-WB8 F3Z>QYH'X<CWZ; 'E^Z(BZ>W;QJN<FG?*(_48HMN
M1H.62VX LS)ZU>,01\C7%< \@ 3W8.(&8/?LRZ#Z3',? PO5_M]/XRG,";G0
M?,F79NP.0QI+_-/0.TF"8)_3"Y?JC)_KWVU=[Q%SK;>%46G,0=Y./SIXS4,,
M=&PO:UL%[>/!(:*-7E*N1WMSO,SQ6,TT%<\7N6L\/BNT=E^FS5(^+2LW-!PR
M KD]UY-9LB.Z<M(*!DH*M\XA5IU&Q^J'8N>,7^>52&<$3WCV7F4;S?[QB,C]
MAC+AXT#8!>977<6TDKO=8OIJ%QYR R7RJRFW)Y'3N9A\1.0='.MO1( 4_=S;
MK;T-EJA"#?VGH\#EA"=$CXB$M95'.0>MUL===@>UQM"C\_AH,.Y+8_U;H9CL
M_ 9X^?7CQG2?WW:@(P+[JSO%J\-*>LTS$F_G:_.YJ&*^J(FB7K2N8M60X1Q2
MCWIL8R K<RJ]H%EK=SL/IV(.I<*):),_4[V3A9YLSIMJ/LE7M0$8<JV8?84E
M_ON,-X!:FTF0G8C9E 0PUP:3TEU;D"M?:'U>MJO=5(ZA7+H*'WQ^J8D6&1VR
M^0,. %/B^#'.G1RKX.""Z&#?$J<[]5% (VAU.398135TQWFUBL;EJHSX='/L
MO-#@_A&EQXGB,7@N4KY^NI537V^N/_"2/P9P8=X2LWLJC=4J'K'_=@OEEHI
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MN-SO[>;MQ?_5G.[1Y%M!HDTN4Y,6P51]W_78_?$DB?FT)'3^:15V#6VB%JF
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M5_[5<KE_(I>]TV9L:I16*9O>I( XO':[C$K9A,7"3\N24__'^S-*BBTQ)XW
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MX.75'WV1=<S4392]D LJ;$D?QX<FSNW.:[,\L;JU7,HLZU,+V/TW4$L#!!0
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MS!=*<DPVUM.-P^,-#.I+$(I!IG)E[UMQ:;X;ACN.QWMKR<-@@D044FG/]QQ
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MS(C^3^> 8\(YX+O'X,Z_.W?/#_JS24P>AI=8:G.: @7_!Q7\]T*]6N&TE:>
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M-F%L[GI/5%GS"ZNPANO_:+LYL+Y]FCF_;>#4;RIJ26>,:T%R_UWA(3%AQ3'
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MIHRX&T*Z _EEN<M^ ,"Q+#5) \O=92C0JH'=_':J&_T;GUWL(<!M&#?-<1W
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MEH*YQ=3O9&8W;KMK,\<&H?S\_(%-[6VMV0Y12YS&H\(MK)_*/J1VOP2(S,3
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MU3-Q"N&.<D7-!>)A9Q5DP>_8<GP*0;\@"*7EUOIK]]C#:]A+<=I(GOT&N_4
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MMQK+K[[0=_/A9\E\PEX<D*ES^7/"]D#?'R(EHNJD"V?M'RB-##P?BK^*'>U
MQ?VS=/V'IA!)&N?(:N?!4L)ZE)XJ^3;-J6V\%T>3Y+N);.-_JY6\<T 068H@
M_GT:C5+'G) +)OA>PD>B"(1@_E@_RQC;]\I^XLK2/&.Y156EZ.$'-U:$BW7\
MSHMQG>[@?QY6'P0UF#K\PV/EXU-\MC:^'$!JAFM%#-TR%2LR"JT\\$H]VH:/
M&%_0K_IV,#N*IZ@9\1KERA)U@FQ =B#B5($]4&8"N"?5C2Q"L&AVSFL<*I;(
MMJQ -\;Y>G>NGD Y>PVGQS-Y[K6<.*!'8Q6@O##-'ZWV501CHE;[E%^H]> P
MRY/$*SO@3(N,I:6G2=LBB6\+: *HTM%O7\!^FK$'65H9@G0;2[?L?=[T].+B
M[<K]O!YK:?P:YAH(N)KY%<NQ$AT+%]I"<).TL-%=YNV28X[!\DAV6]<W&L?O
M6N^*N6Y*MNDG4/>#_*A^F']'8B'(65T*U=HC$MDM2?)G[S*7CKKA0%QD95,S
M4\^AU3G \^X;FSO3.U*5*9(1ST4%'6@TS>3HN4YHN.KYIB2F$O7V&VY5W,UU
M-R[&A\Z2(>< ;T,3?!HV>5<7FX4W)U Z&O57[$$GM'I[W.*7IO+7<3L!B,77
M6"&/C*&]C;MBH3&% 0$WA"6I0<W/D3J(CJ>_0;$0+!A)$(?\772D3B78^-,T
MXPQ;3U%)WI]E%$<_;[-H;GZQIV*4%]O>1?-\3X%Z*@%E?>&XH(*.=C9<6X(5
M)($D6;R-_V%GO:0%+;/H\[D:R/HP34NN/)PZ9?#J"V%FTS$+UCO"&"!!.I#$
M?K$'B35N8^Q$L+73PBP:L27=*,!P,LMPN8WA%:0O=9K.(6TF=7!%T=UPB_7[
MB&Q%+GY2_YF[2H9J1FE9BE&<5]M\R]Q.0-!Q37/ZIY$G:VOS^IZYF;](QY3L
M?4U)/Z FZ]^?_9T#["$,Y)EE)I3;.2#&"MP[&(9X-/'Y6$-S9S=S1BGKUL,3
MUF]?=#?FO<)5WJH-:;%R@>3C:,L0'3QUP->(_XVY]XQJ*GC?1:,H*%6:="*"
M@%2EBI2(2A,A(KU&0+H4Z24D*E*D"@A(C73IO4B+]"8@TCN$WA.0&$CAAM_Z
MGWO/76>=6SZ=\V%V5C[LV;-GWGG>YYT][S-H+2#N#B0:M%P"YY$1C0%;8)92
M*$/R9X><!1/:)3BYS$UX8O4*,_IENJI4+.[',SIZD$!X=U@7!&TR,KN$7< )
MX;E(BVT2-1B)3U]=_RYQ^ROJQ,OX6_LW[#!Q%=9$P;ZY[O$^X<KF>)Y3G"+;
M2HX'ZC%A57@(:19^#;X<<0ZH*D]Q(5OK)=G8+_6>-1'6XW2-CUY_2;63PQK1
M--;_66MM%[UK,N0;-+&M'KTY-!2@51YO*?&VW(SUCMF-M^NU-@A3E7J5'G*7
MW"4[A&K#I:X*QHM=:>2IB8P&W:A3ED0%.ONB<2[=L]3;N]8"4R7* _<!97-J
M,O9\8L]'*4T-%&],$V]7="W-Q9&H@_%/22,7N3Y"9/NP)E?ZT-]S1US[)]87
MQMF(N1+X1GYJ*NVC8X(67?5S@1C^3ZPMI^N0%K=[W^/%*G[@E<@/U@,M?R<;
MV>'<9B>HJH' 6FA0BU&)6]W=NOV'H%6X[7NDY2;HY%JV5A?T]#VOT(\C:'<\
M;7SV\&]-LV.790Q[W&)]G;$6,BC)=:QJVQHS_09T4/K7UU72+Y5<-\BN@799
MSS0P+J:%(]<__3G:J (U)#5E.IG;F*CQQTTR-W:'>.N:@Z.-@$S._=ML(M=>
M[&:\-BI0E[;2VOO?('?O_T/QROK"'%L+T--),$%%#XH6%Q^9QEUNA'! 34Q,
M:P]I'O;-AS7SK^LC5JYXG6R??-OJ7'&Q*?8<,R;$C_H7]G)*ANJS>04D5@Z8
M]PXR9K5U[D[5!11^@KJ6X_)3W1V.EA>.YKH[\ Y3!0&'VZ;ZVK*_AKR\1+4$
M8GXL#&O)S&;9[MXSM:05SSM)@1]=VE;C_6N0]8W,S"XA4$O4.'BO"NLX@14U
M)**X+VHRME$UOF<_/!<5\*)7P.$*MU05%6\=X0 VN%0)[Y:,20:QJ+!!Q29J
MB4*KX)]QS#SF6I8/49KE/E\BC1J:/TD,7EMU,8]2=!)/__>Z;AX?1?F$X:_#
M6#Z,EC1V#J@>B6PA@]W5!@Q\+V:E(E)[65D(5=\D,"$I\RG3-GEX8VR_@B7^
MPP?CI! &L<PR@1"%H:"9.Z:23C1S3_%[)V/EX5V8,%XI_\!R[L7CF,2:?\G)
MP6(3(U7(Y0P$6F\D#(Y^N?31K&*/#O_6T>BS/\E5(EB%-/4RAA_,I,'8G_9@
M#;( >5*IJ/;AR2,'G6]2:L=3!*:&;LZI/0X\G'"Q&<X,]L>(46<%P:,CE\3M
MR7#?H<FQQDD.-VW#U7SW6:5HHW0'0U*]JM48IH%$UXX+R/=G;O<#58UTMX([
MK930BX7<:1612JI! C%%);K _5N/ 0UI#*>OJT3"#*G7VNQ UE 5XCL2BU8%
MSGA5<E_2H1#Z E>WDBF_IXT!FHSFUB4;F!=F,8G?!CF8\EVU-?T0\/6EW^4#
M.H/N5TX=SHENTGAE@^2A (Z5H_E#1J.H+C61+VG_#GT>**/.ZEO% GO)O).,
MGG2P:SC!WI7>#A"%4Q;/[UI<A]EVFDY.)Y,')8H%.OPVV7?P_EJ"ENQI+GDD
M?I%?V@?J@4'N7UT&SC%@Y="4/XIQ/<?ZM6-U?7]I:S];/=IZ(\OTB/?1BS:+
MQ)J(49N/F5_MW<<)E]J_,3@?>30.3)N1)IS/EHI..&*-PWY5PHW3JIN<%SCW
M7D%%VC"3A>C!SMGP;AXF'OFN!D[Q$EP(N*')],\LNJO <5+-T/C2/[J?@"#J
M+>G8NX#V_HH$T'(V'&T(OTAQ4VF3)BCBO%9'/D[],V.(+C"5E627.:B?#<X9
M6K?X\O338H UPY4RSN-JU??)+[P*GQ6(5(C=+#_HF8[6!4ITWIU,RBFMP#D'
MLNW7D-^3GHA ODJ'T\ []M(-$W9[.!/-'>L?JGU*T]!<>^\F:*-I:-*%J;IR
M\&9%5:&WZ?+]-%S%*GP_E^P!)I<H2?S09S@*=&<GB+O%$$VI>>*B##0;BW[K
M,7"T:#JDY)\FJ^G&<-# P3E^E58@-&\%=ODB;T+)#N]+_A6!R4(?QXM#01B-
M]C;F2=MQ<:A(RHUBM[ID;<7F5X?\Y<;"&E]_"82FKQNK6L+UBD2TOM>./3,^
MGM,-3R=6J;,7=8^_C(KZPF3^O2( 8G\X?8*8%2+1N))1_!Q 3",)+A'X,>Y=
MP4^,)VM3T^@LE>[GUZW)&=/\^Q;PY(K4W94D[3>O^N9,334^P]LA(->*V%G)
MO5;T+K:7//#^I-^!EKT?R@A/-2+=:R&W5_?I1)Y.?I+JRRO.%:L:HKCJ,7;+
MATMW"0%:#D54@_?4\/:P7T@F%2#!'<T35K5J-)%J/RXAP?<P*2:C4J3;R][W
M]/-^XEN)N?$^2G6IPHM-3O)080RPJ]4=FTS^8P35QLC&3(6=2-(O<D4M2*!,
M5VHFWU38UFCOJC-P]G/XQCYI9) Q^TD_,5^VHT$5TFG@:>R6;C$U4S@!E%6:
MD_UU#_TQ3:\\OV]Y]HL=STOWD:)AW";I^B>V?2YR=_0VD1_QS3\(9=^*&HGD
M+.O^%]'BY"#^5[NPM=0OA<:?+V;_CY[,M?2O',\8:3_<FXD!;QD3;D1AD>0(
M"CP=#OZMY%XBN_2)Q+L ?[5C+/U\1'RA^)N+UOP7H/P7:.ZQXOT&B:'4>TKR
M)+KI,:03DL(1R0*W=X\Y!]#Z#$*HG *C9*-GZ^+Q IS)T/2Y!_FS1B]VUQ4,
MXS^[+N;^*QTZA*!UP#B!4A :7!'-JX@K<<>4[YJ$=UNY9H:'B_W%N-JZ.V#?
MRT@]R__:LB7-^?EQ3K_0XJ)<C[551M%X]DOCMT[MIRII7*\?/!S?M<9\]9<I
M9.,LVB[&F^T<C-PGLVERK/,J;I8!6X?6^  3)HV0>-.[C'FOQAE8FG<:U3#[
MR,A?7NB:K,RZXX-7%+V-N/]/G=$DVCAN9PG]#(D3#B>P.O3Z(NOD]UM78YA7
M)(KHT^WL5A9N7D"*8_(2V+BIL5,5F^__6NOU8R8GSL="KMVTJEPGNQ1_(H^W
M-KY&RK ^R,_?VR_+VOKWUD+^0X^MG55>OI,9IBVFC/FPL&BS38F82F(DN.'\
M<G$4V%BT1-3JR-Y7\>. \FV]&N5?-E)C!9XV$J,?!LH^J!C-YX6L@= O(#A!
MH<YSP%S42D4(5&@%R6,)?3#9QF-9VG9UL@5DP\DC IHO>5S?+\#O:.X/K8[C
M>CK*IU\K)3_.WLW:"V8TR_B2*UZO_ Q'RWN;W(4?G+6$%N9<_52$B%GPY4_
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M"7K:.3M$,"7:KU,2I["+]4:S0!I8EC@):BBND1NX#]=\@!\#L=EO2Y>DYB$
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M'&#L'+-6E/0#*!+2>/2 =0;*0_P*LCV<&4.%A6.F>D!H/<EKNW(PEO'L\7-
M=8N\_:&?CX N!_^+!,4;)@"/PNA-"L%FI['"?EZ[7+/FT[9PE(5I-T</0T25
MOX6*G#>9Z(X5TH+J]+]\R<R_<W/5-V'!/1NS%$F01#%0X!)?H/VB9'Z(^2A+
M'&E;/AY^XQ;VVJ8T+SKDP\,/JCM2HJ8PX/8^^GW;72#0$>D,8:23)C'"ZQCV
M*8"?[?"0E(Q3A5-Y6Z[&BFJ5AU 7G#S#WDP.::H>4@/^*#O"C#M$W6R*UT$-
M"5B(F'[JOVR@?EGKLHA(0I>@.<>0OU7-"I+*!5%)GXWQ@;+ES^ZF@#B'<A;-
M3&\KR<44*B'MU2E$;\ >TS\H54Z+-G/;OX.;(XQ\&VP<D?KE,2X$81 !M<5P
M*'87Z<ASY#7HZ;@CU>J60C:B5\N"XS"]O8@K<'M0.)SR@"")%_5GMIIL44./
M:8]#U8)1.L(CW /&&S1,27K2]=JZ<^G?MLV10)^XF0JL#;'J#8S:GQFKB8;E
M9[M,!?J,1'!U_=8*]H@*J/U:&O7 W"#F]8-+NF KUK>%$ZT'5FXM2)4/A2A!
MD>KPZL$"8I[S,UX"FXR3=K+KPJ)BN7E%T*#72LMH_"[$:I; A#;N@,\"45/O
M59AA V>]78>,_NX6>/F0O\U#4MI$_N=U;PX3]I^^+_0HJV-]S\%5S7[Y(2@&
M>$FF3'L9V7$.B 8RPQV M/X,/<Q0BUKTP8\<G-N#W-K6RM3G@YNS>0D!TA)#
MT7'A[8IAU._O=P[HZ:@L15490G4'G5#?.Z?;GA7+N7ELM&3OLQV<9IRZV@VY
M>'G7%W:>YLJ>(/<1F*CEBTU@L^Y=0,HV(&P P9!-1O@P@IZK<M>8H^B=]1DM
M_BQ_I=Z!/'J:I_R&EXRS2^J1-;T=[N&(NL,NR8A%?O1$Z&8G@@8GM]K#*9'Y
MUJW,*8AUO>V->,>]6=7D%\6M%.I4MOI[^A/:.N[KKKJ15K?NO L39?Z8)/L2
M45N0D3,_L?S%>_29[MOJ'Y@%CEXSGXGVIA\)Z]FQ(*G'^-LOBG\H_*3XQA,:
MK(VFZ P\@S*/R@)GS@%89C!PY]\4TSF@PQ)UR.OOL!_H*=7WU&,6J*3!HEDH
M];S[^JV#%77!&)#3^M&/OTIJ78PK!%K1 81T8EW&ZK4R+NB?="U7NV:W?O[U
MZ-$T/ J/=<9)DSU"^W/2#9S;X<K-..L<W&[[6Y<L/C34LSNHT'RAM6XK03@R
M)2:'X7+U_AVO 4RT%Y#BA.$=HK:WZQS  _N5 JDF1\G>EC>G.L]:>\-\]@6'
M-4^"%,HH9#RU/"%2FU>2;DFJB1A'_C%0\':'!('1!] $C#R#/AVW#K? NL[+
M4*?^9[QK=Q3:M^$!A93$A<FB?[AFV25_]V5*),I]9JD+46M9_L.)-W,ETW/D
M>6.EC_M#XT:@:!&^D>?8*@XOYL^\DO(1Y(  DB:7&*&7'%!S%31+)MLJG&A2
MJ<ET^F#8!FJ%)4Y6+Y#O%*S T0[1GH )^TNB1@A,>)30)QG@QR;@1Q]'@D]N
M9YD9SG[A6^4/_J\%L4Q#ZW)_#-\]4*3P$4RIB2R8"YQ1#)S>&F[LY>*&WL-Q
M2JW%"L9P3+2X!CRCUUMW3YNO;I"M3:P^@$+46(RHMO_#^2#?(>A'AZ<"5DKG
M@*J$I7. 5C?,:FJ'C7!#D:3%%@?:>]UP#OCSUM($C"+$=4/AYX!$=W."]SE
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MK2*Q3"BBQK$I3H0R"&]0K?$Q1^R73HT>7JIIDEH "02=<(KH%#M!<"O(]0K
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MV4TE?300K1-2A=PT]W?_3/M)!P!TE'#K9;K&MK/K0EX]JL:^.RRGA6&2F]*
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M#1VJG#LU6Z-\57TQP<S <D:LZU.YRI:+S&A4LM,( SZ_?/FO8_$JJXOQQO,
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M)"YCW=NS>1LU.TJN4+5\>.ZR\457]RD-Y9CCGF-=_U1;X'BUP?2O]T 7^ZF
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M?]$G!CV,#-,5_[BV*N5+4 BN?'L/9ZY.J%^@1HJ^&'61/7G>H>Y.M_C4NMO
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MG'@;LQ4@J3ZVAK!G\60K5>S8Y$E(ZHL1RNOE?!N=4D([K?Y#F1>72KQEA_^
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M,:>>,:J*]F.:OD+9FY]KH\0L?:T5!>YP'ZU3<H*Q"B0J=RQP2;13DS8(=I<
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MOYSE/#[2YMUGP63MUI/O(YS0JA<*LO&<@:SE_R8Q,BCN17]S>^F@[0)J#C)
MRU2;O1Q=-LCGK'2!S;SK?;==@H/QP0;0E<8_AD-(-W'J'?&1*)D&'&^<,N<<
M9%8Y/L<!7X :]14^ON N%"(6N7*7Z4T5GYIP1@QT5!+5O(1'X0I#%%_G0X'1
M;3"^L:/[HZ0;ZY/RB=.6W%VCFU(*"TD."MSZ$]K7=@5;MZ@F\:,:IO='CHFW
MV=L*GE<\F!TKTLM-<O2JUON8J*LA*&CNCW[[)V^U?;%A+^3=QFPS_@L6;5%O
MXJRH:L7ME6C':9G/JC##?OCBP#FP'YHC-Q]'52S*I1WE6YIOGNZ;)L?U:J0G
M%I$<N! \'?6U/\7X0=5UT:GO[CF9Z6;*HV:=Q#2=Y=N/E:H'G=VIU;F=C)XN
MZY64R ?1/N)'3$'-@[J-QDMA/.LC)UZP^Y%E=L'VX"IPV95?=VXDG!0.Q*=T
MZ'6Q1(=W<SW)[1>D%>T,\*:@*C5M9MWAR4OM+?ASWOYOI7%CXLT07S8VBB%>
M?@:)#.;%=1A;8!M+T-I1>17<?G@6WHVN+-]Y@JR2;25'L3.R[Q45;F1;^2XP
M>TP/*-]WV,;XFL'GJS2$"K2^?.]>>7G1I_2NMD3L7$V-LK'R,.Z3BWP*[145
MP^('VOGYRD]R=9*5?&WV9+D3'83G$M4[67(5<6 CV& :;Z?P)3-"Z1(H%'S!
M WEQTRLM2-UA$<D)&3%]O""=HO[:/FR78?YM3^OE<(C MV6:<X"L\ZF^3#/N
M-HERCCSWXE +++)#A\7'=5%1'JK,^]/4#B+H6]K4505)CM5[R[S7QPC^Z_K*
M6RD/9YVT,R23Z];CM2V?4%;?'7:J7":6H0PV0U&I356I$RN6Q\DR.7NZL@W1
M1JZ8^?;)F*DY<#5R1Q?GC_<E@+ WQA8*D,#P/1%EANGAKYLI-6[2G:/7KP1F
MCF?SW31_]8-[^9 A^_0I] X!3I:-2G=!E%H3TZ@%TL9UQ@5_A4P:B96(:PGA
M]K(O/+P$0SUMY8G<='_R?6OV7>=9F>7\.: G QF/8_@(>8/]1E](=1 <<Y(W
M0>' K]K&;P%AT\![*4OW'.4^V *_\JG%]Q,*>7=8%O=FMDCT Y82V,M^*;E?
M'$"44O/25G%\&+NGR[5T#_>Y^[_WF!IDI"AZLJ$O$Z4+8,/H"MXP94&"Z!(\
MG,1,:.]"W1O_,MZD4VY_["T[8CX[](913(IQ_X1+G"))(+_6ZO,/+C6)E[T;
M&W;-C7,X1J[XBFEV'KDW;R,-2C9.>5CC'+XE?"P7>>;BYJ8+G2SDGO_X$E';
M\798N"G(_K[]/&R+ZU44I,?:*U']U\"[@>[$ ,AV?!1,A*".8R,Q@*.D16-A
M[+CN3FIP9(I,0TLS!DV+,LU4?VZK%>\Q-M=1.<C6%<'L7M%-P<(,Q^K#9^T6
M4?FGCXF/"9>L%D6_$T30%H;G@!#8$.H!)M%F1E"[0V0U(8\G^O:0F[Y>AD/7
M\9;-\7T/&T6;OVQ/DJ\+"]V*R6>IK^][L1+#R]QB*."HKY.>)ONB96C@1#N*
MKT1G1+MQ 4[\R'T.^*Y,#GL+MJ*6(95GV:](/PDC&/2-W9FS^J]PJY/IX23\
M!$1'%MA9-82NY?+Z9>.>T#493X!,D,*CU4G/J,X!1YNII&2#__&9&R=>'$Q]
MA00Z!_36EI+DX9^.)^AU+1.(%WWM=LR_S;1$+L2'1ZV=ZG?"Z9M 5Z-OC-48
M?V^R<%EF7$]W\BB>N>I6GVO 8O<B0+L)C,\'X?S_W!MP*LR$_AU"R&G.*0-?
MAMFZD;A;P!_^=3[(BK"V"'P/8R; X(Q$#5Q7/.9,8,+[Y:;9:CY#?I-FG8B9
MAJFAFJDZ;_&%7\99\7-V"](]I^KA2[C)9NM?<Q!.1H+6HI*Y=J/EJ#G*=%K3
MU8UEAUM/GK-C@D_;_-[+)8Z902+T+*N%1X4<PRN??8==4G5U*W9P0X;![MBG
M,E'3XFO#=E\^M92!IP[7U)FLO7BVIR/^V#K4U?8GC)- W4:Z.ZEH@<F^["#O
M4KK(DI/:P9H9ETXORYJ14)C*]NMI%*OMDQ.#>A[CP,!.WSVB3&HK"77C3Z'8
M,*9.-+'X,VP63'$.6-?YSY=*00$]N7;YI-4]5\U/J'B%Y,D:HOSOK& ,*!Q,
M2[PB4@0*;*+-72\G,_LBB%;>1H5YYB/<A.&NW?ZX;V5ESB4NFPC#RUC!9,19
M M)&$!B)Q#:4P&W!X3]]^G>$W<FTU$GY>H7%\X$^P[S3%]&#*(-DX4;N6_)&
MZG^$V_M]NT4(C@G%>9\#!-;)(HT2E,X!C[P[XXEB+2+G@!4+'M;>^9<N!M8E
M.P2.\$YP(/ARB_Q&C9]LUUYP"P,N-BO;$U],#6;P@<V]B)N%,AQ8F8ZT*5.R
MO:>X''-@9OF X+\@&ME"WX#E[<B^O*%\Y^=>[OY>=8"[5M3N)$;RV)+?,*&[
MXK)QUCF@W0'*>0[XHK#836(&,\'WR^()SJ+!Z$->J GY3>K%/9+AZ$HIQ#0^
M*W;/PQ-)V7*!>)U F?_2'GQ)^;J/3JN7;"IGP'QV"%'!N?"Q8N.CD[B4]:A!
MA('+G0P^CE ''R9,87MYZ*S!;Z9V'<!Z"T=%0TL:?G7X\2BF.LS\D_:&G76D
M@52<KQV7.Z>&] _X_T"<GTMF9M6=++IQ45W;R,KN[4[9CG, P6(,-@2[[,I*
MJ=BZN(J-39B0W9EIW+$T3L]$BGA[+.6_RZXU?@]R1'(2F>- TZ==OSG3%V-E
M36J:ZT:@6G;L:=X1V[K(4:G>F<4/'57W#>2_ROT0>I]*ME<L6760?Z\Y>?]J
MOI3-9NT/9W]''7I.0)#JQ]E\4(&S,.4'1 ?"$7:IDU/Q+%29D338<HE@M^BV
M6-Q,_:.A-/D,'77T,:+3R7S;J ;WF%[E4[3R\8) $'-E0#M.9R&^-3LN[3J,
M@3"/36I7EAC%U)EBQJ"&G^<V&3?X+E->=L_]^HKR0L4'RJ,R!1*;YL+Q&>4Y
M@!&$;2,TG@.2/;+_)K?VWVF\HS;"W+^FMBA3P(,?C&H^W*C<(&06AI.HB!S8
M['9?Y1L^8 PHK!I];=!..@_%\/UG*6;,NO8C0\IMIXA[?)B_))+;K\I12 OO
MM8%#_5+;@['NN@0'S&G\-<3["E>JP=R'LPX(P 6*F2A?2Q/ :YF=I?RWZ'^2
M(O?_R(K^#U$]XX5M]VP=\]44I/QLND.)TMZ826SH5/BV]:C9U'9I?J]]K,NK
MN=H^\81:6W2JBWB<^,OL-O",/]Z!0.'O6P2E/LLB<^;&6!5=:4HB+T9!27K7
MT+WZJ?/BHP47)[L'O]S&I\B@2I./]2>%[$4#":^A%N> O@80IKJ%%OXS$V=U
M#K@N&HT\,=9)J6SY'9T6C-@IZ/[LXX\I;R^G]$DUQ66'*E[)V4CKCLB/ ]]T
M3(.ETLO*YR44F: 6G[P8DR@2R.^]PW[=R"44"UR AY)X-L$L1$FL>UN#:XST
M5VBF5:>7,F=-N!XR?OGD?OV36WW(QOBP-\JJI/5NKO^16)HIE>O=@ZI'%B2[
M+)_LA=J=2Z=JL/D6%MQQ%VW(;V"X,BN1O:ZE&6OY.>M.'.FTDS5S@/^Z]WV>
M2*V/+[K7;&6\;-U93MXK!*PM72W%W7Y,,"]W1%,J\G(V+D9X?(H//_Q4?@NE
MD#X8\J2<.T3@/I%1KN?%6\H?BCI$F>P_0$7Z#Z#:&E6\N]@LV45BJ\991D.*
M'D/\.0EO)J7\,Y57U)Z>K32/NPW2+>TV\'<_:*4W6%W63:P$CYVV9?-6OXMN
MA(^></J?LL"&Q$C]<(!4?!A3+7:3=:E?.7]QT)$/?PYPV#S6DYKRIN#B9F$/
M'7YB8'GQO9)>G+^NOMZ[(M[[%@_4,@Q>_,N2>O(S(IP8HRF%<T"X0Q=?%(N(
MM<EK%BM+T*D*Z:=#;K<;=@N#^HRV_V4U@; WW_425U.''KE,_UA[\+5+/SE!
M(N-5V=":P=G7%L[U[)OWL#SS8QJLJPJ#EC*<3VZO7:#]NI7"SM\-_JO<LV2K
MV.YFW$2PQKV@DJ;WA<U0#LM6+.W2YCJN?0$8P51X"@H9\^0W)RDBIZ'G@'Y1
MG5VKL=T=?=I^MHZNK+M]1@F[0@/;%M-5G)J<AQ\WOB3.#+A?![J$^$4YNV?^
M_RU?4ZA@=DPL.H1%F'TCQ)KVVXD0O;IIWL19FZS[[?P]9<5:R&A=A.D2\W9_
M=D. @'54M-#_N/+@?_L8*^ DNV5(5[&_4C'!%EK[IFKPR,:L\/=R:V7BJ-"R
M(-=DBXSP;G1$O&,V-L3^F,?Z%=N+1)EE?G;UL185Q<,?ZY!>_F-O8]GC6Y:6
MOQ2KGG7F)<P)#?@E.B3/7]OOZJ;/'Q0,_9,G>*%]U9Y"VMA\LAI^PWX*=A?'
M6.AJ53AMKN$6X.LI%L=W5U5H7X&3P5"%.PO \IDV]!P B2<(\^QMNYV:;2(O
M*PN0!LU6D*$['HRI&E/1O+/2FCFA.6ETR#Y_-2>UIZ[B-Q;[6)X_'D%:11=G
M$_B.MU<6T+.\^)]GZ8KBD%*3S0-'3LIZA 10A$[1E6'Y0F9^C=!/M6L20+$G
MP OLPK[P'2NL.EZ('*JU0;6Q9<D+\7.3<\/8^:;><\"ULE W5]E9PU%UA]?J
MLR0O76H@Z@*[5JB>IG%OC<R?2YQ<"7=K.P(@.EBR8LYU@6FD*3FMZR"F+A[%
MZ3Y_,=0KFZ(+ABZG<VA0=60??>'ZX$^7JY;/P K;T5$H;QS'K5@BY(<,E39A
M1G#??M@(G+.%GTQZ:[QWE!9 T? +R%H$,L9(OB 0<UK<:;]:6U'_*;%M<?[>
M@'Y1Q,/V90G?%!QFI.DG.@^,U8PGW#]N%YU>^F$$9,A6::G%G0.BFG@*'R_:
MNXJD/2WA-DDNB+OL81S3>Y_SX4J$YVPC_96"<T"KJ*+IJ0/4']L=!9,A_>*D
M&MUV/E+RM26X%:#MQ<T=S2R^-14\_>M:0E.(U:VVT=OB_))RK8]@M3^VHOI9
MHE)%*\R<_94XP^H4A7R;JQI14V;%W\E$>4!)[,]>\[QA%JG;T\:#2*SN'H$/
M39;N-@8"1BNUE"XYF\V'AS8)U (42_O."IRLNUW"Y9R@VXU,&<FCF7*37[\P
M%$L6Z=$[U/>NQ^F0J#+)G%0;:[?-NS!,>*1X<])OJF/0=B1=8]3LX<B&6T*@
MKP>%@OLQUT*/RC+??22%HN_2, OQ!2XE'T>[R!M9+AWK:MP B=74;_FK5VB?
M<SG[!^ !@/Q'I>B_A&8AZN&R"G&W%X$1NX@ 5Y,F_U)-O:8DCZ2^;I[XPL^7
M_GP0(,C+_J8%>26X,*2P8,\+&B;)HL^DMV=32<67TZC--=H"@,+'E1D<+SV>
M8M6,O;KXO!?(4\J<9:VRL=G\.\[OS*+ ,85U,$2^(,F;HQ/1\1J3Q72]K/#+
M9<_RP*U1I-TY('XVO*U9Q4/XG7JV2EVJA'K0H&-W2>3.O[4FUO@FJ--G^E&C
M-\F>M)4XO#E\4=&KN.W(85GN\-?W1*\05%E2 - '1$PM")\<-PP0-1@[*E7F
M,-=HCEN<713##MZVL=!Y1&-2_MZA<R9[G8=UO(+^_V0E'.:E\ Y'S_ERI5[8
M UZ]B7%/>W<W85):0%9&8O"]<B'"TVIAM3GF'-!FC@$2A81 A!T#*WZG."$C
MA0N!D"T&KJOXQF=K/($:M3&7++R)_,W^I##TM7, YO7K<T"W_3D@5+8<_G/N
MW]L:5Q5-+Y-0/>0@_1[03TZ(ZC!^IAR?A&/:7BK?G&)L81J#JGPA)&DZRW:@
MV"8FFF(?C6?L_,J3<BE,=AOC#3;)QA9*HW^S0<DN-30T_!S \1G*/J5#'&RA
M(TO8UGX.B)M0D\X5S'-;9=YE&?SNWK98_.A%RE8:RG%0:DQ[4/J;7VX](?[4
MU-ZOL,T?'02Z2+J\CJ95!)5:/O9<!'W?3)4/17T=8=S/]8].$:K@=VX%G/Y:
MOJB"2]N"8[2VT(<R?RIW45/3DA14"+)EYX"_]<R)W+-;L0Y].\PVTG7&W.T-
M#YZ-/-/Y5"O+K]$HV*?GHC7#4SS#\W,Y8I#CJF )672%_VCZ9U!$_^NP.09D
M:G<7GC4GPG\^ 6&YWX%UU>0&/9'8@J.]O^][+HE^E:P/CUU#X-COW\\!2]7^
M\IG!I_YD4OLY(F!]^2O@1E##"-;= G3PGW*K_],<X3T5*/!XC7. RLW3D=X7
MZ@CR+_V74<[[)YDYAPI?D5"]LK\[_@CXZDW4/PW0/_V0@[] 9CBY4^2O^;=>
M&1B3PVXJNTX)8@KK5-C>?9 7:KC32.+I.4#UUO*"^R'#T%;:C5I,II$%;8>?
MTD3H,AMTR[R'5>ZV +.-R46)/+K-:US!SUY\]%;79I+JKTA:_F(D$9"D==;Y
MC"\G;U<!>+D;LD1[82OK<M/'LT:=\%.[=DAUDE!"LGGCZY^ R;G"?LZ:9Q'4
MFL'=M*66V*D(!"VE3]!PQZS1<+7)+^Z1DN*/4&!=.]>[[R>F_D'J?N.$8LP.
M4SM*JL&5RC=[VBS^-SQ\%A/\5,B69U'C&O/!"Z"(5KTNMPO]]PMQB<=%A7,Z
M^Z1F6B9:4F?:4#3!\12WG5=2D%J6J.E?7[LR-*+*\&GGCP^F*NEI'8GZ+F?$
M4;P^+TFBHKDR@0I?.@=$G .JO$.)6CCJ=D9QLW683%-+0VC%+><PS73[7ZKN
M]SQ_3:^+76 IS]P66AYW_3*&26.>]4V13ERTB9/F7A+:?O3UB/L]Q?T&5X)^
MP]X9S7_:Q^3XBAGHPCY1-14[]%K ;9!5"YR*>NOEIV$I+,OBS+?]._=G"Q-L
M=A8=[D'+YL.U!&[/!"W>#UX:?.T9Z]AMT)(V]/IKN# ^8K7V;I(7S.82P=A!
MMTZZ/ )=<V@I<Y8E#9J);L^^ )7#P*DU2\P=Y;E9E3IVA#^.[*(.-,2]&A)5
M[VI6O+S"S+#ZQY3_JSJCFO]>G1%@I,>)<,$<K#%+L)=PT60E>C4J[:-MJ=XS
M@1>5,1_IZPT2-2RG(.KY@^ X>/757!RRO>4*]N@X[,O8U _2[?!'04_+GH=M
M<,D=F#"P:1RR_)X8C@,C:*-(XE#CGS!1A[0W!'\#+#Z^T-1AS\[#F@\/"?GK
M5F[B6[<@9<0PO"UC"KGNC(TG,3("B5[Q!/VT?QC'\7- M0S:&YX-[]C-U0S"
MXO*^/#!+3(MZU_ LMVFRW-*E%IFP7?MG?PJ0D.D(9E04/7U ,%<E?"DQT7 .
M6-H2G"N8'KW?*W*ORENL4QR\M):1>(W;F 7KBJ],^I%-X]IR#6I",,XGJF M
M5G#(VA%$=.].P?>F!P.3QV(?<"Z75G6/FROGZM $?;_COY=KA&Q3[I9D;EW;
M!B*8F,!QLV5.ZM([*S797MW9.O>QI"Q&#RZ^66T1TNC+D66"G,W@X!6V%D/&
MCR[;"#M7'#6^I1&GM!?L ;I %!Z%<BV@+VW1.?KIA!PV%EF;E@5S*1XSW4H\
M>#KG%0;RU!;3UE@"V0.CCY% F"0A>NE^;HYZP> BATK9<D68U;VV9X'5XH"L
MK*"<?\(/]:]0(*XS/V8V/[0TJ\@50JWI*1/^3<7OKBK;I[\>;3\T/(GLHG_W
ME$'",*]Y^73;[Y,-)VT_1#_E5AY]+HNJLM><7N+'LCGHD)Y&S>[<YKM#7=4W
M 8&SI$'XOAN2]ARP[3T*/ZP46/SFK* W[O'GK,S(WFIU4_4G6T1#S<=N;@G^
M7V4E>0RO'MX)_J"FZ@FNEDDML(<#B9XYZPT>C%Y>,(F).]75B!!U=G&>7]^^
M1GV^\N)/$'#I8C4J/I<X1;S42:*]2<;>_KYG*,LAE^,C_#=4S-+6_WX1,#[F
M<]0QOHD =_6]U<^!? _5]W5ECZY_4V?>3,7P267C3I3OTG4Y2JGH#(5+&S_>
M-(T>R]?NA!><('GQM.WF>[RN1,0I[(L#TOL4.3.RQ 'M&E:Q3#73M%FWXT"7
MGY 1QS3M"KWM?^X=$DPF=.,8X6$M5$F&HU+31S2.OQ<5:&DVW@U8F>^HN:9<
M^_1#@6O^0&%A.];BN]?"D2'[Y.18+WO57-<.]5YHI@K?W+-E/XZ2=JX*KN8'
M>U\S9RL?9%^&7L76A!>K+Z'92BQY<8$)!:D=:9GU7@@RLU=@7G90;G6Y1&^2
MX[0#Z-GOL33>_:[$]UG_8SZO%U^GJNE5BGQFSH^Z>B]>^>D&;JC2 _X7_\?R
M_QNZI1W&(O+R\2V;M(C7*8NZ]!HITDOH:N .)6,237<[,MPLJ'JH0,G<,.1L
MJ(LOOKSXQJ<?:PFZ,86"]VSXVF1?_V&<N@YT+Z%R!&\HJ]<9JKB8/,7NDWP]
M>].U+@_7$A8,="T.-[HRG.(HQY,U+$(Y*E09K#E73A6A[ZK3=1 $BR7!"(PX
M;$]]/,])5.G.!_S:;NU//^/O&NP?>D:>I9MJL^@X$FI:@LXR85(JB[$RH/ L
ML7'X(L0U=-1ES2F@0/'ZH^[&.*^UO8L4NL,<CC+'.9XCI7 O]4+=9WT]G2QO
M55HY/R8/_6,U@[][+JR6V3>D.TR96IW6+JH,<QYI1P&V)R;&Y=F+EH%F9IW8
MR6_F))ZJK.!CYS-!Q_]=R0^NAH:@OEG-_B*C!U]BFA(E7PD$)FH<=D*W<,!N
M)I@"CCLM29+:I(KC8X!,=U:>-;&[_AQPP:)[AW*I>KJ%8HS7N3-XD]TMCJH0
M>1PG_\I_J0]2$".\)YE6_?L.F6:X W*BGKM5LP(6/<IGU1=$ZG'Q>F?94LCH
MM.LM,J-OXC3WJ&-5KRP*=EFS67&S7%.I#W+A*\FO"7M)S"?SB5)L^0X/;JP=
M3 .W1@>B+N"N[$;C+G46 6,5'^<['$N:.7CAM)PJ A"?(SM>N&8,F0X!JGDA
MSGW$/V7<$&=1L-O$"[@IHHQH.W"630^[%Z]H6NJ*P$;-#RN1\GU6!J9DDH2R
MG.B^5=L;<^I=_%K2F!NS VL'8RU%Z7VN+@XO>!/I)=L;/LKJ2CG0QB*K!HS%
M.WF35P(JI]XD?F')DRPP37+=G:G<VQIIJ^MZ$*5\G#2"/JI8GNCLTDOAK&U<
MK:G-AF0K01^2T<7/)]7LK(!T;QV-U7G@F2FJ0[CRVJ6A-EJZ_&;OE152^27&
M+(BO520C9>HM9]4[S@B1/!9#"C02JPJ<T\'GGY7"6" RV=4ZP<L-B)^C\QY@
M#N91VAW5.UTCBE 6=BDGU+N+,=[%SC87FBB6NHFW)/'?"=DX_6X0/=**=A;<
M=HR^ 9, *^T6\90U<SNXV7&3WD9FW1685RL;#BH/U^UABXH?=9V)7S */)6$
M#;?0$J@Q76&:<.IU,5--3QKDQUKO"^Y*0P.9I4)=&D][VY_Z2OML:\EAQEWR
M#H\L]@XD?V VU6^NV#%OK9^:+WN_?Q/%5TZ/_]NYWAONK64Z2]Y=R+#LJNYV
M&O,EBLYA>O,-^1O1CK9-#9_JK8CB:LV6ZDX"=WIM[]Q /!/1XN;74+7(R-XI
M.GU)!)U%*@,<LSE:[CR<@CAN0/(V;O[BUMOT'KVT8IXKXY99,O#P345NRR25
M*EP1B5#?T<'YXSL)G0&XPB69FEKYV-%K0CO"K>;.RA.FGX0_/])X.M[(;ITX
M,*!ARWT$K]W;:<=QX3<).U^A:CC;+U)F5S+'L3ZR*EW3AW,7SP%W!.L#,R=T
M\Z&9PV-4=,;MQ5L2Q.MOJT_R<:#VGA.A=G:<H9P5MKQ[@ S3A_%2_P;81+)%
M*0DN4.Q<^ H50EI06Z28D[GFXU4U9=MJ*Z+#3E8Q.E%NZ\@KM6CC]U#FC=)\
MBVXW9S?6WNLC-8;C<=?* X>UDS?  +@]S6.,Y><&SKK17_:R-*<]^Z:ES-E'
M$4I*QDC=87#*L(1TE';SE;TCBW/  LGNR"Y066$"XU>]S_X[-^66]L_TB5'7
MW#W:,U[/+T<U]E^E=K3;C;^'&XSN+M75UL5H7/]9L^*I=$U:"4JM%UT%^OE,
MNFBJD/7C<CZ+8 %"2RDMP.7/=9L/_[$&O"09FJS]1OY6T^@_O%,1=C@>5"WL
M<0X 0%61D.P;:B0#"<UK*0$<'/U2-8.QF]\&]J6HVN0HG=X/L+\;-U33B^OF
ME+P4WJV_\A5A+MT$]FF):5X$W]BTI)^T^7GT&IC.JGZO2<)%@RN!\>FR_KPI
MBXG'@]<?:!G42C<;=HM*.^UN%,KW" DSSHZ?O&*(D!33>[AV)4XR*>;&>\-G
M>HA#J;:SUZ\7B^>R9N=L3\NF4/,RC;\$RY_4XN+;^&_#4[_ZR( E;=$I2]KU
MGPPR<(C%.L^E50EA-#8"!GM49C^[6_192W'V)49YPDZX](?U=4Y^)@C_99CZ
MUSMT/864/$C];/&V\0[]D"(%[5MZT3 S#4]"S@I'9KGG-U5Y,JDY_)>W>Y0X
MF)45?7%,F5T-+WIIBC;]Q8WW3DF2>M<J(&:=P/%4H._'S1]!UWJ^';YXCJ%*
M<$ML\)/"VUE\DX<^P^[F+VG\+&C.^_82\BZL;U-,0T 5GP)L%TMY<N/=DRS'
M&H;D@8Q8CVP*XD-%49S"XPE;4VZ$[)9KD7G76Q>GU;/! 8JS3W<3GPY_=3<A
MW1NQQ:Y%B#8I*?9SIS ESO7>L[NNVY>H5%?*LZ>J6:[?^P--&5<4!+[X[.V^
M5O72>EK#=KZ-=<+SP[(Y?'*"",@>S@'^@5EHPGGE>CI(9.1A-=_MJPIPQL2S
M"19?#S.Z?.N:=$=6\A3T[3D@@0"?IB#SQ#%G!#5!9P+VQ9STC(J6E&EX#AA=
MSXC]I[-W)_[@KV#LP[T3;DO%<T!%(OH<H-'I'$(2[2'6=I\#3F2.D-TZ!\J_
MR1YE%/1>1ZH"Y'#V79I?^!S@4X.\X32ZDI1P6^FL5=5U-X6JX](X?_=CRU1+
MNP7PB?QP1#:>GP Y!ZAM3FPDYVN-[JMY'$4'H(F7AN".>[/Q&-=M5ZRHV=EG
M93&+>9'XW'NT52:/5U^B=+@N1Z'HN5T2?KV_^I ]\>'EJ=YC.-9X>'8),Q^2
MS0"R=R5PBW:X7B.*UCYV^TIHF^J4F8W%9]OZ:D8>3@3)W7LA9G-59YZF8W<N
M>.\/QW - E\Z!SCHS+1L+?!V#<=,*E\^!X2D&U758K.0GM\>NPJ9S?9Q#CRL
MDH^.O!Y%\>'&VN70.YCP?DN1;!)U_^D]'W6#%MPVD/+/=P <\&^<O48WNT]E
MS=*UG]C4A?%POI0 \KE:"0QM:U"5^"@],!E9=G&P_&U176I39>'R^[!B,#K9
M?I#/<G(J^?[>:K:FUY;[(5<KIR1VJL/UZ@;H)I3MFWI 'B3-B>FWQ;9P<A;*
MOB.A1RGJ.RC6T7A9:7AG9\%U#K3T>UT&?1UD'TFZ[@/Z(4_3%8P]Q<.QS?MO
M?N/'AJR^ZA0HZK6S4T'_RE%[8L4FUE=$PX@\]2!-9E<.MX'C&L!MH' @AQ3X
MHCJF67D)HQ/1HN CCT=MM3<D#VY[I3(ZN/N4N'P06K1OFO+6IQO"U&7RI(X?
M^N>=>F@=US3"Y%G4Q0JGS.UG]R;R9W^[$H#EU;8M"B.@A6SD+>6+/L&8X<Z]
M8'@-;53N5(FTOQOND4Y$EECS.!F9F$S[*&9UG0L2<A 9%<*4H;H&"1_>"B80
M C#"^B0JT"D$^K:2,()[W&4&#X3=) 2AVU"WL>"0IM?>N>H\4Q\J7SK*2LQH
MT(_V#":KBJY\$S\Q>=].6]S]:=:,>VX,(M7B[6SNFH"<M.E)C\-K6NQY[U=J
MKZ%,AY\)'AQCC#M<H]'7272D:7C%<:2R" 3%!PXBT:<M_2")32!H?E>:@.UK
MF6ZJ2&T$'9A7/Z'T>7/M <,R_ZD"8>_/[5IB&^> VMBI'5V<F4ZT&6U[#U0S
MGQ (NP,6KG:@0Z4XVZT&9)D0FXKL8O-LY43\=(]\9GK[YX\]:XB]B,)D!&U)
M+X(!Z(\:/7VW?W2P:@0R$>Q".H)GYT@LY8O -M %>!N2-$OF?D5+*]BI620"
M-GSV*=WW_JD:FI^X=^3O92._YLVL?.74#38"9%74Q]KA70G2"SI E(^F$>$<
ML*@DJ(,3C:HV910L9KM?;9Z>7V-[65WHTVQI3. '.>D5= UP&_[Z5 PV ZR,
M/0>TNT9S2K9@:XIP00\0M#2$QLY4OQ_Q+S0UGGM_Z/?9UV2Q'RBZ1S$-]WH4
M)+".R=U)_$H:BR^M/=QNZBF-2JUX5X!8T3MLWMFJ*=S(<N^1,G ')5U.LMHM
M>O";BGAR%HNTT[(B4>E@]5^>58#L16>!BX8U]4LT_D;!K7[PD"9/[WQ3PJ.N
MR5U_B$T8:O))G&^P^JK"2Z&H;L>/73O$<0R+FEY2993QR8[-/MQMS"BWL"^Q
M,:GRQ 46J@M.;1$]*R=#8!00^Q@8:2DQ!;LSKX*C_<$IYDH%BJG^_SA[S[BF
MNBY].%:D"-)!FDJ5JE2!D-CH @+2A:CT+M("A$1$0)$B(* @($TZD8ZT2!<1
M0D="#[TGE!!,X1_O>YYGWIEYYC<S[X?S(>>7<\XZ:^^]]KK.7ONZ&L-/U^U:
M;9A7: >^1S/AU5Y?"_C*[!.) 3TGIL^I>Q/%P)MW\&!"!DX\KLD9.WOQUIS.
MMIR_'!^T=N=!W(+)36*CI9@O9\M:P0R^K?"E5C''"6LTR^:"V$Q_+_KN^.?5
M'YG"&,/KT=.V1U;U*%M3C3U" \W]QP"F,I(\<8$00XLE1J00ZH59YBFWK%_'
M &^2W"0P'YVZ?/0L*(A*Z.K.+L^==Z8UP;PC61ZWTP'91%<@O%U2&J)^D7<4
MON_E6 &;B;:_IF/FG'F_K4$^' -JQ3=5L1I\5'I>+ 2C980)QRH7X-E(\PWN
MH.LC-?$7'TZ[-DRI7,N=GDCGLG?G@#^,N>*2JVT>IU"_E[E'H%**X>+DTY37
M*&=(A! #DFSQV!]_VT!(>[3&Z,3J\C'@892!/L]B?;S1RV?C)B>+7YZ\.1W#
MSUK2UC65$)@J'_\Y[A@@HS)K$),B:V'J-KCX[*"F;*^NUQ8]*"FUB[Q)S,72
MWAC%1^4CAA/$*9DH3QF0.I+'<FWV0K5<-)QEW+O:5E_W0\RS:5V9O7Y/IY?U
M;Q4=V?GJ3CS7SH')$$^4PG_]"<HL&.]66GAH427?K<,%OC@(Y82ISJ.9B-A#
M_3C,[O:WHU2^LD5S=2[."5XQF2$=*YZ/ SA8^;:YN;>GGX\-!"G_A=J<_\[?
M4[3\T&#'*R608C3((*GN(EQ=%S=V85+X9LG7US=."1A9)]:',N_<_U?"9O_U
M4+AYUG7PCDQ'"8=4BD9AI/A7'R;]%*_DA6, #?^>$8P5Z&[/B@J<7>/=/;"U
MY@6ME!HGS%9XX%_0 :-C'%6MV*]JL3:R8%@(+PT$9$$"9+41\!#<I<;3G/U0
MG2<7U/RLO>!6OP[NHD3Y;[\%0V7MTRN2B8TT'%CZE^)/OC9T2I>/TU'5W/0%
M2YDHQXG]PV_'@!AZO+N^I_ #@S1"NGO+BE? =%N>7)H&#UMV&'!%N)S.$<*_
M:KU<-I]A-VLW@%RL::Q)@BEH!9E2;O%?@%["MN03+?!BW5A4!*(6&\?C+V5?
M9581T;(0D'QK4=@WKEZ5]T;YQ9&O2C8"(VY[+H=J%R5R*I3_.[AZVBFV/1OS
M;?':EJUY4F%YKHLHNK])IR7RJW5-[CIX8AQNSS)=QQ:JX2J?I%9\E3.\?$FQ
MYLS_K[57>^A>%U?F.=PB9OJ;N<^N3=M/[0^75U'9X%LVXC,M"")JH7T!PL93
M.D6)[$Q3MZ/K?Z8"'IBS_Q70PYE_8T\G.G'I=>_,S+2;2I(;]W!0DM'EH(?Q
M31V[T,+5G$;F2W\W]I$W-I7,R3>?U>Y-@ZSMJ"\O,SGCL LF=:9(8LY&QP6K
MUMPI?:_AR=:E'X /&< <[?=1AZNL#L\NK!EFZ)45EDR:JB5?':Y*JMD':=!F
MBTT8F(C$J1#:B1!2D&MMJMHQ($HQO0S<6_6V=]&U+H7;_=D7G5:]3H&NS2(Z
MZ1Z54X!:%C)' 96!_1AP&D.I/P;8.^$%/\RK-R)BW)7J!SSD%%T7FH;R]K#<
M,J(CEG699U^HF#%M&ZZBW\4PH\=9>(A2K2A6F(+_'/H5B&-8:5KPZ/;,FG7G
MRT#S<89SEX F)TOE3RSZGVQY@C,BLZI0Z4?G(*^<L:)9K5;(O+AU]70!<;.Q
M<EEI3Q%M"]L*!3C^6?W5JPF6;#P7W(>R8SX5=6/$H9Y>+??VW.=*&A()GM8A
MLP79SE1Z%1)['XF7?++^Q0K6<>45:EXN;=R\*L[EIX\K >E5_E;:H58(EECU
MY9*RQ=)I-GAAWEW+@2NRH\;/Z=RL]]Q&DMWBGJT'/RCJBE4Z]T?NZF_RZW/;
MY66;97E-C1_LHWEZ>X3YS]R7UR5+X1!4QLO'@#-20K7(SG-P;ICHF"QXWAIJ
MLEKSVN&<4NRMP%S( C*%-?HN7T;IYDUY3LAG\%PC F<:]FEB7>C+^+<^IUT!
M0\=;"Y1G71N]EF43IQ!.N9>GNC2]9RD#W*P9I$4S<A+GOI4A77*(VYMA,CJC
MKV(*_6LXV)^&0&GY[@SPPG_6XOJSE@D? 7&N,V:[QQU>/-_Q(1&D;WU]XTH(
M(BAD03@39>&:EA]9\YBY)&^FT\?=AP?J%'$H5;1ZBQ.G$6RQ>0S 'P/N$ZT*
MRR.0^J)=X3[*#O$[2KF"E>)UQ53:U3*9#N[_OI8)+@&>PV.0C",%;U=&^?^Y
ME'DH1-5O&/B-B4;FKP?#JPK:B]<L7OMX_WE6;&5Y03:G_2PG[OR-1@7*Z5SK
MC&#C(D,]XT0#Q>VT$,7?GVGH\M\K'R&NU+X]*.-\X"9W <P67(&, EUUQT1U
M,&;(>V\9<$SUGJFOVSOEI3/]A??F2GQ:BS2RON44[!ZEN(4'T:KHYVE#,+3U
M)3U9P,:.J*42F%\TO,QR)%T%R_/D81K;8+_XYYP_"L:HURGLKK6LDH<[>4:*
MDN9=-;MGD*>/5B2?NJ<$ZST]3-Q7/0;$7W1N0]*FR,K,9KRW*>6M!YR9F-L^
M<_G+%]RDZU-==V_LB:=&Z73O5L,R14_>)MY@RA46$6(AQI*XX4.SY\BJA5 D
MUJ*]<#]$0UK*EE)E]X7=0U[ZB<X\^P?1V]O%@DJ.XL) _E K3^PL)F0A==,9
M+VY-:?'C.ZC%498SP,]K$*S04$72]P.M=U>C.5FUK'CU(CV;!2*-U&$J5 8;
MGW)B"97A#+9/M$9@J&8FU=&1D$J9TB=(W2\)?\ON,Z5U/=%0WL#5^J-J4E53
MV9'7.$)X 2JDUE^X/"KOIN3:E:'ZX&/:NXU6+<GXKWIY>?G>H5]5(2D6>LH#
M"TU") ;JJ)W:L"+%M/T8P'C3UII5-MF]T'V,R\(B(2$96K8MKNM@HL9YFZ_6
MC>44D0_+$@6_2#8?K#%Z;AZXY_+V5SOV/,1R=[X)5T7)?\>3>)N_.H;)XP(;
M8"7Z]YLN! N(RP5<FQ79Q([7[@!S@<1@=E\:AD">8(/*8;\ A@HUH&%ZOL[E
M^&51>\DNY5ZF"FZPZ[DSJ#=@3P=+6%,\LWSYE+-"G.N/Y!N=/S3R5VJ:F@YF
M1_QH^8_23Y]WN)H%^MLYN28R6D]K\!SSVW4@UZZAAJ08V;$*M]4CN59(!6I+
MF):H89P[9AG(:E9 <*EB[^/2:?< \]K-01W[ISO [U?46^\+N3X!/1Q7P ?.
M(3O!SZF2@HS$FKG)6#YC=__ZR*L.NFPN-ML]_ E5VE<$X8Y/;B#]B#LEZ\:(
M5GGXV=7K=CJU51N8_:K;I;<;RZ;"= 7P]0L;9B@O]]<[\--4-'?@L^K$K$A-
MIMC#Z%+2 ^=?3.9F1</Q*C*42=AV?%D/,1?<L5S-=7G8S]V\P]C8V,V8( NK
M?/;,=?IVW[.R[:P[*Y[L=\> NB48(J+]MVWGUL%B[_G\_%(Q7;&$N)/%<;IB
MS>S=617(+3G<<)M%I@H^M9U>9I^BTJM68K.>DJK@2J+N8!Y'6J3,:H"A)>&M
MK=A&.:+HP4R8,\D3JGHPL;7@%/)^?T+6I]I.J?$50F#QQ,X#ZGFB$*'B*[Z@
M,T2 NS.\/=4:$7D@C+]-Z@C:=:A5;UH5%;OJ*U(0\!-@21D3<+,W!/5I>.WL
MUL3? 6+O]=)G&C%JY4OZK=W.T W1E$)G>@$K?.!;90TQR*NB#CY@)H3C,2 N
MBP>H+AX#/#_W+DDW;H$6F#!IGY&N!9.ZRO+VNK)+KQV>JA4G:L,>I'5OYI-N
M0Q$+LEDDT$86TW89S+9$YTW^FJGMS1+_)K8R_DERBFGX'MUDM_6A@<U\=[L1
M([P73.] *0&)P.Z,E1[TJI>@3Q(MYJE1]@1]CJ#=07W%?&O=/"<F':9URQA^
M!U)JQWDQ V["+TJ"QR(NEOKR,<X_QCUO/17B4E_)V"3-UENATB#+D?%IT8]S
MD%]&1:1F6OP04AN_ [K#B57VT;Y><O%AXN>%UT\/11+]A,6Y\A8_;B^XYI].
M"C )5L''%9 8X:-I6F%%T+C#>>D6PWB70^O\4K6:CZDI W(SR5LF]C=NJDY7
M\>FHMIZM1T0< ^A!(F07O#P1/.\=OJ-4IIF[=Y'/[,23&$&'A%\O8\\&!5Z^
MN9@ ,:&V8@@5?P0(3 [*M*U&1.O3[Z/P%YI</]:EY1GL?CS@9U9[*A5'B?.L
MZ;,A&%,^-8%Q"S\17 ^A(?>@GC1_+RQ[*LF=:+;$][)(J;][=JL[>.6E:S]#
M\$0785_CM4_@A4<N6-<GM- 1W:XG;_SNL5"I0>M>N1/F\T+(M*W+UE=:5LI%
MR_!C4*=*]RFF6.=P>+=]\?;%@'SGPLD9S)1\(B]7B*M(S)=+2X%> IU^("%*
M%,K-FWU5&7YY",ZIN[2NC'(9]MA1>J/N/OF]XNT QD >+7%)H/'"]NI7I49<
M'2T:<<FT *"!G5D7@!![=UPR_.JOK8$#49#CUAPVJ*S['?SN2QT1T!.D![O=
M&BG '7Q>^AC@&=)H:T^PQG<UEZ^G<B42M2T'6X1U/1I>@JR#Y)PO6J)2BJ%M
MZH_#5'O*<K721Z=M\Y>K47>I-OQ6!7P^7,S-P#-TAF6:6P^+;ZN\(7B!=J37
M38T#DE=<T2D8N^U9$1B8DD65)YL0PT)PR&\M@*8F/%>&MX_&=MSF6R.V;^!@
MAA^]*9#MF H@P$"\,_[Y,8 #3M?G[(E7N5U=D72?+313/=2K'U_Y?J9<9NEM
MQ[<O/UJ&T7JD.W/CL3"C,EICW@==(M;9X@20+P_JX8+K3H>Z56-)][D.K__J
M8N1=N&OQ3&OYZ!:3CNJ5EA-IV)#7:>X?TK03WB@TLEG%F^ANNU],B+W1Z1](
M%J@%Q4=!PX'H*K_\'L,8E\$BB?P^<<F*)%<#O1[-?&=G_\/8/XK+^_\*B9SL
M2H K-EN/F[H<OG%_OR3)K.+YR.>W^4J7%/<P7!J:V*][BG-LVW!.PT&&XIZN
M(55!//2NP\8NES12[W I7^Q.C3\ >U:^V/F!QGOLU7HM!$S-^X;E4/D.($4+
M8X<*Z\JD!^L0ZG2R>N@4>N?&PD<?V\"N%UY 4_N2PH[ &;ZAQ0BC&89:X[N^
M.PW*:YGG?C-K->R\06V0U?_P@64= W+Z6*E\1V<5IOJO5=G4F,@-YLOU2RRZ
M_]_6=UO^Q?JNT3?W#P>HN"R^FEAC<F^&2O=%KRA'L9-'P3 [P:&=W*A3 .R*
M27.2SQET1G7% TV(.5*4DHK ^F*S8H18I4&><AT0+B]$Y6>@8M8$QBX]Q]8Q
MN'QR2W;W>E9314E,21&HQL(42T()JR'H9H\R-4E>\*[9\\< K_CGX[.G0,+K
MUI%IE;9W0G,WTNZ%R5:7$&W\5*ZS=SW W5K/>_Y@/JHW50AW;Y8HZ?R&?&/V
M-%4<T?K8/V0G2N4:Y<W]VF'R"7OOLBG+^$;>D9M[O5\8RI=Z_*7YGCYA63UQ
M@[<<TC9[$<Y!G&W#1,4!%1;Z0"N:0P=2;QBW[-&[6_;U+XPD'?8@#*TB9QBO
M2GVU\GU[<RC6K1H[XF\SD3=*:,DSS]7+2TJ)=R]P]MS*WC/;(;,+=1P#3L*O
MK(*YP7.96;P>(/[U-$3X9I,<<A5T!7<TZA>*,*J.]ZQ.917Y\D/6?EU,ES-=
MA/U%:P&$*$K.XFUBP1NR3-HLF*W$ 77Q]GI1!BT-@Q[]&070X+&3=M.*D^9!
MP%HK91VTL$[_8*%'3.3O$4Y@M+4WN[5-<\C!#.D88%O+\;3:O,AU,G<M(#YN
M$S&7*51=T"EC/W\8@?*0PR!U\<CG5)Z-E(:6V-Q5*FLHB&3;5$W+]%25=#'8
MN^^U;CZKT.8)Z-]<;I 3A-."C0",D60 S25D4UY3U5T$+Z"(8>Y>F4 <.@9X
M5:PH?];V9G0"I./+0YO>\UV=OV95M9GTKWJP'G#1Y5N,^ALHW!EV'O,OTYOI
M[Q_C2EE?7W>,NV%OG!+@=$DRK$=DC@%48?:#VJS2<K@3(O?U9-N@<5V!;5E-
MH^41<EZ(S-ZR-X_>/,0'MH*N$KMIW>E5%I^T=WQL4U#A6D5;Y33:8:SB* !_
M0;@NPO+E*\&S0;PEJ<> +Y_K@FC8K2V)2K\+NF)=MD>^<0QX:4]E0VPN[X8?
MA0"/ >)PGUFO3=+XX* ^/[YTH*%2?LG*\ Z+\99AMVI1LENB :B6-@I,];?O
M%0X6<*6M(<AI?74S!&VTD"#JD:?4 FJS<\X[G!VF]8<:Y@V(KS8U= XEX,JU
MT#_LKR^1HEC/JBJ)KV<JXV,[Y_45,/Z!6/!'_0<">T9+T'!9M!EB2X;T$!KX
MH)YHAGTYX@'4F$><Z2U8.[QVY%'92"^;[^NWM12O$-#YX/)]+K&6X6] 5FWK
M0FQQV\/>D%DO9$AP@K0,KZ9FF70**;\2_H*3Z9JV<31Q[\^B*IPZAJ@:[:8E
M$+04?-Q:*!(D1.PU;QQ9& ":S847V4*=UK?>3]5^4 QDE2QRVN,4US5^Z.PM
MA]HT3$:OH3A:A-9G66O +U,$)>H0;*N_0YL)V;FU2VE25KVEIH!OWK%I*K:]
M;WEU;@#-_98DZKQ*S)K'?J>-O'3F[!N<UB@E#.^"?/#.9+:5-BX$SH"&WXGB
M*VW>_+T%L;<MO;R!9J482HY[[^S6N1TO6:<'5[_F.3P"7)*0/'L[^K<P%M'F
M?8;L2-0O@W$1$SZ'HF[CF=\HIY;8>$DXOM#YH<SSK"S\K?:EN;CDX<#<%Q)%
MYODV11J3".5$<B*GFN*:(K;6_,@6U5<UAWH-P>E#)K6Q%IL%H22F#4A=7)9X
M.U01]64UU6#N1</B@&9?6=G6P-?=I1?R%Z[%B01:CNKOZA+0&'8J/65^!\-.
M<,2!6V/O8,\0PK'(*/!$70LC?BR6X>BW79$S6U<J(]^2+=]I1<^WMS;>G@]E
MU=(HT7WBKH]\L#.V@2QB;1N,-XQ37G,>'CB"&%+BP![>;R"L0#ZLT"0+H6;0
M/YZ9R&W^QKP"AVY'G^O-%:M"7)3OELV63C6M?I5>=RYW=T'D(Y*QKIF2\8>!
MPF@N:DL47[ PNA,S-W*)6%;BJI*"\0CPY'-MZY^8E^RW?*W"/76.,280Z9Y;
M<,M46E/;_W,Q1LIK&!$->3IV,=%U?7/8FF @UXIJ4MM7--9\XO6_4@Q=?9R"
M-9(4F>IZ]3@-:\PAE:+T]\<V.L$$SK^*32(W(J<%RXKOD 5BC+/LOCX>_J3:
M+WG]W9+#O7P>K4TC# OA191NY,(\NKWQP/7#O>#R,L90M*6],,K):RJLW^??
MBTT8DD5-+!YK<IB]_?\:P$,H0T5E L?@?-#RV<XT'JT4_M*WWT%6N4!YH<*=
M7W-CHAQ*/TM;019^H0G9Q/!;>/AKNFB8E/^*Y51\:N#,:_R>UD(5RS' 6,.M
M$S:)XUM@.@:<K]G9;/;:UL)1]K/6<)*INUD\[)>^M]+Q5?08#[S-:7GG;X;!
M?Q=49;7CY<XMXF4"Y33]?D?Y6!K,L1ZB,^7Y=Q72O_XPQM=R<?1T!24R\.@=
M?$=C?!A7%KSP*%/?U1P:QVNHZ9_"_1KA5F=<KN(/N;-F>B7'0)/CP;O_DX*K
MKZ9F:(AW@95!H9T.EX2]JXC]Q,T>Q1.=,'_\#V)@N^<G*_70*F/;3T7=J=QX
M%<-C0""_/]H+IEQ#]L?V9ETDIBU /@24QM;.*)!9XSC\@8<:E08.%HXW=CL6
MBF1=::]@S1L!6,GG&/J1*UIXZC7E<Q-D 0* ]\-!>'1[Z'4D\$X.4<6T96"+
M:V)9P4[37;CMA>+E+-EBY:+3^_SC\TS*8)S1[&O4E\_->"&L42>2HYVD8X"T
MM?M1AW!IM/6R^/JC_&30[:O"23+"W\6L$F:ETY\@:D#RB-9.<RH]<1 )Y:/-
M-%5L&W:L0THKPV)CLDH[LNZ%@]%Z/UZ(QR]/7M:4O?60?9:K"4R20[3*(>;R
MLLX=Q+\6^C+S(8^L06P5&9Q:,^XK?HBQ=3DD[$I'&[RT.'N"OXB^8U"KG1E-
MK;#5_AI18$K'.&I@6^!_!!9N[S3DZ<$D&?:4@/N"4IKLCP%G-"CY* ?$1/@<
M>G,R%Z:8U9U5+?9U7ET_0U][I-3+6ZRR1OTGZ[3-S35_T3V;8J_8VOK+T[V"
M?&NT$"<ZOM5:#I^%5*D26[&H<]:KF)E4+/V^K=MY8-V$4^:-1^E]S]45<CCJ
MXY><GO!<Z^$1W]UH$^*D7D6T*B \$*\R92@E<"$(3(LX#XIP]YZ3<=O5;AAV
M;OBH]7DK36>A_N.KMKNQK'=V#;@MF+,*(#A=[PFCSJQ*Y\TWSO,[K^H.V:!9
MG9B.&0F\:-/Z@XEI6TV&(SX]86&1IQT"EFRB>]=\GBMT#68;L?@E3QJ #D?)
M"9_/EE_)#U'>3#((J'VSC/Y<F!.-1S^2R(D9.)%V1$=E.*+Y@V,8_,0H; AJ
M\:VAK"F+M0GB+E,7M67B/>L:L%F*+*J,"V/I%=RD2_WD&'<3%$W)!JD2N0EN
M1"6L4.PQ@/5 8LLOBV5MRT=!IR-HR-GC?OF)H\6$1*4Y<K_442_E"\H-+42=
M0 G6(.-0%R[8Z!;J5*PUW%,QT6=.=PEG;>5]!CVU_.1D9$  PU>,QKVZ,P?1
M34-VZV2KI64HNF1H,9Z69)V9VK,U,ADY*#-<L!ZKD7K3V]LS$]+;6)2FZYS\
MJTJ]BLWJM4BBKLC'M,AHJ0V6I*G_CL]_'_E<2.B )2+MQ6KP1I_/I_[9IE>P
M/K<.RKY@9LELX0IR]+=7?L'&19A:>6J@0&=SQQ,=I]>5Y7D.K)!3%OFPOZB9
M8%(C9R/*FU+_^=T1^#U\>#3D@/_@R&-/V#)O8\#N&& V2YM=K.:TXT9OV)4!
MHT"%2R^3JL4._-)7?]?_<Q.$BNF7,>G+HXHE]=LRV\(L3 /UCOX:K0*T*';*
M4/;G,>"6Q%B^W3LWT\1W#N5I@7_J4DP9)'+"_ZI+0>H3]4GV\&'$2=BU&4:B
M)C[)?,"OMMX]LJ)JE\#+Q^O]0;?G&U*QC.4\%-EAQXSR-&U7R\4\U*5_G1=[
M2U27CC]\BN5'L;Q/"F$?N#DLU[9LJ:+5?,[<IG!$MVO#:3O?VT:A@EA',J<.
MH@2V-C>ILK!'8S7?%8]@DS8AC3%W$Q&()\_SHY[<$O[HK_0#NM>=>8V8@9U$
M"] \!,EZ,'IP]DY0J&_L;K*FICB F?.!WY:-$*ZY1>88,+#A<PR TV88[)^]
M%UM_)#%M_DT2TPQZ#% @H>8RM5AD.AW7I&596 Q[\GO%^<2&7:T3*SW%QFV$
M/X\@O(0P*V:X!PCF'90+A%TYB9^>8;+\DQFYNFM4OEQ$ Z#JI4VG%(Z%8, +
M\3%>0-U +.+5^&$BM(T/2KXWY-&?\X6_3:0MOB'8GA-"Y:[[H]WI!?Y+N_,?
M)F[]PT2WCR-U2=069PW^UX_S^[3EVC5G#JW=_7;R!;:3#G3WM;PJ\%+=P<>
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M0I6S85XGX^57VFL/55CB'-.,E_6EA+"! <Y.P*KKXB))=A^L'U"%KV3AQG-
MM,CRH@P^0+U.24<]@7!"D?.E?2S1-3TR,-7YH.&=.Z$(^4F1DM;>2P'^/$MO
M+7ZB<)9RX0@.T(D_:DTM;+"+1%[QEX__;&J%^<PWRMPAN8TME8N-G/F)</[
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ME"*$8U:,KPU1!GCW]^>"_+6&'#2C5J2%9D5]K,T2-R._''O2JR9T5O 60GF
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M(BKDUT2])&N4WDVP[CR/2MGPP)>OV<>I2RD&/>UL"A='DT)H6$^+$@,7ILZ
M*\O&OX$C9B_6L)Q:MU!;RNCL/&C>'YB$6"WE-%0WZD1NO+](G_?VIEY)'P??
MAP?LD',P#;P*F961>BX4;Z]+M%C@,[#H1O!4@R6%V(D33?+C)BY[^H"$@CA5
MH=[JTZ<9OO"*/:AG<'CJH+0SYP.N-ZY3L-&4ZZQ:V6.2)VQ#& *:TLEL-XX!
MQ,L(,ILX81W'TIW%0IU&<)&=?7 D@Q>Z8]Z,Z[W M+I790Y1CVW>!TJVGPI*
M?_>C[Q*4L^G3255*,;)W%A-.93@&X \)/I0"JA!\)-BN9@[-#>\!LSJ$WZT:
M:5()$CGD0G)4,:;WJ+15:4+3)S!3PEKX26F;%(,AB[66L/(UD,1 :9/!IQF9
MSKA<5X&^C+:BDY9Y][]_N\ B>6O1J=Z7_HFDH9*;:/G8FE=FX4YO;E0!O<GG
MR=K##7A+3)TFA\7'8-$^;A,U_U4GH<:D)81W\/H)NNQR.5SYF_;@\!GK('9E
MAS<QF1N8SYIWAW*B)?7^=W0GQ797QJ7)2CD/-U+[2(TN;Q9(W954\9//@;V$
M:/S;-"B0T^$8( W-Q'\ES7Y#I8KC]I66:NPM1[V5IJT7K$:$_,9-%1/M;YS.
M#->(NK5EMM' NA0;Q]N;9D&[?>';3S&$G ^^OM[.WJ+34VL<QME!(@DOBB5X
M19(&3LP\!YVB#8EN\D/B-#Z^$\1#^^$ [PVX\!":BSU3Y082^5#SQL5<0_;R
M57?7TQ]SZE*<G$ZK6BI?:=F52OPC' <+(!Z10#"_,=1<,J(:]4*ZS NH;J]Q
M&.E=3;IK](Y5)"P#8//>47O/_GW\-8$?1]\M&^6($F R^V37,:"VK@O" A\]
M!GR)WQ*?;^;N"CY?..QOJR7']E"KY&*4RV(<]ON]0;W3$0P>]W\<R21$$HVP
ML[%@=\0O[BX(3],)TEW7-&1TBP1THRT@32P);U73^.9[Z?XSA9!%76!0TL\X
M?6C=%]U+4KO)LO2'A:8%-@Q%6N.UTZ8MU*APNWSK&TAW*0QIWVTR.,O)12V+
MS&K:A<*9S#*OPL\,V0_"KT"=.Y@:/&<23MH0?2U'C85Z7^[:NPXY_[SWANMH
M+O94SZXP-?9$7#(164#M0E3-1K8HPW_, A!.*^D/B=F%=E;0 FQ@3),<]O/;
M"<N\7L68.!%W'>O+_"0F!'A;^+2ZON Q ./_VX(9=#U>)F\F U%>$'#2)#%C
MR'I_GSR0J[&:$[V'OBF1$Y[0[W(*?0QPD\. YU<V,W J'4("<#%(:3#\C0/Z
M?&$2&V0JX97GD[EE7:%S-]H6JQZ;O:)Z(US0\8(JE,]4%6C\0D&'>FWJ SSS
M)^<$J^2F5\_IF2X5%TKQZR6$5SM<NH&L0,TU(NJ6B_"'"WZSE>-AVQUV++BS
M>8/K$6:,;M8_O'3Y&Y)(];>N2SX-/(H(4S\)HX.8)3^BQ JYBNZ OQ\]'.?=
M6B?=0/G#I<_Z]'$8VU4L_G<40O\\Z KT)#ZQZ!%/D6ZZ"3'4G!DX&$NA(45$
MYC5]I5QV:@5=P=]($9Y19.E&N+">9CL5R'7(^OKRWTCQM,6WT35(U3&@>^,8
M$!'\8M5ZH;DKW$?,P=#J#WNFD?>.'#PW$R65N>C^G_DO XO^XK\\T)86R2CJ
M6U]3&3P,/P;T!%H+V1B;[?<9MEM]B3(;0CZIKZV/ 2K<GD\>V;\470$Y.?P/
M2I+\ORA)1(8-UPJJC(K_6?KQ!_HV4Y*/ 8LK</YCP*^#O&/ FH/9P<Y6>[X5
M=>HZ[-ZXHBWH'%44QHG7RG4-<G?G82F#^LOF64Y)+/8 >&[TW]28.H'OWEPJ
M=Q7DI7PB,V+!%]Q8K7ZM4:\->\EY;?-Y/.U(-:YJ%/PF(9)URRX*NX.Q/@;,
MLVP= [!H#/<\J(8YVP465#2E-;;G53<J+?;U;;7#OLMB#(D@_%:J6#X\)UNV
MC%Q;16UX2"Z(EO?H%>BZUC5G:E9X_]GG@Z5WR9I]AD;NABIOULOS:C7N6!$9
ML2P8B[FZ320.T=[PTMS$S1K\"K/^VU\ZI18_2Y=H(J]0\P"?D#3E7^[<"JE$
M;5;AV[L,<!9S,RB\?'O'4+O\:N8EO%8J'<&\#&BLL+EKHI0RZH#12PV4O'$I
MR6X-KT[HIR2!6,EV1!8\^YQ77B71R'#PH'.L.E39<]R:*3B]:X?WU@]% Y'W
MMP:T(\1/ ?6(Q:1OF)I#6O>GM::5OT%(Z_W)7E!2'E2[BWNEPSI<GOVTS.F$
MS=HG3WDS7CU\M-6O-98O-KF]4]=;/I.>E3ZO("N?^Z)@TTR/U2UOK3LET%_4
M+M<G,5;UJN+'T(GZS@*_0_>5T$ "?+!)@R3.$HN)7<X6>I5+_. _7U+"KN@T
M>B5R4%0:8##C1'B<07I*)[".ZD"_L./%039[<>,+YNE%;FQN<(6FL>R1LI6$
M\TWZSHJZO*].,]$S!WHY]71='VI6F#?8:??&,!*TQUI.NF?Q^PF=)>;T8N]E
MBE<TX$?W$S#K7'LV(LR1\\+VRT6VW4N]SI_II2P(S:-PAK6LRI56&A2 ,(!D
M?D%K=]JYK0\)2Z/OO'G8#119OMJ_I6-EXS5^+XOG?71-\[%$IY9!0"QJUX9:
M![[5YOQAG)#/=,;9%$-Q*U!;3)6K\%N>#[))32'7COM[A>'C":&4A)93," N
MXACP!JB],&W3*:A,#'1%_EK[;=OYT;R6F_WFY-U^7!70^]HER>??HW6=I*_M
M\%+10I7<F_BR-00#+=SP07?WNE3, \;5]C/9]75*86#"J\&AJUQ^@0W^%C.=
MO"=.2ZR(?45-WNF>N8#/[V[K:>+#ZFOHK!X#SE7KG]?>K*(C*4WIBW]@7,@M
MU]+V&,^'^>"BOH$G;;"<!5O7\ZDCU/,XZ.CFYG@W2 #O,'X!\FNJE<GGAZ>P
MSGM;J2O;#Z^=:;&=^&X+D2J2?5"=C-J:;$;()2S=_NP3U8OSKR"6WG4=,W,T
M,3;XH71E2X]>HHZG?L^O.NTAV@8D*T04GXT1IA3O' .<:;D:3ZM@TN=5;RQC
M/)>FT]#5P;NW;_E]":__.E6TM*+>+Z\M;M,.J>S>7,'_7K'$R6UN'P/8%;,X
M?OV:LG-!X=(QD[K.97D2FP/A3,;I5CP2CK*VB)=[?0$8;3(']WQ$UM9P$>SN
ME^;1ZME3,U 6ZH40C> Q<9L-?<V[$X62<OT\!CRAN<OG@KWX7#'Q,4!M7*[1
M.- >KTYER"J$-NI']CO@9B)PA]W<E6[!R;UG=V%X:4<9>WYND9:S-U6[L-?;
M26 9_Z-&_Y:QM:(5^RHOL']A2)!>AI&C;JNHNF$N\2CWG)ZL1>4[1XG",K,:
M]PB\]N8\Z0I,D'@5UXL=[SP&<! )NQO=:4RISU;A_&E]@MRZ 4TYNMF7A0&%
MY^XHL'4_BVCM)T:1Z'4=2;90"T( $;*@U3+4Y)./<;]XMJ*HK4BF)4OQF<Z6
M6A&#G5*D2<"<\L!-WF_]E%(88@[%368E"F43G3L(@>-IW&'+-6.>6Y^9"+Y\
MB:TB0FT=ON%V&7A&0C'1&7<,(+029?#IFN,R!]/"[5E,^],*'4(3SUY?/(FW
M;?41HOC=S0J8?1@\0ETW=<TKDX*5'@,>Q&LSOEH RC*GB"7KU4B91TKB$YOL
M)50V2TN_0C0#=X+6O$JH]'MS.[\J62;U[P["6: [W3+8\^?+X>A0K%2(]Q?W
M=)D\JY=7V:13"E3]]GAW2ZIW;R'3$$[@B9UV",]LIYT&\0-VHXRE%71JV'X$
M:!!:@"D=-Y%.//*QN5EZ<\]1/=DJS$Q8A+7UMQ3A-M&5)$WMGZTQS,!O= C5
MUH4=R#'OU"/.8R9ZU&85C!BW2![/M$I<6"U7I'4?<0,R:K"HBKJ.^(C:&1YB
M+$F-;(MW(P;J$9/S,#83Q#3]@!0!M=\87Y'SU^SNWGL8Z?7\F0[O(^MM8(\=
MVC!UU7?^.L]O?P5I0UOSIN&""$/?EU^'5HJVOG)\^IA_KG;(."!8M%*@$(Y&
MG*#*PKCP%IWQ$X$6>#^5F=.1ZB@VJ'>7B76?R!AS*WST]-C:17)4P.J$[B4'
MP4Z,^":)!"1+$=7GA:*S:N1>P1Z+SL9SZ6>PM%//NUOF5WW1Y06- U/I+X62
M.6(?\#^S^;*N^)K*!>\"5QUV>#-KX]%M<'5\5H>G@*(!"-VJ8FH[L480;4T+
M6DF4^/9,1;+KA"HFZ/26_A+1AN1$9B#Z9MN1@W&ISYLL<#NZ:EQ%S@M2165E
M2(]32>?[FE[S1;UEOJ@0]^Q9+J^J??^127-*AMPXKBY[6KI;B0!LF4&-:-0T
MUTDW(\4K6\A-Y)9)35F;9J2G#HB/VHD"-)GA&[NHC(V4;%0-3&@>%>4++>[N
MA//M.B(D%1@5?>_LP?'&4XJWDNLB%I])T<UIMR.?(W@0'D(GR3>(0F7DVSAJ
M0C&P8G8]$--9N?[44#BCZO3;F\71QNS%%>J_?&RSPH&!)'$8"(_N]&8F\XW;
M5PW8S-EN1]F7N@6R"T/?F%\1V--*NB[A^&C2_GXN8UOT'@M1_!@0"Q3'[1 Z
M<7*Q0%\LHZV4[I>1SR%]MPGW$VY_QIB=>;^_&$8<:,ZJ?FE6-KLBVY*BE+,W
MY63SX<FZ6?FT&NN#7,7<0$F#KWKT5GV-ZJ&I@^JY^90,U/^C[#VCFHRV=>$H
M*DH5!>F@@HA4$1"D146Z@(#T$A61#M(D2$B4(E(C(" @1)I("4@)("41:0("
M4D.1%J1(32CAA12^N/?=9YS][7/ON/?'^I$Q,MZRUEQS/O-=<SZ/2T4DCO?L
MO B.9-_90$YW)2X.K;^9L=D/,%"+R^"BM@72YJN*^![O9XG/QZ+G<>.KY#"2
MZUIC*7QPIKKBM8:C#Y87O[XSP^7FI) \ZB[L Q[I9TM;?L$^=IS?X,9E,3XU
MU'&X!%7K)YV?/FCG5$&@L(8BS[J[Y8B^\GR!_J0RF4TZ35>L64H<22*6$CC#
ME5# 97R[;[1=>JQ7+CX(P>TV]"?S?LH1S1]^71G"O,4L:CDC(DN79=-;$>I3
MZ>859[1%K7E9,(A@"/O);]/S1:KFEH()&.NWY9L;F"'S'42UZ-?^2 @'59[@
M.R'@*[IJMQ1?8Q.4 -8F"C=Q260]O. GE-+OQQTGUE7#)7!<ZH2!>EI]_T0I
MV2N"C!AI4B\#G-O2!3JCFESRY$KG&BFKX&J'UW4\4->XRUZ?GG*HWCCF_$8K
M"CE?7DFY Q,ARE.EP)-5,W-:C7.BK!-_^\CJ8C0,0C[:_GK-)&-=NW4SL4KQ
MTY%T?D%K=>C4G&BM:QLG!U#7H09^154AS;2CN%Y%%.X+I,<TZ15KC.[QQM]*
M7[MRGN,-FV2/?]L9K7ME(Z\3+HD&8[,\L(>@'YV1VW)R;7Y*#^/?8X+"R@10
M,N:X2Q4GOX%=4SO\EXSKPO ) SH\W^'#/%,P:4S=,)R?:E*#C3?@046N[0K:
M3!8$&Z#=1U>O'H+<M(/],W8RFCVCRAMGL^JHER:B*GVG>F=I,"-1(G9*8D7G
M6'!KWM4=%XMAEL%TTIG-HIE< HF194=F=(6EGT+,*L;19/R5\6ZHK5M-QH<@
M9WCT(:B@ >.O/ K8JZ!.:CA^/(MYB!O<%9Y&"SK81QYP/>M%W1>IL0!0^=3H
M;'?=MP>ZZ.MT?Z-MM]^E_V]=D-/_O0LRI&C] V*>4TN&#=&KC$?LS&@^=PQA
M7A\HG7(_!%4G+$4_N$\!QU'-YOJ95^*_;ABQ^SI^'I2;5D2EN=1B,_(?\5O=
MC$K]*A5FAVC3VZ=9 %Z[!PO8JU3M>L!Y]A7I1'9!>>XG!\B$C;M=J.D"[>/*
MXMSY^#,\61[ITY.6[R[> ,WS#._P+*)JN"C!<5ANX)%S7)@%P3PL-WV3L^J/
M6BHUU-2KU_6TAE#N@ZOZYY'-%PQ)'P,1)[6$P*WRQR:7,W/J@Q(\YLSGV[ 7
MD\>T)2H_\0U(- :R?=-<.#'6(BT@I5M__YY:K&2Q=]=46KK47VV -]_^I^*&
M_YN1)IFST&8F9]M@WLI6=R;$3&+Q7XU#YY \?^LK@E>&KJV-*+O9;SQOY1>F
MG%O_+K3$P]?M7R5A'B_V3/0??#YQ_^+ST>@L6?G9M:?Y*#Z1%L?4H8 O>C&@
M$SQ4).!7I2IU_R])+;>9U<W_?E!F?8,4T#)]&7A)G+$A^D9H((+F'"WN5;N5
MP;1=F+-D(R.1TU)ICFW/'P>5)\:"J!32WAJ-X@F5)B<3.;\>8QC#6VCWG(:W
M:W'?1.Z I3%J_/SV4['M/MJ4UM;\-/8=8.N+H @!4IVW:!_!'IH6'?@<2=)C
MM6=191X3,C$7OF0J+DQ$O>ZI$96=#.4Q^Y6HV$N%'H+>)L*8#T&?P3&XG=A\
MQCU2G>S=X8* $7I%4>;Z,[!@C8&O7(%JXK&M#>L D=@O#ZY!%QN;"THM"GG)
MV3EQ7UK7Y@P+#:0I):O68WNB_# [ ,' )VU8(2(B#K-9Y:$E,RQ>1:3AQEU2
MU@,*GE@9?R^T.%FPT)VH\)[DX-O6/^E)?@!H$L(@+1 N[!6]HE4!X>::B5=9
MM/1@I4DY\ A?LN2[/OW]V/:FO/ ?W$?UWL/'<N2(\W \P[A1X6(CL]X6]#.T
MV[ME:3<?ZQ^/C&E._W0\"Y13K[KL4?$-P;'<$$WE\274O:Y06G9IJB1*Q*8%
MG]%EO2WNH#4T>?[!?!U/MIK"V_N%$Z8;SW13I0T5_9![B"W/7YORX-D\1&5J
M^@L9^"54HI7BG^=1/][8=SH73?URDHG))ABIYGJ^NSV?(NYQXG?7/E[KY1PJ
M$<+<])"(%4V BP(I^;US-\KH0S3<I2T=;R'H[^];/%NQ.RYA99&GOY[6@6U3
MF '3UNNBF.!UZ6);MW-^#HAO(6PB7L]6T LU(LZ73:*Z'JGG&$,OM9>GY]._
MVW5DE=COP]F'#D&>I_)).@T5&Q<'\.8/5E:'NMD7-H05K 6X2[1LIF#RD$TE
M'&O*>LFM "/+$%EP0Q;5*RR7&$U>H;VEJT._P$XQH.POWLR:2J6TVN!,EZF8
M1LN5!RIFNG5\0DG\SG6+?WK=J,ZT"@;:![\06(4Z$Y;:/@4FZ+M7SN@]"J1D
M+.8PI^99G&D5S+#WKS5C4BNI?L-]KH*?83?9OP 7+"=5/6Z.FH8F%&//NRW-
M_1DDA[0W+?QZ<*4_?6&];R;]>$"'=,!](CVE]._G[IIL:_/*1,\$E=GXY/&N
MBR>V'GO?RW7IU\9D!.#9PMQU$V[8KJ0W(RA!D)M!);JR;C.-/M/;E9O3QTFX
M:"UQ0.4N:2]B\U+]("9.<F-G-:9LH<[]H=\7T9Y42_SYB%?WGCZWJN3_V"GT
M-*^5S:.D-,K2 :1Y9:1+&J)=KC$Z?! W"VE[25+\6BR2^ZRB;'GE A;IVRL#
MWNKSA6M9:?I?>WJRO %K KB2F"P!=\(J@ML=UV33953ZQ+D6^N[AVQ>ZT!O\
MRU]%1G8C>9\_*W3Q+7/#&VEF_[YH[VX6X6+JE7A-3?3Y+-HTV<XK>*"X7U0A
MI&3 ;4)#H(E^(<*PSHA2"D5O^*8=/VO$9BRF)ZBE<BW?Z(KE9187?X7ZQ5Z>
MF$HB;CWF$'3L"&-JP^ C,SQ!OA/,'>G35XD^E:4.1J$$HXI30/@T:^B?,;G5
M&/.-Z: $K+D!LN=8M>)1$\]YR&GX+QS1$ %<;%W!L8)G40BVLX2]MOHYL >0
M@EX9W:O]V;=\UYT\QF,Y(I:=1*C6?[NV-47M7<-50&HJOIHRPX<A1S1L*9K
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M\#U&_P4^]6PY_5YKH3M=NLZU.JM-ND8C_0K?/:[\I N^U\%3^K_+6Q94?7/
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M2O,I57#(:(GCRS[4C&#D:_3M"'R(D8_?VGE]2SY=_J*<3KD#@Q*1:^/$TGL
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MNL./="V_8'*4DZ^ 'O 'BS&] L7/OO"77G(U*;P^G#8AJF."5DLRD=L;II*
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MV$&T63<D%>G)::CD+MG&6+*V,<E\Y3Z8$U TNQDNRJ:\&8<Z'03U"H1P_ F
M>/!:7 ?I#V?G@]*>J%K>8U6\5A*N?[Q#SKR*NR!?L'JV E ]2Y[' IK$1#Q9
MERCTL[R"Q&3JWJ0=**$5E/.VZB7F:/WY/E+3X\]2SK;WCYI8DV"!Y11R+BV/
M&D*Q@063>#MQK_$L$VG-S_@?)EB:CTZ=UCO&PGTD,H8K(+[R>)9,6PYS)D6#
M0W2E/DBD.<PTKH/@)'UZ::CH@YD.SYC_?Y7K!XD>H[/#[M!RZ;( 8A;QS?L(
M!LP%Y-]/;#6HMF;%6FO:OGOQ.E_FASY+B<&LM3P$AFC!- 1';S+\5@F</]T^
MEC<3W_J\9L(M2\B!%7;T"UVV\.!9KZM=456^6AI.RG?#6BX;[&Y^M;E\D#(^
M#KL/_)7^L64X/WMH%/PX?5B+A12]+DHR%[3IC%^K 9\QSG?#"M>?QZ6P3C:9
M=\D-YJ9.WSO!N3$IJ4"7@+?@/B/7)RE2P"3Y.^,2CK9 5HO:3&N6S08LB&C?
M+A !$3\7#LY<[%[1"['AT7NSGTC)<+P9?]R"5+&>4@I-<:*AZ9<]IJ]>0[CW
MST_95FB,7HJ@E=]"?JMW%#0GF61X/Y\6&E9FA1K7JR559NI )#^;3GO/^RRQ
M;ONE,1577$\4P-S5\%1#9A=L(H*;T8R)T!08^330;AC[\?U9C]&]1B?*#'%+
M"TM[CW,_! %B\N%:+&XBO+1\Q&R&B 2I+D%FG5_C%B%./E8@-=XN$NM\>O68
MM502M=#ZR,UYY5W4^LR<*7!^;^U*,'$%WW8((AHA3@,OJ'< A#NA5+<2P*"U
MR:I%3XXRSSP/OCJY%\VL#% 5ZF)IO(>@B%?@WXH4A4/0>-WRS,$UN_=/A,,>
M99DG+Z4T%ZQ7/_?\F-]BY9-]A] \YN@H/4VRVQM \<-'G6[0LN 7J;[#3=:4
M2]336"!X-@2]CC<FEN>6&Q<;>5]L*U7,6 Q^-G/^":BRX^G5$]*]'6YYS7:!
M\X:9X7]FK/=RO T3"WZAG":.__^KA?Z.>V[_5*?MI/U5EU72#"JH_^DC_B.F
MRU/W<L;I8-%I)YJ>)KQ\*$B=_=$W80O#IL1_GH>PO4P=WCL65/%R];\H!YIO
M!0H_TT/]I1R08_VG>-!>^G\=B6 OAN\=E#,F#*%X4/T5*;SRM-DNA"/,K$D\
MNWCX>8/Q3A@#EFTYCOZ#!E3>XO.HUX61P-*Q#=ER,4ZV@>N6PSOG1V*!<^\=
M,^CAYJ4FS:K#19<DNR0R1Y3([KMW)?.5_N?.51[TK"DWZ@2TJK_-V'=)^ZQ&
M<-I^)\KWHI*%S@XT>W@I7N4&3XJ.:E>'M:YJO*:&E<A]#^D.@Z+EWHK7(ER(
M8]"2>>W$98>)5*,$N7WX^L+[$O%P/]H4J:K2XM5MPZM65F9QCI%/*Q*P9WHO
M,M#F6=$358VZ/?0ZH_IW5[P[BU*"9#RKQ>LF@T''?$Q%+97=';WZ9$JYS#\*
M#Y9MFF<MI&P,&AO1I^/,MYH;1 U6,M-?_OV.V'(#)C^+5B34O=J9.0UE;K/#
M;!3.T3S-*9I3OQ5A)%JJ(7W_M>I735W%'*FIG%1B#SF%E@@7 C@XD7 N(O*U
MEO#TRF=/.T2\\@D,10<S,O2K@/Q;+*2-J>8#?W\1_WXTTV#LT&2 TVHHY#>L
MK5[.$%S?;G@FRGWTX_ZC?6&=2ZHU.\FP0<RNM2.ROAPK!>^?%J9]!C^9W#Q)
M?3BXR\D.!;=<MQ(H>BU1;R/V2K_W^Y,,A\6CX^R5Q&[A6R"2@^B:*<EH#A]^
M"/+QY07FV['7AY2F1+8ZVXP\BYVF"YYV#Z9OA3>>YEB+#^CWV'_\XGGL569N
M6B,YUFJ\;F^2FJBF)3PGN8 AHFQ2R#7-*2F&Y*7W^S55S8LCM3\/6,F\P,M9
M)!/4>5ZG+E[#NNA/LB>8I<(K\"VVP:9WJD<_ZA'2;__]BZ?YF>M::NZ(4S@?
MFFDK6"C0=$*^!<X^C&^M?0Y)" 0+>)BZ*Q>0E[E[O*YS^<=_$7,7!JF*O]PR
MD?RZ4VQI+16?.E@WA]A6([WG%,BHJ;XK)W&_M/'2);XNR2U)P^NI0PVQP5-*
M#8[@>JPH? AW9%=^TMH8]U/#C[TBG"I*A$-.+3?0ZV<>TW]N>3M:F5=Y2ST.
M]KH"VID-K#A!BZ]HNN)=NEK,NRY:0I4GY8]](B)>\]Z[?N P^'B_=B_QDRV3
MQ#/L@J6F_U/..&>L9/ZD488!8^O$^>Y*($&S3^L%QCQX"E+U+:(FXG&O?F\,
MF5Q;\H=UE2H'EH5%4:RH+C]W-\?#5UL0-9?;#T%'J29 80!ZTF@.=QHJ-WU#
M?$CF])'S7QIC^9*-6PQ??Y=3.2$>ST5:SN?+JRZ6=S?K^;)&Q'&8S<5C;>PL
M_!=34@9TKS2ZGT2+"2O%K@8WL@@6<HND7AXPFG/UIA@P%KF&-T%^ .'W"9I)
M/NAXN.<CZR/A/IO!21)/TD^6YN!WU/]^L90JNU^#XK_=U CH&I>HU4XV6GF%
M\=@B/QS;.5$&>_8E[CY)+JYB/'NT+N?4S^2)VPKUD^Z?;8U;?C\*=4_/:?2_
M=E(<8.I/W,2M&9!4Z.\V2_/ICV2GZ*[?]?9@9TW"W,TC,^F[T@;MY."XN!64
M,8?$?U(W4ILKAN6!\\'49'D1Q%B7[R&H@%#ZE\Z1B 6K ]Z,< ?_2^?HY$ZZ
MI3.S?I:([5A:>B6Z7CJ6Y]M0=\KM<UD^+5>X;9FSH$P=7XC/!!BNWP,^ C\Q
MJ-=%RYHS#C"_%K1])*UCIJ?3=[>QNG^JX\;WW0NX+M32KFG4\XH?.R7;IN$X
MTC6@CF3?9K!51+UD]3PX[?E&Q%W,HT.0]E(\)]GXN6,(9"TI^#INCI,7NLA(
MC":#D+$Y5Q+7=*^^L/' J]T5U//=\=::";XLWUQ_3/(3E3T2JX2\GQ?[3\HE
MIFR@F7@@&@<Y134EEB]9>/)1C>8HO5)&WPD</V7;.+G>7!'SN[??H>LWBF4G
MIE.Y.,DE1+V7:W ^P)[.>HGD:T)<S"HJC,I!%OW!WKUJ5[)V^@,O5(?UZU<"
M3D<276Q=K$MMAJ5,#G=@6(+0O4.]:!IGMM:9OU4'X,?(R)FJ)\T4H=8Y;VT'
MXDS<W4&@T0*/8;I>A';L]L<']+T$PTZ:E\7F&H:?\#?-*J*>L2<@XYK4/U(Y
M@;]TVV>!F/G^B G'80X4QRX[IS$FASY]BF<6TSP\&^_PJ^WZ)[^M<Z 'N4RB
M[HF2)0<C/J[2*X<@Y>K]L[MV0K$:#?)X!*YX:[.#$Y"8+@XBE<R38VB)8'=T
MP"PB3CGANB#GN>M1<Q19"^/1N:BC-[?&G:[$N";<O"6U_=F9OZOB"L.[.3LR
MD>\S (L3?<#I_(B6N"=6C=2?T"0O>PA*U @F/(EW]$@_&2-PL?-,V3,RJ?S.
MTT\7N.=E1[' )]\UF2"C&THTDV[!N)!TK\_]?(%^R[=F8U-?%_=T3Z,*-STW
M'V$KC+(R9!'V=F0M+D": :\^DZP9%O02PDD]3O(DCY/P,5HLY3&%'F94T:8A
MK_Q$G=-Z4K:FQ;KA&Z%* 2]9KS^3DELK7Z%@^[KQ)M71II6UB9(/$IQ?20Y+
MY1UY\>$9R,\TG,\[USX4FJ8Z?^_3ZWI+I@],GXLL'RGP2/?657O3?L\1AXE$
M Y]DZQV-%'(G[6W-S,3>'#EB5MBH(\#-/1<Z;T@2<&AY<EE1^>WT@\CPGA<T
MUL=)RY[2Y'9:-/4*Q8:3'>@Q)-$K9\&OG4XV>58<H]XF3G3@,YWKC^KGW#C"
M0 4W05"'AY]O""W]TGIK95:L.M'OBL@H*!Y*W4];Z1\*6$2]Q!%-4=Q0WWEC
MW#H_Q1H^HB4&],[+7C:J'X+)^I6Z/;,S0>79_9**^7'=2K]R?PMD^?'RI:OU
M?%W;AZ 3##,3HTM F5HSH[^:GD"TW,%>^ ,^MLM^>^L9X%NXK/;8^JG]+_TA
M _=S90/*;6;\-FDG>?T5BXZ/]^/-8/I$=CSR"6#M.2^L9GK&_D_^O?J?\PU6
M#:^&ZV\I=G!8LIX^HMKO-3NZ= ,-K[1'R$W8A]7^ZE_900AN;(;:;VEI Z&,
M-<OZJ25*[Q9E0[BP(A+P>#O?;X>@V'O05OWA@H%[1D\K'1T<T"D5F3<%RX5"
M/BR!8)AU2"URK><AQ9G^ RY+R\28GNO], F4=*B[*WN&WE*?7,N\$7Q,)O<+
M4EC/;E?*LU['U2=6T7:X[7[68LIJ[_80I(77E-,$U7A\<$8VD&I+$,4@U\P*
MZ2/@JCX4Y>H*^+2<DF<HZ[K 7-#KP-V,&8H6M)!U(?V>RKO/)G"'O78G()UR
MX<_,&;"G;]0A".-%5\T979K+R2@9GUPN?806!IHCNF4&?4YH9M]D"5AW1'Y%
M(1&L.'=P]!OJ?4"]HJO$+0 R;:L7<NEM[>]>3[]+33U5EE;[+C%XU98.W5LG
M&J6*[Z--C#6%)_<Q3PR+= L"1^QFQ ]!/[9$3\*[,H,C<=Y@/O@X%W0PI+S)
M?G8=?#/EEN<EF_6T45V_J^G/;&K7O"<4$C^64@5H24HSX:B:B@[.B4?]'8HK
MZ:+G.)+W!&32I 5LPL*G;<++LI 9N!]=WQV<FT.5>;1&"]'PM'W>M>)I\BHB
M ]ASG6=@ZGE3 $&2;LU4H7+S=AR"0('\N[TVT$8R9+C,2V*DH%%1WTE8(N0\
MQ>&ITYFR<R.0C,>.4[=I0XQU]0,4YTU?0(C&N%>B[/#SR[QV)FB.](!0O\+I
M#BM/G<:FG!75 HONALYK)RRVF=[</!][(+'7DL,YC+'$!W&RN%?/Z-XO_#VJ
M4%.B=_<&/]]Z/T\!2%@Z[Z-T)K+:B &QL(<@G'-.#D\GU[K@!'F?+OIL3H?;
MFG_LGTHCCY(7VA0D%GTD7_'[7.*ZD^'L!/['N8 ;R0&F#@1].E$?I+ R4::W
M\4SA3EB836#?D7[#?U/U#8_3C?V'T,@LGIW2;&'%6.N1@[_-!8K/?G.$B##I
M\,R8O'?O^#Y;;&YYZ1GCIK;_44)H@SKSB/3^$,09]%U+V$&'H^G ^-MR57]"
M3*"SK^1[4@*PVHGV'H4D4,4*H(R->% 4KDRZ/(;QY/>6:\I@4=4S+RCEB&:.
M&/O940>^094F5!R%@0<#PWC)"2-:JC!A .,=6.V!.KN[BM8V'Y3W27M0M7#N
M"<;3W38V_")7)"C#5&;&$,9!\BFL0+3H867&M0DA%8%OB?+1Y4J .2EG+.1U
M6Y? [T^_KOJK(>WB[M%B$6Z;IV%7?,<;VV8P&,PAZ(5 ;^"^QN;Q?$_3!_6L
M1QH5W_4</P)KY2#DEV]F8G918_GMV!- M2<IE&P#-+K/4O+GU,$<*YD^7^8.
M0>M&]HU&EJP^7T,&U/1+CFY,WV)*ZJHPM'3KFJ8);(VXD8=(&LN#:.%T7T>!
M;;S1RIH_BKGI5KD'3@CGR2YO-KI1+AM(B5.JK,M<R%%W4;,X9S/\_OSEY!/7
M/!D9P6/<&!':2#^UGT^U'<'*0QOP':+$A/ZP.4<+0Y)..P8;+20K9M\BW.3S
M6>W-B^\NNH_Z#D%75<5FM$#T]HG-ORH\Y>ARZH.LMG34V8\&Y?+R2NVOC-QA
MT0EC:V'EK#>D2DY+O6B:5^Z$@6DO<6ZH5PS YWT(>N++#A^3YHQ8J X-,Z5?
M.>Y]6W7AB?M\3;TB@3NL]\4?,0GRQ%=GKO6+'^9/V6ZU0'HE4 1K\4)+0S_O
M ./)KJW)+8U&,IH4 1]&$0WD66 !0(*OHN>/P#\2::-;]M#IV2G9IL%W!!==
MSIK/5L<N>'TZQ@2Y!W.GH=8E:$G*FQ&B+!AA:Z-,O$XRA-.!W6/1\[4/P;=&
M.V,AJ?"IBR5SP/MBZ:'8B'F5-<_9_M>(*CWJ-=]P95?B1I9+T<3D<GJX?(V@
M59V+6_;PYVW_GK2NXU4FM\HIW\Y T[]"V)WK@042DTYST^>H22M\;J6 =X9Q
M)YNY@8/NT=DS#N&W-%R/2EO%%W=9/-N;-.HJ]&WGT8V?M^+PH*\8[T_1X_?1
M=*55AC_$?J%H HHM=IB%9FRN#^SA?$=5O=N$I->]5K*M85*K4UU:SZ^BRA*Z
M'."(ICYG0(-WT-)_'+&)K9)S6(?@(G_J&BJB [/]0Q4^W74)BC'ZMBKNQK'H
M+'CET:=3[1Z(ENO8TX"K+JFBW3=!A ,7VL_AJ:70.$3E>?HU!#%.<C!0PAH(
M/U2QN,L3/3V>V4;B;65<?%J!<:,\:(\U<(MD!699M8.T&LN4U67J8ZN;7AF,
M:5C<PEYKO6!KZVAK^_R-OKI.RZ/DQ)PU5+['(>A5W&^7'OD'DWB;PL44(Q)^
M4P:F 201*L;%YO4ZD"^MIL5&8#IS#'2H?@B*G/Q6VS"R/?7+_:LXUB4]6XQ?
MY-IWELU'-X7]VU!\1.:8% *DY3LCW@[-6:^;E5&-\&A$#1H6/#=UC>3E5<YW
M(LKK0^(?[YSQJZ"9LVGFG6)2O&N(<%25]]\V6S[H)F$S7K C1XZTVS !9%EF
MMMG;AR5P)<G,UK%]D[S=^-0VH[I+M5RQ%559MRY&G/FZ)\J$Y:;C%?[0CTH1
MW=,FTB,&5ZT&RW[?\(3*:^R:\\IP%<2,'V$2EWK)56KLJ+)IZUF+QQF1_Z#C
M4J4R;4/KGL/25^$-#CO]8X<@AN_GT;H([Z7SD$P[-D^M",C'B0_]4%M(+'XT
M.I21EY2WG2G!]/#M^70^4,A[O]B=DB7X69@B<;,%%RT ;A4]E3%I.N!E/G%*
M[N,U(SFMG60%2M\/(X4-&[R. Z:0W^IM?K77GWQ^W7AGV4$6R;PJ94UU\D,@
M$29/. 0!=Y03C'H&@U!)J>.W=?PZNOR?!TZ$\/]2>R.];) ;&F)WBOD'.@)R
M#C^"8];P$VWS?47.',9K/<EWCC.^IQ3UK@J9K-L/OC:[]/[]]AM/)!>KUN.@
MN:6@[K[$6,GR@ (J(UA%O/W;"1'',%_1KZAC, _@Q@<'SSH(ZR:&>50#[,*Q
MOS2TJ5.1]32BE"]S4+.;^5?23)X0T-\!!FY(DX,&X$=LJ:=HD;C'82;"VA:#
MEX9D=[+M.@2EV6477W^P>5@=[)F_J/54(P_0"!\7+9\YJR4"-2+LM:).PRZ3
MZ&]]:T2YW>KL3#"/+R?+U]@Y?/O9*P*,.ZKHKJE(G^#_?GX6O^#;5A%_""(:
MB (J6Z$540AF.-LOJC:PP)-0ZL%KA]R4^[!],D,D=/Q^YZ./*F=.>CO+4!YL
M,TM?)3^US+5++I2\H=I\9B#D%\EOV,.L9*7#0\IHVM>ZR'FA?RR ?E*0 J>/
MS'#63(HB162'X3S4:T9_E(7!.GAJE_SE^D<70U_O3'5?>!3[U>!&0L;M5"L#
M)OPJ<LUXGG/,E6R(+T/,IC R#;K6]*K(-:))NO+JLM:%^K30 6XD.?V$']NS
MQJ_OP4GG^"V6KNQ-X^0N $6,?R\QMF,']<[ KFFTG57NK.AQ&R?[E4Q[&7\W
MND@"#"B7W9 33[(SOG?E=$/Y^/#KG@)M.=-5SE8<((%?H\QQ3K+,TUF.%+OO
MI<#NCR@IU8R6HX/X+>YZIGCS--5=G51X<GN@\[.TNJ15WQ3P?.AJ\15IZ\QQ
M#-\._$E(D&K[="3DSH)<Z?<#090AE1'EPM,9P5>$80!9,Q/53HS?D?1Q!$:Y
M\R56:%7:[6 QO- J3,\R=D+'S;OPY*!WLK3;[RWG1-NIM/F'-[L6Z(76*?2)
M0U E[AMX$D>&#Q^"7)'QHT/LUP]6IE?P9M6)\I@_^*O?A5WK0KB:ZJ2Q$@^.
M*!A+N7)X_OAFG292Y5Z3DS@YMJL A1(D:PA9=J7K 5O7M^FL2")J=C.Z@):.
MFXT#?XY=KLNL0B=FH2'N$H2#Q5L"X@%Q-O')4R:%A1/X,UUI$QL57W[2M.>0
M?P\8@A@SK,-X#V\ ,H>B<L]W/N^/H(9\!%80I_\\3[8;[P]6CJ\$IZ4_JRQS
M]YEUZ X_K=TF%G_5G,UHFWN&:(T84Z>?^G-\:6V=@>*2: F'H+GS^,73XRIM
MIF=TY"<PQOHO10]JM8.#7@4?U6CA2RW@NL/UT@OU E(G2N46G$6MC\RB)I;H
M+)TD)D+Z2ZP(-&(=,9X)FSZ;NL.OT:/+-8G.5#WG8G[GXN-8^[3)Z._NCR'^
MA2R)&L/YW7O&C5U4)$?V<]@OC,N/6G=I'5C_+]-H^*E!K  ,_),NY&;->]8&
M0.AAAKP6&EW<G20OVB2]+_DD8ZFK#SK[DR.U\MZ?B817%0]/E!8ZM09Y!K'T
M> ?XGH<N)+RR'(EF*SA]2^BTA\=^4>A*F(QWSP?+7I9=K]WCKF!I*GH]9]<D
M5EO=4.IC'*QNE&5_/WW!;]ECZLG_D;B/YQL51K(FBT:"*S\DI849-U76)%$J
MPZE(AY<;?+$;I4LS\=-BIES0@Q7]]S7/7MAUIG;^NAQ,U["K*11QYQ])ES&Q
M8OB@UOB_;..,(.B.C**+ ^,4+:!G3C12PVZ"HYA@RC'E3E;[MGD(TDFVZ7ZE
M?M(K("+B_5E\+@#IM-M<_TM9]^BOY L@WT)G):Z!3^_:@[F='* IMDC3+XT#
M-<+*<:HOD1E" Z7?EZV,X_BT/+++!C+ .AA'7]V?ZZ.;]B/K9037DU6.)I7%
M7F?C*YE4F;<*AY0=Q>QJ*3[(XLFI;S9(M0F7)']U%Q-%1VY/-;^:?.CT(6CH
MQJJ9Y25H]R"F@I$64*M^'H)\-X%+,U3N0]"=(:HHY3E,NI(HGWAN=+I/GJ=+
M/IWS8/3"P^'[IRY$!U2_*V=.%7T_H_BPH.(!X^$#&1M00@;\&#6AZSMQ>0ZR
M;J$22Q=:P0J[$FF)6<\&$G0-C%Y/_$'_OK[WLY/U7 +I5;+QG-C66UP!?'2&
MJ+LYUDK^./ QL__K4ZA@FQ$K+;I-A!.3.":3=?1#YM@1;E)XB>&<T(N6Q[?;
M2X=Q#_O'+6[1XG!/4)SP_@.1O,S(3+O>Z\6EK($)&-8OA>[BJ>$OAY[J3'UA
MY/SFO767RVLETD<F\B9PX\\K4E27YSPH@:OBZR7) ]1^^Y;"O-AMSGM_ET]A
M%9*&(OI9KV=Y?@1"=6FQ3:P5/HW# IJ0CE7/8/K'*1-O61?+%<?.'+/74F)1
MM4D7K](D !S)NN40Q(3EA48P(EV;L-%:@WRTTI>*W5,JDLY"'O:/?%S8Q80N
MRNDNN9AU\5 'X(.BPC!'REV8/TFETU10_Q#D0SI7>@D_/NVKN/8YY35ZI+;<
M2O7;!W7=VTM,RJL+?+[>]A.:^?LYNKZQY/MAF=.0I+8!'9[=RSW_1EWU'+P6
M3;D+S)/5: 54,8H!54LGQ8Q87BF,'_L=5AS"/)4YE:AJ>]'UME]2H]@;Z3[)
M_# ^T2(<)GJMF&%_?PL*LZ!;J^0F6A)B-A?"#N<&(MJ3T7L)6&&J^^BK^+3@
M9)]ME[KLE].VZ1+*UI L^"[;F8]$9-O,6 7]9#Y%&=@V BY03*'!\];K7"31
M5MR8-QK*8N:7"SSJMK1*Z6FRDM;B$/1_L[8J\!;I+$!MRFN:65LL#N4QHVA-
M>$]0QG80-;PUY+[,I<URVCK#I]\33TJ!A"!:@N!7J>) 8RF\;PLF"13.S7#+
MQ1&9#88P:<2-.M_G,O)<OV=\59+7%PR_\"=\;M6(!:['KI1&)]C>M@8<#T&L
M0C6>W;&9F/U4',.L;^;%2G_X^K]5#/C;(:(I34;0/@1Q1M6M?E@=[/'[X* ?
MW*'UI,:9ZKZ.:L*9_Z7_RB@>\_RG[IL0>8^K[,W?)AC][^?Q7SN+#/\E&_>7
M_FO5P._#+W OWZ7,@9A#D,V_I-\<_B']-H?'C00S@,L^:@1[#+II$;5B\3U@
M)6%.?-TD_V\GS"8G[7(8$OWID]*Z8:OUY^C[@QOS]77U\09L/S^[!(F%GURU
MV)[ 'B_B?8+X$%AJ46&B?*7+\)JUL4=FJ-+!7U4[]O]L\EG#GJ>RD3I;P=%T
M3B"5 /FK40$0^@BK.A3-%O>CMU>0BW(#-0NO;MPH8V!A'!OL%BF=())%[/^&
MKSVW=Y"O7[OMD>YTE[7J^IL-F'#3A4[AIU)?7'I[O$U.+F; B-<Z=/,"\WM#
M AW0Q6&]2C06. OI-J#GY&@2RA3L*=M46S<:)Y_VI"Z5S5\2)IR 2?S_"'OS
M>"C_MV]XBBAKMFPQE:TL2=FWJ83DRT1V,96=D.P9,T7V+800DY#=9-]GLH<D
MV\A89X0LPPP9$S/C'K_?=3W/?5W7_=S/'_XY7SC/SW$>G^-XOS_'>1QO4>:3
M)RY&WQH0D)ILPSH8>5PQ'[W[=<;4X%:_@+BGS]^GOJ9) G:6BPUI1J@U1ZSW
M5#C]%_B3X:?ATIG>*H=9^^GZP:LE#4VV1<G:U&^QWU_]Y'A3/,'7A\.T'@$V
M@=/=]'AT,H@X/WT$V,$VY\@62HF-P>&_ORF%:%*R9=AV2WQ2[]?MK;Q&S 8=
M 7X"Z^ T ?AY.*ZC[@BPW #\"3J^D/+_7/ 3KE)D6=?43<5W@.Z3SF6)D?.;
M[JFP:[0:^RS(QY]FKN!7B#%K,14./5EEJC"3 0.MA.[M4 -%KI?69+@XSZ45
M!OLD[-O7%=$[:>]!ORLH2T< 3@+B"*!0!O\,<CT"',C2U8\ W6%N1X ASY5V
M%UQ+NQA^SKBK;M#96_?@+G/4S5T!FY<_F9<D6(75AUU_+ NUJ2/[J=W<KWJ>
M7.ZKT@ZT%I8<;U#(KZ [B*')K)L+C'P#Z0=2?)\> ?YZ&_Z/*P_U^3N*X,?/
MZ47+8&#3#UATH"+=(FB!L?"8_]T2BF3N__FG88S )4N%?P/5UB#^B%IO%1\!
M!I.VSU)8M@W'N6,#\H)-,,H-J4YA!-7%=+[SBT9\49G:2]'.;&! VFDAT+T)
MHEN\C[887B[<Y8)Q0F"@_:%P5H!UYN&K$,F'25^_O(C@.GWAY1WTV7;Y?';2
MIP)<6ZBX<5AHD\V(C&YX76F:\*TO'$@^B6@F+Q8.]4MOT_Q6#-[94>*%T.5/
MI+YAGR=6N8YY*(^-K6]8.F]_M%+1O70$* XQ[-1,A*S'Q#@WC-"4DP_6WH4K
M7=JU@KL]\M55]$ )I\2UZWN%?[#]NA"DE60P&";D</C:]BK/NY=W[_]D7A1!
M758()<*[7L1S** *RFVNYQ>_F?ENOY:0 ;34G?0G.Q\!TM,IQU45# -,%Z=:
MU="U89 "O%403OOIB]XG?$> +Y^. -+9W?^SQ022U7 0Q8C"7$> -/VED4-A
MA2/ G_>6QXTGNGS](W]5&^#]X%W= Z0R)H7J"HQF.'?.!OS@V5C%V,: MG *
MQ0<9>P0@&[4+'@%*0/Q3%5S((?H).GSDXRXCKK^8]QJ /T(OT'N. &?VXE!A
M'?:XK=1RSR:3;UE-4T&ILW,.]^:<<[SB7'*,A#+3C!Q^9CXQG2+8^Y]JVAPB
MG7 +1[L3807>W*PKF5[!\2KDH=;$?);G=X55L"$PK)<"R^#@BDZMGIO(W196
M#OZ3ZOL,=G"5_O@(H B#(*A*S_^SWX1;C8:$NR]PTP= ==:)<'<$[[3*A+C@
MZ/R*J(#WIYWEV.3Y6?$^HWSUW1F8%QZ-35^*H9[3(SO0$E3 ,]:VE ;BB%UH
MP+MM%=\3MA2I15]V?3_9T\6-[1X+A.%SE)XXY;MLV=>^6=JACN7S8J 7*>&D
M);(<)898@<_JT5'L>J%;]J$FO0<[^2<(\\*AY[DD9I_/2$*V7)+48WJ7F2,8
MR3#K8B%<".T[<BQ,( <U(8[T@VHQ*;@\S9GN3%7Z!4HJ,.4/3<\$4X59.8W7
M?'CN^S[7E.%@?WXJLQ$PK=-_[E7\V\PX5$A)>(L]A.@[Y90B<-56KC%+/C]O
M"BX';6KYPTI@ /)3O%.ZIRB%N)C-Z45PO#@S$92@*^F15.:).(N2@.BQI..J
M5*4@U^%7;9_8)\2=SXCG7:\TJS44^$[_QB"0]T<$?Z,;]J/0+HJQB$9(YTB*
M)KB'76Y-6V<)&%UGAUU8"\;\B,L9(P]BMU94HI:LE0:%SCWZ\@?@"9N!U[#V
M@&/A K"S]&D0&XJ;XHLWJ%H$<@T4AJ3C4N+IWU*]7CS]790;ZO,J6NL=PE\Q
M-\K[YVSSJC$93KE":NI%'X]2AET&;4HM@E["SA ;\G#M-9KPF.V].1C9INN.
M>;B.E+U<2"3HRO6!BU(VI_H(3SZOY[9"/ ]#=V:07O:P$J"J[,/J;7=[N-Q?
MW2;4')<<3J9?D7(EAA!Z>)L*I9@1<Y>0$516W#9C._#(C-4[A)D3@>2JX9\[
MNV*I*2-1 OS0;8VK?UU./.,*.P),R]#9;N!]^6%?'-5H)6B/.98^SC"<:56U
MA_BUE.[!T9F%68]:_@7 F[1\]Y_73)G2;C*QJ<$7$>@Z=)]B!$CX"."^?0X*
M)L+)CHBED42^#1A?,_U'4RX!PWGR0NY3\QOZNR=5OPK0*B)IF?!'D+C6E$TS
MTB[9D7+X$1TM2<DFR?1FM5IV.=K/ 3\O_"."V=B_KB[\Q5<AOIF)^8K*VV(#
M"RE1!0F6M@53WXGUY0J1T8SYVK3P*C=O'>\R?.,"\0$<"S:GG%]HJ 01S1C+
M\1FQ2C?V=ET@!S=/5(JX-$YW/ 6:TW_8TF>6]\ 7N+5^+3[3<5I2(^PST.,3
MDN'F2 &L9PK+E2#8O\VU'AQL#;L\SKGC'L=9?Z.C;^*R:\B#$7;Q7[:2T\U1
M7ZLE.H%U,00OXC[Y10,M9^E8HXLJ,]D>6O2[\,X8_3I8+09R)SM-\:J859B'
MQ8+62Z9V Y:%"Q):-JF$+$@MN&^.E?R)E@FUYTI_7.%^!." WL"+*HIN'#@T
M).=ZGQK^_K[&8-16?QDG[OU%7NELI&ACLM?'DDE+_<$,Y"=LA0ZAFKQ@_]XO
M9,1U:XY0?3@';2/\V(1)>2*:5CN1TRGWB,B(7Z-T.:C=9+L^+5<FGL'&G<;J
MJZZ.V?Z2,&^NYSLWS=E\\XEA4.C=7]5>/<6T<O13\/0-\B'EP:$\]06M7%>,
M:C>N>UFEMW@%442Q4N"V(VX.\!EQ=MOK!VJX2_:-2BPJ60.N ! &C)77P+X#
M@8P(%(,Z54>YA;NQI,!^BU2O1@=1GFC?SH%0I7)LDM[.A.YH&MRNX5R^.YBL
M^;Z4=54+]%-Q*9T^ 3JIJT3E.2;G(=:+VQ%4IJ6_5]N-/MI24HP0]BW)>";1
M!1-)WGJ#>;'"ITK#DI6N,D.B7MK FM)M<VQC?IR]B8X*MH\RX@6>*PF_E#,W
MM^#0M-LR#KU*9"4(*U(%A_ F<T@"]R=]-R_BA@%J4G[F2^EP6&'#>&Q];SH!
MU)K*+;W!85^2*3>.7OQP!&A:B$.=A?W0Y:&EP(2HSRA>1+05B2M&N@.O& ?D
M5SG-.Z(_;NXKQ8N=]RBPKRASMF8751<U&^B?M\_)ZMS&@G$0JD"6&>U3NPQ1
MU5<PA*]_@?L/FG/]!287+\KNH:VETC%S8T1;\'J_)&GS4?=7KGX.U57A$5HK
MV@D9]V*!X(L#SOCB()O[.%#"T">**9B=TH9#QHM\UU"4SUD<$9A+;"K\:AQ;
M%/3U3:FS?,$KC3+SDBOW'S3))B'*30>H!/2RW\YD2M,O](TTKU$L^2_$&\XD
M2+[)L&[\QCZD40RY:4]2(Y=1K$FU0%Y*T)(5@W) HA_8WQX=\6$"ERS8SLS.
M&K(_G24UIZ_8?+^EL*-/K%B:HO)[D5=_M%L>FM('%\[!Q$.LOV@ZMH264$'$
MX%AM*05JOGSR=[=DHVW%<P%> ME99Y8E7U_Y=44TMX*616>F>F&. )Y",.4-
M=,W4*Q@S!:CWP[6AEECU*?7#O%=.7X$BRXKQ$/,;NR^IF6;G_5F>PQXW7=@%
M,;!2-WJFGWR"B(@#N0 C0;51*3V@,XT=\##B5%_%4H(<N_?U^1T/27MO\S._
M!&6^NBX3TAY<$@<\CK BFU++_)_O-2"#PU4[JDHJ9J]HUGAEHTR]O<.*7;P=
M&SOVMC_U'_=#7D)/-$ H,H+1>R9N]U35LG3E2<I-00K2VW5?L<MK[KNO\HI2
MWW/@43W('/AB&N@$2A4V#*\1CR3FDF.(U!>^"=Z!A.<;#YJB=X1'4:/E#[^G
M5=S>:@Y(?7B5,"C*<8*9N[A"N\LL\[J/%N13W\_3@^H6.=OH"K;+'X]G]_^K
MK^;&31:/43V%G@I^N4R=TFB9%C\.XTR?C'_W]YPZ%_>?,[H@ZWL.=L*@R8/>
MXW%>(T(2R$O_1>#@P](H+SP&P=7 1$;F*-A;OCX"5&P^23S8&^+*8]7H__\<
MZ)5_XY8Z,M>;L7VQ;4OH9*@MZV8-3I')/@32J?D+JS)?L@1N&%!M"&<K-!9H
MG6EE#W28@?;OGI#G8AGC-.#-(XR;NZAW3:UOAEE'T*]3E2EQQ5YV4Q'M]IPT
M9$R@5A+(+D<]3[_J&T#XB=9;7@N>KU]7(SQ7N^%QNJ<I;8MMP%@$%_26>-G'
M]7O#3N%LURL+'-Z\.<]RW+8<@,P"+;Y#24]NHYBHCTA!-;CZ6A0\WO%":^N8
M3^ZPC<O.1=>H%-$O&@_&)<9:%:/A#50Z)\/1GV)AF!<EW9S2&E4!N0D(BD&[
M@N?3RDCVEDN6^M)ZO+Q,2G];:_H]YQNXW:Y(C2W$1<G.CPWO9RV.E+@CW\.X
MJ6ZT>FWC,HIO3VL&H@O"\'6'3*F)(HIOA9% 7P('8N?/2.!STIQ!C.R0D+7Z
M8&12@^T1P,,76[*4D@SU+H$-T+F(#S6Y7ZJ$!B00#/LBMFQ5.FXK6Z>)NC2E
M,E\,EOV;_)!W<?%11'%,F;#MGX7!.?I.86S)Y3F(0_OVSP/'EB, @]KRTX%4
M$>+K>6U*'OYN0)[X_-VE_ /WN0SAV4L<%V0R&;9YC[I"GP76BV?A$)%U%,%%
M"TU0G*Z4EW6.03$.>=YNMO-JGC^O@/77R_-6I!6?R]"O-4G%M2J,?0B.AXBC
M3L/Z#M I,!6*+Z[_&*97VO4U7OL=?-V#]^8^S\?,Z%"LWH4!C7G !;]^R6>[
M*]:-M8V'ZYD(&/Z@YREA%.)=[PMI<UJS>+0N;'IKV]B1[]"#/@YD0'(W&[I8
M)[&MLY41'9:X1>W=TST.7J4:5WX@\'RM9C9I VJQ6@IKF<I%D60(1H?>5"G*
M$F[A)81'5YRJ,]7@&ZL:S-JYCSJ?LX-9 #?'K+YUC)LWR%1.4'Q'/B=7SYTK
M6Q!39N:H@W4,FJ2?D+]SD11D\E?F(Q5<R7T>P]J=$C?/S(B6Q:24[A0>_7*/
MI$"5UKENT?+L2_[G$V( U,JB (*C#M&0'$?9$R2HE=('X?7Y,3A;E4@<A'(W
MP"2L\\ULMY?.Y^R+(47QR[\"WV@Y7WO*D\^B\9TB>&@0DFY&>ZUM>WC38_X,
M\7MZN;LJ2J*U;NQ/N,KB9P_Y^<6"D)[<Y%TAQ9A3<9("(VP6LY=^47.:<KUV
M]0W*W[ZU#D+]0OP:*8*S:08AD[?17D> F2Q]6LX?Q(R$'<6/N 85;W6H+J@.
M\51#T2?#K!\A_?CG'T?+1UOS7+]K^9P]?7Q>5P/J1GFUN!W=JMM"=,(YK,8W
M+/!![*;75"M\KS34[OY 8[<ED\ 9OD+"3_S2+&^=JCU/W+O2IN7K??#:J\ON
M+V3YUPL79Z_&?&;27&,Q<:.GL=6TCB.S5"6)[4"]6N!#UC.PYKFOEP^!HM&B
M3D[J*KLKB$,CV"3P-,.]0:>@/+2B35VQ=2P\!37N6[0.8XG?P7JQESI=]\Z7
MRW:936[&&LS[3PE5JY%%(LDO(3,Q2W4AZ1;$L+4*O!R(8F3>#VZU_96^F4)V
M>FIG7EK@M\+*8?1]KAXC;M]4G N1>>(2&U]K-+]F/U6V)QVSQ!T%$R8E(;]P
M<S[\Z7%0G!6#.1CJ;E3--[=?^[IQVMG23.12C27;Z?['\9A&HEMD)=72;ZD"
MQ.91XQ6<6>856FGH)#('/GF^"'Q9=)I_AS_MQ&^YH2, SLT1.#, 8_#"+JF"
M< 1=P&M]80;Q"(2UCZ+ZA2.^SZ5(<+:Y+K2?&/%<"01AV<DYE"%20B^<$^["
MR=UY[@7DE6(6F,0:!_47F^N:6S\E,-S0?J[VSJ $ZTKJNXB[@&<F4J;/Z[9R
M?0?)<E@#-7"AD:*6#"/+'$@H6X^(<])JM9V0])'C^3T+/!20R1A, BH]CNR/
M5;;,WI)W7!=5RQ<N?&29,^^0S=ZL^7+0]*93)X0^M=!T->90U0/4J-M$7,"-
M430"VAST'A)GGT/$; G._^$IVEO_X2DUOY=B2F?L B"4<Q7;W)6WIZPW-AA$
MV8\L)6"M/WD1\R?!P76"1V"RW=] M!ISO_N/BN=GC][IG+Y[9B;_DK=TC#E4
MH>I'?D&!'+1L6G?^='CH5RUIO[L[ VI[LYJ2D7S=[V7/:C5TY^6]O,%GX8:>
MV88YJK+7ES-&ZK<>I6&"FMY !W]^LE8A!N,5FGI& /808SG5LD\&C=C:6MK2
M5R/_Q+-?_'^'_)$I1FJ4"+J^4,I2]HEH9R=7THXKC@3[WCKZ'()!C#J'@3TB
MB&XXRVP3.;/)QV>Q<9SP>O].KINTL!A'>NV-B[(CJ1'EU@M>F10<L<V LD!T
MZT6PM.OS#I10ZKJML3KX^N3<PI97N$>VIQ]=6\VXD#P94#)@IM4P/Q=;<4K3
MVXZ&G*5:$;,(<PP*>:RQVP:U(@45'[*O/P\!=KXXCVBIJ\G!CHG:9$\-1-A/
MOZF?^J<PC%E6";UL(=OP9Y_*&TQG QX^MX?]S#D"4/F,Z6R&!:'TZS5C*VCB
M?AQGJZ%*?\9NK5(4L_59(SYAB;P@[YWXL\O]61/PSA,H)M@4HF8D2E<6UL_(
M\_!.^&8XL(NN:'P$X*1TJ4DO.*:M,_/F!GV?_FB#:WHV>,(@ _]&/O9K.YQZ
MKIM<3TL$/8'$H_AH)70QJBH1F 3W,&9?D_]3NMV0D!4N\LV^MF-NKZ,H'N@V
MP&_V;53IQMW1-(FWUBWF%AN83!'^<:M]NWF:*#P;-YYTCU\B+L\@C_:+W+!G
M!#-<6V;-H;C1SW0R;-),%*3R^R[1BXGPXP-YE1'VG[84%^3F7KCC[V]3P6;?
M/MI#]83C3O9*^@@7<_2\$7P)GIW$6Q4^X-8UJK@Q4VB7?PFA+39*1!*\28Q_
M^8"Q#^"4*C6"Z!)\&G^7X?H&+1,-7N%>^L39K*FF*5U7GV]JUHK+=NW1I*8B
M7_%EOW;O:<A[=#TKPT24*W#J>8W2:0K?8O\FVK>(JDFD-Y%SC21<O;1$?R^Z
M//8O_U935!<:+'?X;M04D]2.JH9[HST0/Q?(GK2:@ Y6 UH1BM^#?J6!.(^D
M%1=UAW= RQ)-1$_>CR#5-@WS\2::J\K>NP*,@S<Q7J: '!E#F<3[QL'8:!&P
MR47T2] 9-_K7"468\,R73(1;VDK8'538D(OHI=8@?]X[G:J7FD]E_-+];B_U
MP$9N.+Q,1]!+HO>;TV9];KWX:/SD7K ;87\SA:@ =P5/)WR!U^V3"U"^IT,<
M1_[)V0W"R:?V,7W6LI:U#[K^84E8&'D'V0?_V<;8#^U'@$<IV)%%1.<"5F9I
M=D$(Q4.%C@<<^I[8N.;%,RLDV1PBD>P]5F%:Q?2]3-Z%W#K4?*,^C'7SB\9*
M>[NK>("G0_UVU539^B/2V2K34:O&S,?Z_-97,!XAKD> S7V$:_K6\!>RS^2H
MM>CY)/X$V?!E#8$IVUF%N<K@*U0O1$G#/_%Q4O^75K@3222F'IDN.C<*X_1&
MON:+?IL?_3.QXQ8K\ZK8QDJ?:VIBFNJ*4Z;KNLF++,)%?'#FRDC7-<(T\,"D
M<[LMPXSP*GT[=?S\7Y_PBO)$;]'W#<6A-I<_QO_LD47$!A)$NUHY]^.H^J6&
M;B5KC6D.$(=_GKWI%LD,]GWT(?U/1<97: C%J(3Z@J*$3XG(0<?N<4J/]-I)
M]66'PHO_PJ#/OD4!?=]5MI?)/M=4ZF1EMGCZJ_J?EA:')M#E2A0?; Q!=#P"
M).<K4%) O4;M0&),5VN1%4ITO%IMMJN:_\K.(W&;&]IA*VD>NBXW))UD ?^
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MO6?W4A@\]+B.=]#VS\2F2JY0H(GLCER"5VQWM[)BBP/X]NGCWB\&M]C&GF1
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M))<WC%"5:<TH?J@Y+7UO>X:[FRY&XM<5)FYJSC8UJF5^5CA,NFJ+;_Z9<,/
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MU=37;HT& 2E21'H-"@*"@-)[;'01Z4V("M*+@/1 5*0W 8&?M*#T+KT3Z4U
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M=::] 1:;'Q,?SH1P\'7%/D:O=:<^Y!6"'8[KO1V0^J1EVC%1M[T_:?3]%P.
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MS08GM!M*EZ/P%[7/07>^GX.^6ISP!Q"D(3'(0]Z&O_6_BL]!/'F$ET"<Z%
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MS\(QY3GWE#!4!@FU07UO/92YW-=^VE?">#W0U5R!9WAS;!2!M:Y7I1>!33?
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M>F@]>_M+L6EXGE]IS7YRK\+]<%>G0N[,<NTM[:S2L__8KBVC 5%\I<RK'H<
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MPK?9$R@C%5"_KZ:#X=?J(+K#4<?.1J#U)@M'P@RE;TC4<=E&_(RK<23BE!W
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MD76_? $:.Y1QV^;\V?.]AD$X< /3]CJ!?9E]VS\*+]634MK4$D1M6454CT)
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MNC) /U# />VIQ(-:DB,* /H]*0?'UT_ 2:V@__*F&Y$F^?TG /9]-B.Z-J3
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M#2K9U(0G:"M,^WFWR^#G3%43YY4:BCC?B:>:AG_@^.#V3CS4QHWOES_2WT?
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MI@(I )VARX+H@4IGA2TM$2MCY'@1DE_BGS/SU\-)#%*#"R^B(6)I2: FS/8
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MQ&$=AFD]>I=9PAPJ-CB59.#KW68A>BWQJ&#,0<CU07DLXW)+>A'+B._IGNW
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M\/,4DN^B7^THXR=N(TZQ1[P]Q2YUM,>WP6BVE@9EZ+D&AM[COA@#'4#^9&!
M^*6_M;+*AZ"_TU@H?M?B&7?+)_!N&SI459IO<'D+!^-G)COIG<^<B(<DL2Y:
M8>^XS=OP[<BW^AT;%VKWVMBST*WQ7,BV(@SQ 5  YFQ*<OQ$"L'UV:VF7)Z;
MR65<'+]=?#=X[+*P$P"W\U8_*(V21/Y,CT="T)-L!+5T/&A:"Y]2A@.=F9M*
MGQ-WWY-QX378%\IJK$JY.UGN_]602PDG>*I#QZ?ON2I]6G5+Z==UJ73GPJ#Q
M0EMILH ]NFLH#GF, 8!Y<PO!890V//+8'P&K?A>O8EA3Y[EIK^8ZA;@USM[G
MO\LNW%U\_&937D34R12D"\+-L;1=?B@&Y(T)GRY8GZ#J>WZ=A=\ABJ="%>.:
M)'^XD932DT3,9&;J-LZ\Y_E.C4P=M)K^Q]>:=53^\TC\+(.=":B<RV<"_J"L
MT4J9I\$.UJ_2M";W7&*BV[3U="S*$6_ADG0T$_ 4$S\OE=Z&/ KR!(8C5'\I
MKMN2%PR)J;'/5.4_EB4/"_M'S5LY"09*F"]ZG;KX]D6';C1X<((F;,4$R,J3
MXND)&RQD9R:LB+Q3<)T0XW].0]LX-V-= <.OX"IDD5B+3R,!IV\S. VH[(SO
MY/T><@B]N%GD"]:C7<+O2WEQ75IE:>*!48=9[8Y21L#B.>N(^Z4#;TH-VE#$
M%P(T_OT><&5Y$H3*P_C1(ELW2G,B#)PJA[L01*Y;S_^V?19CKG%!R[]+I[T4
MI;N@\ #>5SC2(4-[28]@ G"9P)HM&E\!P64_#..&.L$$>.HT]X,BFVW0X/37
M(%,5T.%,>MC)P?7.NE3A?A7 #XG'I0:NW/*Q1N+SS0?.E*HDH32C6*33+>U1
M6OSOH XD\7D\[>Q^E^/%49IR/F/JW//95:N?TW:]13 #VZHZ0\GG42.S]C:2
ME_6Y3HWT_1%6LIEZQ*-;2+$AY>"V>D"GT#$M'#1KXD3,-7]7BW&X8OG,ZKFN
MY$__[)SWMP\S>#ATW-KO!.8?QC4FH"V7E4'7A31S^1',WF*J02'-D)+I+H6>
MCKI:%8^K#L5WUB^^=?-P5M%Z%VOI?-(&7ETH@!IB J90Y"_T(@PN'54= SZ#
M$%AM+ B%6^"_W9^!A72\RCV=,"_'DV2-M=-5SSK^<Y$])H-4>;=P#4.VY.4U
M:58TKAEF NZN,,:[G5Q3Y#*25N/7N52747P8EM.=W,$%1,VTHH0QGEMA+=P3
M/'/27B)=XIJC?X?-[U3>YMN1WW@FJG;9I^L%BFC*/5.'WZ?Q0<FF/Y$>J",>
M+SQ>. ZHAD=H@WQ\1),\A#]PU[H+9H%D12[%9)3^'.*JS'K"2K(9I\,7&)Q%
MA=R'";M0^@E;7.OCEKHHLHH_EJASTE]KM1[L=?PUAG=_'[^_,44]"[<EQ:9V
M#(4B:Y7;AWAA(>8!)NJWB4Q IYC:]O9&LK#^V8Z3/S9O25R9/LUOG7E$=;6&
MYD3CHK01T%/4!7 (0QLFOBRX%W^<DMUC-YJ&?^IN:V?W[J-DB8B\MDD5)/NK
M0DQ_)H0J6DU!X:*W0H?AKM6_]F'>7L?]"O>4*_M4GCS>Z6RQ :O0P0-UWIN3
M0_PV*> ]X>(K 29"2Y_")_[T]MKD^Z#.(KVADR@\>\R6KBC-EOX5<8X"[M2$
MIM*SOE"B"2<R7 (AR_J5!9].CLKG_YX3]6:36^UX>\J$V$$>I\<RU"BUR@"X
M$+V4(41I<DP3D@K7(P[%[5*I#1(W4_W".#[U%2XF7&:W9>B#W#$QMEL;1TA,
M0#=6#/X D:K.N$IRS2J=->;\7A'B^WS[7>Q3A3\\89P1G<EZ%AM@#V1;Y=^I
M/#:T*TS D\PZ)B WOZE"2,']\9R;^DLT1/21;W%R17%45)5_ UT.EM,E+D0T
M"*OA%J*,=EIJZL;G3O8'E7A.YTW;S=C8W0E=3+.Q#XV[IJ<PV"GWQO \YP[P
M'V3;#=!C)B!"5^8KT> -Q@OYKG&^IGA.JC8UUP-X=K<_O:3W(_Y)E,R*LD12
MJ\6QI!%6.H4K6&&HHJDW6:K,2[)BI'E##E)9'I\%8?K,=-E8_YJ-('>S(/'L
M;^+DN<Q+DAN0WS=Z7'G;";*C#S#J!Y.,.A4]8"@<R<J26!;T-HV;<@F\7MZB
M0WP=EUY(V>D2V,BC*-\;%[Y])M7)PWON#()TP2$WZ^G)P>AZ-Y1N\O5?A5G'
M_8=NY=T=SE]1?+_+W0.<1I-=Z9]*G<= [N#X>6ZBN=FQQ&D# O2LG4W_RT(.
MZ*7KHMH#/7,Q*KRMQQ+DER^Q$L\8$"[VM[KZ!N+Y]07\?H098V'M8("H'L)R
M/UL4F?T-+3?\J7,. 03N3C-!S]-#/D%:1GWBEHDV2[[;,S,Y=P<'MKO??#Z2
MP/U;O1-$N99#[B-N=<C #5FJ37Y'%(B@/> O[B^D.-[=+,UR/:.BK5;G'7/)
M5\9Z=#!N3E!MW[VBFIK8MTW3R8HH\]"=X^9P_4@S60K/@Y6CBZAMQ(*%\#9D
M' ,(/0<_0VG"QPMY0"[$UBASKOTZ#&VLE^2_>F.SX;N$T"IWGA\_+9 Q!*PN
MV&")X]@F/4>@!\7I-W"[?5Z9F%E/;EP.+=0G<"S5O2=DMC-FY)>5X),9IF(<
M3V+BV+C_)/8S.$.(_98L(=RW1[:9*IK$UL3H M(MA!V6MB61,QSI/OG0DQU!
MV&#/'*UHS9@3&N6B_G8/V<WEE#\9N_KC5&06))1<^F4VXUTH6U0[1#^VZOC;
M56"UP08[CB7<2$77^IHZDD"$UX:WTD)D .@]5WTB_DU/KW 5SPU XI$#%..B
M,NO9&LAA''(91&(%PO-6.UE(-&,$0S1'S9SH8?!LG5./1$C 34BJWT*_+9?!
M+H2Z9MYX?T=ENPTJ>%[!4RU;:=P1 ,J^SS*2;%1-"%R+,5Y/+V*(HZ.U:R7T
MXOH.JND,IR.(F:7(RP]/FDU5BBRU :]LIEB]:9_62*M-^HW!?^H2'16+2H)Y
M6D6M#LT,O0'5"*RO41]2=('BC$&,<+/Z@J*2]7"F%]>C. _%3SEQ9G*PX!W%
M)0X%EZQD\SOS;'*9\LVL]!<IBCA-6ME0IQYG#/MZ(KA(XA4X4(3C\8G<VF8[
MN^2YX^/->4_?WL_+;HA(EOL>T"7'<WK7&UD23Y'&;CCG(&:1%05_&U:EZT=I
M8/#RP^JK:C][+N:U9!VKM)UOS]8[::E5Z'9C-HPKV=5<D+@L%-1:WZO5;:?2
MI/0#T30@9)#R8$Z\5X_/*NV54]H!ACQ,>?',+QH<F7(9L;GO5?NESX"GF!8;
MUYS]/M/@.[N0T.%M](D*Q 6*_D2/(\=8L[2O\-?FFJ<QO<-/17->:G0 ?-_"
MRF2'I@94-!/("17$,KX_N+1? 34-D3FL#.;B55P)V]M_UCUJ5L6M_^/C<PJ:
M  S6/BDA?I44EYY7W3< Y=];U=\YWNTOJ_5Y6^.^Z=V]'*NOCC/I?%9LTMVQ
M09VI%7^P' C>->'%%[**:,\.JK31NSC]IQDFG6UC\$0[NR$AJ1>_.1Y349PT
M?](S%S]T)!G!']FPW2Q=8.#K"WR=33A4CPTG)GH%/[ZJQAMLG[$K@:HM<"OV
M/+2,=(?NE9G.#Q[7\"C/MQY#*-PHEV8(B[0U[NV3#=I?:]TG=0VE+E]C"$4^
M'278X\+'))]6\\C*?CQG6<^Y2KCXZ3'W.^ );0XWZ>AFOR5/%;VP)I) K)]R
M36/5&8W$I2B[+-_W)V]I)']>UYN+\L^BWH+=(K#'XW^%E,-&*,B249I*P2:/
M[Z!WN;"\QO.FCX%5/<VR'-^B2LRC?I?+&N[Y<^73L^"V;W\-GF)OJUV?S"3-
MU=@-9 C>^1@EB&)_T;?L8O[1751=S.#=-46KCE>BKRQK%DR,.P4XU^T>CN-K
M#&=Y$W)M.T["Q$Z<$?63W+'_(0"N!D;AC+^_Q'!3;@E]T+Q9J+*:6B$KQ'7U
MSO"M1.[&7M&J\X^-^L^W73$@LMV=<&.,4HH6H&=@E4L?-^N^C4O6C%IPZ][]
M6G-EIE^XPM6RWC ?J/0'_(1?K'%FD9.NO,/ W"X<;SD/X[YA'.F'%?ZC9NQ9
M.F$24*0G^$[9?.:C%UO+*RL=)N"4"E6="1ANI4@S 9PE(,9U.V&#=FCH--?,
M0 [\^L^-W!H7B$?6B)-59/#W"[6+9X)65'\^HF:Z!#$,N/_%:@/:M:%U+.I
M0_D8$X"W<&,">N3KL^-]?^CLA#,!89_HZ4S ;QR<EPD(M4 Q :)?_C8_0_YM
MOPBB6-@P :2^39F<V1UNY'<\:WT^TG7K4 /X7Z1D_A6)<D*4SM#E_4$@0]B-
M#&4"<H*)9@Q^2R3M13S% S6%8<3]#\3W$4Y;GT'_QB8K?V?#H6ARI:Q48 E(
M' 55(>FBW&^1Q.(J)F A>?:!P2:M ZN!_&]D0/^-L__I)G/^&V=-43+[VBS2
MOM1[C $ZQEWY_],6ZY$#_[<$'+KX@C*=M@Y$_W?WV+ L?L#R81TL3K"[SW4Y
MF(#V8A;>C7OP[^)=89AR_1^?W_^#-A/P+XC_#[KS'YS_)3[Q_R+NK^E8E+_V
MRJNE*L?SC,/47&N2[9SM#\DX]\D35OKFMV6/G;G9QGZQ(#N\_Z> ^OW_K+-6
M:Q&%0/"8".%+WQ1&>L3R2Z"2 QP',4]N-G/;E^MKA411N3HO']A6O[OT<])E
M__LB(Q =6;8,"8K8Y'_A_+SU%6YB1CBY?U4M1;BC\*&?LV@H.S%1)?Y7/4E^
M_MYZ!\@O.X_O@?W*C?]>U,-WI AO<Q3;;$TE,2Q^6JG@>V1+NME)\FP';H=6
M)@\5^^+:]/@>?>!?8 *J:WXHEWGX!S,!@6*E<?V_\]ZPXJD8*#GH."Q^0\#G
MV+QVF$:^I7OUY"\+RV,Y4/^V78WS]'_VRF1HKGZ8L.?7_FWBKCUX0X@5NL5I
MMRE<"]P FA)FU M^LXSBO]EA6/_+.-IZ.>52S+4\_H_* X-\*&>'+.V77\0U
M+?1-KYIP/EB.OD?SI#BQ<,@L*ZHO,GHU9V!(\BM*^I*'_U6MF:X<V*KTB'3@
M?6B"#?CXK5E<5:O(BT5_SP6,FPD;@\N RJ:W8!:A>X2>MK=6U SVA?@1HC><
M]1B_&AO2KE^:N<1CF3R7N7IK(TSZN@X'>M8)92L_PAC]7%[P3]-6_DHZ/=54
M[?GGY-H)YSX65H8"X2\I.51%F!:!?4,6K[$+$EY-\QTH\_"95L4D4_\<D\I^
M82OM?L?T>Z"EJ_W)QZ_RQ.JSFZ?ZTTSRG(=C I\D!;#DGOOERVYV\5KC<C0^
M@V>G$R$YOO&2#C*K25QF, [Q3\*F^<R'%.(ZY2X6*E@G (ZE09Y/,CPQ4#,!
MB+@FO08A1XD&7ZGIH% ?U4$OZ914BJ2&:NQ-":^,[3B:/%Q-*R\J7PT07JXK
MLG=T=+37WD]-?7@M<4B^PO7]7*3"C[\SZ Q["^6W9'M2TAP2=4_D-A2KSX7R
M/;"\^R_4Y+^I31;>["1$7(UDFHX;XKY1N2I<FW4J.<;K_(T=(_P9'IB0JVCF
M\=<]0)H(RQJ/>[VT @<?GA9\BNSR*4"25@]XR2Y,0%("A071G6N3F8"\]U83
M**)/2D@YF 6T++6]?%QRYDQ$/(1UIR[6N3YDA @\EP\7,J_V'"DPR1L8\!]G
MB(-59S?:1W+D5.4>F6S/W-GX1D,Y]R A&(IDP,8!]33,4/<\XB?X:+D"3==(
M87HSN? F$O)LL\M""B;6G&W&YL\N\?F]/6;=BJ5-!_1").Y+INRO9B!5F:+9
M;]U"I,<$O,JU2OMQ[HE&1I_L"=?[LW$AEUJV66IW^0_P'%R$M6J:7E2S-8V\
M-Z:(8)N#7V\25A"_9!DWLF:]70#>E4H2>L$P/V<J#)4YZG!7%$D3Z?BRUB)+
M=-NPP*-.NM>]2LDKA',WU'T=7?>:]MAT]<LPUQ@^XN;_!'"?0Q)GI5#Q,>K1
M6E>-M(GTR^J)'*LYL2MMPR5R/(9YUU]4SS?:/:(B"EA![<PXLLV.Y8##W4$4
M^S]8VJOF*H(;[>PH>8=B0-6#29,M24,=)DHSW:@S99O2Q%J40&3I8AS^PK'O
MMA8)N;!I!$FH_#RR3?5OOWNV>,ICY5@4Q7,/R3! 7Z<4$-T6V%N'>- ANNIP
M:9)RB%]8G5WH"-SBRZS'_J5SD@J9CW['5B<\GVQK*RL<0YL;[P\'_$YI0D9T
MUVA>CJ:/I::_@OY^G?4?3%;UM-)9[H(K0XL)B+?2(;DQ3AVR#C.3QD-Q0\,=
M*>'$ +V:GS3UO('"U8G+E.YVRZAY*87ULU(*G4=^'C5YQ4T3N89<T-9F>>.G
MJ2R5^IF%'D+QGJ0DW1^B,0$F3$!6VE"Z.,DT7OME5,#2YG0M@X5S@<54;P/2
MBYGT7JV-Y9>H4TAW5!SFGXL-510/$J136"?E2\6EDMSI5?/7X0^C+K<Y-=4\
M<6H*AS1^=#6(33&P-"]MW0(C1GXA+G\T)EF1$92 ,L.Z?JIC+/XC3>OJG>N/
M'HWH#D 3.I,D6K<O>^7U%1_;/KR^X1B=8VI*GF@9VC+(+!Z+JAEZ-+R%?#(D
M."<"%7!G GBTV3[^0!?#$! @;_O3[_1.?W5V4]C/Q??RCGW]7V4-L-_D0>LK
M!6M*2+P=XB>(FZ973]  U>2/%"A.<7H^GWD[N?H@\S)L'O)C<)UD=.+$%>,I
M(]!)U!"8 HH(NON-@)&H)]6MCY*V\%NA=@3V2 ;_:D>'X=7V>;E1O$":65K/
MT0NOO1UG6V RDK/<Q]BZGA\,W;9#<B,NP>]2# F/2*CV^ CAE="]B&Q8SGBS
M5HF)RXO"A9/9UC;61S4D-'36OB:1RRA)I5J&"RPT:-!U<J/14'7KQ&3U]G?$
M;J49G\^ 9&ROA]C4Q\3.S>O9>PN-9JR$%?0#Y*M4A@!-S ;FG_9-D_^EJ/V:
M"J34&25B>U!50Y%PY9*!CV5[T/"6:]C\*8/X%+=1U;O>;DT?>&:2_>1?^OW#
MGG);:Y@%,?2((+"NVUN0YRG-.;,?7RFC'59IS_I"0C#KV=LZU$:Y[ZUHR;><
MPQMEI$LM5K1R\4'J-28 K3+@CC8=!SD/Q1/=K1R5B-"0+%)YM+/[?EI*!7'?
MHFX"/^IU*Y47JQC=?RFM-/B3'N'&HH%RWTGS8SN0?I$YW0?'Z9^_7G=HNQ13
M)#%QHEQ5=HQB^[2/)^YW5-15'?<229GLF)]'#.#+43)LA10I8D$G4 QQA6*%
MJPMU?E^CS$]Y.V18M>W$<SDQ,.7RK12'3N]!]9,+0F(0JB!%AXAIQQQKX8.Y
MX5:"JRD;+Z&<O]5>F:9ZB:\;0*&<G2'+KL[;7Y8^1:X:7E>ET5F^L0Q8*9Y$
M:B)/_ *YQXM0'JB>DL#[1TB/2#;6^8?I>"Z1;Y[7NO>,U%YWFC]NR5<TZFIP
M^*ZIR@0_:?9F!/ECJ.'K9$K5N@:2>YVX64(%)YZ+DD$##O^].<'NWVE'H"B4
MB"R2=_7W-[O[GY$+RY@O0Y,AC--G_E: P\_2HQ%G:(*4$%*07<T$[0(1<V/8
MK]\:#D3*=05""FX>^UY>P?]<4O](\/D%B2@&G.;* $?Y>5S9]^,8!.%<,?K:
MADS B6F:_Q@&AVKAI=<QCM+<HKNG4R-TQ2=A+53\*LS4+JC>R_M:&YQH:RBZ
M4[/7GG)6\HG,M+G^+,\9>KZ3,9O55.F=SR]'B;K*;%9B1GZ.XK)K:,*K"9I
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M&4H_-B%^FZ;)B-[34MDB/-A#9M%SX6>%*,KX,\C?UE^9@)&7Z!!6U/\-?KM
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M9!@]@W$*T0=BWT6]057]7^R]!U037?LO&NR(B$B3&A0$% 'I*B4BTD1$141
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M?<8)?OD^V_7E==Y*[0#K)[%P-ZSLP$OSW9E.OS#1[@8!YU&T$R@&G\<4B[.
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M4=/O-"VX1WHJO[NCX5%O1U\"]'9<2;<,'N_TK@IJ<V=>7<K[CC3ZRT8/[12
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M>9_DZ>;N+? SP-R04LKQ?WYA<;]Y-]#;N$0;31X;D!SFX0;P _@$^&NG0=5
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MZYS(JF:-:" #'N+G$=VOD"&O4OQ+:+:ZY]@@C <%R]KOAF( ]#D[K),;G.U
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MG24?BG%3H^;;,ZA41(D=_X77&]M[^6_8[3_WUQ4/K&:Q#+$4-DC&C BFGPY
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M5CB&#7I:CJ+XH9KC: #D70*Z?![!T6IUZO6'OY /R@,#B6B(4 (HVHT-(CS
M,^S 9(PN .0_*E!D#1A+,='K"%5%>U?,)J G;Z"YV* Y&PA-5!- >J._&(H9
M:]4![-2Y\(>D>8Z:XJR78H-<KO6P06:U\<C6OYJPUC-JP>)LHXLBA[(/E--\
MZ/H(25W)WD+_6S^+'@!F2?Y4T+ [<_-R&:RJ.C[AJ/N^OBN,D?:+4@A%E2RQ
MRQXF6C*^I$_^\@[3!RH#4,?]K#9VEBV:036)0>9^ %KU\/XHR)9N(BU2E76
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M$58#_EY*>GW+_MV^-['E9>78H!4EQ7=W2*'2-WNDZHX(6.J=C 9QI$#Y&&8
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MQ$.+09B.@FE **@N)](>:RXN :D4&Q2+(QOC=NJM_+6E4>AMXD;LV25P'>L
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MPJV1E8:Z^*#P.T//95$/[A9OL?CO)?H*I7Z;%1=KY^ LKUU]<8OZ].=EB9V
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MG-KY,CC1><^'^^4?=>27\'>)?B0&76D!W;P 3(418]K&5[-UL]_WJ T001>
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MH"X P<=43-VE]\<02W='1[23\L&_=L1XG]*N6[\:(O%$C?6<UR=K[!G) E-
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MC]X:-::6A2EX;T'<> ])W,B1UY^^G5<7//.6V/C=KE@FG =V:_L_,GL\V45
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MNSW\]19_X8RMMU0U?F/S4/E+> 'O^9-DYVWK4S;. -EA^O&8#GG[#YG'JA>
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MS\ _#@^=3^DGB?09P15@%9WP7$8+DI39_:^$-7T>46%>WPZ002O&?, ]<*J
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M.,D($F<[B .Z(6)J,O4"S<5NVW7A]O5XU5HV^%!XT%:_W #,%,\$')F&]V0
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M#S<#^RXA=Q:YM/DLQT6-F>/_%U!+ P04    " #E-6-<D82,I9*R  "_Q0
M%    '-O<&@M,C R-3$R,S%?9S@N:G!G[+MW7%/;MC:\Z!VD%VG2BW2I @&1
M+AWI1:0)2*\B$ 0!*8IT!24"(@)2I#<)O0I(;]*EM] #"<D7W6>[SSEWW_O>
M]_OW/2.,WQJ9F6O..>8:Y1EK+=!3Z$7@BI::IAJ A04 &I@/@%X"7%6#7)P
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M3FH>EH>4L"@?(FO;BXJDL+<50[+!QV&5*_L1):AK2/:)7?]=CO55ZEG%W1<
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MQOE>EUH-;U\@0XMPP8OZMF5GQFJ'(=^8H*SH\KJ-R<Y5<*/FG&]#1H-;1GJ
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M8\T:VN7.7NBK236S*GF_ZRF\LE:DU2?QY*4R(ZUWOBPO7W$^-.G-5IN0FN[
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MM:DA=QFNTG[XZO><XH-/C%8_GS"I5YUIC%Q:VMZ)N^;RXZA24"X2A_1!?X]
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MT1\C<?$C&6JAM)G=)2VG] II,?F0$(:)_YFU>,,^UP'_.=<-UA^?_=_S!H
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M[.@&K.;VN1-/O\/&=)%?\1)+(:"_ZN3KE$6GXUF63JI9%LRO0V1;WL''\_5
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M>C5Q_C9KAGG;)T=#^! UM0N(LV<_# #7 GOLGV4APFT8RLE RM&ZB8RD>O*
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MV\1CP3);#6&[@&0E)>QD6:S5&,="K55,NWFIZ6MN[=Q%=='K^EI#?D$VH??
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M!4N8[H"OG+DOE,%5_G[ @U?3[V]*57,]?NW\HX=8./_IAG >W$P=@T(++<=
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M)>#3^1[>^#CGG&\O?9.SL6=I,&DI"CUU?M_^0JY&PS%YGR6Q<YJ'K]ZNQ7(
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MAS_9-_^P;?]DJ_UA>WNZ>A[8C_ZPW8T-[Q_8=@?V38>_L&W_PH:YNO]1/O+
M5D,Z>\'^[#?@G#T*8G2P/7VP\ (\ (8 +<"]/_C_J8A+&@"@M X ''OSYWVV
M\0! <3  P#7PYWV"[P& BZ\ @*+V/^_[LR:N3]R?_,>NXP?+T:=/ 8"5; #@
MO!D P/85 &"Q^$\A_H9OO_R';UH EX.7 \ 98'^P1P>  L  4@>6+. 60 :@
ML,\ W#]HSO\]_%')_VX=1_9_![">/O;L=,JQ(ZR HZQ'CK$>V:\%7#^@=/3H
ML3\*_"?=TV=.L9PX>?;XL:-_%(!? APY>A)P],2ITR=.G3Q]%L &.'[BR-%C
M)T^=/F/*#7W7T\O*QLYU%4]@N<PA%I?=MW3EAI;C%*>R3\CKXGI^&25P:(.
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MRQO2--$W5'8Y3@FS]$MIH9'M^K,VYV:$^Y5RI,*30M?5"_IYSITN93+,K_L
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M&SU=?3O[S2YX9:_B^8!IS7H0A;6UX]63?8#\$RZM/?#_ZWQA^X <%6E"@NW
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M<"C"H0B'(AR*<"C"H0C_9XN0.G_;)/6"=OVE/5"Q[373?4"*TM2)K1O[ +6
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MJI-C@;-)I>G=1HUWI>>V>H-"I<Q7\V_IK'8(*XXXSXIBH0] 'Y$"RD:<P]G
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M]O^P]EYA369KP#9[JS-C%VE*T1DZ"> ()$AUJX0>$-(@-*5*$D!:D.K6$94
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M'WN7X1W>YE]UP.O(:DP<_FR+3U@.?S$?8. T9'X=7K%5Y<S<VB,=:%:?'-P
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M;*M@7<JJC.-Y_\75R$8C]BE\*\6WISBEFPFEN^ .R:_ZX:Q0\5BAL :;ZAD
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ME]L$$<Y$W\&4-)3.*1[D4-;((RI["N_4_G4-6]1!G.M^R?B7WAWKXT'%<QE
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MBRXEE,Y 2QEL!,QS>ZFB+VBMY),;WLOVK\@J[=JKX$+1A9R3[^XA<ZH7>@W
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M)J<B!V)Z;6W/CQC E+Q;NYT?N-3HPI;E<NI'G(;FH!TM=:?],X2(; '+3&I
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M?B@I$08H(-%F0H"N1&@N K,KCFK'2V>YI%\^I@5>+"ZM=*C0"R4QG>7L3ZP
M,]KYXYA*S))91%,I%4X\%%/E7AVMPS[%?6]B#CPV?L;2)Z):=V4'BO1*5\"^
MQM2H<?W!D\N8Z_K?BD/+0UV72K,+XZU\0SDY$HAUOH4>)B(TRM]_M?$@&?&T
M&A#YB1+#;ER#2-ICXJB.U\9F=V7PYN4-I6%O""_IFMC_L,RR".CG?LG&*5B
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MC;1D)N@H;;#03- [,C[R2#;J^+D"NZQD0\?.@8&W$'LI+3U_R7-7+TK>8X6
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M$1&11//RJHB(1#1KK]YXCH5VDGW_YEK;1\$%02@?A]H!<Z5V(O]Q^?;/F(7
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M,@ !JY$WLT',="$9$ JB!>I"QL-IT#F\C0%6^8L)O#YTH-><9CF'-PTIR5!
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M_N(_+./1\B\X?VS[K]SMZ\I8" NH(4MRF,PT%];3_0X'^L! 19(3C5_.+S#
MIRS/+R%^YL_ BV@!I.+!IJ$T@HEI</?5,ZRKPB^^M \/*>#J6O]6S2/="K7_
MI9S_,_0>!=^3NZ(3XCN#V]?FZK<,5#67?6M[_ @.4+^L&:@?]BCA_IEYC2;O
M@B/7/7YXX7#.JGVG-@4Q1<3-=3"[*7[])*_1+2O9]G?B^7&M&9+F@K1L#K5P
MGOFH,(\/X[B0;36+M\U07I>2@1DWR#1Q(*JA\=^D/TU..6F8*H!70?,33<1
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MUQ>WRN5/2FL 9L1_@[>V$@4EW6UG*!2 JLH=ESH=J,W;P1'A64R<[/H&45A
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MA[IYT;D<O943I?B?O6KEK.^]L",W^]\T*S+ &I3+71*VJ)>-3IT2(,. 0=6
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M?OOTS:O]<?KU=UY?(_4_IP4%14?-! 5RMJP")7HJ.^H%P9X>)(]YETX_\=&
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M /DH'L?4-K2ROGF_)!OT"6VJK&AFFD-2TQ*8K56AM4^/XFF$^$PP%*!2DH(
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M^K2)\WDU_>,DS(W^[<[JY&SC'R;[3XYM<&R#8QL<V^#8!L<V.+;!L0W^E]L
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MRBL8 2-S(<4EO>._&C40;]Z4L&+!:J P.VG:LD@)1RO[%OMN%:<K'W(%J)Q
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M@;U1LAKHZMFFD@2NB,6,BI6DS8(FA>TLB-P4?"RC\6<&FU$CBYV[O?HL*#Z
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MD2=ZDA<3%%:5(:497(RW\@PDXA)>%5W=EH:5]:K(;BE?L;Y=(AD+O"-A%=J
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M'F3P49UVF1_V5/;XE*6/FQU9[G;"YA(I6[BDY'+WQNIX8XPL]>+TX(]F]55
M\COC[OWSLN,JNZW(4AJI-LR;TGZV\F78!GZ[QH?VN2T.%2SB>TY+#[P-3>X\
MQ\$:W-M4TLY"^+5VN1Q6I :F#[-5'S,-YD[&F 5;&X+G_G% !UDUE$YY%!W?
M4V<MUO4?O_DC_Y8)+T<_1ZK+4FK-,P8H:N_@'-@N0=J/Q$[S"DN11D#S:-3T
MY "8Q10$O--UM>=(7NOAQ0VQ;Y^8A3NK3N[T-D[_S [3YV"._/)_1R\Q/I74
M-BK1#<8A$6:"^+W)WD..5G(0(?MLZ(U.((VT'@/]4!O"^+ZXR ]^1'F0M9.T
MYE\[2/=NV;FV],57N'RA"LV&'RY!9)/?(AF;3#Z8#X=9B0CPY!VX1L(*87;X
M8-H,C$X]P.)&[6*'$@"A83$[CB\?DO9]+B#2\VU[/?^CRC6E</GN?+3[8W_:
MKHV"9UJ<V+A;,N]Y5!^O._15>[,G]E@-^%Y4GZNZ\:G:-@LSU;C\VICZT 19
M&YF,RE*$QU45NH<*0)44]Y&!+' F^YW;HS!#49R+(QM*NIT()4#Y=#P6 VX[
M[(2)" X;N_9ZHC[KDQ4P-WHG=]PNNI?)9%^_[@FQ4;Q[?VU[" )D:,X^:3OO
M8%1-.3>'T,\-?Y\UHYS%RTH@3N $7RX.<CM(F5 H\.-\%[#^> C4D7#2'FXJ
M66.>@)8IRR'(U)/G4NVC0WIU3#5NR,P2/6X=OYGZJ_5(#776J@ B>34]/1OV
M4T-U/0&H$"IE;<(0Y1-!V"$0!#?O>0&6 1>7 BH9Q N^3/M\_P3Z;/X.H,[,
M!L >3&3!??X?]MXTJJFLW??E?4NK[*L4$*31*EH)C8($I)-2"0@8,)"&! )%
M+PD!!!*DT]<&E= H@00)$J4)D(0$"22!0*!$Z47:T >4OD<1B(#(<7\Z>]RQ
MQQWCGK/W/??NX?_[6F/.WWK&,_]S/G/->7K<?&!TO:'V:P#!_N(KQK#VPK O
M::_1I3Q_]L*G:2V',C7BC1W73A<JVP'H]WB>^NRSXZG/SWD,/@>ZO>QS^^MA
MZUCR_/QUBR1#YKQ902$K_\VZ 8>2IQW2MA=\ 9+5OJ>KREI7PZ6LU+=V@IHD
MW1^Q^J_%)/.N2J #G8$=WNBG\8QBY=8&D,-#IQMHP\C'[^N'#^C/]?3<U4I$
M>^@("N^_S"-1F16S]D[V$_LV#()]58],*(V%36]GV$CUH1)GM=CVH6IKOWJO
M@=[F4$%; -?D\\TJ2:7%.\TP7PY,#.S6Q'4?(H< /32O<D6!;+SJ.:;?<-VY
M<=\"A-G1J^G/RF@7@MY;_W4!.$AX'='?>3[F4_%R8EJ5!3TV[WVS'NZQ,U,E
MJ.ANZW((^)U#)POI4B-FYC$ YSMF*QA=F1M7!BA]9HJ]A,\>G('L5N8ZAEE:
MRRHC1!,V+6FK6JVUS_VS@($;H%5WG/_6"BQTY>M0<^N)97F7KH8@_H2\../X
M%P8:\$I54Q^F!_SM[^9A9<#1GKRPCEB)W/J)^.;,>W6_1>,JV\T9H6VHG!@(
M]>:E;/5G7\1[Q^!7['_M-^ZK4?G#Y6BR)C7G]*7;>B^3R]XGP$YC-G!?*RY(
MYT3%=0O2S#5^UF,4@QTN#8\R$DX_&LA4$54]EH 0B&X0N7=0D5EW0X OA&_/
MI\8L#K!XZOU'\)87>QPSBCHWL-YBC[%\Z*K>@O_?GRIEZ=0CG[R+G.*850>E
MG4S Q5:@1E */)K220%XJS7;?ZZ<BUW ;@^O#BO7328B C,#WLDKM*PL27;T
M5SY>S9+8*418UFH+A :U*W;_U!\<J [JA\0IZ[6,>AZ-&'[0T^M>_4U+WV""
ME49F[$E]#^L,71[\]6#.;Q*/?U1VMF65RW5Q<;^XFW\+J?*\[GD^MS7!7ZJ0
M5ZEF0QLK"^D'[IO3B;Y"$RE=R9H%YA5DM]L#,"Y=)%4A /4(HSC3R/913VNK
MZ8A&55L^FH))K]!6SWR?$#%W^D5=U+T,E.*B[C_>/K]=Z^)E*&2!#U'TWI&N
MS"V%4*AY>8X4D'\!,;#AHG&7U>=^>X3%%,+,/T;4Y@%O-*O@]BM49Y[TPI&L
MAA1.SOL+SRR* S89.9V_MYC>JUC">N^S!2J/ 'XO3&M,+B/%S&)/YVHZN$(3
M[,VSB[?$ONE8M$OQY/8LE].[4[%JT'%F%.JE4]'OD;>>(#V&XL81V'W;$M:?
M+UOT>8LVR.O,P#>+&2DE]T+3>,;MQ9&]'>%F9;U&9BI-^3!6^:^RA /'$;]:
MI3DG+Q4JQT0'L] TKLGQ#+V6.12D=JDBM"7H6O!5VC-&FKO3KSW:X/W^SK:H
M^0M^W'JV?>!3#M8WGZS85V:M#O[N5=(3?(('$LL#R82B49AESK)#5?N3**<Y
MCRK_H2D\9JP4^)8VX^[JI;MR05]2)+BZ"9@B+QA+4>X81R-FBUK3\<]DMP;<
MU:^T1@\_SN) 5*;&XGSX\&58BD-?L9 :/:I<4G1 H&]!!]<IO4S!1,+,NP7=
M'O+=NS)D!^=<USZ:@^,M_Y 4AB*W350>KR1^'-)>G.U!TKW=]P:VW58^"C.U
MWM;B;08?1QN^** (]0!"P1_XJ8J5M I@U%8 ZGG @^EDJ._8865.Q+!/YHA(
MLJ.K--.3GU_3_BJ$3XW,#LEF^^GA'LF^M]R$H'[>TWQ4_<6J\$W5"$W[&EGX
M/<&:E7ARN5(=9@_9)0$S#X"=6$!0"U;Q^QI[H.I'BY^I,(M[;<!3( 0@+UX,
M&ZK#PPB,F<*'8C0+OVTS7PI44!)FX=7!PWO![S!9,Z2[S]4JNJ_Q=9C/-D_9
M[;4\5%A@:^9-5'0_9%&2HC0DMVEU:FMDH&.KJGQ79LFHVZ!_I];YJ^:NS(KW
M[*[,!GA7IB;^>Z "5JP7'SV>T;@A-Y"\*R.(NF7V8?U163L]#NWTSN19E@LY
M,\!LJN91CQ^=>==4OB5J5&=&,+ $/:POR\+\.4X1P?L&75V8']!XF]GBK[4<
M9*#GNJ_BG#R$@U7D-C]Z_L%JMO@1.V3CC6V^ZUCXXM"M<4G;D'<A5=._99O^
M.;A0^AA9S AU?CUVNZ[;^WP#;HL U>2*?<L<ALGUGR#N'@.Z@*!"7\P\!<&E
M  @MYQ;"A_A<SKEQ2,K3U>%\U$AM%Z\RJWX3[\V\R\*PZ!._#W5P,*>=>A/*
M^-?[2J:,CW=?N6/DII,%W@=)?O+XW3SPE.IER*@=WP\1V[;<-<M:B;;6GUI5
MAN&%'P8#PSFPL'H&X'V];D7HN<*FXF4]IC\4CK$,6 DM2+7M@\)@>4;FT)6H
M=HA>VS&0UK?5PC;O3="IS>6\VQN<J.]D*V^F5<=^O/7F^:Z,B9+7_W6[2]3A
MF_7FZJQ/][T5;VNRSZ[6GTVVY#+1>IT[7JOUUVV//MS\H&A[="?,HM?ZTY7;
MWF,[R\:!0I&\13XP"A.\*_,)[[)Y:[7'A7EFJ8AL?>79+\']+_^3EXK^G^DG
MK^]!],'JY3"2]RZZY^3H@#^E,RRPS/W]6+3UZ*R! XQ-Z6WVT"9J78T-XW4X
ME/2J0U1N95$P+ZG'^M.,O173Y F;151[Q=FT4MM%.[/96EL@2^ K_V\G="&:
M8WQ'^B4YA>:F^<8QT>ENYUJW)?HA(!>>B6Z(M2LFUD < >U1@WH8Q?J[>[XA
M*YM'W<V7E_>-+ X^[D@+_&WE%G!^=2C%I>6+P=]X/C)DN)N=!J,W?H3//QC)
M50[\?:C?9] #QBVOJ^KZW+Z(F=7,.G>IXQD_+P;O;7M_'>JR(+XT]SXN&)[_
MC#W @=FLFLD3%D%>T1<^/:O.YIDTY O;'LUK.=H12KD#R"=&?$K37E50M_-!
M7],DH'GW*R\TKB#]'K/RLD:+?K#R2Q.$H5]:2>*GA03:DRGT[TUFE[I;^X]<
MJ$2?B15SQ[&LQV@#4^C^)W_X% Q: =>7'>$]$+#?O"8M*$C;MC#Y=+W]>*%L
MNY)+6)=+RU62!K%A#!X\@C@S%<5?&L7>V@H>K&C9&4!WNH5&'G=^Y!DV[ D.
M+FA:!/);&_W6"$SS+ PFY""TW]4.4S.:%WDX":^R&?C Z2B,<7Q>79(NV+X4
MG#+;!#X4XFR=BU1J<1'5_UUWFM\3<?=T91$I/4?XA0AT1:!QEKU.=X7,(+(V
M*B$B1G,. "51WQPY!8M,86""T2TG!#>&3?+RMI?"XZ>@X*0I>"GY*,2C'QI+
MK2XP.C*3G">LI3Q\_85_41YHXIAZ@=&;9!W3RBD0#C---5-I2W^V8'P3_8D.
M,<R8K+DB6[/>=6C%S;97'8F7+5R2G8;+^-B3&FAXC0H2%7'! ^S#<N 4O4,"
MW8_J%Y !#0Y^#)<8!MG$U2FOKH,DW SJV"MK^^5"J4]3[1N?[;EZBQN(M>%J
MWFU_5,RO:$G'2)&[^_$@&%VZ\ ![M3&*'1_P2X)CVBL]_<&?D&G@&(K;'XEO
M?=WU@*FD\U*/5GS$38U!9X^RA(Z$ER&&;Z0)VU[:'HK?Q*!@@*@7"**4M\);
MF%U!)#_9\^9B"ISRZ __0OKEN^14N>R",'=+>29;K_PWV]G<5%/K>#>)9"F;
M428?A4J44B4I(*E8%K,(&XBV9T;C\R_T6E:?*YM(&X>_I7R"$!Z>(I;795T&
MNABN/W;(*"SP$?(%M0:_$@'77Q22&+V=0&\BT*,O0NZ?O"_W/XZ^C,I)RYI'
MS#_=E3%$XK#N.(L^DE+(X50<1K<AF-(^.7:&ZL:CDN8R3@>[W4'+OP4\\X!U
MO9@ N12*T0"A2>]B!"(<7O@&YAP^.<Q36J)YJ3$7H5(^DVG1_* _RD@*]<OI
M *YO2-W=2>\%\\V %1,%J#F5F\H]WYW3CY5W6'FU-V*.=)HY-^\=;]4(0+EY
MZ:M_(#(!9Y_?<?KDB$K)_TKW)E+\ECW)5C%12YMK\OLV@^H-7-UYP2A88%B*
MSOPEI$X^U9#E@(G0IV2L(JAG7I$M"+= 4JF@/RIT;CME9=BV=#%^5^:R^TZ:
MP0PO45HG7][HY>[X-U][XN;*?3]PJN>Z8[:1=F/&\%*(./ZRZXWFM3N>J2EG
MK'\.&VAZ.G'5(,6J.3/^589BZ5!JB%2]M4Y-CK_4.K$'V&W0V'X 8^;"/^W.
M:2]^[NZ-8LYECAS3)T30K4R!AS,FQ_.P0<_W/$:L<%:9T4=3![)-CQ(6)5#0
M4!T%70U1JF;,4'*E\,E-IQH4L$F!ZW[CX .35I0R;(\%1DLXI //,V-PA;/9
M#MLUF0[FS*1XE\;6R$*!^0%SN_S9<19>7Z)R,$KI77R5_E<K:EE/H;DP("F&
ME[0\/%KOL=RDL?Y7CM5G+,^]-*5U,E>-^I'HEQIU>/\'JYB,V<Z4FT7J.<'%
M6++2[(C8JRU4EU T%@%3\-D1VR""M^=#Z<^W_]A2B!.@EI&-OV1 _(\_H$.-
MUS;<?[9S!H5%H+@MCST!RX2M8M@R$6C//+T4KM4\-"-2_W#L_<VPL&[^VHVR
MK<4J SF%;\$UP[+G1!ZX9@S]+]Y3QFDR)BF@DSBH(]1Q&!>2@,YG#.2N]>-S
MRC@..' D"9H&35!5B,7%CCPFMY2/+$E\XGLQG(9PYB:L-7'2QL9FE541*WPN
MK)^3[$>$<(=PY/-]__!A480/^F'76CB([/1Q-[5JS^Z<=P4/4*BHCL-[]QJ3
M#;OH:-\Q)'QSX.7E$7Q]A#?[B-H!DZ[6C=?RGWCH>\U9&%N_,](&QXFUF*5;
M0M7LW][V>YTL]+[7KN1LKV.0>Y#F9XRYDJ?3SZ0X0-C]N#TM+NFAH*K78=FF
M.:+J.E%YP'1[M;5SP)@P4.]YM?754/1;R*Q(_Y[E8T#(TXGSKBRF?N7G&[LR
M^P?9%*J2,*/DL39ELN+7^$,=16FX_=<VS#5(5/F(KIRDQ+J#N'])#M_W:5,4
M?GQ=8K+@J2?0P^\K7;B[CHW)&<R;K/&4*\ZC2IKZ'4YD%X'#\HHNE2Q#>]L]
M20R,!MW) 8;=Z8,X0DSW-=FFC& )9AY)//E;GU6R+>OBDI:O+O_= _ZE!_#U
MS)FR&5-=.MP+7]<$21G6DZ=L=/6[ZV5 ;#9#HH&T7("[/C_J2F.W4"/EDVY
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M0)/KSD4X[)^BW+962K=-?@Z-)+ER T1O86FR47B/XNRC+5-#?;LR0\ZQH1)
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M%,:J69?6/,HV=<7@P$Q6&<%@(;TY^(+OSI,=O<9/S.%;*>\S[;P E<B@.)W
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M%5.LI.KC<;\FMG+8RF-WM?I\5%(_$(*6;P>'^+)FYLZ9Z8M*5=S3AY3%'3,
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M%M.'1%M=#J].-;-3[Q<M/6V_VG=3QV<4YA<$N[+A@3F96'9*'^21&K,DN3+
M4 XS+=5:B+A7D?,BO"/6T50AYO:L@>I\0WIQ1BUPW?&#KO5ZF]K&H_5)24@8
M(;WB"'+E^OB*\\[>UR(W+OYH8RTC3C/P6Y6?9]?)FFSVNR/=A#MM5DLJZ+E=
MF1>54:SC3GGG^\5G[I?LRO3K)0VI]Z?CJUX-.76:!8KRDT36:PI'UGU:>NV4
MMN@?R<^WIM)B;6)60P3G+>R'?M&35MR(*OIV]\-H"=+\T807M/98^:Z,!_?,
M]<>>X+Z97X(L_IRB;:0:K.W*='I8B).T(2K8^<QZ^.T%"FCIZ$*+<.3]DO9U
ME?+1KH;1YUL''\:4^<VKI\2[?''HV EO%N5919NZ/U,M6/J)$CMTOKIG5^9B
MV I<+\?F1BG3:S]R5X:#5*BP^W=H[/XGF=0?8'Z ^0'F!Y@?8'Z ^0'F!Y@?
M8'Z ^0'F!Y@?8'Z ^0'F!Y@?8'Z ^0'F!Y@?8/X[@DD,]#A?3L&^W95ITUY]
M_=2(@MA1_N9L;7<[H^0.P<OKSWC#K8BUNLXZ^I'E.E"\[IIK8+?GO6DKB]G)
MD^DS\8>ML_O>S09'G7IY,_>]KCRU;>S6J972/<.GV9+/?]^4_==*ZN>[)Y7O
M?"A\7PE>_C4A/2)PWU)UXD@VQ=_,[O$WH\FJGT&C%P#2S(>AILJ":&E'<OSG
MT=K?&,4KM[ZLW#Q_ZV!$POL_/IA6:H7TG?EW/0&G_\\O*.OTY;_U]_D1N#_
M_ #S \P/,#_ _ #S \P/,#_ _"^"V97QKLDNW5=_=D0U?[7^[..%@4-EBK=*
MU^M-@[T5;W..WO<^]=GVY)_"J*)Y(DWMPZB7=OH);MZN#/LTOVBQ*$.K!$,%
MG#GQO6-IA,T(E437%FE7"(#XO*"XN"[R)?OLA&^YF_F:W_6.3.QHS&MLOZ;]
MC6YA4<'4DZ4*(-/>WG&]E""FV"'\'P4U'F :>K2.I)F[Y)MK$-W$@"2ZGOOS
MJ OCR,.U>7$!Q$,A.W*A\6>B5T#8DC0V# =$GQ0_^-FA]@//.#GQ(S-_TF\Q
M=$]5M>,VLSS99\'1D3JBW6:8->6'?UR"U1"YYX7GHQ$@5!\7Q4NTUB"1>('V
M0V(_HY[FI<]X"]3,7R)V=LPJ3_58K;N"NSJL):0F]_D[=;Q?[.6++>P&O4_W
MR[+,WSA</TT_0:>$9KF<,D<&K-8K_8*T=[V(@%U&'IR;GYW7HC/OV@QJ .56
MS77R8J()YF:*T]4^3!QH@/FPV!A8(0"8.R8<^B2&(%PO(NU<#PKRB@L9B>47
MC4-V9?:3WFR(6%+4I-E$">%?_\$FL)_<0C.>;HSG/+RF+W30)M,'Q\Z+.([[
M\P_@G^'6;N;^A$J<W)5IH4:V< *)D=/)EMQ63LD?D_<_1Q.D51>HVK! >6(O
M\GU1$R/_5H>N#Y/T6:\=).U2V3HO[[J\K#UZ^?)V);8H]9Z3/CN<#D0'0-"Z
M)INJ5K7*<G++@RL OD6.B]I.^_K@"H/YJBJ0]O[_Y2UP_[GZY\3YJ[?&ZKAU
MTE3,\\B9G7T[J[LR'W]>C5*\W>>\8K$SI_-VZ+7MW_^53?A'W>U? IMT'SZ8
MYI;B(>9DG2$C954 62NYQV$X..!0 JZ\Z'Y LN_^8\;&N?9.7I\=G9));?L<
M]UTZ>7V!;0RELC-!!R')\2 N'2+KH\?C6_C[+:_&]W=8/H9M,Z=@JXS%,Q'H
M8.GAHW_/%!/6TKHDQ=1J&.%B<'/(QA!\$X88<76YU$Y;#5FTL1E(>/HTX]U?
M_U$C6;=;77=E1JIW\JU'["MS6NK6MJ6L;Y^HOTA:=F5@NS)UH5(;<<W(Y3__
MWI/,!?Z$-8*Q-5<>KU>?]R0D1):AB%/\3_&3BZWS5.1T$1!NMR=XW;4VKF6*
MBIP,S,';J^N-F5^Y='05%G*B3R&HQ!W?H=MT79?Z[8B#0W7#'OG?1*X8DSP=
M;2R#7T0^'IFB@ GV BBXP[,Q\JNCF5B37RD>2ZDI_D3A@U>1#'IQBCR*4T %
M((S*??+R^.2 \&!T\8/#E>QJ8F>,5P@Z^5>XJ%X,1QT)-I5UF;8KG.]Q)554
M('A5UZY6J2*+>XO@*,QI5YKQO+WE'R<"*(9E+N+N?M<F!,C5&>EHI)O+H%/-
MB=$H(AMA9VP0%ZYF)L]DA^<! +&S=!?^ _XP#'BX,95YEY_3W$HT'XH.PKR(
MX9U,IM((=GI.\"J.K2@%ADTC!$-=J64W:B^WGKG&_Y3S,'K2D6@<KW;(!,B1
M$BRW+ &N^4J[,K9G<SWY<G_ V8 ;+*63(?( >XV ^SUM^]:7$5@T[7GMLA1P
M$&VPL1(W@M69?3$ZP)'88_R(0,(";+AXJ?HH(N"-*^]ZV6CI.GK"IP)]!L:4
M?/M<T0GSP A,J9)O_TS5H8_8F;$1(2'YSQZQ>->:3UBX$2P._D'NU__KF2 5
M.;UVTT%Z<V([-X$8)&[72)QMW1!QDZ!0*,/%X4+*7EJ:9O14KI49IFGZ*"7Y
MM5Q=R]^#1A::?9%CP\Z7(_(9C($WL(CJ4;.<"^-JNH(O5@T8W318K8O/SIV
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M=/%A9 &EH*+/M#0O!X5)*[),KW?H]:,:@?4Z'[93CZ:0J(54[G%H-_0BS!F
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M_-]<%6L-K-PXY ,V>.7X%JS@XE2,$:"Y*\3+&"#QJQJS?+-FPE+10)J"9EM
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M7)EK=<\=PW@JY^MFXXKFU8N& I,L;M)YTC7TKF- '[8N\K)K!P%)&5$%!C6
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MB#WV^N+4*V/C$> SFWN-#6K1^:?FWS06JO:T6*7!WVPO#GR8*B;$B04N(7A
M@TE#PE/[CH!E74X"LN6"IE9[;"$V/C6P\F*<[@>+Q>8)4T#1N<'=RAD3MHM?
M\XS/X!1HO#=U6G+TD&_W6U7=8F/EF\J9G\7!8S^-C7^R ;J[[H=\"H@'AWP
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MS\D]]R<@,E+S !,3"+)#;GIIU2 K^A?0KZ=+QOU*.::: I91*5ET=O%&IT^
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MSO.X^0+X&TD-@0E%XF4]/7*5UQ?C&"/\&O2)D &IVE4O$SM7NX^&LOA\1K[
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M]8K/%97E==Y.3I25FPPA:)=A'G;D_4VA8+"R'GJ V]OPBRIMGXOCS>8B#N?
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M9UJNVC^L])1EY)>0Y(&*"O=S8V3^Z(8*VW3]C*!4RCIV9JC1.B!I5F,M=SR
M&AM!1HIUD#&XG$VHM<7M3[!5".5#I[BD! K6D2V=-;-QT.JB:V+Y_\#-^O5
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M3-D0+JZ+I E8S#[!(B>E!45$H(YUBLBJ=;":@-';\6 !1/JE-LR?+$UV1]J
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M1W!SO$*W!E&!DR[HZ5.8:S:;+$OX/V^Q?-!GB\A_)$N?^:<*RY9F"1F/S)B
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MUN -YH9MTP=7D;;CQ!YRW!,G'U>.@&[5[/?'[0\*F&-+F'$]I>#")/\)TF0
M6=X](;T\ M'_SQ[4#0/0".)*E9TW8=/'^E"P(C8SZI_*#OP;NQE2A([H ,+"
M<B$K9"QV&5.2FZ]06.P?,TH#HO\.]0(.=I[D)Q/5RGS_<3!Y-+=Z8]XD.SJE
M3%B+I.$0"(S+(0D[[=1[U %>Y_FZC4V%]ME/&WS&A&+\:,8F.U7)/PFQ8XZ[
M,ENUW8W SE)^Q;YF30WLB,P9F54^.:&#"#LD5H'2X<K!:".2SB43(8IGK ]R
MMIBX#04QV?H'2*]U5M7!,5\0B0J=)6IB)7/%BQ*1PQ>'T_1G[UH;D'B=U5<8
M2J10Q  ']GZNR.-V2+#I8B;P7G6%OL"&M3Y_K<TJ3X\YT74]6M[# 8_.#OGT
MSTKU6,#?!6)[KS<=,%JGFM.*#-[:E/LCTMPI/(#17#RHV&#IT0F"A^D"&A?=
M)A]4)F<5)!Z,N0+&LZUAY_'0 )!@S+M1B33S;H;?CR#F-]ITU/.V%+/K!-/<
M=LD7D2\"L22ATOW*1*=)"T!+NWM) 864Z/>],-.F/"[5&S".'M3.(V@+$EI%
MC("S\?F7O=S3U!(T= ^U0*?W+3]/K@-'-'5M8M3'YG\0VF*&X9Z%B]?F:,63
MLQ-R1^-YLEX2D_/"[4U;ZB(Q0\9!<6/+>Z21F)9+KW:26ZS7F#]&RIN^O(TY
M3+>TO9Z=@OM?%_F_1+^2PQZ"*IYLH1IB&K)EL%YXN;D8KV,^)=PQWXKEX]&)
M+[W=/U7^T5].,=GVE+J\/),2C^AUKY7*_?6C/V25[^3>"3IZ_J3^8=@A;U_M
MW9F@^_^?^Q#_.XP3/1?"[PR@ F**9/\YYHO4\EEJS#GR^JZZ)YD<PY2W%F2A
M-VTXY1O'?&I'@8Y/JQW-?QE3<GSR\,M!@O)X2CFV\MJX:6$NV8+06>M$?_)Q
MBPJ1V?;N#_% )/A6*4+,L['WXOS5D1<MSE58GS$X;3R-K796<#$,K>ES7)BQ
MM>MW5+A?5A*<)B+8*6 HD^(X3F.OCL^M.B4^)A9OAKT9; UBCOMI8A^;TE/9
M/!3L+J*E#NHXR+%I%RYM542][3[D^4)FG.*Q3346?FHI;ZO[VW3ER(QZ>'\R
M3!?E5R<Z3WW_E:PV0%*8$/.I[?]KU>!FD<RW_.F[D%O<QUAC%UV-@6[GZON7
MP62JSJBSW+,^A-'J=\P4JQ]@>6&D<>GLN%#AHPDX9"&[>7Q7-PSZ!\L99 )=
MW[(9+=?N@076]/3\GA]?O.N\9/Z2YU5+*3$;%3#4ZU"964FKGUCVW*"6N2O/
MGB=<Y@7LT'Y'5:V>=WHS_+"%)6\M1E'.>OBC%CJZ +3,!U*M1GI/#FA5=^49
MH>&V]^2L18(A&L)[0Q -:=OZSR\]]BG8\LL-J=/(F:%]=A9>?<D#,O[1K.1S
MOT,:?4,]+GA74W9N*?]2I&C1TN_J1J.XOS7:<9IS*ELAPF$10Z5YH?MML[$O
MXNS_M&N ]RLI>9VC[<EN7$[_TSW["7$-K)5JW>BW\@1?5@(X>4ER.:#>L1<N
MU)];N'4Q6NHKW8TB6$*FNQB;6)51T@W"B_+,LYD;0J&=$$:G:0>_'CN>9]1L
MITF:M!  Z.BU/9W_>D]-4W$L!;)+51QGBO3 %6NR9I>E&-$]/^ELG3-##71Y
M?[0(!XZ&O>0&5>A?+39S-WW)"#M]45LZ102:@@G_W;BG2]M?\N8XHD6_PT&L
MN;J\*EC+>6<[)W)L\(/DS*0:B+YYG4UVD/CTNA;:]:B]^7R[TT!9GC!VL#@Y
MUP,>#@RT&RI[84X&=N:0N8&TZC;"*)6VND4D:EPL3.L@0*VAYPG];81FX:??
M)<4)IM,/Q^= ,/(P8284:9%RDOQS^5=]&O]BK\)!=-+Q)P$](HGV"/$4D-(W
M0]3%#[>_*>&5B$G"_:V502;YTP3;Q]I9H=.UN-.#2<7]#\-9:]CH=XJ5 JU^
M;!7W:'<\&(%<R!Z1',46!^ "S)!FB@#[%+"(PE*GLCE<)M?>6#*":HY<\EE8
M]J$LRR^Y18$T6/=:H1#H^:=TPI7/F>6)]KE<1*.VV)RV"+2M-+24AL6Q0GC\
M>"?XR6B)/D[?8)^MA86=!50H[9LU!'9BFGRV($*Z@"3'6@F2)O_DH-JZ$T>-
M%;@V]D;[I:+1YWZ[.CX*VDYV#2W?0AU3A;/ZH7_%DN=;9Y/&10:,'JF%F,DP
MJ(44@EP^.5FFP-P,\*4&A1M,-%U0UMQ7]#@/W$Y,'+<X*2)CH3BN1),$:00:
M-!-,&DUH]HF[=;VA/&UX^%I-$FN'C<K96 Q\.U9B.JKW?AD%"V1DOFEI<_5E
MX0G=4"GP>=]$C:A4TVFTM%\+2U [2UQUMNQ^[#RVI<Y$:KJE<UA$M+.;W=+
M0)F='!OY2;="5G=UC$]K;JTOE,J%XO/ TG10B (T.* (H.V.+$;F1*8DMC\@
MI&)9N=P0\J1TT6O2M'\AG1!OQY9C([6!KD1.O_8G@WE]$33QTT<JE<F$5?JT
M!^F>!VWM*!XN=5KC$]XX_5DUCJ5_&GN-]D1?+T],?>#@('0%=J^E]=[PY<%>
M=:@@($+W>W70!**"'DG]F7D_@ZHRVNKM1?](_>$&%6-QYPT+J+(M2,@)<0 C
M&&?%W5Z@\4ST+H4D*7216+:;%F)P.<(=%LE"^7U%XK2+-XOGJ,PP&:71Y!6
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MUU);*CGDV;8!@Z^.@-X<N*P^/MNNV8V6DR]F-#(@L.E*A3=]8/?2^G&F?]@
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M:K"V69,<KEPZKJ_4P[W]7MO7W4Z6/<P7%4;^&4QTRE5N5K1)$3+M7]S)LRI
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M+5-T3M.=8AO/9'J4U<V.#7B)EO\J9"=3#DDR[0SI=MEFODR\#2B*"V_=L?[
M82W=^DXJW:[Q\],JGL)X-$4W?@SFL)X*<]QDF:Q%*P^B]R$867%A7I: 0O7
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M=5_H(-<.7Y3K>6-D)YQ79D3GH>0&/)S>IH8K+2SWL]5+)0UJ7(F>9CGLNM6
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M\>H07;,#.3LRO:?;^M8FKMN6O[S!J+4)VJ4BT^@@V$EJO/4AP,SA.)X6*#*
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MA?_Z;CE3R5XB>N;'W1RYU/O)J.N6OU,"/HAY560L2KP+6>3FL_*87>4$>_O
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MF5-I7;7W^,REX,963,P>4L?%?1O^NQU!,%UASJ*@'V=)5F!GV+0JY;2S$DZ
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M!O-/()>HR_SB_.2>[HA07K=3;O2(B'@1A5:P<LS-3E>OFU1@O:VET3:G%-J
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MQ#^P ZW\V6JL2_OTH'RTZM3>\95[[\ACV\Y/&26IQ[$#_FP:,3G !'*X;M;
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MI?I6BN$-HC$7^$9?+;/HBE?UAN?IA8ZCE-,5'A4C2HCBW88BPVRC]E6#JF%
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M?NN_Y+ O]$EJ^WO+J'+"RSA_JM$/7?[/(::&9?OO^T)/MNKWA0C:^T+MF+?
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M5!&GF9EG(J(CH1H]5L+$L0Y4L?(<^!19L$9597K1#(H,J,9881VD.1!+ !$
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MG:(*L)]>,"<T-B9=52V\1VZRUVJAE_NC\;0KNF2M^(T@9QN/,$JB-\%J]L!
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M/A9FM:P=O^E#Q^'>(]HL"OA^#ZX\NSOQZ1Q4,1GF$$ RA_?_[N:?Q EE]G[
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MLK&E0_2?Q(Z7B[;K725JU[;3$%'NB[^?>^1@?]GQ &C<J][3SC3CX2<DU.H
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MH04"!I( @8 0@I 0>A$"LJ*@M+BT(*$H+9! @I0$"$4! 2D!(806BA21WHN
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M<Y9"I0JC2&E8/(M\5=W R[BT8SH@KG0D$^%9Z,'N$ 15HWN)!!JZ4 QLUA&
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M8*6@$"C=9.(3Q4P$GI]A-\/I2K \Q!+_-N;J:D[S8[DI] ?-C5O?#F("?)W
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MQZ_-PC 6DS;_PL*JQ*RKPTWV%6WD>K.>&6*5^Q36&8&29O_EQ-5ZL)X#0[%
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M9]Y5U3)G:LT?JYC0SB"RH@A:Q$E3[,6VD\1*><=G" LMD,4YQWI:D8BC*:I
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M0C#"H0L]=I9S8F0YJ5#BH#A)PWJ#D9 N9R&&E8 2T8Z G&9A]5UW]'GM77#
MP15@/ #&A'9T)/20=I34E!-#J]RAQ4*B0#KDA']&]!"[K70I+2G!9S69V$CK
MJ3<IR0YTGMR;"HKP<U6FA.#Z/>7X3]YJNNGSG]HK^-"W"(S"T&8-;C%$KIM
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M1#+9[BV"I%^,IQAS=@SXBCN(]7F+Y8$SY2\^AYD1C_&A^"_ 9]PQ].*\QH=
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MC']]H!D_)&A@=>7#A#YP3P\=&L=65<>_HW\OJYL*YP6JGKE7=EBGZZ!??>I
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MF,4>(D%H(X(E,UIER!M>_&U+V:(L8,> H@M?"E&5XZ=.G):<0LL)P-;K'2L
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M=D>V]!B&6>3 */$S& >I'Y,P31(D5&EC.2NFUR7EH+ND92S(FOK* (L> M:
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MW(181#@.<H:088.IHPQ:TE>@(PZN)2[;YV":UP4ZA9=3 )-RJU2BGP- (J9
M$Q!JD0/R'X)<6(" <+.7_W/OKW?%+R#%P46^R/.& K[?/3QNRF="NF-J'T1
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M DDR7!3$DU.0>)3F7I8RX E[F)!CQ:':=Z^)OA+077#6*A%5]8U5J^5[N7E
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MN,(TY8XII2B:+5NJD:[F:PNI.H63;:/$W3E]UEJ/TR%R7_=Q H]+UX"<#N=
M/<@9!IU<#:XMQ*2:'EZO5O5W(@$Y*9WD"YR'::RLM3SQB,>+T"A$U8R<8U6G
M GNI=C]KTKK8*B(]\9UK[$W#Y0EX35:0KH&7L32PZF9%"*:TCLO$M<21HHZV
MY&?%P[I4W$1<YBD6-_@-N2D7-R(OH&#<T"BO53)N1**1HG%C;TWNRKWO#.L5
MA7:"2=N4K$CS<M.IAY,[ U%$.(NXAT42!%E,O3#P<V#F$9R+G^#^@/?ZM"UE
MS#E:*QXM;DQM9L'41'2,+5#+#AA[RDC<0MG6*5;G2\W2%F\W3:[AD"S7OAK
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M.@OM3GZ#;]4GV';]"*0N"V.2JLKN'!=Y$&(>T23,"\]+0J,^@',QY#I@HN5
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M;&IY7$4/?,40D?_JN.G^"DZ2'<'1=,'.A YL_2JB\IM!I2*KT#$%PB8#]K*
M[K->1WA8.M/U,AP#V:T&+UG'SJW4G>9^R]*;:KUIGMO:Z8>;L#Z5T]C'&2\"
M>3[/TT0(SZ<1\$1PD:9CQ=#1/^RS6^Y8L&U!?!%*4ZTP*T PW3 5&YM .%-I
MW<>^7>1DZ7 W4V@&(MR,7[55'5_D";!9D]6MN'E\(F6C1OZM7J_W[S ^-[4H
M-[>-^KW6)+E@.0X#$N(TYP+G(<UPDD2\R$A&6&Q7;@_*B='RF5QZK^<*;%B
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MVHF*B)95]S<ZT^90LLM1J22>%)3R"E^<J>[]]_F.K \-/_\G-#%2Y_7F;=$
MH%<0\Q7CBEYO4L?#E5Z1+POWV&?>*.C+;_Q=PUFYN;YO.._+=],'_FZO*FD:
M9P*+D/MR@PX8+CCGV!-AD#+*,IZ;)XP9$G6\B7;$T#N =\,4+@,?DP,08#O
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M"=#G/43&M6-;D>R*(<FWK<\R@PB9+N.I<L/6,%ADBP4\)I'SU3M(?.&E.P;
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M*[KF:-O 3]<BW?LM;5FT;M(S97I,-=%"H,,4E6N\+=39##@YUW93>%Q8&<X
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M<=8<C5&9W.=I#)-?.E=C%(2!?(WQYRU<W/M;].]D\]P<[L]#;;!O*Z5#&FT
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M#5O_%R?-W??ZV.8C?HYS%B8X\CT>)!%A-#:*$C2FZ'K-?Z_1BZ0$"2TQ LK
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M,4ORE!1AZ'/MMX,)!XY?"RU+79>2KL:I03O)%6HD6U@L^M3^O4'KS1;5>]8
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ME)R@7=.VX=GTC""RYP0^H,X$6$Y]G(=1BN,TIB0*2,*I5NZ]4V -@H8]L*\
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MW12M'VZHZC%=G8]#9=3')"D\[*>\\ AE99YZYL5?VGRX-] 'Y3K%H G[6I6
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M'1[J&5P,:8 QMQCB9B:>:^1A1J 5L"9-PWD4EC,8K2!Q9$;:6=&D/*$+M,D
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MFLR[?KSC:SG6[K+;GI0^)E'L2QV>EYP480(8@7V!B&,EW5)%'5GELT*&?%T
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M*+/<+/6\))2\"&(*JO'H<RNP"YQ>L5!"CYSZ>'OH/+0Z@.>>7#[ YW^]9PH
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M3QGAVA?YEE(Y<==O\2MU6,6AX_TH<?(@OXKZ-/1[S(N+C3?I&8:A%R$8XX1
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M-'9#R332:4&F4[KZ3MHLG5J]],X!-:)V8[G"<C;BW:C/2RZD]Z+R.U-*K5B
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MKYLVOL2:0I=U\QXUY+ZLGD];]? ;:ID+8Q]CUJ\'$R^FO_4BN:B.C'C#)GN
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M:9:FQ!@V/0<M!-3ZKTV2(VI;EJHL9S^H-%9U5UAC!?,PIY!Q$S I?.5I/D?
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M?F#QE[U)-=;1'V%]R)_RE!3I=;U?<@3.P[W @7'FN=#VK(3^QG+B0#(,(HG
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MN'*@?C&5IV'ZY:]4\*W_QCMH-[?))K_GQKB>J"<0P3!"'HQB','$#:DM#./
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M_0 ().G\;.9'0"F*KXFS%6+]2Y&N?B*@B=JI<P-=KU8NZ-(=6?3'%1]_L0X
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M,30'4FD&C"=0&JT90BP+3#;7[@04<7) .5+(1638/U43_]O]MCR.#@A(2S6
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M80TLID*2()T+)",^EJMV \?IY%Z/ENS8R?EEL<M%_%@]G?K)M@@.ZGA0.LP
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MMH4<+D\--C[%/]D0B'4X^F&( QL@U]P*:44N;^7%PMT <CJ)W!SR+0HBR[S
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M@,*< 4L41@@R2P(>#&,MA(Y=)M@3RG*IYC0KY5/#@,;?Q'BG^N9SE\UO?GR
M&OHW.,I64/^XYOG+)9>'[2YPZN"!1!P#0;P.T<^"1/G!=G<WFON,-B72P%B1
M!K)I;@B.'F=K;[-QH\W^C%D/Z-DG]FQ50R$WB(M<\A["(1JE>3SIIEUHB*R+
MP<QPE85O43OVZ3D(X+*JK C'+3%33]/)<AYV<7=UH^=_5)/)NW@JVXF>S:I0
M>7=5+[??>9,VX&\^"OY*_]@IZ)0,,M&_P%ZB8*62VK5-U,@+WKZX'-O*YL7C
MEB<F!8"CB&VRB_LU9^LKP@]5B!3ZJ?6S\^FBF^MDZYM4@2&0%#I /'>."8X4
M';B&\@ANQH9]&;CL?#KT I*BM\4^PM_H[\<P4- QP+70Q!+C@VIK8S3,UMB'
MH[%=H1/;'KV!I8C4_C[*^*V>'Z,/KVSJHJH7 WPI<=S0UNEVX_E8>S(Z]H8J
MR,WJ$R)%'REKSE+QU2*)F0[/KS'BT[/[9ID;.P\??*BFWKWST_B+^<5$;U8T
M2.R DA)' 'MF#:5>B>$25+FY.R5/K%?H[NV,]8JCPC-,>VIDPR^U#!B'- A*
M$0H-$=0/%\MG8FKL,^7T=DZ?J"G"5=O%^,;QKC"0 B[<3T$HU=ZW3N,;!O]C
M]ZGHV4G*HIPB8-:!">,DD!Q10"V3'G'C#!LV6UH8N ;)[A^KF%+1M4^MG!06
M2.4U0)Q8*"37P0SWWG9/XL?NGS(6*K,I-!MB>Z_I>*>C$V[]Y8WW\Z-K.%Y^
MK*>:C1:*^ZC1^%1-XW*5GES4RPER.ZL@4?3#>+# 0:&=$1A+,9SWTH7BXXW@
M60SKYK.=_C C0&.B@:3<<0*A0:AM-FY>";RD;>P /CN"-@W8$<HH(B.UFOO;
MS@8G"FB#(%!:V*"H(V1 3&TE<6QH':/WS5/P:"64@24]2WW1TG\^_N_[ZIN>
MI S YIDM@((,12\30>P,IT$/=P6VG<:QT90! )N@.EX;1:#JJM'N\77RXYQ[
MZR-'9DM[4!D%)+EU $(774\7(^\PW .F-X@=/2_7 \YRZJ<(P'V>?HLLU,V6
M5D"40&"H)T 2! W&2 4XW$'XC+"Q4Q9] .E0N1<!FI5 +AI_IQ\6%RVOML12
M5!N/$DAZM:4DB'_J,>04HP'?[W8D>NQ,1"^G8P_Z*@F(V\F', !-A090&A$(
M(@22 5.O>X.JQP?C/8+J -D7D5W]K9[:+E(AP47\1W8$(DH9+CBRPR59=E$Y
MMF^5-2+,HHHB[-%%4]_Y9OZ0Z@SFT<:F6&31,WM#0D("+4R,1)"B'@IEO=)#
M/B[:3N;8H6$>)&Q[791!+44@['/4Q_2ZBL'&4D*+4_SJ1D]_J6OWO8H_\?H0
MM]&JVT" 5RI8C;2-!GE +_X-<L<V9#TA+J^:BD#>U^KZ9EZ'^YG??N13IH%!
MU /*,.%.2$CA<(_:7E,W=LS8$ZZ.4D(1,/K-SS^LUDZ%3ENYP Y%[Q$1H+R3
M3#$G3>L,]<P^UQ8*QXX*>X+3T<HH E(+X_I:0AO]SS0"TC,)0N &4JN@4\,U
MW-E*XMA184^@.EX=1:#J+0Z<@3%<YAXPKS#62&AIAFNO>1"6>NP2UI>!.D8)
M1>09MM.M* 9IUCC 7#N!K"4X#%><58:+E#6'<("8BX!'"D7G#S$F77>LKOQ.
MD6CM@>9& QZ0$]I3:P<\PMHH'3N*&Z#V)9NBBCC<5LG;#KR8>$9'MX\#%@44
MI!9(R,'+80Z%7)^=Y++A85=F_5CE% &T;1?F%_IA<5M^52_^]O+^[FY2;9F9
M"Z4 RBD/C(306:H=)L,=DOM0/C88<R&F4[U#%O6-/6IA?7ME;7/OW:J/]J;_
M #V0Z7&\A@)"9 *WXE7YUHX)"]N_/_8YF1DGN219A*5:\;'.ARSK\^/_3^Y=
M-;U>_>UZV/<S"6X.JTFOH2 'W"BM'.'"L>'RH(=R,78PT)L%&T2M)0'XB]?Q
MD[L983@ !:T"5NG@:.":VP%[2VPG<NS\:M_P.THI):'KK?E*ED&@8C %*&82
M&:J98X.'"P?-O^J__*8W=!VEE)+0U;9#J /2. >(2?\+AED\7*GS)GUC)UQ[
MMU@'JJ*(K-I3VKB#?)S2<7= "J"05"GJ _7#U>*TDCIVO-!CDB.?BHHP8%_J
MZ77\WNV[NFGJ[ZD]^V9M$8X.)&* *Z24XM0&-%Q<L$G?V#F+C #8 ->1VB@"
M4<_D\X;SZ.*O% T*: 6AA(1S8X8K=-Y-Y]C6JT^$9=).84C[ZFU]/:UF_KG!
MWVRAM;&9? #:P.A?.@,ATXA1.5RB=F_RQ\YU#(/+/G19!%Q?U9>T;#W(97))
M$ @X.*(EAU(-W)MY*YUC9SOZ!& F[12!M$YL8$Z ="2 0! U!&%&_7!3D ['
MUR"%9;T>O ?JI(@(M85XF:[,=(S7=?05%*7:&#E@H%#.G4"/T>>AXB\".RNY
M[)"$< 1H*3B@U',FH88<#EXEM$_^HL>#KD<$':&$(LZVS[/9O7?O]5T5@;EQ
MV<5%>@JJ@&)(8TVI96:X.Z(7I(V=ICA&SYO/@@X6>A&868P:O&C\;75_N_%Z
M..X<Q8('G$@JB$>4#-A*^#EE8Z<=LB+F8)$7 9BK9M&,^V'!Q68 8"$P+$A@
ME8MPQXPY-IR5>4E;(;Y.'M <(?;]8:.6L)GZZ]0K\2IWH/\U:J+YMJ6@2&*@
MH4ZO"1P,(@@MX<"MF]>D%>+EY,'.X4(OPN)\]7.=,ESK(;D;TH HO3^Q %+.
M/66,2#+<-?)KZL8.U+,BYRC1%P&>I3@VWM0&![2C%"CC+"-"Q&-VN!Y^2YK&
MKC;("I0#Q%Q2W/TBFMPHMK *R*1+2R!"#$4>PG"O K=16(B-Z3$&/UPAI],U
M^\7<\,7LP5DU7=F&%\P<.0?]U:>'F(+>QDTO,]"7"WZ>MALU)$0$3GI &!3U
MW@2O\"C=M7?0FR&<W[G&57K@L=GM/C7'40A(:I%APE V8 '+&\2.G2;*C*\M
MB8",RBK"V7H^-FDEJ1_5AOG6S$<!\>@:*"$5"4$9.N!KBJTTEHNU Z#0.L/P
M0+T4BJ\/]6T,4#;\SC2X2!L"*($<81W]C@&;S>RB<FR,Y4!!!V@=H)(BP/4B
MD?^KOS6^V;B#9@S(N-V MA8*:(7# ][#;2&P/$@=HOWV.Y4#5%$$GEYF;+=S
M0:4#DF,/DJ. ;3 .V>$*3;91./9-2T^(.EH914#J^<W1=AZ$MD"9H(&/[@$F
M' 4YX'"*3?K&OH/I"4Y'*J((,+VX%=C.!#("&$@YX(191A53A SGJ6\A<.QK
MF9[@=*PJBL#3Z[N"[7S8D!Z:>0P$3YDK2;P9L'YW.XUCIU-[0E4&A10!K-VQ
M\9?(WN?X=YM!#$GWF3&(H=0YXPFF+@R'L@X$C^UF]9MOR*VQ(F#XVWW:/N=A
MZ4(N0Y2-FPD4-U.0).ZH&)(0Z$.PPUU%;Z-P[ @Q.Q0VJ\>/U<O!Z+KS356G
MBX]FWNMM-4S9&!2-/S=8*0RM$P-FZ?>XK1[%8.7"T0&R+P@Y%TT=JOF7>K9E
M;@L!T5G$@#)*%<:8$CM<,O2)KK%#P?X1=* .BCC=EMW@WIZQSK %6KD8W!*%
MI2.<.#U<,YA=5(X=%_:/K2SZ.1AIWWQCZJS7.&^QP1F0(K)!G#<(<:Z@&/:.
M\!"$]1@C]H^P8[521#U7I#ME>OT'O_SOU4U3WU_?+'Q#$W_O+I;3\JX:/9UI
MF_2WV1:.!2!A^C]%$8X<6JJ&J_<ZA(.Q2PG[!V?O>AV[>>ESPO^HYC?GWZ?Q
MP[L*30*4D8L8CR/A,$'QKR![=6^THXEI^SJ=@"1.#TBY13PV6E[$O.=W"Y8^
M_O"-3;TAUKU]EX+[/(W\W2\*\_[#S^:I7>;B7[U[MFO.4J^Y:[]M?!IDT95@
M$ *'L(]67QJ*;2>D]4?C.#F-[!BJRU/HV+C>8>;7DC@/*]%$B23>J^EU_*.M
MHMD>S2,3C450#A H-400<<U))S3GIFR<?$JO&!Y5>6,C=[V!7Q8:;,]&0L:!
M3'/DE9=0IP)V_+J]R!LV==LJX^17!K&*1PNUB!3+I9[X\V9!_6N6-J-X!XP2
M#&")G;,X1+]FP$+UW82.DVCI"V3Y=5.*&5I:T(W]PKD6@$N.EE=Z!C$,@A4$
M(^8UL6PO([2YQCA)DD%,T)$"+<( K>#]['2-Y.-(?N 1UI$1Q:,1M=%Z$LHD
M1G3@VM8U:>.D,_HW,H?+OPCX=+EH)3)U6DK5 H0[;HU$,1XO_P)<Y@93:1?@
MK7HY\AKSX]3U>OV-F &21)4SZSQ$*&C.AFM#LX=)4J>,H@-DGQ4WPSZWU;.;
M3Y/Z^^PE*T<^M'W\Z!!/;+=ST,OCVO52.^=ZDGAT4:<!@HY*#Q6!>IQ7I*\I
MS7!7N?[DI[@K?Y^E;-MYA*].Z8NSZ"=\:WW\CF"4#$86&.)]W(2!*SU<'>)^
MM)=4*784XK9<;?:GQ"(\LZ?"DW<^U(V_TC\V6F * Y2T\4AP$$;/T@A+QJ@"
M>B1P;+CUB8F6RJ##%%0$RL[<?][/YHOSYU/=I%[D4UM-_!-O.UN 8 4,)0HP
M1RAT#CI-AKM0[TSVV"6.@R*R'V46B-,//E)BJX4>5Y,L-[8>I$ '*@"1CFJ+
M,9-ZN*#U37+'MI0]0>4-2!ZKMS*@>%LW\VK6QH20#$@O&$C=81&-*-$#'LQ;
M"!S;# X&MR-U,W:J_Z6</E53/;5^Q<BR?.\WO]G6#06@$88@,*NPE9)9^FHP
MVHZL?Z?EQJ[Q[A<[/8F],"#IJOD//4F)ZK=F4,8P+')%,8#!(@VI\\JJ0\"T
M>\FQ"[N'!U0F\1_;]#<WK-[']5<2FT0?-VV:C98>UL?@)XTTU<2CH+7P!\%I
MRU)C5V\/#J-CQ5V&]_2"I8U:W\V,MZ% <<YC,,0]\=HP[(>[PGR+VK&+M,=Q
MXX_46H$X?%WF]GGZ\?9N4C]XOQK!UM*Y-'X=2)5>44 5;38-%KOAZGH.YV/L
MNO!QL-N;ILOR^%+CD4C+S97^L3PV-K+ME &%(B^*2Q_%R*4DW:IFWUAH[+OY
MP8_EXT1=TB"'EWS]HJMIDM?Y]$,UNZMG>C*+0KSSS?PA#:2<GTU=NE^^VU:0
MCAU-O24<4$::Z,$B@\5P(T,.YV/LDH!Q;&)OFAX?W(O]NLG?>7@Q#G@C#(L;
M%6@<;,J^!R:#A13)3M;Q[;6ZI7[AJ8*L#XD7@J,_ZN;/:GJ]ZF&YJMG9)2QJ
M"##$<A"41LH9@2Q!G2#4NDPW])SLS4%F.1<8:CPYGNO_7C7:^3-KZ_O%-&A?
M?=O6KDF)U!>5^&ARA3#6V2C!X=J*'L;#B(_Z,F+HS4NM'A1Z$L"]:/R=KMPJ
M4;X1+KDTP"P8!VA0F,#()A;#M179D_@1W^Z-"=5C5'@2&/T\_1;_KFZV39].
MDQUD4, %%H2"",9(K1A\/B-\Q%> 8V+S4-45B,O-K-/RC%@] K_0#^F$V&PQ
M10+05!.@$-3>6XRE&Z[4]" 61GQ,.!Q6^U!G$:C=7:ZVH_>*5O&$@%PA"XVG
MC@UG/UM)';MF8="ROWQ**Z7=4WV;JFG]["*Z)E]]N)^Z]Q,]FU6A\NYLMD62
M&[O;<6"$)-&#$1A:$G?=@..(#N%@[**(01';NXK'3QCM*]D-SYMI((6  'M'
M.='!"S]<?74WFL>NP"C$RAZLQB+,[1:^DN,]ZR9$91V05J6QG11%+QQ)[8:[
MZ-F/]K&+8(=]#)5+B47XI1?WC;W1J=_0SHNIY\?'%MXW?'&+@.'& 4PEB9*V
M'@[8?_MX?L9^0- GXC:?6@VK_I*\AR?6/T?]3J^K&%B>S69^/MN38V(TT%QQ
M0(S5#"O)A1[.H3B8C;&-]D@X[U/9X\-[D:Y9Y6FJ__+NL@[S[U$A'_PW/ZF7
M^[F>;985>D;2P"0(A-$:6:PUYMT:5W98K,"<06ZD]2+W4:O2=^P='[4WGZT%
MN$C;K>[CO/M4-[_/HDR7S3%^]?.;>MWWR0B@E9) B,709TGC06%B>$ TD@.^
M;CV*E0(3"0,9S%Z57@C*MTAW\^+D\J9NYE$<MQ_\73VKYJD[YS.A;+PYX1A(
M$FSJH<V)E5J$,&JJ86^."DQ$](?YP2%01 2XWM_+>@KO]G2(L(@RUE0"KX1"
M3C)*V7!#O/8D?NQ7)8/"N4_%%H'<;M+<;-*E4NL0"8+P3B#G'5+#%<]THWGL
M%R1CF]UCU5AJ_G?Y +J3$*W!P'CM@154XZ"\5%R/"=,6VL<.\(;-_^928A$V
M]**IK?=NP=Y&[_F-C<U@/!(DBH>#MV3YEP.F=MM(+3!KFPTGVQID95):$1A<
M.RKIQOJYD[)%@.O(T@ JN0>"> ^4%P@XPX,S6"H2ANMVN@?A!69;^\-G7PH=
M/[^Z?0^^JYNF_IZFAG?A]KE<490K50I(KP76D5\;X"@&M3,+8Y_UHQG:?I1<
MA %^SF;JB!W9>3;-(4HJ@$!QB@F9!,H2";"$V,5SA#@[W%.9G606F)D=!I.'
M*ZL,W*V:7+QZPAAEM><6"QX"XQ@'VC&(9" 0LN%B^H/9*#"[VB-N!U%V22Y"
M-_%N]&F,OI!2S *-L23!>VO8<'UYNM%<8!ZU/^#VH,8B\E.;;RT2IV=3E_Z3
MKO.^Z4G:L,LFS!]#\'9^'C[^L(OW'U_C;EF]!-EXCYPJX0,7,?;$,,UO=VC
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MWH5;G=0EN%XS6BWD&7_F(..SXU,Y;5 7:G.X.XN%'O6_A-D*!;_Y^2Z8L4"
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MULHV6LG81[=VEI[M'F*W7OS[C*9K-UW9K-='W4S3&_H+OQQVOPL\P1N@+3*
M4"LH"TH:/-SL]UU4YK5-KU=I ;LG&,3P20(JC8$.4A?D<$^..A(]MJ7*@JUV
MPY1+967;I_3@( 9=-O['/WMH<<C]X/8OY;PH[$!K-NNU_4'&3K]=<Z"]5$!Q
MZK&PT<WV8[^6Z>GB<>M:+9O#IA=101G@48B2,5H1.$[AUYNDCVW5,F+NC2O)
MK$HLV\*M2GAGS=-$Y0.LVY:O9+1L;]&8S:J]&+'XK )G%\8\)L#@J/PTP!9B
MBQPTP_EF;U&;U[+M6JTM 2U#NCZ#@' 6/0S'+73C),0Z$#^V=<N*O7;[EEN5
M95NX]8S?A\,28^M_G#4QMI6B?,Y9:B/D%]?HC^.-=\'(&0XDU@X(JKGPE'@9
M!FP"W4)I[O37XP(M,,?*@1@$.6"8-($PA,B 0SG>IG=L(Y4-66]EO8Y65MDV
MZ:+Q=[IRL_1$.AEA>]\D!>C%(*9#[%3[!S/:KCTHSW'_N%ANV2YM?6"]7ZZX
M'%JU"WPX>O_*!0*\MIA IC31Y"TA[K5B7O.T9=7E<JUY%0:,41IP%5T QK1%
M?!QCU87Z$6\?>P%1NP7+KL_2[=ER9F*T"GX]+O$P,[;E.UFMUUMT]O)&<N=(
MR9W(0P+H8 7P"FJMM()0C7,1]R;IN>W@CN5:]@V-D9"2WJ0I&(0[@@4UXU2N
M=:%^;!>N/UR^91$S:[9LB_AZNN:!16DOOY&WSJR%OEZLX.LEMX ,8PM$>D>B
M.#< "6H=A,(*,EQ(VH7BW*'IRU6V;XB%:))W8)"# !',!.66.UB&: JU<%DP
M]U:PFD=]9=NS1:OJ@ZS8ZE_FK,[80DLVBW7QC+A5A^[9I[KYXJ-RMUVD+^'#
M*#!2$@ IE(9CJ[0;L.UZ%Y+SVJSE(BU0UP@#&=(@D^@D4"P8Y70<2[5!ZMCV
M*3_"V@W4<;HJVRPM(NMI/3TZ@;;]0[F?.+53FJ\R-FK?3Z*Z?7T_^^UQS?8C
MT#H,M*$!,&\@BLZVD7C JM@N)/?P3NKU4BW;!,5 1%K. 2-6$6H]4R.5GKU%
M^=@6+C_^.KR/RJ7)L@W>NA;B3C\<6ZRQ_D0/E1I;J<MFWB[OC5U-2K'+SIKG
M8:GS9[-45BF&'>,O%C"( @%&,PN<PDB32)KTPV79#N6BQ[*.BZ7:VK:.,W&7
M>L0!@9+ H(*B;+A2OGTH']L(#H+2/0H]CE5N\7:QN?=N]5#R(!?P]2?RVL7=
MU.6X)UTML'J.LA-+4%&@@TP=FB0U%A$9!'Q++FT+Y#5&KQ=9(??9?FD!+X06
M:(X1")II*%V@1(_3/78O-D:\%\T!FG8#U)]"R[9&%_5L[J/-J1=7P";^?:@.
M+.S8_J6<=Z(=:,W=:>QYAW13W\\3#1\?:7BWHF$7("76J? GHB-Z[ZEU,8-$
M=K)BA].0^<'38AWOUZNT)6>D!%JK&!9I8;&&U#LZ3MO<%J(+Z536(ZS>> V5
M29]E6[7%0R^C9][%/TH6??'=0ZS:CB_E[(3=@=9>;CFO?'.;#KKW]=15*[?_
MB9C5[,^SIDG]#G9<M2]P(H0!AJ9^PH9;'##QS+-Q JT#.<IK,MM6;-MOJ4K4
M.!\ Q8A3Y;#59IP'5ETY&#MP'1S-[;:U%\67;6B?)JP?8ER?_>N,!G473;T8
MT0]^KJM)&C#[\D!_(F(GT'0 ,D4LSCC(!&9!TG&V>W<>\AK*I^^W; X"#8B>
M2$@9=VII\):3X5ZNO4EN22:P)RRV&[WCE5BVA?OJ)VG(>-3'_,!14:^^D'4
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MLSYVL7IA^ZPLJ)U"+/[*(#V3U4MYM,=1&$%@M)/I"4#PR$EO7;?.*?W1./:
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MT)X0=;0RBH#4U_38X=%HZT %$,ZF_Z,::"-2ES^/E<:8! 4'P]$C687,Y![
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M[6O&O#= *8P!@E1%H6*F7;?>@?NL.K91ZTWS]1!J*!Y?'U=7["T,&D* \9P
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MS+03W,5L9 6F@"%/F#=61E>NJ7Y_NBM.5FX$I^.H]%+ OA_16[;'XL&H+DE
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MN<5=WN ?M@49!YW;G (E$YU)$ Q+@FQ@Y7)F]ZFK[7>=!D\=GJI+M-+$ ^M
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M<U>NG0Q4!8>3JJ<V]IXYM[P+N5G/:LB^<D2 UH*!$P)QC9!$QO6"WID+UTX
MJH*\*953&WAO9Q\^KF_BGZOP+$EO??ZV,I3FD1H.&)(6NZ PTJH7],Y>NG9N
M3A7P3:N@VO#;'V-U-G<\1#"4!.!1,<<T1P+WZP5Z]M*U,VJJP&]:!37Q]M[&
M[7HS)$62G:0(O/4H4DIP%.4\2D\06SL9IC1&I]%B$[#<DULW&Q8E^2"/@"?
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ME^JC"53MG^[); ZOUN'3X3.%*="<._"$<\DTHX35,SH?R:SM:9_B=AQ')TW
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M!AR"]'962<764H(M8='U2D[I^O3JCHRQ83".'"^UFT=S1CP*Y<#L)\GLIT$
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M#!:;#(!<]RZ;"F!7ML]Z>LL[Q9!4HY#VP+ 6(1H75$'W\B0L-AEBN>Y]-A7
MKFR?760^2Y4L9Q\48(X\XQ()QLJU#*CY1BL= +KNO38=R!I*"#O[BG\ZRM I
M#FE!<Z1!.&50LJJ=M['!/7<6DQ5?:^VX']N"4FW/_9X,WH9<VI@.D#S1>32]
M".-!24K!"Z(50<KPGO[Y2<BK^)QJ-FA50?$MFG"/8GB^F&\XNC.W6XD<R<KH
MVO"&6K!*Y0;D7 MJ@_"TF@=B$$?MQ*EJX/*IBV)ZD+1Z*QPPO',QGLI58A:!
M=DJ"$D@82JDSME\UU*64M&/R5$1R>9U>=;O*?YG;N\UW7LT_IPT]7:O*(PN5
M:U/9A].F6U0&;'/3#0%,&9;V@F56EJM2^T%;5"HGP>K$,^6:<BDBUAI?A5!_
MV!:5)W%>H$7E24@T8<@/;43GC4AV&&= DEQM0$H)9HN!_:=M47D:4*.UJ#RI
MW:O!;7?#*2?3"T+'/*$]F6'*<RUUN?Y(/WZ+RM/8&;%%Y4E%UGX*GMNLC$N7
MGK3. *8D/4D$HR+T:U T2FNX)IM3GE;P):WA3DJ[B?/M;99-U_82!H%"44$T
M&&-GHV<%+]Y'LGZX%FUGWJS#]-,.M+IW'/<!+ E)"(9JS)DS1)1SP>X05OO0
M&JC>;I@,D'430/EEL5XO/MW$#1/=!VD>OF(()A"DC5%@[0TO]^;M(+ )X Q1
M^ %T+I5^$Q!ZO_A\DH.@"6CG*?@0,+&81RS*Y0OL4U?[4AL//!?)O0GD3-*G
M$@L#*N  DDE"5""4DA^Q-VZCD][',+S*XZ*)[; 7AMIPN<FXZ:B!Z(J;8HK
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MAS'$<A0=#$,!4LQQAWS@L%-=5\_[K#<(_:8.4O^8.5E[]"(2F<D)G!ZP+*%
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MG*5M[1?]CV;^*_%IK:?2NJ50U@&'O8CF)UXK-",B0H=:K[ WD.;U6WUMI=/
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M9-(#JGIC>6GL/'FC23?_XM"O,"P-J;0$69)F]!C@"8-"H^@N2).%FO;//ZW
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MJV\OVBF$+@ -)0(4*^RC+Q!]S?%J! _;>^FH3*\8'%!L52B\SD7I2"A@**&
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M> >T@CQ>D11F2B*)G<O21+O7J#TCKP=MU!.#*XF&K.O61$74K \D;:5)8)Q
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M2A+D1HOX=)-'/5#:T;O;IZDDRH# G$:&,<;=>!61:QLK?<WN*-YVF'3@=15
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M?_^/_P]02P$"% ,4    " #E-6-<0DA]64NF   9% @ '@
M@ $     97AH:6)I=#$Q86]A<V=S86YO=F5M8F5R,C N:'1M4$L! A0#%
M  @ Y35C7/?\G#C_!P  9"0  !X              ( !AZ8  &5X:&EB:70Q
M,C%C96\S,#)C97)T:69I8V%T+FAT;5!+ 0(4 Q0    ( .4U8UPO>1=^\P<
M %@D   >              "  <*N  !E>&AI8FET,3(R8V9O,S R8V5R=&EF
M:6-A="YH=&U02P$"% ,4    " #E-6-<RD3[LTX$  "W#@  '@
M    @ 'QM@  97AH:6)I=#$S,6-E;SDP-F-E<G1I9FEC870N:'1M4$L! A0#
M%     @ Y35C7"%[X+!"!   &@X  !X              ( !>[L  &5X:&EB
M:70Q,S)C9F\Y,#9C97)T:69I8V%T+FAT;5!+ 0(4 Q0    ( .4U8USE7_3'
MC0(  !4'   <              "  ?F_  !E>&AI8FET,34Q<'=C8V]N<V5N
M=&9Y,C4N:'1M4$L! A0#%     @ Y35C7,F]<]6.8P  6J$" !X
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M+3(P,C4Q,C,Q7V1E9BYX;6Q02P$"% ,4    " #E-6-<JMF OS1' 0! B@$
M%               @ $#;0< <V]P:"TR,#(U,3(S,5]G,2YJ<&=02P$"% ,4
M    " #E-6-<0L=:4H29 P#(/00 %0              @ %IM @ <V]P:"TR
M,#(U,3(S,5]G,3 N:G!G4$L! A0#%     @ Y35C7'X^9<2Y_0  Y$L! !4
M             ( !($X, '-O<&@M,C R-3$R,S%?9S$Q+FIP9U!+ 0(4 Q0
M   ( .4U8USN;#N9Z!L! ,DN 0 5              "  0Q,#0!S;W!H+3(P
M,C4Q,C,Q7V<Q,BYJ<&=02P$"% ,4    " #E-6-<C'2!_UB@  !<N0  %0
M            @ $G: X <V]P:"TR,#(U,3(S,5]G,3,N:G!G4$L! A0#%
M  @ Y35C7+G2@DI9$@( 3%$" !4              ( !L@@/ '-O<&@M,C R
M-3$R,S%?9S$T+FIP9U!+ 0(4 Q0    ( .4U8UP)%SI96>$  %Z( 0 5
M          "  3X;$0!S;W!H+3(P,C4Q,C,Q7V<Q-2YJ<&=02P$"% ,4
M" #E-6-<Y%C]:9$C @"P5 ( %               @ '*_!$ <V]P:"TR,#(U
M,3(S,5]G,BYJ<&=02P$"% ,4    " #E-6-<+27:K-X& 0!<5@$ %
M        @ &-(!0 <V]P:"TR,#(U,3(S,5]G,RYJ<&=02P$"% ,4    " #E
M-6-<G6V!^-UQ 0"8E $ %               @ &=)Q4 <V]P:"TR,#(U,3(S
M,5]G-"YJ<&=02P$"% ,4    " #E-6-<2>WF&"7]   '%@$ %
M    @ &LF18 <V]P:"TR,#(U,3(S,5]G-2YJ<&=02P$"% ,4    " #E-6-<
M&)Q_.7I7" "9;0D %               @ $#EQ< <V]P:"TR,#(U,3(S,5]G
M-BYJ<&=02P$"% ,4    " #E-6-<&==C0P=& P"9C , %
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L '-O<&@M,C R-3$R,S%?<')E+GAM;%!+!08     '0 = ,T'  !:OB@    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>181
<FILENAME>soph-20251231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:soph="http://www.sophiagenetics.com/20251231"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="soph-20251231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:SharePremiumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsSASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsIntermediacaoDeNegociosLTDAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsPtyLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsSRLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SOPHiAGENETICSGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:BR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CH</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:IT</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:ES</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:ES</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:ES</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInEuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInEuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInEuropeMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:EuropeTheMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:EuropeTheMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:EuropeTheMiddleEastAndAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInNorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInNorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:OtherCountriesInNorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:SOPHiADDMPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:SOPHiADDMPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:SOPHiADDMPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:WorkflowEquipmentAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:WorkflowEquipmentAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">soph:WorkflowEquipmentAndServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">soph:CustomerOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">soph:CustomerOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">ifrs-full:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:SellingAndMarketingExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:SellingAndMarketingExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:SellingAndMarketingExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:CostOfRevenue1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:CostOfRevenue1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">soph:CostOfRevenue1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:DepreciationAndAmortizationRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:AccruedPensionRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:RightOfUseAssetsRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:LeaseLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:DepreciationAndAmortizationRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:AccruedPensionRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:RightOfUseAssetsRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:LeaseLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:DepreciationAndAmortizationRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:AccruedPensionRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:RightOfUseAssetsRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:LeaseLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:DepreciationAndAmortizationRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:AccruedPensionRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:RightOfUseAssetsRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:LeaseLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:DepreciationAndAmortizationRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:AccruedPensionRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:RightOfUseAssetsRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">soph:LeaseLiabilitiesRelatedTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:OtherTemporaryDifferencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:UnusedTaxLossesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:TemporaryDifferenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">ifrs-full:TemporaryDifferenceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">soph:SophiaGeneticsSASMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:ContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:ContractAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:MachineryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CapitalisedDevelopmentExpenditureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-03</startDate>
            <endDate>2021-03-03</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-25</startDate>
            <endDate>2022-01-25</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-07-01</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-01</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-01</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-25</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:RolleSwitzerlandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BostonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-27</startDate>
            <endDate>2024-06-27</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BostonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BostonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BidartFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BidartFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-01</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BidartFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">soph:BidartFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:ConsumerPriceIndicesInSwitzerlandAndFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:ConsumerPriceIndicesInSwitzerlandAndFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:OfficeSpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:SwissPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">soph:FrenchPensionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">soph:ActuarialAssumptionOfExpectedInterestRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">soph:ActuarialAssumptionOfExpectedInterestRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyOrPartlyFundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:FundingArrangementsOfDefinedBenefitPlansAxis">ifrs-full:WhollyUnfundedDefinedBenefitPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-22</startDate>
            <endDate>2021-04-22</endDate>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2022-01-19</endDate>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2013IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2019IncentiveShareOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:ShareBasedPaymentArrangementsVestingAxis">soph:ShareBasedPaymentArrangementVestingTrancheThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:A2021EmployeeIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">soph:RestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:ResearchAndDevelopmentExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:SalesAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:SalesAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:SalesAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:IncomeStatementLocation1Axis">soph:GeneralAndAdministrativeExpense1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:BorrowingTermsAxis">soph:TermSecuredOvernightFinancingRateSOFRFloorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:BorrowingTermsAxis">soph:TermSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:BorrowingTermsAxis">soph:TermSecuredOvernightFinancingRateSOFRUponDefaultMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-25</startDate>
            <endDate>2025-06-25</endDate>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-25</instant>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-23</startDate>
            <endDate>2026-01-23</endDate>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-23</instant>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-23</instant>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-23</instant>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:BorrowingTermsAxis">soph:TermSecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-23</instant>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:BorrowingTermsAxis">soph:TermSecuredOvernightFinancingRateSOFRFloorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-23</instant>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-23</startDate>
            <endDate>2026-01-23</endDate>
        </period>
    </context>
    <context id="c-422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-23</instant>
        </period>
    </context>
    <context id="c-423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:PerceptiveCreditHoldingsIVLPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-23</instant>
        </period>
    </context>
    <context id="c-424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-02</startDate>
            <endDate>2024-05-02</endDate>
        </period>
    </context>
    <context id="c-425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-25</instant>
        </period>
    </context>
    <context id="c-429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExercisePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-25</instant>
        </period>
    </context>
    <context id="c-430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExercisePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-25</instant>
        </period>
    </context>
    <context id="c-432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-25</instant>
        </period>
    </context>
    <context id="c-434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedVolatilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-25</instant>
        </period>
    </context>
    <context id="c-436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedVolatilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedTermMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-25</instant>
        </period>
    </context>
    <context id="c-438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedTermMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:DividendYieldMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-25</instant>
        </period>
    </context>
    <context id="c-440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:DividendYieldMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:BlackScholesPricingModelValueMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-25</instant>
        </period>
    </context>
    <context id="c-442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:BlackScholesPricingModelValueMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-02</instant>
        </period>
    </context>
    <context id="c-443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExercisePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExercisePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedVolatilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedVolatilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedTermMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedTermMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:DividendYieldMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:DividendYieldMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:BlackScholesPricingModelValueMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:BlackScholesPricingModelValueMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExercisePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:SharePriceMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">ifrs-full:InterestRateMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedVolatilityMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:ExpectedTermMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:DividendYieldMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="soph:WarrantTermsAxis">soph:WarrantRightsTrancheBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:UnobservableInputsAxis">soph:BlackScholesPricingModelValueMeasurementInputMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementTrancheBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-25</instant>
        </period>
    </context>
    <context id="c-465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:PerceptiveCreditHoldingsWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementExistingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:CreditSuisseSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-23</startDate>
            <endDate>2024-04-23</endDate>
        </period>
    </context>
    <context id="c-475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementNewMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:CreditSuisseSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-04-23</instant>
        </period>
    </context>
    <context id="c-476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementNewMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:CreditSuisseSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-27</startDate>
            <endDate>2025-11-27</endDate>
        </period>
    </context>
    <context id="c-477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementNewMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:UBSSwitzerlandAGMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">soph:MajorBorrowingTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-20</instant>
        </period>
    </context>
    <context id="c-478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementNewMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:CreditSuisseSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:CreditAgreementNewMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">soph:CreditSuisseSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-02</startDate>
            <endDate>2024-05-02</endDate>
        </period>
    </context>
    <context id="c-481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="c-482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">soph:GuardantHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:CommencementOfMajorLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-31</endDate>
        </period>
    </context>
    <context id="c-483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:CashAndCashEquivalentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-486">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:FinancialAssetsAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:OtherFinancialNonCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-488">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:OtherFinancialNonCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-489">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-490">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-491">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-492">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-493">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:AccountsPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-494">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:AccountsPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-495">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:AccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-496">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:AccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-498">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-499">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-500">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:LongtermBorrowingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-501">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-503">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:WarrantObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:WarrantObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">soph:GenesisHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">soph:GenesisHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-507">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">soph:GenesisHealthcareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-30</instant>
        </period>
    </context>
    <context id="c-508">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-509">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-511">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:EquityInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-516">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-517">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-518">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-519">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-521">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-522">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">soph:CashAndCashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-523">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-524">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfLiabilitiesAxis">soph:WarrantLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:RecurringFairValueMeasurementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-529">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:CashAndCashEquivalentsAndTermDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">soph:CashAndCashEquivalentsAndTermDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:NonadjustingEventsAfterReportingPeriodAxis">ifrs-full:MajorOrdinaryShareTransactionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-03</endDate>
        </period>
    </context>
    <context id="c-532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-533">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-534">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-535">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-537">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-539">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-541">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-542">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-543">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-546">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-547">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-548">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-549">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-550">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyEURAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-551">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-553">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-554">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-556">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyGBPAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:FunctionalCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-557">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c-558">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-559">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-560">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-561">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndCHFMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-562">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndEURMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-563">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndEURMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-564">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndEURMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-565">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndEURMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-566">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndGBPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-567">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndGBPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-568">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndGBPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-569">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">soph:DifferencesOfCurrencyUSDAndGBPMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CurrencyInWhichInformationIsDisplayedAxis">soph:PresentationCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-571">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840706</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">soph:PerceptiveCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="chf">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="chfPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:CHF</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="unit">
        <measure>soph:unit</measure>
    </unit>
    <unit id="lease">
        <measure>soph:lease</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="member">
        <measure>soph:member</measure>
    </unit>
    <unit id="plan">
        <measure>soph:plan</measure>
    </unit>
    <unit id="year">
        <measure>soph:year</measure>
    </unit>
    <unit id="instrument">
        <measure>soph:instrument</measure>
    </unit>
    <unit id="personnel">
        <measure>soph:personnel</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="usdPerCHF">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:CHF</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPerEUR">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:EUR</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPerGBP">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:GBP</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPerBRL">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>iso4217:BRL</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-39">0001840706</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-40">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-41">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-42">false</dei:AmendmentFlag>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-171" id="f-909">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <soph:NumberOfCashGeneratingUnit contextRef="c-1" decimals="INF" id="f-1115" unitRef="unit">1</soph:NumberOfCashGeneratingUnit>
    <soph:LeaseTerm contextRef="c-287" id="f-1144">P1Y</soph:LeaseTerm>
    <soph:BorrowingMaturityTerm contextRef="c-480" id="f-1877">P5Y</soph:BorrowingMaturityTerm>
    <soph:RedemptionPeriodOfWarrantRights contextRef="c-480" id="f-1878">P10Y</soph:RedemptionPeriodOfWarrantRights>
    <dei:DocumentType contextRef="c-1" id="f-1">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c-1" id="f-2">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-3">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-4">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-5">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-6">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c-1" id="f-7">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-8">001-40627</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-9">SOPHiA GENETICS SA</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-10">V8</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-11">La Pi&#xe8;ce 12</dei:EntityAddressAddressLine1>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">CH-1180</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-13">Rolle</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="c-1" id="f-14">CH</dei:EntityAddressCountry>
    <dei:ContactPersonnelName contextRef="c-2" id="f-15">George Cardoza</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c-2" id="f-16">401 Park Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-2" id="f-17">Suite 505</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-2" id="f-18">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-2" id="f-19">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-2" id="f-20">02215</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-2" id="f-21">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-2" id="f-22">982-1210</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-23">Ordinary shares, par value CHF 0.05 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-24">SOPH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-25">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-26" unitRef="shares">68486338</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-27">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-28">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-29">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-30">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-31">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-32">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-33">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-34">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-35">true</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentFinStmtRestatementRecoveryAnalysisFlag contextRef="c-1" id="f-36">false</dei:DocumentFinStmtRestatementRecoveryAnalysisFlag>
    <dei:DocumentAccountingStandard contextRef="c-1" id="f-37">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="c-1" id="f-38">false</dei:EntityShellCompany>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-43">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-46">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;At SOPHiA GENETICS, cybersecurity risk management is an integral part of our enterprise risk management program. Our cybersecurity risk management program is derived from the ISO27001 family of standards and &lt;/span&gt;&lt;/div&gt;underpins our Information Security Management System (&#x201c;ISMS&#x201d;) framework. This determines how we design our polices, guidelines, controls, and best practices to manage the organization&#x2019;s information security risks while permitting us to leverage NIST, STRIDE, and SANS frameworks to inform our handling of cybersecurity threats and incidents. Additionally, we are certified in accordance to and maintain our cybersecurity framework consistent with ISO 27001 standards.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-45">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;At SOPHiA GENETICS, cybersecurity risk management is an integral part of our enterprise risk management program. Our cybersecurity risk management program is derived from the ISO27001 family of standards and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;underpins our Information Security Management System (&#x201c;ISMS&#x201d;) framework. This determines how we design our polices, guidelines, controls, and best practices to manage the organization&#x2019;s information security risks while permitting us to leverage NIST, STRIDE, and SANS frameworks to inform our handling of cybersecurity threats and incidents. Additionally, we are certified in accordance to and maintain our cybersecurity framework consistent with ISO 27001 standards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The scope of applicability includes our globally accessible cloud-native solution offering along with all physical associated geographical locations: Switzerland, the U.S., and France. This is designed to achieve comprehensive global risk coverage across operations, application development, wet-lab analysis, and R&amp;amp;D. Many of these capabilities are delivered in-house, however third-party services are engaged in a modest capacity to support specific activities, such as security operations center capabilities and annual penetration testing. Where engaged, the organization has vendor management procedures in place that require cross-functional participation from the areas of Quality, Procurement, Regulatory, Legal, and Cybersecurity. These procedures are also interlinked directly with cybersecurity&#x2019;s ISMS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Our framework includes tools and processes to identify and assess the severity of cybersecurity threats and incidents including, but not limited to, data loss, theft, and system penetration. Additionally our framework allows us to identify if the threat or incident is associated with a third-party provider, dynamically implementing cybersecurity countermeasures and mitigation strategies and informing management and our board of directors of material cybersecurity threats and incidents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The cybersecurity team is further responsible for assessing our cybersecurity risk management program and communicating these risks to senior leadership and the Board. Although the assessment is solely performed within the cybersecurity team, external engagements influence such determination e.g.:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt"&gt;Annual penetration testing and Tabletop exercises &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt"&gt;Quarterly phishing exercises results&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt"&gt;Monthly SOC read-out calls&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt"&gt;External threat feeds&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt"&gt;Cyber insurance evaluation&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt"&gt;External Audit activities (ISO 27001, ISO 27017, ISO 27018, ISO 13485)&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt"&gt;Board and Executive team feedback&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The cybersecurity team is also responsible for providing all employee training, awareness, and education. It performs this by carrying out:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt"&gt;Quarterly phishing exercises &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt"&gt;Digital awareness campaigns through intranet posts, email updates, digital presentations &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:12.44pt"&gt;Reach-out engagements to cross-functional teams aligned to their delivery schedules.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-44">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-47">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-48">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-49">Our board of directors has overall oversight responsibility for our risk management and delegates cybersecurity risk management oversight to the audit committee of the board of directors. The audit committee is responsible for ensuring that management has processes in place designed to identify and evaluate cybersecurity risks to which the company is exposed and implement processes and programs to manage cybersecurity risks and mitigate cybersecurity incidents. The audit committee also reports material cybersecurity risks to our full board of directors.</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-50">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-51">The audit committee is responsible for ensuring that management has processes in place designed to identify and evaluate cybersecurity risks to which the company is exposed and implement processes and programs to manage cybersecurity risks and mitigate cybersecurity incidents.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-52">The audit committee also reports material cybersecurity risks to our full board of directors.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-54">Management is responsible for identifying, considering and assessing material cybersecurity risks on an ongoing basis, establishing processes to ensure that such potential cybersecurity risk exposures are monitored, putting in place appropriate mitigation measures and maintaining cybersecurity programs. Our cybersecurity programs are executed under the direction of our Chief Technology Officer (&#x201c;CTO&#x201d;), who has over 20 years of technology leadership, receives reports from our cybersecurity team and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents. Our dedicated personnel hold a multitude of certifications, including but not limited to Certified information systems security professional (&#x201c;CISSP&#x201d;), Certified Ethical Hacker, and experienced information systems security professionals and information security managers with many years of experience. Management, including the CTO and our cybersecurity team, update the audit committee on the company&#x2019;s cybersecurity programs, material cybersecurity risks and mitigation strategies and provide cybersecurity reports annually that cover, among other topics, such as, key performance metrics, developments in cybersecurity and updates to the company&#x2019;s cybersecurity programs and mitigation strategies.</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-53">Management is responsible for identifying, considering and assessing material cybersecurity risks on an ongoing basis, establishing processes to ensure that such potential cybersecurity risk exposures are monitored, putting in place appropriate mitigation measures and maintaining cybersecurity programs. Our cybersecurity programs are executed under the direction of our Chief Technology Officer (&#x201c;CTO&#x201d;)</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-56">Chief Technology Officer (&#x201c;CTO&#x201d;), who has over 20 years of technology leadership</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-55">Chief Technology Officer (&#x201c;CTO&#x201d;), who has over 20 years of technology leadership, receives reports from our cybersecurity team and monitors the prevention, detection, mitigation, and remediation of cybersecurity incidents.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-57">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-58">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-59">1358</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-60">PricewaterhouseCoopers SA</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-61">Lausanne, Switzerland</dei:AuditorLocation>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-1" decimals="-3" id="f-62" unitRef="usd">77271000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">65173000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-5" decimals="-3" id="f-64" unitRef="usd">62371000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:CostOfSales contextRef="c-1" decimals="-3" id="f-65" unitRef="usd">25194000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c-4" decimals="-3" id="f-66" unitRef="usd">21236000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales contextRef="c-5" decimals="-3" id="f-67" unitRef="usd">19458000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit contextRef="c-1" decimals="-3" id="f-68" unitRef="usd">52077000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">43937000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit contextRef="c-5" decimals="-3" id="f-70" unitRef="usd">42913000</ifrs-full:GrossProfit>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-71" unitRef="usd">34216000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c-4" decimals="-3" id="f-72" unitRef="usd">34366000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-3" id="f-73" unitRef="usd">36969000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c-1" decimals="-3" id="f-74" unitRef="usd">36118000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">29369000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense contextRef="c-5" decimals="-3" id="f-76" unitRef="usd">28423000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-77" unitRef="usd">52563000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">46953000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-79" unitRef="usd">53301000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-80" unitRef="usd">-86000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c-4" decimals="-3" id="f-81" unitRef="usd">183000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-82" unitRef="usd">954000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c-1" decimals="-3" id="f-83" unitRef="usd">-70906000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">-66568000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities contextRef="c-5" decimals="-3" id="f-85" unitRef="usd">-74826000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:RevenueFromInterest contextRef="c-1" decimals="-3" id="f-86" unitRef="usd">1872000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest contextRef="c-4" decimals="-3" id="f-87" unitRef="usd">3362000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest contextRef="c-5" decimals="-3" id="f-88" unitRef="usd">4547000</ifrs-full:RevenueFromInterest>
    <ifrs-full:InterestExpense contextRef="c-1" decimals="-3" id="f-89" unitRef="usd">4554000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense contextRef="c-4" decimals="-3" id="f-90" unitRef="usd">1913000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense contextRef="c-5" decimals="-3" id="f-91" unitRef="usd">588000</ifrs-full:InterestExpense>
    <soph:AdjustmentsForFairValueOfWarrantLiability contextRef="c-1" decimals="-3" id="f-92" unitRef="usd">-497000</soph:AdjustmentsForFairValueOfWarrantLiability>
    <soph:AdjustmentsForFairValueOfWarrantLiability contextRef="c-4" decimals="-3" id="f-93" unitRef="usd">370000</soph:AdjustmentsForFairValueOfWarrantLiability>
    <soph:AdjustmentsForFairValueOfWarrantLiability contextRef="c-5" decimals="-3" id="f-94" unitRef="usd">0</soph:AdjustmentsForFairValueOfWarrantLiability>
    <soph:ForeignExchangeAndOtherGainLoss contextRef="c-1" decimals="-3" id="f-95" unitRef="usd">-3402000</soph:ForeignExchangeAndOtherGainLoss>
    <soph:ForeignExchangeAndOtherGainLoss contextRef="c-4" decimals="-3" id="f-96" unitRef="usd">3479000</soph:ForeignExchangeAndOtherGainLoss>
    <soph:ForeignExchangeAndOtherGainLoss contextRef="c-5" decimals="-3" id="f-97" unitRef="usd">-7628000</soph:ForeignExchangeAndOtherGainLoss>
    <ifrs-full:ProfitLossBeforeTax contextRef="c-1" decimals="-3" id="f-98" unitRef="usd">-77487000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c-4" decimals="-3" id="f-99" unitRef="usd">-61270000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c-5" decimals="-3" id="f-100" unitRef="usd">-78495000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-1" decimals="-3" id="f-101" unitRef="usd">1512000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-4" decimals="-3" id="f-102" unitRef="usd">1223000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-5" decimals="-3" id="f-103" unitRef="usd">486000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss contextRef="c-1" decimals="-3" id="f-104" unitRef="usd">-78999000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-4" decimals="-3" id="f-105" unitRef="usd">-62493000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-5" decimals="-3" id="f-106" unitRef="usd">-78981000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c-1" decimals="-3" id="f-107" unitRef="usd">-78999000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c-4" decimals="-3" id="f-108" unitRef="usd">-62493000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c-5" decimals="-3" id="f-109" unitRef="usd">-78981000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-1"
      decimals="2"
      id="f-110"
      unitRef="usdPerShare">-1.17</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-1"
      decimals="2"
      id="f-111"
      unitRef="usdPerShare">-1.17</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-4"
      decimals="2"
      id="f-112"
      unitRef="usdPerShare">-0.95</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-4"
      decimals="2"
      id="f-113"
      unitRef="usdPerShare">-0.95</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-5"
      decimals="2"
      id="f-114"
      unitRef="usdPerShare">-1.22</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-5"
      decimals="2"
      id="f-115"
      unitRef="usdPerShare">-1.22</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:ProfitLoss contextRef="c-1" decimals="-3" id="f-116" unitRef="usd">-78999000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-4" decimals="-3" id="f-117" unitRef="usd">-62493000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-5" decimals="-3" id="f-118" unitRef="usd">-78981000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c-1" decimals="-3" id="f-119" unitRef="usd">11292000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c-4" decimals="-3" id="f-120" unitRef="usd">-9679000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation contextRef="c-5" decimals="-3" id="f-121" unitRef="usd">15037000</ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="c-1" decimals="-3" id="f-122" unitRef="usd">11292000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="c-4" decimals="-3" id="f-123" unitRef="usd">-9679000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax contextRef="c-5" decimals="-3" id="f-124" unitRef="usd">15037000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-125" unitRef="usd">704000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-126" unitRef="usd">327000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-5" decimals="-3" id="f-127" unitRef="usd">-212000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax contextRef="c-1" decimals="-3" id="f-128" unitRef="usd">704000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax contextRef="c-4" decimals="-3" id="f-129" unitRef="usd">327000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax contextRef="c-5" decimals="-3" id="f-130" unitRef="usd">-212000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-1" decimals="-3" id="f-131" unitRef="usd">11996000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-4" decimals="-3" id="f-132" unitRef="usd">-9352000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-5" decimals="-3" id="f-133" unitRef="usd">14825000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-1" decimals="-3" id="f-134" unitRef="usd">-67003000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-4" decimals="-3" id="f-135" unitRef="usd">-71845000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-5" decimals="-3" id="f-136" unitRef="usd">-64156000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="c-1" decimals="-3" id="f-137" unitRef="usd">-67003000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="c-4" decimals="-3" id="f-138" unitRef="usd">-71845000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent contextRef="c-5" decimals="-3" id="f-139" unitRef="usd">-64156000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:CashAndCashEquivalents contextRef="c-3" decimals="-3" id="f-140" unitRef="usd">70289000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-6" decimals="-3" id="f-141" unitRef="usd">80226000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c-3" decimals="-3" id="f-142" unitRef="usd">15001000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:TradeAndOtherCurrentReceivables contextRef="c-6" decimals="-3" id="f-143" unitRef="usd">7436000</ifrs-full:TradeAndOtherCurrentReceivables>
    <ifrs-full:Inventories contextRef="c-3" decimals="-3" id="f-144" unitRef="usd">6351000</ifrs-full:Inventories>
    <ifrs-full:Inventories contextRef="c-6" decimals="-3" id="f-145" unitRef="usd">5868000</ifrs-full:Inventories>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c-3" decimals="-3" id="f-146" unitRef="usd">7438000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c-6" decimals="-3" id="f-147" unitRef="usd">5875000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c-3" decimals="-3" id="f-148" unitRef="usd">99079000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="c-6" decimals="-3" id="f-149" unitRef="usd">99405000</ifrs-full:CurrentAssets>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-150" unitRef="usd">5665000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-151" unitRef="usd">5209000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-3" decimals="-3" id="f-152" unitRef="usd">35891000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="c-6" decimals="-3" id="f-153" unitRef="usd">28998000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RightofuseAssets contextRef="c-3" decimals="-3" id="f-154" unitRef="usd">12382000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c-6" decimals="-3" id="f-155" unitRef="usd">14168000</ifrs-full:RightofuseAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c-3" decimals="-3" id="f-156" unitRef="usd">1831000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:NetDeferredTaxAssets contextRef="c-6" decimals="-3" id="f-157" unitRef="usd">1767000</ifrs-full:NetDeferredTaxAssets>
    <ifrs-full:OtherNoncurrentAssets contextRef="c-3" decimals="-3" id="f-158" unitRef="usd">8183000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets contextRef="c-6" decimals="-3" id="f-159" unitRef="usd">5762000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c-3" decimals="-3" id="f-160" unitRef="usd">63952000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="c-6" decimals="-3" id="f-161" unitRef="usd">55904000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets contextRef="c-3" decimals="-3" id="f-162" unitRef="usd">163031000</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="c-6" decimals="-3" id="f-163" unitRef="usd">155309000</ifrs-full:Assets>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c-3" decimals="-3" id="f-164" unitRef="usd">8960000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c-6" decimals="-3" id="f-165" unitRef="usd">5220000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <soph:CurrentAccruedExpenses contextRef="c-3" decimals="-3" id="f-166" unitRef="usd">20736000</soph:CurrentAccruedExpenses>
    <soph:CurrentAccruedExpenses contextRef="c-6" decimals="-3" id="f-167" unitRef="usd">13217000</soph:CurrentAccruedExpenses>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities contextRef="c-3" decimals="-3" id="f-168" unitRef="usd">16720000</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities contextRef="c-6" decimals="-3" id="f-169" unitRef="usd">5732000</ifrs-full:CurrentDeferredIncomeIncludingCurrentContractLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c-3" decimals="-3" id="f-170" unitRef="usd">2700000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c-6" decimals="-3" id="f-171" unitRef="usd">2190000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentWarrantLiability contextRef="c-3" decimals="-3" id="f-172" unitRef="usd">1412000</ifrs-full:CurrentWarrantLiability>
    <ifrs-full:CurrentWarrantLiability contextRef="c-6" decimals="-3" id="f-173" unitRef="usd">444000</ifrs-full:CurrentWarrantLiability>
    <ifrs-full:CurrentLiabilities contextRef="c-3" decimals="-3" id="f-174" unitRef="usd">50528000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="c-6" decimals="-3" id="f-175" unitRef="usd">26803000</ifrs-full:CurrentLiabilities>
    <ifrs-full:LongtermBorrowings contextRef="c-3" decimals="-3" id="f-176" unitRef="usd">47733000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="c-6" decimals="-3" id="f-177" unitRef="usd">13237000</ifrs-full:LongtermBorrowings>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c-3" decimals="-3" id="f-178" unitRef="usd">12587000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c-6" decimals="-3" id="f-179" unitRef="usd">14603000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan contextRef="c-3" decimals="-3" id="f-180" unitRef="usd">4162000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan contextRef="c-6" decimals="-3" id="f-181" unitRef="usd">3839000</ifrs-full:NoncurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:OtherNoncurrentLiabilities contextRef="c-3" decimals="-3" id="f-182" unitRef="usd">876000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities contextRef="c-6" decimals="-3" id="f-183" unitRef="usd">337000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c-3" decimals="-3" id="f-184" unitRef="usd">65358000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="c-6" decimals="-3" id="f-185" unitRef="usd">32016000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities contextRef="c-3" decimals="-3" id="f-186" unitRef="usd">115886000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="c-6" decimals="-3" id="f-187" unitRef="usd">58819000</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital contextRef="c-3" decimals="-3" id="f-188" unitRef="usd">4814000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital contextRef="c-6" decimals="-3" id="f-189" unitRef="usd">4188000</ifrs-full:IssuedCapital>
    <ifrs-full:SharePremium contextRef="c-3" decimals="-3" id="f-190" unitRef="usd">473675000</ifrs-full:SharePremium>
    <ifrs-full:SharePremium contextRef="c-6" decimals="-3" id="f-191" unitRef="usd">472244000</ifrs-full:SharePremium>
    <ifrs-full:TreasuryShares contextRef="c-3" decimals="-3" id="f-192" unitRef="usd">1218000</ifrs-full:TreasuryShares>
    <ifrs-full:TreasuryShares contextRef="c-6" decimals="-3" id="f-193" unitRef="usd">702000</ifrs-full:TreasuryShares>
    <ifrs-full:OtherReserves contextRef="c-3" decimals="-3" id="f-194" unitRef="usd">89150000</ifrs-full:OtherReserves>
    <ifrs-full:OtherReserves contextRef="c-6" decimals="-3" id="f-195" unitRef="usd">61037000</ifrs-full:OtherReserves>
    <ifrs-full:RetainedEarnings contextRef="c-3" decimals="-3" id="f-196" unitRef="usd">-519276000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings contextRef="c-6" decimals="-3" id="f-197" unitRef="usd">-440277000</ifrs-full:RetainedEarnings>
    <ifrs-full:Equity contextRef="c-3" decimals="-3" id="f-198" unitRef="usd">47145000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-6" decimals="-3" id="f-199" unitRef="usd">96490000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities contextRef="c-3" decimals="-3" id="f-200" unitRef="usd">163031000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="c-6" decimals="-3" id="f-201" unitRef="usd">155309000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:NumberOfSharesIssued contextRef="c-7" decimals="INF" id="f-202" unitRef="shares">66398164</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-7" decimals="-3" id="f-203" unitRef="usd">3464000</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesIssued contextRef="c-8" decimals="INF" id="f-204" unitRef="shares">2166944</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-8" decimals="-3" id="f-205" unitRef="usd">-117000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-9" decimals="-3" id="f-206" unitRef="usd">471623000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-10" decimals="-3" id="f-207" unitRef="usd">23963000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-11" decimals="-3" id="f-208" unitRef="usd">-298803000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-12" decimals="-3" id="f-209" unitRef="usd">200130000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c-13" decimals="-3" id="f-210" unitRef="usd">-78981000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-5" decimals="-3" id="f-211" unitRef="usd">-78981000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-14" decimals="-3" id="f-212" unitRef="usd">14825000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-5" decimals="-3" id="f-213" unitRef="usd">14825000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-14" decimals="-3" id="f-214" unitRef="usd">14825000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-13" decimals="-3" id="f-215" unitRef="usd">-78981000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-5" decimals="-3" id="f-216" unitRef="usd">-64156000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-14" decimals="-3" id="f-217" unitRef="usd">15242000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-5" decimals="-3" id="f-218" unitRef="usd">15242000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <soph:NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement
      contextRef="c-15"
      decimals="INF"
      id="f-219"
      unitRef="shares">999339</soph:NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-15" decimals="-3" id="f-220" unitRef="usd">55000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-16" decimals="-3" id="f-221" unitRef="usd">223000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-14" decimals="-3" id="f-222" unitRef="usd">-52000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-5" decimals="-3" id="f-223" unitRef="usd">226000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:NumberOfTreasurySharesIssued
      contextRef="c-17"
      decimals="INF"
      id="f-224"
      unitRef="shares">10500000</soph:NumberOfTreasurySharesIssued>
    <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="c-17" decimals="-3" id="f-225" unitRef="usd">584000</ifrs-full:SaleOrIssueOfTreasuryShares>
    <soph:NumberOfTreasurySharesIssued
      contextRef="c-15"
      decimals="INF"
      id="f-226"
      unitRef="shares">10500000</soph:NumberOfTreasurySharesIssued>
    <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="c-15" decimals="-3" id="f-227" unitRef="usd">-584000</ifrs-full:SaleOrIssueOfTreasuryShares>
    <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="c-5" decimals="-3" id="f-228" unitRef="usd">0</ifrs-full:SaleOrIssueOfTreasuryShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-18"
      decimals="INF"
      id="f-229"
      unitRef="shares">76898164</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-18" decimals="-3" id="f-230" unitRef="usd">4048000</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-19"
      decimals="INF"
      id="f-231"
      unitRef="shares">11667605</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-19" decimals="-3" id="f-232" unitRef="usd">-646000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-20" decimals="-3" id="f-233" unitRef="usd">471846000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-21" decimals="-3" id="f-234" unitRef="usd">53978000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-22" decimals="-3" id="f-235" unitRef="usd">-377784000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-23" decimals="-3" id="f-236" unitRef="usd">151442000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c-24" decimals="-3" id="f-237" unitRef="usd">-62493000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-4" decimals="-3" id="f-238" unitRef="usd">-62493000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-25" decimals="-3" id="f-239" unitRef="usd">-9352000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-4" decimals="-3" id="f-240" unitRef="usd">-9352000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-25" decimals="-3" id="f-241" unitRef="usd">-9352000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-24" decimals="-3" id="f-242" unitRef="usd">-62493000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-4" decimals="-3" id="f-243" unitRef="usd">-71845000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-25" decimals="-3" id="f-244" unitRef="usd">16488000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-4" decimals="-3" id="f-245" unitRef="usd">16488000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <soph:NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement
      contextRef="c-26"
      decimals="INF"
      id="f-246"
      unitRef="shares">1456526</soph:NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-26" decimals="-3" id="f-247" unitRef="usd">84000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-27" decimals="-3" id="f-248" unitRef="usd">398000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-25" decimals="-3" id="f-249" unitRef="usd">-77000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-4" decimals="-3" id="f-250" unitRef="usd">405000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:NumberOfTreasurySharesIssued
      contextRef="c-28"
      decimals="INF"
      id="f-251"
      unitRef="shares">2423056</soph:NumberOfTreasurySharesIssued>
    <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="c-28" decimals="-3" id="f-252" unitRef="usd">140000</ifrs-full:SaleOrIssueOfTreasuryShares>
    <soph:NumberOfTreasurySharesIssued
      contextRef="c-26"
      decimals="INF"
      id="f-253"
      unitRef="shares">2423056</soph:NumberOfTreasurySharesIssued>
    <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="c-26" decimals="-3" id="f-254" unitRef="usd">-140000</ifrs-full:SaleOrIssueOfTreasuryShares>
    <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="c-4" decimals="-3" id="f-255" unitRef="usd">0</ifrs-full:SaleOrIssueOfTreasuryShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-29"
      decimals="INF"
      id="f-256"
      unitRef="shares">79321220</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-29" decimals="-3" id="f-257" unitRef="usd">4188000</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-30"
      decimals="INF"
      id="f-258"
      unitRef="shares">12634135</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-30" decimals="-3" id="f-259" unitRef="usd">-702000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-31" decimals="-3" id="f-260" unitRef="usd">472244000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-32" decimals="-3" id="f-261" unitRef="usd">61037000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-33" decimals="-3" id="f-262" unitRef="usd">-440277000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-6" decimals="-3" id="f-263" unitRef="usd">96490000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss contextRef="c-34" decimals="-3" id="f-264" unitRef="usd">-78999000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss contextRef="c-1" decimals="-3" id="f-265" unitRef="usd">-78999000</ifrs-full:ProfitLoss>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-35" decimals="-3" id="f-266" unitRef="usd">11996000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome contextRef="c-1" decimals="-3" id="f-267" unitRef="usd">11996000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-35" decimals="-3" id="f-268" unitRef="usd">11996000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-34" decimals="-3" id="f-269" unitRef="usd">-78999000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome contextRef="c-1" decimals="-3" id="f-270" unitRef="usd">-67003000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-35" decimals="-3" id="f-271" unitRef="usd">16205000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-1" decimals="-3" id="f-272" unitRef="usd">16205000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <soph:NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement
      contextRef="c-36"
      decimals="INF"
      id="f-273"
      unitRef="shares">1571015</soph:NumberOfShareOptionsExercisedAndOtherEquityInstrumentsVestedInShareBasedPaymentArrangement>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-36" decimals="-3" id="f-274" unitRef="usd">96000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-37" decimals="-3" id="f-275" unitRef="usd">338000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-35" decimals="-3" id="f-276" unitRef="usd">-88000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity contextRef="c-1" decimals="-3" id="f-277" unitRef="usd">346000</soph:IncreaseDecreaseThroughExerciseOfOptionsAndVestingOfOtherEquityInstrumentsEquity>
    <soph:NumberOfTreasurySharesIssued
      contextRef="c-38"
      decimals="INF"
      id="f-278"
      unitRef="shares">10000000</soph:NumberOfTreasurySharesIssued>
    <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="c-38" decimals="-3" id="f-279" unitRef="usd">626000</ifrs-full:SaleOrIssueOfTreasuryShares>
    <soph:NumberOfTreasurySharesIssued
      contextRef="c-36"
      decimals="INF"
      id="f-280"
      unitRef="shares">10000000</soph:NumberOfTreasurySharesIssued>
    <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="c-36" decimals="-3" id="f-281" unitRef="usd">-626000</ifrs-full:SaleOrIssueOfTreasuryShares>
    <ifrs-full:SaleOrIssueOfTreasuryShares contextRef="c-1" decimals="-3" id="f-282" unitRef="usd">0</ifrs-full:SaleOrIssueOfTreasuryShares>
    <soph:NumberOfEquitySharesIssued
      contextRef="c-36"
      decimals="INF"
      id="f-283"
      unitRef="shares">228238</soph:NumberOfEquitySharesIssued>
    <ifrs-full:IssueOfEquity contextRef="c-36" decimals="-3" id="f-284" unitRef="usd">14000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c-37" decimals="-3" id="f-285" unitRef="usd">1093000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity contextRef="c-1" decimals="-3" id="f-286" unitRef="usd">1107000</ifrs-full:IssueOfEquity>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-39"
      decimals="INF"
      id="f-287"
      unitRef="shares">89321220</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-39" decimals="-3" id="f-288" unitRef="usd">4814000</ifrs-full:Equity>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-40"
      decimals="INF"
      id="f-289"
      unitRef="shares">20834882</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:Equity contextRef="c-40" decimals="-3" id="f-290" unitRef="usd">-1218000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-41" decimals="-3" id="f-291" unitRef="usd">473675000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-42" decimals="-3" id="f-292" unitRef="usd">89150000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-43" decimals="-3" id="f-293" unitRef="usd">-519276000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="c-3" decimals="-3" id="f-294" unitRef="usd">47145000</ifrs-full:Equity>
    <ifrs-full:ProfitLossBeforeTax contextRef="c-1" decimals="-3" id="f-295" unitRef="usd">-77487000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c-4" decimals="-3" id="f-296" unitRef="usd">-61270000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax contextRef="c-5" decimals="-3" id="f-297" unitRef="usd">-78495000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c-1" decimals="-3" id="f-298" unitRef="usd">3976000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c-4" decimals="-3" id="f-299" unitRef="usd">4575000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AdjustmentsForDepreciationExpense contextRef="c-5" decimals="-3" id="f-300" unitRef="usd">5508000</ifrs-full:AdjustmentsForDepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-1" decimals="-3" id="f-301" unitRef="usd">5553000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-4" decimals="-3" id="f-302" unitRef="usd">4021000</ifrs-full:AmortisationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-5" decimals="-3" id="f-303" unitRef="usd">2828000</ifrs-full:AmortisationExpense>
    <soph:AdjustmentsForFinanceExpenseIncomeNet contextRef="c-1" decimals="-3" id="f-304" unitRef="usd">5127000</soph:AdjustmentsForFinanceExpenseIncomeNet>
    <soph:AdjustmentsForFinanceExpenseIncomeNet contextRef="c-4" decimals="-3" id="f-305" unitRef="usd">-5210000</soph:AdjustmentsForFinanceExpenseIncomeNet>
    <soph:AdjustmentsForFinanceExpenseIncomeNet contextRef="c-5" decimals="-3" id="f-306" unitRef="usd">2934000</soph:AdjustmentsForFinanceExpenseIncomeNet>
    <soph:AdjustmentsForFairValueOfWarrantLiability contextRef="c-1" decimals="-3" id="f-307" unitRef="usd">-497000</soph:AdjustmentsForFairValueOfWarrantLiability>
    <soph:AdjustmentsForFairValueOfWarrantLiability contextRef="c-4" decimals="-3" id="f-308" unitRef="usd">370000</soph:AdjustmentsForFairValueOfWarrantLiability>
    <soph:AdjustmentsForFairValueOfWarrantLiability contextRef="c-5" decimals="-3" id="f-309" unitRef="usd">0</soph:AdjustmentsForFairValueOfWarrantLiability>
    <soph:AdjustmentsForCreditLossAllowance contextRef="c-1" decimals="-3" id="f-310" unitRef="usd">57000</soph:AdjustmentsForCreditLossAllowance>
    <soph:AdjustmentsForCreditLossAllowance contextRef="c-4" decimals="-3" id="f-311" unitRef="usd">-523000</soph:AdjustmentsForCreditLossAllowance>
    <soph:AdjustmentsForCreditLossAllowance contextRef="c-5" decimals="-3" id="f-312" unitRef="usd">214000</soph:AdjustmentsForCreditLossAllowance>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c-1" decimals="-3" id="f-313" unitRef="usd">16205000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c-4" decimals="-3" id="f-314" unitRef="usd">16488000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments contextRef="c-5" decimals="-3" id="f-315" unitRef="usd">15242000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="c-1" decimals="-3" id="f-316" unitRef="usd">649000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="c-4" decimals="-3" id="f-317" unitRef="usd">1617000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities contextRef="c-5" decimals="-3" id="f-318" unitRef="usd">308000</ifrs-full:AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities>
    <soph:AdjustmentsForResearchTaxCredit contextRef="c-1" decimals="-3" id="f-319" unitRef="usd">977000</soph:AdjustmentsForResearchTaxCredit>
    <soph:AdjustmentsForResearchTaxCredit contextRef="c-4" decimals="-3" id="f-320" unitRef="usd">726000</soph:AdjustmentsForResearchTaxCredit>
    <soph:AdjustmentsForResearchTaxCredit contextRef="c-5" decimals="-3" id="f-321" unitRef="usd">1129000</soph:AdjustmentsForResearchTaxCredit>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-322" unitRef="usd">0</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-323" unitRef="usd">0</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-324" unitRef="usd">-28000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <soph:GainLossOnDisposalOfLeaseLiability contextRef="c-1" decimals="-3" id="f-325" unitRef="usd">0</soph:GainLossOnDisposalOfLeaseLiability>
    <soph:GainLossOnDisposalOfLeaseLiability contextRef="c-4" decimals="-3" id="f-326" unitRef="usd">0</soph:GainLossOnDisposalOfLeaseLiability>
    <soph:GainLossOnDisposalOfLeaseLiability contextRef="c-5" decimals="-3" id="f-327" unitRef="usd">733000</soph:GainLossOnDisposalOfLeaseLiability>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c-1" decimals="-3" id="f-328" unitRef="usd">-6603000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c-4" decimals="-3" id="f-329" unitRef="usd">5892000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable contextRef="c-5" decimals="-3" id="f-330" unitRef="usd">-6500000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses contextRef="c-1" decimals="-3" id="f-331" unitRef="usd">334000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses contextRef="c-4" decimals="-3" id="f-332" unitRef="usd">-1157000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses contextRef="c-5" decimals="-3" id="f-333" unitRef="usd">1375000</ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c-1" decimals="-3" id="f-334" unitRef="usd">46000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c-4" decimals="-3" id="f-335" unitRef="usd">69000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories contextRef="c-5" decimals="-3" id="f-336" unitRef="usd">-874000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="c-1" decimals="-3" id="f-337" unitRef="usd">16930000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="c-4" decimals="-3" id="f-338" unitRef="usd">-7385000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables contextRef="c-5" decimals="-3" id="f-339" unitRef="usd">6871000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables>
    <ifrs-full:CashFlowsFromUsedInOperations contextRef="c-1" decimals="-3" id="f-340" unitRef="usd">-35693000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations contextRef="c-4" decimals="-3" id="f-341" unitRef="usd">-43979000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:CashFlowsFromUsedInOperations contextRef="c-5" decimals="-3" id="f-342" unitRef="usd">-52423000</ifrs-full:CashFlowsFromUsedInOperations>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="c-1" decimals="-3" id="f-343" unitRef="usd">200000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="c-4" decimals="-3" id="f-344" unitRef="usd">536000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="c-5" decimals="-3" id="f-345" unitRef="usd">801000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-346" unitRef="usd">-35893000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c-4" decimals="-3" id="f-347" unitRef="usd">-44515000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c-5" decimals="-3" id="f-348" unitRef="usd">-53224000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c-1" decimals="-3" id="f-349" unitRef="usd">574000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c-4" decimals="-3" id="f-350" unitRef="usd">244000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="c-5" decimals="-3" id="f-351" unitRef="usd">1494000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c-1" decimals="-3" id="f-352" unitRef="usd">108000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c-4" decimals="-3" id="f-353" unitRef="usd">195000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="c-5" decimals="-3" id="f-354" unitRef="usd">263000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <soph:CapitalizedSoftwareDevelopmentCosts contextRef="c-1" decimals="-3" id="f-355" unitRef="usd">7938000</soph:CapitalizedSoftwareDevelopmentCosts>
    <soph:CapitalizedSoftwareDevelopmentCosts contextRef="c-4" decimals="-3" id="f-356" unitRef="usd">7737000</soph:CapitalizedSoftwareDevelopmentCosts>
    <soph:CapitalizedSoftwareDevelopmentCosts contextRef="c-5" decimals="-3" id="f-357" unitRef="usd">7469000</soph:CapitalizedSoftwareDevelopmentCosts>
    <ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod contextRef="c-1" decimals="-3" id="f-358" unitRef="usd">1885000</ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod contextRef="c-4" decimals="-3" id="f-359" unitRef="usd">0</ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod contextRef="c-5" decimals="-3" id="f-360" unitRef="usd">0</ifrs-full:PurchaseOfInterestsInInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments contextRef="c-1" decimals="-3" id="f-361" unitRef="usd">0</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments contextRef="c-4" decimals="-3" id="f-362" unitRef="usd">0</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments contextRef="c-5" decimals="-3" id="f-363" unitRef="usd">17546000</ifrs-full:CashFlowsFromUsedInDecreaseIncreaseInShorttermDepositsAndInvestments>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities contextRef="c-1" decimals="-3" id="f-364" unitRef="usd">1835000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities contextRef="c-4" decimals="-3" id="f-365" unitRef="usd">3421000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:InterestReceivedClassifiedAsInvestingActivities contextRef="c-5" decimals="-3" id="f-366" unitRef="usd">4655000</ifrs-full:InterestReceivedClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-367" unitRef="usd">-8670000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c-4" decimals="-3" id="f-368" unitRef="usd">-4755000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c-5" decimals="-3" id="f-369" unitRef="usd">12975000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="c-1" decimals="-3" id="f-370" unitRef="usd">346000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="c-4" decimals="-3" id="f-371" unitRef="usd">405000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:ProceedsFromExerciseOfOptions contextRef="c-5" decimals="-3" id="f-372" unitRef="usd">226000</ifrs-full:ProceedsFromExerciseOfOptions>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c-1" decimals="-3" id="f-373" unitRef="usd">3953000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c-4" decimals="-3" id="f-374" unitRef="usd">1728000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:InterestPaidClassifiedAsFinancingActivities contextRef="c-5" decimals="-3" id="f-375" unitRef="usd">6000</ifrs-full:InterestPaidClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c-1" decimals="-3" id="f-376" unitRef="usd">34563000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c-4" decimals="-3" id="f-377" unitRef="usd">13930000</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="c-5" decimals="-3" id="f-378" unitRef="usd">0</ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-1" decimals="-3" id="f-379" unitRef="usd">1093000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-4" decimals="-3" id="f-380" unitRef="usd">0</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-5" decimals="-3" id="f-381" unitRef="usd">0</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c-1" decimals="-3" id="f-382" unitRef="usd">1872000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c-4" decimals="-3" id="f-383" unitRef="usd">2750000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="c-5" decimals="-3" id="f-384" unitRef="usd">3043000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-385" unitRef="usd">30177000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c-4" decimals="-3" id="f-386" unitRef="usd">9857000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c-5" decimals="-3" id="f-387" unitRef="usd">-2823000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="c-1" decimals="-3" id="f-388" unitRef="usd">-14386000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="c-4" decimals="-3" id="f-389" unitRef="usd">-39413000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="c-5" decimals="-3" id="f-390" unitRef="usd">-43072000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c-1" decimals="-3" id="f-391" unitRef="usd">4449000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c-4" decimals="-3" id="f-392" unitRef="usd">-3612000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="c-5" decimals="-3" id="f-393" unitRef="usd">5018000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-6" decimals="-3" id="f-394" unitRef="usd">80226000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-23" decimals="-3" id="f-395" unitRef="usd">123251000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-12" decimals="-3" id="f-396" unitRef="usd">161305000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-3" decimals="-3" id="f-397" unitRef="usd">70289000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-6" decimals="-3" id="f-398" unitRef="usd">80226000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-23" decimals="-3" id="f-399" unitRef="usd">123251000</ifrs-full:CashAndCashEquivalents>
    <soph:DisclosureOfCompanyInformationAndOperationsTextBlock contextRef="c-1" id="f-400">Company information and operations&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;General information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOPHiA GENETICS SA and its consolidated subsidiaries (NASDAQ: SOPH) (&#x201c;the Company&#x201d;) is a cloud-native software technology company in the healthcare space, incorporated on&#160;March 18, 2011, and headquartered in Rolle, Switzerland. The Company is dedicated to establishing the practice of data-driven medicine as the standard of care in healthcare and for life sciences research. The Company has built a cloud-native software platform capable of analyzing data and generating insights from complex multimodal datasets and different diagnostic modalities. This platform, commercialized as &#x201c;SOPHiA DDM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#x201d; standardizes, computes, and analyzes digital health data and is used in decentralized locations to break down data silos. The Company collectively refers to SOPHiA DDM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Platform and related products and solutions as &#x201c;SOPHiA DDM Platform.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025, the Company had the following wholly-owned subsidiaries:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Country of domicile&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS S.A.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS LTD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS Intermedia&#xe7;&#xe3;o de Neg&#xf3;cios LTDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brazil&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS PTY LTD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS S.R.L.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS GmbH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s Board of Directors approved the issue of the consolidated financial statements on&#160;March&#160;3, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Issued share capital&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025, the Company had issued 89,321,220 shares of which 68,486,338 are outstanding and 20,834,882 are held by the Company as treasury shares. As of December 31, 2024, the Company had issued 79,321,220 shares of which 66,687,085 are outstanding and 12,634,135 are held by the Company as treasury shares. All shares were considered paid as of December 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Capital Range&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Under the Company&#x2019;s articles of association, the board of directors is authorized, at any time and including for anti&#x2011;takeover and change&#x2011;of&#x2011;control purposes, to increase the Company&#x2019;s nominal share capital until June 18, 2030, within a capital range extending from CHF 3,319,908.20 ($4,192,193.63) (lower limit) to CHF 4,979,862.30 ($6,288,042.55) (upper limit). Within this capital range, the board is authorized to increase the Company&#x2019;s nominal share capital by up to CHF 4,979,862.30 ($6,288,042.55) through the issuance of up to 33,199,082 fully paid&#x2011;in ordinary shares, each with a par value of CHF 0.05 ($0.06). In addition to the increase of share capital, our board of directors has the right to reduce the share capital to the minimum amount of CHF3,319,908.20 ($4,192,193.63). According to the articles of association, our board of directors is entitled to determine the use of the reduction amount, to the extent necessary.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Treasury shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2023, the Company issued 10,500,000 registered shares to SOPHiA GENETICS LTD pursuant to a share delivery and repurchase agreement, which were immediately exercised, and repurchased the shares to hold as treasury shares. During the third quarter of 2024, the Company issued 2,423,056 registered shares to SOPHiA GENETICS LTD pursuant to a share delivery and repurchase agreement, which were immediately exercised, and repurchased the shares to hold as treasury shares for the purposes of administering the Company's equity incentive programs. During the fourth quarter of 2025, the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company issued 10,000,000 registered shares to SOPHiA GENETICS LTD pursuant to a share delivery and repurchase agreement, which were immediately exercised, and repurchased the shares to hold as treasury shares. The Company held 20,834,882 and 12,634,135 treasury shares as of December 31, 2025 and 2024, respectively. The issuance of the 10,000,000 shares in 2025 was made out of the Company&#x2019;s capital range in accordance with the board of directors&#x2019; authorization under the Company&#x2019;s articles of association.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Treasury shares are recognized at acquisition cost and recorded as treasury shares at the time of the transaction. Upon exercise of share options or vesting of restricted stock units, the treasury shares are subsequently transferred. Any consideration received is included in shareholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Conditional share capital&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;Conditional Share Capital for Financing, Acquisitions and Other Purposes&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may increase its share capital for anti&#x2011;takeover and change&#x2011;of&#x2011;control purposes through the exercise or mandatory exercise of conversion, exchange, option, warrant or similar rights granted to shareholders or third parties, whether issued on a standalone basis or in connection with other securities or contractual obligations of the Company or its subsidiaries. As of December 31, 2025, the conditional share capital available for financing, acquisitions and other strategic purposes consisted of 18,277,363 ordinary shares with a par value of CHF 0.05 ($ 0.06) each, compared to 21,599,082 ordinary shares as of December 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9.55pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline"&gt;Conditional Share Capital for Employee Participation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may issue registered shares to employees, agents and members of the Board of Directors under its stock option and other equity&#x2011;based incentive plans. As of December 31, 2025, the conditional share capital available for employee participation consisted of 21,383,247 ordinary shares with a par value of CHF 0.05 ($ 0.06) each, compared to 18,061,528 ordinary shares as of December 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;ATM Program&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2025, the Company established a new at-the-market (&#x201c;ATM&#x201d;) offering program pursuant to which  from time to time the Company may sell ordinary shares having an aggregate offering price of $50.0&#160;million. For the year ended December 31, 2025, 228,238 ordinary shares were sold for total gross proceeds of $1.1&#160;million under this program.&lt;/span&gt;&lt;/div&gt;</soph:DisclosureOfCompanyInformationAndOperationsTextBlock>
    <soph:DisclosureOfDetailedInformationAboutSubsidiariesTextBlock contextRef="c-1" id="f-401">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025, the Company had the following wholly-owned subsidiaries:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:78.142%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.052%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Country of domicile&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS S.A.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS LTD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.K.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS Intermedia&#xe7;&#xe3;o de Neg&#xf3;cios LTDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brazil&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS PTY LTD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Australia&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS S.R.L.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA GENETICS GmbH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Germany&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutSubsidiariesTextBlock>
    <ifrs-full:NameOfSubsidiary contextRef="c-44" id="f-402">SOPHiA GENETICS S.A.S.</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DomicileOfEntity contextRef="c-44" id="f-403">France</ifrs-full:DomicileOfEntity>
    <ifrs-full:NameOfSubsidiary contextRef="c-45" id="f-404">SOPHiA GENETICS LTD</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DomicileOfEntity contextRef="c-45" id="f-405">U.K.</ifrs-full:DomicileOfEntity>
    <ifrs-full:NameOfSubsidiary contextRef="c-46" id="f-406">SOPHiA GENETICS, Inc.</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DomicileOfEntity contextRef="c-46" id="f-407">U.S.</ifrs-full:DomicileOfEntity>
    <ifrs-full:NameOfSubsidiary contextRef="c-47" id="f-408">SOPHiA GENETICS Intermedia&#xe7;&#xe3;o de Neg&#xf3;cios LTDA</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DomicileOfEntity contextRef="c-47" id="f-409">Brazil</ifrs-full:DomicileOfEntity>
    <ifrs-full:NameOfSubsidiary contextRef="c-48" id="f-410">SOPHiA GENETICS PTY LTD</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DomicileOfEntity contextRef="c-48" id="f-411">Australia</ifrs-full:DomicileOfEntity>
    <ifrs-full:NameOfSubsidiary contextRef="c-49" id="f-412">SOPHiA GENETICS S.R.L.</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DomicileOfEntity contextRef="c-49" id="f-413">Italy</ifrs-full:DomicileOfEntity>
    <ifrs-full:NameOfSubsidiary contextRef="c-50" id="f-414">SOPHiA GENETICS GmbH</ifrs-full:NameOfSubsidiary>
    <ifrs-full:DomicileOfEntity contextRef="c-50" id="f-415">Germany</ifrs-full:DomicileOfEntity>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-39"
      decimals="INF"
      id="f-416"
      unitRef="shares">89321220</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="c-39"
      decimals="INF"
      id="f-417"
      unitRef="shares">68486338</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-40"
      decimals="INF"
      id="f-418"
      unitRef="shares">20834882</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-29"
      decimals="INF"
      id="f-419"
      unitRef="shares">79321220</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesOutstanding
      contextRef="c-29"
      decimals="INF"
      id="f-420"
      unitRef="shares">66687085</ifrs-full:NumberOfSharesOutstanding>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-30"
      decimals="INF"
      id="f-421"
      unitRef="shares">12634135</ifrs-full:NumberOfSharesIssued>
    <soph:IncreaseDecreaseInAuthorisedCapital contextRef="c-51" decimals="2" id="f-422" unitRef="chf">3319908.2</soph:IncreaseDecreaseInAuthorisedCapital>
    <soph:IncreaseDecreaseInAuthorisedCapital contextRef="c-51" decimals="2" id="f-423" unitRef="usd">4192193.63</soph:IncreaseDecreaseInAuthorisedCapital>
    <soph:IncreaseDecreaseInAuthorisedCapital contextRef="c-52" decimals="2" id="f-424" unitRef="chf">4979862.3</soph:IncreaseDecreaseInAuthorisedCapital>
    <soph:IncreaseDecreaseInAuthorisedCapital contextRef="c-52" decimals="2" id="f-425" unitRef="usd">6288042.55</soph:IncreaseDecreaseInAuthorisedCapital>
    <soph:IncreaseDecreaseInAuthorisedCapital contextRef="c-52" decimals="2" id="f-426" unitRef="chf">4979862.3</soph:IncreaseDecreaseInAuthorisedCapital>
    <soph:IncreaseDecreaseInAuthorisedCapital contextRef="c-52" decimals="2" id="f-427" unitRef="usd">6288042.55</soph:IncreaseDecreaseInAuthorisedCapital>
    <soph:IncreaseDecreaseInNumberOfSharesAuthorised
      contextRef="c-53"
      decimals="INF"
      id="f-428"
      unitRef="shares">33199082</soph:IncreaseDecreaseInNumberOfSharesAuthorised>
    <ifrs-full:ParValuePerShare
      contextRef="c-54"
      decimals="INF"
      id="f-429"
      unitRef="chfPerShare">0.05</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="c-54"
      decimals="INF"
      id="f-430"
      unitRef="usdPerShare">0.06</ifrs-full:ParValuePerShare>
    <soph:IncreaseDecreaseInAuthorisedCapital contextRef="c-51" decimals="2" id="f-431" unitRef="chf">3319908.2</soph:IncreaseDecreaseInAuthorisedCapital>
    <soph:IncreaseDecreaseInAuthorisedCapital contextRef="c-51" decimals="2" id="f-432" unitRef="usd">4192193.63</soph:IncreaseDecreaseInAuthorisedCapital>
    <soph:NumberOfTreasurySharesIssued
      contextRef="c-55"
      decimals="INF"
      id="f-433"
      unitRef="shares">10500000</soph:NumberOfTreasurySharesIssued>
    <soph:NumberOfTreasurySharesIssued
      contextRef="c-56"
      decimals="INF"
      id="f-434"
      unitRef="shares">2423056</soph:NumberOfTreasurySharesIssued>
    <soph:NumberOfTreasurySharesIssued
      contextRef="c-57"
      decimals="INF"
      id="f-435"
      unitRef="shares">10000000</soph:NumberOfTreasurySharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-40"
      decimals="INF"
      id="f-436"
      unitRef="shares">20834882</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="c-30"
      decimals="INF"
      id="f-437"
      unitRef="shares">12634135</ifrs-full:NumberOfSharesIssued>
    <soph:NumberOfTreasurySharesIssued
      contextRef="c-57"
      decimals="INF"
      id="f-438"
      unitRef="shares">10000000</soph:NumberOfTreasurySharesIssued>
    <soph:NumberOfConditionalSharesAuthorised
      contextRef="c-58"
      decimals="INF"
      id="f-439"
      unitRef="shares">18277363</soph:NumberOfConditionalSharesAuthorised>
    <ifrs-full:ParValuePerShare
      contextRef="c-58"
      decimals="INF"
      id="f-440"
      unitRef="chfPerShare">0.05</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="c-58"
      decimals="INF"
      id="f-441"
      unitRef="usdPerShare">0.06</ifrs-full:ParValuePerShare>
    <soph:NumberOfConditionalSharesAuthorised
      contextRef="c-59"
      decimals="INF"
      id="f-442"
      unitRef="shares">21599082</soph:NumberOfConditionalSharesAuthorised>
    <soph:NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement
      contextRef="c-58"
      decimals="INF"
      id="f-443"
      unitRef="shares">21383247</soph:NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement>
    <ifrs-full:ParValuePerShare
      contextRef="c-58"
      decimals="INF"
      id="f-444"
      unitRef="chfPerShare">0.05</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="c-58"
      decimals="INF"
      id="f-445"
      unitRef="usdPerShare">0.06</ifrs-full:ParValuePerShare>
    <soph:NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement
      contextRef="c-59"
      decimals="INF"
      id="f-446"
      unitRef="shares">18061528</soph:NumberOfConditionalSharesAuthorisedInShareBasedPaymentArrangement>
    <ifrs-full:IssueOfEquity contextRef="c-60" decimals="-5" id="f-447" unitRef="usd">50000000.0</ifrs-full:IssueOfEquity>
    <soph:NumberOfEquitySharesIssued contextRef="c-1" decimals="INF" id="f-448" unitRef="shares">228238</soph:NumberOfEquitySharesIssued>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-1" decimals="-5" id="f-449" unitRef="usd">1100000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory contextRef="c-1" id="f-450">Material accounting policies&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of preparation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Compliance with International Financial Reporting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements of the Company have been prepared in accordance with IFRS Accounting Standards and interpretations issued by the IFRS Interpretations Committee (&#x201c;IFRS IC&#x201d;) applicable to companies reporting under IFRS Accounting Standards. The consolidated financial statements comply with IFRS Accounting Standards as issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A subsidiary is an entity over which the Company has control. The Company controls an entity when it has the power to direct its activities and has rights to its variable returns. Subsidiaries are fully consolidated from the date on which control is transferred to the Company and deconsolidated from the date that control ceases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the consolidation process intercompany transactions, balances, and unrealized gains on transactions between companies are eliminated. Unrealized losses are also eliminated unless there is evidence of an impairment of the transferred asset. In order to ensure consistency with the accounting policies of the Company, the accounting policies of subsidiaries have been changed where necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign currency translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Items included in the consolidated financial statements of each of the Company&#x2019;s entities are measured using the currency of the primary economic environment in which the entity operates (&#x201c;functional currency&#x201d;). In individual entities, transactions in foreign currencies are translated as of transaction date. Monetary assets and liabilities in foreign currencies are translated at month end rates. The Company&#x2019;s reporting currency of the Company&#x2019;s consolidated financial statements is the U.S. dollar (&#x201c;USD&#x201d;). Assets and liabilities denominated in foreign currencies are translated at the month-end spot exchange rates, income statement accounts are translated at average rates of exchange for the period presented, and equity is translated at historical exchange rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On consolidation, assets and liabilities of foreign operations reported in their local functional currencies are translated into USD. Differences arising from the retranslation of opening net assets of foreign operations, together with differences arising from the translation of the net results for the year of foreign operations, are recognized in other comprehensive income under currency translation adjustments. Gains or losses resulting from foreign currency transactions are included in net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company selected the U.S. dollar as its presentation currency for purposes of its consolidated financial statements instead of the Company&#x2019;s functional currency, the Swiss franc, because of the global nature of its business, its expectation that an increasing portion of revenues and expenses will be denominated in USD, and its plans to continue to access U.S. capital markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with IFRS Accounting Standards requires the use of accounting estimates. It also requires management to exercise judgment in applying the Company&#x2019;s accounting policies. The Company&#x2019;s significant estimates and judgments included in the preparation of the consolidated financial statements are related to revenue recognition, capitalized internal software development costs, defined benefit liability and share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Disclosed in the corresponding sections within the footnotes are the areas which require a high degree of judgment, significant assumptions, and/or estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Going concern basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements have been prepared on a going concern basis (See Note 27 &#x2013; &#x201c;Capital management&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Historical cost convention&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements have been prepared on a historical cost basis except for certain assets and liabilities, which are carried at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The material accounting policies adopted in the preparation of the consolidated financial statements have been consistently applied, unless otherwise stated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Provisions and contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provisions comprise liabilities of uncertain timing or amount. The provisions and liabilities are recognized when the Company has a present legal or constructive obligation as a result of past events, it is probable that an outflow of resources will be required to settle the obligation, and the amount can &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;be reliably estim&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ated. Provisions are not recognized for future operating losses. Provisions are measured at the present value of management&#x2019;s best estimate of the expenditure required to settle the present obligation at the end of the reporting period, unless the impact of discounting is immaterial. The discount rate used to determine the present value is a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. The increase in the provision due to the passage of time is recognized as interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent liabilities are possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not fully within the control of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The likelihood of occurrence of provisions and contingent liabilities requires use of judgment. Judgment is also required to determine if an outflow of economic resources is probable, or possible but not probable. Where it is probable, a liability is recognized, and further judgment is used to determine the level of the provision. Where it is possible but not probable, further judgment is used to determine if the likelihood is remote, in which case no disclosures are provided; if the likelihood is not remote then judgment is used to determine the contingent liability disclosed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial assets classification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon recognition, financial assets are classified on the basis of how the financial assets are measured: at amortized cost or fair value through income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The classification of financial assets at initial recognition depends on the financial asset&#x2019;s contractual cash flow characteristics and the Company&#x2019;s business model for managing them. Except for accounts receivable that do not contain a significant financing component, the Company initially measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through income, transaction costs. Accounts receivable that do not contain a significant financing component are measured at the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s business model for managing financial assets is defined by whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets held in order to collect contractual cash flows are measured at amortized cost. Financial assets held both to collect contractual cash flows and for sale are measured at fair value through other comprehensive income/loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases or sales of financial assets that require delivery of assets within a time frame established by regulation or convention in the marketplace (regular way trades) are recognized on the trade date, i.e., the date that the Company commits to purchase or sell the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial assets measured at amortized cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets initially measured at amortized cost are subsequently measured using the effective interest rate (&#x201c;EIR&#x201d;) method and are subject to impairment. Gains and losses are recognized in income when the asset is derecognized, modified, or impaired. The Company&#x2019;s financial assets at amortized cost include cash and accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial assets&#x2014;derecognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Company&#x2019;s consolidated balance sheet) when:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the rights to receive cash flows from the asset have expired or;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material delay to a third party under a &#x2018;pass-through&#x2019; arrangement; and either;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the Company has transferred substantially all the risks and rewards of the asset, or;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the Company has neither transferred nor retained substantially all the risks and rewards of the asset but has transferred control of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Company has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risks and rewards of ownership.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Company has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control of the asset, the Company continues to recognize the transferred asset to the extent of its continuing involvement. In that case, the Company also recognizes an associated liability. The transferred &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;asset and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Continuing involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that the Company could be required to repay.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial assets&#x2014;impairment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For cash and cash equivalents, the Company invests in short-term highly liquid assets where it has never incurred and does not expect to incur credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For accounts receivable the Company recognizes a loss allowance based on lifetime estimated credit losses (&#x201c;ECL&#x201d;) at each reporting date. When estimating the ECL the Company takes into consideration: readily available relevant and supportable information (this includes quantitative and qualitative data), the Company&#x2019;s historical experience and forward-looking information specific to the receivables and the economic environment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 12 &#x2013; &#x201c;Accounts receivable&#x201d; for further information about the Company&#x2019;s accounting for trade receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial liabilities classification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial liabilities are classified upon initial recognition as financial liabilities measured at fair value through income or at amortized cost. The Company&#x2019;s financial liabilities include accounts payable and debt (including borrowings and lease liabilities), which are measured at amortized cost, and derivatives, which are measured at fair value through income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest-bearing borrowings are initially recognized at fair value less directly attributable costs and subsequently measured at amortized cost using the EIR method. Gains and losses are recognized in income when the liabilities are derecognized as well as through the EIR amortization process.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortized cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included as interest expense in the statement of loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial liabilities&#x2014;derecognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A financial liability is derecognized when the obligation under the liability is discharged or canceled or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recognized in the statements of loss.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Change in accounting policies &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Statement of Cash Flows - Interest Classification&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective January 1, 2025, the Company revised its accounting policy regarding the classification of interest paid and interest received in the Statement of Cash Flows. Interest paid was reclassified from Net cash flows used in operating activities to Net cash flows used in financing activities, and interest received was reclassified from Net cash flows used in operating activities to Net cash flows used in investing activities. The Company assessed the change in accounting policy under IAS 8, in accordance with the guidance regarding a voluntary change in accounting policy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reclassification of interest paid was elected to provide a more cohesive presentation of payments related to the Company&#x2019;s borrowings and lease liabilities. Prior to the change in accounting policy, interest paid on borrowings and lease liabilities were classified as operating cash flows, while proceeds from borrowings, net of transaction costs and payments of principal portion of lease liabilities are classified as financing cash flows. The change aligns interest payments with their associated transactions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company reclassified interest received to investing activities, as the majority of interest received relates to interest earned on cash and cash equivalents and short-term investments. The Company believes this updated classification better reflects the nature and source of these cash inflows and provides more relevant and reliable information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the voluntary change in accounting policy did not have an impact on basic and diluted earnings per share under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IAS 33 - Earnings per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applied the change in accounting policy retrospectively and has recast prior period comparative information within the Statement of Cash Flows to ensure consistency and comparability with the current period presentation. As part of the retrospective application, cash flows changed as follows for the year ended December&#160;31,&#160;2024: Net cash used in operating activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;increased by $1.7&#160;million, Net cash flow used in investing activities decreased by $3.4&#160;million, and Net cash flow provided by financing activities decreased by $1.7&#160;million. Cash flows changed as follows for the year ended December 31, 2023: Net cash used in operating activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;increased by $4.6&#160;million, Net cash flow provided by investing activities increased by $4.7&#160;million, and Net cash flow used in financing activities decreased by less than $0.1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New standards, amendments to standards and interpretations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;New standards, amendments to standards, and interpretations issued not yet effective&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2024, IFRS 18, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Presentation and Disclosure in Financial Statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was issued to achieve comparability of the financial performance of similar entities. The standard, which will replace IAS 1 impacts the presentation of primary financial statements and notes, including the statement of profit and loss where companies will be required to present separate categories of income and expense for operating, investing, and financing activities with prescribed subtotals for each new category. The standard will also require management-defined performance measures to be explained and included in a separate note within the consolidated financial statements. The standard is effective for annual reporting periods beginning on or after January 1, 2027, and requires retrospective application. While IFRS 18 will not change recognition criteria or measurement bases, it might have a significant impact on presenting information in the financial statements, in particular the income statement. The Company is currently assessing impacts and data readiness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no other IFRS Accounting Standards or IFRS IC interpretations that are not yet effective and that could have a material impact to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfMaterialAccountingPolicyInformationExplanatory>
    <soph:DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock contextRef="c-1" id="f-451">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of preparation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Compliance with International Financial Reporting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements of the Company have been prepared in accordance with IFRS Accounting Standards and interpretations issued by the IFRS Interpretations Committee (&#x201c;IFRS IC&#x201d;) applicable to companies reporting under IFRS Accounting Standards. The consolidated financial statements comply with IFRS Accounting Standards as issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;).&lt;/span&gt;&lt;/div&gt;</soph:DescriptionOfAccountingPolicyForBasisOfPreparationTextBlock>
    <soph:DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock contextRef="c-1" id="f-452">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A subsidiary is an entity over which the Company has control. The Company controls an entity when it has the power to direct its activities and has rights to its variable returns. Subsidiaries are fully consolidated from the date on which control is transferred to the Company and deconsolidated from the date that control ceases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the consolidation process intercompany transactions, balances, and unrealized gains on transactions between companies are eliminated. Unrealized losses are also eliminated unless there is evidence of an impairment of the transferred asset. In order to ensure consistency with the accounting policies of the Company, the accounting policies of subsidiaries have been changed where necessary.&lt;/span&gt;&lt;/div&gt;</soph:DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="c-1" id="f-453">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign currency translation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Items included in the consolidated financial statements of each of the Company&#x2019;s entities are measured using the currency of the primary economic environment in which the entity operates (&#x201c;functional currency&#x201d;). In individual entities, transactions in foreign currencies are translated as of transaction date. Monetary assets and liabilities in foreign currencies are translated at month end rates. The Company&#x2019;s reporting currency of the Company&#x2019;s consolidated financial statements is the U.S. dollar (&#x201c;USD&#x201d;). Assets and liabilities denominated in foreign currencies are translated at the month-end spot exchange rates, income statement accounts are translated at average rates of exchange for the period presented, and equity is translated at historical exchange rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On consolidation, assets and liabilities of foreign operations reported in their local functional currencies are translated into USD. Differences arising from the retranslation of opening net assets of foreign operations, together with differences arising from the translation of the net results for the year of foreign operations, are recognized in other comprehensive income under currency translation adjustments. Gains or losses resulting from foreign currency transactions are included in net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company selected the U.S. dollar as its presentation currency for purposes of its consolidated financial statements instead of the Company&#x2019;s functional currency, the Swiss franc, because of the global nature of its business, its expectation that an increasing portion of revenues and expenses will be denominated in USD, and its plans to continue to access U.S. capital markets.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory>
    <soph:DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock contextRef="c-1" id="f-454">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with IFRS Accounting Standards requires the use of accounting estimates. It also requires management to exercise judgment in applying the Company&#x2019;s accounting policies. The Company&#x2019;s significant estimates and judgments included in the preparation of the consolidated financial statements are related to revenue recognition, capitalized internal software development costs, defined benefit liability and share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Disclosed in the corresponding sections within the footnotes are the areas which require a high degree of judgment, significant assumptions, and/or estimates.&lt;/span&gt;&lt;/div&gt;</soph:DescriptionOfAccountingPolicyForUseOfEstimatesTextBlock>
    <soph:DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock contextRef="c-1" id="f-455">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Going concern basis&lt;/span&gt;&lt;/div&gt;The consolidated financial statements have been prepared on a going concern basis</soph:DescriptionOfAccountingPolicyForGoingConcernBasisTextBlock>
    <soph:DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock contextRef="c-1" id="f-456">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Historical cost convention&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements have been prepared on a historical cost basis except for certain assets and liabilities, which are carried at fair value.&lt;/span&gt;&lt;/div&gt;</soph:DescriptionOfAccountingPolicyForHistoricalCostConventionTextBlock>
    <soph:DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock contextRef="c-1" id="f-457">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The material accounting policies adopted in the preparation of the consolidated financial statements have been consistently applied, unless otherwise stated.&lt;/span&gt;&lt;/div&gt;</soph:DescriptionOfAccountingPolicyForAccountingPoliciesTextBlock>
    <soph:DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock contextRef="c-1" id="f-458">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Provisions and contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provisions comprise liabilities of uncertain timing or amount. The provisions and liabilities are recognized when the Company has a present legal or constructive obligation as a result of past events, it is probable that an outflow of resources will be required to settle the obligation, and the amount can &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;be reliably estim&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ated. Provisions are not recognized for future operating losses. Provisions are measured at the present value of management&#x2019;s best estimate of the expenditure required to settle the present obligation at the end of the reporting period, unless the impact of discounting is immaterial. The discount rate used to determine the present value is a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. The increase in the provision due to the passage of time is recognized as interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent liabilities are possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not fully within the control of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The likelihood of occurrence of provisions and contingent liabilities requires use of judgment. Judgment is also required to determine if an outflow of economic resources is probable, or possible but not probable. Where it is probable, a liability is recognized, and further judgment is used to determine the level of the provision. Where it is possible but not probable, further judgment is used to determine if the likelihood is remote, in which case no disclosures are provided; if the likelihood is not remote then judgment is used to determine the contingent liability disclosed.&lt;/span&gt;&lt;/div&gt;</soph:DescriptionOfAccountingPolicyForProvisionsAndContingenciesTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory contextRef="c-1" id="f-459">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial assets classification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon recognition, financial assets are classified on the basis of how the financial assets are measured: at amortized cost or fair value through income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The classification of financial assets at initial recognition depends on the financial asset&#x2019;s contractual cash flow characteristics and the Company&#x2019;s business model for managing them. Except for accounts receivable that do not contain a significant financing component, the Company initially measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through income, transaction costs. Accounts receivable that do not contain a significant financing component are measured at the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s business model for managing financial assets is defined by whether cash flows will result from collecting contractual cash flows, selling the financial assets, or both. Financial assets held in order to collect contractual cash flows are measured at amortized cost. Financial assets held both to collect contractual cash flows and for sale are measured at fair value through other comprehensive income/loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchases or sales of financial assets that require delivery of assets within a time frame established by regulation or convention in the marketplace (regular way trades) are recognized on the trade date, i.e., the date that the Company commits to purchase or sell the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial assets measured at amortized cost&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets initially measured at amortized cost are subsequently measured using the effective interest rate (&#x201c;EIR&#x201d;) method and are subject to impairment. Gains and losses are recognized in income when the asset is derecognized, modified, or impaired. The Company&#x2019;s financial assets at amortized cost include cash and accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial assets&#x2014;derecognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A financial asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e., removed from the Company&#x2019;s consolidated balance sheet) when:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the rights to receive cash flows from the asset have expired or;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows in full without material delay to a third party under a &#x2018;pass-through&#x2019; arrangement; and either;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the Company has transferred substantially all the risks and rewards of the asset, or;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the Company has neither transferred nor retained substantially all the risks and rewards of the asset but has transferred control of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Company has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates if, and to what extent, it has retained the risks and rewards of ownership.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When the Company has neither transferred nor retained substantially all of the risks and rewards of the asset, nor transferred control of the asset, the Company continues to recognize the transferred asset to the extent of its continuing involvement. In that case, the Company also recognizes an associated liability. The transferred &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;asset and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Continuing involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of the asset and the maximum amount of consideration that the Company could be required to repay.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial assets&#x2014;impairment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For cash and cash equivalents, the Company invests in short-term highly liquid assets where it has never incurred and does not expect to incur credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For accounts receivable the Company recognizes a loss allowance based on lifetime estimated credit losses (&#x201c;ECL&#x201d;) at each reporting date. When estimating the ECL the Company takes into consideration: readily available relevant and supportable information (this includes quantitative and qualitative data), the Company&#x2019;s historical experience and forward-looking information specific to the receivables and the economic environment.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory contextRef="c-1" id="f-460">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial liabilities classification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial liabilities are classified upon initial recognition as financial liabilities measured at fair value through income or at amortized cost. The Company&#x2019;s financial liabilities include accounts payable and debt (including borrowings and lease liabilities), which are measured at amortized cost, and derivatives, which are measured at fair value through income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest-bearing borrowings are initially recognized at fair value less directly attributable costs and subsequently measured at amortized cost using the EIR method. Gains and losses are recognized in income when the liabilities are derecognized as well as through the EIR amortization process.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortized cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR. The EIR amortization is included as interest expense in the statement of loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Financial liabilities&#x2014;derecognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A financial liability is derecognized when the obligation under the liability is discharged or canceled or expires. When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recognized in the statements of loss.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory>
    <soph:DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock contextRef="c-1" id="f-461">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Change in accounting policies &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Statement of Cash Flows - Interest Classification&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective January 1, 2025, the Company revised its accounting policy regarding the classification of interest paid and interest received in the Statement of Cash Flows. Interest paid was reclassified from Net cash flows used in operating activities to Net cash flows used in financing activities, and interest received was reclassified from Net cash flows used in operating activities to Net cash flows used in investing activities. The Company assessed the change in accounting policy under IAS 8, in accordance with the guidance regarding a voluntary change in accounting policy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reclassification of interest paid was elected to provide a more cohesive presentation of payments related to the Company&#x2019;s borrowings and lease liabilities. Prior to the change in accounting policy, interest paid on borrowings and lease liabilities were classified as operating cash flows, while proceeds from borrowings, net of transaction costs and payments of principal portion of lease liabilities are classified as financing cash flows. The change aligns interest payments with their associated transactions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company reclassified interest received to investing activities, as the majority of interest received relates to interest earned on cash and cash equivalents and short-term investments. The Company believes this updated classification better reflects the nature and source of these cash inflows and provides more relevant and reliable information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined the voluntary change in accounting policy did not have an impact on basic and diluted earnings per share under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IAS 33 - Earnings per Share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applied the change in accounting policy retrospectively and has recast prior period comparative information within the Statement of Cash Flows to ensure consistency and comparability with the current period presentation. As part of the retrospective application, cash flows changed as follows for the year ended December&#160;31,&#160;2024: Net cash used in operating activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;increased by $1.7&#160;million, Net cash flow used in investing activities decreased by $3.4&#160;million, and Net cash flow provided by financing activities decreased by $1.7&#160;million. Cash flows changed as follows for the year ended December 31, 2023: Net cash used in operating activities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;increased by $4.6&#160;million, Net cash flow provided by investing activities increased by $4.7&#160;million, and Net cash flow used in financing activities decreased by less than $0.1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New standards, amendments to standards and interpretations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;New standards, amendments to standards, and interpretations issued not yet effective&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2024, IFRS 18, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Presentation and Disclosure in Financial Statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was issued to achieve comparability of the financial performance of similar entities. The standard, which will replace IAS 1 impacts the presentation of primary financial statements and notes, including the statement of profit and loss where companies will be required to present separate categories of income and expense for operating, investing, and financing activities with prescribed subtotals for each new category. The standard will also require management-defined performance measures to be explained and included in a separate note within the consolidated financial statements. The standard is effective for annual reporting periods beginning on or after January 1, 2027, and requires retrospective application. While IFRS 18 will not change recognition criteria or measurement bases, it might have a significant impact on presenting information in the financial statements, in particular the income statement. The Company is currently assessing impacts and data readiness.&lt;/span&gt;&lt;/div&gt;There are no other IFRS Accounting Standards or IFRS IC interpretations that are not yet effective and that could have a material impact to the consolidated financial statements</soph:DescriptionOfAccountingPolicyForChangesAndNewStandardsTextBlock>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c-61" decimals="-5" id="f-462" unitRef="usd">1700000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c-61" decimals="-5" id="f-463" unitRef="usd">-3400000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c-61" decimals="-5" id="f-464" unitRef="usd">-1700000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="c-62" decimals="-5" id="f-465" unitRef="usd">4600000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="c-62" decimals="-5" id="f-466" unitRef="usd">4700000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="c-62" decimals="-5" id="f-467" unitRef="usd">-100000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory contextRef="c-1" id="f-468">Segment reporting&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a single operating segment. The Company&#x2019;s financial information is reviewed, and its performance assessed as a single segment by the senior management team led by the Chief Executive Officer (&#x201c;CEO&#x201d;), the Company&#x2019;s Chief Operating Decision Maker (&#x201c;CODM&#x201d;). As announced in January 2026, the Company&#x2019;s President will be promoted to CEO in 2026 and become the CODM.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2025 and 2024, respectively, the Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.&#160;An analysis of the location of non-current assets other than financial instruments and deferred tax assets by country is as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brazil&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total non-current assets other than financial instruments &lt;br/&gt;and deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53,938&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48,375&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <ifrs-full:DisclosureOfGeographicalAreasExplanatory contextRef="c-1" id="f-469">An analysis of the location of non-current assets other than financial instruments and deferred tax assets by country is as follows (in USD thousands):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.962%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Brazil&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total non-current assets other than financial instruments &lt;br/&gt;and deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53,938&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48,375&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfGeographicalAreasExplanatory>
    <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="c-63" decimals="-3" id="f-470" unitRef="usd">49777000</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts>
    <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="c-64" decimals="-3" id="f-471" unitRef="usd">44282000</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts>
    <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="c-65" decimals="-3" id="f-472" unitRef="usd">2574000</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts>
    <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="c-66" decimals="-3" id="f-473" unitRef="usd">2184000</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts>
    <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="c-67" decimals="-3" id="f-474" unitRef="usd">1584000</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts>
    <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="c-68" decimals="-3" id="f-475" unitRef="usd">1906000</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts>
    <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="c-69" decimals="-3" id="f-476" unitRef="usd">3000</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts>
    <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="c-70" decimals="-3" id="f-477" unitRef="usd">3000</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts>
    <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="c-3" decimals="-3" id="f-478" unitRef="usd">53938000</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts>
    <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="c-6" decimals="-3" id="f-479" unitRef="usd">48375000</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts>
    <ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory contextRef="c-1" id="f-480">Revenue&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Critical accounting estimates and judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s sales transactions may consist of various performance obligations that are satisfied at different times. It requires judgment to determine when different obligations are satisfied, including whether enforceable commitments for further obligations exist and when they arise. Depending on the determination of the performance obligations and the point in time or period over which those obligations are fulfilled, this may result in all revenue being calculated at inception, and either being recognized at once, or on contract completion or spread over the term of a longer performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accounting for contracts that contain promises to deliver more than one good or service, management has to determine how to allocate the total transaction price to the performance obligations of the contract. The total transaction price of a customer contract is allocated to the distinct performance obligations under the contract based on their standalone selling prices (&#x201c;SSP&#x201d;), the determination of which can require significant judgment from management. The best evidence of this is an observable price from the standalone sales of the good or service to similarly situated customers. However, where standalone selling prices are not observable, it requires judgment to estimate the cost of satisfying a performance obligation and adding an appropriate margin to that good or service. In some cases, SSP is not available and the residual approach is used to determine the stand-alone selling price of certain performance obligations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue represents amounts received and receivable from third parties for goods supplied and services rendered to customers. Revenues are reported net of rebates and discounts and net of sales and value added taxes in an amount that reflects the consideration that is expected to be received for goods or services. The majority of the sales revenue is recognized: (i)&#160;when customers generate analyses on their patient data through the SOPHiA DDM Platform, (ii)&#160;when consumables, namely DNA enrichment kits, are delivered to customers at which point control transfers, (iii)&#160;when services, namely&#160;set-up&#160;programs, are performed and (iv)&#160;over the duration of the software licensing arrangements for the Alamut software offerings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products and services are sold both directly to customers and through distributors, generally under agreements with payment terms typically o&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;f 30 to 60 days and in rare cases with payment terms extended up to&#160;180 days.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Therefore, contracts do not contain a significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For all contracts with customers the following steps are performed to determine the amount of revenue to be recognized and when it should be recognized: (1)&#160;identify the contract or contracts; (2)&#160;determine whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (3)&#160;measure the transaction price, including the constraint on variable consideration; (4)&#160;allocate the transaction price to the performance obligations based on estimated selling prices; and (5)&#160;recognize revenue when (or as) each performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SOPHiA DDM Platform&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the SOPHiA DDM Platform revenue is derived from each use of the SOPHiA DDM Platform by customers to generat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e analyses on &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;their patient data. Analysis revenue is recognized as analysis results are made available to the customer on the SOPHiA DDM Platform. The Company recognizes accrued contract revenue in accounts receivable for any analyses performed by customers that have not been invoiced at the reporting date and where the right to consideration is unconditional. Any payments received in advance of customers generating analyses are recorded as deferred contract revenue until the analyses are performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customers use the SOPHiA DDM Platform to perform analyses under three different models: dry lab access; bundle access; and integrated solutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For dry lab contracts, customers use the testing instruments and consumables of their choice and the SOPHiA DDM Platform and algorithms for variant detection and identification. In these arrangements, the Company has identified one performance obligation, which is the delivery of the analysis result to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For bundle arrangements, customers purchase a DNA enrichment kit along with each analysis. Customers use the DNA enrichment kit in the process of performing their own sequencing of each sample. Customers then &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;upload their patient data to the SOPHiA DDM Platform for analysis. In these arrangements, the Company has identified two performance obligations: the delivery of the DNA enrichment kits and the performance of the analyses. Revenue is recognized for the DNA enrichment kits when control of products has transferred to the customer, which is generally at the time of delivery, as this is when title and risk of loss have been transferred. Revenue for the performance of the analyses is recognized on delivery of the analysis results to the customer. Refer to&#160;"&#x2014;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Arrangements with multiple performance obligations&#x201d;&#160;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;below for how revenue is allocated between the performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred contract revenue balances relating to analyses not performed&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within 12 months from the date of the delivery date are recognized as revenue. This policy is not based on contractual conditions but on the Company&#x2019;s experience of customer behavior and expiration dates of the kits associated with the analyses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For integrated arrangements, customers have their samples processed and sequenced through selected SOPHiA DDM Platform partners within the clinical network and access their data through the SOPHiA DDM Platform. The Company has identified one performance obligation, which is delivery of the analysis results to the customer through the SOPHiA DDM Platform.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also sells access to its Alamut software application (&#x201c;Alamut&#x201d;) through the SOPHiA DDM Platform. Some arrangements with customers allow customers to use Alamut as a hosted software service over the contract period without the customer taking possession of the software. Other customers take possession of the software, but the utility of that software is limited by access to the Company&#x2019;s proprietary SOPHiA database, which is provided to the customer on a fixed term basis. Under both models, revenue is recognized on a straight-line basis over the duration of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also derives revenue from the SOPHiA DDM Platform by providing services to biopharma customers who engage the Company to (i)&#160;develop and perform customized genomic analyses and/or (ii)&#160;access the database for use in clinical trials and other research projects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does enter into biopharma contracts that contain multiple products or services or&#160;non-standard&#160;terms and conditions. The biopharma contracts are generally unique in nature and each contract is assessed upon execution. Contracts may contain multiple performance obligations or performance obligations that are recognized overtime, at a point-in-time, or a combination depending on the Company&#x2019;s ability to satisfy the requirements to recognize revenue over time and reasonably estimate the amount of revenue to recognize. See "&#x2014;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Arrangements with multiple performance obligation&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s&#x201d; below for further discussion on treatment of biopharma contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, the primary performance obligation in these arrangements is the delivery of analysis results in the form of a final report, resulting in revenue being recognized, in most cases, upon the issuance of the final report or successful recruitment of clinical trial participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Workflow materials and services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from workflow materials and services includes all revenue from the sale of materials and services that do not form part of a contract for the provision of platform services. These include the provision of&#160;set-up&#160;programs and training and the sale of kits and tests that are not linked to use of the platform.&#160;Set-up&#160;programs and training are typically combined with a customer&#x2019;s first order prior to the customer beginning to use the SOPHiA DDM Platform.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from services is generally recognized when the services are performed. Revenue from materials is recognized when control of the goods is transferred to the customer, generally at the time of delivery. This category of re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;venue also includes the revenue from the sale of DNA sequencing automation equipment accounted for under IFRS 16,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;IFRS 16&#x201d;), leasing &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and the fees charged for the maintenance of this equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Arrangements with multiple performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells different combinations of analyses, consumables, and services to its customers under its various SOPHiA DDM Platform models.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined that the stand-alone selling prices for services and DNA enrichment kits are directly observable. For&#160;set-up&#160;programs and training sold along with dry lab arrangements or bundle arrangements, the stand-alone selling price of these services is determined on a time and materials basis. For DNA enrichment kits sold as part of a bundle, the SSP is based on an expected cost-plus-margin approach of the kit portion of the bundle.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined that the SSP for the analyses, in both a dry lab arrangement and bundle arrangeme&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nt, is highly variable and therefore a representative SSP is not discernible from past transactions. As a result, the residual approach is used to determine the stand-alone selling price of the analyses in dry lab arrangements that include services and in bundle arrangements that include DNA enrichment kits and, in some cases, services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For bundle contracts with a fixed term that also include providing the customer with DNA sequencing automation equipment, the Company determines if there is an IFRS 16 leasing component. In these arrangements the Company provides DNA sequencing automation equipment to the customer over the fixed term and at completion of the contract term the customer takes possession of the equipment. If the Company has determined that it is a dealer lessor, provision of this equipment to the customer is classified as a finance lease. Over the term of the agreement, the minimum lease payment is deducted from the proceeds of the bundle sales in order to reduce the net investment in the corresponding lease receivable over the contract term and interest income is recognized as the discount on the lease receivable unwinds. The remaining proceeds from the contract are accounted for under IFRS 15,&#160;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;(&#x201c;IFRS 15&#x201d;), using the policies described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses biopharma contrac&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ts upon execution of each contract given their unique nature. The Company establishes each performance obligation within the contract and determines the appropriate value to be ascribed to each performance obligation. When relevant the Company utilizes previous established SSPs of its dry lab and bundle solutions or other service. When the performance obligation is specific to only the contract the Company utilizes all available information to reasonably estimate the correct value allocated to the performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Deferred contract costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred contract costs comprise deferred fulfillment costs related to biopharma, prepayments on contracts, and prepaid maintenance costs relating to DNA sequencing automation equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs are incurred to fulfill obligations under certain contracts once obtained, but before transferring goods or services to the customer. Fulfillment costs are recognized as an asset, provided these costs are not addressed by other accounting standards, if the following criteria are met: (i)&#160;the costs relate directly to a contract or an anticipated contract that the Company can specifically identify, (ii)&#160;the costs generate or enhance resources of the Company that will be used in satisfying (or continuing to satisfy) performance obligations in the future and (iii)&#160;the costs are expected to be recovered.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The asset recognized from deferring the costs to fulfill a contract is recorded in the consolidated balance sheet as deferred contract costs within other current assets and amortized on a systematic basis consistent with the&#160;pattern of the transfer of the goods or services to which the asset relates, which depends on the nature of the performance obligation(s) in the contract. The amortization of these assets is recorded in cost of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition and billings can result in accrued contract revenue, which is presented within accounts receivable in the consolidated balance sheet and deferred contract revenue which is presented on the face of the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accrued contract revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued contract revenue relates to revenue recognized from satisfied performance obligations prior to invoicing and is primarily related to Dry Lab to be invoiced for the most recently completed month and some portions of biopharma contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Deferred contract revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred contract revenue relates to prepayments received from customers before revenue is recognized and is primarily related to SOPHiA DDM Platform analyses invoiced in advance of the customers performing the analyses, deferred Alamut software revenue, and progress payments received as part of biopharma contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred contract revenue brought forward as of January&#160;1, 2025 and 2024 amounts to $5.7 million and $9.5 million, respectively. During the twelve months ended December 31, 2025 and 2024, the Company satisfied the performance obligations associated with that deferred contract revenue to the extent that revenue was recognized of $5.7 million and $9.5&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the platform revenue is derived from contracts with&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; an original expected length of one year or less. There are also certain biopharma and Alamut contracts in which performance obligations extend over multiple years, however, these contracts are immaterial. The Company has elected to apply the practical expedient not to disclose the value of remaining performance obligations associated with these types of contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregated revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When disaggregating revenue, the Company considered all of the economic factors that may affect its revenues. The Company assesses its revenues by four geographic regions Europe, the Middle East, and Africa (&#x201c;EMEA&#x201d;); North America (&#x201c;NORAM&#x201d;); Latin America (&#x201c;LATAM&#x201d;); and Asia-Pacific (&#x201c;APAC&#x201d;). Additionally, the Company assesses revenues generated in its domiciled country and any country with significant revenue. The following table disaggregates the Company's revenue from contracts with customers by geographic market (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;55,576&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46,929&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;43,958&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of NORAM&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NORAM&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,300&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,726&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LATAM&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,086&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,990&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,054&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;77,271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65,173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;62,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue streams&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue from contracts with customers has been allocated to the revenue streams indicated in the table below (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA DDM Platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workflow equipment and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;77,271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65,173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;62,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Workflow equipment and services includes revenues from payments from leased equipment recognized under IFRS 16, Leases. During the years ended December 31, 2025, 2024, and 2023, the Company recognized no revenue, $0.1&#160;million, and $0.1&#160;million, respectively related to leased equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from one customer, a distributor for the Company, represented approximately $8.7 million and $8.2 million of the Company&#x2019;s total revenues for the fiscal years ended December 31, 2025 and 2024, respectively. The Company did not have revenues greater than 10% from a single customer in the fiscal year ended December 31, 2023.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue contextRef="c-1" id="f-481">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Critical accounting estimates and judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s sales transactions may consist of various performance obligations that are satisfied at different times. It requires judgment to determine when different obligations are satisfied, including whether enforceable commitments for further obligations exist and when they arise. Depending on the determination of the performance obligations and the point in time or period over which those obligations are fulfilled, this may result in all revenue being calculated at inception, and either being recognized at once, or on contract completion or spread over the term of a longer performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accounting for contracts that contain promises to deliver more than one good or service, management has to determine how to allocate the total transaction price to the performance obligations of the contract. The total transaction price of a customer contract is allocated to the distinct performance obligations under the contract based on their standalone selling prices (&#x201c;SSP&#x201d;), the determination of which can require significant judgment from management. The best evidence of this is an observable price from the standalone sales of the good or service to similarly situated customers. However, where standalone selling prices are not observable, it requires judgment to estimate the cost of satisfying a performance obligation and adding an appropriate margin to that good or service. In some cases, SSP is not available and the residual approach is used to determine the stand-alone selling price of certain performance obligations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue represents amounts received and receivable from third parties for goods supplied and services rendered to customers. Revenues are reported net of rebates and discounts and net of sales and value added taxes in an amount that reflects the consideration that is expected to be received for goods or services. The majority of the sales revenue is recognized: (i)&#160;when customers generate analyses on their patient data through the SOPHiA DDM Platform, (ii)&#160;when consumables, namely DNA enrichment kits, are delivered to customers at which point control transfers, (iii)&#160;when services, namely&#160;set-up&#160;programs, are performed and (iv)&#160;over the duration of the software licensing arrangements for the Alamut software offerings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products and services are sold both directly to customers and through distributors, generally under agreements with payment terms typically o&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;f 30 to 60 days and in rare cases with payment terms extended up to&#160;180 days.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Therefore, contracts do not contain a significant financing component.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For all contracts with customers the following steps are performed to determine the amount of revenue to be recognized and when it should be recognized: (1)&#160;identify the contract or contracts; (2)&#160;determine whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (3)&#160;measure the transaction price, including the constraint on variable consideration; (4)&#160;allocate the transaction price to the performance obligations based on estimated selling prices; and (5)&#160;recognize revenue when (or as) each performance obligation is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SOPHiA DDM Platform&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the SOPHiA DDM Platform revenue is derived from each use of the SOPHiA DDM Platform by customers to generat&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e analyses on &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;their patient data. Analysis revenue is recognized as analysis results are made available to the customer on the SOPHiA DDM Platform. The Company recognizes accrued contract revenue in accounts receivable for any analyses performed by customers that have not been invoiced at the reporting date and where the right to consideration is unconditional. Any payments received in advance of customers generating analyses are recorded as deferred contract revenue until the analyses are performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customers use the SOPHiA DDM Platform to perform analyses under three different models: dry lab access; bundle access; and integrated solutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For dry lab contracts, customers use the testing instruments and consumables of their choice and the SOPHiA DDM Platform and algorithms for variant detection and identification. In these arrangements, the Company has identified one performance obligation, which is the delivery of the analysis result to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For bundle arrangements, customers purchase a DNA enrichment kit along with each analysis. Customers use the DNA enrichment kit in the process of performing their own sequencing of each sample. Customers then &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;upload their patient data to the SOPHiA DDM Platform for analysis. In these arrangements, the Company has identified two performance obligations: the delivery of the DNA enrichment kits and the performance of the analyses. Revenue is recognized for the DNA enrichment kits when control of products has transferred to the customer, which is generally at the time of delivery, as this is when title and risk of loss have been transferred. Revenue for the performance of the analyses is recognized on delivery of the analysis results to the customer. Refer to&#160;"&#x2014;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Arrangements with multiple performance obligations&#x201d;&#160;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;below for how revenue is allocated between the performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred contract revenue balances relating to analyses not performed&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; within 12 months from the date of the delivery date are recognized as revenue. This policy is not based on contractual conditions but on the Company&#x2019;s experience of customer behavior and expiration dates of the kits associated with the analyses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For integrated arrangements, customers have their samples processed and sequenced through selected SOPHiA DDM Platform partners within the clinical network and access their data through the SOPHiA DDM Platform. The Company has identified one performance obligation, which is delivery of the analysis results to the customer through the SOPHiA DDM Platform.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also sells access to its Alamut software application (&#x201c;Alamut&#x201d;) through the SOPHiA DDM Platform. Some arrangements with customers allow customers to use Alamut as a hosted software service over the contract period without the customer taking possession of the software. Other customers take possession of the software, but the utility of that software is limited by access to the Company&#x2019;s proprietary SOPHiA database, which is provided to the customer on a fixed term basis. Under both models, revenue is recognized on a straight-line basis over the duration of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also derives revenue from the SOPHiA DDM Platform by providing services to biopharma customers who engage the Company to (i)&#160;develop and perform customized genomic analyses and/or (ii)&#160;access the database for use in clinical trials and other research projects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does enter into biopharma contracts that contain multiple products or services or&#160;non-standard&#160;terms and conditions. The biopharma contracts are generally unique in nature and each contract is assessed upon execution. Contracts may contain multiple performance obligations or performance obligations that are recognized overtime, at a point-in-time, or a combination depending on the Company&#x2019;s ability to satisfy the requirements to recognize revenue over time and reasonably estimate the amount of revenue to recognize. See "&#x2014;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Arrangements with multiple performance obligation&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s&#x201d; below for further discussion on treatment of biopharma contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, the primary performance obligation in these arrangements is the delivery of analysis results in the form of a final report, resulting in revenue being recognized, in most cases, upon the issuance of the final report or successful recruitment of clinical trial participants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Workflow materials and services&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from workflow materials and services includes all revenue from the sale of materials and services that do not form part of a contract for the provision of platform services. These include the provision of&#160;set-up&#160;programs and training and the sale of kits and tests that are not linked to use of the platform.&#160;Set-up&#160;programs and training are typically combined with a customer&#x2019;s first order prior to the customer beginning to use the SOPHiA DDM Platform.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from services is generally recognized when the services are performed. Revenue from materials is recognized when control of the goods is transferred to the customer, generally at the time of delivery. This category of re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;venue also includes the revenue from the sale of DNA sequencing automation equipment accounted for under IFRS 16,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;IFRS 16&#x201d;), leasing &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and the fees charged for the maintenance of this equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Arrangements with multiple performance obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells different combinations of analyses, consumables, and services to its customers under its various SOPHiA DDM Platform models.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined that the stand-alone selling prices for services and DNA enrichment kits are directly observable. For&#160;set-up&#160;programs and training sold along with dry lab arrangements or bundle arrangements, the stand-alone selling price of these services is determined on a time and materials basis. For DNA enrichment kits sold as part of a bundle, the SSP is based on an expected cost-plus-margin approach of the kit portion of the bundle.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined that the SSP for the analyses, in both a dry lab arrangement and bundle arrangeme&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nt, is highly variable and therefore a representative SSP is not discernible from past transactions. As a result, the residual approach is used to determine the stand-alone selling price of the analyses in dry lab arrangements that include services and in bundle arrangements that include DNA enrichment kits and, in some cases, services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For bundle contracts with a fixed term that also include providing the customer with DNA sequencing automation equipment, the Company determines if there is an IFRS 16 leasing component. In these arrangements the Company provides DNA sequencing automation equipment to the customer over the fixed term and at completion of the contract term the customer takes possession of the equipment. If the Company has determined that it is a dealer lessor, provision of this equipment to the customer is classified as a finance lease. Over the term of the agreement, the minimum lease payment is deducted from the proceeds of the bundle sales in order to reduce the net investment in the corresponding lease receivable over the contract term and interest income is recognized as the discount on the lease receivable unwinds. The remaining proceeds from the contract are accounted for under IFRS 15,&#160;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;(&#x201c;IFRS 15&#x201d;), using the policies described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses biopharma contrac&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ts upon execution of each contract given their unique nature. The Company establishes each performance obligation within the contract and determines the appropriate value to be ascribed to each performance obligation. When relevant the Company utilizes previous established SSPs of its dry lab and bundle solutions or other service. When the performance obligation is specific to only the contract the Company utilizes all available information to reasonably estimate the correct value allocated to the performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Deferred contract costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred contract costs comprise deferred fulfillment costs related to biopharma, prepayments on contracts, and prepaid maintenance costs relating to DNA sequencing automation equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs are incurred to fulfill obligations under certain contracts once obtained, but before transferring goods or services to the customer. Fulfillment costs are recognized as an asset, provided these costs are not addressed by other accounting standards, if the following criteria are met: (i)&#160;the costs relate directly to a contract or an anticipated contract that the Company can specifically identify, (ii)&#160;the costs generate or enhance resources of the Company that will be used in satisfying (or continuing to satisfy) performance obligations in the future and (iii)&#160;the costs are expected to be recovered.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The asset recognized from deferring the costs to fulfill a contract is recorded in the consolidated balance sheet as deferred contract costs within other current assets and amortized on a systematic basis consistent with the&#160;pattern of the transfer of the goods or services to which the asset relates, which depends on the nature of the performance obligation(s) in the contract. The amortization of these assets is recorded in cost of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition and billings can result in accrued contract revenue, which is presented within accounts receivable in the consolidated balance sheet and deferred contract revenue which is presented on the face of the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accrued contract revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued contract revenue relates to revenue recognized from satisfied performance obligations prior to invoicing and is primarily related to Dry Lab to be invoiced for the most recently completed month and some portions of biopharma contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Deferred contract revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred contract revenue relates to prepayments received from customers before revenue is recognized and is primarily related to SOPHiA DDM Platform analyses invoiced in advance of the customers performing the analyses, deferred Alamut software revenue, and progress payments received as part of biopharma contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred contract revenue brought forward as of January&#160;1, 2025 and 2024 amounts to $5.7 million and $9.5 million, respectively. During the twelve months ended December 31, 2025 and 2024, the Company satisfied the performance obligations associated with that deferred contract revenue to the extent that revenue was recognized of $5.7 million and $9.5&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the platform revenue is derived from contracts with&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; an original expected length of one year or less. There are also certain biopharma and Alamut contracts in which performance obligations extend over multiple years, however, these contracts are immaterial. The Company has elected to apply the practical expedient not to disclose the value of remaining performance obligations associated with these types of contracts.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue>
    <soph:RevenueFromContractsWithCustomersPaymentTerm contextRef="c-51" id="f-482">P30D</soph:RevenueFromContractsWithCustomersPaymentTerm>
    <soph:RevenueFromContractsWithCustomersPaymentTerm contextRef="c-52" id="f-483">P60D</soph:RevenueFromContractsWithCustomersPaymentTerm>
    <soph:RevenueFromContractsWithCustomersExtendedPaymentTerm contextRef="c-1" id="f-484">P180D</soph:RevenueFromContractsWithCustomersExtendedPaymentTerm>
    <soph:DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod contextRef="c-1" decimals="-5" id="f-485" unitRef="usd">5700000</soph:DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
    <soph:DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod contextRef="c-4" decimals="-5" id="f-486" unitRef="usd">9500000</soph:DeferredRevenueThatWasIncludedInContractLiabilityBalanceAtBeginningOfPeriod>
    <soph:DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods contextRef="c-1" decimals="-5" id="f-487" unitRef="usd">5700000</soph:DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods>
    <soph:DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods contextRef="c-4" decimals="-5" id="f-488" unitRef="usd">9500000</soph:DeferredRevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods>
    <ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory contextRef="c-1" id="f-489">The following table disaggregates the Company's revenue from contracts with customers by geographic market (in USD thousands):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Switzerland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;France&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Italy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;EMEA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;55,576&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46,929&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;43,958&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of NORAM&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NORAM&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,400&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,300&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,726&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LATAM&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,086&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,890&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,990&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,054&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;77,271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65,173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;62,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue streams&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue from contracts with customers has been allocated to the revenue streams indicated in the table below (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SOPHiA DDM Platform&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workflow equipment and services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;77,271&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65,173&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;62,371&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-71" decimals="-3" id="f-490" unitRef="usd">1776000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-72" decimals="-3" id="f-491" unitRef="usd">1494000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-73" decimals="-3" id="f-492" unitRef="usd">1432000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-74" decimals="-3" id="f-493" unitRef="usd">11317000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-75" decimals="-3" id="f-494" unitRef="usd">10333000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-76" decimals="-3" id="f-495" unitRef="usd">10076000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-77" decimals="-3" id="f-496" unitRef="usd">10805000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-78" decimals="-3" id="f-497" unitRef="usd">9983000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-79" decimals="-3" id="f-498" unitRef="usd">8554000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-80" decimals="-3" id="f-499" unitRef="usd">6027000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-81" decimals="-3" id="f-500" unitRef="usd">5788000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-82" decimals="-3" id="f-501" unitRef="usd">6512000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-83" decimals="-3" id="f-502" unitRef="usd">25651000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-84" decimals="-3" id="f-503" unitRef="usd">19331000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-85" decimals="-3" id="f-504" unitRef="usd">17384000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-86" decimals="-3" id="f-505" unitRef="usd">55576000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-87" decimals="-3" id="f-506" unitRef="usd">46929000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-88" decimals="-3" id="f-507" unitRef="usd">43958000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-89" decimals="-3" id="f-508" unitRef="usd">10872000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-90" decimals="-3" id="f-509" unitRef="usd">9323000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-91" decimals="-3" id="f-510" unitRef="usd">9465000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-92" decimals="-3" id="f-511" unitRef="usd">2528000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-93" decimals="-3" id="f-512" unitRef="usd">1977000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-94" decimals="-3" id="f-513" unitRef="usd">1261000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-95" decimals="-3" id="f-514" unitRef="usd">13400000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-96" decimals="-3" id="f-515" unitRef="usd">11300000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-97" decimals="-3" id="f-516" unitRef="usd">10726000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-98" decimals="-3" id="f-517" unitRef="usd">3086000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-99" decimals="-3" id="f-518" unitRef="usd">2890000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-100" decimals="-3" id="f-519" unitRef="usd">3990000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-101" decimals="-3" id="f-520" unitRef="usd">5209000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-102" decimals="-3" id="f-521" unitRef="usd">4054000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-103" decimals="-3" id="f-522" unitRef="usd">3697000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-1" decimals="-3" id="f-523" unitRef="usd">77271000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-4" decimals="-3" id="f-524" unitRef="usd">65173000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-5" decimals="-3" id="f-525" unitRef="usd">62371000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-104" decimals="-3" id="f-526" unitRef="usd">74915000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-105" decimals="-3" id="f-527" unitRef="usd">63546000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-106" decimals="-3" id="f-528" unitRef="usd">60904000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-107" decimals="-3" id="f-529" unitRef="usd">2356000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-108" decimals="-3" id="f-530" unitRef="usd">1627000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-109" decimals="-3" id="f-531" unitRef="usd">1467000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-1" decimals="-3" id="f-532" unitRef="usd">77271000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-4" decimals="-3" id="f-533" unitRef="usd">65173000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-5" decimals="-3" id="f-534" unitRef="usd">62371000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:OperatingLeaseIncome contextRef="c-107" decimals="-5" id="f-535" unitRef="usd">0</ifrs-full:OperatingLeaseIncome>
    <ifrs-full:OperatingLeaseIncome contextRef="c-108" decimals="-5" id="f-536" unitRef="usd">100000</ifrs-full:OperatingLeaseIncome>
    <ifrs-full:OperatingLeaseIncome contextRef="c-109" decimals="-5" id="f-537" unitRef="usd">100000</ifrs-full:OperatingLeaseIncome>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-110" decimals="-5" id="f-538" unitRef="usd">8700000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers contextRef="c-111" decimals="-5" id="f-539" unitRef="usd">8200000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:DisclosureOfCostOfSalesExplanatory contextRef="c-1" id="f-540">Cost of revenue&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue comprises costs directly incurred in earning revenue, including computer costs and data storage fees paid to hosting providers, manufacturing costs, materials and consumables, the cost of equipment leased out under finance leases, personnel-related expenses and amortization of capitalized development costs.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfCostOfSalesExplanatory>
    <soph:DescriptionOfAccountingPolicyForCostOfSalesTextBlock contextRef="c-1" id="f-541">&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue comprises costs directly incurred in earning revenue, including computer costs and data storage fees paid to hosting providers, manufacturing costs, materials and consumables, the cost of equipment leased out under finance leases, personnel-related expenses and amortization of capitalized development costs.&lt;/span&gt;&lt;/div&gt;</soph:DescriptionOfAccountingPolicyForCostOfSalesTextBlock>
    <soph:DisclosureOfOperatingExpenseTextBlock contextRef="c-1" id="f-542">Operating expense&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs consist of personnel and related expenses for technology, application, and product development, depreciation and amortization, laboratory supplies, consulting services, computational and data storage fees paid to hosting providers related to research and development, and allocated overhead costs. These costs are stated net of government grants for research and development and innovation received as tax credits and net of capitalized costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Government grants for research and development and innovation received as tax credits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company receives government grants in France for research and development and innovation by way of tax credits. Total government grants for research and development and innovation recognized in the statement of loss amounts to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.0 million, $0.7 million, and $1.1 million f&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or the years ended December 31, 2025, 2024, and 2023, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Selling and marketing costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling and marketing costs consist of personnel and related expenses for the employees of the sales and marketing organization, costs of communications materials that are produced to generate greater awareness and utilization of the platform among customers, costs of third-party market research, costs related to transportation and distribution of products and allocated overhead costs, and commissions to sales employees. The Company also records increases to, reversals of, and write-offs of the allowance for expected credit losses to selling and marketing costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company pays sales commission to its employees for obtaining contracts. These costs are expensed as part of employee compensation in selling and marketing costs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The portion of commission payments to employees where the amortization period is greater than one year are capitalized and expensed as the associated revenue is recognized, see Note 14 &#x2014; &#x201c;Prepaids and other current assets&#x201d; and Note 18 &#x2014; &#x201c;Other non-current assets&#x201d; for the amounts capitalized.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General and administrative costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative costs consist of personnel and related expenses for executive, accounting and finance, legal, quality, support and human resources functions, depreciation and amortization, professional &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;services fees incurred by these functions, general corporate costs and allocated overhead costs, which include occupancy costs and information technology costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating expense&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization have been charged in the following expense categories (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;For the year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Selling and marketing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;General and administrative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(497)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(3,976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(5,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(4,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(4,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(5,508)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(2,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table presents employee costs by function,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which consists of &#x201c;Employee benefit expenses&#x201d;, &#x201c;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Social charges&#x201d; and &#x201c;Share-based compensation&#x201d; (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the year ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;86,149&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90,181&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has made adjustments to previously reported employee benefit expenses for the years ended December 31, 2024 and 2023 to include $2.2 million and $2.7 million, respectively, of employee benefit expenses included in cost of revenue to correct for immaterial misstatements.&lt;/span&gt;&lt;/div&gt;</soph:DisclosureOfOperatingExpenseTextBlock>
    <ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory contextRef="c-1" id="f-543">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs consist of personnel and related expenses for technology, application, and product development, depreciation and amortization, laboratory supplies, consulting services, computational and data storage fees paid to hosting providers related to research and development, and allocated overhead costs. These costs are stated net of government grants for research and development and innovation received as tax credits and net of capitalized costs.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory>
    <soph:ResearchTaxCredit contextRef="c-1" decimals="-5" id="f-544" unitRef="usd">1000000.0</soph:ResearchTaxCredit>
    <soph:ResearchTaxCredit contextRef="c-4" decimals="-5" id="f-545" unitRef="usd">700000</soph:ResearchTaxCredit>
    <soph:ResearchTaxCredit contextRef="c-5" decimals="-5" id="f-546" unitRef="usd">1100000</soph:ResearchTaxCredit>
    <soph:DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock contextRef="c-1" id="f-547">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Selling and marketing costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling and marketing costs consist of personnel and related expenses for the employees of the sales and marketing organization, costs of communications materials that are produced to generate greater awareness and utilization of the platform among customers, costs of third-party market research, costs related to transportation and distribution of products and allocated overhead costs, and commissions to sales employees. The Company also records increases to, reversals of, and write-offs of the allowance for expected credit losses to selling and marketing costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company pays sales commission to its employees for obtaining contracts. These costs are expensed as part of employee compensation in selling and marketing costs. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The portion of commission payments to employees where the amortization period is greater than one year are capitalized and expensed as the associated revenue is recognized, see Note 14 &#x2014; &#x201c;Prepaids and other current assets&#x201d; and Note 18 &#x2014; &#x201c;Other non-current assets&#x201d; for the amounts capitalized.&lt;/span&gt;&lt;/div&gt;</soph:DescriptionOfAccountingPolicyForSellingAndMarketingExpenseTextBlock>
    <soph:DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock contextRef="c-1" id="f-548">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General and administrative costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative costs consist of personnel and related expenses for executive, accounting and finance, legal, quality, support and human resources functions, depreciation and amortization, professional &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;services fees incurred by these functions, general corporate costs and allocated overhead costs, which include occupancy costs and information technology costs.&lt;/span&gt;&lt;/div&gt;</soph:DescriptionOfAccountingPolicyForGeneralAndAdministrativeExpenseTextBlock>
    <soph:DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock contextRef="c-1" id="f-549">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization have been charged in the following expense categories (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.784%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;For the year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(5,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(3,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,649)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,961)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(2,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;Selling and marketing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,468)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;General and administrative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(497)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(1,546)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(3,976)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(5,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(4,575)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(4,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(5,508)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"&gt;(2,828)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutDepreciationAndAmortizationChargedInOperatingExpensesTableTextBlock>
    <ifrs-full:DepreciationExpense contextRef="c-112" decimals="-3" id="f-550" unitRef="usd">0</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-112" decimals="-3" id="f-551" unitRef="usd">5266000</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-113" decimals="-3" id="f-552" unitRef="usd">0</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-113" decimals="-3" id="f-553" unitRef="usd">3524000</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-114" decimals="-3" id="f-554" unitRef="usd">0</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-114" decimals="-3" id="f-555" unitRef="usd">2099000</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-115" decimals="-3" id="f-556" unitRef="usd">1649000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-115" decimals="-3" id="f-557" unitRef="usd">0</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-116" decimals="-3" id="f-558" unitRef="usd">1961000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-116" decimals="-3" id="f-559" unitRef="usd">0</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-117" decimals="-3" id="f-560" unitRef="usd">2494000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-117" decimals="-3" id="f-561" unitRef="usd">0</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-118" decimals="-3" id="f-562" unitRef="usd">1226000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-118" decimals="-3" id="f-563" unitRef="usd">0</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-119" decimals="-3" id="f-564" unitRef="usd">1349000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-119" decimals="-3" id="f-565" unitRef="usd">0</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-120" decimals="-3" id="f-566" unitRef="usd">1468000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-120" decimals="-3" id="f-567" unitRef="usd">0</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-121" decimals="-3" id="f-568" unitRef="usd">1101000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-121" decimals="-3" id="f-569" unitRef="usd">287000</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-122" decimals="-3" id="f-570" unitRef="usd">1265000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-122" decimals="-3" id="f-571" unitRef="usd">497000</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-123" decimals="-3" id="f-572" unitRef="usd">1546000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-123" decimals="-3" id="f-573" unitRef="usd">729000</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-1" decimals="-3" id="f-574" unitRef="usd">3976000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-1" decimals="-3" id="f-575" unitRef="usd">5553000</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-4" decimals="-3" id="f-576" unitRef="usd">4575000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-4" decimals="-3" id="f-577" unitRef="usd">4021000</ifrs-full:AmortisationExpense>
    <ifrs-full:DepreciationExpense contextRef="c-5" decimals="-3" id="f-578" unitRef="usd">5508000</ifrs-full:DepreciationExpense>
    <ifrs-full:AmortisationExpense contextRef="c-5" decimals="-3" id="f-579" unitRef="usd">2828000</ifrs-full:AmortisationExpense>
    <soph:DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock contextRef="c-1" id="f-580">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table presents employee costs by function,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; which consists of &#x201c;Employee benefit expenses&#x201d;, &#x201c;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Social charges&#x201d; and &#x201c;Share-based compensation&#x201d; (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the year ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;93,657&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;86,149&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90,181&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutEmployeeBenefitExpensesIncludedInOperatingExpenseTableTextBlock>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-124" decimals="-3" id="f-581" unitRef="usd">3200000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-125" decimals="-3" id="f-582" unitRef="usd">2247000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-126" decimals="-3" id="f-583" unitRef="usd">2660000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-115" decimals="-3" id="f-584" unitRef="usd">31638000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-116" decimals="-3" id="f-585" unitRef="usd">31321000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-117" decimals="-3" id="f-586" unitRef="usd">31280000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-118" decimals="-3" id="f-587" unitRef="usd">25089000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-119" decimals="-3" id="f-588" unitRef="usd">20038000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-120" decimals="-3" id="f-589" unitRef="usd">20174000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-121" decimals="-3" id="f-590" unitRef="usd">33730000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-122" decimals="-3" id="f-591" unitRef="usd">32543000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-123" decimals="-3" id="f-592" unitRef="usd">36067000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-1" decimals="-3" id="f-593" unitRef="usd">93657000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-4" decimals="-3" id="f-594" unitRef="usd">86149000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-5" decimals="-3" id="f-595" unitRef="usd">90181000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-125" decimals="-5" id="f-596" unitRef="usd">2200000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="c-126" decimals="-5" id="f-597" unitRef="usd">2700000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory contextRef="c-1" id="f-598">Other operating income, net&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records income and expenses that are not regularly occurring or normal business income and expense to other operating income, net. Other operating income, net consists of gains and losses related to the disposal of tangible assets, write-offs of intangible assets and other operating income (expense).&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory>
    <soph:DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock contextRef="c-1" id="f-599">&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records income and expenses that are not regularly occurring or normal business income and expense to other operating income, net. Other operating income, net consists of gains and losses related to the disposal of tangible assets, write-offs of intangible assets and other operating income (expense).&lt;/span&gt;&lt;/div&gt;</soph:DescriptionOfAccountingPolicyForOtherOperatingIncomeExpenseTextBlock>
    <ifrs-full:DisclosureOfFinanceCostExplanatory contextRef="c-1" id="f-600">Interest income, Interest expense and Foreign exchange (losses) gains, net&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income consists of interest income earned on cash and cash equivalents, short-term investments, and lease receivables. Interest expense consists of interest expense incurred on lease liabilities and loans, which includes interest on commercial borrowings. The foreign exchange gains and losses arise principally on intercompany receivable balances in the parent company, whose functional currency is the Swiss Franc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Interest income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table presents interest income (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,872&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,362&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,547&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table presents interest expense (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,554)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Foreign exchange gains (losses), net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e table presents foreign exchange gains (losses), net (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gains (losses), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total foreign exchange gains (losses), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFinanceCostExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory contextRef="c-1" id="f-601">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income consists of interest income earned on cash and cash equivalents, short-term investments, and lease receivables. Interest expense consists of interest expense incurred on lease liabilities and loans, which includes interest on commercial borrowings. The foreign exchange gains and losses arise principally on intercompany receivable balances in the parent company, whose functional currency is the Swiss Franc.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForInterestIncomeAndExpenseExplanatory>
    <soph:DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock contextRef="c-1" id="f-602">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table presents interest income (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,872&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,362&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,547&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutInterestIncomeTableTextBlock>
    <ifrs-full:RevenueFromInterest contextRef="c-1" decimals="-3" id="f-603" unitRef="usd">1872000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest contextRef="c-4" decimals="-3" id="f-604" unitRef="usd">3362000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest contextRef="c-5" decimals="-3" id="f-605" unitRef="usd">4547000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest contextRef="c-1" decimals="-3" id="f-606" unitRef="usd">1872000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest contextRef="c-4" decimals="-3" id="f-607" unitRef="usd">3362000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest contextRef="c-5" decimals="-3" id="f-608" unitRef="usd">4547000</ifrs-full:RevenueFromInterest>
    <soph:DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock contextRef="c-1" id="f-609">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table presents interest expense (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,554)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,913)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutInterestExpenseTableTextBlock>
    <ifrs-full:InterestExpenseOnBankLoansAndOverdrafts contextRef="c-1" decimals="-3" id="f-610" unitRef="usd">3953000</ifrs-full:InterestExpenseOnBankLoansAndOverdrafts>
    <ifrs-full:InterestExpenseOnBankLoansAndOverdrafts contextRef="c-4" decimals="-3" id="f-611" unitRef="usd">1339000</ifrs-full:InterestExpenseOnBankLoansAndOverdrafts>
    <ifrs-full:InterestExpenseOnBankLoansAndOverdrafts contextRef="c-5" decimals="-3" id="f-612" unitRef="usd">0</ifrs-full:InterestExpenseOnBankLoansAndOverdrafts>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c-1" decimals="-3" id="f-613" unitRef="usd">573000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c-4" decimals="-3" id="f-614" unitRef="usd">567000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="c-5" decimals="-3" id="f-615" unitRef="usd">545000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnOtherFinancialLiabilities contextRef="c-1" decimals="-3" id="f-616" unitRef="usd">28000</ifrs-full:InterestExpenseOnOtherFinancialLiabilities>
    <ifrs-full:InterestExpenseOnOtherFinancialLiabilities contextRef="c-4" decimals="-3" id="f-617" unitRef="usd">7000</ifrs-full:InterestExpenseOnOtherFinancialLiabilities>
    <ifrs-full:InterestExpenseOnOtherFinancialLiabilities contextRef="c-5" decimals="-3" id="f-618" unitRef="usd">43000</ifrs-full:InterestExpenseOnOtherFinancialLiabilities>
    <ifrs-full:InterestExpense contextRef="c-1" decimals="-3" id="f-619" unitRef="usd">4554000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense contextRef="c-4" decimals="-3" id="f-620" unitRef="usd">1913000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense contextRef="c-5" decimals="-3" id="f-621" unitRef="usd">588000</ifrs-full:InterestExpense>
    <soph:DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock contextRef="c-1" id="f-622">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e table presents foreign exchange gains (losses), net (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gains (losses), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total foreign exchange gains (losses), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutForeignExchangeGainLossNetTableTextBlock>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-1" decimals="-3" id="f-623" unitRef="usd">-3402000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-4" decimals="-3" id="f-624" unitRef="usd">3479000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-5" decimals="-3" id="f-625" unitRef="usd">-7628000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-1" decimals="-3" id="f-626" unitRef="usd">-3402000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-4" decimals="-3" id="f-627" unitRef="usd">3479000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-5" decimals="-3" id="f-628" unitRef="usd">-7628000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="c-1" id="f-629">Income tax&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to taxes in different countries. Taxes and related fiscal assets and liabilities recognized in the Company&#x2019;s consolidated financial statements reflect management&#x2019;s best estimate of the outcome based on the facts known at the balance sheet date in each individual country. These facts may include but are not limited to change in tax laws and interpretation thereof in the various jurisdictions where the Company operates. They may have an impact on the income tax as well as the resulting income tax assets and liabilities. Any differences between tax estimates and final tax assessments are charged to the statement of loss in the period in which they are incurred. Taxes include current and deferred taxes on income as well as actual or potential withholding taxes on current and expected transfers of income from subsidiaries and tax adjustments relating to prior years. Income tax is recognized in the statement of loss, except to the extent that it relates to an item directly taken to other comprehensive income/loss or equity, in which case it is recognized against other comprehensive income/loss or equity, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current income tax liabilities refer to the portion of the tax on the current year taxable profit (as determined according to the rules of the taxation authorities) and includes uncertain tax liabilities. The Company determines the taxable profit (tax loss), tax bases, unused tax losses, unused tax credits and tax rates consistently with the tax treatment used or planned to be used in its income tax filings if the Company concludes it is probable that the taxation authority will accept an uncertain tax treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Otherwise, the Company reflects the effect of uncertainty using either the most likely outcome or the expected value outcome, depending on which method the entity expects to better predict the resolution of the uncertainty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred taxes are based on the temporary differences that arise when taxation authorities recognize and measure assets and liabilities with rules that differ from the accounting policies of the Company&#x2019;s consolidated &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;financial statements. They also arise on temporary differences stemming from tax losses carried forward. Deferred taxes are measured at the rates of tax expected to prevail when the temporary differences reverse, subject to such rates being substantively enacted at the balance sheet date. Any changes of the tax rates are recognized in the statement of loss unless related to items directly recognized against other comprehensive income. Deferred tax liabilities are recognized on all taxable temporary differences excluding non-deductible goodwill. Deferred tax assets are recognized for unused tax losses, unused tax credits and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If the amount of taxable temporary differences is insufficient to recognize a deferred tax asset in full, then future taxable profits, adjusted for reversals of existing temporary differences, are considered, on the basis of the business plans for individual subsidiaries in the Company. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax impact of a transaction or item can be uncertain until a conclusion is reached with the relevant tax authority or through a legal process. The Company uses in-house tax experts when assessing uncertain tax positions and seeks the advice of external professional advisors where appropriate. The assessment of the uncertain tax position is done by first making a determination of whether it is more likely than not that a tax position would be sustained upon an examination, and then by calculating the amount of the benefit, of that tax position that meets the more likely than not threshold, that should be recognized in the financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025, and 2024, the Company recorded a provi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;sion of $0.2 million and $0.2 million, respectively,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for unrecognized tax liabilities including interest and penalties. The Company records interest and penalties related to income tax amounts as a component of income tax &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company files tax returns as prescribed by the tax laws of the jurisdictions in which it operates and is therefore subject to tax examination by various taxing authorities. In the normal course of business, the Company is subject to examination by local tax authorities in Switzerland, France, Italy, Brazil, Australia, Germany, the U.K. and the U.S. In 2022 a tax assessment examination was rendered by the French tax authority during an audit of the Company&#x2019;s 2018 and 2019 tax returns. In 2023, a tax assessment was rendered by the French tax authority during the review of the 2022 tax return with no additional tax liabilities resulting from the review. In 2024, a tax assessment was rendered by the Swiss tax authority regarding the Company&#x2019;s 2019 through 2023 tax returns. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company is not aware of any additional issues that could result in any other significant payments, accruals or material deviation from its tax positions. There are no tax examinations in progress as of December 31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records tax liabilities or benefits for all years subject to examination based upon management&#x2019;s evaluation of the facts, circumstances and information available at the reporting date. There is inherent uncertainty in quantifying income tax positions, especially considering the complex tax laws and regulations in each of the jurisdictions in which the Company operates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Presentation of income tax (expense) benefits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the current and deferred income tax (expense) benefits (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.714%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.107%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred income tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Origination and reversal of temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total deferred income tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total income tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the reconciliation of the expected tax expense to the tax expense report in the statement of loss (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(77,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(61,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(78,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax at Swiss statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of tax rates in foreign jurisdictions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tax effect of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Unrecognized deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(8,879)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Income not subject to tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Expense not deductible for tax purposes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Movement in the deferred tax balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2025, the Company recognized deferred tax assets for its foreign subsidiaries due to intercompany transfer pricing arrangements that will assure realization of their respective deferred tax assets in each country. The following table presents the changes in the Company&#x2019;s deferred tax assets and deferred tax liabilities (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Depreciation &amp;amp;&lt;br/&gt;amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net operating loss&lt;br/&gt;carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,047&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,150&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,767&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;570&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,831&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Depreciation &amp;amp;&lt;br/&gt;amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net operating loss&lt;br/&gt;carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;794&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;696&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,010&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,720&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Recognized in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,047&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,150&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,767&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrecognized deferred tax assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and 2024, the Company recognized deferred tax assets to the extent that it was probable that they would be realized.&#160;The following table consists of the gross tax loss carryforwards and the deferred tax assets that have not been recognized because it is not probable that there will be future taxable profits to use these benefits (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.109%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductible temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;451,324&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;60,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;352,156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and 2024, the Company had various net operating loss (&#x201c;NOL&#x201d;) carryforwards in Switzerland, the U.K., the U.S., and Brazil that are available to reduce future taxable income and income taxes, the majority of which will expire at various dates through&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 2032.&#160;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and 2024, the Company had the following expiring amounts of unrecognized NOL carryforwards (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Two years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Four years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter and unlimited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;443,992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;347,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future realization of the tax benefits of existing temporary differences and NOL carryforwards ultimately depends on the existence of sufficient taxable income within the carryforward period. As of December 31, 2025, the Company performed an evaluation to determine the likelihood of realization of these tax benefits. In assessing the realization of the deferred tax assets, the Company considered whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company considered all available evidence, both positive and negative, which included the results of operations for the current and preceding years. The Company determined that it was not possible to reasonably quantify future taxable income and determined that it is not probable that all of the deferred tax assets will be realized in Switzerland and Brazil but has recognized deferred tax assets in France, Italy, the U.K. and the U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unrecognized deferred tax liability on retained earnings of subsidiaries&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews its plan to indefinitely reinvest on a periodic basis for each one of its foreign subsidiaries. In making its decision to indefinitely reinvest, the Company evaluates its plans of reinvestment, its ability to control repatriation and to mobilize funds without triggering basis differences, and the profitability of its Swiss operations and associated cash requirements and the need, if any, to repatriate funds. If the assessment of the Company with respect to any earnings of its foreign subsidiaries&#x2019; changes, deferred Swiss income taxes, foreign income taxes, and foreign withholding taxes may have to be accrued.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not provide for foreign income and withholding taxes, Swiss income taxes or&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; tax benefits on the excess of the financial reporting basis over the tax basis of its investments in foreign subsidiaries to the&#160;extent that such amounts are indefinitely reinvested to support operations and continued growth plans outside of Switzerland, or if the Company has determined that no tax liability would arise in case of distribution. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025, the Company plans to indefinitely reinvest any undistributed foreign &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;earnings for all its foreign subsidiaries except France. During the year 2025, the Company received a dividend payment from its French subsidiary in the amount of $3.5 million, paid on August&#160;28, 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the year 2024, the Company received a dividend payment from its French subsidiary in the amount of $3.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has determined that the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;repatriation of foreign earnings from France does not trigger a tax liability, based on the application of Swiss Participation Exemption rules and exemptions provided by the Double Tax Treaty signed between France and Switzerland, based on which &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;dividends are exempt from withholding tax. The total amount of temporary differences associated with the other investments in subsidiaries is not material.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="c-1" id="f-630">&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to taxes in different countries. Taxes and related fiscal assets and liabilities recognized in the Company&#x2019;s consolidated financial statements reflect management&#x2019;s best estimate of the outcome based on the facts known at the balance sheet date in each individual country. These facts may include but are not limited to change in tax laws and interpretation thereof in the various jurisdictions where the Company operates. They may have an impact on the income tax as well as the resulting income tax assets and liabilities. Any differences between tax estimates and final tax assessments are charged to the statement of loss in the period in which they are incurred. Taxes include current and deferred taxes on income as well as actual or potential withholding taxes on current and expected transfers of income from subsidiaries and tax adjustments relating to prior years. Income tax is recognized in the statement of loss, except to the extent that it relates to an item directly taken to other comprehensive income/loss or equity, in which case it is recognized against other comprehensive income/loss or equity, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current income tax liabilities refer to the portion of the tax on the current year taxable profit (as determined according to the rules of the taxation authorities) and includes uncertain tax liabilities. The Company determines the taxable profit (tax loss), tax bases, unused tax losses, unused tax credits and tax rates consistently with the tax treatment used or planned to be used in its income tax filings if the Company concludes it is probable that the taxation authority will accept an uncertain tax treatment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Otherwise, the Company reflects the effect of uncertainty using either the most likely outcome or the expected value outcome, depending on which method the entity expects to better predict the resolution of the uncertainty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred taxes are based on the temporary differences that arise when taxation authorities recognize and measure assets and liabilities with rules that differ from the accounting policies of the Company&#x2019;s consolidated &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;financial statements. They also arise on temporary differences stemming from tax losses carried forward. Deferred taxes are measured at the rates of tax expected to prevail when the temporary differences reverse, subject to such rates being substantively enacted at the balance sheet date. Any changes of the tax rates are recognized in the statement of loss unless related to items directly recognized against other comprehensive income. Deferred tax liabilities are recognized on all taxable temporary differences excluding non-deductible goodwill. Deferred tax assets are recognized for unused tax losses, unused tax credits and deductible temporary differences to the extent that it is probable that future taxable profits will be available against which they can be used. Future taxable profits are determined based on the reversal of relevant taxable temporary differences. If the amount of taxable temporary differences is insufficient to recognize a deferred tax asset in full, then future taxable profits, adjusted for reversals of existing temporary differences, are considered, on the basis of the business plans for individual subsidiaries in the Company. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized; such reductions are reversed when the probability of future taxable profits improves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax impact of a transaction or item can be uncertain until a conclusion is reached with the relevant tax authority or through a legal process. The Company uses in-house tax experts when assessing uncertain tax positions and seeks the advice of external professional advisors where appropriate. The assessment of the uncertain tax position is done by first making a determination of whether it is more likely than not that a tax position would be sustained upon an examination, and then by calculating the amount of the benefit, of that tax position that meets the more likely than not threshold, that should be recognized in the financial statements.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory>
    <soph:TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties contextRef="c-3" decimals="-5" id="f-631" unitRef="usd">200000</soph:TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties>
    <soph:TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties contextRef="c-6" decimals="-5" id="f-632" unitRef="usd">200000</soph:TaxLiabilitiesThatHaveNotBeenRecognisedIncludingInterestAndPenalties>
    <soph:DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-633">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the current and deferred income tax (expense) benefits (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.714%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.107%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Deferred income tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Origination and reversal of temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total deferred income tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total income tax (expense) benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutCurrentAndDeferredTaxExpenseBenefitTableTextBlock>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c-1" decimals="-3" id="f-634" unitRef="usd">1458000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c-4" decimals="-3" id="f-635" unitRef="usd">1115000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome contextRef="c-5" decimals="-3" id="f-636" unitRef="usd">215000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod contextRef="c-1" decimals="-3" id="f-637" unitRef="usd">84000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod contextRef="c-4" decimals="-3" id="f-638" unitRef="usd">155000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod contextRef="c-5" decimals="-3" id="f-639" unitRef="usd">40000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods contextRef="c-1" decimals="-3" id="f-640" unitRef="usd">1542000</ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods>
    <ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods contextRef="c-4" decimals="-3" id="f-641" unitRef="usd">1270000</ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods>
    <ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods contextRef="c-5" decimals="-3" id="f-642" unitRef="usd">255000</ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences contextRef="c-1" decimals="-3" id="f-643" unitRef="usd">-30000</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences contextRef="c-4" decimals="-3" id="f-644" unitRef="usd">-47000</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences contextRef="c-5" decimals="-3" id="f-645" unitRef="usd">231000</ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c-1" decimals="-3" id="f-646" unitRef="usd">-30000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c-4" decimals="-3" id="f-647" unitRef="usd">-47000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome contextRef="c-5" decimals="-3" id="f-648" unitRef="usd">231000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-1" decimals="-3" id="f-649" unitRef="usd">1512000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-4" decimals="-3" id="f-650" unitRef="usd">1223000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-5" decimals="-3" id="f-651" unitRef="usd">486000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <soph:DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-652">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the reconciliation of the expected tax expense to the tax expense report in the statement of loss (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(77,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(61,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(78,495)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax at Swiss statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of tax rates in foreign jurisdictions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(833)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tax effect of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Unrecognized deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,542)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(8,879)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Income not subject to tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Expense not deductible for tax purposes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(2,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutReconciliationOfIncomeTaxExpenseBenefitTableTextBlock>
    <ifrs-full:AccountingProfit contextRef="c-1" decimals="-3" id="f-653" unitRef="usd">-77487000</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit contextRef="c-4" decimals="-3" id="f-654" unitRef="usd">-61270000</ifrs-full:AccountingProfit>
    <ifrs-full:AccountingProfit contextRef="c-5" decimals="-3" id="f-655" unitRef="usd">-78495000</ifrs-full:AccountingProfit>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c-1" decimals="-3" id="f-656" unitRef="usd">-10475000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c-4" decimals="-3" id="f-657" unitRef="usd">-8222000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="c-5" decimals="-3" id="f-658" unitRef="usd">-10453000</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxEffectOfForeignTaxRates contextRef="c-1" decimals="-3" id="f-659" unitRef="usd">1197000</ifrs-full:TaxEffectOfForeignTaxRates>
    <ifrs-full:TaxEffectOfForeignTaxRates contextRef="c-4" decimals="-3" id="f-660" unitRef="usd">893000</ifrs-full:TaxEffectOfForeignTaxRates>
    <ifrs-full:TaxEffectOfForeignTaxRates contextRef="c-5" decimals="-3" id="f-661" unitRef="usd">833000</ifrs-full:TaxEffectOfForeignTaxRates>
    <soph:TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense contextRef="c-1" decimals="-3" id="f-662" unitRef="usd">-8542000</soph:TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense>
    <soph:TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense contextRef="c-4" decimals="-3" id="f-663" unitRef="usd">-6025000</soph:TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense>
    <soph:TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense contextRef="c-5" decimals="-3" id="f-664" unitRef="usd">-8879000</soph:TaxBenefitArisingFromUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceDeferredTaxExpense>
    <soph:TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c-1" decimals="-3" id="f-665" unitRef="usd">-260000</soph:TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <soph:TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c-4" decimals="-3" id="f-666" unitRef="usd">-249000</soph:TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <soph:TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c-5" decimals="-3" id="f-667" unitRef="usd">-303000</soph:TaxEffectOfIncomeNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c-1" decimals="-3" id="f-668" unitRef="usd">1857000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c-4" decimals="-3" id="f-669" unitRef="usd">2263000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="c-5" decimals="-3" id="f-670" unitRef="usd">2085000</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod contextRef="c-1" decimals="-3" id="f-671" unitRef="usd">84000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod contextRef="c-4" decimals="-3" id="f-672" unitRef="usd">155000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod contextRef="c-5" decimals="-3" id="f-673" unitRef="usd">40000</ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="c-1" decimals="-3" id="f-674" unitRef="usd">567000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="c-4" decimals="-3" id="f-675" unitRef="usd">358000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome contextRef="c-5" decimals="-3" id="f-676" unitRef="usd">-595000</ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-1" decimals="-3" id="f-677" unitRef="usd">1512000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-4" decimals="-3" id="f-678" unitRef="usd">1223000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations contextRef="c-5" decimals="-3" id="f-679" unitRef="usd">486000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory contextRef="c-1" id="f-680">The following table presents the changes in the Company&#x2019;s deferred tax assets and deferred tax liabilities (in USD thousands):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Depreciation &amp;amp;&lt;br/&gt;amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net operating loss&lt;br/&gt;carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,047&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,150&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,767&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Recognized in OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;570&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;517&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,831&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.445%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Depreciation &amp;amp;&lt;br/&gt;amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrued pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ROU asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net operating loss&lt;br/&gt;carryforward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;794&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;696&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,010&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,720&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Recognized in profit or loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,047&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,150&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;1,767&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;2,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(897)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The following table consists of the gross tax loss carryforwards and the deferred tax assets that have not been recognized because it is not probable that there will be future taxable profits to use these benefits (in USD thousands):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.664%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.109%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Tax effect&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductible temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;451,324&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;60,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;352,156&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-127" decimals="-3" id="f-681" unitRef="usd">136000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-128" decimals="-3" id="f-682" unitRef="usd">0</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-129" decimals="-3" id="f-683" unitRef="usd">897000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-130" decimals="-3" id="f-684" unitRef="usd">-1047000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-131" decimals="-3" id="f-685" unitRef="usd">-603000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-132" decimals="-3" id="f-686" unitRef="usd">-1150000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-6" decimals="-3" id="f-687" unitRef="usd">-1767000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-133" decimals="-3" id="f-688" unitRef="usd">-148000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-134" decimals="-3" id="f-689" unitRef="usd">0</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-135" decimals="-3" id="f-690" unitRef="usd">-531000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-136" decimals="-3" id="f-691" unitRef="usd">523000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-137" decimals="-3" id="f-692" unitRef="usd">90000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-138" decimals="-3" id="f-693" unitRef="usd">36000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-1" decimals="-3" id="f-694" unitRef="usd">-30000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="c-133" decimals="-3" id="f-695" unitRef="usd">0</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="c-134" decimals="-3" id="f-696" unitRef="usd">-3000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="c-135" decimals="-3" id="f-697" unitRef="usd">0</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="c-136" decimals="-3" id="f-698" unitRef="usd">0</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="c-137" decimals="-3" id="f-699" unitRef="usd">0</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="c-138" decimals="-3" id="f-700" unitRef="usd">0</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome contextRef="c-1" decimals="-3" id="f-701" unitRef="usd">-3000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-133" decimals="-3" id="f-702" unitRef="usd">12000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-134" decimals="-3" id="f-703" unitRef="usd">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-135" decimals="-3" id="f-704" unitRef="usd">36000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-136" decimals="-3" id="f-705" unitRef="usd">-46000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-137" decimals="-3" id="f-706" unitRef="usd">-4000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-138" decimals="-3" id="f-707" unitRef="usd">-29000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-1" decimals="-3" id="f-708" unitRef="usd">-31000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-139" decimals="-3" id="f-709" unitRef="usd">0</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-140" decimals="-3" id="f-710" unitRef="usd">-3000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-141" decimals="-3" id="f-711" unitRef="usd">402000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-142" decimals="-3" id="f-712" unitRef="usd">-570000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-143" decimals="-3" id="f-713" unitRef="usd">-517000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-144" decimals="-3" id="f-714" unitRef="usd">-1143000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-3" decimals="-3" id="f-715" unitRef="usd">-1831000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxAssets contextRef="c-139" decimals="-3" id="f-716" unitRef="usd">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-140" decimals="-3" id="f-717" unitRef="usd">3000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-141" decimals="-3" id="f-718" unitRef="usd">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-142" decimals="-3" id="f-719" unitRef="usd">570000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-143" decimals="-3" id="f-720" unitRef="usd">539000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-144" decimals="-3" id="f-721" unitRef="usd">1143000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-3" decimals="-3" id="f-722" unitRef="usd">2255000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-139" decimals="-3" id="f-723" unitRef="usd">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-140" decimals="-3" id="f-724" unitRef="usd">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-141" decimals="-3" id="f-725" unitRef="usd">402000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-142" decimals="-3" id="f-726" unitRef="usd">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-143" decimals="-3" id="f-727" unitRef="usd">22000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-144" decimals="-3" id="f-728" unitRef="usd">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-3" decimals="-3" id="f-729" unitRef="usd">424000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-145" decimals="-3" id="f-730" unitRef="usd">19000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-146" decimals="-3" id="f-731" unitRef="usd">0</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-147" decimals="-3" id="f-732" unitRef="usd">761000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-148" decimals="-3" id="f-733" unitRef="usd">-794000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-149" decimals="-3" id="f-734" unitRef="usd">-696000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-150" decimals="-3" id="f-735" unitRef="usd">-1010000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-23" decimals="-3" id="f-736" unitRef="usd">-1720000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-151" decimals="-3" id="f-737" unitRef="usd">123000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-152" decimals="-3" id="f-738" unitRef="usd">0</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-153" decimals="-3" id="f-739" unitRef="usd">166000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-154" decimals="-3" id="f-740" unitRef="usd">-287000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-155" decimals="-3" id="f-741" unitRef="usd">91000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-156" decimals="-3" id="f-742" unitRef="usd">-140000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss contextRef="c-4" decimals="-3" id="f-743" unitRef="usd">-47000</ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-151" decimals="-3" id="f-744" unitRef="usd">-6000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-152" decimals="-3" id="f-745" unitRef="usd">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-153" decimals="-3" id="f-746" unitRef="usd">-30000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-154" decimals="-3" id="f-747" unitRef="usd">34000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-155" decimals="-3" id="f-748" unitRef="usd">2000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-156" decimals="-3" id="f-749" unitRef="usd">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset contextRef="c-4" decimals="-3" id="f-750" unitRef="usd">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesDeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-127" decimals="-3" id="f-751" unitRef="usd">136000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-128" decimals="-3" id="f-752" unitRef="usd">0</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-129" decimals="-3" id="f-753" unitRef="usd">897000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-130" decimals="-3" id="f-754" unitRef="usd">-1047000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-131" decimals="-3" id="f-755" unitRef="usd">-603000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-132" decimals="-3" id="f-756" unitRef="usd">-1150000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxLiabilityAsset contextRef="c-6" decimals="-3" id="f-757" unitRef="usd">-1767000</ifrs-full:DeferredTaxLiabilityAsset>
    <ifrs-full:DeferredTaxAssets contextRef="c-127" decimals="-3" id="f-758" unitRef="usd">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-128" decimals="-3" id="f-759" unitRef="usd">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-129" decimals="-3" id="f-760" unitRef="usd">0</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-130" decimals="-3" id="f-761" unitRef="usd">1047000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-131" decimals="-3" id="f-762" unitRef="usd">670000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-132" decimals="-3" id="f-763" unitRef="usd">1150000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets contextRef="c-6" decimals="-3" id="f-764" unitRef="usd">2867000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-127" decimals="-3" id="f-765" unitRef="usd">136000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-128" decimals="-3" id="f-766" unitRef="usd">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-129" decimals="-3" id="f-767" unitRef="usd">897000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-130" decimals="-3" id="f-768" unitRef="usd">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-131" decimals="-3" id="f-769" unitRef="usd">67000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-132" decimals="-3" id="f-770" unitRef="usd">0</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities contextRef="c-6" decimals="-3" id="f-771" unitRef="usd">1100000</ifrs-full:DeferredTaxLiabilities>
    <soph:UnrecognizedDeferredTaxAssetsGross contextRef="c-157" decimals="-3" id="f-772" unitRef="usd">7332000</soph:UnrecognizedDeferredTaxAssetsGross>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c-157" decimals="-3" id="f-773" unitRef="usd">1014000</ifrs-full:TaxEffectOfTaxLosses>
    <soph:UnrecognizedDeferredTaxAssetsGross contextRef="c-158" decimals="-3" id="f-774" unitRef="usd">4623000</soph:UnrecognizedDeferredTaxAssetsGross>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c-158" decimals="-3" id="f-775" unitRef="usd">661000</ifrs-full:TaxEffectOfTaxLosses>
    <soph:UnrecognizedDeferredTaxAssetsGross contextRef="c-138" decimals="-3" id="f-776" unitRef="usd">443992000</soph:UnrecognizedDeferredTaxAssetsGross>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c-138" decimals="-3" id="f-777" unitRef="usd">59871000</ifrs-full:TaxEffectOfTaxLosses>
    <soph:UnrecognizedDeferredTaxAssetsGross contextRef="c-156" decimals="-3" id="f-778" unitRef="usd">347533000</soph:UnrecognizedDeferredTaxAssetsGross>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c-156" decimals="-3" id="f-779" unitRef="usd">46544000</ifrs-full:TaxEffectOfTaxLosses>
    <soph:UnrecognizedDeferredTaxAssetsGross contextRef="c-1" decimals="-3" id="f-780" unitRef="usd">451324000</soph:UnrecognizedDeferredTaxAssetsGross>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c-1" decimals="-3" id="f-781" unitRef="usd">60885000</ifrs-full:TaxEffectOfTaxLosses>
    <soph:UnrecognizedDeferredTaxAssetsGross contextRef="c-4" decimals="-3" id="f-782" unitRef="usd">352156000</soph:UnrecognizedDeferredTaxAssetsGross>
    <ifrs-full:TaxEffectOfTaxLosses contextRef="c-4" decimals="-3" id="f-783" unitRef="usd">47205000</ifrs-full:TaxEffectOfTaxLosses>
    <soph:DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock contextRef="c-1" id="f-784">&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and 2024, the Company had the following expiring amounts of unrecognized NOL carryforwards (in USD thousands):&lt;/span&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:67.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;One year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Two years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Four years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter and unlimited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;443,992&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;347,533&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutExpiringAmountsOfUnrecognizedNetOperatingLossCarryforwardsTableTextBlock>
    <soph:NetOperatingLossCarryforwardsYearOne contextRef="c-3" decimals="-3" id="f-785" unitRef="usd">27446000</soph:NetOperatingLossCarryforwardsYearOne>
    <soph:NetOperatingLossCarryforwardsYearOne contextRef="c-6" decimals="-3" id="f-786" unitRef="usd">15853000</soph:NetOperatingLossCarryforwardsYearOne>
    <soph:NetOperatingLossCarryforwardsYearTwo contextRef="c-3" decimals="-3" id="f-787" unitRef="usd">56969000</soph:NetOperatingLossCarryforwardsYearTwo>
    <soph:NetOperatingLossCarryforwardsYearTwo contextRef="c-6" decimals="-3" id="f-788" unitRef="usd">23958000</soph:NetOperatingLossCarryforwardsYearTwo>
    <soph:NetOperatingLossCarryforwardsYearThree contextRef="c-3" decimals="-3" id="f-789" unitRef="usd">78915000</soph:NetOperatingLossCarryforwardsYearThree>
    <soph:NetOperatingLossCarryforwardsYearThree contextRef="c-6" decimals="-3" id="f-790" unitRef="usd">49729000</soph:NetOperatingLossCarryforwardsYearThree>
    <soph:NetOperatingLossCarryforwardsYearFour contextRef="c-3" decimals="-3" id="f-791" unitRef="usd">89906000</soph:NetOperatingLossCarryforwardsYearFour>
    <soph:NetOperatingLossCarryforwardsYearFour contextRef="c-6" decimals="-3" id="f-792" unitRef="usd">68886000</soph:NetOperatingLossCarryforwardsYearFour>
    <soph:NetOperatingLossCarryforwardsThereafter contextRef="c-3" decimals="-3" id="f-793" unitRef="usd">190756000</soph:NetOperatingLossCarryforwardsThereafter>
    <soph:NetOperatingLossCarryforwardsThereafter contextRef="c-6" decimals="-3" id="f-794" unitRef="usd">189107000</soph:NetOperatingLossCarryforwardsThereafter>
    <soph:NetOperatingLossCarryforwards contextRef="c-3" decimals="-3" id="f-795" unitRef="usd">443992000</soph:NetOperatingLossCarryforwards>
    <soph:NetOperatingLossCarryforwards contextRef="c-6" decimals="-3" id="f-796" unitRef="usd">347533000</soph:NetOperatingLossCarryforwards>
    <ifrs-full:DividendsReceived contextRef="c-44" decimals="-5" id="f-797" unitRef="usd">3500000</ifrs-full:DividendsReceived>
    <ifrs-full:DividendsReceived contextRef="c-159" decimals="-5" id="f-798" unitRef="usd">3300000</ifrs-full:DividendsReceived>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="c-1" id="f-799">Loss per share&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s shares comprised of ordinary shares. Each share has a nominal value of $0.06&#160;(CHF&#160;0.05). The basic loss per share is calculated by dividing the net loss attributable to shareholders by the weighted average number of shares in issue during the period excluding treasury shares, which are owned by the Company.&#160;The table presents the loss for the year ended December 31, 2025, 2024, and 2023, respectively (in USD thousands, except shares and loss per share):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributed to shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of shares in issue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,539,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,062,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,750,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic and diluted loss per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(0.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2025, 2024 and 2023, the potential impact, on the calculation of loss per share, of the existing potential ordinary shares related to the share option plans and warrants are not presented, as the impact would be to dilute a loss, which causes them to be deemed &#x201c;non-dilutive&#x201d; for the purposes of the required disclosure, for additional details refer to Note 22 &#x2014; &#x201c;Share-Based Compensation&#x201d; and Note 23 &#x2014; &#x201c;Borrowings&#x201d;.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <ifrs-full:ParValuePerShare
      contextRef="c-58"
      decimals="INF"
      id="f-800"
      unitRef="usdPerShare">0.06</ifrs-full:ParValuePerShare>
    <ifrs-full:ParValuePerShare
      contextRef="c-58"
      decimals="INF"
      id="f-801"
      unitRef="chfPerShare">0.05</ifrs-full:ParValuePerShare>
    <ifrs-full:EarningsPerShareExplanatory contextRef="c-1" id="f-802">The table presents the loss for the year ended December 31, 2025, 2024, and 2023, respectively (in USD thousands, except shares and loss per share):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributed to shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of shares in issue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,539,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,062,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,750,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic and diluted loss per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(0.95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:EarningsPerShareExplanatory>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c-1" decimals="-3" id="f-803" unitRef="usd">-78999000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c-4" decimals="-3" id="f-804" unitRef="usd">-62493000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent contextRef="c-5" decimals="-3" id="f-805" unitRef="usd">-78981000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:WeightedAverageShares contextRef="c-1" decimals="0" id="f-806" unitRef="shares">67539835</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c-1" decimals="0" id="f-807" unitRef="shares">67539835</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c-4" decimals="0" id="f-808" unitRef="shares">66062205</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c-4" decimals="0" id="f-809" unitRef="shares">66062205</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares contextRef="c-5" decimals="0" id="f-810" unitRef="shares">64750886</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:WeightedAverageShares contextRef="c-5" decimals="0" id="f-811" unitRef="shares">64750886</ifrs-full:WeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-1"
      decimals="2"
      id="f-812"
      unitRef="usdPerShare">-1.17</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-1"
      decimals="2"
      id="f-813"
      unitRef="usdPerShare">-1.17</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-4"
      decimals="2"
      id="f-814"
      unitRef="usdPerShare">-0.95</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-4"
      decimals="2"
      id="f-815"
      unitRef="usdPerShare">-0.95</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="c-5"
      decimals="2"
      id="f-816"
      unitRef="usdPerShare">-1.22</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="c-5"
      decimals="2"
      id="f-817"
      unitRef="usdPerShare">-1.22</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory contextRef="c-1" id="f-818">Cash and cash equivalents&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include cash on hand, deposits held at call with external financial institutions, money market funds, and short-term deposits and other short-term highly liquid investments with original maturities of three months or less. They are both readily convertible to known amounts of cash and so near to their maturity that they present insignificant risk of changes in value because of changes in interest rates. Amounts held in money market funds are classified as cash equivalents and are measured as level 1 fair value financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the allocation between the Company&#x2019;s cash and cash equivalents (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash on hand&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37,459&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,783&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term deposits less than 3 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,302&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,857&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32,830&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66,443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70,289&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;80,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="c-1" id="f-819">&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;Cash and cash equivalents include cash on hand, deposits held at call with external financial institutions, money market funds, and short-term deposits and other short-term highly liquid investments with original maturities of three months or less. They are both readily convertible to known amounts of cash and so near to their maturity that they present insignificant risk of changes in value because of changes in interest rates. Amounts held in money market funds are classified as cash equivalents and are measured as level 1 fair value financial instruments.</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <soph:DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="c-1" id="f-820">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the allocation between the Company&#x2019;s cash and cash equivalents (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash on hand&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37,459&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,783&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term deposits less than 3 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,302&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,857&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32,830&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66,443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70,289&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;80,226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutScheduleOfCashAndCashEquivalentsTableTextBlock>
    <ifrs-full:BalancesWithBanks contextRef="c-3" decimals="-3" id="f-821" unitRef="usd">37459000</ifrs-full:BalancesWithBanks>
    <ifrs-full:BalancesWithBanks contextRef="c-6" decimals="-3" id="f-822" unitRef="usd">13783000</ifrs-full:BalancesWithBanks>
    <ifrs-full:Cash contextRef="c-3" decimals="-3" id="f-823" unitRef="usd">37459000</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="c-6" decimals="-3" id="f-824" unitRef="usd">13783000</ifrs-full:Cash>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents contextRef="c-3" decimals="-3" id="f-825" unitRef="usd">27528000</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents contextRef="c-6" decimals="-3" id="f-826" unitRef="usd">39586000</ifrs-full:ShorttermInvestmentsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="c-3" decimals="-3" id="f-827" unitRef="usd">5302000</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="c-6" decimals="-3" id="f-828" unitRef="usd">26857000</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents>
    <ifrs-full:CashEquivalents contextRef="c-3" decimals="-3" id="f-829" unitRef="usd">32830000</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents contextRef="c-6" decimals="-3" id="f-830" unitRef="usd">66443000</ifrs-full:CashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-3" decimals="-3" id="f-831" unitRef="usd">70289000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-6" decimals="-3" id="f-832" unitRef="usd">80226000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="c-1" id="f-833">Accounts receivable&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable-trade balances are&#160;non-interest&#160;bearing and payment terms are generally under agreements with payment terms typically between 30 and 60 days with payment terms extended up to&#160;180 days. The Company&#x2019;s customers primarily consist of government-owned or government-funded hospitals, laboratories with low credit risk, and biopharmaceutical companies. The Company has had minimal instances of actual credit losses and believes that this will continue to be the case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has adopted the simplified method indicated in IFRS 9,&#160;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&#160;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;IFRS 9&#x201d;), to build its allowance for expected credit losses (&#x201c;ECL&#x201d;). The Company uses a matrix based on a calculation of collectability rates according to historical accounts receivable. Allowance is made for lifetime expected credit losses as invoices are issued or when accrued revenue is recognized. The amount of allowance initially recognized is based on historical experience, tempered by expected changes in future cash collections, due to, for example, expected improved customer liquidity or more active credit management.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the trade receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, accrued contract revenue,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and lease receivable less the expected credit loss (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,001&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records increases to, reversals of, and write-offs of the allowance for expected credit losses as &#x201c;Selling and Marketing&#x201d; expenses within its consolidated statements of loss. The following table provides a rollforward of the allowance for expected credit losses for the year ended December 31, 2025 and 2024, that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,181&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;366&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and 2024, the Company&#x2019;s largest customer balance represented&#160;15% and&#160;18% of accounts receivable, respectively. All customer balances that individually exceeded&#160;1% of accounts receivable in aggregate amounted to $8.3 million and $5.0 million as of December 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded no long-term lease receivables as of December 31, 2025 and 2024, respectively. As of December 31, 2025 and 2024, the Company recorded no net lease receivables, respectively.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory contextRef="c-1" id="f-834">&lt;div style="margin-top:12pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable-trade balances are&#160;non-interest&#160;bearing and payment terms are generally under agreements with payment terms typically between 30 and 60 days with payment terms extended up to&#160;180 days. The Company&#x2019;s customers primarily consist of government-owned or government-funded hospitals, laboratories with low credit risk, and biopharmaceutical companies. The Company has had minimal instances of actual credit losses and believes that this will continue to be the case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has adopted the simplified method indicated in IFRS 9,&#160;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&#160;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;IFRS 9&#x201d;), to build its allowance for expected credit losses (&#x201c;ECL&#x201d;). The Company uses a matrix based on a calculation of collectability rates according to historical accounts receivable. Allowance is made for lifetime expected credit losses as invoices are issued or when accrued revenue is recognized. The amount of allowance initially recognized is based on historical experience, tempered by expected changes in future cash collections, due to, for example, expected improved customer liquidity or more active credit management.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory>
    <soph:AccountsReceivableNonInterestBearingPaymentTerms contextRef="c-51" id="f-835">P30D</soph:AccountsReceivableNonInterestBearingPaymentTerms>
    <soph:AccountsReceivableNonInterestBearingPaymentTerms contextRef="c-52" id="f-836">P60D</soph:AccountsReceivableNonInterestBearingPaymentTerms>
    <soph:AccountsReceivableNonInterestBearingExtendedPaymentTerm contextRef="c-1" id="f-837">P180D</soph:AccountsReceivableNonInterestBearingExtendedPaymentTerm>
    <soph:DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock contextRef="c-1" id="f-838">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the trade receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, accrued contract revenue,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and lease receivable less the expected credit loss (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for expected credit losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(366)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(394)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,001&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutAccountsReceivableAndLeaseReceivableTableTextBlock>
    <ifrs-full:FinancialAssets contextRef="c-160" decimals="-3" id="f-839" unitRef="usd">14404000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-161" decimals="-3" id="f-840" unitRef="usd">7088000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-162" decimals="-3" id="f-841" unitRef="usd">963000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-163" decimals="-3" id="f-842" unitRef="usd">742000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-164" decimals="-3" id="f-843" unitRef="usd">-366000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-165" decimals="-3" id="f-844" unitRef="usd">-394000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-166" decimals="-3" id="f-845" unitRef="usd">15001000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-167" decimals="-3" id="f-846" unitRef="usd">7436000</ifrs-full:FinancialAssets>
    <soph:DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock contextRef="c-1" id="f-847">The following table provides a rollforward of the allowance for expected credit losses for the year ended December 31, 2025 and 2024, that is deducted from the amortized cost basis of accounts receivable to present the net amount expected to be collected (in USD thousands):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,181&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reversals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(463)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;366&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;394&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutAllowanceForCreditLossesInAccountsReceivableTableTextBlock>
    <ifrs-full:FinancialAssets contextRef="c-165" decimals="-3" id="f-848" unitRef="usd">-394000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-168" decimals="-3" id="f-849" unitRef="usd">-1181000</ifrs-full:FinancialAssets>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLoss contextRef="c-169" decimals="-3" id="f-850" unitRef="usd">520000</ifrs-full:ImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLoss contextRef="c-170" decimals="-3" id="f-851" unitRef="usd">114000</ifrs-full:ImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="c-169" decimals="-3" id="f-852" unitRef="usd">463000</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="c-170" decimals="-3" id="f-853" unitRef="usd">637000</ifrs-full:ReversalOfImpairmentLossRecognisedInProfitOrLoss>
    <ifrs-full:DecreaseThroughWriteoffFinancialAssets contextRef="c-169" decimals="-3" id="f-854" unitRef="usd">-155000</ifrs-full:DecreaseThroughWriteoffFinancialAssets>
    <ifrs-full:DecreaseThroughWriteoffFinancialAssets contextRef="c-170" decimals="-3" id="f-855" unitRef="usd">-213000</ifrs-full:DecreaseThroughWriteoffFinancialAssets>
    <ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets contextRef="c-169" decimals="-3" id="f-856" unitRef="usd">-70000</ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets>
    <ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets contextRef="c-170" decimals="-3" id="f-857" unitRef="usd">51000</ifrs-full:IncreaseDecreaseThroughForeignExchangeFinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-164" decimals="-3" id="f-858" unitRef="usd">-366000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-165" decimals="-3" id="f-859" unitRef="usd">-394000</ifrs-full:FinancialAssets>
    <soph:PercentageOfCustomerBalanceAccountReceivable contextRef="c-1" decimals="2" id="f-860" unitRef="number">0.15</soph:PercentageOfCustomerBalanceAccountReceivable>
    <soph:PercentageOfCustomerBalanceAccountReceivable contextRef="c-4" decimals="2" id="f-861" unitRef="number">0.18</soph:PercentageOfCustomerBalanceAccountReceivable>
    <soph:AccountsReceivableInAggregateAmount contextRef="c-3" decimals="-5" id="f-862" unitRef="usd">8300000</soph:AccountsReceivableInAggregateAmount>
    <soph:AccountsReceivableInAggregateAmount contextRef="c-6" decimals="-5" id="f-863" unitRef="usd">5000000.0</soph:AccountsReceivableInAggregateAmount>
    <soph:LongTermLeaseReceivables contextRef="c-3" decimals="INF" id="f-864" unitRef="usd">0</soph:LongTermLeaseReceivables>
    <soph:LongTermLeaseReceivables contextRef="c-6" decimals="INF" id="f-865" unitRef="usd">0</soph:LongTermLeaseReceivables>
    <soph:NetLeaseReceivables contextRef="c-3" decimals="-5" id="f-866" unitRef="usd">0</soph:NetLeaseReceivables>
    <soph:NetLeaseReceivables contextRef="c-6" decimals="-5" id="f-867" unitRef="usd">0</soph:NetLeaseReceivables>
    <ifrs-full:DisclosureOfInventoriesExplanatory contextRef="c-1" id="f-868">Inventory&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Raw materials and finished goods are stated at the lower of cost calculated using the first-in, first-out (&#x201c;FIFO&#x201d;) method and net realizable value. Work in progress is stated at the lower of its weighted average cost and net realizable value. Cost comprises direct materials, direct labor, and an appropriate proportion of variable and fixed overhead expenditure, the latter being allocated on the basis of normal operating capacity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consists of the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.004%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,868&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory provision movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.004%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(554)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfInventoriesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories contextRef="c-1" id="f-869">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Raw materials and finished goods are stated at the lower of cost calculated using the first-in, first-out (&#x201c;FIFO&#x201d;) method and net realizable value. Work in progress is stated at the lower of its weighted average cost and net realizable value. Cost comprises direct materials, direct labor, and an appropriate proportion of variable and fixed overhead expenditure, the latter being allocated on the basis of normal operating capacity.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
    <soph:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock contextRef="c-1" id="f-870">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consists of the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.004%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,868&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutInventoriesTableTextBlock>
    <ifrs-full:RawMaterials contextRef="c-3" decimals="-3" id="f-871" unitRef="usd">5543000</ifrs-full:RawMaterials>
    <ifrs-full:RawMaterials contextRef="c-6" decimals="-3" id="f-872" unitRef="usd">5526000</ifrs-full:RawMaterials>
    <ifrs-full:WorkInProgress contextRef="c-3" decimals="-3" id="f-873" unitRef="usd">2047000</ifrs-full:WorkInProgress>
    <ifrs-full:WorkInProgress contextRef="c-6" decimals="-3" id="f-874" unitRef="usd">1321000</ifrs-full:WorkInProgress>
    <ifrs-full:FinishedGoods contextRef="c-3" decimals="-3" id="f-875" unitRef="usd">204000</ifrs-full:FinishedGoods>
    <ifrs-full:FinishedGoods contextRef="c-6" decimals="-3" id="f-876" unitRef="usd">105000</ifrs-full:FinishedGoods>
    <soph:ProvisionOfInventory contextRef="c-3" decimals="-3" id="f-877" unitRef="usd">1443000</soph:ProvisionOfInventory>
    <soph:ProvisionOfInventory contextRef="c-6" decimals="-3" id="f-878" unitRef="usd">1084000</soph:ProvisionOfInventory>
    <ifrs-full:Inventories contextRef="c-3" decimals="-3" id="f-879" unitRef="usd">6351000</ifrs-full:Inventories>
    <ifrs-full:Inventories contextRef="c-6" decimals="-3" id="f-880" unitRef="usd">5868000</ifrs-full:Inventories>
    <soph:DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock contextRef="c-1" id="f-881">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory provision movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.004%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(554)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(284)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(159)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,084)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutInventoryProvisionMovementTableTextBlock>
    <soph:ProvisionOfInventory contextRef="c-6" decimals="-3" id="f-882" unitRef="usd">1084000</soph:ProvisionOfInventory>
    <soph:ProvisionOfInventory contextRef="c-23" decimals="-3" id="f-883" unitRef="usd">2134000</soph:ProvisionOfInventory>
    <soph:InventoryIncreaseInProvision contextRef="c-1" decimals="-3" id="f-884" unitRef="usd">554000</soph:InventoryIncreaseInProvision>
    <soph:InventoryIncreaseInProvision contextRef="c-4" decimals="-3" id="f-885" unitRef="usd">284000</soph:InventoryIncreaseInProvision>
    <ifrs-full:InventoryWritedown2011 contextRef="c-1" decimals="-3" id="f-886" unitRef="usd">354000</ifrs-full:InventoryWritedown2011>
    <ifrs-full:InventoryWritedown2011 contextRef="c-4" decimals="-3" id="f-887" unitRef="usd">1241000</ifrs-full:InventoryWritedown2011>
    <soph:InventoryCurrencyTranslationAdjustment contextRef="c-1" decimals="-3" id="f-888" unitRef="usd">159000</soph:InventoryCurrencyTranslationAdjustment>
    <soph:InventoryCurrencyTranslationAdjustment contextRef="c-4" decimals="-3" id="f-889" unitRef="usd">-93000</soph:InventoryCurrencyTranslationAdjustment>
    <soph:ProvisionOfInventory contextRef="c-3" decimals="-3" id="f-890" unitRef="usd">1443000</soph:ProvisionOfInventory>
    <soph:ProvisionOfInventory contextRef="c-6" decimals="-3" id="f-891" unitRef="usd">1084000</soph:ProvisionOfInventory>
    <ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory contextRef="c-1" id="f-892">Prepaids and other current assets&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents prepaids and other current assets (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grants receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,875&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2025, $0.2 million of current contract acquisition costs were amortized through Selling and marketing costs.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfPrepaymentsAndOtherAssetsExplanatory>
    <soph:DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock contextRef="c-1" id="f-893">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents prepaids and other current assets (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepayments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government grants receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,875&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationOfPrepaymentsAndOtherCurrentAssetsTableTextBlock>
    <ifrs-full:CurrentPrepayments contextRef="c-3" decimals="-3" id="f-894" unitRef="usd">3154000</ifrs-full:CurrentPrepayments>
    <ifrs-full:CurrentPrepayments contextRef="c-6" decimals="-3" id="f-895" unitRef="usd">3786000</ifrs-full:CurrentPrepayments>
    <ifrs-full:CurrentValueAddedTaxReceivables contextRef="c-3" decimals="-3" id="f-896" unitRef="usd">1385000</ifrs-full:CurrentValueAddedTaxReceivables>
    <ifrs-full:CurrentValueAddedTaxReceivables contextRef="c-6" decimals="-3" id="f-897" unitRef="usd">1254000</ifrs-full:CurrentValueAddedTaxReceivables>
    <soph:CurrentGovernmentGrantsReceivable contextRef="c-3" decimals="-3" id="f-898" unitRef="usd">139000</soph:CurrentGovernmentGrantsReceivable>
    <soph:CurrentGovernmentGrantsReceivable contextRef="c-6" decimals="-3" id="f-899" unitRef="usd">0</soph:CurrentGovernmentGrantsReceivable>
    <soph:CurrentContractAcquisitionCosts contextRef="c-3" decimals="-3" id="f-900" unitRef="usd">2002000</soph:CurrentContractAcquisitionCosts>
    <soph:CurrentContractAcquisitionCosts contextRef="c-6" decimals="-3" id="f-901" unitRef="usd">0</soph:CurrentContractAcquisitionCosts>
    <soph:CurrentOtherAssetsMiscellaneous contextRef="c-3" decimals="-3" id="f-902" unitRef="usd">758000</soph:CurrentOtherAssetsMiscellaneous>
    <soph:CurrentOtherAssetsMiscellaneous contextRef="c-6" decimals="-3" id="f-903" unitRef="usd">835000</soph:CurrentOtherAssetsMiscellaneous>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c-3" decimals="-3" id="f-904" unitRef="usd">7438000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets contextRef="c-6" decimals="-3" id="f-905" unitRef="usd">5875000</ifrs-full:CurrentPrepaymentsAndOtherCurrentAssets>
    <soph:AmortisationCurrentContractAcquisitionCosts contextRef="c-1" decimals="-5" id="f-906" unitRef="usd">200000</soph:AmortisationCurrentContractAcquisitionCosts>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="c-1" id="f-907">Property and equipment&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment include leasehold improvements, computer hardware, machinery, and furniture and fixtures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are shown on the balance sheet at their historical cost. The cost of an asset, less any residual value, is depreciated using the straight-line method over the useful life of the asset. For this purpose, assets with similar useful lives have been grouped as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Leasehold improvements&#x2014;Shorter of the useful life of the asset or the remaining term of the lease&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Computer hardware&#x2014;&lt;span style="-sec-ix-hidden:f-909"&gt;Three&lt;/span&gt; to five years&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Machinery and equipment&#x2014;Five years&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Furniture and fixtures&#x2014;Five years&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Useful lives, components, and residual amounts are reviewed annually. Such a review takes into consideration the nature of the assets, their intended use, including but not limited to the closure of facilities, and the evolution of the technology and competitive pressures that may lead to technical obsolescence. Depreciation of property and equipment is allocated to the appropriate headings of expenses by function in the statement of loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reviews of the carrying amount of the Company&#x2019;s property and equipment are performed when there is an indication of impairment. If any such indication exists, then the asset&#x2019;s recoverable amount is estimated. The recoverable amount of an asset is the greater of its value in use and its fair value less costs of disposal. In assessing the value in use, the estimated future cash flows are discounted to their present value, based on the time value of money and the risks specific to the country where the assets are located.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company rec&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ords property and equipment under&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; accrued expense for amounts to be paid within the next 12 months. F&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;or the year ended December 31, 2025, $1.0 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was recorded in accrued expense for property and equipment, an&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d for the year ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2024, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;no amounts were recorded.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Computer hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,456&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,361&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,922&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,285&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,557&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,466&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(955)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(399)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net book value at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;899&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,665&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Computer hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,975&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,460&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,310&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,600&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(815)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,456&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,361&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,922&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(955)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net book value at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,841&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;691&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;388&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;289&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in leasehold improvements and machinery and equipment are &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.1 million and&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$0.3 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively, related to assets under construction that have not yet been placed into service and begun depreciating as of December 31, 2025. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These assets are primarily related to a lab expansion that was completed in early 2026.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="c-1" id="f-908">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment include leasehold improvements, computer hardware, machinery, and furniture and fixtures.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-172" id="f-910">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-173" id="f-911">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment contextRef="c-174" id="f-912">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <soph:CurrentAccruedExpensesOnPropertyPlantAndEquipment contextRef="c-3" decimals="-5" id="f-913" unitRef="usd">1000000.0</soph:CurrentAccruedExpensesOnPropertyPlantAndEquipment>
    <soph:CurrentAccruedExpensesOnPropertyPlantAndEquipment contextRef="c-6" decimals="INF" id="f-914" unitRef="usd">0</soph:CurrentAccruedExpensesOnPropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="c-1" id="f-915">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Computer hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,456&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,361&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,922&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,285&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,557&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,466&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(955)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,810)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(399)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,658)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,859)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net book value at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;899&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;248&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,665&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Computer hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,975&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,460&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,310&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,600&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(815)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,456&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,361&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,922&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(993)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(831)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,131)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(973)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(955)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net book value at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,841&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;691&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;388&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;289&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-175" decimals="-3" id="f-916" unitRef="usd">6456000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-176" decimals="-3" id="f-917" unitRef="usd">1861000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-177" decimals="-3" id="f-918" unitRef="usd">1361000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-178" decimals="-3" id="f-919" unitRef="usd">1244000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-179" decimals="-3" id="f-920" unitRef="usd">10922000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-180" decimals="-3" id="f-921" unitRef="usd">1110000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-181" decimals="-3" id="f-922" unitRef="usd">403000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-182" decimals="-3" id="f-923" unitRef="usd">2000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-183" decimals="-3" id="f-924" unitRef="usd">0</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-184" decimals="-3" id="f-925" unitRef="usd">1515000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-180" decimals="-3" id="f-926" unitRef="usd">252000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-181" decimals="-3" id="f-927" unitRef="usd">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-182" decimals="-3" id="f-928" unitRef="usd">55000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-183" decimals="-3" id="f-929" unitRef="usd">181000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-184" decimals="-3" id="f-930" unitRef="usd">488000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-180" decimals="-3" id="f-931" unitRef="usd">971000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-181" decimals="-3" id="f-932" unitRef="usd">293000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-182" decimals="-3" id="f-933" unitRef="usd">158000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-183" decimals="-3" id="f-934" unitRef="usd">153000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-184" decimals="-3" id="f-935" unitRef="usd">1575000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-185" decimals="-3" id="f-936" unitRef="usd">8285000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-186" decimals="-3" id="f-937" unitRef="usd">2557000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-187" decimals="-3" id="f-938" unitRef="usd">1466000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-188" decimals="-3" id="f-939" unitRef="usd">1216000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-189" decimals="-3" id="f-940" unitRef="usd">13524000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-190" decimals="-3" id="f-941" unitRef="usd">-2615000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-191" decimals="-3" id="f-942" unitRef="usd">-1170000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-192" decimals="-3" id="f-943" unitRef="usd">-973000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-193" decimals="-3" id="f-944" unitRef="usd">-955000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-194" decimals="-3" id="f-945" unitRef="usd">-5713000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-195" decimals="-3" id="f-946" unitRef="usd">-1181000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-196" decimals="-3" id="f-947" unitRef="usd">-303000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-197" decimals="-3" id="f-948" unitRef="usd">-180000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-198" decimals="-3" id="f-949" unitRef="usd">-146000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-199" decimals="-3" id="f-950" unitRef="usd">-1810000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-195" decimals="-3" id="f-951" unitRef="usd">-252000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-196" decimals="-3" id="f-952" unitRef="usd">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-197" decimals="-3" id="f-953" unitRef="usd">-55000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-198" decimals="-3" id="f-954" unitRef="usd">-181000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-199" decimals="-3" id="f-955" unitRef="usd">-488000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-195" decimals="-3" id="f-956" unitRef="usd">-399000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-196" decimals="-3" id="f-957" unitRef="usd">-185000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-197" decimals="-3" id="f-958" unitRef="usd">-120000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-198" decimals="-3" id="f-959" unitRef="usd">-120000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-199" decimals="-3" id="f-960" unitRef="usd">-824000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-200" decimals="-3" id="f-961" unitRef="usd">-3943000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-201" decimals="-3" id="f-962" unitRef="usd">-1658000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-202" decimals="-3" id="f-963" unitRef="usd">-1218000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-203" decimals="-3" id="f-964" unitRef="usd">-1040000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-204" decimals="-3" id="f-965" unitRef="usd">-7859000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-205" decimals="-3" id="f-966" unitRef="usd">4342000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-206" decimals="-3" id="f-967" unitRef="usd">899000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-207" decimals="-3" id="f-968" unitRef="usd">248000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-208" decimals="-3" id="f-969" unitRef="usd">176000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-970" unitRef="usd">5665000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-209" decimals="-3" id="f-971" unitRef="usd">6855000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-210" decimals="-3" id="f-972" unitRef="usd">1975000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-211" decimals="-3" id="f-973" unitRef="usd">1460000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-212" decimals="-3" id="f-974" unitRef="usd">1310000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-213" decimals="-3" id="f-975" unitRef="usd">11600000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-214" decimals="-3" id="f-976" unitRef="usd">86000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-215" decimals="-3" id="f-977" unitRef="usd">115000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-216" decimals="-3" id="f-978" unitRef="usd">1000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-217" decimals="-3" id="f-979" unitRef="usd">15000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-218" decimals="-3" id="f-980" unitRef="usd">217000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-214" decimals="-3" id="f-981" unitRef="usd">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-215" decimals="-3" id="f-982" unitRef="usd">66000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-216" decimals="-3" id="f-983" unitRef="usd">14000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-217" decimals="-3" id="f-984" unitRef="usd">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-218" decimals="-3" id="f-985" unitRef="usd">80000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-214" decimals="-3" id="f-986" unitRef="usd">-485000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-215" decimals="-3" id="f-987" unitRef="usd">-163000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-216" decimals="-3" id="f-988" unitRef="usd">-86000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-217" decimals="-3" id="f-989" unitRef="usd">-81000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-218" decimals="-3" id="f-990" unitRef="usd">-815000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-175" decimals="-3" id="f-991" unitRef="usd">6456000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-176" decimals="-3" id="f-992" unitRef="usd">1861000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-177" decimals="-3" id="f-993" unitRef="usd">1361000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-178" decimals="-3" id="f-994" unitRef="usd">1244000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-179" decimals="-3" id="f-995" unitRef="usd">10922000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-219" decimals="-3" id="f-996" unitRef="usd">-1576000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-220" decimals="-3" id="f-997" unitRef="usd">-993000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-221" decimals="-3" id="f-998" unitRef="usd">-831000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-222" decimals="-3" id="f-999" unitRef="usd">-731000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-223" decimals="-3" id="f-1000" unitRef="usd">-4131000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-224" decimals="-3" id="f-1001" unitRef="usd">-1182000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-225" decimals="-3" id="f-1002" unitRef="usd">-269000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-226" decimals="-3" id="f-1003" unitRef="usd">-208000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-227" decimals="-3" id="f-1004" unitRef="usd">-276000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="c-228" decimals="-3" id="f-1005" unitRef="usd">-1935000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-224" decimals="-3" id="f-1006" unitRef="usd">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-225" decimals="-3" id="f-1007" unitRef="usd">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-226" decimals="-3" id="f-1008" unitRef="usd">-14000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-227" decimals="-3" id="f-1009" unitRef="usd">0</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment contextRef="c-228" decimals="-3" id="f-1010" unitRef="usd">-14000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-224" decimals="-3" id="f-1011" unitRef="usd">143000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-225" decimals="-3" id="f-1012" unitRef="usd">92000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-226" decimals="-3" id="f-1013" unitRef="usd">52000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-227" decimals="-3" id="f-1014" unitRef="usd">52000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment contextRef="c-228" decimals="-3" id="f-1015" unitRef="usd">339000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-190" decimals="-3" id="f-1016" unitRef="usd">-2615000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-191" decimals="-3" id="f-1017" unitRef="usd">-1170000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-192" decimals="-3" id="f-1018" unitRef="usd">-973000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-193" decimals="-3" id="f-1019" unitRef="usd">-955000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-194" decimals="-3" id="f-1020" unitRef="usd">-5713000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-229" decimals="-3" id="f-1021" unitRef="usd">3841000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-230" decimals="-3" id="f-1022" unitRef="usd">691000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-231" decimals="-3" id="f-1023" unitRef="usd">388000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-232" decimals="-3" id="f-1024" unitRef="usd">289000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-1025" unitRef="usd">5209000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:ConstructionInProgress contextRef="c-205" decimals="-5" id="f-1026" unitRef="usd">1100000</ifrs-full:ConstructionInProgress>
    <ifrs-full:ConstructionInProgress contextRef="c-206" decimals="-5" id="f-1027" unitRef="usd">300000</ifrs-full:ConstructionInProgress>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="c-1" id="f-1028">Intangible Assets&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill impairment testing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as&#160;a single cash-generating unit (&#x201c;CGU&#x201d;). As a single CGU, goodwill is tested by considering its recoverability in terms of the entire business. Management assesses the recoverable value of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;goodwill by comparing the Company&#x2019;s equity value, either from observable market prices or based on discounted cash flow &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;forecasts, to the net assets as reported in the Company&#x2019;s consolidated financial statements. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Impairment testing is performed on an annual basis as of October 1. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized internally developed software costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized costs are based on the employment costs of individuals working on software development and based on timesheets. Special attention is paid to distinguishing between costs incurred on developing new software or software upgrades, which typically are eligible for capitalization, and costs incurred in maintenance and in the correction of problems, which are not eligible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Judgment is required in identifying whether individual projects meet all of the criteria required to permit capitalization, in particular, whether the software will generate probable future economic benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is initially measured as the difference between the aggregate of the value of the consideration transferred and the fair value of net assets acquired. Goodwill is not amortized but it is tested for impairment annually, or more frequently if events or changes in circumstances indicate that it might be impaired and is carried at cost less accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment testing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are allocated to CGUs for the purpose of impairment testing. The allocation is made to those CGUs or groups of CGUs that are expected to benefit from the business combination in which the goodwill arose. The CGUs or groups of CGUs are identified at the lowest level at which goodwill is monitored for internal management purposes, being the operating segments. As the Company operates as a single CGU, the Company has only a single cash generating unit for impairment testing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management assesses the recoverable value of goodwill by comparing the Company&#x2019;s equity value, either inferred from the public prices of share issues based on the fair value less cost of disposal (&#x201c;FVLCOD&#x201d;) method or based on discounted cash flow forecasts, with the net assets as reported in its consolidated financial statements based on the value in use (&#x201c;ViU&#x201d;) method. The discounted cash flow approach involves key assumptions that leave considerable scope for judgment. The Company typically compares the two methods and utilizes the greater recoverable amount for the purposes of its impairment testing. Impairment testing is performed on an annual basis as of October 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchased software&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The costs of accessing software services are not capitalized if the Company does not have any contractual right to take possession of the software at any time during the term of the agreement and it is not feasible for the Company either to run the software on its own hardware or to contract with a third party unrelated to the vendor. Such costs represent software as a service costs and are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does capitalize software implementation costs, such as fees paid to outside consultants to set up a software arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For cloud computing costs, the Company capitalized costs for certain configuration and customization costs paid by a customer in a cloud computing or hosting arrangement. IAS 38 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible assets (&#x201c;IAS 38&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; aligns the accounting treatment of these costs incurred in a hosting arrangement treat&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ed as a service contract with the requirements for capitalization and amortization costs to develop or obtain an intangible asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased software and associated capitalized costs are amortized using the&#160;straight-line method&#160;over an estimated life of five years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized internally developed software costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred in the internal development of software are capitalized as intangible assets when they satisfy the criteria required by IAS 38 as set out below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software development costs consist entirely of capitalized internally generated costs that are directly attributable to the design, testing, and enhancement of identifiable and unique software applications and products controlled by the Company and incorporated principally within the Company&#x2019;s SOPHiA DDM Platform. They are recognized as intangible assets where the following criteria are met:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;it is technically feasible to complete the software so that it will be available for use;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;management intends to complete the software and use or sell it;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;there is an ability to use or sell the software;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;it can be demonstrated how the software will generate probable future economic benefits;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;adequate technical, financial, and other resources to complete the development and to use or sell the software are available, and;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the expenditure attributable to the software during its development can be reliably measured.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Directly attributable costs that are capitalized as part of the software comprise principally employee costs. Capitalized development costs are recorded as intangible assets and amortized from the point at which the asset is ready for use on a straight-line basis over its expected useful life. Capitalized software development costs are amortized using the&#160;straight-line method&#160;over an estimated life of&#160;five years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchased software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capitalized internally developed software costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,046&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,709&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,748&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,616&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53,920&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(14,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(18,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net book value at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;719&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,616&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,891&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchased software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capitalized internally developed software costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,999&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,162&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,367&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34,528&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,046&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,709&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,001)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net book value at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;801&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28,998&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill arose from the Company&#x2019;s acquisition of Interactive Biosoftware (&#x201c;IBS&#x201d;) in June 2018. Through this acquisition the Company added Alamut (a genomic mutation interpretation software) to its existing SOPHiA DDM Platform.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is tested for impairment on an annual basis as of October 1 and at the occurrence of a potential indication of impairment. A triggering assessment is performed each quarter to ensure no occurrence of impairment triggering events. As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2025 and 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively,&#160;no&#160;impairment charges were recorded related to the Company&#x2019;s goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 1, 2025 and 2024, respectively, the Company utilized the equity method (&#x201c;FVLCOD&#x201d;) to perform its annual assessment. The estimated equity value of the Company as of October 1, 2025 was $301.9&#160;million, which exceeds the reported net assets of the Company of $60.7&#160;million at that date by $241.2&#160;million. The estimated equity value of the Company as of October 1, 2024 was $242.5 million, which exceeds the reported net assets of the Company of $113.5 at that date by $129.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On the basis of the analyses performed, the Company concludes that the recoverable amount exceeds the carrying amount of the goodwill and&#160;no&#160;impairment is needed as of December 31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory contextRef="c-1" id="f-1029">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill impairment testing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates as&#160;a single cash-generating unit (&#x201c;CGU&#x201d;). As a single CGU, goodwill is tested by considering its recoverability in terms of the entire business. Management assesses the recoverable value of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;goodwill by comparing the Company&#x2019;s equity value, either from observable market prices or based on discounted cash flow &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;forecasts, to the net assets as reported in the Company&#x2019;s consolidated financial statements. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Impairment testing is performed on an annual basis as of October 1. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized internally developed software costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized costs are based on the employment costs of individuals working on software development and based on timesheets. Special attention is paid to distinguishing between costs incurred on developing new software or software upgrades, which typically are eligible for capitalization, and costs incurred in maintenance and in the correction of problems, which are not eligible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Judgment is required in identifying whether individual projects meet all of the criteria required to permit capitalization, in particular, whether the software will generate probable future economic benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is initially measured as the difference between the aggregate of the value of the consideration transferred and the fair value of net assets acquired. Goodwill is not amortized but it is tested for impairment annually, or more frequently if events or changes in circumstances indicate that it might be impaired and is carried at cost less accumulated impairment losses. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment testing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are allocated to CGUs for the purpose of impairment testing. The allocation is made to those CGUs or groups of CGUs that are expected to benefit from the business combination in which the goodwill arose. The CGUs or groups of CGUs are identified at the lowest level at which goodwill is monitored for internal management purposes, being the operating segments. As the Company operates as a single CGU, the Company has only a single cash generating unit for impairment testing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management assesses the recoverable value of goodwill by comparing the Company&#x2019;s equity value, either inferred from the public prices of share issues based on the fair value less cost of disposal (&#x201c;FVLCOD&#x201d;) method or based on discounted cash flow forecasts, with the net assets as reported in its consolidated financial statements based on the value in use (&#x201c;ViU&#x201d;) method. The discounted cash flow approach involves key assumptions that leave considerable scope for judgment. The Company typically compares the two methods and utilizes the greater recoverable amount for the purposes of its impairment testing. Impairment testing is performed on an annual basis as of October 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchased software&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The costs of accessing software services are not capitalized if the Company does not have any contractual right to take possession of the software at any time during the term of the agreement and it is not feasible for the Company either to run the software on its own hardware or to contract with a third party unrelated to the vendor. Such costs represent software as a service costs and are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does capitalize software implementation costs, such as fees paid to outside consultants to set up a software arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For cloud computing costs, the Company capitalized costs for certain configuration and customization costs paid by a customer in a cloud computing or hosting arrangement. IAS 38 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible assets (&#x201c;IAS 38&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; aligns the accounting treatment of these costs incurred in a hosting arrangement treat&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ed as a service contract with the requirements for capitalization and amortization costs to develop or obtain an intangible asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Purchased software and associated capitalized costs are amortized using the&#160;straight-line method&#160;over an estimated life of five years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized internally developed software costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred in the internal development of software are capitalized as intangible assets when they satisfy the criteria required by IAS 38 as set out below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software development costs consist entirely of capitalized internally generated costs that are directly attributable to the design, testing, and enhancement of identifiable and unique software applications and products controlled by the Company and incorporated principally within the Company&#x2019;s SOPHiA DDM Platform. They are recognized as intangible assets where the following criteria are met:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;it is technically feasible to complete the software so that it will be available for use;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;management intends to complete the software and use or sell it;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;there is an ability to use or sell the software;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;it can be demonstrated how the software will generate probable future economic benefits;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;adequate technical, financial, and other resources to complete the development and to use or sell the software are available, and;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;the expenditure attributable to the software during its development can be reliably measured.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Directly attributable costs that are capitalized as part of the software comprise principally employee costs. Capitalized development costs are recorded as intangible assets and amortized from the point at which the asset is ready for use on a straight-line basis over its expected useful life. Capitalized software development costs are amortized using the&#160;straight-line method&#160;over an estimated life of&#160;five years.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c-233" id="f-1030">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill contextRef="c-234" id="f-1031">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory contextRef="c-1" id="f-1032">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net movement for the years ended December 31, 2025 and 2024, respectively are as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchased software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capitalized internally developed software costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,046&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,709&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,748&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,616&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53,920&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(290)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,563)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,755)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(14,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(18,029)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net book value at December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;719&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,616&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,891&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Purchased software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Capitalized internally developed software costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,999&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,162&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,367&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34,528&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,751)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,046&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;39,709&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,001)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,343)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,537)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(7,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(10,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net book value at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;801&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28,998&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-235" decimals="-3" id="f-1033" unitRef="usd">8342000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-236" decimals="-3" id="f-1034" unitRef="usd">4046000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-237" decimals="-3" id="f-1035" unitRef="usd">27321000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-179" decimals="-3" id="f-1036" unitRef="usd">39709000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-238" decimals="-3" id="f-1037" unitRef="usd">0</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-239" decimals="-3" id="f-1038" unitRef="usd">108000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-240" decimals="-3" id="f-1039" unitRef="usd">8098000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-184" decimals="-3" id="f-1040" unitRef="usd">8206000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-238" decimals="-3" id="f-1041" unitRef="usd">1214000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-239" decimals="-3" id="f-1042" unitRef="usd">594000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-240" decimals="-3" id="f-1043" unitRef="usd">4197000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-184" decimals="-3" id="f-1044" unitRef="usd">6005000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-241" decimals="-3" id="f-1045" unitRef="usd">9556000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-242" decimals="-3" id="f-1046" unitRef="usd">4748000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-243" decimals="-3" id="f-1047" unitRef="usd">39616000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-189" decimals="-3" id="f-1048" unitRef="usd">53920000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-244" decimals="-3" id="f-1049" unitRef="usd">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-245" decimals="-3" id="f-1050" unitRef="usd">-3245000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-246" decimals="-3" id="f-1051" unitRef="usd">-7466000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-194" decimals="-3" id="f-1052" unitRef="usd">-10711000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-247" decimals="-3" id="f-1053" unitRef="usd">0</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-248" decimals="-3" id="f-1054" unitRef="usd">-290000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-249" decimals="-3" id="f-1055" unitRef="usd">-5273000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-199" decimals="-3" id="f-1056" unitRef="usd">-5563000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-247" decimals="-3" id="f-1057" unitRef="usd">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-248" decimals="-3" id="f-1058" unitRef="usd">-494000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-249" decimals="-3" id="f-1059" unitRef="usd">-1261000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-199" decimals="-3" id="f-1060" unitRef="usd">-1755000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-250" decimals="-3" id="f-1061" unitRef="usd">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-251" decimals="-3" id="f-1062" unitRef="usd">-4029000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-252" decimals="-3" id="f-1063" unitRef="usd">-14000000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-204" decimals="-3" id="f-1064" unitRef="usd">-18029000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-253" decimals="-3" id="f-1065" unitRef="usd">9556000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-254" decimals="-3" id="f-1066" unitRef="usd">719000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-255" decimals="-3" id="f-1067" unitRef="usd">25616000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-3" decimals="-3" id="f-1068" unitRef="usd">35891000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-256" decimals="-3" id="f-1069" unitRef="usd">8999000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-257" decimals="-3" id="f-1070" unitRef="usd">4162000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-258" decimals="-3" id="f-1071" unitRef="usd">21367000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-213" decimals="-3" id="f-1072" unitRef="usd">34528000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-259" decimals="-3" id="f-1073" unitRef="usd">0</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-260" decimals="-3" id="f-1074" unitRef="usd">195000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-261" decimals="-3" id="f-1075" unitRef="usd">7737000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-218" decimals="-3" id="f-1076" unitRef="usd">7932000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-259" decimals="-3" id="f-1077" unitRef="usd">-657000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-260" decimals="-3" id="f-1078" unitRef="usd">-311000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-261" decimals="-3" id="f-1079" unitRef="usd">-1783000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-218" decimals="-3" id="f-1080" unitRef="usd">-2751000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-235" decimals="-3" id="f-1081" unitRef="usd">8342000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-236" decimals="-3" id="f-1082" unitRef="usd">4046000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-237" decimals="-3" id="f-1083" unitRef="usd">27321000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-179" decimals="-3" id="f-1084" unitRef="usd">39709000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-262" decimals="-3" id="f-1085" unitRef="usd">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-263" decimals="-3" id="f-1086" unitRef="usd">-3001000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-264" decimals="-3" id="f-1087" unitRef="usd">-4342000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-223" decimals="-3" id="f-1088" unitRef="usd">-7343000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-265" decimals="-3" id="f-1089" unitRef="usd">0</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-266" decimals="-3" id="f-1090" unitRef="usd">-484000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-267" decimals="-3" id="f-1091" unitRef="usd">-3537000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill contextRef="c-228" decimals="-3" id="f-1092" unitRef="usd">-4021000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-265" decimals="-3" id="f-1093" unitRef="usd">0</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-266" decimals="-3" id="f-1094" unitRef="usd">240000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-267" decimals="-3" id="f-1095" unitRef="usd">413000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill contextRef="c-228" decimals="-3" id="f-1096" unitRef="usd">653000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-244" decimals="-3" id="f-1097" unitRef="usd">0</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-245" decimals="-3" id="f-1098" unitRef="usd">-3245000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-246" decimals="-3" id="f-1099" unitRef="usd">-7466000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-194" decimals="-3" id="f-1100" unitRef="usd">-10711000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-268" decimals="-3" id="f-1101" unitRef="usd">8342000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-269" decimals="-3" id="f-1102" unitRef="usd">801000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-270" decimals="-3" id="f-1103" unitRef="usd">19855000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="c-6" decimals="-3" id="f-1104" unitRef="usd">28998000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill contextRef="c-4" decimals="INF" id="f-1105" unitRef="usd">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill contextRef="c-1" decimals="INF" id="f-1106" unitRef="usd">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets contextRef="c-3" decimals="-5" id="f-1107" unitRef="usd">301900000</ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwillRevaluationSurplus contextRef="c-3" decimals="-5" id="f-1108" unitRef="usd">60700000</ifrs-full:IntangibleAssetsOtherThanGoodwillRevaluationSurplus>
    <ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets contextRef="c-3" decimals="-5" id="f-1109" unitRef="usd">241200000</ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets contextRef="c-6" decimals="-5" id="f-1110" unitRef="usd">242500000</ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountOfRevaluedAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwillRevaluationSurplus contextRef="c-6" decimals="-5" id="f-1111" unitRef="usd">113500000</ifrs-full:IntangibleAssetsOtherThanGoodwillRevaluationSurplus>
    <ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets contextRef="c-6" decimals="-5" id="f-1112" unitRef="usd">129000000.0</ifrs-full:IntangibleAssetsOtherThanGoodwillCarryingAmountAtCostOfRevaluedAssets>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill contextRef="c-1" decimals="INF" id="f-1113" unitRef="usd">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill contextRef="c-4" decimals="INF" id="f-1114" unitRef="usd">0</ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill>
    <ifrs-full:DisclosureOfLeasesExplanatory contextRef="c-1" id="f-1116">Leases&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses at inception of the contract whether a contract is or contains a lease. This assessment involves determining whether the Company obtains substantially all the economic benefits from the use of that asset, and whether the Company has the right to direct the use of the asset. When these conditions are met, the Company recognizes a&#160;right-of-use&#160;(&#x201c;ROU&#x201d;) asset and a lease liability at the lease commencement date, except for short-term leases of 12 months or less, which are expensed in the statements of loss on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, the ROU asset comprises the initial lease liability, initial direct costs, and any obligations to refurbish the asset, less any incentives granted by the lessors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ROU asset is depreciated over the shorter of the duration of the lease contract (including contractually agreed optional extension periods whose exercise is deemed to be reasonably certain) and the useful life of the underlying asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ROU asset is subject to testing for impairment if there is an indicator for impairment, as for owned assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that is not readily determinable, the incremental borrowing rate (&#x201c;IBR&#x201d;) at the lease commencement date. The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. Lease payments can include fixed payments; variable payments that depend on an index or rate known at the commencement date; and extension option payments or purchase options that the Company is reasonably certain to exercise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease liability is subsequently measured at amortized cost using the effective interest rate method and remeasured (with a corresponding adjustment to the related ROU asset) when there is a change in future lease payments due to renegotiation, changes in an index or rate, or a reassessment of options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s leases include options to extend the lease, and these options are included in the lease term to the extent they are reasonably certain to be exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases out laboratory equipment to certain customers. These leases are classified as finance leases as the Company transfers substantially all the risks and rewards incidental to ownership of the asset to the customer. Refer to Note 4 &#x2014; &#x201c;Revenue&#x201d; fo&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r disclosure of revenue recognized from leased laboratory equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the commencement of the lease term, the Company records revenue and the associated costs of sales, being the sale proceeds at fair value of the asset (computed at cost plus a margin) and the cost of the asset, derecognizes the leased asset from inventory, and recognizes a finance lease receivable on the balance sheet equal to the net investment in the lease. The Company notes these lease agreements ended during 2023, and as of December 31, 2025 and 2024, the Company did not have any leases of laboratory equipment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Company leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2024, the Company entered into&#160;one&#160;office lease as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Rolle office&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 3, 2021, the Company entered into a&#160;120-month lease for office space in Rolle, Switzerland primarily to support the expansion of the research and development department. The lease in total is for approximately&#160;65,860&#160;square feet, including an additional 21,258 square feet based on a lease amendment as described below, with the Company gaining access to areas on prescribed dates. The Company gained access to&#160;38,761&#160;square feet on July 1, 2021,&#160;5,840&#160;square feet on January 1, 2022, and the remaining&#160;21,258&#160;square feet on February 1, 2023. The&#160;expected lease commitments&#160;are linked to changes in the Swiss Consumer Price Index as published by Swiss Federal Statistical Office.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 25, 2022, the Company entered into an amendment to the lease for office space in Rolle, Switzerland. The amendment provides the Company with an additional floor of approximately 21,258 square feet with lease commencement initiating on April 1, 2022. Upon commencement of the lease, the Company recorded a right-of-use asset of $4.5&#160;million and a lease liability of $4.5&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company makes fixed payments and additional variable payments depending on the usage of the asset during the contract period. Upon commencement of the lease, the Company recorded a ROU asset of $7.7&#160;million and a lease liability of $8.5&#160;million. The difference between the ROU and lease liability of $0.8&#160;million is driven by lease incentives and expected restoration costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Boston office&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 27, 2024, the Company entered into a 73-month lease for office space in Boston, Massachusetts primarily to support the expansion of the Company&#x2019;s growth in the United States. The lease in total is for approximately 12,807 square feet. The Company makes fixed payments and additional variable payments depending on the usage of the asset during the contract period. Upon gaining access to the space in September 2024, the Company recorded a right-of-use asset of $2.0&#160;million and a lease liability of $1.9&#160;million. The difference between the ROU and lease liability of less than $0.1&#160;million is driven by initial direct costs to obtain the lease. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Bidart office&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2023, the Company entered into a 108-month lease for office space in Bidart, France primarily to support the expansion of the research and development department and the Company&#x2019;s administrative functions. The lease in total is for approximately 13,509 square feet. Upon commencement of the lease, the Company recorded a right-of-use asset of $2.3&#160;million and a lease liability of $2.3&#160;million. The expected lease commitments resulting from this contract are $0.1&#160;million in 2023 and $0.3&#160;million per year from 2024 onward.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, lease terms for office buildings are between &lt;span style="-sec-ix-hidden:f-1144"&gt;one&lt;/span&gt; and&#160;ten years. Any leases with terms less than 12 months and/or with low value are expensed in accordance with the IFRS 16 practical expedients for short-term leases and&#160;low-value&#160;leases. These expenses amounted to $0.1&#160;million,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; less than $0.1&#160;million, and $0.1&#160;million for the years ended December 31, 2025, 2024, and 2023, respectively. The Company had cash outflows related to leases less than 12 months and/or with low value of $0.1&#160;million, less than $0.1&#160;million, and $0.1&#160;million for the years ended December 31, 2025, 2024, and 2023, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has lease liabilities amounting to $12.7&#160;million and $12.1&#160;million for the years ended December 31, 2025 and 2024, respectively, that are linked to consumer price indices in Switzerland, France, and the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The future cash flow in relation to short-term leases and leases of low value assets is disclosed in Note 25 &#x2014; &#x201c;Commitments and contingencies.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The future cash flow in relation to leases accounted for under IFRS 16 is disclosed in Note 26 &#x2014; &#x201c;Financial instruments and risks.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has several leases with extension and termination options. Management determines, on the basis of the business needs, whether they expect to exercise these options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that is not readily determinable, the IBR at the lease commencement date. The IBR is the rate of interest that the Company would have had to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. On the basis of this policy, the IBRs used by the Company to discount lease payments outstanding at December 31, 2025 and 2024, respectively, in the countries in which it has recognized&#160;right-of-use&#160;assets and lease liabilities have been in the range of&#160;to&#160;2.76% and 11.42% and&#160;2.76% to&#160;11.42%, respectively. The Company notes the variation in IBRs used is due to the timing of lease commencement as well as geographical differences based on the physical location of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presen&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ts the ROU assets (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.004%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Office space leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,382&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,168&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December 31, 2025 and 2024, the Company had additions to ROUs of $0.4 million and $2.2 million, respectively and depreciation charges of $2.2 million and $2.6 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the lease liabilities (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.909%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.719%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.719%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.891%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December 31, 2025 and 2024, the Company made payments of $2.5 million and $3.3 million, respectively, of which $0.7 million and $0.6 million was interest, respectively.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="c-1" id="f-1117">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses at inception of the contract whether a contract is or contains a lease. This assessment involves determining whether the Company obtains substantially all the economic benefits from the use of that asset, and whether the Company has the right to direct the use of the asset. When these conditions are met, the Company recognizes a&#160;right-of-use&#160;(&#x201c;ROU&#x201d;) asset and a lease liability at the lease commencement date, except for short-term leases of 12 months or less, which are expensed in the statements of loss on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, the ROU asset comprises the initial lease liability, initial direct costs, and any obligations to refurbish the asset, less any incentives granted by the lessors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ROU asset is depreciated over the shorter of the duration of the lease contract (including contractually agreed optional extension periods whose exercise is deemed to be reasonably certain) and the useful life of the underlying asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The ROU asset is subject to testing for impairment if there is an indicator for impairment, as for owned assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the interest rate implicit in the lease or, if that is not readily determinable, the incremental borrowing rate (&#x201c;IBR&#x201d;) at the lease commencement date. The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the ROU asset in a similar economic environment. Lease payments can include fixed payments; variable payments that depend on an index or rate known at the commencement date; and extension option payments or purchase options that the Company is reasonably certain to exercise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease liability is subsequently measured at amortized cost using the effective interest rate method and remeasured (with a corresponding adjustment to the related ROU asset) when there is a change in future lease payments due to renegotiation, changes in an index or rate, or a reassessment of options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company&#x2019;s leases include options to extend the lease, and these options are included in the lease term to the extent they are reasonably certain to be exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessor&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases out laboratory equipment to certain customers. These leases are classified as finance leases as the Company transfers substantially all the risks and rewards incidental to ownership of the asset to the customer. Refer to Note 4 &#x2014; &#x201c;Revenue&#x201d; fo&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r disclosure of revenue recognized from leased laboratory equipment.&lt;/span&gt;&lt;/div&gt;At the commencement of the lease term, the Company records revenue and the associated costs of sales, being the sale proceeds at fair value of the asset (computed at cost plus a margin) and the cost of the asset, derecognizes the leased asset from inventory, and recognizes a finance lease receivable on the balance sheet equal to the net investment in the lease. The Company notes these lease agreements ended during 2023, and as of December 31, 2025 and 2024, the Company did not have any leases of laboratory equipment.</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <soph:NumberOfLeases
      contextRef="c-271"
      decimals="INF"
      id="f-1118"
      unitRef="lease">1</soph:NumberOfLeases>
    <soph:LeaseTerm contextRef="c-272" id="f-1119">P120M</soph:LeaseTerm>
    <soph:AreaOfOfficeSpaceLeased
      contextRef="c-272"
      decimals="INF"
      id="f-1120"
      unitRef="sqft">65860</soph:AreaOfOfficeSpaceLeased>
    <soph:AreaOfOfficeSpaceGainedAccessUnderLease
      contextRef="c-273"
      decimals="INF"
      id="f-1121"
      unitRef="sqft">21258</soph:AreaOfOfficeSpaceGainedAccessUnderLease>
    <soph:AreaOfOfficeSpaceGainedAccessUnderLease
      contextRef="c-273"
      decimals="INF"
      id="f-1122"
      unitRef="sqft">21258</soph:AreaOfOfficeSpaceGainedAccessUnderLease>
    <soph:AreaOfOfficeSpaceGainedAccessUnderLease
      contextRef="c-274"
      decimals="INF"
      id="f-1123"
      unitRef="sqft">38761</soph:AreaOfOfficeSpaceGainedAccessUnderLease>
    <soph:AreaOfOfficeSpaceGainedAccessUnderLease
      contextRef="c-275"
      decimals="INF"
      id="f-1124"
      unitRef="sqft">5840</soph:AreaOfOfficeSpaceGainedAccessUnderLease>
    <soph:AreaOfOfficeSpaceGainedAccessUnderLease
      contextRef="c-276"
      decimals="INF"
      id="f-1125"
      unitRef="sqft">21258</soph:AreaOfOfficeSpaceGainedAccessUnderLease>
    <soph:AreaOfOfficeSpaceGainedAccessUnderLease
      contextRef="c-273"
      decimals="INF"
      id="f-1126"
      unitRef="sqft">21258</soph:AreaOfOfficeSpaceGainedAccessUnderLease>
    <soph:AreaOfOfficeSpaceGainedAccessUnderLease
      contextRef="c-273"
      decimals="INF"
      id="f-1127"
      unitRef="sqft">21258</soph:AreaOfOfficeSpaceGainedAccessUnderLease>
    <ifrs-full:RightofuseAssets contextRef="c-277" decimals="-5" id="f-1128" unitRef="usd">4500000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities contextRef="c-277" decimals="-5" id="f-1129" unitRef="usd">4500000</ifrs-full:LeaseLiabilities>
    <ifrs-full:RightofuseAssets contextRef="c-278" decimals="-5" id="f-1130" unitRef="usd">7700000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities contextRef="c-278" decimals="-5" id="f-1131" unitRef="usd">8500000</ifrs-full:LeaseLiabilities>
    <soph:LeaseIncentivesAndExpectedRestorationCosts contextRef="c-279" decimals="-5" id="f-1132" unitRef="usd">800000</soph:LeaseIncentivesAndExpectedRestorationCosts>
    <soph:LeaseTerm contextRef="c-280" id="f-1133">P73M</soph:LeaseTerm>
    <soph:AreaOfOfficeSpaceLeased
      contextRef="c-280"
      decimals="INF"
      id="f-1134"
      unitRef="sqft">12807</soph:AreaOfOfficeSpaceLeased>
    <ifrs-full:RightofuseAssets contextRef="c-281" decimals="-5" id="f-1135" unitRef="usd">2000000.0</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities contextRef="c-281" decimals="-5" id="f-1136" unitRef="usd">1900000</ifrs-full:LeaseLiabilities>
    <soph:LeaseDirectCosts contextRef="c-282" decimals="-5" id="f-1137" unitRef="usd">100000</soph:LeaseDirectCosts>
    <soph:LeaseTerm contextRef="c-283" id="f-1138">P108M</soph:LeaseTerm>
    <soph:AreaOfOfficeSpaceLeased
      contextRef="c-283"
      decimals="INF"
      id="f-1139"
      unitRef="sqft">13509</soph:AreaOfOfficeSpaceLeased>
    <ifrs-full:RightofuseAssets contextRef="c-284" decimals="-5" id="f-1140" unitRef="usd">2300000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities contextRef="c-284" decimals="-5" id="f-1141" unitRef="usd">2300000</ifrs-full:LeaseLiabilities>
    <soph:ExpectedLeaseCommitments contextRef="c-285" decimals="-5" id="f-1142" unitRef="usd">100000</soph:ExpectedLeaseCommitments>
    <soph:ExpectedLeaseCommitments contextRef="c-286" decimals="-5" id="f-1143" unitRef="usd">300000</soph:ExpectedLeaseCommitments>
    <soph:LeaseTerm contextRef="c-288" id="f-1145">P10Y</soph:LeaseTerm>
    <soph:LeaseExpenses contextRef="c-1" decimals="-5" id="f-1146" unitRef="usd">100000</soph:LeaseExpenses>
    <soph:LeaseExpenses contextRef="c-4" decimals="-5" id="f-1147" unitRef="usd">100000</soph:LeaseExpenses>
    <soph:LeaseExpenses contextRef="c-5" decimals="-5" id="f-1148" unitRef="usd">100000</soph:LeaseExpenses>
    <ifrs-full:CashOutflowForLeases contextRef="c-1" decimals="-5" id="f-1149" unitRef="usd">100000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases contextRef="c-4" decimals="-5" id="f-1150" unitRef="usd">100000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases contextRef="c-5" decimals="-5" id="f-1151" unitRef="usd">100000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:LeaseLiabilities contextRef="c-289" decimals="-5" id="f-1152" unitRef="usd">12700000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c-290" decimals="-5" id="f-1153" unitRef="usd">12100000</ifrs-full:LeaseLiabilities>
    <soph:RightOfUseAssetsDiscountedPaymentsRate contextRef="c-3" decimals="4" id="f-1154" unitRef="number">0.0276</soph:RightOfUseAssetsDiscountedPaymentsRate>
    <soph:LeaseLiabilitiesDiscountedPaymentsRate contextRef="c-3" decimals="4" id="f-1155" unitRef="number">0.1142</soph:LeaseLiabilitiesDiscountedPaymentsRate>
    <soph:RightOfUseAssetsDiscountedPaymentsRate contextRef="c-6" decimals="4" id="f-1156" unitRef="number">0.0276</soph:RightOfUseAssetsDiscountedPaymentsRate>
    <soph:LeaseLiabilitiesDiscountedPaymentsRate contextRef="c-6" decimals="4" id="f-1157" unitRef="number">0.1142</soph:LeaseLiabilitiesDiscountedPaymentsRate>
    <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory contextRef="c-1" id="f-1158">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presen&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ts the ROU assets (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.004%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Office space leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,382&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14,168&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory>
    <ifrs-full:RightofuseAssets contextRef="c-291" decimals="-3" id="f-1159" unitRef="usd">12382000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="c-292" decimals="-3" id="f-1160" unitRef="usd">14168000</ifrs-full:RightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c-1" decimals="-3" id="f-1161" unitRef="usd">400000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:AdditionsToRightofuseAssets contextRef="c-4" decimals="-3" id="f-1162" unitRef="usd">2200000</ifrs-full:AdditionsToRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c-1" decimals="-3" id="f-1163" unitRef="usd">2200000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:DepreciationRightofuseAssets contextRef="c-4" decimals="-3" id="f-1164" unitRef="usd">2600000</ifrs-full:DepreciationRightofuseAssets>
    <soph:DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock contextRef="c-1" id="f-1165">&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the lease liabilities (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:65.909%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.719%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.888%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.719%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.891%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutLeaseLiabilitiesTableTextBlock>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c-3" decimals="-3" id="f-1166" unitRef="usd">2700000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="c-6" decimals="-3" id="f-1167" unitRef="usd">2190000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c-3" decimals="-3" id="f-1168" unitRef="usd">12587000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="c-6" decimals="-3" id="f-1169" unitRef="usd">14603000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c-3" decimals="-3" id="f-1170" unitRef="usd">15287000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="c-6" decimals="-3" id="f-1171" unitRef="usd">16793000</ifrs-full:LeaseLiabilities>
    <soph:PrincipalPaidOnLeaseLiabilities contextRef="c-1" decimals="-3" id="f-1172" unitRef="usd">2500000</soph:PrincipalPaidOnLeaseLiabilities>
    <soph:PrincipalPaidOnLeaseLiabilities contextRef="c-4" decimals="-3" id="f-1173" unitRef="usd">3300000</soph:PrincipalPaidOnLeaseLiabilities>
    <soph:InterestPaidOnLeaseLiabilities contextRef="c-1" decimals="-3" id="f-1174" unitRef="usd">700000</soph:InterestPaidOnLeaseLiabilities>
    <soph:InterestPaidOnLeaseLiabilities contextRef="c-4" decimals="-3" id="f-1175" unitRef="usd">600000</soph:InterestPaidOnLeaseLiabilities>
    <ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory contextRef="c-1" id="f-1176">Other non-current assets&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other non-current assets consist of the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research tax credit receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Guarantee deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non&#x2011;current contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory>
    <soph:DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock contextRef="c-1" id="f-1177">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other non-current assets consist of the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research tax credit receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Guarantee deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non&#x2011;current contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutNonCurrentAssetsAndOtherExplanatoryTableTextBlock>
    <ifrs-full:NoncurrentValueAddedTaxReceivables contextRef="c-3" decimals="-3" id="f-1178" unitRef="usd">4013000</ifrs-full:NoncurrentValueAddedTaxReceivables>
    <ifrs-full:NoncurrentValueAddedTaxReceivables contextRef="c-6" decimals="-3" id="f-1179" unitRef="usd">4244000</ifrs-full:NoncurrentValueAddedTaxReceivables>
    <soph:NonCurrentDepositsGuarantyAssets contextRef="c-3" decimals="-3" id="f-1180" unitRef="usd">1995000</soph:NonCurrentDepositsGuarantyAssets>
    <soph:NonCurrentDepositsGuarantyAssets contextRef="c-6" decimals="-3" id="f-1181" unitRef="usd">1518000</soph:NonCurrentDepositsGuarantyAssets>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="c-3" decimals="-3" id="f-1182" unitRef="usd">1977000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod contextRef="c-6" decimals="-3" id="f-1183" unitRef="usd">0</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <soph:NonCurrentContractAcquisitionCosts contextRef="c-3" decimals="-3" id="f-1184" unitRef="usd">198000</soph:NonCurrentContractAcquisitionCosts>
    <soph:NonCurrentContractAcquisitionCosts contextRef="c-6" decimals="-3" id="f-1185" unitRef="usd">0</soph:NonCurrentContractAcquisitionCosts>
    <ifrs-full:OtherNoncurrentAssets contextRef="c-3" decimals="-3" id="f-1186" unitRef="usd">8183000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets contextRef="c-6" decimals="-3" id="f-1187" unitRef="usd">5762000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory contextRef="c-1" id="f-1188">Accounts payable&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable consist of the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT, sales, and other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,960&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,220&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory>
    <soph:DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock contextRef="c-1" id="f-1189">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable consist of the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;VAT, sales, and other taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,960&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,220&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutAccountsPayablesTableTextBlock>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers contextRef="c-3" decimals="-3" id="f-1190" unitRef="usd">5315000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers contextRef="c-6" decimals="-3" id="f-1191" unitRef="usd">1932000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <soph:EmployeeRelatedPayables contextRef="c-3" decimals="-3" id="f-1192" unitRef="usd">2840000</soph:EmployeeRelatedPayables>
    <soph:EmployeeRelatedPayables contextRef="c-6" decimals="-3" id="f-1193" unitRef="usd">2630000</soph:EmployeeRelatedPayables>
    <soph:ValueAddedTaxesSalesTaxesAndOtherTaxesPayables contextRef="c-3" decimals="-3" id="f-1194" unitRef="usd">805000</soph:ValueAddedTaxesSalesTaxesAndOtherTaxesPayables>
    <soph:ValueAddedTaxesSalesTaxesAndOtherTaxesPayables contextRef="c-6" decimals="-3" id="f-1195" unitRef="usd">658000</soph:ValueAddedTaxesSalesTaxesAndOtherTaxesPayables>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c-3" decimals="-3" id="f-1196" unitRef="usd">8960000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers contextRef="c-6" decimals="-3" id="f-1197" unitRef="usd">5220000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory contextRef="c-1" id="f-1198">Accrued expenses&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consist of the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued inventory purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued IT support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,736&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,217&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory>
    <soph:DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock contextRef="c-1" id="f-1199">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consist of the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued inventory purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued IT support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,736&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,217&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutAccruedExpensesTableTextBlock>
    <soph:AccruedCompensation contextRef="c-3" decimals="-3" id="f-1200" unitRef="usd">15853000</soph:AccruedCompensation>
    <soph:AccruedCompensation contextRef="c-6" decimals="-3" id="f-1201" unitRef="usd">10781000</soph:AccruedCompensation>
    <soph:AccruedProfessionalFees contextRef="c-3" decimals="-3" id="f-1202" unitRef="usd">1778000</soph:AccruedProfessionalFees>
    <soph:AccruedProfessionalFees contextRef="c-6" decimals="-3" id="f-1203" unitRef="usd">1422000</soph:AccruedProfessionalFees>
    <soph:AccruedInventoryPurchases contextRef="c-3" decimals="-3" id="f-1204" unitRef="usd">420000</soph:AccruedInventoryPurchases>
    <soph:AccruedInventoryPurchases contextRef="c-6" decimals="-3" id="f-1205" unitRef="usd">121000</soph:AccruedInventoryPurchases>
    <soph:AccruedITSupport contextRef="c-3" decimals="-3" id="f-1206" unitRef="usd">701000</soph:AccruedITSupport>
    <soph:AccruedITSupport contextRef="c-6" decimals="-3" id="f-1207" unitRef="usd">570000</soph:AccruedITSupport>
    <soph:AccruedLegalFees contextRef="c-3" decimals="-3" id="f-1208" unitRef="usd">824000</soph:AccruedLegalFees>
    <soph:AccruedLegalFees contextRef="c-6" decimals="-3" id="f-1209" unitRef="usd">0</soph:AccruedLegalFees>
    <soph:AccruedOther contextRef="c-3" decimals="-3" id="f-1210" unitRef="usd">1160000</soph:AccruedOther>
    <soph:AccruedOther contextRef="c-6" decimals="-3" id="f-1211" unitRef="usd">323000</soph:AccruedOther>
    <soph:CurrentAccruedExpenses contextRef="c-3" decimals="-3" id="f-1212" unitRef="usd">20736000</soph:CurrentAccruedExpenses>
    <soph:CurrentAccruedExpenses contextRef="c-6" decimals="-3" id="f-1213" unitRef="usd">13217000</soph:CurrentAccruedExpenses>
    <ifrs-full:DisclosureOfEmployeeBenefitsExplanatory contextRef="c-1" id="f-1214">Post-employment benefits&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Critical accounting estimates and judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The liability or asset recognize&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d on the balance&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation at the end of the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by independent actuaries using the projected unit credit method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms approximating to the terms of the related obligation. In countries where there is no deep market in such bonds, the market rates on government bonds are used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the statement of loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remeasurement gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which they occur, directly in other comprehens&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ive income. The remeasurement gains and losses are included in retained earnings in the statement of changes in equity and on the balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in income as past service costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For defined contribution plans, the Company pays contributions to publicly or privately administered pension insurance plans. Employee contributions to these plans is voluntary and these contributions are matched by the employer. The Company has no further payment obligations once the contributions have been paid. The contributions are recognized as employee benefit expense when they are due. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in the future payments is available. Contributions are charged to the statement of loss as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates defined benefit and defined contribution pension plans. Funded schemes are generally funded through payments to insurance companies or trustee-administered funds, determined by periodic actuarial calculations. A defined &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity (a fund) and has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods. A defined benefit plan is a pension plan that is not a defined contribution plan. Typically, defined benefit plans define an amount of pension benefit that an employee will receive on retirement, usually dependent on one or more factors such as age, years of service and compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The actual return on plan assets, excluding interest income measured at the discount rate, is recognized in other comprehensive income/loss within defined benefit plan remeasurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a funded defined benefit plan in Switzerland, an unfunded defined benefit plan in France, and a defined&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; contribution plan in the U.S. The Company has no occupational pension plans in the U.K. and Brazil.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Swiss pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company contracted with the Swiss Life Collective BVG Foundation based in Zurich for the provision of occupational benefits. All benefits in accordance with the regulations are reinsured in their entirety with Swiss Life SA within the framework of the corresponding contract. This pension solution fully reinsures the risks of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;disability, death and longevity with Swiss Life. Swiss Life invests the vested pension capital and provides a&#160;100% capital and interest guarantee. The pension plan is entitled to an annual bonus from Swiss Life comprising the effective savings, risk and cost results. As of January 1, 2025, the Company switched from Swiss Life Collective BVG Foundation to Profond for the provision of occupational benefits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the amount of ultimate pension benefit is not defined, certain legal obligations of the plan create constructive obligations on the employer to pay further contributions to fund an eventual deficit; this results in the plan nevertheless being accounted for as a defined benefit plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;French pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In France, the bulk of pensions are paid by national pension schemes, which are unfunded. In addition, French employers are obliged by law to pay a retirement indemnity. Its amount depends on the last salary of the employee and on the period of activity with its employer. Rights to this benefit are acquired during the service life with the same employer on the condition that the employee will be with its employer at retirement date; it means that the rights are only vested on retirement date. This indemnit&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;y is in substance a defined benefit plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional details on the defined benefit plans&#x2019; funded status (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of defined benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net pension liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the movement in the defined benefit obligation (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.948%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.948%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.948%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.948%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.948%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.952%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(22,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which past service cost including effects from curtailment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers (in) out due to (joiners) leavers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(28,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(28,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The service cost and interest expense are charged to the statement of loss as research and development, general and administrative costs, selling and marketing, and interest income, net, respectively. Actuarial gains (losses) are credited or charged to other comprehensive income (loss) as defined benefit plan remeasurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s of December 31, 2025, the Swiss and French plans had&#160;210&#160;and 89&#160;active members, respectively. As of December 31, 2024, the Swiss and French plans had&#160;209&#160;and&#160;84&#160;active members, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the reduction in conversion factors, the Company incurred a past service cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; gain including curtailment of $0.9&#160;million &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the year ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the movement in the defined benefit plans&#x2019; assets (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,927&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return on plan assets, excl. interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers in (out) due to joiners (leavers)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the defined benefit plan assets, which include the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.004%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,895&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;French plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Swiss plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Profond, and previously the Swiss Life Collective BVG Foundation, to which the Swiss pension plan is affiliated, manages its funds in the interests of all members, with due attention to the priorities of liquidity, security, and return. The Company&#x2019;s pension plan benefits from the economies of scale and diversification of risk available through this affiliation. The Company has no influence over the investment policy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the pension costs recognized in sta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;tement of loss (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,851)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,648)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the pension remeasurement recognized in statement of other comprehensive loss (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.328%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in demographic assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in financial assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Experience adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;185&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;180&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;401&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;403&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;709&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;704&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Demographic assumptions had no impact for 2025&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; as these assumptions had no significant changes from 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The positive impact of changes in demographic assumptions in 2023 was due principally to an increase in the weighted turnover f&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rom&#160;15.80% to&#160;19.50%. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The positive impact of changes in financial assumptions for the funded plan in 2025 was due to an increase in the discount rate from 0.95% to 1.10%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The negative impact of chan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ges in financial assumptions in 2024 was due to a decrease in the discount rate from 1.50% to 0.95%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The negative experience adjustments for the funded plan in 2025 was primarily due to actual effective salary increases exceeding the assumed rate as well as by departure-related payments that were lower than expected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The positive experience adjustments in 2024 was due largely to the surplus between the additional defined benefit obligation attributable to new joiners and the assets that they transferred into the plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Key actuarial assumptions by plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Discount rate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In estimating the defined benefit obligation, the discount rates used were, for the Swiss plan, 1.10% and&#160;0.95% and, for the French plan,&#160;4.05% and&#160;3.55% for the years ended December 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Expected rate of salary increase&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;T&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he expected rate of annual salary increase was assumed to be, for the Swiss plan,&#160;2.50% and&#160;2.50% and, for the French plan,&#160;3.00% and&#160;3.00% for the years ended December 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Pension plan modified duration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average modified duration of the Swi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ss plan is 13.7 and&#160;13.6 years and of the French plan 15.1 and&#160;15.3 years for the years ended December 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Interest rates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the Swiss plan, the interest on old age accounts is 2.30% for the year ended December 31, 2025. For the year ended December 31, 2024 the interest on old age accounts is based, for the LPP account, on the LPP interest rate, which was&#160;2.30% and, for the extra mandatory part, is equivalent to the discount rate, which was&#160;2.30%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Inflation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected annual rate of inflation was assumed to be, for the Swiss plan, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.75% &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.00%&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for the French plan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.00% &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.00%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the years ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2025 and 2024, respectively. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The exp&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ected annual rate of inflation for the Swiss plan is based on the inflation forecast of the Swiss National Bank. and for the French plan is based on the inflation forecast of the European Central Bank.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Mortality tables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assumptions regarding future mortality experience are set based on actuarial advice provided in accordance with published statistics and experience and are based on the mortality generational tables BGV 2020 (Swiss) and TH/TF&#160;00-02&#160;(French). For the Swiss plan, the average life expectancy in years after retirement of a pensioner retiring at age 65 (male) and 65 (female) on the balance sheet date is, respe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ctively, 23.07 and 24.81 and 22.82 and 24.59, for the years ended December 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sensitivity analysis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables demonstrate the sensitivity of the defined benefit obligations to changes in the discount rate, expected rates of salary increase, interest credited on savings accounts (interest rate), inflation, and life expectancy at retirement age.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the sensitivity analysis for the funded plans (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(682)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected rates of salary increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inflation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Life expectancy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of 1 year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 1 year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the sensitivity analysis for the unfunded plans (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of&#160;50&#160;basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 50 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected rates of salary increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of&#160;50&#160;basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 50 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The above sensitivity analyses are based on a change in an assumption while holding all other assumptions constant. In practice, this is unlikely to occur, and changes in some of the assumptions may be correlated. When calculating the sensitivity of the defined benefit obligation to significant actuarial assumptions the same method (present value of the defined benefit obligation calculated with the projected unit credit method at the end of the reporting period) has been applied as when calculating the pension liability recognized on the balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The methods and types of assumptions used in preparing the sensitivity analysis did not change compared to the prior period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Future employer contributions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected employer contributions to the Swiss defined benefit pension plan for the year ending December 31, 2026 amount to $1.3&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Defined contribution plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;U.S. pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a multiple employer 401(k) defined contribution plan in the U.S. The expense recognized in respect of the defined contribution plan in the U.S. was $0.3&#160;million for the years ended December 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfEmployeeBenefitsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory contextRef="c-1" id="f-1215">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Critical accounting estimates and judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The liability or asset recognize&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d on the balance&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; sheet in respect of defined benefit pension plans is the present value of the defined benefit obligation at the end of the reporting period less the fair value of plan assets. The defined benefit obligation is calculated annually by independent actuaries using the projected unit credit method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The present value of the defined benefit obligation is determined by discounting the estimated future cash outflows using interest rates of high-quality corporate bonds that are denominated in the currency in which the benefits will be paid, and that have terms approximating to the terms of the related obligation. In countries where there is no deep market in such bonds, the market rates on government bonds are used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The net interest cost is calculated by applying the discount rate to the net balance of the defined benefit obligation and the fair value of plan assets. This cost is included in employee benefit expense in the statement of loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Remeasurement gains and losses arising from experience adjustments and changes in actuarial assumptions are recognized in the period in which they occur, directly in other comprehens&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ive income. The remeasurement gains and losses are included in retained earnings in the statement of changes in equity and on the balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the present value of the defined benefit obligation resulting from plan amendments or curtailments are recognized immediately in income as past service costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For defined contribution plans, the Company pays contributions to publicly or privately administered pension insurance plans. Employee contributions to these plans is voluntary and these contributions are matched by the employer. The Company has no further payment obligations once the contributions have been paid. The contributions are recognized as employee benefit expense when they are due. Prepaid contributions are recognized as an asset to the extent that a cash refund or a reduction in the future payments is available. Contributions are charged to the statement of loss as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates defined benefit and defined contribution pension plans. Funded schemes are generally funded through payments to insurance companies or trustee-administered funds, determined by periodic actuarial calculations. A defined &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity (a fund) and has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods. A defined benefit plan is a pension plan that is not a defined contribution plan. Typically, defined benefit plans define an amount of pension benefit that an employee will receive on retirement, usually dependent on one or more factors such as age, years of service and compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The actual return on plan assets, excluding interest income measured at the discount rate, is recognized in other comprehensive income/loss within defined benefit plan remeasurements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a funded defined benefit plan in Switzerland, an unfunded defined benefit plan in France, and a defined&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; contribution plan in the U.S. The Company has no occupational pension plans in the U.K. and Brazil.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Swiss pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company contracted with the Swiss Life Collective BVG Foundation based in Zurich for the provision of occupational benefits. All benefits in accordance with the regulations are reinsured in their entirety with Swiss Life SA within the framework of the corresponding contract. This pension solution fully reinsures the risks of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;disability, death and longevity with Swiss Life. Swiss Life invests the vested pension capital and provides a&#160;100% capital and interest guarantee. The pension plan is entitled to an annual bonus from Swiss Life comprising the effective savings, risk and cost results. As of January 1, 2025, the Company switched from Swiss Life Collective BVG Foundation to Profond for the provision of occupational benefits. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the amount of ultimate pension benefit is not defined, certain legal obligations of the plan create constructive obligations on the employer to pay further contributions to fund an eventual deficit; this results in the plan nevertheless being accounted for as a defined benefit plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;French pension plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In France, the bulk of pensions are paid by national pension schemes, which are unfunded. In addition, French employers are obliged by law to pay a retirement indemnity. Its amount depends on the last salary of the employee and on the period of activity with its employer. Rights to this benefit are acquired during the service life with the same employer on the condition that the employee will be with its employer at retirement date; it means that the rights are only vested on retirement date. This indemnit&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;y is in substance a defined benefit plan.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory>
    <ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory contextRef="c-1" id="f-1216">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides additional details on the defined benefit plans&#x2019; funded status (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of defined benefit obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net pension liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfAdditionalInformationAboutDefinedBenefitPlansExplanatory>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-3" decimals="-3" id="f-1217" unitRef="usd">28429000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-6" decimals="-3" id="f-1218" unitRef="usd">23199000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c-3" decimals="-3" id="f-1219" unitRef="usd">24267000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c-6" decimals="-3" id="f-1220" unitRef="usd">19360000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:SurplusDeficitInPlan contextRef="c-3" decimals="-3" id="f-1221" unitRef="usd">-4162000</ifrs-full:SurplusDeficitInPlan>
    <ifrs-full:SurplusDeficitInPlan contextRef="c-6" decimals="-3" id="f-1222" unitRef="usd">-3839000</ifrs-full:SurplusDeficitInPlan>
    <soph:DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock contextRef="c-1" id="f-1223">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the movement in the defined benefit obligation (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.948%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.948%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.948%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.948%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.948%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.952%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(22,972)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which current service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,683)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;of which past service cost including effects from curtailment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;(942)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(229)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actual plan participants&#x2019; contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,295)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers (in) out due to (joiners) leavers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(28,345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(28,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,147)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(23,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the sensitivity analysis for the unfunded plans (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of&#160;50&#160;basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 50 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected rates of salary increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of&#160;50&#160;basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 50 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutMovementInDefinedBenefitObligationTableTextBlock>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-293" decimals="-3" id="f-1224" unitRef="usd">23147000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-294" decimals="-3" id="f-1225" unitRef="usd">52000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-6" decimals="-3" id="f-1226" unitRef="usd">23199000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-295" decimals="-3" id="f-1227" unitRef="usd">22972000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-296" decimals="-3" id="f-1228" unitRef="usd">41000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-23" decimals="-3" id="f-1229" unitRef="usd">23013000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1230" unitRef="usd">1827000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1231" unitRef="usd">14000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1232" unitRef="usd">1841000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1233" unitRef="usd">2625000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1234" unitRef="usd">12000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1235" unitRef="usd">2637000</soph:ServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1236" unitRef="usd">1827000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1237" unitRef="usd">14000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1238" unitRef="usd">1841000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1239" unitRef="usd">1683000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1240" unitRef="usd">12000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:CurrentServiceCostDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1241" unitRef="usd">1695000</ifrs-full:CurrentServiceCostDefinedBenefitPlans>
    <ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1242" unitRef="usd">0</ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans>
    <ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1243" unitRef="usd">0</ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans>
    <ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1244" unitRef="usd">0</ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans>
    <ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1245" unitRef="usd">-942000</ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans>
    <ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1246" unitRef="usd">0</ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans>
    <ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1247" unitRef="usd">-942000</ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1248" unitRef="usd">227000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1249" unitRef="usd">2000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1250" unitRef="usd">229000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1251" unitRef="usd">293000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1252" unitRef="usd">1000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <ifrs-full:InterestExpenseDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1253" unitRef="usd">294000</ifrs-full:InterestExpenseDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1254" unitRef="usd">185000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1255" unitRef="usd">-5000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1256" unitRef="usd">180000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1257" unitRef="usd">-1342000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1258" unitRef="usd">0</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1259" unitRef="usd">-1342000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset contextRef="c-297" decimals="-3" id="f-1260" unitRef="usd">1461000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset contextRef="c-298" decimals="-3" id="f-1261" unitRef="usd">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset contextRef="c-1" decimals="-3" id="f-1262" unitRef="usd">1461000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset contextRef="c-299" decimals="-3" id="f-1263" unitRef="usd">1295000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset contextRef="c-300" decimals="-3" id="f-1264" unitRef="usd">0</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset contextRef="c-4" decimals="-3" id="f-1265" unitRef="usd">1295000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1266" unitRef="usd">1587000</soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans>
    <soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1267" unitRef="usd">0</soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans>
    <soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1268" unitRef="usd">1587000</soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans>
    <soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1269" unitRef="usd">3644000</soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans>
    <soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1270" unitRef="usd">0</soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans>
    <soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1271" unitRef="usd">3644000</soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1272" unitRef="usd">-3455000</soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1273" unitRef="usd">-11000</soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1274" unitRef="usd">-3466000</soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1275" unitRef="usd">1736000</soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1276" unitRef="usd">2000</soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1277" unitRef="usd">1738000</soph:IncreaseDecreaseThroughNetExchangeDifferencesDefinedBenefitPlans>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-301" decimals="-3" id="f-1278" unitRef="usd">28345000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-302" decimals="-3" id="f-1279" unitRef="usd">84000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-3" decimals="-3" id="f-1280" unitRef="usd">28429000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-293" decimals="-3" id="f-1281" unitRef="usd">23147000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-294" decimals="-3" id="f-1282" unitRef="usd">52000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="c-6" decimals="-3" id="f-1283" unitRef="usd">23199000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <soph:NumberOfActiveMembers
      contextRef="c-303"
      decimals="INF"
      id="f-1284"
      unitRef="member">210</soph:NumberOfActiveMembers>
    <soph:NumberOfActiveMembers
      contextRef="c-304"
      decimals="INF"
      id="f-1285"
      unitRef="member">89</soph:NumberOfActiveMembers>
    <soph:NumberOfActiveMembers
      contextRef="c-305"
      decimals="INF"
      id="f-1286"
      unitRef="member">209</soph:NumberOfActiveMembers>
    <soph:NumberOfActiveMembers
      contextRef="c-306"
      decimals="INF"
      id="f-1287"
      unitRef="member">84</soph:NumberOfActiveMembers>
    <ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans contextRef="c-299" decimals="-5" id="f-1288" unitRef="usd">-900000</ifrs-full:PastServiceCostAndLossesGainsArisingFromSettlementsDefinedBenefitPlans>
    <soph:DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock contextRef="c-1" id="f-1289">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the movement in the defined benefit plans&#x2019; assets (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,927&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return on plan assets, excl. interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transfers in (out) due to joiners (leavers)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,587)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutMovementInDefinedBenefitPlanAssetsTableTextBlock>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="c-6" decimals="-3" id="f-1290" unitRef="usd">-19360000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="c-23" decimals="-3" id="f-1291" unitRef="usd">-19927000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset contextRef="c-1" decimals="-3" id="f-1292" unitRef="usd">203000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset contextRef="c-4" decimals="-3" id="f-1293" unitRef="usd">270000</ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset contextRef="c-1" decimals="-3" id="f-1294" unitRef="usd">-524000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset contextRef="c-4" decimals="-3" id="f-1295" unitRef="usd">-1668000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <soph:AdministrativeExpensesNetDefinedBenefitLiabilityAsset contextRef="c-1" decimals="-3" id="f-1296" unitRef="usd">65000</soph:AdministrativeExpensesNetDefinedBenefitLiabilityAsset>
    <soph:AdministrativeExpensesNetDefinedBenefitLiabilityAsset contextRef="c-4" decimals="-3" id="f-1297" unitRef="usd">61000</soph:AdministrativeExpensesNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset contextRef="c-1" decimals="-3" id="f-1298" unitRef="usd">1562000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset contextRef="c-4" decimals="-3" id="f-1299" unitRef="usd">1390000</ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset contextRef="c-1" decimals="-3" id="f-1300" unitRef="usd">1461000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset contextRef="c-4" decimals="-3" id="f-1301" unitRef="usd">1295000</ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset>
    <soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1302" unitRef="usd">1587000</soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans>
    <soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1303" unitRef="usd">3644000</soph:TransfersOutInDueToJoinersLeaversDefinedBenefitPlans>
    <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset contextRef="c-1" decimals="-3" id="f-1304" unitRef="usd">2809000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
    <ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset contextRef="c-4" decimals="-3" id="f-1305" unitRef="usd">-1485000</ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="c-3" decimals="-3" id="f-1306" unitRef="usd">-24267000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans contextRef="c-6" decimals="-3" id="f-1307" unitRef="usd">-19360000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory contextRef="c-1" id="f-1308">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the defined benefit plan assets, which include the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.402%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.004%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,895&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;French plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Swiss plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;19,360&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory>
    <ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets contextRef="c-3" decimals="-3" id="f-1309" unitRef="usd">0</ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets>
    <ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets contextRef="c-6" decimals="-3" id="f-1310" unitRef="usd">465000</ifrs-full:CashAndCashEquivalentsAmountContributedToFairValueOfPlanAssets>
    <ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets contextRef="c-3" decimals="-3" id="f-1311" unitRef="usd">24267000</ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets>
    <ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets contextRef="c-6" decimals="-3" id="f-1312" unitRef="usd">18895000</ifrs-full:QualifyingInsurancePoliciesAmountContributedToFairValueOfPlanAssets>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c-3" decimals="-3" id="f-1313" unitRef="usd">24267000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c-6" decimals="-3" id="f-1314" unitRef="usd">19360000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c-307" decimals="-3" id="f-1315" unitRef="usd">0</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c-308" decimals="-3" id="f-1316" unitRef="usd">0</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c-309" decimals="-3" id="f-1317" unitRef="usd">24267000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c-310" decimals="-3" id="f-1318" unitRef="usd">19360000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c-3" decimals="-3" id="f-1319" unitRef="usd">24267000</ifrs-full:PlanAssetsAtFairValue>
    <ifrs-full:PlanAssetsAtFairValue contextRef="c-6" decimals="-3" id="f-1320" unitRef="usd">19360000</ifrs-full:PlanAssetsAtFairValue>
    <soph:DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock contextRef="c-1" id="f-1321">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the pension costs recognized in sta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;tement of loss (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.930%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,827)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,625)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,321)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(413)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,851)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,867)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,648)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,661)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,724)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,735)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutPensionCostsRecognizedInStatementOfIncomeLossTableTextBlock>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1322" unitRef="usd">1827000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1323" unitRef="usd">14000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1324" unitRef="usd">1841000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1325" unitRef="usd">2625000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1326" unitRef="usd">12000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1327" unitRef="usd">2637000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-311" decimals="-3" id="f-1328" unitRef="usd">1311000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-312" decimals="-3" id="f-1329" unitRef="usd">10000</soph:ServiceCostDefinedBenefitPlans>
    <soph:ServiceCostDefinedBenefitPlans contextRef="c-5" decimals="-3" id="f-1330" unitRef="usd">1321000</soph:ServiceCostDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1331" unitRef="usd">24000</ifrs-full:InterestExpenseIncomeDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1332" unitRef="usd">2000</ifrs-full:InterestExpenseIncomeDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1333" unitRef="usd">26000</ifrs-full:InterestExpenseIncomeDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1334" unitRef="usd">23000</ifrs-full:InterestExpenseIncomeDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1335" unitRef="usd">1000</ifrs-full:InterestExpenseIncomeDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1336" unitRef="usd">24000</ifrs-full:InterestExpenseIncomeDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeDefinedBenefitPlans contextRef="c-311" decimals="-3" id="f-1337" unitRef="usd">413000</ifrs-full:InterestExpenseIncomeDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeDefinedBenefitPlans contextRef="c-312" decimals="-3" id="f-1338" unitRef="usd">1000</ifrs-full:InterestExpenseIncomeDefinedBenefitPlans>
    <ifrs-full:InterestExpenseIncomeDefinedBenefitPlans contextRef="c-5" decimals="-3" id="f-1339" unitRef="usd">414000</ifrs-full:InterestExpenseIncomeDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1340" unitRef="usd">1851000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1341" unitRef="usd">16000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1342" unitRef="usd">1867000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1343" unitRef="usd">2648000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1344" unitRef="usd">13000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1345" unitRef="usd">2661000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans contextRef="c-311" decimals="-3" id="f-1346" unitRef="usd">1724000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans contextRef="c-312" decimals="-3" id="f-1347" unitRef="usd">11000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans contextRef="c-5" decimals="-3" id="f-1348" unitRef="usd">1735000</ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans>
    <soph:DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-1349">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the pension remeasurement recognized in statement of other comprehensive loss (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.506%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.328%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Funded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unfunded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in demographic assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in financial assumptions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(901)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Experience adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total actuarial gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;185&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;180&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,342)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;401&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;403&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;709&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;704&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;326&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutPensionRemeasurementRecognizedInStatementOtherComprehensiveIncomeLossTableTextBlock>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1350" unitRef="usd">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1351" unitRef="usd">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1352" unitRef="usd">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1353" unitRef="usd">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1354" unitRef="usd">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1355" unitRef="usd">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-311" decimals="-3" id="f-1356" unitRef="usd">700000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-312" decimals="-3" id="f-1357" unitRef="usd">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-5" decimals="-3" id="f-1358" unitRef="usd">700000</ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1359" unitRef="usd">439000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1360" unitRef="usd">-5000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1361" unitRef="usd">434000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1362" unitRef="usd">-1908000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1363" unitRef="usd">0</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1364" unitRef="usd">-1908000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-311" decimals="-3" id="f-1365" unitRef="usd">-901000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-312" decimals="-3" id="f-1366" unitRef="usd">-2000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans contextRef="c-5" decimals="-3" id="f-1367" unitRef="usd">-903000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1368" unitRef="usd">-254000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1369" unitRef="usd">0</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1370" unitRef="usd">-254000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1371" unitRef="usd">566000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1372" unitRef="usd">0</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1373" unitRef="usd">566000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans contextRef="c-311" decimals="-3" id="f-1374" unitRef="usd">602000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans contextRef="c-312" decimals="-3" id="f-1375" unitRef="usd">4000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans contextRef="c-5" decimals="-3" id="f-1376" unitRef="usd">606000</ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetOfTaxDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1377" unitRef="usd">185000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1378" unitRef="usd">-5000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1379" unitRef="usd">180000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1380" unitRef="usd">-1342000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1381" unitRef="usd">0</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1382" unitRef="usd">-1342000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-311" decimals="-3" id="f-1383" unitRef="usd">401000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-312" decimals="-3" id="f-1384" unitRef="usd">2000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <soph:ActuarialGainsLossesNetDefinedBenefitPlans contextRef="c-5" decimals="-3" id="f-1385" unitRef="usd">403000</soph:ActuarialGainsLossesNetDefinedBenefitPlans>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset contextRef="c-297" decimals="-3" id="f-1386" unitRef="usd">-524000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset contextRef="c-298" decimals="-3" id="f-1387" unitRef="usd">0</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset contextRef="c-1" decimals="-3" id="f-1388" unitRef="usd">-524000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset contextRef="c-299" decimals="-3" id="f-1389" unitRef="usd">-1668000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset contextRef="c-300" decimals="-3" id="f-1390" unitRef="usd">0</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset contextRef="c-4" decimals="-3" id="f-1391" unitRef="usd">-1668000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset contextRef="c-311" decimals="-3" id="f-1392" unitRef="usd">654000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset contextRef="c-312" decimals="-3" id="f-1393" unitRef="usd">0</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset contextRef="c-5" decimals="-3" id="f-1394" unitRef="usd">654000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1395" unitRef="usd">0</soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1396" unitRef="usd">0</soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1397" unitRef="usd">0</soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1398" unitRef="usd">0</soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1399" unitRef="usd">-1000</soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1400" unitRef="usd">-1000</soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans contextRef="c-311" decimals="-3" id="f-1401" unitRef="usd">-37000</soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans contextRef="c-312" decimals="-3" id="f-1402" unitRef="usd">-2000</soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans>
    <soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans contextRef="c-5" decimals="-3" id="f-1403" unitRef="usd">-39000</soph:IncreaseDecreaseThroughNetExchangeDifferencesPensionRemeasurementOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-297" decimals="-3" id="f-1404" unitRef="usd">709000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-298" decimals="-3" id="f-1405" unitRef="usd">-5000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-1" decimals="-3" id="f-1406" unitRef="usd">704000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-299" decimals="-3" id="f-1407" unitRef="usd">326000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-300" decimals="-3" id="f-1408" unitRef="usd">1000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-4" decimals="-3" id="f-1409" unitRef="usd">327000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-311" decimals="-3" id="f-1410" unitRef="usd">-216000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-312" decimals="-3" id="f-1411" unitRef="usd">4000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans contextRef="c-5" decimals="-3" id="f-1412" unitRef="usd">-212000</ifrs-full:OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans>
    <soph:DemographicAssumptionOfWeightedTurnoverRates contextRef="c-12" decimals="4" id="f-1413" unitRef="number">0.1580</soph:DemographicAssumptionOfWeightedTurnoverRates>
    <soph:DemographicAssumptionOfWeightedTurnoverRates contextRef="c-23" decimals="4" id="f-1414" unitRef="number">0.1950</soph:DemographicAssumptionOfWeightedTurnoverRates>
    <soph:FinancialAssumptionOfDiscountRates
      contextRef="c-293"
      decimals="4"
      id="f-1415"
      unitRef="number">0.0095</soph:FinancialAssumptionOfDiscountRates>
    <soph:FinancialAssumptionOfDiscountRates
      contextRef="c-301"
      decimals="4"
      id="f-1416"
      unitRef="number">0.0110</soph:FinancialAssumptionOfDiscountRates>
    <soph:FinancialAssumptionOfDiscountRates contextRef="c-23" decimals="4" id="f-1417" unitRef="number">0.0150</soph:FinancialAssumptionOfDiscountRates>
    <soph:FinancialAssumptionOfDiscountRates contextRef="c-6" decimals="4" id="f-1418" unitRef="number">0.0095</soph:FinancialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="c-303"
      decimals="4"
      id="f-1419"
      unitRef="number">0.0110</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="c-305"
      decimals="4"
      id="f-1420"
      unitRef="number">0.0095</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="c-304"
      decimals="4"
      id="f-1421"
      unitRef="number">0.0405</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfDiscountRates
      contextRef="c-306"
      decimals="4"
      id="f-1422"
      unitRef="number">0.0355</ifrs-full:ActuarialAssumptionOfDiscountRates>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="c-303"
      decimals="4"
      id="f-1423"
      unitRef="number">0.0250</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="c-305"
      decimals="4"
      id="f-1424"
      unitRef="number">0.0250</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="c-304"
      decimals="4"
      id="f-1425"
      unitRef="number">0.0300</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases
      contextRef="c-306"
      decimals="4"
      id="f-1426"
      unitRef="number">0.0300</ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreases>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019 contextRef="c-313" id="f-1427">P13Y8M12D</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019 contextRef="c-314" id="f-1428">P13Y7M6D</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019 contextRef="c-315" id="f-1429">P15Y1M6D</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019 contextRef="c-316" id="f-1430">P15Y3M18D</ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation2019>
    <soph:LPPInterestRate
      contextRef="c-313"
      decimals="4"
      id="f-1431"
      unitRef="number">0.0230</soph:LPPInterestRate>
    <soph:LPPInterestRate
      contextRef="c-314"
      decimals="4"
      id="f-1432"
      unitRef="number">0.0230</soph:LPPInterestRate>
    <soph:ExtraMandatoryPartEquivalentToDiscountRate
      contextRef="c-314"
      decimals="4"
      id="f-1433"
      unitRef="number">0.0230</soph:ExtraMandatoryPartEquivalentToDiscountRate>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="c-303"
      decimals="4"
      id="f-1434"
      unitRef="number">0.0075</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="c-305"
      decimals="4"
      id="f-1435"
      unitRef="number">0.0100</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="c-304"
      decimals="4"
      id="f-1436"
      unitRef="number">0.0200</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation
      contextRef="c-306"
      decimals="4"
      id="f-1437"
      unitRef="number">0.0200</ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation>
    <soph:AverageLifeExpectancyInYearsAfterRetirementForMale contextRef="c-1" id="f-1438">P23Y25D</soph:AverageLifeExpectancyInYearsAfterRetirementForMale>
    <soph:AverageLifeExpectancyInYearsAfterRetirementForFemale contextRef="c-1" id="f-1439">P24Y9M21D</soph:AverageLifeExpectancyInYearsAfterRetirementForFemale>
    <soph:AverageLifeExpectancyInYearsAfterRetirementForMale contextRef="c-4" id="f-1440">P22Y9M25D</soph:AverageLifeExpectancyInYearsAfterRetirementForMale>
    <soph:AverageLifeExpectancyInYearsAfterRetirementForFemale contextRef="c-4" id="f-1441">P24Y7M2D</soph:AverageLifeExpectancyInYearsAfterRetirementForFemale>
    <ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory contextRef="c-1" id="f-1442">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the sensitivity analysis for the funded plans (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(682)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected rates of salary increases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(258)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inflation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 25 basis points&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Life expectancy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase of 1 year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease of 1 year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(182)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="c-317"
      decimals="4"
      id="f-1443"
      unitRef="number">0.0025</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-317" decimals="-3" id="f-1444" unitRef="usd">-763000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-318" decimals="-3" id="f-1445" unitRef="usd">-682000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="c-317"
      decimals="4"
      id="f-1446"
      unitRef="number">0.0025</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-317" decimals="-3" id="f-1447" unitRef="usd">826000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-318" decimals="-3" id="f-1448" unitRef="usd">738000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="c-319"
      decimals="4"
      id="f-1449"
      unitRef="number">0.0025</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-319" decimals="-3" id="f-1450" unitRef="usd">262000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-320" decimals="-3" id="f-1451" unitRef="usd">140000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="c-319"
      decimals="4"
      id="f-1452"
      unitRef="number">0.0025</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-319" decimals="-3" id="f-1453" unitRef="usd">-261000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-320" decimals="-3" id="f-1454" unitRef="usd">-137000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="c-321"
      decimals="4"
      id="f-1455"
      unitRef="number">0.0025</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-321" decimals="-3" id="f-1456" unitRef="usd">265000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-322" decimals="-3" id="f-1457" unitRef="usd">231000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="c-321"
      decimals="4"
      id="f-1458"
      unitRef="number">0.0025</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-321" decimals="-3" id="f-1459" unitRef="usd">-258000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-322" decimals="-3" id="f-1460" unitRef="usd">-226000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="c-323"
      decimals="4"
      id="f-1461"
      unitRef="number">0.0025</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-323" decimals="-3" id="f-1462" unitRef="usd">-46000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-324" decimals="-3" id="f-1463" unitRef="usd">-19000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="c-323"
      decimals="4"
      id="f-1464"
      unitRef="number">0.0025</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-323" decimals="-3" id="f-1465" unitRef="usd">48000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-324" decimals="-3" id="f-1466" unitRef="usd">18000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <soph:PeriodOfReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-325" id="f-1467">P1Y</soph:PeriodOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-325" decimals="-3" id="f-1468" unitRef="usd">182000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-326" decimals="-3" id="f-1469" unitRef="usd">170000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <soph:PeriodOfReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-325" id="f-1470">P1Y</soph:PeriodOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-325" decimals="-3" id="f-1471" unitRef="usd">-182000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-326" decimals="-3" id="f-1472" unitRef="usd">-171000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="c-327"
      decimals="4"
      id="f-1473"
      unitRef="number">0.0050</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-327" decimals="-3" id="f-1474" unitRef="usd">-5000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-328" decimals="-3" id="f-1475" unitRef="usd">-4000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="c-327"
      decimals="4"
      id="f-1476"
      unitRef="number">0.0050</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-327" decimals="-3" id="f-1477" unitRef="usd">6000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-328" decimals="-3" id="f-1478" unitRef="usd">4000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="c-329"
      decimals="4"
      id="f-1479"
      unitRef="number">0.0050</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-329" decimals="-3" id="f-1480" unitRef="usd">6000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption contextRef="c-330" decimals="-3" id="f-1481" unitRef="usd">4000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="c-329"
      decimals="4"
      id="f-1482"
      unitRef="number">0.0050</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-329" decimals="-3" id="f-1483" unitRef="usd">-5000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption contextRef="c-330" decimals="-3" id="f-1484" unitRef="usd">-4000</ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan contextRef="c-313" decimals="-5" id="f-1485" unitRef="usd">1300000</ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans contextRef="c-89" decimals="-5" id="f-1486" unitRef="usd">300000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans contextRef="c-90" decimals="-5" id="f-1487" unitRef="usd">300000</ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans>
    <ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory contextRef="c-1" id="f-1488">Share-based compensation&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Critical accounting estimates and judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2025, 2024, and 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the Company granted share options under one plan - the SOPHiA GENETICS 2021 Equity Incentive Plan (the &#x201c;2021 Equity Incentive Plan&#x201d; or the &#x201c;2021 EIP&#x201d;). Under this plan, directors may offer options to directors, employees, and advisors. The exercise price of the share options is set at the time they are granted. Options, once vested, can be exchanged for an equal number of ordinary shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measuring the cost of share options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the options under all plans are measured at each grant date using the Black-Scholes option pricing model, taking into account the terms and conditions upon which the options were granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For options up to September 2020, the fair value at grant date is independently determined using an adjusted form of the Black-Scholes option pricing model that takes into account the strike price, the fair value of the share at grant date, the expected life of the award, the expected price volatility of the underlying share, the risk-free interest rate for the term of the award, and the expected dividend yield.&#160;For options granted on and subsequent to September&#160;2020 until July 22, 2021, the fair value at grant date is based &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on a probability-weighted expected returns method that takes account of both the value derived by using an adjusted form of the Black-Scholes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;option pricing model, as described above, and a discounted estimate of the price that might be achieved in a future transaction.&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For options granted on and subsequent to July 22, 2021, the fair value at grant date is determined by using the Black-Scholes option pricing model.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has used an independent valuation firm to assist in calculating the fair value of the award grants per participant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The key inputs used in the valuation model, for the stock options granted in the years ended December 31, 2025, 2024, and 2023, respectively, are outlined below. Stock options were only granted under the 2021 Equity Incentive Plan (&#x201c;2021 EIP&#x201d;).&#160;No&#160;grants have been made under the 2019 Incentive Share Option Plan (&#x201c;2019 ISOP&#x201d;) since 2021 and the SOPHiA GENETICS Incentive Share Option Plan (&#x201c;2013 ISOP&#x201d;) since 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Company&#x2019;s IPO, the price of the ordinary shares at grant date, which represents a critical input into this model, has been determined on one of the following two bases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;B&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;y reference to a contemporaneous transaction involving another class of share, using an adjusted form of the Black-Scholes option pricing model as described above, and considering the timing, amount, liquidation preferences, and dividend rights of issues of other classes of shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;On the basis of discounted cash flow forecasts, where there was no contemporaneous or closely contemporaneous transaction in another class of share and the time interval was too large to permit an assumption that there had been no significant change in the Company&#x2019;s equity value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the IPO, the price of the ordinary shares at grant date, which represents a critical input into this model, has been determined on the most recent close price of the Company&#x2019;s stock price on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has&#160;three&#160;share option plans for directors, employees, and advisors which are accounted for as equity-settled share-based compensation plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of options granted under these plans is recognized as an employee benefits expense, with a corresponding increase in equity. The total amount to be expensed is determined by reference to the fair value of the options granted:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;including any market performance conditions (e.g., the entity&#x2019;s share price);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;excluding the impact of any service and non-market performance vesting conditions (e.g., profitability, sales growth; targets and remaining an employee of the entity over a specified time period), and;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;including the impact of any non-vesting conditions (e.g., the requirement for employees to save or hold shares for a specific period of time).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total expense is recognized over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied. At the end of each period, the entity revises its estimates of the number of options that are expected to vest based on the non-market vesting and service conditions. It recognizes the impact of the revision to original estimates, if any, in income, with a corresponding adjustment to equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimating fair value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including the share price, or the fair value of a share, the expected life of the share option, the volatility of the share price, the risk-free interest rate, the dividend yield, and making certain assumptions about the inputs. The assumptions used for estimating fair value for share-based payment transactions are disclosed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The volatility used in the estimation of fair value is calculated utilizing a mix of the Company&#x2019;s own share price volatility and the volatility of the share prices of a set list of publicly traded peer companies based on a defined proportion. Share price volatility is calculated for each tranche of share options on a historical basis over a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;period of time equal to the average life of the share options granted in each tranche. In the event that a company used in the volatility calculation has not been publicly traded for the requisite amount of time, the entirety of its trading history was used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the shares are not listed, estimating their fair value also requires determination of the most appropriate valuation model, such as:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;By reference to a contemporaneous transaction involving another class of share, using an adjusted form of an option pricing model above, and considering the timing, amount, liquidation preferences and dividend rights of issues of other classes of shares;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;On the basis of discounted cash flow forecasts, where there was no contemporaneous or closely contemporaneous transaction in another class of share and the time interval was too large to permit an assumption that there had been no significant change in the Company&#x2019;s equity value;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Share based compensation expense is measured at the fair value of the options at the grant date and recognized over the vesting period. Share based compensation expense is presented in the statement of loss and allocated to the various expense categories based on the functions of the employees to whom the options are granted (e.g., research and development, selling and marketing, general &amp;amp; administrative).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of the cost of the Company&#x2019;s share option grants and of the fair value of the ordinary shares at the grant date requires the selection of an appropriate valuation model and is based on key assumptions that leave considerable scope for judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recognizing the cost of share options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At each reporting date, the Company recognizes expense for the vested options granted and for partially earned but&#160;non-vested&#160;portions of options granted. This results in a front-loaded expense to the statement of loss. The Company accounts for these plans as equity-settled transactions. The charge to the statements of loss therefore results in a corresponding credit being booked to &#x201c;Other reserves&#x201d; within equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;The plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has&#160;three&#160;share option plans: the 2013 ISOP (launched in&#160;September 2013), the 2019 ISOP (launched&#160;March 2019), and the 2021 EIP (launched&#160;June 2021). Under these plans, directors may offer options to directors, employees, and advisors. The exercise price of the share options is set at the time they are granted. Options, once vested, can be exchanged for an equal number of ordinary shares. Under the 2021 EIP, the Company can grant restricted stock units (&#x201c;RSUs&#x201d;) which represent the right to receive ordinary shares upon meeting specific vesting requirements. RSUs are able to be granted to directors, executives, and employees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The options have a life of&#160;ten years.&#160;Options under the 2013 ISOP vest&#160;50% on the second anniversary of the grant date and a further&#160;50% on the third anniversary of the grant date. Options under the 2019 ISOP vest&#160;25% on each anniversary of the grant date over four years. The options under the 2021 EIP vest&#160;under one of five methods, i) 25% on the first anniversary of the grant date and the remaining&#160;75% vesting ratably on a monthly basis over the remaining three years, ii) 25% on the first anniversary of the grant date and the remaining&#160;75% vesting ratably on a quarterly basis over the remaining three years, iii) on the second anniversary of the grant date, iv) annually over four years on each anniversary of the grant date or v) 50% on the first anniversary of the grant date and the remaining 50% vesting ratably on a monthly basis over the remaining year. Refer to&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Restricted Stock Units&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;below for the vesting schedules of the RSUs under the 2021 EIP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 22, 2021, the Board amended the 2019 ISOP to the effect that, in the event of a successful IPO or public listing of the Company&#x2019;s shares, only those unvested options that otherwise would vest within six months following the effective date of the IPO or such public listing should become fully vested immediately as of such date (accelerated vesting). The remaining unvested options (i.e., unvested options that would only vest after the six-month period following the effective date of the IPO or public listing) would not be subject to accelerated vesting and, subject to certain conditions, would vest on the basis of the original vesting schedule. Additionally, the Board instituted a black-out period, irrespective of a successful IPO or public listing of the Company, in which no options could be exercised from May 1, 2021 to January 19, 2022, and to accelerate the vesting of options that would otherwise vest during that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2013 ISOP&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2025, under the 2013 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;560,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.54&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;480,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.73&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;480,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.73&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2024, under the 2013 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;606,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.00&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.49&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;560,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.54&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;560,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.54&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2023, under the 2013 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;657,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.24&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;606,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.00&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.49&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;606,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.00&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.49&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options outstanding as of December 31, 2025, under the 2013 ISOP expire between&#160;2026&#160;and&#160;2029 and have exercise prices between $2.96 and $3.34.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average share price at the date of exercise were $3.48, $4.72, and $4.82 for the years ended December 31, 2025, 2024, and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2019 ISOP&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2025, under the 2019 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,308,760&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,253,387&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.00&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.42&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,253,367&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.00&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.42&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2024, under the 2019 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,402,510&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,308,760&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,033,490&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.80&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2023, under the 2019 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,629,516&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,402,510&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,651,493&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options outstanding as of December 31, 2025, under the 2019 ISOP expire between&#160;2028&#160;and&#160;2031 and have exercise prices between $3.16 and $6.31.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average share price at the date of exercise were $4.61, $4.70, and $4.65 for the years ended December 31, 2025, 2024, and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 EIP&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2025, under the 2021 EIP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,044,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,280,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(909,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,385,514&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.98&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,989,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2024, under the 2021 EIP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,708,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.84&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.74&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,840,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(454,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,044,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,806,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.37&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2023, under the 2021 EIP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,624,297&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12.32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.88&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(645,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,708,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.84&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.74&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,155,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.57&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation inputs for the 2021 EIP grants were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.998%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at grant date (in USD)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;$3.04 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.53&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.72&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of share options (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.96%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.03%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.67%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options outstanding as of December 31, 2025, under the 2021 EIP expire between&#160;2026 and 2034 and have exercise prices between $2.06 and $18.00.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average share price at the date of exercise were $4.14 and $4.59&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the years ended December 31, 2025 and 2024, respectively; and no options were exercised for the year ended December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share options granted during the year&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options granted during the years ended December 31, 2025, 2024, and 2023, respectively (in USD):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 EIP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the 2021 EIP, the Company initiated granting of RSUs, which represent the right to receive shares of ordinary shares upon meeting specified vesting requirements. In the year ended December 31, 2025, the Company granted&#160;1,136,975&#160;RSUs under the 2021 plan. Under the terms of the 2021 plan,&#160;103,374 of the RSUs granted are subject to a four-year vesting schedule with&#160;25% vesting on the first anniversary of the grant date and the remaining&#160;75% ratably on a quarterly basis over the remaining three years, 864,681&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;are subject to a two year vesting period on the second anniversary from the date of grant, and the remaining&#160;168,920&#160;of the RSUs granted to non-executive members of the Company&#x2019;s board of directors are subject to a vesting period &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;set to be completed upon the Company&#x2019;s 2026 Annual General Meeting.&#160;The activity for the year ended December 31, 2025 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,053,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,434,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,584,209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.04&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the year ended December 31, 2024, the Company granted 1,373,816 RSUs under the 2021 plan. Under the terms of the 2021 plan, 1,168,896 of the RSUs granted are subject to a four-year vesting schedule with 25% vesting on the first anniversary of the grant date and the remaining 75% ratably on a quarterly basis over the remaining three years, and the remaining 204,920 of the RSUs granted to non-executive members of the Company&#x2019;s board of directors are subject to a vesting period set to be completed upon the Company&#x2019;s 2025 Annual General Meeting. The activity for the year ended December 31, 2024 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,335,268&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.77&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,331,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,053,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the year ended December 31, 2023, the Company granted 2,658,150 RSUs under the 2021 plan. Under the terms of the 2021 plan, 2,260,649 of the RSUs granted are subject to a four-year vesting schedule with 25% vesting on the first anniversary of the grant date and the remaining 75% ratably on a monthly basis over the remaining three years, 107,647 are subject to a two year vesting period on the second anniversary from the date of grant, and the remaining 289,854 of the RSUs granted to non-executive members of the Company&#x2019;s board of directors are subject to a vesting period set to be completed upon the Company&#x2019;s 2024 Annual General Meeting. The activity for the year ended December 31, 2023 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,865,433&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,658,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(927,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(261,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,335,268&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.77&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-based compensation expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Movements in the share-based compensation reserve were as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,075&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Movement in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40,317&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Movement in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56,805&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Movement in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73,010&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense by financial statement caption for all stock awards consists of the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="c-1" id="f-1489">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Critical accounting estimates and judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2025, 2024, and 2023&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the Company granted share options under one plan - the SOPHiA GENETICS 2021 Equity Incentive Plan (the &#x201c;2021 Equity Incentive Plan&#x201d; or the &#x201c;2021 EIP&#x201d;). Under this plan, directors may offer options to directors, employees, and advisors. The exercise price of the share options is set at the time they are granted. Options, once vested, can be exchanged for an equal number of ordinary shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Measuring the cost of share options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the options under all plans are measured at each grant date using the Black-Scholes option pricing model, taking into account the terms and conditions upon which the options were granted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For options up to September 2020, the fair value at grant date is independently determined using an adjusted form of the Black-Scholes option pricing model that takes into account the strike price, the fair value of the share at grant date, the expected life of the award, the expected price volatility of the underlying share, the risk-free interest rate for the term of the award, and the expected dividend yield.&#160;For options granted on and subsequent to September&#160;2020 until July 22, 2021, the fair value at grant date is based &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on a probability-weighted expected returns method that takes account of both the value derived by using an adjusted form of the Black-Scholes &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;option pricing model, as described above, and a discounted estimate of the price that might be achieved in a future transaction.&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For options granted on and subsequent to July 22, 2021, the fair value at grant date is determined by using the Black-Scholes option pricing model.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has used an independent valuation firm to assist in calculating the fair value of the award grants per participant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The key inputs used in the valuation model, for the stock options granted in the years ended December 31, 2025, 2024, and 2023, respectively, are outlined below. Stock options were only granted under the 2021 Equity Incentive Plan (&#x201c;2021 EIP&#x201d;).&#160;No&#160;grants have been made under the 2019 Incentive Share Option Plan (&#x201c;2019 ISOP&#x201d;) since 2021 and the SOPHiA GENETICS Incentive Share Option Plan (&#x201c;2013 ISOP&#x201d;) since 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Company&#x2019;s IPO, the price of the ordinary shares at grant date, which represents a critical input into this model, has been determined on one of the following two bases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;B&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;y reference to a contemporaneous transaction involving another class of share, using an adjusted form of the Black-Scholes option pricing model as described above, and considering the timing, amount, liquidation preferences, and dividend rights of issues of other classes of shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;On the basis of discounted cash flow forecasts, where there was no contemporaneous or closely contemporaneous transaction in another class of share and the time interval was too large to permit an assumption that there had been no significant change in the Company&#x2019;s equity value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the IPO, the price of the ordinary shares at grant date, which represents a critical input into this model, has been determined on the most recent close price of the Company&#x2019;s stock price on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accounting policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has&#160;three&#160;share option plans for directors, employees, and advisors which are accounted for as equity-settled share-based compensation plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of options granted under these plans is recognized as an employee benefits expense, with a corresponding increase in equity. The total amount to be expensed is determined by reference to the fair value of the options granted:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;including any market performance conditions (e.g., the entity&#x2019;s share price);&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;excluding the impact of any service and non-market performance vesting conditions (e.g., profitability, sales growth; targets and remaining an employee of the entity over a specified time period), and;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;including the impact of any non-vesting conditions (e.g., the requirement for employees to save or hold shares for a specific period of time).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total expense is recognized over the vesting period, which is the period over which all of the specified vesting conditions are to be satisfied. At the end of each period, the entity revises its estimates of the number of options that are expected to vest based on the non-market vesting and service conditions. It recognizes the impact of the revision to original estimates, if any, in income, with a corresponding adjustment to equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimating fair value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including the share price, or the fair value of a share, the expected life of the share option, the volatility of the share price, the risk-free interest rate, the dividend yield, and making certain assumptions about the inputs. The assumptions used for estimating fair value for share-based payment transactions are disclosed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The volatility used in the estimation of fair value is calculated utilizing a mix of the Company&#x2019;s own share price volatility and the volatility of the share prices of a set list of publicly traded peer companies based on a defined proportion. Share price volatility is calculated for each tranche of share options on a historical basis over a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;period of time equal to the average life of the share options granted in each tranche. In the event that a company used in the volatility calculation has not been publicly traded for the requisite amount of time, the entirety of its trading history was used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the shares are not listed, estimating their fair value also requires determination of the most appropriate valuation model, such as:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;By reference to a contemporaneous transaction involving another class of share, using an adjusted form of an option pricing model above, and considering the timing, amount, liquidation preferences and dividend rights of issues of other classes of shares;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;On the basis of discounted cash flow forecasts, where there was no contemporaneous or closely contemporaneous transaction in another class of share and the time interval was too large to permit an assumption that there had been no significant change in the Company&#x2019;s equity value;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Share based compensation expense is measured at the fair value of the options at the grant date and recognized over the vesting period. Share based compensation expense is presented in the statement of loss and allocated to the various expense categories based on the functions of the employees to whom the options are granted (e.g., research and development, selling and marketing, general &amp;amp; administrative).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of the cost of the Company&#x2019;s share option grants and of the fair value of the ordinary shares at the grant date requires the selection of an appropriate valuation model and is based on key assumptions that leave considerable scope for judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recognizing the cost of share options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At each reporting date, the Company recognizes expense for the vested options granted and for partially earned but&#160;non-vested&#160;portions of options granted. This results in a front-loaded expense to the statement of loss. The Company accounts for these plans as equity-settled transactions. The charge to the statements of loss therefore results in a corresponding credit being booked to &#x201c;Other reserves&#x201d; within equity.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c-331"
      decimals="INF"
      id="f-1490"
      unitRef="shares">0</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c-332"
      decimals="INF"
      id="f-1491"
      unitRef="shares">0</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <soph:NumberOfShareOptionPlans contextRef="c-1" decimals="INF" id="f-1492" unitRef="plan">3</soph:NumberOfShareOptionPlans>
    <soph:NumberOfShareOptionPlans contextRef="c-1" decimals="INF" id="f-1493" unitRef="plan">3</soph:NumberOfShareOptionPlans>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="c-333"
      decimals="INF"
      id="f-1494"
      unitRef="year">10</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis
      contextRef="c-334"
      decimals="2"
      id="f-1495"
      unitRef="number">0.50</soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis
      contextRef="c-335"
      decimals="2"
      id="f-1496"
      unitRef="number">0.50</soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis
      contextRef="c-336"
      decimals="2"
      id="f-1497"
      unitRef="number">0.25</soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis contextRef="c-336" id="f-1498">P4Y</soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis
      contextRef="c-337"
      decimals="2"
      id="f-1499"
      unitRef="number">0.25</soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis
      contextRef="c-337"
      decimals="2"
      id="f-1500"
      unitRef="number">0.75</soph:VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis contextRef="c-337" id="f-1501">P3Y</soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis
      contextRef="c-338"
      decimals="2"
      id="f-1502"
      unitRef="number">0.25</soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis
      contextRef="c-338"
      decimals="2"
      id="f-1503"
      unitRef="number">0.75</soph:VestingPercentageOfShareBasedPaymentArrangementOptionOnQuarterlyBasis>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis contextRef="c-338" id="f-1504">P3Y</soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnQuarterlyBasis>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis contextRef="c-338" id="f-1505">P4Y</soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis
      contextRef="c-339"
      decimals="2"
      id="f-1506"
      unitRef="number">0.50</soph:VestingPercentageOfShareBasedPaymentArrangementOptionsOnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis
      contextRef="c-339"
      decimals="2"
      id="f-1507"
      unitRef="number">0.50</soph:VestingPercentageOfShareBasedPaymentArrangementOptionOnMonthlyBasis>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis contextRef="c-340" id="f-1508">P6M</soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis contextRef="c-340" id="f-1509">P6M</soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c-341"
      decimals="INF"
      id="f-1510"
      unitRef="shares">0</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory contextRef="c-1" id="f-1511">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2025, under the 2013 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;560,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.54&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;480,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.73&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;480,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.73&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2024, under the 2013 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;606,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.00&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.49&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;560,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.54&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;560,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.03&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.54&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2023, under the 2013 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;657,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.92&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.24&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;606,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.00&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.49&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;606,980&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.00&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.49&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2025, under the 2019 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,308,760&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,373)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,253,387&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.00&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.42&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,253,367&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.00&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.42&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2024, under the 2019 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,402,510&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,308,760&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,033,490&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.80&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2023, under the 2019 ISOP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,629,516&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(195,006)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,402,510&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,651,493&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.03&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2025, under the 2021 EIP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,044,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,280,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(909,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,385,514&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.98&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,989,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.11&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2024, under the 2021 EIP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,708,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.84&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.74&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,840,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,119)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(454,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,044,607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.40&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,806,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.37&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for the year ended December 31, 2023, under the 2021 EIP was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted average remaining life in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,624,297&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12.32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.88&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(645,310)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,708,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.84&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8.74&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercisable as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,155,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.57&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-342"
      decimals="INF"
      id="f-1512"
      unitRef="shares">560980</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-342"
      decimals="2"
      id="f-1513"
      unitRef="usdPerShare">3.03</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-343" id="f-1514">P2Y6M14D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c-333"
      decimals="INF"
      id="f-1515"
      unitRef="shares">68000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c-333"
      decimals="2"
      id="f-1516"
      unitRef="usdPerShare">1.96</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c-333"
      decimals="INF"
      id="f-1517"
      unitRef="shares">12000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c-333"
      decimals="2"
      id="f-1518"
      unitRef="usdPerShare">3.17</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-344"
      decimals="INF"
      id="f-1519"
      unitRef="shares">480980</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-344"
      decimals="2"
      id="f-1520"
      unitRef="usdPerShare">3.18</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-333" id="f-1521">P1Y8M23D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="c-344"
      decimals="INF"
      id="f-1522"
      unitRef="shares">480980</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="c-344"
      decimals="2"
      id="f-1523"
      unitRef="usdPerShare">3.18</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions contextRef="c-333" id="f-1524">P1Y8M23D</soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-345"
      decimals="INF"
      id="f-1525"
      unitRef="shares">606980</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-345"
      decimals="2"
      id="f-1526"
      unitRef="usdPerShare">3.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-346" id="f-1527">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c-343"
      decimals="INF"
      id="f-1528"
      unitRef="shares">32000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c-343"
      decimals="2"
      id="f-1529"
      unitRef="usdPerShare">3.16</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c-343"
      decimals="INF"
      id="f-1530"
      unitRef="shares">14000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c-343"
      decimals="2"
      id="f-1531"
      unitRef="usdPerShare">1.75</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-342"
      decimals="INF"
      id="f-1532"
      unitRef="shares">560980</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-342"
      decimals="2"
      id="f-1533"
      unitRef="usdPerShare">3.03</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-343" id="f-1534">P2Y6M14D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="c-342"
      decimals="INF"
      id="f-1535"
      unitRef="shares">560980</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="c-342"
      decimals="2"
      id="f-1536"
      unitRef="usdPerShare">3.03</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions contextRef="c-343" id="f-1537">P2Y6M14D</soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-347"
      decimals="INF"
      id="f-1538"
      unitRef="shares">657980</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-347"
      decimals="2"
      id="f-1539"
      unitRef="usdPerShare">2.92</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-348" id="f-1540">P4Y2M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c-346"
      decimals="INF"
      id="f-1541"
      unitRef="shares">39000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c-346"
      decimals="2"
      id="f-1542"
      unitRef="usdPerShare">2.52</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c-346"
      decimals="INF"
      id="f-1543"
      unitRef="shares">12000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c-346"
      decimals="2"
      id="f-1544"
      unitRef="usdPerShare">0.05</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-345"
      decimals="INF"
      id="f-1545"
      unitRef="shares">606980</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-345"
      decimals="2"
      id="f-1546"
      unitRef="usdPerShare">3.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-346" id="f-1547">P3Y5M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="c-345"
      decimals="INF"
      id="f-1548"
      unitRef="shares">606980</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="c-345"
      decimals="2"
      id="f-1549"
      unitRef="usdPerShare">3.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions contextRef="c-346" id="f-1550">P3Y5M26D</soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-349"
      decimals="2"
      id="f-1551"
      unitRef="usdPerShare">2.96</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-350"
      decimals="2"
      id="f-1552"
      unitRef="usdPerShare">3.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019
      contextRef="c-333"
      decimals="2"
      id="f-1553"
      unitRef="usdPerShare">3.48</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019
      contextRef="c-343"
      decimals="2"
      id="f-1554"
      unitRef="usdPerShare">4.72</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019
      contextRef="c-346"
      decimals="2"
      id="f-1555"
      unitRef="usdPerShare">4.82</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-351"
      decimals="INF"
      id="f-1556"
      unitRef="shares">2308760</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-351"
      decimals="2"
      id="f-1557"
      unitRef="usdPerShare">4.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-352" id="f-1558">P5Y4M24D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c-336"
      decimals="INF"
      id="f-1559"
      unitRef="shares">40373</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c-336"
      decimals="2"
      id="f-1560"
      unitRef="usdPerShare">3.49</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c-336"
      decimals="INF"
      id="f-1561"
      unitRef="shares">15000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c-336"
      decimals="2"
      id="f-1562"
      unitRef="usdPerShare">5.06</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-353"
      decimals="INF"
      id="f-1563"
      unitRef="shares">2253387</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-353"
      decimals="2"
      id="f-1564"
      unitRef="usdPerShare">5.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-336" id="f-1565">P4Y5M1D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="c-353"
      decimals="INF"
      id="f-1566"
      unitRef="shares">2253367</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="c-353"
      decimals="2"
      id="f-1567"
      unitRef="usdPerShare">5.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions contextRef="c-336" id="f-1568">P4Y5M1D</soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-354"
      decimals="INF"
      id="f-1569"
      unitRef="shares">2402510</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-354"
      decimals="2"
      id="f-1570"
      unitRef="usdPerShare">4.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-355" id="f-1571">P6Y3M18D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c-352"
      decimals="INF"
      id="f-1572"
      unitRef="shares">38250</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c-352"
      decimals="2"
      id="f-1573"
      unitRef="usdPerShare">4.12</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c-352"
      decimals="INF"
      id="f-1574"
      unitRef="shares">55500</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c-352"
      decimals="2"
      id="f-1575"
      unitRef="usdPerShare">5.46</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-351"
      decimals="INF"
      id="f-1576"
      unitRef="shares">2308760</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-351"
      decimals="2"
      id="f-1577"
      unitRef="usdPerShare">4.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-352" id="f-1578">P5Y4M24D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="c-351"
      decimals="INF"
      id="f-1579"
      unitRef="shares">2033490</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="c-351"
      decimals="2"
      id="f-1580"
      unitRef="usdPerShare">4.80</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions contextRef="c-352" id="f-1581">P5Y3M21D</soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-356"
      decimals="INF"
      id="f-1582"
      unitRef="shares">2629516</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-356"
      decimals="2"
      id="f-1583"
      unitRef="usdPerShare">4.96</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-357" id="f-1584">P7Y2M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c-355"
      decimals="INF"
      id="f-1585"
      unitRef="shares">32000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c-355"
      decimals="2"
      id="f-1586"
      unitRef="usdPerShare">4.06</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c-355"
      decimals="INF"
      id="f-1587"
      unitRef="shares">195006</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c-355"
      decimals="2"
      id="f-1588"
      unitRef="usdPerShare">4.94</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-354"
      decimals="INF"
      id="f-1589"
      unitRef="shares">2402510</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-354"
      decimals="2"
      id="f-1590"
      unitRef="usdPerShare">4.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-355" id="f-1591">P6Y3M18D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="c-354"
      decimals="INF"
      id="f-1592"
      unitRef="shares">1651493</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="c-354"
      decimals="2"
      id="f-1593"
      unitRef="usdPerShare">4.64</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions contextRef="c-355" id="f-1594">P6Y10D</soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-358"
      decimals="2"
      id="f-1595"
      unitRef="usdPerShare">3.16</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-359"
      decimals="2"
      id="f-1596"
      unitRef="usdPerShare">6.31</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019
      contextRef="c-336"
      decimals="2"
      id="f-1597"
      unitRef="usdPerShare">4.61</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019
      contextRef="c-352"
      decimals="2"
      id="f-1598"
      unitRef="usdPerShare">4.70</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019
      contextRef="c-355"
      decimals="2"
      id="f-1599"
      unitRef="usdPerShare">4.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-360"
      decimals="INF"
      id="f-1600"
      unitRef="shares">9044607</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-360"
      decimals="2"
      id="f-1601"
      unitRef="usdPerShare">6.69</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-361" id="f-1602">P8Y4M24D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c-362"
      decimals="INF"
      id="f-1603"
      unitRef="shares">3280275</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="c-362"
      decimals="2"
      id="f-1604"
      unitRef="usdPerShare">3.29</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c-362"
      decimals="INF"
      id="f-1605"
      unitRef="shares">29412</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c-362"
      decimals="2"
      id="f-1606"
      unitRef="usdPerShare">2.78</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c-362"
      decimals="INF"
      id="f-1607"
      unitRef="shares">909956</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c-362"
      decimals="2"
      id="f-1608"
      unitRef="usdPerShare">6.69</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-363"
      decimals="INF"
      id="f-1609"
      unitRef="shares">11385514</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-363"
      decimals="2"
      id="f-1610"
      unitRef="usdPerShare">5.72</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-362" id="f-1611">P7Y11M23D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="c-363"
      decimals="INF"
      id="f-1612"
      unitRef="shares">4989270</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="c-363"
      decimals="2"
      id="f-1613"
      unitRef="usdPerShare">7.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions contextRef="c-362" id="f-1614">P7Y1M9D</soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-364"
      decimals="INF"
      id="f-1615"
      unitRef="shares">5708059</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-364"
      decimals="2"
      id="f-1616"
      unitRef="usdPerShare">7.84</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-365" id="f-1617">P8Y8M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c-361"
      decimals="INF"
      id="f-1618"
      unitRef="shares">3840087</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="c-361"
      decimals="2"
      id="f-1619"
      unitRef="usdPerShare">4.78</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c-361"
      decimals="INF"
      id="f-1620"
      unitRef="shares">49119</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="c-361"
      decimals="2"
      id="f-1621"
      unitRef="usdPerShare">2.87</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c-361"
      decimals="INF"
      id="f-1622"
      unitRef="shares">454420</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c-361"
      decimals="2"
      id="f-1623"
      unitRef="usdPerShare">5.37</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-360"
      decimals="INF"
      id="f-1624"
      unitRef="shares">9044607</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-360"
      decimals="2"
      id="f-1625"
      unitRef="usdPerShare">6.69</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-361" id="f-1626">P8Y4M24D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="c-360"
      decimals="INF"
      id="f-1627"
      unitRef="shares">2806356</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="c-360"
      decimals="2"
      id="f-1628"
      unitRef="usdPerShare">10.22</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions contextRef="c-361" id="f-1629">P7Y4M13D</soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-366"
      decimals="INF"
      id="f-1630"
      unitRef="shares">2624297</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-366"
      decimals="2"
      id="f-1631"
      unitRef="usdPerShare">12.32</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-367" id="f-1632">P8Y10M17D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="c-365"
      decimals="INF"
      id="f-1633"
      unitRef="shares">3734266</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="c-365"
      decimals="2"
      id="f-1634"
      unitRef="usdPerShare">4.44</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="c-365"
      decimals="INF"
      id="f-1635"
      unitRef="shares">645310</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="c-365"
      decimals="2"
      id="f-1636"
      unitRef="usdPerShare">6.43</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="c-364"
      decimals="INF"
      id="f-1637"
      unitRef="shares">5708059</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-364"
      decimals="2"
      id="f-1638"
      unitRef="usdPerShare">7.84</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="c-365" id="f-1639">P8Y8M26D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="c-364"
      decimals="INF"
      id="f-1640"
      unitRef="shares">1155231</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="c-364"
      decimals="2"
      id="f-1641"
      unitRef="usdPerShare">14.64</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions contextRef="c-365" id="f-1642">P7Y6M25D</soph:WeightedAverageRemainingContractualLifeOfExercisableShareOptions>
    <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory contextRef="c-1" id="f-1643">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation inputs for the 2021 EIP grants were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.354%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.998%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December&#160;31,&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at grant date (in USD)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;$3.04 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.53&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.72&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life of share options (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.60%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.95%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.96%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.03%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.40%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.67%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield (%)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c-368"
      decimals="2"
      id="f-1644"
      unitRef="usdPerShare">3.04</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c-369"
      decimals="2"
      id="f-1645"
      unitRef="usdPerShare">4.73</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c-370"
      decimals="2"
      id="f-1646"
      unitRef="usdPerShare">3.4</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c-371"
      decimals="2"
      id="f-1647"
      unitRef="usdPerShare">4.96</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c-372"
      decimals="2"
      id="f-1648"
      unitRef="usdPerShare">2.53</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019
      contextRef="c-373"
      decimals="2"
      id="f-1649"
      unitRef="usdPerShare">4.72</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="c-368" decimals="2" id="f-1650" unitRef="year">5.50</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="c-369" decimals="2" id="f-1651" unitRef="year">7.00</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="c-370" decimals="2" id="f-1652" unitRef="year">5.50</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="c-371" decimals="2" id="f-1653" unitRef="year">7.00</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="c-372" decimals="2" id="f-1654" unitRef="year">5.50</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted contextRef="c-373" decimals="2" id="f-1655" unitRef="year">7.00</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c-368"
      decimals="4"
      id="f-1656"
      unitRef="number">0.7384</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c-369"
      decimals="4"
      id="f-1657"
      unitRef="number">0.7760</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c-370"
      decimals="4"
      id="f-1658"
      unitRef="number">0.7286</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c-371"
      decimals="4"
      id="f-1659"
      unitRef="number">0.7495</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c-372"
      decimals="4"
      id="f-1660"
      unitRef="number">0.6950</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="c-373"
      decimals="4"
      id="f-1661"
      unitRef="number">0.7496</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c-368"
      decimals="4"
      id="f-1662"
      unitRef="number">0.0368</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c-369"
      decimals="4"
      id="f-1663"
      unitRef="number">0.0403</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c-370"
      decimals="4"
      id="f-1664"
      unitRef="number">0.0350</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c-371"
      decimals="4"
      id="f-1665"
      unitRef="number">0.0440</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c-372"
      decimals="4"
      id="f-1666"
      unitRef="number">0.0345</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="c-373"
      decimals="4"
      id="f-1667"
      unitRef="number">0.0467</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c-362"
      decimals="INF"
      id="f-1668"
      unitRef="number">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c-361"
      decimals="INF"
      id="f-1669"
      unitRef="number">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="c-365"
      decimals="INF"
      id="f-1670"
      unitRef="number">0</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-374"
      decimals="2"
      id="f-1671"
      unitRef="usdPerShare">2.06</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="c-375"
      decimals="2"
      id="f-1672"
      unitRef="usdPerShare">18.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019
      contextRef="c-362"
      decimals="2"
      id="f-1673"
      unitRef="usdPerShare">4.14</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019
      contextRef="c-361"
      decimals="2"
      id="f-1674"
      unitRef="usdPerShare">4.59</ifrs-full:WeightedAverageExercisePriceOfShareOptionsInSharebasedPaymentArrangementExercisedDuringPeriodAtDateOfExercise2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="c-365"
      decimals="INF"
      id="f-1675"
      unitRef="shares">0</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <soph:DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock contextRef="c-1" id="f-1676">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average fair value of options granted during the years ended December 31, 2025, 2024, and 2023, respectively (in USD):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 EIP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutWeightedAverageFairValueOfOptionsGrantedTableTextBlock>
    <soph:WeightedAverageFairValueShareOptionsGranted
      contextRef="c-362"
      decimals="2"
      id="f-1677"
      unitRef="usdPerShare">2.26</soph:WeightedAverageFairValueShareOptionsGranted>
    <soph:WeightedAverageFairValueShareOptionsGranted
      contextRef="c-361"
      decimals="2"
      id="f-1678"
      unitRef="usdPerShare">3.27</soph:WeightedAverageFairValueShareOptionsGranted>
    <soph:WeightedAverageFairValueShareOptionsGranted
      contextRef="c-365"
      decimals="2"
      id="f-1679"
      unitRef="usdPerShare">2.91</soph:WeightedAverageFairValueShareOptionsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-376"
      decimals="INF"
      id="f-1680"
      unitRef="shares">1136975</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-377"
      decimals="INF"
      id="f-1681"
      unitRef="shares">103374</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis contextRef="c-377" id="f-1682">P4Y</soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis
      contextRef="c-377"
      decimals="2"
      id="f-1683"
      unitRef="number">0.25</soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis
      contextRef="c-377"
      decimals="2"
      id="f-1684"
      unitRef="number">0.75</soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis contextRef="c-377" id="f-1685">P3Y</soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-378"
      decimals="INF"
      id="f-1686"
      unitRef="shares">864681</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis contextRef="c-378" id="f-1687">P2Y</soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-379"
      decimals="INF"
      id="f-1688"
      unitRef="shares">168920</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory contextRef="c-1" id="f-1689">The activity for the year ended December 31, 2025 was as follows:&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of January 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,053,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,434,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(171,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,584,209&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.04&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The activity for the year ended December 31, 2024 was as follows:&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,335,268&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.77&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,331,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(324,277)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,053,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The activity for the year ended December 31, 2023 was as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.083%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-average grant date fair value per share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,865,433&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,658,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(927,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(261,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,335,268&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.77&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-380"
      decimals="INF"
      id="f-1690"
      unitRef="shares">3053076</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement
      contextRef="c-380"
      decimals="2"
      id="f-1691"
      unitRef="usdPerShare">4.69</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-381"
      decimals="INF"
      id="f-1692"
      unitRef="shares">1136975</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement
      contextRef="c-381"
      decimals="2"
      id="f-1693"
      unitRef="usdPerShare">3.30</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-381"
      decimals="INF"
      id="f-1694"
      unitRef="shares">1434646</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement
      contextRef="c-381"
      decimals="2"
      id="f-1695"
      unitRef="usdPerShare">4.84</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="c-381"
      decimals="INF"
      id="f-1696"
      unitRef="shares">171196</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement
      contextRef="c-381"
      decimals="2"
      id="f-1697"
      unitRef="usdPerShare">4.10</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-382"
      decimals="INF"
      id="f-1698"
      unitRef="shares">2584209</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement
      contextRef="c-382"
      decimals="2"
      id="f-1699"
      unitRef="usdPerShare">4.04</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-383"
      decimals="INF"
      id="f-1700"
      unitRef="shares">1373816</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-384"
      decimals="INF"
      id="f-1701"
      unitRef="shares">1168896</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis contextRef="c-384" id="f-1702">P4Y</soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis
      contextRef="c-384"
      decimals="2"
      id="f-1703"
      unitRef="number">0.25</soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis
      contextRef="c-384"
      decimals="2"
      id="f-1704"
      unitRef="number">0.75</soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis contextRef="c-384" id="f-1705">P3Y</soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAQuarterlyBasis>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-385"
      decimals="INF"
      id="f-1706"
      unitRef="shares">204920</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-386"
      decimals="INF"
      id="f-1707"
      unitRef="shares">3335268</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement
      contextRef="c-386"
      decimals="2"
      id="f-1708"
      unitRef="usdPerShare">4.77</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-387"
      decimals="INF"
      id="f-1709"
      unitRef="shares">1373816</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement
      contextRef="c-387"
      decimals="2"
      id="f-1710"
      unitRef="usdPerShare">4.71</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-387"
      decimals="INF"
      id="f-1711"
      unitRef="shares">1331731</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement
      contextRef="c-387"
      decimals="2"
      id="f-1712"
      unitRef="usdPerShare">4.95</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="c-387"
      decimals="INF"
      id="f-1713"
      unitRef="shares">324277</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement
      contextRef="c-387"
      decimals="2"
      id="f-1714"
      unitRef="usdPerShare">4.56</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-380"
      decimals="INF"
      id="f-1715"
      unitRef="shares">3053076</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement
      contextRef="c-380"
      decimals="2"
      id="f-1716"
      unitRef="usdPerShare">4.69</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-388"
      decimals="INF"
      id="f-1717"
      unitRef="shares">2658150</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-389"
      decimals="INF"
      id="f-1718"
      unitRef="shares">2260649</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis contextRef="c-389" id="f-1719">P4Y</soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis
      contextRef="c-389"
      decimals="2"
      id="f-1720"
      unitRef="number">0.25</soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAnAnnualBasis>
    <soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis
      contextRef="c-389"
      decimals="2"
      id="f-1721"
      unitRef="number">0.75</soph:VestingPercentageOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis contextRef="c-389" id="f-1722">P3Y</soph:VestingPeriodOfShareBasedPaymentArrangementOtherEquityInstrumentsOnAMonthlyBasis>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-390"
      decimals="INF"
      id="f-1723"
      unitRef="shares">107647</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis contextRef="c-389" id="f-1724">P2Y</soph:VestingPeriodOfShareBasedPaymentArrangementOptionOnAnnualBasis>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-391"
      decimals="INF"
      id="f-1725"
      unitRef="shares">289854</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-392"
      decimals="INF"
      id="f-1726"
      unitRef="shares">1865433</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement
      contextRef="c-392"
      decimals="2"
      id="f-1727"
      unitRef="usdPerShare">5.20</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="c-393"
      decimals="INF"
      id="f-1728"
      unitRef="shares">2658150</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement
      contextRef="c-393"
      decimals="2"
      id="f-1729"
      unitRef="usdPerShare">4.42</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsGrantedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
      contextRef="c-393"
      decimals="INF"
      id="f-1730"
      unitRef="shares">927155</ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement
      contextRef="c-393"
      decimals="2"
      id="f-1731"
      unitRef="usdPerShare">4.65</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsVestedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
      contextRef="c-393"
      decimals="INF"
      id="f-1732"
      unitRef="shares">261160</ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement
      contextRef="c-393"
      decimals="2"
      id="f-1733"
      unitRef="usdPerShare">4.75</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsForfeitedInShareBasedPaymentArrangement>
    <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
      contextRef="c-386"
      decimals="INF"
      id="f-1734"
      unitRef="shares">3335268</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement>
    <soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement
      contextRef="c-386"
      decimals="2"
      id="f-1735"
      unitRef="usdPerShare">4.77</soph:WeightedAverageGrantDateFairValueOfOtherEquityInstrumentsOutstandingInShareBasedPaymentArrangement>
    <ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions contextRef="c-1" id="f-1736">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Movements in the share-based compensation reserve were as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,075&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Movement in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40,317&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Movement in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56,805&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Movement in the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73,010&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense by financial statement caption for all stock awards consists of the following (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.084%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,488&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,242&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnFinancialPositions>
    <ifrs-full:ReserveOfSharebasedPayments contextRef="c-12" decimals="-3" id="f-1737" unitRef="usd">25075000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-5" decimals="-3" id="f-1738" unitRef="usd">15242000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:ReserveOfSharebasedPayments contextRef="c-23" decimals="-3" id="f-1739" unitRef="usd">40317000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-4" decimals="-3" id="f-1740" unitRef="usd">16488000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:ReserveOfSharebasedPayments contextRef="c-6" decimals="-3" id="f-1741" unitRef="usd">56805000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="c-1" decimals="-3" id="f-1742" unitRef="usd">16205000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:ReserveOfSharebasedPayments contextRef="c-3" decimals="-3" id="f-1743" unitRef="usd">73010000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-394" decimals="-3" id="f-1744" unitRef="usd">4070000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-395" decimals="-3" id="f-1745" unitRef="usd">4370000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-396" decimals="-3" id="f-1746" unitRef="usd">3440000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-397" decimals="-3" id="f-1747" unitRef="usd">1230000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-398" decimals="-3" id="f-1748" unitRef="usd">1357000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-399" decimals="-3" id="f-1749" unitRef="usd">1266000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-400" decimals="-3" id="f-1750" unitRef="usd">10905000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-401" decimals="-3" id="f-1751" unitRef="usd">10761000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-402" decimals="-3" id="f-1752" unitRef="usd">10536000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-1" decimals="-3" id="f-1753" unitRef="usd">16205000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-4" decimals="-3" id="f-1754" unitRef="usd">16488000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets contextRef="c-5" decimals="-3" id="f-1755" unitRef="usd">15242000</ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:DisclosureOfBorrowingsExplanatory contextRef="c-1" id="f-1756">Borrowings&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Perceptive Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 2, 2024 (the &#x201c;closing date&#x201d;), the Company and its subsidiary SOPHiA GENETICS, Inc. entered into a credit agreement and guaranty (the &#x201c;Perceptive Credit Agreement&#x201d;) with Perceptive Credit Holdings IV, LP, as lender and administrative agent, pursuant to which the Company may borrow up to $50.0&#160;million principal amount of term loans, including (i) an initial tranche of $15.0&#160;million principal amount of term loans on the closing date (&#x201c;Tranche A&#x201d;) and (ii) a second tranche of $35.0&#160;million principal amount of term loans that the Company may draw upon on or prior to March 31, 2026 (&#x201c;Tranche B&#x201d;), subject to satisfaction of certain &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;customary conditions. The term loans are scheduled to mature on the fifth anniversary of the closing date and accrue interest at Term Secured Overnight Financing Rate (&#x201c;Term SOFR&#x201d;) (floored at 4% per annum) plus 6.25% per annum; provided that upon the occurrence and during the continuation of any event of default, the term loans will accrue interest at Term SOFR plus 9.25% per annum. Term SOFR means the Term SOFR reference rate that is two business days prior to the first day of the preceding calendar month. The Company has the right to prepay the term loans at any time subject to applicable prepayment premiums. The Perceptive Credit Agreement also contains certain mandatory prepayment provisions, including prepayments from the proceeds from certain asset sales and casualty events (subject to a right to reinvest such proceeds in assets used in the Company&#x2019;s business within 180 days) and from issuances or incurrences of non-permitted debt, which will also be subject to prepayment premiums. The obligations under the Perceptive Credit Agreement are secured by substantially all of the Company&#x2019;s and certain of the Company&#x2019;s subsidiaries&#x2019; assets and are guaranteed initially on the closing date by SOPHiA GENETICS SA and SOPHiA GENETICS, Inc. The Perceptive Credit Agreement contains customary covenants, including an affirmative covenant to maintain qualified cash of at least $3.0&#160;million, an affirmative last twelve months revenue covenant of $67.4 million as of December 31, 2025. The last twelve months revenue covenant is tested on a quarterly basis beginning June 30, 2024, and negative covenants including limitations on indebtedness, liens, fundamental changes, asset sales, investments, dividends and other restricted payments and other matters customarily restricted in such agreements. The Perceptive Credit Agreement also contains customary events of default, including payment defaults, material inaccuracy of representations and warranties, covenant defaults, bankruptcy and insolvency proceedings, cross-defaults to certain other agreements, judgments against the Company and the Company&#x2019;s subsidiaries and change in control, the occurrence of which gives the lenders the right to declare the term loans and all obligations under the Perceptive Credit Agreement immediately due and payable. The Company was in full compliance with all covenants contained in the Perceptive Credit Agreement as of December 31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company issued to Perceptive Credit Holdings IV, LP a warrant certificate (the &#x201c;Warrant Certificate&#x201d;) representing the right to purchase up to 400,000 ordinary shares at $4.9992 per share, with the right to purchase 200,000 ordinary shares available immediately and the right to purchase an additional 200,000 ordinary shares to be available upon the drawdown of the second tranche of the term loans. The purchase rights represented by the Warrant Certificate are exercisable after becoming available, on a cash basis, at the option of the holder at any time prior to 5:00 p.m., Eastern time on the tenth anniversary of the applicable date of availability. The Warrant Certificate contains customary anti-dilution adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company drew down the $35.0&#160;million of Tranche B on June 25, 2025 and the right to purchase an additional 200,000 ordinary shares became available under the Warrant Certificate.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On January 23, 2026, the Company entered into an amendment (the &#x201c;2026 Amendment&#x201d;) to the Perceptive Credit Agreement. The 2026 Amendment provides for, among other things, $25.0&#160;million of additional term loan commitments consisting of (i) an additional $12.5&#160;million tranche of term loan commitments (&#x201c;Tranche C&#x201d;), which may be drawn subject to certain customary conditions, and (ii) an additional $12.5&#160;million tranche of term loan commitments (&#x201c;Tranche D&#x201d;), which may be drawn at such time as the Company&#x2019;s revenue for a trailing twelve-month period exceed $85.0&#160;million and otherwise subject to customary conditions. Tranche C and Tranche D, if drawn, will have terms and conditions consistent with the Company&#x2019;s existing term loans, will bear interest at rate per annum equal to Term SOFR (floored at 4% per annum) + 6.25% and will mature in 2029. In connection with the 2026 Amendment, the Company amended and restated the warrant certificate in order to issue to Perceptive Credit Holdings IV, LP the right to purchase an additional 75,000 ordinary shares, which right is exercisable immediately. The Warrant Certificate also grants Perceptive Credit Holdings IV, LP the right to purchase an additional (1) 100,000 ordinary shares, which right will become exercisable upon the Company&#x2019;s draw down of the Tranche C under the Perceptive Credit Agreement and (2) another 100,000 ordinary shares, which right will become exercisable upon the Company&#x2019;s draw down of the Tranche D under the Perceptive Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Accounting for Tranches A and B&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for each tranche of the term loans and warrants as two separate financial instruments: (i) a warrant obligation and (ii) a loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;i) The warrant obligation is presented in the consolidated balance sheet as a short-term liability given the warrants are not settled in the entity&#x2019;s functional currency and thus are not considered to be settled in a fixed amount and can be exercised currently without restriction or right to defer. The warrant obligation was initially &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;measured at fair value using a Black-Scholes pricing model and is subsequently remeasured to fair value at each reporting date. Changes in the fair value (gains or losses) of the warrant obligation at the end of each period are recorded in the consolidated statement of loss. The Company determined the Tranche A warrant obligation qualified as a level 2 fair value liability as inputs to the fair value measurement are derived principally from or corroborated by observable market data by correlation or other means. Refer to Note 26 &#x2014; &#x201c;Financial instruments and risks&#x201d; for the current fair value amount for the warrant obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ii) The term loans were initially recorded at their amortized costs of $15.0&#160;million and $35.0&#160;million for Tranches A and B, respectively, less any capitalized expenses and fees payable upon the issuance (&#x201c;transaction costs&#x201d;) and after allocating a portion of the proceeds to the fair value of the warrant obligation. The loans are presented as a long-term financial liability in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the allocation of transaction costs in accordance with IFRS 9 and determined the allocation to warrants was immaterial, as such the Company allocated the total amount of the transaction costs to the term loan. The transaction costs are presented net of the term loan on the consolidated balance sheet. The transaction costs are amortized as non-cash interest expense recorded to the consolidated statement of loss as the difference between the stated interest rate and the EIR. The EIR was determined upon the initial draw down at 15.2% and 12.4% for Tranches A and B, respectively, and reassessed based on changes in the variable interest rate from the Perceptive Credit Agreement. As of December 31, 2025 and 2024 the EIR was 12.1% and 14.8%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company calculated the fair value of the warrant obligation on issuance using the Black-Scholes pricing model. The warrant obligation for Tranche A was recorded at an initial fair value of $0.7&#160;million on May 2, 2024 and the warrant obligation for Tranche B was recorded at an initial fair value of $0.5&#160;million on June 25, 2025. Key inputs for the valuation of the warrant obligation upon issuance were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:34.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.425%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.495%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.674%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 25, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of May 2, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.08&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.24%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.53%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility (annualized)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.77%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Black-Scholes value in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.06&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company remeasures the fair value of the warrant obligation on a quarterly basis. Key inputs for the remeasurement of the Tranche A warrant obligation were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.475%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.113%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of  December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of  December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.67&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.07&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.01%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.51%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.39%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.52%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Black-Scholes value in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.22&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Key inputs for the remeasurement of the Tranche B warrant obligation were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:34.059%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.146%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.495%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of  December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.67&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.48&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Black-Scholes value in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.71&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tranche A was recorded at an initial amortized cost of $13.3&#160;million on May 2, 2024. This amount represents the residual amount of the $15.0&#160;million draw down after allocating $0.7&#160;million for the fair value of the warrant obligation and the $1.1&#160;million of transaction costs to be amortized as interest expense over the life of the loan. Tranche B was recorded at an initial amortized cost of $34.1&#160;million on June 25, 2025. This amount represents the residual amount of the $35.0&#160;million draw down after allocating $0.5&#160;million for the fair value of the warrant obligation and the $0.4&#160;million of transaction costs to be amortized as interest expense over the life of the loan. The following table presents the allocation of the loan proceeds and any movements in the liability for the year ended December 31, 2025, (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.997%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.097%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross proceeds from Tranche A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Proceeds net of transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,930&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant obligation at issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross proceeds from Tranche B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(437)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Proceeds net of transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34,563&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant obligation at issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,733&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the movements in the warrant obligation liability for the year ended December 31, 2025, (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.030%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.629%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.833%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Warrant Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of warrants from Tranche A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of warrants from Tranche B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revolving credit facility&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 23, 2024 the Company terminated its existing credit agreement with Credit Suisse SA for up to CHF 5.0&#160;million ($5.5&#160;million). Additionally, the Company entered into a new credit agreement with Credit Suisse SA for up to CHF 0.1&#160;million ($0.1&#160;million) to be used for cash credits, contingent liabilities, or as margin for OTC derivative transactions. Borrowings under the new credit agreement will bear interest at a rate to be established between the Company and Credit Suisse SA at the time of each draw down. On November 27, 2025 the Company terminated this CHF 0.1&#160;million facility ($0.1&#160;million). On February 20, 2025 the Company entered into a new credit agreement with UBS Switzerland AG for up to CHF 0.3&#160;million ($0.3&#160;million), intended solely for the issuance of bank guarantees. As of December 31, 2025 and 2024, the Company had no borrowings outstanding under these credit facilities.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfBorrowingsExplanatory>
    <soph:BorrowingFacilitiesMaximumBorrowingCapacity contextRef="c-403" decimals="INF" id="f-1757" unitRef="usd">50000000.0</soph:BorrowingFacilitiesMaximumBorrowingCapacity>
    <soph:BorrowingFacilitiesMaximumBorrowingCapacity contextRef="c-404" decimals="INF" id="f-1758" unitRef="usd">15000000.0</soph:BorrowingFacilitiesMaximumBorrowingCapacity>
    <soph:BorrowingFacilitiesMaximumBorrowingCapacity contextRef="c-405" decimals="INF" id="f-1759" unitRef="usd">35000000.0</soph:BorrowingFacilitiesMaximumBorrowingCapacity>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="c-406"
      decimals="2"
      id="f-1760"
      unitRef="number">0.04</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="c-407"
      decimals="4"
      id="f-1761"
      unitRef="number">0.0625</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="c-408"
      decimals="4"
      id="f-1762"
      unitRef="number">0.0925</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <soph:BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets contextRef="c-403" id="f-1763">P180D</soph:BorrowingFacilitiesPrepaymentTermsBusinessThresholdDaysForRightToReinvestCertainProceedsInAssets>
    <soph:BorrowingsCovenantCashAndCashEquivalentsMinimum contextRef="c-403" decimals="-5" id="f-1764" unitRef="usd">3000000.0</soph:BorrowingsCovenantCashAndCashEquivalentsMinimum>
    <soph:BorrowingsCovenantRevenueFromContractsWithCustomersMinimum contextRef="c-409" decimals="-5" id="f-1765" unitRef="usd">67400000</soph:BorrowingsCovenantRevenueFromContractsWithCustomersMinimum>
    <soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-410"
      decimals="INF"
      id="f-1766"
      unitRef="shares">400000</soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights>
    <soph:ExercisePriceOfWarrantRights
      contextRef="c-410"
      decimals="4"
      id="f-1767"
      unitRef="usdPerShare">4.9992</soph:ExercisePriceOfWarrantRights>
    <soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-411"
      decimals="INF"
      id="f-1768"
      unitRef="shares">200000</soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights>
    <soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-412"
      decimals="INF"
      id="f-1769"
      unitRef="shares">200000</soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights>
    <soph:ProceedsFromBorrowings contextRef="c-413" decimals="-5" id="f-1770" unitRef="usd">35000000.0</soph:ProceedsFromBorrowings>
    <soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-414"
      decimals="INF"
      id="f-1771"
      unitRef="shares">200000</soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights>
    <soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity contextRef="c-415" decimals="-5" id="f-1772" unitRef="usd">25000000.0</soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity>
    <soph:BorrowingFacilitiesMaximumBorrowingCapacity contextRef="c-416" decimals="INF" id="f-1773" unitRef="usd">12500000</soph:BorrowingFacilitiesMaximumBorrowingCapacity>
    <soph:BorrowingFacilitiesMaximumBorrowingCapacity contextRef="c-417" decimals="INF" id="f-1774" unitRef="usd">12500000</soph:BorrowingFacilitiesMaximumBorrowingCapacity>
    <soph:BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger contextRef="c-418" decimals="-5" id="f-1775" unitRef="usd">85000000.0</soph:BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="c-419"
      decimals="2"
      id="f-1776"
      unitRef="number">0.04</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="c-420"
      decimals="4"
      id="f-1777"
      unitRef="number">0.0625</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <soph:WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-421"
      decimals="INF"
      id="f-1778"
      unitRef="shares">75000</soph:WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights>
    <soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-422"
      decimals="INF"
      id="f-1779"
      unitRef="shares">100000</soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights>
    <soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-423"
      decimals="INF"
      id="f-1780"
      unitRef="shares">100000</soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights>
    <soph:NumberOfFinancialInstruments
      contextRef="c-424"
      decimals="INF"
      id="f-1781"
      unitRef="instrument">2</soph:NumberOfFinancialInstruments>
    <soph:ProceedsFromBorrowings contextRef="c-424" decimals="-5" id="f-1782" unitRef="usd">15000000.0</soph:ProceedsFromBorrowings>
    <soph:ProceedsFromBorrowings contextRef="c-413" decimals="-5" id="f-1783" unitRef="usd">35000000.0</soph:ProceedsFromBorrowings>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c-404"
      decimals="3"
      id="f-1784"
      unitRef="number">0.152</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c-405"
      decimals="3"
      id="f-1785"
      unitRef="number">0.124</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c-425"
      decimals="3"
      id="f-1786"
      unitRef="number">0.121</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:BorrowingsInterestRate
      contextRef="c-426"
      decimals="3"
      id="f-1787"
      unitRef="number">0.148</ifrs-full:BorrowingsInterestRate>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-427" decimals="-5" id="f-1788" unitRef="usd">700000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-428" decimals="-5" id="f-1789" unitRef="usd">500000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory contextRef="c-1" id="f-1790">Key inputs for the valuation of the warrant obligation upon issuance were as follows:&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:34.006%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.425%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.495%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.674%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of June 25, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of May 2, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.08&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.24%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.53%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility (annualized)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.98%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.77%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Black-Scholes value in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.06&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company remeasures the fair value of the warrant obligation on a quarterly basis. Key inputs for the remeasurement of the Tranche A warrant obligation were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.475%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.113%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of  December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of  December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.67&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.07&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.01%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.51%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.39%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72.52%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.33&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Black-Scholes value in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.35&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.22&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Key inputs for the remeasurement of the Tranche B warrant obligation were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:34.059%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.146%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.495%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of  December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$5.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$4.67&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.02%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.48&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Black-Scholes value in USD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.71&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-429"
      decimals="2"
      id="f-1791"
      unitRef="number">5.00</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-430"
      decimals="2"
      id="f-1792"
      unitRef="number">5.00</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-431"
      decimals="2"
      id="f-1793"
      unitRef="number">3.17</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-432"
      decimals="2"
      id="f-1794"
      unitRef="number">5.08</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-433"
      decimals="4"
      id="f-1795"
      unitRef="number">0.0424</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-434"
      decimals="4"
      id="f-1796"
      unitRef="number">0.0453</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-435"
      decimals="4"
      id="f-1797"
      unitRef="number">0.7298</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-436"
      decimals="4"
      id="f-1798"
      unitRef="number">0.7177</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-437"
      decimals="INF"
      id="f-1799"
      unitRef="number">10</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-438"
      decimals="INF"
      id="f-1800"
      unitRef="number">10</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-439"
      decimals="INF"
      id="f-1801"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-440"
      decimals="INF"
      id="f-1802"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-441"
      decimals="2"
      id="f-1803"
      unitRef="number">2.37</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-442"
      decimals="2"
      id="f-1804"
      unitRef="number">4.06</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-443"
      decimals="2"
      id="f-1805"
      unitRef="number">5.00</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-444"
      decimals="2"
      id="f-1806"
      unitRef="number">5.00</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-445"
      decimals="2"
      id="f-1807"
      unitRef="number">4.67</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-446"
      decimals="2"
      id="f-1808"
      unitRef="number">3.07</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-447"
      decimals="4"
      id="f-1809"
      unitRef="number">0.0401</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-448"
      decimals="4"
      id="f-1810"
      unitRef="number">0.0451</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-449"
      decimals="4"
      id="f-1811"
      unitRef="number">0.6839</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-450"
      decimals="4"
      id="f-1812"
      unitRef="number">0.7252</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-451"
      decimals="2"
      id="f-1813"
      unitRef="number">8.34</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-452"
      decimals="2"
      id="f-1814"
      unitRef="number">9.33</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-453"
      decimals="INF"
      id="f-1815"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-454"
      decimals="INF"
      id="f-1816"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-455"
      decimals="2"
      id="f-1817"
      unitRef="number">3.35</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-456"
      decimals="2"
      id="f-1818"
      unitRef="number">2.22</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-457"
      decimals="2"
      id="f-1819"
      unitRef="number">5.00</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-458"
      decimals="2"
      id="f-1820"
      unitRef="number">4.67</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-459"
      decimals="4"
      id="f-1821"
      unitRef="number">0.0402</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-460"
      decimals="4"
      id="f-1822"
      unitRef="number">0.7610</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-461"
      decimals="2"
      id="f-1823"
      unitRef="number">9.48</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-462"
      decimals="INF"
      id="f-1824"
      unitRef="number">0</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:SignificantUnobservableInputLiabilities
      contextRef="c-463"
      decimals="2"
      id="f-1825"
      unitRef="number">3.71</ifrs-full:SignificantUnobservableInputLiabilities>
    <ifrs-full:Borrowings contextRef="c-404" decimals="-5" id="f-1826" unitRef="usd">13300000</ifrs-full:Borrowings>
    <soph:ProceedsFromBorrowings contextRef="c-424" decimals="-5" id="f-1827" unitRef="usd">15000000.0</soph:ProceedsFromBorrowings>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-427" decimals="-5" id="f-1828" unitRef="usd">700000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:BorrowingCostsIncurred contextRef="c-424" decimals="-5" id="f-1829" unitRef="usd">1100000</ifrs-full:BorrowingCostsIncurred>
    <ifrs-full:Borrowings contextRef="c-464" decimals="-5" id="f-1830" unitRef="usd">34100000</ifrs-full:Borrowings>
    <soph:ProceedsFromBorrowings contextRef="c-413" decimals="-5" id="f-1831" unitRef="usd">35000000.0</soph:ProceedsFromBorrowings>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-428" decimals="-5" id="f-1832" unitRef="usd">500000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:BorrowingCostsIncurred contextRef="c-413" decimals="-5" id="f-1833" unitRef="usd">400000</ifrs-full:BorrowingCostsIncurred>
    <ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory contextRef="c-1" id="f-1834">The following table presents the allocation of the loan proceeds and any movements in the liability for the year ended December 31, 2025, (in USD thousands):&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.606%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.997%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.097%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross proceeds from Tranche A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,070)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Proceeds net of transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,930&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant obligation at issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross proceeds from Tranche B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(437)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Proceeds net of transaction costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;34,563&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant obligation at issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency translation adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47,733&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory>
    <ifrs-full:Borrowings contextRef="c-465" decimals="-3" id="f-1835" unitRef="usd">0</ifrs-full:Borrowings>
    <soph:ProceedsFromBorrowings contextRef="c-466" decimals="-3" id="f-1836" unitRef="usd">15000000</soph:ProceedsFromBorrowings>
    <ifrs-full:BorrowingCostsIncurred contextRef="c-467" decimals="-3" id="f-1837" unitRef="usd">1070000</ifrs-full:BorrowingCostsIncurred>
    <soph:ProceedsFromBorrowingsNetOfCostsIncurred contextRef="c-466" decimals="-3" id="f-1838" unitRef="usd">13930000</soph:ProceedsFromBorrowingsNetOfCostsIncurred>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-426" decimals="-3" id="f-1839" unitRef="usd">656000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:InterestExpenseOnBorrowings contextRef="c-466" decimals="-3" id="f-1840" unitRef="usd">1290000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="c-466" decimals="-3" id="f-1841" unitRef="usd">1152000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <soph:BorrowingsForeignCurrencyTranslationGainLoss contextRef="c-466" decimals="-3" id="f-1842" unitRef="usd">-175000</soph:BorrowingsForeignCurrencyTranslationGainLoss>
    <ifrs-full:Borrowings contextRef="c-426" decimals="-3" id="f-1843" unitRef="usd">13237000</ifrs-full:Borrowings>
    <soph:ProceedsFromBorrowings contextRef="c-409" decimals="-3" id="f-1844" unitRef="usd">35000000</soph:ProceedsFromBorrowings>
    <ifrs-full:BorrowingCostsIncurred contextRef="c-468" decimals="-3" id="f-1845" unitRef="usd">437000</ifrs-full:BorrowingCostsIncurred>
    <soph:ProceedsFromBorrowingsNetOfCostsIncurred contextRef="c-409" decimals="-3" id="f-1846" unitRef="usd">34563000</soph:ProceedsFromBorrowingsNetOfCostsIncurred>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-425" decimals="-3" id="f-1847" unitRef="usd">474000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:InterestExpenseOnBorrowings contextRef="c-409" decimals="-3" id="f-1848" unitRef="usd">3891000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities contextRef="c-409" decimals="-3" id="f-1849" unitRef="usd">3521000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <soph:BorrowingsForeignCurrencyTranslationGainLoss contextRef="c-409" decimals="-3" id="f-1850" unitRef="usd">37000</soph:BorrowingsForeignCurrencyTranslationGainLoss>
    <ifrs-full:Borrowings contextRef="c-425" decimals="-3" id="f-1851" unitRef="usd">47733000</ifrs-full:Borrowings>
    <soph:DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock contextRef="c-1" id="f-1852">&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the movements in the warrant obligation liability for the year ended December 31, 2025, (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.030%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.389%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.629%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.833%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Warrant Obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of January 1, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of warrants from Tranche A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Issuance of warrants from Tranche B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,412&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutWarrantLiabilityTextBlock>
    <ifrs-full:CurrentWarrantLiability contextRef="c-469" decimals="-3" id="f-1853" unitRef="usd">0</ifrs-full:CurrentWarrantLiability>
    <soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-469"
      decimals="INF"
      id="f-1854"
      unitRef="shares">0</soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights>
    <soph:ProceedsFromWarrantLiability contextRef="c-470" decimals="-3" id="f-1855" unitRef="usd">656000</soph:ProceedsFromWarrantLiability>
    <soph:WarrantsOrRightsNumberOfWarrantsIssued
      contextRef="c-470"
      decimals="INF"
      id="f-1856"
      unitRef="shares">200000</soph:WarrantsOrRightsNumberOfWarrantsIssued>
    <soph:AdjustmentsForFairValueOfWarrantLiability contextRef="c-470" decimals="-3" id="f-1857" unitRef="usd">-370000</soph:AdjustmentsForFairValueOfWarrantLiability>
    <soph:WarrantLiabilityForeignExchangeGainLoss contextRef="c-470" decimals="-3" id="f-1858" unitRef="usd">-158000</soph:WarrantLiabilityForeignExchangeGainLoss>
    <ifrs-full:CurrentWarrantLiability contextRef="c-471" decimals="-3" id="f-1859" unitRef="usd">444000</ifrs-full:CurrentWarrantLiability>
    <soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-471"
      decimals="INF"
      id="f-1860"
      unitRef="shares">200000</soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights>
    <soph:ProceedsFromWarrantLiability contextRef="c-472" decimals="-3" id="f-1861" unitRef="usd">474000</soph:ProceedsFromWarrantLiability>
    <soph:WarrantsOrRightsNumberOfWarrantsIssued
      contextRef="c-470"
      decimals="INF"
      id="f-1862"
      unitRef="shares">200000</soph:WarrantsOrRightsNumberOfWarrantsIssued>
    <soph:AdjustmentsForFairValueOfWarrantLiability contextRef="c-472" decimals="-3" id="f-1863" unitRef="usd">497000</soph:AdjustmentsForFairValueOfWarrantLiability>
    <soph:WarrantLiabilityForeignExchangeGainLoss contextRef="c-472" decimals="-3" id="f-1864" unitRef="usd">3000</soph:WarrantLiabilityForeignExchangeGainLoss>
    <ifrs-full:CurrentWarrantLiability contextRef="c-473" decimals="-3" id="f-1865" unitRef="usd">1412000</ifrs-full:CurrentWarrantLiability>
    <soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-473"
      decimals="INF"
      id="f-1866"
      unitRef="shares">400000</soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights>
    <soph:TerminationOfBorrowings contextRef="c-474" decimals="-5" id="f-1867" unitRef="chf">5000000.0</soph:TerminationOfBorrowings>
    <soph:TerminationOfBorrowings contextRef="c-474" decimals="-5" id="f-1868" unitRef="usd">5500000</soph:TerminationOfBorrowings>
    <soph:BorrowingFacilitiesMaximumBorrowingCapacity contextRef="c-475" decimals="-5" id="f-1869" unitRef="usd">100000</soph:BorrowingFacilitiesMaximumBorrowingCapacity>
    <soph:BorrowingFacilitiesMaximumBorrowingCapacity contextRef="c-475" decimals="-5" id="f-1870" unitRef="usd">100000</soph:BorrowingFacilitiesMaximumBorrowingCapacity>
    <soph:TerminationOfBorrowings contextRef="c-476" decimals="-5" id="f-1871" unitRef="chf">100000</soph:TerminationOfBorrowings>
    <soph:TerminationOfBorrowings contextRef="c-476" decimals="-5" id="f-1872" unitRef="usd">100000</soph:TerminationOfBorrowings>
    <soph:BorrowingFacilitiesMaximumBorrowingCapacity contextRef="c-477" decimals="-5" id="f-1873" unitRef="chf">300000</soph:BorrowingFacilitiesMaximumBorrowingCapacity>
    <soph:BorrowingFacilitiesMaximumBorrowingCapacity contextRef="c-477" decimals="-5" id="f-1874" unitRef="usd">300000</soph:BorrowingFacilitiesMaximumBorrowingCapacity>
    <ifrs-full:Borrowings contextRef="c-478" decimals="-5" id="f-1875" unitRef="usd">0</ifrs-full:Borrowings>
    <ifrs-full:Borrowings contextRef="c-479" decimals="-5" id="f-1876" unitRef="usd">0</ifrs-full:Borrowings>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="c-1" id="f-1879">Related parties&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Related parties comprise the Company&#x2019;s executive officers and directors, including their affiliates, and any person that directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control, with the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Key management personnel comprised of six Executive Officers and Directors and six Non-Executive Directors for the year ended December 31, 2025. Key management personnel comprised of six Executive Officers and Directors and six Non-Executive Directors for the year ended December 31, 2024. Key management personnel comprised of six Executive Officers and Directors and seven Non-Executive Directors for the year ended December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation for key management and non-executive directors recognized during the year comprised (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and other short-term employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,786&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <soph:NumberOfExecutiveOfficers
      contextRef="c-1"
      decimals="INF"
      id="f-1880"
      unitRef="personnel">6</soph:NumberOfExecutiveOfficers>
    <soph:NumberOfNonExecutiveOfficers
      contextRef="c-1"
      decimals="INF"
      id="f-1881"
      unitRef="personnel">6</soph:NumberOfNonExecutiveOfficers>
    <soph:NumberOfExecutiveOfficers
      contextRef="c-4"
      decimals="INF"
      id="f-1882"
      unitRef="personnel">6</soph:NumberOfExecutiveOfficers>
    <soph:NumberOfNonExecutiveOfficers
      contextRef="c-4"
      decimals="INF"
      id="f-1883"
      unitRef="personnel">6</soph:NumberOfNonExecutiveOfficers>
    <soph:NumberOfExecutiveOfficers
      contextRef="c-5"
      decimals="INF"
      id="f-1884"
      unitRef="personnel">6</soph:NumberOfExecutiveOfficers>
    <soph:NumberOfNonExecutiveOfficers
      contextRef="c-5"
      decimals="INF"
      id="f-1885"
      unitRef="personnel">7</soph:NumberOfNonExecutiveOfficers>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory contextRef="c-1" id="f-1886">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compensation for key management and non-executive directors recognized during the year comprised (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.627%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.051%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Salaries and other short-term employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,786&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15,059&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="c-1" decimals="-3" id="f-1887" unitRef="usd">5784000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="c-4" decimals="-3" id="f-1888" unitRef="usd">4206000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits contextRef="c-5" decimals="-3" id="f-1889" unitRef="usd">4234000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="c-1" decimals="-3" id="f-1890" unitRef="usd">281000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="c-4" decimals="-3" id="f-1891" unitRef="usd">253000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits contextRef="c-5" decimals="-3" id="f-1892" unitRef="usd">228000</ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c-1" decimals="-3" id="f-1893" unitRef="usd">11935000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c-4" decimals="-3" id="f-1894" unitRef="usd">12327000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment contextRef="c-5" decimals="-3" id="f-1895" unitRef="usd">10597000</ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c-1" decimals="-3" id="f-1896" unitRef="usd">18000000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c-4" decimals="-3" id="f-1897" unitRef="usd">16786000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation contextRef="c-5" decimals="-3" id="f-1898" unitRef="usd">15059000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory contextRef="c-1" id="f-1899">Commitments and contingencies&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has no commitments for future lease payments under short-term leases not recognize&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;d on the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;balance sheet as of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2025 and 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a minimum purchase agreement with a vendor related to computational and hosting-related costs. As part of the agreement, the Company has a total minimum commitment of approximately $80.9&#160;million from the period beginning November 1, 2022 through October 31, 2029 and an additional one-year grace period to meet the minimum commitment by October 31, 2030. As of December 31, 2025 and 2024, the Company has remaining commitments of $58.2 million and $56.9 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and 2024 the Company had&#160;no&#160;contingent assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company is regularly subject to lawsuits, claims, arbitration proceedings, administrative actions and other legal and regulatory proceedings involving intellectual property disputes, commercial disputes, competition and other matters, and the Company may become subject to additional types of lawsuits, claims, arbitration proceedings, administrative actions, government investigations and legal and regulatory proceedings in the future. As of December 31, 2025 and 2024, the Company has concluded that losses are not probable and no provisions have been recorded.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Guardant Health&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In 2025 Guardant Health ("Guardant") filed suit against the Company in multiple jurisdictions. Guardant filed suit in the U.K., and in the EU at the Unified Patent Court (the &#x201c;UPC&#x201d;) in Paris, alleging that the Company&#x2019;s MSK-Access liquid biopsy test infringes certain of their patents and seeking remedies, including unspecified monetary damages and injunctive relief. In January 2026, the UPC Paris Local Division issued a final order rejecting Guardant's application for provisional measures and ordered Guardant to pay an interim award of costs of &#x20ac;400,000 ($470,080), which Guardant has appealed. The U.K. proceedings remain pending. The Company continues to defend itself against these claims.  As of December 31, 2025, the Company has concluded that losses related to this matter are not probable and no provision has been recorded.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory>
    <soph:FutureLeasePaymentsUnderShortTermLeasesNotRecognized contextRef="c-6" decimals="INF" id="f-1900" unitRef="usd">0</soph:FutureLeasePaymentsUnderShortTermLeasesNotRecognized>
    <soph:FutureLeasePaymentsUnderShortTermLeasesNotRecognized contextRef="c-3" decimals="INF" id="f-1901" unitRef="usd">0</soph:FutureLeasePaymentsUnderShortTermLeasesNotRecognized>
    <ifrs-full:ContractualCapitalCommitments contextRef="c-481" decimals="-5" id="f-1902" unitRef="usd">80900000</ifrs-full:ContractualCapitalCommitments>
    <ifrs-full:CapitalCommitments contextRef="c-3" decimals="-5" id="f-1903" unitRef="usd">58200000</ifrs-full:CapitalCommitments>
    <ifrs-full:CapitalCommitments contextRef="c-6" decimals="-5" id="f-1904" unitRef="usd">56900000</ifrs-full:CapitalCommitments>
    <ifrs-full:EstimatedFinancialEffectOfContingentAssets contextRef="c-3" decimals="INF" id="f-1905" unitRef="usd">0</ifrs-full:EstimatedFinancialEffectOfContingentAssets>
    <ifrs-full:EstimatedFinancialEffectOfContingentAssets contextRef="c-6" decimals="INF" id="f-1906" unitRef="usd">0</ifrs-full:EstimatedFinancialEffectOfContingentAssets>
    <ifrs-full:LossesOnLitigationSettlements contextRef="c-482" decimals="-3" id="f-1907" unitRef="eur">400000</ifrs-full:LossesOnLitigationSettlements>
    <ifrs-full:LossesOnLitigationSettlements contextRef="c-482" decimals="0" id="f-1908" unitRef="usd">470080</ifrs-full:LossesOnLitigationSettlements>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="c-1" id="f-1909">Financial instruments and risks&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds the following financial instruments (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.105%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets at amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other financial non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial assets at amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87,285&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;88,656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets at fair value through statement of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87,285&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;88,656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities at amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial liabilities at amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92,716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities at fair value through statement of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;94,128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48,911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s exposure to various risks associated with the financial instruments is discussed below in &#x201c;Financial risk management.&#x201d; The maximum exposure to credit risk at the end of the reporting period is the carrying amount of each class of financial assets mentioned above. See Note 12 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x201c;Accounts receivable&#x201d; for expected credit loss provisions on accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2025, the Company signed a stock purchase and subscription agreement to acquire a non-controlling minority equity interest in A.D.A.M. Innovations, formerly known as Genesis Healthcare, in two tranches totaling $2.0&#160;million. The Company acquired shares totaling $0.5&#160;million in September 2025 and shares totaling $1.5&#160;million in October 2025. These financial assets are initially measured at fair value and subsequently re-measured at fair value at each reporting date. Changes in fair values for these financial assets are recorded through profit or loss in accordance with IFRS 9 Financial Instruments. As of December 31, 2025 purchase price approximated fair value and no changes in fair value had been recorded in the Consolidated Statements of Loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair value measurement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2025 and 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the carrying amount was a reasonable approximation of fair value for the following financial assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial assets&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Other non-current assets&#x2014;lease deposits &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Accounts payable&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt"&gt;Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair value measurement methodology&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures financial instruments at fair value at each balance sheet date. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either in the principal market for the asset or liability or, in the absence of a principal market, in the most advantageous market for the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A fair value measurement of a non-financial asset takes into account a market participant&#x2019;s ability to generate econo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;mic benefits by using the asset or by sell&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ing it to another market participant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses valuation techniques to measure fair value maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All assets and liabilities for which fair value is measured or disclosed in the consolidated financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1&#x2014;Quoted (unadjusted) market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2&#x2014;Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3&#x2014;Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For assets and liabilities that are recognized in the consolidated financial statements at fair value on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to the fair value measurement as a whole) at the end of each reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management determines the policies and procedures for both recurring fair value measurement and for non-recurring measurement with the involvement of experts and external consultants when needed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds money market funds which are classified as cash equivalents which are measured as a level 1 valuation. Refer to Note 11 &#x2013; &#x201c;Cash and cash equivalents.&#x201d; The Company also has warrant obligations related to the Perceptive Credit Agreement, which are measured as a level 2 valuation. Refer to Note 23 &#x2014; &#x201c;Borrowings&#x201d;. The Company also holds a minority equity interest in A.D.A.M. Innovations, which is measured as a level 2 valuation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recurring fair-value measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2025 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;Equity Investments: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Warrant obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perceptive Credit Holdings warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2024 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Warrant obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perceptive Credit Holdings warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;474&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2025 and 2024 there were no significant changes in the business or economic circumstances that affect the fair value of the Company&#x2019;s financial assets and financial liabilities. There were also&#160;no&#160;transfers between categories.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Financial risk management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior management reg&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ularly reviews th&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e Company&#x2019;s cash forecast and related risks. They also perform the risk assessment, define any necessary measures and ensure the monitoring of the internal control system.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s principal financial liabilities include borrowings and accounts payable. The Company&#x2019;s principal financial assets include cash and cash equivalents and accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the course of its business, the Company is exposed to a number of financial risks including credit and counterparty risk, funding and liquidity risk, and market risk (i.e. foreign currency risk and interest rate risk). This note presents the Company&#x2019;s objectives, policies, and processes for managing these risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit and counterparty risk management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Company is exposed to credit risk from its operating activities, primarily accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concentration risk arises when a number of counterparties are engaged in similar business activities, or activities in the same geographical region, or have economic features that would cause their ability to meet contractual obligations to be similarly affected by changes in economic, political, or other conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s policy with regard to assessing and providing for expected credit losses on accounts receivable is set out in Note &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x201c;Accounts receivable.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit risk from balances with banks and financial institutions is managed by the Company&#x2019;s treasury department in accordance with the Company&#x2019;s policy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial transactions are predominantly entered into with investment grade financial institutions and in principle the Company requires a minimum long-term rating of&#160;A3/A-&#160;for its cash investments and term deposits. The Company may deviate from this requirement from time to time for operational reasons. The highest exposure to a single financial counterparty within cash and cash equivalents and term deposits amounted to $24.4 million and $26.1 million as of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2025 and 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&#160;non-current&#160;financial assets include cash deposits for leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Funding and liquidity risk management&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Funding and liquidity risk is the risk that a company may encounter difficulties in meeting its obligations associated with financial liabilities that are settled by delivering cash or other financial assets. Such risk may result from inadequate market depth or disruption or refinancing problems.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company views equity funding as its primary source of liquidity only partly complemented with revenue generated from the sale of the platform, applications, products, and services and borrowings. The Company has &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$50.0&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of outstanding term loans under the Perceptive Credit Agreement, see Note 23 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x201c;Borrowings&#x201d; fo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;r additional information.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Short term liquidity is managed based on projected cash flows. As&#160;of&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2025 and 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&#160;the&#160;Company&#x2019;s liquidity consisted of&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$70.3 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$80.2 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;in cash and cash equivalents, respectively. In 2025 the Company has sold, from its treasury shares, 228,238 ordinary shares for total gross proceeds of $1.1&#160;million under the Company&#x2019;s ATM program. In 2026, as described in Note 28 - &#x201c;Events After the Reporting Period&#x201d;, the Company has sold, from its treasury shares, 2,795,485 ordinary shares for total gross proceeds of $14.3&#160;million under the Company&#x2019;s ATM program and signed an amendment to the Perceptive Credit Agreement which provided an additional &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$25.0&#160;million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; available for draw. On the basis of the current operating performance and liquidity position, Board of Directors believes that the available cash balances will be sufficient for operating activities, working capital, interest, capital expenditures and scheduled debt repayments for the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarizes the maturity profile of the Company&#x2019;s financial liabilities based on contractual undiscounted cash flows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.855%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.111%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Within 1 year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Between 1 and 5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;After 5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total contractual liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92,716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37,813&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73,797&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;113,073&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.855%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.111%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Within 1 year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Between 1 and 5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;After 5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total contractual liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,798&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32,923&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,469&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;60,190&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has made adjustments to previously reported future maturities of borrowings as of December 31, 2024 to incorporate contractual cash interest payments of $1.6 million within 1 year and $5.4 million between 1 and 5 years to correct for immaterial misstatements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Market risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Market risk includes currency risk and interest rate risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Currency risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency risk is the risk that the fair value or future cash flows of an exposure will fluctuate because of changes in foreign exchange rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant exchange rates that have been applied to these consolidated financial statements are listed below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Spot rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD/CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.79208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.83064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.88064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD/EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.85092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.96530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.88644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.92455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.92478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD/GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.74179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.79870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.78267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD/BRL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.49560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.17360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.97372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sensitivity of the Company&#x2019;s income to possible changes in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;foreign exchange rates is measured at the local entity level as it depends on the functional currency of each entity. As of December 31, 2025, 2024, and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company was exposed principally to movements in four cross currency pairs. The sensitivity of the Company&#x2019;s loss before tax to such changes was as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in USD/CHF exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,101&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(562)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,034)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in EUR/CHF exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,020)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(508)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in GBP/CHF exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s exposure to foreign currency changes for all other currencies is not material. The Company does not use derivative financial instruments to hedge exposures and under no circumstances may enter into derivative instruments for speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sensitivity of the Company&#x2019;s reported equity or net assets to possible changes in foreign exchange rates is measured at the consolidated level as it depends on the presentation currency selected for the consolidated financial statements. Such effects are reported not in income but in the currency translation account within other reserves. As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2025 and 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the sensitivity of the Company&#x2019;s equity to such changes, measured against the USD, was as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.994%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in USD/CHF exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,561)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,520)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,520&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in USD/EUR exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(663)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,244&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,244)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in USD/GBP exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Interest rate risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s&#160;cash&#160;and cash&#160;equivalents&#160;are subject to market risk&#160;associated with&#160;interest rate&#160;fluctuations. Fixed rate securities may have their market value adversely affected due to a rise in interest rates.&#160;The C&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ompany concluded that fluctuations in the interest rate did not have a material impact on the Company&#x2019;s cash and cash equivalents balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2025 and 2024, the Company currently has $50.0&#160;million and $15.0&#160;million, respectively, of debt outstanding under the Perceptive Credit Agreement. Based on the terms of the Perceptive Credit Agreement, the monthly interest expense fluctuates based on the Term SOFR reference rate that is two business days prior to the first day of the preceding calendar month. Given the Company&#x2019;s outstanding debt under this agreement, the Company is subject to interest rate risk related to debt obligations if the SOFR were to move significantly. Based on the borrowings exposed to floating interest rates at year-end, an increase in interest rates of 100 basis points would cause an increase in cash interest costs on an annualized basis of $0.5&#160;million and $0.2&#160;million as of December 31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory contextRef="c-1" id="f-1910">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds the following financial instruments (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.282%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.105%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets at amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other financial non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial assets at amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87,285&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;88,656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets at fair value through statement of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87,285&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;88,656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities at amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial liabilities at amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92,716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities at fair value through statement of loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;94,128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48,911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory>
    <ifrs-full:FinancialAssets contextRef="c-483" decimals="-3" id="f-1911" unitRef="usd">70289000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-484" decimals="-3" id="f-1912" unitRef="usd">80226000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-485" decimals="-3" id="f-1913" unitRef="usd">15001000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-486" decimals="-3" id="f-1914" unitRef="usd">7436000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-487" decimals="-3" id="f-1915" unitRef="usd">1995000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-488" decimals="-3" id="f-1916" unitRef="usd">994000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-489" decimals="-3" id="f-1917" unitRef="usd">87285000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-490" decimals="-3" id="f-1918" unitRef="usd">88656000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-491" decimals="-3" id="f-1919" unitRef="usd">1977000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-492" decimals="-3" id="f-1920" unitRef="usd">0</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-3" decimals="-3" id="f-1921" unitRef="usd">87285000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets contextRef="c-6" decimals="-3" id="f-1922" unitRef="usd">88656000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialLiabilities contextRef="c-493" decimals="-3" id="f-1923" unitRef="usd">8960000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-494" decimals="-3" id="f-1924" unitRef="usd">5220000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-495" decimals="-3" id="f-1925" unitRef="usd">20736000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-496" decimals="-3" id="f-1926" unitRef="usd">13217000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-497" decimals="-3" id="f-1927" unitRef="usd">15287000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-498" decimals="-3" id="f-1928" unitRef="usd">16793000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-499" decimals="-3" id="f-1929" unitRef="usd">47733000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-500" decimals="-3" id="f-1930" unitRef="usd">13237000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-501" decimals="-3" id="f-1931" unitRef="usd">92716000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-502" decimals="-3" id="f-1932" unitRef="usd">48467000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-503" decimals="-3" id="f-1933" unitRef="usd">1412000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-504" decimals="-3" id="f-1934" unitRef="usd">444000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-3" decimals="-3" id="f-1935" unitRef="usd">94128000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities contextRef="c-6" decimals="-3" id="f-1936" unitRef="usd">48911000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c-505" decimals="-5" id="f-1937" unitRef="usd">2000000.0</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c-506" decimals="-5" id="f-1938" unitRef="usd">500000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss contextRef="c-507" decimals="-5" id="f-1939" unitRef="usd">1500000</ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss>
    <ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory contextRef="c-1" id="f-1941">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2025 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;Equity Investments: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Warrant obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perceptive Credit Holdings warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2024 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Warrant obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perceptive Credit Holdings warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;474&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory>
    <ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory contextRef="c-1" id="f-1940">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2025 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;Equity Investments: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Warrant obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perceptive Credit Holdings warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the Company&#x2019;s fair value hierarchy for its financial assets and financial liabilities that were measured at fair value on a recurring basis as of December 31, 2024 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.085%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.599%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Warrant obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perceptive Credit Holdings warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;474&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfFairValueMeasurementOfAssetsExplanatory>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-508" decimals="-3" id="f-1942" unitRef="usd">27528000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-509" decimals="-3" id="f-1943" unitRef="usd">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-510" decimals="-3" id="f-1944" unitRef="usd">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-511" decimals="-3" id="f-1945" unitRef="usd">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-512" decimals="-3" id="f-1946" unitRef="usd">1977000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-513" decimals="-3" id="f-1947" unitRef="usd">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-514" decimals="-3" id="f-1948" unitRef="usd">27528000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-515" decimals="-3" id="f-1949" unitRef="usd">1977000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-516" decimals="-3" id="f-1950" unitRef="usd">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-517" decimals="-3" id="f-1951" unitRef="usd">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-518" decimals="-3" id="f-1952" unitRef="usd">1412000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-519" decimals="-3" id="f-1953" unitRef="usd">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-514" decimals="-3" id="f-1954" unitRef="usd">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-515" decimals="-3" id="f-1955" unitRef="usd">1412000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-516" decimals="-3" id="f-1956" unitRef="usd">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-520" decimals="-3" id="f-1957" unitRef="usd">39586000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-521" decimals="-3" id="f-1958" unitRef="usd">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-522" decimals="-3" id="f-1959" unitRef="usd">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-523" decimals="-3" id="f-1960" unitRef="usd">39586000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-524" decimals="-3" id="f-1961" unitRef="usd">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="c-525" decimals="-3" id="f-1962" unitRef="usd">0</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-526" decimals="-3" id="f-1963" unitRef="usd">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-527" decimals="-3" id="f-1964" unitRef="usd">474000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-528" decimals="-3" id="f-1965" unitRef="usd">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-523" decimals="-3" id="f-1966" unitRef="usd">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-524" decimals="-3" id="f-1967" unitRef="usd">474000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="c-525" decimals="-3" id="f-1968" unitRef="usd">0</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:MaximumExposureToCreditRisk contextRef="c-529" decimals="-5" id="f-1969" unitRef="usd">24400000</ifrs-full:MaximumExposureToCreditRisk>
    <ifrs-full:MaximumExposureToCreditRisk contextRef="c-530" decimals="-5" id="f-1970" unitRef="usd">26100000</ifrs-full:MaximumExposureToCreditRisk>
    <soph:ProceedsFromBorrowings contextRef="c-480" decimals="-5" id="f-1971" unitRef="usd">50000000.0</soph:ProceedsFromBorrowings>
    <ifrs-full:CashAndCashEquivalents contextRef="c-3" decimals="-5" id="f-1972" unitRef="usd">70300000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-6" decimals="-5" id="f-1973" unitRef="usd">80200000</ifrs-full:CashAndCashEquivalents>
    <soph:NumberOfEquitySharesIssued
      contextRef="c-1"
      decimals="INF"
      id="f-1974"
      unitRef="shares">228238</soph:NumberOfEquitySharesIssued>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-1" decimals="-5" id="f-1975" unitRef="usd">1100000</ifrs-full:ProceedsFromIssuingShares>
    <soph:NumberOfEquitySharesIssued
      contextRef="c-531"
      decimals="INF"
      id="f-1976"
      unitRef="shares">2795485</soph:NumberOfEquitySharesIssued>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-531" decimals="-5" id="f-1977" unitRef="usd">14300000</ifrs-full:ProceedsFromIssuingShares>
    <soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity contextRef="c-415" decimals="-5" id="f-1978" unitRef="usd">25000000.0</soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity>
    <ifrs-full:DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory contextRef="c-1" id="f-1979">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below summarizes the maturity profile of the Company&#x2019;s financial liabilities based on contractual undiscounted cash flows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.855%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.111%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Within 1 year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Between 1 and 5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;After 5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total contractual liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;92,716&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37,813&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73,797&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;113,073&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.855%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.111%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Within 1 year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Between 1 and 5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;After 5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total contractual liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48,467&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,798&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32,923&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,469&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;60,190&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ifrs-full:DisclosureOfMaturityAnalysisOfUndiscountedCashOutflowsToRepurchaseDerecognisedFinancialAssetsExplanatory>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-189" decimals="-3" id="f-1980" unitRef="usd">15287000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-532" decimals="-3" id="f-1981" unitRef="usd">2992000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-533" decimals="-3" id="f-1982" unitRef="usd">11839000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-534" decimals="-3" id="f-1983" unitRef="usd">1463000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-3" decimals="-3" id="f-1984" unitRef="usd">16294000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows contextRef="c-189" decimals="-3" id="f-1985" unitRef="usd">8960000</ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows>
    <ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows contextRef="c-532" decimals="-3" id="f-1986" unitRef="usd">8960000</ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows>
    <ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows contextRef="c-533" decimals="-3" id="f-1987" unitRef="usd">0</ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows>
    <ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows contextRef="c-534" decimals="-3" id="f-1988" unitRef="usd">0</ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows>
    <ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows contextRef="c-3" decimals="-3" id="f-1989" unitRef="usd">8960000</ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows>
    <soph:AccruedExpensesUndiscountedCashFlows contextRef="c-189" decimals="-3" id="f-1990" unitRef="usd">20736000</soph:AccruedExpensesUndiscountedCashFlows>
    <soph:AccruedExpensesUndiscountedCashFlows contextRef="c-532" decimals="-3" id="f-1991" unitRef="usd">20736000</soph:AccruedExpensesUndiscountedCashFlows>
    <soph:AccruedExpensesUndiscountedCashFlows contextRef="c-533" decimals="-3" id="f-1992" unitRef="usd">0</soph:AccruedExpensesUndiscountedCashFlows>
    <soph:AccruedExpensesUndiscountedCashFlows contextRef="c-534" decimals="-3" id="f-1993" unitRef="usd">0</soph:AccruedExpensesUndiscountedCashFlows>
    <soph:AccruedExpensesUndiscountedCashFlows contextRef="c-3" decimals="-3" id="f-1994" unitRef="usd">20736000</soph:AccruedExpensesUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-189" decimals="-3" id="f-1995" unitRef="usd">47733000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-532" decimals="-3" id="f-1996" unitRef="usd">5125000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-533" decimals="-3" id="f-1997" unitRef="usd">61958000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-534" decimals="-3" id="f-1998" unitRef="usd">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-3" decimals="-3" id="f-1999" unitRef="usd">67083000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-189" decimals="-3" id="f-2000" unitRef="usd">92716000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-532" decimals="-3" id="f-2001" unitRef="usd">37813000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-533" decimals="-3" id="f-2002" unitRef="usd">73797000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-534" decimals="-3" id="f-2003" unitRef="usd">1463000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-3" decimals="-3" id="f-2004" unitRef="usd">113073000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-179" decimals="-3" id="f-2005" unitRef="usd">16793000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-535" decimals="-3" id="f-2006" unitRef="usd">2739000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-536" decimals="-3" id="f-2007" unitRef="usd">12518000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-537" decimals="-3" id="f-2008" unitRef="usd">4469000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:GrossLeaseLiabilities contextRef="c-6" decimals="-3" id="f-2009" unitRef="usd">19726000</ifrs-full:GrossLeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows contextRef="c-179" decimals="-3" id="f-2010" unitRef="usd">5220000</ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows>
    <ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows contextRef="c-535" decimals="-3" id="f-2011" unitRef="usd">5220000</ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows>
    <ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows contextRef="c-536" decimals="-3" id="f-2012" unitRef="usd">0</ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows>
    <ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows contextRef="c-537" decimals="-3" id="f-2013" unitRef="usd">0</ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows>
    <ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows contextRef="c-6" decimals="-3" id="f-2014" unitRef="usd">5220000</ifrs-full:TradeAndOtherPayablesUndiscountedCashFlows>
    <soph:AccruedExpensesUndiscountedCashFlows contextRef="c-179" decimals="-3" id="f-2015" unitRef="usd">13217000</soph:AccruedExpensesUndiscountedCashFlows>
    <soph:AccruedExpensesUndiscountedCashFlows contextRef="c-535" decimals="-3" id="f-2016" unitRef="usd">13217000</soph:AccruedExpensesUndiscountedCashFlows>
    <soph:AccruedExpensesUndiscountedCashFlows contextRef="c-536" decimals="-3" id="f-2017" unitRef="usd">0</soph:AccruedExpensesUndiscountedCashFlows>
    <soph:AccruedExpensesUndiscountedCashFlows contextRef="c-537" decimals="-3" id="f-2018" unitRef="usd">0</soph:AccruedExpensesUndiscountedCashFlows>
    <soph:AccruedExpensesUndiscountedCashFlows contextRef="c-6" decimals="-3" id="f-2019" unitRef="usd">13217000</soph:AccruedExpensesUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-179" decimals="-3" id="f-2020" unitRef="usd">13237000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-535" decimals="-3" id="f-2021" unitRef="usd">1622000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-536" decimals="-3" id="f-2022" unitRef="usd">20405000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-537" decimals="-3" id="f-2023" unitRef="usd">0</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:BankBorrowingsUndiscountedCashFlows contextRef="c-6" decimals="-3" id="f-2024" unitRef="usd">22027000</ifrs-full:BankBorrowingsUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-179" decimals="-3" id="f-2025" unitRef="usd">48467000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-535" decimals="-3" id="f-2026" unitRef="usd">22798000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-536" decimals="-3" id="f-2027" unitRef="usd">32923000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-537" decimals="-3" id="f-2028" unitRef="usd">4469000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows contextRef="c-6" decimals="-3" id="f-2029" unitRef="usd">60190000</ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows>
    <soph:BankBorrowingsInterestPaidUndiscountedCashFlows contextRef="c-535" decimals="-5" id="f-2030" unitRef="usd">1600000</soph:BankBorrowingsInterestPaidUndiscountedCashFlows>
    <soph:BankBorrowingsInterestPaidUndiscountedCashFlows contextRef="c-536" decimals="-5" id="f-2031" unitRef="usd">5400000</soph:BankBorrowingsInterestPaidUndiscountedCashFlows>
    <soph:DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock contextRef="c-1" id="f-2032">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant exchange rates that have been applied to these consolidated financial statements are listed below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.960%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Spot rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Average rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD/CHF&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.79208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.83064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.88064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD/EUR&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.85092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.96530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.88644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.92455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.92478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD/GBP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.74179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.79870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.78267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD/BRL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.49560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.17360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.39155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.97372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutForeignExchangeRatesTableTextBlock>
    <soph:ForeignExchangeSpotRate
      contextRef="c-3"
      decimals="5"
      id="f-2033"
      unitRef="usdPerCHF">0.79208</soph:ForeignExchangeSpotRate>
    <soph:ForeignExchangeSpotRate
      contextRef="c-6"
      decimals="5"
      id="f-2034"
      unitRef="usdPerCHF">0.90740</soph:ForeignExchangeSpotRate>
    <soph:AverageForeignExchangeRates
      contextRef="c-1"
      decimals="5"
      id="f-2035"
      unitRef="usdPerCHF">0.83064</soph:AverageForeignExchangeRates>
    <soph:AverageForeignExchangeRates
      contextRef="c-4"
      decimals="5"
      id="f-2036"
      unitRef="usdPerCHF">0.88064</soph:AverageForeignExchangeRates>
    <soph:AverageForeignExchangeRates
      contextRef="c-5"
      decimals="5"
      id="f-2037"
      unitRef="usdPerCHF">0.89855</soph:AverageForeignExchangeRates>
    <soph:ForeignExchangeSpotRate
      contextRef="c-3"
      decimals="5"
      id="f-2038"
      unitRef="usdPerEUR">0.85092</soph:ForeignExchangeSpotRate>
    <soph:ForeignExchangeSpotRate
      contextRef="c-6"
      decimals="5"
      id="f-2039"
      unitRef="usdPerEUR">0.96530</soph:ForeignExchangeSpotRate>
    <soph:AverageForeignExchangeRates
      contextRef="c-1"
      decimals="5"
      id="f-2040"
      unitRef="usdPerEUR">0.88644</soph:AverageForeignExchangeRates>
    <soph:AverageForeignExchangeRates
      contextRef="c-4"
      decimals="5"
      id="f-2041"
      unitRef="usdPerEUR">0.92455</soph:AverageForeignExchangeRates>
    <soph:AverageForeignExchangeRates
      contextRef="c-5"
      decimals="5"
      id="f-2042"
      unitRef="usdPerEUR">0.92478</soph:AverageForeignExchangeRates>
    <soph:ForeignExchangeSpotRate
      contextRef="c-3"
      decimals="5"
      id="f-2043"
      unitRef="usdPerGBP">0.74179</soph:ForeignExchangeSpotRate>
    <soph:ForeignExchangeSpotRate
      contextRef="c-6"
      decimals="5"
      id="f-2044"
      unitRef="usdPerGBP">0.79870</soph:ForeignExchangeSpotRate>
    <soph:AverageForeignExchangeRates
      contextRef="c-1"
      decimals="5"
      id="f-2045"
      unitRef="usdPerGBP">0.75887</soph:AverageForeignExchangeRates>
    <soph:AverageForeignExchangeRates
      contextRef="c-4"
      decimals="5"
      id="f-2046"
      unitRef="usdPerGBP">0.78267</soph:AverageForeignExchangeRates>
    <soph:AverageForeignExchangeRates
      contextRef="c-5"
      decimals="5"
      id="f-2047"
      unitRef="usdPerGBP">0.80428</soph:AverageForeignExchangeRates>
    <soph:ForeignExchangeSpotRate
      contextRef="c-3"
      decimals="5"
      id="f-2048"
      unitRef="usdPerBRL">5.49560</soph:ForeignExchangeSpotRate>
    <soph:ForeignExchangeSpotRate
      contextRef="c-6"
      decimals="5"
      id="f-2049"
      unitRef="usdPerBRL">6.17360</soph:ForeignExchangeSpotRate>
    <soph:AverageForeignExchangeRates
      contextRef="c-1"
      decimals="5"
      id="f-2050"
      unitRef="usdPerBRL">5.58911</soph:AverageForeignExchangeRates>
    <soph:AverageForeignExchangeRates
      contextRef="c-4"
      decimals="5"
      id="f-2051"
      unitRef="usdPerBRL">5.39155</soph:AverageForeignExchangeRates>
    <soph:AverageForeignExchangeRates
      contextRef="c-5"
      decimals="5"
      id="f-2052"
      unitRef="usdPerBRL">4.97372</soph:AverageForeignExchangeRates>
    <soph:DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock contextRef="c-1" id="f-2053">&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The sensitivity of the Company&#x2019;s income to possible changes in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;foreign exchange rates is measured at the local entity level as it depends on the functional currency of each entity. As of December 31, 2025, 2024, and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company was exposed principally to movements in four cross currency pairs. The sensitivity of the Company&#x2019;s loss before tax to such changes was as follows (in USD thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.996%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in USD/CHF exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,101&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(562)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,034)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in EUR/CHF exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,020)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(75)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(508)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in GBP/CHF exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutSensitivityOfLossBeforeTaxToChangesInForeignExchangeRatesTableTextBlock>
    <soph:SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent
      contextRef="c-538"
      decimals="INF"
      id="f-2054"
      unitRef="number">0.10</soph:SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-539" decimals="-3" id="f-2055" unitRef="usd">-2101000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-540" decimals="-3" id="f-2056" unitRef="usd">2101000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-541" decimals="-3" id="f-2057" unitRef="usd">562000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-542" decimals="-3" id="f-2058" unitRef="usd">-562000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-543" decimals="-3" id="f-2059" unitRef="usd">3034000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-544" decimals="-3" id="f-2060" unitRef="usd">-3034000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <soph:SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent
      contextRef="c-538"
      decimals="INF"
      id="f-2061"
      unitRef="number">0.10</soph:SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-545" decimals="-3" id="f-2062" unitRef="usd">1020000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-546" decimals="-3" id="f-2063" unitRef="usd">-1020000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-547" decimals="-3" id="f-2064" unitRef="usd">-75000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-548" decimals="-3" id="f-2065" unitRef="usd">75000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-549" decimals="-3" id="f-2066" unitRef="usd">508000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-550" decimals="-3" id="f-2067" unitRef="usd">-508000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <soph:SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent
      contextRef="c-538"
      decimals="INF"
      id="f-2068"
      unitRef="number">0.10</soph:SensitivityAnalysisForForeignExchangeGainLossReasonablyPossibleChangeInCurrencyVariablePercent>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-551" decimals="-3" id="f-2069" unitRef="usd">36000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-552" decimals="-3" id="f-2070" unitRef="usd">-36000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-553" decimals="-3" id="f-2071" unitRef="usd">25000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-554" decimals="-3" id="f-2072" unitRef="usd">-25000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-555" decimals="-3" id="f-2073" unitRef="usd">-23000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="c-556" decimals="-3" id="f-2074" unitRef="usd">23000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss>
    <soph:DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock contextRef="c-1" id="f-2075">As of &lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2025 and 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the sensitivity of the Company&#x2019;s equity to such changes, measured against the USD, was as follows (in USD thousands):&lt;/span&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.406%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.990%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.012%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.994%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in USD/CHF exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,561)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,561&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,520)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,520&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in USD/EUR exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(663)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,244&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,244)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase / (decrease) in USD/GBP exchange rate by&#160;10%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;/&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</soph:DisclosureOfDetailedInformationAboutSensitivityOfEquityToChangesInForeignExchangeRatesTableTextBlock>
    <soph:SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent
      contextRef="c-557"
      decimals="INF"
      id="f-2076"
      unitRef="number">0.10</soph:SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-558" decimals="-3" id="f-2077" unitRef="usd">-2561000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-559" decimals="-3" id="f-2078" unitRef="usd">2561000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-560" decimals="-3" id="f-2079" unitRef="usd">-1520000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-561" decimals="-3" id="f-2080" unitRef="usd">1520000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <soph:SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent
      contextRef="c-557"
      decimals="INF"
      id="f-2081"
      unitRef="number">0.10</soph:SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-562" decimals="-3" id="f-2082" unitRef="usd">-663000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-563" decimals="-3" id="f-2083" unitRef="usd">663000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-564" decimals="-3" id="f-2084" unitRef="usd">2244000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-565" decimals="-3" id="f-2085" unitRef="usd">-2244000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <soph:SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent
      contextRef="c-557"
      decimals="INF"
      id="f-2086"
      unitRef="number">0.10</soph:SensitivityAnalysisForReserveOfExchangeDifferencesOnTranslationReasonablyPossibleChangeInCurrencyVariablePercent>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-566" decimals="-3" id="f-2087" unitRef="usd">-95000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-567" decimals="-3" id="f-2088" unitRef="usd">95000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-568" decimals="-3" id="f-2089" unitRef="usd">61000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:ReserveOfExchangeDifferencesOnTranslation contextRef="c-569" decimals="-3" id="f-2090" unitRef="usd">-61000</ifrs-full:ReserveOfExchangeDifferencesOnTranslation>
    <ifrs-full:Borrowings contextRef="c-570" decimals="-5" id="f-2091" unitRef="usd">50000000.0</ifrs-full:Borrowings>
    <ifrs-full:Borrowings contextRef="c-571" decimals="-5" id="f-2092" unitRef="usd">15000000.0</ifrs-full:Borrowings>
    <soph:SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage
      contextRef="c-409"
      decimals="4"
      id="f-2093"
      unitRef="number">0.0100</soph:SensitivityAnalysisForBorrowingsReasonablyPossibleChangeInInterestRatePercentage>
    <soph:SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings contextRef="c-425" decimals="-5" id="f-2094" unitRef="usd">500000</soph:SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings>
    <soph:SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings contextRef="c-426" decimals="-5" id="f-2095" unitRef="usd">200000</soph:SensitivityAnalysisForBorrowingsInterestExpenseOnBorrowings>
    <soph:DisclosureOfCapitalManagementExplanatoryTextBlock contextRef="c-1" id="f-2096">Capital management&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers equity as equivalent to the IFRS Accounting Standards equity on the balance sheet (including share capital, share premium, and all other equity reserves attributable to the owners of the Company). Other reserves are comprised of comprehensive income/loss and share-based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary objective of the Company&#x2019;s capital management is to maximize shareholder value. The Board regularly reviews its shareholders&#x2019; return strategy. For the foreseeable future, the Board will maintain a capital structure that supports the Company&#x2019;s strategic objectives through managing funding and liquidity risks and optimizing shareholder return.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December 31, 2025 and 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company&#x2019;s cash and cash equivalents amounted to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$70.3 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$80.2 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As noted in Note 28 &#x2014; &#x201c;Events after the reporting date&#x201d;, the Company also has access to $25.0&#160;million available, of which $12.5&#160;million can be drawn immediately, under the Perceptive Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Board of Directors believes that the Company has sufficient financial resources to meet all of its obligations for at least the next twelve months. Moreover, the Company is not exposed to liquidity risk through requests for early repayment of loans.&lt;/span&gt;&lt;/div&gt;</soph:DisclosureOfCapitalManagementExplanatoryTextBlock>
    <ifrs-full:CashAndCashEquivalents contextRef="c-3" decimals="-5" id="f-2097" unitRef="usd">70300000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="c-6" decimals="-5" id="f-2098" unitRef="usd">80200000</ifrs-full:CashAndCashEquivalents>
    <soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity contextRef="c-415" decimals="-5" id="f-2099" unitRef="usd">25000000.0</soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity>
    <ifrs-full:UndrawnBorrowingFacilities contextRef="c-425" decimals="-5" id="f-2100" unitRef="usd">12500000</ifrs-full:UndrawnBorrowingFacilities>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="c-1" id="f-2101">Events after the reporting date&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has evaluated, for potential recognition and disclosure, events that occurred prior to the date at which the consolidated financial statements were authorized for issuance. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On January 23, 2026, the Company entered into an amendment (the &#x201c;2026 Amendment&#x201d;) to the Perceptive Credit Agreement. The 2026 Amendment provides for, among other things, $25.0&#160;million of additional term loan commitments consisting of (i) an additional $12.5&#160;million tranche of term loan commitments (&#x201c;Tranche C&#x201d;), which may be drawn subject to certain customary conditions, and (ii) an additional $12.5&#160;million tranche of term loan commitments (&#x201c;Tranche D&#x201d;), which may be drawn at such time as the Company&#x2019;s revenue for a trailing twelve-month period exceed $85.0&#160;million and otherwise subject to customary conditions. Tranche C and Tranche D, if drawn, will have terms and conditions consistent with the Company&#x2019;s existing term loans, will bear interest at rate per annum equal to Term SOFR (floored at 4% per annum) + 6.25% and will mature in 2029. In connection with the 2026 Amendment, the Company amended and restated the warrant certificate in order to issue to Perceptive Credit Holdings IV, LP the right to purchase an additional 75,000 ordinary shares, which right is exercisable immediately. The Warrant Certificate also grants Perceptive Credit Holdings IV, LP the right to purchase an additional (1) 100,000 ordinary shares, which right will become exercisable upon the Company&#x2019;s draw down of the Tranche C under the Perceptive Credit Agreement and (2) another 100,000 ordinary shares, which right will become exercisable upon the Company&#x2019;s draw down of the Tranche D under the Perceptive Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2026, through its ATM program, the Company has sold, from its treasury shares&lt;/span&gt;, 2,795,485 ordinary shares for total gross proceeds of $14.3&#160;million</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity contextRef="c-415" decimals="-5" id="f-2102" unitRef="usd">25000000.0</soph:BorrowingFacilitiesIncreaseDecreaseInMaximumBorrowingCapacity>
    <soph:BorrowingFacilitiesMaximumBorrowingCapacity contextRef="c-416" decimals="INF" id="f-2103" unitRef="usd">12500000</soph:BorrowingFacilitiesMaximumBorrowingCapacity>
    <soph:BorrowingFacilitiesMaximumBorrowingCapacity contextRef="c-417" decimals="INF" id="f-2104" unitRef="usd">12500000</soph:BorrowingFacilitiesMaximumBorrowingCapacity>
    <soph:BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger contextRef="c-418" decimals="-5" id="f-2105" unitRef="usd">85000000.0</soph:BorrowingFacilitiesThresholdTrailingTwelveMonthsRevenueThresholdAllowableProceedsFromBorrowingsTrigger>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="c-419"
      decimals="2"
      id="f-2106"
      unitRef="number">0.04</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <ifrs-full:BorrowingsAdjustmentToInterestRateBasis
      contextRef="c-420"
      decimals="4"
      id="f-2107"
      unitRef="number">0.0625</ifrs-full:BorrowingsAdjustmentToInterestRateBasis>
    <soph:WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-421"
      decimals="INF"
      id="f-2108"
      unitRef="shares">75000</soph:WarrantsOrRightsIncreaseDecreaseInNumberOfSharesCalledByWarrantsOrRights>
    <soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-422"
      decimals="INF"
      id="f-2109"
      unitRef="shares">100000</soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights>
    <soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights
      contextRef="c-423"
      decimals="INF"
      id="f-2110"
      unitRef="shares">100000</soph:WarrantsOrRightsNumberOfSharesCalledByWarrantsOrRights>
    <soph:NumberOfEquitySharesIssued
      contextRef="c-531"
      decimals="INF"
      id="f-2111"
      unitRef="shares">2795485</soph:NumberOfEquitySharesIssued>
    <ifrs-full:ProceedsFromIssuingShares contextRef="c-531" decimals="-5" id="f-2112" unitRef="usd">14300000</ifrs-full:ProceedsFromIssuingShares>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#f-336"
          xlink:label="f-336"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-332"
          xlink:label="f-332"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-374"
          xlink:label="f-374"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-309"
          xlink:label="f-309"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-320"
          xlink:label="f-320"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-335"
          xlink:label="f-335"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-342"
          xlink:label="f-342"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-326"
          xlink:label="f-326"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-327"
          xlink:label="f-327"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-344"
          xlink:label="f-344"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-347"
          xlink:label="f-347"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-371"
          xlink:label="f-371"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-392"
          xlink:label="f-392"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-317"
          xlink:label="f-317"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-393"
          xlink:label="f-393"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-398"
          xlink:label="f-398"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-318"
          xlink:label="f-318"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-308"
          xlink:label="f-308"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-329"
          xlink:label="f-329"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-324"
          xlink:label="f-324"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-333"
          xlink:label="f-333"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-354"
          xlink:label="f-354"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-299"
          xlink:label="f-299"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-362"
          xlink:label="f-362"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-390"
          xlink:label="f-390"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-395"
          xlink:label="f-395"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-348"
          xlink:label="f-348"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-323"
          xlink:label="f-323"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-384"
          xlink:label="f-384"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-368"
          xlink:label="f-368"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-300"
          xlink:label="f-300"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-306"
          xlink:label="f-306"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-353"
          xlink:label="f-353"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-389"
          xlink:label="f-389"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-396"
          xlink:label="f-396"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-338"
          xlink:label="f-338"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-360"
          xlink:label="f-360"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-312"
          xlink:label="f-312"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-381"
          xlink:label="f-381"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-372"
          xlink:label="f-372"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-351"
          xlink:label="f-351"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-314"
          xlink:label="f-314"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-311"
          xlink:label="f-311"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-297"
          xlink:label="f-297"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-357"
          xlink:label="f-357"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-365"
          xlink:label="f-365"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-366"
          xlink:label="f-366"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-315"
          xlink:label="f-315"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-386"
          xlink:label="f-386"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-399"
          xlink:label="f-399"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-359"
          xlink:label="f-359"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-350"
          xlink:label="f-350"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-377"
          xlink:label="f-377"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-321"
          xlink:label="f-321"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-356"
          xlink:label="f-356"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-296"
          xlink:label="f-296"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-363"
          xlink:label="f-363"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-378"
          xlink:label="f-378"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-341"
          xlink:label="f-341"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-345"
          xlink:label="f-345"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-369"
          xlink:label="f-369"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-375"
          xlink:label="f-375"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-330"
          xlink:label="f-330"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-339"
          xlink:label="f-339"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-383"
          xlink:label="f-383"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-380"
          xlink:label="f-380"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-303"
          xlink:label="f-303"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-305"
          xlink:label="f-305"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-302"
          xlink:label="f-302"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-387"
          xlink:label="f-387"
          xlink:type="locator"/>
        <link:footnote id="fn-1" xlink:label="fn-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Refer to &#x201c;Note 2&#x2014;Material Accounting Policies&#x2014;Statement of Cash Flows - Interest Classification&#x201d; for details on change in accounting policy. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-336"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-332"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-374"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-309"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-320"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-335"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-342"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-326"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-327"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-344"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-347"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-371"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-392"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-317"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-393"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-398"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-318"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-308"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-329"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-324"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-333"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-354"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-299"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-362"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-390"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-395"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-348"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-323"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-384"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-368"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-300"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-306"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-353"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-389"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-396"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-338"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-360"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-312"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-381"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-372"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-351"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-314"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-311"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-297"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-357"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-365"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-366"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-315"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-386"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-399"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-359"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-350"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-377"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-321"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-356"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-296"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-363"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-378"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-341"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-345"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-369"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-375"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-330"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-339"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-383"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-380"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-303"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-305"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-302"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-387"
          xlink:to="fn-1"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
